id|nct_id|name|downcase_name
5100|NCT03541707|TMS|tms
5583|NCT03538691|MDD|mdd
5700|NCT03538028|LAG-3|lag-3
5900|NCT03536884|PSO|pso
7837|NCT03524456|sms|sms
8719|NCT03519165|SVV|svv
9377|NCT03515291|MRI|mri
10120|NCT03510897|AKI|aki
10975|NCT03504982|QT/QTc|qt/qtc
11211|NCT03503604|mAb|mab
11827|NCT03499340|emotion|emotion
12330|NCT03496012|CHM|chm
13099|NCT03490903|VR|vr
13839|NCT03486054|Anemia|anemia
14341|NCT03482778|AYA|aya
15351|NCT03476057|NGS|ngs
15691|NCT03474120|POI|poi
17223|NCT03464708|HMB|hmb
17397|NCT03463564|MDI|mdi
18491|NCT03455699|GSV|gsv
18742|NCT03454243|AXL|axl
18848|NCT03453840|HIV|hiv
19972|NCT03446677|HIV|hiv
21736|NCT03436277|Obesity|obesity
21857|NCT03435536|kinetic|kinetic
22761|NCT03429868|PET|pet
23700|NCT03424356|LMA|lma
24871|NCT03417154|AML|aml
25196|NCT03415022|SAD|sad
25242|NCT03414671|apnea|apnea
25975|NCT03410134|MTA|mta
27271|NCT03401411|ICU|icu
27719|NCT03398434|D-dimer|d-dimer
28851|NCT03391869|LCT|lct
29332|NCT03388762|Banaba|banaba
29736|NCT03386110|MSM|msm
31102|NCT03377491|TTF|ttf
31420|NCT03375593|RCT|rct
33336|NCT03363581|Fat|fat
34333|NCT03356808|CAR-T|car-t
34465|NCT03356028|Trauma|trauma
35183|NCT03350828|CF|cf
36444|NCT03342976|ICT|ict
36682|NCT03341195|SMS|sms
38681|NCT03329079|men|men
39825|NCT03322046|CVD|cvd
42558|NCT03304314|ICP|icp
44681|NCT03290391|ART|art
44938|NCT03288597|SUVmax|suvmax
45980|NCT03282019|HOT|hot
46823|NCT03276611|artery|artery
46945|NCT03275688|VOC|voc
47638|NCT03271073|S1|s1
48206|NCT03267173|CEA|cea
48457|NCT03265444|MSA|msa
48583|NCT03264573|PRP|prp
49112|NCT03261284|INR|inr
53048|NCT03236181|Satiety|satiety
55672|NCT03219502|EEG|eeg
55807|NCT03219008|e-MBC|e-mbc
56729|NCT03213132|CBT|cbt
56992|NCT03211533|MRI|mri
57447|NCT03208244|HCV|hcv
59426|NCT03195712|BMI|bmi
59836|NCT03193320|PVI|pvi
59932|NCT03192722|Filters|filters
61218|NCT03184779|Ski|ski
63123|NCT03172442|RCT|rct
65180|NCT03158441|DTI|dti
65837|NCT03155113|HCV|hcv
67567|NCT03143855|Belviq|belviq
70206|NCT03125759|Omentin|omentin
70379|NCT03124160|IUD|iud
70713|NCT03122067|fMRI|fmri
74414|NCT03099161|PD1|pd1
75222|NCT03095287|ITI|iti
75239|NCT03095144|infants|infants
75532|NCT03093415|HCV|hcv
75615|NCT03092817|HIV|hiv
75991|NCT03090230|DTA|dta
77863|NCT03078751|LEE011|lee011
78508|NCT03075150|PVI|pvi
80062|NCT03066193|PEA|pea
80252|NCT03065192|MRI|mri
80985|NCT03060200|CBT|cbt
81009|NCT03059940|NRT|nrt
81267|NCT03058276|AAT|aat
81554|NCT03056339|ALL|all
81654|NCT03055533|Social|social
81778|NCT03054701|PFP|pfp
82661|NCT03049176|ART|art
83748|NCT03042481|relapse|relapse
85251|NCT03032991|MFSD2a|mfsd2a
86355|NCT03026348|RSV|rsv
88155|NCT03015012|BMI|bmi
88895|NCT03010332|CMV|cmv
90930|NCT02997982|HSV|hsv
91712|NCT02992275|Hip|hip
91906|NCT02991131|Abscess|abscess
92028|NCT02990429|Warming|warming
92164|NCT02989285|HIV|hiv
92900|NCT02985034|HCC|hcc
93269|NCT02982824|IQ|iq
93453|NCT02981602|HBV|hbv
94562|NCT02975557|MGD|mgd
94907|NCT02973542|IBS|ibs
96782|NCT02961309|THC|thc
97039|NCT02960022|MDV3100|mdv3100
97278|NCT02958527|Effexor|effexor
97787|NCT02955602|PBC|pbc
97953|NCT02954653|AML|aml
99701|NCT02943642|MF|mf
100930|NCT02935270|Stroke|stroke
102099|NCT02928237|VAS|vas
102694|NCT02924428|Acne|acne
102944|NCT02923206|PE|pe
104181|NCT02916108|EEG|eeg
105488|NCT02907788|PMN|pmn
105587|NCT02907281|MS,|ms,
105707|NCT02906501|DBD|dbd
106955|NCT02897947|Surgery|surgery
107071|NCT02897141|HIV|hiv
107254|NCT02895789|SMA|sma
107700|NCT02893137|Optune|optune
108954|NCT02884973|NIRS|nirs
109076|NCT02884206|CHF|chf
109221|NCT02883153|PET/CT|pet/ct
109391|NCT02882321|AML|aml
109450|NCT02882035|pain|pain
110095|NCT02877836|DTI|dti
110391|NCT02876107|IBC|ibc
110968|NCT02872064|PDT|pdt
111964|NCT02865486|MRI|mri
112239|NCT02864290|AML|aml
112969|NCT02859415|Sarcoma|sarcoma
113091|NCT02858830|FPL|fpl
113226|NCT02857985|MRI|mri
113642|NCT02855190|FDG|fdg
114229|NCT02851342|MEG|meg
114389|NCT02850146|tau|tau
114470|NCT02849730|Epi-PCA|epi-pca
114661|NCT02848586|HIV|hiv
116266|NCT02838992|ATG|atg
116613|NCT02836405|TMS|tms
120137|NCT02814864|colitis|colitis
120383|NCT02813473|FFR|ffr
120760|NCT02811380|CVC|cvc
121269|NCT02808117|MFI|mfi
121720|NCT02805465|CRT|crt
122167|NCT02802501|ACT|act
122437|NCT02801071|PPS|pps
122900|NCT02798458|Fabry|fabry
123186|NCT02797132|CF|cf
124785|NCT02787811|IUI|iui
125155|NCT02785965|diet|diet
125677|NCT02783118|CBT|cbt
126220|NCT02780297|PH|ph
127718|NCT02771509|CPB|cpb
129369|NCT02761174|IPL|ipl
130464|NCT02754752|Surveys|surveys
131125|NCT02750397|HIV|hiv
131592|NCT02747563|PSA|psa
131961|NCT02745080|CASPAR|caspar
135044|NCT02725970|DGA|dga
135237|NCT02724943|BMI|bmi
135739|NCT02722122|CF|cf
135863|NCT02721381|RCT|rct
136024|NCT02720237|HIV|hiv
136256|NCT02718755|AML|aml
136500|NCT02717494|HIV|hiv
137138|NCT02713789|ED|ed
137754|NCT02710253|XRT|xrt
138104|NCT02707692|HIV|hiv
138490|NCT02705196|cancer|cancer
139285|NCT02700477|FBS|fbs
140204|NCT02694978|IDA|ida
140889|NCT02691130|HAI|hai
141156|NCT02689752|14C|14c
141261|NCT02689284|PD|pd
141876|NCT02685098|MSCs|mscs
142257|NCT02682719|LCZ696|lcz696
142914|NCT02678520|RT|rt
143273|NCT02676128|HIV|hiv
145780|NCT02660567|PPH|pph
146157|NCT02658812|IBC|ibc
146911|NCT02654327|Lung|lung
147316|NCT02651974|FIT|fit
147786|NCT02649140|Vinegar|vinegar
147915|NCT02648438|AZD7594|azd7594
148533|NCT02644317|balance|balance
150165|NCT02635113|gait|gait
151081|NCT02630316|PH|ph
151364|NCT02628912|HPV|hpv
151691|NCT02627417|ITP|itp
152072|NCT02625298|MTA|mta
152549|NCT02622373|Pea Pod|pea pod
152808|NCT02620852|DCIS|dcis
152946|NCT02620228|Biopsy|biopsy
153060|NCT02619383|HBOT|hbot
153961|NCT02613390|MRI|mri
155212|NCT02605343|PGx|pgx
155466|NCT02603835|PCI|pci
156638|NCT02596893|IBD|ibd
156847|NCT02595619|AKI|aki
157099|NCT02594124|SMA|sma
158173|NCT02587832|RDS|rds
158757|NCT02583880|ICU|icu
159589|NCT02579096|CKD|ckd
162597|NCT02562352|eHealth|ehealth
164340|NCT02551835|25(OH)D|25(oh)d
165245|NCT02546219|EoE|eoe
165592|NCT02544022|QOL|qol
165722|NCT02543294|ECG|ecg
167500|NCT02531880|MRI|mri
167841|NCT02530034|AML|aml
167999|NCT02529306|men|men
168911|NCT02523326|PCR|pcr
168968|NCT02522962|balance|balance
169476|NCT02519634|SMP|smp
170234|NCT02514967|SLE|sle
170730|NCT02512146|IBS|ibs
171110|NCT02509689|EEG|eeg
172006|NCT02504866|TBI|tbi
172238|NCT02503540|rvo|rvo
172481|NCT02502240|ALK|alk
172996|NCT02499432|PTSD|ptsd
173757|NCT02495233|ASP2215|asp2215
173879|NCT02494583|PD1|pd1
174630|NCT02489773|GA|ga
174768|NCT02488915|Stroke|stroke
175014|NCT02487563|rhTPO|rhtpo
176536|NCT02478723|Teeth|teeth
176920|NCT02476695|CHB|chb
177076|NCT02475707|ALL|all
178091|NCT02469987|PK|pk
178596|NCT02467374|OCD|ocd
178917|NCT02465541|Yoga|yoga
179586|NCT02461862|IUD|iud
179782|NCT02460731|PSP|psp
179941|NCT02459821|Robotic|robotic
181582|NCT02449629|HIV|hiv
181698|NCT02448940|obesity|obesity
182349|NCT02444897|PCA|pca
183001|NCT02441413|FRI|fri
184402|NCT02433158|SCD|scd
185346|NCT02428374|MRI|mri
186895|NCT02420704|IVF|ivf
187500|NCT02417753|Ascites|ascites
190841|NCT02399124|RCC|rcc
191426|NCT02395380|CRP|crp
193204|NCT02385279|CAD|cad
194056|NCT02380625|Ebola|ebola
194174|NCT02380027|MRI|mri
196011|NCT02369263|DVT|dvt
196336|NCT02367456|MDS|mds
196838|NCT02364427|AKI|aki
200339|NCT02344420|CRT|crt
201112|NCT02339883|MRI|mri
201389|NCT02338193|GDM|gdm
203719|NCT02324595|Robotic|robotic
205354|NCT02315872|ACTH|acth
205644|NCT02314481|ALK|alk
207366|NCT02304796|CBT|cbt
208600|NCT02297776|NSE|nse
210579|NCT02286583|RTM|rtm
210826|NCT02285114|TAF|taf
212972|NCT02272686|SCT|sct
215966|NCT02255097|PD1|pd1
216575|NCT02251743|EEG|eeg
217438|NCT02247492|STEMI|stemi
217945|NCT02245347|TB|tb
219201|NCT02239211|PSC|psc
220449|NCT02233530|Nigeria|nigeria
220580|NCT02232906|CKD|ckd
220702|NCT02232269|CYP3A4|cyp3a4
221485|NCT02229071|HCC|hcc
222977|NCT02222740|Safety|safety
223121|NCT02222116|BMS|bms
225536|NCT02211014|Btk|btk
226875|NCT02204995|Thumb|thumb
227518|NCT02201953|HCV|hcv
227638|NCT02201524|JAK|jak
229379|NCT02193646|ADR|adr
230944|NCT02187146|IVF|ivf
232295|NCT02180061|PD1|pd1
232445|NCT02179346|hip|hip
232885|NCT02176720|PET|pet
233134|NCT02175420|BCG|bcg
233501|NCT02173379|BVS|bvs
233970|NCT02170142|MRI|mri
234384|NCT02168244|ice|ice
234493|NCT02167763|IUD|iud
235249|NCT02163967|CES|ces
235627|NCT02162524|obesity|obesity
236060|NCT02160444|CBT|cbt
236616|NCT02158026|IVF|ivf
237620|NCT02153255|Morquio|morquio
239629|NCT02144077|PDT|pdt
240553|NCT02139774|Men|men
241742|NCT02134145|mHealth|mhealth
242568|NCT02130466|PD1|pd1
242992|NCT02128867|GER|ger
247020|NCT02111551|P50|p50
247387|NCT02109796|EMG|emg
247603|NCT02108860|GPA|gpa
250895|NCT02094378|Healthy|healthy
252240|NCT02087852|DNA|dna
254772|NCT02076438|c diff|c diff
255770|NCT02071875|SAH|sah
255877|NCT02071329|Flu|flu
255994|NCT02070809|wound|wound
256934|NCT02066311|SLE|sle
256998|NCT02065986|HIV|hiv
257142|NCT02065349|PHN|phn
257259|NCT02064894|opioids|opioids
258250|NCT02060448|NSSI|nssi
258633|NCT02058745|Family|family
258748|NCT02058212|ICSI|icsi
259630|NCT02054416|AKA|aka
259878|NCT02053194|Aged|aged
260033|NCT02052453|ICD|icd
260255|NCT02051530|mood|mood
260370|NCT02051023|dry eye|dry eye
260727|NCT02049437|HIV|hiv
262378|NCT02042612|Obesity|obesity
263008|NCT02039726|Tablets|tablets
263202|NCT02038868|BPH|bph
265409|NCT02028416|ATG|atg
265640|NCT02027506|ECG|ecg
266662|NCT02022787|RCC|rcc
269153|NCT02011295|OLT|olt
270729|NCT02004457|HIV|hiv
272642|NCT01996007|Parents|parents
273449|NCT01992029|ALS|als
273889|NCT01989871|preterm|preterm
274015|NCT01989182|China|china
274783|NCT01985646|infants|infants
275350|NCT01983293|QLV|qlv
275699|NCT01981785|IgG|igg
276113|NCT01979692|CLM|clm
276176|NCT01979380|KD101|kd101
276494|NCT01977976|IVF|ivf
276811|NCT01976819|HME|hme
276955|NCT01976208|IgE|ige
277693|NCT01972659|female|female
278411|NCT01969500|SOS|sos
280549|NCT01960335|obesity|obesity
281163|NCT01957098|sucrose|sucrose
283575|NCT01945762|MTC|mtc
284101|NCT01943396|AMD|amd
284321|NCT01942291|HDL|hdl
284564|NCT01941251|TMS|tms
284736|NCT01940289|VAS|vas
285833|NCT01935115|MDD|mdd
286559|NCT01931904|IOP|iop
287153|NCT01928823|DCS|dcs
288294|NCT01923844|Newborn|newborn
288917|NCT01920789|SBRT|sbrt
289074|NCT01920217|SNP|snp
289312|NCT01919450|PET|pet
292652|NCT01903395|Adult|adult
292980|NCT01901796|CBT|cbt
293160|NCT01901016|HIV|hiv
294625|NCT01893996|tnf|tnf
294781|NCT01893320|AML|aml
294907|NCT01892761|MPA|mpa
295303|NCT01891344|CO-338|co-338
296417|NCT01886274|EEG|eeg
296660|NCT01885169|Vaccine|vaccine
297442|NCT01881763|bipolar|bipolar
297678|NCT01880983|EPP|epp
298443|NCT01877551|HIV|hiv
298581|NCT01876992|bmi|bmi
300909|NCT01866059|GIC|gic
301312|NCT01864395|albumin|albumin
302289|NCT01860183|Chronic|chronic
302927|NCT01857245|arm|arm
303252|NCT01856114|FBT|fbt
303306|NCT01855867|HIV|hiv
303558|NCT01854775|HIV|hiv
303691|NCT01854333|ADOS|ados
304807|NCT01849796|Pain|pain
305196|NCT01848106|Regado|regado
305373|NCT01847287|MRI|mri
305574|NCT01846377|diet|diet
306949|NCT01839656|SMA|sma
307117|NCT01838941|PBD|pbd
307214|NCT01838590|HCV|hcv
310267|NCT01824589|TBI|tbi
311625|NCT01818258|HIV|hiv
311740|NCT01817647|AL|al
312120|NCT01815918|BSF-2|bsf-2
312736|NCT01813188|Bone|bone
313100|NCT01811576|TV-1106|tv-1106
315868|NCT01799265|OSA|osa
316371|NCT01796977|NSM|nsm
316875|NCT01794793|bRAF|braf
317876|NCT01789866|DHA|dha
318376|NCT01787721|Gait|gait
318773|NCT01786174|ALS|als
319384|NCT01783314|MRI|mri
319530|NCT01782664|PGA|pga
320124|NCT01779765|IBS|ibs
321040|NCT01775930|RCC|rcc
321392|NCT01774318|aEEG|aeeg
321943|NCT01772017|OSA|osa
324251|NCT01761656|PCI|pci
325872|NCT01754038|PRO|pro
328538|NCT01741519|PK|pk
329161|NCT01738984|DVD|dvd
330125|NCT01735162|AKI|aki
330406|NCT01733732|Dry eye|dry eye
330531|NCT01733004|Phase I|phase i
332287|NCT01725165|SRS|srs
334187|NCT01716598|IPS|ips
334494|NCT01715246|HMO|hmo
336975|NCT01704404|COPD|copd
337610|NCT01701895|HIV|hiv
337875|NCT01700790|HIV|hiv
338346|NCT01698762|CERSG|cersg
338597|NCT01697319|GALNS|galns
339513|NCT01693224|TB|tb
341503|NCT01684384|PRO|pro
341788|NCT01683084|AAA|aaa
341875|NCT01682746|GBM|gbm
342623|NCT01679574|PCO|pco
343441|NCT01675921|ACT|act
343751|NCT01674582|Glioma|glioma
345163|NCT01668407|PSP|psp
345286|NCT01667978|HIV|hiv
345535|NCT01666990|HIV|hiv
347156|NCT01659021|CLL|cll
347795|NCT01656070|HIV|hiv
348672|NCT01651975|DSS|dss
350819|NCT01641796|CL|cl
351399|NCT01639352|HCC|hcc
352460|NCT01634126|FIT|fit
352814|NCT01632397|HIV|hiv
353419|NCT01629511|CLL|cll
354034|NCT01626833|GH|gh
354254|NCT01625871|Sudan|sudan
354510|NCT01624805|AA|aa
355394|NCT01620801|AAV|aav
357044|NCT01613976|MDS|mds
357567|NCT01611285|FDA|fda
358516|NCT01607879|Men|men
358763|NCT01606696|CAD|cad
360410|NCT01599637|CIU|ciu
360677|NCT01598584|RCT|rct
361387|NCT01595698|IGF-1|igf-1
361653|NCT01594554|RNA|rna
362574|NCT01590732|TCL|tcl
363396|NCT01586754|obesity|obesity
366050|NCT01575990|Age|age
368132|NCT01567202|Vaccine|vaccine
369391|NCT01561482|PSA|psa
371758|NCT01551706|SOD|sod
371954|NCT01550809|CGM|cgm
372306|NCT01549444|renin|renin
373250|NCT01545648|DTC|dtc
373498|NCT01544712|hip|hip
375177|NCT01537471|PPI|ppi
375777|NCT01534819|AAA|aaa
376282|NCT01532388|Alcohol|alcohol
376430|NCT01531842|CNV|cnv
377309|NCT01528358|VOT|vot
377684|NCT01526486|urology|urology
378364|NCT01523496|HIV|hiv
379428|NCT01519011|PK|pk
381928|NCT01508273|HRQOL|hrqol
383070|NCT01503879|SPB|spb
383959|NCT01500161|AML|aml
384322|NCT01498458|GBG|gbg
386053|NCT01491217|MTD|mtd
387680|NCT01484678|Muscle|muscle
388357|NCT01481675|PYY|pyy
389437|NCT01477476|DKA|dka
389826|NCT01475591|neck|neck
390447|NCT01473173|Safety|safety
390597|NCT01472627|MM|mm
392375|NCT01465360|AD|ad
394212|NCT01457768|SOF|sof
395292|NCT01453114|CBT|cbt
395710|NCT01451489|CTX|ctx
396087|NCT01449942|EBV|ebv
396475|NCT01448252|safety|safety
396982|NCT01446198|HPV|hpv
397723|NCT01443377|Neorec|neorec
397935|NCT01442519|BCG|bcg
397969|NCT01442363|fistula|fistula
398150|NCT01441609|IL9|il9
398859|NCT01438944|NRT|nrt
399241|NCT01437475|HBV|hbv
399361|NCT01436877|BPH|bph
399626|NCT01435785|TCI|tci
399883|NCT01434706|HIV|hiv
400727|NCT01431391|PSA|psa
402119|NCT01425996|HCC|hcc
402347|NCT01425086|PCM|pcm
403476|NCT01421004|cancer|cancer
403957|NCT01419119|D3|d3
403979|NCT01419028|HPP|hpp
404111|NCT01418313|MRI|mri
404248|NCT01417637|TMD|tmd
405522|NCT01412437|PKU|pku
406272|NCT01409473|IPL|ipl
407251|NCT01406054|ACL|acl
409619|NCT01395420|Phase 1|phase 1
409766|NCT01394900|HIV|hiv
410123|NCT01393223|LP-08|lp-08
410537|NCT01391650|ACL|acl
410665|NCT01391117|HCV|hcv
412096|NCT01384981|NIV|niv
412218|NCT01384292|OIC|oic
412781|NCT01381835|HCV|hcv
412871|NCT01381510|Surgery|surgery
413246|NCT01379976|lung|lung
414013|NCT01377012|RA|ra
414260|NCT01375881|naive|naive
415394|NCT01371175|HIV|hiv
416155|NCT01368029|LGG|lgg
416331|NCT01367210|HIV|hiv
416406|NCT01366937|egg|egg
417012|NCT01364415|MTD|mtd
417349|NCT01363128|CVC|cvc
417431|NCT01362803|NF1|nf1
417668|NCT01361945|ER+|er+
418527|NCT01358383|VIMOVO|vimovo
419427|NCT01354314|HIV|hiv
419794|NCT01352858|RA|ra
420046|NCT01351740|HIV|hiv
423069|NCT01339182|PK|pk
424056|NCT01335191|HIV|hiv
424296|NCT01334203|ETT|ett
427097|NCT01322386|PSC|psc
428816|NCT01315886|PID|pid
429012|NCT01314976|RCT|rct
429150|NCT01314404|HPV|hpv
430721|NCT01307488|HIV|hiv
431170|NCT01305954|UNC|unc
431498|NCT01304641|Statin|statin
432004|NCT01302574|gut|gut
432248|NCT01301690|FNA|fna
432784|NCT01299324|CHF|chf
434370|NCT01292798|Macula|macula
436997|NCT01281345|icu|icu
437853|NCT01277627|HCV|hcv
438241|NCT01275976|Sepsis|sepsis
438917|NCT01273376|MDD|mdd
439097|NCT01272765|obesity|obesity
440329|NCT01267565|amylase|amylase
440966|NCT01264770|OSKIRA|oskira
441144|NCT01263938|HIV|hiv
441970|NCT01260350|FDC|fdc
442700|NCT01257035|FAZA|faza
443073|NCT01255332|ITP|itp
443196|NCT01254890|MDS|mds
443563|NCT01253096|IL2|il2
443689|NCT01252641|HIV|hiv
443817|NCT01252095|PG545|pg545
445177|NCT01245790|RA|ra
446175|NCT01241344|Adv|adv
446422|NCT01240395|MCS|mcs
446801|NCT01238575|PDD|pdd
447309|NCT01236820|L5|l5
449424|NCT01227044|HIV|hiv
451999|NCT01215851|PA-824|pa-824
453016|NCT01211496|leg|leg
454024|NCT01207089|PK|pk
454246|NCT01206036|DPFS|dpfs
454497|NCT01204918|MDD|mdd
455461|NCT01201330|ONJ|onj
455654|NCT01200537|IVF|ivf
455999|NCT01199315|AD|ad
457982|NCT01191021|breath|breath
458958|NCT01186744|chronic|chronic
459838|NCT01183455|AAT|aat
461207|NCT01177618|COPD|copd
461770|NCT01175551|PTB|ptb
462100|NCT01174212|hip|hip
462211|NCT01173692|XRT|xrt
462586|NCT01172067|CRT|crt
465371|NCT01160640|PID|pid
466286|NCT01156584|GBM|gbm
467086|NCT01153295|IBS|ibs
467231|NCT01152684|CAM|cam
469688|NCT01142557|Rebif|rebif
469935|NCT01141634|ADD|add
470527|NCT01139151|AML|aml
470785|NCT01138111|MCI|mci
471664|NCT01135576|Women|women
471809|NCT01134913|ACS|acs
472606|NCT01131637|rhNRG-1|rhnrg-1
473199|NCT01128998|S1|s1
474082|NCT01125176|CLL|cll
475103|NCT01120821|PV|pv
475464|NCT01119144|eye|eye
475916|NCT01117740|MPE|mpe
476290|NCT01116388|Reflux|reflux
477736|NCT01110941|SOL|sol
478107|NCT01109433|Uveitis|uveitis
478470|NCT01107834|HIV|hiv
479002|NCT01105611|HIV|hiv
479128|NCT01105117|PAH|pah
479825|NCT01101906|OSI-906|osi-906
480141|NCT01101191|Opioid|opioid
481362|NCT01096316|women|women
482089|NCT01093495|CPAP|cpap
482262|NCT01092949|MRI|mri
483579|NCT01087411|DXA|dxa
484282|NCT01084694|HSCT|hsct
487453|NCT01072032|EEG|eeg
487966|NCT01069653|CDCA1|cdca1
488126|NCT01069081|TTP|ttp
488709|NCT01066533|MTA|mta
489819|NCT01062022|family|family
490060|NCT01060982|Calcium|calcium
490427|NCT01059448|RA|ra
490927|NCT01057407|CKD|ckd
491550|NCT01054664|RNA|rna
492167|NCT01052350|PIB|pib
493160|NCT01048619|MDS|mds
493654|NCT01047683|EPA|epa
494299|NCT01045369|HIV|hiv
494796|NCT01043341|HPV|hpv
495169|NCT01041859|Painful|painful
497501|NCT01031914|OSA|osa
497900|NCT01030536|NHL|nhl
498375|NCT01028651|PAH|pah
498506|NCT01027988|CHF|chf
498854|NCT01026480|IBD|ibd
499253|NCT01024829|HX4|hx4
500583|NCT01019317|Fludara|fludara
501417|NCT01015781|Triage|triage
501770|NCT01014481|HIV|hiv
501809|NCT01014273|PCI|pci
501928|NCT01013844|SSE|sse
503906|NCT01005745|skin|skin
504388|NCT01003782|bile|bile
505753|NCT00998361|Sarcoma|sarcoma
507306|NCT00993122|SVR|svr
507933|NCT00990665|CRT|crt
511163|NCT00978432|NHL|nhl
512033|NCT00974961|HRV|hrv
513717|NCT00968461|CLL|cll
514131|NCT00967044|NHL|nhl
514726|NCT00964795|AMD|amd
515029|NCT00963664|Intron|intron
515182|NCT00963248|EBV|ebv
516611|NCT00957697|Stroke|stroke
516824|NCT00956605|ADD|add
517009|NCT00956462|NSAIDS|nsaids
517167|NCT00955916|AML|aml
518360|NCT00951522|CF|cf
520563|NCT00943774|Stress|stress
521061|NCT00941915|CaP|cap
522185|NCT00937404|IPV|ipv
524694|NCT00927550|RCT|rct
526920|NCT00919217|MS|ms
528157|NCT00914225|HIV|hiv
530369|NCT00904995|Vfend|vfend
532728|NCT00899353|SMM|smm
534346|NCT00896584|COPD|copd
535281|NCT00892762|OAG|oag
535525|NCT00891865|OB|ob
536027|NCT00890344|BIA|bia
536245|NCT00889590|GCT|gct
536648|NCT00887926|AML|aml
536790|NCT00887328|MRI|mri
536844|NCT00887068|AML|aml
537822|NCT00883324|fFN|ffn
538340|NCT00881010|IVR|ivr
538596|NCT00880074|PET|pet
539570|NCT00876395|RAD001|rad001
539811|NCT00875316|Phase I|phase i
540589|NCT00872261|HIV|hiv
540675|NCT00871845|obesity|obesity
541566|NCT00868439|HF|hf
541726|NCT00867750|HCC|hcc
542209|NCT00866073|AML|aml
542571|NCT00864578|IOP|iop
543419|NCT00860977|HIV|hiv
543542|NCT00860509|diet|diet
543913|NCT00858611|HV|hv
544780|NCT00855062|Uganda|uganda
544910|NCT00854516|3M|3m
545394|NCT00852579|Asthma|asthma
547034|NCT00846287|MRI|mri
547504|NCT00844311|hCG|hcg
547739|NCT00843219|PET|pet
548106|NCT00841711|HIV|hiv
548371|NCT00840762|HIV|hiv
548461|NCT00840320|Safety|safety
549972|NCT00833820|ALS|als
551093|NCT00829335|HCC|hcc
551363|NCT00828360|CRT|crt
551410|NCT00828126|PET-CT|pet-ct
551547|NCT00827580|HFS|hfs
552266|NCT00824993|BMT|bmt
555381|NCT00813969|MSC|msc
555407|NCT00813826|PHN|phn
555669|NCT00813124|CML|cml
556050|NCT00811577|VAS|vas
556191|NCT00811122|AD|ad
556244|NCT00810888|ICH|ich
556491|NCT00809965|ACS|acs
558285|NCT00802841|CML|cml
559000|NCT00800046|MR|mr
559253|NCT00799071|CGD|cgd
559860|NCT00796627|CAC|cac
560596|NCT00793234|TKR|tkr
560966|NCT00791609|cancer|cancer
561462|NCT00789828|RAD001|rad001
562158|NCT00787748|COPD|copd
562793|NCT00785265|LDKT|ldkt
562976|NCT00784745|GIP|gip
563396|NCT00782756|GBM|gbm
564112|NCT00779766|vaccine|vaccine
564248|NCT00779259|humans|humans
565328|NCT00774384|Mucosal|mucosal
565672|NCT00772902|LDL|ldl
565918|NCT00771927|LCM|lcm
567574|NCT00765375|acne|acne
569151|NCT00758108|Obesity|obesity
569525|NCT00756470|IBC|ibc
570737|NCT00751946|PTSD|ptsd
572658|NCT00745134|RT|rt
573771|NCT00741208|soy|soy
574262|NCT00739401|AAA|aaa
575516|NCT00735020|flu|flu
577897|NCT00726583|PI-3K|pi-3k
578161|NCT00725400|Erbitux|erbitux
578524|NCT00724022|Reduced|reduced
579376|NCT00720577|PAD|pad
580410|NCT00717197|GBM|gbm
580889|NCT00715533|TIA|tia
582377|NCT00710060|HIV|hiv
582933|NCT00707941|PCR|pcr
583162|NCT00706901|MI|mi
583275|NCT00706381|HV|hv
583902|NCT00703079|GH|gh
583996|NCT00702793|champix|champix
584857|NCT00699166|IBS|ibs
586640|NCT00691717|IOP|iop
587172|NCT00690079|pain|pain
587628|NCT00688493|QT|qt
588626|NCT00684398|NF1|nf1
589031|NCT00682825|BIS|bis
590048|NCT00678730|THC|thc
590194|NCT00678262|ECG|ecg
590810|NCT00675870|APL|apl
591050|NCT00675064|safety|safety
595111|NCT00660205|DVT|dvt
596086|NCT00656175|fat|fat
597654|NCT00649701|HIV|hiv
598385|NCT00645411|Flu|flu
598789|NCT00643305|HIV|hiv
599613|NCT00639847|nursing|nursing
599854|NCT00638859|CAP|cap
602308|NCT00629200|SSG|ssg
602455|NCT00628693|CPR|cpr
604782|NCT00619671|MG|mg
604845|NCT00619619|MDD|mdd
605424|NCT00617383|MS|ms
607087|NCT00610909|IBS|ibs
607456|NCT00609401|RCC|rcc
607935|NCT00607633|ARB|arb
608106|NCT00606931|PET|pet
608288|NCT00605982|MRI|mri
608863|NCT00603304|BPH|bph
608926|NCT00603018|PET|pet
609650|NCT00599937|APL|apl
609988|NCT00598286|PET|pet
611115|NCT00593398|Malaria|malaria
611535|NCT00591526|APL|apl
611992|NCT00589667|pharynx|pharynx
612456|NCT00588341|TMZ|tmz
613441|NCT00583557|RA|ra
616600|NCT00569660|MF|mf
617173|NCT00567411|Laser|laser
618442|NCT00561912|RCC|rcc
619608|NCT00556868|Fasting|fasting
619879|NCT00555698|DBS|dbs
619992|NCT00555282|cvc|cvc
623060|NCT00542152|IBD|ibd
625301|NCT00534352|HIV|hiv
626213|NCT00530270|ACS|acs
626448|NCT00529399|T1D|t1d
627526|NCT00525486|PTL|ptl
628804|NCT00521196|tms|tms
629135|NCT00519545|one|one
630701|NCT00513422|NSAIDs|nsaids
632891|NCT00506090|scar|scar
635087|NCT00499512|Survey|survey
635242|NCT00499278|hip|hip
635391|NCT00498719|CNS|cns
635443|NCT00498498|CSF|csf
635934|NCT00496678|PNRP|pnrp
640135|NCT00480610|Adult|adult
640656|NCT00478647|human|human
640999|NCT00477399|QOL|qol
641888|NCT00474435|HIV|hiv
642009|NCT00473993|Heroin|heroin
642533|NCT00471783|RCT|rct
642759|NCT00471107|HV|hv
642900|NCT00470483|PET|pet
645422|NCT00461500|Therapy|therapy
645551|NCT00460902|TMS|tms
645814|NCT00459992|Obesity|obesity
646049|NCT00459069|GM-CSF|gm-csf
646453|NCT00457678|AMD|amd
646789|NCT00456183|TB|tb
646925|NCT00455741|PET|pet
648231|NCT00451269|RDT|rdt
648865|NCT00448695|MRI|mri
649066|NCT00448292|MDD|mdd
650357|NCT00445341|MCL|mcl
650533|NCT00444561|Symlin|symlin
651005|NCT00443313|HPV|hpv
651344|NCT00442806|AMI|ami
651697|NCT00441376|RFA|rfa
653517|NCT00434837|ACL|acl
653719|NCT00434161|KGF|kgf
655502|NCT00427843|hip|hip
655560|NCT00427674|Imaging|imaging
655684|NCT00427297|HIV-1|hiv-1
657291|NCT00421720|Germany|germany
658819|NCT00416299|elderly|elderly
659807|NCT00413036|NHL|nhl
660003|NCT00412243|Clolar|clolar
661731|NCT00405184|PID|pid
662616|NCT00401999|PET|pet
662679|NCT00401726|Anxiety|anxiety
663780|NCT00397111|HV|hv
664655|NCT00393692|drusen|drusen
665511|NCT00390559|Gender|gender
665994|NCT00388752|amputee|amputee
669158|NCT00377091|heparin|heparin
669879|NCT00375219|CML|cml
670342|NCT00373438|ECMO|ecmo
672430|NCT00365339|HIV|hiv
672800|NCT00364390|CAD|cad
673001|NCT00363454|Phase I|phase i
674218|NCT00358956|MTC|mtc
674340|NCT00358501|Liver|liver
674581|NCT00357604|HIV|hiv
674825|NCT00357058|HV|hv
676147|NCT00352352|Autism|autism
677010|NCT00348933|Ataxia|ataxia
677167|NCT00348049|PRK|prk
677744|NCT00345839|CKD|ckd
678863|NCT00341705|Cancer|cancer
679914|NCT00338585|PAO|pao
681114|NCT00333632|Sleep|sleep
681605|NCT00331201|NEC|nec
681765|NCT00330564|VHL|vhl
682876|NCT00326209|UC|uc
683347|NCT00324467|PET|pet
683587|NCT00323882|PSA|psa
683863|NCT00322673|AML|aml
684057|NCT00321711|MDS|mds
686165|NCT00313846|opioid|opioid
686422|NCT00312832|HIV|hiv
686551|NCT00312351|AMD|amd
686786|NCT00311298|hiv|hiv
687733|NCT00307502|HIV|hiv
687764|NCT00307398|AMD|amd
688323|NCT00305643|pain|pain
689038|NCT00303264|CCK|cck
689738|NCT00300820|BP|bp
694096|NCT00285441|HIV|hiv
695243|NCT00281697|MBC|mbc
698835|NCT00266773|CBT|cbt
699233|NCT00265499|Length|length
699826|NCT00262574|BNP|bnp
700130|NCT00261001|HIV|hiv
700244|NCT00260598|COPD|copd
703174|NCT00249496|HIV|hiv
703276|NCT00249197|skin|skin
703551|NCT00248469|HIV|hiv
703590|NCT00248391|supine|supine
704207|NCT00246051|Fatigue|fatigue
704343|NCT00245349|FLT|flt
705501|NCT00240682|Skin|skin
705628|NCT00239889|Pain|pain
706676|NCT00236041|Cancer|cancer
707763|NCT00230607|GL3|gl3
707860|NCT00230061|HIV|hiv
708556|NCT00226694|Stress|stress
709788|NCT00221351|cough|cough
712398|NCT00208416|Hip|hip
713774|NCT00200928|BCG|bcg
714311|NCT00198601|Uniject|uniject
716081|NCT00187590|HIV|hiv
716808|NCT00183131|Alcohol|alcohol
719405|NCT00170391|PSG|psg
719931|NCT00167947|Kidney|kidney
720202|NCT00166933|UVB|uvb
721159|NCT00161564|ITP|itp
721590|NCT00160563|Xyzal|xyzal
721866|NCT00158964|pacing|pacing
723572|NCT00150098|HIV|hiv
726176|NCT00137384|HV|hv
726285|NCT00136825|cocaine|cocaine
726406|NCT00136422|MDS|mds
726682|NCT00135278|CSF|csf
726776|NCT00134667|Macugen|macugen
727439|NCT00132327|HV|hv
728809|NCT00127270|OAB|oab
729233|NCT00125645|AMI|ami
729309|NCT00125398|ICU|icu
731265|NCT00117858|FTP|ftp
731878|NCT00115791|RSD1235|rsd1235
732280|NCT00114517|CAD|cad
733882|NCT00109772|CRPS|crps
734441|NCT00107965|AK|ak
735749|NCT00103025|HV|hv
736494|NCT00100503|TMS|tms
737065|NCT00098293|HIV|hiv
738453|NCT00093379|XRT|xrt
739583|NCT00090662|HV|hv
739930|NCT00090103|BPH|bph
740139|NCT00089999|ErbB2|erbb2
741900|NCT00088296|Placebo|placebo
742064|NCT00005805|fatigue|fatigue
743436|NCT00086541|HCV|hcv
743469|NCT00086567|Blood|blood
744180|NCT00085917|Pegasys|pegasys
747312|NCT00082615|HV|hv
747340|NCT00082550|OCD|ocd
747763|NCT00004246|RT|rt
747938|NCT00003646|cancer|cancer
748689|NCT00003398|anemia|anemia
752109|NCT00080093|Condom|condom
753413|NCT00078806|SOJRA|sojra
753612|NCT00078663|ICU|icu
753808|NCT00078546|EBV|ebv
754058|NCT00078377|Nuvigil|nuvigil
754523|NCT00078104|Pain|pain
755510|NCT00076752|Lupus|lupus
756961|NCT00073606|HV|hv
757585|NCT00072605|Healthy|healthy
757820|NCT00071292|MBSR|mbsr
758048|NCT00070733|Libido|libido
759277|NCT00068068|Litx™|litx™
761830|NCT00063180|HV|hv
762639|NCT00061789|HV|hv
763063|NCT00061048|ATL|atl
763592|NCT00060593|Balance|balance
767752|NCT00047060|CTCL|ctcl
768585|NCT00040885|fatigue|fatigue
769541|NCT00029029|pain|pain
769845|NCT00027586|PTK|ptk
769965|NCT00026247|pain|pain
780046|NCT00001232|FSH|fsh
781094|NCT00044304|HES|hes
782889|NCT00035308|SLE|sle
783402|NCT00033774|HV|hv
783924|NCT00029939|HV|hv
790427|NCT00000886|Mannose|mannose
790941|NCT00000802|Dapsone|dapsone
791869|NCT00000647|IgG|igg
792514|NCT00018070|AMD|amd
792622|NCT00017745|DNA|dna
793128|NCT00013546|Turners|turners
793772|NCT00007241|OA|oa
795938|NCT00001967|HIV|hiv
796706|NCT00001746|HCM|hcm
797482|NCT00001512|GM-CSF|gm-csf
798534|NCT00001184|IBD|ibd
798739|NCT00001145|KLH|klh
4948|NCT03542942|locally advanced|locally advanced
4949|NCT03542942|radiotherapy|radiotherapy
4950|NCT03542942|DW-MRI|dw-mri
4951|NCT03542942|target volume|target volume
4952|NCT03542890|Anesthesia, General|anesthesia, general
4953|NCT03542890|Baska|baska
4954|NCT03542890|I-gel|i-gel
4955|NCT03542877|Cabozantinib|cabozantinib
4956|NCT03542877|Progression Free Survival|progression free survival
4957|NCT03542877|Metastatic Colorectal Cancer|metastatic colorectal cancer
4958|NCT03542877|Tumor|tumor
4959|NCT03542864|obesity|obesity
4960|NCT03542864|overweight|overweight
4961|NCT03542864|fat percentage|fat percentage
4962|NCT03542864|body fat|body fat
4963|NCT03542864|enteral feeding|enteral feeding
4964|NCT03542864|fat loss|fat loss
4965|NCT03542825|Iron|iron
4966|NCT03542825|Deficiency|deficiency
4967|NCT03542812|L-citrulline|l-citrulline
4968|NCT03542812|Nitric oxide|nitric oxide
4969|NCT03542786|HIV-1|hiv-1
4970|NCT03542760|Methylene Blue|methylene blue
4971|NCT03542747|Airway, Extraglottic Airway Device|airway, extraglottic airway device
4972|NCT03542721|chronic fatigue symptom|chronic fatigue symptom
4973|NCT03542721|blood circulation|blood circulation
4974|NCT03542656|Stroke|stroke
4975|NCT03542656|intracerebral hemorrhage|intracerebral hemorrhage
4976|NCT03542656|amyoid PET|amyoid pet
4977|NCT03542656|cerebral amyloid angiopathy|cerebral amyloid angiopathy
4978|NCT03542643|ADHD|adhd
4979|NCT03542643|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
4980|NCT03542643|children|children
4981|NCT03542643|adolescents|adolescents
4982|NCT03542513|Human Papillomavirus|human papillomavirus
4983|NCT03542513|Biomarker|biomarker
4984|NCT03542513|Self-sampling|self-sampling
4985|NCT03542513|First-void urine|first-void urine
4986|NCT03542513|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
4987|NCT03542513|LLETZ|lletz
4988|NCT03542487|Self Monitoring of Blood Glucose|self monitoring of blood glucose
4989|NCT03542487|Electronic Medical Records|electronic medical records
4990|NCT03542487|Nudge|nudge
4991|NCT03542487|Secure Messaging|secure messaging
4992|NCT03542487|Behavioral Economics|behavioral economics
4993|NCT03542461|Squamous NSCLC|squamous nsclc
4994|NCT03542461|Nivolumab|nivolumab
4995|NCT03542396|CBT|cbt
4996|NCT03542396|Endurance exercise|endurance exercise
4997|NCT03542383|Gulf War Illness|gulf war illness
4998|NCT03542383|Memory|memory
4999|NCT03542383|Word Finding|word finding
5000|NCT03542383|High Definition Transcranial Direct Current Stimulation|high definition transcranial direct current stimulation
5001|NCT03542383|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5002|NCT03542370|dietary approaches to stop hypertension|dietary approaches to stop hypertension
5003|NCT03542370|DASH|dash
5004|NCT03542370|cardiometabolic health|cardiometabolic health
5005|NCT03542370|Umbrella Review|umbrella review
5006|NCT03542370|GRADE|grade
5007|NCT03542370|Systematic review and meta-analysis|systematic review and meta-analysis
5008|NCT03542318|Pulmonary Rehabilitation|pulmonary rehabilitation
5009|NCT03542318|Functional outcomes|functional outcomes
5010|NCT03542318|Health Status|health status
5011|NCT03542318|Exercise|exercise
5012|NCT03542279|Autoimmune encephalitis, Plasma exchange, Immunotherapy, Outcome, Therapeutic effect|autoimmune encephalitis, plasma exchange, immunotherapy, outcome, therapeutic effect
5013|NCT03542266|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
5014|NCT03542266|Azacitidine|azacitidine
5015|NCT03542266|Lymphoma|lymphoma
5016|NCT03542253|Early lung cancer,ground-glass nodule,CT,exosome|early lung cancer,ground-glass nodule,ct,exosome
5017|NCT03542240|curcumin|curcumin
5018|NCT03542240|microbiome|microbiome
5019|NCT03542240|dietary supplements|dietary supplements
5020|NCT03542240|gut bacteria|gut bacteria
5021|NCT03542227|Antibodies|antibodies
5022|NCT03542227|Vaccination|vaccination
5023|NCT03542227|Self-sampling|self-sampling
5024|NCT03542227|First-void urine|first-void urine
5025|NCT03542188|Large Vessel Occlusion|large vessel occlusion
5026|NCT03542188|Stroke|stroke
5027|NCT03542188|EVT|evt
5028|NCT03542175|Rucaparib|rucaparib
5029|NCT03542175|Radiotherapy|radiotherapy
5030|NCT03542175|Triple Negative Breast Cancer|triple negative breast cancer
5031|NCT03542175|18-002|18-002
5032|NCT03542162|Healaflow|healaflow
5033|NCT03542162|Rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
5034|NCT03542162|27-gauge Pars plana vitrectomy|27-gauge pars plana vitrectomy
5035|NCT03542162|Minimally invasive surgery|minimally invasive surgery
5036|NCT03542162|Complications|complications
5037|NCT03542136|Polyneuropathy|polyneuropathy
5038|NCT03542136|Oxaliplatin|oxaliplatin
5039|NCT03542136|Colorectal cancer|colorectal cancer
5040|NCT03542123|Electrical Stimulation Therapy; Electrodes; Parasympathetic Nervous System; Sympathetic Fibers, Post Ganglionic; Congestive Heart Failure; Heart Failure|electrical stimulation therapy; electrodes; parasympathetic nervous system; sympathetic fibers, post ganglionic; congestive heart failure; heart failure
5041|NCT03542097|Ewing Sarcoma|ewing sarcoma
5042|NCT03542032|i-gel|i-gel
5043|NCT03542032|jaw-thrust|jaw-thrust
5044|NCT03541993|Resveratrol|resveratrol
5045|NCT03541993|Cerebral blood flow|cerebral blood flow
5046|NCT03541993|Cognition|cognition
5047|NCT03541993|Hypoxia|hypoxia
5048|NCT03541993|Polyphenols|polyphenols
5049|NCT03541980|sickle cell|sickle cell
5050|NCT03541980|acetaminophen in pain crises|acetaminophen in pain crises
5051|NCT03541980|opioid-sparing|opioid-sparing
5052|NCT03541967|bone conduction|bone conduction
5053|NCT03541954|sensitization|sensitization
5054|NCT03541954|pain thresholds|pain thresholds
5055|NCT03541941|Liposomal Bupivacaine|liposomal bupivacaine
5056|NCT03541941|Exparel|exparel
5057|NCT03541941|Transversus Abdominis Plane block|transversus abdominis plane block
5058|NCT03541941|Hernia|hernia
5059|NCT03541928|gene therapy|gene therapy
5060|NCT03541928|untreated prostate cancer|untreated prostate cancer
5061|NCT03541902|Malignant Neoplasms of Urinary Tract|malignant neoplasms of urinary tract
5062|NCT03541902|Renal cell carcinoma|renal cell carcinoma
5063|NCT03541902|Cabozantinib|cabozantinib
5064|NCT03541902|XL-184|xl-184
5065|NCT03541902|XL184|xl184
5066|NCT03541902|Sunitinib|sunitinib
5067|NCT03541902|Sunitinib Malate|sunitinib malate
5068|NCT03541902|SU011248|su011248
5069|NCT03541902|Sutent|sutent
5070|NCT03541876|children|children
5071|NCT03541876|treatment|treatment
5072|NCT03541876|observatory|observatory
5073|NCT03541863|Fulvestrant|fulvestrant
5074|NCT03541863|Progression|progression
5075|NCT03541863|Endocrine sensitivity|endocrine sensitivity
5076|NCT03541837|Bilateral ESP Catheter|bilateral esp catheter
5077|NCT03541837|Open heart surgery|open heart surgery
5078|NCT03541837|opioid free post op analgesia|opioid free post op analgesia
5079|NCT03541811|gait|gait
5080|NCT03541811|motion capture|motion capture
5081|NCT03541811|hemophilia joint health score|hemophilia joint health score
5082|NCT03541811|physical activity|physical activity
5083|NCT03541811|body composition|body composition
5084|NCT03541811|gait deviation index|gait deviation index
5085|NCT03541811|hemophilia|hemophilia
5086|NCT03541798|traditional sitting position|traditional sitting position
5087|NCT03541798|combine spinal-epidural anesthesia|combine spinal-epidural anesthesia
5088|NCT03541798|orthopedic surgery|orthopedic surgery
5089|NCT03541785|NGAL|ngal
5090|NCT03541785|Renal Angina Index|renal angina index
5091|NCT03541772|Head Carcinoma|head carcinoma
5092|NCT03541772|Neck Carcinoma|neck carcinoma
5093|NCT03541772|Chemotherapy|chemotherapy
5094|NCT03541772|Radiotherapy|radiotherapy
5095|NCT03541772|Oncoxin Viusid|oncoxin viusid
5096|NCT03541772|Nutritional supplement|nutritional supplement
5097|NCT03541759|Elective shoulder surgery, hydromorphone, piritramide|elective shoulder surgery, hydromorphone, piritramide
5098|NCT03541733|magnetic resonance enterography|magnetic resonance enterography
5099|NCT03541733|bowel preparation|bowel preparation
5101|NCT03541707|EEG|eeg
5102|NCT03541707|Depression|depression
5103|NCT03541707|adolescents|adolescents
5104|NCT03541694|Yellow fever|yellow fever
5105|NCT03541694|Stamaril®|stamaril®
5106|NCT03541681|Epidural Steroid Injections|epidural steroid injections
5107|NCT03541681|Cervical Epidural Injections|cervical epidural injections
5108|NCT03541681|Transforaminal Epidural Injections|transforaminal epidural injections
5109|NCT03541681|Steroids|steroids
5110|NCT03541681|Local Anesthetic|local anesthetic
5111|NCT03541655|total knee replacement|total knee replacement
5112|NCT03541655|pain|pain
5113|NCT03541655|celecoxib|celecoxib
5114|NCT03541655|intra-articular|intra-articular
5115|NCT03541603|PH-HFpEF|ph-hfpef
5116|NCT03541590|percutaneous biliary drainage|percutaneous biliary drainage
5117|NCT03541538|joint manipulation|joint manipulation
5118|NCT03541538|cervical|cervical
5119|NCT03541538|pressure pain|pressure pain
5120|NCT03541538|manual therapy|manual therapy
5121|NCT03541512|Mindfulness therapy|mindfulness therapy
5122|NCT03541512|Vulvodynia|vulvodynia
5123|NCT03541512|Vulvar pain|vulvar pain
5124|NCT03541499|B. pertussis Vaccine|b. pertussis vaccine
5125|NCT03541499|BPZE1|bpze1
5126|NCT03541499|Immunogenicity|immunogenicity
5127|NCT03541499|Safety|safety
5128|NCT03541486|ascorbic acid|ascorbic acid
5129|NCT03541486|ascorbate|ascorbate
5130|NCT03541486|sodium ascorbate|sodium ascorbate
5131|NCT03541486|radiotherapy|radiotherapy
5132|NCT03541486|radiotherapy, image-guided|radiotherapy, image-guided
5133|NCT03541486|gemcitabine|gemcitabine
5134|NCT03541460|centenarians|centenarians
5135|NCT03541460|epigenome|epigenome
5136|NCT03541460|longevity|longevity
5137|NCT03541460|healthy aging|healthy aging
5138|NCT03541460|epigenetic|epigenetic
5139|NCT03541447|ADPKD, Tolvaptan, Octrotide LAR|adpkd, tolvaptan, octrotide lar
5140|NCT03541434|obstructive sleep apnea|obstructive sleep apnea
5141|NCT03541434|tonsillitis|tonsillitis
5142|NCT03541434|middle ear effusion|middle ear effusion
5143|NCT03541434|pathophysiology|pathophysiology
5144|NCT03541434|score|score
5145|NCT03541382|HIV|hiv
5146|NCT03541382|HIV Self-Testing|hiv self-testing
5147|NCT03541382|Malawi|malawi
5148|NCT03541356|Parkinsons|parkinsons
5149|NCT03541356|L-dopa|l-dopa
5150|NCT03541356|levodopa|levodopa
5151|NCT03541356|ON|on
5152|NCT03541356|OFF|off
5153|NCT03541356|PD|pd
5154|NCT03541356|POD device|pod device
5155|NCT03541356|I231|i231
5156|NCT03541356|benserazide|benserazide
5157|NCT03541356|Precision olfactory delivery|precision olfactory delivery
5158|NCT03541356|MDS-UPDRS|mds-updrs
5159|NCT03541330|Siblings|siblings
5160|NCT03541330|information|information
5161|NCT03541330|malignant haemopathy|malignant haemopathy
5162|NCT03541317|Adaptive implementation|adaptive implementation
5163|NCT03541317|Coaching|coaching
5164|NCT03541317|Facilitation|facilitation
5165|NCT03541317|School mental health|school mental health
5166|NCT03541317|Implementation intervention|implementation intervention
5167|NCT03541304|high dose radiotherapy|high dose radiotherapy
5168|NCT03541304|rectal cancer|rectal cancer
5169|NCT03541278|Breast Cancer|breast cancer
5170|NCT03541278|Internal Mammary Lymph Node|internal mammary lymph node
5171|NCT03541278|Internal Mammary Sentinel Lymph Node Biopsy|internal mammary sentinel lymph node biopsy
5172|NCT03541278|Detection Rate|detection rate
5173|NCT03541265|liposomal bupivacaine|liposomal bupivacaine
5174|NCT03541265|total knee arthroplasty|total knee arthroplasty
5175|NCT03541213|ferric carboxymaltose|ferric carboxymaltose
5176|NCT03541213|mitochondrial metabolism|mitochondrial metabolism
5177|NCT03541213|cardiomyocyte|cardiomyocyte
5178|NCT03541187|cockroach|cockroach
5179|NCT03541187|immunotherapy|immunotherapy
5180|NCT03541187|inner city asthma|inner city asthma
5181|NCT03541187|subcutaneous immunotherapy (SCIT)|subcutaneous immunotherapy (scit)
5182|NCT03541187|Nasal Allergen Challenge (NAC)|nasal allergen challenge (nac)
5183|NCT03541161|Early rehabilitation|early rehabilitation
5184|NCT03541161|Conventional protocol|conventional protocol
5185|NCT03541161|Tissue expander insertion|tissue expander insertion
5186|NCT03541148|Cutaneous malignant melanoma|cutaneous malignant melanoma
5187|NCT03541148|Nutritional supplement|nutritional supplement
5188|NCT03541148|survival|survival
5189|NCT03541148|Green tea|green tea
5190|NCT03541135|Cardiovascular health|cardiovascular health
5191|NCT03541135|Diet|diet
5192|NCT03541135|Functional limitations|functional limitations
5193|NCT03541135|Frailty|frailty
5194|NCT03541135|Older Adults|older adults
5195|NCT03541109|Cardiovascular disease|cardiovascular disease
5196|NCT03541109|fixed dose combination therapy|fixed dose combination therapy
5197|NCT03541109|cost effectiveness|cost effectiveness
5198|NCT03541070|kinesiology taping|kinesiology taping
5199|NCT03541070|balance|balance
5200|NCT03541070|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5201|NCT03541018|TRV Reposition Chair|trv reposition chair
5202|NCT03541018|Epley Maneuvre|epley maneuvre
5203|NCT03541005|Overweight|overweight
5204|NCT03541005|Obesity|obesity
5205|NCT03541005|Nutritional supplement|nutritional supplement
5206|NCT03541005|Weight loss|weight loss
5207|NCT03541005|waist|waist
5208|NCT03540953|Endoscopic injection of Mitomycin C|endoscopic injection of mitomycin c
5209|NCT03540927|Well-being|well-being
5210|NCT03540927|Entrepreneurs|entrepreneurs
5211|NCT03540927|Conflict affected settings|conflict affected settings
5212|NCT03540927|Psychosocial intervention|psychosocial intervention
5213|NCT03540927|Psychological Capital|psychological capital
5214|NCT03540914|healthy participants older than 40 years|healthy participants older than 40 years
5215|NCT03540914|right heart function|right heart function
5216|NCT03540914|prevention|prevention
5217|NCT03540914|acetazolamide|acetazolamide
5218|NCT03540901|prevention|prevention
5219|NCT03540901|acetazolamide|acetazolamide
5220|NCT03540901|obstructive airway disease|obstructive airway disease
5221|NCT03540901|lung water|lung water
5222|NCT03540888|Dynamic Stretching|dynamic stretching
5223|NCT03540888|Static Stretching|static stretching
5224|NCT03540888|Manual Therapy|manual therapy
5225|NCT03540875|Anesthesia, general|anesthesia, general
5226|NCT03540875|Total intravenous anesthesia|total intravenous anesthesia
5227|NCT03540875|Closed loop anesthesia|closed loop anesthesia
5228|NCT03540875|Conox|conox
5229|NCT03540875|EEG monitoring|eeg monitoring
5230|NCT03540875|qCon|qcon
5231|NCT03540875|qNox|qnox
5232|NCT03540862|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5233|NCT03540862|Maintenance Negative Pressure Ventilation- assisted pulmonary rehabilitation|maintenance negative pressure ventilation- assisted pulmonary rehabilitation
5234|NCT03540862|Six minute walk test|six minute walk test
5235|NCT03540862|Overall survival|overall survival
5236|NCT03540810|antiphospholipid syndrome|antiphospholipid syndrome
5237|NCT03540810|thrombosis|thrombosis
5238|NCT03540810|hydroxychloroquine|hydroxychloroquine
5239|NCT03540784|muscle weakness|muscle weakness
5240|NCT03540784|muscle mass|muscle mass
5241|NCT03540784|whole-body electromyostimulation|whole-body electromyostimulation
5242|NCT03540784|WB-EMS|wb-ems
5243|NCT03540784|nutrition|nutrition
5244|NCT03540784|protein|protein
5245|NCT03540784|crohn's disease|crohn's disease
5246|NCT03540784|ulcerative colitis|ulcerative colitis
5247|NCT03540771|palliative care|palliative care
5248|NCT03540771|hepatology|hepatology
5249|NCT03540758|type 2 diabetes|type 2 diabetes
5250|NCT03540758|diabetes|diabetes
5251|NCT03540758|insulin resistance|insulin resistance
5252|NCT03540758|diazoxide|diazoxide
5253|NCT03540719|classification|classification
5254|NCT03540719|questionnaires|questionnaires
5255|NCT03540719|open reduction|open reduction
5256|NCT03540719|internal fixation|internal fixation
5257|NCT03540706|Respiratory Infections|respiratory infections
5258|NCT03540706|C-reactive protein|c-reactive protein
5259|NCT03540706|antibiotic prescription|antibiotic prescription
5260|NCT03540693|Bariatric surgery|bariatric surgery
5261|NCT03540693|gastric bypass surgery|gastric bypass surgery
5262|NCT03540693|sleeve gastrectomy|sleeve gastrectomy
5263|NCT03540693|laparoscopic gastric banding|laparoscopic gastric banding
5264|NCT03540693|food preferences|food preferences
5265|NCT03540693|flavor perception|flavor perception
5266|NCT03540667|Total hip arthroplasty|total hip arthroplasty
5267|NCT03540667|Total knee arthroplasty|total knee arthroplasty
5268|NCT03540667|Total joint arthroplasty|total joint arthroplasty
5269|NCT03540667|Low middle income country|low middle income country
5270|NCT03540667|Enhanced recovery pathway|enhanced recovery pathway
5271|NCT03540641|Binge Eating Disorder|binge eating disorder
5272|NCT03540641|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5273|NCT03540641|Food Craving|food craving
5274|NCT03540602|Polyphenol rich supplementation|polyphenol rich supplementation
5275|NCT03540602|Tart cherry|tart cherry
5276|NCT03540602|Lifting|lifting
5277|NCT03540602|Recovery|recovery
5278|NCT03540563|ctDNA|ctdna
5279|NCT03540511|cardiac surgery|cardiac surgery
5280|NCT03540511|troponin|troponin
5281|NCT03540511|mortality|mortality
5282|NCT03540498|Oral health|oral health
5283|NCT03540498|Probiotics|probiotics
5284|NCT03540498|L. plantarum|l. plantarum
5285|NCT03540498|L. brevis|l. brevis
5286|NCT03540498|Periodontics|periodontics
5287|NCT03540472|tacrolimus|tacrolimus
5288|NCT03540472|refractory pure red cell aplasia|refractory pure red cell aplasia
5289|NCT03540472|prospective study|prospective study
5290|NCT03540420|Atezolizumab|atezolizumab
5291|NCT03540420|Chemoradiotherapy|chemoradiotherapy
5292|NCT03540420|Immunotherapy|immunotherapy
5293|NCT03540407|Cervical carcinoma|cervical carcinoma
5294|NCT03540407|Endometrial adenocarcinoma|endometrial adenocarcinoma
5295|NCT03540407|Oncoxin-Viusid|oncoxin-viusid
5296|NCT03540407|Nutritional supplement|nutritional supplement
5297|NCT03540407|Antioxidant|antioxidant
5298|NCT03540381|Neoatherosclerosis|neoatherosclerosis
5299|NCT03540381|Cholesterol Uptake Capacity|cholesterol uptake capacity
5300|NCT03540368|Gastrointestinal bleeding|gastrointestinal bleeding
5301|NCT03540368|Tranexamic acid|tranexamic acid
5302|NCT03540368|Clinical trial|clinical trial
5303|NCT03540342|coronary artery disease|coronary artery disease
5304|NCT03540342|aortic atherosclerotic disease|aortic atherosclerotic disease
5305|NCT03540342|one-stop|one-stop
5306|NCT03540342|percutaneous coronary intervention|percutaneous coronary intervention
5307|NCT03540342|endovascular aortic repair|endovascular aortic repair
5308|NCT03540329|osteogenesis|osteogenesis
5309|NCT03540329|distraction|distraction
5310|NCT03540329|Lower face asymmetry|lower face asymmetry
5311|NCT03540303|relapsed/refractory, B cell, lymphoma, CAR|relapsed/refractory, b cell, lymphoma, car
5312|NCT03540277|prevention program|prevention program
5313|NCT03540277|body-image|body-image
5314|NCT03540277|self-esteem|self-esteem
5315|NCT03540277|parents|parents
5316|NCT03540277|adolescents|adolescents
5317|NCT03540238|sedation|sedation
5318|NCT03540238|endoscopy|endoscopy
5319|NCT03540238|anesthesia|anesthesia
5320|NCT03540238|gastroenterologist|gastroenterologist
5321|NCT03540225|Progesterone|progesterone
5322|NCT03540199|activated CIK|activated cik
5323|NCT03540199|MUC1|muc1
5324|NCT03540199|bispecific antibody|bispecific antibody
5325|NCT03540199|kidney cancer|kidney cancer
5326|NCT03540147|blood flow restriction|blood flow restriction
5327|NCT03540147|blood pressure|blood pressure
5328|NCT03540147|yoga|yoga
5329|NCT03540134|DBS|dbs
5330|NCT03540121|video|video
5331|NCT03540121|contract|contract
5332|NCT03540121|patient education|patient education
5333|NCT03540108|hypercholesterolemia|hypercholesterolemia
5334|NCT03540108|bile acid synthesis|bile acid synthesis
5335|NCT03540108|cholesterol|cholesterol
5336|NCT03540108|bile salt hydrolysis|bile salt hydrolysis
5337|NCT03540108|vitamin D|vitamin d
5338|NCT03540082|Aging|aging
5339|NCT03540082|Older Adults|older adults
5340|NCT03540082|Fall prevention|fall prevention
5341|NCT03540082|Fall safety|fall safety
5342|NCT03540082|Safe landing|safe landing
5343|NCT03540056|varicocele|varicocele
5344|NCT03540056|testicular growth|testicular growth
5345|NCT03540043|Mild moderate atopic dermatitis|mild moderate atopic dermatitis
5346|NCT03540030|Primary Total Shoulder Arthroplasty|primary total shoulder arthroplasty
5347|NCT03540030|Reverse Total Shoulder Arthroplasty|reverse total shoulder arthroplasty
5348|NCT03540017|Ovarian Cancer|ovarian cancer
5349|NCT03540017|Fallopian Tube Cancer|fallopian tube cancer
5350|NCT03540017|Primary Peritoneal Cancer|primary peritoneal cancer
5351|NCT03539991|Tobacco counseling|tobacco counseling
5352|NCT03539991|e-Learning|e-learning
5353|NCT03539991|Smartphone App|smartphone app
5354|NCT03539991|Virtual meetings|virtual meetings
5355|NCT03539965|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
5356|NCT03539965|Predictive Biomarkers|predictive biomarkers
5357|NCT03539965|Prognostic Biomarkers|prognostic biomarkers
5358|NCT03539965|Complete Pathological Response|complete pathological response
5359|NCT03539965|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
5360|NCT03539965|PD-L1|pd-l1
5361|NCT03539965|PD-L2|pd-l2
5362|NCT03539939|Gingival crevicular fluid|gingival crevicular fluid
5363|NCT03539939|Gingival recession|gingival recession
5364|NCT03539939|Saliva|saliva
5365|NCT03539939|Smoking|smoking
5366|NCT03539939|Wound healing|wound healing
5367|NCT03539926|Cystinuria|cystinuria
5368|NCT03539926|pH Control|ph control
5369|NCT03539887|Ketamine|ketamine
5370|NCT03539887|Depression|depression
5371|NCT03539887|Suicidal Ideation|suicidal ideation
5372|NCT03539887|Alcohol Abuse|alcohol abuse
5373|NCT03539861|End Stage Renal Disease|end stage renal disease
5374|NCT03539861|Hemodialysis|hemodialysis
5375|NCT03539861|Chronic Kidney Disease Stage 5|chronic kidney disease stage 5
5376|NCT03539848|TBI|tbi
5377|NCT03539848|Community Setting|community setting
5378|NCT03539848|Mild TBI|mild tbi
5379|NCT03539835|Breast Cancer Survivors|breast cancer survivors
5380|NCT03539835|Resistance Training|resistance training
5381|NCT03539835|Fatigue|fatigue
5382|NCT03539835|Physical Function|physical function
5383|NCT03539835|Behavioral Function|behavioral function
5384|NCT03539835|Kynurenine metabolism|kynurenine metabolism
5385|NCT03539822|Cabozantinib|cabozantinib
5386|NCT03539822|Durvalumab|durvalumab
5387|NCT03539822|MEDI4736|medi4736
5388|NCT03539809|Branched Chain Amino Acids|branched chain amino acids
5389|NCT03539809|Direct Amino Acid Oxidation|direct amino acid oxidation
5390|NCT03539809|Stable isotopes|stable isotopes
5391|NCT03539796|dural puncture epidurals|dural puncture epidurals
5392|NCT03539796|DPE|dpe
5393|NCT03539796|combined-spinal epidural|combined-spinal epidural
5394|NCT03539796|CSE|cse
5395|NCT03539796|cesarean section|cesarean section
5396|NCT03539796|patient satisfaction|patient satisfaction
5397|NCT03539783|Endotype|endotype
5398|NCT03539783|Pediatric Acute Respiratory Distress Syndrome|pediatric acute respiratory distress syndrome
5399|NCT03539783|Gene Expression|gene expression
5400|NCT03539783|Transcriptomics|transcriptomics
5401|NCT03539770|Lung Development|lung development
5402|NCT03539770|Lung Regeneration|lung regeneration
5403|NCT03539770|Hyperpolarized Helium|hyperpolarized helium
5404|NCT03539757|Liver fibrosis|liver fibrosis
5405|NCT03539757|Fontan surgery|fontan surgery
5406|NCT03539757|MRI|mri
5407|NCT03539757|Novel Methods|novel methods
5408|NCT03539744|Cancer, Multiple Myeloma (MM), Relapsed or Refractory Multiple Myeloma (R/R MM), pharmacokinetics|cancer, multiple myeloma (mm), relapsed or refractory multiple myeloma (r/r mm), pharmacokinetics
5409|NCT03539679|Exercise, sickness absences, health, military fitness|exercise, sickness absences, health, military fitness
5410|NCT03539640|PEEP|peep
5411|NCT03539640|Diaphragm|diaphragm
5412|NCT03539627|diabetes mellitus|diabetes mellitus
5413|NCT03539627|Edarbi|edarbi
5414|NCT03539627|hypertension|hypertension
5415|NCT03539614|Prazosin|prazosin
5416|NCT03539614|Nightmares|nightmares
5417|NCT03539614|N-of-1|n-of-1
5418|NCT03539601|Atopic Dermatitis, Crisaborole ointment 2%, TCS, TCI|atopic dermatitis, crisaborole ointment 2%, tcs, tci
5419|NCT03539588|dry needling|dry needling
5420|NCT03539588|electrical stimulation|electrical stimulation
5421|NCT03539588|E-Stim|e-stim
5422|NCT03539588|LBP|lbp
5423|NCT03539588|low back pain|low back pain
5424|NCT03539588|trigger point|trigger point
5425|NCT03539588|chronic|chronic
5426|NCT03539588|subacute|subacute
5427|NCT03539575|K2|k2
5428|NCT03539575|Spice|spice
5429|NCT03539575|Synthetic Marijuana|synthetic marijuana
5430|NCT03539536|Non-small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
5431|NCT03539536|Cancer|cancer
5432|NCT03539536|Telisotuzumab vedotin|telisotuzumab vedotin
5433|NCT03539536|ABBV-399|abbv-399
5434|NCT03539536|c-Met, c-Met overexpression|c-met, c-met overexpression
5435|NCT03539536|metastatic|metastatic
5436|NCT03539523|L test|l test
5437|NCT03539523|cerebral palsy|cerebral palsy
5438|NCT03539523|children|children
5439|NCT03539523|validity|validity
5440|NCT03539523|reliability|reliability
5441|NCT03539497|biomarker|biomarker
5442|NCT03539445|AIS|ais
5443|NCT03539445|butylphthalide|butylphthalide
5444|NCT03539445|mechanical thrombectomy|mechanical thrombectomy
5445|NCT03539445|iv-rtPA|iv-rtpa
5446|NCT03539445|recovery of dysfunction|recovery of dysfunction
5447|NCT03539419|Psoriasis|psoriasis
5448|NCT03539419|Plaque Psoriasis|plaque psoriasis
5449|NCT03539419|Apremilast|apremilast
5450|NCT03539419|CC-10004|cc-10004
5451|NCT03539367|healthy participants older than 40 years|healthy participants older than 40 years
5452|NCT03539367|lung water|lung water
5453|NCT03539367|prevention|prevention
5454|NCT03539367|acetazolamide|acetazolamide
5455|NCT03539354|Atrial fibrillation|atrial fibrillation
5456|NCT03539354|Spinal cord stimulatoin|spinal cord stimulatoin
5457|NCT03539354|Coronary artery bypass grafting|coronary artery bypass grafting
5458|NCT03539302|Inhaled Flecainide|inhaled flecainide
5459|NCT03539289|IPF|ipf
5460|NCT03539289|Mitigating Adverse Events|mitigating adverse events
5461|NCT03539276|quality improvement|quality improvement
5462|NCT03539276|long term care|long term care
5463|NCT03539276|polypharmacy|polypharmacy
5464|NCT03539250|Radiation-induced temporal lobe injury;NPC|radiation-induced temporal lobe injury;npc
5465|NCT03539250|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5466|NCT03539250|Intensity-modulated radiotherapy|intensity-modulated radiotherapy
5467|NCT03539237|Video demonstration|video demonstration
5468|NCT03539237|Intensity levels|intensity levels
5469|NCT03539237|Physical activity|physical activity
5470|NCT03539237|Self-report|self-report
5471|NCT03539237|Accelerometer|accelerometer
5472|NCT03539185|Airtraq|airtraq
5473|NCT03539185|Fiberoptic|fiberoptic
5474|NCT03539185|Awake|awake
5475|NCT03539185|Tracheal intubation|tracheal intubation
5476|NCT03539185|laryngeal nerve blocks|laryngeal nerve blocks
5477|NCT03539159|Allogeneic serum eye drops|allogeneic serum eye drops
5478|NCT03539159|Micro eye drops|micro eye drops
5479|NCT03539159|Cross-over multicenter trial|cross-over multicenter trial
5480|NCT03539159|Ocular Surface Disease Index (OSDI)|ocular surface disease index (osdi)
5481|NCT03539146|byproducts|byproducts
5482|NCT03539146|functional yogurt|functional yogurt
5483|NCT03539146|satiety|satiety
5484|NCT03539146|sensory analysis|sensory analysis
5485|NCT03539146|sustainable health|sustainable health
5486|NCT03539146|novel food ingredient|novel food ingredient
5487|NCT03539133|STEMI|stemi
5488|NCT03539133|infarction|infarction
5489|NCT03539133|coronary artery disease|coronary artery disease
5490|NCT03539133|comorbidities|comorbidities
5491|NCT03539133|diabetes|diabetes
5492|NCT03539133|anemia|anemia
5493|NCT03539094|Multiple Sclerosis|multiple sclerosis
5494|NCT03539094|Intermittent fasting|intermittent fasting
5495|NCT03539094|western diet|western diet
5496|NCT03539094|microbiome|microbiome
5497|NCT03539081|Epidural Spinal Cord Stimulation|epidural spinal cord stimulation
5498|NCT03539081|Muscle Sympathetic Nerve Activity|muscle sympathetic nerve activity
5499|NCT03539081|Blood Flow|blood flow
5500|NCT03539068|Veteran|veteran
5501|NCT03539068|Mental Health|mental health
5502|NCT03539068|War|war
5503|NCT03539068|Shared decision-making|shared decision-making
5504|NCT03539068|Access to care|access to care
5505|NCT03539055|DRT|drt
5506|NCT03539055|Device related thrombus|device related thrombus
5507|NCT03539055|Dabigatran etexilate|dabigatran etexilate
5508|NCT03539055|Aspirin|aspirin
5509|NCT03539055|Watchman|watchman
5510|NCT03539042|DNA methylation|dna methylation
5511|NCT03539042|Physical activity|physical activity
5512|NCT03539042|Exercise capacity|exercise capacity
5513|NCT03539016|Chronic hepatitis B, Mother-to-child transmission|chronic hepatitis b, mother-to-child transmission
5514|NCT03538990|Nutrition|nutrition
5515|NCT03538990|Dietary Approaches to Stop Hypertension|dietary approaches to stop hypertension
5516|NCT03538990|Cardiometabolic Outcomes|cardiometabolic outcomes
5517|NCT03538990|Pulmonary Artery Pressure|pulmonary artery pressure
5518|NCT03538990|CardioMEMS|cardiomems
5519|NCT03538977|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
5520|NCT03538977|Hydrotherapy|hydrotherapy
5521|NCT03538977|Electromyography|electromyography
5522|NCT03538977|Pain|pain
5523|NCT03538977|Prematurity|prematurity
5524|NCT03538964|Cataract|cataract
5525|NCT03538964|Low Astigmatism|low astigmatism
5526|NCT03538951|actinic keratosis|actinic keratosis
5527|NCT03538951|efficacy|efficacy
5528|NCT03538951|safety|safety
5529|NCT03538951|VDA-1102|vda-1102
5530|NCT03538938|Smoking|smoking
5531|NCT03538938|Smoking cessation|smoking cessation
5532|NCT03538938|Quitline|quitline
5533|NCT03538938|Nicotine Replacement Therapy|nicotine replacement therapy
5534|NCT03538938|SmokefreeTXT text messages|smokefreetxt text messages
5535|NCT03538938|Financial incentives|financial incentives
5536|NCT03538912|empirical antifungal therapy|empirical antifungal therapy
5537|NCT03538912|invasive candidiasis|invasive candidiasis
5538|NCT03538912|biomarkers|biomarkers
5539|NCT03538912|de-escalation|de-escalation
5540|NCT03538912|ICU|icu
5541|NCT03538899|Artemis-deficient Severe Combined Immunodeficiency|artemis-deficient severe combined immunodeficiency
5542|NCT03538899|gene therapy|gene therapy
5543|NCT03538899|autologous stem cell transplant|autologous stem cell transplant
5544|NCT03538886|Coronary revascularization|coronary revascularization
5545|NCT03538873|Subsyndromic symptoms of depression|subsyndromic symptoms of depression
5546|NCT03538873|Subsyndromic symptoms of anxiety|subsyndromic symptoms of anxiety
5547|NCT03538873|Elderly|elderly
5548|NCT03538873|Physical activity|physical activity
5549|NCT03538873|Population-based study|population-based study
5550|NCT03538860|Telepsychiatry|telepsychiatry
5551|NCT03538860|AsynchronousTelepsychiatry|asynchronoustelepsychiatry
5552|NCT03538860|Automated Translation|automated translation
5553|NCT03538847|postoperative pain|postoperative pain
5554|NCT03538847|eye surgery|eye surgery
5555|NCT03538847|vitrectomy|vitrectomy
6143|NCT03535077|Melanoma|melanoma
5556|NCT03538847|pain control protocol|pain control protocol
5557|NCT03538795|stroke|stroke
5558|NCT03538795|hemiplegia|hemiplegia
5559|NCT03538795|hemiparesis|hemiparesis
5560|NCT03538795|arm|arm
5561|NCT03538795|upper-extremity|upper-extremity
5562|NCT03538795|motor impairment|motor impairment
5563|NCT03538795|TMS|tms
5564|NCT03538795|brain stimulation|brain stimulation
5565|NCT03538795|neuroplasticity|neuroplasticity
5566|NCT03538782|percutaneous biliary drainage|percutaneous biliary drainage
5567|NCT03538782|radiation exposure|radiation exposure
5568|NCT03538756|Balance|balance
5569|NCT03538756|Peripheral Neuropathy|peripheral neuropathy
5570|NCT03538756|Neuropathy|neuropathy
5571|NCT03538743|Type 2 diabetes mellitus|type 2 diabetes mellitus
5572|NCT03538717|Axitinib,|axitinib,
5573|NCT03538717|Renal Carcinoma,|renal carcinoma,
5574|NCT03538717|Long responders|long responders
5575|NCT03538704|Endometrial cancer|endometrial cancer
5576|NCT03538704|Atypical hyperplasia|atypical hyperplasia
5577|NCT03538704|Fertility-preserving|fertility-preserving
5578|NCT03538704|Remission time|remission time
5579|NCT03538704|Recurrence|recurrence
5580|NCT03538704|Pregnancy|pregnancy
5581|NCT03538704|Progesterone receptor|progesterone receptor
5582|NCT03538691|Brexpiprazole|brexpiprazole
5584|NCT03538665|Endometrial Cancer|endometrial cancer
5585|NCT03538665|Somatic Mutations|somatic mutations
5586|NCT03538665|Early Detection|early detection
5587|NCT03538665|Tampon Sampling|tampon sampling
5588|NCT03538665|Tissue Discovery|tissue discovery
5589|NCT03538652|CBT|cbt
5590|NCT03538652|Mindfulness|mindfulness
5591|NCT03538652|Opiates|opiates
5592|NCT03538652|Ecological Monetary Assessment (EMA)|ecological monetary assessment (ema)
5593|NCT03538652|Microrandomized Trial|microrandomized trial
5594|NCT03538639|Etiology of Rare and Orphan Diseases with Vascular Phenotype|etiology of rare and orphan diseases with vascular phenotype
5595|NCT03538639|Natural History of Rare and Orphan Diseases with Vascular Phenotype|natural history of rare and orphan diseases with vascular phenotype
5596|NCT03538639|Pathophysiology of Uncommon Vascular Diseases|pathophysiology of uncommon vascular diseases
5597|NCT03538639|Undiagnosed Diseases|undiagnosed diseases
5598|NCT03538639|Rare Human Diseases with Vascular Features|rare human diseases with vascular features
5599|NCT03538626|Immune Cells|immune cells
5600|NCT03538626|bNAb|bnab
5601|NCT03538626|Plasma Cell|plasma cell
5602|NCT03538626|HIV|hiv
5603|NCT03538626|Immunotherapy|immunotherapy
5604|NCT03538613|Adoptive Cell Therapy|adoptive cell therapy
5605|NCT03538613|Immunotherapy|immunotherapy
5606|NCT03538613|Gene Therapy|gene therapy
5607|NCT03538600|Blood|blood
5608|NCT03538600|Microbiome Analysis|microbiome analysis
5609|NCT03538600|Stool|stool
5610|NCT03538600|Saliva|saliva
5611|NCT03538600|Skin|skin
5612|NCT03538587|high-grade astrocytoma|high-grade astrocytoma
5613|NCT03538587|Diffuse Intrinsic Pontine Glioma|diffuse intrinsic pontine glioma
5614|NCT03538587|Glioblastoma Multiforme|glioblastoma multiforme
5615|NCT03538587|Meditation|meditation
5616|NCT03538587|Quality of Life|quality of life
5617|NCT03538548|Cocaine Abuse|cocaine abuse
5618|NCT03538548|Cocaine Use Disorder|cocaine use disorder
5619|NCT03538548|Substance-Related Disorders|substance-related disorders
5620|NCT03538535|reinforcement learning|reinforcement learning
5621|NCT03538535|computational models|computational models
5622|NCT03538535|neuroimaging|neuroimaging
5623|NCT03538457|Bariatric surgery|bariatric surgery
5624|NCT03538457|Gastrointestinal tract|gastrointestinal tract
5625|NCT03538457|Biological availability|biological availability
5626|NCT03538457|Pharmacokinetics|pharmacokinetics
5627|NCT03538457|Acetaminophen|acetaminophen
5628|NCT03538431|Autism Spectrum Disorder|autism spectrum disorder
5629|NCT03538431|ASD|asd
5630|NCT03538431|Anxiety|anxiety
5631|NCT03538418|Frailty|frailty
5632|NCT03538418|Wearable technology|wearable technology
5633|NCT03538418|Physical activity|physical activity
5634|NCT03538418|Behaviour change|behaviour change
5635|NCT03538405|harmonic techniques|harmonic techniques
5636|NCT03538405|supporting cushions|supporting cushions
5637|NCT03538405|intervention|intervention
5638|NCT03538379|Tourniquets|tourniquets
5639|NCT03538379|Bleeding Control Basic (B-Con) Course|bleeding control basic (b-con) course
5640|NCT03538379|Layperson training|layperson training
5641|NCT03538366|Ulcerative Colitis|ulcerative colitis
5642|NCT03538366|Inflammatory bowel disease|inflammatory bowel disease
5643|NCT03538366|Pouchitis|pouchitis
5644|NCT03538366|Fecal microbiota transplant|fecal microbiota transplant
5645|NCT03538366|Fecal microbiota treatment|fecal microbiota treatment
5646|NCT03538340|Thoracotomy|thoracotomy
5647|NCT03538340|Cryoanalgesia|cryoanalgesia
5648|NCT03538340|Pain|pain
5649|NCT03538327|essential hypertension|essential hypertension
5650|NCT03538327|insulin resistance|insulin resistance
5651|NCT03538327|silybin|silybin
5652|NCT03538262|SURE-PD3|sure-pd3
5653|NCT03538262|STEADY-PD III|steady-pd iii
5654|NCT03538262|Parkinson disease|parkinson disease
5655|NCT03538262|PD|pd
5656|NCT03538262|Parkinson Study Group (PSG)|parkinson study group (psg)
5657|NCT03538262|Telemedicine|telemedicine
5658|NCT03538262|Smartphone|smartphone
5659|NCT03538262|Disease progression|disease progression
5660|NCT03538262|Televisits|televisits
5661|NCT03538262|Patient-reported outcomes|patient-reported outcomes
5662|NCT03538249|Heart Failure|heart failure
5663|NCT03538249|Aerobic Exercise|aerobic exercise
5664|NCT03538249|Respiratory Muscle Training|respiratory muscle training
5665|NCT03538249|Strength Training|strength training
5666|NCT03538223|Music listening|music listening
5667|NCT03538223|Radiotherapy|radiotherapy
5668|NCT03538223|Breast cancer|breast cancer
5669|NCT03538223|Psychological rehabilitation|psychological rehabilitation
5670|NCT03538210|obesity, bariatric surgery, gastrointestinal functions, adipose tissu, steatohepatitis|obesity, bariatric surgery, gastrointestinal functions, adipose tissu, steatohepatitis
5671|NCT03538197|suicide attempt|suicide attempt
5672|NCT03538197|suicide re attempt|suicide re attempt
5673|NCT03538158|Older adults|older adults
5674|NCT03538158|Physical well-being|physical well-being
5675|NCT03538158|Quality of life|quality of life
5676|NCT03538119|Cardiac Rehabilitation|cardiac rehabilitation
5677|NCT03538119|High Intensity Interval Training|high intensity interval training
5678|NCT03538119|Exercise-based Rehabilitation|exercise-based rehabilitation
5679|NCT03538119|Secondary prevention|secondary prevention
5680|NCT03538119|Sedentary Behavior|sedentary behavior
5681|NCT03538106|Cesrean delivery|cesrean delivery
5682|NCT03538106|Risks factors|risks factors
5683|NCT03538106|Diabetes Type 1|diabetes type 1
5684|NCT03538093|arthrodesis|arthrodesis
5685|NCT03538093|core stabilization|core stabilization
5686|NCT03538093|physical therapy|physical therapy
5687|NCT03538080|venous disease|venous disease
5688|NCT03538080|peripheral vascular disease|peripheral vascular disease
5689|NCT03538080|vascular surgery|vascular surgery
5690|NCT03538080|ultrasound imaging|ultrasound imaging
5691|NCT03538067|percutaneous coronary intervention|percutaneous coronary intervention
5692|NCT03538067|stent apposition|stent apposition
5693|NCT03538067|stent deployment|stent deployment
5694|NCT03538067|stent expansion|stent expansion
5695|NCT03538067|intravascular ultrasound|intravascular ultrasound
5696|NCT03538054|Fibromyalgia|fibromyalgia
5697|NCT03538041|autoimmune hemolytic anemia|autoimmune hemolytic anemia
5698|NCT03538041|phosphatidylinositol 3-kinase (PI3K) inhibitor|phosphatidylinositol 3-kinase (pi3k) inhibitor
5699|NCT03538028|lymphocyte activation gene (LAG)|lymphocyte activation gene (lag)
5701|NCT03538028|advanced solid tumor|advanced solid tumor
5702|NCT03538028|metastatic solid tumor|metastatic solid tumor
5703|NCT03538028|relapsed/refractory DLCBL|relapsed/refractory dlcbl
5704|NCT03538015|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5705|NCT03538015|β-blocker|β-blocker
5706|NCT03538002|blue light filtering spectacle lens|blue light filtering spectacle lens
5707|NCT03537989|fluid therapy|fluid therapy
5708|NCT03537989|Restricted fluid therapy|restricted fluid therapy
5709|NCT03537989|saline|saline
5710|NCT03537963|HCT survivors|hct survivors
5711|NCT03537963|hematopoietic stem cell transplant (HCT)|hematopoietic stem cell transplant (hct)
5712|NCT03537963|survivors of hematopoietic stem cell transplant|survivors of hematopoietic stem cell transplant
5713|NCT03537950|Cannabidiol|cannabidiol
5714|NCT03537950|Cannabidivarin|cannabidivarin
5715|NCT03537950|E-I balance|e-i balance
5716|NCT03537950|pharmacological imaging|pharmacological imaging
5717|NCT03537924|healthy participants older than 40 years|healthy participants older than 40 years
5718|NCT03537924|right heart function during exercise|right heart function during exercise
5719|NCT03537924|prevention|prevention
5720|NCT03537924|acetazolamide|acetazolamide
5721|NCT03537898|balanced crystalloid|balanced crystalloid
5722|NCT03537898|crystalloid|crystalloid
5723|NCT03537898|isotonic|isotonic
5724|NCT03537898|acetate|acetate
5725|NCT03537898|non-acetate|non-acetate
5726|NCT03537898|lactated Ringer's|lactated ringer's
5727|NCT03537898|Normosol|normosol
5728|NCT03537859|hospitalized child|hospitalized child
5729|NCT03537859|salivary cortisol|salivary cortisol
5730|NCT03537859|augmented reality|augmented reality
5731|NCT03537807|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5732|NCT03537807|ALS|als
5733|NCT03537807|Lou Gehrig Disease|lou gehrig disease
5734|NCT03537807|Lou Gehrig's Disease|lou gehrig's disease
5735|NCT03537807|Lou-Gehrigs Disease|lou-gehrigs disease
5736|NCT03537807|Motor Neuron Disease, Amyotrophic Lateral Sclerosis|motor neuron disease, amyotrophic lateral sclerosis
5737|NCT03537807|Riluzole|riluzole
5738|NCT03537807|Rilutek®|rilutek®
5739|NCT03537807|Sublingual|sublingual
5740|NCT03537807|Oral formulation|oral formulation
5741|NCT03537807|Neuroprotective Agents|neuroprotective agents
5742|NCT03537807|Administration, Sublingual|administration, sublingual
5743|NCT03537807|Administration, Oral|administration, oral
5744|NCT03537807|Biological Availability|biological availability
5745|NCT03537781|food choice, food labels|food choice, food labels
5746|NCT03537742|Heart Transplant|heart transplant
5747|NCT03537729|Alzheimer's disease|alzheimer's disease
5748|NCT03537729|Age related memory disorders|age related memory disorders
5749|NCT03537729|Environment design|environment design
5750|NCT03537729|Long term care|long term care
5751|NCT03537729|Dementia|dementia
5752|NCT03537716|Abdominal Fat|abdominal fat
5753|NCT03537703|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5754|NCT03537703|tDCS|tdcs
5755|NCT03537703|Auditory Processing|auditory processing
5756|NCT03537703|tone matching|tone matching
5757|NCT03537664|Periapical Periodontitis|periapical periodontitis
5758|NCT03537664|Bacterial Infections|bacterial infections
5759|NCT03537664|Root Canal Preparation|root canal preparation
5760|NCT03537664|Calcium Hydroxide|calcium hydroxide
5761|NCT03537664|Real-Time Polymerase Chain Reaction|real-time polymerase chain reaction
5762|NCT03537664|RNA-Directed DNA Polymerase|rna-directed dna polymerase
5763|NCT03537638|Lupus|lupus
5764|NCT03537638|Quality of life|quality of life
5765|NCT03537638|Multicomponent intervention|multicomponent intervention
5766|NCT03537638|Clinical Practice Guideline|clinical practice guideline
5767|NCT03537638|Computerized clinical decision support system|computerized clinical decision support system
5768|NCT03537638|Activity|activity
5769|NCT03537612|Post-operative pain|post-operative pain
5770|NCT03537573|Pragmatic clinical trial|pragmatic clinical trial
5771|NCT03537573|Primary care|primary care
5772|NCT03537573|Provider-targeted|provider-targeted
5773|NCT03537573|Behavioral intervention|behavioral intervention
5774|NCT03537573|Electronic health record|electronic health record
5775|NCT03537547|treatment naive|treatment naive
5776|NCT03537547|major depression|major depression
5777|NCT03537547|pharmacotherapy|pharmacotherapy
5778|NCT03537547|pharmacogenomic|pharmacogenomic
5779|NCT03537547|genomics|genomics
5780|NCT03537521|severe bleeding|severe bleeding
5781|NCT03537521|dabigatran|dabigatran
5782|NCT03537521|rivaroxaban|rivaroxaban
5783|NCT03537521|apixaban|apixaban
5784|NCT03537521|edoxaban|edoxaban
5785|NCT03537521|PCC|pcc
5786|NCT03537521|aPCC|apcc
5787|NCT03537521|rVIIa|rviia
5788|NCT03537521|hemodialysis|hemodialysis
5789|NCT03537521|antidots|antidots
5790|NCT03537521|idarucizumab|idarucizumab
5791|NCT03537521|urgent surgery|urgent surgery
5792|NCT03537521|andexanet alpha|andexanet alpha
5793|NCT03537508|Meningococcal meningitis|meningococcal meningitis
5794|NCT03537508|MenACYW conjugate vaccine|menacyw conjugate vaccine
5795|NCT03537508|Quadrivalent meningococcal vaccine|quadrivalent meningococcal vaccine
5796|NCT03537495|tuberculous meningitis|tuberculous meningitis
5797|NCT03537495|linezolid|linezolid
5798|NCT03537495|pharmacokinetic study|pharmacokinetic study
5799|NCT03537456|Dermal Filler|dermal filler
5800|NCT03537456|Hyaluronic Acid|hyaluronic acid
5801|NCT03537443|Childhood|childhood
5802|NCT03537443|Vitamin D|vitamin d
5803|NCT03537443|Bone mineral density|bone mineral density
5804|NCT03537443|Bone mineral content|bone mineral content
5805|NCT03537430|Postoperative pain|postoperative pain
5806|NCT03537430|Tubeless Uniportal Video-assisted Thoracoscopic Surgery|tubeless uniportal video-assisted thoracoscopic surgery
5807|NCT03537430|Hospital costs|hospital costs
5808|NCT03537404|hepatitis C|hepatitis c
5809|NCT03537404|chronic|chronic
5810|NCT03537404|pharmacokinetics|pharmacokinetics
5811|NCT03537404|HIV|hiv
5812|NCT03537404|coinfection|coinfection
5813|NCT03537404|concomitant therapy|concomitant therapy
5814|NCT03537391|prostate cancer|prostate cancer
5815|NCT03537391|imaging of prostate cancer|imaging of prostate cancer
5816|NCT03537391|staging of prostate cancer|staging of prostate cancer
5817|NCT03537391|prostate specific membrane antigen (PSMA)|prostate specific membrane antigen (psma)
5818|NCT03537391|positron emission tomography|positron emission tomography
5819|NCT03537391|bone scintigraphy|bone scintigraphy
5820|NCT03537391|whole body magnetic resonance imaging|whole body magnetic resonance imaging
5821|NCT03537391|whole body computer tomography|whole body computer tomography
5822|NCT03537391|single photon emission tomography (SPECT)|single photon emission tomography (spect)
5823|NCT03537378|Hybrid APC,Early Central Lung Cancer,|hybrid apc,early central lung cancer,
5824|NCT03537365|Human Milk Fortification|human milk fortification
5825|NCT03537365|Bovine Colostrum|bovine colostrum
5826|NCT03537365|Very Preterm Infants|very preterm infants
5827|NCT03537365|Enteral feeding|enteral feeding
5828|NCT03537365|Human Milk|human milk
5829|NCT03537365|Neonatology|neonatology
5830|NCT03537365|Colostrum|colostrum
5831|NCT03537326|doping|doping
5832|NCT03537261|Parent Training|parent training
5833|NCT03537261|Aggressive Behavior|aggressive behavior
5834|NCT03537235|Libramed|libramed
5835|NCT03537235|Policaptil Gel retard|policaptil gel retard
5836|NCT03537235|Overweigth|overweigth
5837|NCT03537235|Obesity|obesity
5838|NCT03537235|Medical Device|medical device
5839|NCT03537235|glycemic profile|glycemic profile
5840|NCT03537235|incretin|incretin
5841|NCT03537222|quality of life|quality of life
5842|NCT03537222|psychometrics|psychometrics
5843|NCT03537196|People who inject drugs|people who inject drugs
5844|NCT03537196|Hepatitis C|hepatitis c
5845|NCT03537196|Direct Acting Antiviral|direct acting antiviral
5846|NCT03537196|HCV Elimination|hcv elimination
5847|NCT03537196|Vietnam|vietnam
5848|NCT03537183|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
5849|NCT03537183|exercise training|exercise training
5850|NCT03537183|PCWP|pcwp
5851|NCT03537157|Crohn Disease recurrence|crohn disease recurrence
5852|NCT03537144|Patent ductus arteriosus|patent ductus arteriosus
5853|NCT03537144|acetaminophen|acetaminophen
5854|NCT03537144|indomethacin|indomethacin
5855|NCT03537131|diabetes|diabetes
5856|NCT03537131|dapagliflozin|dapagliflozin
5857|NCT03537131|exercise|exercise
5858|NCT03537131|hypoglycemia|hypoglycemia
5859|NCT03537105|cytokine|cytokine
5860|NCT03537105|skin inflammation|skin inflammation
5861|NCT03537079|hypoxia|hypoxia
5862|NCT03537079|exercise training|exercise training
5863|NCT03537079|heart failure|heart failure
5864|NCT03537079|cardiac remodeling|cardiac remodeling
5865|NCT03537053|Sedentary Lifestyle|sedentary lifestyle
5866|NCT03537027|vitamin D3|vitamin d3
5867|NCT03537027|cholecalciferol|cholecalciferol
5868|NCT03537027|calcidiol|calcidiol
5869|NCT03537027|25-hydroxyvitamin D|25-hydroxyvitamin d
5870|NCT03537027|gene expression|gene expression
5871|NCT03537027|vitamin D receptor|vitamin d receptor
5872|NCT03537027|adults|adults
5873|NCT03537027|clinical trial|clinical trial
5874|NCT03537001|Methoxyflurane|methoxyflurane
5875|NCT03537001|Penthrox|penthrox
5876|NCT03537001|anesthetic|anesthetic
5877|NCT03537001|analgesia|analgesia
5878|NCT03537001|acute|acute
5879|NCT03537001|traumatic|traumatic
5880|NCT03537001|pain|pain
5881|NCT03537001|prehospital setting|prehospital setting
5882|NCT03537001|visual numeric scale|visual numeric scale
5883|NCT03536988|Ulcerative Colitiis|ulcerative colitiis
5884|NCT03536988|Ileal pouch anal anastomosis|ileal pouch anal anastomosis
5885|NCT03536988|Transanal Minimally Invasive Surgery|transanal minimally invasive surgery
5886|NCT03536988|Postoperative Outcome|postoperative outcome
5887|NCT03536975|Dementia|dementia
5888|NCT03536975|Mild Dementia|mild dementia
5889|NCT03536975|Cognitive Impairment|cognitive impairment
5890|NCT03536923|Female|female
5891|NCT03536910|copeptin levels|copeptin levels
5892|NCT03536910|Cesarean section|cesarean section
5893|NCT03536910|general anesthesia|general anesthesia
5894|NCT03536910|spinal anesthesia|spinal anesthesia
5895|NCT03536897|breast cancer|breast cancer
5896|NCT03536897|invasive ductal carcinoma|invasive ductal carcinoma
5897|NCT03536897|intraoperative radiation therapy|intraoperative radiation therapy
5898|NCT03536897|iort|iort
5899|NCT03536884|Bimekizumab|bimekizumab
5901|NCT03536884|Psoriasis|psoriasis
5902|NCT03536858|End Stage Renal Disease|end stage renal disease
5903|NCT03536858|Hemodialysis|hemodialysis
5904|NCT03536858|Social Network|social network
5905|NCT03536832|Cesarean Section; Complications|cesarean section; complications
5906|NCT03536832|suture material|suture material
5907|NCT03536806|Pharmacological cardioversion|pharmacological cardioversion
5908|NCT03536806|Canrenone|canrenone
5909|NCT03536793|Early detection of pancreatic cancer|early detection of pancreatic cancer
5910|NCT03536793|Endo180|endo180
5911|NCT03536793|Urinary tissue factor|urinary tissue factor
5912|NCT03536728|DFMO|dfmo
5913|NCT03536728|AMXT 1501|amxt 1501
5914|NCT03536689|Amniotic fluid index|amniotic fluid index
5915|NCT03536676|Breakfast|breakfast
5916|NCT03536676|Obesity|obesity
5917|NCT03536676|Mood|mood
5918|NCT03536676|Eating Behavior|eating behavior
5919|NCT03536676|Cognitive Function|cognitive function
5920|NCT03536650|Metabolic diseases|metabolic diseases
5921|NCT03536624|prevention|prevention
5922|NCT03536624|biomarkers|biomarkers
5923|NCT03536624|stress|stress
5924|NCT03536624|burn out|burn out
5925|NCT03536624|occupation|occupation
5926|NCT03536624|work|work
5927|NCT03536624|spa bath|spa bath
5928|NCT03536611|dabigatran|dabigatran
5929|NCT03536611|warfarin|warfarin
5930|NCT03536611|non-valve atrial fibrillation|non-valve atrial fibrillation
5931|NCT03536611|percutaneous coronary intervention|percutaneous coronary intervention
5932|NCT03536572|Sleep Apnea Syndromes|sleep apnea syndromes
5933|NCT03536572|Chronic Disease|chronic disease
5934|NCT03536572|Adherence|adherence
5935|NCT03536572|Self-Care|self-care
5936|NCT03536572|Patient Outcomes|patient outcomes
5937|NCT03536559|gold|gold
5938|NCT03536559|nanocrystal|nanocrystal
5939|NCT03536559|multifocal visual evoked potential|multifocal visual evoked potential
5940|NCT03536559|full field visual evoked potential|full field visual evoked potential
5941|NCT03536559|low contrast vision|low contrast vision
5942|NCT03536559|low contrast letter acuity|low contrast letter acuity
5943|NCT03536559|remyelination|remyelination
5944|NCT03536559|demyelination|demyelination
5945|NCT03536546|Veterans Health|veterans health
5946|NCT03536546|Intervention, Brief|intervention, brief
5947|NCT03536546|Peer|peer
6045|NCT03535805|Children and Adolescents|children and adolescents
5948|NCT03536520|healthy participants older than 40 years|healthy participants older than 40 years
5949|NCT03536520|cognition|cognition
5950|NCT03536520|visuo-motor learning performance|visuo-motor learning performance
5951|NCT03536520|prevention|prevention
5952|NCT03536520|acetazolamide|acetazolamide
5953|NCT03536507|healthy participants older than 40 years|healthy participants older than 40 years
5954|NCT03536507|sleep disordered breathing|sleep disordered breathing
5955|NCT03536507|periodic breathing|periodic breathing
5956|NCT03536507|prevention|prevention
5957|NCT03536507|acetazolamide|acetazolamide
5958|NCT03536494|Overactive bladder|overactive bladder
5959|NCT03536494|Mirabegron|mirabegron
5960|NCT03536494|Deprescribing|deprescribing
5961|NCT03536494|Persistence|persistence
5962|NCT03536494|Patient-Centered Care|patient-centered care
5963|NCT03536494|Inappropriate prescribing|inappropriate prescribing
5964|NCT03536468|Tooth loss, edentulousness, psychology, oral health-related|tooth loss, edentulousness, psychology, oral health-related
5965|NCT03536455|healthy participants older than 40 years|healthy participants older than 40 years
5966|NCT03536455|exercise performance|exercise performance
5967|NCT03536455|prevention|prevention
5968|NCT03536455|acetazolamide|acetazolamide
5969|NCT03536442|antenatal|antenatal
5970|NCT03536442|postpartum|postpartum
5971|NCT03536442|mental health|mental health
5972|NCT03536429|healthy participants older than 40 years|healthy participants older than 40 years
5973|NCT03536429|postural control|postural control
5974|NCT03536429|prevention|prevention
5975|NCT03536429|acetazolamide|acetazolamide
5976|NCT03536416|Self-management|self-management
5977|NCT03536416|Children and young people|children and young people
5978|NCT03536416|Schools|schools
5979|NCT03536377|Diabetes Mellitus Remission|diabetes mellitus remission
5980|NCT03536377|Prediabetic State|prediabetic state
5981|NCT03536377|caloric restriction|caloric restriction
5982|NCT03536377|weight loss|weight loss
5983|NCT03536377|diet|diet
5984|NCT03536377|Barbados|barbados
5985|NCT03536351|social skills|social skills
5986|NCT03536351|child|child
5987|NCT03536351|theory of mind|theory of mind
5988|NCT03536351|drama|drama
5989|NCT03536351|occupational therapy|occupational therapy
5990|NCT03536351|speech-language pathology|speech-language pathology
5991|NCT03536351|neural activation|neural activation
5992|NCT03536338|Sit-to-stand; Spinal Stimulation; transcutaneous|sit-to-stand; spinal stimulation; transcutaneous
5993|NCT03536299|Physical therapy|physical therapy
5994|NCT03536299|Gait training|gait training
5995|NCT03536299|Cognitive-motor interference|cognitive-motor interference
5996|NCT03536299|Rehabilitation|rehabilitation
5997|NCT03536273|sedentary|sedentary
5998|NCT03536273|pilates exercises|pilates exercises
5999|NCT03536273|functional movement screen|functional movement screen
6000|NCT03536273|posture|posture
6001|NCT03536273|quality of life|quality of life
6002|NCT03536247|bile duct stones|bile duct stones
6003|NCT03536247|choledocholithiasis|choledocholithiasis
6004|NCT03536247|ERCP|ercp
6005|NCT03536247|endoscopic retrograde cholangiopancreatograhy|endoscopic retrograde cholangiopancreatograhy
6006|NCT03536195|renal replacement therapy|renal replacement therapy
6007|NCT03536195|acute renal failure|acute renal failure
6008|NCT03536195|coagulation|coagulation
6009|NCT03536195|bleeding|bleeding
6010|NCT03536156|Dental implant|dental implant
6011|NCT03536156|Implant Emergence Profile|implant emergence profile
6012|NCT03536130|chest tube, lung resection, air leakage|chest tube, lung resection, air leakage
6013|NCT03536078|home phototherapy|home phototherapy
6014|NCT03536078|parental bonding|parental bonding
6015|NCT03536039|CNS lymphoma|cns lymphoma
6016|NCT03536039|BBB permeabilization|bbb permeabilization
6017|NCT03536039|R-CHOP|r-chop
6018|NCT03536039|TNF|tnf
6019|NCT03536000|Cardiac function|cardiac function
6020|NCT03536000|Fetal|fetal
6021|NCT03536000|Strain|strain
6022|NCT03535935|Chinese medicine|chinese medicine
6023|NCT03535935|Astragalus|astragalus
6024|NCT03535935|Pragmatic trial|pragmatic trial
6025|NCT03535922|Hemodialysis|hemodialysis
6026|NCT03535922|Chronic Kidney Disease|chronic kidney disease
6027|NCT03535909|CHF|chf
6028|NCT03535909|central venous pressure|central venous pressure
6029|NCT03535909|noninvasive|noninvasive
6030|NCT03535909|ADHF|adhf
6031|NCT03535909|stroke volume|stroke volume
6032|NCT03535857|overactive bladder|overactive bladder
6033|NCT03535857|OAB|oab
6034|NCT03535857|urge urinary incontinence|urge urinary incontinence
6035|NCT03535857|PTNS|ptns
6036|NCT03535844|Wolfberry (Goji berry)|wolfberry (goji berry)
6037|NCT03535844|Healthy diet|healthy diet
6038|NCT03535844|Cardiovascular diseases|cardiovascular diseases
6039|NCT03535844|Endothelial function|endothelial function
6040|NCT03535844|Lipidomics|lipidomics
6041|NCT03535844|Middle-aged and older adults|middle-aged and older adults
6042|NCT03535844|Oxidative stress|oxidative stress
6043|NCT03535844|Inflammation|inflammation
6044|NCT03535805|Cognitive and Behavioral Therapies|cognitive and behavioral therapies
6046|NCT03535805|Community Health Care|community health care
6047|NCT03535805|Early Intervention|early intervention
6048|NCT03535740|Drug Therapy|drug therapy
6049|NCT03535714|anorexia nervosa|anorexia nervosa
6050|NCT03535714|treatment|treatment
6051|NCT03535714|adolescents|adolescents
6052|NCT03535714|young adults|young adults
6053|NCT03535688|Chronic Pain|chronic pain
6054|NCT03535688|Low Back Pain|low back pain
6055|NCT03535688|D-cycloserine|d-cycloserine
6056|NCT03535649|Drug therapy|drug therapy
6057|NCT03535636|Polysomnography|polysomnography
6058|NCT03535636|Refugees|refugees
6059|NCT03535623|remote ischemic preconditioning|remote ischemic preconditioning
6060|NCT03535623|free flap reconstruction|free flap reconstruction
6061|NCT03535623|preoperative radiotherapy|preoperative radiotherapy
6062|NCT03535610|Embolization|embolization
6063|NCT03535610|Uterine Leiomyoma|uterine leiomyoma
6064|NCT03535610|Embospheres|embospheres
6065|NCT03535610|Microspheres|microspheres
6066|NCT03535597|Transradial Access|transradial access
6067|NCT03535597|Hemostasis|hemostasis
6068|NCT03535571|Energy increase|energy increase
6069|NCT03535571|Energy|energy
6070|NCT03535571|Healthy|healthy
6071|NCT03535571|anti-inflammatory|anti-inflammatory
6072|NCT03535571|Open-label|open-label
6073|NCT03535571|Salmon protein|salmon protein
6074|NCT03535571|Natural health product|natural health product
6075|NCT03535571|Dietary supplement|dietary supplement
6076|NCT03535545|PET Imaging|pet imaging
6077|NCT03535545|Molecular Imaging|molecular imaging
6078|NCT03535532|resistant hypertension|resistant hypertension
6079|NCT03535532|Adrenal Disease|adrenal disease
6080|NCT03535532|medical treatment|medical treatment
6081|NCT03535532|laparoscopic adrenalectomy|laparoscopic adrenalectomy
6082|NCT03535506|Breast Cancer|breast cancer
6083|NCT03535506|DCIS|dcis
6084|NCT03535506|Ductal Carcinoma In Situ|ductal carcinoma in situ
6085|NCT03535506|Palbociclib|palbociclib
6086|NCT03535493|Acceptance and Commitment Therapy (ACT)|acceptance and commitment therapy (act)
6087|NCT03535493|Burnout Syndrome|burnout syndrome
6088|NCT03535493|Float REST|float rest
6089|NCT03535493|Float Therapy|float therapy
6090|NCT03535493|Floatation Restricted Environmental Stimulation Therapy|floatation restricted environmental stimulation therapy
6091|NCT03535480|ovarian reserve|ovarian reserve
6092|NCT03535467|Caregivers|caregivers
6093|NCT03535467|Exoskeleton Device|exoskeleton device
6094|NCT03535467|Stroke Rehabilitation|stroke rehabilitation
6095|NCT03535454|Fibromyalgia|fibromyalgia
6096|NCT03535454|Musculoskeletal Diseases|musculoskeletal diseases
6097|NCT03535454|Work|work
6098|NCT03535441|hemorrhagic shock|hemorrhagic shock
6099|NCT03535441|HMGB1|hmgb1
6100|NCT03535376|Bariatric surgery|bariatric surgery
6101|NCT03535376|Gastrointestinal tract|gastrointestinal tract
6102|NCT03535376|Biological availability|biological availability
6103|NCT03535376|Pharmacokinetics|pharmacokinetics
6104|NCT03535376|Valsartan|valsartan
6105|NCT03535363|Osimertinib|osimertinib
6106|NCT03535350|ibrutinib|ibrutinib
6107|NCT03535350|temozolomide|temozolomide
6108|NCT03535350|brain cancer|brain cancer
6109|NCT03535337|Interventions|interventions
6110|NCT03535337|youth living with HIV|youth living with hiv
6111|NCT03535337|mHealth|mhealth
6112|NCT03535337|ART adherence|art adherence
6113|NCT03535337|adaptive intervention|adaptive intervention
6114|NCT03535337|cell phone|cell phone
6115|NCT03535337|text messaging|text messaging
6116|NCT03535285|periodontal ligament|periodontal ligament
6117|NCT03535285|dentoalveolar|dentoalveolar
6118|NCT03535285|distraction|distraction
6119|NCT03535285|orthodontic|orthodontic
6120|NCT03535259|hepatocellular carcinoma|hepatocellular carcinoma
6121|NCT03535259|intensity-modulated radiotherapy|intensity-modulated radiotherapy
6122|NCT03535259|sorafenib|sorafenib
6123|NCT03535259|portal vein thrombosis|portal vein thrombosis
6124|NCT03535259|lymph node metastasis|lymph node metastasis
6125|NCT03535246|immunotherapy|immunotherapy
6126|NCT03535246|T cell|t cell
6127|NCT03535246|Cancer|cancer
6128|NCT03535246|Gene therapy|gene therapy
6129|NCT03535233|Alopecia areata, intralesional corticosteroid, minoxidil, clobetasol propionate, IL-23, TGFβ-1|alopecia areata, intralesional corticosteroid, minoxidil, clobetasol propionate, il-23, tgfβ-1
6130|NCT03535220|Multiple Myeloma|multiple myeloma
6131|NCT03535220|Sickle Cell Disease|sickle cell disease
6132|NCT03535194|Interleukin-23 (IL-23)|interleukin-23 (il-23)
6133|NCT03535168|Healthy volunteers|healthy volunteers
6134|NCT03535155|Ultrasound image, Neuraxial anesthesia, Landmark|ultrasound image, neuraxial anesthesia, landmark
6135|NCT03535129|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
6136|NCT03535129|Neurofeedback|neurofeedback
6137|NCT03535129|Drug Relapse|drug relapse
6138|NCT03535090|Graves' Disease|graves' disease
6139|NCT03535090|Graves Ophthalmopathy|graves ophthalmopathy
6140|NCT03535090|Blood Coagulation|blood coagulation
6141|NCT03535090|Venous Thromboembolism|venous thromboembolism
6142|NCT03535090|Methylprednisolone|methylprednisolone
6144|NCT03535077|Nevus|nevus
6145|NCT03535077|Mole|mole
6146|NCT03535077|Atypical Nevi|atypical nevi
6147|NCT03535064|HAND HYGIENE, HAND WASHING, INFLUENZA, SCHOOL ABSENCE, SCHOOL CHILDREN, UPPER RESPIRATORY INFECTIONS|hand hygiene, hand washing, influenza, school absence, school children, upper respiratory infections
6148|NCT03535051|vitiligo|vitiligo
6149|NCT03535051|fractional carbon dioxide laser|fractional carbon dioxide laser
6150|NCT03535051|tacrolimus|tacrolimus
6151|NCT03535051|drug delivery|drug delivery
6152|NCT03535038|Intravascular volume|intravascular volume
6153|NCT03535038|Inferior vena cava diameter|inferior vena cava diameter
6154|NCT03535038|Ultrasonography|ultrasonography
6155|NCT03535038|Vascular Pedicle Width|vascular pedicle width
6156|NCT03535038|Chest x-ray|chest x-ray
6157|NCT03534999|TENS,|tens,
6158|NCT03534999|VAS,|vas,
6159|NCT03534999|Oxford-Hip-score,|oxford-hip-score,
6160|NCT03534999|Hip-arthroplasthy,|hip-arthroplasthy,
6161|NCT03534999|Pain-intensity|pain-intensity
6162|NCT03534973|Cataract|cataract
6163|NCT03534973|Caffeine|caffeine
6164|NCT03534947|Neoadjuvant|neoadjuvant
6165|NCT03534947|Sonidegib|sonidegib
6166|NCT03534934|COPD|copd
6167|NCT03534934|Osteoporosis|osteoporosis
6168|NCT03534921|Diabetes mellitus|diabetes mellitus
6169|NCT03534921|Schizophrenia|schizophrenia
6170|NCT03534921|Schizoaffective disorder|schizoaffective disorder
6171|NCT03534921|Bipolar disorder|bipolar disorder
6172|NCT03534921|Severe mental illness|severe mental illness
6173|NCT03534895|midazolam|midazolam
6174|NCT03534895|ambulatory surgery|ambulatory surgery
6175|NCT03534882|anti-glaucoma medications|anti-glaucoma medications
6176|NCT03534882|glaucoma|glaucoma
6177|NCT03534882|prostaglandin analogues|prostaglandin analogues
6178|NCT03534882|medication washout|medication washout
6179|NCT03534869|auricular acupuncture|auricular acupuncture
6180|NCT03534869|episiotomy|episiotomy
6181|NCT03534869|acupuncture|acupuncture
6182|NCT03534869|pain relief|pain relief
6183|NCT03534869|analgesic therapy|analgesic therapy
6184|NCT03534843|Spontaneous rupture|spontaneous rupture
6185|NCT03534843|survival|survival
6186|NCT03534843|hepatocellular carcinoma|hepatocellular carcinoma
6187|NCT03534843|Child-Pugh|child-pugh
6188|NCT03534843|Albumin-bilirubin|albumin-bilirubin
6189|NCT03534817|Cardiac Rehabilitation|cardiac rehabilitation
6190|NCT03534817|Early Access Cardiac Rehabilitation|early access cardiac rehabilitation
6191|NCT03534817|Cardiac Rehabilitation Adherence|cardiac rehabilitation adherence
6192|NCT03534817|Myocardial Infarction|myocardial infarction
6193|NCT03534817|Ventricular Remodeling|ventricular remodeling
6194|NCT03534765|Laparotomy|laparotomy
6195|NCT03534765|Frailty|frailty
6196|NCT03534765|Sacropenia|sacropenia
6197|NCT03534752|Inborn errors of Metabolism|inborn errors of metabolism
6198|NCT03534752|Adulthood|adulthood
6199|NCT03534752|Clinical characteristics|clinical characteristics
6200|NCT03534739|conditioned pain modulation (CPM)|conditioned pain modulation (cpm)
6201|NCT03534739|diffuse noxious inhibitory control (DNIC)|diffuse noxious inhibitory control (dnic)
6202|NCT03534739|massage|massage
6203|NCT03534739|hypoalgesia|hypoalgesia
6204|NCT03534713|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
6205|NCT03534713|Cervical Cancer|cervical cancer
6206|NCT03534713|Paraaortic Lymph Node Involvement|paraaortic lymph node involvement
6207|NCT03534713|Carboplatin|carboplatin
6208|NCT03534713|Paclitaxel|paclitaxel
6209|NCT03534700|sacrococcygeal pilonidal disease|sacrococcygeal pilonidal disease
6210|NCT03534687|RAGE|rage
6211|NCT03534687|ADAM10|adam10
6212|NCT03534687|Exercise|exercise
6213|NCT03534687|sRAGE|srage
6214|NCT03534635|metastatic melanoma|metastatic melanoma
6215|NCT03534635|tumor microenvironment|tumor microenvironment
6216|NCT03534635|pembrolizumab|pembrolizumab
6217|NCT03534635|PD1|pd1
6218|NCT03534596|cohort|cohort
6219|NCT03534596|surgery|surgery
6220|NCT03534596|adhesive small bowel obstruction|adhesive small bowel obstruction
6221|NCT03534557|spirometry|spirometry
6222|NCT03534544|artificial pancreas|artificial pancreas
6223|NCT03534544|pediatric|pediatric
6224|NCT03534544|parents|parents
6225|NCT03534544|adherence|adherence
6226|NCT03534505|Inguinal Herniorrhaphy|inguinal herniorrhaphy
6227|NCT03534505|Analgesic Effects of Local Wound|analgesic effects of local wound
6228|NCT03534492|urothelial|urothelial
6229|NCT03534492|bladder cancer|bladder cancer
6230|NCT03534492|olaparib|olaparib
6231|NCT03534492|durvalumab|durvalumab
6232|NCT03534466|treadmill|treadmill
6233|NCT03534466|infants|infants
6234|NCT03534466|neonatal encephalopathy|neonatal encephalopathy
6235|NCT03534466|neonatal brain injury|neonatal brain injury
6236|NCT03534453|ovarian cancer|ovarian cancer
6237|NCT03534453|PARP Inhibitor|parp inhibitor
6238|NCT03534453|Platinum sensitive|platinum sensitive
6239|NCT03534440|Diastolic Dysfunction|diastolic dysfunction
6240|NCT03534440|Anesthesia|anesthesia
6241|NCT03534440|Preoperative assessment|preoperative assessment
6242|NCT03534440|Postoperative care|postoperative care
6243|NCT03534440|TEVAR|tevar
6244|NCT03534427|arterial stiffness|arterial stiffness
6245|NCT03534427|endothelin-1|endothelin-1
6246|NCT03534427|c-reactive protein|c-reactive protein
6247|NCT03534427|adiposity|adiposity
6248|NCT03534427|exercise|exercise
6249|NCT03534427|jump rope|jump rope
6250|NCT03534414|dietary portfolio|dietary portfolio
6251|NCT03534414|plant sterols|plant sterols
6252|NCT03534414|plant protein|plant protein
6253|NCT03534414|viscous fibre|viscous fibre
6254|NCT03534414|nuts|nuts
6255|NCT03534401|Reproductive Coercion|reproductive coercion
6256|NCT03534401|Gender-based violence|gender-based violence
6257|NCT03534401|Contraception|contraception
6258|NCT03534401|Clinic-based screening for IPV|clinic-based screening for ipv
6259|NCT03534401|Clinic-based counseling|clinic-based counseling
6260|NCT03534362|Propel Stent|propel stent
6261|NCT03534362|Nasopore|nasopore
6262|NCT03534349|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
6263|NCT03534349|lower limb flexibility|lower limb flexibility
6264|NCT03534349|performance|performance
6265|NCT03534336|Weight Reduction|weight reduction
6266|NCT03534336|Health Literacy|health literacy
6267|NCT03534336|Financial Incentives|financial incentives
6268|NCT03534336|Lifestyle Change|lifestyle change
6269|NCT03534323|chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
6270|NCT03534310|obesity|obesity
6271|NCT03534310|sleeve-gastrectomy|sleeve-gastrectomy
6272|NCT03534310|liraglutide|liraglutide
6273|NCT03534310|Weight-loss|weight-loss
6274|NCT03534297|heart failure|heart failure
6275|NCT03534297|systolic heart failure|systolic heart failure
6276|NCT03534284|Hemodialysis|hemodialysis
6277|NCT03534284|Kidney disease|kidney disease
6278|NCT03534284|Trazodone|trazodone
6279|NCT03534284|Cognitive behavioral therapy|cognitive behavioral therapy
6280|NCT03534245|Mosquito Salivary Protein|mosquito salivary protein
6281|NCT03534245|Dengue Fever|dengue fever
6282|NCT03534245|Zika|zika
6283|NCT03534245|Chikungunya|chikungunya
6284|NCT03534245|Kampong Speu|kampong speu
6285|NCT03534232|Fasting Insulin|fasting insulin
6286|NCT03534232|Fasting Glucose|fasting glucose
6287|NCT03534232|Pancreatic Ductal Adenocarcinoma|pancreatic ductal adenocarcinoma
6288|NCT03534232|Lung Cancer|lung cancer
6289|NCT03534232|Obesity|obesity
6290|NCT03534219|Earpopper|earpopper
6291|NCT03534219|Prophylaxis|prophylaxis
6292|NCT03534219|Randomized controlled trial|randomized controlled trial
6293|NCT03534167|depression|depression
6294|NCT03534167|anxiety|anxiety
6295|NCT03534167|gay|gay
6296|NCT03534167|youth|youth
6297|NCT03534167|Cognitive Behavior Therapy|cognitive behavior therapy
6298|NCT03534141|Hypothermia|hypothermia
6299|NCT03534141|NGAL - Neutrophil Gelatinase-associated Lipocalin|ngal - neutrophil gelatinase-associated lipocalin
6300|NCT03534128|Traumatic Brain Injury|traumatic brain injury
6301|NCT03534128|Spatial navigation|spatial navigation
6302|NCT03534128|Virtual Reality|virtual reality
6303|NCT03534128|Cues|cues
6304|NCT03534115|bleaching, toxicity, NAC|bleaching, toxicity, nac
6305|NCT03534102|Total Hip Arthroplasty|total hip arthroplasty
6306|NCT03534102|Total Knee Arthroplasty|total knee arthroplasty
6307|NCT03534102|Opioid Dependence|opioid dependence
6308|NCT03534102|Opioid Tapering|opioid tapering
6309|NCT03534063|Arthroplasty Surgery|arthroplasty surgery
6310|NCT03534063|Genotype-Guided Pain Management|genotype-guided pain management
6311|NCT03534050|Glioma|glioma
6312|NCT03534050|Low-Grade Glioma (LGG)|low-grade glioma (lgg)
6313|NCT03534050|Neurobehavioral Assessments|neurobehavioral assessments
6314|NCT03534050|Neurocognitive Functions (NCF)|neurocognitive functions (ncf)
6315|NCT03534050|Radiation Therapy (RT)|radiation therapy (rt)
6316|NCT03534050|Hippocampus|hippocampus
6317|NCT03534050|Progression-Free Survival (PFS)|progression-free survival (pfs)
6318|NCT03534037|Serum uric acid|serum uric acid
6319|NCT03534037|Metabolic syndrome|metabolic syndrome
6320|NCT03534037|Left ventricular diastolic dysfunction|left ventricular diastolic dysfunction
6321|NCT03534037|Febuxostat|febuxostat
6322|NCT03534037|Benzbromarone|benzbromarone
6323|NCT03534011|Balloon occlusion|balloon occlusion
6324|NCT03534011|Air ambulances|air ambulances
6325|NCT03534011|Aorta|aorta
6326|NCT03534011|Resuscitation|resuscitation
6327|NCT03533985|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
6328|NCT03533985|Music therapy|music therapy
6329|NCT03533985|Attachment|attachment
6330|NCT03533985|Music medicine|music medicine
6331|NCT03533985|Multi-modal stimulation|multi-modal stimulation
6332|NCT03533959|in-stent neoatherosclerosis|in-stent neoatherosclerosis
6333|NCT03533959|alirocumab|alirocumab
6334|NCT03533933|collagen matrix|collagen matrix
6335|NCT03533933|connective tissue graft|connective tissue graft
6336|NCT03533933|histometry|histometry
6337|NCT03533933|xenograft|xenograft
6338|NCT03533933|periodontal regeneration|periodontal regeneration
6339|NCT03533933|biometry|biometry
6340|NCT03533881|collagen|collagen
6341|NCT03533881|volatile oils|volatile oils
6342|NCT03533881|metabolic syndrome|metabolic syndrome
6343|NCT03533881|insulin resistance|insulin resistance
6344|NCT03533868|Point-of-care|point-of-care
6345|NCT03533868|Viral load monitoring|viral load monitoring
6346|NCT03533868|Nigeria|nigeria
6347|NCT03533829|vaccination|vaccination
6348|NCT03533829|pre-syncope|pre-syncope
6349|NCT03533829|syncope prevention|syncope prevention
6350|NCT03533816|Gamma delta T-cells|gamma delta t-cells
6351|NCT03533816|Hematopoietic Stem Cell Transplantation (HCT)|hematopoietic stem cell transplantation (hct)
6352|NCT03533816|Post-transplant Cyclophosphamide (PTCy)|post-transplant cyclophosphamide (ptcy)
6353|NCT03533816|Expanded/Activated gamma delta (EAGD)|expanded/activated gamma delta (eagd)
6354|NCT03533816|Graft versus host disease (GVHD)|graft versus host disease (gvhd)
6355|NCT03533816|haploidentical|haploidentical
6356|NCT03533764|Asthma Self-Management for Adolescents (ASMA)|asthma self-management for adolescents (asma)
6357|NCT03533764|Community Health Workers (CHW)|community health workers (chw)
6358|NCT03533725|Initiation, Exclusivity, Duration|initiation, exclusivity, duration
6359|NCT03533647|high myopia|high myopia
6360|NCT03533647|ocular biometric parameters|ocular biometric parameters
6361|NCT03533647|adolescent|adolescent
6362|NCT03533647|children|children
6363|NCT03533634|midshaft clavicle fracture|midshaft clavicle fracture
6364|NCT03533634|functional outcome|functional outcome
6365|NCT03533634|anteroinferior plate|anteroinferior plate
6366|NCT03533634|superior plate|superior plate
6367|NCT03533634|reconstruction plate|reconstruction plate
6368|NCT03533608|PTSD|ptsd
6369|NCT03533608|Prolonged Exposure|prolonged exposure
6370|NCT03533608|Group Therapy|group therapy
6371|NCT03533569|pain|pain
6372|NCT03533569|inflammation|inflammation
6373|NCT03533543|Myocardial infarction|myocardial infarction
6374|NCT03533543|New-onset atrial fibrillation|new-onset atrial fibrillation
6375|NCT03533543|Retrospective|retrospective
6376|NCT03533543|Prognosis|prognosis
6377|NCT03533530|Electrical source imaging|electrical source imaging
6378|NCT03533504|pharmacokinetics|pharmacokinetics
6379|NCT03533504|hemophilia|hemophilia
6380|NCT03533504|factor VII|factor vii
6381|NCT03533504|factor IX|factor ix
6382|NCT03533504|population pharmacokinetics|population pharmacokinetics
6383|NCT03533478|Nutritional supplement|nutritional supplement
6384|NCT03533478|Diabetic Macular Edema|diabetic macular edema
6385|NCT03533478|Diabetes|diabetes
6386|NCT03533478|Alzer|alzer
6387|NCT03533478|Oxidative Stress|oxidative stress
6388|NCT03533478|Diamel|diamel
6389|NCT03533400|respiratory therapy|respiratory therapy
6390|NCT03533400|videogaming therapy|videogaming therapy
6391|NCT03533400|incentive spirometry|incentive spirometry
6392|NCT03533374|Accuracy|accuracy
6393|NCT03533374|Inter-ictal EEG Discharges|inter-ictal eeg discharges
6394|NCT03533374|Inter-rater agreement|inter-rater agreement
6395|NCT03533374|Long Term Monitoring|long term monitoring
6396|NCT03533374|Sensitivity|sensitivity
6397|NCT03533374|Sharp transients|sharp transients
6398|NCT03533374|Specificity|specificity
6399|NCT03533374|Source Space|source space
6400|NCT03533374|Voltage maps|voltage maps
6401|NCT03533361|expanded access program|expanded access program
6402|NCT03533361|radioiodine refractory|radioiodine refractory
6403|NCT03533361|differentiated|differentiated
6404|NCT03533361|lenvatinib|lenvatinib
6405|NCT03533335|Oral Hygiene|oral hygiene
6406|NCT03533335|Oral Sprays|oral sprays
6407|NCT03533335|Oral Health|oral health
6408|NCT03533335|Frail Elderly|frail elderly
6409|NCT03533335|Nursing Homes|nursing homes
6410|NCT03533335|Chlorhexidine|chlorhexidine
6411|NCT03533335|Chlorine Dioxide|chlorine dioxide
6412|NCT03533309|horizontal defect, Anterior maxillary|horizontal defect, anterior maxillary
6413|NCT03533244|Hyperemia|hyperemia
6414|NCT03533231|Pulp regeneration, intracanal medication|pulp regeneration, intracanal medication
6415|NCT03533218|endotracheal tube, point of care ultrasound|endotracheal tube, point of care ultrasound
6416|NCT03533179|Glucagon|glucagon
6417|NCT03533179|Beta-adrenergic antagonist|beta-adrenergic antagonist
6418|NCT03533179|poisoning|poisoning
6419|NCT03533166|Peri-implant mucositis|peri-implant mucositis
6420|NCT03533166|Chlorhexidine|chlorhexidine
6421|NCT03533166|CPC|cpc
6422|NCT03533166|Treatment|treatment
6423|NCT03533153|MSC|msc
6424|NCT03533101|Tocilizumab|tocilizumab
6425|NCT03533101|Haploidentical|haploidentical
6426|NCT03533101|Peripheral blood|peripheral blood
6427|NCT03533088|shoulder|shoulder
6428|NCT03533088|rotator cuff|rotator cuff
6429|NCT03533088|scapula|scapula
6430|NCT03533062|OAB , Botox , anticholinergics , quality of life|oab , botox , anticholinergics , quality of life
6431|NCT03533036|Virtual Reality|virtual reality
6432|NCT03533036|Anxiety|anxiety
6433|NCT03533023|Firefighters|firefighters
6434|NCT03533023|San Diego Fire and Rescue|san diego fire and rescue
6435|NCT03533023|Cardiometabolic Health|cardiometabolic health
6436|NCT03533023|First Responder|first responder
6437|NCT03533023|Shift Workers|shift workers
6438|NCT03533010|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
6439|NCT03533010|Bone Health|bone health
6440|NCT03533010|Treatment|treatment
6441|NCT03533010|Vitamin D|vitamin d
6442|NCT03533010|Calcium|calcium
6443|NCT03532971|BK virus|bk virus
6444|NCT03532971|BK polyomavirus|bk polyomavirus
6445|NCT03532971|hematopoietic-cell transplantation|hematopoietic-cell transplantation
6446|NCT03532932|Drug therapy|drug therapy
6447|NCT03532893|COPD incidence|copd incidence
6448|NCT03532893|Decline in FEV1|decline in fev1
6449|NCT03532893|Inflammatory biomarkers|inflammatory biomarkers
6450|NCT03532893|EBC|ebc
6451|NCT03532893|microRNA-23a|microrna-23a
6452|NCT03532880|Olaparib|olaparib
6453|NCT03532880|Radiation therapy|radiation therapy
6454|NCT03532880|18-195|18-195
6455|NCT03532880|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
6456|NCT03532867|Exercise Test|exercise test
6457|NCT03532867|Blood Pressure|blood pressure
6458|NCT03532867|Choroid|choroid
6459|NCT03532815|Cardiovascular Diseases, Framingham risk score, Life style modification, Randomized Controlled Trial|cardiovascular diseases, framingham risk score, life style modification, randomized controlled trial
6460|NCT03532802|metoprolol|metoprolol
6461|NCT03532802|heart diseases|heart diseases
6462|NCT03532802|cardiovascular diseases|cardiovascular diseases
6463|NCT03532802|ventricular outflow obstruction|ventricular outflow obstruction
6464|NCT03532802|hemodynamics|hemodynamics
6465|NCT03532763|Inflammation|inflammation
6466|NCT03532763|Tocotrienols|tocotrienols
6467|NCT03532763|Cardiovascular disease|cardiovascular disease
6468|NCT03532737|head and neck cancer|head and neck cancer
6469|NCT03532737|check point inhibitor|check point inhibitor
6470|NCT03532737|Pembrolizumab|pembrolizumab
6471|NCT03532737|Chemoradiation|chemoradiation
6472|NCT03532724|Patient Self-management, Acenocoumarol, Warfarin|patient self-management, acenocoumarol, warfarin
6473|NCT03532698|lung cancer|lung cancer
6474|NCT03532698|Aspirin|aspirin
6475|NCT03532698|Osimertinib|osimertinib
6476|NCT03532698|EGFR-TKI|egfr-tki
6477|NCT03532698|resistance|resistance
6478|NCT03532685|Asthma|asthma
6479|NCT03532685|severity|severity
6480|NCT03532685|follow up|follow up
6481|NCT03532685|obesity|obesity
6482|NCT03532685|bariatric surgery|bariatric surgery
6483|NCT03532672|Acute fasting|acute fasting
6484|NCT03532672|Inflammatory response|inflammatory response
6485|NCT03532672|Energy Expenditure|energy expenditure
6486|NCT03532659|adolescents|adolescents
6487|NCT03532659|obesity|obesity
6488|NCT03532659|lung function|lung function
6489|NCT03532659|microcirculation|microcirculation
6490|NCT03532659|intima media thickness|intima media thickness
6491|NCT03532633|infant|infant
6492|NCT03532633|cord|cord
6493|NCT03532633|micronutrients|micronutrients
6494|NCT03532633|purine|purine
6495|NCT03532633|pyrimidine|pyrimidine
6496|NCT03532620|Pitavastatin|pitavastatin
6497|NCT03532620|Prediabetic State|prediabetic state
6498|NCT03532620|Hypertension|hypertension
6499|NCT03532620|Dyslipidemias|dyslipidemias
6500|NCT03532620|Cardiovascular Disease|cardiovascular disease
6501|NCT03532607|Chronic|chronic
6502|NCT03532594|Protamine|protamine
6503|NCT03532594|Heparin Antagonists|heparin antagonists
6504|NCT03532594|Cardiopulmonary Bypass|cardiopulmonary bypass
6505|NCT03532555|zinc|zinc
6506|NCT03532542|Duchenne muscular dystrophy|duchenne muscular dystrophy
6507|NCT03532542|Exon Skipping|exon skipping
6508|NCT03532542|DMD|dmd
6509|NCT03532542|Exon 53|exon 53
6510|NCT03532542|Exon 45|exon 45
6511|NCT03532503|pregnancy termination|pregnancy termination
6512|NCT03532503|second trimester|second trimester
6513|NCT03532503|foley catheter|foley catheter
6514|NCT03532477|Bariatric surgery|bariatric surgery
6515|NCT03532477|Gastrointestinal tract|gastrointestinal tract
6516|NCT03532477|Biological availability|biological availability
6517|NCT03532477|Pharmacokinetics|pharmacokinetics
6518|NCT03532477|Venlafaxine Hydrochloride|venlafaxine hydrochloride
6519|NCT03532464|Chlamydia Trachomatis; Infection; Vaginal ; Anal|chlamydia trachomatis; infection; vaginal ; anal
6520|NCT03532451|Muscle-Invasive|muscle-invasive
6521|NCT03532451|Cisplatin-Ineligible|cisplatin-ineligible
6522|NCT03532451|Nivolumab|nivolumab
6523|NCT03532451|Lirilumab|lirilumab
6524|NCT03532412|Polysomnography, Sleep apnea, Central sleep apnea|polysomnography, sleep apnea, central sleep apnea
6525|NCT03532399|Bivalirudin|bivalirudin
6526|NCT03532386|Infertility|infertility
6527|NCT03532386|male factor infertility|male factor infertility
6528|NCT03532386|oligoasthenospermia|oligoasthenospermia
6529|NCT03532386|vaginal hydrocele|vaginal hydrocele
6530|NCT03532334|19F MRI gas Ventilation|19f mri gas ventilation
6531|NCT03532334|133 XE ventilation Scintigraphy|133 xe ventilation scintigraphy
6532|NCT03532321|Stress|stress
6533|NCT03532321|occupational risks|occupational risks
6534|NCT03532321|hospital organization|hospital organization
6535|NCT03532321|longitudinal|longitudinal
6536|NCT03532308|Fermented Soy|fermented soy
6537|NCT03532269|sleep|sleep
6538|NCT03532269|nightmare|nightmare
6539|NCT03532269|app|app
6540|NCT03532256|Quality Improvement|quality improvement
6541|NCT03532256|Prescription Use|prescription use
6542|NCT03532256|Patient Experience|patient experience
6543|NCT03532256|SMS Messaging|sms messaging
6544|NCT03532256|Crowd Sourcing|crowd sourcing
6545|NCT03532243|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
6546|NCT03532243|inspiratory muscle training|inspiratory muscle training
6547|NCT03532243|Central Drive|central drive
6548|NCT03532230|Chronic Low Back Pain|chronic low back pain
6549|NCT03532230|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
6550|NCT03532204|Oligometastatis|oligometastatis
6551|NCT03532204|SBRT|sbrt
6552|NCT03532191|Quality Improvement|quality improvement
6553|NCT03532191|Healthcare Providers|healthcare providers
6554|NCT03532191|Health Disparity|health disparity
6555|NCT03532178|Electroconvulsive Therapy, Neuromuscular Blockade|electroconvulsive therapy, neuromuscular blockade
6556|NCT03532152|VR|vr
6557|NCT03532152|moderate stress|moderate stress
6558|NCT03532139|Ovarian Cancer|ovarian cancer
6559|NCT03532113|Cognitive intervention|cognitive intervention
6560|NCT03532113|Cognitive training|cognitive training
6561|NCT03532113|Aging|aging
6562|NCT03532113|Working memory|working memory
6563|NCT03532113|Cognitive reserve|cognitive reserve
6564|NCT03532113|Brain imaging|brain imaging
6565|NCT03532113|Brain plasticity|brain plasticity
6566|NCT03532113|Polymorphisms|polymorphisms
6567|NCT03532113|Transfer|transfer
6568|NCT03532113|Inhibition|inhibition
6569|NCT03532113|Updating|updating
6570|NCT03532100|lower limb prosthesis|lower limb prosthesis
6571|NCT03532100|transtibial amputation|transtibial amputation
6572|NCT03532100|below knee amputation|below knee amputation
6573|NCT03532100|biomechanics|biomechanics
6574|NCT03532100|gait|gait
6575|NCT03532087|Breast cancer|breast cancer
6576|NCT03532087|Denosumab|denosumab
6577|NCT03532087|Chemotherapy|chemotherapy
6578|NCT03532087|Immunity|immunity
6579|NCT03532087|Immune system|immune system
6580|NCT03532087|PERIDENO|perideno
6581|NCT03532061|Familial Caregiver|familial caregiver
6582|NCT03532061|Cancer|cancer
6583|NCT03532061|Symptom Management|symptom management
6584|NCT03532061|COPE Principles|cope principles
6585|NCT03532061|Problem-solving Skills Training Program|problem-solving skills training program
6586|NCT03532048|Hispanic|hispanic
6587|NCT03532048|Fathers|fathers
6588|NCT03532048|Child|child
6589|NCT03532048|Obesity Prevention|obesity prevention
6590|NCT03532048|Cultural adaptation|cultural adaptation
6591|NCT03532048|Weight Loss|weight loss
6592|NCT03532009|Heart Failure|heart failure
6593|NCT03532009|Chronic Heart Failure|chronic heart failure
6594|NCT03532009|Hyperkalaemia|hyperkalaemia
6595|NCT03531996|Pulmonary Surfactant|pulmonary surfactant
6596|NCT03531996|Rare Lung Disease|rare lung disease
6597|NCT03531996|Registry|registry
6598|NCT03531983|gamma nail|gamma nail
6599|NCT03531970|inferior alveolar nerve block|inferior alveolar nerve block
6600|NCT03531970|irreversible pulpitis|irreversible pulpitis
6601|NCT03531970|local anesthesia|local anesthesia
6602|NCT03531970|dexamethasone|dexamethasone
6603|NCT03531957|eczema|eczema
6604|NCT03531905|diabetes|diabetes
6605|NCT03531905|cholesterolemia|cholesterolemia
6606|NCT03531905|type 2 diabetes|type 2 diabetes
6607|NCT03531905|LDL-C|ldl-c
6608|NCT03531905|T2D|t2d
6609|NCT03531905|diabetes mellitus|diabetes mellitus
6610|NCT03531892|Ulcerative Colitis|ulcerative colitis
6611|NCT03531892|Inflammatory Bowel Disease, Ulcerative Colitis Type|inflammatory bowel disease, ulcerative colitis type
6612|NCT03531892|Colitis|colitis
6613|NCT03531892|AJM300|ajm300
6614|NCT03531840|DNA Mismatch Repair|dna mismatch repair
6615|NCT03531840|BAP1|bap1
6616|NCT03531840|BRCA|brca
6617|NCT03531827|Androgen Receptor Antagonist|androgen receptor antagonist
6618|NCT03531827|PSA|psa
6619|NCT03531827|Hormonal Therapy|hormonal therapy
6620|NCT03531827|Nanoparticle Drug|nanoparticle drug
6621|NCT03531827|Antitumor|antitumor
6622|NCT03531814|Plexiform Neurofibromas|plexiform neurofibromas
6623|NCT03531814|Medication Event Monitoring Systems|medication event monitoring systems
6624|NCT03531814|Oral Medication|oral medication
6625|NCT03531801|Referred pain|referred pain
6626|NCT03531801|pressure algometry|pressure algometry
6627|NCT03531801|pain mapping|pain mapping
6628|NCT03531788|dynamic arm support|dynamic arm support
6629|NCT03531788|mobile arm support|mobile arm support
6630|NCT03531788|rehabilitation|rehabilitation
6631|NCT03531788|occupational therapy|occupational therapy
6632|NCT03531775|upright MRI|upright mri
6633|NCT03531775|COPD with hyperinflation|copd with hyperinflation
6634|NCT03531775|Diaphragmatic weakness|diaphragmatic weakness
6635|NCT03531762|Proton Pump Inhibitor|proton pump inhibitor
6636|NCT03531762|Omeprazole|omeprazole
6637|NCT03531762|Tepotinib|tepotinib
6638|NCT03531762|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
6639|NCT03531762|Pharmacokinetics|pharmacokinetics
6640|NCT03531736|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
6641|NCT03531736|intensity conditioning regimen|intensity conditioning regimen
6642|NCT03531736|17-639|17-639
6643|NCT03531723|external ventricular derivation|external ventricular derivation
6644|NCT03531697|Loteprednol Etabonate|loteprednol etabonate
6645|NCT03531645|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
6646|NCT03531645|Advanced low grade serous ovarian, primary peritoneal, or fallopian tube carcinomas|advanced low grade serous ovarian, primary peritoneal, or fallopian tube carcinomas
6647|NCT03531645|Fulvestrant|fulvestrant
6648|NCT03531645|Faslodex|faslodex
6649|NCT03531645|Palbociclib|palbociclib
6650|NCT03531645|PD-0332991|pd-0332991
6651|NCT03531645|Ibrance|ibrance
6652|NCT03531619|posturography|posturography
6653|NCT03531619|quality of life|quality of life
6654|NCT03531619|pressure algometry|pressure algometry
6655|NCT03531619|cervicogenic dizziness|cervicogenic dizziness
6656|NCT03531593|MTX|mtx
6657|NCT03531593|IBD|ibd
6658|NCT03531593|US Elastography|us elastography
6659|NCT03531593|Liver Fibrosis|liver fibrosis
6660|NCT03531567|Upper Extremity Hemiparesis|upper extremity hemiparesis
6661|NCT03531567|Virtual Reality (VR)|virtual reality (vr)
6662|NCT03531554|Fatty acid Oxidation Disorders|fatty acid oxidation disorders
6663|NCT03531554|ketone ester|ketone ester
6664|NCT03531554|VLCAD deficiency|vlcad deficiency
6665|NCT03531541|TENS|tens
6666|NCT03531541|cervical manipulation|cervical manipulation
6667|NCT03531541|pressure pain|pressure pain
6668|NCT03531502|tachycardia|tachycardia
6669|NCT03531502|defibrillator|defibrillator
6670|NCT03531502|arrythmia|arrythmia
6671|NCT03531476|Mindfulness|mindfulness
6672|NCT03531476|Chronic Pain|chronic pain
6673|NCT03531476|Disability|disability
6674|NCT03531476|Quality of Life|quality of life
6675|NCT03531476|Online|online
6676|NCT03531463|Displaced|displaced
6677|NCT03531463|Non-Operative treatment|non-operative treatment
6678|NCT03531463|Reversed Total Shoulder Prosthesis|reversed total shoulder prosthesis
6679|NCT03531450|Gastroparesis|gastroparesis
6680|NCT03531424|Coronary Stenosis|coronary stenosis
6681|NCT03531424|Percutaneous Coronary Intervention|percutaneous coronary intervention
6682|NCT03531424|Stents|stents
6683|NCT03531424|Computed Tomography Angiography|computed tomography angiography
6684|NCT03531424|Augmented Reality|augmented reality
6685|NCT03531411|nutrition|nutrition
6686|NCT03531411|wellness|wellness
6687|NCT03531385|Behcet's disease|behcet's disease
6688|NCT03531385|Central sensitisation|central sensitisation
6689|NCT03531385|Neuropathic pain|neuropathic pain
6690|NCT03531385|Sleep disturbance|sleep disturbance
6691|NCT03531346|Tear film|tear film
6692|NCT03531346|Tear osmolarity|tear osmolarity
6693|NCT03531346|Contact lenses|contact lenses
6694|NCT03531333|Glioma, intraoperative ultrasound, gross total resection, quality of life|glioma, intraoperative ultrasound, gross total resection, quality of life
6695|NCT03531307|Lactate|lactate
6696|NCT03531307|Ki-67|ki-67
6697|NCT03531307|Mitotic index|mitotic index
6698|NCT03531307|Brain tumor|brain tumor
6699|NCT03531268|Pharmacogenomic Analysis|pharmacogenomic analysis
6700|NCT03531268|Clinical Utility|clinical utility
6701|NCT03531268|Outcomes|outcomes
6702|NCT03531203|soursop|soursop
6703|NCT03531203|supplementation|supplementation
6704|NCT03531203|prehypertension|prehypertension
6705|NCT03531203|uric acid|uric acid
6706|NCT03531203|randomized controlled trial|randomized controlled trial
6707|NCT03531190|Head and neck cancer|head and neck cancer
6708|NCT03531190|wound healing|wound healing
6709|NCT03531190|pre and post-surgical nutrition|pre and post-surgical nutrition
6710|NCT03531190|zinc, arginine, vitamin C, protein, oral supplements|zinc, arginine, vitamin c, protein, oral supplements
6711|NCT03531177|type 2 diabetes|type 2 diabetes
6712|NCT03531177|Ethnicity|ethnicity
6713|NCT03531177|African-caribbean|african-caribbean
6714|NCT03531177|Education|education
6715|NCT03531177|Self-management|self-management
6716|NCT03531164|spinal cord injuries|spinal cord injuries
6717|NCT03531164|kayak|kayak
6718|NCT03531164|trunk control|trunk control
6719|NCT03531138|performance test|performance test
6720|NCT03531138|exercise capacity|exercise capacity
6721|NCT03531138|rehabilitation outcome|rehabilitation outcome
6722|NCT03531138|pulmonary rehabilitation|pulmonary rehabilitation
6723|NCT03531099|Prostate cancer|prostate cancer
6724|NCT03531099|HIFU focal|hifu focal
6725|NCT03531099|adverse effect|adverse effect
6726|NCT03531099|low risk|low risk
6727|NCT03531086|dopamine transporter binding|dopamine transporter binding
6728|NCT03531073|treat to target|treat to target
6729|NCT03531047|progressive|progressive
6730|NCT03531047|cross-linking|cross-linking
6731|NCT03531047|customised|customised
6732|NCT03531047|refractive|refractive
6733|NCT03531034|Blood Pressure Variability|blood pressure variability
6734|NCT03531034|Ambulatorial Blood Pressure Monitoring|ambulatorial blood pressure monitoring
6735|NCT03531034|Combined Exercise|combined exercise
6736|NCT03531021|type 1 diabetes|type 1 diabetes
6737|NCT03531021|cardiovascular risk factor|cardiovascular risk factor
6738|NCT03531021|teenager|teenager
6739|NCT03531008|focal;|focal;
6740|NCT03530956|AMPfoot|ampfoot
6741|NCT03530956|dual-task|dual-task
6742|NCT03530956|cognitive performance|cognitive performance
6743|NCT03530956|physical performance|physical performance
6744|NCT03530956|lower-limb prosthesis|lower-limb prosthesis
6745|NCT03530891|anterior mandible fracture|anterior mandible fracture
6746|NCT03530891|surgery computer assisted|surgery computer assisted
6747|NCT03530865|mandibular molars|mandibular molars
6748|NCT03530865|extra root|extra root
6749|NCT03530865|extra root canal|extra root canal
6750|NCT03530865|root morphology|root morphology
6751|NCT03530865|cbct endodontics|cbct endodontics
6752|NCT03530839|lesser toe deformity|lesser toe deformity
6753|NCT03530839|claw toe|claw toe
6754|NCT03530839|PIP joint|pip joint
6755|NCT03530839|arthrodesis|arthrodesis
6756|NCT03530839|resection arthroplasty|resection arthroplasty
6757|NCT03530813|School|school
6758|NCT03530813|Management|management
6759|NCT03530813|Technology|technology
6760|NCT03530813|Asthma Education|asthma education
6761|NCT03530787|Ginger|ginger
6762|NCT03530787|Curcumin|curcumin
6763|NCT03530787|Zingerone|zingerone
6764|NCT03530774|physical performance battery|physical performance battery
6765|NCT03530774|24-hour dietary recalls|24-hour dietary recalls
6766|NCT03530774|dual-energy X-ray absorptimetry|dual-energy x-ray absorptimetry
6767|NCT03530774|dietary supplement|dietary supplement
6768|NCT03530774|protein|protein
6769|NCT03530735|Fingerprick Autologous Blood|fingerprick autologous blood
6770|NCT03530696|Breast Cancer|breast cancer
6771|NCT03530696|HER2-positive|her2-positive
6772|NCT03530696|T-DM1|t-dm1
6773|NCT03530696|HER2-positive Breast Cancer|her2-positive breast cancer
6774|NCT03530696|Recurrent Breast Cancer|recurrent breast cancer
6775|NCT03530696|Metastatic Breast Cancer|metastatic breast cancer
6776|NCT03530683|Neoplasms|neoplasms
6777|NCT03530683|Lymphoma|lymphoma
6778|NCT03530683|Myeloma|myeloma
6779|NCT03530644|Non-invasive glucose monitoring|non-invasive glucose monitoring
6780|NCT03530605|PCNSL, primary central nervous system lymphoma|pcnsl, primary central nervous system lymphoma
6781|NCT03530579|Diabetes Prevention|diabetes prevention
6782|NCT03530566|PnK Method|pnk method
6783|NCT03530566|obesity|obesity
6784|NCT03530566|very low calorie ketogenic diet|very low calorie ketogenic diet
6785|NCT03530566|Comorbidity|comorbidity
6786|NCT03530566|Bariatric Surgery|bariatric surgery
6787|NCT03530566|weight loss|weight loss
6788|NCT03530527|ERCP|ercp
6789|NCT03530527|Endoscopic ultrasound (EUS) guided biliary drainage|endoscopic ultrasound (eus) guided biliary drainage
6790|NCT03530501|microbiota|microbiota
6791|NCT03530501|obesity|obesity
6792|NCT03530462|episodic memory|episodic memory
6793|NCT03530462|executive control|executive control
6794|NCT03530462|fMRI|fmri
6795|NCT03530436|Bioavailability|bioavailability
6796|NCT03530436|Pharmacokinetics|pharmacokinetics
6797|NCT03530436|Curcumin|curcumin
6798|NCT03530436|Demethoxycurcumin|demethoxycurcumin
6799|NCT03530436|Bisdemethoxycurcumin|bisdemethoxycurcumin
6800|NCT03530397|Advanced solid tumors|advanced solid tumors
6801|NCT03530397|MEDI5752|medi5752
6802|NCT03530397|durvalumab|durvalumab
6803|NCT03530397|immuno-oncology|immuno-oncology
6804|NCT03530397|Cancer|cancer
6805|NCT03530397|PD-1/CTLA-4 Bispecific|pd-1/ctla-4 bispecific
6806|NCT03530397|PD-1|pd-1
6807|NCT03530397|CTLA-4|ctla-4
6808|NCT03530397|Bispecific|bispecific
6809|NCT03530397|Chemotherapy|chemotherapy
6810|NCT03530397|Pemetrexed|pemetrexed
6811|NCT03530397|Carboplatin|carboplatin
6812|NCT03530397|Pembrolizumab|pembrolizumab
6813|NCT03530358|Muscle Synergies|muscle synergies
6814|NCT03530358|MRI|mri
6815|NCT03530358|Virtual Reality|virtual reality
6816|NCT03530358|Robotics|robotics
6817|NCT03530345|Neridronic Acid|neridronic acid
6818|NCT03530345|Neridronate|neridronate
6819|NCT03530345|CRPS|crps
6820|NCT03530345|RSD (reflex sympathetic dystrophy)|rsd (reflex sympathetic dystrophy)
6821|NCT03530332|Preterm Birth|preterm birth
6822|NCT03530332|Prematurity Prevention Clinic|prematurity prevention clinic
6823|NCT03530332|Maternal-Fetal Medicine|maternal-fetal medicine
6824|NCT03530319|Mycoplasma pneumoniae|mycoplasma pneumoniae
6825|NCT03530319|Macrolide-resistance|macrolide-resistance
6826|NCT03530319|Children|children
6827|NCT03530280|pregabalin|pregabalin
6828|NCT03530280|adductor canal block|adductor canal block
6829|NCT03530280|postoperative pain|postoperative pain
6830|NCT03530267|colorectal cancer|colorectal cancer
6831|NCT03530267|5-FU|5-fu
6832|NCT03530267|Aflibercept|aflibercept
6833|NCT03530267|Oxaliplatin|oxaliplatin
6834|NCT03530254|Endometrial receptivity|endometrial receptivity
6835|NCT03530254|Preimplantation Genetic Diagnosis (PGD)|preimplantation genetic diagnosis (pgd)
6836|NCT03530254|Preimplantation Genetic Testing for Aneuploidy (PGT-A)|preimplantation genetic testing for aneuploidy (pgt-a)
6837|NCT03530254|Embryo Transfer (ET)|embryo transfer (et)
6838|NCT03530254|Endometrial Receptivity Analysis (ERA)|endometrial receptivity analysis (era)
6839|NCT03530254|Endometrial Diagnosis|endometrial diagnosis
6840|NCT03530254|Live Newborn Rate (LBR)|live newborn rate (lbr)
6841|NCT03530241|fluorescence|fluorescence
6842|NCT03530241|cholangiography|cholangiography
6843|NCT03530241|cholecystectomy, laparoscopic|cholecystectomy, laparoscopic
6844|NCT03530215|Cardiotoxicity|cardiotoxicity
6845|NCT03530215|Antineoplastic and immunomodulating agents|antineoplastic and immunomodulating agents
6846|NCT03530202|muscle thickness|muscle thickness
6847|NCT03530202|strength|strength
6848|NCT03530202|power|power
6849|NCT03530202|functionality|functionality
6850|NCT03530189|Hyperglycemia;|hyperglycemia;
6851|NCT03530189|Hypoglycemia;|hypoglycemia;
6852|NCT03530189|Neurodevelopment;|neurodevelopment;
6853|NCT03530189|Prematurity|prematurity
6854|NCT03530163|Exercise|exercise
6855|NCT03530163|Aerobic|aerobic
6856|NCT03530163|Cognitive Function|cognitive function
6857|NCT03530150|Burns|burns
6858|NCT03530150|Partial-thickness burn wounds|partial-thickness burn wounds
6859|NCT03530150|Re-epithelization|re-epithelization
6860|NCT03530150|Second-Degree Wound|second-degree wound
6861|NCT03530150|Pirfenidone|pirfenidone
6862|NCT03530150|Wound Healing|wound healing
6863|NCT03530137|homelessness|homelessness
6864|NCT03530137|homeless children|homeless children
6865|NCT03530137|homeless families|homeless families
6866|NCT03530124|apnea following vaccination|apnea following vaccination
6867|NCT03530111|Adipose tissue|adipose tissue
6868|NCT03530111|Adipose turnover|adipose turnover
6869|NCT03530111|Adipose kinetics|adipose kinetics
6870|NCT03530111|Exercise|exercise
6871|NCT03530111|Deuterium|deuterium
6872|NCT03530098|Age Determination by Skeleton|age determination by skeleton
6873|NCT03530098|Machine Learning|machine learning
6874|NCT03530098|Deep Learning|deep learning
6875|NCT03530098|Artificial Intelligence|artificial intelligence
6876|NCT03530098|Prospective|prospective
6877|NCT03530098|Clinical Validation|clinical validation
6878|NCT03530059|Home-based training program|home-based training program
6879|NCT03530020|monolithic zirconia|monolithic zirconia
6880|NCT03530020|tooth wear|tooth wear
6881|NCT03530020|all ceramic crown|all ceramic crown
6882|NCT03529981|mindfulness, awareness|mindfulness, awareness
6883|NCT03529968|esophageal adenocarcinoma|esophageal adenocarcinoma
6884|NCT03529968|staging|staging
6885|NCT03529968|CT|ct
6886|NCT03529968|PET-CT|pet-ct
6887|NCT03529968|EUS|eus
6888|NCT03529955|dermatomyositis|dermatomyositis
6889|NCT03529955|apremilast|apremilast
6890|NCT03529955|recalcitrant cutaneous disease|recalcitrant cutaneous disease
6891|NCT03529942|Osteoarthritis|osteoarthritis
6892|NCT03529942|Knee|knee
6893|NCT03529942|Pain|pain
6894|NCT03529942|Intra-articular|intra-articular
6895|NCT03529942|Injection|injection
6896|NCT03529942|Corticosteroid|corticosteroid
6897|NCT03529929|glucocorticoids|glucocorticoids
6898|NCT03529929|aging|aging
6899|NCT03529929|NFKB|nfkb
6900|NCT03529929|Medrol|medrol
6901|NCT03529929|methylprednisolone|methylprednisolone
6902|NCT03529903|behavior change|behavior change
6903|NCT03529903|health coaching|health coaching
6904|NCT03529903|wearable activity tracker|wearable activity tracker
6905|NCT03529903|text messaging|text messaging
6906|NCT03529903|lifestyle-related chronic diseases|lifestyle-related chronic diseases
6907|NCT03529890|locally advanced urothelial carcinoma|locally advanced urothelial carcinoma
6908|NCT03529890|immunotherapy|immunotherapy
6909|NCT03529890|cystectomy|cystectomy
6910|NCT03529890|radiation|radiation
6911|NCT03529890|nivolumab|nivolumab
6912|NCT03529877|Epidermolysis Bullosa|epidermolysis bullosa
6913|NCT03529877|Epidermolysis Bullosa Dystrophica|epidermolysis bullosa dystrophica
6914|NCT03529877|Skin Abnormalities|skin abnormalities
6915|NCT03529877|Congenital Abnormalities|congenital abnormalities
6916|NCT03529877|Skin Diseases, Genetic|skin diseases, genetic
6917|NCT03529877|Somatic Cell Therapy|somatic cell therapy
6918|NCT03529877|Mesenchymal Stem Cells|mesenchymal stem cells
6919|NCT03529877|ABCB5|abcb5
6920|NCT03529877|Allogeneic|allogeneic
6921|NCT03529851|Patient reported outcomes|patient reported outcomes
6922|NCT03529851|Symptom monitoring|symptom monitoring
6923|NCT03529851|Follow-up|follow-up
6924|NCT03529838|Combined Exercise|combined exercise
6925|NCT03529838|Ambulatorial Blood Pressure Monitoring|ambulatorial blood pressure monitoring
6926|NCT03529838|Blood analysis|blood analysis
6927|NCT03529838|Salivary analysis|salivary analysis
6928|NCT03529838|Heart rate variability|heart rate variability
6929|NCT03529825|Rifaximin|rifaximin
6930|NCT03529825|Microbiome|microbiome
6931|NCT03529825|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
6932|NCT03529825|Blood stream infections|blood stream infections
6933|NCT03529825|Acute graft versus host disease|acute graft versus host disease
6934|NCT03529812|Behavioral intervention|behavioral intervention
6935|NCT03529812|Social intervention|social intervention
6936|NCT03529799|mTBI|mtbi
6937|NCT03529799|TBI|tbi
6938|NCT03529799|brain injury|brain injury
6939|NCT03529799|concussion|concussion
6940|NCT03529786|Hunter Syndrome|hunter syndrome
6941|NCT03529786|Natural History|natural history
6942|NCT03529786|Iduronate-2-sulfatase|iduronate-2-sulfatase
6943|NCT03529786|glycosaminoglycans|glycosaminoglycans
6944|NCT03529773|Respiratory tract infections, RSV, vaccine|respiratory tract infections, rsv, vaccine
6945|NCT03529760|Leukemia, occult hepatitis B virus infection|leukemia, occult hepatitis b virus infection
6946|NCT03529734|Anticipatory postural adjustments|anticipatory postural adjustments
6947|NCT03529734|Trunk muscles reflex responses|trunk muscles reflex responses
6948|NCT03529734|Sitting balance|sitting balance
6949|NCT03529734|Kinesthesia|kinesthesia
6950|NCT03529695|obesity|obesity
6951|NCT03529695|childhood obesity|childhood obesity
6952|NCT03529695|maternal and child health|maternal and child health
6953|NCT03529695|health disparities|health disparities
6954|NCT03529695|prevention|prevention
6955|NCT03529695|low-income|low-income
6956|NCT03529695|social network|social network
6957|NCT03529695|home environment|home environment
6958|NCT03529682|Circuit Exercise|circuit exercise
6959|NCT03529682|Trunk Control|trunk control
6960|NCT03529682|Functional Strength Training|functional strength training
6961|NCT03529669|Cancer|cancer
6962|NCT03529669|Oesophageal Cancer|oesophageal cancer
6963|NCT03529669|Gastrointestinal|gastrointestinal
6964|NCT03529656|Liver transplantation|liver transplantation
6965|NCT03529656|rehabilitation|rehabilitation
6966|NCT03529656|ICU acquired weakness|icu acquired weakness
6967|NCT03529604|Oral Cancer|oral cancer
6968|NCT03529604|Potentially Malignant Oral Disorders|potentially malignant oral disorders
6969|NCT03529604|Saliva|saliva
6970|NCT03529604|Squamous cell carcinoma antigen 1|squamous cell carcinoma antigen 1
6971|NCT03529604|Squamous cell carcinoma antigen 2|squamous cell carcinoma antigen 2
6972|NCT03529604|Trophoblast cell surface antigen|trophoblast cell surface antigen
6973|NCT03529604|Diadenosine tetraphosphate|diadenosine tetraphosphate
6974|NCT03529578|Pressure Ulcer, Decubitus Ulcer|pressure ulcer, decubitus ulcer
6975|NCT03529539|neuroendocrine disease of the pancreas.|neuroendocrine disease of the pancreas.
6976|NCT03529500|dental caries|dental caries
6977|NCT03529500|saliva|saliva
6978|NCT03529500|child|child
6979|NCT03529461|severe obesity|severe obesity
6980|NCT03529461|non-invasive positive pressure ventilation|non-invasive positive pressure ventilation
6981|NCT03529461|endoscopy|endoscopy
6982|NCT03529461|hypoxia|hypoxia
6983|NCT03529461|bariatric surgery|bariatric surgery
6984|NCT03529461|sedation|sedation
6985|NCT03529461|adverse events|adverse events
6986|NCT03529461|BMI|bmi
6987|NCT03529461|anesthesia|anesthesia
6988|NCT03529461|complications|complications
6989|NCT03529448|Glioblastoma|glioblastoma
6990|NCT03529435|Posttraumatic Stress Disorder|posttraumatic stress disorder
6991|NCT03529435|PTSD|ptsd
6992|NCT03529435|Post-Traumatic Stress|post-traumatic stress
6993|NCT03529435|Trauma and Stressor Related Disorders|trauma and stressor related disorders
6994|NCT03529435|Trauma|trauma
6995|NCT03529435|Combat|combat
6996|NCT03529435|Military|military
6997|NCT03529435|Veterans|veterans
6998|NCT03529435|Prolonged Exposure|prolonged exposure
6999|NCT03529435|Exposure Therapy|exposure therapy
7000|NCT03529435|Behavior Therapy|behavior therapy
7001|NCT03529435|Psychological Treatment|psychological treatment
7002|NCT03529435|Psychotherapy|psychotherapy
7003|NCT03529422|Head and Neck|head and neck
7004|NCT03529422|Larynx|larynx
7005|NCT03529422|Lip|lip
7006|NCT03529422|Oral Cancer|oral cancer
7007|NCT03529409|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
7008|NCT03529409|Substance Use|substance use
7009|NCT03529409|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
7010|NCT03529409|Immune System Diseases|immune system diseases
7011|NCT03529409|Behavioral Symptoms|behavioral symptoms
7012|NCT03529409|RNA Virus Infections|rna virus infections
7013|NCT03529409|HIV Infections|hiv infections
7014|NCT03529409|Alcohol Use|alcohol use
7015|NCT03529409|Drug Use|drug use
7016|NCT03529396|G6PD deficiency|g6pd deficiency
7017|NCT03529396|Acute hemolytic anemia|acute hemolytic anemia
7018|NCT03529396|Vivax malaria|vivax malaria
7019|NCT03529396|Primaquine|primaquine
7020|NCT03529396|Weekly primaquine|weekly primaquine
7021|NCT03529396|Chloroquine|chloroquine
7022|NCT03529396|Weekly chloroquine|weekly chloroquine
7023|NCT03529396|Brazilian Amazon|brazilian amazon
7024|NCT03529396|Oxidative stress|oxidative stress
7025|NCT03529383|Localized breast cancer|localized breast cancer
7026|NCT03529383|Exercise|exercise
7027|NCT03529383|Adapted physical activity|adapted physical activity
7028|NCT03529383|Sedentary|sedentary
7029|NCT03529383|Connected device|connected device
7030|NCT03529383|Activity trackers|activity trackers
7031|NCT03529383|Therapeutic education|therapeutic education
7032|NCT03529383|Obesity|obesity
7033|NCT03529357|Biological Age|biological age
7034|NCT03529357|Motivation|motivation
7035|NCT03529331|Pain Medications, Analgesia, Emergency Medicine|pain medications, analgesia, emergency medicine
7036|NCT03529305|Stroke|stroke
7037|NCT03529305|rTMS|rtms
7038|NCT03529305|MRI|mri
7039|NCT03529253|Alirocumab|alirocumab
7040|NCT03529253|NIRS-IVUS|nirs-ivus
7041|NCT03529253|LCBI|lcbi
7042|NCT03529240|kinesiology taping|kinesiology taping
7043|NCT03529240|performance|performance
7044|NCT03529240|energy consumption|energy consumption
7045|NCT03529240|gait|gait
7046|NCT03529240|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
7047|NCT03529227|chlorambucil|chlorambucil
7048|NCT03529227|obinutuzumab|obinutuzumab
7049|NCT03529214|Quality Improvement|quality improvement
7050|NCT03529214|Program Evaluation|program evaluation
7051|NCT03529214|Quality Assurance|quality assurance
7052|NCT03529214|Feasibility|feasibility
7053|NCT03529214|Acceptability|acceptability
7054|NCT03529188|Diabetes type 1|diabetes type 1
7055|NCT03529188|Child ans teenager|child ans teenager
7056|NCT03529188|Fear of Hypoglycaemia|fear of hypoglycaemia
7057|NCT03529162|Biceps Tendinitis|biceps tendinitis
7058|NCT03529162|Subpectoral biceps tenodesis|subpectoral biceps tenodesis
7059|NCT03529162|Biceps tendon disorder|biceps tendon disorder
7060|NCT03529136|Mesenchymal Stem Cell|mesenchymal stem cell
7061|NCT03529136|MSC|msc
7062|NCT03529110|Breast Cancer|breast cancer
7063|NCT03529110|Metastatic breast cancer|metastatic breast cancer
7064|NCT03529110|DS-8201a|ds-8201a
7065|NCT03529084|Non small cell lung cancer|non small cell lung cancer
7066|NCT03529084|NSCLC|nsclc
7067|NCT03529084|EGFR mutation|egfr mutation
7068|NCT03529084|EGF816|egf816
7069|NCT03529084|nazartinib|nazartinib
7070|NCT03529084|erlotinib|erlotinib
7071|NCT03529084|gefitinib|gefitinib
7072|NCT03529071|communication|communication
7073|NCT03529071|patient activation|patient activation
7074|NCT03529045|VNS|vns
7075|NCT03529045|VNS Therapy|vns therapy
7076|NCT03529045|Vagus Nerve Stimulation|vagus nerve stimulation
7077|NCT03529032|methadone|methadone
7078|NCT03529032|postoperative pain|postoperative pain
7079|NCT03529032|acute pain therapy|acute pain therapy
7080|NCT03529032|postoperative pain therapy|postoperative pain therapy
7081|NCT03529019|Enhanced Recovery After Surgery Protocol|enhanced recovery after surgery protocol
7082|NCT03529006|bioresorbable vascular scaffold|bioresorbable vascular scaffold
7083|NCT03529006|drug eluting balloon|drug eluting balloon
7084|NCT03528993|stroke, hippotherapy, balance, postural control, gait|stroke, hippotherapy, balance, postural control, gait
7085|NCT03528980|fertility|fertility
7086|NCT03528980|bariatric surgery|bariatric surgery
7087|NCT03528954|Emergence agitation|emergence agitation
7088|NCT03528954|Propofol|propofol
7089|NCT03528954|General anesthesia|general anesthesia
7090|NCT03528941|Chronic Lymphoid Leukemia|chronic lymphoid leukemia
7091|NCT03528941|Hepatitis B|hepatitis b
7092|NCT03528941|Ibrutinib|ibrutinib
7093|NCT03528928|pelvic floor|pelvic floor
7094|NCT03528928|electrical stimulation|electrical stimulation
7095|NCT03528928|bladder|bladder
7096|NCT03528928|ultrasound|ultrasound
7097|NCT03528915|neonate, infant; eyewash; delivery room; prophylaxis; risk factor's|neonate, infant; eyewash; delivery room; prophylaxis; risk factor's
7098|NCT03528876|gastric cancer|gastric cancer
7099|NCT03528876|esophageal cancer|esophageal cancer
7100|NCT03528876|adnocarcinoma|adnocarcinoma
7101|NCT03528876|FOLFIRI|folfiri
7102|NCT03528876|FOLFOX|folfox
7103|NCT03528876|Metastatic cancer|metastatic cancer
7104|NCT03528811|Diabetes|diabetes
7105|NCT03528811|Peripheral Vascular Disease|peripheral vascular disease
7106|NCT03528811|Microcirculation|microcirculation
7107|NCT03528785|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
7108|NCT03528785|Liposomial IrinoTecan|liposomial irinotecan
7109|NCT03528785|nal-IRI|nal-iri
7110|NCT03528785|Resectable pancreatic cancer|resectable pancreatic cancer
7111|NCT03528772|anal fissure, minoxidil, glycreyl trinitrate|anal fissure, minoxidil, glycreyl trinitrate
7112|NCT03528746|Patellar tendinopathy|patellar tendinopathy
7113|NCT03528720|Tomography, Optical Coherence|tomography, optical coherence
7114|NCT03528720|Fluorescein Angiography|fluorescein angiography
7115|NCT03528720|Fundus photographs|fundus photographs
7116|NCT03528694|Durvalumab|durvalumab
7117|NCT03528694|BCG|bcg
7118|NCT03528694|MEDI4736|medi4736
7119|NCT03528694|NMIBC|nmibc
7120|NCT03528694|PD-L1|pd-l1
7121|NCT03528694|DFS|dfs
7122|NCT03528694|OS|os
7123|NCT03528655|separation care|separation care
7124|NCT03528655|rooming-in care|rooming-in care
7125|NCT03528655|patient decision aid|patient decision aid
7126|NCT03528629|pharmacokinetics|pharmacokinetics
7127|NCT03528629|tolerability|tolerability
7128|NCT03528629|safety|safety
7129|NCT03528629|ASP8951|asp8951
7130|NCT03528629|immunogenicity|immunogenicity
7131|NCT03528603|platelet, aggregation, phenolic, olive oil, oleocanthal|platelet, aggregation, phenolic, olive oil, oleocanthal
7132|NCT03528590|laryngeal mask airway|laryngeal mask airway
7133|NCT03528590|breast surgery|breast surgery
7134|NCT03528564|Preoperative Anemia|preoperative anemia
7135|NCT03528564|Intravenous Iron|intravenous iron
7136|NCT03528564|Erythropoietin|erythropoietin
7137|NCT03528538|Fenugreek|fenugreek
7138|NCT03528538|Aging Male Symptoms|aging male symptoms
7139|NCT03528538|Testosterone|testosterone
7140|NCT03528538|Supplementation|supplementation
7141|NCT03528538|Double Blind|double blind
7142|NCT03528538|Body Composition|body composition
7143|NCT03528525|Diseases|diseases
7144|NCT03528525|Children|children
7145|NCT03528525|Respiratory|respiratory
7146|NCT03528525|Monogenic diseases|monogenic diseases
7147|NCT03528525|China|china
7148|NCT03528512|Pediatric|pediatric
7149|NCT03528512|analgesia|analgesia
7150|NCT03528512|pain control|pain control
7151|NCT03528512|sedation|sedation
7152|NCT03528512|intranasal ketamine|intranasal ketamine
7153|NCT03528512|intranasal midazolam|intranasal midazolam
7154|NCT03528512|intranasal fentanyl|intranasal fentanyl
7155|NCT03528499|Scapula|scapula
7156|NCT03528499|Physical Therapy|physical therapy
7157|NCT03528499|Movement|movement
7158|NCT03528499|Rehabilitation|rehabilitation
7159|NCT03528460|Parkinson Disease|parkinson disease
7160|NCT03528460|Deep Brain Stimulation|deep brain stimulation
7161|NCT03528460|Subthalamic Nucleus|subthalamic nucleus
7162|NCT03528460|Predictive factors|predictive factors
7163|NCT03528447|lung transplantation|lung transplantation
7164|NCT03528447|cognition|cognition
7165|NCT03528447|MOCA|moca
7166|NCT03528447|exercise|exercise
7167|NCT03528447|pulmonary rehabilitation|pulmonary rehabilitation
7168|NCT03528434|Zinc|zinc
7169|NCT03528421|CAR-T|car-t
7170|NCT03528395|Balance|balance
7171|NCT03528395|Baropodometry|baropodometry
7172|NCT03528395|Video games|video games
7173|NCT03528395|Virtual reality|virtual reality
7174|NCT03528343|appendicitis|appendicitis
7175|NCT03528343|postoperative pain|postoperative pain
7176|NCT03528343|patient satisfaction|patient satisfaction
7177|NCT03528343|children|children
7178|NCT03528343|pediatric|pediatric
7179|NCT03528343|narcotic|narcotic
7180|NCT03528343|pain control|pain control
7181|NCT03528304|Obesity|obesity
7182|NCT03528304|Overweight|overweight
7183|NCT03528304|Current smoker|current smoker
7184|NCT03528304|American Indian/Alaska Native|american indian/alaska native
7185|NCT03528291|Human,|human,
7186|NCT03528291|adult,|adult,
7187|NCT03528291|intensive care unit,|intensive care unit,
7188|NCT03528291|cardiogenic shock,|cardiogenic shock,
7189|NCT03528291|Transient circulatory support,|transient circulatory support,
7190|NCT03528291|extra corporeal life support|extra corporeal life support
7191|NCT03528291|Impella|impella
7192|NCT03528265|lateral flow immunoassay|lateral flow immunoassay
7193|NCT03528265|validation|validation
7194|NCT03528252|cholesterol|cholesterol
7195|NCT03528252|LDL cholesterol|ldl cholesterol
7196|NCT03528252|Triglycerides|triglycerides
7197|NCT03528252|Diet|diet
7198|NCT03528252|Food|food
7199|NCT03528252|Lipoproteins|lipoproteins
7200|NCT03528226|Type 1 diabetes|type 1 diabetes
7201|NCT03528226|endothelial function|endothelial function
7202|NCT03528226|exercise training|exercise training
7203|NCT03528226|physical activity|physical activity
7204|NCT03528213|sepsis|sepsis
7205|NCT03528213|fluid balance|fluid balance
7206|NCT03528213|metabolism|metabolism
7207|NCT03528213|ischemia-reperfusion|ischemia-reperfusion
7208|NCT03528213|treatment|treatment
7209|NCT03528161|hypersensitive troponin|hypersensitive troponin
7210|NCT03528161|risk of serious adverse events|risk of serious adverse events
7211|NCT03528161|emergency|emergency
7212|NCT03528148|Post stroke|post stroke
7213|NCT03528148|Gait|gait
7214|NCT03528148|Elliptical cross bike.|elliptical cross bike.
7215|NCT03528148|Postural control|postural control
7216|NCT03528148|Balance|balance
7217|NCT03528122|amniotic membrane|amniotic membrane
7218|NCT03528122|retinal detachment|retinal detachment
7219|NCT03528122|Myopic|myopic
7220|NCT03528122|macular hole|macular hole
7221|NCT03528122|internal limiting membrane|internal limiting membrane
7222|NCT03528083|Bronchiolitis|bronchiolitis
7223|NCT03528083|Children|children
7224|NCT03528083|Hospital|hospital
7225|NCT03528070|Sarcoidosis|sarcoidosis
7226|NCT03528070|Tranilast|tranilast
7227|NCT03528070|skin|skin
7228|NCT03528070|lung|lung
7229|NCT03528057|Kidney|kidney
7230|NCT03528044|Bariatric surgery|bariatric surgery
7231|NCT03528044|Reward|reward
7232|NCT03528044|Cognition|cognition
7233|NCT03528044|Working memory|working memory
7234|NCT03528044|Grey matter|grey matter
7235|NCT03528044|GLP-1|glp-1
7236|NCT03528044|Inflammation|inflammation
7237|NCT03528044|Stress|stress
7238|NCT03528044|Follow-up|follow-up
7239|NCT03528044|Psychiatric|psychiatric
7240|NCT03528018|Virtual Reality|virtual reality
7241|NCT03528018|Rehabilitation|rehabilitation
7242|NCT03528018|Physical therapy|physical therapy
7243|NCT03528005|Integrated Health Care Systems|integrated health care systems
7244|NCT03528005|Multimorbid|multimorbid
7245|NCT03528005|Multi-domain intervention|multi-domain intervention
7246|NCT03528005|Clinical Trials, Randomized|clinical trials, randomized
7247|NCT03527992|Randomized Therapeutic trial|randomized therapeutic trial
7248|NCT03527992|Hypoxemic pneumonia|hypoxemic pneumonia
7249|NCT03527992|Automated oxygen therapy|automated oxygen therapy
7250|NCT03527992|Length of stay|length of stay
7251|NCT03527992|medico-economic cost|medico-economic cost
7252|NCT03527953|bulk-fill restorative resins, dental caries|bulk-fill restorative resins, dental caries
7253|NCT03527927|COPD|copd
7254|NCT03527914|Depression|depression
7255|NCT03527914|Psychosis|psychosis
7256|NCT03527914|Personality Disorder|personality disorder
7257|NCT03527914|Substance Abuse|substance abuse
7258|NCT03527901|aggressive periodontitis|aggressive periodontitis
7259|NCT03527901|healthy peri-implant|healthy peri-implant
7260|NCT03527901|chairside test|chairside test
7261|NCT03527901|chronic periodontitis|chronic periodontitis
7262|NCT03527849|Osteoarthritis|osteoarthritis
7263|NCT03527849|Knee Osteoarthritis|knee osteoarthritis
7264|NCT03527849|Knee Pain|knee pain
7265|NCT03527823|Fertilization in Vitro|fertilization in vitro
7266|NCT03527823|Granulosa Cells|granulosa cells
7267|NCT03527823|Apoptosis|apoptosis
7268|NCT03527810|sleeve gastrectomy|sleeve gastrectomy
7269|NCT03527810|hiatal interrogation|hiatal interrogation
7270|NCT03527810|GERD|gerd
7271|NCT03527797|Critical illness associated diaphragm weakness|critical illness associated diaphragm weakness
7272|NCT03527797|Mechanical ventilation|mechanical ventilation
7273|NCT03527797|Critical illness|critical illness
7274|NCT03527797|Respiratory muscle dysfunction|respiratory muscle dysfunction
7275|NCT03527784|rectal adenocarcinoma|rectal adenocarcinoma
7276|NCT03527784|abdominoperineal resection|abdominoperineal resection
7277|NCT03527784|hernia prophylaxis|hernia prophylaxis
7278|NCT03527758|Biomarkers|biomarkers
7279|NCT03527758|Hypotension|hypotension
7280|NCT03527758|Organ Protection|organ protection
7281|NCT03527758|Intraoperative|intraoperative
7282|NCT03527719|Hypertension|hypertension
7283|NCT03527719|Stroke|stroke
7284|NCT03527719|China|china
7285|NCT03527719|Protocol-based treatment|protocol-based treatment
7286|NCT03527693|Knee Chondropathy, Osteoarthritis, Micro-fragmented fat.|knee chondropathy, osteoarthritis, micro-fragmented fat.
7287|NCT03527628|Stage II B Classical Hodgkin Lymphoma|stage ii b classical hodgkin lymphoma
7288|NCT03527628|Stage III Classical Hodgkin Lymphoma|stage iii classical hodgkin lymphoma
7289|NCT03527628|Stage IV Classical Hodgkin Lymphoma|stage iv classical hodgkin lymphoma
7290|NCT03527602|Apical patency|apical patency
7291|NCT03527602|Endodontics|endodontics
7292|NCT03527589|Prostatic Artery Embolization|prostatic artery embolization
7293|NCT03527589|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
7294|NCT03527589|Lower Urinary Tract Symptoms|lower urinary tract symptoms
7295|NCT03527589|PAE|pae
7296|NCT03527589|BPH|bph
7297|NCT03527589|LUTS|luts
7298|NCT03527589|Embolization|embolization
7299|NCT03527589|Embolic|embolic
7300|NCT03527589|Embosphere Microsphere|embosphere microsphere
7301|NCT03527563|Hypertension|hypertension
7302|NCT03527550|impulsivity|impulsivity
7303|NCT03527550|Inhibition (Psychology)|inhibition (psychology)
7304|NCT03527550|Working memory|working memory
7305|NCT03527550|Cognitive Remediation|cognitive remediation
7306|NCT03527524|exercise|exercise
7307|NCT03527472|cognitive dysfunction|cognitive dysfunction
7308|NCT03527472|memantine|memantine
7309|NCT03527472|lupus|lupus
7310|NCT03527446|Metabolic flexibility|metabolic flexibility
7311|NCT03527446|Insulin sensitivity|insulin sensitivity
7312|NCT03527446|Sprint interval training|sprint interval training
7313|NCT03527446|Obesity|obesity
7314|NCT03527446|Exercise intensity|exercise intensity
7315|NCT03527433|Incisional hernia|incisional hernia
7316|NCT03527433|Wound infection|wound infection
7317|NCT03527433|Midline laparotomy|midline laparotomy
7318|NCT03527420|Obesity|obesity
7319|NCT03527420|DNA methylation|dna methylation
7320|NCT03527420|Exercise|exercise
7321|NCT03527420|Weight loss|weight loss
7322|NCT03527420|Bariatric|bariatric
7323|NCT03527420|Macrovascular|macrovascular
7324|NCT03527420|Microvascular|microvascular
7325|NCT03527420|Epigenetics|epigenetics
7326|NCT03527420|Adipose tissue|adipose tissue
7327|NCT03527420|Adipocytokines|adipocytokines
7328|NCT03527420|Inflammation|inflammation
7329|NCT03527420|Cardiovascular|cardiovascular
7330|NCT03527394|Obesity|obesity
7331|NCT03527394|Pediatric|pediatric
7332|NCT03527394|Parent|parent
7333|NCT03527394|Family|family
7334|NCT03527394|Motivational Interviewing|motivational interviewing
7335|NCT03527394|Lifestyle|lifestyle
7336|NCT03527394|Health Behavior|health behavior
7337|NCT03527381|Cardiopulmonary Bypass|cardiopulmonary bypass
7338|NCT03527381|Nitric Oxide|nitric oxide
7339|NCT03527381|Kidney Function Tests|kidney function tests
7340|NCT03527381|Renal Insufficiency|renal insufficiency
7341|NCT03527381|Protective Agents|protective agents
7342|NCT03527381|Coronary Artery Bypass|coronary artery bypass
7343|NCT03527381|Cardiac Surgery|cardiac surgery
7344|NCT03527355|Typhoid|typhoid
7345|NCT03527355|Vi-DT|vi-dt
7346|NCT03527355|Conjugate vaccine|conjugate vaccine
7347|NCT03527355|First in human|first in human
7348|NCT03527355|New vaccine|new vaccine
7349|NCT03527329|Prewarming|prewarming
7350|NCT03527329|Tympanic temperature|tympanic temperature
7351|NCT03527303|stress|stress
7352|NCT03527303|health|health
7353|NCT03527303|meditation|meditation
7354|NCT03527303|mindfulness|mindfulness
7355|NCT03527303|employees|employees
7356|NCT03527303|job strain|job strain
7357|NCT03527303|burnout|burnout
7358|NCT03527303|work|work
7359|NCT03527303|mood|mood
7360|NCT03527303|affect|affect
7361|NCT03527303|work related stress|work related stress
7362|NCT03527277|orange juice|orange juice
7363|NCT03527277|sugar-sweetened beverage|sugar-sweetened beverage
7364|NCT03527277|triglyceride|triglyceride
7365|NCT03527277|low density lipoprotein cholesterol|low density lipoprotein cholesterol
7366|NCT03527277|apolipoprotein B|apolipoprotein b
7367|NCT03527277|uric acid|uric acid
7368|NCT03527277|de novo lipogenesis|de novo lipogenesis
7369|NCT03527277|hepatic triglyceride|hepatic triglyceride
7370|NCT03527277|hepatic glucose production|hepatic glucose production
7371|NCT03527277|whole body insulin sensitivity|whole body insulin sensitivity
7372|NCT03527264|cervical cancer|cervical cancer
7373|NCT03527264|Stage IB|stage ib
7374|NCT03527264|Stage IIA|stage iia
7375|NCT03527264|Stage IIB|stage iib
7376|NCT03527264|Stage IIIA|stage iiia
7377|NCT03527264|Stage IIIB|stage iiib
7378|NCT03527264|Stage IVA|stage iva
7379|NCT03527251|clinical trial, phase I|clinical trial, phase i
7380|NCT03527251|CTLA-4 antibody|ctla-4 antibody
7381|NCT03527251|PD-1 antibody|pd-1 antibody
7382|NCT03527251|non-small cell lung cancer|non-small cell lung cancer
7383|NCT03527238|Phenotypic Precision Medicine (PPM)|phenotypic precision medicine (ppm)
7384|NCT03527238|Tacrolimus|tacrolimus
7385|NCT03527238|Calcineurin Inhibitors|calcineurin inhibitors
7386|NCT03527225|Music Therapy|music therapy
7387|NCT03527225|First Radiotherapy|first radiotherapy
7388|NCT03527225|Anxiety Reduction|anxiety reduction
7389|NCT03527225|Psychosocial Functioning|psychosocial functioning
7390|NCT03527225|State - Trait Anxiety Inventory (STAI)|state - trait anxiety inventory (stai)
7391|NCT03527225|Symptom Distress Thermometer (SDT)|symptom distress thermometer (sdt)
7392|NCT03527212|Dry Eye Disease|dry eye disease
7393|NCT03527212|Corneal Epithelial Disorders|corneal epithelial disorders
7394|NCT03527212|Re-Epithelialization|re-epithelialization
7395|NCT03527173|Challenge|challenge
7396|NCT03527173|Efficacy|efficacy
7397|NCT03527173|Shigellosis|shigellosis
7398|NCT03527173|Vaccination|vaccination
7399|NCT03527160|AKI|aki
7400|NCT03527160|NGAL|ngal
7401|NCT03527147|Acalabrutinib|acalabrutinib
7402|NCT03527147|CALQUENCE®|calquence®
7403|NCT03527147|ACP-196|acp-196
7404|NCT03527147|Platform study|platform study
7405|NCT03527147|Master protocol|master protocol
7406|NCT03527147|PRISM|prism
7407|NCT03527121|Ankle|ankle
7408|NCT03527121|Exercise|exercise
7409|NCT03527121|Activities of daily living|activities of daily living
7410|NCT03527121|Treatment outcome|treatment outcome
7411|NCT03527108|Non-small cell lung cancer|non-small cell lung cancer
7412|NCT03527108|Immunotherapy|immunotherapy
7413|NCT03527095|Cystic Fibrosis|cystic fibrosis
7414|NCT03527082|mesh|mesh
7415|NCT03527082|erosion|erosion
7416|NCT03527082|transvaginal|transvaginal
7417|NCT03527082|prolapse|prolapse
7418|NCT03527082|laparoscopic|laparoscopic
7419|NCT03527082|tension free tape|tension free tape
7420|NCT03527056|CRE|cre
7421|NCT03527030|Tobacco Use|tobacco use
7422|NCT03527030|IQOS|iqos
7423|NCT03527017|Tobacco Use|tobacco use
7424|NCT03527017|IQOS|iqos
7425|NCT03527004|Tobacco Use|tobacco use
7426|NCT03527004|IQOS|iqos
7427|NCT03526991|Freezing of Gait|freezing of gait
7428|NCT03526991|Locomotion|locomotion
7429|NCT03526991|Spinal cord stimulation|spinal cord stimulation
7430|NCT03526978|Sabin strain|sabin strain
7431|NCT03526978|Inactivated poliovirus vaccine|inactivated poliovirus vaccine
7432|NCT03526978|poliomyelitis|poliomyelitis
7433|NCT03526978|safety|safety
7434|NCT03526978|immunogenicity|immunogenicity
7435|NCT03526978|infant|infant
7436|NCT03526939|Persons who inject drugs|persons who inject drugs
7437|NCT03526939|HIV|hiv
7438|NCT03526939|Hepatitis C|hepatitis c
7439|NCT03526939|Vietnam|vietnam
7440|NCT03526939|Behavioral Intervention|behavioral intervention
7441|NCT03526926|newly-diagnosed t-AML or AML-MRC|newly-diagnosed t-aml or aml-mrc
7442|NCT03526913|chronic leg ulcers, PRP|chronic leg ulcers, prp
7443|NCT03526913|split-thickness skin graft|split-thickness skin graft
7444|NCT03526913|platelet-rich plasma|platelet-rich plasma
7445|NCT03526874|Pain|pain
7446|NCT03526874|Chronic Migraine|chronic migraine
7447|NCT03526874|Episodic Migraine|episodic migraine
7448|NCT03526874|Headache|headache
7449|NCT03526874|Nerve Block|nerve block
7450|NCT03526848|3BNC117|3bnc117
7451|NCT03526848|10-1074|10-1074
7452|NCT03526848|Broadly Neutralizing Antibody|broadly neutralizing antibody
7453|NCT03526835|Bispecific antibody|bispecific antibody
7454|NCT03526835|First-in-human|first-in-human
7455|NCT03526835|MCLA-158|mcla-158
7456|NCT03526835|Antibodies|antibodies
7457|NCT03526835|Bispecific|bispecific
7458|NCT03526835|immunologic factors|immunologic factors
7459|NCT03526835|Cytokines|cytokines
7460|NCT03526835|EGFR|egfr
7461|NCT03526835|LGR5|lgr5
7462|NCT03526809|Magnetic resonance imaging|magnetic resonance imaging
7463|NCT03526796|Pouchitis|pouchitis
7464|NCT03526796|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
7465|NCT03526783|Obesity Surgery|obesity surgery
7466|NCT03526783|Failed Sleeve Gastrectomy|failed sleeve gastrectomy
7467|NCT03526783|Roux-en-Y gastric bypass|roux-en-y gastric bypass
7468|NCT03526783|Mini/One anastomosis gastric bypass|mini/one anastomosis gastric bypass
7469|NCT03526770|pH of saliva|ph of saliva
7470|NCT03526770|carbonated drink|carbonated drink
7471|NCT03526770|buffering agent|buffering agent
7472|NCT03526770|oral hygiene|oral hygiene
7473|NCT03526757|Postural balance|postural balance
7474|NCT03526757|Pilates method|pilates method
7475|NCT03526757|Elderly|elderly
7476|NCT03526744|Dietary Supplements|dietary supplements
7477|NCT03526744|Fish Proteins|fish proteins
7478|NCT03526744|Protein Hydrolysates|protein hydrolysates
7479|NCT03526744|Aged|aged
7480|NCT03526718|Transmission|transmission
7481|NCT03526718|Genotyping|genotyping
7482|NCT03526718|Risk factors|risk factors
7483|NCT03526692|Mild cognitive impairment|mild cognitive impairment
7484|NCT03526692|Neurofeedback|neurofeedback
7485|NCT03526692|electroencephalography|electroencephalography
7486|NCT03526692|attention|attention
7487|NCT03526692|memory|memory
7488|NCT03526679|soft tissue sarcoma|soft tissue sarcoma
7489|NCT03526679|phase Ib/II|phase ib/ii
7490|NCT03526679|advanced cancer|advanced cancer
7491|NCT03526666|Vitamin C|vitamin c
7492|NCT03526666|Ascorbic Acid|ascorbic acid
7493|NCT03526666|Epigenetics|epigenetics
7494|NCT03526666|5-hydroxymethylcytosine|5-hydroxymethylcytosine
7495|NCT03526666|5-methylcytosine|5-methylcytosine
7496|NCT03526627|advanced care management, advanced heart failure|advanced care management, advanced heart failure
7497|NCT03526601|heart failure|heart failure
7498|NCT03526601|prevalence|prevalence
7499|NCT03526588|CDH|cdh
7500|NCT03526523|Mindfulness based stress reduction|mindfulness based stress reduction
7501|NCT03526523|Perimenopausal depression|perimenopausal depression
7502|NCT03526523|Menopause transition|menopause transition
7503|NCT03526510|High Risk Prostate Cancer|high risk prostate cancer
7504|NCT03526510|Radiotherapy|radiotherapy
7505|NCT03526497|Catheterization, Peripheral/methods|catheterization, peripheral/methods
7506|NCT03526497|Humans|humans
7507|NCT03526497|Acute Disease|acute disease
7508|NCT03526497|Aged|aged
7509|NCT03526497|Female|female
7510|NCT03526497|Male|male
7511|NCT03526497|Follow-Up Studies|follow-up studies
7512|NCT03526497|Heart Failure/physiopathology|heart failure/physiopathology
7513|NCT03526497|Prospective Studies|prospective studies
7514|NCT03526497|Stroke Volume/physiology|stroke volume/physiology
7515|NCT03526497|Venous Pressure/physiology|venous pressure/physiology
7516|NCT03526484|UTI|uti
7517|NCT03526484|Urinalysis|urinalysis
7518|NCT03526484|Urine Culture|urine culture
7519|NCT03526484|Cystoscopy|cystoscopy
7520|NCT03526484|BCG treatment|bcg treatment
7521|NCT03526484|Prostate Biopsy|prostate biopsy
7522|NCT03526471|Left Atrial Appendage|left atrial appendage
7523|NCT03526471|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
7524|NCT03526458|Holmium Laser|holmium laser
7525|NCT03526458|Laser setting|laser setting
7526|NCT03526458|Stone fragmentation|stone fragmentation
7527|NCT03526445|Glucagon|glucagon
7528|NCT03526445|Stable isotope|stable isotope
7529|NCT03526445|Energy expenditure|energy expenditure
7530|NCT03526445|Lipid metabolism|lipid metabolism
7531|NCT03526445|Glucose metabolism|glucose metabolism
7532|NCT03526445|Appetite|appetite
7533|NCT03526419|Liposomal bupivacaine|liposomal bupivacaine
7534|NCT03526419|TAP block|tap block
7535|NCT03526419|cesarean section|cesarean section
7536|NCT03526406|Cognition|cognition
7537|NCT03526406|Mood|mood
7538|NCT03526406|Flavonoid|flavonoid
7539|NCT03526406|Grape Seed|grape seed
7540|NCT03526406|Catechin|catechin
7541|NCT03526406|Epicatechin|epicatechin
7542|NCT03526406|Proanthocyanidin|proanthocyanidin
7543|NCT03526380|Drug overdose|drug overdose
7544|NCT03526380|Substance-Related Disorders|substance-related disorders
7545|NCT03526380|Chemically-Induced Disorders|chemically-induced disorders
7546|NCT03526380|Risk Reduction Behavior|risk reduction behavior
7547|NCT03526380|Harm Reduction|harm reduction
7548|NCT03526354|Schizophrenia|schizophrenia
7549|NCT03526354|Schizoaffective Disorder|schizoaffective disorder
7752|NCT03524924|SHARE-FI|share-fi
7550|NCT03526354|Substance Use Disorders|substance use disorders
7551|NCT03526354|Alcohol Use Disorder|alcohol use disorder
7552|NCT03526354|Cannabis Use Disorder|cannabis use disorder
7553|NCT03526354|Cocaine Use Disorder|cocaine use disorder
7554|NCT03526354|Heroin Use Disorder|heroin use disorder
7555|NCT03526328|DCLK1|dclk1
7556|NCT03526328|Serum Biomarker|serum biomarker
7557|NCT03526328|Barrett's Esophagus|barrett's esophagus
7558|NCT03526328|Esophageal Adenocarcinoma|esophageal adenocarcinoma
7559|NCT03526328|Tumor Stem Cell Marker|tumor stem cell marker
7560|NCT03526315|CPP-ACP paste|cpp-acp paste
7561|NCT03526315|Fluoride toothpaste|fluoride toothpaste
7562|NCT03526315|Combined use of fluoride and CPP-ACP paste|combined use of fluoride and cpp-acp paste
7563|NCT03526315|MS reduction|ms reduction
7564|NCT03526315|Antibacterial|antibacterial
7565|NCT03526315|Children|children
7566|NCT03526276|Quantitative Laser Fluorescence (QLF)|quantitative laser fluorescence (qlf)
7567|NCT03526276|CPP-ACP paste|cpp-acp paste
7568|NCT03526276|Fluoride toothpaste|fluoride toothpaste
7569|NCT03526276|Combined use of fluoride and CPP-ACP paste|combined use of fluoride and cpp-acp paste
7570|NCT03526276|Primary teeth|primary teeth
7571|NCT03526263|Gastric Mucosal Devitalization|gastric mucosal devitalization
7572|NCT03526263|Obesity|obesity
7573|NCT03526263|Endoscopic Bariatric Therapies|endoscopic bariatric therapies
7574|NCT03526263|Bariatric surgery|bariatric surgery
7575|NCT03526237|diabetes|diabetes
7576|NCT03526237|prevention|prevention
7577|NCT03526237|risk|risk
7578|NCT03526237|obesity|obesity
7579|NCT03526237|weight loss|weight loss
7580|NCT03526237|community based|community based
7581|NCT03526211|Intensive care unit acquired muscle weakness|intensive care unit acquired muscle weakness
7582|NCT03526211|Cycloergometer|cycloergometer
7583|NCT03526211|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
7584|NCT03526211|FES Cycling|fes cycling
7585|NCT03526198|Force plate|force plate
7586|NCT03526198|Center of mass|center of mass
7587|NCT03526159|Herlitz|herlitz
7588|NCT03526159|Laminin 332|laminin 332
7589|NCT03526159|Laminin beta 3|laminin beta 3
7590|NCT03526159|JEB|jeb
7591|NCT03526133|sleep apnea|sleep apnea
7592|NCT03526133|polygraph|polygraph
7593|NCT03526133|home sleep apnea test (HSAT)|home sleep apnea test (hsat)
7594|NCT03526133|apnea hypopnea index (AHI)|apnea hypopnea index (ahi)
7595|NCT03526133|oxygen desaturation index (ODI)|oxygen desaturation index (odi)
7596|NCT03526133|portable monitor|portable monitor
7597|NCT03526120|Human subjects|human subjects
7598|NCT03526120|Pistachio snack|pistachio snack
7599|NCT03526120|Body mass index|body mass index
7600|NCT03526120|Energy intake|energy intake
7601|NCT03526120|Fat mass|fat mass
7602|NCT03526107|flavanol|flavanol
7603|NCT03526107|ADME|adme
7604|NCT03526107|polyphenols|polyphenols
7605|NCT03526107|cocoa|cocoa
7606|NCT03526107|epicatechin|epicatechin
7607|NCT03526107|methylxanthine|methylxanthine
7608|NCT03526107|caffeine|caffeine
7609|NCT03526094|flavanol|flavanol
7610|NCT03526094|ADME|adme
7611|NCT03526094|polyphenols|polyphenols
7612|NCT03526094|Cocoa|cocoa
7613|NCT03526094|Banana|banana
7614|NCT03526094|epicatechin|epicatechin
7615|NCT03526081|flavone|flavone
7616|NCT03526081|ADME|adme
7617|NCT03526081|apigenin|apigenin
7618|NCT03526081|parsley|parsley
7619|NCT03526081|chamomile|chamomile
7620|NCT03526081|polyphenols|polyphenols
7621|NCT03526016|Sleep Apnea|sleep apnea
7622|NCT03526016|Acromegaly|acromegaly
7623|NCT03526016|Transsphenoidal surgery|transsphenoidal surgery
7624|NCT03526016|Respiratory polygraphy|respiratory polygraphy
7625|NCT03525964|Individualized treatment|individualized treatment
7626|NCT03525964|Functional outcome|functional outcome
7627|NCT03525847|Contrast endosonograpy|contrast endosonograpy
7628|NCT03525834|TSC|tsc
7629|NCT03525834|tuberous sclerosis complex|tuberous sclerosis complex
7630|NCT03525834|AML|aml
7631|NCT03525834|afinitor|afinitor
7632|NCT03525834|everolimus|everolimus
7633|NCT03525834|RAD001|rad001
7634|NCT03525834|mTOR|mtor
7635|NCT03525834|kidney|kidney
7636|NCT03525834|lymphangioleiomyomatosis|lymphangioleiomyomatosis
7637|NCT03525834|renal angiomyolipoma|renal angiomyolipoma
7638|NCT03525808|Pancreatic necrosis|pancreatic necrosis
7639|NCT03525795|Phase 1/2|phase 1/2
7640|NCT03525795|Oncology|oncology
7641|NCT03525795|EZH2 Inhibitor|ezh2 inhibitor
7642|NCT03525782|CAR-T cell therapy|car-t cell therapy
7643|NCT03525782|MUC+|muc+
7644|NCT03525782|PD-1 Knockout|pd-1 knockout
7645|NCT03525782|Non-small cell lung cancer|non-small cell lung cancer
7646|NCT03525756|cystogram|cystogram
7647|NCT03525756|Foley catheter|foley catheter
7648|NCT03525743|Intubation|intubation
7649|NCT03525730|HIV|hiv
7650|NCT03525730|Latency reversing agents|latency reversing agents
7651|NCT03525730|HDAC inhibitor|hdac inhibitor
7652|NCT03525730|BAF inhibitor|baf inhibitor
7653|NCT03525730|HIV reservoir|hiv reservoir
7654|NCT03525730|HIV cure|hiv cure
7655|NCT03525717|healthy volunteers|healthy volunteers
7656|NCT03525717|metabolism|metabolism
7657|NCT03525717|fat oxidation|fat oxidation
7658|NCT03525717|obesity|obesity
7659|NCT03525717|sleep|sleep
7660|NCT03525678|Relapsed / refractory multiple myeloma|relapsed / refractory multiple myeloma
7661|NCT03525678|Antibody-drug conjugate|antibody-drug conjugate
7662|NCT03525678|Patient-Reported Outcome Version of the Common Term Criteria for Adverse Events|patient-reported outcome version of the common term criteria for adverse events
7663|NCT03525678|Quality of Life Questionnaire 20-item Multiple Myeloma module|quality of life questionnaire 20-item multiple myeloma module
7664|NCT03525678|Multiple Myeloma|multiple myeloma
7665|NCT03525678|Quality of Life Questionnaire 30-item Core module|quality of life questionnaire 30-item core module
7666|NCT03525665|Follicular lymphoma|follicular lymphoma
7667|NCT03525665|FDG-PET|fdg-pet
7668|NCT03525665|Relapse/progression|relapse/progression
7669|NCT03525652|Prostate Cancer|prostate cancer
7670|NCT03525652|Therapeutic vaccine|therapeutic vaccine
7671|NCT03525652|PD-1 knockout|pd-1 knockout
7672|NCT03525639|Cardiac Magnetic Resonance|cardiac magnetic resonance
7673|NCT03525639|Acute Myocarditis|acute myocarditis
7674|NCT03525639|Myocardial Inflammation|myocardial inflammation
7675|NCT03525626|Tic Disorders|tic disorders
7676|NCT03525626|Mindfulness|mindfulness
7677|NCT03525626|Meditation|meditation
7678|NCT03525626|Online|online
7679|NCT03525626|Internet-based|internet-based
7680|NCT03525626|Treatment|treatment
7681|NCT03525587|Quality Improvement|quality improvement
7682|NCT03525587|Quality of Life|quality of life
7683|NCT03525587|Smartphone APP|smartphone app
7684|NCT03525522|Lichen sclerosus|lichen sclerosus
7685|NCT03525522|laser|laser
7686|NCT03525522|Nd:YAG|nd:yag
7687|NCT03525522|randomized controlled trial|randomized controlled trial
7688|NCT03525509|Methadone|methadone
7689|NCT03525509|Morphine|morphine
7690|NCT03525509|Quantitative sensory testing|quantitative sensory testing
7691|NCT03525509|Epidural|epidural
7692|NCT03525496|Iodinated contrast agents|iodinated contrast agents
7693|NCT03525496|Immediate hypersensitivity reactions|immediate hypersensitivity reactions
7694|NCT03525496|Reintroduction tests|reintroduction tests
7695|NCT03525483|ECMO|ecmo
7696|NCT03525483|Acute renal failure|acute renal failure
7697|NCT03525470|Hydration|hydration
7698|NCT03525470|Brain functioning|brain functioning
7699|NCT03525470|Heart-rate variability|heart-rate variability
7700|NCT03525457|Glomerular filtration rate|glomerular filtration rate
7701|NCT03525457|Periodontitis|periodontitis
7702|NCT03525457|Chronic kidney disease|chronic kidney disease
7703|NCT03525431|Exome|exome
7704|NCT03525431|Sequencing|sequencing
7705|NCT03525431|Clinical Utility|clinical utility
7706|NCT03525431|Pediatric|pediatric
7707|NCT03525431|Underrepresented|underrepresented
7708|NCT03525431|Underserved|underserved
7709|NCT03525418|Pediatrics|pediatrics
7710|NCT03525379|Skeletal Muscle Blood Flow|skeletal muscle blood flow
7711|NCT03525379|(calf muscle) targeted exercise|(calf muscle) targeted exercise
7712|NCT03525340|Engagement to care, peer navigation, transgender|engagement to care, peer navigation, transgender
7713|NCT03525327|Dance|dance
7714|NCT03525301|Short Course Radiotherapy|short course radiotherapy
7715|NCT03525301|Symptomatic brain metastases|symptomatic brain metastases
7716|NCT03525262|Erectile dysfunction, Neurovascular, Prostate, Rectal spacer, Radiotherapy|erectile dysfunction, neurovascular, prostate, rectal spacer, radiotherapy
7717|NCT03525223|23Na MRI|23na mri
7718|NCT03525197|Muscle Physiology|muscle physiology
7719|NCT03525197|Nutrition|nutrition
7720|NCT03525145|Platelet Reactivity|platelet reactivity
7721|NCT03525145|Thrombotic Events|thrombotic events
7722|NCT03525119|Vaccine|vaccine
7723|NCT03525054|Psychotic Disorders|psychotic disorders
7724|NCT03525054|Diagnosis, Psychiatric|diagnosis, psychiatric
7725|NCT03525054|Schizophrenia Prodromal|schizophrenia prodromal
7726|NCT03525054|Ultra High Risk|ultra high risk
7727|NCT03525054|Prediction Of Psychosis|prediction of psychosis
7728|NCT03525054|Machine Learning|machine learning
7729|NCT03525054|Automated Language Analysis|automated language analysis
7730|NCT03525054|Semantic Coherence|semantic coherence
7731|NCT03525054|Syntaxic Complexity|syntaxic complexity
7732|NCT03524989|hbot|hbot
7733|NCT03524989|hyperbaric oxygen|hyperbaric oxygen
7734|NCT03524989|sport|sport
7735|NCT03524989|mitochondria|mitochondria
7736|NCT03524989|athletes|athletes
7737|NCT03524989|aerobic|aerobic
7738|NCT03524976|endovascular treatment|endovascular treatment
7739|NCT03524976|liquid embolization|liquid embolization
7740|NCT03524950|stress|stress
7741|NCT03524950|dexmedetomidine|dexmedetomidine
7742|NCT03524937|Delirium|delirium
7743|NCT03524937|Mechanical ventilation|mechanical ventilation
7744|NCT03524937|Intensive care unit|intensive care unit
7745|NCT03524937|Prevention|prevention
7746|NCT03524937|Pharmacokinetics|pharmacokinetics
7747|NCT03524937|Melatonin|melatonin
7748|NCT03524924|atrial fibrillation|atrial fibrillation
7749|NCT03524924|elderly|elderly
7750|NCT03524924|edoxaban|edoxaban
7751|NCT03524924|frailty|frailty
7753|NCT03524924|Stroke|stroke
7754|NCT03524924|Major bleeding|major bleeding
7755|NCT03524911|Nutrition education|nutrition education
7756|NCT03524911|Evaluation|evaluation
7757|NCT03524911|Child diet|child diet
7758|NCT03524911|EFNEP|efnep
7759|NCT03524898|Nab-Paclitaxel|nab-paclitaxel
7760|NCT03524898|Gemcitabine|gemcitabine
7761|NCT03524898|Advanced soft tissue sarcoma|advanced soft tissue sarcoma
7762|NCT03524898|Cancer|cancer
7763|NCT03524898|Sarcoma|sarcoma
7764|NCT03524898|Abraxane®|abraxane®
7765|NCT03524859|Cystic Fibrosis|cystic fibrosis
7766|NCT03524859|Sit-to-stand|sit-to-stand
7767|NCT03524859|Lung Function|lung function
7768|NCT03524859|Handgrip|handgrip
7769|NCT03524859|Walking Speed|walking speed
7770|NCT03524859|Power|power
7771|NCT03524859|Velocity|velocity
7772|NCT03524859|Gait Speed|gait speed
7773|NCT03524859|Chair rise|chair rise
7774|NCT03524846|Ascorbic acid|ascorbic acid
7775|NCT03524846|hemodialysis vascular access|hemodialysis vascular access
7776|NCT03524846|restenosis|restenosis
7777|NCT03524833|Lansoprazole, Amoxicillin, Metronidazole|lansoprazole, amoxicillin, metronidazole
7778|NCT03524820|cetuximab, colon cancer, RAS|cetuximab, colon cancer, ras
7779|NCT03524807|pelvic floor muscle electrophysiologic therapy|pelvic floor muscle electrophysiologic therapy
7780|NCT03524807|enhanced recovery|enhanced recovery
7781|NCT03524807|muscle soreness|muscle soreness
7782|NCT03524807|postoperative retention of urine|postoperative retention of urine
7783|NCT03524807|Intrauterine Adhesions|intrauterine adhesions
7784|NCT03524807|enhanced recovery after gynecologic surgery|enhanced recovery after gynecologic surgery
7785|NCT03524781|Anti-reflux surgery|anti-reflux surgery
7786|NCT03524781|Proton-pump inhibitors|proton-pump inhibitors
7787|NCT03524781|Upper endoscopy|upper endoscopy
7788|NCT03524768|endothelial function, microvascular|endothelial function, microvascular
7789|NCT03524768|laser speckle contrast imaging|laser speckle contrast imaging
7790|NCT03524768|capillaroscopy, skin|capillaroscopy, skin
7791|NCT03524742|Diet|diet
7792|NCT03524742|Cholesterol|cholesterol
7793|NCT03524729|Rocker bottom shoe|rocker bottom shoe
7794|NCT03524729|Ankle-foot orthosis|ankle-foot orthosis
7795|NCT03524729|Ankle osteoarthritis|ankle osteoarthritis
7796|NCT03524716|physical activity|physical activity
7797|NCT03524716|digital health|digital health
7798|NCT03524716|text messages|text messages
7799|NCT03524716|intervention|intervention
7800|NCT03524716|exercise|exercise
7801|NCT03524716|randomized|randomized
7802|NCT03524716|Fitbit|fitbit
7803|NCT03524703|dysphagia|dysphagia
7804|NCT03524703|anterior cervical fusion|anterior cervical fusion
7805|NCT03524703|chewing gum|chewing gum
7806|NCT03524677|pancreatic cancer|pancreatic cancer
7807|NCT03524677|liquid biopsy|liquid biopsy
7808|NCT03524677|borderline resectable|borderline resectable
7809|NCT03524651|Iron Deficiency Anemia|iron deficiency anemia
7810|NCT03524651|Fe-ASP|fe-asp
7811|NCT03524651|Casein|casein
7812|NCT03524651|Iron protein acetyl aspartylate|iron protein acetyl aspartylate
7813|NCT03524651|Restoration of decreased hemoglobin|restoration of decreased hemoglobin
7814|NCT03524651|Ferrous sulfate|ferrous sulfate
7815|NCT03524612|Thrombocytopenic|thrombocytopenic
7816|NCT03524612|Immune|immune
7817|NCT03524612|Platelets|platelets
7818|NCT03524612|Bleeding|bleeding
7819|NCT03524612|ITP|itp
7820|NCT03524612|eltrombopag|eltrombopag
7821|NCT03524612|ETB115|etb115
7822|NCT03524612|induce sustained remission|induce sustained remission
7823|NCT03524612|refractory or relapsed|refractory or relapsed
7824|NCT03524612|first-line steroids|first-line steroids
7825|NCT03524599|Heavy drinking|heavy drinking
7826|NCT03524599|Primary health care|primary health care
7827|NCT03524599|Training|training
7828|NCT03524599|Community|community
7829|NCT03524560|comprehensive geriatric assesment, polypharmacy,geriatric depression scale,neutrophil/lymphocyte ratio|comprehensive geriatric assesment, polypharmacy,geriatric depression scale,neutrophil/lymphocyte ratio
7830|NCT03524495|Subjective well-being|subjective well-being
7831|NCT03524495|Cognitive function|cognitive function
7832|NCT03524495|Self-efficacy|self-efficacy
7833|NCT03524495|Cash-transfer|cash-transfer
7834|NCT03524495|Homeless|homeless
7835|NCT03524482|culturally specific|culturally specific
7836|NCT03524456|home blood pressure monitoring|home blood pressure monitoring
7838|NCT03524456|primary care|primary care
7839|NCT03524443|Affective symptom|affective symptom
7840|NCT03524443|Art Therapy|art therapy
7841|NCT03524443|alexithymia|alexithymia
7842|NCT03524443|emotional disturbance|emotional disturbance
7843|NCT03524443|hyperphagia|hyperphagia
7844|NCT03524443|psychotherapy|psychotherapy
7845|NCT03524443|rehabilitation|rehabilitation
7846|NCT03524443|factor of resistance|factor of resistance
7847|NCT03524430|Early breast cancer|early breast cancer
7848|NCT03524417|Rabies immunoglobulin|rabies immunoglobulin
7849|NCT03524378|repetitive strain|repetitive strain
7850|NCT03524378|ergonomics|ergonomics
7851|NCT03524378|participatory ergonomics|participatory ergonomics
8250|NCT03521804|distal cap|distal cap
7852|NCT03524378|chronic low back pain|chronic low back pain
7853|NCT03524378|seafood workers|seafood workers
7854|NCT03524352|recurrent pouchitis|recurrent pouchitis
7855|NCT03524352|fecal microbiota transplant|fecal microbiota transplant
7856|NCT03524326|cetuximab|cetuximab
7857|NCT03524326|Lenvatinib|lenvatinib
7858|NCT03524326|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
7859|NCT03524326|17-635|17-635
7860|NCT03524313|cardiac output|cardiac output
7861|NCT03524313|end tidal carbon monoxide|end tidal carbon monoxide
7862|NCT03524313|echocardiography|echocardiography
7863|NCT03524313|intensive care|intensive care
7864|NCT03524300|Stomach Neoplasm|stomach neoplasm
7865|NCT03524300|Robotic Surgery|robotic surgery
7866|NCT03524300|Total Gastrectomy|total gastrectomy
7867|NCT03524287|Stomach Neoplasms|stomach neoplasms
7868|NCT03524287|Robotic Surgery|robotic surgery
7869|NCT03524287|Spleen-Preserving|spleen-preserving
7870|NCT03524287|No.10 Lymph Node Dissection|no.10 lymph node dissection
7871|NCT03524274|PD-1 activated CIK|pd-1 activated cik
7872|NCT03524274|MUC1|muc1
7873|NCT03524274|bispecific antibody|bispecific antibody
7874|NCT03524274|Colorectal Cancer|colorectal cancer
7875|NCT03524261|activated CIK|activated cik
7876|NCT03524261|MUC1|muc1
7877|NCT03524261|bispecific antibody|bispecific antibody
7878|NCT03524261|breast cancer|breast cancer
7879|NCT03524235|Relapsed/Refractory Lymphoma|relapsed/refractory lymphoma
7880|NCT03524235|Multiple Myeloma|multiple myeloma
7881|NCT03524235|CLL|cll
7882|NCT03524235|Bendamustine|bendamustine
7883|NCT03524235|Haploidentical Stem Cell Transplantation|haploidentical stem cell transplantation
7884|NCT03524235|GVHD|gvhd
7885|NCT03524235|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
7886|NCT03524235|Natural Killer Cell|natural killer cell
7887|NCT03524235|CliniMACS|clinimacs
7888|NCT03524235|Post-transplantation cyclophosphamide|post-transplantation cyclophosphamide
7889|NCT03524235|Donor Lymphocyte Infusion|donor lymphocyte infusion
7890|NCT03524235|Minimal Residual Disease|minimal residual disease
7891|NCT03524209|Spondylodiscitis|spondylodiscitis
7892|NCT03524209|spinal infection|spinal infection
7893|NCT03524209|back pain|back pain
7894|NCT03524209|quality of life|quality of life
7895|NCT03524209|fusion|fusion
7896|NCT03524209|minimal invasive surgery|minimal invasive surgery
7897|NCT03524209|brace treatment|brace treatment
7898|NCT03524170|Malignant neoplasm of breast|malignant neoplasm of breast
7899|NCT03524170|Metastatic HR+/HER2- breast cancer|metastatic hr+/her2- breast cancer
7900|NCT03524170|M7824|m7824
7901|NCT03524170|MSB0011359C|msb0011359c
7902|NCT03524170|Radiation therapy|radiation therapy
7903|NCT03524170|XRT|xrt
7904|NCT03524170|External beam radiation therapy|external beam radiation therapy
7905|NCT03524157|Humylub PF|humylub pf
7906|NCT03524157|artificial tears|artificial tears
7907|NCT03524157|Ophthalmic lubricant|ophthalmic lubricant
7908|NCT03524157|Chondroitin sulfate|chondroitin sulfate
7909|NCT03524157|Sodium hyaluronate|sodium hyaluronate
7910|NCT03524105|Socio Economic Adversity|socio economic adversity
7911|NCT03524105|Child Development|child development
7912|NCT03524105|Poverty|poverty
7913|NCT03524105|racial disparity|racial disparity
7914|NCT03524105|ethnic disparity|ethnic disparity
7915|NCT03524092|Interleukin-23 (IL-23)|interleukin-23 (il-23)
7916|NCT03524092|IL-23p19|il-23p19
7917|NCT03524092|Inflammatory Bowel Disease|inflammatory bowel disease
7918|NCT03524040|Selective Photothermolysis|selective photothermolysis
7919|NCT03524040|Reflectance Confocal Microscopy|reflectance confocal microscopy
7920|NCT03524040|Optical Coherence Tomography|optical coherence tomography
7921|NCT03524040|Pilosebaceous Unit|pilosebaceous unit
7922|NCT03524040|Gold Microparticles|gold microparticles
7923|NCT03524027|Vertebral Column Resection|vertebral column resection
7924|NCT03524027|Congenital Spinal Deformity|congenital spinal deformity
7925|NCT03524027|Congenital Thoracolumbar Kyphoscoliosis|congenital thoracolumbar kyphoscoliosis
7926|NCT03523988|Pre-emptive analgesics|pre-emptive analgesics
7927|NCT03523988|Acetaminophen|acetaminophen
7928|NCT03523988|Ibuprofen|ibuprofen
7929|NCT03523962|Surgical Site Infection|surgical site infection
7930|NCT03523962|Open Fracture|open fracture
7931|NCT03523962|Lower Extremity Fracture|lower extremity fracture
7932|NCT03523962|Pelvis; Fracture|pelvis; fracture
7933|NCT03523962|DuraPrep|duraprep
7934|NCT03523962|ChloraPrep|chloraprep
7935|NCT03523962|Peri-operative Preparation Solutions|peri-operative preparation solutions
7936|NCT03523949|Pain Neuroscience Education|pain neuroscience education
7937|NCT03523949|Elderly|elderly
7938|NCT03523949|Pain Education|pain education
7939|NCT03523936|antibiotics, prebiotics, dysbiosis|antibiotics, prebiotics, dysbiosis
7940|NCT03523923|Collaborative Care|collaborative care
7941|NCT03523923|Effectiveness Study|effectiveness study
7942|NCT03523845|"early apical peri-implantitis; implant periapical lesion; retrograde peri-implantitis; implant failure"|"early apical peri-implantitis; implant periapical lesion; retrograde peri-implantitis; implant failure"
7943|NCT03523819|Solid Tumors|solid tumors
7944|NCT03523793|Outpatient Physical Therapy|outpatient physical therapy
7945|NCT03523754|Induction of labor|induction of labor
7946|NCT03523754|isosorbide mononitrate|isosorbide mononitrate
7947|NCT03523754|misoprostol|misoprostol
7948|NCT03523741|genetic polymorphism|genetic polymorphism
7949|NCT03523741|pharmacodynamic variability|pharmacodynamic variability
7950|NCT03523741|personalized pharmacotherapy|personalized pharmacotherapy
7951|NCT03523741|adverse drug reaction|adverse drug reaction
7952|NCT03523741|quality of life|quality of life
7953|NCT03523689|Malignant neoplasms of respiratory and intrathoracic organs|malignant neoplasms of respiratory and intrathoracic organs
7954|NCT03523689|Endobronchial ultrasound-guided transbronchial needle aspiration|endobronchial ultrasound-guided transbronchial needle aspiration
7955|NCT03523689|EBUS-TBNA|ebus-tbna
7956|NCT03523624|factor XIII|factor xiii
7957|NCT03523624|intramyocardial haemorrhage|intramyocardial haemorrhage
7958|NCT03523624|microvascular injury|microvascular injury
7959|NCT03523624|STEMI|stemi
7960|NCT03523624|cardiac magnetic resonance|cardiac magnetic resonance
7961|NCT03523611|lung cancer|lung cancer
7962|NCT03523611|Ventricular Failure|ventricular failure
7963|NCT03523585|Breast Cancer|breast cancer
7964|NCT03523585|Metastatic breast cancer|metastatic breast cancer
7965|NCT03523585|DS 8201a|ds 8201a
7966|NCT03523572|Human epidermal growth factor receptor-2|human epidermal growth factor receptor-2
7967|NCT03523572|HER2|her2
7968|NCT03523572|Refractory|refractory
7969|NCT03523572|Metastatic|metastatic
7970|NCT03523572|Urothelial cancer|urothelial cancer
7971|NCT03523572|Breast Cancer|breast cancer
7972|NCT03523520|constipation|constipation
7973|NCT03523520|opioid|opioid
7974|NCT03523507|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
7975|NCT03523507|Military|military
7976|NCT03523468|VATS|vats
7977|NCT03523468|Lung Cancer|lung cancer
7978|NCT03523455|Iron|iron
7979|NCT03523455|Exercise Performance|exercise performance
7980|NCT03523455|Fatigue|fatigue
7981|NCT03523403|Obesity|obesity
7982|NCT03523403|Diet|diet
7983|NCT03523403|Apples|apples
7984|NCT03523403|Polyphenols|polyphenols
7985|NCT03523403|Soluble fibre|soluble fibre
7986|NCT03523403|Blood lipids|blood lipids
7987|NCT03523403|Lipid digestion|lipid digestion
7988|NCT03523403|Inflammation|inflammation
7989|NCT03523403|Cytokines|cytokines
7990|NCT03523403|Microbiota|microbiota
7991|NCT03523403|Dysbiosis|dysbiosis
7992|NCT03523403|Type 2 diabetes risk|type 2 diabetes risk
7993|NCT03523403|Cardiovascular disease risk|cardiovascular disease risk
7994|NCT03523390|Metastatic Solid Tumors|metastatic solid tumors
7995|NCT03523390|Avelumab|avelumab
7996|NCT03523390|MSB0010718C|msb0010718c
7997|NCT03523377|Fasting|fasting
7998|NCT03523377|18-199|18-199
7999|NCT03523351|Palliative Radiation|palliative radiation
8000|NCT03523351|18-196|18-196
8001|NCT03523325|Tendinopathy|tendinopathy
8002|NCT03523325|Tendon|tendon
8003|NCT03523325|Rehabilitation|rehabilitation
8004|NCT03523325|Exercise treatment|exercise treatment
8005|NCT03523312|Ablative Irradiation|ablative irradiation
8006|NCT03523312|18-090|18-090
8007|NCT03523299|invasive ductal carcinoma|invasive ductal carcinoma
8008|NCT03523299|breast cancer|breast cancer
8009|NCT03523299|cryoablation|cryoablation
8010|NCT03523286|Catheter ablation|catheter ablation
8011|NCT03523286|ECG imaging|ecg imaging
8012|NCT03523247|Cholesterol|cholesterol
8013|NCT03523247|LDL|ldl
8014|NCT03523247|HDL|hdl
8015|NCT03523247|triglycerides|triglycerides
8016|NCT03523247|c-reactive protein|c-reactive protein
8017|NCT03523247|whole food diet|whole food diet
8018|NCT03523247|plant based diet|plant based diet
8019|NCT03523247|community based enrollment|community based enrollment
8020|NCT03523234|neoadjuvant therapy|neoadjuvant therapy
8021|NCT03523234|surgery|surgery
8022|NCT03523182|Micronutrient supplementation|micronutrient supplementation
8023|NCT03523182|Home fortification|home fortification
8024|NCT03523182|Spirulina|spirulina
8025|NCT03523182|Zambia|zambia
8026|NCT03523169|Septic associated encephalopathy|septic associated encephalopathy
8027|NCT03523169|Cerebral oxygenation|cerebral oxygenation
8028|NCT03523169|Prognosis|prognosis
8029|NCT03523169|Passive leg raising|passive leg raising
8030|NCT03523156|Antibiotics|antibiotics
8031|NCT03523156|Infectious diseases|infectious diseases
8032|NCT03523156|Tropical medicine|tropical medicine
8033|NCT03523156|Public health|public health
8034|NCT03523143|early screening|early screening
8035|NCT03523143|early intervention|early intervention
8036|NCT03523143|gestational diabetes mellitus|gestational diabetes mellitus
8037|NCT03523143|pregnancy outcomes|pregnancy outcomes
8038|NCT03523143|randomized controlled trial|randomized controlled trial
8039|NCT03523130|Macrophage-specific inflammation|macrophage-specific inflammation
8040|NCT03523130|Arterial inflammation|arterial inflammation
8041|NCT03523130|Neuroinflammation|neuroinflammation
8042|NCT03523130|SPECT/CT|spect/ct
8043|NCT03523130|Tilmanocept|tilmanocept
8044|NCT03523091|OnabotulinumtoxinA|onabotulinumtoxina
8045|NCT03523091|Bladder Injections|bladder injections
8046|NCT03523039|Cardiac Arrest|cardiac arrest
8047|NCT03523039|Cytokine Hemoadsorption|cytokine hemoadsorption
8048|NCT03523026|Metabolic Syndrome|metabolic syndrome
8049|NCT03523026|Coronary Artery Patients|coronary artery patients
8050|NCT03523026|Neuromuscular Electrical Stimulation,|neuromuscular electrical stimulation,
8051|NCT03523026|Respiratory Muscle Training|respiratory muscle training
8052|NCT03523026|Peripheral Muscle Training|peripheral muscle training
8053|NCT03523000|intractable chronic low back pain|intractable chronic low back pain
8054|NCT03523000|lumbar post-laminectomy syndrome|lumbar post-laminectomy syndrome
8055|NCT03523000|vertebral compression fracture|vertebral compression fracture
8056|NCT03523000|intrathecal drug delivery system|intrathecal drug delivery system
8057|NCT03522987|Neurologic Disorders|neurologic disorders
8058|NCT03522987|Chronic Care|chronic care
8059|NCT03522987|Management|management
8060|NCT03522987|Treatment|treatment
8061|NCT03522987|SSRI Medication|ssri medication
8062|NCT03522987|SNRI Medication|snri medication
8063|NCT03522987|Learning Healthcare System|learning healthcare system
8064|NCT03522948|heavy drinking|heavy drinking
8065|NCT03522948|sexual risk behavior|sexual risk behavior
8066|NCT03522922|Acne scars|acne scars
8067|NCT03522922|dermaroller|dermaroller
8068|NCT03522922|vitamin C|vitamin c
8069|NCT03522909|obstetric anesthesia|obstetric anesthesia
8070|NCT03522909|telemedicine|telemedicine
8071|NCT03522883|Martial Arts|martial arts
8072|NCT03522870|Flash glucose monitoring system|flash glucose monitoring system
8073|NCT03522870|FGMS|fgms
8074|NCT03522844|mindfulness|mindfulness
8075|NCT03522844|escitalopram|escitalopram
8076|NCT03522844|anxiety|anxiety
8077|NCT03522831|dyspnea|dyspnea
8078|NCT03522831|exercise endurance|exercise endurance
8079|NCT03522831|lung disease|lung disease
8080|NCT03522805|copd|copd
8081|NCT03522805|lung|lung
8082|NCT03522805|non-invasive ventilation|non-invasive ventilation
8083|NCT03522805|hypercapnia|hypercapnia
8084|NCT03522805|hypoventilation|hypoventilation
8085|NCT03522792|food intake|food intake
8086|NCT03522792|appetite|appetite
8087|NCT03522792|obesity treatment|obesity treatment
8088|NCT03522792|neurotensin|neurotensin
8089|NCT03522792|gastrointestinal|gastrointestinal
8090|NCT03522792|peptide|peptide
8091|NCT03522740|Chronic Kidney Disease|chronic kidney disease
8092|NCT03522740|Chronic Kidney Failure|chronic kidney failure
8093|NCT03522740|Palliative Care|palliative care
8094|NCT03522740|Dialysis|dialysis
8095|NCT03522740|End-of-life care|end-of-life care
8096|NCT03522740|Decision making|decision making
8097|NCT03522714|support surface, pressure ulcer, flap closure|support surface, pressure ulcer, flap closure
8098|NCT03522701|Adolescents|adolescents
8099|NCT03522701|Youth|youth
8100|NCT03522701|Insomnia|insomnia
8101|NCT03522688|dexmedetomidine|dexmedetomidine
8102|NCT03522688|acute kidney injury|acute kidney injury
8103|NCT03522688|liver transplantation|liver transplantation
8104|NCT03522649|CRC|crc
8105|NCT03522636|Prehospital transfusion|prehospital transfusion
8106|NCT03522636|Trauma|trauma
8107|NCT03522636|Trauma induced coagulopathy|trauma induced coagulopathy
8108|NCT03522623|colitis, costs, Crohn, pediatrics|colitis, costs, crohn, pediatrics
8109|NCT03522610|Prevention|prevention
8110|NCT03522610|Military Families|military families
8111|NCT03522610|Parenting|parenting
8112|NCT03522597|Obesity|obesity
8113|NCT03522597|Gestational Diabetes|gestational diabetes
8114|NCT03522597|Breast Milk|breast milk
8115|NCT03522597|Microbiome|microbiome
8116|NCT03522597|Infant Growth|infant growth
8117|NCT03522545|treatment-resistant bipolar depression|treatment-resistant bipolar depression
8118|NCT03522545|bipolar disorder|bipolar disorder
8119|NCT03522545|manic depression|manic depression
8120|NCT03522532|dental restorations|dental restorations
8121|NCT03522532|gingival crevicular fluid|gingival crevicular fluid
8122|NCT03522532|glutathione|glutathione
8123|NCT03522532|lipid peroxidation|lipid peroxidation
8124|NCT03522532|superoxide dismutase|superoxide dismutase
8125|NCT03522519|Physical Activity|physical activity
8126|NCT03522519|Upper Extremity|upper extremity
8127|NCT03522519|Movement Sensors|movement sensors
8128|NCT03522519|Prognosis|prognosis
8129|NCT03522519|Observational Cohort Study|observational cohort study
8130|NCT03522506|Drug Therapy|drug therapy
8131|NCT03522480|cystic fibrosis|cystic fibrosis
8132|NCT03522480|autogenic drainage|autogenic drainage
8133|NCT03522480|respiratory therapy|respiratory therapy
8134|NCT03522480|videogaming therapy|videogaming therapy
8135|NCT03522467|Cannabis oil|cannabis oil
8136|NCT03522467|Cannabis|cannabis
8137|NCT03522467|Pain|pain
8138|NCT03522467|Cancer|cancer
8139|NCT03522454|Frailty|frailty
8140|NCT03522454|TAVR|tavr
8141|NCT03522428|vitamin b12|vitamin b12
8142|NCT03522428|pregnancy|pregnancy
8143|NCT03522428|anemia|anemia
8144|NCT03522402|head position|head position
8145|NCT03522402|obstructive airway|obstructive airway
8146|NCT03522402|minimum alveolar concentration(MACendotracheal intubation)|minimum alveolar concentration(macendotracheal intubation)
8147|NCT03522402|sevoflurane concentration|sevoflurane concentration
8148|NCT03522389|Action Observation Training|action observation training
8149|NCT03522389|Gait|gait
8150|NCT03522363|oral health|oral health
8151|NCT03522363|Streptococcus dentisani|streptococcus dentisani
8152|NCT03522350|Infertility|infertility
8153|NCT03522350|Embryo develpoment|embryo develpoment
8154|NCT03522350|IVF|ivf
8155|NCT03522350|ICSI|icsi
8156|NCT03522350|EmbryoScope|embryoscope
8157|NCT03522337|preschool children|preschool children
8158|NCT03522337|special needs|special needs
8159|NCT03522337|tooth brushing|tooth brushing
8160|NCT03522337|social story|social story
8161|NCT03522337|visual pedagogy|visual pedagogy
8162|NCT03522324|Cannabis|cannabis
8163|NCT03522324|Pain|pain
8164|NCT03522324|Cytokines|cytokines
8165|NCT03522324|Inflammation|inflammation
8166|NCT03522324|Cognition|cognition
8167|NCT03522298|newly diagnosed|newly diagnosed
8168|NCT03522298|unmethylated O6 methylguanine-methyltransferase (MGMT) promoter status|unmethylated o6 methylguanine-methyltransferase (mgmt) promoter status
8169|NCT03522285|hip arthroplasty|hip arthroplasty
8170|NCT03522285|chronic renal diseases|chronic renal diseases
8171|NCT03522272|denture|denture
8172|NCT03522272|removable partial denture|removable partial denture
8173|NCT03522272|denture cleansers|denture cleansers
8174|NCT03522272|ultrasonics|ultrasonics
8175|NCT03522272|cetylpyridinium chloride|cetylpyridinium chloride
8176|NCT03522272|Staphylococcus aureus|staphylococcus aureus
8177|NCT03522272|Gram negative bacilli|gram negative bacilli
8178|NCT03522272|Candida|candida
8179|NCT03522272|yeast|yeast
8180|NCT03522259|Rivaroxaban|rivaroxaban
8181|NCT03522259|Thromboembolic prophylaxis|thromboembolic prophylaxis
8182|NCT03522259|Venous thromboembolism|venous thromboembolism
8183|NCT03522246|PARP inhibitor|parp inhibitor
8184|NCT03522246|PARPi|parpi
8185|NCT03522246|HRD|hrd
8186|NCT03522246|ATHENA|athena
8187|NCT03522246|homologous recombination|homologous recombination
8188|NCT03522246|DNA repair|dna repair
8189|NCT03522246|LOH|loh
8190|NCT03522246|DNA defect|dna defect
8191|NCT03522246|DNA anomaly|dna anomaly
8192|NCT03522246|Rucaparib|rucaparib
8193|NCT03522246|Nivolumab|nivolumab
8194|NCT03522246|PD-1|pd-1
8195|NCT03522246|Immuno-|immuno-
8196|NCT03522246|oncology|oncology
8197|NCT03522246|Tumor|tumor
8198|NCT03522246|mutational|mutational
8199|NCT03522246|burden|burden
8200|NCT03522246|BRCA|brca
8201|NCT03522155|Conjoint Analysis|conjoint analysis
8202|NCT03522155|Life Expectancy|life expectancy
8203|NCT03522155|Patient-centered|patient-centered
8204|NCT03522142|Advanced solid tumors|advanced solid tumors
8205|NCT03522142|AXL|axl
8206|NCT03522142|MER|mer
8207|NCT03522142|AXL/MER|axl/mer
8208|NCT03522129|Alzheimer's Disease|alzheimer's disease
8209|NCT03522103|Cannabis|cannabis
8210|NCT03522103|Marijuana|marijuana
8211|NCT03522103|Cognition|cognition
8212|NCT03522077|Angiogram|angiogram
8213|NCT03522077|Hemostatic|hemostatic
8214|NCT03522077|Activated clotting time|activated clotting time
8215|NCT03522077|Quality of Life|quality of life
8216|NCT03522064|Castrate-resistant prostate cancer|castrate-resistant prostate cancer
8217|NCT03522064|bipolar androgen therapy|bipolar androgen therapy
8218|NCT03522064|homologous recombination deficiency|homologous recombination deficiency
8219|NCT03522064|BRCA|brca
8220|NCT03522051|teeth|teeth
8221|NCT03522051|pulpitis|pulpitis
8222|NCT03522051|deep caries|deep caries
8223|NCT03522051|pulpotomy|pulpotomy
8224|NCT03522051|Mineral Trioxide Aggregate (MTA)|mineral trioxide aggregate (mta)
8225|NCT03522038|coronary chronic total occlusion|coronary chronic total occlusion
8226|NCT03522038|functional evaluation|functional evaluation
8227|NCT03522012|Pharmacokinetics|pharmacokinetics
8228|NCT03522012|Tocilizumab|tocilizumab
8229|NCT03521999|PTSD|ptsd
8230|NCT03521999|peer resource|peer resource
8231|NCT03521999|Veterans|veterans
8232|NCT03521999|web-based intervention|web-based intervention
8233|NCT03521999|digital story telling|digital story telling
8234|NCT03521986|Mediastinal Neoplasms|mediastinal neoplasms
8235|NCT03521986|Pain|pain
8236|NCT03521986|Quality of life|quality of life
8237|NCT03521973|Plasmodium falciparum|plasmodium falciparum
8238|NCT03521973|PfSPZ Vaccine|pfspz vaccine
8239|NCT03521960|Buspirone|buspirone
8240|NCT03521947|MCP|mcp
8241|NCT03521856|spinal cord injuries|spinal cord injuries
8242|NCT03521856|SCI|sci
8243|NCT03521843|femoropopliteal occlusive disease|femoropopliteal occlusive disease
8244|NCT03521843|local drug delivery|local drug delivery
8245|NCT03521843|endovascular treatment|endovascular treatment
8246|NCT03521804|Chronic Total Occlusion|chronic total occlusion
8247|NCT03521804|coronary|coronary
8248|NCT03521804|SoundBite™ Crossing System|soundbite™ crossing system
8249|NCT03521804|CTO|cto
8251|NCT03521804|true lumen|true lumen
8252|NCT03521804|Active wire|active wire
8253|NCT03521804|Device|device
8254|NCT03521804|Procedure|procedure
8255|NCT03521804|Stenosis|stenosis
8256|NCT03521804|CAD|cad
8257|NCT03521804|Coronary Artery Disease|coronary artery disease
8258|NCT03521791|zebesten|zebesten
8259|NCT03521791|ocular anti-inflammatory|ocular anti-inflammatory
8260|NCT03521791|ocular analgesic|ocular analgesic
8261|NCT03521791|pterygium|pterygium
8262|NCT03521791|anti-inflammatory non-steroidal ophthalmic|anti-inflammatory non-steroidal ophthalmic
8263|NCT03521765|quality of life|quality of life
8264|NCT03521765|occupational therapy|occupational therapy
8265|NCT03521752|BALANCE|balance
8266|NCT03521752|INSTITUTIONALIZED ELDERLY PEOPLE|institutionalized elderly people
8267|NCT03521752|THERAPEUTIC EXERCISE|therapeutic exercise
8268|NCT03521752|FUNCTIONAL CAPACITY|functional capacity
8269|NCT03521739|blood pressure|blood pressure
8270|NCT03521739|pulse wave velocity|pulse wave velocity
8271|NCT03521739|ankle brachial index|ankle brachial index
8272|NCT03521739|cardiovascular events|cardiovascular events
8273|NCT03521726|Rabeprazole|rabeprazole
8274|NCT03521726|Amoxicillin|amoxicillin
8275|NCT03521726|Helicobacter Pylori|helicobacter pylori
8276|NCT03521700|Renal Artery Obstruction|renal artery obstruction
8277|NCT03521700|Stents|stents
8278|NCT03521700|Glomerular filtration rate|glomerular filtration rate
8279|NCT03521687|Central centrifugal cicatricial alopecia|central centrifugal cicatricial alopecia
8280|NCT03521687|open-label pilot study|open-label pilot study
8281|NCT03521674|second trimester pregnancy termination|second trimester pregnancy termination
8282|NCT03521674|double-balloon catheter|double-balloon catheter
8283|NCT03521674|foley catheter|foley catheter
8284|NCT03521661|Vertebral fracture|vertebral fracture
8285|NCT03521661|Kyphotic deformity|kyphotic deformity
8286|NCT03521661|Kyphoplasty|kyphoplasty
8287|NCT03521661|Vertebroplasty|vertebroplasty
8288|NCT03521648|Prostatic Artery Embolization|prostatic artery embolization
8289|NCT03521648|Transurethral Prostate Resection|transurethral prostate resection
8290|NCT03521648|Transurethral Electroresection of Prostate|transurethral electroresection of prostate
8291|NCT03521648|Contact Laser Ablation of Prostate|contact laser ablation of prostate
8292|NCT03521648|Laser Enucleation of Prostate|laser enucleation of prostate
8293|NCT03521648|Open prostatectomy|open prostatectomy
8294|NCT03521622|counseling, behavioral therapy, tobacco, alcohol drinking|counseling, behavioral therapy, tobacco, alcohol drinking
8295|NCT03521596|IgM monoclonal gammopathy|igm monoclonal gammopathy
8296|NCT03521596|Waldenström's Macroglobulinemia|waldenström's macroglobulinemia
8297|NCT03521596|Minimal residual disease|minimal residual disease
8298|NCT03521596|Clonal evolution|clonal evolution
8299|NCT03521583|von Willebrand disease|von willebrand disease
8300|NCT03521583|von Willebrand factor|von willebrand factor
8301|NCT03521583|Nationwide study|nationwide study
8302|NCT03521583|Prospective study|prospective study
8303|NCT03521531|Quality of Life|quality of life
8304|NCT03521531|Sarcoma|sarcoma
8305|NCT03521531|Patient Reported Outcomes|patient reported outcomes
8306|NCT03521505|Sedation|sedation
8307|NCT03521505|dexmedetomidine|dexmedetomidine
8308|NCT03521505|brain perfusion|brain perfusion
8309|NCT03521505|bronchoscopy|bronchoscopy
8310|NCT03521492|Early childhood caries, Vitamin D deficiency, Parathyroid hormone, Calcium|early childhood caries, vitamin d deficiency, parathyroid hormone, calcium
8311|NCT03521479|Squaric Acid|squaric acid
8312|NCT03521479|SADBE|sadbe
8313|NCT03521479|Squaric acid dibutyl ester|squaric acid dibutyl ester
8314|NCT03521466|Smoking cessation counselling|smoking cessation counselling
8315|NCT03521466|Medical Students|medical students
8316|NCT03521466|India|india
8317|NCT03521440|Therapeutic relaxation|therapeutic relaxation
8318|NCT03521440|Elderly|elderly
8319|NCT03521440|Community dwelling|community dwelling
8320|NCT03521427|Intensive Therapy|intensive therapy
8321|NCT03521427|Cerebral Palsy|cerebral palsy
8322|NCT03521414|Bispectral index|bispectral index
8323|NCT03521414|Glasgow Coma Scale|glasgow coma scale
8324|NCT03521414|intracranial pathology|intracranial pathology
8325|NCT03521401|Adverse Childhood Experiences|adverse childhood experiences
8326|NCT03521401|Exercise Intervention|exercise intervention
8327|NCT03521401|Inflammation|inflammation
8328|NCT03521401|Resilience|resilience
8329|NCT03521401|Health|health
8330|NCT03521388|depression|depression
8331|NCT03521388|adolescence|adolescence
8332|NCT03521388|prevention|prevention
8333|NCT03521388|early intervention|early intervention
8334|NCT03521388|internet-based|internet-based
8335|NCT03521375|lung|lung
8336|NCT03521375|cancer|cancer
8337|NCT03521375|lobectomy|lobectomy
8338|NCT03521362|mHealth|mhealth
8339|NCT03521362|Adolescent|adolescent
8340|NCT03521349|Electroencephalography|electroencephalography
8341|NCT03521349|Executive Function|executive function
8342|NCT03521349|Egg|egg
8343|NCT03521349|Diet|diet
8344|NCT03521336|Spinal cord injury|spinal cord injury
8345|NCT03521336|Umbilical Cord Mesenchymal Stem Cells|umbilical cord mesenchymal stem cells
8346|NCT03521323|umbilical cord mesenchymal stem cells|umbilical cord mesenchymal stem cells
8347|NCT03521323|spinal cord injury|spinal cord injury
8348|NCT03521310|IPISTOSS|ipistoss
8349|NCT03521310|Skin to skin|skin to skin
8350|NCT03521310|SSC|ssc
8351|NCT03521310|Neonatal|neonatal
8352|NCT03521284|perinatal period|perinatal period
8353|NCT03521271|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
8354|NCT03521271|Upper limb|upper limb
8355|NCT03521271|Hand functions|hand functions
8356|NCT03521271|Performance|performance
8357|NCT03521271|Grip Strength|grip strength
8358|NCT03521245|breast cancer|breast cancer
8359|NCT03521245|epidermal growth factor receptor|epidermal growth factor receptor
8360|NCT03521245|HER2|her2
8361|NCT03521245|EGFR|egfr
8362|NCT03521245|biomarkers|biomarkers
8363|NCT03521245|targeted therapy|targeted therapy
8364|NCT03521245|NGS|ngs
8365|NCT03521245|RNAseq|rnaseq
8366|NCT03521245|mRNA|mrna
8367|NCT03521245|transcriptome analysis|transcriptome analysis
8368|NCT03521245|signaling pathway|signaling pathway
8369|NCT03521245|intracellular molecular pathway|intracellular molecular pathway
8370|NCT03521245|OncoBox|oncobox
8371|NCT03521245|trastuzumab|trastuzumab
8372|NCT03521206|Advance directives|advance directives
8373|NCT03521206|Effectiveness|effectiveness
8374|NCT03521206|Process evaluation|process evaluation
8375|NCT03521206|Care staff|care staff
8376|NCT03521193|Migraine;|migraine;
8377|NCT03521193|PFO|pfo
8378|NCT03521193|platelet reactivity|platelet reactivity
8379|NCT03521193|aura|aura
8380|NCT03521180|Celiac Disease|celiac disease
8381|NCT03521180|Gluten|gluten
8382|NCT03521180|Immune Response|immune response
8383|NCT03521180|Challenge|challenge
8384|NCT03521154|Phase III|phase iii
8385|NCT03521154|Osimertinib|osimertinib
8386|NCT03521154|Non Small Cell Lung Cancer (Stage III)|non small cell lung cancer (stage iii)
8387|NCT03521154|Unresectable NSCLC|unresectable nsclc
8388|NCT03521154|EGFR|egfr
8389|NCT03521154|chemoradiation therapy|chemoradiation therapy
8390|NCT03521141|Tobacco Use Cessation|tobacco use cessation
8391|NCT03521141|Precision Medicine|precision medicine
8392|NCT03521089|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
8393|NCT03521089|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
8394|NCT03521076|Botulinum Toxin Injections|botulinum toxin injections
8395|NCT03521076|Virtual Reality|virtual reality
8396|NCT03521063|bronchopulmonary dysplasia|bronchopulmonary dysplasia
8397|NCT03521063|respiratory distress syndrome|respiratory distress syndrome
8398|NCT03521063|budesonide|budesonide
8399|NCT03521063|poractant alfa|poractant alfa
8400|NCT03521037|rucaparib|rucaparib
8401|NCT03521037|CO-338|co-338
8402|NCT03521037|Clovis|clovis
8403|NCT03521037|Clovis Oncology|clovis oncology
8404|NCT03521037|PARP inhibitor|parp inhibitor
8405|NCT03521037|hepatic impairment|hepatic impairment
8406|NCT03521024|Zirconia implants|zirconia implants
8407|NCT03521024|PEKK crowns|pekk crowns
8408|NCT03521024|high performance polymer crowns|high performance polymer crowns
8409|NCT03520985|refractory Multiple Myeloma|refractory multiple myeloma
8410|NCT03520985|Phase II|phase ii
8411|NCT03520985|Pomalidomide|pomalidomide
8412|NCT03520985|OptiPOM|optipom
8413|NCT03520959|Synovate Study|synovate study
8414|NCT03520959|NY-ESO-1|ny-eso-1
8415|NCT03520959|cancer vaccine|cancer vaccine
8416|NCT03520946|colorectal cancer|colorectal cancer
8417|NCT03520946|ramucirumab|ramucirumab
8418|NCT03520946|tas102|tas102
8419|NCT03520933|Embryo|embryo
8420|NCT03520933|Blastocyst|blastocyst
8421|NCT03520933|Non-invasive|non-invasive
8422|NCT03520933|PGT-A|pgt-a
8423|NCT03520933|Chromosome|chromosome
8424|NCT03520933|Aneuploidy|aneuploidy
8425|NCT03520933|Spent culture medium|spent culture medium
8426|NCT03520933|Trophectoderm biopsy|trophectoderm biopsy
8427|NCT03520907|transversalis fascia|transversalis fascia
8428|NCT03520907|ilioinguinal/iliohypogastric nerve|ilioinguinal/iliohypogastric nerve
8429|NCT03520907|inguinal hernia repair|inguinal hernia repair
8430|NCT03520907|children|children
8431|NCT03520881|asthma|asthma
8432|NCT03520855|Type 1 Diabetes|type 1 diabetes
8433|NCT03520855|Paediatrics patients|paediatrics patients
8434|NCT03520816|Fibronectin|fibronectin
8435|NCT03520816|Prealbumin|prealbumin
8436|NCT03520816|Physiotherapy|physiotherapy
8437|NCT03520816|Major Burns|major burns
8438|NCT03520816|biochemical parameters|biochemical parameters
8439|NCT03520803|obesity|obesity
8440|NCT03520803|bariatric surgery|bariatric surgery
8441|NCT03520803|enhanced recovery after surgery|enhanced recovery after surgery
8442|NCT03520803|sleeve gastrectomy|sleeve gastrectomy
8443|NCT03520803|gastric bypass|gastric bypass
8444|NCT03520790|Pancreatic Cancer|pancreatic cancer
8445|NCT03520751|CMT1A|cmt1a
8446|NCT03520751|scAAV1.tMCK.NTF3|scaav1.tmck.ntf3
8447|NCT03520751|NTF3|ntf3
8448|NCT03520725|antioxidant capacity|antioxidant capacity
8449|NCT03520712|Hemophilia A|hemophilia a
8450|NCT03520712|Blood Coagulation Disorders, Inherited|blood coagulation disorders, inherited
8451|NCT03520712|Blood Coagulation Disorders|blood coagulation disorders
8452|NCT03520712|Hematologic Diseases|hematologic diseases
8453|NCT03520712|Coagulation Protein Disorders|coagulation protein disorders
8454|NCT03520712|Hemorrhagic Disorders|hemorrhagic disorders
8455|NCT03520712|Genetic Diseases, Inborn|genetic diseases, inborn
8456|NCT03520712|Factor VIII|factor viii
8457|NCT03520712|Coagulants|coagulants
8458|NCT03520712|AAV5 antibodies|aav5 antibodies
8459|NCT03520699|metabolic surgery|metabolic surgery
8460|NCT03520699|metabolic disease|metabolic disease
8461|NCT03520686|Pembrolizumab|pembrolizumab
8462|NCT03520686|ALT-803|alt-803
8463|NCT03520686|Non-Small Cell Lung Cancer|non-small cell lung cancer
8464|NCT03520686|Immunotherapy|immunotherapy
8465|NCT03520673|Lower Urinary Tract Symptoms|lower urinary tract symptoms
8466|NCT03520673|Primary Care|primary care
8467|NCT03520673|Urology|urology
8468|NCT03520660|Natural History|natural history
8469|NCT03520660|Hepatitis C Virus|hepatitis c virus
8470|NCT03520660|Hepatocellular Carcinoma|hepatocellular carcinoma
8471|NCT03520660|Fibrosis|fibrosis
8472|NCT03520660|Immune Response|immune response
8473|NCT03520647|Haploidentical CD34+cells|haploidentical cd34+cells
8474|NCT03520647|Non-Myeloablative|non-myeloablative
8475|NCT03520634|Melanoma|melanoma
8476|NCT03520634|PD-L1|pd-l1
8477|NCT03520634|Brain metastases|brain metastases
8478|NCT03520634|PET imaging|pet imaging
8479|NCT03520621|sulfur amino acid|sulfur amino acid
8480|NCT03520556|EPA|epa
8481|NCT03520556|DHA|dha
8482|NCT03520556|low-grade inflammation|low-grade inflammation
8483|NCT03520556|CRP|crp
8484|NCT03520556|IL-6|il-6
8485|NCT03520556|TNF-alpha|tnf-alpha
8486|NCT03520556|adiponectin|adiponectin
8487|NCT03520556|randomized controlled trials|randomized controlled trials
8488|NCT03520556|systematic review and meta-analysis|systematic review and meta-analysis
8489|NCT03520543|PET imaging|pet imaging
8490|NCT03520543|Noradrenaline|noradrenaline
8491|NCT03520543|Radiotracer|radiotracer
8492|NCT03520530|second stage|second stage
8493|NCT03520530|spontaneous vaginal delivery|spontaneous vaginal delivery
8494|NCT03520517|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
8495|NCT03520517|ALS|als
8496|NCT03520517|Biohaven|biohaven
8497|NCT03520517|Motor Neuron Disease, Amyotrophic Lateral Sclerosis|motor neuron disease, amyotrophic lateral sclerosis
8498|NCT03520517|Lou Gehrig's Disease|lou gehrig's disease
8499|NCT03520517|Lou-Gehrigs Disease|lou-gehrigs disease
8500|NCT03520517|Lou Gehrig Disease|lou gehrig disease
8501|NCT03520517|Riluzole|riluzole
8502|NCT03520517|Rilutek®|rilutek®
8503|NCT03520517|Neuroprotective Agents|neuroprotective agents
8504|NCT03520517|Administration, Sublingual|administration, sublingual
8505|NCT03520517|Administration, Oral|administration, oral
8506|NCT03520517|Biological Availability|biological availability
8507|NCT03520504|Proton Radiation|proton radiation
8508|NCT03520504|craniospinal irradiation (CSI)|craniospinal irradiation (csi)
8509|NCT03520504|18-205|18-205
8510|NCT03520491|Immunotherapy|immunotherapy
8511|NCT03520491|Nivolumab|nivolumab
8512|NCT03520491|Ipilimumab|ipilimumab
8513|NCT03520491|18-042|18-042
8514|NCT03520478|Hormone sensitive prostate cancer|hormone sensitive prostate cancer
8515|NCT03520478|SHR3680|shr3680
8516|NCT03520478|Anti-androgen receptor|anti-androgen receptor
8517|NCT03520439|Adenomyosis|adenomyosis
8518|NCT03520439|mifepristone|mifepristone
8519|NCT03520439|the selective progesterone receptor modulators|the selective progesterone receptor modulators
8520|NCT03520439|treatment|treatment
8521|NCT03520413|Complex Care|complex care
8522|NCT03520413|Outcomes|outcomes
8523|NCT03520413|Telemedicine|telemedicine
8524|NCT03520413|Rural Health|rural health
8525|NCT03520413|Diabetes|diabetes
8526|NCT03520400|Cardiovascular Disease|cardiovascular disease
8527|NCT03520400|Percutaneous Intervention|percutaneous intervention
8528|NCT03520400|coronary artery disease|coronary artery disease
8529|NCT03520400|exercise therapy|exercise therapy
8530|NCT03520387|Randomized controlled trial|randomized controlled trial
8531|NCT03520387|Chronic pain|chronic pain
8532|NCT03520374|ultrasound|ultrasound
8533|NCT03520374|gastric contents|gastric contents
8534|NCT03520361|Colonoscopy|colonoscopy
8535|NCT03520361|Bowel preparation|bowel preparation
8536|NCT03520361|Oral sulfate solution|oral sulfate solution
8537|NCT03520361|Polyethylene glycol|polyethylene glycol
8538|NCT03520361|Ascorbic acid|ascorbic acid
8539|NCT03520348|dry eye|dry eye
8540|NCT03520348|eye lubricants|eye lubricants
8541|NCT03520348|eye lubricant gel|eye lubricant gel
8542|NCT03520348|PRO-167|pro-167
8543|NCT03520335|stroke|stroke
8544|NCT03520335|conjugated eye deviation|conjugated eye deviation
8545|NCT03520335|prehospital|prehospital
8546|NCT03520335|stroke scale|stroke scale
8547|NCT03520335|large vessel occlusion|large vessel occlusion
8548|NCT03520309|Diagnosis|diagnosis
8549|NCT03520309|Visual inspection|visual inspection
8550|NCT03520309|Quality of Life|quality of life
8551|NCT03520309|Restorations|restorations
8552|NCT03520244|Microbiome|microbiome
8553|NCT03520244|High intensity interval training|high intensity interval training
8554|NCT03520244|Exercise|exercise
8555|NCT03520244|Holistic education|holistic education
8556|NCT03520244|Quality of life|quality of life
8557|NCT03520244|Fatigue|fatigue
8558|NCT03520205|stress response|stress response
8559|NCT03520205|kidney donor|kidney donor
8560|NCT03520205|Cellular Imunological Function|cellular imunological function
8561|NCT03520205|quadratus lumborum block|quadratus lumborum block
8562|NCT03520192|Paediatric|paediatric
8563|NCT03520192|Critical care|critical care
8564|NCT03520192|Transport|transport
8565|NCT03520166|urgency|urgency
8566|NCT03520166|frequency|frequency
8567|NCT03520166|overactive bladder|overactive bladder
8568|NCT03520166|LUTS|luts
8569|NCT03520166|pelvic pain|pelvic pain
8570|NCT03520166|electrostimulation|electrostimulation
8571|NCT03520140|Familial hypercholesterolemia|familial hypercholesterolemia
8572|NCT03520140|Coronary artery disease|coronary artery disease
8573|NCT03520114|Retropubic sling|retropubic sling
8574|NCT03520114|Single-incision sling|single-incision sling
8575|NCT03520114|Vaginal repair|vaginal repair
8576|NCT03520114|Management|management
8577|NCT03520088|Rectal cancer|rectal cancer
8578|NCT03520088|Sexual dysfunction|sexual dysfunction
8579|NCT03520088|Urinary dysfunction|urinary dysfunction
8580|NCT03520088|Rectal nerves damage|rectal nerves damage
8581|NCT03520088|Total Mesorectal Excision|total mesorectal excision
8582|NCT03520075|Neoplasms|neoplasms
8583|NCT03520075|Solid Tumors|solid tumors
8584|NCT03520075|Antineoplastic Agents|antineoplastic agents
8585|NCT03520075|MAPK|mapk
8586|NCT03520075|ERK|erk
8587|NCT03520062|Amylase|amylase
8588|NCT03520062|Lipase|lipase
8589|NCT03520062|GLP-1|glp-1
8590|NCT03520049|Thrombocytopenia|thrombocytopenia
8591|NCT03520049|ITP|itp
8592|NCT03520049|Platelets|platelets
8593|NCT03520049|Bleeding|bleeding
8594|NCT03520049|Immune|immune
8595|NCT03520049|Oseltamivir|oseltamivir
8596|NCT03520049|Glycoprotein|glycoprotein
8597|NCT03520049|Sialylation|sialylation
8598|NCT03520049|Antibody|antibody
8599|NCT03520049|Autoantibody|autoantibody
8600|NCT03519971|Locally Advanced, Unresectable Non-small Cell Lung Cancer, NSCLC, Carcinoma, Non-Small-Cell Lung Cancer|locally advanced, unresectable non-small cell lung cancer, nsclc, carcinoma, non-small-cell lung cancer
8601|NCT03519945|Inflammatory Bowel Disease|inflammatory bowel disease
8602|NCT03519906|Bariatric surgery|bariatric surgery
8603|NCT03519906|Gastrointestinal tract|gastrointestinal tract
8604|NCT03519906|Biological availability|biological availability
8605|NCT03519906|Pharmacokinetics|pharmacokinetics
8606|NCT03519906|Metoprolol|metoprolol
8607|NCT03519893|Bariatric surgery|bariatric surgery
8608|NCT03519893|Gastrointestinal tract|gastrointestinal tract
8609|NCT03519893|Biological availability|biological availability
8610|NCT03519893|Pharmacokinetics|pharmacokinetics
8611|NCT03519893|Losartan|losartan
8612|NCT03519880|amyotrophic lateral sclerosis, non-invasive ventilation, mask, custom, 3D-printing|amyotrophic lateral sclerosis, non-invasive ventilation, mask, custom, 3d-printing
8613|NCT03519841|Non-invasive glucose monitoring|non-invasive glucose monitoring
8614|NCT03519815|dry eye|dry eye
8615|NCT03519815|eye spray|eye spray
8616|NCT03519802|Cognitive functions|cognitive functions
8617|NCT03519802|MoCA test|moca test
8618|NCT03519789|Change blindness|change blindness
8619|NCT03519789|Eye tracking|eye tracking
8620|NCT03519789|Implicit response|implicit response
8621|NCT03519750|Melatonin|melatonin
8622|NCT03519750|Safety|safety
8623|NCT03519750|Pharmacokinetics|pharmacokinetics
8624|NCT03519737|Stroke|stroke
8625|NCT03519737|Acute Stroke|acute stroke
8626|NCT03519685|Contraception|contraception
8627|NCT03519685|Hormonal contraception|hormonal contraception
8628|NCT03519685|Long-acting reversible contraception|long-acting reversible contraception
8629|NCT03519685|Condoms|condoms
8630|NCT03519685|Emergency contraception|emergency contraception
8631|NCT03519685|Family planning services|family planning services
8632|NCT03519646|Enzyme Replacement Therapy|enzyme replacement therapy
8633|NCT03519646|Eliglustat (Cerdelga®)|eliglustat (cerdelga®)
8634|NCT03519607|Infertility|infertility
8635|NCT03519607|Distress|distress
8636|NCT03519607|Coping|coping
8637|NCT03519607|Men|men
8638|NCT03519594|angioembolization|angioembolization
8639|NCT03519594|computed tomography|computed tomography
8640|NCT03519581|DME|dme
8641|NCT03519581|micropulse laser|micropulse laser
8642|NCT03519529|sex hormone-binding globulin|sex hormone-binding globulin
8643|NCT03519516|ocular antibiotic|ocular antibiotic
8644|NCT03519516|quinolone|quinolone
8645|NCT03519516|levofloxacin|levofloxacin
8646|NCT03519516|ophthalmic antibiotic|ophthalmic antibiotic
8647|NCT03519516|antibiotic in drops|antibiotic in drops
8648|NCT03519503|HIV|hiv
8649|NCT03519503|Neuropsychological tests|neuropsychological tests
8650|NCT03519503|PMTCT|pmtct
8651|NCT03519503|PreP|prep
8652|NCT03519490|Myopia|myopia
8653|NCT03519490|Myopia Control|myopia control
8654|NCT03519490|Bifocal Contact Lenses|bifocal contact lenses
8655|NCT03519490|Multifocal Contact Lenses|multifocal contact lenses
8656|NCT03519490|Hybrid Contact Lenses|hybrid contact lenses
8657|NCT03519490|Randomized Controlled Clinical Trial|randomized controlled clinical trial
8658|NCT03519490|Distance Center Multifocal Contact Lens|distance center multifocal contact lens
8659|NCT03519490|Near Center Multifocal Contact Lens|near center multifocal contact lens
8660|NCT03519477|clinical decision support|clinical decision support
8661|NCT03519477|drug levels in blood|drug levels in blood
8662|NCT03519477|therapeutic drug monitoring|therapeutic drug monitoring
8663|NCT03519477|medication adherence|medication adherence
8664|NCT03519477|medication therapy management|medication therapy management
8665|NCT03519464|Gardasil 9|gardasil 9
8666|NCT03519464|Seroconversion|seroconversion
8667|NCT03519464|Humoral immune response|humoral immune response
8668|NCT03519464|Cellular Immune Response|cellular immune response
8669|NCT03519464|Mucosal Lesions|mucosal lesions
8670|NCT03519451|Smartphone mobile app|smartphone mobile app
8671|NCT03519451|Questionnaires|questionnaires
8672|NCT03519451|Surveys|surveys
8673|NCT03519451|Phone calls|phone calls
8674|NCT03519451|Interview|interview
8675|NCT03519451|Tobacco cessation|tobacco cessation
8676|NCT03519425|Tuberculosis|tuberculosis
8677|NCT03519425|HIV|hiv
8678|NCT03519425|Randomised controlled trial|randomised controlled trial
8679|NCT03519425|Africa|africa
8680|NCT03519425|Public Health|public health
8681|NCT03519425|Screening|screening
8682|NCT03519412|DNA Mismatch Repair|dna mismatch repair
8683|NCT03519412|Pembrolizumab|pembrolizumab
8684|NCT03519399|Bile Acids, Fetal ECG, Stillbirth,|bile acids, fetal ecg, stillbirth,
8685|NCT03519360|arrythmia|arrythmia
8686|NCT03519360|hemodialysis|hemodialysis
8687|NCT03519334|Employment|employment
8688|NCT03519334|Return to work|return to work
8689|NCT03519334|Career Mobility|career mobility
8690|NCT03519334|Employment supported|employment supported
8691|NCT03519334|Workplace|workplace
8692|NCT03519334|Chronic disease|chronic disease
8693|NCT03519321|Early Onset Scoliosis (EOS)|early onset scoliosis (eos)
8694|NCT03519295|Epidermoid Cancers of the Anal Canal|epidermoid cancers of the anal canal
8695|NCT03519269|total knee replacement|total knee replacement
8696|NCT03519269|robotic surgery|robotic surgery
8697|NCT03519191|teen dating violence|teen dating violence
8698|NCT03519191|sexual assault|sexual assault
8699|NCT03519191|reproductive coercion|reproductive coercion
8700|NCT03519178|Hormone Receptor (HR) Positive Breast Cancer|hormone receptor (hr) positive breast cancer
8701|NCT03519178|Estrogen receptor (ER) positive|estrogen receptor (er) positive
8702|NCT03519178|Progesterone receptor (PR) positive|progesterone receptor (pr) positive
8703|NCT03519178|Cyclin-dependent kinase (CDK)|cyclin-dependent kinase (cdk)
8704|NCT03519178|Human epidermal growth factor receptor 2 (HER2) negative|human epidermal growth factor receptor 2 (her2) negative
8705|NCT03519178|Advanced breast cancer|advanced breast cancer
8706|NCT03519178|Metastatic breast cancer (MBC)|metastatic breast cancer (mbc)
8833|NCT03518216|mindfulness meditation|mindfulness meditation
8707|NCT03519178|Triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
8708|NCT03519178|Epithelial ovarian cancer (EOC)|epithelial ovarian cancer (eoc)
8709|NCT03519178|Fallopian tube cancer|fallopian tube cancer
8710|NCT03519178|Primary peritoneal cancer (PPC)|primary peritoneal cancer (ppc)
8711|NCT03519178|CDK4/6 inhibitor|cdk4/6 inhibitor
8712|NCT03519178|Endocrine Therapy (ET)|endocrine therapy (et)
8713|NCT03519178|Measurable disease|measurable disease
8714|NCT03519178|Luteinizing Hormone Releasing Hormone (LHRH) Agonist|luteinizing hormone releasing hormone (lhrh) agonist
8715|NCT03519178|Goserelin|goserelin
8716|NCT03519178|Leuprolide acetate|leuprolide acetate
8717|NCT03519165|Ovarian cancer|ovarian cancer
8718|NCT03519165|goal-directed fluid therapy|goal-directed fluid therapy
8720|NCT03519139|Geriatric patients, nutritional counselling, homevisit|geriatric patients, nutritional counselling, homevisit
8721|NCT03519126|Urinary Bladder, Overactive; Electric Stimulation|urinary bladder, overactive; electric stimulation
8722|NCT03519113|HBV-related liver transplantation|hbv-related liver transplantation
8723|NCT03519113|Hepatitis B immunoglobulin|hepatitis b immunoglobulin
8724|NCT03519035|borderline|borderline
8725|NCT03519035|hallucinations|hallucinations
8726|NCT03519035|dissociation|dissociation
8727|NCT03519035|post-traumatic stress disorder|post-traumatic stress disorder
8728|NCT03519009|Employment|employment
8729|NCT03518970|uncertainty|uncertainty
8730|NCT03518970|caregivers|caregivers
8731|NCT03518970|palliative care|palliative care
8732|NCT03518970|nursing|nursing
8733|NCT03518970|Hospice and Palliative Care Nursing|hospice and palliative care nursing
8734|NCT03518918|Premature ovarian insufficiency|premature ovarian insufficiency
8735|NCT03518918|Diagnosis standard|diagnosis standard
8736|NCT03518918|Risk factors|risk factors
8737|NCT03518892|Resting Metabolic Rate|resting metabolic rate
8738|NCT03518879|informatics|informatics
8739|NCT03518879|asthma|asthma
8740|NCT03518827|asymmetry|asymmetry
8741|NCT03518827|pain|pain
8742|NCT03518827|sport|sport
8743|NCT03518827|injury|injury
8744|NCT03518827|risk factor|risk factor
8745|NCT03518814|Melanoma stage IV|melanoma stage iv
8746|NCT03518814|Remission|remission
8747|NCT03518814|Quality of life|quality of life
8748|NCT03518801|cannabidiol|cannabidiol
8749|NCT03518801|CBD|cbd
8750|NCT03518801|PTSD|ptsd
8751|NCT03518801|Veterans|veterans
8752|NCT03518749|Depression|depression
8753|NCT03518749|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
8754|NCT03518723|Muscle dysfunction|muscle dysfunction
8755|NCT03518710|child|child
8756|NCT03518710|reading|reading
8757|NCT03518710|vision|vision
8758|NCT03518710|attention|attention
8759|NCT03518710|therapeutical perspectives|therapeutical perspectives
8760|NCT03518697|Exercise|exercise
8761|NCT03518697|Physical fitness|physical fitness
8762|NCT03518697|Physical activity|physical activity
8763|NCT03518697|Accelerometer|accelerometer
8764|NCT03518697|Sleep|sleep
8765|NCT03518671|head and neck cancer|head and neck cancer
8766|NCT03518671|body image disturbance|body image disturbance
8767|NCT03518671|cognitive behavioral therapy|cognitive behavioral therapy
8768|NCT03518671|survivorship|survivorship
8769|NCT03518658|remote monitoring|remote monitoring
8770|NCT03518658|transmission compliance|transmission compliance
8771|NCT03518658|patient engagement|patient engagement
8772|NCT03518645|Coronary Artery Disease|coronary artery disease
8773|NCT03518645|OPN NC|opn nc
8774|NCT03518645|Angina|angina
8775|NCT03518645|Stable|stable
8776|NCT03518645|Unstable|unstable
8777|NCT03518632|Exercise|exercise
8778|NCT03518632|Adapted physical activity|adapted physical activity
8779|NCT03518632|preoperative|preoperative
8780|NCT03518632|liver resection|liver resection
8781|NCT03518632|hepatectomy|hepatectomy
8782|NCT03518606|Advanced solid tumours|advanced solid tumours
8783|NCT03518606|Durvalumab|durvalumab
8784|NCT03518606|Tremelimumab|tremelimumab
8785|NCT03518606|Metronomic vinorelbine|metronomic vinorelbine
8786|NCT03518606|High mutational load malignancies|high mutational load malignancies
8787|NCT03518606|Immunotherapy|immunotherapy
8788|NCT03518606|Early phase|early phase
8789|NCT03518606|Combination study|combination study
8790|NCT03518580|mobile technology|mobile technology
8791|NCT03518580|real-time assessment|real-time assessment
8792|NCT03518580|active life engagement|active life engagement
8793|NCT03518515|nutrition intervention|nutrition intervention
8794|NCT03518515|potato consumption|potato consumption
8795|NCT03518515|energy balance|energy balance
8796|NCT03518437|coronary artery disease|coronary artery disease
8797|NCT03518437|CT|ct
8798|NCT03518437|MACE|mace
8799|NCT03518424|Association football|association football
8800|NCT03518424|Soccer|soccer
8801|NCT03518424|Injury|injury
8802|NCT03518424|Epidemiology|epidemiology
8803|NCT03518398|Intense pulsed light|intense pulsed light
8804|NCT03518398|Meibomian gland dysfunction|meibomian gland dysfunction
8805|NCT03518398|Dry eye|dry eye
8806|NCT03518398|cytokines|cytokines
8807|NCT03518372|Hypoxia|hypoxia
8808|NCT03518372|Myocardial Injury|myocardial injury
8809|NCT03518372|Surgery--Complications|surgery--complications
8810|NCT03518372|Tissue Oximetry|tissue oximetry
8811|NCT03518372|Near-infrared Spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
8812|NCT03518359|Residents|residents
8813|NCT03518359|Stress|stress
8814|NCT03518359|Well-being|well-being
8815|NCT03518320|Bladder Cancer|bladder cancer
8816|NCT03518320|Urothelial Carcinoma|urothelial carcinoma
8817|NCT03518320|Cystectomy|cystectomy
8818|NCT03518320|Radical Cystectomy|radical cystectomy
8819|NCT03518307|Merkel carcinoma|merkel carcinoma
8820|NCT03518294|NAFLD|nafld
8821|NCT03518294|NASH|nash
8822|NCT03518268|probiotics|probiotics
8823|NCT03518268|aromatase inhibitors|aromatase inhibitors
8824|NCT03518268|bone mass|bone mass
8825|NCT03518268|postmenopausal|postmenopausal
8826|NCT03518255|Nursing Care|nursing care
8827|NCT03518255|Complementary therapies|complementary therapies
8828|NCT03518255|Oncological Nursing|oncological nursing
8829|NCT03518255|Photography|photography
8830|NCT03518229|cancer prevention|cancer prevention
8831|NCT03518229|sunburn|sunburn
8832|NCT03518216|cognitive behavioral therapy|cognitive behavioral therapy
8834|NCT03518216|fMRI|fmri
8835|NCT03518216|neuroimaging|neuroimaging
8836|NCT03518203|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
8837|NCT03518164|ACDF|acdf
8838|NCT03518164|allograft|allograft
8839|NCT03518164|autograft|autograft
8840|NCT03518164|cervical fusion|cervical fusion
8841|NCT03518164|NDI|ndi
8842|NCT03518164|EQ-5D|eq-5d
8843|NCT03518164|PROMIS-PF|promis-pf
8844|NCT03518164|DSQ|dsq
8845|NCT03518151|public health|public health
8846|NCT03518151|dietary inequalities|dietary inequalities
8847|NCT03518151|environment design|environment design
8848|NCT03518125|Anthrax|anthrax
8849|NCT03518125|Bacillaceae Infections|bacillaceae infections
8850|NCT03518125|Gram-Positive Bacterial Infections|gram-positive bacterial infections
8851|NCT03518125|Bacterial Infections|bacterial infections
8852|NCT03518125|Anthrax Vaccine Adsorbed|anthrax vaccine adsorbed
8853|NCT03518125|BioThrax|biothrax
8854|NCT03518125|AV7909|av7909
8855|NCT03518125|CPG 7909|cpg 7909
8856|NCT03518125|Adjuvant|adjuvant
8857|NCT03518125|Vaccines|vaccines
8858|NCT03518125|Post-exposure Prophylaxis|post-exposure prophylaxis
8859|NCT03518112|Leukemia|leukemia
8860|NCT03518112|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
8861|NCT03518112|ALL|all
8862|NCT03518112|Relapsed/Refractory|relapsed/refractory
8863|NCT03518112|Philadelphia Chromosome Negative|philadelphia chromosome negative
8864|NCT03518112|Cyclophosphamide|cyclophosphamide
8865|NCT03518112|Cytoxan|cytoxan
8866|NCT03518112|Neosar|neosar
8867|NCT03518112|Mesna|mesna
8868|NCT03518112|Mesnex|mesnex
8869|NCT03518112|Vincristine|vincristine
8870|NCT03518112|Dexamethasone|dexamethasone
8871|NCT03518112|Decadron|decadron
8872|NCT03518112|G-CSF|g-csf
8873|NCT03518112|Filgrastim|filgrastim
8874|NCT03518112|Neupogen|neupogen
8875|NCT03518112|Methotrexate|methotrexate
8876|NCT03518112|Cytarabine|cytarabine
8877|NCT03518112|Ara-C|ara-c
8878|NCT03518112|Cytosar|cytosar
8879|NCT03518112|DepoCyt|depocyt
8880|NCT03518112|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
8881|NCT03518112|Rituximab|rituximab
8882|NCT03518112|Rituxan|rituxan
8883|NCT03518112|Blinatumomab|blinatumomab
8884|NCT03518086|Interleukin-23 (IL-23) antibody|interleukin-23 (il-23) antibody
8885|NCT03518086|IL-23p19|il-23p19
8886|NCT03518073|Memory problems|memory problems
8887|NCT03518073|Cognitive impairment|cognitive impairment
8888|NCT03518073|PERISCOPE-ALZ|periscope-alz
8889|NCT03518073|Dementia|dementia
8890|NCT03518073|Tauopathy|tauopathy
8891|NCT03518073|Neurofibrillary tangles|neurofibrillary tangles
8892|NCT03518060|2 drug regimen|2 drug regimen
8893|NCT03518060|Juluca|juluca
8894|NCT03518060|Rilpivirine|rilpivirine
8895|NCT03518060|Dolutegravir|dolutegravir
8896|NCT03518060|Antiretroviral|antiretroviral
8897|NCT03518060|One pill regimen|one pill regimen
8898|NCT03518047|Plaque Psoriasis|plaque psoriasis
8899|NCT03518034|hypogonadism|hypogonadism
8900|NCT03518034|cardiovascular (CV) disease|cardiovascular (cv) disease
8901|NCT03518034|AndroGel|androgel
8902|NCT03518034|testosterone replacement therapy (TRT)|testosterone replacement therapy (trt)
8903|NCT03518021|Naloxone|naloxone
8904|NCT03518021|Administration, Intranasal|administration, intranasal
8905|NCT03518021|Injections, Intramuscular|injections, intramuscular
8906|NCT03518021|Narcotic Antagonists|narcotic antagonists
8907|NCT03517995|primary bladder tumor|primary bladder tumor
8908|NCT03517995|non-muscle invasive bladder tumor|non-muscle invasive bladder tumor
8909|NCT03517995|muscle invasive bladder tumor|muscle invasive bladder tumor
8910|NCT03517995|sulforaphane|sulforaphane
8911|NCT03517995|chemoprevention|chemoprevention
8912|NCT03517982|MyOra|myora
8913|NCT03517982|Mycophenolate Mofetil|mycophenolate mofetil
8914|NCT03517982|End stage renal disease|end stage renal disease
8915|NCT03517982|De novo Renal transplant|de novo renal transplant
8916|NCT03517982|Post authorization safety study|post authorization safety study
8917|NCT03517982|Immunosuppressant|immunosuppressant
8918|NCT03517982|Cohort study|cohort study
8919|NCT03517956|Phase I|phase i
8920|NCT03517956|Locally advanced or metastatic solid tumor|locally advanced or metastatic solid tumor
8921|NCT03517956|Urothelial cancer|urothelial cancer
8922|NCT03517956|FGFR inhibitor|fgfr inhibitor
8923|NCT03517943|Upper respiratory allergy symptoms including congestion|upper respiratory allergy symptoms including congestion
8924|NCT03517930|Upper respiratory allergy symptoms including congestion|upper respiratory allergy symptoms including congestion
8925|NCT03517904|Femoropopliteal artery disease, drug-coated balloon, angioplasty, antiplatelet therapy|femoropopliteal artery disease, drug-coated balloon, angioplasty, antiplatelet therapy
8926|NCT03517891|Physical activity|physical activity
8927|NCT03517891|Sleep pattern|sleep pattern
8928|NCT03517891|Nutrition|nutrition
8929|NCT03517891|Education|education
8930|NCT03517878|Community Health Worker|community health worker
8931|NCT03517878|Pregnancy|pregnancy
8932|NCT03517878|Breast Feeding|breast feeding
8933|NCT03517878|Child Development|child development
8934|NCT03517878|Home Visits|home visits
8935|NCT03517878|Infants|infants
8936|NCT03517839|Dyspnea|dyspnea
8937|NCT03517839|Inspiratory Muscle Training|inspiratory muscle training
8938|NCT03517839|Kinesiophobia|kinesiophobia
8939|NCT03517826|COPD|copd
8940|NCT03517826|Dyspnea|dyspnea
8941|NCT03517826|Kinesiophobia|kinesiophobia
8942|NCT03517800|Embolization|embolization
8943|NCT03517800|surgery|surgery
8944|NCT03517800|hysterectomy|hysterectomy
8945|NCT03517800|arterial ligation|arterial ligation
8946|NCT03517761|CCJ|ccj
8947|NCT03517761|Bone Marrow Concentrate|bone marrow concentrate
8948|NCT03517761|Stem Cell Therapy|stem cell therapy
8949|NCT03517761|Alar Ligament|alar ligament
8950|NCT03517761|Transverse Ligament|transverse ligament
8951|NCT03517670|Cerebral vasospasm|cerebral vasospasm
8952|NCT03517670|Subarachnoid hemorrhage|subarachnoid hemorrhage
8953|NCT03517670|Milrinone|milrinone
8954|NCT03517670|Hemodynamic tolerance|hemodynamic tolerance
8955|NCT03517657|upper limb|upper limb
8956|NCT03517657|occupational therapy|occupational therapy
8957|NCT03517657|bilateral priming|bilateral priming
8958|NCT03517631|HIV|hiv
8959|NCT03517631|AIDS|aids
8960|NCT03517631|Lentivirus|lentivirus
8961|NCT03517631|shRNA|shrna
8962|NCT03517631|Multiplex|multiplex
8963|NCT03517631|Gene therapy|gene therapy
8964|NCT03517618|A phase II study|a phase ii study
8965|NCT03517618|Heavily pre-treated metastatic colorectal cancer|heavily pre-treated metastatic colorectal cancer
8966|NCT03517618|S-1|s-1
8967|NCT03517618|oral leucovrin|oral leucovrin
8968|NCT03517605|Cardiac Rehabilitation|cardiac rehabilitation
8969|NCT03517605|Quality of Life|quality of life
8970|NCT03517605|Rehabilitation Nursing|rehabilitation nursing
8971|NCT03517566|atopic dermatitis, AD, eczema, atopic eczema, itch, pruritus, histamine 4 receptor|atopic dermatitis, ad, eczema, atopic eczema, itch, pruritus, histamine 4 receptor
8972|NCT03517566|antagonist, H4R, ZPL389, ZPL389A2203, dermatitis|antagonist, h4r, zpl389, zpl389a2203, dermatitis
8973|NCT03517553|electrical muscle stimulation|electrical muscle stimulation
8974|NCT03517540|Steatohepatitis|steatohepatitis
8975|NCT03517540|NASH|nash
8976|NCT03517540|NAFLD|nafld
8977|NCT03517540|Fatty Liver Disease|fatty liver disease
8978|NCT03517540|Liver|liver
8979|NCT03517527|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
8980|NCT03517527|Metabolic Control|metabolic control
8981|NCT03517527|Walking Exercise|walking exercise
8982|NCT03517527|Transtheoretical Model|transtheoretical model
8983|NCT03517527|Nurse|nurse
8984|NCT03517514|Heart Failure|heart failure
8985|NCT03517514|Physical Therapy|physical therapy
8986|NCT03517514|Hospital Readmission|hospital readmission
8987|NCT03517488|DUET-2|duet-2
8988|NCT03517488|Melanoma|melanoma
8989|NCT03517488|Triple Negative Breast Cancer|triple negative breast cancer
8990|NCT03517488|Hepatocellular|hepatocellular
8991|NCT03517488|Urothelial Cancer|urothelial cancer
8992|NCT03517488|Bladder Cancer|bladder cancer
8993|NCT03517488|Renal Cell Cancer|renal cell cancer
8994|NCT03517488|Head and Neck Cancer|head and neck cancer
8995|NCT03517488|MSI-high Colorectal Cancer|msi-high colorectal cancer
8996|NCT03517488|MSI-high Endometrial Cancer|msi-high endometrial cancer
8997|NCT03517488|Non-small Cell Lung Cancer|non-small cell lung cancer
8998|NCT03517488|Gastric Cancer|gastric cancer
8999|NCT03517488|Gastroesophageal Junction Cancer|gastroesophageal junction cancer
9000|NCT03517462|mass drug administration|mass drug administration
9001|NCT03517462|ophthalmology|ophthalmology
9002|NCT03517449|programmed cell death 1 (PD-1, PD1)|programmed cell death 1 (pd-1, pd1)
9003|NCT03517449|programmed cell death ligand 1 (PD-L1, PDL1)|programmed cell death ligand 1 (pd-l1, pdl1)
9004|NCT03517449|programmed cell death ligand 2 (PD-L2, PDL2)|programmed cell death ligand 2 (pd-l2, pdl2)
9005|NCT03517449|vascular endothelial growth factor (VEGF) receptors|vascular endothelial growth factor (vegf) receptors
9006|NCT03517449|lenvatinib|lenvatinib
9007|NCT03517449|pembrolizumab|pembrolizumab
9008|NCT03517449|doxorubicin|doxorubicin
9009|NCT03517449|paclitaxel|paclitaxel
9010|NCT03517449|phase 3 endometrial cancer|phase 3 endometrial cancer
9011|NCT03517436|THV|thv
9012|NCT03517436|Transcatheter Heart Valve|transcatheter heart valve
9013|NCT03517436|CENTERA|centera
9014|NCT03517436|self-expanding|self-expanding
9015|NCT03517423|brivaracetam|brivaracetam
9016|NCT03517423|post-marketing observational study|post-marketing observational study
9017|NCT03517410|Mechanical Low Back Pain|mechanical low back pain
9018|NCT03517410|Smart phone|smart phone
9019|NCT03517410|Low Back Pain|low back pain
9020|NCT03517410|Chronic Mechanical Low Back Pain|chronic mechanical low back pain
9021|NCT03517410|CLBP|clbp
9022|NCT03517397|Smoking Cessation|smoking cessation
9023|NCT03517397|Socioeconomic Disadvantage|socioeconomic disadvantage
9024|NCT03517397|Contingency Management|contingency management
9025|NCT03517397|Financial Incentives|financial incentives
9026|NCT03517397|Mobile Health|mobile health
9027|NCT03517397|Biochemical Verification|biochemical verification
9028|NCT03517371|Parkinson disease|parkinson disease
9029|NCT03517371|Walking|walking
9030|NCT03517371|Exercise|exercise
9031|NCT03517371|Mobile Health|mobile health
9032|NCT03517371|Physical Therapy|physical therapy
9033|NCT03517371|Cognitive Behavioral|cognitive behavioral
9034|NCT03517345|Bariatric surgery|bariatric surgery
9035|NCT03517345|Prebiotics|prebiotics
9036|NCT03517345|gut microbiota|gut microbiota
9037|NCT03517345|GLP-1|glp-1
9038|NCT03517345|PYY|pyy
9039|NCT03517306|lung cancer, FDG, PET/CT, radiomics|lung cancer, fdg, pet/ct, radiomics
9040|NCT03517280|Malnutrition|malnutrition
9041|NCT03517280|Childhood Cancer|childhood cancer
9042|NCT03517280|Nutrition Aspect of Cancer|nutrition aspect of cancer
9043|NCT03517280|Child Malnutrition|child malnutrition
9044|NCT03517280|Brazil|brazil
9045|NCT03517280|Sao Paolo|sao paolo
9046|NCT03517254|Glutamine,|glutamine,
9047|NCT03517228|Robotic Uterine Manipulator|robotic uterine manipulator
9048|NCT03517228|18-173|18-173
9049|NCT03517202|Urologic surgery|urologic surgery
9050|NCT03517202|Urinary incontinence|urinary incontinence
9051|NCT03517202|Tension Free Vaginal Tape|tension free vaginal tape
9052|NCT03517202|Post-operative urinary retention|post-operative urinary retention
9053|NCT03517202|Outpatient surgery|outpatient surgery
9054|NCT03517163|Asperger's|asperger's
9055|NCT03517163|autism|autism
9056|NCT03517163|autism spectrum disorder|autism spectrum disorder
9057|NCT03517163|ASD|asd
9058|NCT03517137|advanced Hodgkin lymphoma|advanced hodgkin lymphoma
9059|NCT03517137|brentuximab vedotin|brentuximab vedotin
9060|NCT03517137|phase 2|phase 2
9061|NCT03517124|Zirconium oxide|zirconium oxide
9062|NCT03517124|surface treatment|surface treatment
9063|NCT03517124|resin cement|resin cement
9064|NCT03517098|Enhanced recovery after surgery|enhanced recovery after surgery
9065|NCT03517098|Desflurane|desflurane
9066|NCT03517098|Total hip arthroplasty|total hip arthroplasty
9067|NCT03517098|Total knee arthroplasty|total knee arthroplasty
9068|NCT03517085|glycogen storage disorder Ia|glycogen storage disorder ia
9069|NCT03517085|AAV|aav
9070|NCT03517085|gene therapy|gene therapy
9071|NCT03517085|von Gierke disease|von gierke disease
9072|NCT03517085|glucose metabolism disorder|glucose metabolism disorder
9073|NCT03517059|Levodopa|levodopa
9074|NCT03517059|axial symptoms|axial symptoms
9075|NCT03517046|Arthritis|arthritis
9076|NCT03517046|Articular Cartilage|articular cartilage
9077|NCT03517046|Autologous Chondrocyte Implantation|autologous chondrocyte implantation
9078|NCT03517046|Degenerative Arthritis|degenerative arthritis
9079|NCT03517046|Cartilage Lesion|cartilage lesion
9080|NCT03517046|Cartilage Defect|cartilage defect
9081|NCT03517007|antibiotic de-escalation|antibiotic de-escalation
9082|NCT03517007|sepsis|sepsis
9083|NCT03517007|antimicrobial stewardship|antimicrobial stewardship
9084|NCT03516994|Advance Care Planning|advance care planning
9085|NCT03516994|Disparities|disparities
9086|NCT03516994|Palliative Care|palliative care
9087|NCT03516994|End of Life Care|end of life care
9088|NCT03516994|African Americans|african americans
9089|NCT03516981|programmed cell death 1 (PD-1)|programmed cell death 1 (pd-1)
9090|NCT03516981|programmed death ligand 1 (PD-L1)|programmed death ligand 1 (pd-l1)
9091|NCT03516981|anti-PD-1|anti-pd-1
9092|NCT03516981|anti PD-1|anti pd-1
9093|NCT03516968|Obesity|obesity
9094|NCT03516968|Vitamin D deficiency,|vitamin d deficiency,
9095|NCT03516968|supplementation,|supplementation,
9096|NCT03516968|Child|child
9097|NCT03516968|Adolescent|adolescent
9098|NCT03516955|Superstat|superstat
9099|NCT03516955|Rosuvastatin|rosuvastatin
9100|NCT03516955|Statins|statins
9101|NCT03516955|LDL-C|ldl-c
9102|NCT03516955|Cholesterol|cholesterol
9103|NCT03516955|Hypercholesterolemia|hypercholesterolemia
9104|NCT03516955|Dyslipidemia|dyslipidemia
9105|NCT03516955|Coronary Artery Disease|coronary artery disease
9106|NCT03516955|Cardiovascular Disease|cardiovascular disease
9107|NCT03516916|Rectal cancer, HRQoL, Stoma, Colostomy, Patient reported outcome measure (PROM)|rectal cancer, hrqol, stoma, colostomy, patient reported outcome measure (prom)
9108|NCT03516903|Anterior myocardial infarction|anterior myocardial infarction
9109|NCT03516903|Methotrexate|methotrexate
9110|NCT03516903|Myocardial remodeling|myocardial remodeling
9111|NCT03516890|Partial hepatectomy|partial hepatectomy
9112|NCT03516890|Emergency|emergency
9113|NCT03516890|Staged|staged
9114|NCT03516890|Peritoneal dissemination|peritoneal dissemination
9115|NCT03516890|Propensity score matching|propensity score matching
9116|NCT03516877|Mindfulness-Bases Stress Reduction, Stress, Resilience, Well-being|mindfulness-bases stress reduction, stress, resilience, well-being
9117|NCT03516864|tissue oxygenation|tissue oxygenation
9118|NCT03516864|near-infrared|near-infrared
9119|NCT03516864|diabetic foot ulcer (DFU)|diabetic foot ulcer (dfu)
9120|NCT03516864|diabetes|diabetes
9121|NCT03516864|vascularity|vascularity
9122|NCT03516851|Moyamoya Disease|moyamoya disease
9123|NCT03516851|multimodal neuronavigation|multimodal neuronavigation
9124|NCT03516851|flow800|flow800
9125|NCT03516851|direct revascularization|direct revascularization
9126|NCT03516838|Dental caries|dental caries
9127|NCT03516838|Class II|class ii
9128|NCT03516838|Primary molar|primary molar
9129|NCT03516838|Restorative material|restorative material
9130|NCT03516838|Bioactive material|bioactive material
9131|NCT03516838|Compomer|compomer
9132|NCT03516838|Activa bioactive|activa bioactive
9133|NCT03516838|Ryge criteria|ryge criteria
9134|NCT03516825|Musical Neglect Training|musical neglect training
9135|NCT03516825|Neurologic Music Therapy|neurologic music therapy
9136|NCT03516825|unilateral visual neglect|unilateral visual neglect
9137|NCT03516825|hemispatial neglect|hemispatial neglect
9138|NCT03516825|stroke|stroke
9139|NCT03516825|spatial perception and attention|spatial perception and attention
9140|NCT03516825|music therapy|music therapy
9141|NCT03516799|pain management of adolescent and young adults with cancer|pain management of adolescent and young adults with cancer
9142|NCT03516773|Hypoparathyroidism, PTH(1-34), Parathyroid Hormone|hypoparathyroidism, pth(1-34), parathyroid hormone
9143|NCT03516747|cytology|cytology
9144|NCT03516747|parathyroidectomy|parathyroidectomy
9145|NCT03516747|parathyroid hormone level|parathyroid hormone level
9146|NCT03516734|Iron deficiency|iron deficiency
9147|NCT03516734|Food-based dietary intervention|food-based dietary intervention
9148|NCT03516695|Registry|registry
9149|NCT03516695|Liver Cancers|liver cancers
9150|NCT03516695|HCC|hcc
9151|NCT03516695|Dosimetry|dosimetry
9152|NCT03516695|Simplicit90Y™|simplicit90y™
9153|NCT03516695|TheraSphere®|therasphere®
9154|NCT03516682|Logistic Barriers to Vaccination|logistic barriers to vaccination
9155|NCT03516669|Lansoprazole, Amoxicillin, clarithromycin|lansoprazole, amoxicillin, clarithromycin
9156|NCT03516630|Trazodone|trazodone
9157|NCT03516630|QTc interval|qtc interval
9158|NCT03516630|Moxifloxacin|moxifloxacin
9159|NCT03516578|non-ST-elevation myocardial infarction|non-st-elevation myocardial infarction
9160|NCT03516578|cardiac magnetic resonance|cardiac magnetic resonance
9161|NCT03516578|prognosis|prognosis
9162|NCT03516565|gingivitis|gingivitis
9163|NCT03516565|saliva|saliva
9164|NCT03516565|gingival crevicular fluid|gingival crevicular fluid
9165|NCT03516539|Videolaryngoscopy|videolaryngoscopy
9166|NCT03516526|natalizumab|natalizumab
9167|NCT03516487|PKU|pku
9168|NCT03516474|nir|nir
9169|NCT03516474|diabetes|diabetes
9170|NCT03516474|diabetic foot ulcer (DFU).|diabetic foot ulcer (dfu).
9171|NCT03516474|wound|wound
9172|NCT03516461|Gut Microbiota|gut microbiota
9173|NCT03516461|Selective Microbiota Transplantation|selective microbiota transplantation
9174|NCT03516461|Radiation Enteritis|radiation enteritis
9175|NCT03516435|Intravaginal electrical stimulation|intravaginal electrical stimulation
9176|NCT03516435|Parasacral transcutaneous electrical stimulation|parasacral transcutaneous electrical stimulation
9177|NCT03516422|ultrasound debridement|ultrasound debridement
9178|NCT03516422|diabetic foot ulcer|diabetic foot ulcer
9179|NCT03516422|chronic wound|chronic wound
9180|NCT03516422|biofilm|biofilm
9181|NCT03516409|probiotics|probiotics
9182|NCT03516409|prebiotics|prebiotics
9183|NCT03516409|diarrhoea|diarrhoea
9184|NCT03516396|Nepal|nepal
9185|NCT03516396|child growth|child growth
9186|NCT03516396|nutrition education|nutrition education
9187|NCT03516396|community development|community development
9188|NCT03516370|chronic periodontitis|chronic periodontitis
9189|NCT03516370|Sacchraomyces boulardii|sacchraomyces boulardii
9190|NCT03516370|probiotics|probiotics
9191|NCT03516344|Breathing Exercises|breathing exercises
9192|NCT03516344|Manipulation, Osteopathic|manipulation, osteopathic
9193|NCT03516344|Quantitative Ultrasonography|quantitative ultrasonography
9194|NCT03516344|Therapy, Soft Tissue|therapy, soft tissue
9195|NCT03516344|Portal Vein|portal vein
9196|NCT03516344|Venous flow|venous flow
9197|NCT03516331|Cystic Fibrosis|cystic fibrosis
9198|NCT03516318|HIV|hiv
9199|NCT03516318|Youth|youth
9200|NCT03516318|Social support|social support
9201|NCT03516318|Social media|social media
9202|NCT03516318|Retention|retention
9203|NCT03516292|overactive bladder|overactive bladder
9204|NCT03516292|biomarker|biomarker
9205|NCT03516292|nerve growth factor|nerve growth factor
9206|NCT03516292|vaginal prolapse|vaginal prolapse
9207|NCT03516292|urinary incontinence|urinary incontinence
9208|NCT03516266|Pelvic floor muscle strength|pelvic floor muscle strength
9209|NCT03516266|Premenopausal nullipara|premenopausal nullipara
9210|NCT03516266|Childbirth|childbirth
9211|NCT03516266|Postmenopausal|postmenopausal
9212|NCT03516214|Acquired resistance|acquired resistance
9213|NCT03516214|EGFR p.T790M-positive|egfr p.t790m-positive
9214|NCT03516201|bariatric surgery|bariatric surgery
9215|NCT03516201|Periodontitis|periodontitis
9216|NCT03516201|Caries|caries
9217|NCT03516201|erosive tooth wear|erosive tooth wear
9218|NCT03516201|Gingivitis|gingivitis
9219|NCT03516201|BMI|bmi
9220|NCT03516201|oral health|oral health
9221|NCT03516201|obesity|obesity
9222|NCT03516188|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
9223|NCT03516188|Acid pocket|acid pocket
9224|NCT03516188|Acid Reflux|acid reflux
9225|NCT03516188|Alginate antacid|alginate antacid
9226|NCT03516188|Obesity|obesity
9227|NCT03516162|Behaviour|behaviour
9228|NCT03516162|Brain Tumor|brain tumor
9229|NCT03516162|Hydrocephalus|hydrocephalus
9230|NCT03516162|Smartphone|smartphone
9231|NCT03516162|Big Data|big data
9232|NCT03516162|Neuropsychology|neuropsychology
9233|NCT03516162|Neuroradiology|neuroradiology
9234|NCT03516162|Neurosurgery|neurosurgery
9235|NCT03516162|Outcome Assessment|outcome assessment
9236|NCT03516162|Functional Impairment|functional impairment
9237|NCT03516162|Cognitive Function|cognitive function
9238|NCT03516162|Touchscreen|touchscreen
9239|NCT03516149|elbow|elbow
9240|NCT03516149|foam rolling|foam rolling
9241|NCT03516149|proprioception|proprioception
9242|NCT03516149|sensorimotor|sensorimotor
9243|NCT03516149|acute|acute
9244|NCT03516071|Hepatocellular Carcinoma, HCC, Brivanib|hepatocellular carcinoma, hcc, brivanib
9245|NCT03516045|18F-AlF-NOTA-neurotensin|18f-alf-nota-neurotensin
9246|NCT03516032|exercises therapy|exercises therapy
9247|NCT03516032|rehabilitation|rehabilitation
9248|NCT03516032|aged|aged
9249|NCT03516032|inpatients|inpatients
9250|NCT03516019|mHealth|mhealth
9251|NCT03516019|digital BP monitoring|digital bp monitoring
9252|NCT03516019|patient provider communication|patient provider communication
9253|NCT03516019|smart watch|smart watch
9254|NCT03516019|user engagement|user engagement
9255|NCT03516019|population health data|population health data
9256|NCT03515993|long-term survival|long-term survival
9257|NCT03515993|gynecologic cancer|gynecologic cancer
9258|NCT03515993|quality of life|quality of life
9259|NCT03515967|concussion, mild traumatic brain injury|concussion, mild traumatic brain injury
9260|NCT03515954|conjunctiva|conjunctiva
9261|NCT03515954|squamous neoplasia|squamous neoplasia
9262|NCT03515954|amniotic|amniotic
9263|NCT03515941|chemotherapy|chemotherapy
9264|NCT03515941|chemoradiation|chemoradiation
9265|NCT03515928|Ultrasound, Hearing|ultrasound, hearing
9266|NCT03515915|multiple myeloma|multiple myeloma
9267|NCT03515915|HDAC inhibitor|hdac inhibitor
9268|NCT03515915|Biomarker|biomarker
9269|NCT03515902|Dentine Hypersensitivity|dentine hypersensitivity
9270|NCT03515902|Toothpaste|toothpaste
9271|NCT03515902|Tooth erosion|tooth erosion
9272|NCT03515837|PD1|pd1
9273|NCT03515837|PD-1|pd-1
9274|NCT03515837|PDL1|pdl1
9275|NCT03515837|PD-L1|pd-l1
9276|NCT03515785|acute lymphoblastic leukemia|acute lymphoblastic leukemia
9277|NCT03515785|ponatinib|ponatinib
9278|NCT03515785|tyrosine kinase inhibitor|tyrosine kinase inhibitor
9279|NCT03515772|dolutegravir|dolutegravir
9280|NCT03515772|darunavir|darunavir
9281|NCT03515772|amlodipine|amlodipine
9282|NCT03515772|rosuvastatin|rosuvastatin
9283|NCT03515772|atorvastatin|atorvastatin
9284|NCT03515759|PREECLAMPSIA|preeclampsia
9285|NCT03515759|DOPPLER|doppler
9286|NCT03515759|IUGR|iugr
9287|NCT03515759|UMBILICAL ARTERY|umbilical artery
9288|NCT03515759|MIDDLE CEREBRAL ARTERY|middle cerebral artery
9289|NCT03515746|exergaming|exergaming
9290|NCT03515746|physiotherapy|physiotherapy
9291|NCT03515746|upper extremities|upper extremities
9292|NCT03515746|telerehabilitation|telerehabilitation
9293|NCT03515694|Bridion|bridion
9294|NCT03515694|Sugammadex|sugammadex
9295|NCT03515694|TOF|tof
9296|NCT03515681|Text messaging|text messaging
9297|NCT03515642|Gut microbiota|gut microbiota
9298|NCT03515642|Hepatic function|hepatic function
9299|NCT03515642|Obesity|obesity
9300|NCT03515642|Exercise|exercise
9301|NCT03515629|Stage IIIB|stage iiib
9302|NCT03515629|Stage IV|stage iv
9303|NCT03515629|Non-squamous NSCLC|non-squamous nsclc
9304|NCT03515629|Squamous NSCLC|squamous nsclc
9305|NCT03515551|Melanoma|melanoma
9306|NCT03515551|Lung Cancer|lung cancer
9307|NCT03515551|Bladder Cancer|bladder cancer
9308|NCT03515551|Sarcoma|sarcoma
9309|NCT03515551|IMCnyeso|imcnyeso
9310|NCT03515551|Immunotherapy|immunotherapy
9311|NCT03515538|head and neck cancer|head and neck cancer
9312|NCT03515538|squamous|squamous
9313|NCT03515538|neck cancer|neck cancer
9314|NCT03515538|oral cancer|oral cancer
9315|NCT03515538|mucositis|mucositis
9316|NCT03515538|sores|sores
9317|NCT03515538|mouth|mouth
9318|NCT03515525|Breast surgery|breast surgery
9319|NCT03515525|Closed-suction drains|closed-suction drains
9320|NCT03515512|Acute Myeloid Leukemia|acute myeloid leukemia
9321|NCT03515512|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
9322|NCT03515499|Adherence|adherence
9323|NCT03515499|Incentives|incentives
9324|NCT03515486|Stroke|stroke
9325|NCT03515486|Cerebellum|cerebellum
9326|NCT03515486|Depression|depression
9327|NCT03515486|Anxiety|anxiety
9328|NCT03515486|Mood|mood
9329|NCT03515486|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
9330|NCT03515473|cochlear implant|cochlear implant
9331|NCT03515473|CI532|ci532
9332|NCT03515473|CI512|ci512
9333|NCT03515473|CI522|ci522
9334|NCT03515473|electrode array|electrode array
9335|NCT03515473|perimodiolar|perimodiolar
9336|NCT03515473|electrophysiology|electrophysiology
9337|NCT03515460|vascular endothelial function|vascular endothelial function
9338|NCT03515460|systemic microvascular reactivity|systemic microvascular reactivity
9339|NCT03515460|dysglycemia|dysglycemia
9340|NCT03515460|dyslipidemia|dyslipidemia
9341|NCT03515447|transfusion saving strategy|transfusion saving strategy
9342|NCT03515447|heart or lung transplantation|heart or lung transplantation
9343|NCT03515447|assist device|assist device
9344|NCT03515447|Extra Corporal Life Support (ECLS)|extra corporal life support (ecls)
9345|NCT03515447|Left Ventricular Assist Device (LVAD )|left ventricular assist device (lvad )
9346|NCT03515447|Total artificial Heart|total artificial heart
9347|NCT03515408|fMRI|fmri
9348|NCT03515408|rTMS|rtms
9349|NCT03515408|functional connectivity|functional connectivity
9350|NCT03515395|exergaming|exergaming
9351|NCT03515395|hip fracture|hip fracture
9352|NCT03515395|training|training
9353|NCT03515395|acceptance|acceptance
9354|NCT03515369|hepatocellular carcinoma|hepatocellular carcinoma
9355|NCT03515369|tumor recurrence|tumor recurrence
9356|NCT03515369|adjuvant therapy|adjuvant therapy
9357|NCT03515369|traditional Chinese medicine|traditional chinese medicine
9358|NCT03515343|Cancer prevention|cancer prevention
9359|NCT03515343|Endoscopy|endoscopy
9360|NCT03515343|Gastroenterology|gastroenterology
9361|NCT03515330|mHealth|mhealth
9362|NCT03515330|liver transplantation|liver transplantation
9363|NCT03515330|medication adherence|medication adherence
9364|NCT03515330|video directly observed therapy|video directly observed therapy
9365|NCT03515317|Cognitive impairments|cognitive impairments
9366|NCT03515317|Low Resolution tomography|low resolution tomography
9367|NCT03515317|Neurofeedback|neurofeedback
9368|NCT03515317|Traumatic brain injury|traumatic brain injury
9369|NCT03515291|Heart|heart
9370|NCT03515291|CABG|cabg
9371|NCT03515291|Injection|injection
9372|NCT03515291|Scar|scar
9373|NCT03515291|Fibrosis|fibrosis
9374|NCT03515291|Cell|cell
9375|NCT03515291|Progenitor|progenitor
9376|NCT03515291|Immunomodulatory|immunomodulatory
9378|NCT03515291|Randomized|randomized
9379|NCT03515278|Frozen shoulder|frozen shoulder
9380|NCT03515278|adhesive capsulitis|adhesive capsulitis
9381|NCT03515278|ultrasound-guided intervention|ultrasound-guided intervention
9382|NCT03515278|suprascapular nerve block|suprascapular nerve block
9383|NCT03515278|intra-articular injection|intra-articular injection
9384|NCT03515265|Fiber reinforced composite|fiber reinforced composite
9385|NCT03515265|Microhybrid composite|microhybrid composite
9386|NCT03515226|workforce development|workforce development
9387|NCT03515226|intelligent tutoring systems|intelligent tutoring systems
9388|NCT03515187|Dug induced dry eye|dug induced dry eye
9389|NCT03515187|meibomian gland dysfunction, MGD|meibomian gland dysfunction, mgd
9390|NCT03515187|Sodium hyaluronate ophthalmic solution|sodium hyaluronate ophthalmic solution
9391|NCT03515187|Sodium bromide hydrate eye drops|sodium bromide hydrate eye drops
9392|NCT03515187|Meibomian gland massage|meibomian gland massage
9393|NCT03515174|Adolescent and Young Adult Oncology|adolescent and young adult oncology
9394|NCT03515174|Carcinoma|carcinoma
9395|NCT03515174|Lymphoma|lymphoma
9396|NCT03515174|Sarcoma|sarcoma
9397|NCT03515174|Cancer|cancer
9398|NCT03515161|closedloop|closedloop
9399|NCT03515161|vasopressor|vasopressor
9400|NCT03515148|Achilles Tendinopathy|achilles tendinopathy
9401|NCT03515148|Rectus Abominis|rectus abominis
9402|NCT03515148|Vibration|vibration
9403|NCT03515148|Cryotherapy|cryotherapy
9404|NCT03515148|Eccentric Exercise|eccentric exercise
9405|NCT03515135|ADHD|adhd
9406|NCT03515135|executive function|executive function
9407|NCT03515135|preschool|preschool
9408|NCT03515135|intervention|intervention
9409|NCT03515122|Epidemiology|epidemiology
9410|NCT03515122|Rehabilitation|rehabilitation
9411|NCT03515122|Clinical protocols|clinical protocols
9412|NCT03515122|Middle aged|middle aged
9413|NCT03515109|stress incontinence|stress incontinence
9414|NCT03515109|female|female
9415|NCT03515109|altis|altis
9416|NCT03515109|transobturator tape|transobturator tape
9417|NCT03515109|minisling|minisling
9418|NCT03515096|rhTPO|rhtpo
9419|NCT03515096|HSCT|hsct
9420|NCT03515096|Thrombopoietin|thrombopoietin
9421|NCT03515083|apixaban|apixaban
9422|NCT03515083|atrial fibrillation|atrial fibrillation
9423|NCT03515070|Gastrointestinal Microbiome|gastrointestinal microbiome
9424|NCT03515070|Genetics|genetics
9425|NCT03515031|High Flow Nasal Cannula|high flow nasal cannula
9426|NCT03515031|Venturi mask|venturi mask
9427|NCT03515018|Leukemia, Myeloid, Chronic-Phase|leukemia, myeloid, chronic-phase
9428|NCT03515018|hydroxyurea|hydroxyurea
9429|NCT03515018|Imatinib Mesylate|imatinib mesylate
9430|NCT03515018|Pulse Therapy, Drug|pulse therapy, drug
9431|NCT03515005|Hypertension|hypertension
9432|NCT03515005|Community Health Workers|community health workers
9433|NCT03515005|Community-Based Participatory Research|community-based participatory research
9434|NCT03515005|Health Equity|health equity
9435|NCT03514992|Developmental Dysgraphia|developmental dysgraphia
9436|NCT03514992|Ambidexterity|ambidexterity
9437|NCT03514992|Outcom study|outcom study
9438|NCT03514966|Position change|position change
9439|NCT03514966|Magnetically controlled capsule endoscopy|magnetically controlled capsule endoscopy
9440|NCT03514966|Gastric preparation|gastric preparation
9441|NCT03514914|LARC, contraception, family planning, India, male engagement|larc, contraception, family planning, india, male engagement
9442|NCT03514888|High-risk bladder cancer|high-risk bladder cancer
9443|NCT03514888|Urothelial cancer|urothelial cancer
9444|NCT03514888|HIPEC|hipec
9445|NCT03514888|Mitomycin|mitomycin
9446|NCT03514836|Castrate-resistant|castrate-resistant
9447|NCT03514810|Major depressive disorder|major depressive disorder
9448|NCT03514810|sertraline|sertraline
9449|NCT03514810|ketoprofen|ketoprofen
9450|NCT03514797|Tooth bleaching|tooth bleaching
9451|NCT03514797|Hydrogen peroxide|hydrogen peroxide
9452|NCT03514797|Carbamide peroxide|carbamide peroxide
9453|NCT03514797|Tooth Bleaching Agents|tooth bleaching agents
9454|NCT03514784|Autism Spectrum Disorder, Gastrointestinal Symptoms, Constipation, Diarrhea,|autism spectrum disorder, gastrointestinal symptoms, constipation, diarrhea,
9455|NCT03514719|89Zr-avelumab PET|89zr-avelumab pet
9456|NCT03514719|avelumab|avelumab
9457|NCT03514706|Extravascular lung water|extravascular lung water
9458|NCT03514706|one lung ventilation|one lung ventilation
9459|NCT03514706|volume controlled ventilation|volume controlled ventilation
9460|NCT03514706|pressure controlled ventilation|pressure controlled ventilation
9461|NCT03514693|Persistent atrial fibrillation|persistent atrial fibrillation
9462|NCT03514693|non-inferiority trial|non-inferiority trial
9463|NCT03514680|Cancer Care|cancer care
9464|NCT03514654|Breast Cancer|breast cancer
9465|NCT03514654|Mastectomy|mastectomy
9466|NCT03514654|Therapeutic Mammoplasty|therapeutic mammoplasty
9467|NCT03514654|Multiple Ipsilateral Breast Cancers|multiple ipsilateral breast cancers
9468|NCT03514628|Valsalva Manoeuvre|valsalva manoeuvre
9469|NCT03514628|SVT|svt
9470|NCT03514628|Valsalva Assist Device|valsalva assist device
9471|NCT03514576|gastric bypass|gastric bypass
9472|NCT03514576|hypoglycemia|hypoglycemia
9473|NCT03514576|hyperinsulinemia|hyperinsulinemia
9474|NCT03514563|Cleft Lip and Palate|cleft lip and palate
9475|NCT03514563|Maxillofacial|maxillofacial
9476|NCT03514563|Growth|growth
9477|NCT03514563|3D|3d
9478|NCT03514498|anesthesia|anesthesia
9479|NCT03514485|asthma disparities|asthma disparities
9480|NCT03514485|community health worker|community health worker
9481|NCT03514485|childhood asthma|childhood asthma
9482|NCT03514472|Hb, Anemia,|hb, anemia,
9483|NCT03514433|Patient Navigation|patient navigation
9484|NCT03514433|Disparity|disparity
9485|NCT03514433|Social Determinants|social determinants
9486|NCT03514420|Lipodystrophy|lipodystrophy
9487|NCT03514420|Lipodystrophy, Familial Partial|lipodystrophy, familial partial
9488|NCT03514420|Lipid Metabolism Disorders|lipid metabolism disorders
9489|NCT03514420|Dyslipidemias|dyslipidemias
9490|NCT03514420|Kobberling-Dunnigan syndrome (type 1 and 2)|kobberling-dunnigan syndrome (type 1 and 2)
9491|NCT03514420|Lipoatrophic Diabetes|lipoatrophic diabetes
9492|NCT03514407|Relapsed Ewing sarcoma|relapsed ewing sarcoma
9493|NCT03514407|refractory Ewing sarcoma|refractory ewing sarcoma
9494|NCT03514407|bromodomain-containing protein (BRD) inhibitor|bromodomain-containing protein (brd) inhibitor
9495|NCT03514407|lysine demethylase 1 (LSD1) inhibitor|lysine demethylase 1 (lsd1) inhibitor
9496|NCT03514381|Soft Tissue Sarcoma|soft tissue sarcoma
9497|NCT03514381|Ifosfamide|ifosfamide
9498|NCT03514381|Aprepitant|aprepitant
9499|NCT03514381|Doxorubicin|doxorubicin
9500|NCT03514368|Immune checkpoint modulation|immune checkpoint modulation
9501|NCT03514368|Tumor antigens|tumor antigens
9502|NCT03514368|Adaptive immune responses|adaptive immune responses
9503|NCT03514368|Tumor molecular signature|tumor molecular signature
9504|NCT03514342|Heart rate variability|heart rate variability
9505|NCT03514342|Scotopic pupil size|scotopic pupil size
9506|NCT03514329|Non Small Cell Lung Cancer|non small cell lung cancer
9507|NCT03514329|Metastatic Lung Cancer|metastatic lung cancer
9508|NCT03514329|Lung Cancer|lung cancer
9509|NCT03514329|Vapor Ablation|vapor ablation
9510|NCT03514329|BTVA|btva
9511|NCT03514316|gingival overgrowth|gingival overgrowth
9512|NCT03514316|diode laser gingivectomy|diode laser gingivectomy
9513|NCT03514316|scalpel gingivectomy|scalpel gingivectomy
9514|NCT03514316|orthodontic treatment|orthodontic treatment
9515|NCT03514303|Skin test, Microarray test|skin test, microarray test
9516|NCT03514290|Laser|laser
9517|NCT03514290|Color|color
9518|NCT03514264|Endodontics|endodontics
9519|NCT03514264|Biomaterials|biomaterials
9520|NCT03514264|Dental pulp cavity|dental pulp cavity
9521|NCT03514264|Periapical abscess|periapical abscess
9522|NCT03514264|Root canal therapy|root canal therapy
9523|NCT03514264|Root canal obturation|root canal obturation
9524|NCT03514251|Thyroid Cancer|thyroid cancer
9525|NCT03514251|Hypoparathyroidism|hypoparathyroidism
9526|NCT03514251|parathyroid marker|parathyroid marker
9527|NCT03514238|Exercise|exercise
9528|NCT03514238|Physical Activity|physical activity
9529|NCT03514238|Cardio-metabolic Health|cardio-metabolic health
9530|NCT03514238|Myokines|myokines
9531|NCT03514238|Cardiorespiratory Fitness|cardiorespiratory fitness
9532|NCT03514238|Obesity|obesity
9533|NCT03514238|Type 2 Diabetes|type 2 diabetes
9534|NCT03514225|Metacognitive Therapy|metacognitive therapy
9535|NCT03514212|physical activity|physical activity
9536|NCT03514212|intervention|intervention
9537|NCT03514212|walking|walking
9538|NCT03514186|Aphasia|aphasia
9539|NCT03514186|Speech and Language Treatment|speech and language treatment
9540|NCT03514186|ICAP|icap
9541|NCT03514186|Intensive Comprehensive Aphasia Program|intensive comprehensive aphasia program
9542|NCT03514147|Women|women
9543|NCT03514147|Pelvic Floor Muscles|pelvic floor muscles
9544|NCT03514108|Heart failure|heart failure
9545|NCT03514108|Diabetes|diabetes
9546|NCT03514108|Insulin resistance|insulin resistance
9547|NCT03514108|Metformin|metformin
9548|NCT03514108|Hydralazine|hydralazine
9549|NCT03514108|Isosorbide Dinitrate|isosorbide dinitrate
9550|NCT03514069|ruxolitinib|ruxolitinib
9551|NCT03514069|radiation|radiation
9552|NCT03514069|temozolomide|temozolomide
9553|NCT03514056|Fibromyalgia|fibromyalgia
9554|NCT03514056|Behcet Disease|behcet disease
9555|NCT03514056|Trigger points|trigger points
9556|NCT03514043|Ambulatory care|ambulatory care
9557|NCT03514043|Emergency general surgery|emergency general surgery
9558|NCT03514043|Patient satisfaction|patient satisfaction
9559|NCT03514017|Lymphocytic|lymphocytic
9560|NCT03514017|Leukemia|leukemia
9561|NCT03514017|CLL|cll
9562|NCT03514017|Blood disease|blood disease
9563|NCT03514017|White blood cells|white blood cells
9564|NCT03514017|Bone marrow disease|bone marrow disease
9565|NCT03514017|Immunotherapy|immunotherapy
9566|NCT03514004|Suicide prevention|suicide prevention
9567|NCT03514004|Information and Communication Technologies|information and communication technologies
9568|NCT03514004|Cluster Randomized Controlled Trial|cluster randomized controlled trial
9569|NCT03514004|Latin America|latin america
9570|NCT03513991|human milk|human milk
9571|NCT03513991|infant formula with low protein|infant formula with low protein
9572|NCT03513991|alpha lactoalbumin|alpha lactoalbumin
9573|NCT03513991|growth velocity|growth velocity
9574|NCT03513991|gastrointestinal events|gastrointestinal events
9575|NCT03513978|Soccer|soccer
9576|NCT03513978|Prevention injury|prevention injury
9577|NCT03513965|food allergy|food allergy
9578|NCT03513965|oral immunotherapy|oral immunotherapy
9579|NCT03513965|mindsets|mindsets
9580|NCT03513965|patient experience|patient experience
9581|NCT03513939|Type 1 Diabetes Mellitus, Diabetes, hypoglycemia|type 1 diabetes mellitus, diabetes, hypoglycemia
9582|NCT03513926|miRNA|mirna
9583|NCT03513926|Cardiovascular Risk|cardiovascular risk
9584|NCT03513926|CPAP|cpap
9585|NCT03513926|Obstructive Sleep Apnea|obstructive sleep apnea
9586|NCT03513926|Hypertension|hypertension
9587|NCT03513926|Molecular profile|molecular profile
9588|NCT03513913|in vitro fertilization|in vitro fertilization
9589|NCT03513913|intracytoplasmic sperm injection|intracytoplasmic sperm injection
9590|NCT03513913|fertilization|fertilization
9591|NCT03513913|Assisted reproduction|assisted reproduction
9592|NCT03513900|Cirrhosis|cirrhosis
9593|NCT03513900|Non-invasive methods|non-invasive methods
9594|NCT03513900|portal hypertensive gastropathy|portal hypertensive gastropathy
9595|NCT03513887|cirrhosis,varices,variceal bleeding, noninvasive tests,TE|cirrhosis,varices,variceal bleeding, noninvasive tests,te
9596|NCT03513861|Low and Middle Income Countries|low and middle income countries
9597|NCT03513861|Limited resource settings|limited resource settings
9598|NCT03513861|Early warning signs|early warning signs
9599|NCT03513822|KETAMINE|ketamine
9600|NCT03513822|CHRONIC PAIN|chronic pain
9601|NCT03513822|NEUROPATHIC PAIN|neuropathic pain
9602|NCT03513822|KYNURENINE|kynurenine
9603|NCT03513822|KYNURENINE PATHWAY|kynurenine pathway
9604|NCT03513822|BEDSORES|bedsores
9605|NCT03513822|ANTI-INFLAMMATORY|anti-inflammatory
9606|NCT03513822|ULCER PRESSURE|ulcer pressure
9607|NCT03513809|Acute Hypoxemic Respiratory Failure|acute hypoxemic respiratory failure
9608|NCT03513809|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
9609|NCT03513809|Electrical impedance tomography|electrical impedance tomography
9610|NCT03513809|Spontaneous breathing|spontaneous breathing
9611|NCT03513809|Ventilation induced-lung injury|ventilation induced-lung injury
9612|NCT03513809|Patient self-inflicted lung injury|patient self-inflicted lung injury
9613|NCT03513783|Spinal Cord Injury|spinal cord injury
9614|NCT03513783|tendon transfer|tendon transfer
9615|NCT03513783|muscle synergy|muscle synergy
9616|NCT03513783|muscle co-activation|muscle co-activation
9617|NCT03513783|electromyography|electromyography
9618|NCT03513770|venous distension reflex|venous distension reflex
9619|NCT03513744|human milk oligosaccharides|human milk oligosaccharides
9620|NCT03513744|infant formula|infant formula
9621|NCT03513718|Acute kidney injury, AKI|acute kidney injury, aki
9622|NCT03513705|implementation|implementation
9623|NCT03513705|randomized trial|randomized trial
9624|NCT03513705|pancreatic cancer|pancreatic cancer
9625|NCT03513705|nationwide|nationwide
9626|NCT03513705|survival|survival
9627|NCT03513705|quality of life|quality of life
9628|NCT03513653|acute heart failure|acute heart failure
9629|NCT03513653|global longitudinal strain|global longitudinal strain
9630|NCT03513653|ejection fraction|ejection fraction
9631|NCT03513653|echocardiography|echocardiography
9632|NCT03513653|mortality|mortality
9633|NCT03513627|periimplant soft tissue|periimplant soft tissue
9634|NCT03513627|gingiva|gingiva
9635|NCT03513627|human|human
9636|NCT03513627|microcirculation|microcirculation
9637|NCT03513614|Tailored Axillary Surgery|tailored axillary surgery
9638|NCT03513614|TAXIS|taxis
9639|NCT03513614|Breast Cancer|breast cancer
9640|NCT03513614|node-positive breast cancer|node-positive breast cancer
9641|NCT03513614|phase III trial|phase iii trial
9642|NCT03513614|IBCSG 57-18|ibcsg 57-18
9643|NCT03513614|ABCSG|abcsg
9644|NCT03513601|Curative effect evaluation|curative effect evaluation
9645|NCT03513601|Adverse reactions|adverse reactions
9646|NCT03513601|Clinical characteristics|clinical characteristics
9647|NCT03513601|PR|pr
9648|NCT03513601|PFS|pfs
9649|NCT03513601|OS|os
9650|NCT03513575|pH of saliva|ph of saliva
9651|NCT03513575|Flavored Milk|flavored milk
9652|NCT03513575|buffering agent|buffering agent
9653|NCT03513575|oral hygiene|oral hygiene
9654|NCT03513549|Agitation|agitation
9655|NCT03513549|Schizophrenia|schizophrenia
9656|NCT03513549|Bipolar I disorder|bipolar i disorder
9657|NCT03513536|Aromatherapy|aromatherapy
9658|NCT03513536|Essential Oils|essential oils
9659|NCT03513510|evidence-based programs|evidence-based programs
9660|NCT03513510|community-based participatory research|community-based participatory research
9661|NCT03513510|program adoption|program adoption
9662|NCT03513497|Teeth|teeth
9663|NCT03513497|Periodontal disease|periodontal disease
9664|NCT03513497|acute inflammatory response|acute inflammatory response
9665|NCT03513497|stent-induced biofilm overgrowth|stent-induced biofilm overgrowth
9666|NCT03513497|periodontal pathogens|periodontal pathogens
9667|NCT03513471|Late Phase Asthmatic Response|late phase asthmatic response
9668|NCT03513471|Allergen Challenge|allergen challenge
9669|NCT03513458|Late Phase Asthmatic Response|late phase asthmatic response
9670|NCT03513458|Allergen Challenge|allergen challenge
9671|NCT03513432|Gut microbiota|gut microbiota
9672|NCT03513432|Beer|beer
9673|NCT03513432|Alcohol|alcohol
9674|NCT03513432|Cardiovascular disease|cardiovascular disease
9675|NCT03513406|muscle function|muscle function
9676|NCT03513393|velpatasvir|velpatasvir
9677|NCT03513393|cola|cola
9678|NCT03513393|omeprazole|omeprazole
9679|NCT03513393|proton pump inhibitors|proton pump inhibitors
9680|NCT03513380|Exercise therapy|exercise therapy
9681|NCT03513380|Physical fitness|physical fitness
9682|NCT03513380|Gaming|gaming
9683|NCT03513380|Adult|adult
9684|NCT03513380|Healthy lifestyle|healthy lifestyle
9685|NCT03513380|Fitness testing|fitness testing
9686|NCT03513367|Duchenne Muscular Dystrophy,|duchenne muscular dystrophy,
9687|NCT03513367|Pediatric Quality of Life Inventory|pediatric quality of life inventory
9688|NCT03513367|disability paradox|disability paradox
9689|NCT03513354|Aging; Physical activity; Motor activity; Quality of life|aging; physical activity; motor activity; quality of life
9690|NCT03513341|Physical activity|physical activity
9691|NCT03513341|Sedentary behaviour|sedentary behaviour
9692|NCT03513341|Undergraduate|undergraduate
9693|NCT03513328|human leukocyte antigen (HLA)|human leukocyte antigen (hla)
9694|NCT03513315|Heat-related illnesses|heat-related illnesses
9695|NCT03513315|Heat Illnesses|heat illnesses
9696|NCT03513315|Community based interventions|community based interventions
9697|NCT03513315|heatwave|heatwave
9698|NCT03513315|Pakistan|pakistan
9699|NCT03513315|emergency preparedness|emergency preparedness
9700|NCT03513315|emergency medicine|emergency medicine
9701|NCT03513315|heat stroke|heat stroke
9702|NCT03513315|heat exhaustion|heat exhaustion
9703|NCT03513315|urban health|urban health
9704|NCT03513302|nitric oxide|nitric oxide
9705|NCT03513289|ICU delirium|icu delirium
9706|NCT03513289|post-intensive care syndrome|post-intensive care syndrome
9707|NCT03513289|critical illness myopathy|critical illness myopathy
9708|NCT03513211|Biochemically recurrent prostate cancer|biochemically recurrent prostate cancer
9709|NCT03513211|Hormone sensitive prostate cancer|hormone sensitive prostate cancer
9710|NCT03513198|contrast-enhanced endoscopic ultrasound|contrast-enhanced endoscopic ultrasound
9711|NCT03513198|endoscopic ultrasound elastography|endoscopic ultrasound elastography
9712|NCT03513198|tumor vascularity|tumor vascularity
9713|NCT03513198|prognostic|prognostic
9714|NCT03513185|somatic symptom disorder|somatic symptom disorder
9715|NCT03513185|the Somatic Symptom Scale-China|the somatic symptom scale-china
9716|NCT03513185|mental disorders management|mental disorders management
9717|NCT03513172|Intraocular Pressure|intraocular pressure
9718|NCT03513172|Anti-VEGF Agents|anti-vegf agents
9719|NCT03513172|alpha2-agonists|alpha2-agonists
9720|NCT03513159|transitional care, geriatric, readmission|transitional care, geriatric, readmission
9721|NCT03513133|working memory|working memory
9722|NCT03513133|cognitive rehabilitation|cognitive rehabilitation
9723|NCT03513133|functional neuroimaging|functional neuroimaging
9724|NCT03513120|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
9725|NCT03513120|Posterior Spinal Fusion|posterior spinal fusion
9726|NCT03513120|Return to Sport|return to sport
9727|NCT03513107|Osteoporosis|osteoporosis
9728|NCT03513094|Kinetics|kinetics
9729|NCT03513094|Transversus abdominis|transversus abdominis
9730|NCT03513081|food neophobia|food neophobia
9731|NCT03513081|preschool|preschool
9732|NCT03513081|children|children
9733|NCT03513068|COPD|copd
9734|NCT03513068|POC|poc
9735|NCT03513068|Oxygen|oxygen
9736|NCT03513068|QoL|qol
9737|NCT03513055|glucose excursions|glucose excursions
9738|NCT03513055|insulin technique|insulin technique
9739|NCT03513055|insulin antibodies|insulin antibodies
9740|NCT03513055|premixed insulin|premixed insulin
9741|NCT03513042|intensity-modulated proton therapy|intensity-modulated proton therapy
9742|NCT03513042|therapy response evaluation|therapy response evaluation
9743|NCT03513042|positron emission tomography (PET)|positron emission tomography (pet)
9744|NCT03513042|hypoxia|hypoxia
9745|NCT03513042|metabolism|metabolism
9746|NCT03513042|18F-fluoroazomycin-arabinoside (FAZA)|18f-fluoroazomycin-arabinoside (faza)
9747|NCT03513042|18F-2-fluoro-2-deoxy-D-glucose (FDG)|18f-2-fluoro-2-deoxy-d-glucose (fdg)
9748|NCT03513042|head and neck neoplasms|head and neck neoplasms
9749|NCT03513042|image-guided proton therapy|image-guided proton therapy
9750|NCT03513042|treatment outcome|treatment outcome
9751|NCT03513042|predictive biomarker|predictive biomarker
9752|NCT03513029|PAF|paf
9753|NCT03513029|atrial fibrillation|atrial fibrillation
9754|NCT03513029|ablation|ablation
9755|NCT03513029|low intensity collimated ultrasound|low intensity collimated ultrasound
9756|NCT03513016|Osteoarthritis|osteoarthritis
9757|NCT03513016|Painful Osteoarthritis|painful osteoarthritis
9758|NCT03513016|Osteoarthritis, Knee|osteoarthritis, knee
9759|NCT03513016|Senescence|senescence
9760|NCT03512990|Brachial Plexus Block|brachial plexus block
9761|NCT03512990|Superior Trunk|superior trunk
9762|NCT03512990|Phrenic Nerve|phrenic nerve
9763|NCT03512977|spinal anesthesia|spinal anesthesia
9764|NCT03512977|sphenopalatine ganglion block|sphenopalatine ganglion block
9765|NCT03512977|postspinal headache|postspinal headache
9766|NCT03512951|Hearing aids|hearing aids
9767|NCT03512951|Remote microphone systems|remote microphone systems
9768|NCT03512951|Roger technology|roger technology
9769|NCT03512951|Sound externalization|sound externalization
9770|NCT03512951|Auditory distance estimation|auditory distance estimation
9771|NCT03512938|Generalized aggressive periodontitis|generalized aggressive periodontitis
9772|NCT03512938|Non-surgical periodontal therapy|non-surgical periodontal therapy
9773|NCT03512938|Periodontopathogens|periodontopathogens
9774|NCT03512938|Smoking|smoking
9775|NCT03512938|Gingival crevicular fluid|gingival crevicular fluid
9776|NCT03512925|Coercion|coercion
9777|NCT03512925|Debriefing|debriefing
9778|NCT03512925|Mental health|mental health
9779|NCT03512925|Seclusion|seclusion
9780|NCT03512925|Mechanical restraint|mechanical restraint
9781|NCT03512899|implantable port|implantable port
9782|NCT03512886|Multiple sclerosis|multiple sclerosis
9783|NCT03512886|Multi-task training|multi-task training
9784|NCT03512886|Balance|balance
9785|NCT03512886|Mobility|mobility
9786|NCT03512886|Cognition|cognition
9787|NCT03512886|Upper extremity function|upper extremity function
9788|NCT03512873|Scleredema Diabeticorum|scleredema diabeticorum
9789|NCT03512873|Tranilast|tranilast
9790|NCT03512860|Estetrol|estetrol
9791|NCT03512860|Drospirenone|drospirenone
9792|NCT03512860|Uridine diphosphate glucuronosyltransferase-2B7|uridine diphosphate glucuronosyltransferase-2b7
9793|NCT03512860|Drug-drug interaction|drug-drug interaction
9794|NCT03512860|Valproic acid|valproic acid
9795|NCT03512847|liquid biopsy|liquid biopsy
9796|NCT03512847|genomic profiling|genomic profiling
9797|NCT03512847|ctDNA|ctdna
9798|NCT03512834|angiosarcoma|angiosarcoma
9799|NCT03512834|paclitaxel|paclitaxel
9800|NCT03512834|avelumab|avelumab
9801|NCT03512769|jaw support device, third molars, wisdom teeth, partially erupted or impacted|jaw support device, third molars, wisdom teeth, partially erupted or impacted
9802|NCT03512756|Pancreatic cancer|pancreatic cancer
9803|NCT03512756|Pancreas cancer|pancreas cancer
9804|NCT03512756|Pancreatic|pancreatic
9805|NCT03512756|Pancreas|pancreas
9806|NCT03512756|cancer|cancer
9807|NCT03512756|non- toxic|non- toxic
9808|NCT03512756|no toxicity|no toxicity
9809|NCT03512756|chemotherapy|chemotherapy
9810|NCT03512756|metastatic|metastatic
9811|NCT03512743|bone mineral density|bone mineral density
9812|NCT03512743|bone turnover markers|bone turnover markers
9813|NCT03512743|ferritin|ferritin
9814|NCT03512730|regenera|regenera
9815|NCT03512704|Heart failure|heart failure
9816|NCT03512704|clinical prediction rules|clinical prediction rules
9817|NCT03512704|health services research|health services research
9818|NCT03512691|Risk perceptions and attitudes, time preference, information|risk perceptions and attitudes, time preference, information
9819|NCT03512665|Pre-diabetes|pre-diabetes
9820|NCT03512665|cardiovascular risk|cardiovascular risk
9821|NCT03512665|lipids|lipids
9822|NCT03512665|insulin resistance|insulin resistance
9823|NCT03512665|obesity|obesity
9824|NCT03512665|overweight|overweight
10075|NCT03511209|Hypnotics and Sedatives|hypnotics and sedatives
9825|NCT03512639|Mastectomy, Breast Reconstruction, Homeopathic Treatment|mastectomy, breast reconstruction, homeopathic treatment
9826|NCT03512626|OptiVis|optivis
9827|NCT03512626|hybrid multifocal intraocular lens|hybrid multifocal intraocular lens
9828|NCT03512626|multifocal intraocular lens|multifocal intraocular lens
9829|NCT03512626|presbyopia|presbyopia
9830|NCT03512600|lithiasis|lithiasis
9831|NCT03512600|uric acid|uric acid
9832|NCT03512600|crystallization|crystallization
9833|NCT03512587|Personalized quantum sonotherapy|personalized quantum sonotherapy
9834|NCT03512587|Regional anesthesia|regional anesthesia
9835|NCT03512587|Peripheral nerve block|peripheral nerve block
9836|NCT03512574|pregabalin, dexmedetomidine, postoperative pain|pregabalin, dexmedetomidine, postoperative pain
9837|NCT03512522|chronic pain|chronic pain
9838|NCT03512522|pain self-management|pain self-management
9839|NCT03512522|remote delivery|remote delivery
9840|NCT03512522|workbook|workbook
9841|NCT03512522|online|online
9842|NCT03512496|Energy Drink|energy drink
9843|NCT03512496|Pediatric|pediatric
9844|NCT03512496|Metabolism|metabolism
9845|NCT03512496|Glucose|glucose
9846|NCT03512496|Caffeine|caffeine
9847|NCT03512496|Obesity|obesity
9848|NCT03512496|Nutrition|nutrition
9849|NCT03512496|Metabolomics|metabolomics
9850|NCT03512496|Health Behavior|health behavior
9851|NCT03512496|Glucose Intolerance|glucose intolerance
9852|NCT03512483|Atrial Fibrillation|atrial fibrillation
9853|NCT03512483|Rural|rural
9854|NCT03512483|Virtual|virtual
9855|NCT03512483|Older Adults|older adults
9856|NCT03512470|surgical wound|surgical wound
9857|NCT03512470|Prevena System|prevena system
9858|NCT03512457|Melanoma|melanoma
9859|NCT03512457|Skin self-examination|skin self-examination
9860|NCT03512457|mammogram|mammogram
9861|NCT03512444|negative pressure therapy|negative pressure therapy
9862|NCT03512444|negative pressure|negative pressure
9863|NCT03512444|Wound therapy|wound therapy
9864|NCT03512444|NPWT|npwt
9865|NCT03512444|Vacuum therapy|vacuum therapy
9866|NCT03512444|VAC|vac
9867|NCT03512431|analytical method validation|analytical method validation
9868|NCT03512431|renal transplantation|renal transplantation
9869|NCT03512431|limited sampling strategy|limited sampling strategy
9870|NCT03512418|HIV prevention|hiv prevention
9871|NCT03512418|Pre-exposure prophylaxis|pre-exposure prophylaxis
9872|NCT03512418|Digital Pill|digital pill
9873|NCT03512418|Substance use disorder|substance use disorder
9874|NCT03512418|Stimulant use|stimulant use
9875|NCT03512392|fluid therapy|fluid therapy
9876|NCT03512392|furosemide|furosemide
9877|NCT03512392|diuretics|diuretics
9878|NCT03512392|Injections, Intravenous|injections, intravenous
9879|NCT03512392|Infusions, Intravenous|infusions, intravenous
9880|NCT03512392|Spironolactone|spironolactone
9881|NCT03512392|Indapamide|indapamide
9882|NCT03512379|robot-assisted surgery|robot-assisted surgery
9883|NCT03512379|pedicle screw|pedicle screw
9884|NCT03512379|spine|spine
9885|NCT03512366|inguinal hernia|inguinal hernia
9886|NCT03512366|lichtenstein's technique|lichtenstein's technique
9887|NCT03512366|desarda's technique|desarda's technique
9888|NCT03512366|local anaesthesia|local anaesthesia
9889|NCT03512340|CD47|cd47
9890|NCT03512340|SiRP α|sirp α
9891|NCT03512340|tumor microenvironment|tumor microenvironment
9892|NCT03512340|macrophage|macrophage
9893|NCT03512340|solid tumor|solid tumor
9894|NCT03512340|Phase 1|phase 1
9895|NCT03512340|safety|safety
9896|NCT03512340|efficacy|efficacy
9897|NCT03512340|hematologic malignancies|hematologic malignancies
9898|NCT03512340|SRF231|srf231
9899|NCT03512275|Hidradenitis Suppurativa|hidradenitis suppurativa
9900|NCT03512262|BA058|ba058
9901|NCT03512262|abaloparatide|abaloparatide
9902|NCT03512262|abaloparatide-SC|abaloparatide-sc
9903|NCT03512262|osteoporosis|osteoporosis
9904|NCT03512262|male osteoporosis|male osteoporosis
9905|NCT03512262|TYMLOS™|tymlos™
9906|NCT03512262|fracture|fracture
9907|NCT03512262|bone loss|bone loss
9908|NCT03512197|Newly diagnosed FLT3-mutation negative|newly diagnosed flt3-mutation negative
9909|NCT03512197|PKC412|pkc412
9910|NCT03512197|midostaurin|midostaurin
9911|NCT03512197|cytarabine|cytarabine
9912|NCT03512197|daunorubicin|daunorubicin
9913|NCT03512197|idarubicin|idarubicin
9914|NCT03512197|acute myeloid leukemia|acute myeloid leukemia
9915|NCT03512197|AML|aml
9916|NCT03512197|FLT3-MN (SR<0.05)|flt3-mn (sr<0.05)
9917|NCT03512197|combination treatment|combination treatment
9918|NCT03512197|induction failure|induction failure
9919|NCT03512197|event free survival|event free survival
9920|NCT03512197|EFS|efs
9921|NCT03512197|minimal residual disease|minimal residual disease
9922|NCT03512119|Cystic fibrosis|cystic fibrosis
9923|NCT03512119|Glucose tolerance abnormalities|glucose tolerance abnormalities
9924|NCT03512119|CFTR corrector and potentiator|cftr corrector and potentiator
9925|NCT03512106|Arterial Hypertension|arterial hypertension
9926|NCT03512106|Acupuncture|acupuncture
9927|NCT03512093|Preterm Infant|preterm infant
9928|NCT03512080|Warfarin|warfarin
9929|NCT03512080|Anticoagulation|anticoagulation
9930|NCT03512080|Clinical Dosing Algorithm|clinical dosing algorithm
9931|NCT03512080|Genetic Dosing Algorithm|genetic dosing algorithm
9932|NCT03512080|International Normalised Ratio|international normalised ratio
9933|NCT03512080|Uganda|uganda
9934|NCT03512080|Cape Town|cape town
9935|NCT03512080|Cardiovascular Disease|cardiovascular disease
9936|NCT03512080|Genome-wide Association Study|genome-wide association study
9937|NCT03512080|Stratified Medicine|stratified medicine
9938|NCT03512080|Pharmacogenetics|pharmacogenetics
9939|NCT03512067|Mechanical Ventilation|mechanical ventilation
9940|NCT03512067|Respiratory Support|respiratory support
9941|NCT03512054|Tracheostomy|tracheostomy
9942|NCT03512054|Decannulation|decannulation
9943|NCT03512054|Rehabilitation|rehabilitation
9944|NCT03512054|Brain injury|brain injury
9945|NCT03512054|Neurosurgery|neurosurgery
9946|NCT03512041|ischemic conditioning, motor learning|ischemic conditioning, motor learning
9947|NCT03512028|ischemic conditioning, motor learning, strength, cognition|ischemic conditioning, motor learning, strength, cognition
9948|NCT03512015|Lung Cancer|lung cancer
9949|NCT03512002|Neurotechnology|neurotechnology
9950|NCT03512002|Autonomic Dysregulation|autonomic dysregulation
9951|NCT03512002|Hyperarousal|hyperarousal
9952|NCT03512002|Brain Electrical Activity|brain electrical activity
9953|NCT03512002|HIRREM|hirrem
9954|NCT03512002|Acoustic Stimulation|acoustic stimulation
9955|NCT03512002|Perimenopausal|perimenopausal
9956|NCT03512002|Postmenopausal|postmenopausal
9957|NCT03512002|Hot Flashes|hot flashes
9958|NCT03512002|Night Sweats|night sweats
9959|NCT03512002|Vasomotor Symptoms|vasomotor symptoms
9960|NCT03512002|Allostatis|allostatis
9961|NCT03511937|Food and beverage purchases|food and beverage purchases
9962|NCT03511937|Sugar-sweetened beverages|sugar-sweetened beverages
9963|NCT03511937|Beverages|beverages
9964|NCT03511924|resistance training|resistance training
9965|NCT03511924|circulating microRNA´s|circulating microrna´s
9966|NCT03511924|muscle strength|muscle strength
9967|NCT03511911|Pelvic floor muscle strength|pelvic floor muscle strength
9968|NCT03511911|modified Oxford Grading Scale|modified oxford grading scale
9969|NCT03511911|Levator ani testing|levator ani testing
9970|NCT03511911|vaginal contraction pressure|vaginal contraction pressure
9971|NCT03511911|reliability|reliability
9972|NCT03511885|Cardiovascular|cardiovascular
9973|NCT03511885|Prevention|prevention
9974|NCT03511885|EUROASPIRE|euroaspire
9975|NCT03511872|Basic life support|basic life support
9976|NCT03511872|cardiopulmonary resuscitation|cardiopulmonary resuscitation
9977|NCT03511872|medical undergraduate students|medical undergraduate students
9978|NCT03511872|crisis|crisis
9979|NCT03511872|randomized controlled trial.|randomized controlled trial.
9980|NCT03511859|Breast cancer. Circulating tumor cells. CTCs. Cell free DNA. cfDNA|breast cancer. circulating tumor cells. ctcs. cell free dna. cfdna
9981|NCT03511846|Brain Freeze|brain freeze
9982|NCT03511846|Capsaicin|capsaicin
9983|NCT03511833|Intra nasal ketamine|intra nasal ketamine
9984|NCT03511833|IV morphine|iv morphine
9985|NCT03511833|acute traumatic pain|acute traumatic pain
9986|NCT03511820|Amphotericin B|amphotericin b
9987|NCT03511820|liposome|liposome
9988|NCT03511820|post marketing surveillance|post marketing surveillance
9989|NCT03511794|Hepatitis B Reactivation|hepatitis b reactivation
9990|NCT03511794|Allogenic Stem Cell Transplant|allogenic stem cell transplant
9991|NCT03511768|18F-AlF-NOTA-octreotide|18f-alf-nota-octreotide
9992|NCT03511729|Tau/P-Tau|tau/p-tau
9993|NCT03511729|biomarker|biomarker
9994|NCT03511729|neurocognitive|neurocognitive
9995|NCT03511729|outcomes|outcomes
9996|NCT03511729|children|children
9997|NCT03511716|Mitral Insufficiency|mitral insufficiency
9998|NCT03511716|Mitral Valve Incompetence|mitral valve incompetence
9999|NCT03511690|Latinas, African Americans|latinas, african americans
10000|NCT03511677|Insole|insole
10001|NCT03511677|Morton Neuroma|morton neuroma
10002|NCT03511677|Pain|pain
10003|NCT03511677|Function|function
10004|NCT03511664|mCRPC|mcrpc
10005|NCT03511664|177Lu-PSMA-617|177lu-psma-617
10006|NCT03511664|PSMA-617|psma-617
10007|NCT03511664|PSMA-11|psma-11
10008|NCT03511664|radioligand therapy|radioligand therapy
10009|NCT03511560|Envarsus XR|envarsus xr
10010|NCT03511560|Tacrolimus|tacrolimus
10011|NCT03511560|Kidney Transplantation|kidney transplantation
10012|NCT03511534|treatment, psychotherapy, pharmacotherapy|treatment, psychotherapy, pharmacotherapy
10013|NCT03511521|steroid|steroid
10014|NCT03511521|prednisone|prednisone
10015|NCT03511521|methylprednisolone|methylprednisolone
10016|NCT03511521|hyperglycemia|hyperglycemia
10017|NCT03511521|insulin|insulin
10018|NCT03511521|hypoglycemia|hypoglycemia
10019|NCT03511508|pregnancy|pregnancy
10020|NCT03511508|maternity Care|maternity care
10021|NCT03511508|complex intervention|complex intervention
10022|NCT03511508|interdisiplinary team|interdisiplinary team
10023|NCT03511508|chronic disease|chronic disease
10024|NCT03511508|interdisciplinary|interdisciplinary
10025|NCT03511508|midwifery|midwifery
10026|NCT03511469|Kontralateral Education, Bankart, Rehabilitation, Shoulder,|kontralateral education, bankart, rehabilitation, shoulder,
10027|NCT03511456|leg pain|leg pain
10028|NCT03511456|waist pain|waist pain
10029|NCT03511456|life quality|life quality
10030|NCT03511443|hsRDT|hsrdt
10031|NCT03511443|usRDT|usrdt
10032|NCT03511443|Reactive Case Detection (RCD)|reactive case detection (rcd)
10033|NCT03511443|High risk for malaria|high risk for malaria
10034|NCT03511430|Acute Coronary Syndrome|acute coronary syndrome
10035|NCT03511430|Heart Diseases|heart diseases
10036|NCT03511430|Cardiovascular Diseases|cardiovascular diseases
10037|NCT03511430|Vascular Diseases|vascular diseases
10038|NCT03511404|Non specific chronic low back pain|non specific chronic low back pain
10039|NCT03511404|surface electromyography (EMG)|surface electromyography (emg)
10040|NCT03511404|neuromuscular function|neuromuscular function
10041|NCT03511404|physiotherapy|physiotherapy
10042|NCT03511404|Numeric Pain Rating Scale|numeric pain rating scale
10043|NCT03511391|radiotherapy|radiotherapy
10044|NCT03511391|checkpoint inhibitors|checkpoint inhibitors
10045|NCT03511378|Breast Carcinoma|breast carcinoma
10046|NCT03511378|Breast neoplasms|breast neoplasms
10047|NCT03511378|Breast Tumors|breast tumors
10048|NCT03511378|Cancer of Breast|cancer of breast
10049|NCT03511378|Anti-Drug Antibodies (ADA)|anti-drug antibodies (ada)
10050|NCT03511378|Immunogenicity|immunogenicity
10051|NCT03511365|Probiotic|probiotic
10052|NCT03511365|Microbiome|microbiome
10053|NCT03511365|Inflammation|inflammation
10054|NCT03511365|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
10055|NCT03511326|field-treatment|field-treatment
10056|NCT03511313|Primary Hypertension|primary hypertension
10057|NCT03511313|Renal Denervation|renal denervation
10058|NCT03511300|Cognition|cognition
10059|NCT03511300|Apathy|apathy
10060|NCT03511287|inspiratory muscle training|inspiratory muscle training
10061|NCT03511287|advanced lung disease|advanced lung disease
10062|NCT03511287|maximal inspiratory pressure|maximal inspiratory pressure
10063|NCT03511287|inspiratory endurance|inspiratory endurance
10064|NCT03511274|Cytomegalovirus Congenital|cytomegalovirus congenital
10065|NCT03511274|CMV|cmv
10066|NCT03511274|Cytomegalovirus infections|cytomegalovirus infections
10067|NCT03511261|Oral submucous fibrosis|oral submucous fibrosis
10068|NCT03511261|curcumin|curcumin
10069|NCT03511261|potentially malignant disease|potentially malignant disease
10070|NCT03511248|Heart Failure|heart failure
10071|NCT03511248|Heart Failure with Reduced Ejection Fraction|heart failure with reduced ejection fraction
10072|NCT03511248|Nitric Oxide|nitric oxide
10073|NCT03511248|Inorganic Nitrate|inorganic nitrate
10074|NCT03511209|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
10076|NCT03511196|stage IV castration sensitive prostate cancer|stage iv castration sensitive prostate cancer
10077|NCT03511196|advanced castration sensitive prostate cancer|advanced castration sensitive prostate cancer
10078|NCT03511157|ischemic preconditioning|ischemic preconditioning
10079|NCT03511131|HIV prevention|hiv prevention
10080|NCT03511131|Adolescent risk-taking behaviors|adolescent risk-taking behaviors
10081|NCT03511105|Lipopolysaccharide|lipopolysaccharide
10082|NCT03511105|Pharmacodynamics|pharmacodynamics
10083|NCT03511105|Healthy subjects|healthy subjects
10084|NCT03511105|GSK2798745|gsk2798745
10085|NCT03511105|Placebo|placebo
10086|NCT03511105|Segmental challenge|segmental challenge
10087|NCT03511092|Leucine metabolites|leucine metabolites
10088|NCT03511092|Resistance training|resistance training
10089|NCT03511092|Hypertrophy|hypertrophy
10090|NCT03511092|Strength|strength
10091|NCT03511092|Supplement|supplement
10092|NCT03511079|Music|music
10093|NCT03511066|efficacy|efficacy
10094|NCT03511066|safety|safety
10095|NCT03511027|Medication Adherence|medication adherence
10096|NCT03511027|Medication Dispensing|medication dispensing
10097|NCT03511027|Homecare|homecare
10098|NCT03511027|Elderly|elderly
10099|NCT03510975|behavioural therapy|behavioural therapy
10100|NCT03510975|mono symptomatic nocturnal enuresis|mono symptomatic nocturnal enuresis
10101|NCT03510975|compliance|compliance
10102|NCT03510975|response|response
10103|NCT03510962|pH of saliva|ph of saliva
10104|NCT03510962|Fruit juice|fruit juice
10105|NCT03510962|buffering agent|buffering agent
10106|NCT03510962|oral hygiene|oral hygiene
10107|NCT03510936|Probiotics|probiotics
10108|NCT03510936|Gut Microbiome|gut microbiome
10109|NCT03510936|Infants|infants
10110|NCT03510936|Jaundice|jaundice
10111|NCT03510923|Appendix|appendix
10112|NCT03510923|Appendectomy|appendectomy
10113|NCT03510923|Gallbladder|gallbladder
10114|NCT03510923|Cholecystectomy|cholecystectomy
10115|NCT03510923|Neoplasms|neoplasms
10116|NCT03510923|Pathology|pathology
10117|NCT03510923|Selective|selective
10118|NCT03510923|Routine|routine
10119|NCT03510897|MAKE|make
10121|NCT03510871|neoadjuvant therapy|neoadjuvant therapy
10122|NCT03510819|Dental trauma|dental trauma
10123|NCT03510819|Emergency management|emergency management
10124|NCT03510819|Tooth avulsion|tooth avulsion
10125|NCT03510819|Knowledge|knowledge
10126|NCT03510819|Practice|practice
10127|NCT03510819|Traumatic injuries|traumatic injuries
10128|NCT03510819|Attitude|attitude
10129|NCT03510793|microcirculation; aortic aneurysm; anesthesia|microcirculation; aortic aneurysm; anesthesia
10130|NCT03510780|Platlet rich fibrin|platlet rich fibrin
10131|NCT03510780|Enamel Matrix Derivative|enamel matrix derivative
10132|NCT03510780|Bone graft|bone graft
10133|NCT03510780|Non-inferiority study|non-inferiority study
10134|NCT03510754|Endoscopic ultrasound|endoscopic ultrasound
10135|NCT03510754|Biliary drainage|biliary drainage
10136|NCT03510754|Endoscopic ultrasound guided biliary drainage|endoscopic ultrasound guided biliary drainage
10137|NCT03510741|Schizophrenia|schizophrenia
10138|NCT03510741|Sodium Benzoate|sodium benzoate
10139|NCT03510741|N-Acetylcysteine|n-acetylcysteine
10140|NCT03510741|NMDA receptor|nmda receptor
10141|NCT03510741|Psychopharmacology|psychopharmacology
10142|NCT03510741|Anti-oxidant|anti-oxidant
10143|NCT03510741|Inflammation|inflammation
10144|NCT03510728|Protective Behavioral Strategies|protective behavioral strategies
10145|NCT03510702|Epigenetic.|epigenetic.
10146|NCT03510702|microRNA.|microrna.
10147|NCT03510702|Periodontitis.|periodontitis.
10148|NCT03510650|Hemophagocytic Lymphohistiocytosis (HLH)|hemophagocytic lymphohistiocytosis (hlh)
10149|NCT03510650|Hemophagocytic syndrome (HPS)|hemophagocytic syndrome (hps)
10150|NCT03510650|critically ill|critically ill
10151|NCT03510650|Intensive care unit (ICU)|intensive care unit (icu)
10152|NCT03510637|Hepatitis C, Genotype 4, DAAs, Real life evaluation|hepatitis c, genotype 4, daas, real life evaluation
10153|NCT03510585|mucociliary clearance|mucociliary clearance
10154|NCT03510585|air pollution|air pollution
10155|NCT03510585|nasal lavage|nasal lavage
10156|NCT03510585|exhaled breath condensate|exhaled breath condensate
10157|NCT03510585|inflammation|inflammation
10158|NCT03510572|[18F]PI-2620, tauopathy, positron emission computed tomography|[18f]pi-2620, tauopathy, positron emission computed tomography
10159|NCT03510533|autoantibodies (autoAc) circulating|autoantibodies (autoac) circulating
10160|NCT03510533|neuropeptides (Ghrelin, l'α-MSH)|neuropeptides (ghrelin, l'α-msh)
10161|NCT03510533|potential digestive origin|potential digestive origin
10162|NCT03510520|Hemodialysis|hemodialysis
10163|NCT03510520|Haemodialysis|haemodialysis
10164|NCT03510520|Hemodiafiltration|hemodiafiltration
10165|NCT03510520|Haemodiafiltration|haemodiafiltration
10166|NCT03510520|Dialysis membrane|dialysis membrane
10167|NCT03510520|Endothelial Microvesicles|endothelial microvesicles
10168|NCT03510520|Pulse Wave Velocity|pulse wave velocity
10169|NCT03510507|Lyme arthritis|lyme arthritis
10170|NCT03510507|Borrelia burgdorferi|borrelia burgdorferi
10171|NCT03510507|vector tick|vector tick
10172|NCT03510507|Arthritis|arthritis
10173|NCT03510507|joints|joints
10174|NCT03510481|Infection|infection
10175|NCT03510481|Malaria|malaria
10176|NCT03510481|Transmission|transmission
10177|NCT03510481|Treatment|treatment
10178|NCT03510481|Disease|disease
10179|NCT03510468|Antiretrovial Therapy|antiretrovial therapy
10180|NCT03510468|Human Immunodeficiency Virus|human immunodeficiency virus
10181|NCT03510468|Latent Tuberculosis Infection (LTBI)|latent tuberculosis infection (ltbi)
10182|NCT03510468|Drug-Drug Interaction|drug-drug interaction
10183|NCT03510468|Rifamycin|rifamycin
10184|NCT03510455|Renal Phosphate Wasting|renal phosphate wasting
10185|NCT03510455|Phosphaturic Mesenchymal Tumors|phosphaturic mesenchymal tumors
10186|NCT03510455|Fibroblast Growth Factor (FGF23)|fibroblast growth factor (fgf23)
10187|NCT03510455|FGFR Inhibitors|fgfr inhibitors
10188|NCT03510455|Hypophosphatemia|hypophosphatemia
10189|NCT03510442|Inflammation|inflammation
10190|NCT03510442|Fever|fever
10191|NCT03510442|Arthritis|arthritis
10192|NCT03510442|Sequencing|sequencing
10193|NCT03510416|apatinib，TACE， hepatocellular carcinoma|apatinib，tace， hepatocellular carcinoma
10194|NCT03510390|head and neck cancer|head and neck cancer
10195|NCT03510390|tissue hypoxia|tissue hypoxia
10196|NCT03510390|metformin|metformin
10197|NCT03510364|Subjective social status|subjective social status
10198|NCT03510364|Obesity|obesity
10199|NCT03510364|High calorie intake|high calorie intake
10200|NCT03510364|Energy balance|energy balance
10201|NCT03510364|Eating behavior|eating behavior
10202|NCT03510325|Schizophrenia; Antipsychotics；Cost-Effectiveness Analyses|schizophrenia; antipsychotics；cost-effectiveness analyses
10203|NCT03510286|proteinuria|proteinuria
10204|NCT03510286|preeclampsia|preeclampsia
10205|NCT03510286|diagnostic|diagnostic
10206|NCT03510286|dipstick|dipstick
10207|NCT03510286|protein|protein
10208|NCT03510286|urine|urine
10209|NCT03510286|creatinine|creatinine
10210|NCT03510273|Thermocoagulation|thermocoagulation
10211|NCT03510273|Treatment|treatment
10212|NCT03510273|Cervical precancer|cervical precancer
10213|NCT03510260|Cesarean, Consent, Electronic, Satisfaction|cesarean, consent, electronic, satisfaction
10214|NCT03510234|Pigmentary retinopathy|pigmentary retinopathy
10215|NCT03510234|Argus II retinal prosthesis|argus ii retinal prosthesis
10216|NCT03510234|Self-confidence|self-confidence
10217|NCT03510221|Hypertension|hypertension
10218|NCT03510221|Oxidative stress|oxidative stress
10219|NCT03510221|Antioxidant|antioxidant
10220|NCT03510221|Autonomic imbalance|autonomic imbalance
10221|NCT03510221|Insulin resistance|insulin resistance
10222|NCT03510221|Cytokines|cytokines
10223|NCT03510143|thyroid cancer|thyroid cancer
10224|NCT03510143|Neoveil|neoveil
10225|NCT03510143|seroma|seroma
10226|NCT03510143|chyle leakage|chyle leakage
10227|NCT03510117|Mindfulness|mindfulness
10228|NCT03510117|Patient reported outcomes measures|patient reported outcomes measures
10229|NCT03510117|PROMIS|promis
10230|NCT03510104|MerTK|mertk
10231|NCT03510078|Diabetes Mellitus|diabetes mellitus
10232|NCT03510078|hyperglycemic control|hyperglycemic control
10233|NCT03510078|hospitalization|hospitalization
10234|NCT03510078|internal medicine|internal medicine
10235|NCT03510065|hip arthroplasty|hip arthroplasty
10236|NCT03510065|revision arthroplasty|revision arthroplasty
10237|NCT03510065|survival|survival
10238|NCT03510052|diet|diet
10239|NCT03510052|Fecal Incontinence|fecal incontinence
10240|NCT03510052|FI|fi
10241|NCT03510052|ABL|abl
10242|NCT03510039|Involuntary commitment hospitalization|involuntary commitment hospitalization
10243|NCT03510039|close relative|close relative
10244|NCT03510026|internal thoracic artery harvesting|internal thoracic artery harvesting
10245|NCT03510026|arterial graft patency|arterial graft patency
10246|NCT03510026|electrosurgery|electrosurgery
10247|NCT03510026|arterial graft preparation|arterial graft preparation
10248|NCT03510013|low flow anesthesia|low flow anesthesia
10249|NCT03510013|wash-in|wash-in
10250|NCT03510013|sevoflurane|sevoflurane
10251|NCT03510000|T1DM|t1dm
10252|NCT03510000|artificial pancreas|artificial pancreas
10253|NCT03510000|insulin pump|insulin pump
10254|NCT03510000|empagliflozin|empagliflozin
10255|NCT03510000|SGLT2 inhibitor|sglt2 inhibitor
10256|NCT03510000|carbohydrate counting|carbohydrate counting
10257|NCT03509935|ultrasound,|ultrasound,
10258|NCT03509935|high-risk surgery|high-risk surgery
10259|NCT03509935|intensive care|intensive care
10260|NCT03509909|yoga|yoga
10261|NCT03509909|exercise|exercise
10262|NCT03509909|randomized controlled trial|randomized controlled trial
10263|NCT03509870|diabetes|diabetes
10264|NCT03509818|Klotho|klotho
10265|NCT03509818|Exercise|exercise
10266|NCT03509818|Physical Fitness|physical fitness
10267|NCT03509805|sleep apnea syndrome|sleep apnea syndrome
10268|NCT03509805|obesity|obesity
10269|NCT03509805|pregnancy|pregnancy
10270|NCT03509805|preeclampsia|preeclampsia
10271|NCT03509766|allergic|allergic
10272|NCT03509766|rhinitis|rhinitis
10273|NCT03509766|allergy|allergy
10274|NCT03509766|asthma|asthma
10275|NCT03509766|food allergy|food allergy
10276|NCT03509766|skin testing|skin testing
10277|NCT03509766|skin prick test|skin prick test
10278|NCT03509753|Prebiotic fiber|prebiotic fiber
10279|NCT03509701|Reversible cerebral vasoconstriction syndrome|reversible cerebral vasoconstriction syndrome
10280|NCT03509701|Herpes zoster|herpes zoster
10281|NCT03509701|Varicella-zoster virus infection|varicella-zoster virus infection
10282|NCT03509688|entecavir|entecavir
10283|NCT03509688|resveratrol|resveratrol
10284|NCT03509688|thymosin|thymosin
10285|NCT03509688|hepatitis B|hepatitis b
10286|NCT03509675|Oral Ulceration|oral ulceration
10287|NCT03509662|Vitamin C|vitamin c
10288|NCT03509662|Cardiac Arrest|cardiac arrest
10289|NCT03509662|Post-cardiac arrest syndrome|post-cardiac arrest syndrome
10290|NCT03509662|Oxidative stress|oxidative stress
10291|NCT03509623|neovascular age-related macular degeneration|neovascular age-related macular degeneration
10292|NCT03509623|aflibercept|aflibercept
10293|NCT03509623|intravitreal anti-VEGF|intravitreal anti-vegf
10294|NCT03509623|coagulation|coagulation
10295|NCT03509623|platelet count|platelet count
10296|NCT03509623|D-Dimer|d-dimer
10297|NCT03509623|Fibrinogen|fibrinogen
10298|NCT03509610|Physical Activity|physical activity
10299|NCT03509610|Nutrition|nutrition
10300|NCT03509610|Carbohydrates|carbohydrates
10301|NCT03509597|Cognitive remediation|cognitive remediation
10302|NCT03509597|Aerobic exercise|aerobic exercise
10303|NCT03509597|Physical exercise|physical exercise
10304|NCT03509597|Negative symptoms|negative symptoms
10305|NCT03509597|Functional outcome|functional outcome
10306|NCT03509597|Cognition|cognition
10307|NCT03509558|Spinal electrical stimulation|spinal electrical stimulation
10308|NCT03509545|natriuresis|natriuresis
10309|NCT03509519|neuromuscular electrical stimulation|neuromuscular electrical stimulation
10310|NCT03509519|physical activity|physical activity
10311|NCT03509519|muscular strength|muscular strength
10312|NCT03509493|Primary prevention|primary prevention
10313|NCT03509493|Secondary prevention|secondary prevention
10314|NCT03509493|Clinical practice|clinical practice
10315|NCT03509467|skin cancer prevention|skin cancer prevention
10316|NCT03509467|educational materials|educational materials
10317|NCT03509467|skin cancer risk|skin cancer risk
10318|NCT03509467|questionnaire|questionnaire
10319|NCT03509467|MC1R genotype|mc1r genotype
10320|NCT03509441|South Asian|south asian
10321|NCT03509441|Insulin Resistance|insulin resistance
10322|NCT03509441|Cardiac Fibrosis|cardiac fibrosis
10323|NCT03509441|MRI|mri
10324|NCT03509441|Diabetes|diabetes
10325|NCT03509441|Cardiomyopathy|cardiomyopathy
10326|NCT03509428|Exercise|exercise
10327|NCT03509428|mortality|mortality
10328|NCT03509428|morbidity|morbidity
10329|NCT03509428|surgery|surgery
10330|NCT03509428|colorectal|colorectal
10331|NCT03509428|upper gastrointestinal|upper gastrointestinal
10332|NCT03509428|hepatobiliary|hepatobiliary
10333|NCT03509428|urology|urology
10334|NCT03509428|lung|lung
10335|NCT03509428|nutrition|nutrition
10336|NCT03509428|psychology|psychology
10337|NCT03509415|Confocal|confocal
10338|NCT03509415|RCM|rcm
10339|NCT03509415|Imaging|imaging
10340|NCT03509415|Skin cancer|skin cancer
10341|NCT03509402|short dental implants|short dental implants
10342|NCT03509402|full-arch prosthesis|full-arch prosthesis
10343|NCT03509350|Vitamin C|vitamin c
10344|NCT03509350|Thiamine|thiamine
10345|NCT03509350|Corticosteroid|corticosteroid
10346|NCT03509337|Elastography, Nervous tissue, Muscle tonus|elastography, nervous tissue, muscle tonus
10347|NCT03509311|Asthma|asthma
10348|NCT03509311|Physical activity|physical activity
10349|NCT03509311|Cardiorespiratory fitness|cardiorespiratory fitness
10350|NCT03509311|Quality of life|quality of life
10351|NCT03509298|activated CIK|activated cik
10352|NCT03509298|MUC1|muc1
10353|NCT03509298|bispecific antibody|bispecific antibody
10354|NCT03509298|pancreatic cancer|pancreatic cancer
10355|NCT03509233|periodontitis|periodontitis
10356|NCT03509233|full mouth scaling|full mouth scaling
10357|NCT03509233|air abrasion|air abrasion
10358|NCT03509233|scaling|scaling
10359|NCT03509220|Colonoscopy|colonoscopy
10360|NCT03509220|PBK-1701TC|pbk-1701tc
10361|NCT03509220|Bowel cleansing|bowel cleansing
10362|NCT03509207|Uterine sarcoma|uterine sarcoma
10363|NCT03509207|Histone deacetylases|histone deacetylases
10364|NCT03509194|liver|liver
10365|NCT03509194|children|children
10366|NCT03509194|liver transplantation|liver transplantation
10367|NCT03509194|liver cirrhosis|liver cirrhosis
10368|NCT03509181|interpretation bias|interpretation bias
10369|NCT03509181|smartphone|smartphone
10370|NCT03509181|partial hospital|partial hospital
10371|NCT03509155|Infant and Young Child Feeding|infant and young child feeding
10372|NCT03509155|Program Evaluation|program evaluation
10373|NCT03509155|Food Supplementation|food supplementation
10374|NCT03509155|Biscuit|biscuit
10375|NCT03509155|wasting children|wasting children
10376|NCT03509116|patient experience|patient experience
10377|NCT03509116|disease-related malnutrition|disease-related malnutrition
10378|NCT03509116|nutritional care|nutritional care
10379|NCT03509116|dietetic consultation|dietetic consultation
10380|NCT03509116|older adults|older adults
10381|NCT03509116|oral nutritional support|oral nutritional support
10382|NCT03509103|Partograpgh|partograpgh
10383|NCT03509090|regional anesthesia|regional anesthesia
10384|NCT03509090|erector spinae plane block|erector spinae plane block
10385|NCT03509090|postoperative pain|postoperative pain
10386|NCT03509077|geriatric|geriatric
10387|NCT03509077|addiction|addiction
10388|NCT03509064|Primary sjogren syndrome|primary sjogren syndrome
10389|NCT03509064|Small fiber neuropathy|small fiber neuropathy
10390|NCT03509064|Quality of life|quality of life
10391|NCT03509064|Medico-economic impact|medico-economic impact
10392|NCT03509051|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
10393|NCT03509012|Durvalumab|durvalumab
10394|NCT03509012|Chemotherapy|chemotherapy
10395|NCT03509012|Radiotherapy|radiotherapy
10396|NCT03509012|HNSCC|hnscc
10397|NCT03509012|NSCLC|nsclc
10398|NCT03509012|SCLC|sclc
10399|NCT03508934|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
10400|NCT03508934|hypoglycemia|hypoglycemia
10401|NCT03508934|Continuous Glucose Monitoring|continuous glucose monitoring
10402|NCT03508934|hospital|hospital
10403|NCT03508934|inpatient|inpatient
10404|NCT03508921|Onabotulinumtoxin|onabotulinumtoxin
10405|NCT03508908|HIV testing|hiv testing
10406|NCT03508908|ART|art
10407|NCT03508908|partner notification|partner notification
10408|NCT03508908|PrEP|prep
10409|NCT03508895|Hemp protein|hemp protein
10410|NCT03508895|Protein hydrolysate|protein hydrolysate
10411|NCT03508895|Bioactive peptides|bioactive peptides
10412|NCT03508895|Cannabis sativa|cannabis sativa
10413|NCT03508882|Eyelid|eyelid
10414|NCT03508882|Dystonia|dystonia
10415|NCT03508882|Botulinum injection|botulinum injection
10416|NCT03508882|Oculoplastics|oculoplastics
10417|NCT03508830|Liposomal Bupivacaine|liposomal bupivacaine
10418|NCT03508830|Intercostal Nerve Block|intercostal nerve block
10419|NCT03508830|Minimally Invasive Thoracic Surgery|minimally invasive thoracic surgery
10420|NCT03508817|Atropine, myopia, children|atropine, myopia, children
10421|NCT03508804|surgical abortion|surgical abortion
10422|NCT03508804|cervical anesthesia|cervical anesthesia
10423|NCT03508804|pain control|pain control
10424|NCT03508765|ASCT|asct
10425|NCT03508765|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
10426|NCT03508765|18-154|18-154
10427|NCT03508726|Sarcoma|sarcoma
10428|NCT03508726|Soft tissue|soft tissue
10429|NCT03508713|Rheumatoid Arthritis|rheumatoid arthritis
10430|NCT03508713|prognosis|prognosis
10431|NCT03508700|TNX-102 SL|tnx-102 sl
10432|NCT03508700|Bedtime|bedtime
10433|NCT03508700|Sublingual|sublingual
10434|NCT03508700|Safety|safety
10435|NCT03508700|PTSD|ptsd
10436|NCT03508661|Scleroderma|scleroderma
10437|NCT03508661|Systemic Sclerosis|systemic sclerosis
10438|NCT03508661|Support group|support group
10439|NCT03508661|Training|training
10440|NCT03508661|Feasibility|feasibility
10441|NCT03508635|Glucocorticoid receptor; antagonist|glucocorticoid receptor; antagonist
10442|NCT03508583|mpoc|mpoc
10443|NCT03508583|Validity and Reliability|validity and reliability
10444|NCT03508518|Accessibility of health services|accessibility of health services
10445|NCT03508518|Access to psychiatric care|access to psychiatric care
10446|NCT03508518|Consultation-liaison|consultation-liaison
10447|NCT03508518|General practitioner and psychiatrist collaboration|general practitioner and psychiatrist collaboration
10448|NCT03508518|Care pathway|care pathway
10449|NCT03508505|Acute Heart Failure|acute heart failure
10450|NCT03508505|Low Output Heart Failure|low output heart failure
10451|NCT03508505|Cardiac Low Output|cardiac low output
10452|NCT03508505|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
10453|NCT03508505|ECMO|ecmo
10454|NCT03508505|Venoarterial Extracorporeal membrane oxygenation|venoarterial extracorporeal membrane oxygenation
10455|NCT03508505|Cardiac Surgery|cardiac surgery
10456|NCT03508466|hypersensitivity|hypersensitivity
10457|NCT03508453|monoclonal antibody|monoclonal antibody
10458|NCT03508427|Bipolar Disorder|bipolar disorder
10459|NCT03508427|Smartphone|smartphone
10460|NCT03508427|Self-monitoring|self-monitoring
10461|NCT03508427|Objective data|objective data
10462|NCT03508414|Relapse-remitting Multiple Sclerosis|relapse-remitting multiple sclerosis
10463|NCT03508401|superior vena cava|superior vena cava
10464|NCT03508388|Liver volume|liver volume
10465|NCT03508388|Alcoholic cirrhosis|alcoholic cirrhosis
10466|NCT03508388|Liver transplantation|liver transplantation
10467|NCT03508336|disorders of consciousness|disorders of consciousness
10468|NCT03508336|swallowing|swallowing
10469|NCT03508336|prognosis prediction|prognosis prediction
10470|NCT03508336|minimally conscious state|minimally conscious state
10471|NCT03508336|vegetative state|vegetative state
10472|NCT03508297|Confocal|confocal
10473|NCT03508297|RCM|rcm
10474|NCT03508297|Imaging|imaging
10475|NCT03508297|Skin cancer|skin cancer
10476|NCT03508284|Multiple sclerosis|multiple sclerosis
10477|NCT03508284|Dual-task|dual-task
10478|NCT03508284|Balance|balance
10479|NCT03508284|Mobility|mobility
10480|NCT03508284|Cognition|cognition
10481|NCT03508245|Tourette Syndrome|tourette syndrome
10482|NCT03508245|Tourette's|tourette's
10483|NCT03508245|Tics|tics
10484|NCT03508245|Circadian|circadian
10485|NCT03508245|Sleep|sleep
10486|NCT03508219|Coronary Artery Disease (CAD)|coronary artery disease (cad)
10487|NCT03508219|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
10488|NCT03508219|Left Main Bifurcation|left main bifurcation
10489|NCT03508206|Students, cognitive functions, memory|students, cognitive functions, memory
10490|NCT03508180|Supportive care|supportive care
10491|NCT03508180|cancer|cancer
10492|NCT03508180|foot reflexology|foot reflexology
10493|NCT03508180|nausea|nausea
10494|NCT03508180|vomiting|vomiting
10495|NCT03508141|Fibrinogen Concentrate|fibrinogen concentrate
10496|NCT03508141|Cryoprecipitate|cryoprecipitate
10497|NCT03508102|remifentanil|remifentanil
10498|NCT03508102|bispectral index|bispectral index
10499|NCT03508102|Caesarean delivery|caesarean delivery
10500|NCT03508102|general anesthesia|general anesthesia
10501|NCT03508076|Vibrating Capsule|vibrating capsule
10502|NCT03508076|Efficacy and Safety|efficacy and safety
10503|NCT03508076|Chronic Constipation|chronic constipation
10504|NCT03508076|different vibrating modes|different vibrating modes
10505|NCT03508011|Breast Cancer|breast cancer
10506|NCT03508011|Ovarian Cancer|ovarian cancer
10507|NCT03508011|Prostate Cancer|prostate cancer
10508|NCT03508011|Advanced solid tumours|advanced solid tumours
10509|NCT03507985|morphine|morphine
10510|NCT03507985|attention disorders|attention disorders
10511|NCT03507972|ankle|ankle
10512|NCT03507972|diagnostic|diagnostic
10513|NCT03507972|ankle's ultrasound|ankle's ultrasound
10514|NCT03507972|traumatic lesion|traumatic lesion
10515|NCT03507933|villo-nodular synovitis|villo-nodular synovitis
10516|NCT03507933|Hip|hip
10517|NCT03507933|Surgery|surgery
10518|NCT03507907|neck pain|neck pain
10519|NCT03507907|older adults|older adults
10520|NCT03507907|mobilization|mobilization
10521|NCT03507894|rehabilitation|rehabilitation
10522|NCT03507894|exercise|exercise
10523|NCT03507894|stroke|stroke
10524|NCT03507894|adherence|adherence
10525|NCT03507881|isthmic spondylolisthesis|isthmic spondylolisthesis
10526|NCT03507816|Tuberculosis|tuberculosis
10527|NCT03507816|Multi-drug Resistant Tuberculosis|multi-drug resistant tuberculosis
10528|NCT03507816|Observational retrospective study|observational retrospective study
10529|NCT03507816|Clinical epidemiology|clinical epidemiology
10530|NCT03507816|Treatment outcome|treatment outcome
10531|NCT03507816|Migrant|migrant
10532|NCT03507816|Precarity|precarity
10533|NCT03507803|Gait training|gait training
10534|NCT03507803|Walking|walking
10535|NCT03507790|Alzheimer's Disease|alzheimer's disease
10536|NCT03507764|Treadmills|treadmills
10537|NCT03507764|Exercise|exercise
10538|NCT03507764|Number of steps|number of steps
10539|NCT03507764|Dispatchers|dispatchers
10540|NCT03507725|mind-body intervention|mind-body intervention
10541|NCT03507725|18-189|18-189
10542|NCT03507712|Asymmetric, Inferior Oblique, Overaction, Surgery, Symmetric|asymmetric, inferior oblique, overaction, surgery, symmetric
10543|NCT03507699|radiotherapy|radiotherapy
10544|NCT03507699|radiosurgery|radiosurgery
10545|NCT03507699|immunotherapy|immunotherapy
10546|NCT03507699|PD-1|pd-1
10547|NCT03507699|CTLA-4|ctla-4
10548|NCT03507699|TLR9|tlr9
10549|NCT03507686|NightstaRx|nightstarx
10550|NCT03507686|NSR-REP1|nsr-rep1
10551|NCT03507686|Choroideremia|choroideremia
10552|NCT03507686|CHM|chm
10553|NCT03507686|Gene Therapy|gene therapy
10554|NCT03507686|AAV|aav
10555|NCT03507686|REP1|rep1
10556|NCT03507660|verbal instruction, pelvic diaphragm, muscle contraction|verbal instruction, pelvic diaphragm, muscle contraction
10557|NCT03507647|randomized controlled trial|randomized controlled trial
10558|NCT03507647|Mindfulness based cognitive therapy|mindfulness based cognitive therapy
10559|NCT03507647|clinical effectiveness|clinical effectiveness
10560|NCT03507647|cost-effectiveness|cost-effectiveness
10561|NCT03507647|working mechanisms|working mechanisms
10562|NCT03507634|Lidocaine|lidocaine
10563|NCT03507634|Dexmedetomidine|dexmedetomidine
10564|NCT03507634|Opioid Free|opioid free
10565|NCT03507634|Bariatric surgery|bariatric surgery
10566|NCT03507595|prostate specific membrane antigen(PMSA)|prostate specific membrane antigen(pmsa)
10567|NCT03507595|prostate cancer|prostate cancer
10568|NCT03507595|PET/CT|pet/ct
10569|NCT03507556|immature teeth, necrotic teeth|immature teeth, necrotic teeth
10570|NCT03507543|Breast Cancer|breast cancer
10571|NCT03507543|Ovarian Cancer|ovarian cancer
10572|NCT03507543|Prostate Cancer|prostate cancer
10573|NCT03507543|Advanced solid tumours|advanced solid tumours
10574|NCT03507543|primary peritoneal Cancer|primary peritoneal cancer
10575|NCT03507530|physiotherapy and rehabilitation|physiotherapy and rehabilitation
10576|NCT03507530|fear of falling|fear of falling
10577|NCT03507530|quality of life|quality of life
10578|NCT03507517|prevention|prevention
10579|NCT03507504|psychiatric aspects|psychiatric aspects
10580|NCT03507491|Pediatric|pediatric
10581|NCT03507491|Sarcoma|sarcoma
10582|NCT03507491|Neuroblastoma|neuroblastoma
10583|NCT03507491|Ewing sarcoma|ewing sarcoma
10584|NCT03507491|Osteosarcoma|osteosarcoma
10585|NCT03507491|Rhabdomyosarcoma|rhabdomyosarcoma
10586|NCT03507491|Wilms tumor|wilms tumor
10587|NCT03507491|Hepatoblastoma|hepatoblastoma
10588|NCT03507491|Adolescent and young adult|adolescent and young adult
10589|NCT03507491|Germ cell tumor|germ cell tumor
10590|NCT03507465|letrozole|letrozole
10591|NCT03507465|metronomic|metronomic
10592|NCT03507465|capecitabine|capecitabine
10593|NCT03507465|neoadjuvant|neoadjuvant
10594|NCT03507465|chemotherapy|chemotherapy
10595|NCT03507465|ER+/HER2-|er+/her2-
10596|NCT03507452|Malignant Mesothelioma|malignant mesothelioma
10597|NCT03507452|Malignant Pleural Epithelioid Mesothelioma|malignant pleural epithelioid mesothelioma
10598|NCT03507452|Malignant Peritoneal Epithelioid Mesothelioma|malignant peritoneal epithelioid mesothelioma
10599|NCT03507452|Serous Ovarian Cancer|serous ovarian cancer
10600|NCT03507439|Heart failure with preserved ejection fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
10601|NCT03507439|Heart failure with reduced ejection fraction (HFrEF)|heart failure with reduced ejection fraction (hfref)
10602|NCT03507426|Retrobulbar block|retrobulbar block
10603|NCT03507426|Ketamine|ketamine
10604|NCT03507426|Ocular enucleation|ocular enucleation
10605|NCT03507426|Analgesia|analgesia
10606|NCT03507413|abdominal aortic aneurysm|abdominal aortic aneurysm
10607|NCT03507413|metformin|metformin
10608|NCT03507413|non-diabetic|non-diabetic
10609|NCT03507413|placebo|placebo
10610|NCT03507400|Introvision: mental and emotional self-regulation technique|introvision: mental and emotional self-regulation technique
10611|NCT03507400|Mindfulness, perception technique|mindfulness, perception technique
10612|NCT03507400|Migraine|migraine
10613|NCT03507387|Intramuscular|intramuscular
10614|NCT03507387|Phenylephrine|phenylephrine
10615|NCT03507374|Stroke|stroke
10616|NCT03507374|alirocumab|alirocumab
10617|NCT03507374|Intracranial Atherosclerosis|intracranial atherosclerosis
10618|NCT03507374|Intraplaque Hemorrhage|intraplaque hemorrhage
10619|NCT03507374|atorvastatin|atorvastatin
10620|NCT03507374|praluent|praluent
10621|NCT03507348|Anti-HLA alloantibodies|anti-hla alloantibodies
10622|NCT03507348|Desensitization therapy|desensitization therapy
10623|NCT03507348|Tocilizumab|tocilizumab
10624|NCT03507348|Rituximab|rituximab
10625|NCT03507335|Arrhythmia Atrial|arrhythmia atrial
10626|NCT03507335|heart rate monitoring|heart rate monitoring
10627|NCT03507335|stroke|stroke
10628|NCT03507335|atrial fibrillation|atrial fibrillation
10629|NCT03507322|texturization|texturization
10630|NCT03507322|pregnancy rate|pregnancy rate
10631|NCT03507322|oocyte donation|oocyte donation
10632|NCT03507322|2D ultrasound|2d ultrasound
10633|NCT03507322|3D ultrasound|3d ultrasound
10634|NCT03507322|assisted reproductive technology (ART)|assisted reproductive technology (art)
10635|NCT03507283|Pterygium|pterygium
10636|NCT03507283|double-headed|double-headed
10637|NCT03507283|vertical|vertical
10638|NCT03507270|FABP|fabp
10639|NCT03507270|non ST Segment Elevation Myocardial Infarction|non st segment elevation myocardial infarction
10640|NCT03507257|Cognitively Normal|cognitively normal
10641|NCT03507257|Amyloid|amyloid
10642|NCT03507257|Plaques|plaques
10643|NCT03507257|Neuroimaging|neuroimaging
10644|NCT03507257|Biomarkers|biomarkers
10645|NCT03507257|Cognition Disorder|cognition disorder
10646|NCT03507257|Dementia|dementia
10647|NCT03507257|Tau|tau
10648|NCT03507257|Early Onset Alzheimer's Disease|early onset alzheimer's disease
10649|NCT03507257|Alzheimer's Disease|alzheimer's disease
10650|NCT03507257|Mild Cognitive Impairment|mild cognitive impairment
10651|NCT03507244|Leptomeningeal metastasis|leptomeningeal metastasis
10652|NCT03507244|Malignant solid tumors|malignant solid tumors
10653|NCT03507244|Pemetrexed|pemetrexed
10654|NCT03507244|Intrathecal chemotherapy|intrathecal chemotherapy
10655|NCT03507244|Radiotherapy|radiotherapy
10656|NCT03507231|incentives|incentives
10657|NCT03507231|field study|field study
10658|NCT03507231|vaccination|vaccination
10659|NCT03507218|Obsessive Compulsive Disorder|obsessive compulsive disorder
10660|NCT03507218|Anxiety Disorder|anxiety disorder
10661|NCT03507218|PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated d|pandas (pediatric autoimmune neuropsychiatric disorders associated d
10662|NCT03507218|Eating Disorders|eating disorders
10663|NCT03507205|Everolimus|everolimus
10664|NCT03507205|Sirolimus|sirolimus
10665|NCT03507205|Zotarolimus|zotarolimus
10666|NCT03507205|Biolimus|biolimus
10667|NCT03507205|Drug-eluting stent|drug-eluting stent
10668|NCT03507192|MCI, Alzheimer's disease, muscle relaxation|mci, alzheimer's disease, muscle relaxation
10669|NCT03507166|RC48-ADC|rc48-adc
10670|NCT03507166|HER2|her2
10671|NCT03507153|"Nylon denture base and PEEK partial denture"|"nylon denture base and peek partial denture"
10672|NCT03507140|cirrhosis|cirrhosis
10673|NCT03507140|hepatocellular carcinoma|hepatocellular carcinoma
10674|NCT03507140|Liver transplantation|liver transplantation
10675|NCT03507140|Microbiota|microbiota
10676|NCT03507114|Rumination|rumination
10677|NCT03507114|Cognitive behavioural therapy (CBT)|cognitive behavioural therapy (cbt)
10678|NCT03507114|Depression|depression
10679|NCT03507114|Anxiety|anxiety
10680|NCT03507088|fulvestrant 500 mg|fulvestrant 500 mg
10681|NCT03507088|fluorine-18 fluoroestradiol PET-CT|fluorine-18 fluoroestradiol pet-ct
10682|NCT03507062|pH|ph
10683|NCT03507062|crystalloids|crystalloids
10684|NCT03507036|knee area|knee area
10685|NCT03507036|suprapatellar skin|suprapatellar skin
10686|NCT03507036|aging|aging
10687|NCT03507036|laxity|laxity
10688|NCT03507010|Radiotherapy|radiotherapy
10689|NCT03507010|Pain|pain
10690|NCT03506997|Immune checkpoint inhibitor|immune checkpoint inhibitor
10691|NCT03506997|Pembrolizumab|pembrolizumab
10692|NCT03506971|Young child's development|young child's development
10693|NCT03506971|Home visits|home visits
10694|NCT03506971|Early interactions|early interactions
10695|NCT03506971|attachment|attachment
10696|NCT03506971|parenthood|parenthood
10697|NCT03506932|blood sugar|blood sugar
10698|NCT03506932|insulin|insulin
10699|NCT03506932|peas|peas
10700|NCT03506932|bread|bread
10701|NCT03506932|metabolites|metabolites
10702|NCT03506906|Chronic hypoventilation syndrome|chronic hypoventilation syndrome
10703|NCT03506906|Polysomnography|polysomnography
10704|NCT03506906|Transcutaneous Capnometry|transcutaneous capnometry
10705|NCT03506906|Noninvasive Ventilation|noninvasive ventilation
10706|NCT03506906|home mechanical ventilation|home mechanical ventilation
10707|NCT03506906|Ventilator´s set-up|ventilator´s set-up
10708|NCT03506893|refractory ascite|refractory ascite
10709|NCT03506893|pump system|pump system
10710|NCT03506867|Health Equity|health equity
10711|NCT03506867|Community Based Participatory Action Research|community based participatory action research
10712|NCT03506867|Poverty Reduction|poverty reduction
10713|NCT03506815|Upper Extremity Deep Vein Thrombosis|upper extremity deep vein thrombosis
10714|NCT03506815|Thromboprophylaxis|thromboprophylaxis
10715|NCT03506815|Cancer|cancer
10716|NCT03506815|Randomized Trial|randomized trial
10717|NCT03506763|office hysteroscopy, pain measure|office hysteroscopy, pain measure
10718|NCT03506750|Conbercept|conbercept
10719|NCT03506750|PLGF|plgf
10720|NCT03506724|Hypertension, Pregnancy-induced|hypertension, pregnancy-induced
10721|NCT03506724|Pregnancy Induced Hypertension|pregnancy induced hypertension
10722|NCT03506724|Gestational Hypertension|gestational hypertension
10723|NCT03506724|Transient Hypertension, Pregnancy|transient hypertension, pregnancy
10724|NCT03506724|Pharmacogenetics|pharmacogenetics
10725|NCT03506711|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
10726|NCT03506711|MRI|mri
10727|NCT03506711|Isometric handgrip exercise|isometric handgrip exercise
10728|NCT03506711|Children|children
10729|NCT03506711|Adolescents|adolescents
10730|NCT03506698|Birth weight|birth weight
10731|NCT03506685|dry needling|dry needling
10732|NCT03506685|ACL reconstruction|acl reconstruction
10733|NCT03506685|knee ROM|knee rom
10734|NCT03506685|pain management|pain management
10735|NCT03506685|opioid use|opioid use
10736|NCT03506672|Behavioral and psychological symptoms of dementia|behavioral and psychological symptoms of dementia
10737|NCT03506672|Psychosocial interventions|psychosocial interventions
10738|NCT03506672|Well-being|well-being
10739|NCT03506672|Long-term care facilities|long-term care facilities
10740|NCT03506672|Family and formal caregivers|family and formal caregivers
10741|NCT03506672|Partnership|partnership
10742|NCT03506620|femoroacetabular impingement|femoroacetabular impingement
10743|NCT03506620|hip arthroscopy|hip arthroscopy
10744|NCT03506620|QL nerve block|ql nerve block
10745|NCT03506607|exercise|exercise
10746|NCT03506607|cardiovascular|cardiovascular
10747|NCT03506607|normobaric hypoxia|normobaric hypoxia
10748|NCT03506568|Adherence|adherence
10749|NCT03506568|Medication|medication
10750|NCT03506568|Glaucoma|glaucoma
10751|NCT03506568|Device|device
10752|NCT03506555|Laparoscopy|laparoscopy
10753|NCT03506555|Hasson technique|hasson technique
10754|NCT03506555|Veress needle technique|veress needle technique
10755|NCT03506555|complications|complications
10756|NCT03506529|TEP|tep
10757|NCT03506529|hypermetabolism|hypermetabolism
10758|NCT03506516|alcohol, hangover|alcohol, hangover
10759|NCT03506503|nanofat|nanofat
10760|NCT03506503|hair loss|hair loss
10761|NCT03506503|prp|prp
10762|NCT03506477|skin of color|skin of color
10763|NCT03506477|psoriasis|psoriasis
10764|NCT03506477|Enstilar|enstilar
10765|NCT03506477|skin diseases|skin diseases
10766|NCT03506464|Plantar Fasciitis|plantar fasciitis
10767|NCT03506464|physical therapy|physical therapy
10768|NCT03506464|sonoelastography|sonoelastography
10769|NCT03506451|Financial toxicity|financial toxicity
10770|NCT03506438|critical illness|critical illness
10771|NCT03506438|palliative care|palliative care
10772|NCT03506438|mobile app|mobile app
10773|NCT03506438|psychological distress|psychological distress
10774|NCT03506438|depression|depression
10775|NCT03506438|anxiety|anxiety
10776|NCT03506438|informal caregiver|informal caregiver
10777|NCT03506412|Heart Failure|heart failure
10778|NCT03506412|HFpEF|hfpef
10779|NCT03506412|Entresto™|entresto™
10780|NCT03506412|Neprilysin|neprilysin
10781|NCT03506412|Diastolic Heart Failure|diastolic heart failure
10782|NCT03506386|Real World Evidence , Multiple Myeloma Profile, Brazil|real world evidence , multiple myeloma profile, brazil
10783|NCT03506321|colonoscopy|colonoscopy
10784|NCT03506321|Residual adenoma|residual adenoma
10785|NCT03506321|Recurrent adenoma|recurrent adenoma
10786|NCT03506282|Running biomechanics|running biomechanics
10787|NCT03506282|Vertical loading rate|vertical loading rate
10788|NCT03506282|Music exercise|music exercise
10789|NCT03506282|Gait analysis|gait analysis
10790|NCT03506256|urinary tract infection|urinary tract infection
10791|NCT03506256|Norfloxacin|norfloxacin
10792|NCT03506256|Fluroquinolone|fluroquinolone
10793|NCT03506256|Safety|safety
10794|NCT03506256|Pakistan|pakistan
10795|NCT03506243|IVF, rhFSH|ivf, rhfsh
10796|NCT03506230|Rewards|rewards
10797|NCT03506230|Medication Adherence|medication adherence
10798|NCT03506230|Health Behavior|health behavior
10799|NCT03506230|Diabetes Mellitus|diabetes mellitus
10800|NCT03506230|Copayments|copayments
10801|NCT03506217|mitral valve prolaps,|mitral valve prolaps,
10802|NCT03506217|chorda tendinea,|chorda tendinea,
10803|NCT03506217|cardiac output|cardiac output
10804|NCT03506204|Pelvic floor muscle strength|pelvic floor muscle strength
10805|NCT03506204|Pelvic floor dysfunction|pelvic floor dysfunction
10806|NCT03506204|Postpartum|postpartum
10807|NCT03506204|primipara|primipara
10808|NCT03506191|Stenotrophomonas maltophilia|stenotrophomonas maltophilia
10809|NCT03506191|Pneumonia|pneumonia
10810|NCT03506191|Intensive Care Unit|intensive care unit
10811|NCT03506178|Upper airway|upper airway
10812|NCT03506178|Obstructive sleep apnea|obstructive sleep apnea
10813|NCT03506178|Polysomnography|polysomnography
10814|NCT03506139|Radiotherapy|radiotherapy
10815|NCT03506139|Magnetic Resonance Imaging|magnetic resonance imaging
10816|NCT03506126|amino acid requirement|amino acid requirement
10817|NCT03506126|elderly|elderly
10818|NCT03506126|leucine|leucine
10819|NCT03506126|dietary requirement|dietary requirement
10820|NCT03506113|Gram staining|gram staining
10821|NCT03506113|Antimicrobial therapy|antimicrobial therapy
10822|NCT03506113|Empirical therapy|empirical therapy
10823|NCT03506113|Nosocomial infection|nosocomial infection
10824|NCT03506113|Mechanical ventilation|mechanical ventilation
10825|NCT03506113|Intensive care|intensive care
10826|NCT03506113|Sepsis|sepsis
10827|NCT03506100|Spirometry|spirometry
10828|NCT03506100|swimming|swimming
10829|NCT03506100|water walking|water walking
10830|NCT03506087|Advance Care Planning|advance care planning
10831|NCT03506087|Shared Decision Making|shared decision making
10832|NCT03506074|Obesity|obesity
10833|NCT03506074|Flavor|flavor
10834|NCT03506035|Shared epitope|shared epitope
10835|NCT03506035|HLA-DRB1|hla-drb1
10836|NCT03506035|Citrullinated peptides|citrullinated peptides
10837|NCT03506035|Autoantibodies|autoantibodies
10838|NCT03506022|Sleep apnea syndrome, polysomnography and glucose monitoring continu glycemia (CGMS )|sleep apnea syndrome, polysomnography and glucose monitoring continu glycemia (cgms )
10839|NCT03505983|Prosthetic Limb Design|prosthetic limb design
10840|NCT03505983|Prosthesis Fitting|prosthesis fitting
10841|NCT03505970|Physiological Phenomena|physiological phenomena
10842|NCT03505957|IV Dislodgement|iv dislodgement
10843|NCT03505931|Peripheral artery disease|peripheral artery disease
10844|NCT03505931|femoropopliteal|femoropopliteal
10845|NCT03505931|drug-eluting stent|drug-eluting stent
10846|NCT03505931|restenosis|restenosis
10847|NCT03505892|Ankylosing Spondylitis (AS)|ankylosing spondylitis (as)
10848|NCT03505892|Adalimumab|adalimumab
10849|NCT03505892|Humira|humira
10850|NCT03505879|Next Generation Sequencing|next generation sequencing
10851|NCT03505866|HIV|hiv
10852|NCT03505866|Anti-retroviral therapy|anti-retroviral therapy
10853|NCT03505866|Intervention|intervention
10854|NCT03505866|Mental Health|mental health
10855|NCT03505853|RNAi therapeutic|rnai therapeutic
10856|NCT03505853|Porphyria|porphyria
10857|NCT03505853|Acute Hepatic Porphyria (AHP)|acute hepatic porphyria (ahp)
10858|NCT03505853|Acute Intermittent Porphyria (AIP)|acute intermittent porphyria (aip)
10859|NCT03505827|TECNIS Symfony|tecnis symfony
10860|NCT03505814|post extubation care|post extubation care
10861|NCT03505814|neonatal surgical critical care|neonatal surgical critical care
10862|NCT03505814|oxygen therapy|oxygen therapy
10863|NCT03505814|high nasal flow cannula|high nasal flow cannula
10864|NCT03505775|Hormone replacement|hormone replacement
10865|NCT03505775|Mineralocorticoids|mineralocorticoids
10866|NCT03505775|23Na-magnetic resonance imaging|23na-magnetic resonance imaging
10867|NCT03505775|Tissue sodium content|tissue sodium content
10868|NCT03505723|Noncardiac surgery|noncardiac surgery
10869|NCT03505723|Myocardial injury|myocardial injury
10870|NCT03505723|Perioperative myocardial infarction|perioperative myocardial infarction
10871|NCT03505723|Tranexamic Acid|tranexamic acid
10872|NCT03505723|Hypotension|hypotension
10873|NCT03505723|Hypertension|hypertension
10874|NCT03505710|HER2 over-expression|her2 over-expression
10875|NCT03505710|HER2 mutation|her2 mutation
10876|NCT03505710|Unresectable or metastatic|unresectable or metastatic
10877|NCT03505710|Non-squamous|non-squamous
10878|NCT03505710|NSCLC|nsclc
10879|NCT03505697|rehabilitation|rehabilitation
10880|NCT03505697|exercise|exercise
10881|NCT03505697|maximal inspiratory pressure|maximal inspiratory pressure
10882|NCT03505697|6-minute walk test|6-minute walk test
10883|NCT03505619|home care service|home care service
10884|NCT03505619|reablement service|reablement service
10885|NCT03505619|rehabilitation|rehabilitation
10886|NCT03505606|Amblyopia|amblyopia
10887|NCT03505606|Visual Acuity|visual acuity
10888|NCT03505606|Crowding|crowding
10889|NCT03505554|ALK|alk
10890|NCT03505554|relapsed|relapsed
10891|NCT03505554|lorlatinib|lorlatinib
10892|NCT03505528|Nanoparticle albumin-bound paclitaxel (Abraxane)|nanoparticle albumin-bound paclitaxel (abraxane)
10893|NCT03505528|Phenelzine Sulfate|phenelzine sulfate
10894|NCT03505528|Cancer stem cells|cancer stem cells
10895|NCT03505528|epigenetics|epigenetics
10896|NCT03505528|LSD1|lsd1
10897|NCT03505502|Cesarean Myomectomy|cesarean myomectomy
10898|NCT03505502|Tranexamic Acid|tranexamic acid
10899|NCT03505489|Mannitol|mannitol
10900|NCT03505489|Methacholine|methacholine
10901|NCT03505489|Deep inhalation|deep inhalation
10902|NCT03505489|Tidal breathing|tidal breathing
10903|NCT03505476|Ileus|ileus
10904|NCT03505476|Abdominal surgery|abdominal surgery
10905|NCT03505476|Bowel obstruction|bowel obstruction
10906|NCT03505476|Postoperative Ileus|postoperative ileus
10907|NCT03505463|Spinal cord injury|spinal cord injury
10908|NCT03505463|Biomarkers|biomarkers
10909|NCT03505463|Inflammation|inflammation
10910|NCT03505463|Trauma|trauma
10911|NCT03505450|decision support tools,|decision support tools,
10912|NCT03505437|anxiety disorders|anxiety disorders
10913|NCT03505437|spider phobia|spider phobia
10914|NCT03505437|stress|stress
10915|NCT03505437|exposure therapy|exposure therapy
10916|NCT03505437|generalization|generalization
10917|NCT03505424|Premature Infant|premature infant
10918|NCT03505424|Premature Birth|premature birth
10919|NCT03505424|Smartphone App|smartphone app
10920|NCT03505424|NICU|nicu
10921|NCT03505411|Melatonin|melatonin
10922|NCT03505411|Glutathione|glutathione
10923|NCT03505411|Glutathione peroxidase|glutathione peroxidase
10924|NCT03505411|Malondialdehyde|malondialdehyde
10925|NCT03505411|Isoprostanes|isoprostanes
10926|NCT03505411|anti-ox-LDL|anti-ox-ldl
10927|NCT03505411|Superoxide dismutase|superoxide dismutase
10928|NCT03505411|Glutathione reductase|glutathione reductase
10929|NCT03505411|Interleukin-6|interleukin-6
10930|NCT03505411|C-reactive protein|c-reactive protein
10931|NCT03505411|Autonomic nervous system|autonomic nervous system
10932|NCT03505385|Co-creation|co-creation
10933|NCT03505385|Service-learning methodology|service-learning methodology
10934|NCT03505372|Atypical ductal hyperplasia|atypical ductal hyperplasia
10935|NCT03505372|ADH|adh
10936|NCT03505346|Positron Emission Tomography|positron emission tomography
10937|NCT03505346|nuclear medicine|nuclear medicine
10938|NCT03505346|prognosis|prognosis
10939|NCT03505320|oxaliplatin|oxaliplatin
10940|NCT03505320|fluorouracil|fluorouracil
10941|NCT03505320|IMAB362|imab362
10942|NCT03505320|Gastro-Esophageal Junction cancer|gastro-esophageal junction cancer
10943|NCT03505320|Gastric cancer|gastric cancer
10944|NCT03505294|Multiple Sclerosis|multiple sclerosis
10945|NCT03505294|task-oriented training|task-oriented training
10946|NCT03505294|physical performance|physical performance
10947|NCT03505294|cognition|cognition
10948|NCT03505268|Glycosylated hemoglobin A1c (HbA1c), Telemedicine|glycosylated hemoglobin a1c (hba1c), telemedicine
10949|NCT03505164|Doxorubicin|doxorubicin
10950|NCT03505164|suPAR|supar
10951|NCT03505164|Caridomyopathy|caridomyopathy
10952|NCT03505164|Heart Failure|heart failure
10953|NCT03505164|Breast Cancer|breast cancer
10954|NCT03505138|COPD|copd
10955|NCT03505138|hospitalization|hospitalization
10956|NCT03505138|telemedicine platform|telemedicine platform
10957|NCT03505112|Goal-directed therapy|goal-directed therapy
10958|NCT03505112|stroke volume index|stroke volume index
10959|NCT03505099|gene therapy|gene therapy
10960|NCT03505047|second trimester medical abortion|second trimester medical abortion
10961|NCT03505047|Immediate versus delayed insertion|immediate versus delayed insertion
10962|NCT03505047|copper intrauterine device|copper intrauterine device
10963|NCT03505034|Spinal cord injury，Umbilical Cord Mesenchymal Stem Cells|spinal cord injury，umbilical cord mesenchymal stem cells
10964|NCT03505008|Methotrexate|methotrexate
10965|NCT03505008|Adalimumab|adalimumab
10966|NCT03505008|Autoimmune Disease|autoimmune disease
10967|NCT03505008|Connective Tissue Diseases|connective tissue diseases
10968|NCT03505008|Rheumatic Disease|rheumatic disease
10969|NCT03505008|Rheumatoid Arthritis|rheumatoid arthritis
10970|NCT03504995|Prostate|prostate
10971|NCT03504995|Irreversible Electroporation|irreversible electroporation
10972|NCT03504995|Prostate Cancer|prostate cancer
10973|NCT03504982|Vericiguat|vericiguat
10974|NCT03504982|Stable CAD|stable cad
10976|NCT03504969|umbilical cord|umbilical cord
10977|NCT03504956|MRI technique|mri technique
10978|NCT03504956|High Resolution MRI Technique|high resolution mri technique
10979|NCT03504943|Exercise|exercise
10980|NCT03504943|Hemodialysis|hemodialysis
10981|NCT03504943|Intradialytic hypotension|intradialytic hypotension
10982|NCT03504930|Surgical|surgical
10983|NCT03504930|Ileal pouch-anal anastomosis|ileal pouch-anal anastomosis
10984|NCT03504904|Chronic pain|chronic pain
10985|NCT03504904|Self-criticism|self-criticism
10986|NCT03504904|Internet-based treatment|internet-based treatment
10987|NCT03504904|ACT|act
10988|NCT03504904|CFT|cft
10989|NCT03504904|Guided self-help|guided self-help
10990|NCT03504904|Acceptance|acceptance
10991|NCT03504904|Compassion|compassion
10992|NCT03504865|Exparel|exparel
10993|NCT03504865|Bupivacaine|bupivacaine
10994|NCT03504852|psoriasis|psoriasis
10995|NCT03504852|weight|weight
10996|NCT03504852|secukinumab|secukinumab
10997|NCT03504839|defibrillator|defibrillator
10998|NCT03504826|adaptive robotics|adaptive robotics
10999|NCT03504826|locomotor training|locomotor training
11000|NCT03504826|Spinal Cord diseases|spinal cord diseases
11001|NCT03504826|walking rehabilitation|walking rehabilitation
11002|NCT03504826|Spinal Cord Injury|spinal cord injury
11003|NCT03504813|Elderly|elderly
11004|NCT03504813|Quality of life|quality of life
11005|NCT03504813|Wearables|wearables
11006|NCT03504813|Urinary incontinence|urinary incontinence
11007|NCT03504813|Insomnia|insomnia
11008|NCT03504813|Risk of falls|risk of falls
11009|NCT03504800|OCT|oct
11010|NCT03504800|Keratoconus|keratoconus
11011|NCT03504787|cerebral palsy|cerebral palsy
11012|NCT03504787|upper extremity|upper extremity
11013|NCT03504787|selective motor control|selective motor control
11014|NCT03504748|deep repetitive transcranial magnetic stimulation|deep repetitive transcranial magnetic stimulation
11015|NCT03504748|chronic pain|chronic pain
11016|NCT03504748|parkinson|parkinson
11017|NCT03504748|treatment|treatment
11018|NCT03504748|non-motor symptom|non-motor symptom
11019|NCT03504670|Labor induction|labor induction
11020|NCT03504670|Cesarean delivery|cesarean delivery
11021|NCT03504670|Preterm labor induction|preterm labor induction
11022|NCT03504670|Duration of labor induction|duration of labor induction
11023|NCT03504657|Vertebral Artery Stenosis|vertebral artery stenosis
11024|NCT03504657|Drug-coated balloon angioplasty|drug-coated balloon angioplasty
11025|NCT03504657|Stenting|stenting
11026|NCT03504631|tamoxifen|tamoxifen
11027|NCT03504631|breast cancer|breast cancer
11028|NCT03504631|Z-endoxifen|z-endoxifen
11029|NCT03504579|rt-fMRI|rt-fmri
11030|NCT03504579|MRI|mri
11031|NCT03504579|schizophrenia|schizophrenia
11032|NCT03504579|auditory hallucinations|auditory hallucinations
11033|NCT03504579|neurofeedback|neurofeedback
11034|NCT03504540|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
11035|NCT03504540|Age Related Macular Degeneration|age related macular degeneration
11036|NCT03504540|"Pseudo-drusen-like deposits"|"pseudo-drusen-like deposits"
11037|NCT03504527|ICS|ics
11038|NCT03504527|LABA|laba
11039|NCT03504527|LAMA|lama
11040|NCT03504527|therapy|therapy
11041|NCT03504527|asthma|asthma
11042|NCT03504527|COPD|copd
11043|NCT03504527|ACO|aco
11044|NCT03504514|non invasive ventilation|non invasive ventilation
11045|NCT03504514|invasive ventilation|invasive ventilation
11046|NCT03504514|neuromuscular disorder|neuromuscular disorder
11047|NCT03504514|phonation|phonation
11048|NCT03504514|speech|speech
11049|NCT03504501|RASopathies, neurofibromatosis type 1, noonan syndrome, synaptic plasticity, transcranial magnetic stimulation|rasopathies, neurofibromatosis type 1, noonan syndrome, synaptic plasticity, transcranial magnetic stimulation
11050|NCT03504462|Foot surgery|foot surgery
11051|NCT03504462|Regional Anesthesia|regional anesthesia
11052|NCT03504462|Regional Analgesia|regional analgesia
11053|NCT03504462|Ultrasound|ultrasound
11054|NCT03504462|Distal block|distal block
11055|NCT03504462|Plantar nerve block|plantar nerve block
11056|NCT03504397|HER2|her2
11057|NCT03504397|IMAB362|imab362
11058|NCT03504397|leucovorin|leucovorin
11059|NCT03504397|fluorouracil|fluorouracil
11060|NCT03504397|Gastric cancer|gastric cancer
11061|NCT03504397|oxaliplatin|oxaliplatin
11062|NCT03504397|adenocarcinoma|adenocarcinoma
11063|NCT03504397|Gastro-Esophageal Junction cancer|gastro-esophageal junction cancer
11064|NCT03504397|HER2 Negative mFOLFOX6|her2 negative mfolfox6
11065|NCT03504371|oesophageal surgeries-epidural-erector block|oesophageal surgeries-epidural-erector block
11066|NCT03504358|surgery|surgery
11067|NCT03504358|scoring system|scoring system
11068|NCT03504358|hepatocellular carcinoma|hepatocellular carcinoma
11069|NCT03504358|homogeneity and discriminatory ability|homogeneity and discriminatory ability
11070|NCT03504358|survival|survival
11071|NCT03504332|immature teeth, revascularization|immature teeth, revascularization
11072|NCT03504319|exercise|exercise
11073|NCT03504319|inflammation|inflammation
11074|NCT03504319|metabolic inflexibility|metabolic inflexibility
11075|NCT03504319|insulin resistance|insulin resistance
11076|NCT03504319|neonatal adiposity|neonatal adiposity
11077|NCT03504293|Endosonography|endosonography
11078|NCT03504293|Endoscopic retrograde choledochography|endoscopic retrograde choledochography
11079|NCT03504280|hypovitaminosis D|hypovitaminosis d
11080|NCT03504280|cholecalciferol|cholecalciferol
11081|NCT03504280|mehadose|mehadose
11082|NCT03504267|physical activity|physical activity
11083|NCT03504267|exercise|exercise
11084|NCT03504267|patient-provider communication|patient-provider communication
11085|NCT03504254|cervical spondylotic myelopathy|cervical spondylotic myelopathy
11086|NCT03504254|diffusion tensor imaging|diffusion tensor imaging
11087|NCT03504254|functional magnetic resonance imaging|functional magnetic resonance imaging
11088|NCT03504241|mesenchymal stromal cells (MSCs)|mesenchymal stromal cells (mscs)
11089|NCT03504241|anti-rejection drugs|anti-rejection drugs
11090|NCT03504241|operational tolerance|operational tolerance
11091|NCT03504215|extremely preterm|extremely preterm
11092|NCT03504215|young adults|young adults
11093|NCT03504215|term|term
11094|NCT03504215|exercise capacity|exercise capacity
11095|NCT03504215|pulmonary function|pulmonary function
11096|NCT03504215|muscle oxygenation|muscle oxygenation
11097|NCT03504189|Fetal monitoring, Prenatal monitoring|fetal monitoring, prenatal monitoring
11098|NCT03504163|Pembrolizumab (MK-3475)|pembrolizumab (mk-3475)
11099|NCT03504163|17-602|17-602
11100|NCT03504137|mHealth|mhealth
11101|NCT03504137|kidney transplantation|kidney transplantation
11102|NCT03504137|medication adherence|medication adherence
11103|NCT03504137|video directly observed therapy|video directly observed therapy
11104|NCT03504098|One-carbon metabolism|one-carbon metabolism
11105|NCT03504098|Folate|folate
11106|NCT03504098|Choline|choline
11107|NCT03504098|metabolomic marker|metabolomic marker
11108|NCT03504098|Cancer risk|cancer risk
11109|NCT03504085|Chronic Low Back Pain|chronic low back pain
11110|NCT03504085|CLBP|clbp
11111|NCT03504085|Chronic Neck Pain|chronic neck pain
11112|NCT03504085|CNP|cnp
11113|NCT03504085|Chronic Pain|chronic pain
11114|NCT03504085|Military|military
11115|NCT03504085|Active Duty|active duty
11116|NCT03504085|Yoga|yoga
11117|NCT03504085|Mindbody|mindbody
11118|NCT03504072|Etanercept|etanercept
11119|NCT03504072|Infection|infection
11120|NCT03504072|Tofacitinib|tofacitinib
11121|NCT03504072|Tuberculosis|tuberculosis
11122|NCT03504072|Spondyloarthritis|spondyloarthritis
11123|NCT03504059|Obesity|obesity
11124|NCT03504059|Cardiovascular Diseases|cardiovascular diseases
11125|NCT03504059|Diabetes|diabetes
11126|NCT03504059|Adolescents|adolescents
11127|NCT03504059|Physical Activity|physical activity
11128|NCT03504059|Diet|diet
11129|NCT03504059|School-Based|school-based
11130|NCT03504046|artificial pancreas|artificial pancreas
11131|NCT03504046|hyperglycemia|hyperglycemia
11132|NCT03504046|hypoglycemia|hypoglycemia
11133|NCT03504033|Xenon|xenon
11134|NCT03504033|Liver resection|liver resection
11135|NCT03504033|post-operative liver failure|post-operative liver failure
11136|NCT03504033|anesthetics, inhalation|anesthetics, inhalation
11137|NCT03504033|Desflurane|desflurane
11138|NCT03504033|Randomized controlled trail|randomized controlled trail
11139|NCT03504033|RCT|rct
11140|NCT03504007|Deep Vein Thrombosis|deep vein thrombosis
11141|NCT03504007|Pulmonary Embolism|pulmonary embolism
11142|NCT03504007|Apixaban|apixaban
11143|NCT03504007|Rivaroxaban|rivaroxaban
11144|NCT03504007|Dabigatran|dabigatran
11145|NCT03504007|Edoxaban|edoxaban
11146|NCT03503981|Process-outcome study|process-outcome study
11147|NCT03503981|Mechanisms of change|mechanisms of change
11148|NCT03503916|Accidental fall|accidental fall
11149|NCT03503916|Postural Balance|postural balance
11150|NCT03503903|Wet cupping therapy|wet cupping therapy
11151|NCT03503903|antioxidant capacity|antioxidant capacity
11152|NCT03503890|Expanded Access, Pre-approval Access, Compassionate Use, Special Access Program, Named Patient Basis, Special Access Scheme.|expanded access, pre-approval access, compassionate use, special access program, named patient basis, special access scheme.
11153|NCT03503864|Neuroblastoma|neuroblastoma
11154|NCT03503864|Arsenic Trioxide|arsenic trioxide
11155|NCT03503864|Children|children
11156|NCT03503851|Mitral Regurgitation|mitral regurgitation
11157|NCT03503851|transcatheter mitral valve repair|transcatheter mitral valve repair
11158|NCT03503851|MitraClip|mitraclip
11159|NCT03503812|Randomized clinical trial|randomized clinical trial
11160|NCT03503812|Public Health Intervention|public health intervention
11161|NCT03503812|Behavioral Intervention|behavioral intervention
11162|NCT03503812|Exposure-Reduction Approaches|exposure-reduction approaches
11163|NCT03503812|Desert dust storm events|desert dust storm events
11164|NCT03503812|Climate change|climate change
11165|NCT03503812|Asthma in children|asthma in children
11166|NCT03503812|Atrial Fibrillation|atrial fibrillation
11167|NCT03503812|Air pollution|air pollution
11168|NCT03503799|breast cancer|breast cancer
11169|NCT03503799|EndoPredict®|endopredict®
11170|NCT03503799|endocrine therapy|endocrine therapy
11171|NCT03503786|PD-L1 Expression|pd-l1 expression
11172|NCT03503786|advanced endometrial cancer|advanced endometrial cancer
11173|NCT03503786|recurrent endometrial cancer|recurrent endometrial cancer
11174|NCT03503786|Patient reported outcomes|patient reported outcomes
11175|NCT03503773|Renal Denervation|renal denervation
11176|NCT03503773|Neurolysis|neurolysis
11177|NCT03503760|Extremely low magnetic field (ELF)|extremely low magnetic field (elf)
11178|NCT03503760|Fibromyalgia impact questionnaire (FIQ)|fibromyalgia impact questionnaire (fiq)
11179|NCT03503760|Pittsburgh Sleep Quality Index (PSQI)|pittsburgh sleep quality index (psqi)
11180|NCT03503760|Short Form-12 of Physical and Mental Health Summary (SF-12)|short form-12 of physical and mental health summary (sf-12)
11181|NCT03503760|"LIMFA Therapy® machine from Eywa Srl system"|"limfa therapy® machine from eywa srl system"
11182|NCT03503747|type 1 diabetes|type 1 diabetes
11183|NCT03503747|Infants|infants
11184|NCT03503747|INGR1D|ingr1d
11185|NCT03503721|BipolEP|bipolep
11186|NCT03503721|TURP|turp
11187|NCT03503695|auricular acupuncture|auricular acupuncture
11188|NCT03503695|battlefield acupuncture|battlefield acupuncture
11189|NCT03503695|insomnia|insomnia
11190|NCT03503695|chronic pain|chronic pain
11191|NCT03503695|randomized|randomized
11192|NCT03503682|Short Course Radiotherapy|short course radiotherapy
11193|NCT03503682|Complicated Bone Metastases|complicated bone metastases
11194|NCT03503669|Memory impairment|memory impairment
11195|NCT03503669|Meditation|meditation
11196|NCT03503669|Yoga|yoga
11197|NCT03503669|Memory Training|memory training
11198|NCT03503669|Mild Cognitive Impairment|mild cognitive impairment
11199|NCT03503669|MCI|mci
11200|NCT03503669|Geriatric|geriatric
11201|NCT03503669|fMRI|fmri
11202|NCT03503669|Alzheimer's disease|alzheimer's disease
11203|NCT03503669|Cardiovascular risk|cardiovascular risk
11204|NCT03503643|prostate cancer|prostate cancer
11205|NCT03503643|cryoablation|cryoablation
11206|NCT03503630|Locally advanced rectal cancer|locally advanced rectal cancer
11207|NCT03503630|Immunotherapy|immunotherapy
11208|NCT03503630|Short course radiation|short course radiation
11209|NCT03503630|Folfox|folfox
11210|NCT03503630|Response rate|response rate
11212|NCT03503604|VEGF|vegf
11213|NCT03503604|antibody|antibody
11214|NCT03503604|phase1|phase1
11215|NCT03503591|tympanostomy|tympanostomy
11216|NCT03503591|myringotomy|myringotomy
11217|NCT03503591|otitis media|otitis media
11218|NCT03503591|ear tubes|ear tubes
11219|NCT03503591|ear infection|ear infection
11220|NCT03503565|one-lung ventilation|one-lung ventilation
11221|NCT03503565|thoracic surgery|thoracic surgery
11222|NCT03503565|atelectasis|atelectasis
11223|NCT03503565|postoperative pulmonary complication|postoperative pulmonary complication
11224|NCT03503500|Breastfeeding|breastfeeding
11225|NCT03503500|Laid-back position|laid-back position
11226|NCT03503500|Breast problems|breast problems
11227|NCT03503500|Exclusive breastfeeding|exclusive breastfeeding
11228|NCT03503461|Calcineurin inhibitors|calcineurin inhibitors
11229|NCT03503461|hypertension|hypertension
11230|NCT03503461|kidney transplant|kidney transplant
11231|NCT03503461|acidosis|acidosis
11232|NCT03503461|Gordon syndrome|gordon syndrome
11233|NCT03503448|surgically assisted rapid maxillary expansion|surgically assisted rapid maxillary expansion
11234|NCT03503448|surgically assisted rapid palatal expansion|surgically assisted rapid palatal expansion
11235|NCT03503448|Malocclusion|malocclusion
11236|NCT03503435|Heart Rate Variability|heart rate variability
11237|NCT03503435|Art Therapy|art therapy
11238|NCT03503435|Total Laryngectomy|total laryngectomy
11239|NCT03503396|drunk driving|drunk driving
11240|NCT03503396|alcohol impaired driving|alcohol impaired driving
11241|NCT03503396|drinking and driving|drinking and driving
11242|NCT03503396|ambulatory assessment|ambulatory assessment
11243|NCT03503383|Hypertension with pregnancy|hypertension with pregnancy
11244|NCT03503383|anxiety|anxiety
11245|NCT03503383|depression|depression
11246|NCT03503383|preeclampsia|preeclampsia
11247|NCT03503383|mental health|mental health
11248|NCT03503370|topical chlorhexidine|topical chlorhexidine
11249|NCT03503370|prevention|prevention
11250|NCT03503370|clinical trial|clinical trial
11251|NCT03503357|Consciousness|consciousness
11252|NCT03503357|Electroencephalography|electroencephalography
11253|NCT03503357|Anesthesia|anesthesia
11254|NCT03503305|Adipose-derived stem cells|adipose-derived stem cells
11255|NCT03503305|osteoarthritis|osteoarthritis
11256|NCT03503292|Pharmacogenetics|pharmacogenetics
11257|NCT03503292|CYP2D6|cyp2d6
11258|NCT03503292|Ondansetron|ondansetron
11259|NCT03503292|Granisetron|granisetron
11260|NCT03503292|Bariatric surgery|bariatric surgery
11261|NCT03503266|Mass Balance Study with MT-7117|mass balance study with mt-7117
11262|NCT03503240|Quality of Life|quality of life
11263|NCT03503240|survey|survey
11264|NCT03503240|18-168|18-168
11265|NCT03503214|Acid-base equilibrium|acid-base equilibrium
11266|NCT03503214|Stewart's approach|stewart's approach
11267|NCT03503214|In vitro study|in vitro study
11268|NCT03503214|Respiratory acid-base derangements|respiratory acid-base derangements
11269|NCT03503162|bowel prepartion|bowel prepartion
11270|NCT03503136|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
11271|NCT03503136|Induction chemotherapy|induction chemotherapy
11272|NCT03503136|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
11273|NCT03503136|Nedaplatin|nedaplatin
11274|NCT03503136|Capecitabine|capecitabine
11275|NCT03503097|Prostate cancer|prostate cancer
11276|NCT03503097|Genetic testing|genetic testing
11277|NCT03503097|Cancer risk|cancer risk
11278|NCT03503097|BRCA1|brca1
11279|NCT03503097|BRCA2|brca2
11280|NCT03503097|Metastatic|metastatic
11281|NCT03503084|Tai Chi Chuan|tai chi chuan
11282|NCT03503084|insulin resistance|insulin resistance
11283|NCT03503084|cholesterol|cholesterol
11284|NCT03503084|endothelin-1|endothelin-1
11285|NCT03503058|Plasmodium falciparum|plasmodium falciparum
11286|NCT03503058|Sporozoites|sporozoites
11287|NCT03503058|PfSPZ|pfspz
11288|NCT03503045|Diabetes Mellitus|diabetes mellitus
11289|NCT03503045|Polypharmacy|polypharmacy
11290|NCT03503045|Overtreatment|overtreatment
11291|NCT03503045|Undertreatment|undertreatment
11292|NCT03503032|Extracardiac Fontan|extracardiac fontan
11293|NCT03503032|Total cavo-pulmonary connection|total cavo-pulmonary connection
11294|NCT03503032|Fenestrated|fenestrated
11295|NCT03503032|Congenital heart defects|congenital heart defects
11296|NCT03503032|Pediatrics|pediatrics
11297|NCT03502993|children|children
11298|NCT03502980|Peripherally Inserted Central Catheter Line Insertion|peripherally inserted central catheter line insertion
11299|NCT03502980|Catheterization, Peripheral Venous|catheterization, peripheral venous
11300|NCT03502967|Traumatic Brain Injury|traumatic brain injury
11301|NCT03502967|TBI|tbi
11302|NCT03502915|breech presentation|breech presentation
11303|NCT03502915|nitrous oxide|nitrous oxide
11304|NCT03502915|analgesia|analgesia
11305|NCT03502915|pregnancy|pregnancy
11306|NCT03502889|Total Knee Arthroplasty|total knee arthroplasty
11307|NCT03502889|SPANK Block|spank block
11308|NCT03502889|Adductor Canal Block|adductor canal block
11309|NCT03502889|Regional Anesthesia|regional anesthesia
11310|NCT03502837|ERP;DOC;auditory|erp;doc;auditory
11311|NCT03502824|Chronic wounds|chronic wounds
11312|NCT03502824|PHMB|phmb
11313|NCT03502824|Pressure Ulcer|pressure ulcer
11314|NCT03502824|Wound Management|wound management
11315|NCT03502824|Collagen|collagen
11316|NCT03502824|Stage II|stage ii
11317|NCT03502824|Stage III|stage iii
11318|NCT03502824|Stage IV|stage iv
11319|NCT03502824|Pressure Injury|pressure injury
11320|NCT03502811|MitraClip|mitraclip
11321|NCT03502811|MitraClip NTR|mitraclip ntr
11322|NCT03502811|MitraClip XTR|mitraclip xtr
11323|NCT03502811|Mitral Regurgitation|mitral regurgitation
11324|NCT03502759|SUDEP|sudep
11325|NCT03502759|Epilepsy|epilepsy
11326|NCT03502681|Cisplatin-Ineligible|cisplatin-ineligible
11327|NCT03502681|Avelumab|avelumab
11328|NCT03502681|PD-L1 Monoclonal Antibody|pd-l1 monoclonal antibody
11329|NCT03502681|Eribulin Mesylate|eribulin mesylate
11330|NCT03502668|low risk myelodysplastic syndromes, MDS, ASTX727|low risk myelodysplastic syndromes, mds, astx727
11331|NCT03502655|Pain|pain
11332|NCT03502655|Peripheral intravenous catheter|peripheral intravenous catheter
11333|NCT03502655|Peripheral catheterization|peripheral catheterization
11334|NCT03502655|Communication|communication
11335|NCT03502655|Emergency Department|emergency department
11336|NCT03502642|Ropivacaine|ropivacaine
11337|NCT03502642|wound infusion|wound infusion
11338|NCT03502642|analgesia|analgesia
11339|NCT03502642|cesarean|cesarean
11340|NCT03502642|intrathecal morphine|intrathecal morphine
11341|NCT03502642|randomized controlled trial|randomized controlled trial
11342|NCT03502564|Posttraumatic stress disorder|posttraumatic stress disorder
11343|NCT03502564|Eating disorders|eating disorders
11344|NCT03502564|Cognitive behavior therapy|cognitive behavior therapy
11345|NCT03502564|Cognitive processing therapy|cognitive processing therapy
11346|NCT03502564|Randomized controlled trial|randomized controlled trial
11347|NCT03502551|ketamine|ketamine
11348|NCT03502551|suicide|suicide
11349|NCT03502512|Breast reconstruction|breast reconstruction
11350|NCT03502512|REVOLVE Tissue Process|revolve tissue process
11351|NCT03502512|PureGraft Tissue Process|puregraft tissue process
11352|NCT03502512|Questionnaires|questionnaires
11353|NCT03502512|Surveys|surveys
11354|NCT03502473|fat flanks|fat flanks
11355|NCT03502460|Lung ultrasonography|lung ultrasonography
11356|NCT03502460|fluid administration|fluid administration
11357|NCT03502460|limitation|limitation
11358|NCT03502460|stroke volume variation|stroke volume variation
11359|NCT03502460|esophageal Doppler|esophageal doppler
11360|NCT03502421|Ketamine|ketamine
11361|NCT03502343|Pancreatic cancer|pancreatic cancer
11362|NCT03502343|Metastatic|metastatic
11363|NCT03502343|Modified|modified
11364|NCT03502343|Gemcitabine|gemcitabine
11365|NCT03502343|nab-Paclitaxel|nab-paclitaxel
11366|NCT03502317|Prehabilitation|prehabilitation
11367|NCT03502317|Gastrointestinal Cancer|gastrointestinal cancer
11368|NCT03502317|Physical Activity|physical activity
11369|NCT03502317|Exercise|exercise
11370|NCT03502317|Surgery|surgery
11371|NCT03502304|Metabolic syndrome|metabolic syndrome
11372|NCT03502304|Obesity|obesity
11373|NCT03502291|Human challenge models|human challenge models
11374|NCT03502291|Immunity|immunity
11375|NCT03502291|Streptococcus pneumoniae|streptococcus pneumoniae
11376|NCT03502291|Live Attenuated Influenza Vaccine|live attenuated influenza vaccine
11377|NCT03502278|refugee|refugee
11378|NCT03502252|early childhood development|early childhood development
11379|NCT03502252|social and emotional development|social and emotional development
11380|NCT03502252|secure parenting relationships|secure parenting relationships
11381|NCT03502213|Prostate Cancer|prostate cancer
11382|NCT03502213|Localized Prostate Cancer|localized prostate cancer
11383|NCT03502213|Low Risk Prostate Cancer|low risk prostate cancer
11384|NCT03502213|Active Surveillance|active surveillance
11385|NCT03502213|Active Monitoring|active monitoring
11386|NCT03502213|OncotypeDX GPS|oncotypedx gps
11387|NCT03502213|Genomic Prostate Score|genomic prostate score
11388|NCT03502213|Genomic Test|genomic test
11389|NCT03502213|Molecular Test|molecular test
11390|NCT03502122|stroke|stroke
11391|NCT03502122|rehabilitation|rehabilitation
11392|NCT03502109|Medication review|medication review
11393|NCT03502109|Pharmacist|pharmacist
11394|NCT03502109|Medication therapy management|medication therapy management
11395|NCT03502109|Cardiovascular diseases|cardiovascular diseases
11396|NCT03502109|Economics|economics
11397|NCT03502109|Elderly|elderly
11398|NCT03502109|Primary Care|primary care
11399|NCT03502096|portion size|portion size
11400|NCT03502096|food intake|food intake
11401|NCT03502096|energy intake|energy intake
11402|NCT03502096|food choice|food choice
11403|NCT03502070|CF, Human Factors, TOBI® Podhaler™, user interface, IFU|cf, human factors, tobi® podhaler™, user interface, ifu
11404|NCT03502044|Myalgic Encephalomyelitis|myalgic encephalomyelitis
11405|NCT03502044|Chronic Fatigue Syndrome|chronic fatigue syndrome
11406|NCT03502044|Kinetic Oscillatory Stimulation in nasal cavity|kinetic oscillatory stimulation in nasal cavity
11407|NCT03502018|Exparel|exparel
11408|NCT03502018|Bupivacaine|bupivacaine
11409|NCT03502018|Intracapsular Fracture of the Femur|intracapsular fracture of the femur
11410|NCT03502018|Femoral Neck Fracture|femoral neck fracture
11411|NCT03502018|Hip Hemiarthroplasty|hip hemiarthroplasty
11412|NCT03501992|Papillomavirus vaccines|papillomavirus vaccines
11413|NCT03501992|Vaccination|vaccination
11414|NCT03501992|Patient acceptance of health care|patient acceptance of health care
11415|NCT03501992|Child|child
11416|NCT03501992|Parents|parents
11417|NCT03501992|Primary health care|primary health care
11418|NCT03501992|Health personnel|health personnel
11419|NCT03501992|Primary prevention|primary prevention
11420|NCT03501992|Neoplasms|neoplasms
11421|NCT03501979|HER2+|her2+
11422|NCT03501979|metastatic breast cancer|metastatic breast cancer
11423|NCT03501979|leptomeningeal disease|leptomeningeal disease
11424|NCT03501979|tucatinib|tucatinib
11425|NCT03501979|trastuzumab|trastuzumab
11426|NCT03501979|capecitabine|capecitabine
11427|NCT03501966|headache|headache
11428|NCT03501966|idiopathic intracranial hypertension (IIH)|idiopathic intracranial hypertension (iih)
11429|NCT03501966|shunt|shunt
11430|NCT03501966|fenestration|fenestration
11431|NCT03501966|acetazolamide|acetazolamide
11432|NCT03501966|visual loss|visual loss
11433|NCT03501966|diamox|diamox
11434|NCT03501953|Cognitive Change|cognitive change
11435|NCT03501953|Physical Activity|physical activity
11436|NCT03501953|Environmental Exposure|environmental exposure
11437|NCT03501953|Health Behavior|health behavior
11438|NCT03501927|Ultrasound|ultrasound
11439|NCT03501927|FOCUS|focus
11440|NCT03501927|Surgery|surgery
11441|NCT03501927|Anesthesia|anesthesia
11442|NCT03501914|Care givers|care givers
11443|NCT03501914|Adults|adults
11444|NCT03501914|Intellectual Disability|intellectual disability
11445|NCT03501914|Mindfulness|mindfulness
11446|NCT03501901|ESBL-producing enterobacteria|esbl-producing enterobacteria
11447|NCT03501901|hospital- and community-acquired urinary tract infections|hospital- and community-acquired urinary tract infections
11448|NCT03501888|Acceptance and Commitment Therapy|acceptance and commitment therapy
11449|NCT03501888|ACT|act
11450|NCT03501888|Cognitive Behavior Therapy|cognitive behavior therapy
11451|NCT03501888|CBT|cbt
11452|NCT03501888|Schizophrenia|schizophrenia
11453|NCT03501888|Psychoses|psychoses
11454|NCT03501862|Mindfulness|mindfulness
11455|NCT03501862|Cognitive therapy|cognitive therapy
11456|NCT03501849|Cancer prevention|cancer prevention
11457|NCT03501849|Cancer detection|cancer detection
11458|NCT03501849|Colonoscopy|colonoscopy
11459|NCT03501849|Polypectomy|polypectomy
11460|NCT03501849|Cold Snare|cold snare
11461|NCT03501849|Optivista|optivista
11462|NCT03501771|Acupuncture|acupuncture
11463|NCT03501771|Back pain|back pain
11464|NCT03501771|Low Back Pain|low back pain
11465|NCT03501771|Lumbago|lumbago
11466|NCT03501771|pulse diagnosis|pulse diagnosis
11467|NCT03501771|radial pressure pulse|radial pressure pulse
11468|NCT03501758|ulcerative colitis|ulcerative colitis
11469|NCT03501758|ultrasound|ultrasound
11470|NCT03501758|remission|remission
11471|NCT03501758|relapse|relapse
11472|NCT03501719|HIV|hiv
11473|NCT03501719|inflammation|inflammation
11474|NCT03501719|antiretroviral therapy|antiretroviral therapy
11475|NCT03501719|cohort studies|cohort studies
11476|NCT03501719|mortality|mortality
11477|NCT03501719|non-AIDS events|non-aids events
11478|NCT03501706|intertemporal tradeoffs|intertemporal tradeoffs
11479|NCT03501706|delayed gratification|delayed gratification
11480|NCT03501706|executive functioning|executive functioning
11481|NCT03501706|delay discounting|delay discounting
11482|NCT03501706|working memory|working memory
11483|NCT03501680|hyperlipidaemic pancreatitis|hyperlipidaemic pancreatitis
11484|NCT03501680|Plasmapheresis|plasmapheresis
11485|NCT03501680|insulin|insulin
11486|NCT03501654|Lenses, Intraocular|lenses, intraocular
11487|NCT03501641|cognitive load|cognitive load
11488|NCT03501641|competence|competence
11489|NCT03501641|heart rate variation|heart rate variation
11490|NCT03501641|learning|learning
11491|NCT03501641|otolaryngology|otolaryngology
11492|NCT03501641|video|video
11493|NCT03501641|virtual reality|virtual reality
11494|NCT03501615|Early Access, leukemia, hairy cell, Moxetumomab Pasudotox, PNA, Purine analog, BRAF Inhibitor, rituximab, Pseudomonas-immunotoxin naïve|early access, leukemia, hairy cell, moxetumomab pasudotox, pna, purine analog, braf inhibitor, rituximab, pseudomonas-immunotoxin naïve
11495|NCT03501602|aintree, LMA protector; I-gel LMA, Fiberoptic Bronchoscope|aintree, lma protector; i-gel lma, fiberoptic bronchoscope
11496|NCT03501563|hypotensive anesthesia|hypotensive anesthesia
11497|NCT03501563|thiol / disulfide|thiol / disulfide
11498|NCT03501563|oxidative stress markers|oxidative stress markers
11499|NCT03501563|septoplasty|septoplasty
11500|NCT03501550|HCV|hcv
11501|NCT03501550|GT1|gt1
11502|NCT03501511|Diabetes MellitusType1;Fasting;Health Education;Hypoglycemia|diabetes mellitustype1;fasting;health education;hypoglycemia
11503|NCT03501498|Intestinal Transit, Bile Salts, Gut Bacteria, Volatile Organic Compounds|intestinal transit, bile salts, gut bacteria, volatile organic compounds
11504|NCT03501472|pictorial warning labels|pictorial warning labels
11505|NCT03501472|risk knowledge|risk knowledge
11506|NCT03501472|emotion|emotion
11507|NCT03501472|memory|memory
11508|NCT03501472|risk perceptions|risk perceptions
11509|NCT03501472|quit intentions|quit intentions
11510|NCT03501472|numeracy|numeracy
11511|NCT03501446|PEEP optimization|peep optimization
11512|NCT03501446|Lung volumes|lung volumes
11513|NCT03501433|postpandial|postpandial
11514|NCT03501433|lipemia|lipemia
11515|NCT03501433|microvascular|microvascular
11516|NCT03501420|Belimumab|belimumab
11517|NCT03501420|Disease Specific Programme|disease specific programme
11518|NCT03501420|rheumatologist|rheumatologist
11519|NCT03501420|Benlysta|benlysta
11520|NCT03501420|Primary Sjögren's Syndrome|primary sjögren's syndrome
11521|NCT03501420|Adelphi pSS DSP|adelphi pss dsp
11522|NCT03501394|Magnetic Resonance Imaging|magnetic resonance imaging
11523|NCT03501394|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
11524|NCT03501368|cutaneous|cutaneous
11525|NCT03501368|refractory|refractory
11526|NCT03501368|melanoma|melanoma
11527|NCT03501368|ceritinib|ceritinib
11528|NCT03501355|pacemaker|pacemaker
11529|NCT03501355|inspiratory muscle training|inspiratory muscle training
11530|NCT03501355|exercise capacity|exercise capacity
11531|NCT03501355|Quality of Life|quality of life
11532|NCT03501355|Respiratory Muscle Strength|respiratory muscle strength
11533|NCT03501342|Multiple Sclerosis|multiple sclerosis
11534|NCT03501342|virtual reality|virtual reality
11535|NCT03501342|balance|balance
11536|NCT03501342|mobility|mobility
11537|NCT03501342|fatigue|fatigue
11538|NCT03501316|Root Surface Debridement|root surface debridement
11539|NCT03501316|Hand Instrumentation|hand instrumentation
11540|NCT03501316|Ultrasonic Instrumentation|ultrasonic instrumentation
11541|NCT03501316|Systemic|systemic
11542|NCT03501316|Immune|immune
11543|NCT03501316|CRP|crp
11544|NCT03501290|Frailty|frailty
11545|NCT03501290|Malnutrition|malnutrition
11546|NCT03501290|Older adults|older adults
11547|NCT03501290|Oral Nutritional Supplements|oral nutritional supplements
11548|NCT03501290|Compliance|compliance
11549|NCT03501277|Drug therapy|drug therapy
11550|NCT03501199|immediate implant placement|immediate implant placement
11551|NCT03501186|Backward walking, stroke, gait training|backward walking, stroke, gait training
11552|NCT03501160|Regressive behaviors|regressive behaviors
11553|NCT03501160|Childish behaviors|childish behaviors
11554|NCT03501160|Affection expression socially inappropriate behaviors|affection expression socially inappropriate behaviors
11555|NCT03501160|Social Inappropriate Behaviors|social inappropriate behaviors
11556|NCT03501160|Social Impairment|social impairment
11557|NCT03501134|Pro000888900|pro000888900
11558|NCT03501134|Katherine Peters|katherine peters
11559|NCT03501134|Optune|optune
11560|NCT03501134|NovoTTF|novottf
11561|NCT03501134|ACTION|action
11562|NCT03501134|Quality of life|quality of life
11563|NCT03501134|Tumor treating fields|tumor treating fields
11564|NCT03501121|intra-operative radiation therapy|intra-operative radiation therapy
11565|NCT03501108|Polypharmacy|polypharmacy
11566|NCT03501108|Multi-morbidity|multi-morbidity
11567|NCT03501108|Deprescribing|deprescribing
11568|NCT03501108|Older people|older people
11569|NCT03501108|Elderly|elderly
11570|NCT03501082|Gut microbiome|gut microbiome
11571|NCT03501069|Drug Therapy|drug therapy
11572|NCT03501056|PD-1 activated CIK|pd-1 activated cik
11573|NCT03501056|MUC1|muc1
11574|NCT03501056|Bispecific antibody|bispecific antibody
11575|NCT03501056|lung cancer|lung cancer
11576|NCT03500991|CNS, CAR T cell, HER2-positive, brain tumor|cns, car t cell, her2-positive, brain tumor
11577|NCT03500991|pediatric, young adults|pediatric, young adults
11578|NCT03500965|pictorial warning labels|pictorial warning labels
11579|NCT03500965|risk knowledge|risk knowledge
11580|NCT03500965|emotion|emotion
11581|NCT03500965|memory|memory
11582|NCT03500965|risk perceptions|risk perceptions
11583|NCT03500965|quit intentions|quit intentions
11584|NCT03500913|Growth Hormone Deficiency|growth hormone deficiency
11585|NCT03500913|Adipose Tissue|adipose tissue
11586|NCT03500913|Inflammation|inflammation
11587|NCT03500900|gastric accommodation|gastric accommodation
11588|NCT03500900|food intake|food intake
11589|NCT03500900|gastrointestinal hormones|gastrointestinal hormones
11590|NCT03500861|headache characteristics, health-related quality of life.|headache characteristics, health-related quality of life.
11591|NCT03500848|Liver transplantation|liver transplantation
11592|NCT03500848|Sirolimus|sirolimus
11593|NCT03500848|Tacrolimus|tacrolimus
11594|NCT03500848|HCC recurrence free survival|hcc recurrence free survival
11595|NCT03500822|dynamic hyperinflation|dynamic hyperinflation
11596|NCT03500822|diastolic dysfunction|diastolic dysfunction
11597|NCT03500822|COPD|copd
11598|NCT03500822|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
11599|NCT03500822|Metronome-paced Tachypnea|metronome-paced tachypnea
11600|NCT03500822|Expiratory-stenosis Breathing|expiratory-stenosis breathing
11601|NCT03500783|Cardioprotection|cardioprotection
11602|NCT03500783|Ischemia-reperfusion injury|ischemia-reperfusion injury
11603|NCT03500783|Nitric oxide|nitric oxide
11604|NCT03500783|Cardiopulmonary bypass|cardiopulmonary bypass
11605|NCT03500783|Coronary artery bypass grafting|coronary artery bypass grafting
11606|NCT03500770|Post Treatment Lyme Disease Syndrome|post treatment lyme disease syndrome
11607|NCT03500757|HoloLens|hololens
11608|NCT03500757|3D holographic guidance|3d holographic guidance
11609|NCT03500731|Lung Transplantation|lung transplantation
11610|NCT03500731|Stem Cell Transplantation|stem cell transplantation
11611|NCT03500731|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
11612|NCT03500731|Emphysema or COPD|emphysema or copd
11613|NCT03500731|Bone marrow transplantation|bone marrow transplantation
11614|NCT03500731|Cadaveric donor|cadaveric donor
11615|NCT03500731|Unrelated donor|unrelated donor
11616|NCT03500731|HLA-Mismatch|hla-mismatch
11617|NCT03500731|BMT|bmt
11618|NCT03500731|HSCT|hsct
11619|NCT03500718|cochlear implant|cochlear implant
11620|NCT03500718|threshold of electrically evoked compound action potential|threshold of electrically evoked compound action potential
11621|NCT03500718|neural response telemetry|neural response telemetry
11622|NCT03500692|Mitral Valve Regurgitation|mitral valve regurgitation
11623|NCT03500692|MitraClip|mitraclip
11624|NCT03500692|MitraClip NT|mitraclip nt
11625|NCT03500692|Japan MitraClip NT Postmarketing Surveillance|japan mitraclip nt postmarketing surveillance
11626|NCT03500666|Thyroid carcinoma|thyroid carcinoma
11627|NCT03500666|Robot surgery|robot surgery
11628|NCT03500666|Endoscopic surgery|endoscopic surgery
11629|NCT03500640|Intervention|intervention
11630|NCT03500640|Prevention|prevention
11631|NCT03500640|Weight Management|weight management
11632|NCT03500640|Physical Activity|physical activity
11633|NCT03500640|Physical Function|physical function
11634|NCT03500627|Adrenoleukodystrophy (ALD)|adrenoleukodystrophy (ald)
11635|NCT03500627|Childhood Cerebral Adrenoleukodystrophy (ccALD)|childhood cerebral adrenoleukodystrophy (ccald)
11636|NCT03500627|OP-101|op-101
11637|NCT03500627|Dendrimer|dendrimer
11638|NCT03500627|N-Acetyl-Cysteine (NAC)|n-acetyl-cysteine (nac)
11639|NCT03500614|particulate matter|particulate matter
11640|NCT03500614|phthalates|phthalates
11641|NCT03500614|cytokines|cytokines
11642|NCT03500614|chemokines|chemokines
11643|NCT03500614|epigenetics|epigenetics
11644|NCT03500614|DNA methylation|dna methylation
11645|NCT03500614|peripheral blood mononuclear cells|peripheral blood mononuclear cells
11646|NCT03500614|immune function|immune function
11647|NCT03500601|Cognition|cognition
11648|NCT03500601|Metagenomics|metagenomics
11649|NCT03500601|Metabolomics|metabolomics
11650|NCT03500575|induction therapy, photopheresis|induction therapy, photopheresis
11651|NCT03500497|reticulocyte hemoglobin content (RetHe)|reticulocyte hemoglobin content (rethe)
11652|NCT03500497|perioperative|perioperative
11653|NCT03500497|colorectal surgery|colorectal surgery
11654|NCT03500497|anemia|anemia
11655|NCT03500471|Laparoscopic|laparoscopic
11656|NCT03500471|Robotic|robotic
11657|NCT03500471|Total Gastrectomy|total gastrectomy
11658|NCT03500471|AGC|agc
11659|NCT03500432|transperineal prostate biopsy|transperineal prostate biopsy
11660|NCT03500432|local anesthesia|local anesthesia
11661|NCT03500432|prostate cancer diagnosis|prostate cancer diagnosis
11662|NCT03500367|mammilian target of rapamycin inhibitor|mammilian target of rapamycin inhibitor
11663|NCT03500367|Rapamycin (sirolimus)|rapamycin (sirolimus)
11664|NCT03500367|Treatment|treatment
11665|NCT03500367|Complications|complications
11666|NCT03500354|malnutrition|malnutrition
11667|NCT03500276|yoga|yoga
11668|NCT03500276|health-related quality of life|health-related quality of life
11669|NCT03500276|proinflammatory genes|proinflammatory genes
11670|NCT03500276|inflammatory markers|inflammatory markers
11671|NCT03500276|rheumatoid arthritis|rheumatoid arthritis
11672|NCT03500250|Complex intervention|complex intervention
11673|NCT03500250|Depression|depression
11674|NCT03500250|Nursing|nursing
11675|NCT03500250|Stroke|stroke
11676|NCT03500250|Feasibility|feasibility
11677|NCT03500237|anxiety|anxiety
11678|NCT03500237|depression|depression
11679|NCT03500237|internet-delivered cognitive behaviour therapy|internet-delivered cognitive behaviour therapy
11680|NCT03500237|randomized controlled trial|randomized controlled trial
11681|NCT03500237|patient-centered|patient-centered
11682|NCT03500237|knowledge implementation|knowledge implementation
11683|NCT03500237|mental health system|mental health system
11684|NCT03500237|therapist-assistance|therapist-assistance
11685|NCT03500224|Drug therapy|drug therapy
11686|NCT03500211|Cesarean section|cesarean section
11687|NCT03500211|Postoperative pain|postoperative pain
11688|NCT03500185|Physiotherapy|physiotherapy
11689|NCT03500185|Pelvic floor|pelvic floor
11690|NCT03500185|Urinary Incontinence|urinary incontinence
11691|NCT03500172|HIV|hiv
11692|NCT03500172|Female Sex Workers|female sex workers
11693|NCT03500172|Viral Suppression|viral suppression
11694|NCT03500172|South Africa|south africa
11695|NCT03500172|Decentralized care|decentralized care
11696|NCT03500172|Antiretroviral therapy|antiretroviral therapy
11697|NCT03500172|Differentiated care|differentiated care
12073|NCT03497546|Morbid obesity|morbid obesity
11698|NCT03500133|Pediatric Hodgkin Lymphoma, therapy, reduced radiotherapy|pediatric hodgkin lymphoma, therapy, reduced radiotherapy
11699|NCT03500107|Blue Light Emitting Diode|blue light emitting diode
11700|NCT03500107|Women|women
12300|NCT03496168|Obstructive|obstructive
11701|NCT03500094|Lysosomal storage disease|lysosomal storage disease
11702|NCT03500094|migalastat|migalastat
11703|NCT03500094|AT1001|at1001
11704|NCT03500068|Pancreatic cancer|pancreatic cancer
11705|NCT03500068|Organoids|organoids
11706|NCT03500042|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
11707|NCT03500042|inspiratory muscle training|inspiratory muscle training
11708|NCT03500042|expiratory muscle training|expiratory muscle training
11709|NCT03500042|Neural Respiratory Drive|neural respiratory drive
11710|NCT03500029|Depression|depression
11711|NCT03500029|Transcranial magnetic stimulation(TMS)|transcranial magnetic stimulation(tms)
11712|NCT03500029|Resting-state functional MRI(fMRI)|resting-state functional mri(fmri)
11713|NCT03500016|Insulin resistance|insulin resistance
11714|NCT03500016|Obesity|obesity
11715|NCT03500016|Type 2 diabetes|type 2 diabetes
11716|NCT03500016|Exercise training|exercise training
11717|NCT03500003|dairy products|dairy products
11718|NCT03500003|milk|milk
11719|NCT03500003|yogurt|yogurt
11720|NCT03500003|metabolomics|metabolomics
11721|NCT03500003|elderly|elderly
11722|NCT03499990|Adrenal crisis|adrenal crisis
11723|NCT03499990|Risk factors|risk factors
11724|NCT03499977|Physical Activity|physical activity
11725|NCT03499977|Executive function|executive function
11726|NCT03499977|Anti-saccade|anti-saccade
11727|NCT03499964|pivotal trial|pivotal trial
11728|NCT03499964|randomized|randomized
11729|NCT03499964|lower urinary tract symptoms (LUTS)|lower urinary tract symptoms (luts)
11730|NCT03499964|urethral stricture|urethral stricture
11731|NCT03499964|obstruction|obstruction
11732|NCT03499951|Quality of life|quality of life
11733|NCT03499951|Participation|participation
11734|NCT03499951|Training|training
11735|NCT03499938|Asthma|asthma
11736|NCT03499938|Bronchiolitis|bronchiolitis
11737|NCT03499938|Wheezing|wheezing
11738|NCT03499938|Structured Light Plethysmography|structured light plethysmography
11739|NCT03499925|mental health|mental health
11740|NCT03499925|intervention|intervention
11741|NCT03499925|pregnancy-related complications|pregnancy-related complications
11742|NCT03499912|Acute myeloid leukemia|acute myeloid leukemia
11743|NCT03499912|IDH1|idh1
11744|NCT03499912|IDH2|idh2
11745|NCT03499912|Genetic mutations|genetic mutations
11746|NCT03499912|Prognosis|prognosis
11747|NCT03499899|triple-negative breast cancer|triple-negative breast cancer
11748|NCT03499899|checkpoint inhibition|checkpoint inhibition
11749|NCT03499899|LAG525|lag525
11750|NCT03499899|spartalizumab|spartalizumab
11751|NCT03499899|PDR001|pdr001
11752|NCT03499899|carboplatin|carboplatin
11753|NCT03499834|Immune Cell Therapy|immune cell therapy
11754|NCT03499834|IKC|ikc
11755|NCT03499795|High-grade squamous intraepithelial lesions (HSIL)|high-grade squamous intraepithelial lesions (hsil)
11756|NCT03499795|Human papillomavirus (HPV)|human papillomavirus (hpv)
11757|NCT03499795|HPV-16|hpv-16
11758|NCT03499795|HPV-18|hpv-18
11759|NCT03499795|Anal intraepithelial neoplasia 2 (AIN2)|anal intraepithelial neoplasia 2 (ain2)
11760|NCT03499795|Anal intraepithelial neoplasia 3 (AIN3)|anal intraepithelial neoplasia 3 (ain3)
11761|NCT03499795|Peri-anal intraepithelial neoplasia 2 (PAIN2)|peri-anal intraepithelial neoplasia 2 (pain2)
11762|NCT03499795|Peri-anal intraepithelial neoplasia 3 (PAIN3)|peri-anal intraepithelial neoplasia 3 (pain3)
11763|NCT03499782|Prognosis|prognosis
11764|NCT03499782|Surgery options|surgery options
11765|NCT03499782|Bayesian networks|bayesian networks
11766|NCT03499756|Postnatal depression, interpersonal psychotherapy|postnatal depression, interpersonal psychotherapy
11767|NCT03499730|Midazolam|midazolam
11768|NCT03499730|Inguinal hernia|inguinal hernia
11769|NCT03499717|Fall Risk|fall risk
11770|NCT03499717|Patient Falls|patient falls
11771|NCT03499717|Fall Prevention|fall prevention
11772|NCT03499717|Patient Safety|patient safety
11773|NCT03499704|Drug therapy|drug therapy
11774|NCT03499665|Bruxism|bruxism
11775|NCT03499665|Pain|pain
11776|NCT03499665|Exercises|exercises
11777|NCT03499665|Myofascial|myofascial
11778|NCT03499665|Releasing|releasing
11779|NCT03499613|Movement analysis|movement analysis
11780|NCT03499613|Spinal kinematics|spinal kinematics
11781|NCT03499613|Muscle activity|muscle activity
11782|NCT03499613|Pain-related fear|pain-related fear
11783|NCT03499613|Rehabilitation|rehabilitation
11784|NCT03499613|Spine|spine
11785|NCT03499600|Cultural assessment|cultural assessment
11786|NCT03499600|Engagement|engagement
11787|NCT03499600|Diverse Populations|diverse populations
11788|NCT03499548|Intensive|intensive
11789|NCT03499548|Cognitive Behavioral Therapy|cognitive behavioral therapy
11790|NCT03499548|Male prisoners|male prisoners
11791|NCT03499535|Risk Perception|risk perception
11792|NCT03499522|Hemophilic arthropathy|hemophilic arthropathy
11793|NCT03499522|Pain|pain
11794|NCT03499522|Functional Disease Present|functional disease present
11795|NCT03499522|Quality of life|quality of life
11796|NCT03499522|Anxiety|anxiety
11797|NCT03499522|Stress|stress
11798|NCT03499522|Coping strategies|coping strategies
11799|NCT03499496|plaques detection by ultrasound|plaques detection by ultrasound
12404|NCT03495635|prevention|prevention
11800|NCT03499483|Post Exposure Prophylaxis|post exposure prophylaxis
11801|NCT03499470|copd|copd
11802|NCT03499470|exacerbation|exacerbation
11803|NCT03499470|structured discharge|structured discharge
11804|NCT03499470|readmission|readmission
11805|NCT03499470|chronic respiratory failure|chronic respiratory failure
11806|NCT03499457|Penicillin Allergy|penicillin allergy
11807|NCT03499457|chalenge test|chalenge test
11808|NCT03499457|primary clinic|primary clinic
11809|NCT03499418|newborn|newborn
11810|NCT03499418|TTN|ttn
11811|NCT03499418|PPHN|pphn
11812|NCT03499405|development and health disparities and navigation|development and health disparities and navigation
11813|NCT03499392|psychological factors|psychological factors
11814|NCT03499379|Intrauterine device (IUD)|intrauterine device (iud)
11815|NCT03499379|Depression|depression
11816|NCT03499379|Stress hormones|stress hormones
11817|NCT03499379|Mood changes|mood changes
11818|NCT03499366|enterovirus D68|enterovirus d68
11819|NCT03499366|AFP|afp
11820|NCT03499366|AFM|afm
11821|NCT03499366|EV-D68|ev-d68
11822|NCT03499366|acute flaccid myelitis|acute flaccid myelitis
11823|NCT03499366|acute flaccid paresis|acute flaccid paresis
11824|NCT03499353|Neoadjuvant Therapy, Triple Negative Breast Cancer, BRACA Positive|neoadjuvant therapy, triple negative breast cancer, braca positive
11825|NCT03499340|pictorial warning labels|pictorial warning labels
11826|NCT03499340|risk knowledge|risk knowledge
11828|NCT03499340|memory|memory
11829|NCT03499340|risk perceptions|risk perceptions
11830|NCT03499340|quit intentions|quit intentions
11831|NCT03499327|vitamin D|vitamin d
11832|NCT03499327|ergosterol|ergosterol
11833|NCT03499327|7-dehydro-cholesterol|7-dehydro-cholesterol
11834|NCT03499327|wheat germ oil|wheat germ oil
11835|NCT03499314|Anodal transcranial stimulation (tDCS)|anodal transcranial stimulation (tdcs)
11836|NCT03499301|Chronic pain|chronic pain
11837|NCT03499301|Emergency|emergency
11838|NCT03499301|Satisfaction|satisfaction
11839|NCT03499288|Cerebral Palsy|cerebral palsy
11840|NCT03499275|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
11841|NCT03499262|Social ABCs|social abcs
11842|NCT03499262|Early Intervention|early intervention
11843|NCT03499262|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
11844|NCT03499262|Toddler|toddler
11845|NCT03499262|Pivotal Response Treatment (PRT)|pivotal response treatment (prt)
11846|NCT03499262|Group Intervention|group intervention
11847|NCT03499262|Parent-Mediated|parent-mediated
11848|NCT03499262|Caregiver-Mediated|caregiver-mediated
11849|NCT03499262|Social Communication|social communication
11850|NCT03499262|Positive Affect|positive affect
11851|NCT03499262|Social Smiling|social smiling
11852|NCT03499262|Social Orienting|social orienting
11853|NCT03499262|Naturalistic Developmental Behaviour Intervention|naturalistic developmental behaviour intervention
11854|NCT03499262|NDBI|ndbi
11855|NCT03499262|Autism|autism
11856|NCT03499262|Early Identification|early identification
11857|NCT03499249|Biliary Atresia|biliary atresia
11858|NCT03499249|N-Acetylcysteine|n-acetylcysteine
11859|NCT03499249|Glutathione|glutathione
11860|NCT03499249|Kasai portoenterostomy|kasai portoenterostomy
11861|NCT03499249|Bile flow|bile flow
11862|NCT03499249|Serum bile acids|serum bile acids
11863|NCT03499249|Serum bilirubin|serum bilirubin
11864|NCT03499210|Stroke|stroke
11865|NCT03499210|Exoskeleton|exoskeleton
11866|NCT03499210|Hemiparesis|hemiparesis
11867|NCT03499210|Hemiplegia|hemiplegia
11868|NCT03499145|conjunctivitis|conjunctivitis
11869|NCT03499145|keratitis|keratitis
11870|NCT03499145|pterygium|pterygium
11871|NCT03499145|cataracts|cataracts
11872|NCT03499132|anesthesia, obstructive sleep apnea|anesthesia, obstructive sleep apnea
11873|NCT03499093|esthetics|esthetics
11874|NCT03499093|orofacial esthetic scale|orofacial esthetic scale
11875|NCT03499080|Medication free treatment, mental illness, outcome|medication free treatment, mental illness, outcome
11876|NCT03499054|Breathing exercises|breathing exercises
11877|NCT03499054|fatigue|fatigue
11878|NCT03499054|quality of life|quality of life
11879|NCT03499002|Simulation|simulation
11880|NCT03499002|Medical Students|medical students
11881|NCT03499002|In Situ Simulation|in situ simulation
11882|NCT03498976|painful shoulder|painful shoulder
11883|NCT03498937|Borderline Personality Disorder|borderline personality disorder
11884|NCT03498937|Impulsive behavior|impulsive behavior
11885|NCT03498937|Suicidal behavior|suicidal behavior
11886|NCT03498937|Cognitive control|cognitive control
11887|NCT03498937|tDCS|tdcs
11888|NCT03498937|Noninvasive brain stimulation|noninvasive brain stimulation
11889|NCT03498924|tumor marker|tumor marker
11890|NCT03498924|HE4|he4
11891|NCT03498924|CA125|ca125
11892|NCT03498924|staging|staging
11893|NCT03498924|diagnosis|diagnosis
11894|NCT03498924|Endometrial Cancer|endometrial cancer
11895|NCT03498898|Beta adrenergic receptor blockers|beta adrenergic receptor blockers
11896|NCT03498898|Analgesia nociceptive index|analgesia nociceptive index
11897|NCT03498898|Total hip replacement|total hip replacement
11898|NCT03498885|Rectal Cancer|rectal cancer
11899|NCT03498885|inferior mesenteric artery|inferior mesenteric artery
11900|NCT03498885|Laparoscopic|laparoscopic
11901|NCT03498872|AMPfoot|ampfoot
11902|NCT03498872|Prosthetics|prosthetics
11903|NCT03498872|gait|gait
11904|NCT03498872|electro-encephalography|electro-encephalography
11905|NCT03498872|dual-task walking|dual-task walking
11906|NCT03498859|Rehabilitation|rehabilitation
11907|NCT03498833|domains|domains
11908|NCT03498833|item development|item development
11909|NCT03498833|osteoarthritis|osteoarthritis
11910|NCT03498833|scale formulation|scale formulation
11911|NCT03498833|test retest reliability|test retest reliability
11912|NCT03498820|Analgesia-Nociception Index (ANI)|analgesia-nociception index (ani)
11913|NCT03498820|General anesthesia|general anesthesia
11914|NCT03498820|Opioids|opioids
11915|NCT03498820|Remifentanil|remifentanil
11916|NCT03498820|Pain|pain
11917|NCT03498820|Monitoring|monitoring
11918|NCT03498807|ARDS|ards
11919|NCT03498807|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
11920|NCT03498807|PEEP|peep
11921|NCT03498807|pressure-volume loop|pressure-volume loop
11922|NCT03498807|Positive End-Expiratory Pressure|positive end-expiratory pressure
11923|NCT03498807|hysteresis|hysteresis
11924|NCT03498781|Exercise|exercise
11925|NCT03498755|fisheries|fisheries
11926|NCT03498755|Ghana|ghana
11927|NCT03498755|sub-Saharan Africa|sub-saharan africa
11928|NCT03498755|value chain|value chain
11929|NCT03498755|fish processing|fish processing
11930|NCT03498755|fish smoking|fish smoking
11931|NCT03498742|asthma|asthma
11932|NCT03498742|SABA|saba
11933|NCT03498729|Autoimmune Diseases|autoimmune diseases
11934|NCT03498690|online trial|online trial
11935|NCT03498690|decision analysis|decision analysis
11936|NCT03498677|online trial|online trial
11937|NCT03498677|decision analysis|decision analysis
11938|NCT03498664|EMR-C; EMR-S; LST|emr-c; emr-s; lst
11939|NCT03498651|Anxiety|anxiety
11940|NCT03498651|Cognitive bias|cognitive bias
11941|NCT03498651|Telemedicine|telemedicine
11942|NCT03498599|neuroimaging|neuroimaging
11943|NCT03498599|fear conditioning|fear conditioning
11944|NCT03498547|caudal block|caudal block
11945|NCT03498547|saddle block|saddle block
11946|NCT03498534|Treatment|treatment
11947|NCT03498534|Latent infection|latent infection
11948|NCT03498534|Tuberculosis|tuberculosis
11949|NCT03498534|Interferon gamma|interferon gamma
11950|NCT03498508|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
11951|NCT03498508|Knowledge|knowledge
11952|NCT03498508|In-hospital cardiac arrest|in-hospital cardiac arrest
11953|NCT03498508|Skills|skills
11954|NCT03498469|reintegration, reunification, child development|reintegration, reunification, child development
11955|NCT03498430|Indolent Non-Hodgkin's Lymphoma (iNHL) (excluding CLL)|indolent non-hodgkin's lymphoma (inhl) (excluding cll)
11956|NCT03498378|Avelumab|avelumab
11957|NCT03498378|Palbociclib|palbociclib
11958|NCT03498378|Cetuximab|cetuximab
11959|NCT03498378|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
11960|NCT03498378|cancer|cancer
11961|NCT03498378|Recurrent Head and Neck Squamous Cell Carcinoma|recurrent head and neck squamous cell carcinoma
11962|NCT03498378|Metastatic Head and Neck Squamous Cell Carcinoma|metastatic head and neck squamous cell carcinoma
11963|NCT03498365|decision analysis|decision analysis
11964|NCT03498365|decision support|decision support
11965|NCT03498352|cardiopulmonary exercise testing, thoracic surgery|cardiopulmonary exercise testing, thoracic surgery
11966|NCT03498326|pancreatic cancer|pancreatic cancer
11967|NCT03498326|gemcitabine|gemcitabine
11968|NCT03498326|celecoxib|celecoxib
11969|NCT03498326|R0 resection|r0 resection
11970|NCT03498313|steroid hormones|steroid hormones
11971|NCT03498313|estradiol|estradiol
11972|NCT03498313|estrogen|estrogen
11973|NCT03498313|progesterone|progesterone
11974|NCT03498313|depression|depression
11975|NCT03498313|suicide|suicide
11976|NCT03498287|carpal tunnel syndrome|carpal tunnel syndrome
11977|NCT03498287|carpal tunnel|carpal tunnel
11978|NCT03498287|CTS|cts
11979|NCT03498287|musculoskeletal disorder|musculoskeletal disorder
11980|NCT03498287|peripheral neuropathy|peripheral neuropathy
11981|NCT03498287|repetitive stress injury|repetitive stress injury
11982|NCT03498287|non-invasive device|non-invasive device
11983|NCT03498287|non-significant risk|non-significant risk
11984|NCT03498287|medical device|medical device
11985|NCT03498274|Fitting|fitting
11986|NCT03498235|sevoflurane|sevoflurane
11987|NCT03498235|propofol|propofol
11988|NCT03498235|intracranial pressure|intracranial pressure
11989|NCT03498235|optic nerve sheath diameter|optic nerve sheath diameter
11990|NCT03498196|muscle invasive bladder cancer|muscle invasive bladder cancer
11991|NCT03498196|non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
11992|NCT03498196|radical cystectomy|radical cystectomy
11993|NCT03498196|monoclonal antibodies|monoclonal antibodies
11994|NCT03498196|Avelumab|avelumab
11995|NCT03498196|Invasive Resectable disease|invasive resectable disease
11996|NCT03498196|MIBC|mibc
11997|NCT03498196|NMIBC|nmibc
11998|NCT03498196|neoadjuvant chemotherapy|neoadjuvant chemotherapy
11999|NCT03498170|Healthy Male Volunteers|healthy male volunteers
12000|NCT03498157|Prehabilitation|prehabilitation
12001|NCT03498157|Exercise|exercise
12002|NCT03498157|Breast Cancer|breast cancer
12003|NCT03498157|Physical Activity|physical activity
12004|NCT03498157|Surgery|surgery
12005|NCT03498144|acquired punctal stenosis|acquired punctal stenosis
12006|NCT03498144|epiphora|epiphora
12007|NCT03498144|lower punctum|lower punctum
12008|NCT03498144|AS-OCT|as-oct
12009|NCT03498131|Multiple Sclerosis|multiple sclerosis
12010|NCT03498131|MS|ms
12011|NCT03498131|Melatonin|melatonin
12012|NCT03498131|Supplement|supplement
12013|NCT03498118|Transversus Abdominis Plane Block|transversus abdominis plane block
12014|NCT03498118|Cesarean Delivery|cesarean delivery
12015|NCT03498105|Acute Chest Syndrome|acute chest syndrome
12016|NCT03498066|Myocardial Infarction|myocardial infarction
12017|NCT03498066|Beta-Blockers|beta-blockers
12018|NCT03498066|Stable Coronary Artery Disease|stable coronary artery disease
12019|NCT03497936|vaccine narratives|vaccine narratives
12020|NCT03497936|HPV prevention|hpv prevention
12021|NCT03497936|vaccine promotion|vaccine promotion
12022|NCT03497923|rocuronium, magnesium sulphate, neostigmine, sugammadex|rocuronium, magnesium sulphate, neostigmine, sugammadex
12023|NCT03497897|Acne, efficacy, safety|acne, efficacy, safety
12024|NCT03497884|fMRI|fmri
12025|NCT03497884|rTMS|rtms
12026|NCT03497884|functional connectivity|functional connectivity
12027|NCT03497871|Heart failure|heart failure
12028|NCT03497871|Self-management|self-management
12029|NCT03497871|Health-related quality of life|health-related quality of life
12030|NCT03497871|mHealth|mhealth
12031|NCT03497845|vaccine|vaccine
12032|NCT03497845|adjuvant|adjuvant
12033|NCT03497845|Influenza in Birds|influenza in birds
12034|NCT03497845|MF59|mf59
12035|NCT03497845|AS03|as03
12036|NCT03497832|Proton Magnetic Resonance Spectroscopy|proton magnetic resonance spectroscopy
12037|NCT03497819|CART|cart
12038|NCT03497819|Pancreatic Cancer|pancreatic cancer
12039|NCT03497819|artery infusion|artery infusion
12040|NCT03497780|Healthy Volunteers|healthy volunteers
12041|NCT03497780|ACL (Anterior Cruciate Ligament) tear|acl (anterior cruciate ligament) tear
12042|NCT03497767|Non Small Cell Lung Cancer (NSCLC)|non small cell lung cancer (nsclc)
12043|NCT03497767|EGFR mutation|egfr mutation
12044|NCT03497767|Osimertinib|osimertinib
12045|NCT03497767|Stereotactic Radiosurgery|stereotactic radiosurgery
12046|NCT03497754|ultrasound|ultrasound
12047|NCT03497754|cardiac output|cardiac output
12048|NCT03497754|Probefix|probefix
12049|NCT03497754|passive leg raising test|passive leg raising test
12050|NCT03497741|Intensive Care Unit|intensive care unit
12051|NCT03497689|pulmonary hypertension|pulmonary hypertension
12052|NCT03497689|treprostinil|treprostinil
12053|NCT03497689|pulmonary arterial hypertension|pulmonary arterial hypertension
12054|NCT03497689|PAH|pah
12055|NCT03497689|Remodulin|remodulin
12056|NCT03497689|Orenitram|orenitram
12057|NCT03497663|Familial high risk|familial high risk
12058|NCT03497663|offspring|offspring
12059|NCT03497663|schizophrenia|schizophrenia
12060|NCT03497663|bipolar disorder|bipolar disorder
12061|NCT03497663|recurrent depression|recurrent depression
12062|NCT03497663|early intervention|early intervention
12063|NCT03497663|parental training|parental training
12064|NCT03497663|family based intervention|family based intervention
12065|NCT03497611|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
12066|NCT03497611|Pacemaker|pacemaker
12067|NCT03497611|Aortic valve calcification|aortic valve calcification
12068|NCT03497611|PPI|ppi
12069|NCT03497598|D-mannose|d-mannose
12070|NCT03497585|Rehabilitation|rehabilitation
12071|NCT03497585|Pain Management|pain management
12072|NCT03497572|Leptospirosis|leptospirosis
12074|NCT03497546|Exercise|exercise
12075|NCT03497546|Weight loss|weight loss
12076|NCT03497546|Cardiometabolic risk|cardiometabolic risk
12077|NCT03497546|Bariatric surgery|bariatric surgery
12078|NCT03497533|CD19|cd19
12079|NCT03497533|CAR-T|car-t
12080|NCT03497533|TriCAR-T-CD19|tricar-t-cd19
12081|NCT03497533|non-Hodgkin lymphoma|non-hodgkin lymphoma
12082|NCT03497533|NHL|nhl
12083|NCT03497520|surface EMG|surface emg
12084|NCT03497520|cobb angle|cobb angle
12085|NCT03497520|exercise|exercise
12086|NCT03497520|Spinal Curvatures|spinal curvatures
12087|NCT03497507|Shivering|shivering
12088|NCT03497507|Cesarean delivery|cesarean delivery
12089|NCT03497507|acupressure|acupressure
12090|NCT03497507|P6 acupoint|p6 acupoint
12091|NCT03497481|eye's anterior chamber fluid|eye's anterior chamber fluid
12092|NCT03497481|cerebrospinal fluid|cerebrospinal fluid
12093|NCT03497481|inflammatory pathology|inflammatory pathology
12094|NCT03497468|task-oriented training|task-oriented training
12095|NCT03497468|exercise training|exercise training
12096|NCT03497468|mobility|mobility
12097|NCT03497468|balance|balance
12098|NCT03497468|fatigue|fatigue
12099|NCT03497468|quality of life|quality of life
12100|NCT03497416|Preoperative Anemia|preoperative anemia
12101|NCT03497416|elderly|elderly
12102|NCT03497416|healthcare outcomes|healthcare outcomes
12103|NCT03497390|Type 2 diabetes|type 2 diabetes
12104|NCT03497390|Obesity|obesity
12105|NCT03497364|Cesarean Section|cesarean section
12106|NCT03497364|Hypotension|hypotension
12107|NCT03497364|Combined spinal-epidural anesthesia|combined spinal-epidural anesthesia
12108|NCT03497312|Rehabilitation|rehabilitation
12109|NCT03497312|children with disabilities|children with disabilities
12110|NCT03497312|general anesthesia|general anesthesia
12111|NCT03497312|Children with special healthcare need|children with special healthcare need
12112|NCT03497312|handicapped children|handicapped children
12113|NCT03497312|full mouth rehabilitation|full mouth rehabilitation
12114|NCT03497299|Schizophrenia|schizophrenia
12115|NCT03497299|Smoking|smoking
12116|NCT03497299|Lapse|lapse
12117|NCT03497299|Varenicline|varenicline
12118|NCT03497299|Sham Repetitive Transcranial Magnetic Stimulation (rTMS)|sham repetitive transcranial magnetic stimulation (rtms)
12119|NCT03497286|maternal health|maternal health
12120|NCT03497286|maternal stress|maternal stress
12121|NCT03497286|infant health|infant health
12122|NCT03497273|JAK1 inhibitor|jak1 inhibitor
12123|NCT03497273|GVHD|gvhd
12124|NCT03497273|acute GVHD|acute gvhd
12125|NCT03497273|Japan|japan
12126|NCT03497273|corticosteroids|corticosteroids
12127|NCT03497260|Type 1 Diabetes, Fructose, Exercise, Hypoglycaemia, Degludec|type 1 diabetes, fructose, exercise, hypoglycaemia, degludec
12128|NCT03497221|Nursing Education|nursing education
12129|NCT03497208|Surgery|surgery
12130|NCT03497208|melanocytes|melanocytes
12131|NCT03497208|dermarolling system|dermarolling system
12132|NCT03497169|Bariatric surgery|bariatric surgery
12133|NCT03497169|Gastrointestinal tract|gastrointestinal tract
12134|NCT03497169|Biological availability|biological availability
12135|NCT03497169|Pharmacokinetics|pharmacokinetics
12136|NCT03497169|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate
12137|NCT03497156|Bariatric surgery|bariatric surgery
12138|NCT03497156|Gastrointestinal tract|gastrointestinal tract
12139|NCT03497156|Biological availability|biological availability
12140|NCT03497156|Pharmacokinetics|pharmacokinetics
12141|NCT03497156|Lercanidipine|lercanidipine
12142|NCT03497143|Bariatric surgery|bariatric surgery
12143|NCT03497143|Gastrointestinal tract|gastrointestinal tract
12144|NCT03497143|Biological availability|biological availability
12145|NCT03497143|Pharmacokinetics|pharmacokinetics
12146|NCT03497143|Lamotrigine|lamotrigine
12147|NCT03497130|skin regimen|skin regimen
12148|NCT03497130|moisturizer|moisturizer
12149|NCT03497130|dry skin|dry skin
12150|NCT03497130|dry|dry
12151|NCT03497130|itchy skin|itchy skin
12152|NCT03497130|skin care|skin care
12153|NCT03497117|imaging|imaging
12154|NCT03497117|hyperpolarized|hyperpolarized
12155|NCT03497117|perfluorinated|perfluorinated
12156|NCT03497117|MRI|mri
12157|NCT03497117|lung|lung
12158|NCT03497117|multiple breath washout|multiple breath washout
12159|NCT03497117|lung clearance index|lung clearance index
12160|NCT03497078|collimator|collimator
12161|NCT03497078|bone scintigraphy|bone scintigraphy
12162|NCT03497078|image quality|image quality
12163|NCT03497078|scintigraphy|scintigraphy
12164|NCT03497065|Dental devices|dental devices
12165|NCT03497065|Home care|home care
12166|NCT03497065|Awareness|awareness
12167|NCT03497065|Peri-implant mucositis|peri-implant mucositis
12168|NCT03497065|Peri-implantitis|peri-implantitis
12169|NCT03497052|IVF culture media|ivf culture media
12170|NCT03497052|Blastocyst|blastocyst
12171|NCT03497052|Time-lapse microscopy|time-lapse microscopy
12172|NCT03497013|transcranial Direct Current Stimulation|transcranial direct current stimulation
12173|NCT03497013|Randomized Controlled Trial|randomized controlled trial
12174|NCT03497013|Schizophrenia|schizophrenia
12175|NCT03497013|Tardive Dyskinesia|tardive dyskinesia
12176|NCT03497013|Abnormal Involuntary Movements Scale|abnormal involuntary movements scale
12177|NCT03497013|Tardive Dyskinesia Rating Scale|tardive dyskinesia rating scale
12178|NCT03497013|Cognition|cognition
12179|NCT03497000|optical coherence tomography angiography|optical coherence tomography angiography
12180|NCT03497000|central serous chorioretinopathy|central serous chorioretinopathy
12181|NCT03497000|photodynamic therapy|photodynamic therapy
12182|NCT03496987|Pleural Effusion|pleural effusion
12183|NCT03496987|Pleural Drainage|pleural drainage
12184|NCT03496987|Thoracentesis|thoracentesis
12185|NCT03496961|Yan Nian Jiu Zhuan Fa|yan nian jiu zhuan fa
12186|NCT03496948|PAD|pad
12187|NCT03496948|Peripheral Artery Disease|peripheral artery disease
12188|NCT03496948|Peripheral Arterial Disease|peripheral arterial disease
12189|NCT03496935|Renal replacement therapy|renal replacement therapy
12190|NCT03496922|Unventilated Cigarettes|unventilated cigarettes
12191|NCT03496922|Experimental Tobacco Marketplace|experimental tobacco marketplace
12192|NCT03496922|Demand|demand
12193|NCT03496922|Delay Discounting|delay discounting
12194|NCT03496896|Randomized Controlled Trial|randomized controlled trial
12195|NCT03496896|Patient readmission|patient readmission
12196|NCT03496896|Patient transfer|patient transfer
12197|NCT03496896|Health care utilization|health care utilization
12198|NCT03496896|Prognosis|prognosis
12199|NCT03496896|Multimorbidity|multimorbidity
12200|NCT03496896|Internal medicine|internal medicine
12201|NCT03496857|labor pain|labor pain
12202|NCT03496831|Hospitalization|hospitalization
12203|NCT03496831|Infection|infection
12204|NCT03496805|Muscadine Grape Extract|muscadine grape extract
12205|NCT03496805|Androgen Deprivation Therapy|androgen deprivation therapy
12206|NCT03496792|venous distension reflex|venous distension reflex
12207|NCT03496779|Brentuximab Vedotin|brentuximab vedotin
12208|NCT03496779|T-cell lymphoma|t-cell lymphoma
12209|NCT03496753|nipple fissure|nipple fissure
12210|NCT03496740|Postoperative pain|postoperative pain
12211|NCT03496740|Ultrasound|ultrasound
12212|NCT03496740|Dorsal Penile Nerve Block|dorsal penile nerve block
12213|NCT03496740|Pudendal Block|pudendal block
12214|NCT03496740|Hypospadias|hypospadias
12215|NCT03496727|pain, VATS|pain, vats
12216|NCT03496714|Posttraumatic stress disorder|posttraumatic stress disorder
12217|NCT03496714|Safety behaviors|safety behaviors
12218|NCT03496714|Threat appraisal|threat appraisal
12219|NCT03496714|Secondary prevention|secondary prevention
12220|NCT03496714|Internet-based|internet-based
12221|NCT03496714|PTSD|ptsd
12222|NCT03496688|Sinus floor augmentation|sinus floor augmentation
12223|NCT03496688|Bone regeneration|bone regeneration
12224|NCT03496688|Histology|histology
12225|NCT03496688|Biocompatible materials|biocompatible materials
12226|NCT03496688|Bone transplantation|bone transplantation
12227|NCT03496649|Primary Adductor tendinopathies|primary adductor tendinopathies
12228|NCT03496649|Pubalgia|pubalgia
12229|NCT03496649|Botulinum toxin type A|botulinum toxin type a
12230|NCT03496636|Ovary|ovary
12231|NCT03496636|Transplant|transplant
12232|NCT03496623|Pulmonary Hypertension|pulmonary hypertension
12233|NCT03496623|COPD|copd
12234|NCT03496623|Inhaled Treprostinil|inhaled treprostinil
12235|NCT03496623|6-Minute Walk Test|6-minute walk test
12236|NCT03496623|Tyvaso|tyvaso
12237|NCT03496610|Bupivacaine|bupivacaine
12238|NCT03496610|Living donor nephrectomy|living donor nephrectomy
12239|NCT03496571|Eosinophilic Gastritis|eosinophilic gastritis
12240|NCT03496571|Eosinophilic Gastroenteritis|eosinophilic gastroenteritis
12241|NCT03496571|Eosinophil|eosinophil
12242|NCT03496571|EG|eg
12243|NCT03496571|EGE|ege
12244|NCT03496571|Eosinophilic gastrointestinal disorders|eosinophilic gastrointestinal disorders
12245|NCT03496571|EGID|egid
12246|NCT03496558|lactogenesis, pregnant, TG, lipidic profile, breastfeeding.|lactogenesis, pregnant, tg, lipidic profile, breastfeeding.
12247|NCT03496545|fever|fever
12248|NCT03496545|central fever|central fever
12249|NCT03496545|neurogenic fever|neurogenic fever
12250|NCT03496545|hyperthermia|hyperthermia
12251|NCT03496545|bromocriptine|bromocriptine
12252|NCT03496545|subarachnoid hemorrhage|subarachnoid hemorrhage
12253|NCT03496545|SAH|sah
12254|NCT03496545|subdural hematoma|subdural hematoma
12255|NCT03496545|SDH|sdh
12256|NCT03496545|intracerebral hemorrhage|intracerebral hemorrhage
12257|NCT03496545|ICH|ich
12258|NCT03496545|traumatic brain injury|traumatic brain injury
12259|NCT03496545|TBI|tbi
12260|NCT03496545|ischemic stroke|ischemic stroke
12261|NCT03496519|Durvalumab|durvalumab
12262|NCT03496519|Trabectedin|trabectedin
12263|NCT03496519|Maximum Tolerated Dose|maximum tolerated dose
12264|NCT03496519|Lung Cancer|lung cancer
12265|NCT03496519|Sarcoma|sarcoma
12266|NCT03496506|selexipag|selexipag
12267|NCT03496506|clopidogrel|clopidogrel
12268|NCT03496493|perioperative|perioperative
12269|NCT03496493|monitoring|monitoring
12270|NCT03496493|plethysmography|plethysmography
12271|NCT03496493|pulse oximetery|pulse oximetery
12272|NCT03496480|ptsd|ptsd
12273|NCT03496480|stress|stress
12274|NCT03496480|traumatization|traumatization
12275|NCT03496467|Treatment of pain and inflammation after Cataract Surgery|treatment of pain and inflammation after cataract surgery
12276|NCT03496454|malaria|malaria
12277|NCT03496454|infection|infection
12278|NCT03496454|controlled|controlled
12279|NCT03496428|intra-oral scanner|intra-oral scanner
12280|NCT03496428|customized impression coping|customized impression coping
12281|NCT03496428|extra-oral scanner|extra-oral scanner
12282|NCT03496428|accuracy|accuracy
12283|NCT03496376|kinesio taping|kinesio taping
12284|NCT03496376|COPD|copd
12285|NCT03496376|functional capacity|functional capacity
12286|NCT03496376|pulmonary functions|pulmonary functions
12287|NCT03496376|pulmonary rehabilitation|pulmonary rehabilitation
12288|NCT03496363|Children|children
12289|NCT03496337|activities of daily living|activities of daily living
12290|NCT03496337|assessment of motor and process skills|assessment of motor and process skills
12291|NCT03496337|validation study|validation study
12292|NCT03496337|responsiveness study|responsiveness study
12293|NCT03496259|Postoperative pain, on-Q pump, epidural, children|postoperative pain, on-q pump, epidural, children
12294|NCT03496207|PAH|pah
12295|NCT03496181|fMRI|fmri
12296|NCT03496181|MRI|mri
12297|NCT03496181|18-121|18-121
12298|NCT03496181|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
12299|NCT03496168|Symptomatic|symptomatic
12301|NCT03496168|Left ventricular outflow tract gradient|left ventricular outflow tract gradient
12302|NCT03496155|parent-teen communication|parent-teen communication
12303|NCT03496155|teen strengths|teen strengths
12304|NCT03496155|adolescence|adolescence
12305|NCT03496142|Prostate biopsy approach|prostate biopsy approach
12306|NCT03496142|Transrectal prostate biopsy|transrectal prostate biopsy
12307|NCT03496142|Transperineal prostate biopsy|transperineal prostate biopsy
12308|NCT03496142|Iatrogenic infection|iatrogenic infection
12309|NCT03496142|Prevention|prevention
12310|NCT03496090|Diverticulitis|diverticulitis
12311|NCT03496090|Uncomplicated Diverticular Disease|uncomplicated diverticular disease
12312|NCT03496090|Free diet|free diet
12313|NCT03496090|Dietary restriction|dietary restriction
12314|NCT03496090|Acute Diverticulitis|acute diverticulitis
12315|NCT03496077|Dual Use|dual use
12316|NCT03496077|Little Cigars and Cigarillos|little cigars and cigarillos
12317|NCT03496077|Cigarettes|cigarettes
12318|NCT03496077|Flavored Tobacco Use|flavored tobacco use
12319|NCT03496077|Addiction Potential|addiction potential
12320|NCT03496064|Thrombectomy|thrombectomy
12321|NCT03496064|Eligibility|eligibility
12322|NCT03496064|Large vessel occlusion|large vessel occlusion
12323|NCT03496025|facial nerve palsy|facial nerve palsy
12324|NCT03496025|facial paralysis|facial paralysis
12325|NCT03496025|functional electrical stimulation|functional electrical stimulation
12326|NCT03496025|facial pacing|facial pacing
12327|NCT03496012|NightstaRx|nightstarx
12328|NCT03496012|NSR-REP1|nsr-rep1
12329|NCT03496012|Choroideremia|choroideremia
12331|NCT03496012|Gene Therapy|gene therapy
12332|NCT03496012|AAV|aav
12333|NCT03496012|REP1|rep1
12334|NCT03495999|Hyperuricemia|hyperuricemia
12335|NCT03495999|Metabolic syndrome|metabolic syndrome
12336|NCT03495999|Left ventricular diastolic dysfunction|left ventricular diastolic dysfunction
12337|NCT03495999|Inflammation|inflammation
12338|NCT03495986|Functional Electrical Stimulation|functional electrical stimulation
12339|NCT03495986|Exercise|exercise
12340|NCT03495986|Body Composition|body composition
12341|NCT03495960|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
12342|NCT03495960|elderly|elderly
12343|NCT03495960|PCNSL|pcnsl
12344|NCT03495947|High Flow Nasal Cannula (HFNC).|high flow nasal cannula (hfnc).
12345|NCT03495947|Mechanical ventilation|mechanical ventilation
12346|NCT03495947|Extubation failure|extubation failure
12347|NCT03495921|ESFT|esft
12348|NCT03495921|Immunotherapy|immunotherapy
12349|NCT03495921|Phase 3|phase 3
12350|NCT03495908|VGo|vgo
12351|NCT03495908|Insulin|insulin
12352|NCT03495908|Type 2 Diabetes|type 2 diabetes
12353|NCT03495895|Disadvantaged families|disadvantaged families
12354|NCT03495895|Pregnancy|pregnancy
12355|NCT03495895|Intervention|intervention
12356|NCT03495895|Minding the Baby|minding the baby
12357|NCT03495856|Mindfulness-based stress reduction|mindfulness-based stress reduction
12358|NCT03495856|Mindfulness|mindfulness
12359|NCT03495856|chronic pain|chronic pain
12360|NCT03495856|Feasibility|feasibility
12361|NCT03495856|Intervention|intervention
12362|NCT03495804|CT enterography|ct enterography
12363|NCT03495804|oral contrast agent|oral contrast agent
12364|NCT03495791|RA|ra
12365|NCT03495791|Rheumatoid Arthritis|rheumatoid arthritis
12366|NCT03495791|Arthritis|arthritis
12367|NCT03495765|Diabetic macular oedema|diabetic macular oedema
12368|NCT03495765|Lucentis|lucentis
12369|NCT03495752|muscle performance|muscle performance
12370|NCT03495752|injury prevention|injury prevention
12371|NCT03495752|step down|step down
12372|NCT03495752|fatigue|fatigue
12373|NCT03495726|Contemplative|contemplative
12374|NCT03495726|Applications|applications
12375|NCT03495726|Well-being|well-being
12376|NCT03495687|Respiratory function|respiratory function
12377|NCT03495687|Spinal mobility|spinal mobility
12378|NCT03495687|Chest expansion|chest expansion
12379|NCT03495674|Lynch Syndrome|lynch syndrome
12380|NCT03495674|Cycling Exercise|cycling exercise
12381|NCT03495674|Lower GI Endoscopy|lower gi endoscopy
12382|NCT03495674|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
12383|NCT03495674|CPET|cpet
12384|NCT03495674|EKG|ekg
12385|NCT03495674|Questionnaires|questionnaires
12386|NCT03495674|Surveys|surveys
12387|NCT03495674|FITBIT|fitbit
12388|NCT03495661|lumbar spine stenosis|lumbar spine stenosis
12389|NCT03495661|decompression|decompression
12390|NCT03495661|laminectomy|laminectomy
12391|NCT03495661|physiotherapy|physiotherapy
12392|NCT03495661|physical therapy|physical therapy
12393|NCT03495661|electroneurography|electroneurography
12394|NCT03495661|ENG|eng
12395|NCT03495661|electromyography|electromyography
12396|NCT03495661|EMG|emg
12397|NCT03495661|Neurogenic Claudication|neurogenic claudication
12398|NCT03495661|Pseudoclaudication|pseudoclaudication
12399|NCT03495648|farmers market|farmers market
12400|NCT03495648|Appalachia|appalachia
12401|NCT03495648|physical activity|physical activity
12402|NCT03495648|fruit and vegetable voucher program|fruit and vegetable voucher program
12403|NCT03495635|mentoring|mentoring
12405|NCT03495622|Text messaging|text messaging
12406|NCT03495622|Community health worker|community health worker
12407|NCT03495622|Smoking cessation|smoking cessation
12408|NCT03495622|India|india
12409|NCT03495622|Cardiovascular mortality|cardiovascular mortality
12410|NCT03495583|Food allergy|food allergy
12411|NCT03495583|Child Health|child health
12412|NCT03495583|Oral tolerance induction|oral tolerance induction
12413|NCT03495583|Food allergic sensitisation|food allergic sensitisation
12414|NCT03495583|Obesity|obesity
12415|NCT03495570|immunological|immunological
12416|NCT03495557|Hernia|hernia
12417|NCT03495557|Cholecystectomy|cholecystectomy
12418|NCT03495557|Mesh fixation|mesh fixation
12419|NCT03495531|virtual reality|virtual reality
12420|NCT03495531|obstetrics|obstetrics
12421|NCT03495531|labor procedures|labor procedures
12422|NCT03495531|regional anesthesia|regional anesthesia
12423|NCT03495518|Cancer|cancer
12424|NCT03495518|Randomized Control Trial|randomized control trial
12425|NCT03495518|Children|children
12426|NCT03495518|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
12427|NCT03495518|Quality of Life|quality of life
12428|NCT03495505|WiSE-CRT|wise-crt
12429|NCT03495505|Endocardial Pacing Optimisation|endocardial pacing optimisation
12430|NCT03495505|Cardiac Resynchronisation Therapy|cardiac resynchronisation therapy
12431|NCT03495492|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
12432|NCT03495492|CLL|cll
12433|NCT03495492|Dermal Chelation|dermal chelation
12434|NCT03495492|Nutritional Therapy|nutritional therapy
12435|NCT03495479|Prostate Cancer|prostate cancer
12436|NCT03495479|PC|pc
12437|NCT03495479|Active Surveillance|active surveillance
12438|NCT03495479|Chemonaiive|chemonaiive
12439|NCT03495479|OMN54|omn54
12440|NCT03495479|Aneustat (TM)|aneustat (tm)
12441|NCT03495479|PSA|psa
12442|NCT03495479|BPH|bph
12443|NCT03495440|Emotional Security|emotional security
12444|NCT03495440|Intellectual Disability|intellectual disability
12445|NCT03495440|Developmental Disability|developmental disability
12446|NCT03495427|radioactive diagnostic imaging|radioactive diagnostic imaging
12447|NCT03495375|Impulsivity|impulsivity
12448|NCT03495375|Compulsivity|compulsivity
12449|NCT03495375|Aggression|aggression
12450|NCT03495375|Microbiome|microbiome
12451|NCT03495375|Probiotic|probiotic
12452|NCT03495375|Nutrition|nutrition
12453|NCT03495375|Psychiatric disorders|psychiatric disorders
12454|NCT03495375|Synbiotic2000Forte|synbiotic2000forte
12455|NCT03495362|Yeast Beta-glucan|yeast beta-glucan
12456|NCT03495362|Immune Function|immune function
12457|NCT03495362|Prediabetes|prediabetes
12458|NCT03495362|Gut Microbiota|gut microbiota
12459|NCT03495336|Boiled coffee|boiled coffee
12460|NCT03495336|Cardiovascular disease|cardiovascular disease
12461|NCT03495336|Cholesterol|cholesterol
12462|NCT03495336|Homocysteine|homocysteine
12463|NCT03495336|Turkish coffee|turkish coffee
12464|NCT03495336|Diterpenes|diterpenes
12465|NCT03495336|Unfiltered coffee|unfiltered coffee
12466|NCT03495323|Cancer Care|cancer care
12467|NCT03495297|subcutaneous implantable cardioverter defibrillator|subcutaneous implantable cardioverter defibrillator
12468|NCT03495297|Defibrillation testing|defibrillation testing
12469|NCT03495271|Hemodialysis|hemodialysis
12470|NCT03495271|Taste|taste
12471|NCT03495271|Blood|blood
12472|NCT03495271|Saliva|saliva
12473|NCT03495245|pain|pain
12474|NCT03495245|opioid|opioid
12475|NCT03495245|fibromyalgia|fibromyalgia
12476|NCT03495232|Total Knee Arthroplasty|total knee arthroplasty
12477|NCT03495232|Persona knee system|persona knee system
12478|NCT03495232|osteoarthrosis|osteoarthrosis
12479|NCT03495232|Knee|knee
12480|NCT03495193|exercise|exercise
12481|NCT03495128|muscle protein breakdown|muscle protein breakdown
12482|NCT03495128|inactivity|inactivity
12483|NCT03495128|bed rest|bed rest
12484|NCT03495115|Breast Cancer|breast cancer
12485|NCT03495089|Screening; Sudomotor reflex; DEC; Primary Care|screening; sudomotor reflex; dec; primary care
12486|NCT03495076|Tactile acuity|tactile acuity
12487|NCT03495076|Tactile dysfunction|tactile dysfunction
12488|NCT03495076|Sensory dissociation|sensory dissociation
12489|NCT03495076|Two-point discrimination|two-point discrimination
12490|NCT03495076|Perception|perception
12491|NCT03495050|Bicuspid|bicuspid
12492|NCT03495050|TAVI|tavi
12493|NCT03495050|TAVR|tavr
12494|NCT03495050|self-expanding|self-expanding
12495|NCT03495050|Evolut|evolut
12496|NCT03495037|Age-related cognitive changes|age-related cognitive changes
12497|NCT03495024|Schizophrenia|schizophrenia
12498|NCT03495024|Schizoaffective disorder|schizoaffective disorder
12499|NCT03495024|Antipsychotics|antipsychotics
12500|NCT03495024|Tobacco smoking|tobacco smoking
12501|NCT03495024|Tardive dyskinesia|tardive dyskinesia
12502|NCT03495024|Parkinsonism|parkinsonism
12503|NCT03495011|Ductal Carcinoma in Situ|ductal carcinoma in situ
12504|NCT03495011|MRI|mri
12505|NCT03495011|Oncotype Dx|oncotype dx
12506|NCT03494959|Pentaglobin|pentaglobin
12507|NCT03494959|Carbapenem-resistant Klebsiella pneumoniae|carbapenem-resistant klebsiella pneumoniae
12508|NCT03494959|Pseudomonas aeruginosa|pseudomonas aeruginosa
12509|NCT03494959|febrile neutropenia|febrile neutropenia
12510|NCT03494959|infection-related mortality|infection-related mortality
12511|NCT03494946|Liver metastasis|liver metastasis
12512|NCT03494946|Colorectal cancer|colorectal cancer
12513|NCT03494920|Stroke|stroke
12514|NCT03494920|Ischemia|ischemia
12515|NCT03494920|Cerebral Infarction|cerebral infarction
12516|NCT03494920|Cerebrovascular Disorders|cerebrovascular disorders
12517|NCT03494920|Brain Diseases|brain diseases
12518|NCT03494920|Central Nervous System Diseases|central nervous system diseases
12519|NCT03494920|Nervous System Diseases|nervous system diseases
12520|NCT03494920|Vascular Diseases|vascular diseases
12521|NCT03494920|Cardiovascular Diseases|cardiovascular diseases
12522|NCT03494920|Pathologic Processes|pathologic processes
12523|NCT03494920|Brain Infarction|brain infarction
12524|NCT03494920|Brain Ischemia|brain ischemia
12525|NCT03494920|Tissue Plasminogen Activator|tissue plasminogen activator
12526|NCT03494920|Plasminogen|plasminogen
12527|NCT03494920|Fibrinolytic Agents|fibrinolytic agents
12528|NCT03494920|Fibrin Modulating Agents|fibrin modulating agents
12529|NCT03494920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
12530|NCT03494842|TENS|tens
12531|NCT03494842|pain relief|pain relief
12532|NCT03494842|STOP|stop
12533|NCT03494842|surgical abortion|surgical abortion
12534|NCT03494829|early onset scoliosis|early onset scoliosis
12535|NCT03494829|motor competence|motor competence
12536|NCT03494829|physical activity|physical activity
12537|NCT03494829|pulmonary function|pulmonary function
12538|NCT03494829|health related quality of life|health related quality of life
12539|NCT03494816|Neoadjuvant|neoadjuvant
12540|NCT03494816|Venous Tumour Thrombus|venous tumour thrombus
12541|NCT03494816|Axitinib|axitinib
12542|NCT03494816|Mayo Classification|mayo classification
12543|NCT03494816|Nephrectomy|nephrectomy
12544|NCT03494816|Thrombectomy|thrombectomy
12545|NCT03494790|MMP|mmp
12546|NCT03494790|Matrix metalloproteinase|matrix metalloproteinase
12547|NCT03494790|Metabolomics|metabolomics
12548|NCT03494790|FGF-21|fgf-21
12549|NCT03494790|Quick SOFA|quick sofa
12550|NCT03494790|Infection|infection
12551|NCT03494790|Triage|triage
12552|NCT03494777|ART adherence|art adherence
12553|NCT03494764|Hyperbaric Oxygen Therapy|hyperbaric oxygen therapy
12554|NCT03494751|Monitoring|monitoring
12555|NCT03494751|Myocardial infarction|myocardial infarction
12556|NCT03494751|Clinical trial|clinical trial
12557|NCT03494738|Prenatal alcohol exposure|prenatal alcohol exposure
12558|NCT03494725|Probiotic|probiotic
12559|NCT03494725|Gut-brain axis|gut-brain axis
12560|NCT03494725|Stress|stress
12561|NCT03494725|Anxiety|anxiety
12562|NCT03494712|healthy volunteer|healthy volunteer
12563|NCT03494712|antimiR|antimir
12564|NCT03494712|single ascending dose|single ascending dose
12565|NCT03494686|conization|conization
12566|NCT03494686|LLETZ|lletz
12567|NCT03494686|randomized controlled trial|randomized controlled trial
12568|NCT03494686|loop excision|loop excision
12569|NCT03494686|general anaesthesia|general anaesthesia
12570|NCT03494686|local anaesthesia|local anaesthesia
12571|NCT03494673|White matter hyperintensity|white matter hyperintensity
12572|NCT03494673|Cerebrovascular reactivity|cerebrovascular reactivity
12573|NCT03494660|Subchondroplasty|subchondroplasty
12574|NCT03494660|Bone Marrow Lesion|bone marrow lesion
12575|NCT03494660|Arthroscopy|arthroscopy
12576|NCT03494660|Bone Substitute Material|bone substitute material
12577|NCT03494660|AccuFill|accufill
12578|NCT03494660|Subchondral Bone Defect|subchondral bone defect
12579|NCT03494608|cognitive function|cognitive function
12580|NCT03494608|quality of life|quality of life
12581|NCT03494608|anxiety|anxiety
12582|NCT03494608|depression|depression
12583|NCT03494608|neurological function|neurological function
12584|NCT03494595|Pediatric Liver Transplantation, Thromboelastometry|pediatric liver transplantation, thromboelastometry
12585|NCT03494543|Ampullary Adenoma|ampullary adenoma
12586|NCT03494543|Endoscopic Papillectomy|endoscopic papillectomy
12587|NCT03494543|Familial Adenomatous Polyposis|familial adenomatous polyposis
12588|NCT03494478|Cohort study|cohort study
12589|NCT03494478|Emotion dysregulation|emotion dysregulation
12590|NCT03494478|Questionnaires|questionnaires
12591|NCT03494478|Actimetry|actimetry
12592|NCT03494478|Neuropsychology|neuropsychology
12593|NCT03494452|electromyography, strength, strength endurance|electromyography, strength, strength endurance
12594|NCT03494400|Breast cancer|breast cancer
12595|NCT03494400|Physical exercise|physical exercise
12596|NCT03494400|Body mass|body mass
12597|NCT03494387|Antioxidant|antioxidant
12598|NCT03494387|Hyperoxia|hyperoxia
12599|NCT03494387|Troponin|troponin
12600|NCT03494387|MINS|mins
12601|NCT03494387|Ascorbic acid|ascorbic acid
12602|NCT03494387|N-acetylcysteine|n-acetylcysteine
12603|NCT03494374|pes planus|pes planus
12604|NCT03494374|UCBL|ucbl
12605|NCT03494374|exercise|exercise
12606|NCT03494361|deglutition disorders|deglutition disorders
12607|NCT03494361|electromyography|electromyography
12608|NCT03494348|Radiostereometry (RSA)|radiostereometry (rsa)
12609|NCT03494348|Total Knee Arthroplasty|total knee arthroplasty
12610|NCT03494309|Mandibular Subcondylar Fractures|mandibular subcondylar fractures
12611|NCT03494309|Mouth Opening|mouth opening
12612|NCT03494309|Open Reduction and Internal Fixation|open reduction and internal fixation
12613|NCT03494309|Closed Reduction with External Fixation|closed reduction with external fixation
12614|NCT03494283|CrossFit injuries|crossfit injuries
12615|NCT03494257|phacoemulsification|phacoemulsification
12616|NCT03494257|intraocular pressure|intraocular pressure
12617|NCT03494257|cataract|cataract
12618|NCT03494257|brinzolamide|brinzolamide
12619|NCT03494257|brimonidinde|brimonidinde
12620|NCT03494257|fixed combination|fixed combination
12621|NCT03494244|acellular dermal matrix|acellular dermal matrix
12622|NCT03494244|breast reconstruction|breast reconstruction
12623|NCT03494244|efficacy|efficacy
12624|NCT03494231|Metastatic|metastatic
12625|NCT03494231|Refractory|refractory
12626|NCT03494231|Cancer|cancer
12627|NCT03494231|Solid|solid
12628|NCT03494231|Tumor|tumor
12629|NCT03494218|disorders of consciousness|disorders of consciousness
12630|NCT03494218|vegetative state|vegetative state
12631|NCT03494218|minimally conscious state|minimally conscious state
12632|NCT03494218|consciousness|consciousness
12633|NCT03494218|pain assessment|pain assessment
12634|NCT03494218|nociception test|nociception test
12635|NCT03494205|Radiation Dermatitis|radiation dermatitis
12636|NCT03494205|Urtica comp.|urtica comp.
12637|NCT03494192|acromiohumeral distance|acromiohumeral distance
12638|NCT03494192|pain|pain
12639|NCT03494192|functional level|functional level
12640|NCT03494192|Subacromial Impingement Syndrome|subacromial impingement syndrome
12641|NCT03494127|wheelchair seating|wheelchair seating
12642|NCT03494127|tissue health|tissue health
12643|NCT03494088|Autism|autism
12644|NCT03494088|Abdominal Pain|abdominal pain
12645|NCT03494075|Patients|patients
12646|NCT03494075|Caregivers|caregivers
12647|NCT03494036|synbiotic|synbiotic
12648|NCT03494036|probiotic|probiotic
12649|NCT03494036|lupus|lupus
12650|NCT03494036|connective tissue disease|connective tissue disease
12651|NCT03494010|Kidney Transplantation|kidney transplantation
12652|NCT03493971|carotid endarterectomy|carotid endarterectomy
12653|NCT03493971|carotid stenting|carotid stenting
12654|NCT03493971|autonomic function|autonomic function
12655|NCT03493971|computational fluid dynamic|computational fluid dynamic
12656|NCT03493971|cognitive function|cognitive function
12657|NCT03493958|Alcohol Dependence|alcohol dependence
12658|NCT03493958|Alcohol use Disorder|alcohol use disorder
12659|NCT03493958|Insomnia|insomnia
12660|NCT03493945|Immunotherapy|immunotherapy
12661|NCT03493945|Combined Treatment|combined treatment
12662|NCT03493945|PD-1/PD-L1|pd-1/pd-l1
12663|NCT03493945|Tumor-Specific T Cells|tumor-specific t cells
12664|NCT03493945|Novel Cancer Vaccine|novel cancer vaccine
12665|NCT03493932|Glioblastoma|glioblastoma
12666|NCT03493932|Glioma|glioma
12667|NCT03493932|Brain Tumor|brain tumor
12668|NCT03493932|Immune Therapy|immune therapy
12669|NCT03493932|Checkpoint Inhibition|checkpoint inhibition
12670|NCT03493919|Immunological assays|immunological assays
12671|NCT03493919|Human blood donors|human blood donors
12672|NCT03493919|Meningococcal vaccination|meningococcal vaccination
12673|NCT03493919|Meningococcal disease|meningococcal disease
12674|NCT03493867|Non-invasive blood pressure monitoring|non-invasive blood pressure monitoring
12675|NCT03493867|Wearable device|wearable device
12676|NCT03493867|Medical device verification study|medical device verification study
12677|NCT03493802|ADPKD|adpkd
12678|NCT03493802|Endothelial dysfunction|endothelial dysfunction
12679|NCT03493802|Oxidative stress|oxidative stress
12680|NCT03493802|NADPH oxidase 4 (NOX4)|nadph oxidase 4 (nox4)
12681|NCT03493802|Mitochondria|mitochondria
12682|NCT03493763|Recurrence Monitoring|recurrence monitoring
12683|NCT03493763|5-Hydroxymethylcytosine|5-hydroxymethylcytosine
12684|NCT03493763|Liquid biopsy|liquid biopsy
12685|NCT03493763|Cell-free DNA|cell-free dna
12686|NCT03493672|Phase I clinical trial|phase i clinical trial
12687|NCT03493672|Phase II clinical trial|phase ii clinical trial
12688|NCT03493672|Early trial discontinuation|early trial discontinuation
12689|NCT03493672|Objective smartphone measurements|objective smartphone measurements
12690|NCT03493672|Physical activity|physical activity
12691|NCT03493672|Physical fitness|physical fitness
12692|NCT03493659|Standing|standing
12693|NCT03493659|Sitting|sitting
12694|NCT03493659|Learning|learning
12695|NCT03493659|Problem-Based Learning|problem-based learning
12696|NCT03493659|Undergraduate|undergraduate
12697|NCT03493646|Myelodysplastic Syndrome|myelodysplastic syndrome
12698|NCT03493646|MDS|mds
12699|NCT03493646|Acute Myeloid Leukemia|acute myeloid leukemia
12700|NCT03493646|AML|aml
12701|NCT03493646|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
12702|NCT03493646|CMML|cmml
12703|NCT03493607|AMO-01|amo-01
12704|NCT03493607|Shank3|shank3
12705|NCT03493607|Clinical Trial|clinical trial
12706|NCT03493594|Early nutrition|early nutrition
12707|NCT03493594|Breastfeeding|breastfeeding
12708|NCT03493594|Infant growth|infant growth
12709|NCT03493529|Endometrial microbiome|endometrial microbiome
12710|NCT03493529|Obesity|obesity
12711|NCT03493529|Bacterial pathogens|bacterial pathogens
12712|NCT03493529|Dysbiosis|dysbiosis
12713|NCT03493529|Endometrial receptivity|endometrial receptivity
12714|NCT03493516|Positron Emission Tomography|positron emission tomography
12715|NCT03493516|Sympathetic Innervation|sympathetic innervation
12716|NCT03493516|Sudden Death|sudden death
12717|NCT03493516|Ventricular Fibrillation|ventricular fibrillation
12718|NCT03493516|LMI-1195|lmi-1195
12719|NCT03493516|Ischemic Cardiomyopathy|ischemic cardiomyopathy
12720|NCT03493516|Risk Prediction|risk prediction
12721|NCT03493490|Double-Blind Method|double-blind method
12722|NCT03493490|placebo-controlled|placebo-controlled
12723|NCT03493490|parallel-group|parallel-group
12724|NCT03493490|single-centre|single-centre
12725|NCT03493490|exploratory clinical study|exploratory clinical study
12726|NCT03493399|Gambling|gambling
12727|NCT03493399|Craving|craving
12728|NCT03493399|Urge|urge
12729|NCT03493399|Desire|desire
12730|NCT03493399|Interference|interference
12731|NCT03493399|Elaborated Intrusion Theory|elaborated intrusion theory
12732|NCT03493399|Treatment|treatment
12733|NCT03493399|Intervention|intervention
12734|NCT03493399|Clinical Sample|clinical sample
12735|NCT03493399|Single case|single case
12736|NCT03493386|Japan|japan
12737|NCT03493386|Crossover|crossover
12738|NCT03493386|Daprodustat|daprodustat
12739|NCT03493386|Bioequivalence|bioequivalence
12740|NCT03493386|Pharmacokinetics|pharmacokinetics
12741|NCT03493269|Rheumatoid Arthritis;|rheumatoid arthritis;
12742|NCT03493269|Psoriasis|psoriasis
12743|NCT03493243|Adolescent|adolescent
12744|NCT03493243|Post Traumatic Stress Disorder|post traumatic stress disorder
12745|NCT03493243|Terrorist Attack|terrorist attack
12746|NCT03493204|Hepatic Encephalopathy|hepatic encephalopathy
12747|NCT03493204|Ascites|ascites
12748|NCT03493204|Liver Diseases|liver diseases
12749|NCT03493204|Cirrhosis|cirrhosis
12750|NCT03493126|postpartum, local estrogen|postpartum, local estrogen
12751|NCT03493113|EEG|eeg
12752|NCT03493100|oral nutritional supplementation|oral nutritional supplementation
12753|NCT03493100|geriatrics|geriatrics
12754|NCT03493100|bone fracture|bone fracture
12755|NCT03493087|Dialysis, Vitamin-K, Malnutrition|dialysis, vitamin-k, malnutrition
12756|NCT03493035|Middle Cerebral Artery|middle cerebral artery
12757|NCT03493035|Aneurysm|aneurysm
12758|NCT03493035|computed tomography angiogram|computed tomography angiogram
12759|NCT03493035|hemodynamical theory|hemodynamical theory
12760|NCT03492983|Cocoa|cocoa
12761|NCT03492983|Vascular function|vascular function
12762|NCT03492983|Body composition|body composition
12763|NCT03492983|Quality of life|quality of life
12764|NCT03492983|Cognitive performance|cognitive performance
12765|NCT03492983|Postmenopausal women|postmenopausal women
12766|NCT03492957|physical activity|physical activity
12767|NCT03492957|exercise|exercise
12768|NCT03492957|non-ambulatory|non-ambulatory
12769|NCT03492957|feasibility|feasibility
12770|NCT03492957|mixed methods|mixed methods
12771|NCT03492931|Hb SS disease, Hb S Beta 0 Thalassemia|hb ss disease, hb s beta 0 thalassemia
12772|NCT03492892|acupuncture|acupuncture
12773|NCT03492892|hypertension|hypertension
12774|NCT03492892|targeted metabolome|targeted metabolome
12775|NCT03492892|pilot clinical trial|pilot clinical trial
12776|NCT03492814|impacted third molar|impacted third molar
12777|NCT03492814|suturing|suturing
12778|NCT03492814|post-operative morbidity|post-operative morbidity
12779|NCT03492788|cardiac resynchronization therapy|cardiac resynchronization therapy
12780|NCT03492788|electrocardiographic imaging|electrocardiographic imaging
12781|NCT03492775|indolent lymphoma|indolent lymphoma
12782|NCT03492775|Obinutuzumab|obinutuzumab
12783|NCT03492775|GA101|ga101
12784|NCT03492775|Bendamustine|bendamustine
12785|NCT03492775|medically non-fit patients|medically non-fit patients
12786|NCT03492684|nerve injury after total hip arthroplasty|nerve injury after total hip arthroplasty
12787|NCT03492671|Pancreatic Cancer|pancreatic cancer
12788|NCT03492658|abatacept|abatacept
12789|NCT03492658|ACPA expressing B cells|acpa expressing b cells
12790|NCT03492632|psoriasis|psoriasis
12791|NCT03492632|Anti mullerian hormone|anti mullerian hormone
12792|NCT03492632|ovarian reserve|ovarian reserve
12793|NCT03492632|astral follicle count|astral follicle count
12794|NCT03492619|obesity|obesity
12795|NCT03492619|food insecurity|food insecurity
12796|NCT03492619|depressive symptoms|depressive symptoms
12797|NCT03492619|empowerment|empowerment
12798|NCT03492593|carotenoids|carotenoids
12799|NCT03492593|vitamin E|vitamin e
12800|NCT03492593|digestion|digestion
12801|NCT03492593|stability|stability
12802|NCT03492593|metabolism|metabolism
12803|NCT03492567|Cystic fibrosis|cystic fibrosis
12804|NCT03492567|CFTR|cftr
12805|NCT03492567|CFTR modulators|cftr modulators
12806|NCT03492567|Monocyte|monocyte
12807|NCT03492567|Osteoclast|osteoclast
12808|NCT03492567|Osteoporosis|osteoporosis
12809|NCT03492541|mixed dry eye|mixed dry eye
12810|NCT03492541|aqueous-deficient dry eye|aqueous-deficient dry eye
12811|NCT03492541|lipid-deficient dry eye|lipid-deficient dry eye
12812|NCT03492541|evaporative dry eye|evaporative dry eye
12813|NCT03492541|tear film|tear film
12814|NCT03492541|eye drops|eye drops
12815|NCT03492541|artificial tears|artificial tears
12816|NCT03492541|lipid layer|lipid layer
12817|NCT03492541|eye symptoms|eye symptoms
12818|NCT03492541|meibomian gland dysfunction|meibomian gland dysfunction
12819|NCT03492541|MGD|mgd
12820|NCT03492541|SYSTANE|systane
12821|NCT03492541|SYSTANE Complete|systane complete
12822|NCT03492541|nanoemulsion|nanoemulsion
12823|NCT03492515|immune thrombocytopenia|immune thrombocytopenia
12824|NCT03492502|Fecal microbiota transplantation|fecal microbiota transplantation
12825|NCT03492502|allogeneic stem cell transplantation|allogeneic stem cell transplantation
12826|NCT03492502|microbiome|microbiome
12827|NCT03492476|Lymphedema of Upper Arm reduction|lymphedema of upper arm reduction
12828|NCT03492476|Lymphedema Upper Arm device|lymphedema upper arm device
12829|NCT03492463|Nicotine addiction|nicotine addiction
12830|NCT03492463|Cigarette smoking|cigarette smoking
12831|NCT03492463|Nicotine patches|nicotine patches
12832|NCT03492463|E-cigarettes|e-cigarettes
12833|NCT03492450|Treadmill training|treadmill training
12834|NCT03492450|Instrumented assessment|instrumented assessment
12835|NCT03492450|Disease progression|disease progression
12836|NCT03492437|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
12837|NCT03492437|P-glycoprotein|p-glycoprotein
12838|NCT03492437|Tepotinib|tepotinib
12839|NCT03492437|Dabigatran Etexilate|dabigatran etexilate
12840|NCT03492424|prostate cancer|prostate cancer
12841|NCT03492424|cryotherapy|cryotherapy
12842|NCT03492424|focal therapy|focal therapy
12843|NCT03492411|Breastfeeding|breastfeeding
12844|NCT03492411|Co-parenting|co-parenting
12845|NCT03492411|eHealth|ehealth
12846|NCT03492411|patient education|patient education
12847|NCT03492411|fathers|fathers
12848|NCT03492398|atopic dermatitis|atopic dermatitis
12849|NCT03492359|COPD, Structured Light Plethysmography, COPD severity|copd, structured light plethysmography, copd severity
12850|NCT03492346|LGMD2E|lgmd2e
12851|NCT03492346|Limb Girdle Muscular Dystrophy|limb girdle muscular dystrophy
12852|NCT03492346|sarcoglycanopathy|sarcoglycanopathy
12853|NCT03492346|β -sarcoglycan|β -sarcoglycan
12854|NCT03492346|Natural History|natural history
12855|NCT03492333|antigliadin, gluten free diet, transit|antigliadin, gluten free diet, transit
12856|NCT03492320|HRQoL|hrqol
12857|NCT03492320|Quality of Life|quality of life
12858|NCT03492320|End Stage Osteoarthritis|end stage osteoarthritis
12859|NCT03492320|Total Knee Arthroplasty|total knee arthroplasty
12860|NCT03492320|WOMAC|womac
12861|NCT03492320|SF 36|sf 36
12862|NCT03492320|Total Knee Replacement|total knee replacement
12863|NCT03492307|High Flow Nasal Cannula|high flow nasal cannula
12864|NCT03492294|disorders of consciousness|disorders of consciousness
12865|NCT03492294|music stimulation|music stimulation
12866|NCT03492294|functional magnetic resonance imaging|functional magnetic resonance imaging
12867|NCT03492281|Beta-3 adrenergic receptor (β3-AR) agonists|beta-3 adrenergic receptor (β3-ar) agonists
12868|NCT03492281|Incontinence|incontinence
12869|NCT03492281|OAB|oab
12870|NCT03492281|Vibegron|vibegron
12871|NCT03492281|Urge urinary incontinence|urge urinary incontinence
12872|NCT03492281|Urinary bladder, overactive|urinary bladder, overactive
12873|NCT03492281|Urologic Diseases|urologic diseases
12874|NCT03492281|Lower Urinary Tract Symptoms|lower urinary tract symptoms
12875|NCT03492281|Urological Agents|urological agents
12876|NCT03492242|Anti-PD-1|anti-pd-1
12877|NCT03492242|Anti-PD-L1|anti-pd-l1
12878|NCT03492242|Anti-CTLA-4|anti-ctla-4
12879|NCT03492242|Immune checkpoint inhibitors|immune checkpoint inhibitors
12880|NCT03492242|Immune adverse drug reactions|immune adverse drug reactions
12881|NCT03492229|Gait|gait
12882|NCT03492229|Brain stimulation|brain stimulation
12883|NCT03492229|tDCS|tdcs
12884|NCT03492229|Walking|walking
12885|NCT03492203|Cognitive Remediation|cognitive remediation
12886|NCT03492203|Neurocognition|neurocognition
12887|NCT03492203|Severe mental illness|severe mental illness
12888|NCT03492203|Remote treatment|remote treatment
12889|NCT03492190|protein availability|protein availability
12890|NCT03492190|beans|beans
12891|NCT03492190|children|children
12892|NCT03492190|elderly|elderly
12893|NCT03492177|Pediatric|pediatric
12894|NCT03492151|Confocal laser endomicroscopy|confocal laser endomicroscopy
12895|NCT03492138|Multiple Myeloma|multiple myeloma
12896|NCT03492138|Relapsed and Refractory|relapsed and refractory
12897|NCT03492086|Rosmarinus officinalis L|rosmarinus officinalis l
12898|NCT03492086|alkylglycerols|alkylglycerols
12899|NCT03492086|immuno-nutrition|immuno-nutrition
12900|NCT03492086|colon cancer|colon cancer
12901|NCT03492073|Mindfulness|mindfulness
12902|NCT03492073|Oncology|oncology
12903|NCT03492073|Cancer|cancer
12904|NCT03492073|Emotional distress|emotional distress
12905|NCT03492073|Quality of life|quality of life
12906|NCT03492060|Gene Variant|gene variant
12907|NCT03492047|paclitaxel|paclitaxel
12908|NCT03492047|peripheral neuropathy|peripheral neuropathy
12909|NCT03492047|N-acetyl cysteine|n-acetyl cysteine
12910|NCT03492021|rehabilitative nutrition|rehabilitative nutrition
12911|NCT03492021|protein|protein
12912|NCT03492021|beef|beef
12913|NCT03492021|ACL reconstruction|acl reconstruction
12914|NCT03492021|protein synthesis|protein synthesis
12915|NCT03492021|proteolysis|proteolysis
12916|NCT03492021|muscle mass|muscle mass
12917|NCT03492021|muscle strength|muscle strength
12918|NCT03492008|nasogastric tube|nasogastric tube
12919|NCT03492008|general anesthesia|general anesthesia
12920|NCT03492008|head position|head position
12921|NCT03491982|Cardiac Rehabilitation|cardiac rehabilitation
12922|NCT03491930|Weight Loss|weight loss
12923|NCT03491930|Obesity|obesity
12924|NCT03491930|Pre-Diabetes|pre-diabetes
12925|NCT03491930|Metabolic Syndrome|metabolic syndrome
12926|NCT03491891|Very Late Stent Thrombosis|very late stent thrombosis
12927|NCT03491891|New generation DES|new generation des
12928|NCT03491774|memory impairment, montessori intervention, neurocognitive disorder|memory impairment, montessori intervention, neurocognitive disorder
12929|NCT03491761|Platelet Rich Plasma (PRP)|platelet rich plasma (prp)
12930|NCT03491761|Viscosupplementation|viscosupplementation
12931|NCT03491761|Knee Osteoarthritis|knee osteoarthritis
12932|NCT03491761|Hyaluronic Acid (HA)|hyaluronic acid (ha)
12933|NCT03491761|Supartz|supartz
12934|NCT03491761|WOMAC|womac
12935|NCT03491761|KOOS|koos
12936|NCT03491748|Pharmacokinetics|pharmacokinetics
12937|NCT03491748|ETX0282|etx0282
12938|NCT03491748|Single Ascending Dose|single ascending dose
12939|NCT03491748|Multiple Ascending Doses|multiple ascending doses
12940|NCT03491748|ETX1317|etx1317
12941|NCT03491748|Cefpodoxime Proxetil|cefpodoxime proxetil
12942|NCT03491748|Cefpodoxime|cefpodoxime
12943|NCT03491748|Enterobacteriaceae Infections|enterobacteriaceae infections
12944|NCT03491735|patterns|patterns
12945|NCT03491735|glaucoma|glaucoma
12946|NCT03491735|egypt|egypt
12947|NCT03491735|india|india
12948|NCT03491735|2018|2018
12949|NCT03491696|Depressive disorder|depressive disorder
12950|NCT03491696|Metyrapone|metyrapone
12951|NCT03491696|Dexamethasone Suppression Test|dexamethasone suppression test
12952|NCT03491696|Antidepressive association|antidepressive association
12953|NCT03491696|Hypothalamic-pituitary-adrenal axis|hypothalamic-pituitary-adrenal axis
12954|NCT03491696|Cortisol|cortisol
12955|NCT03491696|Selective Serotonin Reuptake Inhibitor|selective serotonin reuptake inhibitor
12956|NCT03491696|Serotonin and Norepinephrine Reuptake Inhibitor|serotonin and norepinephrine reuptake inhibitor
12957|NCT03491683|Glioblastoma|glioblastoma
12958|NCT03491683|immunotherapy|immunotherapy
12959|NCT03491683|DNA therapy|dna therapy
12960|NCT03491683|checkpoint inhibitor|checkpoint inhibitor
12961|NCT03491657|virtual reality pain|virtual reality pain
12962|NCT03491657|opioid|opioid
12963|NCT03491657|pediatric burn|pediatric burn
12964|NCT03491657|wound care|wound care
12965|NCT03491644|Traumatic accident|traumatic accident
12966|NCT03491644|Oxygen|oxygen
12967|NCT03491644|Intensive Care|intensive care
12968|NCT03491644|Emergency|emergency
12969|NCT03491618|lumbar facet joint pain|lumbar facet joint pain
12970|NCT03491618|Lumbar Medial Branch Neurotomy|lumbar medial branch neurotomy
12971|NCT03491618|Chronic Low Back Pain|chronic low back pain
12972|NCT03491605|chronic EBV infection, hemophagocytic lymphohistiocytosis|chronic ebv infection, hemophagocytic lymphohistiocytosis
12973|NCT03491592|Physical Activity|physical activity
12974|NCT03491592|Latinas|latinas
12975|NCT03491592|Spanish-language|spanish-language
12976|NCT03491592|Text-Message|text-message
12977|NCT03491592|Exercise|exercise
12978|NCT03491592|Web-based|web-based
12979|NCT03491579|AML|aml
12980|NCT03491579|Epacadostat|epacadostat
12981|NCT03491579|Cladribine|cladribine
12982|NCT03491579|Cytarabine|cytarabine
12983|NCT03491540|Mechanical Bowel Preparation (MBP)|mechanical bowel preparation (mbp)
12984|NCT03491540|Oral antibiotics|oral antibiotics
12985|NCT03491540|Rectal cancer surgery|rectal cancer surgery
12986|NCT03491540|Surgical site infection|surgical site infection
12987|NCT03491501|Industrial work|industrial work
12988|NCT03491501|physical effort|physical effort
12989|NCT03491501|mental effort|mental effort
12990|NCT03491501|questionnaires|questionnaires
12991|NCT03491501|ergonomic evaluation|ergonomic evaluation
12992|NCT03491488|executive function|executive function
12993|NCT03491488|Early childhood education|early childhood education
12994|NCT03491488|self regulation|self regulation
12995|NCT03491475|Ajmaline test|ajmaline test
12996|NCT03491462|arimoclomol|arimoclomol
12997|NCT03491462|ALS|als
12998|NCT03491449|Brain ischemia|brain ischemia
12999|NCT03491449|Cerebral ischemia|cerebral ischemia
13000|NCT03491410|Metastatic|metastatic
13001|NCT03491410|Active Surveillance|active surveillance
13002|NCT03491397|Microspheres|microspheres
13003|NCT03491397|Artery Embolization|artery embolization
13004|NCT03491397|Knee Osteoarthritis|knee osteoarthritis
13005|NCT03491397|Chronic Pain|chronic pain
13006|NCT03491397|Embozene|embozene
13007|NCT03491384|anxiety|anxiety
13008|NCT03491384|inflammation|inflammation
13009|NCT03491384|cannabis|cannabis
13010|NCT03491384|marijuana|marijuana
13011|NCT03491384|stress|stress
13012|NCT03491371|apatinib|apatinib
13013|NCT03491371|tyrosine-kinase inhibitors|tyrosine-kinase inhibitors
13014|NCT03491371|osteosarcoma|osteosarcoma
13015|NCT03491371|Ewing sarcoma|ewing sarcoma
13016|NCT03491371|chondrosarcoma|chondrosarcoma
13017|NCT03491371|soft-tissue sarcoma|soft-tissue sarcoma
13018|NCT03491358|vibrating mesh nebulizer|vibrating mesh nebulizer
13019|NCT03491358|allergen challenge|allergen challenge
13020|NCT03491319|Anesthetics, Local|anesthetics, local
13021|NCT03491319|Head-Down Tilt|head-down tilt
13022|NCT03491319|Anesthesia, Spinal|anesthesia, spinal
13023|NCT03491319|hypotension|hypotension
13024|NCT03491306|PEEK|peek
13025|NCT03491306|Breflex|breflex
13026|NCT03491293|internet|internet
13027|NCT03491293|behavioral weight loss|behavioral weight loss
13028|NCT03491293|obesity|obesity
13029|NCT03491280|Rare Diseases|rare diseases
13030|NCT03491280|Genetic Predisposition|genetic predisposition
13031|NCT03491280|Omics Technology|omics technology
13032|NCT03491280|Next Generation Sequencing (NGS)|next generation sequencing (ngs)
13033|NCT03491267|alopecia|alopecia
13034|NCT03491215|Graft versus host disease (GvHD)|graft versus host disease (gvhd)
13035|NCT03491215|acute graft versus host disease (aGvHD)|acute graft versus host disease (agvhd)
13036|NCT03491215|Steroid refractory acute graft versus host disease (SR-aGvHD)|steroid refractory acute graft versus host disease (sr-agvhd)
13037|NCT03491215|Ruxolitinib|ruxolitinib
13038|NCT03491215|INC424|inc424
13039|NCT03491215|allogeneic stem cell transplantation|allogeneic stem cell transplantation
13040|NCT03491176|Head and Neck Cancer|head and neck cancer
13041|NCT03491176|Magnetic resonance imaging|magnetic resonance imaging
13042|NCT03491176|MRI|mri
13043|NCT03491176|Biomarker testing|biomarker testing
13044|NCT03491176|Blood draws|blood draws
13045|NCT03491176|Questionnaires|questionnaires
13046|NCT03491176|Surveys|surveys
13047|NCT03491163|syndecan-1|syndecan-1
13048|NCT03491163|endothelial glycocalyx|endothelial glycocalyx
13049|NCT03491163|On-pump heart surgery|on-pump heart surgery
13050|NCT03491150|Dementia|dementia
13051|NCT03491150|Neurodegenerative Diseases|neurodegenerative diseases
13052|NCT03491150|Brain Diseases|brain diseases
13053|NCT03491150|Central Nervous System Diseases|central nervous system diseases
13054|NCT03491150|Nervous System Diseases|nervous system diseases
13055|NCT03491150|Tauopathies|tauopathies
13056|NCT03491150|Neurocognitive Disorders|neurocognitive disorders
13057|NCT03491150|Mental Disorders|mental disorders
13058|NCT03491137|Wireless monitoring, postoperative complications|wireless monitoring, postoperative complications
13059|NCT03491111|Cerebrovascular disease|cerebrovascular disease
13060|NCT03491111|respiratory muscle training|respiratory muscle training
13061|NCT03491111|spirometry|spirometry
13062|NCT03491111|peak flow|peak flow
13063|NCT03491111|maximal inspiratory pressure, maximal expiratory pressure|maximal inspiratory pressure, maximal expiratory pressure
13064|NCT03491098|Otitis Media with Effusion|otitis media with effusion
13065|NCT03491072|extracorporeal shock-wave Lithotripsy,|extracorporeal shock-wave lithotripsy,
13066|NCT03491072|pain relief during extracorporeal shock-wave Lithotripsy|pain relief during extracorporeal shock-wave lithotripsy
13067|NCT03491072|fentanyl|fentanyl
13068|NCT03491072|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
13069|NCT03491033|advanced-stage ovarian cancer|advanced-stage ovarian cancer
13070|NCT03491033|neoadjuvant chemotherapy|neoadjuvant chemotherapy
13071|NCT03491033|residual disease|residual disease
13072|NCT03491033|genomic profiling|genomic profiling
13073|NCT03491033|immunohistochemistry|immunohistochemistry
13074|NCT03491020|Emission Patterns|emission patterns
13075|NCT03491020|Respiratory|respiratory
13076|NCT03491020|Aerosolization|aerosolization
13077|NCT03491020|Airborne|airborne
13078|NCT03491007|PTSD|ptsd
13079|NCT03491007|DHEA|dhea
13080|NCT03490981|primary care|primary care
13081|NCT03490981|chronic pain|chronic pain
13082|NCT03490981|musculoskeletal pain|musculoskeletal pain
13083|NCT03490981|cognitive behavioral therapy|cognitive behavioral therapy
13084|NCT03490981|integrated primary care|integrated primary care
13085|NCT03490942|glucagon|glucagon
13086|NCT03490942|hypoglycemia counter-regulation|hypoglycemia counter-regulation
13087|NCT03490916|Acetazolamide|acetazolamide
13088|NCT03490916|High-altitude illness|high-altitude illness
13089|NCT03490916|High-altitude pulmonary edema|high-altitude pulmonary edema
13090|NCT03490916|Lung comets|lung comets
13091|NCT03490916|Lung ultrasound|lung ultrasound
13092|NCT03490916|Subclinical high-altitude pulmonary edema|subclinical high-altitude pulmonary edema
13093|NCT03490903|virtual reality|virtual reality
13094|NCT03490903|anxiety|anxiety
13095|NCT03490903|vasospasm|vasospasm
13096|NCT03490903|pain|pain
13097|NCT03490903|coronary artery angiography|coronary artery angiography
13098|NCT03490903|angiogram|angiogram
13399|NCT03489304|Insomnia|insomnia
13100|NCT03490890|microwave ablation|microwave ablation
13101|NCT03490890|lung cancer|lung cancer
13102|NCT03490890|ground glass nodules|ground glass nodules
13103|NCT03490877|Atopic Dermatitis|atopic dermatitis
13104|NCT03490877|Pruritus|pruritus
13105|NCT03490877|Sleep Disturbance|sleep disturbance
13106|NCT03490786|GT-001|gt-001
13107|NCT03490773|Cpeptide|cpeptide
13108|NCT03490773|Immunology|immunology
13109|NCT03490760|Metastatic Adenocarcinoma of the Pancreas|metastatic adenocarcinoma of the pancreas
13110|NCT03490747|Physical Activity|physical activity
13111|NCT03490747|Pragmatic Evaluation|pragmatic evaluation
13112|NCT03490747|Exercise Referral|exercise referral
13113|NCT03490747|Mixed-methods|mixed-methods
13114|NCT03490747|Behaviour Change|behaviour change
13115|NCT03490747|Intervention|intervention
13116|NCT03490734|nutrition|nutrition
13117|NCT03490734|obesity|obesity
13118|NCT03490734|weight gain|weight gain
13119|NCT03490734|sugar|sugar
13120|NCT03490734|sugar sweetened beverage|sugar sweetened beverage
13121|NCT03490734|dopamine|dopamine
13122|NCT03490734|neurobehavioral adaptation|neurobehavioral adaptation
13123|NCT03490708|Mucinoses|mucinoses
13124|NCT03490708|Tranilast|tranilast
13125|NCT03490643|Plantar Pressure Distribution|plantar pressure distribution
13126|NCT03490643|Posture|posture
13127|NCT03490643|Posturescreen Mobile|posturescreen mobile
13128|NCT03490643|RDC/TMD|rdc/tmd
13129|NCT03490643|TMD|tmd
13130|NCT03490630|patient reported outcome|patient reported outcome
13131|NCT03490630|postoperative pain|postoperative pain
13132|NCT03490630|pain related impairment|pain related impairment
13133|NCT03490630|quality of life|quality of life
13134|NCT03490630|prospective association study|prospective association study
13135|NCT03490617|Intrauterine device|intrauterine device
13136|NCT03490617|Misoprostol|misoprostol
13137|NCT03490617|Nulliparous women|nulliparous women
13138|NCT03490617|Contraception|contraception
13139|NCT03490591|Cerebral Palsy|cerebral palsy
13140|NCT03490591|Robotic rehabilitation|robotic rehabilitation
13141|NCT03490591|Hand function|hand function
13142|NCT03490591|Activities of Daily Living|activities of daily living
13143|NCT03490578|Parkinson Disease|parkinson disease
13144|NCT03490578|Gait|gait
13145|NCT03490578|Balance|balance
13146|NCT03490578|Rehabilitation|rehabilitation
13147|NCT03490578|Robot-assisted gait training|robot-assisted gait training
13148|NCT03490565|exercise training|exercise training
13149|NCT03490565|treatment tolerability|treatment tolerability
13150|NCT03490565|treatment complications|treatment complications
13151|NCT03490539|observational|observational
13152|NCT03490539|comparative effectiveness|comparative effectiveness
13153|NCT03490539|myasthenia gravis|myasthenia gravis
13154|NCT03490500|protein S100B|protein s100b
13155|NCT03490500|negative predictive value|negative predictive value
13156|NCT03490500|headache|headache
13157|NCT03490500|intracranial hemorrhage|intracranial hemorrhage
13158|NCT03490474|conditioned pain modulation (CPM)|conditioned pain modulation (cpm)
13159|NCT03490474|diffuse noxious inhibitory control (DNIC)|diffuse noxious inhibitory control (dnic)
13160|NCT03490474|massage|massage
13161|NCT03490474|hypoalgesia|hypoalgesia
13162|NCT03490448|vitamin D|vitamin d
13163|NCT03490448|obesity|obesity
13164|NCT03490448|body composition|body composition
13165|NCT03490448|glucose metabolism|glucose metabolism
13166|NCT03490448|lipid metabolism|lipid metabolism
13167|NCT03490435|Per os invasions|per os invasions
13168|NCT03490435|Giardiasis|giardiasis
13169|NCT03490435|Toxoplasmosis|toxoplasmosis
13170|NCT03490435|Taeniasis|taeniasis
13171|NCT03490435|Cryptosporidiosis|cryptosporidiosis
13172|NCT03490435|Trichinosis|trichinosis
13173|NCT03490435|Ascariasis|ascariasis
13174|NCT03490435|Echinococcosis|echinococcosis
13175|NCT03490422|pulpotomy|pulpotomy
13176|NCT03490422|permanent teeth|permanent teeth
13177|NCT03490422|deep caries management|deep caries management
13178|NCT03490422|risk factors|risk factors
13179|NCT03490422|clinical indicators for pulpotomy|clinical indicators for pulpotomy
13180|NCT03490409|Arthroplasty|arthroplasty
13181|NCT03490409|Replacement|replacement
13182|NCT03490409|Knee|knee
13183|NCT03490409|Compression|compression
13184|NCT03490409|Edema|edema
13185|NCT03490409|Pain|pain
13186|NCT03490396|Oral Mucositis|oral mucositis
13187|NCT03490396|Stomatitis|stomatitis
13188|NCT03490396|Myeloablative|myeloablative
13189|NCT03490383|ERCP|ercp
13190|NCT03490383|CBD stone|cbd stone
13191|NCT03490383|Microbial Colonization|microbial colonization
13192|NCT03490344|bony plasmacytoma|bony plasmacytoma
13193|NCT03490344|extramedullary plasmacytoma|extramedullary plasmacytoma
13194|NCT03490344|Daratumumab|daratumumab
13195|NCT03490344|lenalidomide|lenalidomide
13196|NCT03490344|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
13197|NCT03490344|18-048|18-048
13198|NCT03490331|JEB|jeb
13199|NCT03490331|Stem cells|stem cells
13200|NCT03490331|Gene Therapy|gene therapy
13201|NCT03490305|War injury|war injury
13400|NCT03489304|Zaleplon|zaleplon
13202|NCT03490305|Penetrating abdominal trauma|penetrating abdominal trauma
13203|NCT03490305|Exploratory laparotomy|exploratory laparotomy
13204|NCT03490305|Improvised explosive device|improvised explosive device
13205|NCT03490305|Mosul|mosul
13206|NCT03490266|Ventral Hernia|ventral hernia
13207|NCT03490266|Hernia Repair|hernia repair
13208|NCT03490227|neonates|neonates
13209|NCT03490227|brown adipose tissue|brown adipose tissue
13210|NCT03490227|body composition|body composition
13211|NCT03490214|Optoacoustics|optoacoustics
13212|NCT03490214|MSOT|msot
13213|NCT03490214|Multispectral Optoacoustic Tomography|multispectral optoacoustic tomography
13214|NCT03490175|genetic association study|genetic association study
13215|NCT03490175|postoperative nausea and vomiting|postoperative nausea and vomiting
13216|NCT03490175|patient reported outcome|patient reported outcome
13217|NCT03490175|antiemetics|antiemetics
13218|NCT03490162|Anti-Malarial|anti-malarial
13219|NCT03490162|DM1157|dm1157
13220|NCT03490162|Pharmacokinetics|pharmacokinetics
13221|NCT03490162|Safety|safety
13222|NCT03490149|ECT|ect
13223|NCT03490149|Electroconvulsive Therapy|electroconvulsive therapy
13224|NCT03490149|Depression|depression
13225|NCT03490149|Memory|memory
13226|NCT03490149|Memory Impairment|memory impairment
13227|NCT03490123|Azithromycin|azithromycin
13228|NCT03490123|Endemic treponematoses|endemic treponematoses
13229|NCT03490123|Mass drug administration|mass drug administration
13230|NCT03490123|Eradication|eradication
13231|NCT03490123|Papua New Guinea|papua new guinea
13232|NCT03490110|cognitive rehabilitation|cognitive rehabilitation
13233|NCT03490110|EEG|eeg
13234|NCT03490110|TBI|tbi
13235|NCT03490110|brain networks|brain networks
13236|NCT03490110|attention|attention
13237|NCT03490110|memory|memory
13238|NCT03490110|executive function|executive function
13239|NCT03490084|multiple myeloma|multiple myeloma
13240|NCT03490084|elderly patients|elderly patients
13241|NCT03490084|health outcomes|health outcomes
13242|NCT03490084|hospital-at-home|hospital-at-home
13243|NCT03490084|day hospitalization|day hospitalization
13244|NCT03490084|quality of life|quality of life
13245|NCT03490084|medico-economic evaluation|medico-economic evaluation
13246|NCT03490084|qualitative study|qualitative study
13247|NCT03490071|Longstanding hip and groin pain|longstanding hip and groin pain
13248|NCT03490071|Patient reported outcome|patient reported outcome
13249|NCT03490058|pre-exposure prophylaxis|pre-exposure prophylaxis
13250|NCT03490058|young women|young women
13251|NCT03490058|delivery of health care|delivery of health care
13252|NCT03490058|HIV infections/prevention|hiv infections/prevention
13253|NCT03490045|Diaper Need|diaper need
13254|NCT03490045|Well-Child Care|well-child care
13255|NCT03490045|Infant Immunizations|infant immunizations
13256|NCT03490045|Incentives|incentives
13257|NCT03490045|Basic Needs|basic needs
13258|NCT03490006|regional anesthesia|regional anesthesia
13259|NCT03490006|postoperative pain|postoperative pain
13260|NCT03490006|mastectomy|mastectomy
13261|NCT03490006|erector spinae plane block|erector spinae plane block
13262|NCT03490006|paravertebral block|paravertebral block
13263|NCT03489993|FGF23|fgf23
13264|NCT03489993|Angiotensin-(1-7)|angiotensin-(1-7)
13265|NCT03489993|Hypophosphatemia|hypophosphatemia
13266|NCT03489980|STAI Questionnaire|stai questionnaire
13267|NCT03489980|ECTM2-Qa|ectm2-qa
13268|NCT03489967|Hypoglycemia, carbohydrates|hypoglycemia, carbohydrates
13269|NCT03489954|Non-specific Chronic Neck Pain|non-specific chronic neck pain
13270|NCT03489954|Balance Master|balance master
13271|NCT03489954|Joint Position Error|joint position error
13272|NCT03489954|Neck pain|neck pain
13273|NCT03489928|Labour|labour
13274|NCT03489928|Induction|induction
13275|NCT03489928|Misoprostol|misoprostol
13276|NCT03489928|Dinoprostone|dinoprostone
13277|NCT03489928|Oxytocin|oxytocin
13278|NCT03489889|Liver Cirrhosis, Biliary|liver cirrhosis, biliary
13279|NCT03489889|Ursodeoxycholic Acid|ursodeoxycholic acid
13280|NCT03489876|Metatarsophalangeal Joint|metatarsophalangeal joint
13281|NCT03489876|Arthritis|arthritis
13282|NCT03489876|Synthetic Cartilage Implant|synthetic cartilage implant
13283|NCT03489876|Cartiva|cartiva
13284|NCT03489876|Osteochondral Autograft Transfer|osteochondral autograft transfer
13285|NCT03489863|clopidogrel|clopidogrel
13286|NCT03489863|prasugrel|prasugrel
13287|NCT03489863|ticagrelor|ticagrelor
13288|NCT03489811|Essential Oils|essential oils
13289|NCT03489811|Aromatherapy|aromatherapy
13290|NCT03489811|Anxiety|anxiety
13291|NCT03489811|Autism Spectrum Disorder|autism spectrum disorder
13292|NCT03489798|Induction of labor|induction of labor
13293|NCT03489798|Misoprostol|misoprostol
13294|NCT03489798|Failed induction|failed induction
13295|NCT03489785|Predicted factor|predicted factor
13296|NCT03489785|Motor Evoked Potentials|motor evoked potentials
13297|NCT03489759|Acute Kidney Injury|acute kidney injury
13298|NCT03489759|Oxidative Stress|oxidative stress
13299|NCT03489759|Renal Replacement Therapy|renal replacement therapy
13300|NCT03489759|Vitamine E-coated Polysulfone Membrane|vitamine e-coated polysulfone membrane
13301|NCT03489746|Inhaled corticosteroids|inhaled corticosteroids
13302|NCT03489746|Quality improvement|quality improvement
13303|NCT03489746|Cluster randomized Trial|cluster randomized trial
13304|NCT03489707|anal cancer|anal cancer
13305|NCT03489707|human papillomavirus|human papillomavirus
13306|NCT03489694|skin test endpoint|skin test endpoint
13307|NCT03489681|acupuncture, sciatica, default mode network|acupuncture, sciatica, default mode network
13308|NCT03489668|PCOS|pcos
13309|NCT03489668|Androgen|androgen
13310|NCT03489668|3D ultrasound|3d ultrasound
13311|NCT03489655|Healthy Homes|healthy homes
13312|NCT03489655|Asthma|asthma
13313|NCT03489655|Community Health Worker|community health worker
13314|NCT03489629|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
13315|NCT03489629|Early infection|early infection
13316|NCT03489629|Treatment|treatment
13317|NCT03489629|Forced Expiratory Volume in 1 Second (FEV1)|forced expiratory volume in 1 second (fev1)
13318|NCT03489603|Troponin|troponin
13319|NCT03489590|Lung|lung
13320|NCT03489590|imaging|imaging
13321|NCT03489590|hyperpolarized|hyperpolarized
13322|NCT03489590|perfluorinated|perfluorinated
13323|NCT03489590|MRI|mri
13324|NCT03489577|Inflammation|inflammation
13325|NCT03489577|Multiple Organ Failure|multiple organ failure
13326|NCT03489577|Sepsis|sepsis
13327|NCT03489577|Wounds and Injuries|wounds and injuries
13328|NCT03489577|Pathologic Processes|pathologic processes
13329|NCT03489577|Shock|shock
13330|NCT03489577|Infection|infection
13331|NCT03489577|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
13332|NCT03489577|Neutrophils|neutrophils
13333|NCT03489577|PMN|pmn
13334|NCT03489577|Granulocytes|granulocytes
13335|NCT03489577|Innate immunity|innate immunity
13336|NCT03489577|ICU|icu
13337|NCT03489577|Intensive Care|intensive care
13338|NCT03489577|polytrauma|polytrauma
13339|NCT03489577|host-pathogen|host-pathogen
13340|NCT03489564|Pregnancy|pregnancy
13341|NCT03489564|Mitochondrial metabolism|mitochondrial metabolism
13342|NCT03489564|Placenta|placenta
13343|NCT03489538|bariatric surgery|bariatric surgery
13344|NCT03489538|gastric bypass|gastric bypass
13345|NCT03489538|homocysteine|homocysteine
13346|NCT03489538|folate|folate
13347|NCT03489538|vitamin b12|vitamin b12
13348|NCT03489525|multiple myeloma|multiple myeloma
13349|NCT03489525|relapsed/refractory|relapsed/refractory
13350|NCT03489525|open-label|open-label
13351|NCT03489499|postoperative pain|postoperative pain
13352|NCT03489499|analgesics|analgesics
13353|NCT03489499|patient reported outcome|patient reported outcome
13354|NCT03489499|pain related impairment|pain related impairment
13355|NCT03489499|genetic association study|genetic association study
13356|NCT03489486|Presepsin|presepsin
13357|NCT03489486|sCD14-ST|scd14-st
13358|NCT03489486|biomarker|biomarker
13359|NCT03489486|perioperative risk|perioperative risk
13360|NCT03489473|Hormonal therapy|hormonal therapy
13361|NCT03489473|FES PET scan|fes pet scan
13362|NCT03489473|Estrogen receptor|estrogen receptor
13363|NCT03489460|sleep health|sleep health
13364|NCT03489434|adolescents|adolescents
13365|NCT03489434|primary care|primary care
13366|NCT03489434|sexual assault|sexual assault
13367|NCT03489434|substance use|substance use
13368|NCT03489434|sexual risk behavior|sexual risk behavior
13369|NCT03489408|Proximal humerus fracture fixation|proximal humerus fracture fixation
13370|NCT03489382|self-harm|self-harm
13371|NCT03489382|problem-solving therapy|problem-solving therapy
13372|NCT03489382|emergency department|emergency department
13373|NCT03489382|e-therapy|e-therapy
13374|NCT03489382|suicide prevention|suicide prevention
13375|NCT03489369|Locally advanced/unresectable|locally advanced/unresectable
13376|NCT03489369|Metastatic solid tumor|metastatic solid tumor
13377|NCT03489369|Lymphoma|lymphoma
13378|NCT03489369|Anti-LAG-3|anti-lag-3
13379|NCT03489369|LAG-3|lag-3
13380|NCT03489369|LAG3|lag3
13381|NCT03489356|Addressing Behavior Change (ABC)|addressing behavior change (abc)
13382|NCT03489356|Addressing Behavior Change (ABC) Intervention|addressing behavior change (abc) intervention
13383|NCT03489356|Addressing Behavior Change (ABC) Intervention Method|addressing behavior change (abc) intervention method
13384|NCT03489343|Locally advanced/unresectable|locally advanced/unresectable
13385|NCT03489343|Metastatic solid tumor|metastatic solid tumor
13386|NCT03489343|Lymphoma|lymphoma
13387|NCT03489343|Anti-TIM-3|anti-tim-3
13388|NCT03489343|TIM-3|tim-3
13389|NCT03489343|TIM3|tim3
13390|NCT03489330|Anti-Bacterial Agents/therapeutic use|anti-bacterial agents/therapeutic use
13391|NCT03489330|Drug Utilization/statistics & numerical data|drug utilization/statistics & numerical data
13392|NCT03489330|Hospitals/statistics & numerical data|hospitals/statistics & numerical data
13393|NCT03489330|Data Analysis, Statistical|data analysis, statistical
13394|NCT03489330|Interpretation, Statistical Data|interpretation, statistical data
13395|NCT03489330|Antibiotic Stewardship|antibiotic stewardship
13396|NCT03489330|Electronic Medical Record|electronic medical record
13397|NCT03489317|gut microbiome|gut microbiome
13398|NCT03489317|stool|stool
13401|NCT03489291|Hemophilia,|hemophilia,
13402|NCT03489291|Gene Therapy|gene therapy
13403|NCT03489291|Bleeding|bleeding
13404|NCT03489291|Factor IX|factor ix
13405|NCT03489291|FIX|fix
13406|NCT03489291|viral vector|viral vector
13407|NCT03489291|Padua|padua
13408|NCT03489226|capsaicin|capsaicin
13409|NCT03489226|energy expenditure|energy expenditure
13410|NCT03489226|satiety|satiety
13411|NCT03489226|food intake|food intake
13412|NCT03489174|Opioid Substitution Therapy|opioid substitution therapy
13413|NCT03489174|Pregnancy Tests|pregnancy tests
13414|NCT03489148|Stress|stress
13415|NCT03489148|Relaxation|relaxation
13416|NCT03489148|Health promotion|health promotion
13417|NCT03489122|Depressive Disorder, Major|depressive disorder, major
13418|NCT03489122|yoga|yoga
13419|NCT03489122|breathing exercise|breathing exercise
13420|NCT03489122|parasympathetic|parasympathetic
13421|NCT03489122|anxiety|anxiety
13422|NCT03489122|Post Traumatic Stress Disorder|post traumatic stress disorder
13423|NCT03489122|polyvagal|polyvagal
13424|NCT03489109|Fasting|fasting
13425|NCT03489096|Cryoballoon Ablation|cryoballoon ablation
13426|NCT03489096|Persistent atrial fibrillation|persistent atrial fibrillation
13427|NCT03489096|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
13428|NCT03489083|Diabetes|diabetes
13429|NCT03489083|Heat Shock Response|heat shock response
13430|NCT03489083|Aging|aging
13431|NCT03489083|Exercise|exercise
13432|NCT03489070|Liver resection|liver resection
13433|NCT03489070|Liver Hemorrhage|liver hemorrhage
13434|NCT03489070|Traumastem|traumastem
13435|NCT03489070|Surgicel|surgicel
13436|NCT03489057|symptom|symptom
13437|NCT03489057|family research|family research
13438|NCT03489057|self-management|self-management
13439|NCT03489057|caregiving|caregiving
13440|NCT03489057|social support|social support
13441|NCT03489057|mHealth|mhealth
13442|NCT03489057|healthy behavior|healthy behavior
13443|NCT03489057|self-efficacy|self-efficacy
13444|NCT03489057|quality of life|quality of life
13445|NCT03489057|care transition|care transition
13446|NCT03489044|Alzheimer|alzheimer
13447|NCT03489044|Seizure|seizure
13448|NCT03489044|Epilepsy|epilepsy
13449|NCT03489044|Anti-epileptic drug|anti-epileptic drug
13450|NCT03489044|Levetiracetam|levetiracetam
13451|NCT03489005|BIA 5-1058|bia 5-1058
13452|NCT03489005|Pulmonary arterial hypertension|pulmonary arterial hypertension
13453|NCT03489005|Heart failure|heart failure
13454|NCT03489005|Cardiovascular Disease|cardiovascular disease
13455|NCT03488992|dietary supplement, cardiovascular health, oxidative stress|dietary supplement, cardiovascular health, oxidative stress
13456|NCT03488979|Heart Failure|heart failure
13457|NCT03488979|Medication Adherence|medication adherence
13458|NCT03488966|Mindfulness|mindfulness
13459|NCT03488966|Bariatric Surgery|bariatric surgery
13460|NCT03488966|Obesity|obesity
13461|NCT03488966|Group psychotherapy|group psychotherapy
13462|NCT03488953|Liver transplantation|liver transplantation
13463|NCT03488953|Two-stage hepatectomy|two-stage hepatectomy
13464|NCT03488953|Living donor liver transplantation|living donor liver transplantation
13465|NCT03488940|Sepsis|sepsis
13466|NCT03488940|intestinal dysfunction|intestinal dysfunction
13467|NCT03488940|enteral feeding|enteral feeding
13468|NCT03488927|Sexual Violence|sexual violence
13469|NCT03488927|Interpersonal Violence|interpersonal violence
13470|NCT03488927|Prevention|prevention
13471|NCT03488927|Mixed-Methods|mixed-methods
13472|NCT03488927|Randomized Controlled Trial|randomized controlled trial
13473|NCT03488927|Outcome Evaluation|outcome evaluation
13474|NCT03488927|College Students|college students
13475|NCT03488927|Post-traumatic Stress Disorder|post-traumatic stress disorder
13476|NCT03488927|Alcohol|alcohol
13477|NCT03488927|Sexual Assault|sexual assault
13478|NCT03488927|Disclosure|disclosure
13479|NCT03488927|Social Reactions|social reactions
13480|NCT03488927|Coping|coping
13481|NCT03488927|Depression|depression
13482|NCT03488927|Intervention|intervention
13483|NCT03488823|Endothelial Function|endothelial function
13484|NCT03488823|Flavonols|flavonols
13485|NCT03488823|Intima Injury|intima injury
13486|NCT03488810|Apalutamide Prostate Cancer Radiotherapy|apalutamide prostate cancer radiotherapy
13487|NCT03488771|kidney transplantation|kidney transplantation
13488|NCT03488771|rejection|rejection
13489|NCT03488771|infection|infection
13490|NCT03488771|immunosuppression|immunosuppression
13491|NCT03488667|resectable adenocarcinoma of Gastroesophageal Junction|resectable adenocarcinoma of gastroesophageal junction
13492|NCT03488667|resectable adenocarcinoma of Stomach|resectable adenocarcinoma of stomach
13493|NCT03488641|Biomarker|biomarker
13494|NCT03488641|Signal Transduction Pathway Deregulation|signal transduction pathway deregulation
13495|NCT03488641|Outcome|outcome
13496|NCT03488641|Drug sensitivity testing|drug sensitivity testing
13497|NCT03488641|Targeted Therapy|targeted therapy
13498|NCT03488641|Genomic landscape|genomic landscape
13499|NCT03488628|respiratory failure|respiratory failure
13500|NCT03488628|oxygen therapy|oxygen therapy
13501|NCT03488628|Noninvasive ventilation|noninvasive ventilation
13502|NCT03488563|Headache|headache
13503|NCT03488498|Balneotherapy|balneotherapy
13504|NCT03488498|Chronic low back pain|chronic low back pain
13505|NCT03488498|Controlled|controlled
13506|NCT03488498|Randomized trial|randomized trial
13507|NCT03488498|weight bath traction|weight bath traction
13508|NCT03488498|follow-up|follow-up
13509|NCT03488485|Mukh Mantri Punjab Hepatitis C Relief Fund,MMPHCRF|mukh mantri punjab hepatitis c relief fund,mmphcrf
13510|NCT03488485|Direct antivirals, DAAs|direct antivirals, daas
13511|NCT03488485|Chronic hepatitis C|chronic hepatitis c
13512|NCT03488459|anxiety|anxiety
13513|NCT03488459|preoperative education|preoperative education
13514|NCT03488459|psychologist|psychologist
13515|NCT03488459|thoracotomy|thoracotomy
13516|NCT03488459|Ravitch procedure|ravitch procedure
13517|NCT03488459|postoperative pain|postoperative pain
13518|NCT03488446|Gastric Cancer|gastric cancer
13519|NCT03488446|Radiomics|radiomics
13520|NCT03488446|Computed Tomograpy|computed tomograpy
13521|NCT03488446|Lymph Node Metastasis|lymph node metastasis
13522|NCT03488446|Prediction|prediction
13523|NCT03488433|Postoperative shoulder immobilization|postoperative shoulder immobilization
13524|NCT03488433|Reverse total shoulder arthroplasty|reverse total shoulder arthroplasty
13525|NCT03488433|Neutral rotation shoulder brace|neutral rotation shoulder brace
13526|NCT03488433|Antirotation sling|antirotation sling
13527|NCT03488407|Primary angioplasty|primary angioplasty
13528|NCT03488407|Radial access|radial access
13529|NCT03488407|STEMI|stemi
13530|NCT03488394|Mucopolysaccharidosis IH|mucopolysaccharidosis ih
13531|NCT03488394|Gene Therapy|gene therapy
13532|NCT03488394|Transplantation, Autologous|transplantation, autologous
13533|NCT03488394|Lentiviral vector|lentiviral vector
13534|NCT03488355|Catheter|catheter
13535|NCT03488342|Rives technique|rives technique
13536|NCT03488342|Lichtenstein repair|lichtenstein repair
13537|NCT03488329|Hospital readmissions|hospital readmissions
13538|NCT03488329|Seniors|seniors
13539|NCT03488290|Parents|parents
13540|NCT03488290|Young Children|young children
13541|NCT03488290|Trauma Focused Cognitive Behavior Therapy|trauma focused cognitive behavior therapy
13542|NCT03488290|Learning Through Play|learning through play
13543|NCT03488225|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
13544|NCT03488225|ALL|all
13545|NCT03488225|B-Cell Lineage|b-cell lineage
13546|NCT03488225|Cyclophosphamide|cyclophosphamide
13547|NCT03488225|Cytoxan|cytoxan
13548|NCT03488225|Neosar|neosar
13549|NCT03488225|Mesna|mesna
13550|NCT03488225|Mesnex|mesnex
13551|NCT03488225|Doxorubicin hydrochloride|doxorubicin hydrochloride
13552|NCT03488225|Adriamycin PFS|adriamycin pfs
13553|NCT03488225|Adriamycin RDF|adriamycin rdf
13554|NCT03488225|Rubex|rubex
13555|NCT03488225|Adriamycin|adriamycin
13556|NCT03488225|Doxorubicin|doxorubicin
13557|NCT03488225|Vincristine|vincristine
13558|NCT03488225|Ofatumumab|ofatumumab
13559|NCT03488225|Arzerra|arzerra
13560|NCT03488225|Rituximab|rituximab
13561|NCT03488225|Rituxan|rituxan
13562|NCT03488225|Pegfilgrastim|pegfilgrastim
13563|NCT03488225|Neulasta|neulasta
13564|NCT03488225|PEG-G-CSF|peg-g-csf
13565|NCT03488225|Filgrastim|filgrastim
13566|NCT03488225|G-CSF|g-csf
13567|NCT03488225|Neupogen|neupogen
13568|NCT03488225|Methotrexate|methotrexate
13569|NCT03488225|Cytarabine|cytarabine
13570|NCT03488225|Ara-C|ara-c
13571|NCT03488225|Cytosar|cytosar
13572|NCT03488225|DepoCyt|depocyt
13573|NCT03488225|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
13574|NCT03488225|Citrovorum|citrovorum
13575|NCT03488225|Leucovorin|leucovorin
13576|NCT03488225|Wellcovorin|wellcovorin
13577|NCT03488225|Inotuzumab Ozogamicin|inotuzumab ozogamicin
13578|NCT03488225|CMC-544|cmc-544
13579|NCT03488225|6-MP 6|6-mp 6
13580|NCT03488225|Mercaptopurine|mercaptopurine
13581|NCT03488225|Purinethol|purinethol
13582|NCT03488225|MTX|mtx
13583|NCT03488225|Prednisone|prednisone
13584|NCT03488160|lymphoma CAR-T|lymphoma car-t
13585|NCT03488147|Esomeprazole Magnesium|esomeprazole magnesium
13586|NCT03488147|Postoperative dysphagia|postoperative dysphagia
13587|NCT03488147|Gastroesophageal reflux disease|gastroesophageal reflux disease
13588|NCT03488147|Anterior cervical surgery|anterior cervical surgery
13589|NCT03488147|Proton pump inhibitor|proton pump inhibitor
13590|NCT03488134|Exosome|exosome
13591|NCT03488134|Anaplastic thyroid cancer|anaplastic thyroid cancer
13592|NCT03488134|Urine|urine
13593|NCT03488134|Biological marker|biological marker
13594|NCT03488134|Thyroglobuin|thyroglobuin
13595|NCT03488134|Galectin-3|galectin-3
13596|NCT03488095|Tobacco, smokeless, chewing, betel quid|tobacco, smokeless, chewing, betel quid
13597|NCT03488082|saccadic adaptation|saccadic adaptation
13598|NCT03488082|visual-spatial perception|visual-spatial perception
13599|NCT03488082|fMRI|fmri
13600|NCT03488069|critical care|critical care
13601|NCT03488069|sedation|sedation
13602|NCT03488069|practice|practice
13603|NCT03488069|survey|survey
13604|NCT03488056|Dental Caries, ICCMS, Risk Assessment|dental caries, iccms, risk assessment
14002|NCT03485170|PET|pet
13605|NCT03488043|Lung lesions|lung lesions
13606|NCT03488043|Pneumothorax|pneumothorax
13607|NCT03488043|CT-guided transthoracic biopsy|ct-guided transthoracic biopsy
13608|NCT03488043|Risk score|risk score
13609|NCT03488030|Drug therapy|drug therapy
13610|NCT03487991|autonomic balance|autonomic balance
13611|NCT03487991|sleep|sleep
13612|NCT03487991|endothelial function|endothelial function
13613|NCT03487991|behavior|behavior
13614|NCT03487991|stress|stress
13615|NCT03487965|dicarbonyl compounds|dicarbonyl compounds
13616|NCT03487965|skin elasticity|skin elasticity
13617|NCT03487965|glycation|glycation
13618|NCT03487952|Lung nodule|lung nodule
13619|NCT03487952|Computed tomography|computed tomography
13620|NCT03487952|Artificial intelligence|artificial intelligence
13621|NCT03487887|continuous glucose monitoring|continuous glucose monitoring
13622|NCT03487887|glycemic variability|glycemic variability
13623|NCT03487887|hypoglycemia|hypoglycemia
13624|NCT03487874|8th cervical nerve root block|8th cervical nerve root block
13625|NCT03487861|transglutaminase type 2|transglutaminase type 2
13626|NCT03487861|kidney transplantation|kidney transplantation
13627|NCT03487861|chronic allograft nephropathy|chronic allograft nephropathy
13628|NCT03487861|biomarker|biomarker
13629|NCT03487835|Athletic tape. Accidental Falls. Aging.|athletic tape. accidental falls. aging.
13630|NCT03487809|Asthma|asthma
13631|NCT03487809|Inhaled corticosteroid|inhaled corticosteroid
13632|NCT03487809|pharmacogenomics|pharmacogenomics
13633|NCT03487809|Therapeutic effect|therapeutic effect
13634|NCT03487783|Tourette|tourette
13635|NCT03487783|Aripiprazole Oral Solution|aripiprazole oral solution
13636|NCT03487770|Autistic|autistic
13637|NCT03487770|Aripiprazole Oral Solution|aripiprazole oral solution
13638|NCT03487744|Tube Feeding|tube feeding
13639|NCT03487744|Diarrhea|diarrhea
13640|NCT03487744|Enteral Nutrition|enteral nutrition
13641|NCT03487744|Critically Ill|critically ill
13642|NCT03487744|Surgical|surgical
13643|NCT03487744|Cardiovascular|cardiovascular
13644|NCT03487731|stem cells|stem cells
13645|NCT03487731|back pain|back pain
13646|NCT03487718|Platelet-Rich Fibrin|platelet-rich fibrin
13647|NCT03487718|high-density polytetrafluoroethylene membrane|high-density polytetrafluoroethylene membrane
13648|NCT03487692|diabetes|diabetes
13649|NCT03487692|group visit|group visit
13650|NCT03487692|shared medical appointment|shared medical appointment
13651|NCT03487692|text messaging|text messaging
13652|NCT03487679|Microbiome|microbiome
13653|NCT03487679|High Density Lipoprotein|high density lipoprotein
13654|NCT03487679|Inflammation|inflammation
13655|NCT03487666|Triple Negative Breast Cancer|triple negative breast cancer
13656|NCT03487666|Nivolumab|nivolumab
13657|NCT03487666|Capecitabine|capecitabine
13658|NCT03487640|constipation, surgery|constipation, surgery
13659|NCT03487627|adolescent|adolescent
13660|NCT03487627|parental support|parental support
13661|NCT03487627|parental coping|parental coping
13662|NCT03487614|pediatric obesity|pediatric obesity
13663|NCT03487614|preschool children|preschool children
13664|NCT03487614|non-responsive feeding|non-responsive feeding
13665|NCT03487614|body mass index|body mass index
13666|NCT03487614|parenting|parenting
13667|NCT03487601|docetaxel|docetaxel
13668|NCT03487601|Stage I - IV|stage i - iv
13669|NCT03487601|chemotherapy|chemotherapy
13670|NCT03487575|Adolescent|adolescent
13671|NCT03487575|Parental Support|parental support
13672|NCT03487575|Parental Coping|parental coping
13673|NCT03487523|Behavioural Economics|behavioural economics
13674|NCT03487510|treatment standards|treatment standards
13675|NCT03487510|diagnostical approaches|diagnostical approaches
13676|NCT03487510|descriptive|descriptive
13677|NCT03487497|gait analysis|gait analysis
13678|NCT03487497|electromyography|electromyography
13679|NCT03487497|strength test|strength test
13680|NCT03487497|walking|walking
13681|NCT03487419|left atrial echocardiography|left atrial echocardiography
13682|NCT03487419|new onset atrial fibrillation|new onset atrial fibrillation
13683|NCT03487419|coronary artery bypass grafting|coronary artery bypass grafting
13684|NCT03487419|speckle tracking echocardiography|speckle tracking echocardiography
13685|NCT03487393|facial nerve|facial nerve
13686|NCT03487393|magnetic stimulation|magnetic stimulation
13687|NCT03487393|cerebral blood flow|cerebral blood flow
13688|NCT03487367|spinocerebellar ataxia|spinocerebellar ataxia
13689|NCT03487367|ataxia|ataxia
13690|NCT03487367|ataxias|ataxias
13691|NCT03487367|SCA1|sca1
13692|NCT03487367|SCA3|sca3
13693|NCT03487367|spinocerebellar ataxia type 1|spinocerebellar ataxia type 1
13694|NCT03487367|spinocerebellar ataxia type 3|spinocerebellar ataxia type 3
13695|NCT03487367|READISCA|readisca
13696|NCT03487328|treatment|treatment
13697|NCT03487276|hidradenitis suppurativa|hidradenitis suppurativa
13698|NCT03487276|monoclonal antibody|monoclonal antibody
13699|NCT03487276|complement factor C5a|complement factor c5a
13700|NCT03487276|IFX-1|ifx-1
13701|NCT03487276|hidradenitis Suppurativa Clinical Response|hidradenitis suppurativa clinical response
13702|NCT03487276|Inflammation|inflammation
13703|NCT03487276|skin diseases|skin diseases
13704|NCT03487263|motor neurone disease|motor neurone disease
13705|NCT03487263|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
13706|NCT03487263|IC14 [anti-CD14 (cluster of differentiation 14) monoclonal antibody]|ic14 [anti-cd14 (cluster of differentiation 14) monoclonal antibody]
13707|NCT03487263|monoclonal antibody|monoclonal antibody
13708|NCT03487263|anti-CD14|anti-cd14
13709|NCT03487237|Syncope|syncope
13710|NCT03487237|Pulmonary embolism|pulmonary embolism
13711|NCT03487237|emergency department|emergency department
13712|NCT03487237|clinical decision rule|clinical decision rule
13713|NCT03487224|Hoarding Disorder|hoarding disorder
13714|NCT03487211|Fibromyalgia treatment|fibromyalgia treatment
13715|NCT03487211|Duloxetine|duloxetine
13716|NCT03487211|Escitalopram|escitalopram
13717|NCT03487198|Major Depressive Disorder|major depressive disorder
13718|NCT03487198|Brexpiprazole|brexpiprazole
13719|NCT03487185|CPAP|cpap
13720|NCT03487185|Apnea|apnea
13721|NCT03487185|pregnancy|pregnancy
13722|NCT03487107|Chronic Genotype 1 HCV Infection|chronic genotype 1 hcv infection
13723|NCT03487029|diabetes|diabetes
13724|NCT03487029|high intensity interval training|high intensity interval training
13725|NCT03487029|cardiorespiratory fitness|cardiorespiratory fitness
13726|NCT03487016|Pancreatic Cancer|pancreatic cancer
13727|NCT03487016|First line|first line
13728|NCT03487016|Metastatic|metastatic
13729|NCT03487003|laryngeal mask airway|laryngeal mask airway
13730|NCT03487003|children, preschool|children, preschool
13731|NCT03487003|muscle relaxant|muscle relaxant
13732|NCT03486990|safety|safety
13733|NCT03486990|tolerability|tolerability
13734|NCT03486990|pharmacokinetics|pharmacokinetics
13735|NCT03486990|celiac|celiac
13736|NCT03486990|gliadin|gliadin
13737|NCT03486990|gluten|gluten
13738|NCT03486951|outpatient surgery|outpatient surgery
13739|NCT03486951|ambulatory surgery|ambulatory surgery
13740|NCT03486951|length of hospital stay|length of hospital stay
13741|NCT03486925|oxytocin, eye-tracking, attention inhibition|oxytocin, eye-tracking, attention inhibition
13742|NCT03486873|PD1|pd1
13743|NCT03486873|PD-1|pd-1
13744|NCT03486873|PDL1|pdl1
13745|NCT03486873|PD-L1|pd-l1
13746|NCT03486821|Radiation Therapy|radiation therapy
13747|NCT03486821|ultra-short Radiation|ultra-short radiation
13748|NCT03486821|SBRT|sbrt
13749|NCT03486821|prostate|prostate
13750|NCT03486821|quality of life|quality of life
13751|NCT03486821|financial toxicity|financial toxicity
13752|NCT03486808|transcranial direct current stimulation|transcranial direct current stimulation
13753|NCT03486808|motor function|motor function
13754|NCT03486795|transcranial direct current stimulation|transcranial direct current stimulation
13755|NCT03486795|motor function|motor function
13756|NCT03486782|transcranial direct current stimulation|transcranial direct current stimulation
13757|NCT03486782|dual stimulation|dual stimulation
13758|NCT03486769|transcranial direct current stimulation|transcranial direct current stimulation
13759|NCT03486769|dual stimulation|dual stimulation
13760|NCT03486756|Asthma|asthma
13761|NCT03486756|Anxiety|anxiety
13762|NCT03486756|Stress|stress
13763|NCT03486743|LARC contraception cultural acceptance|larc contraception cultural acceptance
13764|NCT03486678|BTC|btc
13765|NCT03486678|PD-1 antibody|pd-1 antibody
13766|NCT03486639|Urodynamics|urodynamics
13767|NCT03486639|Bladder sensation|bladder sensation
13768|NCT03486639|confounding factors|confounding factors
13769|NCT03486587|afatinib|afatinib
13770|NCT03486587|diarrhea|diarrhea
13771|NCT03486587|Bacillus Cereus|bacillus cereus
13772|NCT03486587|NSCLC|nsclc
13773|NCT03486561|Ranolazine|ranolazine
13774|NCT03486561|Pakistan|pakistan
13775|NCT03486561|Ischemic Heart Disease|ischemic heart disease
13776|NCT03486548|popliteal sciatic nerve block|popliteal sciatic nerve block
13777|NCT03486548|total knee artgroplasty|total knee artgroplasty
13778|NCT03486548|adductor canal block|adductor canal block
13779|NCT03486548|dexamethasone|dexamethasone
13780|NCT03486535|Diabetes mellitus|diabetes mellitus
13781|NCT03486535|Infraclavicular brachial plexus block|infraclavicular brachial plexus block
13782|NCT03486535|Block duration|block duration
13783|NCT03486535|Time-to-first pain|time-to-first pain
13784|NCT03486535|Postoperative analgesia|postoperative analgesia
13785|NCT03486522|termination of pregnancy|termination of pregnancy
13786|NCT03486509|afatinib|afatinib
13787|NCT03486496|Lung Adenocarcinoma|lung adenocarcinoma
13788|NCT03486496|EGFR mutation|egfr mutation
13789|NCT03486496|Gefitinib|gefitinib
13790|NCT03486496|Berberine|berberine
13791|NCT03486457|psoriatic arthritis|psoriatic arthritis
13792|NCT03486457|tofacitinib|tofacitinib
13793|NCT03486431|Stereotactic Ablative Body Radiotherapy (SABR)|stereotactic ablative body radiotherapy (sabr)
13794|NCT03486366|epilepsy, TSC, biomarkers, mTOR pathway|epilepsy, tsc, biomarkers, mtor pathway
13795|NCT03486353|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
13796|NCT03486314|Drug therapy|drug therapy
13797|NCT03486301|TLR|tlr
13798|NCT03486301|Immuno-oncology|immuno-oncology
13799|NCT03486288|delirium|delirium
14003|NCT03485144|Dengue Vaccine|dengue vaccine
13800|NCT03486288|postoperative cognitive dysfunction|postoperative cognitive dysfunction
13801|NCT03486288|spine surgery|spine surgery
13802|NCT03486288|elderly|elderly
13803|NCT03486288|neuroinflammation|neuroinflammation
13804|NCT03486288|magnetic resonance imaging|magnetic resonance imaging
13805|NCT03486288|resting state fmri|resting state fmri
13806|NCT03486288|cerebral vasculature|cerebral vasculature
13807|NCT03486288|quality of life|quality of life
13808|NCT03486275|GENERAL PRACTICE|general practice
13809|NCT03486275|SERIOUS GAME|serious game
13810|NCT03486275|EVIDENCE BASED MEDICINE|evidence based medicine
13811|NCT03486275|RANDOMIZED CONTROLLED TRIAL|randomized controlled trial
13812|NCT03486275|PEDAGOGY|pedagogy
13813|NCT03486262|Lung cancer; Idiopathic pulmonary fibrosis|lung cancer; idiopathic pulmonary fibrosis
13814|NCT03486249|diaphragm dysfunction|diaphragm dysfunction
13815|NCT03486249|ventilator weaning|ventilator weaning
13816|NCT03486249|pulmonary edema|pulmonary edema
13817|NCT03486171|difficult intubation|difficult intubation
13818|NCT03486171|prehospital emergency|prehospital emergency
13819|NCT03486171|risk factors|risk factors
13820|NCT03486158|Leukocyte L1 Antigen Complex|leukocyte l1 antigen complex
13821|NCT03486158|Feces|feces
13822|NCT03486158|Cell Phone|cell phone
13823|NCT03486158|Biomarkers|biomarkers
13824|NCT03486158|Recurrence|recurrence
13825|NCT03486158|Prognosis|prognosis
13826|NCT03486158|Clinical Chemistry Tests|clinical chemistry tests
13827|NCT03486145|beetroot juice|beetroot juice
13828|NCT03486145|nitrates and nitrites|nitrates and nitrites
13829|NCT03486119|Non -small cell lung cancer|non -small cell lung cancer
13830|NCT03486093|Venous central catheter|venous central catheter
13955|NCT03485352|Bariatric Surgery|bariatric surgery
13831|NCT03486093|Central line-associated bloodstream infections|central line-associated bloodstream infections
13832|NCT03486093|Port protector|port protector
13833|NCT03486093|Respiratory semi-Intensive Care Unit|respiratory semi-intensive care unit
13834|NCT03486067|Multiple Myeloma|multiple myeloma
13835|NCT03486067|BCMA X CD3 T Cell|bcma x cd3 t cell
13836|NCT03486067|Antibody|antibody
13837|NCT03486067|CC-93269|cc-93269
13838|NCT03486067|Relapsed and Refractory|relapsed and refractory
13840|NCT03486054|Transfusion|transfusion
13841|NCT03486054|Pathogen inactivation|pathogen inactivation
13842|NCT03486054|low-resource|low-resource
13843|NCT03486054|Sub-saharan Africa|sub-saharan africa
13844|NCT03486054|Uganda|uganda
13845|NCT03486054|Transfusion-transmitted infection|transfusion-transmitted infection
13846|NCT03486054|dose escalation|dose escalation
13847|NCT03486054|Whole blood|whole blood
13848|NCT03486028|Patient-Centered Outcomes Research Institute (PCORI)|patient-centered outcomes research institute (pcori)
13849|NCT03486028|American Society of Addiction Medicine (ASAM)|american society of addiction medicine (asam)
13850|NCT03486028|substance use|substance use
13851|NCT03486028|addiction|addiction
13852|NCT03486028|treatment|treatment
13853|NCT03486028|RTI International|rti international
13854|NCT03486028|UCLA|ucla
13855|NCT03485989|hazelnuts|hazelnuts
13856|NCT03485989|vitamin E|vitamin e
13857|NCT03485989|aging|aging
13858|NCT03485976|Ixekizumab|ixekizumab
13859|NCT03485976|IL-17|il-17
13860|NCT03485976|Pityriasis Rubra Pilaris (PRP)|pityriasis rubra pilaris (prp)
13861|NCT03485950|Other infectious diseases|other infectious diseases
13862|NCT03485950|Febrile neutropenic adults with cancer|febrile neutropenic adults with cancer
13863|NCT03485950|Ceftolozane-Tazobactam|ceftolozane-tazobactam
13864|NCT03485950|Cefepime|cefepime
13865|NCT03485950|Meropenem|meropenem
13866|NCT03485950|Piperacillin/Tazobactam|piperacillin/tazobactam
13867|NCT03485937|anxiety|anxiety
13868|NCT03485937|patient satisfaction|patient satisfaction
13869|NCT03485937|video education|video education
13870|NCT03485937|skin cancer|skin cancer
13871|NCT03485937|linear closure on the face|linear closure on the face
13872|NCT03485911|BCX7353|bcx7353
13873|NCT03485898|UCC|ucc
13874|NCT03485898|mortality|mortality
13875|NCT03485898|alzheimer's disease|alzheimer's disease
13876|NCT03485898|longitudinal study|longitudinal study
13877|NCT03485885|anthocyanins, maqui berries, bioavailability|anthocyanins, maqui berries, bioavailability
13878|NCT03485846|hepatitis C|hepatitis c
13879|NCT03485846|chronic|chronic
13880|NCT03485846|1b genotype|1b genotype
13881|NCT03485846|oral treatment|oral treatment
13882|NCT03485833|end-expiratory occlusion test|end-expiratory occlusion test
13883|NCT03485833|end-inspiratory occlusion test|end-inspiratory occlusion test
13884|NCT03485833|transesophageal echocardiography|transesophageal echocardiography
13885|NCT03485833|passive legs raising|passive legs raising
13886|NCT03485833|fluid challenge|fluid challenge
13887|NCT03485820|environmental modifications|environmental modifications
13888|NCT03485820|activity performance|activity performance
13889|NCT03485807|aggressive behavior|aggressive behavior
13890|NCT03485807|mindfulness|mindfulness
13891|NCT03485807|coping control|coping control
13892|NCT03485781|EEG|eeg
13893|NCT03485781|Intensive Care|intensive care
13894|NCT03485781|Propofol|propofol
13895|NCT03485768|cervical vertigo|cervical vertigo
14299|NCT03483103|liso-cel|liso-cel
13896|NCT03485768|percutaneous disc decompression with coblation nucleoplasty|percutaneous disc decompression with coblation nucleoplasty
13897|NCT03485768|manual therapy|manual therapy
13898|NCT03485768|clinical efficacy|clinical efficacy
13899|NCT03485768|randomized controlled trial|randomized controlled trial
13900|NCT03485755|microflora|microflora
13901|NCT03485755|microbiome|microbiome
13902|NCT03485755|bacteria taxa|bacteria taxa
13903|NCT03485716|metabolism|metabolism
13904|NCT03485716|metabolome|metabolome
13905|NCT03485716|physical activity|physical activity
13906|NCT03485716|hypoxia|hypoxia
13907|NCT03485690|COPD|copd
13908|NCT03485690|Cohort study|cohort study
13909|NCT03485690|Prospective|prospective
13910|NCT03485651|adrexal mass|adrexal mass
13911|NCT03485651|ovarian cancer|ovarian cancer
13912|NCT03485651|fallopian tube cancer|fallopian tube cancer
13913|NCT03485651|peritoneal cancer|peritoneal cancer
13914|NCT03485612|Optic Nerve Sheath Diameter|optic nerve sheath diameter
13915|NCT03485612|Urological Anaesthesia|urological anaesthesia
13916|NCT03485612|point of care USG|point of care usg
13917|NCT03485586|cataract, higher order aberration,vitrectomy,diabetic retinopathy|cataract, higher order aberration,vitrectomy,diabetic retinopathy
13918|NCT03485560|chronic skin disease|chronic skin disease
13919|NCT03485560|psoriasis|psoriasis
13920|NCT03485560|Eczema|eczema
13921|NCT03485560|atopic dermatitis|atopic dermatitis
13922|NCT03485547|Blastic Plasmacytoid Dendritic Cell Neoplasm|blastic plasmacytoid dendritic cell neoplasm
13923|NCT03485547|BPDCN|bpdcn
13924|NCT03485521|High Fidelity Simulation Training|high fidelity simulation training
13925|NCT03485521|physiotherapy|physiotherapy
13926|NCT03485521|tracheobronchial aspiration.|tracheobronchial aspiration.
13927|NCT03485482|Pharmacokinetic drug interaction|pharmacokinetic drug interaction
13928|NCT03485482|ivabtadine|ivabtadine
13929|NCT03485482|bisoprolol|bisoprolol
13930|NCT03485469|Obesity|obesity
13931|NCT03485469|bariatric surgery|bariatric surgery
13932|NCT03485469|Hypnosis|hypnosis
13933|NCT03485456|Dry powder inhalation|dry powder inhalation
13934|NCT03485456|Tobramycin|tobramycin
13935|NCT03485443|fluid infusion|fluid infusion
13936|NCT03485443|vomiting|vomiting
13937|NCT03485443|otorhinolaringology|otorhinolaringology
13938|NCT03485417|stimulant|stimulant
13939|NCT03485417|psychosis|psychosis
13940|NCT03485417|schizophrenia|schizophrenia
13941|NCT03485417|dependence|dependence
13942|NCT03485417|pharmacotherapy|pharmacotherapy
13943|NCT03485404|POCD|pocd
13944|NCT03485404|vitamin B12|vitamin b12
13945|NCT03485404|folic acid|folic acid
13946|NCT03485378|Stereotactic|stereotactic
13947|NCT03485378|Ablative|ablative
13948|NCT03485378|Radiation|radiation
13949|NCT03485365|Pain|pain
13950|NCT03485365|Osteoarthritis of the knee|osteoarthritis of the knee
13951|NCT03485365|Target engagement|target engagement
13952|NCT03485365|GSK3858279|gsk3858279
13953|NCT03485365|Pharmacokinetics|pharmacokinetics
13954|NCT03485365|Sequential|sequential
13956|NCT03485352|Sleep|sleep
13957|NCT03485352|Chronotype|chronotype
13958|NCT03485326|Osimertinib|osimertinib
13959|NCT03485326|Tagrisso|tagrisso
13960|NCT03485326|NSCLC|nsclc
13961|NCT03485326|Non-small cell lung cancer|non-small cell lung cancer
13962|NCT03485326|Safety|safety
13963|NCT03485313|Healthy|healthy
13964|NCT03485313|Volunteer|volunteer
13965|NCT03485313|Female|female
13966|NCT03485313|Pregnancy|pregnancy
13967|NCT03485287|PTSD|ptsd
13968|NCT03485287|MDMA|mdma
13969|NCT03485287|Psychotherapy|psychotherapy
13970|NCT03485274|Cannabis|cannabis
13971|NCT03485274|depression|depression
13972|NCT03485274|anxiety|anxiety
13973|NCT03485274|medication|medication
13974|NCT03485248|HIV/AIDS|hiv/aids
13975|NCT03485248|Arterial stiffness|arterial stiffness
13976|NCT03485248|Flow mediated-dilatation|flow mediated-dilatation
13977|NCT03485248|Muscle oxygenation|muscle oxygenation
13978|NCT03485248|Exercise performance|exercise performance
13979|NCT03485248|Dietary Nitrate|dietary nitrate
13980|NCT03485222|Cardiovascular diseases|cardiovascular diseases
13981|NCT03485222|Heart Failure|heart failure
13982|NCT03485222|LV remodeling|lv remodeling
13983|NCT03485222|SGLT-2 Inhibitors|sglt-2 inhibitors
13984|NCT03485222|Empagliflozin|empagliflozin
13985|NCT03485222|Cardiac MRI|cardiac mri
13986|NCT03485209|Colorectal cancer|colorectal cancer
13987|NCT03485209|NSCLC|nsclc
13988|NCT03485209|SCCHN|scchn
13989|NCT03485209|CRC|crc
13990|NCT03485209|Pancreatic cancer|pancreatic cancer
13991|NCT03485209|Head and neck cancer|head and neck cancer
13992|NCT03485196|Microsatellite Instability|microsatellite instability
13993|NCT03485196|Fluorouracil|fluorouracil
13994|NCT03485196|Adjuvant chemotherapy|adjuvant chemotherapy
13995|NCT03485196|Efficacy|efficacy
13996|NCT03485196|Operation|operation
13997|NCT03485183|delirium|delirium
13998|NCT03485183|white noise|white noise
13999|NCT03485183|pink noise|pink noise
14000|NCT03485170|Hemophilia|hemophilia
14001|NCT03485170|Hemophilic arthropathy|hemophilic arthropathy
14004|NCT03485118|Previously untreated DLBCL|previously untreated dlbcl
14005|NCT03485105|Gastric cancer|gastric cancer
14006|NCT03485105|biomarker|biomarker
14007|NCT03485105|chemotherapy|chemotherapy
14008|NCT03485105|precise medicine|precise medicine
14009|NCT03485092|heart failure|heart failure
14010|NCT03485092|diabetes mellitus|diabetes mellitus
14011|NCT03485092|empagliflozin|empagliflozin
14012|NCT03485092|Randomised, placebo controlled trial|randomised, placebo controlled trial
14013|NCT03485040|Rehabilitation|rehabilitation
14014|NCT03485040|Neurorehabilitation|neurorehabilitation
14015|NCT03485040|Neurotechnology|neurotechnology
14016|NCT03485040|Neurorecovery|neurorecovery
14017|NCT03485040|Neurorestoration|neurorestoration
14018|NCT03484988|Polyunsaturated fatty acids|polyunsaturated fatty acids
14019|NCT03484988|Echium oil|echium oil
14020|NCT03484988|Hyperlipidemias|hyperlipidemias
14021|NCT03484988|Metabolites|metabolites
14022|NCT03484988|Gut Microbiota|gut microbiota
14023|NCT03484962|activated CIK|activated cik
14024|NCT03484962|MUC1|muc1
14025|NCT03484962|bispecific antibody|bispecific antibody
14026|NCT03484962|liver cancer|liver cancer
14027|NCT03484949|Gastric cancer|gastric cancer
14028|NCT03484949|Screening|screening
14029|NCT03484949|Risk assessment|risk assessment
14030|NCT03484936|Intracranial Hemorrhages|intracranial hemorrhages
14031|NCT03484936|remote ischemic conditioning|remote ischemic conditioning
14032|NCT03484923|Unresectable|unresectable
14033|NCT03484923|melanoma|melanoma
14034|NCT03484923|metastatic melanoma|metastatic melanoma
14035|NCT03484923|advanced melanoma|advanced melanoma
14036|NCT03484923|spartalizumab|spartalizumab
14037|NCT03484923|PDR001|pdr001
14038|NCT03484923|LAG525|lag525
14039|NCT03484923|capmatinib|capmatinib
14040|NCT03484923|INC280|inc280
14041|NCT03484923|canakinumab|canakinumab
14042|NCT03484923|ACZ885|acz885
14043|NCT03484923|immunotherapy|immunotherapy
14044|NCT03484923|platform study|platform study
14045|NCT03484884|nodal metastases|nodal metastases
14046|NCT03484884|17-538|17-538
14047|NCT03484884|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
14048|NCT03484793|AESOP Model|aesop model
14049|NCT03484793|Big data|big data
14050|NCT03484793|medication error|medication error
14051|NCT03484793|data mining|data mining
14052|NCT03484793|patient safety|patient safety
14053|NCT03484793|CPOE|cpoe
14054|NCT03484793|CDSS|cdss
14055|NCT03484793|alarm fatigue|alarm fatigue
14056|NCT03484793|association rule mining.|association rule mining.
14057|NCT03484780|Implantable Heart Failure Device Therapy|implantable heart failure device therapy
14058|NCT03484780|Asymptomatic Diaphragmatic Stimulation|asymptomatic diaphragmatic stimulation
14059|NCT03484767|methylmalonic acidemia|methylmalonic acidemia
14060|NCT03484767|MMA|mma
14061|NCT03484767|organic acidemia|organic acidemia
14062|NCT03484767|mut deficiency|mut deficiency
14063|NCT03484767|inborn errors of metabolism|inborn errors of metabolism
14064|NCT03484767|mut0|mut0
14065|NCT03484767|mut-|mut-
14066|NCT03484728|Conditional pain modulation|conditional pain modulation
14067|NCT03484728|pain|pain
14068|NCT03484728|placebo|placebo
14069|NCT03484715|Physical Activity|physical activity
14070|NCT03484715|Nursing Home|nursing home
14071|NCT03484715|Feasibility|feasibility
14072|NCT03484715|Older Adults|older adults
14073|NCT03484702|Non-Hodgkin lymphoma|non-hodgkin lymphoma
14074|NCT03484702|Aggressive B-cell non-Hodgkin lymphoma|aggressive b-cell non-hodgkin lymphoma
14075|NCT03484702|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
14076|NCT03484702|Relapse / refractory lymphoma|relapse / refractory lymphoma
14077|NCT03484702|Transplant not eligible|transplant not eligible
14078|NCT03484702|Double-hit lymphoma|double-hit lymphoma
14079|NCT03484702|Triple-hit lymphoma|triple-hit lymphoma
14080|NCT03484702|Primary/secondary central nervous system lymphoma|primary/secondary central nervous system lymphoma
14081|NCT03484702|Richter's transformation/syndrome|richter's transformation/syndrome
14082|NCT03484702|Transformed follicular lymphoma|transformed follicular lymphoma
14083|NCT03484702|Follicular lymphoma Grade 3B|follicular lymphoma grade 3b
14084|NCT03484702|JCAR017|jcar017
14085|NCT03484702|CAR T cell therapy|car t cell therapy
14086|NCT03484702|CD19 targeted therapy.|cd19 targeted therapy.
14087|NCT03484702|Efficacy and safety|efficacy and safety
14088|NCT03484702|Europe / Japan|europe / japan
14089|NCT03484702|TPTD|tptd
14090|NCT03484689|Diabetes-related distress|diabetes-related distress
14091|NCT03484689|Mindfulness|mindfulness
14092|NCT03484637|motivation|motivation
14093|NCT03484637|Treatment adherence|treatment adherence
14094|NCT03484637|Waist circumference|waist circumference
14095|NCT03484637|obesity|obesity
14096|NCT03484637|overweight|overweight
14097|NCT03484624|Muscle; Fatigue|muscle; fatigue
14098|NCT03484624|Wearable hip assist robot|wearable hip assist robot
14099|NCT03484624|Metabolic energy expenditure|metabolic energy expenditure
14100|NCT03484585|Mass Balance, metabolism and excretion pattern|mass balance, metabolism and excretion pattern
14101|NCT03484559|In-hospital Cardiac Arrest|in-hospital cardiac arrest
14102|NCT03484546|ovarian reserve|ovarian reserve
14103|NCT03484546|endometriosis|endometriosis
14104|NCT03484546|endometrioma|endometrioma
14105|NCT03484520|Cancer, Acute Myeloid Leukemia (AML), venetoclax, dinaciclib, Relapsed/refractory AML, Pharmacokinetics, Venetoclax, Dinaciclib|cancer, acute myeloid leukemia (aml), venetoclax, dinaciclib, relapsed/refractory aml, pharmacokinetics, venetoclax, dinaciclib
14106|NCT03484494|Geriatric|geriatric
14107|NCT03484494|Low Field Magnetic Stimulation|low field magnetic stimulation
14108|NCT03484494|Antidepressant|antidepressant
14109|NCT03484494|fMRI|fmri
14110|NCT03484494|MRS|mrs
14111|NCT03484468|lasik|lasik
14112|NCT03484468|flap_thickness|flap_thickness
14113|NCT03484468|femtosecond|femtosecond
14114|NCT03484468|laser|laser
14115|NCT03484468|moria|moria
14116|NCT03484468|microkeratome|microkeratome
14117|NCT03484429|Neurostimulation|neurostimulation
14118|NCT03484429|Peripheral nerve stimulation|peripheral nerve stimulation
14119|NCT03484390|mindfulness|mindfulness
14120|NCT03484390|posttraumatic stress disorder|posttraumatic stress disorder
14121|NCT03484351|Falls|falls
14122|NCT03484325|Registry|registry
14123|NCT03484325|Joint Registry|joint registry
14124|NCT03484325|OA|oa
14125|NCT03484325|Osteoarthritis|osteoarthritis
14126|NCT03484325|Osteo arthritis|osteo arthritis
14127|NCT03484325|knee|knee
14128|NCT03484325|hip|hip
14129|NCT03484325|tka|tka
14130|NCT03484325|tha|tha
14131|NCT03484273|Tilt Table|tilt table
14132|NCT03484273|Compression|compression
14133|NCT03484273|Dysautonomia|dysautonomia
14134|NCT03484273|POTS|pots
14135|NCT03484260|Risk factors predicting the initiation of testosterone use|risk factors predicting the initiation of testosterone use
14136|NCT03484247|infraclavicular block|infraclavicular block
14137|NCT03484247|axillary block|axillary block
14138|NCT03484234|Drug eluting stent|drug eluting stent
14139|NCT03484234|everolimus eluting stent|everolimus eluting stent
14140|NCT03484234|sirolimus eluting stent|sirolimus eluting stent
14141|NCT03484182|Upper extremity|upper extremity
14142|NCT03484182|Stroke|stroke
14143|NCT03484182|Web-based program|web-based program
14144|NCT03484182|Home exercise training|home exercise training
14145|NCT03484169|Muscle Stretching Exercises|muscle stretching exercises
14146|NCT03484169|Pelvic Floor|pelvic floor
14147|NCT03484169|motor control|motor control
14148|NCT03484169|motor skill|motor skill
14149|NCT03484169|motor activity|motor activity
14150|NCT03484156|Elderly|elderly
14151|NCT03484156|Frailty|frailty
14152|NCT03484156|Tele-monitoring|tele-monitoring
14153|NCT03484156|Disability|disability
14154|NCT03484143|Moderate to Severe Alzheimer's Disease,|moderate to severe alzheimer's disease,
14155|NCT03484130|primary aldosteronism|primary aldosteronism
14156|NCT03484104|Cardiopulmonary bypass|cardiopulmonary bypass
14157|NCT03484104|Hypothermic circulatory arrest|hypothermic circulatory arrest
14158|NCT03484104|Aortic arch surgery|aortic arch surgery
14159|NCT03484091|Hyruan-One|hyruan-one
14160|NCT03484091|Hylan G-F 20|hylan g-f 20
14161|NCT03484091|Hyaluronic acid|hyaluronic acid
14162|NCT03484091|Knee osteoarthritis|knee osteoarthritis
14163|NCT03484091|Pain level|pain level
14164|NCT03484065|Congenital fibrinogen disorders|congenital fibrinogen disorders
14165|NCT03484039|memory problems|memory problems
14166|NCT03484039|stress|stress
14167|NCT03484039|depression|depression
14168|NCT03484039|adherence|adherence
14169|NCT03484039|seizure documentation|seizure documentation
14170|NCT03484026|Iron Deficiency|iron deficiency
14171|NCT03484026|Anemia|anemia
14172|NCT03484026|Medical Food|medical food
14173|NCT03483987|Hepatitis c virus|hepatitis c virus
14174|NCT03483987|Direct acting antiviral drugs|direct acting antiviral drugs
14175|NCT03483987|Virological relapse|virological relapse
14176|NCT03483974|Hyperspectrum, excreta, neoplasm,|hyperspectrum, excreta, neoplasm,
14177|NCT03483909|gesture|gesture
14178|NCT03483909|rTMS|rtms
14179|NCT03483909|nonverbal communication|nonverbal communication
14180|NCT03483909|schizophrenia|schizophrenia
14181|NCT03483909|psychosis|psychosis
14182|NCT03483870|Granisetron, serum serotonin, morphine|granisetron, serum serotonin, morphine
14183|NCT03483857|Peer Navigation|peer navigation
14184|NCT03483844|scoliosis|scoliosis
14185|NCT03483844|low dose|low dose
14186|NCT03483844|arthrodesis|arthrodesis
14187|NCT03483844|dual-energy CT|dual-energy ct
14188|NCT03483818|Community Pharmacy|community pharmacy
14189|NCT03483818|Antiviral Therapy|antiviral therapy
14190|NCT03483805|synbiotic|synbiotic
14191|NCT03483805|nutrition|nutrition
14192|NCT03483805|permeability|permeability
14193|NCT03483805|gluten free diet|gluten free diet
14194|NCT03483805|quality of life|quality of life
14195|NCT03483805|digestive comfort|digestive comfort
14196|NCT03483792|PCOS|pcos
14197|NCT03483792|AMH|amh
14198|NCT03483792|Pregnancy|pregnancy
14199|NCT03483792|Heritability|heritability
14200|NCT03483792|LH|lh
14201|NCT03483753|Vasopressin|vasopressin
14202|NCT03483753|Norepinephrine|norepinephrine
14203|NCT03483753|Post-operative|post-operative
14204|NCT03483753|Critical Care|critical care
14205|NCT03483740|HIV-Associated Neurocognitive Disorder (HAND)|hiv-associated neurocognitive disorder (hand)
14206|NCT03483740|Cognitive remediation group therapy|cognitive remediation group therapy
14207|NCT03483740|Mutual aid group therapy|mutual aid group therapy
14208|NCT03483714|Manipulation|manipulation
14209|NCT03483714|Spinal|spinal
14210|NCT03483714|electromyography|electromyography
14211|NCT03483714|kinetics|kinetics
14212|NCT03483714|kinematic|kinematic
14213|NCT03483701|Cognitive Remediation Therapy|cognitive remediation therapy
14214|NCT03483688|B-cell Non-Hodgkin Lymphoma|b-cell non-hodgkin lymphoma
14215|NCT03483688|Refractory|refractory
14216|NCT03483688|Relapsed|relapsed
14217|NCT03483662|hypertension|hypertension
14218|NCT03483662|blood pressure|blood pressure
14219|NCT03483662|medication adherence|medication adherence
14220|NCT03483662|lifestyle modification|lifestyle modification
14221|NCT03483662|blood pressure control|blood pressure control
14222|NCT03483662|implementation|implementation
14223|NCT03483636|Drug-alcohol interaction|drug-alcohol interaction
14224|NCT03483636|Lemborexant|lemborexant
14225|NCT03483636|E2006|e2006
14226|NCT03483636|Postural stability|postural stability
14227|NCT03483636|Cognitive performance|cognitive performance
14228|NCT03483623|NATO Litter|nato litter
14229|NCT03483623|Dolphin Fluid Immersion System|dolphin fluid immersion system
14230|NCT03483623|Raven 90C litter|raven 90c litter
14231|NCT03483623|Laser doppler pressure monitor|laser doppler pressure monitor
14232|NCT03483623|Transcutanous oxygenation|transcutanous oxygenation
14233|NCT03483623|WELP mattress|welp mattress
14234|NCT03483571|asymptomatic|asymptomatic
14235|NCT03483571|submicroscopic|submicroscopic
14236|NCT03483571|PCR|pcr
14237|NCT03483558|vegetable metabolite signature|vegetable metabolite signature
14238|NCT03483558|human serum/urinary metabolite|human serum/urinary metabolite
14239|NCT03483558|liquid chromatography mass spectrometry|liquid chromatography mass spectrometry
14240|NCT03483545|Ovarian Response|ovarian response
14241|NCT03483545|In vitro fertilization|in vitro fertilization
14242|NCT03483545|Controlled ovarian stimulation|controlled ovarian stimulation
14243|NCT03483532|lithiasis|lithiasis
14244|NCT03483532|uric acid|uric acid
14245|NCT03483532|crystallization|crystallization
14246|NCT03483493|Tic disorders|tic disorders
14247|NCT03483493|Tourette Syndrome|tourette syndrome
14248|NCT03483493|Online delivered therapy|online delivered therapy
14249|NCT03483454|exercise, fitness, sleep, children, obesity|exercise, fitness, sleep, children, obesity
14250|NCT03483402|Pseudoexfoliation Glaucoma|pseudoexfoliation glaucoma
14251|NCT03483402|Primary Open-angle Glaucoma|primary open-angle glaucoma
14252|NCT03483402|Micropulse Laser Trabeculoplasty|micropulse laser trabeculoplasty
14253|NCT03483402|Intraocular Pressure|intraocular pressure
14254|NCT03483376|black stain|black stain
14255|NCT03483376|dental plaque|dental plaque
14256|NCT03483376|antimicrobial photodynamic therapy|antimicrobial photodynamic therapy
14257|NCT03483376|curcumin|curcumin
14258|NCT03483376|tooth discoloration|tooth discoloration
14259|NCT03483337|(DW)-MRI|(dw)-mri
14260|NCT03483337|oncological biomarkers|oncological biomarkers
14261|NCT03483337|18-053|18-053
14262|NCT03483285|intubation|intubation
14263|NCT03483285|airtraq|airtraq
14264|NCT03483285|open heart surgery|open heart surgery
14265|NCT03483285|hemodynamic parameters|hemodynamic parameters
14266|NCT03483272|Terlipressin|terlipressin
14267|NCT03483272|Pharmacological respons|pharmacological respons
14268|NCT03483272|Magnetic Resonance Imaging|magnetic resonance imaging
14269|NCT03483272|Hemodynamic assessments|hemodynamic assessments
14270|NCT03483272|Echocardiography|echocardiography
14271|NCT03483272|Hepatorenal syndrome - acute kidney injury|hepatorenal syndrome - acute kidney injury
14272|NCT03483259|Pharmacokinetics|pharmacokinetics
14273|NCT03483259|Relative bioavailability|relative bioavailability
14274|NCT03483246|Ulcerative colitis|ulcerative colitis
14275|NCT03483246|Inflammatory bowel disease|inflammatory bowel disease
14276|NCT03483246|Fecal microbiota transplantation|fecal microbiota transplantation
14277|NCT03483233|Gyrus Cinguli|gyrus cinguli
14278|NCT03483233|Cognitive Control Process|cognitive control process
14279|NCT03483233|Check process|check process
14280|NCT03483233|Decision Making|decision making
14281|NCT03483233|fMRI|fmri
14282|NCT03483220|Addiction, MRI, Decision making|addiction, mri, decision making
14283|NCT03483194|Therapeutic Virtual Reality|therapeutic virtual reality
14284|NCT03483194|Pain related medical procedure management|pain related medical procedure management
14285|NCT03483194|Anxiety management|anxiety management
14286|NCT03483194|Osteo-medullary biopsy|osteo-medullary biopsy
14287|NCT03483116|Dose ranging|dose ranging
14288|NCT03483116|Neonatal vaccine|neonatal vaccine
14289|NCT03483116|RV3-BB vaccine|rv3-bb vaccine
14290|NCT03483103|JCAR017|jcar017
14291|NCT03483103|lisocabtagene maraleucel|lisocabtagene maraleucel
14292|NCT03483103|NHL|nhl
14293|NCT03483103|chimeric antigen receptor|chimeric antigen receptor
14294|NCT03483103|CAR|car
14295|NCT03483103|CAR T cell|car t cell
14296|NCT03483103|autologous T cell therapy|autologous t cell therapy
14297|NCT03483103|immunotherapy|immunotherapy
14298|NCT03483103|cell therapy|cell therapy
14300|NCT03483090|mild|mild
14301|NCT03483090|moderate|moderate
14302|NCT03483090|krill oil|krill oil
14303|NCT03483090|pain|pain
14304|NCT03483090|osteoarthritis|osteoarthritis
14305|NCT03483090|supplement|supplement
14306|NCT03483051|aortic stenosis, aortic valve replacement|aortic stenosis, aortic valve replacement
14307|NCT03483038|pancreatic adenocarcinoma|pancreatic adenocarcinoma
14308|NCT03483038|neoadjuvant|neoadjuvant
14309|NCT03483038|ONIVYDE|onivyde
14310|NCT03483038|chemotherapy|chemotherapy
14311|NCT03483038|borderline resectable|borderline resectable
14312|NCT03483012|Breast Cancer|breast cancer
14313|NCT03482986|Diet|diet
14314|NCT03482986|Dietary Habits|dietary habits
14315|NCT03482986|Weight changes|weight changes
14316|NCT03482973|Cardiopulmonary Bypass|cardiopulmonary bypass
14317|NCT03482973|Cardiac Surgery|cardiac surgery
14318|NCT03482973|Sternotomy|sternotomy
14319|NCT03482960|imaging|imaging
14320|NCT03482960|hyperpolarized|hyperpolarized
14321|NCT03482960|perfluorinated|perfluorinated
14322|NCT03482960|MRI|mri
14323|NCT03482960|lung|lung
14324|NCT03482947|Dexmedetomidine|dexmedetomidine
14325|NCT03482947|pediatrics; postoperative;|pediatrics; postoperative;
14326|NCT03482947|Analgesia; caudal|analgesia; caudal
14327|NCT03482908|Responsive parenting|responsive parenting
14328|NCT03482895|Gastric Bypass|gastric bypass
14329|NCT03482895|Intestinal Absorption|intestinal absorption
14330|NCT03482895|Gastrointestinal Hormones|gastrointestinal hormones
14331|NCT03482895|Enteroendocrine Cells|enteroendocrine cells
14332|NCT03482869|walking impairment|walking impairment
14333|NCT03482869|disability|disability
14334|NCT03482869|diabetes mellitus|diabetes mellitus
14335|NCT03482830|Inflammation|inflammation
14336|NCT03482830|Insulin-glucose homeostasis|insulin-glucose homeostasis
14337|NCT03482830|Hypothalamic-pituitary-adrenal axis|hypothalamic-pituitary-adrenal axis
14338|NCT03482830|Endothelial function and damage|endothelial function and damage
14339|NCT03482830|Thyroid hormones|thyroid hormones
14340|NCT03482778|PROMIS|promis
14342|NCT03482778|ONCOLOGY|oncology
14343|NCT03482778|HRQOL|hrqol
14344|NCT03482778|Adolescent and Young Adult|adolescent and young adult
14345|NCT03482778|Health Related Quality of Life Measurement|health related quality of life measurement
14346|NCT03482778|Patient-Reported Outcomes Measurement Information System|patient-reported outcomes measurement information system
14347|NCT03482739|HPV|hpv
14348|NCT03482739|Vaccine|vaccine
14349|NCT03482739|HIV|hiv
14350|NCT03482739|Solid organ transplantation|solid organ transplantation
14351|NCT03482726|bicycle|bicycle
14352|NCT03482726|cadence|cadence
14353|NCT03482726|cyclist|cyclist
14354|NCT03482726|modulation|modulation
14355|NCT03482700|COPD; GP Surgeries|copd; gp surgeries
14356|NCT03482687|adolescent behavior|adolescent behavior
14357|NCT03482687|interpersonal relationships|interpersonal relationships
14358|NCT03482687|intimate partner violence|intimate partner violence
14359|NCT03482687|violence/prevention & control|violence/prevention & control
14360|NCT03482687|program evaluation|program evaluation
14361|NCT03482687|teen dating violence|teen dating violence
14362|NCT03482674|Health literacy|health literacy
14363|NCT03482674|Innovation Fund|innovation fund
14364|NCT03482674|lifestyle intervention|lifestyle intervention
14365|NCT03482674|risk screening|risk screening
14366|NCT03482674|type 2 diabetes mellitus|type 2 diabetes mellitus
14367|NCT03482674|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
14368|NCT03482661|Magnetic steering|magnetic steering
14369|NCT03482661|MCE|mce
14370|NCT03482661|CECR|cecr
14371|NCT03482648|Pellino-1|pellino-1
14372|NCT03482622|Raman spectroscopy|raman spectroscopy
14373|NCT03482596|Sedentary Behaviour|sedentary behaviour
14374|NCT03482596|Prevention|prevention
14375|NCT03482583|Smoking, Cancer, Treatment|smoking, cancer, treatment
14376|NCT03482570|Activity behaviors|activity behaviors
14377|NCT03482570|Malignant pleural effusion|malignant pleural effusion
14378|NCT03482557|Breast Cancer|breast cancer
14379|NCT03482557|screening|screening
14380|NCT03482557|breast MRI|breast mri
14381|NCT03482557|contrast enhanced spectral mammography|contrast enhanced spectral mammography
14382|NCT03482544|pregabalin|pregabalin
14383|NCT03482544|ischemia reperfusion injury|ischemia reperfusion injury
14384|NCT03482544|muscle|muscle
14385|NCT03482531|limit nocturnal activity|limit nocturnal activity
14386|NCT03482531|cervical ripening|cervical ripening
14387|NCT03482492|Acetaminophen|acetaminophen
14388|NCT03482492|Tramadol|tramadol
14389|NCT03482492|Discogenic pain|discogenic pain
14390|NCT03482492|Lumbar Discectomy|lumbar discectomy
14391|NCT03482453|Drug Therapy|drug therapy
14392|NCT03482440|preeclampsia|preeclampsia
14393|NCT03482440|microvascular|microvascular
14394|NCT03482440|inflammation|inflammation
14395|NCT03482440|angiotensin II|angiotensin ii
14396|NCT03482414|stroke|stroke
14397|NCT03482414|upper limb rehabilitation|upper limb rehabilitation
14398|NCT03482414|neuro-rehabilitation|neuro-rehabilitation
14399|NCT03482401|Polyphenol|polyphenol
14400|NCT03482401|Methylxanthine|methylxanthine
14401|NCT03482401|Metabolism|metabolism
14402|NCT03482401|Breast tissue|breast tissue
14403|NCT03482401|Disposition|disposition
14404|NCT03482401|UPLC-QTOF|uplc-qtof
14405|NCT03482388|Hepatitis|hepatitis
14406|NCT03482388|Hepatitis B|hepatitis b
14407|NCT03482388|Hepatitis C|hepatitis c
14408|NCT03482388|Men who have sex with men|men who have sex with men
14409|NCT03482388|Crowdsourcing|crowdsourcing
14410|NCT03482388|China|china
14411|NCT03482388|Testing|testing
14412|NCT03482375|Gall Stones|gall stones
14413|NCT03482375|ERCP|ercp
14414|NCT03482375|Cholangioscopy|cholangioscopy
14415|NCT03482362|vinorelbine|vinorelbine
14416|NCT03482336|labeling|labeling
14417|NCT03482336|Front of pack|front of pack
14418|NCT03482336|nutrition|nutrition
14419|NCT03482336|nutrition facts panel|nutrition facts panel
14420|NCT03482310|Brain computer interface|brain computer interface
14421|NCT03482310|electric stimulation|electric stimulation
14422|NCT03482258|Stress|stress
14423|NCT03482258|Galactooligosaccharide|galactooligosaccharide
14424|NCT03482258|Prebiotic|prebiotic
14425|NCT03482258|Early life stress|early life stress
14426|NCT03482258|Emotional eating|emotional eating
14427|NCT03482258|Gut microbiota|gut microbiota
14428|NCT03482258|Short-chain fatty acids|short-chain fatty acids
14429|NCT03482258|Serotonin|serotonin
14430|NCT03482258|Cortisol|cortisol
14431|NCT03482245|pneumonia|pneumonia
14432|NCT03482245|appendicitis|appendicitis
14433|NCT03482245|diverticulitis|diverticulitis
14434|NCT03482245|circadian rhythms|circadian rhythms
14435|NCT03482245|blue light|blue light
14436|NCT03482245|sepsis|sepsis
14437|NCT03482232|patient safety|patient safety
14438|NCT03482232|quality assurance|quality assurance
14439|NCT03482232|overuse|overuse
14440|NCT03482167|blood pressure|blood pressure
14441|NCT03482167|arterial stiffness|arterial stiffness
14442|NCT03482167|cerebrovascular function|cerebrovascular function
14443|NCT03482167|cognitive function|cognitive function
14444|NCT03482128|transfusion|transfusion
14445|NCT03482128|coagulation|coagulation
14446|NCT03482128|cardiac surgery|cardiac surgery
14447|NCT03482115|coma|coma
14448|NCT03482115|traumatic brain injury|traumatic brain injury
14449|NCT03482115|anoxic encephalopathy|anoxic encephalopathy
14450|NCT03482115|brain connectome|brain connectome
14451|NCT03482115|neuroinflammation|neuroinflammation
14452|NCT03482115|prognosis|prognosis
14453|NCT03482102|Hepatocellular Carcinoma|hepatocellular carcinoma
14454|NCT03482102|Biliary Tract Cancer|biliary tract cancer
14455|NCT03482063|B vitamin|b vitamin
14456|NCT03482063|herbal supplement|herbal supplement
14457|NCT03482063|attention|attention
14458|NCT03482011|Psoriasis|psoriasis
14459|NCT03482011|IL-23|il-23
14460|NCT03481998|CDK4/6 inhibitor|cdk4/6 inhibitor
14461|NCT03481998|Breast cancer|breast cancer
14462|NCT03481998|Postmenopausal women|postmenopausal women
14463|NCT03481998|Hormone-receptor positive|hormone-receptor positive
14464|NCT03481998|HER2 negative|her2 negative
14465|NCT03481985|Fontan-associated liver disease|fontan-associated liver disease
14466|NCT03481959|TDAH|tdah
14467|NCT03481959|Methylphenidate|methylphenidate
14468|NCT03481959|Cannabis|cannabis
14469|NCT03481920|pancreatic cancer, inmunotherapy|pancreatic cancer, inmunotherapy
14470|NCT03481907|collagen powder|collagen powder
14471|NCT03481907|punch biopsy wound|punch biopsy wound
14472|NCT03481894|Parenteral nutrition|parenteral nutrition
14473|NCT03481894|Malnutrition|malnutrition
14474|NCT03481894|Pediatrics|pediatrics
14475|NCT03481894|nutritional needs|nutritional needs
14476|NCT03481881|pharmacokinetics|pharmacokinetics
14477|NCT03481868|chronic myeloid leukemia|chronic myeloid leukemia
14478|NCT03481868|epigenetic|epigenetic
14479|NCT03481868|leukemic stem cell|leukemic stem cell
14480|NCT03481842|Endometriosis|endometriosis
14481|NCT03481842|VEGF(R)|vegf(r)
14482|NCT03481829|American Indians|american indians
14483|NCT03481829|Obesity|obesity
14484|NCT03481829|Pregnancy|pregnancy
14485|NCT03481829|Diabetes|diabetes
14486|NCT03481829|Children|children
14487|NCT03481816|mCRPC|mcrpc
14488|NCT03481816|Therapeutic Cancer Vaccines|therapeutic cancer vaccines
14489|NCT03481816|ETBX-071|etbx-071
14490|NCT03481816|ETBX-061|etbx-061
14491|NCT03481816|ETBX-051|etbx-051
14492|NCT03481803|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
14493|NCT03481790|iron deficiency anemia of pregnancy - lactoferrin|iron deficiency anemia of pregnancy - lactoferrin
14494|NCT03481777|Remote Ischemic Conditioning|remote ischemic conditioning
14495|NCT03481777|Neuroprotection|neuroprotection
14496|NCT03481764|febrile seizure|febrile seizure
14497|NCT03481764|HRC-test|hrc-test
14498|NCT03481764|genetic variation|genetic variation
14499|NCT03481764|epilepsy|epilepsy
14500|NCT03481751|Crohn Disease|crohn disease
14501|NCT03481751|Ultrasound|ultrasound
14502|NCT03481751|Monitoring|monitoring
14503|NCT03481751|Disease activity|disease activity
14504|NCT03481738|Glycolytic enzymopathy|glycolytic enzymopathy
14599|NCT03481114|radiation therapy|radiation therapy
14505|NCT03481738|Congenital Non-spherocytic hemolytic anemia (CNSA)|congenital non-spherocytic hemolytic anemia (cnsa)
14506|NCT03481699|Adolescence|adolescence
14507|NCT03481699|Prevention|prevention
14508|NCT03481699|Emotional disorders|emotional disorders
14509|NCT03481699|Aggressive behavior|aggressive behavior
14510|NCT03481686|Erythropoiesis|erythropoiesis
14511|NCT03481686|stimulating|stimulating
14512|NCT03481686|agents|agents
14513|NCT03481686|therapeutic|therapeutic
14514|NCT03481686|education|education
14515|NCT03481686|program|program
14516|NCT03481673|Childhood Asthma|childhood asthma
14517|NCT03481673|Childhood Anxiety|childhood anxiety
14518|NCT03481673|Childhood Depression|childhood depression
14519|NCT03481673|Childhood Quality of Life|childhood quality of life
14520|NCT03481660|Diabetic Macular Edema|diabetic macular edema
14521|NCT03481660|intravitreal injection|intravitreal injection
14522|NCT03481660|brolucizumab|brolucizumab
14523|NCT03481660|aflibercept|aflibercept
14524|NCT03481660|double-masked|double-masked
14525|NCT03481634|Diabetic Macular Edema|diabetic macular edema
14526|NCT03481634|intravitreal injection|intravitreal injection
14527|NCT03481634|brolucizumab|brolucizumab
14528|NCT03481634|aflibercept|aflibercept
14529|NCT03481634|double-masked|double-masked
14530|NCT03481621|Vulvodynia|vulvodynia
14531|NCT03481608|fatty acid|fatty acid
14532|NCT03481608|nutrition|nutrition
14533|NCT03481608|metabolism|metabolism
14534|NCT03481608|lauric acid|lauric acid
14535|NCT03481608|dilauroylphosphatidylcholine|dilauroylphosphatidylcholine
14536|NCT03481608|lrh-1|lrh-1
14537|NCT03481582|Nitroglycerin Trans-dermal Patch|nitroglycerin trans-dermal patch
14538|NCT03481543|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
14539|NCT03481543|Nebulization|nebulization
14540|NCT03481543|Respiratory failure|respiratory failure
14541|NCT03481543|Non-invasive ventilation(NIV)|non-invasive ventilation(niv)
14542|NCT03481517|adult|adult
14543|NCT03481517|appendectomy|appendectomy
14544|NCT03481517|appendicitis|appendicitis
14545|NCT03481517|local anesthesia|local anesthesia
14546|NCT03481517|pain|pain
14547|NCT03481491|Cerebellum|cerebellum
14548|NCT03481491|Striatum|striatum
14549|NCT03481491|Human|human
14550|NCT03481491|fMRI|fmri
14551|NCT03481491|Transcranial magnetic stimulation|transcranial magnetic stimulation
14552|NCT03481491|Genetic dystonia|genetic dystonia
14553|NCT03481478|occult|occult
14554|NCT03481478|proximal humeral neck fractures|proximal humeral neck fractures
14555|NCT03481478|greater tuberosity|greater tuberosity
14556|NCT03481478|shoulder dislocation|shoulder dislocation
14557|NCT03481465|Biomarkers|biomarkers
14558|NCT03481465|Hepatic dysfunction|hepatic dysfunction
14559|NCT03481465|Metabolic dysfunction|metabolic dysfunction
14560|NCT03481465|Endothelial dysfunction|endothelial dysfunction
14561|NCT03481465|Antipsychotics|antipsychotics
14562|NCT03481465|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
14563|NCT03481452|anxiety|anxiety
14564|NCT03481452|regulation of states|regulation of states
14565|NCT03481452|NBO|nbo
14566|NCT03481452|HAMA|hama
14567|NCT03481439|Pharmacist|pharmacist
14568|NCT03481439|Led medication review|led medication review
14569|NCT03481439|Orthopaedic surgery|orthopaedic surgery
14570|NCT03481439|Traumatology|traumatology
14571|NCT03481426|musculoskelelal disorder|musculoskelelal disorder
14572|NCT03481426|occupational health service|occupational health service
14573|NCT03481400|Calcitonin gene-related peptide|calcitonin gene-related peptide
14574|NCT03481361|Obstructive sleep apnoea (OSA)|obstructive sleep apnoea (osa)
14575|NCT03481361|Type 1 diabetes (T1D)|type 1 diabetes (t1d)
14576|NCT03481361|Type 2 diabetes (T2D)|type 2 diabetes (t2d)
14577|NCT03481361|Insulin-Dependent Diabetes Mellitus (IDDM)|insulin-dependent diabetes mellitus (iddm)
14578|NCT03481322|sodium chloride; diet; cooking|sodium chloride; diet; cooking
14579|NCT03481309|transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
14580|NCT03481309|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
14581|NCT03481309|electroencephalography (EEG)|electroencephalography (eeg)
14582|NCT03481296|Colorectal Cancer Screening|colorectal cancer screening
14583|NCT03481296|Asian Americans|asian americans
14584|NCT03481296|Patient Navigation|patient navigation
14585|NCT03481296|Decision Counseling Program|decision counseling program
14586|NCT03481283|Amylin|amylin
14587|NCT03481218|Type 1 diabetes|type 1 diabetes
14588|NCT03481218|Quality of life|quality of life
14589|NCT03481218|Personality traits|personality traits
14590|NCT03481218|Young adults|young adults
14591|NCT03481205|remote limb ischemic conditioning|remote limb ischemic conditioning
14592|NCT03481205|large vessel occlusion|large vessel occlusion
14593|NCT03481205|helicopter transport|helicopter transport
14594|NCT03481179|Repetitive transcranial magnetic stimulation, Physiotherapy, Stroke, Spasticity|repetitive transcranial magnetic stimulation, physiotherapy, stroke, spasticity
14595|NCT03481166|pilot|pilot
14596|NCT03481166|randomized controlled trial|randomized controlled trial
14597|NCT03481166|prenatal education|prenatal education
14598|NCT03481166|anticipatory guidance|anticipatory guidance
14600|NCT03481114|chemotherapy|chemotherapy
14601|NCT03481114|PET Imaging|pet imaging
14602|NCT03481101|early response evaluation|early response evaluation
14603|NCT03481101|immunotherapy|immunotherapy
14604|NCT03481101|chemotherapy|chemotherapy
14605|NCT03481101|liquid biopsy|liquid biopsy
14606|NCT03481101|FDG-PET/CT|fdg-pet/ct
14607|NCT03481075|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
14608|NCT03481075|Imaging, Three-Dimensional|imaging, three-dimensional
14609|NCT03481075|Tomography Scanners, X-Ray Computed|tomography scanners, x-ray computed
14610|NCT03481075|Angiography, Digital Subtraction|angiography, digital subtraction
14611|NCT03481075|Endovascular Procedures|endovascular procedures
14612|NCT03481075|Radiography, Interventional|radiography, interventional
14613|NCT03481036|Mukh Mantri Punjab Hepatitis C Relief Fund,MMPHCRF|mukh mantri punjab hepatitis c relief fund,mmphcrf
14614|NCT03481036|Direct acting antiviral agents (DAA)|direct acting antiviral agents (daa)
14615|NCT03481036|Chronic Hepatitis C|chronic hepatitis c
14616|NCT03481036|Pediatric population|pediatric population
14617|NCT03481036|Adolescent Chronic Hepatitis C|adolescent chronic hepatitis c
14618|NCT03481023|Atrial Fibrillation|atrial fibrillation
14619|NCT03481023|Esophageal Cooling Device|esophageal cooling device
14620|NCT03481023|Radiofrequency Ablation|radiofrequency ablation
14621|NCT03481023|Arrhythmia|arrhythmia
14622|NCT03480971|cisplatin toxicity|cisplatin toxicity
14623|NCT03480958|erector spinae plane block|erector spinae plane block
14624|NCT03480958|thoracic paravertebral block|thoracic paravertebral block
14625|NCT03480958|breast surgery|breast surgery
14626|NCT03480958|postoperative pain|postoperative pain
14627|NCT03480932|directly observed therapy|directly observed therapy
14628|NCT03480932|sofosbuvir|sofosbuvir
14629|NCT03480932|daclatasvir|daclatasvir
14630|NCT03480932|pegylated interferon|pegylated interferon
14631|NCT03480932|resource-limited setting|resource-limited setting
14632|NCT03480893|laminectomy|laminectomy
14633|NCT03480893|laminotomy|laminotomy
14634|NCT03480893|lumbar canal stenosis|lumbar canal stenosis
14635|NCT03480880|Bispectral Index|bispectral index
14636|NCT03480815|Asthma|asthma
14637|NCT03480815|Controlled Laminar Airflow Device|controlled laminar airflow device
14638|NCT03480815|Omalizumab|omalizumab
14639|NCT03480802|Conjugate pneumococcal vaccine, 15-valent, 22F, 33F|conjugate pneumococcal vaccine, 15-valent, 22f, 33f
14640|NCT03480750|Copper chelator|copper chelator
14641|NCT03480750|Epithelial ovarian cancer|epithelial ovarian cancer
14642|NCT03480750|Tubal cancer|tubal cancer
14643|NCT03480750|Peritoneal cancer|peritoneal cancer
14644|NCT03480750|Trientine|trientine
14645|NCT03480750|Pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
14646|NCT03480750|Carboplatin|carboplatin
14647|NCT03480711|subscleral trabeculectomy|subscleral trabeculectomy
14648|NCT03480711|extended subscleral tunnel|extended subscleral tunnel
14649|NCT03480711|mitomycinC|mitomycinc
14650|NCT03480698|acute ischemic stroke|acute ischemic stroke
14651|NCT03480646|Phase 1/2|phase 1/2
14652|NCT03480646|Oncology|oncology
14653|NCT03480646|EZH2 Inhibitor|ezh2 inhibitor
14654|NCT03480620|Telehealth|telehealth
14655|NCT03480620|Telerehabilitation|telerehabilitation
14656|NCT03480620|Chronic pain|chronic pain
14657|NCT03480620|Post-discharge care|post-discharge care
14658|NCT03480581|Neurological|neurological
14659|NCT03480581|Gait|gait
14660|NCT03480581|Cardiorespiratory fitness|cardiorespiratory fitness
14661|NCT03480581|Rehabilitation|rehabilitation
14662|NCT03480581|Walking|walking
14663|NCT03480581|Locomotor training|locomotor training
14664|NCT03480581|Robotics|robotics
14665|NCT03480568|Alirocumab|alirocumab
14666|NCT03480529|adverse event|adverse event
14667|NCT03480529|arthritis|arthritis
14668|NCT03480529|Systemic Lupus Erythematosus|systemic lupus erythematosus
14669|NCT03480529|Capillary Leak Syndrome|capillary leak syndrome
14670|NCT03480516|Silver Diamine Fluoride|silver diamine fluoride
14671|NCT03480516|Sodium Fluoride Varnish|sodium fluoride varnish
14672|NCT03480516|Arrest caries|arrest caries
14673|NCT03480516|Caries prevention|caries prevention
14674|NCT03480503|Apelin12|apelin12
14675|NCT03480477|Adverse Childhood Experiences|adverse childhood experiences
14676|NCT03480412|Luteal Phase Stimulation|luteal phase stimulation
14677|NCT03480412|Poor Ovarian Response|poor ovarian response
14678|NCT03480412|In Vitro Fertilization|in vitro fertilization
14679|NCT03480399|retroperitoneal sarcoma|retroperitoneal sarcoma
14680|NCT03480399|quality of life|quality of life
14681|NCT03480399|morbidity|morbidity
14682|NCT03480399|surgery|surgery
14683|NCT03480386|Pulmonary Rehabilitation|pulmonary rehabilitation
14684|NCT03480373|Nicotine|nicotine
14685|NCT03480373|Nicotine addiction|nicotine addiction
14686|NCT03480373|Tobacco Use Disorder|tobacco use disorder
14687|NCT03480373|Pregnancy|pregnancy
14688|NCT03480373|Electronic cigarettes|electronic cigarettes
14689|NCT03480373|Cigarettes|cigarettes
14690|NCT03480373|Vaping|vaping
14691|NCT03480373|Carcinoma|carcinoma
14692|NCT03480373|Pregnant|pregnant
14693|NCT03480373|Birth Outcomes|birth outcomes
14694|NCT03480373|E-liquid|e-liquid
14695|NCT03480360|haploidentical|haploidentical
14696|NCT03480360|transplant|transplant
14697|NCT03480360|peripheral blood|peripheral blood
14698|NCT03480360|allogeneic|allogeneic
14699|NCT03480321|Peripheral Artery Disease|peripheral artery disease
14700|NCT03480321|Cilostazol|cilostazol
14701|NCT03480321|PMR|pmr
14702|NCT03480321|Extended-Release Tablet of Cilostazol|extended-release tablet of cilostazol
14703|NCT03480282|Life expectancy|life expectancy
14704|NCT03480282|Older adults|older adults
14705|NCT03480282|Primary care|primary care
14706|NCT03480282|Cancer screening|cancer screening
14707|NCT03480256|SHR6390|shr6390
14708|NCT03480256|Pyrotinib|pyrotinib
14709|NCT03480256|gastric cancer|gastric cancer
14710|NCT03480256|Her-2 positive|her-2 positive
14711|NCT03480243|Padsevonil|padsevonil
14712|NCT03480230|Non-small cell lung cancer|non-small cell lung cancer
14713|NCT03480230|Platinum doublet chemotherapy|platinum doublet chemotherapy
14714|NCT03480230|Neoadjuvant|neoadjuvant
14715|NCT03480217|hypertension|hypertension
14716|NCT03480217|screening|screening
14717|NCT03480217|guidelines|guidelines
14718|NCT03480217|implementation|implementation
14719|NCT03480217|randomized|randomized
14720|NCT03480165|Randomized controlled trial|randomized controlled trial
14721|NCT03480165|Double blind|double blind
14722|NCT03480165|Parallel group|parallel group
14723|NCT03480152|Metastatic Cancer|metastatic cancer
14724|NCT03480152|Immunotherapy|immunotherapy
14725|NCT03480152|Tumor Regression|tumor regression
14726|NCT03480152|Cancer Vaccine|cancer vaccine
14727|NCT03480139|Prematurity|prematurity
14728|NCT03480139|Perinatal Mortality|perinatal mortality
14729|NCT03480139|Pregnancy Complications|pregnancy complications
14730|NCT03480139|Prediction of Adverse Pregnancy Outcome|prediction of adverse pregnancy outcome
14731|NCT03480139|Premature Rupture of Membranes|premature rupture of membranes
14732|NCT03480100|rhinosinusitis|rhinosinusitis
14733|NCT03480100|nasal irrigation|nasal irrigation
14734|NCT03480100|nasal douche|nasal douche
14735|NCT03480100|Ectoin|ectoin
14736|NCT03480087|strain-rate echocardiography|strain-rate echocardiography
14737|NCT03480087|chemotherapy|chemotherapy
14738|NCT03480087|radiotherapy, mediastinal|radiotherapy, mediastinal
14739|NCT03480087|Lymphoma|lymphoma
14740|NCT03480087|Hodgkin|hodgkin
14741|NCT03480022|prediabetes|prediabetes
14742|NCT03480022|PCOS|pcos
14743|NCT03480022|GLP-1 agonist|glp-1 agonist
14744|NCT03480022|weight loss|weight loss
14745|NCT03480009|medication abortion|medication abortion
14746|NCT03480009|dextromethorphan|dextromethorphan
14747|NCT03480009|pain control|pain control
14748|NCT03479983|Indian gooseberry|indian gooseberry
14749|NCT03479983|Total cholesterol|total cholesterol
14750|NCT03479983|Triglycerides|triglycerides
14751|NCT03479866|Gut microbiome|gut microbiome
14752|NCT03479866|Personalised Nutrition|personalised nutrition
14753|NCT03479866|Metabolic health|metabolic health
14754|NCT03479853|Ocular Rosacea|ocular rosacea
14755|NCT03479853|Keratoconjunctivitis|keratoconjunctivitis
14756|NCT03479853|Meibomian Gland|meibomian gland
14757|NCT03479853|Interferometry|interferometry
14758|NCT03479853|Child|child
14759|NCT03479840|SYNTAX score, PCI, elderly|syntax score, pci, elderly
14760|NCT03479814|rectal cancer|rectal cancer
14761|NCT03479814|neoadjuvant chemoradiation|neoadjuvant chemoradiation
14762|NCT03479814|IMRT-SIB|imrt-sib
14763|NCT03479814|adaptive radiotherapy|adaptive radiotherapy
14764|NCT03479788|sleep apnea, coronary artery, diabetes|sleep apnea, coronary artery, diabetes
14765|NCT03479697|HIRREM|hirrem
14766|NCT03479697|Neurotechnology|neurotechnology
14767|NCT03479697|Closed-Loop|closed-loop
14768|NCT03479697|Allostasis|allostasis
14769|NCT03479697|Stress|stress
14770|NCT03479697|Autonomic Dysregulation|autonomic dysregulation
14771|NCT03479697|Hyperarousal|hyperarousal
14772|NCT03479697|Brain Electrical Activity|brain electrical activity
14773|NCT03479697|Acoustic Stimulation|acoustic stimulation
14774|NCT03479697|Primary Hypertension|primary hypertension
14775|NCT03479697|High Blood Pressure|high blood pressure
14776|NCT03479684|warfarin|warfarin
14777|NCT03479684|gene|gene
14778|NCT03479658|HIIT|hiit
14779|NCT03479658|nutritional education|nutritional education
14780|NCT03479658|Dose-effect|dose-effect
14781|NCT03479658|school|school
14782|NCT03479658|children|children
14783|NCT03479658|cardiovascular|cardiovascular
14784|NCT03479658|adiposity|adiposity
14785|NCT03479658|blood pressure|blood pressure
14786|NCT03479658|fitness|fitness
14787|NCT03479645|Colon cancer|colon cancer
14788|NCT03479645|Bowel cancer|bowel cancer
14789|NCT03479645|Cancer screening|cancer screening
14790|NCT03479645|text message|text message
14791|NCT03479645|Fecal immunochemistry test (FIT)|fecal immunochemistry test (fit)
14792|NCT03479645|opt-out|opt-out
14793|NCT03479645|behavioral intervention|behavioral intervention
14794|NCT03479619|lancing device|lancing device
14795|NCT03479619|lancet|lancet
14796|NCT03479606|Traumatic Brain Injury|traumatic brain injury
14797|NCT03479606|TBI|tbi
14798|NCT03479606|Executive Dysfunction|executive dysfunction
14799|NCT03479606|Emotional Regulation|emotional regulation
14800|NCT03479606|Emotional Dysfunction|emotional dysfunction
14801|NCT03479606|Problem Solving|problem solving
14802|NCT03479606|Self-regulation|self-regulation
14803|NCT03479606|Cognitive Rehabilitation|cognitive rehabilitation
14804|NCT03479606|Metacognitive Strategies|metacognitive strategies
14805|NCT03479606|Cognitive-behavioral therapy|cognitive-behavioral therapy
14806|NCT03479606|Online Therapy|online therapy
14807|NCT03479606|GroupTherapy|grouptherapy
14808|NCT03479606|Group videoconference|group videoconference
14809|NCT03479606|Telehealth|telehealth
14810|NCT03479606|Telerehabilitation|telerehabilitation
14811|NCT03479593|NSTEMI|nstemi
14812|NCT03479593|Culprit|culprit
14813|NCT03479593|Cardiac magnetic resonance|cardiac magnetic resonance
14814|NCT03479593|Optical Coherence Tomography|optical coherence tomography
14815|NCT03479580|Cardiomyopathy|cardiomyopathy
14816|NCT03479580|Multimodal imaging|multimodal imaging
14817|NCT03479580|Coronary artery disease|coronary artery disease
14818|NCT03479580|Coronary microvascular disease|coronary microvascular disease
14819|NCT03479580|Prognosis|prognosis
14820|NCT03479580|Atherosclerosis|atherosclerosis
14821|NCT03479580|Myocardial ischemia|myocardial ischemia
14822|NCT03479554|antihypertensive treatment|antihypertensive treatment
14823|NCT03479541|mild traumatic brain injury|mild traumatic brain injury
14824|NCT03479541|vestibular impairment|vestibular impairment
14825|NCT03479541|balance and gait|balance and gait
14826|NCT03479541|dual-tasking|dual-tasking
14827|NCT03479541|veterans|veterans
14828|NCT03479541|quality of life|quality of life
14829|NCT03479541|rehabilitation|rehabilitation
14830|NCT03479528|Dyspepsia,alarm symptoms，Roman IV|dyspepsia,alarm symptoms，roman iv
14831|NCT03479476|Congenital Abnormalities|congenital abnormalities
14832|NCT03479476|Metformin|metformin
14833|NCT03479476|Nervous System Diseases|nervous system diseases
14834|NCT03479476|Chromosome Disorders|chromosome disorders
14835|NCT03479437|Obesity|obesity
14836|NCT03479437|Melanocortin|melanocortin
14837|NCT03479437|TEMPO|tempo
14838|NCT03479437|MC4R|mc4r
14839|NCT03479437|Genetic Obesity|genetic obesity
14840|NCT03479437|hypothalamic|hypothalamic
14841|NCT03479437|POMC|pomc
14842|NCT03479437|LEPR|lepr
14843|NCT03479437|PCSK1|pcsk1
14844|NCT03479398|Fidelity|fidelity
14845|NCT03479398|Cognitive Behavioral Therapy|cognitive behavioral therapy
14846|NCT03479398|Mobile Application|mobile application
14847|NCT03479398|Routine Practice|routine practice
14848|NCT03479372|AMD|amd
14849|NCT03479372|wet AMD|wet amd
14850|NCT03479372|exudative AMD|exudative amd
14851|NCT03479372|macular degeneration|macular degeneration
14852|NCT03479359|Prostate cancer; Benign Prostatic Hyperplasia; Digital Rectal Examination; Accuracy|prostate cancer; benign prostatic hyperplasia; digital rectal examination; accuracy
14853|NCT03479346|Obesity|obesity
14854|NCT03479346|Metabolic syndrome|metabolic syndrome
14855|NCT03479346|Traditional Korean Medicine|traditional korean medicine
14856|NCT03479346|Galgeun-tang|galgeun-tang
14857|NCT03479255|Smartphone|smartphone
14858|NCT03479255|Exercise|exercise
14859|NCT03479255|Functional capacity|functional capacity
14860|NCT03479229|vaginal laxity|vaginal laxity
14861|NCT03479229|sexual function|sexual function
14862|NCT03479229|vaginal childbirth|vaginal childbirth
14863|NCT03479229|sexual dysfunction|sexual dysfunction
14864|NCT03479229|diminished sexual function|diminished sexual function
14865|NCT03479229|satisfaction|satisfaction
14866|NCT03479229|arousal|arousal
14867|NCT03479229|desire|desire
14868|NCT03479229|lubrication|lubrication
14869|NCT03479229|orgasm|orgasm
14870|NCT03479216|Analgesia|analgesia
14871|NCT03479216|Anesthesia|anesthesia
14872|NCT03479216|Arthroscopy|arthroscopy
14873|NCT03479216|Bupivacaine|bupivacaine
14874|NCT03479216|Dexmedetomidine|dexmedetomidine
14875|NCT03479216|Injections, Intra-Articular|injections, intra-articular
14876|NCT03479216|Magnesium|magnesium
14877|NCT03479216|Pain, Postoperative|pain, postoperative
14878|NCT03479203|Inflammation|inflammation
14879|NCT03479151|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
14880|NCT03479151|High Intensity Focused Ultrasound (HIFU)|high intensity focused ultrasound (hifu)
14881|NCT03479138|severe asthma|severe asthma
14882|NCT03479138|induced sputum|induced sputum
14883|NCT03479138|asthma phenotypes|asthma phenotypes
14884|NCT03479138|neutrophilic inflammation|neutrophilic inflammation
14885|NCT03479138|microbiome|microbiome
14886|NCT03479112|Tourniquets, Layperson, hemorrhage control, first responder|tourniquets, layperson, hemorrhage control, first responder
14887|NCT03479099|Lung cancer|lung cancer
14888|NCT03479099|Circulating Tumor Cell|circulating tumor cell
14889|NCT03479099|Cell-Free Tumor DNA|cell-free tumor dna
14890|NCT03479099|Liquid Biopsy|liquid biopsy
14891|NCT03479060|Wet cupping therapy|wet cupping therapy
14892|NCT03479060|Migraine|migraine
14893|NCT03479060|MIDAS|midas
14894|NCT03479047|diaphragm ultrasound|diaphragm ultrasound
14895|NCT03479047|spontaneous breathing trial|spontaneous breathing trial
14896|NCT03479047|mechanical ventilation weaning|mechanical ventilation weaning
14897|NCT03479047|rapid shallow breathing index|rapid shallow breathing index
14898|NCT03479034|digital|digital
14899|NCT03479034|prescription|prescription
14900|NCT03479034|Application|application
14901|NCT03478995|Phase1b|phase1b
14902|NCT03478917|Vasoocclusive Crisis|vasoocclusive crisis
14903|NCT03478917|Sickle Cell Disease|sickle cell disease
14904|NCT03478917|Acute Chest Syndrome|acute chest syndrome
14905|NCT03478917|Pulmonary Syndrome|pulmonary syndrome
14906|NCT03478917|Pneumonia|pneumonia
14907|NCT03478904|Castration Resistant Prostate Cancer|castration resistant prostate cancer
14908|NCT03478904|Androgen Receptor|androgen receptor
14909|NCT03478891|Ebola Virus|ebola virus
14910|NCT03478891|Immune Response|immune response
14911|NCT03478891|Filovirus|filovirus
14912|NCT03478891|Ebola Hemorrhagic Fever|ebola hemorrhagic fever
14913|NCT03478891|First in Human|first in human
14914|NCT03478878|Eye Examinations|eye examinations
14915|NCT03478878|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
14916|NCT03478878|Retinal Pigment Epithelium|retinal pigment epithelium
14917|NCT03478865|Eye Examinations|eye examinations
14918|NCT03478865|Retinal Pigment Epithelium|retinal pigment epithelium
14919|NCT03478852|Seizure Disorder|seizure disorder
14920|NCT03478852|Seizures|seizures
14921|NCT03478852|Antiepileptic Drug|antiepileptic drug
14922|NCT03478852|Natural History Study|natural history study
14923|NCT03478852|Screening Protocol|screening protocol
14924|NCT03478839|Generalized Arterial Calcification of Infancy|generalized arterial calcification of infancy
14925|NCT03478839|Autosomal Recessive Hypophosphatemic Rickets|autosomal recessive hypophosphatemic rickets
14926|NCT03478839|Pseudoxanthoma Elasticum|pseudoxanthoma elasticum
14927|NCT03478839|Idiopathic Infantile Arterial Calcification|idiopathic infantile arterial calcification
14928|NCT03478826|ILD|ild
14929|NCT03478813|Intervention|intervention
14930|NCT03478813|Implementation|implementation
14931|NCT03478813|Children|children
14932|NCT03478813|Urotherapy|urotherapy
14933|NCT03478787|Plaque Psoriasis|plaque psoriasis
14934|NCT03478761|CYP24A1 mutation|cyp24a1 mutation
14935|NCT03478761|CYP24A1|cyp24a1
14936|NCT03478761|24-hydroxylase deficiency|24-hydroxylase deficiency
14937|NCT03478748|Dental caries|dental caries
14938|NCT03478748|Oral health literacy|oral health literacy
14939|NCT03478709|vasoplegia|vasoplegia
14940|NCT03478709|dynamic arterial elastance|dynamic arterial elastance
14941|NCT03478709|microcirculation|microcirculation
14942|NCT03478696|fluticasone furoate/umeclidinium/vilanterol|fluticasone furoate/umeclidinium/vilanterol
14943|NCT03478696|HRQoL|hrqol
14944|NCT03478696|COPD|copd
14945|NCT03478696|long-acting muscarinic receptor antagonists|long-acting muscarinic receptor antagonists
14946|NCT03478696|Tiotropium|tiotropium
14947|NCT03478696|Budesonide/formoterol|budesonide/formoterol
14948|NCT03478683|long-acting muscarinic receptor antagonists|long-acting muscarinic receptor antagonists
14949|NCT03478683|tiotropium|tiotropium
14950|NCT03478683|HRQoL|hrqol
14951|NCT03478683|Budesonide/formoterol|budesonide/formoterol
14952|NCT03478683|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
14953|NCT03478683|COPD|copd
14954|NCT03478670|gene therapy|gene therapy
14955|NCT03478670|retroviral vector|retroviral vector
14956|NCT03478670|inherited immune disorder|inherited immune disorder
14957|NCT03478670|ADA-SCID|ada-scid
14958|NCT03478670|GSK2696273|gsk2696273
14959|NCT03478670|Strimvelis|strimvelis
14960|NCT03478657|Asthma|asthma
14961|NCT03478657|Dry Powder Inhaler|dry powder inhaler
14962|NCT03478657|Metered Dose Inhaler|metered dose inhaler
14963|NCT03478657|Long Acting beta 2 Agonist|long acting beta 2 agonist
14964|NCT03478657|ELLIPTA|ellipta
14965|NCT03478631|nitrate|nitrate
14966|NCT03478631|vegetables|vegetables
14967|NCT03478605|olanzapine|olanzapine
14968|NCT03478605|aprepitant|aprepitant
14969|NCT03478605|CINV|cinv
14970|NCT03478605|nausea|nausea
14971|NCT03478605|vomiting|vomiting
14972|NCT03478605|nausea and vomiting|nausea and vomiting
14973|NCT03478605|antiemetics|antiemetics
14974|NCT03478592|Slow-freezing|slow-freezing
14975|NCT03478592|Vitrification|vitrification
14976|NCT03478592|Automated system|automated system
14977|NCT03478592|Embryos|embryos
14978|NCT03478592|Implantation|implantation
14979|NCT03478579|serious game|serious game
14980|NCT03478579|simulation|simulation
14981|NCT03478579|virtual emergency department|virtual emergency department
14982|NCT03478579|nontechnical skills|nontechnical skills
14983|NCT03478527|Probiotics|probiotics
14984|NCT03478527|Psychiatric Symptoms|psychiatric symptoms
14985|NCT03478527|Cognitive Function|cognitive function
14986|NCT03478527|Hippocampus|hippocampus
14987|NCT03478527|Oxytocin|oxytocin
14988|NCT03478527|Immunological Parameters|immunological parameters
14989|NCT03478514|mantle cell lymphoma|mantle cell lymphoma
14990|NCT03478514|B-cell lymphoma|b-cell lymphoma
14991|NCT03478501|firearm|firearm
14992|NCT03478501|lethal means|lethal means
14993|NCT03478501|decision aid|decision aid
14994|NCT03478475|Vitamin D|vitamin d
14995|NCT03478475|HOMA-IR|homa-ir
14996|NCT03478475|Glucose|glucose
14997|NCT03478475|HbA1C|hba1c
14998|NCT03478475|insulin resistance|insulin resistance
14999|NCT03478436|pharmacokinetics|pharmacokinetics
15000|NCT03478436|microdialysis|microdialysis
15001|NCT03478436|healthy volunteers|healthy volunteers
15002|NCT03478410|Epicardial fat|epicardial fat
15003|NCT03478397|cervical cancer prevention|cervical cancer prevention
15004|NCT03478397|self-collection HPV test|self-collection hpv test
15005|NCT03478397|mHealth|mhealth
15006|NCT03478397|Argentina|argentina
15007|NCT03478384|self-efficacy expectation|self-efficacy expectation
15008|NCT03478371|tampon|tampon
15009|NCT03478319|ACE-2494|ace-2494
15010|NCT03478241|Endodontic retreatment|endodontic retreatment
15011|NCT03478241|postoperative pain|postoperative pain
15012|NCT03478241|OneShape|oneshape
15013|NCT03478241|Revo-S|revo-s
15014|NCT03478241|WaveOne|waveone
15015|NCT03478228|fracture|fracture
15016|NCT03478228|rehabilitation|rehabilitation
15017|NCT03478228|wrist|wrist
15018|NCT03478228|sensation|sensation
15019|NCT03478228|exercise|exercise
15020|NCT03478215|kidney transplantation|kidney transplantation
15021|NCT03478215|graft rejection|graft rejection
15022|NCT03478176|Intraabdominal hypertension|intraabdominal hypertension
15023|NCT03478176|Kidney transplantation|kidney transplantation
15024|NCT03478163|Bakri|bakri
15025|NCT03478163|Intrauterine balloon tamponade|intrauterine balloon tamponade
15026|NCT03478163|Antibiotics|antibiotics
15027|NCT03478137|Cognition|cognition
15028|NCT03478137|Intervention|intervention
15029|NCT03478098|Gut hormones|gut hormones
15030|NCT03478098|Glucose excursions|glucose excursions
15031|NCT03478033|Tuberculosis|tuberculosis
15032|NCT03478033|AIDS|aids
15033|NCT03478033|Rifampicin|rifampicin
15034|NCT03478033|Rifabutin|rifabutin
15035|NCT03478007|Exercise Compliance|exercise compliance
15036|NCT03478007|Health Coaching|health coaching
15037|NCT03477994|dexmedetomidine, clonidine, postoperative, CABG|dexmedetomidine, clonidine, postoperative, cabg
15038|NCT03477955|spinopelvic alignment|spinopelvic alignment
15039|NCT03477955|short lumbosacral instrumentation|short lumbosacral instrumentation
15040|NCT03477955|PEEK|peek
15041|NCT03477955|silicon spacer|silicon spacer
15042|NCT03477929|In vitro fertilization|in vitro fertilization
15043|NCT03477929|gnrh antagonist|gnrh antagonist
15044|NCT03477929|pituitary suppression|pituitary suppression
15045|NCT03477903|Drug therapy|drug therapy
15046|NCT03477877|Intimate Partner Violence|intimate partner violence
15047|NCT03477877|Gender-Based violence|gender-based violence
15048|NCT03477877|Spouse Abuse|spouse abuse
15049|NCT03477877|Rwanda|rwanda
15050|NCT03477877|Heterosexual Couples|heterosexual couples
15051|NCT03477877|Activists|activists
15052|NCT03477877|Opinion Leaders|opinion leaders
15053|NCT03477877|Social Change|social change
15054|NCT03477877|Social-Ecological Model|social-ecological model
15055|NCT03477877|Diffusion of Innovation|diffusion of innovation
15056|NCT03477877|Cluster Randomized Controlled Trial|cluster randomized controlled trial
15057|NCT03477877|Community Randomized Controlled Trial|community randomized controlled trial
15058|NCT03477851|sciatic nerve block|sciatic nerve block
15059|NCT03477851|tramadol|tramadol
15060|NCT03477851|foot fracture|foot fracture
15061|NCT03477838|continuous glucose monitoring|continuous glucose monitoring
15062|NCT03477799|gambling disorder|gambling disorder
15063|NCT03477799|cognition|cognition
15064|NCT03477773|high-intensity interval training|high-intensity interval training
15065|NCT03477773|video games|video games
15066|NCT03477773|heart rate|heart rate
15067|NCT03477773|boxing|boxing
15068|NCT03477773|metabolic syndrome|metabolic syndrome
15069|NCT03477747|Microcurrent|microcurrent
15070|NCT03477747|Exercise training|exercise training
15071|NCT03477747|Hypertrophy|hypertrophy
15072|NCT03477747|Muscle damage|muscle damage
15073|NCT03477747|Recovery|recovery
15074|NCT03477747|Performance|performance
15075|NCT03477721|Agrin Fragment C-terminus (CAF)|agrin fragment c-terminus (caf)
15076|NCT03477669|Colic|colic
15077|NCT03477656|ABO incompatible kidney transplantation|abo incompatible kidney transplantation
15078|NCT03477656|Desensitization|desensitization
15079|NCT03477656|Double Filtration PlasmaPherisis (DFPP)|double filtration plasmapherisis (dfpp)
15080|NCT03477656|Specific immunoadsorption|specific immunoadsorption
15081|NCT03477656|Living donor kidney transplantation|living donor kidney transplantation
15082|NCT03477630|gonarthrosis|gonarthrosis
15083|NCT03477604|Below the knee|below the knee
15084|NCT03477604|Stent|stent
15085|NCT03477591|Screening|screening
15086|NCT03477591|PSA testing|psa testing
15087|NCT03477591|Patient Decision Aid|patient decision aid
15088|NCT03477552|Sickle Cell Crisis|sickle cell crisis
15089|NCT03477552|intravenous catheter|intravenous catheter
15090|NCT03477552|transillumination|transillumination
15091|NCT03477526|pulmonary fibrosis|pulmonary fibrosis
15092|NCT03477526|COPD|copd
15093|NCT03477526|pulmonary rehabilitation|pulmonary rehabilitation
15094|NCT03477526|mental status (anxiety and depression)|mental status (anxiety and depression)
15677|NCT03474159|stiffness|stiffness
15095|NCT03477526|quality of life|quality of life
15096|NCT03477526|physical activity|physical activity
15097|NCT03477500|multiple sclerosis,|multiple sclerosis,
15098|NCT03477500|HSCT|hsct
15099|NCT03477500|alemtuzumab|alemtuzumab
15100|NCT03477500|RCT|rct
15101|NCT03477487|inflammation|inflammation
15102|NCT03477487|Cytokines|cytokines
15103|NCT03477487|Interleukin-10|interleukin-10
15104|NCT03477487|Gene therapy|gene therapy
15105|NCT03477474|Guardant Health|guardant health
15106|NCT03477435|smoking|smoking
15107|NCT03477435|tobacco dependence|tobacco dependence
15108|NCT03477435|quitline|quitline
15109|NCT03477435|smoking cessation|smoking cessation
15110|NCT03477422|CSE-1034 Double Blind Study|cse-1034 double blind study
15111|NCT03477422|Elores|elores
15112|NCT03477422|Meropenem|meropenem
15113|NCT03477422|PLEA-CT|plea-ct
15114|NCT03477422|Bacterial Infections|bacterial infections
15115|NCT03477422|ESBL|esbl
15116|NCT03477422|MBL|mbl
15117|NCT03477422|beta-lactamase|beta-lactamase
15118|NCT03477422|Anti-Infective Agents, Urinary|anti-infective agents, urinary
15119|NCT03477422|Anti-Infective Agents|anti-infective agents
15120|NCT03477422|Urinary Tract Infections|urinary tract infections
15121|NCT03477422|Pyelonephritis|pyelonephritis
15122|NCT03477422|Infection|infection
15123|NCT03477422|Sulbactam|sulbactam
15124|NCT03477422|EDTA|edta
15125|NCT03477422|Disodium EDTA|disodium edta
15126|NCT03477422|Antibiotic Adjuvant Entity|antibiotic adjuvant entity
15127|NCT03477422|Antibiotic Resistance Breaker|antibiotic resistance breaker
15128|NCT03477409|plasticizers|plasticizers
15129|NCT03477409|medical devices|medical devices
15130|NCT03477409|neonates|neonates
15131|NCT03477409|exposition|exposition
15132|NCT03477383|diagnosis|diagnosis
15133|NCT03477383|economics|economics
15134|NCT03477383|cell-free DNA|cell-free dna
15135|NCT03477383|digital droplet PCR|digital droplet pcr
15136|NCT03477383|heart failure|heart failure
15137|NCT03477344|Cardiac Surgery|cardiac surgery
15138|NCT03477344|Delirium|delirium
15139|NCT03477344|Sleep deprivation|sleep deprivation
15140|NCT03477331|Direct oral anticoagulant|direct oral anticoagulant
15141|NCT03477331|P2Y12 inhibitors|p2y12 inhibitors
15142|NCT03477331|Physiologically-based pharmacokinetic model (PBPK)|physiologically-based pharmacokinetic model (pbpk)
15143|NCT03477331|Population-based pharmacokinetic model (POPPK)|population-based pharmacokinetic model (poppk)
15144|NCT03477318|colonoscopy, polyp, endoscopist|colonoscopy, polyp, endoscopist
15145|NCT03477305|older adults|older adults
15146|NCT03477305|community gardening|community gardening
15147|NCT03477305|cooperative extension|cooperative extension
15148|NCT03477279|couple HIV testing and counseling|couple hiv testing and counseling
15149|NCT03477279|disclosure|disclosure
15150|NCT03477279|Malawi|malawi
15151|NCT03477266|Postoperative ileus|postoperative ileus
15152|NCT03477266|mosapride|mosapride
15153|NCT03477266|mouth dissolving tablets|mouth dissolving tablets
15154|NCT03477266|Intraoperative vomiting|intraoperative vomiting
15155|NCT03477240|Cervical Cancer|cervical cancer
15156|NCT03477240|TELEPHONIC QUESTIONNAIRE|telephonic questionnaire
15157|NCT03477240|Follow up|follow up
15158|NCT03477227|compression stocking|compression stocking
15159|NCT03477227|elastic stocking|elastic stocking
15160|NCT03477227|endovenous radiofrequency ablation|endovenous radiofrequency ablation
15161|NCT03477227|compression therapy|compression therapy
15162|NCT03477188|Stroke|stroke
15163|NCT03477188|Vestibular|vestibular
15164|NCT03477188|Somatosensory|somatosensory
15165|NCT03477188|Rehabilitation|rehabilitation
15166|NCT03477188|Balance|balance
15167|NCT03477175|lenvatinib|lenvatinib
15168|NCT03477175|E7080|e7080
15169|NCT03477149|liquid embolics|liquid embolics
15170|NCT03477123|Incomplete spinal cord injury|incomplete spinal cord injury
15171|NCT03477123|Walking|walking
15172|NCT03477123|Rehabilitation|rehabilitation
15173|NCT03477123|Robotic exoskeleton|robotic exoskeleton
15174|NCT03477097|Frailty|frailty
15175|NCT03477097|Social Determinants|social determinants
15176|NCT03477097|Biological Risk Factors|biological risk factors
15177|NCT03477097|Intervention|intervention
15178|NCT03477097|Cost Effectiveness|cost effectiveness
15179|NCT03477071|Transplant renal artery stenosis|transplant renal artery stenosis
15180|NCT03477071|Endovascular repair|endovascular repair
15181|NCT03477071|Post-operative outcome|post-operative outcome
15182|NCT03477058|chronic pruritus|chronic pruritus
15183|NCT03477058|acute pruritus|acute pruritus
15184|NCT03477045|omega 3 polyunsaturated fatty acid|omega 3 polyunsaturated fatty acid
15185|NCT03477045|camelina sativa|camelina sativa
15186|NCT03477045|fatty acid composition|fatty acid composition
15187|NCT03477045|immune modulation|immune modulation
15188|NCT03477019|Ultrasonic Therapy|ultrasonic therapy
15189|NCT03477019|Liver|liver
15190|NCT03477019|Neoplasm Metastasis|neoplasm metastasis
15191|NCT03476993|primary biliary cholangitis|primary biliary cholangitis
15192|NCT03476993|IL-17 monoclonal antibody|il-17 monoclonal antibody
15193|NCT03476980|Neurodevelopmental impairment, prematurity|neurodevelopmental impairment, prematurity
15194|NCT03476980|Disability|disability
15195|NCT03476980|Umbilical cord milking|umbilical cord milking
15196|NCT03476980|Delayed cord clamping|delayed cord clamping
15197|NCT03476967|optic disc topography|optic disc topography
15198|NCT03476967|panretinal photocoagulation|panretinal photocoagulation
15199|NCT03476967|confocal scanning laser ophthalmoscopy|confocal scanning laser ophthalmoscopy
15200|NCT03476967|stereoscopic disc photographs|stereoscopic disc photographs
15201|NCT03476967|diabetic retinopathy|diabetic retinopathy
15202|NCT03476967|optic nerve head parameters|optic nerve head parameters
15203|NCT03476902|OCD|ocd
15204|NCT03476902|Mobile|mobile
15205|NCT03476902|Technology|technology
15206|NCT03476902|CBT|cbt
15207|NCT03476902|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
15208|NCT03476876|acellular matrix|acellular matrix
15209|NCT03476837|secondhand smoke, African Americans, policies, tobacco use|secondhand smoke, african americans, policies, tobacco use
15210|NCT03476785|LVH|lvh
15211|NCT03476785|Ventricular Stiffness|ventricular stiffness
15212|NCT03476785|Fitness|fitness
15213|NCT03476785|HFpEF|hfpef
15214|NCT03476733|Drug related problem|drug related problem
15215|NCT03476733|inpatient|inpatient
15216|NCT03476733|Medication Error|medication error
15217|NCT03476733|Clinical Pharmacist|clinical pharmacist
15218|NCT03476681|NEO-201|neo-201
15219|NCT03476681|Monoclonal Antibody|monoclonal antibody
15220|NCT03476681|Colorectal Cancer|colorectal cancer
15221|NCT03476681|Pancreatic Cancer|pancreatic cancer
15222|NCT03476681|Adenocarcinoma of Lung|adenocarcinoma of lung
15223|NCT03476681|Squamous Cell Lung Cancer|squamous cell lung cancer
15224|NCT03476681|Breast Cancer|breast cancer
15225|NCT03476681|Mucinous Carcinoma of Ovary|mucinous carcinoma of ovary
15226|NCT03476681|Signet Ring Cell Carcinoma of Ovary|signet ring cell carcinoma of ovary
15227|NCT03476629|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
15228|NCT03476629|Rehabilitation|rehabilitation
15229|NCT03476629|Distance Traveled|distance traveled
15230|NCT03476629|Functional Capacity|functional capacity
15231|NCT03476629|Autonomic Nervous System|autonomic nervous system
15232|NCT03476616|Hypertension|hypertension
15233|NCT03476616|Obesity|obesity
15234|NCT03476616|Ambulatory Blood Pressure|ambulatory blood pressure
15235|NCT03476616|Eplerenone|eplerenone
15236|NCT03476616|Valsartan|valsartan
15237|NCT03476616|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists
15238|NCT03476616|Angiotensin II Receptor Blockers|angiotensin ii receptor blockers
15239|NCT03476603|Bariatric surgery|bariatric surgery
15240|NCT03476603|Gastrointestinal tract|gastrointestinal tract
15241|NCT03476603|Biological availability|biological availability
15242|NCT03476603|Pharmacokinetics|pharmacokinetics
15243|NCT03476603|Irbesartan|irbesartan
15244|NCT03476590|heart failure|heart failure
15245|NCT03476590|ambulatory care|ambulatory care
15246|NCT03476590|telemedicine|telemedicine
15247|NCT03476590|impedance cardiography|impedance cardiography
15248|NCT03476577|Bariatric surgery|bariatric surgery
15249|NCT03476577|Gastrointestinal tract|gastrointestinal tract
15250|NCT03476577|Biological availability|biological availability
15251|NCT03476577|Pharmacokinetics|pharmacokinetics
15252|NCT03476577|Ibuprofen|ibuprofen
15253|NCT03476564|assisted reproductive techniques|assisted reproductive techniques
15254|NCT03476551|Bariatric surgery|bariatric surgery
15255|NCT03476551|Gastrointestinal tract|gastrointestinal tract
15256|NCT03476551|Biological availability|biological availability
15257|NCT03476551|Pharmacokinetics|pharmacokinetics
15258|NCT03476551|Hydrochlorothiazide|hydrochlorothiazide
15259|NCT03476538|Bariatric surgery|bariatric surgery
15260|NCT03476538|Gastrointestinal tract|gastrointestinal tract
15261|NCT03476538|Biological availability|biological availability
15262|NCT03476538|Pharmacokinetics|pharmacokinetics
15263|NCT03476538|Gabapentin|gabapentin
15264|NCT03476525|Bariatric surgery|bariatric surgery
15265|NCT03476525|Gastrointestinal tract|gastrointestinal tract
15266|NCT03476525|Biological availability|biological availability
15267|NCT03476525|Pharmacokinetics|pharmacokinetics
15268|NCT03476525|Fluoxetine|fluoxetine
15269|NCT03476512|Treatment adherence|treatment adherence
15270|NCT03476512|Ambulatory hypertensive patients|ambulatory hypertensive patients
15271|NCT03476512|Blood pressure|blood pressure
15272|NCT03476512|Non-pharmacological measures|non-pharmacological measures
15273|NCT03476473|Asthma|asthma
15274|NCT03476473|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
15275|NCT03476473|Spirometry|spirometry
15276|NCT03476473|Lung disease|lung disease
15277|NCT03476473|Smoke|smoke
15278|NCT03476460|Acute kidney failure|acute kidney failure
15279|NCT03476460|CT scan|ct scan
15280|NCT03476460|Iodine contrast|iodine contrast
15281|NCT03476460|Sodium chloride|sodium chloride
15282|NCT03476434|sessile serrated polyp|sessile serrated polyp
15283|NCT03476434|chromoendoscopy|chromoendoscopy
15284|NCT03476434|indigo carmine|indigo carmine
15285|NCT03476382|Osteoarthritis|osteoarthritis
15286|NCT03476382|Knee|knee
15287|NCT03476382|Bone Growth Stimulators|bone growth stimulators
15288|NCT03476382|Rheumatic Diseases|rheumatic diseases
15289|NCT03476382|Musculoskeletal Diseases|musculoskeletal diseases
15290|NCT03476382|Joint Diseases|joint diseases
15291|NCT03476382|Arthritis|arthritis
15292|NCT03476343|NICU|nicu
15293|NCT03476343|MRI|mri
15294|NCT03476343|Neonatal|neonatal
15295|NCT03476343|Cincinnati|cincinnati
15296|NCT03476330|Hematopoietic cell transplantation|hematopoietic cell transplantation
15297|NCT03476291|macular diseases|macular diseases
15298|NCT03476291|screening|screening
15299|NCT03476291|OCT|oct
15300|NCT03476291|Deep learning|deep learning
15301|NCT03476291|AI|ai
15302|NCT03476278|Outcome Assessment (Health Care)|outcome assessment (health care)
15303|NCT03476278|Patient Satisfaction|patient satisfaction
15304|NCT03476278|Perioperative Period|perioperative period
15305|NCT03476278|Regional Anesthesia|regional anesthesia
15306|NCT03476278|Surveys and Questionnaires|surveys and questionnaires
15307|NCT03476239|Relapsed|relapsed
15308|NCT03476239|Refractory|refractory
15309|NCT03476239|B-precursor|b-precursor
15310|NCT03476239|Acute Lymphoblastic|acute lymphoblastic
15311|NCT03476239|Leukemia ALL|leukemia all
15312|NCT03476239|Blinatumomab|blinatumomab
15313|NCT03476239|Chinese Adult Subjects|chinese adult subjects
15314|NCT03476226|Quality of Life|quality of life
15315|NCT03476226|Cognitive Dysfunction|cognitive dysfunction
15316|NCT03476226|Breast Cancer|breast cancer
15317|NCT03476213|Anesthesia Awareness|anesthesia awareness
15318|NCT03476213|Dreaming in anesthesia|dreaming in anesthesia
15319|NCT03476213|Total intravenous anesthesia|total intravenous anesthesia
15320|NCT03476213|Target-controll infusion|target-controll infusion
15321|NCT03476200|Cognitive Behavioral Therapy|cognitive behavioral therapy
15322|NCT03476200|Hair Cortisol|hair cortisol
15323|NCT03476200|Hypothalamic Pituitary Adrenal Axis|hypothalamic pituitary adrenal axis
15324|NCT03476200|Stress|stress
15325|NCT03476200|Psychopathology|psychopathology
15326|NCT03476135|Meningococcal Meningitis|meningococcal meningitis
15327|NCT03476135|MenACYW conjugate vaccine|menacyw conjugate vaccine
15328|NCT03476135|Quadrivalent meningococcal vaccine|quadrivalent meningococcal vaccine
15329|NCT03476122|Colorectal cancer|colorectal cancer
15330|NCT03476122|CRC|crc
15331|NCT03476122|Circulating tumor cells|circulating tumor cells
15332|NCT03476122|CTCs|ctcs
15333|NCT03476122|Early detection|early detection
15334|NCT03476122|Automated|automated
15335|NCT03476096|pregnancy|pregnancy
15336|NCT03476096|microcirculation|microcirculation
15337|NCT03476083|Mother to Child Transmission|mother to child transmission
15338|NCT03476083|Hepatitis B Infection|hepatitis b infection
15339|NCT03476083|Congenital Defects or Malformation|congenital defects or malformation
15340|NCT03476083|Hepatitis B Vaccine|hepatitis b vaccine
15341|NCT03476083|Hepatitis B Immunoglobulin|hepatitis b immunoglobulin
15342|NCT03476083|Pregnancy|pregnancy
15343|NCT03476083|Antiviral Treatment|antiviral treatment
15344|NCT03476070|Adolescents and Young Adults (AYA)|adolescents and young adults (aya)
15345|NCT03476070|breast cancer|breast cancer
15346|NCT03476070|lymphoma|lymphoma
15347|NCT03476070|germ cell tumor|germ cell tumor
15348|NCT03476070|cognitive impairment|cognitive impairment
15349|NCT03476070|survivorship|survivorship
15350|NCT03476070|Singapore|singapore
15352|NCT03476057|cfDNA|cfdna
15353|NCT03476057|OS|os
15354|NCT03475966|Nutrition|nutrition
15355|NCT03475966|Exercise|exercise
15356|NCT03475966|Relaxation techniques|relaxation techniques
15357|NCT03475966|Prehabilitation|prehabilitation
15358|NCT03475953|Advanced solid tumor|advanced solid tumor
15359|NCT03475953|Metastatic tumor|metastatic tumor
15360|NCT03475953|Phase Ib/II trial|phase ib/ii trial
15361|NCT03475953|Colorectal cancer not MSI-H or MMR-deficient|colorectal cancer not msi-h or mmr-deficient
15362|NCT03475953|GIST|gist
15363|NCT03475953|Oesophageal or Gastric Carcinoma|oesophageal or gastric carcinoma
15364|NCT03475953|Biliary Tract cancer|biliary tract cancer
15365|NCT03475953|Hepatocellular Carcinoma|hepatocellular carcinoma
15366|NCT03475914|Psoriasis Guttate, Psoriasis vulgaris|psoriasis guttate, psoriasis vulgaris
15367|NCT03475901|procedural anxiety|procedural anxiety
15368|NCT03475901|virtual reality|virtual reality
15369|NCT03475901|anxiolysis|anxiolysis
15370|NCT03475901|laceration repair|laceration repair
15371|NCT03475901|pediatric|pediatric
15372|NCT03475888|Chronic Total Occlusion of Coronary Artery|chronic total occlusion of coronary artery
15373|NCT03475888|Ventricular Arrythmia|ventricular arrythmia
15374|NCT03475888|Sustained VT|sustained vt
15375|NCT03475888|Ventricular Fibrillation|ventricular fibrillation
15376|NCT03475888|Implantable loop recorder|implantable loop recorder
15377|NCT03475849|Roux-en-Y Gastric Bypass Surgery|roux-en-y gastric bypass surgery
15378|NCT03475849|Bile Acid Circulation|bile acid circulation
15379|NCT03475849|Obesity|obesity
15380|NCT03475849|Bariatric Surgery|bariatric surgery
15381|NCT03475836|Mentha|mentha
15382|NCT03475836|Mint|mint
15383|NCT03475836|Essential oil|essential oil
15384|NCT03475836|Cognition|cognition
15385|NCT03475836|Mood|mood
15386|NCT03475836|Humans|humans
15387|NCT03475810|VIRTUAL REALITY|virtual reality
15388|NCT03475810|ANXIETY|anxiety
15389|NCT03475810|SPINAL ANESTHESIA|spinal anesthesia
15390|NCT03475745|resting-state|resting-state
15391|NCT03475745|DTI|dti
15392|NCT03475745|aphasia|aphasia
15393|NCT03475745|stroke|stroke
15394|NCT03475732|XueBiJing injection|xuebijing injection
15395|NCT03475732|Sepsis|sepsis
15396|NCT03475732|Septic shock|septic shock
15397|NCT03475732|Pharmacokinetics|pharmacokinetics
15398|NCT03475706|overactive bladder|overactive bladder
15399|NCT03475706|urinary conditions|urinary conditions
15400|NCT03475706|urgency urinary incontinence|urgency urinary incontinence
15401|NCT03475706|urgency|urgency
15402|NCT03475706|micturitions|micturitions
15403|NCT03475680|Mechanical Bowel Preparation (MBP)|mechanical bowel preparation (mbp)
15404|NCT03475680|Oral antibiotics|oral antibiotics
15405|NCT03475680|Colon cancer surgery|colon cancer surgery
15406|NCT03475680|Surgical site infection|surgical site infection
15407|NCT03475667|Septic Shock|septic shock
15408|NCT03475667|hemodynamic monitoring|hemodynamic monitoring
15409|NCT03475667|blood pressure determination|blood pressure determination
15410|NCT03475654|exercise|exercise
15411|NCT03475654|therapy|therapy
15412|NCT03475654|rehabilitation|rehabilitation
15413|NCT03475654|home|home
15414|NCT03475641|pain|pain
15415|NCT03475641|femoral nerve blockade|femoral nerve blockade
15416|NCT03475641|varicose vein|varicose vein
15417|NCT03475589|apatinib； Adverse drug reactions； gastric cancer; non-small cell lung cancer;breast cancer; ovarian cancer|apatinib； adverse drug reactions； gastric cancer; non-small cell lung cancer;breast cancer; ovarian cancer
15418|NCT03475576|elderly|elderly
15419|NCT03475576|caregiving|caregiving
15420|NCT03475576|needs|needs
15421|NCT03475576|support|support
15422|NCT03475563|Drug-eluting stent|drug-eluting stent
15423|NCT03475563|Dedicated bifurcation stent|dedicated bifurcation stent
15424|NCT03475563|Cobalt-chromium|cobalt-chromium
15425|NCT03475563|Sirolimus-eluting stent|sirolimus-eluting stent
15426|NCT03475485|Ingestion event marker, ingestible sensor, medication adherence, ID-Cap Medication Adherence Feedback System|ingestion event marker, ingestible sensor, medication adherence, id-cap medication adherence feedback system
15427|NCT03475459|QTc prolongation effect|qtc prolongation effect
15428|NCT03475446|tES|tes
15429|NCT03475446|Memory Impairment|memory impairment
15430|NCT03475446|Cognitive Training|cognitive training
15431|NCT03475433|Cancer|cancer
15432|NCT03475433|Questionnaire|questionnaire
15433|NCT03475433|Survey|survey
15434|NCT03475433|Sleep Disturbance|sleep disturbance
15435|NCT03475433|Sleep Quality|sleep quality
15436|NCT03475433|E-health|e-health
15437|NCT03475433|M-health|m-health
15438|NCT03475433|Actigraphy|actigraphy
15439|NCT03475433|Physical activity|physical activity
15440|NCT03475433|Dyssomnias Medical Subject Headings [MeSH]|dyssomnias medical subject headings [mesh]
15441|NCT03475433|Sleep Wake Disorders [MeSH]|sleep wake disorders [mesh]
15442|NCT03475433|Parasomnias [MeSH]|parasomnias [mesh]
15443|NCT03475433|Nervous System Diseases [MeSH]|nervous system diseases [mesh]
15444|NCT03475433|Mental Disorders [MeSH]|mental disorders [mesh]
15445|NCT03475433|Neurologic Manifestations [MeSH]|neurologic manifestations [mesh]
15446|NCT03475433|Signs and Symptoms [MeSH]|signs and symptoms [mesh]
15447|NCT03475433|Telemedicine [MeSH]|telemedicine [mesh]
15448|NCT03475433|Actigraphy [MeSH]|actigraphy [mesh]
15449|NCT03475433|Quality of Life [MeSH]|quality of life [mesh]
15450|NCT03475433|Motor Activity [MeSH]|motor activity [mesh]
15451|NCT03475433|Breast Neoplasms [MeSH]|breast neoplasms [mesh]
15452|NCT03475433|Prostatic Neoplasms [MeSH]|prostatic neoplasms [mesh]
15453|NCT03475433|Sleep Hygiene [MeSH]|sleep hygiene [mesh]
15454|NCT03475433|Neoplasms [MeSH]|neoplasms [mesh]
15455|NCT03475407|Diabetic macular edema|diabetic macular edema
15456|NCT03475407|cytokine|cytokine
15457|NCT03475407|dexamethasone|dexamethasone
15458|NCT03475394|Chlorhexidine gluconate|chlorhexidine gluconate
15459|NCT03475394|Morus alba|morus alba
15460|NCT03475394|Microbiology|microbiology
15461|NCT03475394|Gel|gel
15462|NCT03475394|Root planing|root planing
15463|NCT03475381|Cystic Fibrosis|cystic fibrosis
15464|NCT03475381|ivacaftor|ivacaftor
15465|NCT03475381|lumacaftor|lumacaftor
15466|NCT03475355|action observation|action observation
15467|NCT03475355|parkinson's disease|parkinson's disease
15468|NCT03475355|physical therapy|physical therapy
15469|NCT03475355|home-based|home-based
15470|NCT03475355|neural plasticity|neural plasticity
15471|NCT03475355|telerehabilitation|telerehabilitation
15472|NCT03475342|prevention, postpartum haemorrhage|prevention, postpartum haemorrhage
15473|NCT03475342|moderate anaemia|moderate anaemia
15474|NCT03475342|severe anaemia|severe anaemia
15475|NCT03475342|antifibrinolytic|antifibrinolytic
15476|NCT03475342|tranexamic acid|tranexamic acid
15477|NCT03475342|pregnancy|pregnancy
15478|NCT03475329|pediatric obstructive sleep disordered breathing-partial tonsillectomy -unilateral complete tonsillectomy -adenoidectomy|pediatric obstructive sleep disordered breathing-partial tonsillectomy -unilateral complete tonsillectomy -adenoidectomy
15479|NCT03475290|e-mental health|e-mental health
15480|NCT03475290|stress|stress
15481|NCT03475290|burnout|burnout
15482|NCT03475290|self-efficacy|self-efficacy
15483|NCT03475290|social support|social support
15484|NCT03475264|Lung MRI, Bronchopulmonary Dysplasia, hyperpolarized xenon,|lung mri, bronchopulmonary dysplasia, hyperpolarized xenon,
15485|NCT03475238|critical care|critical care
15486|NCT03475225|Epilepsy|epilepsy
15487|NCT03475225|Drug-resistance|drug-resistance
15488|NCT03475225|Vitamin D deficiency|vitamin d deficiency
15489|NCT03475225|Metabolism|metabolism
15490|NCT03475225|Controlled study antiepileptic drugs|controlled study antiepileptic drugs
15491|NCT03475212|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
15492|NCT03475212|Primary Immune Deficiency Disease|primary immune deficiency disease
15493|NCT03475186|Memory|memory
15494|NCT03475186|Brain Cancer|brain cancer
15495|NCT03475186|Ramipril|ramipril
15496|NCT03475173|Optic Neuropathy|optic neuropathy
15497|NCT03475173|, Retinopathy|, retinopathy
15498|NCT03475095|Low Back Pain|low back pain
15499|NCT03475095|Tuina therapy|tuina therapy
15500|NCT03475095|lumbar disc herniation|lumbar disc herniation
15501|NCT03475095|central motion control|central motion control
15502|NCT03475095|functional magnetic resonanceimaging|functional magnetic resonanceimaging
15503|NCT03475095|effect mechanism|effect mechanism
15504|NCT03475095|Chronic nonspecific low Back pain|chronic nonspecific low back pain
15505|NCT03475069|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
15506|NCT03475069|Exercise|exercise
15507|NCT03475069|Physical Performance|physical performance
15508|NCT03475069|Physiological Cost Index|physiological cost index
15509|NCT03475056|Marburg virus|marburg virus
15510|NCT03475056|Marburg vaccine|marburg vaccine
15511|NCT03475056|cAd3-Marburg vaccine|cad3-marburg vaccine
15512|NCT03475004|Pembrolizumab|pembrolizumab
15513|NCT03475004|Binimetinib|binimetinib
15514|NCT03475004|Bevacizumab|bevacizumab
15515|NCT03475004|Combination Therapy|combination therapy
15516|NCT03474965|SEG101|seg101
15517|NCT03474965|Sickle cell disease|sickle cell disease
15518|NCT03474965|crizanlizumab|crizanlizumab
15519|NCT03474965|pediatric|pediatric
15520|NCT03474965|pharmacokinetic|pharmacokinetic
15521|NCT03474965|P-selectin|p-selectin
15522|NCT03474952|remote ischemic preconditioning|remote ischemic preconditioning
15523|NCT03474952|free flap reconstruction|free flap reconstruction
15524|NCT03474952|tissue oxygen saturation|tissue oxygen saturation
15525|NCT03474926|urothelial cancer|urothelial cancer
15526|NCT03474926|nephroureterectomy|nephroureterectomy
15527|NCT03474926|Upper urinary tract|upper urinary tract
15528|NCT03474913|Prostate Cancer|prostate cancer
15529|NCT03474913|Magnetic Resonance Imaging|magnetic resonance imaging
15530|NCT03474913|case cross over|case cross over
15531|NCT03474913|diagnostic|diagnostic
15532|NCT03474913|clinical trial|clinical trial
15533|NCT03474913|prostate imaging|prostate imaging
15534|NCT03474913|PSA|psa
15535|NCT03474900|intramedullary nailing|intramedullary nailing
15536|NCT03474900|randomised controlled trial|randomised controlled trial
15537|NCT03474900|biodegradable|biodegradable
15538|NCT03474900|children|children
15539|NCT03474900|forearm shaft fractures|forearm shaft fractures
15540|NCT03474887|Telemedicine|telemedicine
15541|NCT03474887|Remote consultation|remote consultation
15542|NCT03474887|Mobile health|mobile health
15543|NCT03474887|Telehealth|telehealth
15544|NCT03474887|mhealth|mhealth
15545|NCT03474887|eVisits|evisits
15546|NCT03474887|eConsultation|econsultation
15547|NCT03474887|ehealth|ehealth
15548|NCT03474848|cerebral palsy|cerebral palsy
15549|NCT03474848|rehabilitation|rehabilitation
15550|NCT03474848|hand function|hand function
15551|NCT03474848|daily functioning|daily functioning
15552|NCT03474848|hand-arm bimanual intensive training|hand-arm bimanual intensive training
15553|NCT03474835|atherosclerosis|atherosclerosis
15554|NCT03474835|angiogenesis|angiogenesis
15555|NCT03474835|cardiooncology|cardiooncology
15556|NCT03474822|Advanced breast cancer|advanced breast cancer
15557|NCT03474822|advanced liver cancer|advanced liver cancer
15558|NCT03474822|Plasmodium immunotherapy|plasmodium immunotherapy
15559|NCT03474822|Plasmodiun vivax|plasmodiun vivax
15560|NCT03474809|Sepsis, PSP, Abionic|sepsis, psp, abionic
15561|NCT03474718|scalp|scalp
15562|NCT03474718|hair loss|hair loss
15563|NCT03474718|platelet-rich plasma therapy|platelet-rich plasma therapy
15564|NCT03474705|Clinical Pain|clinical pain
15565|NCT03474705|Hyperalgesia|hyperalgesia
15566|NCT03474705|Intervention|intervention
15567|NCT03474705|Musculoskeletal disorders|musculoskeletal disorders
15568|NCT03474705|Computer Work|computer work
15569|NCT03474705|Strength Training|strength training
15570|NCT03474666|Liver Transplantation|liver transplantation
15571|NCT03474666|Surgical Wound Infection|surgical wound infection
15572|NCT03474666|Hiperglycemia|hiperglycemia
15573|NCT03474653|Stress urinary incontinence|stress urinary incontinence
15574|NCT03474653|Bulking|bulking
15575|NCT03474653|Bulkamid|bulkamid
15576|NCT03474640|immunotherapy|immunotherapy
15577|NCT03474640|check point inhibitor|check point inhibitor
15578|NCT03474640|PD-1 antibody|pd-1 antibody
15579|NCT03474640|solid tumor|solid tumor
15580|NCT03474640|esophageal carcinoma|esophageal carcinoma
15581|NCT03474640|gastric carcinoma|gastric carcinoma
15582|NCT03474640|nasopharyngeal carcinoma|nasopharyngeal carcinoma
15583|NCT03474640|endometrial cancer|endometrial cancer
15584|NCT03474640|soft tissue sarcoma|soft tissue sarcoma
15585|NCT03474640|orphan tumors|orphan tumors
15586|NCT03474640|phase 1 trial|phase 1 trial
15587|NCT03474601|Pituitary Diseases|pituitary diseases
15588|NCT03474601|Pituitary incidentaloma|pituitary incidentaloma
15589|NCT03474601|Central Diabetes Insipidus|central diabetes insipidus
15590|NCT03474601|Pituitary Neoplasms|pituitary neoplasms
15591|NCT03474575|homecare, COPD, Exacerbation|homecare, copd, exacerbation
15592|NCT03474549|Mechanical thrombectomy,|mechanical thrombectomy,
15593|NCT03474549|Brain|brain
15594|NCT03474549|Brain clot|brain clot
15595|NCT03474549|Brain infarction|brain infarction
15596|NCT03474549|Cerebral ischemia|cerebral ischemia
15597|NCT03474549|Neurovascular intervention|neurovascular intervention
15598|NCT03474549|Revascularization|revascularization
15599|NCT03474549|Reperfusion|reperfusion
15600|NCT03474549|Stent retriever|stent retriever
15601|NCT03474549|Tigertriever|tigertriever
15602|NCT03474549|Stroke|stroke
15603|NCT03474549|Rapid Medical|rapid medical
15604|NCT03474536|Lung transplantation|lung transplantation
15605|NCT03474536|HLA antibodies|hla antibodies
15606|NCT03474536|concentration|concentration
15607|NCT03474536|affinity|affinity
15608|NCT03474536|surface plasmon resonance|surface plasmon resonance
15609|NCT03474523|radio frequency diathermy|radio frequency diathermy
15610|NCT03474523|cavitation|cavitation
15611|NCT03474523|ultrasound|ultrasound
15612|NCT03474523|edemato-fibrosclerotic panniculopathy|edemato-fibrosclerotic panniculopathy
15613|NCT03474523|cellulitis|cellulitis
15614|NCT03474510|pain control|pain control
15615|NCT03474510|EXPAREL|exparel
15616|NCT03474510|shoulder surgery|shoulder surgery
15617|NCT03474510|continuous interscalene nerve block|continuous interscalene nerve block
15618|NCT03474484|Biomarkers|biomarkers
15619|NCT03474484|Sensitivity and Specificity|sensitivity and specificity
15620|NCT03474484|Clinical Deterioration|clinical deterioration
15621|NCT03474380|Caregiver|caregiver
15622|NCT03474380|Veterans|veterans
15623|NCT03474380|Skills training|skills training
15624|NCT03474380|Informal care|informal care
15625|NCT03474380|Days at home|days at home
15626|NCT03474367|Unplanned Peritoneal Dialysis|unplanned peritoneal dialysis
15627|NCT03474367|Unplanned Hemodialysis|unplanned hemodialysis
15628|NCT03474367|Cost-Benefit Analysis|cost-benefit analysis
15629|NCT03474367|Dialysis|dialysis
15630|NCT03474367|Peritoneal Dialysis|peritoneal dialysis
15631|NCT03474367|Hemodialysis|hemodialysis
15632|NCT03474354|chemoembolization|chemoembolization
15633|NCT03474354|drug eluting beads|drug eluting beads
15634|NCT03474341|Neoadjuvant chemoradiotherapy (nCRT)|neoadjuvant chemoradiotherapy (ncrt)
15635|NCT03474341|Pathologic complete response (pCR)|pathologic complete response (pcr)
15636|NCT03474341|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
15637|NCT03474341|PET-CT|pet-ct
15638|NCT03474341|Circulating tumor DNA (ctDNA)|circulating tumor dna (ctdna)
15639|NCT03474341|endoscopy|endoscopy
15640|NCT03474315|Cardiac implantable electronic device|cardiac implantable electronic device
15641|NCT03474315|Cardiac resynchronization therapy|cardiac resynchronization therapy
15642|NCT03474315|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
15643|NCT03474315|Machine learning|machine learning
15644|NCT03474315|Mobile application|mobile application
15645|NCT03474315|Patient's assistance|patient's assistance
15646|NCT03474302|African American|african american
15647|NCT03474302|Aging|aging
15648|NCT03474302|Physical activity|physical activity
15649|NCT03474302|Cognition|cognition
15650|NCT03474276|Children|children
15651|NCT03474276|Africa|africa
15652|NCT03474276|Metagenomic|metagenomic
15653|NCT03474276|Prebiotic|prebiotic
15654|NCT03474276|Randomized Controlled Trial|randomized controlled trial
15655|NCT03474276|Pragmatic trial|pragmatic trial
15656|NCT03474276|Azithromycin|azithromycin
15657|NCT03474276|Cognitive impairment|cognitive impairment
15658|NCT03474263|Motor Neurone Disease (MND)|motor neurone disease (mnd)
15659|NCT03474263|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
15660|NCT03474237|algorithms|algorithms
15661|NCT03474237|adrenal adenoma|adrenal adenoma
15662|NCT03474237|cushing syndrome|cushing syndrome
15663|NCT03474237|pheochromocytoma|pheochromocytoma
15664|NCT03474237|adrenal incidentaloma|adrenal incidentaloma
15665|NCT03474237|adreocortical carcinoma|adreocortical carcinoma
15666|NCT03474237|primary hyperaldosteronism|primary hyperaldosteronism
15667|NCT03474224|stroke volume|stroke volume
15668|NCT03474224|goal directed therapy|goal directed therapy
15669|NCT03474224|major abdominal surgery|major abdominal surgery
15670|NCT03474172|Pediatric Tuina|pediatric tuina
15671|NCT03474172|Massage therapy|massage therapy
15672|NCT03474172|Sham Tuina|sham tuina
15673|NCT03474172|Sham massage|sham massage
15674|NCT03474172|Sham device|sham device
15675|NCT03474159|Bicuspid aortic valve|bicuspid aortic valve
15676|NCT03474159|aortic aneurysm|aortic aneurysm
15678|NCT03474159|Pulse wave velocity|pulse wave velocity
15679|NCT03474146|Mouthrinse|mouthrinse
15680|NCT03474146|Ocimum sanctum|ocimum sanctum
15681|NCT03474146|Periodontal Diseases|periodontal diseases
15682|NCT03474146|Tulsi|tulsi
15683|NCT03474133|Hodgkin's lymphoma|hodgkin's lymphoma
15684|NCT03474133|Hodgkin lymphoma|hodgkin lymphoma
15685|NCT03474133|relapsed|relapsed
15686|NCT03474133|refractory|refractory
15687|NCT03474133|brentuximab vedotin|brentuximab vedotin
15688|NCT03474133|autologous stem cell transplantation|autologous stem cell transplantation
15689|NCT03474120|Genetic causes|genetic causes
15690|NCT03474120|etiology|etiology
15692|NCT03474120|DOR|dor
15693|NCT03474107|antibody drug conjugate|antibody drug conjugate
15694|NCT03474107|enfortumab vedotin (EV)|enfortumab vedotin (ev)
15695|NCT03474107|ASG-22ME|asg-22me
15696|NCT03474107|ASG-22CE|asg-22ce
15697|NCT03474107|urothelial cancer|urothelial cancer
15698|NCT03474094|Clinical Trial|clinical trial
15699|NCT03474094|randomized|randomized
15700|NCT03474094|phase II|phase ii
15701|NCT03474094|atezolizumab|atezolizumab
15702|NCT03474094|PD-L1|pd-l1
15703|NCT03474081|Umeclidinium|umeclidinium
15704|NCT03474081|Lung function|lung function
15705|NCT03474081|RESPIMAT|respimat
15706|NCT03474081|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
15707|NCT03474081|Triple Therapy|triple therapy
15708|NCT03474081|Vilanterol|vilanterol
15709|NCT03474081|HANDIHALER|handihaler
15710|NCT03474081|Tiotropium|tiotropium
15711|NCT03474081|Fluticasone furoate|fluticasone furoate
15712|NCT03474068|Emergency Medical Services, Stroke, Ambulances|emergency medical services, stroke, ambulances
15713|NCT03474055|Liquid rotavirus vaccine|liquid rotavirus vaccine
15714|NCT03474055|LBRV-PV|lbrv-pv
15715|NCT03474055|Gastroenteritis|gastroenteritis
15716|NCT03474055|Diarrhoea|diarrhoea
15717|NCT03474029|latent tuberculosis|latent tuberculosis
15718|NCT03474029|rifapentine|rifapentine
15719|NCT03474003|Score prediction|score prediction
15720|NCT03474003|Allograft survival|allograft survival
15721|NCT03473990|Home-based|home-based
15722|NCT03473990|Short-term|short-term
15723|NCT03473990|Randomised Control Trial|randomised control trial
15724|NCT03473951|Hyperuricemia|hyperuricemia
15725|NCT03473951|Metabolic syndrome|metabolic syndrome
15726|NCT03473951|Left ventricular hypertrophy|left ventricular hypertrophy
15727|NCT03473938|Obesity|obesity
15728|NCT03473938|Weight loss|weight loss
15729|NCT03473938|Intragastric balloons|intragastric balloons
15730|NCT03473938|Adjustable gastric balloon|adjustable gastric balloon
15731|NCT03473938|Weight loss plateau|weight loss plateau
15732|NCT03473938|Intolerance|intolerance
15733|NCT03473860|prognosis|prognosis
15734|NCT03473860|all-cause mortality|all-cause mortality
15735|NCT03473860|myocardial infarction|myocardial infarction
15736|NCT03473860|stroke|stroke
15737|NCT03473847|VHF digital ultrasound|vhf digital ultrasound
15738|NCT03473847|Optical coherence tomography|optical coherence tomography
15739|NCT03473847|Corneal thickness|corneal thickness
15740|NCT03473847|Epithelial thickness|epithelial thickness
15741|NCT03473847|LASIK|lasik
15742|NCT03473847|SMILE|smile
15743|NCT03473834|Parkinson's disease|parkinson's disease
15744|NCT03473834|Exercise|exercise
15745|NCT03473834|Rigidity|rigidity
15746|NCT03473834|Turning|turning
15747|NCT03473821|ACL Injury|acl injury
15748|NCT03473821|Return to Sport|return to sport
15749|NCT03473821|Mental Training|mental training
15750|NCT03473821|Motor Imagery|motor imagery
15751|NCT03473808|Hand Function|hand function
15752|NCT03473808|Occupational Therapy|occupational therapy
15753|NCT03473808|Physical Stimulation|physical stimulation
15754|NCT03473795|Patient Outcomes|patient outcomes
15755|NCT03473795|18-114|18-114
15756|NCT03473769|Hospital Admission|hospital admission
15757|NCT03473756|Locally advanced or metastatic urothelial carcinoma|locally advanced or metastatic urothelial carcinoma
15758|NCT03473756|Bladder cancer|bladder cancer
15759|NCT03473756|Checkpoint inhibition|checkpoint inhibition
15760|NCT03473756|FGFR inhibition|fgfr inhibition
15761|NCT03473730|Malignant neoplasms of urinary tract|malignant neoplasms of urinary tract
15762|NCT03473730|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
15763|NCT03473730|Muscle invasive bladder cancer|muscle invasive bladder cancer
15764|NCT03473730|Daratumumab|daratumumab
15765|NCT03473717|pain|pain
15766|NCT03473717|Intrauterine device (IUD)|intrauterine device (iud)
15767|NCT03473717|Intrauterine system (IUS)|intrauterine system (ius)
15768|NCT03473717|Patient-Reported Outcome|patient-reported outcome
15769|NCT03473704|Type 1 diabetes|type 1 diabetes
15770|NCT03473704|Depression|depression
15771|NCT03473704|Telematic Program|telematic program
15772|NCT03473704|Treatment|treatment
15773|NCT03473704|Web-based|web-based
15774|NCT03473665|ankylsoing spondylitis|ankylsoing spondylitis
15775|NCT03473665|spondyloarthritis|spondyloarthritis
15776|NCT03473639|Residual invasive breast cancer|residual invasive breast cancer
15777|NCT03473639|Metastatic breast cancer|metastatic breast cancer
15778|NCT03473613|Calcium infusion|calcium infusion
15779|NCT03473613|Cabergoline|cabergoline
15780|NCT03473548|Childhood OSA|childhood osa
15781|NCT03473535|self-harm|self-harm
15782|NCT03473535|problem-solving therapy|problem-solving therapy
15783|NCT03473535|emergency department|emergency department
15784|NCT03473535|e-therapy|e-therapy
15785|NCT03473535|suicide prevention|suicide prevention
15786|NCT03473522|Transcranial Direct Current Stimulation|transcranial direct current stimulation
15787|NCT03473522|therapeutic exercises|therapeutic exercises
15788|NCT03473522|Parkinson|parkinson
15789|NCT03473496|BCMA-CART|bcma-cart
15790|NCT03473496|CD138-CART|cd138-cart
15791|NCT03473496|CD56-CART|cd56-cart
15792|NCT03473496|CD38-CART|cd38-cart
15793|NCT03473483|nicotine|nicotine
15794|NCT03473483|tobacco|tobacco
15795|NCT03473483|research electronic cigarette|research electronic cigarette
15796|NCT03473483|e-cigarette|e-cigarette
15797|NCT03473483|SREC|srec
15798|NCT03473470|Maternal and Neonatal Hypothermia, cesarean delivery|maternal and neonatal hypothermia, cesarean delivery
15799|NCT03473457|CD38-CART|cd38-cart
15800|NCT03473457|CD33-CART|cd33-cart
15801|NCT03473457|CD56-CART|cd56-cart
15802|NCT03473457|CD123-CART|cd123-cart
15803|NCT03473457|CD117-CART|cd117-cart
15804|NCT03473457|CD133-CART|cd133-cart
15805|NCT03473457|CD34-CART|cd34-cart
15806|NCT03473457|Mucl-CART|mucl-cart
15807|NCT03473444|uric acid|uric acid
15808|NCT03473444|prevalence|prevalence
15809|NCT03473444|pakistan|pakistan
15810|NCT03473405|Total knee replacement|total knee replacement
15811|NCT03473405|Operating room airborne CFU|operating room airborne cfu
15812|NCT03473392|pre-treatment|pre-treatment
15813|NCT03473392|antibiotherapy|antibiotherapy
15814|NCT03473392|prosthetic joint infection|prosthetic joint infection
15815|NCT03473392|treatment failure|treatment failure
15816|NCT03473379|economic difficulty, financial toxicity|economic difficulty, financial toxicity
15817|NCT03473353|Medical Scribe|medical scribe
15818|NCT03473353|Outpatient|outpatient
15819|NCT03473353|EHR|ehr
15820|NCT03473340|CLAD|clad
15821|NCT03473340|Chronic Rejection|chronic rejection
15822|NCT03473340|Lung Transplant|lung transplant
15823|NCT03473327|colorectal neoplasms|colorectal neoplasms
15824|NCT03473327|Immunologic Factors|immunologic factors
15825|NCT03473327|Postoperative Period|postoperative period
15826|NCT03473314|Inhaled nitric oxide|inhaled nitric oxide
15827|NCT03473314|Non-tuberculous mycobacteria|non-tuberculous mycobacteria
15828|NCT03473314|Drug resistant bacteria|drug resistant bacteria
15829|NCT03473314|Antimicrobial drug resistance|antimicrobial drug resistance
15830|NCT03473301|CP|cp
15831|NCT03473301|Cerebral Palsy|cerebral palsy
15832|NCT03473301|Stem Cell|stem cell
15833|NCT03473301|Cord Blood|cord blood
15834|NCT03473301|MSCs|mscs
15835|NCT03473275|Sympathetic nervous system|sympathetic nervous system
15836|NCT03473275|Blood oxygen level dependent|blood oxygen level dependent
15837|NCT03473275|Brainstem|brainstem
15838|NCT03473275|Contrast enhanced ultrasound|contrast enhanced ultrasound
15839|NCT03473275|Kidney function|kidney function
15840|NCT03473275|Hypertension|hypertension
15841|NCT03473275|Renal denervation|renal denervation
15842|NCT03473262|Type 2 diabetes|type 2 diabetes
15843|NCT03473262|Sodium glucose cotransporter 2 inhibitor|sodium glucose cotransporter 2 inhibitor
15844|NCT03473262|Empagliflozin|empagliflozin
15845|NCT03473262|Insulin glargine|insulin glargine
15846|NCT03473171|nasal non-invasive ventilation|nasal non-invasive ventilation
15847|NCT03473171|RAM Cannula|ram cannula
15848|NCT03473171|Pediatric Complex Care|pediatric complex care
15849|NCT03473171|Tracheostomy Avoidance|tracheostomy avoidance
15850|NCT03473158|fetal reduction|fetal reduction
15851|NCT03473158|embryo reduction|embryo reduction
15852|NCT03473158|feticide|feticide
15853|NCT03473158|potassium chloride|potassium chloride
15854|NCT03473158|multiple pregnancy|multiple pregnancy
15855|NCT03473158|multifetal pregnancy|multifetal pregnancy
15856|NCT03473119|Sphingosine-1-phosphate|sphingosine-1-phosphate
15857|NCT03473106|Pneumatic Tourniquet|pneumatic tourniquet
15858|NCT03473106|Postoperative Muscle Dysfunction|postoperative muscle dysfunction
15859|NCT03473080|OCD|ocd
15860|NCT03473080|ASD|asd
15861|NCT03473080|Obsessive Compulsive Disorder|obsessive compulsive disorder
15862|NCT03473080|Autism Spectrum Disorder|autism spectrum disorder
15863|NCT03473080|ICBT|icbt
15864|NCT03473080|eHealth|ehealth
15865|NCT03473080|Internet|internet
15866|NCT03473080|CBT|cbt
15867|NCT03473080|Pediatric|pediatric
15868|NCT03473080|Adolescents|adolescents
15869|NCT03473080|Children|children
15870|NCT03473080|Internet-delivered|internet-delivered
15871|NCT03473054|Stroke|stroke
15872|NCT03473054|Cerebrovascular Accident|cerebrovascular accident
15873|NCT03473054|Stress|stress
15874|NCT03473054|Anxiety|anxiety
15875|NCT03473054|Depression|depression
15876|NCT03473054|Mindfulness|mindfulness
15877|NCT03473054|Family caregivers|family caregivers
15878|NCT03473054|Web-based|web-based
15879|NCT03473041|female stress incontinence|female stress incontinence
16080|NCT03471871|Lemborexant|lemborexant
15880|NCT03473041|Transobturator tension free vaginal tape TVTO|transobturator tension free vaginal tape tvto
15881|NCT03473028|obesity|obesity
15882|NCT03473028|embryo transfer|embryo transfer
15883|NCT03473028|invitro fertilization|invitro fertilization
15884|NCT03473002|Immunogenicity|immunogenicity
15885|NCT03473002|Respiratory Syncytial Virus|respiratory syncytial virus
15886|NCT03473002|Safety|safety
15887|NCT03473002|Sendai Virus|sendai virus
15888|NCT03473002|Vaccine|vaccine
15889|NCT03472989|plantar fasciopathy|plantar fasciopathy
15890|NCT03472989|foot orthosis|foot orthosis
15891|NCT03472989|rESWT|reswt
15892|NCT03472989|exercise|exercise
15893|NCT03472976|A/H7N9 Vaccine|a/h7n9 vaccine
15894|NCT03472976|Adults|adults
15895|NCT03472976|Immunogenicity|immunogenicity
15896|NCT03472976|Influenza|influenza
15897|NCT03472976|Phase I|phase i
15898|NCT03472976|Reactogenicity|reactogenicity
15899|NCT03472976|Safety|safety
15900|NCT03472963|Post-Exposure Prophylaxis|post-exposure prophylaxis
15901|NCT03472963|Anti-Retroviral|anti-retroviral
15902|NCT03472963|Pharmacokinetics|pharmacokinetics
15903|NCT03472937|Mechanical cervical ripening|mechanical cervical ripening
15904|NCT03472937|Transcervical catheter|transcervical catheter
15905|NCT03472937|Foley catheter for labor induction|foley catheter for labor induction
15906|NCT03472937|Cervical ripening|cervical ripening
15907|NCT03472937|Induction of labor|induction of labor
15908|NCT03472924|AMI|ami
15909|NCT03472885|PNH|pnh
15910|NCT03472885|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
15911|NCT03472885|ACH-0144471|ach-0144471
15912|NCT03472885|eculizumab|eculizumab
15913|NCT03472872|acetaminophen|acetaminophen
15914|NCT03472872|ketorolac|ketorolac
15915|NCT03472872|prochlorperazine|prochlorperazine
15916|NCT03472872|diphenhydramine|diphenhydramine
15917|NCT03472859|laser|laser
15918|NCT03472859|lasers|lasers
15919|NCT03472859|KTP|ktp
15920|NCT03472859|semiconductor|semiconductor
15921|NCT03472859|tgs|tgs
15922|NCT03472859|rosacea|rosacea
15923|NCT03472859|telangiectasia|telangiectasia
15924|NCT03472833|V|v
15925|NCT03472820|Diet|diet
15926|NCT03472820|Lifestyle|lifestyle
15927|NCT03472820|DNA methylation|dna methylation
15928|NCT03472768|ECMO|ecmo
15929|NCT03472755|hip arthroplasty, surgeries, physical fitness, perception, energetic cost, autonomy|hip arthroplasty, surgeries, physical fitness, perception, energetic cost, autonomy
15930|NCT03472729|Social isolation|social isolation
15931|NCT03472729|Older adults|older adults
15932|NCT03472729|Technology|technology
15933|NCT03472716|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
15934|NCT03472716|βig-h3|βig-h3
15935|NCT03472716|Pronostic marker|pronostic marker
15936|NCT03472703|fMRI|fmri
15937|NCT03472703|Cognitive processes|cognitive processes
15938|NCT03472703|Inhibition|inhibition
15939|NCT03472703|Food reward|food reward
15940|NCT03472703|Appetite|appetite
15941|NCT03472690|Inflammatory Bowel Disease 1|inflammatory bowel disease 1
15942|NCT03472677|Osteoarthritis|osteoarthritis
15943|NCT03472677|Knee Pain|knee pain
15944|NCT03472664|Memory|memory
15945|NCT03472664|Diet|diet
15946|NCT03472664|ketogenic|ketogenic
15947|NCT03472612|OSA|osa
15948|NCT03472612|CPAP|cpap
15949|NCT03472612|upper airway collapse|upper airway collapse
15950|NCT03472612|neural respiratory drive|neural respiratory drive
15951|NCT03472599|Neurogenic bladder dysfunction|neurogenic bladder dysfunction
15952|NCT03472599|Genital Nerve Stimulation|genital nerve stimulation
15953|NCT03472599|Electrical Stimulation|electrical stimulation
15954|NCT03472599|Urinary Incontinence|urinary incontinence
15955|NCT03472599|Spinal cord injury|spinal cord injury
15956|NCT03472560|Cancer|cancer
15957|NCT03472560|non-small cell lung cancer|non-small cell lung cancer
16207|NCT03471000|implant|implant
15958|NCT03472560|non small cell lung cancer|non small cell lung cancer
15959|NCT03472560|NSCLC|nsclc
15960|NCT03472560|lung cancer|lung cancer
15961|NCT03472560|urothelial cancer|urothelial cancer
15962|NCT03472560|bladder cancer|bladder cancer
15963|NCT03472560|Avelumab|avelumab
15964|NCT03472560|Bavencio|bavencio
15965|NCT03472560|Axitinib|axitinib
15966|NCT03472560|Inlyta|inlyta
15967|NCT03472508|Folic acid|folic acid
15968|NCT03472508|Homocysteine|homocysteine
15969|NCT03472508|MTHFR C677T|mthfr c677t
15970|NCT03472508|RCT|rct
15971|NCT03472508|Precision treatment|precision treatment
15972|NCT03472495|Diltiazem|diltiazem
15973|NCT03472495|Atrial Fibrillation|atrial fibrillation
15974|NCT03472495|Atrial Flutter|atrial flutter
15975|NCT03472495|Emergency Medicine|emergency medicine
15976|NCT03472482|Alzheimer's disease|alzheimer's disease
15977|NCT03472482|Dementia|dementia
15978|NCT03472482|Lewy body disease|lewy body disease
15979|NCT03472482|Retina|retina
15980|NCT03472482|Retinal imaging|retinal imaging
15981|NCT03472482|Optical Coherence Tomography|optical coherence tomography
15982|NCT03472482|Hyperspectral imaging|hyperspectral imaging
15983|NCT03472482|Mild Cognitive Impairment|mild cognitive impairment
15984|NCT03472430|Oocyte Retrieval|oocyte retrieval
15985|NCT03472430|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
15986|NCT03472430|Pain relief|pain relief
15987|NCT03472430|Conscious sedation|conscious sedation
15988|NCT03472365|PD-1|pd-1
15989|NCT03472365|SHR-1210|shr-1210
15990|NCT03472365|Capecitabine|capecitabine
15991|NCT03472365|Oxaliplatin|oxaliplatin
15992|NCT03472365|Apatinib|apatinib
15993|NCT03472339|Acute limb injury, Diclofenac, pain management|acute limb injury, diclofenac, pain management
15994|NCT03472313|HV|hv
15995|NCT03472300|Knee Osteoarthritis|knee osteoarthritis
15996|NCT03472300|pain|pain
15997|NCT03472300|Complementary Therapies|complementary therapies
15998|NCT03472300|Survey|survey
15999|NCT03472300|questionnaire|questionnaire
16000|NCT03472261|cerebral palsy|cerebral palsy
16001|NCT03472261|botulinum toxin-A|botulinum toxin-a
16002|NCT03472261|pronator deformity|pronator deformity
16003|NCT03472248|Adolescents|adolescents
16004|NCT03472248|Acceptance and Commitment Therapy|acceptance and commitment therapy
16005|NCT03472248|Smartphone|smartphone
16006|NCT03472209|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
16007|NCT03472209|Gynecological Laparoscopic Surgery|gynecological laparoscopic surgery
16008|NCT03472209|End-tidal carbon dioxide|end-tidal carbon dioxide
16009|NCT03472183|Enteric nervous system|enteric nervous system
16010|NCT03472183|Alzheimer disease|alzheimer disease
16011|NCT03472183|biomarker|biomarker
16012|NCT03472183|colonic biopsies|colonic biopsies
16013|NCT03472183|neurodegenerative disease|neurodegenerative disease
16014|NCT03472170|bovine lactoferrin, late sepsis|bovine lactoferrin, late sepsis
16015|NCT03472157|Gastric bypass|gastric bypass
16016|NCT03472157|Sleeve gastrectomy|sleeve gastrectomy
16017|NCT03472157|Lifestyle therapy|lifestyle therapy
16018|NCT03472157|NASH|nash
16019|NCT03472157|Advanced fibrosis|advanced fibrosis
16020|NCT03472157|Cirrhosis|cirrhosis
16021|NCT03472131|Spondylodiscitis|spondylodiscitis
16022|NCT03472131|Titanium Cage|titanium cage
16023|NCT03472131|Posterolateral Debridement|posterolateral debridement
16024|NCT03472131|Immunosuppressed|immunosuppressed
16025|NCT03472131|Less Invasive|less invasive
16026|NCT03472131|Spine Infection|spine infection
16027|NCT03472118|Anesthesia, general|anesthesia, general
16028|NCT03472118|Adult|adult
16029|NCT03472118|Humans|humans
16030|NCT03472118|Apnea|apnea
16031|NCT03472118|Oxygen|oxygen
16032|NCT03472118|Carbon dioxide|carbon dioxide
16033|NCT03472118|Acidosis, respiratory|acidosis, respiratory
16034|NCT03472118|Administration, Intranals/methods|administration, intranals/methods
16035|NCT03472118|Airway management/methods|airway management/methods
16036|NCT03472118|Continuous positive airway pressure/methods|continuous positive airway pressure/methods
16037|NCT03472118|Insufflation/methods|insufflation/methods
16038|NCT03472118|Oxygen/administration&dosage|oxygen/administration&dosage
16039|NCT03472118|Laryngoscopy|laryngoscopy
16040|NCT03472118|Larynx/surgery|larynx/surgery
16041|NCT03472092|headache|headache
16042|NCT03472092|migraine|migraine
16043|NCT03472092|cognitive behavioral therapy|cognitive behavioral therapy
16044|NCT03472092|amitriptyline|amitriptyline
16045|NCT03472092|functional magnetic resonance imaging|functional magnetic resonance imaging
16046|NCT03472092|conditioned pain modulation|conditioned pain modulation
16047|NCT03472092|brain connectivity|brain connectivity
16048|NCT03472092|pediatrics|pediatrics
16049|NCT03472079|Acute kidney injury, septic shock, TIMP2*IGFBP7|acute kidney injury, septic shock, timp2*igfbp7
16050|NCT03472053|Lung cancer|lung cancer
16051|NCT03472053|non small cell|non small cell
16052|NCT03472053|metastasis|metastasis
16053|NCT03472040|BCX7353|bcx7353
16054|NCT03472040|Hereditary Angioedema|hereditary angioedema
16055|NCT03472040|HAE|hae
16056|NCT03471988|deep mycosis|deep mycosis
16057|NCT03471988|aspergillosis|aspergillosis
16058|NCT03471988|mucormycosis|mucormycosis
16059|NCT03471988|cryptococcosis|cryptococcosis
16060|NCT03471988|isavuconazonium sulfate|isavuconazonium sulfate
16061|NCT03471988|isavuconazole|isavuconazole
16062|NCT03471988|AK1820|ak1820
16063|NCT03471988|Cresemba|cresemba
16064|NCT03471975|Video laryngoscopy|video laryngoscopy
16065|NCT03471962|respiratory quotient (RQ), anaerobic metabolism, major surgery.|respiratory quotient (rq), anaerobic metabolism, major surgery.
16066|NCT03471936|Congenital Heart Disease|congenital heart disease
16067|NCT03471936|pressure-volume loops|pressure-volume loops
16068|NCT03471936|diastolic function|diastolic function
16069|NCT03471910|Chronic venous insufficiency|chronic venous insufficiency
16070|NCT03471910|Diosmin|diosmin
16071|NCT03471910|Hesperidin|hesperidin
16072|NCT03471897|glycosaminoglycans|glycosaminoglycans
16073|NCT03471897|biomarkers|biomarkers
16074|NCT03471897|diagnostics|diagnostics
16075|NCT03471897|prognostic|prognostic
16076|NCT03471897|liquid biopsy|liquid biopsy
16077|NCT03471884|Thoracoscopic surgery,Airway Management,Anesthesia|thoracoscopic surgery,airway management,anesthesia
16078|NCT03471871|Elderly Healthy Subjects|elderly healthy subjects
16079|NCT03471871|Adult Healthy Subjects|adult healthy subjects
16081|NCT03471871|Respiratory Safety|respiratory safety
16082|NCT03471871|Peripheral Oxygen Saturation|peripheral oxygen saturation
16083|NCT03471871|Total Sleep Time|total sleep time
16084|NCT03471858|caesarean, uterus|caesarean, uterus
16085|NCT03471845|Major Adverse Cardiac Events (MACE)|major adverse cardiac events (mace)
16086|NCT03471845|Myocardial Infarction (MI)|myocardial infarction (mi)
16087|NCT03471845|Late Lumen Loss (LLL)|late lumen loss (lll)
16088|NCT03471845|Target Lesion Revascularization (TLR)|target lesion revascularization (tlr)
16089|NCT03471845|Target Vessel Revascularization (TVR)|target vessel revascularization (tvr)
16090|NCT03471845|Target Vessel Failure (TVF)|target vessel failure (tvf)
16091|NCT03471845|Target Lesion Failure (TLF)|target lesion failure (tlf)
16092|NCT03471845|Stent Thrombosis (ST)|stent thrombosis (st)
16093|NCT03471845|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
16094|NCT03471819|Atopic Dermatitis|atopic dermatitis
16095|NCT03471819|serotonin|serotonin
16096|NCT03471806|Bulimia Nervosa|bulimia nervosa
16097|NCT03471806|Eating disorder|eating disorder
16098|NCT03471806|Dopamine|dopamine
16099|NCT03471806|Food|food
16100|NCT03471806|Reward|reward
16101|NCT03471806|Positron Emission Tomography|positron emission tomography
16102|NCT03471806|Magnetic Resonance|magnetic resonance
16103|NCT03471806|Metabolic hormones|metabolic hormones
16104|NCT03471767|Smoking cessation|smoking cessation
16105|NCT03471767|Nicotine dependence|nicotine dependence
16106|NCT03471767|Bupropion|bupropion
16107|NCT03471767|DXM|dxm
16108|NCT03471767|Nicotine addiction|nicotine addiction
16109|NCT03471767|Cigarette smoking|cigarette smoking
16110|NCT03471767|Dextromethorphan|dextromethorphan
16111|NCT03471754|Depression, transcranial electronic stimulation, pilot, open label, safety, efficacy|depression, transcranial electronic stimulation, pilot, open label, safety, efficacy
16112|NCT03471741|breast cancer|breast cancer
16113|NCT03471741|radiotherapy|radiotherapy
16114|NCT03471741|cutaneous toxicity|cutaneous toxicity
16115|NCT03471741|subcutaneous toxicity|subcutaneous toxicity
16116|NCT03471741|local control|local control
16117|NCT03471741|IMRT|imrt
16118|NCT03471728|Linzess|linzess
16119|NCT03471728|Irritable Bowel Syndrome|irritable bowel syndrome
16120|NCT03471728|linaclotide|linaclotide
16121|NCT03471715|frequency fenesration dehiscence cbct population|frequency fenesration dehiscence cbct population
16122|NCT03471689|Multimodal|multimodal
16123|NCT03471689|Pain perception|pain perception
16124|NCT03471689|Regulation|regulation
16125|NCT03471689|Mindfulness|mindfulness
16126|NCT03471650|J17149|j17149
16127|NCT03471650|PSMA|psma
16128|NCT03471650|18F-DCFPyL PET/CT|18f-dcfpyl pet/ct
16129|NCT03471637|Chronic Pain|chronic pain
16130|NCT03471637|Compassion-Focused Therapy|compassion-focused therapy
16131|NCT03471637|Self-Compassion|self-compassion
16132|NCT03471637|Psychological Flexibility|psychological flexibility
16133|NCT03471624|Tenofovir alafenamide (TAF)|tenofovir alafenamide (taf)
16134|NCT03471585|THC|thc
16135|NCT03471585|adult|adult
16136|NCT03471572|BRCA, ovarian cancer, fallopian tube cancer|brca, ovarian cancer, fallopian tube cancer
16137|NCT03471546|Palliative Care|palliative care
16138|NCT03471546|Pro00091481|pro00091481
16139|NCT03471546|Malignant Glioma|malignant glioma
16140|NCT03471546|Katherine Peters|katherine peters
16141|NCT03471546|David Casarett|david casarett
16142|NCT03471494|Surgery|surgery
16143|NCT03471494|Quality|quality
16144|NCT03471494|Outcomes|outcomes
16145|NCT03471468|Microparticles|microparticles
16146|NCT03471468|Pancreatic cancer|pancreatic cancer
16147|NCT03471468|Gastric cancer|gastric cancer
16148|NCT03471468|Chemotherapy|chemotherapy
16149|NCT03471468|Venous thromboembolism|venous thromboembolism
16150|NCT03471429|Anxiety|anxiety
16151|NCT03471429|Dog|dog
16152|NCT03471429|Canine|canine
16153|NCT03471429|Therapy|therapy
16154|NCT03471429|Depression|depression
16155|NCT03471429|Pain|pain
16156|NCT03471416|Guatemala|guatemala
16157|NCT03471416|Guatemala City|guatemala city
16158|NCT03471416|Malnutrition|malnutrition
16159|NCT03471416|Leukemia|leukemia
16160|NCT03471416|Childhood Cancer|childhood cancer
16161|NCT03471403|Cold snare polypectomy|cold snare polypectomy
16162|NCT03471390|Nursing Home|nursing home
16163|NCT03471377|Planned Surgical Case|planned surgical case
16164|NCT03471377|Predictive Modeling|predictive modeling
16165|NCT03471377|18-115|18-115
16166|NCT03471351|Hodgkin lymphoma|hodgkin lymphoma
16167|NCT03471351|RP6530|rp6530
16168|NCT03471351|Pembrolizumab|pembrolizumab
16169|NCT03471351|Tenalisib|tenalisib
16170|NCT03471338|multiple sclerosis|multiple sclerosis
16171|NCT03471338|cognition|cognition
16172|NCT03471338|neuropsychology|neuropsychology
16173|NCT03471338|cognitive rehabilitation|cognitive rehabilitation
16174|NCT03471325|plaque removal|plaque removal
16175|NCT03471299|Ultrafiltration rate|ultrafiltration rate
16176|NCT03471260|Other diseases of blood and blood-forming organs|other diseases of blood and blood-forming organs
16177|NCT03471260|Advanced hematologic malignancies|advanced hematologic malignancies
16178|NCT03471260|Acute myeloid leukemia|acute myeloid leukemia
16179|NCT03471260|AML|aml
16180|NCT03471260|IDH1 mutation|idh1 mutation
16181|NCT03471260|Relapsed/refractory|relapsed/refractory
16182|NCT03471260|Ivosidenib|ivosidenib
16183|NCT03471260|AG120|ag120
16184|NCT03471260|Venetoclax|venetoclax
16185|NCT03471260|AB-199|ab-199
16186|NCT03471260|GDC-0199|gdc-0199
16187|NCT03471234|coronary disease|coronary disease
16188|NCT03471234|drug eluting stent|drug eluting stent
16189|NCT03471234|Inspiron|inspiron
16190|NCT03471182|Cocaine Dependence|cocaine dependence
16191|NCT03471182|Cocaine Addiction|cocaine addiction
16192|NCT03471169|antithrombotic therapy|antithrombotic therapy
16193|NCT03471117|blood pressure|blood pressure
16194|NCT03471117|pioglitazone|pioglitazone
16195|NCT03471117|hypertension|hypertension
16196|NCT03471104|Diabetes-related distress|diabetes-related distress
16197|NCT03471104|Living with diabetes|living with diabetes
16198|NCT03471104|Patient-Reported Outcome Measures (PROMs)|patient-reported outcome measures (proms)
16199|NCT03471078|CIT|cit
16200|NCT03471078|Thrombocytopenia|thrombocytopenia
16201|NCT03471065|Transcatheter|transcatheter
16202|NCT03471065|Transcatheter Valve Replacement|transcatheter valve replacement
16203|NCT03471065|SAPIEN 3 Ultra|sapien 3 ultra
16204|NCT03471013|schizophrenia|schizophrenia
16205|NCT03471013|beliefs|beliefs
16206|NCT03471013|caregiver|caregiver
16208|NCT03471000|dental implant|dental implant
16209|NCT03470987|obesity|obesity
16210|NCT03470987|periodontitis|periodontitis
16211|NCT03470987|cytokines|cytokines
16212|NCT03470961|Grafalon ATG SPK|grafalon atg spk
16213|NCT03470948|surgical apgar score, postoperative complication|surgical apgar score, postoperative complication
16214|NCT03470935|breast cancer|breast cancer
16215|NCT03470935|young women|young women
16216|NCT03470922|Cancer|cancer
16217|NCT03470922|Advanced Cancer|advanced cancer
16218|NCT03470909|Remaining breast tissue|remaining breast tissue
16219|NCT03470909|Skin-Sparing Mastectomy|skin-sparing mastectomy
16220|NCT03470909|Nipple-Sparing Mastectomy|nipple-sparing mastectomy
16221|NCT03470909|Prophylactic|prophylactic
16222|NCT03470896|preanesthesia teleconsultation|preanesthesia teleconsultation
16223|NCT03470896|video-conference|video-conference
16224|NCT03470896|ambulatory surgery|ambulatory surgery
16225|NCT03470896|telemedicine|telemedicine
16226|NCT03470883|endoscopic resection|endoscopic resection
16227|NCT03470883|colorectal adenomas|colorectal adenomas
16228|NCT03470883|Colorectal adenocarcinomas|colorectal adenocarcinomas
16229|NCT03470870|Enhanced recovery after surgery|enhanced recovery after surgery
16230|NCT03470870|gynecologic oncology surgery|gynecologic oncology surgery
16231|NCT03470870|Nomogram control|nomogram control
16232|NCT03470857|Positron Emission Tomography Computed Tomography|positron emission tomography computed tomography
16233|NCT03470857|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
16234|NCT03470857|Cancer|cancer
16235|NCT03470857|Superooxide Dismutase|superooxide dismutase
16236|NCT03470857|Catalase|catalase
16237|NCT03470857|Glutathione Peroxidase|glutathione peroxidase
16238|NCT03470857|Malondialdehyde|malondialdehyde
16239|NCT03470857|Conjugated Dienes|conjugated dienes
16240|NCT03470857|Acid Phosphatase|acid phosphatase
16241|NCT03470857|Cathepsin D|cathepsin d
16242|NCT03470857|Alpha-1-Antitrypsin|alpha-1-antitrypsin
16243|NCT03470857|Arylsulfatase|arylsulfatase
16244|NCT03470857|8-iso-Prostaglandin F2alpha|8-iso-prostaglandin f2alpha
16245|NCT03470857|4-Hydroxynonenal|4-hydroxynonenal
16246|NCT03470857|Total Antioxidant Capacity|total antioxidant capacity
16247|NCT03470857|Vitamin A|vitamin a
16248|NCT03470857|Vitamin E|vitamin e
16249|NCT03470844|Major burns|major burns
16250|NCT03470844|Intensive Care Medicine|intensive care medicine
16251|NCT03470844|Neurocognitive dysfunction|neurocognitive dysfunction
16252|NCT03470844|Functional magnetic resonance imaging|functional magnetic resonance imaging
16253|NCT03470844|Neuroinflammation|neuroinflammation
16254|NCT03470844|Long term quality of life|long term quality of life
16255|NCT03470818|Medical Education|medical education
16256|NCT03470818|Flipped Classroom|flipped classroom
16257|NCT03470818|Anxiety|anxiety
16258|NCT03470818|Simulation|simulation
16259|NCT03470818|Achievement Emotions|achievement emotions
16260|NCT03470792|Microcirculation, extracorporeal membrane oxygenation|microcirculation, extracorporeal membrane oxygenation
16261|NCT03470766|Neuromodulation|neuromodulation
16262|NCT03470766|HF10|hf10
16263|NCT03470766|HF-10|hf-10
16264|NCT03470766|Nevro|nevro
16265|NCT03470766|High-frequency|high-frequency
16266|NCT03470766|10kHz|10khz
16267|NCT03470766|Spinal Cord Stimulation|spinal cord stimulation
16268|NCT03470766|CNLBP|cnlbp
16269|NCT03470766|Chronic Neuropathic Low Back Pain|chronic neuropathic low back pain
16270|NCT03470766|Double blind randomised sham-controlled|double blind randomised sham-controlled
16271|NCT03470766|PANARC|panarc
16272|NCT03470766|SCS|scs
16273|NCT03470714|Force Irradiation|force irradiation
16274|NCT03470714|Kinesiotaping|kinesiotaping
16275|NCT03470714|EMG|emg
16276|NCT03470662|Hip fractures|hip fractures
16277|NCT03470662|Delirium|delirium
16278|NCT03470662|Aged|aged
16279|NCT03470662|Care bundle|care bundle
16280|NCT03470623|hallux valgus|hallux valgus
16281|NCT03470623|chevron osteotomy|chevron osteotomy
16282|NCT03470623|bioabsorbable screw|bioabsorbable screw
16283|NCT03470623|steel screw|steel screw
16284|NCT03470610|Progesterone|progesterone
16285|NCT03470610|HRT|hrt
16286|NCT03470610|frozen embryo transfer|frozen embryo transfer
16287|NCT03470584|Diet, vegetarian|diet, vegetarian
16288|NCT03470584|Dementia|dementia
16289|NCT03470584|Depression|depression
16290|NCT03470584|Cardiovascular Diseases|cardiovascular diseases
16291|NCT03470584|Stroke|stroke
16292|NCT03470584|Gout|gout
16293|NCT03470584|Cataract|cataract
16294|NCT03470584|Gallstone|gallstone
16295|NCT03470584|Urinary Tract Infections|urinary tract infections
16296|NCT03470558|Diet|diet
16297|NCT03470558|Dietary Habits|dietary habits
16298|NCT03470558|Weight changes|weight changes
16299|NCT03470545|Symptomatic, left ventricular outflow tract gradient|symptomatic, left ventricular outflow tract gradient
16300|NCT03470428|Fontan|fontan
16301|NCT03470428|Single Ventricle|single ventricle
16302|NCT03470402|Breast Cancer Prevention|breast cancer prevention
16303|NCT03470402|Genetic Testing|genetic testing
16304|NCT03470402|Genetic Counseling|genetic counseling
16305|NCT03470402|Personalized Prevention|personalized prevention
16306|NCT03470402|Precision Prevention|precision prevention
16307|NCT03470402|Precision Medicine|precision medicine
16308|NCT03470402|Risk Assessment|risk assessment
16309|NCT03470402|Decision Making|decision making
16310|NCT03470402|Decision Aid|decision aid
16311|NCT03470376|cholesterol|cholesterol
16312|NCT03470376|nutraceutical|nutraceutical
16313|NCT03470376|HIV|hiv
16314|NCT03470376|PCSK9|pcsk9
16315|NCT03470376|hsCRP|hscrp
16316|NCT03470376|stiffness|stiffness
16317|NCT03470363|total knee arthroplasty|total knee arthroplasty
16318|NCT03470363|tourniquet|tourniquet
16319|NCT03470363|sevoflurane|sevoflurane
16320|NCT03470363|spinal anesthesia|spinal anesthesia
16321|NCT03470363|myeloperoxidase|myeloperoxidase
16322|NCT03470363|elastase|elastase
16323|NCT03470363|neutrophil|neutrophil
16324|NCT03470350|TGF-beta activatied|tgf-beta activatied
16325|NCT03470337|Thrombophlebitis|thrombophlebitis
16326|NCT03470324|Parkinson's disease|parkinson's disease
16327|NCT03470324|Dysphagia|dysphagia
16328|NCT03470324|Parkinsonian Disorders|parkinsonian disorders
16329|NCT03470324|Neurodegenerative Diseases|neurodegenerative diseases
16330|NCT03470324|Movement Disorders|movement disorders
16331|NCT03470324|Nervous System Diseases|nervous system diseases
16332|NCT03470324|Basal Ganglia Diseases|basal ganglia diseases
16333|NCT03470324|Brain Diseases|brain diseases
16334|NCT03470324|Central Nervous System Diseases|central nervous system diseases
16335|NCT03470324|Deep brain stimulation|deep brain stimulation
16336|NCT03470324|substantia nigra pars reticulata|substantia nigra pars reticulata
16337|NCT03470324|subthalamic nucleus|subthalamic nucleus
16338|NCT03470311|Eosinophils|eosinophils
16339|NCT03470311|asthma|asthma
16340|NCT03470311|inflammation|inflammation
16341|NCT03470311|prednisone|prednisone
16342|NCT03470298|Endometrial Scratching|endometrial scratching
16343|NCT03470298|Unexplained infertility|unexplained infertility
16344|NCT03470298|ICSI|icsi
16345|NCT03470285|Mulitparametric MR Imaging|mulitparametric mr imaging
16346|NCT03470285|Small solid renal tumors|small solid renal tumors
16347|NCT03470246|Accelerometer|accelerometer
16348|NCT03470246|Aortic valve replacement|aortic valve replacement
16349|NCT03470246|Aortic valve stenosis|aortic valve stenosis
16350|NCT03470246|Coronary artery bypass grafting|coronary artery bypass grafting
16351|NCT03470246|Coronary artery disease|coronary artery disease
16352|NCT03470246|eHealth|ehealth
16353|NCT03470246|Interactive guidance|interactive guidance
16354|NCT03470246|Mitral valve insufficiency|mitral valve insufficiency
16355|NCT03470246|Mitral valve repair|mitral valve repair
16356|NCT03470246|Rehabilitation|rehabilitation
16357|NCT03470194|Quality Care|quality care
16358|NCT03470194|Access to health care|access to health care
16359|NCT03470194|Interpretation services|interpretation services
16360|NCT03470181|Chronic nausea, intermittent vomiting, impaired accommodation|chronic nausea, intermittent vomiting, impaired accommodation
16361|NCT03470155|annuloplasty mitral valve|annuloplasty mitral valve
16362|NCT03470155|reduced LV function|reduced lv function
16363|NCT03470142|laparoscopy-assisted surgery|laparoscopy-assisted surgery
16364|NCT03470142|NOSES|noses
16365|NCT03470116|MacGrath MAC|macgrath mac
16366|NCT03470116|curarization|curarization
16367|NCT03470116|intubation|intubation
16368|NCT03470116|MacIntosh|macintosh
16369|NCT03470116|laryngoscope|laryngoscope
16370|NCT03470103|Wet age-related macular degeneration(wAMD)|wet age-related macular degeneration(wamd)
16371|NCT03470103|Diabetic macular edema(DME)|diabetic macular edema(dme)
16372|NCT03470090|Physical activity|physical activity
16373|NCT03470090|Function|function
16374|NCT03470090|Balance|balance
16375|NCT03470090|Neuromuscular exercises|neuromuscular exercises
16376|NCT03470090|Osteoarthritis|osteoarthritis
16377|NCT03470038|NGF-induced pain|ngf-induced pain
16378|NCT03470038|Ischemia-induced pain|ischemia-induced pain
16379|NCT03470038|Muscle hypersensitivity|muscle hypersensitivity
16380|NCT03470038|NGF pain model|ngf pain model
16381|NCT03470025|Rehabilitation|rehabilitation
16382|NCT03470025|Psychological Intervention|psychological intervention
16383|NCT03470025|Quality of life|quality of life
16384|NCT03469999|Botulinum toxin A|botulinum toxin a
16385|NCT03469999|Walking efficiency|walking efficiency
16386|NCT03469999|Spasticity|spasticity
16387|NCT03469999|Dysport|dysport
16388|NCT03469960|IFCT|ifct
16389|NCT03469960|DICIPLE|diciple
16390|NCT03469960|NSCLC|nsclc
16391|NCT03469947|Tranexamic Acid|tranexamic acid
16392|NCT03469947|TXA|txa
16393|NCT03469921|Malignant haemopathies|malignant haemopathies
16394|NCT03469921|Acute Leukemia|acute leukemia
16395|NCT03469921|Non-hodgkin Lymphoma|non-hodgkin lymphoma
16396|NCT03469921|Hodgkin Lymphoma|hodgkin lymphoma
16397|NCT03469921|Young adults|young adults
16398|NCT03469921|Adolescent|adolescent
16399|NCT03469895|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
16400|NCT03469895|Autoimmune Cytopenias|autoimmune cytopenias
16401|NCT03469895|BCR inhibitors|bcr inhibitors
16402|NCT03469882|Protein, exercise, critical illness, outcome,|protein, exercise, critical illness, outcome,
16403|NCT03469869|Obesity|obesity
16404|NCT03469843|Congenital Heart Disease|congenital heart disease
16405|NCT03469843|Cardiac denervation|cardiac denervation
16406|NCT03469843|123I-metaiodobenzylguanidine|123i-metaiodobenzylguanidine
16407|NCT03469843|Arterial switch operation|arterial switch operation
16408|NCT03469830|insert|insert
16409|NCT03469830|pressure therapy|pressure therapy
16410|NCT03469830|silicone gel|silicone gel
16411|NCT03469817|Bone apposition|bone apposition
16412|NCT03469817|Stryker|stryker
16413|NCT03469817|MRI|mri
16414|NCT03469817|Trident II|trident ii
16415|NCT03469817|Total Hip Replacement|total hip replacement
16416|NCT03469791|Degenerative Spondylolisthesis|degenerative spondylolisthesis
16417|NCT03469791|Treatment|treatment
16418|NCT03469791|Decompression alone|decompression alone
16419|NCT03469791|Instrumented fusion|instrumented fusion
16420|NCT03469791|Oswestry Disability Index|oswestry disability index
16421|NCT03469778|stroke|stroke
16422|NCT03469778|rehabilitation|rehabilitation
16423|NCT03469778|upper limb|upper limb
16424|NCT03469778|motor activity|motor activity
16425|NCT03469778|robotic|robotic
16426|NCT03469765|AKI|aki
16427|NCT03469752|Hispanic Latino families|hispanic latino families
16428|NCT03469739|Intimate Partner Violence|intimate partner violence
16429|NCT03469726|Liver metastases|liver metastases
16430|NCT03469726|Diffusion weighted MRI|diffusion weighted mri
16431|NCT03469674|Radiotherapy|radiotherapy
16432|NCT03469674|Vaginal brachytherapy|vaginal brachytherapy
16433|NCT03469674|Molecular risk factors|molecular risk factors
16434|NCT03469622|Adenoma|adenoma
16435|NCT03469622|Polyp|polyp
16436|NCT03469622|EndoRings|endorings
16437|NCT03469622|Colonoscopy|colonoscopy
16438|NCT03469622|Endoscopic device|endoscopic device
16439|NCT03469622|Colon cancer screening|colon cancer screening
16440|NCT03469609|infants|infants
16441|NCT03469609|necrotizing enterocolitis (NEC)|necrotizing enterocolitis (nec)
16442|NCT03469609|focal intestinal perforation (FIP)|focal intestinal perforation (fip)
16443|NCT03469609|enterostomy creation|enterostomy creation
16444|NCT03469609|bowel reanastomosis|bowel reanastomosis
16445|NCT03469609|enteral feeding|enteral feeding
16446|NCT03469609|caloric intake|caloric intake
16447|NCT03469609|parenteral nutrition|parenteral nutrition
16448|NCT03469609|complication rate|complication rate
16449|NCT03469609|reduction of hospital expenses|reduction of hospital expenses
16450|NCT03469609|length of hospital stay|length of hospital stay
16451|NCT03469570|Non-cardiac|non-cardiac
16452|NCT03469570|Non-Thoracic|non-thoracic
16453|NCT03469570|Fluid Management|fluid management
16454|NCT03469570|Perioperative Goal Directed Therapy|perioperative goal directed therapy
16455|NCT03469531|Cervical Cancer|cervical cancer
16456|NCT03469531|Radiation Therapy|radiation therapy
16457|NCT03469531|Chemotherapy|chemotherapy
16458|NCT03469531|Nimotuzumab|nimotuzumab
16459|NCT03469531|Cisplatin|cisplatin
16460|NCT03469518|beta-cryptoxanthin|beta-cryptoxanthin
16461|NCT03469518|cholesterol|cholesterol
16462|NCT03469518|Galactooligosaccharides|galactooligosaccharides
16463|NCT03469518|Plant Sterols|plant sterols
16464|NCT03469518|Cardiovascular risk|cardiovascular risk
16465|NCT03469518|Bone Turnover markers|bone turnover markers
16466|NCT03469518|Intestinal Inflammatory markers|intestinal inflammatory markers
16467|NCT03469518|Microbiota|microbiota
16468|NCT03469479|Neoadjuvant hepatic arterial infusion chemotherapy|neoadjuvant hepatic arterial infusion chemotherapy
16469|NCT03469479|BCLC A/B|bclc a/b
16470|NCT03469479|FOLFOX|folfox
16471|NCT03469479|Resection|resection
16472|NCT03469453|GAD|gad
16473|NCT03469453|Adolescents|adolescents
16474|NCT03469453|Internet-delivered Cognitive behavioral therapy|internet-delivered cognitive behavioral therapy
16475|NCT03469453|ICBT|icbt
16476|NCT03469453|CBT|cbt
16477|NCT03469440|lactate|lactate
16675|NCT03468075|Ascorbate|ascorbate
16478|NCT03469440|central venous saturation|central venous saturation
16479|NCT03469440|Pediatric Cardiac Surgery|pediatric cardiac surgery
16480|NCT03469388|EVAR, central pressure, arterial stiffness, AAA, elective surgery|evar, central pressure, arterial stiffness, aaa, elective surgery
16481|NCT03469375|FOLFIRINOX|folfirinox
16482|NCT03469375|Pancreatic cancer|pancreatic cancer
16483|NCT03469375|Conversion surgery|conversion surgery
16484|NCT03469375|Overall survival|overall survival
16485|NCT03469349|Drug Therapy|drug therapy
16486|NCT03469336|Psoriasis|psoriasis
16487|NCT03469336|Topical|topical
16488|NCT03469323|Nonintubated video-assisted thoracic surgery (VATS)|nonintubated video-assisted thoracic surgery (vats)
16489|NCT03469310|endocrine surgery|endocrine surgery
16490|NCT03469310|opioid addiction|opioid addiction
16491|NCT03469310|pain management|pain management
16492|NCT03469310|analgesia|analgesia
16493|NCT03469284|Diseases of Oral Cavity Salivary Glands and Jaws|diseases of oral cavity salivary glands and jaws
16494|NCT03469284|Methylene Blue|methylene blue
16495|NCT03469284|MB|mb
16496|NCT03469284|Oral Mucositis|oral mucositis
16497|NCT03469271|Pneumonia|pneumonia
16498|NCT03469258|Pancreatic Cancer|pancreatic cancer
16499|NCT03469245|Endovascular|endovascular
16500|NCT03469245|Fenestrated endovascular repair|fenestrated endovascular repair
16501|NCT03469245|numerical simulation|numerical simulation
16502|NCT03469219|granulysin|granulysin
16503|NCT03469193|knee unicompartmental prosthesis|knee unicompartmental prosthesis
16504|NCT03469193|KneeKG system|kneekg system
16505|NCT03469193|robotic-assisted|robotic-assisted
16506|NCT03469193|alignment|alignment
16507|NCT03469193|implants positioning|implants positioning
16508|NCT03469193|International Knee Society|international knee society
16509|NCT03469193|Forgotten joint score|forgotten joint score
16510|NCT03469180|Treadmill Training|treadmill training
16511|NCT03469180|Whole Body Vibration Training|whole body vibration training
16512|NCT03469167|Bleeding|bleeding
16513|NCT03469154|Layperson|layperson
16514|NCT03469154|Paediatric Basic life Support|paediatric basic life support
16515|NCT03469154|education|education
16516|NCT03469141|Wheelchair|wheelchair
16517|NCT03469141|Pressure Relief|pressure relief
16518|NCT03469141|Activity|activity
16519|NCT03469141|Monitor|monitor
16520|NCT03469128|PTSD|ptsd
16521|NCT03469128|CPT|cpt
16522|NCT03469128|SUD|sud
16523|NCT03469102|Positron emission tomography|positron emission tomography
16524|NCT03469102|Texture indices|texture indices
16525|NCT03469102|Diagnostic performance|diagnostic performance
16526|NCT03469089|schizophrenia|schizophrenia
16527|NCT03469089|cognitive symptom|cognitive symptom
16528|NCT03469089|healthy volunteer|healthy volunteer
16529|NCT03469089|cognitive testing|cognitive testing
16530|NCT03469076|Acne, Comedonal, Mild to Moderate Papulopustular Acne|acne, comedonal, mild to moderate papulopustular acne
16531|NCT03469050|Recurrent acute diverticulitis|recurrent acute diverticulitis
16532|NCT03469050|Prevention|prevention
16533|NCT03469050|Diverticular complications|diverticular complications
16534|NCT03469050|Rifaximin delayed release|rifaximin delayed release
16535|NCT03469050|Diverticulitis|diverticulitis
16536|NCT03469050|SIBO|sibo
16537|NCT03469037|Dyspnea, High flow nasal cannula|dyspnea, high flow nasal cannula
16538|NCT03469024|Low back pain|low back pain
16539|NCT03469024|Electroanalgesia|electroanalgesia
16540|NCT03469024|Exercise program|exercise program
16541|NCT03469024|Randomized clinical trial|randomized clinical trial
16542|NCT03468998|Bone allograft|bone allograft
16543|NCT03468998|Particle size|particle size
16544|NCT03468998|Ridge preservation|ridge preservation
16545|NCT03468998|Ridge augmentation|ridge augmentation
16546|NCT03468998|Socket grafting|socket grafting
16547|NCT03468998|Histology|histology
16548|NCT03468998|New bone|new bone
16549|NCT03468972|IgA nephropathy|iga nephropathy
16550|NCT03468972|immunosuppression|immunosuppression
16551|NCT03468946|taste perception|taste perception
16552|NCT03468946|caries risk|caries risk
16553|NCT03468946|cariogram|cariogram
16554|NCT03468946|children|children
16555|NCT03468907|hepatitis B virus|hepatitis b virus
16556|NCT03468907|exacerbation|exacerbation
16557|NCT03468907|antiviral agents|antiviral agents
16558|NCT03468907|pregnancy|pregnancy
16559|NCT03468907|flare|flare
16560|NCT03468894|prolonged sitting|prolonged sitting
16561|NCT03468894|sedentary behaviour|sedentary behaviour
16562|NCT03468894|physical activity|physical activity
16563|NCT03468894|office workplace|office workplace
16564|NCT03468868|Multiple sclerosis|multiple sclerosis
16565|NCT03468868|Exercise|exercise
16566|NCT03468868|Physical activity|physical activity
16567|NCT03468868|Telerehabilitation|telerehabilitation
16568|NCT03468868|Comparative effectiveness study|comparative effectiveness study
16569|NCT03468868|Social cognitive theory|social cognitive theory
16570|NCT03468868|Health behavior change|health behavior change
16571|NCT03468842|Streptococcus dentisani|streptococcus dentisani
16572|NCT03468842|caries|caries
16573|NCT03468842|salivary pH|salivary ph
16574|NCT03468842|S. mutans|s. mutans
16575|NCT03468764|anesthesia|anesthesia
16576|NCT03468764|hemodynamic management|hemodynamic management
16577|NCT03468764|lung recruitment maneuver|lung recruitment maneuver
16578|NCT03468764|hypovolemia|hypovolemia
16579|NCT03468751|Metastatic; Refractory; Cancer; Solid; Tumor|metastatic; refractory; cancer; solid; tumor
16580|NCT03468725|Transcranial magnetic stimulation|transcranial magnetic stimulation
16581|NCT03468712|mortality|mortality
16582|NCT03468712|morbidity|morbidity
16583|NCT03468712|neoadjuvant chemotherapy|neoadjuvant chemotherapy
16584|NCT03468712|laparoscopic gastrectomy|laparoscopic gastrectomy
16585|NCT03468712|gastric cancer|gastric cancer
16586|NCT03468699|Autologous bone marrow Transplantation|autologous bone marrow transplantation
16587|NCT03468699|biliary atresia|biliary atresia
16588|NCT03468699|Kasai's operation|kasai's operation
16589|NCT03468699|liver cirrhosis|liver cirrhosis
16590|NCT03468673|AIDS|aids
16591|NCT03468673|HCV|hcv
16592|NCT03468673|Questionnaire|questionnaire
16593|NCT03468673|Qualitative analysis|qualitative analysis
16594|NCT03468673|Sexual Quality of Life|sexual quality of life
16595|NCT03468673|Psychometric validation|psychometric validation
16596|NCT03468660|Accented speech perception|accented speech perception
16597|NCT03468647|frailty|frailty
16598|NCT03468647|tele-monitoring|tele-monitoring
16599|NCT03468647|self-management|self-management
16600|NCT03468634|endoscopy|endoscopy
16601|NCT03468634|Raman spectroscopy|raman spectroscopy
16602|NCT03468621|woundclosure|woundclosure
16603|NCT03468621|technique|technique
16604|NCT03468621|surgical|surgical
16605|NCT03468621|site|site
16606|NCT03468621|infection|infection
16607|NCT03468621|intrademal|intrademal
16608|NCT03468621|transdermal|transdermal
16609|NCT03468621|suture|suture
16610|NCT03468608|procedural sedation|procedural sedation
16611|NCT03468608|paediatric|paediatric
16612|NCT03468608|parental satisfaction|parental satisfaction
16613|NCT03468595|Listerine, CHX|listerine, chx
16614|NCT03468569|Athletic Performance|athletic performance
16615|NCT03468569|Functional Movement Screen|functional movement screen
16616|NCT03468569|Handball Athletes|handball athletes
16617|NCT03468569|Injury Prevention|injury prevention
16618|NCT03468569|Injury History|injury history
16619|NCT03468517|General Anaesthesia|general anaesthesia
16620|NCT03468517|Preoperative Anxiety|preoperative anxiety
16621|NCT03468517|BATHE method|bathe method
16622|NCT03468465|Hyperactive Bladder Syndrome|hyperactive bladder syndrome
16623|NCT03468439|nerve block|nerve block
16624|NCT03468413|CP1050|cp1050
16625|NCT03468413|Phase 1|phase 1
16626|NCT03468413|Healthy subjects|healthy subjects
16627|NCT03468400|sleep disorders|sleep disorders
16628|NCT03468400|assessment|assessment
16629|NCT03468400|diagnosis|diagnosis
16630|NCT03468348|duloxetine|duloxetine
16631|NCT03468348|mastectomy|mastectomy
16632|NCT03468348|postoperative pain|postoperative pain
16633|NCT03468335|Second-line therapy|second-line therapy
16634|NCT03468335|Nal-IRI|nal-iri
16635|NCT03468335|failure gemcitabine/nab-paclitaxel|failure gemcitabine/nab-paclitaxel
16636|NCT03468335|predictive role of 1st-line therapy|predictive role of 1st-line therapy
16637|NCT03468309|polypharmacy|polypharmacy
16638|NCT03468309|drug interactions|drug interactions
16639|NCT03468309|DNA testing|dna testing
16640|NCT03468309|mental health diagnosis|mental health diagnosis
16641|NCT03468309|drug side effects|drug side effects
16642|NCT03468309|presciption treatment plans|presciption treatment plans
16643|NCT03468309|mental health medication treatment plans|mental health medication treatment plans
16644|NCT03468296|age-related macular degeneration|age-related macular degeneration
16645|NCT03468283|Mobile healthcare|mobile healthcare
16646|NCT03468283|Health Services Research|health services research
16647|NCT03468283|Community Health Services|community health services
16648|NCT03468283|Diabetes self-management education|diabetes self-management education
16649|NCT03468231|Hepatocellular Carcinoma|hepatocellular carcinoma
16650|NCT03468231|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
16651|NCT03468231|Sorafenib|sorafenib
16652|NCT03468231|Oxaliplatin plus Fluorouracil/Leucovorin|oxaliplatin plus fluorouracil/leucovorin
16653|NCT03468231|Oxaliplatin|oxaliplatin
16654|NCT03468205|breathlessness|breathlessness
16655|NCT03468205|dyspnea|dyspnea
16656|NCT03468205|measurement|measurement
16657|NCT03468179|Diet|diet
16658|NCT03468179|N-acyl-phosphatidylethanolamine|n-acyl-phosphatidylethanolamine
16659|NCT03468179|N-acyl-ethanolamine|n-acyl-ethanolamine
16660|NCT03468179|NAPE|nape
16661|NCT03468179|NAE|nae
16662|NCT03468179|Oatmeal|oatmeal
16663|NCT03468166|Motor function|motor function
16664|NCT03468166|Gait pattern|gait pattern
16665|NCT03468127|Soy protein|soy protein
16666|NCT03468127|LDL-Cholesterol|ldl-cholesterol
16667|NCT03468127|Total Cholesterol|total cholesterol
16668|NCT03468127|Cardiovascular disease|cardiovascular disease
16669|NCT03468101|COPD|copd
16670|NCT03468101|Dairy farmers|dairy farmers
16671|NCT03468101|Exposure Occupational|exposure occupational
16672|NCT03468101|FEV1|fev1
16673|NCT03468075|Sarcoma|sarcoma
16674|NCT03468075|Soft tissue|soft tissue
16676|NCT03468036|critical illness|critical illness
16677|NCT03468036|ICU|icu
16678|NCT03468036|extubation|extubation
16679|NCT03468036|respiratory failure|respiratory failure
16680|NCT03468023|Cast treatment|cast treatment
16681|NCT03468023|above-elbow cast|above-elbow cast
16682|NCT03468023|below-elbow cast|below-elbow cast
16683|NCT03468023|long arm cast|long arm cast
16684|NCT03468023|short arm cast|short arm cast
16685|NCT03467971|Metformin|metformin
16686|NCT03467971|Bioavailability|bioavailability
16687|NCT03467971|Food effect|food effect
16688|NCT03467971|Pharmacokinetics|pharmacokinetics
16689|NCT03467958|Crohn's Disease|crohn's disease
16690|NCT03467958|Crohn Disease|crohn disease
16691|NCT03467958|Oral|oral
16692|NCT03467958|Ozanimod|ozanimod
16693|NCT03467958|Moderately active|moderately active
16694|NCT03467958|Severely active|severely active
16695|NCT03467958|RPC01|rpc01
16696|NCT03467958|RPC01-3204|rpc01-3204
16697|NCT03467945|Metformin|metformin
16698|NCT03467945|Gliclazide|gliclazide
16699|NCT03467945|Bioequivalence|bioequivalence
16700|NCT03467945|Drug-drug Interaction|drug-drug interaction
16701|NCT03467945|Pharmacokinetics|pharmacokinetics
16702|NCT03467919|osteoarthritis|osteoarthritis
16703|NCT03467919|stem cell|stem cell
16704|NCT03467919|knee pain|knee pain
16705|NCT03467919|adipose derived stem cell|adipose derived stem cell
16706|NCT03467919|injection|injection
16707|NCT03467906|Diet|diet
16708|NCT03467906|Dietary Habits|dietary habits
16709|NCT03467906|Weight changes|weight changes
16710|NCT03467880|Impulse Oscillometry|impulse oscillometry
16711|NCT03467880|Chinese|chinese
16712|NCT03467880|Healthy Subjects|healthy subjects
16713|NCT03467880|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
16714|NCT03467880|Asthma|asthma
16715|NCT03467880|Interstitial Lung Disease|interstitial lung disease
16716|NCT03467880|Upper Airway Obstruction|upper airway obstruction
16717|NCT03467880|Reference Values|reference values
16718|NCT03467867|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
16719|NCT03467867|Leukemia|leukemia
16720|NCT03467867|Venetoclax|venetoclax
16721|NCT03467867|Rituximab|rituximab
16722|NCT03467867|Lymphoid|lymphoid
16723|NCT03467867|Lymphoproliferative Disorders|lymphoproliferative disorders
16724|NCT03467867|Antineoplastic Agents|antineoplastic agents
16725|NCT03467867|Neoplasm|neoplasm
16726|NCT03467854|ECMO|ecmo
16727|NCT03467854|Antimicrobials|antimicrobials
16728|NCT03467815|Wireless monitoring|wireless monitoring
16729|NCT03467815|Continuous monitoring|continuous monitoring
16730|NCT03467815|Vital parameters|vital parameters
16731|NCT03467815|Clinical deterioration|clinical deterioration
16732|NCT03467802|Gingival Recession|gingival recession
16733|NCT03467802|Enamel Matrix Derivative|enamel matrix derivative
16734|NCT03467802|Porcine Collagen Matrix|porcine collagen matrix
16735|NCT03467789|Vitamin D|vitamin d
16736|NCT03467789|Photodynamic Therapy|photodynamic therapy
16737|NCT03467776|infants|infants
16738|NCT03467776|asthma|asthma
16739|NCT03467776|bronchial dilation test|bronchial dilation test
16740|NCT03467776|plethysmography|plethysmography
16741|NCT03467750|Adenotonsillectomy|adenotonsillectomy
16742|NCT03467750|Opioids|opioids
16743|NCT03467750|Post-surgical pain|post-surgical pain
16744|NCT03467750|Anesthesiology|anesthesiology
16745|NCT03467750|Pediatrics|pediatrics
16746|NCT03467724|Fractional Radiofrequency|fractional radiofrequency
16747|NCT03467698|Aging|aging
16748|NCT03467698|Memory|memory
16749|NCT03467698|Associative learning|associative learning
16750|NCT03467698|transcranial direct current stimulation|transcranial direct current stimulation
16751|NCT03467581|gastric sleeve|gastric sleeve
16752|NCT03467568|Mood Salt|mood salt
16753|NCT03467542|Fistula|fistula
16754|NCT03467542|Intracranial|intracranial
16755|NCT03467542|Dural|dural
16756|NCT03467542|Arteriovenous|arteriovenous
16757|NCT03467542|Liquid Embolic|liquid embolic
16758|NCT03467529|Superficial esophageal cancer|superficial esophageal cancer
16759|NCT03467529|Squamous cell cancer|squamous cell cancer
16760|NCT03467529|Mini invasive imaging|mini invasive imaging
16761|NCT03467529|Pre therapeutic assessment|pre therapeutic assessment
16762|NCT03467529|Optical coherence tomography|optical coherence tomography
16763|NCT03467516|Metastatic Uveal Melanoma|metastatic uveal melanoma
16764|NCT03467516|Uveal Diseases|uveal diseases
16765|NCT03467516|Melanoma|melanoma
16766|NCT03467464|Autism, EMDR; Children|autism, emdr; children
16767|NCT03467438|heartburn|heartburn
16768|NCT03467438|pyrosis|pyrosis
16769|NCT03467438|regurgitation|regurgitation
16770|NCT03467425|FF/VI/UMEC|ff/vi/umec
16771|NCT03467425|TRELEGY ELLIPTA|trelegy ellipta
16772|NCT03467425|COPD|copd
16773|NCT03467425|Effectiveness|effectiveness
16774|NCT03467347|Healthy Women|healthy women
16775|NCT03467347|Contraception|contraception
16776|NCT03467347|Vaginal Ring|vaginal ring
16777|NCT03467347|dapivirine|dapivirine
16778|NCT03467347|Levonorgestrel|levonorgestrel
16779|NCT03467334|Infant colic|infant colic
16780|NCT03467334|Bifidobacterium breve|bifidobacterium breve
16781|NCT03467334|Lactobacillus fermentum|lactobacillus fermentum
16782|NCT03467308|colorectal cancer|colorectal cancer
16783|NCT03467308|TIGAR|tigar
16784|NCT03467308|TRIM59|trim59
16785|NCT03467295|Cavernous Malformations, treatment.|cavernous malformations, treatment.
16786|NCT03467243|schizophrenia|schizophrenia
16787|NCT03467243|Veterans|veterans
16788|NCT03467243|depression|depression
16789|NCT03467243|peer specialist|peer specialist
16790|NCT03467243|social skills training|social skills training
16791|NCT03467217|Losartan|losartan
16792|NCT03467217|Nonalcoholic Fatty Liver Disease|nonalcoholic fatty liver disease
16793|NCT03467165|MRgFUS|mrgfus
16794|NCT03467165|Pain|pain
16795|NCT03467165|Hip|hip
16796|NCT03467165|Trapeziometacarpal joint|trapeziometacarpal joint
16797|NCT03467165|Osteoarthritis|osteoarthritis
16798|NCT03467152|E2027|e2027
16799|NCT03467152|Montreal Cognitive Assessment|montreal cognitive assessment
16800|NCT03467152|Neuropsychiatric Inventory|neuropsychiatric inventory
16801|NCT03467152|Mini-Mental State Examination|mini-mental state examination
16802|NCT03467152|Cognitive Fluctuation Inventory|cognitive fluctuation inventory
16803|NCT03467139|Adhesive Capsulitis|adhesive capsulitis
16804|NCT03467139|Breathing exercises|breathing exercises
16805|NCT03467139|Pain|pain
16806|NCT03467139|Sleep quality|sleep quality
16807|NCT03467139|Quality of life|quality of life
16808|NCT03467126|Atrial Fibrillation|atrial fibrillation
16809|NCT03467113|Dravet Syndrome|dravet syndrome
16810|NCT03467113|LGS|lgs
16811|NCT03467087|Stem cell transplantation|stem cell transplantation
16812|NCT03467087|Chemotherapy|chemotherapy
16813|NCT03467087|Rehabilitation|rehabilitation
16814|NCT03467087|Electrical muscle stimulation|electrical muscle stimulation
16815|NCT03467022|alcohol withdrawal|alcohol withdrawal
16816|NCT03467022|scurvy|scurvy
16817|NCT03467022|vitamin C|vitamin c
16818|NCT03467022|tiredness|tiredness
16819|NCT03467009|cyber-victimization|cyber-victimization
16820|NCT03467009|text message|text message
16821|NCT03467009|mhealth|mhealth
16822|NCT03466996|Transition to adult care|transition to adult care
16823|NCT03466996|Telemedicine|telemedicine
16824|NCT03466996|Myelomeningocele|myelomeningocele
16825|NCT03466957|image guided brachytherapy|image guided brachytherapy
16826|NCT03466957|3D print|3d print
16827|NCT03466957|gynecological cancer|gynecological cancer
16828|NCT03466944|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
16829|NCT03466944|Leukaemia|leukaemia
16830|NCT03466944|Whole-Body DiffusionWeighted-Magnetic Resonance Imaging (WB DW-MRI)|whole-body diffusionweighted-magnetic resonance imaging (wb dw-mri)
16831|NCT03466944|Paediatrics|paediatrics
16832|NCT03466918|TAVI|tavi
16833|NCT03466918|TAVR|tavr
16834|NCT03466918|CHINA|china
16835|NCT03466918|SAPIEN 3|sapien 3
16836|NCT03466918|High Risk|high risk
16837|NCT03466918|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
16838|NCT03466918|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
16839|NCT03466892|Repetitive Negative Thinking|repetitive negative thinking
16840|NCT03466892|Rumination|rumination
16841|NCT03466892|Fibromyalgia|fibromyalgia
16842|NCT03466892|Chronic pain|chronic pain
16843|NCT03466892|Attentional Bias|attentional bias
16844|NCT03466840|Ridge Augmentation|ridge augmentation
16845|NCT03466840|Titanium mesh|titanium mesh
16846|NCT03466840|Flap advancement|flap advancement
16847|NCT03466801|prednisone alone|prednisone alone
16848|NCT03466801|methylprednisolone and cyclophosphamide|methylprednisolone and cyclophosphamide
16849|NCT03466801|membranous nephropathy in stage I|membranous nephropathy in stage i
16850|NCT03466775|Kidney transplantation|kidney transplantation
16851|NCT03466775|Allograft rejection|allograft rejection
16852|NCT03466775|Allograft survival|allograft survival
16853|NCT03466775|Anti-angiotensin II type 1 receptor antibody|anti-angiotensin ii type 1 receptor antibody
16854|NCT03466762|Quality of life|quality of life
16855|NCT03466762|Resilience|resilience
16856|NCT03466762|Cancer Survivors|cancer survivors
16857|NCT03466762|Life Satisfaction|life satisfaction
16858|NCT03466762|Post-Cancer Depression|post-cancer depression
16859|NCT03466762|Coping|coping
16860|NCT03466749|Coronary Disease|coronary disease
16861|NCT03466749|Drug eluting balloon|drug eluting balloon
16862|NCT03466749|De-novo lesions|de-novo lesions
16863|NCT03466736|practice effects|practice effects
16864|NCT03466736|amyloid imaging|amyloid imaging
16865|NCT03466710|Colposcopy|colposcopy
16866|NCT03466710|Uterine cervical neoplasm|uterine cervical neoplasm
16867|NCT03466710|HPV|hpv
16868|NCT03466710|Pap|pap
16869|NCT03466684|Trauma|trauma
16870|NCT03466684|Open abdomen|open abdomen
16871|NCT03466684|Fluid resuscitation|fluid resuscitation
16872|NCT03466684|Fascial closure|fascial closure
16873|NCT03466684|Bioelectrical impedance analysis|bioelectrical impedance analysis
16874|NCT03466645|SSI|ssi
16875|NCT03466645|elective Craniotomy|elective craniotomy
16876|NCT03466645|Vancomycin|vancomycin
16877|NCT03466645|Cefazolin|cefazolin
16878|NCT03466645|Antibiotic|antibiotic
16879|NCT03466593|Prehabilitation|prehabilitation
16880|NCT03466593|Recovery|recovery
16881|NCT03466593|Complications|complications
16882|NCT03466580|Caregivers|caregivers
16883|NCT03466580|Support needs|support needs
16884|NCT03466580|Intervention|intervention
16885|NCT03466580|Randomised controlled trial|randomised controlled trial
16886|NCT03466541|Alcohol consumption|alcohol consumption
16887|NCT03466541|Sick leave|sick leave
16888|NCT03466541|Workplace interventions|workplace interventions
16889|NCT03466541|Presenteeism|presenteeism
16890|NCT03466515|stem cells therapy|stem cells therapy
16891|NCT03466502|vancomycin|vancomycin
16892|NCT03466502|Clostridium difficile|clostridium difficile
16893|NCT03466502|Clostridium difficile infection|clostridium difficile infection
16894|NCT03466502|Recurrent Clostridium difficile infection|recurrent clostridium difficile infection
16895|NCT03466489|total joint arthroplasty|total joint arthroplasty
16896|NCT03466476|Wearable Technology|wearable technology
16897|NCT03466476|Total Knee Arthroplasty|total knee arthroplasty
16898|NCT03466463|Crigler-Najjar|crigler-najjar
16899|NCT03466463|Adeno Associated Virus|adeno associated virus
16900|NCT03466450|glioblastoma|glioblastoma
16901|NCT03466450|glasdegib|glasdegib
16902|NCT03466450|temozolomide|temozolomide
16903|NCT03466450|combined therapy|combined therapy
16904|NCT03466424|Short-course radiotherapy|short-course radiotherapy
16905|NCT03466424|dose escalation|dose escalation
16906|NCT03466424|neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
16907|NCT03466424|mFOLFOX6|mfolfox6
16908|NCT03466424|rectal cancer|rectal cancer
16909|NCT03466424|Phase I trial|phase i trial
16910|NCT03466398|Remote Patient Monitoring|remote patient monitoring
16911|NCT03466398|Adolescents|adolescents
16912|NCT03466385|Non-invasive ventilation|non-invasive ventilation
16913|NCT03466385|Nasal High Flow|nasal high flow
16914|NCT03466372|gait biofeedback|gait biofeedback
16915|NCT03466372|gait rehabilitation|gait rehabilitation
16916|NCT03466372|paretic propulsion|paretic propulsion
16917|NCT03466372|gait motor learning|gait motor learning
16918|NCT03466359|appetite control|appetite control
16919|NCT03466359|obesity|obesity
16920|NCT03466359|Adolescents|adolescents
16921|NCT03466359|Physical activity|physical activity
16922|NCT03466333|preterm pre-eclampsia|preterm pre-eclampsia
16923|NCT03466333|cardiovascular dysfunction|cardiovascular dysfunction
16924|NCT03466307|Nocturnal pain|nocturnal pain
16925|NCT03466307|shoulder pain|shoulder pain
16926|NCT03466307|ultrasonography|ultrasonography
16927|NCT03466307|resistive index|resistive index
16928|NCT03466307|quality of life|quality of life
16929|NCT03466307|anterior circumflex humeral artery|anterior circumflex humeral artery
16930|NCT03466294|Azacitidine|azacitidine
16931|NCT03466294|Venetoclax|venetoclax
16932|NCT03466294|AML|aml
16933|NCT03466268|Safety|safety
16934|NCT03466268|Tolerability|tolerability
16935|NCT03466268|Pharmacokinetics|pharmacokinetics
16936|NCT03466268|Anti-tumor activity|anti-tumor activity
16937|NCT03466242|intranasal dexmedetomidine|intranasal dexmedetomidine
16938|NCT03466229|sperm DNA strand breaks|sperm dna strand breaks
16939|NCT03466229|antioxidants|antioxidants
16940|NCT03466216|somatostatin receptor|somatostatin receptor
16941|NCT03466203|obesity|obesity
16942|NCT03466203|hypertriglyceridemia|hypertriglyceridemia
16943|NCT03466190|Mandibular body fractures, PEEK plates, titanium plates.|mandibular body fractures, peek plates, titanium plates.
16944|NCT03466177|Alzheimer's disease|alzheimer's disease
16945|NCT03466177|Dementia|dementia
16946|NCT03466177|Mild cognitive impairment|mild cognitive impairment
16947|NCT03466177|Optical coherence tomography|optical coherence tomography
16948|NCT03466177|Hyperspectral imaging|hyperspectral imaging
16949|NCT03466177|Multimodal retinal imaging|multimodal retinal imaging
16950|NCT03466151|Major Adverse Cardiac Events (MACE)|major adverse cardiac events (mace)
16951|NCT03466151|Myocardial Infarction (MI)|myocardial infarction (mi)
16952|NCT03466151|Late Lumen Loss (LLL)|late lumen loss (lll)
16953|NCT03466151|Target Lesion Revascularization (TLR)|target lesion revascularization (tlr)
16954|NCT03466151|Target Vessel Revascularization (TVR)|target vessel revascularization (tvr)
16955|NCT03466151|Target Vessel Failure (TVF)|target vessel failure (tvf)
16956|NCT03466151|Target Lesion Failure (TLF)|target lesion failure (tlf)
16957|NCT03466151|Stent Thrombosis (ST)|stent thrombosis (st)
17333|NCT03463980|African American|african american
16958|NCT03466151|The Randomized Controlled Trial|the randomized controlled trial
16959|NCT03466151|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
16960|NCT03466112|exercise|exercise
16961|NCT03466073|recombinant human plasma gelsolin (rhu-pGSN)|recombinant human plasma gelsolin (rhu-pgsn)
16962|NCT03466073|severe community-acquired pneumonia (sCAP)|severe community-acquired pneumonia (scap)
16963|NCT03466073|adjunctive therapy|adjunctive therapy
16964|NCT03466034|TP53|tp53
16965|NCT03466034|Hypoxia|hypoxia
16966|NCT03466034|Endometriod and Mucinous Carcinomas|endometriod and mucinous carcinomas
16967|NCT03466034|Serous and Clear Cell Carcinomas|serous and clear cell carcinomas
16968|NCT03466034|Magnetic Resonance Imaging, MRI|magnetic resonance imaging, mri
16969|NCT03466021|GLP-1 receptor agonist|glp-1 receptor agonist
16970|NCT03466021|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
16971|NCT03466021|FDG/PET-CT|fdg/pet-ct
16972|NCT03466021|inflammation|inflammation
16973|NCT03466021|weightloss|weightloss
16974|NCT03466021|quality of life|quality of life
16975|NCT03466008|whole body cryotherapy|whole body cryotherapy
16976|NCT03466008|fibromyalgia|fibromyalgia
16977|NCT03466008|chronic pain|chronic pain
16978|NCT03466008|quality of life|quality of life
16979|NCT03466008|perceived health|perceived health
16980|NCT03465982|rectal cancer|rectal cancer
16981|NCT03465982|robotic rectal cancer resection|robotic rectal cancer resection
16982|NCT03465982|minimally invasive surgery|minimally invasive surgery
16983|NCT03465982|Colorectal Cancer|colorectal cancer
16984|NCT03465982|chemoradiation treatment rectal cancer|chemoradiation treatment rectal cancer
16985|NCT03465969|Kidney transplantation|kidney transplantation
16986|NCT03465969|A Bioanalytical Method Cross-validation|a bioanalytical method cross-validation
16987|NCT03465969|Advagraf|advagraf
16988|NCT03465969|Liver transplantation|liver transplantation
16989|NCT03465930|Lymphedema|lymphedema
16990|NCT03465930|Lymphatic collecting vessels|lymphatic collecting vessels
16991|NCT03465930|Supermicrosurgery|supermicrosurgery
16992|NCT03465930|Lymphatic-venous anastomoses|lymphatic-venous anastomoses
16993|NCT03465930|Immunohistochemistry|immunohistochemistry
16994|NCT03465891|Advanced Stage Follicular Lymphoma|advanced stage follicular lymphoma
16995|NCT03465891|Relapsed|relapsed
16996|NCT03465891|Refractory|refractory
16997|NCT03465891|Atezolizumab|atezolizumab
16998|NCT03465891|Dose Local Radiotherapy (2 x 2Gy)|dose local radiotherapy (2 x 2gy)
16999|NCT03465891|17-360|17-360
17000|NCT03465800|overweight|overweight
17001|NCT03465800|obesity|obesity
17002|NCT03465800|physical activity|physical activity
17003|NCT03465800|exercise|exercise
17004|NCT03465787|Schizophrenia|schizophrenia
17005|NCT03465787|Acutely Psychotic Patients with Schizophrenia|acutely psychotic patients with schizophrenia
17006|NCT03465787|Latuda|latuda
17007|NCT03465787|Lurasidone|lurasidone
17008|NCT03465774|Malignant neoplasms of respiratory and intrathoracic organs|malignant neoplasms of respiratory and intrathoracic organs
17009|NCT03465774|Pleural effusions|pleural effusions
17010|NCT03465774|Indwelling Pleural Catheter|indwelling pleural catheter
17011|NCT03465774|IPC|ipc
17012|NCT03465774|Fentanyl|fentanyl
17013|NCT03465774|Sublimaze|sublimaze
17014|NCT03465774|Doxycycline|doxycycline
17015|NCT03465774|Vibramycin|vibramycin
17016|NCT03465774|Periostat|periostat
17017|NCT03465774|Doryx|doryx
17018|NCT03465774|Questionnaires|questionnaires
17019|NCT03465774|Surveys|surveys
17020|NCT03465761|MRgFUS|mrgfus
17021|NCT03465761|ExAblate|exablate
17022|NCT03465761|Bilateral Essential Tremor|bilateral essential tremor
17023|NCT03465735|Deep|deep
17024|NCT03465735|Pulmonary|pulmonary
17025|NCT03465735|Venous|venous
17026|NCT03465735|Vascular|vascular
17027|NCT03465735|Post|post
17028|NCT03465735|Vein|vein
17029|NCT03465735|Thrombosis|thrombosis
17030|NCT03465735|Embolism|embolism
17031|NCT03465735|Thromboembolism|thromboembolism
17032|NCT03465735|Thrombotic|thrombotic
17033|NCT03465735|Syndrome|syndrome
17034|NCT03465722|Other Relapsed or Refractory Solid Tumors|other relapsed or refractory solid tumors
17035|NCT03465722|BLU-285|blu-285
17036|NCT03465722|BLU 285|blu 285
17037|NCT03465722|BLUE-285|blue-285
17038|NCT03465722|BLUE 285|blue 285
17039|NCT03465722|Avapritinib|avapritinib
17040|NCT03465722|GIST imatinib relapse|gist imatinib relapse
17041|NCT03465722|GIST gleevec relapse|gist gleevec relapse
17042|NCT03465722|GIST KIT|gist kit
17043|NCT03465722|GIST relapse|gist relapse
17044|NCT03465722|GIST refractory|gist refractory
17045|NCT03465722|GIST imatinib intolerance|gist imatinib intolerance
17046|NCT03465722|GIST TKI treatment|gist tki treatment
17047|NCT03465722|GIST tyrosine kinase inhibitor treatment|gist tyrosine kinase inhibitor treatment
17048|NCT03465722|GIST TKI|gist tki
17049|NCT03465722|GIST tyrosine kinase inhibitor|gist tyrosine kinase inhibitor
17050|NCT03465722|Advanced GIST|advanced gist
17051|NCT03465722|GIST mutations|gist mutations
17052|NCT03465722|GIST treatments|gist treatments
17053|NCT03465722|Blueprint GIST|blueprint gist
17054|NCT03465722|Relapsed GIST clinical trial|relapsed gist clinical trial
17055|NCT03465722|Refractory GIST clinical trial|refractory gist clinical trial
17056|NCT03465722|KIT-mutant GIST|kit-mutant gist
17057|NCT03465722|cancer gist|cancer gist
17058|NCT03465722|gastrointestinal stromal tumor|gastrointestinal stromal tumor
17059|NCT03465722|gist cancer|gist cancer
17060|NCT03465722|PDGFRA|pdgfra
17061|NCT03465696|psoriasis|psoriasis
17062|NCT03465696|biologics|biologics
17063|NCT03465696|treatment decision-making|treatment decision-making
17064|NCT03465670|chlorhexidine|chlorhexidine
17065|NCT03465670|hyaluronic acid|hyaluronic acid
17066|NCT03465670|tooth discoloration|tooth discoloration
17067|NCT03465657|Child Health|child health
17068|NCT03465657|Sodium intake|sodium intake
17069|NCT03465657|Food Sources|food sources
17070|NCT03465657|Blood Pressure|blood pressure
17071|NCT03465657|BMI|bmi
17072|NCT03465657|Urinary sodium excretion|urinary sodium excretion
17073|NCT03465644|antithrombotic strategy|antithrombotic strategy
17074|NCT03465644|dual antiplatelet therapy|dual antiplatelet therapy
17075|NCT03465631|stroke rehabilitation|stroke rehabilitation
17076|NCT03465618|89Zr-cRGDY Ultrasmall Silica Particle Tracers|89zr-crgdy ultrasmall silica particle tracers
17077|NCT03465618|Pet Scan|pet scan
17078|NCT03465618|17-599|17-599
17079|NCT03465579|Diagnosis Prostate Cancer|diagnosis prostate cancer
17080|NCT03465579|TNM staging|tnm staging
17081|NCT03465579|68Ga-PSMA PET/CT guided prostate biopsy|68ga-psma pet/ct guided prostate biopsy
17082|NCT03465579|mp-3TMRI guided prostate biopsy|mp-3tmri guided prostate biopsy
17083|NCT03465579|pre-surgical staging|pre-surgical staging
17084|NCT03465579|clinically-suspected prostate cancer|clinically-suspected prostate cancer
17085|NCT03465566|Emotion|emotion
17086|NCT03465566|Social cognition|social cognition
17087|NCT03465566|Childhood epilepsy|childhood epilepsy
17088|NCT03465553|palliative care|palliative care
17089|NCT03465553|thoracic cancer|thoracic cancer
17090|NCT03465553|radiotherapy|radiotherapy
17091|NCT03465553|pain|pain
17092|NCT03465553|quality of life|quality of life
17093|NCT03465540|Multiple Myeloma|multiple myeloma
17094|NCT03465540|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
17095|NCT03465540|Acute Myeloid Leukemia|acute myeloid leukemia
17096|NCT03465501|Anal Canal Cancer|anal canal cancer
17097|NCT03465501|brachytherapy|brachytherapy
17098|NCT03465488|parasitology|parasitology
17099|NCT03465488|helminth infections|helminth infections
17100|NCT03465488|diagnosis|diagnosis
17101|NCT03465488|drug resistance|drug resistance
17102|NCT03465488|albendazole|albendazole
17103|NCT03465488|benzimidazole drugs|benzimidazole drugs
17104|NCT03465488|Ascaris|ascaris
17105|NCT03465488|Trichuris|trichuris
17106|NCT03465488|hookworm|hookworm
17107|NCT03465488|qPCR|qpcr
17108|NCT03465488|microscopy|microscopy
17109|NCT03465475|Low flow anesthesia|low flow anesthesia
17110|NCT03465475|Desflurane|desflurane
17111|NCT03465475|Cost analysis|cost analysis
17112|NCT03465462|hypertension,|hypertension,
17113|NCT03465462|zinc|zinc
17114|NCT03465462|zinc supplementation|zinc supplementation
17115|NCT03465462|antihypertensive monotherapy|antihypertensive monotherapy
17116|NCT03465462|mineral status|mineral status
17117|NCT03465384|Parent-Child relations|parent-child relations
17118|NCT03465384|Parenting|parenting
17119|NCT03465384|Non-inferiority trial|non-inferiority trial
17120|NCT03465384|Externalizing behaviors|externalizing behaviors
17121|NCT03465384|Randomized controlled trial|randomized controlled trial
17122|NCT03465384|Cost-effectiveness|cost-effectiveness
17123|NCT03465332|blood eosinophil count|blood eosinophil count
17124|NCT03465332|COPD|copd
17125|NCT03465332|diagnostic test|diagnostic test
17126|NCT03465332|doctor's questionnaire|doctor's questionnaire
17127|NCT03465332|Lung specialist|lung specialist
17128|NCT03465319|oxygen concentration|oxygen concentration
17129|NCT03465319|volatile anesthetics concentration|volatile anesthetics concentration
17130|NCT03465319|prediction model|prediction model
17131|NCT03465306|Obesity|obesity
17132|NCT03465306|Cognitive Behavioral Therapy|cognitive behavioral therapy
17133|NCT03465293|Symptomatic diverticulosis|symptomatic diverticulosis
17134|NCT03465293|Microbiota|microbiota
17135|NCT03465293|Bowel preparation|bowel preparation
17136|NCT03465280|Recurrent respiratory papillomatosis|recurrent respiratory papillomatosis
17137|NCT03465267|stroke|stroke
17138|NCT03465267|upper extremity rehabilitation robot|upper extremity rehabilitation robot
17139|NCT03465267|stroke rehabilitation|stroke rehabilitation
17140|NCT03465241|Non-Small Cell Lung Cancer|non-small cell lung cancer
17141|NCT03465241|stage II to IIIA|stage ii to iiia
17142|NCT03465241|circulating tumor DNA|circulating tumor dna
17143|NCT03465241|The next generation of high-throughput gene sequencing|the next generation of high-throughput gene sequencing
17144|NCT03465228|Low Back Pain|low back pain
17145|NCT03465228|Photobiomodulation|photobiomodulation
17146|NCT03465228|Deep Water Running|deep water running
17147|NCT03465228|Training|training
17148|NCT03465228|Running|running
17149|NCT03465202|Capecitabine|capecitabine
17150|NCT03465202|Pharmacokinetics|pharmacokinetics
17151|NCT03465202|Ageing|ageing
17152|NCT03465202|Frailty|frailty
17153|NCT03465202|Breast cancer|breast cancer
17154|NCT03465202|Colorectal cancer|colorectal cancer
17155|NCT03465176|aromatherapy|aromatherapy
17156|NCT03465176|fatigue|fatigue
17157|NCT03465176|hypothyroidism|hypothyroidism
17158|NCT03465176|essential oils|essential oils
17159|NCT03465150|Acne|acne
17160|NCT03465150|Cohort|cohort
17161|NCT03465150|prospective|prospective
17162|NCT03465150|risk factors|risk factors
17163|NCT03465137|Exposure therapy|exposure therapy
17164|NCT03465137|Behavioral therapy|behavioral therapy
17165|NCT03465137|fMRI|fmri
17166|NCT03465137|Extinction learning|extinction learning
17167|NCT03465137|Social anxiety|social anxiety
17168|NCT03465111|Scleritis|scleritis
17169|NCT03465111|anterior|anterior
17170|NCT03465111|adrenocorticotropic hormone|adrenocorticotropic hormone
17171|NCT03465111|ACTH|acth
17172|NCT03465111|Non-infectious|non-infectious
17173|NCT03465098|Infective endocarditis|infective endocarditis
17174|NCT03465098|PET/CT 18F-FDG|pet/ct 18f-fdg
17175|NCT03465098|Low carbohydrate diet as Atkins diet|low carbohydrate diet as atkins diet
17176|NCT03465085|ARDS|ards
17177|NCT03465085|Streptokinase|streptokinase
17178|NCT03465085|Heparin|heparin
17179|NCT03465085|Nebulization|nebulization
17180|NCT03465085|Inhaled Thrombolytics|inhaled thrombolytics
17181|NCT03465085|Inhaled Anticoagulation|inhaled anticoagulation
17182|NCT03465059|BGB-3111|bgb-3111
17183|NCT03465059|Zanubrutinib|zanubrutinib
17184|NCT03465059|pharmacokinetics|pharmacokinetics
17185|NCT03465059|healthy subjects|healthy subjects
17186|NCT03465059|hepatic impairment|hepatic impairment
17187|NCT03465046|infantile hemiplegia|infantile hemiplegia
17188|NCT03465046|upper extremity|upper extremity
17189|NCT03465046|physical therapy|physical therapy
17190|NCT03465033|Orthognathic surgery|orthognathic surgery
17191|NCT03465033|Jaw rehabilitation|jaw rehabilitation
17192|NCT03465033|Jaw Physiotherapy|jaw physiotherapy
17193|NCT03465033|Pain|pain
17194|NCT03465033|Mandibular range of motion|mandibular range of motion
17195|NCT03465033|Sensorial disturbance|sensorial disturbance
17196|NCT03465020|Idiopathic|idiopathic
17197|NCT03465020|Thrombocytopenic|thrombocytopenic
17198|NCT03465020|Purpura|purpura
17199|NCT03465007|hemodialysis|hemodialysis
17200|NCT03465007|cortisol|cortisol
17201|NCT03465007|Hydrocortisone|hydrocortisone
17202|NCT03464994|Hereditary ichthyosis|hereditary ichthyosis
17203|NCT03464994|keratoconus|keratoconus
17204|NCT03464968|second line|second line
17205|NCT03464968|FOLFOX|folfox
17206|NCT03464968|FOLFIRI|folfiri
17207|NCT03464916|CAR2 Anti-CD38 A2 CAR-T Cells|car2 anti-cd38 a2 car-t cells
17208|NCT03464903|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
17209|NCT03464903|progressive muscular atrophy|progressive muscular atrophy
17210|NCT03464903|motor neuron disease|motor neuron disease
17211|NCT03464903|ALS reversals|als reversals
17212|NCT03464903|whole genome sequencing|whole genome sequencing
17213|NCT03464851|carotid artery stenosis|carotid artery stenosis
17214|NCT03464851|plaque|plaque
17215|NCT03464851|carotid duplex|carotid duplex
17216|NCT03464851|ultrasound|ultrasound
17217|NCT03464851|fibromsucular dysplasia|fibromsucular dysplasia
17218|NCT03464851|carotid atherosclerosis|carotid atherosclerosis
17219|NCT03464812|Diabetes education|diabetes education
17220|NCT03464812|Psychosocial management of diabetes|psychosocial management of diabetes
17221|NCT03464747|Lactic Acid|lactic acid
17222|NCT03464708|Critical illness|critical illness
17224|NCT03464708|Nutrition|nutrition
17225|NCT03464708|Muscle wasting|muscle wasting
17226|NCT03464708|Recovery|recovery
17227|NCT03464695|closed-loop|closed-loop
17228|NCT03464695|oxygen treatment|oxygen treatment
17229|NCT03464656|semen|semen
17230|NCT03464656|male infertility|male infertility
17231|NCT03464656|semen quality|semen quality
17232|NCT03464656|sperm DNA fragmentation|sperm dna fragmentation
17233|NCT03464656|oxidation reduction potential|oxidation reduction potential
17234|NCT03464565|Large Vessel Occlusion|large vessel occlusion
17235|NCT03464565|Acute Ischemic Stroke|acute ischemic stroke
17236|NCT03464565|Mechanical Thrombectomy|mechanical thrombectomy
17237|NCT03464565|Penumbra System|penumbra system
17238|NCT03464565|3D Revascularization|3d revascularization
17239|NCT03464552|colposcopy - colposcopic directed biopsy - celecoxib|colposcopy - colposcopic directed biopsy - celecoxib
17240|NCT03464448|Teriflunomide|teriflunomide
17241|NCT03464448|B cell|b cell
17242|NCT03464448|T cell|t cell
17243|NCT03464448|cytokines|cytokines
17244|NCT03464435|Refractory Vernal Keratoconjunctivitis|refractory vernal keratoconjunctivitis
17245|NCT03464435|0.1% tacrolimus|0.1% tacrolimus
17246|NCT03464435|loteprednol etabonate 0.5%/tobramycin 0.3%|loteprednol etabonate 0.5%/tobramycin 0.3%
17247|NCT03464422|HIV|hiv
17248|NCT03464422|MSM|msm
17249|NCT03464409|Nerve Transfer Surgery|nerve transfer surgery
17250|NCT03464409|Tendon Transfer Surgery|tendon transfer surgery
17251|NCT03464409|Decision Support Intervention|decision support intervention
17252|NCT03464396|Periodic breathing|periodic breathing
17253|NCT03464396|Apnea of prematurity|apnea of prematurity
17254|NCT03464396|Chronic Lung disease|chronic lung disease
17255|NCT03464396|Prematurity|prematurity
17256|NCT03464396|Respiratory disease|respiratory disease
17257|NCT03464396|Hypoxia|hypoxia
17258|NCT03464396|Pulmonary Hypertension|pulmonary hypertension
17259|NCT03464383|Neurologic Disorders|neurologic disorders
17260|NCT03464383|Chronic Care|chronic care
17261|NCT03464383|Management|management
17262|NCT03464383|Treatment|treatment
17263|NCT03464383|SSRI Medication|ssri medication
17264|NCT03464383|SNRI Medication|snri medication
17265|NCT03464383|Learning Healthcare System|learning healthcare system
17266|NCT03464370|amygdala enlargement|amygdala enlargement
17267|NCT03464370|temporal lobe epilepsy|temporal lobe epilepsy
17268|NCT03464370|stress|stress
17269|NCT03464370|attentional bias|attentional bias
17270|NCT03464370|anxiety|anxiety
17271|NCT03464370|depression|depression
17272|NCT03464370|PTSD|ptsd
17273|NCT03464357|functional MRI|functional mri
17274|NCT03464344|intracerebral hemorrhage|intracerebral hemorrhage
17275|NCT03464344|cerebral amyloid angiopathy|cerebral amyloid angiopathy
17276|NCT03464344|cortical superficial siderosis|cortical superficial siderosis
17277|NCT03464344|Magnetic Resonance Imaging|magnetic resonance imaging
17278|NCT03464318|idiopathic scoliosis|idiopathic scoliosis
17279|NCT03464318|radiographs|radiographs
17280|NCT03464318|low dose|low dose
17281|NCT03464305|Colonic Neoplasms|colonic neoplasms
17282|NCT03464305|Colorectal Neoplasms|colorectal neoplasms
17283|NCT03464305|Intestinal Neoplasms|intestinal neoplasms
17284|NCT03464305|Gastrointestinal Neoplasms|gastrointestinal neoplasms
17285|NCT03464305|Digestive System Neoplasms|digestive system neoplasms
17286|NCT03464305|Neoplasms by Site|neoplasms by site
17287|NCT03464305|Neoplasms|neoplasms
17288|NCT03464305|Colonic Diseases|colonic diseases
17289|NCT03464305|Aspirin|aspirin
17290|NCT03464305|Recurrence|recurrence
17291|NCT03464305|Digestive System Diseases|digestive system diseases
17292|NCT03464305|Intestinal Diseases|intestinal diseases
17293|NCT03464305|Disease Attributes|disease attributes
17294|NCT03464305|Pathologic Processes|pathologic processes
17295|NCT03464227|Phase 1|phase 1
17296|NCT03464227|UCB0107|ucb0107
17297|NCT03464214|Vibration|vibration
17298|NCT03464214|Cervical stabilization exercises|cervical stabilization exercises
17299|NCT03464214|Physiotherapy and rehabilitation|physiotherapy and rehabilitation
17300|NCT03464214|Sensory organization test|sensory organization test
17301|NCT03464214|Balance|balance
17302|NCT03464188|early palliative care|early palliative care
17303|NCT03464188|family caregiver|family caregiver
17304|NCT03464188|rural|rural
17305|NCT03464188|African-American|african-american
17306|NCT03464188|telehealth|telehealth
17307|NCT03464162|Social Network Meetings|social network meetings
17308|NCT03464162|First Episode Psychosis|first episode psychosis
17309|NCT03464162|OnTrackNY|ontrackny
17310|NCT03464097|Crohn's Disease|crohn's disease
17311|NCT03464097|Crohn Disease|crohn disease
17312|NCT03464097|Oral|oral
17313|NCT03464097|Ozanimod|ozanimod
17314|NCT03464097|Moderately active|moderately active
17315|NCT03464097|Severely active|severely active
17316|NCT03464097|RPC01|rpc01
17317|NCT03464097|RPC01-3203|rpc01-3203
17318|NCT03464071|sepsis|sepsis
17319|NCT03464071|biomarkers|biomarkers
17320|NCT03464071|lung injury|lung injury
17321|NCT03464058|Pharmacokinetics|pharmacokinetics
17322|NCT03464058|Food Effect|food effect
17323|NCT03464058|Proton Pump Inhibitors|proton pump inhibitors
17324|NCT03464058|Drug Interaction|drug interaction
17325|NCT03464058|Oral Prototype Formulations|oral prototype formulations
17326|NCT03464019|Paroxysmal supraventricular tachycardia|paroxysmal supraventricular tachycardia
17327|NCT03464019|cardiac monitoring|cardiac monitoring
17328|NCT03464019|atrioventricular nodal reentrant tachycardia|atrioventricular nodal reentrant tachycardia
17329|NCT03464019|atrioventricular reciprocating tachycardia|atrioventricular reciprocating tachycardia
17330|NCT03464019|calcium channel blocker|calcium channel blocker
17331|NCT03464019|conversion rate|conversion rate
17332|NCT03463980|Meditation|meditation
17334|NCT03463980|Randomized controlled trial|randomized controlled trial
17335|NCT03463967|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
17336|NCT03463967|obesity|obesity
17337|NCT03463967|dyslipidemia|dyslipidemia
17338|NCT03463967|diet|diet
17339|NCT03463967|children|children
17340|NCT03463967|adolescents|adolescents
17341|NCT03463954|less than or equal to 15 mm|less than or equal to 15 mm
17342|NCT03463941|African American|african american
17343|NCT03463941|Faith institutions|faith institutions
17344|NCT03463941|Dyads|dyads
17345|NCT03463941|Health disparities|health disparities
17346|NCT03463915|Interstitial cystitis|interstitial cystitis
17347|NCT03463915|Bladder pain syndrome|bladder pain syndrome
17348|NCT03463915|IC/BPS|ic/bps
17349|NCT03463915|Women|women
17350|NCT03463915|Pelvic pain|pelvic pain
17351|NCT03463915|Urologic pain|urologic pain
17352|NCT03463915|gabapentin|gabapentin
17353|NCT03463915|Antiepileptic|antiepileptic
17354|NCT03463902|Gesture|gesture
17355|NCT03463902|tDCS|tdcs
17356|NCT03463902|schizophrenia|schizophrenia
17357|NCT03463902|nonverbal communication|nonverbal communication
17358|NCT03463798|structured light plethysmography|structured light plethysmography
17359|NCT03463798|sonar|sonar
17360|NCT03463798|transdiaphragmatic pressure|transdiaphragmatic pressure
17361|NCT03463785|obstructive sleep apnea|obstructive sleep apnea
17362|NCT03463785|race|race
17363|NCT03463785|upper airway|upper airway
17364|NCT03463785|cone beam computed tomography|cone beam computed tomography
17365|NCT03463772|in vitro maturation|in vitro maturation
17366|NCT03463772|polycystic ovarian syndrome|polycystic ovarian syndrome
17367|NCT03463772|oocyte|oocyte
17368|NCT03463733|Glioma|glioma
17369|NCT03463733|Recurrent glioma|recurrent glioma
17370|NCT03463733|Glioblastoma multiforme|glioblastoma multiforme
17371|NCT03463733|Recurrent Glioblastoma multiforme|recurrent glioblastoma multiforme
17372|NCT03463733|Hydroxyurea|hydroxyurea
17373|NCT03463733|Temozolomide|temozolomide
17374|NCT03463668|duodenal stenosis|duodenal stenosis
17375|NCT03463668|pyloric stenosis|pyloric stenosis
17376|NCT03463668|digestive neoplasias|digestive neoplasias
17377|NCT03463668|non-digestive neoplasias|non-digestive neoplasias
17378|NCT03463668|duodenal prosthesis|duodenal prosthesis
17379|NCT03463655|palliative|palliative
17380|NCT03463655|solid tumor|solid tumor
17381|NCT03463655|ascites|ascites
17382|NCT03463629|Multidisciplinary Team|multidisciplinary team
17383|NCT03463629|Hispanic adults|hispanic adults
17384|NCT03463616|Rectal Cancer|rectal cancer
17385|NCT03463616|Liver Metastases|liver metastases
17386|NCT03463616|CT abdomen|ct abdomen
17387|NCT03463616|MRI Liver|mri liver
17388|NCT03463603|ischemic heart disease|ischemic heart disease
17389|NCT03463603|acute coronary syndrome|acute coronary syndrome
17390|NCT03463603|racial bias|racial bias
17391|NCT03463590|Habenula|habenula
17392|NCT03463590|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
17393|NCT03463590|Deep brain stimulation|deep brain stimulation
17394|NCT03463564|type 1 diabetes|type 1 diabetes
17395|NCT03463564|transition|transition
17396|NCT03463564|CSII|csii
17398|NCT03463564|glycemic control|glycemic control
17399|NCT03463564|glucose variability|glucose variability
17400|NCT03463525|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
17401|NCT03463486|outpatient cardiac rehabilitation, exercise training,|outpatient cardiac rehabilitation, exercise training,
17402|NCT03463447|Dynamometer|dynamometer
17403|NCT03463447|Handgrip|handgrip
17404|NCT03463447|children|children
17405|NCT03463434|pressure ulcer treatment|pressure ulcer treatment
17406|NCT03463434|wound healing|wound healing
17407|NCT03463421|Adherence to oral anticoagulation|adherence to oral anticoagulation
17408|NCT03463421|Persistence to oral anticoagulation|persistence to oral anticoagulation
17409|NCT03463421|AF patients|af patients
17410|NCT03463421|Previous ischemic stroke|previous ischemic stroke
17411|NCT03463408|Sarcoma|sarcoma
17412|NCT03463382|Pediatric Surgery|pediatric surgery
17413|NCT03463382|Postoperative Pain|postoperative pain
17414|NCT03463382|Erector spinae plane block|erector spinae plane block
17415|NCT03463382|quadratus lumborum block|quadratus lumborum block
17416|NCT03463317|Atrial Fibrillation|atrial fibrillation
17417|NCT03463317|Anticoagulation|anticoagulation
17418|NCT03463317|Left atrial appendage closure|left atrial appendage closure
17419|NCT03463317|Stroke|stroke
17420|NCT03463304|Gut Microbiota|gut microbiota
17421|NCT03463304|endocannabinoide|endocannabinoide
17422|NCT03463304|Metabolic health|metabolic health
17423|NCT03463304|Gastrointestinal health|gastrointestinal health
17424|NCT03463304|Mental wellbeing|mental wellbeing
17425|NCT03463239|Autologous tissue engineered corpora|autologous tissue engineered corpora
17426|NCT03463226|Testosterone Deficiency|testosterone deficiency
17427|NCT03463226|Sympathetic overactivity|sympathetic overactivity
17428|NCT03463226|Exercise Intolerance|exercise intolerance
17429|NCT03463213|health behavior|health behavior
17430|NCT03463213|chronic disease prevention|chronic disease prevention
17431|NCT03463213|healthy lifestyle|healthy lifestyle
17432|NCT03463200|bandage|bandage
17433|NCT03463200|low back pain|low back pain
17434|NCT03463200|muscle fatigue|muscle fatigue
17435|NCT03463200|electromyography|electromyography
17436|NCT03463174|overdenture|overdenture
17437|NCT03463174|edentulism|edentulism
17438|NCT03463174|dental implant|dental implant
17439|NCT03463174|cost-effectiveness|cost-effectiveness
17440|NCT03463174|economic analysis|economic analysis
17441|NCT03463174|effectiveness|effectiveness
17442|NCT03463122|stroke|stroke
17443|NCT03463122|neglect|neglect
17444|NCT03463122|virtual reality|virtual reality
17445|NCT03463122|head mount display|head mount display
17446|NCT03463122|rehabilitation|rehabilitation
17447|NCT03463109|Chronic low back pain|chronic low back pain
17448|NCT03463096|respiratory|respiratory
17449|NCT03463096|physiology|physiology
17450|NCT03463096|gravity|gravity
17451|NCT03463070|misoprostol|misoprostol
17452|NCT03463070|postpartum haemorrhage|postpartum haemorrhage
17453|NCT03463031|GSP 301 nasal spray for the treatment of Seasonal Allergic Rhinitis|gsp 301 nasal spray for the treatment of seasonal allergic rhinitis
17454|NCT03463018|Echinacea, Subthreshold Anxiety|echinacea, subthreshold anxiety
17455|NCT03462979|Gluten-free diet|gluten-free diet
17456|NCT03462979|Urine|urine
17457|NCT03462979|Stool|stool
17458|NCT03462979|home testing|home testing
17459|NCT03462966|Rifaximin|rifaximin
17460|NCT03462966|Xifaxan|xifaxan
17461|NCT03462940|Tauroursodeoxycholic acid (TUDCA)|tauroursodeoxycholic acid (tudca)
17462|NCT03462940|Endothelial function in humans|endothelial function in humans
17463|NCT03462940|Endoplasmic Reticulum Stress|endoplasmic reticulum stress
17464|NCT03462901|Fixation of midshaft clavicular fracture by intramedullary|fixation of midshaft clavicular fracture by intramedullary
17465|NCT03462888|Rhabdomyosarcoma|rhabdomyosarcoma
17568|NCT03462082|Parkinson's disease|parkinson's disease
17466|NCT03462888|Adolescents and young adults|adolescents and young adults
17467|NCT03462888|prognostic factors|prognostic factors
17468|NCT03462888|molecular profiling|molecular profiling
17469|NCT03462875|Crohn's Disease|crohn's disease
17470|NCT03462875|Microbiota|microbiota
17471|NCT03462875|Dietary Pattern|dietary pattern
17472|NCT03462875|Environmental factors|environmental factors
17473|NCT03462862|PEEK|peek
17474|NCT03462862|Breflex|breflex
17475|NCT03462849|ARDS|ards
17476|NCT03462849|expiratory flow limitation|expiratory flow limitation
17477|NCT03462849|trans-pulmonary pressure|trans-pulmonary pressure
17478|NCT03462849|airway closure|airway closure
17479|NCT03462823|ACL Reconstruction|acl reconstruction
17480|NCT03462823|Osteoconductive Scaffold|osteoconductive scaffold
17481|NCT03462823|Bone Tunnel Widening|bone tunnel widening
17482|NCT03462810|cabotegravir, CAB|cabotegravir, cab
17483|NCT03462810|GSK1265744|gsk1265744
17484|NCT03462810|Individual Patient Compassionate Use|individual patient compassionate use
17485|NCT03462810|HIV|hiv
17486|NCT03462771|elderly|elderly
17487|NCT03462771|sarcopenia|sarcopenia
17488|NCT03462771|dietary supplementation|dietary supplementation
17489|NCT03462771|omega-3 fatty acid|omega-3 fatty acid
17490|NCT03462758|Mirena|mirena
17491|NCT03462758|ParaGard|paragard
17492|NCT03462758|Skyla|skyla
17493|NCT03462758|Liletta|liletta
17494|NCT03462758|Kyleena|kyleena
17495|NCT03462758|Intrauterine Device|intrauterine device
17496|NCT03462758|Intrauterine System|intrauterine system
17497|NCT03462758|Postpartum|postpartum
17498|NCT03462758|Expulsion|expulsion
17499|NCT03462706|Polyp Resection|polyp resection
17500|NCT03462706|Cold Snare|cold snare
17501|NCT03462706|Hot Snare|hot snare
17502|NCT03462706|Cold Endoscopic Mucosal Resection (EMR)|cold endoscopic mucosal resection (emr)
17503|NCT03462706|Hot Endoscopic Mucosal Resection (EMR)|hot endoscopic mucosal resection (emr)
17504|NCT03462706|Colonoscopy|colonoscopy
17505|NCT03462654|Health promotion|health promotion
17506|NCT03462654|Behaviour change|behaviour change
17507|NCT03462654|Physical activity|physical activity
17508|NCT03462654|Fall prevention|fall prevention
17509|NCT03462641|Gait|gait
17510|NCT03462641|Balance|balance
17511|NCT03462641|Flumazenil|flumazenil
17512|NCT03462641|PET Imaging|pet imaging
17513|NCT03462641|MRI|mri
17514|NCT03462641|Mobility|mobility
17515|NCT03462641|Intravenous|intravenous
17516|NCT03462628|substrate modification|substrate modification
17517|NCT03462628|pulmonary vein isolation|pulmonary vein isolation
17518|NCT03462628|ablation|ablation
17519|NCT03462628|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
17520|NCT03462615|malaria|malaria
17521|NCT03462615|pregnancy|pregnancy
17522|NCT03462615|diagnosis|diagnosis
17523|NCT03462615|rapid diagnostic test|rapid diagnostic test
17524|NCT03462537|Aerobic Exercise|aerobic exercise
17525|NCT03462537|Lipolytic Laser|lipolytic laser
17526|NCT03462537|Lipid Profile|lipid profile
17527|NCT03462537|C-reactive protein|c-reactive protein
17528|NCT03462537|Lipolysis|lipolysis
17529|NCT03462511|Hydroxyurea|hydroxyurea
17530|NCT03462511|Community health worker (CHW)|community health worker (chw)
17531|NCT03462511|Text messages|text messages
17532|NCT03462511|Medication adherence|medication adherence
17533|NCT03462498|Acute Coronary Syndrome|acute coronary syndrome
17534|NCT03462498|Acute Myocardial Infarction|acute myocardial infarction
17535|NCT03462498|Coronary Artery Disease|coronary artery disease
17536|NCT03462498|Percutaneous Coronary Intervention|percutaneous coronary intervention
17537|NCT03462498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
17538|NCT03462446|Atrial fibrillation|atrial fibrillation
17539|NCT03462446|VKA|vka
17540|NCT03462446|Stroke|stroke
17541|NCT03462433|Ruptured Intracranial Aneurysms|ruptured intracranial aneurysms
17542|NCT03462433|Unruptured Intracranial Aneurysms|unruptured intracranial aneurysms
17543|NCT03462433|Prospective cohort study|prospective cohort study
17544|NCT03462433|China|china
17545|NCT03462420|Adhesive capsulitis|adhesive capsulitis
17546|NCT03462420|Frozen shoulder|frozen shoulder
17547|NCT03462420|Diabetes|diabetes
17548|NCT03462420|Physiotherapy|physiotherapy
17549|NCT03462329|Post-Lyme symptoms|post-lyme symptoms
17550|NCT03462329|Pretreatment expectations|pretreatment expectations
17551|NCT03462290|Botulinum Toxins, Type A|botulinum toxins, type a
17552|NCT03462290|Injections|injections
17553|NCT03462290|Sphenopalatine Ganglion Block|sphenopalatine ganglion block
17554|NCT03462251|Breast Cancer|breast cancer
17555|NCT03462251|HR positive|hr positive
17556|NCT03462251|HER2 negative|her2 negative
17557|NCT03462251|Mamma carcinoma|mamma carcinoma
17558|NCT03462199|Kiwi|kiwi
17559|NCT03462199|Constipation|constipation
17560|NCT03462199|Bowel Movements|bowel movements
17561|NCT03462199|Healthy|healthy
17562|NCT03462199|Functional Constipation|functional constipation
17563|NCT03462160|Urinary Tract Infection|urinary tract infection
17564|NCT03462160|prophylaxis|prophylaxis
17565|NCT03462160|probiotics|probiotics
17566|NCT03462121|Alzheimer's Disease,|alzheimer's disease,
17567|NCT03462121|Dementia|dementia
17569|NCT03462082|axial motor dysfunction|axial motor dysfunction
17570|NCT03462082|asymmetric neuromodulation|asymmetric neuromodulation
17571|NCT03462082|subthalamic nucleus deep brain stimulation|subthalamic nucleus deep brain stimulation
17572|NCT03462030|food allergy|food allergy
17573|NCT03462030|oral immunotherapy|oral immunotherapy
17574|NCT03462004|Healthy Volunteer|healthy volunteer
17575|NCT03461965|3D printing|3d printing
17576|NCT03461965|Patient education|patient education
17577|NCT03461939|ePRIME|eprime
17578|NCT03461939|PRO|pro
17579|NCT03461939|PROM|prom
17580|NCT03461939|Adverse event|adverse event
17581|NCT03461939|QTool|qtool
17582|NCT03461939|Early phase|early phase
17583|NCT03461939|CTCAE|ctcae
17584|NCT03461926|Sedentary Behaviour|sedentary behaviour
17585|NCT03461926|Health Behaviour Change|health behaviour change
17586|NCT03461926|Health Action Process Approach|health action process approach
17587|NCT03461926|mHealth|mhealth
17588|NCT03461926|Intervention|intervention
17589|NCT03461926|Non-Sedentary Behaviours|non-sedentary behaviours
17590|NCT03461926|Break Frequency|break frequency
17591|NCT03461926|Break Duration|break duration
17592|NCT03461926|Action Planning|action planning
17593|NCT03461926|Coping Planning|coping planning
17594|NCT03461926|Work Performance|work performance
17595|NCT03461926|Health Outcomes|health outcomes
17596|NCT03461900|Septic shock|septic shock
17597|NCT03461900|Fluid optimisation|fluid optimisation
17598|NCT03461900|Minifluid challenge|minifluid challenge
17599|NCT03461900|Fluid overload|fluid overload
17600|NCT03461887|exercise|exercise
17601|NCT03461887|minimal equipment|minimal equipment
17602|NCT03461887|home-based|home-based
17603|NCT03461887|COPD|copd
17604|NCT03461874|High-Frequency Migraine without aura|high-frequency migraine without aura
17605|NCT03461874|ACT|act
17606|NCT03461861|Healthy|healthy
17607|NCT03461861|Adult|adult
17608|NCT03461861|Normal Memory|normal memory
17609|NCT03461861|APOE 4|apoe 4
17610|NCT03461861|Brain|brain
17611|NCT03461861|Magnetic Resonance Imaging|magnetic resonance imaging
17612|NCT03461861|MRI|mri
17613|NCT03461861|Alzheimer's disease|alzheimer's disease
17614|NCT03461861|Hippocampus|hippocampus
17615|NCT03461861|Genetic testing|genetic testing
17616|NCT03461861|Dementia|dementia
17617|NCT03461809|diplopia; ocular motor nerve palsy; acupuncture|diplopia; ocular motor nerve palsy; acupuncture
17618|NCT03461770|atelectasis|atelectasis
17619|NCT03461770|children|children
17620|NCT03461770|ultrasound|ultrasound
17621|NCT03461757|Acute Migraine|acute migraine
17622|NCT03461757|phonophobia|phonophobia
17623|NCT03461757|photophobia|photophobia
17624|NCT03461757|nausea|nausea
17625|NCT03461731|Low-Level Light Therapy|low-level light therapy
17626|NCT03461705|Coronary Artery Stenosis|coronary artery stenosis
17627|NCT03461705|Stenosis|stenosis
17628|NCT03461705|Resting Flow Reserve (RFR)|resting flow reserve (rfr)
17629|NCT03461705|Volcano Verrata Pressure Wire|volcano verrata pressure wire
17630|NCT03461666|Primary insomnia|primary insomnia
17631|NCT03461666|Behavioral treatment of primary insomnia|behavioral treatment of primary insomnia
17632|NCT03461666|Focus of attention|focus of attention
17633|NCT03461666|cognitive behavioral therapy for insomnia|cognitive behavioral therapy for insomnia
17634|NCT03461627|randomized|randomized
17635|NCT03461627|double-blind|double-blind
17636|NCT03461627|double-dummy|double-dummy
17637|NCT03461627|positive-controlled|positive-controlled
17638|NCT03461627|parallel-group|parallel-group
17639|NCT03461614|pulmonary function|pulmonary function
17640|NCT03461614|respiratory muscle strength|respiratory muscle strength
17641|NCT03461614|functional capacity|functional capacity
17642|NCT03461614|core exercises|core exercises
17643|NCT03461614|rehabilitation|rehabilitation
17644|NCT03461562|Aerobic Exercise|aerobic exercise
17645|NCT03461562|Whole Body Vibration Therapy|whole body vibration therapy
17646|NCT03461549|pressure sensor|pressure sensor
17647|NCT03461549|temperature sensor|temperature sensor
17648|NCT03461549|wearables|wearables
17649|NCT03461510|Cognition|cognition
17650|NCT03461510|MRI|mri
17651|NCT03461510|Functional MRI|functional mri
17652|NCT03461510|Pediatric Obesity|pediatric obesity
17653|NCT03461510|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
17654|NCT03461510|Adolescents|adolescents
17655|NCT03461510|Continuous Glucose Monitoring|continuous glucose monitoring
17656|NCT03461510|Insulin Clamp|insulin clamp
17657|NCT03461497|Patient-Reported Outcome|patient-reported outcome
17658|NCT03461497|Patient Outcome Assessment|patient outcome assessment
17659|NCT03461497|Questionnaire|questionnaire
17660|NCT03461497|Self-Report|self-report
17661|NCT03461497|Abdominal Surgery|abdominal surgery
17662|NCT03461497|Postoperative Period|postoperative period
17663|NCT03461497|Recovery of Function|recovery of function
17664|NCT03461497|Psychometrics|psychometrics
17665|NCT03461497|Qualitative Research|qualitative research
17666|NCT03461497|Patient-Centered|patient-centered
17667|NCT03461458|Degenerative Disc Disease|degenerative disc disease
17668|NCT03461458|Musculoskeletal Diseases|musculoskeletal diseases
17669|NCT03461458|Lumbar|lumbar
17670|NCT03461445|Elderly|elderly
17671|NCT03461445|Neurotoxicity|neurotoxicity
17672|NCT03461445|Calcineurin inhibitors|calcineurin inhibitors
17673|NCT03461445|Tacrolimus|tacrolimus
17674|NCT03461432|Cognitive Remediation Therapy CRT|cognitive remediation therapy crt
17675|NCT03461419|Multiple Sclerosis|multiple sclerosis
17676|NCT03461419|Demyelinating Disease|demyelinating disease
17677|NCT03461419|Nervous System Degenerative Disease|nervous system degenerative disease
17678|NCT03461419|Autoimmune Disease|autoimmune disease
17679|NCT03461393|AMD|amd
17680|NCT03461393|Mobile Device|mobile device
17681|NCT03461393|Training|training
17682|NCT03461380|Cimicifuga, Rhodiola, Menopause Symptoms|cimicifuga, rhodiola, menopause symptoms
17683|NCT03461328|magnesium sulphate, chronic obstructive pulmonary diseases|magnesium sulphate, chronic obstructive pulmonary diseases
17684|NCT03461315|home care|home care
17685|NCT03461315|primary care|primary care
17686|NCT03461315|preventive home visits|preventive home visits
17687|NCT03461250|HCV infection|hcv infection
17688|NCT03461250|hemodialysis|hemodialysis
17689|NCT03461250|HCV genotype|hcv genotype
17690|NCT03461250|Liver Fibrosis stage|liver fibrosis stage
17691|NCT03461237|Second Hip Fracture|second hip fracture
17692|NCT03461237|Quantitative Computed Tomography|quantitative computed tomography
17693|NCT03461237|Bone structure|bone structure
17694|NCT03461237|Muscle|muscle
17695|NCT03461224|breast cancer|breast cancer
17696|NCT03461224|radiotherapy|radiotherapy
17697|NCT03461224|cutaneous toxicity|cutaneous toxicity
17698|NCT03461224|subcutaneous toxicity|subcutaneous toxicity
17699|NCT03461224|IMRT|imrt
17700|NCT03461172|surgery|surgery
17701|NCT03461172|breast cancer|breast cancer
17702|NCT03461159|operant conditioning|operant conditioning
17703|NCT03461159|H-reflex|h-reflex
17704|NCT03461159|motor evoked potential|motor evoked potential
17705|NCT03461159|transcranial magnetic stimulation|transcranial magnetic stimulation
17706|NCT03461159|motor control|motor control
17707|NCT03461042|Chronic insomnia|chronic insomnia
17708|NCT03461042|Ramelteon|ramelteon
17709|NCT03461042|Rozerem|rozerem
17710|NCT03461042|dose reduction|dose reduction
17711|NCT03461029|Sedation|sedation
17712|NCT03461016|Smartphones|smartphones
17713|NCT03461016|Exposure Therapy|exposure therapy
17714|NCT03461016|Dental Anxiety|dental anxiety
17715|NCT03460977|efficacy|efficacy
17716|NCT03460977|safety|safety
17717|NCT03460977|pharmacokinetics|pharmacokinetics
17718|NCT03460977|pharmacodynamics|pharmacodynamics
17719|NCT03460977|dose escalation|dose escalation
17720|NCT03460977|dose expansion|dose expansion
17721|NCT03460977|open-label|open-label
17722|NCT03460977|EZH2|ezh2
17723|NCT03460977|enhancer of zeste homolog 2|enhancer of zeste homolog 2
17724|NCT03460977|castrate resistant prostate cancer|castrate resistant prostate cancer
17725|NCT03460977|CRPC|crpc
17726|NCT03460977|small cell lung cancer|small cell lung cancer
17727|NCT03460977|SCLC|sclc
17728|NCT03460977|follicular lymphoma|follicular lymphoma
17729|NCT03460977|FL|fl
17730|NCT03460977|relapsed|relapsed
17731|NCT03460977|refractory|refractory
17732|NCT03460964|Sensor|sensor
17733|NCT03460964|Glucose|glucose
17734|NCT03460964|Sweat|sweat
17735|NCT03460951|Feasibility and reproductibility|feasibility and reproductibility
17736|NCT03460951|DTI parameters (Fractional Anisotropy, Apparent Diffusion Coefficient)|dti parameters (fractional anisotropy, apparent diffusion coefficient)
17737|NCT03460951|MRI morphological parameters (T1, STIR)|mri morphological parameters (t1, stir)
17738|NCT03460925|pancreatic cancer|pancreatic cancer
17739|NCT03460925|stereotactic body radiotherapy|stereotactic body radiotherapy
17740|NCT03460925|resectability|resectability
17741|NCT03460912|IONM|ionm
17742|NCT03460912|thyroidectomy|thyroidectomy
17743|NCT03460912|bipolar probe|bipolar probe
17744|NCT03460912|monopolar probe|monopolar probe
17745|NCT03460899|Hypoglycaemia|hypoglycaemia
17746|NCT03460899|Platelet activity|platelet activity
17747|NCT03460899|Type 2 diabetes mellitus|type 2 diabetes mellitus
17748|NCT03460886|transcranial direct current stimulation|transcranial direct current stimulation
17749|NCT03460834|Asthma|asthma
17750|NCT03460834|Obesity|obesity
17751|NCT03460834|Observational Study|observational study
17752|NCT03460808|steroid-resistant|steroid-resistant
17753|NCT03460808|refractory|refractory
17754|NCT03460808|Atorvastatin|atorvastatin
17755|NCT03460808|Acetylcysteine|acetylcysteine
17756|NCT03460808|Danazol|danazol
17757|NCT03460782|Ipilimumab|ipilimumab
17758|NCT03460782|Glioblastoma|glioblastoma
17759|NCT03460782|Glioma|glioma
17760|NCT03460769|Pancreatic Cancer|pancreatic cancer
17761|NCT03460769|Chronic Pancreatitis|chronic pancreatitis
17762|NCT03460769|Diabetes Mellitus Type 3c|diabetes mellitus type 3c
17763|NCT03460769|Data management|data management
17764|NCT03460756|Postpartum Care|postpartum care
17765|NCT03460756|Postpartum Depression|postpartum depression
17766|NCT03460743|hemagglutinin influenza vaccine|hemagglutinin influenza vaccine
17767|NCT03460743|recombinant influenza vaccine|recombinant influenza vaccine
17768|NCT03460730|Invasive Pneumococcal Disease|invasive pneumococcal disease
17769|NCT03460691|bariatric surgery|bariatric surgery
17770|NCT03460691|central sensitization|central sensitization
17771|NCT03460691|knee pain|knee pain
17772|NCT03460691|function|function
17773|NCT03460691|quality of life|quality of life
17774|NCT03460678|Generic Erlotinib|generic erlotinib
17775|NCT03460678|Generic Pemetrexed|generic pemetrexed
17776|NCT03460678|NSCLC|nsclc
17777|NCT03460678|Non-squamous|non-squamous
17778|NCT03460678|Randomized Study|randomized study
17779|NCT03460678|Maintenance Therapy|maintenance therapy
17780|NCT03460678|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
17781|NCT03460678|Antifolate antineoplastic agents|antifolate antineoplastic agents
17782|NCT03460639|Masseter muscle|masseter muscle
17783|NCT03460639|initial fatigue|initial fatigue
17784|NCT03460639|low-level laser|low-level laser
17785|NCT03460626|stress|stress
17786|NCT03460626|pharmacy students|pharmacy students
17787|NCT03460626|Saudi Arabia|saudi arabia
17788|NCT03460561|TEA|tea
17789|NCT03460561|Rectus sheath block|rectus sheath block
17790|NCT03460561|Major abdominal cancer surgery|major abdominal cancer surgery
17791|NCT03460535|Rythmia system|rythmia system
17792|NCT03460496|preterm infants|preterm infants
17793|NCT03460496|transition to home|transition to home
17794|NCT03460496|advanced practice nurse|advanced practice nurse
17795|NCT03460496|cost-analysis|cost-analysis
17796|NCT03460444|NLR Family, Pyrin Domain-Containing 3 Protein|nlr family, pyrin domain-containing 3 protein
17797|NCT03460444|Caspase 1|caspase 1
17798|NCT03460444|3-Hydroxybutyric Acid|3-hydroxybutyric acid
17799|NCT03460444|Histone Deacetylase Inhibitors|histone deacetylase inhibitors
17800|NCT03460444|MCT Oil|mct oil
17801|NCT03460392|Human microbiota|human microbiota
17802|NCT03460379|Bariatric surgery|bariatric surgery
17803|NCT03460379|Gastrointestinal tract|gastrointestinal tract
17804|NCT03460379|Biological availability|biological availability
17805|NCT03460379|Pharmacokinetics|pharmacokinetics
17806|NCT03460379|Citalopram|citalopram
17807|NCT03460366|Bariatric surgery|bariatric surgery
17808|NCT03460366|Gastrointestinal tract|gastrointestinal tract
17809|NCT03460366|Biological availability|biological availability
17810|NCT03460366|Pharmacokinetics|pharmacokinetics
17811|NCT03460366|Enalapril|enalapril
17812|NCT03460353|Bariatric surgery|bariatric surgery
17813|NCT03460353|Gastrointestinal tract|gastrointestinal tract
17814|NCT03460353|Biological availability|biological availability
17815|NCT03460353|Pharmacokinetics|pharmacokinetics
17816|NCT03460353|Dextroamphetamine|dextroamphetamine
17817|NCT03460340|dTMS|dtms
17818|NCT03460340|Fibromyalgia|fibromyalgia
17819|NCT03460327|Bariatric surgery|bariatric surgery
17820|NCT03460327|Gastrointestinal tract|gastrointestinal tract
17821|NCT03460327|Biological availability|biological availability
17822|NCT03460327|Pharmacokinetics|pharmacokinetics
17823|NCT03460327|Candesartan|candesartan
17824|NCT03460314|Bariatric surgery|bariatric surgery
17825|NCT03460314|Gastrointestinal tract|gastrointestinal tract
17826|NCT03460314|Biological availability|biological availability
17827|NCT03460314|Pharmacokinetics|pharmacokinetics
17828|NCT03460314|Buprenorphine|buprenorphine
17829|NCT03460288|Gambling, Problematic Gambling, Pathological Gambling|gambling, problematic gambling, pathological gambling
17830|NCT03460275|Osimertinib|osimertinib
17831|NCT03460236|PRP|prp
17832|NCT03460236|osteoarthritis|osteoarthritis
17833|NCT03460236|MRI|mri
17834|NCT03460236|gait|gait
17960|NCT03459352|Symptom management|symptom management
17835|NCT03460236|patient reported outcome|patient reported outcome
17836|NCT03460210|Bariatric surgery|bariatric surgery
17837|NCT03460210|Gastrointestinal tract|gastrointestinal tract
17838|NCT03460210|Biological availability|biological availability
17839|NCT03460210|Pharmacokinetics|pharmacokinetics
17840|NCT03460210|Atomoxetine hydrochloride|atomoxetine hydrochloride
17841|NCT03460197|Capillary technique|capillary technique
17842|NCT03460197|Wet technique|wet technique
17843|NCT03460197|Endoscopic Ultrasound-Guided Fine-Needle Aspiration|endoscopic ultrasound-guided fine-needle aspiration
17844|NCT03460171|Human Metapneumovirus|human metapneumovirus
17845|NCT03460171|Paramyxoviridae infections|paramyxoviridae infections
17846|NCT03460171|Lower-respiratory tract infections|lower-respiratory tract infections
17847|NCT03460171|Pneumonia|pneumonia
17848|NCT03460158|facial filler|facial filler
17849|NCT03460158|Retylane|retylane
17850|NCT03460158|aesthetic improvement|aesthetic improvement
17851|NCT03460158|volumizing fillers|volumizing fillers
17852|NCT03460145|Lavender Oil,|lavender oil,
17853|NCT03460145|Propofol|propofol
17854|NCT03460132|orthodontic miniscrews|orthodontic miniscrews
17855|NCT03460132|biological effect|biological effect
17856|NCT03460132|cytotoxicity|cytotoxicity
17857|NCT03460132|metal release|metal release
17858|NCT03460119|High Flow Nasal Cannula|high flow nasal cannula
17859|NCT03460119|Emergency department|emergency department
17860|NCT03460119|Respiratory care|respiratory care
17861|NCT03460106|Asthma Medical Adherence|asthma medical adherence
17862|NCT03460093|nerve blockade|nerve blockade
17863|NCT03460093|hypogastric plexus|hypogastric plexus
17864|NCT03460093|cesarean section|cesarean section
17865|NCT03460080|Hepatocellular carcinoma|hepatocellular carcinoma
17866|NCT03460080|AFP-L3|afp-l3
17867|NCT03460080|PIVKA-II|pivka-ii
17868|NCT03460067|omission of radiation|omission of radiation
17869|NCT03460067|trastuzumab|trastuzumab
17870|NCT03460067|pertuzumab|pertuzumab
17871|NCT03460067|biospecimen collection|biospecimen collection
17872|NCT03460067|lumpectomy|lumpectomy
17873|NCT03460015|COPD exacerbation|copd exacerbation
17874|NCT03460015|Sevoflurane|sevoflurane
17875|NCT03460015|Airway Resistance|airway resistance
17876|NCT03460002|Measles vaccine|measles vaccine
17877|NCT03460002|Oral polio vaccine|oral polio vaccine
17878|NCT03460002|Campaign|campaign
17879|NCT03460002|Child mortality|child mortality
17880|NCT03460002|Child morbidity|child morbidity
17881|NCT03460002|Non-specific effects|non-specific effects
17882|NCT03459989|hadlock|hadlock
17883|NCT03459989|thigh soft tissue|thigh soft tissue
17884|NCT03459963|catheter|catheter
17885|NCT03459963|cesarean section|cesarean section
17886|NCT03459963|urinary tract infection|urinary tract infection
17887|NCT03459963|patient's satisfaction|patient's satisfaction
17888|NCT03459937|obesity|obesity
17889|NCT03459937|yoga|yoga
17890|NCT03459937|mindfulness|mindfulness
17891|NCT03459937|weight loss|weight loss
17892|NCT03459937|physical activity|physical activity
17893|NCT03459924|Right ventricular function|right ventricular function
17894|NCT03459924|Liver transplantation|liver transplantation
17895|NCT03459924|Transesophageal echocardiography|transesophageal echocardiography
17896|NCT03459911|Bioequivalence|bioequivalence
17897|NCT03459872|acupuncture|acupuncture
17898|NCT03459872|quantitative data|quantitative data
17899|NCT03459872|outcomes based rehabilitation|outcomes based rehabilitation
17900|NCT03459872|fine motor control|fine motor control
17901|NCT03459846|Urinary Bladder Neoplasms|urinary bladder neoplasms
17902|NCT03459833|premature ejaculation|premature ejaculation
17903|NCT03459833|IELT|ielt
17904|NCT03459833|hyaluronic acid|hyaluronic acid
17905|NCT03459833|glans penis augmentation|glans penis augmentation
17906|NCT03459807|Blood pressure|blood pressure
17907|NCT03459807|Hemodialysis|hemodialysis
17908|NCT03459807|End-stage-renal-disease|end-stage-renal-disease
17909|NCT03459807|Chronic kidney disease|chronic kidney disease
17910|NCT03459742|Obesity|obesity
17911|NCT03459742|Gamification|gamification
17912|NCT03459742|Schools|schools
17913|NCT03459742|Cluster Randomized Trial|cluster randomized trial
17914|NCT03459729|Anti-tumor B|anti-tumor b
17915|NCT03459729|ACAPHA|acapha
17916|NCT03459729|Pharmacokinetics|pharmacokinetics
17917|NCT03459716|Biomarkers|biomarkers
17918|NCT03459716|Endothelial microparticles|endothelial microparticles
17919|NCT03459690|Meditation, EEG|meditation, eeg
17920|NCT03459677|School Refusal|school refusal
17921|NCT03459677|Truancy|truancy
17922|NCT03459677|School Absenteeism|school absenteeism
17923|NCT03459677|Anxiety|anxiety
17924|NCT03459677|Depression|depression
17925|NCT03459677|Behavioral problems|behavioral problems
17926|NCT03459677|CBT|cbt
17927|NCT03459664|stepped care|stepped care
17928|NCT03459664|common mental disorders|common mental disorders
17929|NCT03459664|managed care|managed care
17930|NCT03459664|integrated care|integrated care
17931|NCT03459664|psychiatric disorders|psychiatric disorders
17932|NCT03459664|psychotherapy|psychotherapy
17933|NCT03459664|severe mental disorders|severe mental disorders
17934|NCT03459651|numeracy|numeracy
17935|NCT03459651|number sense|number sense
17936|NCT03459638|Screening|screening
17937|NCT03459599|Antibiotic|antibiotic
17938|NCT03459599|Endometritis|endometritis
17939|NCT03459599|Placental membranes|placental membranes
17940|NCT03459599|Prophylaxis|prophylaxis
17941|NCT03459599|Ragged membranes|ragged membranes
17942|NCT03459586|Parkinson|parkinson
17943|NCT03459560|antihypertensive agents|antihypertensive agents
17944|NCT03459560|acetylsalicylic acid|acetylsalicylic acid
17945|NCT03459560|atorvastatin|atorvastatin
17946|NCT03459508|Antiphospholipid Syndrome - Bad obstetric history - Ocular|antiphospholipid syndrome - bad obstetric history - ocular
17947|NCT03459495|migraine, therapeutic ultrasound, pain, disability|migraine, therapeutic ultrasound, pain, disability
17948|NCT03459456|OCD|ocd
17949|NCT03459456|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
17950|NCT03459430|trunk stability|trunk stability
17951|NCT03459430|accelerometer|accelerometer
17952|NCT03459430|smartphone|smartphone
17953|NCT03459430|core training|core training
17954|NCT03459430|isometric exercises|isometric exercises
17955|NCT03459391|Healthy volunteers|healthy volunteers
17956|NCT03459391|Phase I|phase i
17957|NCT03459391|PHARMENTERPRISES|pharmenterprises
17958|NCT03459352|Cancer|cancer
17959|NCT03459352|Patient Reported Outcomes|patient reported outcomes
17961|NCT03459326|male sexuality|male sexuality
17962|NCT03459326|medical assisted to procreation|medical assisted to procreation
17963|NCT03459326|International Index of Erectile Function questionnaire|international index of erectile function questionnaire
17964|NCT03459300|actimetry|actimetry
17965|NCT03459287|INTERCEPT|intercept
17966|NCT03459287|Red Blood Cells|red blood cells
17967|NCT03459287|RBC|rbc
17968|NCT03459287|Pathogen Inactivation|pathogen inactivation
17969|NCT03459287|Cerus|cerus
17970|NCT03459287|Pathogen Reduction|pathogen reduction
17971|NCT03459287|Cardiovascular surgery|cardiovascular surgery
17972|NCT03459261|osteomyelitis|osteomyelitis
17973|NCT03459261|tibial fracture|tibial fracture
17974|NCT03459261|cytokines|cytokines
17975|NCT03459261|PCT|pct
17976|NCT03459261|CRP|crp
17977|NCT03459261|albumin|albumin
17978|NCT03459235|rectal cancer|rectal cancer
17979|NCT03459235|proctectomy|proctectomy
17980|NCT03459235|digestive sequelae|digestive sequelae
17981|NCT03459235|quality of life|quality of life
17982|NCT03459235|Urinary and Sexual sequelae|urinary and sexual sequelae
17983|NCT03459222|immunotherapy|immunotherapy
17984|NCT03459222|Relatlimab|relatlimab
17985|NCT03459196|Interventional|interventional
17986|NCT03459196|Radiofrequency Ablation|radiofrequency ablation
17987|NCT03459196|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
17988|NCT03459170|leukemia|leukemia
17989|NCT03459170|myelodysplastic syndrome|myelodysplastic syndrome
17990|NCT03459170|lymphoma|lymphoma
17991|NCT03459170|minimal residual disease|minimal residual disease
17992|NCT03459170|BPX-501|bpx-501
17993|NCT03459170|AP1903|ap1903
17994|NCT03459170|rimiducid|rimiducid
17995|NCT03459157|HIV infection|hiv infection
17996|NCT03459157|Men who have sex with men|men who have sex with men
17997|NCT03459157|Pre-exposure prophylaxis|pre-exposure prophylaxis
17998|NCT03459144|polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
17999|NCT03459144|photodynamic therapy|photodynamic therapy
18000|NCT03459144|ranibizumab|ranibizumab
18001|NCT03459144|combination therapy|combination therapy
18002|NCT03459144|cost-benefit|cost-benefit
18003|NCT03459092|Botulinum toxin, strabismus surgery, binocular vision|botulinum toxin, strabismus surgery, binocular vision
18004|NCT03459066|Spasticity|spasticity
18005|NCT03459066|Stroke|stroke
18006|NCT03459066|Predictors|predictors
18007|NCT03459066|Functionality|functionality
18008|NCT03459066|Quality of life|quality of life
18009|NCT03459027|exercise hyperemia|exercise hyperemia
18010|NCT03459027|vasodilation|vasodilation
18011|NCT03459027|nitric oxide|nitric oxide
18012|NCT03459027|dietary nitrate|dietary nitrate
18013|NCT03459014|Robot-Assisted Gait Training|robot-assisted gait training
18014|NCT03459014|Virtual Reality|virtual reality
18015|NCT03459014|Optic Flow|optic flow
18016|NCT03459014|Active Participation|active participation
18017|NCT03458988|Blood pressure measuring|blood pressure measuring
18018|NCT03458975|microbubbles|microbubbles
18019|NCT03458975|sonoporation|sonoporation
18020|NCT03458975|hepatic metastases of colorectal cancer|hepatic metastases of colorectal cancer
18021|NCT03458962|Nicklaus Children's|nicklaus children's
18022|NCT03458962|Pediatric|pediatric
18023|NCT03458962|Genomic|genomic
18024|NCT03458962|Precision Medicine|precision medicine
18025|NCT03458962|Biorepository|biorepository
18026|NCT03458962|Rady Children's|rady children's
18027|NCT03458936|Depression|depression
18028|NCT03458936|Adolescence|adolescence
18029|NCT03458936|Resilience|resilience
18030|NCT03458936|Risk Factor|risk factor
18031|NCT03458936|Biomarker|biomarker
18032|NCT03458923|Diclofenac|diclofenac
18033|NCT03458923|Ranibizumab|ranibizumab
18034|NCT03458923|Diabetic Macular Edema|diabetic macular edema
18035|NCT03458910|heart rate variability, HRV|heart rate variability, hrv
18036|NCT03458897|bone marrow cellularity|bone marrow cellularity
18037|NCT03458897|bone marrow transplant|bone marrow transplant
18038|NCT03458884|Stroke|stroke
18039|NCT03458884|Fatigue|fatigue
18040|NCT03458884|PROBE design|probe design
18041|NCT03458884|Cardiorespiratory fitness|cardiorespiratory fitness
18042|NCT03458884|Cardiorespiratory training|cardiorespiratory training
18043|NCT03458871|electric stimulation|electric stimulation
18044|NCT03458845|Cirrhosis|cirrhosis
18045|NCT03458845|Sarcopenia|sarcopenia
18046|NCT03458845|Malnutrition|malnutrition
18047|NCT03458845|Inguinal hernia|inguinal hernia
18048|NCT03458845|Umbilical hernia|umbilical hernia
18049|NCT03458845|Undernutrition|undernutrition
18050|NCT03458832|muscular dystrophy.|muscular dystrophy.
18051|NCT03458832|FSHD|fshd
18052|NCT03458806|Auscultation|auscultation
18053|NCT03458806|Phonocardiogram|phonocardiogram
18054|NCT03458806|Machine Learning|machine learning
18055|NCT03458806|Heart Sounds|heart sounds
18056|NCT03458793|randomised controlled study|randomised controlled study
18057|NCT03458793|physical activity|physical activity
18058|NCT03458793|loneliness|loneliness
18059|NCT03458780|yellow fever vaccine|yellow fever vaccine
18060|NCT03458780|immune response|immune response
18061|NCT03458780|"droplet microfluidics single cell (inDrop) RNA-Seq"|"droplet microfluidics single cell (indrop) rna-seq"
18062|NCT03458767|Cognitive function|cognitive function
18063|NCT03458767|Physical activity|physical activity
18064|NCT03458767|Self-management|self-management
18462|NCT03455855|Atherectomy|atherectomy
18065|NCT03458754|Peripheral Arterial Disease|peripheral arterial disease
18066|NCT03458754|Exercise capacity|exercise capacity
18067|NCT03458754|Physical activity|physical activity
18068|NCT03458754|Respiratory muscle strength|respiratory muscle strength
18069|NCT03458754|Peripheric muscle strength|peripheric muscle strength
18070|NCT03458728|Phase I: relapsed or refractory solid tumors or lymphoma|phase i: relapsed or refractory solid tumors or lymphoma
18071|NCT03458728|Phase II: relapsed or refractory solid tumors (neuroblastoma, osteosarcoma, rhabdomyosarcoma or Ewing sarcoma)|phase ii: relapsed or refractory solid tumors (neuroblastoma, osteosarcoma, rhabdomyosarcoma or ewing sarcoma)
18072|NCT03458715|SGLT2 inhibitor|sglt2 inhibitor
18073|NCT03458715|DPP4 inhibitor|dpp4 inhibitor
18074|NCT03458702|autonomic function|autonomic function
18075|NCT03458702|emotion|emotion
18076|NCT03458702|heart rate variability|heart rate variability
18077|NCT03458676|Advanced magnetic resonance imaging|advanced magnetic resonance imaging
18078|NCT03458676|AMRI|amri
18079|NCT03458624|FURESTEM-AD Inj.|furestem-ad inj.
18080|NCT03458624|Stem cells|stem cells
18081|NCT03458585|ionising radiation|ionising radiation
18082|NCT03458585|patient awareness|patient awareness
18083|NCT03458585|patient knowledge|patient knowledge
18084|NCT03458572|Caesarean section|caesarean section
18085|NCT03458559|Bone metastases|bone metastases
18086|NCT03458559|Rhenium-188-HEDP|rhenium-188-hedp
18087|NCT03458559|Radium 223-chloride|radium 223-chloride
18088|NCT03458559|Survival|survival
18089|NCT03458559|Prostate cancer|prostate cancer
18090|NCT03458533|Pituitary|pituitary
18091|NCT03458533|Obesity|obesity
18092|NCT03458533|Overweight|overweight
18093|NCT03458533|Metabolic syndrome|metabolic syndrome
18094|NCT03458533|MRI|mri
18095|NCT03458507|Neuromuscular diseases|neuromuscular diseases
18096|NCT03458507|Non-invasive ventilation|non-invasive ventilation
18097|NCT03458507|Nasal mask|nasal mask
18098|NCT03458507|Oronasal mask|oronasal mask
18099|NCT03458507|Alveolar hypoventilation|alveolar hypoventilation
18100|NCT03458507|leaks|leaks
18101|NCT03458507|Sleep disorder breathing|sleep disorder breathing
18102|NCT03458507|Side effects|side effects
18103|NCT03458494|type 2 diabetes|type 2 diabetes
18104|NCT03458494|glucose|glucose
18105|NCT03458494|insulin|insulin
18106|NCT03458494|CRP|crp
18107|NCT03458494|Metabolomics|metabolomics
18108|NCT03458494|gene-diet interaction|gene-diet interaction
18109|NCT03458494|TCF7L2|tcf7l2
18110|NCT03458481|Chronic Genotype 1 HCV Infection|chronic genotype 1 hcv infection
18111|NCT03458468|tranexamic acid|tranexamic acid
18112|NCT03458468|anterior shoulder instability|anterior shoulder instability
18113|NCT03458468|latarjet|latarjet
18114|NCT03458468|hematoma|hematoma
18115|NCT03458455|TREATMENT|treatment
18116|NCT03458455|Vessel Architectural Imaging|vessel architectural imaging
18117|NCT03458455|Brain Metastases|brain metastases
18118|NCT03458442|education|education
18119|NCT03458442|developing country|developing country
18120|NCT03458442|developing countries|developing countries
18121|NCT03458442|low-and middle-income country|low-and middle-income country
18122|NCT03458442|low-and middle-income countries|low-and middle-income countries
18123|NCT03458442|surgical training|surgical training
18124|NCT03458442|blindness|blindness
18125|NCT03458442|china|china
18126|NCT03458442|simulation|simulation
18127|NCT03458442|model|model
18128|NCT03458429|Young Donor Plasma|young donor plasma
18129|NCT03458429|Frailty|frailty
18130|NCT03458429|Aging|aging
18131|NCT03458429|Immune Function|immune function
18132|NCT03458429|G-CSF|g-csf
18133|NCT03458403|Digestive endoscopy|digestive endoscopy
18134|NCT03458403|Tracking motion|tracking motion
18135|NCT03458377|Colonoscopy|colonoscopy
18136|NCT03458377|Quality|quality
18137|NCT03458377|Telephone intervention|telephone intervention
18138|NCT03458364|Weaning; Noninvasive ventilation; High flow nasal cannula|weaning; noninvasive ventilation; high flow nasal cannula
18139|NCT03458351|platelet activation|platelet activation
18140|NCT03458351|remote ischemic preconditioning|remote ischemic preconditioning
18141|NCT03458338|chronic kidney disease|chronic kidney disease
18142|NCT03458338|communicable disease|communicable disease
18143|NCT03458338|sub-Saharan Africa|sub-saharan africa
18144|NCT03458338|Tanzania|tanzania
18145|NCT03458338|neglected disease|neglected disease
18146|NCT03458338|prevalence|prevalence
18147|NCT03458338|double burden|double burden
18148|NCT03458299|American Indian|american indian
18149|NCT03458286|Diabetic Foot Ulcers|diabetic foot ulcers
18150|NCT03458286|Chronic|chronic
18151|NCT03458286|Combined ultrasound and electric current stimulation|combined ultrasound and electric current stimulation
18152|NCT03458286|Adjunctive therapy|adjunctive therapy
18153|NCT03458273|Atrial Arrhythmia|atrial arrhythmia
18154|NCT03458273|Ventricular Arrythmia|ventricular arrythmia
18155|NCT03458273|ablation|ablation
18156|NCT03458273|fluoroscopy|fluoroscopy
18157|NCT03458260|Diffuse Large B-Cell Lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
18158|NCT03458260|relapsed or refractory|relapsed or refractory
18159|NCT03458247|Prostate Cancer|prostate cancer
18160|NCT03458247|Castration resistance|castration resistance
18161|NCT03458247|Drug monitoring|drug monitoring
18162|NCT03458247|Abiraterone acetate|abiraterone acetate
18163|NCT03458234|Focal therapy|focal therapy
18164|NCT03458234|Prostate cancer|prostate cancer
18165|NCT03458234|SBRT|sbrt
18166|NCT03458234|Intra-urethral transponder|intra-urethral transponder
18167|NCT03458221|ovarian carcinoma|ovarian carcinoma
18168|NCT03458221|Signal Transduction Pathway|signal transduction pathway
18169|NCT03458221|therapy|therapy
18170|NCT03458208|AUC|auc
18171|NCT03458208|Cmax|cmax
18172|NCT03458208|Pharmacokinetics|pharmacokinetics
18173|NCT03458208|metformin|metformin
18174|NCT03458208|fed|fed
18175|NCT03458208|fasting|fasting
18176|NCT03458195|ileo-caecal resection; post-operative recurrence|ileo-caecal resection; post-operative recurrence
18177|NCT03458143|ketamine|ketamine
18178|NCT03458143|remifentanil|remifentanil
18179|NCT03458078|Bupivacaine,|bupivacaine,
18180|NCT03458078|Anesthetics|anesthetics
18181|NCT03458078|Adjuvants|adjuvants
18182|NCT03458078|Analgesics|analgesics
18183|NCT03458078|Peripheral system|peripheral system
18184|NCT03458078|Central Nervous|central nervous
18185|NCT03458078|sensory system|sensory system
18186|NCT03458078|Agents|agents
18187|NCT03458078|Physiological effects of drugs|physiological effects of drugs
18188|NCT03458078|opioid|opioid
18189|NCT03458078|Pain|pain
18190|NCT03458078|Postoperative|postoperative
18191|NCT03458078|Signs and Symptoms|signs and symptoms
18192|NCT03458052|Intensive and critical care|intensive and critical care
18193|NCT03458052|Organ donation|organ donation
18194|NCT03458052|Knowledge|knowledge
18195|NCT03458039|mental health capacity building|mental health capacity building
18196|NCT03458039|low and middle-income country|low and middle-income country
18197|NCT03458039|train the trainer strategy|train the trainer strategy
18198|NCT03458039|technology-based training|technology-based training
18199|NCT03458026|activity|activity
18200|NCT03458026|Connected object|connected object
18201|NCT03458013|Mindfulness|mindfulness
18202|NCT03458013|Complementary Medicine|complementary medicine
18203|NCT03458013|Integrative Health|integrative health
18204|NCT03458013|Hand Therapy|hand therapy
18205|NCT03457987|protein load|protein load
18206|NCT03457987|cardiac surgery|cardiac surgery
18207|NCT03457974|saliva composition|saliva composition
18208|NCT03457974|antioxidant activity|antioxidant activity
18209|NCT03457974|caries risk factors|caries risk factors
18210|NCT03457974|congenital cardiac disease|congenital cardiac disease
18211|NCT03457961|Perampanel|perampanel
18212|NCT03457961|focal onset seizure|focal onset seizure
18213|NCT03457961|epilepsy|epilepsy
18214|NCT03457909|string|string
18215|NCT03457909|capsule endoscopy|capsule endoscopy
18216|NCT03457896|NSABP|nsabp
18217|NCT03457896|PUMA|puma
18218|NCT03457896|Neratinib|neratinib
18219|NCT03457896|Trastuzumab|trastuzumab
18220|NCT03457896|Cetuximab|cetuximab
18221|NCT03457896|RAS|ras
18222|NCT03457896|NRAS|nras
18223|NCT03457896|BRAF|braf
18224|NCT03457896|PIK3CA wild-type|pik3ca wild-type
18225|NCT03457896|Quadruple wild-type|quadruple wild-type
18226|NCT03457896|HER2 status|her2 status
18227|NCT03457883|Pelvic organ prolapse|pelvic organ prolapse
18228|NCT03457883|Vaginal mesh|vaginal mesh
18229|NCT03457883|biological graft|biological graft
18230|NCT03457883|Recurrence|recurrence
18231|NCT03457870|Intermittent fasting|intermittent fasting
18232|NCT03457870|Adult hippocampal neurogenesis|adult hippocampal neurogenesis
18233|NCT03457870|Mastication|mastication
18234|NCT03457870|Pattern separation|pattern separation
18235|NCT03457870|Recognition memory|recognition memory
18236|NCT03457870|Klotho|klotho
18237|NCT03457857|Microbiome|microbiome
18238|NCT03457857|Microbiota|microbiota
18239|NCT03457805|prostate cancer|prostate cancer
18240|NCT03457805|prostate|prostate
18241|NCT03457805|embolization|embolization
18242|NCT03457805|minimally invasive|minimally invasive
18243|NCT03457805|cytoreductive therapy|cytoreductive therapy
18244|NCT03457753|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
18245|NCT03457740|muscular strength|muscular strength
18246|NCT03457740|testosterone|testosterone
18247|NCT03457740|sexual function|sexual function
18248|NCT03457740|quality of life|quality of life
18249|NCT03457727|Danirixin|danirixin
18250|NCT03457727|Healthy|healthy
18251|NCT03457727|Food effect|food effect
18252|NCT03457727|Relative Bioavailability|relative bioavailability
18253|NCT03457727|Hydrobromide Salt|hydrobromide salt
18254|NCT03457714|spinal cord injuries|spinal cord injuries
18255|NCT03457714|anxiety|anxiety
18256|NCT03457714|depression|depression
18257|NCT03457714|internet-delivered cognitive behaviour therapy|internet-delivered cognitive behaviour therapy
18258|NCT03457714|pilot study|pilot study
18259|NCT03457675|Deep Brain Stimulation (DBS)|deep brain stimulation (dbs)
18260|NCT03457675|Treatment Resistant OCD|treatment resistant ocd
18261|NCT03457675|Intractable OCD|intractable ocd
18262|NCT03457675|Obsessive Compulsive Disorder (OCD)|obsessive compulsive disorder (ocd)
18263|NCT03457610|chronic cough|chronic cough
18264|NCT03457610|speech and language intervention|speech and language intervention
18265|NCT03457610|difficult-to-treat cough|difficult-to-treat cough
18266|NCT03457532|Safety, Tolerability, Pharmacokinetics, Anti-tumor Activity|safety, tolerability, pharmacokinetics, anti-tumor activity
18267|NCT03457519|ChARM|charm
18268|NCT03457519|community health worker|community health worker
18269|NCT03457506|Cancer|cancer
18270|NCT03457506|Digital pet|digital pet
18271|NCT03457506|Conventional pet|conventional pet
18272|NCT03457480|Cancer Prevention|cancer prevention
18273|NCT03457480|Focus Group|focus group
18274|NCT03457480|Text messaging|text messaging
18275|NCT03457480|Questionnaires|questionnaires
18276|NCT03457480|Surveys|surveys
18277|NCT03457467|oligometacosis|oligometacosis
18278|NCT03457467|anti-angiogenic|anti-angiogenic
18279|NCT03457467|apatinib|apatinib
18280|NCT03457428|obstructive sleep apnea|obstructive sleep apnea
18281|NCT03457428|home sleep testing|home sleep testing
18282|NCT03457415|LDCT|ldct
18283|NCT03457415|Sputum|sputum
18284|NCT03457415|High-risk Smoker|high-risk smoker
18285|NCT03457415|Porphyrin|porphyrin
18286|NCT03457415|Early detection|early detection
18287|NCT03457402|delay discounting|delay discounting
18288|NCT03457402|shaping|shaping
18289|NCT03457389|Prolactinoma|prolactinoma
18290|NCT03457389|Cabergoline|cabergoline
18291|NCT03457389|Recurrence|recurrence
18292|NCT03457363|oxygen|oxygen
18293|NCT03457363|nasal cannula|nasal cannula
18294|NCT03457363|double trunk mask|double trunk mask
18295|NCT03457363|hypoxia|hypoxia
18296|NCT03457350|hysteroscopy|hysteroscopy
18297|NCT03457350|cervical stenosis|cervical stenosis
18298|NCT03457350|probing|probing
18299|NCT03457324|JCM-16021|jcm-16021
18300|NCT03457324|Trial|trial
18301|NCT03457324|Irritable Bowel Syndrome|irritable bowel syndrome
18302|NCT03457324|Chinese Medicine|chinese medicine
18303|NCT03457311|GSP, oral galactose single point (OGSP)|gsp, oral galactose single point (ogsp)
18304|NCT03457285|Ankylosing spondylitis; physiotherapy; Salaso|ankylosing spondylitis; physiotherapy; salaso
18305|NCT03457272|Patient Safety|patient safety
18306|NCT03457272|Risk Factors|risk factors
18307|NCT03457272|Quality Indicators, Health Care|quality indicators, health care
18308|NCT03457272|Risk Assessment|risk assessment
18309|NCT03457259|Midline catheter, peripheral venous catheter, central venous catheter, complication rate|midline catheter, peripheral venous catheter, central venous catheter, complication rate
18310|NCT03457246|solar lentigos|solar lentigos
18311|NCT03457246|physical Hyperpigmentation therapies|physical hyperpigmentation therapies
18312|NCT03457246|cosmetic topical depigmenting product|cosmetic topical depigmenting product
18313|NCT03457246|topical Hyperpigmentation therapies|topical hyperpigmentation therapies
18314|NCT03457194|Obesity|obesity
18315|NCT03457194|Vaccination|vaccination
18316|NCT03457194|Pregnancy|pregnancy
18317|NCT03457194|Influenza|influenza
18318|NCT03457194|Pertussis|pertussis
18319|NCT03457194|Maternal antibodies|maternal antibodies
18320|NCT03457168|Sleep-time hypertension|sleep-time hypertension
18321|NCT03457168|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
18322|NCT03457168|Hypertension chronotherapy|hypertension chronotherapy
18323|NCT03457168|Asleep blood pressure|asleep blood pressure
18324|NCT03457168|Cardiovascular risk|cardiovascular risk
18325|NCT03457168|Type 2 diabetes|type 2 diabetes
18326|NCT03457168|Chronic kidney disease|chronic kidney disease
18327|NCT03457129|Epilepsy|epilepsy
18328|NCT03457129|Epilepsy, partial onset|epilepsy, partial onset
18329|NCT03457129|Epilepsy, generalized onset|epilepsy, generalized onset
18330|NCT03457129|Fycompa|fycompa
18331|NCT03457129|perampanel|perampanel
18332|NCT03457090|neurologic complication, transcranial Doppler ultrasound|neurologic complication, transcranial doppler ultrasound
18333|NCT03457077|brief intervention|brief intervention
18334|NCT03457077|fMRI|fmri
18335|NCT03457038|Mannose-Binding Lectin, PAMPs,|mannose-binding lectin, pamps,
18336|NCT03457025|Oxygen Therapy|oxygen therapy
18337|NCT03457025|Bells Palsy|bells palsy
18338|NCT03456999|BKV, renal transplant, renal and kidney transplant|bkv, renal transplant, renal and kidney transplant
18339|NCT03456934|Protein requirements|protein requirements
18340|NCT03456934|Adiposity|adiposity
18341|NCT03456934|Body composition|body composition
18342|NCT03456934|Cardiovascular health|cardiovascular health
18343|NCT03456921|health games|health games
18344|NCT03456921|community engagement|community engagement
18345|NCT03456882|AMYOTROPHIC LATERAL SCLEROSIS|amyotrophic lateral sclerosis
18346|NCT03456882|RNS60|rns60
18347|NCT03456882|Biomarkers|biomarkers
18348|NCT03456882|clinical trial|clinical trial
18349|NCT03456882|therapy|therapy
18350|NCT03456869|patient specific implant|patient specific implant
18351|NCT03456869|computer-aided surgery|computer-aided surgery
18352|NCT03456869|clinical accuracy|clinical accuracy
18353|NCT03456856|Cardiac|cardiac
18354|NCT03456856|Congestive|congestive
18355|NCT03456856|Decompensation|decompensation
18356|NCT03456856|Heart Failure|heart failure
18357|NCT03456856|Left-Sided|left-sided
18358|NCT03456856|Myocardial|myocardial
18359|NCT03456856|Corlanor|corlanor
18360|NCT03456856|Ivabradine|ivabradine
18361|NCT03456856|African American|african american
18362|NCT03456856|Black|black
18363|NCT03456856|Michigan|michigan
18364|NCT03456830|Kidney stones|kidney stones
18365|NCT03456830|Hyperoxaluria|hyperoxaluria
18366|NCT03456830|Enteric hyperoxaluria|enteric hyperoxaluria
18367|NCT03456830|Oxalate|oxalate
18368|NCT03456791|Epididymal secretory protein E4|epididymal secretory protein e4
18369|NCT03456791|Major epididymis specific protein E4|major epididymis specific protein e4
18370|NCT03456778|Sonographic imaging|sonographic imaging
18371|NCT03456778|Platelet-rich plasma (PRP) injection|platelet-rich plasma (prp) injection
18372|NCT03456778|Shear Wave Elastography|shear wave elastography
18373|NCT03456752|Inflammatory Bowel Diseases|inflammatory bowel diseases
18374|NCT03456752|Glucocorticosteroids|glucocorticosteroids
18375|NCT03456752|Postoperative Outcome|postoperative outcome
18376|NCT03456726|EZH2 gene mutation|ezh2 gene mutation
18377|NCT03456726|Tazemetostat|tazemetostat
18378|NCT03456726|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
18379|NCT03456726|Follicular lymphoma|follicular lymphoma
18380|NCT03456687|Exenatide|exenatide
18381|NCT03456661|Pectoral block|pectoral block
18382|NCT03456661|Ultrasound|ultrasound
18383|NCT03456661|Mastectomy|mastectomy
18384|NCT03456661|Levobupivacaine|levobupivacaine
18385|NCT03456661|Dexmedetomidine|dexmedetomidine
18386|NCT03456635|antimicrobial|antimicrobial
18387|NCT03456635|prophylaxys|prophylaxys
18388|NCT03456635|CDSS|cdss
18389|NCT03456622|G7|g7
18390|NCT03456596|CBPR|cbpr
18391|NCT03456596|RE-AIM|re-aim
18392|NCT03456583|Breast Biopsy|breast biopsy
18393|NCT03456583|Breast Biopsy Imaging|breast biopsy imaging
18394|NCT03456583|Stereotactic Imaging|stereotactic imaging
18395|NCT03456414|exercise|exercise
18396|NCT03456414|physical function|physical function
18397|NCT03456414|health related quality of life|health related quality of life
18398|NCT03456375|progesterone|progesterone
18399|NCT03456375|artificial endometrial preparation cycle|artificial endometrial preparation cycle
18400|NCT03456375|endometrial receptivity|endometrial receptivity
18401|NCT03456349|Alzheimer's disease|alzheimer's disease
18402|NCT03456323|Critical Illness|critical illness
18403|NCT03456323|Frailty|frailty
18404|NCT03456323|Palliative Care|palliative care
18405|NCT03456297|Web-based clinical pedagogy program|web-based clinical pedagogy program
18406|NCT03456297|nurse preceptors|nurse preceptors
18407|NCT03456297|teaching competency|teaching competency
18408|NCT03456232|hemodialysis|hemodialysis
18409|NCT03456232|hemodiafiltration|hemodiafiltration
18410|NCT03456232|end-stage renal disease|end-stage renal disease
18411|NCT03456219|Food intake|food intake
18412|NCT03456219|Sleep|sleep
18413|NCT03456219|Shift work|shift work
18414|NCT03456219|Postprandial metabolic response|postprandial metabolic response
18415|NCT03456206|Life Style|life style
18416|NCT03456206|Diet|diet
18417|NCT03456206|Food|food
18418|NCT03456206|CID|cid
18419|NCT03456206|Disease risk|disease risk
18420|NCT03456180|septic shock|septic shock
18421|NCT03456180|microcirculation|microcirculation
18422|NCT03456180|acute renal failure|acute renal failure
18423|NCT03456180|renal replacement therapy|renal replacement therapy
18424|NCT03456180|haemoadsorption|haemoadsorption
18425|NCT03456167|telemedicine|telemedicine
18426|NCT03456167|mobile applications|mobile applications
18427|NCT03456167|ERAS|eras
18428|NCT03456167|postoperative care|postoperative care
18429|NCT03456167|patient satisfaction|patient satisfaction
18430|NCT03456167|breast reconstruction|breast reconstruction
18431|NCT03456167|gynecologic oncology|gynecologic oncology
18432|NCT03456167|mastectomy|mastectomy
18433|NCT03456128|Older Adult|older adult
18434|NCT03456128|Rehospitalization|rehospitalization
18435|NCT03456128|Physical function|physical function
18436|NCT03456115|nasal obstruction|nasal obstruction
18437|NCT03456115|nasal valve collapse|nasal valve collapse
18438|NCT03456089|urodynamics|urodynamics
18439|NCT03456089|neurogenic|neurogenic
18440|NCT03456089|bladder|bladder
18441|NCT03456076|NSCLC, alectinib, ALK positive,adjuvant treatment, platinum based chemotherapy, complete resection, Stage IB-IIIA.|nsclc, alectinib, alk positive,adjuvant treatment, platinum based chemotherapy, complete resection, stage ib-iiia.
18442|NCT03456037|HBsAg|hbsag
18443|NCT03456037|Anti-HCV,|anti-hcv,
18444|NCT03456037|seropositivity|seropositivity
18445|NCT03455998|morbid obesity|morbid obesity
18446|NCT03455998|gastric bypass|gastric bypass
18447|NCT03455998|pain|pain
18448|NCT03455998|symptoms|symptoms
18449|NCT03455959|Asthma|asthma
18450|NCT03455959|Allergic|allergic
18451|NCT03455959|Inflammation|inflammation
18452|NCT03455959|Airway|airway
18453|NCT03455946|Digital Health|digital health
18454|NCT03455946|Amazon Alexa|amazon alexa
18455|NCT03455907|Bevacizumab|bevacizumab
18456|NCT03455894|Fall detection|fall detection
18457|NCT03455894|Smart carpet|smart carpet
18458|NCT03455894|Elderly people|elderly people
18459|NCT03455881|TEF|tef
18460|NCT03455881|EA|ea
18461|NCT03455881|Tracheal Esophageal birth Defect (TED)|tracheal esophageal birth defect (ted)
18463|NCT03455855|occlusive atherosclerotic lesions|occlusive atherosclerotic lesions
18464|NCT03455829|Lung Cancer|lung cancer
18465|NCT03455829|Non-small Cell Lung Cancer|non-small cell lung cancer
18466|NCT03455829|CDK 4/6 Inhibitor|cdk 4/6 inhibitor
18467|NCT03455829|EGFR-Positive|egfr-positive
18468|NCT03455829|EGFR Mutation- Positive|egfr mutation- positive
18469|NCT03455829|T790M|t790m
18470|NCT03455829|EGFR Mutant|egfr mutant
18471|NCT03455816|mobile app|mobile app
18472|NCT03455790|Wheelchair Basketball,|wheelchair basketball,
18473|NCT03455790|Isokinetic|isokinetic
18474|NCT03455790|Anaerobic Capacity|anaerobic capacity
18475|NCT03455790|Shoulder Muscle Strength|shoulder muscle strength
18476|NCT03455790|Aerobic Capacity,|aerobic capacity,
18477|NCT03455790|Sportive Performance|sportive performance
18478|NCT03455764|Melanoma|melanoma
18479|NCT03455751|Pain Management|pain management
18480|NCT03455751|Pharmacogenomics|pharmacogenomics
18481|NCT03455738|Vasoplegia, norepinephrine, dynamic arterial elastance|vasoplegia, norepinephrine, dynamic arterial elastance
18482|NCT03455725|Cardiovascular Stem Cell Therapy|cardiovascular stem cell therapy
18483|NCT03455725|Bone Marrow Mononuclear Stem Cells|bone marrow mononuclear stem cells
18484|NCT03455725|Intramyocardial Injection|intramyocardial injection
18485|NCT03455712|Pregnancy|pregnancy
18486|NCT03455712|Gestational weight gain|gestational weight gain
18487|NCT03455712|Weight gain|weight gain
18488|NCT03455712|Patient education|patient education
18489|NCT03455712|Patient knowledge|patient knowledge
18490|NCT03455712|Institute of Medicine|institute of medicine
18492|NCT03455686|magnetic resonance imaging|magnetic resonance imaging
18493|NCT03455686|hyperpolarized xenon-129|hyperpolarized xenon-129
18494|NCT03455686|lung function|lung function
18495|NCT03455686|lung structure|lung structure
18496|NCT03455660|Cesarean|cesarean
18497|NCT03455660|C-Section|c-section
18498|NCT03455647|stunting|stunting
18499|NCT03455647|underweight|underweight
18500|NCT03455647|wasting|wasting
18501|NCT03455634|quality of life|quality of life
18502|NCT03455621|dental caries|dental caries
18503|NCT03455621|fluoride|fluoride
18504|NCT03455621|toothpaste|toothpaste
18505|NCT03455621|dentifrice|dentifrice
18506|NCT03455608|dysphagia|dysphagia
18507|NCT03455608|swallowing disorder|swallowing disorder
18508|NCT03455608|speech pathology|speech pathology
18509|NCT03455608|swallowing therapy|swallowing therapy
18510|NCT03455608|head and neck cancer|head and neck cancer
18511|NCT03455608|radiotherapy|radiotherapy
18512|NCT03455608|toxicity|toxicity
18513|NCT03455608|supportive care|supportive care
18514|NCT03455582|cognitive impairment|cognitive impairment
18515|NCT03455582|ecological assessment|ecological assessment
18516|NCT03455582|brain MRI|brain mri
18517|NCT03455569|Behavioral sleep management|behavioral sleep management
18518|NCT03455569|Alzheimer's disease|alzheimer's disease
18519|NCT03455569|Informal caregiver|informal caregiver
18520|NCT03455517|Chronic myeloid leukemia|chronic myeloid leukemia
18521|NCT03455517|Umutated IGVH|umutated igvh
18522|NCT03455517|Disrupted TP53|disrupted tp53
18523|NCT03455504|Acute myeloid leukemia|acute myeloid leukemia
18524|NCT03455504|Venetoclax|venetoclax
18525|NCT03455413|electrical impedance tomography|electrical impedance tomography
18526|NCT03455387|sFLt1|sflt1
18527|NCT03455387|PlGF|plgf
18528|NCT03455361|implant stability, dental implants, primary stability|implant stability, dental implants, primary stability
18529|NCT03455309|Als3|als3
18530|NCT03455309|SSTI|ssti
18531|NCT03455309|vaccine|vaccine
18532|NCT03455309|NDV-3A|ndv-3a
18533|NCT03455309|incident nasal colonization|incident nasal colonization
18534|NCT03455270|Breast Cancer|breast cancer
18535|NCT03455270|Oral SERD|oral serd
18536|NCT03455270|SERD|serd
18537|NCT03455270|HER2-Negative|her2-negative
18538|NCT03455270|ER-Positive|er-positive
18539|NCT03455270|ER+|er+
18540|NCT03455270|HER2-|her2-
18541|NCT03455270|HER2 -ve|her2 -ve
18542|NCT03455270|ER +ve|er +ve
18543|NCT03455231|palliative care|palliative care
18544|NCT03455231|complicated bone metastases|complicated bone metastases
18545|NCT03455231|radiotherapy|radiotherapy
18546|NCT03455231|pain|pain
18547|NCT03455231|quality of life|quality of life
18548|NCT03455218|Cardiopulmonary Bypass|cardiopulmonary bypass
18549|NCT03455218|Infant|infant
18550|NCT03455218|Nitric Oxide|nitric oxide
18551|NCT03455218|Thrombocytopenia|thrombocytopenia
18552|NCT03455218|Blood Platelets|blood platelets
18553|NCT03455192|gingivitis|gingivitis
18554|NCT03455192|gingival crevicular fluid|gingival crevicular fluid
18555|NCT03455192|probiotics|probiotics
18556|NCT03455192|smoking|smoking
18557|NCT03455192|periodontal medicine|periodontal medicine
18558|NCT03455179|Older|older
18559|NCT03455179|Physical function|physical function
18560|NCT03455179|Power training|power training
18561|NCT03455179|Oxidative stress|oxidative stress
18562|NCT03455179|Elastic band|elastic band
18563|NCT03455179|OMNI-RES perceived exertion scale|omni-res perceived exertion scale
18564|NCT03455179|Strength training|strength training
18565|NCT03455153|Pulmonary Rehabilitation|pulmonary rehabilitation
18566|NCT03455153|Neutrophils|neutrophils
18567|NCT03455140|Arginine|arginine
18568|NCT03455140|Arginase|arginase
18569|NCT03455140|Children|children
18570|NCT03455140|Young Adult|young adult
18571|NCT03455127|Child Development|child development
18572|NCT03455127|Home Visiting|home visiting
18573|NCT03455127|Parenting Program|parenting program
18574|NCT03455127|Social Protection|social protection
18575|NCT03455127|Public Works|public works
18576|NCT03455101|Cardiovascular risk status|cardiovascular risk status
18577|NCT03455101|Optimal metabolic control|optimal metabolic control
18578|NCT03455075|Healthy Men|healthy men
18579|NCT03455075|Male Contraception|male contraception
18580|NCT03455075|Androgen|androgen
18581|NCT03455075|Dimethandrolone|dimethandrolone
18582|NCT03455075|Levonorgestrel|levonorgestrel
18583|NCT03455062|Transplant, fertility|transplant, fertility
18584|NCT03455036|whole body vibration, erythema, tryptase, unpleasantness|whole body vibration, erythema, tryptase, unpleasantness
18585|NCT03455023|Cancer pain|cancer pain
18586|NCT03455023|Pharmaceutical care|pharmaceutical care
18587|NCT03455010|Ambulatory load|ambulatory load
18588|NCT03455010|Biomarker|biomarker
18589|NCT03455010|Articular cartilage|articular cartilage
18590|NCT03454945|Mycosis fungoides|mycosis fungoides
18591|NCT03454945|Doxycycline|doxycycline
18592|NCT03454932|Rheumatoid Arthritis|rheumatoid arthritis
18593|NCT03454932|Psoriatic Arthritis|psoriatic arthritis
18594|NCT03454932|Spondylarthritis|spondylarthritis
18595|NCT03454932|Rheumatic diseases|rheumatic diseases
18596|NCT03454932|Inflammation|inflammation
18597|NCT03454932|Autoimmune diseases|autoimmune diseases
18598|NCT03454932|Osteoimmunology|osteoimmunology
18599|NCT03454906|hemodialysis|hemodialysis
18600|NCT03454906|hemoglobin variability|hemoglobin variability
18601|NCT03454906|mortality|mortality
18602|NCT03454906|nutrition|nutrition
18603|NCT03454906|inflammation|inflammation
18604|NCT03454880|Accelerometry|accelerometry
18605|NCT03454880|Wearable electronic devices|wearable electronic devices
18606|NCT03454854|risk evaluation|risk evaluation
18607|NCT03454854|individualized treatment|individualized treatment
18608|NCT03454854|coronary artery disease|coronary artery disease
18609|NCT03454854|antithrombotic therapy|antithrombotic therapy
18610|NCT03454854|Chinese people|chinese people
18611|NCT03454854|Application|application
18612|NCT03454841|prasugrel|prasugrel
18613|NCT03454841|ticagrelor|ticagrelor
18614|NCT03454841|VASP|vasp
18615|NCT03454841|platelet reactivity|platelet reactivity
18616|NCT03454841|STEMI|stemi
18617|NCT03454841|NSTEMI|nstemi
18618|NCT03454815|Apical Patency|apical patency
18619|NCT03454815|Root Canal Treatment|root canal treatment
18620|NCT03454789|brachial plexus block|brachial plexus block
18621|NCT03454789|local anesthetic mixture solution|local anesthetic mixture solution
18622|NCT03454789|axillary-supraclavicular approach|axillary-supraclavicular approach
18623|NCT03454789|outcome quality|outcome quality
18624|NCT03454789|lidocaine, bupivacaine|lidocaine, bupivacaine
18625|NCT03454789|onset time|onset time
18626|NCT03454789|duration action local anesthetic|duration action local anesthetic
18627|NCT03454789|postoperative analgesia|postoperative analgesia
18628|NCT03454763|sst2-positive tumors|sst2-positive tumors
18629|NCT03454763|Neuroendocrine Tumors|neuroendocrine tumors
18630|NCT03454763|radiolabelled somatostatin analogues (PRRT)|radiolabelled somatostatin analogues (prrt)
18631|NCT03454750|Metastatic castration resistant prostate cancer|metastatic castration resistant prostate cancer
18632|NCT03454750|68Ga-PSMA PET/CT positive|68ga-psma pet/ct positive
18633|NCT03454724|BioResorbable Vascular Scaffold System|bioresorbable vascular scaffold system
18634|NCT03454711|Obesity|obesity
18635|NCT03454711|Food addictions|food addictions
18636|NCT03454711|Functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
18637|NCT03454711|Metabolomics|metabolomics
18638|NCT03454633|Hyperthermic circulatory arrest; Surgery|hyperthermic circulatory arrest; surgery
18639|NCT03454607|FREE|free
18640|NCT03454607|Robotic|robotic
18641|NCT03454594|hypertension|hypertension
18642|NCT03454594|high blood viscosity|high blood viscosity
18643|NCT03454581|Temporomandibular Diseases|temporomandibular diseases
18644|NCT03454581|Photobiomodulation|photobiomodulation
18645|NCT03454581|Low level laser|low level laser
18646|NCT03454581|Treatment|treatment
18647|NCT03454581|Manual Therapy|manual therapy
18648|NCT03454568|Stem Cell Transplant|stem cell transplant
18649|NCT03454555|Pragmatic Clinical Trial|pragmatic clinical trial
18650|NCT03454555|Comparative Effectiveness Research|comparative effectiveness research
18651|NCT03454555|Analgesics, Opioid|analgesics, opioid
18652|NCT03454555|Decision Making, Shared|decision making, shared
18653|NCT03454555|Motivational Interviewing|motivational interviewing
18654|NCT03454555|Cognitive Therapy|cognitive therapy
18655|NCT03454555|Patient Reported Outcome Measures|patient reported outcome measures
18656|NCT03454516|Hypertension|hypertension
18657|NCT03454516|Telemonitoring|telemonitoring
18658|NCT03454516|Digital Health|digital health
18659|NCT03454503|Imatinib|imatinib
18660|NCT03454503|Generic Imatinib|generic imatinib
18661|NCT03454503|Leukemia|leukemia
18662|NCT03454503|Chronic myeloid leukemia|chronic myeloid leukemia
18663|NCT03454503|Philadelphia chromosome-positive|philadelphia chromosome-positive
18664|NCT03454503|Chronic phase|chronic phase
18665|NCT03454503|Observational study|observational study
18666|NCT03454503|Switched patients|switched patients
18667|NCT03454503|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
18668|NCT03454490|Gingival graft|gingival graft
18669|NCT03454490|Pseudoaneurysm|pseudoaneurysm
18670|NCT03454490|Postoperative complication|postoperative complication
18671|NCT03454490|Gingival recession treatment|gingival recession treatment
18672|NCT03454490|Palatine mass|palatine mass
18673|NCT03454490|Palatine bleeding|palatine bleeding
18674|NCT03454477|Endoscopy|endoscopy
18675|NCT03454477|Robotics|robotics
18676|NCT03454477|Thyroidectomy|thyroidectomy
18677|NCT03454477|Papillary Thyroid Carcinoma|papillary thyroid carcinoma
18678|NCT03454451|NSCLC|nsclc
18679|NCT03454451|RCC|rcc
18680|NCT03454451|TNBC|tnbc
18681|NCT03454451|mCRPC|mcrpc
18682|NCT03454451|CRC|crc
18683|NCT03454451|Lung Cancer|lung cancer
18684|NCT03454451|Kidney Cancer|kidney cancer
18685|NCT03454451|Rectal Cancer|rectal cancer
18686|NCT03454451|Breast Cancer|breast cancer
18687|NCT03454451|Sarcoma|sarcoma
18688|NCT03454451|Endometrial|endometrial
18689|NCT03454451|Pancreatic|pancreatic
18690|NCT03454451|Ovarian|ovarian
18691|NCT03454451|SCCHN|scchn
18692|NCT03454438|Referral|referral
18693|NCT03454438|Primary care|primary care
18694|NCT03454438|Rheumatologist|rheumatologist
18695|NCT03454425|Parkinson's Disease|parkinson's disease
18696|NCT03454425|ExAblate|exablate
18697|NCT03454425|MRgFUS|mrgfus
18698|NCT03454425|Sub-Thalamotomy|sub-thalamotomy
18699|NCT03454412|Cerebral Palsy|cerebral palsy
18700|NCT03454412|Rehabilitation|rehabilitation
18701|NCT03454412|Hand|hand
18702|NCT03454386|Irritable Bowel Syndrome (IBS)|irritable bowel syndrome (ibs)
18703|NCT03454386|Stress|stress
18704|NCT03454386|Resilience|resilience
18705|NCT03454386|Stress Management and Resilience Training Program (SMART)|stress management and resilience training program (smart)
18706|NCT03454373|HIV|hiv
18707|NCT03454373|Food Insecurities|food insecurities
18708|NCT03454373|Antiretroviral Therapy|antiretroviral therapy
18709|NCT03454360|TAVI|tavi
18710|NCT03454360|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
18711|NCT03454360|Transcatheter Aortic Valve|transcatheter aortic valve
18712|NCT03454360|Transapical Access|transapical access
18713|NCT03454321|Rotator cuff tendinopathy|rotator cuff tendinopathy
18714|NCT03454321|ultrasound|ultrasound
18715|NCT03454321|subacromial bursitis|subacromial bursitis
18716|NCT03454321|steroid injection|steroid injection
18717|NCT03454295|Cancer Caregivers|cancer caregivers
18718|NCT03454295|Caregiver|caregiver
18719|NCT03454295|Caregivers|caregivers
18720|NCT03454295|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
18721|NCT03454295|18-075|18-075
18722|NCT03454282|Breast|breast
18723|NCT03454282|Cancer|cancer
18724|NCT03454282|Malignant|malignant
18725|NCT03454282|Melanoma|melanoma
18726|NCT03454282|Fasting Mimicking Diet (FMD)|fasting mimicking diet (fmd)
18727|NCT03454282|Tumor|tumor
18728|NCT03454282|Immunity|immunity
18729|NCT03454282|Metabolic Effects|metabolic effects
18730|NCT03454282|Immunological Effects|immunological effects
18731|NCT03454269|Parkinson disease|parkinson disease
18732|NCT03454269|Visual Hallucinations|visual hallucinations
18733|NCT03454269|Illusions|illusions
18734|NCT03454269|Retina|retina
18735|NCT03454256|Virtual Reality|virtual reality
18736|NCT03454256|Total Knee Replacement|total knee replacement
18737|NCT03454256|Proprioception|proprioception
18738|NCT03454256|Balance|balance
18739|NCT03454256|Gait|gait
18740|NCT03454243|Solid Tumors|solid tumors
18741|NCT03454243|TYRO3|tyro3
18743|NCT03454243|MER|mer
18744|NCT03454243|Receptor tyrosine kinases (RTKs)|receptor tyrosine kinases (rtks)
18745|NCT03454243|Checkpoint inhibitors|checkpoint inhibitors
18746|NCT03454243|Melanoma|melanoma
18747|NCT03454243|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
18748|NCT03454243|Squamous cell carcinoma|squamous cell carcinoma
18749|NCT03454243|Hodgkin lymphoma|hodgkin lymphoma
18750|NCT03454243|Urothelial carcinoma|urothelial carcinoma
18751|NCT03454243|Microsatellite instability-high carcinomas|microsatellite instability-high carcinomas
18752|NCT03454243|TAM Inhibitor|tam inhibitor
18753|NCT03454230|Intensive care unit|intensive care unit
18754|NCT03454230|ICU|icu
18755|NCT03454230|adult critical care patients|adult critical care patients
18756|NCT03454230|repositioning schedule|repositioning schedule
18757|NCT03454230|patient handling|patient handling
18758|NCT03454230|practical nursing|practical nursing
18759|NCT03454230|nursing care|nursing care
18760|NCT03454230|pressure ulcers|pressure ulcers
18761|NCT03454230|decubitus ulcers|decubitus ulcers
18762|NCT03454230|pressure injury|pressure injury
18763|NCT03454178|AOBP|aobp
18764|NCT03454178|ABPM|abpm
18765|NCT03454139|percutaneous nephrolithotomy|percutaneous nephrolithotomy
18766|NCT03454139|subcostal transversus abdominis plane block|subcostal transversus abdominis plane block
18767|NCT03454139|pain|pain
18768|NCT03454139|paracetamol|paracetamol
18769|NCT03454139|tramadol|tramadol
18770|NCT03454139|morphine|morphine
18771|NCT03454139|nephrolithiasis|nephrolithiasis
18772|NCT03454139|lidocaine|lidocaine
18773|NCT03454139|bupivacaine|bupivacaine
18774|NCT03454126|Chronic pain|chronic pain
18775|NCT03454126|Neuropathic pain|neuropathic pain
18776|NCT03454126|Neuralgia|neuralgia
18777|NCT03454126|Healthy volunteers|healthy volunteers
18778|NCT03454113|dialysis autogenous arterio-venous fistula|dialysis autogenous arterio-venous fistula
18779|NCT03454087|enteral nutrition|enteral nutrition
18780|NCT03454087|inflammation|inflammation
18781|NCT03454087|incretin hormones|incretin hormones
18782|NCT03454087|microbiome|microbiome
18783|NCT03454074|healthy aging|healthy aging
18784|NCT03454074|behavior change|behavior change
18785|NCT03454074|older adults|older adults
18786|NCT03454061|sport|sport
18787|NCT03454061|physical activity|physical activity
18788|NCT03454061|education|education
18789|NCT03454061|fundamental motor skills|fundamental motor skills
18790|NCT03454061|childhood|childhood
18791|NCT03454061|exercise|exercise
18792|NCT03454061|health|health
18793|NCT03454061|training|training
18794|NCT03454061|intervention|intervention
18795|NCT03454061|gross motor development|gross motor development
18796|NCT03454009|multi-modal intervention;|multi-modal intervention;
18797|NCT03454009|office-based employees|office-based employees
18798|NCT03454009|hand hygiene|hand hygiene
18799|NCT03454009|hand sanitizer|hand sanitizer
18800|NCT03454009|hand sanitizer surface wipes|hand sanitizer surface wipes
18801|NCT03454009|self-reported infections|self-reported infections
18802|NCT03454009|absenteeism|absenteeism
18803|NCT03454009|presenteeism|presenteeism
18804|NCT03453996|acute kidney injury|acute kidney injury
18805|NCT03453996|heart disease|heart disease
18806|NCT03453996|cardiac catheterization|cardiac catheterization
18807|NCT03453983|Neurodevelopment|neurodevelopment
18808|NCT03453983|Pediatrics|pediatrics
18809|NCT03453983|Motor Learning|motor learning
18810|NCT03453983|Brain Imaging|brain imaging
18811|NCT03453983|Neuroscience|neuroscience
18812|NCT03453970|patient education|patient education
18813|NCT03453970|self-care|self-care
18814|NCT03453970|Controlled Trial|controlled trial
18815|NCT03453957|Practice based research|practice based research
18816|NCT03453944|Expiratory muscles|expiratory muscles
18817|NCT03453944|Mechanically ventilated patients|mechanically ventilated patients
18818|NCT03453944|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
18819|NCT03453944|Respiratory function|respiratory function
18820|NCT03453944|Ventilator-acquired muscle atrophy|ventilator-acquired muscle atrophy
18821|NCT03453931|Corticosteroids|corticosteroids
18822|NCT03453931|Arrhythmia|arrhythmia
18823|NCT03453931|Heart Rate Variability|heart rate variability
18824|NCT03453931|Albuminuria|albuminuria
18825|NCT03453918|Iron absorption|iron absorption
18826|NCT03453918|Polyphenols|polyphenols
18827|NCT03453918|Dysmetabolic iron overload syndrome|dysmetabolic iron overload syndrome
18828|NCT03453918|Metabolic syndrome X|metabolic syndrome x
18829|NCT03453918|Genetic Hemochromatosis|genetic hemochromatosis
18830|NCT03453918|Oxylipin|oxylipin
18831|NCT03453918|Lipidomic analysis|lipidomic analysis
18832|NCT03453905|CT-based Finite Element Analysis|ct-based finite element analysis
18833|NCT03453905|Randomized Controlled Study|randomized controlled study
18834|NCT03453905|Preventive bone fixation|preventive bone fixation
18835|NCT03453905|Randomized Controlled Trial|randomized controlled trial
18836|NCT03453892|Metastatic cancer|metastatic cancer
18837|NCT03453892|Radiotherapy|radiotherapy
18838|NCT03453892|Immunotherapy|immunotherapy
18839|NCT03453892|radioimmuno therapy|radioimmuno therapy
18840|NCT03453866|Hip Arthroscopy|hip arthroscopy
18841|NCT03453866|Warmed Fluids|warmed fluids
18842|NCT03453853|Percutaneous mitral valve repair|percutaneous mitral valve repair
18843|NCT03453853|Coronary sinus annuloplasty|coronary sinus annuloplasty
18844|NCT03453853|Mitral loop cerclage|mitral loop cerclage
18845|NCT03453853|atrial fibrillation|atrial fibrillation
18846|NCT03453853|Mitral Regurgitation|mitral regurgitation
18847|NCT03453840|malaria|malaria
18849|NCT03453840|Children|children
18850|NCT03453840|Efavirenz|efavirenz
18851|NCT03453840|artemether|artemether
18852|NCT03453840|lumefantrine|lumefantrine
18853|NCT03453827|Pseudoexfoliation Syndrome|pseudoexfoliation syndrome
18854|NCT03453827|Cataract|cataract
18855|NCT03453827|Aberration|aberration
18856|NCT03453827|IOL decentration|iol decentration
18857|NCT03453827|IOL tilt|iol tilt
18858|NCT03453814|PICU|picu
18859|NCT03453814|critical care|critical care
18860|NCT03453814|music|music
18861|NCT03453814|music therapy|music therapy
18862|NCT03453814|agitation|agitation
18962|NCT03453307|NSCLC|nsclc
18863|NCT03453801|Inactivated, influenza vaccine quadrivalent|inactivated, influenza vaccine quadrivalent
18864|NCT03453801|Live, attenuated influenza vaccine quadrivalent|live, attenuated influenza vaccine quadrivalent
18865|NCT03453801|Young children|young children
18866|NCT03453801|Identical twins|identical twins
18867|NCT03453788|follow up|follow up
18868|NCT03453788|side effects|side effects
18869|NCT03453788|smartphone app|smartphone app
18870|NCT03453788|physical activity|physical activity
18871|NCT03453788|empowerment|empowerment
18872|NCT03453788|patient reported outcomes|patient reported outcomes
18873|NCT03453749|Traumatic brain injury|traumatic brain injury
18874|NCT03453749|Cerebral edema|cerebral edema
18875|NCT03453749|Microdialysis|microdialysis
18876|NCT03453749|Inflammatory cytokines|inflammatory cytokines
18877|NCT03453736|Robotic surgery|robotic surgery
18878|NCT03453736|theatre staff|theatre staff
18879|NCT03453736|teamwork|teamwork
18880|NCT03453736|patient safety|patient safety
18881|NCT03453723|hypnoanalgesia|hypnoanalgesia
18882|NCT03453723|lidocaine|lidocaine
18883|NCT03453723|propofol|propofol
18884|NCT03453723|children|children
18885|NCT03453710|Bankart Repair|bankart repair
18886|NCT03453710|Remplissage|remplissage
18887|NCT03453710|Latarjet coracoid transfer|latarjet coracoid transfer
18888|NCT03453697|Intermittent Hypoxemia|intermittent hypoxemia
18889|NCT03453697|diffusion tensor imaging|diffusion tensor imaging
18890|NCT03453697|oxidative stress|oxidative stress
18891|NCT03453658|Endodontics|endodontics
18892|NCT03453658|Primary Teeth|primary teeth
18893|NCT03453658|Reciprocating instrumentation|reciprocating instrumentation
18894|NCT03453658|Mechanized instrumentation|mechanized instrumentation
18895|NCT03453645|ablation|ablation
18896|NCT03453645|sudden death|sudden death
18897|NCT03453645|signal averaged ECG|signal averaged ecg
18898|NCT03453645|T wave alternans|t wave alternans
18899|NCT03453645|heart rate variability|heart rate variability
18900|NCT03453632|Dermatology|dermatology
18901|NCT03453632|Rare skin diseases|rare skin diseases
18902|NCT03453632|epidermolysis bullosa simplex|epidermolysis bullosa simplex
18903|NCT03453632|botulinic toxin|botulinic toxin
18904|NCT03453632|blisters|blisters
18905|NCT03453606|Pulmonary rehabilitation|pulmonary rehabilitation
18906|NCT03453606|home-based|home-based
18907|NCT03453593|Trauma|trauma
18908|NCT03453593|India|india
18909|NCT03453593|Computed tomography|computed tomography
18910|NCT03453567|TAVR|tavr
18911|NCT03453567|SAVR|savr
18912|NCT03453567|TAVI|tavi
18913|NCT03453567|Conventional AVR|conventional avr
18914|NCT03453567|Sutureless AVR|sutureless avr
18915|NCT03453554|technology|technology
18916|NCT03453554|activities of daily living|activities of daily living
18917|NCT03453554|everyday functioning|everyday functioning
18918|NCT03453554|quality of life|quality of life
18919|NCT03453554|memory impairment|memory impairment
18920|NCT03453528|mCRPC or advanced/metastatic solid tumors|mcrpc or advanced/metastatic solid tumors
18921|NCT03453528|Prostate-specific membrane antigen|prostate-specific membrane antigen
18922|NCT03453502|quality improvement|quality improvement
18923|NCT03453502|breast milk|breast milk
18924|NCT03453476|Photodynamic therapy|photodynamic therapy
18925|NCT03453476|Interleukin 1-beta|interleukin 1-beta
18926|NCT03453476|Tumour necrosis factor - alpha|tumour necrosis factor - alpha
18927|NCT03453476|Interleukin-6|interleukin-6
18928|NCT03453476|Interleukin-8|interleukin-8
18929|NCT03453476|Matrix metalloproteinase-8|matrix metalloproteinase-8
18930|NCT03453463|sarcopenia|sarcopenia
18931|NCT03453463|osteopenia|osteopenia
18932|NCT03453463|older men|older men
18933|NCT03453463|community dwelling|community dwelling
18934|NCT03453463|physical functioning|physical functioning
18935|NCT03453450|Primary Care|primary care
18936|NCT03453411|Equimolar Mixture of Oxygen and Nitrous Oxide (EMONO)|equimolar mixture of oxygen and nitrous oxide (emono)
18937|NCT03453411|Substance-Related Disorders|substance-related disorders
18938|NCT03453398|Chronotype|chronotype
18939|NCT03453398|Shift work|shift work
18940|NCT03453398|Health status|health status
18941|NCT03453385|Smoking|smoking
18942|NCT03453385|Nicotine|nicotine
18943|NCT03453385|Tobacco|tobacco
18944|NCT03453385|Electronic Cigarette|electronic cigarette
18945|NCT03453372|Osteoarthritis|osteoarthritis
18946|NCT03453372|Knee|knee
18947|NCT03453372|MRgFUS|mrgfus
18948|NCT03453372|ExAblate|exablate
18949|NCT03453372|Pain|pain
18950|NCT03453372|High-Intensity Focused Ultrasound Ablation|high-intensity focused ultrasound ablation
18951|NCT03453359|deep sedation|deep sedation
18952|NCT03453359|spontaneous ventilation|spontaneous ventilation
18953|NCT03453346|Hepatitis C virus|hepatitis c virus
18954|NCT03453346|Sofosbuvir|sofosbuvir
18955|NCT03453346|RNA polymerase inhibitor|rna polymerase inhibitor
18956|NCT03453346|Ribavirin|ribavirin
18957|NCT03453346|Genotype 2|genotype 2
18958|NCT03453346|Sustained virologic response|sustained virologic response
18959|NCT03453346|Confirmatory study|confirmatory study
18960|NCT03453307|Tumor Organoids|tumor organoids
18961|NCT03453307|Drug Sensitivity|drug sensitivity
18963|NCT03453294|THRIVE|thrive
18964|NCT03453281|Aflibercept|aflibercept
18965|NCT03453281|Diabetic Macular Edema|diabetic macular edema
18966|NCT03453281|Electroretinogram|electroretinogram
18967|NCT03453281|Central Macular Thickness|central macular thickness
18968|NCT03453281|ETDRS|etdrs
18969|NCT03453268|Blood pressure|blood pressure
18970|NCT03453268|Aged|aged
18971|NCT03453268|Frailty|frailty
18972|NCT03453268|Polypharmacy|polypharmacy
18973|NCT03453255|AML, chidamide, decitabine|aml, chidamide, decitabine
18974|NCT03453242|Osteoporosis|osteoporosis
18975|NCT03453203|Chronic migraine|chronic migraine
18976|NCT03453203|Osteopathic manipulative treatment|osteopathic manipulative treatment
18977|NCT03453203|Cervicalgia|cervicalgia
18978|NCT03453164|Radiotherapy|radiotherapy
18979|NCT03453164|anti-PD-1 antibody|anti-pd-1 antibody
18980|NCT03453138|laryngel mask airway|laryngel mask airway
18981|NCT03453138|laparoscopic surgery|laparoscopic surgery
18982|NCT03453125|cognitive rehabilitation|cognitive rehabilitation
18983|NCT03453125|memory|memory
18984|NCT03453112|Peek Expiratory Flow (PEF) Lung function tests|peek expiratory flow (pef) lung function tests
18985|NCT03453099|propofol|propofol
18986|NCT03453099|anaesthetic dose|anaesthetic dose
18987|NCT03453099|sleep|sleep
18988|NCT03453099|caffeine|caffeine
18989|NCT03453099|anxiety|anxiety
18990|NCT03453099|induction|induction
18991|NCT03453073|Coronary heart disease|coronary heart disease
18992|NCT03453073|stroke|stroke
18993|NCT03453073|chocolate consumption|chocolate consumption
18994|NCT03453073|postmenopausal women|postmenopausal women
18995|NCT03453073|nutrition|nutrition
18996|NCT03453073|dietary intake|dietary intake
18997|NCT03453073|epidemiology|epidemiology
18998|NCT03453047|S100β|s100β
18999|NCT03453047|Neuron specific enolase|neuron specific enolase
19000|NCT03453047|Liver transplantation|liver transplantation
19001|NCT03453034|TQ-B3233|tq-b3233
19002|NCT03453034|tumor|tumor
19003|NCT03453034|toleration|toleration
19004|NCT03453034|pharmacokinetics|pharmacokinetics
19005|NCT03453021|asthma|asthma
19006|NCT03453021|mepolizumab|mepolizumab
19007|NCT03453021|corticosteroids|corticosteroids
19008|NCT03453008|Cerebrovascular Accident|cerebrovascular accident
19009|NCT03453008|Botulinum toxin A|botulinum toxin a
19010|NCT03453008|Stroke|stroke
19011|NCT03452982|SENTINEL LYMPH NODE|sentinel lymph node
19012|NCT03452969|visual outcomes|visual outcomes
19013|NCT03452969|mulitfocal intraocular lens|mulitfocal intraocular lens
19014|NCT03452969|patient satisfaction|patient satisfaction
19015|NCT03452969|spectacle independence|spectacle independence
19016|NCT03452969|contrast sensitivity|contrast sensitivity
19017|NCT03452943|Tourette Syndrome|tourette syndrome
19018|NCT03452943|adolescents|adolescents
19019|NCT03452943|children|children
19020|NCT03452930|Malignant neoplasms of eye brain and other parts of central nervous system|malignant neoplasms of eye brain and other parts of central nervous system
19021|NCT03452930|Unmethylated Glioblastoma|unmethylated glioblastoma
19022|NCT03452930|nGBM|ngbm
19023|NCT03452930|Glioma|glioma
19024|NCT03452930|Gliosarcoma|gliosarcoma
19025|NCT03452930|EDO-S101|edo-s101
19026|NCT03452930|Radiation Therapy|radiation therapy
19027|NCT03452930|XRT|xrt
19028|NCT03452904|In suit coronary lesions|in suit coronary lesions
19029|NCT03452904|Drug-coated balloon|drug-coated balloon
19030|NCT03452904|Drug-eluting stent|drug-eluting stent
19031|NCT03452904|Restenosis|restenosis
19032|NCT03452878|Amygdala, neurosurgery, aggressive behavior|amygdala, neurosurgery, aggressive behavior
19033|NCT03452865|proton pump inhibitor|proton pump inhibitor
19034|NCT03452865|esomeprazole|esomeprazole
19035|NCT03452865|sepsis|sepsis
19036|NCT03452865|septic shock|septic shock
19037|NCT03452865|organ failure|organ failure
19038|NCT03452865|SOFA|sofa
19039|NCT03452865|mortality|mortality
19040|NCT03452852|Split thickness skin graft|split thickness skin graft
19041|NCT03452852|Lower leg|lower leg
19042|NCT03452852|Compression therapy|compression therapy
19043|NCT03452852|PICO|pico
19044|NCT03452852|Coban 2 lite|coban 2 lite
19045|NCT03452839|meropenem|meropenem
19046|NCT03452839|antibiotic resistance|antibiotic resistance
19047|NCT03452839|critical illness|critical illness
19048|NCT03452839|β-lactams|β-lactams
19049|NCT03452839|continuous antibacterial drug infusion|continuous antibacterial drug infusion
19050|NCT03452839|mortality|mortality
19051|NCT03452813|transitions of care|transitions of care
19052|NCT03452813|stroke disparities|stroke disparities
19053|NCT03452800|addiction|addiction
19054|NCT03452800|mental health|mental health
19055|NCT03452787|Body mass index|body mass index
19056|NCT03452787|genetics|genetics
19057|NCT03452787|diet|diet
19058|NCT03452787|saturated fat|saturated fat
19059|NCT03452774|artificial intelligence|artificial intelligence
19060|NCT03452774|virtual tumor board|virtual tumor board
19061|NCT03452774|clinical trial|clinical trial
19062|NCT03452774|clinical trial matching|clinical trial matching
19063|NCT03452774|electronic medical record|electronic medical record
19064|NCT03452774|machine learning|machine learning
19065|NCT03452774|cost of care|cost of care
19066|NCT03452774|targeted therapy|targeted therapy
19067|NCT03452774|immunotherapy|immunotherapy
19068|NCT03452774|precision medicine|precision medicine
19069|NCT03452774|precision oncology|precision oncology
19070|NCT03452774|cancer|cancer
19071|NCT03452774|value based care|value based care
19072|NCT03452774|real world data|real world data
19073|NCT03452774|data analytics|data analytics
19074|NCT03452761|exogenous ketone salts|exogenous ketone salts
19075|NCT03452761|ketosis|ketosis
19076|NCT03452761|safety|safety
19077|NCT03452761|comprehensive metabolic panel|comprehensive metabolic panel
19078|NCT03452761|complete blood count|complete blood count
19079|NCT03452761|lipid panel|lipid panel
19080|NCT03452761|insulin|insulin
19081|NCT03452735|Chronic inflammatory rheumatism|chronic inflammatory rheumatism
19082|NCT03452735|Fertility|fertility
19083|NCT03452735|Procreation|procreation
19084|NCT03452722|secondary brain injury|secondary brain injury
19085|NCT03452722|neuroinflammation|neuroinflammation
19086|NCT03452709|Cardiovascular Disease;|cardiovascular disease;
19087|NCT03452709|primary prevention;|primary prevention;
19088|NCT03452709|physical activity;|physical activity;
19089|NCT03452709|Blood Pressure Monitoring, Ambulatory|blood pressure monitoring, ambulatory
19090|NCT03452670|Workplace|workplace
19091|NCT03452670|Applications|applications
19092|NCT03452670|Anxiety|anxiety
19093|NCT03452670|Burnout|burnout
19094|NCT03452670|Meditation|meditation
19095|NCT03452670|Mindfulness|mindfulness
19096|NCT03452644|US-CNB|us-cnb
19097|NCT03452644|Soft Tissue Mass|soft tissue mass
19098|NCT03452644|Soft Tissue Sarcoma|soft tissue sarcoma
19099|NCT03452644|Soft Tissue Neoplasm|soft tissue neoplasm
19100|NCT03452644|Soft Tissue Lesion|soft tissue lesion
19101|NCT03452631|Psoas hematomas|psoas hematomas
19102|NCT03452618|diagnostic criteria|diagnostic criteria
19103|NCT03452579|Nivolumab|nivolumab
19104|NCT03452579|Bevacizumab|bevacizumab
19105|NCT03452566|actinic cheilitis|actinic cheilitis
19106|NCT03452566|ingenol mebutate|ingenol mebutate
19107|NCT03452566|treatment|treatment
19108|NCT03452566|phase 1/2 clinical trial|phase 1/2 clinical trial
19109|NCT03452553|Liver Cancer|liver cancer
19110|NCT03452553|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
19111|NCT03452553|Trans Arterial Chemo Embolization (TACE)|trans arterial chemo embolization (tace)
19112|NCT03452553|Drug Eluting Beads (DEB)|drug eluting beads (deb)
19113|NCT03452553|Doxorubicin (DOX)|doxorubicin (dox)
19114|NCT03452501|Infliximab|infliximab
19115|NCT03452501|Remsima|remsima
19116|NCT03452501|Biosimilar|biosimilar
19117|NCT03452501|Inflammatory Bowel Diseases|inflammatory bowel diseases
19118|NCT03452501|Crohn's Disease|crohn's disease
19119|NCT03452501|Ulcerative Colitis|ulcerative colitis
19120|NCT03452501|Fistulizing Crohn's Disease|fistulizing crohn's disease
19121|NCT03452501|Observational|observational
19122|NCT03452501|Follow up|follow up
19123|NCT03452501|Safety|safety
19124|NCT03452501|Effectiveness|effectiveness
19125|NCT03452501|Disease modifying anti-rheumatic drugs|disease modifying anti-rheumatic drugs
19126|NCT03452501|Tumor necrosis factor-alpha inhibitors|tumor necrosis factor-alpha inhibitors
19127|NCT03452488|Sarcopenia|sarcopenia
19128|NCT03452488|Sarcopenic Obesity|sarcopenic obesity
19129|NCT03452488|6-minute walking distance|6-minute walking distance
19130|NCT03452488|400 meters walking test|400 meters walking test
19131|NCT03452488|Patient Reported Outcomes|patient reported outcomes
19132|NCT03452488|BIO101|bio101
19133|NCT03452488|SPPB|sppb
19134|NCT03452488|ALM; ALM/BMI|alm; alm/bmi
19135|NCT03452449|activity monitor|activity monitor
19136|NCT03452449|questionnaire|questionnaire
19137|NCT03452449|Oswestry Disability Index|oswestry disability index
19138|NCT03452436|Cancer-related Cognitive Impairment|cancer-related cognitive impairment
19139|NCT03452436|Cognitive Dysfunction|cognitive dysfunction
19140|NCT03452436|Cognition Disorders|cognition disorders
19141|NCT03452436|Neurocognitive Disorder|neurocognitive disorder
19142|NCT03452436|Testosterone|testosterone
19143|NCT03452436|Endocrinology|endocrinology
19144|NCT03452436|Testicular Cancer|testicular cancer
19145|NCT03452436|Prostate Cancer|prostate cancer
19146|NCT03452423|Osteoarthritis of knees|osteoarthritis of knees
19147|NCT03452423|Arthroscopic cartilage regeneration facilitating procedure (ACRFP)|arthroscopic cartilage regeneration facilitating procedure (acrfp)
19148|NCT03452423|Foot pressure|foot pressure
19149|NCT03452423|Gait|gait
19150|NCT03452410|Vestibular neuritis|vestibular neuritis
19151|NCT03452410|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
19152|NCT03452410|Vertigo|vertigo
19153|NCT03452410|Fluid attenuated inversion recuperation (FLAIR)|fluid attenuated inversion recuperation (flair)
19154|NCT03452384|Acupuncture|acupuncture
19155|NCT03452384|Traditional chinese medicine|traditional chinese medicine
19156|NCT03452384|Major depressive disorder|major depressive disorder
19157|NCT03452371|Patient Navigation|patient navigation
19158|NCT03452371|Hospitalized smokers|hospitalized smokers
19159|NCT03452332|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
19160|NCT03452332|Cervical Cancer|cervical cancer
19161|NCT03452332|Vaginal Cancer|vaginal cancer
19162|NCT03452332|Vulvar Cancer|vulvar cancer
19163|NCT03452332|Durvalumab|durvalumab
19164|NCT03452332|MEDI4736|medi4736
19165|NCT03452332|Tremelimumab|tremelimumab
19166|NCT03452332|Ticilimumab|ticilimumab
19167|NCT03452332|CP-675,206|cp-675,206
19168|NCT03452332|Stereotactic Ablative Radiotherapy|stereotactic ablative radiotherapy
19169|NCT03452332|SABR|sabr
19170|NCT03452332|Radiation therapy|radiation therapy
19171|NCT03452319|Thoracoabdominal surgery|thoracoabdominal surgery
19172|NCT03452319|Physical Therapy|physical therapy
19173|NCT03452319|Inspiratory Muscle Training|inspiratory muscle training
19174|NCT03452319|Physical Activity|physical activity
19175|NCT03452306|AUC|auc
19176|NCT03452306|Cmax|cmax
19177|NCT03452306|Pharmacokinetics|pharmacokinetics
19178|NCT03452306|metformin|metformin
19179|NCT03452306|fed|fed
19180|NCT03452306|fasting|fasting
19181|NCT03452254|Stroke|stroke
19182|NCT03452254|Upper Extremity Paresis|upper extremity paresis
19183|NCT03452254|Neuro Rehabilitation|neuro rehabilitation
19184|NCT03452254|tDCS|tdcs
19185|NCT03452254|mCIMT|mcimt
19186|NCT03452254|Occupational Therapy|occupational therapy
19187|NCT03452241|Screening, Brief Intervention, and Referral to Treatment|screening, brief intervention, and referral to treatment
19188|NCT03452241|Substance Use|substance use
19189|NCT03452215|Pregnancy|pregnancy
19190|NCT03452215|Mobile Phone Application|mobile phone application
19191|NCT03452202|Stroke|stroke
19192|NCT03452111|Healthy Men|healthy men
19193|NCT03452111|Couple|couple
19194|NCT03452111|Gel|gel
19195|NCT03452111|Male Contraception|male contraception
19196|NCT03452111|Nestorone|nestorone
19197|NCT03452111|Testosterone|testosterone
19198|NCT03452085|xerostomia|xerostomia
19199|NCT03452085|diabetes type II|diabetes type ii
19200|NCT03452085|salivary flow|salivary flow
19201|NCT03452085|antioxidant capacity of saliva|antioxidant capacity of saliva
19202|NCT03452085|aldiamed|aldiamed
19203|NCT03452059|Paralysis|paralysis
19204|NCT03452059|Lower Extremities|lower extremities
19205|NCT03452059|Ai-Robotics|ai-robotics
19206|NCT03452046|Ultrasound,inferior vena cava, positive pressure|ultrasound,inferior vena cava, positive pressure
19207|NCT03452033|glaucoma|glaucoma
19208|NCT03452007|Epidural Stimulation|epidural stimulation
19209|NCT03452007|Bladder dysfunction|bladder dysfunction
19210|NCT03452007|Spinal cord injury|spinal cord injury
19211|NCT03451981|surgical therapy|surgical therapy
19212|NCT03451981|laser|laser
19213|NCT03451981|air powder|air powder
19214|NCT03451968|amino acid|amino acid
19215|NCT03451968|stable isotope|stable isotope
19216|NCT03451968|critical care|critical care
19217|NCT03451955|gluten|gluten
19218|NCT03451955|gluten free diet|gluten free diet
19219|NCT03451955|blood brain barrier permeability|blood brain barrier permeability
19220|NCT03451955|intestinal permeability|intestinal permeability
19221|NCT03451955|neuroinflammation|neuroinflammation
19222|NCT03451955|autoimmunity|autoimmunity
19223|NCT03451929|primary healthcare|primary healthcare
19224|NCT03451929|cohort|cohort
19225|NCT03451903|stroke|stroke
19226|NCT03451903|thrombectomy|thrombectomy
19227|NCT03451903|procedure time|procedure time
19228|NCT03451903|revascularisation|revascularisation
19229|NCT03451903|thrombolytic therapy|thrombolytic therapy
19230|NCT03451890|Healthy participants|healthy participants
19231|NCT03451890|E2730|e2730
19232|NCT03451890|Pharmacokinetics|pharmacokinetics
19233|NCT03451877|High myopia|high myopia
19234|NCT03451877|TGFB1Gene Polymorphisms|tgfb1gene polymorphisms
19235|NCT03451877|LAMA1 Gene Polymorphisms|lama1 gene polymorphisms
19236|NCT03451825|Avelumab|avelumab
19237|NCT03451825|Anti PD-L1|anti pd-l1
19238|NCT03451825|Solid tumors|solid tumors
19239|NCT03451825|CNS tumors|cns tumors
19240|NCT03451825|Lymphoma|lymphoma
19241|NCT03451825|Pediatric subjects|pediatric subjects
19242|NCT03451812|prostate cancer|prostate cancer
19243|NCT03451812|metabolomics|metabolomics
19244|NCT03451812|molecular imaging|molecular imaging
19245|NCT03451812|PET|pet
19246|NCT03451812|MRI|mri
19247|NCT03451812|11C-choline tracer|11c-choline tracer
19248|NCT03451799|Glioblastoma|glioblastoma
19249|NCT03451799|Ketogenic diet|ketogenic diet
19250|NCT03451799|Keto diet|keto diet
19251|NCT03451799|GBM|gbm
19252|NCT03451773|TGF Ligand Trap|tgf ligand trap
19253|NCT03451773|Extracellular Domain of Human TGF Receptor II|extracellular domain of human tgf receptor ii
19254|NCT03451773|Avelumab|avelumab
19255|NCT03451773|Human IgG1 mAb Directed Against Human PD-L1|human igg1 mab directed against human pd-l1
19256|NCT03451773|Health-Related Quality of Life|health-related quality of life
19257|NCT03451747|hypertension|hypertension
19258|NCT03451747|female|female
19259|NCT03451643|colorectal cancer|colorectal cancer
19260|NCT03451643|liver metastases|liver metastases
19261|NCT03451643|stage IV|stage iv
19262|NCT03451591|Cerebral Small Vessel Diseases|cerebral small vessel diseases
19263|NCT03451591|Stroke, Lacunar|stroke, lacunar
19264|NCT03451591|Dementia|dementia
19265|NCT03451591|Alzheimer's disease|alzheimer's disease
19266|NCT03451578|macular degeneration|macular degeneration
19267|NCT03451578|blindness|blindness
19268|NCT03451565|Hypotension|hypotension
19269|NCT03451565|Systemic blood pressure|systemic blood pressure
19270|NCT03451552|Community Resources, Patient Navigator|community resources, patient navigator
19271|NCT03451539|Anaesthetist|anaesthetist
19272|NCT03451539|ICU|icu
19273|NCT03451539|Intensif care unit|intensif care unit
19274|NCT03451526|Chinese|chinese
19275|NCT03451526|real-world evidences|real-world evidences
19276|NCT03451526|NSCLC|nsclc
19277|NCT03451526|surgeries|surgeries
19278|NCT03451513|Prevention|prevention
19279|NCT03451513|Sexual minority men|sexual minority men
19280|NCT03451513|Internalization of the appearance ideal|internalization of the appearance ideal
19281|NCT03451513|Body dissatisfaction|body dissatisfaction
19282|NCT03451500|GPR 143|gpr 143
19283|NCT03451500|PEDF|pedf
19284|NCT03451500|VEGF|vegf
19285|NCT03451500|LDOPA|ldopa
19286|NCT03451487|acetaminophen|acetaminophen
19287|NCT03451487|acute liver failure|acute liver failure
19288|NCT03451461|Asynchronies|asynchronies
19289|NCT03451448|PET/MRI|pet/mri
19290|NCT03451448|ultra-small-superparamagnetic particles|ultra-small-superparamagnetic particles
19291|NCT03451422|AMG 592|amg 592
19292|NCT03451422|Systemic lupus erythematosus|systemic lupus erythematosus
19293|NCT03451422|Phase 1b/2a|phase 1b/2a
19294|NCT03451396|Dry eye|dry eye
19295|NCT03451396|Tear osmolarity|tear osmolarity
19296|NCT03451396|Lifitegrast|lifitegrast
19297|NCT03451383|breast cancer|breast cancer
19298|NCT03451383|cognitive decline|cognitive decline
19299|NCT03451370|Bevacizumab|bevacizumab
19300|NCT03451370|Capecitabine|capecitabine
19301|NCT03451370|Oxaliplatin|oxaliplatin
19302|NCT03451370|CRASH score|crash score
19303|NCT03451370|ECOG PS|ecog ps
19304|NCT03451370|G8 score|g8 score
19305|NCT03451357|stroke|stroke
19306|NCT03451357|dependence degree|dependence degree
19307|NCT03451357|social care|social care
19308|NCT03451357|health care|health care
19309|NCT03451357|disability|disability
19310|NCT03451344|Mobile Health|mobile health
19311|NCT03451344|Illicit drug use|illicit drug use
19312|NCT03451344|Rehabilitation|rehabilitation
19313|NCT03451344|Community|community
19314|NCT03451344|China|china
19315|NCT03451331|cisplatin-ineligible|cisplatin-ineligible
19316|NCT03451331|gemcitabine|gemcitabine
19317|NCT03451331|carboplatin|carboplatin
19318|NCT03451331|nivolumab|nivolumab
19319|NCT03451331|oxaliplatin|oxaliplatin
19320|NCT03451305|Compression fracture, postural reduction, vertebroplasty|compression fracture, postural reduction, vertebroplasty
19321|NCT03451266|preeclampsia|preeclampsia
19322|NCT03451266|vitamin C|vitamin c
19323|NCT03451266|lung ultrasound|lung ultrasound
19324|NCT03451240|Stress|stress
19325|NCT03451240|Resilience|resilience
19326|NCT03451227|Sedation, Analgesia|sedation, analgesia
19327|NCT03451201|Exercise|exercise
19328|NCT03451201|High-Intensity Interval Training|high-intensity interval training
19329|NCT03451201|Type 1 diabetes|type 1 diabetes
19330|NCT03451201|Endothelial Dysfunction|endothelial dysfunction
19331|NCT03451175|Overactive Detrusor|overactive detrusor
19332|NCT03451175|Multiple Sclerosis|multiple sclerosis
19333|NCT03451175|Reproductibility|reproductibility
19334|NCT03451175|Cystometry|cystometry
19335|NCT03451149|TIPS|tips
19336|NCT03451136|Placenta previa|placenta previa
19337|NCT03451136|Cervical length|cervical length
19338|NCT03451136|Antepartum haemorrhage|antepartum haemorrhage
19339|NCT03451110|Drug-Drug Interactions|drug-drug interactions
19340|NCT03451110|Lemborexant|lemborexant
19341|NCT03451110|Oral Contraceptive|oral contraceptive
19342|NCT03451110|Famotidine|famotidine
19343|NCT03451110|Fluconazole|fluconazole
19344|NCT03451110|Pharmacokinetics|pharmacokinetics
19345|NCT03451110|Proton pump inhibitors|proton pump inhibitors
19346|NCT03451110|CYP3A inhibitors|cyp3a inhibitors
19347|NCT03451084|AML, ASLAN, DHODH|aml, aslan, dhodh
19348|NCT03451058|Traumatic brain injury, eye tracking, EEG, cognition|traumatic brain injury, eye tracking, eeg, cognition
19349|NCT03451045|Pulmonary exacerbation, lenabasum, JBT-101|pulmonary exacerbation, lenabasum, jbt-101
19350|NCT03451032|HIV exposition treatment|hiv exposition treatment
19351|NCT03451032|sexual risk|sexual risk
19352|NCT03451032|blood risk|blood risk
19353|NCT03451019|chronic kidney disease - mineral bone disorder, phosphate-binders|chronic kidney disease - mineral bone disorder, phosphate-binders
19354|NCT03450993|Mind-Body|mind-body
19355|NCT03450980|Double Vision, Amblyopia|double vision, amblyopia
19356|NCT03450928|Peroral Endoscopic Myotomy|peroral endoscopic myotomy
19357|NCT03450928|Endoscopy|endoscopy
19358|NCT03450928|POEM|poem
19359|NCT03450928|Submucosal endoscopy|submucosal endoscopy
19360|NCT03450915|Influenza|influenza
19361|NCT03450915|vaccine|vaccine
19362|NCT03450915|universal|universal
19363|NCT03450915|M-001|m-001
19364|NCT03450915|Multimeric-001|multimeric-001
19365|NCT03450915|Flu|flu
19366|NCT03450902|Urinary incontinence, Chinese herb, Acupuncture|urinary incontinence, chinese herb, acupuncture
19367|NCT03450837|Coronary artery disease; HDL; anabolic steroids|coronary artery disease; hdl; anabolic steroids
19368|NCT03450824|Patellofemoral Pain Syndrome|patellofemoral pain syndrome
19369|NCT03450824|Anterior Knee Pain|anterior knee pain
19370|NCT03450824|Knee Varus|knee varus
19371|NCT03450811|complication|complication
19372|NCT03450811|uroflowmetry|uroflowmetry
19373|NCT03450759|Heart failure.|heart failure.
19374|NCT03450759|Mineralocorticoid receptor modulator.|mineralocorticoid receptor modulator.
19375|NCT03450759|Heart failure with preserved ejection fraction (HFpEF).|heart failure with preserved ejection fraction (hfpef).
19376|NCT03450733|Metal-on-Metal|metal-on-metal
19377|NCT03450733|MOM|mom
19378|NCT03450733|Total Hip Arthroplasty|total hip arthroplasty
19379|NCT03450733|THA|tha
19380|NCT03450707|cardiac arrest|cardiac arrest
19381|NCT03450707|post-arrest|post-arrest
19382|NCT03450681|Pain Management|pain management
19383|NCT03450681|Knee Replacement Arthroplasty|knee replacement arthroplasty
19384|NCT03450681|Postoperative Pain|postoperative pain
19385|NCT03450681|Pulsed Radiofrequency Treatment|pulsed radiofrequency treatment
19386|NCT03450668|neonatal, incubator, thermal-regulation|neonatal, incubator, thermal-regulation
19387|NCT03450590|heart rate variability|heart rate variability
19388|NCT03450590|intraarterial chemotherapy|intraarterial chemotherapy
19389|NCT03450590|ophthalmic arterial chemotherapy|ophthalmic arterial chemotherapy
19390|NCT03450538|Trauma|trauma
19391|NCT03450538|Computed tomography|computed tomography
19392|NCT03450538|India|india
19393|NCT03450512|Neutropenic enterocolitis, acute myeloid leukemia, abdominal tomodensitometry|neutropenic enterocolitis, acute myeloid leukemia, abdominal tomodensitometry
19394|NCT03450486|dynamic balance|dynamic balance
19395|NCT03450486|star excursion balance test|star excursion balance test
19396|NCT03450486|exercise|exercise
19397|NCT03450473|Mesh|mesh
19398|NCT03450460|peer support|peer support
19399|NCT03450460|feasibility trial|feasibility trial
19400|NCT03450460|mixed methods|mixed methods
19401|NCT03450447|Head and Neck Cancer|head and neck cancer
19402|NCT03450447|Esophageal Cancer|esophageal cancer
19403|NCT03450447|endoscopic submucosal dissection|endoscopic submucosal dissection
19404|NCT03450447|quality of life|quality of life
19405|NCT03450447|median survival time|median survival time
19406|NCT03450382|community health|community health
19407|NCT03450382|mental health|mental health
19408|NCT03450382|behavior change|behavior change
19409|NCT03450382|social support|social support
19410|NCT03450382|health promotion|health promotion
19411|NCT03450304|Multidetector Computed Tomography|multidetector computed tomography
19412|NCT03450304|Pulmonary Embolism|pulmonary embolism
19413|NCT03450304|Hypertension Pulmonary Secondary|hypertension pulmonary secondary
19414|NCT03450291|Computational|computational
19415|NCT03450252|HCM|hcm
19416|NCT03450252|Mid-cavity|mid-cavity
19417|NCT03450252|Pacing|pacing
19418|NCT03450239|MRI|mri
19419|NCT03450200|Diabetic Peripheral Neuropathy, Exercises|diabetic peripheral neuropathy, exercises
19420|NCT03450148|aversive therapy|aversive therapy
19421|NCT03450135|puberty|puberty
19422|NCT03450135|EEG|eeg
19423|NCT03450135|estradiol|estradiol
19424|NCT03450135|mood|mood
19425|NCT03450135|stress|stress
19426|NCT03450122|Malignant neoplasms of bone and articular cartilage|malignant neoplasms of bone and articular cartilage
19427|NCT03450122|Malignant neoplasms of mesothelial and soft tissue|malignant neoplasms of mesothelial and soft tissue
19428|NCT03450122|Synovial sarcoma|synovial sarcoma
19429|NCT03450122|Myxoid liposarcoma|myxoid liposarcoma
19430|NCT03450122|CD8+ antigen specific T cells|cd8+ antigen specific t cells
19431|NCT03450122|Cyclophosphamide|cyclophosphamide
19432|NCT03450122|Cytoxan|cytoxan
19433|NCT03450122|Neosar|neosar
19434|NCT03450122|IL-2|il-2
19435|NCT03450122|Aldesleukin|aldesleukin
19436|NCT03450122|Interleukin|interleukin
19437|NCT03450122|Proleukin|proleukin
19438|NCT03450122|LV305|lv305
19439|NCT03450122|ID-LV305|id-lv305
19440|NCT03450122|CMB305|cmb305
19441|NCT03450044|Chemotherapy|chemotherapy
19442|NCT03450044|Breast Cancer|breast cancer
19443|NCT03450044|Dendritic cells|dendritic cells
19444|NCT03450044|Immunotherapy|immunotherapy
19445|NCT03450044|Doxorubicine|doxorubicine
19446|NCT03450018|Gemcitabine|gemcitabine
19447|NCT03450018|SLC-0111|slc-0111
19448|NCT03450018|PDAC|pdac
19449|NCT03449979|tACS|tacs
19450|NCT03449979|transcranial alternating current stimulation|transcranial alternating current stimulation
19451|NCT03449979|stimulation|stimulation
19452|NCT03449979|heart rate variability|heart rate variability
19453|NCT03449979|electroencephalogram|electroencephalogram
19454|NCT03449979|EEG|eeg
19455|NCT03449966|pCLE|pcle
19456|NCT03449966|confocal|confocal
19457|NCT03449966|Advanced gastric cancer|advanced gastric cancer
19458|NCT03449966|chemotherapy|chemotherapy
19459|NCT03449940|Penile fracture|penile fracture
19460|NCT03449940|Delayed|delayed
19461|NCT03449940|Localized|localized
19462|NCT03449940|Repair|repair
19463|NCT03449927|Nutrition Tool|nutrition tool
19464|NCT03449927|Melphalan Autologous Transplant|melphalan autologous transplant
19465|NCT03449914|ECOG PS|ecog ps
19466|NCT03449914|Timed Up and Go test|timed up and go test
19467|NCT03449914|G8 score|g8 score
19468|NCT03449823|Renal Artery Doppler|renal artery doppler
19469|NCT03449810|Muscles Energy Technique, Low Back Pain|muscles energy technique, low back pain
19470|NCT03449797|aldosterone|aldosterone
19471|NCT03449797|cortisol|cortisol
19472|NCT03449797|adrenal vein sampling|adrenal vein sampling
19473|NCT03449797|primary aldosteronism|primary aldosteronism
19474|NCT03449784|dyslipidemia|dyslipidemia
19475|NCT03449784|lipid-lowering therapy|lipid-lowering therapy
19476|NCT03449784|cardiovascular risk|cardiovascular risk
19477|NCT03449784|diabetes|diabetes
19478|NCT03449784|low-density lipoprotein cholesterol|low-density lipoprotein cholesterol
19479|NCT03449771|HIV|hiv
19480|NCT03449771|Pre-exposure prophylaxis|pre-exposure prophylaxis
19481|NCT03449771|Recreational drugs|recreational drugs
19482|NCT03449771|Chemsex|chemsex
19483|NCT03449771|Mental disorders|mental disorders
19484|NCT03449745|Acute Myeloid Leukemia|acute myeloid leukemia
19485|NCT03449745|Immune Checkpoint Ligand|immune checkpoint ligand
19486|NCT03449745|Flow Cytometry|flow cytometry
19487|NCT03449706|Reservoir|reservoir
19488|NCT03449680|hip arthroscopy|hip arthroscopy
19489|NCT03449680|femoral articular branch block|femoral articular branch block
19490|NCT03449615|Cutaneous melanoma|cutaneous melanoma
19491|NCT03449615|Sentinel node biopsy|sentinel node biopsy
19492|NCT03449602|thoracoscopy|thoracoscopy
19493|NCT03449602|pleuroscopy|pleuroscopy
19494|NCT03449602|metastatic cancer|metastatic cancer
19495|NCT03449602|lung cancer|lung cancer
19496|NCT03449602|malignant pleural effusion|malignant pleural effusion
19497|NCT03449602|tuberculosis|tuberculosis
19498|NCT03449576|PTSD|ptsd
19499|NCT03449576|neuroimaging|neuroimaging
19500|NCT03449576|fMRI|fmri
19501|NCT03449576|veterans|veterans
19502|NCT03449576|exposure therapy|exposure therapy
19503|NCT03449576|treatment|treatment
19504|NCT03449563|thoracic paravertebral block|thoracic paravertebral block
19505|NCT03449563|postoperative analgesia|postoperative analgesia
19506|NCT03449563|pulmonary lobectomy|pulmonary lobectomy
19507|NCT03449550|Child obstructive sleep apnea|child obstructive sleep apnea
19508|NCT03449550|Home Respiratory Polygraphy|home respiratory polygraphy
19509|NCT03449550|Diagnosis|diagnosis
19510|NCT03449550|Validity|validity
19511|NCT03449550|Polysomnography|polysomnography
19512|NCT03449524|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
19513|NCT03449524|Pulmonary Hypertension|pulmonary hypertension
19514|NCT03449524|PAH|pah
19515|NCT03449524|Connective Tissue Disease-Associated|connective tissue disease-associated
19516|NCT03449524|6 Minute Walk Test|6 minute walk test
19517|NCT03449524|6 Minute Walk Distance|6 minute walk distance
19518|NCT03449524|Pulmonary Vascular Resistance|pulmonary vascular resistance
19519|NCT03449524|Cardiac MRI|cardiac mri
19520|NCT03449524|Right Ventricular Function|right ventricular function
19521|NCT03449524|Hypertension|hypertension
19522|NCT03449524|Familial Primary Pulmonary Hypertension|familial primary pulmonary hypertension
19523|NCT03449524|Connective Tissue Diseases|connective tissue diseases
19524|NCT03449524|Vascular Diseases|vascular diseases
19525|NCT03449524|Cardiovascular Diseases|cardiovascular diseases
19526|NCT03449524|Hypertension, Pulmonary|hypertension, pulmonary
19527|NCT03449524|Lung Diseases|lung diseases
19528|NCT03449485|Bariatric surgery|bariatric surgery
19529|NCT03449485|Gastrointestinal tract|gastrointestinal tract
19530|NCT03449485|Biological availability|biological availability
19531|NCT03449485|Pharmacokinetics|pharmacokinetics
19532|NCT03449485|Chlorprothixene|chlorprothixene
19533|NCT03449472|Bariatric surgery|bariatric surgery
19534|NCT03449472|Gastrointestinal tract|gastrointestinal tract
19535|NCT03449472|Biological availability|biological availability
19536|NCT03449472|Pharmacokinetics|pharmacokinetics
19537|NCT03449472|Quetiapine fumarate|quetiapine fumarate
19538|NCT03449459|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
19539|NCT03449459|aerosol inhaled amikacin|aerosol inhaled amikacin
19540|NCT03449459|oral probiotics|oral probiotics
19541|NCT03449459|combined influenza and pneumococcal vaccine inoculation|combined influenza and pneumococcal vaccine inoculation
19542|NCT03449459|bacterial decolonization in lower respiratory tract|bacterial decolonization in lower respiratory tract
19543|NCT03449420|thromboelastography|thromboelastography
19544|NCT03449407|Auditory hallucinations|auditory hallucinations
19545|NCT03449407|Psychosis|psychosis
19546|NCT03449407|Mood|mood
19547|NCT03449407|Brain imaging|brain imaging
19548|NCT03449407|Experience sampling method|experience sampling method
19549|NCT03449394|Psychosis|psychosis
19550|NCT03449394|Depression|depression
19551|NCT03449394|Metacognition|metacognition
19552|NCT03449394|Attribution|attribution
19553|NCT03449394|Emotions|emotions
19554|NCT03449355|sexuality|sexuality
19555|NCT03449355|mode of delivery|mode of delivery
19556|NCT03449355|quality of life|quality of life
19557|NCT03449316|Nebulizers and Vaporizers|nebulizers and vaporizers
19558|NCT03449303|breast cancer|breast cancer
19559|NCT03449303|CIPN|cipn
19560|NCT03449303|Pain|pain
19561|NCT03449303|QOL|qol
19562|NCT03449303|Essential Oils|essential oils
19563|NCT03449251|Apelin|apelin
19564|NCT03449251|Relaxin|relaxin
19565|NCT03449212|SOD1|sod1
19566|NCT03449212|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
19567|NCT03449212|ALS|als
19568|NCT03449212|Kinetics|kinetics
19569|NCT03449212|Amyotrophic Lateral Sclerosis, Familial|amyotrophic lateral sclerosis, familial
19570|NCT03449212|Amyotrophic Lateral Sclerosis, Sporadic|amyotrophic lateral sclerosis, sporadic
19571|NCT03449186|periodontitis|periodontitis
19572|NCT03449186|postpartum|postpartum
19573|NCT03449121|Breathing|breathing
19574|NCT03449121|Mind-body|mind-body
19575|NCT03449108|Malignant neoplasms of bone and articular cartilage|malignant neoplasms of bone and articular cartilage
19576|NCT03449108|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
19577|NCT03449108|Cyclophosphamide|cyclophosphamide
19578|NCT03449108|Cytoxan|cytoxan
19579|NCT03449108|Neosar|neosar
19580|NCT03449108|Fludarabine|fludarabine
19581|NCT03449108|Fludarabine phosphate|fludarabine phosphate
19582|NCT03449108|Fludara|fludara
19583|NCT03449108|LN-145|ln-145
19584|NCT03449108|IL-2|il-2
19585|NCT03449108|Aldesleukin|aldesleukin
19586|NCT03449108|Interleukin|interleukin
19587|NCT03449108|Proleukin|proleukin
19588|NCT03449108|Mesna|mesna
19589|NCT03449108|Questionnaires|questionnaires
19590|NCT03449108|Surveys|surveys
19591|NCT03449082|adipose derived mesenchymal stem cell|adipose derived mesenchymal stem cell
19592|NCT03449082|allogeneic stem cell|allogeneic stem cell
19593|NCT03449030|Drug Therapy|drug therapy
19594|NCT03449017|nicotine|nicotine
19595|NCT03449017|alcohol|alcohol
19596|NCT03449017|vape|vape
19597|NCT03449017|electronic cigarette|electronic cigarette
19598|NCT03449004|Validation|validation
19599|NCT03449004|questionnaire|questionnaire
19600|NCT03449004|satisfaction|satisfaction
19601|NCT03449004|online information|online information
19602|NCT03448991|NPO time|npo time
19603|NCT03448991|Gastric content|gastric content
19604|NCT03448991|Gastric pH|gastric ph
19605|NCT03448939|papulopustular rosacea|papulopustular rosacea
19606|NCT03448926|DCIS|dcis
19607|NCT03448926|molecular testing|molecular testing
19608|NCT03448926|risk of recurrence|risk of recurrence
19609|NCT03448913|Anesthesia, Regional ;PECS block|anesthesia, regional ;pecs block
19610|NCT03448900|Cessation|cessation
19611|NCT03448900|College student|college student
19612|NCT03448900|Motivational Interview|motivational interview
19613|NCT03448900|Self-efficacy|self-efficacy
19614|NCT03448900|Intention|intention
19615|NCT03448900|Beliefs|beliefs
19616|NCT03448900|Young adult|young adult
19617|NCT03448887|End-stage renal disease|end-stage renal disease
19618|NCT03448887|Medium cut-off dialyzer|medium cut-off dialyzer
19619|NCT03448887|Hemodiafiltration|hemodiafiltration
19620|NCT03448887|Cardiovascular|cardiovascular
19621|NCT03448887|Pulse wave velocity|pulse wave velocity
19622|NCT03448835|short term immunotherapy|short term immunotherapy
19623|NCT03448835|surgical resection|surgical resection
19624|NCT03448835|atezolizumab|atezolizumab
19625|NCT03448835|capecitabine|capecitabine
19626|NCT03448835|oxaliplatin|oxaliplatin
19627|NCT03448835|docetaxel|docetaxel
19628|NCT03448809|Cognitive and Behavioral Therapies|cognitive and behavioral therapies
19629|NCT03448809|Children and Adolescents|children and adolescents
19630|NCT03448809|Community Health Care|community health care
19631|NCT03448809|Early Intervention|early intervention
19632|NCT03448809|Feasibility Study|feasibility study
19633|NCT03448796|High tibial osteotomy|high tibial osteotomy
19634|NCT03448796|Osteoarthrosis|osteoarthrosis
19635|NCT03448796|Tomofix|tomofix
19636|NCT03448796|Randomized controlled trial|randomized controlled trial
19637|NCT03448783|Bariatric surgery|bariatric surgery
19638|NCT03448783|Gastrointestinal tract|gastrointestinal tract
19639|NCT03448783|Biological availability|biological availability
19640|NCT03448783|Pharmacokinetics|pharmacokinetics
19641|NCT03448783|Apixaban|apixaban
19642|NCT03448757|LEEF|leef
19643|NCT03448757|hemodynamic parameters|hemodynamic parameters
19644|NCT03448757|heart beat|heart beat
19645|NCT03448757|biofeedback effect|biofeedback effect
19646|NCT03448744|thymosin alpha|thymosin alpha
19647|NCT03448744|entecavir|entecavir
19648|NCT03448705|influenza|influenza
19649|NCT03448679|glycocalyx|glycocalyx
19650|NCT03448679|serum albumin|serum albumin
19651|NCT03448679|orthotopic liver transplantation|orthotopic liver transplantation
19652|NCT03448679|colloid osmotic pressure|colloid osmotic pressure
19653|NCT03448679|endothelial dysfunction|endothelial dysfunction
19654|NCT03448666|ECT|ect
19655|NCT03448666|pembrolizumab|pembrolizumab
19656|NCT03448666|advanced melanoma|advanced melanoma
19657|NCT03448627|stem cell transplantation|stem cell transplantation
19658|NCT03448627|Pulmonary Functions|pulmonary functions
19659|NCT03448627|muscle strength|muscle strength
19660|NCT03448627|exercise capacity|exercise capacity
19758|NCT03448003|Surveys|surveys
19661|NCT03448614|skull base reconstrction|skull base reconstrction
19662|NCT03448601|Precision Medicine|precision medicine
19663|NCT03448575|Youth|youth
19664|NCT03448575|Mental Health|mental health
19665|NCT03448575|Psychotropic|psychotropic
19666|NCT03448575|Medication Safety|medication safety
19667|NCT03448575|Quality Improvement|quality improvement
19668|NCT03448562|Atrial Fibrillation|atrial fibrillation
19669|NCT03448562|Pulmonary Vein Isolation|pulmonary vein isolation
19670|NCT03448562|Catheter Ablation|catheter ablation
19671|NCT03448562|Substrate Modification|substrate modification
19672|NCT03448549|Tegafur，gimeracil and oteracil potassium|tegafur，gimeracil and oteracil potassium
19673|NCT03448549|Capecitabine|capecitabine
19674|NCT03448549|compliance|compliance
19675|NCT03448549|quality of life|quality of life
19676|NCT03448549|adverse reaction|adverse reaction
19677|NCT03448549|disease free survival|disease free survival
19678|NCT03448549|overall survival|overall survival
19679|NCT03448536|Primary dysmenorrhea of at least moderate severity|primary dysmenorrhea of at least moderate severity
19680|NCT03448510|lower urinary tract symptoms|lower urinary tract symptoms
19681|NCT03448510|male|male
19682|NCT03448510|benign prostatic obstruction|benign prostatic obstruction
19683|NCT03448510|irreversible electroporation|irreversible electroporation
19684|NCT03448510|urodynamics|urodynamics
19685|NCT03448471|stem cell transplantation|stem cell transplantation
19686|NCT03448471|Fatigue|fatigue
19687|NCT03448471|muscle strength|muscle strength
19688|NCT03448471|exercise capacity|exercise capacity
19689|NCT03448471|Depression|depression
19690|NCT03448471|Quality of Life|quality of life
19691|NCT03448445|High-risk|high-risk
19692|NCT03448445|Low-risk|low-risk
19693|NCT03448445|Alzheimer's disease|alzheimer's disease
19694|NCT03448445|Observational study|observational study
19695|NCT03448432|Pregnancy Anemia|pregnancy anemia
19696|NCT03448393|CD-19 expressing tumor|cd-19 expressing tumor
19697|NCT03448393|CD-22 Expressing Tumor|cd-22 expressing tumor
19698|NCT03448393|Adoptive Immunotherapy|adoptive immunotherapy
19699|NCT03448393|Philadelphia chromosome (Ph)+ ALL|philadelphia chromosome (ph)+ all
19700|NCT03448393|Lymphoma|lymphoma
19701|NCT03448354|HIPEC|hipec
19702|NCT03448354|Interval debulking surgery|interval debulking surgery
19703|NCT03448341|radiotherapy|radiotherapy
19704|NCT03448341|IMRT|imrt
19705|NCT03448341|dysphagia|dysphagia
19706|NCT03448341|Oropharynx|oropharynx
19707|NCT03448341|Nasopharynx|nasopharynx
19708|NCT03448341|FEES|fees
19709|NCT03448341|VFS|vfs
19710|NCT03448328|muscular strength|muscular strength
19711|NCT03448328|inflammation|inflammation
19712|NCT03448328|protein|protein
19713|NCT03448315|brain stimulation, tDCS, acute postoperative pain, chronic pain|brain stimulation, tdcs, acute postoperative pain, chronic pain
19714|NCT03448289|Postpartum|postpartum
19715|NCT03448289|Contraception|contraception
19716|NCT03448276|Osteoporosis|osteoporosis
19717|NCT03448276|Muscle Strength|muscle strength
19718|NCT03448276|Postural Balance|postural balance
19719|NCT03448276|Vibration|vibration
19720|NCT03448276|Walking|walking
19721|NCT03448263|pain|pain
19722|NCT03448263|post endodontic pain|post endodontic pain
19723|NCT03448263|root canal treatment|root canal treatment
19724|NCT03448198|total knee arthroplasty|total knee arthroplasty
19725|NCT03448198|patellar resurfacing|patellar resurfacing
19726|NCT03448198|patellar tracking|patellar tracking
19727|NCT03448198|patello-femoral joint kinematics|patello-femoral joint kinematics
19728|NCT03448198|surgical navigation|surgical navigation
19729|NCT03448198|computer-aided surgery|computer-aided surgery
19730|NCT03448159|Stroke|stroke
19731|NCT03448159|Exercise|exercise
19732|NCT03448159|Fluoxetine|fluoxetine
19733|NCT03448159|Randomized Control Trial|randomized control trial
19734|NCT03448159|Rehabilitation|rehabilitation
19735|NCT03448120|Muscle fatigue|muscle fatigue
19736|NCT03448120|Thermography|thermography
19737|NCT03448120|Acupuncture|acupuncture
19738|NCT03448120|Dry needling|dry needling
19739|NCT03448107|dental caries|dental caries
19740|NCT03448107|caries arrest|caries arrest
19741|NCT03448107|caries prevention|caries prevention
19742|NCT03448107|silver diamine fluoride|silver diamine fluoride
19743|NCT03448107|sealants|sealants
19744|NCT03448107|interim therapeutic restorations|interim therapeutic restorations
19745|NCT03448055|MCI, AD, MRI, GSH, Immunocal, brain health, neuropsychological evaluation|mci, ad, mri, gsh, immunocal, brain health, neuropsychological evaluation
19746|NCT03448029|Vascular Diseases|vascular diseases
19747|NCT03448029|Peripheral Artery Disease|peripheral artery disease
19748|NCT03448029|Revascularisation|revascularisation
19749|NCT03448029|Outcome|outcome
19750|NCT03448029|Quality Management|quality management
19751|NCT03448029|Registry|registry
19752|NCT03448029|Endovascular Intervention|endovascular intervention
19753|NCT03448029|Limb Amputation|limb amputation
19754|NCT03448003|Benign Neoplasms|benign neoplasms
19755|NCT03448003|Cancer prevention|cancer prevention
19756|NCT03448003|Online counseling|online counseling
19757|NCT03448003|Questionnaires|questionnaires
19759|NCT03447977|neck pain|neck pain
19760|NCT03447977|manual therapy|manual therapy
19761|NCT03447977|respiratory function|respiratory function
19762|NCT03447964|sphingolipids|sphingolipids
19763|NCT03447964|hepatic steatosis|hepatic steatosis
19764|NCT03447964|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
19765|NCT03447964|macrovascular complications|macrovascular complications
19766|NCT03447964|insulin resistance|insulin resistance
19767|NCT03447964|microvasclar complications|microvasclar complications
19768|NCT03447964|NAFLD|nafld
19769|NCT03447925|callosities; keratosis; diabetes mellitus; plants, medicinal; herbal medicine; keratolytic agents|callosities; keratosis; diabetes mellitus; plants, medicinal; herbal medicine; keratolytic agents
19770|NCT03447912|Behavioral intervention|behavioral intervention
19771|NCT03447912|Social intervention|social intervention
19772|NCT03447912|Public health|public health
19773|NCT03447912|Smoking behavior|smoking behavior
19774|NCT03447886|Breast Cancer|breast cancer
19775|NCT03447873|Antiretroviral treatment|antiretroviral treatment
19776|NCT03447873|Treatment simplification|treatment simplification
19777|NCT03447873|Dual therapy|dual therapy
19778|NCT03447873|Immune recovery|immune recovery
19779|NCT03447834|intracoronary cooling|intracoronary cooling
19780|NCT03447821|Infectious diarrhoea|infectious diarrhoea
19781|NCT03447821|rifamycin SV|rifamycin sv
19782|NCT03447821|rifamycin SV MMX|rifamycin sv mmx
19783|NCT03447821|MMX|mmx
19784|NCT03447782|New Daily Persistent Headache|new daily persistent headache
19785|NCT03447782|Chronic Headache|chronic headache
19786|NCT03447769|Non-Small Cell Lung Cancer|non-small cell lung cancer
19787|NCT03447769|NSCLC|nsclc
19788|NCT03447769|ACZ885|acz885
19789|NCT03447769|canakinumab|canakinumab
19790|NCT03447769|adjuvant|adjuvant
19791|NCT03447769|AJCC/UICC v. 8 stages II-IIIA and IIIB (T>5cm N2)|ajcc/uicc v. 8 stages ii-iiia and iiib (t>5cm n2)
19792|NCT03447717|hemiplegic gait|hemiplegic gait
19793|NCT03447717|peroneal nerve stimulation|peroneal nerve stimulation
19794|NCT03447717|gait analysis|gait analysis
19795|NCT03447704|Ankylosing Spondylitis|ankylosing spondylitis
19796|NCT03447704|interleukin 17|interleukin 17
19797|NCT03447704|monoclonal antibody|monoclonal antibody
19798|NCT03447665|Infant behavioral sleep intervention|infant behavioral sleep intervention
19799|NCT03447665|Infant sleep|infant sleep
19800|NCT03447665|Pediatric insomnia|pediatric insomnia
19801|NCT03447665|Infant night wakings|infant night wakings
19802|NCT03447639|Catheter associated UTI|catheter associated uti
19803|NCT03447639|Povidine iodine|povidine iodine
19804|NCT03447639|Bladder Irrigation|bladder irrigation
19805|NCT03447613|retinal nerve fiber layer|retinal nerve fiber layer
19806|NCT03447613|cerebrospinal fluid Aβ and Tau|cerebrospinal fluid aβ and tau
19807|NCT03447587|Randomized controlled trial|randomized controlled trial
19808|NCT03447587|Sleep|sleep
19809|NCT03447587|Traditional Chinese medicine|traditional chinese medicine
19810|NCT03447587|Oxidative stress|oxidative stress
19811|NCT03447561|Dopamine|dopamine
19812|NCT03447561|Food|food
19813|NCT03447561|Reward|reward
19814|NCT03447561|Anticipatory|anticipatory
19815|NCT03447561|Consummatory|consummatory
19816|NCT03447561|Positron Emission Tomography|positron emission tomography
19817|NCT03447561|Magnetic Resonance|magnetic resonance
19818|NCT03447561|Metabolic hormones|metabolic hormones
19819|NCT03447548|Cognitive training|cognitive training
19820|NCT03447548|Social function|social function
19821|NCT03447548|Processing speed|processing speed
19822|NCT03447535|Oppositional defiant disorder|oppositional defiant disorder
19823|NCT03447535|Family|family
19824|NCT03447535|Disruptive, impulse control and conduct disorders|disruptive, impulse control and conduct disorders
19825|NCT03447535|Anxiety disorder|anxiety disorder
19826|NCT03447535|Intrafamilial disruptive behaviours disorder|intrafamilial disruptive behaviours disorder
19827|NCT03447509|Spinal cord injury|spinal cord injury
19828|NCT03447509|neural control|neural control
19829|NCT03447509|motor function|motor function
19830|NCT03447509|hand movement|hand movement
19831|NCT03447483|Solid tumor|solid tumor
19832|NCT03447483|Immune Checkpoint Inhibitor|immune checkpoint inhibitor
19833|NCT03447483|immune-related Adverse Event|immune-related adverse event
19834|NCT03447444|dignity|dignity
19835|NCT03447444|music therapy|music therapy
19836|NCT03447444|physical activity|physical activity
19837|NCT03447431|colorectal cancers|colorectal cancers
19838|NCT03447431|Microsatellite Instability|microsatellite instability
19839|NCT03447431|Tumor development|tumor development
19840|NCT03447418|Lung Clearance Index|lung clearance index
19841|NCT03447418|Breath Nitrogen Washout|breath nitrogen washout
19842|NCT03447418|Healthy subjects|healthy subjects
19843|NCT03447405|Music Therapy|music therapy
19844|NCT03447405|NICU|nicu
19845|NCT03447405|Infants|infants
19846|NCT03447405|multisensory processing|multisensory processing
19847|NCT03447392|Patient Education|patient education
19848|NCT03447392|Chinese Medicine|chinese medicine
19849|NCT03447353|driving|driving
19850|NCT03447353|Xanax|xanax
19851|NCT03447353|Norco|norco
19852|NCT03447353|simulation|simulation
19853|NCT03447314|GSK1795091|gsk1795091
19854|NCT03447314|Dose-escalation|dose-escalation
19855|NCT03447314|204686|204686
19856|NCT03447314|Immunotherapies|immunotherapies
19857|NCT03447314|Phase I|phase i
19858|NCT03447314|anticancer agent|anticancer agent
19859|NCT03447314|OX40|ox40
19860|NCT03447314|201212|201212
19861|NCT03447314|TLR4|tlr4
19862|NCT03447314|GSK3174998|gsk3174998
19863|NCT03447314|Advanced Solid Tumors|advanced solid tumors
19864|NCT03447301|Saudi Arabia, Extra Virgin Olive Oil, Blood Glucose|saudi arabia, extra virgin olive oil, blood glucose
19865|NCT03447288|Dyssynchrony|dyssynchrony
19866|NCT03447288|Breath-stacking|breath-stacking
19867|NCT03447288|Asynchrony|asynchrony
19868|NCT03447288|Reverse Triggering|reverse triggering
19869|NCT03447288|Mechanical Ventilation|mechanical ventilation
19870|NCT03447288|Sedation|sedation
19871|NCT03447236|Older people|older people
19872|NCT03447236|Cognitive training|cognitive training
19873|NCT03447236|MCI|mci
19874|NCT03447223|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
19875|NCT03447223|circulating metabolites|circulating metabolites
19876|NCT03447223|metagenome|metagenome
19877|NCT03447210|Persons who inject drugs (PWID)|persons who inject drugs (pwid)
19878|NCT03447210|Phylogenetics|phylogenetics
19879|NCT03447210|HIV testing|hiv testing
19880|NCT03447210|HCV testing|hcv testing
19881|NCT03447210|HIV care cascade|hiv care cascade
19882|NCT03447210|Assisted partner services|assisted partner services
19883|NCT03447171|Amblyopia|amblyopia
19884|NCT03447171|Myopia|myopia
19885|NCT03447171|Hyperopia|hyperopia
19886|NCT03447171|Risk Factors|risk factors
19887|NCT03447171|Amblyopia Risk Factors|amblyopia risk factors
19888|NCT03447171|Smartphone Application (App)|smartphone application (app)
19889|NCT03447171|Photoscreening|photoscreening
19890|NCT03447171|Vision Screening|vision screening
19891|NCT03447171|Mobile Vision Screening|mobile vision screening
19892|NCT03447171|Vision Screening App|vision screening app
19893|NCT03447171|Preschool children|preschool children
19894|NCT03447171|Objective vision screening|objective vision screening
19895|NCT03447132|Breast Cancer|breast cancer
19896|NCT03447132|Luminal|luminal
19897|NCT03447132|Neoadjuvant|neoadjuvant
19898|NCT03447132|pCR|pcr
19899|NCT03447132|Surgery|surgery
19900|NCT03447093|oral microbiota|oral microbiota
19901|NCT03447093|16S rRNA gene|16s rrna gene
19902|NCT03447093|Graves' disease|graves' disease
19903|NCT03447093|Methimazole|methimazole
19904|NCT03447093|Propylthiouracil|propylthiouracil
19905|NCT03447093|Hashimoto's thyroiditis|hashimoto's thyroiditis
19906|NCT03447054|Alcohol|alcohol
19907|NCT03447054|tDCS|tdcs
19908|NCT03447054|inhibition|inhibition
19909|NCT03447054|cognitive training|cognitive training
19910|NCT03447054|implicit cognition|implicit cognition
19911|NCT03447054|relapse|relapse
19912|NCT03447054|craving|craving
19913|NCT03447041|Keratopathy|keratopathy
19914|NCT03447041|Visual Quality|visual quality
19915|NCT03447041|Contrast Sensitivity Function|contrast sensitivity function
19916|NCT03447028|Triglyseride-Glucose index|triglyseride-glucose index
19917|NCT03447028|prostate cancer|prostate cancer
19918|NCT03447028|radical prostatectomy|radical prostatectomy
19919|NCT03447028|metabolic syndrome|metabolic syndrome
19920|NCT03447015|ambulation|ambulation
19921|NCT03447015|labour|labour
19922|NCT03447015|Randomized Controlled Trial|randomized controlled trial
19923|NCT03447015|Jordan|jordan
19924|NCT03447002|premature|premature
19925|NCT03447002|pvc|pvc
19926|NCT03446989|case management|case management
19927|NCT03446989|rheumatoid arthritis|rheumatoid arthritis
19928|NCT03446989|Effectiveness|effectiveness
19929|NCT03446989|Generalized Estimating Equations|generalized estimating equations
19930|NCT03446950|vaginal surgery|vaginal surgery
19931|NCT03446950|patient position|patient position
19932|NCT03446950|stirrups|stirrups
19933|NCT03446950|functional status|functional status
19934|NCT03446950|urogynecology|urogynecology
19935|NCT03446937|Antenal corticosteroids|antenal corticosteroids
19936|NCT03446937|Late preterm delivery|late preterm delivery
19937|NCT03446937|Neonatal morbidity|neonatal morbidity
19938|NCT03446924|Nutraceuticals|nutraceuticals
19939|NCT03446924|Muscle anabolism|muscle anabolism
19940|NCT03446924|Ageing|ageing
19941|NCT03446911|SABR|sabr
19942|NCT03446911|Immunotherapy|immunotherapy
19943|NCT03446859|Transcutaneous nerve electrical stimulation,|transcutaneous nerve electrical stimulation,
19944|NCT03446859|Pain intensity|pain intensity
19945|NCT03446859|Primary dysmenorrhea|primary dysmenorrhea
19946|NCT03446859|Female|female
19947|NCT03446859|Undergraduates|undergraduates
19948|NCT03446833|Parkinson's Disease|parkinson's disease
19949|NCT03446833|Deep Brain Stimulation|deep brain stimulation
19950|NCT03446807|fatigue|fatigue
19951|NCT03446807|Droxidopa|droxidopa
19952|NCT03446794|Left Atrial Appendage Closure|left atrial appendage closure
19953|NCT03446794|Watchman device|watchman device
19954|NCT03446768|COPD|copd
19955|NCT03446768|OSA|osa
19956|NCT03446742|Rehabilitation Service|rehabilitation service
20256|NCT03444974|dependency|dependency
19957|NCT03446742|Signals and symptons|signals and symptons
19958|NCT03446742|Heart Rate|heart rate
19959|NCT03446742|Blood pressure|blood pressure
19960|NCT03446742|Respiratory Muscles|respiratory muscles
19961|NCT03446742|autonomic modulation|autonomic modulation
19962|NCT03446742|exercise|exercise
19963|NCT03446742|risk measurement|risk measurement
19964|NCT03446742|muscle strength|muscle strength
19965|NCT03446742|inflammation|inflammation
19966|NCT03446742|cytosines|cytosines
19967|NCT03446703|social cognition|social cognition
19968|NCT03446703|psychotherapy|psychotherapy
19969|NCT03446703|rehabilitation|rehabilitation
19970|NCT03446703|theory of mind|theory of mind
19971|NCT03446690|Enamel decalcification|enamel decalcification
19973|NCT03446677|Balance|balance
19974|NCT03446677|Vestibular|vestibular
19975|NCT03446677|Somatosensory|somatosensory
19976|NCT03446677|postural stability|postural stability
19977|NCT03446677|center of pressure|center of pressure
19978|NCT03446651|Sodium Homeostasis|sodium homeostasis
19979|NCT03446638|myelodysplastic syndromes|myelodysplastic syndromes
19980|NCT03446638|MDS|mds
19981|NCT03446638|computational biology|computational biology
19982|NCT03446638|relapsed|relapsed
19983|NCT03446638|refractory|refractory
19984|NCT03446625|resveratrol|resveratrol
19985|NCT03446625|OHSS|ohss
19986|NCT03446625|PCOS|pcos
19987|NCT03446612|Daprodustat, Darbepoetin alfa, Efficacy and FBF-CKD|daprodustat, darbepoetin alfa, efficacy and fbf-ckd
19988|NCT03446599|cardiac surgery|cardiac surgery
19989|NCT03446599|vasoplegia|vasoplegia
19990|NCT03446599|cardiopulmonary bypass|cardiopulmonary bypass
19991|NCT03446573|Switch study|switch study
19992|NCT03446573|non-inferiority|non-inferiority
19993|NCT03446573|HIV-1|hiv-1
19994|NCT03446573|tenofovir alafenamide|tenofovir alafenamide
19995|NCT03446573|dolutegravir plus lamivudine|dolutegravir plus lamivudine
19996|NCT03446560|Compliance|compliance
19997|NCT03446560|Telemedicine|telemedicine
19998|NCT03446560|Patient related outcome measures|patient related outcome measures
19999|NCT03446547|SBRT|sbrt
20000|NCT03446547|Immunotherapy|immunotherapy
20001|NCT03446534|pneumonia|pneumonia
20002|NCT03446534|pre-school children|pre-school children
20003|NCT03446534|antibiotics|antibiotics
20004|NCT03446534|amoxicillin|amoxicillin
20005|NCT03446508|High definition transcranial direct stimulation|high definition transcranial direct stimulation
20006|NCT03446508|Mild Cognitive Impairment|mild cognitive impairment
20007|NCT03446508|Memory|memory
20008|NCT03446495|ovarian cancer, trabectedin, recurrent ovarian cancer|ovarian cancer, trabectedin, recurrent ovarian cancer
20009|NCT03446469|Chronic ankle instability|chronic ankle instability
20010|NCT03446469|Functional instability|functional instability
20011|NCT03446469|Ankle sprain|ankle sprain
20012|NCT03446469|postural sway|postural sway
20013|NCT03446469|Fascial Manipulation|fascial manipulation
20014|NCT03446456|Magnetic Resonance Imaging|magnetic resonance imaging
20015|NCT03446456|Healthy Volunteers|healthy volunteers
20016|NCT03446430|arterial stiffness|arterial stiffness
20017|NCT03446430|pulse wave velocity|pulse wave velocity
20018|NCT03446430|laser Doppler vibrometry|laser doppler vibrometry
20019|NCT03446365|Asthma|asthma
20020|NCT03446365|Latino children|latino children
20021|NCT03446365|middle school|middle school
20022|NCT03446365|peer models|peer models
20023|NCT03446365|educational intervention|educational intervention
20024|NCT03446365|high school students|high school students
20025|NCT03446352|Falls|falls
20026|NCT03446352|Elderly|elderly
20027|NCT03446352|Psychomotor exercise program|psychomotor exercise program
20028|NCT03446352|Whole body vibration|whole body vibration
20029|NCT03446326|pacemaker|pacemaker
20030|NCT03446326|stroke volume|stroke volume
20031|NCT03446326|cardiac output|cardiac output
20032|NCT03446326|heart rate|heart rate
20033|NCT03446300|High Myopia, fundus structure, early visual impairment|high myopia, fundus structure, early visual impairment
20034|NCT03446248|vibroacoustic stimulation|vibroacoustic stimulation
20035|NCT03446235|Obesity|obesity
20036|NCT03446235|Physical Activity|physical activity
20037|NCT03446235|Exercise|exercise
20038|NCT03446235|Wearable device|wearable device
20039|NCT03446196|Transplantation, Fluid Balance|transplantation, fluid balance
20040|NCT03446170|Young adults|young adults
20041|NCT03446170|Cigarette smoking|cigarette smoking
20042|NCT03446170|Warning labels|warning labels
20043|NCT03446157|colon cancer|colon cancer
20044|NCT03446157|metastatic colon cancer|metastatic colon cancer
20045|NCT03446157|palbociclib|palbociclib
20046|NCT03446157|cetuximab|cetuximab
20047|NCT03446144|Geographic Atrophy|geographic atrophy
20048|NCT03446144|Age Related Macular Degeneration|age related macular degeneration
20049|NCT03446144|IONIS-FB-Lrx|ionis-fb-lrx
20050|NCT03446144|Complement Factor B|complement factor b
20051|NCT03446131|transfemoral amputation|transfemoral amputation
20052|NCT03446131|limb salvage|limb salvage
20053|NCT03446131|bilateral amputation|bilateral amputation
20054|NCT03446131|Department of Defense|department of defense
20055|NCT03446131|orthosis|orthosis
20056|NCT03446131|prosthesis|prosthesis
20057|NCT03446131|rehabilitation|rehabilitation
20058|NCT03446131|military treatment facilities|military treatment facilities
20059|NCT03446131|military|military
20060|NCT03446131|injured lower extremity|injured lower extremity
20061|NCT03446131|prevent falls|prevent falls
20062|NCT03446131|trauma lower extremity|trauma lower extremity
20063|NCT03446131|service members|service members
20064|NCT03446131|retired service members|retired service members
20065|NCT03446131|active service members|active service members
20066|NCT03446131|unilateral lower extremity trauma|unilateral lower extremity trauma
20067|NCT03446131|limb amputation|limb amputation
20068|NCT03446131|limb preservation|limb preservation
20069|NCT03446131|preserved limb|preserved limb
20070|NCT03446131|trips|trips
20071|NCT03446131|slips|slips
20072|NCT03446131|transtibial amputation|transtibial amputation
20073|NCT03446118|EoE|eoe
20074|NCT03446105|Cancer survivor|cancer survivor
20075|NCT03446105|App-based intervention|app-based intervention
20076|NCT03446105|Behavioral intervention|behavioral intervention
20077|NCT03446092|Cancer|cancer
20078|NCT03446092|Mindfulness|mindfulness
20079|NCT03446092|Palliative care|palliative care
20080|NCT03446079|Genetic|genetic
20081|NCT03446079|Skin|skin
20082|NCT03446079|Anti Aging|anti aging
20083|NCT03446079|SNP|snp
20084|NCT03446053|Methicillin-Resistant Staphylococcus Aureus|methicillin-resistant staphylococcus aureus
20085|NCT03446053|Methicillin-Sensitive Staphylococcus Aureus|methicillin-sensitive staphylococcus aureus
20086|NCT03446053|N-Rephasin SAL200|n-rephasin sal200
20087|NCT03445962|Autonomic nervous system|autonomic nervous system
20088|NCT03445962|Heart rate variability|heart rate variability
20089|NCT03445962|Physical Activity|physical activity
20090|NCT03445962|exercise|exercise
20091|NCT03445962|biological parameters|biological parameters
20092|NCT03445962|cephalometry|cephalometry
20093|NCT03445962|body composition|body composition
20094|NCT03445962|actigraphy|actigraphy
20095|NCT03445962|motor capacity|motor capacity
20096|NCT03445962|physical fitness|physical fitness
20097|NCT03445962|aerobic capacity|aerobic capacity
20098|NCT03445962|seismocardiography|seismocardiography
20099|NCT03445949|atrial fibrillation, stroke, bleeding, left atrial appendage|atrial fibrillation, stroke, bleeding, left atrial appendage
20100|NCT03445936|loop-ileostomy reversal|loop-ileostomy reversal
20101|NCT03445936|hernia prevention|hernia prevention
20102|NCT03445910|human chorionic gonadotropin|human chorionic gonadotropin
20103|NCT03445884|positron emission tomography|positron emission tomography
20104|NCT03445884|nuclear medicine|nuclear medicine
20105|NCT03445884|prognosis|prognosis
20106|NCT03445871|Rheumatoid Arthritis|rheumatoid arthritis
20107|NCT03445871|Methotrexate|methotrexate
20108|NCT03445871|Erythrocyte polyglutamate|erythrocyte polyglutamate
20109|NCT03445871|Compliance Questionnaire Rheumatology|compliance questionnaire rheumatology
20110|NCT03445845|TNF blocker|tnf blocker
20111|NCT03445845|change of biotherapy|change of biotherapy
20112|NCT03445819|Patella Fracture, elderly|patella fracture, elderly
20113|NCT03445806|IOP fluctuations|iop fluctuations
20114|NCT03445806|iCare Home|icare home
20115|NCT03445806|Trabeculectomy|trabeculectomy
20116|NCT03445806|self-tonometry|self-tonometry
20117|NCT03445793|DeltaF508deletion (F508del) mutation in 2 copies|deltaf508deletion (f508del) mutation in 2 copies
20118|NCT03445767|Peri-operative care|peri-operative care
20119|NCT03445767|Medication management|medication management
20120|NCT03445741|Aerobic exercise|aerobic exercise
20121|NCT03445741|Metabolic syndrome|metabolic syndrome
20122|NCT03445741|Pedometer|pedometer
20123|NCT03445676|Hand Hygiene|hand hygiene
20124|NCT03445676|WHO 5-moments|who 5-moments
20125|NCT03445663|Relapsed/ Refractory Multiple Myeloma|relapsed/ refractory multiple myeloma
20126|NCT03445663|Multiple Myeloma|multiple myeloma
20127|NCT03445663|Oncology/Hematology|oncology/hematology
20128|NCT03445663|Immunotherapy|immunotherapy
20129|NCT03445650|ADX-102, Sjögren-Larsson Syndrome|adx-102, sjögren-larsson syndrome
20130|NCT03445637|Metastatic breast cancer, safety, ibrance|metastatic breast cancer, safety, ibrance
20131|NCT03445598|depression|depression
20132|NCT03445598|anxiety|anxiety
20133|NCT03445598|CBT|cbt
20134|NCT03445598|psychotherapy|psychotherapy
20135|NCT03445598|e-health|e-health
20136|NCT03445598|CCBT|ccbt
20137|NCT03445572|Advanced Cancer|advanced cancer
20138|NCT03445572|Meditative Slow Breathing|meditative slow breathing
20139|NCT03445572|MSB|msb
20140|NCT03445572|Isha Kriya Meditation|isha kriya meditation
20141|NCT03445572|IK|ik
20142|NCT03445572|Questionnaires|questionnaires
20143|NCT03445572|Surveys|surveys
20144|NCT03445559|Prostate Cancer|prostate cancer
20145|NCT03445559|Imaging|imaging
20146|NCT03445559|Veterans Affairs|veterans affairs
20147|NCT03445559|Guideline Adherence|guideline adherence
20148|NCT03445559|Implementation|implementation
20149|NCT03445533|Melanoma|melanoma
20150|NCT03445533|PD1|pd1
20151|NCT03445533|PD-1|pd-1
20152|NCT03445533|refractory|refractory
20153|NCT03445533|metastatic|metastatic
20154|NCT03445533|IMO-2125|imo-2125
20155|NCT03445533|illuminate 301|illuminate 301
20156|NCT03445533|TLR9 agonist|tlr9 agonist
20157|NCT03445533|advanced melanoma|advanced melanoma
20158|NCT03445533|CTLA4|ctla4
20159|NCT03445533|CTLA-4|ctla-4
20160|NCT03445533|immunotherapy|immunotherapy
20161|NCT03445533|skin cancer|skin cancer
20162|NCT03445533|ILLUMINATE-301|illuminate-301
20163|NCT03445520|Transitions|transitions
20164|NCT03445520|Passport|passport
20165|NCT03445520|Building Better Bridges|building better bridges
20166|NCT03445520|Snapshot|snapshot
20167|NCT03445507|tobacco|tobacco
20168|NCT03445507|cessation|cessation
20169|NCT03445507|medical apps for smartphones|medical apps for smartphones
20170|NCT03445468|Influenza vaccine|influenza vaccine
20171|NCT03445468|Split influenza vaccine|split influenza vaccine
20172|NCT03445468|Seasonal influenza vaccine|seasonal influenza vaccine
20173|NCT03445442|Elderly|elderly
20174|NCT03445442|Native tissue repair|native tissue repair
20175|NCT03445442|Pelvic Organ Prolapse|pelvic organ prolapse
20176|NCT03445442|Sacrocolpopexy|sacrocolpopexy
20177|NCT03445442|Vaginal mesh repair|vaginal mesh repair
20178|NCT03445403|Offset analgesia|offset analgesia
20179|NCT03445403|Quantitive sensory testing|quantitive sensory testing
20180|NCT03445364|Primary PCI|primary pci
20181|NCT03445364|Coronary injection pressure|coronary injection pressure
20182|NCT03445364|Reperfusion|reperfusion
20183|NCT03445364|Resolution of ST elevation|resolution of st elevation
20184|NCT03445364|Myocardial Blush Grade|myocardial blush grade
20185|NCT03445351|Exercise Therapy;|exercise therapy;
20186|NCT03445351|Sleep;|sleep;
20187|NCT03445351|; Immune Markers;|; immune markers;
20188|NCT03445351|HIV|hiv
20189|NCT03445325|obesity|obesity
20190|NCT03445325|physical activity|physical activity
20191|NCT03445325|nutrition|nutrition
20192|NCT03445325|adolescents|adolescents
20193|NCT03445325|gamification|gamification
20194|NCT03445325|sedentary activity|sedentary activity
20195|NCT03445286|Gingivitis and geriatric patients|gingivitis and geriatric patients
20196|NCT03445286|Silver Diamine Fluoride and gingivitis|silver diamine fluoride and gingivitis
20197|NCT03445286|Sliver Diamine Fluoride|sliver diamine fluoride
20198|NCT03445247|Diabetic Nephropathies|diabetic nephropathies
20199|NCT03445247|Extracorporeal low intensity shockwave therapy|extracorporeal low intensity shockwave therapy
20200|NCT03445247|Proteinuria|proteinuria
20201|NCT03445234|exercise|exercise
20202|NCT03445234|innate immune function|innate immune function
20203|NCT03445234|metabolomics|metabolomics
20204|NCT03445234|inflammation|inflammation
20205|NCT03445221|Oral Immunonutrition|oral immunonutrition
20206|NCT03445221|Cardiac Patient|cardiac patient
20207|NCT03445221|Mitral Valve Replacement|mitral valve replacement
20208|NCT03445182|pain control|pain control
20209|NCT03445182|paediatric dental patients|paediatric dental patients
20210|NCT03445182|local anaesthesia|local anaesthesia
20211|NCT03445182|dentalvibe|dentalvibe
20212|NCT03445156|First-person shooter (FPS)|first-person shooter (fps)
20213|NCT03445156|Violent video game|violent video game
20214|NCT03445156|Headshot|headshot
20215|NCT03445156|Gun|gun
20216|NCT03445156|Operant conditioning theory|operant conditioning theory
20217|NCT03445143|yoga|yoga
20346|NCT03444402|Nexium|nexium
20218|NCT03445143|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
20219|NCT03445143|Stress Education|stress education
20220|NCT03445130|Preoperative Anxiety|preoperative anxiety
20221|NCT03445130|Breast Surgery|breast surgery
20222|NCT03445130|Lavender Aromatherapy|lavender aromatherapy
20223|NCT03445117|influenza|influenza
20224|NCT03445117|pneumonia|pneumonia
20225|NCT03445117|vaccination|vaccination
20226|NCT03445117|education|education
20227|NCT03445117|public health|public health
20228|NCT03445104|Huperzine A|huperzine a
20229|NCT03445104|acetylcholinesterase inhibitor|acetylcholinesterase inhibitor
20230|NCT03445104|AChEI|achei
20231|NCT03445104|exercise|exercise
20232|NCT03445104|Physical performance|physical performance
20233|NCT03445104|cognitive function|cognitive function
20234|NCT03445104|rating of perceived exertion|rating of perceived exertion
20235|NCT03445104|RPE|rpe
20236|NCT03445091|compression socks|compression socks
20237|NCT03445091|venous insufficiency|venous insufficiency
20238|NCT03445091|compression stockings|compression stockings
20239|NCT03445091|compression|compression
20240|NCT03445091|compression therapy|compression therapy
20241|NCT03445052|Adherence|adherence
20242|NCT03445052|Behaviour change|behaviour change
20243|NCT03445052|Intervention|intervention
20244|NCT03445052|Photoprotection|photoprotection
20245|NCT03445052|Ultraviolet radiation|ultraviolet radiation
20246|NCT03445039|Dental implants, Trans-alveolar sinus floor elevation, Bone grafting|dental implants, trans-alveolar sinus floor elevation, bone grafting
20247|NCT03445000|RET-rearrangement|ret-rearrangement
20248|NCT03445000|advanced NSCLC|advanced nsclc
20249|NCT03444987|Uterine fibroid|uterine fibroid
20250|NCT03444987|FAP|fap
20251|NCT03444987|Autophagy|autophagy
20252|NCT03444974|drugs|drugs
20253|NCT03444974|youth|youth
20254|NCT03444974|adolescence|adolescence
20255|NCT03444974|abuse|abuse
20257|NCT03444974|Tetrahydrocannabinol (THC)|tetrahydrocannabinol (thc)
20258|NCT03444974|Methamphetamine (Crystal Meth)|methamphetamine (crystal meth)
20259|NCT03444974|Marihuana|marihuana
20260|NCT03444974|comorbidity|comorbidity
20261|NCT03444974|treatment|treatment
20262|NCT03444974|etiopathology|etiopathology
20263|NCT03444974|sociodemographics|sociodemographics
20264|NCT03444974|Saxony|saxony
20265|NCT03444961|Argus II Retinal Prosthesis System|argus ii retinal prosthesis system
20266|NCT03444961|Rehabilitation|rehabilitation
20267|NCT03444935|Phone|phone
20268|NCT03444935|Brief Contact Intervention|brief contact intervention
20269|NCT03444935|Caring Contact|caring contact
20270|NCT03444935|Follow-up|follow-up
20271|NCT03444935|Suicide|suicide
20272|NCT03444935|Suicidal Ideation|suicidal ideation
20273|NCT03444935|Suicidal Behaviour|suicidal behaviour
20274|NCT03444935|Suicide Attempt|suicide attempt
20275|NCT03444909|Monitoring|monitoring
20276|NCT03444857|Continuous Positive Airway Pressure|continuous positive airway pressure
20277|NCT03444857|Myocardial Salvage|myocardial salvage
20278|NCT03444857|Obstructive Sleep Apnea|obstructive sleep apnea
20279|NCT03444857|ST Elevation Myocardial Infarction|st elevation myocardial infarction
20280|NCT03444831|Functional Dyspepsia|functional dyspepsia
20281|NCT03444818|E6007|e6007
20282|NCT03444818|Pharmacokinetics|pharmacokinetics
20283|NCT03444818|Radioactivity|radioactivity
20284|NCT03444805|Autoimmune diseases|autoimmune diseases
20285|NCT03444805|Systemic sclerosis|systemic sclerosis
20286|NCT03444805|Autologous hematopoietic stem cell transplant (AHSCT)|autologous hematopoietic stem cell transplant (ahsct)
20287|NCT03444805|Post-AHSCT management|post-ahsct management
20288|NCT03444805|Immune reconstitution|immune reconstitution
20289|NCT03444727|vulvar biopsy|vulvar biopsy
20290|NCT03444727|ice|ice
20291|NCT03444727|anesthesia|anesthesia
20292|NCT03444727|pain|pain
20293|NCT03444727|vulva|vulva
20294|NCT03444714|intratumoral|intratumoral
20295|NCT03444701|Solid tumors|solid tumors
20296|NCT03444701|Her2-negative breast cancer|her2-negative breast cancer
20297|NCT03444701|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
20298|NCT03444688|Robotic Walker|robotic walker
20299|NCT03444675|Transplantation; intestine|transplantation; intestine
20300|NCT03444675|endoscopy|endoscopy
20301|NCT03444675|severity score|severity score
20302|NCT03444675|transplant rejection|transplant rejection
20303|NCT03444675|transplant; complications|transplant; complications
20304|NCT03444649|AML|aml
20305|NCT03444649|Epacadostat|epacadostat
20306|NCT03444649|Idarubicin|idarubicin
20307|NCT03444649|Cytarabine|cytarabine
20308|NCT03444636|Multimodal analgesia|multimodal analgesia
20309|NCT03444636|Thoracic epidural|thoracic epidural
20310|NCT03444636|Postoperative pain|postoperative pain
20311|NCT03444636|Postoperative Complications|postoperative complications
20312|NCT03444636|Patient Satisfaction|patient satisfaction
20313|NCT03444623|predictive factor|predictive factor
20314|NCT03444623|prognostic factor|prognostic factor
20315|NCT03444584|0382, T2DM|0382, t2dm
20316|NCT03444558|metabolic parameters|metabolic parameters
20317|NCT03444558|cardio-metabolic parameters|cardio-metabolic parameters
20318|NCT03444545|Cardiac output|cardiac output
20319|NCT03444545|Carbon dioxide|carbon dioxide
20320|NCT03444545|Intraoperative monitoring|intraoperative monitoring
20321|NCT03444545|Pulmonary blood flow|pulmonary blood flow
20322|NCT03444519|brain relaxation|brain relaxation
20323|NCT03444519|mannitol|mannitol
20324|NCT03444519|supratentorial tumours|supratentorial tumours
20325|NCT03444506|SAR|sar
20326|NCT03444454|Telerehabilitation|telerehabilitation
20327|NCT03444454|Virtual reality|virtual reality
20328|NCT03444454|Quality of life|quality of life
20329|NCT03444441|Foot|foot
20330|NCT03444441|Ankle|ankle
20331|NCT03444441|Finnish|finnish
20332|NCT03444441|Validation|validation
20333|NCT03444441|FAOS|faos
20334|NCT03444441|EFAS|efas
20335|NCT03444441|LEFS|lefs
20336|NCT03444441|FAAM|faam
20337|NCT03444441|VAS-FA|vas-fa
20338|NCT03444441|MOxFA|moxfa
20339|NCT03444415|Obesity|obesity
20340|NCT03444415|Children|children
20341|NCT03444415|Pregnancy|pregnancy
20342|NCT03444415|Motivational interview|motivational interview
20343|NCT03444415|Family Care|family care
20344|NCT03444415|Primary Care|primary care
20345|NCT03444402|CKD-381|ckd-381
20347|NCT03444376|keytruda|keytruda
20348|NCT03444376|pembrolizumab|pembrolizumab
20349|NCT03444376|GX-188E|gx-188e
20350|NCT03444363|laser|laser
20351|NCT03444363|periodontal treatment|periodontal treatment
20352|NCT03444363|systemic inflammation|systemic inflammation
20353|NCT03444363|glycemic control|glycemic control
20354|NCT03444350|Periodontal treatment|periodontal treatment
20355|NCT03444350|Ozone|ozone
20356|NCT03444350|oxidative stress|oxidative stress
20357|NCT03444337|ablation|ablation
20358|NCT03444337|atrial fibrillation|atrial fibrillation
20359|NCT03444337|FIRM|firm
20360|NCT03444324|Fibrinogen|fibrinogen
20361|NCT03444311|microbiota|microbiota
20362|NCT03444311|ulcerative colitis|ulcerative colitis
20363|NCT03444311|fiber|fiber
20364|NCT03444311|probiotic|probiotic
20365|NCT03444285|Thermotherapy|thermotherapy
20366|NCT03444285|warm-up|warm-up
20367|NCT03444285|extensibility|extensibility
20368|NCT03444285|pain|pain
20369|NCT03444285|athletes|athletes
20370|NCT03444259|Atrial fibrillation|atrial fibrillation
20371|NCT03444259|Aortic stenosis|aortic stenosis
20372|NCT03444259|Coronary artery disease|coronary artery disease
20373|NCT03444259|Cardiac surgery|cardiac surgery
20374|NCT03444259|Atrial appendage|atrial appendage
20375|NCT03444207|obesity|obesity
20376|NCT03444207|inflammation|inflammation
20377|NCT03444207|C-reactive protein|c-reactive protein
20378|NCT03444207|training|training
20379|NCT03444207|tumor necrosis factor alfa|tumor necrosis factor alfa
20380|NCT03444194|liver metastasis|liver metastasis
20381|NCT03444194|chemotherapy|chemotherapy
20382|NCT03444194|liver biopsy|liver biopsy
20383|NCT03444194|colorectal caner|colorectal caner
20384|NCT03444168|lumbar spine surgery|lumbar spine surgery
20385|NCT03444168|lumbar failed back surgery syndrome|lumbar failed back surgery syndrome
20386|NCT03444142|Diabetes|diabetes
20387|NCT03444142|Hyperglycemia|hyperglycemia
20388|NCT03444142|ABPM|abpm
20389|NCT03444142|Variability of blood pressure|variability of blood pressure
20390|NCT03444142|Exenatide LAR or Dulaglutide 0.75mg|exenatide lar or dulaglutide 0.75mg
20391|NCT03444142|Glucagon-like peptide analogues type 1 (GLP1).|glucagon-like peptide analogues type 1 (glp1).
20392|NCT03444103|IL-6 blockade|il-6 blockade
20393|NCT03444064|Islet transplantation|islet transplantation
20394|NCT03444064|Diabetes treatment|diabetes treatment
20395|NCT03444064|PolyTregs|polytregs
20396|NCT03444064|Immunotherapy|immunotherapy
20397|NCT03444051|EUS-FNB|eus-fnb
20398|NCT03444051|comparative study|comparative study
20399|NCT03443999|Coronary Artery Disease|coronary artery disease
20400|NCT03443999|Sirolimus-eluting Stent|sirolimus-eluting stent
20401|NCT03443999|Biodegradable Polymers|biodegradable polymers
20402|NCT03443986|Diabetes Mellitus|diabetes mellitus
20403|NCT03443986|Blood Flow Velocity|blood flow velocity
20404|NCT03443986|Skin Temperature|skin temperature
20405|NCT03443986|Postural Balance|postural balance
20406|NCT03443986|Combined Modality Therapy|combined modality therapy
20407|NCT03443986|Vibration|vibration
20408|NCT03443986|Resistance Training|resistance training
20409|NCT03443934|Hemodynamic assessments|hemodynamic assessments
20410|NCT03443934|Echocardiography|echocardiography
20411|NCT03443934|MR-Elastography|mr-elastography
20412|NCT03443934|Liver vein catheterization|liver vein catheterization
20413|NCT03443934|Liver Cirrhosis|liver cirrhosis
20414|NCT03443934|Cirrhotic cardiomyopathy|cirrhotic cardiomyopathy
20415|NCT03443934|Cirrhotic complications|cirrhotic complications
20416|NCT03443934|Magnetic Resonance Imaging|magnetic resonance imaging
20417|NCT03443921|Artery Divestment Technique|artery divestment technique
20418|NCT03443921|Locally Advanced Pancreatic Cancer|locally advanced pancreatic cancer
20419|NCT03443921|Neoadjuvant Therapy|neoadjuvant therapy
20420|NCT03443921|Borderline Resectable Pancreatic Cancer|borderline resectable pancreatic cancer
20421|NCT03443908|lung cancer|lung cancer
20422|NCT03443908|non small cell lung cancer|non small cell lung cancer
20423|NCT03443908|nsclc|nsclc
20424|NCT03443908|small cell lung cancer|small cell lung cancer
20425|NCT03443908|sclc|sclc
20426|NCT03443908|metastic lung mass|metastic lung mass
20427|NCT03443908|sleep disordered breathing|sleep disordered breathing
20428|NCT03443908|sdb|sdb
20429|NCT03443908|obstructive sleep apnea|obstructive sleep apnea
20430|NCT03443830|Zika virus|zika virus
20431|NCT03443830|Tyzivumab|tyzivumab
20432|NCT03443830|Monoclonal antibody|monoclonal antibody
20433|NCT03443830|Infectious diseases|infectious diseases
20434|NCT03443830|Phase 1A first in human study|phase 1a first in human study
20435|NCT03443830|Singapore|singapore
20436|NCT03443817|Feasibility|feasibility
20437|NCT03443817|tele-rehabilitation|tele-rehabilitation
20438|NCT03443817|follow-up|follow-up
20439|NCT03443817|COPD|copd
20440|NCT03443791|CMV|cmv
20441|NCT03443791|Congenital Birth|congenital birth
20442|NCT03443791|Infectious Diseases|infectious diseases
20443|NCT03443778|tonsillectomy pain|tonsillectomy pain
20444|NCT03443778|dexamethasone|dexamethasone
20445|NCT03443778|bupivacaine|bupivacaine
20446|NCT03443739|Intermittent Fasting|intermittent fasting
20447|NCT03443739|Religious Fast|religious fast
20448|NCT03443739|Bahá'í|bahá'í
20449|NCT03443739|Hydration|hydration
20450|NCT03443739|Calorimetry|calorimetry
20451|NCT03443739|Microdialysis|microdialysis
20452|NCT03443739|circadian clock|circadian clock
20453|NCT03443739|circadian rhythm|circadian rhythm
20454|NCT03443739|spirituality|spirituality
20455|NCT03443739|self-efficacy|self-efficacy
20456|NCT03443726|Lower third molar extraction|lower third molar extraction
20457|NCT03443726|Infiltration anesthesia|infiltration anesthesia
20458|NCT03443726|Articaine|articaine
20459|NCT03443700|SCI|sci
20460|NCT03443700|gait|gait
20461|NCT03443700|incomplete motor SCI|incomplete motor sci
20462|NCT03443700|robotic gait training|robotic gait training
20463|NCT03443700|locomotor training|locomotor training
20464|NCT03443700|walking training|walking training
20465|NCT03443700|rehabilitation|rehabilitation
20466|NCT03443700|exoskeleton|exoskeleton
20467|NCT03443700|EKSO|ekso
20468|NCT03443700|EKSO-GT|ekso-gt
20469|NCT03443700|neuroplasticity|neuroplasticity
20470|NCT03443700|brain cortical plasticity|brain cortical plasticity
20471|NCT03443661|5-Fluorouracil|5-fluorouracil
20472|NCT03443661|rectal cancer|rectal cancer
20473|NCT03443661|irinotecan|irinotecan
20474|NCT03443661|oxaliplatin|oxaliplatin
20475|NCT03443661|neoadjuvant chemotherapy|neoadjuvant chemotherapy
20476|NCT03443622|SC-43|sc-43
20477|NCT03443622|refractory solid tumor|refractory solid tumor
20478|NCT03443622|Phase I|phase i
20479|NCT03443609|occult prostate cancer recurrence|occult prostate cancer recurrence
20480|NCT03443609|PSA|psa
20481|NCT03443609|68Ga-HBED-CC-PSMA PET / CT|68ga-hbed-cc-psma pet / ct
20482|NCT03443596|stroke|stroke
20483|NCT03443596|blood pressure|blood pressure
20484|NCT03443596|hemodynamic|hemodynamic
20485|NCT03443570|immune thrombocytopenia|immune thrombocytopenia
20486|NCT03443570|Thrombocytopenia|thrombocytopenia
20487|NCT03443557|Oral nutrition supplement|oral nutrition supplement
20488|NCT03443557|malnutrition|malnutrition
20489|NCT03443557|mortality|mortality
20490|NCT03443544|fournier's|fournier's
20491|NCT03443544|gangrene|gangrene
20492|NCT03443531|Bronchiectasis|bronchiectasis
20493|NCT03443531|Traditional Chinese Medicine|traditional chinese medicine
20494|NCT03443518|EVAR, analgesia|evar, analgesia
20495|NCT03443505|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
20496|NCT03443505|Acute exacerbation|acute exacerbation
20497|NCT03443505|Neural respiratory drive|neural respiratory drive
20498|NCT03443505|Parasternal electromyography|parasternal electromyography
20499|NCT03443505|Respiratory physiology|respiratory physiology
20500|NCT03443479|Non invasive ventilation|non invasive ventilation
20501|NCT03443479|BiPAP|bipap
20502|NCT03443479|High-Flow Oxygen Therapy|high-flow oxygen therapy
20503|NCT03443479|High-Flow Nasal Cannula|high-flow nasal cannula
20504|NCT03443479|COPD|copd
20505|NCT03443479|Hypercapnia|hypercapnia
20506|NCT03443479|Hypercapnic Respiratory failure|hypercapnic respiratory failure
20507|NCT03443479|Chronic obstructive Pulmonary Disease|chronic obstructive pulmonary disease
20508|NCT03443466|Electric stimulation|electric stimulation
20509|NCT03443466|Cesarean section|cesarean section
20510|NCT03443427|Non-typeable Haemophilus influenzae|non-typeable haemophilus influenzae
20511|NCT03443427|Moraxella catarrhalis|moraxella catarrhalis
20512|NCT03443427|Safety|safety
20513|NCT03443427|Third vaccine dose|third vaccine dose
20514|NCT03443427|Vaccination|vaccination
20515|NCT03443427|Immunogenicity|immunogenicity
20516|NCT03443414|COPD, bronchodilation, FEV1|copd, bronchodilation, fev1
20517|NCT03443388|head injury from seizures|head injury from seizures
20518|NCT03443388|seizures resulting in fall|seizures resulting in fall
20519|NCT03443388|helmet for seizures|helmet for seizures
20520|NCT03443388|novel helmet design|novel helmet design
20521|NCT03443388|inflatable helmet|inflatable helmet
20522|NCT03443388|Hovding Inc|hovding inc
20523|NCT03443388|helmet|helmet
20524|NCT03443388|device|device
20525|NCT03443375|Older adults|older adults
20526|NCT03443375|Physical function|physical function
20527|NCT03443375|Muscle mass|muscle mass
20528|NCT03443375|Short-term memory|short-term memory
20529|NCT03443375|Executive function|executive function
20530|NCT03443375|Blood Pressure|blood pressure
20531|NCT03443375|Resistance training|resistance training
20532|NCT03443375|Exercise training|exercise training
20533|NCT03443375|Periodization|periodization
20534|NCT03443362|Chronic Urticaria|chronic urticaria
20535|NCT03443362|Endothelial cells|endothelial cells
20536|NCT03443349|Delivering Women|delivering women
20537|NCT03443323|Executive Function|executive function
20538|NCT03443323|Behavioral Research|behavioral research
20539|NCT03443323|Cost Analysis|cost analysis
20540|NCT03443323|Students|students
20541|NCT03443323|Schools|schools
20542|NCT03443323|Randomized Controlled Trial|randomized controlled trial
20543|NCT03443323|Behavior Therapy|behavior therapy
20544|NCT03443310|DVT|dvt
20545|NCT03443310|TKA|tka
20546|NCT03443310|THA|tha
20547|NCT03443310|Hip Fracture|hip fracture
20548|NCT03443310|High risk|high risk
20549|NCT03443310|Ultrasound|ultrasound
20550|NCT03443310|U/S|u/s
20551|NCT03443284|Total Knee Arthroplasty|total knee arthroplasty
20552|NCT03443284|Total Hip Arthroplasty|total hip arthroplasty
20553|NCT03443284|Total Knee Replacement|total knee replacement
20554|NCT03443284|Total Hip Replacement|total hip replacement
20555|NCT03443284|Hospital Care Plan|hospital care plan
20556|NCT03443284|mHealth|mhealth
20557|NCT03443271|transversus abdominis plane block|transversus abdominis plane block
20558|NCT03443271|abdominal hysterectomy|abdominal hysterectomy
20559|NCT03443271|stress response|stress response
20560|NCT03443219|Airway Management|airway management
20561|NCT03443219|Extraglottic airway device|extraglottic airway device
20562|NCT03443219|Laryngeal mask airway|laryngeal mask airway
20563|NCT03443219|Spritztube|spritztube
20564|NCT03443206|adolescent|adolescent
20565|NCT03443206|mental health|mental health
20566|NCT03443206|social media|social media
20567|NCT03443193|aerobic exercise training|aerobic exercise training
20568|NCT03443193|periodization|periodization
20569|NCT03443193|cerebral oxygenation and perfusion|cerebral oxygenation and perfusion
20570|NCT03443193|cognition|cognition
20571|NCT03443180|Siblings|siblings
20572|NCT03443167|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
20573|NCT03443167|Teaching Material|teaching material
20574|NCT03443167|Primary education|primary education
20575|NCT03443154|Cerclage|cerclage
20576|NCT03443154|Preterm birth|preterm birth
20577|NCT03443128|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
20578|NCT03443128|Recurrent|recurrent
20579|NCT03443128|Childhood|childhood
20580|NCT03443128|Adolescent|adolescent
20581|NCT03443128|Treatment|treatment
20582|NCT03443089|medroxyprogesterone acetate|medroxyprogesterone acetate
20583|NCT03443089|estradiol cypionate|estradiol cypionate
20584|NCT03443089|bioavailability|bioavailability
20585|NCT03443089|monthly contraceptive|monthly contraceptive
20586|NCT03443063|severe renal impairment|severe renal impairment
20587|NCT03443063|lemborexant|lemborexant
20588|NCT03443063|normal renal function|normal renal function
20589|NCT03443063|healthy participants|healthy participants
20590|NCT03443063|metabolites|metabolites
20591|NCT03443063|E2006|e2006
20592|NCT03443063|pharmacokinetics|pharmacokinetics
20593|NCT03443037|Coma|coma
20594|NCT03443037|Disability|disability
20595|NCT03443037|amantadine|amantadine
20596|NCT03443024|Eczema|eczema
20597|NCT03442985|Multiple osteochondromas|multiple osteochondromas
20598|NCT03442985|Osteochondroma|osteochondroma
20599|NCT03442985|Palovarotene|palovarotene
20600|NCT03442985|Hereditary multiple exostoses|hereditary multiple exostoses
20601|NCT03442985|HME|hme
20602|NCT03442985|MO|mo
20603|NCT03442985|Retinoic acid receptor gamma agonist|retinoic acid receptor gamma agonist
20604|NCT03442985|Retinoic acid receptor agonist|retinoic acid receptor agonist
20605|NCT03442972|Intestinal lipoprotein|intestinal lipoprotein
20606|NCT03442972|Duodenal biopsy|duodenal biopsy
20607|NCT03442972|Gut Peptide|gut peptide
20608|NCT03442972|Chylomicrons|chylomicrons
20609|NCT03442959|Small intestine neuroendocrine tumor|small intestine neuroendocrine tumor
20610|NCT03442959|palliative surgery|palliative surgery
20611|NCT03442946|nutrition guidelines|nutrition guidelines
20612|NCT03442946|critical care|critical care
20613|NCT03442946|cardiovascular|cardiovascular
20614|NCT03442946|nutrition therapy|nutrition therapy
20615|NCT03442933|Muscle Fatigue|muscle fatigue
20616|NCT03442933|Cycling|cycling
20617|NCT03442933|MTB|mtb
20618|NCT03442933|Tensiomiography|tensiomiography
20619|NCT03442920|obesity|obesity
20620|NCT03442920|periodontal diseases|periodontal diseases
20621|NCT03442920|gingival crevicular fluid|gingival crevicular fluid
20622|NCT03442920|saliva|saliva
20623|NCT03442920|serum|serum
20624|NCT03442894|Shoulder pain|shoulder pain
20625|NCT03442894|Subacromial|subacromial
20626|NCT03442894|bursitis|bursitis
20627|NCT03442894|rotator cuff|rotator cuff
20628|NCT03442894|tendinopathy|tendinopathy
20629|NCT03442894|dry needling|dry needling
20630|NCT03442894|myofascial trigger point|myofascial trigger point
20631|NCT03442855|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
20632|NCT03442829|sweet taste, food preferences, food intake|sweet taste, food preferences, food intake
20633|NCT03442803|sedation|sedation
20634|NCT03442803|Emergency Department|emergency department
20635|NCT03442803|Target Controlled infusion|target controlled infusion
20636|NCT03442803|propofol|propofol
20637|NCT03442790|CVC confirmation|cvc confirmation
20638|NCT03442790|Agitated Saline|agitated saline
20639|NCT03442790|CXR|cxr
20640|NCT03442738|ADR|adr
20641|NCT03442738|adenoma|adenoma
20642|NCT03442738|polyp|polyp
20643|NCT03442738|colon|colon
20644|NCT03442738|screening|screening
20645|NCT03442738|colorectal carcinoma (CRC)|colorectal carcinoma (crc)
20646|NCT03442738|cap|cap
20647|NCT03442738|endoscopy|endoscopy
20648|NCT03442738|colonoscopy|colonoscopy
20649|NCT03442738|private practice|private practice
20650|NCT03442712|obesity|obesity
20651|NCT03442712|weight loss|weight loss
20652|NCT03442712|ear acupressure|ear acupressure
20653|NCT03442712|smartphone application|smartphone application
20654|NCT03442699|cognitive behavioral therapy|cognitive behavioral therapy
20655|NCT03442699|suicidal ideology|suicidal ideology
20656|NCT03442699|suicidal behavior|suicidal behavior
20657|NCT03442673|Multiple Myeloma|multiple myeloma
20658|NCT03442673|Vinorelbine|vinorelbine
20659|NCT03442673|Gemcitabine|gemcitabine
20660|NCT03442673|G-CSF|g-csf
20661|NCT03442673|ASCT|asct
20662|NCT03442634|bowel movements|bowel movements
20663|NCT03442634|cesarean section|cesarean section
20664|NCT03442634|oral hydration|oral hydration
20665|NCT03442543|sentinel lymph node biopsy|sentinel lymph node biopsy
20666|NCT03442530|pregnancy, smoking cessation, tobacco, preterm birth, ToPIC|pregnancy, smoking cessation, tobacco, preterm birth, topic
20667|NCT03442517|group-based counseling|group-based counseling
20668|NCT03442517|phone counseling|phone counseling
20669|NCT03442517|conference calls|conference calls
20670|NCT03442504|metastatic Breast cancer|metastatic breast cancer
20671|NCT03442504|FES PET/CT|fes pet/ct
20672|NCT03442504|menopausal patients|menopausal patients
20673|NCT03442504|recurrence after a 1st line of hormone therapy|recurrence after a 1st line of hormone therapy
20674|NCT03442491|Postpartum Hemorrhage|postpartum hemorrhage
20675|NCT03442491|Hayman's Haemostatic Suture|hayman's haemostatic suture
20676|NCT03442465|18-014|18-014
20677|NCT03442465|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
20678|NCT03442439|Family Nurture Intervention|family nurture intervention
20679|NCT03442439|Martha G. Welch MD|martha g. welch md
20680|NCT03442439|Randomized Controlled Trial|randomized controlled trial
20681|NCT03442439|Preschool Intervention|preschool intervention
20682|NCT03442439|Pre-school Intervention|pre-school intervention
20683|NCT03442439|Multiple Family Group Intervention|multiple family group intervention
20684|NCT03442439|Emotional Connection|emotional connection
20685|NCT03442439|Co-regulation|co-regulation
20686|NCT03442426|Primary Health Care|primary health care
20687|NCT03442426|Frail Elderly|frail elderly
20688|NCT03442426|Qualitative Methods|qualitative methods
20689|NCT03442426|Quantitative Methods|quantitative methods
20690|NCT03442426|Cost-Benefit Analysis|cost-benefit analysis
20691|NCT03442426|Patient Participation|patient participation
20692|NCT03442400|Coronary Artery Stenoses|coronary artery stenoses
20693|NCT03442400|Aortic Stenosis|aortic stenosis
20694|NCT03442374|Multifidus|multifidus
20695|NCT03442374|Muscle|muscle
20696|NCT03442374|Degeneration|degeneration
20697|NCT03442374|Lumbar Spine|lumbar spine
20698|NCT03442374|Disc|disc
20699|NCT03442348|Omega 3|omega 3
20700|NCT03442348|Fibre|fibre
20701|NCT03442348|Gut microbiome|gut microbiome
20702|NCT03442348|Metabolic profile|metabolic profile
20703|NCT03442348|Dietary intervention|dietary intervention
20704|NCT03442348|Randomised Control Trial|randomised control trial
20705|NCT03442335|embryo implantation|embryo implantation
20706|NCT03442335|endometrial receptivity|endometrial receptivity
20707|NCT03442335|chromohysteroscopy|chromohysteroscopy
20708|NCT03442335|transcriptomics|transcriptomics
20709|NCT03442335|proteomics|proteomics
20710|NCT03442335|metabolomics|metabolomics
20711|NCT03442335|implantation window|implantation window
20712|NCT03442335|luteal phase|luteal phase
20713|NCT03442322|long term care residents|long term care residents
20714|NCT03442322|nursing home care|nursing home care
20715|NCT03442309|dental caries|dental caries
20716|NCT03442309|caries arrest|caries arrest
20717|NCT03442309|caries prevention|caries prevention
20718|NCT03442309|quality of life|quality of life
20719|NCT03442309|silver diamine fluoride|silver diamine fluoride
20720|NCT03442309|sealants|sealants
20721|NCT03442309|interim therapeutic restorations|interim therapeutic restorations
20722|NCT03442309|student achievement|student achievement
20723|NCT03442309|school attendance|school attendance
20724|NCT03442283|Supplements, Cardiovascular Diseases, All-cause mortality, Meta-Analysis|supplements, cardiovascular diseases, all-cause mortality, meta-analysis
20725|NCT03442270|Serrated Adenoma, Colonoscopy|serrated adenoma, colonoscopy
20726|NCT03442257|Hypertension|hypertension
20727|NCT03442257|Text Messaging|text messaging
20728|NCT03442257|Primary Prevention|primary prevention
20729|NCT03442257|Cardiovascular Risk Factor|cardiovascular risk factor
20730|NCT03442257|Primary Health Care|primary health care
20731|NCT03442257|Health Promotion|health promotion
20732|NCT03442231|osteoarthritis|osteoarthritis
20733|NCT03442231|traumatic arthritis|traumatic arthritis
20734|NCT03442231|avascular necrosis|avascular necrosis
20735|NCT03442218|Cesarean|cesarean
20736|NCT03442218|Operative site infection|operative site infection
20737|NCT03442218|Vaginal wash|vaginal wash
20738|NCT03442218|Clorhexidine|clorhexidine
20739|NCT03442218|Endometritis|endometritis
20740|NCT03442205|Common Bile Duct Stone;|common bile duct stone;
20741|NCT03442205|Laparoscopic Common Bile Duct Exploration;|laparoscopic common bile duct exploration;
20742|NCT03442205|ERCP;|ercp;
20743|NCT03442192|PrEP|prep
20744|NCT03442192|virtual|virtual
20745|NCT03442192|adherence|adherence
20746|NCT03442192|retention|retention
20747|NCT03442179|Aging|aging
20748|NCT03442179|Anesthesia|anesthesia
20749|NCT03442179|EEG monitoring|eeg monitoring
20750|NCT03442179|Burst suppression|burst suppression
20751|NCT03442140|COPD|copd
20752|NCT03442140|Shortness of breath|shortness of breath
20753|NCT03442140|Harmonica|harmonica
20754|NCT03442114|shared decision making|shared decision making
20755|NCT03442114|parent-provider communication|parent-provider communication
20756|NCT03442114|hydroxyurea|hydroxyurea
20757|NCT03442114|sickle cell disease|sickle cell disease
20758|NCT03442075|Cancer of Prostate|cancer of prostate
20759|NCT03442075|Analgesic method|analgesic method
20760|NCT03442062|quality improvement|quality improvement
20761|NCT03442062|HPV vaccine|hpv vaccine
20762|NCT03442049|Multiple Sclerosis|multiple sclerosis
20763|NCT03442049|Gait|gait
20764|NCT03442049|Spinal Stabilization Exercises|spinal stabilization exercises
20765|NCT03442049|Plantar Pressure Distribution|plantar pressure distribution
20766|NCT03442049|Rehabilitation|rehabilitation
20767|NCT03442036|Regional Anesthesia|regional anesthesia
20768|NCT03442036|Sciatic Nerve Block|sciatic nerve block
20769|NCT03442036|Continuous Nerve Block|continuous nerve block
20770|NCT03442036|Perineural Catheter|perineural catheter
20771|NCT03442023|Chlorhexidine|chlorhexidine
20772|NCT03442023|Gram-negative|gram-negative
20773|NCT03442023|Colonization|colonization
20774|NCT03442010|Emergency department|emergency department
20775|NCT03442010|Clinical Pharmacist|clinical pharmacist
20776|NCT03442010|Adverse drug event|adverse drug event
20777|NCT03441997|exercise|exercise
20778|NCT03441997|low intensity exercise|low intensity exercise
20779|NCT03441997|pain|pain
20780|NCT03441997|fatigue|fatigue
20781|NCT03441997|sleep problems|sleep problems
20782|NCT03441984|Pediatric dispersible tablets|pediatric dispersible tablets
20783|NCT03441984|Bioavailability|bioavailability
20784|NCT03441958|hematopoietic stem cell transplant|hematopoietic stem cell transplant
20785|NCT03441958|Expanded cord blood|expanded cord blood
20786|NCT03441945|Magnetic|magnetic
20787|NCT03441945|Capsule Endoscopy|capsule endoscopy
20788|NCT03441945|enhance|enhance
20789|NCT03441945|gastric emptying|gastric emptying
20790|NCT03441932|Dysphagia|dysphagia
20791|NCT03441932|Pharyngeal residue scale|pharyngeal residue scale
20792|NCT03441932|Stroke|stroke
20793|NCT03441932|Pneumonia|pneumonia
20794|NCT03441893|ulcerative colitis, intestinal parasites, helminths, intestinal protozoan, nitazoxanide, mesalazine, combination therapy|ulcerative colitis, intestinal parasites, helminths, intestinal protozoan, nitazoxanide, mesalazine, combination therapy
20795|NCT03441867|Cognitive Behavioral Therapy|cognitive behavioral therapy
20796|NCT03441867|Veterans|veterans
20797|NCT03441867|Quality of Life|quality of life
20798|NCT03441867|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
20799|NCT03441867|Convulsion, Non-Epileptic|convulsion, non-epileptic
20800|NCT03441867|civilians|civilians
20801|NCT03441854|Gas exchange|gas exchange
20802|NCT03441854|Non invasive ventilation|non invasive ventilation
20803|NCT03441854|Liver transplantation|liver transplantation
20804|NCT03441841|local anesthetics|local anesthetics
20805|NCT03441841|pharmacokinetics|pharmacokinetics
20806|NCT03441841|nanotechnology|nanotechnology
20807|NCT03441815|Healthy volunteers|healthy volunteers
20808|NCT03441815|Phase I|phase i
20809|NCT03441815|Histamine glutarimide|histamine glutarimide
20810|NCT03441815|PHARMENTERPRISES|pharmenterprises
20811|NCT03441776|TBI|tbi
20812|NCT03441776|Rehabilitation|rehabilitation
20813|NCT03441776|Vestibular|vestibular
20814|NCT03441776|Dizziness|dizziness
20815|NCT03441763|Foot pressure, Obese, and normal Subjects|foot pressure, obese, and normal subjects
20816|NCT03441737|Aerobic exercise|aerobic exercise
20817|NCT03441737|Antisaccades|antisaccades
20818|NCT03441737|Urge to Smoke|urge to smoke
20819|NCT03441737|Adults|adults
20820|NCT03441672|Prenatal Screening|prenatal screening
20821|NCT03441672|Interactive educational technology|interactive educational technology
20822|NCT03441633|atrial fibrillation|atrial fibrillation
20823|NCT03441633|apixaban|apixaban
20824|NCT03441633|stroke|stroke
20825|NCT03441594|Food Insecurity|food insecurity
20826|NCT03441581|IBS-D|ibs-d
20827|NCT03441581|BAM|bam
20828|NCT03441555|Cancer|cancer
20829|NCT03441555|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
20830|NCT03441555|relapsed Acute Myeloid Leukemia|relapsed acute myeloid leukemia
20831|NCT03441555|refractory Acute Myeloid Leukemia|refractory acute myeloid leukemia
20832|NCT03441542|Care cascade|care cascade
20833|NCT03441542|Patient navigation services|patient navigation services
20834|NCT03441542|Injection drug users|injection drug users
20835|NCT03441542|Opioid substitution therapy|opioid substitution therapy
20836|NCT03441490|Learning Support|learning support
20837|NCT03441490|Chat|chat
20838|NCT03441490|Adolescents|adolescents
20839|NCT03441464|Fluorescence|fluorescence
20840|NCT03441464|Prostate|prostate
20841|NCT03441464|Cancer detection|cancer detection
20842|NCT03441451|Bariatric Surgery|bariatric surgery
20843|NCT03441438|alcohol sensitivity|alcohol sensitivity
20844|NCT03441438|red wine|red wine
20845|NCT03441438|aerd|aerd
20846|NCT03441425|CRM Skills|crm skills
20847|NCT03441425|ACLS|acls
20848|NCT03441425|Simulation|simulation
20849|NCT03441425|Stress|stress
20850|NCT03441399|Medication Adherence|medication adherence
20851|NCT03441360|eribulin mesylate|eribulin mesylate
20852|NCT03441360|pediatric|pediatric
20853|NCT03441347|Physical therapy|physical therapy
20854|NCT03441347|Occupational therapy|occupational therapy
20855|NCT03441347|Rehabilitation|rehabilitation
20856|NCT03441347|Motor control|motor control
20857|NCT03441308|Dieting|dieting
20858|NCT03441308|learning to eat|learning to eat
20859|NCT03441308|group treatment|group treatment
20860|NCT03441295|ACL|acl
20861|NCT03441269|Emergency Medicine|emergency medicine
20862|NCT03441269|Acute Pain|acute pain
20863|NCT03441269|Oral Ibuprofen|oral ibuprofen
20864|NCT03441230|stomach|stomach
20865|NCT03441230|motility|motility
20866|NCT03441217|Duration of labor|duration of labor
20867|NCT03441217|Hyoscine butylbromide|hyoscine butylbromide
20868|NCT03441204|COPD|copd
20869|NCT03441204|Long-term oxygen therapy (LTOT)|long-term oxygen therapy (ltot)
20870|NCT03441204|Registry|registry
20871|NCT03441204|Registry-based randomized controlled trial (R-RCT)|registry-based randomized controlled trial (r-rct)
20872|NCT03441204|Treatment duration|treatment duration
20873|NCT03441204|Mortality|mortality
20874|NCT03441165|ACL|acl
20875|NCT03441165|MAT|mat
20876|NCT03441165|REVISION|revision
20877|NCT03441165|LAXITY|laxity
20878|NCT03441152|Mild Cognitive Impairment|mild cognitive impairment
20879|NCT03441152|Neuromodulation|neuromodulation
20880|NCT03441139|Randomized controlled trial|randomized controlled trial
20881|NCT03441139|Musculoskeletal metastasis|musculoskeletal metastasis
20882|NCT03441139|Cancer pain|cancer pain
20883|NCT03441139|Percutaneous cryotherapy|percutaneous cryotherapy
20884|NCT03441139|Medical supportive care|medical supportive care
20885|NCT03441126|Diagnostic Stewardship|diagnostic stewardship
20886|NCT03441126|Pediatric|pediatric
20887|NCT03441126|Blood Culture Test|blood culture test
20888|NCT03441100|T-Cell therapy|t-cell therapy
20889|NCT03441100|Immunotherapy|immunotherapy
20890|NCT03441100|Adoptive cellular therapy|adoptive cellular therapy
20891|NCT03441100|T-Cell Receptor|t-cell receptor
20892|NCT03441100|Cell Therapy|cell therapy
20893|NCT03441100|Cytotherapy|cytotherapy
20894|NCT03441100|IMA202|ima202
20895|NCT03441087|transvaginal ultrasonography|transvaginal ultrasonography
20896|NCT03441087|hysteroscopy|hysteroscopy
20897|NCT03441087|abnormal uterine bleeding|abnormal uterine bleeding
20898|NCT03441061|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
20899|NCT03441061|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
20900|NCT03441061|ALL|all
20901|NCT03441061|Inotuzumab Ozogamicin|inotuzumab ozogamicin
20902|NCT03441061|CMC-544|cmc-544
20903|NCT03441048|Acute myeloid leukemia|acute myeloid leukemia
20904|NCT03441048|Relapsed/refractory acute myeloid leukemia|relapsed/refractory acute myeloid leukemia
20905|NCT03441048|CLAG-M|clag-m
20906|NCT03441048|Lintuzumab|lintuzumab
20907|NCT03441022|Cardioversion|cardioversion
20908|NCT03441022|BodyGuardian|bodyguardian
20909|NCT03441022|Amiigo Wristband|amiigo wristband
20910|NCT03441009|PSH, Rehabilitation, Medication, ANS|psh, rehabilitation, medication, ans
20911|NCT03440996|toothpaste|toothpaste
20912|NCT03440983|optimize the imaging protocols|optimize the imaging protocols
20913|NCT03440983|validate technical parameters in healthy volunteers|validate technical parameters in healthy volunteers
20914|NCT03440970|Chloride homeostasisH|chloride homeostasish
20915|NCT03440957|advanced cancer|advanced cancer
20916|NCT03440957|osteopathy|osteopathy
20917|NCT03440957|pain|pain
20918|NCT03440957|bedridden|bedridden
20919|NCT03440944|vascular access|vascular access
20920|NCT03440944|midline cather|midline cather
20921|NCT03440944|ultrasound guided IV|ultrasound guided iv
20922|NCT03440918|Infection|infection
20923|NCT03440892|survivin|survivin
20924|NCT03440892|biomarker of pharmacological response|biomarker of pharmacological response
20925|NCT03440892|antirheumatic treatment|antirheumatic treatment
20926|NCT03440892|methotrexate|methotrexate
20927|NCT03440892|sulfasalazin|sulfasalazin
20928|NCT03440892|abatacept|abatacept
20929|NCT03440892|tocilizumab|tocilizumab
20930|NCT03440892|tofacitinib/baricitinib|tofacitinib/baricitinib
20931|NCT03440827|low-flow vascular malformations, scale of life's quality|low-flow vascular malformations, scale of life's quality
20932|NCT03440814|PWS|pws
20933|NCT03440814|Prader-Willi Syndrome|prader-willi syndrome
20934|NCT03440762|Screening|screening
20935|NCT03440762|Education|education
20936|NCT03440762|AFib Awareness|afib awareness
20937|NCT03440762|Stroke prevention|stroke prevention
20938|NCT03440749|rhythm|rhythm
20939|NCT03440749|serial Reaction Time Task|serial reaction time task
20940|NCT03440736|Psoriasis|psoriasis
20941|NCT03440736|Metabolic syndrome|metabolic syndrome
20942|NCT03440736|Diabetes|diabetes
20943|NCT03440736|Obesity|obesity
20944|NCT03440736|Life-style|life-style
20945|NCT03440736|Life-style intervention|life-style intervention
20946|NCT03440736|Secukinumab|secukinumab
20947|NCT03440736|CAIN457A|cain457a
20948|NCT03440736|CAIN457ADE08|cain457ade08
20949|NCT03440736|AIN457A|ain457a
20950|NCT03440736|Skin condition|skin condition
20951|NCT03440736|skin disease|skin disease
20952|NCT03440736|itching condition|itching condition
20953|NCT03440736|psoriasis vulgaris|psoriasis vulgaris
20954|NCT03440736|relapsing/remitting psoriasis|relapsing/remitting psoriasis
20955|NCT03440736|immune-mediated systemic disease|immune-mediated systemic disease
20956|NCT03440736|skin lesions|skin lesions
20957|NCT03440736|red skin lesions|red skin lesions
20958|NCT03440736|scaly patches|scaly patches
20959|NCT03440736|papules|papules
20960|NCT03440736|plaques|plaques
20961|NCT03440736|itching|itching
20962|NCT03440723|Cervical Dilation|cervical dilation
20963|NCT03440723|Dilation|dilation
20964|NCT03440723|Sterile vaginal examination|sterile vaginal examination
20965|NCT03440697|Cardiovascular Disease|cardiovascular disease
20966|NCT03440684|Core stability, hand, function, balance, strength|core stability, hand, function, balance, strength
20967|NCT03440658|brachial plexus palsy|brachial plexus palsy
20968|NCT03440658|isokinetics|isokinetics
20969|NCT03440658|shoulder|shoulder
20970|NCT03440658|strenght|strenght
20971|NCT03440606|Randomized Wait-List Control Trial|randomized wait-list control trial
20972|NCT03440606|Mindful-Compassion Art Therapy Supervision|mindful-compassion art therapy supervision
20973|NCT03440606|End-of-Life Care|end-of-life care
20974|NCT03440606|Self-Care|self-care
20975|NCT03440593|sepsis|sepsis
20976|NCT03440593|nutrition|nutrition
20977|NCT03440593|indirect calorimetry|indirect calorimetry
20978|NCT03440593|muscle thickness|muscle thickness
20979|NCT03440580|physical activity|physical activity
20980|NCT03440580|serious game|serious game
20981|NCT03440580|school intervention|school intervention
20982|NCT03440580|children|children
20983|NCT03440554|Prostate Cancer|prostate cancer
20984|NCT03440554|Restriction spectrum imaging|restriction spectrum imaging
20985|NCT03440554|Magnetic resonance imaging|magnetic resonance imaging
20986|NCT03440554|MRI|mri
20987|NCT03440554|RSI|rsi
20988|NCT03440541|Amniotic membrane|amniotic membrane
20989|NCT03440541|Psoriasis|psoriasis
20990|NCT03440541|Treatment|treatment
20991|NCT03440528|Skin ulcer, Human amniotic membrane, Treatment|skin ulcer, human amniotic membrane, treatment
20992|NCT03440515|gastrointestinal stromal tumor|gastrointestinal stromal tumor
20993|NCT03440515|skin rash|skin rash
20994|NCT03440515|imatinib|imatinib
20995|NCT03440502|spinal anaesthesia|spinal anaesthesia
20996|NCT03440502|cesarean section|cesarean section
20997|NCT03440502|diabetes mellitus|diabetes mellitus
20998|NCT03440450|Liposomal gemcitabine|liposomal gemcitabine
20999|NCT03440437|FS118|fs118
21000|NCT03440437|Immuno-oncology|immuno-oncology
21001|NCT03440437|bispecific antibody|bispecific antibody
21002|NCT03440437|check-point inhibitor|check-point inhibitor
21003|NCT03440437|dose escalation|dose escalation
21004|NCT03440437|cohort expansion|cohort expansion
21005|NCT03440437|PK|pk
21006|NCT03440437|PD|pd
21007|NCT03440437|biomarker|biomarker
21008|NCT03440424|mild hepatic impairment|mild hepatic impairment
21009|NCT03440424|moderate hepatic impairment|moderate hepatic impairment
21010|NCT03440424|lemborexant|lemborexant
21011|NCT03440424|healthy participants|healthy participants
21012|NCT03440424|metabolites|metabolites
21013|NCT03440424|E2006|e2006
21014|NCT03440424|pharmacokinetics|pharmacokinetics
21015|NCT03440411|biochemical relapse|biochemical relapse
21016|NCT03440398|Robotic Mastectomy|robotic mastectomy
21017|NCT03440398|Nipple Sparing Mastectomy|nipple sparing mastectomy
21018|NCT03440398|Conservative mastectomy|conservative mastectomy
21019|NCT03440398|Breast reconstruction|breast reconstruction
21020|NCT03440385|Crohn's Disease|crohn's disease
21021|NCT03440385|Crohn Disease|crohn disease
21022|NCT03440385|Oral|oral
21023|NCT03440385|Ozanimod|ozanimod
21024|NCT03440385|Moderately active|moderately active
21025|NCT03440385|Severely active|severely active
21026|NCT03440385|RPC01|rpc01
21027|NCT03440385|RPC01-3202|rpc01-3202
21028|NCT03440372|Crohn's Disease|crohn's disease
21029|NCT03440372|Crohn Disease|crohn disease
21030|NCT03440372|Oral|oral
21031|NCT03440372|Ozanimod|ozanimod
21032|NCT03440372|Moderately active|moderately active
21033|NCT03440372|Severely active|severely active
21034|NCT03440372|RPC01|rpc01
21035|NCT03440372|RPC01-3201|rpc01-3201
21036|NCT03440359|PCOS, crinone, vaginal progesterone, ovulation induction|pcos, crinone, vaginal progesterone, ovulation induction
21037|NCT03440346|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
21038|NCT03440346|ADHD|adhd
21039|NCT03440346|child|child
21040|NCT03440346|human|human
21041|NCT03440346|diet|diet
21042|NCT03440346|few-foods diet|few-foods diet
21043|NCT03440346|brain|brain
21044|NCT03440346|gut|gut
21045|NCT03440346|microbiota|microbiota
21046|NCT03440320|Caregiving Dyad|caregiving dyad
21047|NCT03440320|Pain-related Disability|pain-related disability
21048|NCT03440294|windsurfer|windsurfer
21049|NCT03440294|neoprene suit|neoprene suit
21050|NCT03440294|spirometry|spirometry
21051|NCT03440294|cardiopulmonary exercise testing|cardiopulmonary exercise testing
21052|NCT03440268|cardiac surgery|cardiac surgery
21053|NCT03440268|post operatory complications|post operatory complications
21054|NCT03440268|Acute kidney injury|acute kidney injury
21055|NCT03440268|N-acetylcystein|n-acetylcystein
21056|NCT03440255|Transcutaneous Vagus nerve Stimulation|transcutaneous vagus nerve stimulation
21057|NCT03440255|Generalized Anxiety Disorder|generalized anxiety disorder
21058|NCT03440255|Chronic Pain|chronic pain
21059|NCT03440255|Irritable Bowel Syndrome|irritable bowel syndrome
21060|NCT03440255|Private Practice|private practice
21061|NCT03440216|temocillin|temocillin
21062|NCT03440216|ceftriaxone|ceftriaxone
21063|NCT03440216|meropenem|meropenem
21064|NCT03440216|pharmacokinetics|pharmacokinetics
21065|NCT03440216|pharmacodynamics|pharmacodynamics
21066|NCT03440216|Intensive Care|intensive care
21067|NCT03440216|dosing|dosing
21068|NCT03440216|total concentration|total concentration
21069|NCT03440216|free concentration|free concentration
21070|NCT03440190|Bariatric surgery|bariatric surgery
21071|NCT03440190|Gastrointestinal tract|gastrointestinal tract
21072|NCT03440190|Biological availability|biological availability
21073|NCT03440190|Pharmacokinetics|pharmacokinetics
21074|NCT03440190|Methylphenidate|methylphenidate
21075|NCT03440177|Bariatric surgery|bariatric surgery
21076|NCT03440177|Gastrointestinal tract|gastrointestinal tract
21077|NCT03440177|Biological availability|biological availability
21078|NCT03440177|Pharmacokinetics|pharmacokinetics
21079|NCT03440177|Ramipril|ramipril
21080|NCT03440164|liver fibrosis|liver fibrosis
21081|NCT03440164|Hepatoprotective|hepatoprotective
21082|NCT03440164|Sylimarin|sylimarin
21083|NCT03440151|Tongue Squamous Cell Carcinoma,|tongue squamous cell carcinoma,
21084|NCT03440151|Contralateral Submental Flap|contralateral submental flap
21085|NCT03440151|Submental Flap|submental flap
21086|NCT03440151|oncological safety|oncological safety
21087|NCT03440125|Low Back Pain|low back pain
21088|NCT03440125|Capsicum|capsicum
21089|NCT03440125|Physical Therapy|physical therapy
21090|NCT03440125|Pain|pain
21091|NCT03440112|Gait|gait
21092|NCT03440112|Balance|balance
21093|NCT03440112|GABA|gaba
21094|NCT03440112|Clarithromycin|clarithromycin
21095|NCT03440112|PET Imaging|pet imaging
21096|NCT03440112|MRI|mri
21097|NCT03440112|Mobility|mobility
21098|NCT03440099|Resistance Training|resistance training
21099|NCT03440099|Sex Differences|sex differences
21100|NCT03440086|Laparoscopic surgery|laparoscopic surgery
21101|NCT03440086|Pain|pain
21102|NCT03440086|Jackson-Pratt drain|jackson-pratt drain
21103|NCT03440073|pregnancy|pregnancy
21104|NCT03440073|pain|pain
21105|NCT03440073|pelvis|pelvis
21106|NCT03440073|spine|spine
21107|NCT03440073|manual therapy|manual therapy
21108|NCT03440060|procalcitonin|procalcitonin
21109|NCT03440060|mechanical ventilation|mechanical ventilation
21110|NCT03440060|COPD exacerbation|copd exacerbation
21111|NCT03440047|endoscopic image|endoscopic image
21112|NCT03440047|Fujifilm|fujifilm
21113|NCT03440047|Blue light imaging|blue light imaging
21114|NCT03440034|IBM|ibm
21115|NCT03440034|inclusion body myositis|inclusion body myositis
21116|NCT03440021|Noradrenalin Agents|noradrenalin agents
21117|NCT03440021|Physiological Effects of Drugs|physiological effects of drugs
21118|NCT03440021|Mood disorders|mood disorders
21119|NCT03440021|Behavioral Symptoms|behavioral symptoms
21120|NCT03439982|Hepatic encephalopathy, fecal microbiota transplant|hepatic encephalopathy, fecal microbiota transplant
21121|NCT03439969|Gingivitis|gingivitis
21122|NCT03439969|SMS|sms
21123|NCT03439969|Text messages|text messages
21124|NCT03439969|Behavior change|behavior change
21125|NCT03439969|HAPA|hapa
21126|NCT03439969|Dental Hygiene|dental hygiene
21127|NCT03439956|Obstetric outcomes|obstetric outcomes
21128|NCT03439956|Transvaginal specimen extraction|transvaginal specimen extraction
21129|NCT03439956|Gynecological laparoscopy|gynecological laparoscopy
21130|NCT03439904|pharmaceutical care|pharmaceutical care
21131|NCT03439904|adherence|adherence
21132|NCT03439852|physical activity|physical activity
21133|NCT03439839|Complement, alternative pathway, paroxysmal nocturnal hemoglobinuria,|complement, alternative pathway, paroxysmal nocturnal hemoglobinuria,
21134|NCT03439839|hemolysis|hemolysis
21135|NCT03439813|stroke|stroke
21136|NCT03439813|transient ischemic attack|transient ischemic attack
21137|NCT03439813|anxiety|anxiety
21138|NCT03439813|psychotherapy|psychotherapy
21139|NCT03439787|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
21140|NCT03439787|Anesthetics, Local|anesthetics, local
21141|NCT03439787|Pain, Postoperative|pain, postoperative
21142|NCT03439787|Nerve Block|nerve block
21143|NCT03439787|Bupivacaine|bupivacaine
21144|NCT03439787|Epinephrine|epinephrine
21145|NCT03439735|Breast Cancer|breast cancer
21146|NCT03439735|Metastatic Breast Cancer|metastatic breast cancer
21147|NCT03439735|Aromatase Inhibitors|aromatase inhibitors
21148|NCT03439735|Palbociclib|palbociclib
21149|NCT03439735|Hormone Receptor Positive Metastatic Breast Cancer|hormone receptor positive metastatic breast cancer
21150|NCT03439722|cluster headache|cluster headache
21151|NCT03439722|sleep disturbances|sleep disturbances
21152|NCT03439709|acromegaly|acromegaly
21153|NCT03439709|pituitary adenoma|pituitary adenoma
21154|NCT03439709|gamma knife radiosurgery|gamma knife radiosurgery
21155|NCT03439709|adjuvant treatment|adjuvant treatment
21156|NCT03439696|Thoracoscopy|thoracoscopy
21157|NCT03439696|VATS|vats
21158|NCT03439696|Needlescopy|needlescopy
21159|NCT03439696|Uniportal|uniportal
21160|NCT03439670|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
21161|NCT03439670|Vamorolone|vamorolone
21162|NCT03439657|HZ|hz
21163|NCT03439657|Safety|safety
21164|NCT03439657|Immunogenicity|immunogenicity
21165|NCT03439657|Shingles|shingles
21166|NCT03439657|Adults|adults
21167|NCT03439657|Prevenar 13|prevenar 13
21168|NCT03439605|Troponin-T|troponin-t
21169|NCT03439605|Haemolysis|haemolysis
21170|NCT03439579|Telehealth|telehealth
21171|NCT03439579|Remote weight loss|remote weight loss
21172|NCT03439579|Self-monitoring|self-monitoring
21173|NCT03439579|Diet|diet
21174|NCT03439579|Physical activity|physical activity
21175|NCT03439566|pain measures|pain measures
21176|NCT03439566|prediction of pain|prediction of pain
21177|NCT03439566|pain management|pain management
21178|NCT03439540|Plantago major|plantago major
21179|NCT03439540|obesity|obesity
21180|NCT03439540|mineral content|mineral content
21181|NCT03439540|adipose tissue|adipose tissue
21182|NCT03439527|Muscle Precursor Cells|muscle precursor cells
21183|NCT03439514|cardiomyopathy|cardiomyopathy
21184|NCT03439514|Lamin Type A|lamin type a
21185|NCT03439514|heart failure|heart failure
21186|NCT03439514|ARRY-797|arry-797
21187|NCT03439488|First in Human|first in human
21188|NCT03439488|Healthy Volunteers|healthy volunteers
21189|NCT03439488|Hepatitis B Virus|hepatitis b virus
21190|NCT03439488|JNJ-64530440|jnj-64530440
21191|NCT03439449|History taking, Risk stratification|history taking, risk stratification
21192|NCT03439410|Internal medicine|internal medicine
21193|NCT03439410|Chronic disease|chronic disease
21194|NCT03439410|Healthcare expenditure|healthcare expenditure
21195|NCT03439371|Acute Myeloid Leukemia|acute myeloid leukemia
21196|NCT03439371|Micro-transplantation|micro-transplantation
21197|NCT03439371|Elderly|elderly
21198|NCT03439371|Graft-versus-leukemia|graft-versus-leukemia
21199|NCT03439358|Epidural top-up|epidural top-up
21200|NCT03439358|Shivering|shivering
21201|NCT03439358|Magnesium|magnesium
21202|NCT03439332|Highly infiltrative|highly infiltrative
21203|NCT03439332|Deeply invasive|deeply invasive
21204|NCT03439332|Strong vascular proliferation|strong vascular proliferation
21205|NCT03439332|Robust angiogenesis|robust angiogenesis
21206|NCT03439332|Vascular heterogeneity|vascular heterogeneity
21207|NCT03439332|Perfusion Biormarker|perfusion biormarker
21208|NCT03439332|Non-Invasive Biomarker|non-invasive biomarker
21209|NCT03439332|Predictor of overall survival|predictor of overall survival
21210|NCT03439332|Predictor of progression-free survival|predictor of progression-free survival
21211|NCT03439319|MyndMove|myndmove
21212|NCT03439319|Electrical neuromodulation|electrical neuromodulation
21213|NCT03439319|conventional therapy|conventional therapy
21214|NCT03439293|Drug Therapy|drug therapy
21215|NCT03439293|Ixazomib|ixazomib
21216|NCT03439293|Daratumumab|daratumumab
21217|NCT03439293|Dexamethasone|dexamethasone
21218|NCT03439280|Drug therapy|drug therapy
21219|NCT03439254|Compensated Cirrhosis|compensated cirrhosis
21220|NCT03439254|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
21221|NCT03439254|Fatty Liver Disease|fatty liver disease
21222|NCT03439254|NASH|nash
21223|NCT03439215|ROS1 positive, NSCLC|ros1 positive, nsclc
21224|NCT03439202|Hypoxia|hypoxia
21225|NCT03439202|Baro-reflex sensitivity|baro-reflex sensitivity
21226|NCT03439202|Low-intensity exercise|low-intensity exercise
21227|NCT03439202|Hear rate variability|hear rate variability
21228|NCT03439202|EEG|eeg
21229|NCT03439202|Concentration performance|concentration performance
21230|NCT03439150|Absolute flow measurement|absolute flow measurement
21231|NCT03439150|Microvascular resistance|microvascular resistance
21232|NCT03439150|Left ventricular function|left ventricular function
21233|NCT03439111|Lycium chinense fruit|lycium chinense fruit
21234|NCT03439085|Malignant Neoplasms of Digestive Organs|malignant neoplasms of digestive organs
21235|NCT03439085|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
21236|NCT03439085|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
21237|NCT03439085|Human Papilloma Virus|human papilloma virus
21238|NCT03439085|MEDI0457|medi0457
21239|NCT03439085|Durvalumab|durvalumab
21240|NCT03439085|MEDI4736|medi4736
21241|NCT03439085|Electroporation|electroporation
21242|NCT03439085|EP|ep
21243|NCT03439072|glucagon|glucagon
21244|NCT03439072|hypoglycemia|hypoglycemia
21245|NCT03439059|Older adults|older adults
21246|NCT03439059|Sedentary behaviour|sedentary behaviour
21247|NCT03439059|Assisted living facility|assisted living facility
21248|NCT03439059|cognitive function|cognitive function
21249|NCT03439046|HHR-positive HER2-negative|hhr-positive her2-negative
21250|NCT03439046|advanced breast cancer|advanced breast cancer
21251|NCT03439046|LEE011|lee011
21252|NCT03439046|ribociclib|ribociclib
21253|NCT03439046|letrozole|letrozole
21254|NCT03439046|CDK|cdk
21255|NCT03439046|CDK4|cdk4
21256|NCT03439046|CDK6|cdk6
21257|NCT03439046|CDK4/6|cdk4/6
21258|NCT03439046|Phase IIIb|phase iiib
21259|NCT03439046|ER-positive|er-positive
21260|NCT03439046|PR-positivel|pr-positivel
21261|NCT03439046|postmenopausal|postmenopausal
21262|NCT03439046|biomarker|biomarker
21263|NCT03439046|ctDNA|ctdna
21264|NCT03439046|liquid biopsy|liquid biopsy
21265|NCT03439033|prostate cancer|prostate cancer
21266|NCT03439007|Dehydration|dehydration
21267|NCT03438994|autism|autism
21268|NCT03438994|movement|movement
21269|NCT03438994|tablet|tablet
21270|NCT03438994|gameplay|gameplay
21271|NCT03438981|Pharmacokinetics|pharmacokinetics
21272|NCT03438981|Ceftriaxone|ceftriaxone
21273|NCT03438981|critical illness|critical illness
21274|NCT03438981|capillary leak|capillary leak
21275|NCT03438981|hypoalbuminemia|hypoalbuminemia
21276|NCT03438942|iron|iron
21277|NCT03438942|folate|folate
21278|NCT03438942|childbearing age|childbearing age
21279|NCT03438942|bioavailability|bioavailability
21280|NCT03438916|Non-selective beta-blocker|non-selective beta-blocker
21281|NCT03438916|Pharmacological respons|pharmacological respons
21282|NCT03438916|Magnetic Resonance Imaging|magnetic resonance imaging
21283|NCT03438916|Hemodynamic assessments|hemodynamic assessments
21284|NCT03438916|Echocardiography|echocardiography
21285|NCT03438916|MR-elastography|mr-elastography
21286|NCT03438916|Propranolol|propranolol
21287|NCT03438916|Liver vein catheterization|liver vein catheterization
21288|NCT03438864|Radius fracture, Interferential current, edema, pain|radius fracture, interferential current, edema, pain
21289|NCT03438838|Achalasia, LHM, Anterior fundoplication|achalasia, lhm, anterior fundoplication
21290|NCT03438773|Hispanic|hispanic
21291|NCT03438773|First time kidney recipients|first time kidney recipients
21292|NCT03438760|Language Disorders|language disorders
21293|NCT03438760|Communication Disorders|communication disorders
21294|NCT03438760|Neurobehavioral Manifestations|neurobehavioral manifestations
21295|NCT03438760|Developmental Language Disorder|developmental language disorder
21296|NCT03438760|Randomized Controlled Trial|randomized controlled trial
21297|NCT03438734|Bariatric surgery|bariatric surgery
21298|NCT03438734|Low flow anesthesia|low flow anesthesia
21299|NCT03438734|Bispectral index|bispectral index
21300|NCT03438734|Regional cerebral oximetry|regional cerebral oximetry
21301|NCT03438708|Renal Cell Carcinoma|renal cell carcinoma
21302|NCT03438708|Axitinib|axitinib
21303|NCT03438708|Nephrectomy|nephrectomy
21304|NCT03438708|Neoadjuvant|neoadjuvant
21305|NCT03438708|Clear Cell Renal Carcinoma|clear cell renal carcinoma
21306|NCT03438695|endoscopy, motorized spiral enteroscopy|endoscopy, motorized spiral enteroscopy
21307|NCT03438669|visual acuity|visual acuity
21308|NCT03438669|ETDRS|etdrs
21309|NCT03438669|quality of life|quality of life
21310|NCT03438656|Depression|depression
21311|NCT03438656|Childhood adversity|childhood adversity
21312|NCT03438656|Behavioral Activation|behavioral activation
21313|NCT03438656|Reward Processing|reward processing
21314|NCT03438656|fMRI|fmri
21315|NCT03438643|Graft versus host disease|graft versus host disease
21316|NCT03438643|Extracorporeal photopheresis|extracorporeal photopheresis
21317|NCT03438643|Immunomodulatory|immunomodulatory
21318|NCT03438630|socioeconomic factors|socioeconomic factors
21319|NCT03438630|comorbidity|comorbidity
21320|NCT03438630|replacement surgery|replacement surgery
21321|NCT03438617|Diabetes|diabetes
21322|NCT03438617|Self-Management|self-management
21323|NCT03438617|Primary Care|primary care
21324|NCT03438617|Community Health Center|community health center
21325|NCT03438617|Peer Support|peer support
21326|NCT03438617|Group Support|group support
21327|NCT03438617|Integrated Care|integrated care
21328|NCT03438617|China|china
21329|NCT03438617|Urban|urban
21330|NCT03438591|cerclage pacing|cerclage pacing
21331|NCT03438591|cerclage-CRT|cerclage-crt
21332|NCT03438591|wide QRS|wide qrs
21333|NCT03438578|Patient safety|patient safety
21334|NCT03438578|Postoperative care|postoperative care
21335|NCT03438578|Monitoring, physiologic|monitoring, physiologic
21336|NCT03438578|Safety management|safety management
21337|NCT03438565|Asahi Chikai Black 18 Neurovascular Guidewire|asahi chikai black 18 neurovascular guidewire
21338|NCT03438565|Prospective|prospective
21339|NCT03438565|Retrospective|retrospective
21340|NCT03438513|Caregivers|caregivers
21341|NCT03438513|Burden|burden
21342|NCT03438513|Coping|coping
21343|NCT03438513|Quality of life|quality of life
21344|NCT03438513|Problem solving therapy|problem solving therapy
21345|NCT03438448|Ultrasensitive Troponin T|ultrasensitive troponin t
21346|NCT03438448|MINS|mins
21347|NCT03438448|Cost-effectiveness|cost-effectiveness
21348|NCT03438448|Myocardial Ischemia|myocardial ischemia
21349|NCT03438383|Bi-PAP|bi-pap
21350|NCT03438383|BiPAP|bipap
21351|NCT03438383|morbid obesity|morbid obesity
21352|NCT03438383|anesthesia|anesthesia
21353|NCT03438383|bariatric surgery|bariatric surgery
21354|NCT03438383|sham Bi-PAP|sham bi-pap
21355|NCT03438383|sham BiPAP|sham bipap
21356|NCT03438383|postoperative complications|postoperative complications
21357|NCT03438331|Insomnia|insomnia
21358|NCT03438331|Depression|depression
21359|NCT03438331|Adolescents|adolescents
21360|NCT03438331|Youth|youth
21361|NCT03438292|Berberine|berberine
21362|NCT03438292|TPGS|tpgs
21363|NCT03438292|Pharmacokinetics|pharmacokinetics
21364|NCT03438292|Human intervention study|human intervention study
21365|NCT03438253|Intraoperative penile engorgement|intraoperative penile engorgement
21366|NCT03438253|Anaesthesia|anaesthesia
21367|NCT03438253|Urogenital surgery|urogenital surgery
21368|NCT03438227|Iron Deficiency Anemia of Pregnancy|iron deficiency anemia of pregnancy
21369|NCT03438227|oral iron supplementation|oral iron supplementation
21370|NCT03438227|parenteral iron supplementation|parenteral iron supplementation
21371|NCT03438227|maternal anemia|maternal anemia
21372|NCT03438214|Vancomycin infusion|vancomycin infusion
21373|NCT03438214|critical ill patients|critical ill patients
21374|NCT03438214|MRSA|mrsa
21375|NCT03438201|Cancer, ICU, Surgery, Protein, Physical Activity|cancer, icu, surgery, protein, physical activity
21376|NCT03438188|Nicotine Addiction|nicotine addiction
21377|NCT03438188|Quitting Smoking|quitting smoking
21378|NCT03438175|Post-traumatic Stress Disorder|post-traumatic stress disorder
21379|NCT03438175|Web-site|web-site
21380|NCT03438175|Communication|communication
21381|NCT03438175|Intensive Care Unit|intensive care unit
21382|NCT03438175|Comprehension|comprehension
21383|NCT03438149|microparticles|microparticles
21384|NCT03438149|cardiovascular outcomes|cardiovascular outcomes
21385|NCT03438110|Preterm birth|preterm birth
21386|NCT03438110|Neonatal death|neonatal death
21387|NCT03438110|Stillbirth|stillbirth
21388|NCT03438110|Asia|asia
21389|NCT03438110|Africa|africa
21390|NCT03438097|Fluid therapy|fluid therapy
21391|NCT03438097|Non-resuscitation fluids|non-resuscitation fluids
21392|NCT03438097|Septic shock|septic shock
21393|NCT03438084|Interesterified|interesterified
21394|NCT03438084|Postprandial|postprandial
21395|NCT03438084|Lipid|lipid
21396|NCT03438058|Solid Organ Transplantation|solid organ transplantation
21397|NCT03438058|Graft survival|graft survival
21398|NCT03438058|Rejection|rejection
21399|NCT03438058|Complement-activating anti-HLA DSA|complement-activating anti-hla dsa
21400|NCT03438058|Meta-analysis|meta-analysis
21401|NCT03438058|Prognosis|prognosis
21402|NCT03438045|Chinese American|chinese american
21403|NCT03438045|implementation science|implementation science
21404|NCT03438045|feasibility|feasibility
21405|NCT03438045|acceptability|acceptability
21406|NCT03438045|oral health|oral health
21407|NCT03438045|dental care|dental care
21408|NCT03438045|health equity|health equity
21409|NCT03438045|urban health|urban health
21410|NCT03438019|Maximal Respiratory Pressures, Inspiratory Muscle Training, TIRE, COPD|maximal respiratory pressures, inspiratory muscle training, tire, copd
21411|NCT03438006|Safety|safety
21412|NCT03438006|Human Papillomavirus Vaccine|human papillomavirus vaccine
21413|NCT03438006|Adverse Event Following Immunization|adverse event following immunization
21414|NCT03437993|ADHD|adhd
21415|NCT03437993|executive functioning|executive functioning
21416|NCT03437993|game|game
21417|NCT03437941|Prostate Cancer|prostate cancer
21418|NCT03437941|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
21419|NCT03437941|Glucocorticoid receptor|glucocorticoid receptor
21420|NCT03437941|Antagonist|antagonist
21421|NCT03437941|mCRPC|mcrpc
21422|NCT03437941|enzalutamide|enzalutamide
21423|NCT03437941|androgen receptor|androgen receptor
21424|NCT03437928|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
21425|NCT03437928|MDD|mdd
21426|NCT03437928|Neuromodulation|neuromodulation
21427|NCT03437928|Deep Brain Stimulation (DBS)|deep brain stimulation (dbs)
21428|NCT03437928|DBS|dbs
21429|NCT03437928|Electrophysiology|electrophysiology
21430|NCT03437928|Imaging|imaging
21431|NCT03437902|Type 2 diabetes|type 2 diabetes
21432|NCT03437902|Rutin|rutin
21433|NCT03437902|Vitamin C|vitamin c
21434|NCT03437902|oxidative stress|oxidative stress
21435|NCT03437902|Insulin resistance|insulin resistance
21436|NCT03437902|lipid profile|lipid profile
21437|NCT03437889|epidural|epidural
21438|NCT03437876|HBV induced cirrhosis|hbv induced cirrhosis
21439|NCT03437876|intestinal microbiota transplantation|intestinal microbiota transplantation
21440|NCT03437876|microbiota|microbiota
21441|NCT03437863|self-management|self-management
21442|NCT03437863|health assets|health assets
21443|NCT03437863|Strengths|strengths
21444|NCT03437863|mHealth|mhealth
21445|NCT03437863|Feasibility|feasibility
21446|NCT03437811|airway clearance system|airway clearance system
21447|NCT03437811|cystic fibrosis|cystic fibrosis
21448|NCT03437811|lung secretion clearance|lung secretion clearance
21449|NCT03437798|Periodontal Disease|periodontal disease
21450|NCT03437798|Diabetes|diabetes
21451|NCT03437798|Osteoporosis|osteoporosis
21452|NCT03437798|Cardiovascular Risk Factor|cardiovascular risk factor
21453|NCT03437798|Genomic|genomic
21454|NCT03437785|Acute Gastritis|acute gastritis
21455|NCT03437785|Chronic Gastritis|chronic gastritis
21456|NCT03437785|Cinnamic acid|cinnamic acid
21457|NCT03437785|CKD-495|ckd-495
21458|NCT03437759|macular hole (MH)|macular hole (mh)
21459|NCT03437759|exosomes|exosomes
21460|NCT03437759|mesenchymal stem cells|mesenchymal stem cells
21461|NCT03437759|pars plana vitrectomy|pars plana vitrectomy
21462|NCT03437733|Radiofrequency Ablation|radiofrequency ablation
21463|NCT03437733|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
21464|NCT03437707|Postoperative pain|postoperative pain
21465|NCT03437707|Intravenous ibuprofen|intravenous ibuprofen
21466|NCT03437707|Intravenous paracetamol|intravenous paracetamol
21467|NCT03437707|Lumbar disc surgery|lumbar disc surgery
21468|NCT03437694|HIV|hiv
21469|NCT03437694|AIDS|aids
21470|NCT03437694|Diabetes Melliltus, Type 2|diabetes melliltus, type 2
21471|NCT03437694|Hypertension|hypertension
21472|NCT03437694|Pharmacist|pharmacist
21473|NCT03437694|Medication optimization|medication optimization
21474|NCT03437694|medication therapy management|medication therapy management
21475|NCT03437681|Sleep|sleep
21476|NCT03437681|Blood Sugar|blood sugar
21477|NCT03437668|Schizophrenia|schizophrenia
21478|NCT03437668|Withania Somnifera|withania somnifera
21479|NCT03437616|Rehabilitation|rehabilitation
21480|NCT03437616|Coronary heart disease|coronary heart disease
21481|NCT03437616|Cardiovascular diseases|cardiovascular diseases
21482|NCT03437616|Risk factors|risk factors
21483|NCT03437616|Life-style changes|life-style changes
21484|NCT03437616|Efficacy|efficacy
21485|NCT03437603|Eltrombopag|eltrombopag
21486|NCT03437603|Allogenetic Hematopoietic Stem Cell Transplantation|allogenetic hematopoietic stem cell transplantation
21487|NCT03437603|Poor Graft Function|poor graft function
21488|NCT03437577|Kidney|kidney
21489|NCT03437577|Transplant|transplant
21490|NCT03437551|Diabetes Mellitus 1|diabetes mellitus 1
21491|NCT03437551|long-term intensified insulin therapy|long-term intensified insulin therapy
21492|NCT03437551|diabetic retinopathy|diabetic retinopathy
21493|NCT03437551|diabetic macular edema|diabetic macular edema
21494|NCT03437538|Dialysis|dialysis
21495|NCT03437538|MCO|mco
21496|NCT03437538|Middle molecules|middle molecules
21497|NCT03437538|High Retention Onset|high retention onset
21498|NCT03437538|Medium Cut-Off|medium cut-off
21499|NCT03437525|Diabetes|diabetes
21500|NCT03437525|Self-Management|self-management
21501|NCT03437525|Primary Care|primary care
21502|NCT03437525|Community Health Center|community health center
21503|NCT03437525|Peer Support|peer support
21504|NCT03437525|Group Support|group support
21505|NCT03437525|Integrated Care|integrated care
21506|NCT03437525|Insulin|insulin
21507|NCT03437525|China|china
21508|NCT03437525|Urban|urban
21509|NCT03437512|tDCS|tdcs
21510|NCT03437512|MRI|mri
21511|NCT03437512|Speech|speech
21512|NCT03437512|fluency|fluency
21513|NCT03437460|Productivity|productivity
21514|NCT03437460|Cognitive Function|cognitive function
21515|NCT03437460|Decision Making|decision making
21516|NCT03437460|Well-Being|well-being
21517|NCT03437460|Health|health
21518|NCT03437460|Labor|labor
21519|NCT03437447|Bioavailability|bioavailability
21520|NCT03437447|Bioequivalence|bioequivalence
21521|NCT03437447|Praziquantel|praziquantel
21522|NCT03437447|Cysticide|cysticide
21523|NCT03437447|Pharmacokinetics|pharmacokinetics
21524|NCT03437421|myocardial function|myocardial function
21525|NCT03437421|vitamin D|vitamin d
21526|NCT03437421|stress echocardiography|stress echocardiography
21527|NCT03437421|diabetes|diabetes
21528|NCT03437408|Ventricular Tachycardia|ventricular tachycardia
21529|NCT03437408|Catheter Ablation|catheter ablation
21530|NCT03437408|Late Potential|late potential
21531|NCT03437408|Ablation Index|ablation index
21532|NCT03437408|Pacing|pacing
21533|NCT03437395|Lumpectomy|lumpectomy
21534|NCT03437395|Unifocal Disease|unifocal disease
21535|NCT03437395|Stage 0 or 1 Disease|stage 0 or 1 disease
21536|NCT03437382|Hepatocellular carcinoma|hepatocellular carcinoma
21537|NCT03437382|Radiofrequency ablation (RFA)|radiofrequency ablation (rfa)
21538|NCT03437382|Radioembolization|radioembolization
21539|NCT03437382|Quirem Spheres|quirem spheres
21540|NCT03437382|Selective internal radiation therapy|selective internal radiation therapy
21541|NCT03437369|Ivabradine, heart rate, acute heart failure|ivabradine, heart rate, acute heart failure
21542|NCT03437356|persistent atrial fibrillation|persistent atrial fibrillation
21543|NCT03437356|pulmonary vein isolation|pulmonary vein isolation
21544|NCT03437356|antiarrhythmic drug therapy|antiarrhythmic drug therapy
21545|NCT03437343|EOS|eos
21546|NCT03437343|total hip arthroplasty|total hip arthroplasty
21547|NCT03437343|performance of surgeons|performance of surgeons
21548|NCT03437343|leg length discrepancy|leg length discrepancy
21549|NCT03437343|HOOS|hoos
21550|NCT03437317|Social Anxiety|social anxiety
21551|NCT03437317|Threat processing|threat processing
21552|NCT03437317|Magnetoencephalography (MEG)|magnetoencephalography (meg)
21553|NCT03437304|Vaccine|vaccine
21554|NCT03437278|Anti-IgE|anti-ige
21555|NCT03437278|Chronic spontaneous urticaria,|chronic spontaneous urticaria,
21556|NCT03437252|COPD|copd
21557|NCT03437252|COPD exacerbation|copd exacerbation
21558|NCT03437252|COPD AE|copd ae
21559|NCT03437252|Physical activity|physical activity
21560|NCT03437252|Wearable arm device|wearable arm device
21561|NCT03437239|Bicep tenodesis|bicep tenodesis
21562|NCT03437226|Heart Failure, Levosimendan|heart failure, levosimendan
21563|NCT03437200|œsophageal cancer nivolumab ipilimumab|œsophageal cancer nivolumab ipilimumab
21564|NCT03437174|Hypoparathyroidism|hypoparathyroidism
21565|NCT03437174|Parathyroid Disease|parathyroid disease
21566|NCT03437174|Burden of Illness|burden of illness
21567|NCT03437174|SF-36|sf-36
21568|NCT03437174|Quality of Life|quality of life
21569|NCT03437161|Radiation|radiation
21570|NCT03437161|Prone position|prone position
21571|NCT03437161|Supine position|supine position
21572|NCT03437161|DIBH|dibh
21573|NCT03437161|Invasive Breast Carcinoma|invasive breast carcinoma
21574|NCT03437161|Ductal Breast Carcinoma In Situ|ductal breast carcinoma in situ
21575|NCT03437148|Pulmonary to systemic blood flow|pulmonary to systemic blood flow
21576|NCT03437148|Non-invasive measurement|non-invasive measurement
21577|NCT03437148|Inert gas rebreathing|inert gas rebreathing
21578|NCT03437148|Bioimpedance cardiograph|bioimpedance cardiograph
21579|NCT03437148|Atrial Septal Defect|atrial septal defect
21580|NCT03437148|Congenital heart disease|congenital heart disease
21581|NCT03437148|Cardiac Output|cardiac output
21582|NCT03437135|diabetes|diabetes
21583|NCT03437135|hearing problems|hearing problems
21584|NCT03437135|otoscopy|otoscopy
21585|NCT03437122|lung, nasal mucosa, respiratory mucosa|lung, nasal mucosa, respiratory mucosa
21586|NCT03437083|Breast neoplasms|breast neoplasms
21587|NCT03437083|Metastatic breast cancer|metastatic breast cancer
21588|NCT03437083|E7389|e7389
21589|NCT03437070|Advanced Leiomyosarcoma|advanced leiomyosarcoma
21590|NCT03437070|Recurrent Leiomyosarcoma|recurrent leiomyosarcoma
21591|NCT03437057|ECL|ecl
21592|NCT03437057|Hematoma|hematoma
21593|NCT03437057|Antiplatelet|antiplatelet
21594|NCT03437044|diabetes mellitus|diabetes mellitus
21595|NCT03437044|percutaneous coronary intervention|percutaneous coronary intervention
21596|NCT03437044|ticagrelor|ticagrelor
21597|NCT03437044|clopidogrel|clopidogrel
21598|NCT03437044|coronary artery disease|coronary artery disease
21599|NCT03437031|Labor Pain|labor pain
21600|NCT03437031|Virtual Reality|virtual reality
21601|NCT03437031|Alternative Medicine|alternative medicine
21602|NCT03437018|moderate diabetic retinopathy|moderate diabetic retinopathy
21603|NCT03437018|tele-expertise|tele-expertise
21604|NCT03437005|Human microbiome|human microbiome
21605|NCT03437005|Topical|topical
21606|NCT03437005|Steroid|steroid
21607|NCT03437005|Anti-fungal|anti-fungal
21608|NCT03436992|Estrogen, Diabetes|estrogen, diabetes
21609|NCT03436979|prolapse|prolapse
21610|NCT03436979|sacrospinous fixation|sacrospinous fixation
21611|NCT03436979|minimally invasive|minimally invasive
21612|NCT03436927|Multiple Sclerosis|multiple sclerosis
21613|NCT03436927|rehabilitation|rehabilitation
21614|NCT03436927|postural balance|postural balance
21615|NCT03436927|exercise|exercise
21616|NCT03436901|magnetic resonance imaging|magnetic resonance imaging
21617|NCT03436901|diffusion weighted imaging|diffusion weighted imaging
21618|NCT03436862|Nivolumab|nivolumab
21619|NCT03436862|Autologous Stem Cell Transplant|autologous stem cell transplant
21620|NCT03436862|Blood cancers|blood cancers
21621|NCT03436849|ASP2693|asp2693
21622|NCT03436849|Pharmacodynamics|pharmacodynamics
21623|NCT03436849|Pharmacokinetics|pharmacokinetics
21624|NCT03436849|ESN364|esn364
21625|NCT03436849|Safety|safety
21626|NCT03436810|Motor Imagery|motor imagery
21627|NCT03436810|Task-Oriented Circuit Class Training|task-oriented circuit class training
21628|NCT03436810|Health Education|health education
21629|NCT03436771|long-term follow-up|long-term follow-up
21630|NCT03436771|chimeric antigen receptor (CAR) T cells|chimeric antigen receptor (car) t cells
21631|NCT03436771|JCAR017|jcar017
21632|NCT03436771|JCARH125|jcarh125
21633|NCT03436758|uterine fluids|uterine fluids
21634|NCT03436758|Biobank|biobank
21635|NCT03436758|culture medium|culture medium
21636|NCT03436745|Insomnia|insomnia
21637|NCT03436745|Enzyme Expression|enzyme expression
21638|NCT03436745|PSA|psa
21639|NCT03436745|TESTOSTERONE|testosterone
21640|NCT03436745|Recommended Dose|recommended dose
21641|NCT03436732|Immunotoxin|immunotoxin
21642|NCT03436732|Rapamycin|rapamycin
21643|NCT03436732|Targeted Therapy|targeted therapy
21644|NCT03436732|Mesothelin|mesothelin
21645|NCT03436719|Surgical Site Infection|surgical site infection
21646|NCT03436719|Rectal Cancer Surgery|rectal cancer surgery
21647|NCT03436719|Oral Antibiotic|oral antibiotic
21648|NCT03436719|Antibiotic Prophylaxis|antibiotic prophylaxis
21649|NCT03436693|Diabetic Nephropathy|diabetic nephropathy
21650|NCT03436693|Canagliflozin|canagliflozin
21651|NCT03436693|Canaglu|canaglu
21652|NCT03436693|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
21653|NCT03436680|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
21654|NCT03436680|Chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
21655|NCT03436680|CIPN|cipn
21656|NCT03436680|Home-based neurofeedback|home-based neurofeedback
21657|NCT03436680|HBNF|hbnf
21658|NCT03436680|Questionnaires|questionnaires
21659|NCT03436680|Surveys|surveys
21660|NCT03436680|Electroencephalogram|electroencephalogram
21661|NCT03436680|EEG|eeg
21662|NCT03436654|prostate cancer|prostate cancer
21663|NCT03436654|apalutamide|apalutamide
21664|NCT03436654|abiraterone acetate|abiraterone acetate
21665|NCT03436654|memorial sloan kettering cancer center|memorial sloan kettering cancer center
21666|NCT03436654|17-646|17-646
21667|NCT03436602|Personalized risk assessment|personalized risk assessment
21668|NCT03436602|Risk stratification model|risk stratification model
21669|NCT03436589|Supplemental Nutrition Assistance Program-Education|supplemental nutrition assistance program-education
21670|NCT03436589|nutrition education intervention|nutrition education intervention
21671|NCT03436576|Autologous serum|autologous serum
21672|NCT03436576|Concentration|concentration
21673|NCT03436576|Autologous serum 20%|autologous serum 20%
21674|NCT03436576|Autologous serum 50%|autologous serum 50%
21675|NCT03436576|Severe dry eye|severe dry eye
21676|NCT03436563|Adenocarcinoma of the colon|adenocarcinoma of the colon
21677|NCT03436563|Adenocarcinoma of the rectum|adenocarcinoma of the rectum
21678|NCT03436563|Microsatellite instability-high metastatic colorectal cancer|microsatellite instability-high metastatic colorectal cancer
21679|NCT03436563|Treatment-refractory, consensus molecular subtype 4 (CMS4) mCRC|treatment-refractory, consensus molecular subtype 4 (cms4) mcrc
21680|NCT03436563|MSI-H non CRC solid tumors who have progressed on immune checkpoint blockade therapy|msi-h non crc solid tumors who have progressed on immune checkpoint blockade therapy
21681|NCT03436563|M7824|m7824
21682|NCT03436563|MSB0011359C|msb0011359c
21683|NCT03436550|Hepatic Venous Pressure Gradient|hepatic venous pressure gradient
21684|NCT03436550|Magnetic Resonance Imaging|magnetic resonance imaging
21685|NCT03436550|Acoustic Radiation Force Impulse|acoustic radiation force impulse
21686|NCT03436550|Elastography|elastography
21687|NCT03436550|Ultrasound|ultrasound
21688|NCT03436550|Liver Cirrhosis|liver cirrhosis
21689|NCT03436537|aesthetic|aesthetic
21690|NCT03436537|development|development
21691|NCT03436537|periodontal|periodontal
21692|NCT03436537|reliability|reliability
21693|NCT03436537|validity|validity
21694|NCT03436524|Early stage CLL|early stage cll
21695|NCT03436524|Binet A|binet a
21696|NCT03436524|Prognosis|prognosis
21697|NCT03436511|Health resource utilization|health resource utilization
21698|NCT03436511|Eosinophilic COPD|eosinophilic copd
21699|NCT03436511|Mepolizumab|mepolizumab
21700|NCT03436472|aged|aged
21701|NCT03436472|operative|operative
21702|NCT03436472|delirium|delirium
21703|NCT03436472|dexmedetomidine|dexmedetomidine
21704|NCT03436472|long-term outcome|long-term outcome
21705|NCT03436459|extracorporeal shock wave therapy (ESWT)|extracorporeal shock wave therapy (eswt)
21706|NCT03436459|Low level laser therapy (LLLT)|low level laser therapy (lllt)
21707|NCT03436459|Myofascial Pain Syndrome|myofascial pain syndrome
21708|NCT03436446|Patient Reported Outcomes (PRO)|patient reported outcomes (pro)
21709|NCT03436446|Social Incentives|social incentives
21710|NCT03436420|Pediatrics|pediatrics
21711|NCT03436420|Lipids|lipids
21712|NCT03436420|Liver Diseases|liver diseases
21713|NCT03436420|Obesity|obesity
21714|NCT03436394|Renal Impairment|renal impairment
21715|NCT03436394|Evobrutinib|evobrutinib
21716|NCT03436394|Pharmacokinetics|pharmacokinetics
21717|NCT03436368|Continuous spinal anesthesia|continuous spinal anesthesia
21718|NCT03436368|General anesthesia|general anesthesia
21719|NCT03436368|Renal transplantation|renal transplantation
21720|NCT03436368|Chronic renal failure|chronic renal failure
21721|NCT03436355|Behavioral|behavioral
21722|NCT03436355|Physical activity|physical activity
21723|NCT03436355|Intervention|intervention
21724|NCT03436355|School children|school children
21725|NCT03436329|Lung cancer|lung cancer
21726|NCT03436329|Surgical technique|surgical technique
21727|NCT03436329|vessel ligation|vessel ligation
21728|NCT03436329|Circulating tumor cell|circulating tumor cell
21729|NCT03436316|Phosphoinositide 3-kinase (PI3K) inhibitor|phosphoinositide 3-kinase (pi3k) inhibitor
21730|NCT03436316|First-in-human (FiH) study|first-in-human (fih) study
21731|NCT03436303|Menopause Syndrome|menopause syndrome
21732|NCT03436303|low dose estrogen|low dose estrogen
21733|NCT03436303|progestin|progestin
21734|NCT03436290|Palliative Care|palliative care
21735|NCT03436277|Overweight|overweight
21737|NCT03436277|L-Carnitine|l-carnitine
21738|NCT03436277|Body weight|body weight
21739|NCT03436277|Body fat percentage|body fat percentage
21740|NCT03436251|hyperthermia|hyperthermia
21741|NCT03436251|human papillomavirus virus|human papillomavirus virus
21742|NCT03436251|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
21743|NCT03436238|Perioperative|perioperative
21744|NCT03436238|Biomarkers|biomarkers
21745|NCT03436238|Troponin|troponin
21746|NCT03436238|Prodrenomedullin|prodrenomedullin
21747|NCT03436238|Endothelin|endothelin
21748|NCT03436238|Perioperative Complications|perioperative complications
21749|NCT03436225|steroid therapy.|steroid therapy.
21750|NCT03436186|Thyroidectomy|thyroidectomy
21751|NCT03436186|voice|voice
21752|NCT03436186|swallowing problems|swallowing problems
21753|NCT03436186|dysphagia|dysphagia
21754|NCT03436147|vaginal hysterectomy|vaginal hysterectomy
21755|NCT03436147|laparoscopic hysteropexy|laparoscopic hysteropexy
21756|NCT03436147|pelvic organ prolapse quantification|pelvic organ prolapse quantification
21757|NCT03436134|Donor-specific antibodies|donor-specific antibodies
21758|NCT03436134|Double-Filtration PlasmaPheresis (DFPP)|double-filtration plasmapheresis (dfpp)
21759|NCT03436134|Plasma Exchange (PE)|plasma exchange (pe)
21760|NCT03436095|Bundle|bundle
21761|NCT03436095|difficult ventilator weaning|difficult ventilator weaning
21762|NCT03436069|Breast cancer|breast cancer
21763|NCT03436069|biomarkers|biomarkers
21764|NCT03436069|prognostic|prognostic
21765|NCT03436069|ectopic gene expression|ectopic gene expression
21766|NCT03436069|expression profile|expression profile
21767|NCT03436069|tissue-specific genes|tissue-specific genes
21768|NCT03436069|response to treatment|response to treatment
21769|NCT03436056|Non-small-cell lunG cancer|non-small-cell lung cancer
21770|NCT03436056|NSCLC|nsclc
21771|NCT03436056|metastatic|metastatic
21772|NCT03436056|pembrolizumab|pembrolizumab
21773|NCT03436056|radiotherapy|radiotherapy
21774|NCT03436043|Walled of necrosis|walled of necrosis
21775|NCT03436017|adhd|adhd
21776|NCT03436017|metabolomics|metabolomics
21777|NCT03436017|child|child
21778|NCT03436004|Colonoscopy|colonoscopy
21779|NCT03436004|Adenoma|adenoma
21780|NCT03436004|Adenoma detection rate|adenoma detection rate
21781|NCT03435991|Experience Sampling Method|experience sampling method
21782|NCT03435991|Ecological Momentary Assessment|ecological momentary assessment
21783|NCT03435991|Momentary Symptom Assessment|momentary symptom assessment
21784|NCT03435991|Patient Reported Outcome Measure|patient reported outcome measure
21785|NCT03435978|diet|diet
21786|NCT03435978|metabolic syndrome|metabolic syndrome
21787|NCT03435978|obese children|obese children
21788|NCT03435952|Pembrolizumab|pembrolizumab
21789|NCT03435952|Keytruda|keytruda
21790|NCT03435952|MK-3475|mk-3475
21791|NCT03435952|SCH-900475|sch-900475
21792|NCT03435952|Clostridium Novyi-NT|clostridium novyi-nt
21793|NCT03435952|C. novyi-NT|c. novyi-nt
21794|NCT03435952|Doxycycline|doxycycline
21795|NCT03435952|Vibramycin|vibramycin
21796|NCT03435952|Periostat|periostat
21797|NCT03435952|Doryx|doryx
21798|NCT03435952|Solid tumor malignancies|solid tumor malignancies
21799|NCT03435913|Mechanical ventilation|mechanical ventilation
21800|NCT03435913|Driving Pressure|driving pressure
21801|NCT03435913|Protective Lung VEntilation|protective lung ventilation
21802|NCT03435887|Point of Care Testing|point of care testing
21803|NCT03435887|HIV|hiv
21804|NCT03435887|Pediatric HIV-exposed infants|pediatric hiv-exposed infants
21805|NCT03435887|at-birth testing|at-birth testing
21806|NCT03435887|early infant diagnosis|early infant diagnosis
21807|NCT03435887|Kenya|kenya
21808|NCT03435848|Acute Myeloid Leukemia|acute myeloid leukemia
21809|NCT03435848|Unfit for standard induction therapy|unfit for standard induction therapy
21810|NCT03435848|Cytarabine|cytarabine
21811|NCT03435822|asthma|asthma
21812|NCT03435822|children|children
21813|NCT03435822|action plan|action plan
21814|NCT03435822|China|china
21815|NCT03435822|CCAAP|ccaap
21816|NCT03435796|Long-term follow up|long-term follow up
21817|NCT03435796|Gene-Modified T Cells|gene-modified t cells
21818|NCT03435796|CAR T Cell|car t cell
21819|NCT03435770|EUS-guided RFA|eus-guided rfa
21820|NCT03435770|Endoscopic ultrasound|endoscopic ultrasound
21821|NCT03435770|radio frequency ablation|radio frequency ablation
21822|NCT03435731|OSA|osa
21823|NCT03435731|Continous Positive Airway Pressure (CPAP)|continous positive airway pressure (cpap)
21824|NCT03435731|Mandibular Advancement Split (MAS)|mandibular advancement split (mas)
21825|NCT03435731|Mandibular Advancement Oral Appliance|mandibular advancement oral appliance
21826|NCT03435731|Dual Therapy|dual therapy
21827|NCT03435718|oxfendazole|oxfendazole
21828|NCT03435718|albendazole|albendazole
21829|NCT03435718|Trichuris trichiura|trichuris trichiura
21830|NCT03435679|infection|infection
21831|NCT03435679|knee arthroplasty|knee arthroplasty
21832|NCT03435679|surgical treatment|surgical treatment
21833|NCT03435679|one-stage|one-stage
21834|NCT03435679|two-stage|two-stage
21835|NCT03435679|outcome|outcome
21836|NCT03435640|NKTR-214|nktr-214
21837|NCT03435640|NKTR-262|nktr-262
21838|NCT03435640|Nivolumab|nivolumab
21839|NCT03435640|Opdivo|opdivo
21840|NCT03435640|Metastatic|metastatic
21841|NCT03435640|Locally advanced|locally advanced
21842|NCT03435640|Relapsed/Refractory|relapsed/refractory
21843|NCT03435640|TLR7/8|tlr7/8
21844|NCT03435640|CD122|cd122
21845|NCT03435614|Opioid|opioid
21846|NCT03435614|Withdrawal|withdrawal
21847|NCT03435614|Critically ill adults|critically ill adults
21848|NCT03435614|Cortisol|cortisol
21849|NCT03435601|Rheumatoid Arthritis|rheumatoid arthritis
21850|NCT03435601|RA|ra
21851|NCT03435601|IFN-Signature|ifn-signature
21852|NCT03435601|Anifrolumab|anifrolumab
21853|NCT03435575|physical activity|physical activity
21854|NCT03435575|serious game|serious game
21855|NCT03435575|childhood obesity|childhood obesity
21856|NCT03435536|circulating tumor DNA|circulating tumor dna
21858|NCT03435536|pancreatic cancer|pancreatic cancer
21859|NCT03435536|pancreatoduodenectomy|pancreatoduodenectomy
21860|NCT03435536|Next Generation Sequencing|next generation sequencing
21861|NCT03435510|Live Donor Kidney Transplant|live donor kidney transplant
21862|NCT03435510|Education|education
21863|NCT03435510|Advocacy|advocacy
21864|NCT03435510|Live Donor|live donor
21865|NCT03435471|Prophylactic Swallowing Therapy|prophylactic swallowing therapy
21866|NCT03435458|Induced labor|induced labor
21867|NCT03435458|Maternal obesity|maternal obesity
21868|NCT03435445|obesity|obesity
21869|NCT03435445|overweight|overweight
21870|NCT03435445|telemedicine|telemedicine
21871|NCT03435445|ehealth|ehealth
21872|NCT03435419|cutaneous leishmaniasis|cutaneous leishmaniasis
21873|NCT03435419|RDT|rdt
21874|NCT03435419|LAMP|lamp
21875|NCT03435419|PCR|pcr
21876|NCT03435406|Hepatitis B, Chronic|hepatitis b, chronic
21877|NCT03435406|Cirrhosis|cirrhosis
21878|NCT03435406|Hepatopulmonary Syndrome|hepatopulmonary syndrome
21879|NCT03435380|Cancer Survivors|cancer survivors
21880|NCT03435380|Smartphone|smartphone
21881|NCT03435380|Mobile Applications|mobile applications
21882|NCT03435354|Physical activity|physical activity
21883|NCT03435354|Quality of life|quality of life
21884|NCT03435354|Activity motivation|activity motivation
21885|NCT03435354|Children|children
21886|NCT03435354|Adolescents|adolescents
21887|NCT03435354|Cluster-randomized trial|cluster-randomized trial
21888|NCT03435341|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
21889|NCT03435341|Observational|observational
21890|NCT03435341|Standard Clinical Practice|standard clinical practice
21891|NCT03435341|Survival|survival
21892|NCT03435341|Tolerability|tolerability
21893|NCT03435341|Spain|spain
21894|NCT03435328|TENS|tens
21895|NCT03435302|Mucosal Melanoma,Adjuvant Therapy,IFN-a2b,Temozolomide|mucosal melanoma,adjuvant therapy,ifn-a2b,temozolomide
21896|NCT03435289|Advanced Pancreatic Cancer|advanced pancreatic cancer
21897|NCT03435276|Heart failure.|heart failure.
21898|NCT03435276|Oral selective mineralocorticoid receptor modulator.|oral selective mineralocorticoid receptor modulator.
21899|NCT03435276|Heart failure with preserved ejection fraction (HFpEF).|heart failure with preserved ejection fraction (hfpef).
21900|NCT03435263|premature rupture of membranes|premature rupture of membranes
21901|NCT03435250|MTAP|mtap
21902|NCT03435250|MTAP deletion|mtap deletion
21903|NCT03435250|CDKN2A deletion|cdkn2a deletion
21904|NCT03435250|MAT2A inhibitor|mat2a inhibitor
21905|NCT03435250|Advanced solid tumors|advanced solid tumors
21906|NCT03435250|Lymphoma|lymphoma
21907|NCT03435237|Optical Coherence Tomography|optical coherence tomography
21908|NCT03435237|Bronchial Thermoplasty|bronchial thermoplasty
21909|NCT03435185|Pain|pain
21910|NCT03435185|Nerve Blocks|nerve blocks
21911|NCT03435185|Headache|headache
21912|NCT03435185|Local Anaesthetics|local anaesthetics
21913|NCT03435185|Migraine|migraine
21914|NCT03435172|Thermal Burn|thermal burn
21915|NCT03435172|Adipose Derived Regenerative Cells|adipose derived regenerative cells
21916|NCT03435172|Skin Graft|skin graft
21917|NCT03435159|Chiropractic, Manipulation, Vertebrobasilar Artery|chiropractic, manipulation, vertebrobasilar artery
21918|NCT03435146|3HP|3hp
21919|NCT03435146|LTBI|ltbi
21920|NCT03435146|IMPAACT4TB|impaact4tb
21921|NCT03435146|DDI|ddi
21922|NCT03435146|Pharmacokinetics|pharmacokinetics
21923|NCT03435146|Dolutegravir|dolutegravir
21924|NCT03435133|Primary angioplasty|primary angioplasty
21925|NCT03435133|Prasugrel|prasugrel
21926|NCT03435133|Ticagrelor|ticagrelor
21927|NCT03435133|STEMI|stemi
21928|NCT03435133|cardiac magnetic resonance|cardiac magnetic resonance
21929|NCT03435133|infarct size|infarct size
21930|NCT03435133|infarct injury|infarct injury
21931|NCT03435120|Breakthrough Cancer Pain|breakthrough cancer pain
21932|NCT03435120|Quality of life|quality of life
21933|NCT03435120|Medical Oncology|medical oncology
21934|NCT03435081|eczema|eczema
21935|NCT03435081|atopic eczema|atopic eczema
21936|NCT03435068|rotary|rotary
21937|NCT03435068|diode laser|diode laser
21938|NCT03435068|gingivectomy|gingivectomy
21939|NCT03435068|wound healing|wound healing
21940|NCT03435029|aging|aging
21941|NCT03435029|cognitive rehabilitation|cognitive rehabilitation
21942|NCT03435029|REHACOP|rehacop
21943|NCT03435003|Bariatric Procedure|bariatric procedure
21944|NCT03434990|spinal manipulative therapy|spinal manipulative therapy
21945|NCT03434990|Myofascial release|myofascial release
21946|NCT03434990|Low back pain|low back pain
21947|NCT03434938|Stroke|stroke
21948|NCT03434938|Geriatric|geriatric
21949|NCT03434938|Rehabilitation|rehabilitation
21950|NCT03434938|Functional recovery|functional recovery
21951|NCT03434938|Physical activity|physical activity
21952|NCT03434938|Motivational interviewing|motivational interviewing
21953|NCT03434938|Adherence|adherence
21954|NCT03434938|Clinical trial|clinical trial
21955|NCT03434925|colorectal neoplasia|colorectal neoplasia
21956|NCT03434925|adenoma|adenoma
21957|NCT03434925|colonoscopy|colonoscopy
21958|NCT03434925|gene mutation|gene mutation
21959|NCT03434925|follow-up|follow-up
21960|NCT03434925|recurrence|recurrence
21961|NCT03434925|multiparametric test|multiparametric test
21962|NCT03434873|magnetic stimulation, multiple sclerosis|magnetic stimulation, multiple sclerosis
21963|NCT03434821|Hyperoxemia|hyperoxemia
21964|NCT03434821|ventilator-associated|ventilator-associated
21965|NCT03434821|pneumonia|pneumonia
21966|NCT03434821|critical illness|critical illness
21967|NCT03434769|Cyclophosphamide|cyclophosphamide
21968|NCT03434769|Fludarabine|fludarabine
21969|NCT03434769|Chimeric antigen receptor T cells|chimeric antigen receptor t cells
21970|NCT03434756|ultrasound imaging|ultrasound imaging
21971|NCT03434756|propioception|propioception
21972|NCT03434756|training|training
21973|NCT03434743|oral feeding|oral feeding
21974|NCT03434743|early intervention|early intervention
21975|NCT03434743|premature infant|premature infant
21976|NCT03434743|sucking|sucking
21977|NCT03434730|tocilizumab|tocilizumab
21978|NCT03434730|17-616|17-616
21979|NCT03434730|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
21980|NCT03434678|General Anesthesia|general anesthesia
21981|NCT03434678|Epidural|epidural
21982|NCT03434678|Pancreaticoduodenectomy|pancreaticoduodenectomy
21983|NCT03434678|18-056|18-056
21984|NCT03434665|Angiography|angiography
21985|NCT03434665|Bariatric embolization|bariatric embolization
21986|NCT03434665|Gastric artery|gastric artery
21987|NCT03434665|Obesity|obesity
21988|NCT03434665|Transradial|transradial
21989|NCT03434639|Gut permeability|gut permeability
21990|NCT03434639|Fluorescence|fluorescence
21991|NCT03434639|Spectroscopy|spectroscopy
21992|NCT03434639|Wearable sensor|wearable sensor
21993|NCT03434639|Leaky gut|leaky gut
21994|NCT03434587|fifth metacarpal neck, fracture, syndactyly, inmobilization, RCT|fifth metacarpal neck, fracture, syndactyly, inmobilization, rct
21995|NCT03434574|(Poly)phenols|(poly)phenols
21996|NCT03434574|Aronia berry|aronia berry
21997|NCT03434574|Blood pressure|blood pressure
21998|NCT03434574|Vascular function|vascular function
21999|NCT03434561|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
22000|NCT03434509|Motor Control|motor control
22001|NCT03434509|Attention|attention
22002|NCT03434509|Cognitive Control|cognitive control
22003|NCT03434496|PD; Gait training 3; treadmill.|pd; gait training 3; treadmill.
22004|NCT03434483|Microbiota|microbiota
22005|NCT03434483|Immunity|immunity
22006|NCT03434483|Genetics|genetics
22007|NCT03434483|Atherosclerosis|atherosclerosis
22008|NCT03434483|Diabetes|diabetes
22009|NCT03434470|Ultrasound|ultrasound
22010|NCT03434470|Shear wave elastography|shear wave elastography
22011|NCT03434470|SWE|swe
22012|NCT03434470|Hepatitis C|hepatitis c
22013|NCT03434470|HCV|hcv
22014|NCT03434457|Fetal growth retardation|fetal growth retardation
22015|NCT03434457|Early adversity|early adversity
22016|NCT03434457|Depressive Symptoms|depressive symptoms
22017|NCT03434444|propranolol|propranolol
22018|NCT03434444|oxytocin|oxytocin
22019|NCT03434444|uterine contraction|uterine contraction
22020|NCT03434431|metabolic adaptation|metabolic adaptation
22021|NCT03434431|weight regain|weight regain
22022|NCT03434431|reverse dieting|reverse dieting
22023|NCT03434418|EGFR Mutation|egfr mutation
22024|NCT03434418|osimertinib|osimertinib
22025|NCT03434418|exon 18 G719X|exon 18 g719x
22026|NCT03434418|exon 20 S7681|exon 20 s7681
22027|NCT03434418|exon 21 L861Q|exon 21 l861q
22028|NCT03434405|schizophrenia|schizophrenia
22029|NCT03434405|mindfulness|mindfulness
22030|NCT03434405|social cognition|social cognition
22031|NCT03434405|SocialMind|socialmind
22032|NCT03434405|AGES-Mind|ages-mind
22033|NCT03434392|Chronic Pain|chronic pain
22034|NCT03434392|Chronic Pancreatitis|chronic pancreatitis
22035|NCT03434392|Sphincter of Oddi Dysfunction|sphincter of oddi dysfunction
22036|NCT03434392|Recurrent Acute Pancreatitis|recurrent acute pancreatitis
22037|NCT03434392|Chronic Abdominal Pain|chronic abdominal pain
22038|NCT03434392|Functional Dyspepsia|functional dyspepsia
22039|NCT03434366|Autism Spectrum Disorder|autism spectrum disorder
22040|NCT03434366|ketamine|ketamine
22041|NCT03434366|dexmedetomidine|dexmedetomidine
22042|NCT03434340|peppermint oil|peppermint oil
22043|NCT03434340|morphine|morphine
22044|NCT03434340|nausea and vomiting|nausea and vomiting
22045|NCT03434340|lower segment cesarean section|lower segment cesarean section
22046|NCT03434314|Paraplegia|paraplegia
22047|NCT03434314|Aortic Aneurysm Repair|aortic aneurysm repair
22048|NCT03434314|Staging|staging
22049|NCT03434314|Embolization|embolization
22050|NCT03434314|TAAA|taaa
22051|NCT03434314|Thoracoabdominal aortic aneurysm|thoracoabdominal aortic aneurysm
22052|NCT03434314|MISACE|misace
22053|NCT03434314|Spinal cord ischemia|spinal cord ischemia
22054|NCT03434314|Spinal cord ischaemia|spinal cord ischaemia
22055|NCT03434314|Spinal cord injury|spinal cord injury
22056|NCT03434314|Spinal cord ischemic injury|spinal cord ischemic injury
22057|NCT03434314|Spinal cord ischaemic injury|spinal cord ischaemic injury
22058|NCT03434314|Permanent paraplegia|permanent paraplegia
22059|NCT03434314|Temporary paraplegia|temporary paraplegia
22060|NCT03434314|Paraparesis|paraparesis
22061|NCT03434314|SCI|sci
22062|NCT03434314|TAAA repair|taaa repair
22063|NCT03434314|Open TAAA repair|open taaa repair
22064|NCT03434314|Open surgical TAAA repair|open surgical taaa repair
22065|NCT03434314|Endovascular TAAA repair|endovascular taaa repair
22066|NCT03434314|TEVAR|tevar
22067|NCT03434314|Aortic surgery|aortic surgery
22068|NCT03434314|Thoracoabdominal aortic surgery|thoracoabdominal aortic surgery
22069|NCT03434314|Type B aortic dissection|type b aortic dissection
22070|NCT03434314|Chronic type B aortic dissection|chronic type b aortic dissection
22071|NCT03434314|Stanford type B aortic dissection|stanford type b aortic dissection
22072|NCT03434314|Collateral network|collateral network
22073|NCT03434314|Paraspinal collateral network|paraspinal collateral network
22074|NCT03434314|Paraspinous collateral network|paraspinous collateral network
22075|NCT03434314|Arteriogenesis|arteriogenesis
22076|NCT03434314|Intercostal arteries|intercostal arteries
22077|NCT03434301|Surgery|surgery
22078|NCT03434301|Laparotomy|laparotomy
22079|NCT03434301|Tack|tack
22080|NCT03434301|Non-absorbable Tack|non-absorbable tack
22081|NCT03434301|Absorbable Tack|absorbable tack
22082|NCT03434301|Pain|pain
22083|NCT03434288|Diabetes|diabetes
22084|NCT03434288|Diabetic foot|diabetic foot
22085|NCT03434288|Osteomyelitis|osteomyelitis
22086|NCT03434275|Total Knee Arthroplasty|total knee arthroplasty
22087|NCT03434275|Pain|pain
22088|NCT03434275|Analgesia|analgesia
22089|NCT03434275|N1539|n1539
22090|NCT03434275|Phase 3b|phase 3b
22091|NCT03434275|Knee Replacement|knee replacement
22092|NCT03434262|ATRT|atrt
22093|NCT03434262|Brain Tumors in Adolescents|brain tumors in adolescents
22094|NCT03434262|Brain Tumors in Children|brain tumors in children
22095|NCT03434262|Brain Tumors in Young Adults|brain tumors in young adults
22096|NCT03434262|CDK4 amplification|cdk4 amplification
22097|NCT03434262|CDK 4/6|cdk 4/6
22098|NCT03434262|CDK 4/6 inhibitor|cdk 4/6 inhibitor
22099|NCT03434262|CDK 4/6 pathway|cdk 4/6 pathway
22100|NCT03434262|CDK 4/6/cyclin/RB/E2F pathway|cdk 4/6/cyclin/rb/e2f pathway
22101|NCT03434262|CDK6 amplification|cdk6 amplification
22102|NCT03434262|CyclinD1|cyclind1
22103|NCT03434262|DAWN|dawn
22104|NCT03434262|D-type Cyclins|d-type cyclins
22105|NCT03434262|Hedgehog pathway inhibitor|hedgehog pathway inhibitor
22106|NCT03434262|HGG|hgg
22107|NCT03434262|MAPK pathway|mapk pathway
22108|NCT03434262|MEK|mek
22109|NCT03434262|MEK inhibitor|mek inhibitor
22110|NCT03434262|MEK1|mek1
22111|NCT03434262|MEK2|mek2
22112|NCT03434262|Mekinist|mekinist
22113|NCT03434262|Molecular|molecular
22114|NCT03434262|Molecular therapy|molecular therapy
22115|NCT03434262|MYC amplification|myc amplification
22116|NCT03434262|PTCH1|ptch1
22117|NCT03434262|Rare brain tumor|rare brain tumor
22118|NCT03434262|Recurrent ATRT|recurrent atrt
22119|NCT03434262|Recurrent brain tumor|recurrent brain tumor
22120|NCT03434262|Recurrent ependymoma|recurrent ependymoma
22121|NCT03434262|Recurrent high grade glioma|recurrent high grade glioma
22122|NCT03434262|Recurrent malignant glioma|recurrent malignant glioma
22123|NCT03434262|Recurrent medulloblastoma|recurrent medulloblastoma
22124|NCT03434262|Refractory brain tumor|refractory brain tumor
22125|NCT03434262|Small molecule inhibitor|small molecule inhibitor
22126|NCT03434262|SMO antagonist|smo antagonist
22127|NCT03434262|Smoothened protein|smoothened protein
22128|NCT03434262|Sonic hedgehog|sonic hedgehog
22129|NCT03434262|Combination therapy|combination therapy
22130|NCT03434249|Bifidobacterium|bifidobacterium
22131|NCT03434236|omega-3|omega-3
22132|NCT03434236|specialized proresolving mediators|specialized proresolving mediators
22133|NCT03434210|schizophrenia|schizophrenia
22134|NCT03434210|violence risk|violence risk
22135|NCT03434210|long-acting antipsychotics|long-acting antipsychotics
22136|NCT03434210|community-based|community-based
22137|NCT03434197|Osteoarthritis Knee Pain|osteoarthritis knee pain
22138|NCT03434184|Walking analysis|walking analysis
22139|NCT03434184|spinal surgery|spinal surgery
22140|NCT03434184|scoliosis|scoliosis
22141|NCT03434184|pelvic fixation|pelvic fixation
22142|NCT03434158|Metastatic Prostate Cancer Resistant to Castration|metastatic prostate cancer resistant to castration
22143|NCT03434132|Open Radical Cystectomy|open radical cystectomy
22144|NCT03434132|Robotic Radical cystectomy|robotic radical cystectomy
22145|NCT03434132|Intracorporeal urinary diversion|intracorporeal urinary diversion
22146|NCT03434132|Prospective randdomized trial|prospective randdomized trial
22147|NCT03434106|meibomian gland dysfunction|meibomian gland dysfunction
22148|NCT03434106|Sjögren's syndrome|sjögren's syndrome
22149|NCT03434106|dry eye disease|dry eye disease
22150|NCT03434093|Paired Associative Stimulation (PAS)|paired associative stimulation (pas)
22151|NCT03434093|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
22152|NCT03434093|Electrical Field Modeling|electrical field modeling
22153|NCT03434093|Working Memory|working memory
22154|NCT03434080|Pediatric|pediatric
22155|NCT03434080|Neuroimaging|neuroimaging
22156|NCT03434080|Brain Function|brain function
22157|NCT03434080|Voluntary Movement|voluntary movement
22158|NCT03434067|hyperthyroidism|hyperthyroidism
22159|NCT03434067|thyroidectomy|thyroidectomy
22160|NCT03434067|PTH|pth
22161|NCT03434067|immunochromatographic assay|immunochromatographic assay
22162|NCT03434054|losartan|losartan
22163|NCT03434054|emotional processing|emotional processing
22164|NCT03434054|anxiety|anxiety
22165|NCT03434054|magnet resonance imaging|magnet resonance imaging
22166|NCT03434054|MRI|mri
22167|NCT03434028|Fluid management|fluid management
22168|NCT03434028|Sepsis-induced hypotension|sepsis-induced hypotension
22169|NCT03434028|vasopressors|vasopressors
22170|NCT03434015|Atrial fibrillation|atrial fibrillation
22171|NCT03434015|Left atrial septal closure|left atrial septal closure
22172|NCT03434002|Virtual Reality Simulation|virtual reality simulation
22173|NCT03434002|Teaching and Assessment|teaching and assessment
22174|NCT03434002|Anesthesia Crisis Management|anesthesia crisis management
22175|NCT03433989|Post-Traumatic Stress Disorder|post-traumatic stress disorder
22176|NCT03433989|Pregnancy loss|pregnancy loss
22177|NCT03433976|Caesarean section|caesarean section
22178|NCT03433976|spinal anesthesia|spinal anesthesia
22179|NCT03433976|Prilocaïne|prilocaïne
22180|NCT03433976|motor block|motor block
22181|NCT03433963|air pollution|air pollution
22182|NCT03433963|blood pressure|blood pressure
22183|NCT03433963|cardiac ischemia|cardiac ischemia
22184|NCT03433963|L-arginine|l-arginine
22185|NCT03433963|nitric oxide|nitric oxide
22186|NCT03433950|antiparkinson|antiparkinson
22187|NCT03433911|Permanent contraception|permanent contraception
22188|NCT03433911|Birth control|birth control
22189|NCT03433885|macular pigment optical density (MPOD)|macular pigment optical density (mpod)
22190|NCT03433885|Age-related Macular Degeneration (AMD)|age-related macular degeneration (amd)
22191|NCT03433885|drusen|drusen
22192|NCT03433885|Chroidal neovascularization (CNV)|chroidal neovascularization (cnv)
22193|NCT03433885|lutein|lutein
22194|NCT03433885|zeaxanthin|zeaxanthin
22195|NCT03433872|Infant-toddler care|infant-toddler care
22196|NCT03433872|Early child development|early child development
22197|NCT03433872|Professional development|professional development
22198|NCT03433846|Sepsis|sepsis
22199|NCT03433846|Prematurity|prematurity
22200|NCT03433807|idebenone, DMD, Duchenne|idebenone, dmd, duchenne
22201|NCT03433781|ASCORBIC ACID|ascorbic acid
22202|NCT03433755|Evolocumab|evolocumab
22203|NCT03433755|Repatha|repatha
22204|NCT03433755|Statin|statin
22205|NCT03433755|Chinese|chinese
22206|NCT03433755|China|china
22207|NCT03433755|Hypercholesterolemia|hypercholesterolemia
22208|NCT03433755|Mixed Dyslipidemia|mixed dyslipidemia
22209|NCT03433755|High Cholesterol|high cholesterol
22210|NCT03433755|Lowering cholesterol|lowering cholesterol
22211|NCT03433742|metal ion levels, total hip replacement, Trident II cup.|metal ion levels, total hip replacement, trident ii cup.
22212|NCT03433729|Outpatient Clinics, Hospital|outpatient clinics, hospital
22213|NCT03433729|Humans|humans
22214|NCT03433729|Outcome Assessment (Health Care)|outcome assessment (health care)
22215|NCT03433729|Patient Outcome Assessment|patient outcome assessment
22216|NCT03433729|Patient satisfaction|patient satisfaction
22217|NCT03433729|Hospitalists|hospitalists
22218|NCT03433729|Secondary care|secondary care
22219|NCT03433716|Percutaneous Neuromodulation, radial nerve, pain|percutaneous neuromodulation, radial nerve, pain
22220|NCT03433703|Unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
22221|NCT03433703|Lenvatinib|lenvatinib
22222|NCT03433703|E7080|e7080
22223|NCT03433690|Child Obesity|child obesity
22224|NCT03433690|Adolescents|adolescents
22225|NCT03433690|High Intensity Interval Training|high intensity interval training
22226|NCT03433690|Moderate training|moderate training
22227|NCT03433677|insulin pump|insulin pump
22228|NCT03433664|CO2 laser|co2 laser
22229|NCT03433664|Ablative fractional laser|ablative fractional laser
22230|NCT03433651|depression|depression
22231|NCT03433638|Juvenile dermatomyositis|juvenile dermatomyositis
22232|NCT03433638|Inflammatory myopathy|inflammatory myopathy
22233|NCT03433638|Clinical features|clinical features
22234|NCT03433638|Treatment|treatment
22235|NCT03433625|Cognitive-behavioural therapy|cognitive-behavioural therapy
22236|NCT03433612|Anatomical Landmarks|anatomical landmarks
22237|NCT03433599|Intermittent Hypoxia|intermittent hypoxia
22238|NCT03433599|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
22239|NCT03433560|febrile neutropenia|febrile neutropenia
22240|NCT03433560|neutropenia|neutropenia
22241|NCT03433547|macular buckling|macular buckling
22242|NCT03433547|full-thickness macular hole|full-thickness macular hole
22243|NCT03433547|macular detachment|macular detachment
22244|NCT03433547|internal limiting membrane peeling|internal limiting membrane peeling
22245|NCT03433547|high myopia|high myopia
22246|NCT03433534|nivolumab|nivolumab
22247|NCT03433534|monoclonal antibody|monoclonal antibody
22248|NCT03433534|Opdivo|opdivo
22249|NCT03433534|antineoplastic agent|antineoplastic agent
22250|NCT03433534|ELISA|elisa
22251|NCT03433534|pharmacokinetic|pharmacokinetic
22252|NCT03433521|Spatio-Temporal Diagnostic Pattern|spatio-temporal diagnostic pattern
22253|NCT03433495|stroke|stroke
22254|NCT03433495|aphasia|aphasia
22255|NCT03433495|melodic intonation therapy|melodic intonation therapy
22256|NCT03433482|Meningococcal disease|meningococcal disease
22257|NCT03433482|Liquid formulation|liquid formulation
22258|NCT03433482|Meningitis|meningitis
22259|NCT03433456|obesity|obesity
22260|NCT03433456|low-income|low-income
22261|NCT03433456|health disparities|health disparities
22262|NCT03433456|home visitation|home visitation
22263|NCT03433456|prevention|prevention
22264|NCT03433456|childhood obesity|childhood obesity
22265|NCT03433456|habit|habit
22266|NCT03433443|Spinal Fusion|spinal fusion
22267|NCT03433443|Case Managers|case managers
22268|NCT03433443|Rehabilitation|rehabilitation
22269|NCT03433352|gut microbiota|gut microbiota
22270|NCT03433352|16S rRNA gene|16s rrna gene
22271|NCT03433352|Graves' disease|graves' disease
22272|NCT03433352|Methimazole|methimazole
22273|NCT03433352|Propylthiouracil|propylthiouracil
22274|NCT03433339|depression|depression
22275|NCT03433339|transcutaneous spinal direct current stimulation|transcutaneous spinal direct current stimulation
22276|NCT03433339|non-invasive|non-invasive
22277|NCT03433339|major depressive disorder|major depressive disorder
22278|NCT03433248|Type 2 diabetes mellitus|type 2 diabetes mellitus
22279|NCT03433248|Diabetic kidney disease|diabetic kidney disease
22280|NCT03433248|Diabetic nephropathy|diabetic nephropathy
22281|NCT03433248|Renoprotection|renoprotection
22282|NCT03433248|SGLT2 inhibitor|sglt2 inhibitor
22283|NCT03433248|Empagliflozin|empagliflozin
22284|NCT03433248|DPP-4 inhibitor|dpp-4 inhibitor
22285|NCT03433248|Linagliptin|linagliptin
22286|NCT03433248|SU derivative|su derivative
22287|NCT03433248|Gliclazide|gliclazide
22288|NCT03433222|light emitting diode-red light|light emitting diode-red light
22289|NCT03433222|high fluence|high fluence
22290|NCT03433222|red light|red light
22291|NCT03433222|RCT|rct
22292|NCT03433209|Advanced bipolar energy devices|advanced bipolar energy devices
22293|NCT03433209|ENSEAL|enseal
22294|NCT03433209|LigaSure|ligasure
22295|NCT03433209|Operative time|operative time
22296|NCT03433209|Total laparoscopic hysterectomy|total laparoscopic hysterectomy
22297|NCT03433157|stainless stain crowns|stainless stain crowns
22298|NCT03433157|Hall technique|hall technique
22299|NCT03433157|children|children
22300|NCT03433118|fatigue|fatigue
22301|NCT03433118|health-related quality of life|health-related quality of life
22302|NCT03433105|oxygen uptake,prolonged mechanical ventilation,weaning|oxygen uptake,prolonged mechanical ventilation,weaning
22303|NCT03433092|Serum carotenoids|serum carotenoids
22304|NCT03433092|Gastrointestinal tract cancer|gastrointestinal tract cancer
22305|NCT03433092|Meta-analysis|meta-analysis
22306|NCT03433079|Acute Kidney Injury|acute kidney injury
22307|NCT03433079|Severe Trauma|severe trauma
22308|NCT03433079|NGAL|ngal
22309|NCT03433079|Tissue Hypoxia|tissue hypoxia
22310|NCT03433079|Inflammatory Response|inflammatory response
22311|NCT03433079|Rhabdomyolysis|rhabdomyolysis
22312|NCT03433066|advanced platelet-rich fibrin|advanced platelet-rich fibrin
22313|NCT03432988|Nursing Solution-Focused|nursing solution-focused
22314|NCT03432988|hemodialysis|hemodialysis
22315|NCT03432988|Psychosocial intervention|psychosocial intervention
22316|NCT03432988|Adherence|adherence
22317|NCT03432949|Radium-223|radium-223
22318|NCT03432949|Dexamethasone|dexamethasone
22319|NCT03432949|mCRPC|mcrpc
22320|NCT03432910|Forced Breath Technique|forced breath technique
22321|NCT03432910|auto-CPAP|auto-cpap
22322|NCT03432910|CPAP|cpap
22323|NCT03432910|Obstructive sleep apnea|obstructive sleep apnea
22324|NCT03432910|central sleep apnea|central sleep apnea
22325|NCT03432897|High risk|high risk
22326|NCT03432897|Defects|defects
22327|NCT03432897|prostate|prostate
22328|NCT03432884|Phase 1|phase 1
22329|NCT03432884|pharmacokinetics|pharmacokinetics
22330|NCT03432884|safety|safety
22331|NCT03432871|Mitochondria|mitochondria
22332|NCT03432871|Mitochondrial disease|mitochondrial disease
22333|NCT03432871|Nicotinamide Riboside|nicotinamide riboside
22334|NCT03432871|Niagen|niagen
22335|NCT03432871|PEO|peo
22336|NCT03432871|Single deletion|single deletion
22337|NCT03432871|mtDNA deletion|mtdna deletion
22338|NCT03432871|MELAS|melas
22339|NCT03432871|m.3243A>G|m.3243a>g
22340|NCT03432858|Endoscopic Carpal Tunnel Release|endoscopic carpal tunnel release
22341|NCT03432858|Prophylactic Antibiotics|prophylactic antibiotics
22342|NCT03432819|Latino, men who have sex with men|latino, men who have sex with men
22343|NCT03432806|Tissue samples|tissue samples
22344|NCT03432806|17-594|17-594
22345|NCT03432793|DDI|ddi
22346|NCT03432793|Itraconazole|itraconazole
22347|NCT03432793|Fluvoxamine|fluvoxamine
22348|NCT03432793|TD-9855|td-9855
22349|NCT03432793|Smoking|smoking
22350|NCT03432793|Caffeine|caffeine
22351|NCT03432793|CYP1A2|cyp1a2
22352|NCT03432793|CYP3A4|cyp3a4
22353|NCT03432767|pregnancy|pregnancy
22354|NCT03432767|postpartum hemorrhage|postpartum hemorrhage
22355|NCT03432767|vaginal delivery|vaginal delivery
22356|NCT03432767|shock index|shock index
22357|NCT03432767|hemoglobin|hemoglobin
22358|NCT03432754|Older adults|older adults
22359|NCT03432754|Mindfulness|mindfulness
22360|NCT03432754|Mind wandering|mind wandering
22361|NCT03432754|Health education|health education
22362|NCT03432754|Working memory|working memory
22363|NCT03432754|Cognitive functioning|cognitive functioning
22364|NCT03432754|Emotion regulation|emotion regulation
22365|NCT03432754|Emotional functioning|emotional functioning
22366|NCT03432728|Antioxidant Capacity|antioxidant capacity
22367|NCT03432715|School|school
22368|NCT03432715|Policy|policy
22369|NCT03432715|Nutrition|nutrition
22370|NCT03432715|Physical Activity|physical activity
22371|NCT03432715|Local Wellness Policy|local wellness policy
22372|NCT03432676|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
22373|NCT03432676|Homologous recombination repair deficiency|homologous recombination repair deficiency
22374|NCT03432676|HRD|hrd
22375|NCT03432676|Pembrolizumab|pembrolizumab
22376|NCT03432676|Keytruda|keytruda
22377|NCT03432676|MK-3475|mk-3475
22378|NCT03432676|SCH-900475|sch-900475
22379|NCT03432676|Epacadostat|epacadostat
22380|NCT03432676|INCB024360|incb024360
22381|NCT03432663|Atrial Fibrillation|atrial fibrillation
22382|NCT03432663|Intravenous Amiodarone|intravenous amiodarone
22383|NCT03432663|Drug safety profile|drug safety profile
22384|NCT03432663|Chemical cardioversion|chemical cardioversion
22385|NCT03432637|Complications, Postoperative/Perioperative|complications, postoperative/perioperative
22386|NCT03432637|video assisted thoracic surgery|video assisted thoracic surgery
22387|NCT03432637|non-intubated anaesthesia|non-intubated anaesthesia
22388|NCT03432611|mHealth|mhealth
22389|NCT03432611|dysmenorrhea|dysmenorrhea
22390|NCT03432611|acupressure|acupressure
22391|NCT03432611|self-management|self-management
22392|NCT03432611|self-care|self-care
22393|NCT03432585|feasibility|feasibility
22394|NCT03432585|attendance|attendance
22395|NCT03432585|conference|conference
22396|NCT03432559|endoscopy|endoscopy
22397|NCT03432533|Post-Menopausal osteoporosis|post-menopausal osteoporosis
22398|NCT03432494|Transcather|transcather
22399|NCT03432494|Transcaval|transcaval
22400|NCT03432494|Bioprosthesis|bioprosthesis
22401|NCT03432494|Closure Device|closure device
22402|NCT03432494|Aortic Stenosis|aortic stenosis
22403|NCT03432481|Osteoarthritis, Knee|osteoarthritis, knee
22404|NCT03432468|Hypertension|hypertension
22405|NCT03432468|Left Ventricular Hypertrophy|left ventricular hypertrophy
22406|NCT03432468|Women|women
22407|NCT03432455|Incidence|incidence
22408|NCT03432455|prevalence|prevalence
22409|NCT03432455|epidemiology|epidemiology
22410|NCT03432455|juvenile dermatomyositis|juvenile dermatomyositis
22411|NCT03432455|inflammatory myopathy|inflammatory myopathy
22412|NCT03432429|Tumours|tumours
22413|NCT03432429|Breast conserving surgery|breast conserving surgery
22414|NCT03432429|Margin assessment technology|margin assessment technology
22415|NCT03432429|Mass spectrometry|mass spectrometry
22416|NCT03432416|Healthy Women|healthy women
22417|NCT03432416|Female Contraception|female contraception
22418|NCT03432416|Vaginal Ring|vaginal ring
22419|NCT03432416|Contraceptive Vaginal Ring|contraceptive vaginal ring
22420|NCT03432364|Beta thalassemia|beta thalassemia
22421|NCT03432364|Beta-thalassemia|beta-thalassemia
22422|NCT03432364|Thalassemia major|thalassemia major
22423|NCT03432364|Cooley's anemia|cooley's anemia
22424|NCT03432364|ZFN mediated genome editing|zfn mediated genome editing
22425|NCT03432364|zinc finger nuclease|zinc finger nuclease
22426|NCT03432351|EEG|eeg
22427|NCT03432351|Electroencephalography|electroencephalography
22428|NCT03432351|Pediatric anesthesia|pediatric anesthesia
22429|NCT03432299|Thyroid Diseases|thyroid diseases
22430|NCT03432299|Radiofrequency Ablation|radiofrequency ablation
22431|NCT03432260|Alcoholic Hepatitis|alcoholic hepatitis
22432|NCT03432260|acute alcoholic liver disease|acute alcoholic liver disease
22433|NCT03432260|progressive inflammatory liver injury|progressive inflammatory liver injury
22434|NCT03432260|IV infusion|iv infusion
22435|NCT03432247|music therapy|music therapy
22436|NCT03432247|bone pain|bone pain
22437|NCT03432247|pain management|pain management
22438|NCT03432247|advanced cancer|advanced cancer
22439|NCT03432234|COPD|copd
22440|NCT03432234|Microbiome|microbiome
22441|NCT03432234|Exacerbation|exacerbation
22442|NCT03432221|Cognition, antidepressants drugs, SNRI, hot cognition, functioning|cognition, antidepressants drugs, snri, hot cognition, functioning
22443|NCT03432182|Premature infant|premature infant
22444|NCT03432182|sleep state|sleep state
22445|NCT03432182|body movement|body movement
22446|NCT03432182|neurodevelopmental outcome|neurodevelopmental outcome
22447|NCT03432156|immunotherapy|immunotherapy
22448|NCT03432156|NSCLC|nsclc
22449|NCT03432143|Peer Review|peer review
22450|NCT03432143|Community-Based Research|community-based research
22553|NCT03431168|Cameroon|cameroon
22451|NCT03432143|Community Perspectives|community perspectives
22452|NCT03432130|hip-hop dance, injuries, body fat|hip-hop dance, injuries, body fat
22453|NCT03432117|respiratory rehabilitation|respiratory rehabilitation
22454|NCT03432117|personalized mobile services|personalized mobile services
22455|NCT03432091|melatonin|melatonin
22456|NCT03432091|melatonin receptor agonist|melatonin receptor agonist
22457|NCT03432091|circadian-clock-related genes|circadian-clock-related genes
22458|NCT03432065|Autism Spectrum Disorders|autism spectrum disorders
22459|NCT03432065|Anxiety|anxiety
22460|NCT03432065|Pervasive Developmental Disorders|pervasive developmental disorders
22461|NCT03432065|Buspar|buspar
22462|NCT03432065|Buspirone|buspirone
22463|NCT03432052|centralization|centralization
22464|NCT03431987|Marijuana|marijuana
22465|NCT03431987|Alcohol|alcohol
22466|NCT03431987|THC|thc
22467|NCT03431987|fMRI|fmri
22468|NCT03431987|MRI|mri
22469|NCT03431987|Driving Simulation|driving simulation
22470|NCT03431987|Cannabis|cannabis
22471|NCT03431987|Intoxication|intoxication
22472|NCT03431974|Anti-folate|anti-folate
22473|NCT03431935|Health Care Transition|health care transition
22474|NCT03431935|Adolescent|adolescent
22475|NCT03431935|Young Adult|young adult
22476|NCT03431909|Human Urinary Kallidinogenase|human urinary kallidinogenase
22477|NCT03431909|Acute ischemic stroke|acute ischemic stroke
22478|NCT03431909|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
22479|NCT03431909|CT perfusion|ct perfusion
22480|NCT03431857|Shoulder arthroplasty|shoulder arthroplasty
22481|NCT03431857|Medical device|medical device
22482|NCT03431857|Shoulder prosthesis|shoulder prosthesis
22483|NCT03431857|Performance|performance
22484|NCT03431805|Randomized|randomized
22485|NCT03431805|double blind placebo controlled trial|double blind placebo controlled trial
22486|NCT03431805|prevention|prevention
22487|NCT03431805|tranexamic acid|tranexamic acid
22488|NCT03431805|postpartum hemorrhage|postpartum hemorrhage
22489|NCT03431805|cesarean|cesarean
22490|NCT03431792|CDH, FETO, fetal surgery, long tail FETO|cdh, feto, fetal surgery, long tail feto
22491|NCT03431766|chlorhexidine gel|chlorhexidine gel
22492|NCT03431766|dental implant|dental implant
22493|NCT03431753|STHLM3-test|sthlm3-test
22494|NCT03431753|prostate cancer|prostate cancer
22495|NCT03431753|MR-imaging|mr-imaging
22496|NCT03431753|MR-targeted biopsy|mr-targeted biopsy
22497|NCT03431753|MRI|mri
22498|NCT03431753|Novel biomarkers|novel biomarkers
22499|NCT03431753|Genetic screening|genetic screening
22500|NCT03431636|sports for people with disabilities|sports for people with disabilities
22501|NCT03431636|immersion therapy|immersion therapy
22502|NCT03431636|cryotherapy|cryotherapy
22503|NCT03431636|physiotherapy|physiotherapy
22504|NCT03431571|ReLEx|relex
22505|NCT03431571|SMILE|smile
22506|NCT03431571|Hyperopia|hyperopia
22507|NCT03431571|VisuMax|visumax
22508|NCT03431571|Small Incision Lenticule Extraction|small incision lenticule extraction
22509|NCT03431571|Lenticule|lenticule
22510|NCT03431571|Farsightedness|farsightedness
22511|NCT03431558|Bovine Lactoferrin, Neonatal infection, Low Birth Weight|bovine lactoferrin, neonatal infection, low birth weight
22512|NCT03431532|anesthesia|anesthesia
22513|NCT03431532|general anesthesia|general anesthesia
22514|NCT03431532|neuraxial anesthesia|neuraxial anesthesia
22515|NCT03431532|monocyte funtion|monocyte funtion
22516|NCT03431532|CD 14, HLA-DR|cd 14, hla-dr
22517|NCT03431532|Interleukines|interleukines
22518|NCT03431519|Thoracolumbar fractures|thoracolumbar fractures
22519|NCT03431519|PMMA|pmma
22520|NCT03431519|KIVA|kiva
22521|NCT03431519|PEEK|peek
22522|NCT03431480|cord blood stem cell|cord blood stem cell
22523|NCT03431480|Norwood heart surgery|norwood heart surgery
22524|NCT03431480|congenital|congenital
22525|NCT03431480|heart|heart
22526|NCT03431467|ECMO|ecmo
22527|NCT03431467|Heart Failure|heart failure
22528|NCT03431467|RCT|rct
22529|NCT03431467|Mechanical unloading|mechanical unloading
22530|NCT03431415|Lung|lung
22531|NCT03431415|Cancer|cancer
22532|NCT03431415|Early-Stage|early-stage
22533|NCT03431415|Video-assisted Thoracic Surgery|video-assisted thoracic surgery
22534|NCT03431415|VATS|vats
22535|NCT03431415|SBRT|sbrt
22536|NCT03431415|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
22537|NCT03431376|potato consumption|potato consumption
22538|NCT03431376|hypertension|hypertension
22539|NCT03431376|CHNS|chns
22540|NCT03431311|MSI|msi
22541|NCT03431298|Knee osteoarthritis|knee osteoarthritis
22542|NCT03431298|Physical activity|physical activity
22543|NCT03431298|Exercise|exercise
22544|NCT03431272|contact lens, discomfort, dry eye|contact lens, discomfort, dry eye
22545|NCT03431233|protein-enriched bar|protein-enriched bar
22546|NCT03431233|food intake|food intake
22547|NCT03431233|appetite|appetite
22548|NCT03431233|satiety related hormones|satiety related hormones
22549|NCT03431194|Acute Kidney Injury|acute kidney injury
22550|NCT03431194|midodrine|midodrine
22551|NCT03431194|intensive care unit|intensive care unit
22552|NCT03431168|STI Prevention|sti prevention
22554|NCT03431168|sub-Saharan Africa|sub-saharan africa
22555|NCT03431168|HIV pregnancy|hiv pregnancy
22556|NCT03431168|Malaria in pregnancy|malaria in pregnancy
22557|NCT03431155|children|children
22558|NCT03431155|cancer|cancer
22559|NCT03431155|mother|mother
22560|NCT03431155|uncertainty|uncertainty
22561|NCT03431155|nursing intervention|nursing intervention
22562|NCT03431155|education|education
22563|NCT03431129|Xenon MRI, Lung, Radiation Induced Lung Injury,|xenon mri, lung, radiation induced lung injury,
22564|NCT03431103|overlap|overlap
22565|NCT03431103|exercise|exercise
22566|NCT03431103|inflammation|inflammation
22567|NCT03431051|Healthy Beverage Initiative, Sugar Sweetened Beverages|healthy beverage initiative, sugar sweetened beverages
22568|NCT03431012|Adherence, medication|adherence, medication
22569|NCT03431012|Pandemic Influenza|pandemic influenza
22570|NCT03430973|aggressive driving; road rage|aggressive driving; road rage
22571|NCT03430960|mCare|mcare
22572|NCT03430960|post surgery|post surgery
22573|NCT03430960|mobile|mobile
22574|NCT03430960|healthcare|healthcare
22575|NCT03430960|application|application
22576|NCT03430947|Stereotactic radiosurgery|stereotactic radiosurgery
22577|NCT03430947|BRAF inhibitor|braf inhibitor
22578|NCT03430947|MEK inhibitor|mek inhibitor
22579|NCT03430947|Vemurafenib|vemurafenib
22580|NCT03430947|Cobimetinib|cobimetinib
22581|NCT03430934|Mohs tumor|mohs tumor
22582|NCT03430908|endotracheal tube|endotracheal tube
22583|NCT03430908|gastric tube|gastric tube
22584|NCT03430908|17-653|17-653
22585|NCT03430908|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
22586|NCT03430895|Durvalumab (MEDI4736)|durvalumab (medi4736)
22587|NCT03430895|Tremelimumab|tremelimumab
22588|NCT03430895|immunotherapy|immunotherapy
22589|NCT03430895|17-511|17-511
22590|NCT03430882|Solid tumor malignancy|solid tumor malignancy
22591|NCT03430882|TAK-228|tak-228
22592|NCT03430882|MLN0128|mln0128
22593|NCT03430882|TAK228|tak228
22594|NCT03430882|Paclitaxel|paclitaxel
22595|NCT03430882|Taxol|taxol
22596|NCT03430882|Carboplatin|carboplatin
22597|NCT03430882|Paraplatin|paraplatin
22598|NCT03430869|late-life depression|late-life depression
22599|NCT03430869|major depressive disorder|major depressive disorder
22600|NCT03430869|Alzheimer's disease dementia|alzheimer's disease dementia
22601|NCT03430869|neurodegeneration|neurodegeneration
22602|NCT03430869|amyloid plague, tau protein|amyloid plague, tau protein
22603|NCT03430856|Oral insulin|oral insulin
22604|NCT03430843|Unresectable|unresectable
22605|NCT03430843|metastatic|metastatic
22606|NCT03430843|second-line|second-line
22607|NCT03430843|squamous|squamous
22608|NCT03430843|esophagus|esophagus
22609|NCT03430843|chemotherapy|chemotherapy
22610|NCT03430843|paclitaxel|paclitaxel
22611|NCT03430843|docetaxel|docetaxel
22612|NCT03430843|irinotecan|irinotecan
22613|NCT03430791|bevacizumab-naïve|bevacizumab-naïve
22614|NCT03430791|recurrent glioblastoma|recurrent glioblastoma
22615|NCT03430739|Deformational Plagiocephaly, Orthotics, Helmet|deformational plagiocephaly, orthotics, helmet
22616|NCT03430726|Probiotics; paediatrics; gut microbiota|probiotics; paediatrics; gut microbiota
22617|NCT03430713|tooth color|tooth color
22618|NCT03430713|measurement|measurement
22619|NCT03430713|accuracy|accuracy
22620|NCT03430713|shade guide|shade guide
22621|NCT03430713|spectrophotometer|spectrophotometer
22622|NCT03430700|platinum-resistant|platinum-resistant
22623|NCT03430648|Tau protein|tau protein
22624|NCT03430648|PET imaging|pet imaging
22625|NCT03430648|Alzheimer's disease|alzheimer's disease
22626|NCT03430609|endometrioma|endometrioma
22627|NCT03430609|laparoscopy|laparoscopy
22628|NCT03430609|ovarian reserve|ovarian reserve
22629|NCT03430609|anti-mullerian hormone|anti-mullerian hormone
22630|NCT03430583|Fontan|fontan
22631|NCT03430583|Ultrasound|ultrasound
22632|NCT03430583|Magnetic Resonance Imaging Elastography|magnetic resonance imaging elastography
22633|NCT03430570|Adolescent risk behavior|adolescent risk behavior
22634|NCT03430570|digital|digital
22635|NCT03430570|early adolescence|early adolescence
22636|NCT03430570|emotion regulation|emotion regulation
22637|NCT03430570|prevention|prevention
22638|NCT03430557|Endodontic surgery|endodontic surgery
22639|NCT03430544|cariprazine|cariprazine
22640|NCT03430544|fMRI|fmri
22641|NCT03430544|D3 receptor|d3 receptor
22642|NCT03430544|cocaine use disorder|cocaine use disorder
22643|NCT03430544|urine|urine
22644|NCT03430518|Durvalumab (MEDI4736) (Anti-PDL1)|durvalumab (medi4736) (anti-pdl1)
22645|NCT03430518|Eribulin|eribulin
22646|NCT03430518|Recurrent Ovarian cancer|recurrent ovarian cancer
22647|NCT03430518|Her2-negative Metastatic Breast Cancer|her2-negative metastatic breast cancer
22648|NCT03430518|Ovarian cancer|ovarian cancer
22649|NCT03430518|Metastatic Breast Cancer|metastatic breast cancer
22650|NCT03430505|Asthma, noninvasive ventilation|asthma, noninvasive ventilation
22651|NCT03430492|Psychological Resilience|psychological resilience
22652|NCT03430492|Biomarkers|biomarkers
22653|NCT03430492|Molecular Fingerprint|molecular fingerprint
22654|NCT03430492|Quality of Life (QoL)|quality of life (qol)
22655|NCT03430492|Body and Mind|body and mind
22656|NCT03430492|CD-RISC|cd-risc
22657|NCT03430492|SF-36|sf-36
22658|NCT03430453|Regional Anesthesia|regional anesthesia
22659|NCT03430453|Ultrasound guidance|ultrasound guidance
22660|NCT03430453|Nerve stimulation|nerve stimulation
22661|NCT03430453|Orthopedic surgery|orthopedic surgery
22662|NCT03430427|BNET|bnet
22663|NCT03430427|Brain Networks|brain networks
22664|NCT03430427|Mobility Function|mobility function
22665|NCT03430427|SMCCS|smccs
22666|NCT03430401|memory encoding|memory encoding
22667|NCT03430401|functional performance|functional performance
22668|NCT03430388|vaccine|vaccine
22669|NCT03430388|Yellow Fever|yellow fever
22670|NCT03430388|Rheumatic disease|rheumatic disease
22671|NCT03430375|wheelchair cushion|wheelchair cushion
22672|NCT03430375|pressure mapping|pressure mapping
22673|NCT03430375|pressure wounds|pressure wounds
22674|NCT03430349|IPV-primed|ipv-primed
22675|NCT03430349|adults|adults
22676|NCT03430349|vaccination|vaccination
22677|NCT03430349|containment|containment
22678|NCT03430349|shedding|shedding
22679|NCT03430349|genetic stability|genetic stability
22680|NCT03430349|safety|safety
22681|NCT03430349|neurovirulence|neurovirulence
22682|NCT03430349|novel polio vaccine candidates|novel polio vaccine candidates
22683|NCT03430297|anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
22684|NCT03430297|the First Line Therapy|the first line therapy
22685|NCT03430297|Dacarbazine|dacarbazine
22686|NCT03430297|Melanoma|melanoma
22687|NCT03430284|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
22688|NCT03430284|Diabetic Vascular Complications|diabetic vascular complications
22689|NCT03430284|Multifactorial Intervention|multifactorial intervention
22690|NCT03430284|Digital and Network Management|digital and network management
22691|NCT03430245|Circumference reduction|circumference reduction
22692|NCT03430219|AccuFill|accufill
22693|NCT03430219|Injectable Calcium Phosphate|injectable calcium phosphate
22694|NCT03430219|Subchondroplasty|subchondroplasty
22695|NCT03430206|high-flow|high-flow
22696|NCT03430206|nasal cannula|nasal cannula
22697|NCT03430206|laryngoscopy|laryngoscopy
22698|NCT03430206|otolaryngology|otolaryngology
22699|NCT03430206|oxygen|oxygen
22700|NCT03430206|desaturation|desaturation
22701|NCT03430206|anesthesia|anesthesia
22702|NCT03430206|pediatric|pediatric
22703|NCT03430193|rehabilitation|rehabilitation
22704|NCT03430193|multi-disciplinary rehabilitation|multi-disciplinary rehabilitation
22705|NCT03430193|clinical pathway|clinical pathway
22706|NCT03430193|Fragility|fragility
22707|NCT03430167|Reverse Total Shoulder Arthroplasty|reverse total shoulder arthroplasty
22708|NCT03430167|post operative physical therapy|post operative physical therapy
22709|NCT03430115|Obese|obese
22710|NCT03430115|Exercise|exercise
22711|NCT03430089|Influenza|influenza
22712|NCT03430089|Flu|flu
22713|NCT03430076|vascular prostheses|vascular prostheses
22714|NCT03430076|heparin|heparin
22715|NCT03430076|ischemia lesions|ischemia lesions
22716|NCT03430076|vascular|vascular
22717|NCT03430076|critical limb ischemia lesions|critical limb ischemia lesions
22718|NCT03430063|Advanced non-squamous NSCLC|advanced non-squamous nsclc
22719|NCT03430063|Advanced squamous NSCLC|advanced squamous nsclc
22720|NCT03430063|Metastatic non-squamous NSCLC|metastatic non-squamous nsclc
22721|NCT03430063|Metastatic squamous NSCLC|metastatic squamous nsclc
22722|NCT03430050|Progesterone|progesterone
22723|NCT03430050|Ovarian hormones|ovarian hormones
22724|NCT03430050|Gender|gender
22725|NCT03430050|Cannabis|cannabis
22726|NCT03430050|Withdrawal|withdrawal
22727|NCT03430050|Cognitive functioning|cognitive functioning
22728|NCT03430037|Inflammation|inflammation
22729|NCT03430037|Frailty|frailty
22730|NCT03430024|Myosin VI|myosin vi
22731|NCT03430024|Estrogen receptor|estrogen receptor
22732|NCT03430011|JCARH125|jcarh125
22733|NCT03430011|chimeric antigen receptor|chimeric antigen receptor
22734|NCT03430011|multiple myeloma|multiple myeloma
22735|NCT03430011|CAR T cells|car t cells
22736|NCT03430011|B-cell maturation antigen|b-cell maturation antigen
22737|NCT03430011|BCMA|bcma
22738|NCT03430011|autologous T-cell therapy|autologous t-cell therapy
22739|NCT03430011|immunotherapy|immunotherapy
22740|NCT03429998|cardiovascular risk|cardiovascular risk
22741|NCT03429998|evolocumab|evolocumab
22742|NCT03429998|LDL-apheresis|ldl-apheresis
22743|NCT03429985|Sexual and Reproductive Health|sexual and reproductive health
22744|NCT03429985|Parent-based Intervention|parent-based intervention
22745|NCT03429985|Sexual risk behavior|sexual risk behavior
22746|NCT03429985|Adolescent males|adolescent males
22747|NCT03429985|Father-son Intervention|father-son intervention
22748|NCT03429972|Paclitaxel|paclitaxel
22749|NCT03429972|Neuropathy|neuropathy
22750|NCT03429920|Fermented Soy|fermented soy
22751|NCT03429920|Cardiovascular Disease|cardiovascular disease
22752|NCT03429920|Inflammation|inflammation
22753|NCT03429920|DNA Methylation|dna methylation
22754|NCT03429907|Malignant neoplasm of breast|malignant neoplasm of breast
22755|NCT03429907|Mind-Body Exercises|mind-body exercises
22756|NCT03429907|Questionnaires|questionnaires
22757|NCT03429907|Surveys|surveys
22758|NCT03429868|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
22759|NCT03429868|Nead neck cancer|nead neck cancer
22760|NCT03429868|Prognosis|prognosis
22762|NCT03429868|MRI|mri
22763|NCT03429855|Physiotherapy|physiotherapy
22764|NCT03429855|Trunk control|trunk control
22765|NCT03429855|Bobath concept|bobath concept
22766|NCT03429855|Stroke rehabilitation|stroke rehabilitation
22767|NCT03429829|Caries|caries
22768|NCT03429829|Fluoride Varnish|fluoride varnish
22769|NCT03429829|Dental Health|dental health
22770|NCT03429803|low-grade glioma|low-grade glioma
22771|NCT03429790|caesarean section|caesarean section
22772|NCT03429790|cell salvage|cell salvage
22773|NCT03429790|blood transfusion|blood transfusion
22774|NCT03429777|Smartphone|smartphone
22775|NCT03429777|Medical application|medical application
22776|NCT03429777|Hearing-in-noise test|hearing-in-noise test
22777|NCT03429777|Digits-in-noise test|digits-in-noise test
22778|NCT03429777|Speech reception threshold|speech reception threshold
22779|NCT03429777|Hearing Loss|hearing loss
22780|NCT03429777|Hearing Disorders|hearing disorders
22781|NCT03429777|Hearing Abnormalities|hearing abnormalities
22782|NCT03429777|Tinnitus|tinnitus
22783|NCT03429777|Hearing aids|hearing aids
22784|NCT03429777|Cochlear implants|cochlear implants
22785|NCT03429751|lung ultrasound, fluid, hysterectomy, B lines|lung ultrasound, fluid, hysterectomy, b lines
22786|NCT03429738|Ibuprofen|ibuprofen
22787|NCT03429738|phase-I-study|phase-i-study
22788|NCT03429738|pharmacokinetic|pharmacokinetic
22789|NCT03429738|combination therapy|combination therapy
22790|NCT03429738|bioavailability|bioavailability
22791|NCT03429738|bioequivalence|bioequivalence
22792|NCT03429738|pseudoephedrine hydrochloride|pseudoephedrine hydrochloride
22793|NCT03429712|CT Scan|ct scan
22794|NCT03429686|dementia|dementia
22795|NCT03429686|reminiscence therapy|reminiscence therapy
22796|NCT03429686|touch screen technology|touch screen technology
22797|NCT03429686|digital reminiscence therapy|digital reminiscence therapy
22798|NCT03429673|Chinese|chinese
22799|NCT03429673|real-world evidences|real-world evidences
22800|NCT03429673|NSCLC|nsclc
22801|NCT03429673|surgeries|surgeries
22802|NCT03429660|Disease epidemiology|disease epidemiology
22803|NCT03429660|Risk assessment|risk assessment
22804|NCT03429660|Drug utilisation study|drug utilisation study
22805|NCT03429660|Effectiveness evaluation|effectiveness evaluation
22806|NCT03429582|Human Papilloma Virus|human papilloma virus
22807|NCT03429582|Thermoablation|thermoablation
22808|NCT03429582|Thermocoagulation|thermocoagulation
22809|NCT03429582|Cryotherapy|cryotherapy
22810|NCT03429582|Cervica Pre-cancer|cervica pre-cancer
22811|NCT03429582|Low and Middle Income Countries (LMICs)|low and middle income countries (lmics)
22812|NCT03429569|Keratoconus|keratoconus
22813|NCT03429569|Cross-linking|cross-linking
22814|NCT03429569|Confocal microscopy|confocal microscopy
22815|NCT03429569|Postoperative morphological|postoperative morphological
22816|NCT03429569|Iotonphoresis|iotonphoresis
22817|NCT03429556|pain, neurotoxin|pain, neurotoxin
22818|NCT03429517|HDL-C|hdl-c
22819|NCT03429517|Triglycerides|triglycerides
22820|NCT03429517|Non HDL-C and Acute coronary syndrome|non hdl-c and acute coronary syndrome
22821|NCT03429504|Obesity|obesity
22822|NCT03429504|Breast cancer|breast cancer
22823|NCT03429504|Body mass index|body mass index
22824|NCT03429478|Music|music
22825|NCT03429478|Laparoscopic Surgery|laparoscopic surgery
22826|NCT03429478|Sterile Inflammation|sterile inflammation
22827|NCT03429465|Digital Health Intervention|digital health intervention
22828|NCT03429465|Executive Function|executive function
22829|NCT03429465|Depression|depression
22830|NCT03429465|Anxiety|anxiety
22831|NCT03429452|structural heart abnormality|structural heart abnormality
22832|NCT03429452|spatial method|spatial method
22833|NCT03429452|echocardiography|echocardiography
22834|NCT03429452|electrocardiogram|electrocardiogram
22835|NCT03429452|mediterranean diet|mediterranean diet
22836|NCT03429452|exercise|exercise
22837|NCT03429452|social status|social status
22838|NCT03429452|rural|rural
22839|NCT03429439|chronic hepatitis B|chronic hepatitis b
22840|NCT03429439|intestinal microbiota transplantation|intestinal microbiota transplantation
22841|NCT03429439|microbiota|microbiota
22842|NCT03429439|antiviral therapy|antiviral therapy
22843|NCT03429426|Rheumatoid Arthritis|rheumatoid arthritis
22844|NCT03429426|High-resolution peripheral quantitative computed tomography|high-resolution peripheral quantitative computed tomography
22845|NCT03429426|Radiography|radiography
22846|NCT03429413|Health Information Technology (HIT)|health information technology (hit)
22847|NCT03429387|Diagnosis|diagnosis
22848|NCT03429348|Firefighter|firefighter
22849|NCT03429348|Post-Fire Rehabilitation|post-fire rehabilitation
22850|NCT03429348|Sauna|sauna
22851|NCT03429335|Transition|transition
22852|NCT03429335|Adolescents|adolescents
22853|NCT03429335|Smart phone|smart phone
22854|NCT03429322|traumatic brain injury|traumatic brain injury
22855|NCT03429322|pragmatic clinical trial|pragmatic clinical trial
22856|NCT03429322|telemedicine|telemedicine
22857|NCT03429322|cost|cost
22858|NCT03429309|telomere|telomere
22859|NCT03429309|propofol|propofol
22860|NCT03429309|anesthesia-induction|anesthesia-induction
22861|NCT03429296|Cancer|cancer
22862|NCT03429296|Autohypnosis|autohypnosis
22863|NCT03429296|Quality of life|quality of life
22864|NCT03429283|Epidemiology,|epidemiology,
22865|NCT03429283|Achromobacter xylosoxidans,|achromobacter xylosoxidans,
22866|NCT03429283|antibiotic resistance|antibiotic resistance
22867|NCT03429257|Aflatoxin B1|aflatoxin b1
22868|NCT03429257|Environmental Enteric Dysfunction|environmental enteric dysfunction
22869|NCT03429257|L:M Test|l:m test
22870|NCT03429257|Pregnancy|pregnancy
22871|NCT03429257|Linear Growth Faltering|linear growth faltering
22872|NCT03429257|Birth Outcomes|birth outcomes
22873|NCT03429257|Uganda|uganda
22874|NCT03429218|Tolero, Phase 1, First in Human, Solid Tumors, Advanced Malignancy, Cancer|tolero, phase 1, first in human, solid tumors, advanced malignancy, cancer
22875|NCT03429205|Sleeve gastrectomy|sleeve gastrectomy
22876|NCT03429205|Roux-Y gastric bypass|roux-y gastric bypass
22877|NCT03429205|Single anastomosis gastric bypass|single anastomosis gastric bypass
22878|NCT03429205|Hypothermia|hypothermia
22879|NCT03429205|External heating blanket|external heating blanket
22880|NCT03429192|Chinese, real-world evidences, NSCLC, lymph skip metastases|chinese, real-world evidences, nsclc, lymph skip metastases
22881|NCT03429179|butorphanol|butorphanol
22882|NCT03429179|preoperative anxiety|preoperative anxiety
22883|NCT03429179|sedation|sedation
22884|NCT03429153|endocarditis|endocarditis
22885|NCT03429127|balanced fluids, neurosurgery, plasma osmolality|balanced fluids, neurosurgery, plasma osmolality
22886|NCT03429101|Poziotinib|poziotinib
22887|NCT03429101|HER2 Positive|her2 positive
22888|NCT03429101|T-DM1|t-dm1
22889|NCT03429075|depression|depression
22890|NCT03429075|mdd|mdd
22891|NCT03429075|major depression|major depression
22892|NCT03429075|major depressive disorder|major depressive disorder
22893|NCT03429075|unipolar depression|unipolar depression
22894|NCT03429075|psilocybin|psilocybin
22895|NCT03429075|psychedelics|psychedelics
22896|NCT03429075|psychedelic|psychedelic
22897|NCT03429075|escitalopram|escitalopram
22898|NCT03429075|ssri|ssri
22899|NCT03429062|balance|balance
22900|NCT03429062|gait|gait
22901|NCT03429062|Multiple Sclerosis|multiple sclerosis
22902|NCT03429036|Genomic DNA|genomic dna
22903|NCT03429036|DNA Banking|dna banking
22904|NCT03429036|Tissue Sample|tissue sample
22905|NCT03429036|Saliva|saliva
22906|NCT03429036|Blood Collection|blood collection
22907|NCT03429023|Mucormycosis|mucormycosis
22908|NCT03429010|Anesthesia|anesthesia
22909|NCT03429010|Hip Fracture|hip fracture
22910|NCT03428971|atrial fibrillation|atrial fibrillation
22911|NCT03428971|p-wave|p-wave
22912|NCT03428971|hospitalization|hospitalization
22913|NCT03428958|Relapsed metastatic adenocarcinoma of colon/rectum|relapsed metastatic adenocarcinoma of colon/rectum
22914|NCT03428945|TrialNet|trialnet
22915|NCT03428932|Insulin pump|insulin pump
22916|NCT03428932|Closed loop|closed loop
22917|NCT03428932|Brain development|brain development
22918|NCT03428932|Pediatric|pediatric
22919|NCT03428932|Type 1 Diabetes|type 1 diabetes
22920|NCT03428932|MRI|mri
22921|NCT03428932|Cognitive development|cognitive development
22922|NCT03428919|ICSI|icsi
22923|NCT03428919|Conventional IVF|conventional ivf
22924|NCT03428919|Non-male factor|non-male factor
22925|NCT03428906|intranasal oxytocin|intranasal oxytocin
22926|NCT03428906|functional brain network|functional brain network
22927|NCT03428906|multiple tasks|multiple tasks
22928|NCT03428906|resting state|resting state
22929|NCT03428893|Exercise, mhealth, physical therapy|exercise, mhealth, physical therapy
22930|NCT03428880|quadratus lumborum block|quadratus lumborum block
22931|NCT03428880|cesarean section|cesarean section
22932|NCT03428880|spinal morphine|spinal morphine
22933|NCT03428880|ultrasound guidance|ultrasound guidance
22934|NCT03428841|audiometry|audiometry
22935|NCT03428841|dural puncture|dural puncture
22936|NCT03428841|epidural|epidural
22937|NCT03428828|Neurofeedback|neurofeedback
22938|NCT03428828|major depressive disorder|major depressive disorder
22939|NCT03428828|treatment resistant|treatment resistant
22940|NCT03428828|amygdala|amygdala
22941|NCT03428789|breast reconstruction|breast reconstruction
22942|NCT03428789|DIEP flap|diep flap
22943|NCT03428789|Nerve coaptation|nerve coaptation
22944|NCT03428789|Sensory recovery|sensory recovery
22945|NCT03428763|Arthritis, Rheumatoid|arthritis, rheumatoid
22946|NCT03428763|Telerehabilitation|telerehabilitation
22947|NCT03428763|controlled randomised trial|controlled randomised trial
22948|NCT03428737|: pressure support ventilation, pressure control ventilation, sleep, weaning, chronic obstructive respiratory disease, weaning duration period|: pressure support ventilation, pressure control ventilation, sleep, weaning, chronic obstructive respiratory disease, weaning duration period
22949|NCT03428711|Superficial Venous Thrombosis of Leg|superficial venous thrombosis of leg
22950|NCT03428711|secondary prevention|secondary prevention
22951|NCT03428711|prophylaxis|prophylaxis
22952|NCT03428698|third molar extraction|third molar extraction
22953|NCT03428698|hyaluronic acid|hyaluronic acid
22954|NCT03428659|Motor function|motor function
22955|NCT03428659|Recovery|recovery
22956|NCT03428659|Gait|gait
22957|NCT03428659|Magnetic resonance imaging|magnetic resonance imaging
22958|NCT03428646|Eczema|eczema
22959|NCT03428620|Functional Performance|functional performance
22960|NCT03428620|Rehabilitation|rehabilitation
22961|NCT03428620|Manipulation|manipulation
22962|NCT03428581|Axillary|axillary
22963|NCT03428581|Lymph node|lymph node
22964|NCT03428581|Dissection|dissection
22965|NCT03428581|Reverse Mapping|reverse mapping
22966|NCT03428581|Lympho-venous Bypass|lympho-venous bypass
22967|NCT03428568|Herbal Melanin|herbal melanin
22968|NCT03428568|H.Pylori|h.pylori
22969|NCT03428542|yoga|yoga
22970|NCT03428542|stress|stress
22971|NCT03428542|anxiety|anxiety
22972|NCT03428542|depression|depression
22973|NCT03428542|sleep quality|sleep quality
22974|NCT03428542|physiological stress|physiological stress
22975|NCT03428542|biomarkers|biomarkers
22976|NCT03428503|paracetamol|paracetamol
22977|NCT03428503|dexketoprofen|dexketoprofen
22978|NCT03428503|emergency department|emergency department
22979|NCT03428503|musculoskeletal pain|musculoskeletal pain
22980|NCT03428490|Integrated Treatment|integrated treatment
22981|NCT03428490|Alcohol Use Disorder|alcohol use disorder
22982|NCT03428490|Social Anxiety Disorder|social anxiety disorder
22983|NCT03428490|Comorbidity|comorbidity
22984|NCT03428490|Cognitive Behavioral Therapy|cognitive behavioral therapy
22985|NCT03428477|Liver metastases|liver metastases
22986|NCT03428477|Colon Cancer|colon cancer
22987|NCT03428451|TURP|turp
22988|NCT03428451|hypertonic saline|hypertonic saline
22989|NCT03428451|TURP syndrome|turp syndrome
22990|NCT03428451|hyponatraemia|hyponatraemia
22991|NCT03428412|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
22992|NCT03428412|Acute exacerbation|acute exacerbation
22993|NCT03428412|Traditional Chinese medicine|traditional chinese medicine
22994|NCT03428399|breast reconstruction|breast reconstruction
22995|NCT03428399|mastectomy|mastectomy
22996|NCT03428373|Multiple Myeloma|multiple myeloma
22997|NCT03428360|Seizure|seizure
22998|NCT03428347|Ebola|ebola
22999|NCT03428347|Ebola Virus Disease|ebola virus disease
23000|NCT03428347|Monoclonal antibody|monoclonal antibody
23001|NCT03428334|Sputum leukocyte density|sputum leukocyte density
23002|NCT03428321|Microwave ablation|microwave ablation
23003|NCT03428321|Percutaneous thermalablation|percutaneous thermalablation
23004|NCT03428321|High risk location|high risk location
23005|NCT03428321|Articifial pneumothorax|articifial pneumothorax
23006|NCT03428321|Lipiodol marked|lipiodol marked
23007|NCT03428321|Prognostic factor|prognostic factor
23008|NCT03428295|artificial pancreas|artificial pancreas
23009|NCT03428295|automated insulin delivery|automated insulin delivery
23010|NCT03428295|hybrid closed loop|hybrid closed loop
23011|NCT03428295|APDS|apds
23012|NCT03428295|fully automated closed loop|fully automated closed loop
23013|NCT03428269|simulation|simulation
23014|NCT03428269|clinical reasoning|clinical reasoning
23015|NCT03428269|patient deterioration|patient deterioration
23016|NCT03428217|Tumor Metabolism|tumor metabolism
23017|NCT03428217|RCC|rcc
23018|NCT03428217|Glutaminase Inhibitor|glutaminase inhibitor
23019|NCT03428217|CB-839|cb-839
23020|NCT03428217|CANTATA|cantata
23021|NCT03428217|TKI|tki
23022|NCT03428217|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
23023|NCT03428217|cabozantinib|cabozantinib
23024|NCT03428217|Cabometyx|cabometyx
23025|NCT03428217|Cometriq|cometriq
23026|NCT03428217|glutaminase|glutaminase
23027|NCT03428217|glutamine|glutamine
23028|NCT03428217|renal cell|renal cell
23029|NCT03428217|clear cell|clear cell
23030|NCT03428217|kidney cancer|kidney cancer
23031|NCT03428217|cMET|cmet
23032|NCT03428217|MET|met
23033|NCT03428217|HGFR|hgfr
23034|NCT03428191|dexmedetomidine|dexmedetomidine
23035|NCT03428191|remifentanil|remifentanil
23036|NCT03428191|prostate puncture and biopsy|prostate puncture and biopsy
23037|NCT03428178|Acute LHON|acute lhon
23038|NCT03428178|onset within three months|onset within three months
23039|NCT03428178|onset between 3 to 6 months|onset between 3 to 6 months
23040|NCT03428178|onset between 6 to 12 months|onset between 6 to 12 months
23041|NCT03428178|onset between 12 to 24 months|onset between 12 to 24 months
23042|NCT03428178|onset between 24 to 60 months|onset between 24 to 60 months
23043|NCT03428178|onset over 60 months|onset over 60 months
23044|NCT03428152|superior hypogastric plexus block|superior hypogastric plexus block
23045|NCT03428152|hysterectomy|hysterectomy
23046|NCT03428152|postoperative pain|postoperative pain
23047|NCT03428139|lumbosacral radicular pain|lumbosacral radicular pain
23048|NCT03428139|pulsed radiofrequency|pulsed radiofrequency
23049|NCT03428139|Alpha Lipoic acid|alpha lipoic acid
23050|NCT03428126|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
23051|NCT03428126|Colorectal Cancer|colorectal cancer
23153|NCT03427502|bupivacaine|bupivacaine
23052|NCT03428126|Colon Cancer|colon cancer
23053|NCT03428126|Durvalumab|durvalumab
23054|NCT03428126|MEDI4736|medi4736
23055|NCT03428126|Trametinib|trametinib
23056|NCT03428126|GSK1120212|gsk1120212
23057|NCT03428100|eczema|eczema
23058|NCT03428100|atopic eczema|atopic eczema
23059|NCT03428074|Chinese, esophageal cancer, surgeries of Ivor-Lewis/Mckeown|chinese, esophageal cancer, surgeries of ivor-lewis/mckeown
23060|NCT03428061|Prevention|prevention
23061|NCT03428061|Disease Management|disease management
23062|NCT03428061|Integrated care|integrated care
23063|NCT03428061|Primary Health Care|primary health care
23064|NCT03428035|Randomized controlled trial|randomized controlled trial
23065|NCT03428035|package insert|package insert
23066|NCT03428035|nocebo|nocebo
23067|NCT03428022|Apatinib|apatinib
23068|NCT03428022|EGFR-TKI resistance|egfr-tki resistance
23069|NCT03428022|slowly progress|slowly progress
23070|NCT03428009|Dystonia|dystonia
23071|NCT03428009|Control|control
23072|NCT03428009|Magnetic Resonance Imagine|magnetic resonance imagine
23073|NCT03428009|Genotype|genotype
23074|NCT03428009|Phenotype|phenotype
23075|NCT03427996|rotational atherectomy|rotational atherectomy
23076|NCT03427957|Hysteroscopy|hysteroscopy
23077|NCT03427957|Endometrial biopsy|endometrial biopsy
23078|NCT03427957|Menopause|menopause
23079|NCT03427944|Calcium Dobesilate|calcium dobesilate
23080|NCT03427944|Non Dialysis Patients With CKD(3-5)|non dialysis patients with ckd(3-5)
23081|NCT03427944|Glomerular filtration rate|glomerular filtration rate
23082|NCT03427944|serum creatinine|serum creatinine
23083|NCT03427931|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
23084|NCT03427931|Islet Transplantation|islet transplantation
23085|NCT03427931|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
23086|NCT03427892|mood|mood
23087|NCT03427892|bipolar|bipolar
23088|NCT03427892|depression|depression
23089|NCT03427866|Myelofibrosis|myelofibrosis
23090|NCT03427840|Superior Hypogastric Plexus Block|superior hypogastric plexus block
23091|NCT03427840|Hysterectomy|hysterectomy
23092|NCT03427840|Minimally invasive surgery|minimally invasive surgery
23093|NCT03427840|Laparoscopy|laparoscopy
23094|NCT03427840|Pain|pain
23095|NCT03427840|Gynecologic Disease|gynecologic disease
23096|NCT03427827|PD-1 antibody|pd-1 antibody
23097|NCT03427827|Adjuvant treatment|adjuvant treatment
23098|NCT03427827|Immune checkpoint inhibitors|immune checkpoint inhibitors
23099|NCT03427814|BGB-290|bgb-290
23100|NCT03427814|PARP inhibitor|parp inhibitor
23101|NCT03427814|Phase 3|phase 3
23102|NCT03427814|maintenance therapy|maintenance therapy
23103|NCT03427814|gastric cancer|gastric cancer
23104|NCT03427814|oral treatment|oral treatment
23105|NCT03427801|erythropoiesis-stimulating agent|erythropoiesis-stimulating agent
23106|NCT03427775|multimodal analgesia, quality of recovery, quality of pain management|multimodal analgesia, quality of recovery, quality of pain management
23107|NCT03427762|balance|balance
23108|NCT03427762|postural controll|postural controll
23109|NCT03427762|motor controll|motor controll
23110|NCT03427762|posturgraphy|posturgraphy
23111|NCT03427762|quality of life|quality of life
23112|NCT03427749|Myocardial Blood Flow|myocardial blood flow
23113|NCT03427749|SPECT|spect
23114|NCT03427723|Peripheral intravenous cannulation|peripheral intravenous cannulation
23115|NCT03427723|children|children
23116|NCT03427723|near-infrared light|near-infrared light
23117|NCT03427684|Gastric cancer|gastric cancer
23118|NCT03427684|Chemo-radiotherapy|chemo-radiotherapy
23119|NCT03427684|Phase I study|phase i study
23120|NCT03427684|Hypo-fractionated radiotherapy|hypo-fractionated radiotherapy
23121|NCT03427658|sweet taste|sweet taste
23122|NCT03427658|food preferences|food preferences
23123|NCT03427658|food intake|food intake
23124|NCT03427645|surrogate decision maker|surrogate decision maker
23125|NCT03427632|PVP|pvp
23126|NCT03427632|bone tumor|bone tumor
23127|NCT03427606|sacral colpopexy|sacral colpopexy
23128|NCT03427606|laparoscopy|laparoscopy
23129|NCT03427606|mesh fixation|mesh fixation
23130|NCT03427593|CVID|cvid
23131|NCT03427593|Neutropenia|neutropenia
23132|NCT03427593|Autoimmunity|autoimmunity
23133|NCT03427593|Lymphoproliferation|lymphoproliferation
23134|NCT03427580|Schizophrenia|schizophrenia
23135|NCT03427580|Psychotherapy|psychotherapy
23136|NCT03427580|Metacognitive abilities|metacognitive abilities
23137|NCT03427580|Session by session assessment|session by session assessment
23138|NCT03427580|Outcome|outcome
23139|NCT03427567|Chinese|chinese
23140|NCT03427567|real-world evidences|real-world evidences
23141|NCT03427567|NSCLC|nsclc
23142|NCT03427567|sublobar dissection|sublobar dissection
23143|NCT03427541|Chinese|chinese
23144|NCT03427541|non-small cell lung cancer|non-small cell lung cancer
23145|NCT03427541|oligometastases|oligometastases
23146|NCT03427515|Psychobiotics|psychobiotics
23147|NCT03427515|Probiotics|probiotics
23148|NCT03427515|Examination|examination
23149|NCT03427515|Stress|stress
23150|NCT03427502|general anesthesia|general anesthesia
23151|NCT03427502|nasal surgery|nasal surgery
23152|NCT03427502|anterior ehtmoidal nerve block|anterior ehtmoidal nerve block
23154|NCT03427502|postoperative confusion|postoperative confusion
23155|NCT03427489|Biomarkers|biomarkers
23156|NCT03427489|Genetic Markers|genetic markers
23157|NCT03427489|Controls|controls
23158|NCT03427476|renal cell carcinoma|renal cell carcinoma
23159|NCT03427476|RCC|rcc
23160|NCT03427476|prostate specific membrane antigen|prostate specific membrane antigen
23161|NCT03427476|PSMA|psma
23162|NCT03427476|metastatic renal cancer|metastatic renal cancer
23163|NCT03427476|positron emission tomography|positron emission tomography
23164|NCT03427476|PET|pet
23165|NCT03427450|circulating tumor cells|circulating tumor cells
23166|NCT03427450|liquid biopsy|liquid biopsy
23167|NCT03427450|microfluidics|microfluidics
23168|NCT03427437|sacral canal|sacral canal
23169|NCT03427437|sacral hiatus|sacral hiatus
23170|NCT03427437|ultrasound|ultrasound
23171|NCT03427424|Opioid use Disorder|opioid use disorder
23172|NCT03427424|Alcohol use Disorder|alcohol use disorder
23173|NCT03427424|Physician Health Program|physician health program
23174|NCT03427424|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
23175|NCT03427424|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
23176|NCT03427411|TGFR1 pathway signaling and overexpression|tgfr1 pathway signaling and overexpression
23177|NCT03427411|PD-1 inhibitors|pd-1 inhibitors
23178|NCT03427411|Manageable Safety Profile|manageable safety profile
23179|NCT03427411|Bifunctional Fusion Protein|bifunctional fusion protein
23180|NCT03427411|Refractory/Recurrent HPV Associated Malignancies|refractory/recurrent hpv associated malignancies
23181|NCT03427385|Neuromuscular blockade|neuromuscular blockade
23182|NCT03427359|nasopharyngeal carcinoma|nasopharyngeal carcinoma
23183|NCT03427359|induction chemotherapy|induction chemotherapy
23184|NCT03427359|cisplatin|cisplatin
23185|NCT03427359|capecitabine|capecitabine
23186|NCT03427359|chemoradiotherapy|chemoradiotherapy
23187|NCT03427346|Barrett Esophagus|barrett esophagus
23188|NCT03427346|ESD|esd
23189|NCT03427346|EMR|emr
23190|NCT03427346|Esophagus Neoplasm|esophagus neoplasm
23191|NCT03427346|endoscopic resection technique|endoscopic resection technique
23192|NCT03427346|ablation of esophageal mucosa|ablation of esophageal mucosa
23193|NCT03427333|VT|vt
23194|NCT03427333|Pacemaker Lead Extraction|pacemaker lead extraction
23195|NCT03427333|epicardial access|epicardial access
23196|NCT03427333|pericardial access|pericardial access
23197|NCT03427320|[131]I-IAZA Imaging study|[131]i-iaza imaging study
23198|NCT03427307|Lipopolysaccharide-binding protein|lipopolysaccharide-binding protein
23199|NCT03427307|inflammation|inflammation
23200|NCT03427307|ASCVD|ascvd
23201|NCT03427255|superficial dyspareunia; CBT|superficial dyspareunia; cbt
23202|NCT03427242|biliary tract carcinoma|biliary tract carcinoma
23203|NCT03427242|apatinib|apatinib
23204|NCT03427229|fecal microbiota transplantation|fecal microbiota transplantation
23205|NCT03427229|Clostridium difficile infection|clostridium difficile infection
23206|NCT03427229|pseudomembranous colitis|pseudomembranous colitis
23207|NCT03427190|Suicide|suicide
23208|NCT03427190|Suicide attempted|suicide attempted
23209|NCT03427190|Secondary Prevention|secondary prevention
23210|NCT03427190|Relapse prevention|relapse prevention
23211|NCT03427190|Case Management|case management
23212|NCT03427190|Intervention Study|intervention study
23213|NCT03427164|Transjugular Intrahepatic Portosystemic Shunt|transjugular intrahepatic portosystemic shunt
23214|NCT03427164|TIPS|tips
23215|NCT03427164|cirrhosis|cirrhosis
23216|NCT03427164|hepatitis|hepatitis
23217|NCT03427164|portal vein thrombosis|portal vein thrombosis
23218|NCT03427164|Budd-Chiari Disease|budd-chiari disease
23219|NCT03427164|Elastography|elastography
23220|NCT03427086|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
23221|NCT03427086|Biotin|biotin
23222|NCT03427034|Urine|urine
23223|NCT03427034|Haematuria|haematuria
23224|NCT03427034|Flexible cystoscopy|flexible cystoscopy
23225|NCT03427034|Recurrence|recurrence
23226|NCT03427034|Cytology|cytology
23227|NCT03427008|mHealth|mhealth
23228|NCT03427008|kidney transplantation|kidney transplantation
23229|NCT03427008|medication adherence|medication adherence
23230|NCT03427008|video directly observed therapy|video directly observed therapy
23231|NCT03426969|Myelofibrosis|myelofibrosis
23232|NCT03426969|MF|mf
23233|NCT03426969|Haploidentical hematopoietic cell transplantation|haploidentical hematopoietic cell transplantation
23234|NCT03426969|Haplo-HCT|haplo-hct
23235|NCT03426969|Melphalan|melphalan
23236|NCT03426969|Alkeran|alkeran
23237|NCT03426969|Evomela|evomela
23238|NCT03426969|Fludarabine|fludarabine
23239|NCT03426969|Fludarabine phosphate|fludarabine phosphate
23240|NCT03426969|Fludara|fludara
23241|NCT03426969|Tacrolimus|tacrolimus
23242|NCT03426969|Prograf|prograf
23243|NCT03426969|Mycophenolate Mofetil|mycophenolate mofetil
23244|NCT03426969|MMF|mmf
23245|NCT03426969|CellCept|cellcept
23246|NCT03426969|G-CSF|g-csf
23247|NCT03426969|Filgrastim|filgrastim
23248|NCT03426969|Neupogen|neupogen
23249|NCT03426969|Total body irradiation|total body irradiation
23250|NCT03426969|TBI|tbi
23251|NCT03426969|External beam radiation therapy|external beam radiation therapy
23252|NCT03426956|Glucagon-like Peptide-1|glucagon-like peptide-1
23253|NCT03426956|Glucose|glucose
23254|NCT03426956|Gastric bypass|gastric bypass
23255|NCT03426956|Bariatric surgery|bariatric surgery
23256|NCT03426956|Obesity|obesity
23257|NCT03426956|Diabetes|diabetes
23258|NCT03426891|Immunotherapy|immunotherapy
23259|NCT03426891|Radiotherapy|radiotherapy
23260|NCT03426891|Glioblastoma|glioblastoma
23261|NCT03426878|Lynch syndrome|lynch syndrome
23262|NCT03426878|Hereditary breast and ovarian cancer|hereditary breast and ovarian cancer
23263|NCT03426865|retroperitoneal lymph node dissection|retroperitoneal lymph node dissection
23264|NCT03426865|testicular cancer|testicular cancer
23265|NCT03426865|testis cancer|testis cancer
23266|NCT03426865|germ cell tumor|germ cell tumor
23267|NCT03426865|PET scan|pet scan
23268|NCT03426865|Axumin|axumin
23269|NCT03426865|teratoma|teratoma
23270|NCT03426852|Biomechanical Phenomenon|biomechanical phenomenon
23271|NCT03426852|Gait|gait
23272|NCT03426852|Lumbar Disc Degeneration|lumbar disc degeneration
23273|NCT03426839|hemostatic techniques|hemostatic techniques
23274|NCT03426839|perioperative hemorrhage|perioperative hemorrhage
23275|NCT03426839|platelet function test|platelet function test
23276|NCT03426839|point of care technology|point of care technology
23277|NCT03426839|thromboelastometry|thromboelastometry
23278|NCT03426839|vascular surgical procedures|vascular surgical procedures
23279|NCT03426826|FMT|fmt
23280|NCT03426826|Gut Microbiome|gut microbiome
23281|NCT03426826|Fecal Microbiata Transplantation|fecal microbiata transplantation
23282|NCT03426826|Autism Spectrum Disorder|autism spectrum disorder
23283|NCT03426826|16s rRNA|16s rrna
23284|NCT03426826|Gastro-Intestinal Disorder|gastro-intestinal disorder
23285|NCT03426813|mobilization|mobilization
23286|NCT03426813|physiotherapy|physiotherapy
23287|NCT03426813|community-acquired pneumonia|community-acquired pneumonia
23288|NCT03426800|Acupuncture|acupuncture
23289|NCT03426800|Training|training
23290|NCT03426800|Children|children
23291|NCT03426800|Effect|effect
23292|NCT03426787|Patient Centered|patient centered
23293|NCT03426787|Pre-Post Design|pre-post design
23294|NCT03426787|Decision Support|decision support
23295|NCT03426787|Health Literacy|health literacy
23296|NCT03426748|Brachytherapy|brachytherapy
23297|NCT03426748|Quality of life|quality of life
23298|NCT03426748|High dose rate vs. low dose rate|high dose rate vs. low dose rate
23299|NCT03426748|Intermediate risk group|intermediate risk group
23300|NCT03426735|Iodine|iodine
23301|NCT03426735|Iodized|iodized
23302|NCT03426735|Computerized Tomography|computerized tomography
23303|NCT03426735|Extravasation|extravasation
23304|NCT03426735|contrast media|contrast media
23305|NCT03426709|Depression|depression
23306|NCT03426709|Multimorbidity|multimorbidity
23307|NCT03426709|Computer-delivered psychotherapy|computer-delivered psychotherapy
23308|NCT03426709|Randomized-controlled trial|randomized-controlled trial
23309|NCT03426709|Cost-effectiveness|cost-effectiveness
23310|NCT03426696|psychological status|psychological status
23311|NCT03426696|Related Factors|related factors
23312|NCT03426696|Thyroid Related Eye Disease|thyroid related eye disease
23313|NCT03426683|Inflammatory Bowel Disease(IBD)|inflammatory bowel disease(ibd)
23314|NCT03426683|Ulcerative colitis(UC)|ulcerative colitis(uc)
23315|NCT03426683|Crohn's disease(CD)|crohn's disease(cd)
23316|NCT03426683|intestinal microbiota transplantation|intestinal microbiota transplantation
23317|NCT03426683|microbiota|microbiota
23318|NCT03426670|HIV self-testing|hiv self-testing
23319|NCT03426670|Pre-exposure prophylaxis|pre-exposure prophylaxis
23320|NCT03426670|Sex workers|sex workers
23321|NCT03426644|Childhood sleep promotion|childhood sleep promotion
23322|NCT03426644|Sleep promotion|sleep promotion
23323|NCT03426644|Sleep|sleep
23324|NCT03426592|HIV|hiv
23325|NCT03426592|Inflammation|inflammation
23326|NCT03426592|Vitamin D|vitamin d
23327|NCT03426592|Immunomodulation|immunomodulation
23328|NCT03426592|Virus latency|virus latency
23329|NCT03426566|diabetic foot|diabetic foot
23330|NCT03426566|pedobarography|pedobarography
23331|NCT03426566|diabetic neuropathy|diabetic neuropathy
23332|NCT03426566|plantar pressure|plantar pressure
23333|NCT03426553|Patogen inactivation|patogen inactivation
23334|NCT03426553|Pathogen reduction|pathogen reduction
23335|NCT03426553|clinical use|clinical use
23336|NCT03426553|riboflavin+UV|riboflavin+uv
23337|NCT03426553|RBC transfusion|rbc transfusion
23338|NCT03426553|whole blood|whole blood
23339|NCT03426514|Colorectal cancer|colorectal cancer
23340|NCT03426514|Laparoscopic surgery|laparoscopic surgery
23341|NCT03426514|Three-port|three-port
23342|NCT03426501|heart rate variability|heart rate variability
23343|NCT03426501|prognosis|prognosis
23344|NCT03426475|nursing home residents|nursing home residents
23345|NCT03426475|interprofessional collaboration|interprofessional collaboration
23346|NCT03426475|reduction of hospitalisation|reduction of hospitalisation
23347|NCT03426462|Pharmacodynamic|pharmacodynamic
23348|NCT03426462|Permutation Entropy|permutation entropy
23349|NCT03426462|EEG|eeg
23350|NCT03426423|Gender|gender
23351|NCT03426423|Metabolism|metabolism
23352|NCT03426423|Microbiota|microbiota
23353|NCT03426397|Complete response|complete response
23354|NCT03426397|Organ preservation|organ preservation
23355|NCT03426397|Wait-and-See|wait-and-see
23356|NCT03426397|Watch-and-Wait|watch-and-wait
23357|NCT03426397|Watchful Waiting|watchful waiting
23358|NCT03426384|SLE|sle
23359|NCT03426384|FLARE|flare
23360|NCT03426384|Lupus|lupus
23361|NCT03426384|Digital Therapeutics|digital therapeutics
23362|NCT03426384|Health Coaching|health coaching
23363|NCT03426384|Smartphone App|smartphone app
23364|NCT03426358|Veno Occlusive Disease|veno occlusive disease
23365|NCT03426358|Sinusoidal Obstruction Syndrome|sinusoidal obstruction syndrome
23366|NCT03426358|HSCT|hsct
23367|NCT03426358|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
23368|NCT03426358|Stem Cell Transplant Complications|stem cell transplant complications
23369|NCT03426358|Liver Stiffness Measurement|liver stiffness measurement
23370|NCT03426358|Sinusoidal Obstructive Syndrome|sinusoidal obstructive syndrome
23371|NCT03426358|Transient Elastography|transient elastography
23372|NCT03426332|Adrenal Insufficiency|adrenal insufficiency
23373|NCT03426332|Adrenal crisis|adrenal crisis
23374|NCT03426332|Adrenal emergency|adrenal emergency
23375|NCT03426332|Glucocorticoid injection|glucocorticoid injection
23376|NCT03426319|Primary adrenal insufficiency|primary adrenal insufficiency
23377|NCT03426319|Cardiovascular status|cardiovascular status
23378|NCT03426319|Metabolic profile|metabolic profile
23379|NCT03426306|4-Dimensional Computed Tomography|4-dimensional computed tomography
23380|NCT03426293|heparin;ACT;non-cardiac vascular;peri-procedural|heparin;act;non-cardiac vascular;peri-procedural
23381|NCT03426254|Subcutaneously Talazoparib|subcutaneously talazoparib
23382|NCT03426241|chronic periodontitis|chronic periodontitis
23383|NCT03426241|smoking|smoking
23384|NCT03426241|mmp-2|mmp-2
23385|NCT03426241|mmp-9|mmp-9
23386|NCT03426228|IVF, Glucose Homeostasis, Metabolic Parameters|ivf, glucose homeostasis, metabolic parameters
23387|NCT03426202|modafinil|modafinil
23388|NCT03426202|emotion|emotion
23389|NCT03426202|cognitive processing|cognitive processing
23390|NCT03426189|HIV|hiv
23391|NCT03426189|Latent reservoir|latent reservoir
23392|NCT03426189|Leukapheresis|leukapheresis
23393|NCT03426189|Inguinal lymph node biopsy|inguinal lymph node biopsy
23394|NCT03426189|Immune checkpoint|immune checkpoint
23395|NCT03426189|PD1|pd1
23396|NCT03426189|CTLA4|ctla4
23397|NCT03426176|oxytocin|oxytocin
23398|NCT03426176|acute tryptophan depletion|acute tryptophan depletion
23399|NCT03426176|emotion|emotion
23400|NCT03426163|virtual reality|virtual reality
23401|NCT03426163|knee|knee
23402|NCT03426137|Oxycodone|oxycodone
23403|NCT03426137|Placebo|placebo
23404|NCT03426137|Expectancy Induced Analgesia|expectancy induced analgesia
23405|NCT03426137|NSAID|nsaid
23406|NCT03426124|venous thromboembolism|venous thromboembolism
23407|NCT03426111|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
23408|NCT03426111|NASH|nash
23409|NCT03426111|Obesity|obesity
23410|NCT03426111|Endoscopic gastric tubulization|endoscopic gastric tubulization
23411|NCT03426111|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
23412|NCT03426072|quality improvement|quality improvement
23413|NCT03426059|Phelan-McDermid Syndrome|phelan-mcdermid syndrome
23414|NCT03426059|PMS|pms
23415|NCT03426059|Genotype|genotype
23416|NCT03426059|Phenotype|phenotype
23417|NCT03426059|Mapping|mapping
23418|NCT03426059|22q13 Deletion Syndrome|22q13 deletion syndrome
23419|NCT03426059|SHANK3|shank3
23420|NCT03426059|Autism Spectrum Disorder|autism spectrum disorder
23421|NCT03426059|ASD|asd
23422|NCT03426059|Intellectual Disability|intellectual disability
23423|NCT03426059|ID|id
23424|NCT03426046|Biodentine|biodentine
23425|NCT03426046|Cariously exposed pulp|cariously exposed pulp
23426|NCT03426046|MTA|mta
23427|NCT03426046|Partial pulpotomy|partial pulpotomy
23428|NCT03426046|Image J Software|image j software
23429|NCT03426020|Premedication|premedication
23430|NCT03426020|Pediatric patients|pediatric patients
23431|NCT03426020|Emergence agitation|emergence agitation
23432|NCT03426007|uterine lavage|uterine lavage
23433|NCT03426007|intrauterine insemination|intrauterine insemination
23434|NCT03426007|embryo|embryo
23435|NCT03426007|blastocyst|blastocyst
23436|NCT03426007|in vivo|in vivo
23437|NCT03426007|superovulation|superovulation
23438|NCT03425981|WB-EMS|wb-ems
23439|NCT03425981|Running economy|running economy
23440|NCT03425981|VO2max|vo2max
23441|NCT03425968|Injury rate|injury rate
23442|NCT03425942|Cognitive Behavioral Therapy|cognitive behavioral therapy
23443|NCT03425942|Applied Relaxation Techniques|applied relaxation techniques
23444|NCT03425942|Internet treatment|internet treatment
23445|NCT03425929|amygdala, fear, intrusion, oxytocin, trauma disclosure|amygdala, fear, intrusion, oxytocin, trauma disclosure
23446|NCT03425916|Hypopressive exercises|hypopressive exercises
23447|NCT03425916|Ultrasonography|ultrasonography
23448|NCT03425903|Fibromyalgia, Whole body cryotherapy|fibromyalgia, whole body cryotherapy
23449|NCT03425890|Upper Limb|upper limb
23450|NCT03425890|Self-exercise|self-exercise
23451|NCT03425877|arousal, valence, emotion, heart rate variability, electrodermal activity, u-shape curve, performance, neurorehabilitation|arousal, valence, emotion, heart rate variability, electrodermal activity, u-shape curve, performance, neurorehabilitation
23452|NCT03425851|Diaper need|diaper need
23453|NCT03425851|Infants|infants
23454|NCT03425851|Well baby visits|well baby visits
23455|NCT03425851|Low-income families|low-income families
23456|NCT03425851|Caregiver stress|caregiver stress
23457|NCT03425838|CDK 4/6 inhibitor|cdk 4/6 inhibitor
23458|NCT03425825|Small Cell Lung Cancer (SCLC)|small cell lung cancer (sclc)
23459|NCT03425812|Axial Spondyloarthritis|axial spondyloarthritis
23460|NCT03425812|Anti-Inflammatory Drugs|anti-inflammatory drugs
23461|NCT03425812|Flare|flare
23462|NCT03425773|HER2/neu|her2/neu
23463|NCT03425773|IHC 1+|ihc 1+
23464|NCT03425773|BVAC|bvac
23465|NCT03425773|Cellid|cellid
23466|NCT03425773|B-cell|b-cell
23467|NCT03425773|Monocyte|monocyte
23468|NCT03425773|Immunotherapeutic vaccine|immunotherapeutic vaccine
23469|NCT03425773|Breast cancer|breast cancer
23470|NCT03425773|Colorectal cancer|colorectal cancer
23471|NCT03425773|Pancreatic cancer|pancreatic cancer
23472|NCT03425747|calcium carbonate|calcium carbonate
23473|NCT03425747|calcium citrate|calcium citrate
23474|NCT03425747|quality of life|quality of life
23475|NCT03425747|hypoparathyroidism|hypoparathyroidism
23476|NCT03425747|hypocalcemia|hypocalcemia
23477|NCT03425708|Uric Acid|uric acid
23478|NCT03425708|Febuxostat|febuxostat
23479|NCT03425708|Chronic Renal Disease|chronic renal disease
23480|NCT03425695|Free gingival graft, Low level laser therapy, Shrinkage|free gingival graft, low level laser therapy, shrinkage
23481|NCT03425682|Anterior Cervical Discectomy and Fusion (ACDF)|anterior cervical discectomy and fusion (acdf)
23725|NCT03424070|laryngoscopy|laryngoscopy
23482|NCT03425682|Transforaminal Lumbar Interbody Fusion (TLIF)|transforaminal lumbar interbody fusion (tlif)
23483|NCT03425682|Posterior Lumbar Interbody Fusion (PLIF)|posterior lumbar interbody fusion (plif)
23484|NCT03425669|Acoustic and vestibular noise stimulation|acoustic and vestibular noise stimulation
23485|NCT03425656|breast cancer|breast cancer
23486|NCT03425656|AryoTrust™|aryotrust™
23487|NCT03425656|Herceptin®|herceptin®
23488|NCT03425656|non-Inferiority|non-inferiority
23489|NCT03425578|Monosodium glutamate|monosodium glutamate
23490|NCT03425578|Amino acids|amino acids
23491|NCT03425578|Glucose tolerance|glucose tolerance
23492|NCT03425526|Hematological Malignancies|hematological malignancies
23493|NCT03425526|Immunocompromised Patients|immunocompromised patients
23494|NCT03425526|Adenovirus Specific T Cells|adenovirus specific t cells
23495|NCT03425513|Belgium|belgium
23496|NCT03425513|Prevalence|prevalence
23497|NCT03425513|Risk factor|risk factor
23498|NCT03425513|Ethnicity|ethnicity
23499|NCT03425513|Linkage of care|linkage of care
23500|NCT03425487|Mindfulness|mindfulness
23501|NCT03425487|Compassion|compassion
23502|NCT03425487|Mental Health Services|mental health services
23503|NCT03425422|Vagus nerve stimulation|vagus nerve stimulation
23504|NCT03425383|Cardiovascular disease, FMD, c-IMT|cardiovascular disease, fmd, c-imt
23505|NCT03425370|Surgical wounds|surgical wounds
23506|NCT03425370|Tissue adhesive|tissue adhesive
23507|NCT03425370|Sutures|sutures
23508|NCT03425370|Wound healing|wound healing
23509|NCT03425331|Non-Small Cell Lung Cancer|non-small cell lung cancer
23510|NCT03425305|Serum uric acid|serum uric acid
23511|NCT03425305|Cardiovascular disease|cardiovascular disease
23512|NCT03425305|Atherosclerosis|atherosclerosis
23513|NCT03425292|immunotherapy|immunotherapy
23514|NCT03425292|nivolumab|nivolumab
23515|NCT03425292|ipilimumab|ipilimumab
23516|NCT03425266|shared decision-making|shared decision-making
23517|NCT03425266|decision support tool|decision support tool
23518|NCT03425266|patient-provider communication|patient-provider communication
23519|NCT03425266|managing chronic pain|managing chronic pain
23520|NCT03425266|patient preferences|patient preferences
23521|NCT03425266|values clarification|values clarification
23522|NCT03425253|Lower Face Contouring|lower face contouring
23523|NCT03425240|Erectile Dysfunction|erectile dysfunction
23524|NCT03425240|Prostate Cancer|prostate cancer
23525|NCT03425240|Neuromodulation|neuromodulation
23526|NCT03425227|Frailty|frailty
23527|NCT03425227|Elderly People|elderly people
23528|NCT03425227|Exergame|exergame
23529|NCT03425227|Physical Activity|physical activity
23530|NCT03425227|Kinect|kinect
23531|NCT03425227|Biofeeback|biofeeback
23532|NCT03425214|functional MRI|functional mri
23533|NCT03425214|Reward system|reward system
23534|NCT03425214|REM sleep behaviour disorder|rem sleep behaviour disorder
23535|NCT03425214|Narco-cataplexy|narco-cataplexy
23536|NCT03425175|Non-relevant conversation|non-relevant conversation
23537|NCT03425175|Surgical safety|surgical safety
23538|NCT03425175|Audio recording|audio recording
23539|NCT03425162|quadratus lumborum block|quadratus lumborum block
23540|NCT03425162|pain|pain
23541|NCT03425162|ultrasound|ultrasound
23542|NCT03425162|percutaneous nephrolithotomy|percutaneous nephrolithotomy
23543|NCT03425149|vaccine|vaccine
23544|NCT03425149|prevention|prevention
23545|NCT03425136|Prevention of Mother-to-Child HIV Transmission|prevention of mother-to-child hiv transmission
23546|NCT03425136|HIV|hiv
23547|NCT03425136|PMTCT|pmtct
23548|NCT03425123|Regenerative endodontic procedure (REP)|regenerative endodontic procedure (rep)
23549|NCT03425123|Mineral Trioxide Aggregate (MTA) apexification|mineral trioxide aggregate (mta) apexification
23550|NCT03425123|Calcium Hydroxide -Ca(OH)2|calcium hydroxide -ca(oh)2
23551|NCT03425123|Permanent non-vital tooth|permanent non-vital tooth
23552|NCT03425123|Children 7-18 years of age|children 7-18 years of age
23553|NCT03425071|Tacrolimus|tacrolimus
23554|NCT03425071|T Lymphocytes|t lymphocytes
23555|NCT03425071|B lymphocytes|b lymphocytes
23556|NCT03425071|Monitoring, Immunologic|monitoring, immunologic
23557|NCT03425058|Molecular Evaluation|molecular evaluation
23558|NCT03425058|Locally Advanced Gastric Cancer|locally advanced gastric cancer
23559|NCT03425058|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
23560|NCT03425058|ctDNA|ctdna
23561|NCT03425058|CTC|ctc
23562|NCT03425058|dMMR/MSI|dmmr/msi
23563|NCT03425045|chronic tinnitus|chronic tinnitus
23564|NCT03425045|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
23565|NCT03425045|hypacusion|hypacusion
23566|NCT03425045|depression|depression
23567|NCT03425045|treatment|treatment
23568|NCT03425045|placebo|placebo
23569|NCT03425045|medication therapy|medication therapy
23570|NCT03425019|Knee Osteoarthritis|knee osteoarthritis
23571|NCT03425019|Chronic Pain|chronic pain
23572|NCT03425019|Osteoarthritis|osteoarthritis
23573|NCT03425019|Transcranial Direct Current Stimulation|transcranial direct current stimulation
23574|NCT03425019|tDCS|tdcs
23575|NCT03424993|Endothelium, vascular|endothelium, vascular
23576|NCT03424993|Cardiovascular Disease|cardiovascular disease
23577|NCT03424993|Hemodynamics|hemodynamics
23578|NCT03424993|Oxidative Stress|oxidative stress
23579|NCT03424993|Dietary Sodium|dietary sodium
23580|NCT03424993|Dietary Counseling|dietary counseling
23581|NCT03424980|Non-small cell lung cancer, Chinese, brain metastases|non-small cell lung cancer, chinese, brain metastases
23582|NCT03424967|attention-bias modification|attention-bias modification
23583|NCT03424967|statistical learning|statistical learning
23584|NCT03424967|social anxiety disorder|social anxiety disorder
23585|NCT03424967|treatment outcome|treatment outcome
23586|NCT03424941|Aortic Stenosis (AS)|aortic stenosis (as)
23587|NCT03424941|Multi Vessel Coronary Artery Disease (MVD)|multi vessel coronary artery disease (mvd)
23588|NCT03424941|TransCatheter Aortic Valve Implantation (TAVI)|transcatheter aortic valve implantation (tavi)
23589|NCT03424941|Coronary Artery By-pass Grafting (CABG)|coronary artery by-pass grafting (cabg)
23590|NCT03424941|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
23591|NCT03424941|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
23592|NCT03424941|Surgical Aortic Valve Replacement (SAVR)|surgical aortic valve replacement (savr)
23593|NCT03424928|Pomalidomide|pomalidomide
23594|NCT03424928|Multiple myeloma|multiple myeloma
23595|NCT03424928|Bioequivalence|bioequivalence
23596|NCT03424889|Bronchoscopy|bronchoscopy
23597|NCT03424889|Lignocaine|lignocaine
23598|NCT03424889|Anaesthesia|anaesthesia
23599|NCT03424876|Sunitinib Imatinib|sunitinib imatinib
23600|NCT03424798|mechanical ventilation|mechanical ventilation
23601|NCT03424798|lung function|lung function
23602|NCT03424798|cardiopulmonary monitoring|cardiopulmonary monitoring
23603|NCT03424785|Aortic intramural hematoma|aortic intramural hematoma
23604|NCT03424785|Chinese patients|chinese patients
23605|NCT03424785|Clinical outcomes|clinical outcomes
23606|NCT03424733|demyelination|demyelination
23607|NCT03424733|relapse rate|relapse rate
23608|NCT03424733|Pegylated interferon beta-1a|pegylated interferon beta-1a
23609|NCT03424733|side effects|side effects
23610|NCT03424733|flu-like symptoms|flu-like symptoms
23611|NCT03424733|injection site reactions|injection site reactions
23612|NCT03424733|prednisone|prednisone
23613|NCT03424694|Brachytherapy|brachytherapy
23614|NCT03424694|Monotherapy|monotherapy
23615|NCT03424694|HDR Brachytherapy|hdr brachytherapy
23616|NCT03424694|Toxicity|toxicity
23617|NCT03424694|Quality of Life|quality of life
23618|NCT03424694|Progression Free Survival|progression free survival
23619|NCT03424668|nutrition|nutrition
23620|NCT03424668|physical activity|physical activity
23621|NCT03424668|lifestyle|lifestyle
23622|NCT03424668|smoking|smoking
23623|NCT03424655|post -endodontic pain|post -endodontic pain
23624|NCT03424655|endodontic pain|endodontic pain
23625|NCT03424655|pain|pain
23626|NCT03424642|prenatal depression|prenatal depression
23627|NCT03424642|prenatal anxiety|prenatal anxiety
23628|NCT03424642|prenatal mental disorders|prenatal mental disorders
23629|NCT03424642|interactive ultrasound examination|interactive ultrasound examination
23630|NCT03424642|maternal-fetal relations|maternal-fetal relations
23631|NCT03424629|psoriasis|psoriasis
23632|NCT03424629|UC-MSCs|uc-mscs
23633|NCT03424616|Opiate dependence|opiate dependence
23634|NCT03424616|Deep brain stimulation|deep brain stimulation
23635|NCT03424616|Nucleus accumbens|nucleus accumbens
23636|NCT03424577|H3B-6527|h3b-6527
23637|NCT03424577|Healthy Participants|healthy participants
23638|NCT03424577|Pharmacokinetics|pharmacokinetics
23639|NCT03424564|Perampanel|perampanel
23640|NCT03424564|Pharmacokinetics|pharmacokinetics
23641|NCT03424564|E2007|e2007
23642|NCT03424564|Chinese|chinese
23643|NCT03424551|vibration|vibration
23644|NCT03424551|muscle spindle|muscle spindle
23645|NCT03424551|H reflex|h reflex
23646|NCT03424551|tonic vibration reflex|tonic vibration reflex
23647|NCT03424538|multiple sclerosis|multiple sclerosis
23648|NCT03424538|posture|posture
23649|NCT03424538|neurorehabilitation|neurorehabilitation
23650|NCT03424538|balance|balance
23651|NCT03424499|neurogenic bladder|neurogenic bladder
23652|NCT03424499|intermittent urethral catheterization|intermittent urethral catheterization
23653|NCT03424499|Clean intermittent catheterization|clean intermittent catheterization
23654|NCT03424486|Cystic fibrosis|cystic fibrosis
23655|NCT03424486|Anxiety|anxiety
23656|NCT03424486|Depression|depression
23657|NCT03424486|Adolescence|adolescence
23658|NCT03424473|tucatinib|tucatinib
23659|NCT03424473|Breast Cancer|breast cancer
23660|NCT03424473|ARRY-380|arry-380
23661|NCT03424473|ONT-380|ont-380
23662|NCT03424473|HER2 Positive Breast Carcinoma|her2 positive breast carcinoma
23663|NCT03424473|HER2 Positive Locally Advanced Breast Cancer|her2 positive locally advanced breast cancer
23664|NCT03424473|HER-2 Positive Breast Cancer|her-2 positive breast cancer
23665|NCT03424473|HER-2 Positive Locally Advanced Breast Cancer|her-2 positive locally advanced breast cancer
23666|NCT03424473|Recurrent Breast Carcinoma|recurrent breast carcinoma
23667|NCT03424473|Stage IV Breast Cancer|stage iv breast cancer
23668|NCT03424473|Metastatic Breast Cancer|metastatic breast cancer
23669|NCT03424473|Breast Carcinoma|breast carcinoma
23670|NCT03424473|Metastatic Malignant Neoplasm in the Brain|metastatic malignant neoplasm in the brain
23671|NCT03424473|Brain Metastases in Breast Cancer|brain metastases in breast cancer
23672|NCT03424473|Breast Neoplasms|breast neoplasms
23673|NCT03424473|Neoplasms by Site|neoplasms by site
23674|NCT03424473|Neoplasms|neoplasms
23675|NCT03424473|Breast Diseases|breast diseases
23676|NCT03424460|Myotonic dystrophy 1|myotonic dystrophy 1
23677|NCT03424460|Venous thromboembolism|venous thromboembolism
23678|NCT03424460|Pulmonary embolism|pulmonary embolism
23679|NCT03424460|Deep vein thrombosis|deep vein thrombosis
23680|NCT03424460|Hypercoagulability|hypercoagulability
23681|NCT03424460|Thrombophilia|thrombophilia
23682|NCT03424460|RNA alternative splicing|rna alternative splicing
23683|NCT03424434|Occupational blood exposure|occupational blood exposure
23684|NCT03424434|underreporting|underreporting
23685|NCT03424434|medical|medical
23686|NCT03424434|hospital|hospital
23687|NCT03424421|Shoulder Joint|shoulder joint
23688|NCT03424421|Orthopedics|orthopedics
23689|NCT03424421|Arthroscopy|arthroscopy
23690|NCT03424395|personalized dietary and wellness program|personalized dietary and wellness program
23691|NCT03424395|oral protein glucose lipid tolerance test|oral protein glucose lipid tolerance test
23692|NCT03424395|metabolism|metabolism
23693|NCT03424395|behavior|behavior
23694|NCT03424395|health|health
23695|NCT03424395|body composition|body composition
23696|NCT03424395|single nucleotide polymorphisms|single nucleotide polymorphisms
23697|NCT03424395|genotype|genotype
23698|NCT03424395|dietary and wellness coaching/advice|dietary and wellness coaching/advice
23699|NCT03424395|liquid meal challenge test|liquid meal challenge test
23701|NCT03424356|Rocuronium bromur|rocuronium bromur
23702|NCT03424356|propofol|propofol
23703|NCT03424343|survivors|survivors
23704|NCT03424343|parents|parents
23705|NCT03424343|sibling|sibling
23706|NCT03424343|family environment|family environment
23707|NCT03424343|psychosocial functioning|psychosocial functioning
23708|NCT03424343|longitudinal|longitudinal
23709|NCT03424343|cancer|cancer
23710|NCT03424343|identity|identity
23711|NCT03424343|adolescence|adolescence
23712|NCT03424343|emerging adulthood|emerging adulthood
23713|NCT03424278|Low back pain|low back pain
23714|NCT03424278|Exercise|exercise
23715|NCT03424252|Cystic Fibrosis|cystic fibrosis
23716|NCT03424239|Roux-en-Y gastric bypass|roux-en-y gastric bypass
23717|NCT03424174|TKA, cytokine, coating|tka, cytokine, coating
23718|NCT03424122|Diffuse large B-cell lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
23719|NCT03424122|follicular lymphoma (FL)|follicular lymphoma (fl)
23720|NCT03424122|marginal zone lymphoma (MZL)|marginal zone lymphoma (mzl)
23721|NCT03424122|mantle cell lymphoma (MCL)|mantle cell lymphoma (mcl)
23722|NCT03424122|phosphatidylinositol 3-kinase delta (PI3Kδ) inhibitor|phosphatidylinositol 3-kinase delta (pi3kδ) inhibitor
23723|NCT03424109|Emergency Department|emergency department
23724|NCT03424109|Palliative Care|palliative care
23726|NCT03424070|pediatric|pediatric
23727|NCT03424070|airway|airway
23728|NCT03424070|gel roll|gel roll
23729|NCT03424070|larynx|larynx
23730|NCT03424070|glottis|glottis
23731|NCT03424057|Karydakis modification|karydakis modification
23732|NCT03424057|pilonidal sinus|pilonidal sinus
23733|NCT03424057|seroma|seroma
23734|NCT03424044|glucagon|glucagon
23735|NCT03424044|closed-loop|closed-loop
23736|NCT03424044|Omnipod|omnipod
23737|NCT03424044|exercise|exercise
23738|NCT03424018|ACH|ach
23739|NCT03424018|Achondroplasia|achondroplasia
23740|NCT03424018|Bone Diseases|bone diseases
23741|NCT03424018|Bone Diseases, Developmental|bone diseases, developmental
23742|NCT03424018|Dwarfism|dwarfism
23743|NCT03424018|Genetic Diseases, Inborn|genetic diseases, inborn
23744|NCT03424018|Musculoskeletal Diseases|musculoskeletal diseases
23745|NCT03424018|Natriuretic Agents|natriuretic agents
23746|NCT03424018|Natriuretic Peptide, C-Type|natriuretic peptide, c-type
23747|NCT03424018|Osteochondrodysplasias|osteochondrodysplasias
23748|NCT03424018|Physiological Effects of Drugs|physiological effects of drugs
23749|NCT03424018|Skeletal Dysplasias|skeletal dysplasias
23750|NCT03423979|BPH|bph
23751|NCT03423953|osteoarthritis|osteoarthritis
23752|NCT03423953|avascular necrosis|avascular necrosis
23753|NCT03423953|rheumatoid arthritis|rheumatoid arthritis
23754|NCT03423940|Functional communication training|functional communication training
23755|NCT03423940|Reinforcement Schedule Thinning|reinforcement schedule thinning
23756|NCT03423940|Resurgence|resurgence
23757|NCT03423940|Treatment Dosage|treatment dosage
23758|NCT03423940|Treatment Relapse|treatment relapse
23759|NCT03423914|writing|writing
23760|NCT03423914|postraumatic stress|postraumatic stress
23761|NCT03423914|coping|coping
23762|NCT03423901|Complications|complications
23763|NCT03423888|Dyspnea|dyspnea
23764|NCT03423888|palliative care|palliative care
23765|NCT03423888|high-flow nasal oxygen|high-flow nasal oxygen
23766|NCT03423888|pilot study|pilot study
23767|NCT03423875|Delirium, Delirium Recognition|delirium, delirium recognition
23768|NCT03423823|Neovascularization|neovascularization
23769|NCT03423797|silver nitrate|silver nitrate
23770|NCT03423797|sodium fluoride|sodium fluoride
23771|NCT03423797|dental caries|dental caries
23772|NCT03423797|equivalence trial|equivalence trial
23773|NCT03423784|teething in infants and children|teething in infants and children
23774|NCT03423784|oral gels|oral gels
23775|NCT03423784|paediatric dentistry|paediatric dentistry
23776|NCT03423758|Pseudoexfoliation Glaucoma, Angle block glaucoma, Genetic|pseudoexfoliation glaucoma, angle block glaucoma, genetic
23777|NCT03423745|intubation|intubation
23778|NCT03423745|cardiopulmonary resuscitation|cardiopulmonary resuscitation
23779|NCT03423745|number of endotracheal intubation experience|number of endotracheal intubation experience
23780|NCT03423693|Small airway obstruction|small airway obstruction
23781|NCT03423693|Asthma|asthma
23782|NCT03423693|COPD|copd
23783|NCT03423693|ACOS|acos
23784|NCT03423667|N-acetylcysteine|n-acetylcysteine
23785|NCT03423667|Craving|craving
23786|NCT03423641|Drug-Related Side Effects and Adverse Reactions|drug-related side effects and adverse reactions
23787|NCT03423641|Antiviral Agents / Adverse Effects|antiviral agents / adverse effects
23788|NCT03423641|Antiviral Agents / Toxicity|antiviral agents / toxicity
23789|NCT03423641|Simeprevir|simeprevir
23790|NCT03423641|Sofosbuvir|sofosbuvir
23791|NCT03423641|Ledipasvir|ledipasvir
23792|NCT03423641|Ombitasvir|ombitasvir
23793|NCT03423641|Paritaprevir|paritaprevir
23794|NCT03423641|Ritonavir|ritonavir
23795|NCT03423641|Dasabuvir|dasabuvir
23796|NCT03423641|Daclatasvir|daclatasvir
23797|NCT03423641|Elbasvir|elbasvir
23798|NCT03423641|Grazoprevir|grazoprevir
23799|NCT03423641|Velpatasvir|velpatasvir
23800|NCT03423641|Ribavirin|ribavirin
23801|NCT03423628|glioblastoma|glioblastoma
23802|NCT03423628|brain metastases|brain metastases
23803|NCT03423628|Ataxia-telangiectasia mutated kinase (ATM) inhibition|ataxia-telangiectasia mutated kinase (atm) inhibition
23804|NCT03423628|radiation therapy|radiation therapy
23805|NCT03423615|School Health Services|school health services
23806|NCT03423615|Health Education|health education
23807|NCT03423615|Primary Schools|primary schools
23808|NCT03423615|Republic of India|republic of india
23809|NCT03423602|Percutaneous vascular closure device|percutaneous vascular closure device
23810|NCT03423602|Large hole closure device|large hole closure device
23811|NCT03423602|Arteriotomy closure|arteriotomy closure
23812|NCT03423602|Vascular closure device|vascular closure device
23813|NCT03423589|Siblings|siblings
23814|NCT03423576|health services|health services
23815|NCT03423576|FEV1|fev1
23816|NCT03423576|BMI|bmi
23817|NCT03423576|quality of life|quality of life
23818|NCT03423576|mental stress|mental stress
23819|NCT03423524|Intraocular lens|intraocular lens
23820|NCT03423524|Monofocal|monofocal
23821|NCT03423524|Hydrophobic|hydrophobic
23822|NCT03423511|MiStent|mistent
23823|NCT03423511|Coronary Artery Disease|coronary artery disease
23824|NCT03423511|Coronary Disease|coronary disease
23825|NCT03423511|Myocardial Ischemia|myocardial ischemia
23826|NCT03423511|Heart Disease|heart disease
23827|NCT03423511|Cardiovascular Diseases|cardiovascular diseases
23828|NCT03423511|Arteriosclerosis|arteriosclerosis
23829|NCT03423511|Arterial Occlusive Diseases|arterial occlusive diseases
23830|NCT03423511|Vascular Diseases|vascular diseases
23831|NCT03423498|hallux valgus,|hallux valgus,
23832|NCT03423498|toe-spread-out exercise|toe-spread-out exercise
23833|NCT03423498|abductor hallucis muscle|abductor hallucis muscle
23834|NCT03423498|surface electromyography|surface electromyography
23835|NCT03423485|Colorectal Surgery|colorectal surgery
23836|NCT03423472|Nutrition|nutrition
23837|NCT03423472|Women|women
23838|NCT03423472|Young children|young children
23839|NCT03423472|Ethiopia|ethiopia
23840|NCT03423472|Vitamin A|vitamin a
23841|NCT03423472|Orange flesh sweet potato|orange flesh sweet potato
23842|NCT03423433|Chronic|chronic
23843|NCT03423433|Stroke|stroke
23844|NCT03423433|Blood Pressure|blood pressure
23845|NCT03423433|Oxygen Perfusion|oxygen perfusion
23846|NCT03423433|Stroop|stroop
23847|NCT03423433|Cognitive Performance|cognitive performance
23848|NCT03423433|Cognition|cognition
23849|NCT03423394|Motivational enhancement therapy|motivational enhancement therapy
23850|NCT03423368|Libramed|libramed
23851|NCT03423368|Policaptil Gel Retard|policaptil gel retard
23852|NCT03423368|Overweight|overweight
23853|NCT03423368|Obesity|obesity
23854|NCT03423368|Medical Device|medical device
23855|NCT03423368|glycemic profile|glycemic profile
23856|NCT03423368|lipid profile|lipid profile
23857|NCT03423342|nicotinamide riboside|nicotinamide riboside
23858|NCT03423342|Nicotinamide-Adenine Dinucleotide|nicotinamide-adenine dinucleotide
23859|NCT03423303|Prostate cancer|prostate cancer
23860|NCT03423303|Screening|screening
23861|NCT03423303|Randomised trial|randomised trial
23862|NCT03423303|Kallikrein|kallikrein
23863|NCT03423303|Magnetic resonance imaging|magnetic resonance imaging
23864|NCT03423303|Prostate-specific antigen|prostate-specific antigen
23865|NCT03423264|HPV-related oropharyngeal cancer|hpv-related oropharyngeal cancer
23866|NCT03423264|oropharyngeal cancer|oropharyngeal cancer
23867|NCT03423264|HPV-related squamous cell carcinoma|hpv-related squamous cell carcinoma
23868|NCT03423264|prophylactic gabapentin|prophylactic gabapentin
23869|NCT03423264|Optima II study|optima ii study
23870|NCT03423238|Cardiac|cardiac
23871|NCT03423238|Rehab|rehab
23872|NCT03423238|Diet|diet
23873|NCT03423238|Exercise|exercise
23874|NCT03423238|Obese|obese
23875|NCT03423225|ADVAGRAF®|advagraf®
23876|NCT03423225|Liver Transplantation|liver transplantation
23877|NCT03423225|tacrolimus|tacrolimus
23878|NCT03423199|breast Cancer|breast cancer
23879|NCT03423199|palbociclib (PD-0332991)|palbociclib (pd-0332991)
23880|NCT03423199|tamoxifen|tamoxifen
23881|NCT03423199|goserelin|goserelin
23882|NCT03423199|any menopausal status|any menopausal status
23883|NCT03423199|hormone receptor positive|hormone receptor positive
23884|NCT03423199|HER2 negative|her2 negative
23885|NCT03423199|locally advanced|locally advanced
23886|NCT03423199|metastatic|metastatic
23887|NCT03423173|Vaccine|vaccine
23888|NCT03423147|Cesarean section|cesarean section
23889|NCT03423147|Labor|labor
23890|NCT03423147|Surgical Site Infections|surgical site infections
23891|NCT03423147|Chlorhexidine gluconate|chlorhexidine gluconate
23892|NCT03423108|Exercise|exercise
23893|NCT03423108|Aging|aging
23894|NCT03423108|Elderly|elderly
23895|NCT03423108|Physical Activity|physical activity
23896|NCT03423108|Cardiovascular Disease|cardiovascular disease
23897|NCT03423069|Irritable bowel syndrome|irritable bowel syndrome
23898|NCT03423069|FODMAPs|fodmaps
23899|NCT03423069|Dietary advice|dietary advice
23900|NCT03423069|Gastrointestinal symptoms|gastrointestinal symptoms
23901|NCT03423069|Intestinal permeability|intestinal permeability
23902|NCT03423069|Gastrointestinal peptides|gastrointestinal peptides
23903|NCT03423069|Microbiome|microbiome
23904|NCT03423069|Lipidomic profile|lipidomic profile
23905|NCT03423056|Gastrointestinal Neoplasms|gastrointestinal neoplasms
23906|NCT03423056|Exercise|exercise
23907|NCT03423056|Preoperative Period|preoperative period
23908|NCT03423056|Preoperative Care|preoperative care
23909|NCT03423017|Pierre Robin sequence|pierre robin sequence
23910|NCT03423017|Brainstem|brainstem
23911|NCT03423017|pathogenesis|pathogenesis
23912|NCT03423017|swallowing|swallowing
23913|NCT03423017|apnea|apnea
23914|NCT03423004|psoriasis|psoriasis
23915|NCT03423004|IL-22|il-22
23916|NCT03423004|miR-21|mir-21
23917|NCT03422991|Heart Failure|heart failure
23918|NCT03422991|Heart Diseases|heart diseases
23919|NCT03422991|Cardiovascular Diseases|cardiovascular diseases
23920|NCT03422991|Vascular Diseases|vascular diseases
23921|NCT03422991|Cohort|cohort
23922|NCT03422978|Dexmedetomidine|dexmedetomidine
23923|NCT03422965|Retina|retina
23924|NCT03422965|OCT|oct
23925|NCT03422965|Optical Coherence Tomography|optical coherence tomography
23926|NCT03422965|Optical Coherence Tomography Angiography|optical coherence tomography angiography
23927|NCT03422965|Systemic|systemic
23928|NCT03422965|Blood|blood
23929|NCT03422965|Diabetes Mellitus|diabetes mellitus
23930|NCT03422965|Diabetic Retinopathy|diabetic retinopathy
23931|NCT03422939|FBDG|fbdg
23932|NCT03422939|dietitians|dietitians
23933|NCT03422939|portion sizes|portion sizes
23934|NCT03422939|time frame|time frame
23935|NCT03422939|visual references|visual references
23936|NCT03422887|postoperative pain|postoperative pain
23937|NCT03422887|general anesthesia|general anesthesia
23938|NCT03422887|postoperative discomfort|postoperative discomfort
23939|NCT03422874|Advanced Solid Tumors|advanced solid tumors
23940|NCT03422874|Lymphoma|lymphoma
23941|NCT03422874|Nelfinavir|nelfinavir
23942|NCT03422874|MLN9708|mln9708
23943|NCT03422874|proteasome inhibitor|proteasome inhibitor
23944|NCT03422861|Nabilone|nabilone
23945|NCT03422861|Inflammatory Bowel Disease|inflammatory bowel disease
23946|NCT03422861|Opioid|opioid
23947|NCT03422848|hydration|hydration
23948|NCT03422848|water|water
23949|NCT03422848|vasopressin|vasopressin
23950|NCT03422848|copeptin|copeptin
23951|NCT03422848|glucose|glucose
23952|NCT03422848|OGTT|ogtt
23953|NCT03422848|insulin|insulin
23954|NCT03422848|glucagon|glucagon
23955|NCT03422835|transanal surgery|transanal surgery
23956|NCT03422835|robotic surgery|robotic surgery
23957|NCT03422835|total mesorectal excision|total mesorectal excision
23958|NCT03422822|atopic dermatitis|atopic dermatitis
23959|NCT03422822|atopic eczema|atopic eczema
23960|NCT03422822|eczema|eczema
23961|NCT03422822|JAK|jak
23962|NCT03422822|janus kinase|janus kinase
23963|NCT03422809|Plasma volume, micronutrient, estrogen, progesterone|plasma volume, micronutrient, estrogen, progesterone
23964|NCT03422783|Monitoring|monitoring
23965|NCT03422783|Biomarker|biomarker
23966|NCT03422783|Thoracoscopy|thoracoscopy
23967|NCT03422770|Myocardium|myocardium
23968|NCT03422770|Predictive Value of Tests|predictive value of tests
23969|NCT03422770|Prognosis|prognosis
23970|NCT03422770|Clinical Decision-making|clinical decision-making
23971|NCT03422770|Heart Ventricles|heart ventricles
23972|NCT03422770|Echocardiography|echocardiography
23973|NCT03422718|stroke|stroke
23974|NCT03422718|hypertension|hypertension
23975|NCT03422692|Resorbable membrane, amnion-chorion membrane, collagen membrane, ridge preservation.|resorbable membrane, amnion-chorion membrane, collagen membrane, ridge preservation.
23976|NCT03422679|advanced solid tumours|advanced solid tumours
23977|NCT03422679|haematological malignancies|haematological malignancies
23978|NCT03422679|phase I/II|phase i/ii
23979|NCT03422679|NOTCH pathway|notch pathway
23980|NCT03422679|pan-NOTCH inhibitor|pan-notch inhibitor
23981|NCT03422666|Intestinal lipoprotein|intestinal lipoprotein
23982|NCT03422666|Gut Peptide|gut peptide
23983|NCT03422666|Chylomicrons|chylomicrons
23984|NCT03422653|Hemodialysis|hemodialysis
23985|NCT03422640|Frontal Fibrosing Alopecia|frontal fibrosing alopecia
23986|NCT03422640|Apremilast|apremilast
23987|NCT03422549|diaphragm|diaphragm
23988|NCT03422549|non-invasive ventilation|non-invasive ventilation
23989|NCT03422549|high-frequency oscillation|high-frequency oscillation
23990|NCT03422549|CPAP|cpap
23991|NCT03422536|Head and Neck Cancer|head and neck cancer
23992|NCT03422536|Oropharyngeal Cancer|oropharyngeal cancer
23993|NCT03422536|Squamous Cell Carcinoma|squamous cell carcinoma
23994|NCT03422536|lip carcinoma|lip carcinoma
23995|NCT03422536|oral cavity carcinoma|oral cavity carcinoma
23996|NCT03422536|HNSCC|hnscc
23997|NCT03422536|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
23998|NCT03422536|AVEO|aveo
23999|NCT03422523|Refractory|refractory
24000|NCT03422523|Relapsed|relapsed
24001|NCT03422523|Hematological cancer|hematological cancer
24002|NCT03422510|FSGS|fsgs
24003|NCT03422510|Kidney Disease|kidney disease
24004|NCT03422510|Proteinuria|proteinuria
24005|NCT03422510|Nephrotic Syndrome|nephrotic syndrome
24006|NCT03422510|FIRSTx|firstx
24007|NCT03422510|Nitro fatty acids|nitro fatty acids
24008|NCT03422510|OA-NO2|oa-no2
24009|NCT03422510|10-nitro oleic acid|10-nitro oleic acid
24010|NCT03422510|Nitro oleic acid|nitro oleic acid
24011|NCT03422484|Internal medecine unit|internal medecine unit
24012|NCT03422484|Medication Error|medication error
24013|NCT03422484|Clinical Pharmacist|clinical pharmacist
24014|NCT03422484|Medication reconciliation|medication reconciliation
24015|NCT03422445|Apatinib|apatinib
24016|NCT03422445|Temozolomide|temozolomide
24017|NCT03422445|Advanced Melanoma|advanced melanoma
24018|NCT03422406|Iodine excess|iodine excess
24019|NCT03422406|Cause|cause
24020|NCT03422406|Pregnancy|pregnancy
24021|NCT03422406|Urinary iodine concentration|urinary iodine concentration
24022|NCT03422406|Serum iodine concentration|serum iodine concentration
24023|NCT03422406|Breast milk iodine concentration|breast milk iodine concentration
24024|NCT03422393|venetoclax|venetoclax
24025|NCT03422393|ibrutinib|ibrutinib
24026|NCT03422393|high-dose ibrutinib|high-dose ibrutinib
24027|NCT03422393|chronic lymphocytic leukemia|chronic lymphocytic leukemia
24028|NCT03422393|progressive disease|progressive disease
24029|NCT03422393|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
24030|NCT03422393|cancer|cancer
24031|NCT03422380|energy expenditure|energy expenditure
24032|NCT03422380|adaptive thermogenesis|adaptive thermogenesis
24033|NCT03422380|metabolic adaptation|metabolic adaptation
24034|NCT03422380|weight loss maintenance|weight loss maintenance
24035|NCT03422367|autism|autism
24036|NCT03422367|epilepsy|epilepsy
24037|NCT03422367|asd|asd
24038|NCT03422367|TSC|tsc
24039|NCT03422367|UCLA|ucla
24040|NCT03422367|Los Angeles|los angeles
24041|NCT03422367|JASPER|jasper
24042|NCT03422367|intervention|intervention
24043|NCT03422367|Boston|boston
24044|NCT03422367|BCH|bch
24045|NCT03422367|MGH|mgh
24046|NCT03422328|macitentan|macitentan
24047|NCT03422328|long-term safety|long-term safety
24048|NCT03422328|open-label|open-label
24049|NCT03422328|single-arm|single-arm
24050|NCT03422315|Propofol|propofol
24051|NCT03422315|Population pharmacokinetics|population pharmacokinetics
24052|NCT03422315|Individualized administration|individualized administration
24053|NCT03422302|Malignant neoplasms of respiratory and intrathoracic organs|malignant neoplasms of respiratory and intrathoracic organs
24054|NCT03422302|Lung cancer|lung cancer
24055|NCT03422302|Continuous Positive Airway Pressure Device|continuous positive airway pressure device
24056|NCT03422302|CPAP|cpap
24057|NCT03422302|Deep inspiration breath hold|deep inspiration breath hold
24058|NCT03422302|DIBH|dibh
24059|NCT03422289|myo-inositol|myo-inositol
24060|NCT03422289|alpha-lactalbumin|alpha-lactalbumin
24061|NCT03422289|anovulation|anovulation
24062|NCT03422289|infertility|infertility
24063|NCT03422276|Transition|transition
24064|NCT03422276|Rehabilitation Discharge|rehabilitation discharge
24065|NCT03422263|Type 2 diabetes mellitus, SGLT-2-Inhibitors, Empagliflozin, Canagliflozin, Dapagliflozin, 6-minute walk test.|type 2 diabetes mellitus, sglt-2-inhibitors, empagliflozin, canagliflozin, dapagliflozin, 6-minute walk test.
24066|NCT03422172|GSK1265744|gsk1265744
24067|NCT03422172|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
24068|NCT03422172|Human immunodeficiency virus|human immunodeficiency virus
24069|NCT03422172|Cabotegravir|cabotegravir
24070|NCT03422172|Pharmacokinetics|pharmacokinetics
24071|NCT03422120|Immune Suppression|immune suppression
24072|NCT03422120|Natural Killer Cell Mediated Immunity|natural killer cell mediated immunity
24073|NCT03422120|Natural Killer Cell Cytokine Production|natural killer cell cytokine production
24074|NCT03422120|Perioperative/Postoperative Complications|perioperative/postoperative complications
24075|NCT03422107|Peripheral Nerve Injuries|peripheral nerve injuries
24076|NCT03422107|Thoracic Surgery|thoracic surgery
24077|NCT03422107|Minimally invasive cardiac surgery|minimally invasive cardiac surgery
24078|NCT03422081|endothelial dysfunction|endothelial dysfunction
24079|NCT03422081|doppler ultrasound examination|doppler ultrasound examination
24080|NCT03422081|nitric oxide|nitric oxide
24081|NCT03422055|safety 99mTc-Fucoïdane scintigraphy|safety 99mtc-fucoïdane scintigraphy
24082|NCT03422029|ORR|orr
24083|NCT03422029|Safety|safety
24084|NCT03422029|PFS|pfs
24085|NCT03422016|electroretinogram|electroretinogram
24086|NCT03422003|Breast Cancer|breast cancer
24087|NCT03422003|Radiation|radiation
24088|NCT03422003|Hypofractionation|hypofractionation
24089|NCT03422003|Randomization|randomization
24090|NCT03421951|spine|spine
24091|NCT03421951|lower limb|lower limb
24092|NCT03421938|total knee arthroplasty|total knee arthroplasty
24093|NCT03421938|walking exercises|walking exercises
24094|NCT03421938|uphill-downhill walking exercises|uphill-downhill walking exercises
24095|NCT03421938|functional level|functional level
24096|NCT03421912|Prevention strategy|prevention strategy
24097|NCT03421912|Cutaneous toxicity|cutaneous toxicity
24098|NCT03421912|Quality of life|quality of life
24099|NCT03421912|Patient satisfaction|patient satisfaction
24100|NCT03421912|Dermatology Life Quality Index (DLQI)|dermatology life quality index (dlqi)
24101|NCT03421912|Epidermal Repair Score (SCOREPI)|epidermal repair score (scorepi)
24102|NCT03421912|Topical treatment|topical treatment
24103|NCT03421899|Mitochondria|mitochondria
24104|NCT03421899|Mitochondrial dysfunction|mitochondrial dysfunction
24105|NCT03421899|Parkin|parkin
24106|NCT03421899|PINK1|pink1
24107|NCT03421860|Spinal anesthesia|spinal anesthesia
24108|NCT03421860|cardiac output|cardiac output
24109|NCT03421860|vasopressor|vasopressor
24110|NCT03421847|depression|depression
24111|NCT03421847|vestibular disorder|vestibular disorder
24112|NCT03421847|rotatory test|rotatory test
24113|NCT03421847|electronystagmography|electronystagmography
24114|NCT03421834|Ventricular Tachycardia|ventricular tachycardia
24115|NCT03421834|Ischemic Cardiomyopathy|ischemic cardiomyopathy
24116|NCT03421834|Primary prevention|primary prevention
24117|NCT03421834|Heart Failure|heart failure
24118|NCT03421821|quadratus lumborum block|quadratus lumborum block
24119|NCT03421821|anterior thoracolumbar fascia|anterior thoracolumbar fascia
24120|NCT03421821|subfascial injection|subfascial injection
24121|NCT03421821|extrafascial injection|extrafascial injection
24122|NCT03421808|TMS|tms
24123|NCT03421808|transcranial magnetic stimulation|transcranial magnetic stimulation
24124|NCT03421808|brain stimulation|brain stimulation
24125|NCT03421795|pain assessment/management|pain assessment/management
24126|NCT03421795|developmental disabilities|developmental disabilities
24127|NCT03421795|children|children
24128|NCT03421795|education|education
24129|NCT03421795|respite workers|respite workers
24130|NCT03421730|mild asthma|mild asthma
24131|NCT03421730|budesonide|budesonide
24132|NCT03421730|nebulizer|nebulizer
24133|NCT03421730|pediatric|pediatric
24134|NCT03421730|pharmacokinetics|pharmacokinetics
24135|NCT03421665|titanium wedge|titanium wedge
24136|NCT03421665|Evans|evans
24137|NCT03421665|Cotton|cotton
24138|NCT03421613|PHN, acute, herpes zoster|phn, acute, herpes zoster
24139|NCT03421600|image enhanced endoscopy|image enhanced endoscopy
24140|NCT03421600|colonoscopy|colonoscopy
24141|NCT03421600|colonic polyp|colonic polyp
24142|NCT03421600|colonic adenoma|colonic adenoma
24143|NCT03421535|Glenohumeral internal rotational deficit|glenohumeral internal rotational deficit
24144|NCT03421535|GIRD|gird
24145|NCT03421535|Sleeper stretch|sleeper stretch
24146|NCT03421535|SI joint stretch|si joint stretch
24147|NCT03421522|PPSP|ppsp
24148|NCT03421522|ICBN|icbn
24149|NCT03421509|cutaneous silent period|cutaneous silent period
24150|NCT03421509|spasticity|spasticity
24151|NCT03421509|stroke|stroke
24152|NCT03421483|Folate|folate
24153|NCT03421483|Absorption|absorption
24154|NCT03421483|Metabolism|metabolism
24155|NCT03421483|Colon|colon
24156|NCT03421483|Receptor|receptor
24157|NCT03421483|Enzyme|enzyme
24158|NCT03421457|Pelvic Organ Prolapse|pelvic organ prolapse
24159|NCT03421457|Translabial ultrasound|translabial ultrasound
24160|NCT03421457|Transperineal ultrasound|transperineal ultrasound
24161|NCT03421457|Lateral Mesh Suspension|lateral mesh suspension
24162|NCT03421457|Descensus uteri|descensus uteri
24163|NCT03421457|Laparoscopic pelvic organ prolapse repair|laparoscopic pelvic organ prolapse repair
24164|NCT03421457|Uterus preserving|uterus preserving
24165|NCT03421457|hysteropexy|hysteropexy
24166|NCT03421457|uterine-preserving|uterine-preserving
24167|NCT03421457|fertility-sparing|fertility-sparing
24168|NCT03421457|sacropexy|sacropexy
24169|NCT03421457|cervicopexy|cervicopexy
24170|NCT03421457|sacrocervicopexy|sacrocervicopexy
24171|NCT03421457|sacrohysteropexy|sacrohysteropexy
24172|NCT03421457|mesh prolapse surgery|mesh prolapse surgery
24173|NCT03421444|Children|children
24174|NCT03421444|Obesity|obesity
24175|NCT03421444|Metabolic Disease|metabolic disease
24176|NCT03421431|NASH|nash
24177|NCT03421431|Non-Alcoholic Steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
24178|NCT03421392|constitutive thrombocytopenia|constitutive thrombocytopenia
24179|NCT03421392|central thrombocytopenia|central thrombocytopenia
24180|NCT03421392|platelets|platelets
24181|NCT03421392|sialylation|sialylation
24182|NCT03421392|flow cytometry|flow cytometry
24183|NCT03421366|posaconazole|posaconazole
24184|NCT03421353|AZD9150|azd9150
24185|NCT03421353|Durvalumab|durvalumab
24186|NCT03421353|NSCLC|nsclc
24187|NCT03421353|Non-small-cell lung cancer|non-small-cell lung cancer
24188|NCT03421353|Advanced solid malignancies|advanced solid malignancies
24189|NCT03421340|ERCP|ercp
24190|NCT03421340|DSC|dsc
24191|NCT03421340|Spy Glass|spy glass
24192|NCT03421340|Biliary Stones|biliary stones
24193|NCT03421340|Choledocholithiasis|choledocholithiasis
24194|NCT03421340|Non-Complex|non-complex
24195|NCT03421340|Stones|stones
24196|NCT03421301|gut microbiota|gut microbiota
24197|NCT03421301|functional foods|functional foods
24198|NCT03421301|branched chain amino acids|branched chain amino acids
24199|NCT03421301|TMAO|tmao
24200|NCT03421301|type 2 diabetes|type 2 diabetes
24201|NCT03421275|fentanyl|fentanyl
24202|NCT03421275|esketamine|esketamine
24203|NCT03421275|ketamine|ketamine
24204|NCT03421275|analgesia|analgesia
24205|NCT03421275|acute pain|acute pain
24206|NCT03421275|minor trauma|minor trauma
24207|NCT03421184|autoimmune disease|autoimmune disease
24208|NCT03421184|endocrine disruptors|endocrine disruptors
24209|NCT03421184|isoflavones|isoflavones
24210|NCT03421184|lignans|lignans
24211|NCT03421184|diet exposure|diet exposure
24212|NCT03421184|risk factor|risk factor
24213|NCT03421158|neonates|neonates
24214|NCT03421158|Non-pharmacological|non-pharmacological
24215|NCT03421119|type 2 diabetes|type 2 diabetes
24216|NCT03421119|liraglutide|liraglutide
24217|NCT03421119|efficacy|efficacy
24218|NCT03421119|safety|safety
24219|NCT03421106|Food insecurity|food insecurity
24220|NCT03421106|Food pantries|food pantries
24221|NCT03421093|Lung cancer|lung cancer
24222|NCT03421093|Chinese|chinese
24223|NCT03421093|surgeries|surgeries
24224|NCT03421093|adjuvant therapies|adjuvant therapies
24225|NCT03421015|localized prostate cancer|localized prostate cancer
24226|NCT03421015|prostatectomy|prostatectomy
24227|NCT03421015|biomarkers|biomarkers
24228|NCT03421015|metastatic recurrence|metastatic recurrence
24229|NCT03421015|genomic|genomic
24230|NCT03421002|candida meningitis|candida meningitis
24231|NCT03421002|Mycamine|mycamine
24232|NCT03421002|candidiasis, systemic|candidiasis, systemic
24233|NCT03421002|micafungin|micafungin
24234|NCT03420989|carob|carob
24235|NCT03420989|seaweed|seaweed
24236|NCT03420989|snack food|snack food
24237|NCT03420989|obese subjects|obese subjects
24338|NCT03420300|Hemodialysis|hemodialysis
24238|NCT03420976|Small Intestinal Bacterial Overgrowth|small intestinal bacterial overgrowth
24239|NCT03420976|SIBO|sibo
24240|NCT03420963|Natural killer cells|natural killer cells
24241|NCT03420963|NK cells|nk cells
24242|NCT03420963|Cyclophosphamide|cyclophosphamide
24243|NCT03420963|Cytoxan|cytoxan
24244|NCT03420963|Neosar|neosar
24245|NCT03420963|Etoposide|etoposide
24246|NCT03420963|VePesid|vepesid
24247|NCT03420937|deep neuromuscular block|deep neuromuscular block
24248|NCT03420937|laparoscopic surgery|laparoscopic surgery
24249|NCT03420937|robotic surgery|robotic surgery
24250|NCT03420937|lung protective ventilation|lung protective ventilation
24251|NCT03420937|respiratory functions|respiratory functions
24252|NCT03420937|post-operative recovery|post-operative recovery
24253|NCT03420924|intraoperative hypothermia|intraoperative hypothermia
24254|NCT03420924|thermal suit|thermal suit
24255|NCT03420924|forced-air warming|forced-air warming
24256|NCT03420911|pain|pain
24257|NCT03420911|anxiety|anxiety
24258|NCT03420911|emergency department|emergency department
24259|NCT03420911|pain management|pain management
24260|NCT03420885|Ba Duan Jin|ba duan jin
24261|NCT03420885|Pulmonary Nodules|pulmonary nodules
24262|NCT03420885|Clinical Intervention|clinical intervention
24263|NCT03420872|Nutrition|nutrition
24264|NCT03420872|Nutrients|nutrients
24265|NCT03420872|Mixtures|mixtures
24266|NCT03420872|Neurodevelopment|neurodevelopment
24267|NCT03420872|Prenatal|prenatal
24268|NCT03420872|Children|children
24269|NCT03420820|intravitreal injection|intravitreal injection
24270|NCT03420820|povidone-iodine|povidone-iodine
24271|NCT03420820|ocular surface flora|ocular surface flora
24272|NCT03420820|endophthalmitis|endophthalmitis
24273|NCT03420820|betadine|betadine
24274|NCT03420781|diabetic gastroparesis|diabetic gastroparesis
24275|NCT03420781|vomiting|vomiting
24276|NCT03420742|Drug therapy, brigatinib, lung cancer, ALK, ROS1|drug therapy, brigatinib, lung cancer, alk, ros1
24277|NCT03420716|functional foods|functional foods
24278|NCT03420716|dairy foods|dairy foods
24279|NCT03420716|calcium absorption|calcium absorption
24280|NCT03420716|prebiotics and probiotics|prebiotics and probiotics
24281|NCT03420716|young women|young women
24282|NCT03420716|bone health|bone health
24283|NCT03420703|erector spinae plane block|erector spinae plane block
24284|NCT03420703|laparoscopic cholecystectomy|laparoscopic cholecystectomy
24285|NCT03420703|postoperative pain|postoperative pain
24286|NCT03420664|cast|cast
24287|NCT03420664|orthosis|orthosis
24288|NCT03420664|immobilisation|immobilisation
24289|NCT03420664|venous stasis|venous stasis
24290|NCT03420664|circulation|circulation
24291|NCT03420638|Adults|adults
24292|NCT03420638|Pain|pain
24293|NCT03420625|Intermittent Pneumatic Compression Devices|intermittent pneumatic compression devices
24294|NCT03420625|Electric Stimulation Therapy|electric stimulation therapy
24295|NCT03420625|Blood Flow Velocity|blood flow velocity
24296|NCT03420625|Hemodynamics|hemodynamics
24297|NCT03420599|Gut microbiota|gut microbiota
24298|NCT03420599|Splenectomy|splenectomy
24299|NCT03420599|Infection|infection
24300|NCT03420599|Immune|immune
24301|NCT03420599|Cytokines|cytokines
24302|NCT03420586|Anesthetics, Inhalation|anesthetics, inhalation
24303|NCT03420586|Anesthesia Recovery Period|anesthesia recovery period
24304|NCT03420586|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
24305|NCT03420586|Pain, Postoperative|pain, postoperative
24306|NCT03420508|Ensartinib|ensartinib
24307|NCT03420508|ALK Inhibitor|alk inhibitor
24308|NCT03420508|ALK Alterations|alk alterations
24309|NCT03420508|Aberrant ALK Expression|aberrant alk expression
24310|NCT03420508|17-471|17-471
24311|NCT03420495|OCD|ocd
24312|NCT03420495|Intolerance of Uncertainty|intolerance of uncertainty
24313|NCT03420482|Microbiome|microbiome
24314|NCT03420482|Fecal Microbiota Transplant|fecal microbiota transplant
24315|NCT03420443|radiotherapy, probiotics|radiotherapy, probiotics
24316|NCT03420417|Mechanical ventilation|mechanical ventilation
24317|NCT03420391|phototherapy|phototherapy
24318|NCT03420391|performance|performance
24319|NCT03420391|muscular recovery|muscular recovery
24320|NCT03420391|photobiomodulation therapy|photobiomodulation therapy
24321|NCT03420391|time-window|time-window
24322|NCT03420378|Central Sensitisation|central sensitisation
24323|NCT03420378|Cutaneous Silent Period|cutaneous silent period
24324|NCT03420378|Vitamin D Deficiency|vitamin d deficiency
24325|NCT03420339|stimulant medication|stimulant medication
24326|NCT03420339|behavioral function|behavioral function
24327|NCT03420339|preferences|preferences
24328|NCT03420339|delay discounting|delay discounting
24329|NCT03420326|Atrial Fibrillation|atrial fibrillation
24330|NCT03420326|Frailty status|frailty status
24331|NCT03420326|Body composition|body composition
24332|NCT03420326|Sarcopenia|sarcopenia
24333|NCT03420313|buprenorphine|buprenorphine
24334|NCT03420313|waitlist|waitlist
24335|NCT03420313|interim treatment|interim treatment
24336|NCT03420313|opioid use disorder|opioid use disorder
24337|NCT03420300|Hepatitis C virus|hepatitis c virus
24339|NCT03420300|Direct acting antiviral agent|direct acting antiviral agent
24340|NCT03420274|Shared decision-making|shared decision-making
24341|NCT03420274|Prenatal genetic testing|prenatal genetic testing
24342|NCT03420274|Noninvasive prenatal testing (NIPT)|noninvasive prenatal testing (nipt)
24343|NCT03420274|Cell free fetal DNA (cfDNA)|cell free fetal dna (cfdna)
24344|NCT03420274|Informed consent|informed consent
24345|NCT03420261|Goal-directed therapy|goal-directed therapy
24346|NCT03420261|Fluid loading|fluid loading
24347|NCT03420261|Abdominal surgery|abdominal surgery
24348|NCT03420261|Postoperative morbidity|postoperative morbidity
24349|NCT03420261|Postoperative mortality|postoperative mortality
24350|NCT03420261|Individualized goal-directed fluid therapy|individualized goal-directed fluid therapy
24351|NCT03420261|Elective or emergency abdominal surgery|elective or emergency abdominal surgery
24352|NCT03420261|General Anesthesia|general anesthesia
24353|NCT03420261|Moderate-to-high risk surgical patients|moderate-to-high risk surgical patients
24354|NCT03420235|quality of life|quality of life
24355|NCT03420235|eHealth|ehealth
24356|NCT03420235|patient-reported outcomes|patient-reported outcomes
24357|NCT03420235|home spirometry|home spirometry
24358|NCT03420235|cost-effectiveness|cost-effectiveness
24359|NCT03420235|home monitoring|home monitoring
24360|NCT03420222|Intermittent Explosive Disorder|intermittent explosive disorder
24361|NCT03420222|AVP-786|avp-786
24362|NCT03420209|proprioceptive neuromuscular facilitation|proprioceptive neuromuscular facilitation
24363|NCT03420209|respiratory functions|respiratory functions
24364|NCT03420209|elastic band|elastic band
24365|NCT03420209|posture|posture
24366|NCT03420196|low back pain|low back pain
24367|NCT03420196|physical therapy|physical therapy
24368|NCT03420196|randomized clinical trial|randomized clinical trial
24369|NCT03420196|exercise program|exercise program
24370|NCT03420183|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
24371|NCT03420183|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
24372|NCT03420183|Mantle cell lymphoma|mantle cell lymphoma
24373|NCT03420183|Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1)|receptor tyrosine kinase-like orphan receptor 1 (ror1)
24374|NCT03420183|Bruton Tyrosine Kinase (BTK)|bruton tyrosine kinase (btk)
24375|NCT03420183|Leukemia, lymphoid|leukemia, lymphoid
24376|NCT03420183|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
24377|NCT03420183|Leukemia|leukemia
24378|NCT03420183|Lymphoma|lymphoma
24379|NCT03420183|Lymphoma, mantle cell|lymphoma, mantle cell
24380|NCT03420183|Neoplasms by histologic type|neoplasms by histologic type
24381|NCT03420183|Neoplasms|neoplasms
24382|NCT03420183|Lymphoproliferative Disorders|lymphoproliferative disorders
24383|NCT03420183|Lymphatic Diseases|lymphatic diseases
24384|NCT03420183|Immunoproliferative Disorders|immunoproliferative disorders
24385|NCT03420183|Immune System Diseases|immune system diseases
24386|NCT03420183|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
24387|NCT03420170|Spinal Cord Injuries|spinal cord injuries
24388|NCT03420170|Physical Fitness|physical fitness
24389|NCT03420170|Exercise Self-Efficacy|exercise self-efficacy
24390|NCT03420170|Physical Activity|physical activity
24391|NCT03420157|Cervical cancer screening|cervical cancer screening
24392|NCT03420157|vaginal self-sampling|vaginal self-sampling
24393|NCT03420157|Focus group|focus group
24394|NCT03420157|communication|communication
24395|NCT03420144|Growth hormone|growth hormone
24396|NCT03420144|cirrhosis|cirrhosis
24397|NCT03420131|instantaneous Flow Ratio|instantaneous flow ratio
24398|NCT03420131|Quantitative Flow Ratio|quantitative flow ratio
24399|NCT03420131|Fractional Flow Reserve|fractional flow reserve
24400|NCT03420092|vasoactive leukotrienes by leukocytes|vasoactive leukotrienes by leukocytes
24401|NCT03420092|bioavailability|bioavailability
24402|NCT03420053|PfSPZ Vaccine|pfspz vaccine
24403|NCT03420053|HIV+|hiv+
24404|NCT03420053|Plasmodium falciparum|plasmodium falciparum
24405|NCT03420053|Sporozoites|sporozoites
24406|NCT03420040|Glargine Insulin|glargine insulin
24407|NCT03420040|QS-M Needle Free Injector|qs-m needle free injector
24408|NCT03420027|predictive score|predictive score
24409|NCT03420027|difficult intubation|difficult intubation
24410|NCT03420001|VBAC, levator ani avulsion, quality of life|vbac, levator ani avulsion, quality of life
24411|NCT03419988|Nrf2|nrf2
24412|NCT03419949|pain|pain
24413|NCT03419936|Stomach Neoplasms|stomach neoplasms
24414|NCT03419936|Helicobacter pylori|helicobacter pylori
24415|NCT03419936|Subtotal gastrectomy|subtotal gastrectomy
24416|NCT03419897|Advanced liver cancer|advanced liver cancer
24417|NCT03419871|economically stressed communities|economically stressed communities
24418|NCT03419858|Pain|pain
24419|NCT03419858|Slow-Breathing|slow-breathing
24420|NCT03419858|Mindfulness|mindfulness
24421|NCT03419858|Opioids|opioids
24422|NCT03419858|Placebo|placebo
24423|NCT03419832|ARIC|aric
24424|NCT03419819|Phenylketonuria|phenylketonuria
24425|NCT03419819|GMP|gmp
24426|NCT03419819|Sphere|sphere
24427|NCT03419819|Child|child
24428|NCT03419819|Adult|adult
24429|NCT03419819|Phenylalanine|phenylalanine
24430|NCT03419819|PKU|pku
24431|NCT03419819|Glycomacropeptide|glycomacropeptide
24930|NCT03416829|Ambulatory|ambulatory
24432|NCT03419767|carotid stenosis|carotid stenosis
24433|NCT03419767|melatonin|melatonin
24434|NCT03419767|insulin resistance|insulin resistance
24435|NCT03419767|inflammation|inflammation
24436|NCT03419767|carotid revascularization|carotid revascularization
24437|NCT03419767|antioxidants|antioxidants
24438|NCT03419741|Cancer, Nicotine Addiction, Smoking Cessation|cancer, nicotine addiction, smoking cessation
24439|NCT03419728|Teen pregnancy prevention|teen pregnancy prevention
24440|NCT03419728|Long-acting reversible contraception (LARCs)|long-acting reversible contraception (larcs)
24441|NCT03419728|Healthy Families Healthy Futures|healthy families healthy futures
24442|NCT03419728|Home visiting|home visiting
24443|NCT03419715|migraine|migraine
24444|NCT03419715|headache|headache
24445|NCT03419715|bimatoprost|bimatoprost
24446|NCT03419676|Pancreatoduodenectomy|pancreatoduodenectomy
24447|NCT03419676|Postoperative pancreatic fistula|postoperative pancreatic fistula
24448|NCT03419676|Sealant|sealant
24449|NCT03419676|Hemopatch|hemopatch
24450|NCT03419663|cereal|cereal
24451|NCT03419663|whole grain|whole grain
24452|NCT03419663|refined grain|refined grain
24453|NCT03419663|gastric cancer|gastric cancer
24454|NCT03419663|meta analysis|meta analysis
24455|NCT03419650|PsA|psa
24456|NCT03419624|Dapagliflozin|dapagliflozin
24457|NCT03419624|Exenatide|exenatide
24458|NCT03419624|high-dose insulin therapy|high-dose insulin therapy
24459|NCT03419624|SGLT-2 inhibitor|sglt-2 inhibitor
24460|NCT03419624|GLP-1 receptor agonist|glp-1 receptor agonist
24461|NCT03419611|Communication Intervention|communication intervention
24462|NCT03419598|virtual clinical trial|virtual clinical trial
24463|NCT03419598|high tibial osteotomy|high tibial osteotomy
24464|NCT03419598|3D|3d
24465|NCT03419598|computer simulation|computer simulation
24466|NCT03419598|finite element analysis|finite element analysis
24467|NCT03419598|medial unicompartmental knee osteoarthritis|medial unicompartmental knee osteoarthritis
24468|NCT03419559|LN-145|ln-145
24469|NCT03419559|Cell Therapy|cell therapy
24470|NCT03419559|Autologous Adoptive Cell Transfer|autologous adoptive cell transfer
24471|NCT03419559|Cellular Immuno-therapy|cellular immuno-therapy
24472|NCT03419559|TIL|til
24473|NCT03419559|IL-2|il-2
24474|NCT03419559|Durvalumab|durvalumab
24475|NCT03419520|Schoolchildren|schoolchildren
24476|NCT03419520|Overweight|overweight
24477|NCT03419520|Obesity|obesity
24478|NCT03419520|Polymorphisms|polymorphisms
24479|NCT03419520|Genetics|genetics
24480|NCT03419520|Nutritional counseling|nutritional counseling
24481|NCT03419520|Healthy strategies|healthy strategies
24482|NCT03419507|endotracheal tube introducer|endotracheal tube introducer
24483|NCT03419507|manikin|manikin
24484|NCT03419507|chest compression|chest compression
24485|NCT03419455|Obesity|obesity
24486|NCT03419455|Lifelong Obesity|lifelong obesity
24487|NCT03419455|Metabolic abnormalties|metabolic abnormalties
24488|NCT03419455|Low-grade chronic inflammation|low-grade chronic inflammation
24489|NCT03419455|Hyperinsulinemia|hyperinsulinemia
24490|NCT03419455|IGF signalling|igf signalling
24491|NCT03419455|Sex hormones|sex hormones
24492|NCT03419455|Inflammatory response|inflammatory response
24493|NCT03419455|Adipokines|adipokines
24494|NCT03419455|Diet|diet
24495|NCT03419442|Prostate cancer|prostate cancer
24496|NCT03419442|Bone metastases|bone metastases
24497|NCT03419442|Xofigo|xofigo
24498|NCT03419429|Guided tissue membranes|guided tissue membranes
24499|NCT03419429|EDTA|edta
24500|NCT03419429|Simvastatin|simvastatin
24501|NCT03419403|Glioblastoma Multiforme (GBM)|glioblastoma multiforme (gbm)
24502|NCT03419403|cancer|cancer
24503|NCT03419403|chemoradiation therapy|chemoradiation therapy
24504|NCT03419403|epidermal growth factor receptor-amplified glioblastoma|epidermal growth factor receptor-amplified glioblastoma
24505|NCT03419403|radiation|radiation
24506|NCT03419403|temozolomide|temozolomide
24507|NCT03419390|Hydra01|hydra01
24508|NCT03419377|Treatment|treatment
24509|NCT03419377|Quality of Life|quality of life
24510|NCT03419377|Sexology|sexology
24511|NCT03419377|Women|women
24512|NCT03419338|Maxillary Sinus|maxillary sinus
24513|NCT03419338|Sinus lifting|sinus lifting
24514|NCT03419338|Bone graft|bone graft
24515|NCT03419325|percutaneous coronary interventions (PCI)|percutaneous coronary interventions (pci)
24516|NCT03419325|secondary stroke prevention|secondary stroke prevention
24517|NCT03419325|dual antiplatelet therapy (DAPT)|dual antiplatelet therapy (dapt)
24518|NCT03419312|Spinal Cord Stimulation|spinal cord stimulation
24519|NCT03419312|Burst Spinal Cord Stimulation|burst spinal cord stimulation
24520|NCT03419312|SCS|scs
24521|NCT03419260|seizures|seizures
24522|NCT03419260|status epilepticus|status epilepticus
24523|NCT03419260|EEG monitoring|eeg monitoring
24524|NCT03419221|Staphylococcus aureus|staphylococcus aureus
24525|NCT03419221|bloodstream infection|bloodstream infection
24526|NCT03419221|deep foci of infection|deep foci of infection
24527|NCT03419221|18 FDG PET/CT|18 fdg pet/ct
24528|NCT03419221|antibiotics|antibiotics
24529|NCT03419208|Systemic Sclerosis|systemic sclerosis
24530|NCT03419208|Scleroderma|scleroderma
24531|NCT03419208|Hand Function|hand function
24532|NCT03419208|Intervention|intervention
24533|NCT03419208|Exercise|exercise
24534|NCT03419208|Telerehabilitation|telerehabilitation
24535|NCT03419208|eHealth|ehealth
24536|NCT03419208|Physical Therapy|physical therapy
24537|NCT03419195|Type 2 Diabetes|type 2 diabetes
24538|NCT03419195|Overweight|overweight
24539|NCT03419195|Exercise Training|exercise training
24540|NCT03419195|Exercise Impairment|exercise impairment
24541|NCT03419195|Healthy Control|healthy control
24542|NCT03419195|Veteran|veteran
24543|NCT03419195|Blood Flow|blood flow
24544|NCT03419182|Geriatric|geriatric
24545|NCT03419182|Acetabular|acetabular
24546|NCT03419182|Arthroplasty|arthroplasty
24547|NCT03419169|Patient|patient
24548|NCT03419169|Rehabilitation|rehabilitation
24549|NCT03419169|Ligament reconstruction|ligament reconstruction
24550|NCT03419169|Surgery|surgery
24551|NCT03419156|text message|text message
24552|NCT03419156|telemedicine|telemedicine
24553|NCT03419104|bariatric surgery|bariatric surgery
24554|NCT03419104|extubation|extubation
24555|NCT03419091|ureteroscopy|ureteroscopy
24556|NCT03419091|lithovue|lithovue
24557|NCT03419091|nephrolithiasis|nephrolithiasis
24558|NCT03419091|single use ureteroscope|single use ureteroscope
24559|NCT03419078|enteral nutrition|enteral nutrition
24560|NCT03419078|parenteral nutrition|parenteral nutrition
24561|NCT03419078|artificial nutrition support|artificial nutrition support
24562|NCT03419078|non-relapse mortality|non-relapse mortality
24563|NCT03419078|survival|survival
24564|NCT03419039|Mild Cognitive Impairment|mild cognitive impairment
24565|NCT03419000|GTCS|gtcs
24566|NCT03419000|Epilepsies, Partial|epilepsies, partial
24567|NCT03419000|Drug Resistant Epilepsy|drug resistant epilepsy
24568|NCT03419000|Circulating MicroRNA|circulating microrna
24569|NCT03419000|Diagnostic|diagnostic
24570|NCT03418987|3D imaging|3d imaging
24571|NCT03418987|vertebral vector|vertebral vector
24572|NCT03418987|Scoliosis|scoliosis
24573|NCT03418974|Dyslipidemia|dyslipidemia
24574|NCT03418974|Cardiovascular Diseases|cardiovascular diseases
24575|NCT03418974|Hypertension|hypertension
24576|NCT03418974|LDL-C|ldl-c
24577|NCT03418935|obstructive jaundice, non-malignant|obstructive jaundice, non-malignant
24578|NCT03418935|mechanical jaundice, non-malignant|mechanical jaundice, non-malignant
24579|NCT03418935|Methionine|methionine
24580|NCT03418935|Succinic acid|succinic acid
24581|NCT03418883|Stroke|stroke
24582|NCT03418883|rehabilitation|rehabilitation
24583|NCT03418883|mirror therapy|mirror therapy
24584|NCT03418883|upper limb|upper limb
24585|NCT03418870|Intensive Care Units, Neonatal|intensive care units, neonatal
24586|NCT03418870|Parents|parents
24587|NCT03418870|Mobile application|mobile application
24588|NCT03418857|probiotics|probiotics
24589|NCT03418857|Human|human
24590|NCT03418857|obesity|obesity
24591|NCT03418857|non-pharmacologic therapy|non-pharmacologic therapy
24592|NCT03418857|gut health|gut health
24593|NCT03418857|microbiome|microbiome
24594|NCT03418857|inflammation|inflammation
24595|NCT03418831|negtive symptoms|negtive symptoms
24596|NCT03418831|cognitive function|cognitive function
24597|NCT03418818|hypoxia|hypoxia
24598|NCT03418818|sarcoma|sarcoma
24599|NCT03418818|FAZA|faza
24600|NCT03418818|PET Imaging|pet imaging
24601|NCT03418805|Ibuprofen|ibuprofen
24602|NCT03418805|Controlled-Release|controlled-release
24603|NCT03418805|pain control|pain control
24604|NCT03418805|Healthy Volunteers|healthy volunteers
24605|NCT03418805|Food Effect|food effect
24606|NCT03418779|decoction|decoction
24607|NCT03418779|immunosuppressive therapy|immunosuppressive therapy
24608|NCT03418766|Right-to-left Shunt|right-to-left shunt
24609|NCT03418766|Brain White Matter Lesions|brain white matter lesions
24610|NCT03418766|Migraine|migraine
24611|NCT03418753|noninvasive diagnosis|noninvasive diagnosis
24612|NCT03418740|Friedreich|friedreich
24613|NCT03418740|Ataxia|ataxia
24614|NCT03418740|FRDA|frda
24615|NCT03418740|FA|fa
24616|NCT03418740|Friedrich Ataxia (FRDA)|friedrich ataxia (frda)
24617|NCT03418701|Women's health|women's health
24618|NCT03418662|Colonoscopy|colonoscopy
24619|NCT03418649|low back pain|low back pain
24620|NCT03418649|radicular pain|radicular pain
24621|NCT03418649|degenerative disc disease|degenerative disc disease
24622|NCT03418636|People who inject drugs|people who inject drugs
24623|NCT03418636|Hepatitis C prevention|hepatitis c prevention
24624|NCT03418636|Young adults|young adults
24625|NCT03418636|Behavioral interventions|behavioral interventions
24626|NCT03418623|Glutamate|glutamate
24627|NCT03418623|Alcohol use|alcohol use
24628|NCT03418623|GABA|gaba
24629|NCT03418623|GET73|get73
24630|NCT03418623|Non-treatment seeking|non-treatment seeking
24631|NCT03418610|Rosacea|rosacea
24632|NCT03418597|Virtual reality|virtual reality
24633|NCT03418597|Radio-guided biopsy|radio-guided biopsy
24634|NCT03418597|Pain|pain
24635|NCT03418597|Anxiety|anxiety
24636|NCT03418597|Patient's satisfaction|patient's satisfaction
24637|NCT03418584|argon plasma coagulation|argon plasma coagulation
24638|NCT03418584|submucosal injection|submucosal injection
24639|NCT03418584|Barrett Esophagus|barrett esophagus
24640|NCT03418558|HER2 AMPLIFICATION|her2 amplification
24641|NCT03418532|DARPin®protein|darpin®protein
24642|NCT03418532|MP0250|mp0250
24643|NCT03418532|VEGF|vegf
24644|NCT03418532|HGF|hgf
24645|NCT03418532|NSCLC|nsclc
24646|NCT03418532|EGFR mutated|egfr mutated
24647|NCT03418532|Osimertinib|osimertinib
24648|NCT03418506|Smokeless tobacco|smokeless tobacco
24649|NCT03418506|adolescent|adolescent
24650|NCT03418506|oral cancer|oral cancer
24651|NCT03418506|betal quid|betal quid
24652|NCT03418506|areca nut|areca nut
24653|NCT03418467|Tachycardiomyopathy|tachycardiomyopathy
24654|NCT03418467|atrial fibrillation|atrial fibrillation
24655|NCT03418467|EMID (enrichment of mitochondria at the intercalated discs)|emid (enrichment of mitochondria at the intercalated discs)
24656|NCT03418467|Biopsy|biopsy
24657|NCT03418467|empathy|empathy
24658|NCT03418441|Nationwide prospective observational cohort study|nationwide prospective observational cohort study
24659|NCT03418441|Epidemiology|epidemiology
24660|NCT03418441|Central Nervous System Infections|central nervous system infections
24661|NCT03418441|Meningitis|meningitis
24662|NCT03418441|Encephalitis|encephalitis
24663|NCT03418441|Brain abscess|brain abscess
24664|NCT03418441|Lyme disease|lyme disease
24665|NCT03418441|Neuroborreliosis|neuroborreliosis
24666|NCT03418441|Neurosyphilis|neurosyphilis
24667|NCT03418441|Tertiary syphilis|tertiary syphilis
24668|NCT03418363|Oral contraceptives|oral contraceptives
24669|NCT03418363|Venous thromboembolism|venous thromboembolism
24670|NCT03418363|androgenic combined oral contraception|androgenic combined oral contraception
24671|NCT03418337|cough, dexlansoprazole, GERD, globus, non-cardiac chest pain|cough, dexlansoprazole, gerd, globus, non-cardiac chest pain
24672|NCT03418324|Prostate Cancer|prostate cancer
24673|NCT03418324|Metastatic Prostate Cancer|metastatic prostate cancer
24674|NCT03418324|Castration Resistant Prostate Cancer|castration resistant prostate cancer
24675|NCT03418324|Metastatic Castration Resistant|metastatic castration resistant
24676|NCT03418311|Twin pregnancy|twin pregnancy
24677|NCT03418311|Cervical Pessary|cervical pessary
24678|NCT03418311|short cervix|short cervix
24679|NCT03418311|Prevention|prevention
24680|NCT03418272|ICU|icu
24681|NCT03418272|OR|or
24682|NCT03418272|Pneumonia|pneumonia
24683|NCT03418272|PICU|picu
24684|NCT03418272|Pediatric|pediatric
24685|NCT03418272|PCR|pcr
24686|NCT03418246|gingiva|gingiva
24687|NCT03418246|plaque|plaque
24688|NCT03418246|pocket depth|pocket depth
24689|NCT03418220|Age related Macular Degeneration|age related macular degeneration
24690|NCT03418220|Atrophy|atrophy
24691|NCT03418220|Inflammation|inflammation
24692|NCT03418220|Cytokines|cytokines
24693|NCT03418220|test LUMINEX®|test luminex®
24694|NCT03418207|TPS system|tps system
24695|NCT03418207|trans-perineal template-guided mapping biopsy|trans-perineal template-guided mapping biopsy
24696|NCT03418207|prostate cancer|prostate cancer
24697|NCT03418207|spatial distribution|spatial distribution
24698|NCT03418207|large tissue slice|large tissue slice
24699|NCT03418194|Anesthesia, General|anesthesia, general
24700|NCT03418181|Residual Kidney Function|residual kidney function
24701|NCT03418181|Haemodialysis|haemodialysis
24702|NCT03418181|Preserve Residual Kidney Function|preserve residual kidney function
24703|NCT03418129|Military Veterans|military veterans
24704|NCT03418051|Ankle Instability|ankle instability
24705|NCT03418051|Manual Therapy|manual therapy
24706|NCT03418051|Massage|massage
24707|NCT03418051|Ankle Joint Mobilization|ankle joint mobilization
24708|NCT03418051|Biomechanics|biomechanics
24709|NCT03418051|Neuromuscular|neuromuscular
24710|NCT03418012|Cervical Pessary|cervical pessary
24711|NCT03418012|Short Cervix|short cervix
24712|NCT03418012|Recurrent Preterm Birth|recurrent preterm birth
24713|NCT03418012|history of cervical surgery|history of cervical surgery
24714|NCT03418012|history of conisation|history of conisation
24715|NCT03417999|Intranasal|intranasal
24716|NCT03417999|Pharmacokinetic|pharmacokinetic
24717|NCT03417999|Pediatric|pediatric
24718|NCT03417986|Thiethylperazine|thiethylperazine
24719|NCT03417986|Alzheimer Disease|alzheimer disease
24720|NCT03417973|dorsal root ganglion|dorsal root ganglion
24721|NCT03417960|post partum depression|post partum depression
24722|NCT03417960|theta burst|theta burst
24723|NCT03417960|transcranial magnetic stimulation|transcranial magnetic stimulation
24724|NCT03417947|Bolus supplementation|bolus supplementation
24725|NCT03417947|Pilot randomised controlled trial|pilot randomised controlled trial
24726|NCT03417947|Vitamin D|vitamin d
24727|NCT03417908|Proprioceptive neuromuscular facilitation|proprioceptive neuromuscular facilitation
24728|NCT03417908|Pulmonary Rehabilitation|pulmonary rehabilitation
24729|NCT03417908|muscle activation|muscle activation
24730|NCT03417908|COPD|copd
24731|NCT03417882|PD-L1+|pd-l1+
24732|NCT03417856|Ichthyosis|ichthyosis
24733|NCT03417856|Netherton Syndrome|netherton syndrome
24734|NCT03417843|ablation catheter|ablation catheter
24735|NCT03417843|pancreatic premalignant and early malignant cystic lesion|pancreatic premalignant and early malignant cystic lesion
24736|NCT03417830|miridesap|miridesap
24737|NCT03417830|GSK2315698|gsk2315698
24738|NCT03417830|89Zirconium labelled|89zirconium labelled
24739|NCT03417830|Positron Emission Tomography|positron emission tomography
24740|NCT03417830|Transthyretin cardiomyopathy|transthyretin cardiomyopathy
24741|NCT03417830|GSK2398852|gsk2398852
24742|NCT03417830|dezamizumab|dezamizumab
24743|NCT03417791|recovery|recovery
24744|NCT03417791|serum creatinine|serum creatinine
24745|NCT03417765|gastrointestinal mucositis|gastrointestinal mucositis
24746|NCT03417765|myeloablative chemotherapy|myeloablative chemotherapy
24747|NCT03417765|autologous transplantation|autologous transplantation
24748|NCT03417739|Uveal Melanoma|uveal melanoma
24749|NCT03417726|Cerebral Palsy|cerebral palsy
24750|NCT03417726|Balance|balance
24751|NCT03417700|vitamin D|vitamin d
24752|NCT03417700|exercise|exercise
24753|NCT03417700|training|training
24754|NCT03417700|aging|aging
24755|NCT03417648|Rheumatoid Arthritis, Diet, Fat-Restricted, Diet, Vegetarian|rheumatoid arthritis, diet, fat-restricted, diet, vegetarian
24756|NCT03417635|Meditation|meditation
24757|NCT03417635|Cognitive assessment|cognitive assessment
24758|NCT03417635|Executive function|executive function
24759|NCT03417635|Older adults|older adults
24760|NCT03417635|Randomized control trial|randomized control trial
24761|NCT03417635|Mobility|mobility
24762|NCT03417622|resection margin|resection margin
24763|NCT03417622|neoadjuvant therapy|neoadjuvant therapy
24764|NCT03417622|breast conservative surgery|breast conservative surgery
24765|NCT03417622|locally advanced breast cancer|locally advanced breast cancer
24766|NCT03417609|Sarcopenia|sarcopenia
24767|NCT03417609|Tongue strength|tongue strength
24768|NCT03417544|HER2-positive metastatic Breast Cancer|her2-positive metastatic breast cancer
24769|NCT03417544|Central Nervous System Metastases|central nervous system metastases
24770|NCT03417531|Protein supplementation|protein supplementation
24771|NCT03417531|Home exercise program|home exercise program
24772|NCT03417531|Falls prevention|falls prevention
24773|NCT03417531|Seniors|seniors
24774|NCT03417531|Autonomy|autonomy
24775|NCT03417518|Oxidative stress|oxidative stress
24776|NCT03417518|Bariatric surgery|bariatric surgery
24777|NCT03417505|Contact lens discomfort|contact lens discomfort
24778|NCT03417505|Scleral lens|scleral lens
24779|NCT03417505|Tangible Hydra-PEG|tangible hydra-peg
24780|NCT03417492|TBI|tbi
24781|NCT03417492|CVR|cvr
24782|NCT03417492|Hypercapnia|hypercapnia
24783|NCT03417492|fNIRS|fnirs
24784|NCT03417492|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
24785|NCT03417492|American football|american football
24786|NCT03417466|Diabetes Type I Type II|diabetes type i type ii
24787|NCT03417453|normal patients|normal patients
24788|NCT03417453|eye drops dispensers|eye drops dispensers
24789|NCT03417453|aids|aids
24790|NCT03417453|glacuoma|glacuoma
24791|NCT03417453|cataract|cataract
24792|NCT03417440|smartphone app, physical activity, older adults|smartphone app, physical activity, older adults
24793|NCT03417427|acute myeloid leukemia|acute myeloid leukemia
24794|NCT03417427|Intermediate-risk|intermediate-risk
24795|NCT03417427|demethylation drug|demethylation drug
24796|NCT03417427|complete remission|complete remission
24797|NCT03417388|Coronary Angiography|coronary angiography
24798|NCT03417388|Coronary CT Angiogram|coronary ct angiogram
24799|NCT03417388|Ischemia|ischemia
24800|NCT03417388|Non-obstructive CAD|non-obstructive cad
24801|NCT03417362|education|education
24802|NCT03417362|audiovisual|audiovisual
24803|NCT03417362|information|information
24804|NCT03417362|acceptability|acceptability
24805|NCT03417349|Acute Ischemic Stroke|acute ischemic stroke
24806|NCT03417349|Thrombectomy|thrombectomy
24807|NCT03417349|Aspiration Thrombectomy|aspiration thrombectomy
24808|NCT03417349|Observational study|observational study
24809|NCT03417310|closed reduction|closed reduction
24810|NCT03417310|locked intramedullary nailing|locked intramedullary nailing
24811|NCT03417284|Multiple Myeloma|multiple myeloma
24812|NCT03417284|MM|mm
24813|NCT03417284|Evomela|evomela
24814|NCT03417284|Melphalan|melphalan
24815|NCT03417284|Alkeran|alkeran
24816|NCT03417284|G-CSF|g-csf
24817|NCT03417284|Filgrastim|filgrastim
24818|NCT03417284|Neupogen|neupogen
24819|NCT03417284|Stem cell transplant|stem cell transplant
24820|NCT03417258|phytoestrogens|phytoestrogens
24821|NCT03417258|isoflavones|isoflavones
24822|NCT03417258|adenomatous polyps|adenomatous polyps
24823|NCT03417258|microbiome|microbiome
24824|NCT03417245|RNAi therapeutic|rnai therapeutic
24825|NCT03417245|Hemophilia A|hemophilia a
24826|NCT03417245|Hemophilia B|hemophilia b
24827|NCT03417245|Hemophilia A, Severe|hemophilia a, severe
24828|NCT03417245|Hemophilia B, Severe|hemophilia b, severe
24829|NCT03417245|Blood Coagulation Disorders, Inherited|blood coagulation disorders, inherited
24830|NCT03417245|Blood Coagulation Disorders|blood coagulation disorders
24831|NCT03417245|Hematologic Diseases|hematologic diseases
24931|NCT03416829|Biofeedback|biofeedback
24832|NCT03417245|Coagulation Protein Disorders|coagulation protein disorders
24833|NCT03417245|Hemorrhagic Disorders|hemorrhagic disorders
24834|NCT03417245|Genetic Diseases, Inborn|genetic diseases, inborn
24835|NCT03417245|Genetic Diseases, X-Linked|genetic diseases, x-linked
24836|NCT03417245|Factor VIII|factor viii
24837|NCT03417245|Factor IX|factor ix
24838|NCT03417245|Coagulants|coagulants
24839|NCT03417245|Fitusiran|fitusiran
24840|NCT03417232|gingival recession|gingival recession
24841|NCT03417232|coronally advanced flap|coronally advanced flap
24842|NCT03417232|complete root coverage|complete root coverage
24843|NCT03417232|flap elevation|flap elevation
24844|NCT03417232|flap thickness|flap thickness
24845|NCT03417219|Caregivers|caregivers
24846|NCT03417219|Family|family
24847|NCT03417219|Veterans|veterans
24848|NCT03417219|Alzheimer Disease|alzheimer disease
24849|NCT03417219|Memory|memory
24850|NCT03417206|Pupillary Dilatation Reflex (PRD)|pupillary dilatation reflex (prd)
24851|NCT03417206|Intraoperative Blood Loss (IBL)|intraoperative blood loss (ibl)
24852|NCT03417206|Boezaart Bleeding Scale (BBS)|boezaart bleeding scale (bbs)
24853|NCT03417206|Spectral Entropy (SE)|spectral entropy (se)
24854|NCT03417206|Adequacy of Anaesthesia (AoA)|adequacy of anaesthesia (aoa)
24855|NCT03417206|Total Intravenous Anaesthesia (TIVA)|total intravenous anaesthesia (tiva)
24856|NCT03417206|Sevoflurane|sevoflurane
24857|NCT03417206|Desflurane|desflurane
24858|NCT03417193|Lidocaine|lidocaine
24859|NCT03417193|Dexmedetomidine|dexmedetomidine
24860|NCT03417193|Opioid-free|opioid-free
24861|NCT03417180|Surgical Pleth Index (SPI)|surgical pleth index (spi)
24862|NCT03417180|Intraoperative Blood Loss (IBL)|intraoperative blood loss (ibl)
24863|NCT03417180|Boezaart Bleeding Scale (BBS)|boezaart bleeding scale (bbs)
24864|NCT03417180|Spectral Entropy (SE)|spectral entropy (se)
24865|NCT03417180|Adequacy of Anaesthesia (AoA)|adequacy of anaesthesia (aoa)
24866|NCT03417180|Total Intravenous Anaesthesia (TIVA)|total intravenous anaesthesia (tiva)
24867|NCT03417180|Sevoflurane|sevoflurane
24868|NCT03417180|Desflurane|desflurane
24869|NCT03417167|synovial biopsy|synovial biopsy
24870|NCT03417167|US guided synovial biopsy|us guided synovial biopsy
24872|NCT03417154|MDS|mds
24873|NCT03417141|Valchor|valchor
24874|NCT03417115|Breast Cancer|breast cancer
24875|NCT03417115|Epidemiology|epidemiology
24876|NCT03417115|Registry|registry
24877|NCT03417115|Health Services Research|health services research
24878|NCT03417115|Germany|germany
24879|NCT03417115|Palliative Treatment|palliative treatment
24880|NCT03417102|RNAi therapeutic|rnai therapeutic
24881|NCT03417102|Hemophilia A|hemophilia a
24882|NCT03417102|Hemophilia B|hemophilia b
24883|NCT03417102|Hemophilia A, Severe|hemophilia a, severe
24884|NCT03417102|Hemophilia B, Severe|hemophilia b, severe
24885|NCT03417102|Blood Coagulation Disorders, Inherited|blood coagulation disorders, inherited
24886|NCT03417102|Blood Coagulation Disorders|blood coagulation disorders
24887|NCT03417102|Hematologic Diseases|hematologic diseases
24888|NCT03417102|Coagulation Protein Disorders|coagulation protein disorders
24889|NCT03417102|Hemorrhagic Disorders|hemorrhagic disorders
24890|NCT03417102|Genetic Diseases, Inborn|genetic diseases, inborn
24891|NCT03417102|Genetic Diseases, X-Linked|genetic diseases, x-linked
24892|NCT03417102|Factor VIII|factor viii
24893|NCT03417102|Factor IX|factor ix
24894|NCT03417102|Inhibitor|inhibitor
24895|NCT03417102|Bypassing agents|bypassing agents
24896|NCT03417102|Coagulants|coagulants
24897|NCT03417102|Fitusiran|fitusiran
24898|NCT03417063|Intracranial artery|intracranial artery
24899|NCT03417063|Atherosclerosis|atherosclerosis
24900|NCT03417063|Intracranial artery stenosis|intracranial artery stenosis
24901|NCT03417063|High-Resolution Magnetic Resonance|high-resolution magnetic resonance
24902|NCT03417050|coronary artery bypass grafting|coronary artery bypass grafting
24903|NCT03417050|percutaneous coronary intervention|percutaneous coronary intervention
24904|NCT03417050|drug eluting stent|drug eluting stent
24905|NCT03417050|survival status|survival status
24906|NCT03417050|long-term follow-up|long-term follow-up
24907|NCT03417050|complex coronary artery disease|complex coronary artery disease
24908|NCT03416998|Photherapy|photherapy
24909|NCT03416998|Photobiomodulation|photobiomodulation
24910|NCT03416998|Creatine Kinase|creatine kinase
24911|NCT03416998|Soccer|soccer
24912|NCT03416998|Muscle Recovery|muscle recovery
24913|NCT03416946|Total knee replacement|total knee replacement
24914|NCT03416933|ctDNA|ctdna
24915|NCT03416933|MAPK inhibition|mapk inhibition
24916|NCT03416933|BRAF(V600) mutated|braf(v600) mutated
24917|NCT03416907|Informed consent|informed consent
24918|NCT03416881|HIV infection|hiv infection
24919|NCT03416881|antiretroviral|antiretroviral
24920|NCT03416881|aging population|aging population
24921|NCT03416881|drug interactions|drug interactions
24922|NCT03416881|cross-sectional study|cross-sectional study
24923|NCT03416881|SNIIRAM|sniiram
24924|NCT03416868|Ambulatory|ambulatory
24925|NCT03416868|Biofeedback|biofeedback
24926|NCT03416868|Voice|voice
24927|NCT03416842|outpatient|outpatient
24928|NCT03416842|wearable sensors|wearable sensors
24929|NCT03416842|home exercise|home exercise
24932|NCT03416829|Voice|voice
24933|NCT03416816|DSP-0337|dsp-0337
24934|NCT03416790|Central Nervous System|central nervous system
24935|NCT03416790|HIV Persistence|hiv persistence
24936|NCT03416790|HIV Reservoirs|hiv reservoirs
24937|NCT03416777|vegetarian|vegetarian
24938|NCT03416777|meat|meat
24939|NCT03416777|fish|fish
24940|NCT03416764|PTSD, neurofeedback (NF)|ptsd, neurofeedback (nf)
24941|NCT03416712|Social Determinants of Health|social determinants of health
24942|NCT03416699|Transnal Total Mesorectal Excision|transnal total mesorectal excision
24943|NCT03416699|Rectal Cancer|rectal cancer
24944|NCT03416686|differentiated thyroid cancer|differentiated thyroid cancer
24945|NCT03416686|Radiofrequency|radiofrequency
24946|NCT03416660|Fractional laser|fractional laser
24947|NCT03416660|Postburn scar|postburn scar
24948|NCT03416660|Density|density
24949|NCT03416647|Superior Mesenteric Artery Syndrome|superior mesenteric artery syndrome
24950|NCT03416647|Chronic duodenal obstruction|chronic duodenal obstruction
24951|NCT03416647|Duodenojejunostomy|duodenojejunostomy
24952|NCT03416647|Wilkie's syndrome|wilkie's syndrome
24953|NCT03416634|Health promotion|health promotion
24954|NCT03416634|Behavioral research|behavioral research
24955|NCT03416634|Preventive medicine|preventive medicine
24956|NCT03416634|Obesity|obesity
24957|NCT03416634|Cardiovascular disease|cardiovascular disease
24958|NCT03416621|Light Smoker|light smoker
24959|NCT03416608|ultrasound|ultrasound
24960|NCT03416608|patient experience|patient experience
24961|NCT03416608|diagnostic test|diagnostic test
24962|NCT03416608|general practice|general practice
24963|NCT03416608|family medicine|family medicine
24964|NCT03416595|probiotic|probiotic
24965|NCT03416595|Lactobacillus paracasei N1115|lactobacillus paracasei n1115
24966|NCT03416595|young children|young children
24967|NCT03416543|Rheumatoid arthritis|rheumatoid arthritis
24968|NCT03416543|Dendritics cells|dendritics cells
24969|NCT03416517|Ewing Sarcoma|ewing sarcoma
24970|NCT03416517|Anlotinib|anlotinib
24971|NCT03416517|Irinotecan|irinotecan
24972|NCT03416517|Refractory|refractory
24973|NCT03416517|Metastatic|metastatic
24974|NCT03416504|OCD|ocd
24975|NCT03416491|Chronic hepatitis C|chronic hepatitis c
24976|NCT03416491|Hepatitis C virus|hepatitis c virus
24977|NCT03416491|KW-136|kw-136
24978|NCT03416491|sofosbuvir|sofosbuvir
24979|NCT03416491|nonstructural protein 5A|nonstructural protein 5a
24980|NCT03416491|nonstructural protein 5B|nonstructural protein 5b
24981|NCT03416491|panogentypic regimen|panogentypic regimen
24982|NCT03416478|Colorectal Cancer|colorectal cancer
24983|NCT03416478|ctDNA|ctdna
24984|NCT03416478|Surveillance|surveillance
24985|NCT03416465|hospitalization|hospitalization
24986|NCT03416465|cancer|cancer
24987|NCT03416465|general practitioner|general practitioner
24988|NCT03416452|Gait|gait
24989|NCT03416452|Parkinson's Disease|parkinson's disease
24990|NCT03416426|patent foramen ovale|patent foramen ovale
24991|NCT03416426|PFO closure|pfo closure
24992|NCT03416426|residual shunt|residual shunt
24993|NCT03416426|bubble contrast transesophageal echocardiography|bubble contrast transesophageal echocardiography
24994|NCT03416400|Vitrification|vitrification
24995|NCT03416400|In vitro maturation|in vitro maturation
24996|NCT03416400|Cytoskeleton|cytoskeleton
24997|NCT03416400|chromosomes|chromosomes
24998|NCT03416400|High resolution imaging|high resolution imaging
24999|NCT03416387|complex liver surgery|complex liver surgery
25000|NCT03416387|3D printing|3d printing
25001|NCT03416361|Left ventricular dysfunction|left ventricular dysfunction
25002|NCT03416361|Vitamin D|vitamin d
25003|NCT03416348|amputation|amputation
25004|NCT03416348|amputations|amputations
25005|NCT03416348|sweating|sweating
25006|NCT03416348|residual limb|residual limb
25007|NCT03416348|service members|service members
25008|NCT03416348|civilians|civilians
25009|NCT03416335|DSP-0509|dsp-0509
25010|NCT03416322|Adenoma|adenoma
25011|NCT03416322|Adenoma detection rate|adenoma detection rate
25012|NCT03416322|Colorectal cancer|colorectal cancer
25013|NCT03416309|pharmacokinetics|pharmacokinetics
25014|NCT03416309|pharmacogenetics|pharmacogenetics
25015|NCT03416309|Time To Positivity|time to positivity
25016|NCT03416270|SGLT2 inhibtion|sglt2 inhibtion
25017|NCT03416270|Ertugliflozin|ertugliflozin
25018|NCT03416270|Type 2 Diabetes|type 2 diabetes
25019|NCT03416270|Heart Failure|heart failure
25020|NCT03416231|apatinib|apatinib
25021|NCT03416231|Docetaxel|docetaxel
25022|NCT03416218|STEM Skills|stem skills
25023|NCT03416192|Dialysis|dialysis
25024|NCT03416192|MCO|mco
25025|NCT03416192|Middle molecules|middle molecules
25026|NCT03416179|glasdegib;|glasdegib;
25027|NCT03416179|untreated;|untreated;
25028|NCT03416179|Hedgehog Inhibitor|hedgehog inhibitor
25029|NCT03416166|Tricuspid Valve|tricuspid valve
25030|NCT03416166|tricuspid regurgitation|tricuspid regurgitation
25031|NCT03416166|transcatheter tricuspid regurgitation|transcatheter tricuspid regurgitation
25032|NCT03416127|Diabetes Mellitus type 2|diabetes mellitus type 2
25033|NCT03416127|Glycemic control|glycemic control
25034|NCT03416127|Propolis|propolis
25035|NCT03416127|Metformin|metformin
25036|NCT03416114|rare headaches|rare headaches
25037|NCT03416114|epidemiology|epidemiology
25038|NCT03416101|esophageal cancer|esophageal cancer
25039|NCT03416101|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
25040|NCT03416101|esophageal surgery|esophageal surgery
25041|NCT03416088|wine,coffee,reading,retinal microcirculation,optical coherence tomography angiography|wine,coffee,reading,retinal microcirculation,optical coherence tomography angiography
25042|NCT03416062|Jaundice, obstructive|jaundice, obstructive
25043|NCT03416062|Methionine|methionine
25044|NCT03416062|Succinic acid|succinic acid
25045|NCT03416049|ulcers|ulcers
25046|NCT03416049|leg ulcers|leg ulcers
25047|NCT03416049|venous stasis|venous stasis
25048|NCT03416049|ulcer treatment|ulcer treatment
25049|NCT03416049|leg ulcer treatment|leg ulcer treatment
25050|NCT03416049|venous stasis treatment|venous stasis treatment
25051|NCT03416049|non invasive treatment|non invasive treatment
25052|NCT03416049|pulsed electromagnetic|pulsed electromagnetic
25053|NCT03416049|pulsed electromagnetic therapy|pulsed electromagnetic therapy
25054|NCT03416049|pulsed electromagnetic treatment|pulsed electromagnetic treatment
25055|NCT03416049|pulsed magnetic|pulsed magnetic
25056|NCT03416049|pulsed magnetic therapy|pulsed magnetic therapy
25057|NCT03416049|pulsed magnetic treatment|pulsed magnetic treatment
25058|NCT03416049|varicose Ulcer|varicose ulcer
25059|NCT03416049|ulcer pain|ulcer pain
25060|NCT03416023|Implant|implant
25061|NCT03416023|continence control|continence control
25062|NCT03416023|titanium|titanium
25063|NCT03416010|emotional distress pregnancy disparities minority depression|emotional distress pregnancy disparities minority depression
25064|NCT03415984|Parkinson Disease|parkinson disease
25065|NCT03415984|Age Related Macular Degeneration|age related macular degeneration
25066|NCT03415984|L-DOPA|l-dopa
25067|NCT03415958|prospective|prospective
25068|NCT03415958|adolescent|adolescent
25069|NCT03415958|displaced|displaced
25070|NCT03415958|clavicle|clavicle
25071|NCT03415958|fracture|fracture
25072|NCT03415958|mid-shaft|mid-shaft
25073|NCT03415906|angiotensin receptor blocker|angiotensin receptor blocker
25074|NCT03415906|neprilysin inhibition|neprilysin inhibition
25075|NCT03415906|sympathetic activity|sympathetic activity
25076|NCT03415906|baroreflex|baroreflex
25077|NCT03415906|microneurography|microneurography
25078|NCT03415906|functional MRI|functional mri
25079|NCT03415893|high-resolution manometry|high-resolution manometry
25080|NCT03415893|esophageal atresia|esophageal atresia
25081|NCT03415893|teenagers|teenagers
25082|NCT03415880|Diabetes mellitus|diabetes mellitus
25083|NCT03415880|Type2 Diabetes|type2 diabetes
25084|NCT03415880|Sedentary Lifestyle|sedentary lifestyle
25085|NCT03415880|Physical Activity|physical activity
25086|NCT03415880|Pulse wave velocity|pulse wave velocity
25087|NCT03415880|arterial stiffness|arterial stiffness
25088|NCT03415880|aortic stiffness|aortic stiffness
25089|NCT03415880|artery disease|artery disease
25090|NCT03415880|light intensity physical activity|light intensity physical activity
25091|NCT03415867|Graft-versus-host disease|graft-versus-host disease
25092|NCT03415867|Bone marrow transplantation|bone marrow transplantation
25093|NCT03415867|Hedgehog inhibitor|hedgehog inhibitor
25094|NCT03415841|Post MI|post mi
25095|NCT03415841|Cardiac Rehabilitation|cardiac rehabilitation
25096|NCT03415841|Wearable Devices|wearable devices
25097|NCT03415841|Smartphone-based Program|smartphone-based program
25098|NCT03415815|Chinese, real-world evidences, T1-T3 esophageal cancer|chinese, real-world evidences, t1-t3 esophageal cancer
25099|NCT03415802|Nab-Paclitaxel|nab-paclitaxel
25100|NCT03415802|S-1|s-1
25101|NCT03415802|Advanced Pancreatic Cancer|advanced pancreatic cancer
25102|NCT03415789|Non ischemic dilated cardiomyopathy|non ischemic dilated cardiomyopathy
25103|NCT03415789|Cardiac thrombosis|cardiac thrombosis
25104|NCT03415789|Silent brain infarct|silent brain infarct
25105|NCT03415789|Fluid dynamics|fluid dynamics
25106|NCT03415789|Intracardiac blood flow|intracardiac blood flow
25107|NCT03415789|Echocardiography|echocardiography
25108|NCT03415776|Hemodialysis|hemodialysis
25109|NCT03415776|Sessions frequency|sessions frequency
25110|NCT03415776|Mortality|mortality
25111|NCT03415776|Morbidity|morbidity
25112|NCT03415763|Rectal Neoplasms|rectal neoplasms
25113|NCT03415763|Adjuvant Chemotherapy|adjuvant chemotherapy
25114|NCT03415763|Neoadjuvant Chemoradiotherapy|neoadjuvant chemoradiotherapy
25115|NCT03415750|Renal transplant|renal transplant
25116|NCT03415698|Regenerative medicine|regenerative medicine
25117|NCT03415672|Interleukin-2|interleukin-2
25118|NCT03415672|Hepatitis B Vaccines|hepatitis b vaccines
25119|NCT03415672|Non-responders|non-responders
25120|NCT03415672|Liver Diseases|liver diseases
25121|NCT03415672|Digestive system|digestive system
25122|NCT03415672|Vaccines|vaccines
25123|NCT03415659|HWH340|hwh340
25124|NCT03415659|pharmacokinetics|pharmacokinetics
25125|NCT03415659|dose-escalation|dose-escalation
25126|NCT03415659|safety|safety
25127|NCT03415659|tolerability|tolerability
25128|NCT03415646|erector spinae plane block|erector spinae plane block
25129|NCT03415646|breast surgery|breast surgery
25130|NCT03415646|postoperative pain|postoperative pain
25131|NCT03415633|Home Respiratory Polygraphy|home respiratory polygraphy
25132|NCT03415633|Standard Polysomnography|standard polysomnography
25133|NCT03415633|Validity|validity
25134|NCT03415633|Cost-effectiveness|cost-effectiveness
25135|NCT03415568|Postprandial lipid metabolism|postprandial lipid metabolism
25136|NCT03415568|Medium-chain triglycerides|medium-chain triglycerides
25137|NCT03415568|Diacylglycerols|diacylglycerols
25138|NCT03415568|Serum triglycerides|serum triglycerides
25139|NCT03415568|Chylomicron triglycerides|chylomicron triglycerides
25140|NCT03415555|Erector Spinae Plane blockade|erector spinae plane blockade
25141|NCT03415555|patient control anlagesia|patient control anlagesia
25142|NCT03415555|mitral valve replacement|mitral valve replacement
25143|NCT03415542|Attitudes|attitudes
25144|NCT03415542|Ecological momentary assessment|ecological momentary assessment
25145|NCT03415529|Lung|lung
25146|NCT03415529|ARDS|ards
25147|NCT03415529|Acute Respiratory Syndrome|acute respiratory syndrome
25148|NCT03415529|Prognosis|prognosis
25149|NCT03415529|Outcome Research|outcome research
25150|NCT03415529|Respiratory infection|respiratory infection
25151|NCT03415529|Sepsis|sepsis
25152|NCT03415529|Organ failure|organ failure
25153|NCT03415529|Hypercapnia|hypercapnia
25154|NCT03415503|anthocyanins|anthocyanins
25155|NCT03415503|dyslipidemias|dyslipidemias
25156|NCT03415503|Hyperglycemia|hyperglycemia
25157|NCT03415490|general anesthesia|general anesthesia
25158|NCT03415490|self-adherent wrap|self-adherent wrap
25159|NCT03415490|pressure|pressure
25160|NCT03415477|aneurysmal bone cyst, denosumab, surgical treatment, complication|aneurysmal bone cyst, denosumab, surgical treatment, complication
25161|NCT03415451|cancer patients, Nutritional status|cancer patients, nutritional status
25162|NCT03415438|thoracolumbar fascia|thoracolumbar fascia
25163|NCT03415438|subacromial impingement syndrome|subacromial impingement syndrome
25164|NCT03415412|non-caries cervical lesion|non-caries cervical lesion
25165|NCT03415412|universal adhesives|universal adhesives
25166|NCT03415399|relapsed/refractory CD19+ Lymphomas, B-Cell|relapsed/refractory cd19+ lymphomas, b-cell
25167|NCT03415360|cryoablation|cryoablation
25168|NCT03415347|Pilonidal abscess|pilonidal abscess
25169|NCT03415347|Pilonidal disease|pilonidal disease
25170|NCT03415347|Pilonidal sinus|pilonidal sinus
25171|NCT03415334|Hepatitis C|hepatitis c
25172|NCT03415334|social marketing|social marketing
25173|NCT03415334|Communication for behavior development|communication for behavior development
25174|NCT03415321|Postpartum, Sense of Security, Mobile Support Application|postpartum, sense of security, mobile support application
25175|NCT03415308|Implicit Bias|implicit bias
25176|NCT03415308|Healthcare Equity|healthcare equity
25177|NCT03415295|Trimethylamine-N-oxide; Gestational diabetes mellitus|trimethylamine-n-oxide; gestational diabetes mellitus
25178|NCT03415269|acute|acute
25179|NCT03415191|ketamine, post-thoracotomy pain, analgesia|ketamine, post-thoracotomy pain, analgesia
25180|NCT03415152|Omacor|omacor
25181|NCT03415152|Omega-3-acid ethyl esters|omega-3-acid ethyl esters
25182|NCT03415152|patient adherence|patient adherence
25183|NCT03415152|patient reported outcomes|patient reported outcomes
25184|NCT03415126|KRAS mutant|kras mutant
25185|NCT03415126|NRAS mutant|nras mutant
25186|NCT03415126|BRAF mutant|braf mutant
25187|NCT03415126|HRAS mutant|hras mutant
25188|NCT03415126|ERK 1/2 inhibitor|erk 1/2 inhibitor
25189|NCT03415113|Medication reconciliation at discharge, potentially inappropriate medications, elderly.|medication reconciliation at discharge, potentially inappropriate medications, elderly.
25190|NCT03415074|low protein diet|low protein diet
25191|NCT03415074|Diabetic Kidney Disease|diabetic kidney disease
25192|NCT03415035|Venetoclax|venetoclax
25193|NCT03415035|Venclyxto|venclyxto
25194|NCT03415035|Cancer|cancer
25195|NCT03415035|Chronic lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
25197|NCT03415022|Social Anxiety|social anxiety
25198|NCT03415022|Social Phobia|social phobia
25199|NCT03415009|IL28B gene|il28b gene
25200|NCT03414996|Interval training|interval training
25201|NCT03414996|Autonomic nervous system|autonomic nervous system
25202|NCT03414996|Post-acute coronary syndrome|post-acute coronary syndrome
25203|NCT03414957|Malay women, PCOS, Metabolic Syndrome, Rotterdam criteria|malay women, pcos, metabolic syndrome, rotterdam criteria
25204|NCT03414944|Non-small cell lung cancer|non-small cell lung cancer
25205|NCT03414944|Brain metastases|brain metastases
25206|NCT03414944|SIB|sib
25207|NCT03414944|hippocampus avoidance|hippocampus avoidance
25208|NCT03414944|inner ear avoidance|inner ear avoidance
25209|NCT03414918|Macrolides, KCNJ5 potassium channel, aldosteronism|macrolides, kcnj5 potassium channel, aldosteronism
25210|NCT03414892|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
25211|NCT03414892|Glucokinase Activator|glucokinase activator
25212|NCT03414866|Thoracic Aorta|thoracic aorta
25213|NCT03414866|Dissection|dissection
25214|NCT03414866|Aneurysm|aneurysm
25215|NCT03414866|Frozen Elephant Trunk|frozen elephant trunk
25216|NCT03414853|Appendicitis, abdominal pain, free text prediction|appendicitis, abdominal pain, free text prediction
25217|NCT03414840|coronary artery disease|coronary artery disease
25314|NCT03414203|Cognitive Symptoms|cognitive symptoms
25218|NCT03414840|coronary computed tomography angiography|coronary computed tomography angiography
25219|NCT03414840|statins|statins
25220|NCT03414840|coronary atherosclerosis|coronary atherosclerosis
25221|NCT03414814|NSCLC|nsclc
25222|NCT03414814|Osimertinib|osimertinib
25223|NCT03414814|EGFR exon 20 insertion mutation|egfr exon 20 insertion mutation
25224|NCT03414801|Environmental Exposure Unit|environmental exposure unit
25225|NCT03414801|Cat Allergen|cat allergen
25226|NCT03414801|Rhinitis|rhinitis
25227|NCT03414801|Subject Validation|subject validation
25228|NCT03414788|Positron Emission Tomography (PET), Ulcerative Colitis, Safety, PKPlasma|positron emission tomography (pet), ulcerative colitis, safety, pkplasma
25229|NCT03414775|microbiome|microbiome
25230|NCT03414775|gastrointestinal microbiome|gastrointestinal microbiome
25231|NCT03414775|pediatrics|pediatrics
25232|NCT03414775|critical illness|critical illness
25233|NCT03414762|cesarean section|cesarean section
25234|NCT03414762|negative-pressure wound therapy|negative-pressure wound therapy
25235|NCT03414762|surgical wound dehiscence|surgical wound dehiscence
25236|NCT03414762|hospital readmission|hospital readmission
25237|NCT03414762|surgical site infection|surgical site infection
25238|NCT03414710|uptake of voluntary medical male circumcision|uptake of voluntary medical male circumcision
25239|NCT03414697|umbilical cord-derived mesenchymal stem cells|umbilical cord-derived mesenchymal stem cells
25240|NCT03414697|cerebral palsy|cerebral palsy
25241|NCT03414684|Breast Cancer|breast cancer
25243|NCT03414658|Breast Cancer|breast cancer
25244|NCT03414632|Heart Failure|heart failure
25245|NCT03414632|Diastolic Heart Failure|diastolic heart failure
25246|NCT03414632|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
25247|NCT03414632|Transthyretin Cardiac Amyloidosis|transthyretin cardiac amyloidosis
25248|NCT03414632|Amyloidosis|amyloidosis
25249|NCT03414619|OCD|ocd
25250|NCT03414619|GAD|gad
25251|NCT03414619|MDD|mdd
25252|NCT03414619|Rumination|rumination
25253|NCT03414619|Obsession|obsession
25254|NCT03414619|Worry|worry
25255|NCT03414593|preemptive analgic effect|preemptive analgic effect
25256|NCT03414593|popliteal sciatic nerve block|popliteal sciatic nerve block
25257|NCT03414593|Bilateral Hallux Valgus|bilateral hallux valgus
25258|NCT03414567|Follicular fluid|follicular fluid
25259|NCT03414567|nicotine|nicotine
25260|NCT03414567|cotinine|cotinine
25261|NCT03414567|Benzo(a)pyrene|benzo(a)pyrene
25262|NCT03414502|Methotrexate|methotrexate
25263|NCT03414489|Clinical Trial, Phase II|clinical trial, phase ii
25264|NCT03414489|Multicenter Trials|multicenter trials
25265|NCT03414489|Clinical Study|clinical study
25266|NCT03414489|Clinical Trials, Non-Randomized|clinical trials, non-randomized
25267|NCT03414489|Oral capsule|oral capsule
25268|NCT03414489|Single arm|single arm
25269|NCT03414489|Anti-cancer|anti-cancer
25270|NCT03414489|Anti-inflammatory|anti-inflammatory
25271|NCT03414489|ABC294640|abc294640
25272|NCT03414489|Expanded Access Program|expanded access program
25273|NCT03414489|Compassionate Use|compassionate use
25274|NCT03414489|Special Access Program|special access program
25275|NCT03414489|Yeliva ®|yeliva ®
25276|NCT03414463|Brain Injury|brain injury
25277|NCT03414450|Mnk kinase inhibitor, Mnk kinase|mnk kinase inhibitor, mnk kinase
25278|NCT03414424|transcutaneous electric nerve stimulation|transcutaneous electric nerve stimulation
25279|NCT03414424|transcranial magnetic stimulation|transcranial magnetic stimulation
25280|NCT03414411|HIV|hiv
25281|NCT03414411|Alcohol Use|alcohol use
25282|NCT03414411|Substance Use|substance use
25283|NCT03414411|Bone Disease|bone disease
25284|NCT03414411|Falls|falls
25285|NCT03414411|Fractures|fractures
25286|NCT03414372|MSM|msm
25287|NCT03414372|HIV|hiv
25288|NCT03414372|disclosure|disclosure
25289|NCT03414372|eHealth|ehealth
25290|NCT03414372|virtual reality|virtual reality
25291|NCT03414346|Cryotherapy|cryotherapy
25292|NCT03414346|Skin temperature|skin temperature
25293|NCT03414346|Physical therapy modalities|physical therapy modalities
25294|NCT03414346|Physical therapy|physical therapy
25295|NCT03414346|Thermography|thermography
25296|NCT03414346|Pain measurement|pain measurement
25297|NCT03414333|obesity|obesity
25298|NCT03414333|cognitive dysfunction|cognitive dysfunction
25299|NCT03414320|type 1 diabetes|type 1 diabetes
25300|NCT03414320|insulin pump|insulin pump
25301|NCT03414320|bolus calculator|bolus calculator
25302|NCT03414320|continuous glucose monitoring|continuous glucose monitoring
25303|NCT03414320|carbohydrate to insulin ratio|carbohydrate to insulin ratio
25304|NCT03414320|insulin sensitivity factor|insulin sensitivity factor
25305|NCT03414281|quadratus lumborum block, thoracic paravertebral block, nephrectomy|quadratus lumborum block, thoracic paravertebral block, nephrectomy
25306|NCT03414268|Chronic plantar fasciitis|chronic plantar fasciitis
25307|NCT03414268|Heel pain|heel pain
25308|NCT03414255|Chronic Achilles Tendonitis|chronic achilles tendonitis
25309|NCT03414229|Epacadostat|epacadostat
25310|NCT03414229|Pembrolizumab|pembrolizumab
25311|NCT03414229|17-508|17-508
25312|NCT03414203|Transcranial Direct Current Stimulation|transcranial direct current stimulation
25313|NCT03414203|Migraine Disorders|migraine disorders
25315|NCT03414190|Acute Coronary Syndrome|acute coronary syndrome
25316|NCT03414190|Text Messaging|text messaging
25317|NCT03414190|Risk Factors|risk factors
25318|NCT03414177|Telemedicine|telemedicine
25319|NCT03414177|Clinical follow up visits|clinical follow up visits
25320|NCT03414138|Pain|pain
25321|NCT03414138|Mindfulness|mindfulness
25322|NCT03414138|Meditation|meditation
25323|NCT03414138|fMRI|fmri
25324|NCT03414125|Colorectal Cancer|colorectal cancer
25325|NCT03414125|Colon Cancer|colon cancer
25326|NCT03414125|FIT Screening Strategy|fit screening strategy
25327|NCT03414125|Colon Screening Strategy|colon screening strategy
25328|NCT03414125|Colorectal Neoplasms|colorectal neoplasms
25329|NCT03414125|Mass Screening|mass screening
25330|NCT03414125|Health Services Research|health services research
25331|NCT03414125|Comparative Effectiveness Research|comparative effectiveness research
25332|NCT03414099|Pain|pain
25333|NCT03414099|Kratom|kratom
25334|NCT03414099|Ketum|ketum
25335|NCT03414099|mitragynine|mitragynine
25336|NCT03414086|PM|pm
25337|NCT03414086|DM|dm
25338|NCT03414073|dental floss|dental floss
25339|NCT03414073|gingival embrasure|gingival embrasure
25340|NCT03414073|oral hygiene|oral hygiene
25341|NCT03414073|interdental brush|interdental brush
25342|NCT03414060|obstetric fistula|obstetric fistula
25343|NCT03414060|vesicovaginal fistula|vesicovaginal fistula
25344|NCT03414060|menstrual cup|menstrual cup
25345|NCT03414060|pad test|pad test
25346|NCT03414060|non-surgical management|non-surgical management
25347|NCT03414060|feasibility|feasibility
25348|NCT03414060|acceptability|acceptability
25349|NCT03414060|innovation|innovation
25350|NCT03414047|DNA damage repair|dna damage repair
25351|NCT03414047|replication stress|replication stress
25352|NCT03414034|PLK1|plk1
25353|NCT03414034|PLK Inhibitor|plk inhibitor
25354|NCT03414021|Nuclear Medicine|nuclear medicine
25355|NCT03414021|SPECT-CT Scan|spect-ct scan
25356|NCT03414021|gamma-camera with semiconductor|gamma-camera with semiconductor
25357|NCT03413995|metastatic hormone sensitive|metastatic hormone sensitive
25358|NCT03413956|Chinese|chinese
25359|NCT03413956|T1 non-small cell lung cancer|t1 non-small cell lung cancer
25360|NCT03413956|Lymph metastases|lymph metastases
25361|NCT03413930|TaTME|tatme
25362|NCT03413930|Rectal cancer|rectal cancer
25363|NCT03413930|Laparoscopic Surgery|laparoscopic surgery
25364|NCT03413917|genomic markers|genomic markers
25365|NCT03413904|taTME|tatme
25366|NCT03413891|Anticoagulants|anticoagulants
25367|NCT03413891|Tranexamic Acid|tranexamic acid
25368|NCT03413878|snow|snow
25369|NCT03413878|avalanche|avalanche
25370|NCT03413878|hypercapnia|hypercapnia
25371|NCT03413878|work of breathing|work of breathing
25372|NCT03413839|Scoliosis|scoliosis
25373|NCT03413839|PSSE|psse
25374|NCT03413826|weight loss|weight loss
25375|NCT03413826|exercise|exercise
25376|NCT03413826|reinforcement|reinforcement
25377|NCT03413826|compensation|compensation
25378|NCT03413813|Magmaris|magmaris
25379|NCT03413800|hematopoietic stem cell transplant|hematopoietic stem cell transplant
25380|NCT03413800|lenalidomide|lenalidomide
25381|NCT03413800|DLI|dli
25382|NCT03413722|Liver transplant|liver transplant
25383|NCT03413722|Cognitive function|cognitive function
25384|NCT03413709|Parenting Time, Father Involvement|parenting time, father involvement
25385|NCT03413696|HIV|hiv
25386|NCT03413696|Health literacy|health literacy
25387|NCT03413696|Hepatitis C|hepatitis c
25388|NCT03413696|Hepatitis C knowledge|hepatitis c knowledge
25389|NCT03413696|HIV knowledge|hiv knowledge
25390|NCT03413696|Hepatitis C treatment|hepatitis c treatment
25391|NCT03413644|Hematological diseases|hematological diseases
25392|NCT03413631|prenatal substance abuse|prenatal substance abuse
25393|NCT03413631|mentalization|mentalization
25394|NCT03413631|prenatal depression|prenatal depression
25395|NCT03413631|prenatal anxiety|prenatal anxiety
25396|NCT03413631|maternal-fetal attachment|maternal-fetal attachment
25397|NCT03413631|prenatal intervention|prenatal intervention
25398|NCT03413631|ultrasound|ultrasound
25399|NCT03413631|perinatal outcome|perinatal outcome
25400|NCT03413631|fetal exposure|fetal exposure
25401|NCT03413631|parenting|parenting
25402|NCT03413631|parenthood|parenthood
25403|NCT03413631|prenatal treatment|prenatal treatment
25404|NCT03413618|deep vein thrombosis|deep vein thrombosis
25405|NCT03413618|postthrombotic syndrome|postthrombotic syndrome
25406|NCT03413618|anticoagulation|anticoagulation
25407|NCT03413618|treatment|treatment
25408|NCT03413618|prevention|prevention
25409|NCT03413579|Cervix|cervix
25410|NCT03413579|Oncology,|oncology,
25411|NCT03413579|hR3,|hr3,
25412|NCT03413579|Nimotuzumab,|nimotuzumab,
25413|NCT03413579|Chemotherapy,|chemotherapy,
25414|NCT03413579|Survival|survival
25415|NCT03413579|Monoclonal antibody|monoclonal antibody
25416|NCT03413579|RECIST|recist
25417|NCT03413579|Cisplatin|cisplatin
25418|NCT03413579|Vinorelbine|vinorelbine
25419|NCT03413579|Paclitaxel|paclitaxel
25420|NCT03413579|Carboplatine|carboplatine
25421|NCT03413579|Randomisation|randomisation
25422|NCT03413579|Placebo|placebo
25423|NCT03413579|cancer|cancer
25424|NCT03413566|Trends|trends
25425|NCT03413566|Prevalence|prevalence
25426|NCT03413566|Registries/statistics & numerical data|registries/statistics & numerical data
25427|NCT03413566|Epidemiology|epidemiology
25428|NCT03413553|immediate implant|immediate implant
25429|NCT03413553|connective tissue graft|connective tissue graft
25430|NCT03413540|jumping|jumping
25431|NCT03413540|bone health|bone health
25432|NCT03413527|rTMS|rtms
25433|NCT03413514|shared decision making|shared decision making
25434|NCT03413514|neoadjuvant chemotherapy|neoadjuvant chemotherapy
25435|NCT03413514|cycle|cycle
25436|NCT03413514|MRI|mri
25437|NCT03413514|clinical response|clinical response
25438|NCT03413488|Shoulder impingement syndrome|shoulder impingement syndrome
25439|NCT03413488|Kinesio tape|kinesio tape
25440|NCT03413488|Round shoulder posture|round shoulder posture
25441|NCT03413475|Edentulism|edentulism
25442|NCT03413475|complete removable prosthesis|complete removable prosthesis
25443|NCT03413475|quality of life|quality of life
25444|NCT03413436|adjuvant chemotherapy|adjuvant chemotherapy
25445|NCT03413436|multicenter retrospective study|multicenter retrospective study
25446|NCT03413423|smoking|smoking
25447|NCT03413423|depression|depression
25448|NCT03413423|Behavioral Activation|behavioral activation
25449|NCT03413423|Mood management|mood management
25450|NCT03413423|Secondary Prevention|secondary prevention
25451|NCT03413384|Parkinson's Disease|parkinson's disease
25452|NCT03413384|Parkinson's Disease Dementia|parkinson's disease dementia
25453|NCT03413371|Surgical Pleth Index (SPI)|surgical pleth index (spi)
25454|NCT03413371|General Anaesthesia (GA),|general anaesthesia (ga),
25455|NCT03413371|Numerical Rating Scale (NRS)|numerical rating scale (nrs)
25456|NCT03413371|Adequacy of Anaesthesia (AoA)|adequacy of anaesthesia (aoa)
25457|NCT03413371|Peribulbar Block (PBB)|peribulbar block (pbb)
25458|NCT03413371|bupivacaine|bupivacaine
25459|NCT03413371|ropivacaine|ropivacaine
25460|NCT03413371|lidocaine|lidocaine
25461|NCT03413332|Chinese American Women|chinese american women
25462|NCT03413332|Provider-patient Communication|provider-patient communication
25463|NCT03413332|Survivorship Care|survivorship care
25464|NCT03413306|aplastic anemia|aplastic anemia
25465|NCT03413306|immunosupressive therapy|immunosupressive therapy
25466|NCT03413306|ATG|atg
25467|NCT03413306|eltrombopag|eltrombopag
25468|NCT03413280|preemptive analgic effect|preemptive analgic effect
25469|NCT03413280|Rectus Sheath Block|rectus sheath block
25470|NCT03413280|laparoscopic cholecystectomy|laparoscopic cholecystectomy
25471|NCT03413267|micronutrient|micronutrient
25472|NCT03413267|bioavailability|bioavailability
25473|NCT03413267|bioaccessibility|bioaccessibility
25474|NCT03413267|food structure|food structure
25475|NCT03413267|food texture|food texture
25476|NCT03413254|pT4 colon cancer|pt4 colon cancer
25477|NCT03413254|Peritoneal metastases|peritoneal metastases
25478|NCT03413254|Early detection|early detection
25479|NCT03413254|Diagnostic laparoscopy|diagnostic laparoscopy
25480|NCT03413254|Second look surgery|second look surgery
25481|NCT03413254|Third look surgery|third look surgery
25482|NCT03413241|High functioning autism spectrum disorder|high functioning autism spectrum disorder
25483|NCT03413202|butylphthalide(NBP)|butylphthalide(nbp)
25484|NCT03413202|large-artery atherosclerosis acute ischemic stroke|large-artery atherosclerosis acute ischemic stroke
25485|NCT03413202|dynamic Cerebral Autoregulation(dCA)|dynamic cerebral autoregulation(dca)
25486|NCT03413189|Exercise|exercise
25487|NCT03413189|Dosage|dosage
25488|NCT03413189|Function|function
25489|NCT03413176|VEGFR|vegfr
25490|NCT03413176|VEGF|vegf
25491|NCT03413176|antiangiogenics|antiangiogenics
25492|NCT03413176|angiogenesis|angiogenesis
25493|NCT03413163|Ultrasound Guided Erector Spinae Plane Block|ultrasound guided erector spinae plane block
25494|NCT03413163|postoperative pain|postoperative pain
25495|NCT03413163|retropubic radical prostatectomy|retropubic radical prostatectomy
25496|NCT03413137|Prostate cancer|prostate cancer
25497|NCT03413137|transperineal mp-MRI-fusion/TRUS biopsies|transperineal mp-mri-fusion/trus biopsies
25498|NCT03413137|mp-MRI fusion/TRUS transrectal biopsy|mp-mri fusion/trus transrectal biopsy
25499|NCT03413111|ERCP|ercp
25500|NCT03413111|double guidewire technique|double guidewire technique
25501|NCT03413085|Myopia control|myopia control
25502|NCT03413046|Regulatory T cell|regulatory t cell
25503|NCT03413046|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
25504|NCT03413046|Minimal residual disease|minimal residual disease
25505|NCT03413033|Semi-occluded vocal tract|semi-occluded vocal tract
25506|NCT03413033|resonance tubes|resonance tubes
25507|NCT03413033|tongue trill|tongue trill
25508|NCT03413033|voice therapy|voice therapy
25509|NCT03413020|Helicobacter pylori|helicobacter pylori
25510|NCT03413020|Rescue therapy|rescue therapy
25511|NCT03413020|Tailored therapy|tailored therapy
25512|NCT03413020|Antimicrobial susceptibility testing|antimicrobial susceptibility testing
25513|NCT03412942|Comfort|comfort
25514|NCT03412942|Confidence|confidence
25515|NCT03412942|Usage outcomes|usage outcomes
25516|NCT03412916|Orthopaedic|orthopaedic
25517|NCT03412916|Orthopedic|orthopedic
25518|NCT03412903|Acute geriatric treatment|acute geriatric treatment
25519|NCT03412903|Inpatient treatment team|inpatient treatment team
25520|NCT03412903|Elderly|elderly
25521|NCT03412903|Pharmacist|pharmacist
25522|NCT03412903|Comprehensive pharmaceutical assessment|comprehensive pharmaceutical assessment
25523|NCT03412903|Medication history|medication history
25524|NCT03412903|Medication reconciliation|medication reconciliation
25525|NCT03412903|Adherence|adherence
25526|NCT03412903|Medication therapy management|medication therapy management
25527|NCT03412903|Pharmaceutical consultation|pharmaceutical consultation
25528|NCT03412903|Drug-Related Side Effects and Adverse Reactions|drug-related side effects and adverse reactions
25529|NCT03412903|Drug interactions|drug interactions
25530|NCT03412903|Pharmaceutical Council|pharmaceutical council
25531|NCT03412903|Drug regime acceptance|drug regime acceptance
25532|NCT03412903|Patient Care Team|patient care team
25533|NCT03412903|Hospital Pharmacy Service|hospital pharmacy service
25534|NCT03412903|Polypharmacy|polypharmacy
25535|NCT03412903|Hospitalization|hospitalization
25536|NCT03412903|Pharmaceutical Services|pharmaceutical services
25537|NCT03412877|Gene Therapy|gene therapy
25538|NCT03412877|Immunotherapy|immunotherapy
25539|NCT03412877|Cell Therapy|cell therapy
25540|NCT03412877|Adoptive Cell Therapy|adoptive cell therapy
25541|NCT03412864|chondrocyte cells|chondrocyte cells
25542|NCT03412864|osteoarthritis|osteoarthritis
25543|NCT03412864|gene therapy|gene therapy
25544|NCT03412851|Thrombectomy|thrombectomy
25545|NCT03412851|Stentriever|stentriever
25546|NCT03412851|ADAPT|adapt
25547|NCT03412838|Bone block allograft|bone block allograft
25548|NCT03412838|Bone density|bone density
25549|NCT03412838|Graft resorption|graft resorption
25550|NCT03412838|PRP|prp
25551|NCT03412838|RCT|rct
25552|NCT03412812|Brain Metastases|brain metastases
25553|NCT03412812|Stereotactic Radiosurgery|stereotactic radiosurgery
25554|NCT03412773|Advanced liver cancer|advanced liver cancer
25555|NCT03412760|hydrops fetalis|hydrops fetalis
25556|NCT03412760|birth defect|birth defect
25557|NCT03412760|fetal anomaly|fetal anomaly
25558|NCT03412760|whole exome sequencing|whole exome sequencing
25559|NCT03412747|Bimekizumab|bimekizumab
25560|NCT03412747|PSO|pso
25561|NCT03412747|Psoriasis|psoriasis
25562|NCT03412721|laser analgesia|laser analgesia
25563|NCT03412721|pediatric dentistry|pediatric dentistry
25564|NCT03412695|Disease-related malnutrition|disease-related malnutrition
25565|NCT03412695|eHealth|ehealth
25566|NCT03412695|Decision support system|decision support system
25567|NCT03412695|Clinical nutrition|clinical nutrition
25568|NCT03412682|Ulcerative colitis|ulcerative colitis
25569|NCT03412682|FE999315|fe999315
25570|NCT03412682|Mesalazine|mesalazine
25571|NCT03412682|Colitis|colitis
25572|NCT03412682|Colitis, Ulcerative|colitis, ulcerative
25573|NCT03412669|Addiction affected family members|addiction affected family members
25574|NCT03412669|Counselling|counselling
25575|NCT03412669|Psychosocial intervention|psychosocial intervention
25576|NCT03412669|Low and Middle Income Countries|low and middle income countries
25577|NCT03412669|India|india
25578|NCT03412669|Pilot Randomised Controlled Trial|pilot randomised controlled trial
25579|NCT03412656|CUFF|cuff
25580|NCT03412656|Soft Hand Pro|soft hand pro
25581|NCT03412656|SHP|shp
25582|NCT03412656|SH Pro|sh pro
25583|NCT03412656|SoftHand|softhand
25584|NCT03412617|Healthy Eating|healthy eating
25585|NCT03412617|Blood glucose|blood glucose
25586|NCT03412617|Bifidobacterium|bifidobacterium
25587|NCT03412617|Obese women|obese women
25588|NCT03412604|Alzheimer Disease|alzheimer disease
25589|NCT03412539|resistant pain|resistant pain
25590|NCT03412513|Overactive Bladder|overactive bladder
25591|NCT03412513|Parkinson Disease|parkinson disease
25592|NCT03412500|Methicillin-Resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
25593|NCT03412500|Vancomycin|vancomycin
25594|NCT03412474|suprazygomatic block, dexmedetomidine|suprazygomatic block, dexmedetomidine
25595|NCT03412461|Transition-aged youth|transition-aged youth
25596|NCT03412461|Mental Health|mental health
25597|NCT03412461|Accessibility|accessibility
25598|NCT03412448|chronic pain|chronic pain
25599|NCT03412448|cardiac surgery|cardiac surgery
25600|NCT03412448|opioids|opioids
25601|NCT03412435|Acute myocardial infarction|acute myocardial infarction
25602|NCT03412435|Myocardial infarction|myocardial infarction
25603|NCT03412422|Passive Leg Raise|passive leg raise
25604|NCT03412422|Fluid Challenge|fluid challenge
25605|NCT03412422|Common carotid artery|common carotid artery
25606|NCT03412409|RIC regimen|ric regimen
25607|NCT03412409|comorbidity|comorbidity
25608|NCT03412409|elderly|elderly
25609|NCT03412409|haploidentical|haploidentical
25610|NCT03412409|transplant-related mortality|transplant-related mortality
25611|NCT03412396|Prostate Cancer|prostate cancer
25612|NCT03412396|Apalutamide|apalutamide
25613|NCT03412396|ARN-509|arn-509
25614|NCT03412396|Prostatectomy|prostatectomy
25615|NCT03412396|Questionnaires|questionnaires
25616|NCT03412396|Surveys|surveys
25617|NCT03412396|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
25618|NCT03412357|pleurectomy/decortication|pleurectomy/decortication
25619|NCT03412357|indwelling pleural catheter|indwelling pleural catheter
25620|NCT03412344|clinical trial|clinical trial
25621|NCT03412344|patient|patient
25622|NCT03412344|questionnaire|questionnaire
25623|NCT03412305|Dental implants, antibiotic prophylaxis|dental implants, antibiotic prophylaxis
25624|NCT03412279|Chronic Low Back Pain|chronic low back pain
25625|NCT03412279|Oswestry Disability Index|oswestry disability index
25626|NCT03412279|Roland Morris Disability Questionnaire|roland morris disability questionnaire
25627|NCT03412279|SF-12 Health Survey|sf-12 health survey
25628|NCT03412279|Pain Catastrophizing Scale|pain catastrophizing scale
25629|NCT03412279|Back Beliefs Questionnaire|back beliefs questionnaire
25630|NCT03412266|RIC regimen; MDS; haplo-HSCT; survival|ric regimen; mds; haplo-hsct; survival
25631|NCT03412253|metabolic surgery, BMI 25-30 kg/m2, SAGB, T2DM remission.|metabolic surgery, bmi 25-30 kg/m2, sagb, t2dm remission.
25632|NCT03412227|Anxiety|anxiety
25633|NCT03412227|Depression|depression
25634|NCT03412227|Children|children
25635|NCT03412227|Adolescents|adolescents
25636|NCT03412227|CBT|cbt
25637|NCT03412201|Disease management|disease management
25638|NCT03412201|Medication therapy management|medication therapy management
25639|NCT03412201|Biomarkers|biomarkers
25640|NCT03412188|Chronic ITP|chronic itp
25641|NCT03412188|persistent ITP|persistent itp
25642|NCT03412188|Eltrombopag|eltrombopag
25643|NCT03412188|GPVI receptor|gpvi receptor
25644|NCT03412162|Discrimination|discrimination
25645|NCT03412162|Cortisol|cortisol
25646|NCT03412162|Sleep|sleep
25647|NCT03412162|Identity|identity
25648|NCT03412149|Malabsorption, Mini Gastric Bypass, Roux en Y Gastric Bypass|malabsorption, mini gastric bypass, roux en y gastric bypass
25649|NCT03412136|Testosterone|testosterone
25650|NCT03412136|Food Intake|food intake
25651|NCT03412136|Appetite|appetite
25652|NCT03412110|chiropractic|chiropractic
25653|NCT03412097|chiropractic|chiropractic
25654|NCT03412084|Sedentary Lifestyle|sedentary lifestyle
25655|NCT03412084|physical function|physical function
25656|NCT03412058|PD-1|pd-1
25657|NCT03412058|PD-L1|pd-l1
25658|NCT03412019|Music|music
25659|NCT03412019|Patient Satisfaction|patient satisfaction
25660|NCT03412006|type II diabetes|type ii diabetes
25661|NCT03412006|diabetic kidney disease|diabetic kidney disease
25662|NCT03411980|Pharmacokinetics|pharmacokinetics
25663|NCT03411954|hippocampus avoidance|hippocampus avoidance
25664|NCT03411954|cognitive changes|cognitive changes
25665|NCT03411954|intensity modulated radiotherapy|intensity modulated radiotherapy
25666|NCT03411941|nAMD: neovascular Age-related Macular Degeneration|namd: neovascular age-related macular degeneration
25667|NCT03411915|NET|net
25668|NCT03411915|GIST|gist
25669|NCT03411915|DUET-1|duet-1
25670|NCT03411902|Bone Health|bone health
25671|NCT03411876|IPF|ipf
25672|NCT03411876|Oxymizer|oxymizer
25673|NCT03411876|oxygen conserving device|oxygen conserving device
25674|NCT03411876|pulmonary disease|pulmonary disease
25675|NCT03411863|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
25676|NCT03411863|transcranial magnetic stimulation|transcranial magnetic stimulation
25677|NCT03411837|Atopic Dermatitis, dupilumab|atopic dermatitis, dupilumab
25678|NCT03411824|diagnosis|diagnosis
25679|NCT03411824|Point-of-Care-Ultrasound|point-of-care-ultrasound
25680|NCT03411824|lung ultrasound|lung ultrasound
25681|NCT03411811|tendinopathy|tendinopathy
25682|NCT03411811|wrist|wrist
25683|NCT03411811|chronic pain|chronic pain
25684|NCT03411811|sprain|sprain
25685|NCT03411798|ankylosing spondylitis(AS)|ankylosing spondylitis(as)
25686|NCT03411798|TNFi|tnfi
25687|NCT03411798|Yisaipu®|yisaipu®
25688|NCT03411798|Disease modifying anti-rheumatic drugs (DMARDs)|disease modifying anti-rheumatic drugs (dmards)
25689|NCT03411759|CYP2D6|cyp2d6
25690|NCT03411759|Chronic pain|chronic pain
25691|NCT03411759|Cytochrome P450|cytochrome p450
25692|NCT03411759|Opioids|opioids
25693|NCT03411733|acne vlugaris|acne vlugaris
25694|NCT03411733|prevalence|prevalence
25695|NCT03411733|Helicobacter Pylori|helicobacter pylori
25696|NCT03411707|Colorectal cancer screening|colorectal cancer screening
25697|NCT03411707|Stool DNA test|stool dna test
25698|NCT03411707|Blood mRNA test|blood mrna test
25699|NCT03411694|Survey|survey
25700|NCT03411694|Anesthesia|anesthesia
25701|NCT03411694|Anesthesiologist|anesthesiologist
25702|NCT03411694|Patient perspective|patient perspective
25703|NCT03411668|undergraduate nursing students|undergraduate nursing students
25704|NCT03411668|evidence based practice beliefs|evidence based practice beliefs
25705|NCT03411668|evidence based practice knowledge|evidence based practice knowledge
25706|NCT03411668|evidence based practice implementation|evidence based practice implementation
25707|NCT03411668|Evidence based practice Education programme|evidence based practice education programme
25708|NCT03411642|Stroke, echocardiography|stroke, echocardiography
25709|NCT03411629|Necrotizing Pancreatitis|necrotizing pancreatitis
25808|NCT03411148|prosthetic|prosthetic
25710|NCT03411629|Critically ill|critically ill
25711|NCT03411629|Mortality|mortality
25712|NCT03411616|Eating behavior|eating behavior
25713|NCT03411616|Excessive weight|excessive weight
25714|NCT03411616|Food craving|food craving
25715|NCT03411616|Liver transplantation|liver transplantation
25716|NCT03411616|Obesity|obesity
25717|NCT03411616|Weight gain|weight gain
25718|NCT03411603|nutrient profiling|nutrient profiling
25719|NCT03411564|dating violence|dating violence
25720|NCT03411564|health promotion|health promotion
25721|NCT03411564|educational intervention|educational intervention
25722|NCT03411564|health assets|health assets
25723|NCT03411564|participation action research|participation action research
25724|NCT03411551|Intravenous anesthesia|intravenous anesthesia
25725|NCT03411551|Nerve Block|nerve block
25726|NCT03411551|Regional anesthesia|regional anesthesia
25727|NCT03411538|antibiotic-resistant infections|antibiotic-resistant infections
25728|NCT03411538|risk factors|risk factors
25729|NCT03411538|prospective surveillance|prospective surveillance
25730|NCT03411512|congenital heart defects|congenital heart defects
25731|NCT03411512|near-infrared spectroscopy|near-infrared spectroscopy
25732|NCT03411512|newborn|newborn
25733|NCT03411512|tissue oxygenation|tissue oxygenation
25734|NCT03411499|Adult|adult
25735|NCT03411499|Endocarditis/surgery|endocarditis/surgery
25736|NCT03411499|Embolism/prevention & control|embolism/prevention & control
25737|NCT03411499|Cardiovascular Diseases|cardiovascular diseases
25738|NCT03411499|Costs and Cost Analysis|costs and cost analysis
25739|NCT03411499|Quality of life|quality of life
25740|NCT03411447|vasoactive drug|vasoactive drug
25741|NCT03411447|mechanical ventilation|mechanical ventilation
25742|NCT03411447|early enteral nutrition|early enteral nutrition
25743|NCT03411447|intensive care unit|intensive care unit
25744|NCT03411447|early parenteral nutrition|early parenteral nutrition
25745|NCT03411447|critical care medicine|critical care medicine
25746|NCT03411447|nosocomial infection|nosocomial infection
25747|NCT03411447|mortality|mortality
25748|NCT03411447|shock|shock
25749|NCT03411434|oculomotor performances|oculomotor performances
25750|NCT03411434|neurocognition|neurocognition
25751|NCT03411434|methylphenidate|methylphenidate
25752|NCT03411408|Hypofractionated radiotherapy|hypofractionated radiotherapy
25753|NCT03411408|image - guided helical tomotherapy|image - guided helical tomotherapy
25754|NCT03411408|hyperbaric oxygen therapy|hyperbaric oxygen therapy
25755|NCT03411408|malignant glioma|malignant glioma
25756|NCT03411408|high grade glioma|high grade glioma
25757|NCT03411408|recurrent glioma|recurrent glioma
25758|NCT03411395|Diabetes|diabetes
25759|NCT03411395|Prediabetes|prediabetes
25760|NCT03411395|Blood sugar regulation|blood sugar regulation
25761|NCT03411369|Creatine, ribose, ischemic heart disease.|creatine, ribose, ischemic heart disease.
25762|NCT03411343|Postoperative Shoulder Analgesia|postoperative shoulder analgesia
25763|NCT03411343|Hemidiaphragmatic Paralysis|hemidiaphragmatic paralysis
25764|NCT03411343|Alternative blocks|alternative blocks
25765|NCT03411317|Aortic stenosis|aortic stenosis
25766|NCT03411317|progression|progression
25767|NCT03411317|Left ventricular remodeling|left ventricular remodeling
25768|NCT03411304|Aortic valvular replacement|aortic valvular replacement
25769|NCT03411304|Aortic stenosis|aortic stenosis
25770|NCT03411304|Left ventricular remodeling|left ventricular remodeling
25771|NCT03411304|biomarkers|biomarkers
25772|NCT03411291|Alzheimer's, magnetic resonance imaging|alzheimer's, magnetic resonance imaging
25773|NCT03411278|recovery|recovery
25774|NCT03411278|deep oscillation|deep oscillation
25775|NCT03411278|soccer|soccer
25776|NCT03411278|sports|sports
25777|NCT03411278|training|training
25778|NCT03411278|electrotherapy|electrotherapy
25779|NCT03411278|physical therapy|physical therapy
25780|NCT03411239|Airway pressure|airway pressure
25781|NCT03411239|Oesophageal pressure|oesophageal pressure
25782|NCT03411239|transpulmonary pressure|transpulmonary pressure
25783|NCT03411239|laparoscopic surgery|laparoscopic surgery
25784|NCT03411226|Inguinal Hernia|inguinal hernia
25785|NCT03411226|TREPP|trepp
25786|NCT03411226|Recurrence|recurrence
25787|NCT03411200|Older|older
25788|NCT03411200|Advanced Cancer|advanced cancer
25789|NCT03411200|Exercise|exercise
25790|NCT03411200|Resistance training|resistance training
25791|NCT03411200|Counseling|counseling
25792|NCT03411200|Mobilization|mobilization
25793|NCT03411187|Endoscopy|endoscopy
25794|NCT03411187|Thyroidectomy|thyroidectomy
25795|NCT03411187|Thyroid Cancer|thyroid cancer
25796|NCT03411174|breast cancer|breast cancer
25797|NCT03411174|hypofractionated partial breast irradiation|hypofractionated partial breast irradiation
25798|NCT03411161|Mps1|mps1
25799|NCT03411161|Mps1i|mps1i
25800|NCT03411161|S81694|s81694
25801|NCT03411161|breast cancer|breast cancer
25802|NCT03411161|triple negative breast cancer|triple negative breast cancer
25803|NCT03411161|phase I|phase i
25804|NCT03411161|phase II|phase ii
25805|NCT03411148|fear avoidance|fear avoidance
25806|NCT03411148|cognitive behavioral therapy|cognitive behavioral therapy
25807|NCT03411148|physical therapy|physical therapy
25809|NCT03411148|fear of falling|fear of falling
25810|NCT03411148|gait|gait
25811|NCT03411122|Enzyme Inhibitors|enzyme inhibitors
25812|NCT03411122|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers
25813|NCT03411109|intrathecal analgesia|intrathecal analgesia
25814|NCT03411109|colorectal|colorectal
25815|NCT03411109|enhanced recovery|enhanced recovery
25816|NCT03411083|Rehabilitation|rehabilitation
25817|NCT03411083|Recovery of function|recovery of function
25818|NCT03411083|Outcome Assessment (Health Care)|outcome assessment (health care)
25819|NCT03411083|Patient Reported outcome Measures|patient reported outcome measures
25820|NCT03411083|Treatment Outcome|treatment outcome
25821|NCT03411083|Pain, Postoperative|pain, postoperative
25822|NCT03411083|Pain Management|pain management
25823|NCT03411083|Orthopedic Surgery|orthopedic surgery
25824|NCT03411057|Mindfulness|mindfulness
25825|NCT03411057|Mindfulness Based Stress Reduction|mindfulness based stress reduction
25826|NCT03411057|Rheumatoid Arthritis|rheumatoid arthritis
25827|NCT03411057|Anxiety|anxiety
25828|NCT03411057|Depression|depression
25829|NCT03411044|Total Hip Arthroplasty|total hip arthroplasty
25830|NCT03411044|Fitmore|fitmore
25831|NCT03411044|Minimal Invasive Surgery|minimal invasive surgery
25832|NCT03411044|Short Stem|short stem
25833|NCT03411031|lenalidomide maintenance|lenalidomide maintenance
25834|NCT03411031|hematopoietic cell transplantation|hematopoietic cell transplantation
25835|NCT03411031|serologic relapse|serologic relapse
25836|NCT03411018|lung protective strategies|lung protective strategies
25837|NCT03411018|Less invasive respiratory support|less invasive respiratory support
25838|NCT03411018|preterm infant|preterm infant
25839|NCT03411005|Lysine, Adult, Protein Quality|lysine, adult, protein quality
25840|NCT03410992|Bimekizumab|bimekizumab
25841|NCT03410992|PSO|pso
25842|NCT03410992|Psoriasis|psoriasis
25843|NCT03410940|Total Hip Arthroplasty|total hip arthroplasty
25844|NCT03410940|CLS Brevius|cls brevius
25845|NCT03410940|Kinectiv|kinectiv
25846|NCT03410940|Medical Device|medical device
25847|NCT03410940|Performance|performance
25848|NCT03410940|Safety|safety
25849|NCT03410940|Hip Prosthesis|hip prosthesis
25850|NCT03410927|Phase I|phase i
25851|NCT03410927|solid tumors|solid tumors
25852|NCT03410927|pharmacokinetics|pharmacokinetics
25853|NCT03410927|pharmacodynamics|pharmacodynamics
25854|NCT03410927|MTD|mtd
25855|NCT03410927|TAS0728|tas0728
25856|NCT03410927|HER2|her2
25857|NCT03410927|HER3 mutation|her3 mutation
25858|NCT03410927|amplification or overexpression|amplification or overexpression
25859|NCT03410927|Urothelial cancer with HER2 or HER3 mutation|urothelial cancer with her2 or her3 mutation
25860|NCT03410927|Biliary tract cancer with HER2 or HER3 mutation|biliary tract cancer with her2 or her3 mutation
25861|NCT03410927|MBC with HER2 amplification or overexpression or HER3 mutation|mbc with her2 amplification or overexpression or her3 mutation
25862|NCT03410927|NSCLC with HER2 or HER3 mutation|nsclc with her2 or her3 mutation
25863|NCT03410927|CRC with HER2 or HER3 mutation|crc with her2 or her3 mutation
25864|NCT03410927|amplification|amplification
25865|NCT03410914|Hemopatch|hemopatch
25866|NCT03410888|sciatic nerve block|sciatic nerve block
25867|NCT03410888|infragluteal approach|infragluteal approach
25868|NCT03410888|popliteal approach|popliteal approach
25869|NCT03410875|Leukemia|leukemia
25870|NCT03410875|Hairy Cell Leukemia|hairy cell leukemia
25871|NCT03410875|BRAF|braf
25872|NCT03410875|vemurafenib|vemurafenib
25873|NCT03410875|obinutuzumab|obinutuzumab
25874|NCT03410875|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
25875|NCT03410875|17-513|17-513
25876|NCT03410862|Elderberry|elderberry
25877|NCT03410862|Influenza|influenza
25878|NCT03410836|lidocaine|lidocaine
25879|NCT03410836|colorectal cancer|colorectal cancer
25880|NCT03410836|laparoscopy surgery|laparoscopy surgery
25881|NCT03410836|anesthesia|anesthesia
25882|NCT03410836|inflammation|inflammation
25883|NCT03410836|cytokine|cytokine
25884|NCT03410836|post-operative immunosuppression|post-operative immunosuppression
25885|NCT03410823|hip fracture|hip fracture
25886|NCT03410823|exercise|exercise
25887|NCT03410823|protein|protein
25888|NCT03410810|Prematurity|prematurity
25889|NCT03410810|Neuroimaging|neuroimaging
25890|NCT03410797|SOVT|sovt
25891|NCT03410797|semi occluded vocal tract|semi occluded vocal tract
25892|NCT03410797|voice disorder|voice disorder
25893|NCT03410797|voice therapy|voice therapy
25894|NCT03410797|muscle tension dysphonia|muscle tension dysphonia
25895|NCT03410797|MTD|mtd
25896|NCT03410797|vocal fold lesions|vocal fold lesions
25897|NCT03410797|vocal fold atrophy|vocal fold atrophy
25898|NCT03410784|PD-L1 Expression|pd-l1 expression
25899|NCT03410784|prognostic factors|prognostic factors
25900|NCT03410784|predictive factors|predictive factors
25901|NCT03410784|Patient reported outcomes|patient reported outcomes
25902|NCT03410771|Distribution Volume|distribution volume
25903|NCT03410771|Antibiotics|antibiotics
25904|NCT03410745|exercise|exercise
25905|NCT03410745|cytokines|cytokines
25906|NCT03410745|collagen|collagen
26107|NCT03409302|web-based|web-based
25907|NCT03410732|dendritic cell|dendritic cell
25908|NCT03410732|immunotherapy|immunotherapy
25909|NCT03410732|tumor cell membrane proteins|tumor cell membrane proteins
25910|NCT03410706|Venous thromboembolism|venous thromboembolism
25911|NCT03410706|Anticoagulation|anticoagulation
25912|NCT03410706|Rivaroxaban|rivaroxaban
25913|NCT03410706|Observation study|observation study
25914|NCT03410693|Urothelial carcinoma|urothelial carcinoma
25915|NCT03410680|Antiretroviral Therapy|antiretroviral therapy
25916|NCT03410680|Adherence|adherence
25917|NCT03410680|HIV|hiv
25918|NCT03410680|Men who have sex with men|men who have sex with men
25919|NCT03410680|Sexual minorities|sexual minorities
25920|NCT03410680|habit-formation|habit-formation
25921|NCT03410680|gamification|gamification
25922|NCT03410641|cancer risk|cancer risk
25923|NCT03410641|randomised trial|randomised trial
25924|NCT03410641|intervention|intervention
25925|NCT03410641|smoking cessation|smoking cessation
25926|NCT03410641|dietary intervention|dietary intervention
25927|NCT03410641|weight loss|weight loss
25928|NCT03410602|Nonsurgical periodontal therapy|nonsurgical periodontal therapy
25929|NCT03410602|Orthodontic bands|orthodontic bands
25930|NCT03410576|Matrix metalloproteinase|matrix metalloproteinase
25931|NCT03410576|Carotid artery stenting|carotid artery stenting
25932|NCT03410576|Carotid endarterectomy|carotid endarterectomy
25933|NCT03410563|Pain|pain
25934|NCT03410563|Auditory inputs|auditory inputs
25935|NCT03410524|Bowel wall visualization|bowel wall visualization
25936|NCT03410524|Intraluminal bubbles|intraluminal bubbles
25937|NCT03410524|Intraluminal foam|intraluminal foam
25938|NCT03410524|Simethicone|simethicone
25939|NCT03410485|NoL index|nol index
25940|NCT03410485|Bispectral index|bispectral index
25941|NCT03410485|Intraoperative monitoring|intraoperative monitoring
25942|NCT03410420|Thoracic Aortic Aneurysm|thoracic aortic aneurysm
25943|NCT03410420|Hypoxia|hypoxia
25944|NCT03410420|Ascending Aorta|ascending aorta
25945|NCT03410420|Hypoxyprobe|hypoxyprobe
25946|NCT03410420|Pimonidazole|pimonidazole
25947|NCT03410407|Acute Myeloid Leukemia|acute myeloid leukemia
25948|NCT03410407|Central Nervous System|central nervous system
25949|NCT03410407|Relapse|relapse
25950|NCT03410407|Prognostic factors|prognostic factors
25951|NCT03410394|adrenal|adrenal
25952|NCT03410394|thyroid|thyroid
25953|NCT03410394|parathyroid|parathyroid
25954|NCT03410394|endocrine pancreas|endocrine pancreas
25955|NCT03410394|endocrine digestive tube|endocrine digestive tube
25956|NCT03410381|Psychiatry|psychiatry
25957|NCT03410381|Suicide|suicide
25958|NCT03410381|Prediction|prediction
25959|NCT03410381|Smartphone application|smartphone application
25960|NCT03410381|Ecological Momentary Assessment|ecological momentary assessment
25961|NCT03410368|maintenance therapy|maintenance therapy
25962|NCT03410368|immunotherapy|immunotherapy
25963|NCT03410368|adoptive cell transfer|adoptive cell transfer
25964|NCT03410368|natural killer cell|natural killer cell
25965|NCT03410316|Obesity, common diseases, epidemiology, etiology|obesity, common diseases, epidemiology, etiology
25966|NCT03410225|Pregnancy Prevention|pregnancy prevention
25967|NCT03410225|Male Involvement|male involvement
25968|NCT03410212|Inferior alveolar nerve block|inferior alveolar nerve block
25969|NCT03410212|ketorolac|ketorolac
25970|NCT03410212|success|success
25971|NCT03410160|adrenal crisis|adrenal crisis
25972|NCT03410160|predisposing factors|predisposing factors
25973|NCT03410134|Permanent teeth|permanent teeth
25974|NCT03410134|Vital pulp therapy|vital pulp therapy
25976|NCT03410043|Malignant neoplasms of respiratory and intrathoracic organs|malignant neoplasms of respiratory and intrathoracic organs
25977|NCT03410043|Non-small cell lung cancer|non-small cell lung cancer
25978|NCT03410043|NSCLC|nsclc
25979|NCT03410043|Osimertinib|osimertinib
25980|NCT03410043|AZD9291|azd9291
25981|NCT03410043|Local consolidative therapy|local consolidative therapy
25982|NCT03410043|LCT|lct
25983|NCT03410043|Radiotherapy|radiotherapy
25984|NCT03410043|Surgical resection|surgical resection
25985|NCT03410017|Functional Listening Index|functional listening index
25986|NCT03409991|Psychiatric Rehabilitation|psychiatric rehabilitation
25987|NCT03409991|Career Counseling|career counseling
25988|NCT03409978|Infants, newborn|infants, newborn
25989|NCT03409978|General Movements|general movements
25990|NCT03409978|Video Recording|video recording
25991|NCT03409978|Mobile Applications|mobile applications
25992|NCT03409978|Prognosis|prognosis
25993|NCT03409978|Parents|parents
25994|NCT03409939|nutrition|nutrition
25995|NCT03409939|phenylalanine|phenylalanine
25996|NCT03409939|tyrosine|tyrosine
25997|NCT03409939|stable isotope|stable isotope
25998|NCT03409926|Heart Disease|heart disease
25999|NCT03409926|Cardiovascular Disease|cardiovascular disease
26000|NCT03409926|Diet|diet
26001|NCT03409926|Fiber|fiber
26002|NCT03409926|Microbiome|microbiome
26003|NCT03409913|positron emissions tomography|positron emissions tomography
26004|NCT03409913|diagnostic accuracy|diagnostic accuracy
26005|NCT03409913|case-control|case-control
26006|NCT03409900|Lumbar Plexus Block|lumbar plexus block
26108|NCT03409302|adherence|adherence
26007|NCT03409900|Quadratus Lumborum Block|quadratus lumborum block
26008|NCT03409900|Direct Anterior Approach|direct anterior approach
26009|NCT03409900|Post-Operative|post-operative
26010|NCT03409900|Pain Management|pain management
26011|NCT03409887|root canal treatment, intraorifice barrier.|root canal treatment, intraorifice barrier.
26012|NCT03409809|Implementation Support|implementation support
26013|NCT03409809|Eating Disorder|eating disorder
26014|NCT03409809|Dissemination|dissemination
26015|NCT03409809|Prevention|prevention
26016|NCT03409809|Peer Leader|peer leader
26017|NCT03409796|Gluten Challenge|gluten challenge
26018|NCT03409757|microbiome|microbiome
26019|NCT03409744|HoFH|hofh
26020|NCT03409731|Drug eluting Bio-resolvable Scaffold (BRS)|drug eluting bio-resolvable scaffold (brs)
26021|NCT03409731|Bio-resolvable Scaffold (BRS)|bio-resolvable scaffold (brs)
26022|NCT03409731|Real world|real world
26023|NCT03409718|Total Shoulder Arthroplasty|total shoulder arthroplasty
26024|NCT03409718|Medical Device|medical device
26025|NCT03409718|Performance|performance
26026|NCT03409718|Safety|safety
26027|NCT03409718|Shoulder Prosthesis|shoulder prosthesis
26028|NCT03409666|Total Hip Arthroplasty|total hip arthroplasty
26029|NCT03409666|Medical Device|medical device
26030|NCT03409666|Performance|performance
26031|NCT03409666|Safety|safety
26032|NCT03409666|Hip prosthesis|hip prosthesis
26033|NCT03409666|Roentgen Stereophotogrammetric Analysis|roentgen stereophotogrammetric analysis
26034|NCT03409627|retrograde coronary sinus infusion|retrograde coronary sinus infusion
26035|NCT03409627|DNA|dna
26036|NCT03409627|non-viral|non-viral
26037|NCT03409627|triple effector plasmid|triple effector plasmid
26038|NCT03409627|gene therapy|gene therapy
26039|NCT03409627|regenerative medicine|regenerative medicine
26040|NCT03409627|non-stem cell|non-stem cell
26041|NCT03409614|Stage IIIB|stage iiib
26042|NCT03409614|Stage IV|stage iv
26043|NCT03409614|Non-squamous NSCLC|non-squamous nsclc
26044|NCT03409614|Squamous NSCLC|squamous nsclc
26045|NCT03409601|Obesity, eating behavior, food, nutrition|obesity, eating behavior, food, nutrition
26046|NCT03409588|Chronic Thromboembolic Disease, CTED, Treatment Post PEA surgery|chronic thromboembolic disease, cted, treatment post pea surgery
26047|NCT03409575|neuromuscular electrical stimulation|neuromuscular electrical stimulation
26048|NCT03409575|geriatric population|geriatric population
26049|NCT03409575|physical function|physical function
26050|NCT03409575|quadriceps|quadriceps
26051|NCT03409575|fatigue|fatigue
26052|NCT03409562|low back pain|low back pain
26053|NCT03409562|pain neurophysiology education|pain neurophysiology education
26054|NCT03409562|motor control|motor control
26055|NCT03409536|SSEP Monitoring|ssep monitoring
26056|NCT03409536|Diagnostic threshold|diagnostic threshold
26057|NCT03409510|vitamin D|vitamin d
26058|NCT03409510|25(OH)D|25(oh)d
26059|NCT03409510|skin pigmentation|skin pigmentation
26060|NCT03409510|UVB|uvb
26061|NCT03409510|pigment genes|pigment genes
26062|NCT03409471|Urine|urine
26063|NCT03409471|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
26064|NCT03409471|Self-Sampling|self-sampling
26065|NCT03409471|HPV Testing|hpv testing
26066|NCT03409471|Cervical Cancer Screening|cervical cancer screening
26067|NCT03409471|ASCUS|ascus
26068|NCT03409471|LSIL|lsil
26069|NCT03409458|Advanced Solid Tumors|advanced solid tumors
26070|NCT03409458|NSCLC|nsclc
26071|NCT03409458|mUC|muc
26072|NCT03409458|mBC|mbc
26073|NCT03409458|CRPC|crpc
26074|NCT03409458|SCCHN|scchn
26075|NCT03409419|Advanced|advanced
26076|NCT03409419|Recurrent|recurrent
26077|NCT03409419|Immune Therapy|immune therapy
26078|NCT03409406|developmental disability|developmental disability
26079|NCT03409406|speech and language disorder|speech and language disorder
26080|NCT03409406|mobile health technology|mobile health technology
26081|NCT03409406|parent training|parent training
26082|NCT03409406|communication intervention|communication intervention
26083|NCT03409393|Human|human
26084|NCT03409393|Denmark|denmark
26085|NCT03409393|Adult|adult
26086|NCT03409393|Adolescent|adolescent
26087|NCT03409393|Young Adult|young adult
26088|NCT03409393|Male|male
26089|NCT03409393|Female|female
26090|NCT03409393|Physical Activity|physical activity
26091|NCT03409393|Maximum Oxygen Consumption|maximum oxygen consumption
26092|NCT03409393|Resistance Training|resistance training
26093|NCT03409393|High-Intensity Functional Training|high-intensity functional training
26094|NCT03409393|Aerobic Exercise|aerobic exercise
26095|NCT03409393|Motivation|motivation
26096|NCT03409393|Feasibility|feasibility
26097|NCT03409393|Relevance|relevance
26098|NCT03409393|Health Behavior|health behavior
26099|NCT03409380|growth hormone|growth hormone
26100|NCT03409367|Prevention|prevention
26101|NCT03409367|Emollient|emollient
26102|NCT03409367|Pragmatic clinical trial|pragmatic clinical trial
26103|NCT03409315|Centralized Therapeutic Drug Monitoring|centralized therapeutic drug monitoring
26104|NCT03409315|Fluoroquinolones|fluoroquinolones
26105|NCT03409302|ACT|act
26106|NCT03409302|digital intervention|digital intervention
26109|NCT03409289|Spontaneous Circulation (ROSC)|spontaneous circulation (rosc)
26110|NCT03409289|Shock and Hypotension (RUSH) exam|shock and hypotension (rush) exam
26111|NCT03409263|Cirrhosis|cirrhosis
26112|NCT03409263|Advanced chronic liver disease|advanced chronic liver disease
26113|NCT03409263|Ascites|ascites
26114|NCT03409263|Variceal hemorrhage|variceal hemorrhage
26115|NCT03409263|Transjugular intrahepatic portosystemic shunt|transjugular intrahepatic portosystemic shunt
26116|NCT03409250|CNV due to Age Related Macular Degeneration|cnv due to age related macular degeneration
26117|NCT03409198|Neoplasms|neoplasms
26118|NCT03409185|Cataract surgery|cataract surgery
26119|NCT03409185|Intraocular lens|intraocular lens
26120|NCT03409185|Glistenings|glistenings
26121|NCT03409172|High intensity interval training|high intensity interval training
26122|NCT03409172|Inflammation|inflammation
26123|NCT03409172|Obesity|obesity
26124|NCT03409172|adipokines|adipokines
26125|NCT03409133|Prosthesis User|prosthesis user
26126|NCT03409133|Phantom Sensation|phantom sensation
26127|NCT03409133|Sensory Feedback|sensory feedback
26128|NCT03409120|Dystonia|dystonia
26129|NCT03409120|Parkinson's Disease|parkinson's disease
26130|NCT03409107|Non-Dialysis|non-dialysis
26131|NCT03409107|Anemia|anemia
26132|NCT03409107|Chronic kidney disease|chronic kidney disease
26133|NCT03409107|Recombinant human erythropoietin naïve|recombinant human erythropoietin naïve
26134|NCT03409107|Hemoglobin|hemoglobin
26135|NCT03409107|Daprodustat|daprodustat
26136|NCT03409081|Expanded Access|expanded access
26137|NCT03409081|FMS-like Tyrosine Kinase 3|fms-like tyrosine kinase 3
26138|NCT03409081|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
26139|NCT03409081|gilteritinib|gilteritinib
26140|NCT03409081|ASP2215|asp2215
26141|NCT03409068|Carotid thromboendarterectomy|carotid thromboendarterectomy
26142|NCT03409068|Carotidodynia|carotidodynia
26143|NCT03409042|Caloric compensation|caloric compensation
26144|NCT03409029|bladder|bladder
26145|NCT03409029|radiotherapy|radiotherapy
26146|NCT03409029|magnetic resonance imaging|magnetic resonance imaging
26147|NCT03409016|Immune Checkpoint Inhibitors|immune checkpoint inhibitors
26148|NCT03409016|Biomarkers|biomarkers
26149|NCT03409016|Immune Related Adverse Event|immune related adverse event
26150|NCT03409003|urea cycle disorder|urea cycle disorder
26151|NCT03408977|meal ingestion|meal ingestion
26152|NCT03408977|meal tolerance|meal tolerance
26153|NCT03408977|postprandial responses|postprandial responses
26154|NCT03408977|hedonic sensations|hedonic sensations
26155|NCT03408977|homeostatic sensations|homeostatic sensations
26156|NCT03408925|elite orienteering|elite orienteering
26157|NCT03408899|Microbicides|microbicides
26158|NCT03408886|fecal transplant|fecal transplant
26159|NCT03408886|fecal microbiota transplant|fecal microbiota transplant
26160|NCT03408886|microbiota transplant|microbiota transplant
26161|NCT03408886|vancomycin|vancomycin
26162|NCT03408886|moviprep|moviprep
26163|NCT03408873|Antipsychotic Drugs|antipsychotic drugs
26164|NCT03408873|Antipsychotics|antipsychotics
26165|NCT03408873|Injectables|injectables
26166|NCT03408873|Long Acting Injectable Antipsychotic|long acting injectable antipsychotic
26167|NCT03408873|Bipolar Disorder|bipolar disorder
26168|NCT03408873|Medication Adherence|medication adherence
26169|NCT03408873|Medication Non-Adherence|medication non-adherence
26170|NCT03408847|Ulcerative colitis|ulcerative colitis
26171|NCT03408847|UC|uc
26172|NCT03408847|Extra virgin olive oil|extra virgin olive oil
26173|NCT03408847|Polyphenols|polyphenols
26174|NCT03408834|NGAL|ngal
26175|NCT03408834|PVI|pvi
26176|NCT03408808|wrist|wrist
26177|NCT03408808|ganglion|ganglion
26178|NCT03408808|platelet rich plasma|platelet rich plasma
26179|NCT03408808|aspiration|aspiration
26180|NCT03408782|Surgical Site Infection|surgical site infection
26181|NCT03408782|Surgical drains|surgical drains
26182|NCT03408769|Cancer|cancer
26183|NCT03408769|Sexuality|sexuality
26184|NCT03408769|Quality of life|quality of life
26185|NCT03408769|Intimacy|intimacy
26186|NCT03408769|BISF-WBrief Index of Sexual Functioning for Women questionnaire|bisf-wbrief index of sexual functioning for women questionnaire
26187|NCT03408769|Quality of life questionnaire (EORTC QLQ-BR23):|quality of life questionnaire (eortc qlq-br23):
26188|NCT03408769|Partnership questionnaire (partnerschaftsfragebogen; PFB)|partnership questionnaire (partnerschaftsfragebogen; pfb)
26189|NCT03408743|Multiphase optimization strategy|multiphase optimization strategy
26190|NCT03408743|College students|college students
26191|NCT03408730|Hepatitis B Vaccines|hepatitis b vaccines
26192|NCT03408717|Breast cancer|breast cancer
26193|NCT03408717|Chronic pain|chronic pain
26194|NCT03408717|Acute Pain|acute pain
26195|NCT03408717|Depression|depression
26196|NCT03408717|Anxiety|anxiety
26197|NCT03408704|Streptococcus Pyogenes Infection|streptococcus pyogenes infection
26198|NCT03408704|Randomized Controlled Trial|randomized controlled trial
26199|NCT03408691|probiotic|probiotic
26200|NCT03408691|permeability|permeability
26201|NCT03408691|stress|stress
26202|NCT03408678|body composition|body composition
26203|NCT03408678|glucocorticoids|glucocorticoids
26204|NCT03408678|inflammation|inflammation
26205|NCT03408678|black African|black african
26206|NCT03408678|sex|sex
26207|NCT03408678|gonadal steroid hormones|gonadal steroid hormones
26208|NCT03408652|Bone Metastases|bone metastases
26209|NCT03408639|End-Stage Renal Disease, Anemia, Erythropoietin, Hemoglobine|end-stage renal disease, anemia, erythropoietin, hemoglobine
26210|NCT03408613|Obstructive Sleep Apnea|obstructive sleep apnea
26211|NCT03408613|Glucose Metabolism|glucose metabolism
26212|NCT03408600|Abdominal sepsis|abdominal sepsis
26213|NCT03408600|Secondary peritonitis|secondary peritonitis
26214|NCT03408600|Complicated intra-abdominal infections|complicated intra-abdominal infections
26215|NCT03408587|CVA21|cva21
26216|NCT03408587|CAVATAK|cavatak
26217|NCT03408587|Coxsackievirus|coxsackievirus
26218|NCT03408587|ocular|ocular
26219|NCT03408587|eye|eye
26220|NCT03408587|ipilimumab|ipilimumab
26221|NCT03408587|yervoy|yervoy
26222|NCT03408587|oncolytic|oncolytic
26223|NCT03408587|virus|virus
26224|NCT03408587|checkpoint|checkpoint
26225|NCT03408587|CTLA-4|ctla-4
26226|NCT03408574|nicotinic system|nicotinic system
26227|NCT03408574|cognitive aging|cognitive aging
26228|NCT03408574|working memory|working memory
26229|NCT03408574|fMRI|fmri
26230|NCT03408548|Bifidobacterium animalis subsp. lactis|bifidobacterium animalis subsp. lactis
26231|NCT03408548|Probiotic|probiotic
26232|NCT03408548|Periodontitis treatment|periodontitis treatment
26233|NCT03408548|Periodontitis|periodontitis
26234|NCT03408535|eHealth|ehealth
26235|NCT03408535|Online Rehabilitation|online rehabilitation
26236|NCT03408535|Hearing Problems|hearing problems
26237|NCT03408535|Adult|adult
26238|NCT03408535|Hearing Aids|hearing aids
26239|NCT03408496|Myofascial release|myofascial release
26240|NCT03408496|Pain|pain
26241|NCT03408496|Manual therapy|manual therapy
26242|NCT03408496|Muscle stretching|muscle stretching
26243|NCT03408496|Quality of life|quality of life
26244|NCT03408483|Quadratus Lumborum Block|quadratus lumborum block
26245|NCT03408470|Absolute Bioavailability|absolute bioavailability
26246|NCT03408470|ADME|adme
26247|NCT03408470|Healthy Normal Males|healthy normal males
26248|NCT03408457|Surgical wound infection|surgical wound infection
26249|NCT03408457|antibiotic concentration|antibiotic concentration
26250|NCT03408457|blood level|blood level
26251|NCT03408418|Platelet-rich fibrin|platelet-rich fibrin
26252|NCT03408418|Tooth Extraction|tooth extraction
26253|NCT03408418|Alveolar Bone Grafting|alveolar bone grafting
26254|NCT03408392|Single dose|single dose
26255|NCT03408392|Oral suspension|oral suspension
26256|NCT03408392|Bioequivalence|bioequivalence
26257|NCT03408392|Cefixime|cefixime
26258|NCT03408392|Two-way crossover|two-way crossover
26259|NCT03408379|intracranial aneurysms|intracranial aneurysms
26260|NCT03408379|ruptured aneurysm|ruptured aneurysm
26261|NCT03408379|platelet activity|platelet activity
26262|NCT03408366|Laparotomy|laparotomy
26263|NCT03408366|Surgical Incisions|surgical incisions
26264|NCT03408366|Wound Perfusion|wound perfusion
26265|NCT03408366|17-650|17-650
26266|NCT03408340|Anesthesiology|anesthesiology
26267|NCT03408340|Pediatric surgery|pediatric surgery
26268|NCT03408340|Anesthesia, Regional|anesthesia, regional
26269|NCT03408340|Anesthesia, Cardiac Procedures|anesthesia, cardiac procedures
26270|NCT03408340|Nerve Block|nerve block
26271|NCT03408327|Schizophrenia|schizophrenia
26272|NCT03408327|Physical Activity|physical activity
26273|NCT03408327|Health Promotion|health promotion
26274|NCT03408327|Wearable Technology|wearable technology
26275|NCT03408327|Fitness Wristband|fitness wristband
26276|NCT03408327|mobile health, mHealth|mobile health, mhealth
26277|NCT03408314|Advanced Cancer|advanced cancer
26278|NCT03408275|Dietary patterns|dietary patterns
26279|NCT03408275|Pregnancy|pregnancy
26280|NCT03408275|Woman|woman
26281|NCT03408275|Diet|diet
26282|NCT03408275|Lead|lead
26283|NCT03408275|ALSPAC|alspac
26284|NCT03408249|Crohn's disease, ulcerative colitis, fecal calprotectin|crohn's disease, ulcerative colitis, fecal calprotectin
26285|NCT03408197|inadvertent, intraoperative hypothermia, prewarming|inadvertent, intraoperative hypothermia, prewarming
26286|NCT03408171|liver biopsy|liver biopsy
26287|NCT03408171|endoscopic ultrasound guided liver biopsy|endoscopic ultrasound guided liver biopsy
26288|NCT03408171|FNA|fna
26289|NCT03408171|FNB|fnb
26290|NCT03408158|HPA|hpa
26291|NCT03408158|Blood disease|blood disease
26292|NCT03408145|Stem Cell Therapy|stem cell therapy
26293|NCT03408145|Injection|injection
26294|NCT03408145|Hyaluronic Acid|hyaluronic acid
26295|NCT03408145|Synovial Fluid|synovial fluid
26296|NCT03408119|prune|prune
26297|NCT03408119|dried plum|dried plum
26298|NCT03408119|osteoporosis|osteoporosis
26299|NCT03408119|osteopenia|osteopenia
26300|NCT03408119|men|men
26301|NCT03408093|Interferon beta-1b (INFb-1b)|interferon beta-1b (infb-1b)
26302|NCT03408093|Multiple Sclerosis (MS)|multiple sclerosis (ms)
26303|NCT03408093|Relapsing-remitting MS (RRMS)|relapsing-remitting ms (rrms)
26304|NCT03408093|Secondary progressive MS (SPMS)|secondary progressive ms (spms)
26305|NCT03408093|Clinically isolated syndrome (CIS)|clinically isolated syndrome (cis)
26306|NCT03408054|Uterine contraction|uterine contraction
26307|NCT03408054|Oxytocin|oxytocin
26308|NCT03408054|Nitroglycerin|nitroglycerin
26309|NCT03408041|Alzheimer Disease|alzheimer disease
26310|NCT03408041|Objective parameters|objective parameters
26311|NCT03408041|Scheltens index|scheltens index
26312|NCT03408028|Therapeutic code|therapeutic code
26313|NCT03408028|Geriatry|geriatry
26314|NCT03408015|dry eye disease|dry eye disease
26315|NCT03408015|neutrophil|neutrophil
26316|NCT03408015|T cell|t cell
26317|NCT03408015|lifitegrast|lifitegrast
26318|NCT03408015|contact lens discomfort|contact lens discomfort
26319|NCT03408015|ocular surface homeostasis|ocular surface homeostasis
26320|NCT03408002|preoperative anxiety|preoperative anxiety
26321|NCT03408002|self-efficacy|self-efficacy
26322|NCT03408002|psychophysiology|psychophysiology
26323|NCT03408002|psychotherapy|psychotherapy
26324|NCT03408002|pancreatic surgery|pancreatic surgery
26325|NCT03407950|Deficit Schizophrenia|deficit schizophrenia
26326|NCT03407950|long stay inpatients|long stay inpatients
26327|NCT03407950|cognitive remediation|cognitive remediation
26328|NCT03407950|negative symptoms|negative symptoms
26329|NCT03407937|Hypnosis|hypnosis
26330|NCT03407937|Meditation|meditation
26331|NCT03407937|Conditioned pain modulation|conditioned pain modulation
26332|NCT03407937|Placebo|placebo
26333|NCT03407937|Endocannabinoids|endocannabinoids
26334|NCT03407937|Opioid peptides|opioid peptides
26335|NCT03407937|Norepinephrine|norepinephrine
26336|NCT03407937|Pain|pain
26337|NCT03407937|Analgesia|analgesia
26338|NCT03407937|Genes|genes
26339|NCT03407937|Heart rate variability|heart rate variability
26340|NCT03407911|Peri-implant pocket microbiota|peri-implant pocket microbiota
26341|NCT03407911|Periodontal pocket microbiota|periodontal pocket microbiota
26342|NCT03407859|CD19-CART|cd19-cart
26343|NCT03407859|CD20-CART|cd20-cart
26344|NCT03407859|CD10-CART|cd10-cart
26345|NCT03407859|CD22-CART|cd22-cart
26346|NCT03407859|Relapsed/Refractory B-ALL|relapsed/refractory b-all
26347|NCT03407859|MRD|mrd
26348|NCT03407807|Fetal Splenic cyst|fetal splenic cyst
26349|NCT03407807|Differential Diagnosis|differential diagnosis
26350|NCT03407807|Evolution and complication|evolution and complication
26351|NCT03407768|Premenopausal breast cancer|premenopausal breast cancer
26352|NCT03407768|Individualized interventions|individualized interventions
26353|NCT03407768|Exercise|exercise
26354|NCT03407768|Combination hormone therapy|combination hormone therapy
26355|NCT03407768|Massage therapy|massage therapy
26356|NCT03407768|Yoga|yoga
26357|NCT03407768|Acupuncture|acupuncture
26358|NCT03407768|Treatment tolerance|treatment tolerance
26359|NCT03407768|Treatment adherence|treatment adherence
26360|NCT03407768|Adverse effects|adverse effects
26361|NCT03407768|Quality of life|quality of life
26362|NCT03407755|Intraocular gas|intraocular gas
26363|NCT03407755|Positioning|positioning
26364|NCT03407755|DMEK|dmek
26365|NCT03407755|Endothelial keratoplasty|endothelial keratoplasty
26366|NCT03407729|Hypoxia, Brain|hypoxia, brain
26367|NCT03407729|Neural networks|neural networks
26368|NCT03407729|Magnetic Resonance Imaging|magnetic resonance imaging
26369|NCT03407729|EEG|eeg
26370|NCT03407703|genotype 1|genotype 1
26371|NCT03407703|genotype 4|genotype 4
26372|NCT03407638|Opioid Use Disorder|opioid use disorder
26373|NCT03407638|Primary Care|primary care
26374|NCT03407638|Buprenorphine|buprenorphine
26375|NCT03407638|Naltrexone|naltrexone
26376|NCT03407625|Pregnancy|pregnancy
26377|NCT03407625|Labor Induction|labor induction
26378|NCT03407625|Cervical Ripening|cervical ripening
26379|NCT03407612|continuous passive motion device|continuous passive motion device
26380|NCT03407612|HOS-ADL|hos-adl
26381|NCT03407612|hip arthroscopy|hip arthroscopy
26382|NCT03407586|point-of-care testing|point-of-care testing
26383|NCT03407586|sexually transmitted infections|sexually transmitted infections
26384|NCT03407586|expedited partner therapy|expedited partner therapy
26385|NCT03407586|genital inflammation|genital inflammation
26386|NCT03407560|bone substitute|bone substitute
26387|NCT03407560|spinal fusion|spinal fusion
26388|NCT03407560|lumbar spine disease|lumbar spine disease
26389|NCT03407547|upper limb|upper limb
26390|NCT03407547|recovery|recovery
26391|NCT03407547|somatosensory|somatosensory
26392|NCT03407547|impairment|impairment
26393|NCT03407547|electroencephalography|electroencephalography
26394|NCT03407547|acute phase|acute phase
26395|NCT03407534|Exocrine|exocrine
26396|NCT03407534|Pancreatic Insufficiency|pancreatic insufficiency
26397|NCT03407534|Diarrhea|diarrhea
26398|NCT03407534|Bloating|bloating
26399|NCT03407534|Loose Stool|loose stool
26400|NCT03407521|second trimester abortion|second trimester abortion
26401|NCT03407495|Hepatocellular Carcinoma|hepatocellular carcinoma
26402|NCT03407495|Magnetic Resonance Imaging|magnetic resonance imaging
26403|NCT03407469|Questionnaires|questionnaires
26404|NCT03407469|Surveys|surveys
26405|NCT03407469|Cancer-related Venous Thromboembolism|cancer-related venous thromboembolism
26406|NCT03407469|VTE|vte
27006|NCT03403725|ADC|adc
26407|NCT03407443|mental health promotion campaign|mental health promotion campaign
26408|NCT03407443|veterans|veterans
26409|NCT03407430|Pregabalin|pregabalin
26410|NCT03407430|Bone pain|bone pain
26411|NCT03407430|Pegfilgrastim|pegfilgrastim
26412|NCT03407430|Supportive care|supportive care
26413|NCT03407430|prevention|prevention
26414|NCT03407391|Picky eater|picky eater
26415|NCT03407391|Fussy eater|fussy eater
26416|NCT03407391|Faddy eater|faddy eater
26417|NCT03407391|Nutrition|nutrition
26418|NCT03407352|Exercise|exercise
26419|NCT03407352|Video Games|video games
26420|NCT03407352|Physical Activity|physical activity
26421|NCT03407352|Children|children
26422|NCT03407352|Appetite|appetite
26423|NCT03407326|severe acute malnutrition, SAM|severe acute malnutrition, sam
26424|NCT03407313|Submental fullness|submental fullness
26425|NCT03407313|Submental fat|submental fat
26426|NCT03407313|Loose skin|loose skin
26427|NCT03407300|Non-small Cell Lung Cancer (NSCLC), XH1|non-small cell lung cancer (nsclc), xh1
26428|NCT03407222|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
26429|NCT03407222|Physical Activity|physical activity
26430|NCT03407222|Personal health record|personal health record
26431|NCT03407222|Intervention|intervention
26432|NCT03407209|Epidural analgesia|epidural analgesia
26433|NCT03407209|Patient Controlled Epidural Analgesia (PCEA)|patient controlled epidural analgesia (pcea)
26434|NCT03407209|Patient Epidural Intermittent Bolus (PEIB)|patient epidural intermittent bolus (peib)
26435|NCT03407209|Local anesthetics|local anesthetics
26436|NCT03407196|Diabetes|diabetes
26437|NCT03407196|Dapagliflozin|dapagliflozin
26438|NCT03407196|Endocrinology|endocrinology
26439|NCT03407196|Internal diseases|internal diseases
26440|NCT03407196|Type II diabetes mellitus|type ii diabetes mellitus
26441|NCT03407196|HbA1c|hba1c
26442|NCT03407196|BMI|bmi
26443|NCT03407196|BP|bp
26444|NCT03407170|Programmed Cell Death-1 (PD-1)|programmed cell death-1 (pd-1)
26445|NCT03407170|PD1|pd1
26446|NCT03407170|Programmed Cell Death-Ligand 1 (PD-L1)|programmed cell death-ligand 1 (pd-l1)
26447|NCT03407170|Programmed Cell Death-Ligand 2 (PD-L2)|programmed cell death-ligand 2 (pd-l2)
26448|NCT03407170|PDL1|pdl1
26449|NCT03407170|PDL2|pdl2
26450|NCT03407157|Probiotics|probiotics
26451|NCT03407157|Pregnancy|pregnancy
26452|NCT03407157|GBS|gbs
26453|NCT03407157|Group B Streptococcus|group b streptococcus
26454|NCT03407144|Programmed Death-1 (PD-1)|programmed death-1 (pd-1)
26455|NCT03407144|PD1|pd1
26456|NCT03407144|Programmed Death-Ligand 1 (PD-L1)|programmed death-ligand 1 (pd-l1)
26457|NCT03407144|PDL1|pdl1
26458|NCT03407131|Intertrochanteric fracture, Medical complications|intertrochanteric fracture, medical complications
26459|NCT03407079|Drug Metabolism|drug metabolism
26460|NCT03407079|Artificial Sweetner|artificial sweetner
26461|NCT03407079|P-Glycoprotein|p-glycoprotein
26462|NCT03407079|Cytochrome P 450|cytochrome p 450
26463|NCT03407079|Microbiome|microbiome
26464|NCT03407066|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
26465|NCT03407066|MEG|meg
26466|NCT03407066|Color Vision|color vision
26467|NCT03407066|Neuroimaging|neuroimaging
26468|NCT03407053|Calories|calories
26469|NCT03407053|Food Intake|food intake
26470|NCT03407053|Glucose|glucose
26471|NCT03407053|Body Composition|body composition
26472|NCT03407053|Body Weight Regulation|body weight regulation
26473|NCT03407040|Blood|blood
26474|NCT03407040|Tissue|tissue
26475|NCT03407040|Immunotherapy|immunotherapy
26476|NCT03407040|Tumor|tumor
26477|NCT03407040|Somatic|somatic
26478|NCT03407027|Quadratus lumborum syndrome; ultrasound- guided infiltration|quadratus lumborum syndrome; ultrasound- guided infiltration
26479|NCT03407001|Diseases of liver|diseases of liver
26480|NCT03407001|Hepatocellular carcinoma|hepatocellular carcinoma
26481|NCT03407001|HCC|hcc
26482|NCT03407001|Lumason|lumason
26483|NCT03407001|Ultrasounds|ultrasounds
26484|NCT03406988|Systemic Sclerosis|systemic sclerosis
26485|NCT03406988|Digital Ulcer|digital ulcer
26486|NCT03406988|Autologous fat grafting|autologous fat grafting
26487|NCT03406988|Adipose tissue stem cells|adipose tissue stem cells
26488|NCT03406962|inherited metabolic disorders|inherited metabolic disorders
26489|NCT03406962|cerebral adrenoleukodystrophy|cerebral adrenoleukodystrophy
26490|NCT03406962|Hurler syndrome|hurler syndrome
26491|NCT03406962|globoid cell leukodystrophy|globoid cell leukodystrophy
26492|NCT03406962|Krabbe disease|krabbe disease
26493|NCT03406962|metachromatic leukodystrophy|metachromatic leukodystrophy
26494|NCT03406962|hematopoietic stem cells|hematopoietic stem cells
26495|NCT03406962|hematopoietic stem cell transplant|hematopoietic stem cell transplant
26496|NCT03406962|umbilical cord blood|umbilical cord blood
26497|NCT03406962|umbilical cord blood transplant|umbilical cord blood transplant
26498|NCT03406962|MGTA-456|mgta-456
26499|NCT03406962|myeloablative conditioning regimen|myeloablative conditioning regimen
26500|NCT03406962|bone marrow transplant|bone marrow transplant
26501|NCT03406962|mucopolysaccharidosis-1H|mucopolysaccharidosis-1h
26502|NCT03406923|Health literacy|health literacy
26503|NCT03406923|Self-efficacy|self-efficacy
26504|NCT03406923|Beliefs about diabetes|beliefs about diabetes
26505|NCT03406923|Beliefs in medicines|beliefs in medicines
26506|NCT03406910|egg|egg
26507|NCT03406910|meat|meat
26508|NCT03406910|western diet|western diet
26509|NCT03406910|type 2 diabetes|type 2 diabetes
26510|NCT03406910|Adventist Health Study|adventist health study
26511|NCT03406910|Vegetarian cohort|vegetarian cohort
26512|NCT03406910|Adventist|adventist
26513|NCT03406884|stem cells|stem cells
26514|NCT03406884|pediatric|pediatric
26515|NCT03406871|Regorafenib|regorafenib
26516|NCT03406871|Nivolumab|nivolumab
26517|NCT03406871|Phase I clinical trial|phase i clinical trial
26518|NCT03406832|Prevention|prevention
26519|NCT03406832|Slow flow|slow flow
26520|NCT03406832|No reflow|no reflow
26521|NCT03406832|Nitroprusside|nitroprusside
26522|NCT03406832|Tirofiban|tirofiban
26523|NCT03406819|Prevention|prevention
26524|NCT03406819|Slow flow|slow flow
26525|NCT03406819|No reflow|no reflow
26526|NCT03406819|Nitroprusside|nitroprusside
26527|NCT03406819|Tirofiban|tirofiban
26528|NCT03406793|Zinc|zinc
26529|NCT03406793|Multiple micronutrient powders|multiple micronutrient powders
26530|NCT03406793|Diarrhea|diarrhea
26531|NCT03406793|Stunting|stunting
26532|NCT03406780|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
26533|NCT03406780|Cell Therapy|cell therapy
26534|NCT03406780|Performance of the Upper Limb|performance of the upper limb
26535|NCT03406780|Pulmonary Function|pulmonary function
26536|NCT03406780|Ambulatory|ambulatory
26537|NCT03406780|Non-Ambulatory|non-ambulatory
26538|NCT03406780|Glucocorticoids|glucocorticoids
26539|NCT03406728|Parkinson's Disease|parkinson's disease
26540|NCT03406728|Virtual Reality|virtual reality
26541|NCT03406728|Training|training
26542|NCT03406728|Balance|balance
26543|NCT03406728|Falls|falls
26544|NCT03406728|PDSAFEX|pdsafex
26545|NCT03406715|SCLC|sclc
26546|NCT03406715|Lung Cancer|lung cancer
26547|NCT03406715|Lung Disease|lung disease
26548|NCT03406715|Relapsed SCLC|relapsed sclc
26549|NCT03406702|Epilepsy, Generalized Epileptic Syndromes, Absence Seizures|epilepsy, generalized epileptic syndromes, absence seizures
26550|NCT03406689|Pain|pain
26551|NCT03406689|Intravitreal Injection|intravitreal injection
26552|NCT03406689|Anti-VEGF|anti-vegf
26553|NCT03406689|Nepafenac eye drops|nepafenac eye drops
26554|NCT03406689|Short Form McGill Pain Questionnaire|short form mcgill pain questionnaire
26555|NCT03406676|Methylene blue; Peripheral vascular resistance|methylene blue; peripheral vascular resistance
26556|NCT03406663|Insulin|insulin
26557|NCT03406650|muscle invasive urothelial cancer|muscle invasive urothelial cancer
26558|NCT03406650|cancer|cancer
26559|NCT03406650|immunotherapy|immunotherapy
26560|NCT03406650|durvalumab|durvalumab
26561|NCT03406650|MEDI4736|medi4736
26562|NCT03406650|adjuvant|adjuvant
26563|NCT03406650|neoadjuvant|neoadjuvant
26564|NCT03406650|radical cystectomy|radical cystectomy
26565|NCT03406650|bladder|bladder
26566|NCT03406624|Modic changes|modic changes
26567|NCT03406624|biomarkers|biomarkers
26568|NCT03406624|low back pain|low back pain
26569|NCT03406598|Shock|shock
26570|NCT03406598|Microcirculation|microcirculation
26571|NCT03406598|Nurses|nurses
26572|NCT03406572|Acute on chronic respiratory failure|acute on chronic respiratory failure
26573|NCT03406572|High-Flow heated and humidified nasal oxygen therapy|high-flow heated and humidified nasal oxygen therapy
26574|NCT03406520|peritoneal dialysis|peritoneal dialysis
26575|NCT03406520|chlorhexidine|chlorhexidine
26576|NCT03406520|exit site infection|exit site infection
26577|NCT03406520|tunnel tract infection|tunnel tract infection
26578|NCT03406494|sepsis|sepsis
26579|NCT03406494|critical illness|critical illness
26580|NCT03406494|intensive care unit|intensive care unit
26581|NCT03406494|mechanical ventilation|mechanical ventilation
26582|NCT03406494|rehabilitation|rehabilitation
26583|NCT03406494|mortality|mortality
26584|NCT03406494|physical function|physical function
26585|NCT03406494|health-related quality of life|health-related quality of life
26586|NCT03406468|non small cell lung cancer|non small cell lung cancer
26587|NCT03406468|immune therapy|immune therapy
26588|NCT03406468|radiotherapy|radiotherapy
26589|NCT03406455|wearable|wearable
26590|NCT03406455|mhealth|mhealth
26591|NCT03406429|rTMS|rtms
26592|NCT03406429|PPA|ppa
26593|NCT03406390|contrast sensitivity|contrast sensitivity
26594|NCT03406390|Pterygium|pterygium
26595|NCT03406325|mast cell|mast cell
26596|NCT03406325|allergy|allergy
26597|NCT03406325|genomic|genomic
26598|NCT03406325|biomarkers|biomarkers
26599|NCT03406312|Roux en Y Gastric Bypass Surgery, Hypoglycemia, Postprandial|roux en y gastric bypass surgery, hypoglycemia, postprandial
26600|NCT03406299|SLOG|slog
26601|NCT03406286|Post Marketing Surveillance|post marketing surveillance
26602|NCT03406208|Psychiatry|psychiatry
26603|NCT03406208|Psychology|psychology
26604|NCT03406208|Psychosocial|psychosocial
26605|NCT03406208|Behavioral|behavioral
26606|NCT03406195|transcranial magnetic stimulation|transcranial magnetic stimulation
26607|NCT03406182|stunting|stunting
27689|NCT03398590|Obesity|obesity
26608|NCT03406182|under-weight|under-weight
26609|NCT03406182|Pakistan|pakistan
26610|NCT03406182|infant|infant
26611|NCT03406182|time-use|time-use
26612|NCT03406182|women|women
26613|NCT03406182|body mass index|body mass index
26614|NCT03406182|growth|growth
26615|NCT03406169|penile rehabilitation|penile rehabilitation
26616|NCT03406156|Cancer Chronic Lymphocytic Leukemia 17p Deletion debulking obinutuzumab bendamustine tumor lysis syndrome venetoclax|cancer chronic lymphocytic leukemia 17p deletion debulking obinutuzumab bendamustine tumor lysis syndrome venetoclax
26617|NCT03406104|Heredity Optic Atrophy|heredity optic atrophy
26618|NCT03406104|Leber Hereditary Optic Atrophy|leber hereditary optic atrophy
26619|NCT03406104|Leber Hereditary Optic Neuropathy|leber hereditary optic neuropathy
26620|NCT03406104|LHON|lhon
26621|NCT03406104|Eye Diseases|eye diseases
26622|NCT03406104|Hereditary Eye Diseases|hereditary eye diseases
26623|NCT03406104|Inborn Genetic Disease|inborn genetic disease
26624|NCT03406104|Gene Therapy|gene therapy
26625|NCT03406104|Intravitreal Injections|intravitreal injections
26626|NCT03406104|Mitochondrial Disease|mitochondrial disease
26627|NCT03406104|AAV2 Vectors|aav2 vectors
26628|NCT03406104|Nervous System Diseases|nervous system diseases
26629|NCT03406104|Neurodegenerative Disease|neurodegenerative disease
26630|NCT03406104|Heredodegenerative Disorders of the Nervous System|heredodegenerative disorders of the nervous system
26631|NCT03406078|Asthma|asthma
26632|NCT03406065|Sodium bicarbonate|sodium bicarbonate
26633|NCT03406065|NaHCO3|nahco3
26634|NCT03406065|Combat Sports|combat sports
26635|NCT03406065|Physical capacity|physical capacity
26636|NCT03406065|Dummy test|dummy test
26637|NCT03406039|Alcohol Use Disorder|alcohol use disorder
26638|NCT03406039|Emotional Disorder|emotional disorder
26639|NCT03406039|Cognitive Behavioural Therapy|cognitive behavioural therapy
26640|NCT03406039|Motivational Interviewing|motivational interviewing
26641|NCT03406039|Online Intervention|online intervention
26642|NCT03406039|Randomized Controlled Trial|randomized controlled trial
26643|NCT03406026|Stroke|stroke
26644|NCT03406026|Balance rehabilitation|balance rehabilitation
26645|NCT03406026|Physiotherapy|physiotherapy
26646|NCT03405974|Osteonecrosis|osteonecrosis
26647|NCT03405974|Aspirin|aspirin
26648|NCT03405961|PAR scoring|par scoring
26649|NCT03405961|Digital study models|digital study models
26650|NCT03405909|contrast-enhanced ultrasound|contrast-enhanced ultrasound
26651|NCT03405909|non-invasive diagnosis|non-invasive diagnosis
26652|NCT03405909|focal liver lesion|focal liver lesion
26653|NCT03405909|liver cirrhosis|liver cirrhosis
26654|NCT03405909|standardised diagnostic algorithm|standardised diagnostic algorithm
26655|NCT03405909|intrahepatic cholangiocellular carcinoma|intrahepatic cholangiocellular carcinoma
26656|NCT03405909|ESCULAP|esculap
26657|NCT03405909|CEUS LI-RADS|ceus li-rads
26658|NCT03405909|imaging|imaging
26659|NCT03405909|hepatocellular carcinoma|hepatocellular carcinoma
26660|NCT03405909|MRI|mri
26661|NCT03405909|diagnostic accuracy|diagnostic accuracy
26662|NCT03405909|interobserver agreement|interobserver agreement
26663|NCT03405909|Erlanger Synopsis of CEUS for Liver lesion Assessment in Patients at risk|erlanger synopsis of ceus for liver lesion assessment in patients at risk
26664|NCT03405909|CEUS Liver Imaging Reporting and Data System|ceus liver imaging reporting and data system
26665|NCT03405870|cholesterol|cholesterol
26666|NCT03405870|lipids|lipids
26667|NCT03405870|total parenteral nutrition|total parenteral nutrition
26668|NCT03405857|mild cognitive impairment|mild cognitive impairment
26669|NCT03405857|cognitive training program|cognitive training program
26670|NCT03405844|Shoulder|shoulder
26671|NCT03405844|glenohumeral|glenohumeral
26672|NCT03405844|stretching|stretching
26673|NCT03405831|Heart transplantation|heart transplantation
26674|NCT03405831|Exercise capacity|exercise capacity
26675|NCT03405831|Heart rate|heart rate
26676|NCT03405831|Cardiac allograft vasculopathy|cardiac allograft vasculopathy
26677|NCT03405818|Fungal infection of the nail|fungal infection of the nail
26678|NCT03405792|Tumor Treating Electric Fields (TTFields)|tumor treating electric fields (ttfields)
26679|NCT03405714|Epilepsy|epilepsy
26680|NCT03405714|Brivaracetam|brivaracetam
26681|NCT03405714|Briviact|briviact
26682|NCT03405714|Open-label|open-label
26683|NCT03405714|pediatric|pediatric
26684|NCT03405714|intravenous|intravenous
26685|NCT03405688|Sickle cell|sickle cell
26686|NCT03405688|Heterozygous|heterozygous
26687|NCT03405688|Blood donor|blood donor
26688|NCT03405675|Dementia|dementia
26689|NCT03405675|Mild cognitive impairment|mild cognitive impairment
26690|NCT03405675|Cognitive abilities and changes|cognitive abilities and changes
26691|NCT03405675|Functional change and disabilities|functional change and disabilities
26692|NCT03405675|Depression|depression
26693|NCT03405675|Health and social services utilization|health and social services utilization
26694|NCT03405675|Quality of life|quality of life
26695|NCT03405675|Adverse drug effects|adverse drug effects
26696|NCT03405675|Social network and support|social network and support
26697|NCT03405675|Self-rated health|self-rated health
26698|NCT03405675|Medical morbidities|medical morbidities
26699|NCT03405675|Falls|falls
27786|NCT03397927|pain|pain
26700|NCT03405675|Health risk behaviors|health risk behaviors
26701|NCT03405675|Nutrition|nutrition
26702|NCT03405675|Apo-E lipoprotein|apo-e lipoprotein
26703|NCT03405675|Phytochemicals|phytochemicals
26704|NCT03405675|B12|b12
26705|NCT03405675|Folate|folate
26706|NCT03405675|Homocysteine|homocysteine
26707|NCT03405675|Lifestyle|lifestyle
26708|NCT03405675|Physical activity|physical activity
26709|NCT03405675|Leisure activity|leisure activity
26710|NCT03405675|Successful ageing|successful ageing
26711|NCT03405675|Mortality|mortality
26712|NCT03405649|postpartum|postpartum
26713|NCT03405649|exercise|exercise
26714|NCT03405649|intervention|intervention
26715|NCT03405610|Psychiatry|psychiatry
26716|NCT03405610|Psychology|psychology
26717|NCT03405610|Psychosocial|psychosocial
26718|NCT03405610|Mind-Body|mind-body
26719|NCT03405584|Helicobacter pylori|helicobacter pylori
26720|NCT03405584|Therapy|therapy
26721|NCT03405506|Fractional Flow Reserve|fractional flow reserve
26722|NCT03405506|Quantitative Coronary Angiography|quantitative coronary angiography
26723|NCT03405506|Coronary artery disease|coronary artery disease
26724|NCT03405506|Quantitative Flow Ratio|quantitative flow ratio
26725|NCT03405506|Tandem lesion|tandem lesion
26726|NCT03405506|Virtual stenting|virtual stenting
26727|NCT03405493|Circadian Rhythm|circadian rhythm
26728|NCT03405493|Light Therapy|light therapy
26729|NCT03405493|Wake Therapy|wake therapy
26730|NCT03405493|Sleep Phase Advance|sleep phase advance
26731|NCT03405493|Major Depression|major depression
26732|NCT03405480|Pulmonary embolism|pulmonary embolism
26733|NCT03405480|Dyspnea|dyspnea
26734|NCT03405480|Post Pulmonary Embolism Syndrome|post pulmonary embolism syndrome
26735|NCT03405480|PPS|pps
26736|NCT03405480|Rehabilitation|rehabilitation
26737|NCT03405480|Cardiac magnetic resonance imaging (CMR)|cardiac magnetic resonance imaging (cmr)
26738|NCT03405428|Ultrasonography|ultrasonography
26739|NCT03405428|Radial Artery Diameter|radial artery diameter
26740|NCT03405428|Allen Test|allen test
26741|NCT03405428|Arterial Cannulation|arterial cannulation
26742|NCT03405428|Doppler Ultrasonography|doppler ultrasonography
26743|NCT03405428|Ulnar Artery|ulnar artery
26744|NCT03405402|Sickle cell disease|sickle cell disease
26745|NCT03405402|Allo-immunization|allo-immunization
26746|NCT03405402|Blood transfusion|blood transfusion
26747|NCT03405389|mandibulo-maxillary fixation|mandibulo-maxillary fixation
26748|NCT03405389|malocclusion|malocclusion
26749|NCT03405324|brain stimulation, tDCS, nausea and vomiting|brain stimulation, tdcs, nausea and vomiting
26750|NCT03405311|Labor analgesia|labor analgesia
26751|NCT03405311|Ultrasound|ultrasound
26752|NCT03405311|Obesity, Morbid|obesity, morbid
26753|NCT03405311|Pregnancy|pregnancy
26754|NCT03405311|Labor Epidural Analgesia|labor epidural analgesia
26755|NCT03405285|Improved Bladder Management|improved bladder management
26756|NCT03405285|Neurogenic Lower Urinary Tract Dysfunction|neurogenic lower urinary tract dysfunction
26757|NCT03405285|Bladder function following Spinal Cord Injury|bladder function following spinal cord injury
26758|NCT03405285|Urinary Retention|urinary retention
26759|NCT03405272|Full human anti-EGFR monoclonal antibody (SCT200)|full human anti-egfr monoclonal antibody (sct200)
26760|NCT03405272|metastatic colorectal cancer （mCRC）|metastatic colorectal cancer （mcrc）
26761|NCT03405246|Childhood obesity|childhood obesity
26762|NCT03405246|Weight gain in children|weight gain in children
26763|NCT03405246|Diet intervention|diet intervention
26764|NCT03405233|ESRD|esrd
26765|NCT03405233|ePTFE|eptfe
26766|NCT03405233|neointemal hyperplasia|neointemal hyperplasia
26767|NCT03405220|smoking|smoking
26768|NCT03405220|self-affirmation|self-affirmation
26769|NCT03405220|mobile application|mobile application
26770|NCT03405220|cessation|cessation
26771|NCT03405194|HIV/AIDS|hiv/aids
26772|NCT03405194|Same-Day ART|same-day art
26773|NCT03405194|Genvoya|genvoya
26774|NCT03405194|Efavirenz|efavirenz
26775|NCT03405129|Smoking Cessation|smoking cessation
26776|NCT03405129|Smartphone App|smartphone app
26777|NCT03405129|Dynamic Treatment|dynamic treatment
26778|NCT03405103|self-management|self-management
26779|NCT03405103|m-Health|m-health
26780|NCT03405077|interpersonal psychotherapy|interpersonal psychotherapy
26781|NCT03405077|treatment|treatment
26782|NCT03405077|training|training
26783|NCT03405077|dissemination and implementation|dissemination and implementation
26784|NCT03405077|eating disorders|eating disorders
26785|NCT03405051|hypokalemia|hypokalemia
26786|NCT03405051|cardiac failure|cardiac failure
26787|NCT03404960|Platinum|platinum
26788|NCT03404960|chemotherapy|chemotherapy
26789|NCT03404960|Niraparib|niraparib
26790|NCT03404960|Ipilimumab|ipilimumab
26791|NCT03404960|Nivolumab|nivolumab
26792|NCT03404960|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
26793|NCT03404960|PARP inhibitor|parp inhibitor
26794|NCT03404960|Pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
26795|NCT03404960|DDR|ddr
26796|NCT03404960|PDAC|pdac
26797|NCT03404947|Exercise|exercise
26798|NCT03404947|Metabolism|metabolism
26799|NCT03404947|Nutrition|nutrition
26800|NCT03404934|Adaptive anastomosis|adaptive anastomosis
26801|NCT03404934|C-REX|c-rex
26802|NCT03404934|Colorectal cancer|colorectal cancer
26803|NCT03404921|Endoscopic submucosal dissection|endoscopic submucosal dissection
26804|NCT03404921|Endoscopic submucosal tunnelling dissection|endoscopic submucosal tunnelling dissection
26805|NCT03404921|procedure time|procedure time
26806|NCT03404908|transversus abdominis plane block|transversus abdominis plane block
26807|NCT03404908|quadratus lumborum block|quadratus lumborum block
26808|NCT03404908|neuropathic pain|neuropathic pain
26809|NCT03404895|DFU|dfu
26810|NCT03404895|Vein|vein
26811|NCT03404895|Stent|stent
26812|NCT03404791|Bladder Cancer|bladder cancer
26813|NCT03404791|Urothelial Carcinoma|urothelial carcinoma
26814|NCT03404791|Cystectomy|cystectomy
26815|NCT03404791|Radical Cystectomy|radical cystectomy
26816|NCT03404778|Reverse Shoulder Arthroplasty|reverse shoulder arthroplasty
26817|NCT03404778|Medical Device|medical device
26818|NCT03404778|Performance|performance
26819|NCT03404778|Safety|safety
26820|NCT03404778|Shoulder Prosthesis|shoulder prosthesis
26821|NCT03404778|Glenoid Erosion|glenoid erosion
26822|NCT03404765|Tai Chi|tai chi
26823|NCT03404765|Cognition|cognition
26824|NCT03404765|Instrumental activities of daily living|instrumental activities of daily living
26825|NCT03404765|Health-related Quality of Life|health-related quality of life
26826|NCT03404752|breast cancer|breast cancer
26827|NCT03404752|chemotherapy|chemotherapy
26828|NCT03404752|Neutropenia|neutropenia
26829|NCT03404752|Peg-filgrastim|peg-filgrastim
26830|NCT03404752|biosimilar|biosimilar
26831|NCT03404739|Antibiotic prophylaxis|antibiotic prophylaxis
26832|NCT03404739|Infectious complications|infectious complications
26833|NCT03404739|Peroral endoscopic myotomy|peroral endoscopic myotomy
26834|NCT03404726|Acute myeloid leukemia|acute myeloid leukemia
26835|NCT03404726|Myelodysplastic Syndromes|myelodysplastic syndromes
26836|NCT03404726|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
26837|NCT03404726|Dihydroorotate dehydrogenase (DHODH) inhibitor|dihydroorotate dehydrogenase (dhodh) inhibitor
26838|NCT03404713|adolescence|adolescence
26839|NCT03404713|adolescent|adolescent
26840|NCT03404713|binge eating|binge eating
26841|NCT03404713|loss-of-control eating|loss-of-control eating
26842|NCT03404713|behavioral weight loss|behavioral weight loss
26843|NCT03404713|weight management|weight management
26844|NCT03404713|acceptance commitment therapy|acceptance commitment therapy
26845|NCT03404713|overweight|overweight
26846|NCT03404713|obesity|obesity
26847|NCT03404700|Eggs, saturated fat, insulin resistance,|eggs, saturated fat, insulin resistance,
26848|NCT03404674|ETEC|etec
26849|NCT03404674|Escherichia coli|escherichia coli
26850|NCT03404674|enteric|enteric
26851|NCT03404648|high risk|high risk
26852|NCT03404648|prostate cancer|prostate cancer
26853|NCT03404648|C11-choline|c11-choline
26854|NCT03404648|PET/MR|pet/mr
26855|NCT03404648|mpMRI|mpmri
26856|NCT03404596|cigarettes|cigarettes
26857|NCT03404596|quit smoking|quit smoking
26858|NCT03404596|nicotine|nicotine
26859|NCT03404596|mindfulness|mindfulness
26860|NCT03404596|mHealth|mhealth
26861|NCT03404596|mobile health|mobile health
26862|NCT03404583|Person-centred care|person-centred care
26863|NCT03404570|Sweaty Hands|sweaty hands
26864|NCT03404557|Crohn's Disease|crohn's disease
26865|NCT03404557|Ulcerative colitis|ulcerative colitis
26866|NCT03404557|Macrophages|macrophages
26867|NCT03404557|Adherent-Invasive Escherichia coli|adherent-invasive escherichia coli
26868|NCT03404557|Proteomic analysis|proteomic analysis
26869|NCT03404518|Thyroidectomy|thyroidectomy
26870|NCT03404518|Parotidectomy|parotidectomy
26871|NCT03404518|Tympanoplasty|tympanoplasty
26872|NCT03404518|Mastoidectomy|mastoidectomy
26873|NCT03404518|Septoplasty|septoplasty
26874|NCT03404518|Sinus Surgery|sinus surgery
26875|NCT03404518|Postoperative pain|postoperative pain
26876|NCT03404518|Outpatient surgery|outpatient surgery
26877|NCT03404505|infant|infant
26878|NCT03404505|play|play
26879|NCT03404505|parents|parents
26880|NCT03404479|Knee Osteoarthritis|knee osteoarthritis
26881|NCT03404479|Diacerein|diacerein
26882|NCT03404453|Airway prediction|airway prediction
26883|NCT03404453|Difficult airway|difficult airway
26884|NCT03404440|helicobacter pylori|helicobacter pylori
26885|NCT03404440|L. Reuteri|l. reuteri
26886|NCT03404440|Proton Pump Inhibitor|proton pump inhibitor
26887|NCT03404375|scheduled cesarean section|scheduled cesarean section
26888|NCT03404375|term pregnancy|term pregnancy
26889|NCT03404375|estimated blood loss|estimated blood loss
26890|NCT03404375|postpartum hemorrhage|postpartum hemorrhage
26891|NCT03404362|Bone Metastases|bone metastases
26892|NCT03404336|migraine|migraine
26893|NCT03404336|chronic|chronic
26894|NCT03404336|well-being therapy|well-being therapy
26895|NCT03404336|psychotherapy|psychotherapy
26896|NCT03404336|therapy|therapy
26897|NCT03404323|central retinal thickness|central retinal thickness
26898|NCT03404323|epiretinal membrane|epiretinal membrane
26899|NCT03404323|cataract surgery|cataract surgery
27875|NCT03397394|DNA repair|dna repair
26900|NCT03404323|pseudophakic cystoid macular edema|pseudophakic cystoid macular edema
26901|NCT03404310|HPV|hpv
26902|NCT03404310|ASCUS|ascus
26903|NCT03404310|LSIL|lsil
26904|NCT03404310|Cervical Cancer|cervical cancer
26905|NCT03404297|compression therapy|compression therapy
26906|NCT03404297|Kenya|kenya
26907|NCT03404297|Kaposi Sarcoma|kaposi sarcoma
26908|NCT03404297|Locally sourced|locally sourced
26909|NCT03404297|wrapping|wrapping
26910|NCT03404297|chronic leg ulcers|chronic leg ulcers
26911|NCT03404284|Immunization|immunization
26912|NCT03404245|Physical Activity|physical activity
26913|NCT03404245|Exercise|exercise
26914|NCT03404245|Rheumatoid|rheumatoid
26915|NCT03404245|Arthritis|arthritis
26916|NCT03404245|Self-management|self-management
26917|NCT03404245|Symptoms|symptoms
26918|NCT03404206|Postsurgical pain|postsurgical pain
26919|NCT03404193|Other diseases of blood and blood-forming organs|other diseases of blood and blood-forming organs
26920|NCT03404193|Acute Myeloid Leukemia|acute myeloid leukemia
26921|NCT03404193|AML|aml
26922|NCT03404193|Myelodysplastic Syndrome|myelodysplastic syndrome
26923|NCT03404193|MDS|mds
26924|NCT03404193|Decitabine|decitabine
26925|NCT03404193|Dacogen|dacogen
26926|NCT03404193|Ventoclax|ventoclax
26927|NCT03404193|ABT-199|abt-199
26928|NCT03404193|GDC-0199|gdc-0199
26929|NCT03404167|ETX0914|etx0914
26930|NCT03404167|Plasma Pharmacokinetic|plasma pharmacokinetic
26931|NCT03404167|Safety|safety
26932|NCT03404167|Tolerability|tolerability
26933|NCT03404167|Zoliflodacin|zoliflodacin
26934|NCT03404141|Stress|stress
26935|NCT03404141|pregnancy|pregnancy
26936|NCT03404141|psychological therapy|psychological therapy
26937|NCT03404141|cortisol|cortisol
26938|NCT03404115|reproxalap|reproxalap
26939|NCT03404089|device drug monitoring|device drug monitoring
26940|NCT03404089|β-lactam antibiotic|β-lactam antibiotic
26941|NCT03404089|health care-associated infection|health care-associated infection
26942|NCT03404089|MON4STRAT|mon4strat
26943|NCT03404076|Gastrointestinal Stromal Tumor (GIST)|gastrointestinal stromal tumor (gist)
26944|NCT03404076|Dual Energy CT|dual energy ct
26945|NCT03404076|Tyrosine Kinase Inhibitor (TKI)|tyrosine kinase inhibitor (tki)
26946|NCT03404024|gene therapy|gene therapy
26947|NCT03403998|Pain|pain
26948|NCT03403998|Temporomandibular Disorders|temporomandibular disorders
26949|NCT03403998|Therapeutic exercises|therapeutic exercises
26950|NCT03403998|Musculoskeletal disorders|musculoskeletal disorders
26951|NCT03403998|Randomized controlled trial|randomized controlled trial
26952|NCT03403998|Imaging|imaging
26953|NCT03403998|Brain plasticity|brain plasticity
26954|NCT03403998|Clinical outcomes|clinical outcomes
26955|NCT03403998|Chronic pain|chronic pain
26956|NCT03403998|Neck|neck
26957|NCT03403972|pharmacokinetics|pharmacokinetics
26958|NCT03403972|simvastatin|simvastatin
26959|NCT03403972|vancomycin|vancomycin
26960|NCT03403972|gut microbiome|gut microbiome
26961|NCT03403959|pupillometry|pupillometry
26962|NCT03403959|light therapy|light therapy
26963|NCT03403959|visual impairment|visual impairment
26964|NCT03403959|melatonin|melatonin
26965|NCT03403959|ipRGC|iprgc
26966|NCT03403946|difficult airway|difficult airway
26967|NCT03403946|carvical collar|carvical collar
26968|NCT03403946|endotracheal intubation|endotracheal intubation
26969|NCT03403920|validity|validity
26970|NCT03403920|low back pain|low back pain
26971|NCT03403920|functional|functional
26972|NCT03403920|pain|pain
26973|NCT03403920|questionnaire|questionnaire
26974|NCT03403907|epilepsy|epilepsy
26975|NCT03403907|microbiota|microbiota
26976|NCT03403907|probiotics|probiotics
26977|NCT03403881|Exercise|exercise
26978|NCT03403881|Physical activity|physical activity
26979|NCT03403881|Behavioral change|behavioral change
26980|NCT03403881|Depression|depression
26981|NCT03403881|Major Depressive Disorder|major depressive disorder
26982|NCT03403881|Health promotion|health promotion
26983|NCT03403803|Glioblastoma|glioblastoma
26984|NCT03403803|Brain Tumor|brain tumor
26985|NCT03403790|Bipresso|bipresso
26986|NCT03403790|Drug use-results survey|drug use-results survey
26987|NCT03403790|Quetiapine|quetiapine
26988|NCT03403777|Multiple relapsed/refractory testicular germ cell tumors|multiple relapsed/refractory testicular germ cell tumors
26989|NCT03403777|Avelumab|avelumab
26990|NCT03403777|Anti PD-L1|anti pd-l1
26991|NCT03403764|Intention|intention
26992|NCT03403764|Distant Healing|distant healing
26993|NCT03403764|Wellness|wellness
26994|NCT03403764|Distant Intentionality|distant intentionality
26995|NCT03403764|Distant Healing Intention|distant healing intention
26996|NCT03403751|Abdominal sepsis|abdominal sepsis
26997|NCT03403751|AKI|aki
26998|NCT03403725|Solid Tumors|solid tumors
26999|NCT03403725|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
27000|NCT03403725|NHL|nhl
27001|NCT03403725|MEN1309|men1309
27002|NCT03403725|CD205|cd205
27003|NCT03403725|Relapsed|relapsed
27004|NCT03403725|Refractory|refractory
27005|NCT03403725|R-R NHL|r-r nhl
27007|NCT03403725|Antibody-Drug Coniugate|antibody-drug coniugate
27008|NCT03403725|Metastatic Tumors|metastatic tumors
27009|NCT03403699|inducible pluripotent stem cells|inducible pluripotent stem cells
27010|NCT03403686|Liver X receptor|liver x receptor
27011|NCT03403686|Circulating angiogenic cells|circulating angiogenic cells
27012|NCT03403660|Attire|attire
27013|NCT03403660|White coat|white coat
27014|NCT03403660|Patient physician communication|patient physician communication
27015|NCT03403569|CD4 cell recovery|cd4 cell recovery
27016|NCT03403569|immune activation|immune activation
27017|NCT03403569|anti-inflammation|anti-inflammation
27018|NCT03403556|High ASCVD risk patients with type 2 diabetes|high ascvd risk patients with type 2 diabetes
27019|NCT03403530|IgM|igm
27020|NCT03403530|Immunoglobulin|immunoglobulin
27021|NCT03403530|Neonatal sepsis|neonatal sepsis
27022|NCT03403530|very low birth weight preterm|very low birth weight preterm
27023|NCT03403517|steroids|steroids
27024|NCT03403517|glucocorticoids|glucocorticoids
27025|NCT03403517|liver surgery|liver surgery
27026|NCT03403517|hepatectomy|hepatectomy
27027|NCT03403478|Hemodynamics|hemodynamics
27028|NCT03403478|Aquatic exercise|aquatic exercise
27029|NCT03403478|Elderly|elderly
27030|NCT03403374|Evolocumab|evolocumab
27031|NCT03403374|Hypercholesterolemia|hypercholesterolemia
27032|NCT03403322|intervention|intervention
27033|NCT03403322|children|children
27034|NCT03403309|Multiple system atrophy|multiple system atrophy
27035|NCT03403309|Uric acid|uric acid
27036|NCT03403309|Inosine 5'-monophosphate|inosine 5'-monophosphate
27037|NCT03403309|Inosine monophosphate|inosine monophosphate
27038|NCT03403309|Inosinic acid|inosinic acid
27039|NCT03403270|Mobile App|mobile app
27040|NCT03403270|Sedentary Behaviour|sedentary behaviour
27041|NCT03403270|Workplace Wellness|workplace wellness
27042|NCT03403270|Sitting Time|sitting time
27043|NCT03403257|Caregiving|caregiving
27044|NCT03403257|Hispanic|hispanic
27045|NCT03403257|Mexican American|mexican american
27046|NCT03403257|Epidemiology|epidemiology
27047|NCT03403257|Community|community
27048|NCT03403231|Veterans|veterans
27049|NCT03403231|Type 2 diabetes mellitus|type 2 diabetes mellitus
27050|NCT03403231|Prediabetes|prediabetes
27051|NCT03403231|Secure Messaging|secure messaging
27052|NCT03403231|Health Promotion|health promotion
27053|NCT03403231|Prevention and Control|prevention and control
27054|NCT03403231|Motivation|motivation
27055|NCT03403218|balance, risk of falling|balance, risk of falling
27056|NCT03403192|EZ Blocker|ez blocker
27057|NCT03403192|DLT|dlt
27058|NCT03403192|Double Lumen Tube|double lumen tube
27059|NCT03403192|Thoracic Surgery|thoracic surgery
27060|NCT03403179|Cognition|cognition
27061|NCT03403179|Cognitive Remediation|cognitive remediation
27062|NCT03403179|Mood Disorder|mood disorder
27063|NCT03403179|Functional Impairment|functional impairment
27064|NCT03403179|Psychosocial intervention|psychosocial intervention
27065|NCT03403153|Parent-Child Relationship|parent-child relationship
27066|NCT03403153|military family|military family
27067|NCT03403153|veterans health|veterans health
27068|NCT03403153|stress disorders|stress disorders
27069|NCT03403114|Vaccine hesitancy|vaccine hesitancy
27070|NCT03403114|Hospital specialists (HS)|hospital specialists (hs)
27071|NCT03403114|Vaccination survey|vaccination survey
27072|NCT03403088|Non-carious cervical lesions|non-carious cervical lesions
27073|NCT03403088|dentin hypersensitivity|dentin hypersensitivity
27074|NCT03403075|blood cancer|blood cancer
27075|NCT03403075|exercise|exercise
27076|NCT03403075|therapeutic education|therapeutic education
27077|NCT03403075|fatigue|fatigue
27078|NCT03403075|feasibility|feasibility
27079|NCT03403062|Sepsis|sepsis
27080|NCT03403062|red cell distribution width (RDW)|red cell distribution width (rdw)
27081|NCT03403062|Late onset sepsis (LOS)|late onset sepsis (los)
27082|NCT03403062|Early onset sepsis (EOS)|early onset sepsis (eos)
27083|NCT03403049|pancreatic cancer|pancreatic cancer
27084|NCT03403049|pancreas|pancreas
27085|NCT03403049|cancer|cancer
27086|NCT03403049|locally advanced|locally advanced
27087|NCT03403049|unresectable|unresectable
27088|NCT03403049|radiation|radiation
27089|NCT03403049|radiation therapy|radiation therapy
27090|NCT03403049|radiotherapy|radiotherapy
27091|NCT03403049|carbon|carbon
27092|NCT03403049|carbon ion|carbon ion
27093|NCT03403049|ion|ion
27094|NCT03403036|Psoriasis|psoriasis
27095|NCT03403036|brodalumab|brodalumab
27096|NCT03403023|Dry Eye Disease|dry eye disease
27097|NCT03403023|Tear Film Imager|tear film imager
27098|NCT03403023|tear film|tear film
27099|NCT03403023|Cyclosporine|cyclosporine
27100|NCT03403023|dry eye syndrome|dry eye syndrome
27101|NCT03403023|keratoconjunctivitis sicca|keratoconjunctivitis sicca
27102|NCT03402984|Gastric motility|gastric motility
27103|NCT03402984|Gastric emptying|gastric emptying
27104|NCT03402971|right heart|right heart
27105|NCT03402971|pregnancy|pregnancy
27106|NCT03402971|echocardiography|echocardiography
27107|NCT03402971|reference values|reference values
27108|NCT03402945|negative pressure wound management system|negative pressure wound management system
27109|NCT03402945|open-heart surgery|open-heart surgery
27110|NCT03402945|antibiotic prophylaxis|antibiotic prophylaxis
27111|NCT03402945|surgical site infection|surgical site infection
27112|NCT03402854|pediatric|pediatric
27113|NCT03402854|children|children
27114|NCT03402854|non-invasive brain stimulation|non-invasive brain stimulation
27115|NCT03402854|transcranial direct current stimulation|transcranial direct current stimulation
27116|NCT03402854|bimanual training|bimanual training
27117|NCT03402854|hand training|hand training
27118|NCT03402841|Ovarian cancer|ovarian cancer
27119|NCT03402841|non-gBRCA|non-gbrca
27120|NCT03402841|Platinum|platinum
27121|NCT03402841|Chemotherapy|chemotherapy
27122|NCT03402828|Topicals|topicals
27123|NCT03402828|Long-term|long-term
27124|NCT03402815|HIV|hiv
27125|NCT03402815|Maraviroc|maraviroc
27126|NCT03402815|Atherosclerosis|atherosclerosis
27127|NCT03402802|eye drop|eye drop
27128|NCT03402789|Docosahexaenoic acid|docosahexaenoic acid
27129|NCT03402789|Long chain fatty acid|long chain fatty acid
27130|NCT03402776|haemopoietic stem cell transplantation|haemopoietic stem cell transplantation
27131|NCT03402776|vaccine|vaccine
27132|NCT03402776|diphteria|diphteria
27133|NCT03402776|tetanus|tetanus
27134|NCT03402776|haemophilus influenza|haemophilus influenza
27135|NCT03402776|poliomyelitis|poliomyelitis
27136|NCT03402776|hepatitis B|hepatitis b
27137|NCT03402763|Advance care planning|advance care planning
27138|NCT03402763|Older adults|older adults
27139|NCT03402763|Emergency department|emergency department
27140|NCT03402750|Adherence, Medication, Prescription|adherence, medication, prescription
27141|NCT03402737|Stereotactic body radiotherapy|stereotactic body radiotherapy
27142|NCT03402737|Immunomodulating systemic therapy|immunomodulating systemic therapy
27143|NCT03402711|ACS|acs
27144|NCT03402711|PCI|pci
27145|NCT03402711|Bleeding risk|bleeding risk
27146|NCT03402698|cholecalciferol|cholecalciferol
27147|NCT03402698|BMI|bmi
27148|NCT03402698|winter|winter
27149|NCT03402607|Unresectable|unresectable
27150|NCT03402594|High flow oxygen therapy|high flow oxygen therapy
27151|NCT03402594|Oxygen desaturation index|oxygen desaturation index
27152|NCT03402594|Acute ischemic stroke|acute ischemic stroke
27153|NCT03402568|alcohol|alcohol
27154|NCT03402568|targeted metabolomics|targeted metabolomics
27155|NCT03402568|lipid metabolites|lipid metabolites
27156|NCT03402568|amino acids|amino acids
27157|NCT03402568|acylcarnitines|acylcarnitines
27158|NCT03402529|Contrast Enhanced Spectral Mammography|contrast enhanced spectral mammography
27159|NCT03402516|hysteroscopic myomectomy|hysteroscopic myomectomy
27160|NCT03402516|26Fr resector|26fr resector
27161|NCT03402516|18.5Fr resector|18.5fr resector
27162|NCT03402490|Motivational interviewing|motivational interviewing
27163|NCT03402490|physical activity|physical activity
27164|NCT03402490|feasibility|feasibility
27165|NCT03402490|HFpEF|hfpef
27166|NCT03402477|locally advanced, neo-adjuvant treatment, Watch & Wait|locally advanced, neo-adjuvant treatment, watch & wait
27167|NCT03402425|FET|fet
27168|NCT03402425|PET/MRI|pet/mri
27169|NCT03402425|child|child
27170|NCT03402360|Virtual Reality|virtual reality
27171|NCT03402360|Rehabilitation|rehabilitation
27172|NCT03402360|Acquired Brain Injury|acquired brain injury
27173|NCT03402347|Ex vivo|ex vivo
27174|NCT03402347|Gastric bypass|gastric bypass
27175|NCT03402321|alveogyl, gelatin sponge, free gingival graft, palate, pain|alveogyl, gelatin sponge, free gingival graft, palate, pain
27176|NCT03402282|hemorrhoidal disease|hemorrhoidal disease
27177|NCT03402282|embolization|embolization
27178|NCT03402256|Mobile Technology|mobile technology
27179|NCT03402256|Alcohol|alcohol
27180|NCT03402256|Alcoholic Liver Disease|alcoholic liver disease
27181|NCT03402256|Ethyl Glucuronide|ethyl glucuronide
27182|NCT03402217|Contraception|contraception
27183|NCT03402217|Post Partum Contraception|post partum contraception
27184|NCT03402204|Simvastatin|simvastatin
27185|NCT03402204|Plaque stability|plaque stability
27186|NCT03402204|Acute ischemic stroke|acute ischemic stroke
27187|NCT03402178|E2082|e2082
27188|NCT03402178|male|male
27189|NCT03402178|single ascending dose|single ascending dose
27190|NCT03402178|multiple ascending dose|multiple ascending dose
27191|NCT03402152|Biomarker|biomarker
27192|NCT03402100|myopia|myopia
27193|NCT03402100|schoolchildren|schoolchildren
27194|NCT03402100|atropine|atropine
27195|NCT03402100|allergy|allergy
27196|NCT03402100|eye drops|eye drops
27197|NCT03402100|outdoor|outdoor
27198|NCT03402100|near work|near work
27199|NCT03402048|Lung Cancer|lung cancer
27200|NCT03402048|Elderly|elderly
27201|NCT03402048|First line|first line
27202|NCT03402048|Customized chemotherapy|customized chemotherapy
27203|NCT03402048|Pharmacogenomic-driven|pharmacogenomic-driven
27204|NCT03402048|NSCLC|nsclc
27205|NCT03402035|Whole Blood Resuscitation|whole blood resuscitation
27206|NCT03402022|Sport|sport
27207|NCT03402022|competition|competition
27208|NCT03402022|ultra-endurance|ultra-endurance
27209|NCT03402022|trail running|trail running
27210|NCT03402022|doping|doping
27211|NCT03402009|meditation|meditation
27212|NCT03402009|Mindfulness|mindfulness
27213|NCT03402009|stress|stress
27214|NCT03402009|anxiety|anxiety
27215|NCT03401983|exercise|exercise
27216|NCT03401983|pelvic floor|pelvic floor
27217|NCT03401983|stress urinary incontinence|stress urinary incontinence
27218|NCT03401970|Body composition|body composition
27219|NCT03401970|Internal body fat|internal body fat
27220|NCT03401970|Dietary pattern|dietary pattern
27221|NCT03401970|Dietary carbohydrate|dietary carbohydrate
27222|NCT03401957|colorectal cancer|colorectal cancer
27223|NCT03401957|cetuximab resistance|cetuximab resistance
27224|NCT03401957|liquid biopsy|liquid biopsy
27225|NCT03401957|RAS mutation|ras mutation
27226|NCT03401905|Percutaneous electrical nerve stimulation|percutaneous electrical nerve stimulation
27227|NCT03401905|Myofascial trigger point|myofascial trigger point
27228|NCT03401866|brain tumor|brain tumor
27229|NCT03401840|Head and neck cancers|head and neck cancers
27230|NCT03401840|Radiation oncology|radiation oncology
27231|NCT03401840|Stereotactic radiotherapy|stereotactic radiotherapy
27232|NCT03401827|pancreatic cancer|pancreatic cancer
27233|NCT03401827|second line chemotherapy|second line chemotherapy
27234|NCT03401827|nab-paclitaxel|nab-paclitaxel
27235|NCT03401775|aging, computerized cognitive training|aging, computerized cognitive training
27236|NCT03401762|rehabilitation|rehabilitation
27237|NCT03401736|Sedatives and Hypnotics,Mechanical Ventilation|sedatives and hypnotics,mechanical ventilation
27238|NCT03401723|Validation study|validation study
27239|NCT03401723|Simulation|simulation
27240|NCT03401723|Endoscopy|endoscopy
27241|NCT03401710|Anemia, Acute Kidney injury, ESA, Erythropoietin|anemia, acute kidney injury, esa, erythropoietin
27242|NCT03401684|firefighters|firefighters
27243|NCT03401684|mental resiliency|mental resiliency
27244|NCT03401684|peer support|peer support
27245|NCT03401671|Lanadelumab|lanadelumab
27246|NCT03401632|Enteral nutrition|enteral nutrition
27247|NCT03401632|Vasoactive Drugs|vasoactive drugs
27248|NCT03401632|Critical Care|critical care
27249|NCT03401606|sedation|sedation
27250|NCT03401606|dexmedetomidine|dexmedetomidine
27251|NCT03401606|remifentanil|remifentanil
27252|NCT03401606|cataract surgery|cataract surgery
27253|NCT03401606|surgeon satisfaction|surgeon satisfaction
27254|NCT03401606|patient satisfaction|patient satisfaction
27255|NCT03401593|ablation|ablation
27256|NCT03401593|atrial fibrillation|atrial fibrillation
27257|NCT03401593|stroke|stroke
27258|NCT03401567|blood flow restriction|blood flow restriction
27259|NCT03401567|proprioception|proprioception
27260|NCT03401567|functional performance|functional performance
27261|NCT03401567|muscle strength|muscle strength
27262|NCT03401463|endotracheal tube cuff pressure|endotracheal tube cuff pressure
27263|NCT03401463|Ventilator-Induced Lung Injury|ventilator-induced lung injury
27264|NCT03401463|traning|traning
27265|NCT03401437|adverse effects|adverse effects
27266|NCT03401437|Salpingectomy|salpingectomy
27267|NCT03401437|Essure® device ablation|essure® device ablation
27268|NCT03401437|Cornual resection|cornual resection
27269|NCT03401424|congenital cyst of common bile duct|congenital cyst of common bile duct
27270|NCT03401424|Biliary enteric anastomosis|biliary enteric anastomosis
27272|NCT03401411|ICU Triage Practices|icu triage practices
27273|NCT03401411|Cancer Patients|cancer patients
27274|NCT03401411|Oncology ICU|oncology icu
27275|NCT03401398|hydrocortisone|hydrocortisone
27276|NCT03401398|refractory septic shock|refractory septic shock
27277|NCT03401398|sepsis|sepsis
27278|NCT03401398|new/progressive MODS|new/progressive mods
27279|NCT03401398|mortality|mortality
27280|NCT03401398|health-related quality of life|health-related quality of life
27281|NCT03401398|corticosteroid adverse events|corticosteroid adverse events
27282|NCT03401398|sepsis biomarkers|sepsis biomarkers
27283|NCT03401385|Non-small cell lung cancer|non-small cell lung cancer
27284|NCT03401385|NSCLC|nsclc
27285|NCT03401385|Other solid tumors|other solid tumors
27286|NCT03401372|Primary light chain amyloidosis|primary light chain amyloidosis
27287|NCT03401372|Doxycycline|doxycycline
27288|NCT03401372|Bortezomib|bortezomib
27289|NCT03401372|Prognosis|prognosis
27290|NCT03401372|Progression-free survival|progression-free survival
27291|NCT03401372|Overall survival|overall survival
27292|NCT03401372|Organ response|organ response
27293|NCT03401320|pharmacokinetics|pharmacokinetics
27294|NCT03401320|letrozole|letrozole
27295|NCT03401294|Metastatic colorectal cancer|metastatic colorectal cancer
27296|NCT03401294|Conversion therapy|conversion therapy
27297|NCT03401294|Liver Metastasectomy|liver metastasectomy
27298|NCT03401268|hypogammaglobulinemia|hypogammaglobulinemia
27299|NCT03401268|allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
27300|NCT03401255|Placental alpha microglobulin-1|placental alpha microglobulin-1
27301|NCT03401255|PAMG-1|pamg-1
27302|NCT03401255|preterm labor|preterm labor
27303|NCT03401255|preterm delivery|preterm delivery
27304|NCT03401255|preterm birth|preterm birth
27305|NCT03401255|cervical length|cervical length
27306|NCT03401255|transvaginal ultrasound|transvaginal ultrasound
27307|NCT03401255|corticosteroid|corticosteroid
27308|NCT03401242|Carbapenemase|carbapenemase
27309|NCT03401242|Enterobacteriaceae|enterobacteriaceae
27310|NCT03401242|extended spectrum beta-lactamases|extended spectrum beta-lactamases
27311|NCT03401242|nursing homes|nursing homes
27312|NCT03401242|prevalence|prevalence
27313|NCT03401229|Polyps|polyps
27314|NCT03401229|Nasal polyps|nasal polyps
27315|NCT03401229|Nasal polyposis|nasal polyposis
27316|NCT03401229|Nose diseases|nose diseases
27317|NCT03401229|Respiratory tract diseases|respiratory tract diseases
27318|NCT03401229|Otorhinolaryngologic diseases|otorhinolaryngologic diseases
27319|NCT03401229|Benralizumab|benralizumab
27320|NCT03401229|Mometasone furoate|mometasone furoate
27321|NCT03401216|Optical coherence tomography|optical coherence tomography
27322|NCT03401216|Healing score|healing score
27323|NCT03401216|Neointimal coverage|neointimal coverage
27324|NCT03401216|synergy 48|synergy 48
27325|NCT03401216|long lesion|long lesion
27326|NCT03401203|ISR|isr
27327|NCT03401203|ROTA|rota
27328|NCT03401203|DEB|deb
27329|NCT03401203|PCI|pci
27330|NCT03401151|Heart failure|heart failure
27331|NCT03401151|Skeletal muscle|skeletal muscle
27332|NCT03401151|Exercise capacity|exercise capacity
27333|NCT03401151|Lung function|lung function
27334|NCT03401151|Gene expression|gene expression
27335|NCT03401138|Peripheral perfusion|peripheral perfusion
27336|NCT03401138|Blood Volume|blood volume
27337|NCT03401138|Tissue Prefusion|tissue prefusion
27338|NCT03401138|Near-infrared spectroscopy|near-infrared spectroscopy
27339|NCT03401138|Hemodynamic monitoring|hemodynamic monitoring
27340|NCT03401138|Hemodynamic optimization|hemodynamic optimization
27341|NCT03401138|Preoperative resuscitation|preoperative resuscitation
27342|NCT03401125|Sickle cell disease|sickle cell disease
27343|NCT03401125|Allo-immunization|allo-immunization
27344|NCT03401099|Radiofrequency ablation|radiofrequency ablation
27345|NCT03401099|Cavo-tricuspid isthmus|cavo-tricuspid isthmus
27346|NCT03401099|Pulmonary Vein Isolation|pulmonary vein isolation
27347|NCT03401099|Cryoballoon ablation|cryoballoon ablation
27348|NCT03401073|small Fiber Neuropathy|small fiber neuropathy
27349|NCT03401073|Idiopathic Peripheral Neuropathy|idiopathic peripheral neuropathy
27350|NCT03401073|IVIg|ivig
27351|NCT03401073|Gamunex-C|gamunex-c
27352|NCT03401060|Systemic mastocytosis|systemic mastocytosis
27353|NCT03401060|Osteoporosis|osteoporosis
27354|NCT03401060|Bone mineral density (BMD)|bone mineral density (bmd)
27355|NCT03401060|Denosumab|denosumab
27356|NCT03401060|RANKL|rankl
27357|NCT03401047|PCOS|pcos
27358|NCT03401021|intention to quit smoking|intention to quit smoking
27359|NCT03401021|male smoker|male smoker
27360|NCT03401021|smoking cessation|smoking cessation
27361|NCT03401021|planning for pregnancy|planning for pregnancy
27362|NCT03401008|Acromegaly|acromegaly
27363|NCT03401008|Oral manifestations|oral manifestations
27364|NCT03400969|Palliative|palliative
27365|NCT03400969|Moisturisers|moisturisers
27366|NCT03400969|Dry mouth|dry mouth
27367|NCT03400969|Xerostomia|xerostomia
27368|NCT03400956|Uterine fibroids|uterine fibroids
27369|NCT03400956|Heavy menstrual bleeding|heavy menstrual bleeding
27370|NCT03400943|Uterine fibroids|uterine fibroids
27371|NCT03400943|Heavy menstrual bleeding|heavy menstrual bleeding
27372|NCT03400930|Severe Acute Malnutrition|severe acute malnutrition
27373|NCT03400865|cabergoline|cabergoline
27374|NCT03400865|prolactinomas|prolactinomas
27375|NCT03400865|resistant|resistant
27376|NCT03400865|hydroxychloroquine|hydroxychloroquine
27377|NCT03400865|chloroquine|chloroquine
27378|NCT03400839|Interstitial Lung disease|interstitial lung disease
27379|NCT03400839|prognosis|prognosis
27380|NCT03400839|clinical endpoints|clinical endpoints
27381|NCT03400839|association|association
27382|NCT03400826|simvastatin|simvastatin
27383|NCT03400826|fibroids|fibroids
27384|NCT03400826|medical management|medical management
27385|NCT03400826|uterine fibroids|uterine fibroids
27386|NCT03400826|leiomyoma|leiomyoma
27387|NCT03400813|Eye-Movement Desensitization|eye-movement desensitization
27388|NCT03400813|Reprocessing|reprocessing
27389|NCT03400800|Inclisiran sodium|inclisiran sodium
27390|NCT03400800|ASCVD|ascvd
27391|NCT03400800|LDL-C|ldl-c
27392|NCT03400748|Electrosurgery|electrosurgery
27393|NCT03400748|RF ablation|rf ablation
27394|NCT03400748|Minimally invasive|minimally invasive
27395|NCT03400748|Lung cancer|lung cancer
27396|NCT03400748|Lung metastasis|lung metastasis
27397|NCT03400748|Lung tumor|lung tumor
27398|NCT03400748|Primary|primary
27399|NCT03400748|Metastatic|metastatic
27400|NCT03400748|Endobronchial ultrasound|endobronchial ultrasound
27401|NCT03400748|EBUS|ebus
27402|NCT03400722|Suboptimal ovarian response|suboptimal ovarian response
27403|NCT03400722|Ovarian Stimulation|ovarian stimulation
27404|NCT03400722|Infertility, Female|infertility, female
27405|NCT03400722|In Vitro Fertilisation|in vitro fertilisation
27406|NCT03400709|Cisplatin|cisplatin
27407|NCT03400709|Ototoxicity|ototoxicity
27408|NCT03400709|N-acetylcisteine|n-acetylcisteine
27409|NCT03400696|nutrition, diet, genetics, physical activity, weight loss|nutrition, diet, genetics, physical activity, weight loss
27410|NCT03400670|NCPAP|ncpap
27411|NCT03400670|Respiratory Distress Syndrome|respiratory distress syndrome
27412|NCT03400644|open-door laminoplasty, laminoplasty, cervical collars|open-door laminoplasty, laminoplasty, cervical collars
27413|NCT03400631|Cytokine|cytokine
27414|NCT03400618|Carbohydrates|carbohydrates
27415|NCT03400618|Diet|diet
27416|NCT03400618|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
27417|NCT03400592|gastric adenocarcinoma|gastric adenocarcinoma
27418|NCT03400592|EGFR|egfr
27419|NCT03400592|Irinotecan|irinotecan
27420|NCT03400592|Nimotuzumab|nimotuzumab
27421|NCT03400592|biomarker|biomarker
27422|NCT03400579|Emergency Medical Services|emergency medical services
27423|NCT03400540|verbal instruction, pelvic diaphragm, muscle contraction|verbal instruction, pelvic diaphragm, muscle contraction
27424|NCT03400514|Artificial intelligence|artificial intelligence
27425|NCT03400514|concordance|concordance
27426|NCT03400488|Coronary Artery Disease,|coronary artery disease,
27427|NCT03400488|Cardiovascular disease (CAD),|cardiovascular disease (cad),
27428|NCT03400488|5-lipoxygenase activating protein (FLAP) inhibitor,|5-lipoxygenase activating protein (flap) inhibitor,
27429|NCT03400488|Leukotrienes.|leukotrienes.
27430|NCT03400475|topical|topical
27431|NCT03400475|subgingival|subgingival
27432|NCT03400475|simvastatin|simvastatin
27433|NCT03400462|Dry needling, occlusal splint, NSAID, nimesulide|dry needling, occlusal splint, nsaid, nimesulide
27434|NCT03400423|Caffeine|caffeine
27435|NCT03400423|Caffeine Withdrawal|caffeine withdrawal
27436|NCT03400423|Acute Aerobic Exercise|acute aerobic exercise
27437|NCT03400423|Cognition|cognition
27438|NCT03400423|Working Memory|working memory
27439|NCT03400410|Contraception|contraception
27440|NCT03400410|Education|education
27441|NCT03400410|Male adolescents|male adolescents
27442|NCT03400410|Emergency Department|emergency department
27443|NCT03400410|Unintended pregnancy|unintended pregnancy
27444|NCT03400397|Anxiety|anxiety
27445|NCT03400397|Child|child
27446|NCT03400397|Cognitive behaviour therapy|cognitive behaviour therapy
27447|NCT03400397|CBT|cbt
27448|NCT03400397|effectiveness|effectiveness
27449|NCT03400397|treatment|treatment
27450|NCT03400397|Cool Kids|cool kids
27451|NCT03400384|Deprescribing|deprescribing
27452|NCT03400371|JME|jme
27453|NCT03400371|Epilepsy|epilepsy
27454|NCT03400371|Juvenile Myoclonic Epilepsy|juvenile myoclonic epilepsy
27455|NCT03400371|Genomewide Association Study|genomewide association study
27456|NCT03400371|Genetics|genetics
27457|NCT03400358|uterocervical angle|uterocervical angle
27458|NCT03400358|multiparous|multiparous
27459|NCT03400345|Hand Transplant|hand transplant
27460|NCT03400345|composite tissue allograft (CTA)|composite tissue allograft (cta)
27461|NCT03400345|Vascularized Composite Allotransplantation (VCA)|vascularized composite allotransplantation (vca)
27462|NCT03400345|Amputation|amputation
27463|NCT03400345|Upper Limb|upper limb
27464|NCT03400345|Immunosuppression|immunosuppression
27465|NCT03400319|Thoracic Aortic Aneurysm|thoracic aortic aneurysm
27466|NCT03400319|Obstructive Sleep Apnea|obstructive sleep apnea
27467|NCT03400306|Cancer Ovarian cancer Bioavailability Pharmacokinetics Bioequivalence|cancer ovarian cancer bioavailability pharmacokinetics bioequivalence
27468|NCT03400293|Human Immunodeficiency virus|human immunodeficiency virus
27469|NCT03400293|Health Related Quality of Life|health related quality of life
27470|NCT03400293|Functional Assessment of HIV Infection|functional assessment of hiv infection
27471|NCT03400293|Mobile app|mobile app
27472|NCT03400280|Postoperative pancreatic fistula|postoperative pancreatic fistula
27473|NCT03400280|Pancreatic resection|pancreatic resection
27474|NCT03400228|Probiotics|probiotics
27475|NCT03400228|Chronic kidney disease|chronic kidney disease
27476|NCT03400228|Cardiovascular risk|cardiovascular risk
27477|NCT03400176|Ibrutinib|ibrutinib
27478|NCT03400176|VAY736|vay736
27479|NCT03400176|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
27480|NCT03400176|CLL|cll
27481|NCT03400176|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
27482|NCT03400176|BTK mutation|btk mutation
27483|NCT03400163|First Line Therapy|first line therapy
27484|NCT03400163|NASH|nash
27485|NCT03400085|mHealth|mhealth
27486|NCT03400085|living donor kidney transplant|living donor kidney transplant
27487|NCT03400085|follow-up|follow-up
27488|NCT03400085|health utilization|health utilization
27489|NCT03400059|Prophylaxis, Headache, Preventative Treatment|prophylaxis, headache, preventative treatment
27490|NCT03400033|CKD, EPO, rhEPO, Hemodialysis dependent, Daprodustat|ckd, epo, rhepo, hemodialysis dependent, daprodustat
27491|NCT03400007|dynamic floor magnetic resonance imaging|dynamic floor magnetic resonance imaging
27492|NCT03400007|colpocystodefecagraphy|colpocystodefecagraphy
27493|NCT03400007|prolapse surgery|prolapse surgery
27494|NCT03399968|shockwave|shockwave
27495|NCT03399968|ESWT|eswt
27496|NCT03399929|Rehabilitation|rehabilitation
27497|NCT03399929|Long term outcome|long term outcome
27498|NCT03399838|Procedural Sedation and Analgesia|procedural sedation and analgesia
27876|NCT03397394|LOH|loh
27499|NCT03399838|Pediatric Emergency Department|pediatric emergency department
27500|NCT03399838|intranasal|intranasal
27501|NCT03399838|dexmedetomidine|dexmedetomidine
27502|NCT03399838|midazolam|midazolam
27503|NCT03399838|anxiety relief|anxiety relief
27504|NCT03399786|HoFH|hofh
27505|NCT03399760|i-PRF (injectable platelet rich fibrin)|i-prf (injectable platelet rich fibrin)
27506|NCT03399760|alveolar bone height|alveolar bone height
27507|NCT03399760|canine root resorption|canine root resorption
27508|NCT03399760|bone density|bone density
27509|NCT03399760|cone-beam computed tomography|cone-beam computed tomography
27510|NCT03399734|Perampanel|perampanel
27511|NCT03399734|Bioequivalence|bioequivalence
27512|NCT03399734|fine granules|fine granules
27513|NCT03399734|E2007|e2007
27514|NCT03399734|Japanese|japanese
27515|NCT03399708|apremilast|apremilast
27516|NCT03399708|PDE4 inhibition|pde4 inhibition
27517|NCT03399708|cardiometabolic|cardiometabolic
27518|NCT03399708|immune profile|immune profile
27519|NCT03399695|preoxygenation|preoxygenation
27520|NCT03399695|high flow oxygen|high flow oxygen
27521|NCT03399682|cystography|cystography
27522|NCT03399682|pediatry|pediatry
27523|NCT03399682|urinary infection|urinary infection
27524|NCT03399630|Osteo Arthritis Knee|osteo arthritis knee
27525|NCT03399630|Autologous Adipose Tissue|autologous adipose tissue
27526|NCT03399604|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
27527|NCT03399604|Idiopathic Pulmonary Arterial Hypertension|idiopathic pulmonary arterial hypertension
27528|NCT03399604|Heritable Pulmonary Arterial Hypertension|heritable pulmonary arterial hypertension
27529|NCT03399604|Drug Induced Pulmonary Arterial Hypertension|drug induced pulmonary arterial hypertension
27530|NCT03399604|Toxin Induced Pulmonary Arterial Hypertension|toxin induced pulmonary arterial hypertension
27531|NCT03399604|Connective tissue disease|connective tissue disease
27532|NCT03399591|Gait Disorders|gait disorders
27533|NCT03399591|Spatio-temporal parameters of walking|spatio-temporal parameters of walking
27534|NCT03399591|Alzheimer's disease|alzheimer's disease
27535|NCT03399591|Lewy body disease|lewy body disease
27536|NCT03399552|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
27537|NCT03399552|Avelumab Immunotherapy|avelumab immunotherapy
27538|NCT03399552|17-358|17-358
27539|NCT03399513|Ibrutinib|ibrutinib
27540|NCT03399500|Case Management|case management
27541|NCT03399500|Homelessness|homelessness
27542|NCT03399500|Smartphone|smartphone
27543|NCT03399500|Health Related Quality of Life|health related quality of life
27544|NCT03399500|Mental Health|mental health
27545|NCT03399500|Substance Use Disorders|substance use disorders
27546|NCT03399487|NSCLC|nsclc
27547|NCT03399487|ROS1 rearrangement|ros1 rearrangement
27548|NCT03399487|Ceritinib|ceritinib
27549|NCT03399487|LDK378|ldk378
27550|NCT03399474|Regional Anesthesia, Dexmedetomidine and lidocaine|regional anesthesia, dexmedetomidine and lidocaine
27551|NCT03399461|United States|united states
27552|NCT03399461|United Kingdom|united kingdom
27553|NCT03399461|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
27554|NCT03399461|Caregiver|caregiver
27555|NCT03399461|Interview|interview
27556|NCT03399461|immune deficiency|immune deficiency
27557|NCT03399461|France|france
27558|NCT03399435|Regional anesthesia|regional anesthesia
27559|NCT03399435|Brachial plexus blockade|brachial plexus blockade
27560|NCT03399435|Sensory and motor function testing|sensory and motor function testing
27561|NCT03399422|i-PRF (injectable platelet rich fibrin)|i-prf (injectable platelet rich fibrin)
27562|NCT03399422|canine retraction|canine retraction
27563|NCT03399422|pain and discomfort|pain and discomfort
27564|NCT03399383|Adrenal Insufficiency|adrenal insufficiency
27565|NCT03399383|Adrenal crisis|adrenal crisis
27566|NCT03399383|Adherence|adherence
27567|NCT03399383|Standardized patient education|standardized patient education
27568|NCT03399370|Inclisiran sodium|inclisiran sodium
27569|NCT03399370|ASCVD|ascvd
27570|NCT03399370|LDL-C|ldl-c
27571|NCT03399331|honey, olive oil, oral mucositis, pain|honey, olive oil, oral mucositis, pain
27572|NCT03399318|HRP2|hrp2
27573|NCT03399292|Lipid based eye drops, tearfilm lipid layer thickness|lipid based eye drops, tearfilm lipid layer thickness
27574|NCT03399279|nanohydroxyapatite|nanohydroxyapatite
27575|NCT03399279|Perforated membrane|perforated membrane
27576|NCT03399279|occlusive membrane|occlusive membrane
27577|NCT03399279|Aggressive periodontitis|aggressive periodontitis
27578|NCT03399266|Induction of labor|induction of labor
27579|NCT03399266|Previous cesarean delivery|previous cesarean delivery
27580|NCT03399266|Trial of labor after cesarean|trial of labor after cesarean
27581|NCT03399266|Prelabor rupture of membranes|prelabor rupture of membranes
27582|NCT03399266|balloon induction|balloon induction
27583|NCT03399253|Distal Gastric Cancer, Gastrectomy, Metastasectomy|distal gastric cancer, gastrectomy, metastasectomy
27584|NCT03399227|Bone microarchitecture|bone microarchitecture
27585|NCT03399188|Inflammatory Bowel Diseases, Fecal microbiota transplantation, microbiome|inflammatory bowel diseases, fecal microbiota transplantation, microbiome
27586|NCT03399175|Vogt-Koyanagi-Harada disease|vogt-koyanagi-harada disease
27587|NCT03399175|Immunosuppressive therapy|immunosuppressive therapy
27588|NCT03399175|Indocyanine green angiography|indocyanine green angiography
27589|NCT03399175|Enhanced depth imaging optical coherence tomography|enhanced depth imaging optical coherence tomography
27590|NCT03399175|Electroretinogram|electroretinogram
27591|NCT03399149|Respiratory Insufficiency|respiratory insufficiency
27592|NCT03399149|Hematologic Malignancy|hematologic malignancy
27593|NCT03399149|Intensive Care Unit|intensive care unit
27594|NCT03399136|Exercise training|exercise training
27595|NCT03399136|Intervention|intervention
27596|NCT03399136|Aerobic capacity|aerobic capacity
27597|NCT03399123|Laparoscopic hepatectomy|laparoscopic hepatectomy
27598|NCT03399123|Low tidal volume|low tidal volume
27599|NCT03399123|Blood loss|blood loss
27600|NCT03399110|Gastric cancer,Adjuvant chemtherapy|gastric cancer,adjuvant chemtherapy
27601|NCT03399097|Obesity|obesity
27602|NCT03399084|Ferric carboxymaltose|ferric carboxymaltose
27603|NCT03399084|Anemia|anemia
27604|NCT03399071|Gastric cancer|gastric cancer
27605|NCT03399071|Oesophageal cancer|oesophageal cancer
27606|NCT03399071|Gastro-oesophageal cancer|gastro-oesophageal cancer
27607|NCT03399071|Perioperative|perioperative
27608|NCT03399071|Immunotherapy|immunotherapy
27609|NCT03399071|Anti PDL1|anti pdl1
27610|NCT03399071|Avelumab|avelumab
27611|NCT03399071|FLOT|flot
27612|NCT03399032|caspofungin|caspofungin
27613|NCT03399032|pharmacokinetics|pharmacokinetics
27614|NCT03399019|Bispectral index monitor|bispectral index monitor
27615|NCT03398980|Childhood and Adolescent|childhood and adolescent
27616|NCT03398980|Survivors|survivors
27617|NCT03398980|Radiotherapy|radiotherapy
27618|NCT03398980|Late Sequelae|late sequelae
27619|NCT03398941|Pancreatic fistula|pancreatic fistula
27620|NCT03398915|robotic|robotic
27621|NCT03398915|robot-guided|robot-guided
27622|NCT03398915|navigated|navigated
27623|NCT03398915|computer-assisted|computer-assisted
27624|NCT03398915|pedicle screw|pedicle screw
27625|NCT03398915|instrumentation|instrumentation
27626|NCT03398915|thoracolumbar|thoracolumbar
27627|NCT03398902|sleep|sleep
27628|NCT03398902|sleep extension|sleep extension
27629|NCT03398902|sleep patterns|sleep patterns
27630|NCT03398902|type 2 diabetes|type 2 diabetes
27631|NCT03398902|glucose regulation|glucose regulation
27632|NCT03398902|behavioral intervention|behavioral intervention
27633|NCT03398902|adults|adults
27634|NCT03398889|intestinal microbiome|intestinal microbiome
27635|NCT03398889|atherosclerosis|atherosclerosis
27636|NCT03398889|nutrients|nutrients
27637|NCT03398889|renal function|renal function
27638|NCT03398850|spontaneous coronary artery dissection|spontaneous coronary artery dissection
27639|NCT03398850|acute coronary syndrome|acute coronary syndrome
27640|NCT03398850|coronary angiography|coronary angiography
27641|NCT03398850|coronary tomography|coronary tomography
27642|NCT03398837|Scleroderma|scleroderma
27643|NCT03398837|cannabinoid receptor type 2 agonist|cannabinoid receptor type 2 agonist
27644|NCT03398837|anabasum|anabasum
27645|NCT03398837|JBT-101|jbt-101
27646|NCT03398837|lenabasum|lenabasum
27647|NCT03398824|Fanconi Anemia|fanconi anemia
27648|NCT03398824|Metformin|metformin
27649|NCT03398798|archwire dimension|archwire dimension
27650|NCT03398798|ligation method|ligation method
27651|NCT03398798|bracket type|bracket type
27652|NCT03398785|Primary Aldosteronism|primary aldosteronism
27653|NCT03398785|Hypertension|hypertension
27654|NCT03398785|Ablation|ablation
27655|NCT03398785|Adrenal Gland|adrenal gland
27656|NCT03398759|Butorphanol|butorphanol
27657|NCT03398759|Functional endoscopic sinus surgery|functional endoscopic sinus surgery
27658|NCT03398759|Emergence agitation|emergence agitation
27659|NCT03398746|soft tissue infection|soft tissue infection
27660|NCT03398746|MRSA|mrsa
27661|NCT03398733|Obstructive Sleep Apnea|obstructive sleep apnea
27662|NCT03398733|heart valve replacement|heart valve replacement
27663|NCT03398733|CPAP treatment|cpap treatment
27664|NCT03398707|PICs|pics
27665|NCT03398707|diagnosis|diagnosis
27666|NCT03398707|prevention|prevention
27667|NCT03398707|outcome|outcome
27668|NCT03398681|Heart failure|heart failure
27669|NCT03398681|Iron deficiency|iron deficiency
27670|NCT03398681|Cardiac magnetic resonance|cardiac magnetic resonance
27671|NCT03398681|Ferric carboxymaltose|ferric carboxymaltose
27672|NCT03398681|Myocardial iron|myocardial iron
27673|NCT03398655|Recurrent Ovarian cancer|recurrent ovarian cancer
27674|NCT03398655|Platinum resistant ovarian cancer|platinum resistant ovarian cancer
27675|NCT03398655|Ovarian cancer|ovarian cancer
27676|NCT03398655|Ovarian carcinoma|ovarian carcinoma
27677|NCT03398655|Epithelial ovarian cancer|epithelial ovarian cancer
27678|NCT03398655|paclitaxel|paclitaxel
27679|NCT03398642|Occupational therapy|occupational therapy
27680|NCT03398642|Health promotion|health promotion
27681|NCT03398642|Life Style|life style
27682|NCT03398642|Quality of life|quality of life
27683|NCT03398642|Aging|aging
27684|NCT03398642|Aged|aged
27685|NCT03398642|Community participation|community participation
27686|NCT03398616|Retinal Bloodflow Pressure|retinal bloodflow pressure
27687|NCT03398603|"AMH measurement ElecSys"|"amh measurement elecsys"
27688|NCT03398590|Type 2 Diabetes|type 2 diabetes
27690|NCT03398577|Coronary disease|coronary disease
27691|NCT03398577|diabetes|diabetes
27692|NCT03398577|SGLT2I|sglt2i
27693|NCT03398577|Inflammation Mediators|inflammation mediators
27694|NCT03398564|Erecror Spinae Plan Block|erecror spinae plan block
27695|NCT03398564|postoperative pain|postoperative pain
27696|NCT03398564|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
27697|NCT03398551|pregnancy|pregnancy
27698|NCT03398551|machine learning|machine learning
27699|NCT03398551|fetal Doppler echocardiography|fetal doppler echocardiography
27700|NCT03398538|DFU|dfu
27701|NCT03398538|Ulcer|ulcer
27702|NCT03398525|central venous catheter|central venous catheter
27703|NCT03398525|intensive care|intensive care
27704|NCT03398525|music therapy|music therapy
27705|NCT03398499|pain|pain
27706|NCT03398499|orthognathic surgery|orthognathic surgery
27707|NCT03398499|temporomandibular disorders (TMD)|temporomandibular disorders (tmd)
27708|NCT03398499|Electromagnetic Therapy|electromagnetic therapy
27709|NCT03398499|Light therapy|light therapy
27710|NCT03398486|Kinesiotaping, Manual therapy|kinesiotaping, manual therapy
27711|NCT03398486|Physiotherapy|physiotherapy
27712|NCT03398473|Epoetin Hospira|epoetin hospira
27713|NCT03398473|Pharmacokinetics|pharmacokinetics
27714|NCT03398434|MAA868|maa868
27715|NCT03398434|apixaban|apixaban
27716|NCT03398434|atrial fibrillation|atrial fibrillation
27717|NCT03398434|anticoagulant|anticoagulant
27718|NCT03398434|Factor XI|factor xi
27720|NCT03398434|systemic thromboembolic events|systemic thromboembolic events
27721|NCT03398421|Nemiralisib|nemiralisib
27722|NCT03398421|Pharmacokinetics|pharmacokinetics
27723|NCT03398421|Itraconazole|itraconazole
27724|NCT03398421|Drug-drug Interaction|drug-drug interaction
27725|NCT03398421|Cross-over|cross-over
27726|NCT03398382|Magnesium citrate|magnesium citrate
27727|NCT03398382|Trismus after surgical removal of the lower third molars|trismus after surgical removal of the lower third molars
27728|NCT03398382|Local anesthesia|local anesthesia
27729|NCT03398382|Analgesia after surgical removal of the lower third molars|analgesia after surgical removal of the lower third molars
27730|NCT03398382|Swelling after surgical removal of the lower third molars|swelling after surgical removal of the lower third molars
27731|NCT03398382|Surgical removal of the lower third molars|surgical removal of the lower third molars
27732|NCT03398382|Oral surgical procedures|oral surgical procedures
27733|NCT03398382|Placebo effect|placebo effect
27734|NCT03398356|prediabetes|prediabetes
27735|NCT03398356|impaired fasting glucose|impaired fasting glucose
27736|NCT03398356|impaired glucose tolerance|impaired glucose tolerance
27737|NCT03398356|metformin|metformin
27738|NCT03398356|nitric oxide|nitric oxide
27739|NCT03398317|SDF|sdf
27740|NCT03398317|DFI|dfi
27741|NCT03398317|sperm selection|sperm selection
27742|NCT03398317|PICSI|picsi
27743|NCT03398317|MACS|macs
27744|NCT03398239|respiratory failure, hypercapnia, BPAP, AVAPS|respiratory failure, hypercapnia, bpap, avaps
27745|NCT03398174|Rural individuals|rural individuals
27746|NCT03398174|Exercise|exercise
27747|NCT03398174|Patient Education|patient education
27748|NCT03398161|Mycosis Fungoides|mycosis fungoides
27749|NCT03398161|MF|mf
27750|NCT03398161|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
27751|NCT03398161|Radiation therapy|radiation therapy
27752|NCT03398161|XRT|xrt
27753|NCT03398161|Questionnaire|questionnaire
27754|NCT03398161|Survey|survey
27755|NCT03398161|Photographs|photographs
27756|NCT03398161|Microbiome Analysis|microbiome analysis
27757|NCT03398148|ABBV-066|abbv-066
27758|NCT03398148|BI 655066|bi 655066
27759|NCT03398135|ABBV-066|abbv-066
27760|NCT03398135|BI 655066|bi 655066
27761|NCT03398122|Apatinib|apatinib
27762|NCT03398122|advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
27763|NCT03398070|Functional Neurological Disorder|functional neurological disorder
27764|NCT03398070|Functional Movement Disorder|functional movement disorder
27765|NCT03398070|Psychogenic Nonepileptic Seizures|psychogenic nonepileptic seizures
27766|NCT03398070|Functional Limb Weakness|functional limb weakness
27767|NCT03398057|Breast cancer screening; health education; breast self-examination; clinical breast examination; mammography.|breast cancer screening; health education; breast self-examination; clinical breast examination; mammography.
27768|NCT03398018|dry eye|dry eye
27769|NCT03398018|corticotropin|corticotropin
27770|NCT03398005|Omega-3 Fatty acids|omega-3 fatty acids
27771|NCT03398005|Triglycerides|triglycerides
27772|NCT03397979|atopic dermatitis|atopic dermatitis
27773|NCT03397979|bathing|bathing
27774|NCT03397979|baths|baths
27775|NCT03397966|obesity|obesity
27776|NCT03397966|Cardiovascular Physiological Phenomena|cardiovascular physiological phenomena
27777|NCT03397966|metabolism|metabolism
27778|NCT03397966|Energy Metabolism|energy metabolism
27779|NCT03397953|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
27780|NCT03397953|Childhood|childhood
27781|NCT03397953|Adolescent|adolescent
27782|NCT03397953|Recurrent|recurrent
27783|NCT03397953|Treatment|treatment
27784|NCT03397927|ballet shoe|ballet shoe
27785|NCT03397927|orthosis|orthosis
27787|NCT03397901|chronic radiation proctitis|chronic radiation proctitis
27788|NCT03397901|rectal bleeding|rectal bleeding
27789|NCT03397901|transverse colostomy|transverse colostomy
27790|NCT03397901|refractory|refractory
27791|NCT03397901|moderate to severe anemia|moderate to severe anemia
27792|NCT03397849|Primary prevention|primary prevention
27793|NCT03397849|Lifestyle intervention|lifestyle intervention
27794|NCT03397849|Digital health|digital health
27795|NCT03397849|Cardiovascular disease prevention|cardiovascular disease prevention
27796|NCT03397836|Older adults|older adults
27797|NCT03397836|Optimal aging|optimal aging
27798|NCT03397836|Primary health care|primary health care
27799|NCT03397836|Randomized control trial|randomized control trial
27800|NCT03397836|Integrated care|integrated care
27801|NCT03397836|Health care volunteers|health care volunteers
27802|NCT03397836|interdisciplinary health care teams|interdisciplinary health care teams
27803|NCT03397836|Implementation|implementation
27804|NCT03397836|Health services research|health services research
27805|NCT03397836|Patient centered care|patient centered care
27806|NCT03397810|cardiac amyloidosis|cardiac amyloidosis
27807|NCT03397810|radiotherapy|radiotherapy
27808|NCT03397797|muscle relaxant|muscle relaxant
27809|NCT03397784|Tidal volume challenge|tidal volume challenge
27810|NCT03397784|Fluid responsiveness|fluid responsiveness
27811|NCT03397784|Preload responsiveness|preload responsiveness
27812|NCT03397784|Functional hemodynamic monitoring|functional hemodynamic monitoring
27813|NCT03397784|Cardiac surgery|cardiac surgery
27814|NCT03397784|inferior vena cava variation|inferior vena cava variation
27815|NCT03397771|urinary incontinence, SSRI|urinary incontinence, ssri
27816|NCT03397745|bispectral index|bispectral index
27817|NCT03397745|lateral decubitus position|lateral decubitus position
27818|NCT03397745|one lung ventilation|one lung ventilation
27819|NCT03397732|Matrix metalloproteinase|matrix metalloproteinase
27820|NCT03397732|Tissue inhibitor of matrix metalloproteinase|tissue inhibitor of matrix metalloproteinase
27821|NCT03397732|Vascular surgery|vascular surgery
27822|NCT03397732|Aorta stent implantation|aorta stent implantation
27823|NCT03397732|Aorto-bifemoral bypass surgery|aorto-bifemoral bypass surgery
27824|NCT03397719|Autism Spectrum Disorder|autism spectrum disorder
27825|NCT03397719|Early Intervention|early intervention
27826|NCT03397719|Parent-Mediated Intervention|parent-mediated intervention
27827|NCT03397706|EBV+ post-transplant lymphoproliferative malignancy|ebv+ post-transplant lymphoproliferative malignancy
27828|NCT03397706|EBV-associated lymphoproliferative disorders associated with acquired immunodeficiency including HIV-positive|ebv-associated lymphoproliferative disorders associated with acquired immunodeficiency including hiv-positive
27829|NCT03397706|Relapsed, refractory, EBV+ lymphoid malignancy|relapsed, refractory, ebv+ lymphoid malignancy
27830|NCT03397693|PCOS|pcos
27831|NCT03397693|Unexplained infertiltiy|unexplained infertiltiy
27832|NCT03397693|3D Power Doppler|3d power doppler
27833|NCT03397693|Endometrial thickness|endometrial thickness
27834|NCT03397693|Subendometrial blood perfusion|subendometrial blood perfusion
27835|NCT03397680|Helicobacter Pylori infection|helicobacter pylori infection
27836|NCT03397680|Non-ulcer Dyspepsia|non-ulcer dyspepsia
27837|NCT03397680|Rabeprazole-Levofloxacin|rabeprazole-levofloxacin
27838|NCT03397602|atrial fibrillation|atrial fibrillation
27839|NCT03397602|exercise|exercise
27840|NCT03397576|Prisoner|prisoner
27841|NCT03397563|Continuous Positive Airway Pressure|continuous positive airway pressure
27842|NCT03397563|Sleep Apnea, Obstructive|sleep apnea, obstructive
27843|NCT03397563|Polysomnography|polysomnography
27844|NCT03397550|taste threshold|taste threshold
27845|NCT03397550|salt restriction|salt restriction
27846|NCT03397537|Breast Neoplasms Endocrine-responsive Neoadjuvant Duration Letrozole|breast neoplasms endocrine-responsive neoadjuvant duration letrozole
27847|NCT03397498|computerized cognitive training|computerized cognitive training
27848|NCT03397472|Insomnia|insomnia
27849|NCT03397472|Treatment|treatment
27850|NCT03397472|magnetic field modulation|magnetic field modulation
27851|NCT03397459|cervicobrachial neuralgia|cervicobrachial neuralgia
27852|NCT03397459|sagittal balance|sagittal balance
27853|NCT03397459|lordosis|lordosis
27854|NCT03397446|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate
27855|NCT03397446|Lisdexamfetamine|lisdexamfetamine
27856|NCT03397446|Vyvanse|vyvanse
27857|NCT03397446|Eating Disorders|eating disorders
27858|NCT03397446|Mental Disorders|mental disorders
27859|NCT03397446|Central Nervous System Stimulants|central nervous system stimulants
27860|NCT03397446|Dextroamphetamine|dextroamphetamine
27861|NCT03397446|LDX|ldx
27862|NCT03397446|Binge Eating|binge eating
27863|NCT03397446|Purging|purging
27864|NCT03397446|Bulimia Nervosa|bulimia nervosa
27865|NCT03397433|Antibiotic Stewardship|antibiotic stewardship
27866|NCT03397433|Information Technology|information technology
27867|NCT03397433|Healthcare Outcomes|healthcare outcomes
27868|NCT03397433|Antibiotic Resistance|antibiotic resistance
27869|NCT03397433|Bacterial Infection|bacterial infection
27870|NCT03397394|PARP inhibitor|parp inhibitor
27871|NCT03397394|PARPi|parpi
27872|NCT03397394|HRD|hrd
27873|NCT03397394|ATLAS|atlas
27874|NCT03397394|homologous recombination|homologous recombination
27877|NCT03397394|DNA defect|dna defect
27878|NCT03397394|DNA anomaly|dna anomaly
27879|NCT03397394|Rucaparib|rucaparib
27880|NCT03397394|MIBC|mibc
27881|NCT03397355|Pulmonary Nodule; Lung Cancer; Biopsy; Biomarker.|pulmonary nodule; lung cancer; biopsy; biomarker.
27882|NCT03397329|Healthy Volunteers|healthy volunteers
27883|NCT03397316|immediate implant|immediate implant
27884|NCT03397316|upper esthetic zone|upper esthetic zone
27885|NCT03397316|marginal bone loss|marginal bone loss
27886|NCT03397290|Chest X-ray|chest x-ray
27887|NCT03397290|Ultrasound|ultrasound
27888|NCT03397277|IPV|ipv
27889|NCT03397238|myeloid cell|myeloid cell
27890|NCT03397238|reprogramming|reprogramming
27891|NCT03397238|monocyte|monocyte
27892|NCT03397238|tumor-associated macrophage|tumor-associated macrophage
27893|NCT03397212|NADA|nada
27894|NCT03397173|Azacitidine|azacitidine
27895|NCT03397173|Ascorbic Acid|ascorbic acid
27896|NCT03397160|Prostate cancer|prostate cancer
27897|NCT03397160|Transformative Impact Award|transformative impact award
27898|NCT03397160|Early stage|early stage
27899|NCT03397160|Active surveillance|active surveillance
27900|NCT03397160|Decision aid|decision aid
27901|NCT03397160|Coaching session|coaching session
27902|NCT03397160|Personalized|personalized
27903|NCT03397160|University of California, San Francisco (UCSF)|university of california, san francisco (ucsf)
27904|NCT03397160|Validation|validation
27905|NCT03397121|HeFH|hefh
27906|NCT03397121|LDL-C|ldl-c
27907|NCT03397121|Inclisiran|inclisiran
27908|NCT03397108|Inflammatory Bowel Disease|inflammatory bowel disease
27909|NCT03397108|Crohn disease|crohn disease
27910|NCT03397108|Colitis|colitis
27911|NCT03397108|TNF|tnf
27912|NCT03397108|Breast milk|breast milk
27913|NCT03397108|monoclonal antibody|monoclonal antibody
27914|NCT03397095|stem cells, ischemic heart failure.|stem cells, ischemic heart failure.
27915|NCT03397082|Endouterine manual aspiration|endouterine manual aspiration
27916|NCT03397082|Paracervical blockade|paracervical blockade
27917|NCT03397082|Lidocaine gel|lidocaine gel
27918|NCT03397069|peribubar block - midazolam|peribubar block - midazolam
27919|NCT03397056|Patient willingness|patient willingness
27920|NCT03397056|Participation|participation
27921|NCT03397030|Prostate Cancer|prostate cancer
27922|NCT03397030|Biomarkers|biomarkers
27923|NCT03397030|Exercise|exercise
27924|NCT03397004|Hereditary hemorrhagic telangiectasia|hereditary hemorrhagic telangiectasia
27925|NCT03397004|HHT|hht
27926|NCT03397004|Doxycycline|doxycycline
27927|NCT03396991|Analgesia technique|analgesia technique
27928|NCT03396991|Pain control|pain control
27929|NCT03396939|Stroke|stroke
27930|NCT03396939|Rehabilitation|rehabilitation
27931|NCT03396939|Task oriented training|task oriented training
27932|NCT03396939|Motor recovery|motor recovery
27933|NCT03396939|Hand function|hand function
27934|NCT03396939|Arm function|arm function
27935|NCT03396913|Intense Pulsed Light|intense pulsed light
27936|NCT03396913|Meibomian Gland Dysfunction|meibomian gland dysfunction
27937|NCT03396913|Dry Eye Disease|dry eye disease
27938|NCT03396887|Alcohol Use Disorder|alcohol use disorder
27939|NCT03396887|Smartphone Application|smartphone application
27940|NCT03396861|macular edema|macular edema
27941|NCT03396861|pseudophakia|pseudophakia
27942|NCT03396861|pseudophakic macular edema|pseudophakic macular edema
27943|NCT03396861|retinal swelling|retinal swelling
27944|NCT03396861|aflibercept|aflibercept
27945|NCT03396861|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
27946|NCT03396861|subconjunctival injection|subconjunctival injection
27947|NCT03396848|Rehabilitation|rehabilitation
27948|NCT03396848|Online Clinic|online clinic
27949|NCT03396822|multiple sclerosis|multiple sclerosis
27950|NCT03396822|7T MRI|7t mri
27951|NCT03396822|Meningeal inflammation|meningeal inflammation
27952|NCT03396809|punctal plugs|punctal plugs
27953|NCT03396809|dry eye|dry eye
27954|NCT03396809|ocular surface disease index|ocular surface disease index
27955|NCT03396796|Vagus nerve|vagus nerve
27956|NCT03396796|Delayed gastric emptying|delayed gastric emptying
27957|NCT03396796|Cirrhosis|cirrhosis
27958|NCT03396796|Hypertension|hypertension
27959|NCT03396796|laparoscopy|laparoscopy
27960|NCT03396770|Urinary biomarkers|urinary biomarkers
27961|NCT03396770|Intensive Care Unit|intensive care unit
27962|NCT03396757|Acute Kidney Injury|acute kidney injury
27963|NCT03396757|Critical Care|critical care
27964|NCT03396757|Renal Replacement Therapy|renal replacement therapy
27965|NCT03396731|VLU|vlu
27966|NCT03396731|Venous Leg Ulcer|venous leg ulcer
27967|NCT03396731|Leg Ulcer|leg ulcer
27968|NCT03396731|Leg Wound|leg wound
27969|NCT03396718|Head and neck cancer|head and neck cancer
27970|NCT03396718|Oropharyngeal cancer|oropharyngeal cancer
27971|NCT03396718|postoperative|postoperative
27972|NCT03396718|radiotherapy|radiotherapy
27973|NCT03396718|radiochemotherapy|radiochemotherapy
27974|NCT03396718|de-intensification|de-intensification
27975|NCT03396718|HPV|hpv
27976|NCT03396679|Psoriatic arthritis|psoriatic arthritis
27977|NCT03396679|remission|remission
27978|NCT03396679|ultrasound|ultrasound
27979|NCT03396653|weight loss|weight loss
27980|NCT03396653|weight maintenance|weight maintenance
27981|NCT03396653|weight control|weight control
27982|NCT03396653|peer support|peer support
27983|NCT03396653|patient-provided care|patient-provided care
27984|NCT03396640|anteromedial|anteromedial
27985|NCT03396627|eyelid|eyelid
27986|NCT03396627|Muller|muller
27987|NCT03396588|Opiate use during pregnancy|opiate use during pregnancy
27988|NCT03396588|Clonidine|clonidine
27989|NCT03396588|Morphine|morphine
27990|NCT03396588|Prenatal opiate|prenatal opiate
27991|NCT03396588|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
27992|NCT03396588|Infant, Newborn, Diseases|infant, newborn, diseases
27993|NCT03396588|Substance-Related Disorders|substance-related disorders
27994|NCT03396588|Chemically-Induced Disorders|chemically-induced disorders
27995|NCT03396588|Opiate Alkaloids|opiate alkaloids
27996|NCT03396588|Mental Disorders|mental disorders
27997|NCT03396588|Narcotics|narcotics
27998|NCT03396588|Central Nervous System Depressants|central nervous system depressants
27999|NCT03396588|Physiological Effects of Drugs|physiological effects of drugs
28000|NCT03396588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists
28001|NCT03396588|Adrenergic alpha-Agonists|adrenergic alpha-agonists
28002|NCT03396588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
28003|NCT03396588|Antihypertensive Agents|antihypertensive agents
28004|NCT03396588|Analgesics|analgesics
28005|NCT03396588|Peripheral Nervous System Agents|peripheral nervous system agents
28006|NCT03396588|Sympatholytics|sympatholytics
28007|NCT03396588|Autonomic Agents|autonomic agents
28008|NCT03396588|Neurotransmitter Agents|neurotransmitter agents
28009|NCT03396575|Total tumor mRNA-pulsed autologous Dendritic Cells (DCs) (TTRNA-DCs)|total tumor mrna-pulsed autologous dendritic cells (dcs) (ttrna-dcs)
28010|NCT03396575|Tumor-specific ex vivo expanded autologous lymphocyte transfer (TTRNA-xALT)|tumor-specific ex vivo expanded autologous lymphocyte transfer (ttrna-xalt)
28011|NCT03396575|Autologous G-CSF mobilized HSCs|autologous g-csf mobilized hscs
28012|NCT03396575|Temozolomide (TMZ)|temozolomide (tmz)
28013|NCT03396575|Cyclophosphamide (CTX)|cyclophosphamide (ctx)
28014|NCT03396575|Fludarabine (Flu)|fludarabine (flu)
28015|NCT03396575|Granulocyte Colony Stimulating Factor (G-CSF)|granulocyte colony stimulating factor (g-csf)
28016|NCT03396575|Granulocyte Macrophage Colony Stimulating Factor (GM-CSF)|granulocyte macrophage colony stimulating factor (gm-csf)
28017|NCT03396575|Tetanus Toxoid|tetanus toxoid
28018|NCT03396575|Mesna|mesna
28019|NCT03396562|body composition|body composition
28020|NCT03396562|klinefelter syndrome|klinefelter syndrome
28021|NCT03396562|XXY|xxy
28022|NCT03396562|Trisomy X|trisomy x
28023|NCT03396562|XXX|xxx
28024|NCT03396562|XYY|xyy
28025|NCT03396562|XXYY|xxyy
28026|NCT03396562|XXXY|xxxy
28027|NCT03396562|XXXXY|xxxxy
28028|NCT03396562|sex chromosome variation|sex chromosome variation
28029|NCT03396562|sex chromosome aneuploidy|sex chromosome aneuploidy
28030|NCT03396562|sex chromosome trisomy|sex chromosome trisomy
28031|NCT03396562|testosterone|testosterone
28032|NCT03396562|XYYY|xyyy
28033|NCT03396562|XXXX|xxxx
28034|NCT03396562|XXXXX|xxxxx
28035|NCT03396562|XXXYY|xxxyy
28036|NCT03396562|XXYYY|xxyyy
28037|NCT03396562|XYYYY|xyyyy
28038|NCT03396562|developmental delay|developmental delay
28039|NCT03396562|speech development|speech development
28040|NCT03396549|tDCS|tdcs
28041|NCT03396549|food craving|food craving
28042|NCT03396549|tDCS sham procedure|tdcs sham procedure
28043|NCT03396549|montage|montage
28044|NCT03396549|food intake|food intake
28045|NCT03396536|implant|implant
28046|NCT03396536|oral hygiene|oral hygiene
28047|NCT03396536|discomfort|discomfort
28048|NCT03396523|Losartan|losartan
28049|NCT03396523|Fear extinction|fear extinction
28050|NCT03396510|Cancer Care|cancer care
28051|NCT03396484|TrialNet|trialnet
28052|NCT03396458|Hepatitis B|hepatitis b
28053|NCT03396458|Disease prevalence|disease prevalence
28054|NCT03396458|Screening|screening
28055|NCT03396458|Migrant|migrant
28056|NCT03396458|Turkish|turkish
28057|NCT03396458|Belgium|belgium
28058|NCT03396432|laryngoscope|laryngoscope
28059|NCT03396432|intubation|intubation
28060|NCT03396432|first attempt success|first attempt success
28061|NCT03396432|oxygen saturation|oxygen saturation
28062|NCT03396432|airway management|airway management
28063|NCT03396432|Videolaryngoscopy|videolaryngoscopy
28064|NCT03396432|Direct laryngoscopy|direct laryngoscopy
28065|NCT03396406|trigeminal neuralgia, radiofrequency|trigeminal neuralgia, radiofrequency
28066|NCT03396393|Dihydroartemisinin;Systemic Lupus Erythematosus|dihydroartemisinin;systemic lupus erythematosus
28067|NCT03396367|Relationships|relationships
28068|NCT03396367|YMSM|ymsm
28069|NCT03396367|HIV/AIDS|hiv/aids
28070|NCT03396367|PrEP|prep
28071|NCT03396367|Drug Use|drug use
28072|NCT03396341|BRCA1/2 Mutations|brca1/2 mutations
28073|NCT03396341|17-489|17-489
28074|NCT03396315|premenopausal women|premenopausal women
28075|NCT03396302|Exercise|exercise
28076|NCT03396302|Nutrition|nutrition
28077|NCT03396302|Internet|internet
28078|NCT03396302|Obesity|obesity
28079|NCT03396302|Hypertension|hypertension
28080|NCT03396289|Cerebral Palsy|cerebral palsy
28081|NCT03396289|Balance|balance
28082|NCT03396289|Inspiratory Muscle Training|inspiratory muscle training
28083|NCT03396289|6-Minute Walk Test|6-minute walk test
28084|NCT03396289|Pulmonary Function Test|pulmonary function test
28085|NCT03396289|Postural Stability|postural stability
28086|NCT03396263|Personalised nutrition|personalised nutrition
28087|NCT03396263|Mobile web application|mobile web application
28088|NCT03396224|Total hip arthroplasty|total hip arthroplasty
28089|NCT03396224|Hip implant|hip implant
28090|NCT03396211|Metastatic|metastatic
28091|NCT03396211|Unresectable|unresectable
28092|NCT03396198|Gastrointestinal Microbiome|gastrointestinal microbiome
28093|NCT03396198|Infants|infants
28094|NCT03396172|COPD|copd
28095|NCT03396172|Homecare|homecare
28096|NCT03396172|Oxygen|oxygen
28097|NCT03396172|Telemedicine|telemedicine
28098|NCT03396172|Automated oxygen adjustment|automated oxygen adjustment
28099|NCT03396172|Rehabilitation program|rehabilitation program
28100|NCT03396159|liver transplantation|liver transplantation
28101|NCT03396159|mini fluid challenge|mini fluid challenge
28102|NCT03396146|Pancreatic polypeptide|pancreatic polypeptide
28103|NCT03396146|Type 1 diabetes|type 1 diabetes
28104|NCT03396146|Chronic pancreatitis|chronic pancreatitis
28105|NCT03396133|Dyno|dyno
28106|NCT03396133|symptomatic arrhythmia|symptomatic arrhythmia
28107|NCT03396133|diagnosis|diagnosis
28108|NCT03396133|follow-up|follow-up
28109|NCT03396094|high flow oxygenation, rapid sequence intubation|high flow oxygenation, rapid sequence intubation
28110|NCT03396081|Heart Failure|heart failure
28111|NCT03396081|Care pathway|care pathway
28112|NCT03396081|Transition program|transition program
28113|NCT03396081|Efficiency|efficiency
28114|NCT03396055|decompression surgery|decompression surgery
28115|NCT03396055|functional outcome|functional outcome
28116|NCT03396055|biomechanic|biomechanic
28117|NCT03396055|rehabilitation|rehabilitation
28118|NCT03396042|CEP290|cep290
28119|NCT03396042|Leber congenital amaurosis (LCA)|leber congenital amaurosis (lca)
28120|NCT03396042|LCA10|lca10
28121|NCT03396042|Retinal degenerative diseases (RDD)|retinal degenerative diseases (rdd)
28122|NCT03396029|Lifestyle intervention|lifestyle intervention
28123|NCT03396029|Diet|diet
28124|NCT03396029|Smoking cessation|smoking cessation
28125|NCT03396029|Physical activity|physical activity
28126|NCT03396029|Alcohol|alcohol
28127|NCT03396029|Body mass index|body mass index
28128|NCT03396029|colorectal cancer screening|colorectal cancer screening
28129|NCT03396029|sigmoidoscopy|sigmoidoscopy
28130|NCT03395990|femoral nerve block|femoral nerve block
28131|NCT03395990|adductor canal block|adductor canal block
28132|NCT03395990|analgesia|analgesia
28133|NCT03395977|uric acid|uric acid
28134|NCT03395977|xanthin oxydoreductase|xanthin oxydoreductase
28135|NCT03395977|febuxostat|febuxostat
28136|NCT03395977|uricase|uricase
28137|NCT03395951|Mean Systemic Filling Pressure|mean systemic filling pressure
28138|NCT03395951|Diuretics|diuretics
28139|NCT03395951|Pressure for venous return|pressure for venous return
28140|NCT03395951|Fluid Balance|fluid balance
28141|NCT03395951|De-escalation fluid therapy|de-escalation fluid therapy
28142|NCT03395951|De-resuscitation|de-resuscitation
28143|NCT03395951|Guyton|guyton
28144|NCT03395951|Guytonian Approach|guytonian approach
28145|NCT03395951|Furosemide|furosemide
28146|NCT03395951|Cardiac Output|cardiac output
28147|NCT03395951|Cardiac Index|cardiac index
28148|NCT03395938|SCREENING|screening
28149|NCT03395925|Thyroid Nodule|thyroid nodule
28150|NCT03395925|Bipolar coagulation electrode|bipolar coagulation electrode
28151|NCT03395925|radiofrequency ablation|radiofrequency ablation
28152|NCT03395912|local anesthetics infiltration|local anesthetics infiltration
28153|NCT03395912|cesarean section pain relief|cesarean section pain relief
28154|NCT03395899|Atezolizumab|atezolizumab
28155|NCT03395899|Bevacizumab|bevacizumab
28156|NCT03395899|Cobimetinib|cobimetinib
28157|NCT03395899|Ipatasertib|ipatasertib
28158|NCT03395899|pre-operative|pre-operative
28159|NCT03395899|Window of opportunity|window of opportunity
28160|NCT03395886|noninvasive ventilation|noninvasive ventilation
28161|NCT03395886|remifentanil|remifentanil
28162|NCT03395886|dexmedetomidine|dexmedetomidine
28163|NCT03395886|cardiac surgery|cardiac surgery
28164|NCT03395860|GVHD|gvhd
28165|NCT03395860|ATG|atg
28166|NCT03395860|PTCy|ptcy
28167|NCT03395860|halo-HSCT|halo-hsct
28168|NCT03395847|Diseases of oesophagus stomach and duodenum|diseases of oesophagus stomach and duodenum
28169|NCT03395847|Advanced gastroesophageal adenocarcinoma|advanced gastroesophageal adenocarcinoma
28170|NCT03395847|Pembrolizumab|pembrolizumab
28171|NCT03395847|Keytruda|keytruda
28172|NCT03395847|MK-3475|mk-3475
28173|NCT03395847|Ramucirumab|ramucirumab
28174|NCT03395847|Ramucirumab DP|ramucirumab dp
28175|NCT03395847|IMC-1121B|imc-1121b
28176|NCT03395847|SCH-900475|sch-900475
28177|NCT03395821|competency-based education|competency-based education
28178|NCT03395821|gynecology|gynecology
28179|NCT03395821|laparoscopy|laparoscopy
28180|NCT03395821|resident education|resident education
28181|NCT03395821|simulation|simulation
28182|NCT03395821|surgical curriculum|surgical curriculum
28183|NCT03395795|Infantile Spinal Muscular Atrophy|infantile spinal muscular atrophy
28184|NCT03395795|Respiratory Decompensations|respiratory decompensations
28185|NCT03395756|Depot Medroxyprogesterone acetate|depot medroxyprogesterone acetate
28186|NCT03395756|Injectable birth control|injectable birth control
28187|NCT03395717|Stroke|stroke
28188|NCT03395717|Robot|robot
28189|NCT03395717|Hemiparesis|hemiparesis
28190|NCT03395717|Gait Training|gait training
28191|NCT03395717|Rehabilitation|rehabilitation
28192|NCT03395717|Exoskeleton|exoskeleton
28193|NCT03395717|Functional Recovery|functional recovery
28194|NCT03395691|axillary vein|axillary vein
28195|NCT03395691|central venous catheterization|central venous catheterization
28196|NCT03395691|ultrasound|ultrasound
28197|NCT03395691|cardiac surgery|cardiac surgery
28198|NCT03395691|complication|complication
28199|NCT03395678|Microneedling|microneedling
28200|NCT03395678|Nonablative fractional lasers|nonablative fractional lasers
28201|NCT03395678|Fitzpatrick skin types III-V|fitzpatrick skin types iii-v
28202|NCT03395678|Arophic acne scarring|arophic acne scarring
28203|NCT03395652|pregnancy, physical activity, fetal growth|pregnancy, physical activity, fetal growth
28204|NCT03395639|Children|children
28205|NCT03395639|Pediatrics|pediatrics
28206|NCT03395639|Cardiac disease with potential for thromboembolic complications|cardiac disease with potential for thromboembolic complications
28207|NCT03395639|Prophylactic treatment|prophylactic treatment
28208|NCT03395639|Anticoagulant drugs|anticoagulant drugs
28209|NCT03395587|glioblastoma,|glioblastoma,
28210|NCT03395587|immunotherapy|immunotherapy
28211|NCT03395587|dendritic cells|dendritic cells
28212|NCT03395587|vaccination|vaccination
28213|NCT03395535|Primary Open Angle Glaucoma|primary open angle glaucoma
28214|NCT03395535|Glaucoma|glaucoma
28215|NCT03395535|Ocular Hypertension|ocular hypertension
28216|NCT03395535|POAG|poag
28217|NCT03395535|SLT|slt
28218|NCT03395535|Laser|laser
28219|NCT03395509|Mass screening|mass screening
28220|NCT03395509|cardiovascular disease|cardiovascular disease
28221|NCT03395509|diabetes|diabetes
28222|NCT03395496|pulpotomy|pulpotomy
28223|NCT03395496|pediatric dentistry|pediatric dentistry
28224|NCT03395496|primary molars|primary molars
28225|NCT03395483|peripheral perfusion|peripheral perfusion
28226|NCT03395483|Haemodynamic Instability|haemodynamic instability
28227|NCT03395483|mesenteric bloodflow|mesenteric bloodflow
28228|NCT03395431|Autologuous serum|autologuous serum
28229|NCT03395431|dry eyes disease|dry eyes disease
28230|NCT03395431|fingerprick blood|fingerprick blood
28231|NCT03395418|COPD|copd
28232|NCT03395418|Asthma|asthma
28233|NCT03395418|Inhaled Therapeutics|inhaled therapeutics
28234|NCT03395405|Efficacy|efficacy
28235|NCT03395405|Nitazoxanide|nitazoxanide
28236|NCT03395405|Norovirus|norovirus
28237|NCT03395405|Safety|safety
28238|NCT03395405|Treatment|treatment
28239|NCT03395379|Radiofrequency|radiofrequency
28240|NCT03395379|Thermal Protection|thermal protection
28241|NCT03395379|Percutaneous thermal ablation|percutaneous thermal ablation
28242|NCT03395379|Kidney neoplasms|kidney neoplasms
28243|NCT03395366|Hemodialysis|hemodialysis
28244|NCT03395366|End Stage Renal Disease|end stage renal disease
28245|NCT03395340|cGVHD|cgvhd
28246|NCT03395340|Epidermal|epidermal
28247|NCT03395340|JAK Inhibitors|jak inhibitors
28248|NCT03395340|Skin|skin
28249|NCT03395340|JAK-STAT|jak-stat
28250|NCT03395314|Borderline Personality Disorder|borderline personality disorder
28251|NCT03395314|Ketamine|ketamine
28252|NCT03395314|Suicide|suicide
28253|NCT03395314|Social Cognition|social cognition
28254|NCT03395301|hysteroscopy|hysteroscopy
28255|NCT03395301|fiber platinum coil|fiber platinum coil
28256|NCT03395301|tubal occlusion|tubal occlusion
28257|NCT03395288|UTI|uti
28258|NCT03395288|recurrent UTI|recurrent uti
28259|NCT03395249|safety|safety
28260|NCT03395249|tolerability|tolerability
28261|NCT03395249|pharmacokinetics|pharmacokinetics
28262|NCT03395249|SPR994|spr994
28263|NCT03395223|Acquired Methaemoglobinemia|acquired methaemoglobinemia
28264|NCT03395223|Methylene Blue|methylene blue
28265|NCT03395197|DDR (DNA damage repair), mCRPc (metastatic castration-resistant prostate cancer)|ddr (dna damage repair), mcrpc (metastatic castration-resistant prostate cancer)
28266|NCT03395119|Ozone exposure|ozone exposure
28267|NCT03395119|Healthy Adults|healthy adults
28268|NCT03395106|vaccine|vaccine
28269|NCT03395106|public health|public health
28270|NCT03395093|bronchoscopy|bronchoscopy
28271|NCT03395093|conscious sedation|conscious sedation
28272|NCT03395093|fentanyl|fentanyl
28273|NCT03395093|Bispectral Index|bispectral index
28274|NCT03395080|endometrioid histology|endometrioid histology
28275|NCT03395080|Wnt pathway|wnt pathway
28276|NCT03395080|DKK1|dkk1
28277|NCT03395067|Obesity|obesity
28278|NCT03395067|Infertility|infertility
28279|NCT03395067|In vitro fertilization|in vitro fertilization
28280|NCT03395054|neck pain|neck pain
28281|NCT03395054|pulmonary function test|pulmonary function test
28282|NCT03395054|respiratory muscle strength|respiratory muscle strength
28283|NCT03395054|cervical stabilization exercises|cervical stabilization exercises
28284|NCT03395041|vulnerable plaque, cardiac imaging, oral bacteria, inflammation|vulnerable plaque, cardiac imaging, oral bacteria, inflammation
28285|NCT03395028|Biliary Atresia|biliary atresia
28286|NCT03395028|Granulocyte Colony Stimulating Factor|granulocyte colony stimulating factor
28287|NCT03395028|GCSF|gcsf
28288|NCT03395015|Reconstructive surgical procedures|reconstructive surgical procedures
28289|NCT03395015|Therapy, soft tissue|therapy, soft tissue
28290|NCT03395015|Treatment outcome|treatment outcome
28291|NCT03395015|Outcome Assessment (Health Care)|outcome assessment (health care)
28292|NCT03395015|Photogrammetry|photogrammetry
28293|NCT03395015|Physical Appearance, Body|physical appearance, body
28294|NCT03395002|Tiotropium|tiotropium
28295|NCT03395002|Salmeterol|salmeterol
28296|NCT03395002|Fluticasone|fluticasone
28297|NCT03395002|COPD|copd
28298|NCT03395002|Bronchodilator effect|bronchodilator effect
28299|NCT03395002|Discair|discair
28300|NCT03395002|Diskus|diskus
28301|NCT03395002|Spirometry|spirometry
28302|NCT03394963|Food-Based Dietary guideline|food-based dietary guideline
28303|NCT03394963|Healthy Eating Index|healthy eating index
28304|NCT03394963|Healthy Diet|healthy diet
28305|NCT03394963|Protocol|protocol
28306|NCT03394963|Ethiopia|ethiopia
28307|NCT03394950|thrombolysis|thrombolysis
28308|NCT03394950|Butyphthalide|butyphthalide
28309|NCT03394924|PBC|pbc
28310|NCT03394924|Primary Ciliary Cholangitis (PBC)|primary ciliary cholangitis (pbc)
28311|NCT03394898|Chronic Pain|chronic pain
28312|NCT03394898|Body Mass Index|body mass index
28313|NCT03394898|Eating Habits|eating habits
28314|NCT03394872|Pleural effusion|pleural effusion
28315|NCT03394872|Mechanical Ventilation|mechanical ventilation
28316|NCT03394872|Ultrasonography|ultrasonography
28317|NCT03394872|Drainage|drainage
28318|NCT03394833|preoperative|preoperative
28319|NCT03394833|fluid therapy|fluid therapy
28320|NCT03394833|hemodynamics|hemodynamics
28321|NCT03394833|anesthesia induction|anesthesia induction
28322|NCT03394833|rapid sequence induction|rapid sequence induction
28323|NCT03394833|TCI|tci
28324|NCT03394820|Dexamethasone|dexamethasone
28325|NCT03394820|Supraclavicular block|supraclavicular block
28326|NCT03394794|anorectal physiology|anorectal physiology
28327|NCT03394794|therapies|therapies
28328|NCT03394794|quality fo life|quality fo life
28329|NCT03394755|thrombocytopenia|thrombocytopenia
28330|NCT03394755|bleeding|bleeding
28331|NCT03394742|Peer Group|peer group
28332|NCT03394742|Quality of Life|quality of life
28333|NCT03394729|Propole|propole
28334|NCT03394729|Xylitol|xylitol
28335|NCT03394729|Saliva|saliva
28336|NCT03394716|MRI|mri
28337|NCT03394716|Radiotherapy|radiotherapy
28338|NCT03394703|Lung cancer|lung cancer
28339|NCT03394703|screening|screening
28340|NCT03394703|Low-dose Computed Tomography|low-dose computed tomography
28341|NCT03394703|Smokers|smokers
28342|NCT03394664|Body composition|body composition
28343|NCT03394664|Feeding study|feeding study
28344|NCT03394664|Ketogenic diet|ketogenic diet
28345|NCT03394664|Weight loss|weight loss
28346|NCT03394664|Energy Expenditure|energy expenditure
28347|NCT03394651|male|male
28348|NCT03394651|lower urinary tract symptoms|lower urinary tract symptoms
28349|NCT03394651|comorbidities|comorbidities
28350|NCT03394651|chronic kidney diseases|chronic kidney diseases
28351|NCT03394651|urodynamics|urodynamics
28352|NCT03394651|medical therapy|medical therapy
28353|NCT03394651|surgical treatment|surgical treatment
28354|NCT03394638|eHealth|ehealth
28355|NCT03394638|Bariatric surgery|bariatric surgery
28356|NCT03394638|Obesity|obesity
28357|NCT03394638|Telemedicine|telemedicine
28358|NCT03394625|Socket Shield|socket shield
28359|NCT03394625|immediate implant|immediate implant
28360|NCT03394625|ridge preservation|ridge preservation
28361|NCT03394612|Scar|scar
28362|NCT03394612|Skin|skin
28363|NCT03394612|Wound Healing|wound healing
28364|NCT03394612|Tissue Engineering|tissue engineering
28365|NCT03394612|Dermis|dermis
28366|NCT03394612|Epidermis|epidermis
28367|NCT03394599|Physical Activity|physical activity
28368|NCT03394599|Rehabilitation|rehabilitation
28369|NCT03394599|Exercise|exercise
28370|NCT03394599|Engagement|engagement
28371|NCT03394599|Older Adults|older adults
28372|NCT03394586|Golimumab|golimumab
28373|NCT03394586|TNF-inhibitors|tnf-inhibitors
28374|NCT03394586|Clinical Response|clinical response
28375|NCT03394586|Clinical Remission|clinical remission
28376|NCT03394586|Ulcerative Colitis|ulcerative colitis
28377|NCT03394573|Diabetic macular edema|diabetic macular edema
28378|NCT03394560|Spinal Cord Injury|spinal cord injury
28379|NCT03394560|transcranial magnetic stimulation|transcranial magnetic stimulation
28380|NCT03394560|body weight-support treadmill training|body weight-support treadmill training
28381|NCT03394560|gait|gait
28382|NCT03394534|Comprehensive Geriatric Assessment|comprehensive geriatric assessment
28383|NCT03394534|Frailty|frailty
28384|NCT03394534|electronic Frailty Index|electronic frailty index
28385|NCT03394534|eFI|efi
28386|NCT03394534|Care and Support plan|care and support plan
28387|NCT03394534|Primary Care|primary care
28388|NCT03394521|glaucoma suspect|glaucoma suspect
28389|NCT03394521|ocular hypertension|ocular hypertension
28390|NCT03394521|progression|progression
28391|NCT03394495|Fatigue|fatigue
28392|NCT03394495|Frailty|frailty
28393|NCT03394495|Cluster-RCT|cluster-rct
28394|NCT03394495|Exercise|exercise
28395|NCT03394495|Behavioral change|behavioral change
28396|NCT03394469|Obesity|obesity
28397|NCT03394469|Sarcopenia|sarcopenia
28398|NCT03394430|sevoflurane|sevoflurane
28399|NCT03394430|epileptiform EEG|epileptiform eeg
28400|NCT03394430|midazolam|midazolam
28401|NCT03394430|dexmedetomidine|dexmedetomidine
28402|NCT03394404|ECG-I Mapping Pulmonary Vein Isolation|ecg-i mapping pulmonary vein isolation
28403|NCT03394391|Adherence|adherence
28404|NCT03394391|Adolescents|adolescents
28405|NCT03394391|Antiretroviral therapy|antiretroviral therapy
28406|NCT03394391|HIV|hiv
28407|NCT03394391|Nigeria|nigeria
28408|NCT03394391|Randomized controlled trial|randomized controlled trial
28409|NCT03394391|Short message services|short message services
28410|NCT03394365|Solid organ transplant|solid organ transplant
28411|NCT03394365|EBV-PTLD|ebv-ptld
28412|NCT03394365|Cytotoxic T Lymphocytes|cytotoxic t lymphocytes
28413|NCT03394365|SOT|sot
28414|NCT03394365|Lymphoproliferative disorders|lymphoproliferative disorders
28415|NCT03394365|Post-transplant lymphoproliferative disease|post-transplant lymphoproliferative disease
28416|NCT03394365|EBV-CTL|ebv-ctl
28417|NCT03394365|Epstein-Barr Virus|epstein-barr virus
28418|NCT03394365|Kidney transplant|kidney transplant
28419|NCT03394365|Renal transplant|renal transplant
28420|NCT03394365|Liver transplant|liver transplant
28421|NCT03394365|Heart transplant|heart transplant
28422|NCT03394365|Lung transplant|lung transplant
28423|NCT03394365|Intestinal transplant|intestinal transplant
28424|NCT03394365|Pancreas transplant|pancreas transplant
28425|NCT03394365|Organ transplant complications|organ transplant complications
28426|NCT03394365|Allogeneic, off-the-shelf T-cell immunotherapy|allogeneic, off-the-shelf t-cell immunotherapy
28427|NCT03394365|EBV-LPD|ebv-lpd
28428|NCT03394365|Post-transplant lymphoma|post-transplant lymphoma
28429|NCT03394365|Cancer after transplant|cancer after transplant
28430|NCT03394352|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
28431|NCT03394352|Insulin pump|insulin pump
28432|NCT03394352|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
28433|NCT03394352|Exercise|exercise
28434|NCT03394352|Activity on Board|activity on board
28435|NCT03394352|Decision Support System|decision support system
28436|NCT03394339|Systematic review and meta-anaylsis|systematic review and meta-anaylsis
28437|NCT03394339|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
28438|NCT03394339|Dietary guidelines|dietary guidelines
28439|NCT03394339|Fruit|fruit
28440|NCT03394339|Vegetables|vegetables
28441|NCT03394313|Registry|registry
28442|NCT03394274|transfusion|transfusion
28443|NCT03394274|liberal|liberal
28444|NCT03394274|restrictive|restrictive
28445|NCT03394261|Opioid Use Disorder (OUD)|opioid use disorder (oud)
28446|NCT03394261|Medication Assisted Therapy (MAT)|medication assisted therapy (mat)
28447|NCT03394261|Patient Decision Aid|patient decision aid
28448|NCT03394248|Subconcussive head injury|subconcussive head injury
28449|NCT03394235|hair transplant|hair transplant
28450|NCT03394235|hairline|hairline
28451|NCT03394235|laser hair removal|laser hair removal
28452|NCT03394209|Favipiravir, Influenza, Human, Critical Illness, Pharmacokinetics|favipiravir, influenza, human, critical illness, pharmacokinetics
28453|NCT03394183|cardiac rehabilitation|cardiac rehabilitation
28454|NCT03394183|cardiorespiratory fitness|cardiorespiratory fitness
28455|NCT03394183|functional capacity|functional capacity
28456|NCT03394183|acute exercise response|acute exercise response
28457|NCT03394183|quality of life|quality of life
28458|NCT03394157|sleeve gastrectomy , MGB , type 2 diabetes , obesity , SASI|sleeve gastrectomy , mgb , type 2 diabetes , obesity , sasi
28459|NCT03394118|T790 mutation|t790 mutation
28460|NCT03394118|Liquid biopsy|liquid biopsy
28461|NCT03394105|Pleurodesis|pleurodesis
28462|NCT03394092|immunoglobulin G|immunoglobulin g
28463|NCT03394079|OCT|oct
28464|NCT03394079|IVUS|ivus
28465|NCT03394079|PCI|pci
28466|NCT03394066|Repetitive TMS (rTMS)|repetitive tms (rtms)
28467|NCT03394066|Simultaneous TMS and MRI|simultaneous tms and mri
28468|NCT03394053|PID|pid
28469|NCT03394053|Immune Deficiency|immune deficiency
28470|NCT03394053|Molecular Biology|molecular biology
28471|NCT03394053|T-Cell Lymphocytopenia|t-cell lymphocytopenia
28472|NCT03394053|Genetic Biology|genetic biology
28473|NCT03394040|Diarrhea|diarrhea
28474|NCT03394040|Point-of-Need|point-of-need
28475|NCT03394040|Pathogen Identification|pathogen identification
28476|NCT03394027|Impiridones|impiridones
28477|NCT03394027|TNBC|tnbc
28478|NCT03394027|Metastatic|metastatic
28479|NCT03394027|Male Breast Cancer|male breast cancer
28480|NCT03393988|Transversus abdominis plane block,|transversus abdominis plane block,
28481|NCT03393988|Dexmedetomidine|dexmedetomidine
28482|NCT03393988|Fentanyl|fentanyl
28483|NCT03393988|Live liver donor|live liver donor
28484|NCT03393988|Liver transplantation|liver transplantation
28485|NCT03393962|Ovarian cancer|ovarian cancer
28486|NCT03393962|Cytotoxic lymphocyte|cytotoxic lymphocyte
28487|NCT03393962|Cancer specific antigen|cancer specific antigen
28488|NCT03393949|Methylprednisolone|methylprednisolone
28489|NCT03393949|Postoperative cognitive function|postoperative cognitive function
28490|NCT03393949|Immunological function|immunological function
28491|NCT03393897|fluid responsiveness|fluid responsiveness
28492|NCT03393897|cardiac surgery|cardiac surgery
28493|NCT03393832|Oral care|oral care
28494|NCT03393832|Oropharyngeal mother's milk|oropharyngeal mother's milk
28495|NCT03393819|antimicrobial skin solution|antimicrobial skin solution
28496|NCT03393819|skin preparation|skin preparation
28497|NCT03393806|Asthma Control Questionnaire|asthma control questionnaire
28498|NCT03393806|Allergic fungal airway disease|allergic fungal airway disease
28499|NCT03393806|Asthma Quality of Life Questionnaire|asthma quality of life questionnaire
28500|NCT03393806|Holter monitoring|holter monitoring
28501|NCT03393806|Asthma|asthma
28502|NCT03393793|Heart transplantation|heart transplantation
28503|NCT03393767|CNV|cnv
28504|NCT03393767|AMD|amd
28505|NCT03393767|ranibizumab|ranibizumab
28506|NCT03393754|Hepatitis B Vaccines|hepatitis b vaccines
28507|NCT03393741|Metastatic breast cancer|metastatic breast cancer
28508|NCT03393728|hyperthyroidism|hyperthyroidism
28509|NCT03393728|heart rate variability|heart rate variability
28510|NCT03393728|propanolol|propanolol
28511|NCT03393728|Africa|africa
28512|NCT03393715|Diabetes|diabetes
28513|NCT03393715|Hypertension|hypertension
28514|NCT03393715|Perindopril|perindopril
28515|NCT03393715|chronobiology|chronobiology
28516|NCT03393715|Africa|africa
28517|NCT03393702|Postoperative pain|postoperative pain
28518|NCT03393702|Anxiety|anxiety
28519|NCT03393702|Postoperative Complications|postoperative complications
28520|NCT03393702|Patient Satisfaction|patient satisfaction
28521|NCT03393689|68Ga-NODAGA-E[c(RGDyK)]2|68ga-nodaga-e[c(rgdyk)]2
28522|NCT03393689|Angiogenesis PET/MR|angiogenesis pet/mr
28523|NCT03393689|Acoustic Neuroma|acoustic neuroma
28524|NCT03393676|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
28525|NCT03393676|elderly patients|elderly patients
28526|NCT03393676|Preoperative Pain|preoperative pain
28527|NCT03393663|chronic kidney disease|chronic kidney disease
28528|NCT03393663|cardiovascular disease|cardiovascular disease
28529|NCT03393663|mortality|mortality
28530|NCT03393663|end stage renal disease|end stage renal disease
28531|NCT03393650|exercise|exercise
28532|NCT03393650|protein|protein
28533|NCT03393650|muscle function|muscle function
28534|NCT03393650|aging|aging
28535|NCT03393637|prenatal anxiety|prenatal anxiety
28536|NCT03393637|pregnancy|pregnancy
28537|NCT03393637|depression|depression
28538|NCT03393637|military|military
28539|NCT03393637|intervention|intervention
28540|NCT03393624|Dark circles|dark circles
28541|NCT03393624|Periorbital hyperchromia|periorbital hyperchromia
28542|NCT03393624|Sleep Quality|sleep quality
28543|NCT03393624|Facial aesthetics|facial aesthetics
28544|NCT03393585|Respiratory Rates|respiratory rates
28545|NCT03393546|pain|pain
28546|NCT03393546|acupressure|acupressure
28547|NCT03393546|alzheimer|alzheimer
28548|NCT03393533|Third molar;|third molar;
28549|NCT03393533|Oral surgery;|oral surgery;
28550|NCT03393533|Pain;|pain;
28551|NCT03393533|Edema;|edema;
28552|NCT03393533|Trismus.|trismus.
28553|NCT03393520|Agitation|agitation
28554|NCT03393520|Dementia of the Alzheimer's type|dementia of the alzheimer's type
28555|NCT03393520|Alzheimer's disease|alzheimer's disease
28556|NCT03393520|AVP-786|avp-786
28557|NCT03393520|Deudextromethorphan hydrobromide|deudextromethorphan hydrobromide
28558|NCT03393520|Quinidine sulfate|quinidine sulfate
28559|NCT03393507|ovarian cancer|ovarian cancer
28560|NCT03393481|biologic,|biologic,
28561|NCT03393481|venous thromboembolism,|venous thromboembolism,
28562|NCT03393481|unilateral knee arthroplasty|unilateral knee arthroplasty
28563|NCT03393455|Fetal pathology|fetal pathology
28564|NCT03393455|Obstetrical outcome|obstetrical outcome
28565|NCT03393455|Pediatric outcome|pediatric outcome
28566|NCT03393442|Magnetic Resonance Imaging|magnetic resonance imaging
28567|NCT03393442|Gd-based contrast media|gd-based contrast media
28568|NCT03393442|Gd-deposits|gd-deposits
28569|NCT03393442|brain imaging|brain imaging
28570|NCT03393442|breast cancer screening|breast cancer screening
28571|NCT03393416|MASCT-I|masct-i
28572|NCT03393403|Subcostal transversus abdominis plane block|subcostal transversus abdominis plane block
28573|NCT03393377|arterial stiffness|arterial stiffness
28574|NCT03393377|endothelial dysfunction|endothelial dysfunction
28575|NCT03393377|fluvastatin|fluvastatin
28576|NCT03393377|valsartan|valsartan
28577|NCT03393377|inflammatory markers|inflammatory markers
28578|NCT03393377|oxidative stress|oxidative stress
28579|NCT03393377|SIRT1|sirt1
28580|NCT03393351|Shared Decision-Making|shared decision-making
28581|NCT03393351|Decision Making|decision making
28582|NCT03393351|Patient Participation|patient participation
28583|NCT03393351|Patient Centeredness|patient centeredness
28584|NCT03393351|Health Services Research|health services research
28585|NCT03393351|Implementation Research|implementation research
28586|NCT03393351|Oncology|oncology
28587|NCT03393351|Stepped Wedge Design|stepped wedge design
28588|NCT03393351|Mixed Methods|mixed methods
28589|NCT03393338|Diabetes|diabetes
28590|NCT03393338|African American|african american
28591|NCT03393338|Emergency Department visits|emergency department visits
28592|NCT03393312|Transcranial direct current stimulation|transcranial direct current stimulation
28593|NCT03393312|Biological Psychiatry|biological psychiatry
28594|NCT03393312|Depression|depression
28595|NCT03393312|Decision-making|decision-making
28596|NCT03393299|elderly people|elderly people
28597|NCT03393299|geriatric short-stay|geriatric short-stay
28598|NCT03393299|STOPP/START criteria|stopp/start criteria
28599|NCT03393273|Stem Cell autologous graft|stem cell autologous graft
28600|NCT03393273|Elotuzumab|elotuzumab
28601|NCT03393273|Multiple myeloma|multiple myeloma
28602|NCT03393273|Elderly|elderly
28603|NCT03393260|cancer|cancer
28604|NCT03393260|emergency departments (ED)|emergency departments (ed)
28605|NCT03393247|infliximab|infliximab
28606|NCT03393247|azathioprine|azathioprine
28607|NCT03393234|Ultra-low rectal cancer|ultra-low rectal cancer
28608|NCT03393234|Intersphincteric resection|intersphincteric resection
28609|NCT03393234|IORT|iort
28610|NCT03393208|Diabetes Mellitus|diabetes mellitus
28611|NCT03393208|Glucophage Immediate Release (GIR)|glucophage immediate release (gir)
28612|NCT03393208|Bioequivalence Study|bioequivalence study
28613|NCT03393195|Weight loss|weight loss
28614|NCT03393195|Diet|diet
28615|NCT03393195|Time-restricted feeding|time-restricted feeding
28616|NCT03393143|Primary Health Care; Analgesics, Opioid; Medicaid|primary health care; analgesics, opioid; medicaid
28617|NCT03393130|Burns|burns
28618|NCT03393130|Young Adult|young adult
28619|NCT03393130|Cognitive Impairment|cognitive impairment
28620|NCT03393130|Apolipoprotein E, Deficiency or Defect of|apolipoprotein e, deficiency or defect of
28621|NCT03393130|Intensive Care Neurological Disorder|intensive care neurological disorder
28622|NCT03393130|Quality of Life|quality of life
28623|NCT03393130|Inflammation, Brain|inflammation, brain
28624|NCT03393117|Reconstruction|reconstruction
28625|NCT03393117|Bupivacaine|bupivacaine
28626|NCT03393117|Liposomal Bupivacaine|liposomal bupivacaine
28627|NCT03393104|Chronic Low Back Pain|chronic low back pain
28628|NCT03393104|Motor Control Exercise|motor control exercise
28629|NCT03393104|Patient Education|patient education
28630|NCT03393065|lung ultrasounds|lung ultrasounds
28631|NCT03393065|fluid managements|fluid managements
28632|NCT03393065|critical care patients|critical care patients
28633|NCT03393052|L-RECORD|l-record
28634|NCT03393052|Radial|radial
28635|NCT03393052|Femoral|femoral
28636|NCT03393052|CABG|cabg
28637|NCT03393052|coronary artery bypass graft|coronary artery bypass graft
28638|NCT03393039|fMRI|fmri
28639|NCT03393039|Reward|reward
28640|NCT03393039|Food Choices|food choices
28641|NCT03393039|Negative Affect|negative affect
28642|NCT03393013|immunoproteasome inhibition|immunoproteasome inhibition
28643|NCT03393013|selective proteasome inhibition|selective proteasome inhibition
28644|NCT03393013|proteasome|proteasome
28645|NCT03392987|GSK2696274|gsk2696274
28646|NCT03392987|Cryopreserved formulation|cryopreserved formulation
28647|NCT03392987|Gene therapy|gene therapy
28648|NCT03392987|Metachromatic leukodystrophy|metachromatic leukodystrophy
28649|NCT03392974|Hemophilia A|hemophilia a
28650|NCT03392974|Gene Therapy|gene therapy
28651|NCT03392974|Clotting Disorders|clotting disorders
28652|NCT03392974|Blood Disorder|blood disorder
28653|NCT03392974|Blood Coagulation Disorders|blood coagulation disorders
28654|NCT03392974|Inherited Blood Coagulation Disorders|inherited blood coagulation disorders
28655|NCT03392974|Hematologic Diseases|hematologic diseases
28656|NCT03392974|Coagulation Protein Disorders|coagulation protein disorders
28657|NCT03392974|Hemorrhagic Disorders|hemorrhagic disorders
28658|NCT03392974|Genetic Diseases|genetic diseases
28659|NCT03392974|Inborn|inborn
28660|NCT03392974|Factor VIII|factor viii
28661|NCT03392974|Coagulants|coagulants
28662|NCT03392961|Oral insulin|oral insulin
28663|NCT03392961|Dosing time|dosing time
28664|NCT03392961|Insulin concentration|insulin concentration
28665|NCT03392961|Prandial insulin|prandial insulin
28666|NCT03392961|Post Prandial Glucose (PPG)|post prandial glucose (ppg)
28667|NCT03392948|atrial fibrillation|atrial fibrillation
28668|NCT03392948|prosthetic valves|prosthetic valves
28669|NCT03392948|pulmonary embolism|pulmonary embolism
28670|NCT03392948|venous thrombosis|venous thrombosis
28671|NCT03392948|percutaneous coronary interventions|percutaneous coronary interventions
28672|NCT03392948|chronic anticoagulant treatment|chronic anticoagulant treatment
28673|NCT03392909|Nonsense Mutations|nonsense mutations
28674|NCT03392883|Latin America|latin america
28675|NCT03392883|Depression|depression
28676|NCT03392883|mHealth|mhealth
28677|NCT03392883|Problematic Alcohol Use|problematic alcohol use
28678|NCT03392870|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
28679|NCT03392870|Transition program|transition program
28680|NCT03392857|Critical care|critical care
28681|NCT03392831|Central Venous Catheters|central venous catheters
28682|NCT03392831|Vascular Access Devices|vascular access devices
28683|NCT03392831|Nursing|nursing
28684|NCT03392831|Cost Effectiveness|cost effectiveness
28685|NCT03392831|PICC|picc
28686|NCT03392766|fibreoptic intubation|fibreoptic intubation
28687|NCT03392766|double lumen tube|double lumen tube
28688|NCT03392766|difficult intubation|difficult intubation
28689|NCT03392714|Bendamustine|bendamustine
28690|NCT03392714|CSF|csf
28691|NCT03392714|Pharmacokinetics|pharmacokinetics
28692|NCT03392714|PCNSL|pcnsl
28693|NCT03392714|Salvage therapy|salvage therapy
28694|NCT03392688|onset , hamstring muscles, patellofemoral pain|onset , hamstring muscles, patellofemoral pain
28695|NCT03392675|Breast and Nipple Pain|breast and nipple pain
28696|NCT03392675|Quantitative Sensory Testing|quantitative sensory testing
28697|NCT03392675|Genotyping|genotyping
28698|NCT03392675|Breastfeeding|breastfeeding
28699|NCT03392649|Postoperative Atrial Fibrillation|postoperative atrial fibrillation
28700|NCT03392649|Tragus Stimulation|tragus stimulation
28701|NCT03392623|Epigenetics, Malar melasma,|epigenetics, malar melasma,
28702|NCT03392610|Intratracheal intubation, bronchoscopy, bronchoalveolar lavage, endoscopy, pulmonary medicine, critical care, anesthesia department, disinfection|intratracheal intubation, bronchoscopy, bronchoalveolar lavage, endoscopy, pulmonary medicine, critical care, anesthesia department, disinfection
28703|NCT03392584|Locally advanced rectal cancer|locally advanced rectal cancer
28704|NCT03392584|Deep infection|deep infection
28705|NCT03392584|Microdialysis|microdialysis
28706|NCT03392584|Surgical site infection|surgical site infection
28707|NCT03392571|Resectable pancreatic cancer, NGC-triple regimen|resectable pancreatic cancer, ngc-triple regimen
28708|NCT03392545|recurrent GBM; radiation; immunotherapy|recurrent gbm; radiation; immunotherapy
28709|NCT03392532|Astigmatism|astigmatism
28710|NCT03392532|Axis orientation|axis orientation
28711|NCT03392519|Brain connectivity|brain connectivity
28712|NCT03392519|Magnetic resonance imaging|magnetic resonance imaging
28713|NCT03392519|Brain plasticity|brain plasticity
28714|NCT03392519|Recovery|recovery
28715|NCT03392506|CP-EBUS|cp-ebus
28716|NCT03392506|EBUS-TBNA|ebus-tbna
28717|NCT03392506|Real time elasticity|real time elasticity
28718|NCT03392506|Staging of lung cancer|staging of lung cancer
28719|NCT03392493|Stroke|stroke
28720|NCT03392493|Robotic rehabilitation|robotic rehabilitation
28721|NCT03392493|Hand function|hand function
28722|NCT03392493|Activities of Daily Living|activities of daily living
28723|NCT03392454|Partial Trapeziectomy|partial trapeziectomy
28724|NCT03392454|Tendon Interposition|tendon interposition
28725|NCT03392454|Trapeziectomy|trapeziectomy
28726|NCT03392454|Thumb Carpometacarpal Joint|thumb carpometacarpal joint
28727|NCT03392441|dementia|dementia
28728|NCT03392441|cognition|cognition
28729|NCT03392441|insulin|insulin
28730|NCT03392441|adolescent|adolescent
28731|NCT03392415|chronic total occlusion|chronic total occlusion
28732|NCT03392415|CTO|cto
28733|NCT03392415|PCI|pci
28734|NCT03392415|percutaneus coronary intervention|percutaneus coronary intervention
28735|NCT03392402|Thyroid nodule|thyroid nodule
28736|NCT03392402|Indeterminate thyroid nodule|indeterminate thyroid nodule
28737|NCT03392402|Molecular biopsy|molecular biopsy
28738|NCT03392402|Gene expression classifier|gene expression classifier
28739|NCT03392389|mRNA-1653|mrna-1653
28740|NCT03392389|human metapneumovirus|human metapneumovirus
28741|NCT03392389|human parainfluenza vaccine|human parainfluenza vaccine
28742|NCT03392376|ICU Delirium|icu delirium
28743|NCT03392376|Haloperidol|haloperidol
28744|NCT03392324|atrophic macular degeneration|atrophic macular degeneration
28745|NCT03392324|geographic atrophy|geographic atrophy
28746|NCT03392324|retina implant|retina implant
28747|NCT03392324|retinal prosthesis|retinal prosthesis
28748|NCT03392324|visual prosthesis|visual prosthesis
28749|NCT03392324|macular degeneration|macular degeneration
28750|NCT03392324|dry macular degeneration|dry macular degeneration
28751|NCT03392324|AMD|amd
28752|NCT03392298|Thalassemia|thalassemia
28753|NCT03392298|Pregnancy|pregnancy
28754|NCT03392298|Globin expression|globin expression
28755|NCT03392298|Colla corii asini|colla corii asini
28756|NCT03392272|Ptosis|ptosis
28757|NCT03392272|Müller's Muscle-Conjunctival Resection (MMCR)|müller's muscle-conjunctival resection (mmcr)
28758|NCT03392272|Fibrin Glue|fibrin glue
28759|NCT03392246|Non-Small Cell Lung Cancer|non-small cell lung cancer
28760|NCT03392233|spinal metastases|spinal metastases
28761|NCT03392233|Stereotactic body radiation therapy(SBRT)|stereotactic body radiation therapy(sbrt)
28762|NCT03392233|breast cancer|breast cancer
28763|NCT03392233|prostate cancer|prostate cancer
28764|NCT03392233|non small cell lung cancer|non small cell lung cancer
28765|NCT03392220|clinically negative neck|clinically negative neck
29060|NCT03390478|Frailty|frailty
28766|NCT03392220|regional control rate|regional control rate
28767|NCT03392194|Behavioral interventions|behavioral interventions
28768|NCT03392194|Sleep hygiene|sleep hygiene
28769|NCT03392194|Yoga|yoga
28770|NCT03392194|Community research|community research
28771|NCT03392194|Short sleep duration|short sleep duration
28772|NCT03392194|Low-income population|low-income population
28773|NCT03392168|Psoriasis|psoriasis
28774|NCT03392168|Plaque Psoriasis|plaque psoriasis
28775|NCT03392142|Allogeneic Hematopoietic Cell Transplant|allogeneic hematopoietic cell transplant
28776|NCT03392142|EBV-LPD|ebv-lpd
28777|NCT03392142|Lymphoproliferative Disorders|lymphoproliferative disorders
28778|NCT03392142|Epstein-Barr Virus|epstein-barr virus
28779|NCT03392142|EBV-PTLD|ebv-ptld
28780|NCT03392142|alloHCT|allohct
28781|NCT03392142|Post-transplant lymphoproliferative disease|post-transplant lymphoproliferative disease
28782|NCT03392142|EBV-associated PTLD|ebv-associated ptld
28783|NCT03392142|Post-transplant lymphoma|post-transplant lymphoma
28784|NCT03392142|HCT|hct
28785|NCT03392142|HSCT|hsct
28786|NCT03392142|Cytotoxic T lymphocytes|cytotoxic t lymphocytes
28787|NCT03392142|EBV-CTL|ebv-ctl
28788|NCT03392142|Hematopoietic Cell Transplant|hematopoietic cell transplant
28789|NCT03392142|Stem cell transplant|stem cell transplant
28790|NCT03392142|Bone marrow transplant complications|bone marrow transplant complications
28791|NCT03392142|Cancer after transplant|cancer after transplant
28792|NCT03392142|Allogeneic, off-the-shelf T-cell immunotherapy|allogeneic, off-the-shelf t-cell immunotherapy
28793|NCT03392129|Asthma|asthma
28794|NCT03392129|Child|child
28795|NCT03392129|respiratory exercises|respiratory exercises
28796|NCT03392129|Hydrotherapy|hydrotherapy
28797|NCT03392129|Physical Therapy Specialty|physical therapy specialty
28798|NCT03392129|Sleep|sleep
28799|NCT03392129|Quality of life|quality of life
28800|NCT03392129|Anxiety|anxiety
28801|NCT03392129|Spirometry|spirometry
28802|NCT03392129|Clinical trial|clinical trial
28803|NCT03392103|Raltitrexed|raltitrexed
28804|NCT03392103|IMRT|imrt
28805|NCT03392090|Cancer|cancer
28806|NCT03392064|AMG 119|amg 119
28807|NCT03392064|CART|cart
28808|NCT03392012|anesthesia, patient safety, respiratory complications|anesthesia, patient safety, respiratory complications
28809|NCT03391999|Mental Health, Physical Health|mental health, physical health
28810|NCT03391973|CUP|cup
28811|NCT03391973|Pembrolizumab|pembrolizumab
28812|NCT03391973|KEYTRUDA|keytruda
28813|NCT03391960|CLABSI|clabsi
28814|NCT03391960|Septicemia|septicemia
28815|NCT03391960|Bloodstream infection|bloodstream infection
28816|NCT03391960|Central line associated bloodstream infection|central line associated bloodstream infection
28817|NCT03391960|Catheter related bloodstream infection|catheter related bloodstream infection
28818|NCT03391960|Intravascular device|intravascular device
28819|NCT03391960|Catheter port|catheter port
28820|NCT03391947|gingival recession|gingival recession
28821|NCT03391947|semilunar coronally flap|semilunar coronally flap
28822|NCT03391947|coronally advanced flap|coronally advanced flap
28823|NCT03391934|RAS Wild-type|ras wild-type
28824|NCT03391934|Cetuximab|cetuximab
28825|NCT03391934|Metastatic Colorectal Cancer|metastatic colorectal cancer
28826|NCT03391921|vaccine|vaccine
28827|NCT03391921|woman|woman
28828|NCT03391908|vulnerable plaques, acute coronary syndromes, NSTEMI, vulnerable patient|vulnerable plaques, acute coronary syndromes, nstemi, vulnerable patient
28829|NCT03391895|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
28830|NCT03391895|Scoliosis|scoliosis
28831|NCT03391895|Inspiratory Muscle Training|inspiratory muscle training
28832|NCT03391895|Exercise Training|exercise training
28833|NCT03391895|Respiratory Exercise Training|respiratory exercise training
28834|NCT03391895|Pulmonary Function Test|pulmonary function test
28835|NCT03391895|6-Minute Walk test|6-minute walk test
28836|NCT03391895|Respiratory Muscle Strength|respiratory muscle strength
28837|NCT03391882|Parkinson's Disease|parkinson's disease
28838|NCT03391882|"Off Episodes"|"off episodes"
28839|NCT03391882|motor fluctuations associated with Parkinson's Disease|motor fluctuations associated with parkinson's disease
28840|NCT03391869|Malignant neoplasms of respiratory and intrathoracic organs|malignant neoplasms of respiratory and intrathoracic organs
28841|NCT03391869|Non-small cell lung cancer|non-small cell lung cancer
28842|NCT03391869|NSCLC|nsclc
28843|NCT03391869|Ipilimumab|ipilimumab
28844|NCT03391869|Yervoy|yervoy
28845|NCT03391869|BMS-734016|bms-734016
28846|NCT03391869|MDX010|mdx010
28847|NCT03391869|Nivolumab|nivolumab
28848|NCT03391869|BMS-936558|bms-936558
28849|NCT03391869|Opdivo|opdivo
28850|NCT03391869|Local Consolidative Therapy|local consolidative therapy
28852|NCT03391843|Local Advanced Rectal Cancer|local advanced rectal cancer
28853|NCT03391843|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
28854|NCT03391843|FOLFOXIRI|folfoxiri
28855|NCT03391843|Cetuximab|cetuximab
28856|NCT03391843|EGFR wild type|egfr wild type
28857|NCT03391804|Oxalate|oxalate
28858|NCT03391804|Kidney Stones|kidney stones
28859|NCT03391804|oxalate nephropathy|oxalate nephropathy
28860|NCT03391804|systemic oxalosis|systemic oxalosis
28861|NCT03391791|Cell Therapy|cell therapy
28862|NCT03391791|T Cell Therapy|t cell therapy
28863|NCT03391791|SPEAR T Cell|spear t cell
28864|NCT03391791|Immuno-oncology|immuno-oncology
28865|NCT03391791|Metastatic|metastatic
28866|NCT03391791|T Cell Receptor|t cell receptor
28867|NCT03391791|Long Term Follow Up|long term follow up
28868|NCT03391791|Genetically Engineered|genetically engineered
28869|NCT03391778|Solid and Hematological Malignancies|solid and hematological malignancies
28870|NCT03391778|Cell Therapy|cell therapy
28871|NCT03391778|T Cell Therapy|t cell therapy
28872|NCT03391778|SPEAR T Cell|spear t cell
28873|NCT03391778|Immuno-oncology|immuno-oncology
28874|NCT03391778|NY-ESO-1|ny-eso-1
28875|NCT03391778|Metastatic|metastatic
28876|NCT03391778|Previously Treated|previously treated
28877|NCT03391778|T Cell Receptor|t cell receptor
28878|NCT03391778|Safety|safety
28879|NCT03391778|Long Term Follow Up|long term follow up
28880|NCT03391778|Genetically engineered|genetically engineered
28881|NCT03391765|tauopathy|tauopathy
28882|NCT03391765|Steele-Richardson-Olszewski Syndrome|steele-richardson-olszewski syndrome
28883|NCT03391765|PSP|psp
28884|NCT03391752|malnutrition, screening, assessment, treatment|malnutrition, screening, assessment, treatment
28885|NCT03391713|awareness|awareness
28886|NCT03391713|poster|poster
28887|NCT03391713|stroke|stroke
28888|NCT03391700|muscle relaxant|muscle relaxant
28889|NCT03391687|Gastric Cancer|gastric cancer
28890|NCT03391687|Pancreatic Fistula|pancreatic fistula
28891|NCT03391687|Gastrectomy|gastrectomy
28892|NCT03391635|acupuncture|acupuncture
28893|NCT03391635|functional constipation|functional constipation
28894|NCT03391635|transcutaneous electric nerve stimulation|transcutaneous electric nerve stimulation
28895|NCT03391635|randomized controlled trial|randomized controlled trial
28896|NCT03391622|thrombin generation|thrombin generation
28897|NCT03391622|calibrated automated thrombogram|calibrated automated thrombogram
28898|NCT03391622|ischemic heart disease|ischemic heart disease
28899|NCT03391622|Percutaneous Coronary Intervention|percutaneous coronary intervention
28900|NCT03391596|Family caregivers|family caregivers
28901|NCT03391596|Depressive symptoms|depressive symptoms
28902|NCT03391596|Psychological wellbeing|psychological wellbeing
28903|NCT03391596|Internet-based intervention|internet-based intervention
28904|NCT03391596|Acceptance and Commitment Therapy|acceptance and commitment therapy
28905|NCT03391583|Education|education
28906|NCT03391583|Pain|pain
28907|NCT03391570|Laparoscopic surgery|laparoscopic surgery
28908|NCT03391570|COX-2 inhibitor|cox-2 inhibitor
28909|NCT03391570|Celecoxib|celecoxib
28910|NCT03391570|Prostanoid|prostanoid
28911|NCT03391557|Elastography|elastography
28912|NCT03391557|Lymph node|lymph node
28913|NCT03391557|Diagnosis|diagnosis
28914|NCT03391531|surgery: laparoscopic cholecystectomy|surgery: laparoscopic cholecystectomy
28915|NCT03391531|analgesia: postoperative|analgesia: postoperative
28916|NCT03391531|locoregional analgesia: transversus abdominis plane block|locoregional analgesia: transversus abdominis plane block
28917|NCT03391531|opioid: side effects|opioid: side effects
28918|NCT03391505|Cognition|cognition
28919|NCT03391505|Physical activity|physical activity
28920|NCT03391505|Memory|memory
28921|NCT03391505|Health|health
28922|NCT03391492|ICU|icu
28923|NCT03391427|Lidocaine|lidocaine
28924|NCT03391427|Ketamine|ketamine
28925|NCT03391427|postoperative analgesia|postoperative analgesia
28926|NCT03391414|thick mucus|thick mucus
28927|NCT03391414|obstructive lung disease|obstructive lung disease
28928|NCT03391362|Small Cell Lung Cancer|small cell lung cancer
28929|NCT03391362|Brain Metastases|brain metastases
28930|NCT03391362|Brain metastasis|brain metastasis
28931|NCT03391362|Lung cancer|lung cancer
28932|NCT03391362|Stereotactic radiation|stereotactic radiation
28933|NCT03391362|Stereotactic radiosurgery|stereotactic radiosurgery
28934|NCT03391362|SRS|srs
28935|NCT03391362|Stereotactic|stereotactic
28936|NCT03391362|Radiation|radiation
28937|NCT03391362|Quality of life|quality of life
28938|NCT03391362|Neurocognitive|neurocognitive
28939|NCT03391362|Neurocognition|neurocognition
28940|NCT03391349|proteomes, chronic periodontitis|proteomes, chronic periodontitis
28941|NCT03391336|Carpal tunnel syndrome|carpal tunnel syndrome
28942|NCT03391336|Median nerve injury|median nerve injury
28943|NCT03391336|Steroids|steroids
28944|NCT03391336|Ultrasound|ultrasound
28945|NCT03391336|Injections|injections
28946|NCT03391297|PTSD; prolonged exposure; posttraumatic growth|ptsd; prolonged exposure; posttraumatic growth
28947|NCT03391258|Fibrin|fibrin
28948|NCT03391258|L-PRF|l-prf
28949|NCT03391258|growth-factors|growth-factors
28950|NCT03391258|bone-atrophy|bone-atrophy
28951|NCT03391258|guided-bone-regeneration|guided-bone-regeneration
28952|NCT03391206|Breast cancer related lymphedemas|breast cancer related lymphedemas
28953|NCT03391206|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
28954|NCT03391206|Axillary Lymph Node Dissection|axillary lymph node dissection
28955|NCT03391206|Bioelectrical Impedance Analysis|bioelectrical impedance analysis
28956|NCT03391206|Dietary Fat|dietary fat
28957|NCT03391193|Influenza|influenza
28958|NCT03391193|Quadrivalent Inactivated Influenza Vaccine|quadrivalent inactivated influenza vaccine
28959|NCT03391193|Multi-dose Presentation|multi-dose presentation
28960|NCT03391141|obstructive sleep apnea|obstructive sleep apnea
28961|NCT03391141|sleep endoscopy|sleep endoscopy
28962|NCT03391141|drug induced sleep endoscopy|drug induced sleep endoscopy
28963|NCT03391141|diagnostic validation|diagnostic validation
28964|NCT03391115|Psychosocial|psychosocial
28965|NCT03391115|Underserved|underserved
28966|NCT03391115|Palliative|palliative
28967|NCT03391115|Electronic Health Record|electronic health record
28968|NCT03391115|Narrative|narrative
28969|NCT03391102|Epidemiology|epidemiology
28970|NCT03391102|Community-based study|community-based study
28971|NCT03391050|Melanoma|melanoma
28972|NCT03391050|Malignant melanoma|malignant melanoma
28973|NCT03391050|Skin cancer|skin cancer
28974|NCT03391050|Resistant cancer|resistant cancer
28975|NCT03391050|Unresectable cancer|unresectable cancer
28976|NCT03391050|Metastatic cancer|metastatic cancer
28977|NCT03391050|BRAF mutant|braf mutant
28978|NCT03390998|Pregnancy-related SCAD|pregnancy-related scad
28979|NCT03390998|Myocardial Infarction|myocardial infarction
28980|NCT03390972|Dexmedetomidine|dexmedetomidine
28981|NCT03390972|Swallowing function|swallowing function
28982|NCT03390972|Anesthetic sedation|anesthetic sedation
28983|NCT03390959|Proprioception|proprioception
28984|NCT03390959|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
28985|NCT03390959|Postural Balance|postural balance
28986|NCT03390959|Gait|gait
28987|NCT03390959|Posture|posture
28988|NCT03390946|four-drugs, interval-compression|four-drugs, interval-compression
28989|NCT03390920|regenerative medicine|regenerative medicine
28990|NCT03390920|arthritis|arthritis
28991|NCT03390920|amniotic|amniotic
28992|NCT03390920|stem cell|stem cell
28993|NCT03390920|growth factor|growth factor
28994|NCT03390920|cartilage|cartilage
28995|NCT03390907|Colon polyp|colon polyp
28996|NCT03390907|EMR|emr
28997|NCT03390907|Hybrid-APC|hybrid-apc
28998|NCT03390907|Laterally spreading tumor|laterally spreading tumor
28999|NCT03390894|Long-term Follow-Up|long-term follow-up
29000|NCT03390894|Invasive Breast Cancer Early Stages|invasive breast cancer early stages
29001|NCT03390894|Previous Neoadjuvant treatment|previous neoadjuvant treatment
29002|NCT03390894|Previous Adjuvant treatment|previous adjuvant treatment
29003|NCT03390881|breath acetone|breath acetone
29004|NCT03390881|energy balance|energy balance
29005|NCT03390868|Interaction|interaction
29006|NCT03390868|challenging behaviour|challenging behaviour
29007|NCT03390868|training|training
29008|NCT03390855|IL-6|il-6
29009|NCT03390855|Glucosinolate|glucosinolate
29010|NCT03390855|Brassica oleracea|brassica oleracea
29011|NCT03390855|Sulphoraphane|sulphoraphane
29012|NCT03390855|Biomarkers|biomarkers
29013|NCT03390855|Bioavailability|bioavailability
29014|NCT03390855|Inflammation|inflammation
29015|NCT03390842|blood bicarbonate, kidney disease|blood bicarbonate, kidney disease
29016|NCT03390816|malnutrition|malnutrition
29017|NCT03390816|cancer|cancer
29018|NCT03390816|elderly|elderly
29019|NCT03390764|Incisional hernia|incisional hernia
29020|NCT03390764|4:1-technique|4:1-technique
29021|NCT03390764|RTL-suture|rtl-suture
29022|NCT03390751|atropinic drugs|atropinic drugs
29023|NCT03390751|confusion|confusion
29024|NCT03390751|elderly patients|elderly patients
29025|NCT03390725|Prevention, obesity, parenting, diet, physical activity|prevention, obesity, parenting, diet, physical activity
29026|NCT03390712|Paliperidone palmitate|paliperidone palmitate
29027|NCT03390712|Risperidone long-acting injection|risperidone long-acting injection
29028|NCT03390712|mirror-image|mirror-image
29029|NCT03390673|randomized|randomized
29030|NCT03390673|double-blind|double-blind
29031|NCT03390647|E6130|e6130
29032|NCT03390647|Healthy adult male participants|healthy adult male participants
29033|NCT03390647|Phase 1|phase 1
29034|NCT03390647|Pharmacokinetics|pharmacokinetics
29035|NCT03390621|parent feeding styles|parent feeding styles
29036|NCT03390621|dietary quality|dietary quality
29037|NCT03390621|dinner meal|dinner meal
29038|NCT03390621|preschool|preschool
29039|NCT03390621|low-income|low-income
29040|NCT03390595|Urothelial carcinoma|urothelial carcinoma
29041|NCT03390582|Gut Microbiota|gut microbiota
29042|NCT03390582|Hashimoto Thyroiditis|hashimoto thyroiditis
29043|NCT03390582|Graves' Disease|graves' disease
29044|NCT03390582|Methimazole|methimazole
29045|NCT03390582|Levothyroxine sodium|levothyroxine sodium
29046|NCT03390582|16S rRNA gene|16s rrna gene
29047|NCT03390582|Metabonomics|metabonomics
29048|NCT03390569|GBM|gbm
29049|NCT03390569|Glioblastoma|glioblastoma
29050|NCT03390569|Brain Cancer|brain cancer
29051|NCT03390569|High-Grade Glioma|high-grade glioma
29052|NCT03390569|Glioma|glioma
29053|NCT03390530|Thyroxine|thyroxine
29054|NCT03390530|Intraventricular hemorrhage|intraventricular hemorrhage
29055|NCT03390530|MRI with DTI,|mri with dti,
29056|NCT03390530|Neurodevelopmental outcome|neurodevelopmental outcome
29057|NCT03390517|fluorescence angiography|fluorescence angiography
29058|NCT03390517|indocyanine green|indocyanine green
29059|NCT03390517|anastomotic leakage|anastomotic leakage
29061|NCT03390478|Aged|aged
29062|NCT03390478|Cognitive Stimulation|cognitive stimulation
29063|NCT03390478|Technology|technology
29064|NCT03390452|mHealth|mhealth
29065|NCT03390452|Oral Health|oral health
29066|NCT03390452|Primary School Children|primary school children
29067|NCT03390452|Mobile Phone Messaging|mobile phone messaging
29068|NCT03390439|Striae alba|striae alba
29069|NCT03390439|Microneedling|microneedling
29070|NCT03390439|Fractional nonablative laser|fractional nonablative laser
29071|NCT03390439|dermaroller|dermaroller
29072|NCT03390439|Nd-yap 1340nm laser|nd-yap 1340nm laser
29073|NCT03390439|Percutaneous Collagen Induction Therapy|percutaneous collagen induction therapy
29074|NCT03390426|Perifemoral|perifemoral
29075|NCT03390426|Tourniquet|tourniquet
29076|NCT03390426|Mepivacaine|mepivacaine
29077|NCT03390426|Tourniquet Hypertension|tourniquet hypertension
29078|NCT03390413|Cryoablation|cryoablation
29079|NCT03390413|Robot-assisted surgical resection|robot-assisted surgical resection
29080|NCT03390400|Laser Cataract Surgery|laser cataract surgery
29081|NCT03390387|Acute lymphoblastic leukemia, children, adolescents, treatment|acute lymphoblastic leukemia, children, adolescents, treatment
29082|NCT03390374|Nystatin|nystatin
29083|NCT03390374|Fungal colonization|fungal colonization
29084|NCT03390374|Systemic fungal infections|systemic fungal infections
29085|NCT03390361|Laser Cataract Surgery|laser cataract surgery
29086|NCT03390361|Prostaglandin|prostaglandin
29087|NCT03390296|Acute Myeloid Leukemia|acute myeloid leukemia
29088|NCT03390296|AML|aml
29089|NCT03390296|Relapsed/refractory|relapsed/refractory
29090|NCT03390296|RR|rr
29091|NCT03390296|PF-04518600|pf-04518600
29092|NCT03390296|Avelumab|avelumab
29093|NCT03390296|MSB0010718C|msb0010718c
29094|NCT03390296|Azacitidine|azacitidine
29095|NCT03390296|5-azacytidine|5-azacytidine
29096|NCT03390296|5-AZA|5-aza
29097|NCT03390296|Vidaza|vidaza
29098|NCT03390296|5-AZC|5-azc
29099|NCT03390296|AZA-CR|aza-cr
29100|NCT03390296|Ladakamycin|ladakamycin
29101|NCT03390296|NSC-102816|nsc-102816
29102|NCT03390296|Azacytidine|azacytidine
29103|NCT03390296|Utomilumab|utomilumab
29104|NCT03390296|PF-05082566|pf-05082566
29105|NCT03390296|Anti-CD137|anti-cd137
29106|NCT03390296|Gemtuzumab ozogamicin|gemtuzumab ozogamicin
29107|NCT03390296|Gemtuzumab|gemtuzumab
29108|NCT03390296|Mylotarg|mylotarg
29109|NCT03390296|Glasdegib|glasdegib
29110|NCT03390296|PF-04449913|pf-04449913
29111|NCT03390283|Survey|survey
29112|NCT03390283|Questionnaire|questionnaire
29113|NCT03390270|intensive care units|intensive care units
29114|NCT03390270|critical care|critical care
29115|NCT03390270|risk assessment|risk assessment
29116|NCT03390270|electronic health records|electronic health records
29117|NCT03390257|Endoscopy, BSD|endoscopy, bsd
29118|NCT03390231|Stem Cell Educator|stem cell educator
29119|NCT03390231|Immune modulation|immune modulation
29120|NCT03390231|Diabetes|diabetes
29121|NCT03390231|Autoimmune|autoimmune
29122|NCT03390231|Insulin resistance|insulin resistance
29123|NCT03390231|Pancreatic islets|pancreatic islets
29124|NCT03390192|Noninvasive brain stimulation|noninvasive brain stimulation
29125|NCT03390192|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
29126|NCT03390192|Transcranial Direct Current Stimulation|transcranial direct current stimulation
29127|NCT03390179|diabetes|diabetes
29128|NCT03390179|anesthesia|anesthesia
29129|NCT03390179|surgery|surgery
29130|NCT03390179|glucose|glucose
29131|NCT03390166|GPO Tri Fluvac Vaccine|gpo tri fluvac vaccine
29132|NCT03390166|Tri Fluvac vaccine|tri fluvac vaccine
29133|NCT03390140|Spinal Cord Injuries|spinal cord injuries
29134|NCT03390140|Group Intervention|group intervention
29135|NCT03390140|Self Efficacy|self efficacy
29136|NCT03390127|elderly|elderly
29137|NCT03390127|lithotomy position|lithotomy position
29138|NCT03390127|PEEP|peep
29139|NCT03390127|laryngeal mask airway|laryngeal mask airway
29140|NCT03390114|HIV|hiv
29141|NCT03390114|Insomnia|insomnia
29142|NCT03390114|Cognitive Behavioral Therapy|cognitive behavioral therapy
29143|NCT03390088|Heart failure|heart failure
29144|NCT03390075|shelf nutrition label, NuVal|shelf nutrition label, nuval
29145|NCT03390049|SmartXide 2 V 2 LR|smartxide 2 v 2 lr
29146|NCT03390049|MonaLisa Touch|monalisa touch
29147|NCT03390049|DEKA|deka
29148|NCT03390049|Fractional CO2 Laser|fractional co2 laser
29149|NCT03390049|Sham Laser|sham laser
29150|NCT03390049|Vulvodynia|vulvodynia
29151|NCT03390049|PVD|pvd
29152|NCT03390049|Provoked vestibulodynia|provoked vestibulodynia
29153|NCT03390023|Prenatal Care|prenatal care
29154|NCT03390023|Barriers|barriers
29155|NCT03390023|Clinical Trials|clinical trials
29156|NCT03389997|respiratory tract infections|respiratory tract infections
29157|NCT03389997|virus shedding|virus shedding
29158|NCT03389997|cancer|cancer
29159|NCT03389997|Immunocompromised Host|immunocompromised host
29160|NCT03389958|intrauterine device|intrauterine device
29161|NCT03389958|postpartum contraception|postpartum contraception
29162|NCT03389958|repeat pregnancy|repeat pregnancy
29359|NCT03388619|Rising PSA|rising psa
29163|NCT03389958|adolescent pregnancy|adolescent pregnancy
29164|NCT03389945|Labor analgesia|labor analgesia
29165|NCT03389945|Dural puncture epidural|dural puncture epidural
29166|NCT03389945|Postdural puncture headache|postdural puncture headache
29167|NCT03389945|Neuraxial analgesia|neuraxial analgesia
29168|NCT03389893|randomized double-masked (blind) placebo-controlled trial|randomized double-masked (blind) placebo-controlled trial
29169|NCT03389893|Thelper2 (Th2) effect|thelper2 (th2) effect
29170|NCT03389893|cutaneous microbial community|cutaneous microbial community
29171|NCT03389893|skin barrier|skin barrier
29172|NCT03389867|Male sexual health|male sexual health
29173|NCT03389867|Erectile function|erectile function
29174|NCT03389841|home care services|home care services
29175|NCT03389841|comorbidity|comorbidity
29176|NCT03389841|heart failure|heart failure
29177|NCT03389841|caregivers|caregivers
29178|NCT03389841|health education|health education
29179|NCT03389841|patient admission|patient admission
29180|NCT03389828|Focus Group|focus group
29181|NCT03389828|Health Disparities|health disparities
29182|NCT03389828|Occupational Health|occupational health
29183|NCT03389828|Behaviors|behaviors
29184|NCT03389789|pain|pain
29185|NCT03389789|infant|infant
29186|NCT03389789|near-infrared spectroscopy|near-infrared spectroscopy
29187|NCT03389789|non pharmacological analgesia|non pharmacological analgesia
29188|NCT03389763|Surgical Pleth Index (SPI)|surgical pleth index (spi)
29189|NCT03389763|Pupillary Dilatation Reflex (PRD)|pupillary dilatation reflex (prd)
29190|NCT03389763|Intraoperative Blood Loss (IBL)|intraoperative blood loss (ibl)
29191|NCT03389763|Boezaart Bleeding Scale (BBS)|boezaart bleeding scale (bbs)
29192|NCT03389763|Spectral Entropy (SE)|spectral entropy (se)
29193|NCT03389763|Adequacy of Anaesthesia (AoA)|adequacy of anaesthesia (aoa)
29194|NCT03389763|Total Intravenous Anaesthesia (TIVA)|total intravenous anaesthesia (tiva)
29195|NCT03389711|Rheumatoid Arthritis Mexico|rheumatoid arthritis mexico
29196|NCT03389711|Early Rheumatoid Arthritis Cohort Mexico|early rheumatoid arthritis cohort mexico
29197|NCT03389685|Platelet Rich Plasma|platelet rich plasma
29198|NCT03389672|patient safety|patient safety
29199|NCT03389672|residency training|residency training
29200|NCT03389659|mCRC|mcrc
29201|NCT03389659|oxaliplatin plus fluoropyrimidine|oxaliplatin plus fluoropyrimidine
29202|NCT03389620|CT-fluoroscopy|ct-fluoroscopy
29203|NCT03389620|Corticosteroid injection|corticosteroid injection
29204|NCT03389607|SCUBE-1|scube-1
29205|NCT03389594|Surgical guide|surgical guide
29206|NCT03389594|Computer guided implantology|computer guided implantology
29207|NCT03389594|CBCT voxel size|cbct voxel size
29208|NCT03389555|Sepsis|sepsis
29209|NCT03389555|Metabolic Resuscitation|metabolic resuscitation
29210|NCT03389503|Access site|access site
29211|NCT03389503|Transradial access|transradial access
29212|NCT03389503|Coronary artery disease|coronary artery disease
29213|NCT03389503|Learning curve|learning curve
29214|NCT03389451|68Ga-PSMA-11|68ga-psma-11
29215|NCT03389451|(68Ga)Glu-urea-Lys(Ahx)-HBED-CC|(68ga)glu-urea-lys(ahx)-hbed-cc
29216|NCT03389451|68Ga PSMA-HBED-CC|68ga psma-hbed-cc
29217|NCT03389438|Immunotherapy|immunotherapy
29218|NCT03389399|Brigatinib|brigatinib
29219|NCT03389399|Early Onset Pulmonary Events|early onset pulmonary events
29220|NCT03389386|Congestive Heart Failure|congestive heart failure
29221|NCT03389386|Catestatin|catestatin
29222|NCT03389386|Chromogranin A|chromogranin a
29223|NCT03389386|Echocardiography|echocardiography
29224|NCT03389386|Biomarkers|biomarkers
29225|NCT03389386|Ventricular Dysfunction, Left|ventricular dysfunction, left
29226|NCT03389386|Comorbidity|comorbidity
29227|NCT03389373|Dental Caries|dental caries
29228|NCT03389321|pharmacokinetics|pharmacokinetics
29229|NCT03389321|macitentan|macitentan
29230|NCT03389321|riociguat|riociguat
29231|NCT03389308|Epidermolysis Bullosa Simplex|epidermolysis bullosa simplex
29232|NCT03389308|Epidermolysis Bullosa|epidermolysis bullosa
29233|NCT03389308|Skin Blister|skin blister
29234|NCT03389308|Erosions|erosions
29235|NCT03389295|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
29236|NCT03389295|Reduced Target Delineation|reduced target delineation
29237|NCT03389295|Sequential chemoradiotherapy|sequential chemoradiotherapy
29238|NCT03389282|Tear, Metabolite|tear, metabolite
29239|NCT03389256|apatinib|apatinib
29240|NCT03389256|T790 negative|t790 negative
29241|NCT03389256|NSCLC|nsclc
29242|NCT03389243|Surgical Pleth Index (SPI)|surgical pleth index (spi)
29243|NCT03389243|General Anaesthesia (GA),|general anaesthesia (ga),
29244|NCT03389243|Numerical Rating Scale (NRS)|numerical rating scale (nrs)
29245|NCT03389243|Adequacy of Anaesthesia (AoA)|adequacy of anaesthesia (aoa)
29246|NCT03389243|Oculocardiac reflex (OCR)|oculocardiac reflex (ocr)
29247|NCT03389243|paracetamol|paracetamol
29248|NCT03389243|metamizole|metamizole
29249|NCT03389230|chimeric antigen receptor|chimeric antigen receptor
29250|NCT03389230|glioblastoma|glioblastoma
29251|NCT03389217|Multiple Sclerosis|multiple sclerosis
29252|NCT03389217|Pain|pain
29253|NCT03389217|Transcranial Direct Current Stimulation|transcranial direct current stimulation
29254|NCT03389217|tDCS|tdcs
29255|NCT03389204|Breast surgery|breast surgery
29256|NCT03389204|Physiotherapy|physiotherapy
29257|NCT03389204|Breast Cancer|breast cancer
29258|NCT03389204|Shoulder pain|shoulder pain
29259|NCT03389204|Shoulder motion|shoulder motion
29260|NCT03389178|prenatal stress|prenatal stress
29261|NCT03389178|fetal autonomic nervous system|fetal autonomic nervous system
29262|NCT03389178|multidimensional FHR variability assessment|multidimensional fhr variability assessment
29263|NCT03389165|Wearable hip assist robot|wearable hip assist robot
29264|NCT03389165|Elderly adult|elderly adult
29265|NCT03389165|Metabolic energy expenditure|metabolic energy expenditure
29266|NCT03389165|Stair ascent|stair ascent
29267|NCT03389139|Cesarean|cesarean
29268|NCT03389139|newborn|newborn
29269|NCT03389139|cerebral and renal oxygenation|cerebral and renal oxygenation
29270|NCT03389139|anesthesia|anesthesia
29271|NCT03389100|diabetes|diabetes
29272|NCT03389100|hyperglycemia|hyperglycemia
29273|NCT03389100|tau|tau
29274|NCT03389061|Epclusa|epclusa
29275|NCT03389061|Pharmacokinetics|pharmacokinetics
29276|NCT03389061|Crushing|crushing
29277|NCT03389035|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
29278|NCT03389035|CAR-T|car-t
29279|NCT03389035|CARCIK|carcik
29280|NCT03389035|Transposon|transposon
29281|NCT03388983|Prehabilitation|prehabilitation
29282|NCT03388983|Physical activity|physical activity
29283|NCT03388983|Lumbar decompression surgery|lumbar decompression surgery
29284|NCT03388983|Randomized controlled trial|randomized controlled trial
29285|NCT03388970|vitamin K1|vitamin k1
29286|NCT03388970|spontaneous intracerebral hemorrhage|spontaneous intracerebral hemorrhage
29287|NCT03388970|effectiveness|effectiveness
29288|NCT03388970|outcome|outcome
29289|NCT03388931|Radiotherapy Dose Escalation|radiotherapy dose escalation
29290|NCT03388918|Quality of life|quality of life
29291|NCT03388918|Telerehabilitation|telerehabilitation
29292|NCT03388918|Cardiac patients|cardiac patients
29293|NCT03388918|Heart failure|heart failure
29294|NCT03388905|LifeVest wearable|lifevest wearable
29295|NCT03388905|cardioverter defibrillator|cardioverter defibrillator
29296|NCT03388905|LVEF|lvef
29297|NCT03388892|Angioplasty|angioplasty
29298|NCT03388892|Drug Eluting Balloon|drug eluting balloon
29299|NCT03388892|Arteriovenous Graft|arteriovenous graft
29300|NCT03388866|inhaled aeroallergens|inhaled aeroallergens
29301|NCT03388866|eczema|eczema
29302|NCT03388866|pruritus|pruritus
29303|NCT03388866|life quality|life quality
29304|NCT03388866|immunotheraphy|immunotheraphy
29305|NCT03388866|atopic dermatitis|atopic dermatitis
29306|NCT03388853|Acetylcysteine/Doxofylline|acetylcysteine/doxofylline
29307|NCT03388853|Acetylcysteine|acetylcysteine
29308|NCT03388853|Doxofylline|doxofylline
29309|NCT03388853|Effervescent Tablet|effervescent tablet
29310|NCT03388853|COPD|copd
29311|NCT03388840|platelet rich plasma|platelet rich plasma
29312|NCT03388840|adipose derived stem cells|adipose derived stem cells
29313|NCT03388840|follicular unit extraction|follicular unit extraction
29314|NCT03388840|hair transplantation|hair transplantation
29315|NCT03388814|PPBCS|ppbcs
29316|NCT03388814|Acute|acute
29317|NCT03388814|Postoperative|postoperative
29318|NCT03388814|Mastectomy|mastectomy
29319|NCT03388814|Breast Reconstruction|breast reconstruction
29320|NCT03388775|deep vein thrombosis|deep vein thrombosis
29321|NCT03388775|assessment|assessment
29322|NCT03388775|risk factors|risk factors
29323|NCT03388762|Hyperglycemia|hyperglycemia
29324|NCT03388762|Prediabetes|prediabetes
29325|NCT03388762|Botanical|botanical
29326|NCT03388762|Phytochemicals|phytochemicals
29327|NCT03388762|Dietary Supplements|dietary supplements
29328|NCT03388762|Berberine|berberine
29329|NCT03388762|Fenugreek|fenugreek
29330|NCT03388762|American Ginseng|american ginseng
29331|NCT03388762|Gymnema|gymnema
29333|NCT03388762|Kudzu|kudzu
29334|NCT03388762|Cinnamon|cinnamon
29335|NCT03388762|Glycated hemoglobin|glycated hemoglobin
29336|NCT03388762|Trigonella|trigonella
29337|NCT03388762|Blood Glucose|blood glucose
29338|NCT03388762|Panax|panax
29339|NCT03388762|Plant Extracts|plant extracts
29340|NCT03388762|Public Health|public health
29341|NCT03388762|Chronic Disease|chronic disease
29342|NCT03388736|preoperative|preoperative
29343|NCT03388736|anxiety|anxiety
29344|NCT03388736|orthognathic surgery|orthognathic surgery
29345|NCT03388736|lavender oil|lavender oil
29346|NCT03388723|Epigenetics|epigenetics
29347|NCT03388723|Cardiometabolic risk factors|cardiometabolic risk factors
29348|NCT03388710|airway, children, endotracheal tube, cuff|airway, children, endotracheal tube, cuff
29349|NCT03388658|Atrial Fibrillation; Cryoballoon; Ablation;|atrial fibrillation; cryoballoon; ablation;
29350|NCT03388645|RSV Shedding|rsv shedding
29351|NCT03388645|Immune Responses|immune responses
29352|NCT03388645|Neutralizing Antibody Titer|neutralizing antibody titer
29353|NCT03388645|Upper Respiratory Tract Infection|upper respiratory tract infection
29354|NCT03388632|Immunotherapy|immunotherapy
29355|NCT03388632|T Cells|t cells
29356|NCT03388632|Checkpoint Inhibitor|checkpoint inhibitor
29357|NCT03388632|IL-15|il-15
29358|NCT03388632|Combination Therapy|combination therapy
29360|NCT03388619|No evidence of metastatic disease|no evidence of metastatic disease
29361|NCT03388619|Entire Prostate Bed|entire prostate bed
29362|NCT03388619|Quality of Life|quality of life
29363|NCT03388619|Irradiation|irradiation
29364|NCT03388606|Mood Disorder|mood disorder
29365|NCT03388606|Teenagers|teenagers
29366|NCT03388606|Mechanism|mechanism
29367|NCT03388593|chronic heart failure|chronic heart failure
29368|NCT03388593|neuregulin|neuregulin
29369|NCT03388593|mortality|mortality
29370|NCT03388567|Dispensation|dispensation
29371|NCT03388567|Health Education|health education
29372|NCT03388567|Pharmacovigilance|pharmacovigilance
29373|NCT03388567|Pharmacists|pharmacists
29374|NCT03388528|Dysmotility|dysmotility
29375|NCT03388528|Microbiome|microbiome
29376|NCT03388528|Transit Time|transit time
29377|NCT03388528|Gastrointestinal|gastrointestinal
29378|NCT03388502|Total knee arthroplasty|total knee arthroplasty
29379|NCT03388502|Total hip arthroplasty|total hip arthroplasty
29380|NCT03388476|pulmonary hypertension|pulmonary hypertension
29381|NCT03388476|endtidal co2|endtidal co2
29382|NCT03388476|endtidal carbon dioxide|endtidal carbon dioxide
29383|NCT03388476|pulmonary arterial hypertension|pulmonary arterial hypertension
29384|NCT03388437|Non-invasive Neurally Adjusted Ventilatory Assist NI-NAVA|non-invasive neurally adjusted ventilatory assist ni-nava
29385|NCT03388437|Nasal Intermittent Positive Pressure Ventilation NIPPV|nasal intermittent positive pressure ventilation nippv
29386|NCT03388437|post extubation|post extubation
29387|NCT03388424|bacterial DNA, RNA16S gene|bacterial dna, rna16s gene
29388|NCT03388411|Microbiome|microbiome
29389|NCT03388411|Gut|gut
29390|NCT03388398|Mother-to-child transmission of HIV (MTCT)|mother-to-child transmission of hiv (mtct)
29391|NCT03388398|Prevention of mother-to-child HIV transmission (PMTCT)|prevention of mother-to-child hiv transmission (pmtct)
29392|NCT03388398|Antiretroviral therapy (ART)|antiretroviral therapy (art)
29393|NCT03388398|Antenatal care (ANC)|antenatal care (anc)
29394|NCT03388398|Pediatric infections|pediatric infections
29395|NCT03388398|Pregnancy|pregnancy
29396|NCT03388385|CKD, anemia, iron, endothelial dysfunction, oxidative stress|ckd, anemia, iron, endothelial dysfunction, oxidative stress
29397|NCT03388372|glioma|glioma
29398|NCT03388372|phase 2|phase 2
29399|NCT03388372|nimotozumab|nimotozumab
29400|NCT03388372|temozolomide|temozolomide
29401|NCT03388372|radiotherapy|radiotherapy
29402|NCT03388359|asthma|asthma
29403|NCT03388359|eosinophils|eosinophils
29404|NCT03388359|Extracellular matrix|extracellular matrix
29405|NCT03388359|airway smooth muscle|airway smooth muscle
29406|NCT03388359|airway remodelling|airway remodelling
29407|NCT03388359|fibroblast|fibroblast
29408|NCT03388346|68Ga-PSMA-11|68ga-psma-11
29409|NCT03388346|(68Ga)Glu-urea-Lys(Ahx)-HBED-CC|(68ga)glu-urea-lys(ahx)-hbed-cc
29410|NCT03388346|68Ga PSMA-HBED-CC|68ga psma-hbed-cc
29411|NCT03388294|communication|communication
29412|NCT03388294|sensory|sensory
29413|NCT03388294|early intervention|early intervention
29414|NCT03388294|parent coaching|parent coaching
29415|NCT03388281|Pacemaker|pacemaker
29416|NCT03388281|Gender differences|gender differences
29417|NCT03388281|Survival|survival
29418|NCT03388281|Retrospective|retrospective
29419|NCT03388268|Clostridium difficile|clostridium difficile
29420|NCT03388268|Diarrhea|diarrhea
29421|NCT03388255|Polydeoxyribonucletide|polydeoxyribonucletide
29422|NCT03388255|Placentex|placentex
29423|NCT03388255|PDRN|pdrn
29424|NCT03388229|Dietary pattern|dietary pattern
29425|NCT03388229|glycemic control|glycemic control
29426|NCT03388229|type 2 diabetes|type 2 diabetes
29427|NCT03388229|UAE|uae
29428|NCT03388203|25(OH)D|25(oh)d
29429|NCT03388203|PTH|pth
29430|NCT03388203|mass spectrometry|mass spectrometry
29431|NCT03388203|data mining|data mining
29432|NCT03388190|Colorectal|colorectal
29433|NCT03388190|Cancer|cancer
29434|NCT03388190|Neoplasm|neoplasm
29435|NCT03388190|Nivolumab|nivolumab
29436|NCT03388190|Fluorouracil|fluorouracil
29437|NCT03388190|Metastatic|metastatic
29438|NCT03388190|Oxaliplatin|oxaliplatin
29439|NCT03388190|Leucovorin|leucovorin
29440|NCT03388177|Depression|depression
29441|NCT03388177|Young adult women|young adult women
29442|NCT03388177|Yoga|yoga
29443|NCT03388112|Probiotics,Gut Microbiome,Antibiotics,Infants|probiotics,gut microbiome,antibiotics,infants
29444|NCT03388099|gonadotrophin receptor polymorphism|gonadotrophin receptor polymorphism
29445|NCT03388099|antimüllerian hormone|antimüllerian hormone
29446|NCT03388099|ovarian response|ovarian response
29447|NCT03388099|ovarian stimulation|ovarian stimulation
29448|NCT03388060|Oral Dissolution Therapy|oral dissolution therapy
29449|NCT03388060|Kidney stone|kidney stone
29450|NCT03388060|ESWL|eswl
29451|NCT03388047|Barrett Esophagus|barrett esophagus
29452|NCT03388047|Endoscopy|endoscopy
29453|NCT03388047|Adenocarcinoma|adenocarcinoma
29454|NCT03388021|limb ischemia|limb ischemia
29455|NCT03388021|completion angiography|completion angiography
29456|NCT03388021|thromboembolectomy|thromboembolectomy
29457|NCT03388008|donor-specific HLA antibodies|donor-specific hla antibodies
29458|NCT03388008|lung transplantation|lung transplantation
29459|NCT03387995|treatment outcome|treatment outcome
29460|NCT03387956|Postoperative Nuasea|postoperative nuasea
29461|NCT03387930|Low back pain|low back pain
29462|NCT03387930|lumbar multifidus|lumbar multifidus
29463|NCT03387930|Proprioception|proprioception
29464|NCT03387930|Elastography|elastography
29465|NCT03387930|Magnetic resonance imaging|magnetic resonance imaging
29466|NCT03387917|Advanced Solid Tumors|advanced solid tumors
29467|NCT03387917|doxorubicin|doxorubicin
29468|NCT03387917|TLD-1|tld-1
29469|NCT03387917|phase I|phase i
29470|NCT03387917|Talidox|talidox
29471|NCT03387917|Liposomal|liposomal
29472|NCT03387904|Anlotinib|anlotinib
29473|NCT03387865|banking, biological sampling, tumor tissue, tumor response|banking, biological sampling, tumor tissue, tumor response
29474|NCT03387826|ticagrelor|ticagrelor
29475|NCT03387826|prasugrel|prasugrel
29476|NCT03387813|Heart Failure|heart failure
29477|NCT03387813|Hemodynamic Monitoring|hemodynamic monitoring
29478|NCT03387813|CardioMEMS|cardiomems
29479|NCT03387813|Pulmonary Artery Pressure|pulmonary artery pressure
29480|NCT03387800|randomized controlled trial|randomized controlled trial
29481|NCT03387800|smoking cessation|smoking cessation
29482|NCT03387800|social support|social support
29483|NCT03387800|positive effect|positive effect
29484|NCT03387800|online social networking|online social networking
29485|NCT03387800|theory-based|theory-based
29486|NCT03387787|GlucoTab, Tresiba, Type 2 Diabetes|glucotab, tresiba, type 2 diabetes
29487|NCT03387774|Ulinastatin|ulinastatin
29488|NCT03387774|Radiation-induced acute oral mucositis|radiation-induced acute oral mucositis
29489|NCT03387774|Localregionally Advanced Nasopharyngeal Carcinoma|localregionally advanced nasopharyngeal carcinoma
29490|NCT03387774|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
29491|NCT03387761|Urothelial cancer|urothelial cancer
29492|NCT03387761|Bladder cancer|bladder cancer
29493|NCT03387761|Cancer|cancer
29494|NCT03387761|Resectable|resectable
29495|NCT03387761|Operable|operable
29496|NCT03387761|immunotherapy|immunotherapy
29497|NCT03387761|Ipilimumab|ipilimumab
29498|NCT03387761|Nivolumab|nivolumab
29499|NCT03387761|Neo-Adjuvant|neo-adjuvant
29500|NCT03387735|Hypertension, Hyperlipidemia, Diabetes, Arthritis, Obesity|hypertension, hyperlipidemia, diabetes, arthritis, obesity
29501|NCT03387709|Nondiabetic|nondiabetic
29502|NCT03387709|Overweight|overweight
29503|NCT03387709|Obesity|obesity
29504|NCT03387709|Men|men
29505|NCT03387709|Women|women
29506|NCT03387709|San Diego|san diego
29507|NCT03387709|Weight Loss|weight loss
29508|NCT03387696|Mucormycosis|mucormycosis
29509|NCT03387696|Intensive Care Medicine|intensive care medicine
29510|NCT03387631|Efficacy safety uncomplicated malaria AL|efficacy safety uncomplicated malaria al
29511|NCT03387592|Neuroendocrine Carcinoma|neuroendocrine carcinoma
29512|NCT03387592|second line therapy|second line therapy
29513|NCT03387592|PET imaging|pet imaging
29514|NCT03387592|FOLFIRI|folfiri
29515|NCT03387592|CAPTEM|captem
29516|NCT03387553|Immunotherapy|immunotherapy
29517|NCT03387553|Dendritic Cell Vaccine|dendritic cell vaccine
29518|NCT03387553|DC1|dc1
29519|NCT03387540|Anti-PD-1|anti-pd-1
29520|NCT03387540|Anti-PD-L1|anti-pd-l1
29521|NCT03387540|Anti CTLA-4|anti ctla-4
29522|NCT03387540|Immune checkpoint inhibitors|immune checkpoint inhibitors
29523|NCT03387527|Decision Aid|decision aid
29524|NCT03387514|Clear Cell|clear cell
29525|NCT03387514|Kidney Cancer|kidney cancer
29526|NCT03387514|RCC|rcc
29527|NCT03387475|efficacy|efficacy
29528|NCT03387475|safety|safety
29529|NCT03387462|Adherence|adherence
29530|NCT03387462|PrEP|prep
29531|NCT03387462|HIV Prevention|hiv prevention
29532|NCT03387462|Truvada|truvada
29533|NCT03387462|HIV Risk Reduction|hiv risk reduction
29534|NCT03387462|Mobile App|mobile app
29535|NCT03387436|Palliative care|palliative care
29536|NCT03387436|Advance care planning|advance care planning
29537|NCT03387436|psychological intervention|psychological intervention
29538|NCT03387410|Laparoscopic surgery|laparoscopic surgery
29539|NCT03387410|Fluorescence|fluorescence
29540|NCT03387397|Co-morbidities|co-morbidities
29541|NCT03387371|chronic periodontitis, laser|chronic periodontitis, laser
29542|NCT03387358|intensive care unit|intensive care unit
29543|NCT03387358|nasal bridle securement device|nasal bridle securement device
29544|NCT03387358|small bore feeding tube|small bore feeding tube
29545|NCT03387358|adverse events|adverse events
29546|NCT03387358|enteral nutrition|enteral nutrition
29547|NCT03387345|glucose|glucose
29548|NCT03387345|dietary fiber|dietary fiber
29549|NCT03387345|glycemia|glycemia
29550|NCT03387345|whole grain|whole grain
29551|NCT03387332|Bcl-2/Bcl-xL dual inhibitor|bcl-2/bcl-xl dual inhibitor
29552|NCT03387319|Social stress|social stress
29553|NCT03387319|Inflammation|inflammation
29554|NCT03387306|serum bilirubin|serum bilirubin
29555|NCT03387306|normal-tension glaucoma|normal-tension glaucoma
29556|NCT03387306|oxidative stress|oxidative stress
29557|NCT03387293|Pediatric Obesity|pediatric obesity
29558|NCT03387293|Insulin Resistance|insulin resistance
29559|NCT03387293|Diet|diet
29560|NCT03387280|acute myocardial infarction|acute myocardial infarction
29561|NCT03387280|electrocardiogram|electrocardiogram
29562|NCT03387280|coronary angiography|coronary angiography
29563|NCT03387254|virtual reality|virtual reality
29564|NCT03387254|brain stimulation|brain stimulation
29565|NCT03387241|moderate|moderate
29566|NCT03387241|severe|severe
29567|NCT03387241|persistent|persistent
29568|NCT03387241|reversible|reversible
29569|NCT03387241|Seretide|seretide
29570|NCT03387241|Flutiform|flutiform
29571|NCT03387228|back pain|back pain
29572|NCT03387228|low back pain|low back pain
29573|NCT03387228|Explain Pain|explain pain
29574|NCT03387228|Pain education|pain education
29575|NCT03387202|Pelvic Organ Prolapse|pelvic organ prolapse
29576|NCT03387202|Translabial ultrasound|translabial ultrasound
29577|NCT03387202|Transperineal ultrasound|transperineal ultrasound
29578|NCT03387202|Lateral Mesh Suspension|lateral mesh suspension
29579|NCT03387202|Descensus uteri|descensus uteri
29580|NCT03387202|Laparoscopic pelvic organ prolapse repair|laparoscopic pelvic organ prolapse repair
29581|NCT03387163|Heart failure|heart failure
29582|NCT03387163|Reduced left ventricular ejection fraction|reduced left ventricular ejection fraction
29583|NCT03387163|Chronic Systolic Heart failure|chronic systolic heart failure
29584|NCT03387163|Sacubitril /Valsartan|sacubitril /valsartan
29585|NCT03387163|Patient reported outcomes (PRO)|patient reported outcomes (pro)
29586|NCT03387163|Kansas City Cardiomyopathy Questionnaire (KCCQ)|kansas city cardiomyopathy questionnaire (kccq)
29587|NCT03387163|Patient Centered Outcomes Research Network (PCORNeT)|patient centered outcomes research network (pcornet)
29588|NCT03387163|Common Data Model (CDM)|common data model (cdm)
29589|NCT03387072|Mental stress|mental stress
29590|NCT03387072|Sudden cardiac death|sudden cardiac death
29591|NCT03387072|arrhythmias|arrhythmias
29592|NCT03387072|long QT syndrome|long qt syndrome
29593|NCT03387059|Infertility|infertility
29594|NCT03387059|Forielle|forielle
29595|NCT03387059|Assisted Reproductive Technique (ART)|assisted reproductive technique (art)
29596|NCT03387059|Controlled Ovarian Stimulation (COS)|controlled ovarian stimulation (cos)
29597|NCT03387046|Relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
29598|NCT03387046|D-Aspartate|d-aspartate
29599|NCT03387046|interferon beta-1a|interferon beta-1a
29600|NCT03387007|adolescent|adolescent
29601|NCT03387007|mental health|mental health
29602|NCT03387007|hope|hope
29603|NCT03387007|psycho-social support|psycho-social support
29604|NCT03387007|school teachers|school teachers
29605|NCT03387007|earthquake|earthquake
29606|NCT03386981|Energy metabolism|energy metabolism
29607|NCT03386981|Homeostasis|homeostasis
29608|NCT03386981|Bone turnover markers|bone turnover markers
29609|NCT03386968|virtual reality|virtual reality
29610|NCT03386968|hemiplegia|hemiplegia
29611|NCT03386968|diplegia|diplegia
29612|NCT03386968|video gaming|video gaming
29613|NCT03386968|active video games|active video games
29614|NCT03386968|Playstation X-Box 360|playstation x-box 360
29615|NCT03386968|Rutgers V-Step|rutgers v-step
29616|NCT03386968|Microsoft Kinect|microsoft kinect
29617|NCT03386955|non-small cell lung cancer|non-small cell lung cancer
29618|NCT03386955|NSCLC|nsclc
29619|NCT03386942|Solid Tumors|solid tumors
29620|NCT03386942|Folate Receptor α (FRA)-Positive Triple Negative Breast Cancer|folate receptor α (fra)-positive triple negative breast cancer
29621|NCT03386942|FRA-Positive Type 2 Endometrial Carcinoma|fra-positive type 2 endometrial carcinoma
29622|NCT03386929|NSCLC|nsclc
29623|NCT03386929|tri-therapy|tri-therapy
29624|NCT03386929|avelumab|avelumab
29625|NCT03386929|axitinib|axitinib
29626|NCT03386929|palbociclib|palbociclib
29627|NCT03386929|dual matched normal and tumor biopsies|dual matched normal and tumor biopsies
29628|NCT03386929|SIMS algorithm|sims algorithm
29629|NCT03386929|Sequencing|sequencing
29630|NCT03386929|Gene expression|gene expression
29631|NCT03386916|Technology, Radiologic - Radiography, Interventional - Image-Guided Biopsy - Early Detection of Cancer - Carcinoma, Bronchogenic / diagnosis - Outpatients|technology, radiologic - radiography, interventional - image-guided biopsy - early detection of cancer - carcinoma, bronchogenic / diagnosis - outpatients
29632|NCT03386890|Non-invasive Assessment|non-invasive assessment
29633|NCT03386890|Transient Elastography|transient elastography
29634|NCT03386890|Controlled Attenuation Parameter|controlled attenuation parameter
29635|NCT03386864|Heart Failure, Diabetes Mellitus, Mitochondrial Respiration|heart failure, diabetes mellitus, mitochondrial respiration
29636|NCT03386825|Metastatic Colorectal Cancer|metastatic colorectal cancer
29637|NCT03386812|androgen deprivation therapy|androgen deprivation therapy
29638|NCT03386812|sarcopenia|sarcopenia
29639|NCT03386812|bone loss|bone loss
29640|NCT03386799|Power assistance device|power assistance device
29641|NCT03386799|Wheelchair|wheelchair
29642|NCT03386786|Total Knee Arthroplasty|total knee arthroplasty
29643|NCT03386786|Total Hip Arthroplasty|total hip arthroplasty
29644|NCT03386786|Total Knee Replacement|total knee replacement
29645|NCT03386786|Total Hip Replacement|total hip replacement
29646|NCT03386786|Hospital Care Plan|hospital care plan
29647|NCT03386786|mHealth|mhealth
29648|NCT03386773|patient generated health data|patient generated health data
30034|NCT03384316|ETBX-061|etbx-061
29649|NCT03386773|patient reported outcome measures|patient reported outcome measures
29650|NCT03386773|health information technology|health information technology
29651|NCT03386773|mobile health|mobile health
29652|NCT03386773|consumer health informatics|consumer health informatics
29653|NCT03386760|tattoo|tattoo
29654|NCT03386747|child development|child development
29655|NCT03386747|neonatal mortality|neonatal mortality
29656|NCT03386708|Healing Poor After Uterus Injury, Mesenchymal Stem Cell|healing poor after uterus injury, mesenchymal stem cell
29657|NCT03386695|Cervical Cancer and HPV infection|cervical cancer and hpv infection
29658|NCT03386669|18F-THK5351 PET|18f-thk5351 pet
29659|NCT03386669|Tauopathies|tauopathies
29660|NCT03386656|Osteoarthritis|osteoarthritis
29661|NCT03386656|Tranexamic acid|tranexamic acid
29662|NCT03386643|Oral lichen planus|oral lichen planus
29663|NCT03386643|Probiotics|probiotics
29664|NCT03386643|Immunomodulation.|immunomodulation.
29665|NCT03386604|Whey Protein|whey protein
29666|NCT03386539|heart transplantation|heart transplantation
29667|NCT03386539|children|children
29668|NCT03386539|everolimus|everolimus
29669|NCT03386539|tacrolimus|tacrolimus
29670|NCT03386539|mycophenolate mofetil|mycophenolate mofetil
29671|NCT03386539|randomized clinical trial|randomized clinical trial
29672|NCT03386526|IAP inhibitor|iap inhibitor
29673|NCT03386513|Antibody Drug Conjugate|antibody drug conjugate
29674|NCT03386513|Other Hematologic Malignancies|other hematologic malignancies
29675|NCT03386513|Myeloproliferative Neoplasms|myeloproliferative neoplasms
29676|NCT03386513|CD123|cd123
29677|NCT03386513|MDS|mds
29678|NCT03386513|Relapsed, Refractory|relapsed, refractory
29679|NCT03386513|Acute Lymphocytic Leukaemia|acute lymphocytic leukaemia
29680|NCT03386513|Blastic Plasmacytoid Dendritic Cell Neoplasm|blastic plasmacytoid dendritic cell neoplasm
29681|NCT03386513|Acute Myeloid Leukemia|acute myeloid leukemia
29682|NCT03386474|double-masked, extension study|double-masked, extension study
29683|NCT03386474|neovascular age-related macular degeneration|neovascular age-related macular degeneration
29684|NCT03386474|intravitreal injection|intravitreal injection
29685|NCT03386474|brolucizumab|brolucizumab
29686|NCT03386474|aflibercept|aflibercept
29687|NCT03386461|elderly|elderly
29688|NCT03386461|exercise training|exercise training
29689|NCT03386461|adipose tissue|adipose tissue
29690|NCT03386461|omega-3 polyunsaturated fatty acids|omega-3 polyunsaturated fatty acids
29691|NCT03386461|inflammation|inflammation
29692|NCT03386461|diferentiation of preadipocytes|diferentiation of preadipocytes
29693|NCT03386435|remote ischemic preconditioning|remote ischemic preconditioning
29694|NCT03386435|liver donors|liver donors
29695|NCT03386422|Mindfulness|mindfulness
29696|NCT03386422|Self-Compassion|self-compassion
29697|NCT03386422|Chronic Pain|chronic pain
29698|NCT03386422|Psychological Intervention|psychological intervention
29699|NCT03386422|Cognitive-Behavioural therapy|cognitive-behavioural therapy
29700|NCT03386422|acceptance|acceptance
29701|NCT03386422|catastrophising|catastrophising
29702|NCT03386422|Self-Care|self-care
29703|NCT03386422|Quality of life|quality of life
29704|NCT03386409|Injury prevention|injury prevention
29705|NCT03386383|adolescent and young adult|adolescent and young adult
29706|NCT03386383|cancer survivor|cancer survivor
29707|NCT03386370|Acute ischemia|acute ischemia
29708|NCT03386370|Lower Limb|lower limb
29709|NCT03386318|concentration|concentration
29710|NCT03386292|prevalence|prevalence
29711|NCT03386292|urinary incontinence|urinary incontinence
29712|NCT03386292|anal incontinence|anal incontinence
29713|NCT03386292|risk factors|risk factors
29714|NCT03386292|women|women
29715|NCT03386279|healthy volunteers|healthy volunteers
29716|NCT03386266|Biomarkers|biomarkers
29717|NCT03386266|CMT1A|cmt1a
29718|NCT03386266|Charcot-Marie-Tooth disease|charcot-marie-tooth disease
29719|NCT03386227|Assisted Reproductive Technology|assisted reproductive technology
29720|NCT03386227|Antibiotic Prophylaxis|antibiotic prophylaxis
29721|NCT03386227|Microbiome|microbiome
29722|NCT03386201|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
29723|NCT03386201|Fluorescence|fluorescence
29724|NCT03386162|Breast cancer, PI3K, alpelisib|breast cancer, pi3k, alpelisib
29725|NCT03386149|Herniated Intervertebral Disc of Lumbar Spine|herniated intervertebral disc of lumbar spine
29726|NCT03386149|Low Back Pain|low back pain
29727|NCT03386149|Radiculopathy|radiculopathy
29728|NCT03386149|Bosinji|bosinji
29729|NCT03386149|Herbal Medicine|herbal medicine
29730|NCT03386136|bowel ischemia|bowel ischemia
29731|NCT03386136|bowel perforation|bowel perforation
29732|NCT03386123|Tinnitus|tinnitus
29733|NCT03386123|Insomnia|insomnia
29734|NCT03386123|Cognitive Behaviour Therapy|cognitive behaviour therapy
29735|NCT03386110|Couples|couples
29737|NCT03386110|HIV|hiv
29738|NCT03386110|Drug Use|drug use
29739|NCT03386097|Cholesterol|cholesterol
29740|NCT03386097|Interstitial fluid|interstitial fluid
29741|NCT03386084|capacitive resistive diathermy|capacitive resistive diathermy
29742|NCT03386084|motor control|motor control
29743|NCT03386019|lymphatic massage|lymphatic massage
29744|NCT03386019|static stretching|static stretching
29745|NCT03386019|cold water immersion|cold water immersion
29746|NCT03386006|bariatric surgery|bariatric surgery
29747|NCT03386006|mobile health (mHealth)|mobile health (mhealth)
29748|NCT03386006|psychosocial functioning|psychosocial functioning
29749|NCT03386006|obesity|obesity
29750|NCT03386006|weight loss|weight loss
29751|NCT03386006|behavioral activation|behavioral activation
29752|NCT03385993|Delirium Prevention|delirium prevention
29753|NCT03385993|Virtual Reality|virtual reality
29754|NCT03385993|VR|vr
29755|NCT03385967|upper extremity bone fracture|upper extremity bone fracture
29756|NCT03385954|nursing|nursing
29757|NCT03385954|distance|distance
29758|NCT03385954|education|education
29759|NCT03385954|RSI/WRMD|rsi/wrmd
29760|NCT03385928|ICH|ich
29761|NCT03385928|Stroke|stroke
29762|NCT03385928|Cerebrovascular Disorders|cerebrovascular disorders
29763|NCT03385928|Brain Diseases|brain diseases
29764|NCT03385928|Central Nervous System Diseases|central nervous system diseases
29765|NCT03385928|Nervous System Diseases|nervous system diseases
29766|NCT03385928|Vascular Diseases|vascular diseases
29767|NCT03385928|Cardiovascular Diseases|cardiovascular diseases
29768|NCT03385928|Tranexamic Acid|tranexamic acid
29769|NCT03385928|Antifibrinolytic Agents|antifibrinolytic agents
29770|NCT03385928|Fibrin Modulating Agents|fibrin modulating agents
29771|NCT03385928|Pharmacologic Actions|pharmacologic actions
29772|NCT03385928|Cardiovascular Agents|cardiovascular agents
29773|NCT03385928|Therapeutic Uses|therapeutic uses
29774|NCT03385928|Hematologic Agents|hematologic agents
29775|NCT03385928|Hemostatics|hemostatics
29776|NCT03385928|Contrast Media|contrast media
29777|NCT03385928|Angiography|angiography
29778|NCT03385928|Cerebral Angiography|cerebral angiography
29779|NCT03385928|Tomography, X-Ray Computed|tomography, x-ray computed
29780|NCT03385915|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
29781|NCT03385915|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
29782|NCT03385915|TAVI|tavi
29783|NCT03385915|TAVR|tavr
29784|NCT03385915|Aortic valve replacement|aortic valve replacement
29785|NCT03385915|Surgical aortic valve replacement|surgical aortic valve replacement
29786|NCT03385915|Sutureless|sutureless
29787|NCT03385902|advanced chronic kidney disease|advanced chronic kidney disease
29788|NCT03385902|timing of dialysis initiation|timing of dialysis initiation
29789|NCT03385902|hemodialysis|hemodialysis
29790|NCT03385902|fuzzy mathematics|fuzzy mathematics
29791|NCT03385902|glomerular filtration rate|glomerular filtration rate
29792|NCT03385889|Cervicogenic Headache|cervicogenic headache
29793|NCT03385889|Manual Therapy|manual therapy
29794|NCT03385889|Joint Position Sense|joint position sense
29795|NCT03385889|Balance|balance
29796|NCT03385876|Rady Children's|rady children's
29797|NCT03385876|Pediatric|pediatric
29798|NCT03385876|Genomic|genomic
29799|NCT03385876|Precision Medicine|precision medicine
29800|NCT03385876|Biorepository|biorepository
29801|NCT03385824|traumatic brain injury|traumatic brain injury
29802|NCT03385824|advocacy|advocacy
29803|NCT03385811|Professional quality of life, Medical Professionals, Job Involvement, Intention to Stay,|professional quality of life, medical professionals, job involvement, intention to stay,
29804|NCT03385798|Endo-GIA Stapler|endo-gia stapler
29805|NCT03385798|Endowrist Stapler|endowrist stapler
29806|NCT03385785|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
29807|NCT03385785|Pressure Recording Analytical Method|pressure recording analytical method
29808|NCT03385785|Ventriculo-arterial coupling|ventriculo-arterial coupling
29809|NCT03385785|Monitoring|monitoring
29810|NCT03385785|Hemodynamic|hemodynamic
29811|NCT03385772|sphenopalatine block|sphenopalatine block
29812|NCT03385759|unicompartmental knee|unicompartmental knee
29813|NCT03385759|total knee arthroplasty|total knee arthroplasty
29814|NCT03385759|osteoarthritis|osteoarthritis
29815|NCT03385733|pulmonary hypertension|pulmonary hypertension
29816|NCT03385733|inspiratory muscle training|inspiratory muscle training
29817|NCT03385733|functional capacity|functional capacity
29818|NCT03385733|physical activity|physical activity
29819|NCT03385707|Post-bariatric hypoglycemia|post-bariatric hypoglycemia
29820|NCT03385681|pediatric pain|pediatric pain
29821|NCT03385681|postoperative pain|postoperative pain
29822|NCT03385681|pain assessment|pain assessment
29823|NCT03385681|pain management|pain management
29824|NCT03385681|knowledge|knowledge
29825|NCT03385681|children|children
29826|NCT03385681|nurses|nurses
29827|NCT03385668|Pulmonary fibrosis|pulmonary fibrosis
29828|NCT03385668|Antibodies, Antineutrophil Cytoplasmic|antibodies, antineutrophil cytoplasmic
29829|NCT03385668|Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis|anti-neutrophil cytoplasmic antibody (anca)-associated vasculitis
29830|NCT03385668|Pirfenidone|pirfenidone
29831|NCT03385668|Microscopic Polyangiitis|microscopic polyangiitis
29832|NCT03385668|Interstitial lung disease|interstitial lung disease
29833|NCT03385629|Dental Care|dental care
29834|NCT03385629|Dental Caries|dental caries
29835|NCT03385629|Common Sense Model of Self-Regulation|common sense model of self-regulation
29836|NCT03385590|healthy|healthy
29837|NCT03385551|Vulvovaginal Atrophy|vulvovaginal atrophy
29838|NCT03385525|Healthy Volunteer|healthy volunteer
29839|NCT03385512|Virtual standardized patient coaching|virtual standardized patient coaching
29840|NCT03385512|Standardized patient instructor coaching|standardized patient instructor coaching
29841|NCT03385512|Patient centered communication|patient centered communication
29842|NCT03385499|Congenital toxoplasmosis|congenital toxoplasmosis
29843|NCT03385499|Neonatal biological diagnosis of congenital toxoplasmosis|neonatal biological diagnosis of congenital toxoplasmosis
29844|NCT03385499|neonatal diagnosis|neonatal diagnosis
29845|NCT03385499|ELISPOT|elispot
29846|NCT03385499|IgG|igg
29847|NCT03385486|Melanoma|melanoma
29848|NCT03385486|Resistant|resistant
29849|NCT03385486|Refractory|refractory
29850|NCT03385460|Overactive bladder|overactive bladder
29851|NCT03385460|Botulinum Toxin|botulinum toxin
29852|NCT03385460|low energy shock waves|low energy shock waves
29853|NCT03385460|Intravesical|intravesical
29854|NCT03385434|Colonoscopy; adenoma detection rate; endorings-2; endorings; device-assisted colonoscopy|colonoscopy; adenoma detection rate; endorings-2; endorings; device-assisted colonoscopy
29855|NCT03385369|MEDI0382|medi0382
29856|NCT03385369|Safety|safety
29857|NCT03385369|Tolerability|tolerability
29858|NCT03385369|Pharmacokinetics|pharmacokinetics
29859|NCT03385369|Immunogenicity|immunogenicity
29860|NCT03385330|BPD|bpd
29861|NCT03385330|Prematurity|prematurity
29862|NCT03385330|Supplemental Oxygen|supplemental oxygen
29863|NCT03385330|Oximetry|oximetry
29864|NCT03385330|Infants|infants
29865|NCT03385304|Surgical Site Infection|surgical site infection
29866|NCT03385304|Open Fracture|open fracture
29867|NCT03385304|Povidone-iodine|povidone-iodine
29868|NCT03385304|Chlorhexidine gluconate|chlorhexidine gluconate
29869|NCT03385304|Peri-operative Preparation Solutions|peri-operative preparation solutions
29870|NCT03385291|EEG;DOC;auditory|eeg;doc;auditory
29871|NCT03385278|TMS;DOC|tms;doc
29872|NCT03385252|complementary feeding|complementary feeding
29873|NCT03385252|eggs|eggs
29874|NCT03385252|infant growth|infant growth
29875|NCT03385252|stunting|stunting
29876|NCT03385252|cognitive development|cognitive development
29877|NCT03385252|choline|choline
29878|NCT03385252|vitamin B12|vitamin b12
29879|NCT03385252|microbiome|microbiome
29880|NCT03385239|AKCEA-APOCIII-LRx|akcea-apociii-lrx
29881|NCT03385239|IONIS-APOCIII-LRx|ionis-apociii-lrx
29882|NCT03385239|Dyslipidemia|dyslipidemia
29883|NCT03385239|Metabolic Disease|metabolic disease
29884|NCT03385239|Hyperlipidemia|hyperlipidemia
29885|NCT03385239|Cardiac Disease|cardiac disease
29886|NCT03385239|Lipid Metabolism Disorders|lipid metabolism disorders
29887|NCT03385239|Triglycerides High|triglycerides high
29888|NCT03385239|Vascular Diseases|vascular diseases
29889|NCT03385226|Relapsed|relapsed
29890|NCT03385226|Refractory|refractory
29891|NCT03385213|Microbiota|microbiota
29892|NCT03385213|colorectal cancer|colorectal cancer
29893|NCT03385213|relapse|relapse
29894|NCT03385213|surveillance|surveillance
29895|NCT03385200|breast cancer, neoadjuvant chemotherapy, ultrasound, microbubbles|breast cancer, neoadjuvant chemotherapy, ultrasound, microbubbles
29896|NCT03385161|ethanol ablation of the prostate|ethanol ablation of the prostate
29897|NCT03385161|Benign prostatic hyperplasia (BPH)|benign prostatic hyperplasia (bph)
29898|NCT03385161|Prostate|prostate
29899|NCT03385161|Ethanol|ethanol
29900|NCT03385161|Transrectal|transrectal
29901|NCT03385161|BPH|bph
29902|NCT03385161|onaBoNT-A|onabont-a
29903|NCT03385161|Botox|botox
29904|NCT03385161|Lower urinary tract symptoms|lower urinary tract symptoms
29905|NCT03385161|Botulinum toxin|botulinum toxin
29906|NCT03385161|OnabotulinumtoxinA|onabotulinumtoxina
29907|NCT03385161|Quality of life|quality of life
29908|NCT03385161|IPSS|ipss
29909|NCT03385161|Randomised controlled study|randomised controlled study
29910|NCT03385135|allopurinol|allopurinol
29911|NCT03385135|coronary artery disease|coronary artery disease
29912|NCT03385135|diabetes|diabetes
29913|NCT03385135|endothelial function|endothelial function
29914|NCT03385122|Cardiovascular disease|cardiovascular disease
29915|NCT03385109|Robotic|robotic
29916|NCT03385109|Laparoscopic|laparoscopic
29917|NCT03385044|Endotracheal tube|endotracheal tube
29918|NCT03385044|Intracuff pressure|intracuff pressure
29919|NCT03385044|Minimal occlusive volume technique|minimal occlusive volume technique
29920|NCT03385044|Spirometer|spirometer
29921|NCT03385044|Endotracheal sealing|endotracheal sealing
29922|NCT03385031|Dose-guided radiation therapy|dose-guided radiation therapy
29923|NCT03385031|CBCT|cbct
29924|NCT03385005|Physical and Rehabilitation Medicine|physical and rehabilitation medicine
29925|NCT03385005|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
29926|NCT03385005|Healthy Volunteer|healthy volunteer
29927|NCT03385005|Spinal Cord Injury|spinal cord injury
29928|NCT03385005|Biomedical Engineering|biomedical engineering
29929|NCT03384992|Fear of Cancer Recurrence|fear of cancer recurrence
29930|NCT03384992|ehealth interventions|ehealth interventions
29931|NCT03384992|PROMIS|promis
29932|NCT03384992|FoR|for
29933|NCT03384940|Oncology|oncology
29934|NCT03384940|HER2|her2
29935|NCT03384940|Colorectal cancer|colorectal cancer
29936|NCT03384940|Antibody drug conjugate|antibody drug conjugate
29937|NCT03384940|ADC|adc
29938|NCT03384927|Treatment diary|treatment diary
29939|NCT03384914|axillary nodes|axillary nodes
29940|NCT03384914|HER-2 directed treatment|her-2 directed treatment
29941|NCT03384888|Fibromyalgia, Neurostimulation, TDCS|fibromyalgia, neurostimulation, tdcs
29942|NCT03384875|CytoSorb device|cytosorb device
29943|NCT03384875|Plasma free hemoglobin|plasma free hemoglobin
29944|NCT03384875|inflammation|inflammation
29945|NCT03384875|extracorporeal cardiopulmonary bypass|extracorporeal cardiopulmonary bypass
29946|NCT03384875|cardiopulmonary bypass|cardiopulmonary bypass
29947|NCT03384875|Acute Kidney Injury|acute kidney injury
29948|NCT03384862|Arsenic exposure|arsenic exposure
29949|NCT03384849|Fiber-optic sensor system|fiber-optic sensor system
29950|NCT03384849|Magnetic resonance imaging|magnetic resonance imaging
29951|NCT03384849|Medical monitoring|medical monitoring
29952|NCT03384849|Physiological parameters|physiological parameters
29953|NCT03384836|Melanoma|melanoma
29954|NCT03384836|Immune Checkpoint Inhibitors|immune checkpoint inhibitors
29955|NCT03384836|Beta Adrenergic Blockers|beta adrenergic blockers
29956|NCT03384823|First-in-Human|first-in-human
29957|NCT03384823|Single Ascending Dose|single ascending dose
29958|NCT03384823|Multiple Ascending Dose|multiple ascending dose
29959|NCT03384810|CPR|cpr
29960|NCT03384810|cardiac arrest|cardiac arrest
29961|NCT03384810|inhospital|inhospital
29962|NCT03384797|blood|blood
29963|NCT03384797|biomarker|biomarker
29964|NCT03384797|Parkinson's disease|parkinson's disease
29965|NCT03384784|HIV|hiv
29966|NCT03384784|Neurocognition|neurocognition
29967|NCT03384784|Inflammation|inflammation
29968|NCT03384784|Galantamine|galantamine
29969|NCT03384784|Nicotine|nicotine
29970|NCT03384784|Tobacco Use|tobacco use
29971|NCT03384771|mindfulness, MBSR, teaching|mindfulness, mbsr, teaching
29972|NCT03384758|Compression therapy|compression therapy
29973|NCT03384758|Microcirculation|microcirculation
29974|NCT03384758|Diabetes mellitus|diabetes mellitus
29975|NCT03384758|Peripheral Arterial Disease|peripheral arterial disease
29976|NCT03384732|community-dwelling elderly|community-dwelling elderly
29977|NCT03384732|ICF|icf
29978|NCT03384732|core set development|core set development
29979|NCT03384732|geriatric|geriatric
29980|NCT03384732|functioning|functioning
29981|NCT03384732|health|health
29982|NCT03384732|ageing|ageing
29983|NCT03384719|Growth factor|growth factor
29984|NCT03384719|Protein|protein
29985|NCT03384719|Milk protein|milk protein
29986|NCT03384719|Plant protein|plant protein
29987|NCT03384719|Insulin-like growth factor-1 (IGF-1)|insulin-like growth factor-1 (igf-1)
29988|NCT03384719|Insulin|insulin
29989|NCT03384719|Insulin-like growth factor-binding protein-3 (IGFBP-3)|insulin-like growth factor-binding protein-3 (igfbp-3)
29990|NCT03384706|posttraumatic stress disorder (PTSD)|posttraumatic stress disorder (ptsd)
29991|NCT03384706|Clinical Trial|clinical trial
29992|NCT03384706|Psychotherapy|psychotherapy
29993|NCT03384706|Assessment|assessment
29994|NCT03384706|Effectiveness|effectiveness
29995|NCT03384693|hematopoeitic stem cell transplant|hematopoeitic stem cell transplant
29996|NCT03384693|prophylactic defibrotide|prophylactic defibrotide
29997|NCT03384667|Maekmoondong-tang|maekmoondong-tang
29998|NCT03384667|Mai-men-dong-tang|mai-men-dong-tang
29999|NCT03384667|Bakumondo-to|bakumondo-to
30000|NCT03384628|Contact lens|contact lens
30001|NCT03384628|The Young Theory|the young theory
30002|NCT03384602|subjective cognitive decline|subjective cognitive decline
30003|NCT03384602|falls prevention|falls prevention
30004|NCT03384602|cognitive function|cognitive function
30005|NCT03384602|dalcroze eurhythmics|dalcroze eurhythmics
30006|NCT03384602|home exercise program|home exercise program
30007|NCT03384602|seniors|seniors
30008|NCT03384576|Music|music
30009|NCT03384576|Emergency|emergency
30010|NCT03384576|caregivers|caregivers
30011|NCT03384563|pediatric|pediatric
30012|NCT03384563|anesthesia|anesthesia
30013|NCT03384563|dexmedetomidine|dexmedetomidine
30014|NCT03384537|intra-oral microorganisms.|intra-oral microorganisms.
30015|NCT03384537|cariogenic microorganisms|cariogenic microorganisms
30016|NCT03384511|RGD PET-CT|rgd pet-ct
30017|NCT03384511|Apatinib|apatinib
30018|NCT03384498|Genetic epidemiology|genetic epidemiology
30019|NCT03384498|Antimalarial drug resistance|antimalarial drug resistance
30020|NCT03384472|Malaria Genetic Surveillance|malaria genetic surveillance
30021|NCT03384472|Cambodia|cambodia
30022|NCT03384459|vitiligo|vitiligo
30023|NCT03384459|308-nm excimer laser|308-nm excimer laser
30024|NCT03384459|maintenance therapy|maintenance therapy
30025|NCT03384459|recurrence|recurrence
30026|NCT03384420|Autologous stem cell transplantation|autologous stem cell transplantation
30027|NCT03384355|varicose veins|varicose veins
30028|NCT03384355|chronic venous disease|chronic venous disease
30029|NCT03384355|ecchymosis|ecchymosis
30030|NCT03384355|symptoms|symptoms
30031|NCT03384316|Combination Vaccine|combination vaccine
30032|NCT03384316|Adenoviral|adenoviral
30033|NCT03384316|ETBX-011|etbx-011
30035|NCT03384316|ETBX-051|etbx-051
30036|NCT03384303|Incretines|incretines
30037|NCT03384303|Bile acids|bile acids
30038|NCT03384303|Gut hormones|gut hormones
30039|NCT03384303|Limb lengths|limb lengths
30040|NCT03384303|Biliopancreatic limb|biliopancreatic limb
30041|NCT03384303|Bariatric surgery|bariatric surgery
30042|NCT03384303|Gastric bypass|gastric bypass
30043|NCT03384290|Asthma|asthma
30044|NCT03384290|Anticalin|anticalin
30045|NCT03384290|PRS-060|prs-060
30046|NCT03384290|Healthy Volunteers|healthy volunteers
30047|NCT03384290|Pieris|pieris
30048|NCT03384290|IL-4 receptor alpha|il-4 receptor alpha
30049|NCT03384290|IL-13|il-13
30050|NCT03384290|IL-4|il-4
30051|NCT03384277|Acquired hemophilia A|acquired hemophilia a
30052|NCT03384277|Cyclophosphamide|cyclophosphamide
30053|NCT03384277|Rituximab|rituximab
30054|NCT03384277|Steroid|steroid
30055|NCT03384251|Adolescent pregnancy|adolescent pregnancy
30056|NCT03384251|Teenage pregnancy|teenage pregnancy
30057|NCT03384251|Prevention|prevention
30058|NCT03384251|Ghana|ghana
30059|NCT03384225|cladribine|cladribine
30060|NCT03384225|fludarabine|fludarabine
30061|NCT03384225|relapse|relapse
30062|NCT03384212|cladribine|cladribine
30063|NCT03384212|fludarabine|fludarabine
30064|NCT03384212|relapse|relapse
30065|NCT03384199|Localized Prostate|localized prostate
30066|NCT03384199|VMAT|vmat
30067|NCT03384199|Dose escalation|dose escalation
30068|NCT03384199|Fiducial marker|fiducial marker
30069|NCT03384199|Focal Lesion|focal lesion
30070|NCT03384199|Random error during dose escalation radiotherapy|random error during dose escalation radiotherapy
30071|NCT03384199|fiducial marker image guided technique|fiducial marker image guided technique
30072|NCT03384173|Near Infrared Spectroscopy|near infrared spectroscopy
30073|NCT03384173|Creatinine|creatinine
30074|NCT03384173|Urine Output|urine output
30075|NCT03384160|Pain|pain
30076|NCT03384160|Third molar|third molar
30077|NCT03384160|Articaine|articaine
30078|NCT03384160|Mepivacaine|mepivacaine
30079|NCT03384134|cancer|cancer
30080|NCT03384134|cognitive and behavioral skills training intervention|cognitive and behavioral skills training intervention
30081|NCT03384134|pain|pain
30082|NCT03384134|symptoms|symptoms
30083|NCT03384134|quality of life|quality of life
30084|NCT03384121|CYP24A1|cyp24a1
30085|NCT03384121|Nephrocalcinosis|nephrocalcinosis
30086|NCT03384121|Hypercalcemia|hypercalcemia
30087|NCT03384121|Hypercalcuria|hypercalcuria
30088|NCT03384095|Aromatase Inhibitors|aromatase inhibitors
30089|NCT03384069|Cognitive Impairment|cognitive impairment
30090|NCT03384069|Cognitive- behavioral therapy|cognitive- behavioral therapy
30091|NCT03384069|African Americans|african americans
30092|NCT03384030|Malodor|malodor
30093|NCT03384030|Stress|stress
30094|NCT03384030|STMST|stmst
30095|NCT03384004|Root Canal Treatment|root canal treatment
30096|NCT03383991|Humeral Fracture, Proximal|humeral fracture, proximal
30097|NCT03383991|Arthroplasty, Replacement, Shoulder|arthroplasty, replacement, shoulder
30098|NCT03383991|Reverse Total Shoulder Arthroplasty|reverse total shoulder arthroplasty
30099|NCT03383991|Shoulder Hemiarthroplasty|shoulder hemiarthroplasty
30100|NCT03383939|bronchiectasis|bronchiectasis
30101|NCT03383939|alpha1-antitrypsin|alpha1-antitrypsin
30102|NCT03383939|neutrophilic elastase|neutrophilic elastase
30103|NCT03383926|Longo|longo
30104|NCT03383926|Hemorrhoids|hemorrhoids
30105|NCT03383926|Rectal|rectal
30106|NCT03383926|Prolapse|prolapse
30107|NCT03383926|Anal|anal
30108|NCT03383913|Heart Rate Variability Biofeedback|heart rate variability biofeedback
30109|NCT03383835|Omega 3 supplement|omega 3 supplement
30110|NCT03383835|pre-menopausal|pre-menopausal
30111|NCT03383835|pregnancy|pregnancy
30112|NCT03383809|Self-reported healthy adults|self-reported healthy adults
30113|NCT03383796|Cholangiocarcinoma perihilar|cholangiocarcinoma perihilar
30114|NCT03383796|three dimension laparoscopic|three dimension laparoscopic
30115|NCT03383783|Caries|caries
30116|NCT03383731|Operation mode|operation mode
30117|NCT03383731|Air tamponade|air tamponade
30118|NCT03383731|High myopia|high myopia
30119|NCT03383731|Macular hole retinal detachment|macular hole retinal detachment
30120|NCT03383718|Coronary Artery Disease|coronary artery disease
30121|NCT03383718|Fractional Flow Reserve|fractional flow reserve
30122|NCT03383718|Dobutamine Stress Echocardiography|dobutamine stress echocardiography
30123|NCT03383718|Stable Coronary Artery Disease|stable coronary artery disease
30124|NCT03383718|Bystander Coronary Artery Disease|bystander coronary artery disease
30125|NCT03383718|Non-Culprit Lesions|non-culprit lesions
30126|NCT03383718|Acute Myocardial Infarction|acute myocardial infarction
30127|NCT03383705|Photoaged Skin|photoaged skin
30128|NCT03383692|Unresectable or metastatic solid malignant tumors|unresectable or metastatic solid malignant tumors
30129|NCT03383692|Solid malignant tumors|solid malignant tumors
30130|NCT03383692|Oncology|oncology
30131|NCT03383692|HER2|her2
30132|NCT03383692|Antibody drug conjugate|antibody drug conjugate
30133|NCT03383692|ADC|adc
30134|NCT03383666|Unruptured|unruptured
30330|NCT03382522|prognosis|prognosis
30135|NCT03383666|intracranial aneurysms|intracranial aneurysms
30136|NCT03383666|Endovascular|endovascular
30137|NCT03383653|Td Vaccine|td vaccine
30138|NCT03383653|Safety|safety
30139|NCT03383653|Pregnant|pregnant
30140|NCT03383653|Pregnant Women|pregnant women
30141|NCT03383627|Chronic Kidney Disease|chronic kidney disease
30142|NCT03383601|COPD|copd
30143|NCT03383601|Exacerbation of respiratory symptoms|exacerbation of respiratory symptoms
30144|NCT03383601|Functional exercise capacity|functional exercise capacity
30145|NCT03383601|Heated Tobacco Products|heated tobacco products
30146|NCT03383601|Respiratory symptoms|respiratory symptoms
30147|NCT03383575|Myelodysplastic Syndrome|myelodysplastic syndrome
30148|NCT03383575|MDS|mds
30149|NCT03383575|Enasidenib|enasidenib
30150|NCT03383575|AG-221|ag-221
30151|NCT03383575|IDHIFA|idhifa
30152|NCT03383575|Azacitidine|azacitidine
30153|NCT03383575|5-Azacytidine|5-azacytidine
30154|NCT03383575|Azacytidine|azacytidine
30155|NCT03383575|5-aza|5-aza
30156|NCT03383575|Vidaza|vidaza
30157|NCT03383575|5-AZC|5-azc
30158|NCT03383575|AZA-CR|aza-cr
30159|NCT03383575|Ladakamycin|ladakamycin
30160|NCT03383575|NSC-102816|nsc-102816
30161|NCT03383549|Telerehabilitation [E02.831.891]|telerehabilitation [e02.831.891]
30162|NCT03383549|Cognitive Aging [G07.345.124.260]|cognitive aging [g07.345.124.260]
30163|NCT03383549|Exercise Therapy [E02.760.169.063.500.387]|exercise therapy [e02.760.169.063.500.387]
30164|NCT03383536|fMRI|fmri
30165|NCT03383536|stress|stress
30166|NCT03383536|peptide|peptide
30167|NCT03383536|social|social
30168|NCT03383536|neuroimaging|neuroimaging
30169|NCT03383484|polycystic ovary syndrome|polycystic ovary syndrome
30170|NCT03383484|hyperandrogenism|hyperandrogenism
30171|NCT03383484|nonpharmacological|nonpharmacological
30172|NCT03383484|yoga|yoga
30173|NCT03383484|osteopathic manipulative medicine|osteopathic manipulative medicine
30174|NCT03383471|chondrocyte cells|chondrocyte cells
30175|NCT03383471|osteoarthritis|osteoarthritis
30176|NCT03383471|gene therapy|gene therapy
30177|NCT03383419|Heart Failure, Heart Transplant|heart failure, heart transplant
30178|NCT03383380|Activated PI3K-delta Syndrome|activated pi3k-delta syndrome
30179|NCT03383380|Immunodeficiency Primary|immunodeficiency primary
30180|NCT03383380|Akt/mTOR pathway|akt/mtor pathway
30181|NCT03383380|Rapamycin Therapy|rapamycin therapy
30182|NCT03383380|Hyperphosphorylation|hyperphosphorylation
30183|NCT03383367|mass screening|mass screening
30184|NCT03383367|colonoscopy surveillance|colonoscopy surveillance
30185|NCT03383367|high risk patients|high risk patients
30186|NCT03383341|gut microbiota|gut microbiota
30187|NCT03383341|cricket powder|cricket powder
30188|NCT03383341|prebiotic fiber|prebiotic fiber
30189|NCT03383341|inflammation|inflammation
30190|NCT03383341|dietary intervention|dietary intervention
30191|NCT03383328|Cataract|cataract
30192|NCT03383328|Cataract Surgery|cataract surgery
30193|NCT03383302|Non-small cell lung cancer|non-small cell lung cancer
30194|NCT03383302|NSCLC|nsclc
30195|NCT03383263|Humira®|humira®
30196|NCT03383263|polyarticular juvenile arthritis|polyarticular juvenile arthritis
30197|NCT03383263|Adalimumab|adalimumab
30198|NCT03383250|meal ingestion|meal ingestion
30199|NCT03383250|postprandial sensations|postprandial sensations
30200|NCT03383250|circulating metabolites|circulating metabolites
30201|NCT03383224|smoking cessation treatment|smoking cessation treatment
30202|NCT03383211|RNAseq|rnaseq
30203|NCT03383211|Next Generation Sequencing|next generation sequencing
30204|NCT03383211|Transcriptome|transcriptome
30205|NCT03383211|Peripheral blood transcripts|peripheral blood transcripts
30206|NCT03383211|Tempus Blood RNA Tubes|tempus blood rna tubes
30207|NCT03383185|contraception|contraception
30208|NCT03383185|Body mass index|body mass index
30209|NCT03383185|Metabolic Syndrome|metabolic syndrome
30210|NCT03383185|obesity|obesity
30211|NCT03383172|Prevention|prevention
30212|NCT03383172|Promotion|promotion
30213|NCT03383172|Mental Health|mental health
30214|NCT03383159|Microbiota|microbiota
30215|NCT03383159|Metachronous Adenoma|metachronous adenoma
30216|NCT03383159|Colorectal Cancer|colorectal cancer
30217|NCT03383159|Colonoscopy|colonoscopy
30218|NCT03383146|diabetic gastroparesis|diabetic gastroparesis
30219|NCT03383146|vomiting|vomiting
30220|NCT03383133|sulfotransferase|sulfotransferase
30221|NCT03383133|metabolism|metabolism
30222|NCT03383133|acetaminophen|acetaminophen
30223|NCT03383133|dehydroepiandrosterone|dehydroepiandrosterone
30224|NCT03383133|mefenamic acid|mefenamic acid
30225|NCT03383133|allostery|allostery
30226|NCT03383120|Peri-implantitis|peri-implantitis
30227|NCT03383120|Diode laser|diode laser
30228|NCT03383120|Surgical debridement|surgical debridement
30229|NCT03383094|cancer|cancer
30230|NCT03383094|Head and Neck|head and neck
30231|NCT03383094|Pembrolizumab|pembrolizumab
30232|NCT03383094|Cisplatin|cisplatin
30233|NCT03383094|Radiotherapy|radiotherapy
30234|NCT03383094|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
30235|NCT03383094|p16+|p16+
30236|NCT03383081|osteoarthritis, mesenchymal stem cell|osteoarthritis, mesenchymal stem cell
30237|NCT03383068|PCOS|pcos
30238|NCT03383068|imparied glucose tolerance|imparied glucose tolerance
30239|NCT03383029|Nutrition|nutrition
30240|NCT03383029|Behavioral|behavioral
30241|NCT03383016|Prostate cancer risk|prostate cancer risk
30242|NCT03383016|Environmental risk factors|environmental risk factors
30243|NCT03383016|Biomarkers|biomarkers
30244|NCT03383016|Inflammation and prostate cancer|inflammation and prostate cancer
30245|NCT03383003|Helicobacter pylori eradication|helicobacter pylori eradication
30246|NCT03383003|High dose proton pump inhibitor|high dose proton pump inhibitor
30247|NCT03383003|High dose Amoxicillin|high dose amoxicillin
30248|NCT03383003|Concomitant therapy|concomitant therapy
30249|NCT03382990|Atrial fibrillation|atrial fibrillation
30250|NCT03382990|Acute myocardial infarction|acute myocardial infarction
30251|NCT03382990|Drug-eluting stent|drug-eluting stent
30252|NCT03382977|GBM|gbm
30253|NCT03382977|Glioblastoma|glioblastoma
30254|NCT03382977|eVLP|evlp
30255|NCT03382977|VBI-1901|vbi-1901
30256|NCT03382977|vaccine|vaccine
30257|NCT03382977|immunotherapy|immunotherapy
30258|NCT03382977|CMV|cmv
30259|NCT03382977|CNS|cns
30260|NCT03382977|Brain|brain
30261|NCT03382977|Cancer|cancer
30262|NCT03382964|VLA1553|vla1553
30263|NCT03382964|Chikungunya|chikungunya
30264|NCT03382964|CHIKV|chikv
30265|NCT03382964|Live-attenuated Chikungunya virus vaccine|live-attenuated chikungunya virus vaccine
30266|NCT03382938|dexmedetomidine|dexmedetomidine
30267|NCT03382938|ropivacaine|ropivacaine
30268|NCT03382938|wound infiltration|wound infiltration
30269|NCT03382938|ceasarean section|ceasarean section
30270|NCT03382925|cervical epidural steroid injection|cervical epidural steroid injection
30271|NCT03382925|local anesthetic|local anesthetic
30272|NCT03382925|upper extremity weakness|upper extremity weakness
30273|NCT03382886|Advanced and/or metastatic|advanced and/or metastatic
30274|NCT03382873|Hyperglycemia|hyperglycemia
30275|NCT03382873|Obese|obese
30276|NCT03382873|Overweight|overweight
30277|NCT03382860|Intracranial Hypertension|intracranial hypertension
30278|NCT03382860|Intracranial pressure monitoring|intracranial pressure monitoring
30279|NCT03382860|Non-invasive point-of-care device|non-invasive point-of-care device
30280|NCT03382860|Normal pressure hydrocephalus|normal pressure hydrocephalus
30281|NCT03382821|cervical epidural steroid injection|cervical epidural steroid injection
30282|NCT03382821|transforaminal approach|transforaminal approach
30283|NCT03382821|epidural catheter targeted|epidural catheter targeted
30284|NCT03382821|interlaminar approach|interlaminar approach
30285|NCT03382821|cervical radicular pain|cervical radicular pain
30286|NCT03382795|Epidermal growth factor receptor tyrosine kinase inhibitor|epidermal growth factor receptor tyrosine kinase inhibitor
30287|NCT03382795|Cytotoxic chemotherapy|cytotoxic chemotherapy
30288|NCT03382795|Epidermal growth factor receptor mutation|epidermal growth factor receptor mutation
30289|NCT03382782|Obesity|obesity
30290|NCT03382782|Mental Disorder|mental disorder
30291|NCT03382782|Peer Navigator|peer navigator
30292|NCT03382782|Physical Health|physical health
30293|NCT03382782|Overweight|overweight
30294|NCT03382782|Serious Mental Illness|serious mental illness
30295|NCT03382743|office hysteroscopy|office hysteroscopy
30296|NCT03382743|Lidocaine spray|lidocaine spray
30297|NCT03382704|Peri-ocular|peri-ocular
30298|NCT03382678|Eosinophilic Gastrointestinal Disorders|eosinophilic gastrointestinal disorders
30299|NCT03382665|Revision total hip arthroplasty|revision total hip arthroplasty
30300|NCT03382665|Medical Device|medical device
30301|NCT03382665|Post Market Surveillance Study|post market surveillance study
30302|NCT03382665|Primary total hip arthroplasty|primary total hip arthroplasty
30303|NCT03382652|Total hip arthroplasty|total hip arthroplasty
30304|NCT03382652|Medical Device|medical device
30305|NCT03382652|Post Market Surveillance Study|post market surveillance study
30306|NCT03382652|Performance|performance
30307|NCT03382652|Safety|safety
30308|NCT03382639|Drug therapy|drug therapy
30309|NCT03382626|Traumatic Brain Injury|traumatic brain injury
30310|NCT03382626|Transcranial Direct Current Stimulation|transcranial direct current stimulation
30311|NCT03382626|Computer-assisted training|computer-assisted training
30312|NCT03382626|Cognitive training|cognitive training
30313|NCT03382626|Cognitive function|cognitive function
30314|NCT03382626|Executive function|executive function
30315|NCT03382626|Working memory|working memory
30316|NCT03382626|Attention|attention
30317|NCT03382548|Ventilator Associated Pneumonia|ventilator associated pneumonia
30318|NCT03382548|Pneumonia|pneumonia
30319|NCT03382535|Voice disorder|voice disorder
30320|NCT03382535|Teacher's voice|teacher's voice
30321|NCT03382535|Voice SPL (Voice sound pressure level)|voice spl (voice sound pressure level)
30322|NCT03382535|Voice F0 (Voice fundamental frequency)|voice f0 (voice fundamental frequency)
30323|NCT03382535|Voice therapy|voice therapy
30324|NCT03382535|Voice accumulator|voice accumulator
30325|NCT03382535|Activity noise|activity noise
30326|NCT03382535|Classroom|classroom
30327|NCT03382522|bone scintigraphy|bone scintigraphy
30328|NCT03382522|quantification|quantification
30329|NCT03382522|prostate cancer|prostate cancer
30331|NCT03382457|Functional|functional
30332|NCT03382457|TR|tr
30333|NCT03382457|FTR|ftr
30334|NCT03382457|Transcatheter|transcatheter
30335|NCT03382457|Reconstruction|reconstruction
30336|NCT03382444|cognitive impairment|cognitive impairment
30337|NCT03382444|hemodialysis|hemodialysis
30338|NCT03382444|dementia|dementia
30339|NCT03382444|end stage renal disease|end stage renal disease
30340|NCT03382405|cytomegalovirus vaccine|cytomegalovirus vaccine
30341|NCT03382405|mRNA-1647|mrna-1647
30342|NCT03382405|mRNA-1443|mrna-1443
30343|NCT03382392|Amyotrophic lateral sclerosis,|amyotrophic lateral sclerosis,
30344|NCT03382392|Resting energy expenditure|resting energy expenditure
30345|NCT03382392|Predictive equation|predictive equation
30346|NCT03382379|methamphetamine|methamphetamine
30347|NCT03382379|transcranial Direct Current Stimulation|transcranial direct current stimulation
30348|NCT03382379|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
30349|NCT03382379|amphetamine|amphetamine
30350|NCT03382379|drug craving|drug craving
30351|NCT03382366|Sarcopenia|sarcopenia
30352|NCT03382366|Risk of fall|risk of fall
30353|NCT03382366|Osteoporosis|osteoporosis
30354|NCT03382366|Muscle|muscle
30355|NCT03382366|DXA|dxa
30356|NCT03382366|MR|mr
30357|NCT03382366|Muscle metabolism|muscle metabolism
30358|NCT03382353|primary prevention|primary prevention
30359|NCT03382353|Subjective Cognitive Decline|subjective cognitive decline
30360|NCT03382353|Neuroimaging|neuroimaging
30361|NCT03382353|Alzheimer's disease|alzheimer's disease
30362|NCT03382353|nonpharmacological interventions|nonpharmacological interventions
30363|NCT03382353|multidomain lifestyle interventions|multidomain lifestyle interventions
30364|NCT03382327|Surgical planning|surgical planning
30365|NCT03382327|CT-scan|ct-scan
30366|NCT03382327|MRI|mri
30367|NCT03382327|3D model|3d model
30368|NCT03382327|Hepatocarcinoma eligible for surgical resection|hepatocarcinoma eligible for surgical resection
30369|NCT03382301|Ischemia reperfusion injuries|ischemia reperfusion injuries
30370|NCT03382301|Renal artery stenosis|renal artery stenosis
30371|NCT03382301|Renal functional imaging|renal functional imaging
30372|NCT03382262|Osteoarthritis|osteoarthritis
30373|NCT03382262|Shoulder|shoulder
30374|NCT03382262|Hip|hip
30375|NCT03382262|Pain|pain
30376|NCT03382262|Intra-articular|intra-articular
30377|NCT03382262|Injection|injection
30378|NCT03382262|Corticosteroid|corticosteroid
30379|NCT03382210|Enhanced Recovery Program|enhanced recovery program
30380|NCT03382197|aerosol therapy|aerosol therapy
30381|NCT03382197|positive pressure|positive pressure
30382|NCT03382197|electrical impedance tomography|electrical impedance tomography
30383|NCT03382197|pulmonary scintigraphy|pulmonary scintigraphy
30384|NCT03382158|pleuropulmonary blastoma|pleuropulmonary blastoma
30385|NCT03382158|PPB|ppb
30386|NCT03382158|DICER1|dicer1
30387|NCT03382158|Sertoli-Leydig cell tumor|sertoli-leydig cell tumor
30388|NCT03382158|cystic nephroma|cystic nephroma
30389|NCT03382119|liver stiffness Fontan|liver stiffness fontan
30390|NCT03382093|Anxiety Sensitivity|anxiety sensitivity
30391|NCT03382093|Tobacco|tobacco
30392|NCT03382093|Smoking|smoking
30393|NCT03382093|Anxiety|anxiety
30394|NCT03382093|Feedback|feedback
30395|NCT03382093|Stress|stress
30396|NCT03382080|randomized controlled trial|randomized controlled trial
30397|NCT03382080|drop out|drop out
30398|NCT03382080|upper secondary school|upper secondary school
30399|NCT03382080|psychosocial learning environments|psychosocial learning environments
30400|NCT03382028|developmental abnormalities|developmental abnormalities
30401|NCT03382028|psychomotor development|psychomotor development
30402|NCT03381989|TAVR|tavr
30403|NCT03381989|Native Aortic Valve Failure|native aortic valve failure
30404|NCT03381989|TAVR Associated Coronary Artery Obstruction|tavr associated coronary artery obstruction
30405|NCT03381989|Electrosurgery|electrosurgery
30406|NCT03381963|tamoxifen|tamoxifen
30407|NCT03381963|aromatase inhibitors|aromatase inhibitors
30408|NCT03381963|breast cancer|breast cancer
30409|NCT03381963|venous thromboembolism|venous thromboembolism
30410|NCT03381950|chronic kidney disease|chronic kidney disease
30411|NCT03381950|prospective cohort study|prospective cohort study
30412|NCT03381950|risk profile|risk profile
30413|NCT03381950|patient-reported-outcomes|patient-reported-outcomes
30414|NCT03381937|mechanical ventilation|mechanical ventilation
30415|NCT03381937|noninvasive ventilation|noninvasive ventilation
30416|NCT03381937|neuromuscular disorder|neuromuscular disorder
30417|NCT03381937|phonation|phonation
30418|NCT03381937|mouthpiece ventilation|mouthpiece ventilation
30419|NCT03381924|Migraine disorders|migraine disorders
30420|NCT03381924|Educational models|educational models
30421|NCT03381924|Neuroscience|neuroscience
30422|NCT03381898|Telehealth|telehealth
30423|NCT03381898|Physical therapy exercise|physical therapy exercise
30424|NCT03381898|Speech therapy Lee Silverman voice treatment|speech therapy lee silverman voice treatment
30425|NCT03381898|Pharmacy medication management|pharmacy medication management
30426|NCT03381872|Intravascular Imaging|intravascular imaging
30427|NCT03381872|Intravascular Ultrasound|intravascular ultrasound
30428|NCT03381872|Optical Coherence Tomography|optical coherence tomography
30429|NCT03381872|Complex Lesion|complex lesion
30430|NCT03381872|Percutaneous Coronary Intervention|percutaneous coronary intervention
30431|NCT03381859|Hepatitis C Virus|hepatitis c virus
30432|NCT03381859|Genotype 4|genotype 4
30433|NCT03381859|End Stage Renal Disease|end stage renal disease
30434|NCT03381820|music therapy|music therapy
30435|NCT03381820|hypertension|hypertension
30436|NCT03381820|Asian|asian
30437|NCT03381820|stage-2 hypertension|stage-2 hypertension
30438|NCT03381794|Keratoplasty Registry, PKP, DSAEK, DMEK, DALK|keratoplasty registry, pkp, dsaek, dmek, dalk
30439|NCT03381781|p53 mutation|p53 mutation
30440|NCT03381781|acute myeloid leukemia|acute myeloid leukemia
30441|NCT03381781|decitabine|decitabine
30442|NCT03381781|Arsenic trioxide|arsenic trioxide
30443|NCT03381781|cytarabine|cytarabine
30444|NCT03381768|PD-L1|pd-l1
30445|NCT03381768|PD-L2|pd-l2
30446|NCT03381768|peptide vaccine|peptide vaccine
30447|NCT03381729|Gene Transfer|gene transfer
30448|NCT03381729|Gene Therapy|gene therapy
30449|NCT03381729|Adeno-associated virus|adeno-associated virus
30450|NCT03381729|Survival Motor Neuron|survival motor neuron
30451|NCT03381729|SMN|smn
30452|NCT03381729|AAV9|aav9
30453|NCT03381716|aortic dissection|aortic dissection
30454|NCT03381716|sex|sex
30455|NCT03381716|treatment|treatment
30456|NCT03381703|Accelerated Mass Spectrometry|accelerated mass spectrometry
30457|NCT03381703|Microtracer|microtracer
30458|NCT03381703|Microdose|microdose
30459|NCT03381703|hAME|hame
30460|NCT03381703|Absolute bioavailability|absolute bioavailability
30461|NCT03381677|pedicle lengthening osteotomy|pedicle lengthening osteotomy
30462|NCT03381677|spinal stenosis|spinal stenosis
30463|NCT03381677|decompression|decompression
30464|NCT03381664|bioavailability|bioavailability
30465|NCT03381664|pharmacokinetics|pharmacokinetics
30466|NCT03381664|safety|safety
30467|NCT03381664|tolerability|tolerability
30468|NCT03381664|AVP-923|avp-923
30469|NCT03381664|dextromethorphan|dextromethorphan
30470|NCT03381664|quinidine|quinidine
30471|NCT03381651|Radiation dose|radiation dose
30472|NCT03381638|Concussion|concussion
30473|NCT03381638|TBI|tbi
30474|NCT03381638|Sports|sports
30475|NCT03381638|Medical Device|medical device
30476|NCT03381638|Fast|fast
30477|NCT03381612|Female circumcision, Young Women, Dysmenorrhea,Dysuria|female circumcision, young women, dysmenorrhea,dysuria
30478|NCT03381586|ALT-803|alt-803
30479|NCT03381586|PK|pk
30480|NCT03381560|LASSYC; COPD symptoms.|lassyc; copd symptoms.
30481|NCT03381534|vertebral artery origin|vertebral artery origin
30482|NCT03381534|angioplasty|angioplasty
30483|NCT03381534|distal embolic protection|distal embolic protection
30484|NCT03381521|nerve hydrodissection|nerve hydrodissection
30485|NCT03381508|CPAP|cpap
30486|NCT03381508|masks|masks
30487|NCT03381508|unintentional leak|unintentional leak
30488|NCT03381508|leakage|leakage
30489|NCT03381495|Epidural Labor Analgesia|epidural labor analgesia
30490|NCT03381495|length of labor stage|length of labor stage
30491|NCT03381495|fetal outcomes|fetal outcomes
30492|NCT03381495|maternal outcomes|maternal outcomes
30493|NCT03381482|Alzheimer disease|alzheimer disease
30494|NCT03381482|Extracellular vesicles|extracellular vesicles
30495|NCT03381482|Biomarker|biomarker
30496|NCT03381482|Tau|tau
30497|NCT03381482|CSF|csf
30498|NCT03381482|Plasma|plasma
30499|NCT03381404|Mass Balance Study with MT-8554|mass balance study with mt-8554
30500|NCT03381378|Vitamin D|vitamin d
30501|NCT03381378|s-25-hydroxyvitamin D|s-25-hydroxyvitamin d
30502|NCT03381378|hand grip strength|hand grip strength
30503|NCT03381378|myopathy|myopathy
30504|NCT03381378|muscle|muscle
30505|NCT03381352|Radiotherapy|radiotherapy
30506|NCT03381352|Anal cancer|anal cancer
30507|NCT03381352|IMRT|imrt
30508|NCT03381339|power toothbrush, oscillating rotating|power toothbrush, oscillating rotating
30509|NCT03381326|circulating tumor cells|circulating tumor cells
30510|NCT03381326|Castration-resistant Prostate Cancer|castration-resistant prostate cancer
30511|NCT03381326|cabazitaxel|cabazitaxel
30512|NCT03381326|biomarker|biomarker
30513|NCT03381326|free DNA|free dna
30514|NCT03381326|stem cells|stem cells
30515|NCT03381326|EMT related antigens|emt related antigens
30516|NCT03381261|chronic migraine|chronic migraine
30517|NCT03381261|trigeminal neuralgia|trigeminal neuralgia
30518|NCT03381261|migraine surgery|migraine surgery
30519|NCT03381261|nerve decompression|nerve decompression
30520|NCT03381248|randomized clinical trial|randomized clinical trial
30521|NCT03381248|osteoarthritis|osteoarthritis
30522|NCT03381248|radiofrequency ablation|radiofrequency ablation
30523|NCT03381248|knee|knee
30524|NCT03381248|genicular|genicular
30525|NCT03381248|cross-over|cross-over
30526|NCT03381248|viscosupplemention|viscosupplemention
30527|NCT03381235|Exercise|exercise
30528|NCT03381235|Quality of life|quality of life
30529|NCT03381235|Progression of disease|progression of disease
30530|NCT03381235|Retinitis|retinitis
30531|NCT03381209|Sugammadex|sugammadex
30532|NCT03381209|morbidly obese patients|morbidly obese patients
30533|NCT03381209|bariatric surgery|bariatric surgery
30534|NCT03381209|neuromuscular blockade|neuromuscular blockade
30535|NCT03381170|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
30536|NCT03381157|general movements, fidgety movements, motor optimality score|general movements, fidgety movements, motor optimality score
30537|NCT03381105|Diagnostics, over-diagnosis|diagnostics, over-diagnosis
30538|NCT03381092|neoadjuvant chemotherapy|neoadjuvant chemotherapy
30539|NCT03381092|sentinel lymph node biopsy|sentinel lymph node biopsy
30540|NCT03381092|axillary lymph node dissection|axillary lymph node dissection
30541|NCT03381092|Predictive model|predictive model
30542|NCT03381066|NSCLC|nsclc
30543|NCT03381066|EGFR|egfr
30544|NCT03381066|adjuvant|adjuvant
30545|NCT03381066|gefitinib|gefitinib
30546|NCT03381066|intercalating|intercalating
30547|NCT03381053|GIST|gist
30548|NCT03381053|Grading and Staging|grading and staging
30549|NCT03381027|Infant Sleep|infant sleep
30550|NCT03381027|Baby Massage|baby massage
30551|NCT03381027|Neurodevelopmental Disorders|neurodevelopmental disorders
30552|NCT03381001|cryopreservation|cryopreservation
30553|NCT03381001|human embryos|human embryos
30554|NCT03381001|vitrification|vitrification
30555|NCT03381001|embryo culture|embryo culture
30556|NCT03381001|embryo transfer|embryo transfer
30557|NCT03381001|pregnancy rate|pregnancy rate
30558|NCT03380975|MAAP|maap
30559|NCT03380975|Asthma|asthma
30560|NCT03380975|Allergic rhinits|allergic rhinits
30561|NCT03380962|Donor-Specific Anti-HLA Antibodies|donor-specific anti-hla antibodies
30562|NCT03380962|Kidney Transplantation|kidney transplantation
30563|NCT03380962|Donor Specific Antibody|donor specific antibody
30564|NCT03380949|Analgesia|analgesia
30565|NCT03380949|Monitoring|monitoring
30566|NCT03380949|Opioid|opioid
30567|NCT03380949|Sufentanil|sufentanil
30568|NCT03380949|Sevoflurane|sevoflurane
30569|NCT03380936|subclinical|subclinical
30570|NCT03380936|graft rejection|graft rejection
30571|NCT03380936|AMR (antibody-mediated rejection)|amr (antibody-mediated rejection)
30572|NCT03380936|AMBR (acute antibody-mediated rejection)|ambr (acute antibody-mediated rejection)
30947|NCT03378232|EPA|epa
30573|NCT03380936|DSA (donor specific antibodies)|dsa (donor specific antibodies)
30574|NCT03380923|epigenetics|epigenetics
30575|NCT03380923|exercise dose-response|exercise dose-response
30576|NCT03380923|inter-individual response heterogeneity|inter-individual response heterogeneity
30577|NCT03380923|exercise training adaptations|exercise training adaptations
30578|NCT03380897|induction of labor|induction of labor
30579|NCT03380897|double balloon catheter|double balloon catheter
30580|NCT03380897|mechanical ripening|mechanical ripening
30581|NCT03380884|Distal Radius Fracture, Osteoporosis, Vibration Therapy|distal radius fracture, osteoporosis, vibration therapy
30582|NCT03380871|Personal Vaccine|personal vaccine
30583|NCT03380871|Neoantigen|neoantigen
30584|NCT03380871|Immunotherapy|immunotherapy
30585|NCT03380871|Poly-ICLC|poly-iclc
30586|NCT03380871|Peptide|peptide
30587|NCT03380871|Checkpoint Inhibitor|checkpoint inhibitor
30588|NCT03380806|stereotactic body radiotherapy (SBRT)|stereotactic body radiotherapy (sbrt)
30589|NCT03380806|conventional radiotherapy (CRT)|conventional radiotherapy (crt)
30590|NCT03380806|High risk prostate cancer|high risk prostate cancer
30591|NCT03380806|quality of life (QoL)|quality of life (qol)
30592|NCT03380806|The Expanded Prostate cancer Index Composite (EPIC-26)|the expanded prostate cancer index composite (epic-26)
30593|NCT03380806|International Prostate Symptom Score (IPSS)|international prostate symptom score (ipss)
30594|NCT03380767|trauma-induced coagulopathy|trauma-induced coagulopathy
30595|NCT03380754|Nausea|nausea
30596|NCT03380754|Vomiting|vomiting
30597|NCT03380754|Knee Arthroplasty|knee arthroplasty
30598|NCT03380754|PONV|ponv
30599|NCT03380754|TKA|tka
30600|NCT03380715|Sinusitis|sinusitis
30601|NCT03380715|Endoscopy|endoscopy
30602|NCT03380715|Rhinitis|rhinitis
30603|NCT03380702|colour|colour
30604|NCT03380702|dental aesthetics|dental aesthetics
30605|NCT03380702|perceptions|perceptions
30606|NCT03380702|quality of life|quality of life
30607|NCT03380702|tooth whitening|tooth whitening
30608|NCT03380663|blood flow restricted resistance exercise|blood flow restricted resistance exercise
30609|NCT03380663|remote ischemic conditioning|remote ischemic conditioning
30610|NCT03380663|miRNA|mirna
30611|NCT03380650|femoropopliteal occlusive disease|femoropopliteal occlusive disease
30612|NCT03380650|directional atherectomy|directional atherectomy
30613|NCT03380650|local drug delivery|local drug delivery
30614|NCT03380650|endovascular treatment|endovascular treatment
30615|NCT03380598|Mobile Health, Self-Monitoring, Behavioural Treatment|mobile health, self-monitoring, behavioural treatment
30616|NCT03380572|Robotic Surgery|robotic surgery
30617|NCT03380559|Epicondylitis|epicondylitis
30618|NCT03380559|Botulinum toxin|botulinum toxin
30619|NCT03380559|Corticoid|corticoid
30620|NCT03380546|Diabetes|diabetes
30621|NCT03380546|Pregnancy|pregnancy
30622|NCT03380546|Gestational|gestational
30623|NCT03380546|Acarbose|acarbose
30624|NCT03380507|Septic Shock|septic shock
30625|NCT03380507|Vitamin C|vitamin c
30626|NCT03380507|Thiamine|thiamine
30627|NCT03380507|Hydrocortisone|hydrocortisone
30628|NCT03380507|Critically Ill|critically ill
30629|NCT03380494|Overhead perturbation training; instability, glenohumeral joint|overhead perturbation training; instability, glenohumeral joint
30630|NCT03380468|Lung adenocarcinoma|lung adenocarcinoma
30631|NCT03380468|adjuvant chemotherapy|adjuvant chemotherapy
30632|NCT03380442|fMRI|fmri
30633|NCT03380442|psilocybin|psilocybin
30634|NCT03380442|ketamine|ketamine
30635|NCT03380442|biomarker|biomarker
30636|NCT03380442|rapid-acting antidepressants|rapid-acting antidepressants
30637|NCT03380429|Connected Inhaler System|connected inhaler system
30638|NCT03380429|Metered Dose Inhaler|metered dose inhaler
30639|NCT03380429|ELLIPTA|ellipta
30640|NCT03380429|RELVAR/BREO|relvar/breo
30641|NCT03380429|Dry Powder Inhaler|dry powder inhaler
30642|NCT03380429|Salbutamol|salbutamol
30643|NCT03380429|Asthma|asthma
30644|NCT03380403|diabetic foot|diabetic foot
30645|NCT03380403|Osteomyelitis|osteomyelitis
30646|NCT03380403|PACT|pact
30647|NCT03380403|PDT|pdt
30648|NCT03380403|Singlet oxygen|singlet oxygen
30649|NCT03380403|antimicrobial|antimicrobial
30650|NCT03380403|diabetes|diabetes
30651|NCT03380403|Wagner scale|wagner scale
30652|NCT03380377|kidney transplant|kidney transplant
30653|NCT03380377|Chronic antibody mediated rejection|chronic antibody mediated rejection
30654|NCT03380377|donor specific antibody|donor specific antibody
30655|NCT03380338|Gut microbiota|gut microbiota
30656|NCT03380325|Capillary recruitment|capillary recruitment
30657|NCT03380286|Firehawk|firehawk
30658|NCT03380286|Coronary Artery Disease|coronary artery disease
30659|NCT03380286|Drug Eluting Stent|drug eluting stent
30660|NCT03380247|Emergency, trauma pain, analgesia, Methoxyfurane|emergency, trauma pain, analgesia, methoxyfurane
30661|NCT03380234|Secondhand smoke|secondhand smoke
30662|NCT03380234|Thirdhand smoke|thirdhand smoke
30663|NCT03380234|Children|children
30664|NCT03380234|Cluster randomised controlled trial|cluster randomised controlled trial
30665|NCT03380182|acupuncture|acupuncture
30666|NCT03380182|acupressure|acupressure
30667|NCT03380143|Children|children
30668|NCT03380143|Cancer Prevention|cancer prevention
30669|NCT03380143|Population Health|population health
30670|NCT03380143|Rural|rural
30671|NCT03380143|Community|community
30672|NCT03380143|School|school
30673|NCT03380143|After School|after school
30674|NCT03380143|Youth Sport|youth sport
30675|NCT03380143|Intervention|intervention
30676|NCT03380143|Multilevel|multilevel
30677|NCT03380143|Systems|systems
30678|NCT03380130|Hepatocellular Carcinoma|hepatocellular carcinoma
30679|NCT03380130|Liver cancer|liver cancer
30680|NCT03380130|Hepatoma|hepatoma
30681|NCT03380117|Suicidal Ideation|suicidal ideation
30682|NCT03380117|Suicide Attempt|suicide attempt
30683|NCT03380117|Risk Screening|risk screening
30684|NCT03380117|Online Intervention|online intervention
30685|NCT03380117|Online Counseling|online counseling
30686|NCT03380117|College Students|college students
30687|NCT03380117|Motivational Interviewing|motivational interviewing
30688|NCT03380117|Linkage to Care|linkage to care
30689|NCT03380104|Percutaneous Electrical Nerve Stimulation|percutaneous electrical nerve stimulation
30690|NCT03380091|PCOS|pcos
30691|NCT03380091|Depression|depression
30692|NCT03380091|Vitamin D|vitamin d
30693|NCT03380091|Insulin Resistance|insulin resistance
30694|NCT03380091|Anxiety|anxiety
30695|NCT03380091|Quality of life|quality of life
30696|NCT03380091|Mood disorders|mood disorders
30697|NCT03380078|Implementation Mechanism|implementation mechanism
30698|NCT03380078|Autism Spectrum Disorder|autism spectrum disorder
30699|NCT03380078|Children's Mental Health Services|children's mental health services
30700|NCT03380078|School Services|school services
30701|NCT03380065|coronary angiogram|coronary angiogram
30702|NCT03380065|radial artery|radial artery
30703|NCT03380052|OLGA|olga
30704|NCT03380052|OLGIM|olgim
30705|NCT03380052|Helicobacter pylori|helicobacter pylori
30706|NCT03380052|Gastric cancer|gastric cancer
30707|NCT03380026|CTCL|ctcl
30708|NCT03380026|topical mechlorethamine|topical mechlorethamine
30709|NCT03380026|Valchlor|valchlor
30710|NCT03380026|contact dermatitis|contact dermatitis
30711|NCT03380026|triamcinolone|triamcinolone
30712|NCT03380026|MF|mf
30713|NCT03380026|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
30714|NCT03380013|hypothermia treatment|hypothermia treatment
30715|NCT03380013|OMT in infants|omt in infants
30716|NCT03380000|Dietary nitrate supplementation|dietary nitrate supplementation
30717|NCT03380000|Beetroot juice|beetroot juice
30718|NCT03379961|social categorization|social categorization
30719|NCT03379961|nurse sorting|nurse sorting
30720|NCT03379961|emergencies units|emergencies units
30721|NCT03379909|metformin|metformin
30722|NCT03379909|marker lesion|marker lesion
30723|NCT03379870|cochlear implant|cochlear implant
30724|NCT03379870|electric acoustic stimulation|electric acoustic stimulation
30725|NCT03379870|EAS|eas
30726|NCT03379870|hearing loss|hearing loss
30727|NCT03379870|pediatric|pediatric
30728|NCT03379831|systemic right ventricle|systemic right ventricle
30729|NCT03379831|quality of life|quality of life
30730|NCT03379831|VO2|vo2
30731|NCT03379831|oxygen uptake|oxygen uptake
30732|NCT03379831|exercise test|exercise test
30733|NCT03379831|congenital heart disease|congenital heart disease
30734|NCT03379818|Shape bias|shape bias
30735|NCT03379818|Late Talkers|late talkers
30736|NCT03379792|Obesity|obesity
30737|NCT03379779|Microbiota|microbiota
30738|NCT03379779|Respiratory Failure|respiratory failure
30739|NCT03379779|Pneumonia|pneumonia
30740|NCT03379779|Lower Respiratory Tract Infection|lower respiratory tract infection
30741|NCT03379740|Reduced risk product|reduced risk product
30742|NCT03379727|Midostaurin|midostaurin
30743|NCT03379727|PKC412|pkc412
30744|NCT03379727|FMS-like tyrosine kinase receptor|fms-like tyrosine kinase receptor
30745|NCT03379727|FLT3|flt3
30746|NCT03379727|Acute Myeloid Leukemia|acute myeloid leukemia
30747|NCT03379727|AML|aml
30748|NCT03379727|7+3 chemotherapy|7+3 chemotherapy
30749|NCT03379727|5+2 chemotherapy|5+2 chemotherapy
30750|NCT03379727|Daunorubicin|daunorubicin
30751|NCT03379727|Idarubicin|idarubicin
30752|NCT03379727|Cytarabine|cytarabine
30753|NCT03379701|chronic rhinosinusitis, nasal polyposis|chronic rhinosinusitis, nasal polyposis
30754|NCT03379662|Autism|autism
30755|NCT03379662|Autistic Disorder|autistic disorder
30756|NCT03379662|Autistic Spectrum Disorder|autistic spectrum disorder
30757|NCT03379662|Irritability|irritability
30758|NCT03379662|laser|laser
30759|NCT03379662|light therapy|light therapy
30760|NCT03379649|Recurrent implantation failure|recurrent implantation failure
30761|NCT03379636|Athletic tape|athletic tape
30762|NCT03379636|Electromyography|electromyography
30763|NCT03379636|Rehabilitation|rehabilitation
30764|NCT03379636|Shoulder|shoulder
30765|NCT03379597|Schizophrenia|schizophrenia
30766|NCT03379597|probiotics|probiotics
30767|NCT03379597|cognitive impairment|cognitive impairment
30768|NCT03379597|Metabolic syndrome|metabolic syndrome
30769|NCT03379597|clinical trail|clinical trail
30770|NCT03379597|Efficacy|efficacy
30771|NCT03379597|Safety|safety
30772|NCT03379584|Multiple myeloma|multiple myeloma
30773|NCT03379584|Antibody-drug conjugate|antibody-drug conjugate
30774|NCT03379571|Chronic kidney disease|chronic kidney disease
30775|NCT03379571|Competing-risk analysis|competing-risk analysis
30776|NCT03379571|Epidemiological study|epidemiological study
30777|NCT03379571|Incidence|incidence
30778|NCT03379571|Outcomes|outcomes
30779|NCT03379571|Risk factors|risk factors
30780|NCT03379493|relapsed/refractory CD19+ Lymphomas Non-Hodgkin's B-Cell|relapsed/refractory cd19+ lymphomas non-hodgkin's b-cell
30781|NCT03379480|Schizophrenia, Yoga, fMRI, self reflection, efficacy|schizophrenia, yoga, fmri, self reflection, efficacy
30782|NCT03379467|SMS Reminder|sms reminder
30783|NCT03379467|Two-way Reminder|two-way reminder
30784|NCT03379428|Breast Cancer|breast cancer
30785|NCT03379428|Metastatic Breast Cancer|metastatic breast cancer
30786|NCT03379428|HER2-amplified Metastatic Breast Cancer|her2-amplified metastatic breast cancer
30787|NCT03379428|HER2-positive Metastatic Breast Cancer|her2-positive metastatic breast cancer
30788|NCT03379415|Meniscectomy|meniscectomy
30789|NCT03379415|Footwear|footwear
30790|NCT03379415|Osteoarthritis|osteoarthritis
30791|NCT03379402|causes of community-acquired sepsis|causes of community-acquired sepsis
30792|NCT03379402|diagnostic tests|diagnostic tests
30793|NCT03379363|cushing syndrome, hypercortisolism|cushing syndrome, hypercortisolism
30794|NCT03379350|lung cancer|lung cancer
30795|NCT03379350|surgery|surgery
30796|NCT03379350|chest tube clamping|chest tube clamping
30797|NCT03379350|duration of chest tube drainage|duration of chest tube drainage
30798|NCT03379350|postoperative stay|postoperative stay
30799|NCT03379337|Imaging|imaging
30800|NCT03379324|Rotator Cuff|rotator cuff
30801|NCT03379324|Human Amniotic Fluid|human amniotic fluid
30802|NCT03379324|Amniotic Fluid Allograft|amniotic fluid allograft
30803|NCT03379324|FlōGraft®|flōgraft®
30804|NCT03379324|Amniotic Fluid Biologic|amniotic fluid biologic
30805|NCT03379324|Fatty Atrophy|fatty atrophy
30806|NCT03379324|Fat Degeneration|fat degeneration
30807|NCT03379311|AKC|akc
30808|NCT03379311|PAC|pac
30809|NCT03379311|VKC|vkc
30810|NCT03379285|Gastro Intestinal Bleeding;|gastro intestinal bleeding;
30811|NCT03379285|Transfusion,|transfusion,
30812|NCT03379285|Outcomes|outcomes
30813|NCT03379272|Electroencephalography|electroencephalography
30814|NCT03379272|Epilepsy|epilepsy
30815|NCT03379272|EEG|eeg
30816|NCT03379233|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
30817|NCT03379233|Adherence|adherence
30818|NCT03379233|Dose Tracking|dose tracking
30819|NCT03379233|Concept2|concept2
30820|NCT03379233|Digital Adherence System|digital adherence system
30821|NCT03379233|Ultibro Breezhaler|ultibro breezhaler
30822|NCT03379207|Community-acquired Pneumonia|community-acquired pneumonia
30823|NCT03379207|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
30824|NCT03379207|Innate Immunity|innate immunity
30825|NCT03379207|Non Conventional T Lymphocytes|non conventional t lymphocytes
30826|NCT03379194|antibiotic prescriptions|antibiotic prescriptions
30827|NCT03379194|resistance|resistance
30828|NCT03379194|feedback|feedback
30829|NCT03379194|primary care|primary care
30830|NCT03379181|Brown adipose tissue (BAT)|brown adipose tissue (bat)
30831|NCT03379181|Hyperthyroidism|hyperthyroidism
30832|NCT03379168|knee osteoarthritis|knee osteoarthritis
30833|NCT03379168|mesenchymal stem cell|mesenchymal stem cell
30834|NCT03379168|adipose tissue|adipose tissue
30835|NCT03379168|injection|injection
30836|NCT03379168|nonoperative treatment|nonoperative treatment
30837|NCT03379142|Faith-Based; Community-engaged; Text messaging; Tobacco|faith-based; community-engaged; text messaging; tobacco
30838|NCT03379103|Blood Loss, Surgical|blood loss, surgical
30839|NCT03379103|Blood Transfusion|blood transfusion
30840|NCT03379103|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
30841|NCT03379077|Mothers|mothers
30842|NCT03379077|young children|young children
30843|NCT03379077|Implementation|implementation
30844|NCT03379077|Learning through play Plus|learning through play plus
30845|NCT03379077|Cognitive Behavior Therapy|cognitive behavior therapy
30846|NCT03379064|Irritable Bowel Syndrome, Low Income Country|irritable bowel syndrome, low income country
30847|NCT03379038|Cerebral Palsy|cerebral palsy
30848|NCT03379038|Spasticity|spasticity
30849|NCT03379038|Constipation|constipation
30850|NCT03379038|Gross Motor Functional Classification Scale|gross motor functional classification scale
30851|NCT03379038|Defecation Frequency|defecation frequency
30852|NCT03379038|Constipation Severity|constipation severity
30853|NCT03379025|electronic cigarettes; e-cigarettes|electronic cigarettes; e-cigarettes
30854|NCT03378973|motor evoked potentials|motor evoked potentials
30855|NCT03378947|EBV, DLBCL|ebv, dlbcl
30856|NCT03378934|Coronary Artery Disease|coronary artery disease
30857|NCT03378934|Percutaneous Coronary Intervention|percutaneous coronary intervention
30858|NCT03378934|Antiplatelet|antiplatelet
30859|NCT03378934|Berberine|berberine
30860|NCT03378921|FMT|fmt
30861|NCT03378908|medical therapy nutrition|medical therapy nutrition
30862|NCT03378908|meal|meal
30863|NCT03378908|carbohydrates|carbohydrates
30864|NCT03378908|intervention|intervention
30865|NCT03378908|food intake|food intake
30866|NCT03378882|Angiostrongylosis|angiostrongylosis
30867|NCT03378882|Hypereosinophilia|hypereosinophilia
30868|NCT03378882|Eosinophilic meningitis|eosinophilic meningitis
30869|NCT03378882|Meningoencephalitis|meningoencephalitis
30870|NCT03378882|Achatina fulica|achatina fulica
30871|NCT03378882|Angiostrongylus cantonensis|angiostrongylus cantonensis
30872|NCT03378882|Angiostrongylus costaricensis|angiostrongylus costaricensis
30873|NCT03378843|Polyamine, cardiovascular disease, cancer|polyamine, cardiovascular disease, cancer
30874|NCT03378830|Pain|pain
30875|NCT03378830|Sleep Disordered Breathing|sleep disordered breathing
30876|NCT03378817|Extended criteria donor|extended criteria donor
30877|NCT03378817|Donation after brain death|donation after brain death
30878|NCT03378817|HOPE|hope
30879|NCT03378817|Kidney transplantation|kidney transplantation
30880|NCT03378804|PCEA|pcea
30881|NCT03378804|PIEB|pieb
30882|NCT03378804|epidural analgesia|epidural analgesia
30883|NCT03378752|Computer tomography|computer tomography
30884|NCT03378752|Liver tumor thermoablation|liver tumor thermoablation
30885|NCT03378739|cardiogenic|cardiogenic
30886|NCT03378739|shock|shock
30887|NCT03378713|Poor Ovarian Response|poor ovarian response
30888|NCT03378700|CKD|ckd
30889|NCT03378700|Hope Intervention|hope intervention
30890|NCT03378700|decision making|decision making
30891|NCT03378687|Status Epilepticus|status epilepticus
30892|NCT03378687|Children|children
30893|NCT03378687|Multi-center|multi-center
30894|NCT03378687|etiology|etiology
30895|NCT03378687|treatment|treatment
30896|NCT03378687|outcome|outcome
30897|NCT03378687|risk factor|risk factor
30898|NCT03378661|Chronic, Indeterminate|chronic, indeterminate
30899|NCT03378635|Glucagon|glucagon
30900|NCT03378596|Post-Exercise Hypotension|post-exercise hypotension
30901|NCT03378596|Exercise|exercise
30902|NCT03378596|Arginine|arginine
30903|NCT03378596|Citrulline|citrulline
30904|NCT03378570|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
30905|NCT03378570|rTMS|rtms
30906|NCT03378570|TMS|tms
30907|NCT03378570|F3|f3
30908|NCT03378570|5.5cm rule|5.5cm rule
30909|NCT03378570|Targeting|targeting
30910|NCT03378518|In-hospital Cardiac Arrest, mortality|in-hospital cardiac arrest, mortality
30911|NCT03378479|Influenza|influenza
30912|NCT03378453|Narcolepsy|narcolepsy
30913|NCT03378453|Alzheimer|alzheimer
30914|NCT03378453|Orexin|orexin
30915|NCT03378453|Amyloid|amyloid
30916|NCT03378453|PET-amyloid imaging|pet-amyloid imaging
30917|NCT03378427|Tedizolid|tedizolid
30918|NCT03378427|Adverse effects|adverse effects
30919|NCT03378427|Efficacy|efficacy
30920|NCT03378427|prosthetic joint infection|prosthetic joint infection
30921|NCT03378414|Spinocerebellar Ataxia,Mesenchymal Stem Cells|spinocerebellar ataxia,mesenchymal stem cells
30922|NCT03378388|Drug therapy|drug therapy
30923|NCT03378323|upper extremity surgery|upper extremity surgery
30924|NCT03378297|Ovarian cancer|ovarian cancer
30925|NCT03378297|Phase 0|phase 0
30926|NCT03378297|Window-of-opportunity|window-of-opportunity
30927|NCT03378297|Suregry|suregry
30928|NCT03378297|Repurposing|repurposing
30929|NCT03378297|Metformin|metformin
30930|NCT03378297|Acetylsalicylic acid|acetylsalicylic acid
30931|NCT03378297|Olaparib|olaparib
30932|NCT03378297|Letrozol|letrozol
30933|NCT03378271|Continuous Glucose Monitoring|continuous glucose monitoring
30934|NCT03378271|Flash glucose Monitoring|flash glucose monitoring
30935|NCT03378271|Renal Impairment|renal impairment
30936|NCT03378271|Type 1 Diabetes|type 1 diabetes
30937|NCT03378271|Type 2 Diabetes|type 2 diabetes
30938|NCT03378258|meningococcal|meningococcal
30939|NCT03378258|neisseria meningitidis|neisseria meningitidis
30940|NCT03378258|sepsis|sepsis
30941|NCT03378258|meningitis|meningitis
30942|NCT03378258|procalcitonin|procalcitonin
30943|NCT03378258|PCT|pct
30944|NCT03378258|LAMP|lamp
30945|NCT03378258|loop-mediated-isothermal AMPlification|loop-mediated-isothermal amplification
30946|NCT03378232|DHA|dha
30948|NCT03378232|fatty acids|fatty acids
30949|NCT03378232|blood pressure|blood pressure
30950|NCT03378232|resting metabolic rate|resting metabolic rate
30951|NCT03378232|blood lipids|blood lipids
30952|NCT03378232|muscle sympathetic nerve activity (MSNA)|muscle sympathetic nerve activity (msna)
30953|NCT03378206|genu valgum or varum|genu valgum or varum
30954|NCT03378206|eight-plate|eight-plate
30955|NCT03378206|epiphysis arrest|epiphysis arrest
30956|NCT03378206|hemiepiphysiodesis|hemiepiphysiodesis
30957|NCT03378193|Squamous cell carcinoma|squamous cell carcinoma
30958|NCT03378193|FDG PET/CT|fdg pet/ct
30959|NCT03378193|Textural analysis|textural analysis
30960|NCT03378167|Paediatrics|paediatrics
30961|NCT03378167|Pediatrics|pediatrics
30962|NCT03378167|Crohn's|crohn's
30963|NCT03378167|Crohn|crohn
30964|NCT03378167|Microbiome|microbiome
30965|NCT03378167|Microbiota|microbiota
30966|NCT03378167|FMT|fmt
30967|NCT03378167|Fecal Transplant|fecal transplant
30968|NCT03378167|Fecal Microbiota Transplant|fecal microbiota transplant
30969|NCT03378167|IBD-U|ibd-u
30970|NCT03378167|Inflammatory Bowel Disease Unclassified|inflammatory bowel disease unclassified
30971|NCT03378167|Inflammatory Bowel Disease Indeterminate|inflammatory bowel disease indeterminate
30972|NCT03378167|IBD|ibd
30973|NCT03378167|Colitis|colitis
30974|NCT03378154|King vision|king vision
30975|NCT03378154|Difficult airway|difficult airway
30976|NCT03378154|Videolaryngoscope|videolaryngoscope
30977|NCT03378154|Paediatric intubation|paediatric intubation
30978|NCT03378128|debulking surgery|debulking surgery
30979|NCT03378128|Ovarian Cancer|ovarian cancer
30980|NCT03378102|T Cell Therapy|t cell therapy
30981|NCT03378102|Opportunistic Infection|opportunistic infection
30982|NCT03378089|Music Therapy|music therapy
30983|NCT03378076|Osteoarthritis|osteoarthritis
30984|NCT03378076|Knee|knee
30985|NCT03378076|Corticosteroid|corticosteroid
30986|NCT03378076|Bilateral|bilateral
30987|NCT03378076|Pain|pain
30988|NCT03378076|Intra-articular|intra-articular
30989|NCT03378076|Injection|injection
30990|NCT03378037|Brain Injuries, Traumatic|brain injuries, traumatic
30991|NCT03378037|Alzheimer's disease|alzheimer's disease
30992|NCT03378037|Magnetic resonance imaging|magnetic resonance imaging
30993|NCT03378037|white matter integrity|white matter integrity
30994|NCT03378037|beta-Amyloid|beta-amyloid
30995|NCT03378024|Oscillometric device|oscillometric device
30996|NCT03378024|repetitive Active Pedal Plantarflexion (APP) exercise test|repetitive active pedal plantarflexion (app) exercise test
30997|NCT03378024|brachial-ankle pulse wave velocity (baPWV)|brachial-ankle pulse wave velocity (bapwv)
30998|NCT03377959|dance|dance
30999|NCT03377959|ballet|ballet
31000|NCT03377959|Exercise Movement Techniques|exercise movement techniques
31001|NCT03377959|turnout|turnout
31002|NCT03377946|pre-diabetes,diabetes,probiotics|pre-diabetes,diabetes,probiotics
31003|NCT03377933|Helicobacter pylori|helicobacter pylori
31004|NCT03377933|Probiotics|probiotics
31005|NCT03377933|Efficacy|efficacy
31006|NCT03377933|Safety|safety
31007|NCT03377933|gastromicroecology|gastromicroecology
31008|NCT03377907|IVRA|ivra
31009|NCT03377907|hematoma block|hematoma block
31010|NCT03377842|apatinib|apatinib
31011|NCT03377829|Papillary Thyroid Microcarcinoma|papillary thyroid microcarcinoma
31012|NCT03377829|Percutaneous Laser Ablation|percutaneous laser ablation
31013|NCT03377829|thyroidectomy|thyroidectomy
31014|NCT03377829|ultrasonography|ultrasonography
31015|NCT03377829|double-blind|double-blind
31016|NCT03377816|Emotion Processing|emotion processing
31017|NCT03377816|Art Therapy|art therapy
31018|NCT03377816|Breast Cancer|breast cancer
31019|NCT03377816|Cholinergic anti-inflammatory pathway|cholinergic anti-inflammatory pathway
31020|NCT03377803|Molluscum|molluscum
31021|NCT03377803|Skin Diseases|skin diseases
31022|NCT03377803|Poxviridae Infections|poxviridae infections
31023|NCT03377803|Skin Diseases; Infectious|skin diseases; infectious
31516|NCT03374761|parenting|parenting
31024|NCT03377803|Skin Diseases; Viral|skin diseases; viral
31025|NCT03377803|DNA Poxvirus|dna poxvirus
31026|NCT03377790|Molluscum|molluscum
31027|NCT03377790|Skin Diseases|skin diseases
31028|NCT03377790|Poxviridae Infections|poxviridae infections
31029|NCT03377790|Skin Diseases; Infectious|skin diseases; infectious
31030|NCT03377790|Skin Diseases; Viral|skin diseases; viral
31031|NCT03377790|DNA Poxvirus|dna poxvirus
31032|NCT03377777|Anemia|anemia
31033|NCT03377777|Iron-deficiency|iron-deficiency
31034|NCT03377777|Iron-deficiency anemia|iron-deficiency anemia
31035|NCT03377777|Infants|infants
31036|NCT03377777|Metabolomics|metabolomics
31037|NCT03377777|Microbiome|microbiome
31038|NCT03377764|Spinal Anesthetic,|spinal anesthetic,
31039|NCT03377764|Ultrasound guided Neuroaxial block,|ultrasound guided neuroaxial block,
31040|NCT03377764|Anesthesia Trainees|anesthesia trainees
31041|NCT03377751|Catheter ablation|catheter ablation
31042|NCT03377751|Atrial fibrillation|atrial fibrillation
31043|NCT03377751|Low voltage area|low voltage area
31044|NCT03377738|Spirometry|spirometry
31045|NCT03377738|Primary care|primary care
31046|NCT03377738|Smoking Cessations|smoking cessations
31047|NCT03377725|Myelodysplastic Syndromes|myelodysplastic syndromes
31048|NCT03377725|Decitabine|decitabine
31049|NCT03377725|Arsenic Trioxide|arsenic trioxide
31050|NCT03377725|P53 Mutations|p53 mutations
31051|NCT03377686|paediatrics|paediatrics
31052|NCT03377686|breath analysis|breath analysis
31053|NCT03377686|volatile organic compounds|volatile organic compounds
31054|NCT03377686|respiratory diseases|respiratory diseases
31055|NCT03377660|Esophagectomy|esophagectomy
31056|NCT03377660|Unintentional weight loss|unintentional weight loss
31057|NCT03377660|Gut hormones|gut hormones
31058|NCT03377634|Older Adults|older adults
31059|NCT03377634|Physical Activity|physical activity
31060|NCT03377634|MORPH|morph
31061|NCT03377634|Telecoaching|telecoaching
31062|NCT03377634|mHealth|mhealth
31063|NCT03377634|Weight Loss|weight loss
31064|NCT03377634|Sedentary Behavior|sedentary behavior
31065|NCT03377634|Pain|pain
31066|NCT03377634|Design|design
31067|NCT03377634|RCT|rct
31068|NCT03377634|Randomized Controlled Trial|randomized controlled trial
31069|NCT03377621|whole body vibration|whole body vibration
31070|NCT03377621|sleep|sleep
31071|NCT03377621|apnea|apnea
31072|NCT03377608|tenofovir|tenofovir
31073|NCT03377608|microbiome|microbiome
31074|NCT03377608|inflammation|inflammation
31075|NCT03377582|cardiovascular diseases|cardiovascular diseases
31076|NCT03377582|cardiac rehabilitation|cardiac rehabilitation
31077|NCT03377582|sympathetic nervous system|sympathetic nervous system
31078|NCT03377582|heart rate|heart rate
31079|NCT03377582|blood pressure|blood pressure
31080|NCT03377582|clinical trial|clinical trial
31081|NCT03377582|virtual reality exposure therapy|virtual reality exposure therapy
31082|NCT03377582|barriers to cardiac rehabilitation|barriers to cardiac rehabilitation
31083|NCT03377582|motivation|motivation
31084|NCT03377582|adherence patient|adherence patient
31085|NCT03377582|engagement|engagement
31086|NCT03377582|perceived exertion|perceived exertion
31087|NCT03377582|oxygen saturation|oxygen saturation
31088|NCT03377569|Deep Brain Stimulation|deep brain stimulation
31089|NCT03377569|Polysomnography|polysomnography
31090|NCT03377569|Actigraphy|actigraphy
31091|NCT03377530|Bacillus Cereus|bacillus cereus
31092|NCT03377530|Premature neonates|premature neonates
31093|NCT03377504|complex regional pain syndrome|complex regional pain syndrome
31094|NCT03377504|mirror therapy|mirror therapy
31095|NCT03377504|rehabilitation|rehabilitation
31096|NCT03377491|Locally Advanced Pancreatic Adenocarcinoma|locally advanced pancreatic adenocarcinoma
31097|NCT03377491|TTFields|ttfields
31098|NCT03377491|Tumor Treating Fields|tumor treating fields
31099|NCT03377491|Gemcitabine|gemcitabine
31100|NCT03377491|nab-Paclitaxel|nab-paclitaxel
31101|NCT03377491|Minimal toxicity|minimal toxicity
31103|NCT03377491|Novocure|novocure
31104|NCT03377439|Platelet function|platelet function
31105|NCT03377439|Bleeding risk|bleeding risk
31106|NCT03377439|Immune Thrombocytopenia|immune thrombocytopenia
31107|NCT03377426|Urinary tract infection, LYS228, beta-lactam antibiotics, creatinine clearance, Enterobactericeae|urinary tract infection, lys228, beta-lactam antibiotics, creatinine clearance, enterobactericeae
31108|NCT03377387|Capecitabine|capecitabine
31109|NCT03377387|Neratinib|neratinib
31110|NCT03377387|HER2-Positive|her2-positive
31111|NCT03377387|17-585|17-585
31112|NCT03377335|Dapagliflozin|dapagliflozin
31113|NCT03377335|Type 2 diabetes mellitus|type 2 diabetes mellitus
31114|NCT03377335|Carotid intima-media thickness|carotid intima-media thickness
31115|NCT03377335|Endothelial dysfunction|endothelial dysfunction
31116|NCT03377335|Atherogenic lipoproteins|atherogenic lipoproteins
31117|NCT03377335|Inflammatory markers|inflammatory markers
31118|NCT03377335|microRNAs|micrornas
31119|NCT03377309|Safety|safety
31120|NCT03377309|Tolerability|tolerability
31121|NCT03377309|Perampanel|perampanel
31122|NCT03377270|Oropharyngeal Head and Neck Cancer|oropharyngeal head and neck cancer
31123|NCT03377270|dysphagia|dysphagia
31124|NCT03377270|Respiratory Swallow Training|respiratory swallow training
31125|NCT03377257|Cluster headache|cluster headache
31126|NCT03377257|zolmitriptan|zolmitriptan
31127|NCT03377257|Sublingual administration|sublingual administration
31128|NCT03377231|Pregnancy, Striae gravidarum, Striae distensae, Women's health|pregnancy, striae gravidarum, striae distensae, women's health
31129|NCT03377192|Impedance pneumography|impedance pneumography
31130|NCT03377192|Respiratory function|respiratory function
31131|NCT03377192|Asthma management|asthma management
31132|NCT03377179|Clinical Trial, Phase II|clinical trial, phase ii
31133|NCT03377179|Multicenter Trials|multicenter trials
31134|NCT03377179|Clinical Study|clinical study
31135|NCT03377179|Clinical Trials, Non-Randomized|clinical trials, non-randomized
31136|NCT03377179|Oral capsule|oral capsule
31137|NCT03377179|Single arm|single arm
31138|NCT03377179|Anti-cancer|anti-cancer
31139|NCT03377179|Anti-inflammatory|anti-inflammatory
31140|NCT03377179|ABC294640|abc294640
31141|NCT03377179|Yeliva ®|yeliva ®
31142|NCT03377127|diabetes|diabetes
31143|NCT03377127|pharmacy clinic|pharmacy clinic
31144|NCT03377127|education|education
31145|NCT03377127|diabetes complications|diabetes complications
31146|NCT03377127|hemoglobin A1c|hemoglobin a1c
31147|NCT03377127|health-care cost|health-care cost
31148|NCT03377127|'no show' rate|'no show' rate
31149|NCT03377127|compliance|compliance
31150|NCT03377127|diabetes core measures|diabetes core measures
31151|NCT03377114|Nasotracheal intubation|nasotracheal intubation
31152|NCT03377049|acetazolamide challenge|acetazolamide challenge
31153|NCT03377049|cerebral vasospasm|cerebral vasospasm
31154|NCT03377049|aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
31155|NCT03377036|Breast Cancer|breast cancer
31156|NCT03377036|Population-based Screening|population-based screening
31157|NCT03377036|Digital Breast Tomosynthesis plus synthesized Mammography|digital breast tomosynthesis plus synthesized mammography
31158|NCT03377036|Reconstructed Mammography|reconstructed mammography
31159|NCT03377036|Full-Field Digital Mammography (FFDM)|full-field digital mammography (ffdm)
31160|NCT03377036|Multicentric Randomized Controlled Trial|multicentric randomized controlled trial
31161|NCT03377036|Diagnostic Performance|diagnostic performance
31162|NCT03377036|Recall Rate|recall rate
31163|NCT03377036|Interval Cancer|interval cancer
31164|NCT03377023|Nivolumab|nivolumab
31165|NCT03377023|Ipilimumab|ipilimumab
31166|NCT03377023|Nintedanib|nintedanib
31167|NCT03377023|Immunotherapy|immunotherapy
31168|NCT03377023|Advanced stage non-small cell lung cancer|advanced stage non-small cell lung cancer
31169|NCT03377023|Locally advanced non-small cell lung cancer|locally advanced non-small cell lung cancer
31170|NCT03376997|Bioavailability|bioavailability
31171|NCT03376997|Perampanel|perampanel
31172|NCT03376984|Root Canal Therapy|root canal therapy
31173|NCT03376971|Lesion|lesion
31174|NCT03376971|Lung|lung
31175|NCT03376971|Cancer|cancer
31176|NCT03376971|Diagnosis|diagnosis
31177|NCT03376971|Optical Biopsy|optical biopsy
31178|NCT03376971|Biopsy|biopsy
31179|NCT03376958|R/R DLBCL, DCR, OS, PFS|r/r dlbcl, dcr, os, pfs
31180|NCT03376945|n-3|n-3
31181|NCT03376945|Parenteral nutrition|parenteral nutrition
31182|NCT03376945|Jaundice|jaundice
31183|NCT03376945|Propensity score match|propensity score match
31184|NCT03376932|Vilanterol|vilanterol
31185|NCT03376932|Fluticasone furoate|fluticasone furoate
31186|NCT03376932|Connected Inhaler System|connected inhaler system
31187|NCT03376932|Dry powder inhaler|dry powder inhaler
31188|NCT03376932|Umeclidinium|umeclidinium
31189|NCT03376932|Asthma|asthma
31190|NCT03376919|wearable robotics|wearable robotics
31191|NCT03376919|Unilateral Lower Limb Amputation|unilateral lower limb amputation
31192|NCT03376919|gait efficiency|gait efficiency
31193|NCT03376906|Obesity|obesity
31194|NCT03376906|aerobic exercise|aerobic exercise
31195|NCT03376906|interval exercise|interval exercise
31196|NCT03376867|conditioned pain modulation (CPM)|conditioned pain modulation (cpm)
31197|NCT03376867|Diffuse Noxious Inhibitory Controls (DNIC)|diffuse noxious inhibitory controls (dnic)
31198|NCT03376867|pressure pain threshold (PPT)|pressure pain threshold (ppt)
31199|NCT03376867|reference values|reference values
31200|NCT03376867|clinical decision rule|clinical decision rule
31201|NCT03376854|ARDS, temperature management, neuromuscular blockade|ards, temperature management, neuromuscular blockade
31202|NCT03376841|Liver insufficiency|liver insufficiency
31203|NCT03376841|Hepatic Impairment|hepatic impairment
31204|NCT03376841|Cenicriviroc|cenicriviroc
31205|NCT03376841|Pharmacokinetics|pharmacokinetics
31206|NCT03376828|laryngoscopy|laryngoscopy
31207|NCT03376828|videolaryngoscopy|videolaryngoscopy
31208|NCT03376828|hypertension|hypertension
31209|NCT03376815|Tumor ,landscape ,pathological diagnosis|tumor ,landscape ,pathological diagnosis
31210|NCT03376776|idiopathic macular hole|idiopathic macular hole
31211|NCT03376763|aripiprazole|aripiprazole
31212|NCT03376763|Long-Acting Injection|long-acting injection
31213|NCT03376750|telerehabilitation|telerehabilitation
31214|NCT03376750|occupational therapy|occupational therapy
31215|NCT03376750|RCT|rct
31216|NCT03376750|participation|participation
31708|NCT03373396|Chlordecone|chlordecone
31217|NCT03376750|quality of life|quality of life
31218|NCT03376750|intervention|intervention
31219|NCT03376750|older adults|older adults
31220|NCT03376659|PD-L1|pd-l1
31221|NCT03376633|Randomized Controlled Trial|randomized controlled trial
31222|NCT03376633|RCT|rct
31223|NCT03376633|Chicago Public Schools|chicago public schools
31224|NCT03376633|high school|high school
31225|NCT03376633|trauma-informed counseling|trauma-informed counseling
31226|NCT03376633|group-based counseling|group-based counseling
31227|NCT03376633|counseling|counseling
31228|NCT03376633|mentoring|mentoring
31229|NCT03376633|Cognitive Behavioral Therapy|cognitive behavioral therapy
31230|NCT03376633|CBT|cbt
31231|NCT03376633|adolescents|adolescents
31232|NCT03376633|females|females
31233|NCT03376633|trauma|trauma
31234|NCT03376633|stress|stress
31235|NCT03376633|PTSD|ptsd
31236|NCT03376633|anxiety|anxiety
31237|NCT03376633|depression|depression
31238|NCT03376633|graduation|graduation
31239|NCT03376620|Prevention of hypertrophic scar|prevention of hypertrophic scar
31240|NCT03376607|Primary Health Care|primary health care
31241|NCT03376607|Health Behavior|health behavior
31242|NCT03376607|Quality of Life|quality of life
31243|NCT03376607|Health Literacy|health literacy
31244|NCT03376607|Global Health|global health
31245|NCT03376607|Medication Adherence|medication adherence
31246|NCT03376594|Benjakul Extract|benjakul extract
31247|NCT03376594|Allergic Rhinitis|allergic rhinitis
31248|NCT03376594|Herbal Medicine|herbal medicine
31249|NCT03376568|polysomnographic|polysomnographic
31250|NCT03376568|multiple sleep latency test|multiple sleep latency test
31251|NCT03376568|fMRI|fmri
31252|NCT03376555|Sodium|sodium
31253|NCT03376555|Hypertension|hypertension
31254|NCT03376555|Blood Pressure|blood pressure
31255|NCT03376555|Cardiovascular Disease|cardiovascular disease
31256|NCT03376555|Nitric Oxide|nitric oxide
31257|NCT03376555|Skin|skin
31258|NCT03376555|Dairy|dairy
31259|NCT03376555|Cheese|cheese
31260|NCT03376555|Oxidative Stress|oxidative stress
31261|NCT03376555|Diet|diet
31262|NCT03376555|Flow Mediated Vasodilation|flow mediated vasodilation
31263|NCT03376555|Nitroglycerin|nitroglycerin
31264|NCT03376555|Superoxide|superoxide
31265|NCT03376555|Microcirculation|microcirculation
31266|NCT03376529|safety|safety
31267|NCT03376529|tolerability|tolerability
31268|NCT03376529|pharmacokinetics|pharmacokinetics
31269|NCT03376529|drug-drug interaction|drug-drug interaction
31270|NCT03376529|SPR741|spr741
31271|NCT03376529|antibiotic|antibiotic
31272|NCT03376477|Lenalidomide|lenalidomide
31273|NCT03376477|M-spike negative|m-spike negative
31274|NCT03376477|GVax|gvax
31275|NCT03376477|GM-CSF secreting myeloma vaccine|gm-csf secreting myeloma vaccine
31276|NCT03376464|Xeomin Cosmetic;|xeomin cosmetic;
31277|NCT03376464|Masseteric Hypertrophy|masseteric hypertrophy
31278|NCT03376425|Chest ultrasound,Lung tumor|chest ultrasound,lung tumor
31279|NCT03376399|Sleeve Gastrectomy|sleeve gastrectomy
31280|NCT03376399|Gastric Emptying|gastric emptying
31281|NCT03376399|Diabetic Gastroparesis|diabetic gastroparesis
31282|NCT03376399|Bariatric Surgery Candidate|bariatric surgery candidate
31283|NCT03376386|Adaptive|adaptive
31284|NCT03376386|Image-guided|image-guided
31285|NCT03376386|Radiotherapy|radiotherapy
31286|NCT03376386|Head and Neck cancer|head and neck cancer
31287|NCT03376360|prostate cancer|prostate cancer
31288|NCT03376360|Fcholine|fcholine
31289|NCT03376360|positron emission tomography|positron emission tomography
31290|NCT03376360|MRI|mri
31291|NCT03376347|intraoperative|intraoperative
31292|NCT03376347|hypotension|hypotension
31293|NCT03376347|Hypotension Probability Index|hypotension probability index
31294|NCT03376347|HPI|hpi
31295|NCT03376334|Mental motor imagery|mental motor imagery
31296|NCT03376334|SEBT|sebt
31297|NCT03376308|rocuronium|rocuronium
31298|NCT03376308|propofol|propofol
31299|NCT03376308|pain|pain
31300|NCT03376308|withdrawal|withdrawal
31301|NCT03376308|venous diameter|venous diameter
31302|NCT03376282|HBO|hbo
31303|NCT03376282|kidney functions|kidney functions
31304|NCT03376282|markers|markers
31305|NCT03376269|more than 1 year|more than 1 year
31306|NCT03376256|thoracic epidural|thoracic epidural
31307|NCT03376256|pressure measurement|pressure measurement
31308|NCT03376256|device|device
31309|NCT03376243|Atopic eczema, prevention|atopic eczema, prevention
31310|NCT03376230|Environmental risk factors|environmental risk factors
31311|NCT03376230|Xenobiotic detoxification|xenobiotic detoxification
31312|NCT03376217|malaria|malaria
31313|NCT03376217|malaria in pregnancy|malaria in pregnancy
31314|NCT03376217|intermittent preventive treatment in pregnancy (IPTp)|intermittent preventive treatment in pregnancy (iptp)
31315|NCT03376217|community health workers|community health workers
31316|NCT03376217|Sulfadoxine-pyrimethamine (SP)|sulfadoxine-pyrimethamine (sp)
31317|NCT03376204|Bronchiectasis|bronchiectasis
31318|NCT03376204|Pain mechanisms|pain mechanisms
31319|NCT03376204|Pressure pain threshold|pressure pain threshold
31709|NCT03373396|fibrosis|fibrosis
31320|NCT03376204|Referred pain|referred pain
31321|NCT03376191|Apatinib|apatinib
31322|NCT03376191|lung cancer|lung cancer
31323|NCT03376191|angiogenesis inhibitors|angiogenesis inhibitors
31324|NCT03376191|efficacy|efficacy
31325|NCT03376191|safety|safety
31326|NCT03376178|multiorifice or endhole femoral nerve catheter|multiorifice or endhole femoral nerve catheter
31327|NCT03376165|prognosis|prognosis
31328|NCT03376165|translational research|translational research
31329|NCT03376139|Alcohol|alcohol
31330|NCT03376139|Alcoholic|alcoholic
31331|NCT03376139|Alcoholism|alcoholism
31332|NCT03376139|Alcohol abuse|alcohol abuse
31333|NCT03376139|Alcohol Use Disorder|alcohol use disorder
31334|NCT03376139|Alcohol use|alcohol use
31335|NCT03376139|Alcohol dependence|alcohol dependence
31336|NCT03376139|Alcohol dependent|alcohol dependent
31337|NCT03376139|PTSD|ptsd
31338|NCT03376139|Post-Traumatic Stress Disorder|post-traumatic stress disorder
31339|NCT03376139|Veteran|veteran
31340|NCT03376126|isolated limb perfusion|isolated limb perfusion
31341|NCT03376113|self-harm|self-harm
31342|NCT03376113|psychological intervention|psychological intervention
31343|NCT03376087|Epilepsy|epilepsy
31344|NCT03376087|heart block|heart block
31345|NCT03376087|sudden cardiac death|sudden cardiac death
31346|NCT03376087|loop recorder|loop recorder
31347|NCT03376074|liver transplantation|liver transplantation
31348|NCT03376074|hypothermic machine liver perfusion|hypothermic machine liver perfusion
31349|NCT03376074|extended criteria liver grafts|extended criteria liver grafts
31350|NCT03376061|Tranexamic Acid|tranexamic acid
31351|NCT03376061|Cardiac surgery|cardiac surgery
31352|NCT03376022|Attitudes|attitudes
31353|NCT03376022|Knowledge|knowledge
31354|NCT03376022|Oral Health|oral health
31355|NCT03376022|Nursing personnel|nursing personnel
31356|NCT03376009|Biomarker|biomarker
31357|NCT03375983|Advanced cancer|advanced cancer
31358|NCT03375983|Plasmodium immunotherapy|plasmodium immunotherapy
31359|NCT03375983|Plasmodiun vivax|plasmodiun vivax
31360|NCT03375944|Cardiac tele-rehabilitation, Myocardial revascularization|cardiac tele-rehabilitation, myocardial revascularization
31361|NCT03375931|Quality of Recovery 40 Questionaries|quality of recovery 40 questionaries
31362|NCT03375918|Healthcare disparities|healthcare disparities
31363|NCT03375918|Racial Bias|racial bias
31364|NCT03375905|ethnic Japanese|ethnic japanese
31365|NCT03375892|radiation|radiation
31366|NCT03375892|Deep Inspiration Breath Hold|deep inspiration breath hold
31367|NCT03375892|stage I|stage i
31368|NCT03375892|stage II|stage ii
31369|NCT03375892|stage IIa|stage iia
31370|NCT03375879|Ptosis|ptosis
31371|NCT03375879|Blepharoptosis|blepharoptosis
31372|NCT03375879|bandage contact lens|bandage contact lens
31373|NCT03375879|fasanella servat procedure|fasanella servat procedure
31374|NCT03375853|Obesity|obesity
31375|NCT03375853|Dissonance|dissonance
31376|NCT03375853|Response Training|response training
31377|NCT03375853|Eating Disorder|eating disorder
31378|NCT03375853|Computer-based Training|computer-based training
31379|NCT03375840|pictorial warning labels|pictorial warning labels
31380|NCT03375840|risk knowledge|risk knowledge
31381|NCT03375840|emotion|emotion
31382|NCT03375840|memory|memory
31383|NCT03375840|risk perceptions|risk perceptions
31384|NCT03375840|quit intentions|quit intentions
31385|NCT03375827|Breast Cancer|breast cancer
31386|NCT03375814|Crocin, osteoarthritis, Inflammation, IL-17,T-helper,T-reg|crocin, osteoarthritis, inflammation, il-17,t-helper,t-reg
31387|NCT03375788|tesamorelin|tesamorelin
31388|NCT03375788|obesity|obesity
31389|NCT03375788|fatty liver|fatty liver
31390|NCT03375749|sitting|sitting
31391|NCT03375736|whole body vibration|whole body vibration
31392|NCT03375736|cerebral palsy|cerebral palsy
31393|NCT03375736|functional abilities|functional abilities
31394|NCT03375736|children|children
31395|NCT03375736|adults|adults
31396|NCT03375723|Pain measurement|pain measurement
31397|NCT03375723|Pain|pain
31398|NCT03375710|Heart Failure|heart failure
31399|NCT03375710|Heart Diseases|heart diseases
31400|NCT03375710|Cardiovascular Disease|cardiovascular disease
31401|NCT03375684|Cystic Fibrosis|cystic fibrosis
31402|NCT03375684|Inspiratory Muscle Training|inspiratory muscle training
31403|NCT03375684|Chest Physiotherapy|chest physiotherapy
31404|NCT03375684|Balance|balance
31405|NCT03375684|Postural Stability|postural stability
31406|NCT03375684|Pulmonary Function Test|pulmonary function test
31407|NCT03375684|6-Minute Walk Test|6-minute walk test
31408|NCT03375671|ketamine|ketamine
31409|NCT03375671|aggressive behaviour|aggressive behaviour
31410|NCT03375671|midazolam|midazolam
31411|NCT03375671|haloperidol|haloperidol
31412|NCT03375671|emergency department|emergency department
31413|NCT03375658|Information Science: Algorithms|information science: algorithms
31414|NCT03375658|Information Science: Informatics: Nursing Informatics|information science: informatics: nursing informatics
31415|NCT03375658|Information Science: Data Display: Computer graphics|information science: data display: computer graphics
31416|NCT03375658|Diagnosis: Diagnostic Techiques and Procedures: Monitoring, Physiologic|diagnosis: diagnostic techiques and procedures: monitoring, physiologic
31417|NCT03375658|Health care facilities, Manpower and services: Health services: Emergency Medical Services: Triage|health care facilities, manpower and services: health services: emergency medical services: triage
31418|NCT03375619|CAR-20/19 T-Cell Therapy|car-20/19 t-cell therapy
31419|NCT03375593|pain management|pain management
31421|NCT03375554|esophageal steothoscope, tracheal intubation|esophageal steothoscope, tracheal intubation
31422|NCT03375528|Matrix metalloproteinase|matrix metalloproteinase
31423|NCT03375528|neointimal hyperplasia|neointimal hyperplasia
31424|NCT03375515|hydromorphone titration|hydromorphone titration
31425|NCT03375489|Lung Cancer palliative care|lung cancer palliative care
31426|NCT03375476|postoperative myocardial infraction|postoperative myocardial infraction
31427|NCT03375476|myocardial injury|myocardial injury
31428|NCT03375476|general anesthesia|general anesthesia
31429|NCT03375476|vascular surgery|vascular surgery
31430|NCT03375476|surgical stress|surgical stress
31431|NCT03375476|surgical plethysmographic index|surgical plethysmographic index
31432|NCT03375450|Epidemiology, Chronic Obstructive Disease, Comparative Effectiveness, Exacerbation|epidemiology, chronic obstructive disease, comparative effectiveness, exacerbation
31433|NCT03375437|Clinical Trial|clinical trial
31434|NCT03375437|Multicenter Trial|multicenter trial
31435|NCT03375437|NTRK1|ntrk1
31436|NCT03375437|NTRK2|ntrk2
31437|NCT03375437|NTRK3|ntrk3
31438|NCT03375437|ROS1|ros1
31439|NCT03375437|ALK|alk
31440|NCT03375437|RNAseq|rnaseq
31441|NCT03375437|entrectinib|entrectinib
31442|NCT03375437|STARTRK-2|startrk-2
31443|NCT03375424|Vedolizumab, Crohns disease, Ulcerative colitis, safety|vedolizumab, crohns disease, ulcerative colitis, safety
31444|NCT03375398|SUGARDOWN™|sugardown™
31445|NCT03375398|Galactomannan|galactomannan
31446|NCT03375398|Postprandial blood glucose|postprandial blood glucose
31447|NCT03375398|Insulin|insulin
31448|NCT03375346|Whole body vibration exercise|whole body vibration exercise
31449|NCT03375333|ultrasound|ultrasound
31450|NCT03375333|diagnostics|diagnostics
31451|NCT03375333|general practice|general practice
31452|NCT03375333|family medicine|family medicine
31453|NCT03375294|PTSD|ptsd
31454|NCT03375255|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
31455|NCT03375255|Exon Skipping|exon skipping
31456|NCT03375255|DMD|dmd
31457|NCT03375255|Exon 51|exon 51
31458|NCT03375255|Ambulatory|ambulatory
31459|NCT03375255|Pediatric|pediatric
31460|NCT03375229|Myofascial Pain|myofascial pain
31461|NCT03375229|Pain Pressure Threshold|pain pressure threshold
31462|NCT03375229|Low-Level Laser Therapy|low-level laser therapy
31463|NCT03375229|Dry Needling|dry needling
31464|NCT03375177|multiple sclerosis|multiple sclerosis
31465|NCT03375177|Argentina|argentina
31466|NCT03375177|epidemiology|epidemiology
31467|NCT03375177|registry|registry
31468|NCT03375164|Duchenne|duchenne
31469|NCT03375164|gene therapy|gene therapy
31470|NCT03375164|DMD|dmd
31471|NCT03375164|dystrophin|dystrophin
31472|NCT03375138|Healthy volunteers|healthy volunteers
31473|NCT03375112|Total Hip Arthroplasty|total hip arthroplasty
31474|NCT03375112|Fascia Iliaca|fascia iliaca
31475|NCT03375112|Nerve Block|nerve block
31476|NCT03375112|Pain Control|pain control
31477|NCT03375099|Firearms|firearms
31478|NCT03375099|Guns|guns
31479|NCT03375099|Suicide|suicide
31480|NCT03375099|Means Safety|means safety
31481|NCT03375099|Means Restriction|means restriction
31482|NCT03375099|Lethal Means Counseling|lethal means counseling
31483|NCT03375047|Cystic Fibrosis|cystic fibrosis
31484|NCT03375047|CF|cf
31485|NCT03375034|Chronic pain|chronic pain
31486|NCT03375034|Benzodiazepine|benzodiazepine
31487|NCT03375034|Central sensitization|central sensitization
31488|NCT03375034|Selective compound|selective compound
31489|NCT03375034|GABAA receptors|gabaa receptors
31490|NCT03375034|Antihyperalgesia|antihyperalgesia
31491|NCT03375034|RCT|rct
31492|NCT03375021|ADHD, ampakine, Phase II clinical trial|adhd, ampakine, phase ii clinical trial
31493|NCT03375008|Magnetic resonance imager(MRI)|magnetic resonance imager(mri)
31494|NCT03375008|Nonalcoholic fatty liver disease(NAFLD)|nonalcoholic fatty liver disease(nafld)
31495|NCT03375008|Imaging diagnostic|imaging diagnostic
31496|NCT03374956|Pharmacological|pharmacological
31497|NCT03374956|Obesity Management|obesity management
31498|NCT03374956|Individualized|individualized
31499|NCT03374917|carbidopa|carbidopa
31500|NCT03374917|levodopa|levodopa
31501|NCT03374904|Parenting|parenting
31502|NCT03374904|Parental Mentalization|parental mentalization
31503|NCT03374904|Parental Reflective Function|parental reflective function
31504|NCT03374904|Child Psychopathology|child psychopathology
31505|NCT03374891|Shared Decision Making;|shared decision making;
31506|NCT03374891|Defibrillator|defibrillator
31507|NCT03374878|exercise|exercise
31508|NCT03374878|oral contraceptive|oral contraceptive
31509|NCT03374878|strength training|strength training
31510|NCT03374813|Bone graft substitutes|bone graft substitutes
31511|NCT03374813|Synthetic graft|synthetic graft
31512|NCT03374813|Xenograft|xenograft
31513|NCT03374813|Ridge preservation|ridge preservation
31514|NCT03374813|Alveolar defect|alveolar defect
31515|NCT03374761|child abuse|child abuse
31517|NCT03374761|low and middle income countries|low and middle income countries
31518|NCT03374761|child discipline|child discipline
31519|NCT03374761|Indonesia|indonesia
31520|NCT03374696|Chlamydia infections|chlamydia infections
31521|NCT03374696|condoms|condoms
31522|NCT03374696|theater,|theater,
31523|NCT03374696|sex education|sex education
31524|NCT03374683|Risky play|risky play
31525|NCT03374683|Physical activity|physical activity
31526|NCT03374683|Injury prevention|injury prevention
31527|NCT03374683|Outdoor play|outdoor play
31528|NCT03374670|Zimura|zimura
31529|NCT03374670|ARC1905|arc1905
31530|NCT03374670|Eylea|eylea
31531|NCT03374670|aflibercept|aflibercept
31532|NCT03374670|IPCV|ipcv
31533|NCT03374670|avacincaptad pegol|avacincaptad pegol
31534|NCT03374670|complement factor C5 inhibitor|complement factor c5 inhibitor
31535|NCT03374657|Clinical trials, dark adaptation, gene therapy, RLBP1 mutation, retinitis pigmentosa.|clinical trials, dark adaptation, gene therapy, rlbp1 mutation, retinitis pigmentosa.
31536|NCT03374644|Correlation|correlation
31537|NCT03374644|ETCO2|etco2
31538|NCT03374644|PaCO2|paco2
31539|NCT03374644|nasal cannula|nasal cannula
31540|NCT03374644|Sentri Nasal Cannula|sentri nasal cannula
31541|NCT03374592|Intensity-modulated radiation therapy|intensity-modulated radiation therapy
31542|NCT03374592|Volumetric intensity-modulated arc therapy|volumetric intensity-modulated arc therapy
31543|NCT03374592|Radiotherapy|radiotherapy
31544|NCT03374592|Pain|pain
31545|NCT03374592|Metastasis|metastasis
31546|NCT03374592|Quality of Life|quality of life
31547|NCT03374592|Acute Toxicity|acute toxicity
31548|NCT03374566|Epstein-Barr Virus Infections|epstein-barr virus infections
31549|NCT03374566|Immunodeficiency|immunodeficiency
31550|NCT03374566|Screening|screening
31551|NCT03374566|Immunologic Function|immunologic function
31552|NCT03374527|T-cells|t-cells
31553|NCT03374527|circulation|circulation
31554|NCT03374527|synovial fluid|synovial fluid
31555|NCT03374527|psoriasis|psoriasis
31556|NCT03374527|psoriatic arthritis|psoriatic arthritis
31557|NCT03374514|corticosteroids|corticosteroids
31558|NCT03374514|Electric impedance|electric impedance
31559|NCT03374501|Sugardown™|sugardown™
31560|NCT03374501|Galactomannan|galactomannan
31561|NCT03374501|Postprandial blood glucose|postprandial blood glucose
31562|NCT03374501|Insulin|insulin
31563|NCT03374488|Urothelial carcinoma|urothelial carcinoma
31564|NCT03374488|programmed cell death protein 1 (PD-1) inhibitor|programmed cell death protein 1 (pd-1) inhibitor
31565|NCT03374488|indoleamine 2,3-dioxygenase (IDO) inhibitor|indoleamine 2,3-dioxygenase (ido) inhibitor
31566|NCT03374462|Pediatrics|pediatrics
31567|NCT03374449|Major surgery|major surgery
31568|NCT03374449|Postoperative morbidity and mortality|postoperative morbidity and mortality
31569|NCT03374449|Renin angiotensin system inhibitors|renin angiotensin system inhibitors
31694|NCT03373578|Ear Protective Devices|ear protective devices
31570|NCT03374397|Laparoscopic unilateral ovarian cystectomy|laparoscopic unilateral ovarian cystectomy
31571|NCT03374397|SurgiGuard|surgiguard
31572|NCT03374397|Hemostasis|hemostasis
31573|NCT03374397|Ovarian function preservation|ovarian function preservation
31574|NCT03374397|Bipolar electrocauterization|bipolar electrocauterization
31575|NCT03374371|Staphylococcus epidermidis Infection|staphylococcus epidermidis infection
31576|NCT03374371|Staphylococcus epidermidis Contamination|staphylococcus epidermidis contamination
31577|NCT03374371|intravascular device|intravascular device
31578|NCT03374371|implanted material|implanted material
31579|NCT03374345|Cold Hypersensitivity|cold hypersensitivity
31580|NCT03374345|Korean medicine|korean medicine
31581|NCT03374345|Sipjeondaebo-tang|sipjeondaebo-tang
31582|NCT03374345|Cold intolerance|cold intolerance
31583|NCT03374332|Refractory|refractory
31584|NCT03374332|progression|progression
31585|NCT03374332|recurrence|recurrence
31586|NCT03374306|Myopia|myopia
31587|NCT03374306|Myopia control|myopia control
31588|NCT03374306|Atropine|atropine
31589|NCT03374306|Electroretinogram|electroretinogram
31590|NCT03374306|Multifocal Electroretinogram|multifocal electroretinogram
31591|NCT03374293|pancreatic cancer|pancreatic cancer
31592|NCT03374293|Radiation|radiation
31593|NCT03374293|Anti-PD-1 Antibody|anti-pd-1 antibody
31594|NCT03374280|non small cell lung cancer|non small cell lung cancer
31595|NCT03374280|Gefitinib|gefitinib
31596|NCT03374280|EGFR negative|egfr negative
31597|NCT03374280|Pemetrexed|pemetrexed
31598|NCT03374254|CRC, MSS, non-MSI-H, PD-1, anti-PD-1, anti PD-1, MEK, MEK inhibitor|crc, mss, non-msi-h, pd-1, anti-pd-1, anti pd-1, mek, mek inhibitor
31599|NCT03374215|Adrenal Adenoma|adrenal adenoma
31600|NCT03374215|Molecular Genetics|molecular genetics
31601|NCT03374215|African-American|african-american
31602|NCT03374215|Biomarkers|biomarkers
31603|NCT03374215|Primary Aldosteronism|primary aldosteronism
31604|NCT03374202|ARV Therapy|arv therapy
31605|NCT03374202|Broadly Neutralizing|broadly neutralizing
31606|NCT03374202|Gene Transfer|gene transfer
31607|NCT03374202|Monoclonal Antibody|monoclonal antibody
31608|NCT03374202|AAV8|aav8
31609|NCT03374176|periodontitis|periodontitis
31610|NCT03374176|diabetes mellitus|diabetes mellitus
31611|NCT03374176|systemic antimicrobials|systemic antimicrobials
31612|NCT03374163|infertility , implantion failure, intracytoplasmic sperm injection|infertility , implantion failure, intracytoplasmic sperm injection
31613|NCT03374150|Low-Calorie Diet|low-calorie diet
31614|NCT03374150|Diet, High-Protein|diet, high-protein
31615|NCT03374150|Obesity|obesity
31616|NCT03374150|weight cycling|weight cycling
31617|NCT03374150|body composition|body composition
31618|NCT03374150|high-sensitivity C-Reactive protein|high-sensitivity c-reactive protein
31619|NCT03374150|malondialdehyde|malondialdehyde
31620|NCT03374150|glutathione|glutathione
31621|NCT03374124|Chronic rhinosinusitis|chronic rhinosinusitis
31622|NCT03374124|Eosinophil|eosinophil
31623|NCT03374124|Surgery|surgery
31624|NCT03374124|Diagnosis|diagnosis
31625|NCT03374111|Thalassemia;|thalassemia;
31626|NCT03374111|the Syndrome of Blood Deficiency|the syndrome of blood deficiency
31627|NCT03374111|Anemia|anemia
31628|NCT03374111|Colla Corii Asini|colla corii asini
31629|NCT03374098|Medicaid|medicaid
31630|NCT03374098|Mississippi|mississippi
31631|NCT03374085|Multiple Myeloma|multiple myeloma
31632|NCT03374085|Safety|safety
31633|NCT03374085|Efficacy|efficacy
31634|NCT03374085|CC-92480|cc-92480
31635|NCT03374085|Relapsed|relapsed
31636|NCT03374085|Refractory|refractory
31637|NCT03374033|Preterm infants, growth, nutrition, physical activity|preterm infants, growth, nutrition, physical activity
31638|NCT03373994|FDG, perfusion, hypoxia, tumor, PET|fdg, perfusion, hypoxia, tumor, pet
31639|NCT03373955|T Cell repertoire|t cell repertoire
31640|NCT03373955|lung cancer|lung cancer
31641|NCT03373955|tumor mutation burden|tumor mutation burden
31642|NCT03373955|Circulating tumour DNA|circulating tumour dna
31643|NCT03373942|glaucoma|glaucoma
31644|NCT03373942|EDI OCT|edi oct
31645|NCT03373942|pseudoexfoliation|pseudoexfoliation
31646|NCT03373942|choroidal thickness|choroidal thickness
31647|NCT03373916|Peer Mentorship|peer mentorship
31648|NCT03373916|Psychiatric Hospitalization|psychiatric hospitalization
31649|NCT03373916|Suicide Risk|suicide risk
31650|NCT03373864|Unilateral spinal anesthesia|unilateral spinal anesthesia
31651|NCT03373864|general anesthesia|general anesthesia
31652|NCT03373864|hemodynamic stability|hemodynamic stability
31653|NCT03373864|MINS|mins
31654|NCT03373864|hip fracture|hip fracture
31655|NCT03373864|elderly|elderly
31656|NCT03373864|AKI|aki
31657|NCT03373825|overdose prevention|overdose prevention
31658|NCT03373825|opioid overdose|opioid overdose
31659|NCT03373825|risk behavior|risk behavior
31660|NCT03373825|harm reduction|harm reduction
31661|NCT03373799|rotator cuff|rotator cuff
31662|NCT03373799|physiotherapy|physiotherapy
31663|NCT03373799|video-based rehabilitation|video-based rehabilitation
31664|NCT03373799|exercise|exercise
31665|NCT03373786|Kidney disease|kidney disease
31666|NCT03373786|Nephritis|nephritis
31667|NCT03373786|Hereditary kidney disease|hereditary kidney disease
31668|NCT03373786|Hereditary nephritis|hereditary nephritis
31669|NCT03373773|pelvic reconstructive surgery|pelvic reconstructive surgery
31670|NCT03373773|foley catheter|foley catheter
31671|NCT03373773|Foley removal|foley removal
31672|NCT03373773|Urogynecology|urogynecology
31673|NCT03373773|Urinary Retention|urinary retention
31674|NCT03373773|Gynecologic surgery|gynecologic surgery
31675|NCT03373734|Online Cognitive Behavioural Therapy|online cognitive behavioural therapy
31676|NCT03373734|Pregnancy|pregnancy
31677|NCT03373734|Self-help|self-help
31678|NCT03373669|oral cholera vaccine|oral cholera vaccine
31679|NCT03373669|OCV|ocv
31680|NCT03373669|dose interval|dose interval
31681|NCT03373656|Vaccination|vaccination
31682|NCT03373656|Childhood|childhood
31683|NCT03373656|Hematologic Malignancy|hematologic malignancy
31684|NCT03373656|Solid Tumor|solid tumor
31685|NCT03373656|Immune Deficiency|immune deficiency
31686|NCT03373604|18F-MK-6240|18f-mk-6240
31687|NCT03373604|Cognitive Impairment|cognitive impairment
31688|NCT03373604|Alzheimer's|alzheimer's
31689|NCT03373591|bariatric surgery|bariatric surgery
31690|NCT03373591|liposomal bupivacaine|liposomal bupivacaine
31691|NCT03373578|sleep;|sleep;
31692|NCT03373578|Infant, Premature;|infant, premature;
31693|NCT03373578|Polysomnography;|polysomnography;
31695|NCT03373552|Coronary Artery Disease; Clopidogrel; Polymorphism, genetic|coronary artery disease; clopidogrel; polymorphism, genetic
31696|NCT03373539|Biomarkers|biomarkers
31697|NCT03373539|Neurotrophins|neurotrophins
31698|NCT03373526|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
31699|NCT03373526|Aerobic Exercise|aerobic exercise
31700|NCT03373526|Breathing Exercises|breathing exercises
31701|NCT03373526|Inspiratory Capacity|inspiratory capacity
31702|NCT03373526|Muscle Strength|muscle strength
31703|NCT03373526|Exercise Tolerance|exercise tolerance
31704|NCT03373526|Autonomic Nervous System|autonomic nervous system
31705|NCT03373513|Return-to-work, Visual analogue pain score, Cosmesis|return-to-work, visual analogue pain score, cosmesis
31706|NCT03373461|glomerunephritis, complement driven, chronic kidney disease|glomerunephritis, complement driven, chronic kidney disease
31707|NCT03373409|Dry Powder Inhaler|dry powder inhaler
31710|NCT03373396|cirrhosis|cirrhosis
31711|NCT03373396|chronic hepatitis B, C|chronic hepatitis b, c
31712|NCT03373396|alcohol|alcohol
31713|NCT03373396|viral hepatitis|viral hepatitis
31714|NCT03373396|transaminases|transaminases
31715|NCT03373396|fibroscan|fibroscan
31716|NCT03373383|Epilepsy|epilepsy
31717|NCT03373383|Padsevonil|padsevonil
31718|NCT03373357|sleep apnea|sleep apnea
31719|NCT03373357|arterial hypertension|arterial hypertension
31720|NCT03373357|cardiovascular risk|cardiovascular risk
31721|NCT03373344|emotional processing|emotional processing
31722|NCT03373344|multiple sclerosis|multiple sclerosis
31723|NCT03373344|cognition|cognition
31724|NCT03373331|Emotional Processing|emotional processing
31725|NCT03373331|Cognition|cognition
31726|NCT03373331|Traumatic Brain Injury|traumatic brain injury
31727|NCT03373331|Intervention|intervention
31728|NCT03373292|Stenting|stenting
31729|NCT03373292|Jugular vein stenosis|jugular vein stenosis
31730|NCT03373292|Intracranial hypertension|intracranial hypertension
31731|NCT03373292|Headache|headache
31732|NCT03373292|Tinnitus|tinnitus
31733|NCT03373292|Papilledema|papilledema
31734|NCT03373292|Visual impairment|visual impairment
31735|NCT03373279|Heart Transplant|heart transplant
31736|NCT03373240|Drug use Disorders|drug use disorders
31737|NCT03373240|Cognitive Remediation|cognitive remediation
31738|NCT03373227|Heart Transplant|heart transplant
31739|NCT03373214|Human Hookworm|human hookworm
31740|NCT03373214|Necator americanus|necator americanus
31741|NCT03373214|Hookworm|hookworm
31742|NCT03373214|Hookworm Disease|hookworm disease
31743|NCT03373214|Iron-deficiency anemia|iron-deficiency anemia
31744|NCT03373214|Soil-transmitted helminth infection|soil-transmitted helminth infection
31745|NCT03373214|Neglected Tropical Disease|neglected tropical disease
31746|NCT03373214|Na-GST-1|na-gst-1
31747|NCT03373214|CpG|cpg
31748|NCT03373175|Monitoring NIV, inspiratory muscular unloading, EMG|monitoring niv, inspiratory muscular unloading, emg
31749|NCT03373149|IVF|ivf
31750|NCT03373149|Growth hormone|growth hormone
31751|NCT03373149|Poor responders|poor responders
31752|NCT03373123|Esophageal Varices|esophageal varices
31753|NCT03373123|Variceal Hemorrhage|variceal hemorrhage
31754|NCT03373123|Endoscopy|endoscopy
31755|NCT03373123|Radiomics|radiomics
31756|NCT03373123|Hepatitis B Virus|hepatitis b virus
31757|NCT03373110|Online Therapy|online therapy
31758|NCT03373110|Fitbit|fitbit
31759|NCT03373110|Depression|depression
31760|NCT03373110|Cardiovascular Disease|cardiovascular disease
31761|NCT03373097|Neuroblastoma|neuroblastoma
31762|NCT03373097|GD2 CAR T cell|gd2 car t cell
31763|NCT03373097|CAR T|car t
31764|NCT03373084|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
31765|NCT03373084|Ultrasound|ultrasound
31766|NCT03373084|Sport|sport
31767|NCT03373084|Hamstring muscle|hamstring muscle
31768|NCT03373084|Injury|injury
31769|NCT03373071|CD19-CAR T cell|cd19-car t cell
31770|NCT03373071|CD19-malignancy|cd19-malignancy
31771|NCT03373071|CAR T cell|car t cell
31772|NCT03373071|CD19-ALL|cd19-all
31773|NCT03373071|CD19-LNH|cd19-lnh
31774|NCT03373058|Hyperthermic Intraperitoneal Chemotherapy|hyperthermic intraperitoneal chemotherapy
31775|NCT03373058|Advanced-Stage Epithelial Ovarian Cancer|advanced-stage epithelial ovarian cancer
31776|NCT03373058|Cytoreductive surgery|cytoreductive surgery
31777|NCT03373058|Postoperative Chemotherapy|postoperative chemotherapy
31778|NCT03373045|Severe asthma|severe asthma
31779|NCT03373045|Monoclonal antibody|monoclonal antibody
31780|NCT03373045|Corticosteroid|corticosteroid
31781|NCT03373045|Non-interventional|non-interventional
31782|NCT03373032|Physical Activity|physical activity
31783|NCT03373032|Sensory Neuropathy|sensory neuropathy
31784|NCT03373032|Acupuncture|acupuncture
31785|NCT03373019|chidamide|chidamide
31786|NCT03373019|R-GDP|r-gdp
31787|NCT03373019|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
31788|NCT03372980|Biomarkers|biomarkers
31789|NCT03372967|preventable disease|preventable disease
31790|NCT03372967|vaccine|vaccine
31791|NCT03372967|public health|public health
31792|NCT03372967|vaccine history|vaccine history
31793|NCT03372967|point-of-care|point-of-care
31794|NCT03372941|Acute bacterial skin and skin structure infections|acute bacterial skin and skin structure infections
31795|NCT03372941|Hospital avoidance|hospital avoidance
31796|NCT03372941|Antibiotic therapy|antibiotic therapy
31797|NCT03372941|Dalbavancin|dalbavancin
31798|NCT03372941|Emergency department|emergency department
31799|NCT03372902|Breast imaging|breast imaging
31800|NCT03372902|17-598|17-598
31801|NCT03372889|Anterior Cruciate Ligament|anterior cruciate ligament
31802|NCT03372889|On-Q Catheter|on-q catheter
31803|NCT03372889|nerve block|nerve block
31804|NCT03372889|ACL reconstruction|acl reconstruction
31805|NCT03372889|patient education materials|patient education materials
31806|NCT03372837|Diffuse large B-cell lymphoma, rituximab, SyB L-0501, combination therapy|diffuse large b-cell lymphoma, rituximab, syb l-0501, combination therapy
31807|NCT03372824|mass screening|mass screening
31808|NCT03372798|catheter ablation|catheter ablation
32007|NCT03371355|Fatty Liver|fatty liver
31809|NCT03372798|intraprocedural left atrial wall thickness imaging|intraprocedural left atrial wall thickness imaging
31810|NCT03372785|coronary artery disease|coronary artery disease
31811|NCT03372785|Cardiac magnetic resonance (CMR) imaging|cardiac magnetic resonance (cmr) imaging
31812|NCT03372785|Myocardial Stunning|myocardial stunning
31813|NCT03372785|Percutaneous Coronary Intervention|percutaneous coronary intervention
31814|NCT03372785|Chronic Total Occlusion of Coronary Artery|chronic total occlusion of coronary artery
31815|NCT03372772|Fatigue, Levocarnitine,|fatigue, levocarnitine,
31816|NCT03372746|Biopsy|biopsy
31817|NCT03372733|Omega-7|omega-7
31818|NCT03372733|Palmitoleic Acid|palmitoleic acid
31819|NCT03372733|Monounsaturated Fatty Acids|monounsaturated fatty acids
31820|NCT03372733|Lipoproteins|lipoproteins
31821|NCT03372733|Satiety|satiety
31822|NCT03372707|Cuff leak test|cuff leak test
31823|NCT03372707|Post-extubation airway obstruction|post-extubation airway obstruction
31824|NCT03372707|Laryngeal edema|laryngeal edema
31825|NCT03372681|Distal Gastrectomy|distal gastrectomy
31826|NCT03372681|Postoperative Reflux Rate|postoperative reflux rate
31827|NCT03372681|Gastric Cance|gastric cance
31828|NCT03372681|Laparoscopic Surgery|laparoscopic surgery
31829|NCT03372668|lower limb amputation|lower limb amputation
31830|NCT03372668|PLP|plp
31831|NCT03372616|aortic blood pressure|aortic blood pressure
31832|NCT03372616|diastolic dysfuntion|diastolic dysfuntion
31833|NCT03372616|echocardiography|echocardiography
31834|NCT03372616|left ventricular ejection fraction|left ventricular ejection fraction
31835|NCT03372603|GSK2798745, efficacy, safety, chronic cough, crossover study|gsk2798745, efficacy, safety, chronic cough, crossover study
31836|NCT03372590|general movement assessment|general movement assessment
31837|NCT03372538|placenta accreta|placenta accreta
31838|NCT03372499|Hepatic Encephalopathy|hepatic encephalopathy
31839|NCT03372499|Diet Management|diet management
31840|NCT03372499|Transjugular Intrahepatic Portosystemic Shunt|transjugular intrahepatic portosystemic shunt
31841|NCT03372460|Transcranial Direct Current Stimulation|transcranial direct current stimulation
31842|NCT03372460|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
31843|NCT03372460|Virtual Reality|virtual reality
31844|NCT03372460|Prefrontal Cortex|prefrontal cortex
31845|NCT03372460|Veterans|veterans
31846|NCT03372460|Quality of Life|quality of life
31847|NCT03372395|probiotics implementation|probiotics implementation
31848|NCT03372395|HPV infection|hpv infection
31849|NCT03372395|vaginosis|vaginosis
31850|NCT03372395|yeast vaginitis|yeast vaginitis
31851|NCT03372382|postpartum|postpartum
31852|NCT03372369|contraceptive knowledge|contraceptive knowledge
31853|NCT03372369|contraceptive use|contraceptive use
31854|NCT03372369|educational intervention|educational intervention
31855|NCT03372369|poster|poster
31856|NCT03372369|online survey|online survey
31857|NCT03372356|DT|dt
31858|NCT03372356|HADS|hads
31859|NCT03372356|SPBS|spbs
31860|NCT03372356|CD-RISC|cd-risc
31861|NCT03372356|Psychosocial Screening|psychosocial screening
31862|NCT03372330|peripheral artery disease|peripheral artery disease
31863|NCT03372330|sepsis|sepsis
31864|NCT03372317|Tau|tau
31865|NCT03372317|MK-6240|mk-6240
31866|NCT03372317|Cognition|cognition
31867|NCT03372304|Peripheral regional anesthesia|peripheral regional anesthesia
31868|NCT03372291|Acute Myeloid Leukemia|acute myeloid leukemia
31869|NCT03372278|Total hip arthroplasty|total hip arthroplasty
31870|NCT03372278|Medical Device|medical device
31871|NCT03372278|Safety|safety
31872|NCT03372278|Prothesis|prothesis
31873|NCT03372265|Peripheral regional anesthesia|peripheral regional anesthesia
31874|NCT03372239|Indoximod|indoximod
31875|NCT03372226|Gambling|gambling
31876|NCT03372226|Problematic Gambling|problematic gambling
31877|NCT03372226|Pathological Gambling|pathological gambling
31878|NCT03372187|diet|diet
31879|NCT03372187|MS|ms
31880|NCT03372187|Telehealth|telehealth
31881|NCT03372174|cardiac surgery|cardiac surgery
31882|NCT03372174|mechanical ventilation|mechanical ventilation
31883|NCT03372174|postoperative infections|postoperative infections
31884|NCT03372161|lumbosacral radicular pain|lumbosacral radicular pain
31885|NCT03372161|sciatica|sciatica
31886|NCT03372161|leg pain|leg pain
31887|NCT03372135|POCD|pocd
31888|NCT03372135|RARC|rarc
31889|NCT03372135|Trendelenburg Position|trendelenburg position
31890|NCT03372096|embolization|embolization
31891|NCT03372096|prostate|prostate
31892|NCT03372083|Iron Chelation Therapy|iron chelation therapy
31893|NCT03372083|Deferasirox|deferasirox
31894|NCT03372083|Asunra|asunra
31895|NCT03372083|Jadenu|jadenu
31896|NCT03372083|Exjade|exjade
31897|NCT03372083|ICL 670|icl 670
31898|NCT03372083|Pediatric|pediatric
31899|NCT03372070|primary snoring|primary snoring
31900|NCT03372070|bed partner|bed partner
31901|NCT03372070|home sleep testing|home sleep testing
31902|NCT03372057|Lymphoma|lymphoma
31903|NCT03372057|T-cell Lymphoma|t-cell lymphoma
31904|NCT03372057|Relapse|relapse
31905|NCT03372057|Refractory|refractory
31906|NCT03372057|PI3K-δ,γ|pi3k-δ,γ
31907|NCT03372044|Relative bioavailability|relative bioavailability
31908|NCT03372044|Modified release|modified release
31909|NCT03372044|Pharmacokinetics|pharmacokinetics
31910|NCT03372031|Music Supported Therapy|music supported therapy
31911|NCT03372031|plasticity|plasticity
31912|NCT03372031|multisensory integration|multisensory integration
31913|NCT03372031|bimanual coupling|bimanual coupling
31914|NCT03372031|auditory feedback|auditory feedback
31915|NCT03372031|dexterity|dexterity
31916|NCT03372031|piano therapy|piano therapy
31917|NCT03371992|immunotherapy|immunotherapy
31918|NCT03371992|anti-PD1|anti-pd1
31919|NCT03371992|anti-PDL1|anti-pdl1
31920|NCT03371992|biomarker|biomarker
31921|NCT03371992|drug mechanism|drug mechanism
31922|NCT03371966|Beetroot Juice|beetroot juice
31923|NCT03371966|Older Adults|older adults
31924|NCT03371966|Nitrate|nitrate
31925|NCT03371966|Nitrite|nitrite
31926|NCT03371966|Nitric Oxide|nitric oxide
31927|NCT03371953|vecuronium|vecuronium
31928|NCT03371953|atracurium|atracurium
31929|NCT03371953|combination|combination
31930|NCT03371927|Premature Infants|premature infants
31931|NCT03371927|SINC feeding protocol|sinc feeding protocol
31932|NCT03371914|costing|costing
31933|NCT03371914|behavioral intervention|behavioral intervention
31934|NCT03371914|management|management
31935|NCT03371901|Menisci, Tibial|menisci, tibial
31936|NCT03371901|Cartilage, Articular|cartilage, articular
31937|NCT03371901|Blood Flow Restriction Training|blood flow restriction training
31938|NCT03371901|Resistance training|resistance training
31939|NCT03371901|Physical Therapy Modalities|physical therapy modalities
31940|NCT03371901|Feasibility Studies|feasibility studies
31941|NCT03371862|Liraglutide|liraglutide
31942|NCT03371862|Victoza|victoza
31943|NCT03371836|pediatrics|pediatrics
31944|NCT03371823|Hypertension|hypertension
31945|NCT03371823|Endothelin-1 receptor|endothelin-1 receptor
31946|NCT03371810|attention-deficit / hyperactivity disorder|attention-deficit / hyperactivity disorder
31947|NCT03371810|depression|depression
31948|NCT03371810|obesity|obesity
31949|NCT03371810|prevention|prevention
31950|NCT03371810|bright light therapy|bright light therapy
31951|NCT03371810|exercise|exercise
31952|NCT03371810|mobile healthy system|mobile healthy system
31953|NCT03371797|ALERT, MSSBP, MSDBP|alert, mssbp, msdbp
31954|NCT03371784|Acute myocardial infarction|acute myocardial infarction
31955|NCT03371784|Left ventricular remodeling|left ventricular remodeling
31956|NCT03371784|Coronary wedge pressure|coronary wedge pressure
31957|NCT03371784|Glucocorticoid therapy|glucocorticoid therapy
31958|NCT03371732|Psychological intervention Alcohol|psychological intervention alcohol
31959|NCT03371732|Tobacco consumption|tobacco consumption
31960|NCT03371732|Substance use|substance use
31961|NCT03371732|Health risk behavior|health risk behavior
31962|NCT03371732|Oncology setting|oncology setting
31963|NCT03371732|Women|women
31964|NCT03371732|Supportive care|supportive care
31965|NCT03371706|aphasia|aphasia
31966|NCT03371706|primary progressive aphasia|primary progressive aphasia
31967|NCT03371706|dementia|dementia
31968|NCT03371706|communication|communication
31969|NCT03371706|frontotemporal dementia|frontotemporal dementia
31970|NCT03371706|Alzheimer's disease|alzheimer's disease
31971|NCT03371693|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
31972|NCT03371693|epithelial ovarian cancer|epithelial ovarian cancer
31973|NCT03371667|Hematopoietic Stem Cell|hematopoietic stem cell
31974|NCT03371667|Methotrexate|methotrexate
31975|NCT03371667|Corticosteroids therapy|corticosteroids therapy
31976|NCT03371667|Acute GVHD|acute gvhd
31977|NCT03371667|Allogenic stem cell transplantation|allogenic stem cell transplantation
31978|NCT03371641|Fetal Alcohol Syndrome|fetal alcohol syndrome
31979|NCT03371641|Pregnancy|pregnancy
31980|NCT03371641|Biomarker|biomarker
31981|NCT03371641|PlGF|plgf
31982|NCT03371641|Cognitive development|cognitive development
31983|NCT03371641|Behavior troubles|behavior troubles
31984|NCT03371576|toric IOL|toric iol
31985|NCT03371550|Concurrent 3-D chemoradiotherapy,Docetaxel,Cisplatin,Chemotherapy ·|concurrent 3-d chemoradiotherapy,docetaxel,cisplatin,chemotherapy ·
31986|NCT03371511|Microbiota|microbiota
31987|NCT03371511|Microbiome|microbiome
31988|NCT03371485|Non-small cell lung cancer|non-small cell lung cancer
31989|NCT03371485|Immunotherapy|immunotherapy
31990|NCT03371485|Cancer vaccine|cancer vaccine
31991|NCT03371485|Dendritic cell vaccine|dendritic cell vaccine
31992|NCT03371485|Allogeneic vaccine|allogeneic vaccine
31993|NCT03371446|DNA Methylation. Smoking. SOCS-1 gene.|dna methylation. smoking. socs-1 gene.
31994|NCT03371433|Osteoporosis|osteoporosis
31995|NCT03371433|Hip Fractures|hip fractures
31996|NCT03371433|Soft Drinks|soft drinks
31997|NCT03371368|Obesity|obesity
31998|NCT03371368|Insulin Resistance|insulin resistance
31999|NCT03371368|Bariatric Surgery|bariatric surgery
32000|NCT03371368|Gastric Bypass|gastric bypass
32001|NCT03371368|Sleeve Gastrectomy|sleeve gastrectomy
32002|NCT03371355|Type 2 Diabetes|type 2 diabetes
32003|NCT03371355|Hepatic Steatosis|hepatic steatosis
32004|NCT03371355|Triglycerides|triglycerides
32005|NCT03371355|AKCEA-ANGPTL3-Lrx|akcea-angptl3-lrx
32006|NCT03371355|IONIS-ANGPTL3-Lrx|ionis-angptl3-lrx
32008|NCT03371355|Fatty Liver Without Mention of Alcohol|fatty liver without mention of alcohol
32009|NCT03371355|Liver Fat|liver fat
32010|NCT03371355|Liver Diseases|liver diseases
32011|NCT03371355|Diabetes Mellitus Type 2 in Nonobese|diabetes mellitus type 2 in nonobese
32012|NCT03371355|Diabetes Mellitus|diabetes mellitus
32013|NCT03371355|Triglycerides High|triglycerides high
32014|NCT03371355|High Triglycerides|high triglycerides
32015|NCT03371355|Metabolic Disease|metabolic disease
32016|NCT03371355|Endocrine System Diseases|endocrine system diseases
32017|NCT03371355|Digestive System Disease|digestive system disease
32018|NCT03371355|Glucose Metabolism Disorders|glucose metabolism disorders
32019|NCT03371329|mesenchymal stem cell|mesenchymal stem cell
32020|NCT03371329|stroke|stroke
32021|NCT03371329|intracerebral hemorrhage|intracerebral hemorrhage
32022|NCT03371329|cell therapy|cell therapy
32023|NCT03371264|Liver transplantation|liver transplantation
32024|NCT03371264|Allocation process|allocation process
32025|NCT03371264|Extended-criteria donors|extended-criteria donors
32026|NCT03371264|Survival|survival
32027|NCT03371251|Adults|adults
32028|NCT03371251|BOS161721|bos161721
32029|NCT03371251|standard of care|standard of care
32030|NCT03371251|moderately to severely active Systemic Lupus Erythematosus|moderately to severely active systemic lupus erythematosus
32031|NCT03371212|Dual Mobility, Serum metal levels|dual mobility, serum metal levels
32032|NCT03371186|Implementation Research|implementation research
32033|NCT03371186|Maternal Mortality and Morbidity|maternal mortality and morbidity
32034|NCT03371186|Neonatal Mortality and Morbidity|neonatal mortality and morbidity
32035|NCT03371186|Infant Mortality and Morbidity|infant mortality and morbidity
32036|NCT03371186|Child Mortality and Morbidity|child mortality and morbidity
32037|NCT03371186|Community Health Workers|community health workers
32038|NCT03371186|Health Systems Strengthening|health systems strengthening
32039|NCT03371173|Pulmonary Hypertension|pulmonary hypertension
32040|NCT03371173|Iron Deficiency|iron deficiency
32041|NCT03371108|Diabetes|diabetes
32042|NCT03371108|Diabetes Type 2|diabetes type 2
32043|NCT03371108|Type 2|type 2
32044|NCT03371108|Basal|basal
32045|NCT03371108|Insulin|insulin
32046|NCT03371108|Glargine|glargine
32047|NCT03371108|T2DM|t2dm
32048|NCT03371108|Diabetes Mellitus|diabetes mellitus
32049|NCT03371095|Behcet's Disease|behcet's disease
32050|NCT03371095|Vasculitis|vasculitis
32051|NCT03371095|Biotherapy|biotherapy
32052|NCT03371095|immunosuppressant|immunosuppressant
32053|NCT03371095|Infliximab|infliximab
32054|NCT03371082|Diabetes|diabetes
32055|NCT03371082|Diabetes Type 1|diabetes type 1
32056|NCT03371082|Type 1|type 1
32057|NCT03371082|Basal|basal
32058|NCT03371082|Insulin|insulin
32059|NCT03371082|Glargine|glargine
32060|NCT03371082|T1DM|t1dm
32061|NCT03371082|Diabetes Mellitus|diabetes mellitus
32062|NCT03371082|Insulin Dependent Diabetes|insulin dependent diabetes
32063|NCT03371069|methylphenidate|methylphenidate
32064|NCT03371069|drug utilisation study|drug utilisation study
32065|NCT03371069|pediatrics|pediatrics
32066|NCT03371056|Neonatal infections|neonatal infections
32067|NCT03371056|maternal-fetal infection|maternal-fetal infection
32068|NCT03371056|group B streptococcus|group b streptococcus
32069|NCT03371056|vaginal sample|vaginal sample
32070|NCT03371056|antibiotic prophylaxis|antibiotic prophylaxis
32071|NCT03371056|bacterial resistance|bacterial resistance
32072|NCT03371043|analgesics|analgesics
32073|NCT03371043|opioids|opioids
32074|NCT03371043|outpatient drug use|outpatient drug use
32075|NCT03371043|pediatrics|pediatrics
32076|NCT03371030|distal radius fractures|distal radius fractures
32077|NCT03371030|pronator quadratus|pronator quadratus
32078|NCT03371030|osteosynthesis|osteosynthesis
32079|NCT03371004|DM-CHOC-PEN|dm-choc-pen
32080|NCT03371004|Radiation|radiation
32081|NCT03371004|Cancer|cancer
32082|NCT03370991|Blueberries|blueberries
32083|NCT03370991|Polyphenols|polyphenols
32084|NCT03370991|Cardiovascular Disease|cardiovascular disease
32085|NCT03370991|Atherosclerosis|atherosclerosis
32086|NCT03370991|Oxidative Stress|oxidative stress
32087|NCT03370991|Inflammmation|inflammmation
32088|NCT03370991|Endothelium|endothelium
32089|NCT03370991|Vasodilation|vasodilation
32090|NCT03370991|Blood Pressure|blood pressure
32091|NCT03370991|Menopause|menopause
32092|NCT03370991|Women's Health|women's health
32093|NCT03370991|Functional Food|functional food
32094|NCT03370991|Bioactive Compounds|bioactive compounds
32095|NCT03370991|Dietary Supplements|dietary supplements
32096|NCT03370991|Aging|aging
32097|NCT03370965|optic neuritis|optic neuritis
32098|NCT03370965|neuromyelitis optica|neuromyelitis optica
32099|NCT03370965|multiple sclerosis|multiple sclerosis
32100|NCT03370965|emergent treatment of optic neuritis|emergent treatment of optic neuritis
32101|NCT03370965|optic neuritis disease modifying therapy|optic neuritis disease modifying therapy
32102|NCT03370965|optic neuritis treatment trial|optic neuritis treatment trial
32103|NCT03370965|plasma exchange|plasma exchange
32104|NCT03370939|ischemic stroke|ischemic stroke
32105|NCT03370939|endovascular treatment|endovascular treatment
32106|NCT03370939|workflow|workflow
32107|NCT03370913|Gene Therapy|gene therapy
32108|NCT03370913|Clotting Disorders|clotting disorders
32109|NCT03370913|Blood Disorder|blood disorder
32110|NCT03370913|Blood Coagulation Disorders|blood coagulation disorders
32111|NCT03370913|Inherited Blood Coagulation disorders|inherited blood coagulation disorders
32112|NCT03370913|Hematologic Diseases|hematologic diseases
32113|NCT03370913|Coagulation Protein Disorders|coagulation protein disorders
32114|NCT03370913|Hemorrhagic Disorders|hemorrhagic disorders
32115|NCT03370913|Genetic Diseases|genetic diseases
32116|NCT03370913|Inborn|inborn
32117|NCT03370913|Factor VIII|factor viii
32118|NCT03370913|Coagulants|coagulants
32119|NCT03370900|Education (Medical); Retention;|education (medical); retention;
32120|NCT03370848|Niacin|niacin
32121|NCT03370848|Psyllium|psyllium
32122|NCT03370848|Dietary fiber|dietary fiber
32123|NCT03370835|Beta-Blocker|beta-blocker
32124|NCT03370835|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
32125|NCT03370835|COPD|copd
32126|NCT03370835|Cardioselective|cardioselective
32127|NCT03370822|Fetal monitoring|fetal monitoring
32128|NCT03370822|Acceptability|acceptability
32129|NCT03370822|Fetal Heart Rate|fetal heart rate
32130|NCT03370809|Frailty|frailty
32131|NCT03370809|Oncogeriatric|oncogeriatric
32132|NCT03370809|PET 18F-FDG|pet 18f-fdg
32133|NCT03370809|SPM (Statistical Parametric Mapping)|spm (statistical parametric mapping)
32134|NCT03370809|Neurology|neurology
32135|NCT03370796|dementia|dementia
32136|NCT03370796|cognitive impairment|cognitive impairment
32137|NCT03370796|cognition|cognition
32138|NCT03370796|quality of life|quality of life
32139|NCT03370796|depressive symptoms|depressive symptoms
32140|NCT03370796|Reminiscence Therapy|reminiscence therapy
32141|NCT03370744|subjective cognitive decline|subjective cognitive decline
32142|NCT03370744|brain network|brain network
32143|NCT03370744|multi-modality|multi-modality
32144|NCT03370744|magnetic resonance imaging|magnetic resonance imaging
32145|NCT03370731|pediatric|pediatric
32146|NCT03370731|obstructive sleep apnea|obstructive sleep apnea
32147|NCT03370731|polysomnography|polysomnography
32148|NCT03370731|quality of life|quality of life
32149|NCT03370731|adenotonsillectomy|adenotonsillectomy
32150|NCT03370718|Adrenocortical carcinoma|adrenocortical carcinoma
32151|NCT03370718|ACC|acc
32152|NCT03370718|Cabozantinib|cabozantinib
32153|NCT03370718|XL-184|xl-184
32154|NCT03370718|XL184|xl184
32155|NCT03370692|Outcome|outcome
32156|NCT03370692|Survival|survival
32157|NCT03370692|Prognostication|prognostication
32158|NCT03370679|Premature|premature
32159|NCT03370679|Ventricular|ventricular
32160|NCT03370679|Complexes|complexes
32161|NCT03370679|Beats|beats
32162|NCT03370679|Prognosis|prognosis
32163|NCT03370653|MPS VI|mps vi
32164|NCT03370653|Lysosomal disease|lysosomal disease
32165|NCT03370653|Glycoaminoglycans (GAG)|glycoaminoglycans (gag)
32166|NCT03370653|Odiparcil|odiparcil
32167|NCT03370627|Autoimmune Diseases|autoimmune diseases
32168|NCT03370627|Plasmacytoid Dendritic Cells|plasmacytoid dendritic cells
32169|NCT03370627|Type I Interferons|type i interferons
32170|NCT03370627|Antibodies|antibodies
32171|NCT03370627|Anti-CD303|anti-cd303
32172|NCT03370614|PET|pet
32173|NCT03370614|MRI|mri
32174|NCT03370614|Irritable Bowel Syndrome|irritable bowel syndrome
32175|NCT03370614|Irritable Bowel|irritable bowel
32176|NCT03370614|Positron emission tomography|positron emission tomography
32177|NCT03370614|Magnetic resonance imaging|magnetic resonance imaging
32178|NCT03370614|FDG|fdg
32179|NCT03370614|Fluorodeoxyglucose|fluorodeoxyglucose
32180|NCT03370601|crohn's disease|crohn's disease
32181|NCT03370601|ulcerative colitis|ulcerative colitis
32182|NCT03370601|infliximab|infliximab
32183|NCT03370601|loss of response|loss of response
32184|NCT03370562|dexmedetomidine|dexmedetomidine
32185|NCT03370562|cesarean|cesarean
32186|NCT03370562|spinal anesthesia|spinal anesthesia
32187|NCT03370549|Mental health|mental health
32188|NCT03370549|Suicide|suicide
32189|NCT03370549|Sexual risk behaviors|sexual risk behaviors
32190|NCT03370536|Atrial Fibrillation|atrial fibrillation
32191|NCT03370536|Persistent Atrial Fibrillation|persistent atrial fibrillation
32192|NCT03370536|AFIB|afib
32193|NCT03370536|Arrhythmia|arrhythmia
32194|NCT03370471|aerobic exercise|aerobic exercise
32195|NCT03370471|learning|learning
32196|NCT03370471|language|language
32197|NCT03370471|cognition|cognition
32198|NCT03370432|Vitamin D|vitamin d
32199|NCT03370432|GC|gc
32200|NCT03370432|CYP2R1|cyp2r1
32201|NCT03370432|Gene-environment interaction|gene-environment interaction
32202|NCT03370432|prospective case-cohort study|prospective case-cohort study
32203|NCT03370432|single nucleotide polymorphisms|single nucleotide polymorphisms
32204|NCT03370432|colorectal cancer|colorectal cancer
32205|NCT03370419|Metabolic syndrome|metabolic syndrome
32206|NCT03370419|Habits|habits
32207|NCT03370419|African American|african american
32208|NCT03370419|Emergency Medicine|emergency medicine
32209|NCT03370406|Squamous Cell|squamous cell
32210|NCT03370406|Carcinoma|carcinoma
32211|NCT03370406|Lower Extremities|lower extremities
32212|NCT03370406|5-Fluorouracil|5-fluorouracil
32213|NCT03370406|Imiquimod|imiquimod
32214|NCT03370393|Reward-drive|reward-drive
32215|NCT03370393|Cogntiive-control|cogntiive-control
32216|NCT03370315|Parkinsonian Disorders|parkinsonian disorders
32217|NCT03370315|Dance Therapy|dance therapy
32218|NCT03370315|Rehabilitation|rehabilitation
32219|NCT03370315|Kinematics|kinematics
32220|NCT03370315|Locomotion|locomotion
32221|NCT03370315|Quality of Life|quality of life
32222|NCT03370302|Drug therapy|drug therapy
32223|NCT03370263|Benlysta, systemic lupus erythematosus, safety, efficacy|benlysta, systemic lupus erythematosus, safety, efficacy
32224|NCT03370250|immediate breast reconstruction|immediate breast reconstruction
32225|NCT03370250|free greater omentum|free greater omentum
32226|NCT03370250|breast-conserving surgery|breast-conserving surgery
32227|NCT03370250|luminal breast cancer|luminal breast cancer
32228|NCT03370237|Diabetic foot ulcer|diabetic foot ulcer
32229|NCT03370237|type 2 diabetes|type 2 diabetes
32230|NCT03370237|foot ulcer risk|foot ulcer risk
32231|NCT03370224|Memory|memory
32232|NCT03370224|Learning|learning
32233|NCT03370224|Cognition|cognition
32234|NCT03370224|Treatment|treatment
32235|NCT03370211|resistance training|resistance training
32236|NCT03370211|inflammatory markers|inflammatory markers
32237|NCT03370211|functional capacity|functional capacity
32238|NCT03370185|Leukemia|leukemia
32239|NCT03370185|Lymphoma|lymphoma
32240|NCT03370185|Refractory|refractory
32241|NCT03370185|Relapse|relapse
32242|NCT03370133|Bimekizumab|bimekizumab
32243|NCT03370133|PSO|pso
32244|NCT03370133|Psoriasis|psoriasis
32245|NCT03370120|Drug-Resistant Epilepsy|drug-resistant epilepsy
32246|NCT03370120|Padsevonil|padsevonil
32247|NCT03370081|Capnometry|capnometry
32248|NCT03370081|Capnography|capnography
32249|NCT03370081|ETCO2|etco2
32250|NCT03370081|Recovery room|recovery room
32251|NCT03370081|Post-anesthesia care unit|post-anesthesia care unit
32252|NCT03370068|ICSI|icsi
32253|NCT03370068|IVF|ivf
32254|NCT03370068|Infertility|infertility
32255|NCT03370068|non-male factor|non-male factor
32256|NCT03370068|intracytoplasmic sperm injection|intracytoplasmic sperm injection
32257|NCT03370068|In vitro fertilization|in vitro fertilization
32258|NCT03370055|Exposed tendon or bone|exposed tendon or bone
32259|NCT03370055|LeucoPatch|leucopatch
32260|NCT03370055|Plastic Surgery|plastic surgery
32261|NCT03370055|Granulation tissue|granulation tissue
32262|NCT03370055|Wound|wound
32263|NCT03370042|aesthetics|aesthetics
32264|NCT03370042|root coverage|root coverage
32265|NCT03370042|semilunar coronally positioned flap|semilunar coronally positioned flap
32266|NCT03370042|free gingival graft|free gingival graft
32267|NCT03370042|width of keratinised tissue|width of keratinised tissue
32268|NCT03370029|Exercise capacity|exercise capacity
32269|NCT03370029|Respiratory muscle strength|respiratory muscle strength
32270|NCT03370029|Physical inactivity|physical inactivity
32271|NCT03370029|Quality of life|quality of life
32272|NCT03370016|Radical Prostatectomy|radical prostatectomy
32273|NCT03370016|Robotic Assisted Radical Prostatectomy|robotic assisted radical prostatectomy
32274|NCT03369977|BioGlue Surgical Adhesive|bioglue surgical adhesive
32275|NCT03369977|Type A Aortic Dissection|type a aortic dissection
32276|NCT03369951|ACUMIN|acumin
32277|NCT03369951|Infusion|infusion
32278|NCT03369951|Injection|injection
32279|NCT03369951|Minocycline|minocycline
32280|NCT03369951|Pharmacokinetic|pharmacokinetic
32281|NCT03369951|PK|pk
32282|NCT03369938|left ventricular assist device|left ventricular assist device
32283|NCT03369938|exercise training|exercise training
32284|NCT03369912|Safety, efficacy|safety, efficacy
32285|NCT03369912|pregnant women|pregnant women
32286|NCT03369912|CSJ148|csj148
32287|NCT03369912|HCMV infection|hcmv infection
32288|NCT03369912|congenital HCMV|congenital hcmv
32289|NCT03369886|OCTA|octa
32290|NCT03369886|Angiography|angiography
32291|NCT03369886|Artificial neural network|artificial neural network
32292|NCT03369873|cardiac catheterization|cardiac catheterization
32293|NCT03369873|anxiety|anxiety
32294|NCT03369873|stress|stress
32295|NCT03369873|nursing orientation|nursing orientation
32296|NCT03369847|inhaled corticosteroids|inhaled corticosteroids
32297|NCT03369847|budesonide|budesonide
32298|NCT03369847|beclomethasone|beclomethasone
32299|NCT03369834|phototherapy|phototherapy
32300|NCT03369834|diabetes mellitus|diabetes mellitus
32301|NCT03369834|exercise|exercise
32302|NCT03369821|type 1 diabetes|type 1 diabetes
32303|NCT03369821|monogenic diabetes|monogenic diabetes
32304|NCT03369821|autoimmune diabetes|autoimmune diabetes
32305|NCT03369821|early-onset autoimmune diabetes|early-onset autoimmune diabetes
32306|NCT03369821|beta cell (β-cell) destruction|beta cell (β-cell) destruction
32307|NCT03369821|type 1 diabetes genetic risk|type 1 diabetes genetic risk
32308|NCT03369821|extremely early-onset Type 1 diabetes|extremely early-onset type 1 diabetes
32309|NCT03369821|neonatal diabetes|neonatal diabetes
32310|NCT03369808|H7N9|h7n9
32311|NCT03369795|methotrexate|methotrexate
32312|NCT03369795|add-on|add-on
32313|NCT03369795|schizophrenia|schizophrenia
32314|NCT03369795|schizoaffective|schizoaffective
32315|NCT03369782|Muscle Tension|muscle tension
32316|NCT03369782|Skeletal Muscle Relaxants|skeletal muscle relaxants
32317|NCT03369782|Arthroplasties, Hip Replacement|arthroplasties, hip replacement
32318|NCT03369782|Rocuronium|rocuronium
32319|NCT03369782|sugammadex|sugammadex
32320|NCT03369730|Screening|screening
32321|NCT03369730|Duration of Untreated Psychosis (DUP)|duration of untreated psychosis (dup)
32322|NCT03369730|Coordinated Specialty Care (CSC)|coordinated specialty care (csc)
32323|NCT03369730|First Episode Psychosis (FEP)|first episode psychosis (fep)
32324|NCT03369730|At Risk Mental State (ARMS)|at risk mental state (arms)
32325|NCT03369730|Clinical High Risk for Psychosis (CHR)|clinical high risk for psychosis (chr)
32326|NCT03369717|endoscopic sinus surgery|endoscopic sinus surgery
32327|NCT03369717|antibiotics|antibiotics
32328|NCT03369704|cryptomeria, omalizumab, seasonal allergic rhinitis|cryptomeria, omalizumab, seasonal allergic rhinitis
32329|NCT03369678|Cultural Safety|cultural safety
32330|NCT03369678|Discrimination|discrimination
32331|NCT03369678|Emergency Departments|emergency departments
32332|NCT03369678|Health Equity|health equity
32333|NCT03369678|Indigenous Populations|indigenous populations
32334|NCT03369678|Marginalized Populations|marginalized populations
32335|NCT03369678|Patient Experiences of Care|patient experiences of care
32336|NCT03369678|Trauma- and Violence-Informed Care|trauma- and violence-informed care
32337|NCT03369678|Staff Engagement|staff engagement
32338|NCT03369678|Harm Reduction|harm reduction
32339|NCT03369665|Multiple sclerosis|multiple sclerosis
32340|NCT03369665|Mavenclad®|mavenclad®
32341|NCT03369665|Cladribine|cladribine
32342|NCT03369665|Health-related Quality of Life|health-related quality of life
32343|NCT03369639|late life|late life
32344|NCT03369639|THC|thc
32345|NCT03369639|depression|depression
32346|NCT03369639|anxiety|anxiety
32347|NCT03369639|dronabinol|dronabinol
32348|NCT03369587|Handwriting, Micrographia|handwriting, micrographia
32349|NCT03369548|Bile acids|bile acids
32350|NCT03369548|Lipid metabolism|lipid metabolism
32351|NCT03369548|Cholesterol|cholesterol
32352|NCT03369548|Probiotics|probiotics
32353|NCT03369548|Polyphenols|polyphenols
32354|NCT03369548|Prebiotics|prebiotics
32355|NCT03369548|Gut bacteria|gut bacteria
32356|NCT03369548|Gut microbiota|gut microbiota
32357|NCT03369535|hypertension|hypertension
32358|NCT03369522|seizure detection|seizure detection
32359|NCT03369509|Drug hypersensitivity, drug allergy, cross reaction|drug hypersensitivity, drug allergy, cross reaction
32360|NCT03369496|Social Capital|social capital
32361|NCT03369496|Social Support|social support
32362|NCT03369496|Neighborhood|neighborhood
32363|NCT03369496|Population Health|population health
32364|NCT03369496|Healthy Aging|healthy aging
32365|NCT03369496|Adult|adult
32366|NCT03369496|Canada|canada
32367|NCT03369431|Autism|autism
32368|NCT03369431|Gastrointestinal|gastrointestinal
32369|NCT03369431|behaviour|behaviour
32370|NCT03369431|constipation|constipation
32371|NCT03369431|diarrhoea|diarrhoea
32372|NCT03369431|probiotic|probiotic
32373|NCT03369431|sociability|sociability
32374|NCT03369405|periodontitis|periodontitis
32375|NCT03369405|hypothyroidism|hypothyroidism
32376|NCT03369379|Fibromyalgia|fibromyalgia
32377|NCT03369379|D Vitamin|d vitamin
32378|NCT03369366|Maxillofacial Defects|maxillofacial defects
32379|NCT03369366|Benign, large tumors requiring surgical resection|benign, large tumors requiring surgical resection
32380|NCT03369353|Bone Marrow Transplantation|bone marrow transplantation
32381|NCT03369353|Graft Vs Host Disease|graft vs host disease
32382|NCT03369353|Inflammatory Bowel Diseases|inflammatory bowel diseases
32383|NCT03369353|Functional Gastrointestinal Disorders|functional gastrointestinal disorders
32384|NCT03369340|Nicotine|nicotine
32385|NCT03369340|Reduced risk product|reduced risk product
32386|NCT03369340|Nicotine-containing product|nicotine-containing product
32387|NCT03369275|Mesenchymal Stem Cells|mesenchymal stem cells
32388|NCT03369275|Mesenchymal Stromal Cells|mesenchymal stromal cells
32389|NCT03369275|Randomized Controlled Trial|randomized controlled trial
32390|NCT03369275|Cryopreserved|cryopreserved
32391|NCT03369275|Allogeneic|allogeneic
32392|NCT03369275|Phase II|phase ii
32393|NCT03369262|preterm labor|preterm labor
32394|NCT03369262|preterm birth|preterm birth
32395|NCT03369262|premature birth|premature birth
32396|NCT03369262|tocolysis|tocolysis
32397|NCT03369262|prostaglandin F2α antagonist|prostaglandin f2α antagonist
32398|NCT03369262|PGF2α|pgf2α
32399|NCT03369223|Antibodies|antibodies
32400|NCT03369223|Antineoplastic Agents|antineoplastic agents
32401|NCT03369223|Immunologic Factors|immunologic factors
32402|NCT03369223|Nivolumab|nivolumab
32403|NCT03369223|Antibodies, Monoclonal|antibodies, monoclonal
32404|NCT03369223|Physiological Effects of Drugs|physiological effects of drugs
32405|NCT03369197|procedural sedation|procedural sedation
32406|NCT03369197|monitored anesthesia care|monitored anesthesia care
32407|NCT03369197|endoscopy|endoscopy
32408|NCT03369184|Coronary flow|coronary flow
32409|NCT03369184|Coronary vascular resistance|coronary vascular resistance
32410|NCT03369184|Supplemental oxygen|supplemental oxygen
32411|NCT03369145|Hepatokines|hepatokines
32412|NCT03369145|High Fat Diet|high fat diet
32413|NCT03369145|Glycaemic Control|glycaemic control
32414|NCT03369145|Fibroblast Growth Factor 21|fibroblast growth factor 21
32415|NCT03369145|Leukocyte Cell-derived Chemotaxin 2|leukocyte cell-derived chemotaxin 2
32416|NCT03369145|Fetuin-A|fetuin-a
32417|NCT03369145|Appetite|appetite
32418|NCT03369145|Ghrelin|ghrelin
32419|NCT03369145|Peptide YY|peptide yy
32420|NCT03369119|Acute asthma|acute asthma
32421|NCT03369119|Montelukast|montelukast
32422|NCT03369119|Hospitalized children|hospitalized children
32423|NCT03369119|Preschool children|preschool children
32424|NCT03369093|RCT|rct
32425|NCT03369093|severe pneumonia|severe pneumonia
32426|NCT03369093|amoxicillin|amoxicillin
32427|NCT03369093|under five|under five
32428|NCT03369080|Body Mass Index|body mass index
32429|NCT03369041|chemoembolization|chemoembolization
32430|NCT03369015|Reward Learning|reward learning
32431|NCT03369015|Decision Making|decision making
32432|NCT03369002|Hepatic Impairment|hepatic impairment
32433|NCT03368950|Anxiety|anxiety
32434|NCT03368950|Depression|depression
32435|NCT03368950|Stress|stress
32436|NCT03368937|Artificial Pancreas (AP)|artificial pancreas (ap)
32437|NCT03368937|Closed Loop Control (CLC)|closed loop control (clc)
32438|NCT03368937|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
32439|NCT03368937|Insulin Pump|insulin pump
32440|NCT03368924|sickle cell anemia red blood cell oxidation|sickle cell anemia red blood cell oxidation
32441|NCT03368924|vaso-occlusive crises|vaso-occlusive crises
32442|NCT03368924|anti bande 3 antibodies|anti bande 3 antibodies
32443|NCT03368924|red blood cell oxidation|red blood cell oxidation
32444|NCT03368911|Hoarseness|hoarseness
32445|NCT03368911|Sore Throat|sore throat
32446|NCT03368911|Thyroidectomy|thyroidectomy
32447|NCT03368885|MIYCN -Maternal Infant Young Child Nutrition|miycn -maternal infant young child nutrition
32448|NCT03368885|CGPP - Core Group Polio Project|cgpp - core group polio project
32449|NCT03368885|A&T- Alive and Thrive|a&t- alive and thrive
32450|NCT03368885|PCI- Project Concern International|pci- project concern international
32451|NCT03368885|UP- Uttar Pradesh|up- uttar pradesh
32452|NCT03368885|VHSNC -Village Health, Sanitation and Nutrition Committee|vhsnc -village health, sanitation and nutrition committee
32453|NCT03368885|CMC- Community Mobilization Coordinator|cmc- community mobilization coordinator
32454|NCT03368872|Sarcopenia, muscle function, muscle endurance, fatigue|sarcopenia, muscle function, muscle endurance, fatigue
32455|NCT03368859|cancer|cancer
32456|NCT03368859|colorectal cancer|colorectal cancer
32457|NCT03368859|ABT-165|abt-165
32458|NCT03368859|FOLFIRI|folfiri
32459|NCT03368859|Bevacizumab|bevacizumab
32460|NCT03368859|bowel cancer|bowel cancer
32461|NCT03368859|metastatic colorectal cancer|metastatic colorectal cancer
32462|NCT03368859|metastatic colorectal|metastatic colorectal
32463|NCT03368820|lung neoplasms|lung neoplasms
32464|NCT03368820|cardiovascular co-morbidity|cardiovascular co-morbidity
32465|NCT03368781|Atrial Fibrillation|atrial fibrillation
32466|NCT03368768|Antimicrobial-resistant bacterial infection|antimicrobial-resistant bacterial infection
32467|NCT03368768|Questionaire|questionaire
32468|NCT03368729|metastatic breast cancer|metastatic breast cancer
32469|NCT03368729|HER2 positive|her2 positive
32470|NCT03368729|Poly (ADP-Ribose) polymerase (PARP)|poly (adp-ribose) polymerase (parp)
32471|NCT03368729|Niraparib|niraparib
32472|NCT03368729|Trastuzumab|trastuzumab
32473|NCT03368716|Pediatric Obesity|pediatric obesity
32474|NCT03368716|Executive Function|executive function
32475|NCT03368716|Behavioral Intervention|behavioral intervention
32476|NCT03368703|COPD|copd
32477|NCT03368703|Transcranial direct-current stimulation|transcranial direct-current stimulation
32478|NCT03368703|Transcranial magnetic stimulation|transcranial magnetic stimulation
32479|NCT03368703|Motor-evoked potentials|motor-evoked potentials
32480|NCT03368703|Inhibition|inhibition
32481|NCT03368703|Muscle weakness|muscle weakness
32482|NCT03368690|Polyphenolic extract from pine bark, Antioxidant, Attention deficit/hyperactivity disorder.|polyphenolic extract from pine bark, antioxidant, attention deficit/hyperactivity disorder.
32483|NCT03368638|Degenerative lumbar spinal stenosis|degenerative lumbar spinal stenosis
32484|NCT03368638|Neural mobilization|neural mobilization
32485|NCT03368638|Hip extension mobilization|hip extension mobilization
32486|NCT03368638|Case series|case series
32487|NCT03368638|Neurogenic claudication|neurogenic claudication
32488|NCT03368625|Stereotactic Radiosurgery|stereotactic radiosurgery
32489|NCT03368625|Radiation|radiation
32490|NCT03368625|Surgery|surgery
32491|NCT03368586|Flash Glucose Monitoring|flash glucose monitoring
32492|NCT03368586|Children|children
32493|NCT03368586|Adolescents|adolescents
32494|NCT03368573|ADHD|adhd
32495|NCT03368573|Cognitive Assessment|cognitive assessment
32496|NCT03368573|QbTest|qbtest
32497|NCT03368573|Medication|medication
32498|NCT03368573|Feasibility|feasibility
32499|NCT03368560|Treatment-resistant Late Life Depression|treatment-resistant late life depression
32500|NCT03368560|Sudarshan Kriya Yoga|sudarshan kriya yoga
32501|NCT03368560|Glutathione|glutathione
32502|NCT03368508|Simulation|simulation
32503|NCT03368508|Physiotherapy training|physiotherapy training
32504|NCT03368508|360-degree video|360-degree video
32505|NCT03368495|yellow fever vaccine|yellow fever vaccine
32506|NCT03368495|MMR vaccine|mmr vaccine
32507|NCT03368495|immunogenicity|immunogenicity
32508|NCT03368482|cognition disorders|cognition disorders
32509|NCT03368482|frail elderly|frail elderly
32510|NCT03368482|human physical conditioning|human physical conditioning
32511|NCT03368482|institutionalization|institutionalization
32512|NCT03368482|physical activity|physical activity
32513|NCT03368469|Transcranial|transcranial
32514|NCT03368469|Stimulation|stimulation
32515|NCT03368456|mhealth|mhealth
32516|NCT03368456|preventive intervention|preventive intervention
32517|NCT03368456|primary health care|primary health care
32518|NCT03368443|Parkinson's disease|parkinson's disease
32519|NCT03368443|context-dependent learning|context-dependent learning
32520|NCT03368443|transcranial magnetic stimulation|transcranial magnetic stimulation
32521|NCT03368443|cognitive function|cognitive function
32522|NCT03368430|Melatonin; Chronic periodontitis; Host modulation therapy|melatonin; chronic periodontitis; host modulation therapy
32523|NCT03368417|Hypertension|hypertension
32524|NCT03368417|Wireless Home Blood Pressure Monitoring|wireless home blood pressure monitoring
32525|NCT03368417|Medication Adherence|medication adherence
32526|NCT03368417|Medication Titration|medication titration
32527|NCT03368417|Financial Incentives|financial incentives
32528|NCT03368417|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
32529|NCT03368378|prostate cancer|prostate cancer
32530|NCT03368378|radical prostatectomy|radical prostatectomy
32531|NCT03368378|deep venous complex ligation|deep venous complex ligation
32532|NCT03368365|Monitoring|monitoring
32533|NCT03368365|Home|home
32534|NCT03368365|Lung|lung
32535|NCT03368365|Transplant|transplant
32536|NCT03368365|Hospitalization|hospitalization
32537|NCT03368365|Respiratory function at rest|respiratory function at rest
32538|NCT03368365|Monitoring modem|monitoring modem
32539|NCT03368352|Melatonin|melatonin
32540|NCT03368352|Altitude|altitude
32541|NCT03368352|Sleep|sleep
32542|NCT03368352|Ventilation|ventilation
32543|NCT03368352|Cognition|cognition
32544|NCT03368300|progressive supranuclear palsy|progressive supranuclear palsy
32545|NCT03368300|Caribbean atypical Parkinsonism|caribbean atypical parkinsonism
32546|NCT03368300|Annona Muricata|annona muricata
32547|NCT03368287|Total Knee Arthroplasty|total knee arthroplasty
32548|NCT03368287|steps|steps
32549|NCT03368287|rehabilitation|rehabilitation
32550|NCT03368287|activity tracker|activity tracker
32551|NCT03368261|Pulmonary arterial hypertension|pulmonary arterial hypertension
32552|NCT03368261|SCD|scd
32553|NCT03368261|Epidemiology|epidemiology
32554|NCT03368248|Palliative care|palliative care
32555|NCT03368248|Collegial meetings|collegial meetings
32556|NCT03368248|Neonatal resuscitation services|neonatal resuscitation services
32557|NCT03368248|Survey|survey
32558|NCT03368248|Medico-caring staff of the NICUs|medico-caring staff of the nicus
32559|NCT03368235|rheumatoid arthritis, swollen joints, tender joints, autoimmunity|rheumatoid arthritis, swollen joints, tender joints, autoimmunity
32560|NCT03368222|Non Small Cell Lung Cancer|non small cell lung cancer
32561|NCT03368222|NSCLC|nsclc
32562|NCT03368209|Non-invasive glucose monitoring|non-invasive glucose monitoring
32563|NCT03368196|Stomach cancer|stomach cancer
32564|NCT03368196|Cancer where the esophagus meets the stomach|cancer where the esophagus meets the stomach
32565|NCT03368196|Human epidermal growth factor 2|human epidermal growth factor 2
32566|NCT03368196|HER2|her2
32567|NCT03368196|Breast Cancer|breast cancer
32568|NCT03368196|Adenocarcinoma, Gastroesophageal Junction (GEJ)|adenocarcinoma, gastroesophageal junction (gej)
32569|NCT03368196|Gastric Cancer|gastric cancer
32570|NCT03368196|Antibody drug conjugate (ADC)|antibody drug conjugate (adc)
32571|NCT03368196|Oncology|oncology
32572|NCT03368170|Levodopa induced dyskinesia|levodopa induced dyskinesia
32573|NCT03368118|ABX464|abx464
32574|NCT03368118|Ulcerative Colitis|ulcerative colitis
32575|NCT03368105|Clostridium difficile Infection|clostridium difficile infection
32576|NCT03368105|Lactobacillus plantarum 299v|lactobacillus plantarum 299v
32577|NCT03368105|organ transplantation|organ transplantation
32578|NCT03368105|antibiotic-associated diarrhoea|antibiotic-associated diarrhoea
32579|NCT03368092|severe trauma|severe trauma
32580|NCT03368092|acute respiratory distress syndrome|acute respiratory distress syndrome
32581|NCT03368092|damage-associated molecular patterns|damage-associated molecular patterns
32582|NCT03368092|neutrophil extracellular traps|neutrophil extracellular traps
32583|NCT03368092|dornase alfa|dornase alfa
32584|NCT03368079|Dysphagia|dysphagia
32585|NCT03368079|Oropharyngeal dysphagia|oropharyngeal dysphagia
32586|NCT03368079|Video Fluoroscopic Swallowing Exam (VFSE)|video fluoroscopic swallowing exam (vfse)
32587|NCT03368053|gp120|gp120
32588|NCT03368053|HIV infections|hiv infections
32589|NCT03368053|RV144|rv144
32590|NCT03368053|gp120-NefTat/AS01B vaccine candidate|gp120-neftat/as01b vaccine candidate
32591|NCT03368053|V1V2|v1v2
32592|NCT03368040|body core temperature|body core temperature
32593|NCT03368027|Vision Disorders; Stress, Psychological|vision disorders; stress, psychological
32594|NCT03368014|Sharing|sharing
32595|NCT03368014|Mind|mind
32596|NCT03368014|Enjoyment|enjoyment
32597|NCT03368001|Autism|autism
32598|NCT03367988|Opioid Dependence|opioid dependence
32599|NCT03367988|Analagesia|analagesia
32600|NCT03367988|Opioid-free Anesthesia|opioid-free anesthesia
32601|NCT03367962|PET-CT scan|pet-ct scan
32602|NCT03367962|[18F]F-AraG|[18f]f-arag
32603|NCT03367949|Surgical guide|surgical guide
32604|NCT03367949|impression inversion|impression inversion
32605|NCT03367949|stereolithographic surgical guides|stereolithographic surgical guides
32606|NCT03367936|mobile technology|mobile technology
32607|NCT03367936|feedback message|feedback message
32608|NCT03367936|self-monitoring|self-monitoring
32609|NCT03367910|Urinary tract infection|urinary tract infection
32610|NCT03367910|Multidrug resistant organism|multidrug resistant organism
32611|NCT03367910|Fecal microbiota transplantation|fecal microbiota transplantation
32612|NCT03367897|Helicobacter pylori|helicobacter pylori
32613|NCT03367897|peptic ulcer|peptic ulcer
32614|NCT03367897|erosions|erosions
32615|NCT03367897|bleeding|bleeding
32616|NCT03367897|Nsaids|nsaids
32617|NCT03367897|Noac|noac
32618|NCT03367884|Hypopharyngeal cancer|hypopharyngeal cancer
32619|NCT03367884|Neck dissection|neck dissection
32620|NCT03367884|Induction chemotherapy|induction chemotherapy
32621|NCT03367884|Cervical lymph node metastasis|cervical lymph node metastasis
32622|NCT03367884|definitive radiotherapy|definitive radiotherapy
32623|NCT03367845|Parent sensitivity|parent sensitivity
32624|NCT03367845|Fathers|fathers
32625|NCT03367845|Attachment|attachment
32626|NCT03367845|Marital communication|marital communication
32627|NCT03367780|Head-neck tumours|head-neck tumours
32628|NCT03367780|Radiotherapy|radiotherapy
32629|NCT03367780|Salivary gland toxicity|salivary gland toxicity
32630|NCT03367780|PSMA PET/CT|psma pet/ct
32631|NCT03367767|Blood Sample|blood sample
32632|NCT03367767|Medical History|medical history
32633|NCT03367767|Optical Imaging|optical imaging
32634|NCT03367754|Immunotherapy|immunotherapy
32635|NCT03367754|Immunologic Non-Responder|immunologic non-responder
32636|NCT03367754|Immunologic Response|immunologic response
32637|NCT03367754|Randomized|randomized
32638|NCT03367754|PD-1|pd-1
32639|NCT03367728|Bariatric Surgery|bariatric surgery
32640|NCT03367728|Bariatrics|bariatrics
32641|NCT03367728|Ropivacaine|ropivacaine
32642|NCT03367728|Randomized Controlled Trial|randomized controlled trial
32643|NCT03367728|Enhanced Recovery After Bariatric Surgery|enhanced recovery after bariatric surgery
32644|NCT03367728|TAP Block|tap block
32645|NCT03367728|Rectus Sheath Block|rectus sheath block
32646|NCT03367676|trastuzumab|trastuzumab
32647|NCT03367676|adjuvant therapy|adjuvant therapy
32648|NCT03367650|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
32649|NCT03367650|epidemiology|epidemiology
32650|NCT03367650|genetic|genetic
32651|NCT03367650|environmental factor|environmental factor
32652|NCT03367637|Cancer Pain, Palliative care, Mobile Applications, Rwanda|cancer pain, palliative care, mobile applications, rwanda
32653|NCT03367624|influenza|influenza
32654|NCT03367624|Staphylococcus Aureus|staphylococcus aureus
32655|NCT03367624|Pneumonia|pneumonia
32656|NCT03367624|PV leukocidin|pv leukocidin
32657|NCT03367624|ICU|icu
32658|NCT03367611|Immunochemical faecal occult blood test|immunochemical faecal occult blood test
32659|NCT03367611|iFOBT|ifobt
32660|NCT03367611|Cancer patient pathway|cancer patient pathway
32661|NCT03367611|Colonoscopy|colonoscopy
32662|NCT03367611|Colorectal cancer|colorectal cancer
32663|NCT03367585|Supplementary Feeding|supplementary feeding
32664|NCT03367585|vitamin D|vitamin d
32665|NCT03367585|Muscle Strength|muscle strength
32666|NCT03367585|postural balance|postural balance
32667|NCT03367585|exercise|exercise
32668|NCT03367585|aged|aged
32669|NCT03367559|Rotavirus|rotavirus
32670|NCT03367559|ROTAVAC|rotavac
32671|NCT03367559|Vaccine|vaccine
32672|NCT03367559|Vietnam|vietnam
32673|NCT03367546|SCD|scd
32674|NCT03367546|cALD|cald
32675|NCT03367481|Gingival fissures|gingival fissures
32676|NCT03367481|Gingival recession|gingival recession
32677|NCT03367481|Risk factors|risk factors
32678|NCT03367481|Traumatic toothbrusing|traumatic toothbrusing
32679|NCT03367468|Plantar fascitis|plantar fascitis
32680|NCT03367468|Pain|pain
32681|NCT03367468|Exercise|exercise
32682|NCT03367468|Physiotherapy|physiotherapy
32683|NCT03367468|Quality of life|quality of life
32684|NCT03367455|Potassium|potassium
32685|NCT03367455|Genetic Variants|genetic variants
32686|NCT03367442|Thoracic trauma|thoracic trauma
32687|NCT03367442|mechanical ventilation|mechanical ventilation
32688|NCT03367442|Acute respiratory distress syndrome|acute respiratory distress syndrome
32689|NCT03367442|Esophageal pressure|esophageal pressure
32690|NCT03367442|Pleural pressure|pleural pressure
32691|NCT03367429|stroke|stroke
32692|NCT03367429|spasticity|spasticity
32693|NCT03367403|TRAILBLAZER-ALZ|trailblazer-alz
32694|NCT03367364|Venous Thromboembolism, Deep Venous Thrombosis, Clots|venous thromboembolism, deep venous thrombosis, clots
32695|NCT03367325|non-valvular atrial fibrillation|non-valvular atrial fibrillation
32696|NCT03367325|time in therapeutic range|time in therapeutic range
32697|NCT03367325|primary care|primary care
32698|NCT03367299|Acute Lymphoid Leukemia|acute lymphoid leukemia
32699|NCT03367299|Philadelphia Chromosome-Negative B-Cell Precursor|philadelphia chromosome-negative b-cell precursor
32700|NCT03367299|Adults|adults
32701|NCT03367299|Minimal residual disease|minimal residual disease
32702|NCT03367299|Blinatumomab|blinatumomab
32703|NCT03367260|patient preferences|patient preferences
32704|NCT03367247|Ovarian Cancer|ovarian cancer
32705|NCT03367247|Bowel blockage|bowel blockage
32706|NCT03367247|Ascites|ascites
32707|NCT03367247|Supportive care|supportive care
32708|NCT03367247|Nursing|nursing
32709|NCT03367247|Mobile health|mobile health
32710|NCT03367247|m-Health|m-health
32711|NCT03367247|Tele-health|tele-health
32712|NCT03367247|Palliative Care|palliative care
32713|NCT03367247|Symptom management|symptom management
32714|NCT03367234|Federally Qualified Health Center|federally qualified health center
32715|NCT03367234|Contingency Management|contingency management
32716|NCT03367234|Cognitive Behavioral Therapy|cognitive behavioral therapy
32717|NCT03367234|Cognitive Behavioral / Relapse Prevention|cognitive behavioral / relapse prevention
32718|NCT03367234|Medication Assisted Treatment|medication assisted treatment
32719|NCT03367234|Behavioral Health Consultant|behavioral health consultant
32720|NCT03367234|Integrated Care|integrated care
32721|NCT03367208|metabolomic|metabolomic
32722|NCT03367195|GERD|gerd
32723|NCT03367195|DLBS2411|dlbs2411
32724|NCT03367195|omeprazole|omeprazole
32725|NCT03367169|Pilon fractures|pilon fractures
32726|NCT03367169|Osteosynthesis|osteosynthesis
32727|NCT03367169|Mini invasive plate osteosynthesis|mini invasive plate osteosynthesis
32728|NCT03367169|Locked plate|locked plate
32729|NCT03367169|Open reduction|open reduction
32730|NCT03367156|Dyspnea|dyspnea
32731|NCT03367156|Questionnaires|questionnaires
32732|NCT03367156|Surveys|surveys
32733|NCT03367156|Dexamethasone|dexamethasone
32734|NCT03367156|Decadron|decadron
32735|NCT03367156|Placebo|placebo
32736|NCT03367156|Sugar pill|sugar pill
32737|NCT03367130|Antiretroviral therapy, clinic attendance, Nepal|antiretroviral therapy, clinic attendance, nepal
32738|NCT03367091|Wearable Exoskeleton|wearable exoskeleton
32739|NCT03367091|Stroke|stroke
32740|NCT03367091|Energy Consumption|energy consumption
32741|NCT03367091|Cardiorespiratory Load|cardiorespiratory load
32742|NCT03367078|tDCS|tdcs
32743|NCT03367078|transcranial direct current stimulation|transcranial direct current stimulation
32744|NCT03367078|acquired brain injury|acquired brain injury
32745|NCT03367078|coma|coma
32746|NCT03367078|vigilance|vigilance
32747|NCT03367052|ProDisc-C vivo|prodisc-c vivo
32748|NCT03367052|Hybrid|hybrid
32749|NCT03367052|Cervical degenerative disc disease|cervical degenerative disc disease
32750|NCT03367039|ProDisc-C vivo|prodisc-c vivo
32751|NCT03367039|ACDF|acdf
32752|NCT03367039|Cervical degenerative disc disease|cervical degenerative disc disease
32753|NCT03367026|ivabradine|ivabradine
32754|NCT03367026|sepsis|sepsis
32755|NCT03367026|heart rate|heart rate
32756|NCT03366935|labor analgesia|labor analgesia
32757|NCT03366935|dural puncture epidural (DPE)|dural puncture epidural (dpe)
32758|NCT03366935|standard Epidural (EPL)|standard epidural (epl)
32759|NCT03366935|continuous epidural infusion (CEI)|continuous epidural infusion (cei)
32760|NCT03366935|programmed intermittent epidural bolus (PIEB)|programmed intermittent epidural bolus (pieb)
32761|NCT03366909|mindfulness|mindfulness
32762|NCT03366909|cannabis use|cannabis use
32763|NCT03366883|preoperative chemotherapy|preoperative chemotherapy
32764|NCT03366883|preoperative chemoradiotherapy|preoperative chemoradiotherapy
32765|NCT03366883|clinical trial|clinical trial
32766|NCT03366883|phase III|phase iii
32767|NCT03366883|Esophageal squamous cancer|esophageal squamous cancer
32768|NCT03366870|CBT-I|cbt-i
32769|NCT03366870|Insomnia|insomnia
32770|NCT03366844|invasive adenocarcinoma of the breast|invasive adenocarcinoma of the breast
32771|NCT03366844|ER-positive and HER2-negative breast cancer|er-positive and her2-negative breast cancer
32772|NCT03366844|Triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
32773|NCT03366844|immunotherapy|immunotherapy
32774|NCT03366844|checkpoint inhibitor|checkpoint inhibitor
32775|NCT03366805|opioid|opioid
32776|NCT03366805|analgesic|analgesic
32777|NCT03366805|ambulatory|ambulatory
32778|NCT03366805|orthopedic|orthopedic
32779|NCT03366805|surgery|surgery
32780|NCT03366805|patient education|patient education
32781|NCT03366805|video|video
32782|NCT03366805|medication diary|medication diary
32783|NCT03366779|Lumbar disc herniation, reherniation|lumbar disc herniation, reherniation
32784|NCT03366753|acute normovolemic hemodilution|acute normovolemic hemodilution
32785|NCT03366753|coronary artery bypass graft surgery|coronary artery bypass graft surgery
32786|NCT03366753|hydroxyethyl starch|hydroxyethyl starch
32787|NCT03366753|blood viscosity|blood viscosity
32788|NCT03366740|Persistent diarrhea|persistent diarrhea
32789|NCT03366740|> 6 to 36 months aged children|> 6 to 36 months aged children
32790|NCT03366740|green banana|green banana
32791|NCT03366740|rice suji|rice suji
32792|NCT03366740|milk suji|milk suji
32793|NCT03366740|comminuted chicken|comminuted chicken
32794|NCT03366727|drug eluting balloon|drug eluting balloon
32795|NCT03366714|Noninvasive ventilation, respiratory distress syndrome|noninvasive ventilation, respiratory distress syndrome
32796|NCT03366701|physical activity|physical activity
32797|NCT03366701|sedentary behavior|sedentary behavior
32798|NCT03366701|implicit attitudes|implicit attitudes
32799|NCT03366701|self regulation|self regulation
32800|NCT03366701|intention|intention
32801|NCT03366701|chronic diseases|chronic diseases
32802|NCT03366662|Electromyography|electromyography
32803|NCT03366649|Bypass Surgery|bypass surgery
32804|NCT03366649|Cardiology|cardiology
32805|NCT03366649|Coronary Artery Bypass Surgery|coronary artery bypass surgery
32806|NCT03366649|Mitral Valve Repair|mitral valve repair
32807|NCT03366649|Mitral Valve Surgery|mitral valve surgery
32808|NCT03366649|Coronary Revascularization|coronary revascularization
32809|NCT03366636|Pregnancy|pregnancy
32810|NCT03366636|Adolescents|adolescents
32811|NCT03366636|STIs/STDs|stis/stds
32812|NCT03366636|Self-sufficiency|self-sufficiency
32813|NCT03366623|Pain assessment|pain assessment
32814|NCT03366623|Self report|self report
32815|NCT03366623|Hospital clown intervention|hospital clown intervention
32816|NCT03366597|sevoflurane|sevoflurane
32817|NCT03366597|S100β protein|s100β protein
32818|NCT03366597|regional cerebral oxygen saturation|regional cerebral oxygen saturation
32819|NCT03366597|infant|infant
32820|NCT03366571|Liver Cirrhosis|liver cirrhosis
32821|NCT03366558|motion detectors|motion detectors
32822|NCT03366558|early stage Parkinson's disease|early stage parkinson's disease
32823|NCT03366558|advanced Parkinson's disease|advanced parkinson's disease
32824|NCT03366558|UPDRS|updrs
32825|NCT03366558|observational study with non-diseased controls|observational study with non-diseased controls
32826|NCT03366545|cardiac resynchronization therapy|cardiac resynchronization therapy
32827|NCT03366545|CRT|crt
32828|NCT03366545|clinical routine|clinical routine
32829|NCT03366532|diet|diet
32830|NCT03366532|food frequency questionnaire|food frequency questionnaire
32831|NCT03366532|nutrient|nutrient
32832|NCT03366519|Embolism, Pulmonary|embolism, pulmonary
32833|NCT03366519|echocardiography|echocardiography
32834|NCT03366519|emergency|emergency
32835|NCT03366519|prognosis|prognosis
32836|NCT03366467|dental treatment|dental treatment
32837|NCT03366467|sensory adapted environment|sensory adapted environment
32838|NCT03366428|HER2|her2
32839|NCT03366428|Breast cancer|breast cancer
32840|NCT03366428|Oncology|oncology
32841|NCT03366428|Antibody drug conjugate|antibody drug conjugate
32842|NCT03366428|ADC|adc
32843|NCT03366415|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
32844|NCT03366415|concurrent chemoradiotherapy|concurrent chemoradiotherapy
32845|NCT03366415|sequential chemoradiotherapy|sequential chemoradiotherapy
32846|NCT03366376|hippocampus|hippocampus
32847|NCT03366376|radiotherapy|radiotherapy
32848|NCT03366363|Knee osteoarthritis|knee osteoarthritis
32849|NCT03366363|acupuncture|acupuncture
32850|NCT03366363|electroacupuncture|electroacupuncture
32851|NCT03366363|sham acupuncture|sham acupuncture
32852|NCT03366337|IgA Nephropathy|iga nephropathy
32853|NCT03366337|CKD associated with type 1 diabetes|ckd associated with type 1 diabetes
32854|NCT03366337|Focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
32855|NCT03366337|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
32856|NCT03366337|IgAN|igan
32857|NCT03366337|FSGS|fsgs
32858|NCT03366337|ADPKD|adpkd
32859|NCT03366337|Bardoxolone methyl|bardoxolone methyl
32860|NCT03366337|CDDO-ME|cddo-me
32861|NCT03366337|RTA 402|rta 402
32862|NCT03366311|intubation|intubation
32863|NCT03366311|epiglottis lift|epiglottis lift
32864|NCT03366311|hold high position|hold high position
32865|NCT03366285|Bonding|bonding
32866|NCT03366285|Gene expression|gene expression
32867|NCT03366285|Stress response|stress response
32868|NCT03366285|Neurodevelopment|neurodevelopment
32869|NCT03366246|topical anesthetic|topical anesthetic
32870|NCT03366246|nanocapsules|nanocapsules
32871|NCT03366246|nanotechnology|nanotechnology
32872|NCT03366246|lidocaine|lidocaine
32873|NCT03366246|prilocaine|prilocaine
32874|NCT03366246|fractional CO2 laser resurfacing|fractional co2 laser resurfacing
32875|NCT03366168|Diabetes|diabetes
32876|NCT03366168|Fungiform Papillae|fungiform papillae
32877|NCT03366168|Insulin|insulin
32878|NCT03366155|Unresectable Liver Tumor|unresectable liver tumor
32879|NCT03366155|Response Rates|response rates
32880|NCT03366155|Progression-Free Survival|progression-free survival
32881|NCT03366155|Patient Survival|patient survival
32882|NCT03366142|Autosomal Recessive Disorder|autosomal recessive disorder
32883|NCT03366142|Bacterial Infections|bacterial infections
32884|NCT03366142|Gingival|gingival
32885|NCT03366142|Oral Ulcer|oral ulcer
32886|NCT03366142|Cytokine Expression|cytokine expression
32887|NCT03366129|CEREBROVASCULAR DISEASE|cerebrovascular disease
32888|NCT03366129|Vascular Cognitive Impairment|vascular cognitive impairment
32889|NCT03366129|Stroke|stroke
32890|NCT03366129|Permeability Imaging|permeability imaging
32891|NCT03366116|Pharmacodynamics|pharmacodynamics
32892|NCT03366116|DNA Methylation|dna methylation
32893|NCT03366116|Pharmacokinetics|pharmacokinetics
32894|NCT03366116|NUCLEOSIDE ANALOG|nucleoside analog
32895|NCT03366116|Epigenetics|epigenetics
32896|NCT03366064|Non-small cell lung cancer|non-small cell lung cancer
32897|NCT03366064|Natural killer cells|natural killer cells
32898|NCT03366064|HLA-haploidentical family donor|hla-haploidentical family donor
32899|NCT03366051|Endometrial Cancer|endometrial cancer
32900|NCT03366051|Sentinel Lymph Node|sentinel lymph node
32901|NCT03366051|Lymphadenectomy|lymphadenectomy
32902|NCT03366038|pancreaticoduodenectomy|pancreaticoduodenectomy
32903|NCT03366038|pancreaticojejunostomy|pancreaticojejunostomy
32904|NCT03366038|pancreatic fistula|pancreatic fistula
32905|NCT03366012|Cytosponge|cytosponge
32906|NCT03366012|GERD|gerd
32907|NCT03365986|hereditary|hereditary
32908|NCT03365986|colorectal cancer|colorectal cancer
32909|NCT03365986|screening|screening
32910|NCT03365973|Pathological Fracture|pathological fracture
32911|NCT03365973|Indeterminate Instability|indeterminate instability
32912|NCT03365973|Spinal Metastases|spinal metastases
32913|NCT03365973|Breast Cancer|breast cancer
32914|NCT03365960|Watermelon|watermelon
32915|NCT03365960|Watermelon phytochemicals bioavailability|watermelon phytochemicals bioavailability
32916|NCT03365960|Flow Mediated Vasodilation|flow mediated vasodilation
32917|NCT03365960|Pharmacokinetics|pharmacokinetics
32918|NCT03365934|Microflora|microflora
32919|NCT03365934|Microbiome|microbiome
32920|NCT03365934|skin physiology|skin physiology
32921|NCT03365934|Fitzpatrick Skin Types I-III|fitzpatrick skin types i-iii
32922|NCT03365934|Tape-stripped wounds|tape-stripped wounds
32923|NCT03365908|ACL|acl
32924|NCT03365895|diffusion|diffusion
32925|NCT03365895|tensor|tensor
32926|NCT03365895|imaging|imaging
32927|NCT03365895|chemotherapy|chemotherapy
32928|NCT03365895|peripheral neuropathy|peripheral neuropathy
32929|NCT03365895|breast cancer|breast cancer
32930|NCT03365895|MRI|mri
32931|NCT03365895|Magnetic Resonance Imaging|magnetic resonance imaging
32932|NCT03365895|Diffusion Tensor Imaging|diffusion tensor imaging
32933|NCT03365843|Cardiac surgery|cardiac surgery
32934|NCT03365843|Sternal closure|sternal closure
32935|NCT03365817|cognitive function|cognitive function
32936|NCT03365817|opioid dependence|opioid dependence
32937|NCT03365817|opioid withdrawal|opioid withdrawal
32938|NCT03365817|quality of life|quality of life
32939|NCT03365817|side effect|side effect
32940|NCT03365804|Ultrasound|ultrasound
32941|NCT03365804|Scoliosis|scoliosis
32942|NCT03365804|Orthoses|orthoses
32943|NCT03365804|3D Printing|3d printing
32944|NCT03365791|PDR001|pdr001
32945|NCT03365791|LAG525|lag525
32946|NCT03365791|Immune checkpoint blockade|immune checkpoint blockade
32947|NCT03365791|Solid tumor malignancy|solid tumor malignancy
32948|NCT03365791|lymphoma|lymphoma
32949|NCT03365791|Small cell lung cancer (SCLC)|small cell lung cancer (sclc)
32950|NCT03365791|Gastric/esophageal adenocarcinoma|gastric/esophageal adenocarcinoma
32951|NCT03365791|Castration resistant prostate adenocarcinoma (CRPC)|castration resistant prostate adenocarcinoma (crpc)
32952|NCT03365791|Soft tissue sarcoma|soft tissue sarcoma
32953|NCT03365791|Ovarian adenocarcinoma|ovarian adenocarcinoma
32954|NCT03365791|Advanced well-differentiated neuroendocrine tumors (NETs)|advanced well-differentiated neuroendocrine tumors (nets)
32955|NCT03365791|Diffuse large B cell lymphoma (DLBCL)|diffuse large b cell lymphoma (dlbcl)
32956|NCT03365778|educational intervention|educational intervention
32957|NCT03365778|SLT|slt
32958|NCT03365778|selective laser trabeculoplasty|selective laser trabeculoplasty
32959|NCT03365739|Mango|mango
32960|NCT03365739|Mango pulp phytochemicals bioavailability|mango pulp phytochemicals bioavailability
32961|NCT03365739|Pharmacokinetics|pharmacokinetics
32962|NCT03365713|COPD|copd
32963|NCT03365713|Spirometry|spirometry
32964|NCT03365713|COPD Diagnosis|copd diagnosis
32965|NCT03365713|PEF|pef
32966|NCT03365713|Case Finding|case finding
32967|NCT03365713|LMIC|lmic
32968|NCT03365700|Persistent atrial fibrillation|persistent atrial fibrillation
32969|NCT03365700|Catheter ablation|catheter ablation
32970|NCT03365687|Children|children
32971|NCT03365687|Vitamin D|vitamin d
32972|NCT03365687|Respiratory viral infection|respiratory viral infection
32973|NCT03365687|Randomized controlled trial|randomized controlled trial
32974|NCT03365687|Asthma exacerbations|asthma exacerbations
32975|NCT03365674|Myofascial Pain Syndromes, Gastrocnemius, Trigger points, Injections, Vibration|myofascial pain syndromes, gastrocnemius, trigger points, injections, vibration
32976|NCT03365661|AML|aml
32977|NCT03365661|MDS|mds
32978|NCT03365596|Brain connectivity|brain connectivity
32979|NCT03365596|Magnetic resonance imaging|magnetic resonance imaging
32980|NCT03365596|Recovery prediction|recovery prediction
32981|NCT03365583|Vitamin B12|vitamin b12
32982|NCT03365583|Microbiome|microbiome
32983|NCT03365583|infant|infant
32984|NCT03365570|hemoglobin, iron, oral lesions, oral manifestations,cross-sectional study|hemoglobin, iron, oral lesions, oral manifestations,cross-sectional study
32985|NCT03365531|fasting|fasting
32986|NCT03365518|Psychological Treatment|psychological treatment
32987|NCT03365518|Intimacy|intimacy
32988|NCT03365518|Cognitive Behavioural Therapy|cognitive behavioural therapy
32989|NCT03365518|Cognitive Behavioral Therapy|cognitive behavioral therapy
32990|NCT03365518|Mindfulness|mindfulness
32991|NCT03365518|Group Therapy|group therapy
32992|NCT03365518|Couples Therapy|couples therapy
32993|NCT03365479|pulmonary hypertension|pulmonary hypertension
32994|NCT03365479|iloprost|iloprost
32995|NCT03365479|inhaled|inhaled
32996|NCT03365479|breelib|breelib
32997|NCT03365479|nebulizer|nebulizer
32998|NCT03365479|pulmonary arterial hypertension|pulmonary arterial hypertension
32999|NCT03365466|recurrent implantation failure|recurrent implantation failure
33000|NCT03365466|aspirin|aspirin
33001|NCT03365466|low molecular weight heparin|low molecular weight heparin
33002|NCT03365440|ECG|ecg
33003|NCT03365440|cardiac arrhythmia|cardiac arrhythmia
33004|NCT03365440|heart rhythm|heart rhythm
33005|NCT03365440|esophageal ECG|esophageal ecg
33006|NCT03365440|non-invasive mapping|non-invasive mapping
33007|NCT03365440|supraventricular tachycardia|supraventricular tachycardia
33008|NCT03365440|atrial fibrillation|atrial fibrillation
33009|NCT03365440|atrial flutter|atrial flutter
33010|NCT03365440|extrasystole|extrasystole
33011|NCT03365427|rehabilitation|rehabilitation
33012|NCT03365427|application on smart phones|application on smart phones
33013|NCT03365414|Postural Orthostatic Tachycardia Syndrome|postural orthostatic tachycardia syndrome
33014|NCT03365414|POTS|pots
33015|NCT03365414|Syncope|syncope
33016|NCT03365414|Vasovagal|vasovagal
33017|NCT03365414|Hypotension|hypotension
33018|NCT03365414|Tachycardia|tachycardia
33019|NCT03365401|surgery|surgery
33020|NCT03365401|decompression|decompression
33021|NCT03365375|Chest Pain|chest pain
33022|NCT03365375|Anxiety|anxiety
33023|NCT03365375|Mindfulness|mindfulness
33024|NCT03365375|Emergency Service, Hospital|emergency service, hospital
33025|NCT03365362|directly observed therapy|directly observed therapy
33026|NCT03365362|varenicline|varenicline
33027|NCT03365362|long-term pharmacotherapy|long-term pharmacotherapy
33028|NCT03365323|Periprosthetic Joint Infection|periprosthetic joint infection
33029|NCT03365284|total knee arthroplasty|total knee arthroplasty
33030|NCT03365284|rehabilitation|rehabilitation
33031|NCT03365284|Smart Kneebrace|smart kneebrace
33032|NCT03365219|Surgical Site Infection|surgical site infection
33033|NCT03365219|Cesarean delivery infection|cesarean delivery infection
33034|NCT03365167|LANAP|lanap
33035|NCT03365167|Periodontitis|periodontitis
33036|NCT03365154|Peripheral Artery Disease|peripheral artery disease
33037|NCT03365154|Atherectomy|atherectomy
33038|NCT03365154|Orbital Atherectomy|orbital atherectomy
33039|NCT03365141|vitiligo|vitiligo
33040|NCT03365141|intralesional injection|intralesional injection
33041|NCT03365141|corticosteroid|corticosteroid
33042|NCT03365141|triamcinolone|triamcinolone
33043|NCT03365115|spinal anesthesia|spinal anesthesia
33044|NCT03365115|morphine|morphine
33045|NCT03365115|fentanyl|fentanyl
33046|NCT03365115|pain|pain
33047|NCT03365115|knee|knee
33048|NCT03365089|Hemodialysis fistula|hemodialysis fistula
33049|NCT03365089|Failure to mature|failure to mature
33050|NCT03365089|Collateral vein|collateral vein
33051|NCT03365063|Knowledge Translation|knowledge translation
33052|NCT03365063|Chronic Kidney Disease|chronic kidney disease
33053|NCT03365063|Matched Cluster Randomized Trial|matched cluster randomized trial
33054|NCT03365024|CBT-I|cbt-i
33055|NCT03365024|Insomnia|insomnia
33056|NCT03365011|Nitrous Oxide|nitrous oxide
33057|NCT03364972|cataract|cataract
33058|NCT03364972|cataract extraction|cataract extraction
33059|NCT03364972|interocular lens implant|interocular lens implant
33060|NCT03364972|glistenings|glistenings
33061|NCT03364972|phacoemulsification|phacoemulsification
33062|NCT03364972|hydrophobic acrylic|hydrophobic acrylic
33063|NCT03364972|light scatter|light scatter
33064|NCT03364972|patient related outcome measures|patient related outcome measures
33065|NCT03364933|Child|child
33066|NCT03364933|Critical Illness|critical illness
33067|NCT03364933|Length of Stay|length of stay
33068|NCT03364933|Satisfaction|satisfaction
33069|NCT03364920|Maresin-1|maresin-1
33070|NCT03364920|SAP|sap
33071|NCT03364920|IPN|ipn
33072|NCT03364920|MODS|mods
33073|NCT03364920|Mortality|mortality
33074|NCT03364907|HIPEC|hipec
33075|NCT03364907|oxaliplatin|oxaliplatin
33076|NCT03364907|flushing|flushing
33077|NCT03364907|peritoneal carcinomatosis|peritoneal carcinomatosis
33078|NCT03364894|Parkinson's Disease|parkinson's disease
33079|NCT03364894|Biomarkers|biomarkers
33080|NCT03364894|Wearable sensors|wearable sensors
33081|NCT03364894|Imaging|imaging
33082|NCT03364894|Disease progression|disease progression
33083|NCT03364868|Type 1 diabetes|type 1 diabetes
33084|NCT03364868|T1D|t1d
33085|NCT03364868|diabetes mellitus|diabetes mellitus
33086|NCT03364868|oral insulin|oral insulin
33087|NCT03364868|oral tolerance|oral tolerance
33088|NCT03364868|autoantigen|autoantigen
33089|NCT03364868|self tolerance|self tolerance
33090|NCT03364868|prevention|prevention
33091|NCT03364868|at risk for developing type 1 diabetes|at risk for developing type 1 diabetes
33092|NCT03364868|juvenile diabetes|juvenile diabetes
33093|NCT03364868|autoimmune diabetes|autoimmune diabetes
33094|NCT03364855|Balance|balance
33095|NCT03364855|Patellofemoral pain syndrome|patellofemoral pain syndrome
33096|NCT03364855|Star excursion balance test|star excursion balance test
33097|NCT03364855|Kinesthetic Ability Trainer 2000|kinesthetic ability trainer 2000
33098|NCT03364816|cervical spondylosis|cervical spondylosis
33099|NCT03364816|artificial disc replacement|artificial disc replacement
33100|NCT03364816|complications|complications
33101|NCT03364816|photographic indicators|photographic indicators
33102|NCT03364816|functional efficacy|functional efficacy
33103|NCT03364803|Cushing Syndrome|cushing syndrome
33104|NCT03364803|Cushing's Disease|cushing's disease
33105|NCT03364803|Cushing Disease|cushing disease
33106|NCT03364803|17-592|17-592
33107|NCT03364803|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
33108|NCT03364790|knee - spine syndrome|knee - spine syndrome
33109|NCT03364790|PLIF|plif
33110|NCT03364790|TKA|tka
33111|NCT03364790|sagittal parameters|sagittal parameters
33112|NCT03364790|neuroelectrophysiology|neuroelectrophysiology
33113|NCT03364777|lumbar surgery, emotional state|lumbar surgery, emotional state
33114|NCT03364764|sirolimus|sirolimus
33115|NCT03364764|refractory pure red cell aplasia|refractory pure red cell aplasia
33116|NCT03364764|prospective study|prospective study
33117|NCT03364751|Oral Health|oral health
33118|NCT03364751|Smoking|smoking
33119|NCT03364751|Cigarette|cigarette
33120|NCT03364751|Reduced risk product|reduced risk product
33121|NCT03364751|Tobacco heating system|tobacco heating system
33122|NCT03364751|THS|ths
33123|NCT03364751|Modified risk tobacco product|modified risk tobacco product
33124|NCT03364751|Clinical attachment level|clinical attachment level
33125|NCT03364699|strenuous exercise|strenuous exercise
33126|NCT03364699|dietary supplementation|dietary supplementation
33127|NCT03364699|immune system|immune system
33128|NCT03364699|leucocyte function|leucocyte function
33129|NCT03364699|inflammation|inflammation
33130|NCT03364686|BioRBCs|biorbcs
33131|NCT03364686|Biotin labeled red blood cells|biotin labeled red blood cells
33132|NCT03364673|Ovarian Cancer|ovarian cancer
33133|NCT03364673|Physical Activity|physical activity
33134|NCT03364673|Mobile Health|mobile health
33135|NCT03364673|Fitness Tracker|fitness tracker
33136|NCT03364673|Survivorship|survivorship
33137|NCT03364673|Quality of Life|quality of life
33138|NCT03364660|Epidural Stimulation|epidural stimulation
33139|NCT03364660|Spinal Cord Injury|spinal cord injury
33140|NCT03364660|Task-Specific|task-specific
33141|NCT03364634|decompressive craniectomy|decompressive craniectomy
33142|NCT03364634|intracranial pressure|intracranial pressure
33143|NCT03364634|icp|icp
33144|NCT03364634|telemetry|telemetry
33145|NCT03364634|telemetric|telemetric
33146|NCT03364621|Liver resection|liver resection
33147|NCT03364621|Metastasis|metastasis
33148|NCT03364621|Molecular profiling|molecular profiling
33149|NCT03364621|Epigenetic analysis|epigenetic analysis
33150|NCT03364621|Genomic analysis|genomic analysis
33151|NCT03364621|Sequencing|sequencing
33152|NCT03364595|radial head fracture|radial head fracture
33153|NCT03364595|replacement|replacement
33154|NCT03364595|plate|plate
33155|NCT03364582|Dietary patterns|dietary patterns
33156|NCT03364582|Metabolomics|metabolomics
33157|NCT03364582|Mortaltiy|mortaltiy
33158|NCT03364582|Colorectal cancer|colorectal cancer
33159|NCT03364569|Drainage|drainage
33160|NCT03364569|Breast augmentation|breast augmentation
33161|NCT03364569|Tranexamic acid|tranexamic acid
33162|NCT03364517|Medical regulation|medical regulation
33163|NCT03364517|SPIA|spia
33164|NCT03364517|Imminent delivery|imminent delivery
33165|NCT03364504|PXE|pxe
33166|NCT03364504|renal cells|renal cells
33167|NCT03364504|urine|urine
33168|NCT03364504|calcification|calcification
33169|NCT03364504|omics|omics
33170|NCT03364504|drug screening|drug screening
33171|NCT03364491|Tranexamic Acid|tranexamic acid
33172|NCT03364491|Hemorrhage|hemorrhage
33173|NCT03364491|Cesarean|cesarean
33174|NCT03364478|Surgical approach|surgical approach
33175|NCT03364478|Laparoscopic right hemicolectomy|laparoscopic right hemicolectomy
33176|NCT03364452|Dietary Assessment Methodology|dietary assessment methodology
33177|NCT03364452|beverages|beverages
33178|NCT03364452|non-nutritive sweeteners|non-nutritive sweeteners
33179|NCT03364439|DLBCL|dlbcl
33180|NCT03364387|Acute Coronary Syndrome|acute coronary syndrome
33181|NCT03364387|MINOCA|minoca
33182|NCT03364387|Myocardial Infarction|myocardial infarction
33183|NCT03364387|Atrial Fibrillation|atrial fibrillation
33184|NCT03364374|Stroke rehabilitation|stroke rehabilitation
33185|NCT03364374|Upper extremity|upper extremity
33186|NCT03364374|Posture|posture
33187|NCT03364309|plaque psoriasis|plaque psoriasis
33188|NCT03364309|ixekizumab|ixekizumab
33189|NCT03364309|skin condition|skin condition
33190|NCT03364309|skin disease|skin disease
33191|NCT03364309|itching|itching
33192|NCT03364309|psoriasis vulgaris|psoriasis vulgaris
33193|NCT03364309|immune-mediated systemic disease|immune-mediated systemic disease
33194|NCT03364309|skin lesions|skin lesions
33195|NCT03364309|scaly patches|scaly patches
33196|NCT03364309|papules|papules
33197|NCT03364296|Acute stroke, Biomarkers|acute stroke, biomarkers
33198|NCT03364283|Posterior fossa|posterior fossa
33199|NCT03364283|Pineal region|pineal region
33200|NCT03364270|atherosclerosis|atherosclerosis
33201|NCT03364257|metagenomic|metagenomic
33202|NCT03364257|infection|infection
33203|NCT03364257|diagnosis|diagnosis
33204|NCT03364244|Revatio|revatio
33205|NCT03364244|Pulmonary arterial hypertension|pulmonary arterial hypertension
33206|NCT03364244|Pediatric patients|pediatric patients
33207|NCT03364205|SFA interview technique|sfa interview technique
33208|NCT03364205|adolescence|adolescence
33209|NCT03364205|obesity|obesity
33210|NCT03364205|nutrition|nutrition
33211|NCT03364205|exercise|exercise
33212|NCT03364192|Whole Health Coaching|whole health coaching
33213|NCT03364192|Integrative Health Coaching|integrative health coaching
33214|NCT03364192|Peer Support Specialist|peer support specialist
33215|NCT03364192|Personalized Health Plan|personalized health plan
33216|NCT03364179|dementia|dementia
33217|NCT03364179|young onset dementia|young onset dementia
33218|NCT03364179|quality of death|quality of death
33219|NCT03364179|late onset dementia|late onset dementia
33220|NCT03364179|palliative care|palliative care
33221|NCT03364166|buccal squamous cell carcinoma|buccal squamous cell carcinoma
33222|NCT03364153|Zimura|zimura
33223|NCT03364153|ARC1905|arc1905
33224|NCT03364153|complement factor C5 inhibitor|complement factor c5 inhibitor
33225|NCT03364153|avacincaptad pegol|avacincaptad pegol
33226|NCT03364153|STGD1|stgd1
33227|NCT03364140|Peripartum Cardiomyopathy|peripartum cardiomyopathy
33228|NCT03364140|Heart Failure|heart failure
33229|NCT03364127|Vulvar Pain, Dyspareunia|vulvar pain, dyspareunia
33230|NCT03364088|Total knee arthroplasty|total knee arthroplasty
33231|NCT03364088|Anesthesia|anesthesia
33232|NCT03364088|Surgical tourniquet|surgical tourniquet
33233|NCT03364088|Pain|pain
33234|NCT03364088|Postoperative nausea and vomiting|postoperative nausea and vomiting
33235|NCT03364088|Quality of life|quality of life
33236|NCT03364088|Length of stay|length of stay
33237|NCT03364088|Knee function|knee function
33238|NCT03364088|Bioelectrical impedance|bioelectrical impedance
33239|NCT03364088|Knee endoprosthesis|knee endoprosthesis
33240|NCT03364062|Blood Pressure|blood pressure
33241|NCT03364062|shoulder replacement|shoulder replacement
33242|NCT03364062|proximal humeral fracture|proximal humeral fracture
33243|NCT03364036|Multiple sclerosis|multiple sclerosis
33244|NCT03364036|Mavenclad ®|mavenclad ®
33245|NCT03364036|Cladribine|cladribine
33246|NCT03364010|Motor control|motor control
33247|NCT03364010|Proprioception|proprioception
33248|NCT03363997|estriol|estriol
33249|NCT03363997|pharmacokinetic|pharmacokinetic
33250|NCT03363997|pharmacodynamic|pharmacodynamic
33251|NCT03363997|hormone replacement therapy|hormone replacement therapy
33252|NCT03363997|vaginal ring administration|vaginal ring administration
33253|NCT03363971|soft tissue, pain|soft tissue, pain
33254|NCT03363958|myocardial protection|myocardial protection
33255|NCT03363958|remote ischemic preconditioning|remote ischemic preconditioning
33256|NCT03363958|remote ischemic postconditioning|remote ischemic postconditioning
33257|NCT03363958|cardiac surgery|cardiac surgery
33258|NCT03363945|kidney transplant|kidney transplant
33259|NCT03363945|cellular therapy|cellular therapy
33260|NCT03363945|anti-rejection therapy|anti-rejection therapy
33261|NCT03363945|living donor|living donor
33262|NCT03363945|HLA-matched|hla-matched
33263|NCT03363945|hematopoietic stem cells (HSC)|hematopoietic stem cells (hsc)
33264|NCT03363945|CD34+|cd34+
33265|NCT03363945|CD3+|cd3+
33266|NCT03363945|T cells|t cells
33267|NCT03363932|Ventricular septal defect|ventricular septal defect
33268|NCT03363932|Congenital heart disease|congenital heart disease
33269|NCT03363932|Outcome|outcome
33270|NCT03363919|adolescent|adolescent
33271|NCT03363919|biomarkers|biomarkers
33272|NCT03363880|Severe trauma|severe trauma
33273|NCT03363880|Multiple trauma|multiple trauma
33274|NCT03363880|Regional Trauma management system|regional trauma management system
33275|NCT03363880|Trauma management team|trauma management team
33276|NCT03363867|High grade serous|high grade serous
33277|NCT03363867|C1 molecular subtype|c1 molecular subtype
33278|NCT03363841|Candida auris|candida auris
33279|NCT03363815|Healthy Volunteer|healthy volunteer
33280|NCT03363815|CC-90001|cc-90001
33281|NCT03363815|Pharmacokinetics|pharmacokinetics
33282|NCT03363815|Omeprazole|omeprazole
33283|NCT03363815|Midazolam|midazolam
33284|NCT03363815|Warfarin|warfarin
33285|NCT03363815|Rosuvastatin|rosuvastatin
33286|NCT03363815|Metformin|metformin
33287|NCT03363815|Digoxin|digoxin
33288|NCT03363815|Nintedanib|nintedanib
33289|NCT03363763|rash|rash
33290|NCT03363763|fibroma|fibroma
33291|NCT03363763|skin|skin
33292|NCT03363763|facial|facial
33293|NCT03363763|face|face
33294|NCT03363763|bumps|bumps
33295|NCT03363763|redness|redness
33296|NCT03363763|erythema|erythema
33297|NCT03363763|lesions|lesions
33298|NCT03363763|papules|papules
33299|NCT03363763|blood vessel|blood vessel
33300|NCT03363763|cheeks|cheeks
33301|NCT03363750|Depression|depression
33302|NCT03363750|Adolescent|adolescent
33303|NCT03363750|mind-body-skills|mind-body-skills
33304|NCT03363750|group therapy|group therapy
33305|NCT03363750|primary care|primary care
33306|NCT03363724|Parkinson Disease|parkinson disease
33307|NCT03363724|Deep Brain Stimulation|deep brain stimulation
33308|NCT03363724|Microelectrodes recording|microelectrodes recording
33309|NCT03363724|HaGuide|haguide
33310|NCT03363724|Alpha Omega Engineering Ltd.|alpha omega engineering ltd.
33311|NCT03363698|Chronic Cough|chronic cough
33312|NCT03363698|Upper-Airway Cough Syndrome|upper-airway cough syndrome
33313|NCT03363698|GERD|gerd
33314|NCT03363698|Allergic Rhinitis|allergic rhinitis
33439|NCT03362671|Treatment|treatment
33315|NCT03363698|Methacholine Challenge Test|methacholine challenge test
33316|NCT03363698|Cough Challenge|cough challenge
33317|NCT03363698|Capsaicin|capsaicin
33318|NCT03363685|Survival Prediction|survival prediction
33319|NCT03363685|Spinal Metastases|spinal metastases
33320|NCT03363685|Non Small Cell Lung Cancer Metastatic|non small cell lung cancer metastatic
33321|NCT03363672|Chronic Postoperative Pain|chronic postoperative pain
33322|NCT03363672|Daily Life|daily life
33323|NCT03363672|Risk Factor|risk factor
33324|NCT03363659|Glioblastoma|glioblastoma
33325|NCT03363659|Glioblastoma Multiforme|glioblastoma multiforme
33326|NCT03363659|Glioma|glioma
33327|NCT03363659|Anaplastic Glioma|anaplastic glioma
33328|NCT03363659|Unmethylated|unmethylated
33329|NCT03363633|Venous Ulceration|venous ulceration
33330|NCT03363633|Refluxing Perforator Veins|refluxing perforator veins
33331|NCT03363620|maxillary expansion|maxillary expansion
33332|NCT03363620|self ligating|self ligating
33333|NCT03363620|arch form|arch form
33334|NCT03363594|Diabetes, T2D|diabetes, t2d
33335|NCT03363581|Food preferences|food preferences
33337|NCT03363581|Weight loss|weight loss
33338|NCT03363529|Dynamic lighting, ipRGC|dynamic lighting, iprgc
33339|NCT03363503|COPD|copd
33340|NCT03363503|Salmeterol/Fluticasone|salmeterol/fluticasone
33341|NCT03363503|Discair|discair
33342|NCT03363503|Diskus|diskus
33343|NCT03363503|Spirometry|spirometry
33344|NCT03363490|Self-Management|self-management
33345|NCT03363490|Neuromuscular Exercise Therapy|neuromuscular exercise therapy
33346|NCT03363490|Knee osteoarthritis|knee osteoarthritis
33347|NCT03363477|antithrombotic|antithrombotic
33348|NCT03363477|heparin|heparin
33349|NCT03363477|anticoagulant|anticoagulant
33350|NCT03363477|low molecular weight heparin|low molecular weight heparin
33351|NCT03363477|pharmacodynamic equivalence|pharmacodynamic equivalence
33352|NCT03363425|Dexmedetomidine|dexmedetomidine
33353|NCT03363425|Lidocaine|lidocaine
33354|NCT03363425|Postoperative Pain|postoperative pain
33355|NCT03363425|Analgesic Consumption|analgesic consumption
33356|NCT03363425|Recovery|recovery
33357|NCT03363425|Abdominal Gynaecological Surgery|abdominal gynaecological surgery
33358|NCT03363399|Diagnostic accuracy study|diagnostic accuracy study
33359|NCT03363399|Flow cytometry analysis|flow cytometry analysis
33360|NCT03363399|Myeloperoxidase|myeloperoxidase
33361|NCT03363399|Peripheral blood sample|peripheral blood sample
33362|NCT03363386|aerobic exercise|aerobic exercise
33363|NCT03363386|dynamic balance|dynamic balance
33364|NCT03363386|functional capacity|functional capacity
33365|NCT03363386|HbA1c|hba1c
33366|NCT03363386|proprioceptive exercise training|proprioceptive exercise training
33367|NCT03363373|Antibody, Neuroblastoma, Pediatric, Adult|antibody, neuroblastoma, pediatric, adult
33368|NCT03363334|ITP|itp
33369|NCT03363334|Immune Thrombocytopenia|immune thrombocytopenia
33370|NCT03363321|hemophilia|hemophilia
33371|NCT03363295|endophthalmitis|endophthalmitis
33372|NCT03363282|Crosslinking|crosslinking
33373|NCT03363256|Digital therapeutics|digital therapeutics
33374|NCT03363256|Adaptation|adaptation
33375|NCT03363230|mindfulness|mindfulness
33376|NCT03363230|emotion regulation|emotion regulation
33377|NCT03363230|impulsivity|impulsivity
33378|NCT03363217|Glioma|glioma
33379|NCT03363217|Optic Pathway Glioma|optic pathway glioma
33380|NCT03363217|Low grade glioma|low grade glioma
33381|NCT03363217|MAPK/ERK|mapk/erk
33382|NCT03363217|Plexiform Neurofibroma|plexiform neurofibroma
33383|NCT03363217|Neurofibromatosis Type 1|neurofibromatosis type 1
33384|NCT03363217|Central Nervous System|central nervous system
33385|NCT03363217|CNS|cns
33386|NCT03363217|Brain Tumor|brain tumor
33387|NCT03363217|LGG|lgg
33388|NCT03363217|NF1|nf1
33389|NCT03363217|KIAA1549-BRAF|kiaa1549-braf
33390|NCT03363217|Mitogen-activated Protein Kinase (MEK) inhibitor|mitogen-activated protein kinase (mek) inhibitor
33391|NCT03363217|Trametinib|trametinib
33392|NCT03363191|fluticasone furoate/vilanterol, efficacy, asthma, Chronic obstructive pulmonary disease|fluticasone furoate/vilanterol, efficacy, asthma, chronic obstructive pulmonary disease
33393|NCT03363165|PAD|pad
33394|NCT03363087|Atrial Scar|atrial scar
33395|NCT03363087|Atrial Fibrillation Ablation|atrial fibrillation ablation
33396|NCT03363087|Mapping|mapping
33397|NCT03363087|Persistent Atrial Fibrillation|persistent atrial fibrillation
33398|NCT03363087|Catheter Ablation|catheter ablation
33399|NCT03363074|Low-Level Laser Therapy, Orthotic Insoles|low-level laser therapy, orthotic insoles
33400|NCT03363048|Food restrictions/incentives|food restrictions/incentives
33401|NCT03363048|Food Stamp program|food stamp program
33402|NCT03363048|Policy change|policy change
33403|NCT03363048|Supplemental Nutrition Assistance Program (SNAP)|supplemental nutrition assistance program (snap)
33404|NCT03363009|prehabilitation|prehabilitation
33405|NCT03363009|connected devices|connected devices
33406|NCT03362996|extra virgin olive oil|extra virgin olive oil
33407|NCT03362996|mild cognitive impairment|mild cognitive impairment
33408|NCT03362996|randomized double blind clinical trial|randomized double blind clinical trial
33409|NCT03362970|Bloody Diarrhea|bloody diarrhea
33410|NCT03362970|STEC|stec
33411|NCT03362970|Hematochezia|hematochezia
33412|NCT03362970|BioFire FilmArray|biofire filmarray
33413|NCT03362970|Child|child
33414|NCT03362957|embolization|embolization
33415|NCT03362957|vascular|vascular
33416|NCT03362905|Lidocaine|lidocaine
33417|NCT03362905|Dosage forms|dosage forms
33418|NCT03362905|Pain scores|pain scores
33419|NCT03362879|Advanced Parkinson's Disease|advanced parkinson's disease
33420|NCT03362879|Levodopa-Carbidopa Intestinal Gel (LCIG)|levodopa-carbidopa intestinal gel (lcig)
33421|NCT03362827|Low back pain|low back pain
33422|NCT03362827|Long-term potentiation|long-term potentiation
33423|NCT03362827|Hyperalgesia|hyperalgesia
33424|NCT03362827|Allodynia|allodynia
33425|NCT03362814|HCV|hcv
33426|NCT03362814|Ravidasvir|ravidasvir
33427|NCT03362814|SVR12|svr12
33428|NCT03362801|physical activity|physical activity
33429|NCT03362801|elderly|elderly
33430|NCT03362788|Antithrombotics Antiplatelets Stents Angioplasty|antithrombotics antiplatelets stents angioplasty
33431|NCT03362762|Type 2 diabetes|type 2 diabetes
33432|NCT03362762|insulin|insulin
33433|NCT03362762|Hb1Ac|hb1ac
33434|NCT03362762|glycemia|glycemia
33435|NCT03362762|Guadeloupe|guadeloupe
33436|NCT03362671|OSA|osa
33437|NCT03362671|Mandibular Advancement Splint|mandibular advancement splint
33438|NCT03362671|Oral Appliance|oral appliance
33440|NCT03362671|Orthodontic Implants|orthodontic implants
33441|NCT03362658|Magnetic Resonance Imaging|magnetic resonance imaging
33442|NCT03362658|MRI|mri
33443|NCT03362658|Biomarker|biomarker
33444|NCT03362619|Cervical cancer|cervical cancer
33445|NCT03362619|Cytotoxic lymphocyte|cytotoxic lymphocyte
33446|NCT03362619|CC-CTL|cc-ctl
33447|NCT03362606|Ovarian cancer|ovarian cancer
33448|NCT03362606|Cytotoxic lymphocyte|cytotoxic lymphocyte
33449|NCT03362606|OC-CTL|oc-ctl
33450|NCT03362580|Epiretinal Membrane|epiretinal membrane
33451|NCT03362580|Diabetes|diabetes
33452|NCT03362567|Cervical Radiculopathy|cervical radiculopathy
33453|NCT03362567|Sustained Natural Apophyseal Glides|sustained natural apophyseal glides
33454|NCT03362567|Mechanical Cervical Traction|mechanical cervical traction
33455|NCT03362567|Pain Intensity|pain intensity
33456|NCT03362567|Neck Disability|neck disability
33457|NCT03362554|Insulin|insulin
33458|NCT03362554|Glucose|glucose
33459|NCT03362554|Rab3|rab3
33460|NCT03362541|multiple sclerosis|multiple sclerosis
33461|NCT03362541|fatigue|fatigue
33462|NCT03362541|self-management|self-management
33463|NCT03362541|rehabilitation|rehabilitation
33464|NCT03362502|gene therapy, mini-dystrophin, AAV|gene therapy, mini-dystrophin, aav
33465|NCT03362489|In Vitro Fertilization|in vitro fertilization
33466|NCT03362489|Intra-Uterine Insemination|intra-uterine insemination
33467|NCT03362489|Poor responders|poor responders
33468|NCT03362476|HIV|hiv
33469|NCT03362476|HCV|hcv
33470|NCT03362476|Computer Intervention|computer intervention
33471|NCT03362476|Alcoholism|alcoholism
33472|NCT03362476|Women|women
33473|NCT03362476|Russia|russia
33474|NCT03362450|Midgut volvulus|midgut volvulus
33475|NCT03362450|Fetal volvulus|fetal volvulus
33476|NCT03362450|Whirlpool sign|whirlpool sign
33477|NCT03362450|Pregnant women|pregnant women
33478|NCT03362450|Position of mesenteric vessels|position of mesenteric vessels
33479|NCT03362450|Post natal surgery|post natal surgery
33480|NCT03362450|Foetopathology if performed|foetopathology if performed
33481|NCT03362450|Hydro-meconium level in the dilated loops|hydro-meconium level in the dilated loops
33482|NCT03362411|Healthy participants|healthy participants
33483|NCT03362411|Healthy subjects|healthy subjects
33484|NCT03362385|Obstructive sleep apnea|obstructive sleep apnea
33485|NCT03362385|Acute coronary syndrome|acute coronary syndrome
33486|NCT03362385|Continuous positive airway pressure|continuous positive airway pressure
33487|NCT03362385|Outcome|outcome
33488|NCT03362359|prostatectomy|prostatectomy
33489|NCT03362359|68Ga-PSMA-11|68ga-psma-11
33490|NCT03362359|EPLND|eplnd
33491|NCT03362346|Wavelet transform|wavelet transform
33492|NCT03362346|Deep learning|deep learning
33493|NCT03362307|Low-Level Light Therapy, Osseointegration|low-level light therapy, osseointegration
33494|NCT03362281|Peptic ulcer hemorrhage|peptic ulcer hemorrhage
33495|NCT03362281|Proton Pump Inhibitor|proton pump inhibitor
33496|NCT03362255|Optic Nerve Sheath Diameter Injection Speed|optic nerve sheath diameter injection speed
33497|NCT03362216|soft tissue, pain|soft tissue, pain
33498|NCT03362203|Conditioned pain modulation, neck pain|conditioned pain modulation, neck pain
33499|NCT03362190|Zimura|zimura
33500|NCT03362190|ARC1905|arc1905
33501|NCT03362190|Lucentis|lucentis
33502|NCT03362190|ranibizumab|ranibizumab
33503|NCT03362190|Wet AMD|wet amd
33504|NCT03362190|avacincaptad pegol|avacincaptad pegol
33505|NCT03362190|complement factor C5 inhibitor|complement factor c5 inhibitor
33506|NCT03362177|Chemotherapy Induced Thrombocytopenia|chemotherapy induced thrombocytopenia
33507|NCT03362177|Gastrointestinal Cancer|gastrointestinal cancer
33508|NCT03362177|Colorectal Cancer|colorectal cancer
33509|NCT03362164|Fabry|fabry
33510|NCT03362164|Fibrosis|fibrosis
33511|NCT03362164|Dialysis|dialysis
33512|NCT03362164|Stroke|stroke
33513|NCT03362164|Chronic kidney disease|chronic kidney disease
33514|NCT03362151|type 1 diabetes|type 1 diabetes
33515|NCT03362151|pasta|pasta
33516|NCT03362151|rice|rice
33517|NCT03362151|protein|protein
33518|NCT03362151|carbohydrate|carbohydrate
33519|NCT03362138|melanoma|melanoma
33520|NCT03362138|dysplastic nevus|dysplastic nevus
33521|NCT03362138|artificial intelligence|artificial intelligence
33522|NCT03362138|early diagnosis|early diagnosis
33523|NCT03362112|lipoprotein-associated phospholipase A2|lipoprotein-associated phospholipase a2
33524|NCT03362099|varenicline|varenicline
33525|NCT03362099|bupropion|bupropion
33526|NCT03362086|bone tumor osteosarcoma|bone tumor osteosarcoma
33527|NCT03362073|Ketamine|ketamine
33528|NCT03362073|Refractory cancer pain|refractory cancer pain
33529|NCT03362073|Terminally ill cancer patients|terminally ill cancer patients
33530|NCT03362073|Palliative care|palliative care
33531|NCT03362060|Triple Negative Breast Cancer|triple negative breast cancer
33532|NCT03362060|Vaccine|vaccine
33533|NCT03362060|Immunotherapy|immunotherapy
33534|NCT03362060|PD-1 Inhibitor|pd-1 inhibitor
33535|NCT03362060|Metastatic Breast Cancer|metastatic breast cancer
33536|NCT03362021|transvaginal oocyte retrieval|transvaginal oocyte retrieval
33537|NCT03362021|sedation|sedation
33538|NCT03362021|dexmedetomidine|dexmedetomidine
33539|NCT03362021|fentanyl|fentanyl
33540|NCT03362021|remifentanil|remifentanil
33541|NCT03362021|midazolam|midazolam
33542|NCT03361995|STEMI|stemi
33543|NCT03361969|quality of life|quality of life
33544|NCT03361969|hot flushes|hot flushes
33545|NCT03361969|prostate cancer|prostate cancer
33546|NCT03361969|testosterone|testosterone
33547|NCT03361930|spastic unilateral cerebral palsy, ankle-foot orthosis, AFO, muscle activity, muscular activity, electromyography, EMG,|spastic unilateral cerebral palsy, ankle-foot orthosis, afo, muscle activity, muscular activity, electromyography, emg,
33548|NCT03361917|Colonoscopy screening|colonoscopy screening
33549|NCT03361917|Colonscopy procedure|colonscopy procedure
33550|NCT03361878|Metformin|metformin
33551|NCT03361878|Intolerance|intolerance
33552|NCT03361878|Pharmacokinetics|pharmacokinetics
33553|NCT03361865|Urothelial cancer, programmed cell death 1 (PD-1) inhibitor|urothelial cancer, programmed cell death 1 (pd-1) inhibitor
33554|NCT03361865|indoleamine 2,3-dioxygenase (IDO) inhibitor|indoleamine 2,3-dioxygenase (ido) inhibitor
33555|NCT03361852|Follicular Lymphoma|follicular lymphoma
33556|NCT03361826|Magnetic seizure therapy (MST)|magnetic seizure therapy (mst)
33557|NCT03361826|Treatment resistance|treatment resistance
33558|NCT03361826|Open-label trial|open-label trial
33559|NCT03361826|Borderline Personality Disorder|borderline personality disorder
33560|NCT03361826|Suicidal Ideation|suicidal ideation
33561|NCT03361826|Treatment-resistant depression|treatment-resistant depression
33562|NCT03361826|Dialectical behavior therapy (DBT)|dialectical behavior therapy (dbt)
33563|NCT03361826|MST + DBT|mst + dbt
33564|NCT03361826|Neuroimaging-based biomarkers|neuroimaging-based biomarkers
33565|NCT03361800|Breast Cancer|breast cancer
33566|NCT03361800|ER Negative Breast Cancer|er negative breast cancer
33567|NCT03361800|Triple Negative Breast Cancer|triple negative breast cancer
33568|NCT03361800|PR Negative Breast Cancer|pr negative breast cancer
33569|NCT03361800|ER Positive PR Positive Breast Cancer|er positive pr positive breast cancer
33570|NCT03361787|adolescents|adolescents
33571|NCT03361787|parents|parents
33572|NCT03361787|coaching|coaching
33573|NCT03361761|Chronic disease|chronic disease
33574|NCT03361761|precariousness and vulnerability|precariousness and vulnerability
33575|NCT03361761|Health education|health education
33576|NCT03361748|Multiple Myeloma|multiple myeloma
33577|NCT03361748|Efficacy and Safety|efficacy and safety
33578|NCT03361748|BB2121|bb2121
33579|NCT03361748|CAR T Cell|car t cell
33580|NCT03361748|BCMA|bcma
33581|NCT03361748|Relapsed and Refractory|relapsed and refractory
33582|NCT03361735|PSA Level Greater than or Equal to Two|psa level greater than or equal to two
33583|NCT03361735|Stage IV Prostate Adenocarcinoma AJCC v7|stage iv prostate adenocarcinoma ajcc v7
33584|NCT03361683|High-Flow nasal oxygen|high-flow nasal oxygen
33585|NCT03361618|Uric acid|uric acid
33586|NCT03361618|Adenosine deaminase|adenosine deaminase
33587|NCT03361618|Zinc Sulfate|zinc sulfate
33588|NCT03361618|5'-nucleotidase|5'-nucleotidase
33589|NCT03361618|Asthenospermia.|asthenospermia.
33590|NCT03361618|Xanthine oxidase|xanthine oxidase
33591|NCT03361592|symmetry index, functional performance tests, SMT|symmetry index, functional performance tests, smt
33592|NCT03361579|Placebo|placebo
33593|NCT03361566|physical activity|physical activity
33594|NCT03361566|energy balance|energy balance
33595|NCT03361566|caloric restriction|caloric restriction
33596|NCT03361566|overfeeding|overfeeding
33597|NCT03361566|appetite regulation|appetite regulation
33598|NCT03361540|Pharmacokinetics|pharmacokinetics
33599|NCT03361540|Safety|safety
33600|NCT03361540|ASP8302|asp8302
33601|NCT03361514|antidepressants, discontinuation, primary care, MBCT|antidepressants, discontinuation, primary care, mbct
33602|NCT03361501|Omega-3 Fatty acids|omega-3 fatty acids
33603|NCT03361501|Triglycerides|triglycerides
33604|NCT03361475|Sharing|sharing
33605|NCT03361475|Mind|mind
33606|NCT03361475|Enjoyment|enjoyment
33607|NCT03361462|Sharing|sharing
33608|NCT03361462|Mind|mind
33609|NCT03361462|Enjoyment|enjoyment
33610|NCT03361410|Mild Decline in Cognition|mild decline in cognition
33611|NCT03361410|Mild Cognitive Decline|mild cognitive decline
33612|NCT03361410|Mild Cognitive Impairment|mild cognitive impairment
33613|NCT03361410|Dementia|dementia
33614|NCT03361410|Positron Emission Tomography (PET)|positron emission tomography (pet)
33615|NCT03361410|F-18 Fluorodeoxyglucose (FDG)|f-18 fluorodeoxyglucose (fdg)
33616|NCT03361410|Cerebral Metabolism|cerebral metabolism
33617|NCT03361410|Dietary Supplement|dietary supplement
33618|NCT03361410|MCI|mci
33619|NCT03361410|MDC|mdc
33620|NCT03361410|Grape|grape
33621|NCT03361410|Memory|memory
33622|NCT03361410|Randomized|randomized
33623|NCT03361410|Non-Drug|non-drug
33624|NCT03361410|Supplement|supplement
33625|NCT03361410|Non-Pharmacologic|non-pharmacologic
33626|NCT03361410|Natural|natural
33627|NCT03361410|Red Wine|red wine
33628|NCT03361410|Free|free
33629|NCT03361410|UCLA|ucla
33630|NCT03361410|Brain Scan|brain scan
33631|NCT03361410|Alzheimer's Disease|alzheimer's disease
33632|NCT03361410|Brain Diseases|brain diseases
33633|NCT03361410|Central Nervous System Diseases|central nervous system diseases
33634|NCT03361410|Cognition|cognition
33635|NCT03361410|Cognitive|cognitive
33636|NCT03361410|Neurocognitive|neurocognitive
33637|NCT03361410|Neurodegenerative|neurodegenerative
33638|NCT03361384|men who have sex with men|men who have sex with men
33639|NCT03361371|Nose suctioning|nose suctioning
33640|NCT03361371|Pediatric|pediatric
33641|NCT03361345|Postinflammatory hyperpigmentation|postinflammatory hyperpigmentation
33642|NCT03361345|Acne|acne
33643|NCT03361319|NSCLC|nsclc
33644|NCT03361319|Non-Small Cell Lung Cancer|non-small cell lung cancer
33645|NCT03361319|Adenocarcinoma of lung|adenocarcinoma of lung
33646|NCT03361306|Relapsed|relapsed
33647|NCT03361280|hemodialysis|hemodialysis
33648|NCT03361280|dialytic clearance|dialytic clearance
33649|NCT03361280|pharmacokinetics|pharmacokinetics
33650|NCT03361241|Stroke|stroke
33651|NCT03361241|Postural Balance|postural balance
33652|NCT03361241|Motor Function|motor function
33653|NCT03361241|Gait|gait
33654|NCT03361241|Virtual Reality Exposure Therapy|virtual reality exposure therapy
33655|NCT03361241|Physiotherapist|physiotherapist
33656|NCT03361228|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
33657|NCT03361228|melanoma|melanoma
33658|NCT03361228|urothelial carcinoma|urothelial carcinoma
33659|NCT03361228|squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
33660|NCT03361228|small cell lung cancer (SCLC)|small cell lung cancer (sclc)
33661|NCT03361228|colorectal cancer (CRC)|colorectal cancer (crc)
33662|NCT03361228|arginase 1 inhibitor|arginase 1 inhibitor
33663|NCT03361228|indoleamine 2,3-dioxygenase 1 inhibitor|indoleamine 2,3-dioxygenase 1 inhibitor
33664|NCT03361228|programmed death-1 receptor (PD-1) inhibitor|programmed death-1 receptor (pd-1) inhibitor
33665|NCT03361215|Disease progression|disease progression
33666|NCT03361215|Disease course|disease course
33667|NCT03361215|Immunological characterization|immunological characterization
33668|NCT03361189|Congenital heart disease|congenital heart disease
33669|NCT03361189|Pacemaker|pacemaker
33670|NCT03361189|Sinus node dysfunction|sinus node dysfunction
33671|NCT03361163|Streptococcus pyogenes pharyngitis|streptococcus pyogenes pharyngitis
33672|NCT03361163|Streptococcus Pharyngitis|streptococcus pharyngitis
33673|NCT03361163|Strep Throat|strep throat
33674|NCT03361163|Streptococcus pyogenes Infection|streptococcus pyogenes infection
33675|NCT03361163|Group A Streptococcus: B Hemolytic Pharyngitis|group a streptococcus: b hemolytic pharyngitis
33676|NCT03361163|Group A Streptococcal Infection|group a streptococcal infection
33677|NCT03361163|Controlled human infection model|controlled human infection model
33678|NCT03361163|Challenge study|challenge study
33679|NCT03361150|prehabilitation|prehabilitation
33680|NCT03361111|severe asthma|severe asthma
33681|NCT03361111|anti-IgE|anti-ige
33682|NCT03361111|periostin|periostin
33683|NCT03361111|induced sputum,|induced sputum,
33684|NCT03361111|exhaled breath condensate|exhaled breath condensate
33685|NCT03361098|SGLT2 inhibition; dapagliflozin|sglt2 inhibition; dapagliflozin
33686|NCT03361098|GLP-1 receptor agonist; exenatide|glp-1 receptor agonist; exenatide
33687|NCT03361098|Central satiety and reward circuits|central satiety and reward circuits
33688|NCT03361098|bodyweight|bodyweight
33689|NCT03361098|brain|brain
33690|NCT03361085|non-ventilator-associated hospital acquired pneumonia|non-ventilator-associated hospital acquired pneumonia
33691|NCT03361085|Hospital-acquired Pneumonia|hospital-acquired pneumonia
33692|NCT03361085|Healthcare Associated Infection|healthcare associated infection
33693|NCT03361085|Adherence|adherence
33694|NCT03361085|infection prevention|infection prevention
33695|NCT03361085|implementation|implementation
33696|NCT03361072|oral immunotherapy|oral immunotherapy
33697|NCT03361072|milk|milk
33698|NCT03361072|peanut|peanut
33699|NCT03361072|egg|egg
33700|NCT03361072|adult|adult
33701|NCT03361059|risk factors|risk factors
33702|NCT03361059|elderly patients|elderly patients
33703|NCT03361059|risk of falling|risk of falling
33704|NCT03361046|TAVI|tavi
33705|NCT03361046|valve-in-valve|valve-in-valve
33706|NCT03361046|aortic stenosis|aortic stenosis
33707|NCT03361033|Survivorship|survivorship
33708|NCT03361033|Social Functioning|social functioning
33709|NCT03361033|Social Outcomes|social outcomes
33710|NCT03361007|TAVI|tavi
33711|NCT03361007|common carotid artery|common carotid artery
33712|NCT03360955|Extubation|extubation
33713|NCT03360955|Cardiac Surgery|cardiac surgery
33714|NCT03360929|Lung Cancer|lung cancer
33715|NCT03360916|high cholesterol|high cholesterol
33716|NCT03360916|exercise|exercise
33717|NCT03360916|statins|statins
33718|NCT03360890|thyroid cancer|thyroid cancer
33719|NCT03360890|salivary gland cancer|salivary gland cancer
33720|NCT03360890|pembrolizumab|pembrolizumab
33721|NCT03360890|docetaxel|docetaxel
33722|NCT03360864|Therapeutic education|therapeutic education
33723|NCT03360812|Medical Students|medical students
33724|NCT03360812|Education|education
33725|NCT03360812|Prognosis|prognosis
33726|NCT03360812|Online training resource|online training resource
33727|NCT03360799|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
33728|NCT03360799|Questionnaires|questionnaires
33729|NCT03360799|Surveys|surveys
33730|NCT03360786|sport concussion|sport concussion
33731|NCT03360786|cervical spine|cervical spine
33732|NCT03360786|youth|youth
33733|NCT03360760|osteosarcoma|osteosarcoma
33734|NCT03360760|pelvis|pelvis
33735|NCT03360760|sacrum|sacrum
33736|NCT03360747|Familial Lipoprotein Lipase Deficiency|familial lipoprotein lipase deficiency
33737|NCT03360747|Hyperlipoproteinemias|hyperlipoproteinemias
33738|NCT03360747|Familial Hyperlipoproteinemia Type 1|familial hyperlipoproteinemia type 1
33739|NCT03360747|Hyperlipoproteinemia Type I|hyperlipoproteinemia type i
33740|NCT03360747|Hyperchylomicronemia, Familial|hyperchylomicronemia, familial
33741|NCT03360747|Lipoprotein Lipase Deficiency, Familial|lipoprotein lipase deficiency, familial
33742|NCT03360747|Hyperlipidemias|hyperlipidemias
33743|NCT03360747|Dyslipidemias|dyslipidemias
33744|NCT03360747|Lipid Metabolism Disorders|lipid metabolism disorders
33745|NCT03360747|Lipid Metabolism, Inborn Errors|lipid metabolism, inborn errors
33746|NCT03360747|Metabolic Diseases|metabolic diseases
33747|NCT03360747|Metabolism, Inborn Errors|metabolism, inborn errors
33748|NCT03360747|Genetic Diseases, Inborn|genetic diseases, inborn
33749|NCT03360721|mCRPC|mcrpc
33750|NCT03360721|metastatic castration resistant prostate cancer|metastatic castration resistant prostate cancer
33751|NCT03360721|nonsteroidal antiandrogen|nonsteroidal antiandrogen
33752|NCT03360721|androgen signaling|androgen signaling
33753|NCT03360695|Cancer Care|cancer care
33754|NCT03360695|Major Depression and Cancer|major depression and cancer
33755|NCT03360695|Schizophrenia and Cancer|schizophrenia and cancer
33756|NCT03360695|Bipolar Disorder and Cancer|bipolar disorder and cancer
33757|NCT03360695|Lung Cancer|lung cancer
33758|NCT03360695|Breast Cancer|breast cancer
33759|NCT03360695|Head and Neck Cancer|head and neck cancer
33760|NCT03360695|Gastrointestinal Cancer|gastrointestinal cancer
33761|NCT03360695|Schizophrenia|schizophrenia
33762|NCT03360695|Bipolar Disorder|bipolar disorder
33763|NCT03360695|Major Depression|major depression
33764|NCT03360669|hypertension, blood pressure, systolic, diastolic, AOBP, Omron HEM-907, research, clinical|hypertension, blood pressure, systolic, diastolic, aobp, omron hem-907, research, clinical
33765|NCT03360656|shivering, fever, normothermia|shivering, fever, normothermia
33766|NCT03360643|Point-of-care ultrasound|point-of-care ultrasound
33767|NCT03360643|Intussusception|intussusception
33768|NCT03360643|Pediatric Emergency Medicine|pediatric emergency medicine
33769|NCT03360643|Ultrasound|ultrasound
33770|NCT03360617|IV|iv
33771|NCT03360617|Intravenous|intravenous
33772|NCT03360617|IV Push|iv push
33773|NCT03360617|Piggyback|piggyback
33774|NCT03360617|Antibiotics|antibiotics
33775|NCT03360617|Beta Lactam|beta lactam
33776|NCT03360617|Infection|infection
33777|NCT03360604|glycaemic index|glycaemic index
33778|NCT03360604|glycaemia|glycaemia
33779|NCT03360604|diabetes mellitus|diabetes mellitus
33780|NCT03360604|type 2 diabetes|type 2 diabetes
33781|NCT03360565|Obstructive Sleep Apnea Syndrome (OSAS)|obstructive sleep apnea syndrome (osas)
33782|NCT03360526|PICSI|picsi
33783|NCT03360526|ORP|orp
33784|NCT03360526|TESA|tesa
33785|NCT03360526|seminal oxidation reduction potential|seminal oxidation reduction potential
33786|NCT03360513|Orthodontics|orthodontics
33787|NCT03360513|Dental arch|dental arch
33788|NCT03360513|Orthodontic appliance design.|orthodontic appliance design.
33789|NCT03360500|Osteoarthritis, Knee|osteoarthritis, knee
33790|NCT03360500|Cryotherapy|cryotherapy
33791|NCT03360500|Exercise|exercise
33792|NCT03360500|Physiotherapy|physiotherapy
33793|NCT03360500|Knee|knee
33794|NCT03360448|Gene Transfer|gene transfer
33795|NCT03360422|MSM, young adult|msm, young adult
33796|NCT03360409|Cervical Disc Degeneration|cervical disc degeneration
33797|NCT03360409|cervical anterior discectomy|cervical anterior discectomy
33798|NCT03360409|Spinal alignment|spinal alignment
33799|NCT03360396|severe heterogeneous emphysema|severe heterogeneous emphysema
33800|NCT03360396|severe homogeneous emphysema|severe homogeneous emphysema
33801|NCT03360383|Spinal Fractures/surgery|spinal fractures/surgery
33802|NCT03360383|Vertebroplasty|vertebroplasty
33803|NCT03360383|Quality-Adjusted Life Years|quality-adjusted life years
33804|NCT03360370|Neurodevelopmental disorders,|neurodevelopmental disorders,
33805|NCT03360370|Congenital heart disease|congenital heart disease
33806|NCT03360370|Children|children
33807|NCT03360344|carpal tunnel syndrome, forearm wrist hand pain, kinesio tape|carpal tunnel syndrome, forearm wrist hand pain, kinesio tape
33808|NCT03360318|pediatric|pediatric
33809|NCT03360318|elbow fractures|elbow fractures
33810|NCT03360318|management|management
33811|NCT03360305|emergency department|emergency department
33812|NCT03360305|prevention|prevention
33813|NCT03360305|transitions of care|transitions of care
33814|NCT03360292|Neonatology|neonatology
33815|NCT03360266|remineralization|remineralization
33816|NCT03360266|fluoride varnish|fluoride varnish
33817|NCT03360227|syncope|syncope
33818|NCT03360227|bradycardia|bradycardia
33819|NCT03360227|tachycardia|tachycardia
33820|NCT03360227|sudden cardiac death|sudden cardiac death
33821|NCT03360227|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
33822|NCT03360227|ventricular tachycardia|ventricular tachycardia
33823|NCT03360227|ventricular fibrillation|ventricular fibrillation
33824|NCT03360227|biomarker|biomarker
33825|NCT03360227|thyroid hormone|thyroid hormone
33826|NCT03360214|Mastectomy|mastectomy
33827|NCT03360214|Tissue expander|tissue expander
33828|NCT03360214|PEMF|pemf
33829|NCT03360214|PIB|pib
33830|NCT03360201|Africa|africa
33831|NCT03360201|Kenya|kenya
33832|NCT03360201|Family relations|family relations
33833|NCT03360201|Child mental health|child mental health
33834|NCT03360201|Adolescent mental health|adolescent mental health
33835|NCT03360201|Family therapy|family therapy
33836|NCT03360201|Program evaluation|program evaluation
33837|NCT03360201|Family Conflict|family conflict
33838|NCT03360201|Marital Conflict|marital conflict
33839|NCT03360201|Domestic Violence|domestic violence
33840|NCT03360201|Parenting|parenting
33841|NCT03360201|Parent-Child Relations|parent-child relations
33842|NCT03360201|child abuse|child abuse
33843|NCT03360201|low- and middle-income country|low- and middle-income country
33844|NCT03360149|Hemophilia pregnant|hemophilia pregnant
33845|NCT03360149|Hemophilia delivery|hemophilia delivery
33846|NCT03360149|Hemophilia children|hemophilia children
33847|NCT03360136|Exhaustion Disorder|exhaustion disorder
33848|NCT03360136|Burnout|burnout
33849|NCT03360136|Clinical Burnout|clinical burnout
33850|NCT03360097|In vitro Fertilization|in vitro fertilization
33851|NCT03360097|Slow Developing Blastocyst|slow developing blastocyst
33852|NCT03360097|Fresh Embryo Transfer|fresh embryo transfer
33853|NCT03360097|Frozen Embryo Transfer|frozen embryo transfer
33854|NCT03360097|Live Birth Rate|live birth rate
33855|NCT03360084|CT|ct
33856|NCT03360084|Interventional radiology|interventional radiology
33857|NCT03360084|Lung biopsy|lung biopsy
33858|NCT03360084|Transthoracic biopsy|transthoracic biopsy
33859|NCT03360084|Systemic air embolism|systemic air embolism
33860|NCT03360058|motivational techniques|motivational techniques
33861|NCT03360058|primary care|primary care
33862|NCT03360032|Incremental shuttle walk test|incremental shuttle walk test
33863|NCT03360032|Cardiopulmonary exercise test|cardiopulmonary exercise test
33864|NCT03360032|VO2 peak|vo2 peak
33865|NCT03360006|Castrate-Resistant Prostate Cancer (CRPC)|castrate-resistant prostate cancer (crpc)
33866|NCT03360006|Metastatic Castrate-Resistant Prostate Cancer (CRPC)|metastatic castrate-resistant prostate cancer (crpc)
33867|NCT03360006|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
33868|NCT03360006|Relapsing acute myeloid leukemia|relapsing acute myeloid leukemia
33969|NCT03359408|Discharge management|discharge management
33869|NCT03360006|Remitting acute myeloid leukemia|remitting acute myeloid leukemia
33870|NCT03360006|Dose-limiting toxicity|dose-limiting toxicity
33871|NCT03360006|Recommended phase two dose|recommended phase two dose
33872|NCT03360006|Pharmacokinetics|pharmacokinetics
33873|NCT03359993|Endotracheal intubation|endotracheal intubation
33874|NCT03359993|Neonatal premedication|neonatal premedication
33875|NCT03359993|Delivery room|delivery room
33876|NCT03359954|Malignant neoplasm of breast|malignant neoplasm of breast
33877|NCT03359954|Preoperative boost radiotherapy|preoperative boost radiotherapy
33878|NCT03359954|RT|rt
33879|NCT03359954|XRT|xrt
33880|NCT03359954|HR+/HER2-|hr+/her2-
33881|NCT03359954|Breast surgery|breast surgery
33882|NCT03359941|Integrative Treatments|integrative treatments
33883|NCT03359941|Korean Traditional medicine|korean traditional medicine
33884|NCT03359915|COPD|copd
33885|NCT03359915|Self-Management|self-management
33886|NCT03359915|Action Plan|action plan
33887|NCT03359915|SGRQ|sgrq
33888|NCT03359915|LMIC|lmic
33889|NCT03359915|COPD Diagnosis|copd diagnosis
33890|NCT03359902|Mild Cognitive Impairment|mild cognitive impairment
33891|NCT03359902|Vagal Nerve Stimulation|vagal nerve stimulation
33892|NCT03359902|tVNS|tvns
33893|NCT03359902|Alzheimer's disease|alzheimer's disease
33894|NCT03359876|Real-world study|real-world study
33895|NCT03359876|Atrial fibrillation|atrial fibrillation
33896|NCT03359876|Renal dysfunction|renal dysfunction
33897|NCT03359876|Rivaroxaban|rivaroxaban
33898|NCT03359876|Warfarin|warfarin
33899|NCT03359824|exercise, brown adipose tissue|exercise, brown adipose tissue
33900|NCT03359811|Local Anesthetic Solution|local anesthetic solution
33901|NCT03359811|Bupivacaine HCl|bupivacaine hcl
33902|NCT03359811|Liposomal Bupivacaine|liposomal bupivacaine
33903|NCT03359811|Peritoneal Cancer|peritoneal cancer
33904|NCT03359785|Drug therapy|drug therapy
33905|NCT03359772|Neuropathic Pain|neuropathic pain
33906|NCT03359772|Balance|balance
33907|NCT03359772|Kinesthetic Ability Trainer|kinesthetic ability trainer
33908|NCT03359772|Quality of Life|quality of life
33909|NCT03359759|Telemedicine|telemedicine
33910|NCT03359759|Connected watches|connected watches
33911|NCT03359759|Patient-Reported symptom monitoring|patient-reported symptom monitoring
33912|NCT03359759|Secure Platform|secure platform
33913|NCT03359733|Drug therapy|drug therapy
33914|NCT03359694|breast cancer, neoadjuvant chemotherapy,susceptible gene|breast cancer, neoadjuvant chemotherapy,susceptible gene
33915|NCT03359655|misoprostol|misoprostol
33916|NCT03359655|hyoscine butyl bromide|hyoscine butyl bromide
33917|NCT03359655|cervical dilatation|cervical dilatation
33918|NCT03359655|cervical ripening|cervical ripening
33919|NCT03359655|hysteroscopy|hysteroscopy
33920|NCT03359655|pain|pain
33921|NCT03359642|Microbiota|microbiota
33922|NCT03359642|inflammatory bowel disease|inflammatory bowel disease
33923|NCT03359642|inflammation|inflammation
33924|NCT03359642|anti-TNF alpha|anti-tnf alpha
33925|NCT03359629|Spectrophon|spectrophon
33926|NCT03359629|Glucose|glucose
33927|NCT03359629|Biosensor|biosensor
33928|NCT03359629|Non-invasive testing|non-invasive testing
33929|NCT03359616|rectal cancer|rectal cancer
33930|NCT03359616|laparoscopic surgery|laparoscopic surgery
33931|NCT03359616|total mesorectal excision|total mesorectal excision
33932|NCT03359616|transanal surgery|transanal surgery
33933|NCT03359603|Electro-acupuncture|electro-acupuncture
33934|NCT03359603|Knee osteoarthritis|knee osteoarthritis
33935|NCT03359603|Treatment frequency|treatment frequency
33936|NCT03359577|Chronic plaque psoriasis|chronic plaque psoriasis
33937|NCT03359577|Inflammation|inflammation
33938|NCT03359577|Cardiovascular diseases|cardiovascular diseases
33939|NCT03359564|Lumbar Disc Herniation|lumbar disc herniation
33940|NCT03359564|Micro Endoscopic Discectomy|micro endoscopic discectomy
33941|NCT03359551|Choroideremia|choroideremia
33942|NCT03359551|REP1|rep1
33943|NCT03359551|Retina|retina
33944|NCT03359551|Retinal Degeneration|retinal degeneration
33945|NCT03359551|Retinal Dystrophy|retinal dystrophy
33946|NCT03359551|Natural History|natural history
33947|NCT03359538|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
33948|NCT03359538|Motor Neuron Disease|motor neuron disease
33949|NCT03359538|Rapamycin|rapamycin
33950|NCT03359512|anesthesia monitoring|anesthesia monitoring
33951|NCT03359473|GSK2881078|gsk2881078
33952|NCT03359473|COPD|copd
33953|NCT03359473|muscle weakness|muscle weakness
33954|NCT03359473|post-menopausal|post-menopausal
33955|NCT03359473|selective androgen receptor modulator|selective androgen receptor modulator
33956|NCT03359447|infant|infant
33957|NCT03359447|primary prevention|primary prevention
33958|NCT03359434|Acute Stroke|acute stroke
33959|NCT03359434|Blood Pressure|blood pressure
33960|NCT03359434|Cerebral Hemorrhage|cerebral hemorrhage
33961|NCT03359421|prehospital|prehospital
33962|NCT03359421|aeromedical|aeromedical
33963|NCT03359421|trauma|trauma
33964|NCT03359421|ems|ems
33965|NCT03359421|helicopter|helicopter
33966|NCT03359408|Health care|health care
33967|NCT03359408|Dementia care|dementia care
33968|NCT03359408|Collaborative care|collaborative care
33970|NCT03359408|Hospital|hospital
33971|NCT03359408|Primary care|primary care
33972|NCT03359395|Anesthesia|anesthesia
33973|NCT03359356|alopecia|alopecia
33974|NCT03359356|alopecia areata|alopecia areata
33975|NCT03359356|alopecia universalis|alopecia universalis
33976|NCT03359356|alopecia totalis|alopecia totalis
33977|NCT03359356|dupixent|dupixent
33978|NCT03359356|dupilumab|dupilumab
33979|NCT03359330|Peripheral nervous system diseases|peripheral nervous system diseases
33980|NCT03359330|Wounds and injuries|wounds and injuries
33981|NCT03359330|Nerve regeneration|nerve regeneration
33982|NCT03359330|Biocompatible materials|biocompatible materials
33983|NCT03359330|Surgical procedures|surgical procedures
33984|NCT03359317|Osteoporosis|osteoporosis
33985|NCT03359317|Bone Diseases|bone diseases
33986|NCT03359304|bone tumor|bone tumor
33987|NCT03359291|macitentan|macitentan
33988|NCT03359291|rosuvastatin|rosuvastatin
33989|NCT03359291|pharmacokinetics|pharmacokinetics
33990|NCT03359278|distal radius fracture, sigmoid notch|distal radius fracture, sigmoid notch
33991|NCT03359252|coil embolization|coil embolization
33992|NCT03359252|headache|headache
33993|NCT03359252|stent|stent
33994|NCT03359239|PGV001|pgv001
33995|NCT03359239|atezolizumab|atezolizumab
33996|NCT03359239|urothelial cancer|urothelial cancer
33997|NCT03359239|personalized neoantigen vaccine|personalized neoantigen vaccine
33998|NCT03359187|Radiation- induced mucositis|radiation- induced mucositis
33999|NCT03359187|Head and Neck Cancer|head and neck cancer
34000|NCT03359187|Radiation therapy side effect|radiation therapy side effect
34001|NCT03359161|ambulatory|ambulatory
34002|NCT03359161|Subcutaneous|subcutaneous
34003|NCT03359161|furosemide|furosemide
34004|NCT03359148|Nosocomial infection|nosocomial infection
34005|NCT03359148|Ventilator system|ventilator system
34006|NCT03359148|Closed suction system|closed suction system
34007|NCT03359148|Open suction system|open suction system
34008|NCT03359148|Bacterial contamination|bacterial contamination
34009|NCT03359135|Compression garment|compression garment
34010|NCT03359096|Sleep apnea|sleep apnea
34011|NCT03359096|Tongue stimulation|tongue stimulation
34012|NCT03359096|Cardiovascular function|cardiovascular function
34013|NCT03359083|foot-ankle characteristic|foot-ankle characteristic
34014|NCT03359083|lumbopelvic control|lumbopelvic control
34015|NCT03359083|balance|balance
34016|NCT03359083|physical performance|physical performance
34017|NCT03359070|Tinea cruris|tinea cruris
34018|NCT03359070|dapaconazole|dapaconazole
34019|NCT03359070|topical antifungal|topical antifungal
34020|NCT03359070|dermatophytoses|dermatophytoses
34021|NCT03359057|Folic acid|folic acid
34022|NCT03359057|Supplementation|supplementation
34023|NCT03359057|Ethinyl estradiol|ethinyl estradiol
34024|NCT03359057|Levonorgestrel|levonorgestrel
34025|NCT03359057|Oral contraceptive|oral contraceptive
34026|NCT03359044|Fiberoptic bronchoscopy|fiberoptic bronchoscopy
34027|NCT03359044|Neuropsychological Development|neuropsychological development
34028|NCT03359044|general anesthesia|general anesthesia
34029|NCT03359018|osteosarcoma|osteosarcoma
34030|NCT03359018|advanced|advanced
34031|NCT03359018|apatinib|apatinib
34032|NCT03359018|PD-1|pd-1
34033|NCT03359005|Ewing Sarcoma|ewing sarcoma
34034|NCT03359005|Irinotecan|irinotecan
34035|NCT03359005|Temozolomide|temozolomide
34036|NCT03358992|CESOFB|cesofb
34037|NCT03358992|clinical evaluation|clinical evaluation
34038|NCT03358992|RECIST|recist
34039|NCT03358992|histological response|histological response
34040|NCT03358992|survival|survival
34041|NCT03358992|osteosarcoma|osteosarcoma
34042|NCT03358992|Ewing sarcoma|ewing sarcoma
34043|NCT03358979|Conjunctival Diseases|conjunctival diseases
34044|NCT03358979|Dry Eye Syndromes|dry eye syndromes
34045|NCT03358979|Antigens|antigens
34046|NCT03358979|CD147|cd147
34047|NCT03358966|chronic kidney disease|chronic kidney disease
34048|NCT03358966|energy expenditure|energy expenditure
34049|NCT03358966|metabolic rate|metabolic rate
34050|NCT03358953|electronic cigarettes|electronic cigarettes
34051|NCT03358953|cardiovascular|cardiovascular
34052|NCT03358953|nicotine replacement patches|nicotine replacement patches
34053|NCT03358940|Non-medical abortion|non-medical abortion
34054|NCT03358940|Misoprostol|misoprostol
34055|NCT03358940|miscarriage complications|miscarriage complications
34056|NCT03358940|Guadeloupe|guadeloupe
34057|NCT03358927|HIV/AIDS|hiv/aids
34058|NCT03358927|Fast-track care|fast-track care
34059|NCT03358927|Behavioral economics|behavioral economics
34060|NCT03358927|Differentiated care|differentiated care
34061|NCT03358914|psoriasis, adolescents, quality of life, PRO (patient-reported outcome), validation|psoriasis, adolescents, quality of life, pro (patient-reported outcome), validation
34062|NCT03358862|myopia|myopia
34063|NCT03358862|progressive myopia|progressive myopia
34064|NCT03358862|contact lenses|contact lenses
34065|NCT03358862|extended depth of focus|extended depth of focus
34066|NCT03358862|retrospective clinical series|retrospective clinical series
34067|NCT03358862|axial length|axial length
34068|NCT03358862|refractive error|refractive error
34069|NCT03358836|Hemophilia B|hemophilia b
34070|NCT03358836|FIX|fix
34071|NCT03358836|Factor IX|factor ix
34072|NCT03358836|Factor 9|factor 9
34073|NCT03358823|AS database ; Brain Image;Neural-EEG Data|as database ; brain image;neural-eeg data
34074|NCT03358797|Community-based Intervention|community-based intervention
34075|NCT03358797|Lifestyle intervention|lifestyle intervention
34076|NCT03358797|Women in East Jerusalem|women in east jerusalem
34077|NCT03358797|Diabetes prevention|diabetes prevention
34078|NCT03358797|Leadership|leadership
34079|NCT03358784|Humeral Fractures, Proximal|humeral fractures, proximal
34080|NCT03358784|Arthroplasty, Shoulder Replacement|arthroplasty, shoulder replacement
34081|NCT03358784|Bone Plates|bone plates
34082|NCT03358771|COPD|copd
34083|NCT03358771|AECOPD|aecopd
34084|NCT03358771|Discharge care bundle|discharge care bundle
34085|NCT03358771|Patient Care Bundles|patient care bundles
34086|NCT03358758|Trauma|trauma
34087|NCT03358758|War-Related Injuries|war-related injuries
34088|NCT03358758|Firearm|firearm
34089|NCT03358758|Explosion|explosion
34090|NCT03358758|Bomb|bomb
34091|NCT03358758|Ordnance|ordnance
34092|NCT03358758|IED|ied
34093|NCT03358758|Epidemiology|epidemiology
34094|NCT03358758|Public Health|public health
34095|NCT03358745|Type 2 diabetes risk|type 2 diabetes risk
34096|NCT03358745|Cardiovascular disease risk|cardiovascular disease risk
34097|NCT03358732|embryo transfer, mock embryo transfer, endometrial receptivity, endometrial scratching, IVF|embryo transfer, mock embryo transfer, endometrial receptivity, endometrial scratching, ivf
34098|NCT03358667|peri-implant soft tissue augmentation|peri-implant soft tissue augmentation
34099|NCT03358654|Umbilical Cord Bleeding|umbilical cord bleeding
34100|NCT03358654|Knee Osteoarthritis|knee osteoarthritis
34101|NCT03358654|stem cells|stem cells
34102|NCT03358641|exercise|exercise
34103|NCT03358641|physical activity|physical activity
34104|NCT03358641|radiographic osteoarthritis|radiographic osteoarthritis
34105|NCT03358628|Osteosarcoma|osteosarcoma
34106|NCT03358628|Patient-derived xenograft|patient-derived xenograft
34107|NCT03358615|robson classification|robson classification
34108|NCT03358615|Egypt|egypt
34109|NCT03358602|Supraglottic cancer|supraglottic cancer
34110|NCT03358602|Laryngeal cancer|laryngeal cancer
34111|NCT03358602|Cervical lymph node|cervical lymph node
34112|NCT03358602|Neck dissection|neck dissection
34113|NCT03358563|Prostate Cancer|prostate cancer
34114|NCT03358563|Prostatectomy|prostatectomy
34115|NCT03358563|Chemohormonal therapy|chemohormonal therapy
34116|NCT03358563|Androgen deprivation therapy|androgen deprivation therapy
34117|NCT03358563|docetaxel chemotherapy|docetaxel chemotherapy
34118|NCT03358550|accommodation|accommodation
34119|NCT03358550|dark focus|dark focus
34120|NCT03358550|night myopia|night myopia
34121|NCT03358537|Dietary fiber|dietary fiber
34122|NCT03358472|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
34123|NCT03358472|programmed cell death 1 (PD-1) inhibitor|programmed cell death 1 (pd-1) inhibitor
34124|NCT03358472|indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor|indoleamine 2,3-dioxygenase 1 (ido1) inhibitor
34125|NCT03358459|phenotype; genotype|phenotype; genotype
34126|NCT03358446|central catheterization|central catheterization
34127|NCT03358446|femoral vein central catheterization|femoral vein central catheterization
34128|NCT03358446|leg angulation|leg angulation
34129|NCT03358407|Inflammatory Bowel disease|inflammatory bowel disease
34130|NCT03358407|Pro-drug|pro-drug
34131|NCT03358407|Double-blinded|double-blinded
34132|NCT03358407|Crossover|crossover
34133|NCT03358381|total knee arthroplasty|total knee arthroplasty
34134|NCT03358381|CT scan|ct scan
34135|NCT03358355|PAD|pad
34136|NCT03358355|unacylated ghrelin|unacylated ghrelin
34137|NCT03358355|Peripheral Artery Disease|peripheral artery disease
34138|NCT03358316|Rotator Cuff Tear|rotator cuff tear
34139|NCT03358316|Magnetic Resonance Imaging|magnetic resonance imaging
34140|NCT03358316|humeral migration|humeral migration
34141|NCT03358290|JTE-051|jte-051
34142|NCT03358290|Psoriasis|psoriasis
34143|NCT03358264|Vascular dysfunction, L-citrulline, arginase|vascular dysfunction, l-citrulline, arginase
34144|NCT03358225|Hybrid surgery,ACDF,C-ADR,bi-level cervical spondylosis|hybrid surgery,acdf,c-adr,bi-level cervical spondylosis
34145|NCT03358212|giant cell tumor of bone|giant cell tumor of bone
34146|NCT03358212|Denosumab|denosumab
34147|NCT03358212|post-operative|post-operative
34148|NCT03358199|LOD|lod
34149|NCT03358199|PCOS|pcos
34150|NCT03358199|AMH|amh
34151|NCT03358199|OHSS|ohss
34152|NCT03358186|Periprosthetic Fractures|periprosthetic fractures
34153|NCT03358186|Arthroplasty|arthroplasty
34154|NCT03358186|Surgical procedures|surgical procedures
34155|NCT03358173|Humeral Fractures|humeral fractures
34156|NCT03358173|plate|plate
34157|NCT03358173|Conservative Treatment|conservative treatment
34158|NCT03358134|Peripheral Spondylarthropathies|peripheral spondylarthropathies
34159|NCT03358134|Psoriatic arthritis|psoriatic arthritis
34160|NCT03358134|Reactive arthritis|reactive arthritis
34161|NCT03358056|Mindfulness|mindfulness
34162|NCT03358056|Emotion|emotion
34163|NCT03358056|Mindfulenss-based cognitive therapy|mindfulenss-based cognitive therapy
34164|NCT03358043|respiratory failure|respiratory failure
34165|NCT03358043|mechanical ventilation|mechanical ventilation
34166|NCT03358043|prevalence|prevalence
34167|NCT03358017|Triple negative breast cancer|triple negative breast cancer
34168|NCT03358017|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
34169|NCT03358017|p53|p53
34170|NCT03358017|Zoledronate|zoledronate
34171|NCT03358017|Atorvastatin|atorvastatin
34172|NCT03358017|Mevalonate pathway inhibitors|mevalonate pathway inhibitors
34173|NCT03358017|Hippo pathway|hippo pathway
34174|NCT03358004|TNBC|tnbc
34175|NCT03358004|metronomic chemotherapy|metronomic chemotherapy
34176|NCT03358004|vinorelbine|vinorelbine
34177|NCT03358004|capecitabine|capecitabine
34178|NCT03357991|E6/E7 mRNA|e6/e7 mrna
34179|NCT03357991|anal cancer screening|anal cancer screening
34180|NCT03357991|men who have sex with men|men who have sex with men
34181|NCT03357991|cost-effectiveness analysis|cost-effectiveness analysis
34182|NCT03357991|High resolution anoscopy|high resolution anoscopy
34183|NCT03357978|immunodeficiency|immunodeficiency
34184|NCT03357978|liver disease|liver disease
34185|NCT03357978|cancer risk|cancer risk
34186|NCT03357965|maternal infant bonding|maternal infant bonding
34187|NCT03357965|depression|depression
34188|NCT03357965|anxiety|anxiety
34189|NCT03357939|HLX03|hlx03
34190|NCT03357939|adalimumab|adalimumab
34191|NCT03357939|pharmacokinetics|pharmacokinetics
34192|NCT03357939|biosimilar|biosimilar
34193|NCT03357900|Consciousness Monitor|consciousness monitor
34194|NCT03357900|Clinical Pharmacology|clinical pharmacology
34195|NCT03357861|cancer|cancer
34196|NCT03357861|intensive care unit|intensive care unit
34197|NCT03357861|checkpoint inhibitors|checkpoint inhibitors
34198|NCT03357861|adverse event|adverse event
34199|NCT03357835|trauma|trauma
34200|NCT03357835|triage|triage
34201|NCT03357835|software|software
34202|NCT03357835|emergency|emergency
34203|NCT03357822|Chronic hepatitis B|chronic hepatitis b
34204|NCT03357822|Nucleoside analog|nucleoside analog
34205|NCT03357822|Pegylated Interferon|pegylated interferon
34206|NCT03357822|Sequential combination therapy|sequential combination therapy
34207|NCT03357822|HBsAg loss|hbsag loss
34208|NCT03357796|Depressive Disorder, Major|depressive disorder, major
34209|NCT03357796|Depressive Disorder|depressive disorder
34210|NCT03357796|Mood Disorders|mood disorders
34211|NCT03357796|Mental Disorders|mental disorders
34212|NCT03357796|Desvenlafaxine Succinate|desvenlafaxine succinate
34213|NCT03357796|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors
34214|NCT03357796|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors
34215|NCT03357796|Membrane Transport Modulators|membrane transport modulators
34216|NCT03357796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
34217|NCT03357796|Neurotransmitter Agents|neurotransmitter agents
34218|NCT03357796|Physiological Effects of Drugs|physiological effects of drugs
34219|NCT03357796|Antidepressive Agents|antidepressive agents
34220|NCT03357796|Psychotropic Drugs|psychotropic drugs
34221|NCT03357783|Frequency|frequency
34222|NCT03357783|Macroscopic|macroscopic
34223|NCT03357783|Deciduosis|deciduosis
34224|NCT03357783|Ovarian|ovarian
34225|NCT03357783|Neoplasm|neoplasm
34226|NCT03357783|Pregnancy|pregnancy
34227|NCT03357770|mesenchymal stem cells|mesenchymal stem cells
34228|NCT03357770|Knee Osteoarthritis|knee osteoarthritis
34229|NCT03357770|Umbilical Cord|umbilical cord
34230|NCT03357744|distress|distress
34231|NCT03357744|assessment methods|assessment methods
34232|NCT03357718|premedication|premedication
34233|NCT03357705|alveolar ridge preservation|alveolar ridge preservation
34234|NCT03357692|all on four; piezoelectric; implant; trans-sinusal|all on four; piezoelectric; implant; trans-sinusal
34235|NCT03357679|Bed up head elevated position|bed up head elevated position
34236|NCT03357679|Glidescope assisted tracheal intubation|glidescope assisted tracheal intubation
34237|NCT03357679|Laryngeal exposure|laryngeal exposure
34238|NCT03357679|Time to intubation|time to intubation
34239|NCT03357653|proteinuria|proteinuria
34240|NCT03357653|progression|progression
34241|NCT03357653|early immunoglobulin A (IgA) nephropathy|early immunoglobulin a (iga) nephropathy
34242|NCT03357627|Drug therapy|drug therapy
34243|NCT03357601|High Intensity Interval|high intensity interval
34244|NCT03357601|Moderate Endurance Exercise|moderate endurance exercise
34245|NCT03357601|Fat Loss|fat loss
34246|NCT03357601|Endurance Capacity|endurance capacity
34247|NCT03357575|Knee Osteoarthritis|knee osteoarthritis
34248|NCT03357575|adipose|adipose
34249|NCT03357575|mesenchymal stem cells|mesenchymal stem cells
34250|NCT03357562|Cystic fibrosis|cystic fibrosis
34251|NCT03357562|CT|ct
34252|NCT03357562|MRI|mri
34253|NCT03357562|radiation dose|radiation dose
34254|NCT03357562|contrast agent|contrast agent
34255|NCT03357549|Breast Feeding|breast feeding
34256|NCT03357549|Motivational Interviewing|motivational interviewing
34257|NCT03357549|Self Efficacy|self efficacy
34258|NCT03357497|colorectal surgery, early mobilization, postoperative care|colorectal surgery, early mobilization, postoperative care
34259|NCT03357484|impacted tooth|impacted tooth
34260|NCT03357484|pain|pain
34261|NCT03357484|platelet-rich fibrin|platelet-rich fibrin
34262|NCT03357484|third molar|third molar
34263|NCT03357484|tooth extraction|tooth extraction
34264|NCT03357484|wound healing|wound healing
34265|NCT03357471|Certolizumab Pegol|certolizumab pegol
34266|NCT03357471|E-Device|e-device
34267|NCT03357458|Family Integrated Care|family integrated care
34268|NCT03357458|Parenting education|parenting education
34269|NCT03357458|Nursing|nursing
34270|NCT03357458|Cost effectiveness|cost effectiveness
34271|NCT03357458|Patient engagement|patient engagement
34272|NCT03357458|Randomized controlled trial|randomized controlled trial
34273|NCT03357458|Neonatal intensive care unit|neonatal intensive care unit
34274|NCT03357445|Total hip Arthroplasty|total hip arthroplasty
34275|NCT03357445|Hip implant|hip implant
34276|NCT03357432|collagen|collagen
34277|NCT03357432|gelatin|gelatin
34278|NCT03357432|PINP|pinp
34279|NCT03357406|implant|implant
34280|NCT03357406|piezoelectric|piezoelectric
34281|NCT03357406|drills|drills
34282|NCT03357406|immediate loading|immediate loading
34283|NCT03357341|electronic health record|electronic health record
34284|NCT03357341|Pilot|pilot
34285|NCT03357341|COPD|copd
34286|NCT03357341|Sensor|sensor
34287|NCT03357341|Asthma|asthma
34288|NCT03357328|Phototherapy|phototherapy
34289|NCT03357328|Nursing home|nursing home
34290|NCT03357328|Light therapy|light therapy
34291|NCT03357250|biomarkers|biomarkers
34292|NCT03357185|Femoral bifurcation|femoral bifurcation
34293|NCT03357185|Peripheral arterial disease|peripheral arterial disease
34294|NCT03357185|Vascular surgery|vascular surgery
34295|NCT03357185|Eversion|eversion
34296|NCT03357185|Open surgery|open surgery
34297|NCT03357172|Immune recovery|immune recovery
34298|NCT03357172|Immunomodulatory cells|immunomodulatory cells
34299|NCT03357172|GVHD|gvhd
34300|NCT03357172|GVL|gvl
34301|NCT03357159|anti thymocyte globulin|anti thymocyte globulin
34302|NCT03357159|cyclophospamide|cyclophospamide
34303|NCT03357159|graft-versus-host disease|graft-versus-host disease
34304|NCT03357159|stem cell transplantation|stem cell transplantation
34305|NCT03357120|Breast Cancer|breast cancer
34306|NCT03357120|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
34307|NCT03357120|Circulating tumor DNA|circulating tumor dna
34308|NCT03357094|Pulmonary ventilation|pulmonary ventilation
34309|NCT03357094|Pulmonary perfusion|pulmonary perfusion
34310|NCT03357094|Single Photon Emission Computed Tomography|single photon emission computed tomography
34311|NCT03357055|tourniquet, pain, ketamine|tourniquet, pain, ketamine
34312|NCT03357029|Chronic pancreatitis|chronic pancreatitis
34313|NCT03357029|Vagal nerve stimulation|vagal nerve stimulation
34314|NCT03357029|Visceral Pain|visceral pain
34315|NCT03357016|interval training|interval training
34316|NCT03357016|abdominal fat mass|abdominal fat mass
34317|NCT03357016|postmenopausal women|postmenopausal women
34318|NCT03357016|lipids oxidation|lipids oxidation
34319|NCT03356964|endometrial receptivity progesterone elevation|endometrial receptivity progesterone elevation
34320|NCT03356925|Xpert®MTB/RIF|xpert®mtb/rif
34321|NCT03356925|Xpert®MTB/RIF Ultra|xpert®mtb/rif ultra
34322|NCT03356886|Chronic Low Back Pain|chronic low back pain
34323|NCT03356886|Pain Neuroscience Education|pain neuroscience education
34324|NCT03356886|Spinal Manipulative Techniques|spinal manipulative techniques
34325|NCT03356886|Psychosocial Factors|psychosocial factors
34326|NCT03356860|breast cancer|breast cancer
34327|NCT03356860|immunotherapy|immunotherapy
34328|NCT03356860|anti-PD-L1|anti-pd-l1
34329|NCT03356834|Chronic hepatitis B|chronic hepatitis b
34330|NCT03356834|Efficacy, safety, and tolerability|efficacy, safety, and tolerability
34331|NCT03356834|Tenofovir alafenamide|tenofovir alafenamide
34332|NCT03356808|Lung cancer|lung cancer
34334|NCT03356808|mesothelin|mesothelin
34335|NCT03356808|Muc1|muc1
34336|NCT03356808|GD2|gd2
34337|NCT03356808|MAGE-A4|mage-a4
34338|NCT03356795|Cervical cancer|cervical cancer
34339|NCT03356795|CAR-T|car-t
34340|NCT03356795|GD2|gd2
34341|NCT03356795|PSMA|psma
34342|NCT03356795|Muc1|muc1
34343|NCT03356795|Mesothelin|mesothelin
34344|NCT03356795|HPV|hpv
34345|NCT03356795|solid tumor|solid tumor
34346|NCT03356782|CART|cart
34347|NCT03356782|PD-1|pd-1
34348|NCT03356782|PDL-1|pdl-1
34349|NCT03356782|CTLA-4|ctla-4
34350|NCT03356782|sarcoma|sarcoma
34351|NCT03356782|solid tumor|solid tumor
34352|NCT03356769|refractory seizure|refractory seizure
34353|NCT03356769|cognitive impairment|cognitive impairment
34354|NCT03356769|electroencephalography improvement|electroencephalography improvement
34355|NCT03356769|seizure reduction|seizure reduction
34356|NCT03356769|seizure free|seizure free
34357|NCT03356769|aspirin|aspirin
34358|NCT03356743|lobectomy|lobectomy
34359|NCT03356730|Implants|implants
34360|NCT03356730|Vitamin D|vitamin d
34361|NCT03356730|Osseointegration|osseointegration
34362|NCT03356730|Histomorphometric|histomorphometric
34363|NCT03356717|simulation, high-fidelity, observer tool; learning outcomes|simulation, high-fidelity, observer tool; learning outcomes
34364|NCT03356704|adults|adults
34365|NCT03356691|Spiritist pass|spiritist pass
34366|NCT03356691|adult|adult
34367|NCT03356691|laying of hands|laying of hands
34368|NCT03356665|diagnosis|diagnosis
34369|NCT03356665|sensitivity|sensitivity
34370|NCT03356665|specificity|specificity
34371|NCT03356665|rapid diagnostic test|rapid diagnostic test
34372|NCT03356665|molecular biology|molecular biology
34373|NCT03356665|LAMP|lamp
34374|NCT03356665|RT-PCR|rt-pcr
34375|NCT03356665|serology|serology
34376|NCT03356665|ELISA|elisa
34377|NCT03356665|immune trypanolysis|immune trypanolysis
34378|NCT03356665|clinical symptom|clinical symptom
34379|NCT03356652|Cardiac resynchronizaton therapy|cardiac resynchronizaton therapy
34380|NCT03356652|Electrical activation mapping|electrical activation mapping
34381|NCT03356652|Noninvasive|noninvasive
34382|NCT03356652|Electrical dyssynchrony|electrical dyssynchrony
34383|NCT03356639|Schizophrenia|schizophrenia
34384|NCT03356639|ASP6981|asp6981
34385|NCT03356639|Safety|safety
34386|NCT03356639|Phase 1|phase 1
34387|NCT03356626|fever, inflammation|fever, inflammation
34388|NCT03356600|Brain Metastases|brain metastases
34389|NCT03356587|NGS|ngs
34390|NCT03356587|Nanostring|nanostring
34391|NCT03356587|Biomarker Driven Umbrella Trial|biomarker driven umbrella trial
34392|NCT03356587|abemaciclib|abemaciclib
34393|NCT03356535|targeted metabolomics|targeted metabolomics
34394|NCT03356535|multivariate statistics|multivariate statistics
34395|NCT03356535|metabolic signatures|metabolic signatures
34396|NCT03356535|partial least squares|partial least squares
34397|NCT03356535|healthy lifestyle index|healthy lifestyle index
34398|NCT03356535|EPIC|epic
34399|NCT03356483|Psilocybin|psilocybin
34400|NCT03356470|melanoma|melanoma
34401|NCT03356470|antimelanoma T cells|antimelanoma t cells
34402|NCT03356444|abiraterone|abiraterone
34403|NCT03356444|docetaxel|docetaxel
34404|NCT03356444|Castration-resistant Prostate Cancer|castration-resistant prostate cancer
34405|NCT03356431|Exercise therapy|exercise therapy
34406|NCT03356431|Physical Therapy|physical therapy
34407|NCT03356418|Exercise|exercise
34408|NCT03356418|Vibration|vibration
34409|NCT03356418|Torque|torque
34410|NCT03356418|Aging|aging
34411|NCT03356392|acute stroke, thrombectomy, endovascular treatment|acute stroke, thrombectomy, endovascular treatment
34412|NCT03356379|Diagnosis|diagnosis
34413|NCT03356379|Peripheral artery disease|peripheral artery disease
34414|NCT03356379|sports|sports
34415|NCT03356314|superior mesenteric artery|superior mesenteric artery
34416|NCT03356314|superior mesenteric vein|superior mesenteric vein
34417|NCT03356314|intestinal malrotation|intestinal malrotation
34418|NCT03356314|volvulus|volvulus
34419|NCT03356314|pregnant women|pregnant women
34420|NCT03356314|mesenteric vessels position|mesenteric vessels position
34421|NCT03356314|postnatal diagnosis|postnatal diagnosis
34422|NCT03356314|prophylactic surgery|prophylactic surgery
34423|NCT03356301|Aortic compliance|aortic compliance
34424|NCT03356301|Aortic distensibility|aortic distensibility
34425|NCT03356301|CMR|cmr
34426|NCT03356301|Triathletes|triathletes
34427|NCT03356301|Ventriculo-atrial coupling|ventriculo-atrial coupling
34428|NCT03356288|Capnography, Diagnosis. Breathlessness, Exacerbations, Device|capnography, diagnosis. breathlessness, exacerbations, device
34429|NCT03356262|Cohort study|cohort study
34430|NCT03356249|Sepsis|sepsis
34431|NCT03356249|Septic shock|septic shock
34432|NCT03356249|Next-Generation Sequencing|next-generation sequencing
34433|NCT03356249|Bacteremia|bacteremia
34434|NCT03356223|Clinical Trial|clinical trial
34435|NCT03356223|Phase II|phase ii
34436|NCT03356223|Monotherapy|monotherapy
34437|NCT03356223|Abemaciclib|abemaciclib
34438|NCT03356223|Homozygous deletion of CDKN2A|homozygous deletion of cdkn2a
34439|NCT03356223|Amplification of CCND1|amplification of ccnd1
34440|NCT03356223|Amplification of CDK6|amplification of cdk6
34441|NCT03356223|Multicenter Trial|multicenter trial
34442|NCT03356158|Metastatic Colorectal Cancer,|metastatic colorectal cancer,
34443|NCT03356158|Recombinant Anti-EGFR Monoclonal Antibody|recombinant anti-egfr monoclonal antibody
34444|NCT03356145|paracervical block|paracervical block
34445|NCT03356145|abortion|abortion
34446|NCT03356145|dilation and evacuation|dilation and evacuation
34447|NCT03356145|cervical preparation|cervical preparation
34448|NCT03356132|breast implant|breast implant
34449|NCT03356132|complication|complication
34450|NCT03356132|satisfaction|satisfaction
34451|NCT03356132|quality of life|quality of life
34452|NCT03356132|augmentation|augmentation
34453|NCT03356132|textured|textured
34454|NCT03356132|polyurethane|polyurethane
34455|NCT03356119|Contraceptive Implant|contraceptive implant
34456|NCT03356106|Obstructive sleep apnea|obstructive sleep apnea
34457|NCT03356106|Pre-Eclampsia|pre-eclampsia
34458|NCT03356093|head and neck cancer, symptom cluster, change, radiotherapy|head and neck cancer, symptom cluster, change, radiotherapy
34459|NCT03356080|decitabine|decitabine
34460|NCT03356080|retinoid acid|retinoid acid
34461|NCT03356080|cytarabine C|cytarabine c
34462|NCT03356080|Granulocyte Colony Stimulating Factor|granulocyte colony stimulating factor
34463|NCT03356080|acute myeloid leukemia|acute myeloid leukemia
34464|NCT03356080|Myelodysplastic Syndrome|myelodysplastic syndrome
34466|NCT03356028|Psychiatric Disorder|psychiatric disorder
34467|NCT03356028|mass trauma|mass trauma
34468|NCT03356015|Polyp detection rate|polyp detection rate
34469|NCT03356015|Adenoma detection rate|adenoma detection rate
34470|NCT03356015|Boston Bowel Preparation Scale|boston bowel preparation scale
34471|NCT03355989|Conditional Cash Transfer|conditional cash transfer
34472|NCT03355989|Immunization coverage|immunization coverage
34473|NCT03355989|Immunization reminder|immunization reminder
34474|NCT03355976|recurrent|recurrent
34475|NCT03355976|advanced|advanced
34476|NCT03355976|metastatitic|metastatitic
34477|NCT03355937|unexplained infertility|unexplained infertility
34478|NCT03355937|recurrent implantation failure|recurrent implantation failure
34479|NCT03355885|early onset pneumonia|early onset pneumonia
34480|NCT03355885|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
34481|NCT03355885|prognosis|prognosis
34482|NCT03355885|antibiotic|antibiotic
34483|NCT03355859|Non Hodgkin Lymphoma|non hodgkin lymphoma
34484|NCT03355859|CD19-targeted chimeric antigen receptor|cd19-targeted chimeric antigen receptor
34485|NCT03355859|JWCAR029|jwcar029
34486|NCT03355846|Anal Fissure|anal fissure
34487|NCT03355846|local therapy|local therapy
34488|NCT03355846|pain|pain
34489|NCT03355846|defecation|defecation
34490|NCT03355846|bleeding|bleeding
34491|NCT03355820|Immune response|immune response
34492|NCT03355820|Cervarix|cervarix
34493|NCT03355820|Persistence|persistence
34494|NCT03355820|Chinese|chinese
34495|NCT03355820|Human papillomavirus|human papillomavirus
34496|NCT03355807|sleeve gastrectomy|sleeve gastrectomy
34497|NCT03355807|magnesium sulfate|magnesium sulfate
34498|NCT03355807|postoperative pain|postoperative pain
34499|NCT03355807|bariatric surgery|bariatric surgery
34500|NCT03355794|DIPG|dipg
34501|NCT03355794|High Grade Glioma|high grade glioma
34502|NCT03355794|ribociclib|ribociclib
34503|NCT03355794|everolimus|everolimus
34504|NCT03355781|childhood trauma|childhood trauma
34505|NCT03355781|candidate gene expression|candidate gene expression
34506|NCT03355781|cerebral morphology|cerebral morphology
34507|NCT03355781|schizophrenic symptomatology|schizophrenic symptomatology
34508|NCT03355781|conceptual framework of stress vulnerability|conceptual framework of stress vulnerability
34509|NCT03355768|Romidepsin|romidepsin
34510|NCT03355768|Pralatrexate|pralatrexate
34511|NCT03355768|PTCL|ptcl
34512|NCT03355768|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
34513|NCT03355742|XIENCE|xience
34514|NCT03355742|High bleeding risk (HBR)|high bleeding risk (hbr)
34515|NCT03355742|Dual antiplatelet therapy (DAPT)|dual antiplatelet therapy (dapt)
34516|NCT03355742|Coronary Artery Disease|coronary artery disease
34517|NCT03355742|Drug eluting stent (DES)|drug eluting stent (des)
34518|NCT03355690|thrombectomy|thrombectomy
34519|NCT03355690|thrombolysis|thrombolysis
34520|NCT03355690|Health-economic status|health-economic status
34521|NCT03355690|Outcome after stroke|outcome after stroke
34522|NCT03355677|Case finding|case finding
34523|NCT03355677|complex case management|complex case management
34524|NCT03355664|Malaria, Falciparum|malaria, falciparum
34525|NCT03355664|Malaria|malaria
34526|NCT03355664|Protozoan Infections|protozoan infections
34527|NCT03355664|Lumefantrine|lumefantrine
34528|NCT03355664|Artemether|artemether
34529|NCT03355664|Amodiaquine|amodiaquine
34530|NCT03355664|Piperaquine|piperaquine
34531|NCT03355664|Artemether-lumefantrine combination|artemether-lumefantrine combination
34532|NCT03355664|Artemisinins|artemisinins
34533|NCT03355664|Dihydroartemisinin|dihydroartemisinin
34534|NCT03355664|Mefloquine|mefloquine
34535|NCT03355664|Artemisinin|artemisinin
34536|NCT03355664|Antimalarials|antimalarials
34537|NCT03355664|Antiparasitic Agents|antiparasitic agents
34538|NCT03355664|Anti-Infective Agents|anti-infective agents
34539|NCT03355664|ACT|act
34540|NCT03355664|TACT|tact
34541|NCT03355664|Triple ACT(s)|triple act(s)
34542|NCT03355664|Resistance|resistance
34543|NCT03355664|Antimalarial resistance|antimalarial resistance
34544|NCT03355664|Cardiotoxicity|cardiotoxicity
34545|NCT03355664|Safety|safety
34546|NCT03355664|Tolerability|tolerability
34547|NCT03355664|Efficacy|efficacy
34548|NCT03355651|Anterior Cruciate Ligament Tears|anterior cruciate ligament tears
34549|NCT03355651|Dietary Supplementations|dietary supplementations
34550|NCT03355651|Plasma Rich Proteins|plasma rich proteins
34551|NCT03355651|Collagen|collagen
34552|NCT03355651|Chondroitin Sulfate|chondroitin sulfate
34553|NCT03355651|Hyaluronic Acid|hyaluronic acid
34554|NCT03355625|Flow Cytometry|flow cytometry
34555|NCT03355625|eCPR|ecpr
34556|NCT03355625|Extracorporeal Life Support|extracorporeal life support
34557|NCT03355586|Lung diseases|lung diseases
34558|NCT03355586|Cancer|cancer
34559|NCT03355586|Interventional pulmonology|interventional pulmonology
34560|NCT03355586|Peripheral nodule|peripheral nodule
34561|NCT03355573|Bimekizumab|bimekizumab
34562|NCT03355573|Ankylosing Spondylitis|ankylosing spondylitis
34563|NCT03355573|AS|as
34564|NCT03355534|dexmedetomidine|dexmedetomidine
34565|NCT03355534|general anesthesia|general anesthesia
34566|NCT03355534|cerebral aneurysm|cerebral aneurysm
34567|NCT03355521|functionality|functionality
34568|NCT03355521|gait|gait
34569|NCT03355521|kinematics|kinematics
34570|NCT03355521|electromyographic activity|electromyographic activity
34571|NCT03355521|depressive symptoms|depressive symptoms
34572|NCT03355521|quality of life|quality of life
34573|NCT03355495|Colonoscopy|colonoscopy
34574|NCT03355495|Cecal Intubation Rate|cecal intubation rate
34575|NCT03355456|Persistent atrial fibrillation|persistent atrial fibrillation
34576|NCT03355456|Medication refractory atrial fibrillation|medication refractory atrial fibrillation
34577|NCT03355456|Pulmonary vein isolation procedure|pulmonary vein isolation procedure
34578|NCT03355456|Low voltage directed ablation|low voltage directed ablation
34579|NCT03355443|Colonoscopy|colonoscopy
34580|NCT03355443|Lower Gastrointestinal Tract|lower gastrointestinal tract
34581|NCT03355443|Re-examination|re-examination
34582|NCT03355443|Retroflexion|retroflexion
34583|NCT03355391|SCREENING|screening
34584|NCT03355391|RISK FACTOR|risk factor
34585|NCT03355365|Mesenchymal Stem Cells|mesenchymal stem cells
34586|NCT03355365|Neural Progenitors|neural progenitors
34587|NCT03355365|Autologous|autologous
34588|NCT03355365|Bone Marrow|bone marrow
34589|NCT03355365|Multiple Sclerosis|multiple sclerosis
34590|NCT03355352|Zalviso|zalviso
34591|NCT03355352|sufentanyl|sufentanyl
34592|NCT03355352|PCA|pca
34593|NCT03355352|Dipidolor|dipidolor
34594|NCT03355339|Balance|balance
34595|NCT03355339|Dual-task|dual-task
34596|NCT03355339|King-Devick Test|king-devick test
34597|NCT03355339|Saccades|saccades
34598|NCT03355339|Binasal Occlusion|binasal occlusion
34599|NCT03355313|saliva|saliva
34600|NCT03355313|Low-level light therapy|low-level light therapy
34601|NCT03355313|salivary glands|salivary glands
34602|NCT03355274|Transcutaneous Oximetry|transcutaneous oximetry
34603|NCT03355248|postpartum|postpartum
34604|NCT03355248|postoperative cesarean pain management|postoperative cesarean pain management
34605|NCT03355248|opioid requirements|opioid requirements
34606|NCT03355222|complementary feeding|complementary feeding
34607|NCT03355222|calcium|calcium
34608|NCT03355209|LGS|lgs
34609|NCT03355196|Osteoarthritic patients|osteoarthritic patients
34610|NCT03355196|Cartilage|cartilage
34611|NCT03355196|Safety|safety
34612|NCT03355183|isokinetics|isokinetics
34613|NCT03355183|knee|knee
34614|NCT03355157|Palbociclib|palbociclib
34615|NCT03355157|Endocrine Therapy|endocrine therapy
34616|NCT03355157|Chemotherapy|chemotherapy
34617|NCT03355157|Real world setting|real world setting
34618|NCT03355157|Electronic patient-reported outcome|electronic patient-reported outcome
34619|NCT03355157|Daily Monitoring Treatment Impact|daily monitoring treatment impact
34620|NCT03355157|Health care utilization (call tracking, geofencing)|health care utilization (call tracking, geofencing)
34621|NCT03355105|Neuromuscular disease|neuromuscular disease
34622|NCT03355066|Wnt pathway|wnt pathway
34623|NCT03355066|Wnt inhibition|wnt inhibition
34624|NCT03355066|SM08502|sm08502
34625|NCT03355040|shoulder dystocia|shoulder dystocia
34626|NCT03355040|maternal and neonatal morbidity|maternal and neonatal morbidity
34627|NCT03355027|Low Density Lipoprotein Cholesterol (LDL)|low density lipoprotein cholesterol (ldl)
34628|NCT03355027|PCSK9|pcsk9
34629|NCT03355027|Alirocumab|alirocumab
34630|NCT03355027|Flow Mediated Dilatation|flow mediated dilatation
34631|NCT03355027|Arterial Stiffness|arterial stiffness
34632|NCT03355027|Carotid Intima Media Thickness|carotid intima media thickness
34633|NCT03355027|Inflammation|inflammation
34634|NCT03355027|Endothelial function|endothelial function
34635|NCT03355027|FDG PET-CT|fdg pet-ct
34636|NCT03355027|PET-MR|pet-mr
34637|NCT03355027|Ezetimibe|ezetimibe
34638|NCT03354962|Melanoma|melanoma
34639|NCT03354962|Immune checkpoint|immune checkpoint
34640|NCT03354962|Nivolumab|nivolumab
34641|NCT03354962|Ipilimumab|ipilimumab
34642|NCT03354962|Abscopal effect|abscopal effect
34643|NCT03354962|Stereotactic radiotherapy|stereotactic radiotherapy
34644|NCT03354962|PD-1|pd-1
34645|NCT03354962|CTLA-4|ctla-4
34646|NCT03354949|Wheelchair|wheelchair
34647|NCT03354949|Hemiplegia|hemiplegia
34648|NCT03354949|Stroke|stroke
34649|NCT03354949|Postural control|postural control
34650|NCT03354949|Pain|pain
34651|NCT03354910|Live Donor Kidney Transplantation|live donor kidney transplantation
34652|NCT03354910|LDKT|ldkt
34653|NCT03354910|Disparity|disparity
34654|NCT03354910|African American|african american
34655|NCT03354910|Education|education
34656|NCT03354910|Patient Support|patient support
34657|NCT03354897|stratified medicine, UMOD, torasemide|stratified medicine, umod, torasemide
34658|NCT03354858|follicle flushing|follicle flushing
34659|NCT03354858|direct follicle aspiration|direct follicle aspiration
34660|NCT03354858|fertilization rate|fertilization rate
34661|NCT03354858|maturation|maturation
34662|NCT03354754|Intra-abdominal infection|intra-abdominal infection
34663|NCT03354754|LYS228|lys228
34664|NCT03354754|beta-lactam antibiotics|beta-lactam antibiotics
34665|NCT03354754|creatinine clearance|creatinine clearance
34666|NCT03354754|enterobacteriaceae|enterobacteriaceae
34667|NCT03354676|adipokines, metabolic syndrome, obese children|adipokines, metabolic syndrome, obese children
34668|NCT03354663|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
34669|NCT03354663|PAF|paf
34670|NCT03354663|ablation|ablation
34671|NCT03354585|Mindfulness|mindfulness
34672|NCT03354585|fMRI|fmri
34673|NCT03354585|Pain|pain
34674|NCT03354585|low back|low back
34675|NCT03354585|radicular|radicular
34676|NCT03354559|coagulopathy|coagulopathy
34677|NCT03354559|trauma|trauma
34678|NCT03354559|bleeding|bleeding
34679|NCT03354559|fibrinogen|fibrinogen
34680|NCT03354559|transfusion|transfusion
34681|NCT03354507|topiramate|topiramate
34682|NCT03354507|epilepsy|epilepsy
34683|NCT03354507|sodium bicarbonate|sodium bicarbonate
34684|NCT03354507|urine alkalinization|urine alkalinization
34685|NCT03354494|Oocyte donors|oocyte donors
34686|NCT03354494|Ovarian stimulation|ovarian stimulation
34687|NCT03354494|Desogestrel|desogestrel
34688|NCT03354494|Corifolitropina alfa|corifolitropina alfa
34689|NCT03354494|Gonadotropins|gonadotropins
34690|NCT03354481|Dyscalculia|dyscalculia
34691|NCT03354468|Prevention and Control|prevention and control
34692|NCT03354468|Patient Safety|patient safety
34693|NCT03354468|Aged|aged
34694|NCT03354468|Risk Management|risk management
34695|NCT03354442|Class III treatment|class iii treatment
34696|NCT03354442|Modified Fixed Mandibular Retractor Appliance|modified fixed mandibular retractor appliance
34697|NCT03354442|RCT|rct
34698|NCT03354429|Acute ischaemic stroke; Transient Ischaemic Attack (TIA); Stroke|acute ischaemic stroke; transient ischaemic attack (tia); stroke
34699|NCT03354416|Imaging-Based Prognostic Markers|imaging-based prognostic markers
34700|NCT03354416|Multiparametric MRI (mpMRI)|multiparametric mri (mpmri)
34701|NCT03354416|Translation of Imaging into Treatment Decisions|translation of imaging into treatment decisions
34702|NCT03354416|Decision-Support System|decision-support system
34703|NCT03354416|Artificial Intelligence Research|artificial intelligence research
34704|NCT03354403|XLRS|xlrs
34705|NCT03354403|RS1|rs1
34706|NCT03354403|Carrier|carrier
34707|NCT03354390|genetically modified lymphocytes|genetically modified lymphocytes
34708|NCT03354390|tumor antigens|tumor antigens
34709|NCT03354390|T cell receptor immunotherapy|t cell receptor immunotherapy
34710|NCT03354390|genomic retroviral elements|genomic retroviral elements
34711|NCT03354351|Stepped-care model|stepped-care model
34712|NCT03354351|Men's health|men's health
34713|NCT03354351|Prevention|prevention
34714|NCT03354351|Early treatment|early treatment
34715|NCT03354351|Psychotherapy|psychotherapy
34716|NCT03354338|Periodontal disease|periodontal disease
34717|NCT03354338|Bacteremia|bacteremia
34718|NCT03354338|Amoxicilline|amoxicilline
34719|NCT03354338|Inflamatory markers|inflamatory markers
34720|NCT03354325|Office Visits|office visits
34721|NCT03354312|scaling and root planing|scaling and root planing
34722|NCT03354312|topical anesthesia|topical anesthesia
34723|NCT03354299|malnutrition|malnutrition
34724|NCT03354299|liver cirrhosis|liver cirrhosis
34725|NCT03354299|coconut milk|coconut milk
34726|NCT03354286|670G|670g
34727|NCT03354286|Hybrid closed-loop system|hybrid closed-loop system
34728|NCT03354286|pediatric|pediatric
34729|NCT03354234|Gz accelerations|gz accelerations
34730|NCT03354234|Head up tilt (HUT) test|head up tilt (hut) test
34731|NCT03354234|Lower body negative pressure (LBNP) method|lower body negative pressure (lbnp) method
34732|NCT03354234|Physiological parameters|physiological parameters
34733|NCT03354234|Variable gravitational stimuli|variable gravitational stimuli
34734|NCT03354221|EoE|eoe
34735|NCT03354208|biomarkers|biomarkers
34736|NCT03354182|Mandibular type II furcations|mandibular type ii furcations
34737|NCT03354182|Periodontal treatment|periodontal treatment
34738|NCT03354182|Demineralized bovine bone mineral|demineralized bovine bone mineral
34739|NCT03354182|Collagen membrane|collagen membrane
34740|NCT03354169|Metabolism|metabolism
34741|NCT03354169|Eating|eating
34742|NCT03354169|Circadian Rhythms|circadian rhythms
34743|NCT03354143|Dementia|dementia
34744|NCT03354143|Alzheimer's Disease|alzheimer's disease
34745|NCT03354143|Blood Pressure|blood pressure
34746|NCT03354143|Cognitive Function|cognitive function
34747|NCT03354143|Magnetic Resonance Imaging|magnetic resonance imaging
34748|NCT03354078|Cesarean section|cesarean section
34749|NCT03354078|Wound infection|wound infection
34750|NCT03354078|Gapping|gapping
34751|NCT03354065|pancreatitis|pancreatitis
34752|NCT03354065|mild|mild
34753|NCT03354065|biliary|biliary
34754|NCT03354065|referring|referring
34755|NCT03354052|Pain|pain
34756|NCT03354052|rTMS|rtms
34757|NCT03354052|Rehabilitation|rehabilitation
34758|NCT03354039|DMD|dmd
34759|NCT03354026|Blood-breaking Decotion|blood-breaking decotion
34760|NCT03354013|AOA|aoa
34761|NCT03354013|embryo developmental problems|embryo developmental problems
34762|NCT03354013|genetic screening|genetic screening
34763|NCT03354013|calcium pattern analysis|calcium pattern analysis
34764|NCT03354000|Patient Portal|patient portal
34765|NCT03354000|Healthcare disparities|healthcare disparities
34766|NCT03354000|Safety net healthcare system|safety net healthcare system
34767|NCT03353987|Post-op cognitive dysfunction|post-op cognitive dysfunction
34768|NCT03353987|Cognitive training|cognitive training
34769|NCT03353987|Logbook|logbook
34770|NCT03353987|Elderly|elderly
34771|NCT03353974|Multiple Sclerosis|multiple sclerosis
34772|NCT03353974|Video game therapy|video game therapy
34773|NCT03353974|Balance|balance
34774|NCT03353974|Cognitive functions|cognitive functions
34775|NCT03353961|NSSI|nssi
34776|NCT03353948|Polycystic Ovary Syndrome|polycystic ovary syndrome
34777|NCT03353948|Obesity|obesity
34778|NCT03353948|Infertility|infertility
34779|NCT03353948|IVF|ivf
34780|NCT03353935|surgery|surgery
34781|NCT03353935|pelvic function|pelvic function
34782|NCT03353922|cognitive function|cognitive function
34783|NCT03353909|Intrauterine adhesion|intrauterine adhesion
34784|NCT03353909|Delayed miscarriage|delayed miscarriage
34785|NCT03353909|hyaluronan gel|hyaluronan gel
34786|NCT03353831|Recurrent Ovarian Cancer|recurrent ovarian cancer
34787|NCT03353831|Atezolizumab|atezolizumab
34788|NCT03353831|Bevacizumab|bevacizumab
34789|NCT03353779|Percutaneous coronary intervention|percutaneous coronary intervention
34790|NCT03353779|antiplatelet|antiplatelet
34791|NCT03353779|platelet function|platelet function
34792|NCT03353779|prognosis|prognosis
34793|NCT03353766|Early Orthodontic treatment|early orthodontic treatment
34794|NCT03353766|Orthodontic treatment outcome|orthodontic treatment outcome
34795|NCT03353766|Crossbite treatment|crossbite treatment
34796|NCT03353727|Orthoptic rehabilitation|orthoptic rehabilitation
34797|NCT03353727|low vision|low vision
34798|NCT03353727|eye tracker|eye tracker
34799|NCT03353727|tactile device|tactile device
34800|NCT03353688|Parkinson's|parkinson's
34801|NCT03353688|Parkinson Disease|parkinson disease
34802|NCT03353675|Nivolumab|nivolumab
34803|NCT03353675|Therapeutic Vaccine|therapeutic vaccine
34804|NCT03353662|bio fortification|bio fortification
34805|NCT03353623|Immersive Virtual Environments|immersive virtual environments
34806|NCT03353623|Wearable Haptic Devices|wearable haptic devices
34807|NCT03353623|Neuromotor Impairments|neuromotor impairments
34808|NCT03353623|Rehabilitation|rehabilitation
34809|NCT03353623|Serious Game|serious game
34810|NCT03353623|Randomized Controlled Trial|randomized controlled trial
34811|NCT03353610|Tachycardia|tachycardia
34812|NCT03353610|PSVT episodes|psvt episodes
34813|NCT03353584|Virtual reality|virtual reality
34814|NCT03353584|Pain|pain
34815|NCT03353584|Nonpharmacological|nonpharmacological
34816|NCT03353493|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
34817|NCT03353493|Neural, psychological and molecular mechanisms|neural, psychological and molecular mechanisms
34818|NCT03353480|Azithromycin tablet, Bioequivalence, Phase I, Chinese, Healthy Subjects|azithromycin tablet, bioequivalence, phase i, chinese, healthy subjects
34819|NCT03353454|Cholestasis|cholestasis
34820|NCT03353454|Maralixibat|maralixibat
34821|NCT03353454|Mutation|mutation
34822|NCT03353441|Verbal Learning and Memory Test (VLMT)|verbal learning and memory test (vlmt)
34823|NCT03353441|Stroop Test|stroop test
34824|NCT03353441|Attention|attention
34825|NCT03353441|Working Memory|working memory
34826|NCT03353441|Learning and recognition|learning and recognition
34827|NCT03353441|CogTrack|cogtrack
34828|NCT03353428|Lung cancer|lung cancer
34829|NCT03353428|Cytotoxic lymphocyte|cytotoxic lymphocyte
34830|NCT03353428|LC-CTL|lc-ctl
34831|NCT03353428|NSCLC|nsclc
34832|NCT03353415|Post-bariatric Hypoglycemia;|post-bariatric hypoglycemia;
34833|NCT03353402|Melanoma|melanoma
34834|NCT03353402|Fecal Microbiota Transplantation|fecal microbiota transplantation
34835|NCT03353402|Immunotherapy|immunotherapy
34836|NCT03353389|Acute Kidney Injury|acute kidney injury
34837|NCT03353389|Hospital-acquired Acute Kidney Injury|hospital-acquired acute kidney injury
34838|NCT03353389|Community-acquired Acute Kidney Injury|community-acquired acute kidney injury
34839|NCT03353389|Acute Renal Failure|acute renal failure
34840|NCT03353363|cesarean delivery|cesarean delivery
34841|NCT03353363|liposomal bupivacaine|liposomal bupivacaine
34842|NCT03353363|Exparel|exparel
34843|NCT03353363|bupivacaine|bupivacaine
34844|NCT03353363|wound infiltration|wound infiltration
34845|NCT03353337|neurocognition|neurocognition
34846|NCT03353337|prognosis|prognosis
34847|NCT03353337|aerobic exercise|aerobic exercise
34848|NCT03353311|ERAS|eras
34849|NCT03353311|Fast-track|fast-track
34850|NCT03353311|colorectal surgery|colorectal surgery
34851|NCT03353311|immuno-nutrition|immuno-nutrition
34852|NCT03353298|Uric acid|uric acid
34853|NCT03353298|Left ventricular mass|left ventricular mass
34854|NCT03353298|Nephrectomy|nephrectomy
34855|NCT03353298|Allopurinol|allopurinol
34856|NCT03353298|Magnetic resonance imaging|magnetic resonance imaging
34857|NCT03353233|iPACK|ipack
34858|NCT03353233|Interspace between the Popliteal Artery and Capsule of the Knee|interspace between the popliteal artery and capsule of the knee
34859|NCT03353233|Posterior Capsule block|posterior capsule block
34860|NCT03353233|Nerve Block|nerve block
34861|NCT03353220|Overweight|overweight
34862|NCT03353220|Obesity|obesity
34863|NCT03353220|Weight Loss|weight loss
34864|NCT03353220|Lorcaserin|lorcaserin
34865|NCT03353220|Healthy Volunteers|healthy volunteers
34866|NCT03353207|REM Sleep Without Atonia|rem sleep without atonia
34867|NCT03353207|Dopamine transmission|dopamine transmission
34868|NCT03353207|Neurodegeneration|neurodegeneration
34869|NCT03353194|Cerebral Palsy|cerebral palsy
34870|NCT03353194|Canada|canada
34871|NCT03353194|Registry|registry
34872|NCT03353181|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
34873|NCT03353181|endoscopic drainage|endoscopic drainage
34874|NCT03353181|endoscopic nasobiliary drainage|endoscopic nasobiliary drainage
34875|NCT03353181|stent|stent
34876|NCT03353168|fear|fear
34877|NCT03353168|anxiety|anxiety
34878|NCT03353168|childbirth|childbirth
34879|NCT03353168|pregnancy|pregnancy
34880|NCT03353129|Quality Improvement|quality improvement
34881|NCT03353129|Patient Safety|patient safety
34882|NCT03353129|Outcome Improvements|outcome improvements
34883|NCT03353077|Squamous Cell Carcinoma|squamous cell carcinoma
34884|NCT03353038|assistive technology|assistive technology
34885|NCT03353038|3 Dimensional Printing|3 dimensional printing
34886|NCT03353038|Self-Management|self-management
34887|NCT03353025|non-invasive prolactinoma|non-invasive prolactinoma
34888|NCT03353012|Immediate postpartum implant|immediate postpartum implant
34889|NCT03353012|postpartum implant|postpartum implant
34890|NCT03353012|implant contraception|implant contraception
34891|NCT03353012|Etonogestrel|etonogestrel
34892|NCT03353012|Levonorgestrel|levonorgestrel
34893|NCT03352999|Refractory out-hospital cardiac arrest|refractory out-hospital cardiac arrest
34894|NCT03352999|Extracorporeal Life Support|extracorporeal life support
34895|NCT03352986|Sickle cell disease|sickle cell disease
34896|NCT03352986|anemia|anemia
34897|NCT03352986|Africa|africa
34898|NCT03352934|avelumab|avelumab
34899|NCT03352934|anti-PD-L1|anti-pd-l1
34900|NCT03352934|neuroendocrine tumor|neuroendocrine tumor
34901|NCT03352934|NET G3|net g3
34902|NCT03352934|neuroendocrine carcinoma|neuroendocrine carcinoma
34903|NCT03352934|NEC G3|nec g3
34904|NCT03352921|clinical pilates|clinical pilates
34905|NCT03352921|exercise|exercise
34906|NCT03352921|Sagital Cervical Disorientation|sagital cervical disorientation
34907|NCT03352921|Disorientation|disorientation
34908|NCT03352921|Forward Head Posture|forward head posture
34909|NCT03352908|Dysphagia|dysphagia
34910|NCT03352908|Aspiration|aspiration
34911|NCT03352908|YSP|ysp
34912|NCT03352908|FEES|fees
34913|NCT03352908|Swallow Problems|swallow problems
34914|NCT03352895|Resveratrol|resveratrol
34915|NCT03352895|chronic kidney disease|chronic kidney disease
34916|NCT03352869|Polycystic Ovary Syndrome|polycystic ovary syndrome
34917|NCT03352869|Overweight and Obesity|overweight and obesity
34918|NCT03352869|Impaired Glucose Regulation|impaired glucose regulation
34919|NCT03352869|Exenatide|exenatide
34920|NCT03352869|Metformin|metformin
34921|NCT03352856|Cereal allergy; barley starch, DBPC|cereal allergy; barley starch, dbpc
34922|NCT03352830|household air pollution|household air pollution
34923|NCT03352830|health promotion|health promotion
34924|NCT03352830|clean cookstove adoption|clean cookstove adoption
34925|NCT03352830|clean cookstove sustained use|clean cookstove sustained use
34926|NCT03352765|Rituximab|rituximab
34927|NCT03352765|Bendamustine|bendamustine
34928|NCT03352765|Melphalan|melphalan
34929|NCT03352765|Autologous Stem Cell Transplantation (ASCT)|autologous stem cell transplantation (asct)
34930|NCT03352765|17-373|17-373
34931|NCT03352752|virtual reality|virtual reality
34932|NCT03352752|fractional laser|fractional laser
34933|NCT03352752|scars|scars
34934|NCT03352752|acute pain|acute pain
34935|NCT03352752|anxiety score|anxiety score
34936|NCT03352726|EPIT|epit
34937|NCT03352726|Epicutaneous|epicutaneous
34938|NCT03352726|Immunotherapy|immunotherapy
34939|NCT03352726|Viaskin|viaskin
34940|NCT03352713|self-regulation|self-regulation
34941|NCT03352713|binge eating|binge eating
34942|NCT03352713|smoking|smoking
34943|NCT03352713|ecological momentary assessment|ecological momentary assessment
34944|NCT03352713|mobile sensing|mobile sensing
34945|NCT03352713|mHealth|mhealth
34946|NCT03352687|Shoulder surgery|shoulder surgery
34947|NCT03352687|Local regional anesthesia|local regional anesthesia
34948|NCT03352674|insulin glargine|insulin glargine
34949|NCT03352674|diabetes mellitus|diabetes mellitus
34950|NCT03352674|immunogenicity|immunogenicity
34951|NCT03352635|Ethnic Differences|ethnic differences
34952|NCT03352622|PHARMACOGENOMICS|pharmacogenomics
34953|NCT03352622|POLYMORPHISM|polymorphism
34954|NCT03352609|TMS|tms
34955|NCT03352609|rTMS|rtms
34956|NCT03352609|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
34957|NCT03352609|Smoking|smoking
34958|NCT03352609|Nicotine|nicotine
34959|NCT03352570|anastomotic leakage|anastomotic leakage
34960|NCT03352570|fistula|fistula
35550|NCT03348670|Everolimus|everolimus
34961|NCT03352557|Mild cognitive impairment|mild cognitive impairment
34962|NCT03352557|Alzheimer's disease|alzheimer's disease
34963|NCT03352531|Anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
34964|NCT03352531|immunotherapy|immunotherapy
34965|NCT03352531|immuno-oncology|immuno-oncology
34966|NCT03352531|advanced solid tumors|advanced solid tumors
34967|NCT03352466|Anthrax|anthrax
34968|NCT03352440|Cerebral Palsy|cerebral palsy
34969|NCT03352440|Virtual Reality Exposure Therapy|virtual reality exposure therapy
34970|NCT03352440|Learning|learning
34971|NCT03352440|Motor Activity|motor activity
34972|NCT03352440|Motor Skills|motor skills
34973|NCT03352414|HIPEC|hipec
34974|NCT03352414|peritoneal carcinomatosis|peritoneal carcinomatosis
34975|NCT03352401|Pulmonary aspiration, full stomach, gastric content inhalation, Mendelson syndrom|pulmonary aspiration, full stomach, gastric content inhalation, mendelson syndrom
34976|NCT03352388|Older people|older people
34977|NCT03352388|Nutrition|nutrition
34978|NCT03352388|Snack|snack
34979|NCT03352388|Dairy|dairy
34980|NCT03352388|Protein|protein
34981|NCT03352388|Berries|berries
34982|NCT03352349|Terlipressinum|terlipressinum
34983|NCT03352349|Portal Vein Pressure|portal vein pressure
34984|NCT03352349|Liver Tumor Resection|liver tumor resection
34985|NCT03352336|Atelectasis|atelectasis
34986|NCT03352336|Oxygenation|oxygenation
34987|NCT03352336|Venous admixture|venous admixture
34988|NCT03352336|Computed Tomography|computed tomography
34989|NCT03352336|Oxygenation test|oxygenation test
34990|NCT03352310|umbilical cord blood|umbilical cord blood
34991|NCT03352297|Post burn scar face|post burn scar face
34992|NCT03352297|Unfiltered nanofat|unfiltered nanofat
34993|NCT03352297|Adipose tissue growth factors|adipose tissue growth factors
34994|NCT03352297|Adipose stem cells|adipose stem cells
34995|NCT03352297|POSAS|posas
34996|NCT03352297|Image J|image j
34997|NCT03352297|Face|face
34998|NCT03352284|Zirconia implant|zirconia implant
34999|NCT03352284|One-piece|one-piece
35000|NCT03352284|Monoblock|monoblock
35001|NCT03352284|Single tooth|single tooth
35002|NCT03352271|Incremental hemodialysis|incremental hemodialysis
35003|NCT03352271|Precision medicine|precision medicine
35004|NCT03352271|Individualized care|individualized care
35005|NCT03352258|Alzheimer's Disease|alzheimer's disease
35006|NCT03352258|Amyloid|amyloid
35007|NCT03352258|Radiotherapy|radiotherapy
35008|NCT03352219|Human immunodeficiency virus|human immunodeficiency virus
35009|NCT03352219|Sexually transmitted disease|sexually transmitted disease
35010|NCT03352219|African Americans|african americans
35011|NCT03352219|Young adults|young adults
35012|NCT03352219|Behavioral intervention|behavioral intervention
35013|NCT03352219|Entertainment-Education|entertainment-education
35014|NCT03352219|Serial drama|serial drama
35015|NCT03352219|Sexual behavior|sexual behavior
35016|NCT03352219|HIV testing|hiv testing
35017|NCT03352219|Homophobia|homophobia
35018|NCT03352219|Social cognitive theory|social cognitive theory
35019|NCT03352206|Mass drug administration|mass drug administration
35020|NCT03352206|Effectiveness|effectiveness
35021|NCT03352154|cochlear implant|cochlear implant
35022|NCT03352154|Evoked Potential P300|evoked potential p300
35023|NCT03352102|Electric Stimulation|electric stimulation
35024|NCT03352102|Intensive Care Units|intensive care units
35025|NCT03352102|Mechanical Ventilation|mechanical ventilation
35026|NCT03352102|Ventilator Weaning|ventilator weaning
35027|NCT03352089|Magnetic resonance imaging|magnetic resonance imaging
35028|NCT03352089|Positron emission tomography|positron emission tomography
35029|NCT03352076|Danazol|danazol
35030|NCT03352024|neuro degenerative diseases|neuro degenerative diseases
35031|NCT03352024|Alzheimer's disease|alzheimer's disease
35032|NCT03352024|lumbar puncture|lumbar puncture
35033|NCT03352024|CSF|csf
35034|NCT03352024|hypno analgesia|hypno analgesia
35035|NCT03352024|no drug care|no drug care
35036|NCT03352024|pain|pain
35037|NCT03352024|anxiety|anxiety
35038|NCT03352024|counseling|counseling
35039|NCT03351998|insulin sensitivity|insulin sensitivity
35040|NCT03351998|cardiorespiratory fitness|cardiorespiratory fitness
35041|NCT03351998|skeletal muscle mitochondrial function|skeletal muscle mitochondrial function
35042|NCT03351959|ypT0|ypt0
35043|NCT03351946|Atelectasis|atelectasis
35044|NCT03351946|Oxygenation|oxygenation
35045|NCT03351946|Positive end-expiratory pressure|positive end-expiratory pressure
35046|NCT03351946|Mechanical ventilation|mechanical ventilation
35047|NCT03351946|General anesthesia|general anesthesia
35048|NCT03351946|Computed tomography|computed tomography
35049|NCT03351868|Fanconi anemia|fanconi anemia
35050|NCT03351868|Lentiviral vector|lentiviral vector
35051|NCT03351868|FANCA|fanca
35052|NCT03351868|Gene|gene
35053|NCT03351855|Human papilloma virus|human papilloma virus
35054|NCT03351855|Cytotoxic lymphocyte|cytotoxic lymphocyte
35055|NCT03351855|HPV-CTL|hpv-ctl
35056|NCT03351842|Adjuvant chemotherapy|adjuvant chemotherapy
35057|NCT03351842|Micropapillary Component|micropapillary component
35058|NCT03351842|Early stage lung cancer|early stage lung cancer
35652|NCT03347942|Overweight|overweight
35059|NCT03351829|Beta Thalassemia|beta thalassemia
35060|NCT03351829|Lentiviral vector|lentiviral vector
35061|NCT03351829|Gene|gene
35062|NCT03351803|BRCA|brca
35063|NCT03351803|BFOR|bfor
35064|NCT03351803|Ashkenazi|ashkenazi
35065|NCT03351803|17-568|17-568
35066|NCT03351764|Non-Invasive Brain Stimulation|non-invasive brain stimulation
35067|NCT03351764|fMRI|fmri
35068|NCT03351764|TMS-Evoked Potential|tms-evoked potential
35069|NCT03351764|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
35070|NCT03351764|EEG|eeg
35071|NCT03351751|PF-06372865|pf-06372865
35072|NCT03351751|Safety|safety
35073|NCT03351751|Tolerability|tolerability
35074|NCT03351751|Pharmacokinetics|pharmacokinetics
35075|NCT03351751|Multiple dose|multiple dose
35076|NCT03351751|Healthy subjects|healthy subjects
35077|NCT03351738|coronary heart disease pharmacokinetic pharmacodynamics|coronary heart disease pharmacokinetic pharmacodynamics
35078|NCT03351725|peripheral venous catheter|peripheral venous catheter
35079|NCT03351725|catheter colonization|catheter colonization
35080|NCT03351712|Wearables|wearables
35081|NCT03351712|Activity Trackers|activity trackers
35082|NCT03351712|ACT|act
35083|NCT03351712|Health promotion|health promotion
35084|NCT03351712|Obesity|obesity
35085|NCT03351712|Chronic Health Condition|chronic health condition
35086|NCT03351712|Psychological well-being|psychological well-being
35087|NCT03351712|Quality of life|quality of life
35088|NCT03351712|Behavior modification|behavior modification
35089|NCT03351712|RCT|rct
35090|NCT03351686|tranexamic acid|tranexamic acid
35091|NCT03351647|Crohn Disease|crohn disease
35092|NCT03351647|Ustekinumab|ustekinumab
35093|NCT03351647|Vedolizumab|vedolizumab
35094|NCT03351647|anti-TNF|anti-tnf
35095|NCT03351647|CRP|crp
35096|NCT03351647|calprotectin|calprotectin
35097|NCT03351647|cohort|cohort
35098|NCT03351595|Growth pattern|growth pattern
35099|NCT03351595|Environmental and prenatal exposure|environmental and prenatal exposure
35100|NCT03351582|family therapy|family therapy
35101|NCT03351582|psychological health|psychological health
35102|NCT03351569|Unverricht-Lundborg disease|unverricht-lundborg disease
35103|NCT03351569|progressive myoclonus epilepsy|progressive myoclonus epilepsy
35104|NCT03351569|pharmacoresistant epilepsy|pharmacoresistant epilepsy
35105|NCT03351543|vaccine response|vaccine response
35106|NCT03351543|immune system activity|immune system activity
35107|NCT03351504|household air pollution|household air pollution
35108|NCT03351504|fine particulate matter|fine particulate matter
35109|NCT03351504|kerosene|kerosene
35110|NCT03351491|Health mobile applications|health mobile applications
35111|NCT03351491|Apps|apps
35112|NCT03351491|mhealth|mhealth
35113|NCT03351491|ehealth|ehealth
35114|NCT03351491|France|france
35115|NCT03351491|msanté|msanté
35116|NCT03351491|applications mobiles|applications mobiles
35117|NCT03351439|Hip Arthroscopy|hip arthroscopy
35118|NCT03351426|obesity|obesity
35119|NCT03351426|overweight|overweight
35120|NCT03351426|neuromodulation|neuromodulation
35121|NCT03351426|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
35122|NCT03351413|Fall Prevention|fall prevention
35123|NCT03351413|Older Adults|older adults
35124|NCT03351400|cardiac stem cells|cardiac stem cells
35125|NCT03351400|c-kit|c-kit
35126|NCT03351387|amputation|amputation
35127|NCT03351387|necrosis|necrosis
35128|NCT03351387|high risk lower extremity wound|high risk lower extremity wound
35129|NCT03351374|behavioral health|behavioral health
35130|NCT03351374|software|software
35131|NCT03351374|integration|integration
35132|NCT03351348|Bupivacaine|bupivacaine
35133|NCT03351348|Mastectomy|mastectomy
35134|NCT03351348|17-576|17-576
35135|NCT03351322|Alopecia|alopecia
35136|NCT03351322|Hair Loss|hair loss
35137|NCT03351322|Female Pattern Baldness|female pattern baldness
35138|NCT03351270|CNM|cnm
35139|NCT03351270|XLMTM|xlmtm
35140|NCT03351270|Myotubular myopathy|myotubular myopathy
35141|NCT03351205|Asherman syndrome|asherman syndrome
35142|NCT03351205|hysteroscopy|hysteroscopy
35143|NCT03351205|uterine stent|uterine stent
35144|NCT03351205|Estrogen|estrogen
35145|NCT03351205|Amnion|amnion
35146|NCT03351205|Hysteroscopic Adhesiolysis|hysteroscopic adhesiolysis
35147|NCT03351179|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
35148|NCT03351179|Acute MyocAcute Myocardial Infarction|acute myocacute myocardial infarction
35149|NCT03351179|Predictive factors|predictive factors
35150|NCT03351140|Multiple Myeloma|multiple myeloma
35151|NCT03351140|Patient‐Reported Outcome Measurement Information System (PROMIS)|patient‐reported outcome measurement information system (promis)
35152|NCT03351140|Non‐Small Cell Lung Cancer (NSCLC)|non‐small cell lung cancer (nsclc)
35153|NCT03351140|Breast cancer|breast cancer
35154|NCT03351140|Diffuse Large B‐Cell (DLBCL)|diffuse large b‐cell (dlbcl)
35155|NCT03351140|Follicular Lymphoma|follicular lymphoma
35156|NCT03351140|Prostate Cancer|prostate cancer
35157|NCT03351140|Qualitative interview|qualitative interview
35158|NCT03351114|Morphea, Localized Scleroderma|morphea, localized scleroderma
35159|NCT03351062|premenopausal|premenopausal
35160|NCT03351062|early breast cancer|early breast cancer
35161|NCT03351062|estrogen receptor positive|estrogen receptor positive
35162|NCT03351049|Acute care, support surface|acute care, support surface
35163|NCT03351036|Hypothermia|hypothermia
35164|NCT03351010|Mindfulness, Cancer, Pain Management|mindfulness, cancer, pain management
35165|NCT03350997|Exercise|exercise
35166|NCT03350971|virtual reality|virtual reality
35167|NCT03350971|physical therapy|physical therapy
35168|NCT03350971|myocardial revascualrization|myocardial revascualrization
35169|NCT03350932|sensory imagination; foods|sensory imagination; foods
35170|NCT03350906|Exercise|exercise
35171|NCT03350906|muscle function|muscle function
35172|NCT03350880|Passive|passive
35173|NCT03350880|Stretching|stretching
35174|NCT03350880|Water|water
35175|NCT03350880|Proprioceptive Neuromuscular Facilitation (PNF)|proprioceptive neuromuscular facilitation (pnf)
35176|NCT03350867|Posture|posture
35177|NCT03350867|Orthosis|orthosis
35178|NCT03350867|Foot|foot
35179|NCT03350867|Biomechanical Phenomena|biomechanical phenomena
35180|NCT03350854|early stage breast cancer;|early stage breast cancer;
35181|NCT03350854|treatment decision making|treatment decision making
35182|NCT03350854|newly diagnosed breast cancer|newly diagnosed breast cancer
35184|NCT03350828|Cystic Fibrosis|cystic fibrosis
35185|NCT03350828|Sweat|sweat
35186|NCT03350828|Sweat chloride|sweat chloride
35187|NCT03350828|CFTR Modulator|cftr modulator
35188|NCT03350815|Ankylosing spondylitis, ASDAS inactive disease, secukinumab|ankylosing spondylitis, asdas inactive disease, secukinumab
35189|NCT03350789|acupuncture|acupuncture
35190|NCT03350789|sciatica|sciatica
35191|NCT03350789|MRI, functional|mri, functional
35192|NCT03350776|Neoplasm|neoplasm
35193|NCT03350776|Chronic disease|chronic disease
35194|NCT03350776|Complex cases|complex cases
35195|NCT03350776|Care coordination|care coordination
35196|NCT03350776|Oncologic nursing|oncologic nursing
35197|NCT03350776|Theoretical model|theoretical model
35198|NCT03350763|Pancreatic Cancer|pancreatic cancer
35199|NCT03350763|Biliary decompression|biliary decompression
35200|NCT03350737|No-option patients|no-option patients
35201|NCT03350711|Microbiota composition|microbiota composition
35202|NCT03350711|Microbiota Enrichment Program|microbiota enrichment program
35203|NCT03350711|Fecal microbiota transplant (FMT)|fecal microbiota transplant (fmt)
35204|NCT03350698|Human papilloma virus|human papilloma virus
35205|NCT03350672|HIV prevention|hiv prevention
35206|NCT03350672|PrEP|prep
35207|NCT03350672|Descovy|descovy
35208|NCT03350659|orthostatic hypotension|orthostatic hypotension
35209|NCT03350659|midodrine|midodrine
35210|NCT03350659|atomoxetine|atomoxetine
35211|NCT03350659|treatment|treatment
35212|NCT03350646|embryo transfer|embryo transfer
35213|NCT03350646|volume|volume
35214|NCT03350646|culture medium|culture medium
35215|NCT03350646|loading the catheter|loading the catheter
35216|NCT03350646|clinical pregnancy rate|clinical pregnancy rate
35217|NCT03350620|child, myopia, nearsightedness|child, myopia, nearsightedness
35218|NCT03350607|Epiretinal membrane, sweeper, forceps, microperimetry|epiretinal membrane, sweeper, forceps, microperimetry
35219|NCT03350594|Anorexia Nervosa|anorexia nervosa
35220|NCT03350594|Multiple Family Therapy|multiple family therapy
35221|NCT03350594|Systemic Family Therapy|systemic family therapy
35222|NCT03350594|Adolescence|adolescence
35223|NCT03350594|Randomised controled trial|randomised controled trial
35224|NCT03350581|Catheter ablation|catheter ablation
35225|NCT03350581|Fast anatomical mapping (FAM)|fast anatomical mapping (fam)
35226|NCT03350581|Computed tomography (CT)|computed tomography (ct)
35227|NCT03350581|Magnetic resonance image (MRI)|magnetic resonance image (mri)
35228|NCT03350581|Contact force|contact force
35229|NCT03350581|Atrial fibrillation|atrial fibrillation
35230|NCT03350568|Antioxidants|antioxidants
35231|NCT03350568|Oxidative Stress|oxidative stress
35232|NCT03350568|Atherosclerosis|atherosclerosis
35233|NCT03350568|Epidemiology|epidemiology
35234|NCT03350542|Drug-Eluting Stents|drug-eluting stents
35235|NCT03350529|prostate cancer|prostate cancer
35236|NCT03350529|benign prostatic hyperplasia|benign prostatic hyperplasia
35237|NCT03350529|benign prostatic obstruction|benign prostatic obstruction
35238|NCT03350529|high intensity focused ultrasound|high intensity focused ultrasound
35239|NCT03350529|real-time temperature feedback control|real-time temperature feedback control
35240|NCT03350529|magnetic resonance imaging|magnetic resonance imaging
35241|NCT03350503|phacoemulsification|phacoemulsification
35242|NCT03350503|intraocular lens|intraocular lens
35243|NCT03350503|vision|vision
35244|NCT03350503|toric|toric
35245|NCT03350490|Cancer ablation|cancer ablation
35246|NCT03350490|Life information rehabilitation therapy|life information rehabilitation therapy
35247|NCT03350477|Cancer ablation|cancer ablation
35248|NCT03350477|Life information rehabilitation therapy|life information rehabilitation therapy
35249|NCT03350451|Hyperoxaluria, Primary|hyperoxaluria, primary
35250|NCT03350451|Hyperoxaluria|hyperoxaluria
35251|NCT03350451|Kidney Diseases|kidney diseases
35252|NCT03350451|Urologic Diseases|urologic diseases
35253|NCT03350451|Metabolism, Inborn Errors|metabolism, inborn errors
35254|NCT03350451|Genetic Diseases, Inborn|genetic diseases, inborn
35255|NCT03350451|Metabolic Diseases|metabolic diseases
35256|NCT03350438|participation|participation
35257|NCT03350438|quality of life|quality of life
35258|NCT03350438|occupational therapy|occupational therapy
35259|NCT03350425|hemodialysis|hemodialysis
35260|NCT03350425|pneumococcal vaccination|pneumococcal vaccination
35261|NCT03350347|Renal anemia|renal anemia
35262|NCT03350334|Duloxetine|duloxetine
35263|NCT03350334|laparoscopic hysterectomy|laparoscopic hysterectomy
35264|NCT03350334|postoperative pain|postoperative pain
35265|NCT03350334|postoperative recovery|postoperative recovery
35266|NCT03350295|Relative bioavailability|relative bioavailability
35267|NCT03350295|In vitro dissolution|in vitro dissolution
35268|NCT03350269|Living kidney donation|living kidney donation
35269|NCT03350269|Kidney transplant|kidney transplant
35270|NCT03350269|Lost Wage Reimbursement|lost wage reimbursement
35271|NCT03350243|Neonatal Intensive Care Unit|neonatal intensive care unit
35272|NCT03350243|Mindfulness|mindfulness
35273|NCT03350243|Care coordination|care coordination
35274|NCT03350243|Anticipatory guidance|anticipatory guidance
35275|NCT03350243|Parental support|parental support
35276|NCT03350243|Neonatal follow-up|neonatal follow-up
35277|NCT03350152|Chemotherapy, Low-intensity therapy, elderly, prognosis,|chemotherapy, low-intensity therapy, elderly, prognosis,
35278|NCT03350126|MSI or MMR|msi or mmr
35279|NCT03350113|prognosis|prognosis
35280|NCT03350113|diagnosis|diagnosis
35281|NCT03350087|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
35282|NCT03350087|stroke|stroke
35283|NCT03350087|optimal treatment protocol|optimal treatment protocol
35284|NCT03350087|VR-based cycling training (VCT)|vr-based cycling training (vct)
35285|NCT03350087|randomized controlled trial|randomized controlled trial
35286|NCT03350087|motor control|motor control
35287|NCT03350087|clinical predictors|clinical predictors
35288|NCT03350074|Hepatitis B virus|hepatitis b virus
35289|NCT03350074|PreS/S variability|pres/s variability
35290|NCT03350074|Anti-HBV treatment|anti-hbv treatment
35291|NCT03350048|Tuberculosis|tuberculosis
35292|NCT03350048|Point-of-care test|point-of-care test
35293|NCT03350048|Diagnostics|diagnostics
35294|NCT03350048|Biomarkers|biomarkers
35295|NCT03349957|TACE|tace
35296|NCT03349944|exercise|exercise
35297|NCT03349931|Aspergillosis,|aspergillosis,
35298|NCT03349931|qPCR|qpcr
35299|NCT03349931|allogenic haemopoietic stem-cell transplantation|allogenic haemopoietic stem-cell transplantation
35300|NCT03349931|leukemia|leukemia
35301|NCT03349905|Freeze all|freeze all
35302|NCT03349905|IVF|ivf
35303|NCT03349905|deferred embryo transfer|deferred embryo transfer
35304|NCT03349905|endometriosis|endometriosis
35305|NCT03349853|Palliative care; Acetaminophen; Subcutaneous route; Pain treatment|palliative care; acetaminophen; subcutaneous route; pain treatment
35306|NCT03349840|type 2 diabetes|type 2 diabetes
35307|NCT03349840|insulin|insulin
35308|NCT03349840|glargine u100|glargine u100
35309|NCT03349840|degludec|degludec
35310|NCT03349840|Ramadan|ramadan
35311|NCT03349814|appendicitis|appendicitis
35312|NCT03349814|appendectomy|appendectomy
35313|NCT03349814|yersinia|yersinia
35314|NCT03349801|iAMD|iamd
35315|NCT03349801|biomarker|biomarker
35316|NCT03349801|clinical endpoint|clinical endpoint
35317|NCT03349788|Left colic artery|left colic artery
35318|NCT03349788|Laparoscopic Surgery|laparoscopic surgery
35319|NCT03349788|Anterior resection of rectum|anterior resection of rectum
35320|NCT03349788|Rectum cancer|rectum cancer
35321|NCT03349775|Pulmonary Hypertension|pulmonary hypertension
35322|NCT03349775|BMI|bmi
35323|NCT03349775|Echocardiography|echocardiography
35324|NCT03349775|CPET|cpet
35325|NCT03349775|6-minute walk test|6-minute walk test
35326|NCT03349775|Cardio Metabolic disease|cardio metabolic disease
35327|NCT03349762|Huaier Granule|huaier granule
35328|NCT03349762|multisite|multisite
35329|NCT03349762|open-label|open-label
35330|NCT03349762|prospective|prospective
35331|NCT03349749|intensive care units|intensive care units
35332|NCT03349749|resuscitation|resuscitation
35333|NCT03349749|fluid therapy|fluid therapy
35334|NCT03349749|Vascular Access Devices|vascular access devices
35335|NCT03349749|cardiac output|cardiac output
35336|NCT03349749|monitoring, physiologic|monitoring, physiologic
35337|NCT03349736|Pelvic floor muscle|pelvic floor muscle
35338|NCT03349697|Liver Health|liver health
35339|NCT03349697|Hangover|hangover
35340|NCT03349697|Herbal supplement|herbal supplement
35341|NCT03349697|Liver function|liver function
35342|NCT03349658|total hip arthroplasty|total hip arthroplasty
35343|NCT03349658|cerebral oxygen saturation|cerebral oxygen saturation
35344|NCT03349658|general anesthesia|general anesthesia
35345|NCT03349658|spinal anesthesia|spinal anesthesia
35346|NCT03349593|Heart failure, diastolic dysfunction, venous return|heart failure, diastolic dysfunction, venous return
35347|NCT03349593|Left ventricular filling pressures|left ventricular filling pressures
35348|NCT03349580|rehabilitation|rehabilitation
35349|NCT03349580|randomized controlled trial|randomized controlled trial
35350|NCT03349580|strength training|strength training
35351|NCT03349580|early initiation|early initiation
35352|NCT03349580|intra-abdominal pressure|intra-abdominal pressure
35353|NCT03349554|Parkinson's disease|parkinson's disease
35354|NCT03349554|anxiety|anxiety
35355|NCT03349554|meditation|meditation
35356|NCT03349554|in-patients|in-patients
35357|NCT03349528|bipolar disorder|bipolar disorder
35358|NCT03349528|bipolar depression|bipolar depression
35359|NCT03349528|depressive episode|depressive episode
35360|NCT03349528|probiotic supplement|probiotic supplement
35361|NCT03349528|probiotics|probiotics
35362|NCT03349528|relapse prevention|relapse prevention
35363|NCT03349528|rehospitalization|rehospitalization
35364|NCT03349502|Allogeneic natural killer cell, MG4101|allogeneic natural killer cell, mg4101
35365|NCT03349489|Type 1 diabetes|type 1 diabetes
35366|NCT03349489|Exercise|exercise
35367|NCT03349489|Hypoglycemia|hypoglycemia
35368|NCT03349489|Insulin pump|insulin pump
35369|NCT03349476|Atrial Fibrillation|atrial fibrillation
35370|NCT03349476|AFIB|afib
35371|NCT03349476|Ablation|ablation
35372|NCT03349476|Paroxysmal|paroxysmal
35373|NCT03349476|Persistent|persistent
35374|NCT03349450|Lymphoma|lymphoma
35375|NCT03349450|DLBCL|dlbcl
35376|NCT03349450|Lymphoma, B-Cell|lymphoma, b-cell
35377|NCT03349450|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
35378|NCT03349450|Neoplasms by Histologic Type|neoplasms by histologic type
35379|NCT03349450|Neoplasms|neoplasms
35380|NCT03349450|Lymphoproliferative Disorders|lymphoproliferative disorders
35381|NCT03349450|Lymphatic Diseases|lymphatic diseases
35382|NCT03349450|Immunoproliferative Disorders|immunoproliferative disorders
35383|NCT03349450|Immune System Diseases|immune system diseases
35384|NCT03349450|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
35385|NCT03349450|Cyclophosphamide|cyclophosphamide
35386|NCT03349450|Pembrolizumab|pembrolizumab
35387|NCT03349450|Immunosuppressive Agents|immunosuppressive agents
35388|NCT03349450|Immunologic Factors|immunologic factors
35389|NCT03349450|Physiological Effects of Drugs|physiological effects of drugs
35390|NCT03349450|Antirheumatic Agents|antirheumatic agents
35391|NCT03349450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
35392|NCT03349450|Alkylating Agents|alkylating agents
35393|NCT03349450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
35394|NCT03349450|Antineoplastic Agents|antineoplastic agents
35395|NCT03349450|Myeloablative Agonists|myeloablative agonists
35396|NCT03349450|Canada|canada
35397|NCT03349450|Ontario|ontario
35398|NCT03349450|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
35399|NCT03349450|refractory|refractory
35400|NCT03349450|relapsed|relapsed
35401|NCT03349450|checkpoint inhibitor|checkpoint inhibitor
35402|NCT03349450|vaccine|vaccine
35403|NCT03349450|DPX-Survivac|dpx-survivac
35404|NCT03349450|Survivin|survivin
35405|NCT03349450|Immunotherapy|immunotherapy
35406|NCT03349450|Transformed Lymphoma|transformed lymphoma
35407|NCT03349450|Double Hit|double hit
35408|NCT03349450|Large Cell Lymphoma|large cell lymphoma
35409|NCT03349450|Keytruda|keytruda
35410|NCT03349424|Somatostatin|somatostatin
35411|NCT03349424|Pancreatic Fistula|pancreatic fistula
35412|NCT03349424|Intermediate Risk|intermediate risk
35413|NCT03349424|Pancreaticoduodenectomy|pancreaticoduodenectomy
35414|NCT03349398|Uncut Roux-en-Y|uncut roux-en-y
35415|NCT03349398|Roux-en-Y|roux-en-y
35416|NCT03349385|Secondary revascularization|secondary revascularization
35417|NCT03349385|Repeat revascularization|repeat revascularization
35418|NCT03349385|Coronary revascularization|coronary revascularization
35419|NCT03349385|Coronary artery bypass graft|coronary artery bypass graft
35420|NCT03349333|FOT12-CN-301|fot12-cn-301
35421|NCT03349333|PTCL (peripheral T-cell lymphoma)|ptcl (peripheral t-cell lymphoma)
35422|NCT03349333|pralatrexate|pralatrexate
35423|NCT03349333|vitamin B12|vitamin b12
35424|NCT03349333|folic acid|folic acid
35425|NCT03349320|Alzheimer|alzheimer
35426|NCT03349320|APOE|apoe
35427|NCT03349320|CYP2D6|cyp2d6
35428|NCT03349320|Donepezil|donepezil
35429|NCT03349320|Genetics|genetics
35430|NCT03349307|lobectomy|lobectomy
35431|NCT03349294|Thyroid|thyroid
35432|NCT03349294|Thyroidectomy|thyroidectomy
35433|NCT03349294|Iodine|iodine
35434|NCT03349294|Biokinetic|biokinetic
35435|NCT03349294|Ablation|ablation
35436|NCT03349255|alpha-fetoprotein|alpha-fetoprotein
35437|NCT03349255|AFP|afp
35438|NCT03349255|HCC|hcc
35439|NCT03349255|CAR T cell therapy|car t cell therapy
35440|NCT03349229|care practices|care practices
35441|NCT03349229|geriatry|geriatry
35442|NCT03349229|oncology|oncology
35443|NCT03349151|Postoperative maternal feeding, cesarean section|postoperative maternal feeding, cesarean section
35444|NCT03349138|rehabilitation|rehabilitation
35445|NCT03349138|functional electrical stimulation|functional electrical stimulation
35446|NCT03349138|electrode array|electrode array
35447|NCT03349138|upper limb|upper limb
35448|NCT03349138|chronic|chronic
35449|NCT03349138|motor relearning|motor relearning
35450|NCT03349125|Cervical Brace|cervical brace
35451|NCT03349125|Elderly|elderly
35452|NCT03349125|Dysphagia|dysphagia
35453|NCT03349125|VFSS|vfss
35454|NCT03349125|Videoflouroscopy|videoflouroscopy
35455|NCT03349125|Swallow Problems|swallow problems
35456|NCT03349112|Manometry|manometry
35457|NCT03349112|Lidocaine|lidocaine
35458|NCT03349112|Pharyngeal|pharyngeal
35459|NCT03349112|High Resolution Pharyngeal Manometry (HRPM)|high resolution pharyngeal manometry (hrpm)
35460|NCT03349112|Pressure|pressure
35461|NCT03349086|Botox Injection|botox injection
35462|NCT03349086|Spasmodic|spasmodic
35463|NCT03349086|Dysphonia|dysphonia
35464|NCT03349086|Voice Therapy|voice therapy
35465|NCT03349086|Speech Therapy|speech therapy
35466|NCT03349086|Voice Rest|voice rest
35467|NCT03349060|atopic dermatitis|atopic dermatitis
35468|NCT03349060|atopic eczema|atopic eczema
35469|NCT03349060|eczema|eczema
35470|NCT03349060|JAK|jak
35471|NCT03349060|janus kinase|janus kinase
35472|NCT03349047|Food Allergy|food allergy
35473|NCT03349047|Anxiety|anxiety
35474|NCT03349047|Casual Exposure|casual exposure
35475|NCT03349047|Peanut Hypersensitivity|peanut hypersensitivity
35476|NCT03349047|Tree nut Hypersensitivity|tree nut hypersensitivity
35477|NCT03349047|Adolescents|adolescents
35478|NCT03349034|Local anesthetics|local anesthetics
35479|NCT03349034|Randomized Control Trial|randomized control trial
35480|NCT03349034|Free tissue transfer|free tissue transfer
35481|NCT03349034|Head and neck|head and neck
35482|NCT03349034|Microvascular|microvascular
35483|NCT03349034|Postoperative Pain|postoperative pain
35484|NCT03349021|esophagus|esophagus
35485|NCT03349021|stenosis|stenosis
35486|NCT03349021|bougienage|bougienage
35487|NCT03349008|necro-inflammatory|necro-inflammatory
35488|NCT03349008|glycyrrhizin|glycyrrhizin
35489|NCT03349008|entecavir|entecavir
35490|NCT03349008|hepatic biological parameters|hepatic biological parameters
35491|NCT03349008|liver fibrosis|liver fibrosis
35492|NCT03348982|Physical activity|physical activity
35493|NCT03348982|Sleep|sleep
35494|NCT03348982|Children|children
35495|NCT03348982|Autism Spectrum Disorder|autism spectrum disorder
35496|NCT03348982|Melatonin|melatonin
35497|NCT03348969|Mitomycin C|mitomycin c
35498|NCT03348969|Neoadjuvant|neoadjuvant
35499|NCT03348904|Non-small cell lung cancer|non-small cell lung cancer
35500|NCT03348904|programmed cell death protein 1 (PD-1) antibody|programmed cell death protein 1 (pd-1) antibody
35501|NCT03348904|indoleamine 2,3-dioxygenase (IDO) inhibitor|indoleamine 2,3-dioxygenase (ido) inhibitor
35502|NCT03348891|Melanoma|melanoma
35503|NCT03348891|TNF|tnf
35504|NCT03348891|Immune checkpoints|immune checkpoints
35505|NCT03348891|Tumor-infiltrating lymphocytes|tumor-infiltrating lymphocytes
35506|NCT03348891|Cytokines|cytokines
35507|NCT03348891|Circulating leukocytes|circulating leukocytes
35508|NCT03348878|drug compliance|drug compliance
35509|NCT03348878|hypertension|hypertension
35510|NCT03348878|anti-hypertensive agents|anti-hypertensive agents
35511|NCT03348865|Cognitive Behavioural Therapy|cognitive behavioural therapy
35512|NCT03348839|telemedicine|telemedicine
35513|NCT03348839|telemonitoring|telemonitoring
35514|NCT03348839|educational therapy|educational therapy
35515|NCT03348813|Black|black
35516|NCT03348813|Adolescents|adolescents
35517|NCT03348813|Community-based research|community-based research
35518|NCT03348813|Randomized controlled trial|randomized controlled trial
35519|NCT03348813|Intervention|intervention
35520|NCT03348813|Behavioral science|behavioral science
35521|NCT03348800|Child|child
35522|NCT03348800|RCT|rct
35523|NCT03348800|Anesthesia|anesthesia
35524|NCT03348800|Tooth extraction|tooth extraction
35525|NCT03348787|Behavioral and Cognitive Therapies|behavioral and cognitive therapies
35526|NCT03348774|Disease Course|disease course
35527|NCT03348761|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
35528|NCT03348761|resting-state Functional magnetic resonance imaging|resting-state functional magnetic resonance imaging
35529|NCT03348761|treatment response trajectories|treatment response trajectories
35530|NCT03348722|Active surveillance|active surveillance
35531|NCT03348722|Low risk prostate cancer|low risk prostate cancer
35532|NCT03348722|Prostatic neoplasm/therapy (MESH)|prostatic neoplasm/therapy (mesh)
35533|NCT03348722|Prostatic neoplasm/surgery (MESH)|prostatic neoplasm/surgery (mesh)
35534|NCT03348722|Prostatic neoplasm/radiotherapy (MESH)|prostatic neoplasm/radiotherapy (mesh)
35535|NCT03348722|Prostatectomy (MESH)|prostatectomy (mesh)
35536|NCT03348722|Quality of life (MESH)|quality of life (mesh)
35537|NCT03348722|Costs and Cost Analysis (MESH)|costs and cost analysis (mesh)
35538|NCT03348683|Induction|induction
35539|NCT03348683|Labor|labor
35540|NCT03348683|Propranolol|propranolol
35541|NCT03348670|SCLC|sclc
35542|NCT03348670|SNP|snp
35543|NCT03348670|Oncology|oncology
35544|NCT03348670|Drug|drug
35545|NCT03348670|Etoposide|etoposide
35546|NCT03348670|Methotrexate|methotrexate
35547|NCT03348670|Lung|lung
35548|NCT03348670|Cancer|cancer
35549|NCT03348670|Topotecan|topotecan
35551|NCT03348618|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
35552|NCT03348618|Anxiety|anxiety
35553|NCT03348618|PANS|pans
35554|NCT03348618|PANDAS|pandas
35555|NCT03348618|Children|children
35556|NCT03348605|Amputation|amputation
35557|NCT03348605|Phantom Pain|phantom pain
35558|NCT03348605|Gait analysis|gait analysis
35559|NCT03348592|Microbiome, p-inulin|microbiome, p-inulin
35560|NCT03348579|Intensive care unit|intensive care unit
35561|NCT03348579|Pneumonia|pneumonia
35562|NCT03348579|Ventilator associated|ventilator associated
35563|NCT03348579|Hospital acquired pneumonia|hospital acquired pneumonia
35564|NCT03348579|Guidelines|guidelines
35565|NCT03348553|Omega-fatty-acids|omega-fatty-acids
35566|NCT03348553|Absorption|absorption
35567|NCT03348553|Bioavailability|bioavailability
35568|NCT03348553|Fruit & Vegetable concentrate|fruit & vegetable concentrate
35569|NCT03348553|Lipid Metabolism|lipid metabolism
35570|NCT03348475|Guided self-help|guided self-help
35571|NCT03348475|Group-based intervention|group-based intervention
35572|NCT03348475|Binge Focused Therapy|binge focused therapy
35573|NCT03348475|Brain Over Binge|brain over binge
35574|NCT03348475|Non-expert guided|non-expert guided
35575|NCT03348475|Minimally intensive|minimally intensive
35576|NCT03348462|psoriasis|psoriasis
35577|NCT03348462|anthralin|anthralin
35578|NCT03348462|ethosome|ethosome
35579|NCT03348462|liposome|liposome
35580|NCT03348449|HIV|hiv
35581|NCT03348449|Dual therapy|dual therapy
35582|NCT03348449|Comorbidities|comorbidities
35583|NCT03348449|Nucleoside analogues sparing-regimens|nucleoside analogues sparing-regimens
35584|NCT03348436|paroxysmal supraventricular tachycardia|paroxysmal supraventricular tachycardia
35585|NCT03348436|Left Atrial Function|left atrial function
35586|NCT03348423|Peri-procedural pain|peri-procedural pain
35587|NCT03348423|Pain|pain
35588|NCT03348423|Anxiety|anxiety
35589|NCT03348423|Analgesia|analgesia
35590|NCT03348423|Anxiolysis|anxiolysis
35591|NCT03348371|Incretin effect|incretin effect
35592|NCT03348371|Ethanol|ethanol
35593|NCT03348345|eating disorders|eating disorders
35594|NCT03348345|prevention|prevention
35595|NCT03348345|yoga|yoga
35596|NCT03348345|mindfulness|mindfulness
35597|NCT03348345|embodiment|embodiment
35598|NCT03348345|self-regulation|self-regulation
35599|NCT03348345|functional action|functional action
35600|NCT03348345|interoceptive awareness|interoceptive awareness
35601|NCT03348332|exercise|exercise
35602|NCT03348332|intrapartum|intrapartum
35603|NCT03348332|aerobic exercise|aerobic exercise
35604|NCT03348332|resistance exercise|resistance exercise
35605|NCT03348332|wellbeing|wellbeing
35606|NCT03348293|biodegradable scaffold|biodegradable scaffold
35607|NCT03348293|immediate breast reconstruction|immediate breast reconstruction
35608|NCT03348293|3D printing|3d printing
35609|NCT03348241|Gum Arabic|gum arabic
35610|NCT03348241|Cancer patients|cancer patients
35611|NCT03348241|Chemotherapy|chemotherapy
35612|NCT03348241|Oral mucositis|oral mucositis
35613|NCT03348228|Hydroxycitrate Supplements|hydroxycitrate supplements
35614|NCT03348215|Gait rehabilitation|gait rehabilitation
35615|NCT03348163|Transgender women|transgender women
35616|NCT03348163|Bictegravir|bictegravir
35617|NCT03348150|HIPEC|hipec
35618|NCT03348150|Hyperthermic Intraperitoneal Chemotherapy|hyperthermic intraperitoneal chemotherapy
35619|NCT03348150|gastrectomy|gastrectomy
35620|NCT03348150|cytoreductive surgery|cytoreductive surgery
35621|NCT03348150|oxaliplatin|oxaliplatin
35622|NCT03348150|docetaxel|docetaxel
35623|NCT03348124|Intellectual disability|intellectual disability
35624|NCT03348124|Parenthood|parenthood
35625|NCT03348124|Reproduction|reproduction
35626|NCT03348124|Intervention|intervention
35627|NCT03348124|Adolescents|adolescents
35628|NCT03348111|Mucositis|mucositis
35629|NCT03348111|Peri-Implantitis|peri-implantitis
35630|NCT03348111|Air-Flow Master Piezon®|air-flow master piezon®
35631|NCT03348098|Triple negative breast cancer|triple negative breast cancer
35632|NCT03348046|Infliximab|infliximab
35633|NCT03348046|Remsima|remsima
35634|NCT03348046|Biosimilar|biosimilar
35635|NCT03348046|Autoimmune Disease|autoimmune disease
35636|NCT03348046|Rheumatoid Arthritis|rheumatoid arthritis
35637|NCT03348046|Cohort Study|cohort study
35638|NCT03348046|Disease modifying anti-rheumatic drugs|disease modifying anti-rheumatic drugs
35639|NCT03348046|Tumor necrosis factor-alpha inhibitors|tumor necrosis factor-alpha inhibitors
35640|NCT03347994|Acute Myeloid Leukemia|acute myeloid leukemia
35641|NCT03347994|AML|aml
35642|NCT03347994|Refractory AML|refractory aml
35643|NCT03347994|Relapsed AML|relapsed aml
35644|NCT03347994|Refractory Acute Myeloid Leukemia|refractory acute myeloid leukemia
35645|NCT03347994|Relapsed Acute Myeloid Leukemia|relapsed acute myeloid leukemia
35646|NCT03347981|Intraocular Lens|intraocular lens
35647|NCT03347981|trifocal|trifocal
35648|NCT03347981|hydrophobic|hydrophobic
35649|NCT03347981|hydrophilic|hydrophilic
35650|NCT03347968|type 2 Diabetes Mellitus, MEDI0382|type 2 diabetes mellitus, medi0382
35651|NCT03347955|placebo effect|placebo effect
35653|NCT03347942|Obesity|obesity
35654|NCT03347942|Satiety|satiety
35655|NCT03347942|Cardiovascular risk|cardiovascular risk
35656|NCT03347903|esophagus|esophagus
35657|NCT03347903|motility|motility
35658|NCT03347890|GLP-1|glp-1
35659|NCT03347890|fMRI|fmri
35660|NCT03347877|autologous osteo-periosteal cylinder graft|autologous osteo-periosteal cylinder graft
35661|NCT03347877|autologous osteochondral graft|autologous osteochondral graft
35662|NCT03347877|randomized controlled trial|randomized controlled trial
35663|NCT03347877|Hepple V osteochondral lesions of the talus|hepple v osteochondral lesions of the talus
35664|NCT03347851|mechanical heart valve|mechanical heart valve
35665|NCT03347851|On-X|on-x
35666|NCT03347838|PD-1|pd-1
35667|NCT03347838|Precancerous Conditions|precancerous conditions
35668|NCT03347838|Nivolumab|nivolumab
35669|NCT03347838|Lung Cancer Immunoprevention|lung cancer immunoprevention
35670|NCT03347812|Aortic Arch|aortic arch
35671|NCT03347812|Endovascular Treatment|endovascular treatment
35672|NCT03347812|Traditional Open Surgery|traditional open surgery
35673|NCT03347812|Chimney Technique|chimney technique
35674|NCT03347812|Fenestration Technique|fenestration technique
35675|NCT03347812|Branched Stent-grafts Technique|branched stent-grafts technique
35676|NCT03347799|very premature infants|very premature infants
35677|NCT03347799|screening|screening
35678|NCT03347799|retinopathy|retinopathy
35679|NCT03347773|Oral nutritional supplement|oral nutritional supplement
35680|NCT03347773|Sarcopenic obesity|sarcopenic obesity
35681|NCT03347773|Body composition|body composition
35682|NCT03347760|68-Ga-DOTATOC PET|68-ga-dotatoc pet
35683|NCT03347760|Myocarditis|myocarditis
35684|NCT03347734|eye exercises|eye exercises
35685|NCT03347734|convergence exercise|convergence exercise
35686|NCT03347734|hyperopia|hyperopia
35687|NCT03347734|oculomotor exercise|oculomotor exercise
35688|NCT03347734|school-age children|school-age children
35689|NCT03347708|Lumbar disc degeneration|lumbar disc degeneration
35690|NCT03347708|Low back pain|low back pain
35691|NCT03347708|Intervertebral disc degeneration|intervertebral disc degeneration
35692|NCT03347695|modified Cox-Maze|modified cox-maze
35693|NCT03347695|atrial fibrillation|atrial fibrillation
35694|NCT03347695|surgery|surgery
35695|NCT03347682|Amputation, prosthesis,psychometrics, questionnaires|amputation, prosthesis,psychometrics, questionnaires
35696|NCT03347669|Fibromyalgia|fibromyalgia
35697|NCT03347669|Small fiber neuropathy|small fiber neuropathy
35698|NCT03347669|Sudoscan®|sudoscan®
35699|NCT03347656|Mobilization Therapy|mobilization therapy
35700|NCT03347656|Clitical Illness|clitical illness
35701|NCT03347656|Stroke|stroke
35702|NCT03347656|Intensive Care|intensive care
35703|NCT03347656|Functional Mobility|functional mobility
35704|NCT03347656|Quality of Life|quality of life
35705|NCT03347643|Internet game addiction|internet game addiction
35706|NCT03347643|Internet gaming disorder|internet gaming disorder
35707|NCT03347643|transcranial direct current stimulation|transcranial direct current stimulation
35708|NCT03347643|response inhibition|response inhibition
35709|NCT03347643|craving|craving
35710|NCT03347643|cue reactivity|cue reactivity
35711|NCT03347630|MRI|mri
35712|NCT03347630|oesophagus cancer|oesophagus cancer
35713|NCT03347630|Staging|staging
35714|NCT03347591|Fibrinogen|fibrinogen
35715|NCT03347591|Factor II|factor ii
35716|NCT03347591|Factor V|factor v
35717|NCT03347591|Factor V & VIII|factor v & viii
35718|NCT03347591|Factor VII|factor vii
35719|NCT03347591|Factor X|factor x
35720|NCT03347591|Factor XI|factor xi
35721|NCT03347591|Factor XIII|factor xiii
35722|NCT03347591|α2-antiplasmin|α2-antiplasmin
35723|NCT03347591|Plasminogen activator inhibitor 1|plasminogen activator inhibitor 1
35724|NCT03347591|Epidemiology|epidemiology
35725|NCT03347591|Genetics|genetics
35726|NCT03347591|Phenotype|phenotype
35727|NCT03347565|adolescents, healthy controls|adolescents, healthy controls
35728|NCT03347552|treatment engagement|treatment engagement
35729|NCT03347526|Vigabatrin|vigabatrin
35730|NCT03347526|Cosyntropin|cosyntropin
35731|NCT03347513|H-pylori|h-pylori
35732|NCT03347513|iron deficiency anemia|iron deficiency anemia
35733|NCT03347513|Pregnancy|pregnancy
35734|NCT03347513|iron therapy|iron therapy
35735|NCT03347487|Bilateral Habenula|bilateral habenula
35736|NCT03347487|Treatment Resistant Major Depressive Disorder|treatment resistant major depressive disorder
35737|NCT03347474|Bilateral Ventral Capsule/ Ventral Striatum|bilateral ventral capsule/ ventral striatum
35738|NCT03347474|Methamphetamine Addiction|methamphetamine addiction
35739|NCT03347461|Tympanostomy tube placement|tympanostomy tube placement
35740|NCT03347461|Otiprio|otiprio
35741|NCT03347461|Ciprodex drops|ciprodex drops
35742|NCT03347461|Ear drops|ear drops
35743|NCT03347461|Middle ear|middle ear
35744|NCT03347448|Psychology|psychology
35745|NCT03347448|Skin|skin
35746|NCT03347435|clopidogrel|clopidogrel
35747|NCT03347435|pharmacogenetics|pharmacogenetics
35748|NCT03347435|antiplatelet therapy|antiplatelet therapy
35749|NCT03347435|acute coronary syndromes|acute coronary syndromes
35750|NCT03347409|ERAS, Fast-track surgery, gynecology|eras, fast-track surgery, gynecology
35751|NCT03347370|subcutaneous interferon beta therapy multiple sclerosis (MS)|subcutaneous interferon beta therapy multiple sclerosis (ms)
35752|NCT03347370|injection site reactions (ISR)|injection site reactions (isr)
35753|NCT03347370|flu-like symptoms (FLS)|flu-like symptoms (fls)
35754|NCT03347370|non-interventional study (NIS)|non-interventional study (nis)
35755|NCT03347370|SC Peginterferon beta-1a|sc peginterferon beta-1a
35756|NCT03347370|SC interferon beta-1a|sc interferon beta-1a
35757|NCT03347370|SC interferon beta-1b|sc interferon beta-1b
35758|NCT03347370|Plegridy®|plegridy®
35759|NCT03347370|Betaferon®|betaferon®
35760|NCT03347370|Extavia®|extavia®
35761|NCT03347370|Rebif®|rebif®
35762|NCT03347344|Spinocerebellar ataxia-SCA2|spinocerebellar ataxia-sca2
35763|NCT03347344|SARA (Scale for the Assessment and Rating of Ataxia) score|sara (scale for the assessment and rating of ataxia) score
35764|NCT03347344|Riluzole (Rilutek)|riluzole (rilutek)
35765|NCT03347331|PET imaging- Serotonin-Radiotracer|pet imaging- serotonin-radiotracer
35766|NCT03347305|Energy expenditure|energy expenditure
35767|NCT03347305|Peritoneal dialysis|peritoneal dialysis
35768|NCT03347292|Liver cell carcinoma|liver cell carcinoma
35769|NCT03347292|Liver cancer|liver cancer
35770|NCT03347279|Asthma, Uncontrolled Asthma, Severe Uncontrolled Asthma|asthma, uncontrolled asthma, severe uncontrolled asthma
35771|NCT03347227|AF ablation|af ablation
35772|NCT03347227|Pulmonary vein isolation|pulmonary vein isolation
35773|NCT03347227|Atrial scar ablation|atrial scar ablation
35774|NCT03347214|dbGaP|dbgap
35775|NCT03347201|Cardiopulmonary bypass, Heparin, Protamine|cardiopulmonary bypass, heparin, protamine
35776|NCT03347188|persistent posttraumatic headache (PPTH)|persistent posttraumatic headache (ppth)
35777|NCT03347175|Respiration, Artificial|respiration, artificial
35778|NCT03347175|Advanced Cardiac Life Support|advanced cardiac life support
35779|NCT03347175|Heart Massage|heart massage
35780|NCT03347175|Emergency Service, Hospital|emergency service, hospital
35781|NCT03347162|Cancer|cancer
35782|NCT03347162|Muscle mass|muscle mass
35783|NCT03347162|Muscle strength|muscle strength
35784|NCT03347162|Complications|complications
35785|NCT03347162|Patient reported outcomes|patient reported outcomes
35786|NCT03347162|PRO|pro
35787|NCT03347162|Physical function|physical function
35788|NCT03347149|Alarms|alarms
35789|NCT03347149|Alarm Fatigue|alarm fatigue
35790|NCT03347149|Alarm Nuisance|alarm nuisance
35791|NCT03347149|Alarm Reduction|alarm reduction
35792|NCT03347149|Patient Monitoring|patient monitoring
35793|NCT03347149|Intensive Care|intensive care
35794|NCT03347123|Epacadostat|epacadostat
35795|NCT03347123|nivolumab|nivolumab
35796|NCT03347123|ipilimumab|ipilimumab
35797|NCT03347123|lirilumab|lirilumab
35798|NCT03347123|solid tumor|solid tumor
35799|NCT03347123|melanoma|melanoma
35800|NCT03347123|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
35928|NCT03346265|Parkinson Disease|parkinson disease
35801|NCT03347123|squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
35802|NCT03347123|IDO inhibitor|ido inhibitor
35803|NCT03347110|Bimekizumab|bimekizumab
35804|NCT03347110|Psoriatic Arthritis|psoriatic arthritis
35805|NCT03347110|PsA|psa
35806|NCT03347097|glioma|glioma
35807|NCT03347097|pd-1|pd-1
35808|NCT03347097|pd-L1|pd-l1
35809|NCT03347097|immunotherapy|immunotherapy
35810|NCT03347084|DBS|dbs
35811|NCT03347084|brain imaging|brain imaging
35812|NCT03347084|Memory|memory
35813|NCT03347084|fMRI|fmri
35814|NCT03347071|prevention|prevention
35815|NCT03347071|collegiate athletes|collegiate athletes
35816|NCT03347071|yoga|yoga
35817|NCT03347058|immunotherapy|immunotherapy
35818|NCT03347045|cystectomy|cystectomy
35819|NCT03347045|nutrition|nutrition
35820|NCT03347045|physiotherapy|physiotherapy
35821|NCT03347045|prehabilitation|prehabilitation
35822|NCT03347045|enhanced recovery after surgery|enhanced recovery after surgery
35823|NCT03347019|bankart repair|bankart repair
35824|NCT03347019|accelerated rehabilitation|accelerated rehabilitation
35825|NCT03347019|shoulder|shoulder
35826|NCT03346993|Bupivacaine|bupivacaine
35827|NCT03346993|Brachial Plexus Block|brachial plexus block
35828|NCT03346993|Ultrasound|ultrasound
35829|NCT03346980|Spigelman|spigelman
35830|NCT03346967|AD mesenchymal stem cells;sexual hormone deficiency|ad mesenchymal stem cells;sexual hormone deficiency
35831|NCT03346954|: Cushing's disease, [11C]-Methionine PET/MRI, Sensitivity|: cushing's disease, [11c]-methionine pet/mri, sensitivity
35832|NCT03346915|HPV vaccinaton|hpv vaccinaton
35833|NCT03346915|Cervical cancer screening|cervical cancer screening
35834|NCT03346915|Web-based mobile health education|web-based mobile health education
35835|NCT03346915|brief negotiated interview (BNI|brief negotiated interview (bni
35836|NCT03346889|vestibular evoked myogenic potentials|vestibular evoked myogenic potentials
35837|NCT03346889|head impulse testing|head impulse testing
35838|NCT03346889|quality of life|quality of life
35839|NCT03346876|Pectus excavatum, heart rate variability|pectus excavatum, heart rate variability
35840|NCT03346863|Electrical Cardioversion|electrical cardioversion
35841|NCT03346824|Levosimendan|levosimendan
35842|NCT03346824|Veno-arterial ECMO|veno-arterial ecmo
35843|NCT03346824|Weaning|weaning
35844|NCT03346798|External eating|external eating
35845|NCT03346798|Technology|technology
35846|NCT03346798|Photography|photography
35847|NCT03346798|Social media|social media
35848|NCT03346785|External eating|external eating
35849|NCT03346785|Technology|technology
35850|NCT03346785|Photography|photography
35851|NCT03346785|Social media|social media
35852|NCT03346759|tampon|tampon
35853|NCT03346759|menstruation|menstruation
35854|NCT03346759|menstrual period|menstrual period
35855|NCT03346746|cognition|cognition
35856|NCT03346746|glycaemic|glycaemic
35857|NCT03346746|mood|mood
35858|NCT03346746|diet|diet
35859|NCT03346733|psyllium|psyllium
35860|NCT03346733|viscous fibre|viscous fibre
35861|NCT03346720|Data Sharing|data sharing
35862|NCT03346655|Treatment|treatment
35863|NCT03346642|Relapsed/Refractory|relapsed/refractory
35864|NCT03346642|primary mediastinal large B-cell lymphoma|primary mediastinal large b-cell lymphoma
35865|NCT03346642|PD-1 antibody|pd-1 antibody
35866|NCT03346642|Decitabine|decitabine
35867|NCT03346642|GVD chemotherapy|gvd chemotherapy
35868|NCT03346564|Head and neck cancer|head and neck cancer
35869|NCT03346564|Ritual training|ritual training
35870|NCT03346564|disfigurement|disfigurement
35871|NCT03346564|body image|body image
35872|NCT03346551|Postnatal depression|postnatal depression
35873|NCT03346551|Attachment|attachment
35874|NCT03346551|Self-defining memories|self-defining memories
35875|NCT03346525|echocardiography|echocardiography
35876|NCT03346525|penicillin prophylaxis|penicillin prophylaxis
35877|NCT03346525|intramuscular benzathine penicillin G|intramuscular benzathine penicillin g
35878|NCT03346525|benzathine penicillin G|benzathine penicillin g
35879|NCT03346525|low-resource setting|low-resource setting
35880|NCT03346499|HIV|hiv
35881|NCT03346486|Diet|diet
35882|NCT03346486|Metabolites|metabolites
35883|NCT03346486|Cognitive function|cognitive function
35884|NCT03346486|Physiology|physiology
35885|NCT03346486|LDL|ldl
35886|NCT03346486|Diet Habit|diet habit
35887|NCT03346486|Diet Modification|diet modification
35888|NCT03346434|Eczema|eczema
35889|NCT03346408|Analgesics|analgesics
35890|NCT03346395|Adjustment disorders|adjustment disorders
35891|NCT03346395|Anxiety disorders|anxiety disorders
35892|NCT03346395|Depression|depression
35893|NCT03346395|Mental disorders|mental disorders
35894|NCT03346395|Interventional study|interventional study
35895|NCT03346395|Primary health care|primary health care
35896|NCT03346395|Problem solving|problem solving
35897|NCT03346395|Randomized controlled trial|randomized controlled trial
35898|NCT03346395|Return to work|return to work
35899|NCT03346395|Sick leave|sick leave
35900|NCT03346382|Epilepsy|epilepsy
35901|NCT03346382|Emergency medical services|emergency medical services
35902|NCT03346369|Nephrolithiasis|nephrolithiasis
35903|NCT03346369|Urolithiasis|urolithiasis
35904|NCT03346369|Secondary Hyperoxaluria|secondary hyperoxaluria
35905|NCT03346369|Hyperoxaluria|hyperoxaluria
35906|NCT03346369|Lanthanum Carbonate|lanthanum carbonate
35907|NCT03346369|Phosphate Binder|phosphate binder
35908|NCT03346330|Chronic pain|chronic pain
35909|NCT03346330|Neuropathic pain|neuropathic pain
35910|NCT03346317|Asherman syndrome|asherman syndrome
35911|NCT03346317|hysteroscopy|hysteroscopy
35912|NCT03346317|Uterine stent|uterine stent
35913|NCT03346317|Estrogen|estrogen
35914|NCT03346317|Amnion|amnion
35915|NCT03346317|Hysteroscopic Adhesiolysis|hysteroscopic adhesiolysis
35916|NCT03346304|Autofluorescence Broncoscopy (AFB)|autofluorescence broncoscopy (afb)
35917|NCT03346304|Photodynamic Therapy (PDT)|photodynamic therapy (pdt)
35918|NCT03346304|High Grade Lesions (HGLs)|high grade lesions (hgls)
35919|NCT03346304|lung cancer|lung cancer
35920|NCT03346304|photosensitiser|photosensitiser
35921|NCT03346304|Fotolon|fotolon
35922|NCT03346278|Cardiac Rehabilitation|cardiac rehabilitation
35923|NCT03346278|Text Messaging|text messaging
35924|NCT03346265|progressive modular rebalancing|progressive modular rebalancing
35925|NCT03346265|PMR|pmr
35926|NCT03346265|visual sensory cues|visual sensory cues
35927|NCT03346265|SC|sc
35929|NCT03346265|Movement Disorders|movement disorders
35930|NCT03346265|Parkinson rehabilitation|parkinson rehabilitation
35931|NCT03346265|neurocognitive method|neurocognitive method
35932|NCT03346265|motor performance|motor performance
35933|NCT03346265|improving gait|improving gait
35934|NCT03346265|physiotherapy|physiotherapy
35935|NCT03346265|3D motion analysis system|3d motion analysis system
35936|NCT03346265|improvements|improvements
35937|NCT03346226|Delirium Dexmedetomidine elderly|delirium dexmedetomidine elderly
35938|NCT03346213|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
35939|NCT03346213|Intravenous iron|intravenous iron
35940|NCT03346213|Total haemoglobin mass|total haemoglobin mass
35941|NCT03346148|Food Allergy, Restaurant staff|food allergy, restaurant staff
35942|NCT03346109|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
35943|NCT03346109|medial group retropharyngeal node|medial group retropharyngeal node
35944|NCT03346096|TEAM (Thiotepa, Etoposide, Cytosar, Melphalan )|team (thiotepa, etoposide, cytosar, melphalan )
35945|NCT03346096|autologous stem-cell transplantation (ASCT)|autologous stem-cell transplantation (asct)
35946|NCT03346096|malignant lymphoma|malignant lymphoma
35947|NCT03346057|arrhythmia, bradycardia, neuromuscular blocking agents, surgery, tachycardia|arrhythmia, bradycardia, neuromuscular blocking agents, surgery, tachycardia
35948|NCT03346031|music therapy, pain, oxidative stress parameters|music therapy, pain, oxidative stress parameters
35949|NCT03345992|Macrolides|macrolides
35950|NCT03345979|Alkermes|alkermes
35951|NCT03345979|schizophrenia|schizophrenia
35952|NCT03345979|aripiprazole lauroxil|aripiprazole lauroxil
35953|NCT03345979|ARISTADA|aristada
35954|NCT03345940|Multiple Sclerosis|multiple sclerosis
35955|NCT03345927|S-adenosylhomocysteine|s-adenosylhomocysteine
35956|NCT03345927|Endothelial function|endothelial function
35957|NCT03345914|Eczema|eczema
35958|NCT03345901|pemafibrate|pemafibrate
35959|NCT03345875|human papillomavirus|human papillomavirus
35960|NCT03345875|cervical cancer|cervical cancer
35961|NCT03345875|self-collection|self-collection
35962|NCT03345862|Social isolation, Loneliness, Health Related Quality of Life|social isolation, loneliness, health related quality of life
35963|NCT03345849|Upadacitinib|upadacitinib
35964|NCT03345849|ABT-494|abt-494
35965|NCT03345849|Efficacy|efficacy
35966|NCT03345849|Safety|safety
35967|NCT03345849|Crohn's Disease|crohn's disease
35968|NCT03345836|Upadacitinib|upadacitinib
35969|NCT03345836|Crohn's Disease|crohn's disease
35970|NCT03345836|Efficacy|efficacy
35971|NCT03345836|Safety|safety
35972|NCT03345823|Upadacitinib|upadacitinib
35973|NCT03345823|ABT-494|abt-494
35974|NCT03345823|Extension Study|extension study
35975|NCT03345823|Efficacy|efficacy
35976|NCT03345823|Safety|safety
35977|NCT03345823|Crohn's Disease|crohn's disease
35978|NCT03345823|Maintenance Study|maintenance study
35979|NCT03345810|NSCLC|nsclc
35980|NCT03345810|Non small cell lung cancer|non small cell lung cancer
35981|NCT03345797|Paediatric|paediatric
35982|NCT03345758|respiratory failure, circulatory failure|respiratory failure, circulatory failure
35983|NCT03345745|Fetuin-A|fetuin-a
35984|NCT03345745|S100A12|s100a12
35985|NCT03345745|C-Reactive Protein|c-reactive protein
35986|NCT03345745|Chronic Periodontitis|chronic periodontitis
35987|NCT03345706|Hypothermia,ECPR|hypothermia,ecpr
35988|NCT03345693|Rehabilitation|rehabilitation
35989|NCT03345693|MoTrack Therapy|motrack therapy
35990|NCT03345693|Telemedicine|telemedicine
35991|NCT03345693|Computer Vision|computer vision
35992|NCT03345693|Compliance|compliance
35993|NCT03345680|Dental visits|dental visits
35994|NCT03345680|School-based program|school-based program
35995|NCT03345680|Dental screening|dental screening
35996|NCT03345680|Dental Caries|dental caries
35997|NCT03345641|premature birth|premature birth
35998|NCT03345641|mother's post-traumatic reaction|mother's post-traumatic reaction
35999|NCT03345641|mother-infant interactions|mother-infant interactions
36000|NCT03345628|sedation|sedation
36001|NCT03345628|critical care|critical care
36002|NCT03345628|infant|infant
36003|NCT03345628|neurodevelopment|neurodevelopment
36004|NCT03345615|atrial fibrillation|atrial fibrillation
36005|NCT03345615|myocardial infarction|myocardial infarction
36006|NCT03345615|intensive monitoring|intensive monitoring
36007|NCT03345615|oral anticoagulation|oral anticoagulation
36008|NCT03345615|hospitalization|hospitalization
36009|NCT03345589|Ursodeoxycholic Acid|ursodeoxycholic acid
36010|NCT03345576|Electric Stimulation|electric stimulation
36011|NCT03345576|Spinal Cord Injuries|spinal cord injuries
36012|NCT03345576|Muscle Denervation|muscle denervation
36013|NCT03345576|carbohydrate metabolism|carbohydrate metabolism
36014|NCT03345576|Lipids metabolism|lipids metabolism
36015|NCT03345576|Basal Metabolic Rate|basal metabolic rate
36016|NCT03345576|Muscle Proteins|muscle proteins
36017|NCT03345576|Mitochondria, Muscle|mitochondria, muscle
36018|NCT03345576|RNA|rna
36019|NCT03345576|Rehabilitation|rehabilitation
36020|NCT03345563|Prostate Cancer|prostate cancer
36021|NCT03345563|Fatigue|fatigue
36022|NCT03345563|Elderly|elderly
36023|NCT03345563|Supportive Care|supportive care
36024|NCT03345563|Light Exercise|light exercise
36025|NCT03345563|Quality of Life|quality of life
36026|NCT03345537|Inflammatory|inflammatory
36027|NCT03345537|Optic neuritis|optic neuritis
36028|NCT03345537|autoantibodies anti MOG|autoantibodies anti mog
36029|NCT03345524|Obstructive Sleep Apnea|obstructive sleep apnea
36030|NCT03345524|OSA|osa
36031|NCT03345524|Peer-Buddies|peer-buddies
36032|NCT03345524|CPAP|cpap
36033|NCT03345524|CPAP Adherence|cpap adherence
36034|NCT03345511|ultrasound guided caudal block|ultrasound guided caudal block
36035|NCT03345511|anal surgery|anal surgery
36036|NCT03345485|Phase 1 clinical trial|phase 1 clinical trial
36037|NCT03345485|Solid Tumor|solid tumor
36038|NCT03345485|Small Cell Lung Cancer|small cell lung cancer
36039|NCT03345485|Breast Cancer|breast cancer
36040|NCT03345485|Ovarian Cancer|ovarian cancer
36041|NCT03345485|Soft Tissue Sarcoma|soft tissue sarcoma
36042|NCT03345485|Relapsed/Refractory|relapsed/refractory
36043|NCT03345485|Triple Negative|triple negative
36044|NCT03345485|GIST|gist
36045|NCT03345485|Epithelial cancer|epithelial cancer
36046|NCT03345485|Peritoneal cancer|peritoneal cancer
36047|NCT03345485|Fallopian tube cancer|fallopian tube cancer
36048|NCT03345485|Metastatic|metastatic
36049|NCT03345485|Advanced|advanced
36050|NCT03345459|Internet-based treatment|internet-based treatment
36051|NCT03345407|Nemiralisib|nemiralisib
36052|NCT03345407|Dose-Finding|dose-finding
36053|NCT03345407|GSK2269557|gsk2269557
36054|NCT03345407|Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease|acute moderate or severe exacerbation of chronic obstructive pulmonary disease
36055|NCT03345394|crack cocaine|crack cocaine
36056|NCT03345394|contingency management|contingency management
36057|NCT03345394|ambulatory treatment|ambulatory treatment
36058|NCT03345394|Brazil|brazil
36059|NCT03345368|transcranial magnetic stimulation|transcranial magnetic stimulation
36060|NCT03345368|obesity|obesity
36061|NCT03345368|diet|diet
36062|NCT03345303|Bortezomib|bortezomib
36063|NCT03345290|Aging|aging
36064|NCT03345290|Central pressure|central pressure
36065|NCT03345290|FDG PET|fdg pet
36066|NCT03345290|Quantita|quantita
36067|NCT03345277|Termperature|termperature
36068|NCT03345277|Fever|fever
36069|NCT03345277|Vital Signs|vital signs
36070|NCT03345264|Sexual Dysfunction|sexual dysfunction
36071|NCT03345264|Fertility Disorders|fertility disorders
36072|NCT03345264|Cancer|cancer
36073|NCT03345251|ICSI - physical - Manipulation - scratching|icsi - physical - manipulation - scratching
36074|NCT03345238|Dry Needling|dry needling
36075|NCT03345238|Myofascial Pain Syndrome|myofascial pain syndrome
36076|NCT03345238|Neurophysiological effects|neurophysiological effects
36077|NCT03345238|Autonomic Nervous System|autonomic nervous system
36078|NCT03345225|Chemoembolization (TACE)|chemoembolization (tace)
36079|NCT03345225|HCC|hcc
36080|NCT03345225|Liver Cancer|liver cancer
36081|NCT03345199|Multiple Sclerosis, Inspiratory Muscle Training|multiple sclerosis, inspiratory muscle training
36082|NCT03345186|Outcome|outcome
36083|NCT03345186|Gout|gout
36084|NCT03345147|Vitamin A|vitamin a
36085|NCT03345147|Isotopic dilution|isotopic dilution
36086|NCT03345147|dietary assessment|dietary assessment
36087|NCT03345095|Marizomib|marizomib
36088|NCT03345095|Temozolomide|temozolomide
36089|NCT03345095|Glioblastoma|glioblastoma
36090|NCT03345095|Phase III|phase iii
36091|NCT03345069|Premature|premature
36092|NCT03345069|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
36093|NCT03345069|Neurodevelopmental impairment|neurodevelopmental impairment
36094|NCT03345069|Cerebral Palsy|cerebral palsy
36095|NCT03345069|Cognitive Impairment|cognitive impairment
36096|NCT03345069|Diffusion MRI|diffusion mri
36097|NCT03345069|Functional MRI|functional mri
36098|NCT03345069|Infant|infant
36099|NCT03345069|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
36100|NCT03345043|VAL-339851|val-339851
36101|NCT03345043|H7N9 antigen mRNA|h7n9 antigen mrna
36102|NCT03345043|Influenza vaccine|influenza vaccine
36103|NCT03345030|comet assay|comet assay
36104|NCT03345030|DNA damage|dna damage
36105|NCT03345030|granulosa|granulosa
36106|NCT03345030|IVF outcome|ivf outcome
36107|NCT03345004|Diamyd|diamyd
36108|NCT03345004|Diabetes|diabetes
36109|NCT03345004|Juvenile Diabetes|juvenile diabetes
36110|NCT03345004|Diabetes Type 1|diabetes type 1
36111|NCT03345004|Type 1 Diabetes|type 1 diabetes
36112|NCT03345004|Autoimmune Diabetes|autoimmune diabetes
36113|NCT03345004|Insulin Dependent Diabetes|insulin dependent diabetes
36114|NCT03345004|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
36115|NCT03345004|rhGAD65|rhgad65
36116|NCT03345004|GAD65|gad65
36117|NCT03345004|GAD-Alum|gad-alum
36118|NCT03345004|Diabetes Mellitus|diabetes mellitus
36119|NCT03345004|Diabetes Mellitus Type 1|diabetes mellitus type 1
36120|NCT03345004|Glucose Metabolism Disorders|glucose metabolism disorders
36121|NCT03345004|Metabolic Diseases|metabolic diseases
36122|NCT03345004|Vitamin D|vitamin d
36123|NCT03345004|Vitamins|vitamins
36124|NCT03345004|Micronutrients|micronutrients
36125|NCT03345004|Cholecalciferol|cholecalciferol
36126|NCT03345004|Ergocalciferols|ergocalciferols
36127|NCT03344991|Hypothermia|hypothermia
36128|NCT03344991|Newborn|newborn
36129|NCT03344978|Neonate|neonate
36130|NCT03344978|Premature|premature
36131|NCT03344978|Hypothermia|hypothermia
36132|NCT03344978|Cardboard|cardboard
36133|NCT03344978|Cot|cot
36134|NCT03344965|Metastatic Breast Cancer|metastatic breast cancer
36135|NCT03344965|Invasive Breast Cancer|invasive breast cancer
36136|NCT03344965|Somatic Mutation Breast Cancer (BRCA1)|somatic mutation breast cancer (brca1)
36137|NCT03344965|Somatic Mutation Breast Cancer (BRCA2)|somatic mutation breast cancer (brca2)
36138|NCT03344926|Acceptance and Commitment therapy|acceptance and commitment therapy
36139|NCT03344926|ACT|act
36140|NCT03344926|CBT|cbt
36141|NCT03344926|Smart phone|smart phone
36142|NCT03344926|Internet|internet
36143|NCT03344926|Intervention|intervention
36144|NCT03344900|mHealth|mhealth
36145|NCT03344900|Medication adherence|medication adherence
36146|NCT03344900|Barriers to adherence|barriers to adherence
36147|NCT03344887|anemia|anemia
36148|NCT03344887|donor sex|donor sex
36149|NCT03344887|prospective blinded pragmatic randomized|prospective blinded pragmatic randomized
36150|NCT03344874|heart sounds|heart sounds
36151|NCT03344874|Stethee|stethee
36152|NCT03344874|electronic stethoscope|electronic stethoscope
36153|NCT03344861|lung cancer|lung cancer
36154|NCT03344861|lung carcinoma|lung carcinoma
36155|NCT03344861|lung metastases|lung metastases
36156|NCT03344835|Prostate Cancer|prostate cancer
36157|NCT03344835|Disease Outcome|disease outcome
36158|NCT03344822|68Ga-PSMA PET|68ga-psma pet
36159|NCT03344809|lymphoma|lymphoma
36160|NCT03344809|unclassifiable|unclassifiable
36161|NCT03344809|next|next
36162|NCT03344809|generation|generation
36163|NCT03344809|sequencing|sequencing
36164|NCT03344796|Skin Cancer|skin cancer
36165|NCT03344796|Sunburn, erythema|sunburn, erythema
36166|NCT03344796|UV Exposure, Sunburn|uv exposure, sunburn
36167|NCT03344796|Wearable UV Device|wearable uv device
36168|NCT03344757|prostate cancer|prostate cancer
36169|NCT03344757|localized prostate cancer|localized prostate cancer
36170|NCT03344757|spanish|spanish
36171|NCT03344757|latino|latino
36172|NCT03344757|hispanic|hispanic
36173|NCT03344757|stress management|stress management
36174|NCT03344744|Subarachnoid Haemorrhage|subarachnoid haemorrhage
36175|NCT03344679|Pectoral nerve block|pectoral nerve block
36176|NCT03344679|Adenosine|adenosine
36177|NCT03344679|Magnesium sulphate|magnesium sulphate
36178|NCT03344640|Overuse tendinopathy, shoulder, rotator cuff, IL-17A-Ab|overuse tendinopathy, shoulder, rotator cuff, il-17a-ab
36179|NCT03344614|third-line treatment|third-line treatment
36180|NCT03344614|apatinib|apatinib
36181|NCT03344614|raltitrexed|raltitrexed
36182|NCT03344549|eHealth|ehealth
36183|NCT03344549|Nutrition Therapy|nutrition therapy
36184|NCT03344549|Telehealth|telehealth
36185|NCT03344549|Diabetic Kidney Disease|diabetic kidney disease
36186|NCT03344549|Chronic Kidney Disease|chronic kidney disease
36187|NCT03344536|Debio 1347|debio 1347
36188|NCT03344536|Fulvestrant|fulvestrant
36189|NCT03344536|17-379|17-379
36190|NCT03344510|lidocaine|lidocaine
36191|NCT03344510|vibration|vibration
36192|NCT03344510|anesthesia|anesthesia
36193|NCT03344510|injection|injection
36194|NCT03344510|pain|pain
36195|NCT03344510|discomfort|discomfort
36196|NCT03344510|dermatology|dermatology
36197|NCT03344510|dermatologic surgery|dermatologic surgery
36198|NCT03344510|local|local
36199|NCT03344510|device|device
36200|NCT03344471|preterm delivery|preterm delivery
36201|NCT03344471|PTSD|ptsd
36202|NCT03344471|prematurity|prematurity
36203|NCT03344471|birth|birth
36204|NCT03344471|personality|personality
36205|NCT03344458|Human Growth Hormone|human growth hormone
36206|NCT03344458|hGH|hgh
36207|NCT03344458|GHD|ghd
36208|NCT03344458|rhGH|rhgh
36209|NCT03344458|Pediatric Growth Hormone Deficiency|pediatric growth hormone deficiency
36210|NCT03344458|Long Acting Growth Hormone|long acting growth hormone
36211|NCT03344458|Somatropin|somatropin
36212|NCT03344458|Prodrug|prodrug
36213|NCT03344458|Growth Failure|growth failure
36214|NCT03344458|Growth Hormone Replacement Therapy|growth hormone replacement therapy
36215|NCT03344458|Sustained Release Growth Hormone|sustained release growth hormone
36216|NCT03344458|Growth Hormone Deficiency|growth hormone deficiency
36217|NCT03344458|TransCon GH|transcon gh
36218|NCT03344419|cocaine|cocaine
36219|NCT03344419|mindfulness based relapse prevention|mindfulness based relapse prevention
36220|NCT03344419|motivational enhancement therapy|motivational enhancement therapy
36221|NCT03344406|Asthma|asthma
36222|NCT03344406|Telephone interview|telephone interview
36223|NCT03344406|Cross-sectional|cross-sectional
36224|NCT03344406|Qualitative research|qualitative research
36225|NCT03344406|E-RS: COPD|e-rs: copd
36226|NCT03344380|Gene polymorphism|gene polymorphism
36227|NCT03344380|acute kidney injury|acute kidney injury
36228|NCT03344380|liver transplantation|liver transplantation
36229|NCT03344367|Non Hodgkin Lymphoma|non hodgkin lymphoma
36230|NCT03344367|CD19-targeted chimeric antigen receptor|cd19-targeted chimeric antigen receptor
36231|NCT03344367|JWCAR029|jwcar029
36232|NCT03344341|T2DM|t2dm
36233|NCT03344328|Chemotherapy|chemotherapy
36234|NCT03344328|Bortezomib|bortezomib
36235|NCT03344328|Multiple myeloma|multiple myeloma
36236|NCT03344315|Gingival recession|gingival recession
36237|NCT03344315|Collagen matrix|collagen matrix
36238|NCT03344315|Connective tissue graft|connective tissue graft
36239|NCT03344315|Coronally advanced flap|coronally advanced flap
36240|NCT03344315|Root coverage|root coverage
36241|NCT03344315|keratinized tissue|keratinized tissue
36242|NCT03344315|Periodontal disease|periodontal disease
36243|NCT03344289|Linked-color-imaging|linked-color-imaging
36244|NCT03344289|Advanced Imaging Techniques|advanced imaging techniques
36245|NCT03344276|carotid stenosis|carotid stenosis
36246|NCT03344276|neurocognition|neurocognition
36247|NCT03344276|carotid stenting|carotid stenting
36441|NCT03342976|Frailty|frailty
36248|NCT03344276|circle of willis|circle of willis
36249|NCT03344250|Adoptive Cell Therapy|adoptive cell therapy
36250|NCT03344250|Armed Activated T-cells|armed activated t-cells
36251|NCT03344250|Bispecific Antibodies|bispecific antibodies
36252|NCT03344250|Immunotherapy|immunotherapy
36253|NCT03344185|glycaemic index|glycaemic index
36254|NCT03344185|mood|mood
36255|NCT03344185|glucose|glucose
36256|NCT03344185|diet|diet
36257|NCT03344159|Mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
36258|NCT03344159|Brain natriuretic peptide (BNP)|brain natriuretic peptide (bnp)
36259|NCT03344159|Sympathetic Nervous System|sympathetic nervous system
36260|NCT03344159|Positron Emissions Tomography|positron emissions tomography
36261|NCT03344146|ischemic stroke, direct oral anticoagulants, adherence, electronic monitoring, adherence-improving intervention, polypharmacy|ischemic stroke, direct oral anticoagulants, adherence, electronic monitoring, adherence-improving intervention, polypharmacy
36262|NCT03344133|Obesity|obesity
36263|NCT03344133|Exercise|exercise
36264|NCT03344133|CVD risk factors|cvd risk factors
36265|NCT03344133|Appetite Regulation|appetite regulation
36266|NCT03344133|Gut Microbiota|gut microbiota
36267|NCT03344120|Symptoms and Signs|symptoms and signs
36268|NCT03344120|Pain|pain
36269|NCT03344120|Ureteral Calculi|ureteral calculi
36270|NCT03344120|Ureteroscopy|ureteroscopy
36271|NCT03344120|Ureteral Stents|ureteral stents
36272|NCT03344107|Symptoms and Signs|symptoms and signs
36273|NCT03344107|Pain|pain
36274|NCT03344107|Renal Calculi|renal calculi
36275|NCT03344107|Ureteral Stent|ureteral stent
36276|NCT03344107|Ureteroscopy|ureteroscopy
36277|NCT03344081|attention|attention
36278|NCT03344081|interoception|interoception
36279|NCT03344081|meditation|meditation
36280|NCT03344081|mind wandering|mind wandering
36281|NCT03344068|nasopharyngeal carcinoma|nasopharyngeal carcinoma
36282|NCT03344068|nutritional support|nutritional support
36283|NCT03344068|early and whole course|early and whole course
36284|NCT03344068|efficacy and safety|efficacy and safety
36285|NCT03344055|Adenoma Detection Rate|adenoma detection rate
36286|NCT03344055|Endocuff|endocuff
36287|NCT03344055|Colonoscopy|colonoscopy
36288|NCT03344029|Influenza|influenza
36289|NCT03344029|Flu|flu
36290|NCT03343964|aEEG, cEEG|aeeg, ceeg
36291|NCT03343951|Physical Therapists|physical therapists
36292|NCT03343951|Diagnosis|diagnosis
36293|NCT03343951|Clinical Competence|clinical competence
36294|NCT03343951|Interprofessional Relations|interprofessional relations
36295|NCT03343951|Cost Analysis|cost analysis
36296|NCT03343938|Group embryo culture|group embryo culture
36297|NCT03343938|Low oxygen tension|low oxygen tension
36298|NCT03343938|Closed station|closed station
36299|NCT03343938|Embryo handling|embryo handling
36300|NCT03343925|Reinfection|reinfection
36301|NCT03343912|Estriol|estriol
36302|NCT03343912|Trimegestone|trimegestone
36303|NCT03343912|Vaginal Ring|vaginal ring
36304|NCT03343886|Health Status|health status
36305|NCT03343886|Well-being|well-being
36306|NCT03343886|Mental Health|mental health
36307|NCT03343886|Risk Factors|risk factors
36308|NCT03343886|Aging|aging
36309|NCT03343873|anesthetics; fMRI; EEG; functional connectivity|anesthetics; fmri; eeg; functional connectivity
36310|NCT03343834|Methyl-qPCR|methyl-qpcr
36311|NCT03343834|Allogenic cell stem transplant (HSCT)|allogenic cell stem transplant (hsct)
36312|NCT03343834|EBV-induced lymphoproliferation|ebv-induced lymphoproliferation
36313|NCT03343808|Cooled radiofrequency|cooled radiofrequency
36314|NCT03343808|chronic knee pain|chronic knee pain
36315|NCT03343808|knee arthroplasty|knee arthroplasty
36316|NCT03343808|genicular nerve|genicular nerve
36317|NCT03343782|Diabetes|diabetes
36318|NCT03343782|BM mesenchymal stem cell|bm mesenchymal stem cell
36319|NCT03343717|Pneumonia, Ventilator-Associated|pneumonia, ventilator-associated
36320|NCT03343717|Mechanical ventilation|mechanical ventilation
36321|NCT03343717|Physical therapy|physical therapy
36322|NCT03343665|Nivolumab|nivolumab
36323|NCT03343652|Hodgkin's Lymphoma|hodgkin's lymphoma
36324|NCT03343652|Nivolumab|nivolumab
36325|NCT03343652|Bendamustine Hydrochloride|bendamustine hydrochloride
36326|NCT03343626|Drug therapy|drug therapy
36327|NCT03343613|IDO-1 Inhibitor|ido-1 inhibitor
36328|NCT03343613|IDO1 Inhibitor|ido1 inhibitor
36329|NCT03343613|IDO Inhibitor|ido inhibitor
36330|NCT03343574|Parkinson's Disease|parkinson's disease
36331|NCT03343574|Neurogenic orthostatic hypotension|neurogenic orthostatic hypotension
36332|NCT03343574|Orthostatic intolerance|orthostatic intolerance
36333|NCT03343574|Exercise|exercise
36334|NCT03343574|Abdominal binder|abdominal binder
36335|NCT03343574|Autonomic dysfunction|autonomic dysfunction
36336|NCT03343574|Dizziness|dizziness
36337|NCT03343574|Physical Therapy|physical therapy
36338|NCT03343574|Blood pressure|blood pressure
36339|NCT03343574|Heart rate|heart rate
36340|NCT03343574|Autonomic function testing|autonomic function testing
36341|NCT03343574|Neurology|neurology
36342|NCT03343574|Falls risk|falls risk
36343|NCT03343574|Autonomic Nervous System|autonomic nervous system
36344|NCT03343574|Autonomic reflex screening|autonomic reflex screening
36345|NCT03343574|Cerebral blood flow|cerebral blood flow
36346|NCT03343574|Cerebral perfusion|cerebral perfusion
36347|NCT03343574|Activities of Daily Living|activities of daily living
36348|NCT03343535|portable ex-vivo lung perfusion|portable ex-vivo lung perfusion
36349|NCT03343535|breathing lung transplant|breathing lung transplant
36350|NCT03343535|portable OCS Lung System|portable ocs lung system
36351|NCT03343522|Vascular function|vascular function
36352|NCT03343522|Physical training|physical training
36353|NCT03343522|Laser Speckle Contrast Imaging|laser speckle contrast imaging
36354|NCT03343509|Hemorrhoidectomy|hemorrhoidectomy
36355|NCT03343509|Metronidazole|metronidazole
36356|NCT03343509|Postoperative analgesia|postoperative analgesia
36357|NCT03343496|awake fiberoptic intubation|awake fiberoptic intubation
36358|NCT03343483|Volunteerism|volunteerism
36359|NCT03343483|Aged|aged
36360|NCT03343483|Loneliness|loneliness
36361|NCT03343483|Quality of Life|quality of life
36362|NCT03343470|Cushing Syndrome|cushing syndrome
36363|NCT03343470|Adrenal Insufficiency|adrenal insufficiency
36364|NCT03343470|Peripheral blood mononuclear cells|peripheral blood mononuclear cells
36365|NCT03343470|Melatonin|melatonin
36366|NCT03343470|Cortisol|cortisol
36367|NCT03343470|Immunological profile|immunological profile
36368|NCT03343470|Cushing Disease|cushing disease
36369|NCT03343457|Anxiety|anxiety
36370|NCT03343457|Chronic Pain|chronic pain
36371|NCT03343431|Hepatitis B|hepatitis b
36372|NCT03343431|Hepatitis B eAg|hepatitis b eag
36373|NCT03343431|Pregnancy|pregnancy
36374|NCT03343418|Bleeding|bleeding
36375|NCT03343418|Valve Cardiac Surgery|valve cardiac surgery
36376|NCT03343418|Desmopressin|desmopressin
36377|NCT03343405|Mind/Body|mind/body
36378|NCT03343392|Hydrogen Peroxide, Tooth Bleaching, Analgesics.|hydrogen peroxide, tooth bleaching, analgesics.
36379|NCT03343379|Abdominal muscles|abdominal muscles
36380|NCT03343379|Back muscles|back muscles
36381|NCT03343379|Core stability|core stability
36382|NCT03343379|Field test|field test
36383|NCT03343379|Muscle strength dynamometer|muscle strength dynamometer
36384|NCT03343379|Lower extremity injury|lower extremity injury
36385|NCT03343379|Risk assessment|risk assessment
36386|NCT03343379|Prospective studies|prospective studies
36387|NCT03343366|fasting plasma glucose|fasting plasma glucose
36388|NCT03343366|fasting plasma insulin|fasting plasma insulin
36389|NCT03343366|HOMA-IR insulin resistance|homa-ir insulin resistance
36390|NCT03343366|clinical attachment loss|clinical attachment loss
36391|NCT03343353|burn injury, phototherapy, wound healing|burn injury, phototherapy, wound healing
36392|NCT03343301|gastrointestinal cancer|gastrointestinal cancer
36393|NCT03343288|Silver Hydroxiapatite Coating|silver hydroxiapatite coating
36394|NCT03343288|Antimicrobial|antimicrobial
36395|NCT03343288|Medical Device|medical device
36396|NCT03343275|Catheter, incrustation, pH Control|catheter, incrustation, ph control
36397|NCT03343236|Head and neck cancer|head and neck cancer
36398|NCT03343236|Observational study|observational study
36399|NCT03343236|Three tertiary hospitals|three tertiary hospitals
36400|NCT03343236|Long-term follow-up|long-term follow-up
36401|NCT03343236|Survival|survival
36402|NCT03343236|Immune response|immune response
36403|NCT03343236|Metabolomics|metabolomics
36404|NCT03343197|Glioma|glioma
36405|NCT03343197|IDH1|idh1
36406|NCT03343197|AG-120|ag-120
36407|NCT03343197|AG-881|ag-881
36408|NCT03343184|dentin bonding agents|dentin bonding agents
36409|NCT03343184|tooth sensitivity|tooth sensitivity
36410|NCT03343184|composite resin restoration|composite resin restoration
36411|NCT03343171|total hip arthroplasty|total hip arthroplasty
36412|NCT03343145|Neutropenia|neutropenia
36413|NCT03343106|Acceptance and Commitment Therapy|acceptance and commitment therapy
36414|NCT03343106|Exposure and Response Prevention|exposure and response prevention
36415|NCT03343106|Psychotherapy|psychotherapy
36416|NCT03343106|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
36417|NCT03343106|Treatment Acceptability|treatment acceptability
36418|NCT03343106|Treatment Adherence|treatment adherence
36419|NCT03343093|Erectile Dysfunction|erectile dysfunction
36420|NCT03343080|Cardiac Surgery|cardiac surgery
36421|NCT03343067|Endometriosis associated pain|endometriosis associated pain
36422|NCT03343067|Elagolix|elagolix
36423|NCT03343067|Non-menstrual pelvic pain (NMPP)|non-menstrual pelvic pain (nmpp)
36424|NCT03343067|Dysmenorrhea (DYS)|dysmenorrhea (dys)
36425|NCT03343054|Phase 1|phase 1
36426|NCT03343054|talazoparib|talazoparib
36427|NCT03343054|PF-06944076|pf-06944076
36428|NCT03343054|MDV3800|mdv3800
36429|NCT03343054|BMN673|bmn673
36430|NCT03343054|PARP inhibitor|parp inhibitor
36431|NCT03343054|Japanese|japanese
36432|NCT03343054|solid tumors|solid tumors
36433|NCT03343054|C3441030|c3441030
36434|NCT03343028|veterans|veterans
36435|NCT03343028|post traumatic stress disorder|post traumatic stress disorder
36436|NCT03343028|depression|depression
36437|NCT03343015|TMD, centric relation, complete dentures|tmd, centric relation, complete dentures
36438|NCT03342989|delirium|delirium
36439|NCT03342989|speed of processing|speed of processing
36440|NCT03342989|cognitive decline|cognitive decline
36442|NCT03342976|Physical impairment|physical impairment
36443|NCT03342976|Cognitive decline|cognitive decline
36445|NCT03342937|pembrolizumab|pembrolizumab
36446|NCT03342937|XELOX|xelox
36447|NCT03342937|gastric cancer|gastric cancer
36448|NCT03342924|cognitive control|cognitive control
36449|NCT03342924|physical fitness|physical fitness
36450|NCT03342924|minority|minority
36451|NCT03342898|Drug Therapy|drug therapy
36452|NCT03342885|Low Back Pain|low back pain
36453|NCT03342885|Sleep ergonomics|sleep ergonomics
36454|NCT03342872|Adolescents|adolescents
36455|NCT03342872|Substance Use Disorders|substance use disorders
36456|NCT03342859|uterine fibroids|uterine fibroids
36457|NCT03342859|bleeding reduction|bleeding reduction
36458|NCT03342859|vilaprisan|vilaprisan
36459|NCT03342859|mode of action|mode of action
36460|NCT03342859|hysterectomy|hysterectomy
36461|NCT03342859|pharmacodynamic|pharmacodynamic
36462|NCT03342807|Hypertriglyceridemia-induced acute pancreatitis|hypertriglyceridemia-induced acute pancreatitis
36463|NCT03342807|insulin|insulin
36464|NCT03342807|triglyceride|triglyceride
36465|NCT03342807|treatment|treatment
36466|NCT03342781|bronchiolitis|bronchiolitis
36467|NCT03342781|diffuser mask|diffuser mask
36468|NCT03342781|high-flow nasal oxygen|high-flow nasal oxygen
36469|NCT03342781|pediatric intensive-care unit|pediatric intensive-care unit
36470|NCT03342716|Pancreatitis|pancreatitis
36471|NCT03342716|Multiple Organ Dysfunction Syndrome|multiple organ dysfunction syndrome
36472|NCT03342690|Selara|selara
36473|NCT03342690|Chronic Heart Failure|chronic heart failure
36474|NCT03342677|Cirrhosis|cirrhosis
36475|NCT03342677|HCC|hcc
36476|NCT03342677|Primovist|primovist
36477|NCT03342664|ICH|ich
36478|NCT03342651|Vitamin D|vitamin d
36479|NCT03342651|general anesthesia|general anesthesia
36480|NCT03342651|respiratory complications|respiratory complications
36481|NCT03342625|High intensity focused ultrasound|high intensity focused ultrasound
36482|NCT03342599|Alpha Lipoic Acid|alpha lipoic acid
36483|NCT03342586|resting state functional Magnetic Resonance Imaging|resting state functional magnetic resonance imaging
36484|NCT03342586|rsfMRI|rsfmri
36485|NCT03342586|17-403|17-403
36486|NCT03342560|Liver Fibrosis|liver fibrosis
36487|NCT03342560|Ultrasound Elastography|ultrasound elastography
36488|NCT03342560|Liver Steatosis|liver steatosis
36489|NCT03342560|Shear wave speed|shear wave speed
36490|NCT03342560|Stiffness|stiffness
36491|NCT03342560|Liver Biopsy|liver biopsy
36492|NCT03342547|Norovirus|norovirus
36493|NCT03342521|myocardial infarction|myocardial infarction
36494|NCT03342521|optical coherence tomography|optical coherence tomography
36495|NCT03342521|intracoronary thrombus|intracoronary thrombus
36496|NCT03342521|VerifyNow|verifynow
36497|NCT03342508|Maternal outcomes|maternal outcomes
36498|NCT03342508|Neonatal Outcomes|neonatal outcomes
36499|NCT03342495|transition, young adults, transfer|transition, young adults, transfer
36500|NCT03342482|MSG|msg
36501|NCT03342482|Gulf War Syndrome|gulf war syndrome
36502|NCT03342482|Diet|diet
36503|NCT03342482|Glutamate|glutamate
36504|NCT03342469|ADHD|adhd
36505|NCT03342469|Food Additives|food additives
36506|NCT03342469|Artificial Food Coloring|artificial food coloring
36507|NCT03342469|Diet|diet
36508|NCT03342456|Helicobacter pylori eradication|helicobacter pylori eradication
36509|NCT03342456|Duodenal Ulcer|duodenal ulcer
36510|NCT03342456|Ilaprazole/Doxycycline-based Bismuth-containing quadruple therapy|ilaprazole/doxycycline-based bismuth-containing quadruple therapy
36511|NCT03342443|memantine|memantine
36512|NCT03342443|radiotherapy-related cognitive impairment|radiotherapy-related cognitive impairment
36513|NCT03342417|breast cancer|breast cancer
36514|NCT03342417|ovarian cancer|ovarian cancer
36515|NCT03342417|gastric cancer|gastric cancer
36516|NCT03342404|(β)-Thalassemia|(β)-thalassemia
36517|NCT03342404|Beta-Thalassemia|beta-thalassemia
36518|NCT03342404|Phase 2|phase 2
36519|NCT03342404|Luspatercept|luspatercept
36520|NCT03342404|ACE-536|ace-536
36521|NCT03342404|Safety|safety
36522|NCT03342404|Efficacy|efficacy
36523|NCT03342404|Placebo|placebo
36524|NCT03342404|Red Blood Cell Transfusions|red blood cell transfusions
36525|NCT03342404|Erythrocyte transfusion|erythrocyte transfusion
36526|NCT03342404|Hb increase|hb increase
36527|NCT03342404|NTDT|ntdt
36528|NCT03342378|HPV|hpv
36529|NCT03342378|HPV-positive|hpv-positive
36530|NCT03342378|Oropharynx Cancer|oropharynx cancer
36531|NCT03342352|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
36532|NCT03342352|programmed cell death protein 1 (PD-1) antibody|programmed cell death protein 1 (pd-1) antibody
36533|NCT03342352|indoleamine 2,3-dioxygenase (IDO) inhibitor|indoleamine 2,3-dioxygenase (ido) inhibitor
36534|NCT03342339|influence of emotions|influence of emotions
36535|NCT03342339|positif emotional induction|positif emotional induction
36536|NCT03342339|decision making|decision making
36537|NCT03342339|Iowa Gambling Task|iowa gambling task
36538|NCT03342326|Lexical priming|lexical priming
36539|NCT03342326|Healthy Aging|healthy aging
36540|NCT03342300|soft tissue sarcoma|soft tissue sarcoma
37328|NCT03337230|Weight-Loss|weight-loss
36541|NCT03342300|pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
36542|NCT03342300|pirarubicin|pirarubicin
36543|NCT03342300|toxicity for heart|toxicity for heart
36544|NCT03342300|cumulative dose|cumulative dose
36545|NCT03342287|gut microbiome|gut microbiome
36546|NCT03342287|anxiety|anxiety
36547|NCT03342287|depression|depression
36548|NCT03342287|cognition|cognition
36549|NCT03342235|Excimer Laser Surgery|excimer laser surgery
36550|NCT03342235|Photorefractive Keratectomy|photorefractive keratectomy
36551|NCT03342235|Anisometropic Amblyopia|anisometropic amblyopia
36552|NCT03342235|Visual Acuity|visual acuity
36553|NCT03342235|Refractive Surgical Procedures|refractive surgical procedures
36554|NCT03342235|PRK|prk
36555|NCT03342222|PEEK Interference Screw; Fixation; Anterior Cruciate Ligament Reconstruction|peek interference screw; fixation; anterior cruciate ligament reconstruction
36556|NCT03342209|carbon monoxide toxicity|carbon monoxide toxicity
36557|NCT03342209|high flow nasal cannula|high flow nasal cannula
36558|NCT03342209|emergency department|emergency department
36559|NCT03342196|Thiotepa|thiotepa
36560|NCT03342196|Fludarabine|fludarabine
36561|NCT03342196|Melphalan|melphalan
36562|NCT03342183|Dialysis|dialysis
36563|NCT03342183|Hemodialysis|hemodialysis
36564|NCT03342183|Remote Ischemic Preconditioning|remote ischemic preconditioning
36565|NCT03342144|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
36566|NCT03342144|Cancer|cancer
36567|NCT03342144|Leukemia|leukemia
36568|NCT03342144|venetoclax|venetoclax
36569|NCT03342131|Wnt signaling|wnt signaling
36570|NCT03342105|Rhinitis, Allergic|rhinitis, allergic
36571|NCT03342105|Moxibustion|moxibustion
36572|NCT03342053|Huntington's Disease|huntington's disease
36573|NCT03342053|HTTRx|httrx
36574|NCT03342040|TAP block|tap block
36575|NCT03342040|laparoscopic IPOM|laparoscopic ipom
36576|NCT03342040|post operative pain|post operative pain
36577|NCT03341962|Ulcerative Colitis|ulcerative colitis
36578|NCT03341962|IMU-838|imu-838
36579|NCT03341962|vidofludimus calcium|vidofludimus calcium
36580|NCT03341936|Squamous Cell Carcinoma|squamous cell carcinoma
36581|NCT03341923|contact lenses|contact lenses
36582|NCT03341923|lens centration|lens centration
36583|NCT03341923|multifocal|multifocal
36584|NCT03341897|embolization|embolization
36585|NCT03341897|coiling|coiling
36586|NCT03341897|varicocele|varicocele
36587|NCT03341871|chronic hepatitis C virus (HCV)|chronic hepatitis c virus (hcv)
36588|NCT03341871|Genotype|genotype
36589|NCT03341871|glecaprevir|glecaprevir
36590|NCT03341871|pibrentasvir|pibrentasvir
36591|NCT03341871|sustained virologic response|sustained virologic response
36592|NCT03341871|chronic hepatitis C virus genotype 1|chronic hepatitis c virus genotype 1
36593|NCT03341871|chronic hepatitis C virus genotype 2|chronic hepatitis c virus genotype 2
36594|NCT03341871|chronic hepatitis C virus genotype 3|chronic hepatitis c virus genotype 3
36595|NCT03341871|chronic hepatitis C virus genotype 4|chronic hepatitis c virus genotype 4
36596|NCT03341871|chronic hepatitis C virus genotype 5|chronic hepatitis c virus genotype 5
36597|NCT03341871|chronic hepatitis C virus genotype 6|chronic hepatitis c virus genotype 6
36598|NCT03341806|GBM|gbm
36599|NCT03341806|LITT|litt
36600|NCT03341806|Laser Interstitial Thermal Therapy|laser interstitial thermal therapy
36601|NCT03341806|Bavencio|bavencio
36602|NCT03341806|immunotherapy|immunotherapy
36603|NCT03341767|HIV|hiv
36604|NCT03341767|Cryptosporidium|cryptosporidium
36605|NCT03341767|Clofazimine|clofazimine
36606|NCT03341754|Malaria Infection|malaria infection
36607|NCT03341741|chronic pulmonary infection|chronic pulmonary infection
36608|NCT03341702|jail|jail
36609|NCT03341702|violence|violence
36610|NCT03341702|predictive factors|predictive factors
36611|NCT03341702|prevention|prevention
36612|NCT03341689|Psilocybin|psilocybin
36613|NCT03341663|Stable Angina Pectoris|stable angina pectoris
36614|NCT03341663|Acupoint sensitization|acupoint sensitization
36615|NCT03341663|Correlation analysis|correlation analysis
36616|NCT03341663|Diagnostic value|diagnostic value
36617|NCT03341650|Mediterranean Diet|mediterranean diet
36618|NCT03341650|BMI|bmi
36619|NCT03341650|weight loss|weight loss
36620|NCT03341650|pasta|pasta
36621|NCT03341650|obesity|obesity
36622|NCT03341637|Drug Therapy|drug therapy
36623|NCT03341624|persistent fetal vasculature|persistent fetal vasculature
36624|NCT03341624|congenital cataract|congenital cataract
36625|NCT03341533|Analgesia|analgesia
36626|NCT03341533|Laparoscopy|laparoscopy
36627|NCT03341533|Pain|pain
36628|NCT03341507|laryngoscopy|laryngoscopy
36629|NCT03341507|retromolar|retromolar
36630|NCT03341481|galactagogues, lactogenesis, preterm labor|galactagogues, lactogenesis, preterm labor
36631|NCT03341468|Urethral catheter discomfort|urethral catheter discomfort
36632|NCT03341468|Urethral catheter pain|urethral catheter pain
36633|NCT03341468|Urethral catheter immobilization device|urethral catheter immobilization device
36634|NCT03341468|Prolonged urethral catheterization|prolonged urethral catheterization
36635|NCT03341468|Foley catheter|foley catheter
36636|NCT03341468|Urinary catheter|urinary catheter
36733|NCT03340857|Physical activity|physical activity
36637|NCT03341468|Indwelling urethral catheter support|indwelling urethral catheter support
36638|NCT03341455|Sri Lanka|sri lanka
36639|NCT03341455|preschool|preschool
36640|NCT03341455|randomized control trial|randomized control trial
36641|NCT03341429|obesity|obesity
36642|NCT03341429|GLP-1|glp-1
36643|NCT03341429|liraglutide|liraglutide
36644|NCT03341429|diabetes|diabetes
36645|NCT03341429|bariatric surgery|bariatric surgery
36646|NCT03341416|cerebellar ataxia|cerebellar ataxia
36647|NCT03341416|stroke|stroke
36648|NCT03341416|Spinocerebellar ataxia|spinocerebellar ataxia
36649|NCT03341416|deep brain stimulation|deep brain stimulation
36650|NCT03341416|dentate nucleus|dentate nucleus
36651|NCT03341403|severe asthma|severe asthma
36652|NCT03341403|synbiotic|synbiotic
36653|NCT03341403|immunomodulation|immunomodulation
36654|NCT03341403|sputum|sputum
36655|NCT03341390|Healthy participants|healthy participants
36656|NCT03341390|Healthy subjects|healthy subjects
36657|NCT03341390|Strokes|strokes
36658|NCT03341351|Fourth-degree laceration|fourth-degree laceration
36659|NCT03341351|Beef tongue model|beef tongue model
36660|NCT03341325|animal-assisted therapy|animal-assisted therapy
36661|NCT03341273|Antibiotic Therapy|antibiotic therapy
36662|NCT03341273|Lower Respiratory Tract Infection|lower respiratory tract infection
36663|NCT03341273|Procalcitonin|procalcitonin
36664|NCT03341260|Pulpitis, irreversible Pulpitis,|pulpitis, irreversible pulpitis,
36665|NCT03341260|Diclofenac Potassium|diclofenac potassium
36666|NCT03341260|Premedication, Preoperative Analgesic|premedication, preoperative analgesic
36667|NCT03341260|Postoperative pain|postoperative pain
36668|NCT03341247|Obesity|obesity
36669|NCT03341247|Portion Size Effect|portion size effect
36670|NCT03341247|fMRI|fmri
36671|NCT03341247|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
36672|NCT03341247|Inhibition|inhibition
36673|NCT03341247|Decision Making|decision making
36674|NCT03341247|Satiety Responsiveness|satiety responsiveness
36675|NCT03341247|Anthropometrics|anthropometrics
36676|NCT03341247|DXA|dxa
36677|NCT03341247|Reward Processing|reward processing
36803|NCT03340493|Vascular Diseases|vascular diseases
36678|NCT03341234|Superficial Serratus Plane Block|superficial serratus plane block
36679|NCT03341234|Modified Radical Mastectomy|modified radical mastectomy
36680|NCT03341234|Axillary Lymph Node Disection|axillary lymph node disection
36681|NCT03341234|bupivacaine|bupivacaine
36683|NCT03341195|Automated calls|automated calls
36684|NCT03341195|Routine immunization|routine immunization
36685|NCT03341195|mHealth|mhealth
36686|NCT03341182|epidural steroid injection|epidural steroid injection
36687|NCT03341182|radiation exposure|radiation exposure
36688|NCT03341182|mirror|mirror
36689|NCT03341156|Heart transplantation|heart transplantation
36690|NCT03341143|Unresectable|unresectable
36691|NCT03341143|Stage III|stage iii
36692|NCT03341143|Stage IV|stage iv
36693|NCT03341130|OSA|osa
36694|NCT03341130|Mandibular Advancement Splint|mandibular advancement splint
36695|NCT03341130|Oral Appliance|oral appliance
36696|NCT03341130|Treatment|treatment
36697|NCT03341130|Repositioning Splint|repositioning splint
36698|NCT03341117|acetylsalicylic acid|acetylsalicylic acid
36699|NCT03341117|antioxidant enzyme system|antioxidant enzyme system
36700|NCT03341117|stress oxidative|stress oxidative
36701|NCT03341117|type 2 diabetes mellitus.|type 2 diabetes mellitus.
36702|NCT03341091|Tai-chi|tai-chi
36703|NCT03341091|Dementia|dementia
36704|NCT03341091|Dyad approach|dyad approach
36705|NCT03341091|Fall prevention|fall prevention
36706|NCT03341091|Mobility|mobility
36707|NCT03341078|Ibudilast|ibudilast
36708|NCT03341078|Methamphetamine|methamphetamine
36709|NCT03341078|Neuroinflammation|neuroinflammation
36710|NCT03341013|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
36711|NCT03341013|GLP-1 receptor agonists|glp-1 receptor agonists
36712|NCT03340987|vestibular incision subperiosteal tunnel access|vestibular incision subperiosteal tunnel access
36713|NCT03340987|coronally advanced flap|coronally advanced flap
36714|NCT03340987|subepithelial connective tissue graft|subepithelial connective tissue graft
36715|NCT03340987|multiple gingival recessions|multiple gingival recessions
36716|NCT03340974|Super Oxide Dismutase|super oxide dismutase
36717|NCT03340948|Mindfulness Based Stress Reduction|mindfulness based stress reduction
36718|NCT03340948|Depressive symptoms|depressive symptoms
36719|NCT03340948|Coronary Artery Disease|coronary artery disease
36720|NCT03340948|Mastery|mastery
36721|NCT03340935|fasting mimicking diet|fasting mimicking diet
36722|NCT03340935|malignant neoplasm|malignant neoplasm
36723|NCT03340935|metabolism|metabolism
36724|NCT03340935|metabolic effects|metabolic effects
36725|NCT03340935|adjuvant treatment|adjuvant treatment
36726|NCT03340935|metastatic setting|metastatic setting
36727|NCT03340922|premature ventricular complex|premature ventricular complex
36728|NCT03340922|catheter ablation|catheter ablation
36729|NCT03340922|activation mapping|activation mapping
36730|NCT03340922|wavefront|wavefront
36731|NCT03340896|Larynx, hypopharynx|larynx, hypopharynx
36732|NCT03340857|Post-cancer retraining|post-cancer retraining
37225|NCT03337828|Microbiota|microbiota
36734|NCT03340857|Intelligent electric bicycle|intelligent electric bicycle
36735|NCT03340818|Low back pain, bone marrow concentrate, disc degeneration|low back pain, bone marrow concentrate, disc degeneration
36736|NCT03340805|Sepsis|sepsis
36737|NCT03340805|Septic shock|septic shock
36738|NCT03340805|Pediatric|pediatric
36739|NCT03340805|Fluid resuscitation|fluid resuscitation
36740|NCT03340805|Saline|saline
36741|NCT03340805|Lactated Ringer's|lactated ringer's
36742|NCT03340805|Crystalloid|crystalloid
36743|NCT03340805|Mortality|mortality
36744|NCT03340805|Pragmatic trial|pragmatic trial
36745|NCT03340805|Feasibility|feasibility
36746|NCT03340792|Exoskeleton Device|exoskeleton device
36747|NCT03340792|Rehabilitation|rehabilitation
36748|NCT03340792|Body composition|body composition
36749|NCT03340792|Quality of Life|quality of life
36750|NCT03340779|Norepinephrine|norepinephrine
36751|NCT03340779|Dobutamine|dobutamine
36752|NCT03340779|Shock|shock
36753|NCT03340766|DLBCL Relapsed post-autologous hematopoietic stem cell transplantation (HSCT)|dlbcl relapsed post-autologous hematopoietic stem cell transplantation (hsct)
36754|NCT03340766|Antibodies|antibodies
36755|NCT03340766|Bispecific in combination with PD-1/PD-L1 inhibitor|bispecific in combination with pd-1/pd-l1 inhibitor
36756|NCT03340727|Moderate preterm infant|moderate preterm infant
36757|NCT03340727|Caffeine citrate|caffeine citrate
36758|NCT03340701|progesterone|progesterone
36759|NCT03340701|pharmacology|pharmacology
36760|NCT03340701|pharmacokinetics|pharmacokinetics
36761|NCT03340662|Healthy Volunteer|healthy volunteer
36762|NCT03340662|CC-122|cc-122
36763|NCT03340662|Adult|adult
36764|NCT03340662|Phase 1|phase 1
36765|NCT03340662|CYTOCHROME P450|cytochrome p450
36766|NCT03340623|DIEP|diep
36767|NCT03340623|Venous coupler|venous coupler
36768|NCT03340584|Total Knee Replacement|total knee replacement
36769|NCT03340584|Taping|taping
36770|NCT03340584|Rehabilitation|rehabilitation
36771|NCT03340584|Edema|edema
36772|NCT03340584|Pain|pain
36773|NCT03340571|Alzheimer's Disease|alzheimer's disease
36774|NCT03340571|biomarkers|biomarkers
36775|NCT03340571|blood|blood
36776|NCT03340519|Crohn|crohn
36777|NCT03340519|MRI|mri
36778|NCT03340506|Tafinlar|tafinlar
36779|NCT03340506|Mekinist|mekinist
36780|NCT03340506|Dabrafenib|dabrafenib
36781|NCT03340506|Trametinib|trametinib
36782|NCT03340506|Adult|adult
36783|NCT03340506|Pediatric|pediatric
36784|NCT03340506|Melanoma|melanoma
36785|NCT03340506|Melanoma Stage IV|melanoma stage iv
36786|NCT03340506|Metastatic Melanoma|metastatic melanoma
36787|NCT03340506|Advanced Melanoma|advanced melanoma
36788|NCT03340506|Lung Cancer|lung cancer
36789|NCT03340506|NSLC|nslc
36790|NCT03340506|Non Small Cell Lung Cancer|non small cell lung cancer
36791|NCT03340506|BRAF V600 Mutation|braf v600 mutation
36792|NCT03340506|BRAF Gene Mutation|braf gene mutation
36793|NCT03340506|Solid tumor|solid tumor
36794|NCT03340506|Rare cancers|rare cancers
36795|NCT03340506|High Grade Glioma|high grade glioma
36796|NCT03340493|Stroke|stroke
36797|NCT03340493|Ischemia|ischemia
36798|NCT03340493|Cerebral Infarction|cerebral infarction
36799|NCT03340493|Cerebrovascular Disorders|cerebrovascular disorders
36800|NCT03340493|Brain Diseases|brain diseases
36801|NCT03340493|Central Nervous System Diseases|central nervous system diseases
36802|NCT03340493|Nervous System Diseases|nervous system diseases
36804|NCT03340493|Cardiovascular Diseases|cardiovascular diseases
36805|NCT03340493|Pathologic Processes|pathologic processes
36806|NCT03340493|Brain Infarction|brain infarction
36807|NCT03340493|Brain Ischemia|brain ischemia
36808|NCT03340493|Tenecteplase|tenecteplase
36809|NCT03340493|Fibrinolytic agents|fibrinolytic agents
36810|NCT03340493|Fibrin Modulating agents|fibrin modulating agents
36811|NCT03340493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
36812|NCT03340493|Plasminogen|plasminogen
36813|NCT03340493|Tissue Plasminogen Activator|tissue plasminogen activator
36814|NCT03340454|Diabetes Management|diabetes management
36815|NCT03340454|H. pylori|h. pylori
36816|NCT03340415|Hallux Valgus|hallux valgus
36817|NCT03340415|Bunion|bunion
36818|NCT03340415|Post-operative|post-operative
36819|NCT03340415|Rehabilitation|rehabilitation
36820|NCT03340415|Weight Bearing Status|weight bearing status
36821|NCT03340402|Breast Cancer|breast cancer
36822|NCT03340350|Minocycline|minocycline
36823|NCT03340350|PTSD|ptsd
36824|NCT03340337|electrical stimulation|electrical stimulation
36825|NCT03340337|Muscle Strength|muscle strength
36826|NCT03340337|Fatigue|fatigue
36827|NCT03340337|assessments, pain|assessments, pain
36828|NCT03340324|inflammation|inflammation
36829|NCT03340324|autoimmunity|autoimmunity
36830|NCT03340324|immunotherapy|immunotherapy
36831|NCT03340324|infertility|infertility
36832|NCT03340324|pelvic pain|pelvic pain
36833|NCT03340311|M-Health, GDM, Bluetooth, SMBG|m-health, gdm, bluetooth, smbg
36834|NCT03340272|prostate cancer|prostate cancer
36835|NCT03340272|pelvic irradiation|pelvic irradiation
36836|NCT03340272|hormonal treatment|hormonal treatment
36837|NCT03340259|Congenital malformations of the gastrointestinal tract|congenital malformations of the gastrointestinal tract
36838|NCT03340259|Enterostomy|enterostomy
36839|NCT03340259|Microbiota|microbiota
36840|NCT03340259|Necrotizing enterocolitis|necrotizing enterocolitis
36841|NCT03340259|Newborn Infants|newborn infants
36842|NCT03340259|Spontaneous intestinal perforation|spontaneous intestinal perforation
36843|NCT03340246|Varicose veins, phlebectomy|varicose veins, phlebectomy
36844|NCT03340233|diastolic dysfunction|diastolic dysfunction
36845|NCT03340233|mechanism|mechanism
36846|NCT03340233|MRI magnetic resonance imaging|mri magnetic resonance imaging
36847|NCT03340233|ejection fraction|ejection fraction
36848|NCT03340220|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
36849|NCT03340207|intubation|intubation
36850|NCT03340207|anesthesiology|anesthesiology
36851|NCT03340194|Systemic sclerosis|systemic sclerosis
36852|NCT03340194|Calcinosis cutis|calcinosis cutis
36853|NCT03340181|RIPC, myocardial protective effect|ripc, myocardial protective effect
36854|NCT03340168|Bisphenol S, toxicokinetics|bisphenol s, toxicokinetics
36855|NCT03340129|Immunotherapy|immunotherapy
36856|NCT03340129|Radiotherapy|radiotherapy
36857|NCT03340129|Brain metastases|brain metastases
36858|NCT03340103|Lutein/Zeaxanthin|lutein/zeaxanthin
36859|NCT03340103|Antioxidant|antioxidant
36860|NCT03340103|Oxidative stress|oxidative stress
36861|NCT03340103|Carotenoid|carotenoid
36862|NCT03340103|Preterm newborn|preterm newborn
36863|NCT03340064|Epilepsy|epilepsy
36864|NCT03340064|Partial Seizures|partial seizures
36865|NCT03340064|Levetiracetam|levetiracetam
36866|NCT03340064|Monotherapy|monotherapy
36867|NCT03340064|Adjunctive Treatment|adjunctive treatment
36868|NCT03340038|free flap reconstructive surgery, head and neck|free flap reconstructive surgery, head and neck
36869|NCT03340025|negative pressure wound therapy|negative pressure wound therapy
36870|NCT03340025|split thickness skin graft|split thickness skin graft
36871|NCT03339986|Portion Size|portion size
36872|NCT03339986|Feasibility|feasibility
36873|NCT03339986|Acceptability|acceptability
36874|NCT03339986|Snacking|snacking
36875|NCT03339986|Preschool children|preschool children
36876|NCT03339973|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
36877|NCT03339973|ABCB5|abcb5
36878|NCT03339973|allogeneic|allogeneic
36879|NCT03339973|mesenchymal stem cells|mesenchymal stem cells
36880|NCT03339973|advanced therapy medicinal product|advanced therapy medicinal product
36881|NCT03339973|somatic cell therapy|somatic cell therapy
36882|NCT03339973|phase I/IIa|phase i/iia
36883|NCT03339973|non-healing ulcers|non-healing ulcers
36884|NCT03339947|Multidrug-resistant Enterobacteriaceae acquisition|multidrug-resistant enterobacteriaceae acquisition
36885|NCT03339947|travellers' diarrhoea|travellers' diarrhoea
36886|NCT03339947|international travel|international travel
36887|NCT03339934|Hypofractionation|hypofractionation
36888|NCT03339934|Proton therapy|proton therapy
36889|NCT03339934|3D conformal radiation|3d conformal radiation
36890|NCT03339934|Randomized|randomized
36891|NCT03339934|Phase II|phase ii
36892|NCT03339895|COLORECTAL SURGERY|colorectal surgery
36893|NCT03339895|PVI GUIDED FLUID MANAGEMENT|pvi guided fluid management
36894|NCT03339895|GOAL DIRECTED THERAPY|goal directed therapy
36895|NCT03339882|remifemin|remifemin
36896|NCT03339882|preventive effect|preventive effect
36897|NCT03339882|LHRH-a|lhrh-a
36898|NCT03339882|breast cancer|breast cancer
36899|NCT03339843|cancer|cancer
36900|NCT03339830|SMA|sma
36901|NCT03339830|Spinal Muscular Atrophy|spinal muscular atrophy
36902|NCT03339830|Neuromuscular disease|neuromuscular disease
36903|NCT03339830|Spinraza|spinraza
36904|NCT03339804|Chemotherapy|chemotherapy
36905|NCT03339804|Muscle sympathetic nervous activity|muscle sympathetic nervous activity
36906|NCT03339804|Blood flow|blood flow
36907|NCT03339804|Endothelial microparticles|endothelial microparticles
36908|NCT03339765|Self-advocacy|self-advocacy
36909|NCT03339765|Advanced cancer|advanced cancer
36910|NCT03339765|Serious games|serious games
36911|NCT03339765|Self-management|self-management
36912|NCT03339739|Musculoskeletal Pain|musculoskeletal pain
36913|NCT03339739|Orofacial Pain|orofacial pain
36914|NCT03339739|Physical Therapy Modalities|physical therapy modalities
36915|NCT03339739|Oral Contraceptives|oral contraceptives
36916|NCT03339739|Mandibular Diseases|mandibular diseases
36917|NCT03339739|Muscular Diseases|muscular diseases
36918|NCT03339739|Risk factors|risk factors
36919|NCT03339739|Contraceptive Usage|contraceptive usage
36920|NCT03339739|Pain, Chronic|pain, chronic
36921|NCT03339739|Craniomandibular Disorders|craniomandibular disorders
36922|NCT03339661|CMV infection|cmv infection
36923|NCT03339661|kidney transplant|kidney transplant
36924|NCT03339661|γδ T cells monitoring|γδ t cells monitoring
36925|NCT03339648|School Resource Officer|school resource officer
36926|NCT03339648|Trauma Informed Care|trauma informed care
36927|NCT03339648|Cultural Competency|cultural competency
36928|NCT03339648|Restorative Problem Solving|restorative problem solving
36929|NCT03339648|Social Emotional Learning|social emotional learning
36930|NCT03339648|Professional Development|professional development
37327|NCT03337230|Cancer|cancer
36931|NCT03339648|School Violence|school violence
36932|NCT03339622|uncontrollable cancer pain|uncontrollable cancer pain
36933|NCT03339622|incurable malignancy,|incurable malignancy,
36934|NCT03339596|electroconvulsive therapy|electroconvulsive therapy
36935|NCT03339596|depression|depression
36936|NCT03339596|cognition|cognition
36937|NCT03339596|cognitive side-effects|cognitive side-effects
36938|NCT03339596|erythropoietin|erythropoietin
36939|NCT03339596|functional magnetic resonance imaging|functional magnetic resonance imaging
36940|NCT03339583|chronic insomnia|chronic insomnia
36941|NCT03339583|brief behavioral treatment|brief behavioral treatment
36942|NCT03339583|behavioral treatment|behavioral treatment
36943|NCT03339583|insomnia severity index|insomnia severity index
36944|NCT03339583|predictors|predictors
36945|NCT03339583|treatment response|treatment response
36946|NCT03339531|2D|2d
36947|NCT03339531|prostate neoplasms|prostate neoplasms
36948|NCT03339531|radiotherapy|radiotherapy
36949|NCT03339531|simulation|simulation
36950|NCT03339492|rotator cuff|rotator cuff
36951|NCT03339492|PEMF|pemf
36952|NCT03339492|Pulsed Electromagnetic Field|pulsed electromagnetic field
36953|NCT03339492|Rotator Cuff Repair|rotator cuff repair
36954|NCT03339492|adjunctive therapy|adjunctive therapy
36955|NCT03339479|dielectric property|dielectric property
36956|NCT03339479|lung nodules|lung nodules
36957|NCT03339479|differential diagnosis|differential diagnosis
36958|NCT03339479|frozen pathological examination|frozen pathological examination
36959|NCT03339427|vitamin D|vitamin d
36960|NCT03339427|cardiovascular|cardiovascular
36961|NCT03339427|muscle power|muscle power
36962|NCT03339362|low back pain|low back pain
36963|NCT03339362|lumbar facet joint pain|lumbar facet joint pain
36964|NCT03339362|feasibility|feasibility
36965|NCT03339362|lumbar facet joint injection|lumbar facet joint injection
36966|NCT03339310|CCM Therapy|ccm therapy
36967|NCT03339310|2-Lead|2-lead
36968|NCT03339310|FIX-HF-5C2|fix-hf-5c2
36969|NCT03339310|Optimizer|optimizer
36970|NCT03339258|Posttraumatic Stress Disorder|posttraumatic stress disorder
36971|NCT03339258|Post-traumatic Stress Disorder|post-traumatic stress disorder
36972|NCT03339258|PTSD|ptsd
36973|NCT03339258|Doxazosin|doxazosin
36974|NCT03339258|Nightmares|nightmares
36975|NCT03339258|Sleep Disturbance|sleep disturbance
36976|NCT03339245|obesity|obesity
36977|NCT03339245|fructose|fructose
36978|NCT03339245|glucose|glucose
36979|NCT03339245|fecal microbiota|fecal microbiota
36980|NCT03339245|intestinal permiability|intestinal permiability
36981|NCT03339245|fecal metabolites|fecal metabolites
36982|NCT03339193|atrial fibrillation|atrial fibrillation
36983|NCT03339193|stroke|stroke
36984|NCT03339193|atrial appendage|atrial appendage
36985|NCT03339180|cardiac troponin|cardiac troponin
36986|NCT03339167|Lysine, Adult, Protein Quality|lysine, adult, protein quality
36987|NCT03339154|Healthy|healthy
36988|NCT03339154|Men|men
36989|NCT03339154|Adults|adults
36990|NCT03339154|Methionine|methionine
36991|NCT03339141|Intubation conditions|intubation conditions
36992|NCT03339141|Anaesthetic techniques|anaesthetic techniques
36993|NCT03339141|Laryngoscopy|laryngoscopy
36994|NCT03339128|Irritable Bowel Syndrome with Diarrhea|irritable bowel syndrome with diarrhea
36995|NCT03339128|IBSD|ibsd
36996|NCT03339128|IBS-D|ibs-d
36997|NCT03339128|Irritable Bowel Syndrome|irritable bowel syndrome
36998|NCT03339128|Pediatric|pediatric
36999|NCT03339102|Non-infectious intermediate, posterior and panuveitis|non-infectious intermediate, posterior and panuveitis
37000|NCT03339102|Post-Marketing Surveillance|post-marketing surveillance
37001|NCT03339102|Humira®|humira®
37002|NCT03339089|rheumatoid arthritis|rheumatoid arthritis
37003|NCT03339089|plaque psoriasis|plaque psoriasis
37004|NCT03339089|ankylosing spondylitis|ankylosing spondylitis
37005|NCT03339089|Immune-Mediated Inflammatory Diseases|immune-mediated inflammatory diseases
37006|NCT03339089|Chinese Patients|chinese patients
37007|NCT03339063|Nontuberculous Mycobacteria|nontuberculous mycobacteria
37008|NCT03339063|Non-tuberculous mycobacteria|non-tuberculous mycobacteria
37009|NCT03339063|NTM-PD|ntm-pd
37010|NCT03339063|NTM-LD|ntm-ld
37011|NCT03339063|MAC|mac
37012|NCT03339063|M. avium|m. avium
37013|NCT03339063|M. intracellulare|m. intracellulare
37014|NCT03339063|M. abscessus|m. abscessus
37015|NCT03339063|Atypical mycobacteria|atypical mycobacteria
37016|NCT03339063|NTM|ntm
37017|NCT03339050|church-based health promotion|church-based health promotion
37018|NCT03339050|African Americans|african americans
37019|NCT03339037|HBOT|hbot
37020|NCT03339037|TBI|tbi
37021|NCT03339037|pediatrics|pediatrics
37022|NCT03339037|PCS|pcs
37023|NCT03339037|PPCS|ppcs
37024|NCT03339037|concussion|concussion
37025|NCT03339037|traumatic brain injury|traumatic brain injury
37026|NCT03339037|hyperbaric oxygen|hyperbaric oxygen
37027|NCT03339024|Oxytocin|oxytocin
37028|NCT03339024|Administration, Intranasal|administration, intranasal
37029|NCT03339024|Ethanol|ethanol
37030|NCT03339024|Follow-up Studies|follow-up studies
37031|NCT03338998|stroke|stroke
37032|NCT03338998|intracerebral hemorrhage|intracerebral hemorrhage
37033|NCT03338998|ICH|ich
37034|NCT03338998|BAF312|baf312
37035|NCT03338998|siponimod|siponimod
37036|NCT03338998|sphingosine-1-phosphate receptor|sphingosine-1-phosphate receptor
37037|NCT03338946|Remote monitoring|remote monitoring
37038|NCT03338920|acute migraine|acute migraine
37039|NCT03338920|aura|aura
37040|NCT03338920|sumatriptan nasal powder|sumatriptan nasal powder
37041|NCT03338920|AVP-825|avp-825
37042|NCT03338920|adolescents|adolescents
37043|NCT03338907|cerebral hypoxia|cerebral hypoxia
37044|NCT03338907|CO2|co2
37045|NCT03338907|cerebral perfusion|cerebral perfusion
37046|NCT03338907|hypoxia|hypoxia
37047|NCT03338881|Drug therapy|drug therapy
37048|NCT03338868|physical activity|physical activity
37049|NCT03338868|pain|pain
37050|NCT03338868|uric acid|uric acid
37051|NCT03338855|T2DM, insulin resistance, skeletal muscle, mitochondrial function, Phase 4 trial, dapagliflozin|t2dm, insulin resistance, skeletal muscle, mitochondrial function, phase 4 trial, dapagliflozin
37175|NCT03338192|Low back pain|low back pain
37052|NCT03338816|Acute Intermittent Porphyria (AIP)|acute intermittent porphyria (aip)
37053|NCT03338816|Acute Hepatic Porphyria (AHP)|acute hepatic porphyria (ahp)
37054|NCT03338816|Hereditary Coproporphyria (HCP)|hereditary coproporphyria (hcp)
37055|NCT03338816|Variegate Porphyria (VP)|variegate porphyria (vp)
37056|NCT03338816|ALA dehydratase deficient porphyria (ADP) (ALAD)|ala dehydratase deficient porphyria (adp) (alad)
37057|NCT03338816|RNAi therapeutic|rnai therapeutic
37058|NCT03338816|Porphyria|porphyria
37059|NCT03338777|melanoma|melanoma
37060|NCT03338777|lipoplexes|lipoplexes
37061|NCT03338777|plasmid|plasmid
37062|NCT03338777|herpes simplex thymidine kinase|herpes simplex thymidine kinase
37063|NCT03338777|interleukin-2|interleukin-2
37064|NCT03338777|granulocyte-macrophage colony-stimulating factor|granulocyte-macrophage colony-stimulating factor
37065|NCT03338777|tumor vaccine|tumor vaccine
37066|NCT03338777|suicide gene|suicide gene
37067|NCT03338764|Transient insomnia|transient insomnia
37068|NCT03338764|Insomnia|insomnia
37069|NCT03338764|Sleep initiation and maintenance disorder|sleep initiation and maintenance disorder
37070|NCT03338699|Early infant male circumcision|early infant male circumcision
37071|NCT03338699|ShangRing|shangring
37072|NCT03338699|sub-Saharan Africa|sub-saharan africa
37073|NCT03338699|HIV|hiv
37074|NCT03338699|WHO|who
37075|NCT03338686|Keratinized tissue|keratinized tissue
37076|NCT03338686|Keratinized mucosa|keratinized mucosa
37077|NCT03338686|Attached mucosa|attached mucosa
37078|NCT03338686|Dental implants|dental implants
37079|NCT03338686|Free gingival graft|free gingival graft
37080|NCT03338686|Connective tissue graft|connective tissue graft
37081|NCT03338686|Patient-centered outcomes|patient-centered outcomes
37082|NCT03338647|Stereotactic body radiation therapy|stereotactic body radiation therapy
37083|NCT03338647|transarterial chemoembolization|transarterial chemoembolization
37084|NCT03338647|SBRT|sbrt
37085|NCT03338647|TACE|tace
37086|NCT03338634|Portion Size Effect|portion size effect
37087|NCT03338634|Childhood Obesity|childhood obesity
37088|NCT03338634|fMRI|fmri
37089|NCT03338621|tuberculosis|tuberculosis
37090|NCT03338621|drug-resistant tuberculosis|drug-resistant tuberculosis
37091|NCT03338621|TB|tb
37092|NCT03338621|DR-TB|dr-tb
37093|NCT03338621|pretomanid|pretomanid
37094|NCT03338621|PA-824|pa-824
37095|NCT03338621|bedaquiline|bedaquiline
37096|NCT03338621|TMC207|tmc207
37097|NCT03338621|moxifloxacin|moxifloxacin
37098|NCT03338621|pyrazinamide|pyrazinamide
37099|NCT03338621|HRZE|hrze
37100|NCT03338621|TB Alliance|tb alliance
37101|NCT03338621|NC-008|nc-008
37102|NCT03338608|Cosmesis|cosmesis
37103|NCT03338608|Wound Healing|wound healing
37104|NCT03338608|Anterior Cervical Decompression and Fusion|anterior cervical decompression and fusion
37105|NCT03338608|ACDF|acdf
37106|NCT03338608|Platysma|platysma
37107|NCT03338595|arterial stiffness|arterial stiffness
37108|NCT03338595|flow-mediated dilation|flow-mediated dilation
37109|NCT03338595|endothelial function|endothelial function
37110|NCT03338595|Orkambi|orkambi
37111|NCT03338595|exercise capacity|exercise capacity
37112|NCT03338582|Pacemaker|pacemaker
37113|NCT03338582|Conduction disturbance|conduction disturbance
37114|NCT03338582|TAVI|tavi
37115|NCT03338543|percutaneous electrical nerve stimulation|percutaneous electrical nerve stimulation
37116|NCT03338543|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
37117|NCT03338543|pain|pain
37118|NCT03338543|liver cancer|liver cancer
37119|NCT03338543|hepatocellular carcinoma|hepatocellular carcinoma
37120|NCT03338530|Psychosocial treatment|psychosocial treatment
37121|NCT03338530|School intervention|school intervention
37122|NCT03338530|Autism Spectrum Disorder|autism spectrum disorder
37123|NCT03338504|type 2 myocardial infarction|type 2 myocardial infarction
37124|NCT03338465|Greater Trochanteric Pain Syndrome,|greater trochanteric pain syndrome,
37125|NCT03338465|Gluteal|gluteal
37126|NCT03338465|Tendinopathy|tendinopathy
37127|NCT03338465|ESWT|eswt
37128|NCT03338465|shockwave|shockwave
37129|NCT03338452|ketogenic diet|ketogenic diet
37130|NCT03338452|body composition|body composition
37131|NCT03338452|metabolism|metabolism
37132|NCT03338452|body dissatisfaction|body dissatisfaction
37133|NCT03338452|cognition|cognition
37134|NCT03338413|Rehabilitation|rehabilitation
37135|NCT03338400|Quality of Recovery, Dexamethasone, Same day surgery|quality of recovery, dexamethasone, same day surgery
37136|NCT03338387|neuropeptides|neuropeptides
37137|NCT03338387|microdialysis|microdialysis
37138|NCT03338374|Cardiac chronotropy|cardiac chronotropy
37139|NCT03338374|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
37140|NCT03338374|Rate responsive pacemaker|rate responsive pacemaker
37141|NCT03338374|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
37142|NCT03338361|approach avoidance training|approach avoidance training
37143|NCT03338361|attentional bias training|attentional bias training
37144|NCT03338361|alcohol depencence|alcohol depencence
37145|NCT03338361|relapse|relapse
37146|NCT03338348|Vosaroxin|vosaroxin
37147|NCT03338322|postoperative pain|postoperative pain
37148|NCT03338322|reciproc|reciproc
37149|NCT03338322|twisted file adaptive|twisted file adaptive
37150|NCT03338309|Fractional flow reserve|fractional flow reserve
37151|NCT03338309|Instantaneous wave-free ratio|instantaneous wave-free ratio
37152|NCT03338309|Ischemic heart disease|ischemic heart disease
37153|NCT03338296|body mass index|body mass index
37154|NCT03338296|weight loss|weight loss
37155|NCT03338296|adolescents|adolescents
37156|NCT03338296|lifestyle modification|lifestyle modification
37157|NCT03338270|MRI|mri
37158|NCT03338270|Neuroradiology|neuroradiology
37159|NCT03338270|minute-MRI|minute-mri
37160|NCT03338270|multi EPI-mix|multi epi-mix
37161|NCT03338270|Clinical Validation|clinical validation
37162|NCT03338257|Pre-school children|pre-school children
37163|NCT03338257|fruit and vegetable acceptance|fruit and vegetable acceptance
37164|NCT03338257|service-learning|service-learning
37165|NCT03338257|pre-school nutrition education|pre-school nutrition education
37166|NCT03338257|childhood obesity|childhood obesity
37167|NCT03338244|Childhood mortality|childhood mortality
37168|NCT03338244|Mass treatment|mass treatment
37169|NCT03338244|Azithromycin|azithromycin
37170|NCT03338244|Infection|infection
37171|NCT03338231|Immunity duration|immunity duration
37172|NCT03338218|Hydroxyethylstarch (HES)|hydroxyethylstarch (hes)
37173|NCT03338205|ketamine|ketamine
37174|NCT03338205|pediatric status asthmaticus|pediatric status asthmaticus
37176|NCT03338192|Chronic pain|chronic pain
37177|NCT03338192|Health disparities in chronic low back pain|health disparities in chronic low back pain
37178|NCT03338179|Metamemory|metamemory
37179|NCT03338179|Schizophrenia|schizophrenia
37180|NCT03338114|ALS|als
37181|NCT03338114|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
37182|NCT03338114|Fasciculation|fasciculation
37183|NCT03338114|FLX-787|flx-787
37184|NCT03338062|Radiation Treatment|radiation treatment
37185|NCT03338036|Concussion|concussion
37186|NCT03338036|Post-Concussion Syndrome|post-concussion syndrome
37187|NCT03338036|Biofeedback|biofeedback
37188|NCT03338036|Heart Rate Variability|heart rate variability
37189|NCT03338036|Neurofeedback|neurofeedback
37190|NCT03338023|Insulin Glargine|insulin glargine
37191|NCT03338010|Insulin glargine|insulin glargine
37192|NCT03337997|Irreversible Electroporation|irreversible electroporation
37193|NCT03337997|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
37194|NCT03337984|Diverticulitis|diverticulitis
37195|NCT03337984|Damage Control Surgery|damage control surgery
37196|NCT03337971|Post-menopausal|post-menopausal
37197|NCT03337971|Osteoporosis|osteoporosis
37198|NCT03337971|Bone Turnover Markers|bone turnover markers
37199|NCT03337971|Dairy Products|dairy products
37200|NCT03337958|Education|education
37201|NCT03337958|Dry Powder Inhalers|dry powder inhalers
37202|NCT03337958|Metered Dose Inhalers|metered dose inhalers
37203|NCT03337958|Pulmonary Disease|pulmonary disease
37204|NCT03337958|Chronic Obstructive|chronic obstructive
37205|NCT03337945|CYP450 phenotyping in patients with liver cirrhosis|cyp450 phenotyping in patients with liver cirrhosis
37206|NCT03337906|HIV|hiv
37207|NCT03337867|Recurrent stroke|recurrent stroke
37208|NCT03337867|Stroke|stroke
37209|NCT03337867|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
37210|NCT03337867|Theta-Burst-Stimulation|theta-burst-stimulation
37211|NCT03337854|prognostic|prognostic
37212|NCT03337854|phenotype|phenotype
37213|NCT03337854|Computed tomography|computed tomography
37214|NCT03337854|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
37215|NCT03337841|Hepatocellular carcinoma|hepatocellular carcinoma
37216|NCT03337841|Neo adjuvant chemotherapy|neo adjuvant chemotherapy
37217|NCT03337841|Adjuvant chemotherapy|adjuvant chemotherapy
37218|NCT03337841|Immune checkpoint inhibitor|immune checkpoint inhibitor
37219|NCT03337841|Pembrolizumab|pembrolizumab
37220|NCT03337828|Alcohol-free beer|alcohol-free beer
37221|NCT03337828|Carbohydrates|carbohydrates
37222|NCT03337828|Overweight|overweight
37223|NCT03337828|Obesity|obesity
37224|NCT03337828|Diabetes mellitus type 2|diabetes mellitus type 2
37226|NCT03337828|Glucose metabolism|glucose metabolism
37227|NCT03337776|WhatsApp messenger|whatsapp messenger
37228|NCT03337776|crc screening|crc screening
37229|NCT03337776|screening update rate|screening update rate
37230|NCT03337763|LV-LV conduction delay|lv-lv conduction delay
37231|NCT03337750|Combat|combat
37232|NCT03337750|Psychological Treatment|psychological treatment
37233|NCT03337750|Military|military
37234|NCT03337750|Psychotherapy|psychotherapy
37235|NCT03337750|Trauma|trauma
37236|NCT03337750|Posttraumatic Stress|posttraumatic stress
37237|NCT03337750|Posttraumatic Stress Disorder|posttraumatic stress disorder
37238|NCT03337711|NSCLC;ctDNA;IIA-IIIA|nsclc;ctdna;iia-iiia
37239|NCT03337659|Family-integrated care|family-integrated care
37240|NCT03337659|neonatal intensive care unit|neonatal intensive care unit
37241|NCT03337659|premature|premature
37242|NCT03337659|infant development|infant development
37243|NCT03337646|vyvanse|vyvanse
37244|NCT03337646|executive function|executive function
37245|NCT03337646|safety|safety
37246|NCT03337633|cognitive load|cognitive load
37247|NCT03337633|galvanic skin response|galvanic skin response
37248|NCT03337633|meal size|meal size
37249|NCT03337633|kilocalories|kilocalories
37250|NCT03337633|menu design|menu design
37251|NCT03337620|chronic|chronic
37252|NCT03337607|Extracorporeal shock wave therapy|extracorporeal shock wave therapy
37253|NCT03337607|ESWT|eswt
37254|NCT03337607|Radial extracorporeal shock wave therapy|radial extracorporeal shock wave therapy
37255|NCT03337607|rESWT|reswt
37256|NCT03337607|Chronic non-specific low back pain|chronic non-specific low back pain
37257|NCT03337607|Non-steroidal anti-inflammatory drug|non-steroidal anti-inflammatory drug
37258|NCT03337594|Gadolinium|gadolinium
37259|NCT03337594|MultiHance|multihance
37260|NCT03337594|Dotarem|dotarem
37261|NCT03337594|Contrast agents|contrast agents
37262|NCT03337594|Magnetic Resonance Imaging|magnetic resonance imaging
37263|NCT03337594|Gadolinium retention|gadolinium retention
37264|NCT03337594|Pediatric|pediatric
37265|NCT03337594|Bone|bone
37266|NCT03337581|Dexmedetomidine|dexmedetomidine
37267|NCT03337581|pediatrics|pediatrics
37268|NCT03337581|Pharmacodynamics|pharmacodynamics
37269|NCT03337581|Pharmacokinetics|pharmacokinetics
37270|NCT03337568|AML CR|aml cr
37271|NCT03337568|allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
37272|NCT03337568|busulfan|busulfan
37273|NCT03337568|fludarabine|fludarabine
37274|NCT03337568|ATG|atg
37275|NCT03337542|AR101|ar101
37276|NCT03337542|Characterized Peanut Allergen|characterized peanut allergen
37277|NCT03337542|CPNA (Characterized Peanut Allergen)|cpna (characterized peanut allergen)
37278|NCT03337542|OIT (oral immunotherapy)|oit (oral immunotherapy)
37279|NCT03337542|Peanut Allergy|peanut allergy
37280|NCT03337542|Peanut-Allergic Children|peanut-allergic children
37281|NCT03337542|Desensitization|desensitization
37282|NCT03337542|Food Allergy|food allergy
37283|NCT03337464|exercise|exercise
37284|NCT03337464|EEG|eeg
37285|NCT03337464|EMG|emg
37286|NCT03337464|Motor function|motor function
37287|NCT03337464|Mood|mood
37288|NCT03337464|Cognition|cognition
37289|NCT03337425|Psychotherapy, group|psychotherapy, group
37290|NCT03337425|Adults|adults
37291|NCT03337412|Therapeutic Education|therapeutic education
37292|NCT03337412|physical activity|physical activity
37293|NCT03337412|overweight|overweight
37294|NCT03337412|obesity|obesity
37295|NCT03337399|Lung Cancer|lung cancer
37296|NCT03337373|Critical care|critical care
37297|NCT03337373|Neuromuscular Blocking Agents|neuromuscular blocking agents
37298|NCT03337373|Pharmacodynamics|pharmacodynamics
37299|NCT03337373|Pharmacokinetics|pharmacokinetics
37300|NCT03337373|Physiological Effects of Drugs|physiological effects of drugs
37301|NCT03337360|fertility|fertility
37302|NCT03337360|male subfertility|male subfertility
37303|NCT03337360|foodsupplement|foodsupplement
37304|NCT03337360|oxidative stress|oxidative stress
37305|NCT03337347|Prognostic significance|prognostic significance
37306|NCT03337321|pregnancy|pregnancy
37307|NCT03337321|emotions|emotions
37308|NCT03337321|patient experience|patient experience
37309|NCT03337321|maternal care|maternal care
37310|NCT03337308|hyperlipidemia|hyperlipidemia
37311|NCT03337308|heterozygous familial hypercholesterolemia|heterozygous familial hypercholesterolemia
37312|NCT03337308|atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease
37313|NCT03337308|high cholesterol|high cholesterol
37314|NCT03337308|ASCVD|ascvd
37315|NCT03337308|HeFH|hefh
37316|NCT03337308|LDL|ldl
37317|NCT03337295|Meibomian Gland Dysfunction|meibomian gland dysfunction
37318|NCT03337295|Lipid Layer Thickness|lipid layer thickness
37319|NCT03337282|anesthesia|anesthesia
37320|NCT03337282|noncardiac surgery|noncardiac surgery
37321|NCT03337282|major surgery|major surgery
37322|NCT03337282|POCD|pocd
37323|NCT03337243|Stem Cell Injection|stem cell injection
37324|NCT03337243|Cytokine|cytokine
37325|NCT03337243|Wharton's Jelly|wharton's jelly
37326|NCT03337243|Stem Cells|stem cells
37329|NCT03337230|Social Media|social media
37330|NCT03337217|colonoscopy|colonoscopy
37331|NCT03337191|ultrasound guided caudal injection|ultrasound guided caudal injection
37332|NCT03337191|sacral hiatus|sacral hiatus
37333|NCT03337191|sacral canal|sacral canal
37334|NCT03337165|Rheumatoid arthritis|rheumatoid arthritis
37335|NCT03337165|Auto-immune disorders|auto-immune disorders
37336|NCT03337165|Tolerogenic Dendritic Cells|tolerogenic dendritic cells
37337|NCT03337139|Weight Loss|weight loss
37338|NCT03337139|Obesity|obesity
37339|NCT03337139|Overweight|overweight
37340|NCT03337139|Behavioral Weight Loss|behavioral weight loss
37341|NCT03337100|Opioids|opioids
37342|NCT03337100|Naloxone|naloxone
37343|NCT03337100|Co-dispensing|co-dispensing
37344|NCT03337100|Cluster randomized trial|cluster randomized trial
37345|NCT03337100|Opioid antagonist|opioid antagonist
37346|NCT03337035|Probiotics, Oxytocin|probiotics, oxytocin
37347|NCT03337022|Psoriasis|psoriasis
37348|NCT03337022|CC-90006|cc-90006
37349|NCT03337022|Mild to moderate plaque-type psoriasis|mild to moderate plaque-type psoriasis
37350|NCT03337022|Safety|safety
37351|NCT03337022|Pharmacokinetics|pharmacokinetics
37352|NCT03337022|Pharmacodynamics|pharmacodynamics
37353|NCT03337009|Opioid antagonist|opioid antagonist
37354|NCT03337009|Naloxone|naloxone
37355|NCT03337009|Opioids|opioids
37356|NCT03337009|Web-based intervention|web-based intervention
37357|NCT03336996|Motor nerve injury|motor nerve injury
37358|NCT03336996|umbilical cord interstitial stem cell|umbilical cord interstitial stem cell
37359|NCT03336996|bold-DTI|bold-dti
37360|NCT03336996|reconstruction of motor circuits|reconstruction of motor circuits
37361|NCT03336983|prostate cancer|prostate cancer
37362|NCT03336983|bone metastasis|bone metastasis
37363|NCT03336983|enzalutamide|enzalutamide
37364|NCT03336983|zoledronic acid|zoledronic acid
37365|NCT03336970|single visit root canal treatment, chlorhexidine|single visit root canal treatment, chlorhexidine
37366|NCT03336957|chromogranin A, stress, gingivitis, pregnancy|chromogranin a, stress, gingivitis, pregnancy
37367|NCT03336931|children|children
37368|NCT03336931|precision medicine|precision medicine
37369|NCT03336931|personalised medicine|personalised medicine
37370|NCT03336931|high-risk cancer|high-risk cancer
37371|NCT03336931|refractory|refractory
37372|NCT03336931|recurrent|recurrent
37373|NCT03336931|sequencing|sequencing
37374|NCT03336931|patient derived xenograft|patient derived xenograft
37375|NCT03336931|molecular profiling|molecular profiling
37376|NCT03336931|paediatric|paediatric
37377|NCT03336918|Bipolar Disorder|bipolar disorder
37378|NCT03336918|Bipolar I and II Depression|bipolar i and ii depression
37379|NCT03336918|Lithium|lithium
37380|NCT03336918|Depression|depression
37381|NCT03336905|Adolescent and young adult|adolescent and young adult
37382|NCT03336892|Care Coordination|care coordination
37383|NCT03336879|Gambling Disorder|gambling disorder
37384|NCT03336879|Mental Disorder|mental disorder
37385|NCT03336879|Behavioral Addiction|behavioral addiction
37386|NCT03336827|Emotion Regulation|emotion regulation
37387|NCT03336827|Post-Treatment Breast Cancer Care|post-treatment breast cancer care
37388|NCT03336827|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
37389|NCT03336827|CBT|cbt
37390|NCT03336827|Hypnosis|hypnosis
37391|NCT03336814|Terlipressin|terlipressin
37392|NCT03336814|norepinephrine|norepinephrine
37393|NCT03336801|sevoflurane|sevoflurane
37394|NCT03336801|propofol|propofol
37395|NCT03336775|acupuncure|acupuncure
37396|NCT03336775|dysphagia|dysphagia
37397|NCT03336775|radiation|radiation
37398|NCT03336749|Stroke, upper limb, sensory training, rehabilitation|stroke, upper limb, sensory training, rehabilitation
37399|NCT03336736|Physical Activity|physical activity
37400|NCT03336736|Diet|diet
37401|NCT03336736|Exercise|exercise
37402|NCT03336736|Sarcoidosis|sarcoidosis
37403|NCT03336736|Pulmonary sarcoidosis|pulmonary sarcoidosis
37404|NCT03336736|Lung Function|lung function
37405|NCT03336736|Fitness|fitness
37406|NCT03336736|Strength|strength
37407|NCT03336736|Endurance|endurance
37408|NCT03336710|Self-control|self-control
37409|NCT03336710|Ecological Momentary Assessment|ecological momentary assessment
37410|NCT03336710|Attentional bias|attentional bias
37411|NCT03336710|Respiratory Sinus Arrhythmia|respiratory sinus arrhythmia
37412|NCT03336710|Affect|affect
37413|NCT03336710|Emotion Regulation|emotion regulation
37414|NCT03336710|Well-being|well-being
37415|NCT03336710|Decentering|decentering
37416|NCT03336710|Affective disorders|affective disorders
37417|NCT03336684|Patient education|patient education
37418|NCT03336684|Rheumatoid arthritis|rheumatoid arthritis
37419|NCT03336684|Knowledge|knowledge
37420|NCT03336684|Attitudes|attitudes
37421|NCT03336684|Practice|practice
37422|NCT03336671|Pediatric|pediatric
37423|NCT03336671|Chronic Sinusitis|chronic sinusitis
37424|NCT03336645|Seizure|seizure
37425|NCT03336645|Midazolam hydrochloride|midazolam hydrochloride
37426|NCT03336645|Convulsive|convulsive
37427|NCT03336632|PBSCT|pbsct
37428|NCT03336632|myeloablative conditioning|myeloablative conditioning
37429|NCT03336632|HDACi|hdaci
37430|NCT03336632|chidamide|chidamide
37431|NCT03336619|Influenza|influenza
37432|NCT03336606|immunotherapy|immunotherapy
37433|NCT03336606|OX40|ox40
37434|NCT03336606|antibodies|antibodies
37435|NCT03336606|HNSCC|hnscc
37436|NCT03336606|melanoma|melanoma
37437|NCT03336606|phase 1|phase 1
37438|NCT03336606|squamous cell|squamous cell
37439|NCT03336567|telephonic interview|telephonic interview
37440|NCT03336567|TCR Therapy|tcr therapy
37441|NCT03336567|cross-sectional|cross-sectional
37442|NCT03336567|CGT|cgt
37443|NCT03336567|qualitative|qualitative
37444|NCT03336554|osteosarcoma|osteosarcoma
37445|NCT03336554|epigenetic biomarker|epigenetic biomarker
37446|NCT03336554|hMe-Seal technique|hme-seal technique
37447|NCT03336541|Prenatal depression|prenatal depression
37448|NCT03336541|Ketamine|ketamine
37449|NCT03336541|Cesarean delivery|cesarean delivery
37450|NCT03336541|Postpartum depression|postpartum depression
37451|NCT03336528|Long-acting insulin analog|long-acting insulin analog
37452|NCT03336515|Positional Obstructive Sleep Apnea|positional obstructive sleep apnea
37453|NCT03336515|Postural Device|postural device
37454|NCT03336515|Treatment|treatment
37455|NCT03336476|Direct laryngoscopy|direct laryngoscopy
37456|NCT03336476|Videolaryngoscopy|videolaryngoscopy
37457|NCT03336476|Diabetes Mellitus|diabetes mellitus
37458|NCT03336476|Intubation|intubation
37459|NCT03336476|Anesthesia|anesthesia
37460|NCT03336463|Thrombophilia screening|thrombophilia screening
37461|NCT03336463|Genetic risk score|genetic risk score
37462|NCT03336437|Menopause|menopause
37463|NCT03336437|Vaginal dryness|vaginal dryness
37464|NCT03336437|Vaginal atrophy|vaginal atrophy
37465|NCT03336437|Postmenopause|postmenopause
37466|NCT03336437|Estrogen|estrogen
37467|NCT03336437|Urinary microbiome|urinary microbiome
37468|NCT03336437|Estradiol vaginal ring|estradiol vaginal ring
37469|NCT03336437|Genitourinary Syndrome of Menopause|genitourinary syndrome of menopause
37470|NCT03336437|Vaginal microbiome|vaginal microbiome
37471|NCT03336424|MS|ms
37472|NCT03336424|Multiple sclerosis|multiple sclerosis
37473|NCT03336424|urinary Bladder, Neurogenic|urinary bladder, neurogenic
37474|NCT03336424|Urodynamics|urodynamics
37475|NCT03336424|Randomized controlled trial|randomized controlled trial
37476|NCT03336385|Older adults|older adults
37477|NCT03336385|Prebiotics|prebiotics
37478|NCT03336385|Intestinal permeability|intestinal permeability
37479|NCT03336385|NSAIDS|nsaids
37480|NCT03336359|colonoscopy|colonoscopy
37481|NCT03336359|image enhanced endoscopy|image enhanced endoscopy
37482|NCT03336346|DTG|dtg
37483|NCT03336346|Dolutegravir|dolutegravir
37484|NCT03336346|Efavirenz|efavirenz
37485|NCT03336346|Etonogestrel|etonogestrel
37486|NCT03336333|BGB-3111|bgb-3111
37487|NCT03336333|BTK inhibitor|btk inhibitor
37488|NCT03336333|bendamustine|bendamustine
37489|NCT03336333|rituximab|rituximab
37490|NCT03336333|Phase 3|phase 3
37491|NCT03336307|Parkinson disease|parkinson disease
37492|NCT03336307|movement Disorders|movement disorders
37493|NCT03336307|gait disturbance|gait disturbance
37494|NCT03336307|Parkinson|parkinson
37495|NCT03336307|Parkinson gait|parkinson gait
37496|NCT03336307|3D motion analysis systems|3d motion analysis systems
37497|NCT03336307|motion analysis|motion analysis
37498|NCT03336307|Parkinson rehabilitation|parkinson rehabilitation
37499|NCT03336307|rehabilitation gait improvement|rehabilitation gait improvement
37500|NCT03336307|gait improvement|gait improvement
37501|NCT03336307|SMART Capture|smart capture
37502|NCT03336307|MATLAB software|matlab software
37503|NCT03336294|Sarcopenia|sarcopenia
37504|NCT03336294|Muscle strength|muscle strength
37505|NCT03336294|SRM P31|srm p31
37506|NCT03336294|Phosphocreatine|phosphocreatine
37507|NCT03336229|cancer|cancer
37508|NCT03336229|colorectal|colorectal
37509|NCT03336229|exercise|exercise
37510|NCT03336229|physical fitness|physical fitness
37511|NCT03336203|eGFR, gout, CKD, uric acid, uric acid lowering therapy, hyperuricemia, allopurinol, febuxostat|egfr, gout, ckd, uric acid, uric acid lowering therapy, hyperuricemia, allopurinol, febuxostat
37512|NCT03336190|military|military
37513|NCT03336190|caregiver|caregiver
37514|NCT03336177|gynecology|gynecology
37515|NCT03336177|cancer|cancer
37516|NCT03336177|aged|aged
37517|NCT03336177|delay|delay
37518|NCT03336177|help-seeking behavior|help-seeking behavior
37519|NCT03336177|qualitative research|qualitative research
37520|NCT03336177|semiopragmatic analysis|semiopragmatic analysis
37521|NCT03336177|psychodynamic analysis|psychodynamic analysis
37522|NCT03336112|Non-cardiac chest pain|non-cardiac chest pain
37523|NCT03336112|Psychological distress|psychological distress
37524|NCT03336112|I-CBT|i-cbt
37525|NCT03336047|Exercise|exercise
37526|NCT03336047|Actigraphy|actigraphy
37527|NCT03336047|Prevention and Control|prevention and control
37528|NCT03336047|Cardiorespiratory Fitness|cardiorespiratory fitness
37529|NCT03336034|IBS-C|ibs-c
37530|NCT03336034|Experience sampling method|experience sampling method
37531|NCT03336034|Ecological momentary assessment|ecological momentary assessment
37532|NCT03336034|Abdominal pain|abdominal pain
37533|NCT03336034|Constipation|constipation
37534|NCT03335995|mechanical invasive ventilation|mechanical invasive ventilation
37535|NCT03335995|course of the care|course of the care
37536|NCT03335995|prognosis|prognosis
37537|NCT03335995|stroke|stroke
37538|NCT03335982|transendoscopic enteral tubing|transendoscopic enteral tubing
37539|NCT03335982|mid-gut|mid-gut
37540|NCT03335982|endoscopy|endoscopy
37541|NCT03335982|nasal-jejunal tube|nasal-jejunal tube
37542|NCT03335982|fecal microbiota transplantation|fecal microbiota transplantation
37543|NCT03335982|enteral nutrition|enteral nutrition
37544|NCT03335956|Glucocorticoid receptor; antagonist|glucocorticoid receptor; antagonist
37545|NCT03335943|CDA-2, MDS|cda-2, mds
37546|NCT03335930|exercise|exercise
37547|NCT03335930|blood glucose response|blood glucose response
37548|NCT03335930|metabolic control|metabolic control
37549|NCT03335930|type 2 diabetes.|type 2 diabetes.
37550|NCT03335904|Angiotensin receptor blockade|angiotensin receptor blockade
37551|NCT03335904|control of breathing|control of breathing
37552|NCT03335904|breath-holding|breath-holding
37553|NCT03335891|asthma education program|asthma education program
37554|NCT03335891|balance|balance
37555|NCT03335891|core stabilization exercises|core stabilization exercises
37556|NCT03335839|tPA|tpa
37557|NCT03335826|Elderly|elderly
37558|NCT03335826|Cancer surgery|cancer surgery
37559|NCT03335826|Epidural anesthesia and analgesia|epidural anesthesia and analgesia
37560|NCT03335826|Long-term survival|long-term survival
37561|NCT03335826|Quality of life|quality of life
37562|NCT03335813|brachytherapy|brachytherapy
37563|NCT03335813|multichannel balloon applicator|multichannel balloon applicator
37564|NCT03335787|Athletic Tape|athletic tape
37565|NCT03335787|Proprioception|proprioception
37566|NCT03335787|Hemiplegia|hemiplegia
37567|NCT03335787|Gait|gait
37568|NCT03335761|Urinary|urinary
37569|NCT03335761|Incontinence|incontinence
37570|NCT03335748|ADHD|adhd
37571|NCT03335748|Combined type|combined type
37572|NCT03335748|Cognitive training|cognitive training
37573|NCT03335748|Intervention|intervention
37574|NCT03335748|Youths|youths
37575|NCT03335735|alcohol|alcohol
37576|NCT03335735|driving|driving
37577|NCT03335735|breathalyzers|breathalyzers
37578|NCT03335735|smartphone|smartphone
37579|NCT03335722|stammering|stammering
37580|NCT03335722|speech motor disorder|speech motor disorder
37581|NCT03335722|electrical current stimulation|electrical current stimulation
37582|NCT03335722|metronome-timed speech|metronome-timed speech
37583|NCT03335709|Occupational therapy|occupational therapy
37584|NCT03335696|Epidemiology|epidemiology
37585|NCT03335696|Magnetic resonance imaging|magnetic resonance imaging
37586|NCT03335696|Diffusion tensor imaging|diffusion tensor imaging
37587|NCT03335696|White matter|white matter
37588|NCT03335696|Functional MRI|functional mri
37589|NCT03335696|Connectome|connectome
37590|NCT03335696|Resting state brain networks|resting state brain networks
37591|NCT03335696|Neuropsychology|neuropsychology
37592|NCT03335670|68Ga-pentixafor|68ga-pentixafor
37593|NCT03335670|(68Ga)pentixafor|(68ga)pentixafor
37594|NCT03335670|Gallium Radioisotopes|gallium radioisotopes
37595|NCT03335670|CXCR4|cxcr4
37596|NCT03335644|determinants of dietary patterns and nutritional status|determinants of dietary patterns and nutritional status
37597|NCT03335618|Activity|activity
37598|NCT03335618|Mood|mood
37599|NCT03335605|primary immunodeficiency|primary immunodeficiency
37600|NCT03335527|Aged|aged
37601|NCT03335527|Postoperative period|postoperative period
37602|NCT03335527|Intensive Care Unit|intensive care unit
37603|NCT03335527|Mechanical ventilation|mechanical ventilation
37604|NCT03335527|Sleep quality|sleep quality
37605|NCT03335527|Dexmedetomidine|dexmedetomidine
37606|NCT03335514|GALNT4|galnt4
37607|NCT03335501|Closed-loop control|closed-loop control
37608|NCT03335501|Artificial pancreas|artificial pancreas
37609|NCT03335501|Postprandial glucose control|postprandial glucose control
37610|NCT03335501|Insulin|insulin
37611|NCT03335488|Urea|urea
37612|NCT03335488|Hyperammonemic crisis (HAC)|hyperammonemic crisis (hac)
37613|NCT03335475|congenital heart disease|congenital heart disease
37614|NCT03335475|physical activity|physical activity
37615|NCT03335436|buprenorphine maintenance|buprenorphine maintenance
37616|NCT03335397|education|education
37617|NCT03335397|health science|health science
37618|NCT03335397|app|app
37619|NCT03335397|m-learning|m-learning
37620|NCT03335358|couples|couples
37621|NCT03335358|positive psychology|positive psychology
37622|NCT03335358|behavioral intervention|behavioral intervention
37623|NCT03335358|stroke|stroke
37624|NCT03335358|depression|depression
37625|NCT03335358|wellbeing|wellbeing
37626|NCT03335358|caregiver|caregiver
37627|NCT03335345|Airway Extubation/adverse effects/ Methods|airway extubation/adverse effects/ methods
37628|NCT03335345|Nutrition|nutrition
37629|NCT03335345|Ventilator Weaning/methods|ventilator weaning/methods
37630|NCT03335345|Intensive care Unit|intensive care unit
37631|NCT03335345|Enteral Nutrition|enteral nutrition
37632|NCT03335332|High intensity exercise|high intensity exercise
37633|NCT03335332|Cardiorespiratory fitness|cardiorespiratory fitness
37634|NCT03335332|Stroke volume reserve|stroke volume reserve
37635|NCT03335332|Arrhythmia burden|arrhythmia burden
37636|NCT03335319|Cardiovascular Disease|cardiovascular disease
37637|NCT03335319|Coronary Artery Disease|coronary artery disease
37638|NCT03335319|Cardiopulmonary Exercise Testing|cardiopulmonary exercise testing
37639|NCT03335319|Oxygen Uptake Kinetics|oxygen uptake kinetics
37640|NCT03335319|Skeletal Muscle Oxygenation|skeletal muscle oxygenation
37641|NCT03335319|Exercise Training|exercise training
37642|NCT03335319|Periodized Exercise|periodized exercise
37643|NCT03335306|Body constitution|body constitution
37644|NCT03335306|Chinese Medicine|chinese medicine
37645|NCT03335306|Validation|validation
37646|NCT03335293|pregnancy|pregnancy
37647|NCT03335293|repeat cesarean section|repeat cesarean section
37648|NCT03335293|spinal anesthesia|spinal anesthesia
37649|NCT03335293|bupivacaine|bupivacaine
37650|NCT03335293|epinephrine|epinephrine
37651|NCT03335293|intrathecal|intrathecal
37652|NCT03335293|analgesia|analgesia
37653|NCT03335254|Hypogonadism|hypogonadism
37654|NCT03335254|Testosterone|testosterone
37655|NCT03335254|Testosterone undecanoate|testosterone undecanoate
37656|NCT03335241|Ovarian Cancer|ovarian cancer
37657|NCT03335241|Fludarabine|fludarabine
37658|NCT03335241|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
37659|NCT03335241|Chemotherapy|chemotherapy
37660|NCT03335228|platelet rich plasma, frontal fibrosing alopecia|platelet rich plasma, frontal fibrosing alopecia
37661|NCT03335202|respiratory and intestinal microbiome|respiratory and intestinal microbiome
37662|NCT03335202|antibiotic therapy|antibiotic therapy
37663|NCT03335202|cftr modifier|cftr modifier
37664|NCT03335202|diversity|diversity
37665|NCT03335189|E-Health|e-health
37666|NCT03335189|Smartphone technology|smartphone technology
37667|NCT03335189|Real-time symptom assessment|real-time symptom assessment
37668|NCT03335189|Self-care|self-care
37669|NCT03335189|Symptom management|symptom management
37670|NCT03335150|Parkinson's disease|parkinson's disease
37671|NCT03335150|Rehabilitation|rehabilitation
37672|NCT03335150|Cognition|cognition
37673|NCT03335124|Sepsis|sepsis
37674|NCT03335124|Vitamin C|vitamin c
37675|NCT03335124|Hydrocortisone|hydrocortisone
37676|NCT03335124|Thiamine|thiamine
37677|NCT03335124|Critical Illness|critical illness
37678|NCT03335124|Fluid Responsiveness|fluid responsiveness
37679|NCT03335124|Hemodynamics|hemodynamics
37680|NCT03335111|Remote Ischemic Postconditioning|remote ischemic postconditioning
37681|NCT03335111|Peripheral Immunity|peripheral immunity
37682|NCT03335098|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
37683|NCT03335098|Lymphoplasmacytic lymphoma|lymphoplasmacytic lymphoma
37684|NCT03335098|Bortezomib|bortezomib
37685|NCT03335098|Thalidomide|thalidomide
37686|NCT03335072|Azithromycin|azithromycin
37687|NCT03335072|Mass Drug Administration|mass drug administration
37688|NCT03335072|Antibiotic Resistance|antibiotic resistance
37689|NCT03335059|BCG|bcg
37690|NCT03335059|Bacillus Calmette-Guérin|bacillus calmette-guérin
37691|NCT03335059|CIS|cis
37692|NCT03335059|BCG-unresponsive|bcg-unresponsive
37693|NCT03335059|Synergo|synergo
37694|NCT03335059|chemohyperthermia|chemohyperthermia
37695|NCT03335059|thermochemotherapy|thermochemotherapy
37696|NCT03335059|RF|rf
37697|NCT03335059|radio frequency|radio frequency
37698|NCT03335059|RITE|rite
37699|NCT03335046|Home Visit|home visit
37700|NCT03335046|School Absenteeism|school absenteeism
37701|NCT03335033|Carotid Plaque|carotid plaque
37702|NCT03335033|Contrast Enhanced Ultrasound|contrast enhanced ultrasound
37703|NCT03335033|Shear Wave Elastography|shear wave elastography
37704|NCT03335033|Endarterectomy|endarterectomy
37705|NCT03335033|Stenosis|stenosis
37706|NCT03335020|Ultrasound|ultrasound
37707|NCT03335020|3D ultrasonography|3d ultrasonography
37708|NCT03335020|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
37709|NCT03335020|Shear wave elastography|shear wave elastography
37710|NCT03335007|Aceclofenac|aceclofenac
37711|NCT03335007|pain|pain
37712|NCT03335007|irreversible pulpitis|irreversible pulpitis
37713|NCT03334994|Immediate dental implant, Connective tissue graft, Esthetic zone.|immediate dental implant, connective tissue graft, esthetic zone.
37714|NCT03334981|meconium concentration|meconium concentration
37715|NCT03334981|buprenorphine|buprenorphine
37716|NCT03334981|methadone|methadone
37717|NCT03334981|pregnant|pregnant
37718|NCT03334981|liquid chromatography-tandem mass spectrometry|liquid chromatography-tandem mass spectrometry
37719|NCT03334981|opioid-dependant woman|opioid-dependant woman
37720|NCT03334968|Stroke|stroke
37721|NCT03334968|prolidase|prolidase
37722|NCT03334968|prognosis|prognosis
37723|NCT03334968|biomarker|biomarker
37724|NCT03334955|Polycystic Ovary Syndrome|polycystic ovary syndrome
37725|NCT03334955|Laparoscopic ovarian drilling|laparoscopic ovarian drilling
37726|NCT03334955|subendometrial blood flow|subendometrial blood flow
37727|NCT03334942|youth|youth
37728|NCT03334942|parents|parents
38325|NCT03331380|Low SAR CMR|low sar cmr
37729|NCT03334942|posttraumatic stress|posttraumatic stress
37730|NCT03334942|violence|violence
37731|NCT03334942|violent injuries|violent injuries
37732|NCT03334929|virtual reality|virtual reality
37733|NCT03334929|trigger point injections|trigger point injections
37734|NCT03334903|Total Knee Arthroplasty|total knee arthroplasty
37735|NCT03334903|Neurontin|neurontin
37736|NCT03334903|Gabapentin|gabapentin
37737|NCT03334903|Opioid Tapering|opioid tapering
37738|NCT03334890|colorectal cancer|colorectal cancer
37739|NCT03334890|septin 9|septin 9
37740|NCT03334890|SEPT9|sept9
37741|NCT03334890|methylation|methylation
37742|NCT03334890|CEA|cea
37743|NCT03334864|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
37744|NCT03334838|Food effect|food effect
37745|NCT03334838|Dose proportionality|dose proportionality
37746|NCT03334825|HIV|hiv
37747|NCT03334825|housing|housing
37748|NCT03334825|homelessness|homelessness
37749|NCT03334812|cartilage lesion, ACI|cartilage lesion, aci
37750|NCT03334799|sacroiliac belt|sacroiliac belt
37751|NCT03334799|kinematics|kinematics
37752|NCT03334799|stability|stability
37753|NCT03334799|pelvic girdle pain|pelvic girdle pain
37754|NCT03334799|sacroiliac instability|sacroiliac instability
37755|NCT03334786|ALS|als
37756|NCT03334786|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
37757|NCT03334786|Fasciculation|fasciculation
37758|NCT03334786|FLX-787|flx-787
37759|NCT03334773|Type 2 diabetes, nutrition education programme, intervention, South Africa|type 2 diabetes, nutrition education programme, intervention, south africa
37760|NCT03334760|Cohort study|cohort study
37761|NCT03334760|Infant feeding|infant feeding
37762|NCT03334760|Overweight|overweight
37763|NCT03334760|Child BMI|child bmi
37764|NCT03334760|Breastfeeding|breastfeeding
37765|NCT03334760|Intake of protein|intake of protein
37766|NCT03334747|uncomplicated Plasmodium falciparum Malaria.|uncomplicated plasmodium falciparum malaria.
37767|NCT03334734|Tuberculosis|tuberculosis
37768|NCT03334734|PBTZ169|pbtz169
37769|NCT03334734|antimycobacterial|antimycobacterial
37770|NCT03334708|17-257|17-257
37771|NCT03334669|Childhood obesity|childhood obesity
37772|NCT03334669|Preschool|preschool
37773|NCT03334669|Head Start|head start
37774|NCT03334669|Family Interventions|family interventions
37775|NCT03334669|Community Based Participatory Research (CBPR)|community based participatory research (cbpr)
37776|NCT03334669|Empowerment Theory|empowerment theory
37777|NCT03334669|Family Ecological Theory|family ecological theory
37778|NCT03334669|Step Wedge Design|step wedge design
37779|NCT03334669|Low Income|low income
37780|NCT03334656|Split thickness skin graft donor site|split thickness skin graft donor site
37781|NCT03334656|wound healing|wound healing
37782|NCT03334656|Fetal skin bioconstruct|fetal skin bioconstruct
37783|NCT03334656|Fibroblasts|fibroblasts
37784|NCT03334656|Keratinocytes|keratinocytes
37785|NCT03334643|Type 2 Diabetes|type 2 diabetes
37786|NCT03334643|Dietary fiber|dietary fiber
37787|NCT03334643|Glycemic response|glycemic response
37788|NCT03334630|ablation|ablation
37789|NCT03334630|electrophysiology|electrophysiology
37790|NCT03334630|atrial fibrillation|atrial fibrillation
37791|NCT03334630|catheter|catheter
37792|NCT03334630|paroxysmal|paroxysmal
37793|NCT03334617|Non-small cell lung cancer|non-small cell lung cancer
37794|NCT03334617|NSCLC|nsclc
37795|NCT03334617|anti-PD-1/PD-L1|anti-pd-1/pd-l1
37796|NCT03334617|umbrella study|umbrella study
37797|NCT03334617|Durvalumab|durvalumab
37798|NCT03334617|MEDI4736|medi4736
37799|NCT03334617|Olaparib|olaparib
37800|NCT03334617|AZD2281|azd2281
37801|NCT03334617|AZD9150|azd9150
37802|NCT03334617|AZD6738|azd6738
37803|NCT03334617|Vistusertib|vistusertib
37804|NCT03334617|AZD2014|azd2014
37805|NCT03334604|antibiotic-associated diarrhea|antibiotic-associated diarrhea
37806|NCT03334604|probiotics|probiotics
37807|NCT03334513|Bevacizumab|bevacizumab
37808|NCT03334513|Biometry|biometry
37809|NCT03334513|Ranibizumab|ranibizumab
37810|NCT03334513|Refractive error|refractive error
37811|NCT03334513|Retinopathy of prematurity|retinopathy of prematurity
37812|NCT03334487|Cancer|cancer
37813|NCT03334487|Small Cell Lung Cancer|small cell lung cancer
37814|NCT03334487|Relapsed Small Cell Lung Cancer|relapsed small cell lung cancer
37815|NCT03334487|Remitting Small Cell Lung Cancer|remitting small cell lung cancer
37816|NCT03334487|Delta-like protein 3 (DLL3)|delta-like protein 3 (dll3)
37817|NCT03334487|DLL3 Expressing Small Cell Lung Cancer|dll3 expressing small cell lung cancer
37818|NCT03334487|Rovalpituzumab Tesirine|rovalpituzumab tesirine
37819|NCT03334461|Oral antiseptics|oral antiseptics
37820|NCT03334461|remineralisation agents|remineralisation agents
37821|NCT03334435|eczema|eczema
37822|NCT03334435|atopic eczema|atopic eczema
37823|NCT03334422|eczema|eczema
37824|NCT03334422|atopic eczema|atopic eczema
37825|NCT03334396|eczema|eczema
37826|NCT03334396|atopic eczema|atopic eczema
37827|NCT03334383|Laparoscopic colorectal surgery|laparoscopic colorectal surgery
37828|NCT03334383|Retractor sponge|retractor sponge
37829|NCT03334383|Trendelenburg position|trendelenburg position
37830|NCT03334383|Postoperative complications|postoperative complications
37831|NCT03334370|Diabetes mellitus|diabetes mellitus
37832|NCT03334357|Physical fitness|physical fitness
37833|NCT03334357|Klotho|klotho
37834|NCT03334357|Training|training
37835|NCT03334357|HIIT|hiit
37836|NCT03334357|WB-EMS|wb-ems
37837|NCT03334292|Wilson Disease|wilson disease
37838|NCT03334266|sugar|sugar
37839|NCT03334266|sweetened|sweetened
37840|NCT03334266|beverages|beverages
37841|NCT03334266|responsive|responsive
37842|NCT03334253|Myopia|myopia
37843|NCT03334253|atropine|atropine
37844|NCT03334240|HPV|hpv
37845|NCT03334240|Digoxin|digoxin
37846|NCT03334240|Furosemide|furosemide
37847|NCT03334240|Vulvar HSIL|vulvar hsil
37848|NCT03334227|High-Flow Nasal Cannula|high-flow nasal cannula
37849|NCT03334227|Severe Sepsis|severe sepsis
37850|NCT03334227|qSOFA|qsofa
37851|NCT03334214|Hepatic Steatosis|hepatic steatosis
37852|NCT03334214|IONIS-DGAT2Rx|ionis-dgat2rx
37853|NCT03334214|Type 2 Diabetes|type 2 diabetes
37854|NCT03334162|Children|children
37855|NCT03334162|Adolescents|adolescents
37856|NCT03334162|Cancer|cancer
37857|NCT03334162|brain Tumor|brain tumor
37858|NCT03334162|exercise|exercise
37859|NCT03334162|Chemotherapy-induced Peripheral Neuropathy|chemotherapy-induced peripheral neuropathy
37860|NCT03334162|CIPN|cipn
37861|NCT03334162|Sensorimotor Training|sensorimotor training
37862|NCT03334123|exercise|exercise
37863|NCT03334123|aerobic exercise|aerobic exercise
37864|NCT03334123|functional training|functional training
37865|NCT03334123|strength training|strength training
37866|NCT03334123|resistance training|resistance training
37867|NCT03334123|kidney failure|kidney failure
37868|NCT03334123|rehabilitation|rehabilitation
37869|NCT03334123|physical activity|physical activity
37870|NCT03334123|hemodialysis|hemodialysis
37871|NCT03334123|dialysis patients|dialysis patients
37872|NCT03334123|chronic renal failure|chronic renal failure
37873|NCT03334123|chronic kidney disease|chronic kidney disease
37874|NCT03334123|end-stage renal disease|end-stage renal disease
37875|NCT03334123|intradialytic exercise|intradialytic exercise
37876|NCT03334097|Pregnancy|pregnancy
37877|NCT03334097|fear|fear
37878|NCT03334097|Parturition|parturition
37879|NCT03334097|Prenatal Education|prenatal education
37880|NCT03334045|Neurobiology|neurobiology
37881|NCT03334045|Occupational Stress|occupational stress
37882|NCT03334045|Dopamine|dopamine
37883|NCT03334032|Body composition|body composition
37884|NCT03334032|Total body protein|total body protein
37885|NCT03334032|nutritional recovery|nutritional recovery
37886|NCT03334032|Exercise status|exercise status
37887|NCT03334032|In-vivo neutron activation analysis|in-vivo neutron activation analysis
37888|NCT03334032|Protein depletion|protein depletion
37889|NCT03334006|Pentaglobin®|pentaglobin®
37890|NCT03334006|Personalised Medicine|personalised medicine
37891|NCT03333993|Pilates exercise|pilates exercise
37892|NCT03333993|Fatigue|fatigue
37893|NCT03333993|Quality of Life|quality of life
37894|NCT03333967|apatinib|apatinib
37895|NCT03333954|atrophic macular degeneration|atrophic macular degeneration
37896|NCT03333954|geographic atrophy|geographic atrophy
37897|NCT03333954|macular degeneration|macular degeneration
37898|NCT03333954|dry macular degeneration|dry macular degeneration
37899|NCT03333954|AMD|amd
37900|NCT03333954|retina implant|retina implant
37901|NCT03333954|retinal prosthesis|retinal prosthesis
37902|NCT03333954|visual prosthesis|visual prosthesis
37903|NCT03333902|quadratus lumborum block|quadratus lumborum block
37904|NCT03333902|transversus abdominis plane block|transversus abdominis plane block
37905|NCT03333902|anesthesia|anesthesia
37906|NCT03333837|Improvisation|improvisation
37907|NCT03333837|Memory loss|memory loss
37908|NCT03333837|Caregivers|caregivers
37909|NCT03333837|Quality of Life|quality of life
37910|NCT03333837|Dance|dance
37911|NCT03333837|Social Group|social group
37912|NCT03333837|MRI|mri
37913|NCT03333837|mild cognitive impairment|mild cognitive impairment
37914|NCT03333837|MCI|mci
37915|NCT03333837|Social engagement|social engagement
37916|NCT03333824|Pharmacokinetics, Cardiac Conduction, Mitotic Checkpoint inhibitor, QTc interval|pharmacokinetics, cardiac conduction, mitotic checkpoint inhibitor, qtc interval
37917|NCT03333798|Intimate Partner Violence|intimate partner violence
37918|NCT03333798|Domestic Violence|domestic violence
37919|NCT03333798|Mental Health|mental health
37920|NCT03333798|Cognitive- Behavioral Therapy|cognitive- behavioral therapy
37921|NCT03333798|Community Lay Workers|community lay workers
37922|NCT03333785|Primary Care|primary care
37923|NCT03333785|Oncology|oncology
37924|NCT03333785|Continuity of care|continuity of care
37925|NCT03333785|Integration of care|integration of care
37926|NCT03333785|Communication|communication
37927|NCT03333759|laser|laser
37928|NCT03333759|Er:YAG laser|er:yag laser
37929|NCT03333759|acne|acne
37930|NCT03333759|acne vulgaris|acne vulgaris
37931|NCT03333759|optical coherence tomography|optical coherence tomography
38326|NCT03331380|Gadolinium|gadolinium
37932|NCT03333720|Phenylketonuria|phenylketonuria
37933|NCT03333720|Inherited Metabolic Disorders|inherited metabolic disorders
37934|NCT03333694|Cutaneous Squamous Cell Carcinoma (cSCC) in situ, mTOR kinase inhibitors, PI3K inhibitor.|cutaneous squamous cell carcinoma (cscc) in situ, mtor kinase inhibitors, pi3k inhibitor.
37935|NCT03333681|Rheumatoid arthritis|rheumatoid arthritis
37936|NCT03333681|Stem Cells|stem cells
37937|NCT03333681|Cellular immunity|cellular immunity
37938|NCT03333668|Lisdexamfetamine|lisdexamfetamine
37939|NCT03333668|Guanfacine|guanfacine
37940|NCT03333668|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
37941|NCT03333668|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
37942|NCT03333655|Metastatic Cancer|metastatic cancer
37943|NCT03333642|diabetes|diabetes
37944|NCT03333642|metabolic surgery|metabolic surgery
37945|NCT03333642|ileal interposition|ileal interposition
37946|NCT03333629|Autistic Disorder|autistic disorder
37947|NCT03333629|Early Detection|early detection
37948|NCT03333629|Early Intervention|early intervention
37949|NCT03333616|Genitourinary Cancer|genitourinary cancer
37950|NCT03333603|Schizophrenia|schizophrenia
37951|NCT03333590|DMD|dmd
37952|NCT03333590|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
37953|NCT03333564|Vitamin D3|vitamin d3
37954|NCT03333564|Vitamin D deficiency|vitamin d deficiency
37955|NCT03333564|estradiol|estradiol
37956|NCT03333564|omega-3 fatty acids|omega-3 fatty acids
37957|NCT03333564|menopausal|menopausal
37958|NCT03333551|AL Cardiac Amyloidosis|al cardiac amyloidosis
37959|NCT03333551|18F-Florbetapir (Amyvid)|18f-florbetapir (amyvid)
37960|NCT03333538|Hemorrhagic Fever, Ebola|hemorrhagic fever, ebola
37961|NCT03333538|Ebola Virus Disease|ebola virus disease
37962|NCT03333538|Ebola Virus Vaccines|ebola virus vaccines
37963|NCT03333538|Hemorrhagic Fevers, Viral|hemorrhagic fevers, viral
37964|NCT03333538|GP protein, Ebola virus|gp protein, ebola virus
37965|NCT03333538|Filoviridae Infections|filoviridae infections
37966|NCT03333538|RNA Virus Infections|rna virus infections
37967|NCT03333525|Fat-protein counting|fat-protein counting
37968|NCT03333525|Type 1 diabetes|type 1 diabetes
37969|NCT03333525|Postprandial glucose level|postprandial glucose level
37970|NCT03333512|Nap|nap
37971|NCT03333512|Recovery Sleep|recovery sleep
37972|NCT03333512|Cognitive Functions|cognitive functions
37973|NCT03333512|Glucose Metabolism|glucose metabolism
37974|NCT03333512|Neurobehavioral Functions|neurobehavioral functions
37975|NCT03333512|Mood|mood
37976|NCT03333512|Subjective Sleepiness|subjective sleepiness
37977|NCT03333460|cocaine|cocaine
37978|NCT03333460|addiction|addiction
37979|NCT03333460|transcranial magnetic stimulation|transcranial magnetic stimulation
37980|NCT03333460|neuromodulation|neuromodulation
37981|NCT03333460|neuroimaging|neuroimaging
37982|NCT03333460|brain stimulation|brain stimulation
37983|NCT03333395|Mechanical ventilation|mechanical ventilation
37984|NCT03333395|Acute Exacerbation of chronic obstructive airway disease (AECOPD)|acute exacerbation of chronic obstructive airway disease (aecopd)
37985|NCT03333395|Nebulized heparin|nebulized heparin
37986|NCT03333395|C-Reactive Protein (CRP|c-reactive protein (crp
37987|NCT03333369|resting-state functional MRI|resting-state functional mri
37988|NCT03333369|Dopamine|dopamine
37989|NCT03333369|functional connectivity|functional connectivity
37990|NCT03333343|EGFR-mutant NSCLC|egfr-mutant nsclc
37991|NCT03333343|EGF816|egf816
37992|NCT03333343|LXH254|lxh254
37993|NCT03333343|INC280|inc280
37994|NCT03333343|ribociclib|ribociclib
37995|NCT03333343|trametinib|trametinib
37996|NCT03333343|gefitinib|gefitinib
37997|NCT03333343|EGFR T790M|egfr t790m
37998|NCT03333343|BRAF mutation|braf mutation
37999|NCT03333343|BRAF fusion|braf fusion
38000|NCT03333343|BRAF rearrangement|braf rearrangement
38001|NCT03333343|MET amplification|met amplification
38002|NCT03333330|Carotid atherosclerosis|carotid atherosclerosis
38003|NCT03333330|Carotid plaque|carotid plaque
38004|NCT03333330|Brain magnetic resonance imaging|brain magnetic resonance imaging
38005|NCT03333330|Contrast enhanced ultrasound|contrast enhanced ultrasound
38006|NCT03333330|Carotid CT angiography|carotid ct angiography
38007|NCT03333330|Silent brain ischemia|silent brain ischemia
38008|NCT03333330|Vascular cognitive impairment|vascular cognitive impairment
38009|NCT03333304|Procalcitonin|procalcitonin
38010|NCT03333278|Critical Care|critical care
38011|NCT03333278|Shock, Septic|shock, septic
38012|NCT03333278|Ascorbic Acid|ascorbic acid
38013|NCT03333278|Adult|adult
38014|NCT03333252|Caregiver|caregiver
38015|NCT03333252|Psycho-social intervention|psycho-social intervention
38016|NCT03333252|Cognitive training|cognitive training
38017|NCT03333252|Quality of life|quality of life
38018|NCT03333252|Early on-set Alzheimer's Disease|early on-set alzheimer's disease
38019|NCT03333239|childhood and adolescence|childhood and adolescence
38020|NCT03333226|Breast Neoplasms|breast neoplasms
38021|NCT03333226|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
38022|NCT03333226|Lymph Node Excision|lymph node excision
38023|NCT03333226|Technetium Tc 99m|technetium tc 99m
38024|NCT03333226|Indocyanine Green|indocyanine green
38025|NCT03333226|Lymphatic System|lymphatic system
38026|NCT03333226|Secondary Prevention|secondary prevention
38027|NCT03333200|Pediatric|pediatric
38028|NCT03333200|Rare|rare
38029|NCT03333200|Neurodegenerative|neurodegenerative
38030|NCT03333200|Genetic|genetic
38031|NCT03333200|Neurodevelopment|neurodevelopment
38032|NCT03333200|Brain|brain
38033|NCT03333200|MRI|mri
38034|NCT03333200|Biorepository|biorepository
38035|NCT03333200|NDRD|ndrd
38036|NCT03333200|Longitudinal|longitudinal
38037|NCT03333200|Cognitive|cognitive
38038|NCT03333200|Motor|motor
38039|NCT03333200|Language|language
38040|NCT03333200|Adaptive behavior|adaptive behavior
38041|NCT03333187|Myelofibrosis, Myeloproliferative Disease|myelofibrosis, myeloproliferative disease
38042|NCT03333174|apnea of prematurity|apnea of prematurity
38043|NCT03333174|bradycardia|bradycardia
38044|NCT03333174|hypoxemic episode|hypoxemic episode
38045|NCT03333174|oxygen delivery|oxygen delivery
38046|NCT03333161|apnea of prematurity|apnea of prematurity
38047|NCT03333161|bradycardia|bradycardia
38048|NCT03333161|hypoxemic episode|hypoxemic episode
38049|NCT03333161|permissive hypercapnia|permissive hypercapnia
38050|NCT03333148|Colorectal Surgery|colorectal surgery
38051|NCT03333148|Immunonutrition|immunonutrition
38052|NCT03333148|Complications|complications
38053|NCT03333148|Microbiome|microbiome
38054|NCT03333148|Preoperative nutrition|preoperative nutrition
38055|NCT03333135|Ultramarathons|ultramarathons
38056|NCT03333135|Electromagnetic field therapy|electromagnetic field therapy
38057|NCT03333135|Endurance|endurance
38058|NCT03333135|Exercise|exercise
38059|NCT03333135|Environmental conditions|environmental conditions
38060|NCT03333109|AMG 334, erenumab, migraine, episodic, headache, CGRP|amg 334, erenumab, migraine, episodic, headache, cgrp
38061|NCT03333096|Glaucoma|glaucoma
38062|NCT03333096|Mild Cognitive Impairment|mild cognitive impairment
38063|NCT03333096|Ocusweep|ocusweep
38064|NCT03333096|Reaction Time|reaction time
38065|NCT03333096|Neuropsychology|neuropsychology
38066|NCT03333096|Dementia|dementia
38067|NCT03333096|Alzheimer's Disease|alzheimer's disease
38068|NCT03333096|Brain Diseases|brain diseases
38069|NCT03333083|Lamivudine|lamivudine
38070|NCT03333083|Raltegravir|raltegravir
38071|NCT03333031|cancer|cancer
38072|NCT03333031|imaging agent|imaging agent
38073|NCT03333031|HSP90|hsp90
38074|NCT03333018|COPD|copd
38075|NCT03332979|pre-death grief|pre-death grief
38076|NCT03332979|palliative care|palliative care
38077|NCT03332979|dementia|dementia
38078|NCT03332979|caregiver|caregiver
38079|NCT03332979|preparation for end of life|preparation for end of life
38080|NCT03332966|adolescent|adolescent
38081|NCT03332966|outpatients|outpatients
38082|NCT03332966|questionnaire|questionnaire
38083|NCT03332966|psychotic-like symptoms|psychotic-like symptoms
38084|NCT03332966|psychosis risk|psychosis risk
38085|NCT03332940|Tc99m-tilmanocept|tc99m-tilmanocept
38086|NCT03332940|Tilmanocept|tilmanocept
38087|NCT03332940|NASH|nash
38088|NCT03332940|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
38089|NCT03332914|Osteoarthritis|osteoarthritis
38090|NCT03332914|microcurrent|microcurrent
38091|NCT03332914|knee|knee
38092|NCT03332914|electrotherapy|electrotherapy
38093|NCT03332875|OurRelationship|ourrelationship
38094|NCT03332875|Couple therapy|couple therapy
38095|NCT03332875|Internet|internet
38096|NCT03332875|Marriage Counseling|marriage counseling
38097|NCT03332862|Catheter Ablation|catheter ablation
38098|NCT03332862|Atrial Fibrillation|atrial fibrillation
38099|NCT03332862|Contact Force|contact force
38100|NCT03332862|Continuous Ablation|continuous ablation
38101|NCT03332823|Mental health|mental health
38102|NCT03332823|Mental well-being|mental well-being
38103|NCT03332823|Community-based engagement|community-based engagement
38104|NCT03332823|Positive psychology|positive psychology
38105|NCT03332823|Public health approach|public health approach
38106|NCT03332810|Mental health|mental health
38107|NCT03332810|Mental well-being|mental well-being
38108|NCT03332810|Community-based engagement|community-based engagement
38109|NCT03332810|Positive psychology|positive psychology
38110|NCT03332810|Public health approach|public health approach
38111|NCT03332758|retinal detachment|retinal detachment
38112|NCT03332758|inflammasome|inflammasome
38113|NCT03332758|macular hole|macular hole
38114|NCT03332745|Troponin|troponin
38115|NCT03332732|Healthy Volunteers|healthy volunteers
38116|NCT03332732|Pharmacokinetics|pharmacokinetics
38117|NCT03332654|Urinary Incontinence, Stress|urinary incontinence, stress
38118|NCT03332654|Multiple Sclerosis|multiple sclerosis
38119|NCT03332654|Lower Urinary Tract Symptoms|lower urinary tract symptoms
38120|NCT03332628|Peer Reviewed Research|peer reviewed research
38121|NCT03332615|Palliative Care|palliative care
38122|NCT03332602|Iron deficiency|iron deficiency
38123|NCT03332602|Iron fortification|iron fortification
38124|NCT03332602|Iron encapsulation|iron encapsulation
38125|NCT03332589|Melanoma|melanoma
38126|NCT03332589|CNS metastases|cns metastases
38127|NCT03332589|BRAF mutation|braf mutation
38128|NCT03332589|MEK mutation|mek mutation
38129|NCT03332589|E6201|e6201
38130|NCT03332576|vaccine|vaccine
38131|NCT03332576|immunotherapy|immunotherapy
38132|NCT03332576|combination therapy|combination therapy
38133|NCT03332563|Adolescent|adolescent
38134|NCT03332563|Cognitive Behavioral Therapy|cognitive behavioral therapy
38135|NCT03332563|Chronic Pain|chronic pain
38136|NCT03332563|smartphone application|smartphone application
38137|NCT03332563|internet-delivered|internet-delivered
38138|NCT03332550|laparoscopic lavage|laparoscopic lavage
38139|NCT03332537|Young Adults|young adults
38140|NCT03332537|IBS|ibs
38141|NCT03332537|Self Management|self management
38142|NCT03332537|Pain|pain
38143|NCT03332537|Gut microbiome|gut microbiome
38144|NCT03332537|Genetics|genetics
38145|NCT03332537|Online education|online education
38146|NCT03332524|1st degree burn|1st degree burn
38147|NCT03332498|colon|colon
38148|NCT03332498|rectum|rectum
38149|NCT03332498|advanced|advanced
38150|NCT03332498|refractory|refractory
38151|NCT03332472|type 1 diabetes|type 1 diabetes
38152|NCT03332446|cold water immersion, strength training, training effect|cold water immersion, strength training, training effect
38153|NCT03332433|Hypoxia|hypoxia
38154|NCT03332433|Gastroscope|gastroscope
38155|NCT03332433|High-flow nasal cannula|high-flow nasal cannula
38156|NCT03332420|Huaiqihuang granule|huaiqihuang granule
38157|NCT03332420|primary nephrotic syndrome|primary nephrotic syndrome
38158|NCT03332420|multisite|multisite
38159|NCT03332420|prospective|prospective
38160|NCT03332420|open-label|open-label
38161|NCT03332407|Postoperative delirium|postoperative delirium
38162|NCT03332407|Sleep quality|sleep quality
38163|NCT03332407|Pediatric anesthesia|pediatric anesthesia
38164|NCT03332407|Strabismus surgery|strabismus surgery
38165|NCT03332394|Care Model|care model
38166|NCT03332394|COPD|copd
38167|NCT03332394|Exacerbations|exacerbations
38168|NCT03332394|Health Confidence Score|health confidence score
38169|NCT03332368|Triple-negative breast cancer|triple-negative breast cancer
38170|NCT03332368|Traditional Chinese Medicine|traditional chinese medicine
38171|NCT03332355|glioblastoma multiforme|glioblastoma multiforme
38172|NCT03332355|anaplastic astrocytoma|anaplastic astrocytoma
38173|NCT03332355|high grade glioma|high grade glioma
38174|NCT03332355|temozolomide|temozolomide
38175|NCT03332355|PROCASPASE ACTIVATING COMPOUND-1 (PAC-1)|procaspase activating compound-1 (pac-1)
38176|NCT03332355|advanced malignancy|advanced malignancy
38177|NCT03332355|maximal tolerated dose (MTD)|maximal tolerated dose (mtd)
38178|NCT03332342|dry eye disease|dry eye disease
38179|NCT03332342|tears|tears
38180|NCT03332342|inflammation|inflammation
38181|NCT03332342|ocular surface|ocular surface
38182|NCT03332329|HBsAg|hbsag
38183|NCT03332329|PegIFN|pegifn
38184|NCT03332329|ETV|etv
38185|NCT03332329|Chronic Hepatitis B (CHB)|chronic hepatitis b (chb)
38186|NCT03332329|HBV|hbv
38187|NCT03332329|GMCSF|gmcsf
38188|NCT03332303|Vaginal Dryness|vaginal dryness
38189|NCT03332303|Vaginal and/or Vulvar Irritation/Itching|vaginal and/or vulvar irritation/itching
38190|NCT03332303|Dysuria|dysuria
38191|NCT03332303|Vaginal Pain and Bleeding|vaginal pain and bleeding
38192|NCT03332277|Active Bodysuits|active bodysuits
38193|NCT03332264|PAOD|paod
38194|NCT03332264|drug coated balloon|drug coated balloon
38195|NCT03332264|drug coated stent|drug coated stent
38196|NCT03332264|percutaneous transluminal angioplasty (PTA)|percutaneous transluminal angioplasty (pta)
38197|NCT03332251|Posture Correction Girdle|posture correction girdle
38198|NCT03332225|sepsis|sepsis
38199|NCT03332225|macrophage activation syndrome|macrophage activation syndrome
38200|NCT03332225|immunoparalysis|immunoparalysis
38201|NCT03332225|anakinra|anakinra
38202|NCT03332225|recombinant human interferon-gamma|recombinant human interferon-gamma
38203|NCT03332225|HLA-DR|hla-dr
38204|NCT03332199|symptom cluster|symptom cluster
38205|NCT03332199|oncology|oncology
38206|NCT03332199|psychoeducation|psychoeducation
38207|NCT03332199|symptom management|symptom management
38208|NCT03332199|fatigue|fatigue
38209|NCT03332199|pain|pain
38210|NCT03332199|sleep disturbance|sleep disturbance
38211|NCT03332160|Lymphedema|lymphedema
38212|NCT03332160|Cancer|cancer
38213|NCT03332160|Head Cancer|head cancer
38214|NCT03332160|Neck Cancer|neck cancer
38215|NCT03332160|Head and Neck Cancer|head and neck cancer
38216|NCT03332108|mobile health (mHealth)|mobile health (mhealth)
38217|NCT03332108|electronic health (eHealth)|electronic health (ehealth)
38218|NCT03332108|breastfeeding|breastfeeding
38219|NCT03332108|infant nutrition|infant nutrition
38220|NCT03332108|text messaging intervention|text messaging intervention
38221|NCT03332069|Hyperthermia|hyperthermia
38222|NCT03332069|cervix|cervix
38223|NCT03332069|HIV|hiv
38224|NCT03332056|Ureteral stent pain|ureteral stent pain
38225|NCT03332056|nephrolithiasis|nephrolithiasis
38226|NCT03332056|kidney stone|kidney stone
38227|NCT03332043|HIRREM|hirrem
38228|NCT03332043|Neurotechnology|neurotechnology
38229|NCT03332043|Closed-loop|closed-loop
38327|NCT03331380|Regadenoson|regadenoson
38230|NCT03332043|Acoustic stimulation|acoustic stimulation
38231|NCT03332043|Allostatic|allostatic
38232|NCT03332043|Heart rate variability|heart rate variability
38233|NCT03332043|Baroreflex sensitivity|baroreflex sensitivity
38234|NCT03332043|Blood pressure management|blood pressure management
38235|NCT03332043|Autocalibration|autocalibration
38236|NCT03332043|Neural oscillations|neural oscillations
38237|NCT03332043|Relaxation|relaxation
38238|NCT03332043|Electroencephalic|electroencephalic
38239|NCT03332017|Relapsed/Refractory Follicular non-Hodgkin Lymphoma|relapsed/refractory follicular non-hodgkin lymphoma
38240|NCT03332004|Indocyanine Green|indocyanine green
38241|NCT03332004|Deep Infiltrating Endometriosis|deep infiltrating endometriosis
38242|NCT03332004|Near-Infrared Vision|near-infrared vision
38243|NCT03332004|Occult endometriosis|occult endometriosis
38244|NCT03332004|Invisible endometriosis|invisible endometriosis
38245|NCT03331978|Adherence|adherence
38246|NCT03331978|Antiretroviral treatment|antiretroviral treatment
38247|NCT03331978|Black/ AfricanAmerican|black/ africanamerican
38248|NCT03331965|Interventional Radiology|interventional radiology
38249|NCT03331965|Metoclopramide|metoclopramide
38250|NCT03331965|Gastrojejenostomy|gastrojejenostomy
38251|NCT03331952|Streptococcal Pneumonia|streptococcal pneumonia
38252|NCT03331952|Pneumococcal Conjugate Vaccine|pneumococcal conjugate vaccine
38253|NCT03331887|endodontically treate teeth|endodontically treate teeth
38254|NCT03331887|Emax crowns|emax crowns
38255|NCT03331887|Fiber reinforced composite post|fiber reinforced composite post
38256|NCT03331887|Endocrowns|endocrowns
38257|NCT03331874|confocal|confocal
38258|NCT03331874|basal|basal
38259|NCT03331874|carcinoma|carcinoma
38260|NCT03331848|Levodopa-Induced Dyskinesia (LID)|levodopa-induced dyskinesia (lid)
38261|NCT03331848|Foliglurax|foliglurax
38262|NCT03331848|Parkinson's Disease|parkinson's disease
38263|NCT03331848|mGlu4 PAM|mglu4 pam
38264|NCT03331822|circadian|circadian
38265|NCT03331822|light therapy|light therapy
38266|NCT03331822|ICU nurse|icu nurse
38267|NCT03331809|intubation|intubation
38268|NCT03331809|pharyngitis|pharyngitis
38269|NCT03331796|mild cognitive impairment|mild cognitive impairment
38270|NCT03331796|tms|tms
38271|NCT03331796|rtms|rtms
38272|NCT03331796|transcranial magnetic stimulation|transcranial magnetic stimulation
38273|NCT03331796|noninvasive brain stimulation|noninvasive brain stimulation
38274|NCT03331796|non-pharmacological|non-pharmacological
38275|NCT03331770|Benzalkonium Chloride|benzalkonium chloride
38276|NCT03331770|Latanoprost|latanoprost
38277|NCT03331770|BAK-free|bak-free
38278|NCT03331770|Glaucoma|glaucoma
38279|NCT03331770|Ocular hypertension|ocular hypertension
38280|NCT03331770|conjunctival hyperemia|conjunctival hyperemia
38281|NCT03331770|BUT|but
38282|NCT03331770|OSDI|osdi
38283|NCT03331770|Schirmer I|schirmer i
38284|NCT03331770|Corneal staining|corneal staining
38285|NCT03331770|Tear meniscus height|tear meniscus height
38286|NCT03331744|Infantile hemanioma|infantile hemanioma
38287|NCT03331744|Infantile hepatic hemangioma|infantile hepatic hemangioma
38288|NCT03331744|Ulcerated infantile hemangioma|ulcerated infantile hemangioma
38289|NCT03331744|Clinical characteristics|clinical characteristics
38290|NCT03331744|Demographic characteristics|demographic characteristics
38291|NCT03331718|pancreatoduodenectomy|pancreatoduodenectomy
38292|NCT03331718|pancreaticojejunostomy|pancreaticojejunostomy
38293|NCT03331718|polyethylene glycolic acid|polyethylene glycolic acid
38294|NCT03331718|Neoveil|neoveil
38295|NCT03331718|pancreatic fistula|pancreatic fistula
38296|NCT03331718|pancreas|pancreas
38297|NCT03331666|Hyperlipidemia, Hypercholesterolemia, atherothrombosis|hyperlipidemia, hypercholesterolemia, atherothrombosis
38298|NCT03331653|Cervical Pain|cervical pain
38299|NCT03331653|Motor Control|motor control
38300|NCT03331653|Sternocleidomastoid|sternocleidomastoid
38301|NCT03331653|Dry Needling|dry needling
38302|NCT03331601|Brain metastasis|brain metastasis
38303|NCT03331601|HER2|her2
38304|NCT03331588|Lung cancer|lung cancer
38305|NCT03331588|Pain|pain
38306|NCT03331588|Quality of life|quality of life
38307|NCT03331562|Pembrolizumab|pembrolizumab
38308|NCT03331562|Paricalcitol|paricalcitol
38309|NCT03331562|Pancreatic cancer|pancreatic cancer
38310|NCT03331562|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
38311|NCT03331562|Vitamin D|vitamin d
38312|NCT03331562|Immune Checkpoint Inhibitor|immune checkpoint inhibitor
38313|NCT03331562|VDR agonist|vdr agonist
38314|NCT03331562|PD1 Inhibitor|pd1 inhibitor
38315|NCT03331510|Shoulder, Instability, Latarjet, Dislocation, Strength|shoulder, instability, latarjet, dislocation, strength
38316|NCT03331484|percutaneous coronary intervention|percutaneous coronary intervention
38317|NCT03331484|bleeding|bleeding
38318|NCT03331458|physical activity|physical activity
38319|NCT03331445|inhaled nitric oxide|inhaled nitric oxide
38320|NCT03331445|non tuberculous mycobacteria|non tuberculous mycobacteria
38321|NCT03331445|drug resistant pneumonia|drug resistant pneumonia
38322|NCT03331406|Metastatic gastrointestinal cancer|metastatic gastrointestinal cancer
38323|NCT03331406|Physical Activity|physical activity
38324|NCT03331380|1.5 T CMR|1.5 t cmr
38328|NCT03331380|Adenosine|adenosine
38329|NCT03331367|Cryotherapy|cryotherapy
38330|NCT03331367|Radiation|radiation
38331|NCT03331367|Prostatectomy|prostatectomy
38332|NCT03331367|Immune Response|immune response
38333|NCT03331354|employment|employment
38334|NCT03331354|distance learning|distance learning
38335|NCT03331354|incarceration|incarceration
38336|NCT03331328|MonaLisa|monalisa
38337|NCT03331328|Genitourinary syndrome of menopause (GSM)|genitourinary syndrome of menopause (gsm)
38338|NCT03331250|Epithelioid hemangioendothelioma (EHE)|epithelioid hemangioendothelioma (ehe)
38339|NCT03331250|Angiosarcoma|angiosarcoma
38340|NCT03331211|Leukemia, Lymphoblastic, Acute|leukemia, lymphoblastic, acute
38341|NCT03331198|JCAR017|jcar017
38342|NCT03331198|chimeric antigen receptor|chimeric antigen receptor
38343|NCT03331198|CLL|cll
38344|NCT03331198|SLL|sll
38345|NCT03331198|chronic lymphocytic leukemia|chronic lymphocytic leukemia
38346|NCT03331198|small lymphocytic lymphoma|small lymphocytic lymphoma
38347|NCT03331198|CAR|car
38348|NCT03331198|CAR T cells|car t cells
38349|NCT03331198|autologous T cell therapy|autologous t cell therapy
38350|NCT03331198|immunotherapy|immunotherapy
38351|NCT03331185|Extraction|extraction
38352|NCT03331185|Alveolar Ridge Augmentation|alveolar ridge augmentation
38353|NCT03331185|Freeze Dried Bone Allograft|freeze dried bone allograft
38354|NCT03331185|Leukocytic Platelet Rich Fibrin|leukocytic platelet rich fibrin
38355|NCT03331185|Volumetric Changes|volumetric changes
38356|NCT03331185|Dense Polytetrafluoroethylene Membrane|dense polytetrafluoroethylene membrane
38357|NCT03331172|HIFU|hifu
38358|NCT03331172|thyroid nodule|thyroid nodule
38359|NCT03331172|Benign|benign
38360|NCT03331172|Reapplication|reapplication
38361|NCT03331159|Lumbar Fusion|lumbar fusion
38362|NCT03331159|Hydroxyapatite|hydroxyapatite
38363|NCT03331146|Nitric Oxide|nitric oxide
38364|NCT03331146|Sodium Nitrite|sodium nitrite
38365|NCT03331146|Cardiopulmonary bypass|cardiopulmonary bypass
38366|NCT03331146|cardioplegic cardiac arrest|cardioplegic cardiac arrest
38367|NCT03331146|coronary revacularization|coronary revacularization
38368|NCT03331133|Twin|twin
38369|NCT03331133|Early Development|early development
38370|NCT03331133|Cohort|cohort
38371|NCT03331081|Overactive Bladder Syndrome|overactive bladder syndrome
38372|NCT03331055|percutaneous electrical nerve stimulation|percutaneous electrical nerve stimulation
38373|NCT03331055|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
38374|NCT03331055|pain|pain
38375|NCT03331055|pancreatic cancer|pancreatic cancer
38376|NCT03331042|Insomnia|insomnia
38377|NCT03331042|Transient Insomnia|transient insomnia
38378|NCT03331042|Sleep initiation and maintenance disorder|sleep initiation and maintenance disorder
38379|NCT03331029|3 D Ultrasound, left atrium, Mitral inflow velocity, systolic and diastolic ventricular function|3 d ultrasound, left atrium, mitral inflow velocity, systolic and diastolic ventricular function
38380|NCT03331016|Foster caregiver|foster caregiver
38381|NCT03331016|Kinship caregiver|kinship caregiver
38382|NCT03331016|Foster youth|foster youth
38383|NCT03331016|Unintended pregnancy|unintended pregnancy
38384|NCT03331016|Curriculum|curriculum
38385|NCT03331016|Intervention|intervention
38386|NCT03331016|sexually transmitted infections|sexually transmitted infections
38387|NCT03331016|Behaviorism|behaviorism
38388|NCT03331016|Monitoring|monitoring
38389|NCT03331016|Communication|communication
38390|NCT03331016|Adolescent development|adolescent development
38391|NCT03331016|sexually transmitted diseases|sexually transmitted diseases
38392|NCT03330951|HbA1c|hba1c
38393|NCT03330951|Glycated albumin|glycated albumin
38394|NCT03330938|Hemodialysis|hemodialysis
38395|NCT03330938|Resilience|resilience
38396|NCT03330938|Cognitive Behavioral Therapy|cognitive behavioral therapy
38397|NCT03330873|Asherman syndrome|asherman syndrome
38398|NCT03330873|disposable balloon uterine stent|disposable balloon uterine stent
38399|NCT03330873|hysteroscopy|hysteroscopy
38400|NCT03330873|Foley catheter|foley catheter
38401|NCT03330847|Germline BRCA mutation|germline brca mutation
38402|NCT03330847|Human epidermal growth factor receptor 2|human epidermal growth factor receptor 2
38403|NCT03330847|Olaparib|olaparib
38404|NCT03330847|Homologous Recombinant Repair (HRR)-related Genes|homologous recombinant repair (hrr)-related genes
38405|NCT03330834|CAR-T|car-t
38406|NCT03330834|advanced lung cancer|advanced lung cancer
38407|NCT03330834|single-arm|single-arm
38408|NCT03330834|phase I clinical study|phase i clinical study
38409|NCT03330795|end-stage lung disease|end-stage lung disease
38410|NCT03330795|Bilateral Orthotopic Lung Transplant (BOLT) candidate|bilateral orthotopic lung transplant (bolt) candidate
38411|NCT03330795|CD3/CD19 negative allogeneic hematopoietic stem cells (HSCT)|cd3/cd19 negative allogeneic hematopoietic stem cells (hsct)
38412|NCT03330795|CD3+/CD19+ depleted Bone Marrow Transplant (BMT)|cd3+/cd19+ depleted bone marrow transplant (bmt)
38413|NCT03330795|Cadaveric (Deceased) Donor|cadaveric (deceased) donor
38414|NCT03330795|Unrelated (Deceased) Donor|unrelated (deceased) donor
38415|NCT03330782|pain|pain
38416|NCT03330782|propofol|propofol
38417|NCT03330782|remifentanil|remifentanil
38418|NCT03330769|Psoriatic Arthritis|psoriatic arthritis
38419|NCT03330769|Ultrasonography|ultrasonography
38420|NCT03330769|Minimal disease activity|minimal disease activity
38421|NCT03330756|Roux-en-Y gastric bypass|roux-en-y gastric bypass
38422|NCT03330756|Mini gastric bypass|mini gastric bypass
38423|NCT03330756|Type 2 diabetes mellitus|type 2 diabetes mellitus
38424|NCT03330756|Morbid Obesity|morbid obesity
38425|NCT03330691|CD19|cd19
38426|NCT03330691|CD22|cd22
38427|NCT03330691|CAR T-cell|car t-cell
38428|NCT03330678|Probiotic|probiotic
38429|NCT03330678|Gut microbiome|gut microbiome
38430|NCT03330678|VSL#3|vsl#3
38431|NCT03330652|Quality of life|quality of life
38432|NCT03330652|Cognitive function|cognitive function
38433|NCT03330652|Mental state|mental state
38434|NCT03330652|Functional capacity|functional capacity
38435|NCT03330652|EQ5D|eq5d
38436|NCT03330652|HADS|hads
38437|NCT03330652|Barthel Index|barthel index
38438|NCT03330652|mRS|mrs
38439|NCT03330626|Fluid management|fluid management
38440|NCT03330626|conventional method|conventional method
38441|NCT03330626|InBody S10|inbody s10
38442|NCT03330626|CRRT|crrt
38443|NCT03330574|Glaucoma|glaucoma
38444|NCT03330561|HER2-positive breast cancer|her2-positive breast cancer
38445|NCT03330561|HER2 -positive gastric cancer|her2 -positive gastric cancer
38446|NCT03330561|HER2-positive bladder cancer|her2-positive bladder cancer
38447|NCT03330561|Pieris|pieris
38448|NCT03330561|PRS-343|prs-343
38449|NCT03330561|Anticalin|anticalin
38450|NCT03330561|Bi-specific|bi-specific
38451|NCT03330561|4-1BB|4-1bb
38452|NCT03330561|CD137|cd137
38453|NCT03330561|HER2|her2
38454|NCT03330548|Plant-based diet|plant-based diet
38455|NCT03330548|Hyperlipidemia|hyperlipidemia
38456|NCT03330548|Diabetes|diabetes
38457|NCT03330548|Overweight|overweight
38458|NCT03330548|Veterans|veterans
38459|NCT03330509|Palliative care|palliative care
38460|NCT03330509|Consultation model|consultation model
38461|NCT03330496|infant-newborn|infant-newborn
38462|NCT03330496|infant-premature|infant-premature
38463|NCT03330496|pain|pain
38464|NCT03330496|acute pain|acute pain
38465|NCT03330496|repetitive pain|repetitive pain
38466|NCT03330483|pain|pain
38467|NCT03330483|discomfort|discomfort
38468|NCT03330483|hydrophylic catheter|hydrophylic catheter
38469|NCT03330483|urodynamic study|urodynamic study
38470|NCT03330444|Endometrial microbiota|endometrial microbiota
38471|NCT03330444|Bacterial pathogens|bacterial pathogens
38472|NCT03330444|Assisted reproductive techniques|assisted reproductive techniques
38473|NCT03330444|Dysbiosis|dysbiosis
38474|NCT03330444|Endometrial receptivity|endometrial receptivity
38475|NCT03330444|Endometrial diagnosis|endometrial diagnosis
38476|NCT03330405|NSCLC, TNBC, hormone receptor positive (HR+) breast cancer, recurrent epithelial ovarian cancer, UC, and castration resistant prostate cancer (CRPC).|nsclc, tnbc, hormone receptor positive (hr+) breast cancer, recurrent epithelial ovarian cancer, uc, and castration resistant prostate cancer (crpc).
38477|NCT03330379|Endotracheal tube|endotracheal tube
38478|NCT03330379|ventilator's associated pneumonia|ventilator's associated pneumonia
38479|NCT03330379|intensive care unit|intensive care unit
38480|NCT03330379|orotracheal intubation|orotracheal intubation
38481|NCT03330340|vertebral compression fracture|vertebral compression fracture
38482|NCT03330340|osteoporosis|osteoporosis
38483|NCT03330340|glucocorticoids|glucocorticoids
38484|NCT03330340|vertebroplasty|vertebroplasty
38485|NCT03330262|Postural Instability|postural instability
38486|NCT03330262|Balance Disorder|balance disorder
38487|NCT03330262|Balance Prosthesis|balance prosthesis
38488|NCT03330262|Dizziness|dizziness
38489|NCT03330210|LAAC|laac
38490|NCT03330210|3D printing|3d printing
38491|NCT03330210|Procedure success|procedure success
38492|NCT03330210|Procedure-related complications|procedure-related complications
38493|NCT03330197|DIPG|dipg
38494|NCT03330197|Glioblastoma|glioblastoma
38495|NCT03330197|Anaplastic Astrocytoma|anaplastic astrocytoma
38496|NCT03330197|High Grade Glioma (HGG) Not Otherwise Specified (NOS)|high grade glioma (hgg) not otherwise specified (nos)
38497|NCT03330197|Supratentorial Tumor NOS|supratentorial tumor nos
38498|NCT03330184|Bifidobacterium|bifidobacterium
38499|NCT03330184|People With Abnormal Glucose Level|people with abnormal glucose level
38500|NCT03330171|Immunogenicity|immunogenicity
38501|NCT03330171|Safety|safety
38502|NCT03330171|Vaccine|vaccine
38503|NCT03330145|Complicated Grief|complicated grief
38504|NCT03330145|Risk Factors|risk factors
38505|NCT03330145|Cancer|cancer
38506|NCT03330145|Children|children
38507|NCT03330119|Pregnancy|pregnancy
38508|NCT03330119|cesarean section|cesarean section
38509|NCT03330119|enhanced recovery|enhanced recovery
38510|NCT03330119|narcotic use|narcotic use
38511|NCT03330106|Drug therapy|drug therapy
38512|NCT03330093|Children|children
38513|NCT03330080|Ecological momentary assessment|ecological momentary assessment
38514|NCT03330080|Sleepiness|sleepiness
38515|NCT03330080|Fatigue|fatigue
38516|NCT03330080|Endocrinopathy|endocrinopathy
38517|NCT03330080|Family functioning|family functioning
38518|NCT03330067|laparoscope|laparoscope
38519|NCT03330041|Cutaneous Sutures|cutaneous sutures
38520|NCT03330041|Scar Cosmesis|scar cosmesis
38521|NCT03330041|Linear Wound Closure|linear wound closure
38522|NCT03330041|Wound Cosmesis|wound cosmesis
38523|NCT03330028|Diseases of oesophagus stomach and duodenum|diseases of oesophagus stomach and duodenum
38524|NCT03330028|Gastric cancer|gastric cancer
38525|NCT03330028|Gastroesophageal cancer|gastroesophageal cancer
38526|NCT03330028|Adenocarcinoma of the stomach or gastroesophageal junction|adenocarcinoma of the stomach or gastroesophageal junction
38527|NCT03330028|Hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
38528|NCT03330028|HIPEC|hipec
38529|NCT03330028|Paclitaxel|paclitaxel
38530|NCT03330028|Taxol|taxol
38531|NCT03330028|Dexamethasone|dexamethasone
38532|NCT03330028|Decadron|decadron
38533|NCT03330028|Diphenhydramine|diphenhydramine
38534|NCT03330028|Benadryl|benadryl
38535|NCT03330028|Cisplatin|cisplatin
38536|NCT03330028|Platinol-AQ|platinol-aq
38537|NCT03330028|Platinol|platinol
38538|NCT03330028|CDDP|cddp
38539|NCT03330028|Mitomycin-C|mitomycin-c
38540|NCT03330028|Mitomycin|mitomycin
38541|NCT03330028|Famotidine|famotidine
38542|NCT03330028|Pepcid|pepcid
38543|NCT03330015|postmenopausal bleeding|postmenopausal bleeding
38544|NCT03330015|endometrial cancer|endometrial cancer
38545|NCT03330015|Patient's experience|patient's experience
38546|NCT03330015|Patient's choice|patient's choice
38547|NCT03330002|Arterial Closure Device|arterial closure device
38548|NCT03330002|Large Bore Closure Device|large bore closure device
38549|NCT03329950|CDX-1140|cdx-1140
38550|NCT03329950|Solid Tumors|solid tumors
38551|NCT03329950|Liver Cancer|liver cancer
38552|NCT03329950|GI Cancer|gi cancer
38553|NCT03329950|Kidney Cancer|kidney cancer
38554|NCT03329950|Celldex|celldex
38555|NCT03329898|Asherman syndrome|asherman syndrome
38556|NCT03329898|uterine stent|uterine stent
38557|NCT03329898|hysteroscopy|hysteroscopy
38558|NCT03329872|Neuro-Orthopedics|neuro-orthopedics
38559|NCT03329872|Register|register
38560|NCT03329833|Parkinson's Disease|parkinson's disease
38561|NCT03329833|Parkinson's|parkinson's
38562|NCT03329833|Motivational Interviewing|motivational interviewing
38563|NCT03329833|Exercise|exercise
38564|NCT03329833|Motivation|motivation
38565|NCT03329820|Chronic hepatitis B infection|chronic hepatitis b infection
38566|NCT03329820|Health-related quality of life|health-related quality of life
38567|NCT03329820|Cost-effectiveness|cost-effectiveness
38568|NCT03329820|Treatment|treatment
38569|NCT03329820|Chinese|chinese
38570|NCT03329781|Endotoxaemia, Curcumin.|endotoxaemia, curcumin.
38571|NCT03329755|Advanced melanoma|advanced melanoma
38572|NCT03329755|Immune checkpoint|immune checkpoint
38573|NCT03329755|E-follow-up|e-follow-up
38574|NCT03329716|brace-weaning, cost-effectiveness|brace-weaning, cost-effectiveness
38575|NCT03329703|PNES|pnes
38576|NCT03329703|UPLIFT|uplift
38577|NCT03329703|Depression|depression
38578|NCT03329703|Mindfulness|mindfulness
38579|NCT03329703|CBT|cbt
38580|NCT03329703|Managing Epilepsy Well (MEW) Network|managing epilepsy well (mew) network
38581|NCT03329703|Psychogenic Seizures|psychogenic seizures
38582|NCT03329703|Non-Epileptic Seizures|non-epileptic seizures
38583|NCT03329690|Adenocarcinoma Metastatic|adenocarcinoma metastatic
38584|NCT03329690|Adenocarcinoma of the Stomach|adenocarcinoma of the stomach
38585|NCT03329690|Adenocarcinoma of the Gastroesophageal Junction|adenocarcinoma of the gastroesophageal junction
38586|NCT03329690|HER2 Overexpression|her2 overexpression
38587|NCT03329690|Adenocarcinoma, Locally Advanced|adenocarcinoma, locally advanced
38588|NCT03329625|Triple P|triple p
38589|NCT03329625|RCT|rct
38590|NCT03329625|parent management training|parent management training
38591|NCT03329625|Child welfare|child welfare
38592|NCT03329625|child behavior problems|child behavior problems
38593|NCT03329586|maximum oxygen consumption|maximum oxygen consumption
38594|NCT03329586|organ transplantation|organ transplantation
38595|NCT03329586|physical fitness|physical fitness
38596|NCT03329586|rehabilitation|rehabilitation
38597|NCT03329573|Cross-over|cross-over
38598|NCT03329573|Chinese|chinese
38599|NCT03329573|GSKT|gskt
38600|NCT03329573|Mississauga|mississauga
38601|NCT03329573|Healthy|healthy
38602|NCT03329573|Bioequivalence|bioequivalence
38603|NCT03329573|Paroxetine|paroxetine
38604|NCT03329547|Bioequivalence|bioequivalence
38605|NCT03329547|Pharmacokinetics|pharmacokinetics
38606|NCT03329547|SKF101804|skf101804
38607|NCT03329547|Crossover|crossover
38608|NCT03329547|Cefixime|cefixime
38609|NCT03329521|Cluster Randomized Controlled Trial|cluster randomized controlled trial
38610|NCT03329521|Kidney Transplant|kidney transplant
38611|NCT03329521|Living Kidney Donation|living kidney donation
38612|NCT03329521|Kidney Disease|kidney disease
38613|NCT03329508|Parkinson disease|parkinson disease
38614|NCT03329495|right colon cancer|right colon cancer
38615|NCT03329495|superior mesenteric artery|superior mesenteric artery
38616|NCT03329495|superior mesenteric vein|superior mesenteric vein
38617|NCT03329482|Ultrasound|ultrasound
38618|NCT03329482|kneading-massage|kneading-massage
38619|NCT03329482|low back pain|low back pain
38620|NCT03329482|pain intensity|pain intensity
38621|NCT03329482|disability|disability
38622|NCT03329469|Computed Tomography Fractional Flow Reserve (CT-FFR),|computed tomography fractional flow reserve (ct-ffr),
38623|NCT03329469|Computed Coronary Tomography Angiography (CCTA)|computed coronary tomography angiography (ccta)
38624|NCT03329469|Invasive Fractional Flow Reserve (iFFR)|invasive fractional flow reserve (iffr)
38625|NCT03329469|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
38626|NCT03329469|Emergency Department (ED)|emergency department (ed)
38627|NCT03329469|Emergency Room (ER)|emergency room (er)
38628|NCT03329443|spironolactone|spironolactone
38629|NCT03329404|Thalassemia|thalassemia
38630|NCT03329404|pathogen reduction therapy|pathogen reduction therapy
38631|NCT03329391|Psychosocial model,nursing intervention|psychosocial model,nursing intervention
38632|NCT03329378|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
38633|NCT03329378|locally advanced breast cancer|locally advanced breast cancer
38634|NCT03329378|Her2neu|her2neu
38635|NCT03329365|Flow cytometry|flow cytometry
38636|NCT03329365|Lactate dehydrogenase (LDH) release|lactate dehydrogenase (ldh) release
38637|NCT03329365|Anemia|anemia
38638|NCT03329365|Cytopenia|cytopenia
38639|NCT03329339|diet|diet
38640|NCT03329326|standardized test|standardized test
38641|NCT03329326|prosthesis|prosthesis
38642|NCT03329326|upper limb amputation|upper limb amputation
38643|NCT03329326|rehabilitation outcome|rehabilitation outcome
38644|NCT03329313|Intensive care unit|intensive care unit
38645|NCT03329313|SLEDD-f|sledd-f
38646|NCT03329313|intermittent hemodialysis/diafiltration|intermittent hemodialysis/diafiltration
38647|NCT03329300|Pediatric Obesity|pediatric obesity
38648|NCT03329300|Executive Function|executive function
38649|NCT03329300|Behavioral Intervention|behavioral intervention
38650|NCT03329287|Simplified Cognitive Behavioral Therapy (SCBT)|simplified cognitive behavioral therapy (scbt)
38651|NCT03329287|Generalized Anxiety Disorder|generalized anxiety disorder
38652|NCT03329287|Depression|depression
38653|NCT03329287|Operating manual|operating manual
38654|NCT03329287|Efficacy|efficacy
38655|NCT03329274|registry|registry
38656|NCT03329209|Drug therapy|drug therapy
38657|NCT03329183|Irinotecan|irinotecan
38658|NCT03329183|UGT1A1|ugt1a1
38659|NCT03329183|Advanced Colorectal Cancer|advanced colorectal cancer
38660|NCT03329170|Oral health|oral health
38661|NCT03329170|Dental caries|dental caries
38662|NCT03329170|Heart Defects|heart defects
38663|NCT03329170|Congenital|congenital
38664|NCT03329144|Young mother|young mother
38665|NCT03329144|Depression|depression
38666|NCT03329144|Anxiety|anxiety
38667|NCT03329144|Resilience|resilience
38668|NCT03329144|Emotion regulation|emotion regulation
38669|NCT03329144|Parenting|parenting
38670|NCT03329144|CBT|cbt
38671|NCT03329118|SHR3824,simvastatin, drug-drug interaction|shr3824,simvastatin, drug-drug interaction
38672|NCT03329105|Gingival Health|gingival health
38673|NCT03329105|Biofilm Formation|biofilm formation
38674|NCT03329092|Complicated intra-abdominal infection|complicated intra-abdominal infection
38675|NCT03329092|Hosptial acquired pneumonia|hosptial acquired pneumonia
38676|NCT03329092|Ventilator associated pneumonia|ventilator associated pneumonia
38677|NCT03329092|Gram negative infections|gram negative infections
38678|NCT03329092|Metallo-beta lactamase|metallo-beta lactamase
38679|NCT03329092|Multi drug resistant pathogens|multi drug resistant pathogens
38680|NCT03329079|rural|rural
38682|NCT03329079|community-based participatory research|community-based participatory research
38683|NCT03329079|weight loss|weight loss
38684|NCT03329079|mobile applications|mobile applications
38685|NCT03329079|text messaging|text messaging
38686|NCT03329066|Asthma|asthma
38687|NCT03329066|Sleep|sleep
38688|NCT03329066|Adolescents|adolescents
38689|NCT03329066|Urban|urban
38690|NCT03329066|Intervention|intervention
38691|NCT03329066|High school|high school
38692|NCT03329053|exercise prescription|exercise prescription
38693|NCT03329053|digital exercise prescription tool|digital exercise prescription tool
38694|NCT03329040|Hyperbilirubinemia|hyperbilirubinemia
38695|NCT03329040|Primiparity|primiparity
38696|NCT03329040|multiparity|multiparity
38697|NCT03329001|PARP inhibitor|parp inhibitor
38698|NCT03329001|niraparib|niraparib
38699|NCT03329001|Zejula|zejula
38700|NCT03328988|bladder cancer|bladder cancer
38701|NCT03328988|radical cystectomy|radical cystectomy
38702|NCT03328988|epidural analgesia|epidural analgesia
38703|NCT03328988|quadratus lumborum block|quadratus lumborum block
38704|NCT03328988|postoperative pain|postoperative pain
38705|NCT03328923|post-prandial cognition|post-prandial cognition
38706|NCT03328923|brown seaweed|brown seaweed
38707|NCT03328910|Emergence Delirium|emergence delirium
38708|NCT03328910|pulse oximetry|pulse oximetry
38709|NCT03328910|Children, Preschool|children, preschool
38710|NCT03328897|Chronic spontaneous urticarial|chronic spontaneous urticarial
38711|NCT03328897|ISS7|iss7
38712|NCT03328897|UAS7|uas7
38713|NCT03328897|omalizumab, China|omalizumab, china
38714|NCT03328871|Striae Gravidarum|striae gravidarum
38715|NCT03328871|Fractional Laser|fractional laser
38912|NCT03327519|Asthma|asthma
38716|NCT03328871|Platelet-Rich Plasma (PRP)|platelet-rich plasma (prp)
38717|NCT03328871|Nanofat Graft|nanofat graft
38718|NCT03328871|Combination Therapy|combination therapy
38719|NCT03328858|Ketogenic Diet, brain tumors|ketogenic diet, brain tumors
38720|NCT03328845|Oxidation|oxidation
38721|NCT03328845|Insulin analogues|insulin analogues
38722|NCT03328845|Type 1 diabetes mellitus|type 1 diabetes mellitus
38723|NCT03328832|Thrombin-gelatin matrix|thrombin-gelatin matrix
38724|NCT03328832|Floseal|floseal
38725|NCT03328832|Tranexamic Acid|tranexamic acid
38726|NCT03328832|Total Knee Arthroplasty|total knee arthroplasty
38727|NCT03328819|Acupuncture|acupuncture
38728|NCT03328819|Chronic pain|chronic pain
38729|NCT03328819|Major depressive disorder|major depressive disorder
38730|NCT03328819|Biomarkers|biomarkers
38731|NCT03328819|Gene|gene
38732|NCT03328819|Comorbidity|comorbidity
38733|NCT03328806|low back pain|low back pain
38734|NCT03328806|outcome measures|outcome measures
38735|NCT03328806|cross culture adaptation|cross culture adaptation
38736|NCT03328806|Core Outcome Measure Index|core outcome measure index
38737|NCT03328793|music|music
38738|NCT03328793|gait|gait
38739|NCT03328793|emotions|emotions
38740|NCT03328793|communication|communication
38741|NCT03328780|preoperative|preoperative
38742|NCT03328780|orthopedic surgery|orthopedic surgery
38743|NCT03328754|Pitchfork|pitchfork
38744|NCT03328754|Class II malocclusion|class ii malocclusion
38745|NCT03328754|PowerScope|powerscope
38746|NCT03328741|Clinical Trials, Randomized|clinical trials, randomized
38747|NCT03328741|Telemedicine|telemedicine
38748|NCT03328702|Dysphagia|dysphagia
38749|NCT03328702|Oropharyngeal dysphagia|oropharyngeal dysphagia
38750|NCT03328702|Total Laryngectomy|total laryngectomy
38751|NCT03328702|Video Fluoroscopic Swallowing Exam (VFSE)|video fluoroscopic swallowing exam (vfse)
38752|NCT03328689|prevention|prevention
38753|NCT03328689|exercise|exercise
38754|NCT03328689|randomized controlled trial|randomized controlled trial
38755|NCT03328689|physical activity|physical activity
38756|NCT03328663|Cancer Care|cancer care
38757|NCT03328637|Smartphone Addiction|smartphone addiction
38758|NCT03328637|CBT|cbt
38759|NCT03328637|Evidence based intervention|evidence based intervention
38760|NCT03328585|CBT-I|cbt-i
38761|NCT03328585|Telemedicine|telemedicine
38762|NCT03328494|Paclitaxel|paclitaxel
38763|NCT03328494|BOS172722|bos172722
38764|NCT03328494|triple-negative breast cancer|triple-negative breast cancer
38765|NCT03328468|Stroke|stroke
38766|NCT03328429|bartholin|bartholin
38767|NCT03328429|marsupialisation|marsupialisation
38768|NCT03328429|cystectomy|cystectomy
38769|NCT03328416|Image-Guided Biopsy|image-guided biopsy
38770|NCT03328416|Multidetector Computed Tomography|multidetector computed tomography
38771|NCT03328416|Diagnostic Imaging|diagnostic imaging
38772|NCT03328416|Cryosurgery|cryosurgery
38773|NCT03328416|Ablation Techniques|ablation techniques
38774|NCT03328403|Endovascular therapy|endovascular therapy
38775|NCT03328403|Mechanical thrombectomy|mechanical thrombectomy
38776|NCT03328403|Acute ischaemic stroke treatment|acute ischaemic stroke treatment
38777|NCT03328364|enzalutamide|enzalutamide
38778|NCT03328364|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
38779|NCT03328364|Xtandi|xtandi
38780|NCT03328364|registry based study|registry based study
38781|NCT03328364|MDV3100|mdv3100
38782|NCT03328364|mCRPC|mcrpc
38783|NCT03328351|Manual therapy|manual therapy
38784|NCT03328351|cervical radiculopathy|cervical radiculopathy
38785|NCT03328351|pressure pain threshold|pressure pain threshold
38786|NCT03328351|physiotherapy|physiotherapy
38787|NCT03328338|Mitochondria|mitochondria
38788|NCT03328338|Oxidative phosphorylation (mitochondrial respiration)|oxidative phosphorylation (mitochondrial respiration)
38789|NCT03328338|Subcutaneous abdominal adipose tissue|subcutaneous abdominal adipose tissue
38790|NCT03328338|Heart.|heart.
38791|NCT03328325|Influenza|influenza
38792|NCT03328325|PCR|pcr
38793|NCT03328325|Seasonal Vaccination|seasonal vaccination
38794|NCT03328221|Heart rate variability|heart rate variability
38795|NCT03328221|Observational study|observational study
38796|NCT03328221|Physical activity|physical activity
38797|NCT03328221|Rehabilitation|rehabilitation
38798|NCT03328208|Nonpharmacologic analgesia|nonpharmacologic analgesia
38799|NCT03328208|Medical app|medical app
38800|NCT03328208|Relaxation|relaxation
38801|NCT03328143|Craniotomy, anxiety, malignant, cancer, brain tumor|craniotomy, anxiety, malignant, cancer, brain tumor
38802|NCT03328130|Adeno-associated virus|adeno-associated virus
38803|NCT03328130|AAV|aav
38804|NCT03328130|Retinitis Pigmentosa|retinitis pigmentosa
38805|NCT03328130|PDE6B|pde6b
38806|NCT03328130|Gene Therapy|gene therapy
38807|NCT03328130|Gene Transfer|gene transfer
38808|NCT03328130|Retinal Dystrophy|retinal dystrophy
38809|NCT03328130|Eye Diseases|eye diseases
38810|NCT03328130|Vision Disorders|vision disorders
38811|NCT03328130|Eye Diseases, Hereditary|eye diseases, hereditary
38812|NCT03328130|Retinal Diseases|retinal diseases
38813|NCT03328130|Retinal Degeneration|retinal degeneration
38814|NCT03328104|T- cell acute lymphoblastic leukemia|t- cell acute lymphoblastic leukemia
38815|NCT03328104|T-ALL|t-all
38816|NCT03328104|T-cell lymphoblastic lymphoma|t-cell lymphoblastic lymphoma
38817|NCT03328104|T-LLy|t-lly
38818|NCT03328104|Everolimus|everolimus
38819|NCT03328104|Maximum tolerated dose|maximum tolerated dose
38820|NCT03328091|Prostate Cancer|prostate cancer
38821|NCT03328091|Genetics|genetics
38822|NCT03328078|DLBCL|dlbcl
38823|NCT03328078|MCL|mcl
38824|NCT03328078|WM|wm
38825|NCT03328078|LPL|lpl
38826|NCT03328078|MYD88|myd88
38827|NCT03328078|IRAK4|irak4
38828|NCT03327987|vaccine immunogenicity|vaccine immunogenicity
38829|NCT03327987|vaccine safety|vaccine safety
38830|NCT03327974|Aged between 18 and 65|aged between 18 and 65
38831|NCT03327974|Major depressive disorder|major depressive disorder
38832|NCT03327974|Suicide|suicide
38833|NCT03327974|Ecological momentary assessment|ecological momentary assessment
38834|NCT03327974|Smartphone application|smartphone application
38835|NCT03327948|Sacral neuromodulation (SNM)|sacral neuromodulation (snm)
38836|NCT03327948|SNM|snm
38837|NCT03327922|Subdermal|subdermal
38838|NCT03327922|Suture|suture
38839|NCT03327922|Wound Closure|wound closure
38840|NCT03327922|Wound Cosmesis|wound cosmesis
38841|NCT03327909|Intradialytic Hypotension, Hypertension, Ambulatory Blood Pressure|intradialytic hypotension, hypertension, ambulatory blood pressure
38842|NCT03327896|Quality Measures, Social Determinants of Health|quality measures, social determinants of health
38843|NCT03327883|Diagnostic Imaging|diagnostic imaging
38844|NCT03327883|Review of Patients Records|review of patients records
38845|NCT03327883|PET MRI|pet mri
38846|NCT03327883|Treatment Responses|treatment responses
38847|NCT03327870|Sjogren's Syndrome|sjogren's syndrome
38848|NCT03327870|Sicca|sicca
38849|NCT03327844|Regenerative Endodontic Therapy|regenerative endodontic therapy
38850|NCT03327844|Infected immature permanent teeth|infected immature permanent teeth
38851|NCT03327831|aminolevulinic acid|aminolevulinic acid
38852|NCT03327831|pdt|pdt
38853|NCT03327831|photodynamic therapy|photodynamic therapy
38854|NCT03327831|Photochemotherapy|photochemotherapy
38855|NCT03327805|Choline|choline
38856|NCT03327805|Trimethylamine N-Oxide|trimethylamine n-oxide
38857|NCT03327805|Vascular health|vascular health
38858|NCT03327766|vitamin D and recurrent pregnancy loss|vitamin d and recurrent pregnancy loss
38859|NCT03327753|exercise|exercise
38860|NCT03327753|mobility|mobility
38861|NCT03327753|physiotherapy|physiotherapy
38862|NCT03327753|validation|validation
38863|NCT03327740|Hypersensitivity reactions (HSR)|hypersensitivity reactions (hsr)
38864|NCT03327740|HIV|hiv
38865|NCT03327740|Dolutegravir|dolutegravir
38866|NCT03327727|IA|ia
38867|NCT03327714|mindfulness|mindfulness
38868|NCT03327714|children|children
38869|NCT03327714|anxiety|anxiety
38870|NCT03327714|depression|depression
38871|NCT03327714|mental disorder|mental disorder
38872|NCT03327714|risk factor|risk factor
38873|NCT03327701|Exercise-induced bronchoconstriction|exercise-induced bronchoconstriction
38874|NCT03327701|Benralizumab|benralizumab
38875|NCT03327701|Antiinterleukin 5 receptor α monoclonal antibody|antiinterleukin 5 receptor α monoclonal antibody
38876|NCT03327688|Focus assesment with sonography for trauma|focus assesment with sonography for trauma
38877|NCT03327688|POCUS|pocus
38878|NCT03327688|LOS|los
38879|NCT03327688|Point-of-care ultrasound|point-of-care ultrasound
38880|NCT03327688|length of stay|length of stay
38881|NCT03327688|cost-minimization|cost-minimization
38882|NCT03327688|primary health care|primary health care
38883|NCT03327688|Ultrasound|ultrasound
38884|NCT03327688|Emergency department|emergency department
38885|NCT03327675|prostate-specific membrane antigen|prostate-specific membrane antigen
38886|NCT03327675|Lymph Node Dissection|lymph node dissection
38887|NCT03327675|Prostatectomy|prostatectomy
38888|NCT03327675|Positron-Emission Tomography|positron-emission tomography
38889|NCT03327662|Cabazitaxel|cabazitaxel
38890|NCT03327662|Docetaxel|docetaxel
38891|NCT03327662|Circulating Tumour Cells|circulating tumour cells
38892|NCT03327649|heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
38893|NCT03327649|inflammation|inflammation
38894|NCT03327636|Papillary Thyroid Microcarcinoma|papillary thyroid microcarcinoma
38895|NCT03327636|High intensity focused ultrasound|high intensity focused ultrasound
38896|NCT03327636|Active surveillance|active surveillance
38897|NCT03327623|sleep apnea|sleep apnea
38898|NCT03327623|arrhythmia|arrhythmia
38899|NCT03327610|Respiratory Therapy|respiratory therapy
38900|NCT03327610|Positive Pressure Respiration|positive pressure respiration
38901|NCT03327610|Physical Therapy Modalities|physical therapy modalities
38902|NCT03327597|MGUS|mgus
38903|NCT03327597|Screening|screening
38904|NCT03327597|Population-based|population-based
38905|NCT03327571|Drug therapy|drug therapy
38906|NCT03327545|Trigger points|trigger points
38907|NCT03327545|Trigegeminal nerve|trigegeminal nerve
38908|NCT03327545|Pain|pain
38909|NCT03327532|Acute Heart Failure|acute heart failure
38910|NCT03327532|Congestion|congestion
38911|NCT03327532|Ultrasound|ultrasound
38913|NCT03327519|Insomnia|insomnia
38914|NCT03327506|Premedication/ Hypnosis/ Anxiety/Surgery|premedication/ hypnosis/ anxiety/surgery
38915|NCT03327493|Cardiogenic shock|cardiogenic shock
38916|NCT03327493|Extra-Corporeal-Life-Support (ECLS)|extra-corporeal-life-support (ecls)
38917|NCT03327493|inflammation|inflammation
38918|NCT03327493|adrenergic system|adrenergic system
38919|NCT03327480|osteoarthritis thumb|osteoarthritis thumb
38920|NCT03327480|orthosis|orthosis
38921|NCT03327480|functioning|functioning
38922|NCT03327454|Rheumatoid arthritis|rheumatoid arthritis
38923|NCT03327454|Ankylosing spondylitis|ankylosing spondylitis
38924|NCT03327454|Axial spondyloarthritis|axial spondyloarthritis
38925|NCT03327454|Benepali pen|benepali pen
38926|NCT03327454|Etanercept|etanercept
38927|NCT03327454|Patient questionnaire|patient questionnaire
38928|NCT03327454|Pre-filled pen|pre-filled pen
38929|NCT03327454|Biological DMARDs|biological dmards
38930|NCT03327454|Antirheumatic drug|antirheumatic drug
38931|NCT03327428|Anemia, Sickle Cell|anemia, sickle cell
38932|NCT03327428|Sickle Cell disease|sickle cell disease
38933|NCT03327415|Children|children
38934|NCT03327415|Food practice|food practice
38935|NCT03327415|Food consumption|food consumption
38936|NCT03327415|Nutrient intake|nutrient intake
38937|NCT03327402|SHP465|shp465
38938|NCT03327402|ADHD|adhd
38939|NCT03327402|Hyperactivity|hyperactivity
38940|NCT03327376|central venous catheters|central venous catheters
38941|NCT03327376|venous thrombosis|venous thrombosis
38942|NCT03327376|ultrasound|ultrasound
38943|NCT03327376|critical care|critical care
38944|NCT03327363|ICT based clinical trial,|ict based clinical trial,
38945|NCT03327363|eCRF|ecrf
38946|NCT03327363|electronic -institutional review board (eIRB),|electronic -institutional review board (eirb),
38947|NCT03327363|Centralized monitoring|centralized monitoring
38948|NCT03327363|contract research organization (CRO)|contract research organization (cro)
38949|NCT03327311|No condition|no condition
38950|NCT03327298|Pedicle screw. Free hand. Lumbar fixation|pedicle screw. free hand. lumbar fixation
38951|NCT03327285|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
38952|NCT03327285|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
38953|NCT03327285|Anti-CD19 chimeric antigen receptor T-cell|anti-cd19 chimeric antigen receptor t-cell
38954|NCT03327181|short chain fatty acid metabolism|short chain fatty acid metabolism
38955|NCT03327168|Adipose Tissue, Brown|adipose tissue, brown
38956|NCT03327155|HIV prevention|hiv prevention
38957|NCT03327155|PrEP|prep
38958|NCT03327142|Adrenal Gland|adrenal gland
38959|NCT03327142|Endoscopic Ultrasound Guided FNA|endoscopic ultrasound guided fna
38960|NCT03327116|atopic dermatitis|atopic dermatitis
38961|NCT03327116|pruritus|pruritus
38962|NCT03327116|methotrexate|methotrexate
38963|NCT03327116|inflamation|inflamation
38964|NCT03327116|IL-31|il-31
38965|NCT03327103|decision making|decision making
38966|NCT03327103|advanced prostate cancer|advanced prostate cancer
38967|NCT03327103|decision aid|decision aid
38968|NCT03327103|minorities|minorities
38969|NCT03327103|mHealth|mhealth
38970|NCT03327103|community patient navigator|community patient navigator
38971|NCT03327090|Olympic Weightlifting|olympic weightlifting
38972|NCT03327090|Taping|taping
38973|NCT03327090|Muscles Facilitation|muscles facilitation
38974|NCT03327090|Jumps|jumps
38975|NCT03326999|adductor canal regional block|adductor canal regional block
38976|NCT03326999|obturator nerve regional block|obturator nerve regional block
38977|NCT03326999|total knee arthroplasty|total knee arthroplasty
38978|NCT03326999|knee replacement surgery|knee replacement surgery
38979|NCT03326999|Knee rheumatoid arthritis|knee rheumatoid arthritis
38980|NCT03326973|Quality of Life (QoL)|quality of life (qol)
38981|NCT03326973|17-518|17-518
38982|NCT03326960|general anesthesia|general anesthesia
38983|NCT03326960|postoperative delirium|postoperative delirium
38984|NCT03326960|postoperative cognitive dysfunction|postoperative cognitive dysfunction
38985|NCT03326960|biomarker|biomarker
38986|NCT03326947|TPF induction chemotherapy, randomized, trial,OSCC|tpf induction chemotherapy, randomized, trial,oscc
38987|NCT03326921|HA-1|ha-1
38988|NCT03326921|TCR|tcr
38989|NCT03326921|Immunotherapy|immunotherapy
38990|NCT03326921|Leukemia|leukemia
38991|NCT03326843|low platelet count|low platelet count
38992|NCT03326843|ITP|itp
38993|NCT03326830|Respiratory Insufficiency|respiratory insufficiency
38994|NCT03326830|Oxygen Inhalation Therapy|oxygen inhalation therapy
38995|NCT03326817|Degenerative Arthritis, Rheumatic Diseases|degenerative arthritis, rheumatic diseases
38996|NCT03326804|Hip Resurfacing Arthroplasty|hip resurfacing arthroplasty
38997|NCT03326804|Ceramic|ceramic
38998|NCT03326804|H1|h1
38999|NCT03326791|Acetylsalicylic acid|acetylsalicylic acid
39000|NCT03326791|Aspirin|aspirin
39001|NCT03326791|Trombyl|trombyl
39002|NCT03326791|Secondary prevention|secondary prevention
39003|NCT03326778|Aortic Valve Stenosis|aortic valve stenosis
39004|NCT03326778|Rapid deployment Valve|rapid deployment valve
39005|NCT03326778|CABG|cabg
39006|NCT03326778|Edwards Intuity Elite|edwards intuity elite
39105|NCT03326336|Retinitis Pigmentosa|retinitis pigmentosa
39007|NCT03326765|tuberous sclerosis complex (TSC)|tuberous sclerosis complex (tsc)
39008|NCT03326765|Children|children
39009|NCT03326765|Adults|adults
39010|NCT03326752|Cancer|cancer
39011|NCT03326752|Lung Cancer|lung cancer
39012|NCT03326752|NSCLC|nsclc
39013|NCT03326752|Anti-PD-1 inhibitor|anti-pd-1 inhibitor
39014|NCT03326752|Immuno-oncology|immuno-oncology
39015|NCT03326752|Toll-Like Receptor (TLR) agonist|toll-like receptor (tlr) agonist
39016|NCT03326713|Genetic Testing|genetic testing
39017|NCT03326713|Prevention|prevention
39018|NCT03326687|Language|language
39019|NCT03326687|Anomia|anomia
39020|NCT03326687|Therapy|therapy
39021|NCT03326674|Tesetaxel|tesetaxel
39022|NCT03326674|Capecitabine|capecitabine
39023|NCT03326674|HER2 negative|her2 negative
39024|NCT03326674|Hormone Receptor positive|hormone receptor positive
39025|NCT03326674|Locally advanced or metastatic breast cancer|locally advanced or metastatic breast cancer
39026|NCT03326674|Combination of tesetaxel and capecitabine|combination of tesetaxel and capecitabine
39027|NCT03326674|Taxanes|taxanes
39028|NCT03326674|Metastatic breast cancer|metastatic breast cancer
39029|NCT03326674|Breast cancer|breast cancer
39030|NCT03326661|Tonsillectomy|tonsillectomy
39031|NCT03326661|Aspiration|aspiration
39032|NCT03326661|Quinsy|quinsy
39033|NCT03326648|Sarcopenia|sarcopenia
39034|NCT03326648|Frailty|frailty
39035|NCT03326648|Strength training|strength training
39036|NCT03326648|Autophagy|autophagy
39037|NCT03326635|Resuscitation|resuscitation
39038|NCT03326635|Frailty|frailty
39039|NCT03326635|ICU|icu
39040|NCT03326635|Ageing|ageing
39041|NCT03326635|Rehabilitation|rehabilitation
39042|NCT03326635|Elderly|elderly
39043|NCT03326622|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
39044|NCT03326622|aerobic exercise|aerobic exercise
39045|NCT03326622|functional outcome|functional outcome
39046|NCT03326622|non-invasive ventilation|non-invasive ventilation
39047|NCT03326622|oxygen uptake|oxygen uptake
39048|NCT03326596|Hemorrhage|hemorrhage
39049|NCT03326596|Tranexamic acid (TXA)|tranexamic acid (txa)
39050|NCT03326596|Estimated Blood Loss (EBL)|estimated blood loss (ebl)
39051|NCT03326583|End Stage Renal Disease|end stage renal disease
39052|NCT03326583|ESRD|esrd
39053|NCT03326583|Hyperkalemia|hyperkalemia
39054|NCT03326570|Lung cancer|lung cancer
39055|NCT03326570|Data collection post bronchoscopy|data collection post bronchoscopy
39056|NCT03326557|Induction of Labour|induction of labour
39057|NCT03326557|Previous Caesarean delivery|previous caesarean delivery
39058|NCT03326557|Foley|foley
39059|NCT03326557|Membrane sweeping|membrane sweeping
39060|NCT03326557|Vaginal delivery|vaginal delivery
39061|NCT03326505|Umbilical Cord Mesenchymal Stem Cells|umbilical cord mesenchymal stem cells
39062|NCT03326505|Multiple Sclerosis|multiple sclerosis
39063|NCT03326505|Neuroimmunology|neuroimmunology
39064|NCT03326505|Autoimmune disease|autoimmune disease
39065|NCT03326505|Physical therapy|physical therapy
39066|NCT03326492|Snake bites|snake bites
39067|NCT03326492|Antivenom serum|antivenom serum
39068|NCT03326492|Snake venoms|snake venoms
39069|NCT03326479|Molecular Profiling|molecular profiling
39070|NCT03326479|Biomarker Analysis|biomarker analysis
39071|NCT03326479|Outcomes Database|outcomes database
39072|NCT03326466|Subacromial Impingement Syndrome|subacromial impingement syndrome
39073|NCT03326466|Central Nervous System Sensitization|central nervous system sensitization
39074|NCT03326466|Muscle Function|muscle function
39075|NCT03326466|EMG|emg
39076|NCT03326466|Force Steadiness|force steadiness
39077|NCT03326466|CUFF Algometry|cuff algometry
39078|NCT03326466|Manual Algometry|manual algometry
39079|NCT03326466|Pain|pain
39080|NCT03326466|Maximal Voluntary Isometric Contraction|maximal voluntary isometric contraction
39081|NCT03326453|mini dental implant|mini dental implant
39082|NCT03326453|overdenture|overdenture
39083|NCT03326453|Patient satisfaction|patient satisfaction
39084|NCT03326427|Attention Deficit Hyperactive Disorder|attention deficit hyperactive disorder
39085|NCT03326427|Skill Training Group|skill training group
39086|NCT03326427|Dialectical Behavior Therapy|dialectical behavior therapy
39087|NCT03326401|dietary total antioxidant activity|dietary total antioxidant activity
39088|NCT03326401|nutritional status|nutritional status
39089|NCT03326401|macular degeneration|macular degeneration
39090|NCT03326401|glycemic load|glycemic load
39091|NCT03326401|glycemic index|glycemic index
39092|NCT03326401|nutrient intake|nutrient intake
39093|NCT03326375|TACE|tace
39094|NCT03326375|SBRT|sbrt
39095|NCT03326362|chronic low back pain|chronic low back pain
39096|NCT03326362|strength training|strength training
39097|NCT03326362|biomechanics|biomechanics
39098|NCT03326362|inflammatory biomarkers|inflammatory biomarkers
39099|NCT03326349|computerized cognitive rehabilitation|computerized cognitive rehabilitation
39100|NCT03326336|Eye Diseases|eye diseases
39101|NCT03326336|Hereditary Eye Diseases|hereditary eye diseases
39102|NCT03326336|Retinal degeneration|retinal degeneration
39103|NCT03326336|Inherited retinal diseases|inherited retinal diseases
39104|NCT03326336|Rod & cone dystrophies|rod & cone dystrophies
39106|NCT03326336|Gene Therapy|gene therapy
39107|NCT03326336|Optogenetic|optogenetic
39108|NCT03326336|Intravitreal Injections|intravitreal injections
39109|NCT03326336|AAV Vectors|aav vectors
39110|NCT03326336|Medical device|medical device
39111|NCT03326336|Visual Interface|visual interface
39112|NCT03326323|acute normovolemic hemodilution|acute normovolemic hemodilution
39113|NCT03326310|Chronic Myeloid Leukemia|chronic myeloid leukemia
39114|NCT03326310|Myelofibrosis|myelofibrosis
39115|NCT03326310|selumetinib|selumetinib
39116|NCT03326310|azacitidine|azacitidine
39117|NCT03326297|Infant Colic|infant colic
39118|NCT03326297|Osteopathy|osteopathy
39119|NCT03326297|Stress|stress
39120|NCT03326297|Physiotherapy|physiotherapy
39121|NCT03326284|Hypocaloric diet|hypocaloric diet
39122|NCT03326284|Dietary protein|dietary protein
39123|NCT03326245|Pharmacological MRI|pharmacological mri
39124|NCT03326245|C-11 Raclopride|c-11 raclopride
39125|NCT03326245|PET Imaging|pet imaging
39126|NCT03326245|Neuropsychological Testing|neuropsychological testing
39127|NCT03326219|MOCA|moca
39128|NCT03326219|VSM|vsm
39129|NCT03326219|Clarivein|clarivein
39130|NCT03326219|Histological|histological
39131|NCT03326206|Navajo|navajo
39132|NCT03326206|Community Health Workers|community health workers
39133|NCT03326206|Community Health Representatives|community health representatives
39134|NCT03326206|Tribal health systems|tribal health systems
39135|NCT03326206|American Indian|american indian
39136|NCT03326206|Rural|rural
39137|NCT03326206|Health disparities|health disparities
39138|NCT03326193|Stage IIIb - IV|stage iiib - iv
39139|NCT03326193|gBRCAmut|gbrcamut
39140|NCT03326193|BRCA|brca
39141|NCT03326193|PARP inhibitor|parp inhibitor
39142|NCT03326193|Ovarian|ovarian
39143|NCT03326193|Primary Peritoneal|primary peritoneal
39144|NCT03326193|Fallopian Tube|fallopian tube
39145|NCT03326193|VEGF inhibitor|vegf inhibitor
39146|NCT03326193|Bevacizumab|bevacizumab
39147|NCT03326193|Niraparib|niraparib
39148|NCT03326193|Angiogenesis Inhibitors|angiogenesis inhibitors
39149|NCT03326193|Angiogenesis Modulating Agents|angiogenesis modulating agents
39150|NCT03326193|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors
39151|NCT03326154|cholecystectomy|cholecystectomy
39152|NCT03326154|quality of life|quality of life
39153|NCT03326128|Bupropion XL|bupropion xl
39154|NCT03326128|Anhedonia|anhedonia
39155|NCT03326128|Heavy Smokers|heavy smokers
39156|NCT03326128|Smoking cessation|smoking cessation
39157|NCT03326115|patient activation|patient activation
39158|NCT03326115|peer visitation|peer visitation
39159|NCT03326115|amputee|amputee
39160|NCT03326102|Breast Cancer|breast cancer
39161|NCT03326102|DHP107|dhp107
39162|NCT03326102|Paclitaxel|paclitaxel
39163|NCT03326102|Liporaxel|liporaxel
39164|NCT03326089|pulmonary rehabilitation|pulmonary rehabilitation
39165|NCT03326050|Rhinoscleroma|rhinoscleroma
39166|NCT03326050|Gemifloxacin|gemifloxacin
39167|NCT03326050|Ciprofloxacin|ciprofloxacin
39168|NCT03326037|Nephrotic Syndrome|nephrotic syndrome
39169|NCT03326037|NPHS2 gene mutation|nphs2 gene mutation
39170|NCT03326037|disease association|disease association
39171|NCT03326011|Exoskeleton Device|exoskeleton device
39172|NCT03326011|Gait rehabilitation|gait rehabilitation
39173|NCT03326011|Chronic storke|chronic storke
39174|NCT03325998|Exoskeleton Device|exoskeleton device
39175|NCT03325998|Elderly|elderly
39176|NCT03325998|Gait rehabilitation|gait rehabilitation
39177|NCT03325959|hyperbaric oxygen|hyperbaric oxygen
39178|NCT03325959|HBOT|hbot
39179|NCT03325959|fibromyalgia|fibromyalgia
39180|NCT03325959|pain|pain
39181|NCT03325933|insulin sensitivity|insulin sensitivity
39182|NCT03325933|muscle|muscle
39183|NCT03325933|strength|strength
39184|NCT03325933|resistance training|resistance training
39185|NCT03325933|strength training|strength training
39186|NCT03325933|vascular function|vascular function
39187|NCT03325933|arterial stiffness|arterial stiffness
39188|NCT03325933|glucose tolerance|glucose tolerance
39189|NCT03325920|sleep bruxism|sleep bruxism
39190|NCT03325920|diagnosis|diagnosis
39191|NCT03325920|validation study|validation study
39192|NCT03325920|assessment|assessment
39193|NCT03325907|Biopsy, Needle|biopsy, needle
39194|NCT03325907|Printing, Three-Dimensional|printing, three-dimensional
39195|NCT03325907|Image-Guided Biopsy|image-guided biopsy
39196|NCT03325894|ADHD|adhd
39197|NCT03325894|SHP465|shp465
39198|NCT03325894|Hyperactivity|hyperactivity
39199|NCT03325881|ADHD|adhd
39200|NCT03325881|Hyperactivity|hyperactivity
39201|NCT03325881|SHP465|shp465
39202|NCT03325868|heavy periods, painful periods, adenomyosis|heavy periods, painful periods, adenomyosis
39203|NCT03325855|FMT|fmt
39204|NCT03325855|CDI|cdi
39205|NCT03325855|Fecal Matter Transplant|fecal matter transplant
39206|NCT03325842|Cross-cultural comparison|cross-cultural comparison
39207|NCT03325842|Disability evaluation|disability evaluation
39208|NCT03325842|Self-assessment|self-assessment
39209|NCT03325842|Child|child
39210|NCT03325842|Adolescent|adolescent
39211|NCT03325829|Registry|registry
39212|NCT03325829|Diverticular Disease|diverticular disease
39213|NCT03325829|Diverticulitis|diverticulitis
39214|NCT03325829|Uncomplicated Diverticular Disease|uncomplicated diverticular disease
39215|NCT03325816|nivolumab|nivolumab
39216|NCT03325816|177Lu-DOTA0-Tyr3-Octreotate|177lu-dota0-tyr3-octreotate
39217|NCT03325816|Lutathera|lutathera
39218|NCT03325803|actinic keratosis|actinic keratosis
39219|NCT03325803|ablative fractional laser|ablative fractional laser
39220|NCT03325803|photodynamic therapy|photodynamic therapy
39221|NCT03325803|ablative depth|ablative depth
39222|NCT03325803|protoporphyrin IX|protoporphyrin ix
39223|NCT03325790|Meniere's disease|meniere's disease
39224|NCT03325790|Hearing Loss|hearing loss
39225|NCT03325790|Vertigo|vertigo
39226|NCT03325790|Tinnitus|tinnitus
39227|NCT03325790|Ebselen|ebselen
39228|NCT03325790|Pharmacokinetics|pharmacokinetics
39229|NCT03325790|Safety|safety
39230|NCT03325790|Efficacy|efficacy
39231|NCT03325790|Speech|speech
39232|NCT03325777|Cigarettes|cigarettes
39233|NCT03325777|Tobacco Use|tobacco use
39234|NCT03325764|Obesity|obesity
39235|NCT03325764|bariatric surgery|bariatric surgery
39236|NCT03325764|sleeve gastrectomy|sleeve gastrectomy
39237|NCT03325764|physical activity|physical activity
39238|NCT03325764|movement analysis|movement analysis
39239|NCT03325725|severe aspiration|severe aspiration
39240|NCT03325699|Mild dementia|mild dementia
39241|NCT03325699|Cognitive impairment|cognitive impairment
39242|NCT03325699|Informal caregiver|informal caregiver
39243|NCT03325699|Aging|aging
39244|NCT03325699|Quality of life|quality of life
39245|NCT03325699|Health application|health application
39246|NCT03325699|Information and communication technology (ICT)|information and communication technology (ict)
39247|NCT03325686|vitamin D|vitamin d
39248|NCT03325686|atletes|atletes
39249|NCT03325686|physical performance|physical performance
39250|NCT03325660|Whole body vibration, Pelvic floor muscle|whole body vibration, pelvic floor muscle
39251|NCT03325647|body composition|body composition
39252|NCT03325647|klinefelter syndrome|klinefelter syndrome
39253|NCT03325647|XXY|xxy
39254|NCT03325647|sex chromosome variation|sex chromosome variation
39255|NCT03325647|sex chromosome aneuploidy|sex chromosome aneuploidy
39256|NCT03325647|testosterone|testosterone
39257|NCT03325621|Hepcidin|hepcidin
39258|NCT03325621|Hemoglobin|hemoglobin
39259|NCT03325621|Iron|iron
39260|NCT03325621|Anemia of chronic disease|anemia of chronic disease
39261|NCT03325582|Perianal Fistula Crohn's disease, MRI|perianal fistula crohn's disease, mri
39262|NCT03325556|Dementia|dementia
39263|NCT03325556|Dementia-related psychosis|dementia-related psychosis
39264|NCT03325556|Dementia associated with Parkinson's disease|dementia associated with parkinson's disease
39265|NCT03325556|Dementia with Lewy bodies|dementia with lewy bodies
39266|NCT03325556|Alzheimer's disease|alzheimer's disease
39267|NCT03325556|Behavioral variant frontotemporal dementia|behavioral variant frontotemporal dementia
39268|NCT03325556|Progressive supranuclear palsy|progressive supranuclear palsy
39269|NCT03325556|Corticobasal degeneration|corticobasal degeneration
39270|NCT03325556|Vascular dementia|vascular dementia
39271|NCT03325556|Hallucinations|hallucinations
39272|NCT03325556|Delusions|delusions
39273|NCT03325556|Psychosis|psychosis
39274|NCT03325543|Urinary Incontinence, Stress|urinary incontinence, stress
39275|NCT03325543|Pelvic Floor|pelvic floor
39276|NCT03325543|Exercise|exercise
39277|NCT03325530|Adolescent|adolescent
39278|NCT03325530|Nutrition|nutrition
39279|NCT03325530|Physical Activity|physical activity
39280|NCT03325465|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
39281|NCT03325465|head and neck cancer|head and neck cancer
39282|NCT03325465|neoadjuvant pembrolizumab|neoadjuvant pembrolizumab
39283|NCT03325465|epacadostat|epacadostat
39284|NCT03325439|Electroencephalographic neonatal seizures|electroencephalographic neonatal seizures
39285|NCT03325439|Brivaracetam|brivaracetam
39286|NCT03325439|Epilepsy|epilepsy
39287|NCT03325439|ENS|ens
39288|NCT03325439|Newborns|newborns
39289|NCT03325439|Pharmacokinetic|pharmacokinetic
39290|NCT03325413|Perioperative geriatric care|perioperative geriatric care
39291|NCT03325413|Geriatric assessment|geriatric assessment
39292|NCT03325413|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
39293|NCT03325413|POCD|pocd
39294|NCT03325413|Frailty|frailty
39295|NCT03325413|Depression|depression
39296|NCT03325413|Physical fitness|physical fitness
39297|NCT03325413|Geriatric anesthesia|geriatric anesthesia
39298|NCT03325413|IADL|iadl
39299|NCT03325413|Postoperative functional status|postoperative functional status
39300|NCT03325413|Quality of life|quality of life
39301|NCT03325400|Fluoride toothpaste|fluoride toothpaste
39302|NCT03325400|Cytogenetic damage|cytogenetic damage
39303|NCT03325400|Exfoliated buccal cells|exfoliated buccal cells
39304|NCT03325400|Micronucleus assay|micronucleus assay
39305|NCT03325348|Severe Pre eclampsia|severe pre eclampsia
39306|NCT03325348|Nifidepine|nifidepine
39307|NCT03325348|Labetalol|labetalol
39308|NCT03325335|midazolam premedication|midazolam premedication
39309|NCT03325322|Frailty|frailty
39310|NCT03325322|Inflammation|inflammation
39311|NCT03325322|Mesenchymal stem cell|mesenchymal stem cell
39312|NCT03325322|Mesenchymal stromal cell|mesenchymal stromal cell
39313|NCT03325309|Lumbar spinal stenosis|lumbar spinal stenosis
39314|NCT03325309|Cycling|cycling
39315|NCT03325309|Lumbar-flexion-based training|lumbar-flexion-based training
39316|NCT03325283|stroke prevention|stroke prevention
39317|NCT03325283|embolic protection|embolic protection
39318|NCT03325283|cognition|cognition
39319|NCT03325270|prebiotics|prebiotics
39320|NCT03325270|Galacto-oligosaccharides|galacto-oligosaccharides
39321|NCT03325270|Iron-deficiency|iron-deficiency
39322|NCT03325257|Unresectable melanoma|unresectable melanoma
39323|NCT03325257|metastatic melanoma|metastatic melanoma
39324|NCT03325257|Immunotherapy|immunotherapy
39325|NCT03325257|Nivolumab|nivolumab
39326|NCT03325257|Temporary Auhorization for Use (ATU)|temporary auhorization for use (atu)
39327|NCT03325205|Transcranial direct current stimulation|transcranial direct current stimulation
39328|NCT03325205|Neuromodulation|neuromodulation
39329|NCT03325205|Individualizing brain stimulation|individualizing brain stimulation
39330|NCT03325205|Neuropsychology|neuropsychology
39331|NCT03325192|Indwelling Pleural Catheter|indwelling pleural catheter
39332|NCT03325192|Pleurodesis|pleurodesis
39333|NCT03325192|Iodopovidone|iodopovidone
39334|NCT03325192|Pleural Effusion, Malignant|pleural effusion, malignant
39335|NCT03325179|Simple Obesity|simple obesity
39336|NCT03325179|Thread-embedding Therapy|thread-embedding therapy
39337|NCT03325179|Acupuncture|acupuncture
39338|NCT03325153|Obstructive Sleep Apnea|obstructive sleep apnea
39339|NCT03325153|Bronchoscopy|bronchoscopy
39340|NCT03325153|STOP-Bang questionnaire|stop-bang questionnaire
39341|NCT03325153|Cardiopulmonary events|cardiopulmonary events
39342|NCT03325127|Prostate Cancer, Bone metastases, Xofigo, Zytiga, Xtandi.|prostate cancer, bone metastases, xofigo, zytiga, xtandi.
39343|NCT03325114|type 1 diabetes|type 1 diabetes
39344|NCT03325114|hypercalciuria|hypercalciuria
39345|NCT03325088|Severe Asthma|severe asthma
39346|NCT03325088|airway smooth muscle cells|airway smooth muscle cells
39347|NCT03325088|Rac1 protein|rac1 protein
39348|NCT03325075|VAL-181388|val-181388
39349|NCT03325075|Chikungunya vaccine|chikungunya vaccine
39350|NCT03325049|Family Relations|family relations
39351|NCT03325049|Family Health|family health
39352|NCT03325049|Intervention study|intervention study
39353|NCT03325049|Social support|social support
39354|NCT03325049|Intensive care unit|intensive care unit
39355|NCT03325023|PCOS, microbiota, probiotic,obesity|pcos, microbiota, probiotic,obesity
39356|NCT03324984|Spinal anesthesia|spinal anesthesia
39357|NCT03324984|Pain|pain
39358|NCT03324984|Chloroprocaine|chloroprocaine
39359|NCT03324958|Endometrial cancer|endometrial cancer
39360|NCT03324958|Brachytherapy|brachytherapy
39361|NCT03324958|Virtual reality|virtual reality
39362|NCT03324958|Pain|pain
39363|NCT03324958|Anxiety|anxiety
39364|NCT03324932|bone health|bone health
39365|NCT03324932|hormone-sensitive breast cancer|hormone-sensitive breast cancer
39366|NCT03324932|postmenopausal|postmenopausal
39367|NCT03324932|aromatase inhibitor|aromatase inhibitor
39368|NCT03324932|bone mineral density|bone mineral density
39369|NCT03324919|Psoriasis|psoriasis
39370|NCT03324919|Urticaria|urticaria
39371|NCT03324919|Lupus erythematodes|lupus erythematodes
39372|NCT03324919|qualtiy of life|qualtiy of life
39373|NCT03324906|Prader-Willi Syndrome|prader-willi syndrome
39374|NCT03324906|Obesity|obesity
39375|NCT03324906|Depressive disorder|depressive disorder
39376|NCT03324906|Obsessive-compulsive disorder|obsessive-compulsive disorder
39377|NCT03324906|noninvasive brain stimulation|noninvasive brain stimulation
39378|NCT03324880|rhPTH[1-84)|rhpth[1-84)
39379|NCT03324880|Parathyroid hormone|parathyroid hormone
39380|NCT03324880|Hypocalcemia|hypocalcemia
39381|NCT03324880|Hypoparathyroidism|hypoparathyroidism
39382|NCT03324854|Mosquito net|mosquito net
39383|NCT03324854|Mesh|mesh
39384|NCT03324854|Polypropylene mesh|polypropylene mesh
39385|NCT03324854|Prolene mesh|prolene mesh
39386|NCT03324854|ventral hernia|ventral hernia
39387|NCT03324854|hernia|hernia
39388|NCT03324841|Molecular Profiling|molecular profiling
39389|NCT03324841|Biomarker Analysis|biomarker analysis
39390|NCT03324841|Next Generation Sequencing|next generation sequencing
39391|NCT03324828|anxiety|anxiety
39392|NCT03324828|surgery|surgery
39393|NCT03324828|clown|clown
39394|NCT03324815|Morphine|morphine
39395|NCT03324815|Methadone|methadone
39396|NCT03324815|Pain|pain
39397|NCT03324789|Single implant|single implant
39398|NCT03324789|Anterior edentulism|anterior edentulism
39399|NCT03324789|partial denture|partial denture
39400|NCT03324776|inhaled insulin|inhaled insulin
39401|NCT03324750|corticotherapy|corticotherapy
39402|NCT03324750|qualitative study|qualitative study
39403|NCT03324750|therapeutic education|therapeutic education
39404|NCT03324750|lifestyle change|lifestyle change
39405|NCT03324750|diet|diet
39406|NCT03324737|Prevention|prevention
39898|NCT03321409|SSS-Ch|sss-ch
39407|NCT03324737|Smartphone application|smartphone application
39408|NCT03324737|Randomized control trial|randomized control trial
39409|NCT03324711|Cognitive disorders|cognitive disorders
39410|NCT03324711|Alzheimer's disease|alzheimer's disease
39411|NCT03324711|Mini Mental State Examination|mini mental state examination
39412|NCT03324711|Geriatry|geriatry
39413|NCT03324685|Oral Contraceptive, Healthy Volunteers, Ethinyl Estradiol,|oral contraceptive, healthy volunteers, ethinyl estradiol,
39414|NCT03324685|Levonorgestrel|levonorgestrel
39415|NCT03324672|lumbar pain; pregnancy;|lumbar pain; pregnancy;
39416|NCT03324659|Mindfulness|mindfulness
39417|NCT03324659|Exercise|exercise
39418|NCT03324646|PET Imaging|pet imaging
39419|NCT03324633|HIV|hiv
39420|NCT03324633|HCV|hcv
39421|NCT03324633|cohort|cohort
39422|NCT03324633|natural history|natural history
39423|NCT03324633|cure|cure
39424|NCT03324620|physiotherapy|physiotherapy
39425|NCT03324620|nurse|nurse
39426|NCT03324620|Cost effectiveness|cost effectiveness
39427|NCT03324620|Activities of Daily Living|activities of daily living
39428|NCT03324620|exercise tolerance|exercise tolerance
39429|NCT03324620|Allogeneic|allogeneic
39430|NCT03324620|Quality of Life|quality of life
39431|NCT03324620|Rehabilitation|rehabilitation
39432|NCT03324620|Physical Activity|physical activity
39433|NCT03324594|functional performance|functional performance
39434|NCT03324594|synthetic male condom|synthetic male condom
39435|NCT03324581|ADHD|adhd
39436|NCT03324581|ADD|add
39437|NCT03324516|pterional incision|pterional incision
39438|NCT03324516|Temporal hollowing|temporal hollowing
39439|NCT03324503|Pulmonary Sarcoidosis|pulmonary sarcoidosis
39440|NCT03324503|HRCT|hrct
39441|NCT03324503|Glucocorticoid|glucocorticoid
39442|NCT03324503|Prednisone|prednisone
39443|NCT03324503|FRI|fri
39444|NCT03324503|Prednisolone|prednisolone
39445|NCT03324490|Mid-thoracic spinal anesthesia|mid-thoracic spinal anesthesia
39446|NCT03324490|Mid-thoracic epidural anesthesia|mid-thoracic epidural anesthesia
39447|NCT03324490|Nephrectomy|nephrectomy
39448|NCT03324490|Lung disease|lung disease
39449|NCT03324438|pediatrics|pediatrics
39450|NCT03324425|breast cancer|breast cancer
39451|NCT03324425|metastatic breast cancer|metastatic breast cancer
39452|NCT03324399|ALS|als
39453|NCT03324399|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
39454|NCT03324386|Hypertension|hypertension
39455|NCT03324386|Tecnology|tecnology
39456|NCT03324386|Nursing|nursing
39457|NCT03324386|Education|education
39458|NCT03324347|Animal-Assisted Intervention|animal-assisted intervention
39459|NCT03324347|Dog-Assisted Intervention|dog-assisted intervention
39460|NCT03324347|Dental Care|dental care
39461|NCT03324347|Questionnaire|questionnaire
39462|NCT03324347|Pilot Project|pilot project
39463|NCT03324347|Dental Clinic|dental clinic
39464|NCT03324321|Cerebral Haemodynamics|cerebral haemodynamics
39465|NCT03324321|Carbon Dioxide|carbon dioxide
39466|NCT03324321|Cerebral Autoregulation|cerebral autoregulation
39467|NCT03324308|Coronary Artery Disease|coronary artery disease
39468|NCT03324308|Ischemia|ischemia
39469|NCT03324308|Computed Tomography|computed tomography
39470|NCT03324308|Myocardial perfusion|myocardial perfusion
39471|NCT03324308|Dynamic Imaging|dynamic imaging
39472|NCT03324282|Anti PD1|anti pd1
39473|NCT03324282|Bladder carcinoma|bladder carcinoma
39474|NCT03324282|Chemotherapy|chemotherapy
39475|NCT03324282|Immunological monitoring|immunological monitoring
39476|NCT03324256|Energy drink consumption|energy drink consumption
39477|NCT03324230|Monoclonal antibody|monoclonal antibody
39478|NCT03324230|Mepolizumab|mepolizumab
39479|NCT03324230|Eosinophil|eosinophil
39480|NCT03324217|motor imagery|motor imagery
39481|NCT03324217|action observation|action observation
39482|NCT03324191|Tea extract|tea extract
39483|NCT03324191|Triglycerides|triglycerides
39484|NCT03324191|Energy metabolism|energy metabolism
39485|NCT03324178|Neurofeedback|neurofeedback
39486|NCT03324178|Attention|attention
39487|NCT03324165|Computed Tomography|computed tomography
39488|NCT03324165|Algorithm|algorithm
39489|NCT03324165|Alvarado Score|alvarado score
39490|NCT03324152|High-intensity interval training|high-intensity interval training
39491|NCT03324152|Exercise|exercise
39492|NCT03324152|Muscle function|muscle function
39493|NCT03324152|Inflammation|inflammation
39494|NCT03324126|Preterm infants|preterm infants
39495|NCT03324126|very low birth weight|very low birth weight
39496|NCT03324126|breast milk|breast milk
39497|NCT03324126|individualized fortification|individualized fortification
39498|NCT03324126|targeted protein fortification|targeted protein fortification
39499|NCT03324126|adjustable protein fortification|adjustable protein fortification
39500|NCT03324126|growth|growth
39501|NCT03324087|HRQoL|hrqol
39502|NCT03324087|Immune Thrombocytopenia|immune thrombocytopenia
39503|NCT03324048|Preoperative anxiety|preoperative anxiety
39504|NCT03324048|Relaxation|relaxation
39505|NCT03324048|Autonomous nervous system|autonomous nervous system
39506|NCT03324048|Surgery|surgery
39507|NCT03324048|Visual Analogue Scale (VAS)|visual analogue scale (vas)
39508|NCT03324048|State-Trait Anxiety Inventory (STAI-Y)|state-trait anxiety inventory (stai-y)
39509|NCT03324022|Fibroblast growth factors|fibroblast growth factors
39510|NCT03324022|Fibroblast growth factors receptors|fibroblast growth factors receptors
39511|NCT03324022|Thyroid orbitopathy|thyroid orbitopathy
39512|NCT03323944|metastatic adenocarcinoma, pancreas|metastatic adenocarcinoma, pancreas
39513|NCT03323931|autism spectrum disorder|autism spectrum disorder
39514|NCT03323931|robot-enhanced intervention|robot-enhanced intervention
39515|NCT03323931|imitation|imitation
39516|NCT03323931|joint attention|joint attention
39517|NCT03323931|turn-taking|turn-taking
39518|NCT03323892|preimplantation development|preimplantation development
39519|NCT03323892|DNA fragmentation|dna fragmentation
39520|NCT03323892|abstinence duration|abstinence duration
39521|NCT03323879|brachytherapy|brachytherapy
39522|NCT03323879|LDR|ldr
39523|NCT03323879|HDR|hdr
39524|NCT03323879|monotherapy|monotherapy
39525|NCT03323879|focal|focal
39526|NCT03323801|Infertility|infertility
39527|NCT03323762|Pre-Eclampsia; Mild|pre-eclampsia; mild
39528|NCT03323762|Pre-Eclampsia; Moderate|pre-eclampsia; moderate
39529|NCT03323762|Gestational Hypertension|gestational hypertension
39530|NCT03323762|Remote ischemic conditioning|remote ischemic conditioning
39531|NCT03323749|Myopathy|myopathy
39532|NCT03323749|PMD|pmd
39533|NCT03323749|Primary Mitochondrial Disease|primary mitochondrial disease
39534|NCT03323749|MTP-131|mtp-131
39535|NCT03323749|elamipretide|elamipretide
39536|NCT03323710|Metastatic|metastatic
39537|NCT03323710|Renal Cell Carcinoma|renal cell carcinoma
39538|NCT03323710|Kidney Cancer|kidney cancer
39539|NCT03323710|Sunitinib|sunitinib
39540|NCT03323710|Sutent|sutent
39541|NCT03323710|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
39542|NCT03323710|Angiogenesis Inhibitor|angiogenesis inhibitor
39543|NCT03323710|Propranolol|propranolol
39544|NCT03323710|Beta-blocker|beta-blocker
39545|NCT03323710|First-line|first-line
39546|NCT03323697|Depression|depression
39547|NCT03323697|Anxiety|anxiety
39548|NCT03323697|Herbal Medicine|herbal medicine
39549|NCT03323697|Chinese Medicine|chinese medicine
39550|NCT03323697|Hamilton Scale|hamilton scale
39551|NCT03323697|SSRI|ssri
39552|NCT03323671|primary dysmenorrhea|primary dysmenorrhea
39553|NCT03323671|preemptive analgesia|preemptive analgesia
39554|NCT03323645|prostate cancer|prostate cancer
39555|NCT03323645|erectile dysfunction|erectile dysfunction
39556|NCT03323645|penile prosthesis|penile prosthesis
39557|NCT03323632|Stroke|stroke
39558|NCT03323632|Cerebrovascular accident|cerebrovascular accident
39559|NCT03323632|Upper extremity|upper extremity
39560|NCT03323632|Cerebral Infarction|cerebral infarction
39561|NCT03323632|Brain Infarction|brain infarction
39562|NCT03323632|Brain Ischemia|brain ischemia
39563|NCT03323632|Cerebrovascular Disorders|cerebrovascular disorders
39564|NCT03323632|Cardiovascular Diseases|cardiovascular diseases
39565|NCT03323632|Nervous System Diseases|nervous system diseases
39566|NCT03323632|Central Nervous System Diseases|central nervous system diseases
39567|NCT03323619|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
39568|NCT03323619|Anesthesia technique|anesthesia technique
39569|NCT03323619|Delirium|delirium
39570|NCT03323567|TMD, collagen, intramuscular injection, trigger point|tmd, collagen, intramuscular injection, trigger point
39571|NCT03323554|radical prostatectomy , Device,|radical prostatectomy , device,
39572|NCT03323541|biosimilars|biosimilars
39573|NCT03323541|filgrastim|filgrastim
39574|NCT03323541|Stem cell transplantation|stem cell transplantation
39575|NCT03323541|lymphoma|lymphoma
39576|NCT03323541|multiple myeloma|multiple myeloma
39577|NCT03323528|Dorithricin|dorithricin
39578|NCT03323528|Tyrothricin|tyrothricin
39579|NCT03323528|Benzalkonium chloride|benzalkonium chloride
39580|NCT03323528|Benzocaine|benzocaine
39581|NCT03323528|placebo-controlled|placebo-controlled
39582|NCT03323528|Pharyngitis|pharyngitis
39583|NCT03323528|sore throat|sore throat
39584|NCT03323528|throat pain|throat pain
39585|NCT03323528|difficulty swallowing|difficulty swallowing
39586|NCT03323528|complete responder|complete responder
39587|NCT03323528|lozenge|lozenge
39588|NCT03323528|Non-streptococcal Infections|non-streptococcal infections
39589|NCT03323502|Nursing Homes|nursing homes
39590|NCT03323502|Skilled Nursing Facilities|skilled nursing facilities
39591|NCT03323502|Advance Care Planning|advance care planning
39592|NCT03323502|Advance Directives|advance directives
39593|NCT03323502|Alzheimer Disease|alzheimer disease
39594|NCT03323502|Dementia|dementia
39595|NCT03323502|Do Not Resuscitate Orders|do not resuscitate orders
39596|NCT03323502|Physician Orders for Life-Sustaining Treatment|physician orders for life-sustaining treatment
39597|NCT03323502|Artificial Nutrition|artificial nutrition
39598|NCT03323502|Hospitalization|hospitalization
39599|NCT03323502|Intubation|intubation
39600|NCT03323502|Pragmatic Clinical Trials|pragmatic clinical trials
39601|NCT03323502|Randomized Controlled Trials|randomized controlled trials
39602|NCT03323502|Patient Preferences|patient preferences
39603|NCT03323502|Resuscitation Orders|resuscitation orders
39604|NCT03323489|celiac|celiac
39605|NCT03323489|radiosurgery|radiosurgery
39606|NCT03323489|sbrt|sbrt
39607|NCT03323489|radiotherapy|radiotherapy
39608|NCT03323489|pain|pain
39609|NCT03323463|squamous cell carcinoma of the neck of unknown primary|squamous cell carcinoma of the neck of unknown primary
39610|NCT03323463|HPV-Associated Oropharyngeal Squamous Cell Carcinoma|hpv-associated oropharyngeal squamous cell carcinoma
39611|NCT03323463|Oropharyngeal Squamous Cell Carcinoma|oropharyngeal squamous cell carcinoma
39612|NCT03323463|17-409|17-409
39613|NCT03323463|Hypoxia negative|hypoxia negative
39614|NCT03323463|T1-2n1-2b oropharyngeal squamous cell carcinoma|t1-2n1-2b oropharyngeal squamous cell carcinoma
39615|NCT03323450|High grade gliomas (WHO grade III or IV)|high grade gliomas (who grade iii or iv)
39616|NCT03323450|Low grade gliomas (WHO Grade II)|low grade gliomas (who grade ii)
39617|NCT03323424|Metastatic cancer|metastatic cancer
39618|NCT03323424|Abscopal effect|abscopal effect
39619|NCT03323424|Ionizing radiation|ionizing radiation
39620|NCT03323424|Antibody-Dependant Cell Cytotoxicity (ADCC)|antibody-dependant cell cytotoxicity (adcc)
39621|NCT03323424|Immuno-Radiation effect|immuno-radiation effect
39622|NCT03323424|Stereotactic Body Radio-Therapy (SBRT)|stereotactic body radio-therapy (sbrt)
39623|NCT03323424|Targeted therapies|targeted therapies
39624|NCT03323398|mRNA-2416|mrna-2416
39625|NCT03323398|OX40 ligand|ox40 ligand
39626|NCT03323398|OX40L|ox40l
39627|NCT03323385|Colorectal surgery|colorectal surgery
39628|NCT03323385|Pain|pain
39629|NCT03323385|Analgesia|analgesia
39630|NCT03323385|N1539|n1539
39631|NCT03323385|Phase 3b|phase 3b
39632|NCT03323359|Hemopatch|hemopatch
39633|NCT03323359|Hepatic resection|hepatic resection
39634|NCT03323359|Hemostasis|hemostasis
39635|NCT03323359|Surgery|surgery
39636|NCT03323346|metastatic breast cancer|metastatic breast cancer
39637|NCT03323346|disulfiram|disulfiram
39638|NCT03323346|cooper|cooper
39639|NCT03323294|Obesity|obesity
39640|NCT03323294|Pediatric Health|pediatric health
39641|NCT03323294|Type 2 Diabetes|type 2 diabetes
39642|NCT03323294|Insulin Resistance|insulin resistance
39643|NCT03323294|Metformin Therapy|metformin therapy
39644|NCT03323281|Diabetic foot|diabetic foot
39645|NCT03323281|Cognitive functions|cognitive functions
39646|NCT03323281|Psychiatric disorders|psychiatric disorders
39647|NCT03323281|Neurology|neurology
39648|NCT03323281|Psychiatry|psychiatry
39649|NCT03323268|Intensive care|intensive care
39650|NCT03323268|Cardiogenic shock|cardiogenic shock
39651|NCT03323268|Peripheral veno-arterial extracorporeal membrane oxygenation|peripheral veno-arterial extracorporeal membrane oxygenation
39652|NCT03323268|Left ventricular overload|left ventricular overload
39653|NCT03323268|Native cardiac output|native cardiac output
39654|NCT03323268|Pulmonary artery blood flow|pulmonary artery blood flow
39655|NCT03323268|End-tidal carbon dioxide|end-tidal carbon dioxide
39656|NCT03323268|Swan Ganz catheter|swan ganz catheter
39657|NCT03323268|Blood gaz|blood gaz
39658|NCT03323242|Vessel Sealing Devices|vessel sealing devices
39659|NCT03323242|Liver Transplantation|liver transplantation
39660|NCT03323229|Ultrasonography|ultrasonography
39661|NCT03323229|Ambulances|ambulances
39662|NCT03323229|Satellite Communications|satellite communications
39663|NCT03323229|Telemedicine|telemedicine
39664|NCT03323151|Relapsed Mantle-Cell Lymphoma|relapsed mantle-cell lymphoma
39665|NCT03323151|Refractory Mantle-Cell Lymphoma|refractory mantle-cell lymphoma
39666|NCT03323151|Ixazomib|ixazomib
39667|NCT03323151|Ibrutinib|ibrutinib
39668|NCT03323151|Proteasome Inhibitor|proteasome inhibitor
39669|NCT03323151|Bruton's Tyrosine Kinase Inhibitor|bruton's tyrosine kinase inhibitor
39670|NCT03323138|Ex-PRESS|ex-press
39671|NCT03323138|glaucoma|glaucoma
39672|NCT03323138|filtration surgery|filtration surgery
39673|NCT03323138|phacoemulsification|phacoemulsification
39674|NCT03323112|influenza|influenza
39675|NCT03323112|vaccination|vaccination
39676|NCT03323112|health care workers|health care workers
39677|NCT03323112|immune responses|immune responses
39678|NCT03323112|humoral immunity|humoral immunity
39679|NCT03323112|cellular immunity|cellular immunity
39680|NCT03323073|unipolar|unipolar
39681|NCT03323073|bipolar|bipolar
39682|NCT03323073|depression|depression
39683|NCT03323073|resting state fMRI|resting state fmri
39684|NCT03323073|neural network|neural network
39685|NCT03323073|connectivity|connectivity
39686|NCT03323047|tonsillectomy|tonsillectomy
39687|NCT03323047|acetaminophen|acetaminophen
39688|NCT03323047|dexamethasone|dexamethasone
39689|NCT03323008|Prisoners|prisoners
39690|NCT03323008|End-of-life Care|end-of-life care
39691|NCT03323008|Geriatric Care|geriatric care
39692|NCT03323008|Palliative Care|palliative care
39693|NCT03323008|Hospice Care|hospice care
39694|NCT03323008|Prison|prison
39695|NCT03323008|Corrections|corrections
39696|NCT03323008|Inmates|inmates
39697|NCT03322995|Molecular Profiling|molecular profiling
39698|NCT03322995|Neoadjuvant Therapy|neoadjuvant therapy
39699|NCT03322995|Adaptive therapeutic approach|adaptive therapeutic approach
39700|NCT03322982|diet, low-fat|diet, low-fat
39701|NCT03322956|Low back/lumbar spine|low back/lumbar spine
39702|NCT03322956|Multimodal Physical therapy|multimodal physical therapy
39703|NCT03322956|Quality of life|quality of life
39704|NCT03322956|Range of Motion|range of motion
39705|NCT03322956|Pain|pain
39706|NCT03322943|Ursodeoxycholic Acid|ursodeoxycholic acid
39707|NCT03322943|Response|response
39708|NCT03322930|microperimetry|microperimetry
39709|NCT03322930|rod visual fields|rod visual fields
39710|NCT03322917|dry eye|dry eye
39711|NCT03322917|PRP|prp
39712|NCT03322917|autologous|autologous
39713|NCT03322917|after LASIK|after lasik
39714|NCT03322917|ocular surface|ocular surface
39715|NCT03322904|iris collarette; autonomous nervous system|iris collarette; autonomous nervous system
39716|NCT03322891|Urology|urology
39717|NCT03322878|postoperative pain , pediatrics , magnesium sulfate|postoperative pain , pediatrics , magnesium sulfate
39718|NCT03322839|Guideline-adherence|guideline-adherence
39719|NCT03322839|Implementation|implementation
39720|NCT03322839|Implementation-strategies|implementation-strategies
39721|NCT03322839|Randomized-controlled-trial|randomized-controlled-trial
39722|NCT03322839|Organisational risk-factors|organisational risk-factors
39723|NCT03322839|Schools|schools
39724|NCT03322839|Social risk-factors|social risk-factors
39725|NCT03322813|Glioblastoma|glioblastoma
39726|NCT03322813|Blood Brain Barrier|blood brain barrier
39727|NCT03322813|BBB|bbb
39728|NCT03322813|ExAblate|exablate
39729|NCT03322813|Blood Brain Barrier Disruption|blood brain barrier disruption
39730|NCT03322774|Stepped Care|stepped care
39731|NCT03322761|Multiple sclerosis|multiple sclerosis
39732|NCT03322761|Exercise|exercise
39733|NCT03322761|Disease-modifying treatment|disease-modifying treatment
39734|NCT03322761|Early treatment|early treatment
39735|NCT03322683|Neck Pain|neck pain
39736|NCT03322683|Physical Therapy Modalities|physical therapy modalities
39737|NCT03322683|Massage|massage
39738|NCT03322683|Manual Therapy|manual therapy
39739|NCT03322670|community-acquired pneumonia|community-acquired pneumonia
39740|NCT03322670|family practice|family practice
39741|NCT03322670|streptococcus pneumoniae|streptococcus pneumoniae
39742|NCT03322657|Sugammadex|sugammadex
39743|NCT03322657|Neostigmine|neostigmine
39744|NCT03322657|Reversal of neuromuscular block|reversal of neuromuscular block
39745|NCT03322644|Pancreatitis|pancreatitis
39746|NCT03322644|Pain|pain
39747|NCT03322644|Internet Intervention|internet intervention
39748|NCT03322644|Behavioral Intervention|behavioral intervention
39749|NCT03322566|Non-small cell lung cancer|non-small cell lung cancer
39750|NCT03322566|programmed cell death 1 (PD-1) inhibitor|programmed cell death 1 (pd-1) inhibitor
39751|NCT03322566|indoleamine 2|indoleamine 2
39752|NCT03322566|3-dioxygenase 1 (IDO1) inhibitor|3-dioxygenase 1 (ido1) inhibitor
39753|NCT03322566|chemotherapy|chemotherapy
39754|NCT03322540|non-small cell lung cancer|non-small cell lung cancer
39755|NCT03322540|programmed cell death 1 (PD-1) inhibitor|programmed cell death 1 (pd-1) inhibitor
39756|NCT03322540|indoleamine 2|indoleamine 2
39757|NCT03322540|3-dioxygenase 1 (IDO1) inhibitor|3-dioxygenase 1 (ido1) inhibitor
39758|NCT03322514|gut hormones, obesity, appetite, propionate,fermentation|gut hormones, obesity, appetite, propionate,fermentation
39759|NCT03322449|APOA2|apoa2
39760|NCT03322449|Inflammation|inflammation
39761|NCT03322449|gene|gene
39762|NCT03322449|diet|diet
39763|NCT03322410|Fluid overload|fluid overload
39764|NCT03322410|Hydratation statud|hydratation statud
39765|NCT03322410|Peritoneal hypepermeability|peritoneal hypepermeability
39766|NCT03322410|Peritoneal dialysis|peritoneal dialysis
39767|NCT03322410|Impedancemetry|impedancemetry
39768|NCT03322397|adolescence|adolescence
39769|NCT03322397|immune function|immune function
39770|NCT03322397|gene expression|gene expression
39771|NCT03322397|psychological well-being|psychological well-being
39772|NCT03322397|social connection|social connection
39773|NCT03322397|kindness|kindness
39774|NCT03322345|lymph flow|lymph flow
39775|NCT03322345|Fontan|fontan
39776|NCT03322332|adiponectin|adiponectin
39777|NCT03322332|omentin-1|omentin-1
39778|NCT03322332|resistin|resistin
39779|NCT03322332|RBP4|rbp4
39780|NCT03322332|epicardial fat|epicardial fat
39781|NCT03322332|Coronary artery disease|coronary artery disease
39782|NCT03322319|Cardiac amyloidosis|cardiac amyloidosis
39783|NCT03322319|Caribbean|caribbean
39784|NCT03322319|Diagnosis|diagnosis
39785|NCT03322319|Transthyretin|transthyretin
39786|NCT03322306|genetic screening|genetic screening
39787|NCT03322306|neuro-degenerative disease|neuro-degenerative disease
39788|NCT03322293|Actinic Keratoses|actinic keratoses
39789|NCT03322293|photodynamic therapy|photodynamic therapy
39790|NCT03322293|aminolevulinic acid|aminolevulinic acid
39791|NCT03322293|precancerous skin lesion|precancerous skin lesion
39792|NCT03322280|Hepatocellular carcinoma|hepatocellular carcinoma
39793|NCT03322280|Portal vein tumor thrombus|portal vein tumor thrombus
39794|NCT03322280|Transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
39795|NCT03322280|iodine-125 seed|iodine-125 seed
39796|NCT03322267|Adjuvant pembrolizumab|adjuvant pembrolizumab
39797|NCT03322267|Chemoradiotherapy|chemoradiotherapy
39798|NCT03322228|Hospice|hospice
39799|NCT03322228|Palliative Care|palliative care
39800|NCT03322228|Integrative Medicine|integrative medicine
39801|NCT03322228|Music Therapy|music therapy
39802|NCT03322228|Inpatient|inpatient
39803|NCT03322228|Caregiver|caregiver
39804|NCT03322215|palbociclib|palbociclib
39805|NCT03322215|fulvestrant|fulvestrant
39806|NCT03322215|capecitabine|capecitabine
39807|NCT03322202|Spinal Cord Injury|spinal cord injury
39808|NCT03322202|Motivational Interviewing|motivational interviewing
39809|NCT03322150|Atropine|atropine
39810|NCT03322150|glycopyrrolate|glycopyrrolate
39811|NCT03322150|bradycardia|bradycardia
39812|NCT03322150|dexmedetomidine|dexmedetomidine
39813|NCT03322150|spinal anesthesia|spinal anesthesia
39814|NCT03322098|Atropine|atropine
39815|NCT03322098|glycopyrrolate|glycopyrrolate
39816|NCT03322098|bradycardia|bradycardia
39817|NCT03322098|dexmedetomidine|dexmedetomidine
39818|NCT03322098|spinal anesthesia|spinal anesthesia
39819|NCT03322085|atrial fibrillation|atrial fibrillation
39820|NCT03322085|atrial electrical remodeling|atrial electrical remodeling
39821|NCT03322046|Therapeutic Lifestyle Change|therapeutic lifestyle change
39822|NCT03322046|Cardiovascular Disease|cardiovascular disease
39823|NCT03322046|First Responders|first responders
39824|NCT03322046|Firefighters|firefighters
39826|NCT03322007|pain|pain
39827|NCT03322007|pancreas cancer|pancreas cancer
39828|NCT03322007|Scrambler Therapy|scrambler therapy
39829|NCT03321981|Bispecific Antibody IgG1, HER2 HER3|bispecific antibody igg1, her2 her3
39830|NCT03321981|MCLA-128|mcla-128
39831|NCT03321981|Antibodies, bispecific|antibodies, bispecific
39832|NCT03321981|Immunologic Factors|immunologic factors
39833|NCT03321981|Cytokines|cytokines
39834|NCT03321981|combination Trastuzumab with and without Vinorelbine|combination trastuzumab with and without vinorelbine
39835|NCT03321968|Influenza|influenza
39836|NCT03321968|Human|human
39837|NCT03321968|RNA Virus Infections|rna virus infections
39838|NCT03321968|Lot Consistency|lot consistency
39839|NCT03321968|Immunologic|immunologic
39840|NCT03321968|Orthomyxoviridae Infections|orthomyxoviridae infections
39841|NCT03321968|Infection|infection
39842|NCT03321968|Virus Diseases|virus diseases
39843|NCT03321942|Adipose Tissue-derived Mesenchymal Stem Cells|adipose tissue-derived mesenchymal stem cells
39844|NCT03321942|Chronic Kidney Diseases|chronic kidney diseases
39845|NCT03321916|MacTel|mactel
39846|NCT03321903|Oxygen|oxygen
39847|NCT03321903|Oximetry|oximetry
39848|NCT03321903|Electron Spin Resonance Spectroscopy|electron spin resonance spectroscopy
39849|NCT03321903|Carbon|carbon
39850|NCT03321903|Charcoal|charcoal
39851|NCT03321903|Radiotherapy|radiotherapy
39852|NCT03321903|India Ink|india ink
39853|NCT03321903|EPR|epr
39854|NCT03321903|ESR|esr
39855|NCT03321903|Immunotherapy|immunotherapy
39856|NCT03321890|relapsed or refractory|relapsed or refractory
39857|NCT03321890|peripheral T-cell lymphoma|peripheral t-cell lymphoma
39858|NCT03321890|Combination therapy|combination therapy
39859|NCT03321864|Transperineal biopsy|transperineal biopsy
39860|NCT03321864|Prostate cancer|prostate cancer
39861|NCT03321864|Transrectal ultrasound|transrectal ultrasound
39862|NCT03321864|Fusion biopsy techniques|fusion biopsy techniques
39863|NCT03321812|decalcification bone scaffold|decalcification bone scaffold
39864|NCT03321812|microfracture|microfracture
39865|NCT03321812|randomized controlled trial|randomized controlled trial
39866|NCT03321812|cartilage lesions of the knee|cartilage lesions of the knee
39867|NCT03321773|Helicobacter pylori|helicobacter pylori
39868|NCT03321773|Eradication rate|eradication rate
39869|NCT03321734|Caffeine|caffeine
39870|NCT03321734|Prematurity|prematurity
39871|NCT03321721|hand|hand
39872|NCT03321721|feet lacerations|feet lacerations
39873|NCT03321721|children|children
39874|NCT03321721|conservative management|conservative management
39875|NCT03321682|Cardiopulmonary Capacity|cardiopulmonary capacity
39876|NCT03321682|Quality of Life|quality of life
39877|NCT03321682|Functional Capacity|functional capacity
39878|NCT03321682|Functional Training|functional training
39879|NCT03321630|Pebrolizumab|pebrolizumab
39880|NCT03321630|Lenvatinib|lenvatinib
39881|NCT03321604|hemodialysis|hemodialysis
39882|NCT03321604|kidney|kidney
39883|NCT03321604|dialysis|dialysis
39884|NCT03321578|nosocomial|nosocomial
39885|NCT03321578|hospital acquired|hospital acquired
39886|NCT03321578|clostridium difficile|clostridium difficile
39887|NCT03321565|obesity|obesity
39888|NCT03321552|Desert foot|desert foot
39889|NCT03321552|No-option patients|no-option patients
39890|NCT03321552|Venous arterialization|venous arterialization
39891|NCT03321539|Nasopharyngeal carcinoma;adjuvant chemotherapy|nasopharyngeal carcinoma;adjuvant chemotherapy
39892|NCT03321513|Diabetic Macular Edema|diabetic macular edema
39893|NCT03321513|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
39894|NCT03321487|Blood-Brain Barrier disruption|blood-brain barrier disruption
39895|NCT03321487|Blood-Brain Barrier opening|blood-brain barrier opening
39896|NCT03321487|magnetic resonance-guided focused ultrasound|magnetic resonance-guided focused ultrasound
39897|NCT03321409|Somatic symptom|somatic symptom
39899|NCT03321409|PHQ-15|phq-15
39900|NCT03321409|Suspected CAD|suspected cad
39901|NCT03321409|Coronary angiography|coronary angiography
39902|NCT03321396|Sodium Alginate|sodium alginate
39903|NCT03321396|Calcium Lactate|calcium lactate
39904|NCT03321396|Gel|gel
39905|NCT03321383|dyspepsia|dyspepsia
39906|NCT03321383|health related quality of life|health related quality of life
39907|NCT03321331|Mobile Health|mobile health
39908|NCT03321331|mobile apps|mobile apps
39909|NCT03321331|weight control|weight control
39910|NCT03321331|weight management|weight management
39911|NCT03321331|self-directed intervention|self-directed intervention
39912|NCT03321331|behavioral intervention|behavioral intervention
39913|NCT03321266|Fistula plug|fistula plug
39914|NCT03321253|Posterior Capsule Opacification|posterior capsule opacification
39915|NCT03321253|Macular Pigment Optical Density|macular pigment optical density
39916|NCT03321253|Anterior Chamber Parameters|anterior chamber parameters
39917|NCT03321253|Nd: YAG Laser Posterior Capsulotomy|nd: yag laser posterior capsulotomy
39918|NCT03321253|Posterior Capsulotomy|posterior capsulotomy
39919|NCT03321253|Cystoid Macular Edema|cystoid macular edema
39920|NCT03321253|Choroidal Thickness|choroidal thickness
39921|NCT03321240|focal cortical dysplasia|focal cortical dysplasia
39922|NCT03321240|Pronostic|pronostic
39923|NCT03321240|Epilepsy surgery|epilepsy surgery
39924|NCT03321240|Epiletogenicity index|epiletogenicity index
39925|NCT03321240|SEEG|seeg
39926|NCT03321227|Children|children
39927|NCT03321227|Nutrition|nutrition
39928|NCT03321227|Eggs|eggs
39929|NCT03321227|Cognitive performance|cognitive performance
39930|NCT03321227|Glycemic response|glycemic response
39931|NCT03321227|Appetite|appetite
39932|NCT03321227|Emotion|emotion
39933|NCT03321214|Gluten Free diet|gluten free diet
39934|NCT03321188|Heated intraperitoneal chemotherapy|heated intraperitoneal chemotherapy
39935|NCT03321188|HIPEC|hipec
39936|NCT03321188|cisplatin|cisplatin
39937|NCT03321188|paclitaxel|paclitaxel
39938|NCT03321188|carboplatin|carboplatin
39939|NCT03321188|adjuvant IV chemotherapy|adjuvant iv chemotherapy
39940|NCT03321175|Wound|wound
39941|NCT03321175|infection|infection
39942|NCT03321175|cesarean section|cesarean section
39943|NCT03321162|surgical guide , double scan , triple scan protocol|surgical guide , double scan , triple scan protocol
39944|NCT03321149|Web-based intervention|web-based intervention
39945|NCT03321149|Sedentary behavior|sedentary behavior
39946|NCT03321149|Lifestyle intervention|lifestyle intervention
39947|NCT03321149|Feasibility|feasibility
39948|NCT03321123|B cell Acute Lymphoblastic Leukemia|b cell acute lymphoblastic leukemia
39949|NCT03321123|relapsed or refractory|relapsed or refractory
39950|NCT03321123|CD-19 Positive|cd-19 positive
39951|NCT03321097|stroke rehabilitation|stroke rehabilitation
39952|NCT03321097|spasticity|spasticity
39953|NCT03321097|Botulinum toxin type A injection|botulinum toxin type a injection
39954|NCT03321097|robot-assisted therapy|robot-assisted therapy
39955|NCT03321097|massed therapy|massed therapy
39956|NCT03321097|distributed therapy|distributed therapy
39957|NCT03321084|Osteoarthrosis|osteoarthrosis
39958|NCT03321084|Exercise Movement Techniques|exercise movement techniques
39959|NCT03321084|Pilates|pilates
39960|NCT03321084|Elderly|elderly
39961|NCT03321084|Physiotherapy|physiotherapy
39962|NCT03321058|Drug Substitution|drug substitution
39963|NCT03321058|Multicompartment Compliance Aid|multicompartment compliance aid
39964|NCT03321045|89Zr-Trastuzumab, HER2 Imaging|89zr-trastuzumab, her2 imaging
39965|NCT03321032|Coronary Artery Disease|coronary artery disease
39966|NCT03321032|Diabetes Mellitus|diabetes mellitus
39967|NCT03321032|Drug-eluting stents|drug-eluting stents
39968|NCT03321032|Restenosis|restenosis
39969|NCT03320993|post-prandial glucose control|post-prandial glucose control
39970|NCT03320993|alcohol|alcohol
39971|NCT03320980|ALPPS|alpps
39972|NCT03320980|RALPPS|ralpps
39973|NCT03320980|Portal Vein Embolization|portal vein embolization
39974|NCT03320980|Hilar Cholangiocarcinoma|hilar cholangiocarcinoma
39975|NCT03320980|Intrahepatic Cholangiocarcinoma|intrahepatic cholangiocarcinoma
39976|NCT03320954|Language|language
39977|NCT03320954|Anomia|anomia
39978|NCT03320941|Obesity disease|obesity disease
39979|NCT03320941|Over weight|over weight
39980|NCT03320941|T2DM|t2dm
39981|NCT03320941|interventional study|interventional study
39982|NCT03320941|Weight loss|weight loss
39983|NCT03320902|Family members|family members
39984|NCT03320902|sudden death|sudden death
39985|NCT03320902|sudden death counseling|sudden death counseling
39986|NCT03320902|depression|depression
39987|NCT03320837|metabolomics|metabolomics
39988|NCT03320837|microbiome|microbiome
39989|NCT03320837|infant formula|infant formula
39990|NCT03320837|synbiotics|synbiotics
39991|NCT03320837|urine samples|urine samples
39992|NCT03320837|NMR analysis|nmr analysis
39993|NCT03320811|Celiac disease|celiac disease
39994|NCT03320811|serological tests|serological tests
39995|NCT03320811|anti-deamidated gliadin peptide antibodies|anti-deamidated gliadin peptide antibodies
39996|NCT03320798|Bullous pemphigoid|bullous pemphigoid
41065|NCT03314285|Cervicalgia|cervicalgia
39997|NCT03320798|neurologic disorders|neurologic disorders
39998|NCT03320785|preterm infants|preterm infants
39999|NCT03320785|sepsis|sepsis
40000|NCT03320785|chorioamnionitis|chorioamnionitis
40001|NCT03320785|circulating markers|circulating markers
40002|NCT03320746|Physical activity|physical activity
40003|NCT03320746|Sedentary time|sedentary time
40004|NCT03320746|Intervention|intervention
40005|NCT03320746|Retiree|retiree
40006|NCT03320733|dual energy CT|dual energy ct
40007|NCT03320694|Gestational Diabetes Mellitus, Metformin, Insulin|gestational diabetes mellitus, metformin, insulin
40008|NCT03320681|Neurostimulator|neurostimulator
40009|NCT03320668|Falls Prevention|falls prevention
40010|NCT03320668|Otago Program|otago program
40011|NCT03320668|Community-Dwelling|community-dwelling
40012|NCT03320655|Chronic Heart Failure|chronic heart failure
40013|NCT03320655|Fragility|fragility
40014|NCT03320642|Acute leukemia|acute leukemia
40015|NCT03320642|chronic myelogenous leukemia|chronic myelogenous leukemia
40016|NCT03320642|myelodysplasia|myelodysplasia
40017|NCT03320642|chronic lymphocytic leukemia/small lymphocytic lymphoma|chronic lymphocytic leukemia/small lymphocytic lymphoma
40018|NCT03320642|follicular|follicular
40019|NCT03320642|marginal zone|marginal zone
40020|NCT03320642|diffuse large B-cell|diffuse large b-cell
40021|NCT03320642|Hodgkin's lymphoma|hodgkin's lymphoma
40022|NCT03320642|mantle cell lymphoma|mantle cell lymphoma
40023|NCT03320642|Janus kinase inhibitor|janus kinase inhibitor
40024|NCT03320642|graft-versus-host disease|graft-versus-host disease
40025|NCT03320590|Time lapse Primovision|time lapse primovision
40026|NCT03320590|Spermatic nuclear quality|spermatic nuclear quality
40027|NCT03320590|intracytoplasmic sperm injection (ICSI)|intracytoplasmic sperm injection (icsi)
40028|NCT03320590|Embryonic kinetics|embryonic kinetics
40029|NCT03320564|injections, intravenous|injections, intravenous
40030|NCT03320564|fluorodeoxyglucose F-18|fluorodeoxyglucose f-18
40031|NCT03320551|Education|education
40032|NCT03320538|Jiangzhong Hou Gu® Mi Xi™|jiangzhong hou gu® mi xi™
40033|NCT03320538|Shen Ling Bai Zhu San|shen ling bai zhu san
40034|NCT03320538|peptic ulcer disease|peptic ulcer disease
40035|NCT03320538|traditional Chinese medicine|traditional chinese medicine
40036|NCT03320538|randomized controlled trial|randomized controlled trial
40037|NCT03320525|YKL-40|ykl-40
40038|NCT03320525|Pharmacokinetic|pharmacokinetic
40039|NCT03320525|Solid tumors|solid tumors
40040|NCT03320525|T-ChOS|t-chos
40041|NCT03320525|Benecta|benecta
40042|NCT03320525|chitinase 3 like-1 protein (CHI3L1)|chitinase 3 like-1 protein (chi3l1)
40043|NCT03320512|PrEP|prep
40044|NCT03320512|gamification|gamification
40045|NCT03320512|mHealth|mhealth
40046|NCT03320512|HIV prevention|hiv prevention
40047|NCT03320512|truvada|truvada
40048|NCT03320512|eHealth|ehealth
40049|NCT03320512|app|app
40050|NCT03320512|adherence|adherence
40051|NCT03320512|ymsm|ymsm
40052|NCT03320512|transgender women|transgender women
40053|NCT03320486|Mycoses|mycoses
40054|NCT03320486|Dermatomycoses|dermatomycoses
40055|NCT03320486|Antifugal Agents|antifugal agents
40056|NCT03320486|Dapaconazole|dapaconazole
40057|NCT03320460|oral lichen planus; photobiomodulation; inflammation|oral lichen planus; photobiomodulation; inflammation
40058|NCT03320447|ablative fractional laser|ablative fractional laser
40059|NCT03320447|photodynamic therapy|photodynamic therapy
40060|NCT03320447|protoporphyrin IX|protoporphyrin ix
40061|NCT03320447|methy-aminolevulinate|methy-aminolevulinate
40062|NCT03320421|hypofractionated radiation|hypofractionated radiation
40063|NCT03320421|breast cancer|breast cancer
40064|NCT03320421|breast conserving surgery|breast conserving surgery
40065|NCT03320421|simultaneous boost radiation|simultaneous boost radiation
40066|NCT03320408|biobank|biobank
40067|NCT03320408|pathogenesis|pathogenesis
40068|NCT03320408|Aortic Aneurysm|aortic aneurysm
40069|NCT03320304|Difficult to Treat Depression|difficult to treat depression
40070|NCT03320304|TRD|trd
40071|NCT03320304|VNS Therapy|vns therapy
40072|NCT03320304|Vagus Nerve Stimulation|vagus nerve stimulation
40073|NCT03320304|VNS|vns
40074|NCT03320291|Rhizarthrosis|rhizarthrosis
40075|NCT03320291|Regjoint|regjoint
40076|NCT03320291|Trapeziectomy|trapeziectomy
40077|NCT03320278|endotracheal intubation|endotracheal intubation
40078|NCT03320278|airway management|airway management
40079|NCT03320265|Phosphorylcholine human monoclonal antibody|phosphorylcholine human monoclonal antibody
40080|NCT03320265|Lipoprotein a|lipoprotein a
40081|NCT03320252|CHEVAR|chevar
40082|NCT03320252|Chimney|chimney
40083|NCT03320252|Juxtarenal|juxtarenal
40084|NCT03320252|Short Infrarenal /neck|short infrarenal /neck
40085|NCT03320252|Endurant|endurant
40086|NCT03320239|HIV|hiv
40087|NCT03320239|risk assessment|risk assessment
40088|NCT03320239|HIV testing|hiv testing
40089|NCT03320239|unprotected anal intercourse|unprotected anal intercourse
40090|NCT03320239|Social medica|social medica
40091|NCT03320213|CA125|ca125
40092|NCT03320213|Yolk sac morphology|yolk sac morphology
40093|NCT03320213|Threatened miscarriage|threatened miscarriage
40094|NCT03320174|tafenoquine|tafenoquine
40095|NCT03320174|australia|australia
40096|NCT03320161|Supportive care|supportive care
40097|NCT03320161|Cancer|cancer
40098|NCT03320161|Health-related quality of life|health-related quality of life
40099|NCT03320161|Consensus|consensus
40100|NCT03320161|Participative approach|participative approach
40101|NCT03320161|Patient involvement|patient involvement
40102|NCT03320161|DELPHI method|delphi method
40103|NCT03320135|enamel matrix derivative|enamel matrix derivative
40104|NCT03320135|proximal furcation|proximal furcation
40105|NCT03320135|randomized clinical trial|randomized clinical trial
40106|NCT03320122|Telemedicine|telemedicine
40107|NCT03320083|sleep, infants, behavioural insomnia, breastfeeding|sleep, infants, behavioural insomnia, breastfeeding
40108|NCT03320057|medication abortion|medication abortion
40109|NCT03320057|mifepristone|mifepristone
40110|NCT03320044|Circulating Tumor DNA|circulating tumor dna
40111|NCT03320044|Lung cancer Surgery|lung cancer surgery
40112|NCT03320044|early diagnosis|early diagnosis
40113|NCT03320044|immuno-sequencing|immuno-sequencing
40114|NCT03320031|Linagliptin|linagliptin
40115|NCT03320031|premixedinsulin therapy|premixedinsulin therapy
40116|NCT03320031|peritoneal dialysis|peritoneal dialysis
40117|NCT03320031|glycemic variability|glycemic variability
40118|NCT03320018|neuroprotection|neuroprotection
40119|NCT03320018|antioxidant|antioxidant
40120|NCT03320005|respiratory performance|respiratory performance
40121|NCT03320005|quality of life|quality of life
40122|NCT03320005|physical performance|physical performance
40123|NCT03319992|Robotics [H01.671.293.643]|robotics [h01.671.293.643]
40124|NCT03319992|Exoskeleton Device [E07.341]|exoskeleton device [e07.341]
40125|NCT03319992|Rehabilitation Research [H01.770.644.145.472]|rehabilitation research [h01.770.644.145.472]
40126|NCT03319992|Physical and Rehabilitation Medicine [H02.403.680]|physical and rehabilitation medicine [h02.403.680]
40127|NCT03319992|Exercise Therapy [E02.779.483]|exercise therapy [e02.779.483]
40128|NCT03319992|Patient Outcome Assessment [N05.715.360.575.575.399]|patient outcome assessment [n05.715.360.575.575.399]
40129|NCT03319979|Folate, DHFR|folate, dhfr
40130|NCT03319953|Drug therapy|drug therapy
40131|NCT03319927|integrated pest management|integrated pest management
40132|NCT03319927|environmental health|environmental health
40133|NCT03319927|child care|child care
40134|NCT03319927|preschool children|preschool children
40135|NCT03319927|pesticides|pesticides
40136|NCT03319914|calciphylaxis, calcific uremic arteriolopathy,|calciphylaxis, calcific uremic arteriolopathy,
40137|NCT03319914|calcium metabolism disorders|calcium metabolism disorders
40138|NCT03319914|metabolic diseases|metabolic diseases
40139|NCT03319914|sodium thiosulfate|sodium thiosulfate
40140|NCT03319901|Leukemia|leukemia
40141|NCT03319888|CPAP, Chronic kidney disease, sleep apnea|cpap, chronic kidney disease, sleep apnea
40142|NCT03319875|Epiduroscopy|epiduroscopy
40143|NCT03319875|Discectomy|discectomy
40144|NCT03319875|Holmium Yag laser|holmium yag laser
40145|NCT03319875|Lumbar disc herniation|lumbar disc herniation
40146|NCT03319875|Minimally invasive treatment|minimally invasive treatment
40147|NCT03319849|Ciliary Neurotrophic Factor (CNTF)|ciliary neurotrophic factor (cntf)
40148|NCT03319849|Macular Telangiectasia (MacTel)|macular telangiectasia (mactel)
40149|NCT03319810|MCI, Alzheimer Disease, AD|mci, alzheimer disease, ad
40150|NCT03319797|Autologous chondrocyte transplantation ACT|autologous chondrocyte transplantation act
40151|NCT03319771|exercise|exercise
40152|NCT03319771|neuroimaging|neuroimaging
40153|NCT03319771|walking|walking
40154|NCT03319771|multiple sclerosis|multiple sclerosis
40155|NCT03319758|bone augmentation|bone augmentation
40156|NCT03319758|esthetics|esthetics
40157|NCT03319758|immediate implant|immediate implant
40158|NCT03319758|buccal bone defects|buccal bone defects
40159|NCT03319745|Malignant neoplasms of urinary tract|malignant neoplasms of urinary tract
40160|NCT03319745|Urothelial carcinoma of the bladder|urothelial carcinoma of the bladder
40161|NCT03319745|Pembrolizumab|pembrolizumab
40162|NCT03319745|Keytruda|keytruda
40163|NCT03319745|MK-3475|mk-3475
40164|NCT03319745|SCH-900475|sch-900475
40165|NCT03319654|Unexplained Infertility|unexplained infertility
40166|NCT03319654|Idiopathic Infertility|idiopathic infertility
40167|NCT03319654|DNA damage|dna damage
40168|NCT03319654|DNA fragmentation|dna fragmentation
40169|NCT03319654|Insemination|insemination
40170|NCT03319641|68Ga-PSMA|68ga-psma
40171|NCT03319641|Positron-Emission Tomography|positron-emission tomography
40172|NCT03319641|Immunohistochemistry|immunohistochemistry
40173|NCT03319615|Appetite|appetite
40174|NCT03319615|Energy Intake|energy intake
40175|NCT03319615|Body Composition|body composition
40176|NCT03319615|Energy Expenditure|energy expenditure
40177|NCT03319602|oxygen mask|oxygen mask
40178|NCT03319602|high-flow oxygen therapy|high-flow oxygen therapy
40179|NCT03319602|acute respiratory failure|acute respiratory failure
40180|NCT03319576|Gastrostomy|gastrostomy
40181|NCT03319576|Feeding|feeding
40182|NCT03319576|G-tube|g-tube
40183|NCT03319550|milk protein, endotoxemia, muscle protein synthesis, whey, casein|milk protein, endotoxemia, muscle protein synthesis, whey, casein
40184|NCT03319537|Pevonedistat|pevonedistat
40185|NCT03319537|Pemetrexed|pemetrexed
40186|NCT03319537|Cisplatin|cisplatin
40187|NCT03319537|17-361|17-361
40188|NCT03319511|thoracic spinal|thoracic spinal
40189|NCT03319511|awake mastectomy|awake mastectomy
40190|NCT03319511|paravertebral block|paravertebral block
40191|NCT03319511|analgesia|analgesia
40192|NCT03319511|ultrasound|ultrasound
40193|NCT03319511|breast cancer|breast cancer
40194|NCT03319485|ExAblate|exablate
40195|NCT03319485|TcMRgFUS|tcmrgfus
40196|NCT03319485|Pallidotomy|pallidotomy
40197|NCT03319472|malignant|malignant
40198|NCT03319472|cancer|cancer
40199|NCT03319472|simple bedside test|simple bedside test
40200|NCT03319472|rapid|rapid
40201|NCT03319472|score|score
40202|NCT03319472|widely available|widely available
40203|NCT03319472|feasible|feasible
40204|NCT03319459|Solid Tumor|solid tumor
40205|NCT03319459|HER2|her2
40206|NCT03319459|EGFR|egfr
40207|NCT03319459|Advanced Solid Tumor|advanced solid tumor
40208|NCT03319459|Breast Cancer|breast cancer
40209|NCT03319459|Head and Neck Cancer|head and neck cancer
40210|NCT03319459|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
40211|NCT03319459|Colorectal Cancer|colorectal cancer
40212|NCT03319459|Gastric Cancer|gastric cancer
40213|NCT03319459|HER2 Positive|her2 positive
40214|NCT03319459|EGFR Positive|egfr positive
40215|NCT03319459|EGFR+|egfr+
40216|NCT03319459|HER2+|her2+
40217|NCT03319459|Immunotherapy|immunotherapy
40218|NCT03319459|NK cell therapy|nk cell therapy
40219|NCT03319459|Natural killer cell therapy|natural killer cell therapy
40220|NCT03319459|antibody-dependent cell-mediated cytotoxicity|antibody-dependent cell-mediated cytotoxicity
40221|NCT03319459|ADCC|adcc
40222|NCT03319433|spinal hypotension|spinal hypotension
40223|NCT03319433|perfusion index|perfusion index
40224|NCT03319433|caesarean section|caesarean section
40225|NCT03319394|Firefighters|firefighters
40226|NCT03319394|Exercise Training|exercise training
40227|NCT03319394|Resistance Training|resistance training
40228|NCT03319394|Exercise Test|exercise test
40229|NCT03319394|High-Intensity Interval Training|high-intensity interval training
40230|NCT03319381|Algorithm|algorithm
40231|NCT03319381|In-hospital mortality|in-hospital mortality
40232|NCT03319381|Multiple trauma|multiple trauma
40233|NCT03319381|Standard of care|standard of care
40234|NCT03319355|multicomponent therapy|multicomponent therapy
40235|NCT03319264|Spondylarthropathy|spondylarthropathy
40236|NCT03319264|Sarcopenia|sarcopenia
40237|NCT03319264|lean mass|lean mass
40238|NCT03319264|fat mass|fat mass
40239|NCT03319238|Chronic pain|chronic pain
40240|NCT03319238|Neuropathic pain|neuropathic pain
40241|NCT03319238|Ketamine|ketamine
40242|NCT03319238|Concomitant treatment|concomitant treatment
40243|NCT03319238|Adverse effect|adverse effect
40244|NCT03319173|Mild Cognitive Impairment|mild cognitive impairment
40245|NCT03319173|AMPK activation|ampk activation
40246|NCT03319173|DNA global hypo-methylation|dna global hypo-methylation
40247|NCT03319173|Metabolic Syndrome|metabolic syndrome
40248|NCT03319173|Ketogenic diet|ketogenic diet
40249|NCT03319147|exercise|exercise
40250|NCT03319147|recovery|recovery
40251|NCT03319147|muscle|muscle
40252|NCT03319147|protein|protein
40253|NCT03319121|Non cardiac chest pain|non cardiac chest pain
40254|NCT03319121|Empirical therapy|empirical therapy
40255|NCT03319121|Guided therapy|guided therapy
40256|NCT03319095|pelvic floor, muscle, electrical stimulation, physiotherapy|pelvic floor, muscle, electrical stimulation, physiotherapy
40257|NCT03319043|Cough Variant Asthma|cough variant asthma
40258|NCT03319043|impedance|impedance
40259|NCT03319043|inflammation|inflammation
40260|NCT03319043|Chanqin granules|chanqin granules
40261|NCT03319030|exercise|exercise
40262|NCT03319030|Aerobic Exercise|aerobic exercise
40263|NCT03319017|Hypoxia|hypoxia
40264|NCT03319017|Hyperinflammatory|hyperinflammatory
40265|NCT03319017|Hyperoxia|hyperoxia
40266|NCT03319017|Apoptosis|apoptosis
40267|NCT03319017|Oxygenation|oxygenation
40268|NCT03319017|Polymorphonuclear Cells|polymorphonuclear cells
40269|NCT03319017|Tumor necrosis factor(TNF)-α|tumor necrosis factor(tnf)-α
40270|NCT03319017|Cytokine|cytokine
40271|NCT03318991|thulium laser|thulium laser
40272|NCT03318991|GreenLight laser|greenlight laser
40273|NCT03318991|laser therapy|laser therapy
40274|NCT03318991|resection of the prostate|resection of the prostate
40275|NCT03318991|prostate hyperplasia|prostate hyperplasia
40276|NCT03318978|Benzo[a]pyrene|benzo[a]pyrene
40277|NCT03318978|Accelerator Mass Spectrometry|accelerator mass spectrometry
40278|NCT03318978|Polycyclic Aromatic Hydrocarbons|polycyclic aromatic hydrocarbons
40279|NCT03318965|Mortality|mortality
40280|NCT03318965|Anthropometry|anthropometry
40281|NCT03318965|Nutrition Assessment|nutrition assessment
40282|NCT03318965|Caliper|caliper
40283|NCT03318952|lidocaine injection|lidocaine injection
40284|NCT03318952|articaine injections|articaine injections
40285|NCT03318952|pediatric dental anesthesia|pediatric dental anesthesia
40286|NCT03318952|post dental procedure pain|post dental procedure pain
40287|NCT03318939|EGFR|egfr
40288|NCT03318939|HER2|her2
41163|NCT03313414|Needlestick|needlestick
40289|NCT03318939|Exon 20 insertion mutation|exon 20 insertion mutation
40290|NCT03318926|tea, cup-year, renal stone disease|tea, cup-year, renal stone disease
40291|NCT03318913|Vascular function|vascular function
40292|NCT03318913|Type 2 diabetes mellitus|type 2 diabetes mellitus
40293|NCT03318913|Fish protein hydrolysates|fish protein hydrolysates
40294|NCT03318900|adoptively transferred central memory-type CTL targeting ovarian cancer antigens|adoptively transferred central memory-type ctl targeting ovarian cancer antigens
40295|NCT03318900|in vivo persistence|in vivo persistence
40296|NCT03318900|Adoptive Cellular Therapy|adoptive cellular therapy
40297|NCT03318900|IL-21-Primed CD8+ Tumor Antigen-Specific T Cells|il-21-primed cd8+ tumor antigen-specific t cells
40298|NCT03318900|epithelial ovarian cancer|epithelial ovarian cancer
40299|NCT03318887|Cirrhosis|cirrhosis
40300|NCT03318887|Direct acting antiviral agents|direct acting antiviral agents
40301|NCT03318887|Hepatitis C|hepatitis c
40302|NCT03318887|Pharmacological monitoring|pharmacological monitoring
40303|NCT03318874|Dry Eye Disease|dry eye disease
40304|NCT03318874|Meibomian Gland Dysfunction|meibomian gland dysfunction
40305|NCT03318874|Blephasteam|blephasteam
40306|NCT03318874|THERA°PEARL Eye Mask|thera°pearl eye mask
40307|NCT03318848|students, nursing|students, nursing
40308|NCT03318848|simulation training|simulation training
40309|NCT03318848|Instructional Films and Videos|instructional films and videos
40310|NCT03318848|Aptitude|aptitude
40311|NCT03318835|Thalidomide|thalidomide
40312|NCT03318835|R-CHOP|r-chop
40313|NCT03318835|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
40314|NCT03318822|brain injury|brain injury
40315|NCT03318809|Cardiovascular Diseases|cardiovascular diseases
40316|NCT03318809|Renal Impairment|renal impairment
40317|NCT03318809|Heart Diseases|heart diseases
40318|NCT03318796|Bifurcation lesions|bifurcation lesions
40319|NCT03318783|Eicosanoids|eicosanoids
40320|NCT03318783|Epoxyeicosatrienoic Acids|epoxyeicosatrienoic acids
40321|NCT03318770|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
40322|NCT03318770|adult|adult
40323|NCT03318770|dasatinib|dasatinib
40324|NCT03318770|blinatumomab|blinatumomab
40325|NCT03318770|LAL2116|lal2116
40326|NCT03318757|bupivacaine liposomal injectable|bupivacaine liposomal injectable
40327|NCT03318757|post operative pain|post operative pain
40328|NCT03318757|post operative narcotic use|post operative narcotic use
40329|NCT03318757|bupivacaine hydrochloride|bupivacaine hydrochloride
40330|NCT03318744|Silent Brain Infarction|silent brain infarction
40331|NCT03318744|Antithrombotics|antithrombotics
40332|NCT03318744|Antiplatelet|antiplatelet
40333|NCT03318744|Aspirin|aspirin
40334|NCT03318744|Asymptomatic|asymptomatic
40335|NCT03318731|fenugreek extract|fenugreek extract
40336|NCT03318731|non-resistance trained|non-resistance trained
40337|NCT03318666|Adolescent|adolescent
40338|NCT03318666|Adolescent Medicine|adolescent medicine
40339|NCT03318666|Mental Health Services|mental health services
40340|NCT03318666|eHealth|ehealth
40341|NCT03318666|Online systems|online systems
40342|NCT03318666|Primary Health Care|primary health care
40343|NCT03318666|Social media|social media
40344|NCT03318666|Social support|social support
40345|NCT03318653|Blood pressure|blood pressure
40346|NCT03318653|Dialysis|dialysis
40347|NCT03318640|schizophrenia|schizophrenia
40348|NCT03318640|mindfulness|mindfulness
40349|NCT03318640|parasympathetic system|parasympathetic system
40350|NCT03318614|Gut Microbiota|gut microbiota
40351|NCT03318614|Probiotics|probiotics
40352|NCT03318614|Abdominal Pain|abdominal pain
40353|NCT03318614|Small Intestinal Bacterial Overgrowth|small intestinal bacterial overgrowth
40354|NCT03318614|Mental|mental
40355|NCT03318601|cirrhotic|cirrhotic
40356|NCT03318601|ascite|ascite
40357|NCT03318601|copeptin|copeptin
40358|NCT03318588|Retinal detachment|retinal detachment
40359|NCT03318588|Photoreceptor apoptosis|photoreceptor apoptosis
40360|NCT03318588|Cytokine|cytokine
40361|NCT03318575|remote ischemic conditioning (RIC)|remote ischemic conditioning (ric)
40362|NCT03318575|percutaneous coronary intervention|percutaneous coronary intervention
40363|NCT03318575|PCI|pci
40364|NCT03318575|cardiac troponin I|cardiac troponin i
40365|NCT03318575|cardiac catheterization|cardiac catheterization
40366|NCT03318575|myocardial injury|myocardial injury
40367|NCT03318575|myocardial necrosis|myocardial necrosis
40368|NCT03318575|autoRIC|autoric
40369|NCT03318575|Ischemia-Reperfusion Injury (IRI)|ischemia-reperfusion injury (iri)
40370|NCT03318575|Automated Remote Ischemic Conditioning|automated remote ischemic conditioning
40371|NCT03318549|virtual reality|virtual reality
40372|NCT03318549|glaucoma|glaucoma
40373|NCT03318549|age related macular degeneration|age related macular degeneration
40374|NCT03318549|quality of life|quality of life
40375|NCT03318549|visual field|visual field
40376|NCT03318549|optical coherence tomography|optical coherence tomography
40377|NCT03318536|Serotonin Antagonists|serotonin antagonists
40378|NCT03318536|Sympathomimetics|sympathomimetics
40379|NCT03318523|BIIB054|biib054
40380|NCT03318523|Parkinson's Disease|parkinson's disease
40381|NCT03318523|Alpha-synuclein|alpha-synuclein
40382|NCT03318523|Alpha synuclein|alpha synuclein
41365|NCT03312036|Resin|resin
40383|NCT03318497|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
40384|NCT03318497|18F-FLT|18f-flt
40385|NCT03318497|FLT|flt
40386|NCT03318497|Locally advanced pancreatic adenocarcinoma|locally advanced pancreatic adenocarcinoma
40387|NCT03318497|Borderline resectable pancreatic adenocarcinoma|borderline resectable pancreatic adenocarcinoma
40388|NCT03318471|MgSo4, Mayfield clamp, pressor effect|mgso4, mayfield clamp, pressor effect
40389|NCT03318445|DNA repair mutation|dna repair mutation
40390|NCT03318432|Stroke|stroke
40391|NCT03318432|Acute Stroke|acute stroke
40392|NCT03318432|Ischemic Stroke|ischemic stroke
40393|NCT03318432|Hemorrhagic Stroke|hemorrhagic stroke
40394|NCT03318432|Cerebral Ischemia|cerebral ischemia
40395|NCT03318432|Cerebral Infarction|cerebral infarction
40396|NCT03318432|Cerebral Stroke|cerebral stroke
40397|NCT03318432|Cerebral Vascular Accident|cerebral vascular accident
40398|NCT03318432|Stroke Recovery|stroke recovery
40399|NCT03318406|registry|registry
40400|NCT03318406|vapor ablation|vapor ablation
40401|NCT03318406|InterVapor|intervapor
40402|NCT03318406|BTVA|btva
40403|NCT03318315|AS03-adjuvanted Inactivated Influenza Vaccine|as03-adjuvanted inactivated influenza vaccine
40404|NCT03318315|Co-Administered|co-administered
40405|NCT03318315|Healthy Adults|healthy adults
40406|NCT03318315|Immunogenicity|immunogenicity
40407|NCT03318315|Inactivated Seasonal Influenza Vaccine|inactivated seasonal influenza vaccine
40408|NCT03318315|Phase II|phase ii
40409|NCT03318315|Safety|safety
40410|NCT03318263|Estrogen-receptor-positive breast cancer|estrogen-receptor-positive breast cancer
40411|NCT03318263|aromatase inhibitor,|aromatase inhibitor,
40412|NCT03318263|ESR1,|esr1,
40413|NCT03318263|PIK3CA|pik3ca
40414|NCT03318263|AKT|akt
40415|NCT03318263|endocrine resistance|endocrine resistance
40416|NCT03318263|circulating tumor DNA|circulating tumor dna
40417|NCT03318250|DRG Stimulation|drg stimulation
40418|NCT03318211|preeclampsia|preeclampsia
40419|NCT03318211|Magnisium sulfate|magnisium sulfate
40420|NCT03318198|Graduate Medical Education|graduate medical education
40421|NCT03318198|Attending Supervision of Residents|attending supervision of residents
40422|NCT03318198|Patient Safety|patient safety
40423|NCT03318185|gasless single-port laparoscopic surgery;rectal carcinoma|gasless single-port laparoscopic surgery;rectal carcinoma
40424|NCT03318172|Spinal Cord Stimulation|spinal cord stimulation
40425|NCT03318172|High Density Stimulation|high density stimulation
40426|NCT03318146|Plugged Tear Duct|plugged tear duct
40427|NCT03318133|general anesthesia|general anesthesia
40428|NCT03318133|sacral plexus block|sacral plexus block
40429|NCT03318133|lumbar plexus block|lumbar plexus block
40430|NCT03318133|hip fracture|hip fracture
40431|NCT03318133|elderly|elderly
40432|NCT03318094|insulin resistance|insulin resistance
40433|NCT03318094|phentolamine|phentolamine
40434|NCT03318094|microvascular recruitment|microvascular recruitment
40435|NCT03318094|autonomic nervous system|autonomic nervous system
40436|NCT03318081|Amphetamine-type stimulants|amphetamine-type stimulants
40437|NCT03318081|prefrontal-striatal circuits|prefrontal-striatal circuits
40438|NCT03318081|cognitive rehabilitation therapy|cognitive rehabilitation therapy
40439|NCT03318068|Cancer|cancer
40440|NCT03318068|Pediatric cancer|pediatric cancer
40441|NCT03318068|Yoga|yoga
40442|NCT03318068|Psychological distress|psychological distress
40443|NCT03318068|Outpatient chemotherapy|outpatient chemotherapy
40444|NCT03318029|Vitamin D|vitamin d
40445|NCT03318029|Supplementation|supplementation
40446|NCT03318029|Sunlight|sunlight
40447|NCT03318016|Arsenic Trioxide|arsenic trioxide
40448|NCT03318016|Cyclophosphamide|cyclophosphamide
40449|NCT03317990|Prostate Cancer|prostate cancer
40450|NCT03317990|Nerve sparing|nerve sparing
40451|NCT03317990|NeuroSAFE|neurosafe
40452|NCT03317990|Frozen section|frozen section
40453|NCT03317977|Asthma management, adolescents|asthma management, adolescents
40454|NCT03317925|Pediatric Renal Transplant|pediatric renal transplant
40455|NCT03317925|Renal Allograft|renal allograft
40456|NCT03317925|Angiotensin II|angiotensin ii
40457|NCT03317925|Angiotensin-(1-7)|angiotensin-(1-7)
40458|NCT03317925|ACE|ace
40459|NCT03317925|ACE2|ace2
40460|NCT03317860|perceptual disorders|perceptual disorders
40461|NCT03317860|cerebrovascular disorders|cerebrovascular disorders
40462|NCT03317860|neurobehavioral manifestations|neurobehavioral manifestations
40463|NCT03317860|neurologic manifestations|neurologic manifestations
40464|NCT03317860|neglect|neglect
40465|NCT03317860|non-invasive brain stimulation|non-invasive brain stimulation
40466|NCT03317860|rehabilitation|rehabilitation
40467|NCT03317860|tDCS|tdcs
40468|NCT03317860|paresis|paresis
40469|NCT03317795|Menorrhagia|menorrhagia
40470|NCT03317795|FIbroids|fibroids
40471|NCT03317795|Menstrual Bleeding|menstrual bleeding
40472|NCT03317795|Heavy Bleeding|heavy bleeding
40473|NCT03317795|Menses|menses
40474|NCT03317795|Uterine Fibroids|uterine fibroids
40475|NCT03317730|Xtampza ER|xtampza er
40476|NCT03317730|LAHNC|lahnc
40477|NCT03317730|Head and neck cancer|head and neck cancer
40478|NCT03317730|Pain management|pain management
40479|NCT03317691|myocardial infarction|myocardial infarction
40480|NCT03317691|artificial Intelligence|artificial intelligence
40481|NCT03317691|12 lead electrocardiogram|12 lead electrocardiogram
40482|NCT03317665|biologic|biologic
40483|NCT03317665|prosthetic|prosthetic
40484|NCT03317665|mesh|mesh
40485|NCT03317613|Neuropathic Pain|neuropathic pain
40486|NCT03317613|Qutenza|qutenza
40487|NCT03317613|Capsaicin|capsaicin
40488|NCT03317613|Cancer patient|cancer patient
40489|NCT03317561|troponin|troponin
40490|NCT03317561|major surgery|major surgery
40491|NCT03317535|Anesthesia Methods|anesthesia methods
40492|NCT03317535|Acute Ischemic Stroke|acute ischemic stroke
40493|NCT03317535|Endovascular Treatment|endovascular treatment
40494|NCT03317522|Pregnancy|pregnancy
40495|NCT03317522|teratogenesis|teratogenesis
40496|NCT03317496|Avelumab, immunotherapy, PD-L1 inhibitor, non-small cell lung cancer (NSCLC), urothelial cancer (UC), carboplatin, pemetrexed, gemcitabine, cisplatin|avelumab, immunotherapy, pd-l1 inhibitor, non-small cell lung cancer (nsclc), urothelial cancer (uc), carboplatin, pemetrexed, gemcitabine, cisplatin
40497|NCT03317444|blood bicarbonate, kidney disease|blood bicarbonate, kidney disease
40498|NCT03317431|dopamine,mechanical ventilation,lung injury|dopamine,mechanical ventilation,lung injury
40499|NCT03317366|ARQ 092|arq 092
40500|NCT03317366|ArQule|arqule
40501|NCT03317366|AKT|akt
40502|NCT03317366|PIK3CA|pik3ca
40503|NCT03317366|Overgrowth|overgrowth
40504|NCT03317366|Congenital malformations|congenital malformations
40505|NCT03317353|Vestibular Rehabilitation|vestibular rehabilitation
40506|NCT03317353|Falls in elderly|falls in elderly
40507|NCT03317353|Computerized Dynamic Posturography|computerized dynamic posturography
40508|NCT03317353|Optokinetic stimuli|optokinetic stimuli
40509|NCT03317327|HNSCC|hnscc
40510|NCT03317327|Nivolumab|nivolumab
40511|NCT03317327|immunotherapy|immunotherapy
40512|NCT03317301|Pruritus cutaneus|pruritus cutaneus
40513|NCT03317288|spinal cord injury|spinal cord injury
40514|NCT03317288|pressure ulcer|pressure ulcer
40515|NCT03317288|laser Doppler flowmetry|laser doppler flowmetry
40516|NCT03317262|quality of life, citalopram, quetiapine, pregabalin|quality of life, citalopram, quetiapine, pregabalin
40517|NCT03317249|Inappropriate Sinus Tachycardia|inappropriate sinus tachycardia
40518|NCT03317249|Pregnancy Related|pregnancy related
40519|NCT03317249|IST|ist
40520|NCT03317236|Bioequivalence|bioequivalence
40521|NCT03317236|Quetiapine|quetiapine
40522|NCT03317197|Out-of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
40523|NCT03317197|Vasopressin-steroid-epinephrine (VSE)|vasopressin-steroid-epinephrine (vse)
40524|NCT03317197|Treatment Outcome|treatment outcome
40525|NCT03317197|prognosis|prognosis
40526|NCT03317197|Return of spontaneous circulation|return of spontaneous circulation
40527|NCT03317184|Physical Activity|physical activity
40528|NCT03317184|Pfannenstiel incision|pfannenstiel incision
40529|NCT03317184|Periumbilical incision|periumbilical incision
40530|NCT03317171|dietary supplementation|dietary supplementation
40531|NCT03317171|flavonoids|flavonoids
40532|NCT03317171|omega 3|omega 3
40533|NCT03317158|non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
40534|NCT03317158|BCG|bcg
40535|NCT03317158|immunotherapy|immunotherapy
40536|NCT03317145|venous thromboembolism|venous thromboembolism
40537|NCT03317145|deep vein thrombosis|deep vein thrombosis
40538|NCT03317145|pulmonary embolism|pulmonary embolism
40539|NCT03317145|neuromuscular electrostimulation|neuromuscular electrostimulation
40540|NCT03317145|foot compression|foot compression
40541|NCT03317145|hip replacement|hip replacement
40542|NCT03317132|Vocational, First-episode psychosis|vocational, first-episode psychosis
40543|NCT03317080|lung cancer|lung cancer
40544|NCT03317080|circulating tumor DNA|circulating tumor dna
40545|NCT03317080|molecular classification|molecular classification
40546|NCT03317080|dynamic monitoring|dynamic monitoring
40547|NCT03317080|next generation sequencing|next generation sequencing
40548|NCT03317080|diagnosis|diagnosis
40549|NCT03317080|postoperative relapse|postoperative relapse
40550|NCT03317067|Dexmdetomidine|dexmdetomidine
40551|NCT03317067|Haloperidol|haloperidol
40552|NCT03317067|Delirium|delirium
40553|NCT03317067|Productive Delirium|productive delirium
40554|NCT03317067|Agitation|agitation
40555|NCT03317067|Intubation|intubation
40556|NCT03317067|Ventilatory free days|ventilatory free days
40557|NCT03317067|Sedation|sedation
40558|NCT03317067|ICU patients|icu patients
40559|NCT03317067|Mechanical Ventilation|mechanical ventilation
40560|NCT03317054|Gambing|gambing
40561|NCT03317054|occupational health services|occupational health services
40562|NCT03317054|psychosocial risks|psychosocial risks
40563|NCT03317041|Capacitive-resistive electric transfer therapy|capacitive-resistive electric transfer therapy
40564|NCT03317041|Radiofrequency therapy|radiofrequency therapy
40565|NCT03317041|Recovery intervention|recovery intervention
40566|NCT03317041|Fatigue|fatigue
40567|NCT03317041|Running|running
40568|NCT03316976|Drug therapy|drug therapy
40569|NCT03316963|Neostigmine|neostigmine
40570|NCT03316963|Nerve stimulant medication|nerve stimulant medication
40571|NCT03316963|Treatments for snoring|treatments for snoring
40572|NCT03316950|postmenopause|postmenopause
40573|NCT03316950|rejuvenation|rejuvenation
40574|NCT03316950|radiofrequency|radiofrequency
40575|NCT03316950|diva|diva
40576|NCT03316859|opioid-induced constipation (OIC)|opioid-induced constipation (oic)
40577|NCT03316846|Chronic Pain|chronic pain
40578|NCT03316846|Depression|depression
40579|NCT03316846|Anxiety|anxiety
40580|NCT03316846|Stress|stress
40581|NCT03316846|iCBT|icbt
40582|NCT03316846|Cognitive behavioral therapy|cognitive behavioral therapy
40583|NCT03316846|Internet delivered|internet delivered
40584|NCT03316846|Tailored treatment|tailored treatment
40585|NCT03316807|Hepatitis B, Vaccine|hepatitis b, vaccine
40586|NCT03316807|Randomized Controlled Trial|randomized controlled trial
40587|NCT03316807|HIV|hiv
40588|NCT03316807|Immunogenicity|immunogenicity
40589|NCT03316794|Triple Negative Breast Cancer|triple negative breast cancer
40590|NCT03316794|Cancer|cancer
40591|NCT03316794|Breast Cancer|breast cancer
40592|NCT03316794|Maximum tolerated dose (MTD)|maximum tolerated dose (mtd)
40593|NCT03316794|Pharmacokinetics|pharmacokinetics
40594|NCT03316768|grip|grip
40595|NCT03316768|pinch|pinch
40596|NCT03316768|forces|forces
40597|NCT03316768|pressure|pressure
40598|NCT03316768|Tekscan|tekscan
40599|NCT03316768|sensor|sensor
40600|NCT03316768|ADL|adl
40601|NCT03316768|activities of daily living|activities of daily living
40602|NCT03316768|work requirements|work requirements
40603|NCT03316768|hand biomechanics|hand biomechanics
40604|NCT03316768|forceful precision grip|forceful precision grip
40605|NCT03316768|power grip|power grip
40606|NCT03316768|hominid|hominid
40607|NCT03316768|hominin|hominin
40608|NCT03316768|prehistoric|prehistoric
40609|NCT03316742|Obese|obese
40610|NCT03316742|Overweight|overweight
40611|NCT03316742|Weight loss|weight loss
40612|NCT03316742|West Africa|west africa
40613|NCT03316729|Sub-massive acute pulmonary embolism|sub-massive acute pulmonary embolism
40614|NCT03316716|caesarean section|caesarean section
40615|NCT03316716|neonatal hypothermia|neonatal hypothermia
40616|NCT03316716|maternal hypothermia|maternal hypothermia
40617|NCT03316716|active warming|active warming
40618|NCT03316716|skin-to-skin contact|skin-to-skin contact
40619|NCT03316703|Spine, Spinal injuries, Fractures, Bone|spine, spinal injuries, fractures, bone
40620|NCT03316677|anastomotic leak|anastomotic leak
40621|NCT03316677|colorectal|colorectal
40622|NCT03316677|anastomosis testing|anastomosis testing
40623|NCT03316677|Intraoperative testing|intraoperative testing
40624|NCT03316664|cognitive behavioural therapy|cognitive behavioural therapy
40625|NCT03316664|psychotic disorder|psychotic disorder
40626|NCT03316664|schizophrenia|schizophrenia
40627|NCT03316664|schizoaffective disorder|schizoaffective disorder
40628|NCT03316664|psychological intervention|psychological intervention
40629|NCT03316651|pulmonary alveolar proteinosis|pulmonary alveolar proteinosis
40630|NCT03316651|granulocyte-macrophage colony-stimulating factor|granulocyte-macrophage colony-stimulating factor
40631|NCT03316651|whole lung lavage|whole lung lavage
40632|NCT03316612|Advanced Glycation End Products, Metabolites, Gut Microbiota|advanced glycation end products, metabolites, gut microbiota
40633|NCT03316599|Pancreatic Cancer|pancreatic cancer
40634|NCT03316586|Breast Cancer|breast cancer
40635|NCT03316573|Lymphoma|lymphoma
40636|NCT03316573|Histiocyte sarcoma|histiocyte sarcoma
40637|NCT03316573|Follicular Dendritic Cell Saroma|follicular dendritic cell saroma
40638|NCT03316573|Interdigitating dendritic cell sarcoma|interdigitating dendritic cell sarcoma
40639|NCT03316560|XLRP|xlrp
40640|NCT03316560|retinal degeneration|retinal degeneration
40641|NCT03316560|RPGR|rpgr
40642|NCT03316560|ORF15|orf15
40643|NCT03316560|adeno-associated virus|adeno-associated virus
40644|NCT03316560|gene therapy|gene therapy
40645|NCT03316560|AAV|aav
40646|NCT03316547|preterm|preterm
40647|NCT03316521|complement inhibition|complement inhibition
40648|NCT03316521|C3 complement inhibitor|c3 complement inhibitor
40649|NCT03316521|AMY-101|amy-101
40650|NCT03316521|Compstatin Cp40|compstatin cp40
40651|NCT03316521|Paroxysmal Nocturnal Hemoglobinuria (PNH)|paroxysmal nocturnal hemoglobinuria (pnh)
40652|NCT03316521|C3 glomerulopathy (C3G)|c3 glomerulopathy (c3g)
40653|NCT03316521|Periodontal disease|periodontal disease
40654|NCT03316521|Age-related macular degeneration (AMD)|age-related macular degeneration (amd)
40655|NCT03316521|ABO incompatible kidney transplantation|abo incompatible kidney transplantation
40656|NCT03316508|copeptin|copeptin
40657|NCT03316508|pediatric cardiac surgery|pediatric cardiac surgery
40658|NCT03316508|heart lung machine|heart lung machine
40659|NCT03316469|Anti-mullerian hormone|anti-mullerian hormone
40660|NCT03316456|AL|al
40661|NCT03316443|Glidescope,Macintosh, Laryngscope, intubation,Hypertension.|glidescope,macintosh, laryngscope, intubation,hypertension.
40662|NCT03316404|Multiple Sclerosis|multiple sclerosis
40663|NCT03316404|MS|ms
40664|NCT03316378|Human|human
40665|NCT03316378|Pain|pain
40666|NCT03316378|Biomechanics|biomechanics
40667|NCT03316378|Anesthetics|anesthetics
40668|NCT03316313|Public Health|public health
40669|NCT03316313|Patient Education as Topic|patient education as topic
40670|NCT03316313|Hepatitis C|hepatitis c
42378|NCT03305484|red eye|red eye
40671|NCT03316300|Ciliary Neurotrophic Factor (CNTF)|ciliary neurotrophic factor (cntf)
40672|NCT03316300|Macular Telangiectasia (MacTel)|macular telangiectasia (mactel)
40673|NCT03316261|infants|infants
40674|NCT03316261|type 1 diabetes|type 1 diabetes
40675|NCT03316261|Freder1k|freder1k
40676|NCT03316248|Transtibial amputation|transtibial amputation
40677|NCT03316248|visual feedback|visual feedback
40678|NCT03316248|rehabilitation|rehabilitation
40679|NCT03316196|trauma|trauma
40680|NCT03316196|PTSD|ptsd
40681|NCT03316196|cognition|cognition
40682|NCT03316183|cerebral oximetry|cerebral oximetry
40683|NCT03316183|near-infrared spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
40684|NCT03316183|metabolomic profiling|metabolomic profiling
40685|NCT03316183|neurocognitive outcomes|neurocognitive outcomes
40686|NCT03316183|Cerebral protection|cerebral protection
40687|NCT03316144|immunotherapy|immunotherapy
40688|NCT03316144|check point inhibitor|check point inhibitor
40689|NCT03316144|PD-1 antibody|pd-1 antibody
40690|NCT03316144|phase 1 trial|phase 1 trial
40691|NCT03316144|Malignant Lymphoma|malignant lymphoma
40692|NCT03316131|Gout|gout
40693|NCT03316131|Uric acid|uric acid
40694|NCT03316131|Hyperuricemia|hyperuricemia
40695|NCT03316131|Asymptomatic gout|asymptomatic gout
40696|NCT03316131|Febuxostat|febuxostat
40697|NCT03316131|Dapagliflozin|dapagliflozin
40698|NCT03316131|Uric acid transporter 1 (URAT1) Inhibitor|uric acid transporter 1 (urat1) inhibitor
40699|NCT03316131|Xanthine Oxidase Inhibitor|xanthine oxidase inhibitor
40700|NCT03316131|Sodium-glucose cotransporter 2 (SGLT2) Inhibitor|sodium-glucose cotransporter 2 (sglt2) inhibitor
40701|NCT03316118|anesthesiology|anesthesiology
40702|NCT03316118|pain|pain
40703|NCT03316118|arthroplasty|arthroplasty
40704|NCT03316079|intensive care|intensive care
40705|NCT03316079|invasive mechanical ventilation|invasive mechanical ventilation
40706|NCT03316079|mechanical insufflation-exsufflation|mechanical insufflation-exsufflation
40707|NCT03316079|airway mucus clearance|airway mucus clearance
40708|NCT03316079|chest physiotherapy|chest physiotherapy
40709|NCT03316079|peak expiratory flow|peak expiratory flow
40710|NCT03316079|pulmonary mechanics|pulmonary mechanics
40711|NCT03316066|Stellate Ganglion|stellate ganglion
40712|NCT03316066|Local Anesthetic|local anesthetic
40713|NCT03316040|HIV/AIDS|hiv/aids
40714|NCT03316040|Join-in-Circuit|join-in-circuit
40715|NCT03316014|Pediatry; Adverse drug reactions; Pharmacovigilance|pediatry; adverse drug reactions; pharmacovigilance
40716|NCT03315988|type 2 diabetes|type 2 diabetes
40717|NCT03315988|vegan diet|vegan diet
40718|NCT03315988|TMAO|tmao
40719|NCT03315988|cardiovascular disease|cardiovascular disease
40720|NCT03315975|Influenza vaccine|influenza vaccine
40721|NCT03315923|Active progressive Multiple Sclerosis|active progressive multiple sclerosis
40722|NCT03315923|Glatiramer acetate|glatiramer acetate
40723|NCT03315923|Rituximab|rituximab
40724|NCT03315923|Comparative study|comparative study
40725|NCT03315923|Annualized relapse rate|annualized relapse rate
40726|NCT03315923|Disability|disability
40727|NCT03315923|Randomized clinical trial|randomized clinical trial
40728|NCT03315910|Tobacco Treatment|tobacco treatment
40729|NCT03315910|Lung CT|lung ct
40730|NCT03315910|Cancer Screening|cancer screening
40731|NCT03315910|17-500|17-500
40732|NCT03315897|bipolar disorder|bipolar disorder
40733|NCT03315897|cognition|cognition
40734|NCT03315897|cognitive dysfunction|cognitive dysfunction
40735|NCT03315897|erythropoietin|erythropoietin
40736|NCT03315897|pro-cognitive efficacy|pro-cognitive efficacy
40737|NCT03315897|prefrontal cortex|prefrontal cortex
40738|NCT03315897|functional magnetic resonance imaging|functional magnetic resonance imaging
40739|NCT03315897|biomarker|biomarker
40740|NCT03315884|TASC C, D|tasc c, d
40741|NCT03315884|CFA|cfa
40742|NCT03315884|Supera|supera
40743|NCT03315884|iliac arteries|iliac arteries
40744|NCT03315884|common femoral artery|common femoral artery
40745|NCT03315884|plasty of the common femoral artery|plasty of the common femoral artery
40746|NCT03315884|stenting Supera|stenting supera
40747|NCT03315871|Vaccine|vaccine
40748|NCT03315871|PSA|psa
40749|NCT03315871|Immunotherapy|immunotherapy
40750|NCT03315871|Immune Response|immune response
40751|NCT03315871|Checkpoint Inhibitor|checkpoint inhibitor
40752|NCT03315858|NFAT|nfat
40753|NCT03315858|gene expression|gene expression
40754|NCT03315858|tacrolimus|tacrolimus
40755|NCT03315845|BMI|bmi
40756|NCT03315845|obstetric anaesthesia|obstetric anaesthesia
40757|NCT03315845|neuraxial anaesthesia|neuraxial anaesthesia
40758|NCT03315845|neuraxial ultrasound|neuraxial ultrasound
40759|NCT03315845|difficult neuraxial anaesthesia|difficult neuraxial anaesthesia
40760|NCT03315832|Aortic Valve Stenosis|aortic valve stenosis
40761|NCT03315832|Valsartan|valsartan
40762|NCT03315832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists
40763|NCT03315832|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
40764|NCT03315832|Heart Valve Prosthesis Implantation|heart valve prosthesis implantation
40765|NCT03315832|double-blind phase II study|double-blind phase ii study
40766|NCT03315832|left ventricular mass|left ventricular mass
42780|NCT03302936|Pyridium|pyridium
40767|NCT03315819|glenohumeral dislocation|glenohumeral dislocation
40768|NCT03315819|Arthroscopic|arthroscopic
40769|NCT03315819|capsular lesions|capsular lesions
40770|NCT03315806|Dietary nitrate|dietary nitrate
40771|NCT03315806|Nitrate|nitrate
40772|NCT03315806|Flow-mediated dilation|flow-mediated dilation
40773|NCT03315806|Tissue oxygen saturation|tissue oxygen saturation
40774|NCT03315767|HVPG|hvpg
40775|NCT03315767|portal hypertension|portal hypertension
40776|NCT03315767|ARFI|arfi
40777|NCT03315767|portal vein flow|portal vein flow
40778|NCT03315767|advanced liver chronic disease (ACLD)|advanced liver chronic disease (acld)
40779|NCT03315741|Bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
40780|NCT03315728|Quality improvement|quality improvement
40781|NCT03315728|Indigenous|indigenous
40782|NCT03315728|First Nation|first nation
40783|NCT03315728|Participatory|participatory
40784|NCT03315728|Diabetes|diabetes
40785|NCT03315728|Chronic Disease|chronic disease
40786|NCT03315702|R-spondin proteins, mechanical ventilation, lung injury|r-spondin proteins, mechanical ventilation, lung injury
40787|NCT03315663|Mobile Health|mobile health
40788|NCT03315650|Non-valvular AF|non-valvular af
40789|NCT03315650|ACS|acs
40790|NCT03315650|PCI|pci
40791|NCT03315650|NOAC|noac
40792|NCT03315650|Rivaroxaban|rivaroxaban
40793|NCT03315624|Hemodialysis|hemodialysis
40794|NCT03315624|Hemodiafiltration|hemodiafiltration
40795|NCT03315624|Renal replacement therapy|renal replacement therapy
40796|NCT03315598|Neuralgia, Acupuncture Treatment|neuralgia, acupuncture treatment
40797|NCT03315585|focal therapy|focal therapy
40798|NCT03315585|IRE|ire
40799|NCT03315585|Composite Steep-pulse Treatment Apparatus|composite steep-pulse treatment apparatus
40800|NCT03315585|prostate cancer|prostate cancer
40801|NCT03315572|caregiver|caregiver
40802|NCT03315572|ELLIPTA|ellipta
40803|NCT03315572|Asthma|asthma
40804|NCT03315572|Dry Powder Inhaler|dry powder inhaler
40805|NCT03315572|pediatric|pediatric
40806|NCT03315559|GSK2269557|gsk2269557
40807|NCT03315559|Pharmacokinetics|pharmacokinetics
40808|NCT03315559|Radiolabel|radiolabel
40809|NCT03315559|Healthy|healthy
40810|NCT03315559|Excretion|excretion
40811|NCT03315559|Bioavailability|bioavailability
40812|NCT03315546|deep inspiration breath-hold|deep inspiration breath-hold
40813|NCT03315546|radiotherapy|radiotherapy
40814|NCT03315546|late effects|late effects
40815|NCT03315546|pediatric cancer|pediatric cancer
40816|NCT03315520|Hodgkin Lymphoma|hodgkin lymphoma
40817|NCT03315520|Non-Hodgkin lymphoma|non-hodgkin lymphoma
40818|NCT03315520|autologous hematopoietic stem-cell transplantation|autologous hematopoietic stem-cell transplantation
40819|NCT03315520|conditioning regimen|conditioning regimen
40820|NCT03315494|rheumatoid arthritis|rheumatoid arthritis
40821|NCT03315494|healthy volunteers|healthy volunteers
40822|NCT03315494|moderate to severe|moderate to severe
40823|NCT03315468|melanoma|melanoma
40824|NCT03315468|database|database
40825|NCT03315468|cohort|cohort
40826|NCT03315442|Fluid|fluid
40827|NCT03315442|Balance|balance
40828|NCT03315416|Speech Disorder|speech disorder
40829|NCT03315416|Breast Feeding|breast feeding
40830|NCT03315416|Infant Feeding|infant feeding
40831|NCT03315416|Bottle Feeding|bottle feeding
40832|NCT03315416|Speech Development|speech development
40833|NCT03315416|Speech Sound Development|speech sound development
40834|NCT03315416|Speech Sound Disorder|speech sound disorder
40835|NCT03315416|Non-nutritive Sucking|non-nutritive sucking
40836|NCT03315403|quantitative polymerase chain reaction|quantitative polymerase chain reaction
40837|NCT03315403|qPCR|qpcr
40838|NCT03315403|autolysin|autolysin
40839|NCT03315403|lytA|lyta
40840|NCT03315403|Pneumococcal pneumonia|pneumococcal pneumonia
40841|NCT03315403|Diagnostics|diagnostics
40842|NCT03315403|Community-acquired Pneumonia|community-acquired pneumonia
40843|NCT03315403|Antibiotic resistance|antibiotic resistance
40844|NCT03315390|Narrative Exposure Therapy, ICU Survival, post-traumatic stress disorders, primary health care, randomized controlled trial|narrative exposure therapy, icu survival, post-traumatic stress disorders, primary health care, randomized controlled trial
40845|NCT03315364|Recurrent breast cancer|recurrent breast cancer
40846|NCT03315364|Metastatic breast cancer|metastatic breast cancer
40847|NCT03315364|MBC|mbc
40848|NCT03315364|Firstline chemotherapy|firstline chemotherapy
40849|NCT03315364|Paclitaxel|paclitaxel
40850|NCT03315364|Liporaxel|liporaxel
40851|NCT03315364|Taxol|taxol
40852|NCT03315351|PET-scan|pet-scan
40853|NCT03315351|Brachytherapy|brachytherapy
40854|NCT03315351|Cervical Cancer|cervical cancer
40855|NCT03315325|Aging|aging
40856|NCT03315286|ultraviolet light|ultraviolet light
40857|NCT03315286|dosimetry|dosimetry
40858|NCT03315286|actinic keratosis|actinic keratosis
40859|NCT03315286|skin cancer|skin cancer
40860|NCT03315286|sun counseling|sun counseling
40861|NCT03315286|wearable device|wearable device
40862|NCT03315273|Traumatic brain injury, motor imagery ability, validation|traumatic brain injury, motor imagery ability, validation
40863|NCT03315260|Castration resistant prostate cancer|castration resistant prostate cancer
40864|NCT03315260|Patient reported outcome|patient reported outcome
40865|NCT03315247|Obesity|obesity
40866|NCT03315247|Bariatric Surgery|bariatric surgery
40867|NCT03315247|Bariatrics|bariatrics
40868|NCT03315247|Cognitive Therapy|cognitive therapy
40869|NCT03315247|Binge Eating|binge eating
40870|NCT03315234|SYNTAX score|syntax score
40871|NCT03315234|Coronary Atherosclerosis|coronary atherosclerosis
40872|NCT03315234|Coronary Artery Disease|coronary artery disease
40873|NCT03315234|SNPs|snps
40874|NCT03315234|Genetics|genetics
40875|NCT03315234|Genetic Risk Score|genetic risk score
40876|NCT03315234|Personalized Medicine|personalized medicine
40877|NCT03315208|transdiagnostic treatment|transdiagnostic treatment
40878|NCT03315208|cognitive-behavioral therapy|cognitive-behavioral therapy
40879|NCT03315208|Unified Protocol|unified protocol
40880|NCT03315208|young adults|young adults
40881|NCT03315208|substance use disorder|substance use disorder
40882|NCT03315208|emotional disorder|emotional disorder
40883|NCT03315208|depression|depression
40884|NCT03315208|anxiety|anxiety
40885|NCT03315208|emotion dysregulation|emotion dysregulation
40886|NCT03315208|self-injurious thoughts and behaviors|self-injurious thoughts and behaviors
40887|NCT03315182|MPS IIIB|mps iiib
40888|NCT03315182|Sanfilippo Syndrome B|sanfilippo syndrome b
40889|NCT03315169|Incision and Drainage|incision and drainage
40890|NCT03315169|Packing|packing
40891|NCT03315156|Acute otitis media|acute otitis media
40892|NCT03315156|AOM|aom
40893|NCT03315156|Electrogustometer|electrogustometer
40894|NCT03315156|EGM|egm
40895|NCT03315156|Taste threshold|taste threshold
40896|NCT03315104|influenza A|influenza a
40897|NCT03315104|hospitalized|hospitalized
40898|NCT03315104|H1N1|h1n1
40899|NCT03315104|H3N2|h3n2
40900|NCT03315104|human flu|human flu
40901|NCT03315104|respiratory tract infection|respiratory tract infection
40902|NCT03315104|serious illness|serious illness
40903|NCT03315104|flu|flu
40904|NCT03315091|Pharmacokinetics, WEE1 inhibitor, food effect, safety assessments|pharmacokinetics, wee1 inhibitor, food effect, safety assessments
40905|NCT03315065|thoracic Radiation therapy|thoracic radiation therapy
40906|NCT03315065|Lung Function|lung function
40907|NCT03315052|Graft loss|graft loss
40908|NCT03315052|Renal failure|renal failure
40909|NCT03315052|Infection|infection
40910|NCT03315052|Diabetes|diabetes
40911|NCT03315052|Hypertension|hypertension
40912|NCT03315026|Siltuximab|siltuximab
40913|NCT03315026|Autologous Stem Cell Transplantation (AST)|autologous stem cell transplantation (ast)
40914|NCT03315026|17-365|17-365
40915|NCT03315013|Antiretroviral therapy initiation|antiretroviral therapy initiation
40916|NCT03315013|Sub-Sahara Africa|sub-sahara africa
40917|NCT03315013|ART|art
40918|NCT03315000|methacholine|methacholine
40919|NCT03315000|airway hyperresponsiveness|airway hyperresponsiveness
40920|NCT03314987|air pollution|air pollution
40921|NCT03314987|oxidative stress|oxidative stress
40922|NCT03314987|intervention|intervention
40923|NCT03314974|AML|aml
40924|NCT03314974|ALL|all
40925|NCT03314974|MDS|mds
40926|NCT03314974|NHL|nhl
40927|NCT03314974|CLL|cll
40928|NCT03314974|CML|cml
40929|NCT03314974|SLL|sll
40930|NCT03314961|rectal cancer|rectal cancer
40931|NCT03314935|INCB001158|incb001158
40932|NCT03314935|arginase inhibitor|arginase inhibitor
40933|NCT03314935|oxaliplatin|oxaliplatin
40934|NCT03314935|leucovorin|leucovorin
40935|NCT03314935|5 fluorouracil|5 fluorouracil
40936|NCT03314935|gemcitabine|gemcitabine
40937|NCT03314935|cisplatin|cisplatin
40938|NCT03314935|paclitaxel|paclitaxel
40939|NCT03314935|solid tumors|solid tumors
40940|NCT03314935|colorectal cancer|colorectal cancer
40941|NCT03314935|biliary tract cancer|biliary tract cancer
40942|NCT03314935|gastroesophageal cancer|gastroesophageal cancer
40943|NCT03314935|endometrial cancer|endometrial cancer
40944|NCT03314935|ovarian cancer|ovarian cancer
40945|NCT03314922|Diffuse large B-cell lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
40946|NCT03314922|follicular lymphoma (FL)|follicular lymphoma (fl)
40947|NCT03314922|marginal zone lymphoma (MZL)|marginal zone lymphoma (mzl)
40948|NCT03314922|mantle cell lymphoma (MCL)|mantle cell lymphoma (mcl)
40949|NCT03314922|phosphatidylinositol 3-kinase (PI3K)|phosphatidylinositol 3-kinase (pi3k)
40950|NCT03314909|Renal Dialysis|renal dialysis
40951|NCT03314909|Hemoperfusion|hemoperfusion
40952|NCT03314909|Paraquat|paraquat
40953|NCT03314896|Colonic Neoplasms|colonic neoplasms
40954|NCT03314896|Laparoscopic Surgery|laparoscopic surgery
40955|NCT03314896|T4|t4
40956|NCT03314883|Ultrasound|ultrasound
40957|NCT03314883|Diaphragm|diaphragm
40958|NCT03314883|Non Invasive Ventilation|non invasive ventilation
40959|NCT03314857|TAVI|tavi
40960|NCT03314857|TAVR|tavr
40961|NCT03314857|CHINA|china
40962|NCT03314857|SAPIEN XT|sapien xt
40963|NCT03314857|High Risk|high risk
40964|NCT03314857|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
40965|NCT03314857|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
40966|NCT03314831|sepsis|sepsis
40967|NCT03314831|septic shock|septic shock
40968|NCT03314831|systemic inflammatory response syndrome|systemic inflammatory response syndrome
40969|NCT03314831|tetradecanoic acid|tetradecanoic acid
40970|NCT03314831|myristic acid|myristic acid
40971|NCT03314818|carotid atherosclerosis|carotid atherosclerosis
40972|NCT03314818|plaque progression|plaque progression
40973|NCT03314818|Framingham Risk Score|framingham risk score
40974|NCT03314805|astragalus polysaccharides|astragalus polysaccharides
40975|NCT03314805|breast cancer|breast cancer
40976|NCT03314805|adjuvant chemotherapy|adjuvant chemotherapy
40977|NCT03314792|pain|pain
40978|NCT03314792|postoperative pain|postoperative pain
40979|NCT03314792|postoperative pain management|postoperative pain management
40980|NCT03314792|opioid|opioid
40981|NCT03314792|analgesia|analgesia
40982|NCT03314792|oxycodone|oxycodone
40983|NCT03314792|tapentadol|tapentadol
40984|NCT03314792|hysterectomy|hysterectomy
40985|NCT03314792|respiratory depression|respiratory depression
40986|NCT03314727|Osmolar Concentration|osmolar concentration
40987|NCT03314727|Oxidative Stress|oxidative stress
40988|NCT03314727|Salt|salt
40989|NCT03314727|Inflammation|inflammation
40990|NCT03314727|Endothelial Function|endothelial function
40991|NCT03314727|Hypertension|hypertension
40992|NCT03314701|Resting Energy Expenditure|resting energy expenditure
40993|NCT03314701|Multiple Fracture Ribs|multiple fracture ribs
40994|NCT03314701|Ventilation|ventilation
40995|NCT03314675|CRT-D, LV Latency|crt-d, lv latency
40996|NCT03314649|Peritoneal Lavage, Gene Mutation, Peritoneal Metastasis,Gastric Cancer|peritoneal lavage, gene mutation, peritoneal metastasis,gastric cancer
40997|NCT03314584|TBI|tbi
40998|NCT03314584|traumatic brain injury|traumatic brain injury
40999|NCT03314584|transcranial magnetic stimulation|transcranial magnetic stimulation
41000|NCT03314584|headache|headache
41001|NCT03314571|Epidural analgesia|epidural analgesia
41002|NCT03314571|Labor pain|labor pain
41003|NCT03314571|Satisfaction|satisfaction
41004|NCT03314571|Care assessment|care assessment
41005|NCT03314571|Psychometry|psychometry
41006|NCT03314558|COPD|copd
41007|NCT03314558|pulmonary rehabilitation|pulmonary rehabilitation
41008|NCT03314558|insomnia|insomnia
41009|NCT03314558|sleep quality|sleep quality
41010|NCT03314558|physical activity|physical activity
41011|NCT03314545|endocrown|endocrown
41012|NCT03314545|laminate veneer with coronal post|laminate veneer with coronal post
41013|NCT03314545|post and core|post and core
41014|NCT03314545|crown|crown
41015|NCT03314532|Surgical Resection|surgical resection
41016|NCT03314532|TILA-TACE|tila-tace
41017|NCT03314532|Hepatocellular carcinoma|hepatocellular carcinoma
41018|NCT03314519|Lung ultrasonography|lung ultrasonography
41019|NCT03314519|Lung collapse|lung collapse
41020|NCT03314519|fiberoptic bronchoscopy|fiberoptic bronchoscopy
41021|NCT03314519|double lumen tube|double lumen tube
41022|NCT03314506|exercise|exercise
41023|NCT03314493|Vascular calcification|vascular calcification
41024|NCT03314493|Coronary calcification|coronary calcification
41025|NCT03314493|Peritoneal Dialysis|peritoneal dialysis
41026|NCT03314493|Spironolactone|spironolactone
41027|NCT03314480|Multidetector Computed Tomography|multidetector computed tomography
41028|NCT03314480|Cone Beam Computed Tomography|cone beam computed tomography
41029|NCT03314480|Maxillofacial fractures|maxillofacial fractures
41030|NCT03314480|zygomaticomaxillary fractures|zygomaticomaxillary fractures
41031|NCT03314467|diabetic retinopathy|diabetic retinopathy
41032|NCT03314467|diabetes|diabetes
41033|NCT03314467|arterial hypertension|arterial hypertension
41034|NCT03314467|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
41035|NCT03314441|yoga|yoga
41036|NCT03314441|sleep quality|sleep quality
41037|NCT03314441|sleep quantity|sleep quantity
41038|NCT03314441|sleep efficiency|sleep efficiency
41039|NCT03314441|insomnia|insomnia
41040|NCT03314415|overweight|overweight
41041|NCT03314415|obesity|obesity
41042|NCT03314415|weight loss|weight loss
41043|NCT03314415|robot|robot
41044|NCT03314402|JAK2 inhibitor|jak2 inhibitor
41045|NCT03314402|Tolerance|tolerance
41046|NCT03314402|Pharmacokinetics|pharmacokinetics
41047|NCT03314402|Dose-escalated|dose-escalated
41048|NCT03314389|Cochet bonnet esthesiometer|cochet bonnet esthesiometer
41049|NCT03314376|prehabilitation|prehabilitation
41050|NCT03314376|surgery|surgery
41051|NCT03314376|exercise program|exercise program
41052|NCT03314376|transplant|transplant
41053|NCT03314376|postoperative|postoperative
41054|NCT03314363|Calorimetry, Indirect|calorimetry, indirect
41055|NCT03314363|respiratory dialysis|respiratory dialysis
41056|NCT03314350|Geriatrics|geriatrics
41057|NCT03314350|Frailty|frailty
41058|NCT03314337|Distal Pancreatectomy|distal pancreatectomy
41059|NCT03314337|Pancreatic stent|pancreatic stent
41060|NCT03314337|Post-operative pancreatic fistula|post-operative pancreatic fistula
41061|NCT03314311|Rehabilitation|rehabilitation
41062|NCT03314311|Exercise|exercise
41063|NCT03314311|Nutrition Therapy|nutrition therapy
41064|NCT03314311|Patient Education as Topic|patient education as topic
41066|NCT03314246|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
41067|NCT03314246|Ramadan Fasting|ramadan fasting
41068|NCT03314246|Randomized controlled trial|randomized controlled trial
41069|NCT03314207|XLRP|xlrp
41070|NCT03314207|retinal degeneration|retinal degeneration
41071|NCT03314207|RPGR|rpgr
41072|NCT03314207|ORF15|orf15
41073|NCT03314181|t(11;14) positive relapsed/refractory (R/R) multiple myeloma|t(11;14) positive relapsed/refractory (r/r) multiple myeloma
41074|NCT03314181|Non-refractory Relapsed Multiple Myeloma|non-refractory relapsed multiple myeloma
41075|NCT03314181|Non-refractory Refractory Multiple Myeloma|non-refractory refractory multiple myeloma
41076|NCT03314181|Relapsed Multiple Myeloma|relapsed multiple myeloma
41077|NCT03314181|Refractory Multiple Myeloma|refractory multiple myeloma
41078|NCT03314181|Multiple Myeloma|multiple myeloma
41079|NCT03314181|Cancer|cancer
41080|NCT03314168|Breast Cancer|breast cancer
41081|NCT03314168|Combined training|combined training
41082|NCT03314168|Fatigue|fatigue
41083|NCT03314155|Depressive disorder|depressive disorder
41084|NCT03314155|Treatment Resistant Depression|treatment resistant depression
41085|NCT03314155|[18 F ] DPA- 714|[18 f ] dpa- 714
41086|NCT03314155|PET|pet
41087|NCT03314155|MRI|mri
41088|NCT03314155|Inflammation|inflammation
41089|NCT03314142|blood glucose|blood glucose
41090|NCT03314142|bran particle size|bran particle size
41091|NCT03314142|glucemic index|glucemic index
41092|NCT03314116|hearing loss During basic training, otoacoustic emission|hearing loss during basic training, otoacoustic emission
41093|NCT03314090|Cleft lip|cleft lip
41094|NCT03314090|Scar|scar
41095|NCT03314090|Silicone sheet|silicone sheet
41096|NCT03314090|Silicone gel|silicone gel
41097|NCT03314064|Phase 4|phase 4
41098|NCT03314064|Russian Federation|russian federation
41099|NCT03314064|dolutegravir|dolutegravir
41100|NCT03314064|long-term safety|long-term safety
41101|NCT03314064|Human Immunodeficiency Virus|human immunodeficiency virus
41102|NCT03314051|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
41103|NCT03314051|plasma EBV DNA|plasma ebv dna
41104|NCT03314038|Chronic Atrophic Gastritis|chronic atrophic gastritis
41105|NCT03314038|Malignant Transformation|malignant transformation
41106|NCT03314038|Syndrome|syndrome
41107|NCT03314038|Traditional Chinese Medicine|traditional chinese medicine
41108|NCT03314038|Cross-sectional Study|cross-sectional study
41109|NCT03313999|Lymphedema indentometer|lymphedema indentometer
41110|NCT03313999|Durometer|durometer
41111|NCT03313986|penile curvature|penile curvature
41112|NCT03313986|Peyronie's disease|peyronie's disease
41113|NCT03313986|Nesbit|nesbit
41114|NCT03313960|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
41115|NCT03313960|Afrezza|afrezza
41116|NCT03313934|Hyaluronic Acid Filler|hyaluronic acid filler
41117|NCT03313934|Platelet Rich Fibrin (PRF)|platelet rich fibrin (prf)
41118|NCT03313934|Tear Trough Filler|tear trough filler
41119|NCT03313921|myopia|myopia
41120|NCT03313921|astigmatism|astigmatism
41121|NCT03313921|online assessment|online assessment
41122|NCT03313921|refractive error|refractive error
41123|NCT03313895|cognitive impairment, Alzheimer's disease, exercise, cognitive training, imaging|cognitive impairment, alzheimer's disease, exercise, cognitive training, imaging
41124|NCT03313882|RNA Stability|rna stability
41125|NCT03313882|HuR protein|hur protein
41126|NCT03313882|SCN5A|scn5a
41127|NCT03313869|Metabolism|metabolism
41128|NCT03313869|Lipid oxidation|lipid oxidation
41129|NCT03313869|micronutrient cocktail supplementation|micronutrient cocktail supplementation
41130|NCT03313869|physical inactivity|physical inactivity
41131|NCT03313869|glucose intolerance|glucose intolerance
41132|NCT03313869|oxidative stress|oxidative stress
41133|NCT03313843|Optical Coherence Tomography|optical coherence tomography
41134|NCT03313830|Whey|whey
41135|NCT03313830|Muscle Protein Synthesis|muscle protein synthesis
41136|NCT03313778|mRNA-4157|mrna-4157
41137|NCT03313778|Personalized cancer vaccine|personalized cancer vaccine
41138|NCT03313778|PCV|pcv
41139|NCT03313778|pembrolizumab|pembrolizumab
41140|NCT03313752|diabetes, heart, dapagliflozin,|diabetes, heart, dapagliflozin,
41141|NCT03313726|PSMA-PET|psma-pet
41142|NCT03313700|Stomach Neoplasm|stomach neoplasm
41143|NCT03313700|Robotic Surgery|robotic surgery
41144|NCT03313700|Distal Gastrectomy|distal gastrectomy
41145|NCT03313648|Recurrent HCC|recurrent hcc
41146|NCT03313648|Laparoscopic Hepatectomy|laparoscopic hepatectomy
41147|NCT03313648|RFA|rfa
41148|NCT03313648|RCT|rct
41149|NCT03313635|Prealbumin|prealbumin
41150|NCT03313622|OCD|ocd
41151|NCT03313622|Obsessive Compulsive Disorder|obsessive compulsive disorder
41152|NCT03313557|Continued access, safety assessments|continued access, safety assessments
41153|NCT03313531|Thrombin generation|thrombin generation
41154|NCT03313531|variability|variability
41155|NCT03313531|level of agreement|level of agreement
41156|NCT03313531|hemophilia|hemophilia
41157|NCT03313518|tDCS, Alzheimer Disease|tdcs, alzheimer disease
41158|NCT03313479|Nausea, vomiting|nausea, vomiting
41159|NCT03313440|Fibre|fibre
41160|NCT03313440|diet|diet
41161|NCT03313440|fecal bulk|fecal bulk
41162|NCT03313414|HCV|hcv
41164|NCT03313375|hemodynamics|hemodynamics
41165|NCT03313375|exercise|exercise
41166|NCT03313349|ADHD, Behavioral Problems, Children and Adolescents|adhd, behavioral problems, children and adolescents
41167|NCT03313336|Dermal anesthesia.|dermal anesthesia.
41168|NCT03313336|Venipuncture and intravenous cannulation.|venipuncture and intravenous cannulation.
41169|NCT03313336|Skin blanching or erythema.|skin blanching or erythema.
41170|NCT03313336|Phase I.|phase i.
41171|NCT03313336|Therapeutic equivalence.|therapeutic equivalence.
41172|NCT03313336|Eutectic Mixture of Local anaesthetics (EMLA)|eutectic mixture of local anaesthetics (emla)
41173|NCT03313323|Immuno-PET|immuno-pet
41174|NCT03313323|Ipilimumab|ipilimumab
41175|NCT03313323|Immunotherapy|immunotherapy
41176|NCT03313310|Youth Empowerment|youth empowerment
41177|NCT03313310|Employment Intervention|employment intervention
41178|NCT03313310|Young Men Who Have Sex With Men|young men who have sex with men
41179|NCT03313310|Young Transgender Women|young transgender women
41180|NCT03313297|skin|skin
41181|NCT03313297|wound healing|wound healing
41182|NCT03313297|11 beta-hydroxysteroid dehydrogenase type 1|11 beta-hydroxysteroid dehydrogenase type 1
41183|NCT03313271|lymphoma|lymphoma
41184|NCT03313271|CLAP|clap
41185|NCT03313271|China|china
41186|NCT03313271|patient registry|patient registry
41187|NCT03313193|nausea|nausea
41188|NCT03313193|vomiting|vomiting
41189|NCT03313193|pain|pain
41190|NCT03313193|fatigue|fatigue
41191|NCT03313193|depression|depression
41192|NCT03313193|anxiety|anxiety
41193|NCT03313193|PTSD|ptsd
41194|NCT03313154|Quality of Life|quality of life
41195|NCT03313154|Psychiatric comorbidity|psychiatric comorbidity
41196|NCT03313154|Cognitive impairment|cognitive impairment
41197|NCT03313154|Chronic Hepatitis HCV-related|chronic hepatitis hcv-related
41198|NCT03313089|micronutrient powders|micronutrient powders
41199|NCT03313089|spinkles|spinkles
41200|NCT03313089|nutrition|nutrition
41201|NCT03313089|food security program|food security program
41202|NCT03313089|nutritional program|nutritional program
41203|NCT03313089|hemoglobin|hemoglobin
41204|NCT03313089|anemia|anemia
41205|NCT03313076|burn injury|burn injury
41206|NCT03313076|thermal burn injury|thermal burn injury
41207|NCT03313076|omega 3 fatty acids|omega 3 fatty acids
41208|NCT03313076|vitamin D|vitamin d
41209|NCT03313076|fish oil|fish oil
41210|NCT03313076|chronic pain|chronic pain
41211|NCT03313076|chronic pain due to trauma|chronic pain due to trauma
41212|NCT03313063|magnetic resonance imaging|magnetic resonance imaging
41213|NCT03313063|myocard|myocard
41214|NCT03313063|preeclampsia|preeclampsia
41215|NCT03313011|apraxia of speech|apraxia of speech
41216|NCT03312972|Cancer|cancer
41217|NCT03312972|HDR Brachytherapy|hdr brachytherapy
41218|NCT03312972|Prostate Cancer|prostate cancer
41219|NCT03312920|tDCS, accelerated learning, memory|tdcs, accelerated learning, memory
41220|NCT03312907|immunosuppressants|immunosuppressants
41221|NCT03312907|Systemic Lupus Erythematosus Disease Activity Index|systemic lupus erythematosus disease activity index
41222|NCT03312907|Belimumab|belimumab
41223|NCT03312907|Lupus Low Disease Activity State|lupus low disease activity state
41224|NCT03312907|Systemic Lupus Erythematosus|systemic lupus erythematosus
41225|NCT03312894|Drug therapy|drug therapy
41226|NCT03312881|pain|pain
41227|NCT03312881|neuropathic|neuropathic
41228|NCT03312881|children|children
41229|NCT03312881|QST|qst
41230|NCT03312868|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
41231|NCT03312855|coronary artery disease|coronary artery disease
41232|NCT03312855|platelet inhibition|platelet inhibition
41233|NCT03312790|augmented reality|augmented reality
41234|NCT03312790|fatigue|fatigue
41235|NCT03312790|muscle|muscle
41236|NCT03312790|heart rate|heart rate
41237|NCT03312790|mental function|mental function
41238|NCT03312777|analgesia, Cytochrome P450 2D6|analgesia, cytochrome p450 2d6
41239|NCT03312764|Prediabetes|prediabetes
41240|NCT03312764|Obesity|obesity
41241|NCT03312764|Intensive behavioral counseling|intensive behavioral counseling
41242|NCT03312764|Type 2 Diabetes|type 2 diabetes
41243|NCT03312751|Interferon-gamma|interferon-gamma
41244|NCT03312751|NI-0501|ni-0501
41245|NCT03312751|primary HLH|primary hlh
41246|NCT03312738|everolimus|everolimus
41247|NCT03312738|exemestane|exemestane
41248|NCT03312738|advanced Breast Cancer|advanced breast cancer
41249|NCT03312738|non-steroidal aromatase inhibitors|non-steroidal aromatase inhibitors
41250|NCT03312738|breast carcinoma|breast carcinoma
41251|NCT03312738|breast cancer|breast cancer
41252|NCT03312738|breast lump|breast lump
41253|NCT03312738|HER2 negative|her2 negative
41254|NCT03312738|breast cancer progression|breast cancer progression
41255|NCT03312712|FDG|fdg
41256|NCT03312712|PET|pet
41257|NCT03312712|CT|ct
41258|NCT03312712|Sarcoidosis|sarcoidosis
41259|NCT03312699|Inactivated, quadrivalent influenza vaccine|inactivated, quadrivalent influenza vaccine
41260|NCT03312699|Inactivated Hepatitis A vaccine|inactivated hepatitis a vaccine
41261|NCT03312699|Inactivated, trivalent high-dose influenza vaccine|inactivated, trivalent high-dose influenza vaccine
41364|NCT03312036|Liver failure|liver failure
41262|NCT03312699|Typhoid Vi Polysaccharide Vaccine|typhoid vi polysaccharide vaccine
41263|NCT03312699|Typhoid Vaccine Live Oral Ty21a|typhoid vaccine live oral ty21a
41264|NCT03312699|Influenza Vaccine, Adjuvanted|influenza vaccine, adjuvanted
41265|NCT03312686|endoflip|endoflip
41266|NCT03312660|Prebiotics|prebiotics
41267|NCT03312660|kefir|kefir
41268|NCT03312647|Adverse Drug Reaction|adverse drug reaction
41269|NCT03312647|Latent Tuberculosis Infection|latent tuberculosis infection
41270|NCT03312647|Tuberculosis|tuberculosis
41271|NCT03312634|Interventional study|interventional study
41272|NCT03312634|Clinical trial phase 3|clinical trial phase 3
41273|NCT03312634|Efficacy and safety|efficacy and safety
41274|NCT03312634|Heterotopic ossification|heterotopic ossification
41275|NCT03312634|Flare-up|flare-up
41276|NCT03312634|Palovarotene|palovarotene
41277|NCT03312634|Retinoic acid receptor agonist|retinoic acid receptor agonist
41278|NCT03312634|Retinoic acid receptor gamma agonist|retinoic acid receptor gamma agonist
41279|NCT03312634|Clementia|clementia
41280|NCT03312634|Myositis Ossificans Progressiva|myositis ossificans progressiva
41281|NCT03312634|Munchmeyer's Disease|munchmeyer's disease
41282|NCT03312634|FOP|fop
41283|NCT03312621|Adolescent Health|adolescent health
41284|NCT03312608|cerebral reorganization, TMS|cerebral reorganization, tms
41285|NCT03312556|hypertension|hypertension
41286|NCT03312556|supine hypertension|supine hypertension
41287|NCT03312556|autonomic failure|autonomic failure
41288|NCT03312556|pure autonomic failure|pure autonomic failure
41289|NCT03312556|multiple system atrophy|multiple system atrophy
41290|NCT03312556|cpap|cpap
41291|NCT03312543|Photoaging of Skin, Skin Wrinkling, Solar Aging of Skin, light therapy|photoaging of skin, skin wrinkling, solar aging of skin, light therapy
41292|NCT03312517|insomnia|insomnia
41293|NCT03312517|belsomra|belsomra
41294|NCT03312517|suvorexant|suvorexant
41295|NCT03312504|sport injury|sport injury
41296|NCT03312504|injury prevention|injury prevention
41297|NCT03312504|fitness|fitness
41298|NCT03312504|neuromuscular training|neuromuscular training
41299|NCT03312504|implementation|implementation
41300|NCT03312465|Total Shoulder Arthroplasty|total shoulder arthroplasty
41301|NCT03312465|Hemi Shoulder Arthroplasty|hemi shoulder arthroplasty
41302|NCT03312452|Pediatric|pediatric
41303|NCT03312452|Perioperative|perioperative
41304|NCT03312452|Intravenous fluid|intravenous fluid
41305|NCT03312439|Myocardial infarction|myocardial infarction
41306|NCT03312439|Stroke|stroke
41307|NCT03312439|Diabetes|diabetes
41308|NCT03312439|Depression|depression
41309|NCT03312439|Dementia|dementia
41310|NCT03312439|Fractures|fractures
41311|NCT03312426|Cancer|cancer
41312|NCT03312426|Tumor|tumor
41313|NCT03312426|Healthy Participants|healthy participants
41314|NCT03312426|Healthy Subjects|healthy subjects
41315|NCT03312426|Neoplasm|neoplasm
41316|NCT03312413|dexmedetomidine|dexmedetomidine
41317|NCT03312413|coughing during anesthetic emergence|coughing during anesthetic emergence
41318|NCT03312413|thyroid surgery|thyroid surgery
41319|NCT03312400|Telomeres|telomeres
41320|NCT03312400|Aplastic Anemia|aplastic anemia
41321|NCT03312400|Pulmonary Fibrosis|pulmonary fibrosis
41322|NCT03312400|Androgens|androgens
41323|NCT03312400|Hepatic Fibrosis|hepatic fibrosis
41324|NCT03312335|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
41325|NCT03312335|SLE|sle
41326|NCT03312335|Interleukin-2|interleukin-2
41327|NCT03312335|IL-2|il-2
41328|NCT03312335|T-Lymphocytes, Regulatory|t-lymphocytes, regulatory
41329|NCT03312335|Treg|treg
41330|NCT03312296|Stent Thrombosis|stent thrombosis
41331|NCT03312270|aphasia|aphasia
41332|NCT03312270|comprehension|comprehension
41333|NCT03312270|text-to-speech|text-to-speech
41334|NCT03312270|social validity|social validity
41335|NCT03312231|A/H7N9|a/h7n9
41336|NCT03312231|Immunogenicity|immunogenicity
41337|NCT03312231|Influenza|influenza
41338|NCT03312231|Safety|safety
41339|NCT03312231|Sanofi Pasteur|sanofi pasteur
41340|NCT03312231|Vaccine|vaccine
41341|NCT03312192|Anterior Cervical Discectomy and Fusion|anterior cervical discectomy and fusion
41342|NCT03312192|Stand-Alone Cage|stand-alone cage
41343|NCT03312192|Anterior Plating|anterior plating
41344|NCT03312166|ear lobe|ear lobe
41345|NCT03312166|compression|compression
41346|NCT03312166|medical device|medical device
41347|NCT03312166|recurrence|recurrence
41348|NCT03312101|exercise program|exercise program
41349|NCT03312062|elbow|elbow
41350|NCT03312062|foam rolling|foam rolling
41351|NCT03312062|proprioception|proprioception
41352|NCT03312062|motor performance|motor performance
41353|NCT03312062|strength|strength
41354|NCT03312049|Aflatoxin B1|aflatoxin b1
41355|NCT03312049|Aflatoxin M1|aflatoxin m1
41356|NCT03312049|Aflatoxin|aflatoxin
41357|NCT03312049|Mycotoxin|mycotoxin
41358|NCT03312049|Stunting|stunting
41359|NCT03312049|Linear growth|linear growth
41360|NCT03312049|Pregnancy|pregnancy
41361|NCT03312049|Birth outcomes|birth outcomes
41362|NCT03312049|Nepal|nepal
41363|NCT03312036|CPFA|cpfa
41366|NCT03312036|detoxification|detoxification
41367|NCT03312023|Hepatitis B|hepatitis b
41368|NCT03312023|HBsAg|hbsag
41369|NCT03312023|Ledipasvir/Sofosbuvir|ledipasvir/sofosbuvir
41370|NCT03312023|Hepatitis B treatment|hepatitis b treatment
41371|NCT03311997|RCT|rct
41372|NCT03311997|Hamstring|hamstring
41373|NCT03311997|Suture|suture
41374|NCT03311945|Raltegravir|raltegravir
41375|NCT03311945|Lamivudine|lamivudine
41376|NCT03311776|Pancreatic cancer|pancreatic cancer
41377|NCT03311776|Biomarkers|biomarkers
41378|NCT03311776|Biobank|biobank
41379|NCT03311776|Diagnostic biomarkers|diagnostic biomarkers
41380|NCT03311776|Predictive biomarkers|predictive biomarkers
41381|NCT03311776|Prognostic biomarkers|prognostic biomarkers
41382|NCT03311763|implementation|implementation
41383|NCT03311711|Dementia|dementia
41384|NCT03311711|Aging|aging
41385|NCT03311711|Behavioral Research|behavioral research
41386|NCT03311659|Diphtheria|diphtheria
41387|NCT03311659|Pertussis|pertussis
41388|NCT03311659|Tetanus|tetanus
41389|NCT03311659|Immunogenicity|immunogenicity
41390|NCT03311633|Radius Fracture Distal|radius fracture distal
41391|NCT03311633|Radius Fracture Distal Therapy|radius fracture distal therapy
41392|NCT03311633|Fracture fixation|fracture fixation
41393|NCT03311633|Closed Fracture Reduction|closed fracture reduction
41394|NCT03311607|Post-kala-azar Dermal Leishmaniasis|post-kala-azar dermal leishmaniasis
41395|NCT03311607|Visceral Leishmaniasis|visceral leishmaniasis
41396|NCT03311607|AmBisome|ambisome
41397|NCT03311607|Liposomal amphotericin B|liposomal amphotericin b
41398|NCT03311607|Bangladesh|bangladesh
41399|NCT03311607|Kala azar|kala azar
41400|NCT03311594|Alcohol|alcohol
41401|NCT03311594|Pain|pain
41402|NCT03311568|Ultrasonography|ultrasonography
41403|NCT03311568|Microvessels|microvessels
41404|NCT03311568|Physiopathology|physiopathology
41405|NCT03311568|Diagnostic Imaging|diagnostic imaging
41406|NCT03311568|Critical Care|critical care
41407|NCT03311555|Recurrent PSA-only prostate cancer following prostatectomy|recurrent psa-only prostate cancer following prostatectomy
41408|NCT03311542|GBM|gbm
41409|NCT03311542|Glioma|glioma
41410|NCT03311516|insulin therapy|insulin therapy
41411|NCT03311503|lentiviral|lentiviral
41412|NCT03311503|Gene therapy|gene therapy
41413|NCT03311503|busulfan|busulfan
41414|NCT03311490|Ankle Sprain|ankle sprain
41415|NCT03311490|Prophylaxis|prophylaxis
41416|NCT03311490|Indoor Sports|indoor sports
41417|NCT03311490|Ligamentous sprain|ligamentous sprain
41418|NCT03311490|Prevention|prevention
41419|NCT03311477|ABBV-399|abbv-399
41420|NCT03311477|Maximum tolerated dose (MTD)|maximum tolerated dose (mtd)
41421|NCT03311477|Maximally administered dose (MAD)|maximally administered dose (mad)
41422|NCT03311477|Dose escalation|dose escalation
41423|NCT03311477|Pharmacokinetics|pharmacokinetics
41424|NCT03311477|Advanced solid tumors|advanced solid tumors
41425|NCT03311477|Cancer|cancer
41426|NCT03311477|Solid tumors|solid tumors
41427|NCT03311464|Pyoderma Gangrenosum|pyoderma gangrenosum
41428|NCT03311464|Ulcer|ulcer
41429|NCT03311464|Efficacy|efficacy
41430|NCT03311464|Safety|safety
41431|NCT03311464|Adalimumab|adalimumab
41432|NCT03311464|Humira®|humira®
41433|NCT03311464|Japan|japan
41434|NCT03311425|Anterior cervical discectomy and fusion|anterior cervical discectomy and fusion
41435|NCT03311425|prevertebral swelling|prevertebral swelling
41436|NCT03311425|swallowing|swallowing
41437|NCT03311425|methylprednisolone|methylprednisolone
41438|NCT03311425|intraoperative steroid|intraoperative steroid
41439|NCT03311412|Locally advanced/unresectable|locally advanced/unresectable
41440|NCT03311412|Metastatic solid tumor|metastatic solid tumor
41441|NCT03311412|Lymphoma|lymphoma
41442|NCT03311412|Anti-PD-1|anti-pd-1
41443|NCT03311412|PD-1|pd-1
41444|NCT03311412|PD1|pd1
41445|NCT03311399|Surgical Site Infection|surgical site infection
41446|NCT03311399|mHealth|mhealth
41447|NCT03311399|Cesarean Section|cesarean section
41448|NCT03311373|COPD|copd
41449|NCT03311360|vertebral artery origin stenosis|vertebral artery origin stenosis
41450|NCT03311360|drug-coated balloon|drug-coated balloon
41451|NCT03311360|stenting|stenting
41452|NCT03311360|medical treatment|medical treatment
41453|NCT03311347|pulmonary ultrasound|pulmonary ultrasound
41454|NCT03311347|hypergravity|hypergravity
41455|NCT03311347|human physiology|human physiology
41456|NCT03311347|oxygen|oxygen
41457|NCT03311347|lung ventilation|lung ventilation
41458|NCT03311347|lung perfusion|lung perfusion
41459|NCT03311347|computed tomography|computed tomography
41460|NCT03311347|electrical impedance tomography|electrical impedance tomography
41461|NCT03311347|altitude chamber|altitude chamber
41462|NCT03311334|DSP-7888|dsp-7888
41463|NCT03311334|nivolumab|nivolumab
41464|NCT03311334|atezolizumab|atezolizumab
41465|NCT03311334|immune checkpoint inhibitor|immune checkpoint inhibitor
41466|NCT03311334|cancer vaccine|cancer vaccine
41467|NCT03311334|Wilms Tumor 1|wilms tumor 1
41468|NCT03311334|ICI|ici
41469|NCT03311321|Arterial Stiffness|arterial stiffness
41470|NCT03311321|Endothelial Function|endothelial function
41471|NCT03311321|Vitamin K|vitamin k
41472|NCT03311308|Melanoma|melanoma
41473|NCT03311308|Unresectable|unresectable
41474|NCT03311308|Stage III|stage iii
41475|NCT03311308|Stage IV|stage iv
41476|NCT03311282|breastfeeding|breastfeeding
41477|NCT03311282|infants|infants
41478|NCT03311282|squeezing|squeezing
41479|NCT03311282|breathing|breathing
41480|NCT03311256|Tissue Transit Time|tissue transit time
41481|NCT03311243|cytokines|cytokines
41482|NCT03311243|scaling root planing|scaling root planing
41483|NCT03311243|oral hygiene|oral hygiene
41484|NCT03311243|systemic inflammation|systemic inflammation
41485|NCT03311204|Eyelid margin|eyelid margin
41486|NCT03311204|tear film|tear film
41487|NCT03311204|debridement|debridement
41488|NCT03311204|contact lens and ocular discomfort|contact lens and ocular discomfort
41489|NCT03311178|Shock|shock
41490|NCT03311178|Preterm infant|preterm infant
41491|NCT03311178|Dobutamine|dobutamine
41492|NCT03311165|neonate|neonate
41493|NCT03311165|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
41494|NCT03311165|prognosis|prognosis
41495|NCT03311165|risk factor|risk factor
41496|NCT03311165|clinical course|clinical course
41497|NCT03311152|Hepatocellular carcinoma|hepatocellular carcinoma
41498|NCT03311152|Cirrhosis|cirrhosis
41499|NCT03311152|Circulating epigenetic biomarker|circulating epigenetic biomarker
41500|NCT03311152|Plasma biomarker|plasma biomarker
41501|NCT03311152|SEPT9|sept9
41502|NCT03311152|Septin9|septin9
41503|NCT03311152|DNA methylation biomarker|dna methylation biomarker
41504|NCT03311152|Circulating DNA methylation biomarker|circulating dna methylation biomarker
41505|NCT03311152|Alpha-fetoprotein|alpha-fetoprotein
41506|NCT03311139|Atrial Fibrillation|atrial fibrillation
41507|NCT03311139|Acute Coronary Syndrome|acute coronary syndrome
41508|NCT03311139|Anticoagulation|anticoagulation
41509|NCT03311087|high flow nasal oxygen|high flow nasal oxygen
41510|NCT03311087|acute hypoxemic respiratory failure|acute hypoxemic respiratory failure
41511|NCT03311087|adults|adults
41512|NCT03311087|intensive care unit|intensive care unit
41513|NCT03311074|Sonication Linker Medicated Polymerase Chain Reaction|sonication linker medicated polymerase chain reaction
41514|NCT03311074|GSK2696273|gsk2696273
41515|NCT03311074|Gene therapy|gene therapy
41516|NCT03311074|Adenosine deaminase deficiency|adenosine deaminase deficiency
41517|NCT03311074|Retroviral insertion site|retroviral insertion site
41518|NCT03311074|Severe combined immunodeficiency|severe combined immunodeficiency
41519|NCT03311061|Teen Pregnancy|teen pregnancy
41520|NCT03311061|Prevention|prevention
41521|NCT03311061|Positive Youth Development|positive youth development
41522|NCT03311061|Financial Literacy|financial literacy
41523|NCT03311061|College and Career Readiness|college and career readiness
41524|NCT03311061|School Based Intervention|school based intervention
41525|NCT03311061|Age 13-19|age 13-19
41526|NCT03311061|Behavior Modification|behavior modification
41527|NCT03311048|Cleaning workers|cleaning workers
41528|NCT03311048|Work-related asthma|work-related asthma
41529|NCT03311048|Work-related rhinitis|work-related rhinitis
41530|NCT03311048|Respiratory symptoms|respiratory symptoms
41531|NCT03311048|Nasal swab|nasal swab
41532|NCT03310996|working memory|working memory
41533|NCT03310983|Fat mass|fat mass
41534|NCT03310983|Gestational weight gain|gestational weight gain
41535|NCT03310983|Fetal adipose tissue|fetal adipose tissue
41536|NCT03310970|Peer Reviewed Research|peer reviewed research
41537|NCT03310957|Breast cancer|breast cancer
41538|NCT03310957|Breast carcinoma|breast carcinoma
41539|NCT03310957|Triple negative breast cancer|triple negative breast cancer
41540|NCT03310957|Locally-advanced breast cancer|locally-advanced breast cancer
41541|NCT03310957|Metastatic breast cancer|metastatic breast cancer
41542|NCT03310957|Tumors, breast|tumors, breast
41543|NCT03310957|Breast tumors|breast tumors
41544|NCT03310957|pembrolizumab|pembrolizumab
41545|NCT03310957|LIV-1 protein, human|liv-1 protein, human
41546|NCT03310918|AML|aml
41547|NCT03310905|Research|research
41548|NCT03310905|Transplant|transplant
41549|NCT03310905|Abdominal Wall|abdominal wall
41550|NCT03310905|Hernia|hernia
41551|NCT03310892|Colorectal cancer screening|colorectal cancer screening
41552|NCT03310879|Cancer|cancer
41553|NCT03310853|probiotics|probiotics
41554|NCT03310853|infections|infections
41555|NCT03310853|bacterial vaginosis|bacterial vaginosis
41556|NCT03310827|Nutrition|nutrition
41557|NCT03310827|Nutrigenomics|nutrigenomics
41558|NCT03310801|left atrial appendage occlusion|left atrial appendage occlusion
41559|NCT03310801|antithrombotic therapy|antithrombotic therapy
41560|NCT03310801|atrial fibrillation|atrial fibrillation
41561|NCT03310801|percutaneous coronary intervention|percutaneous coronary intervention
41562|NCT03310801|drug eluting stent|drug eluting stent
41563|NCT03310788|IOP fluctuations|iop fluctuations
41564|NCT03310788|iCare Home|icare home
41565|NCT03310788|SLT|slt
41566|NCT03310788|self-tonometry|self-tonometry
41567|NCT03310775|Social skill training|social skill training
41568|NCT03310775|PEERS|peers
41569|NCT03310762|immunization coverage|immunization coverage
41570|NCT03310762|silicon bracelet|silicon bracelet
41571|NCT03310762|immunization reminders|immunization reminders
41572|NCT03310749|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
41573|NCT03310749|DPP-IV inhibitor|dpp-iv inhibitor
41574|NCT03310749|Drug-Drug Interactions|drug-drug interactions
41575|NCT03310749|Ethnicity|ethnicity
41576|NCT03310736|iron deficiency|iron deficiency
41577|NCT03310736|anemia|anemia
41578|NCT03310736|hepcidin|hepcidin
41579|NCT03310697|Afebrile seizure|afebrile seizure
41580|NCT03310697|Toxicological screening|toxicological screening
41581|NCT03310697|Chromatography|chromatography
41582|NCT03310697|Mass spectrometry|mass spectrometry
41583|NCT03310697|Children|children
41584|NCT03310684|Renin-Angiotensin system|renin-angiotensin system
41585|NCT03310684|Hypertension|hypertension
41586|NCT03310684|Obesity|obesity
41587|NCT03310684|Angiotensin-(1-7)|angiotensin-(1-7)
41588|NCT03310684|Angiotensin II|angiotensin ii
41589|NCT03310684|FGF23|fgf23
41590|NCT03310684|Klotho|klotho
41591|NCT03310684|Uric acid|uric acid
41592|NCT03310684|Left ventricular hypertrophy|left ventricular hypertrophy
41593|NCT03310645|Refractory chronic cough|refractory chronic cough
41594|NCT03310645|healthy volunteers|healthy volunteers
41595|NCT03310632|Antroquinonol|antroquinonol
41596|NCT03310632|Hocena|hocena
41597|NCT03310632|metastatic pancreatic cancer|metastatic pancreatic cancer
41598|NCT03310619|JCAR017|jcar017
41599|NCT03310619|B-Cell Malignancies|b-cell malignancies
41600|NCT03310619|NHL|nhl
41601|NCT03310619|non-Hodgkin lymphoma|non-hodgkin lymphoma
41602|NCT03310619|CAR T cells|car t cells
41603|NCT03310619|chimeric antigen receptor|chimeric antigen receptor
41604|NCT03310606|Therapeutic drug monitoring|therapeutic drug monitoring
41605|NCT03310593|bipolar disorder|bipolar disorder
41606|NCT03310593|bipolar depression|bipolar depression
41607|NCT03310593|cannabidiol|cannabidiol
41608|NCT03310593|endocannabinoids|endocannabinoids
41609|NCT03310541|AZD5363|azd5363
41610|NCT03310541|AKT Mutations|akt mutations
41611|NCT03310541|17-322|17-322
41612|NCT03310528|Aspiration risk|aspiration risk
41613|NCT03310528|GI Endoscopy|gi endoscopy
41614|NCT03310528|Fasting guidelines|fasting guidelines
41615|NCT03310528|Delayed gastric emptying|delayed gastric emptying
41616|NCT03310515|PrEP|prep
41617|NCT03310515|MSM|msm
41618|NCT03310515|seroincidence|seroincidence
41619|NCT03310515|HIV-1|hiv-1
41620|NCT03310515|TGW|tgw
41621|NCT03310515|STIs|stis
41622|NCT03310502|positron emission tomography|positron emission tomography
41623|NCT03310502|skeletal muscle|skeletal muscle
41624|NCT03310502|liver|liver
41625|NCT03310502|adipose tissue|adipose tissue
41626|NCT03310502|brain|brain
41627|NCT03310502|genetics|genetics
41628|NCT03310463|infection|infection
41629|NCT03310463|gram-negative bacterium|gram-negative bacterium
41630|NCT03310463|renal impairment|renal impairment
41631|NCT03310450|troponin-I|troponin-i
41632|NCT03310450|hs-CRP|hs-crp
41633|NCT03310450|Malondialdehyde|malondialdehyde
41634|NCT03310450|predictors|predictors
41635|NCT03310385|Acute Bronchitis, Herbal Medicine|acute bronchitis, herbal medicine
41636|NCT03310333|PROM|prom
41637|NCT03310333|Dinoprostone|dinoprostone
41638|NCT03310333|cervical ripening device|cervical ripening device
41639|NCT03310333|oxytocin|oxytocin
41640|NCT03310320|Plaque psoriasis|plaque psoriasis
41641|NCT03310320|PASI|pasi
41642|NCT03310320|BSA|bsa
41643|NCT03310320|sPGA|spga
41644|NCT03310320|P-VAS|p-vas
41645|NCT03310320|IL17A-|il17a-
41646|NCT03310320|CCL20|ccl20
41647|NCT03310320|PK|pk
41648|NCT03310307|Homocysteine|homocysteine
41649|NCT03310307|Overweight|overweight
41650|NCT03310307|vitamin D3|vitamin d3
41651|NCT03310307|Reproductive women|reproductive women
41652|NCT03310307|RCT|rct
41653|NCT03310294|Lactobacillus|lactobacillus
41654|NCT03310294|Herpes Labial|herpes labial
41655|NCT03310294|Immune repsonse|immune repsonse
41656|NCT03310281|Depression|depression
41657|NCT03310229|cardiovascular complications|cardiovascular complications
41658|NCT03310216|artificial intelligent|artificial intelligent
41659|NCT03310216|visual inspection|visual inspection
41660|NCT03310190|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
41661|NCT03310190|Deletion of the short arm of chromosome 17 (Del[17p])|deletion of the short arm of chromosome 17 (del[17p])
41662|NCT03310190|Relapse Chronic Lymphocytic Leukemia|relapse chronic lymphocytic leukemia
41663|NCT03310190|Refractory Chronic Lymphocytic Leukemia|refractory chronic lymphocytic leukemia
41664|NCT03310190|Chronic Lymphocytic Leukemia with deletion of the short arm of chromosome 17|chronic lymphocytic leukemia with deletion of the short arm of chromosome 17
41665|NCT03310190|Cancer|cancer
41666|NCT03310177|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
41667|NCT03310177|Metabolomics|metabolomics
41668|NCT03310138|treatment|treatment
41669|NCT03310138|brain stimulation|brain stimulation
41670|NCT03310125|Atrial Fibrillation|atrial fibrillation
41671|NCT03310125|Inflammation|inflammation
41672|NCT03310125|Thoracic Surgery|thoracic surgery
41673|NCT03310125|Randomized|randomized
41674|NCT03310125|Colchicine|colchicine
41675|NCT03310099|Obesity|obesity
41676|NCT03310099|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
41677|NCT03310099|HFpEF|hfpef
41678|NCT03310099|unsaturated fatty acids|unsaturated fatty acids
41679|NCT03310099|cardiorespiratory fitness|cardiorespiratory fitness
41680|NCT03310099|dietary intervention|dietary intervention
41681|NCT03310086|corticision|corticision
41682|NCT03310086|CBCT|cbct
41683|NCT03310086|Crowding|crowding
41684|NCT03309995|Cough|cough
41685|NCT03309995|Laryngitis|laryngitis
41686|NCT03309995|Pharyngitis|pharyngitis
41687|NCT03309995|Rhinitis|rhinitis
41688|NCT03309995|Zinc Acetate|zinc acetate
41689|NCT03309995|Zinc Lozenge|zinc lozenge
41690|NCT03309956|Ambulatory Electrocardiography|ambulatory electrocardiography
41691|NCT03309956|Holter Monitor|holter monitor
41692|NCT03309956|Zio Patch Monitor|zio patch monitor
41693|NCT03309956|Pediatrics|pediatrics
41694|NCT03309930|comprehension|comprehension
41695|NCT03309930|Strategies|strategies
41696|NCT03309930|repeated exposure|repeated exposure
41697|NCT03309865|semi-vegetarian diet|semi-vegetarian diet
41698|NCT03309865|vedolizumab|vedolizumab
41699|NCT03309865|ulcerative colitis|ulcerative colitis
41700|NCT03309839|HLA-DR expression|hla-dr expression
41701|NCT03309839|cardiopulmonary bypass|cardiopulmonary bypass
41702|NCT03309839|neonate|neonate
41703|NCT03309826|gestational hypertension|gestational hypertension
41704|NCT03309826|pre-eclampsia|pre-eclampsia
41705|NCT03309826|eclampsia|eclampsia
41706|NCT03309826|obstructive sleep apnea-hypopnea|obstructive sleep apnea-hypopnea
41707|NCT03309826|positive airway pressure|positive airway pressure
41708|NCT03309826|polysomnography|polysomnography
41709|NCT03309826|blood pressure|blood pressure
41710|NCT03309826|arterial stiffness|arterial stiffness
41711|NCT03309813|ExAblate|exablate
41712|NCT03309813|TcMRgFUS|tcmrgfus
41713|NCT03309813|Thalamotomy|thalamotomy
41714|NCT03309800|Acute Bronchitis|acute bronchitis
41715|NCT03309774|Children|children
41716|NCT03309774|Complex Regional Pain Syndrome|complex regional pain syndrome
41717|NCT03309774|Relaxation|relaxation
41718|NCT03309774|Bergès relaxation|bergès relaxation
41719|NCT03309774|Pain|pain
41720|NCT03309748|photodynamic therapy|photodynamic therapy
41721|NCT03309748|black-stain|black-stain
41722|NCT03309748|Pigmented bacteria|pigmented bacteria
41723|NCT03309748|Tannerella forsythia|tannerella forsythia
41724|NCT03309735|threatened miscarriage|threatened miscarriage
41725|NCT03309735|miscarriage|miscarriage
41726|NCT03309735|micronized progesterone|micronized progesterone
41727|NCT03309735|dydrogesterone|dydrogesterone
41728|NCT03309670|psychiatric outcome|psychiatric outcome
41729|NCT03309670|psychosocial outcome|psychosocial outcome
41730|NCT03309670|young|young
41731|NCT03309644|Unplanned admissions|unplanned admissions
41732|NCT03309644|Visits to the ED|visits to the ed
41733|NCT03309644|Readmissions|readmissions
41734|NCT03309644|Death|death
41735|NCT03309631|Gene classifier|gene classifier
41736|NCT03309618|myocardial infarction|myocardial infarction
41737|NCT03309618|arterial stiffness|arterial stiffness
41738|NCT03309618|pulse wave velocity|pulse wave velocity
41739|NCT03309618|flow mediated dilatation|flow mediated dilatation
41740|NCT03309618|fluvastatin|fluvastatin
41741|NCT03309618|valsartan|valsartan
41742|NCT03309605|Translational read through|translational read through
41743|NCT03309579|Aneurysmal subarachnoid hemorrhage (aSAH)|aneurysmal subarachnoid hemorrhage (asah)
41744|NCT03309579|Red Blood Cell Transfusion (RBC)|red blood cell transfusion (rbc)
41745|NCT03309579|Vasospasm|vasospasm
41746|NCT03309579|Intracranial Hemorrhages|intracranial hemorrhages
41747|NCT03309579|Cardiovascular Diseases|cardiovascular diseases
41748|NCT03309540|Low back/lumbar spine|low back/lumbar spine
41749|NCT03309540|Multimodal Physical therapy|multimodal physical therapy
41750|NCT03309540|Quality of life|quality of life
41751|NCT03309540|Range of Motion|range of motion
41752|NCT03309540|Pain|pain
41753|NCT03309527|insomia|insomia
41754|NCT03309527|Depression|depression
41755|NCT03309527|Self Harm|self harm
41756|NCT03309527|Suicide|suicide
41757|NCT03309527|guided self-help|guided self-help
41758|NCT03309527|psychological treatment|psychological treatment
41759|NCT03309527|eCBTI|ecbti
41760|NCT03309527|internet|internet
41761|NCT03309527|Psychotherapy|psychotherapy
41762|NCT03309501|Knee osteoarthritis|knee osteoarthritis
41763|NCT03309501|Randomised Double-blind Controlled trial|randomised double-blind controlled trial
41764|NCT03309501|Tong-Luo-Qu-Tong Plaster|tong-luo-qu-tong plaster
41765|NCT03309488|Food allergy|food allergy
41766|NCT03309488|Milk allergy|milk allergy
41767|NCT03309488|Egg allergy|egg allergy
41768|NCT03309488|Nut allergy|nut allergy
41769|NCT03309488|Basophil activation test|basophil activation test
41770|NCT03309488|Diagnosis|diagnosis
41771|NCT03309488|Specific IgE|specific ige
41772|NCT03309488|Skin prick test|skin prick test
41773|NCT03309475|first episode psychosis|first episode psychosis
41774|NCT03309475|early psychosis|early psychosis
41775|NCT03309475|schizophrenia|schizophrenia
41776|NCT03309475|mindfulness|mindfulness
41777|NCT03309475|social cognition|social cognition
41778|NCT03309475|social functioning|social functioning
41779|NCT03309475|AGES-Mind|ages-mind
41780|NCT03309475|SocialMind|socialmind
41781|NCT03309462|Next generation sequencing|next generation sequencing
41782|NCT03309462|Re-biopsy|re-biopsy
41783|NCT03309462|Acquired resistance|acquired resistance
41784|NCT03309462|Tissue sample|tissue sample
41785|NCT03309462|Peripheral blood|peripheral blood
41786|NCT03309423|Blood gas analysis|blood gas analysis
41787|NCT03309423|Critical care|critical care
41788|NCT03309423|venus to arterial conversion|venus to arterial conversion
41789|NCT03309410|Blood Gas Analysis|blood gas analysis
41790|NCT03309410|Emergency Service, Hospital|emergency service, hospital
41791|NCT03309410|Venous to arterial conversion|venous to arterial conversion
41792|NCT03309410|Matched-Pair Analysis|matched-pair analysis
41793|NCT03309397|adolescent sports|adolescent sports
41794|NCT03309358|Cystic Fibrosis|cystic fibrosis
41795|NCT03309358|Pulmonary exacerbation|pulmonary exacerbation
41796|NCT03309358|Pulmonary inflammation|pulmonary inflammation
41797|NCT03309358|Respiratory tract disease|respiratory tract disease
41798|NCT03309358|Pulmonary disease|pulmonary disease
41799|NCT03309358|Biofilms|biofilms
41800|NCT03309267|pain, thoracotomy|pain, thoracotomy
41801|NCT03309228|elderly people|elderly people
41802|NCT03309228|polymedication,|polymedication,
41803|NCT03309228|ethics|ethics
41804|NCT03309228|qualitative research|qualitative research
41805|NCT03309150|Ataxia telangiectasia mutated and Rad3-related protein inhibitor (ATRi)|ataxia telangiectasia mutated and rad3-related protein inhibitor (atri)
41806|NCT03309150|M6620|m6620
41807|NCT03309150|Solid tumors|solid tumors
41808|NCT03309137|Blood stream infections|blood stream infections
41809|NCT03309137|Prospective|prospective
41810|NCT03309137|Preventative|preventative
41811|NCT03309137|Randomized|randomized
41812|NCT03309124|White potatoes|white potatoes
41813|NCT03309124|Older adults|older adults
41814|NCT03309124|Satiety|satiety
41815|NCT03309124|Glycaemia|glycaemia
41816|NCT03309072|transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
41817|NCT03309072|accelerated learning|accelerated learning
41818|NCT03309072|memory|memory
41819|NCT03309059|Nursing care|nursing care
41820|NCT03309059|diaper rash|diaper rash
41821|NCT03309059|fecal incontinence|fecal incontinence
41822|NCT03309059|urinary incontinence|urinary incontinence
41823|NCT03309046|Parents|parents
41824|NCT03309046|Caregivers|caregivers
41825|NCT03309046|Veterans|veterans
41826|NCT03309033|Vaccine Efficacy|vaccine efficacy
41827|NCT03309033|Immune Response|immune response
41828|NCT03309033|Long-Term Protection|long-term protection
41829|NCT03309020|OCT|oct
41830|NCT03309020|Cataracts|cataracts
41831|NCT03309020|Visual Acuity|visual acuity
41832|NCT03309007|Autophagy|autophagy
41833|NCT03308994|Multiple sclerosis|multiple sclerosis
41834|NCT03308994|Epidemiology|epidemiology
41835|NCT03308994|Oral disease modifying treatments|oral disease modifying treatments
41836|NCT03308994|Therapeutical delays|therapeutical delays
41837|NCT03308994|Socio-Economical Status|socio-economical status
41838|NCT03308981|therapeutic online game|therapeutic online game
41839|NCT03308981|resilience|resilience
41840|NCT03308981|prevention|prevention
41841|NCT03308981|emotional disorders|emotional disorders
41842|NCT03308981|child|child
41843|NCT03308981|adolescent|adolescent
41844|NCT03308942|Niraparib|niraparib
41845|NCT03308942|Zejula|zejula
41846|NCT03308942|PARP Inhibitor|parp inhibitor
41847|NCT03308942|PD-1 Inhibitor|pd-1 inhibitor
41848|NCT03308916|elastography|elastography
41849|NCT03308916|screening|screening
41850|NCT03308916|non-invasive markers|non-invasive markers
41851|NCT03308916|microbiome|microbiome
41852|NCT03308916|gut-liver-axis|gut-liver-axis
41853|NCT03308916|cost-benefit|cost-benefit
41854|NCT03308916|fibroscan|fibroscan
41855|NCT03308916|aixplorer|aixplorer
41856|NCT03308916|ultrasound elastography|ultrasound elastography
41857|NCT03308916|liver fibrosis|liver fibrosis
41858|NCT03308916|alcoholic liver disease|alcoholic liver disease
41859|NCT03308916|advanced fibrosis|advanced fibrosis
41860|NCT03308916|enhanced liver fibrosis test|enhanced liver fibrosis test
41861|NCT03308916|direct liver fibrosis markers|direct liver fibrosis markers
41862|NCT03308916|ELF|elf
41863|NCT03308916|cytokeratin-18|cytokeratin-18
41864|NCT03308916|neoepitopes|neoepitopes
41865|NCT03308916|collagen|collagen
41866|NCT03308916|NAFLD|nafld
41867|NCT03308916|ALD|ald
41868|NCT03308916|metabolomics|metabolomics
41869|NCT03308916|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
41870|NCT03308825|Influenza|influenza
41871|NCT03308825|Flu|flu
41872|NCT03308812|Cardiovascular health|cardiovascular health
41873|NCT03308812|Health coach|health coach
41874|NCT03308812|Cardiovascular risk factors|cardiovascular risk factors
41875|NCT03308812|Ethnic disparities|ethnic disparities
41876|NCT03308812|Behavioral intervention|behavioral intervention
41877|NCT03308812|E-health lifestyle intervention|e-health lifestyle intervention
41878|NCT03308812|Health360x|health360x
41879|NCT03308812|eHealthyStrides|ehealthystrides
41880|NCT03308773|Prediabetes|prediabetes
41881|NCT03308773|insulin resistance|insulin resistance
41882|NCT03308773|T2DM|t2dm
41883|NCT03308773|Carotid IMT/Plaque|carotid imt/plaque
41884|NCT03308747|Low-grade systemic inflammation|low-grade systemic inflammation
41885|NCT03308747|Muscle protein synthesis|muscle protein synthesis
41886|NCT03308747|Proteasome activation|proteasome activation
41887|NCT03308747|Anabolic signaling|anabolic signaling
41888|NCT03308747|Aging|aging
41889|NCT03308747|Sarcopenia|sarcopenia
41890|NCT03308734|High-intensity interval training|high-intensity interval training
41891|NCT03308734|REHIT|rehit
41892|NCT03308734|Prostate cancer|prostate cancer
41893|NCT03308734|cardiorespiratory fitness|cardiorespiratory fitness
41894|NCT03308656|uterocervical angle, labor induction|uterocervical angle, labor induction
41895|NCT03308643|myomectomy|myomectomy
41896|NCT03308643|oxytocin|oxytocin
41897|NCT03308643|blood loss|blood loss
41898|NCT03308617|sonication|sonication
41899|NCT03308578|Obsructive sleep apnea|obsructive sleep apnea
41900|NCT03308578|Adipose tissue|adipose tissue
41901|NCT03308565|AIS grade A or B|ais grade a or b
41902|NCT03308513|Prolonged acute mechanical ventilation|prolonged acute mechanical ventilation
41903|NCT03308500|HIIT|hiit
41904|NCT03308500|Children|children
41905|NCT03308500|Cardiorespiratory fitness|cardiorespiratory fitness
41906|NCT03308500|Body composition|body composition
41907|NCT03308487|Vitamin D|vitamin d
41908|NCT03308487|pregnancy|pregnancy
41909|NCT03308461|difficult defecation|difficult defecation
41910|NCT03308461|fecal microbiota transplantation|fecal microbiota transplantation
41911|NCT03308461|stool pattern|stool pattern
41912|NCT03308448|Traumatic optic neuropathy|traumatic optic neuropathy
41913|NCT03308448|Erythropoietin|erythropoietin
41914|NCT03308448|EPO|epo
41915|NCT03308448|Eprex|eprex
41916|NCT03308422|screens|screens
41917|NCT03308422|preschool children|preschool children
41918|NCT03308422|parenting education|parenting education
41919|NCT03308422|social perceptions|social perceptions
41920|NCT03308396|Durvalumab|durvalumab
41921|NCT03308396|Guadecitabine|guadecitabine
41922|NCT03308357|drug monitoring|drug monitoring
41923|NCT03308331|HIV|hiv
41924|NCT03308331|nicotine|nicotine
41925|NCT03308331|brain|brain
41926|NCT03308331|smoking|smoking
41927|NCT03308318|Deep temporal fascia|deep temporal fascia
41928|NCT03308318|Deep layer of the deep temporal fascia|deep layer of the deep temporal fascia
41929|NCT03308318|Superficial layer of the deep temporal fascia|superficial layer of the deep temporal fascia
41930|NCT03308318|Temporal fascial layers|temporal fascial layers
41931|NCT03308318|Temporal anatomy|temporal anatomy
41932|NCT03308279|dry needling|dry needling
41933|NCT03308279|median nerve|median nerve
41934|NCT03308279|Pronator Teres|pronator teres
41935|NCT03308253|Vascular Surgery|vascular surgery
41936|NCT03308253|Surgical Site Infection|surgical site infection
41937|NCT03308253|Prophylactic Antibiotics|prophylactic antibiotics
41938|NCT03308253|Implantable Beads|implantable beads
41939|NCT03308240|Magic|magic
41940|NCT03308240|Anxiety|anxiety
41941|NCT03308240|Pediatric|pediatric
41942|NCT03308227|Linezolid; PK/PD; Septic shock|linezolid; pk/pd; septic shock
41943|NCT03308214|septic shock; imipenem; VD ;pharmacokinetics|septic shock; imipenem; vd ;pharmacokinetics
41944|NCT03308188|Opioid therapy|opioid therapy
41945|NCT03308188|web-based intervention|web-based intervention
41946|NCT03308188|self-management|self-management
41947|NCT03308162|Integrated Behavioral Health Care|integrated behavioral health care
41948|NCT03308136|epidural steroid injection|epidural steroid injection
41949|NCT03308136|procedural pain|procedural pain
41950|NCT03308136|local Anesthetic Injection|local anesthetic injection
41951|NCT03308097|PrEP|prep
41952|NCT03308097|Uptake|uptake
41953|NCT03308097|MSM|msm
41954|NCT03308097|Black|black
41955|NCT03308084|transforaminal lumbar interbody fusion, methylprednisolone|transforaminal lumbar interbody fusion, methylprednisolone
41956|NCT03308071|Hypnosis|hypnosis
41957|NCT03308071|Hypnotherapy|hypnotherapy
41958|NCT03308071|Perioperative Pain Management|perioperative pain management
41959|NCT03308071|Narcotic reduction|narcotic reduction
41960|NCT03308071|Perioperative Outcomes|perioperative outcomes
41961|NCT03308071|Total knee replacement|total knee replacement
41962|NCT03308071|Total knee arthroplasty|total knee arthroplasty
41963|NCT03308058|Breastfeeding Rural Hispanic Pregnant|breastfeeding rural hispanic pregnant
41964|NCT03308045|plasmid|plasmid
41965|NCT03308045|electrotransfer|electrotransfer
41966|NCT03308045|ciliary muscle|ciliary muscle
41967|NCT03308045|uveitis|uveitis
41968|NCT03307993|Lu AE58054|lu ae58054
41969|NCT03307980|gene therapy|gene therapy
41970|NCT03307928|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
41971|NCT03307928|Aged|aged
41972|NCT03307928|Hypertension|hypertension
41973|NCT03307928|Oxygen Consumption|oxygen consumption
41974|NCT03307928|Exercise|exercise
41975|NCT03307902|Vaccination|vaccination
41976|NCT03307889|perioperative monitoring|perioperative monitoring
41977|NCT03307876|biologic,|biologic,
41978|NCT03307876|Alpha 2 Macroglobulin|alpha 2 macroglobulin
41979|NCT03307876|A2M|a2m
41980|NCT03307876|back pain|back pain
41981|NCT03307876|APIC|apic
41982|NCT03307876|FAC|fac
41983|NCT03307876|FACT|fact
41984|NCT03307863|etonogestrel implant|etonogestrel implant
41985|NCT03307863|anti-epileptic drugs|anti-epileptic drugs
41986|NCT03307863|pharmacokinetics|pharmacokinetics
41987|NCT03307850|type 1 diabetes|type 1 diabetes
41988|NCT03307850|hypoglycemia|hypoglycemia
41989|NCT03307850|exercise|exercise
41990|NCT03307850|stress|stress
41991|NCT03307850|artificial pancreas|artificial pancreas
41992|NCT03307850|cortisol|cortisol
41993|NCT03307837|nilateral Transpositional First Metatarsal Osteotomy|nilateral transpositional first metatarsal osteotomy
41994|NCT03307824|Laparoscopic Surgery|laparoscopic surgery
41995|NCT03307824|synthetic glue IFABONDTM|synthetic glue ifabondtm
41996|NCT03307824|time of surgery|time of surgery
41997|NCT03307811|liver|liver
41998|NCT03307811|biopsy|biopsy
41999|NCT03307811|hepatic|hepatic
42000|NCT03307811|EUS|eus
42001|NCT03307811|fine needle biopsy|fine needle biopsy
42002|NCT03307798|dental implant,bone quality,tactile sensation|dental implant,bone quality,tactile sensation
42003|NCT03307772|lactobacillus|lactobacillus
42004|NCT03307772|Herpes Labialis|herpes labialis
42005|NCT03307772|immune response|immune response
42006|NCT03307720|agonist trigger|agonist trigger
42007|NCT03307720|Ovulation induction|ovulation induction
42008|NCT03307720|Controlled ovarian stimulation (COS)|controlled ovarian stimulation (cos)
42009|NCT03307720|Poor responder|poor responder
42010|NCT03307707|FGF23|fgf23
42011|NCT03307707|klotho|klotho
42012|NCT03307707|Mineral Bone Disorder|mineral bone disorder
42013|NCT03307694|Cancer|cancer
42014|NCT03307694|Thyroid nodule|thyroid nodule
42015|NCT03307694|Imaging|imaging
42016|NCT03307694|Radiology|radiology
42017|NCT03307681|White potatoes|white potatoes
42018|NCT03307681|Children|children
42019|NCT03307681|Satiety|satiety
42020|NCT03307681|Glycaemia|glycaemia
42021|NCT03307655|nitric oxide|nitric oxide
42022|NCT03307655|follicular fluid|follicular fluid
42023|NCT03307655|sperm|sperm
42024|NCT03307655|capacitation|capacitation
42025|NCT03307655|fertilization|fertilization
42026|NCT03307655|phosphorylation|phosphorylation
42027|NCT03307655|nitrosylation|nitrosylation
42028|NCT03307642|Influenza vaccination rates|influenza vaccination rates
42029|NCT03307642|Respiratory Tract Diseases|respiratory tract diseases
42030|NCT03307616|Systemic connective tissue disorders|systemic connective tissue disorders
42031|NCT03307616|Undifferentiated pleomorphic sarcoma|undifferentiated pleomorphic sarcoma
42032|NCT03307616|Dedifferentiated liposarcoma|dedifferentiated liposarcoma
42033|NCT03307616|Dedifferentiated liposarcoma of the retroperitoneum|dedifferentiated liposarcoma of the retroperitoneum
42034|NCT03307616|DDLPS|ddlps
42035|NCT03307616|Undifferentiated pleomorphic sarcoma of the trunk or extremities|undifferentiated pleomorphic sarcoma of the trunk or extremities
42036|NCT03307616|UPS|ups
42037|NCT03307616|Nivolumab|nivolumab
42038|NCT03307616|BMS-936558|bms-936558
42039|NCT03307616|Opdivo|opdivo
42040|NCT03307616|Ipilimumab|ipilimumab
42041|NCT03307616|Yervoy|yervoy
42042|NCT03307616|BMS-734016|bms-734016
42043|NCT03307616|MDX010|mdx010
42044|NCT03307616|Radiation therapy|radiation therapy
42045|NCT03307616|XRT|xrt
42046|NCT03307603|Yttrium-90 radioembolization|yttrium-90 radioembolization
42047|NCT03307603|Nivolumab|nivolumab
42048|NCT03307551|propofol, automated, manual|propofol, automated, manual
42049|NCT03307538|Perihilar cholangiocarcinoma|perihilar cholangiocarcinoma
42050|NCT03307538|Klatskin tumor|klatskin tumor
42051|NCT03307538|Stereotactic body radiation therapy|stereotactic body radiation therapy
42052|NCT03307512|inhaled insulin|inhaled insulin
42053|NCT03307512|asthma|asthma
42054|NCT03307512|COPD|copd
42055|NCT03307486|Gestational diabetes|gestational diabetes
42056|NCT03307486|Type 2 DM after GDM|type 2 dm after gdm
42057|NCT03307473|Physical activity|physical activity
42058|NCT03307473|Bicycling|bicycling
42059|NCT03307473|Transportation|transportation
42060|NCT03307473|Public health|public health
42061|NCT03307447|optical coherence tomography|optical coherence tomography
42062|NCT03307434|Program|program
42063|NCT03307434|Prevention|prevention
42064|NCT03307434|Injury|injury
42065|NCT03307434|Athletics|athletics
42066|NCT03307421|simulation|simulation
42067|NCT03307421|debriefing|debriefing
42068|NCT03307421|team score|team score
42069|NCT03307421|multidisciplinarity|multidisciplinarity
42070|NCT03307421|DEBRIEF sim II|debrief sim ii
42071|NCT03307395|Chronic Subdural Hematoma|chronic subdural hematoma
42072|NCT03307395|Embolization|embolization
42073|NCT03307395|Middle meningeal artery|middle meningeal artery
42074|NCT03307382|Biliary stricture, cholangioscopy|biliary stricture, cholangioscopy
42075|NCT03307369|Severe malaria|severe malaria
42076|NCT03307369|plasmodium vivax|plasmodium vivax
42077|NCT03307356|Uterine Transplant|uterine transplant
42078|NCT03307356|MRKH|mrkh
42079|NCT03307343|sedentary behavior|sedentary behavior
42080|NCT03307343|light intensity physical activity|light intensity physical activity
42081|NCT03307343|behavioral intervention|behavioral intervention
42082|NCT03307343|office workers|office workers
42083|NCT03307343|blood pressure|blood pressure
42084|NCT03307343|pulse wave velocity|pulse wave velocity
42085|NCT03307343|randomized clinical trial|randomized clinical trial
42086|NCT03307330|Obstructive Sleep Apnea|obstructive sleep apnea
42087|NCT03307330|Adipose Tissue|adipose tissue
42088|NCT03307317|Near Infrared Spectroscopy|near infrared spectroscopy
42089|NCT03307317|EEG|eeg
42090|NCT03307317|Functional Brain Activity|functional brain activity
42091|NCT03307317|Neurodevelopment|neurodevelopment
42092|NCT03307304|Batten Disease|batten disease
42093|NCT03307304|Neurodegenerative|neurodegenerative
42094|NCT03307304|Lysosomal Storage|lysosomal storage
42095|NCT03307304|Biomarkers|biomarkers
42096|NCT03307304|Longitudinal Study|longitudinal study
42097|NCT03307265|Weighted Jacket|weighted jacket
42098|NCT03307265|Balance disorder|balance disorder
42099|NCT03307265|Equilibrium disorder|equilibrium disorder
42100|NCT03307226|Suubi|suubi
42101|NCT03307226|Adolescent Girls|adolescent girls
42102|NCT03307226|Poverty|poverty
42103|NCT03307226|Economic Empowement Interventions|economic empowement interventions
42104|NCT03307226|Adherence to HIV antiretroviral therapy|adherence to hiv antiretroviral therapy
42105|NCT03307226|HIV/AIDS-impacted girls|hiv/aids-impacted girls
42106|NCT03307226|Uganda|uganda
42107|NCT03307226|Cost-effectiveness|cost-effectiveness
42108|NCT03307200|Supportive care|supportive care
42109|NCT03307200|Prospective observational study|prospective observational study
42110|NCT03307161|manual therapy|manual therapy
42111|NCT03307161|heart rate|heart rate
42112|NCT03307148|Locally Advanced or Metastatic|locally advanced or metastatic
42113|NCT03307135|Spasticity|spasticity
42114|NCT03307135|electrophysiology|electrophysiology
42115|NCT03307135|biomechanics|biomechanics
42116|NCT03307135|objective assessment|objective assessment
42117|NCT03307096|FURS|furs
42118|NCT03307096|microperc|microperc
42119|NCT03307096|renal calculus|renal calculus
42120|NCT03307096|Randomized Controlled Trial|randomized controlled trial
42121|NCT03307096|Retrograde Intrarenal Surgery|retrograde intrarenal surgery
42122|NCT03307057|Pediatrics|pediatrics
42123|NCT03307057|Behavioral Research|behavioral research
42124|NCT03307031|training volume|training volume
42125|NCT03307031|elderly|elderly
42126|NCT03307031|lipid profile|lipid profile
42127|NCT03307031|postmenopausal|postmenopausal
42128|NCT03307018|Bronchoscopy|bronchoscopy
42129|NCT03307018|Respiratory Complications|respiratory complications
42130|NCT03307018|Anatomical Lung Resection|anatomical lung resection
42131|NCT03306992|Exercise|exercise
42132|NCT03306966|Ascending colon|ascending colon
42133|NCT03306940|botulinum toxin A|botulinum toxin a
42134|NCT03306927|blood sugar|blood sugar
42135|NCT03306927|insulin|insulin
42136|NCT03306927|appetite|appetite
42137|NCT03306927|peas|peas
42138|NCT03306875|multiple sclerosis|multiple sclerosis
42139|NCT03306875|cognitive training|cognitive training
42140|NCT03306875|telerehabilitation|telerehabilitation
42141|NCT03306875|personality|personality
42142|NCT03306875|Conscientiousness|conscientiousness
42143|NCT03306875|predict|predict
42144|NCT03306862|blood sugar|blood sugar
42145|NCT03306862|insulin|insulin
42146|NCT03306862|peas|peas
42147|NCT03306836|Hybrid operation|hybrid operation
42148|NCT03306836|Cerebral Aneurysm|cerebral aneurysm
42149|NCT03306836|Arteriovenous Malformations|arteriovenous malformations
42150|NCT03306836|Anticoagulation|anticoagulation
42151|NCT03306823|Cerebral Aneurysm|cerebral aneurysm
42152|NCT03306823|Arteriovenous Malformations|arteriovenous malformations
42153|NCT03306823|Hybrid operation|hybrid operation
42154|NCT03306823|Anticoagulation|anticoagulation
42155|NCT03306810|Perioperative complications|perioperative complications
42156|NCT03306810|Dysglycemia management team|dysglycemia management team
42157|NCT03306810|Nurse Practitioner|nurse practitioner
42158|NCT03306810|Hospital|hospital
42159|NCT03306797|Music therapy|music therapy
42160|NCT03306797|Sonification technique|sonification technique
42161|NCT03306797|Rehabilitation|rehabilitation
42162|NCT03306784|RAPID3|rapid3
42163|NCT03306784|pain catastrophizing|pain catastrophizing
42164|NCT03306771|Morbid Obesity|morbid obesity
42165|NCT03306771|Carotid Stenosis|carotid stenosis
42166|NCT03306771|Metabolic Syndrome|metabolic syndrome
42167|NCT03306745|Polycystic Ovary Syndrome|polycystic ovary syndrome
42168|NCT03306745|Anti-Mullerian Hormone|anti-mullerian hormone
42169|NCT03306745|Androgens|androgens
42170|NCT03306745|Micronutrient Supplementation|micronutrient supplementation
42171|NCT03306732|Thiamine|thiamine
42172|NCT03306732|Thiamine Supplementation|thiamine supplementation
42173|NCT03306732|Vasoplegia Syndrome|vasoplegia syndrome
42174|NCT03306732|Inotropic support|inotropic support
42175|NCT03306732|Cardiac surgery|cardiac surgery
42176|NCT03306732|Renal Failure|renal failure
42177|NCT03306706|blood sugar|blood sugar
42178|NCT03306706|insulin|insulin
42179|NCT03306706|appetite|appetite
42180|NCT03306706|peas|peas
42181|NCT03306693|Emotional Intelligence|emotional intelligence
42182|NCT03306693|Quality of Life|quality of life
42183|NCT03306628|Skin Scarring|skin scarring
42184|NCT03306628|keloids|keloids
42185|NCT03306628|hypertrophic scars|hypertrophic scars
42186|NCT03306628|CO2 laser therapy|co2 laser therapy
42187|NCT03306615|Muscle Stiffness|muscle stiffness
42188|NCT03306615|Muscle Spasticity|muscle spasticity
42189|NCT03306615|Stroke|stroke
42190|NCT03306615|Cerebral Palsy|cerebral palsy
42191|NCT03306615|Hyperreflexia|hyperreflexia
42192|NCT03306602|Composite Resins|composite resins
42193|NCT03306602|Dental Restorations|dental restorations
42194|NCT03306589|Inflammation|inflammation
42195|NCT03306589|GM-CSF|gm-csf
42196|NCT03306589|LPS|lps
42197|NCT03306589|Skin blisters|skin blisters
42198|NCT03306589|Healthy subjects|healthy subjects
42199|NCT03306589|cantharidin|cantharidin
42200|NCT03306576|composite restoration|composite restoration
42201|NCT03306563|TBI|tbi
42202|NCT03306563|Mild traumatic brain injury|mild traumatic brain injury
42203|NCT03306563|Concussion|concussion
42204|NCT03306563|Diagnostics|diagnostics
42205|NCT03306563|Rapid test|rapid test
42206|NCT03306563|Traumatic Brain Injury|traumatic brain injury
42207|NCT03306563|mTBI|mtbi
42208|NCT03306550|drug-drug interaction|drug-drug interaction
42209|NCT03306550|Asprin|asprin
42210|NCT03306550|salvianolate injection|salvianolate injection
42211|NCT03306550|PK-PD model|pk-pd model
42212|NCT03306550|metabolic enzymes|metabolic enzymes
42213|NCT03306524|mechanical ventilation|mechanical ventilation
42214|NCT03306524|SIPPV|sippv
42215|NCT03306524|PSV|psv
42216|NCT03306524|Device flow|device flow
42217|NCT03306524|Circuit flow|circuit flow
42218|NCT03306524|Slope time|slope time
42219|NCT03306524|neonatal intensive care|neonatal intensive care
42220|NCT03306498|plasma free amino acids|plasma free amino acids
42221|NCT03306459|PCOS|pcos
42222|NCT03306459|Quality of life|quality of life
42223|NCT03306459|Sexuality|sexuality
42224|NCT03306459|Psychological traits|psychological traits
42225|NCT03306433|dental caries|dental caries
42226|NCT03306433|white spot lesion|white spot lesion
42227|NCT03306433|prevention|prevention
42228|NCT03306433|smooth surface sealant|smooth surface sealant
42229|NCT03306420|MS201408-0005A|ms201408-0005a
42230|NCT03306420|MS201408-0005B|ms201408-0005b
42231|NCT03306420|MS201408-0005C|ms201408-0005c
42232|NCT03306420|First-in-Human|first-in-human
42233|NCT03306420|Advanced solid tumors|advanced solid tumors
42234|NCT03306394|metastatic|metastatic
42235|NCT03306394|colorectal|colorectal
42236|NCT03306394|cancer|cancer
42237|NCT03306394|trifluridine/tipiracil|trifluridine/tipiracil
42238|NCT03306394|early access|early access
42239|NCT03306381|IBS|ibs
42240|NCT03306381|Epigenetics|epigenetics
42241|NCT03306381|Dietary intervention|dietary intervention
42242|NCT03306381|Gut Microbiota|gut microbiota
42243|NCT03306381|Inflammation|inflammation
42244|NCT03306381|Genetics|genetics
42245|NCT03306368|OUD|oud
42246|NCT03306368|XR-NTX|xr-ntx
42247|NCT03306368|assertive outreach|assertive outreach
42248|NCT03306368|youth|youth
42249|NCT03306355|Intraocular Lens|intraocular lens
42250|NCT03306355|trifocal|trifocal
42251|NCT03306355|hydrophobic|hydrophobic
42252|NCT03306355|hydrophilic|hydrophilic
42253|NCT03306342|Intraocular Lens|intraocular lens
42254|NCT03306342|trifocal|trifocal
42255|NCT03306342|hydrophobic|hydrophobic
42256|NCT03306342|hydrophilic|hydrophilic
42257|NCT03306303|melatonin|melatonin
42258|NCT03306303|STEMI|stemi
42259|NCT03306303|No-reflow|no-reflow
42260|NCT03306290|Obese|obese
42261|NCT03306290|Bariatric surgery|bariatric surgery
42262|NCT03306290|Antibiotic prophylaxis|antibiotic prophylaxis
42263|NCT03306290|Cefoxitin|cefoxitin
42264|NCT03306264|MDS|mds
42265|NCT03306264|CMML|cmml
42266|NCT03306264|decitabine|decitabine
42267|NCT03306264|Myelodysplastic Syndromes|myelodysplastic syndromes
42268|NCT03306264|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
42269|NCT03306251|HIV|hiv
42270|NCT03306251|Pregnancy|pregnancy
42271|NCT03306251|Prevention of mother-to-child transmission|prevention of mother-to-child transmission
42272|NCT03306238|laparoscopy/ key-hole|laparoscopy/ key-hole
42273|NCT03306238|renal surgery|renal surgery
42274|NCT03306238|open/hasson|open/hasson
42275|NCT03306238|closed/veress|closed/veress
42276|NCT03306212|cerebral palsy|cerebral palsy
42277|NCT03306212|casting|casting
42278|NCT03306212|Botulinum toxin A|botulinum toxin a
42279|NCT03306186|diagnosis|diagnosis
42280|NCT03306186|prognosis|prognosis
42281|NCT03306160|central blood pressure|central blood pressure
42282|NCT03306160|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
42283|NCT03306160|blood pressure variability|blood pressure variability
42284|NCT03306147|Pain|pain
42285|NCT03306147|Opioid|opioid
42286|NCT03306147|Drug monitoring|drug monitoring
42287|NCT03306147|Pain education|pain education
42288|NCT03306121|Nasopharyngeal carcinoma;Induction chemotherapy|nasopharyngeal carcinoma;induction chemotherapy
42289|NCT03306069|Aerobic exercise|aerobic exercise
42290|NCT03306069|Interval training|interval training
42291|NCT03306069|VO2max|vo2max
42292|NCT03306069|Health Promotion|health promotion
42293|NCT03306069|Inflammation|inflammation
42294|NCT03306069|Body Composition|body composition
42295|NCT03306056|Exercise|exercise
42296|NCT03306056|Strength Training|strength training
42297|NCT03306056|Health Promotion|health promotion
42298|NCT03306056|Inflammation|inflammation
42299|NCT03306056|Body Composition|body composition
42300|NCT03306043|hypereosinophilic syndrome|hypereosinophilic syndrome
42301|NCT03306043|hypereosinophilic syndrome flare|hypereosinophilic syndrome flare
42302|NCT03306043|open-label extension study|open-label extension study
42303|NCT03306043|Mepolizumab|mepolizumab
42304|NCT03306043|SB240563|sb240563
42305|NCT03306043|Long-term safety|long-term safety
42306|NCT03306030|PEG|peg
42307|NCT03306030|Bowel preparation|bowel preparation
42308|NCT03306030|Colonoscopy|colonoscopy
42309|NCT03306030|split-does|split-does
42310|NCT03306017|left ventricular assist device|left ventricular assist device
42311|NCT03306017|platelet-leukocyte conjugates|platelet-leukocyte conjugates
42312|NCT03306017|lipo-oxygenase products|lipo-oxygenase products
42313|NCT03305991|tuberculosis|tuberculosis
42314|NCT03305991|pregnancy|pregnancy
42315|NCT03305991|ethiopia|ethiopia
42316|NCT03305978|Ultra low dose chest CT|ultra low dose chest ct
42317|NCT03305978|lung cancer screening|lung cancer screening
42318|NCT03305939|Gestational diabetes,Lifestyle,Type 2 DM|gestational diabetes,lifestyle,type 2 dm
42319|NCT03305913|mCRC|mcrc
42320|NCT03305900|formate|formate
42321|NCT03305900|one-carbon metabolism|one-carbon metabolism
42322|NCT03305887|TKA|tka
42323|NCT03305887|Barbed suture|barbed suture
42324|NCT03305887|Surgical time|surgical time
42325|NCT03305874|contrast-induced nephropathy (CIN)|contrast-induced nephropathy (cin)
42326|NCT03305874|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
42327|NCT03305874|computer-based risk tool|computer-based risk tool
42328|NCT03305861|Thulium Laser Enucleation of the Prostate (ThuLEP)|thulium laser enucleation of the prostate (thulep)
42329|NCT03305861|Greenlight Laser Enucleation of the Prostate (Green LEP)|greenlight laser enucleation of the prostate (green lep)
42330|NCT03305861|Holmium Laser Enucleation of Prostate (HoLEP)|holmium laser enucleation of prostate (holep)
42331|NCT03305835|Primary Hyperoxaluria (PH)|primary hyperoxaluria (ph)
42332|NCT03305835|Hyperoxaluria|hyperoxaluria
42333|NCT03305835|PH|ph
42334|NCT03305835|PH 1|ph 1
42335|NCT03305835|PH 2|ph 2
42336|NCT03305835|PH 3|ph 3
42337|NCT03305835|Dent Disease|dent disease
42338|NCT03305835|Dent 1|dent 1
42339|NCT03305835|Dent 2|dent 2
42340|NCT03305835|Cystinuria|cystinuria
42341|NCT03305835|APRT Deficiency|aprt deficiency
42342|NCT03305835|24-Hydroxylase Deficiency|24-hydroxylase deficiency
42343|NCT03305835|CYP24A1|cyp24a1
42344|NCT03305809|Parkinson disease dementia|parkinson disease dementia
42345|NCT03305809|Parkinson disease|parkinson disease
42346|NCT03305809|Dopamine|dopamine
42347|NCT03305809|Cognition|cognition
42348|NCT03305744|Athlete|athlete
42349|NCT03305744|Middle-aged|middle-aged
42350|NCT03305744|Endurance training|endurance training
42351|NCT03305744|Cardiac Function|cardiac function
42352|NCT03305744|Atrial Fibrillation|atrial fibrillation
42353|NCT03305731|Rehabilitation|rehabilitation
42354|NCT03305731|Disability|disability
42355|NCT03305692|cardiac resynchronization therapy|cardiac resynchronization therapy
42356|NCT03305692|pacing|pacing
42357|NCT03305692|echocardiography|echocardiography
42358|NCT03305692|optimization|optimization
42359|NCT03305692|heart failure|heart failure
42360|NCT03305653|Pediatrics|pediatrics
42361|NCT03305588|essential tremor (ET)|essential tremor (et)
42362|NCT03305588|stereotactic radiosurgery (SRS)|stereotactic radiosurgery (srs)
42363|NCT03305588|radiosurgery (RS)|radiosurgery (rs)
42364|NCT03305588|deep brain stimulation (DBS)|deep brain stimulation (dbs)
42365|NCT03305588|Parkinson's Disease (PD)|parkinson's disease (pd)
42366|NCT03305588|tremor-dominant Parkinson's disease (TDPD)|tremor-dominant parkinson's disease (tdpd)
42367|NCT03305575|Cervical Cerclage|cervical cerclage
42368|NCT03305575|Bupivacaine|bupivacaine
42369|NCT03305575|Chloroprocaine|chloroprocaine
42370|NCT03305575|spinal anesthesia|spinal anesthesia
42371|NCT03305562|Hypertension|hypertension
42372|NCT03305549|Dialysis-requiring Acute Kidney Injury|dialysis-requiring acute kidney injury
42373|NCT03305549|Renal Recovery|renal recovery
42374|NCT03305536|AVD|avd
42375|NCT03305523|circumcision; Thermocautery; Complication|circumcision; thermocautery; complication
42376|NCT03305497|Opioid Overdose; Naloxone|opioid overdose; naloxone
42377|NCT03305484|contact lenses|contact lenses
42379|NCT03305484|corneal infiltrate|corneal infiltrate
42380|NCT03305471|Chronic hemodialysis|chronic hemodialysis
42381|NCT03305471|Investigational drug|investigational drug
42382|NCT03305445|Immunotransplant|immunotransplant
42383|NCT03305445|Relapsed Diffuse Large B-Cell Lymphoma|relapsed diffuse large b-cell lymphoma
42384|NCT03305445|Refractory Diffuse Large B-Cell Lymphoma|refractory diffuse large b-cell lymphoma
42385|NCT03305445|Nivolumab|nivolumab
42386|NCT03305445|Ipilimumab|ipilimumab
42387|NCT03305419|Crossover|crossover
42388|NCT03305419|Sequential|sequential
42389|NCT03305419|GSK2982772|gsk2982772
42390|NCT03305419|Safety|safety
42391|NCT03305419|Pharmacokinetics|pharmacokinetics
42392|NCT03305419|Healthy subjects|healthy subjects
42393|NCT03305393|Heart Failure|heart failure
42394|NCT03305393|CRT|crt
42395|NCT03305393|Cardiac Recynchronization Therapy|cardiac recynchronization therapy
42396|NCT03305393|left bundle branch block|left bundle branch block
42397|NCT03305393|atrio-ventricular conduction|atrio-ventricular conduction
42398|NCT03305380|anti-PD1|anti-pd1
42399|NCT03305380|anti-PD-L1|anti-pd-l1
42400|NCT03305354|mobile health|mobile health
42401|NCT03305354|physical activity|physical activity
42402|NCT03305341|SCLC|sclc
42403|NCT03305341|SNP|snp
42404|NCT03305341|Oncology|oncology
42405|NCT03305341|Drug|drug
42406|NCT03305341|Etoposide|etoposide
42407|NCT03305341|Methotrexate|methotrexate
42408|NCT03305341|Lung|lung
42409|NCT03305341|Cancer|cancer
42410|NCT03305328|Oscillations|oscillations
42411|NCT03305328|Non-invasive Brain Stimulation|non-invasive brain stimulation
42412|NCT03305328|Transcranial Alternating Current Stimulation|transcranial alternating current stimulation
42413|NCT03305276|diet;|diet;
42414|NCT03305276|exercise;|exercise;
42415|NCT03305276|hypertension;|hypertension;
42416|NCT03305276|vitamin d|vitamin d
42417|NCT03305237|Weight loss|weight loss
42418|NCT03305237|Chrono-nutrition|chrono-nutrition
42419|NCT03305237|Diet|diet
42420|NCT03305237|energy expenditure|energy expenditure
42421|NCT03305224|castration-resistant prostate cancer|castration-resistant prostate cancer
42422|NCT03305224|bone metastasis|bone metastasis
42423|NCT03305185|AIS|ais
42424|NCT03305107|Child|child
42425|NCT03305107|Exercise|exercise
42426|NCT03305107|Chocolate milk|chocolate milk
42427|NCT03305107|Blood glucose|blood glucose
42428|NCT03305107|Cognition|cognition
42429|NCT03305107|Appetite|appetite
42430|NCT03305107|Emotions|emotions
42431|NCT03305107|Cortisol|cortisol
42432|NCT03305094|Remote ischemic preconditioning|remote ischemic preconditioning
42433|NCT03305094|Myocardial infarction|myocardial infarction
42434|NCT03305094|Cardiac surgery|cardiac surgery
42435|NCT03305055|opioid|opioid
42436|NCT03305055|ketamine|ketamine
42437|NCT03305042|aging|aging
42438|NCT03305042|alpha-retinol|alpha-retinol
42439|NCT03305042|hypervitaminosis A|hypervitaminosis a
42440|NCT03305042|vitamin A biomarkers|vitamin a biomarkers
42441|NCT03305042|serum retinol|serum retinol
42442|NCT03305029|Age related macular degeneration|age related macular degeneration
42443|NCT03305029|embryonic stem cells|embryonic stem cells
42444|NCT03305029|somatic cell nuclear transfer|somatic cell nuclear transfer
42445|NCT03305016|Human Growth Hormone|human growth hormone
42446|NCT03305016|hGH|hgh
42447|NCT03305016|GHD|ghd
42448|NCT03305016|rhGH|rhgh
42449|NCT03305016|Pediatric Growth Hormone Deficiency|pediatric growth hormone deficiency
42450|NCT03305016|Long Acting Growth Hormone|long acting growth hormone
42451|NCT03305016|Somatropin|somatropin
42452|NCT03305016|Prodrug|prodrug
42453|NCT03305016|Growth Failure|growth failure
42454|NCT03305016|Growth Hormone Replacement Therapy|growth hormone replacement therapy
42455|NCT03305016|Sustained Release Growth Hormone|sustained release growth hormone
42456|NCT03305016|Growth Hormone Deficiency|growth hormone deficiency
42457|NCT03305016|TransCon GH|transcon gh
42458|NCT03304964|FP-025, MMP-12 inhibitor|fp-025, mmp-12 inhibitor
42459|NCT03304912|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
42460|NCT03304912|Injection Drug Use|injection drug use
42461|NCT03304873|rectal MRSA|rectal mrsa
42462|NCT03304873|mupirocin-resistant nasal MRSA|mupirocin-resistant nasal mrsa
42463|NCT03304834|HIFU|hifu
42464|NCT03304834|High intensity focused ultrasound|high intensity focused ultrasound
42465|NCT03304821|Atherosclerotic peripheral artery disease|atherosclerotic peripheral artery disease
42466|NCT03304821|Granulocyte-macrophage colony stimulating factor (GM-CSF)|granulocyte-macrophage colony stimulating factor (gm-csf)
42467|NCT03304821|Atherosclerosis|atherosclerosis
42468|NCT03304821|Cardiology|cardiology
42469|NCT03304821|Vascular disease|vascular disease
42470|NCT03304808|premature ejaculation|premature ejaculation
42471|NCT03304808|cognitive-behavior|cognitive-behavior
42472|NCT03304808|treatment|treatment
42473|NCT03304808|device|device
42474|NCT03304795|Vitamin D|vitamin d
42475|NCT03304795|Asia|asia
42476|NCT03304795|Trend|trend
42477|NCT03304795|KNHANES|knhanes
42478|NCT03304795|Temporal change|temporal change
43380|NCT03299023|Medibyte|medibyte
42479|NCT03304782|Preterm Birth|preterm birth
42480|NCT03304782|FitBit|fitbit
42481|NCT03304782|Preterm Delivery|preterm delivery
42482|NCT03304769|Virtual Reality Distraction|virtual reality distraction
42483|NCT03304769|Pediatric IV placement|pediatric iv placement
42484|NCT03304756|locally advanced breast cancer|locally advanced breast cancer
42485|NCT03304756|triple negative|triple negative
42486|NCT03304756|cisplatin|cisplatin
42487|NCT03304743|dental panoramic radiographs|dental panoramic radiographs
42488|NCT03304743|osteoporosis|osteoporosis
42489|NCT03304743|feasibility study|feasibility study
42490|NCT03304730|Zygapophyseal Joint|zygapophyseal joint
42491|NCT03304730|Low Back Pain|low back pain
42492|NCT03304730|Spine Osteoarthritis|spine osteoarthritis
42493|NCT03304717|Leukodystrophy|leukodystrophy
42494|NCT03304717|Antiretroviral Drugs|antiretroviral drugs
42495|NCT03304704|Assays|assays
42496|NCT03304704|Direct Skin Feeds|direct skin feeds
42497|NCT03304704|Infection|infection
42498|NCT03304704|Parasite|parasite
42499|NCT03304704|Gametocyte|gametocyte
42500|NCT03304691|Malaria|malaria
42501|NCT03304691|Parasitemia|parasitemia
42502|NCT03304691|Anemia|anemia
42503|NCT03304691|Ligand|ligand
42504|NCT03304691|Anopheles gambiae|anopheles gambiae
42505|NCT03304678|mTORC1 Inhibition|mtorc1 inhibition
42506|NCT03304678|VEGF-D|vegf-d
42507|NCT03304678|MicroRNA|microrna
42508|NCT03304665|Healthy Volunteers|healthy volunteers
42509|NCT03304665|Mental Health|mental health
42510|NCT03304665|Common Data Elements|common data elements
42511|NCT03304600|OCD|ocd
42512|NCT03304600|tDCS|tdcs
42513|NCT03304561|knee|knee
42514|NCT03304561|rehabilitation|rehabilitation
42515|NCT03304561|ACL|acl
42516|NCT03304561|Contralateral training|contralateral training
42517|NCT03304548|Telephone interviews|telephone interviews
42518|NCT03304548|Subcutaneous|subcutaneous
42519|NCT03304548|Low-interventional|low-interventional
42520|NCT03304548|Qualitative research|qualitative research
42521|NCT03304548|PAH|pah
42522|NCT03304535|Glaucoma|glaucoma
42523|NCT03304535|Social Worker|social worker
42524|NCT03304496|Nitroglycerin|nitroglycerin
42525|NCT03304496|Vasodilator Agents|vasodilator agents
42526|NCT03304496|Subcutaneous Injection|subcutaneous injection
42527|NCT03304496|Radial Artery|radial artery
42528|NCT03304496|Coronary Angiography|coronary angiography
42529|NCT03304496|Cardiac Catheterization|cardiac catheterization
42530|NCT03304496|Coronary Angioplasty|coronary angioplasty
42531|NCT03304496|Percutaneous Coronary Intervention|percutaneous coronary intervention
42532|NCT03304457|Lurasidone|lurasidone
42533|NCT03304457|Olanzapine|olanzapine
42534|NCT03304457|Brain derived neurotrophic factor|brain derived neurotrophic factor
42535|NCT03304457|Nerve growth factor|nerve growth factor
42536|NCT03304457|Neurotrophin 3|neurotrophin 3
42537|NCT03304431|QT dispersion|qt dispersion
42538|NCT03304431|topical lidocaine|topical lidocaine
42539|NCT03304431|P-wave values|p-wave values
42540|NCT03304405|ASD|asd
42541|NCT03304392|anxiety|anxiety
42542|NCT03304392|depression|depression
42543|NCT03304392|internet-delivered cognitive behaviour therapy|internet-delivered cognitive behaviour therapy
42544|NCT03304392|randomized controlled trial|randomized controlled trial
42545|NCT03304392|patient-centered|patient-centered
42546|NCT03304392|knowledge implementation|knowledge implementation
42547|NCT03304392|mental health system|mental health system
42548|NCT03304392|therapist-assistance|therapist-assistance
42549|NCT03304353|Plantar heel pain|plantar heel pain
42550|NCT03304353|Resistance training|resistance training
42551|NCT03304340|acute stroke,TENS ,posture stability, function|acute stroke,tens ,posture stability, function
42552|NCT03304327|Yoga|yoga
42553|NCT03304327|Mindfulness|mindfulness
42554|NCT03304314|PTC|ptc
42555|NCT03304314|EYES|eyes
42556|NCT03304314|Pseudotumor cerebri|pseudotumor cerebri
42557|NCT03304314|increased Intracranial pressure|increased intracranial pressure
42559|NCT03304301|sunlight exposure|sunlight exposure
42560|NCT03304301|institutionalized elderly|institutionalized elderly
42561|NCT03304301|depression|depression
42562|NCT03304301|quality of life|quality of life
42563|NCT03304301|cognition function|cognition function
42564|NCT03304288|all-trans retinoid acid|all-trans retinoid acid
42565|NCT03304288|rituximab|rituximab
42566|NCT03304288|steroid-resistant|steroid-resistant
42567|NCT03304288|refractory|refractory
42568|NCT03304288|low-dose|low-dose
42569|NCT03304275|Pertussis|pertussis
42570|NCT03304275|Vaccination|vaccination
42571|NCT03304275|Emergency Department|emergency department
42572|NCT03304262|Metaplasticity|metaplasticity
42573|NCT03304262|Motor excitability|motor excitability
42574|NCT03304262|rTMS|rtms
42575|NCT03304262|tDCS|tdcs
42576|NCT03304236|Cervical Myelopahty|cervical myelopahty
42577|NCT03304236|sEMG|semg
42578|NCT03304236|Motion capture analysis|motion capture analysis
42579|NCT03304210|PIPAC|pipac
42580|NCT03304210|Peritoneal carcinomatosis|peritoneal carcinomatosis
42581|NCT03304210|Ovarian cancer|ovarian cancer
43381|NCT03299023|Apnea|apnea
42582|NCT03304210|Pharmacokinetics|pharmacokinetics
42583|NCT03304210|Pharmacodynamics|pharmacodynamics
42584|NCT03304210|Safety and efficacy|safety and efficacy
42585|NCT03304210|Abraxane|abraxane
42586|NCT03304210|Breast cancer|breast cancer
42587|NCT03304210|Pancreas cancer|pancreas cancer
42588|NCT03304210|Stomach cancer|stomach cancer
42589|NCT03304158|Diabetes|diabetes
42590|NCT03304158|Non-communicable disease|non-communicable disease
42591|NCT03304158|Primary health care|primary health care
42592|NCT03304158|Nepal|nepal
42593|NCT03304145|Treatment Care Planning|treatment care planning
42594|NCT03304132|Oral Microbiome|oral microbiome
42595|NCT03304132|reflux disorders|reflux disorders
42596|NCT03304132|esophageal microbiome|esophageal microbiome
42597|NCT03304132|Alcohol Use|alcohol use
42598|NCT03304132|Tobacco Use|tobacco use
42599|NCT03304119|Tipping of tibial tuberosity|tipping of tibial tuberosity
42600|NCT03304119|Torsion of tibial tuberosity|torsion of tibial tuberosity
42601|NCT03304119|Recurrent patellar dislocation|recurrent patellar dislocation
42602|NCT03304119|MRI Measurements|mri measurements
42603|NCT03304119|Patellar instability|patellar instability
42604|NCT03304119|Patellar dislocation|patellar dislocation
42605|NCT03304119|Tibial tubercle position|tibial tubercle position
42606|NCT03304119|Tibial tubercle torsion|tibial tubercle torsion
42607|NCT03304093|IFCT|ifct
42608|NCT03304093|VIH|vih
42609|NCT03304093|Nivolumab|nivolumab
42610|NCT03304093|NSCLC|nsclc
42611|NCT03304080|Breast Neoplasms|breast neoplasms
42612|NCT03304080|Breast Diseases|breast diseases
42613|NCT03304080|Palbociclib|palbociclib
42614|NCT03304080|Trastuzumab|trastuzumab
42615|NCT03304080|Pertuzumab|pertuzumab
42616|NCT03304080|Hormone Antagonists|hormone antagonists
42617|NCT03304054|MuSK antibody positive|musk antibody positive
42618|NCT03304041|low-FODMAP|low-fodmap
42619|NCT03304041|Irritable Bowel Syndrome|irritable bowel syndrome
42620|NCT03304041|stool fermentation|stool fermentation
42621|NCT03304041|Breath test|breath test
42622|NCT03304028|Connected Devices|connected devices
42623|NCT03304028|Pulmonary Exacerbations|pulmonary exacerbations
42624|NCT03304028|Cumulative Sum (CUSUM) Chart|cumulative sum (cusum) chart
42625|NCT03304015|Intervention|intervention
42626|NCT03304015|Violence against Women|violence against women
42627|NCT03304015|Female Garment Workers|female garment workers
42628|NCT03304015|Bangladesh|bangladesh
42629|NCT03303976|pneumococcal vaccine|pneumococcal vaccine
42630|NCT03303976|bioconjugate|bioconjugate
42631|NCT03303963|culture-free|culture-free
42632|NCT03303963|tuberculosis|tuberculosis
42633|NCT03303963|multidrug resistant|multidrug resistant
42634|NCT03303963|diagnosis|diagnosis
42635|NCT03303963|follow-up|follow-up
42636|NCT03303963|africa|africa
42637|NCT03303963|molecular tools|molecular tools
42638|NCT03303937|virulence factor genes;|virulence factor genes;
42639|NCT03303937|phenotyping|phenotyping
42640|NCT03303937|genotyping|genotyping
42641|NCT03303937|antimicrobial susceptibility|antimicrobial susceptibility
42642|NCT03303924|Pharmacokinetic|pharmacokinetic
42643|NCT03303924|Bronchoalveolar Lavage|bronchoalveolar lavage
42644|NCT03303924|Epithelial Lining Fluid|epithelial lining fluid
42645|NCT03303924|Alveolar Macrophage|alveolar macrophage
42646|NCT03303924|Gram-negative bacterium|gram-negative bacterium
42647|NCT03303924|Acinetobacter baumannii|acinetobacter baumannii
42648|NCT03303872|atrial high rate episode|atrial high rate episode
42649|NCT03303872|pacemaker|pacemaker
42650|NCT03303872|atrial fibrillation|atrial fibrillation
42651|NCT03303872|stroke|stroke
42652|NCT03303859|Bacterial vaginosis, preterm delivery, Martinique, stress|bacterial vaginosis, preterm delivery, martinique, stress
42653|NCT03303833|Lifestyle|lifestyle
42654|NCT03303833|Nutrition|nutrition
42655|NCT03303807|Extracorporeal CO2 removal (ECCO2-R)|extracorporeal co2 removal (ecco2-r)
42656|NCT03303807|ARDS|ards
42657|NCT03303794|Total Knee arthroplasty|total knee arthroplasty
42658|NCT03303794|bupivacaine|bupivacaine
42659|NCT03303794|anesthesia|anesthesia
42660|NCT03303729|Carbohydrate|carbohydrate
42661|NCT03303729|Cluster Dextrin|cluster dextrin
42662|NCT03303729|Exercise training|exercise training
42663|NCT03303729|Protein supplement|protein supplement
42664|NCT03303703|cardiac rehabilitation|cardiac rehabilitation
42665|NCT03303677|endoscopic sinus surgery|endoscopic sinus surgery
42666|NCT03303677|topical nasal therapy|topical nasal therapy
42667|NCT03303664|opioid|opioid
42668|NCT03303664|inpatient|inpatient
42669|NCT03303664|pain|pain
42670|NCT03303664|multimodal|multimodal
42671|NCT03303651|Analgesia, Monitoring, Opioid, Sufentanil, Sevoflurane|analgesia, monitoring, opioid, sufentanil, sevoflurane
42672|NCT03303638|Multi-sensory environment|multi-sensory environment
42673|NCT03303638|Snoezelen|snoezelen
42674|NCT03303638|Bathing|bathing
42675|NCT03303638|Showering|showering
42676|NCT03303638|Tub Bathing|tub bathing
42677|NCT03303599|Chronic Hepatitis C|chronic hepatitis c
42678|NCT03303599|Sustained Virological Response|sustained virological response
42679|NCT03303599|Chronic Hepatitis C genotype 1|chronic hepatitis c genotype 1
43382|NCT03299023|Hypopnea|hypopnea
42680|NCT03303599|Chronic Hepatitis C genotype 2|chronic hepatitis c genotype 2
42681|NCT03303599|Chronic Hepatitis C genotype 3|chronic hepatitis c genotype 3
42682|NCT03303599|Chronic Hepatitis C genotype 4|chronic hepatitis c genotype 4
42683|NCT03303599|Chronic Hepatitis C genotype 5|chronic hepatitis c genotype 5
42684|NCT03303599|Chronic Hepatitis C genotype 6|chronic hepatitis c genotype 6
42685|NCT03303586|Asthma|asthma
42686|NCT03303586|Fluid Shift|fluid shift
42687|NCT03303586|Compression stockings|compression stockings
42688|NCT03303586|intrathoracic airway narrowing|intrathoracic airway narrowing
42689|NCT03303573|Erythropoeitin|erythropoeitin
42690|NCT03303547|MRI|mri
42691|NCT03303547|Tissue|tissue
42692|NCT03303547|Imaging|imaging
42693|NCT03303547|Pathology|pathology
42694|NCT03303547|Rectal|rectal
42695|NCT03303547|Cancer|cancer
42696|NCT03303534|inflammation|inflammation
42697|NCT03303534|hydrogen sulfide|hydrogen sulfide
42698|NCT03303534|caloric restriction|caloric restriction
42699|NCT03303534|vascular surgery|vascular surgery
42700|NCT03303495|FOLFIRI|folfiri
42701|NCT03303495|CPT-11|cpt-11
42702|NCT03303495|Bevacizumab|bevacizumab
42703|NCT03303495|2nd-line metastatic colorectal cancer|2nd-line metastatic colorectal cancer
42704|NCT03303456|early psychosis|early psychosis
42705|NCT03303456|clinical high risk|clinical high risk
42706|NCT03303456|mobile health|mobile health
42707|NCT03303430|cerebral microembolisation|cerebral microembolisation
42708|NCT03303430|plaque characteristics|plaque characteristics
42709|NCT03303417|Kiwifruit|kiwifruit
42710|NCT03303378|melatonin|melatonin
42711|NCT03303378|Reperfusion Injury|reperfusion injury
42712|NCT03303378|myocardial infarction|myocardial infarction
42713|NCT03303365|Brain Metastases|brain metastases
42714|NCT03303365|WBRT (whole brain radiotherapy)|wbrt (whole brain radiotherapy)
42715|NCT03303365|SRS (stereotactic radiosurgery)|srs (stereotactic radiosurgery)
42716|NCT03303365|CYBER-Knife|cyber-knife
42717|NCT03303339|PLK1|plk1
42718|NCT03303339|PLK Inhibitor|plk inhibitor
42719|NCT03303326|sexual health|sexual health
42720|NCT03303313|RNAi therapeutic|rnai therapeutic
42721|NCT03303313|Atypical Hemolytic Uremic Syndrome|atypical hemolytic uremic syndrome
42722|NCT03303313|Hemolysis|hemolysis
42723|NCT03303313|Thrombocytopenia|thrombocytopenia
42724|NCT03303313|Renal insufficiency|renal insufficiency
42725|NCT03303313|Thrombotic Microangiopathy|thrombotic microangiopathy
42726|NCT03303313|aHUS|ahus
42727|NCT03303313|TMA|tma
42728|NCT03303287|health education|health education
42729|NCT03303235|methylergonovine|methylergonovine
42730|NCT03303209|opioid|opioid
42731|NCT03303209|opioids|opioids
42732|NCT03303209|taper|taper
42733|NCT03303209|chronic pain|chronic pain
42734|NCT03303196|Post-Pancreatectomy Diabetes|post-pancreatectomy diabetes
42735|NCT03303196|Insulin Therapy|insulin therapy
42736|NCT03303144|Pharmacokinetics|pharmacokinetics
42737|NCT03303144|Equivalence|equivalence
42738|NCT03303118|Hypoxia|hypoxia
42739|NCT03303118|Brain|brain
42740|NCT03303118|Cerebral vaso-reactivity|cerebral vaso-reactivity
42741|NCT03303118|EEG|eeg
42742|NCT03303118|Concentration performance|concentration performance
42743|NCT03303118|Cerebral oxygenation|cerebral oxygenation
42744|NCT03303118|Cerebral blood-flow|cerebral blood-flow
42745|NCT03303118|Heart rate variability|heart rate variability
42746|NCT03303066|Myelodysplastic Syndromes|myelodysplastic syndromes
42747|NCT03303066|Anemia|anemia
42748|NCT03303066|Hemoglobin (Hb)|hemoglobin (hb)
42749|NCT03303066|Low Risk Myelodysplastic Syndrome|low risk myelodysplastic syndrome
42750|NCT03303053|Hyperthyroidism,Graves disease,Cholestyramine,Prednisolone|hyperthyroidism,graves disease,cholestyramine,prednisolone
42751|NCT03303040|Mechanical ventilation|mechanical ventilation
42752|NCT03303040|Diaphragm weakness|diaphragm weakness
42753|NCT03303040|Difficulty weaning from mechanical ventilation|difficulty weaning from mechanical ventilation
42754|NCT03303040|Diaphragm stimulation|diaphragm stimulation
42755|NCT03303027|Cosmesis|cosmesis
42756|NCT03303027|Surgical Wound|surgical wound
42757|NCT03303027|Fast Absorbing Gut|fast absorbing gut
42758|NCT03303027|Linear Cutaneous Wound|linear cutaneous wound
42759|NCT03303014|Suture|suture
42760|NCT03303014|Absorbable|absorbable
42761|NCT03303014|Non-absorbable|non-absorbable
42762|NCT03303014|Split wound|split wound
42763|NCT03303014|Cutaneous Wound|cutaneous wound
42764|NCT03303001|subacromial infiltration|subacromial infiltration
42765|NCT03303001|high volumen|high volumen
42766|NCT03303001|shoulder pain|shoulder pain
42767|NCT03302988|Wound Edge Eversion|wound edge eversion
42768|NCT03302988|Dermal Sutures|dermal sutures
42769|NCT03302975|Running|running
42770|NCT03302975|Biomechanics|biomechanics
42771|NCT03302975|Kinetics|kinetics
42772|NCT03302962|asthma|asthma
42773|NCT03302962|pediatric|pediatric
42774|NCT03302962|american indian|american indian
42775|NCT03302962|children|children
42776|NCT03302949|Nutritional Supplement|nutritional supplement
42777|NCT03302949|Health-related Quality of Life|health-related quality of life
42778|NCT03302949|Dietary Intake|dietary intake
42779|NCT03302936|Midurethral sling|midurethral sling
42781|NCT03302923|Nursing home residents|nursing home residents
42782|NCT03302923|Brisk walking|brisk walking
42783|NCT03302910|Acute Heart Failure, Chronic Heart Failure, Heart Failure, Heart conditions, nitroglycerin|acute heart failure, chronic heart failure, heart failure, heart conditions, nitroglycerin
42784|NCT03302897|Leprosy, vaccine, adjuvant, GLA, GLA-SE|leprosy, vaccine, adjuvant, gla, gla-se
42785|NCT03302871|cerebral palsy|cerebral palsy
42786|NCT03302871|botulinum toxin A|botulinum toxin a
42787|NCT03302871|constraint induced movement therapy|constraint induced movement therapy
42788|NCT03302871|transcranial direct current stimulation|transcranial direct current stimulation
42789|NCT03302832|Total Knee Arthroplasty|total knee arthroplasty
42790|NCT03302832|Total Knee Replacement|total knee replacement
42791|NCT03302806|disability|disability
42792|NCT03302806|EDSS|edss
42793|NCT03302767|Oncology|oncology
42794|NCT03302767|Work Keeping|work keeping
42795|NCT03302767|Social difficulties|social difficulties
42796|NCT03302767|Cognitive Disorders|cognitive disorders
42797|NCT03302741|stroke|stroke
42798|NCT03302728|CD 30 positive, relapsed, refractory|cd 30 positive, relapsed, refractory
42799|NCT03302702|exercise|exercise
42800|NCT03302702|duration|duration
42801|NCT03302689|TAP-block|tap-block
42802|NCT03302689|VAS of pain|vas of pain
42803|NCT03302689|Cesarean section|cesarean section
42804|NCT03302689|Postoperative analgesia|postoperative analgesia
42805|NCT03302676|Saliva substitute|saliva substitute
42806|NCT03302663|Fetal bone heart abnormality|fetal bone heart abnormality
42807|NCT03302624|acute kidney injury|acute kidney injury
42808|NCT03302624|quality of life|quality of life
42809|NCT03302624|Renal replacement therapy|renal replacement therapy
42810|NCT03302624|Intensive care unit|intensive care unit
42811|NCT03302611|major depressive disorder|major depressive disorder
42812|NCT03302611|military|military
42813|NCT03302611|surf therapy|surf therapy
42814|NCT03302611|hike therapy|hike therapy
42815|NCT03302611|randomized controlled trial|randomized controlled trial
42816|NCT03302598|enterocutaneous fistula - C-reactive protein- surgical repair|enterocutaneous fistula - c-reactive protein- surgical repair
42817|NCT03302585|Optic Neuritis|optic neuritis
42818|NCT03302585|Vitamin D|vitamin d
42819|NCT03302572|primary care|primary care
42820|NCT03302572|advance directives|advance directives
42821|NCT03302572|randomized controlled trial|randomized controlled trial
42822|NCT03302533|distal humerus fracture|distal humerus fracture
42823|NCT03302533|total elbow arthroplasty|total elbow arthroplasty
42824|NCT03302533|elbow prosthesis|elbow prosthesis
42825|NCT03302533|delayed arthroplasty|delayed arthroplasty
42826|NCT03302533|revision surgery|revision surgery
42827|NCT03302494|Non-valvular Atrial Fibrillation|non-valvular atrial fibrillation
42828|NCT03302494|Left Atrial Appendage|left atrial appendage
42829|NCT03302481|Obesity surgery|obesity surgery
42830|NCT03302481|liver|liver
42831|NCT03302481|mitochondria|mitochondria
42832|NCT03302481|steatosis|steatosis
42833|NCT03302455|insomia|insomia
42834|NCT03302455|eCBTI|ecbti
42835|NCT03302455|internet|internet
42836|NCT03302455|psychotherapy|psychotherapy
42837|NCT03302455|guided self-help|guided self-help
42838|NCT03302455|psychological treatment|psychological treatment
42839|NCT03302429|Alveolar cleft -Platelet rich fibrin- calcium phosphate|alveolar cleft -platelet rich fibrin- calcium phosphate
42840|NCT03302377|Feasibility|feasibility
42841|NCT03302338|Feeding intolerance|feeding intolerance
42842|NCT03302338|Simulated amniotic fluid like solution|simulated amniotic fluid like solution
42843|NCT03302338|Necrotizing enterocolitis|necrotizing enterocolitis
42844|NCT03302325|stage IV solid tumor|stage iv solid tumor
42845|NCT03302312|Posttraumatic Stress Disorder|posttraumatic stress disorder
42846|NCT03302312|Generalized Anxiety Disorder|generalized anxiety disorder
42847|NCT03302312|Depression|depression
42848|NCT03302312|Distress|distress
42849|NCT03302312|Alcohol Use|alcohol use
42850|NCT03302312|Pain|pain
42851|NCT03302299|Adherence|adherence
42852|NCT03302299|Hepatotoxicity|hepatotoxicity
42853|NCT03302299|Phosphatidtylethanol|phosphatidtylethanol
42854|NCT03302286|Heart-Lung Machine|heart-lung machine
42855|NCT03302286|Cardiopulmonary Bypass|cardiopulmonary bypass
42856|NCT03302273|stem cell therapy|stem cell therapy
42857|NCT03302273|dry eye disease|dry eye disease
42858|NCT03302260|maternal health|maternal health
42859|NCT03302260|pregnancy|pregnancy
42860|NCT03302260|pre-eclampsia|pre-eclampsia
42861|NCT03302234|Programmed Cell Death Receptor 1 (PD-1)|programmed cell death receptor 1 (pd-1)
42862|NCT03302234|Programmed Cell Death Receptor Ligand 1 (PD-L1)|programmed cell death receptor ligand 1 (pd-l1)
42863|NCT03302234|Cytotoxic T-lymphocyte-associated protein 4 (CTLA4)|cytotoxic t-lymphocyte-associated protein 4 (ctla4)
42864|NCT03302234|PD1|pd1
42865|NCT03302234|PD-1|pd-1
42866|NCT03302234|PDL1|pdl1
42867|NCT03302234|PD-L1|pd-l1
42868|NCT03302234|CTLA4|ctla4
42869|NCT03302208|General Anesthesia|general anesthesia
42870|NCT03302195|Heparin|heparin
42871|NCT03302195|Allogeneic blood product transfusions|allogeneic blood product transfusions
42872|NCT03302195|Bleeding|bleeding
42873|NCT03302195|Cardiac surgery|cardiac surgery
42874|NCT03302195|Obesity|obesity
42875|NCT03302169|Prostate Cancer|prostate cancer
42876|NCT03302169|Urinary incontinence|urinary incontinence
42877|NCT03302169|Radical prostatectomy|radical prostatectomy
42878|NCT03302169|Rhabdosphincter|rhabdosphincter
42879|NCT03302169|Robotic Surgery|robotic surgery
42880|NCT03302156|Uterine cancer|uterine cancer
42881|NCT03302156|Ovarian cancer|ovarian cancer
42882|NCT03302156|Hysterectomy|hysterectomy
42883|NCT03302156|Salpingo-oophorectomy|salpingo-oophorectomy
42884|NCT03302143|Dental Implant|dental implant
42885|NCT03302143|Guided Bone Regeneration|guided bone regeneration
42886|NCT03302143|Contour Augmentation|contour augmentation
42887|NCT03302117|Wood smoke|wood smoke
42888|NCT03302117|Bronchoscopy|bronchoscopy
42889|NCT03302065|inhalation|inhalation
42890|NCT03302065|anticholinergic|anticholinergic
42891|NCT03302026|nicotine treatment|nicotine treatment
42892|NCT03302026|real time fMRI|real time fmri
42893|NCT03302013|Arthroplasty|arthroplasty
42894|NCT03302013|Knee|knee
42895|NCT03302013|Bicruciate retaining|bicruciate retaining
42896|NCT03302013|Vanguard XP|vanguard xp
42897|NCT03302013|Vanguard CR|vanguard cr
42898|NCT03302013|Surgery|surgery
42899|NCT03302013|Zimmer Biomet|zimmer biomet
42900|NCT03302013|Joint Replacement|joint replacement
42901|NCT03302013|Osteoarthritis|osteoarthritis
42902|NCT03302000|prematurity|prematurity
42903|NCT03302000|sensory stimulation|sensory stimulation
42904|NCT03302000|rehabilitation|rehabilitation
42905|NCT03302000|infant|infant
42906|NCT03301961|Circulating Tumor DNA|circulating tumor dna
42907|NCT03301961|Early diagnosis|early diagnosis
42908|NCT03301961|Surveillance|surveillance
42909|NCT03301961|Methylation|methylation
42910|NCT03301961|Somatic mutation|somatic mutation
42911|NCT03301935|Risk assessment|risk assessment
42912|NCT03301922|Occupational Health Services|occupational health services
42913|NCT03301922|Metacognitive therapy|metacognitive therapy
42914|NCT03301922|Work focused therapy|work focused therapy
42915|NCT03301922|Sick leave|sick leave
42916|NCT03301896|Phase I|phase i
42917|NCT03301896|LHC165|lhc165
42918|NCT03301896|PDR001|pdr001
42919|NCT03301896|intratumoral injection|intratumoral injection
42920|NCT03301896|abscopal|abscopal
42921|NCT03301896|checkpoint inhibitor|checkpoint inhibitor
42922|NCT03301896|programmed cell death|programmed cell death
42923|NCT03301896|PD-1|pd-1
42924|NCT03301896|TLR-7|tlr-7
42925|NCT03301896|toll-like receptor|toll-like receptor
42926|NCT03301896|melanoma|melanoma
42927|NCT03301896|head and neck|head and neck
42928|NCT03301831|Parents|parents
42929|NCT03301831|Technology-Dependent Child|technology-dependent child
42930|NCT03301831|Resourcefulness|resourcefulness
42931|NCT03301792|Group prenatal care|group prenatal care
42932|NCT03301792|Diabetes|diabetes
42933|NCT03301779|Red Blood Cells|red blood cells
42934|NCT03301766|lidocaine|lidocaine
42935|NCT03301740|Ultrafiltration profiling|ultrafiltration profiling
42936|NCT03301740|Hemodialysis|hemodialysis
42937|NCT03301740|Dialysis|dialysis
42938|NCT03301740|Cardiovascular outcomes|cardiovascular outcomes
42939|NCT03301740|Patient-reported outcomes|patient-reported outcomes
42940|NCT03301740|Crossover study design|crossover study design
42941|NCT03301740|End Stage Renal Disease|end stage renal disease
42942|NCT03301740|Ultrafiltration|ultrafiltration
42943|NCT03301740|Echocardiogram|echocardiogram
42944|NCT03301740|Blood pressure|blood pressure
42945|NCT03301740|Hypotension|hypotension
42946|NCT03301740|Symptoms|symptoms
42947|NCT03301714|motivational interviewing|motivational interviewing
42948|NCT03301714|elderly|elderly
42949|NCT03301714|oral health|oral health
42950|NCT03301688|PD-1 antibody|pd-1 antibody
42951|NCT03301688|phase 1 trial|phase 1 trial
42952|NCT03301675|Orange juice|orange juice
42953|NCT03301675|Healthy diet|healthy diet
42954|NCT03301675|Metabolic syndrome|metabolic syndrome
42955|NCT03301675|Cardiometabolic risk factors|cardiometabolic risk factors
42956|NCT03301675|Body composition|body composition
42957|NCT03301662|atrial fibrillation|atrial fibrillation
42958|NCT03301662|cryptogenic stroke|cryptogenic stroke
42959|NCT03301662|ECG screening|ecg screening
42960|NCT03301662|health-related quality of life|health-related quality of life
42961|NCT03301662|Short Form-36|short form-36
42962|NCT03301662|stroke|stroke
42963|NCT03301662|thumb-ECG|thumb-ecg
42964|NCT03301636|Melanoma, Metastaic Melanoma|melanoma, metastaic melanoma
42965|NCT03301623|Clinical Decision Support|clinical decision support
42966|NCT03301623|Patient Education Materials|patient education materials
42967|NCT03301623|Opioid Use|opioid use
42968|NCT03301623|Chronic Pain|chronic pain
42969|NCT03301610|Pain Education|pain education
42970|NCT03301610|Information Delivery|information delivery
42971|NCT03301610|Mobile Application|mobile application
42972|NCT03301597|Chemotherapy-induced Neutropenia|chemotherapy-induced neutropenia
42973|NCT03301597|Bacterial Infections|bacterial infections
42974|NCT03301597|Fungal Infections|fungal infections
42975|NCT03301584|Hip fracture|hip fracture
42976|NCT03301584|ADL|adl
42977|NCT03301584|patient participation|patient participation
42978|NCT03301584|functional balance|functional balance
42979|NCT03301584|physical performance|physical performance
42980|NCT03301571|Coronary artery bypass graft|coronary artery bypass graft
42981|NCT03301571|Echocardiography|echocardiography
42982|NCT03301545|Bariatric surgery|bariatric surgery
42983|NCT03301545|Obesity|obesity
42984|NCT03301545|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
42985|NCT03301545|Indigenous Population|indigenous population
42986|NCT03301545|Randomized Control Trial|randomized control trial
42987|NCT03301545|Glycoslyated Hemoglobin A1C|glycoslyated hemoglobin a1c
42988|NCT03301545|Anthropometric measurements|anthropometric measurements
42989|NCT03301545|Medication Use|medication use
42990|NCT03301532|G1D, glucose, transporter|g1d, glucose, transporter
42991|NCT03301506|PBC|pbc
42992|NCT03301506|Primary Biliary Cholangitis (PBC)|primary biliary cholangitis (pbc)
42993|NCT03301467|C3 Glomerulonephritis|c3 glomerulonephritis
42994|NCT03301467|C3 glomerulopathy|c3 glomerulopathy
42995|NCT03301467|C3G|c3g
42996|NCT03301467|DDD|ddd
42997|NCT03301467|dense deposit disease|dense deposit disease
42998|NCT03301467|membranoproliferative glomerulonephritis|membranoproliferative glomerulonephritis
42999|NCT03301467|MPGN|mpgn
43000|NCT03301467|C3GN|c3gn
43001|NCT03301467|idiopathic MPGN|idiopathic mpgn
43002|NCT03301441|migraine|migraine
43003|NCT03301441|migraine with aura|migraine with aura
43004|NCT03301441|migraine without aura|migraine without aura
43005|NCT03301441|ischemic stroke|ischemic stroke
43006|NCT03301441|Mismatch|mismatch
43007|NCT03301415|Asymptomatic|asymptomatic
43008|NCT03301415|Congenital CMV Infection|congenital cmv infection
43009|NCT03301415|Valganciclovir Therapy|valganciclovir therapy
43010|NCT03301337|Amino acid uptake|amino acid uptake
43011|NCT03301337|Aging|aging
43012|NCT03301337|Meat protein|meat protein
43013|NCT03301324|intubation|intubation
43014|NCT03301272|Parkinson, Botox, Tremor|parkinson, botox, tremor
43015|NCT03301259|Necrotic pulp|necrotic pulp
43016|NCT03301259|wave-one|wave-one
43017|NCT03301259|one-shape|one-shape
43018|NCT03301259|periapical lesion|periapical lesion
43019|NCT03301194|Hypertension|hypertension
43020|NCT03301194|Effectiveness|effectiveness
43021|NCT03301194|Cost Effectiveness|cost effectiveness
43022|NCT03301194|Cost|cost
43023|NCT03301194|Multi-disciplinary|multi-disciplinary
43024|NCT03301194|Risk Stratification|risk stratification
43025|NCT03301168|ALL|all
43026|NCT03301168|AML|aml
43027|NCT03301168|hematologic neoplasms|hematologic neoplasms
43028|NCT03301168|hematologic malignancies|hematologic malignancies
43029|NCT03301168|primary immune deficiences|primary immune deficiences
43030|NCT03301142|urinary stress incontinence|urinary stress incontinence
43031|NCT03301142|urinary incontinence,stress|urinary incontinence,stress
43032|NCT03301142|laser|laser
43033|NCT03301142|physiotherapy|physiotherapy
43034|NCT03301142|kinesiotherapy|kinesiotherapy
43035|NCT03301116|Exercise|exercise
43036|NCT03301116|Frail Elderly|frail elderly
43037|NCT03301116|Homebound Persons|homebound persons
43038|NCT03301116|Activities of Daily Living|activities of daily living
43039|NCT03301116|Mobility Limitation|mobility limitation
43040|NCT03301116|Home Care Services|home care services
43041|NCT03301116|Long-Term Care|long-term care
43042|NCT03301116|Dual MEDICAID MEDICARE Eligibility|dual medicaid medicare eligibility
43043|NCT03301103|Nutrition|nutrition
43044|NCT03301103|Gastroenteritis|gastroenteritis
43045|NCT03301103|Traveler's diarrhea|traveler's diarrhea
43046|NCT03301103|E. coli|e. coli
43047|NCT03301090|Adults|adults
43048|NCT03301090|Evaluate|evaluate
43049|NCT03301090|Healthy|healthy
43050|NCT03301090|Immunogenicity|immunogenicity
43051|NCT03301090|MERS-CoV|mers-cov
43052|NCT03301090|Pharmacokinetics|pharmacokinetics
43053|NCT03301090|Phase I|phase i
43054|NCT03301090|Placebo|placebo
43055|NCT03301090|REGN MERS|regn mers
43056|NCT03301090|Safety|safety
43057|NCT03301090|Tolerability|tolerability
43058|NCT03301077|children and adolescents|children and adolescents
43059|NCT03301077|mental health|mental health
43060|NCT03301077|epidemiology|epidemiology
43061|NCT03301077|psychiatric disorders|psychiatric disorders
43062|NCT03301064|alcohol, intervention, Latino, community|alcohol, intervention, latino, community
43063|NCT03301051|Influenza|influenza
43064|NCT03301051|Human|human
43065|NCT03301051|RNA Virus Infections|rna virus infections
43066|NCT03301051|Efficacy|efficacy
43067|NCT03301051|Immunologic|immunologic
43068|NCT03301051|Immunogenic Factors|immunogenic factors
43069|NCT03301051|Physiological Effects of Drug|physiological effects of drug
43070|NCT03301051|Virus Diseases|virus diseases
43071|NCT03301051|Orthomyxoviridae Infections|orthomyxoviridae infections
43072|NCT03301051|Infection|infection
43073|NCT03301038|hypercalcemia|hypercalcemia
43074|NCT03301038|nephrocalcinosis|nephrocalcinosis
43075|NCT03301038|CYP24A1|cyp24a1
43076|NCT03301038|hypercalciuria|hypercalciuria
43172|NCT03300297|Temporomandibular Disorders|temporomandibular disorders
43077|NCT03301025|Pregabalin, hypotensive anesthesia, blood loss, analgesia|pregabalin, hypotensive anesthesia, blood loss, analgesia
43078|NCT03301012|Adolescent|adolescent
43079|NCT03301012|Relapse Prevention|relapse prevention
43080|NCT03301012|Smartphone|smartphone
43081|NCT03301012|Recovery Support|recovery support
43082|NCT03300999|ginger tea|ginger tea
43083|NCT03300973|urodynamic study|urodynamic study
43084|NCT03300973|stress urinary incontinence|stress urinary incontinence
43085|NCT03300882|Study co-enrollment (CTOT-20 and CTOT-22)|study co-enrollment (ctot-20 and ctot-22)
43086|NCT03300882|cytomegalovirus (CMV)|cytomegalovirus (cmv)
43087|NCT03300882|CMV seropositive positive recipient|cmv seropositive positive recipient
43088|NCT03300882|CMV infection|cmv infection
43089|NCT03300882|CMV-specific immunity|cmv-specific immunity
43090|NCT03300882|immunologic monitoring|immunologic monitoring
43091|NCT03300869|Spinal Muscular Atrophy|spinal muscular atrophy
43092|NCT03300869|Natural History|natural history
43093|NCT03300856|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
43094|NCT03300856|Electrophysiology|electrophysiology
43095|NCT03300843|Cell Therapy|cell therapy
43096|NCT03300843|Immunotherapy|immunotherapy
43097|NCT03300843|Gene Therapy|gene therapy
43098|NCT03300843|Vaccines|vaccines
43099|NCT03300830|Immunodeficiency|immunodeficiency
43100|NCT03300830|Viral-Associated Cancer|viral-associated cancer
43101|NCT03300830|Kaposi Sarcoma Herpes Virus|kaposi sarcoma herpes virus
43102|NCT03300830|Idiopathic Castleman Disease|idiopathic castleman disease
43103|NCT03300830|Endogenous Retroviruses|endogenous retroviruses
43104|NCT03300804|IBS|ibs
43105|NCT03300791|heart failure|heart failure
43106|NCT03300791|readmission|readmission
43107|NCT03300791|predictive models|predictive models
43108|NCT03300778|neurocognition|neurocognition
43109|NCT03300778|high-risk|high-risk
43110|NCT03300778|prognosis|prognosis
43111|NCT03300765|Thyroid Cancer|thyroid cancer
43112|NCT03300765|Apatinib|apatinib
43113|NCT03300765|Intensity modulated radiation therapy|intensity modulated radiation therapy
43114|NCT03300726|Synaptic injury|synaptic injury
43115|NCT03300713|Mass screening|mass screening
43116|NCT03300713|Pediatrician training|pediatrician training
43117|NCT03300648|coma|coma
43118|NCT03300648|pediatrics|pediatrics
43119|NCT03300583|Interstitial lung disease|interstitial lung disease
43120|NCT03300583|Self-Management|self-management
43121|NCT03300583|Service provision|service provision
43122|NCT03300531|Pure Platelet-rich Plasma|pure platelet-rich plasma
43123|NCT03300531|Randomized Controlled Trial|randomized controlled trial
43124|NCT03300518|GnRH antagonist|gnrh antagonist
43125|NCT03300518|Estrogen pretreatment|estrogen pretreatment
43126|NCT03300518|Poor response patient|poor response patient
43127|NCT03300492|Natural Killer cells|natural killer cells
43128|NCT03300492|NK cells|nk cells
43129|NCT03300492|Immunotherapy|immunotherapy
43130|NCT03300492|haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
43131|NCT03300479|nontraumatic intracerebral hemorrhage|nontraumatic intracerebral hemorrhage
43132|NCT03300479|Cleviprex®|cleviprex®
43133|NCT03300479|Ebrantil®|ebrantil®
43134|NCT03300479|Systolic blood pressure|systolic blood pressure
43135|NCT03300466|Hyaluronic Acid, Lidocaine|hyaluronic acid, lidocaine
43136|NCT03300427|Heart failure with reduced left ventricular ejection fraction|heart failure with reduced left ventricular ejection fraction
43137|NCT03300427|LVEF|lvef
43138|NCT03300427|Cardiac dysfunction|cardiac dysfunction
43139|NCT03300427|Heart muscle dysfunction|heart muscle dysfunction
43140|NCT03300427|Left ventricular (LV) dilation|left ventricular (lv) dilation
43141|NCT03300427|Left ventricular hypertrophy|left ventricular hypertrophy
43142|NCT03300427|HF|hf
43143|NCT03300427|AHF|ahf
43144|NCT03300427|CHF|chf
43145|NCT03300427|CCF|ccf
43146|NCT03300427|acute heart failure|acute heart failure
43147|NCT03300427|chronic heart failure|chronic heart failure
43148|NCT03300427|congestive heart failure|congestive heart failure
43149|NCT03300427|congestive cardiac failure|congestive cardiac failure
43150|NCT03300388|Insulin resistance|insulin resistance
43151|NCT03300388|Exercise|exercise
43152|NCT03300388|Omega-3 fatty acids|omega-3 fatty acids
43153|NCT03300388|Adipose tissue|adipose tissue
43154|NCT03300349|Breast cancer|breast cancer
43155|NCT03300349|Breast cancer-related lymphedema|breast cancer-related lymphedema
43156|NCT03300349|Shoulder injury|shoulder injury
43157|NCT03300349|Prevention|prevention
43158|NCT03300349|Educational activity|educational activity
43159|NCT03300349|Physiotherapy|physiotherapy
43160|NCT03300336|Walking|walking
43161|NCT03300336|Inpatients|inpatients
43162|NCT03300336|Veterans|veterans
43163|NCT03300336|Early Ambulation|early ambulation
43164|NCT03300336|Quality of Life|quality of life
43165|NCT03300323|peri-operative|peri-operative
43166|NCT03300323|fluid|fluid
43167|NCT03300323|microcirculation|microcirculation
43168|NCT03300297|Temporomandibular joint|temporomandibular joint
43169|NCT03300297|Physical Therapy|physical therapy
43170|NCT03300297|Cervical spine thrust joint manipulation|cervical spine thrust joint manipulation
43171|NCT03300297|therapy, exercise|therapy, exercise
43173|NCT03300284|Quality of Life|quality of life
43174|NCT03300284|Decision Making|decision making
43175|NCT03300284|17-382|17-382
43176|NCT03300219|telerehabilitation|telerehabilitation
43177|NCT03300219|occupational therapy|occupational therapy
43178|NCT03300219|rct|rct
43179|NCT03300219|participation|participation
43180|NCT03300219|quality of life|quality of life
43181|NCT03300219|intervention|intervention
43182|NCT03300219|older adults|older adults
43183|NCT03300206|Breast Biopsy|breast biopsy
43184|NCT03300206|Breast Biopsy Imaging|breast biopsy imaging
43185|NCT03300206|Stereotactic Biopsy|stereotactic biopsy
43186|NCT03300193|Magnetic Resonance guided Focused Ultrasound|magnetic resonance guided focused ultrasound
43187|NCT03300193|Tremor|tremor
43188|NCT03300193|Essential Tremor|essential tremor
43189|NCT03300193|Parkinson's Disease|parkinson's disease
43190|NCT03300154|Cardiovascular risk|cardiovascular risk
43191|NCT03300154|Behavioral economics|behavioral economics
43192|NCT03300154|Text messages|text messages
43193|NCT03300154|Financial incentives|financial incentives
43194|NCT03300141|Upper Extremity|upper extremity
43195|NCT03300141|Rehabilitation|rehabilitation
43196|NCT03300141|Arm|arm
43197|NCT03300141|Robotics|robotics
43198|NCT03300141|Stroke Rehabilitation|stroke rehabilitation
43199|NCT03300141|Virtual Reality Thearpy|virtual reality thearpy
43200|NCT03300128|autism|autism
43201|NCT03300128|parenting|parenting
43202|NCT03300128|Incredible Years|incredible years
43203|NCT03300102|personalised medicine|personalised medicine
43204|NCT03300050|live attenuated influenza vaccine|live attenuated influenza vaccine
43205|NCT03300050|inactivated influenza vaccine|inactivated influenza vaccine
43206|NCT03300024|Hemodialysis|hemodialysis
43207|NCT03300024|Arteriovenous|arteriovenous
43208|NCT03300024|Graft|graft
43209|NCT03300024|polytetrafluoroethylene|polytetrafluoroethylene
43210|NCT03300024|Bovine|bovine
43211|NCT03300011|ultrasonic|ultrasonic
43212|NCT03300011|chronic total occlusion|chronic total occlusion
43213|NCT03300011|heart function|heart function
43214|NCT03299985|Gastroesophageal reflux Disease|gastroesophageal reflux disease
43215|NCT03299985|Myofascial release|myofascial release
43216|NCT03299985|Diaphragm|diaphragm
43217|NCT03299972|Sarcopenia|sarcopenia
43218|NCT03299972|Resistance exercise|resistance exercise
43219|NCT03299972|Protein|protein
43220|NCT03299946|Nivolumab|nivolumab
43221|NCT03299946|Cabozantinib|cabozantinib
43222|NCT03299946|Neoadjuvant|neoadjuvant
43223|NCT03299946|Immunotherapy|immunotherapy
43224|NCT03299946|Liver Cancer|liver cancer
43225|NCT03299946|Borderline Resectable|borderline resectable
43226|NCT03299946|Advance Resectable|advance resectable
43227|NCT03299946|Neoplasms|neoplasms
43228|NCT03299946|Hepatocellular Carcinoma|hepatocellular carcinoma
43229|NCT03299946|HCC|hcc
43230|NCT03299946|Resection|resection
43231|NCT03299894|Sepsis|sepsis
43232|NCT03299894|Shock, septic|shock, septic
43233|NCT03299894|Emergency service, hospital|emergency service, hospital
43234|NCT03299894|Anti-infective agents|anti-infective agents
43235|NCT03299894|Outcome assessment|outcome assessment
43236|NCT03299868|Peripherally inserted central catheter|peripherally inserted central catheter
43237|NCT03299868|Terminally ill cancer patients|terminally ill cancer patients
43238|NCT03299868|Palliative care|palliative care
43239|NCT03299855|oncogeriatric|oncogeriatric
43240|NCT03299855|MMS|mms
43241|NCT03299855|MoCA|moca
43242|NCT03299842|seizure|seizure
43243|NCT03299842|tonic clonic|tonic clonic
43244|NCT03299842|epilepsy|epilepsy
43245|NCT03299842|myoclonic|myoclonic
43246|NCT03299842|encephalopathy|encephalopathy
43247|NCT03299829|trientine|trientine
43248|NCT03299829|Wilson's disease|wilson's disease
43249|NCT03299816|Chronic Kidney Disease|chronic kidney disease
43250|NCT03299816|Hypertension|hypertension
43251|NCT03299816|Albuminuria|albuminuria
43252|NCT03299816|African Americans|african americans
43253|NCT03299790|Type 2 diabetes|type 2 diabetes
43254|NCT03299790|Diabetic cardiomyopathy|diabetic cardiomyopathy
43255|NCT03299790|Cardiac function|cardiac function
43256|NCT03299790|Exercise echocardiography|exercise echocardiography
43257|NCT03299790|Exercise training|exercise training
43258|NCT03299751|neonatal sepsis|neonatal sepsis
43259|NCT03299751|biomarker combination|biomarker combination
43260|NCT03299751|diagnostic|diagnostic
43261|NCT03299751|antibiotic use|antibiotic use
43262|NCT03299751|newborn|newborn
43263|NCT03299751|preterm neonates|preterm neonates
43264|NCT03299751|NICU|nicu
43265|NCT03299686|Asthma, allergic, eosinophilic, non-T2 high|asthma, allergic, eosinophilic, non-t2 high
43266|NCT03299647|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
43267|NCT03299647|behavioral deficits|behavioral deficits
43268|NCT03299647|cognitive function|cognitive function
43269|NCT03299647|polyunsaturated fatty acids|polyunsaturated fatty acids
43270|NCT03299647|visual memory|visual memory
43271|NCT03299582|paclitaxel|paclitaxel
43272|NCT03299582|neuropathy|neuropathy
43273|NCT03299582|hypothermia|hypothermia
43274|NCT03299582|cryocompression|cryocompression
43275|NCT03299556|Wearable Health Technology|wearable health technology
43276|NCT03299556|iPhone|iphone
43277|NCT03299556|Apple Watch|apple watch
43278|NCT03299556|Pain Medication|pain medication
43279|NCT03299543|beta-hydroxybutyrate|beta-hydroxybutyrate
43280|NCT03299543|breath acetone|breath acetone
43281|NCT03299530|Corneal Astigmatism|corneal astigmatism
43282|NCT03299530|Scheimpflug|scheimpflug
43283|NCT03299530|pupil size|pupil size
43284|NCT03299530|Toric|toric
43285|NCT03299517|lidocaine|lidocaine
43286|NCT03299517|amiodarone|amiodarone
43287|NCT03299491|Maternity Waiting Area|maternity waiting area
43288|NCT03299491|Ethiopia|ethiopia
43289|NCT03299491|Community Leader|community leader
43290|NCT03299491|Religious Leader|religious leader
43291|NCT03299491|Skilled birth attendance|skilled birth attendance
43292|NCT03299491|Postnatal care|postnatal care
43293|NCT03299491|Information, Education, Communication|information, education, communication
43294|NCT03299491|Safe Motherhood|safe motherhood
43295|NCT03299491|Health Extension Worker|health extension worker
43296|NCT03299491|Antenatal Care|antenatal care
43297|NCT03299465|bone marrow transplantation|bone marrow transplantation
43298|NCT03299465|yoga|yoga
43299|NCT03299452|ex vivo high-throughput drug screening assay|ex vivo high-throughput drug screening assay
43300|NCT03299426|Typhoid|typhoid
43301|NCT03299426|Typhoid in Malawi|typhoid in malawi
43302|NCT03299426|Typhoid Vaccine|typhoid vaccine
43303|NCT03299413|Inflammatory Bowel Disease|inflammatory bowel disease
43304|NCT03299413|Mesenchymal stem cells|mesenchymal stem cells
43305|NCT03299413|Ulcerative colitis|ulcerative colitis
43306|NCT03299413|Neutrophils|neutrophils
43307|NCT03299400|IOP|iop
43308|NCT03299387|urinary tract|urinary tract
43309|NCT03299387|infection|infection
43310|NCT03299387|recurrent|recurrent
43311|NCT03299387|women|women
43312|NCT03299374|Pilates|pilates
43313|NCT03299374|Balance|balance
43314|NCT03299374|Falls|falls
43315|NCT03299374|Older people|older people
43316|NCT03299361|Carpal tunnel syndrome|carpal tunnel syndrome
43317|NCT03299361|Corticosteroid|corticosteroid
43318|NCT03299361|Diffusion tensor imaging|diffusion tensor imaging
43319|NCT03299361|Injection|injection
43320|NCT03299361|Magnetic resonance image|magnetic resonance image
43321|NCT03299361|Ultrasound|ultrasound
43322|NCT03299348|Psychological Mechanisms|psychological mechanisms
43323|NCT03299348|Social-Cognitive Mechanisms|social-cognitive mechanisms
43324|NCT03299322|Bronchial Asthma，TCM，microorganism|bronchial asthma，tcm，microorganism
43325|NCT03299309|Glioma|glioma
43326|NCT03299309|Medulloblastoma|medulloblastoma
43327|NCT03299309|PRiME|prime
43328|NCT03299309|Pro00079843|pro00079843
43329|NCT03299309|Thompson|thompson
43330|NCT03299309|Pediatric|pediatric
43331|NCT03299296|Thromboprophylaxis|thromboprophylaxis
43332|NCT03299296|orthopedic|orthopedic
43333|NCT03299296|rivaroxaban|rivaroxaban
43334|NCT03299296|enoxaparin|enoxaparin
43335|NCT03299270|Surgery|surgery
43336|NCT03299270|Solid malignancy|solid malignancy
43337|NCT03299270|Elderly|elderly
43338|NCT03299270|Functional recovery|functional recovery
43339|NCT03299257|OSA|osa
43340|NCT03299257|CPAP|cpap
43341|NCT03299257|sleepiness|sleepiness
43342|NCT03299257|donepezil|donepezil
43343|NCT03299231|COPD|copd
43344|NCT03299231|acute exacerbation|acute exacerbation
43345|NCT03299231|OPEP|opep
43346|NCT03299218|Specialized Nutritious Food (SNF)|specialized nutritious food (snf)
43347|NCT03299218|Behaviour change communication (BCC)|behaviour change communication (bcc)
43348|NCT03299218|Cash-based transfers|cash-based transfers
43349|NCT03299140|Bipolar disorder|bipolar disorder
43350|NCT03299140|Children|children
43351|NCT03299140|Family Focused Therapy|family focused therapy
43352|NCT03299140|CBT|cbt
43353|NCT03299114|Neuropathic Pain|neuropathic pain
43354|NCT03299114|Whirlpool|whirlpool
43355|NCT03299114|Osteoarthritis|osteoarthritis
43356|NCT03299114|Sleep|sleep
43357|NCT03299101|Frailty|frailty
43358|NCT03299101|Prehabilitation|prehabilitation
43359|NCT03299101|Exercise therapy|exercise therapy
43360|NCT03299101|Surgery|surgery
43361|NCT03299101|Nutrition support|nutrition support
43362|NCT03299075|External eating|external eating
43363|NCT03299075|Technology|technology
43364|NCT03299075|Photography|photography
43365|NCT03299075|Social media|social media
43366|NCT03299049|Long acting Cabotegravir|long acting cabotegravir
43367|NCT03299049|Safety|safety
43368|NCT03299049|HIV-1|hiv-1
43369|NCT03299049|Efficacy|efficacy
43370|NCT03299049|Tolerability|tolerability
43371|NCT03299049|ATLAS-2M|atlas-2m
43372|NCT03299049|Long acting Rilpivirine|long acting rilpivirine
43373|NCT03299036|Hepatoma|hepatoma
43374|NCT03299036|Transcatheter Arterial chemo-embolization|transcatheter arterial chemo-embolization
43375|NCT03299036|Microsphere|microsphere
43376|NCT03299036|Doxorubicin|doxorubicin
43377|NCT03299023|Obstructive Sleep Apnea|obstructive sleep apnea
43378|NCT03299023|Orthodontics|orthodontics
43379|NCT03299023|Tooth Movement|tooth movement
43383|NCT03299023|Sleep|sleep
43384|NCT03299023|Disturbed Breathing|disturbed breathing
43385|NCT03299010|Diabetes Mellitus|diabetes mellitus
43386|NCT03299010|Risk|risk
43387|NCT03299010|Complications|complications
43388|NCT03299010|Mortality|mortality
43389|NCT03299010|Cardiovascular Diseases|cardiovascular diseases
43390|NCT03299010|Chinese|chinese
43391|NCT03299010|Prediction|prediction
43392|NCT03298997|Hemorrhoids|hemorrhoids
43393|NCT03298997|Ligation|ligation
43394|NCT03298997|Ultrasound|ultrasound
43395|NCT03298997|Prospective|prospective
43396|NCT03298997|Randomized Controlled Trial|randomized controlled trial
43397|NCT03298945|colonoscopy|colonoscopy
43398|NCT03298945|colorectal cancer|colorectal cancer
43399|NCT03298945|bowel preparation regimen|bowel preparation regimen
43400|NCT03298945|pragmatic trial|pragmatic trial
43401|NCT03298932|Transesophageal echography|transesophageal echography
43402|NCT03298932|Perioperative cardiac surgery|perioperative cardiac surgery
43403|NCT03298932|Aortic valve replacement|aortic valve replacement
43404|NCT03298932|2D strain of right ventricle|2d strain of right ventricle
43405|NCT03298893|cervical cancer|cervical cancer
43406|NCT03298893|nivolumab|nivolumab
43407|NCT03298893|cisplatin|cisplatin
43408|NCT03298893|radiotherapy|radiotherapy
43409|NCT03298880|Valsalva manoeuvre|valsalva manoeuvre
43410|NCT03298880|Vagal tone|vagal tone
43411|NCT03298880|Modified Valsalva|modified valsalva
43412|NCT03298880|Valsalva Assist Device|valsalva assist device
43413|NCT03298867|Proptosis|proptosis
43414|NCT03298867|Human monoclonal antibody|human monoclonal antibody
43415|NCT03298867|insulin-like growth factor-1 receptor|insulin-like growth factor-1 receptor
43416|NCT03298867|Thyroid-Associated Ophthalmopathy|thyroid-associated ophthalmopathy
43417|NCT03298867|Hyperthyroidism|hyperthyroidism
43418|NCT03298867|Autoimmune Thyroid Disease|autoimmune thyroid disease
43419|NCT03298802|readmission|readmission
43420|NCT03298802|triage visit for pregnancy related hypertension|triage visit for pregnancy related hypertension
43421|NCT03298802|hydrochlorothiazide|hydrochlorothiazide
43422|NCT03298789|static stretching|static stretching
43423|NCT03298789|muscle power|muscle power
43424|NCT03298789|countermovement jump|countermovement jump
43425|NCT03298789|dynamometry|dynamometry
43426|NCT03298789|warm up|warm up
43427|NCT03298789|force plate|force plate
43428|NCT03298750|Mechanical Laboratory Ovarian Stimulation Poor responders|mechanical laboratory ovarian stimulation poor responders
43429|NCT03298711|Central Nervous System Sensitization|central nervous system sensitization
43430|NCT03298711|Neuropeptides|neuropeptides
43431|NCT03298698|Idiopathic nephrotic syndrome|idiopathic nephrotic syndrome
43432|NCT03298698|Minimal change disease|minimal change disease
43433|NCT03298698|Focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
43434|NCT03298698|Rituximab|rituximab
43435|NCT03298698|Randomized clinical trial|randomized clinical trial
43436|NCT03298685|transition|transition
43437|NCT03298685|care program|care program
43438|NCT03298685|needs|needs
43439|NCT03298672|Alzheimer's Disease|alzheimer's disease
43440|NCT03298672|Dementia|dementia
43441|NCT03298672|Brain Diseases|brain diseases
43442|NCT03298672|Central Nervous System Diseases|central nervous system diseases
43443|NCT03298672|Cognition|cognition
43444|NCT03298672|Neurodegenerative Diseases|neurodegenerative diseases
43445|NCT03298672|Neurocognitive Disorders|neurocognitive disorders
43446|NCT03298672|Mental Disorders|mental disorders
43447|NCT03298633|Male infertility|male infertility
43448|NCT03298633|In vitro fertilization|in vitro fertilization
43449|NCT03298633|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
43450|NCT03298620|nursing home|nursing home
43451|NCT03298620|gerodontology|gerodontology
43452|NCT03298620|oral hygiene|oral hygiene
43453|NCT03298568|food intolerance|food intolerance
43454|NCT03298568|histamine intolerance|histamine intolerance
43455|NCT03298568|diamine oxidase|diamine oxidase
43456|NCT03298568|DAO|dao
43457|NCT03298568|DAOsin|daosin
43458|NCT03298529|Glycemic index|glycemic index
43459|NCT03298529|Insulinemic index|insulinemic index
43460|NCT03298529|Traditional egg pasta|traditional egg pasta
43461|NCT03298503|Parkinson's disease|parkinson's disease
43462|NCT03298503|posture balance|posture balance
43463|NCT03298503|attention|attention
43464|NCT03298490|validity|validity
43465|NCT03298490|reliability|reliability
43466|NCT03298490|low back pain|low back pain
43467|NCT03298451|Hepatocellular Carcinoma Non-Resectable|hepatocellular carcinoma non-resectable
43468|NCT03298399|Hematopoietic cell transplantation (HCT)|hematopoietic cell transplantation (hct)
43469|NCT03298399|Haploidentical|haploidentical
43470|NCT03298399|Mesenchymal stromal cells|mesenchymal stromal cells
43471|NCT03298386|Elderly|elderly
43472|NCT03298386|Multimorbidity|multimorbidity
43473|NCT03298386|Polypharmacy|polypharmacy
43474|NCT03298373|Healthy Men|healthy men
43475|NCT03298373|Male Contraception|male contraception
43476|NCT03298373|Androgen|androgen
43477|NCT03298360|HIV cell reservoir|hiv cell reservoir
43478|NCT03298295|Diabetes Mellitus|diabetes mellitus
43479|NCT03298295|Insulin Pump Therapy|insulin pump therapy
43480|NCT03298295|Continuous Subcutaneous Insulin Infusion|continuous subcutaneous insulin infusion
43481|NCT03298256|AIS|ais
43482|NCT03298243|stroke|stroke
43483|NCT03298243|proprioception|proprioception
43484|NCT03298243|sensory substitution|sensory substitution
43485|NCT03298217|Inspiratory flow|inspiratory flow
43486|NCT03298217|High flow nasal cannula, spirometry|high flow nasal cannula, spirometry
43487|NCT03298217|spirometry|spirometry
43488|NCT03298217|physiologic study|physiologic study
43489|NCT03298217|Bronchiolitis patients sverity score mWCAS/ 3-5.|bronchiolitis patients sverity score mwcas/ 3-5.
43490|NCT03298178|TAVR|tavr
43491|NCT03298178|TAVI|tavi
43492|NCT03298178|SAVR|savr
43493|NCT03298152|lithium disilicate endocrowns|lithium disilicate endocrowns
43494|NCT03298152|cerasmart endocrowns|cerasmart endocrowns
43495|NCT03298126|Radial artery occlusion|radial artery occlusion
43496|NCT03298126|TR band|tr band
43497|NCT03298126|Transradial catheterization|transradial catheterization
43498|NCT03298087|oligometastatic|oligometastatic
43499|NCT03298087|SBRT|sbrt
43500|NCT03298087|abiraterone|abiraterone
43501|NCT03298087|apalutamide|apalutamide
43502|NCT03298074|platinum-resistant|platinum-resistant
43503|NCT03298074|recurrent|recurrent
43504|NCT03298061|Eosinophilic Granulomatosis|eosinophilic granulomatosis
43505|NCT03298061|MEA115921|mea115921
43506|NCT03298061|Polyangiitis|polyangiitis
43507|NCT03298061|Long-term access program|long-term access program
43508|NCT03298061|mepolizumab|mepolizumab
43509|NCT03298022|Ulcerative Colitis|ulcerative colitis
43510|NCT03297983|M7583|m7583
43511|NCT03297983|Healthy Subjects|healthy subjects
43512|NCT03297983|Cross-over|cross-over
43513|NCT03297931|Pulse|pulse
43514|NCT03297931|Snack|snack
43515|NCT03297931|Post-prandial glycemia|post-prandial glycemia
43516|NCT03297931|Appetite|appetite
43517|NCT03297931|Food intake|food intake
43518|NCT03297931|Young adults|young adults
43519|NCT03297931|Satiety|satiety
43520|NCT03297905|Chronic Pain|chronic pain
43521|NCT03297905|Military|military
43522|NCT03297853|Descriptive|descriptive
43523|NCT03297853|Support|support
43524|NCT03297853|Retrospective|retrospective
43525|NCT03297853|survey|survey
43526|NCT03297827|diagnosis|diagnosis
43527|NCT03297827|inflammatory biomarkers|inflammatory biomarkers
43528|NCT03297827|cytokines|cytokines
43529|NCT03297827|interleukin|interleukin
43530|NCT03297827|interferons|interferons
43531|NCT03297814|Peripheral arterial disease|peripheral arterial disease
43532|NCT03297814|Platelet lysate|platelet lysate
43533|NCT03297788|SCLC|sclc
43534|NCT03297788|Brain Metastases|brain metastases
43535|NCT03297788|SRS (stereotactic radiosurgery)|srs (stereotactic radiosurgery)
43536|NCT03297788|WBRT (whole brain radiotherapy)|wbrt (whole brain radiotherapy)
43537|NCT03297775|Rheumatoid Arthritis|rheumatoid arthritis
43538|NCT03297775|RA|ra
43539|NCT03297775|Interstitial Lung Disease|interstitial lung disease
43540|NCT03297775|ILD|ild
43541|NCT03297775|lung disease|lung disease
43542|NCT03297775|connective tissue disease|connective tissue disease
43543|NCT03297775|CTD|ctd
43544|NCT03297775|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
43545|NCT03297775|IPF|ipf
43546|NCT03297775|airways disease|airways disease
43547|NCT03297593|renal cell carcinoma|renal cell carcinoma
43548|NCT03297593|Nivolumab|nivolumab
43549|NCT03297593|Ipilimumab|ipilimumab
43550|NCT03297593|metastatic renal cell carcinoma|metastatic renal cell carcinoma
43551|NCT03297593|immunotherapy|immunotherapy
43552|NCT03297593|Opdivo|opdivo
43553|NCT03297593|Yervoy|yervoy
43554|NCT03297567|Elderly|elderly
43555|NCT03297567|Hospitalization|hospitalization
43556|NCT03297567|Immobilization|immobilization
43557|NCT03297567|Exercise|exercise
43558|NCT03297567|Accelerometry|accelerometry
43559|NCT03297515|Omega-3|omega-3
43560|NCT03297515|dry AMD|dry amd
43561|NCT03297515|Stargardt|stargardt
43562|NCT03297515|visual acuity|visual acuity
43563|NCT03297424|PLX2853|plx2853
43564|NCT03297424|Small cell lung cancer (SCLC)|small cell lung cancer (sclc)
43565|NCT03297424|Uveal Melanoma|uveal melanoma
43566|NCT03297424|Ovarian Clear Cell Carcinoma|ovarian clear cell carcinoma
43567|NCT03297424|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
43568|NCT03297424|Advanced Malignancies|advanced malignancies
43569|NCT03297424|Solid Tumor|solid tumor
43570|NCT03297424|Diffuse Large B Cell Lymphoma (DLBCL)|diffuse large b cell lymphoma (dlbcl)
43571|NCT03297424|Follicular Lymphoma (FL)|follicular lymphoma (fl)
43572|NCT03297424|ARID1A|arid1a
43573|NCT03297411|electroconvulsive therapy|electroconvulsive therapy
43574|NCT03297411|computer modelling|computer modelling
43575|NCT03297385|Prostate Cancer|prostate cancer
43576|NCT03297385|Androgen Receptor Genomics|androgen receptor genomics
43577|NCT03297385|Enzalutamide|enzalutamide
43578|NCT03297385|Prostatectomy|prostatectomy
43579|NCT03297385|Neoadjuvant androgen ablation|neoadjuvant androgen ablation
43580|NCT03297372|Intraocular lens|intraocular lens
43581|NCT03297372|monofocal|monofocal
43582|NCT03297372|cataract|cataract
43583|NCT03297372|PhysIOL|physiol
43584|NCT03297359|Dalteparin|dalteparin
43585|NCT03297359|Fragmin|fragmin
43586|NCT03297346|radiotherapy|radiotherapy
43587|NCT03297346|cardiovascular changes|cardiovascular changes
43588|NCT03297346|cardiac imaging|cardiac imaging
43589|NCT03297346|circulating biomarkers|circulating biomarkers
43590|NCT03297346|dosimetry|dosimetry
43591|NCT03297333|Obesity|obesity
43592|NCT03297333|Exercise|exercise
43593|NCT03297333|Cardiac Fat|cardiac fat
43594|NCT03297333|Cardiac Magnetic Resonance|cardiac magnetic resonance
43595|NCT03297333|Vascular Health|vascular health
43596|NCT03297320|Advance Care Planning, End of life, CPR|advance care planning, end of life, cpr
43597|NCT03297294|Painful diabetic neuropathy|painful diabetic neuropathy
43598|NCT03297294|Neuropathic pain|neuropathic pain
43599|NCT03297294|Angiotensin II type 2 receptor antagonist|angiotensin ii type 2 receptor antagonist
43600|NCT03297281|Photovaporization|photovaporization
43601|NCT03297281|Laser|laser
43602|NCT03297281|Benign prostatic hyperplasia|benign prostatic hyperplasia
43603|NCT03297281|Oral anticoagulation|oral anticoagulation
43604|NCT03297281|Complication|complication
43605|NCT03297268|Dementia Caregiver Empowerment|dementia caregiver empowerment
43606|NCT03297268|Caregiver Burden|caregiver burden
43607|NCT03297268|Agitation in Dementia|agitation in dementia
43608|NCT03297268|Environmental Sensors|environmental sensors
43609|NCT03297268|Wearable Technology|wearable technology
43610|NCT03297255|Primary Liver Cancer; Cohort Study|primary liver cancer; cohort study
43611|NCT03297242|Helicobacter Pylori eradication|helicobacter pylori eradication
43612|NCT03297229|Peer mentoring|peer mentoring
43613|NCT03297229|Self-monitoring|self-monitoring
43614|NCT03297229|Behavioral economics|behavioral economics
43615|NCT03297229|Hypertension|hypertension
43616|NCT03297216|PreTerm Birth|preterm birth
43617|NCT03297216|HIV-1-infection|hiv-1-infection
43618|NCT03297216|Antiretroviral Treatment|antiretroviral treatment
43619|NCT03297164|acute myocardial infarction|acute myocardial infarction
43620|NCT03297164|heart failure|heart failure
43621|NCT03297164|optimized treatment|optimized treatment
43622|NCT03297151|Resistance Training|resistance training
43623|NCT03297151|Muscle Function|muscle function
43624|NCT03297151|Protein Synthesis|protein synthesis
43625|NCT03297125|Optune Therapy|optune therapy
43626|NCT03297125|MRI|mri
43627|NCT03297125|NovoCure-TTF-200A|novocure-ttf-200a
43628|NCT03297099|robot-assisted laparosocpic|robot-assisted laparosocpic
43629|NCT03297099|hepatectomy|hepatectomy
43630|NCT03297086|multifocal intraocular lens, angle kappa, presbyopia|multifocal intraocular lens, angle kappa, presbyopia
43631|NCT03297060|Alcohol Screening|alcohol screening
43632|NCT03297047|cast, fracture, immobilization, displacement, child|cast, fracture, immobilization, displacement, child
43633|NCT03297034|Late effects|late effects
43634|NCT03297034|Childhood cancer survivors|childhood cancer survivors
43635|NCT03297034|Swiss Childhood Cancer Registry|swiss childhood cancer registry
43636|NCT03297034|Europe|europe
43637|NCT03297021|ambulatory surgery|ambulatory surgery
43638|NCT03297021|post-operative nausea and vomiting|post-operative nausea and vomiting
43639|NCT03297021|general anesthesia|general anesthesia
43640|NCT03297008|healthy|healthy
43641|NCT03297008|saliva|saliva
43642|NCT03297008|stool|stool
43643|NCT03297008|biomarkers|biomarkers
43644|NCT03297008|Respiratory Syncytial Virus|respiratory syncytial virus
43645|NCT03297008|Rotavirus|rotavirus
43646|NCT03297008|Immunoglobulin|immunoglobulin
43647|NCT03297008|Antibody|antibody
43648|NCT03296995|glucose|glucose
43649|NCT03296995|systemic lupus erythematosus|systemic lupus erythematosus
43650|NCT03296982|Whole blood clotting time|whole blood clotting time
43651|NCT03296956|Postpartum|postpartum
43652|NCT03296956|Dietary Supplement|dietary supplement
43653|NCT03296956|Mood Symptoms|mood symptoms
43654|NCT03296930|Direct Acting Antiviral Agents (DAAs)|direct acting antiviral agents (daas)
43655|NCT03296904|Lower limb amputation|lower limb amputation
43656|NCT03296904|Wearable robotics|wearable robotics
43657|NCT03296891|Ultrasonography|ultrasonography
43658|NCT03296891|Point-of-care ultrasound|point-of-care ultrasound
43659|NCT03296891|Resuscitation|resuscitation
43660|NCT03296891|Critical Care|critical care
43661|NCT03296878|low income|low income
43662|NCT03296865|taping|taping
43663|NCT03296865|functionality|functionality
43664|NCT03296865|rehabilitation|rehabilitation
43665|NCT03296865|muscle activity|muscle activity
43666|NCT03296865|electromyography|electromyography
43667|NCT03296839|colorectal cancer|colorectal cancer
43668|NCT03296839|liver metastases|liver metastases
43669|NCT03296839|SBRT|sbrt
43670|NCT03296813|loop diuretic|loop diuretic
43671|NCT03296787|Drug therapy|drug therapy
43672|NCT03296748|asymptomatic cystocele.|asymptomatic cystocele.
43673|NCT03296748|stress urinary incontinence|stress urinary incontinence
43674|NCT03296696|Phase 1|phase 1
43675|NCT03296696|EGFRvIII-positive glioblastoma|egfrviii-positive glioblastoma
43676|NCT03296696|safety and tolerability|safety and tolerability
43677|NCT03296696|AMG 596|amg 596
43678|NCT03296670|STEMI|stemi
43679|NCT03296670|CSFP|csfp
43680|NCT03296670|Alprostadil|alprostadil
43681|NCT03296670|targeted perfusion microcatheter|targeted perfusion microcatheter
43682|NCT03296631|microbiome|microbiome
43683|NCT03296631|gut|gut
43684|NCT03296631|infant gut|infant gut
43685|NCT03296631|phages|phages
43686|NCT03296631|phages-bacteria interactions|phages-bacteria interactions
43687|NCT03296631|microbiome development|microbiome development
43688|NCT03296618|chronic stroke|chronic stroke
43689|NCT03296618|neural stem cell|neural stem cell
43690|NCT03296618|transplant|transplant
43691|NCT03296618|paralysis|paralysis
43692|NCT03296605|Obesity|obesity
43693|NCT03296592|myelopathy|myelopathy
43694|NCT03296592|diffusion MRI|diffusion mri
43695|NCT03296592|spinal cord injury|spinal cord injury
43696|NCT03296592|spinal cord compression|spinal cord compression
43697|NCT03296592|spondylosis|spondylosis
43698|NCT03296592|cervical|cervical
43699|NCT03296540|STEMI|stemi
43700|NCT03296501|ALS|als
43701|NCT03296501|ADRC|adrc
43702|NCT03296501|adipose derived regenerative cells|adipose derived regenerative cells
43703|NCT03296501|intraspinal transplantation|intraspinal transplantation
43704|NCT03296501|mesenchymal cells|mesenchymal cells
43705|NCT03296488|post-laparotomy wound pain|post-laparotomy wound pain
43706|NCT03296488|NALDEBAIN (150 mg Nalbuphine Sebacate)|naldebain (150 mg nalbuphine sebacate)
43707|NCT03296488|PCA (patient-control-ed alagesia)|pca (patient-control-ed alagesia)
43708|NCT03296449|Hypoxia|hypoxia
43709|NCT03296449|High-Frequency Jet Ventilation|high-frequency jet ventilation
43710|NCT03296449|Continuous Positive Airway Pressure|continuous positive airway pressure
43711|NCT03296423|BCG vaccination|bcg vaccination
43712|NCT03296410|Hand, Foot and Mouth Disease (HFMD)|hand, foot and mouth disease (hfmd)
43713|NCT03296410|immunogenicity|immunogenicity
43714|NCT03296410|safety|safety
43715|NCT03296397|Genital warts|genital warts
43716|NCT03296397|HPV vaccine|hpv vaccine
43717|NCT03296397|Relapse|relapse
43718|NCT03296384|schizophrenia|schizophrenia
43719|NCT03296384|environmental factors|environmental factors
43720|NCT03296358|Acute urticaria|acute urticaria
43721|NCT03296358|Emergency department|emergency department
43722|NCT03296358|Acute allergic syndrome|acute allergic syndrome
43723|NCT03296358|Corticosteroid|corticosteroid
43724|NCT03296358|H1-Antihistamines|h1-antihistamines
43725|NCT03296358|Chronic urticaria|chronic urticaria
43726|NCT03296345|Ketamine|ketamine
43727|NCT03296345|Sickle Cell Disease|sickle cell disease
43728|NCT03296345|Vaso-Occlusive Crisis|vaso-occlusive crisis
43729|NCT03296332|Evaluation|evaluation
43730|NCT03296332|Population-based Intervention|population-based intervention
43731|NCT03296332|Salt intake|salt intake
43732|NCT03296332|Hypertension|hypertension
43733|NCT03296306|urothelial carcinoma|urothelial carcinoma
43734|NCT03296306|cisplatin|cisplatin
43735|NCT03296306|first-line chemotherapy|first-line chemotherapy
43736|NCT03296293|Positive end-expiratory pressure(PEEP)|positive end-expiratory pressure(peep)
43737|NCT03296293|intracranial pressure(ICP)|intracranial pressure(icp)
43738|NCT03296293|central venous pressure(CVP)|central venous pressure(cvp)
43739|NCT03296293|intracranial central venous pressure difference(IVPD)|intracranial central venous pressure difference(ivpd)
43740|NCT03296280|ultrasound|ultrasound
43741|NCT03296280|ultrasonography|ultrasonography
43742|NCT03296280|point of care|point of care
43743|NCT03296280|Doppler ultrasound|doppler ultrasound
43744|NCT03296280|ultrasound imaging|ultrasound imaging
43745|NCT03296280|diagnostic ultrasound|diagnostic ultrasound
43746|NCT03296267|bile acid|bile acid
43747|NCT03296267|bacterial uptake|bacterial uptake
43748|NCT03296254|mindfulness|mindfulness
43749|NCT03296254|meditation|meditation
43750|NCT03296254|stress|stress
43751|NCT03296254|burn-out|burn-out
43752|NCT03296254|personality|personality
43753|NCT03296254|randomized controlled trial|randomized controlled trial
43754|NCT03296241|stress urinary incontinence|stress urinary incontinence
43755|NCT03296241|sexual dysfunction|sexual dysfunction
43756|NCT03296241|laser|laser
43757|NCT03296241|Er:YAG|er:yag
43758|NCT03296241|vaginal laser|vaginal laser
43759|NCT03296241|vaginal tightening|vaginal tightening
43760|NCT03296241|non-ablative|non-ablative
43761|NCT03296241|minimally-invasive|minimally-invasive
43762|NCT03296228|AIS|ais
43763|NCT03296202|HIV|hiv
43764|NCT03296202|cohort studies|cohort studies
43765|NCT03296202|antiretroviral treatment|antiretroviral treatment
43766|NCT03296189|ureteroscopy|ureteroscopy
43767|NCT03296189|ureteric stent|ureteric stent
43768|NCT03296189|intraluminal|intraluminal
43769|NCT03296189|local anaesthetic/anesthetic|local anaesthetic/anesthetic
43770|NCT03296189|steroid/glucocorticoid|steroid/glucocorticoid
43771|NCT03296150|therapeutic educational program|therapeutic educational program
43772|NCT03296150|adherence|adherence
43773|NCT03296150|quality of life|quality of life
43774|NCT03296150|elderly|elderly
43775|NCT03296150|cancer|cancer
43776|NCT03296137|immune therapy|immune therapy
43777|NCT03296137|TILs|tils
43778|NCT03296137|Adoptive cell therapy|adoptive cell therapy
43779|NCT03296124|Prostate Cancer|prostate cancer
43780|NCT03296124|Proton Radiation|proton radiation
43781|NCT03296098|Contraception|contraception
43782|NCT03296098|Healthy Female|healthy female
43783|NCT03296098|Progestin|progestin
43784|NCT03296098|ulipristal acetate|ulipristal acetate
43785|NCT03296033|enoxaparin|enoxaparin
43786|NCT03296033|thromboembolism|thromboembolism
43787|NCT03296033|coagulation|coagulation
43788|NCT03296033|factor Xa|factor xa
43789|NCT03295994|arthroscopy|arthroscopy
43790|NCT03295994|physical therapy|physical therapy
43791|NCT03295994|rehabilitation|rehabilitation
43792|NCT03295994|surgery|surgery
43793|NCT03295994|rotator cuff tear|rotator cuff tear
43794|NCT03295929|3D model|3d model
43795|NCT03295929|Inner ear|inner ear
43796|NCT03295903|Vascular function|vascular function
43797|NCT03295903|Cannabidiol supplementation|cannabidiol supplementation
43798|NCT03295890|myofascial trigger point, tinnitus, dry needling|myofascial trigger point, tinnitus, dry needling
43799|NCT03295864|Arnold-Chiari Malformation, Type 1|arnold-chiari malformation, type 1
43800|NCT03295864|Multifrequency tympanometry|multifrequency tympanometry
43801|NCT03295864|Inner ear pressure|inner ear pressure
43802|NCT03295851|Anemia|anemia
43803|NCT03295851|Pre-operative|pre-operative
43804|NCT03295851|Intravenous Iron|intravenous iron
43805|NCT03295851|Ferric carboxymaltose|ferric carboxymaltose
43806|NCT03295851|abdominal surgery|abdominal surgery
43807|NCT03295838|Borderline personality disorder|borderline personality disorder
43808|NCT03295838|Psychotherapy|psychotherapy
43809|NCT03295838|Treatment outcome|treatment outcome
43810|NCT03295838|Pragmatic clinical trials as topic|pragmatic clinical trials as topic
43811|NCT03295838|Mentalization-based treatment|mentalization-based treatment
43812|NCT03295838|Alexithymia|alexithymia
43813|NCT03295825|Heparin binding protein|heparin binding protein
43814|NCT03295825|Mortality|mortality
43815|NCT03295786|Parkinson|parkinson
43816|NCT03295786|CDNF|cdnf
43817|NCT03295786|Drug Delivery System|drug delivery system
43818|NCT03295786|Intracerebral|intracerebral
43819|NCT03295773|Ischemic Stroke|ischemic stroke
43820|NCT03295773|3D-rotational angiography|3d-rotational angiography
43821|NCT03295773|Morphology|morphology
43822|NCT03295773|Atherosclerosis|atherosclerosis
43823|NCT03295721|bunion|bunion
43824|NCT03295721|bunionectomy|bunionectomy
43825|NCT03295721|bunion surgery|bunion surgery
43826|NCT03295721|postoperative pain|postoperative pain
43827|NCT03295708|Major depressive disorder,Fish Oil|major depressive disorder,fish oil
43828|NCT03295695|Chemotherapy induced cardiotoxicity|chemotherapy induced cardiotoxicity
43829|NCT03295695|Tumor blood perfusion|tumor blood perfusion
43830|NCT03295630|Accelerometry|accelerometry
43831|NCT03295630|Validity|validity
43832|NCT03295617|spinal thoracic herniation|spinal thoracic herniation
43833|NCT03295617|surgery|surgery
43834|NCT03295617|endoscopic approach|endoscopic approach
43835|NCT03295617|thoracic spine|thoracic spine
43836|NCT03295617|minimal invasive access|minimal invasive access
43837|NCT03295604|Gingival recession|gingival recession
43838|NCT03295604|Subepithelial connective tissue grafts|subepithelial connective tissue grafts
43839|NCT03295604|CAD/CAM|cad/cam
43840|NCT03295591|Metastatic colorectal cancer|metastatic colorectal cancer
43841|NCT03295591|Liver resection|liver resection
43842|NCT03295591|Circulating tumor cells|circulating tumor cells
43843|NCT03295578|employees|employees
43844|NCT03295578|continuous glucose monitoring|continuous glucose monitoring
43845|NCT03295578|personalized feedback|personalized feedback
43846|NCT03295578|cognition|cognition
43847|NCT03295578|wellbeing|wellbeing
43848|NCT03295565|Sequencing|sequencing
43849|NCT03295565|cabazitaxel|cabazitaxel
43850|NCT03295565|abiraterone|abiraterone
43851|NCT03295565|enzalutamide|enzalutamide
43852|NCT03295565|clinical benefit rate|clinical benefit rate
43853|NCT03295565|docetaxel|docetaxel
43854|NCT03295565|second line treatment|second line treatment
43855|NCT03295552|decitabine|decitabine
43856|NCT03295552|triple negative breast cancer|triple negative breast cancer
43857|NCT03295552|carboplatin|carboplatin
43858|NCT03295552|metastatic|metastatic
43859|NCT03295526|Cervical Cancer, Lymph nodes debulking surgery|cervical cancer, lymph nodes debulking surgery
43860|NCT03295513|mutilated, root canal treated teeth, and coronal fracture|mutilated, root canal treated teeth, and coronal fracture
43861|NCT03295500|CyberKnife|cyberknife
43862|NCT03295500|hepatocellular|hepatocellular
43863|NCT03295500|dose fraction|dose fraction
43864|NCT03295500|ICG R15|icg r15
43865|NCT03295487|post menopausal stress incontinence|post menopausal stress incontinence
43866|NCT03295487|local estrogen|local estrogen
43867|NCT03295448|fatty acids|fatty acids
43868|NCT03295448|biomarker|biomarker
43869|NCT03295448|carbohydrate|carbohydrate
43870|NCT03295448|lipogenesis|lipogenesis
43871|NCT03295435|Diet|diet
43872|NCT03295435|Oral Health|oral health
43873|NCT03295435|Nutrition|nutrition
43874|NCT03295435|Dentition|dentition
43875|NCT03295422|Persistent Atrial Fibrillation|persistent atrial fibrillation
43876|NCT03295422|Radiofrequency ablation|radiofrequency ablation
43877|NCT03295422|Catheter ablation|catheter ablation
43878|NCT03295383|cyclophosphamide|cyclophosphamide
43879|NCT03295383|Rituximab|rituximab
43880|NCT03295370|Pain mechanisms|pain mechanisms
43881|NCT03295370|Cortical activation|cortical activation
43882|NCT03295370|fNIRS|fnirs
43883|NCT03295370|Accessory spinal nerve|accessory spinal nerve
43884|NCT03295370|Autonomic response|autonomic response
43885|NCT03295370|Muscular perfusion|muscular perfusion
43886|NCT03295318|Neisseria meningitidis|neisseria meningitidis
43887|NCT03295318|conjugate meningococcal vaccine|conjugate meningococcal vaccine
43888|NCT03295318|meningococcal serogroup X|meningococcal serogroup x
43889|NCT03295305|Biomarker|biomarker
43890|NCT03295305|Bipolar Disorder|bipolar disorder
43891|NCT03295305|Cognition|cognition
43892|NCT03295305|Cognitive Impairment|cognitive impairment
43893|NCT03295305|cognitive remediation|cognitive remediation
43894|NCT03295305|functional magnetic resonance imaging|functional magnetic resonance imaging
43895|NCT03295305|pro-cognitive effect|pro-cognitive effect
43896|NCT03295305|Relatives|relatives
43897|NCT03295292|Phototherapeutic Keratectomy (PTK)|phototherapeutic keratectomy (ptk)
43898|NCT03295292|photorefractive Keratectomy (PRK)|photorefractive keratectomy (prk)
43899|NCT03295292|Collagen Cross-linking (CXL)|collagen cross-linking (cxl)
43900|NCT03295292|Stem Cell Therapy|stem cell therapy
43901|NCT03295279|World Trade Center|world trade center
43902|NCT03295279|Quantitative computerized tomography|quantitative computerized tomography
43903|NCT03295279|Qualitative computerized tomography of the chest|qualitative computerized tomography of the chest
43904|NCT03295279|Chronic airway disease|chronic airway disease
43905|NCT03295279|Interstitial lung disease|interstitial lung disease
43906|NCT03295279|Occupational pulmonology|occupational pulmonology
43907|NCT03295253|urinary incontinence|urinary incontinence
43908|NCT03295253|stress urinary incontinence|stress urinary incontinence
43909|NCT03295253|stress incontinence|stress incontinence
43910|NCT03295240|Mantle Cell Lymphoma|mantle cell lymphoma
43911|NCT03295240|MCL|mcl
43912|NCT03295240|Lymphoma|lymphoma
43913|NCT03295240|Venetoclax|venetoclax
43914|NCT03295240|17-216|17-216
43915|NCT03295227|Thymoma|thymoma
43916|NCT03295227|Thymic cancer|thymic cancer
43917|NCT03295227|Pembrolizumab|pembrolizumab
43918|NCT03295227|Keytruda|keytruda
43919|NCT03295227|MK-3475|mk-3475
43920|NCT03295227|SCH-900475|sch-900475
43921|NCT03295214|Acetaminophen|acetaminophen
43922|NCT03295214|Functional Endoscopic Sinus Surgery|functional endoscopic sinus surgery
43923|NCT03295201|Cystic Fibrosis|cystic fibrosis
43924|NCT03295201|Postural exercise|postural exercise
43925|NCT03295201|Pulmonary rehabilitation|pulmonary rehabilitation
43926|NCT03295175|Congenital Abnormalities|congenital abnormalities
43927|NCT03295175|Hypospadias|hypospadias
43928|NCT03295175|Congenital megaprepuce|congenital megaprepuce
43929|NCT03295175|Histology|histology
43930|NCT03295110|Alzheimer's disease and Related Disorders (ADRD)|alzheimer's disease and related disorders (adrd)
43931|NCT03295110|natural caregiver|natural caregiver
43932|NCT03295110|non-medical connected device|non-medical connected device
43933|NCT03295110|caregiver's burden|caregiver's burden
43934|NCT03295110|anxiety|anxiety
43935|NCT03295110|costs|costs
43936|NCT03295110|quality of life|quality of life
43937|NCT03295110|depressive symptoms|depressive symptoms
43938|NCT03295110|independence|independence
43939|NCT03295097|pharmacogenomics|pharmacogenomics
43940|NCT03295071|Heredity Optic Atrophy|heredity optic atrophy
43941|NCT03295071|Leber Hereditary Optic Atrophy|leber hereditary optic atrophy
43942|NCT03295071|Leber Hereditary Optic Neuropathy|leber hereditary optic neuropathy
43943|NCT03295071|Eye Diseases|eye diseases
43944|NCT03295071|Hereditary Eye Diseases|hereditary eye diseases
43945|NCT03295071|Inherited retinal dystrophies or degeneration|inherited retinal dystrophies or degeneration
43946|NCT03295071|Inborn Genetic Disease|inborn genetic disease
43947|NCT03295071|Gene Therapy|gene therapy
43948|NCT03295071|Intravitreal Injections|intravitreal injections
43949|NCT03295071|Mitochondrial Disease|mitochondrial disease
43950|NCT03295071|AAV2 Vectors|aav2 vectors
43951|NCT03295071|Nervous System Diseases|nervous system diseases
43952|NCT03295071|Neurodegenerative Disease|neurodegenerative disease
43953|NCT03295071|Heredodegenerative Disorders of the Nervous System|heredodegenerative disorders of the nervous system
43954|NCT03295006|TheraSphere, hepatocellular carcinoma, dosimetry|therasphere, hepatocellular carcinoma, dosimetry
43955|NCT03294980|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
43956|NCT03294980|Observational study|observational study
43957|NCT03294967|High Myopia|high myopia
43958|NCT03294967|Caffeine|caffeine
43959|NCT03294967|Choroidal Thickness|choroidal thickness
43960|NCT03294967|Choroidal Volume|choroidal volume
43961|NCT03294967|Optical Coherence Tomography|optical coherence tomography
43962|NCT03294967|Optical Coherence Tomography Angiography|optical coherence tomography angiography
43963|NCT03294954|Neuroblastoma|neuroblastoma
43964|NCT03294954|Natural Killer T-Cells|natural killer t-cells
43965|NCT03294954|Chimerical Antigen Receptor|chimerical antigen receptor
43966|NCT03294915|prediabetes|prediabetes
43967|NCT03294915|resistant starch|resistant starch
43968|NCT03294915|insulin sensitivity|insulin sensitivity
43969|NCT03294889|Prostate cancer|prostate cancer
43970|NCT03294889|Stereotactic body radiation therapy|stereotactic body radiation therapy
43971|NCT03294889|Calypso® beacon system|calypso® beacon system
43972|NCT03294876|Glucocorticoid|glucocorticoid
43973|NCT03294876|HPA axis|hpa axis
43974|NCT03294863|Scar|scar
43975|NCT03294863|Cosmesis|cosmesis
43976|NCT03294863|Embrace Device|embrace device
43977|NCT03294863|Split Wound|split wound
43978|NCT03294863|Wound Closure|wound closure
43979|NCT03294863|Cutaneous Wound|cutaneous wound
43980|NCT03294824|NK cells|nk cells
43981|NCT03294824|Cytomegalovirus|cytomegalovirus
43982|NCT03294824|adenovirus|adenovirus
43983|NCT03294824|Allogeneic transplantation|allogeneic transplantation
43984|NCT03294772|Respiratory Tract Infections|respiratory tract infections
43985|NCT03294772|gastroenteritis|gastroenteritis
43986|NCT03294772|hand sanitizer|hand sanitizer
43987|NCT03294772|handwashing|handwashing
43988|NCT03294772|day care|day care
43989|NCT03294759|amion|amion
43990|NCT03294759|stem cell|stem cell
43991|NCT03294759|acl|acl
43992|NCT03294746|Drug induced interstitial lung disease (DIILD)|drug induced interstitial lung disease (diild)
43993|NCT03294694|Metastatic Hormone-Receptor-Positive (HR+) Breast Cancer|metastatic hormone-receptor-positive (hr+) breast cancer
43994|NCT03294694|HER2-Negative Breast Cancer|her2-negative breast cancer
43995|NCT03294694|Metastatic Epithelial Ovarian Cancer|metastatic epithelial ovarian cancer
43996|NCT03294668|social skills group training|social skills group training
43997|NCT03294668|Adolescents|adolescents
43998|NCT03294668|Active control group|active control group
43999|NCT03294668|Australian|australian
44000|NCT03294642|exercise|exercise
44001|NCT03294642|FODMAP|fodmap
44002|NCT03294642|gastrointestinal|gastrointestinal
44003|NCT03294642|endurance|endurance
44004|NCT03294642|cycling|cycling
44005|NCT03294629|cPAP|cpap
44006|NCT03294629|SenseAwake|senseawake
44007|NCT03294616|transcutaneous electroacupuncture|transcutaneous electroacupuncture
44008|NCT03294603|Healthy Volunteer|healthy volunteer
44009|NCT03294603|CC-220|cc-220
44010|NCT03294603|Male|male
44011|NCT03294590|Child oral health behaviors|child oral health behaviors
44012|NCT03294590|Text messages|text messages
44013|NCT03294590|Motivation|motivation
44014|NCT03294590|Self efficacy|self efficacy
44015|NCT03294590|Outcome Expectations|outcome expectations
44016|NCT03294590|Bottle/sippy cup use|bottle/sippy cup use
44017|NCT03294590|Sugar sweetened beverage consumption|sugar sweetened beverage consumption
44018|NCT03294590|Fluoride varnish|fluoride varnish
44019|NCT03294590|Healthy eating|healthy eating
44020|NCT03294590|Parent oral health behaviors|parent oral health behaviors
44021|NCT03294590|Parent oral health attitudes|parent oral health attitudes
44022|NCT03294590|Fluoride|fluoride
44023|NCT03294577|Plinabulin|plinabulin
44024|NCT03294577|Pegfilgrastim|pegfilgrastim
44025|NCT03294577|bone pain|bone pain
44026|NCT03294577|Chemotherapy induced neutropenia|chemotherapy induced neutropenia
44027|NCT03294564|Inflammation|inflammation
44028|NCT03294564|Threat sensitivity|threat sensitivity
44029|NCT03294564|Reward sensitivity|reward sensitivity
44030|NCT03294551|HPV Vaccine|hpv vaccine
44031|NCT03294551|immunization registry|immunization registry
44032|NCT03294551|Reminder recall (R/R)|reminder recall (r/r)
44033|NCT03294486|Glioblastoma|glioblastoma
44034|NCT03294486|Oncolytic viruses|oncolytic viruses
44035|NCT03294473|reminder recall (R/R), influenza vaccines|reminder recall (r/r), influenza vaccines
44036|NCT03294460|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
44037|NCT03294460|Alcohol Use|alcohol use
44038|NCT03294460|Polymorphism, Genetic|polymorphism, genetic
44039|NCT03294460|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
44040|NCT03294447|Fear of falling|fear of falling
44041|NCT03294408|fractal analysis|fractal analysis
44042|NCT03294408|trabecular bone texture|trabecular bone texture
44043|NCT03294408|knee osteoarthritis|knee osteoarthritis
44044|NCT03294408|subchondral bone|subchondral bone
44045|NCT03294408|Medical Resonnance Imaging|medical resonnance imaging
44046|NCT03294395|Antimicrobial resistance|antimicrobial resistance
44047|NCT03294395|Antibiotics|antibiotics
44048|NCT03294395|Fosfomycin|fosfomycin
44049|NCT03294395|Ertapenem|ertapenem
44050|NCT03294395|Gentamicin|gentamicin
44051|NCT03294395|Neisseria Gonorrhoeae|neisseria gonorrhoeae
44052|NCT03294382|epicanthoplasty|epicanthoplasty
44053|NCT03294382|Botulinum Toxins|botulinum toxins
44054|NCT03294382|scar|scar
44055|NCT03294382|intercanthal distance|intercanthal distance
44056|NCT03294382|blepharoplasty|blepharoplasty
44057|NCT03294369|Hypertension|hypertension
44058|NCT03294369|Diabetes|diabetes
44059|NCT03294369|Dyslipidemia|dyslipidemia
44060|NCT03294369|Smoking|smoking
44061|NCT03294369|Cardiovascular|cardiovascular
44062|NCT03294369|Toledo|toledo
44063|NCT03294317|His bundle pacing|his bundle pacing
44064|NCT03294317|Pacemaker|pacemaker
44065|NCT03294304|MIBC|mibc
44066|NCT03294304|UC|uc
44067|NCT03294304|Immunotherapy|immunotherapy
44068|NCT03294304|Bladder Cancer|bladder cancer
44069|NCT03294304|Neoadjuvant|neoadjuvant
44070|NCT03294304|Nivolumab|nivolumab
44071|NCT03294304|Cisplatin|cisplatin
44072|NCT03294304|Gemcitabine|gemcitabine
44073|NCT03294265|Diabetes|diabetes
44074|NCT03294265|Peer support|peer support
44075|NCT03294265|WhatsApp|whatsapp
44076|NCT03294252|PIPAC|pipac
44077|NCT03294252|oxaliplatin|oxaliplatin
44078|NCT03294252|peritoneal metastases|peritoneal metastases
44079|NCT03294187|Upper Extremity|upper extremity
44080|NCT03294187|Feedback|feedback
44081|NCT03294187|Rehabilitation|rehabilitation
44082|NCT03294187|Randomized Controlled Trial|randomized controlled trial
44083|NCT03294161|Meglumine antimoniate|meglumine antimoniate
44084|NCT03294161|L.Braziliensis|l.braziliensis
44085|NCT03294161|Immunotherapy|immunotherapy
44086|NCT03294161|Immucillin|immucillin
44087|NCT03294148|Placebo|placebo
44088|NCT03294148|Back|back
44089|NCT03294148|Pain|pain
44090|NCT03294148|Chronic|chronic
44091|NCT03294148|Mind-Body|mind-body
44092|NCT03294135|Encepur|encepur
44093|NCT03294135|Adults|adults
44094|NCT03294135|Long term immunogenicity|long term immunogenicity
44095|NCT03294135|Tick-borne Encephalitis vaccine|tick-borne encephalitis vaccine
44096|NCT03294135|Booster|booster
44097|NCT03294122|Radiotherapy|radiotherapy
44098|NCT03294122|Adverse effects|adverse effects
44099|NCT03294122|Prostate cancer|prostate cancer
44100|NCT03294122|Head and neck cancer|head and neck cancer
44101|NCT03294122|Patient risk stratification|patient risk stratification
44102|NCT03294122|Mathematical models|mathematical models
44103|NCT03294122|Microbiome|microbiome
44104|NCT03294122|Inflammatory cytokines|inflammatory cytokines
44105|NCT03294122|Magnetic Resonance Imaging|magnetic resonance imaging
44106|NCT03294109|TQL block, TAP block, donor nephrectomy, pain, patient satisfaction|tql block, tap block, donor nephrectomy, pain, patient satisfaction
44107|NCT03294083|Cancer|cancer
44108|NCT03294083|Renal cell carcinoma|renal cell carcinoma
44109|NCT03294083|Clear cell renal cell carcinoma|clear cell renal cell carcinoma
44110|NCT03294070|hemodynamic parameters|hemodynamic parameters
44111|NCT03294070|arterial stiffness|arterial stiffness
44112|NCT03294057|Self-Management IT Program|self-management it program
44113|NCT03294044|Self-Management IT Program|self-management it program
44114|NCT03294031|Parkinson Disease|parkinson disease
44115|NCT03294031|Neurodegenerative Disorder|neurodegenerative disorder
44116|NCT03294031|Physical Activity|physical activity
44117|NCT03294031|Pilates Method|pilates method
44118|NCT03294031|Stabilometer|stabilometer
44119|NCT03293953|HCV|hcv
44120|NCT03293953|HIV|hiv
44121|NCT03293953|Liver Fibrosis|liver fibrosis
44122|NCT03293953|Liver Iron Overload|liver iron overload
44123|NCT03293940|Breast Pain|breast pain
44124|NCT03293940|Nerve Pain|nerve pain
44125|NCT03293940|Mastectomy|mastectomy
44126|NCT03293940|Lumpectomy|lumpectomy
44127|NCT03293940|Breast Reconstruction|breast reconstruction
44128|NCT03293927|children, mechanically ventilated, fentanyl, dexmedetomidine, delirium, polypharmacy|children, mechanically ventilated, fentanyl, dexmedetomidine, delirium, polypharmacy
44129|NCT03293888|Spectral Diagnosis Probe|spectral diagnosis probe
44130|NCT03293888|Chaos Wand|chaos wand
44131|NCT03293888|Spectral Analysis|spectral analysis
44132|NCT03293888|Optical Spectroscopy|optical spectroscopy
44133|NCT03293862|laparotomy|laparotomy
44134|NCT03293862|emergency surgery|emergency surgery
44135|NCT03293862|abdominal wound dehiscence|abdominal wound dehiscence
44136|NCT03293862|prophylactic mesh|prophylactic mesh
44137|NCT03293836|Varicose ulcer|varicose ulcer
44138|NCT03293836|Venous ulcer|venous ulcer
44139|NCT03293836|Radiofrequency ablation|radiofrequency ablation
44140|NCT03293836|Perforating veins insufficiency|perforating veins insufficiency
44141|NCT03293836|Varicose veins treatment|varicose veins treatment
44142|NCT03293797|Mindfulness-based Therapy|mindfulness-based therapy
44143|NCT03293797|Wellbeing|wellbeing
44144|NCT03293797|Treatment|treatment
44145|NCT03293784|Melanoma|melanoma
44146|NCT03293784|Immune checkpoint|immune checkpoint
44147|NCT03293784|Nivolumab|nivolumab
44148|NCT03293784|Ipilimumab|ipilimumab
44149|NCT03293784|Infliximab|infliximab
44150|NCT03293784|Certolizumab|certolizumab
44151|NCT03293784|PD-1|pd-1
44152|NCT03293784|TNFa|tnfa
44153|NCT03293784|CTLA-4|ctla-4
44154|NCT03293771|Transgender women|transgender women
44155|NCT03293771|Male-to-female|male-to-female
44156|NCT03293771|Gender confirmation surgery|gender confirmation surgery
44157|NCT03293771|Voiding disorder|voiding disorder
44158|NCT03293771|Vaginal dysfunction|vaginal dysfunction
44159|NCT03293693|beta-glucan|beta-glucan
44160|NCT03293693|Blood glucose|blood glucose
44161|NCT03293693|Gut microbiota|gut microbiota
44162|NCT03293693|Satiety|satiety
44163|NCT03293693|Dietary intervention|dietary intervention
44164|NCT03293667|Rheumatoid Arthritis|rheumatoid arthritis
44165|NCT03293667|Regulatory T Cells|regulatory t cells
44166|NCT03293641|Children, Sickle Cell Disease, Zinc|children, sickle cell disease, zinc
44167|NCT03293628|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
44168|NCT03293628|haemostasis|haemostasis
44169|NCT03293628|vaginal pack|vaginal pack
44170|NCT03293628|Loop electrical excision procedure|loop electrical excision procedure
44171|NCT03293628|randomized clinical trials|randomized clinical trials
44172|NCT03293628|uterine cervical neoplasm|uterine cervical neoplasm
44173|NCT03293602|prostate cancer|prostate cancer
44174|NCT03293602|MRI|mri
44175|NCT03293602|BOLD|bold
44176|NCT03293602|18F-MISO|18f-miso
44177|NCT03293602|PET|pet
44178|NCT03293589|end-stage renal disease|end-stage renal disease
44179|NCT03293589|critical limb ischemia|critical limb ischemia
44180|NCT03293589|surgical revascularisation|surgical revascularisation
44181|NCT03293589|endovascular therapy|endovascular therapy
44182|NCT03293576|Behavioural Medicine|behavioural medicine
44183|NCT03293576|Health Psychology|health psychology
44184|NCT03293576|Psychosocial Intervention|psychosocial intervention
44185|NCT03293576|People Who Inject Drugs|people who inject drugs
44186|NCT03293563|Kidney cancer|kidney cancer
44187|NCT03293563|Surgical approaches|surgical approaches
44188|NCT03293563|Medical treatment|medical treatment
44189|NCT03293563|Multicentric and multidisciplinary network|multicentric and multidisciplinary network
44190|NCT03293537|Dementia|dementia
44191|NCT03293537|Aphathy|aphathy
44192|NCT03293537|Emotion|emotion
44193|NCT03293537|Images|images
44194|NCT03293537|Skin conductance|skin conductance
44195|NCT03293537|Heart rate|heart rate
44196|NCT03293524|Heredity Optic Atrophy|heredity optic atrophy
44197|NCT03293524|Leber Hereditary Optic Atrophy|leber hereditary optic atrophy
44198|NCT03293524|Leber Hereditary Optic Neuropathy|leber hereditary optic neuropathy
44199|NCT03293524|LHON|lhon
44200|NCT03293524|Eye Diseases|eye diseases
44201|NCT03293524|Hereditary Eye Diseases|hereditary eye diseases
44202|NCT03293524|Inherited retinal dystrophies or degeneration|inherited retinal dystrophies or degeneration
44203|NCT03293524|Inborn Genetic Disease|inborn genetic disease
44204|NCT03293524|Gene Therapy|gene therapy
44205|NCT03293524|Intravitreal Injections|intravitreal injections
44206|NCT03293524|Mitochondrial Disease|mitochondrial disease
44207|NCT03293524|AAV2 Vectors|aav2 vectors
44208|NCT03293524|Nervous System Diseases|nervous system diseases
44209|NCT03293524|Neurodegenerative Disease|neurodegenerative disease
44210|NCT03293524|Heredodegenerative Disorders of the Nervous System|heredodegenerative disorders of the nervous system
44211|NCT03293524|Atrophy|atrophy
44212|NCT03293524|Pathological Conditions, Anatomical|pathological conditions, anatomical
44213|NCT03293524|Anesthetics|anesthetics
44214|NCT03293524|Central Nervous System Depressants|central nervous system depressants
44215|NCT03293524|Physiological Effects of Drugs|physiological effects of drugs
44216|NCT03293511|Oxytocin|oxytocin
44217|NCT03293511|Eye tracking|eye tracking
44218|NCT03293511|Autistic trait|autistic trait
44219|NCT03293407|Pulmonary arterial hypertension|pulmonary arterial hypertension
44220|NCT03293407|PAH|pah
44221|NCT03293394|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
44222|NCT03293394|Motor Neuron Disease|motor neuron disease
44223|NCT03293394|Transcranial Direct Current Stimulation|transcranial direct current stimulation
44224|NCT03293368|Oral|oral
44225|NCT03293368|Lichen planus|lichen planus
44226|NCT03293368|PRP|prp
44227|NCT03293355|People Living with HIV Who Use Drugs (PLHWUD)|people living with hiv who use drugs (plhwud)
44228|NCT03293355|Community Health Workers (CHW)|community health workers (chw)
44229|NCT03293355|Multilevel Service Integration|multilevel service integration
44230|NCT03293355|HIV/AIDS|hiv/aids
44231|NCT03293355|Vietnam|vietnam
44232|NCT03293329|rotator cuff injury|rotator cuff injury
44233|NCT03293329|diaphragm|diaphragm
44234|NCT03293329|physical therapy|physical therapy
44235|NCT03293329|manual therapy|manual therapy
44236|NCT03293316|Transcranial electrical stimulation; random noise;|transcranial electrical stimulation; random noise;
44237|NCT03293316|cognitive interventions; electroencephalography;|cognitive interventions; electroencephalography;
44238|NCT03293316|inter-individual variability; stochastic resonance;|inter-individual variability; stochastic resonance;
44239|NCT03293303|Prevention|prevention
44240|NCT03293303|Physical activity|physical activity
44241|NCT03293303|Sedentary behaviour|sedentary behaviour
44242|NCT03293303|Daily activities|daily activities
44243|NCT03293303|Homecare|homecare
44244|NCT03293303|Nursing|nursing
44245|NCT03293303|Primary care|primary care
44246|NCT03293303|Older adults|older adults
44247|NCT03293303|Function Focused Care|function focused care
44248|NCT03293303|Reablement|reablement
44249|NCT03293303|Restorative Care|restorative care
44250|NCT03293290|HIV pre-exposure prophylaxis|hiv pre-exposure prophylaxis
44251|NCT03293290|criminal justice|criminal justice
44252|NCT03293290|women|women
44253|NCT03293290|risk networks|risk networks
44254|NCT03293264|metabolic syndrome|metabolic syndrome
44255|NCT03293264|exercise training|exercise training
44256|NCT03293264|employees|employees
44257|NCT03293264|workplace|workplace
44258|NCT03293264|operational health service|operational health service
44259|NCT03293238|knee|knee
44260|NCT03293238|osteoarthritis|osteoarthritis
44261|NCT03293238|ultrasound|ultrasound
44262|NCT03293238|sonography|sonography
44263|NCT03293238|injection|injection
44264|NCT03293225|cu|cu
44265|NCT03293212|Postoperative pain|postoperative pain
44266|NCT03293212|Failed back surgery syndrome|failed back surgery syndrome
44267|NCT03293212|Korean medicine|korean medicine
44268|NCT03293173|DLBCL|dlbcl
44269|NCT03293173|Chemoimmunotherapy|chemoimmunotherapy
44270|NCT03293173|High risk|high risk
44271|NCT03293173|CNS prophylaxis|cns prophylaxis
44272|NCT03293173|Biomarker-driven|biomarker-driven
44273|NCT03293147|Blood pressure|blood pressure
44274|NCT03293147|Antihypertensive treatment|antihypertensive treatment
44275|NCT03293147|Adherence|adherence
44276|NCT03293147|Biomarker|biomarker
44277|NCT03293147|Urine|urine
44278|NCT03293147|HPLC-MS/MS|hplc-ms/ms
44279|NCT03293134|Fowler syndrome|fowler syndrome
44280|NCT03293121|running related injuries|running related injuries
44281|NCT03293108|Osteoporosis|osteoporosis
44282|NCT03293108|Denosumab|denosumab
44283|NCT03293095|musculoskeletal pathology|musculoskeletal pathology
44284|NCT03293095|motion sensor|motion sensor
44285|NCT03293095|motion capture|motion capture
44286|NCT03293095|functional task|functional task
44287|NCT03293095|biomarker|biomarker
44288|NCT03293069|Conservative Iron Chelation|conservative iron chelation
44289|NCT03293069|Disease-modifying Strategy|disease-modifying strategy
44290|NCT03293056|aerobic exercises|aerobic exercises
44291|NCT03293056|training|training
44292|NCT03293056|aquatic|aquatic
44293|NCT03293030|atopic dermatitis|atopic dermatitis
44294|NCT03293030|eczema|eczema
44295|NCT03293030|dupilumab|dupilumab
44296|NCT03293004|collagen|collagen
44297|NCT03293004|tendon|tendon
44298|NCT03293004|procollagen type I N-terminal|procollagen type i n-terminal
44299|NCT03293004|athletes|athletes
44300|NCT03293004|vitamin C|vitamin c
44301|NCT03293004|hydrolyzed collagen|hydrolyzed collagen
44302|NCT03292991|Hepatocellular Carcinoma|hepatocellular carcinoma
44303|NCT03292991|SIR Spheres|sir spheres
44304|NCT03292991|SIRT|sirt
44305|NCT03292939|progestrone|progestrone
44306|NCT03292939|doppler indices|doppler indices
44307|NCT03292913|HIV|hiv
44308|NCT03292887|Mucopolysaccharidosis II|mucopolysaccharidosis ii
44309|NCT03292887|Hunter Syndrome|hunter syndrome
44310|NCT03292887|Enzyme Replacement Therapy|enzyme replacement therapy
44311|NCT03292887|Lysosomal|lysosomal
44312|NCT03292887|Glycosaminoglycans|glycosaminoglycans
44313|NCT03292874|prostate cancer|prostate cancer
44314|NCT03292874|MRI|mri
44315|NCT03292848|CNS Disorders|cns disorders
44316|NCT03292848|Brexpiprazole|brexpiprazole
44317|NCT03292835|complex|complex
44318|NCT03292835|zoonotic|zoonotic
44319|NCT03292835|medical device|medical device
44320|NCT03292796|Open Angle Glaucoma|open angle glaucoma
44321|NCT03292796|Cataract|cataract
44322|NCT03292796|Phacoemulsification,|phacoemulsification,
44323|NCT03292796|Cystoid Macular Oedema,|cystoid macular oedema,
44324|NCT03292796|Prostaglandin Analogues|prostaglandin analogues
44325|NCT03292783|VEGF|vegf
44326|NCT03292783|DLL4|dll4
44327|NCT03292783|Solid Tumors|solid tumors
44328|NCT03292783|bispecific antibody|bispecific antibody
44329|NCT03292783|anti-angiogenic|anti-angiogenic
44330|NCT03292770|Embryo Transfer|embryo transfer
44331|NCT03292770|Flushing catheter|flushing catheter
44332|NCT03292770|Pregnancy rate|pregnancy rate
44333|NCT03292770|Frozen Embryo Tranfer|frozen embryo tranfer
44334|NCT03292757|Fluorescence|fluorescence
44335|NCT03292744|immunosenescence|immunosenescence
44336|NCT03292718|PERT|pert
44337|NCT03292718|mobile application|mobile application
44338|NCT03292705|cognitive training|cognitive training
44339|NCT03292705|person-centered approach|person-centered approach
44340|NCT03292614|Multifocal Intraocular Lens|multifocal intraocular lens
44341|NCT03292614|Postoperative Measurements of refraction|postoperative measurements of refraction
44342|NCT03292601|Spinal Orthosis|spinal orthosis
44343|NCT03292601|Spinal Brace|spinal brace
44344|NCT03292588|urban setting|urban setting
44345|NCT03292588|children and adolescents|children and adolescents
44346|NCT03292588|double-masked, placebo-controlled randomized trial|double-masked, placebo-controlled randomized trial
44347|NCT03292588|asthma exacerbations (attacks)|asthma exacerbations (attacks)
44348|NCT03292588|mepolizumab adjunctive therapy|mepolizumab adjunctive therapy
44349|NCT03292588|asthma exacerbations prevention|asthma exacerbations prevention
44350|NCT03292588|difficult-to-control exacerbation-prone asthma|difficult-to-control exacerbation-prone asthma
44351|NCT03292549|Urology|urology
44352|NCT03292549|Robotic surgery|robotic surgery
44353|NCT03292549|Haemostasis|haemostasis
44354|NCT03292549|Partial Nephrectomy|partial nephrectomy
44355|NCT03292523|Hyperventilation syndrome|hyperventilation syndrome
44356|NCT03292523|Work productivity|work productivity
44357|NCT03292523|Absenteeism|absenteeism
44358|NCT03292523|Presenteeism|presenteeism
44359|NCT03292484|AR101|ar101
44360|NCT03292484|Characterized Peanut Allergen|characterized peanut allergen
44361|NCT03292484|OIT (oral immunotherapy)|oit (oral immunotherapy)
44362|NCT03292484|Peanut Allergy|peanut allergy
44363|NCT03292484|Allergy|allergy
44364|NCT03292484|Peanut-Allergic Children|peanut-allergic children
44365|NCT03292484|Peanut-Allergic Adults|peanut-allergic adults
44366|NCT03292484|Desensitization|desensitization
44367|NCT03292484|CPNA (Characterized Peanut Allergen)|cpna (characterized peanut allergen)
44368|NCT03292471|Aphasia|aphasia
44369|NCT03292471|Rehabilitation|rehabilitation
44370|NCT03292471|Stroke|stroke
44371|NCT03292458|spasmodic dysphonia|spasmodic dysphonia
44372|NCT03292458|laryngeal dystonia|laryngeal dystonia
44373|NCT03292458|functional MRI|functional mri
44374|NCT03292458|Xyrem|xyrem
44375|NCT03292432|Adherence, Medication|adherence, medication
44376|NCT03292406|T-Cell|t-cell
44377|NCT03292406|Lymphoma|lymphoma
44378|NCT03292406|Cutaneous|cutaneous
44379|NCT03292406|CTCL|ctcl
44380|NCT03292393|Hypertension|hypertension
44381|NCT03292393|Medication|medication
44382|NCT03292393|Adherence|adherence
44383|NCT03292380|Caffeine|caffeine
44384|NCT03292380|Dietary intake|dietary intake
44385|NCT03292380|Validation|validation
44386|NCT03292380|Dietary methods|dietary methods
44387|NCT03292354|Coronary Computed Tomography Angiography|coronary computed tomography angiography
44388|NCT03292354|Image Quality|image quality
44389|NCT03292354|Contrast Media Reduction|contrast media reduction
44390|NCT03292354|Personalised Injection Protocols|personalised injection protocols
44391|NCT03292328|breast cancer|breast cancer
44392|NCT03292328|neuropathy|neuropathy
44393|NCT03292328|peripheral neuropathy|peripheral neuropathy
44394|NCT03292328|yoga|yoga
44395|NCT03292328|17-449|17-449
44396|NCT03292315|Glucagon-Like Peptide-1|glucagon-like peptide-1
44397|NCT03292302|Translational read through|translational read through
44398|NCT03292289|proctectomy|proctectomy
44399|NCT03292289|coloanal continuity reconstruction|coloanal continuity reconstruction
44400|NCT03292263|Multiple Myeloma|multiple myeloma
44401|NCT03292263|Nivolumab|nivolumab
44402|NCT03292263|Melphalan|melphalan
44403|NCT03292263|Autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
44404|NCT03292250|NGS|ngs
44405|NCT03292250|Nanostring|nanostring
44406|NCT03292250|Biomarker Driven Umbrella Trial|biomarker driven umbrella trial
44407|NCT03292250|BYL719,poziotinib, abemaciclib, nintedanib|byl719,poziotinib, abemaciclib, nintedanib
44408|NCT03292250|Durvalumab + Tremelimumab Combination Treatment|durvalumab + tremelimumab combination treatment
44409|NCT03292237|Energy|energy
44410|NCT03292237|Nutrition|nutrition
44411|NCT03292237|Critical illness|critical illness
44412|NCT03292237|Parenteral nutrition|parenteral nutrition
44413|NCT03292237|Intensive care unit|intensive care unit
44414|NCT03292237|Ward|ward
44415|NCT03292237|Randomised Controlled Trial|randomised controlled trial
44416|NCT03292237|Intensive Nutrition|intensive nutrition
44417|NCT03292211|Early mobilization|early mobilization
44418|NCT03292211|Acute stroke|acute stroke
44419|NCT03292211|Early intervention|early intervention
44420|NCT03292211|Early mobilization therapy|early mobilization therapy
44421|NCT03292198|Subclinical lymphedema|subclinical lymphedema
44422|NCT03292198|bioimpedance|bioimpedance
44423|NCT03292198|breast cancer|breast cancer
44424|NCT03292159|stroke|stroke
44425|NCT03292159|vagus nerve stimulation|vagus nerve stimulation
44426|NCT03292159|upper extremity paresis|upper extremity paresis
44427|NCT03292133|Lung Cancer|lung cancer
44428|NCT03292081|Intracoronary Imaging|intracoronary imaging
44429|NCT03292081|Optical Frequency Domain Imaging|optical frequency domain imaging
44430|NCT03292081|Intravascular Ultrasound|intravascular ultrasound
44431|NCT03292081|Percutaneous Coronary Intervention|percutaneous coronary intervention
44432|NCT03292081|Drug Eluting Stent|drug eluting stent
44433|NCT03292055|food frequency questionnaire; psychometric properties|food frequency questionnaire; psychometric properties
44434|NCT03292042|metabolic syndrome|metabolic syndrome
44435|NCT03292042|lifestyle intervention|lifestyle intervention
44436|NCT03292042|health promotion|health promotion
44437|NCT03292042|mental health nurse|mental health nurse
44438|NCT03292042|serious mental illness|serious mental illness
44439|NCT03292029|Renal replacement therapy|renal replacement therapy
44440|NCT03292029|Haemodialsysis|haemodialsysis
44441|NCT03292029|Calcification Inhibition Test|calcification inhibition test
44442|NCT03292016|Off Episodes|off episodes
44443|NCT03292016|Parkinson Disease|parkinson disease
44444|NCT03292003|rheumatoid arthritis|rheumatoid arthritis
44445|NCT03292003|post-traumatic arthritis|post-traumatic arthritis
44446|NCT03292003|osteoarthritis|osteoarthritis
44447|NCT03292003|degenerative arthritis|degenerative arthritis
44448|NCT03292003|failed osteotomy|failed osteotomy
44449|NCT03291977|surgery - glioblastoma - fluorescein|surgery - glioblastoma - fluorescein
44450|NCT03291938|Malignant neoplasm of breast|malignant neoplasm of breast
44451|NCT03291938|Malignant neoplasms of bone and articular cartilage|malignant neoplasms of bone and articular cartilage
44452|NCT03291938|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
44453|NCT03291938|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
44454|NCT03291938|Malignant neoplasms of lip oral cavity and pharynx|malignant neoplasms of lip oral cavity and pharynx
44754|NCT03289819|TNBC|tnbc
44455|NCT03291938|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
44456|NCT03291938|Malignant neoplasms of mesothelial and soft tissue|malignant neoplasms of mesothelial and soft tissue
44457|NCT03291938|Malignant neoplasms of respiratory and intrathoracic organs|malignant neoplasms of respiratory and intrathoracic organs
44458|NCT03291938|Malignant neoplasms of thyroid and other endocrine glands|malignant neoplasms of thyroid and other endocrine glands
44459|NCT03291938|Malignant neoplasms of urinary tract|malignant neoplasms of urinary tract
44460|NCT03291938|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
44461|NCT03291938|IACS-010759|iacs-010759
44462|NCT03291847|maternal opioid use|maternal opioid use
44463|NCT03291847|neonatal abstinence syndrome|neonatal abstinence syndrome
44464|NCT03291847|buprenorphine-naloxone|buprenorphine-naloxone
44465|NCT03291834|type 1 diabetes mellitus|type 1 diabetes mellitus
44466|NCT03291834|sports|sports
44467|NCT03291834|child|child
44468|NCT03291834|adolescent|adolescent
44469|NCT03291821|DuoStim|duostim
44470|NCT03291821|MitoScore|mitoscore
44471|NCT03291821|Preimplantation genetic diagnosis|preimplantation genetic diagnosis
44472|NCT03291821|MII oocyte|mii oocyte
44473|NCT03291808|Obesity; asthma; Weight loss|obesity; asthma; weight loss
44474|NCT03291743|Crohn's|crohn's
44475|NCT03291743|Capsule endoscopy|capsule endoscopy
44476|NCT03291743|IBD|ibd
44477|NCT03291730|Anxiety|anxiety
44478|NCT03291717|Mental Illness|mental illness
44479|NCT03291717|Community Participation|community participation
44480|NCT03291717|Stigma|stigma
44481|NCT03291717|Photovoice|photovoice
44482|NCT03291704|Dry Eye|dry eye
44483|NCT03291704|Thermal Therapy|thermal therapy
44484|NCT03291704|Meibomian Gland Dysfunction|meibomian gland dysfunction
44485|NCT03291691|Protective Nerve Stimulation|protective nerve stimulation
44486|NCT03291691|Regional Anesthesia|regional anesthesia
44487|NCT03291691|Sciatic nerve block|sciatic nerve block
44488|NCT03291691|femoral nerve block|femoral nerve block
44489|NCT03291691|brachial plexus block|brachial plexus block
44490|NCT03291665|Plantar Fasciitis|plantar fasciitis
44491|NCT03291665|Plantar heel pain|plantar heel pain
44492|NCT03291652|Ischemic Stroke|ischemic stroke
44493|NCT03291652|atherosclerosis|atherosclerosis
44494|NCT03291652|Plaque morphology|plaque morphology
44495|NCT03291652|DSA/3DRA|dsa/3dra
44496|NCT03291613|Sickle Cell Disease|sickle cell disease
44497|NCT03291613|Adolescence|adolescence
44498|NCT03291613|Pain Assessment|pain assessment
44499|NCT03291613|Tablet Application|tablet application
44500|NCT03291613|Pain|pain
44501|NCT03291613|mHealth|mhealth
44502|NCT03291548|Quinoa|quinoa
44503|NCT03291548|Functional food|functional food
44504|NCT03291548|Cardiovascular disease|cardiovascular disease
44505|NCT03291548|Cholesterol|cholesterol
44506|NCT03291548|Lipid profile|lipid profile
44507|NCT03291548|Randomised Control Trial|randomised control trial
44508|NCT03291522|Testicular sperm extraction|testicular sperm extraction
44509|NCT03291509|weight loss|weight loss
44510|NCT03291509|weight management|weight management
44511|NCT03291483|Whole body vibration|whole body vibration
44512|NCT03291483|mesh id D000072797|mesh id d000072797
44513|NCT03291483|Plyometric exercise|plyometric exercise
44514|NCT03291483|Muscle strength|muscle strength
44515|NCT03291483|Physical fitness|physical fitness
44516|NCT03291483|Balance|balance
44517|NCT03291470|knee|knee
44518|NCT03291431|alcohol use disorder|alcohol use disorder
44519|NCT03291431|intermittent theta burst|intermittent theta burst
44520|NCT03291431|Veterans|veterans
44521|NCT03291431|depressive disorder|depressive disorder
44522|NCT03291431|cigarette smoking|cigarette smoking
44523|NCT03291418|Healthy Volunteers, ATB-346, Naproxen sodium, GI safety|healthy volunteers, atb-346, naproxen sodium, gi safety
44524|NCT03291392|Genetics|genetics
44525|NCT03291392|Stroke|stroke
44526|NCT03291392|Biobank|biobank
44527|NCT03291392|Atherosclerosis|atherosclerosis
44528|NCT03291379|mCRC, HCC, radiopaque beads, vandetanib|mcrc, hcc, radiopaque beads, vandetanib
44529|NCT03291301|Insomnia|insomnia
44530|NCT03291301|Cognitive Behavioral Therapy|cognitive behavioral therapy
44531|NCT03291301|CBT-I|cbt-i
44532|NCT03291301|Acupressure|acupressure
44533|NCT03291301|Traditional Chinese Medicine|traditional chinese medicine
44534|NCT03291288|Tenosynovial Giant Cell Tumors (TGCT)|tenosynovial giant cell tumors (tgct)
44535|NCT03291288|Kit-mutant melanoma|kit-mutant melanoma
44536|NCT03291288|Kit-mutant gastrointestinal stromal tumor (GIST)|kit-mutant gastrointestinal stromal tumor (gist)
44537|NCT03291288|Cocktail drug-drug interaction (DDI)|cocktail drug-drug interaction (ddi)
44538|NCT03291210|hyperoxemia|hyperoxemia
44539|NCT03291210|myocardial injury|myocardial injury
44540|NCT03291210|transcatheter aortic valve replacement|transcatheter aortic valve replacement
44541|NCT03291197|Suprascapular nerve block|suprascapular nerve block
44542|NCT03291197|Median nerve block|median nerve block
44543|NCT03291197|CRPS|crps
44544|NCT03291197|Shoulder hand syndrome|shoulder hand syndrome
44545|NCT03291184|neuromuscular blockade|neuromuscular blockade
44546|NCT03291184|neuromuscular monitoring|neuromuscular monitoring
44547|NCT03291171|physical activity|physical activity
44548|NCT03291171|sedentary behaviour|sedentary behaviour
44549|NCT03291171|type 2 diabetes|type 2 diabetes
44550|NCT03291171|eHealth|ehealth
44551|NCT03291171|mHealth|mhealth
44552|NCT03291171|self-regulation|self-regulation
44553|NCT03291171|behaviour change techniques|behaviour change techniques
44554|NCT03291158|Bacterial Infections|bacterial infections
44555|NCT03291145|Long QT Syndrome|long qt syndrome
44556|NCT03291132|Smoke-free|smoke-free
44557|NCT03291132|Teens|teens
44558|NCT03291119|Cervico-medullary, Extubation Failure, Risk Predictors|cervico-medullary, extubation failure, risk predictors
44559|NCT03291093|PET/MRI|pet/mri
44560|NCT03291093|Amyloid|amyloid
44561|NCT03291093|Flutemetamol|flutemetamol
44562|NCT03291054|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
44563|NCT03291054|GIST|gist
44564|NCT03291054|Pembrolizumab|pembrolizumab
44565|NCT03291054|Epacadostat|epacadostat
44566|NCT03291054|Columbia|columbia
44567|NCT03291015|arthroscopy|arthroscopy
44568|NCT03291015|radiographic(plain X ray)|radiographic(plain x ray)
44569|NCT03290963|depression|depression
44570|NCT03290963|bipolar I disorder|bipolar i disorder
44571|NCT03290963|bipolar II disorder|bipolar ii disorder
44572|NCT03290950|Daratumumab|daratumumab
44573|NCT03290950|Carfilzomib|carfilzomib
44574|NCT03290950|Lenalidomide|lenalidomide
44575|NCT03290950|Dexamethasone|dexamethasone
44576|NCT03290950|17-352|17-352
44577|NCT03290937|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
44578|NCT03290937|Colorectal cancer|colorectal cancer
44579|NCT03290937|Metastatic|metastatic
44580|NCT03290937|Refractory to standard therapy|refractory to standard therapy
44581|NCT03290937|Wild type RAS tumor|wild type ras tumor
44582|NCT03290937|Mutated RAS tumor|mutated ras tumor
44583|NCT03290937|Irinotecan|irinotecan
44584|NCT03290937|CPT-11|cpt-11
44585|NCT03290937|Camptosar|camptosar
44586|NCT03290937|PF-05082566|pf-05082566
44587|NCT03290937|Utomilumab|utomilumab
44588|NCT03290937|Anti-CD137|anti-cd137
44589|NCT03290937|Cetuximab|cetuximab
44590|NCT03290937|C225|c225
44591|NCT03290937|Erbitux|erbitux
44592|NCT03290937|IMC-C225|imc-c225
44593|NCT03290937|MOAB C225|moab c225
44594|NCT03290924|institutional delivery|institutional delivery
44595|NCT03290911|low responders|low responders
44596|NCT03290898|Asthma|asthma
44597|NCT03290898|Exercise|exercise
44598|NCT03290898|Asthma treatment|asthma treatment
44599|NCT03290898|Inhaled corticosteroid|inhaled corticosteroid
44600|NCT03290898|Rehabilitation|rehabilitation
44601|NCT03290859|Procedural Sedation|procedural sedation
44602|NCT03290833|Robotics|robotics
44603|NCT03290833|Stroke|stroke
44604|NCT03290833|Hand|hand
44605|NCT03290833|neurorehabilitation|neurorehabilitation
44606|NCT03290820|nasopharyngeal carcinoma|nasopharyngeal carcinoma
44607|NCT03290820|N2-3 disease|n2-3 disease
44608|NCT03290820|distant metastasis|distant metastasis
44609|NCT03290820|aspirin|aspirin
44610|NCT03290820|survival|survival
44611|NCT03290781|Ulcerative colitis|ulcerative colitis
44612|NCT03290755|Hepatitis C|hepatitis c
44613|NCT03290755|sexual network|sexual network
44614|NCT03290755|sexual transmitted|sexual transmitted
44615|NCT03290755|men who have sex with men|men who have sex with men
44616|NCT03290755|HIV positive|hiv positive
44617|NCT03290755|sexual behaviour|sexual behaviour
44618|NCT03290729|wedge implants; atrophic bone|wedge implants; atrophic bone
44619|NCT03290664|AML|aml
44620|NCT03290638|Guided Bone Regeneration|guided bone regeneration
44621|NCT03290638|Dehydrated Human Amnion Chorion Membrane|dehydrated human amnion chorion membrane
44622|NCT03290638|Type I Bovine Collagen Membrane|type i bovine collagen membrane
44623|NCT03290638|Ridge Preservation|ridge preservation
44624|NCT03290638|Ridge Healing|ridge healing
44625|NCT03290638|Teeth Extraction|teeth extraction
44626|NCT03290612|Sleep|sleep
44627|NCT03290612|Vitamin C|vitamin c
44628|NCT03290599|Cognitive dysfunction|cognitive dysfunction
44629|NCT03290599|Hip Surgery|hip surgery
44630|NCT03290599|Mini mental Test,|mini mental test,
44631|NCT03290599|Preoperative Hospitalisation|preoperative hospitalisation
44632|NCT03290599|Spinal Anesthesia|spinal anesthesia
44633|NCT03290534|wedge resection|wedge resection
44634|NCT03290534|sublobar resection|sublobar resection
44635|NCT03290534|brachytherapy|brachytherapy
44636|NCT03290534|CivaSheet|civasheet
44637|NCT03290534|Pd-103|pd-103
44638|NCT03290534|CivaTech Oncology|civatech oncology
44639|NCT03290521|pain|pain
44640|NCT03290521|laparoscopy|laparoscopy
44641|NCT03290521|washing|washing
44642|NCT03290521|intraperitoneal irrigation|intraperitoneal irrigation
44643|NCT03290508|Prolaris|prolaris
44644|NCT03290508|Prostate Cancer|prostate cancer
44645|NCT03290508|Cell Cycle Progression Test|cell cycle progression test
44646|NCT03290495|ketamine|ketamine
44647|NCT03290495|isoflurane|isoflurane
44648|NCT03290495|electroencephalography|electroencephalography
44649|NCT03290495|maintenance|maintenance
44650|NCT03290495|recovery|recovery
44651|NCT03290495|anesthesia|anesthesia
44652|NCT03290469|ICU|icu
44653|NCT03290469|Intensive Care Unit|intensive care unit
44654|NCT03290456|Vasculitis|vasculitis
44655|NCT03290456|GPA|gpa
44656|NCT03290456|Granulomatosis with Polyangitis|granulomatosis with polyangitis
44657|NCT03290456|MPA|mpa
44658|NCT03290456|Microscopic Polyangitis|microscopic polyangitis
44659|NCT03290456|Systemic anti-neutrophil cytoplasmic antibodies (ANCA)|systemic anti-neutrophil cytoplasmic antibodies (anca)
44660|NCT03290456|Prednisone|prednisone
44661|NCT03290456|glucocorticoids|glucocorticoids
44662|NCT03290456|Remission Maintenance|remission maintenance
44663|NCT03290456|Rituximab|rituximab
44664|NCT03290456|Cyclophosphamide|cyclophosphamide
44665|NCT03290443|Hepatic|hepatic
44666|NCT03290443|Pharmacokinetics|pharmacokinetics
44667|NCT03290443|Phase 1|phase 1
44668|NCT03290443|Enasidenib|enasidenib
44669|NCT03290443|CC-90007|cc-90007
44670|NCT03290430|Nicotine Dependence|nicotine dependence
44671|NCT03290430|applied behavioral research|applied behavioral research
44672|NCT03290417|Active Surveillance|active surveillance
44673|NCT03290417|Vitamin D|vitamin d
44674|NCT03290417|Omega-3 Fatty Acid|omega-3 fatty acid
44675|NCT03290417|tumeric curcumin|tumeric curcumin
44676|NCT03290404|Axillary Block|axillary block
44677|NCT03290404|LidocaÏne 1% adrenaliné|lidocaïne 1% adrenaliné
44678|NCT03290391|Russia|russia
44679|NCT03290391|Substance use|substance use
44680|NCT03290391|Peer case managers|peer case managers
44682|NCT03290391|HIV|hiv
44683|NCT03290365|Platelet rich plasma|platelet rich plasma
44684|NCT03290365|Osteoarthritis of knee|osteoarthritis of knee
44685|NCT03290365|Hyaluronic acid|hyaluronic acid
44686|NCT03290339|one-day surgery|one-day surgery
44687|NCT03290339|hysterectomy|hysterectomy
44688|NCT03290339|ambulatory|ambulatory
44689|NCT03290326|Alzheimer|alzheimer
44690|NCT03290326|Memory Problems|memory problems
44691|NCT03290313|Depression|depression
44692|NCT03290313|erectile dysfunction|erectile dysfunction
44693|NCT03290313|shu gan yi yang|shu gan yi yang
44694|NCT03290300|Nasal valve|nasal valve
44695|NCT03290300|Nasal airway obstruction|nasal airway obstruction
44696|NCT03290300|Quality of Life|quality of life
44697|NCT03290287|COPD|copd
44698|NCT03290274|Deep brain stimulation|deep brain stimulation
44699|NCT03290274|Alzheimer´s Disease|alzheimer´s disease
44700|NCT03290274|Fornix|fornix
44701|NCT03290274|Basal nucleus of Meynert|basal nucleus of meynert
44702|NCT03290222|Respiratory symptoms|respiratory symptoms
44703|NCT03290222|Children|children
44704|NCT03290209|Stomach Neoplasm|stomach neoplasm
44705|NCT03290209|Elderly Patients|elderly patients
44706|NCT03290209|Laparoscopic D1 Lymphadenectomy|laparoscopic d1 lymphadenectomy
44707|NCT03290196|Shoulder|shoulder
44708|NCT03290196|Rotator cuff|rotator cuff
44709|NCT03290183|Confocal laser endomicroscopy|confocal laser endomicroscopy
44710|NCT03290157|Colonoscopy|colonoscopy
44711|NCT03290157|preparation|preparation
44712|NCT03290157|new media|new media
44713|NCT03290157|SPA|spa
44714|NCT03290157|APP|app
44715|NCT03290144|Cystic fibrosis - Pregnancy - Diabetes|cystic fibrosis - pregnancy - diabetes
44716|NCT03290105|oropharyngeal colonization|oropharyngeal colonization
44717|NCT03290079|metastatic progressive high-grade neuroendocrine|metastatic progressive high-grade neuroendocrine
44718|NCT03290079|progressive high-grade neuroendocrine|progressive high-grade neuroendocrine
44719|NCT03290079|high grade neuroendocrine|high grade neuroendocrine
44720|NCT03290079|carcinoma originating outside of the lung|carcinoma originating outside of the lung
44721|NCT03290079|poorly differentiated neuroendocrine|poorly differentiated neuroendocrine
44722|NCT03290066|Primary Dysmenorrhea|primary dysmenorrhea
44723|NCT03290066|Kinesio Taping|kinesio taping
44724|NCT03289962|Cancer vaccine|cancer vaccine
44725|NCT03289962|Neoantigen|neoantigen
44726|NCT03289962|Personalized|personalized
44727|NCT03289962|Atezolizumab|atezolizumab
44728|NCT03289962|Vaccine|vaccine
44729|NCT03289962|Immunotherapy|immunotherapy
44730|NCT03289962|Anti-PDL1|anti-pdl1
44731|NCT03289962|Checkpoint Inhibitor|checkpoint inhibitor
44732|NCT03289962|Personalized vaccine|personalized vaccine
44733|NCT03289936|preterm|preterm
44734|NCT03289936|ventilation|ventilation
44735|NCT03289936|nasal intermittent positive pressure ventilation|nasal intermittent positive pressure ventilation
44736|NCT03289936|synchronization|synchronization
44737|NCT03289936|cardio-respiratory events|cardio-respiratory events
44738|NCT03289936|newborn|newborn
44739|NCT03289923|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
44740|NCT03289923|Major Depressive Disorder|major depressive disorder
44741|NCT03289923|Cognitive Therapy|cognitive therapy
44742|NCT03289832|Sulforaphane|sulforaphane
44743|NCT03289832|Curcumin|curcumin
44744|NCT03289832|Crucera-SGS|crucera-sgs
44745|NCT03289832|Meriva-SF|meriva-sf
44746|NCT03289832|Skin|skin
44747|NCT03289832|erythema|erythema
44748|NCT03289832|UV|uv
44749|NCT03289832|Sunburn|sunburn
44750|NCT03289832|Inflammation|inflammation
44751|NCT03289832|Redness|redness
44752|NCT03289832|ultra-violet|ultra-violet
44753|NCT03289832|sunlight|sunlight
44755|NCT03289819|neoadjuvant chemotherapy|neoadjuvant chemotherapy
44756|NCT03289819|triple negative breast cancer|triple negative breast cancer
44757|NCT03289793|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
44758|NCT03289793|ADHD|adhd
44759|NCT03289793|Children|children
44760|NCT03289793|Inattention|inattention
44761|NCT03289793|Hyperactivity|hyperactivity
44762|NCT03289793|Neurofeedback|neurofeedback
44763|NCT03289793|Neuropsychology|neuropsychology
44764|NCT03289754|knee implant|knee implant
44765|NCT03289754|osteoarthritis|osteoarthritis
44766|NCT03289754|patient-specific|patient-specific
44767|NCT03289754|knee osteoarthritis|knee osteoarthritis
44768|NCT03289741|Octreotide|octreotide
44769|NCT03289741|Lanreotide|lanreotide
44770|NCT03289741|17-422|17-422
44771|NCT03289728|elderly patients|elderly patients
44772|NCT03289728|myocardial infarction|myocardial infarction
44773|NCT03289728|myocardial revascularization strategy|myocardial revascularization strategy
44774|NCT03289728|ischemia imaging|ischemia imaging
44775|NCT03289728|coronary artery disease|coronary artery disease
44776|NCT03289663|synergistic combination|synergistic combination
44777|NCT03289663|insecticide resistance|insecticide resistance
44778|NCT03289663|vectors|vectors
44779|NCT03289650|immunosuppression|immunosuppression
44780|NCT03289624|Care Planning|care planning
44781|NCT03289624|Care Values and Preferences|care values and preferences
44782|NCT03289611|Preeclampsia|preeclampsia
44783|NCT03289611|pregnancy|pregnancy
44784|NCT03289611|biomarkers|biomarkers
44785|NCT03289611|prediction|prediction
44786|NCT03289611|safety|safety
44787|NCT03289611|cost|cost
44788|NCT03289585|Hidradenitis Suppurativa|hidradenitis suppurativa
44789|NCT03289585|Registry|registry
44790|NCT03289546|mindfulness|mindfulness
44791|NCT03289546|exercise|exercise
44792|NCT03289546|cognitive function|cognitive function
44793|NCT03289533|Cancer|cancer
44794|NCT03289533|Hepatocellular carcinoma|hepatocellular carcinoma
44795|NCT03289533|Liver disease|liver disease
44796|NCT03289533|Avelumab|avelumab
44797|NCT03289533|Axitinib|axitinib
44798|NCT03289520|Access Blood Flow Monitoring|access blood flow monitoring
44799|NCT03289520|Clinical Trial Vascular Access|clinical trial vascular access
44800|NCT03289520|Fistula Failure|fistula failure
44801|NCT03289520|Hemodialysis|hemodialysis
44802|NCT03289520|Vascular Access|vascular access
44803|NCT03289507|Longvida Curcumin|longvida curcumin
44804|NCT03289507|Pharmacokinetics|pharmacokinetics
44805|NCT03289494|Slowly Digestible Starch|slowly digestible starch
44806|NCT03289494|SDS|sds
44807|NCT03289494|Type 2 diabetes|type 2 diabetes
44808|NCT03289494|T2D|t2d
44809|NCT03289494|Glycemic response|glycemic response
44810|NCT03289494|Continuous Glucose Monitoring System|continuous glucose monitoring system
44811|NCT03289494|CGMS|cgms
44812|NCT03289481|Heart failure|heart failure
44813|NCT03289481|HFpEF|hfpef
44814|NCT03289481|Nitrate supplement|nitrate supplement
44815|NCT03289455|Acute Lymphoblastic Leukaemia|acute lymphoblastic leukaemia
44816|NCT03289455|CD19 Positive|cd19 positive
44817|NCT03289455|CD22 Positive|cd22 positive
44818|NCT03289455|Relapsed Acute Lymphoblastic Leukaemia|relapsed acute lymphoblastic leukaemia
44819|NCT03289455|Refractory Acute Lymphoblastic Leukaemia|refractory acute lymphoblastic leukaemia
44820|NCT03289455|AUTO3|auto3
44821|NCT03289429|Atorvastatin|atorvastatin
44822|NCT03289429|Magnesium sulfate|magnesium sulfate
44823|NCT03289429|POAF|poaf
44824|NCT03289429|Cardiac|cardiac
44825|NCT03289429|Valve|valve
44826|NCT03289416|knee|knee
44827|NCT03289416|osteoarthritis|osteoarthritis
44828|NCT03289416|platelet rich plasma (PRP)|platelet rich plasma (prp)
44829|NCT03289416|bone marrow concentrate (BMC)|bone marrow concentrate (bmc)
44830|NCT03289364|Breast Cancer|breast cancer
44831|NCT03289364|Alopecia|alopecia
44832|NCT03289364|Hair Loss|hair loss
44833|NCT03289364|Scalp Cooling|scalp cooling
44834|NCT03289364|Penguin Cold Caps|penguin cold caps
44835|NCT03289338|Zoledronic acid|zoledronic acid
44836|NCT03289338|Methylprednisolone|methylprednisolone
44837|NCT03289338|Active Charcot's disease|active charcot's disease
44838|NCT03289325|Cardiac surgery|cardiac surgery
44839|NCT03289325|Dexmedetomidine|dexmedetomidine
44840|NCT03289325|Long-term outcome|long-term outcome
44841|NCT03289325|Mortality|mortality
44842|NCT03289325|Quality of life|quality of life
44843|NCT03289312|sepsis, lymphocyte|sepsis, lymphocyte
44844|NCT03289299|myeloma|myeloma
44845|NCT03289299|MRD|mrd
44846|NCT03289299|smoldering|smoldering
44847|NCT03289286|Breast Cancer|breast cancer
44848|NCT03289286|Ambulatory surgery|ambulatory surgery
44849|NCT03289286|Electronic tool|electronic tool
44850|NCT03289286|e-follow-up|e-follow-up
44851|NCT03289273|Liver cancer|liver cancer
44852|NCT03289273|unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
44853|NCT03289273|real-world practice conditions|real-world practice conditions
44854|NCT03289273|safety and effectiveness|safety and effectiveness
44951|NCT03288571|Mesenchymal stem cells|mesenchymal stem cells
44855|NCT03289273|management and treatment of liver cancer|management and treatment of liver cancer
44856|NCT03289260|Condylomata acuminata, Fulguration, Imiquimod|condylomata acuminata, fulguration, imiquimod
44857|NCT03289195|MRI|mri
44858|NCT03289195|Biopsy|biopsy
44859|NCT03289195|17-390|17-390
44860|NCT03289143|Alzheimer Disease|alzheimer disease
44861|NCT03289143|Brain Diseases|brain diseases
44862|NCT03289143|Dementia|dementia
44863|NCT03289143|Neurodegenerative Diseases|neurodegenerative diseases
44864|NCT03289143|Neurocognitive Disorders|neurocognitive disorders
44865|NCT03289117|Urinary catheterization|urinary catheterization
44866|NCT03289117|Gel installation|gel installation
44867|NCT03289117|Novel medical device|novel medical device
44868|NCT03289117|Indwelling urinary catheter|indwelling urinary catheter
44869|NCT03289117|Long-term urinary catheter|long-term urinary catheter
44870|NCT03289117|Male patients|male patients
44871|NCT03289091|aerobic training|aerobic training
44872|NCT03289091|aquatic exercise|aquatic exercise
44873|NCT03289091|aging|aging
44874|NCT03289065|Genetic|genetic
44875|NCT03289065|Fabry Disease|fabry disease
44876|NCT03289065|Glycolipid|glycolipid
44877|NCT03289065|lysosomal|lysosomal
44878|NCT03289052|Hyaluronic acid, midface|hyaluronic acid, midface
44879|NCT03289039|Breast Cancer|breast cancer
44880|NCT03289026|Aripiprazole; Acute schizophrenia episode; positive symptoms|aripiprazole; acute schizophrenia episode; positive symptoms
44881|NCT03289000|osteoarthritis|osteoarthritis
44882|NCT03289000|knee arthroplasty|knee arthroplasty
44883|NCT03289000|knee replacement|knee replacement
44884|NCT03289000|patient specific|patient specific
44885|NCT03288974|Multiple Myeloma|multiple myeloma
44886|NCT03288974|POMALYST®|pomalyst®
44887|NCT03288974|Pomalidomide|pomalidomide
44888|NCT03288974|Observational|observational
44889|NCT03288974|Korea|korea
44890|NCT03288974|Post Marketing Surveillance[PMS]|post marketing surveillance[pms]
44891|NCT03288974|Relapsed and Refractory Multiple Myeloma|relapsed and refractory multiple myeloma
44892|NCT03288935|refugee|refugee
44893|NCT03288935|trauma-informed case management (TICM)|trauma-informed case management (ticm)
44894|NCT03288935|trauma-informed cultural orientation (TICO)|trauma-informed cultural orientation (tico)
44895|NCT03288935|PTSD|ptsd
44896|NCT03288935|depression|depression
44897|NCT03288935|refugee resettlement|refugee resettlement
44898|NCT03288922|Online Hemodiafiltration|online hemodiafiltration
44899|NCT03288922|Super high-flux dialyzer|super high-flux dialyzer
44900|NCT03288922|Protein-bound uremic toxin|protein-bound uremic toxin
44901|NCT03288922|P-cresol|p-cresol
44902|NCT03288896|Adolescence|adolescence
44903|NCT03288896|Alcohol Drinking|alcohol drinking
44904|NCT03288896|Binge Drinking|binge drinking
44905|NCT03288896|I-Change model|i-change model
44906|NCT03288896|Web-based interventions|web-based interventions
44907|NCT03288896|Computer-tailoring|computer-tailoring
44908|NCT03288857|Naspira|naspira
44909|NCT03288857|Suctioning|suctioning
44910|NCT03288857|Nasal suction device|nasal suction device
44911|NCT03288857|Children|children
44912|NCT03288844|LSCD, Holoclar, follow-up|lscd, holoclar, follow-up
44913|NCT03288831|Randomized, double-blinded, placebo-controlled trial|randomized, double-blinded, placebo-controlled trial
44914|NCT03288831|Oral food challenge|oral food challenge
44915|NCT03288753|Cochlear implant|cochlear implant
44916|NCT03288714|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
44917|NCT03288714|TMS|tms
44918|NCT03288714|sTMS|stms
44919|NCT03288701|heart failure|heart failure
44920|NCT03288701|cardial decompensation|cardial decompensation
44921|NCT03288701|smart scale|smart scale
44922|NCT03288701|bioimpedance analysis|bioimpedance analysis
44923|NCT03288701|whole body water|whole body water
44924|NCT03288675|Major depressive disorder|major depressive disorder
44925|NCT03288675|Treatment resistant depression|treatment resistant depression
44926|NCT03288675|Accelerated intermittent thetaburst stimulation|accelerated intermittent thetaburst stimulation
44927|NCT03288675|Cognitive control training|cognitive control training
44928|NCT03288675|Neuroimaging|neuroimaging
44929|NCT03288662|Computed tomography|computed tomography
44930|NCT03288662|thymic epithelial tumors|thymic epithelial tumors
44931|NCT03288610|Copeptin|copeptin
44932|NCT03288610|Vasopressin|vasopressin
44933|NCT03288610|Microcirculation|microcirculation
44934|NCT03288610|Inflammation|inflammation
44935|NCT03288610|Vasodilation|vasodilation
44936|NCT03288610|Cardiopulmonary bypass|cardiopulmonary bypass
44937|NCT03288597|positive rate|positive rate
44939|NCT03288597|relationship|relationship
44940|NCT03288584|Arterial stiffness|arterial stiffness
44941|NCT03288584|Endothelial function|endothelial function
44942|NCT03288584|Endothelial glycocalyx|endothelial glycocalyx
44943|NCT03288584|Left ventricular function|left ventricular function
44944|NCT03288584|Apoptosis|apoptosis
44945|NCT03288584|Oxidative stress|oxidative stress
44946|NCT03288571|Diabetes|diabetes
44947|NCT03288571|nephropathy|nephropathy
44948|NCT03288571|Kidney|kidney
44949|NCT03288571|parenchyma|parenchyma
44950|NCT03288571|Wharton Jelly|wharton jelly
44952|NCT03288545|ASG-22ME|asg-22me
44953|NCT03288545|ASG-22CE|asg-22ce
44954|NCT03288545|Antibody-drug conjugate|antibody-drug conjugate
44955|NCT03288545|Antineoplastic agents|antineoplastic agents
44956|NCT03288545|CPI|cpi
44957|NCT03288545|Enfortumab vedotin|enfortumab vedotin
44958|NCT03288545|Locally advanced urothelial cancer|locally advanced urothelial cancer
44959|NCT03288545|Drug therapy|drug therapy
44960|NCT03288545|Metastatic urothelial cancer|metastatic urothelial cancer
44961|NCT03288545|Nectin-4|nectin-4
44962|NCT03288545|Atezolizumab|atezolizumab
44963|NCT03288545|Checkpoint Inhibitors|checkpoint inhibitors
44964|NCT03288545|Pembrolizumab|pembrolizumab
44965|NCT03288532|Renal Cell Carcinoma|renal cell carcinoma
44966|NCT03288532|Immunotherapy|immunotherapy
44967|NCT03288532|Multi-Arm Multi-Stage|multi-arm multi-stage
44968|NCT03288519|Cerebral aneurysm|cerebral aneurysm
44969|NCT03288519|Endovascular therapy|endovascular therapy
44970|NCT03288519|Classic laryngeal mask airway|classic laryngeal mask airway
44971|NCT03288519|Hemodynamic changes|hemodynamic changes
44972|NCT03288493|CAR-T cells|car-t cells
44973|NCT03288454|Ciraparantag|ciraparantag
44974|NCT03288454|PER977|per977
44975|NCT03288454|Apixaban|apixaban
44976|NCT03288454|Whole Blood Clotting Time (WBCT)|whole blood clotting time (wbct)
44977|NCT03288441|Hematologic Neoplasms|hematologic neoplasms
44978|NCT03288441|Thrombocytopenia|thrombocytopenia
44979|NCT03288441|Anticoagulants|anticoagulants
44980|NCT03288441|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
44981|NCT03288415|Integrated prognostic model|integrated prognostic model
44982|NCT03288389|Membrane Lipid Replacement|membrane lipid replacement
44983|NCT03288389|NTFactor Lipids|ntfactor lipids
44984|NCT03288389|Fibromyalgia|fibromyalgia
44985|NCT03288389|Pain|pain
44986|NCT03288389|Faigue|faigue
44987|NCT03288389|Gastrointestinal symptoms|gastrointestinal symptoms
44988|NCT03288376|obstructive sleep apnea|obstructive sleep apnea
44989|NCT03288376|polysomnography|polysomnography
44990|NCT03288363|tDCS|tdcs
44991|NCT03288363|cognition|cognition
44992|NCT03288350|Phase II Trial|phase ii trial
44993|NCT03288350|Esophago-Gastric Adenocarcinoma|esophago-gastric adenocarcinoma
44994|NCT03288350|Avelumab|avelumab
44995|NCT03288337|Hidradenitis Suppurativa|hidradenitis suppurativa
44996|NCT03288337|Quality of Life|quality of life
44997|NCT03288298|TSCC|tscc
44998|NCT03288298|OSCC|oscc
44999|NCT03288298|luteolin|luteolin
45000|NCT03288298|nanoluteolin|nanoluteolin
45001|NCT03288298|nanotechnology|nanotechnology
45002|NCT03288298|oral cancer|oral cancer
45003|NCT03288298|apoptosis|apoptosis
45004|NCT03288298|PCR|pcr
45005|NCT03288298|MTT|mtt
45006|NCT03288298|ELISA reader|elisa reader
45007|NCT03288285|hemodiafiltration|hemodiafiltration
45008|NCT03288285|pre-dilution|pre-dilution
45009|NCT03288285|post-dilution|post-dilution
45010|NCT03288285|uremic toxins|uremic toxins
45011|NCT03288259|Transnasal endoscopy - Obesity - endoscopy without sedation|transnasal endoscopy - obesity - endoscopy without sedation
45012|NCT03288246|adolescent|adolescent
45013|NCT03288246|HIV|hiv
45014|NCT03288246|point-of-care|point-of-care
45015|NCT03288246|viral load|viral load
45016|NCT03288233|Hemoglobin A1c|hemoglobin a1c
45017|NCT03288233|HbA1c|hba1c
45018|NCT03288233|End tidal carbon monoxide|end tidal carbon monoxide
45019|NCT03288220|Stroke|stroke
45020|NCT03288207|Community-Based Participatory Research|community-based participatory research
45021|NCT03288207|Obesity|obesity
45022|NCT03288207|Cardiovascular Disease Risk|cardiovascular disease risk
45023|NCT03288207|Social Determinants of Health|social determinants of health
45024|NCT03288168|Observation|observation
45025|NCT03288168|Molecular Subgroup|molecular subgroup
45026|NCT03288168|NanoString|nanostring
45027|NCT03288155|Parkinson's|parkinson's
45028|NCT03288155|Fatigue|fatigue
45029|NCT03288155|Flavonoid|flavonoid
45030|NCT03288155|Cocoa|cocoa
45031|NCT03288129|monotherapy|monotherapy
45032|NCT03288129|adjunctive therapy|adjunctive therapy
45033|NCT03288129|open-label|open-label
45034|NCT03288129|multicenter|multicenter
45035|NCT03288064|raisins|raisins
45036|NCT03288064|carbohydrates|carbohydrates
45037|NCT03288064|antioxidant capacity|antioxidant capacity
45038|NCT03288064|substrate oxidation|substrate oxidation
45039|NCT03288064|prolonged cycling|prolonged cycling
45040|NCT03288025|Insulin Resistance|insulin resistance
45041|NCT03288025|Inflammation|inflammation
45042|NCT03288025|Right Ventricular Function|right ventricular function
45043|NCT03288025|Metabolism|metabolism
45044|NCT03288025|Glucose|glucose
45045|NCT03287986|Elderly|elderly
45046|NCT03287986|MRI|mri
45047|NCT03287960|LEPR deficiency obesity|lepr deficiency obesity
45048|NCT03287960|setmelanotide|setmelanotide
45049|NCT03287960|RM-493|rm-493
45050|NCT03287960|Leptin receptor|leptin receptor
45051|NCT03287960|Obesity|obesity
45052|NCT03287960|Melanocortin 4 receptor|melanocortin 4 receptor
45053|NCT03287934|selective laser sintering, stereolithography stents|selective laser sintering, stereolithography stents
45054|NCT03287921|pulmonary care|pulmonary care
45055|NCT03287921|COPD|copd
45056|NCT03287921|small airway disease|small airway disease
45057|NCT03287921|hyperinflation|hyperinflation
45058|NCT03287908|Amgen|amgen
45059|NCT03287908|Phase 1|phase 1
45060|NCT03287908|Clinical Trial|clinical trial
45061|NCT03287908|Oncology/Hematology|oncology/hematology
45062|NCT03287908|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
45063|NCT03287908|Immunotherapy|immunotherapy
45064|NCT03287895|Cardio-pulmonary resuscitation|cardio-pulmonary resuscitation
45065|NCT03287895|CPR|cpr
45066|NCT03287895|Decision-making|decision-making
45067|NCT03287895|Advance Care Planning|advance care planning
45068|NCT03287895|End of life|end of life
45069|NCT03287895|Code Status|code status
45070|NCT03287895|Goals of Care|goals of care
45071|NCT03287895|Communication|communication
45072|NCT03287882|preconception supplementation|preconception supplementation
45073|NCT03287882|multiple micronutrients|multiple micronutrients
45074|NCT03287882|low birth weight|low birth weight
45075|NCT03287869|Bipolar|bipolar
45076|NCT03287869|Mania|mania
45077|NCT03287869|Brexpiprazole|brexpiprazole
45078|NCT03287856|Valve-in-valve|valve-in-valve
45079|NCT03287856|TAVI|tavi
45080|NCT03287843|Locally advanced rectal cancer|locally advanced rectal cancer
45081|NCT03287843|Neoadjuvant chemoradiation|neoadjuvant chemoradiation
45082|NCT03287830|text message|text message
45083|NCT03287830|Short message service (SMS)|short message service (sms)
45084|NCT03287830|mHealth|mhealth
45085|NCT03287817|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
45086|NCT03287817|CD19 Positive|cd19 positive
45087|NCT03287817|CD22 Positive|cd22 positive
45088|NCT03287817|Relapsed Diffuse Large B Cell Lymphoma|relapsed diffuse large b cell lymphoma
45089|NCT03287817|Refractory Diffuse Large B Cell Lymphoma|refractory diffuse large b cell lymphoma
45090|NCT03287817|AUTO3|auto3
45091|NCT03287817|PD-1|pd-1
45092|NCT03287817|Anti PD-1 antibody|anti pd-1 antibody
45093|NCT03287804|Multiple Myeloma|multiple myeloma
45094|NCT03287804|Relapsed Multiple Myeloma|relapsed multiple myeloma
45095|NCT03287804|Refractory Multiple Myeloma|refractory multiple myeloma
45096|NCT03287804|AUTO2|auto2
45097|NCT03287778|Pyridoxine|pyridoxine
45098|NCT03287778|Vitamin B6|vitamin b6
45099|NCT03287778|Neurologic Manifestations|neurologic manifestations
45100|NCT03287778|Involuntary Movements|involuntary movements
45101|NCT03287778|Movement Disorder|movement disorder
45102|NCT03287778|Dyskinesias|dyskinesias
45103|NCT03287778|Physiological Effects of Drugs|physiological effects of drugs
45104|NCT03287778|Psychotic Disorders|psychotic disorders
45105|NCT03287778|Schizophrenia Spectrum and Other Psychotic Disorders|schizophrenia spectrum and other psychotic disorders
45106|NCT03287778|Signs and Symptoms|signs and symptoms
45107|NCT03287765|Dementia|dementia
45108|NCT03287765|Tauopathies|tauopathies
45109|NCT03287765|cognitive impairment|cognitive impairment
45110|NCT03287765|CNS Diseases|cns diseases
45111|NCT03287765|neurodegenerative disease|neurodegenerative disease
45112|NCT03287739|Upper Extremity|upper extremity
45113|NCT03287739|Cohort Studies|cohort studies
45114|NCT03287739|Prognosis|prognosis
45115|NCT03287726|Probiotics|probiotics
45116|NCT03287726|Appetite Regulation|appetite regulation
45117|NCT03287726|Gastrointestinal microbiome|gastrointestinal microbiome
45118|NCT03287726|Caloric Restriction|caloric restriction
45119|NCT03287726|Body weight maintenance|body weight maintenance
45120|NCT03287726|Body composition|body composition
45121|NCT03287661|chronic pain|chronic pain
45122|NCT03287661|online treatment|online treatment
45123|NCT03287661|acceptance-based therapy|acceptance-based therapy
45124|NCT03287648|optical coherence tomography|optical coherence tomography
45125|NCT03287648|blue fundus autofluorescence|blue fundus autofluorescence
45126|NCT03287596|Spondylarthropathy|spondylarthropathy
45127|NCT03287596|Tendinopathy|tendinopathy
45128|NCT03287596|MRI|mri
45129|NCT03287596|Healthy Volunteer|healthy volunteer
45130|NCT03287570|Osteoarthritis, Knee|osteoarthritis, knee
45131|NCT03287570|Moxibustion|moxibustion
45132|NCT03287544|Aphasia|aphasia
45133|NCT03287544|Rehabilitation|rehabilitation
45134|NCT03287544|Communication|communication
45135|NCT03287544|Linguistics|linguistics
45136|NCT03287531|conventional therapy|conventional therapy
45137|NCT03287518|Endothelial function|endothelial function
45138|NCT03287518|Blood pressure|blood pressure
45139|NCT03287518|Lipid metabolism|lipid metabolism
45140|NCT03287518|EndoPAT score RHI|endopat score rhi
45141|NCT03287492|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
45142|NCT03287492|Neoplasms of uncertain or unknown behavior|neoplasms of uncertain or unknown behavior
45143|NCT03287492|Information Materials|information materials
45144|NCT03287492|Questionnaires|questionnaires
45145|NCT03287492|Surveys|surveys
45146|NCT03287479|vitrification|vitrification
45147|NCT03287479|semi-automated|semi-automated
45148|NCT03287479|manual|manual
45149|NCT03287466|oxygen|oxygen
45150|NCT03287466|oxygen saturation|oxygen saturation
45151|NCT03287466|oxygen concentration|oxygen concentration
45152|NCT03287440|Health Disparities|health disparities
45153|NCT03287440|Lung Diseases|lung diseases
45154|NCT03287440|Self-management|self-management
45155|NCT03287440|Chronic Disease|chronic disease
45156|NCT03287440|Socio-economic status|socio-economic status
45157|NCT03287427|Advanced|advanced
45158|NCT03287427|Metastatic|metastatic
45159|NCT03287401|EEG|eeg
45160|NCT03287401|PACU Delirium|pacu delirium
45161|NCT03287388|Laparoscopic surgery|laparoscopic surgery
45162|NCT03287388|Abdominal working space|abdominal working space
45163|NCT03287388|Moderate neuromuscular blockade|moderate neuromuscular blockade
45164|NCT03287388|Deep neuromuscular blockade|deep neuromuscular blockade
45165|NCT03287388|MRI measurement|mri measurement
45166|NCT03287362|major depressive disorder|major depressive disorder
45167|NCT03287362|cognitive behavioral therapy|cognitive behavioral therapy
45168|NCT03287362|supportive therapy|supportive therapy
45169|NCT03287362|schema therapy|schema therapy
45170|NCT03287362|biomarkers|biomarkers
45171|NCT03287362|neuropsychology|neuropsychology
45172|NCT03287362|circadian rhythm|circadian rhythm
45173|NCT03287336|tranexamic acid|tranexamic acid
45174|NCT03287336|postpartum hemorrhage|postpartum hemorrhage
45175|NCT03287323|palliative care|palliative care
45176|NCT03287323|surgical intensive care|surgical intensive care
45177|NCT03287323|family satisfaction|family satisfaction
45178|NCT03287323|ICU decision-making|icu decision-making
45179|NCT03287323|end-of-life care|end-of-life care
45180|NCT03287310|eosinophils|eosinophils
45181|NCT03287310|pharmacokinetics|pharmacokinetics
45182|NCT03287310|First time in Human|first time in human
45183|NCT03287310|GSK3511294|gsk3511294
45184|NCT03287310|pharmacodynamics|pharmacodynamics
45185|NCT03287310|asthma|asthma
45186|NCT03287271|ovarian cancer|ovarian cancer
45187|NCT03287271|cancer|cancer
45188|NCT03287271|ovary|ovary
45189|NCT03287271|carboplatin|carboplatin
45190|NCT03287271|paclitaxel|paclitaxel
45191|NCT03287271|VS-6063|vs-6063
45192|NCT03287271|primary peritoneal carcinoma|primary peritoneal carcinoma
45193|NCT03287271|fallopian tube|fallopian tube
45194|NCT03287271|defactinib|defactinib
45195|NCT03287258|perineal massage|perineal massage
45196|NCT03287258|health education|health education
45197|NCT03287258|perineal tear|perineal tear
45198|NCT03287258|episiotomy|episiotomy
45199|NCT03287258|pelvic floor muscle exercise|pelvic floor muscle exercise
45200|NCT03287245|polycythemia vera|polycythemia vera
45201|NCT03287245|PV|pv
45202|NCT03287245|P vera|p vera
45203|NCT03287245|myeloproliferative diseases|myeloproliferative diseases
45204|NCT03287245|hematologic diseases|hematologic diseases
45205|NCT03287245|myeloproliferative neoplasm|myeloproliferative neoplasm
45206|NCT03287245|MPN|mpn
45207|NCT03287232|Prasterone|prasterone
45208|NCT03287232|DHEA|dhea
45209|NCT03287232|Menopause|menopause
45210|NCT03287232|Sexual Disorder|sexual disorder
45211|NCT03287180|Adolescent Community Reinforcement Approach|adolescent community reinforcement approach
45212|NCT03287180|A-CRA|a-cra
45213|NCT03287180|Opioid-Related Disorders|opioid-related disorders
45214|NCT03287180|Behavior|behavior
45215|NCT03287180|Psychosocial treatment|psychosocial treatment
45216|NCT03287180|Pharmacotherapy|pharmacotherapy
45217|NCT03287180|Randomized controlled|randomized controlled
45218|NCT03287180|Adolescent|adolescent
45219|NCT03287180|Young adult|young adult
45220|NCT03287154|Alcohol Abstinence|alcohol abstinence
45221|NCT03287154|Alcohol Addiction|alcohol addiction
45222|NCT03287154|Alcohol Consumption|alcohol consumption
45223|NCT03287154|Alcohol Dependence|alcohol dependence
45224|NCT03287141|noninvasive ventilation|noninvasive ventilation
45225|NCT03287141|continuous positive airway pressure|continuous positive airway pressure
45226|NCT03287141|intermittent positive-pressure breathing|intermittent positive-pressure breathing
45227|NCT03287141|exercise test|exercise test
45228|NCT03287141|physical endurance|physical endurance
45229|NCT03287141|physical fitness|physical fitness
45230|NCT03287089|Nitrofurantoin|nitrofurantoin
45231|NCT03287089|Prolapse|prolapse
45232|NCT03287089|Pelvic Organ Prolapse|pelvic organ prolapse
45233|NCT03287089|Anti-incontinence procedure|anti-incontinence procedure
45234|NCT03287089|Urinary retention|urinary retention
45235|NCT03287089|Urinary Tract Infection|urinary tract infection
45236|NCT03287089|Short-term catheterization|short-term catheterization
45237|NCT03287076|stroke|stroke
45238|NCT03287076|glucose|glucose
45239|NCT03287076|exenatide|exenatide
45240|NCT03287037|Unipolar depression|unipolar depression
45241|NCT03287037|bipolar depression|bipolar depression
45242|NCT03287037|Transcranial direct current stimulation|transcranial direct current stimulation
45243|NCT03287011|dental plaque|dental plaque
45244|NCT03287011|tooth pastes|tooth pastes
45245|NCT03287011|oral hygiene|oral hygiene
45246|NCT03286998|placenta previa|placenta previa
45247|NCT03286998|color doppler|color doppler
45248|NCT03286998|placenta accreta|placenta accreta
45249|NCT03286998|ultrasonography|ultrasonography
45250|NCT03286933|yoga therapy|yoga therapy
45251|NCT03286933|JIA|jia
45252|NCT03286933|quality of life|quality of life
45253|NCT03286933|pain management|pain management
45254|NCT03286920|home nutrition|home nutrition
45255|NCT03286920|BMI|bmi
45256|NCT03286920|postoperative|postoperative
45257|NCT03286920|body weight|body weight
45258|NCT03286907|Uptake of HPV vaccination|uptake of hpv vaccination
45259|NCT03286881|Common Mental Disorders|common mental disorders
45260|NCT03286881|Brief Psychological Treatments|brief psychological treatments
45261|NCT03286881|Primary Care|primary care
45262|NCT03286881|Randomized Clinical Trial|randomized clinical trial
45263|NCT03286842|HER2-ve metastatic breast cancer.|her2-ve metastatic breast cancer.
45264|NCT03286842|Germline BRCA1/2 mutations.|germline brca1/2 mutations.
45265|NCT03286842|BRCA1|brca1
45266|NCT03286842|BRCA2|brca2
45267|NCT03286816|type 1 diabetes mellitus|type 1 diabetes mellitus
45268|NCT03286816|impaired awareness of hypoglycemia|impaired awareness of hypoglycemia
45269|NCT03286816|lactate|lactate
45270|NCT03286816|MR spectroscopy|mr spectroscopy
45271|NCT03286790|elderly|elderly
45272|NCT03286777|6-prenylnaringenin|6-prenylnaringenin
45273|NCT03286777|Bioavailability|bioavailability
45274|NCT03286777|Pharmacokinetics|pharmacokinetics
45275|NCT03286777|PBMC|pbmc
45276|NCT03286712|Flow mediated dilatation|flow mediated dilatation
45277|NCT03286712|Brachial artery|brachial artery
45278|NCT03286712|Anemia|anemia
45279|NCT03286712|Chronic kidney disease|chronic kidney disease
45280|NCT03286712|Renogen|renogen
45281|NCT03286712|Erythropoietin Alpha|erythropoietin alpha
45282|NCT03286686|optic ataxia|optic ataxia
45283|NCT03286686|posterior parietal cortex functions|posterior parietal cortex functions
45284|NCT03286686|multisensory integration|multisensory integration
45285|NCT03286673|calcium carbonate|calcium carbonate
45286|NCT03286673|calcium phosphate|calcium phosphate
45287|NCT03286673|metabolic effects|metabolic effects
45288|NCT03286673|human study|human study
45289|NCT03286673|calcium and phosphorus metabolism|calcium and phosphorus metabolism
45290|NCT03286660|Exercise tests|exercise tests
45291|NCT03286660|COPD|copd
45292|NCT03286660|Rehabilitation|rehabilitation
45293|NCT03286647|grief, periodontal disease|grief, periodontal disease
45294|NCT03286621|eye tracking|eye tracking
45295|NCT03286621|visual preference|visual preference
45296|NCT03286595|early psychosis|early psychosis
45297|NCT03286595|clinical high risk|clinical high risk
45298|NCT03286595|mobile health|mobile health
45299|NCT03286556|Acute Exacerbation of Idiopathic Pulmonary Fibrosis|acute exacerbation of idiopathic pulmonary fibrosis
45300|NCT03286543|electrical stimulation|electrical stimulation
45301|NCT03286543|neurostimulation|neurostimulation
45302|NCT03286543|TKA pain|tka pain
45303|NCT03286543|pain following total knee replacement|pain following total knee replacement
45304|NCT03286543|total knee arthroplasty|total knee arthroplasty
45305|NCT03286530|Acute Myeloid Leukemia|acute myeloid leukemia
45306|NCT03286530|Acute Myeloid Leukemia in Remission|acute myeloid leukemia in remission
45307|NCT03286530|Allogenic Stem Cell Transplantation|allogenic stem cell transplantation
45308|NCT03286517|Puberty, Sexuality|puberty, sexuality
45309|NCT03286491|acute coronary syndrome, risk classification, 30 day adverse event, clinical decision support system|acute coronary syndrome, risk classification, 30 day adverse event, clinical decision support system
45310|NCT03286478|body image|body image
45311|NCT03286478|school|school
45312|NCT03286478|adolescence|adolescence
45313|NCT03286478|intervention|intervention
45314|NCT03286478|task-shifting|task-shifting
45315|NCT03286465|blood transfusion|blood transfusion
45316|NCT03286452|Antimicrobial|antimicrobial
45317|NCT03286452|Collagen|collagen
45318|NCT03286452|Bioburden|bioburden
45319|NCT03286452|Biofilm|biofilm
45320|NCT03286452|PHMB|phmb
45321|NCT03286452|Chronic wounds|chronic wounds
45322|NCT03286452|Acute wounds|acute wounds
45323|NCT03286426|vision screening|vision screening
45324|NCT03286426|portable fundus camera|portable fundus camera
45325|NCT03286426|acne medication|acne medication
45326|NCT03286400|CTAG|ctag
45327|NCT03286400|TEVAR|tevar
45328|NCT03286387|Memory|memory
45329|NCT03286387|naturalistic|naturalistic
45330|NCT03286387|context|context
45331|NCT03286387|fMRI|fmri
45332|NCT03286387|Attention|attention
45333|NCT03286374|Obesity|obesity
45334|NCT03286374|Occupational rehabilitation|occupational rehabilitation
45335|NCT03286374|Sick leave|sick leave
45336|NCT03286374|Life style treatment|life style treatment
45337|NCT03286335|Brain Tumor|brain tumor
45338|NCT03286283|Rhytides|rhytides
45339|NCT03286283|Wrinkle Reduction|wrinkle reduction
45340|NCT03286283|J-Plasma|j-plasma
45341|NCT03286283|Dermal Resurfacing|dermal resurfacing
45342|NCT03286270|mRUS|mrus
45343|NCT03286270|validation tool|validation tool
45344|NCT03286270|Impaired fractures|impaired fractures
45345|NCT03286257|Vascular function|vascular function
45346|NCT03286257|Vascular structure|vascular structure
45347|NCT03286257|Thermoregulation|thermoregulation
45348|NCT03286257|Hot flushes|hot flushes
45349|NCT03286257|Cerebral blood flow|cerebral blood flow
45350|NCT03286257|Exercise training|exercise training
45851|NCT03282799|efavirenz|efavirenz
45351|NCT03286231|gluteal venous vasculature|gluteal venous vasculature
45352|NCT03286231|prone position|prone position
45353|NCT03286231|jackknife position|jackknife position
45354|NCT03286153|Hemophilia A|hemophilia a
45355|NCT03286153|FVIII|fviii
45356|NCT03286153|Ideal body weight|ideal body weight
45357|NCT03286153|Actual body weight|actual body weight
45358|NCT03286140|endovenous ablation|endovenous ablation
45359|NCT03286075|DLPFC, tDCS, emotional processing|dlpfc, tdcs, emotional processing
45360|NCT03286036|Biomarkers, early detection|biomarkers, early detection
45361|NCT03286023|brain metastases|brain metastases
45362|NCT03286023|stereotactic radiation|stereotactic radiation
45363|NCT03286023|cyberknife|cyberknife
45364|NCT03285997|Quadrivalent Influenza Vaccines|quadrivalent influenza vaccines
45365|NCT03285945|Positron-Emission Tomography|positron-emission tomography
45366|NCT03285932|Brain Metastase|brain metastase
45367|NCT03285932|Radiation of resection cavity|radiation of resection cavity
45368|NCT03285932|WBRT (whole brain radiotherapy)|wbrt (whole brain radiotherapy)
45369|NCT03285932|SRS (stereotactic radiosurgery)|srs (stereotactic radiosurgery)
45370|NCT03285919|perturbed walking|perturbed walking
45371|NCT03285919|stepping response|stepping response
45372|NCT03285854|CKD|ckd
45373|NCT03285854|Dialysis|dialysis
45374|NCT03285854|calcium|calcium
45375|NCT03285854|mineral and bone disorder (MBD)|mineral and bone disorder (mbd)
45376|NCT03285854|calcification|calcification
45377|NCT03285854|DEXA|dexa
45378|NCT03285854|peripheral quantitative CT scan (pqCT)|peripheral quantitative ct scan (pqct)
45379|NCT03285841|cervical cancer|cervical cancer
45380|NCT03285841|vulvar cancer|vulvar cancer
45381|NCT03285841|optical coherence tomography|optical coherence tomography
45382|NCT03285841|autofluorescence imaging|autofluorescence imaging
45383|NCT03285828|medical education, motivational interviewing, medical empathy|medical education, motivational interviewing, medical empathy
45384|NCT03285789|Dyslexia|dyslexia
45385|NCT03285789|Visual Fields|visual fields
45386|NCT03285789|visual attention span|visual attention span
45387|NCT03285789|visual search|visual search
45388|NCT03285789|visual attention field|visual attention field
45389|NCT03285750|GRP120|grp120
45390|NCT03285750|Adipose tissue|adipose tissue
45391|NCT03285750|Type 2 diabetes|type 2 diabetes
45392|NCT03285737|Protein ingestion|protein ingestion
45393|NCT03285737|Muscle protein synthesis|muscle protein synthesis
45394|NCT03285685|Analgesia|analgesia
45395|NCT03285685|Facial pain|facial pain
45396|NCT03285685|Transcranial Direct Current Stimulation|transcranial direct current stimulation
45397|NCT03285685|Temporomandibular disorders|temporomandibular disorders
45398|NCT03285672|Hot Flashes, vasomotor symptoms, postmenopausal|hot flashes, vasomotor symptoms, postmenopausal
45399|NCT03285659|depression|depression
45400|NCT03285659|Primary Health Care|primary health care
45401|NCT03285659|Health Plan Implementation|health plan implementation
45402|NCT03285659|Collaborative care|collaborative care
45403|NCT03285659|Patient-Centered Care|patient-centered care
45404|NCT03285646|Knee|knee
45405|NCT03285646|Hip|hip
45406|NCT03285555|barbed suture|barbed suture
45407|NCT03285555|knoteless suture|knoteless suture
45408|NCT03285555|closure|closure
45409|NCT03285555|wound|wound
45410|NCT03285555|time|time
45411|NCT03285555|total hip arthroplasty|total hip arthroplasty
45412|NCT03285542|adhesive|adhesive
45413|NCT03285542|total knee arthroplasty|total knee arthroplasty
45414|NCT03285542|wound|wound
45415|NCT03285542|closure|closure
45416|NCT03285542|time|time
45417|NCT03285542|barbed suture|barbed suture
45418|NCT03285542|knoteless suture|knoteless suture
45419|NCT03285529|barbed suture|barbed suture
45420|NCT03285529|knoteless suture|knoteless suture
45421|NCT03285529|total knee arthroplasty|total knee arthroplasty
45422|NCT03285529|wound|wound
45423|NCT03285529|closure|closure
45424|NCT03285529|time|time
45425|NCT03285516|transdiagnostic treatment|transdiagnostic treatment
45426|NCT03285516|emotional disorders|emotional disorders
45427|NCT03285516|veterans|veterans
45428|NCT03285516|rural|rural
45429|NCT03285490|Actinic Keratosis|actinic keratosis
45430|NCT03285490|Keratosis|keratosis
45431|NCT03285490|Keratosis, Actinic|keratosis, actinic
45432|NCT03285490|Precancerous Conditions|precancerous conditions
45433|NCT03285490|Neoplasms|neoplasms
45434|NCT03285490|Sun Damaged Skin|sun damaged skin
45435|NCT03285490|Actinic Keratoses|actinic keratoses
45436|NCT03285477|Actinic Keratosis|actinic keratosis
45437|NCT03285477|Keratosis|keratosis
45438|NCT03285477|Keratosis, Actinic|keratosis, actinic
45439|NCT03285477|Skin Diseases|skin diseases
45440|NCT03285477|Actinic Keratoses|actinic keratoses
45441|NCT03285477|Precancerous Conditions|precancerous conditions
45442|NCT03285477|Neoplasms|neoplasms
45443|NCT03285464|knee|knee
45444|NCT03285464|hip|hip
45445|NCT03285464|exercise|exercise
45446|NCT03285464|proximal control|proximal control
45447|NCT03285464|PFPS|pfps
45448|NCT03285451|Submental ultrasound, Obstructive sleep apnea|submental ultrasound, obstructive sleep apnea
45449|NCT03285438|Venous Thromboembolism|venous thromboembolism
45450|NCT03285438|Anticoagulant|anticoagulant
45451|NCT03285438|Direct oral anticoagulant|direct oral anticoagulant
45452|NCT03285438|risk of recurrent venous thromboembolism|risk of recurrent venous thromboembolism
45453|NCT03285438|anticoagulant-related bleeding|anticoagulant-related bleeding
45454|NCT03285425|Batten's disease|batten's disease
45455|NCT03285425|Neuronal Ceroid Lipofuscinosis|neuronal ceroid lipofuscinosis
45456|NCT03285412|Breast Cancer|breast cancer
45457|NCT03285399|Nepal|nepal
45458|NCT03285399|Breastfeeding|breastfeeding
45459|NCT03285399|Micronutrients|micronutrients
45460|NCT03285399|Women|women
45461|NCT03285399|Infants|infants
45462|NCT03285360|Bifluoride, sylc, hypersensitivity,|bifluoride, sylc, hypersensitivity,
45463|NCT03285347|parkinson|parkinson
45464|NCT03285347|executive dysfunction|executive dysfunction
45465|NCT03285347|attention|attention
45466|NCT03285347|computer-based cognitive training|computer-based cognitive training
45467|NCT03285321|Nivolumab|nivolumab
45468|NCT03285321|Ipilimumab|ipilimumab
45469|NCT03285321|immunotherapy|immunotherapy
45470|NCT03285269|shock|shock
45471|NCT03285269|ultrasound|ultrasound
45472|NCT03285256|Prospective memory, working memory, substance abuse|prospective memory, working memory, substance abuse
45473|NCT03285243|Delirium, anesthesia, pediatrics|delirium, anesthesia, pediatrics
45474|NCT03285217|HMB|hmb
45475|NCT03285204|optical coherence tomography|optical coherence tomography
45476|NCT03285204|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
45477|NCT03285191|NRS|nrs
45478|NCT03285191|Concept elicitation|concept elicitation
45479|NCT03285191|Real-time data capture|real-time data capture
45480|NCT03285191|Rheumatoid arthritis|rheumatoid arthritis
45481|NCT03285191|GSK3196165|gsk3196165
45482|NCT03285178|Sickle Cell Disease|sickle cell disease
45483|NCT03285178|SCD|scd
45484|NCT03285152|Ketogenic Diet|ketogenic diet
45485|NCT03285152|17-396|17-396
45486|NCT03285139|Postpartum depression|postpartum depression
45487|NCT03285139|CBT|cbt
45488|NCT03285139|Lay Peer|lay peer
45489|NCT03285074|Diagnostic discordance of obesity|diagnostic discordance of obesity
45490|NCT03285074|all-cause mortality|all-cause mortality
45491|NCT03285048|cognitive impairment|cognitive impairment
45492|NCT03285035|Cryotherapy|cryotherapy
45493|NCT03285035|Palliation|palliation
45494|NCT03285035|Dysphagia|dysphagia
45495|NCT03285022|Incomplete caries removel|incomplete caries removel
45496|NCT03285022|Partial caries removel|partial caries removel
45497|NCT03284970|Interferon beta-1a|interferon beta-1a
45498|NCT03284970|Dimethyl fumarate|dimethyl fumarate
45499|NCT03284970|Rebif|rebif
45500|NCT03284970|Tecfidera|tecfidera
45501|NCT03284970|Relapsing-Remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
45502|NCT03284892|postextubation dysphagia|postextubation dysphagia
45503|NCT03284892|endotracheal intubation|endotracheal intubation
45504|NCT03284892|randomized controlled trial|randomized controlled trial
45505|NCT03284892|dysphagia intervention;|dysphagia intervention;
45506|NCT03284892|dysphagia screening,|dysphagia screening,
45507|NCT03284879|Psoriasis vulgaris|psoriasis vulgaris
45508|NCT03284879|Psoriasis arthropathica|psoriasis arthropathica
45509|NCT03284879|Serious infections|serious infections
45510|NCT03284879|Gastrointestinal Disorders|gastrointestinal disorders
45511|NCT03284879|Serious Hypersensitivity|serious hypersensitivity
45512|NCT03284879|Weight Decrease|weight decrease
45513|NCT03284879|Vasculitis|vasculitis
45514|NCT03284879|Malignancies|malignancies
45515|NCT03284879|Depression and Suicidal Ideation|depression and suicidal ideation
45516|NCT03284840|dietary intake|dietary intake
45517|NCT03284840|nutritional status|nutritional status
45518|NCT03284840|micronutrients|micronutrients
45519|NCT03284840|thyroid health|thyroid health
45520|NCT03284827|edoxaban|edoxaban
45521|NCT03284827|dual antiplatelet therapy|dual antiplatelet therapy
45522|NCT03284827|cerebral embolization|cerebral embolization
45523|NCT03284827|leaflet thrombosis|leaflet thrombosis
45524|NCT03284814|coenzyme q10|coenzyme q10
45525|NCT03284814|single dose bioavailability|single dose bioavailability
45526|NCT03284814|multiple dose bioavailability|multiple dose bioavailability
45527|NCT03284788|acceptance-based therapy|acceptance-based therapy
45528|NCT03284788|adolescents|adolescents
45529|NCT03284788|weight|weight
45530|NCT03284788|weight loss|weight loss
45531|NCT03284788|obesity|obesity
45532|NCT03284788|overweight|overweight
45533|NCT03284749|Copper Oxide|copper oxide
45534|NCT03284749|Antibiotic Resistance|antibiotic resistance
45535|NCT03284723|HER2|her2
45536|NCT03284723|PF-06804103|pf-06804103
45537|NCT03284723|ADC|adc
45538|NCT03284723|breast cancer|breast cancer
45539|NCT03284723|gastric cancer|gastric cancer
45540|NCT03284723|esophagogastric cancer|esophagogastric cancer
45541|NCT03284723|non-small cell lung cancer|non-small cell lung cancer
45542|NCT03284723|neoplasms|neoplasms
45543|NCT03284723|solid tumors|solid tumors
45544|NCT03284723|human epidermal growth receptor 2|human epidermal growth receptor 2
45545|NCT03284710|HIV|hiv
45546|NCT03284671|Transcranial Direct Current Stimulation|transcranial direct current stimulation
46056|NCT03281629|smoking|smoking
45547|NCT03284671|Supplementary motor area|supplementary motor area
45548|NCT03284671|Orbitofrontal cortex|orbitofrontal cortex
45549|NCT03284658|Congenital and Genetic Diseases|congenital and genetic diseases
45550|NCT03284658|Digestive Diseases|digestive diseases
45551|NCT03284658|Kidney and Urinary Diseases|kidney and urinary diseases
45552|NCT03284658|Metabolic disorders|metabolic disorders
45553|NCT03284632|Tobacco|tobacco
45554|NCT03284632|E-Cigarettes|e-cigarettes
45555|NCT03284632|Toxicants|toxicants
45556|NCT03284632|Formaldehyde DNA Adducts|formaldehyde dna adducts
45557|NCT03284632|Oxidative Damage|oxidative damage
45558|NCT03284567|Breast cancer|breast cancer
45559|NCT03284567|Football|football
45560|NCT03284567|Late effects|late effects
45561|NCT03284567|Physical exercise|physical exercise
45562|NCT03284567|Soccer training|soccer training
45563|NCT03284567|Rehabilitation|rehabilitation
45564|NCT03284567|Bone mineralization|bone mineralization
45565|NCT03284567|Body composition|body composition
45566|NCT03284567|Fitness|fitness
45567|NCT03284567|Aerobic capacity|aerobic capacity
45568|NCT03284554|Satiety|satiety
45569|NCT03284554|Nutrients|nutrients
45570|NCT03284554|Appetite|appetite
45571|NCT03284554|Encapsulation|encapsulation
45572|NCT03284554|Lipid|lipid
45573|NCT03284554|Amino acid|amino acid
45574|NCT03284554|Probiotic bacteria|probiotic bacteria
45575|NCT03284489|Pancreatitis|pancreatitis
45576|NCT03284476|Nosocomial Peritonitis|nosocomial peritonitis
45577|NCT03284476|Community-acquired Peritonitis|community-acquired peritonitis
45578|NCT03284476|Post-operative Peritonitis|post-operative peritonitis
45579|NCT03284463|acute ischemic stroke|acute ischemic stroke
45580|NCT03284463|glibenclamide|glibenclamide
45581|NCT03284463|rt-PA|rt-pa
45582|NCT03284463|blood-brain barrier|blood-brain barrier
45583|NCT03284463|brain edema|brain edema
45584|NCT03284450|Dance|dance
45585|NCT03284450|Sprint|sprint
45586|NCT03284450|Females|females
45587|NCT03284450|Recovery|recovery
45588|NCT03284424|PD1|pd1
45589|NCT03284424|PD-1|pd-1
45590|NCT03284424|PDL1|pdl1
45591|NCT03284424|PD-L1|pd-l1
45592|NCT03284398|parenteral nutrition|parenteral nutrition
45593|NCT03284398|ICU|icu
45594|NCT03284398|3-chamber bags|3-chamber bags
45595|NCT03284398|ICD-9-CM|icd-9-cm
45596|NCT03284398|BSI|bsi
45597|NCT03284398|Medical records system|medical records system
45598|NCT03284398|computerized|computerized
45599|NCT03284359|Critical Illness|critical illness
45600|NCT03284359|Mechanical Ventilation|mechanical ventilation
45601|NCT03284359|Economics, Behavioral|economics, behavioral
45602|NCT03284359|Surrogate decision maker|surrogate decision maker
45603|NCT03284307|Sedation|sedation
45604|NCT03284307|Propofol|propofol
45605|NCT03284307|Dexmedetomidine|dexmedetomidine
45606|NCT03284307|Ketamine|ketamine
45607|NCT03284307|Sevoflurane|sevoflurane
45608|NCT03284307|Electroencephalogram|electroencephalogram
45609|NCT03284268|Gene therapy|gene therapy
45610|NCT03284255|Bioresorbable Vascular Scaffold System|bioresorbable vascular scaffold system
45611|NCT03284255|Percutaneous Coronary Intervention|percutaneous coronary intervention
45612|NCT03284255|Cardiac Catheterization|cardiac catheterization
45613|NCT03284255|Tomography, Optical Coherence|tomography, optical coherence
45614|NCT03284242|Kidney|kidney
45615|NCT03284242|Transplant|transplant
45616|NCT03284229|ELCA|elca
45617|NCT03284229|Coronary Artery Disease|coronary artery disease
45618|NCT03284229|India|india
45619|NCT03284151|prostate cancer|prostate cancer
45620|NCT03284151|good prognosis|good prognosis
45621|NCT03284151|focused treatment|focused treatment
45622|NCT03284151|Cyberknife|cyberknife
45623|NCT03284138|Schizophrenia|schizophrenia
45624|NCT03284138|rTMS|rtms
45625|NCT03284138|first rank symptoms|first rank symptoms
45626|NCT03284112|Dementia, Schools, Nutrition, Health|dementia, schools, nutrition, health
45627|NCT03284086|Oxygen consumption|oxygen consumption
45628|NCT03284086|Physical endurance|physical endurance
45629|NCT03284073|uterus|uterus
45630|NCT03284073|transplantation|transplantation
45631|NCT03284073|infertility|infertility
45632|NCT03284060|Cognitive remediation, 22q11.2 deletion syndrome|cognitive remediation, 22q11.2 deletion syndrome
45633|NCT03284008|Breast Neoplasm|breast neoplasm
45634|NCT03284008|Physiotherapy|physiotherapy
45635|NCT03284008|Rehabilitation|rehabilitation
45636|NCT03283982|Ventral Hernia|ventral hernia
45637|NCT03283982|Robotic|robotic
45638|NCT03283982|Laparoscopic|laparoscopic
45639|NCT03283982|Pain scores|pain scores
45640|NCT03283930|anxiety, cbt, abmt|anxiety, cbt, abmt
45641|NCT03283917|Amyloid light chain (AL) amyloidosis|amyloid light chain (al) amyloidosis
45642|NCT03283917|Daratumumab|daratumumab
45643|NCT03283917|Ixazomib|ixazomib
45644|NCT03283917|Dexamethasone|dexamethasone
45645|NCT03283917|MLN 9708|mln 9708
45646|NCT03283917|MLN9708|mln9708
45647|NCT03283917|Decadron|decadron
45648|NCT03283904|Children|children
45649|NCT03283904|Schools|schools
45650|NCT03283891|Educational intervention|educational intervention
45651|NCT03283891|Watson's theory of human caring|watson's theory of human caring
45652|NCT03283891|Quality of working life of haemodialysis nurses|quality of working life of haemodialysis nurses
45653|NCT03283891|Quality of life of haemodialysis patients|quality of life of haemodialysis patients
45654|NCT03283839|Temporo-mandibular dysfunction|temporo-mandibular dysfunction
45655|NCT03283839|Balance control|balance control
45656|NCT03283839|Orientation function|orientation function
45657|NCT03283826|Multiple Sclerosis|multiple sclerosis
45658|NCT03283826|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
45659|NCT03283826|Primary Progressive Multiple Sclerosis|primary progressive multiple sclerosis
45660|NCT03283826|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
45661|NCT03283826|Epstein-Barr Virus (EBV)|epstein-barr virus (ebv)
45662|NCT03283826|EBV-associated Multiple Sclerosis|ebv-associated multiple sclerosis
45663|NCT03283826|Inflammation|inflammation
45664|NCT03283826|Central Nervous System|central nervous system
45665|NCT03283826|Autoimmune Disease|autoimmune disease
45666|NCT03283826|Autoimmunity|autoimmunity
45667|NCT03283826|Demyelination|demyelination
45668|NCT03283826|Cell Therapy|cell therapy
45669|NCT03283826|T-cell|t-cell
45670|NCT03283826|Allogeneic|allogeneic
45671|NCT03283813|Paediatric Obesity|paediatric obesity
45672|NCT03283813|Insulin resistance|insulin resistance
45673|NCT03283813|Zinc|zinc
45674|NCT03283813|Myo-inositol|myo-inositol
45675|NCT03283800|Copper Oxide|copper oxide
45676|NCT03283800|Compression Therapy|compression therapy
45677|NCT03283800|Chronic Venous Disease|chronic venous disease
45678|NCT03283800|Randomised Controlled Trial|randomised controlled trial
45679|NCT03283800|Lipodermatosclerosis|lipodermatosclerosis
45680|NCT03283787|Pressure Ulcer|pressure ulcer
45681|NCT03283787|ACell|acell
45682|NCT03283787|ACell MicroMatrix®|acell micromatrix®
45683|NCT03283787|ACell Cytal™|acell cytal™
45684|NCT03283787|Extracellular Matrix|extracellular matrix
45685|NCT03283787|Urinary Bladder Matrix|urinary bladder matrix
45686|NCT03283787|Wound|wound
45687|NCT03283761|FOLFOX|folfox
45688|NCT03283761|Nab-Paclitaxel|nab-paclitaxel
45689|NCT03283735|Deprescribing|deprescribing
45690|NCT03283735|Polypharmacy|polypharmacy
45691|NCT03283735|Elderly|elderly
45692|NCT03283735|Enablement|enablement
45693|NCT03283735|Quality of Life|quality of life
45694|NCT03283683|rest-activity rhythm|rest-activity rhythm
45695|NCT03283683|survival|survival
45696|NCT03283683|actigraphy|actigraphy
45697|NCT03283670|Depression|depression
45698|NCT03283670|treatment-resistant|treatment-resistant
45699|NCT03283644|gastric bypass|gastric bypass
45700|NCT03283644|Obesity|obesity
45701|NCT03283644|Morbid obesity|morbid obesity
45702|NCT03283644|Matched Healthy Controls|matched healthy controls
45703|NCT03283631|Malignant Glioma|malignant glioma
45704|NCT03283631|INTERCEPT|intercept
45705|NCT03283631|Pro00083828|pro00083828
45706|NCT03283631|Desjardins|desjardins
45707|NCT03283631|Adult|adult
45708|NCT03283631|Chimeric Antigen Receptor|chimeric antigen receptor
45709|NCT03283631|CAR T cell|car t cell
45710|NCT03283618|Weight loss|weight loss
45711|NCT03283618|Video conferencing|video conferencing
45712|NCT03283618|Health coaching|health coaching
45713|NCT03283618|Telemedicine|telemedicine
45714|NCT03283618|mHealth|mhealth
45715|NCT03283618|Obesity|obesity
45716|NCT03283566|Pancreatectomy|pancreatectomy
45717|NCT03283566|Autologous Islet Transplantation|autologous islet transplantation
45718|NCT03283566|Pancreatitis|pancreatitis
45719|NCT03283566|Diabetes|diabetes
45720|NCT03283566|Hydroxychloroquine|hydroxychloroquine
45721|NCT03283553|breast cancer|breast cancer
45722|NCT03283540|Low Anterior Resection|low anterior resection
45723|NCT03283501|TAVI|tavi
45724|NCT03283501|PCI|pci
45725|NCT03283488|anorexia|anorexia
45726|NCT03283488|cachexia|cachexia
45727|NCT03283488|mirtazapine|mirtazapine
45728|NCT03283488|megestrol|megestrol
45729|NCT03283488|palliative care|palliative care
45730|NCT03283436|Laparoscopy|laparoscopy
45731|NCT03283436|Superior hypogastric plexus block|superior hypogastric plexus block
45732|NCT03283410|propofol|propofol
45733|NCT03283410|dose-response|dose-response
45734|NCT03283410|elderly|elderly
45735|NCT03283410|young adults|young adults
45736|NCT03283384|Breast cancer|breast cancer
45737|NCT03283384|Ribociclib|ribociclib
45738|NCT03283384|Letrozole|letrozole
45739|NCT03283384|Chemotherapy|chemotherapy
45740|NCT03283384|CDK4|cdk4
45741|NCT03283384|CDK6|cdk6
45742|NCT03283384|Ki67|ki67
45743|NCT03283384|NEOLBC|neolbc
45744|NCT03283371|Drug Resistant Focal Epilepsy, Natalizumab, Seizure|drug resistant focal epilepsy, natalizumab, seizure
45745|NCT03283358|Prevention and control|prevention and control
45746|NCT03283345|breast cancer|breast cancer
45747|NCT03283345|menstrual cycle|menstrual cycle
45748|NCT03283345|breast surgery|breast surgery
45749|NCT03283345|systemic responses to trauma|systemic responses to trauma
45750|NCT03283332|Ethnicity|ethnicity
45751|NCT03283332|adolescents|adolescents
45752|NCT03283332|cohort|cohort
45753|NCT03283332|longitudinal|longitudinal
45754|NCT03283332|health inequalities|health inequalities
45755|NCT03283319|Influenza|influenza
45756|NCT03283319|human|human
45757|NCT03283319|Influenza in Birds|influenza in birds
45758|NCT03283319|Orthomyxoviridae Infections|orthomyxoviridae infections
45759|NCT03283319|RNA Virus Infections|rna virus infections
45760|NCT03283319|Virus Diseases|virus diseases
45761|NCT03283319|Respiratory Tract Infections|respiratory tract infections
45762|NCT03283319|Respiratory Tract Diseases|respiratory tract diseases
45763|NCT03283319|MF59|mf59
45764|NCT03283319|AS03|as03
45765|NCT03283319|Adjuvants|adjuvants
45766|NCT03283319|Immunologic|immunologic
45767|NCT03283293|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
45768|NCT03283293|Intensity-modulated Radiation Therapy|intensity-modulated radiation therapy
45769|NCT03283293|Target Volume Delineation|target volume delineation
45770|NCT03283293|Locoregional Failure Pattern|locoregional failure pattern
45771|NCT03283293|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
45772|NCT03283280|Short fiber reinforced resin composite|short fiber reinforced resin composite
45773|NCT03283280|Nanohybrid resin composite|nanohybrid resin composite
45774|NCT03283280|Indirect resin composite restoration|indirect resin composite restoration
45775|NCT03283267|Healthy Chinese Subjects, Pharmacodynamic Study|healthy chinese subjects, pharmacodynamic study
45776|NCT03283254|Postpartum Depression Treatment|postpartum depression treatment
45777|NCT03283202|Diffuse B-Cell Lymphoma|diffuse b-cell lymphoma
45778|NCT03283202|R-CHOP-21|r-chop-21
45779|NCT03283202|International Prognostic Index (IPI)|international prognostic index (ipi)
45780|NCT03283189|Use of cosmetics|use of cosmetics
45781|NCT03283189|Pregnant women|pregnant women
45782|NCT03283189|Risk perception|risk perception
45783|NCT03283189|Preventive attitude|preventive attitude
45784|NCT03283189|Qualitative study|qualitative study
45785|NCT03283150|Deep Brain Stimulation(DBS)|deep brain stimulation(dbs)
45786|NCT03283150|Sedation|sedation
45787|NCT03283150|DBS Implantation|dbs implantation
45788|NCT03283150|Microelectrode recording(MER)|microelectrode recording(mer)
45789|NCT03283137|CLL|cll
45790|NCT03283137|B-cell Non Hodgkin Lymphoma|b-cell non hodgkin lymphoma
45791|NCT03283137|pembrolizumab|pembrolizumab
45792|NCT03283137|TGR-1202|tgr-1202
45793|NCT03283098|Secondary hyperparathyroidism|secondary hyperparathyroidism
45794|NCT03283098|Chronic kidney disease CKD|chronic kidney disease ckd
45795|NCT03283098|Intact parathyroid hormone iPTH|intact parathyroid hormone ipth
45796|NCT03283098|Hemodialysis|hemodialysis
45797|NCT03283085|Immunosuppressants|immunosuppressants
45798|NCT03283085|Mesalamine|mesalamine
45799|NCT03283085|Ulcerative Colitis|ulcerative colitis
45800|NCT03283085|Crohn's disease|crohn's disease
45801|NCT03283085|Gastroenteritis|gastroenteritis
45802|NCT03283072|thermal threshold|thermal threshold
45803|NCT03283072|pressure pain threshold|pressure pain threshold
45804|NCT03283072|temporal summation|temporal summation
45805|NCT03283046|Multiple myeloma|multiple myeloma
45806|NCT03283046|Newly diagnosed|newly diagnosed
45807|NCT03283046|Nivolumab|nivolumab
45808|NCT03283046|BMS-936558|bms-936558
45809|NCT03283046|Opdivo|opdivo
45810|NCT03283046|Lenalidomide|lenalidomide
45811|NCT03283046|CC-5013|cc-5013
45812|NCT03283046|Revlimid|revlimid
45813|NCT03283046|Dexamethasone|dexamethasone
45814|NCT03283046|Decadron|decadron
45815|NCT03283046|Ipilimumab|ipilimumab
45816|NCT03283046|Yervoy|yervoy
45817|NCT03283046|BMS-734016|bms-734016
45818|NCT03283046|MDX010|mdx010
45819|NCT03283033|Children|children
45820|NCT03283033|Plate Waste|plate waste
45821|NCT03283033|Fruit and vegetable intake|fruit and vegetable intake
45822|NCT03283033|School lunch|school lunch
45823|NCT03283033|social marketing|social marketing
45824|NCT03283020|Remifentanil|remifentanil
45825|NCT03283020|Methylnaltrexone|methylnaltrexone
45826|NCT03283020|Pharyngeal dysfunction|pharyngeal dysfunction
45827|NCT03283020|Anesthetic sedation|anesthetic sedation
45828|NCT03283007|Nintedanib, lung transplantation, bronchiolitis obliterans syndrome|nintedanib, lung transplantation, bronchiolitis obliterans syndrome
45829|NCT03282968|exergaming|exergaming
45830|NCT03282968|physiotherapy|physiotherapy
45831|NCT03282968|balance|balance
45832|NCT03282942|hypertension|hypertension
45833|NCT03282942|Aerobic training|aerobic training
45834|NCT03282942|Strength training|strength training
45835|NCT03282916|Valacyclovir|valacyclovir
45836|NCT03282916|Anti-viral treatment|anti-viral treatment
45837|NCT03282890|HIV|hiv
45838|NCT03282890|Substance Abuse|substance abuse
45839|NCT03282890|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
45840|NCT03282890|HIV Risk Behavior|hiv risk behavior
45841|NCT03282890|Methadone Maintenance|methadone maintenance
45842|NCT03282864|asthma|asthma
45843|NCT03282864|air pollution|air pollution
45844|NCT03282864|air filtration|air filtration
45845|NCT03282864|indoor air quality|indoor air quality
45846|NCT03282864|respiratory health|respiratory health
45847|NCT03282851|MSB11456|msb11456
45848|NCT03282851|Actemra®|actemra®
45849|NCT03282851|RoActemra®|roactemra®
45850|NCT03282799|etonogestrel|etonogestrel
45852|NCT03282799|antiretroviral therapy|antiretroviral therapy
45853|NCT03282799|HIV|hiv
45854|NCT03282786|Inflammatory Bowel Disease|inflammatory bowel disease
45855|NCT03282786|Crohn's Disease|crohn's disease
45856|NCT03282786|Ulcerative Colitis|ulcerative colitis
45857|NCT03282786|Carbon Dioxide (CO2)|carbon dioxide (co2)
45858|NCT03282786|Colonoscopy|colonoscopy
45859|NCT03282773|acute myocardial infarction|acute myocardial infarction
45860|NCT03282773|percutaneous coronary intervention|percutaneous coronary intervention
45861|NCT03282773|deferred stent implantation|deferred stent implantation
45862|NCT03282760|Cell Transplantation|cell transplantation
45863|NCT03282760|Neural Stem Cells|neural stem cells
45864|NCT03282708|intestinal microbiome|intestinal microbiome
45865|NCT03282708|captive great apes|captive great apes
45866|NCT03282708|human beings|human beings
45867|NCT03282695|Disc Herniation|disc herniation
45868|NCT03282695|Lumbar Herniated Disc|lumbar herniated disc
45869|NCT03282695|Ozone Therapy|ozone therapy
45870|NCT03282682|hypogonadism|hypogonadism
45871|NCT03282682|aging male|aging male
45872|NCT03282682|strength training|strength training
45873|NCT03282682|physical activity|physical activity
45874|NCT03282682|testosterone|testosterone
45875|NCT03282669|Pregnancy|pregnancy
45876|NCT03282669|Transcutaneous Carbon Dioxide Monitoring|transcutaneous carbon dioxide monitoring
45877|NCT03282669|Pulse Oximetry|pulse oximetry
45878|NCT03282669|Cesarean Section|cesarean section
45879|NCT03282669|Postoperative pain control|postoperative pain control
45880|NCT03282669|High BMI|high bmi
45881|NCT03282669|Hypercarbia|hypercarbia
45882|NCT03282669|Hypoxemia|hypoxemia
45883|NCT03282656|Gene therapy|gene therapy
45884|NCT03282656|lentivirus vector|lentivirus vector
45885|NCT03282656|BCL11A|bcl11a
45886|NCT03282656|Fetal Hemoglobin|fetal hemoglobin
45887|NCT03282630|Acupuncture|acupuncture
45888|NCT03282630|Sphenopalatine ganglion|sphenopalatine ganglion
45889|NCT03282630|Allergic rhinitis|allergic rhinitis
45890|NCT03282630|Randomized Trial|randomized trial
45891|NCT03282604|Intubation|intubation
45892|NCT03282604|Intratracheal|intratracheal
45893|NCT03282604|Nasopharynx|nasopharynx
45894|NCT03282578|sternum|sternum
45895|NCT03282578|bone healing|bone healing
45896|NCT03282578|recovery|recovery
45897|NCT03282565|ACL|acl
45898|NCT03282565|Quadriceps|quadriceps
45899|NCT03282565|Muscle|muscle
45900|NCT03282565|Resistance Training|resistance training
45901|NCT03282539|Lumen apposing metal stents|lumen apposing metal stents
45902|NCT03282539|Double pigtail stents|double pigtail stents
45903|NCT03282539|Endoscopic ultrasonography|endoscopic ultrasonography
45904|NCT03282513|AG-120|ag-120
45905|NCT03282513|Healthy Volunteer|healthy volunteer
45906|NCT03282513|Clinical Pharmacology|clinical pharmacology
45907|NCT03282513|Hepatic Impairment|hepatic impairment
45908|NCT03282487|cortisol|cortisol
45909|NCT03282487|adrenal insufficiency|adrenal insufficiency
45910|NCT03282487|hypopituitarism|hypopituitarism
45911|NCT03282487|hydrocortisone|hydrocortisone
45912|NCT03282474|Hepatitis E|hepatitis e
45913|NCT03282422|Cerebral palsy|cerebral palsy
45914|NCT03282422|Hemiplegia|hemiplegia
45915|NCT03282422|Upper-limb splint|upper-limb splint
45916|NCT03282422|Home-based|home-based
45917|NCT03282422|Social Participation|social participation
45918|NCT03282409|Prediction|prediction
45919|NCT03282409|Chronic Renal Disease|chronic renal disease
45920|NCT03282409|Acute Kidney Injury|acute kidney injury
45921|NCT03282396|Hematopoietic/Lymphoid Cancer|hematopoietic/lymphoid cancer
45922|NCT03282396|Mantle Cell Lymphoma|mantle cell lymphoma
45923|NCT03282396|MCL|mcl
45924|NCT03282396|Newly-diagnosed|newly-diagnosed
45925|NCT03282396|Ibrutinib|ibrutinib
45926|NCT03282396|PCI-32765|pci-32765
45927|NCT03282396|Imbruvica|imbruvica
45928|NCT03282383|biomarkers pneumonia severity|biomarkers pneumonia severity
45929|NCT03282370|Japanese Encephalitis|japanese encephalitis
45930|NCT03282370|JECEVAX|jecevax
45931|NCT03282370|Vietnam|vietnam
45932|NCT03282344|NKTR-214|nktr-214
45933|NCT03282344|NIVOLUMAB|nivolumab
45934|NCT03282344|17-366|17-366
45935|NCT03282331|Preoxygenation|preoxygenation
45936|NCT03282331|Intubation|intubation
45937|NCT03282331|Electrical Impedance Tomography|electrical impedance tomography
45938|NCT03282331|Lung aeration|lung aeration
45939|NCT03282331|Alveolar recruitment|alveolar recruitment
45940|NCT03282318|Bladder Pain Syndrome|bladder pain syndrome
45941|NCT03282318|Interstitial Cystitis|interstitial cystitis
45942|NCT03282318|ASP6294|asp6294
45943|NCT03282279|oocyte retrieval|oocyte retrieval
45944|NCT03282279|surgical complications|surgical complications
45945|NCT03282240|Influenza|influenza
45946|NCT03282227|migraine|migraine
45947|NCT03282227|migraine headache|migraine headache
45948|NCT03282227|acute migraine|acute migraine
45949|NCT03282227|acute migraine headache|acute migraine headache
45950|NCT03282214|Energy conservation|energy conservation
45951|NCT03282214|Self management|self management
45952|NCT03282175|BDNF|bdnf
45953|NCT03282175|interleukin-15|interleukin-15
45954|NCT03282175|interleukin-8|interleukin-8
45955|NCT03282175|resistin|resistin
45956|NCT03282175|SPPB|sppb
45957|NCT03282162|Oxytocin|oxytocin
45958|NCT03282162|affective touch|affective touch
45959|NCT03282162|trait autism|trait autism
45960|NCT03282149|inflammation|inflammation
45961|NCT03282149|cytokine|cytokine
45962|NCT03282149|anti-inflammatory|anti-inflammatory
45963|NCT03282149|pain|pain
45964|NCT03282123|MDMA|mdma
45965|NCT03282123|methylenedioxymethamphetamine|methylenedioxymethamphetamine
45966|NCT03282123|psychotherapy|psychotherapy
45967|NCT03282071|Mental health|mental health
45968|NCT03282071|Mental well-being|mental well-being
45969|NCT03282071|Community-based engagement|community-based engagement
45970|NCT03282071|Positive psychology|positive psychology
45971|NCT03282071|Public health approach|public health approach
45972|NCT03282058|Silastic Stenting|silastic stenting
45973|NCT03282058|Trans-nasal Endoscopic Surgery|trans-nasal endoscopic surgery
45974|NCT03282058|Post-operative Intra-nasal Re-mucosalization|post-operative intra-nasal re-mucosalization
45975|NCT03282045|acute sore throat|acute sore throat
45976|NCT03282045|lysobact|lysobact
45977|NCT03282019|myAIRVO2|myairvo2
45978|NCT03282019|high-flow nasal cannula therapy|high-flow nasal cannula therapy
45979|NCT03282019|home oxygen therapy|home oxygen therapy
45981|NCT03282019|COPD|copd
45982|NCT03282006|Pivmecillinam|pivmecillinam
45983|NCT03281993|apnea test, brain death, pupillometry|apnea test, brain death, pupillometry
45984|NCT03281980|Bangladesh|bangladesh
45985|NCT03281980|Child development|child development
45986|NCT03281980|Poor mothers|poor mothers
45987|NCT03281980|Psycho social stimulation|psycho social stimulation
45988|NCT03281980|Unconditional cash transfer|unconditional cash transfer
45989|NCT03281954|anti-PD-L1 antibody|anti-pd-l1 antibody
45990|NCT03281954|TNBC|tnbc
45991|NCT03281915|infertility|infertility
45992|NCT03281915|pain|pain
45993|NCT03281915|pregnancy|pregnancy
45994|NCT03281889|Brain Tumor|brain tumor
45995|NCT03281876|Immunogenicity|immunogenicity
45996|NCT03281876|Vaccination|vaccination
45997|NCT03281876|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
45998|NCT03281876|Non-typeable Haemophilus influenzae|non-typeable haemophilus influenzae
45999|NCT03281876|Acute exacerbation of COPD|acute exacerbation of copd
46000|NCT03281876|Moraxella catarrhalis|moraxella catarrhalis
46001|NCT03281876|Efficacy|efficacy
46002|NCT03281876|Safety|safety
46003|NCT03281837|osteoarthritis|osteoarthritis
46004|NCT03281837|knee osteoarthritis|knee osteoarthritis
46005|NCT03281837|patellofemoral osteoarthritis|patellofemoral osteoarthritis
46006|NCT03281837|tibiofemoral osteoarthritis|tibiofemoral osteoarthritis
46007|NCT03281837|hyaluronan|hyaluronan
46008|NCT03281837|hyaluronic acid|hyaluronic acid
46009|NCT03281837|intra-articular|intra-articular
46010|NCT03281837|arthritis|arthritis
46011|NCT03281837|joint disease|joint disease
46012|NCT03281837|active|active
46013|NCT03281837|viscosupplements|viscosupplements
46014|NCT03281837|Hymovis|hymovis
46015|NCT03281824|HER2 Positive Breast Cancer|her2 positive breast cancer
46016|NCT03281824|ALT-P7|alt-p7
46017|NCT03281824|Antibody-Drug Conjugate|antibody-drug conjugate
46018|NCT03281772|hypertension|hypertension
46019|NCT03281772|clinical decision support software|clinical decision support software
46020|NCT03281772|renin|renin
46021|NCT03281772|aldosterone|aldosterone
46022|NCT03281759|Brain Injuries, Traumatic;|brain injuries, traumatic;
46023|NCT03281759|Diffuse Axonal Injury|diffuse axonal injury
46024|NCT03281759|Low-Level Light Therapy|low-level light therapy
46025|NCT03281759|Neurologic Manifestations|neurologic manifestations
46026|NCT03281759|Quality of Life|quality of life
46027|NCT03281759|Rehabilitation|rehabilitation
46028|NCT03281733|malnutrition|malnutrition
46029|NCT03281733|adult|adult
46030|NCT03281733|hospitalized patients|hospitalized patients
46031|NCT03281733|dietitian|dietitian
46032|NCT03281733|communication|communication
46033|NCT03281733|discharge|discharge
46034|NCT03281733|nutrition|nutrition
46035|NCT03281707|NIRS|nirs
46036|NCT03281707|DO2|do2
46037|NCT03281694|nicotine|nicotine
46038|NCT03281694|positive allosteric modulator|positive allosteric modulator
46039|NCT03281694|attention|attention
46040|NCT03281694|cognition|cognition
46041|NCT03281681|adenocarcinoma of the ovary|adenocarcinoma of the ovary
46042|NCT03281681|ovarian adenocarcinoma|ovarian adenocarcinoma
46043|NCT03281681|ovarian cancer|ovarian cancer
46044|NCT03281681|cancer of the ovary|cancer of the ovary
46045|NCT03281681|ovarian neoplasm|ovarian neoplasm
46046|NCT03281681|AO|ao
46047|NCT03281681|ovarian carcinoma|ovarian carcinoma
46048|NCT03281668|Knee osteoarthritis|knee osteoarthritis
46049|NCT03281655|Visnadine|visnadine
46050|NCT03281655|Prenylflavonoids|prenylflavonoids
46051|NCT03281655|Bovine colostrum|bovine colostrum
46052|NCT03281655|Sexual wellbeing|sexual wellbeing
46053|NCT03281629|Transcranial magnetic stimulation|transcranial magnetic stimulation
46054|NCT03281629|schizophrenia|schizophrenia
46055|NCT03281629|MRI|mri
46057|NCT03281603|Patient satisfaction|patient satisfaction
46058|NCT03281603|Retention|retention
46059|NCT03281590|identification|identification
46060|NCT03281590|diagnosis|diagnosis
46061|NCT03281590|management|management
46062|NCT03281590|investigation|investigation
46063|NCT03281590|prevalence|prevalence
46064|NCT03281590|incidence|incidence
46065|NCT03281590|quality of care|quality of care
46066|NCT03281590|hospitalization|hospitalization
46067|NCT03281590|morbidity|morbidity
46068|NCT03281590|disability|disability
46069|NCT03281577|Drug Therapy|drug therapy
46070|NCT03281525|cardiotransplant|cardiotransplant
46071|NCT03281512|Saturated fatty acids|saturated fatty acids
46072|NCT03281512|CHNS|chns
46073|NCT03281473|ARDS; esophageal pressure; Mechanical ventilation|ards; esophageal pressure; mechanical ventilation
46074|NCT03281460|Hysterectomy, Vaginal|hysterectomy, vaginal
46075|NCT03281460|Uterine Myomatosis|uterine myomatosis
46076|NCT03281460|Morcellation|morcellation
46077|NCT03281460|Laparoscopy|laparoscopy
46078|NCT03281460|in-bag morcellation|in-bag morcellation
46079|NCT03281447|Nurse navigation|nurse navigation
46080|NCT03281447|Family|family
46081|NCT03281447|Self Efficacy|self efficacy
46082|NCT03281447|Needs assessment|needs assessment
46083|NCT03281447|Quality of Life|quality of life
46084|NCT03281447|Colorectal Neoplasms|colorectal neoplasms
46085|NCT03281447|Case Management|case management
46086|NCT03281434|Skeletal muscle|skeletal muscle
46087|NCT03281434|Protein synthesis|protein synthesis
46088|NCT03281434|Protein ingestion|protein ingestion
46089|NCT03281434|Resistance exercise|resistance exercise
46090|NCT03281356|Pilot Study|pilot study
46091|NCT03281356|Early childhood development|early childhood development
46092|NCT03281343|PrEP|prep
46093|NCT03281343|Women|women
46094|NCT03281343|Linkage to Care|linkage to care
46095|NCT03281317|vasoplegicsyndrome|vasoplegicsyndrome
46096|NCT03281317|cardiac surgery|cardiac surgery
46097|NCT03281317|predictive risk score|predictive risk score
46098|NCT03281304|ulcerative colitis|ulcerative colitis
46099|NCT03281304|inflammatory bowel disease|inflammatory bowel disease
46100|NCT03281291|malaria vaccine|malaria vaccine
46101|NCT03281291|infants|infants
46102|NCT03281291|Malaria|malaria
46103|NCT03281291|RTS,S/AS01|rts,s/as01
46104|NCT03281291|falciparum|falciparum
46105|NCT03281291|genomics|genomics
46106|NCT03281291|efficacy|efficacy
46107|NCT03281278|Thrombelastography,acute on chronic liver failure, platelet|thrombelastography,acute on chronic liver failure, platelet
46108|NCT03281265|pre-acute-on-chronic liver failure|pre-acute-on-chronic liver failure
46109|NCT03281265|hepatitis B|hepatitis b
46110|NCT03281252|liver failure|liver failure
46111|NCT03281239|welder, airport agent, Welding fumes|welder, airport agent, welding fumes
46112|NCT03281226|Pulmonary tuberculosis|pulmonary tuberculosis
46113|NCT03281226|HIV/AIDS|hiv/aids
46114|NCT03281226|Glutathione|glutathione
46115|NCT03281226|N-acetylcysteine|n-acetylcysteine
46116|NCT03281226|Oxidative stress|oxidative stress
46117|NCT03281187|Hormonal reposition, Testosterone nasal, Nasotestt|hormonal reposition, testosterone nasal, nasotestt
46118|NCT03281174|Inactivated Enterovirus Type 71 (EV71) Vaccine|inactivated enterovirus type 71 (ev71) vaccine
46119|NCT03281174|5-year Immune Persistence|5-year immune persistence
46120|NCT03281161|skin cancer|skin cancer
46121|NCT03281161|prevention|prevention
46122|NCT03281161|worksite|worksite
46123|NCT03281161|policy|policy
46124|NCT03281161|cost and effectiveness|cost and effectiveness
46125|NCT03281161|implementation|implementation
46126|NCT03281148|immediate implants, accuracy,extraction sockets|immediate implants, accuracy,extraction sockets
46127|NCT03281135|Cervical cancer screening|cervical cancer screening
46128|NCT03281135|Adherance|adherance
46129|NCT03281135|HPV typing|hpv typing
46130|NCT03281135|HDSS|hdss
46131|NCT03281135|Ethiopia|ethiopia
46132|NCT03281109|menstrual cycle|menstrual cycle
46133|NCT03281109|gingivitis|gingivitis
46134|NCT03281109|interleukin 1|interleukin 1
46135|NCT03281109|tumor necrosis factor alpha|tumor necrosis factor alpha
46136|NCT03281083|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
46137|NCT03281083|Diabetes Mellitus, type 2|diabetes mellitus, type 2
46138|NCT03281083|Thyroid hormone|thyroid hormone
46139|NCT03281083|Levothyroxine|levothyroxine
46140|NCT03281070|Anastomotic leakage|anastomotic leakage
46141|NCT03281070|Anterior resection|anterior resection
46142|NCT03281070|Risk factors|risk factors
46143|NCT03281070|Incidence|incidence
46144|NCT03281070|Rectal Cancer|rectal cancer
46145|NCT03281031|MRI|mri
46146|NCT03281031|Acute abdominal pain|acute abdominal pain
46147|NCT03281031|Pelvic pain|pelvic pain
46148|NCT03281031|Diagnostic performance|diagnostic performance
46149|NCT03281031|Young women|young women
46150|NCT03281018|hypnosis|hypnosis
46151|NCT03281018|preoperative anxiety|preoperative anxiety
46152|NCT03281018|hysterectomy|hysterectomy
46153|NCT03281018|hospitalisation|hospitalisation
46154|NCT03281005|Retinitis pigmentosa|retinitis pigmentosa
46155|NCT03281005|Visual function evaluation|visual function evaluation
47151|NCT03274271|mHealth|mhealth
46156|NCT03280940|Inflammation|inflammation
46157|NCT03280940|Immune activation|immune activation
46158|NCT03280940|Integrase Inhibitors|integrase inhibitors
46159|NCT03280940|Naive patients|naive patients
46160|NCT03280927|Onychomycosis|onychomycosis
46161|NCT03280914|obstructive sleep apnea|obstructive sleep apnea
46162|NCT03280914|real world|real world
46163|NCT03280914|community|community
46164|NCT03280901|renal replacement therapy|renal replacement therapy
46165|NCT03280901|haemodialysis|haemodialysis
46166|NCT03280901|haemodiafiltration|haemodiafiltration
46167|NCT03280862|Heart Failure|heart failure
46168|NCT03280862|Branch Block|branch block
46169|NCT03280862|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
46170|NCT03280849|chitosan|chitosan
46171|NCT03280849|endoscopic|endoscopic
46172|NCT03280849|sellar tumor|sellar tumor
46173|NCT03280849|biomaterials|biomaterials
46174|NCT03280849|transphenoidal|transphenoidal
46175|NCT03280823|complement system|complement system
46176|NCT03280810|Schizophrenia|schizophrenia
46177|NCT03280810|Postural|postural
46178|NCT03280810|Cognitive|cognitive
46179|NCT03280810|task|task
46180|NCT03280758|Resistance training|resistance training
46181|NCT03280758|Diabetes Mellitus|diabetes mellitus
46182|NCT03280758|blood-glucose control|blood-glucose control
46183|NCT03280758|Muscle|muscle
46184|NCT03280758|Function|function
46185|NCT03280732|Lung Ultrasound|lung ultrasound
46186|NCT03280732|Chest X-Ray|chest x-ray
46187|NCT03280732|Pneumonia|pneumonia
46188|NCT03280732|Pneumothorax|pneumothorax
46189|NCT03280732|Pleural effusion|pleural effusion
46190|NCT03280719|Prone position|prone position
46191|NCT03280719|Supine position|supine position
46192|NCT03280719|Hypofractionation|hypofractionation
46193|NCT03280719|Accelerated radiotherapy|accelerated radiotherapy
46194|NCT03280719|Regional nodal irradiation|regional nodal irradiation
46195|NCT03280706|Gastric Emptying|gastric emptying
46196|NCT03280706|labor|labor
46197|NCT03280706|maltodextrin|maltodextrin
46198|NCT03280706|orange juice|orange juice
46199|NCT03280706|coffee|coffee
46200|NCT03280706|ultrasound|ultrasound
46201|NCT03280693|Body mass index,|body mass index,
46202|NCT03280693|Bone density|bone density
46203|NCT03280693|Balance|balance
46204|NCT03280693|Postmenopause|postmenopause
46205|NCT03280680|Violence against young women and girls|violence against young women and girls
46206|NCT03280680|Sexual and reproductive health and rights|sexual and reproductive health and rights
46207|NCT03280680|Consent|consent
46208|NCT03280680|Health services|health services
46209|NCT03280680|Legal services|legal services
46210|NCT03280680|Awareness raising|awareness raising
46211|NCT03280680|Community mobilization|community mobilization
46212|NCT03280654|Obesity|obesity
46213|NCT03280654|Overactive Bladder|overactive bladder
46214|NCT03280654|Urinary incontinence|urinary incontinence
46215|NCT03280654|Visceral Adiposity Index|visceral adiposity index
46216|NCT03280654|Waist Circumference|waist circumference
46217|NCT03280615|Albuminuria|albuminuria
46218|NCT03280615|Carotid Intima-Media Thickness|carotid intima-media thickness
46219|NCT03280615|Pulse Wave Velocity|pulse wave velocity
46220|NCT03280615|Inflammation|inflammation
46221|NCT03280589|Heart Rate Variability|heart rate variability
46222|NCT03280589|EEG|eeg
46223|NCT03280589|Respiration|respiration
46224|NCT03280576|Postoperative|postoperative
46225|NCT03280576|Dysfunction Following Cardiac Surgery|dysfunction following cardiac surgery
46226|NCT03280524|Reflexology,diabetes, quality of life|reflexology,diabetes, quality of life
46227|NCT03280485|TBI|tbi
46228|NCT03280485|management|management
46229|NCT03280485|S100B|s100b
46230|NCT03280485|biomarkers|biomarkers
46231|NCT03280485|mild head injury|mild head injury
46232|NCT03280485|intracranial complication|intracranial complication
46233|NCT03280472|Interpretation Bias|interpretation bias
46234|NCT03280472|Interpretation Modification Program|interpretation modification program
46235|NCT03280433|Epicardial adipose tissue|epicardial adipose tissue
46236|NCT03280433|Coronary artery disease|coronary artery disease
46237|NCT03280433|Atrial fibrillation|atrial fibrillation
46238|NCT03280433|Severe aortic stenosis|severe aortic stenosis
46239|NCT03280433|Proteome|proteome
46240|NCT03280433|Mass spectrometry|mass spectrometry
46241|NCT03280433|Computed tomography|computed tomography
46242|NCT03280420|Acute urinary retention|acute urinary retention
46243|NCT03280420|BPH|bph
46244|NCT03280420|TWOC|twoc
46245|NCT03280420|Tamsulosin|tamsulosin
46246|NCT03280407|Neoadjuvant chemotherapy,|neoadjuvant chemotherapy,
46247|NCT03280407|locally advanced rectal cancer,|locally advanced rectal cancer,
46248|NCT03280407|chemotherapy|chemotherapy
46249|NCT03280407|CAPOX (oxaliplatin/capecitabine)|capox (oxaliplatin/capecitabine)
46250|NCT03280407|FOLFOX (oxaliplatin/leucovorin/5FU)|folfox (oxaliplatin/leucovorin/5fu)
46251|NCT03280394|Liquid biopsy|liquid biopsy
46252|NCT03280394|Classical Hodgkin Lymphoma|classical hodgkin lymphoma
46253|NCT03280394|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
46254|NCT03280394|Follicular Lymphoma|follicular lymphoma
46255|NCT03280394|Mantle Cell Lymphoma|mantle cell lymphoma
46256|NCT03280394|Mutations|mutations
46257|NCT03280381|Nifty Cup|nifty cup
46258|NCT03280381|breastfeeding difficulties|breastfeeding difficulties
46259|NCT03280381|preterm infant|preterm infant
46260|NCT03280381|cup feeding|cup feeding
46261|NCT03280355|COPD|copd
46262|NCT03280355|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
46263|NCT03280355|Randomised controlled trial (RCT)|randomised controlled trial (rct)
46264|NCT03280355|Rehabilitation|rehabilitation
46265|NCT03280355|Singing Training|singing training
46266|NCT03280342|Migraine|migraine
46267|NCT03280342|Headache|headache
46268|NCT03280316|Spinal Vascular Disorder|spinal vascular disorder
46269|NCT03280316|Overactive Bladder|overactive bladder
46270|NCT03280290|Lymphocytes CD4|lymphocytes cd4
46271|NCT03280290|Lymphocytes CCR7|lymphocytes ccr7
46272|NCT03280290|ALLOGRAFT|allograft
46273|NCT03280290|Hematopoietic Stem Cells|hematopoietic stem cells
46274|NCT03280251|Cognitive disorders|cognitive disorders
46275|NCT03280251|cognitive training|cognitive training
46276|NCT03280251|symptomatic treatment|symptomatic treatment
46277|NCT03280251|Methylphenidate|methylphenidate
46278|NCT03280251|elderly|elderly
46279|NCT03280225|Suicide|suicide
46280|NCT03280225|Prevention|prevention
46281|NCT03280225|Implementation|implementation
46282|NCT03280225|Facilitation|facilitation
46283|NCT03280212|Chronic subdural hematoma|chronic subdural hematoma
46284|NCT03280212|Tranexamic acid|tranexamic acid
46285|NCT03280212|TXA|txa
46286|NCT03280186|Spinal Vascular Malformations|spinal vascular malformations
46287|NCT03280186|Bladder|bladder
46288|NCT03280186|Surgical intervention|surgical intervention
46289|NCT03280186|Urodynamics|urodynamics
46290|NCT03280147|Neonate|neonate
46291|NCT03280147|Sepsis|sepsis
46292|NCT03280147|Antibiotics|antibiotics
46293|NCT03280147|Duration|duration
46294|NCT03280134|non-sentinel lymph node|non-sentinel lymph node
46295|NCT03280134|breast cancer|breast cancer
46296|NCT03280134|prediction|prediction
46297|NCT03280134|CK19|ck19
46298|NCT03280134|contrast-enhanced ultrasound|contrast-enhanced ultrasound
46299|NCT03280121|transoral incisionless|transoral incisionless
46300|NCT03280056|MSC|msc
46301|NCT03280056|Autologous|autologous
46302|NCT03280056|Neurotrophic factors|neurotrophic factors
46303|NCT03280043|Breast reduction|breast reduction
46304|NCT03280043|Reduction mammoplasty|reduction mammoplasty
46305|NCT03280043|Hematoma|hematoma
46306|NCT03280043|Hemorrhage|hemorrhage
46307|NCT03280043|Ketorolac|ketorolac
46308|NCT03280043|Toradol|toradol
46309|NCT03280030|midostaurin|midostaurin
46310|NCT03280030|PKC412|pkc412
46311|NCT03280030|cytarabine|cytarabine
46312|NCT03280030|daunorubicin|daunorubicin
46313|NCT03280030|acute myeloid leukemia|acute myeloid leukemia
46314|NCT03280030|combination treatment|combination treatment
46315|NCT03280030|FLT3|flt3
46316|NCT03280030|acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
46317|NCT03280030|acute myelogenous leukemia (AML)|acute myelogenous leukemia (aml)
46318|NCT03280017|anesthesia|anesthesia
46319|NCT03280017|thoracic surgery|thoracic surgery
46320|NCT03280017|thoracic paravertebral block|thoracic paravertebral block
46321|NCT03280017|ketamine|ketamine
46322|NCT03279991|biobank|biobank
46323|NCT03279991|chronic disease|chronic disease
46324|NCT03279991|omics|omics
46325|NCT03279991|big data|big data
46326|NCT03279991|4 P medicine|4 p medicine
46327|NCT03279965|Lung MRI cystic fibrosis primary ciliary dyskinesia|lung mri cystic fibrosis primary ciliary dyskinesia
46328|NCT03279913|Depression, neurofeedback, TMS|depression, neurofeedback, tms
46329|NCT03279874|decision-making|decision-making
46330|NCT03279874|repair behavior|repair behavior
46331|NCT03279874|interviews|interviews
46332|NCT03279796|Adipose-drived mesenchymal stem cells|adipose-drived mesenchymal stem cells
46333|NCT03279796|Rotator cuff injury|rotator cuff injury
46334|NCT03279796|Lateral Epicondylitis|lateral epicondylitis
46335|NCT03279796|Randomized controlled trials|randomized controlled trials
46336|NCT03279770|lnRNA|lnrna
46337|NCT03279770|CV disease|cv disease
46338|NCT03279757|Fractional laser|fractional laser
46339|NCT03279757|Topical anesthesia|topical anesthesia
46340|NCT03279757|Drug delivery|drug delivery
46341|NCT03279757|CO2 laser|co2 laser
46342|NCT03279744|Oral Verrucous Hyperplasia|oral verrucous hyperplasia
46343|NCT03279744|Oral Erythroleukoplakia|oral erythroleukoplakia
46344|NCT03279731|eating disorder, pharmacotherapy|eating disorder, pharmacotherapy
46345|NCT03279705|water exchange|water exchange
46346|NCT03279705|water jet channel colonoscopy|water jet channel colonoscopy
46347|NCT03279705|colonoscopy|colonoscopy
46348|NCT03279705|cecal insertion time|cecal insertion time
46349|NCT03279705|adenoma detection rate|adenoma detection rate
46350|NCT03279692|Meningioma|meningioma
46351|NCT03279679|costoclavicular|costoclavicular
46352|NCT03279679|paracoracoid|paracoracoid
46353|NCT03279679|brachial plexus|brachial plexus
46354|NCT03279640|Motor Network|motor network
46355|NCT03279640|Resting-state fMRI|resting-state fmri
46356|NCT03279640|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
46357|NCT03279640|Transcranial Direct Current Stimulation|transcranial direct current stimulation
46358|NCT03279627|inpatient|inpatient
46359|NCT03279627|hypoglycemia|hypoglycemia
46360|NCT03279627|hyperglycemia|hyperglycemia
46361|NCT03279627|hospital readmission|hospital readmission
46362|NCT03279627|discharge planning|discharge planning
46363|NCT03279614|ORR|orr
46364|NCT03279614|OS|os
46365|NCT03279614|PFS|pfs
46366|NCT03279614|safety|safety
46367|NCT03279601|chemotherapy|chemotherapy
46368|NCT03279601|OS|os
46369|NCT03279601|ORR|orr
46370|NCT03279601|PFS|pfs
46371|NCT03279601|safety|safety
46372|NCT03279588|Ultrasound diagnosis|ultrasound diagnosis
46373|NCT03279588|Abdominal Ultrasound|abdominal ultrasound
46374|NCT03279588|Emergency Department|emergency department
46375|NCT03279523|Dementia|dementia
46376|NCT03279523|HIV|hiv
46377|NCT03279523|Brain Disease|brain disease
46378|NCT03279523|CNS Diseases|cns diseases
46379|NCT03279523|Mild Cognitive Impairment|mild cognitive impairment
46380|NCT03279523|Neurodegenerative Disease|neurodegenerative disease
46381|NCT03279523|Tauopathies|tauopathies
46382|NCT03279510|auditory perception|auditory perception
46383|NCT03279510|hearing|hearing
46384|NCT03279484|safety , electrical performance|safety , electrical performance
46385|NCT03279471|autism spectrum disorder|autism spectrum disorder
46386|NCT03279471|anxiety|anxiety
46387|NCT03279471|cognitive behavior therapy|cognitive behavior therapy
46388|NCT03279471|functional neuroimaging|functional neuroimaging
46389|NCT03279458|Capnography|capnography
46390|NCT03279432|VDR, MEGALIN, haplotypes, obesity, metabolic syndrome|vdr, megalin, haplotypes, obesity, metabolic syndrome
46391|NCT03279406|Atrial fibrillation|atrial fibrillation
46392|NCT03279406|Stroke|stroke
46393|NCT03279406|Thrombus|thrombus
46394|NCT03279406|Left atrial appendage|left atrial appendage
46395|NCT03279406|Bleeding|bleeding
46396|NCT03279393|Post-Traumatic Stress Disorder|post-traumatic stress disorder
46397|NCT03279393|PTSD|ptsd
46398|NCT03279393|trauma|trauma
46399|NCT03279393|stress|stress
46400|NCT03279393|atherosclerosis|atherosclerosis
46401|NCT03279393|macrophage|macrophage
46402|NCT03279393|plaque burden|plaque burden
46403|NCT03279393|vascular inflammation|vascular inflammation
46404|NCT03279393|atherosclerotic inflammation|atherosclerotic inflammation
46405|NCT03279393|PET/MRI|pet/mri
46406|NCT03279393|18F-FDG-PET|18f-fdg-pet
46407|NCT03279380|genetic polymorphism|genetic polymorphism
46408|NCT03279380|sport performance|sport performance
46409|NCT03279380|myokines|myokines
46410|NCT03279354|Health-related quality of life|health-related quality of life
46411|NCT03279354|Physical activity|physical activity
46412|NCT03279354|Smartphone application|smartphone application
46413|NCT03279341|laxatives|laxatives
46414|NCT03279341|constipation|constipation
46415|NCT03279315|Iodine|iodine
46416|NCT03279315|Balance experiment|balance experiment
46417|NCT03279315|EAR|ear
46418|NCT03279315|Chinese women|chinese women
46419|NCT03279315|Euthyroid|euthyroid
46420|NCT03279289|FOLFIRI|folfiri
46421|NCT03279289|aflibercept|aflibercept
46422|NCT03279289|5-FU|5-fu
46423|NCT03279289|oxaliplatin|oxaliplatin
46424|NCT03279289|elderly|elderly
46425|NCT03279289|metastatic colorectal cancer|metastatic colorectal cancer
46426|NCT03279276|Hip arthroplasty|hip arthroplasty
46427|NCT03279250|Diseases of Male Genital Organs|diseases of male genital organs
46428|NCT03279250|Prostate Cancer|prostate cancer
46429|NCT03279250|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
46430|NCT03279250|LHRH Agonist|lhrh agonist
46431|NCT03279250|Apalutamide|apalutamide
46432|NCT03279250|ARN-509|arn-509
46433|NCT03279250|Abiraterone Acetate|abiraterone acetate
46434|NCT03279250|Zytiga|zytiga
46435|NCT03279250|Prednisone|prednisone
46436|NCT03279237|GastroEsophageal Cancer|gastroesophageal cancer
46437|NCT03279224|Bipolar, Depression, FMT, Microbiome|bipolar, depression, fmt, microbiome
46438|NCT03279211|digestibility|digestibility
46439|NCT03279211|whey protein|whey protein
46440|NCT03279211|zein|zein
46441|NCT03279211|bioavailability|bioavailability
46442|NCT03279198|breast cancer screening|breast cancer screening
46443|NCT03279198|colorectal cancer screening|colorectal cancer screening
46444|NCT03279198|cervical cancer screening|cervical cancer screening
46445|NCT03279198|cancer screening beliefs|cancer screening beliefs
46446|NCT03279198|cost-effectiveness|cost-effectiveness
46447|NCT03279198|demographics|demographics
46448|NCT03279198|tailored intervention|tailored intervention
46449|NCT03279185|HIV/AIDS, perinatal HIV infection|hiv/aids, perinatal hiv infection
46450|NCT03279172|videolaryngoscope|videolaryngoscope
46451|NCT03279172|intraocular pressure|intraocular pressure
46452|NCT03279172|Direct laryngoscope|direct laryngoscope
46453|NCT03279120|HIV|hiv
46454|NCT03279120|LNG|lng
46455|NCT03279120|TFV|tfv
46456|NCT03279120|IVR|ivr
46457|NCT03279120|Contraception|contraception
46458|NCT03279120|Prevention|prevention
46459|NCT03279094|Sickle Cell Disease|sickle cell disease
46460|NCT03279094|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
46461|NCT03279094|Haploidentical stem cell transplantation|haploidentical stem cell transplantation
46462|NCT03279094|Post-transplant Cytoxan|post-transplant cytoxan
46463|NCT03279081|Crohn's disease|crohn's disease
46464|NCT03279081|complex perianal fistula(s)|complex perianal fistula(s)
46465|NCT03279068|electronic fetal monitoring|electronic fetal monitoring
46466|NCT03279055|Insomnia|insomnia
46467|NCT03279042|En masse retraction|en masse retraction
46468|NCT03279042|Corticotomy|corticotomy
46469|NCT03279042|Acceleration of tooth movement|acceleration of tooth movement
46470|NCT03279042|Piezocision|piezocision
46471|NCT03279042|Flapless corticotomy|flapless corticotomy
46472|NCT03279042|Class II division 1 malocclusion|class ii division 1 malocclusion
46473|NCT03279042|Protrusion of upper incisors|protrusion of upper incisors
46474|NCT03279042|Sliding mechanics|sliding mechanics
46475|NCT03279042|mini-implant based anchorage|mini-implant based anchorage
46476|NCT03279042|temporary anchorage devices|temporary anchorage devices
46477|NCT03278990|PrEP|prep
46478|NCT03278990|Prevention|prevention
46479|NCT03278990|Value Affirmation|value affirmation
46480|NCT03278990|Future Selves|future selves
46481|NCT03278990|Behavioral Intervention|behavioral intervention
46482|NCT03278977|Apparent Life-Threatening Event|apparent life-threatening event
46483|NCT03278977|ALTE|alte
46484|NCT03278977|Sudden Infant Death|sudden infant death
46485|NCT03278964|Graves Disease|graves disease
46486|NCT03278964|Orbital decompression|orbital decompression
46487|NCT03278964|Graves Orbitopathy|graves orbitopathy
46488|NCT03278964|Exophthalmos|exophthalmos
46489|NCT03278964|Diplopia|diplopia
46490|NCT03278964|Restrictive Strabismus|restrictive strabismus
46491|NCT03278951|Weight loss|weight loss
46492|NCT03278951|video conferencing|video conferencing
46493|NCT03278951|mHealth|mhealth
46494|NCT03278951|Telemedicine|telemedicine
46495|NCT03278951|glycemic control|glycemic control
46496|NCT03278938|depression|depression
46497|NCT03278938|citalopram|citalopram
46498|NCT03278938|bupropion|bupropion
46499|NCT03278938|combination therapy|combination therapy
46500|NCT03278912|Inflammatory Bowel Disease|inflammatory bowel disease
46501|NCT03278912|Chronic Granulomatous Disease|chronic granulomatous disease
46502|NCT03278912|Dysbiosis|dysbiosis
46503|NCT03278912|Microbiome|microbiome
46504|NCT03278912|Immunodeficiency|immunodeficiency
46505|NCT03278899|Adrenoleukodystropy|adrenoleukodystropy
46506|NCT03278899|X-ALD|x-ald
46507|NCT03278899|ALD|ald
46508|NCT03278886|Alcohol Use|alcohol use
46509|NCT03278886|Pain|pain
46510|NCT03278886|HIV|hiv
46511|NCT03278886|Low-dose naltrexone|low-dose naltrexone
46512|NCT03278886|Nalmefene|nalmefene
46513|NCT03278860|Oxytocin|oxytocin
46514|NCT03278860|social touch|social touch
46515|NCT03278847|NNRD|nnrd
46516|NCT03278847|matching|matching
46517|NCT03278847|propensity score|propensity score
46518|NCT03278821|Informed choice|informed choice
46519|NCT03278821|Alcohol use disorder|alcohol use disorder
46520|NCT03278821|Addiction treatment|addiction treatment
46521|NCT03278795|Weaning, ventilatory support, assisted ventilation modes|weaning, ventilatory support, assisted ventilation modes
46522|NCT03278782|Refractory Peripheral T-Cell Lymphoma|refractory peripheral t-cell lymphoma
46523|NCT03278782|Cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
46524|NCT03278782|Pembrolizumab|pembrolizumab
46525|NCT03278782|Keytruda|keytruda
46526|NCT03278782|MK-3475|mk-3475
46527|NCT03278782|SCH-900475|sch-900475
46528|NCT03278782|Romidepsin|romidepsin
46529|NCT03278782|Istodax|istodax
46530|NCT03278782|Depsipeptide|depsipeptide
46531|NCT03278782|FK228|fk228
46532|NCT03278756|Depression|depression
46533|NCT03278756|Remission|remission
46534|NCT03278756|Relapse prevention|relapse prevention
46535|NCT03278756|Cognitive control training|cognitive control training
46536|NCT03278756|Internet intervention|internet intervention
46537|NCT03278743|tea|tea
46538|NCT03278743|cognition|cognition
46539|NCT03278743|very old|very old
46540|NCT03278743|Newcastle 85+|newcastle 85+
46541|NCT03278743|epidemiology|epidemiology
46542|NCT03278730|sepsis|sepsis
46543|NCT03278730|para-Tyrosine|para-tyrosine
46544|NCT03278730|ortho-Tyrosine|ortho-tyrosine
46545|NCT03278730|meta-Tyrosine|meta-tyrosine
46546|NCT03278704|Concurrent training|concurrent training
46547|NCT03278704|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
46548|NCT03278704|Resistance exercise|resistance exercise
46549|NCT03278704|High-Intensity Interval Training (HIIT)|high-intensity interval training (hiit)
46550|NCT03278704|Muscle hypertrophy|muscle hypertrophy
46551|NCT03278704|Interference effect|interference effect
46552|NCT03278678|Nutritional screening MNA-SF malnutrition Case Management|nutritional screening mna-sf malnutrition case management
46553|NCT03278665|Cutaneous melanoma|cutaneous melanoma
46554|NCT03278639|gait disorders|gait disorders
46555|NCT03278639|balance disorders|balance disorders
46556|NCT03278639|music|music
46557|NCT03278639|tango|tango
46558|NCT03278639|rhythmic auditory stimulation|rhythmic auditory stimulation
46559|NCT03278639|health-related quality of life|health-related quality of life
46560|NCT03278626|Locally Advanced Esophageal Squamous Cell Carcinoma|locally advanced esophageal squamous cell carcinoma
46561|NCT03278561|asthma|asthma
46562|NCT03278561|age of onset|age of onset
46563|NCT03278561|inflammation|inflammation
46564|NCT03278561|comorbidity|comorbidity
46565|NCT03278561|microbiome|microbiome
46566|NCT03278548|HES|hes
46567|NCT03278548|Hydroxyethylstarch|hydroxyethylstarch
46568|NCT03278522|ramosetron|ramosetron
46569|NCT03278496|addiction|addiction
46570|NCT03278496|substance abuse treatment|substance abuse treatment
46571|NCT03278496|aftercare|aftercare
46572|NCT03278496|outpatient counseling|outpatient counseling
46573|NCT03278496|opiates|opiates
46574|NCT03278496|cocaine|cocaine
46575|NCT03278483|Latent tuberculosis, ,|latent tuberculosis, ,
46576|NCT03278483|isoniazid, rifampin,|isoniazid, rifampin,
46577|NCT03278483|rifampin,|rifampin,
46578|NCT03278483|adverse,|adverse,
46579|NCT03278483|diabetes mellitus|diabetes mellitus
46580|NCT03278457|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
46581|NCT03278457|implantable cardioverter defibrillator|implantable cardioverter defibrillator
46582|NCT03278457|positron emission tomography|positron emission tomography
46583|NCT03278392|pregnancy|pregnancy
46584|NCT03278392|metabolism|metabolism
46585|NCT03278392|stress|stress
46586|NCT03278392|emotional state|emotional state
46587|NCT03278392|diet|diet
46588|NCT03278392|glycemic response|glycemic response
46589|NCT03278353|Expectation|expectation
46590|NCT03278353|Conservative Intervention|conservative intervention
46591|NCT03278340|Skin Cancer|skin cancer
46592|NCT03278340|Prevention|prevention
46593|NCT03278340|Policy|policy
46594|NCT03278340|Worksite|worksite
46595|NCT03278340|Scale-up|scale-up
46596|NCT03278340|Cost and Effectiveness|cost and effectiveness
46597|NCT03278275|urokinase plasminogen activator receptor|urokinase plasminogen activator receptor
46598|NCT03278275|uPAR PET/CT|upar pet/ct
46599|NCT03278275|positron emission tomography|positron emission tomography
46600|NCT03278275|neuroendocrine tumors|neuroendocrine tumors
46601|NCT03278249|brain tumor|brain tumor
46602|NCT03278223|Multipurpose Contact Lens Care System|multipurpose contact lens care system
46603|NCT03278210|EEG-fMRI|eeg-fmri
46604|NCT03278210|brain imaging|brain imaging
46605|NCT03278210|presurgical evaluation|presurgical evaluation
46606|NCT03278210|epilepsy surgery|epilepsy surgery
46607|NCT03278158|safety|safety
46608|NCT03278158|tolerability|tolerability
46609|NCT03278132|Inactivated Enterovirus Type 71 (EV71) Vaccine|inactivated enterovirus type 71 (ev71) vaccine
46610|NCT03278132|Safety|safety
46611|NCT03278132|Immunogenicity|immunogenicity
46612|NCT03278132|Infant|infant
46613|NCT03278093|Physiotherapy|physiotherapy
46614|NCT03278093|Physical therapy|physical therapy
46615|NCT03278093|Balance|balance
46616|NCT03278093|Posturography|posturography
46617|NCT03278067|England|england
46618|NCT03278067|Adverse Event of Interest|adverse event of interest
46619|NCT03278067|Seasonal influenza vaccines|seasonal influenza vaccines
46620|NCT03278067|Pilot study|pilot study
46621|NCT03278067|Prospective passive enhanced safety surveillance|prospective passive enhanced safety surveillance
46622|NCT03278054|apical periodontitis|apical periodontitis
46623|NCT03278054|hybrid|hybrid
46624|NCT03278054|ProTaper|protaper
46625|NCT03278054|rotary|rotary
46626|NCT03278015|S-1|s-1
46627|NCT03278015|nab-paclitaxel|nab-paclitaxel
46628|NCT03277976|atrial fibrillation;|atrial fibrillation;
46629|NCT03277976|catheter ablation;|catheter ablation;
46630|NCT03277976|pulmonary vein isolation|pulmonary vein isolation
46631|NCT03277976|ablation index|ablation index
46632|NCT03277963|Obesity|obesity
46633|NCT03277963|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
46634|NCT03277950|virtual reality|virtual reality
46635|NCT03277950|feedback|feedback
46636|NCT03277937|gastric varices|gastric varices
46637|NCT03277937|endoscopic ultrasound|endoscopic ultrasound
46638|NCT03277937|coils|coils
46639|NCT03277937|cyanoacrylate|cyanoacrylate
46640|NCT03277898|Breast Neoplasms|breast neoplasms
46641|NCT03277898|"Exercis* OR Aerobic Exercise"|"exercis* or aerobic exercise"
46642|NCT03277898|Cognitive Function*|cognitive function*
46643|NCT03277898|"Antineoplastic therapy OR Antineoplastic agent"|"antineoplastic therapy or antineoplastic agent"
46644|NCT03277898|Chemotherapy, Adjuvant|chemotherapy, adjuvant
46645|NCT03277885|Work related chronic pain|work related chronic pain
46646|NCT03277885|Preventive care|preventive care
46647|NCT03277859|Yoga|yoga
46648|NCT03277859|Veterans|veterans
46649|NCT03277859|Traumatic Brain Injury|traumatic brain injury
46650|NCT03277859|Post-concussive Headaches|post-concussive headaches
46651|NCT03277859|Post-concussive Symptoms|post-concussive symptoms
46652|NCT03277768|Premature infant|premature infant
46653|NCT03277768|Tissue Oxygenation|tissue oxygenation
46654|NCT03277768|Patent Ductus Arteriosus|patent ductus arteriosus
46655|NCT03277716|Huge hepatocellular carcinoma|huge hepatocellular carcinoma
46656|NCT03277716|Microwave ablation|microwave ablation
46657|NCT03277716|TACE|tace
46658|NCT03277716|Safety|safety
46659|NCT03277716|Non-resectable|non-resectable
46660|NCT03277716|Treatment|treatment
46661|NCT03277703|Influenza vaccine|influenza vaccine
46662|NCT03277703|Booster dose|booster dose
46663|NCT03277703|immunocompromised|immunocompromised
46664|NCT03277703|Biologic therapy|biologic therapy
46665|NCT03277703|Rheumatologic disease|rheumatologic disease
46666|NCT03277703|inflammatory bowel disease|inflammatory bowel disease
46667|NCT03277690|Cushing Syndrome, Adrenocortical Hyperfunction|cushing syndrome, adrenocortical hyperfunction
46668|NCT03277664|pediatric|pediatric
46669|NCT03277664|asthma adherence|asthma adherence
46670|NCT03277664|electronic device|electronic device
46671|NCT03277651|noninvasive|noninvasive
46672|NCT03277651|Hemodynamics|hemodynamics
46673|NCT03277638|recurrent glioblastoma|recurrent glioblastoma
46674|NCT03277638|brain cancer|brain cancer
46675|NCT03277625|pancreaticoduodenectomy|pancreaticoduodenectomy
46676|NCT03277573|Salsalate|salsalate
46677|NCT03277560|Major Trauma Centre|major trauma centre
46678|NCT03277560|ISS|iss
46679|NCT03277560|Outcome Measures|outcome measures
46680|NCT03277534|electrical stimulation|electrical stimulation
46681|NCT03277508|Brain-computer integration|brain-computer integration
46682|NCT03277482|Recurrent gynecological cancer|recurrent gynecological cancer
46683|NCT03277482|Metastatic Cervical Cancer|metastatic cervical cancer
46684|NCT03277482|Metastatic Ovarian Cancer|metastatic ovarian cancer
46685|NCT03277482|Metastatic Vaginal Cancer|metastatic vaginal cancer
46686|NCT03277482|Metastatic Vulvar Cancer|metastatic vulvar cancer
46687|NCT03277482|Metastatic Endometrial Cancer|metastatic endometrial cancer
46688|NCT03277482|Recurrent Cervical Carcinoma|recurrent cervical carcinoma
46689|NCT03277482|Recurrent Ovarian Carcinoma|recurrent ovarian carcinoma
46690|NCT03277482|Recurrent Vaginal Cancer|recurrent vaginal cancer
46691|NCT03277482|Recurrent Vulvar Cancer|recurrent vulvar cancer
46692|NCT03277482|Recurrent Endometrial Cancer|recurrent endometrial cancer
46693|NCT03277469|Gynecologic Cancer|gynecologic cancer
46694|NCT03277443|Skeletal open bite|skeletal open bite
46695|NCT03277430|uterus transplantation, absolute uterine factor infertility|uterus transplantation, absolute uterine factor infertility
46696|NCT03277404|EDTA|edta
46697|NCT03277404|Postoperative pain|postoperative pain
46698|NCT03277404|Pulp necrosis|pulp necrosis
46699|NCT03277404|Smear layer|smear layer
46700|NCT03277352|cervical cancer|cervical cancer
46701|NCT03277352|endometrial cancer|endometrial cancer
46702|NCT03277352|gastric cancer (including stomach and gastroesophageal junction (GEJ))|gastric cancer (including stomach and gastroesophageal junction (gej))
46703|NCT03277352|esophageal cancer|esophageal cancer
46704|NCT03277352|hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
46705|NCT03277352|melanoma (mucosal or cutaneous)|melanoma (mucosal or cutaneous)
46706|NCT03277352|Merkel cell carcinoma|merkel cell carcinoma
46707|NCT03277352|mesothelioma|mesothelioma
46708|NCT03277352|microsatellite instability-high (MSI-H)|microsatellite instability-high (msi-h)
46709|NCT03277352|solid tumors|solid tumors
46710|NCT03277352|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
46711|NCT03277352|ovarian cancer|ovarian cancer
46712|NCT03277352|squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
46713|NCT03277352|small cell lung cancer (SCLC)|small cell lung cancer (sclc)
46714|NCT03277352|renal cell carcinoma (RCC)|renal cell carcinoma (rcc)
46715|NCT03277352|triple-negative breast cancer (TNBC)|triple-negative breast cancer (tnbc)
46716|NCT03277352|urothelial carcinoma|urothelial carcinoma
46717|NCT03277352|glucocorticoid-induced tumor necrosis factor receptor (GITR)|glucocorticoid-induced tumor necrosis factor receptor (gitr)
46718|NCT03277339|Generalized anxious disorders|generalized anxious disorders
46719|NCT03277339|Thermal cure|thermal cure
46720|NCT03277339|paroxetine|paroxetine
46721|NCT03277274|Drug therapy|drug therapy
46722|NCT03277235|fatigue|fatigue
46723|NCT03277235|colon cancer|colon cancer
46724|NCT03277235|quality of life|quality of life
46725|NCT03277222|Neurocognitive impairment|neurocognitive impairment
46726|NCT03277222|HIV-1|hiv-1
46727|NCT03277222|Intranasal insulin|intranasal insulin
46728|NCT03277222|Neurocognitive Disorder|neurocognitive disorder
46729|NCT03277222|Cognition|cognition
46730|NCT03277222|Memory|memory
46731|NCT03277183|erythropoietin|erythropoietin
46732|NCT03277170|acute asthma exacerbation|acute asthma exacerbation
46733|NCT03277170|pediatric asthma|pediatric asthma
46734|NCT03277170|leukotriene receptor antagonist|leukotriene receptor antagonist
46735|NCT03277170|montelukast|montelukast
46736|NCT03277144|linear stapler|linear stapler
46737|NCT03277092|Child, blood drawing procedure, near Infrared light|child, blood drawing procedure, near infrared light
46738|NCT03277079|coronary artery disease|coronary artery disease
46739|NCT03277079|LDL cholesterol|ldl cholesterol
46740|NCT03277079|therapeutic target|therapeutic target
46741|NCT03277053|colorectal|colorectal
46742|NCT03277053|laparoscopic|laparoscopic
46743|NCT03277053|application|application
46744|NCT03277053|ERP|erp
46745|NCT03277053|adherence|adherence
46746|NCT03277053|mobile|mobile
46747|NCT03277027|cerebral palsy|cerebral palsy
46748|NCT03277027|Health-Related Quality Of Life|health-related quality of life
46749|NCT03277027|Physical Activity|physical activity
46750|NCT03277014|Nutritional monitoring|nutritional monitoring
46751|NCT03277014|insulin-like growth factor-1|insulin-like growth factor-1
46752|NCT03277001|AECOPD|aecopd
46753|NCT03277001|VTE prevention|vte prevention
46754|NCT03277001|Rivaroxaban|rivaroxaban
46755|NCT03277001|LMWHs|lmwhs
46756|NCT03276988|Thyroid cancer|thyroid cancer
46757|NCT03276988|Thyroidectomy|thyroidectomy
46758|NCT03276988|rhTSH|rhtsh
46759|NCT03276988|GX-30|gx-30
46760|NCT03276975|CT fluoroscopy|ct fluoroscopy
46761|NCT03276975|epidural patching|epidural patching
46762|NCT03276975|spontaneous intracranial hypotension|spontaneous intracranial hypotension
46763|NCT03276962|falciparum, efficacy|falciparum, efficacy
46764|NCT03276962|RTS,S/AS01|rts,s/as01
46765|NCT03276962|malaria vaccine|malaria vaccine
46766|NCT03276962|safety|safety
46767|NCT03276962|Malaria|malaria
46768|NCT03276962|immunogenicity|immunogenicity
46769|NCT03276962|infants|infants
46770|NCT03276949|Blood glucose|blood glucose
46771|NCT03276949|non-invasive|non-invasive
46772|NCT03276949|Raman spectroscopy|raman spectroscopy
46773|NCT03276910|antidoping|antidoping
46774|NCT03276871|Balloon dissection|balloon dissection
46775|NCT03276871|Telescopic dissection|telescopic dissection
46776|NCT03276871|Inguinal hernia|inguinal hernia
46777|NCT03276871|TEP|tep
46778|NCT03276845|Ultrasound|ultrasound
46779|NCT03276845|Elastography|elastography
46780|NCT03276845|Doppler Ultrasound|doppler ultrasound
46781|NCT03276845|Contrast enhanced Ultrasound|contrast enhanced ultrasound
46782|NCT03276845|Three-dimensional Ultrasound|three-dimensional ultrasound
46783|NCT03276819|Oral potentially malignant lesions (OPML)|oral potentially malignant lesions (opml)
46784|NCT03276819|Head and neck squamous cell carcinoma (HNSCC)|head and neck squamous cell carcinoma (hnscc)
46785|NCT03276819|Biomarkers|biomarkers
46786|NCT03276819|Smoking cessation program|smoking cessation program
46787|NCT03276819|Loss of heterozigoty (LOH)|loss of heterozigoty (loh)
46788|NCT03276819|Medico-economics|medico-economics
46789|NCT03276819|Sociology|sociology
46790|NCT03276819|Psychology|psychology
46791|NCT03276806|CT low dose|ct low dose
46792|NCT03276806|nurse led intervention|nurse led intervention
46793|NCT03276806|safety net hospital|safety net hospital
46794|NCT03276806|lung cancer screening with CTLD|lung cancer screening with ctld
46795|NCT03276767|online intervention|online intervention
46796|NCT03276767|e-Health|e-health
46797|NCT03276767|reminder|reminder
46798|NCT03276767|SMS-textmessage|sms-textmessage
46799|NCT03276767|e-mail|e-mail
46800|NCT03276767|mobile phone|mobile phone
46801|NCT03276767|cell phone|cell phone
46802|NCT03276754|Pneumococcal infections|pneumococcal infections
46803|NCT03276754|COPD exacerbations|copd exacerbations
46804|NCT03276741|labor|labor
46805|NCT03276741|anesthesia|anesthesia
46806|NCT03276741|oral intake|oral intake
46807|NCT03276741|maternal satisfaction|maternal satisfaction
46808|NCT03276741|newborn complications|newborn complications
46809|NCT03276728|Heart Failure|heart failure
46810|NCT03276728|Cardiovascular Diseases|cardiovascular diseases
46811|NCT03276728|Heart Diseases|heart diseases
46812|NCT03276728|Ejection fraction|ejection fraction
47316|NCT03273062|Cognition|cognition
46813|NCT03276728|Heart Failure with reduced ejection fraction|heart failure with reduced ejection fraction
46814|NCT03276728|Heart Failure with preserved ejection fraction|heart failure with preserved ejection fraction
46815|NCT03276715|malignant pleural effusion|malignant pleural effusion
46816|NCT03276715|lung cancer|lung cancer
46817|NCT03276637|Genome Sequencing|genome sequencing
46818|NCT03276637|Exome Sequencing|exome sequencing
46819|NCT03276637|Military|military
46820|NCT03276637|Air Force|air force
46821|NCT03276611|Assessment|assessment
46822|NCT03276611|pulmonary|pulmonary
46824|NCT03276611|right|right
46825|NCT03276611|sided|sided
46826|NCT03276611|hemodynamics|hemodynamics
46827|NCT03276611|patients|patients
46828|NCT03276611|sleep|sleep
46829|NCT03276611|apnea|apnea
46830|NCT03276611|syndrome|syndrome
46831|NCT03276611|contionous|contionous
46832|NCT03276611|positive|positive
46833|NCT03276611|air|air
46834|NCT03276611|way|way
46835|NCT03276611|pressure|pressure
46836|NCT03276611|treatment|treatment
46837|NCT03276585|home sleep monitor|home sleep monitor
46838|NCT03276585|Sleep Apnea Syndromes|sleep apnea syndromes
46839|NCT03276585|questionnaire|questionnaire
46840|NCT03276559|critically ill|critically ill
46841|NCT03276559|ICU|icu
46842|NCT03276559|uncommunicative|uncommunicative
46843|NCT03276559|caregivers|caregivers
46844|NCT03276533|dexmedetomidine; lidocaine; cytokine|dexmedetomidine; lidocaine; cytokine
46845|NCT03276520|ethyl glucuronide, biomarker, diagnostic randomized trial|ethyl glucuronide, biomarker, diagnostic randomized trial
46846|NCT03276481|melphalan|melphalan
46847|NCT03276481|stem cell transplantation|stem cell transplantation
46848|NCT03276481|17-404|17-404
46849|NCT03276481|hematopoietic cell transplantation|hematopoietic cell transplantation
46850|NCT03276481|HCT|hct
46851|NCT03276468|venetoclax; obinutuzumab; atezolizumab; lymphoma|venetoclax; obinutuzumab; atezolizumab; lymphoma
46852|NCT03276455|Beta thalassemia|beta thalassemia
46853|NCT03276455|Gene therapy|gene therapy
46854|NCT03276455|Beta-globin|beta-globin
46855|NCT03276455|Hematopoietic stem cells|hematopoietic stem cells
46856|NCT03276455|Lentiviral vector|lentiviral vector
46857|NCT03276429|NSCLC|nsclc
46858|NCT03276429|SCLC|sclc
46859|NCT03276429|MOLECULAR BIOMARKERS|molecular biomarkers
46860|NCT03276390|health disparities|health disparities
46861|NCT03276390|living donation|living donation
46862|NCT03276312|Lipogems|lipogems
46863|NCT03276312|ASCs|ascs
46864|NCT03276312|Lipofilling|lipofilling
46865|NCT03276312|diabetic foot|diabetic foot
46866|NCT03276208|Pregnancy|pregnancy
46867|NCT03276208|Tobacco|tobacco
46868|NCT03276208|Massage Therapy|massage therapy
46869|NCT03276208|Mindfulness|mindfulness
46870|NCT03276195|Neurodevelopmental Disorder|neurodevelopmental disorder
46871|NCT03276195|Genomics|genomics
46872|NCT03276195|Genetics|genetics
46873|NCT03276169|atrial fibrillation|atrial fibrillation
46874|NCT03276169|left atrial appendage closure|left atrial appendage closure
46875|NCT03276169|left atrial function|left atrial function
46876|NCT03276130|Blood coagulation disorder|blood coagulation disorder
46877|NCT03276130|Haematologic diseases|haematologic diseases
46878|NCT03276130|Coagulation protein disorder|coagulation protein disorder
46879|NCT03276130|Hemorrhagic disorder|hemorrhagic disorder
46880|NCT03276130|Genetic diseases, inborn|genetic diseases, inborn
46881|NCT03276130|Pain|pain
46882|NCT03276130|Anxiety|anxiety
46883|NCT03276130|Pain medication|pain medication
46884|NCT03276130|Anxiety medication|anxiety medication
46885|NCT03276117|pregnancy.obstructed labour|pregnancy.obstructed labour
46886|NCT03276104|IOL dislocation|iol dislocation
46887|NCT03276104|Cataract|cataract
46888|NCT03276104|Cataract surgery|cataract surgery
46889|NCT03276104|Scleral suturing|scleral suturing
46890|NCT03276104|Verisyse|verisyse
46891|NCT03276104|Iris-claw|iris-claw
46892|NCT03276104|Late in-the-bag IOL dislocation|late in-the-bag iol dislocation
46893|NCT03276091|colonoscopy|colonoscopy
46894|NCT03276091|immunochemical fecal test|immunochemical fecal test
46895|NCT03276091|screening|screening
46896|NCT03276078|COPD|copd
46897|NCT03276052|COPD, Pharmacokinetics|copd, pharmacokinetics
46898|NCT03276026|sugammadex|sugammadex
46899|NCT03276026|post anesthesia care unit recovery|post anesthesia care unit recovery
46900|NCT03276013|Oncology|oncology
46901|NCT03276013|Endometrial Cancer|endometrial cancer
46902|NCT03276013|Pembrolizumab|pembrolizumab
46903|NCT03276013|Doxorubicin|doxorubicin
46904|NCT03276013|Metastatic Endometrial Cancer|metastatic endometrial cancer
46905|NCT03276000|Misoprostol ,office hysteroscopy|misoprostol ,office hysteroscopy
46906|NCT03275987|cancer screening|cancer screening
46907|NCT03275935|ACOS|acos
46908|NCT03275935|Asthma|asthma
46909|NCT03275935|COPD|copd
46910|NCT03275935|inhalation technique|inhalation technique
46911|NCT03275922|Migraine|migraine
46912|NCT03275922|Headache|headache
46913|NCT03275922|Pain|pain
46914|NCT03275922|Efficacy|efficacy
46915|NCT03275922|Pediatric|pediatric
46916|NCT03275909|Chronic schizophrenia|chronic schizophrenia
46917|NCT03275909|Emotional Management Therapy|emotional management therapy
46918|NCT03275909|Integrated Psychological Therapy|integrated psychological therapy
46919|NCT03275844|Physical activity|physical activity
46920|NCT03275844|Physical capacity|physical capacity
46921|NCT03275844|Children|children
46922|NCT03275818|sarcoma|sarcoma
46923|NCT03275818|Desmoid tumor|desmoid tumor
46924|NCT03275818|Desmoplastic small round cell tumor|desmoplastic small round cell tumor
46925|NCT03275818|Ewing sarcoma|ewing sarcoma
46926|NCT03275818|relapsed|relapsed
46927|NCT03275818|refractory|refractory
46928|NCT03275805|Residual dysplasia|residual dysplasia
46929|NCT03275805|Pavlik Harness|pavlik harness
46930|NCT03275792|Shiga-Toxigenic Escherichia coli|shiga-toxigenic escherichia coli
46931|NCT03275792|Child|child
46932|NCT03275753|Visual function|visual function
46933|NCT03275753|Critical flicker fusion|critical flicker fusion
46934|NCT03275753|Dark adaptation|dark adaptation
46935|NCT03275753|Reading test|reading test
46936|NCT03275727|Breast Cancer|breast cancer
46937|NCT03275727|Survivors|survivors
46938|NCT03275727|Internet intervention|internet intervention
46939|NCT03275727|Psychosocial intervention|psychosocial intervention
46940|NCT03275727|Acceptance and Commitment Therapy (ACT)|acceptance and commitment therapy (act)
46941|NCT03275727|Randomized controlled trial|randomized controlled trial
46942|NCT03275688|lung cancer|lung cancer
46943|NCT03275688|volatile organic compound|volatile organic compound
46944|NCT03275688|screening|screening
46946|NCT03275688|clinical trial|clinical trial
46947|NCT03275675|Cancer|cancer
46948|NCT03275675|Oral chemotherapy|oral chemotherapy
46949|NCT03275675|Community Pharmacy|community pharmacy
46950|NCT03275675|Satisfaction|satisfaction
46951|NCT03275636|Haploidentical|haploidentical
46952|NCT03275636|mismatched unrelated donor|mismatched unrelated donor
46953|NCT03275636|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
46954|NCT03275636|donor comparison|donor comparison
46955|NCT03275584|positron emission tomography|positron emission tomography
46956|NCT03275584|NH3|nh3
46957|NCT03275571|Cognition|cognition
46958|NCT03275571|Intervention|intervention
46959|NCT03275571|Therapy|therapy
46960|NCT03275558|Nasal Spray|nasal spray
46961|NCT03275558|Gliosarcoma|gliosarcoma
46962|NCT03275558|Glioblastoma|glioblastoma
46963|NCT03275558|Gliomas|gliomas
46964|NCT03275519|distal hypospadias repair|distal hypospadias repair
46965|NCT03275519|urinary tract infection|urinary tract infection
46966|NCT03275519|prophylactic antibiotic use|prophylactic antibiotic use
46967|NCT03275506|neoadjuvant|neoadjuvant
46968|NCT03275506|debulking surgery|debulking surgery
46969|NCT03275493|CD19+ ,CAR-T, CRS|cd19+ ,car-t, crs
46970|NCT03275454|Autoimmune Diseases|autoimmune diseases
46971|NCT03275454|Hematologic Diseases|hematologic diseases
46972|NCT03275454|Immune System Diseases|immune system diseases
46973|NCT03275454|Blood Platelet Disorders|blood platelet disorders
46974|NCT03275441|electroretinogram|electroretinogram
46975|NCT03275441|ERG|erg
46976|NCT03275441|dark-adaptation|dark-adaptation
46977|NCT03275441|ophthalmology|ophthalmology
46978|NCT03275441|electrophysiology|electrophysiology
46979|NCT03275441|ISCEV|iscev
46980|NCT03275441|electroretinography|electroretinography
46981|NCT03275441|scotopic|scotopic
46982|NCT03275428|THRIVE|thrive
46983|NCT03275428|Non-intubated thoracic surgery|non-intubated thoracic surgery
46984|NCT03275415|BPD|bpd
46985|NCT03275415|surfactant|surfactant
46986|NCT03275415|budesonide|budesonide
46987|NCT03275415|respiratory distress syndrome|respiratory distress syndrome
46988|NCT03275402|Radioimmunotherapy|radioimmunotherapy
46989|NCT03275402|Neuroblastoma|neuroblastoma
46990|NCT03275402|CNS Metastases|cns metastases
46991|NCT03275402|Leptomeningeal Metastases|leptomeningeal metastases
46992|NCT03275402|Pediatric|pediatric
46993|NCT03275389|Safety|safety
46994|NCT03275389|Healthy adults|healthy adults
46995|NCT03275389|Immunogenicity|immunogenicity
46996|NCT03275389|Supra-seasonal universal influenza vaccines - inactivated (SUIVs)|supra-seasonal universal influenza vaccines - inactivated (suivs)
46997|NCT03275363|Subjective cognitive decline|subjective cognitive decline
46998|NCT03275363|Mild Cognitive Impairment|mild cognitive impairment
46999|NCT03275363|Dementia|dementia
47000|NCT03275363|Cerebral aging|cerebral aging
47001|NCT03275337|Social Phobia|social phobia
47002|NCT03275337|Anxiety|anxiety
47003|NCT03275337|Cerebellum|cerebellum
47004|NCT03275337|rTMS|rtms
47005|NCT03275337|Neuromodulation|neuromodulation
47006|NCT03275337|Fear Extinction|fear extinction
47007|NCT03275311|metastatic breast cancer|metastatic breast cancer
47008|NCT03275311|observational study|observational study
47009|NCT03275311|survival|survival
47010|NCT03275311|real world data|real world data
47011|NCT03275311|real life setting|real life setting
47012|NCT03275298|ovarian cancer|ovarian cancer
47013|NCT03275298|observational study|observational study
47014|NCT03275298|survival|survival
47015|NCT03275298|real world data|real world data
47016|NCT03275298|real life setting|real life setting
47017|NCT03275259|Shock wave|shock wave
47018|NCT03275259|Gynoid lipodystrophy|gynoid lipodystrophy
47019|NCT03275259|Cellulits|cellulits
47020|NCT03275246|Primary total knee replacement|primary total knee replacement
47021|NCT03275207|Chronic pain|chronic pain
47022|NCT03275207|CPSP|cpsp
47023|NCT03275207|Dexmedetomidine|dexmedetomidine
47024|NCT03275207|Surgery|surgery
47025|NCT03275155|Autonomic Dysfunction|autonomic dysfunction
47026|NCT03275155|Inflammation|inflammation
47027|NCT03275155|Cognitive impairment|cognitive impairment
47028|NCT03275155|Interoception|interoception
47029|NCT03275155|Gait impairment|gait impairment
47030|NCT03275129|ultrasound assessment|ultrasound assessment
47031|NCT03275116|Bronchodilation|bronchodilation
47032|NCT03275116|Hyperinflation|hyperinflation
47033|NCT03275116|Physical activity|physical activity
47034|NCT03275116|Sleep quality|sleep quality
47035|NCT03275090|lipid emulsions; preterm; sepsis|lipid emulsions; preterm; sepsis
47036|NCT03275077|End stage renal disease|end stage renal disease
47037|NCT03275077|ESRD|esrd
47038|NCT03275077|Thromboelastography|thromboelastography
47039|NCT03275077|Fibrinogen|fibrinogen
47040|NCT03275064|Articular cartilage, partial thickness cartilage lesion, knee, cartilage|articular cartilage, partial thickness cartilage lesion, knee, cartilage
47041|NCT03275064|regeneration|regeneration
47042|NCT03275051|Beta Thalassaemia|beta thalassaemia
47043|NCT03275051|GSK2696277|gsk2696277
47044|NCT03275051|Lentiviral vector|lentiviral vector
47045|NCT03275051|TIGET-BTHAL|tiget-bthal
47046|NCT03275051|Gene therapy|gene therapy
47047|NCT03275038|Neuroimage|neuroimage
47048|NCT03275038|Training|training
47049|NCT03275038|Aging|aging
47050|NCT03275038|Brain|brain
47051|NCT03275038|Cardiovascular risks|cardiovascular risks
47052|NCT03274960|asymptomati bacteriuria, Griess nitrite test, preterm birth|asymptomati bacteriuria, griess nitrite test, preterm birth
47053|NCT03274947|Oropharyngeal Dysphagia|oropharyngeal dysphagia
47054|NCT03274947|Stroke|stroke
47055|NCT03274934|Adolescents|adolescents
47056|NCT03274934|Web- and mobile-based intervention|web- and mobile-based intervention
47057|NCT03274934|Acceptance and Commitment therapy|acceptance and commitment therapy
47058|NCT03274934|Psychological well-being|psychological well-being
47059|NCT03274934|Career preparation|career preparation
47060|NCT03274934|Lifecontrol|lifecontrol
47061|NCT03274934|Successful educational transitions|successful educational transitions
47062|NCT03274934|Learning difficulties|learning difficulties
47063|NCT03274934|Psychological flexibility and mindfulness skills|psychological flexibility and mindfulness skills
47064|NCT03274921|cardiovascular complications|cardiovascular complications
47065|NCT03274921|biomarkers|biomarkers
47066|NCT03274882|metastatic|metastatic
47067|NCT03274882|colorectal|colorectal
47068|NCT03274882|cancer|cancer
47069|NCT03274882|Lonsurf|lonsurf
47070|NCT03274882|S95005|s95005
47071|NCT03274882|Russia|russia
47072|NCT03274869|Scrub typhus|scrub typhus
47073|NCT03274869|Cardiovascular Complication|cardiovascular complication
47074|NCT03274830|primary osteoarthritis|primary osteoarthritis
47075|NCT03274830|secondary osteoarthritis|secondary osteoarthritis
47076|NCT03274830|femoral head fracture|femoral head fracture
47077|NCT03274830|necrosis|necrosis
47078|NCT03274817|Alzheimer's Disease|alzheimer's disease
47079|NCT03274817|Depression|depression
47080|NCT03274817|Escitalopram|escitalopram
47081|NCT03274817|Venlafaxine|venlafaxine
47082|NCT03274791|COPD|copd
47083|NCT03274791|smoking|smoking
47084|NCT03274791|induced sputum|induced sputum
47085|NCT03274791|clinical features|clinical features
47086|NCT03274765|ovarian stimulation|ovarian stimulation
47087|NCT03274765|blood test|blood test
47088|NCT03274765|Medically Assisted Procreation|medically assisted procreation
47089|NCT03274752|Paroxetine|paroxetine
47090|NCT03274674|PRF|prf
47091|NCT03274674|I-PRF|i-prf
47092|NCT03274674|Microneedle|microneedle
47093|NCT03274674|Gingival Thickness|gingival thickness
47094|NCT03274674|Injectable-Platelet-Rich-Fibrin|injectable-platelet-rich-fibrin
47095|NCT03274674|Platelet Rich Fibrin|platelet rich fibrin
47096|NCT03274661|solid tumor, Pembrolizumab,|solid tumor, pembrolizumab,
47097|NCT03274609|Lung diseases|lung diseases
47098|NCT03274609|cancer|cancer
47099|NCT03274609|Interventional pulmonology|interventional pulmonology
47100|NCT03274609|peripheral nodule|peripheral nodule
47101|NCT03274596|Oxidative Damage|oxidative damage
47102|NCT03274596|Vitamin E|vitamin e
47103|NCT03274596|Total Antioxidant Capacity|total antioxidant capacity
47104|NCT03274596|Retinopathy of Prematurity|retinopathy of prematurity
47105|NCT03274583|atrial fibrillation|atrial fibrillation
47106|NCT03274583|smartphone|smartphone
47107|NCT03274583|detection|detection
47108|NCT03274557|Achilles, tendinose, tendinopathy, pain|achilles, tendinose, tendinopathy, pain
47109|NCT03274544|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
47110|NCT03274544|Chinese Medicine|chinese medicine
47111|NCT03274544|Herbal Medicine|herbal medicine
47112|NCT03274518|Hemodialysis|hemodialysis
47113|NCT03274518|Hemodiafiltration|hemodiafiltration
47114|NCT03274518|fluid status|fluid status
47115|NCT03274518|hemodynamics|hemodynamics
47116|NCT03274479|adenosine receptors|adenosine receptors
47117|NCT03274479|checkpoint inhibitors|checkpoint inhibitors
47118|NCT03274479|immune system activator|immune system activator
47119|NCT03274440|OCD|ocd
47120|NCT03274440|Marijuana|marijuana
47121|NCT03274440|THC|thc
47122|NCT03274440|Cannabis|cannabis
47123|NCT03274440|CBD|cbd
47124|NCT03274440|Cannabinoid|cannabinoid
47125|NCT03274414|squamous cell carcinoma|squamous cell carcinoma
47126|NCT03274414|esthesioneuroblastoma|esthesioneuroblastoma
47127|NCT03274414|adenoid cystic carcinoma|adenoid cystic carcinoma
47128|NCT03274414|adenocarcinoma|adenocarcinoma
47129|NCT03274414|cisplatin|cisplatin
47130|NCT03274414|17-442|17-442
47131|NCT03274401|Atrial fibrillation|atrial fibrillation
47132|NCT03274401|Pulmonary embolism|pulmonary embolism
47133|NCT03274401|Screening|screening
47134|NCT03274375|Anti-NMDAR encephalitis|anti-nmdar encephalitis
47135|NCT03274375|IA adsorption|ia adsorption
47136|NCT03274375|Paediatric|paediatric
47137|NCT03274336|patient satisfaction|patient satisfaction
47138|NCT03274336|preanesthesia|preanesthesia
47139|NCT03274336|movie|movie
47140|NCT03274336|brochure|brochure
47141|NCT03274336|face-to-face interview|face-to-face interview
47142|NCT03274310|Influenza|influenza
47143|NCT03274310|Text message|text message
47144|NCT03274310|Influenza-like Illness|influenza-like illness
47145|NCT03274310|Acute Respiratory Infection|acute respiratory infection
47146|NCT03274284|chemoradiation for|chemoradiation for
47147|NCT03274284|T1G3 BC|t1g3 bc
47148|NCT03274271|physical activity|physical activity
47149|NCT03274271|sedentary behaviour|sedentary behaviour
47150|NCT03274271|eHealth|ehealth
47152|NCT03274271|self-regulation|self-regulation
47153|NCT03274271|behaviour change techniques|behaviour change techniques
47154|NCT03274271|action planning|action planning
47155|NCT03274271|coping planning|coping planning
47156|NCT03274271|self-monitoring|self-monitoring
47157|NCT03274271|prevention|prevention
47158|NCT03274258|Renal Medullary Carcinoma|renal medullary carcinoma
47159|NCT03274258|RMC|rmc
47160|NCT03274258|Locally advanced or metastatic|locally advanced or metastatic
47161|NCT03274258|Nivolumab|nivolumab
47162|NCT03274258|BMS-936558|bms-936558
47163|NCT03274258|Opdivo|opdivo
47164|NCT03274258|Ipilimumab|ipilimumab
47165|NCT03274258|Yervoy|yervoy
47166|NCT03274258|BMS-734016|bms-734016
47167|NCT03274258|MDX010|mdx010
47168|NCT03274245|Public Health|public health
47169|NCT03274206|Cervical Intraepithelian Neoplasia Grade 2/3|cervical intraepithelian neoplasia grade 2/3
47170|NCT03274206|CIN 2/3|cin 2/3
47171|NCT03274206|HPV|hpv
47172|NCT03274180|Travel consultation|travel consultation
47173|NCT03274102|Inactivated Enterovirus Type 71 (EV71) Vaccine|inactivated enterovirus type 71 (ev71) vaccine
47174|NCT03274102|Concomitant vaccination|concomitant vaccination
47175|NCT03274102|Safety|safety
47176|NCT03274102|Immunogenicity|immunogenicity
47177|NCT03274102|Infant|infant
47178|NCT03274076|diffuse|diffuse
47179|NCT03274076|scleroderma|scleroderma
47180|NCT03274076|systemic sclerosis|systemic sclerosis
47181|NCT03274050|robot|robot
47182|NCT03274050|surgery|surgery
47183|NCT03274050|pediatry|pediatry
47184|NCT03273998|coagulation|coagulation
47185|NCT03273998|bleeding|bleeding
47186|NCT03273972|Healthy Volunteers|healthy volunteers
47187|NCT03273972|Low Density Lipoprotein Cholesterol (LDL)|low density lipoprotein cholesterol (ldl)
47188|NCT03273972|PCSK9|pcsk9
47189|NCT03273972|Alirocumab|alirocumab
47190|NCT03273972|Forearm Blood Flow|forearm blood flow
47191|NCT03273972|Arterial Stiffness|arterial stiffness
47192|NCT03273972|Carotid Intima Media Thickness|carotid intima media thickness
47193|NCT03273972|Inflammation|inflammation
47194|NCT03273972|Endothelial function|endothelial function
47195|NCT03273959|Physiotherapy|physiotherapy
47196|NCT03273959|Physical Therapy|physical therapy
47197|NCT03273959|Exercise|exercise
47198|NCT03273959|Hospitalization|hospitalization
47199|NCT03273959|Pediatric|pediatric
47200|NCT03273959|Adolescents|adolescents
47201|NCT03273946|CCI18781|cci18781
47202|NCT03273946|Observational|observational
47203|NCT03273946|Post-marketing|post-marketing
47204|NCT03273946|Fluticasone propionate|fluticasone propionate
47205|NCT03273946|Asthma|asthma
47206|NCT03273920|laparoscopy-assisted gastrectomy|laparoscopy-assisted gastrectomy
47207|NCT03273920|robot-assisted gastrectomy|robot-assisted gastrectomy
47208|NCT03273920|advanced gastric cancer|advanced gastric cancer
47209|NCT03273920|D2 Lymphadenectomy|d2 lymphadenectomy
47210|NCT03273907|CyPass Micro-Stent|cypass micro-stent
47211|NCT03273894|Hypothermia, temperature management|hypothermia, temperature management
47212|NCT03273881|Gestational diabetes mellitus|gestational diabetes mellitus
47213|NCT03273881|Pre-gestational diabetes mellitus|pre-gestational diabetes mellitus
47214|NCT03273881|Treatment|treatment
47215|NCT03273881|Neonatal hypoglycemia|neonatal hypoglycemia
47216|NCT03273803|Heart sounds, smartphone, application|heart sounds, smartphone, application
47217|NCT03273777|Cesarean section|cesarean section
47218|NCT03273777|Skin incision|skin incision
47219|NCT03273777|Skewness|skewness
47220|NCT03273777|Line drawing|line drawing
47221|NCT03273764|Preterm, RDS, Surfactant, CPAP|preterm, rds, surfactant, cpap
47222|NCT03273751|Remote Ischemic Preconditioning|remote ischemic preconditioning
47223|NCT03273751|Partial nephrectomy|partial nephrectomy
47224|NCT03273751|Acute kidney injury|acute kidney injury
47225|NCT03273738|type 2 diabetes|type 2 diabetes
47226|NCT03273738|postmenopausal|postmenopausal
47227|NCT03273725|Oral Health|oral health
47228|NCT03273725|Vitamin D|vitamin d
47229|NCT03273686|Esophageal Cancer|esophageal cancer
47230|NCT03273686|Nasogastric Tube|nasogastric tube
47231|NCT03273673|Secondary ACL Injury Prevention|secondary acl injury prevention
47232|NCT03273673|Visual Biofeedback|visual biofeedback
47233|NCT03273673|Tactile Biofeedback|tactile biofeedback
47234|NCT03273634|Palpitations|palpitations
47235|NCT03273608|Hepatocellular Carcinoma|hepatocellular carcinoma
47236|NCT03273608|Advanced HCC|advanced hcc
47237|NCT03273608|Unresectable|unresectable
47238|NCT03273608|deTACE|detace
47239|NCT03273608|HepaSphere|hepasphere
47240|NCT03273517|Glycemia|glycemia
47241|NCT03273517|Preoperative fasting|preoperative fasting
47242|NCT03273517|Pediatric patients|pediatric patients
47243|NCT03273517|Anesthesia|anesthesia
47244|NCT03273517|Knowledge of the resident|knowledge of the resident
47245|NCT03273491|self-weighing|self-weighing
47246|NCT03273491|weight gain|weight gain
47247|NCT03273491|Ecological Momentary Assessment|ecological momentary assessment
47248|NCT03273491|mood|mood
47249|NCT03273491|emerging adulthood|emerging adulthood
47250|NCT03273491|obesity|obesity
47251|NCT03273491|eating disorders|eating disorders
48249|NCT03266835|Peripheral|peripheral
47252|NCT03273478|Bifurcation aneurysm|bifurcation aneurysm
47253|NCT03273478|Unruptured bifurcation aneurysm|unruptured bifurcation aneurysm
47254|NCT03273478|Ruptured bifurcation aneurysm|ruptured bifurcation aneurysm
47255|NCT03273478|Stent-assisted coiling|stent-assisted coiling
47256|NCT03273478|pCONUS2 Bifurcation Aneurysm Implant|pconus2 bifurcation aneurysm implant
47257|NCT03273465|IBD|ibd
47258|NCT03273465|Colitis|colitis
47259|NCT03273465|fecal|fecal
47260|NCT03273465|FMT|fmt
47261|NCT03273465|microbiota|microbiota
47262|NCT03273465|transplantation|transplantation
47263|NCT03273439|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
47264|NCT03273439|Negative symptoms|negative symptoms
47265|NCT03273439|randomized controlled trial|randomized controlled trial
47266|NCT03273439|Schizophrenia|schizophrenia
47267|NCT03273439|cognition|cognition
47268|NCT03273413|Pravastatin|pravastatin
47269|NCT03273413|Statin|statin
47270|NCT03273400|Lumbar, Hamstring, Mobilisation|lumbar, hamstring, mobilisation
47271|NCT03273322|Left atrial appendage closure|left atrial appendage closure
47272|NCT03273322|Rivaroxaban|rivaroxaban
47273|NCT03273322|Dual antiplatelet therapy|dual antiplatelet therapy
47274|NCT03273322|Anticoagulation|anticoagulation
47275|NCT03273322|Stroke prevention|stroke prevention
47276|NCT03273296|microbiota|microbiota
47277|NCT03273296|metabolize|metabolize
47278|NCT03273257|Pulmonary endarterectomy|pulmonary endarterectomy
47279|NCT03273257|PEA|pea
47280|NCT03273257|Medical therapy|medical therapy
47281|NCT03273218|coronary angiography, diagnostic, transradial, catheter|coronary angiography, diagnostic, transradial, catheter
47282|NCT03273205|Transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
47283|NCT03273192|healthy subjects|healthy subjects
47284|NCT03273192|adalimumab|adalimumab
47285|NCT03273192|single dose|single dose
47286|NCT03273192|Phase 1|phase 1
47287|NCT03273192|PK|pk
47288|NCT03273179|cerebral venous sinus thrombosis|cerebral venous sinus thrombosis
47289|NCT03273179|CSF pressure|csf pressure
47290|NCT03273179|modified Rankin Scale|modified rankin scale
47291|NCT03273179|papilledema|papilledema
47292|NCT03273179|NIHSS|nihss
47293|NCT03273127|Asthma, placebo, abediterol, DPI, corticosteroids|asthma, placebo, abediterol, dpi, corticosteroids
47294|NCT03273114|back pain|back pain
47295|NCT03273114|physiotherapy|physiotherapy
47296|NCT03273114|exercise therapy|exercise therapy
47297|NCT03273114|cognitive functional therapy|cognitive functional therapy
47298|NCT03273114|low back pain|low back pain
47299|NCT03273114|backache|backache
47300|NCT03273114|lower back pain|lower back pain
47301|NCT03273114|lumbago|lumbago
47302|NCT03273114|multidimensional|multidimensional
47303|NCT03273114|biopsychosocial|biopsychosocial
47304|NCT03273088|healthy subjects|healthy subjects
47305|NCT03273088|Pharmacokinetics|pharmacokinetics
47306|NCT03273088|etanercept|etanercept
47307|NCT03273088|single dose|single dose
47308|NCT03273088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
47309|NCT03273075|P2Y12r inhibitor|p2y12r inhibitor
47310|NCT03273075|Cardiac Arrest|cardiac arrest
47311|NCT03273075|STEMI|stemi
47312|NCT03273075|HTPR|htpr
47313|NCT03273062|Brain Injury|brain injury
47314|NCT03273062|Traumatic Brain Injury|traumatic brain injury
47315|NCT03273062|Acquired Brain Injury|acquired brain injury
47317|NCT03273062|Neuropsychiatric Symptopms|neuropsychiatric symptopms
47318|NCT03273062|COMT|comt
47319|NCT03272997|Positron emission thomography|positron emission thomography
47320|NCT03272997|Computed tomography|computed tomography
47321|NCT03272997|Sensitivity|sensitivity
47322|NCT03272997|Specificity|specificity
47323|NCT03272971|lung cancer|lung cancer
47324|NCT03272971|radiofrequency ablation|radiofrequency ablation
47325|NCT03272971|bronchoscopy|bronchoscopy
47326|NCT03272971|NSCLC|nsclc
47327|NCT03272958|Pruritus|pruritus
47328|NCT03272958|Bullous pemphigoid|bullous pemphigoid
47329|NCT03272919|Breast Cancer, Peripheral neuropathy, Taxol, carboplatin|breast cancer, peripheral neuropathy, taxol, carboplatin
47330|NCT03272906|aphasia|aphasia
47331|NCT03272906|stroke|stroke
47332|NCT03272906|tDCS|tdcs
47333|NCT03272906|language|language
47334|NCT03272906|stimulation|stimulation
47335|NCT03272906|brain|brain
47336|NCT03272906|speech therapy|speech therapy
47337|NCT03272893|psychoneuroimmunology|psychoneuroimmunology
47338|NCT03272880|Art Therapy|art therapy
47339|NCT03272880|Music Therapy|music therapy
47340|NCT03272815|pneumothorax|pneumothorax
47341|NCT03272815|chest tube removal|chest tube removal
47342|NCT03272815|percussion|percussion
47343|NCT03272802|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
47344|NCT03272802|Edaravone|edaravone
47345|NCT03272776|LMA Protector|lma protector
47346|NCT03272776|Second Generation Laryngeal Masks|second generation laryngeal masks
47347|NCT03272776|Airway|airway
47348|NCT03272776|Dual Gastric Acces|dual gastric acces
47349|NCT03272776|Teleflex|teleflex
47350|NCT03272776|Supraglottic Devices|supraglottic devices
47351|NCT03272776|Ambulatory Surgery|ambulatory surgery
47352|NCT03272737|KAATSU|kaatsu
47353|NCT03272737|Cardiovascular system|cardiovascular system
47354|NCT03272737|Elderly|elderly
47355|NCT03272711|Vortioxetine|vortioxetine
47356|NCT03272711|Elderly|elderly
47357|NCT03272711|Online cognitive training|online cognitive training
47358|NCT03272698|ketamine|ketamine
47359|NCT03272698|treatment-resistant depression|treatment-resistant depression
47360|NCT03272698|electroconvulsive therapy|electroconvulsive therapy
47361|NCT03272685|Reduced nicotine cigarettes|reduced nicotine cigarettes
47362|NCT03272685|Alternative nicotine products|alternative nicotine products
47363|NCT03272685|Biomarkers of tobacco exposure|biomarkers of tobacco exposure
47364|NCT03272659|Fluorescence Sigmoidoscopy|fluorescence sigmoidoscopy
47365|NCT03272659|PDD|pdd
47366|NCT03272659|Photodynamic Diagnosis|photodynamic diagnosis
47367|NCT03272646|Gastric Cancer|gastric cancer
47368|NCT03272607|Adverse Drug Event|adverse drug event
47369|NCT03272607|Choosing Wisely Canada|choosing wisely canada
47370|NCT03272607|Deprescribing|deprescribing
47371|NCT03272607|Elderly|elderly
47372|NCT03272607|Frailty|frailty
47373|NCT03272607|High value healthcare|high value healthcare
47374|NCT03272607|Medication rationalization|medication rationalization
47375|NCT03272607|Medication stewardship|medication stewardship
47376|NCT03272607|Polypharmacy|polypharmacy
47377|NCT03272594|Neonatal pain|neonatal pain
47378|NCT03272594|Pediatric pain|pediatric pain
47379|NCT03272594|Pain assessment|pain assessment
47380|NCT03272594|Breastfeeding|breastfeeding
47381|NCT03272594|Sucrose|sucrose
47382|NCT03272594|Randomized controlled trial|randomized controlled trial
47383|NCT03272594|Behavioural pain response|behavioural pain response
47384|NCT03272594|Neurophysiological pain response|neurophysiological pain response
47385|NCT03272581|Functional|functional
47386|NCT03272581|Training|training
47387|NCT03272581|Performance|performance
47388|NCT03272568|Extended Life Plasma Derived Factor Products|extended life plasma derived factor products
47389|NCT03272568|Female hemophilia A and B carriers|female hemophilia a and b carriers
47390|NCT03272568|Menorrhagia|menorrhagia
47391|NCT03272542|gastric bypass|gastric bypass
47392|NCT03272542|calcium absorption|calcium absorption
47393|NCT03272542|postmenopausal women|postmenopausal women
47394|NCT03272516|Mild to moderate Depression|mild to moderate depression
47395|NCT03272516|Mild to moderate Anxiety|mild to moderate anxiety
47396|NCT03272516|Mindfulness based cognitive therapy|mindfulness based cognitive therapy
47397|NCT03272516|Primary care|primary care
47398|NCT03272516|PHQ-9|phq-9
47399|NCT03272516|GAD-7|gad-7
47400|NCT03272516|Antidepressants|antidepressants
47401|NCT03272516|Anxiolytica|anxiolytica
47402|NCT03272516|Subjective wellbeing|subjective wellbeing
47403|NCT03272503|Pimozide|pimozide
47404|NCT03272490|locking plate|locking plate
47405|NCT03272490|anatomical preshaped|anatomical preshaped
47406|NCT03272490|polyaxial|polyaxial
47407|NCT03272490|outcome|outcome
47408|NCT03272477|hormone receptor positive|hormone receptor positive
47409|NCT03272477|human epidermal growth factor receptor 2 positive|human epidermal growth factor receptor 2 positive
47410|NCT03272477|Early breast cancer|early breast cancer
47411|NCT03272477|HR+/HER2+|hr+/her2+
47412|NCT03272464|Melanoma|melanoma
47413|NCT03272438|steps|steps
47414|NCT03272438|goals|goals
47415|NCT03272386|pelvic floor muscles|pelvic floor muscles
47416|NCT03272386|instruction|instruction
47417|NCT03272386|assessment|assessment
47418|NCT03272386|acceptability|acceptability
47419|NCT03272386|understanding|understanding
47420|NCT03272334|Metastatic Breast Cancer|metastatic breast cancer
47421|NCT03272334|Adoptive Cell Therapy|adoptive cell therapy
47422|NCT03272334|Armed Activated T-cells|armed activated t-cells
47423|NCT03272334|Bispecific Antibodies|bispecific antibodies
47424|NCT03272334|Immunotherapy|immunotherapy
47425|NCT03272321|biomedical intervention|biomedical intervention
47426|NCT03272321|oxytocin|oxytocin
47427|NCT03272321|EEG|eeg
47428|NCT03272321|skin conductance response|skin conductance response
47429|NCT03272321|heart rate|heart rate
47430|NCT03272321|gaze direction|gaze direction
47431|NCT03272321|eye contact|eye contact
47432|NCT03272282|WHO PARTOGRAPG.OBSTRUCTED LABOUR. managment of labour|who partograpg.obstructed labour. managment of labour
47433|NCT03272269|Diabetes Mellitus type 1|diabetes mellitus type 1
47434|NCT03272269|Autoimmune disease|autoimmune disease
47435|NCT03272269|Immunotherapy|immunotherapy
47436|NCT03272269|Diabetes treatment|diabetes treatment
47437|NCT03272269|Residual beta cell function|residual beta cell function
47438|NCT03272269|Adult patients|adult patients
47439|NCT03272243|thoracolumbar fracture|thoracolumbar fracture
47440|NCT03272243|short segment fixation|short segment fixation
47441|NCT03272243|long segment fixation|long segment fixation
47442|NCT03272243|index level|index level
47443|NCT03272230|Apathy|apathy
47444|NCT03272230|Goal-directed behavior|goal-directed behavior
47445|NCT03272230|Assessment|assessment
47446|NCT03272230|Diagnosis|diagnosis
47447|NCT03272230|Sensor|sensor
47448|NCT03272230|Ecological condition|ecological condition
47449|NCT03272230|Neurological disease|neurological disease
49152|NCT03260920|empathy|empathy
47450|NCT03272217|Atezolizumab|atezolizumab
47451|NCT03272217|MPDL3280A|mpdl3280a
47452|NCT03272217|Bevacizumab|bevacizumab
47453|NCT03272217|Avastin|avastin
47454|NCT03272217|Cisplatin-Ineligible|cisplatin-ineligible
47455|NCT03272217|Anti-PD-L1 Antibodies|anti-pd-l1 antibodies
47456|NCT03272204|pubic hair; grooming; urinary tract symptoms; vaginitis|pubic hair; grooming; urinary tract symptoms; vaginitis
47457|NCT03272191|MI|mi
47458|NCT03272191|Infarction|infarction
47459|NCT03272191|Infarct|infarct
47460|NCT03272191|Subacute MI|subacute mi
47461|NCT03272191|stem cell|stem cell
47462|NCT03272165|Healthy Volunteers|healthy volunteers
47463|NCT03272165|Safety|safety
47464|NCT03272165|Tolerability|tolerability
47465|NCT03272165|Pharmacokinetics|pharmacokinetics
47466|NCT03272165|Pharmacodynamics|pharmacodynamics
47467|NCT03272165|Immunogenicity|immunogenicity
47468|NCT03272126|vitamin D|vitamin d
47469|NCT03272100|lateral approach|lateral approach
47470|NCT03272100|bone augmentation|bone augmentation
47471|NCT03272100|sinus lift|sinus lift
47472|NCT03272100|flap|flap
47473|NCT03272087|Thoracoscopy|thoracoscopy
47474|NCT03272048|Firearms|firearms
47475|NCT03272035|General practice|general practice
47476|NCT03272035|death|death
47477|NCT03272035|bereavement|bereavement
47478|NCT03272022|cobalamin, folate|cobalamin, folate
47479|NCT03271996|Pilonidal sinus|pilonidal sinus
47480|NCT03271996|Bascom|bascom
47481|NCT03271996|Cleft lift|cleft lift
47482|NCT03271996|Fistulectomy|fistulectomy
47483|NCT03271996|Karydakis|karydakis
47484|NCT03271918|Pituitary Adenoma|pituitary adenoma
47485|NCT03271918|Dopaminergic Agonist|dopaminergic agonist
47486|NCT03271918|Nonfunctioning Pituitary Adenoma|nonfunctioning pituitary adenoma
47487|NCT03271918|Cabergoline|cabergoline
47488|NCT03271879|Diabetes|diabetes
47489|NCT03271879|Heart|heart
47490|NCT03271879|Arrhythmia|arrhythmia
47491|NCT03271866|Schizophrenia|schizophrenia
47492|NCT03271866|Metabolic syndrome|metabolic syndrome
47493|NCT03271866|Metformin|metformin
47494|NCT03271866|Cognitive impairment|cognitive impairment
47495|NCT03271866|Clinical trial|clinical trial
47496|NCT03271827|Apnoeic oxygenation|apnoeic oxygenation
47497|NCT03271827|Airway management|airway management
47498|NCT03271827|Oxygen insufflation|oxygen insufflation
47499|NCT03271827|Paediatric general anaesthesia|paediatric general anaesthesia
47500|NCT03271775|Dizziness|dizziness
47501|NCT03271775|Instability|instability
47502|NCT03271762|MITRACLIP|mitraclip
47503|NCT03271762|primary Mitral Regurgitation|primary mitral regurgitation
47504|NCT03271762|high surgical risks|high surgical risks
47505|NCT03271749|Fast Track surgical recovery|fast track surgical recovery
47506|NCT03271749|Surgical recovery|surgical recovery
47507|NCT03271749|Thoracic surgery|thoracic surgery
47508|NCT03271736|Parkinson's disease|parkinson's disease
47509|NCT03271736|Auditory cues|auditory cues
47510|NCT03271736|step in place|step in place
47511|NCT03271736|transcranial magnetic stimulation|transcranial magnetic stimulation
47512|NCT03271736|cortical excitability|cortical excitability
47513|NCT03271723|cohort studies|cohort studies
47514|NCT03271723|infant development|infant development
47515|NCT03271723|pregnancy|pregnancy
47516|NCT03271723|Brazil|brazil
47517|NCT03271723|observational studies|observational studies
47518|NCT03271723|epidemiology|epidemiology
47519|NCT03271723|maternal health|maternal health
47520|NCT03271710|Distal embolization|distal embolization
47521|NCT03271710|Percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
47522|NCT03271710|Integrated embolic protection|integrated embolic protection
47523|NCT03271684|stroke, self-management, Bridges, participation, function, self-efficacy|stroke, self-management, bridges, participation, function, self-efficacy
47524|NCT03271671|neurally adjusted ventilator assist|neurally adjusted ventilator assist
47525|NCT03271671|Pressure support ventilation|pressure support ventilation
47526|NCT03271671|non invasive ventilation|non invasive ventilation
47527|NCT03271671|niv|niv
47528|NCT03271658|patient decision aid|patient decision aid
47529|NCT03271658|end-of-life care|end-of-life care
47530|NCT03271658|shared decision making|shared decision making
47531|NCT03271658|informed decision|informed decision
47532|NCT03271658|decision-making|decision-making
47533|NCT03271658|clinical decision-making|clinical decision-making
47534|NCT03271658|web-based decision aid|web-based decision aid
47535|NCT03271658|palliative|palliative
47536|NCT03271658|critical care|critical care
47537|NCT03271658|nursing|nursing
47538|NCT03271645|Depression|depression
47539|NCT03271645|Anxiety|anxiety
47540|NCT03271645|Stress|stress
47541|NCT03271645|Internet-delivered interventions|internet-delivered interventions
47542|NCT03271632|multiple myeloma|multiple myeloma
47543|NCT03271632|chimeric antigen receptor|chimeric antigen receptor
47544|NCT03271632|BCMA|bcma
47545|NCT03271632|CD38|cd38
47546|NCT03271632|CD56|cd56
47547|NCT03271632|CD138|cd138
47548|NCT03271619|Safety Issues|safety issues
47549|NCT03271580|Wound healing|wound healing
47550|NCT03271580|Diabetes|diabetes
47551|NCT03271580|Inflammatory cells|inflammatory cells
47552|NCT03271580|Macrophage|macrophage
47553|NCT03271528|Lacosamide|lacosamide
47554|NCT03271528|Alcohol craving|alcohol craving
47555|NCT03271528|Alcohol Urge Questionnaire|alcohol urge questionnaire
47556|NCT03271528|Obsessive-Compulsive Drinking Scale|obsessive-compulsive drinking scale
47557|NCT03271515|leukemia|leukemia
47558|NCT03271515|lymphoma|lymphoma
47559|NCT03271515|CAR-T|car-t
47560|NCT03271515|bispecific|bispecific
47561|NCT03271515|CD20|cd20
47562|NCT03271515|CD19|cd19
47563|NCT03271489|Elagolix Sodium|elagolix sodium
47564|NCT03271489|Heavy Menstrual Bleeding (HMB)|heavy menstrual bleeding (hmb)
47565|NCT03271489|Heavy Uterine Bleeding|heavy uterine bleeding
47566|NCT03271489|Leiomyomata|leiomyomata
47567|NCT03271489|Menorrhagia|menorrhagia
47568|NCT03271489|Elagolix + Norethindrone Acetate|elagolix + norethindrone acetate
47569|NCT03271489|Elagolix + E2/NETA|elagolix + e2/neta
47570|NCT03271489|Elagolix|elagolix
47571|NCT03271489|Safety|safety
47572|NCT03271489|Efficacy|efficacy
47573|NCT03271489|ABT-620|abt-620
47574|NCT03271476|Breast Cancer|breast cancer
47575|NCT03271476|EMDR|emdr
47576|NCT03271463|stroke|stroke
47577|NCT03271463|selective voluntary motor control|selective voluntary motor control
47578|NCT03271450|dabigatran|dabigatran
47579|NCT03271450|warfarin|warfarin
47580|NCT03271450|apixaban|apixaban
47581|NCT03271450|edoxaban|edoxaban
47582|NCT03271450|extended treatment|extended treatment
47583|NCT03271450|oral anticoagulant|oral anticoagulant
47584|NCT03271450|rivaroxaban|rivaroxaban
47585|NCT03271450|comparative safety|comparative safety
47586|NCT03271450|comparative effectiveness|comparative effectiveness
47587|NCT03271385|hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
47588|NCT03271385|hypertensive Heart Disease|hypertensive heart disease
47589|NCT03271385|cardiac magnetic resonance|cardiac magnetic resonance
47590|NCT03271307|self-test|self-test
47591|NCT03271307|testing|testing
47592|NCT03271307|cost-effectiveness|cost-effectiveness
47593|NCT03271294|pelvic organ prolapse|pelvic organ prolapse
47594|NCT03271294|Exair|exair
47595|NCT03271294|Transvaginal mesh|transvaginal mesh
47596|NCT03271281|68Ga-NODAGA-E[c(RGDyK)]2|68ga-nodaga-e[c(rgdyk)]2
47597|NCT03271281|Angiogenesis PET/CT|angiogenesis pet/ct
47598|NCT03271281|Neuroendocrine tumors|neuroendocrine tumors
47599|NCT03271268|Vascular filling|vascular filling
47600|NCT03271268|Fluid overload|fluid overload
47601|NCT03271268|Biomarkers|biomarkers
47602|NCT03271268|Lung edema|lung edema
47603|NCT03271255|apatinib|apatinib
47604|NCT03271255|bevacizumab|bevacizumab
47605|NCT03271255|FOLFIRI|folfiri
47606|NCT03271255|colorectal cancer|colorectal cancer
47607|NCT03271229|Platelet rich plasma|platelet rich plasma
47608|NCT03271229|bone marrow|bone marrow
47609|NCT03271229|stem cell|stem cell
47610|NCT03271203|Michigan Hand Outcomes Questionnaire|michigan hand outcomes questionnaire
47611|NCT03271203|Real-time data capture|real-time data capture
47612|NCT03271203|Cognitive debriefing|cognitive debriefing
47613|NCT03271203|Hand Osteoarthritis|hand osteoarthritis
47614|NCT03271203|Concept elicitation|concept elicitation
47615|NCT03271190|aging|aging
47616|NCT03271190|memory complaint|memory complaint
47617|NCT03271177|transradial percutaneous coronary intervention|transradial percutaneous coronary intervention
47618|NCT03271138|Celiac Disease|celiac disease
47619|NCT03271138|Gluten-Free Diet|gluten-free diet
47620|NCT03271138|Bifidobacterium infantis NLS super strain|bifidobacterium infantis nls super strain
47621|NCT03271138|gastrointestinal symptoms|gastrointestinal symptoms
47622|NCT03271138|quality of life|quality of life
47623|NCT03271138|microbiota|microbiota
47624|NCT03271138|IgA TTG|iga ttg
47625|NCT03271138|IgA DGP|iga dgp
47626|NCT03271125|Intervention|intervention
47627|NCT03271125|Multiple sclerosis|multiple sclerosis
47628|NCT03271125|Treadmill|treadmill
47629|NCT03271125|Mobility|mobility
47630|NCT03271099|survivorship; navigation|survivorship; navigation
47631|NCT03271086|Relaxation training|relaxation training
47632|NCT03271086|Pediatric clinic|pediatric clinic
47633|NCT03271086|Children 6-11 years|children 6-11 years
47634|NCT03271086|Text messaging|text messaging
47635|NCT03271073|gastric cancer|gastric cancer
47636|NCT03271073|gastroesophageal junction cancer|gastroesophageal junction cancer
47637|NCT03271073|Apatinib|apatinib
47639|NCT03271047|cancer|cancer
47640|NCT03271034|Lipedema|lipedema
47641|NCT03271034|Metabolism|metabolism
47642|NCT03271034|Body Composition|body composition
47643|NCT03271034|Fat Distribution|fat distribution
47644|NCT03271034|Immunology|immunology
47645|NCT03270995|breast cancer|breast cancer
47646|NCT03270995|gynecological cancer|gynecological cancer
47647|NCT03270995|fear of cancer recurrence|fear of cancer recurrence
47648|NCT03270995|clinical trial|clinical trial
47649|NCT03270995|randomized controlled trial|randomized controlled trial
47650|NCT03270995|group therapy|group therapy
47651|NCT03270995|intervention|intervention
47652|NCT03270995|cognitive-existential|cognitive-existential
47653|NCT03270982|Non Inflammatory Degenerative Joint Disease|non inflammatory degenerative joint disease
47654|NCT03270982|Rheumatoid Arthritis|rheumatoid arthritis
47655|NCT03270982|Revision where other devices have failed|revision where other devices have failed
47656|NCT03270982|Correction of functional deformity|correction of functional deformity
47657|NCT03270982|Oncology Applications|oncology applications
47658|NCT03270982|Treatment of acute or Chronic fractures|treatment of acute or chronic fractures
47659|NCT03270930|Operative duration|operative duration
47660|NCT03270930|Pediatric surgery|pediatric surgery
47661|NCT03270930|Emergency laparotomy|emergency laparotomy
47662|NCT03270930|Mortality rate|mortality rate
47663|NCT03270930|Survival|survival
47664|NCT03270930|Kaplan-Meier analysis|kaplan-meier analysis
47665|NCT03270930|ROC curve analysis|roc curve analysis
47666|NCT03270930|Senior resident|senior resident
47667|NCT03270917|Parenchymal preserving|parenchymal preserving
47668|NCT03270917|Postero-superior|postero-superior
47669|NCT03270917|Laparoscopy|laparoscopy
47670|NCT03270891|Pharmacogenomics|pharmacogenomics
47671|NCT03270891|Primary care physicians|primary care physicians
47672|NCT03270878|Glasdegib|glasdegib
47673|NCT03270878|PF-04449913|pf-04449913
47674|NCT03270878|Pharmacokinetics|pharmacokinetics
47675|NCT03270878|Bioavailability|bioavailability
47676|NCT03270813|Child|child
47677|NCT03270813|Adolescent|adolescent
47678|NCT03270787|Acute Mountain sickness|acute mountain sickness
47679|NCT03270787|Compound Danshen Dripping Pills|compound danshen dripping pills
47680|NCT03270748|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
47681|NCT03270748|acute graft-versus-host disease|acute graft-versus-host disease
47682|NCT03270748|Unrelated donors|unrelated donors
47683|NCT03270748|Post-transplant cyclophosphamide|post-transplant cyclophosphamide
47684|NCT03270748|Myeloid Malignancies|myeloid malignancies
47685|NCT03270748|unrelated hematopoietic cell transplantation|unrelated hematopoietic cell transplantation
47686|NCT03270748|GITMO|gitmo
47687|NCT03270709|Vitamin D3|vitamin d3
47688|NCT03270709|Pulmonary disease|pulmonary disease
47689|NCT03270709|Immunosuppression|immunosuppression
47690|NCT03270709|HIV|hiv
47691|NCT03270709|Smoking|smoking
47692|NCT03270683|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
47693|NCT03270683|transcranial Doppler sonography|transcranial doppler sonography
47694|NCT03270683|cerebrovascular circulation|cerebrovascular circulation
47695|NCT03270683|prognosis|prognosis
47696|NCT03270657|Deep Brain Stimulation|deep brain stimulation
47697|NCT03270592|Service dogs|service dogs
47698|NCT03270592|Alert dogs|alert dogs
47699|NCT03270592|Costs|costs
47700|NCT03270592|Quality of Life|quality of life
47701|NCT03270592|Cost-effectiveness|cost-effectiveness
47702|NCT03270566|Water hardness|water hardness
47703|NCT03270566|Atopic eczema prevention|atopic eczema prevention
47704|NCT03270566|Skin barrier function|skin barrier function
47705|NCT03270566|Skin microbiome|skin microbiome
47706|NCT03270527|Dietary fat modification|dietary fat modification
47707|NCT03270527|Lipids|lipids
47708|NCT03270527|LDL cholesterol|ldl cholesterol
47709|NCT03270527|Dietary fatty acids|dietary fatty acids
47710|NCT03270527|Saturated fat|saturated fat
47711|NCT03270514|cardiac surgery|cardiac surgery
47712|NCT03270514|sternotomy|sternotomy
47713|NCT03270514|post-operative pain|post-operative pain
47714|NCT03270514|sternal wound infiltration|sternal wound infiltration
47715|NCT03270488|Thumb|thumb
47716|NCT03270488|Osteoarthritis|osteoarthritis
47717|NCT03270488|Physical Therapy|physical therapy
47718|NCT03270488|Pain|pain
47719|NCT03270449|fibromyalgia|fibromyalgia
47720|NCT03270449|community-based|community-based
47721|NCT03270449|multidisciplinary|multidisciplinary
47722|NCT03270410|neonates|neonates
47723|NCT03270410|non invasive monitoring|non invasive monitoring
47724|NCT03270397|Self Esteem|self esteem
47725|NCT03270397|Body Image|body image
47726|NCT03270397|Eating disorders|eating disorders
47727|NCT03270384|early feasibility|early feasibility
47728|NCT03270384|non-randomized|non-randomized
47729|NCT03270345|Decubitus|decubitus
47730|NCT03270345|Pressure|pressure
47731|NCT03270345|Ulcer|ulcer
47732|NCT03270345|Injuries|injuries
47733|NCT03270345|Sores|sores
47734|NCT03270345|Intensive care|intensive care
47735|NCT03270319|Measurement of cardiac output|measurement of cardiac output
47736|NCT03270280|Chronic Periodontitis|chronic periodontitis
47737|NCT03270280|Phytomedicines|phytomedicines
47738|NCT03270280|Nigella sativa|nigella sativa
47739|NCT03270241|Vitiligo|vitiligo
47740|NCT03270241|Dermatology|dermatology
47741|NCT03270241|Johns Hopkins|johns hopkins
47742|NCT03270241|Compensation|compensation
47743|NCT03270241|Paid|paid
47744|NCT03270241|Phototherapy|phototherapy
47745|NCT03270241|NB-UVB|nb-uvb
47746|NCT03270241|Light treatment|light treatment
47747|NCT03270241|Skin|skin
47748|NCT03270241|Biopsies|biopsies
47749|NCT03270241|Money|money
47750|NCT03270241|Short-term|short-term
47751|NCT03270228|Incidence of cancer|incidence of cancer
47752|NCT03270228|Survival|survival
47753|NCT03270215|Computed Tomography|computed tomography
47754|NCT03270215|Specificity|specificity
47755|NCT03270215|Sensitivity|sensitivity
47756|NCT03270202|Exercise|exercise
47757|NCT03270202|Cardiorespiratory fitness|cardiorespiratory fitness
47758|NCT03270202|Risk factors|risk factors
47759|NCT03270202|Monitoring, physiologic|monitoring, physiologic
47760|NCT03270202|Monitoring, ambulatory|monitoring, ambulatory
47761|NCT03270202|Prognosis|prognosis
47762|NCT03270202|Norway|norway
47763|NCT03270163|Intensive care unit acquired muscle weakness|intensive care unit acquired muscle weakness
47764|NCT03270163|Transcutaneous electrical stimulation|transcutaneous electrical stimulation
47765|NCT03270137|Alzheimer Disease|alzheimer disease
47766|NCT03270137|rTMS|rtms
47767|NCT03270137|Cognition|cognition
47768|NCT03270137|Behavioral Symptoms|behavioral symptoms
47769|NCT03270137|Functionality|functionality
47770|NCT03270124|Aortic Valve Stenosis|aortic valve stenosis
47771|NCT03270124|KAM|kam
47772|NCT03270124|iPAD|ipad
47773|NCT03270124|Physical Exercises|physical exercises
47774|NCT03270124|Quality of Life|quality of life
47775|NCT03270111|breast cancer survivor|breast cancer survivor
47776|NCT03270111|weight loss program|weight loss program
47777|NCT03270098|Schizophrenia|schizophrenia
47778|NCT03270098|Aerobic Exercise|aerobic exercise
47779|NCT03270098|Cognition|cognition
47780|NCT03270098|Daily Functioning|daily functioning
47781|NCT03270098|Biomarkers|biomarkers
47782|NCT03270098|Brain Derived Neurotrophic Factor|brain derived neurotrophic factor
47783|NCT03270046|Bowel preparation|bowel preparation
47784|NCT03270046|CRC screening|crc screening
47785|NCT03270033|Shoulder Joint|shoulder joint
47786|NCT03270033|Arthroscopy|arthroscopy
47787|NCT03270033|Ambulatory surgical procedures|ambulatory surgical procedures
47788|NCT03270033|Pain, Postoperative|pain, postoperative
47789|NCT03270033|Brachial Plexus Block|brachial plexus block
47790|NCT03270033|Corticosteroid|corticosteroid
47791|NCT03270033|Dexamethasone|dexamethasone
47792|NCT03270033|Dexmedetomidine|dexmedetomidine
47793|NCT03270033|Bupivacaine|bupivacaine
47794|NCT03270033|Alpha 2 agonist|alpha 2 agonist
47795|NCT03270033|Postoperative analgesia|postoperative analgesia
47796|NCT03270020|treatment|treatment
47797|NCT03270020|denosumab|denosumab
47798|NCT03270020|Positron Emission Tomography (PET) CT scan|positron emission tomography (pet) ct scan
47799|NCT03269994|pancreatoduodenectomy|pancreatoduodenectomy
47800|NCT03269994|17-418|17-418
47801|NCT03269994|cefoxitin|cefoxitin
47802|NCT03269994|piperacillin-tazobactam|piperacillin-tazobactam
47803|NCT03269981|Adjuvant radiotherapy|adjuvant radiotherapy
47804|NCT03269981|Lymphatic irradiation|lymphatic irradiation
47805|NCT03269981|Taxane|taxane
47806|NCT03269981|Anthracycline|anthracycline
47807|NCT03269981|Prospective study|prospective study
47808|NCT03269942|Intracranial Aneurysm|intracranial aneurysm
47809|NCT03269942|Flow Diverter|flow diverter
47810|NCT03269942|Cerebral Revascularization|cerebral revascularization
47811|NCT03269851|neurological deficit|neurological deficit
47812|NCT03269799|uncontrolled type 2 diabetes mellitus|uncontrolled type 2 diabetes mellitus
47813|NCT03269799|periodontitis|periodontitis
47814|NCT03269799|non surgical periodontal treatment|non surgical periodontal treatment
47815|NCT03269799|vitamin C|vitamin c
47816|NCT03269773|Atopic Dermatitis|atopic dermatitis
47817|NCT03269773|Stem cell|stem cell
47818|NCT03269773|Cell therapy|cell therapy
47819|NCT03269773|skin disease|skin disease
47820|NCT03269773|Umbilical cord Blood|umbilical cord blood
47821|NCT03269773|UCB-MSC|ucb-msc
47822|NCT03269773|hUCB-MSC|hucb-msc
47823|NCT03269773|AD|ad
47824|NCT03269773|furestem|furestem
47825|NCT03269773|dermatitis|dermatitis
47826|NCT03269773|eczema|eczema
47827|NCT03269747|glucocorticoids|glucocorticoids
47828|NCT03269747|brown adipose tissue|brown adipose tissue
47829|NCT03269747|cold induced thermogenesis|cold induced thermogenesis
47830|NCT03269734|Vascular Diseases|vascular diseases
47831|NCT03269734|Cerebrovascular Diseases|cerebrovascular diseases
47832|NCT03269734|Cardiovascular Diseases|cardiovascular diseases
47833|NCT03269734|Aortic aneurysm|aortic aneurysm
47834|NCT03269734|Arteriovenous malformations|arteriovenous malformations
47835|NCT03269734|Catheterization|catheterization
47836|NCT03269721|Cognition|cognition
47837|NCT03269721|Pulmonary|pulmonary
47838|NCT03269721|COPD|copd
47839|NCT03269721|Lung|lung
47840|NCT03269656|Vitamin D|vitamin d
47841|NCT03269656|Cancer|cancer
47842|NCT03269656|Survival|survival
47843|NCT03269617|dysbiosis|dysbiosis
47844|NCT03269617|gut microbiota|gut microbiota
47845|NCT03269617|bacteriophage|bacteriophage
47846|NCT03269617|irritable bowel syndrome|irritable bowel syndrome
47847|NCT03269617|gastrointestinal distress|gastrointestinal distress
47848|NCT03269617|prebiotic|prebiotic
47849|NCT03269604|Urological Surgery|urological surgery
47850|NCT03269604|Bacterial resistance|bacterial resistance
47851|NCT03269591|Dysmenorrhea|dysmenorrhea
47852|NCT03269591|Pulsed electromagnetic field|pulsed electromagnetic field
47853|NCT03269591|Diclofenac|diclofenac
47854|NCT03269578|Pharmacodynamics|pharmacodynamics
47855|NCT03269578|Tissue Collection|tissue collection
47856|NCT03269578|Tissue Biopsies|tissue biopsies
47857|NCT03269578|Biospecimen|biospecimen
47858|NCT03269578|Assay Development|assay development
47859|NCT03269526|Pancreatic Cancer|pancreatic cancer
47860|NCT03269526|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
47861|NCT03269526|Adoptive cell therapy|adoptive cell therapy
47862|NCT03269526|Armed activated T-cells|armed activated t-cells
47863|NCT03269526|Bispecific antibody|bispecific antibody
47864|NCT03269526|Immunotherapy|immunotherapy
47865|NCT03269474|epidermolysis bullosa simplex|epidermolysis bullosa simplex
47866|NCT03269474|genetic expression|genetic expression
47867|NCT03269474|drug repurposing|drug repurposing
47868|NCT03269474|computational approaches|computational approaches
47869|NCT03269474|drug discovery|drug discovery
47870|NCT03269461|stent, DES, INSPIRON, OCT, tissue repair|stent, des, inspiron, oct, tissue repair
47871|NCT03269448|partial pressure of carbon dioxide|partial pressure of carbon dioxide
47872|NCT03269448|carbon dioxide|carbon dioxide
47873|NCT03269448|peripheral venous blood|peripheral venous blood
47874|NCT03269448|central venous blood|central venous blood
47875|NCT03269448|venous blood gas|venous blood gas
47876|NCT03269448|blood gas analysis|blood gas analysis
47877|NCT03269422|17-407|17-407
47878|NCT03269422|Intermediate Risk Prostate Cancer|intermediate risk prostate cancer
47879|NCT03269422|DIL|dil
47880|NCT03269422|Dominant Intra-Prostatic Lesion|dominant intra-prostatic lesion
47881|NCT03269396|severe laryngotracheal dysfunction|severe laryngotracheal dysfunction
47882|NCT03269383|stellate ganglion block|stellate ganglion block
47883|NCT03269383|cardiac surgery|cardiac surgery
47884|NCT03269383|atrial fibrillation|atrial fibrillation
47885|NCT03269370|CBT|cbt
47886|NCT03269370|Self-Help|self-help
47887|NCT03269370|Family|family
47888|NCT03269357|LARC|larc
47889|NCT03269357|contraception|contraception
47890|NCT03269357|counselling|counselling
47891|NCT03269357|unplanned pregnancy|unplanned pregnancy
47892|NCT03269331|nursing practice|nursing practice
47893|NCT03269331|evidence-based practice models|evidence-based practice models
47894|NCT03269331|military nursing|military nursing
47895|NCT03269331|clinical inquiry|clinical inquiry
47896|NCT03269266|Scrub Typhus|scrub typhus
47897|NCT03269266|Positive Rapid Diagnostic Test|positive rapid diagnostic test
47898|NCT03269253|ALSPAC|alspac
47899|NCT03269253|longitudinal|longitudinal
47900|NCT03269227|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
47901|NCT03269227|Radiotherapy|radiotherapy
47902|NCT03269227|Tomotherapy|tomotherapy
47903|NCT03269227|Hypofractionation|hypofractionation
47904|NCT03269214|osteonecrosis|osteonecrosis
47905|NCT03269214|mandible|mandible
47906|NCT03269201|parkinsonism|parkinsonism
47907|NCT03269201|ataxia|ataxia
47908|NCT03269201|tremor|tremor
47909|NCT03269201|dystonia|dystonia
47910|NCT03269175|Clinically Isolated Syndrome suggestive of Multiple Sclerosis or Multiple Sclerosis|clinically isolated syndrome suggestive of multiple sclerosis or multiple sclerosis
47911|NCT03269149|Alzheimer's disease|alzheimer's disease
47912|NCT03269149|African-American Women|african-american women
47913|NCT03269149|Caregivers|caregivers
47914|NCT03269149|Tango|tango
47915|NCT03269149|Dance-based intervention|dance-based intervention
47916|NCT03269136|Multiple Myeloma|multiple myeloma
47917|NCT03269136|relapse/ refractory multiple myeloma|relapse/ refractory multiple myeloma
47918|NCT03269136|bispecific antibody|bispecific antibody
47919|NCT03269136|bispecific|bispecific
47920|NCT03269136|BCMA|bcma
47921|NCT03269136|BCMA- CD3 bispecific|bcma- cd3 bispecific
47922|NCT03269136|Phase 1|phase 1
47923|NCT03269136|PF-06863135|pf-06863135
47924|NCT03269123|Sensory trick|sensory trick
47925|NCT03269123|Geste Antagoniste|geste antagoniste
47926|NCT03269110|neurological|neurological
47927|NCT03269110|autism|autism
47928|NCT03269110|ASD|asd
47929|NCT03269110|behaviour|behaviour
47930|NCT03269110|folic acid|folic acid
47931|NCT03269110|pre-eclampsia|pre-eclampsia
47932|NCT03269110|asthma|asthma
47933|NCT03269110|executive function|executive function
47934|NCT03269071|Multiple Sclerosis|multiple sclerosis
47935|NCT03269071|Cell Therapy|cell therapy
47936|NCT03269071|Human Neural Stem Cells|human neural stem cells
47937|NCT03269032|Mediterranean diet|mediterranean diet
47938|NCT03269032|gut microbiome|gut microbiome
47939|NCT03269032|gastrointestinal|gastrointestinal
47940|NCT03269019|Heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
47941|NCT03269019|Thrombosis|thrombosis
47942|NCT03269019|thrombin-antithrombin|thrombin-antithrombin
47943|NCT03269019|d-dimer|d-dimer
47944|NCT03269019|Thrombelastograghy|thrombelastograghy
47945|NCT03269006|Visceral leishmaniasis|visceral leishmaniasis
47946|NCT03269006|Vector control|vector control
47947|NCT03269006|Sand fly,|sand fly,
47948|NCT03269006|Bangladesh|bangladesh
47949|NCT03268993|prevention|prevention
47950|NCT03268993|dietary supplement|dietary supplement
47951|NCT03268993|broccoli|broccoli
47952|NCT03268967|intensive care|intensive care
47953|NCT03268967|crisis resource management|crisis resource management
47954|NCT03268967|simulation training|simulation training
47955|NCT03268967|before and after study|before and after study
47956|NCT03268954|Drug therapy|drug therapy
47957|NCT03268941|Drug therapy|drug therapy
47958|NCT03268928|Shared Book Reading|shared book reading
47959|NCT03268928|Language Development|language development
47960|NCT03268928|Syntax|syntax
47961|NCT03268928|Vocabulary|vocabulary
47962|NCT03268928|Phonological Awareness|phonological awareness
47963|NCT03268928|Young Children|young children
47964|NCT03268928|Randomised Control Trial|randomised control trial
47965|NCT03268928|Language Intervention|language intervention
47966|NCT03268915|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
47967|NCT03268915|3 minutes sit-to-stand test|3 minutes sit-to-stand test
47968|NCT03268915|Interindividual reproductibility|interindividual reproductibility
47969|NCT03268889|Chidamide, CHOP regimen|chidamide, chop regimen
47970|NCT03268876|Epithelial ovarian cancer|epithelial ovarian cancer
47971|NCT03268876|Surgery|surgery
47972|NCT03268876|Quality of life|quality of life
47973|NCT03268863|pain tolerance|pain tolerance
47974|NCT03268863|perioperative pain|perioperative pain
47975|NCT03268863|virtual reality therapy|virtual reality therapy
47976|NCT03268850|LDKT|ldkt
47977|NCT03268850|Live donor transplantation|live donor transplantation
47978|NCT03268850|Kidney transplantation|kidney transplantation
47979|NCT03268798|stroke|stroke
47980|NCT03268798|strength training|strength training
47981|NCT03268798|rehabilitation|rehabilitation
47982|NCT03268785|Parathyroid glands|parathyroid glands
47983|NCT03268785|Needle puncture|needle puncture
47984|NCT03268785|Diff-quik staining|diff-quik staining
47985|NCT03268785|PTH test assay|pth test assay
47986|NCT03268785|Thyroid cancer|thyroid cancer
47987|NCT03268759|substance abuse|substance abuse
47988|NCT03268733|Folic acid|folic acid
47989|NCT03268733|PCOS|pcos
47990|NCT03268733|Insulin resistance|insulin resistance
47991|NCT03268733|Infertility|infertility
47992|NCT03268720|gluten sensitivity|gluten sensitivity
47993|NCT03268720|gluten-free diet|gluten-free diet
47994|NCT03268720|FODMAP diet|fodmap diet
47995|NCT03268720|microbiome|microbiome
47996|NCT03268707|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
47997|NCT03268707|Pulmonary Vein Isolation|pulmonary vein isolation
47998|NCT03268707|Telemetry Monitoring|telemetry monitoring
47999|NCT03268707|Cryoballoon ablation|cryoballoon ablation
48000|NCT03268655|gingerol|gingerol
48001|NCT03268655|microbiome|microbiome
48002|NCT03268655|gut|gut
48003|NCT03268655|ginger|ginger
48004|NCT03268642|Fulminant Myocarditis|fulminant myocarditis
48005|NCT03268642|Retrospective cohort study|retrospective cohort study
48006|NCT03268629|Insomnia|insomnia
48007|NCT03268629|Mindfulness-based Intervention|mindfulness-based intervention
48008|NCT03268629|Mindfulness Meditation|mindfulness meditation
48009|NCT03268629|Tai Chi|tai chi
48010|NCT03268629|Inflammation|inflammation
48011|NCT03268629|NF-κB|nf-κb
48012|NCT03268616|neural respiratory drive|neural respiratory drive
48013|NCT03268616|noninvasive positive pressure ventilation|noninvasive positive pressure ventilation
48014|NCT03268616|electromyography|electromyography
48015|NCT03268590|Hyperoxia|hyperoxia
48016|NCT03268590|Hypoxia, Brain|hypoxia, brain
48017|NCT03268512|leucocyte- and platelet rich fibrin|leucocyte- and platelet rich fibrin
48018|NCT03268512|ridge preservation|ridge preservation
48019|NCT03268512|growth factors|growth factors
48020|NCT03268512|platelet concentrates|platelet concentrates
48021|NCT03268486|Fetal monitoring|fetal monitoring
48022|NCT03268486|cardiotocography|cardiotocography
48023|NCT03268473|OSAS|osas
48024|NCT03268473|Obstructive Sleep Apnea|obstructive sleep apnea
48025|NCT03268473|Periodontitis|periodontitis
48026|NCT03268434|Depression|depression
48027|NCT03268434|Metacognition|metacognition
48028|NCT03268434|CBT|cbt
48029|NCT03268434|D-MCT|d-mct
48030|NCT03268434|cognitive bias|cognitive bias
48031|NCT03268421|juvenile fibromyalgia|juvenile fibromyalgia
48032|NCT03268421|pain in children|pain in children
48033|NCT03268421|musculoskeletal pain|musculoskeletal pain
48034|NCT03268421|cognitive behavioral therapy|cognitive behavioral therapy
48035|NCT03268421|coping skills training|coping skills training
48036|NCT03268421|neuromuscular exercise|neuromuscular exercise
48037|NCT03268421|graded aerobic exercise|graded aerobic exercise
48038|NCT03268408|community intervention|community intervention
48039|NCT03268408|newsletter|newsletter
48040|NCT03268382|Ovarian Cancer|ovarian cancer
48041|NCT03268382|Ovarian Carcinoma|ovarian carcinoma
48042|NCT03268382|High Grade Serous Ovarian Cancer|high grade serous ovarian cancer
48043|NCT03268382|Recurrent Cancer|recurrent cancer
48044|NCT03268382|Resistant Cancer|resistant cancer
48045|NCT03268304|Upper Limb Motor Function Deficit|upper limb motor function deficit
48046|NCT03268304|Neurorehabilitation|neurorehabilitation
48047|NCT03268304|Virtual Reality|virtual reality
48048|NCT03268304|Action Research Arm Test|action research arm test
48049|NCT03268291|Adherence to therapy|adherence to therapy
49731|NCT03257800|Propofol|propofol
48050|NCT03268291|Myocardial Infarction|myocardial infarction
48051|NCT03268291|Coronary Artery Disease|coronary artery disease
48052|NCT03268291|Communicational program|communicational program
48053|NCT03268278|analgesia|analgesia
48054|NCT03268278|endodontic|endodontic
48055|NCT03268278|postoperative|postoperative
48056|NCT03268187|Cognitive Fatigue|cognitive fatigue
48057|NCT03268187|Multiple Sclerosis|multiple sclerosis
48058|NCT03268187|Biofeedback|biofeedback
48059|NCT03268187|Self-Alert Training|self-alert training
48060|NCT03268187|Vigilance|vigilance
48061|NCT03268187|Autonomic potentials|autonomic potentials
48062|NCT03268161|anti-MAG neuropathy|anti-mag neuropathy
48063|NCT03268161|Waldenström disease|waldenström disease
48064|NCT03268161|Mutational analysis|mutational analysis
48065|NCT03268148|neonates|neonates
48066|NCT03268148|pain|pain
48067|NCT03268148|low level laser|low level laser
48068|NCT03268135|miRNA|mirna
48069|NCT03268135|lncRNAs|lncrnas
48070|NCT03268135|transcriptome|transcriptome
48071|NCT03268135|heart failure|heart failure
48072|NCT03268135|aortic stenosis|aortic stenosis
48073|NCT03268135|biomarkers|biomarkers
48074|NCT03268122|Patient Isolation|patient isolation
48075|NCT03268122|Methicillin-Resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
48076|NCT03268122|Vancomycin-Resistant Enterococci|vancomycin-resistant enterococci
48077|NCT03268083|Foot-and-Mouth Disease|foot-and-mouth disease
48078|NCT03268083|Vaccines|vaccines
48079|NCT03268083|Hand, Foot and Mouth Disease|hand, foot and mouth disease
48080|NCT03268083|EV71 vaccine|ev71 vaccine
48081|NCT03268070|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
48082|NCT03268070|Neurophysiology|neurophysiology
48083|NCT03268070|Neuroscience|neuroscience
48084|NCT03268070|Stroke Rehabilitation|stroke rehabilitation
48085|NCT03268057|Non-Small-Cell Lung|non-small-cell lung
48086|NCT03268057|Carcinoma|carcinoma
48087|NCT03268057|Advanced|advanced
48088|NCT03268057|VX15/2503|vx15/2503
48089|NCT03268057|Semaphorin 4D|semaphorin 4d
48090|NCT03268057|SEMA4D|sema4d
48091|NCT03268057|safety tolerability|safety tolerability
48092|NCT03268057|pharmacokinetics|pharmacokinetics
48093|NCT03268057|monoclonal antibody|monoclonal antibody
48094|NCT03268031|artificial intelligence|artificial intelligence
48095|NCT03268031|glaucoma|glaucoma
48096|NCT03268018|calcium|calcium
48097|NCT03268018|peripheral arterial disease|peripheral arterial disease
48098|NCT03267992|COPD|copd
48099|NCT03267992|Coils|coils
48100|NCT03267992|App|app
48101|NCT03267979|pain assessment|pain assessment
48102|NCT03267979|pupillary diameter|pupillary diameter
48103|NCT03267979|variation coefficient of pupillary diameter|variation coefficient of pupillary diameter
48104|NCT03267979|pain self assessment|pain self assessment
48105|NCT03267979|video-pupillometer|video-pupillometer
48106|NCT03267979|electrocardiogram|electrocardiogram
48107|NCT03267979|analgesic treatment|analgesic treatment
48108|NCT03267966|periampullary cancer|periampullary cancer
48109|NCT03267966|margin status|margin status
48110|NCT03267966|R1 resection|r1 resection
48111|NCT03267966|clearance margin|clearance margin
48112|NCT03267953|Stress management, e-Health, cardiovascular disease, adaptive design, lay coaching, motivational interviewing|stress management, e-health, cardiovascular disease, adaptive design, lay coaching, motivational interviewing
48113|NCT03267940|Extrahepatic Cholangiocarcinoma|extrahepatic cholangiocarcinoma
48114|NCT03267940|Intrahepatic Cholangiocarcinoma|intrahepatic cholangiocarcinoma
48115|NCT03267940|Gallbladder Adenocarcinoma|gallbladder adenocarcinoma
48116|NCT03267940|PEGylated Recombinant Human Hyaluronidase|pegylated recombinant human hyaluronidase
48117|NCT03267940|PEGylated Recombinant Human Hyaluronidase with atezolizumab|pegylated recombinant human hyaluronidase with atezolizumab
48118|NCT03267927|OSA|osa
48119|NCT03267927|Polysomnography|polysomnography
48120|NCT03267927|Rapid palatal expansion|rapid palatal expansion
48121|NCT03267927|Mandibular advancement|mandibular advancement
48122|NCT03267927|Sleep position|sleep position
48123|NCT03267862|biomarker|biomarker
48124|NCT03267849|biomarker|biomarker
48125|NCT03267823|Bleeding|bleeding
48126|NCT03267823|heart surgery|heart surgery
48127|NCT03267823|coagulation|coagulation
48128|NCT03267823|coagulopathy|coagulopathy
48129|NCT03267823|INR|inr
48130|NCT03267810|Neuropathic Pain|neuropathic pain
48131|NCT03267810|Transcutaneous Electrical Nerve Stimulation|transcutaneous electrical nerve stimulation
48132|NCT03267797|Recurrent Implantation Failure|recurrent implantation failure
48133|NCT03267797|Pregnancy Rate|pregnancy rate
48134|NCT03267797|Lymphocyte Therapy|lymphocyte therapy
48135|NCT03267784|diabetic neuropathic ulcer|diabetic neuropathic ulcer
48136|NCT03267784|ABCB5|abcb5
48137|NCT03267784|allogeneic|allogeneic
48138|NCT03267784|mesenchymal stem cells|mesenchymal stem cells
48139|NCT03267784|skin ulcer|skin ulcer
48140|NCT03267784|advanced therapy medicinal product|advanced therapy medicinal product
48141|NCT03267784|somatic cell therapy|somatic cell therapy
48142|NCT03267784|phase I/IIa|phase i/iia
48143|NCT03267784|Diabetic Foot Ulcer|diabetic foot ulcer
48144|NCT03267745|protein|protein
48145|NCT03267745|skeletal muscle|skeletal muscle
48146|NCT03267745|immobilization|immobilization
48147|NCT03267706|Primary care|primary care
48148|NCT03267706|Palliative care|palliative care
48149|NCT03267641|Intra-tumour heterogeneity|intra-tumour heterogeneity
48150|NCT03267641|Cancer immunotherapy|cancer immunotherapy
48151|NCT03267641|Tumour microenvironment|tumour microenvironment
48152|NCT03267641|Driver mutations|driver mutations
48153|NCT03267641|Precision Medicine|precision medicine
48154|NCT03267628|intrathecal morphine|intrathecal morphine
48155|NCT03267628|quadratus lumborum type 2 block|quadratus lumborum type 2 block
48156|NCT03267628|cesarean section|cesarean section
48157|NCT03267628|pain|pain
48158|NCT03267615|Liver Cirrhosis|liver cirrhosis
48159|NCT03267615|Portal Hypertension|portal hypertension
48160|NCT03267589|immunotherapy|immunotherapy
48161|NCT03267589|ovarian cancer|ovarian cancer
48162|NCT03267589|durvalumab|durvalumab
48163|NCT03267589|tremelilumab|tremelilumab
48164|NCT03267589|MEDI 9447|medi 9447
48165|NCT03267589|MEDI 0562|medi 0562
48166|NCT03267537|Insomnia|insomnia
48167|NCT03267537|Sleep|sleep
48168|NCT03267537|Telemedicine|telemedicine
48169|NCT03267368|Comprehensive Care Program|comprehensive care program
48170|NCT03267368|Stereotactic Radiotherapy|stereotactic radiotherapy
48171|NCT03267316|First-in-Human|first-in-human
48172|NCT03267316|Phase 1|phase 1
48173|NCT03267316|Phase 2|phase 2
48174|NCT03267316|Antibody, Monoclonal|antibody, monoclonal
48175|NCT03267316|IL1RAP|il1rap
48176|NCT03267316|Safety|safety
48177|NCT03267316|Tolerability|tolerability
48178|NCT03267316|Cancer|cancer
48179|NCT03267316|Solid tumor|solid tumor
48180|NCT03267316|Malignant|malignant
48181|NCT03267316|Dose escalation|dose escalation
48182|NCT03267316|Dose expansion|dose expansion
48183|NCT03267316|CAN04|can04
48184|NCT03267316|Immunoglobulin|immunoglobulin
48185|NCT03267316|Clinical Trial|clinical trial
48186|NCT03267316|Infusion|infusion
48187|NCT03267316|Antineoplastic|antineoplastic
48188|NCT03267316|Anticancer|anticancer
48189|NCT03267303|Narcolepsy|narcolepsy
48190|NCT03267277|Calcinosis|calcinosis
48191|NCT03267277|Dermatomyositis|dermatomyositis
48192|NCT03267277|Juvenile Dermatomyositis|juvenile dermatomyositis
48193|NCT03267277|Idiopathic Inflammatory Myopathies|idiopathic inflammatory myopathies
48194|NCT03267277|Sodium Thiosulfate|sodium thiosulfate
48195|NCT03267251|Vaccine Decision Making|vaccine decision making
48196|NCT03267251|Public Health|public health
48197|NCT03267251|Health Communication|health communication
48198|NCT03267251|Digital Interventions|digital interventions
48199|NCT03267225|drug interaction|drug interaction
48200|NCT03267225|genetic polymorphism|genetic polymorphism
48201|NCT03267212|Functional Electrical Stimulation (FES)-Rowing|functional electrical stimulation (fes)-rowing
48202|NCT03267212|Ventilatory support|ventilatory support
48203|NCT03267173|Pancreatic Cancer|pancreatic cancer
48204|NCT03267173|CAR-T|car-t
48205|NCT03267173|Mesothelin|mesothelin
48207|NCT03267173|HER2|her2
48208|NCT03267147|Anti-CCP|anti-ccp
48209|NCT03267147|rheumatoid arthritis|rheumatoid arthritis
48210|NCT03267121|head and neck cancer|head and neck cancer
48211|NCT03267121|Apatinib|apatinib
48212|NCT03267121|Tegafur Gimeracil Oteracil|tegafur gimeracil oteracil
48213|NCT03267121|induction chemotherapy|induction chemotherapy
48214|NCT03267108|Pulmonary Fibrosis|pulmonary fibrosis
48215|NCT03267108|PF|pf
48216|NCT03267108|Pulmonary Hypertension|pulmonary hypertension
48217|NCT03267108|Inhaled Nitric Oxide|inhaled nitric oxide
48218|NCT03267108|iNO|ino
48219|NCT03267108|Long Term Oxygen Therapy|long term oxygen therapy
48220|NCT03267108|Oxygen|oxygen
48221|NCT03267056|drug-coated balloon|drug-coated balloon
48222|NCT03267043|preterm birth|preterm birth
48223|NCT03267043|NICU|nicu
48224|NCT03267043|neonatal|neonatal
48225|NCT03267043|skin to skin|skin to skin
48226|NCT03267043|kangaroo care|kangaroo care
48227|NCT03267043|separation stress|separation stress
48228|NCT03267043|family nurture|family nurture
48229|NCT03267043|maternal confidence|maternal confidence
48230|NCT03267043|maternal competence|maternal competence
48231|NCT03267043|calming cycle|calming cycle
48232|NCT03267043|infant neurodevelopment|infant neurodevelopment
48233|NCT03267043|infant psychological development|infant psychological development
48234|NCT03267043|mother-infant co-regulation|mother-infant co-regulation
48235|NCT03267043|postpartum depression|postpartum depression
48236|NCT03267030|Hypersensitivity to PEG-asparaginase|hypersensitivity to peg-asparaginase
48237|NCT03266965|Fatigue|fatigue
48238|NCT03266965|Histamine|histamine
48239|NCT03266952|stroke|stroke
48240|NCT03266952|race|race
48241|NCT03266952|diet|diet
48242|NCT03266952|diabetes|diabetes
48243|NCT03266952|ethnicity|ethnicity
48244|NCT03266952|myocardial infarction|myocardial infarction
48245|NCT03266874|total hip arthroplasty|total hip arthroplasty
48246|NCT03266848|Magnetic Resonance Imaging|magnetic resonance imaging
48247|NCT03266848|Ferumoxytol|ferumoxytol
48248|NCT03266835|Chronic Total Occlusion|chronic total occlusion
48250|NCT03266835|SoundBite™ Crossing System|soundbite™ crossing system
48251|NCT03266835|CTO|cto
48252|NCT03266835|intra-luminal|intra-luminal
48253|NCT03266835|Active wire|active wire
48254|NCT03266835|Device|device
48255|NCT03266835|Procedure|procedure
48256|NCT03266809|Cardiac function|cardiac function
48257|NCT03266809|Cardio-toxicity|cardio-toxicity
48258|NCT03266770|ureteral stent|ureteral stent
48259|NCT03266744|Metastatic Breast Cancer|metastatic breast cancer
48260|NCT03266744|Whole Body MRI|whole body mri
48261|NCT03266744|Computerised Tomography|computerised tomography
48262|NCT03266744|Bone scan|bone scan
48263|NCT03266718|cancer survivor|cancer survivor
48264|NCT03266718|breast cancer|breast cancer
48265|NCT03266718|prostate cancer|prostate cancer
48266|NCT03266718|couples|couples
48267|NCT03266692|BCMA|bcma
48268|NCT03266692|SEA-BCMA|sea-bcma
48269|NCT03266692|B Cell Maturation Antigen|b cell maturation antigen
48270|NCT03266692|ACTR|actr
48271|NCT03266692|ACTR087|actr087
48272|NCT03266692|T cell|t cell
48273|NCT03266692|T cell product|t cell product
48274|NCT03266692|relapsed|relapsed
48275|NCT03266692|refractory|refractory
48276|NCT03266692|multiple myeloma|multiple myeloma
48277|NCT03266692|adoptive T cells|adoptive t cells
48278|NCT03266692|autologous|autologous
48279|NCT03266692|gene therapy|gene therapy
48280|NCT03266692|cell therapy|cell therapy
48281|NCT03266679|bipolar disorder|bipolar disorder
48282|NCT03266679|metacognition|metacognition
48283|NCT03266679|reflective functioning|reflective functioning
48284|NCT03266679|metacognition-based intervention|metacognition-based intervention
48285|NCT03266679|sense of self|sense of self
48286|NCT03266679|insight|insight
48287|NCT03266666|grocery|grocery
48288|NCT03266666|lifestyle|lifestyle
48289|NCT03266666|lifestyle change|lifestyle change
48290|NCT03266666|behavior|behavior
48291|NCT03266666|nutrition|nutrition
48292|NCT03266640|Cytomegalovirus|cytomegalovirus
48293|NCT03266640|CMV|cmv
48294|NCT03266640|cytotoxic t-lymphocytes|cytotoxic t-lymphocytes
48295|NCT03266627|adenovirus|adenovirus
48296|NCT03266627|primary immune deficiency disorder|primary immune deficiency disorder
48297|NCT03266627|cytotoxic t-lymphocytes|cytotoxic t-lymphocytes
48298|NCT03266614|Mental Illness|mental illness
48299|NCT03266614|Loneliness|loneliness
48300|NCT03266614|Hope|hope
48301|NCT03266614|Community|community
48302|NCT03266614|Social Media|social media
48303|NCT03266601|Aged 1-7 years old, within 72 hours of onset patients with herpangina|aged 1-7 years old, within 72 hours of onset patients with herpangina
48304|NCT03266588|migraine|migraine
48305|NCT03266588|acute|acute
48306|NCT03266575|Frailty|frailty
48307|NCT03266575|Sarcopenia|sarcopenia
48308|NCT03266575|Pulmonary Rehabilitation|pulmonary rehabilitation
48309|NCT03266562|Positron Emission Mammography|positron emission mammography
48310|NCT03266549|botulinum toxin|botulinum toxin
48311|NCT03266549|infantile esotropia|infantile esotropia
48312|NCT03266536|Gut microbiota|gut microbiota
48313|NCT03266523|CT|ct
48314|NCT03266523|MRI|mri
48315|NCT03266523|Anxiety-state|anxiety-state
48316|NCT03266523|Anxiety State-Trait|anxiety state-trait
48317|NCT03266510|Inspiratory muscle strength training|inspiratory muscle strength training
48318|NCT03266497|diet quality|diet quality
48319|NCT03266497|health disparities|health disparities
48320|NCT03266497|immigrants|immigrants
48321|NCT03266497|foreign-born|foreign-born
48322|NCT03266497|Blacks/African Americans|blacks/african americans
48323|NCT03266497|place of birth/nativity|place of birth/nativity
48324|NCT03266497|length of residency|length of residency
48325|NCT03266497|NHANES|nhanes
48326|NCT03266497|acculturation|acculturation
48327|NCT03266484|Microbiome|microbiome
48328|NCT03266484|Fatigue|fatigue
48329|NCT03266484|Probiotics|probiotics
48330|NCT03266471|Cytokines|cytokines
48331|NCT03266471|Pharmacogenetics|pharmacogenetics
48332|NCT03266445|relapse|relapse
48333|NCT03266445|buprenorphine/naloxone|buprenorphine/naloxone
48334|NCT03266445|opioids|opioids
48335|NCT03266445|narcotics|narcotics
48336|NCT03266445|post-surgical pain|post-surgical pain
48337|NCT03266393|Envarsus XR|envarsus xr
48338|NCT03266393|Kidney transplantation|kidney transplantation
48339|NCT03266393|Grafting, Kidney|grafting, kidney
48340|NCT03266393|Tacrolimus|tacrolimus
48341|NCT03266393|Rejection|rejection
48342|NCT03266393|Adherence|adherence
48343|NCT03266393|Quality of Life|quality of life
48344|NCT03266393|post-transplant immunosuppression|post-transplant immunosuppression
48345|NCT03266354|Artisan|artisan
48346|NCT03266302|vasodilatory shock|vasodilatory shock
48347|NCT03266302|hemoadsorption|hemoadsorption
48348|NCT03266302|cardiac surgery|cardiac surgery
48349|NCT03266302|cytokines|cytokines
48350|NCT03266250|inferior vena caca ultrasound|inferior vena caca ultrasound
48351|NCT03266237|Influenza|influenza
48352|NCT03266237|Influenza Virus Vaccines|influenza virus vaccines
48353|NCT03266237|Vaxigrip|vaxigrip
48354|NCT03266237|Respiratory Tract Infections|respiratory tract infections
48355|NCT03266237|Orthomyxoviridae Infections|orthomyxoviridae infections
48356|NCT03266237|Frailty|frailty
48357|NCT03266237|Aging|aging
48358|NCT03266237|Safety|safety
48359|NCT03266237|Immunogenicity|immunogenicity
48360|NCT03266224|congenital muscular torticollis|congenital muscular torticollis
48361|NCT03266224|wryneck|wryneck
48362|NCT03266224|sternocleidomastoid|sternocleidomastoid
48363|NCT03266224|ultrasonography|ultrasonography
48364|NCT03266224|digital analysis|digital analysis
48365|NCT03266185|paclitaxel-containing chemotherapy|paclitaxel-containing chemotherapy
48366|NCT03266172|immediate release tablet|immediate release tablet
48367|NCT03266172|GSK2982772|gsk2982772
48368|NCT03266172|Modified release|modified release
48369|NCT03266172|minitablet|minitablet
48370|NCT03266159|Dose escalation|dose escalation
48371|NCT03266159|Small cell lung cancer|small cell lung cancer
48372|NCT03266159|Trametinib|trametinib
48373|NCT03266159|GSK525762|gsk525762
48374|NCT03266159|Ras-mutations|ras-mutations
48375|NCT03266159|BET inhibitor|bet inhibitor
48376|NCT03266146|Drug-induced Liver Injury|drug-induced liver injury
48377|NCT03266146|Recurrence|recurrence
48378|NCT03266146|Methylprednisolone|methylprednisolone
48379|NCT03266146|Short-term|short-term
48380|NCT03266133|Gestational Diabetes Mellitus|gestational diabetes mellitus
48381|NCT03266133|Sleep education|sleep education
48382|NCT03266120|Gardening|gardening
48383|NCT03266120|Therapeutic Arts|therapeutic arts
48384|NCT03266120|Therapeutic Horticulture|therapeutic horticulture
48385|NCT03266120|Anxiety|anxiety
48386|NCT03266120|Depression|depression
48387|NCT03266120|Mood States|mood states
48388|NCT03266120|Quality of Life|quality of life
48389|NCT03266120|Social Interactions|social interactions
48390|NCT03266120|Stress|stress
48391|NCT03266120|Wellness|wellness
48392|NCT03266055|Blueberry|blueberry
48393|NCT03266055|Diet|diet
48394|NCT03266003|Tuberculosis|tuberculosis
48395|NCT03266003|Directly observed therapy|directly observed therapy
48396|NCT03266003|Adherence|adherence
48397|NCT03266003|Video assisted directly observed therapy|video assisted directly observed therapy
48398|NCT03266003|Electronic directly observed therapy|electronic directly observed therapy
48399|NCT03266003|Mobile health|mobile health
48400|NCT03265964|Suicidal Ideation|suicidal ideation
48401|NCT03265964|Veteran|veteran
48402|NCT03265964|Uridine|uridine
48403|NCT03265964|Neuroimaging|neuroimaging
48404|NCT03265951|sleep apnea, PTSD|sleep apnea, ptsd
48405|NCT03265938|Head and Neck cancer|head and neck cancer
48406|NCT03265938|Cancer of oral cavity|cancer of oral cavity
48407|NCT03265938|Ear, Nose and Throat|ear, nose and throat
48408|NCT03265938|Indirect laryngoscopy|indirect laryngoscopy
48409|NCT03265938|Awake intubation|awake intubation
48410|NCT03265938|Expected difficult intubation|expected difficult intubation
48411|NCT03265847|intimate partner violence|intimate partner violence
48412|NCT03265847|safety planning|safety planning
48413|NCT03265847|immigrant, refugee|immigrant, refugee
48414|NCT03265847|Native American|native american
48415|NCT03265847|risk for future violence|risk for future violence
48416|NCT03265847|risk for intimate partner homicide|risk for intimate partner homicide
48417|NCT03265821|Smoking|smoking
48418|NCT03265821|Periodontal treatment|periodontal treatment
48419|NCT03265821|Periodontal disease|periodontal disease
48420|NCT03265821|Healing|healing
48421|NCT03265808|stem cells|stem cells
48422|NCT03265782|efficacy|efficacy
48423|NCT03265782|safety|safety
48424|NCT03265782|paracetamol|paracetamol
48425|NCT03265782|ibuprofen|ibuprofen
48426|NCT03265782|PDA|pda
48427|NCT03265782|preterms|preterms
48428|NCT03265769|Femoral approach|femoral approach
48429|NCT03265769|Radial approach|radial approach
48430|NCT03265769|Chronic total occlusion|chronic total occlusion
48431|NCT03265730|Outpatient clinics|outpatient clinics
48432|NCT03265730|oral antibiotics|oral antibiotics
48433|NCT03265730|diarrhea|diarrhea
48434|NCT03265704|Maternal PIH|maternal pih
48435|NCT03265704|Neonatal thrombocytopenia|neonatal thrombocytopenia
48436|NCT03265704|Neonatal neutropenia|neonatal neutropenia
48437|NCT03265691|Accidental Falls|accidental falls
48438|NCT03265691|Hyponatremia|hyponatremia
48439|NCT03265691|Elderly|elderly
48440|NCT03265691|Risk factors|risk factors
48441|NCT03265691|Nurse|nurse
48442|NCT03265665|walking|walking
48443|NCT03265665|African American women|african american women
48444|NCT03265665|community-based|community-based
48445|NCT03265652|Intense Pulsed Light|intense pulsed light
48446|NCT03265652|Meibomian Gland Dysfunction|meibomian gland dysfunction
48447|NCT03265652|Dry Eye Disease|dry eye disease
48448|NCT03265587|Feng Shui|feng shui
48449|NCT03265587|Inner harmony|inner harmony
48450|NCT03265587|Chi|chi
48451|NCT03265522|Mediterranean diet|mediterranean diet
48452|NCT03265522|Lifestyle|lifestyle
48453|NCT03265483|Personalized prevention trial|personalized prevention trial
48454|NCT03265483|Magnesium|magnesium
48455|NCT03265483|Vitamin D metabolism and synthesis|vitamin d metabolism and synthesis
50420|NCT03253653|hookah|hookah
48456|NCT03265483|Magnesium-vitamin D interaction|magnesium-vitamin d interaction
48458|NCT03265405|pulmonary sarcoidosis|pulmonary sarcoidosis
48459|NCT03265405|corticosteroids|corticosteroids
48460|NCT03265405|glucocorticoids|glucocorticoids
48461|NCT03265405|relapse|relapse
48462|NCT03265405|interstitial lung disease|interstitial lung disease
48463|NCT03265405|diffuse parenchymal lung disease|diffuse parenchymal lung disease
48464|NCT03265405|immunosuppression|immunosuppression
48465|NCT03265405|mediastinal lymphadenopathy|mediastinal lymphadenopathy
48466|NCT03265366|Ultrashort echo time magnetic resonance imaging|ultrashort echo time magnetic resonance imaging
48467|NCT03265353|Potassium|potassium
48468|NCT03265353|Sodium|sodium
48469|NCT03265353|Vascular function|vascular function
48470|NCT03265340|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
48471|NCT03265288|Inflammation|inflammation
48472|NCT03265288|Essential Fatty Acids|essential fatty acids
48473|NCT03265288|Inflammation resolution|inflammation resolution
48474|NCT03265288|Docosahexaenoic acid|docosahexaenoic acid
48475|NCT03265288|Lung function|lung function
48476|NCT03265275|Fast track|fast track
48477|NCT03265223|Ropivacaine|ropivacaine
48478|NCT03265223|local anesthesia|local anesthesia
48479|NCT03265223|intraincisional infiltration|intraincisional infiltration
48480|NCT03265223|intraperitoneal instillation|intraperitoneal instillation
48481|NCT03265223|post-laparoscopic cholecystectomy pain|post-laparoscopic cholecystectomy pain
48482|NCT03265223|shoulder pain|shoulder pain
48483|NCT03265223|rescue analgesia|rescue analgesia
48484|NCT03265223|triple blinding|triple blinding
48485|NCT03265210|Middle-aged and Older Adults|middle-aged and older adults
48486|NCT03265210|Primary Care|primary care
48487|NCT03265197|Tinnitus|tinnitus
48488|NCT03265197|Intra-tympanic|intra-tympanic
48489|NCT03265197|Lidocaine|lidocaine
48490|NCT03265197|Dexamethasone|dexamethasone
48491|NCT03265132|Interleukin 1 receptor antagonist|interleukin 1 receptor antagonist
48492|NCT03265132|IL-1 receptor antagonist|il-1 receptor antagonist
48493|NCT03265132|Kineret|kineret
48494|NCT03265132|anakinra|anakinra
48495|NCT03265132|Adult-Onset Still's Disease|adult-onset still's disease
48496|NCT03265132|Systemic Juvenile Idiopathic Arthritis|systemic juvenile idiopathic arthritis
48497|NCT03265093|Pain Measurement|pain measurement
48498|NCT03265093|Platelet Activation|platelet activation
48499|NCT03265093|Quality of Life|quality of life
48500|NCT03265028|primary care|primary care
48501|NCT03265028|antibiotics|antibiotics
48502|NCT03265028|communication skills|communication skills
48503|NCT03265028|general practice|general practice
48504|NCT03265028|outpatient|outpatient
48505|NCT03265028|ambulatory care|ambulatory care
48506|NCT03265028|anti-bacterial agents|anti-bacterial agents
48507|NCT03265002|fibre|fibre
48508|NCT03265002|inulin|inulin
48509|NCT03265002|psyllium|psyllium
48510|NCT03265002|small bowel MRI|small bowel mri
48511|NCT03264989|Sickle cell disease|sickle cell disease
48512|NCT03264989|sickle cell anemia|sickle cell anemia
48513|NCT03264989|vaso-occlusive crisis|vaso-occlusive crisis
48514|NCT03264989|P-selectin|p-selectin
48515|NCT03264989|SEG101|seg101
48516|NCT03264989|crizanlizumab|crizanlizumab
48517|NCT03264989|monoclonal antibody|monoclonal antibody
48518|NCT03264989|Anemia, Sickle Cell|anemia, sickle cell
48519|NCT03264989|HbS Disease|hbs disease
48520|NCT03264989|Hemoglobin SC Disease|hemoglobin sc disease
48521|NCT03264989|Sickle Cell Disorders|sickle cell disorders
48522|NCT03264989|Sickling Disorder Due to Hemoglobin S|sickling disorder due to hemoglobin s
48523|NCT03264976|diabetic retinopathy|diabetic retinopathy
48524|NCT03264976|miRNA|mirna
48525|NCT03264976|serum exosomes|serum exosomes
48526|NCT03264976|prognostic biomarker|prognostic biomarker
48527|NCT03264963|Upper airway exercises|upper airway exercises
48528|NCT03264963|Smart phone application|smart phone application
48529|NCT03264937|TTR|ttr
48530|NCT03264937|INR|inr
48531|NCT03264937|Warfarin|warfarin
48532|NCT03264937|social software|social software
48533|NCT03264924|physical activity|physical activity
48534|NCT03264924|motivation|motivation
48535|NCT03264924|behaviour change|behaviour change
48536|NCT03264911|pharyngitis|pharyngitis
48537|NCT03264911|amoxicillin|amoxicillin
48538|NCT03264872|Motivational Interviewing|motivational interviewing
48539|NCT03264859|NGAL|ngal
48540|NCT03264859|STEMI|stemi
48541|NCT03264859|no-reflow|no-reflow
48542|NCT03264859|PCI (Percutaneous Coronary Intervention)|pci (percutaneous coronary intervention)
48543|NCT03264820|digital obstructive arterial disease, DOAD|digital obstructive arterial disease, doad
48544|NCT03264807|Lymph Node 14v|lymph node 14v
48545|NCT03264807|D2 lymphadenectomy|d2 lymphadenectomy
48546|NCT03264781|Cyclofem®|cyclofem®
48547|NCT03264781|Implant|implant
48548|NCT03264781|Jadelle|jadelle
48549|NCT03264781|Implanon|implanon
48550|NCT03264781|irregular uterine bleeding|irregular uterine bleeding
48551|NCT03264781|randomized controlled trial|randomized controlled trial
48552|NCT03264768|valves|valves
48553|NCT03264768|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
50421|NCT03253653|NNAL|nnal
48554|NCT03264768|endoscopic long volume reduction|endoscopic long volume reduction
48555|NCT03264742|ghreline, stroke|ghreline, stroke
48556|NCT03264729|plantar heel pain|plantar heel pain
48557|NCT03264716|TACE (transarterial chemoembolization)|tace (transarterial chemoembolization)
48558|NCT03264716|colorectal liver metastasis|colorectal liver metastasis
48559|NCT03264703|Joint pain|joint pain
48560|NCT03264703|Joint stiffness|joint stiffness
48561|NCT03264703|Joint redness|joint redness
48562|NCT03264703|Loss of joint function|loss of joint function
48563|NCT03264703|Swollen joints|swollen joints
48564|NCT03264690|Crohn's disease|crohn's disease
48565|NCT03264690|Ulcerative colitis|ulcerative colitis
48566|NCT03264677|8-week HUT|8-week hut
48567|NCT03264677|Hydro Boost|hydro boost
48568|NCT03264677|Skin healthy signs|skin healthy signs
48569|NCT03264677|Environmental aggressors|environmental aggressors
48570|NCT03264677|Cosmetic|cosmetic
48571|NCT03264664|E7386|e7386
48572|NCT03264664|dose escalation|dose escalation
48573|NCT03264664|advanced or recurrent neoplasms|advanced or recurrent neoplasms
48574|NCT03264651|Selective androgen receptor modulator|selective androgen receptor modulator
48575|NCT03264651|Aromatase inhibitor|aromatase inhibitor
48576|NCT03264638|PCOS|pcos
48577|NCT03264638|Dingkundan|dingkundan
48578|NCT03264638|Diane-35|diane-35
48579|NCT03264625|Cholecalciferol|cholecalciferol
48580|NCT03264625|Peritoneal dialysis|peritoneal dialysis
48581|NCT03264625|Peritonitis|peritonitis
48582|NCT03264573|Atrophic scar|atrophic scar
48584|NCT03264573|ADSCs|adscs
48585|NCT03264560|Telepsychiatry|telepsychiatry
48586|NCT03264560|Synchronous|synchronous
48587|NCT03264560|Asynchronous|asynchronous
48588|NCT03264560|SNF|snf
48589|NCT03264521|Crowdsourcing|crowdsourcing
48590|NCT03264521|Patient Engagement|patient engagement
48591|NCT03264521|Chiropractic|chiropractic
48592|NCT03264508|endothelial function|endothelial function
48593|NCT03264508|arterial stiffness|arterial stiffness
48594|NCT03264508|heat|heat
48595|NCT03264508|hot water immersion|hot water immersion
48596|NCT03264443|physical activity|physical activity
48597|NCT03264443|exercise|exercise
48598|NCT03264443|aging|aging
48599|NCT03264443|older|older
48600|NCT03264430|Perianal fistula|perianal fistula
48601|NCT03264430|Hemorrhoids|hemorrhoids
48602|NCT03264404|Pancreas|pancreas
48603|NCT03264404|pembrolizumab|pembrolizumab
48604|NCT03264404|azacitidine|azacitidine
48605|NCT03264404|metastatic pancreatic cancer|metastatic pancreatic cancer
48606|NCT03264404|first-line|first-line
48607|NCT03264391|OCT-A|oct-a
48608|NCT03264391|Retinal vasculitis|retinal vasculitis
48609|NCT03264391|Behcet's disease|behcet's disease
48610|NCT03264365|Health-related quality of life|health-related quality of life
48611|NCT03264365|Anxiety|anxiety
48612|NCT03264365|Depression|depression
48613|NCT03264365|Post-traumatic stress disorder|post-traumatic stress disorder
48614|NCT03264365|Recovery programme|recovery programme
48615|NCT03264365|Rehabilitation|rehabilitation
48616|NCT03264365|Follow-up programme|follow-up programme
48617|NCT03264365|Aftercare|aftercare
48618|NCT03264365|Randomized controlled Trial|randomized controlled trial
48619|NCT03264365|Multicentre|multicentre
48620|NCT03264339|Infant|infant
48621|NCT03264339|Hand/Growth & Development|hand/growth & development
48622|NCT03264339|Motor activity|motor activity
48623|NCT03264339|Exercise|exercise
48624|NCT03264339|Communication|communication
48625|NCT03264313|tobacco|tobacco
48626|NCT03264313|Smoking Cessation|smoking cessation
48627|NCT03264313|TMS|tms
48628|NCT03264313|Neuromodulation|neuromodulation
48629|NCT03264313|transcranial magnetic stimulation|transcranial magnetic stimulation
48630|NCT03264300|brain tumor, MRI|brain tumor, mri
48631|NCT03264287|acne vulgaris|acne vulgaris
48632|NCT03264287|acupuncture|acupuncture
48633|NCT03264287|cupping|cupping
48634|NCT03264287|ear point tapping|ear point tapping
48635|NCT03264287|randomized controlled trial|randomized controlled trial
48636|NCT03264274|Colorectal|colorectal
48637|NCT03264274|Metastatic|metastatic
48638|NCT03264274|Chemorefractory|chemorefractory
48639|NCT03264274|Ultrasound|ultrasound
48640|NCT03264274|Aflibercept|aflibercept
48641|NCT03264261|stroke, locomotion|stroke, locomotion
48642|NCT03264248|obesity|obesity
48643|NCT03264248|overweight|overweight
48644|NCT03264248|wheelchair|wheelchair
48645|NCT03264235|Powered-Knee Exoskeleton|powered-knee exoskeleton
48646|NCT03264235|Stair Training|stair training
48647|NCT03264235|Keeogo|keeogo
48648|NCT03264196|condylar hear|condylar hear
48649|NCT03264196|fracture|fracture
48650|NCT03264196|randomised controlled trial|randomised controlled trial
48651|NCT03264144|Social norms|social norms
48652|NCT03264144|Adolescent|adolescent
48653|NCT03264144|Smoking|smoking
48654|NCT03264144|Randomised controlled trial|randomised controlled trial
48655|NCT03264131|Brentuximab Vedotin|brentuximab vedotin
48656|NCT03264131|Adcetris|adcetris
48657|NCT03264131|Lymphoma|lymphoma
48658|NCT03264131|Leukemia|leukemia
48659|NCT03264131|CD30|cd30
48660|NCT03264118|Periodontal Guided Tissue Regeneration|periodontal guided tissue regeneration
48661|NCT03264118|Photochemotherapy|photochemotherapy
48662|NCT03264079|RTA 402|rta 402
48663|NCT03264079|Bardoxolone methyl|bardoxolone methyl
48664|NCT03264079|Itraconazole|itraconazole
48665|NCT03264079|Sporanox|sporanox
48666|NCT03264079|CYP3A4|cyp3a4
48667|NCT03264053|socket shield technique|socket shield technique
48668|NCT03264053|crestal bone loss|crestal bone loss
48669|NCT03264053|immediate implanation|immediate implanation
48670|NCT03264040|rounded eyebrows|rounded eyebrows
48671|NCT03264040|large head|large head
48672|NCT03264040|large ears|large ears
48673|NCT03264040|flattened bridge of the nose|flattened bridge of the nose
48674|NCT03264040|deformations of the bones in the spine (vertebrae)|deformations of the bones in the spine (vertebrae)
48675|NCT03263988|pulse contour analysis|pulse contour analysis
48676|NCT03263988|capton|capton
48677|NCT03263988|intraoperative monitoring|intraoperative monitoring
48678|NCT03263962|CHF|chf
48679|NCT03263962|Canrenone|canrenone
48680|NCT03263949|risk prediction|risk prediction
48681|NCT03263949|ventricular arrhythmia|ventricular arrhythmia
48682|NCT03263949|myocardial infarction|myocardial infarction
48683|NCT03263936|Relapse|relapse
48684|NCT03263936|Myelogenous|myelogenous
48685|NCT03263936|Leukemia|leukemia
48686|NCT03263936|Refractory|refractory
48687|NCT03263936|Acute|acute
48688|NCT03263936|Pediatric|pediatric
48689|NCT03263923|grandmother caregivers|grandmother caregivers
48690|NCT03263923|grandfamily|grandfamily
48691|NCT03263923|grandfamilies|grandfamilies
48692|NCT03263923|custodial grandparent|custodial grandparent
48693|NCT03263923|custodial grandmother|custodial grandmother
48694|NCT03263923|multigenerational family|multigenerational family
48695|NCT03263923|Grandmothers raising or living with grandchildren|grandmothers raising or living with grandchildren
48696|NCT03263897|abortive effect|abortive effect
48697|NCT03263897|mobile interface|mobile interface
48698|NCT03263884|nerve growth factor|nerve growth factor
48699|NCT03263884|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
48700|NCT03263884|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
48701|NCT03263871|nutrition|nutrition
48702|NCT03263832|Antibiogramme|antibiogramme
48703|NCT03263832|Antibiofilmogramme|antibiofilmogramme
48704|NCT03263819|Postural Orthostatic Tachycardia Syndrome, gastrointestinal hormones|postural orthostatic tachycardia syndrome, gastrointestinal hormones
48705|NCT03263806|angina|angina
48706|NCT03263806|coronary artery disease|coronary artery disease
48707|NCT03263806|coronary artery catheterization|coronary artery catheterization
48708|NCT03263806|coronary CT angiography|coronary ct angiography
48709|NCT03263806|fractional flow reserve CT|fractional flow reserve ct
48710|NCT03263806|emergency department|emergency department
48711|NCT03263793|singing|singing
48712|NCT03263780|Diagnostic imaging|diagnostic imaging
48713|NCT03263780|High-Intensity Focused Ultrasound|high-intensity focused ultrasound
48714|NCT03263780|HIFU|hifu
48715|NCT03263780|18F-Fluciclovine|18f-fluciclovine
48716|NCT03263780|high resolution diffusion-weighted imaging|high resolution diffusion-weighted imaging
48717|NCT03263767|Peripheral haemopoietic stem cell transplant|peripheral haemopoietic stem cell transplant
48718|NCT03263767|High dose cyclophosphamide|high dose cyclophosphamide
48719|NCT03263767|acute GVHD|acute gvhd
48720|NCT03263767|allogenic transplantation|allogenic transplantation
48721|NCT03263767|RIC (reduced-intensity conditioning)|ric (reduced-intensity conditioning)
48722|NCT03263741|Paclitaxel|paclitaxel
48723|NCT03263741|S-1|s-1
48724|NCT03263741|Oxaliplatin|oxaliplatin
48725|NCT03263741|Efficiency|efficiency
48726|NCT03263741|safety|safety
48727|NCT03263728|Stress Cardiac Magnetic Resonance|stress cardiac magnetic resonance
48728|NCT03263715|Polymyalgia Rheumatica|polymyalgia rheumatica
48729|NCT03263715|Tocilizumab|tocilizumab
48730|NCT03263715|Glucocorticoid|glucocorticoid
48731|NCT03263715|Glucocorticoid-Sparing|glucocorticoid-sparing
48732|NCT03263702|Persistent Atrial Fibrillation|persistent atrial fibrillation
48733|NCT03263702|mapping|mapping
48734|NCT03263663|colorectal cancer|colorectal cancer
48735|NCT03263663|adjuvant|adjuvant
48736|NCT03263650|prostate cancer|prostate cancer
48737|NCT03263650|genomic alterations|genomic alterations
48738|NCT03263650|DNA damage repair|dna damage repair
48739|NCT03263650|DDR pathway gene expression|ddr pathway gene expression
48740|NCT03263650|aggressive-variant prostate carcinomas|aggressive-variant prostate carcinomas
48741|NCT03263650|small cell prostate carcinoma|small cell prostate carcinoma
48742|NCT03263650|neuroendocrine prostate carcinoma|neuroendocrine prostate carcinoma
48743|NCT03263637|Relapsed or refractory haematological malignancies|relapsed or refractory haematological malignancies
48744|NCT03263637|AZD4573|azd4573
48745|NCT03263637|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
48746|NCT03263637|Acute Lymphocytic Leukemia (ALL)|acute lymphocytic leukemia (all)
48747|NCT03263637|Chronic lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
48748|NCT03263637|High risk Myelodysplastic syndrome (MDS)|high risk myelodysplastic syndrome (mds)
48749|NCT03263637|Chronic Myelomonocytic Leukemia (CML)|chronic myelomonocytic leukemia (cml)
50422|NCT03253653|SPMA|spma
48750|NCT03263637|Richter's syndrome|richter's syndrome
48751|NCT03263637|B-cell Non-Hodgkin Lymphoma (B-cell NHL)|b-cell non-hodgkin lymphoma (b-cell nhl)
48752|NCT03263637|T-cell Non-Hodgkin Lymphoma (T-cell NHL)|t-cell non-hodgkin lymphoma (t-cell nhl)
48753|NCT03263637|Small lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
48754|NCT03263637|Multiple Myeloma (MM)|multiple myeloma (mm)
48755|NCT03263624|psoriasis|psoriasis
48756|NCT03263624|laser|laser
48757|NCT03263624|nail|nail
48758|NCT03263611|disc degeneration|disc degeneration
48759|NCT03263611|Intervertebral disc|intervertebral disc
48760|NCT03263611|discogenic pain|discogenic pain
48761|NCT03263611|chronic discogenic lumbar back pain|chronic discogenic lumbar back pain
48762|NCT03263598|liver cirrhosis|liver cirrhosis
48763|NCT03263598|ascites|ascites
48764|NCT03263585|Osteoporosis|osteoporosis
48765|NCT03263585|Vertebral Fracture|vertebral fracture
48766|NCT03263585|Back Pain|back pain
48767|NCT03263585|Spinal orthosis|spinal orthosis
48768|NCT03263585|Elderly women|elderly women
48769|NCT03263572|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
48770|NCT03263572|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
48771|NCT03263572|ALL|all
48772|NCT03263572|Philadelphia chromosome-positive acute lymphoblastic leukemia|philadelphia chromosome-positive acute lymphoblastic leukemia
48773|NCT03263572|Ph+ ALL|ph+ all
48774|NCT03263572|BCR-ABL-positive ALL|bcr-abl-positive all
48775|NCT03263572|ALL relapsed or refractory|all relapsed or refractory
48776|NCT03263572|Methotrexate|methotrexate
48777|NCT03263572|Cytarabine|cytarabine
48778|NCT03263572|Ara-C|ara-c
48779|NCT03263572|Cytosar|cytosar
48780|NCT03263572|DepoCyt|depocyt
48781|NCT03263572|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
48782|NCT03263572|Blinatumomab|blinatumomab
48783|NCT03263572|Dexamethasone|dexamethasone
48784|NCT03263572|Decadron|decadron
48785|NCT03263572|Ponatinib|ponatinib
48786|NCT03263572|Iclusig|iclusig
48787|NCT03263572|AP24534|ap24534
48788|NCT03263559|Reduced Intensity Conditioning|reduced intensity conditioning
48789|NCT03263559|Haploidentical|haploidentical
48790|NCT03263559|Bone Marrow|bone marrow
48791|NCT03263559|Transplant|transplant
48792|NCT03263559|Sickle Cell Disease|sickle cell disease
48793|NCT03263533|schizophrenia|schizophrenia
48794|NCT03263533|clozapine|clozapine
48795|NCT03263533|vorinostat|vorinostat
48796|NCT03263533|HDAC|hdac
48797|NCT03263533|histone deacetylase inhibitor|histone deacetylase inhibitor
48798|NCT03263507|IONIS PKK-LRx|ionis pkk-lrx
48799|NCT03263455|neglect,|neglect,
48800|NCT03263455|stroke,|stroke,
48801|NCT03263455|rehabilitation,|rehabilitation,
48802|NCT03263455|range of motion|range of motion
48803|NCT03263416|Metastatic solid tumor|metastatic solid tumor
48804|NCT03263416|Oral Targeted Therapy|oral targeted therapy
48805|NCT03263416|Treatment adherence|treatment adherence
48806|NCT03263403|Meningococcal Vaccine|meningococcal vaccine
48807|NCT03263403|Ingovax ACWY|ingovax acwy
48808|NCT03263403|adults|adults
48809|NCT03263403|Bangladeshi|bangladeshi
48810|NCT03263403|immunogenicity|immunogenicity
48811|NCT03263390|Obesity|obesity
48812|NCT03263390|Bariatric Surgery|bariatric surgery
48813|NCT03263390|Anti Obesity Medications|anti obesity medications
48814|NCT03263390|Weight Regulation|weight regulation
48815|NCT03263390|Pluripotent Stem Cells|pluripotent stem cells
48816|NCT03263377|School feeding|school feeding
48817|NCT03263377|Fortified Biscuits|fortified biscuits
48818|NCT03263377|Bangladesh|bangladesh
48819|NCT03263312|myocardial fibrosis|myocardial fibrosis
48820|NCT03263312|exercise training|exercise training
48821|NCT03263312|Fontan|fontan
48822|NCT03263273|Minocycline|minocycline
48823|NCT03263273|Topical|topical
48824|NCT03263273|Tetracycline|tetracycline
48825|NCT03263273|Doxycycline|doxycycline
48826|NCT03263273|Rosacea|rosacea
48827|NCT03263273|Skin Disease|skin disease
48828|NCT03263273|Anti-Bacterial Agent|anti-bacterial agent
48829|NCT03263273|Anti-Inflammatory Agent|anti-inflammatory agent
48830|NCT03263260|stent, DES, Inspiron|stent, des, inspiron
48831|NCT03263195|HIV|hiv
48832|NCT03263195|Zika Virus|zika virus
48833|NCT03263195|Pregnancy|pregnancy
48834|NCT03263195|MTCT|mtct
48835|NCT03263182|childbirth|childbirth
48836|NCT03263182|delivery|delivery
48837|NCT03263169|e-health, community networks, pragmatic RCT|e-health, community networks, pragmatic rct
48838|NCT03263156|sleep|sleep
48839|NCT03263156|ADHD|adhd
48840|NCT03263156|behavioural intervention|behavioural intervention
48841|NCT03263156|insomnia|insomnia
48842|NCT03263130|COPD, Emphysema, Asthma COPD Overlap|copd, emphysema, asthma copd overlap
48843|NCT03263117|Acute stroke|acute stroke
48844|NCT03263117|Cerebral Stroke|cerebral stroke
48845|NCT03263091|Myelodysplastic Syndromes|myelodysplastic syndromes
48846|NCT03263091|Anemia|anemia
48847|NCT03263091|Hemoglobin (Hb)|hemoglobin (hb)
48848|NCT03263091|Low Risk Myelodysplastic Syndrome|low risk myelodysplastic syndrome
48849|NCT03263091|Low Risk MDS|low risk mds
50423|NCT03253653|1-HOP|1-hop
48850|NCT03263078|inhalation,intravenous anesthesia|inhalation,intravenous anesthesia
48851|NCT03263065|Nopal|nopal
48852|NCT03263065|Bran|bran
48853|NCT03263065|Psyllium|psyllium
48854|NCT03263052|kidney transplant|kidney transplant
48855|NCT03263052|immunosuppression|immunosuppression
48856|NCT03263052|tacrolimus XR|tacrolimus xr
48857|NCT03263052|elderly|elderly
48858|NCT03263052|quality of life|quality of life
48859|NCT03263052|neurological adverse events|neurological adverse events
48860|NCT03263039|Programmed Cell Death 1 Receptor|programmed cell death 1 receptor
48861|NCT03263039|Pembrolizumab|pembrolizumab
48862|NCT03263039|Keytruda|keytruda
48863|NCT03263039|MK-3475|mk-3475
48864|NCT03263039|Urothelial Carcinoma|urothelial carcinoma
48865|NCT03263026|Lymphoma|lymphoma
48866|NCT03263026|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
48867|NCT03263026|enzastaurin|enzastaurin
48868|NCT03263013|Functional (BOLD) MRI|functional (bold) mri
48869|NCT03263000|Belpharospasm|belpharospasm
48870|NCT03263000|Blink Reflex|blink reflex
48871|NCT03263000|Eyeblink|eyeblink
48872|NCT03262974|Imatinib|imatinib
48873|NCT03262974|Pharmacogenetics|pharmacogenetics
48874|NCT03262974|CML|cml
48875|NCT03262974|Plasma level|plasma level
48876|NCT03262961|Mild pre-eclampsia Sildenafil Citrate|mild pre-eclampsia sildenafil citrate
48877|NCT03262922|systemic scleroderma|systemic scleroderma
48878|NCT03262922|environmental and professional toxics|environmental and professional toxics
48879|NCT03262896|Brain Death|brain death
48880|NCT03262896|Spinal Reflex|spinal reflex
48881|NCT03262896|Electromyography|electromyography
48882|NCT03262883|Prolonged akut mechanical ventilation|prolonged akut mechanical ventilation
48883|NCT03262883|Tracheotomy|tracheotomy
48884|NCT03262857|magnesium sulfate|magnesium sulfate
48885|NCT03262857|pulpitis|pulpitis
48886|NCT03262857|anesthesia|anesthesia
48887|NCT03262805|Knee OA|knee oa
48888|NCT03262805|Joint Pain|joint pain
48889|NCT03262805|Dietary supplement|dietary supplement
48890|NCT03262805|WOMAC|womac
48891|NCT03262805|Lequesne index|lequesne index
48892|NCT03262805|hs-CRP|hs-crp
48893|NCT03262766|Acute Intermittent Hypoxia|acute intermittent hypoxia
48894|NCT03262766|Upper Extremity Training|upper extremity training
48895|NCT03262714|Dance, walking, cardiovascular risk, functional capacity.|dance, walking, cardiovascular risk, functional capacity.
48896|NCT03262688|INL-001|inl-001
48897|NCT03262688|Bupivacaine|bupivacaine
48898|NCT03262688|Collagen|collagen
48899|NCT03262688|Children|children
48900|NCT03262688|Pediatric|pediatric
48901|NCT03262688|Inguinal hernia|inguinal hernia
48902|NCT03262675|Heart Failure|heart failure
48903|NCT03262675|Acute Heart Failure|acute heart failure
48904|NCT03262675|Chronic Heat Failure|chronic heat failure
48905|NCT03262675|Cardiovascular diseases|cardiovascular diseases
48906|NCT03262675|Heart diseases|heart diseases
48907|NCT03262675|Registry|registry
48908|NCT03262675|Tunisia|tunisia
48909|NCT03262597|fluid balance|fluid balance
48910|NCT03262597|dehydration|dehydration
48911|NCT03262597|rehydration|rehydration
48912|NCT03262597|electrolytes|electrolytes
48913|NCT03262597|urine|urine
48914|NCT03262571|Heart failure|heart failure
48915|NCT03262571|Lung ultrasound|lung ultrasound
48916|NCT03262571|B-lines|b-lines
48917|NCT03262558|staphylococcus aureus|staphylococcus aureus
48918|NCT03262558|nosocomial infection|nosocomial infection
48919|NCT03262532|Interactive web-base simulation|interactive web-base simulation
48920|NCT03262493|intubation, gastrointestinal|intubation, gastrointestinal
48921|NCT03262493|nursing|nursing
48922|NCT03262493|clinical trial|clinical trial
48923|NCT03262493|enteral nutrition|enteral nutrition
48924|NCT03262441|HIV|hiv
48925|NCT03262441|Antiretroviral treatment|antiretroviral treatment
48926|NCT03262441|Mycophenolate mofetil|mycophenolate mofetil
48927|NCT03262441|Cure|cure
48928|NCT03262441|Latency|latency
48929|NCT03262441|Reservoir|reservoir
48930|NCT03262441|CD4 T cell|cd4 t cell
48931|NCT03262441|Anti-proliferation|anti-proliferation
48932|NCT03262415|LabPatch Continuous Glucose Monitoring (CGM)|labpatch continuous glucose monitoring (cgm)
48933|NCT03262402|Chronic periodontitis|chronic periodontitis
48934|NCT03262402|Candida spp|candida spp
48935|NCT03262402|Histatin-5|histatin-5
48936|NCT03262402|Lactoferrin|lactoferrin
48937|NCT03262389|positron emission tomography (PET)|positron emission tomography (pet)
48938|NCT03262389|computerized tomography (CT)|computerized tomography (ct)
48939|NCT03262389|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
48940|NCT03262389|Fludeoxyglucose (F-18 FDG)|fludeoxyglucose (f-18 fdg)
48941|NCT03262389|C-11 acetate|c-11 acetate
48942|NCT03262376|Stress|stress
48943|NCT03262376|Anxiety|anxiety
48944|NCT03262376|Cortisol|cortisol
48945|NCT03262376|Vitamins|vitamins
48946|NCT03262376|Botanicals|botanicals
48947|NCT03262376|Minerals|minerals
48948|NCT03262363|nutrigenomics|nutrigenomics
48949|NCT03262363|Diet-gene interaction,|diet-gene interaction,
48950|NCT03262363|Curcumin,|curcumin,
48951|NCT03262363|Antioxidants,|antioxidants,
48952|NCT03262363|Human NFE2L2 protein,|human nfe2l2 protein,
48953|NCT03262363|Polymorphism,|polymorphism,
48954|NCT03262363|Diabetes,|diabetes,
48955|NCT03262363|Chronic kidney disease|chronic kidney disease
48956|NCT03262324|Foot and Ankle|foot and ankle
48957|NCT03262324|Disorders|disorders
48958|NCT03262324|Outcome Measure|outcome measure
48959|NCT03262298|CD22|cd22
48960|NCT03262298|CAR-T|car-t
48961|NCT03262298|Leukemia|leukemia
48962|NCT03262298|Lymphoma|lymphoma
48963|NCT03262220|Haematological malignancy|haematological malignancy
48964|NCT03262220|Total Marrow Irradiation|total marrow irradiation
48965|NCT03262220|Volumetric Arc Therapy|volumetric arc therapy
48966|NCT03262181|Exercise|exercise
48967|NCT03262181|Physical Activity|physical activity
48968|NCT03262181|Biomechanics|biomechanics
48969|NCT03262168|Exercise|exercise
48970|NCT03262168|Physical Activity|physical activity
48971|NCT03262142|COPD|copd
48972|NCT03262142|Pseudomonas Aeruginosa|pseudomonas aeruginosa
48973|NCT03262116|bionic pancreas|bionic pancreas
48974|NCT03262116|insulin|insulin
48975|NCT03262116|continuous glucose monitor|continuous glucose monitor
48976|NCT03262116|type 1 diabetes|type 1 diabetes
48977|NCT03262116|insulin pharmacokinetics|insulin pharmacokinetics
48978|NCT03262103|Prostate Cancer|prostate cancer
48979|NCT03262103|Gleason 8-10|gleason 8-10
48980|NCT03262103|Immunotherapy|immunotherapy
48981|NCT03262103|Neoadjuvant|neoadjuvant
48982|NCT03262090|Emergence Delirium|emergence delirium
48983|NCT03262090|desoflurane|desoflurane
48984|NCT03262090|general anesthesia|general anesthesia
48985|NCT03262077|photodynamic therapy|photodynamic therapy
48986|NCT03262077|periodontal disease|periodontal disease
48987|NCT03262077|dosimetry|dosimetry
48988|NCT03262077|methylene blue|methylene blue
48989|NCT03262051|cytochrome|cytochrome
48990|NCT03262051|chronic inflammation|chronic inflammation
48991|NCT03262051|genotyping|genotyping
48992|NCT03262051|phenotyping|phenotyping
48993|NCT03262051|acute inflammation|acute inflammation
48994|NCT03262051|rheumatoid arthritis|rheumatoid arthritis
48995|NCT03262038|intrathecal morphine|intrathecal morphine
48996|NCT03262025|Primary cecal pathology|primary cecal pathology
48997|NCT03262025|Emergency laparotomy|emergency laparotomy
48998|NCT03262025|Ruptured liver abscess|ruptured liver abscess
48999|NCT03262025|Right hemicolectomy|right hemicolectomy
49000|NCT03262025|Conservative colonic resection|conservative colonic resection
49001|NCT03262025|Fulminant amoebic colitis|fulminant amoebic colitis
49002|NCT03262025|Ileocecal resection|ileocecal resection
49003|NCT03262025|Ileoascending anastomosis|ileoascending anastomosis
49004|NCT03262025|Ileotransverse anastomosis|ileotransverse anastomosis
49005|NCT03262025|Cecal diverticulitis|cecal diverticulitis
49006|NCT03262025|Amoebic typhilitis|amoebic typhilitis
49007|NCT03262025|Idiopathic typhilitis|idiopathic typhilitis
49008|NCT03261999|Prostate Neoplasm Cancer Carcinoma|prostate neoplasm cancer carcinoma
49009|NCT03261986|Trident|trident
49010|NCT03261986|RSA|rsa
49011|NCT03261986|THA|tha
49012|NCT03261947|Drug therapy|drug therapy
49013|NCT03261934|Chronic Atrophic Gastritis|chronic atrophic gastritis
49014|NCT03261934|Malignant Transformation|malignant transformation
49015|NCT03261934|Risk Assessment|risk assessment
49016|NCT03261934|Syndrome Evolution|syndrome evolution
49017|NCT03261934|Traditional Chinese Medicine|traditional chinese medicine
49018|NCT03261934|Registry Study|registry study
49019|NCT03261869|Ice pack therapy, third molar surgery, swelling, pain, trismus|ice pack therapy, third molar surgery, swelling, pain, trismus
49020|NCT03261856|Breath test|breath test
49021|NCT03261856|SIBO|sibo
49022|NCT03261856|GI|gi
49023|NCT03261843|platelet rich plasma , posterior lumbar interbody fusion|platelet rich plasma , posterior lumbar interbody fusion
49024|NCT03261830|Antibiotic|antibiotic
49025|NCT03261830|Pediatric|pediatric
49026|NCT03261817|web|web
49027|NCT03261817|brain imaging|brain imaging
49028|NCT03261817|heart rate variability|heart rate variability
49029|NCT03261817|circadian cycles|circadian cycles
49030|NCT03261817|cognition|cognition
49031|NCT03261817|well-being|well-being
49032|NCT03261817|hippocampus|hippocampus
49033|NCT03261817|N acetyl aspartate|n acetyl aspartate
49034|NCT03261817|white matter|white matter
49035|NCT03261817|physical activity|physical activity
49036|NCT03261791|hepatocellular carcinoma|hepatocellular carcinoma
49037|NCT03261791|apatinib|apatinib
49038|NCT03261791|portal vein invasion|portal vein invasion
49039|NCT03261791|adjuvant therapy|adjuvant therapy
49040|NCT03261791|resection|resection
49041|NCT03261739|NAFLD, CB1 receptor blockade, anti-CB1 monoclonal antibody|nafld, cb1 receptor blockade, anti-cb1 monoclonal antibody
49042|NCT03261726|unilateral deafness|unilateral deafness
49043|NCT03261726|acoustic neuroma|acoustic neuroma
49044|NCT03261726|cochlear implant|cochlear implant
49045|NCT03261713|rehabilitation|rehabilitation
49046|NCT03261713|telerehabilitation|telerehabilitation
49047|NCT03261713|feasibility studies|feasibility studies
49048|NCT03261713|virtual reality|virtual reality
49049|NCT03261700|women Veterans|women veterans
49050|NCT03261700|interpersonal violence|interpersonal violence
49051|NCT03261687|pregnancy|pregnancy
49052|NCT03261687|pelvic girdle pain|pelvic girdle pain
49053|NCT03261687|hydrotherapy|hydrotherapy
49054|NCT03261687|quality of life|quality of life
49055|NCT03261687|physical therapy|physical therapy
49056|NCT03261674|Insomnia|insomnia
49057|NCT03261674|Traumatic Brain Injury|traumatic brain injury
49058|NCT03261674|Cognitive Behavioral Therapy|cognitive behavioral therapy
49059|NCT03261674|Veterans|veterans
49060|NCT03261622|Sacral Nerve Stimulation|sacral nerve stimulation
49061|NCT03261622|Sacral Nerve Modulation|sacral nerve modulation
49062|NCT03261609|extremely preterm|extremely preterm
49063|NCT03261609|young adults|young adults
49064|NCT03261609|CVD risks factors|cvd risks factors
49065|NCT03261609|inflammation|inflammation
49066|NCT03261609|chronic health conditions|chronic health conditions
49067|NCT03261609|term|term
49068|NCT03261596|Soil-transmitted helminth|soil-transmitted helminth
49069|NCT03261596|hookworm|hookworm
49070|NCT03261596|hookworm infections|hookworm infections
49071|NCT03261596|necator americanus|necator americanus
49072|NCT03261596|ancylostoma duodenale|ancylostoma duodenale
49073|NCT03261570|Postural Orthostatic Tachycardia Syndrome (POTS)|postural orthostatic tachycardia syndrome (pots)
49074|NCT03261570|POTS|pots
49075|NCT03261570|Orthostatic Intolerance|orthostatic intolerance
49076|NCT03261570|Digoxin|digoxin
49077|NCT03261570|Pyridostigmine|pyridostigmine
49078|NCT03261570|Mestinon|mestinon
49079|NCT03261531|Overweight|overweight
49080|NCT03261531|Class I Obesity|class i obesity
49081|NCT03261518|ileus|ileus
49082|NCT03261518|Contrast-induced Nephropathy|contrast-induced nephropathy
49083|NCT03261518|vena cava inferior|vena cava inferior
49084|NCT03261505|fMRI|fmri
49085|NCT03261505|acupuncture|acupuncture
49086|NCT03261505|osteoarthritis|osteoarthritis
49087|NCT03261479|pneumonia|pneumonia
49088|NCT03261479|thermal imaging|thermal imaging
49089|NCT03261479|respiratory distress|respiratory distress
49090|NCT03261479|x-ray|x-ray
49091|NCT03261479|thermal|thermal
49092|NCT03261466|obesity|obesity
49093|NCT03261466|paediatric|paediatric
49094|NCT03261466|probiotic|probiotic
49095|NCT03261401|Healthy Subjects|healthy subjects
49096|NCT03261401|M5717|m5717
49097|NCT03261401|Malaria|malaria
49098|NCT03261401|Plasmodium falciparum|plasmodium falciparum
49099|NCT03261349|Follicular lymphoma|follicular lymphoma
49100|NCT03261349|MALT lymphoma|malt lymphoma
49101|NCT03261349|Waldenström's macroglobulinemia|waldenström's macroglobulinemia
49102|NCT03261349|Hepatitis C virus|hepatitis c virus
49103|NCT03261323|Breast Reconstruction|breast reconstruction
49104|NCT03261323|Mastectomy|mastectomy
49105|NCT03261310|acetaminophen|acetaminophen
49106|NCT03261310|pain|pain
49107|NCT03261310|laminectomy|laminectomy
49108|NCT03261310|craniotomy|craniotomy
49109|NCT03261284|D-dimer|d-dimer
49110|NCT03261284|Nonvalvular atrial fibrillation|nonvalvular atrial fibrillation
49111|NCT03261284|Direct thrombin inhibitor|direct thrombin inhibitor
49113|NCT03261193|quadratus lumborum block|quadratus lumborum block
49114|NCT03261193|post-operative pain|post-operative pain
49115|NCT03261193|cesarean section pain|cesarean section pain
49116|NCT03261193|analgesia|analgesia
49117|NCT03261193|nerve block|nerve block
49118|NCT03261167|Botulinum toxin A|botulinum toxin a
49119|NCT03261167|Safety|safety
49120|NCT03261167|post-stroke upper limb spasticity|post-stroke upper limb spasticity
49121|NCT03261167|Efficacy|efficacy
49122|NCT03261167|GSK1358820|gsk1358820
49123|NCT03261167|double blind|double blind
49124|NCT03261154|Serum iPTH|serum ipth
49125|NCT03261154|Calcium|calcium
49126|NCT03261154|Phosphate|phosphate
49127|NCT03261128|cancer|cancer
49128|NCT03261128|chemotherapy|chemotherapy
49129|NCT03261115|Pain, Benzocaine, Clinical trial|pain, benzocaine, clinical trial
49130|NCT03261102|IBD|ibd
49131|NCT03261102|Crohn|crohn
49132|NCT03261102|adalimumab|adalimumab
49133|NCT03261102|ADAL|adal
49134|NCT03261089|coma, prognosis, cardiac arrest|coma, prognosis, cardiac arrest
49135|NCT03261076|Specific Learning Disorder|specific learning disorder
49136|NCT03261076|Learning Disorders|learning disorders
49137|NCT03261076|Neurodevelopmental Disorders|neurodevelopmental disorders
49138|NCT03261076|Mental Disorders|mental disorders
49139|NCT03261076|Developmental Reading Disability|developmental reading disability
49140|NCT03261076|Reading Disorder|reading disorder
49141|NCT03261076|Conduct Disorder|conduct disorder
49142|NCT03261050|Eating disorder|eating disorder
49143|NCT03261050|Counter attitudinal therapy|counter attitudinal therapy
49144|NCT03261050|fMRI|fmri
49145|NCT03261024|En-masse retraction , Class I bimaxillary protrusion|en-masse retraction , class i bimaxillary protrusion
49146|NCT03261011|immunotherapy|immunotherapy
49147|NCT03261011|immuno-oncology|immuno-oncology
49148|NCT03261011|advanced solid tumors|advanced solid tumors
49149|NCT03260920|oxytocin|oxytocin
49150|NCT03260920|frontotemporal dementia|frontotemporal dementia
49151|NCT03260920|apathy|apathy
49153|NCT03260907|Overactive bladder|overactive bladder
49154|NCT03260907|menopause|menopause
49155|NCT03260907|Postmenopausal overactive bladder|postmenopausal overactive bladder
49156|NCT03260907|Electroacupuncture|electroacupuncture
49157|NCT03260894|Renal cell carcinoma|renal cell carcinoma
49158|NCT03260894|programmed cell death 1 (PD-1) inhibitor|programmed cell death 1 (pd-1) inhibitor
49159|NCT03260894|indoleamine 2|indoleamine 2
49160|NCT03260894|3-dioxygenase 1 (IDO1) inhibitor|3-dioxygenase 1 (ido1) inhibitor
49161|NCT03260881|Epicardial Fat|epicardial fat
49162|NCT03260855|Lymphoma|lymphoma
49163|NCT03260855|Cancer survivorship|cancer survivorship
49164|NCT03260855|Fear|fear
49165|NCT03260842|early detection|early detection
49166|NCT03260842|biomarkers|biomarkers
49167|NCT03260842|pancreas cancer|pancreas cancer
49168|NCT03260829|vitamin C|vitamin c
49169|NCT03260829|palatally impacted canines|palatally impacted canines
49170|NCT03260829|intraepidermal injection|intraepidermal injection
49171|NCT03260816|Preschoolers|preschoolers
49172|NCT03260816|Developmental Delay|developmental delay
49173|NCT03260816|Disruptive Behavior|disruptive behavior
49174|NCT03260816|Early Intervention|early intervention
49175|NCT03260816|Parent-Child Interaction Therapy (PCIT)|parent-child interaction therapy (pcit)
49176|NCT03260816|Telehealth|telehealth
49177|NCT03260816|Telemental Health|telemental health
49178|NCT03260816|Telepsychiatry|telepsychiatry
49179|NCT03260803|osteopenia|osteopenia
49180|NCT03260803|oligopin|oligopin
49181|NCT03260803|postmenopause|postmenopause
49182|NCT03260803|antioxidant|antioxidant
49183|NCT03260803|bone|bone
49184|NCT03260790|Vaccine|vaccine
49185|NCT03260790|Pneumococcal|pneumococcal
49186|NCT03260790|Pneumonia|pneumonia
49187|NCT03260764|Multifocal Contact Lenses|multifocal contact lenses
49188|NCT03260764|Bifocal Spectacles|bifocal spectacles
49189|NCT03260764|Congenital Cataracts|congenital cataracts
49190|NCT03260738|Chronic Low Back Pain|chronic low back pain
49191|NCT03260738|Rehabilitation|rehabilitation
49192|NCT03260738|Robot Poppy|robot poppy
49193|NCT03260712|biliary tract cancer|biliary tract cancer
49194|NCT03260712|metastitic cancer|metastitic cancer
49195|NCT03260712|advanced cancer|advanced cancer
49196|NCT03260712|pembrolizumab|pembrolizumab
49197|NCT03260712|cisplatin|cisplatin
49198|NCT03260712|gemcitabine|gemcitabine
49199|NCT03260712|gallbladder cancer|gallbladder cancer
49200|NCT03260673|cataract|cataract
49201|NCT03260673|phacoemulsification|phacoemulsification
49202|NCT03260673|type 2 diabetes mellitus|type 2 diabetes mellitus
49203|NCT03260673|corneal endothelial cells|corneal endothelial cells
49204|NCT03260634|voriconazole|voriconazole
49205|NCT03260634|therapeutic drug monitoring|therapeutic drug monitoring
49206|NCT03260608|dementia, deficits, burden, caregivers, telemedicine.|dementia, deficits, burden, caregivers, telemedicine.
49207|NCT03260582|cardiac rehabilitation|cardiac rehabilitation
49208|NCT03260582|eHealth|ehealth
49209|NCT03260582|smartphone application|smartphone application
49210|NCT03260569|Mechanical ventilation|mechanical ventilation
49211|NCT03260569|Inhaled nitric oxide|inhaled nitric oxide
49212|NCT03260556|pulmonary fibrosis|pulmonary fibrosis
49213|NCT03260543|ginseng powder|ginseng powder
49214|NCT03260543|Fatty Liver|fatty liver
49215|NCT03260543|Clinical Trial|clinical trial
49216|NCT03260491|Oncology|oncology
49217|NCT03260491|Advanced Non-small Cell Lung Cancer|advanced non-small cell lung cancer
49218|NCT03260491|Inoperable Non-small Cell Lung Cancer|inoperable non-small cell lung cancer
49219|NCT03260491|Metastatic|metastatic
49220|NCT03260491|Unresectable|unresectable
49221|NCT03260491|Epidermal growth factor receptor|epidermal growth factor receptor
49222|NCT03260491|EGFR|egfr
49223|NCT03260478|Traumatic Brain Injury (TBI)|traumatic brain injury (tbi)
49224|NCT03260478|Red Blood Cells (RBC) Transfusion|red blood cells (rbc) transfusion
49225|NCT03260478|Intensive Care Unit (ICU)|intensive care unit (icu)
49226|NCT03260478|Transfusion Threshold|transfusion threshold
49227|NCT03260478|Anemia|anemia
49228|NCT03260478|Oxygen Delivery|oxygen delivery
49229|NCT03260478|Neurocritical Care|neurocritical care
49230|NCT03260478|Critical Care Neurology and Trauma|critical care neurology and trauma
49231|NCT03260465|total hip replacement|total hip replacement
49232|NCT03260465|roentgen stereophotogrammetric analysis|roentgen stereophotogrammetric analysis
49233|NCT03260452|Type 2 diabetes|type 2 diabetes
49234|NCT03260452|Adipose tissue|adipose tissue
49235|NCT03260452|Hematopoiesis|hematopoiesis
49236|NCT03260452|Inflammation|inflammation
49237|NCT03260452|Macrophages|macrophages
49238|NCT03260439|tramadol-penile block -circumcision surgery-anesthesia-child|tramadol-penile block -circumcision surgery-anesthesia-child
49239|NCT03260426|Tolerability diet after surgery|tolerability diet after surgery
49240|NCT03260400|RPNI|rpni
49241|NCT03260400|Regenerative Peripheral Nerve Interface|regenerative peripheral nerve interface
49242|NCT03260335|Challenging behaviour|challenging behaviour
49243|NCT03260335|Biofeedback|biofeedback
49244|NCT03260335|Anxiety management|anxiety management
49245|NCT03260322|Oncology|oncology
49246|NCT03260322|Tumors|tumors
49247|NCT03260322|ASP8374|asp8374
49248|NCT03260322|Locally advanced or metastatic solid tumor malignancies|locally advanced or metastatic solid tumor malignancies
49249|NCT03260296|smartphones addiction|smartphones addiction
49250|NCT03260283|pethidine|pethidine
49251|NCT03260257|Neurofeedback, Gamma band response|neurofeedback, gamma band response
49252|NCT03260244|atrial fibrillation|atrial fibrillation
49253|NCT03260244|atrial flutter|atrial flutter
49254|NCT03260244|supraventricular tachycardia|supraventricular tachycardia
49255|NCT03260244|ventricular tachycardia|ventricular tachycardia
49256|NCT03260244|premature ventricular contractions|premature ventricular contractions
49257|NCT03260244|cardiac mapping system|cardiac mapping system
49258|NCT03260218|postoperative delirium|postoperative delirium
49259|NCT03260218|elderly|elderly
49260|NCT03260218|total joint replacement|total joint replacement
49261|NCT03260218|risk factors for delirium|risk factors for delirium
49262|NCT03260218|postoperative confusion|postoperative confusion
49263|NCT03260205|SPD489|spd489
49264|NCT03260205|Lisdexamfetamine dimesylate|lisdexamfetamine dimesylate
49265|NCT03260205|ADHD|adhd
49266|NCT03260205|hyperactivity|hyperactivity
49267|NCT03260205|Neurobehavioral disorder|neurobehavioral disorder
49268|NCT03260192|circulating tumor DNA|circulating tumor dna
49269|NCT03260166|nicotinamide|nicotinamide
49270|NCT03260166|lupus-associated skin lesion|lupus-associated skin lesion
49271|NCT03260166|lupus erythematosus|lupus erythematosus
49272|NCT03260153|Intracerebral Hemorrhage|intracerebral hemorrhage
49273|NCT03260153|Perihematomal edema|perihematomal edema
49274|NCT03260153|Deproteinised Calf Blood Serum Injection|deproteinised calf blood serum injection
49275|NCT03260140|weight loss|weight loss
49276|NCT03260140|lifestyle|lifestyle
49277|NCT03260140|diet|diet
49278|NCT03260140|exercise|exercise
49279|NCT03260140|randomized controlled trial|randomized controlled trial
49280|NCT03260127|PTSD|ptsd
49281|NCT03260127|treatment|treatment
49282|NCT03260127|posttraumatic stress disorder|posttraumatic stress disorder
49283|NCT03260127|therapy|therapy
49284|NCT03260127|cognition|cognition
49285|NCT03260127|thinking|thinking
49286|NCT03260127|executive function|executive function
49287|NCT03260127|computer|computer
49288|NCT03260127|training|training
49289|NCT03260114|Physical activity|physical activity
49290|NCT03260114|Body weight|body weight
49291|NCT03260114|Obesity|obesity
49292|NCT03260062|cochlear implants|cochlear implants
49293|NCT03260062|language development|language development
49294|NCT03260062|parenting intervention|parenting intervention
49295|NCT03260062|maternal sensitivity|maternal sensitivity
49296|NCT03260062|facilitative language techniques|facilitative language techniques
49297|NCT03260036|Urea synthesis|urea synthesis
49298|NCT03260036|Ammonia|ammonia
49299|NCT03260036|Bariatric surgery|bariatric surgery
49300|NCT03260023|Avelumab|avelumab
49301|NCT03260023|Cancer|cancer
49302|NCT03260023|Anti PD-L1|anti pd-l1
49303|NCT03260023|Therapeutic Vaccine|therapeutic vaccine
49304|NCT03259971|Rett syndrome|rett syndrome
49305|NCT03259971|Tourette syndrome|tourette syndrome
49306|NCT03259971|Probiotic|probiotic
49307|NCT03259919|Metformin|metformin
49308|NCT03259919|Pregnancy outcome|pregnancy outcome
49309|NCT03259919|Androgens|androgens
49310|NCT03259893|Proctor Conceptual Model of Implementation Research|proctor conceptual model of implementation research
49311|NCT03259893|Prevention|prevention
49312|NCT03259893|Safety net hospital|safety net hospital
49313|NCT03259893|Diverse inner city patients|diverse inner city patients
49314|NCT03259880|evaluation|evaluation
49315|NCT03259867|Hepatocellular carcinoma|hepatocellular carcinoma
49316|NCT03259867|Colorectal cancer|colorectal cancer
49317|NCT03259867|Immune checkpoint inhibitor|immune checkpoint inhibitor
49318|NCT03259828|Sigmoid colon cancer|sigmoid colon cancer
49319|NCT03259828|Internal organ motion|internal organ motion
49320|NCT03259828|Radiotherapy|radiotherapy
49321|NCT03259815|FFR Targeted PCI|ffr targeted pci
49322|NCT03259815|Post-PCI FFR|post-pci ffr
49323|NCT03259776|Intensive Care|intensive care
49324|NCT03259776|Patient- and Family-Centred Care|patient- and family-centred care
49325|NCT03259776|Patient and Public Involvement|patient and public involvement
49326|NCT03259776|South West London Major Trauma Network|south west london major trauma network
49327|NCT03259776|Service Improvement|service improvement
49328|NCT03259776|Survey Questionnaire|survey questionnaire
49329|NCT03259776|Visitor Experiences|visitor experiences
49330|NCT03259763|Gastroenterostomy|gastroenterostomy
49331|NCT03259763|Gastric Outlet Obstruction|gastric outlet obstruction
49332|NCT03259763|Cancer|cancer
49333|NCT03259763|Endosonography|endosonography
49334|NCT03259750|Self-reported outcome instrument|self-reported outcome instrument
49335|NCT03259750|Sport|sport
49336|NCT03259750|Ankle and foot|ankle and foot
49337|NCT03259750|Injury|injury
49338|NCT03259711|Cardiotoxicity|cardiotoxicity
49339|NCT03259711|selective estrogen receptor modulators|selective estrogen receptor modulators
49340|NCT03259711|aromatase inhibitors|aromatase inhibitors
49341|NCT03259711|hormone replacement therapy|hormone replacement therapy
49342|NCT03259711|estrogen|estrogen
49343|NCT03259685|Non-nutritive sweeteners|non-nutritive sweeteners
49344|NCT03259685|High Sugar Sweetened Beverages|high sugar sweetened beverages
49345|NCT03259685|Diet|diet
49346|NCT03259672|intubation|intubation
49347|NCT03259672|pharyngitis|pharyngitis
49348|NCT03259672|remifentanil|remifentanil
49349|NCT03259633|Neurofibromatosis type1,|neurofibromatosis type1,
49350|NCT03259633|Plexiform Neurofibromas|plexiform neurofibromas
49351|NCT03259633|inoperable, progressive/symptomatic plexiform neurofibromas (PN) without any alternative therapeutic options|inoperable, progressive/symptomatic plexiform neurofibromas (pn) without any alternative therapeutic options
49352|NCT03259633|mutation in the NF1 gene|mutation in the nf1 gene
49353|NCT03259633|Selumetinib|selumetinib
49354|NCT03259633|Early Access|early access
49355|NCT03259633|Intermediate Access Protocol|intermediate access protocol
49356|NCT03259607|Bioequivalence|bioequivalence
49357|NCT03259594|Renal functional reserve|renal functional reserve
49358|NCT03259594|Simple renal cysts|simple renal cysts
49359|NCT03259594|Laparoscopic deroofing|laparoscopic deroofing
49360|NCT03259581|transarterial chemoembolization|transarterial chemoembolization
49361|NCT03259568|TMS|tms
49362|NCT03259555|Brexpiprazole|brexpiprazole
49363|NCT03259555|Bipolar|bipolar
49364|NCT03259555|Manic episode|manic episode
49365|NCT03259529|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
49366|NCT03259529|Nivolumab|nivolumab
49367|NCT03259529|Bendamustine Hydrochloride|bendamustine hydrochloride
49368|NCT03259529|Gemcitabine|gemcitabine
49369|NCT03259529|Rituximab|rituximab
49370|NCT03259516|myelodysplastic syndrome|myelodysplastic syndrome
49371|NCT03259516|nivolumab|nivolumab
49372|NCT03259516|5-azacitidine|5-azacitidine
49373|NCT03259516|cytarabine|cytarabine
49374|NCT03259516|melphalan|melphalan
49375|NCT03259516|all-trans retinoic acid|all-trans retinoic acid
49376|NCT03259516|lymphodepletion|lymphodepletion
49377|NCT03259503|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
49378|NCT03259503|Lymphoma|lymphoma
49379|NCT03259503|Refractory|refractory
49380|NCT03259503|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
49381|NCT03259503|DLBCL|dlbcl
49382|NCT03259503|Palifermin|palifermin
49383|NCT03259503|Kepivance|kepivance
49384|NCT03259503|Olaparib|olaparib
49385|NCT03259503|Lynparza|lynparza
49386|NCT03259503|Vorinostat|vorinostat
49387|NCT03259503|SAHA|saha
49388|NCT03259503|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
49389|NCT03259503|MSK-390|msk-390
49390|NCT03259503|Zolinza|zolinza
49391|NCT03259503|Dexamethasone|dexamethasone
49392|NCT03259503|Decadron|decadron
49393|NCT03259503|Rituximab|rituximab
49394|NCT03259503|Rituxan|rituxan
49395|NCT03259503|Caphosol|caphosol
49396|NCT03259503|Melphalan|melphalan
49397|NCT03259503|Alkeran|alkeran
49398|NCT03259503|Evomela|evomela
49399|NCT03259503|Glutamine|glutamine
49400|NCT03259503|Enterex|enterex
49401|NCT03259503|Glutapak-10|glutapak-10
49402|NCT03259503|NutreStore|nutrestore
49403|NCT03259503|Resource|resource
49404|NCT03259503|GlutaSolve|glutasolve
49405|NCT03259503|Sympt-X G.I|sympt-x g.i
49406|NCT03259503|Sympt-X|sympt-x
49407|NCT03259503|Gemcitabine|gemcitabine
49408|NCT03259503|Gemcitabine Hydrochloride|gemcitabine hydrochloride
49409|NCT03259503|Gemzar|gemzar
49410|NCT03259503|Busulfan|busulfan
49411|NCT03259503|Busulfex|busulfex
49412|NCT03259503|Myleran|myleran
49413|NCT03259503|Pyridoxine|pyridoxine
49414|NCT03259503|Autologous Stem-Cell Transplant|autologous stem-cell transplant
49415|NCT03259503|ASCT|asct
49416|NCT03259503|G-CSF|g-csf
49417|NCT03259503|Filgrastim|filgrastim
49418|NCT03259503|Neupogen|neupogen
49419|NCT03259477|laparoscopic partial nephrectomy|laparoscopic partial nephrectomy
49420|NCT03259477|precise segmental renal arterial clamping|precise segmental renal arterial clamping
49421|NCT03259477|renal cell carcinoma|renal cell carcinoma
49422|NCT03259477|renal functional reserve|renal functional reserve
49423|NCT03259438|Qigong|qigong
49424|NCT03259438|Comprehensive Health Improvement Program (CHIP)|comprehensive health improvement program (chip)
49425|NCT03259438|Pre-Train Injury Prevention Program|pre-train injury prevention program
49426|NCT03259438|Cancer Related Fatigue|cancer related fatigue
49427|NCT03259438|Cancer Survivorship|cancer survivorship
49428|NCT03259438|Inflammation|inflammation
49429|NCT03259438|Flowmetry|flowmetry
49430|NCT03259438|Corticomuscular coherence|corticomuscular coherence
49431|NCT03259438|Heart Rate Variability|heart rate variability
49432|NCT03259438|Neuroimmune Interactions|neuroimmune interactions
49433|NCT03259438|Complex Systems Analysis|complex systems analysis
49434|NCT03259438|Female|female
49435|NCT03259425|Resectable Stage IIIB, IIIC, and IVM1a|resectable stage iiib, iiic, and ivm1a
49436|NCT03259373|AF|af
49437|NCT03259373|AFib|afib
49438|NCT03259373|OAC|oac
49439|NCT03259373|Atrial fibrillation|atrial fibrillation
49440|NCT03259373|Oral anticoagulant|oral anticoagulant
49441|NCT03259373|Education|education
49442|NCT03259360|Tobacco|tobacco
49443|NCT03259360|Gender Identity Minority|gender identity minority
49444|NCT03259360|Sexual Identity Minority|sexual identity minority
49445|NCT03259360|Cessation|cessation
49446|NCT03259360|Intervention|intervention
49447|NCT03259360|Young Adults|young adults
49448|NCT03259360|Social Media|social media
49449|NCT03259360|Internet|internet
49450|NCT03259360|Cigarette|cigarette
49451|NCT03259321|Fish|fish
49452|NCT03259321|Polyunsaturated fatty acids|polyunsaturated fatty acids
49453|NCT03259321|CHNS|chns
49454|NCT03259295|skin tag|skin tag
49455|NCT03259243|Bupivacaine, Port site infiltration ,Postoperative pain ,Gynecologic laparoscopy|bupivacaine, port site infiltration ,postoperative pain ,gynecologic laparoscopy
49456|NCT03259230|Hemophagocytic Lymphohistiocytosis|hemophagocytic lymphohistiocytosis
49457|NCT03259230|Malignancy-Associated Hemophagocytic Lymphohistiocytosis|malignancy-associated hemophagocytic lymphohistiocytosis
49458|NCT03259230|M-HLH|m-hlh
49459|NCT03259230|Patients with known diagnosis of malignancy without HLH|patients with known diagnosis of malignancy without hlh
49460|NCT03259230|Interferon Gamma|interferon gamma
49461|NCT03259230|IFNγ|ifnγ
49462|NCT03259230|Biomarkers|biomarkers
49463|NCT03259230|Inflammatory Markers|inflammatory markers
49464|NCT03259230|Blood draws|blood draws
49465|NCT03259230|Data collection|data collection
49466|NCT03259204|Achilles tendon|achilles tendon
49467|NCT03259204|Microdialysis|microdialysis
49468|NCT03259204|Immobilization|immobilization
49469|NCT03259204|Wound healing|wound healing
49470|NCT03259204|Intermittent Pneumatic Compression|intermittent pneumatic compression
49471|NCT03259204|Ultrasonography|ultrasonography
49472|NCT03259191|Anti-reflux mucosectomy,refractory gastroesophageal reflux disease,safety,efficacy|anti-reflux mucosectomy,refractory gastroesophageal reflux disease,safety,efficacy
49473|NCT03259178|Binocular vision test|binocular vision test
49474|NCT03259165|Heart Failure|heart failure
49475|NCT03259165|Acute Heart Failure|acute heart failure
49476|NCT03259165|Pulmonary Edema|pulmonary edema
49477|NCT03259165|Lung Ultrasound|lung ultrasound
49478|NCT03259165|Extra vascular lung water|extra vascular lung water
49479|NCT03259165|B-lines|b-lines
49480|NCT03259165|Diuretics|diuretics
49481|NCT03259165|Nitrates|nitrates
49482|NCT03259152|Giant cell tumor of bone|giant cell tumor of bone
49483|NCT03259152|Denousmab|denousmab
49484|NCT03259152|Pathologic|pathologic
49485|NCT03259152|Clinical|clinical
49486|NCT03259152|Mechansim|mechansim
49487|NCT03259139|adolescent|adolescent
49488|NCT03259139|gun|gun
49489|NCT03259139|violence|violence
49490|NCT03259139|media|media
49491|NCT03259126|Transradial|transradial
49492|NCT03259126|Coronary|coronary
49493|NCT03259126|X-ray|x-ray
49494|NCT03259126|Radiation|radiation
49495|NCT03259126|Curtain|curtain
49496|NCT03259113|insertable cardiac monitor|insertable cardiac monitor
49497|NCT03259113|atrial fibrillation|atrial fibrillation
49498|NCT03259113|non-sustained ventricular tachycardia|non-sustained ventricular tachycardia
49499|NCT03259074|ankylosing spondylitis, AS, secukinumab, GP2017, adalimumab biosimilar, mSASSS, ASAS20|ankylosing spondylitis, as, secukinumab, gp2017, adalimumab biosimilar, msasss, asas20
49500|NCT03259009|colorectal cancer|colorectal cancer
49501|NCT03259009|anti-EGFR therapy|anti-egfr therapy
49502|NCT03259009|rechallenge|rechallenge
49503|NCT03259009|circulating tumor DNA|circulating tumor dna
49504|NCT03259009|biomarker|biomarker
49505|NCT03259009|RAS mutations|ras mutations
49506|NCT03258996|Gingival recession|gingival recession
49507|NCT03258996|Class III gingival recession|class iii gingival recession
49508|NCT03258996|Multiples gingival recessions|multiples gingival recessions
49509|NCT03258996|Periodontitis|periodontitis
49510|NCT03258996|Mucogingival surgery|mucogingival surgery
49511|NCT03258996|Modified vestibular incision subperiosteal tunnel access|modified vestibular incision subperiosteal tunnel access
49512|NCT03258996|Coronally advanced flap|coronally advanced flap
49513|NCT03258996|Connective tissue graft|connective tissue graft
49514|NCT03258996|Post-surgical pain|post-surgical pain
49515|NCT03258983|Alpha-linolenic acid|alpha-linolenic acid
49516|NCT03258983|Dietary intake|dietary intake
49517|NCT03258983|Adipose tissue|adipose tissue
49518|NCT03258983|Nutritional epidemiology|nutritional epidemiology
49519|NCT03258970|vitamin supplement|vitamin supplement
49520|NCT03258970|Vitamin C|vitamin c
49521|NCT03258970|Vitamin E|vitamin e
49522|NCT03258905|transition-age youth|transition-age youth
49523|NCT03258905|mobile app|mobile app
49524|NCT03258905|grounding|grounding
49525|NCT03258905|Seeking Safety|seeking safety
49526|NCT03258879|Combined spinal epidural analgesia, dural puncture epidural|combined spinal epidural analgesia, dural puncture epidural
49527|NCT03258866|thrombocytopenia|thrombocytopenia
49528|NCT03258866|Immune Thrombocytopenia|immune thrombocytopenia
49529|NCT03258866|purpura|purpura
49530|NCT03258853|cystic fibrosis|cystic fibrosis
49531|NCT03258853|insulin|insulin
49532|NCT03258853|glucagon|glucagon
49533|NCT03258853|continuous glucose monitor|continuous glucose monitor
49534|NCT03258853|bionic pancreas|bionic pancreas
49535|NCT03258840|EPA|epa
49536|NCT03258840|Paraoxonase 1|paraoxonase 1
49537|NCT03258840|Paraoxonase 2|paraoxonase 2
49538|NCT03258840|Type 2 diabetes|type 2 diabetes
49539|NCT03258827|elderly|elderly
49540|NCT03258827|sarcopenia|sarcopenia
49541|NCT03258827|strengthening exercise|strengthening exercise
49542|NCT03258814|axial spondyloarthritis|axial spondyloarthritis
49543|NCT03258814|active supervised training|active supervised training
49544|NCT03258814|physical training|physical training
49545|NCT03258814|adalimumab|adalimumab
49546|NCT03258814|spinal mobility|spinal mobility
49547|NCT03258814|physiotherapy|physiotherapy
49548|NCT03258814|physical function|physical function
49549|NCT03258814|health-related quality of life|health-related quality of life
49550|NCT03258814|pain|pain
49551|NCT03258814|disease activity|disease activity
49552|NCT03258814|psychosocial risk factors|psychosocial risk factors
49553|NCT03258814|workability|workability
49554|NCT03258814|Bath Ankylosing Spondylitis Metrology Index (BASMI)|bath ankylosing spondylitis metrology index (basmi)
49555|NCT03258775|RMR|rmr
49556|NCT03258775|hydration|hydration
49557|NCT03258775|substrate oxidation|substrate oxidation
49558|NCT03258762|Japanese|japanese
49559|NCT03258762|Caucasian|caucasian
49560|NCT03258762|pharmacokinetics|pharmacokinetics
49561|NCT03258762|pyrimethamine|pyrimethamine
49562|NCT03258762|toxoplasmosis|toxoplasmosis
49563|NCT03258749|COPD|copd
49564|NCT03258749|GOLD|gold
49565|NCT03258749|formoterol|formoterol
49566|NCT03258749|tiotropium|tiotropium
49567|NCT03258736|pediatric, inguinal hernia, caudal, ilioinguinal/ilioihypogastric|pediatric, inguinal hernia, caudal, ilioinguinal/ilioihypogastric
49568|NCT03258710|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
49569|NCT03258710|safety|safety
49570|NCT03258710|chronic hepatitis B|chronic hepatitis b
49571|NCT03258710|virological effect|virological effect
49572|NCT03258697|Local analgesia, Pharmacokinetics, Total joint replacement|local analgesia, pharmacokinetics, total joint replacement
49573|NCT03258684|corticosteroid|corticosteroid
49574|NCT03258684|hydrocortisone|hydrocortisone
49575|NCT03258684|septic shock|septic shock
49576|NCT03258684|thiamine|thiamine
49577|NCT03258684|vitamin C|vitamin c
49578|NCT03258658|Urethral Stricture|urethral stricture
49579|NCT03258632|Alcohol Use Disorder|alcohol use disorder
49580|NCT03258606|Research Participants|research participants
49581|NCT03258606|Retrospective Review|retrospective review
49582|NCT03258606|Capacity Assignment|capacity assignment
49583|NCT03258606|Cognitive Impairment|cognitive impairment
49584|NCT03258606|Assent|assent
49585|NCT03258593|Carcinoma-in-situ|carcinoma-in-situ
49586|NCT03258593|High-grade Ta or T1 disease|high-grade ta or t1 disease
49587|NCT03258593|Papillary Tumors|papillary tumors
49588|NCT03258580|Pain|pain
49589|NCT03258580|Visual Analogue Pain Scale|visual analogue pain scale
49590|NCT03258580|Healthy Volunteer|healthy volunteer
49591|NCT03258580|Social Cognition|social cognition
49592|NCT03258580|Eye Movement|eye movement
49593|NCT03258567|Monoclonal Antibody|monoclonal antibody
49594|NCT03258541|TraceIT®|traceit®
49595|NCT03258541|Hydrogel spacer|hydrogel spacer
49596|NCT03258541|Rectal cancer|rectal cancer
49597|NCT03258515|Mesenchymal epithelial transition (MET) receptor|mesenchymal epithelial transition (met) receptor
49598|NCT03258515|Small molecule kinase inhibitors|small molecule kinase inhibitors
49599|NCT03258515|Moxifloxacin (Avelox)|moxifloxacin (avelox)
49600|NCT03258515|QT prolongation|qt prolongation
49601|NCT03258437|sperm motility, Clinical Trial , DA-9401|sperm motility, clinical trial , da-9401
49602|NCT03258385|Vitamin B12, Fortified milk, Immunity, Child development|vitamin b12, fortified milk, immunity, child development
49603|NCT03258359|MDS|mds
49604|NCT03258346|Pomegranate Juice|pomegranate juice
49605|NCT03258346|Functional Tasks of Living|functional tasks of living
49606|NCT03258333|aortic stenosis, aortic valve replacement, pericardium|aortic stenosis, aortic valve replacement, pericardium
49607|NCT03258320|Cabazitaxel|cabazitaxel
49608|NCT03258320|Docetaxel|docetaxel
49609|NCT03258320|Mitoxantrone|mitoxantrone
49610|NCT03258320|Satraplatin|satraplatin
49611|NCT03258320|Surgery|surgery
49612|NCT03258320|Prostate Cancer|prostate cancer
49613|NCT03258320|Localized|localized
49614|NCT03258320|High Risk|high risk
49615|NCT03258294|melatonin|melatonin
49616|NCT03258294|sleep disturbances|sleep disturbances
49617|NCT03258229|Angelica gigas N. extract|angelica gigas n. extract
49618|NCT03258229|Glucose|glucose
49619|NCT03258229|Clinical Trial|clinical trial
49620|NCT03258216|Upper gastrointestinal disorders|upper gastrointestinal disorders
49621|NCT03258216|Automatic tongue diagnosis system|automatic tongue diagnosis system
49622|NCT03258216|Panendoscopy|panendoscopy
49623|NCT03258190|Urolithaisis|urolithaisis
49624|NCT03258190|Recurrence|recurrence
49625|NCT03258190|Citrate|citrate
49626|NCT03258190|Antioxidants|antioxidants
49627|NCT03258190|Lime Powder Regimen|lime powder regimen
49628|NCT03258177|Virtual Visits|virtual visits
49629|NCT03258177|Telehealth|telehealth
49630|NCT03258138|Pragmatic|pragmatic
49631|NCT03258138|Pilot study|pilot study
49632|NCT03258138|Mixed methods|mixed methods
49633|NCT03258138|Randomized controlled trial|randomized controlled trial
49634|NCT03258138|Implementation research|implementation research
49635|NCT03258138|Person-centered care|person-centered care
49636|NCT03258138|Multidisciplinary|multidisciplinary
49637|NCT03258138|Ecological approach|ecological approach
49638|NCT03258073|maternal|maternal
49639|NCT03258073|newborn|newborn
49640|NCT03258073|resuscitation|resuscitation
49641|NCT03258073|emergencies|emergencies
49642|NCT03258073|medical simulation|medical simulation
49643|NCT03258060|Heart Failure|heart failure
49644|NCT03258060|Pacing|pacing
49645|NCT03258060|Resynchronization|resynchronization
49646|NCT03258060|Electrophysiology|electrophysiology
49647|NCT03258060|Imaging|imaging
49648|NCT03258060|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
49649|NCT03258034|Conversion therapy|conversion therapy
49650|NCT03258021|Glioblastoma|glioblastoma
49651|NCT03258021|GBM|gbm
49652|NCT03258021|Tumor-treating fields|tumor-treating fields
49653|NCT03258021|TTFields|ttfields
49654|NCT03258008|Malignant neoplasms of lip oral cavity and pharynx|malignant neoplasms of lip oral cavity and pharynx
49655|NCT03258008|Malignant neoplasms of ill-defined secondary and unspecified sites|malignant neoplasms of ill-defined secondary and unspecified sites
49656|NCT03258008|Oropharyngeal Cancer|oropharyngeal cancer
49657|NCT03258008|Oropharyngeal squamous cell carcinoma|oropharyngeal squamous cell carcinoma
49658|NCT03258008|OPSCC|opscc
49659|NCT03258008|Human Papillomavirus - positive (HPV+)|human papillomavirus - positive (hpv+)
49660|NCT03258008|Utomilumab|utomilumab
49661|NCT03258008|PF-05082566|pf-05082566
49662|NCT03258008|Anti-CD137|anti-cd137
49663|NCT03258008|ISA101b|isa101b
49664|NCT03257995|asthma, asthma attack, difficulty breathing, bronchial diseases, lung, lung diseases, inhaled drugs, bronchodilator, inhaled corticosteriod|asthma, asthma attack, difficulty breathing, bronchial diseases, lung, lung diseases, inhaled drugs, bronchodilator, inhaled corticosteriod
49665|NCT03257982|Brain-computer interface|brain-computer interface
49666|NCT03257982|Functional electrical stimulation|functional electrical stimulation
49667|NCT03257969|Oral chemotherapy|oral chemotherapy
49668|NCT03257969|Health related program|health related program
49669|NCT03257969|Secured drug intake|secured drug intake
49670|NCT03257969|Pharmacist intervention|pharmacist intervention
49671|NCT03257969|Cancer outpatient|cancer outpatient
49672|NCT03257917|Financial Burden|financial burden
49673|NCT03257917|Out of Pocket expenses|out of pocket expenses
49674|NCT03257917|Time spent on Healthcare|time spent on healthcare
49675|NCT03257917|Metastatic Breast Cancer|metastatic breast cancer
49676|NCT03257904|intracranial pressure|intracranial pressure
49677|NCT03257891|Adrenocortical Carcinoma|adrenocortical carcinoma
49678|NCT03257891|Cabazitaxel|cabazitaxel
49679|NCT03257865|Brexpiprazole|brexpiprazole
49680|NCT03257865|Bipolar|bipolar
49681|NCT03257865|Manic episode|manic episode
49682|NCT03257852|Methotrexate|methotrexate
49683|NCT03257852|Arthritis, Rheumatoid|arthritis, rheumatoid
49684|NCT03257852|ASP5094|asp5094
49685|NCT03257839|SoftVue|softvue
49686|NCT03257839|Dense Breast Tissue|dense breast tissue
49687|NCT03257839|Breast Screening|breast screening
49688|NCT03257839|Abnormal Breast|abnormal breast
49689|NCT03257839|Normal Breast|normal breast
49690|NCT03257839|Breast Imaging|breast imaging
49691|NCT03257839|Breast Biopsy|breast biopsy
49692|NCT03257839|Mammography|mammography
49693|NCT03257839|Tomosynthesis|tomosynthesis
49694|NCT03257839|Automated Breast Ultrasound|automated breast ultrasound
49695|NCT03257839|Breast Cancer|breast cancer
49696|NCT03257839|Breast Carcinoma|breast carcinoma
49697|NCT03257839|Breast Tumors|breast tumors
49698|NCT03257839|Mammary Carcinoma|mammary carcinoma
49699|NCT03257839|Malignant Breast Tumor|malignant breast tumor
49700|NCT03257839|Mammary Neoplasm|mammary neoplasm
49701|NCT03257839|Mammary Cancer|mammary cancer
49702|NCT03257839|ABUS|abus
49703|NCT03257839|AWBUS|awbus
49704|NCT03257839|Breast Tomography|breast tomography
49705|NCT03257839|ATUS|atus
49706|NCT03257839|ABTUS|abtus
49707|NCT03257839|Mammogram|mammogram
49708|NCT03257839|3D Mammogram|3d mammogram
49709|NCT03257839|3D ABUS|3d abus
49710|NCT03257839|3D Breast Ultrasound|3d breast ultrasound
49711|NCT03257839|DBT|dbt
49712|NCT03257839|FFDM|ffdm
49713|NCT03257839|Digital Mammography|digital mammography
49714|NCT03257839|Breast Ultrasound|breast ultrasound
49715|NCT03257839|Dense Breasts|dense breasts
49716|NCT03257839|Breast Density|breast density
49717|NCT03257839|Dense Parenchyma|dense parenchyma
49718|NCT03257839|Asymptomatic|asymptomatic
49719|NCT03257839|Delphinus|delphinus
49720|NCT03257839|Delphinus Medical Technologies|delphinus medical technologies
49721|NCT03257839|Screening Breast Ultrasound|screening breast ultrasound
49722|NCT03257826|congenital pseudarthrosis of the tibia|congenital pseudarthrosis of the tibia
49723|NCT03257826|age of surgery|age of surgery
49724|NCT03257826|Percutaneous Kirschner wire|percutaneous kirschner wire
49725|NCT03257813|timolol|timolol
49726|NCT03257813|dorzolamide|dorzolamide
49727|NCT03257813|brimonidine|brimonidine
49728|NCT03257813|Glaucoma|glaucoma
49729|NCT03257813|Ocular hypertension|ocular hypertension
49730|NCT03257800|ketamine|ketamine
49732|NCT03257800|laryngeal masks|laryngeal masks
49733|NCT03257800|anesthesia|anesthesia
49734|NCT03257800|child|child
49735|NCT03257722|Non Small Cell Lung Cancer|non small cell lung cancer
49736|NCT03257722|Metastasis|metastasis
49737|NCT03257722|Recurrence|recurrence
49738|NCT03257722|Immunotherapy|immunotherapy
49739|NCT03257670|Dyspareunia|dyspareunia
49740|NCT03257670|Laser|laser
49741|NCT03257670|CO2|co2
49742|NCT03257670|Breast Cancer|breast cancer
49743|NCT03257670|Vaginal Atrophy|vaginal atrophy
49744|NCT03257670|Lidocaine|lidocaine
49745|NCT03257644|Atopic dermatitis|atopic dermatitis
49746|NCT03257644|Janus kinase (JAK) inhibitor|janus kinase (jak) inhibitor
49747|NCT03257644|pediatric|pediatric
49748|NCT03257644|inflammation|inflammation
49749|NCT03257631|Pediatric|pediatric
49750|NCT03257631|Brain Tumor|brain tumor
49751|NCT03257631|Central Nervous System Neoplasms|central nervous system neoplasms
49752|NCT03257631|Glioma|glioma
49753|NCT03257631|High-grade glioma|high-grade glioma
49754|NCT03257631|HGG|hgg
49755|NCT03257631|Ependymoma|ependymoma
49756|NCT03257631|Medulloblastoma|medulloblastoma
49757|NCT03257631|DIPG|dipg
49758|NCT03257631|Diffuse intrinsic pontine gliomaProgressive|diffuse intrinsic pontine gliomaprogressive
49759|NCT03257631|RecurrentPomalidomide|recurrentpomalidomide
49760|NCT03257631|PomalystImnovid|pomalystimnovid
49761|NCT03257631|CC-4047|cc-4047
49762|NCT03257631|Children|children
49763|NCT03257605|Pharmacogenomics|pharmacogenomics
49764|NCT03257605|Medication Therapy Management|medication therapy management
49765|NCT03257579|Myocardial Infarction|myocardial infarction
49766|NCT03257579|Adherence|adherence
49767|NCT03257579|Medication|medication
49768|NCT03257540|bunion|bunion
49769|NCT03257540|early weight-bearing|early weight-bearing
49770|NCT03257540|Lapidus|lapidus
49771|NCT03257540|arthrodesis|arthrodesis
49772|NCT03257540|intramedullary nail|intramedullary nail
49773|NCT03257540|Hallux Valgus|hallux valgus
49774|NCT03257527|Well-being|well-being
49775|NCT03257527|Comparative Clinical Trial|comparative clinical trial
49776|NCT03257527|Positive Psychology Intervention|positive psychology intervention
49777|NCT03257527|Mindfulness Based Stress Reduction (MBSR)|mindfulness based stress reduction (mbsr)
49778|NCT03257527|Group Therapy|group therapy
49779|NCT03257527|Happiness|happiness
49780|NCT03257527|Bibliotherapy|bibliotherapy
49781|NCT03257475|cervical cance|cervical cance
49782|NCT03257475|vaginal radiation injury|vaginal radiation injury
49783|NCT03257475|PIBS|pibs
49784|NCT03257475|R-V|r-v
49785|NCT03257475|VRL|vrl
49786|NCT03257462|17-hydroxyprogesterone|17-hydroxyprogesterone
49787|NCT03257449|Body Weight|body weight
49788|NCT03257449|Weight loss|weight loss
49789|NCT03257449|BMI|bmi
49790|NCT03257449|Waist Circumference|waist circumference
49791|NCT03257449|Body Fat Percentage|body fat percentage
49792|NCT03257449|Viscofiber|viscofiber
49793|NCT03257449|Viscous Fibres|viscous fibres
49794|NCT03257449|supplement|supplement
49795|NCT03257436|Pacing|pacing
49796|NCT03257423|Uncomplicated acute appendicitis|uncomplicated acute appendicitis
49797|NCT03257423|Complicated acute appendicitis|complicated acute appendicitis
49798|NCT03257423|Antibiotic therapy|antibiotic therapy
49799|NCT03257423|Microbiological etiology|microbiological etiology
49800|NCT03257358|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
49801|NCT03257358|RMS|rms
49802|NCT03257358|Relapsing Multiple Sclerosis (RMS)|relapsing multiple sclerosis (rms)
49803|NCT03257358|Multiple Sclerosis|multiple sclerosis
49804|NCT03257358|MS|ms
49805|NCT03257358|Multiple Sclerosis (MS)|multiple sclerosis (ms)
49806|NCT03257358|Fingolimod|fingolimod
49807|NCT03257358|FLUENT|fluent
49808|NCT03257358|Immune Phenotype|immune phenotype
49809|NCT03257345|Real world outcomes|real world outcomes
49810|NCT03257332|Rectum cancer|rectum cancer
49811|NCT03257332|Low Anterior Rectal Syndrome|low anterior rectal syndrome
49812|NCT03257332|Anorectal muscle function|anorectal muscle function
49813|NCT03257306|Urinary tract stone|urinary tract stone
49814|NCT03257306|ureter double-J stent|ureter double-j stent
49815|NCT03257254|GSV|gsv
49816|NCT03257254|AASV|aasv
49817|NCT03257254|Vein|vein
49818|NCT03257254|Venous|venous
49819|NCT03257254|Ulcer|ulcer
49820|NCT03257254|Vericose Vein|vericose vein
49821|NCT03257254|VLU|vlu
49822|NCT03257254|venous insufficiency|venous insufficiency
49823|NCT03257254|venous disease|venous disease
49824|NCT03257254|chronic VLU|chronic vlu
49825|NCT03257241|aml|aml
49826|NCT03257241|acute myeloid leukemia|acute myeloid leukemia
49827|NCT03257241|DAC|dac
49828|NCT03257241|DA-90|da-90
49829|NCT03257241|FLAG-IDA|flag-ida
49830|NCT03257241|CLAG-M|clag-m
49831|NCT03257241|Ara-C|ara-c
49832|NCT03257241|HiDAC|hidac
49833|NCT03257215|Vitamin D|vitamin d
49834|NCT03257202|Propionibacterium Acnes|propionibacterium acnes
49835|NCT03257202|Surgical Site Infection|surgical site infection
49836|NCT03257202|Shoulder|shoulder
49837|NCT03257137|sleep|sleep
50520|NCT03252873|adherence|adherence
49838|NCT03257137|macronutrients|macronutrients
49839|NCT03257137|dietary patterns|dietary patterns
49840|NCT03257137|sleep quality|sleep quality
49841|NCT03257137|diet quality|diet quality
49842|NCT03257137|polysomnography|polysomnography
49843|NCT03257137|appetite|appetite
49844|NCT03257137|mood|mood
49845|NCT03257137|hunger|hunger
49846|NCT03257111|rehabilitation outcomes|rehabilitation outcomes
49847|NCT03257111|activity level|activity level
49848|NCT03257098|Chronic Venous Ulcer|chronic venous ulcer
49849|NCT03257098|ABCB5|abcb5
49850|NCT03257098|Allogeneic|allogeneic
49851|NCT03257098|Mesenchymal stem cells|mesenchymal stem cells
49852|NCT03257098|varicose ulcer|varicose ulcer
49853|NCT03257098|skin ulcer|skin ulcer
49854|NCT03257098|advanced therapy medicinal product|advanced therapy medicinal product
49855|NCT03257098|somatic cell therapy|somatic cell therapy
49856|NCT03257098|phase I/IIa|phase i/iia
49857|NCT03257072|hookworm|hookworm
49858|NCT03257072|controlled human infection model|controlled human infection model
49859|NCT03257020|OCT|oct
49860|NCT03257020|RNFL|rnfl
49861|NCT03257020|BMO-MRW|bmo-mrw
49862|NCT03257020|Glaucoma|glaucoma
49863|NCT03256981|SBRT|sbrt
49864|NCT03256981|Oligoprogressive disease|oligoprogressive disease
49865|NCT03256981|NSCLC|nsclc
49866|NCT03256981|TKI|tki
49867|NCT03256955|Validation study for a neuromuscular monitoring device|validation study for a neuromuscular monitoring device
49868|NCT03256929|Personalized Diet|personalized diet
49869|NCT03256929|Microbiota|microbiota
49870|NCT03256929|Depression|depression
49871|NCT03256929|Elderly|elderly
49872|NCT03256929|Gut flora|gut flora
49873|NCT03256916|Cervical cancer|cervical cancer
49874|NCT03256903|Methoxyflurane|methoxyflurane
49875|NCT03256903|emergency|emergency
49876|NCT03256903|trauma pain|trauma pain
49877|NCT03256903|inhaled analgesia|inhaled analgesia
49878|NCT03256890|mindfulness|mindfulness
49879|NCT03256890|blood pressure|blood pressure
49880|NCT03256890|hypertension|hypertension
49881|NCT03256890|prehypertension|prehypertension
49882|NCT03256890|self regulation|self regulation
49883|NCT03256890|Science of Behavior Change|science of behavior change
49884|NCT03256890|attention control|attention control
49885|NCT03256890|self awareness|self awareness
49886|NCT03256890|emotion regulation|emotion regulation
49887|NCT03256838|Citric Acid|citric acid
49888|NCT03256838|Ferric Compounds|ferric compounds
49889|NCT03256838|Renal Insufficiency|renal insufficiency
49890|NCT03256838|Anticoagulants|anticoagulants
49891|NCT03256838|Calcium Chelating Agents|calcium chelating agents
49892|NCT03256838|Chelating Agents|chelating agents
49893|NCT03256838|Sequestering Agents|sequestering agents
49894|NCT03256838|Hemodialysis|hemodialysis
49895|NCT03256838|Dialysis|dialysis
49896|NCT03256838|Renal Failure|renal failure
49897|NCT03256838|Kidney Failure|kidney failure
49898|NCT03256838|Urologic Diseases|urologic diseases
49899|NCT03256838|Metabolic Disease|metabolic disease
49900|NCT03256838|Kidney Diseases|kidney diseases
49901|NCT03256838|Renal Insufficiency, Chronic|renal insufficiency, chronic
49902|NCT03256825|Diagnostic accuracy|diagnostic accuracy
49903|NCT03256825|Anti-bacterial agents|anti-bacterial agents
49904|NCT03256825|Decision support systems, clinical|decision support systems, clinical
49905|NCT03256812|Arrhythmias, Atrial Fibrillation|arrhythmias, atrial fibrillation
49906|NCT03256786|cesarean delivery with spinal anesthesia|cesarean delivery with spinal anesthesia
49907|NCT03256786|Hypothermia and shivering|hypothermia and shivering
49908|NCT03256786|Active warming|active warming
49909|NCT03256760|Insomnia, depression|insomnia, depression
49910|NCT03256747|Diabetes Mellitus|diabetes mellitus
49911|NCT03256747|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
49912|NCT03256747|Glucose Metabolism Disorders|glucose metabolism disorders
49913|NCT03256747|Metabolic Diseases|metabolic diseases
49914|NCT03256747|Endocrine System Diseases|endocrine system diseases
49915|NCT03256721|apatinib docetaxel pemetrexed|apatinib docetaxel pemetrexed
49916|NCT03256708|antibiotic-associated diarrhea|antibiotic-associated diarrhea
49917|NCT03256708|probiotic|probiotic
49918|NCT03256708|prebiotic|prebiotic
49919|NCT03256708|placebo|placebo
49920|NCT03256708|synbiotic|synbiotic
49921|NCT03256682|Resilience|resilience
49922|NCT03256682|Mobile video counseling|mobile video counseling
49923|NCT03256682|Emotiona labor|emotiona labor
49924|NCT03256643|traumatic brain injury|traumatic brain injury
49925|NCT03256643|brain contusion|brain contusion
49926|NCT03256643|craniocerebral trauma|craniocerebral trauma
49927|NCT03256643|exercise therapy|exercise therapy
49928|NCT03256643|chronic brain injury|chronic brain injury
49929|NCT03256643|environment impact|environment impact
49930|NCT03256643|cognitive therapy|cognitive therapy
49931|NCT03256643|health facility environment|health facility environment
49932|NCT03256630|Active Surveillance|active surveillance
49933|NCT03256630|Radical Prostatectomy|radical prostatectomy
49934|NCT03256617|low back pain|low back pain
49935|NCT03256617|cognitive reassurance|cognitive reassurance
49936|NCT03256617|physical therapist training|physical therapist training
49937|NCT03256604|point of care, HGF, innate immunity|point of care, hgf, innate immunity
49938|NCT03256578|Resuscitation|resuscitation
49939|NCT03256578|Neonatal Prematurity|neonatal prematurity
49940|NCT03256578|Positive-Pressure Ventilation|positive-pressure ventilation
49941|NCT03256578|Respiratory Function Monitor|respiratory function monitor
49942|NCT03256461|sepsis|sepsis
49943|NCT03256461|lactate clearance|lactate clearance
49944|NCT03256461|protocolized resuscitation|protocolized resuscitation
50062|NCT03255655|Intense Therapeutic Ultrasound (ITU)|intense therapeutic ultrasound (itu)
49945|NCT03256422|Controlled, virological and therapeutic success, treatment discontinution, 4 days per week|controlled, virological and therapeutic success, treatment discontinution, 4 days per week
49946|NCT03256409|biomaterials|biomaterials
49947|NCT03256409|methacrylates|methacrylates
49948|NCT03256409|microbiology|microbiology
49949|NCT03256409|implant dentistry/implantology|implant dentistry/implantology
49950|NCT03256409|removable prosthodontics|removable prosthodontics
49951|NCT03256409|clinical studies/trials|clinical studies/trials
49952|NCT03256396|Intraoperative mechanical ventilation|intraoperative mechanical ventilation
49953|NCT03256396|Positive-end expiratory pressure|positive-end expiratory pressure
49954|NCT03256396|Esophageal pressure|esophageal pressure
49955|NCT03256396|Transpulmonary pressure|transpulmonary pressure
49956|NCT03256396|Laparoscopic gynecologic surgery|laparoscopic gynecologic surgery
49957|NCT03256370|Allergic manifestation, Human milk oligosaccharides, Breast Milk|allergic manifestation, human milk oligosaccharides, breast milk
49958|NCT03256357|unilateral cerebral palsy|unilateral cerebral palsy
49959|NCT03256357|upper limb rehabilitation|upper limb rehabilitation
49960|NCT03256344|Liver Metastases|liver metastases
49961|NCT03256305|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
49962|NCT03256279|Orthodontic Wires|orthodontic wires
49963|NCT03256279|Alloys/therapeutic use|alloys/therapeutic use
49964|NCT03256279|Orthodontics, corrective|orthodontics, corrective
49965|NCT03256253|alcohol use disorder|alcohol use disorder
49966|NCT03256253|alcohol abuse|alcohol abuse
49967|NCT03256253|treatment|treatment
49968|NCT03256253|lyrica|lyrica
49969|NCT03256240|Crohn's recurrence|crohn's recurrence
49970|NCT03256227|Posttraumatic Stress Disorder|posttraumatic stress disorder
49971|NCT03256227|family therapy|family therapy
49972|NCT03256227|patient adherence|patient adherence
49973|NCT03256227|Prolonged Exposure Therapy|prolonged exposure therapy
49974|NCT03256201|Cancer|cancer
49975|NCT03256201|prehabilitation|prehabilitation
49976|NCT03256201|sarcopenia|sarcopenia
49977|NCT03256188|classroom|classroom
49978|NCT03256188|prolonged sitting|prolonged sitting
49979|NCT03256188|sedentary time|sedentary time
49980|NCT03256188|time-on-task|time-on-task
49981|NCT03256188|children|children
49982|NCT03256175|Myocardial Protection|myocardial protection
49983|NCT03256175|Oxygen|oxygen
49984|NCT03256175|Exercise Test|exercise test
49985|NCT03256162|ketamine|ketamine
49986|NCT03256162|glutamate|glutamate
49987|NCT03256136|Lung Cancer|lung cancer
49988|NCT03256123|Vitamin A Deficiency|vitamin a deficiency
49989|NCT03256123|Iron Deficiency|iron deficiency
49990|NCT03256123|Parasite|parasite
49991|NCT03256123|Gut Microbiota|gut microbiota
49992|NCT03256123|Red palm oil|red palm oil
49993|NCT03256110|Advance Care Planning|advance care planning
49994|NCT03256110|Palliative Care|palliative care
49995|NCT03256110|Indians, North American|indians, north american
49996|NCT03256110|Alaska Natives|alaska natives
49997|NCT03256110|Health Communication|health communication
49998|NCT03256110|Primary Health Care|primary health care
49999|NCT03256097|Sound processing strategy|sound processing strategy
50000|NCT03256019|intubation|intubation
50001|NCT03256019|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
50002|NCT03256006|sport exercise|sport exercise
50003|NCT03256006|ultra endurance|ultra endurance
50004|NCT03255954|Interpersonal Counseling|interpersonal counseling
50005|NCT03255941|LHV (Lady Health Visitor)|lhv (lady health visitor)
50006|NCT03255941|LHW (Lady Health Worker|lhw (lady health worker
50007|NCT03255941|DMPA (Depot medroxyprogesterone acetate or Depo Provera)|dmpa (depot medroxyprogesterone acetate or depo provera)
50008|NCT03255941|DMPA IM (Depo Provera intramuscular injection)|dmpa im (depo provera intramuscular injection)
50009|NCT03255941|SP (Sayana Press subcutaneous injection)|sp (sayana press subcutaneous injection)
50010|NCT03255941|Contraception|contraception
50011|NCT03255941|CBA2I (Community-based access to injectables)|cba2i (community-based access to injectables)
50012|NCT03255941|Sayana (Sayana Press)|sayana (sayana press)
50013|NCT03255941|JHPIEGO (Johns Hopkins Program for International Education in Gynaecology and Obstetrics)|jhpiego (johns hopkins program for international education in gynaecology and obstetrics)
50014|NCT03255928|Platelet activation|platelet activation
50015|NCT03255928|Ventricular Assist Device|ventricular assist device
50016|NCT03255928|Thrombosis|thrombosis
50017|NCT03255928|Bleeding|bleeding
50018|NCT03255928|Antithrombotic Pharmacological Therapy|antithrombotic pharmacological therapy
50019|NCT03255928|Mechanical Circulatory Support|mechanical circulatory support
50020|NCT03255915|HIV Prevention|hiv prevention
50021|NCT03255915|Intravaginal Ring|intravaginal ring
51098|NCT03249064|CD91|cd91
50022|NCT03255915|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
50023|NCT03255915|Emtricitabine|emtricitabine
50024|NCT03255889|Safety|safety
50025|NCT03255889|Tolerability|tolerability
50026|NCT03255889|Pharmacokinetics|pharmacokinetics
50027|NCT03255889|Absorption|absorption
50028|NCT03255876|Polyphenols|polyphenols
50029|NCT03255876|Hyperglycemia|hyperglycemia
50030|NCT03255876|Postprandial|postprandial
50031|NCT03255876|Starch|starch
50032|NCT03255876|Alpha-amylase|alpha-amylase
50033|NCT03255863|Psychological Theory|psychological theory
50034|NCT03255850|adolescents|adolescents
50035|NCT03255850|quality of life|quality of life
50036|NCT03255850|psychological well-being|psychological well-being
50037|NCT03255837|Transcranial Stimulation|transcranial stimulation
50038|NCT03255837|Memory|memory
50039|NCT03255824|Oral Surgery|oral surgery
50040|NCT03255824|Third Molars|third molars
50041|NCT03255824|Intravenous Sedation|intravenous sedation
50042|NCT03255824|Dexmedetomidine|dexmedetomidine
50043|NCT03255811|Advanced gastric cancer apatinib Maintenance therapy|advanced gastric cancer apatinib maintenance therapy
50044|NCT03255772|Magnetocardiography|magnetocardiography
50045|NCT03255772|Chest pain|chest pain
50046|NCT03255733|Chronic Lateral Epicondylitis|chronic lateral epicondylitis
50047|NCT03255733|Tennis Elbow|tennis elbow
50048|NCT03255733|Intense Therapeutic Ultrasound (ITU)|intense therapeutic ultrasound (itu)
50049|NCT03255733|Guided Therapy Systems (GTS)|guided therapy systems (gts)
50050|NCT03255733|Ardent Sound, Inc.|ardent sound, inc.
50051|NCT03255733|Actisound|actisound
50052|NCT03255707|Amblyopia|amblyopia
50053|NCT03255707|Interactive Binocular Treatment|interactive binocular treatment
50054|NCT03255707|Dissociative Treatment|dissociative treatment
50055|NCT03255707|Occlusion|occlusion
50056|NCT03255707|Patching|patching
50057|NCT03255681|Cosmetics|cosmetics
50058|NCT03255681|Filler|filler
50059|NCT03255668|Mercaptopurine, acute lymphoblastic leukemia, hematotoxicity|mercaptopurine, acute lymphoblastic leukemia, hematotoxicity
50060|NCT03255655|Chronic Plantar Fasciitis|chronic plantar fasciitis
50061|NCT03255655|Plantar Fascia Pain|plantar fascia pain
50189|NCT03254953|adherence|adherence
50063|NCT03255655|Guided Therapy Systems (GTS)|guided therapy systems (gts)
50064|NCT03255655|Ardent Sound, Inc.|ardent sound, inc.
50065|NCT03255655|Actisound|actisound
50066|NCT03255642|Clonazepam|clonazepam
50067|NCT03255642|Melatonin|melatonin
50068|NCT03255642|Treatment|treatment
50069|NCT03255642|REM Sleep Behavior Disorder|rem sleep behavior disorder
50070|NCT03255603|Resistant Starch|resistant starch
50071|NCT03255603|Dietary Fiber|dietary fiber
50072|NCT03255603|Gastrointestinal Microbiome|gastrointestinal microbiome
50073|NCT03255603|Gastrointestinal Tolerance|gastrointestinal tolerance
50074|NCT03255590|motor recovery|motor recovery
50075|NCT03255590|transcranial magnetic stimulation|transcranial magnetic stimulation
50076|NCT03255590|motor learning|motor learning
50077|NCT03255590|ischemic Stroke|ischemic stroke
50078|NCT03255577|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
50079|NCT03255577|17-384|17-384
50080|NCT03255538|patellar tendon|patellar tendon
50081|NCT03255499|cognitive training|cognitive training
50082|NCT03255499|physical exercise|physical exercise
50083|NCT03255499|brain dynamics|brain dynamics
50084|NCT03255499|cognitive abilities|cognitive abilities
50085|NCT03255499|physiological markers|physiological markers
50086|NCT03255460|Multiple Sclerosis|multiple sclerosis
50087|NCT03255460|Fatigue|fatigue
50088|NCT03255460|Physical Activity|physical activity
50089|NCT03255460|Exercise|exercise
50090|NCT03255447|Idiopathic Membranous Nephropathy|idiopathic membranous nephropathy
50091|NCT03255447|Primary Membranous Nephropathy|primary membranous nephropathy
50092|NCT03255447|Immunoadsorption|immunoadsorption
50093|NCT03255447|Apharesis|apharesis
50094|NCT03255421|urodynamic|urodynamic
50095|NCT03255421|backwards cystometry|backwards cystometry
50096|NCT03255421|reverse cystometry|reverse cystometry
50097|NCT03255421|follow-up|follow-up
50098|NCT03255395|MRI|mri
50099|NCT03255395|Ultrasound|ultrasound
50100|NCT03255395|Phantom Limb Pain|phantom limb pain
50101|NCT03255395|Residual Limb Pain|residual limb pain
50102|NCT03255395|Neuroma|neuroma
50103|NCT03255382|ABBV-0066|abbv-0066
50104|NCT03255382|BI 655066|bi 655066
50105|NCT03255382|risankizumab|risankizumab
50106|NCT03255369|Zika virus|zika virus
50107|NCT03255369|Microcephaly|microcephaly
50108|NCT03255369|Child|child
50109|NCT03255369|pregnancy|pregnancy
50110|NCT03255356|Postoperative pulmonary complications|postoperative pulmonary complications
50111|NCT03255356|Protective mechanical ventilation|protective mechanical ventilation
50112|NCT03255356|Alveolar lung recruitment manoeuvres|alveolar lung recruitment manoeuvres
50113|NCT03255356|Cardiac Surgery Procedures|cardiac surgery procedures
50114|NCT03255317|Substance use, youth, mobile health, data collection adherence, user engagement|substance use, youth, mobile health, data collection adherence, user engagement
50115|NCT03255278|Tuberculosis|tuberculosis
50116|NCT03255278|Recombinant vaccine|recombinant vaccine
50117|NCT03255278|Mycobacterium tuberculosis|mycobacterium tuberculosis
50118|NCT03255265|organ transplantation|organ transplantation
50119|NCT03255265|cfDNA|cfdna
50120|NCT03255265|microchimerism|microchimerism
50121|NCT03255265|acute rejection|acute rejection
50122|NCT03255239|ventral hernia|ventral hernia
50123|NCT03255239|Open mesh repair|open mesh repair
50124|NCT03255239|Polyester mesh|polyester mesh
50125|NCT03255239|Preperitoneal|preperitoneal
50126|NCT03255239|Retromuscular|retromuscular
50127|NCT03255187|Biomarker|biomarker
50128|NCT03255187|Fish oil|fish oil
50129|NCT03255187|Oxidative stress|oxidative stress
50130|NCT03255187|Air pollution|air pollution
50131|NCT03255187|Cardiopulmonary system|cardiopulmonary system
50132|NCT03255174|Bleeding, hemostasis, re-bleeding, hemostatic|bleeding, hemostasis, re-bleeding, hemostatic
50133|NCT03255148|resting state|resting state
50134|NCT03255148|EEG|eeg
50135|NCT03255148|skin conductance|skin conductance
50136|NCT03255148|heart rate|heart rate
50137|NCT03255148|oxytocin|oxytocin
50138|NCT03255109|Lung|lung
50139|NCT03255109|acute|acute
50140|NCT03255109|respiratory|respiratory
50141|NCT03255109|distress|distress
50142|NCT03255109|weaning|weaning
50143|NCT03255109|mechanical ventilation|mechanical ventilation
50144|NCT03255109|respiratory infection|respiratory infection
50145|NCT03255083|Oncology|oncology
50146|NCT03255083|Advanced Non-small Cell Lung Cancer|advanced non-small cell lung cancer
50147|NCT03255083|Inoperable Non-small Cell Lung Cancer|inoperable non-small cell lung cancer
50148|NCT03255083|Metastatic|metastatic
50149|NCT03255083|Non-resectable|non-resectable
50150|NCT03255083|Epidermal growth factor receptor|epidermal growth factor receptor
50151|NCT03255083|EGFR|egfr
50152|NCT03255070|HER2|her2
50153|NCT03255070|Breast Cancer|breast cancer
50154|NCT03255070|ADC|adc
50155|NCT03255070|antibody drug conjugate|antibody drug conjugate
50156|NCT03255070|elevated HER2 expression|elevated her2 expression
50157|NCT03255070|breast neoplasm|breast neoplasm
50158|NCT03255070|stomach neoplasm|stomach neoplasm
50159|NCT03255070|gastrointestinal neoplasm|gastrointestinal neoplasm
50160|NCT03255070|digestive system|digestive system
50161|NCT03255070|breast diseases|breast diseases
50162|NCT03255070|digestive system neoplasm|digestive system neoplasm
50163|NCT03255070|digestive system diseases|digestive system diseases
50164|NCT03255070|stomach diseases|stomach diseases
50165|NCT03255044|statin|statin
50166|NCT03255044|hydrophilic|hydrophilic
50167|NCT03255044|lipophilic|lipophilic
50168|NCT03255031|Ketogenic Diet|ketogenic diet
50169|NCT03255031|Detoxification|detoxification
50170|NCT03255031|Functional MRI|functional mri
50171|NCT03255031|MRI/MRS|mri/mrs
50172|NCT03255031|Alcoholism|alcoholism
50173|NCT03255018|Monoclonal Antibody|monoclonal antibody
50174|NCT03255018|PD-1 Receptor|pd-1 receptor
50175|NCT03255005|obesity|obesity
50176|NCT03255005|endoscopy|endoscopy
50177|NCT03255005|endoscopic sleeve gastroplasty|endoscopic sleeve gastroplasty
50178|NCT03254953|digital health|digital health
50179|NCT03254953|eHealth|ehealth
50180|NCT03254953|technology|technology
50181|NCT03254953|smartphone|smartphone
50182|NCT03254953|obesity|obesity
50183|NCT03254953|overweight|overweight
50184|NCT03254953|weight loss|weight loss
50185|NCT03254953|behavioral intervention|behavioral intervention
50186|NCT03254953|self-monitoring|self-monitoring
50187|NCT03254953|tracking|tracking
50188|NCT03254953|engagement|engagement
50190|NCT03254953|weight change|weight change
50191|NCT03254953|e-mail|e-mail
50192|NCT03254953|mobile application|mobile application
50193|NCT03254953|goal setting|goal setting
50194|NCT03254953|action plan|action plan
50195|NCT03254953|feedback|feedback
50196|NCT03254953|electronic health|electronic health
50197|NCT03254940|text message|text message
50198|NCT03254940|digital health|digital health
50199|NCT03254940|weight loss|weight loss
50200|NCT03254940|personalized|personalized
50201|NCT03254927|Erbitux|erbitux
50202|NCT03254914|Home Blood Pressure|home blood pressure
50203|NCT03254914|Fimasartan|fimasartan
50204|NCT03254875|Breast cancer, Psychosocial intervention|breast cancer, psychosocial intervention
50205|NCT03254862|Functional electrical stimulation|functional electrical stimulation
50206|NCT03254836|Actigraphy|actigraphy
50207|NCT03254836|Major Depression Inventory (MDI)|major depression inventory (mdi)
50208|NCT03254836|Insomnia Severity Index (ISI)|insomnia severity index (isi)
50209|NCT03254797|Rehabilitation|rehabilitation
50210|NCT03254797|Neurological condition|neurological condition
50211|NCT03254797|Walking ability|walking ability
50212|NCT03254797|Feedback|feedback
50213|NCT03254797|External information|external information
50214|NCT03254771|Knee ostheoartritis|knee ostheoartritis
50215|NCT03254771|Arthroplasty|arthroplasty
50216|NCT03254771|Clinical trial|clinical trial
50217|NCT03254771|Decision aids|decision aids
50218|NCT03254745|Rheumatoid Arthritis|rheumatoid arthritis
50219|NCT03254745|Pakistan|pakistan
50220|NCT03254745|Pharmacist|pharmacist
50221|NCT03254745|Intervention|intervention
50222|NCT03254745|Treatment outcome|treatment outcome
50223|NCT03254719|Low Back Pain|low back pain
50224|NCT03254719|Chiropractic|chiropractic
50225|NCT03254719|Veterans|veterans
50226|NCT03254719|PTSD|ptsd
50227|NCT03254719|Depression|depression
50228|NCT03254719|Anxiety|anxiety
50229|NCT03254706|Dentin adhesive; Non-carious cervical lesions; Longevity.|dentin adhesive; non-carious cervical lesions; longevity.
50230|NCT03254693|Non-carious cervical lesions; Universal system; Longevity.|non-carious cervical lesions; universal system; longevity.
50231|NCT03254680|Turmeric Oil|turmeric oil
50232|NCT03254680|antiseizure medications|antiseizure medications
50233|NCT03254680|ar-turmerone|ar-turmerone
50234|NCT03254615|Plain water|plain water
50235|NCT03254615|Educative strategies|educative strategies
50236|NCT03254615|Effectiveness|effectiveness
50237|NCT03254589|Methotrexate|methotrexate
50238|NCT03254589|Rheumatoid arthritis|rheumatoid arthritis
50239|NCT03254589|Blood pressure|blood pressure
50240|NCT03254589|Arterial stiffness|arterial stiffness
50241|NCT03254589|Cardiovascular risk|cardiovascular risk
50242|NCT03254576|Overweight|overweight
50243|NCT03254576|Obesity|obesity
50244|NCT03254576|Body Mass Index|body mass index
50245|NCT03254576|Weight|weight
50246|NCT03254576|Brain imaging|brain imaging
50247|NCT03254576|Child|child
50248|NCT03254576|Learning|learning
50249|NCT03254550|PrEP|prep
50250|NCT03254524|Epidemiology Research|epidemiology research
50251|NCT03254511|neoadjuvant chemoradiation|neoadjuvant chemoradiation
50252|NCT03254511|pathologic response|pathologic response
50253|NCT03254511|low molecular weight heparin|low molecular weight heparin
50254|NCT03254498|colonic adenoma|colonic adenoma
50255|NCT03254498|serrated polyps|serrated polyps
50256|NCT03254498|caecal intubation time|caecal intubation time
50257|NCT03254498|withdrawal time|withdrawal time
50258|NCT03254498|polyp miss rate|polyp miss rate
50259|NCT03254485|Heart Failure|heart failure
50260|NCT03254485|Cardiovascular|cardiovascular
50261|NCT03254485|HF|hf
50262|NCT03254485|HFpEF|hfpef
50263|NCT03254472|Biological markers|biological markers
50264|NCT03254472|Professional practice|professional practice
50265|NCT03254472|Big data analysis|big data analysis
50266|NCT03254472|Measured concentrations|measured concentrations
50267|NCT03254472|Cardiac markers|cardiac markers
50268|NCT03254472|Troponin|troponin
50269|NCT03254472|NTproBNP|ntprobnp
50270|NCT03254472|Creatinin|creatinin
50271|NCT03254472|INR|inr
50272|NCT03254472|Hemogram|hemogram
50273|NCT03254472|Lipid profile|lipid profile
50274|NCT03254446|Diabetes|diabetes
50275|NCT03254446|Hypertension|hypertension
50276|NCT03254446|Dyslipidemia|dyslipidemia
50277|NCT03254446|Cardiovascular Risk|cardiovascular risk
50278|NCT03254433|Neuroimaging|neuroimaging
50279|NCT03254433|Smoking Cessation|smoking cessation
50280|NCT03254433|Weight Loss|weight loss
50281|NCT03254407|bioequivalent|bioequivalent
50282|NCT03254407|IV/PO switch|iv/po switch
50283|NCT03254407|appropriateness|appropriateness
50284|NCT03254407|clinical pharmacy|clinical pharmacy
50285|NCT03254394|Oxaliplatin|oxaliplatin
50286|NCT03254394|Cold hypersensitivity|cold hypersensitivity
50287|NCT03254394|Neuropathy|neuropathy
50288|NCT03254394|Colorectal cancer|colorectal cancer
50289|NCT03254394|CIPN|cipn
50290|NCT03254394|Neuropathic Pain|neuropathic pain
50291|NCT03254381|cognitive assessment|cognitive assessment
50292|NCT03254381|cognitive function|cognitive function
50293|NCT03254381|community dwelling older people|community dwelling older people
50294|NCT03254381|pre-diabetes|pre-diabetes
50295|NCT03254381|randomized control trial|randomized control trial
50296|NCT03254381|exercise|exercise
50297|NCT03254381|pilot study|pilot study
50298|NCT03254381|feasibility study|feasibility study
50299|NCT03254368|Methionine Aminopeptidase 2 Inhibitor|methionine aminopeptidase 2 inhibitor
50300|NCT03254368|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
50301|NCT03254368|Blood Glucose|blood glucose
50302|NCT03254368|Overweight|overweight
50303|NCT03254368|Obesity|obesity
50304|NCT03254355|avulsion injury|avulsion injury
50305|NCT03254355|urinary incontinence|urinary incontinence
50306|NCT03254355|multimodal physiotherapy|multimodal physiotherapy
50307|NCT03254329|human milk|human milk
50308|NCT03254329|micronutrients|micronutrients
50309|NCT03254329|lactation|lactation
50310|NCT03254329|milk volume|milk volume
50311|NCT03254329|milk composition|milk composition
50312|NCT03254329|reference values|reference values
50313|NCT03254303|Sevoflurane, Catheterization, Anesthetics Inhalation, child|sevoflurane, catheterization, anesthetics inhalation, child
50314|NCT03254277|Broadly Neutralizing Antibody|broadly neutralizing antibody
50315|NCT03254277|3BNC117-LS|3bnc117-ls
50316|NCT03254277|First in Human|first in human
50317|NCT03254277|Dose Escalation|dose escalation
50318|NCT03254225|Hypertension|hypertension
50319|NCT03254225|Elderly|elderly
50320|NCT03254225|Resistance training|resistance training
50321|NCT03254225|Heart rate variability|heart rate variability
50322|NCT03254212|Heart failure|heart failure
50323|NCT03254212|Central sleep apnea|central sleep apnea
50324|NCT03254212|oxygen therapy|oxygen therapy
50325|NCT03254199|Charcot-Marie-Tooth|charcot-marie-tooth
50326|NCT03254199|CMT|cmt
50327|NCT03254199|Muscle Cramps|muscle cramps
50328|NCT03254199|Muscle Cramping|muscle cramping
50329|NCT03254199|FLX-787|flx-787
50330|NCT03254199|Hereditary Sensory and Motor Neuropathy|hereditary sensory and motor neuropathy
50331|NCT03254199|Neurogenetic disorder|neurogenetic disorder
50332|NCT03254199|Nervous System Malformations|nervous system malformations
50333|NCT03254199|Nervous System Diseases|nervous system diseases
50334|NCT03254199|Neurodegenerative Diseases|neurodegenerative diseases
50335|NCT03254199|Neuromuscular Diseases|neuromuscular diseases
50336|NCT03254186|Propranolol|propranolol
50337|NCT03254186|Safety|safety
50338|NCT03254186|Efficacy|efficacy
50339|NCT03254186|Tardive Dyskinesia treatment|tardive dyskinesia treatment
50340|NCT03254173|Mirtazapine|mirtazapine
50341|NCT03254173|Anorexia - Cachexia|anorexia - cachexia
50342|NCT03254173|Advanced Cancer|advanced cancer
50343|NCT03254173|Appetite|appetite
50344|NCT03254160|Stroke|stroke
50345|NCT03254160|Rehabilitation|rehabilitation
50346|NCT03254160|Ischemic|ischemic
50347|NCT03254121|Sustained virological response|sustained virological response
50348|NCT03254121|Whole genome sequencing|whole genome sequencing
50349|NCT03254095|Skin temperature|skin temperature
50350|NCT03254095|Plantar pressure|plantar pressure
50351|NCT03254095|Diabetic foot|diabetic foot
50352|NCT03254095|Tissue hardness|tissue hardness
50353|NCT03254095|Neuropathy|neuropathy
50354|NCT03254095|Peripheral artery disease|peripheral artery disease
50355|NCT03254082|sorghum health|sorghum health
50356|NCT03254056|fascial closure device|fascial closure device
50357|NCT03254056|laparoscopic surgery|laparoscopic surgery
50358|NCT03254056|postoperative pain|postoperative pain
50359|NCT03254030|Adenoma|adenoma
50360|NCT03254030|Sessile serrated adenoma|sessile serrated adenoma
50361|NCT03254017|Bilateral Habeluna|bilateral habeluna
50362|NCT03254017|Remote Deep Brain Stimulation|remote deep brain stimulation
50363|NCT03254017|Treatment Resistant Major Depressive Disorder|treatment resistant major depressive disorder
50364|NCT03253900|wobble board|wobble board
50365|NCT03253900|slides|slides
50366|NCT03253900|rowing stroke|rowing stroke
50367|NCT03253900|rowing biomechanics|rowing biomechanics
50368|NCT03253900|power output|power output
50369|NCT03253887|Ethanol lock therapy|ethanol lock therapy
50370|NCT03253887|Pediatrics|pediatrics
50371|NCT03253887|Central Venous Catheter|central venous catheter
50372|NCT03253887|Bloodstream Infection|bloodstream infection
50373|NCT03253874|Pre-operative Testing|pre-operative testing
50374|NCT03253874|Cataract Surgery|cataract surgery
50375|NCT03253874|Health Service Research|health service research
50376|NCT03253874|Low-Value Care|low-value care
50377|NCT03253874|Safety-Net Hospital|safety-net hospital
50378|NCT03253861|Acute necrotizing pancreatitis|acute necrotizing pancreatitis
50379|NCT03253861|Acute pancreatitis|acute pancreatitis
50380|NCT03253861|Sepsis/complications|sepsis/complications
50381|NCT03253861|Infection|infection
50382|NCT03253861|Organ Dysfunction Scores|organ dysfunction scores
50383|NCT03253861|Drainage|drainage
50384|NCT03253861|Catheters|catheters
50385|NCT03253861|Antibiotics|antibiotics
50386|NCT03253861|Multiresistant organism|multiresistant organism
50387|NCT03253861|Pancreatitis/complications|pancreatitis/complications
50388|NCT03253861|Pancreatitis/diagnosis|pancreatitis/diagnosis
50389|NCT03253861|Pancreatitis/surgery|pancreatitis/surgery
50390|NCT03253861|Pancreatitis/therapy|pancreatitis/therapy
50391|NCT03253861|Pancreatitis, Acute Necrotizing/complications|pancreatitis, acute necrotizing/complications
50392|NCT03253861|Pancreatitis, Acute Necrotizing/surgery|pancreatitis, acute necrotizing/surgery
50393|NCT03253861|Pancreatitis, Acute Necrotizing/therapy|pancreatitis, acute necrotizing/therapy
50394|NCT03253822|Colorectal Neoplasms|colorectal neoplasms
50395|NCT03253822|Decision Support Techniques|decision support techniques
50396|NCT03253822|Early Detection of Cancer|early detection of cancer
50397|NCT03253822|Educational Status|educational status
50398|NCT03253822|Decision Making|decision making
50399|NCT03253822|Knowledge, Attitudes, Practice|knowledge, attitudes, practice
50400|NCT03253770|Cognitive Aid|cognitive aid
50401|NCT03253757|PrEP|prep
50402|NCT03253757|HIV|hiv
50403|NCT03253744|Image Guidance|image guidance
50404|NCT03253744|Dose Escalation|dose escalation
50405|NCT03253744|Radiotherapy|radiotherapy
50406|NCT03253744|Re-irradiation|re-irradiation
50407|NCT03253744|Quality of Life|quality of life
50408|NCT03253731|Brain Plasticity|brain plasticity
50409|NCT03253731|Healthy Volunteers|healthy volunteers
50410|NCT03253718|Healthy Volunteers|healthy volunteers
50411|NCT03253705|Assay Development|assay development
50412|NCT03253705|Gene Expression|gene expression
50413|NCT03253705|Metabolomics|metabolomics
50414|NCT03253705|Induced Pluripotent Stem Cell (iPS)|induced pluripotent stem cell (ips)
50415|NCT03253705|PBMCs/DNA/RNA|pbmcs/dna/rna
50416|NCT03253692|Cardiac Computed Tomography|cardiac computed tomography
50417|NCT03253692|Radiation|radiation
50418|NCT03253692|Iterative Reconstruction|iterative reconstruction
50419|NCT03253653|waterpipe|waterpipe
50424|NCT03253653|Furan-BDA-NAL|furan-bda-nal
50425|NCT03253653|Carbon monoxide|carbon monoxide
50426|NCT03253653|Pulmonary Function|pulmonary function
50427|NCT03253640|Costs and Cost Analysis|costs and cost analysis
50428|NCT03253640|Quality of Life|quality of life
50429|NCT03253640|Length of Stay|length of stay
50430|NCT03253640|Cohort study|cohort study
50431|NCT03253601|Rehabilitation|rehabilitation
50432|NCT03253601|Disability|disability
50433|NCT03253601|Mobile Health Technology|mobile health technology
50434|NCT03253575|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
50435|NCT03253575|Breast Cancer|breast cancer
50436|NCT03253575|Non-Small Cell Lung Cancer|non-small cell lung cancer
50437|NCT03253575|Epithelial Ovarian Cancer|epithelial ovarian cancer
50438|NCT03253575|Colorectal Cancer|colorectal cancer
50439|NCT03253575|Local Recurrent Cancer|local recurrent cancer
50440|NCT03253575|Late Stage Cancer|late stage cancer
50441|NCT03253575|Clinical Utility|clinical utility
50442|NCT03253575|Outcomes Study|outcomes study
50443|NCT03253562|diabetes|diabetes
50444|NCT03253562|Metformin|metformin
50445|NCT03253562|vildagliptin|vildagliptin
50446|NCT03253562|hypertension|hypertension
50447|NCT03253562|cardiovascular risk|cardiovascular risk
50448|NCT03253549|remote automated monitoring|remote automated monitoring
50449|NCT03253549|hospital to home virtual care|hospital to home virtual care
50450|NCT03253549|cardiac surgery|cardiac surgery
50451|NCT03253549|major vascular surgery|major vascular surgery
50452|NCT03253549|self-management|self-management
50453|NCT03253536|Hepatocellular Cancer|hepatocellular cancer
50454|NCT03253536|Quality of Life|quality of life
50455|NCT03253536|stereotactic body radiation therapy|stereotactic body radiation therapy
50456|NCT03253536|observational|observational
50457|NCT03253497|chlorhexidine, benzidamine, laryngeal mask|chlorhexidine, benzidamine, laryngeal mask
50458|NCT03253484|scar NAFL laser|scar nafl laser
50459|NCT03253458|Optical coherence tomography|optical coherence tomography
50460|NCT03253458|Confocal Laser Endomicroscopy|confocal laser endomicroscopy
50461|NCT03253458|Histology|histology
50462|NCT03253445|smoking cessation|smoking cessation
50463|NCT03253445|acceptance and commitment therapy|acceptance and commitment therapy
50464|NCT03253445|ACT|act
50465|NCT03253445|schizophrenic patients|schizophrenic patients
50466|NCT03253445|hostel setting|hostel setting
50467|NCT03253445|randomised controlled trial|randomised controlled trial
50468|NCT03253419|Falls|falls
50469|NCT03253419|Hip Replacement|hip replacement
50470|NCT03253419|Home Safety|home safety
50471|NCT03253367|Schizophrenia Spectrum and Other Psychotic Disorders|schizophrenia spectrum and other psychotic disorders
50472|NCT03253341|exercise program|exercise program
50473|NCT03253341|lifestyle changes|lifestyle changes
50474|NCT03253341|fitness program|fitness program
50475|NCT03253341|lifestyle intervention|lifestyle intervention
50476|NCT03253302|transanal surgery|transanal surgery
50477|NCT03253302|total mesorectal excision|total mesorectal excision
50478|NCT03253302|rectal cancer|rectal cancer
50479|NCT03253289|Hepatocellular carcinoma, HCC, Liver cancer|hepatocellular carcinoma, hcc, liver cancer
50480|NCT03253276|Bile Acid Transporter|bile acid transporter
50481|NCT03253237|Glycemic variability|glycemic variability
50482|NCT03253237|Hypoglycemia|hypoglycemia
50483|NCT03253211|Co-management model of care|co-management model of care
50484|NCT03253211|Primary Care|primary care
50485|NCT03253211|Specialty Care|specialty care
50486|NCT03253211|Decision support tools|decision support tools
50487|NCT03253211|Emergency Department Clinicians|emergency department clinicians
50488|NCT03253211|Co-management|co-management
50489|NCT03253185|Cancer|cancer
50490|NCT03253185|Advanced cancer|advanced cancer
50491|NCT03253185|Esophagogastric junction (EGJ) cancers|esophagogastric junction (egj) cancers
50492|NCT03253185|Maximum tolerated dose (MTD)|maximum tolerated dose (mtd)
50493|NCT03253185|Maximum Tolerated Dose|maximum tolerated dose
50494|NCT03253185|Pharmacokinetics|pharmacokinetics
50495|NCT03253146|Vimentin|vimentin
50496|NCT03253146|sepsis|sepsis
50497|NCT03253146|immune cells|immune cells
50498|NCT03253146|apoptosis|apoptosis
50499|NCT03253107|gastric cancer|gastric cancer
50500|NCT03253107|RNA sequencing|rna sequencing
50501|NCT03253107|chemotherapy response|chemotherapy response
50502|NCT03253107|miRNA sequencing|mirna sequencing
50503|NCT03253055|Physical Performance|physical performance
50504|NCT03253055|Bone|bone
50505|NCT03253055|Illness|illness
50506|NCT03253055|Injury|injury
50507|NCT03253042|Exercise|exercise
50508|NCT03253042|Vibration|vibration
50509|NCT03253042|Torque|torque
50510|NCT03253042|Aging|aging
50511|NCT03253029|oncology, cancer cachexia, cachexia anorexia,|oncology, cancer cachexia, cachexia anorexia,
50512|NCT03252977|fentanyl|fentanyl
50513|NCT03252977|Pain Threshold|pain threshold
50514|NCT03252977|predicted|predicted
50515|NCT03252938|solid tumor|solid tumor
50516|NCT03252938|peritoneal carcinomatosis|peritoneal carcinomatosis
50517|NCT03252886|intubation|intubation
50518|NCT03252886|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
50519|NCT03252886|neck injury|neck injury
50521|NCT03252873|pulmonary rehabilitation|pulmonary rehabilitation
50522|NCT03252873|copd|copd
50523|NCT03252847|XLRP RPGR|xlrp rpgr
50524|NCT03252808|Unresectable pancreatic cancer|unresectable pancreatic cancer
50525|NCT03252808|Metastatic pancreatic cancer|metastatic pancreatic cancer
50526|NCT03252808|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
50527|NCT03252808|TBI-1401(HF10)|tbi-1401(hf10)
50528|NCT03252808|HF10|hf10
50529|NCT03252808|Oncolytic virus|oncolytic virus
50530|NCT03252808|Oncolytic viral immunotherapy|oncolytic viral immunotherapy
50531|NCT03252808|Gemcitabine|gemcitabine
50532|NCT03252808|Nab-paclitaxel|nab-paclitaxel
50533|NCT03252808|Albumin-bound paclitaxel|albumin-bound paclitaxel
50534|NCT03252808|Abraxane|abraxane
50535|NCT03252808|Tegafur-gimeracil-oteracil potassium|tegafur-gimeracil-oteracil potassium
50536|NCT03252808|TS-1|ts-1
50537|NCT03252808|canerpaturev|canerpaturev
50538|NCT03252795|Infertility, female|infertility, female
50539|NCT03252795|Mayer Rokitansky Kuster Hauser Syndrome|mayer rokitansky kuster hauser syndrome
50540|NCT03252795|Transplantation; Deceased donor|transplantation; deceased donor
50541|NCT03252782|Soft Tissue|soft tissue
50542|NCT03252782|Functional Appliance|functional appliance
50543|NCT03252782|Maxillary Molar Distalization|maxillary molar distalization
50544|NCT03252756|Cannabidiol|cannabidiol
50545|NCT03252756|Alcohol Use Disorder|alcohol use disorder
50546|NCT03252730|Dry scalp|dry scalp
50547|NCT03252730|Itchy scalp|itchy scalp
50548|NCT03252704|postprandial glucose insulin|postprandial glucose insulin
50549|NCT03252678|Advanced Care Planning|advanced care planning
50550|NCT03252665|STEMI|stemi
50551|NCT03252665|myocardial perfusion|myocardial perfusion
50552|NCT03252665|TMPFC|tmpfc
50553|NCT03252665|Nicorandil|nicorandil
50554|NCT03252665|Alprostadil|alprostadil
50555|NCT03252652|Cranial vessels|cranial vessels
50556|NCT03252652|Normal parameters|normal parameters
50557|NCT03252652|Carotid Duplex|carotid duplex
50558|NCT03252652|Egyptian|egyptian
50559|NCT03252639|Renal Artery Stenosis|renal artery stenosis
50560|NCT03252639|Renal Blood Perfusion|renal blood perfusion
50561|NCT03252613|septic cardiomyopathy|septic cardiomyopathy
50562|NCT03252613|cytokine|cytokine
50563|NCT03252613|iPSC|ipsc
50564|NCT03252613|Inducible pluripotent stem cell|inducible pluripotent stem cell
50565|NCT03252561|TAP block|tap block
50566|NCT03252561|Acute Appendicitis|acute appendicitis
50567|NCT03252561|Post-operative analgesia|post-operative analgesia
50568|NCT03252535|Huntington disease|huntington disease
50569|NCT03252535|Stem cell therapy|stem cell therapy
50570|NCT03252535|Dental pulp stem cell|dental pulp stem cell
50571|NCT03252509|percutaneous radiologic gastrostomy|percutaneous radiologic gastrostomy
50572|NCT03252509|Head and Neck Neoplasms|head and neck neoplasms
50573|NCT03252470|2D laparoscopic surgery|2d laparoscopic surgery
50574|NCT03252470|3D laparascopic surgery|3d laparascopic surgery
50575|NCT03252470|laparoscopic roux-en-y gastric bypass|laparoscopic roux-en-y gastric bypass
50576|NCT03252457|Purpura|purpura
50577|NCT03252457|Thrombocytopenia|thrombocytopenia
50578|NCT03252457|immune throbocytopenia|immune throbocytopenia
50579|NCT03252444|Shoulder dyskinesis|shoulder dyskinesis
50580|NCT03252444|EMG biofeedback training|emg biofeedback training
50581|NCT03252444|Intensive Scapula-focused intervention|intensive scapula-focused intervention
50582|NCT03252418|ascorbic acid|ascorbic acid
50583|NCT03252418|diode laser|diode laser
50584|NCT03252418|gingival hyperpigmentation|gingival hyperpigmentation
50585|NCT03252392|hearing and communication abnormalities|hearing and communication abnormalities
50586|NCT03252366|MAXILLARY SINUS ELEVATION ,Simultaneous implant placement|maxillary sinus elevation ,simultaneous implant placement
50587|NCT03252353|Octreotide Capsules, Acromegaly, OPTIMAL, MYCAPSSA|octreotide capsules, acromegaly, optimal, mycapssa
50588|NCT03252301|pain|pain
50589|NCT03252301|post operative|post operative
50590|NCT03252301|surgery|surgery
50591|NCT03252301|objective|objective
50592|NCT03252236|Stroke|stroke
50593|NCT03252236|Tai Chi|tai chi
50594|NCT03252236|Dual-tasking|dual-tasking
50595|NCT03252236|Arterial compliance|arterial compliance
50596|NCT03252236|Arterial stiffness|arterial stiffness
50597|NCT03252236|Autonomic nervous system|autonomic nervous system
50598|NCT03252236|Heart rate variability|heart rate variability
50599|NCT03252223|polycystic ovary syndrome|polycystic ovary syndrome
50600|NCT03252223|anovulation|anovulation
50601|NCT03252223|hyperandrogenism|hyperandrogenism
50602|NCT03252210|Preoperative localization|preoperative localization
50603|NCT03252210|Stereoscopic Localization|stereoscopic localization
50604|NCT03252210|Wedge Resection|wedge resection
50605|NCT03252210|Ground Glass Opacity|ground glass opacity
50606|NCT03252197|Ultrasound guided central venous cannulation|ultrasound guided central venous cannulation
50607|NCT03252197|new device|new device
50608|NCT03252197|first attempt success|first attempt success
50609|NCT03252184|Phototherapy|phototherapy
50610|NCT03252184|Laser Therapy|laser therapy
50611|NCT03252184|Endothelium-Dependent|endothelium-dependent
50612|NCT03252184|Vascular Endothelium|vascular endothelium
50613|NCT03252184|Low Intensity Light Therapy|low intensity light therapy
50614|NCT03252184|Relaxing Factors|relaxing factors
50615|NCT03252171|CAR-T cell immunotherapy|car-t cell immunotherapy
50616|NCT03252171|GD2|gd2
50617|NCT03252171|glioma|glioma
50618|NCT03252080|type 2 diabetes|type 2 diabetes
50619|NCT03252080|holistic management|holistic management
50620|NCT03252067|Azithromycin eyedrops, pharmacokinetics, tears|azithromycin eyedrops, pharmacokinetics, tears
50621|NCT03252041|PCS|pcs
50622|NCT03252028|Hepatocyte growth factor, Nosocomial infections, VAP, Meningitis, In vitro, point of care, rapid test|hepatocyte growth factor, nosocomial infections, vap, meningitis, in vitro, point of care, rapid test
50623|NCT03252002|Chronic kidney disease|chronic kidney disease
50624|NCT03251989|Brain Tumor|brain tumor
50625|NCT03251989|Central Nervous System|central nervous system
50626|NCT03251989|CNS|cns
50627|NCT03251976|ovarian cancer|ovarian cancer
50628|NCT03251976|cardiopulmonary resuscitation|cardiopulmonary resuscitation
50629|NCT03251976|end of life care|end of life care
50630|NCT03251976|endometrial cancer|endometrial cancer
50631|NCT03251976|cervical cancer|cervical cancer
50632|NCT03251950|Vegetable and fruit intake|vegetable and fruit intake
50633|NCT03251937|Chronic Pain|chronic pain
50634|NCT03251937|Back Pain|back pain
50635|NCT03251937|Leg Pain|leg pain
50636|NCT03251937|Pain|pain
50637|NCT03251937|Stimulation|stimulation
50638|NCT03251937|Spinal Cord Stimulator|spinal cord stimulator
50639|NCT03251937|Implantable Pulse Generator|implantable pulse generator
50640|NCT03251872|pulmonary arterial hypertension|pulmonary arterial hypertension
50641|NCT03251872|PAH|pah
50642|NCT03251872|poly (ADP-ribose) polymerases inhibition|poly (adp-ribose) polymerases inhibition
50643|NCT03251872|PARP-1 inhibition|parp-1 inhibition
50644|NCT03251872|DNA damage|dna damage
50645|NCT03251872|Early-phase clinical trial pilot study|early-phase clinical trial pilot study
50646|NCT03251872|Olaparib|olaparib
50647|NCT03251872|Safety and efficacy|safety and efficacy
50648|NCT03251859|platelet reactivity|platelet reactivity
50649|NCT03251859|ticagrelor|ticagrelor
50650|NCT03251859|myocardial infarction|myocardial infarction
50651|NCT03251859|pharmacodynamics|pharmacodynamics
50652|NCT03251859|antiplatelet therapy|antiplatelet therapy
50653|NCT03251846|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
50654|NCT03251846|self-monitoring blood glucose|self-monitoring blood glucose
50655|NCT03251846|diabetes mobile application|diabetes mobile application
50656|NCT03251846|diabetes management device|diabetes management device
50657|NCT03251820|electrical status epilepticus during slow wave sleep|electrical status epilepticus during slow wave sleep
50658|NCT03251820|seizure|seizure
50659|NCT03251820|cognition|cognition
50660|NCT03251820|continuous spikes and waves during sleep|continuous spikes and waves during sleep
50661|NCT03251807|Low-intensity pulsed ultrasound|low-intensity pulsed ultrasound
50662|NCT03251807|Twin-block|twin-block
50663|NCT03251807|Functional treatment|functional treatment
50664|NCT03251781|Minimal Clinically Important Difference|minimal clinically important difference
50665|NCT03251781|Exercise Test|exercise test
50666|NCT03251781|Rehabilitation|rehabilitation
50667|NCT03251781|Disability Evaluation|disability evaluation
50668|NCT03251768|Chemotherapy|chemotherapy
50669|NCT03251768|Neutropenia|neutropenia
50670|NCT03251768|breast cancer|breast cancer
50671|NCT03251755|type 2 diabetes mellitus|type 2 diabetes mellitus
50672|NCT03251755|insomnia|insomnia
50673|NCT03251755|Dao-in|dao-in
50674|NCT03251742|Fontan operation|fontan operation
50675|NCT03251742|Negative pressure ventilation|negative pressure ventilation
50676|NCT03251742|MRI|mri
50677|NCT03251729|cerclage, preterm birth, short cervix|cerclage, preterm birth, short cervix
50678|NCT03251716|Metabolic syndrome|metabolic syndrome
50679|NCT03251716|Schizophrenia|schizophrenia
50680|NCT03251716|Efficacy|efficacy
50681|NCT03251716|Female|female
50682|NCT03251716|Berberine|berberine
50683|NCT03251638|NHS( newborn hearing screening )|nhs( newborn hearing screening )
50684|NCT03251599|peak temperature|peak temperature
50685|NCT03251599|rewarming rate|rewarming rate
50686|NCT03251599|surgical outcomes|surgical outcomes
50687|NCT03251560|Fuke Qianjin capsule|fuke qianjin capsule
50688|NCT03251560|chronic pelvic pain|chronic pelvic pain
50689|NCT03251547|rFVIIa|rfviia
50690|NCT03251547|Massive Hemorrhage|massive hemorrhage
50691|NCT03251547|non-hemophilia|non-hemophilia
50692|NCT03251534|Eos imaging stereography|eos imaging stereography
50693|NCT03251534|Centromedullary nailing|centromedullary nailing
50694|NCT03251534|Quantification of malunions|quantification of malunions
50695|NCT03251521|pain|pain
50696|NCT03251521|spasticity|spasticity
50697|NCT03251521|stroke|stroke
50698|NCT03251521|injection|injection
50699|NCT03251521|botulinum toxin A|botulinum toxin a
50700|NCT03251508|Peanut|peanut
50701|NCT03251495|Vaccination|vaccination
50702|NCT03251495|Contagious Diseases|contagious diseases
50703|NCT03251495|Tropical Medicine|tropical medicine
50704|NCT03251495|Infectious Diseases|infectious diseases
50705|NCT03251469|tranexamic acid|tranexamic acid
50706|NCT03251469|blood tranfusion|blood tranfusion
50707|NCT03251469|hip fractures|hip fractures
50708|NCT03251469|elderly|elderly
50709|NCT03251469|blood loss|blood loss
50710|NCT03251456|Visual Developmental Disorders|visual developmental disorders
50711|NCT03251456|Tertiary Care|tertiary care
50712|NCT03251456|Pre-school Children|pre-school children
50713|NCT03251417|Irinotecan|irinotecan
50714|NCT03251417|Apatinib|apatinib
50715|NCT03251391|revascularization|revascularization
50716|NCT03251391|blocked arteries|blocked arteries
50717|NCT03251391|leg arteries|leg arteries
50718|NCT03251391|leg pain|leg pain
50719|NCT03251365|Pancreatic cancer|pancreatic cancer
50720|NCT03251365|Gemcitabine|gemcitabine
50721|NCT03251365|Pancreatic carcinomatosis|pancreatic carcinomatosis
50722|NCT03251365|Intrabdominal hyperthermic chemotherapy|intrabdominal hyperthermic chemotherapy
50723|NCT03251352|TKI, CML, discontinuation|tki, cml, discontinuation
50724|NCT03251339|Healthy Subjects|healthy subjects
50725|NCT03251339|MSB11455|msb11455
50726|NCT03251274|bath machine|bath machine
50727|NCT03251274|sleep quality|sleep quality
50728|NCT03251274|nursing home|nursing home
50729|NCT03251274|heart rate variability|heart rate variability
50730|NCT03251248|MSB11455|msb11455
50731|NCT03251248|Healthy subjects|healthy subjects
50732|NCT03251235|cognitive behaviour therapy|cognitive behaviour therapy
50733|NCT03251222|conscious sedation, vitroretinal procedures|conscious sedation, vitroretinal procedures
50734|NCT03251157|Asthma|asthma
50735|NCT03251157|Adults|adults
50736|NCT03251157|Europe|europe
50737|NCT03251157|Lung function|lung function
50738|NCT03251157|Allergy|allergy
50739|NCT03251157|Atopy|atopy
50740|NCT03251157|IgE|ige
50741|NCT03251157|Sensitisation|sensitisation
50742|NCT03251157|Diet|diet
50743|NCT03251157|Dietary patterns|dietary patterns
50744|NCT03251157|Dietary antioxidants|dietary antioxidants
50745|NCT03251157|Flavonoids|flavonoids
50746|NCT03251157|Fruits and vegetables|fruits and vegetables
50747|NCT03251157|Food frequency questionnaire (FFQ)|food frequency questionnaire (ffq)
50748|NCT03251157|Fatty acids|fatty acids
50749|NCT03251144|HIV/AIDS|hiv/aids
50750|NCT03251144|Tenofovir disoproxil fumarate (TDF)|tenofovir disoproxil fumarate (tdf)
50751|NCT03251144|Tenofovir alafenamide (TAF)|tenofovir alafenamide (taf)
50752|NCT03251144|mitochondria|mitochondria
50753|NCT03251144|toxicity|toxicity
50754|NCT03251118|Crohn's Disease|crohn's disease
50755|NCT03251118|Ulcerative colitis|ulcerative colitis
50756|NCT03251118|Indeterminate colitis|indeterminate colitis
50757|NCT03251118|Digestive System Diseases|digestive system diseases
50758|NCT03251066|Nose Saline Solution Irrigation Nasal Spray|nose saline solution irrigation nasal spray
50759|NCT03251066|Sodium propionate Locke-Ringer Solution|sodium propionate locke-ringer solution
50760|NCT03251040|Esophagogastric anastomosis|esophagogastric anastomosis
50761|NCT03251040|Fibrin sealant|fibrin sealant
50762|NCT03251040|Sealing|sealing
50763|NCT03251014|Thrombosis|thrombosis
50764|NCT03251014|Yellowstripe scad|yellowstripe scad
50765|NCT03251014|Salmon|salmon
50766|NCT03251014|Healthy overweight subjects|healthy overweight subjects
50767|NCT03251014|Randomized crossover trial|randomized crossover trial
50768|NCT03251001|gingiva|gingiva
50769|NCT03251001|keratinized mucosa|keratinized mucosa
50770|NCT03251001|gingival graft|gingival graft
50771|NCT03250975|Intubation injury|intubation injury
50772|NCT03250975|Acute laryngeal injury|acute laryngeal injury
50773|NCT03250975|Chronic Laryngeal Injury|chronic laryngeal injury
50774|NCT03250962|Relapsed/Refractory; Hodgkin Lymphoma；Decitabine; SHR-1210|relapsed/refractory; hodgkin lymphoma；decitabine; shr-1210
50775|NCT03250936|trampoline|trampoline
50776|NCT03250923|Oral Candidiasis, Thrush, Oral Moniliasis|oral candidiasis, thrush, oral moniliasis
50777|NCT03250910|hepatitis C virus|hepatitis c virus
50778|NCT03250910|human immunodeficiency virus|human immunodeficiency virus
50779|NCT03250910|Direct acting antiviral agent|direct acting antiviral agent
50780|NCT03250897|Alveolar macrophages|alveolar macrophages
50781|NCT03250897|Blood monocyte-derived macrophages|blood monocyte-derived macrophages
50782|NCT03250897|FACS analysis|facs analysis
50783|NCT03250897|Broncho-alveolar lavage fluids|broncho-alveolar lavage fluids
50784|NCT03250897|Non-infectious lung diseases|non-infectious lung diseases
50785|NCT03250858|Personalised nutrition|personalised nutrition
50786|NCT03250858|Mobile web application|mobile web application
50787|NCT03250845|Multigam|multigam
50788|NCT03250845|Immunoglobulin|immunoglobulin
50789|NCT03250845|Secondary immunodeficiency|secondary immunodeficiency
50790|NCT03250832|advanced solid tumors|advanced solid tumors
50791|NCT03250832|endometrioid ovarian cancer|endometrioid ovarian cancer
50792|NCT03250832|fallopian tube cancer|fallopian tube cancer
50793|NCT03250832|primary peritoneal cancer|primary peritoneal cancer
50794|NCT03250832|breast cancer|breast cancer
50795|NCT03250832|bladder cancer|bladder cancer
50796|NCT03250832|urothelial carcinoma|urothelial carcinoma
50797|NCT03250832|TNBC|tnbc
50798|NCT03250832|triple-negative breast cancer|triple-negative breast cancer
50799|NCT03250832|LAG-3|lag-3
50800|NCT03250806|aortic stenosis, auscultation, target echocardiography|aortic stenosis, auscultation, target echocardiography
50801|NCT03250793|Hernia, DIaphragmatic, Congenital|hernia, diaphragmatic, congenital
50802|NCT03250793|Respiration, Artificial|respiration, artificial
50803|NCT03250793|physiologic pilot study|physiologic pilot study
50804|NCT03250793|NAVA|nava
50805|NCT03250793|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
50806|NCT03250793|esophageal transducer|esophageal transducer
50807|NCT03250793|Work of Breathing|work of breathing
50808|NCT03250754|Acupuncture|acupuncture
50809|NCT03250754|Migraine|migraine
50810|NCT03250754|Tension-type headache|tension-type headache
50811|NCT03250741|Rotigotine|rotigotine
50812|NCT03250741|Dopamine|dopamine
50813|NCT03250728|CDG|cdg
50814|NCT03250728|Stroke-like|stroke-like
50815|NCT03250728|Endothelial progenitor cells (EPCs)|endothelial progenitor cells (epcs)
50816|NCT03250728|Protein C|protein c
50817|NCT03250728|Congenital Disorders og Glycosylation|congenital disorders og glycosylation
50818|NCT03250702|Tanzania|tanzania
50819|NCT03250702|Observational|observational
50820|NCT03250702|Sub-Saharan Africa|sub-saharan africa
50821|NCT03250702|Treatment|treatment
50822|NCT03250689|Danirixin|danirixin
50823|NCT03250689|CXCR2|cxcr2
50824|NCT03250689|NETs|nets
50825|NCT03250689|GSK1325756|gsk1325756
50826|NCT03250689|COPD|copd
50827|NCT03250689|HBr|hbr
50828|NCT03250676|HER2|her2
50829|NCT03250676|estrogen receptor alpha|estrogen receptor alpha
50830|NCT03250676|H3B-6545|h3b-6545
50831|NCT03250676|breast cancer|breast cancer
50832|NCT03250663|topical therapy, atopic dermatitis,|topical therapy, atopic dermatitis,
50833|NCT03250650|Overactive Bladder|overactive bladder
50834|NCT03250650|Electric Stimulation|electric stimulation
50835|NCT03250650|Physical Therapy Modalities|physical therapy modalities
50836|NCT03250637|Gene-environment interaction|gene-environment interaction
50837|NCT03250637|Candidate gene|candidate gene
50838|NCT03250637|Western style diet|western style diet
50839|NCT03250637|Toll-like receptors|toll-like receptors
50840|NCT03250637|Prospective study|prospective study
50841|NCT03250637|Nested case-cohort|nested case-cohort
50842|NCT03250611|Occipital condyle|occipital condyle
50843|NCT03250611|Occipital condyle screw|occipital condyle screw
50844|NCT03250598|Healthy|healthy
50845|NCT03250598|Japanese|japanese
50846|NCT03250585|acute chest syndrome|acute chest syndrome
50847|NCT03250585|secretory phospholipases A2|secretory phospholipases a2
50848|NCT03250585|exhaled breath condensate|exhaled breath condensate
50849|NCT03250585|sickle cell disease|sickle cell disease
50850|NCT03250559|Stone disease|stone disease
50851|NCT03250533|Wound healing|wound healing
50852|NCT03250533|Phototherapy|phototherapy
50853|NCT03250533|Electrotherapy|electrotherapy
50854|NCT03250507|TAP block|tap block
50855|NCT03250507|Liposomal bupivicaine|liposomal bupivicaine
50856|NCT03250494|Duloxetine, Dexamethasone, Postoperative pain, side effects.|duloxetine, dexamethasone, postoperative pain, side effects.
50857|NCT03250481|Sedation, Responsiveness Index, Electromyogram|sedation, responsiveness index, electromyogram
50858|NCT03250390|Lung cancer|lung cancer
50859|NCT03250390|diagnosis|diagnosis
50860|NCT03250390|volatile organic compounds|volatile organic compounds
50861|NCT03250377|Brivaracetam|brivaracetam
50862|NCT03250377|Epilepsy|epilepsy
50863|NCT03250377|Partial seizures with or without secondary generalization|partial seizures with or without secondary generalization
50864|NCT03250377|Asian subjects|asian subjects
50865|NCT03250325|Adoptive cell transfer|adoptive cell transfer
50866|NCT03250325|Cell therapy|cell therapy
50867|NCT03250325|Immunotherapy|immunotherapy
50868|NCT03250325|NY-ESO-1|ny-eso-1
50869|NCT03250325|T cell receptor gene therapy|t cell receptor gene therapy
50870|NCT03250325|Synovial sarcoma|synovial sarcoma
50871|NCT03250312|Osteopathic manipulation|osteopathic manipulation
50872|NCT03250312|low back pain|low back pain
50873|NCT03250312|immune cells|immune cells
50874|NCT03250273|Immunotherapy|immunotherapy
50875|NCT03250273|Nivolumab|nivolumab
50876|NCT03250273|Entinostat|entinostat
50877|NCT03250273|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
50878|NCT03250273|Cholangiocarcinoma|cholangiocarcinoma
50879|NCT03250273|Unresectable|unresectable
50880|NCT03250273|Metastatic|metastatic
50881|NCT03250273|PD-1|pd-1
50882|NCT03250273|Antibody|antibody
50883|NCT03250260|3-dimensional imaging|3-dimensional imaging
50884|NCT03250260|Breast Conserving Treatment|breast conserving treatment
50885|NCT03250260|Simulation|simulation
50886|NCT03250247|deep vein thrombosis|deep vein thrombosis
50887|NCT03250247|superficial venous reflux|superficial venous reflux
50888|NCT03250247|blood clot|blood clot
50889|NCT03250247|post thrombotic syndrome|post thrombotic syndrome
50890|NCT03250247|iliac vein obstruction|iliac vein obstruction
50891|NCT03250234|microRNA, carbohydrate oxidation|microrna, carbohydrate oxidation
50892|NCT03250208|Microbiome|microbiome
50893|NCT03250208|Lactobacillus|lactobacillus
50894|NCT03250208|Probiotic|probiotic
50895|NCT03250208|Fem-Dophilus|fem-dophilus
50896|NCT03250156|Mindfulness|mindfulness
50897|NCT03250156|Attention|attention
50898|NCT03250156|Working Memory|working memory
50899|NCT03250156|Psychological Well-Being|psychological well-being
50900|NCT03250156|Proctored Practice|proctored practice
50901|NCT03250117|Parkinson Disease|parkinson disease
50902|NCT03250117|Dyskinesia|dyskinesia
50903|NCT03250117|ropinirole|ropinirole
50904|NCT03250117|implant|implant
50905|NCT03250117|ProNeura|proneura
50906|NCT03250117|movement disorders|movement disorders
50907|NCT03250117|dopamine agonist|dopamine agonist
50908|NCT03250117|extended-release|extended-release
50909|NCT03250117|Parkinsonian disorders|parkinsonian disorders
50910|NCT03250117|brain diseases|brain diseases
50911|NCT03250117|central nervous system diseases|central nervous system diseases
50912|NCT03250117|Neurodegenerative Diseases|neurodegenerative diseases
50913|NCT03250117|Antiparkinson agents|antiparkinson agents
50914|NCT03250117|Anti-dyskinesia agents|anti-dyskinesia agents
50915|NCT03250117|dopamine agents|dopamine agents
50916|NCT03250117|neurotransmitter agents|neurotransmitter agents
50917|NCT03250117|REQUIP|requip
50918|NCT03250117|subdermal|subdermal
50919|NCT03250104|antimicrobial stewardship|antimicrobial stewardship
50920|NCT03250104|infection control|infection control
50921|NCT03250104|nosocomial infection|nosocomial infection
50922|NCT03250104|clostridium difficile|clostridium difficile
50923|NCT03250104|MRGN bacteria|mrgn bacteria
50924|NCT03250104|health-care associated pathogens|health-care associated pathogens
50925|NCT03250104|VRE|vre
50926|NCT03250091|gastric precancerous lesions|gastric precancerous lesions
50927|NCT03250091|gastric cancer|gastric cancer
50928|NCT03250091|gastric intestinal Metaplasia|gastric intestinal metaplasia
50929|NCT03250091|gastric atrophy|gastric atrophy
50930|NCT03250091|gastric dysplasia|gastric dysplasia
50931|NCT03250078|Pancreas|pancreas
50932|NCT03250078|Cancer|cancer
50933|NCT03250078|Diabetes Mellitus|diabetes mellitus
50934|NCT03250078|MRI|mri
50935|NCT03250078|BRCA|brca
50936|NCT03250078|Early Detection|early detection
50937|NCT03250078|Genetics|genetics
50938|NCT03250052|Fimasartan|fimasartan
50939|NCT03250039|Absorption, Metabolism, Excretion, Absolute Bioavailability|absorption, metabolism, excretion, absolute bioavailability
50940|NCT03250026|primary care|primary care
50941|NCT03250026|convergence dialogue|convergence dialogue
50942|NCT03250026|sick leave|sick leave
50943|NCT03250026|care manager|care manager
50944|NCT03249974|Enlite glucose monitoring|enlite glucose monitoring
50945|NCT03249974|accuracy|accuracy
50946|NCT03249974|usability|usability
50947|NCT03249974|skin reactions|skin reactions
50948|NCT03249974|type 1 diabetes mellitus|type 1 diabetes mellitus
50949|NCT03249961|motor|motor
50950|NCT03249961|transcranial direct current stimulation|transcranial direct current stimulation
50951|NCT03249961|transcranial magnetic stimulation|transcranial magnetic stimulation
50952|NCT03249935|Azithromycin|azithromycin
50953|NCT03249935|Chlamydia|chlamydia
50954|NCT03249935|Correctional|correctional
50955|NCT03249935|Facilities|facilities
50956|NCT03249935|Symptoms|symptoms
50957|NCT03249935|Urethral|urethral
50958|NCT03249935|Urogenital|urogenital
50959|NCT03249935|Youth|youth
50960|NCT03249922|spinal cord stimulation|spinal cord stimulation
50961|NCT03249896|Gestational Diabetes|gestational diabetes
50962|NCT03249896|RCT|rct
50963|NCT03249896|Lifestyle coaching program|lifestyle coaching program
50964|NCT03249896|Smartphone app|smartphone app
50965|NCT03249896|Gestational weight gain|gestational weight gain
50966|NCT03249883|prosthetic feet|prosthetic feet
50967|NCT03249883|double blind study|double blind study
50968|NCT03249883|limited ambulators|limited ambulators
50969|NCT03249883|SACH foot|sach foot
50970|NCT03249883|prosthetic components comparison|prosthetic components comparison
50971|NCT03249857|Bipolar affective disorders|bipolar affective disorders
50972|NCT03249857|Cognition|cognition
50973|NCT03249857|Emotion|emotion
50974|NCT03249857|Embodiment|embodiment
50975|NCT03249857|Sensorimotor|sensorimotor
50976|NCT03249857|Simulation|simulation
50977|NCT03249844|arterial ischemic stroke|arterial ischemic stroke
50978|NCT03249844|children|children
50979|NCT03249844|steroids|steroids
50980|NCT03249844|aspirin|aspirin
50981|NCT03249844|Methylprednisolone|methylprednisolone
50982|NCT03249844|Prednisolone|prednisolone
50983|NCT03249831|Sickle Cell Disease|sickle cell disease
50984|NCT03249831|Sickle Cell Disorders|sickle cell disorders
50985|NCT03249831|Hemoglobinopathies|hemoglobinopathies
50986|NCT03249831|Thalassemia|thalassemia
50987|NCT03249831|Anemia, Sickle Cell|anemia, sickle cell
50988|NCT03249831|Haploidentical Transplant|haploidentical transplant
50989|NCT03249831|Nonmyeloablative Conditioning|nonmyeloablative conditioning
50990|NCT03249831|CD4+ T cell|cd4+ t cell
50991|NCT03249831|CD4+ T cell-depleted Hematopoietic Cell Transplant|cd4+ t cell-depleted hematopoietic cell transplant
50992|NCT03249831|Mixed Chimerism|mixed chimerism
50993|NCT03249805|LMIC|lmic
50994|NCT03249805|Medical device efficacy|medical device efficacy
50995|NCT03249740|Age-related macular degeneration|age-related macular degeneration
50996|NCT03249740|Choroidal neovascularization|choroidal neovascularization
50997|NCT03249727|natural killer cells|natural killer cells
50998|NCT03249727|natural killer cell activity|natural killer cell activity
50999|NCT03249714|double-blind, placebo controlled, ofatumumab, relapsing multiple sclerosis, Japanese patients|double-blind, placebo controlled, ofatumumab, relapsing multiple sclerosis, japanese patients
51000|NCT03249701|Acupoint Stimulation|acupoint stimulation
51001|NCT03249701|postoperative recovery|postoperative recovery
51002|NCT03249701|Postoperative Complications|postoperative complications
51003|NCT03249701|Peri-operation|peri-operation
51004|NCT03249688|Lifestyle intervention|lifestyle intervention
51005|NCT03249688|Medical food|medical food
51006|NCT03249688|Randomized controlled trial|randomized controlled trial
51007|NCT03249688|Prodromal Alzheimer's disease|prodromal alzheimer's disease
51008|NCT03249688|Prevention|prevention
51009|NCT03249688|Intervention|intervention
51010|NCT03249688|Multidomain|multidomain
51011|NCT03249688|Multimodal|multimodal
51012|NCT03249675|mild Traumatic Brain Injury|mild traumatic brain injury
51013|NCT03249675|Concussion|concussion
51014|NCT03249662|periarticular infiltration|periarticular infiltration
51015|NCT03249662|postoperative pain management|postoperative pain management
51016|NCT03249662|plasma level of bupivacaine|plasma level of bupivacaine
51017|NCT03249649|defibulation|defibulation
51018|NCT03249649|healthcare needs assessment|healthcare needs assessment
51019|NCT03249649|CBPR|cbpr
51020|NCT03249623|Weaning|weaning
51021|NCT03249623|Intensive Care|intensive care
51022|NCT03249623|Individualised Care|individualised care
51023|NCT03249623|Open-Loop Decision Support System|open-loop decision support system
51024|NCT03249623|Respiratory Failure|respiratory failure
51025|NCT03249623|Mechanical Ventilation|mechanical ventilation
51026|NCT03249623|Spontaneous breathing Tests|spontaneous breathing tests
51027|NCT03249623|Extubation|extubation
51028|NCT03249597|Sepsis|sepsis
51029|NCT03249597|Emergency Medical Services|emergency medical services
51030|NCT03249597|Prehospital|prehospital
51031|NCT03249597|Emergency Care|emergency care
51032|NCT03249597|Emergency Medicine|emergency medicine
51033|NCT03249571|exercise|exercise
51034|NCT03249571|flavonoids|flavonoids
51035|NCT03249571|gut permeability|gut permeability
51036|NCT03249571|gut-derived phenolics|gut-derived phenolics
51037|NCT03249558|Pain|pain
51038|NCT03249558|Pain Management|pain management
51039|NCT03249519|Radiation therapy|radiation therapy
51040|NCT03249519|Chemoradiation|chemoradiation
51041|NCT03249519|Brachytherapy|brachytherapy
51042|NCT03249519|Hyperthermia|hyperthermia
51043|NCT03249519|Cervical cancer|cervical cancer
51044|NCT03249519|Multimodality treatment of advanced cervical cancer|multimodality treatment of advanced cervical cancer
51045|NCT03249493|Decentralised Area|decentralised area
51046|NCT03249467|HAQ-II|haq-ii
51047|NCT03249467|Rheumatoid arthritis|rheumatoid arthritis
51048|NCT03249454|Incomplete SCI|incomplete sci
51049|NCT03249415|Platelet-Rich Plasma|platelet-rich plasma
51050|NCT03249415|Cell therapy|cell therapy
51051|NCT03249415|Regenerative factors|regenerative factors
51052|NCT03249415|Autologous treatment|autologous treatment
51053|NCT03249415|Paracrine factors|paracrine factors
51054|NCT03249363|Pulse Irrigation Povidone Iodine Spine Surgery|pulse irrigation povidone iodine spine surgery
51055|NCT03249350|Substance Use Disorders|substance use disorders
51056|NCT03249350|Adolescents|adolescents
51057|NCT03249350|Treatment|treatment
51058|NCT03249350|Mediation|mediation
51059|NCT03249324|Pregnancy|pregnancy
51060|NCT03249324|Overweight|overweight
51061|NCT03249324|Obesity|obesity
51062|NCT03249324|Prevention|prevention
51063|NCT03249324|Positive-gain counseling|positive-gain counseling
51064|NCT03249311|Levomilnacipran|levomilnacipran
51065|NCT03249311|Antidepressant|antidepressant
51066|NCT03249311|Ottawa|ottawa
51067|NCT03249311|Selective Norepinephrine Reuptake Inhibitor|selective norepinephrine reuptake inhibitor
51068|NCT03249311|Healthy males|healthy males
51069|NCT03249311|Tyramine response|tyramine response
51070|NCT03249311|Serotonin|serotonin
51071|NCT03249311|Norepinephrine|norepinephrine
51072|NCT03249285|hypertension|hypertension
51073|NCT03249285|pharmacogenomics|pharmacogenomics
51074|NCT03249285|anti-hypertensive therapy|anti-hypertensive therapy
51075|NCT03249246|Sepsis|sepsis
51076|NCT03249246|ICU|icu
51077|NCT03249246|Point prevalence|point prevalence
51078|NCT03249207|Aneurysmal|aneurysmal
51079|NCT03249181|MTCT|mtct
51080|NCT03249181|Antiretroviral|antiretroviral
51081|NCT03249181|Pregnancy|pregnancy
51082|NCT03249181|Africa|africa
51083|NCT03249155|Freezing of Gait, Action Observation|freezing of gait, action observation
51084|NCT03249142|Ovarian Cancer|ovarian cancer
51085|NCT03249142|Anti-PD-L1|anti-pd-l1
51086|NCT03249142|Anti-CLA-4|anti-cla-4
51087|NCT03249142|Neo-adjuvant|neo-adjuvant
51088|NCT03249129|Trauma|trauma
51089|NCT03249129|spinal cord|spinal cord
51090|NCT03249129|autoimmunity|autoimmunity
51091|NCT03249129|antibody|antibody
51092|NCT03249116|human-animal interaction|human-animal interaction
51093|NCT03249116|animal-assisted intervention|animal-assisted intervention
51094|NCT03249103|Fibromyalgia|fibromyalgia
51095|NCT03249077|Prevention|prevention
51096|NCT03249077|Medicare|medicare
51097|NCT03249064|TREGS|tregs
51099|NCT03249064|LRP1|lrp1
51100|NCT03249025|lidocaine|lidocaine
51101|NCT03249025|ketamine|ketamine
51102|NCT03249025|infusion|infusion
51103|NCT03248999|multidrug resistance|multidrug resistance
51104|NCT03248999|nursing home|nursing home
51105|NCT03248999|ESBL|esbl
51106|NCT03248999|CRE|cre
51107|NCT03248947|opioid use disorder|opioid use disorder
51108|NCT03248947|Medication-assisted treatment|medication-assisted treatment
51109|NCT03248947|Buprenorphine treatment|buprenorphine treatment
51110|NCT03248947|Collaborative care model|collaborative care model
51111|NCT03248908|pupillary reflex|pupillary reflex
51112|NCT03248908|nociception|nociception
51113|NCT03248908|heart rate|heart rate
51114|NCT03248908|intraoperative monitoring|intraoperative monitoring
51115|NCT03248895|Inhaler assessment|inhaler assessment
51116|NCT03248895|Direct observation of therapy|direct observation of therapy
51117|NCT03248882|PF-05221304|pf-05221304
51118|NCT03248882|NAFLD|nafld
51119|NCT03248882|NASH|nash
51120|NCT03248882|features of metabolic syndrome|features of metabolic syndrome
51121|NCT03248882|Dose-Ranging Study|dose-ranging study
51122|NCT03248869|asthma|asthma
51123|NCT03248869|mobile application|mobile application
51124|NCT03248869|mobile app|mobile app
51125|NCT03248869|mobile health applications|mobile health applications
51126|NCT03248869|asthma mobile health application|asthma mobile health application
51127|NCT03248843|KN035|kn035
51128|NCT03248843|Solid tumors|solid tumors
51129|NCT03248843|Phase 1|phase 1
51130|NCT03248804|Overweight|overweight
51131|NCT03248804|Obesity|obesity
51132|NCT03248804|Weight Loss|weight loss
51133|NCT03248778|disclosure|disclosure
51134|NCT03248752|Behavioural|behavioural
51135|NCT03248739|Catheter|catheter
51136|NCT03248739|Ventricular|ventricular
51137|NCT03248739|External Ventricular Drain Catheter|external ventricular drain catheter
51138|NCT03248739|EVD Catheter|evd catheter
51139|NCT03248739|Occlusion|occlusion
51140|NCT03248739|Ventriculostomy|ventriculostomy
51141|NCT03248739|Clear Bactiseal catheter|clear bactiseal catheter
51142|NCT03248739|Orange Bactiseal catheter|orange bactiseal catheter
51143|NCT03248739|Ventriculostomy Occlusion|ventriculostomy occlusion
51144|NCT03248739|Neurosurgery|neurosurgery
51145|NCT03248726|Polyethylene Glycol|polyethylene glycol
51146|NCT03248726|Bisacodyl|bisacodyl
51147|NCT03248726|Colonoscopy|colonoscopy
51148|NCT03248726|Bowel preparation|bowel preparation
51149|NCT03248726|Ottawa bowel preparation scale|ottawa bowel preparation scale
51150|NCT03248635|Survey|survey
51151|NCT03248635|Pre-Test|pre-test
51152|NCT03248622|Incidence|incidence
51153|NCT03248622|Hepatitis B Surface Antigen|hepatitis b surface antigen
51154|NCT03248622|Decompensation|decompensation
51155|NCT03248596|Extracorporeal Membrane Oxygenation (ECMO)|extracorporeal membrane oxygenation (ecmo)
51156|NCT03248596|Primary hemostasis|primary hemostasis
51157|NCT03248583|Proof-of-principle|proof-of-principle
51158|NCT03248583|Feasibility|feasibility
51159|NCT03248557|resuscitation|resuscitation
51160|NCT03248557|wavelet analysis|wavelet analysis
51161|NCT03248557|spectral analysis|spectral analysis
51162|NCT03248557|post-cardiac arrest syndrome|post-cardiac arrest syndrome
51163|NCT03248544|vitamin D|vitamin d
51164|NCT03248544|Brain Neoplasms|brain neoplasms
51165|NCT03248544|perioperative complications|perioperative complications
51166|NCT03248544|clinical outcomes|clinical outcomes
51167|NCT03248544|craniotomy|craniotomy
51168|NCT03248544|Immune System|immune system
51169|NCT03248531|Hidradenitis Suppurativa|hidradenitis suppurativa
51170|NCT03248531|Bimekizumab|bimekizumab
51171|NCT03248531|HS|hs
51172|NCT03248531|Moderate to Severe HS|moderate to severe hs
51173|NCT03248518|Inflammatory Rheumatic Disease|inflammatory rheumatic disease
51174|NCT03248518|Fatigue|fatigue
51175|NCT03248518|Exercise|exercise
51176|NCT03248518|Behavioural Intervention|behavioural intervention
51177|NCT03248518|Rheumatoid Arthritis|rheumatoid arthritis
51178|NCT03248518|Systemic Lupus Erythematosus|systemic lupus erythematosus
51179|NCT03248518|Axial Spondyloarthritis|axial spondyloarthritis
51180|NCT03248492|HER-2 positive breast cancer|her-2 positive breast cancer
51181|NCT03248492|Metastatic or Unresectable|metastatic or unresectable
51182|NCT03248492|Resistant or refractory to T-DM1|resistant or refractory to t-dm1
51183|NCT03248479|Hu5F9-G4|hu5f9-g4
51184|NCT03248479|CD47|cd47
51185|NCT03248479|azacitidine|azacitidine
51186|NCT03248466|platelet rich gel|platelet rich gel
51187|NCT03248466|BMMSCs|bmmscs
51188|NCT03248466|diabetic foot ulcer|diabetic foot ulcer
51189|NCT03248453|Simulated colonoscopy|simulated colonoscopy
51190|NCT03248453|Self-regulated learning|self-regulated learning
51191|NCT03248427|Breast Cancer|breast cancer
51192|NCT03248427|Neoadjuvant|neoadjuvant
51193|NCT03248427|Luminal B tumors|luminal b tumors
51194|NCT03248427|Ribociclib|ribociclib
51195|NCT03248375|Unresectable Hepatocellular Carcinoma|unresectable hepatocellular carcinoma
51196|NCT03248375|Radioembolization|radioembolization
51197|NCT03248375|Radiation Segmentectomy|radiation segmentectomy
51198|NCT03248349|Critically ill children|critically ill children
51199|NCT03248349|Pharmacokinetics|pharmacokinetics
51200|NCT03248349|Anti-Bacterial agents|anti-bacterial agents
51201|NCT03248310|Quality of Life (QoL)|quality of life (qol)
51202|NCT03248310|17-377|17-377
51203|NCT03248271|Diabetes|diabetes
51204|NCT03248271|Sarcopenia|sarcopenia
51205|NCT03248271|Hypotension|hypotension
51206|NCT03248271|Tilt Table Test|tilt table test
51207|NCT03248258|Metastatic Breast Cancer|metastatic breast cancer
51208|NCT03248258|Treatment Decision Making|treatment decision making
51209|NCT03248258|Shared Decision Making|shared decision making
51210|NCT03248245|interprofessional team collaboration|interprofessional team collaboration
51211|NCT03248245|primary school|primary school
51212|NCT03248245|learning environment|learning environment
51213|NCT03248245|teacher's self-efficacy|teacher's self-efficacy
51214|NCT03248245|teachers working ours|teachers working ours
51215|NCT03248245|pupils learning outcome|pupils learning outcome
51216|NCT03248245|cluster-randomized|cluster-randomized
51217|NCT03248232|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
51218|NCT03248193|paclitaxel|paclitaxel
51219|NCT03248193|neuropathy|neuropathy
51220|NCT03248193|hypothermia|hypothermia
51221|NCT03248193|cryocompression|cryocompression
51222|NCT03248193|alopecia|alopecia
51223|NCT03248180|antipsychotic|antipsychotic
51224|NCT03248180|guided dose reduction|guided dose reduction
51225|NCT03248180|maintenance treatment|maintenance treatment
51226|NCT03248180|remitted psychosis|remitted psychosis
51227|NCT03248180|relapse|relapse
51228|NCT03248167|Cannabidiol|cannabidiol
51229|NCT03248154|Biofilm|biofilm
51230|NCT03248154|Procellera|procellera
51231|NCT03248141|Hemophilia A Factor VIII|hemophilia a factor viii
51232|NCT03248141|Hemophilia B Factor IX|hemophilia b factor ix
51233|NCT03248141|Cross-sectional|cross-sectional
51234|NCT03248141|Epidemiological|epidemiological
51235|NCT03248141|Clinical practice|clinical practice
51236|NCT03248141|United States|united states
51237|NCT03248128|Fluticasone furoate|fluticasone furoate
51238|NCT03248128|Efficacy|efficacy
51239|NCT03248128|Vilanterol|vilanterol
51240|NCT03248128|Asthma|asthma
51241|NCT03248128|Safety|safety
51242|NCT03248128|GW642444|gw642444
51243|NCT03248128|GW685698|gw685698
51244|NCT03248115|polyphenols|polyphenols
51245|NCT03248115|green tea catechins|green tea catechins
51246|NCT03248115|coffee caffeoylquinic acids|coffee caffeoylquinic acids
51247|NCT03248115|metabolism|metabolism
51248|NCT03248115|inter-individual variability|inter-individual variability
51249|NCT03248115|colonic microbiota|colonic microbiota
51250|NCT03248102|paediatric|paediatric
51251|NCT03248063|Staphylococcus aureus|staphylococcus aureus
51252|NCT03248063|bacteremia|bacteremia
51253|NCT03248063|cloxacillin|cloxacillin
51254|NCT03248063|cefazolin|cefazolin
51255|NCT03248024|Chronic Disease|chronic disease
51256|NCT03248024|Ulcerative Colitis|ulcerative colitis
51257|NCT03248011|hamstring|hamstring
51258|NCT03248011|ultrasound|ultrasound
51259|NCT03248011|intervention|intervention
51260|NCT03247998|Stroke|stroke
51261|NCT03247998|endovascular repair|endovascular repair
51262|NCT03247998|general anesthesia|general anesthesia
51263|NCT03247998|conscious sedation|conscious sedation
51264|NCT03247985|Mesh|mesh
51265|NCT03247985|Repair|repair
51266|NCT03247985|Peritoneal|peritoneal
51267|NCT03247959|oral health education, distraction, videogame|oral health education, distraction, videogame
51268|NCT03247946|infant|infant
51269|NCT03247946|feeding position|feeding position
51270|NCT03247946|respiratory|respiratory
51271|NCT03247946|ear|ear
51272|NCT03247933|COPD|copd
51273|NCT03247933|RESPIRATORY REHABILITATION TELEMEDICINE|respiratory rehabilitation telemedicine
51274|NCT03247920|Antibiotic switch therapy|antibiotic switch therapy
51275|NCT03247920|Amoxicillin/clavulanic acid|amoxicillin/clavulanic acid
51276|NCT03247894|Multiple sclerosis, anesthesia|multiple sclerosis, anesthesia
51277|NCT03247842|post mastectomy pain|post mastectomy pain
51278|NCT03247829|CardioMEMS|cardiomems
51279|NCT03247829|Left Ventricular Assist Device|left ventricular assist device
51280|NCT03247829|Hemodynamic Management|hemodynamic management
51281|NCT03247803|Air-Q® SP|air-q® sp
51282|NCT03247803|Williams Airway Intubator (WA)|williams airway intubator (wa)
51283|NCT03247803|Flexible Bronchoscopic intubation (FBI)|flexible bronchoscopic intubation (fbi)
51284|NCT03247803|Fiberoptic Intubation (FOI)|fiberoptic intubation (foi)
51285|NCT03247803|Fiberoptic Intubating Airway(FIA)|fiberoptic intubating airway(fia)
51286|NCT03247803|Laryngeal Mask Airway|laryngeal mask airway
51287|NCT03247777|golf|golf
51288|NCT03247777|strength training|strength training
51289|NCT03247777|physical performance tests|physical performance tests
51290|NCT03247777|body composition|body composition
51291|NCT03247738|ticagrelor|ticagrelor
51292|NCT03247738|cangrelor|cangrelor
51293|NCT03247712|HNSCC|hnscc
51294|NCT03247712|radiation|radiation
51295|NCT03247712|surgery|surgery
51296|NCT03247712|phase 1|phase 1
51297|NCT03247712|immunotherapy|immunotherapy
51298|NCT03247712|nivolumab|nivolumab
51299|NCT03247712|antibodies|antibodies
51300|NCT03247673|safety|safety
51301|NCT03247673|Pharmacokinetics|pharmacokinetics
51302|NCT03247673|Immunogenicity|immunogenicity
51303|NCT03247647|Alcohol Intervention|alcohol intervention
51304|NCT03247647|College Students|college students
51305|NCT03247634|getting ahead|getting ahead
51306|NCT03247634|vulnerable population|vulnerable population
51307|NCT03247634|safety net practice network|safety net practice network
51308|NCT03247621|external eating, technology|external eating, technology
51309|NCT03247608|Ambio Health|ambio health
51310|NCT03247595|Colonoscopy preparation|colonoscopy preparation
51311|NCT03247595|Magnesium Citrate Capsules|magnesium citrate capsules
51312|NCT03247582|Real World Evidence|real world evidence
51313|NCT03247582|Non-valvular Atrial Fibrillation|non-valvular atrial fibrillation
51314|NCT03247582|Observational Safety|observational safety
51315|NCT03247569|Non-valvular Atrial Fibrillation|non-valvular atrial fibrillation
51316|NCT03247569|Real World Evidence|real world evidence
51317|NCT03247569|Observational Safety|observational safety
51318|NCT03247491|Mindfulness|mindfulness
51319|NCT03247491|Compassion|compassion
51320|NCT03247491|Depression during Pregnancy and Postpartum|depression during pregnancy and postpartum
51321|NCT03247491|Prevention|prevention
51322|NCT03247491|Stress|stress
51323|NCT03247478|Computed tomography (CT) reconstruction|computed tomography (ct) reconstruction
51324|NCT03247478|axillary lymph node status|axillary lymph node status
51325|NCT03247452|Low fiber diet|low fiber diet
51326|NCT03247452|Colonoscopy|colonoscopy
51327|NCT03247452|Bowel Cleansing|bowel cleansing
51328|NCT03247439|CMC Joint|cmc joint
51329|NCT03247439|Osteoarthritis|osteoarthritis
51330|NCT03247439|Cartilage Replacement|cartilage replacement
51331|NCT03247439|First CMC Joint Osteoarthritis|first cmc joint osteoarthritis
51332|NCT03247439|Damaged Articular Surface|damaged articular surface
51333|NCT03247439|LRTI|lrti
51334|NCT03247439|Ligament Reconstruction Tendon Interposition|ligament reconstruction tendon interposition
51335|NCT03247387|Wearable device|wearable device
51336|NCT03247387|Patient monitor|patient monitor
51337|NCT03247374|rehabilitation|rehabilitation
51338|NCT03247374|treatment|treatment
51339|NCT03247374|biofeedback|biofeedback
51340|NCT03247374|bio-feedback|bio-feedback
51341|NCT03247374|dysphagia|dysphagia
51342|NCT03247374|swallowing disorders|swallowing disorders
51343|NCT03247374|post-stroke|post-stroke
51344|NCT03247374|deglutition disorders|deglutition disorders
51345|NCT03247361|Heart Failure; Rehabilitation|heart failure; rehabilitation
51346|NCT03247322|Medication Safety|medication safety
51347|NCT03247322|Mobile Health Technology|mobile health technology
51348|NCT03247309|T-cell therapy|t-cell therapy
51349|NCT03247309|immunotherapy|immunotherapy
51350|NCT03247309|HLA-A*02:01|hla-a*02:01
51351|NCT03247309|adoptive cellular therapy|adoptive cellular therapy
51352|NCT03247309|T-Cell Receptor|t-cell receptor
51353|NCT03247296|Daclatasvir|daclatasvir
51354|NCT03247296|HCC|hcc
51355|NCT03247296|HCV|hcv
51356|NCT03247296|Sofosbuvir|sofosbuvir
51357|NCT03247244|Cannabis|cannabis
51358|NCT03247244|Tics|tics
51359|NCT03247244|Tourette Syndrome|tourette syndrome
51360|NCT03247231|SUBEPITHELIAL TUMORS|subepithelial tumors
51361|NCT03247231|SUBMUCOSAL TUMORS|submucosal tumors
51362|NCT03247231|ENDOSCOPIC BAND LIGATION|endoscopic band ligation
51363|NCT03247205|hip fracture|hip fracture
51364|NCT03247205|cognitive impairment|cognitive impairment
51365|NCT03247205|physical therapy|physical therapy
51366|NCT03247192|resistance training|resistance training
51367|NCT03247192|protein supplementation|protein supplementation
51368|NCT03247192|aging|aging
51369|NCT03247192|Randomized Controlled Trial|randomized controlled trial
51370|NCT03247127|hippocampal avoidance whole brain radiotherapy (HA-WBRT)|hippocampal avoidance whole brain radiotherapy (ha-wbrt)
51371|NCT03247127|brain metastases|brain metastases
51372|NCT03247127|memory preservation|memory preservation
51373|NCT03247127|neurocognitive function|neurocognitive function
51374|NCT03247088|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
51375|NCT03247088|Acute Myeloid Leukemia|acute myeloid leukemia
51376|NCT03247088|AML|aml
51377|NCT03247088|flt3 positive and negative|flt3 positive and negative
51378|NCT03247088|Stem cell transplant|stem cell transplant
51379|NCT03247088|Sorafenib|sorafenib
51380|NCT03247088|Nexavar|nexavar
51381|NCT03247088|BAY 43-9006|bay 43-9006
51382|NCT03247088|Busulfan|busulfan
51383|NCT03247088|Busulfex|busulfex
51384|NCT03247088|Myleran|myleran
51385|NCT03247088|Fludarabine|fludarabine
51386|NCT03247088|Fludarabine Phosphate|fludarabine phosphate
51387|NCT03247088|Fludara|fludara
51388|NCT03247088|Tacrolimus|tacrolimus
51389|NCT03247088|Prograf|prograf
51390|NCT03247088|Filgrastim|filgrastim
51391|NCT03247088|G-CSF|g-csf
51392|NCT03247088|Neupogen|neupogen
51393|NCT03247088|Mycophenolate mofetil|mycophenolate mofetil
51394|NCT03247088|MMF|mmf
51395|NCT03247088|CellCept|cellcept
51396|NCT03247075|Social anxiety disorder|social anxiety disorder
51397|NCT03247075|Cognitive Behavior Therapy|cognitive behavior therapy
51398|NCT03247075|Internet-delivered treatments|internet-delivered treatments
51399|NCT03247075|Children and adolescents|children and adolescents
51400|NCT03247075|Randomized controlled trial|randomized controlled trial
51401|NCT03247062|agitation, sleep deprivation, bundle|agitation, sleep deprivation, bundle
51402|NCT03246997|Food Insecure|food insecure
51403|NCT03246958|Thyroid Cancer|thyroid cancer
51404|NCT03246932|peer expert or specialist|peer expert or specialist
51405|NCT03246932|psycho-education|psycho-education
51406|NCT03246932|schizophrenia|schizophrenia
51407|NCT03246932|outpatients|outpatients
51408|NCT03246893|Sepsis|sepsis
51409|NCT03246893|Septic shock|septic shock
51410|NCT03246893|Severe sepsis|severe sepsis
51411|NCT03246893|Extubation|extubation
51412|NCT03246893|Reintubation|reintubation
51413|NCT03246893|Noninvasive positive pressure ventilation|noninvasive positive pressure ventilation
51414|NCT03246893|High flow oxygen nasal cannula|high flow oxygen nasal cannula
51415|NCT03246867|isolytic stretching|isolytic stretching
51416|NCT03246867|static stretching|static stretching
51417|NCT03246867|Glenohumeral Internal Rotation Deficit|glenohumeral internal rotation deficit
51418|NCT03246854|DBPR112|dbpr112
51419|NCT03246854|EGFR mutated NSCLC|egfr mutated nsclc
51420|NCT03246854|squamous cell cancer of head and neck|squamous cell cancer of head and neck
51421|NCT03246854|maximum tolerated dose|maximum tolerated dose
51422|NCT03246854|recommended Phase 2 dose|recommended phase 2 dose
51423|NCT03246841|Oncogeneticists|oncogeneticists
51424|NCT03246841|Mutations|mutations
51425|NCT03246841|Breast Cancer|breast cancer
51426|NCT03246841|Ovarian cancer|ovarian cancer
51427|NCT03246828|gliclazide|gliclazide
51428|NCT03246828|glucagon|glucagon
51429|NCT03246828|diabetes|diabetes
51430|NCT03246802|recurrent prostate cancer|recurrent prostate cancer
51431|NCT03246802|mpMRI|mpmri
51432|NCT03246802|salvage HDR brachytherapy|salvage hdr brachytherapy
51433|NCT03246763|childhood obesity|childhood obesity
51434|NCT03246750|Brentuximab Vedotin|brentuximab vedotin
51435|NCT03246724|Ocular surgery|ocular surgery
51436|NCT03246724|Intravenous sedation|intravenous sedation
51437|NCT03246724|Oral sedation|oral sedation
51438|NCT03246698|Stretching|stretching
51439|NCT03246698|Subacromial Impingement Syndrome|subacromial impingement syndrome
51440|NCT03246698|Glenohumeral Internal Rotation Deficit|glenohumeral internal rotation deficit
51441|NCT03246672|obesity, morbid|obesity, morbid
51442|NCT03246659|medullary thyroid carcinoma|medullary thyroid carcinoma
51443|NCT03246659|MTC|mtc
51444|NCT03246659|new gastrin analog|new gastrin analog
51445|NCT03246659|111In-CP04|111in-cp04
51446|NCT03246659|CP04 indium|cp04 indium
51447|NCT03246659|personalised diagnostics|personalised diagnostics
51448|NCT03246659|personalised therapy|personalised therapy
51449|NCT03246659|theranostics|theranostics
51450|NCT03246659|advanced MTC|advanced mtc
51451|NCT03246659|CCK-2/gastrin receptor|cck-2/gastrin receptor
51452|NCT03246646|Substance Abuse|substance abuse
51453|NCT03246646|Alcohol Abuse|alcohol abuse
51454|NCT03246620|emergency|emergency
51455|NCT03246620|emergency medicine|emergency medicine
51456|NCT03246620|sedation|sedation
51457|NCT03246620|acute agitation|acute agitation
51458|NCT03246594|atrial fibrillation|atrial fibrillation
51459|NCT03246594|esophageal probe|esophageal probe
51460|NCT03246594|thermolesion|thermolesion
51461|NCT03246581|inhalation|inhalation
51462|NCT03246581|anticholinergic|anticholinergic
51463|NCT03246568|Ablation|ablation
51464|NCT03246568|Renal Denervation|renal denervation
51465|NCT03246568|Cryoballoon|cryoballoon
51466|NCT03246477|maxillomandibular advancement osteotomy|maxillomandibular advancement osteotomy
51467|NCT03246477|long-term results|long-term results
51468|NCT03246477|quality of life|quality of life
51469|NCT03246477|polysomnographic measurements|polysomnographic measurements
51470|NCT03246477|skeletal stability|skeletal stability
51471|NCT03246464|Contact lenses|contact lenses
51472|NCT03246464|Children|children
51473|NCT03246464|Myopia|myopia
51474|NCT03246451|GLP-1|glp-1
51475|NCT03246451|glucagon-like peptide-1|glucagon-like peptide-1
51476|NCT03246451|Metformin|metformin
51477|NCT03246451|Exendin(9-39)|exendin(9-39)
51478|NCT03246399|SM04690|sm04690
51479|NCT03246399|Wnt pathway|wnt pathway
51480|NCT03246399|Samumed|samumed
51481|NCT03246373|cognitive impairment|cognitive impairment
51482|NCT03246334|Cohort study|cohort study
51483|NCT03246334|Critical Care|critical care
51484|NCT03246334|Follow-up study|follow-up study
51485|NCT03246334|Intensive care units|intensive care units
51486|NCT03246334|Long-term outcome|long-term outcome
51487|NCT03246334|Outcome assessment|outcome assessment
51488|NCT03246334|Quality of life|quality of life
51489|NCT03246321|Colorectal Neoplasms|colorectal neoplasms
51490|NCT03246321|Peritoneal Neoplasms|peritoneal neoplasms
51491|NCT03246321|Intraperitoneal Injections|intraperitoneal injections
51492|NCT03246321|Laparoscopy|laparoscopy
51493|NCT03246321|Aerosols|aerosols
51494|NCT03246321|Chemotherapy, Cancer, Regional Perfusion|chemotherapy, cancer, regional perfusion
51495|NCT03246321|Antineoplastic Agents|antineoplastic agents
51496|NCT03246321|Leucovorin|leucovorin
51497|NCT03246321|Fluorouracil|fluorouracil
51498|NCT03246321|Platinum|platinum
51499|NCT03246321|Intraoperative Complications|intraoperative complications
51500|NCT03246321|Postoperative Complications|postoperative complications
51501|NCT03246321|Drug-Related Side Effects and Adverse Reactions|drug-related side effects and adverse reactions
51502|NCT03246321|Metabolic Side Effects of Drugs and Substances|metabolic side effects of drugs and substances
51503|NCT03246321|Disease-free survival|disease-free survival
51504|NCT03246321|Survival|survival
51505|NCT03246321|Mortality|mortality
51506|NCT03246321|Quality of Life|quality of life
51507|NCT03246321|Costs and Cost Analysis|costs and cost analysis
51508|NCT03246321|Translational Medical Research|translational medical research
51509|NCT03246321|Clinical Trials, Phase II as topic|clinical trials, phase ii as topic
51510|NCT03246321|PIPAC|pipac
51511|NCT03246321|Pressurized Intraperitoneal Aerosol Chemotherapy|pressurized intraperitoneal aerosol chemotherapy
51512|NCT03246321|Pressurised Intraperitoneal Aerosol Chemotherapy|pressurised intraperitoneal aerosol chemotherapy
51513|NCT03246321|Peritoneum|peritoneum
51514|NCT03246321|Cecal Neoplasms|cecal neoplasms
51515|NCT03246321|Clinical Trials, Phase I as topic|clinical trials, phase i as topic
51516|NCT03246295|Proteomics|proteomics
51517|NCT03246295|Metabolomics|metabolomics
51518|NCT03246256|acute|acute
51519|NCT03246256|informed consent|informed consent
51520|NCT03246256|thrombolysis|thrombolysis
51521|NCT03246243|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
51522|NCT03246243|Bottle Feeding|bottle feeding
51523|NCT03246230|newborn vaccine responses|newborn vaccine responses
51524|NCT03246178|Haploidentical|haploidentical
51525|NCT03246178|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
51526|NCT03246178|Severe aplastic anemia|severe aplastic anemia
51527|NCT03246152|Anti-VEGF safety|anti-vegf safety
51528|NCT03246152|Ischemic Maculopathy|ischemic maculopathy
51529|NCT03246152|Diabetic Macular Edema|diabetic macular edema
51530|NCT03246152|OCTA|octa
51531|NCT03246139|stroke|stroke
51532|NCT03246139|neurorehabilitation|neurorehabilitation
51533|NCT03246139|mirror neuron system|mirror neuron system
51534|NCT03246139|action observation|action observation
51535|NCT03246139|motor imagery|motor imagery
51536|NCT03246139|MEG|meg
51537|NCT03246113|GBM WHO Grade IV|gbm who grade iv
51538|NCT03246100|centralized reminder/recall|centralized reminder/recall
51539|NCT03246100|influenza vaccine reminders|influenza vaccine reminders
51540|NCT03246100|childhood influenza vaccines|childhood influenza vaccines
51541|NCT03246087|acupuncture|acupuncture
51542|NCT03246087|plantar fasiosis|plantar fasiosis
51543|NCT03246074|Phase I|phase i
51544|NCT03246074|Ovarian Cancer|ovarian cancer
51545|NCT03246074|Fostamatinib and Paclitaxel|fostamatinib and paclitaxel
51546|NCT03246035|Acute Decompensated Heart Failure|acute decompensated heart failure
51547|NCT03246035|Heart Failure|heart failure
51548|NCT03246035|Frailty|frailty
51549|NCT03246035|Geriatrics|geriatrics
51550|NCT03246035|Self-care|self-care
51551|NCT03246035|Emergency Medicine|emergency medicine
51552|NCT03246035|Cardiology|cardiology
51553|NCT03246035|Patient Oriented Research|patient oriented research
51554|NCT03246022|blood pressure fluctuation|blood pressure fluctuation
51555|NCT03246022|hypertension|hypertension
51556|NCT03246022|continuous positive airway pressure|continuous positive airway pressure
51557|NCT03246009|Neutropenia|neutropenia
51558|NCT03246009|Chemotherapy|chemotherapy
51559|NCT03246009|rHSA/GCSF|rhsa/gcsf
51560|NCT03245996|sick sinus syndrome|sick sinus syndrome
51561|NCT03245996|heart rate|heart rate
51562|NCT03245996|aortic blood pressure|aortic blood pressure
51563|NCT03245996|artificial pacemaker|artificial pacemaker
51564|NCT03245944|immature AVF|immature avf
51565|NCT03245944|percutaneous intervention|percutaneous intervention
51566|NCT03245892|Nivolumab|nivolumab
51567|NCT03245892|Paclitaxel|paclitaxel
51568|NCT03245892|Carboplatin|carboplatin
51569|NCT03245892|17-182|17-182
51570|NCT03245866|Subarachnoid Hemorrhage|subarachnoid hemorrhage
51571|NCT03245866|Intracranial Aneurysm|intracranial aneurysm
51572|NCT03245866|Ruptured Intracranial Aneurysm|ruptured intracranial aneurysm
51573|NCT03245866|Neurosurgery|neurosurgery
51574|NCT03245866|Interventional Neuroradiology|interventional neuroradiology
51575|NCT03245866|Neurointensive Care Medicine|neurointensive care medicine
51576|NCT03245866|Switzerland|switzerland
51577|NCT03245853|Keratoconus|keratoconus
51578|NCT03245853|Corneal Crosslinking|corneal crosslinking
51579|NCT03245853|CXL|cxl
51580|NCT03245814|service dogs|service dogs
51581|NCT03245814|human-animal interaction|human-animal interaction
51582|NCT03245801|Juvenile idiopathic arthritis|juvenile idiopathic arthritis
51583|NCT03245801|Canada|canada
51584|NCT03245801|Registry|registry
51585|NCT03245801|Clinical outcomes|clinical outcomes
51586|NCT03245801|Adverse events|adverse events
51587|NCT03245801|CAPRI|capri
51588|NCT03245788|Lay Navigator|lay navigator
51589|NCT03245788|Quality of Care|quality of care
51590|NCT03245788|High-Need Cancer Treatment Regimen|high-need cancer treatment regimen
51591|NCT03245775|health disparities|health disparities
51592|NCT03245775|community-based participatory research|community-based participatory research
51593|NCT03245749|omega-3 status|omega-3 status
51594|NCT03245749|blood lipids|blood lipids
51595|NCT03245749|Eicosapentaenoic acid (EPA)|eicosapentaenoic acid (epa)
51596|NCT03245749|Docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
51597|NCT03245723|premature adults|premature adults
51598|NCT03245723|premature|premature
51599|NCT03245723|premature lung function|premature lung function
51600|NCT03245723|premature cardiac function|premature cardiac function
51601|NCT03245723|MRI|mri
51602|NCT03245723|PET|pet
51603|NCT03245697|breast milk|breast milk
51604|NCT03245697|composition|composition
51605|NCT03245697|Galicia|galicia
51606|NCT03245697|diet|diet
51607|NCT03245697|lactation|lactation
51608|NCT03245684|ARDS|ards
51609|NCT03245684|Ventilator-induced Lung Injury|ventilator-induced lung injury
51610|NCT03245684|cytokines|cytokines
51611|NCT03245684|mechanical ventilation|mechanical ventilation
51612|NCT03245645|FODMAP|fodmap
51613|NCT03245645|IBS|ibs
51614|NCT03245645|Diet|diet
51615|NCT03245645|Re-introduction|re-introduction
51616|NCT03245645|Fructose|fructose
51617|NCT03245619|3-hydroxykynurenine|3-hydroxykynurenine
51618|NCT03245619|Acute pancreatitis|acute pancreatitis
51619|NCT03245619|Dose-escalation|dose-escalation
51620|NCT03245619|Healthy subjects|healthy subjects
51621|NCT03245619|GSK3335065|gsk3335065
51622|NCT03245606|NAFLD|nafld
51623|NCT03245606|steatosis|steatosis
51624|NCT03245606|fibrosis|fibrosis
51625|NCT03245606|transient elastography|transient elastography
51626|NCT03245554|Gastrointestinal Cancer|gastrointestinal cancer
51627|NCT03245554|Propranolol|propranolol
51628|NCT03245541|SBRT/SABR; Durvalumab; Locally advanced; Borderline resectable|sbrt/sabr; durvalumab; locally advanced; borderline resectable
51629|NCT03245502|tissue oxygenation|tissue oxygenation
51630|NCT03245450|eribulin mesilate|eribulin mesilate
51631|NCT03245450|irinotecan|irinotecan
51632|NCT03245450|combination therapy|combination therapy
51633|NCT03245450|children|children
51634|NCT03245437|Social Cognition|social cognition
51635|NCT03245437|Oxytocin|oxytocin
51636|NCT03245372|cardiac output|cardiac output
51637|NCT03245372|perioperative care|perioperative care
51638|NCT03245372|postoperative complications|postoperative complications
51639|NCT03245359|Total Knee Arthroplasty|total knee arthroplasty
51640|NCT03245359|Intra-articular Analgesia|intra-articular analgesia
51641|NCT03245359|Bupivacaine Hydrochloride|bupivacaine hydrochloride
51642|NCT03245294|cervical epidural space|cervical epidural space
51643|NCT03245294|abrupt pressure decrease|abrupt pressure decrease
51644|NCT03245281|Heart Failure|heart failure
51645|NCT03245268|Balloon pulmonary angioplasty|balloon pulmonary angioplasty
51646|NCT03245268|BPA|bpa
51647|NCT03245255|pressure measurements|pressure measurements
51648|NCT03245255|blood pressure|blood pressure
51649|NCT03245255|contrast echocardiography|contrast echocardiography
51650|NCT03245255|ventricular pressures|ventricular pressures
51651|NCT03245255|catheterization|catheterization
51652|NCT03245242|enhanced recovery after surgery|enhanced recovery after surgery
51653|NCT03245242|urologic reconstruction|urologic reconstruction
51654|NCT03245242|pediatric urology|pediatric urology
51655|NCT03245242|bladder augmentation|bladder augmentation
51656|NCT03245242|Mitrofanoff|mitrofanoff
51657|NCT03245242|Malone antegrade continence enema channel|malone antegrade continence enema channel
51658|NCT03245242|appendicovesicostomy|appendicovesicostomy
51659|NCT03245242|ileovesicostomy|ileovesicostomy
51660|NCT03245242|appendicocecostomy|appendicocecostomy
51661|NCT03245216|Parkinson's Disease|parkinson's disease
51662|NCT03245216|motor learning|motor learning
51663|NCT03245216|aerobic exercise|aerobic exercise
51664|NCT03245216|cardiovascular exercise|cardiovascular exercise
51665|NCT03245216|balance|balance
51666|NCT03245216|postural instability|postural instability
51667|NCT03245216|motor skill|motor skill
51668|NCT03245203|neoadjuvant chemotherapy|neoadjuvant chemotherapy
51669|NCT03245164|obese children|obese children
51670|NCT03245164|motor skills|motor skills
51671|NCT03245164|physiotherapy|physiotherapy
51672|NCT03245164|basketball|basketball
51673|NCT03245151|pediatrics|pediatrics
51674|NCT03245151|central nervous system tumors|central nervous system tumors
51675|NCT03245151|lenvatinib|lenvatinib
51676|NCT03245151|E7080|e7080
51677|NCT03245151|everolimus|everolimus
51678|NCT03245151|Ewing sarcoma/peripheral primitive neuroectodermal tumor|ewing sarcoma/peripheral primitive neuroectodermal tumor
51679|NCT03245151|rhabdomyosarcoma|rhabdomyosarcoma
51680|NCT03245151|high grade glioma|high grade glioma
51681|NCT03245151|solid tumors|solid tumors
51682|NCT03245138|endoscopic third ventriculostomy|endoscopic third ventriculostomy
51683|NCT03245138|ventricular peritoneal shunt|ventricular peritoneal shunt
51684|NCT03245138|communicating hydrocephalus|communicating hydrocephalus
51685|NCT03245060|psychosocial well-being|psychosocial well-being
51686|NCT03245060|solution focused brief therapy|solution focused brief therapy
51687|NCT03245034|Medical Residents|medical residents
51688|NCT03245034|Well-Being|well-being
51689|NCT03245034|Stress/Burnout in Medical Residents|stress/burnout in medical residents
51690|NCT03244995|Malignant neoplasms of eye brain and other parts of central nervous system|malignant neoplasms of eye brain and other parts of central nervous system
51691|NCT03244995|High grade glioma|high grade glioma
51692|NCT03244995|HGG|hgg
51693|NCT03244995|Couple-based mind-body program|couple-based mind-body program
51694|NCT03244995|CBMB|cbmb
51695|NCT03244995|Waitlist Control Group|waitlist control group
51696|NCT03244995|Questionnaires|questionnaires
51697|NCT03244995|Surveys|surveys
51698|NCT03244995|Mind-Body Intervention|mind-body intervention
51699|NCT03244995|Compact Discs (CD's)|compact discs (cd's)
51700|NCT03244995|Printed Materials|printed materials
51701|NCT03244995|Phone calls|phone calls
51702|NCT03244982|fluorescein|fluorescein
51703|NCT03244982|angiography|angiography
51704|NCT03244969|Hematoma fracture, angiogenesis, bone formation|hematoma fracture, angiogenesis, bone formation
51705|NCT03244917|Nursing home|nursing home
51706|NCT03244917|Palliative Care|palliative care
51707|NCT03244917|Dementia|dementia
51708|NCT03244917|Infection|infection
51709|NCT03244917|Antimicrobials|antimicrobials
51710|NCT03244904|NGS,SCLC, ctDNA|ngs,sclc, ctdna
51711|NCT03244878|Cognitive Behavior Therapy|cognitive behavior therapy
51712|NCT03244852|OCD|ocd
51713|NCT03244852|deep brain stimulation|deep brain stimulation
51714|NCT03244852|treatment-resistant OCD|treatment-resistant ocd
51715|NCT03244826|Cancer|cancer
51716|NCT03244800|0382, T2DM|0382, t2dm
51717|NCT03244761|high flow tracheal oxygen|high flow tracheal oxygen
51718|NCT03244761|modified interface|modified interface
51719|NCT03244735|Ketogenic Diet|ketogenic diet
51720|NCT03244709|Giant cell arteritis,|giant cell arteritis,
51721|NCT03244709|Tocilizumab|tocilizumab
51722|NCT03244709|Aortitis|aortitis
51723|NCT03244709|Remission|remission
51724|NCT03244696|Multiple Sclerosis|multiple sclerosis
51725|NCT03244696|Sclerosis|sclerosis
51726|NCT03244696|Demyelinating Autoimmune Diseases, Central Nervous System|demyelinating autoimmune diseases, central nervous system
51727|NCT03244696|Autoimmune Diseases of the Nervous System|autoimmune diseases of the nervous system
51728|NCT03244696|Nervous System Diseases|nervous system diseases
51729|NCT03244696|Demyelinating Diseases|demyelinating diseases
51730|NCT03244696|Immune System Diseases|immune system diseases
51731|NCT03244696|Physical Activity|physical activity
51732|NCT03244696|Walking|walking
51733|NCT03244696|Hydration|hydration
51734|NCT03244696|Lifestyle Intervention|lifestyle intervention
51735|NCT03244696|Health Behavior Tracking|health behavior tracking
51736|NCT03244696|Inflammatory Biomarkers|inflammatory biomarkers
51737|NCT03244696|Neurodegenerative Disease|neurodegenerative disease
51738|NCT03244670|Myopia|myopia
51739|NCT03244644|C Difficile Colitis|c difficile colitis
51740|NCT03244644|Clostridium Difficile|clostridium difficile
51741|NCT03244644|CDI|cdi
51742|NCT03244644|C.Difficile Diarrhea|c.difficile diarrhea
51743|NCT03244644|Fecal Transplant|fecal transplant
51744|NCT03244644|Fecal Microbiota Transplant|fecal microbiota transplant
51745|NCT03244644|Microbiota Restoration Therapy|microbiota restoration therapy
51746|NCT03244644|Diarrhea|diarrhea
51747|NCT03244644|FMT|fmt
51748|NCT03244644|Microbial Suspension|microbial suspension
51749|NCT03244592|Minocycline|minocycline
51750|NCT03244566|positron emission tomography|positron emission tomography
51751|NCT03244566|cervical lymphatic metastasis|cervical lymphatic metastasis
51752|NCT03244540|postoperative pain|postoperative pain
51753|NCT03244540|transversus abdominis plane block|transversus abdominis plane block
51754|NCT03244540|quadratus lumborum block|quadratus lumborum block
51755|NCT03244540|neuropathic pain|neuropathic pain
51756|NCT03244527|BCAA|bcaa
51757|NCT03244527|stroke|stroke
51758|NCT03244527|mobility|mobility
51759|NCT03244514|cardiac surgery|cardiac surgery
51760|NCT03244514|KDIGO-Guideline|kdigo-guideline
51761|NCT03244501|tSMS|tsms
51762|NCT03244501|Transcranial Static Magnetic Field Stimulation|transcranial static magnetic field stimulation
51763|NCT03244501|healthy control|healthy control
51764|NCT03244475|mild Traumatic Brain Injury|mild traumatic brain injury
51765|NCT03244475|transcranial electrical stimulation|transcranial electrical stimulation
51766|NCT03244475|neurofeedback|neurofeedback
51767|NCT03244475|magnetoencephalography|magnetoencephalography
51768|NCT03244475|post-traumatic stress disorder|post-traumatic stress disorder
51769|NCT03244449|biomarker|biomarker
51770|NCT03244449|insulin resistance|insulin resistance
51771|NCT03244449|myokine|myokine
51772|NCT03244449|clamp|clamp
51773|NCT03244423|Pediatric|pediatric
51774|NCT03244423|Cyanotic heart disease|cyanotic heart disease
51775|NCT03244423|Tranexamic acid|tranexamic acid
51776|NCT03244423|Postoperative blood loss|postoperative blood loss
51777|NCT03244358|Triple Negative Breast Cancer|triple negative breast cancer
51778|NCT03244358|Epalrestat|epalrestat
51779|NCT03244306|leukemia|leukemia
51780|NCT03244306|CD 22|cd 22
51781|NCT03244306|CAR T cell|car t cell
51782|NCT03244306|pediatric|pediatric
51783|NCT03244306|young adult|young adult
51981|NCT03243006|acute pain|acute pain
51784|NCT03244306|chimeric antigen receptor|chimeric antigen receptor
51785|NCT03244267|Orthopedics|orthopedics
51786|NCT03244254|Celiac Disease|celiac disease
51787|NCT03244254|Children|children
51788|NCT03244254|I-FABP|i-fabp
51789|NCT03244241|Type 2 diabetes, inpatient diabetes management, basal-bolus insulin|type 2 diabetes, inpatient diabetes management, basal-bolus insulin
51790|NCT03244228|First in human|first in human
51791|NCT03244228|Multiple ascending dose|multiple ascending dose
51792|NCT03244228|Single ascending dose|single ascending dose
51793|NCT03244215|Recurrence of stroke|recurrence of stroke
51794|NCT03244215|Corneal Confocal Microscopy|corneal confocal microscopy
51795|NCT03244215|High performance liquid chromatography,|high performance liquid chromatography,
51796|NCT03244215|Inflammatory biomarkers|inflammatory biomarkers
51797|NCT03244215|modified Rankin scale ( mRS)|modified rankin scale ( mrs)
51798|NCT03244202|Incidental Findings|incidental findings
51799|NCT03244202|Decision Aids|decision aids
51800|NCT03244202|Genomic Sequencing|genomic sequencing
51801|NCT03244202|Randomized Controlled Trail|randomized controlled trail
51802|NCT03244202|Genetic Counselling|genetic counselling
51803|NCT03244189|Urinary Stone Disease|urinary stone disease
51804|NCT03244189|Kidney Stone|kidney stone
51805|NCT03244189|Urinary Calculi|urinary calculi
51806|NCT03244176|DLBCL|dlbcl
51807|NCT03244163|Spyglass DS|spyglass ds
51808|NCT03244163|Laser lithotripsy|laser lithotripsy
51809|NCT03244163|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
51810|NCT03244150|Physical activity|physical activity
51811|NCT03244150|Obesity|obesity
51812|NCT03244150|Overweight|overweight
51813|NCT03244150|Lifestyle|lifestyle
51814|NCT03244150|Diet|diet
51815|NCT03244124|dentin bonding agents|dentin bonding agents
51816|NCT03244124|tooth sensitivity|tooth sensitivity
51817|NCT03244124|composite resin restoration|composite resin restoration
51818|NCT03244059|COPD|copd
51819|NCT03244059|belimumab|belimumab
51820|NCT03244059|biologic agent|biologic agent
51821|NCT03244059|GRP78|grp78
51822|NCT03244046|Low Back pain|low back pain
51823|NCT03244046|Pain|pain
51824|NCT03244046|Posttraumatic Stress Disorder|posttraumatic stress disorder
51825|NCT03244046|PTSD|ptsd
51826|NCT03244046|Somatic Experiencing|somatic experiencing
51827|NCT03244046|SE|se
51828|NCT03244033|context|context
51829|NCT03244033|contextual error|contextual error
51830|NCT03244033|contextual care|contextual care
51831|NCT03244033|electronic medical record|electronic medical record
51832|NCT03244033|clinical decision support|clinical decision support
51833|NCT03244007|macular hole|macular hole
51834|NCT03244007|lamellar macular hole|lamellar macular hole
51835|NCT03243994|Cor pulmonale|cor pulmonale
51836|NCT03243994|COPD|copd
51837|NCT03243994|Malabsorption|malabsorption
51838|NCT03243994|D-xylose|d-xylose
51839|NCT03243994|Zinc|zinc
51840|NCT03243955|acupuncture|acupuncture
51841|NCT03243955|TENS|tens
51842|NCT03243955|TEAS|teas
51843|NCT03243955|constipation|constipation
51844|NCT03243955|transcutaneous|transcutaneous
51845|NCT03243942|pressure measurements|pressure measurements
51846|NCT03243942|blood pressure|blood pressure
51847|NCT03243942|contrast echocardiography|contrast echocardiography
51848|NCT03243942|ventricular pressures|ventricular pressures
51849|NCT03243942|catheterization|catheterization
51850|NCT03243916|interventional therapy|interventional therapy
51851|NCT03243916|TACE|tace
51852|NCT03243916|Cyberknife|cyberknife
51853|NCT03243903|T2DM|t2dm
51854|NCT03243903|QS-M needle free injector|qs-m needle free injector
51855|NCT03243903|insulin pen|insulin pen
51856|NCT03243903|effective|effective
51857|NCT03243903|safety|safety
51858|NCT03243877|Screening|screening
51859|NCT03243877|Mammography|mammography
51860|NCT03243851|Glioblastoma|glioblastoma
51861|NCT03243838|Triple-Negative Breast Cancer|triple-negative breast cancer
51862|NCT03243838|apatinib|apatinib
51863|NCT03243838|pCR|pcr
51864|NCT03243838|OS|os
51865|NCT03243838|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
51866|NCT03243825|neoadjuvant chemotherapy|neoadjuvant chemotherapy
51867|NCT03243825|brachytherapy|brachytherapy
51868|NCT03243825|radiotherapy|radiotherapy
51869|NCT03243812|Sickle Cell Disease|sickle cell disease
51870|NCT03243812|Muscle function|muscle function
51871|NCT03243812|Hemorheological disorders|hemorheological disorders
51872|NCT03243760|CCI15106|cci15106
51873|NCT03243760|pharmacokinetics|pharmacokinetics
51874|NCT03243760|BAL|bal
51875|NCT03243760|COPD|copd
51876|NCT03243734|spray cryotherapy|spray cryotherapy
51877|NCT03243734|quality of life|quality of life
51878|NCT03243734|symptom reduction|symptom reduction
51879|NCT03243734|esophageal malignancies|esophageal malignancies
51880|NCT03243734|liquid nitrogen|liquid nitrogen
51881|NCT03243734|ablation|ablation
51882|NCT03243721|multiple sclerosis|multiple sclerosis
51883|NCT03243721|thalamus|thalamus
51884|NCT03243721|high field MRI|high field mri
51885|NCT03243721|cognition|cognition
51886|NCT03243708|Venous Thromboembolism Risk Calculator|venous thromboembolism risk calculator
51887|NCT03243695|immediate implants, implant failure, angled abutments|immediate implants, implant failure, angled abutments
51888|NCT03243682|Shock wave lithotripsy|shock wave lithotripsy
51889|NCT03243682|Bidirectional|bidirectional
51890|NCT03243682|Stones|stones
51891|NCT03243669|Colonoscopy|colonoscopy
51892|NCT03243669|High-definition endoscopy|high-definition endoscopy
51893|NCT03243669|Virtual chromoendoscopy|virtual chromoendoscopy
51894|NCT03243669|Adenoma detection rate (ADR)|adenoma detection rate (adr)
51895|NCT03243604|Cardiotoxicity|cardiotoxicity
51896|NCT03243604|abiraterone acetate|abiraterone acetate
51897|NCT03243604|androgen antagonist|androgen antagonist
51898|NCT03243565|adenoid hypertrophy|adenoid hypertrophy
51899|NCT03243565|Adenoid Hyperplasia|adenoid hyperplasia
51900|NCT03243565|children|children
51901|NCT03243565|respiratory tract infection|respiratory tract infection
51902|NCT03243565|adenotonsillectomy|adenotonsillectomy
51903|NCT03243565|OM-85|om-85
51904|NCT03243539|lung protective ventilation|lung protective ventilation
51905|NCT03243500|atracurium|atracurium
51906|NCT03243500|high myopes|high myopes
51907|NCT03243500|percaruncular|percaruncular
51908|NCT03243500|phacoemulsification|phacoemulsification
51909|NCT03243500|medial canthal|medial canthal
51910|NCT03243500|ophthalmic regional anesthesia|ophthalmic regional anesthesia
51911|NCT03243461|Glioblastoma|glioblastoma
51912|NCT03243461|high grade glioma|high grade glioma
51913|NCT03243461|brain tumor|brain tumor
51914|NCT03243461|Anaplastic astrocytoma|anaplastic astrocytoma
51915|NCT03243461|DIPG|dipg
51916|NCT03243461|Gliomatosis cerebri|gliomatosis cerebri
51917|NCT03243461|Diffuse midline glioma|diffuse midline glioma
51918|NCT03243409|reversed shoulder arthroplasties|reversed shoulder arthroplasties
51919|NCT03243409|clinical complications|clinical complications
51920|NCT03243409|complex proximal humeral fractures|complex proximal humeral fractures
51921|NCT03243396|Mental health|mental health
51922|NCT03243396|Cognitive behavioral therapy|cognitive behavioral therapy
51923|NCT03243396|Task-shifting|task-shifting
51924|NCT03243396|Global health|global health
51925|NCT03243396|Teacher|teacher
51926|NCT03243396|Community health volunteer|community health volunteer
51927|NCT03243396|Children|children
51928|NCT03243396|Orphans|orphans
51929|NCT03243396|Abandoned children|abandoned children
51930|NCT03243396|TF-CBT|tf-cbt
51931|NCT03243396|Mental health policy|mental health policy
51932|NCT03243396|Ministry of Education|ministry of education
51933|NCT03243396|Ministry of Health|ministry of health
51934|NCT03243396|Delivery|delivery
51935|NCT03243396|Implementation science|implementation science
51936|NCT03243396|Qualitative comparative analysis|qualitative comparative analysis
51937|NCT03243396|Implementation practices and policies|implementation practices and policies
51938|NCT03243396|Youth|youth
51939|NCT03243396|Adoption|adoption
51940|NCT03243396|Fidelity|fidelity
51941|NCT03243396|Kenya|kenya
51942|NCT03243396|Bungoma|bungoma
51943|NCT03243396|Kanduyi|kanduyi
51944|NCT03243396|East Africa|east africa
51945|NCT03243396|Posttraumatic stress|posttraumatic stress
51946|NCT03243396|Childhood traumatic grief|childhood traumatic grief
51947|NCT03243396|Grief|grief
51948|NCT03243396|Trauma|trauma
51949|NCT03243383|readmission|readmission
51950|NCT03243370|Validate the Clock'nTest|validate the clock'ntest
51951|NCT03243357|Endodontics, molars, instrumentation, obturation, anatomy|endodontics, molars, instrumentation, obturation, anatomy
51952|NCT03243331|Breast Cancer|breast cancer
51953|NCT03243292|Bronchial Thermoplasty|bronchial thermoplasty
51954|NCT03243292|Alair|alair
51955|NCT03243292|Registry|registry
51956|NCT03243227|carpal tunnel syndrome|carpal tunnel syndrome
51957|NCT03243227|neurodynamics|neurodynamics
51958|NCT03243227|median nerve gliding exercise|median nerve gliding exercise
51959|NCT03243214|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
51960|NCT03243188|Palliative Care|palliative care
51961|NCT03243175|intracerebral hemorrhage|intracerebral hemorrhage
51962|NCT03243175|atrial fibrillation|atrial fibrillation
51963|NCT03243175|microhemorrhage|microhemorrhage
51964|NCT03243175|oral anticoagulation|oral anticoagulation
51965|NCT03243175|left atrial appendage closure|left atrial appendage closure
51966|NCT03243084|tACS|tacs
51967|NCT03243084|transcranial alternating current stimulation|transcranial alternating current stimulation
51968|NCT03243084|low back pain|low back pain
51969|NCT03243084|chronic pain|chronic pain
51970|NCT03243084|alpha oscillations|alpha oscillations
51971|NCT03243084|heart rate variability|heart rate variability
51972|NCT03243071|Medical Care|medical care
51973|NCT03243071|Racial Discrimination|racial discrimination
51974|NCT03243071|Poor Health Literacy|poor health literacy
51975|NCT03243071|Medical Care Disparities|medical care disparities
51976|NCT03243045|Arterial hypertension|arterial hypertension
51977|NCT03243045|Microcirculation|microcirculation
51978|NCT03243045|Sympathetic nervous system|sympathetic nervous system
51979|NCT03243019|cervico-facial|cervico-facial
51980|NCT03243019|rapamycin|rapamycin
51982|NCT03243006|emergency department|emergency department
51983|NCT03243006|opioid consumption|opioid consumption
51984|NCT03242980|HIV|hiv
51985|NCT03242980|Adherence|adherence
51986|NCT03242980|Viral re-suppression|viral re-suppression
51987|NCT03242980|Step-wedgged randomized trial|step-wedgged randomized trial
51988|NCT03242967|Anemia|anemia
51989|NCT03242967|hemoglobin|hemoglobin
51990|NCT03242967|darbepoetin alfa|darbepoetin alfa
51991|NCT03242967|TIW|tiw
51992|NCT03242967|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
51993|NCT03242967|HIF-PHI|hif-phi
51994|NCT03242967|AKB-6548|akb-6548
51995|NCT03242967|vadadustat|vadadustat
51996|NCT03242967|renal|renal
51997|NCT03242967|hypoxia-inducible factor|hypoxia-inducible factor
51998|NCT03242967|HIF|hif
51999|NCT03242967|dialysis-dependent chronic kidney disease|dialysis-dependent chronic kidney disease
52000|NCT03242967|CKD|ckd
52001|NCT03242967|DD-CKD|dd-ckd
52002|NCT03242967|kidney|kidney
52003|NCT03242967|erythropoiesis stimulating agent|erythropoiesis stimulating agent
52004|NCT03242967|ESA|esa
52005|NCT03242928|Cocaine Use Disorder; cocaine dependence|cocaine use disorder; cocaine dependence
52006|NCT03242902|light therapy|light therapy
52007|NCT03242902|cancer related fatigue|cancer related fatigue
52008|NCT03242902|sleep quality|sleep quality
52009|NCT03242902|biological rhythms|biological rhythms
52010|NCT03242850|Reading|reading
52011|NCT03242850|Text Messages|text messages
52012|NCT03242850|Video|video
52013|NCT03242850|Cognitive Development|cognitive development
52014|NCT03242850|Child Development|child development
52015|NCT03242850|Infants|infants
52016|NCT03242811|Medical age assessment|medical age assessment
52017|NCT03242798|liver cirrhosis|liver cirrhosis
52018|NCT03242798|malnutrition|malnutrition
52019|NCT03242798|nutritional status|nutritional status
52020|NCT03242798|nutritional assessment|nutritional assessment
52021|NCT03242785|Self-monitoring|self-monitoring
52022|NCT03242785|Education|education
52023|NCT03242785|Self-titration|self-titration
52024|NCT03242785|antihypertensives|antihypertensives
52025|NCT03242746|LEEP|leep
52026|NCT03242746|Loop Electrosurgical Excision Procedure|loop electrosurgical excision procedure
52027|NCT03242746|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
52028|NCT03242746|pregnancy outcome|pregnancy outcome
52029|NCT03242733|Gastroparesis|gastroparesis
52030|NCT03242694|persistent atrial fibrillation|persistent atrial fibrillation
52031|NCT03242694|pulmonary vein isolation|pulmonary vein isolation
52032|NCT03242694|catheter ablation|catheter ablation
52033|NCT03242694|left atrial function|left atrial function
52034|NCT03242694|left atrial pressure|left atrial pressure
52035|NCT03242694|voltage map|voltage map
52036|NCT03242694|strain|strain
52037|NCT03242694|scar|scar
52038|NCT03242694|success|success
52039|NCT03242694|biomarker|biomarker
52040|NCT03242668|paravertebral block,PVC,PCA|paravertebral block,pvc,pca
52041|NCT03242642|Heart disease|heart disease
52042|NCT03242642|valve disease|valve disease
52043|NCT03242642|heart valve disease|heart valve disease
52044|NCT03242642|mitral regurgitation|mitral regurgitation
52045|NCT03242642|cardiovascular disease|cardiovascular disease
52046|NCT03242642|mitral insufficiency|mitral insufficiency
52047|NCT03242629|pediatric ophthalmic examination|pediatric ophthalmic examination
52048|NCT03242629|chloral hydrate|chloral hydrate
52049|NCT03242629|Effects Comparison|effects comparison
52050|NCT03242603|Relapsed, Refractory, Neuroblastoma|relapsed, refractory, neuroblastoma
52051|NCT03242603|Anti-GD2|anti-gd2
52052|NCT03242603|Natural Killer (NK) Cells|natural killer (nk) cells
52053|NCT03242603|Immunotherapy|immunotherapy
52054|NCT03242538|Exercise|exercise
52055|NCT03242512|RANKL|rankl
52056|NCT03242512|osteoporosis|osteoporosis
52057|NCT03242512|bone resorption|bone resorption
52058|NCT03242512|post-menopausal women|post-menopausal women
52059|NCT03242512|TK006|tk006
52060|NCT03242434|Mannitol|mannitol
52061|NCT03242434|Intestinal permeability|intestinal permeability
52062|NCT03242434|Thermal injury|thermal injury
52063|NCT03242434|HESTIA|hestia
52064|NCT03242434|Sucralose|sucralose
52065|NCT03242434|Lactulose|lactulose
52066|NCT03242421|test-retest reliability|test-retest reliability
52067|NCT03242421|Binocular vision tests|binocular vision tests
52068|NCT03242395|Neuroinflammation|neuroinflammation
52069|NCT03242395|fMRI|fmri
52070|NCT03242395|Post-operative cognitive dysfunction|post-operative cognitive dysfunction
52071|NCT03242395|Systemic inflammation|systemic inflammation
52072|NCT03242395|Severe burns|severe burns
52073|NCT03242382|advanced|advanced
52074|NCT03242382|sarcoma|sarcoma
52075|NCT03242382|cdk4|cdk4
52076|NCT03242369|colorectal neoplasia|colorectal neoplasia
52077|NCT03242369|colonoscopy|colonoscopy
52078|NCT03242369|quality of bowel cleansing|quality of bowel cleansing
52079|NCT03242369|bowel preparation|bowel preparation
52080|NCT03242330|Implant survival|implant survival
52081|NCT03242330|Patient satisfaction|patient satisfaction
52082|NCT03242278|Non-valvular atrial fibrillation (NVAF)|non-valvular atrial fibrillation (nvaf)
52083|NCT03242278|Prevention|prevention
52084|NCT03242278|Stroke|stroke
52085|NCT03242239|HER2 Positive Breast Cancer|her2 positive breast cancer
52086|NCT03242239|Trastuzumab|trastuzumab
52087|NCT03242239|Biosimilar|biosimilar
52088|NCT03242226|+3.00ADD|+3.00add
52089|NCT03242226|single vision spectacle|single vision spectacle
52090|NCT03242200|survivors of childhood cancer|survivors of childhood cancer
52091|NCT03242200|young adult female|young adult female
52092|NCT03242200|mobile app|mobile app
52093|NCT03242200|questionnaire|questionnaire
52094|NCT03242200|health tracking|health tracking
52095|NCT03242187|Minimally invasive surgery|minimally invasive surgery
52096|NCT03242187|trans-anal total mesorectal excision|trans-anal total mesorectal excision
52097|NCT03242187|Laparoscopic total mesoretal excision|laparoscopic total mesoretal excision
52098|NCT03242070|Patient Portals|patient portals
52099|NCT03242070|Chronic Disease|chronic disease
52100|NCT03242070|Older Adults|older adults
52101|NCT03242057|NAVA|nava
52102|NCT03242057|Extubation|extubation
52103|NCT03242057|NIPPV|nippv
52104|NCT03241992|Inflammatory Bowel Disease|inflammatory bowel disease
52105|NCT03241992|IBD|ibd
52106|NCT03241992|Electronic Health Record|electronic health record
52107|NCT03241992|Patient Portal|patient portal
52108|NCT03241992|Quality of Life|quality of life
52109|NCT03241966|Parkinson's Disease|parkinson's disease
52110|NCT03241966|Online Study|online study
52111|NCT03241966|Quality of Life|quality of life
52112|NCT03241966|Activities of Daily Living|activities of daily living
52113|NCT03241966|Perception|perception
52114|NCT03241966|Cognition|cognition
52115|NCT03241966|Gait|gait
52116|NCT03241927|Pembrolizumab|pembrolizumab
52117|NCT03241927|NK Cell Exhaustion|nk cell exhaustion
52118|NCT03241927|PD-1|pd-1
52119|NCT03241927|Unresectable|unresectable
52120|NCT03241927|Stage III|stage iii
52121|NCT03241927|Stage IV|stage iv
52122|NCT03241901|Artemether-Lumefantrine, Primaquine|artemether-lumefantrine, primaquine
52123|NCT03241888|Levonorgestrel-releasing intrauterine system|levonorgestrel-releasing intrauterine system
52124|NCT03241888|megestrol acetate|megestrol acetate
52125|NCT03241888|Atypical Endometrial Hyperplasia|atypical endometrial hyperplasia
52126|NCT03241875|pregabalin|pregabalin
52127|NCT03241875|gabapentin|gabapentin
52128|NCT03241875|post operative pain|post operative pain
52129|NCT03241875|laparoscopic cholecystectomy|laparoscopic cholecystectomy
52130|NCT03241810|Breast Cancer, HER2 Negative, Hormone receptor positive, heregulin|breast cancer, her2 negative, hormone receptor positive, heregulin
52131|NCT03241797|AIP|aip
52132|NCT03241797|EUS-FNA|eus-fna
52133|NCT03241784|ALS|als
52134|NCT03241784|T-Regulatory Cells|t-regulatory cells
52135|NCT03241745|Nivolumab|nivolumab
52136|NCT03241745|17-180|17-180
52137|NCT03241732|Traumatic Brain Injury|traumatic brain injury
52138|NCT03241732|TBI|tbi
52139|NCT03241732|Brain Trauma|brain trauma
52140|NCT03241732|N-acetyl cysteine|n-acetyl cysteine
52141|NCT03241732|Concussion|concussion
52142|NCT03241732|NAC|nac
52143|NCT03241732|Integrative Medicine|integrative medicine
52144|NCT03241732|EEG|eeg
52145|NCT03241732|electroencephalogram|electroencephalogram
52146|NCT03241732|Functional magnetic resonance imaging or functional MRI|functional magnetic resonance imaging or functional mri
52147|NCT03241732|fMRI|fmri
52148|NCT03241732|PET|pet
52149|NCT03241732|Positron emission tomography|positron emission tomography
52150|NCT03241732|MRI|mri
52151|NCT03241732|magnetic resonance imaging|magnetic resonance imaging
52152|NCT03241706|hypoglycemia|hypoglycemia
52153|NCT03241706|type 1 diabetes|type 1 diabetes
52154|NCT03241706|liver glucose metabolism|liver glucose metabolism
52155|NCT03241628|Skin blisters|skin blisters
52156|NCT03241628|Finger webbing|finger webbing
52157|NCT03241628|Finger contracture|finger contracture
52158|NCT03241628|Hand contracture|hand contracture
52159|NCT03241589|Teledermatology|teledermatology
52160|NCT03241589|Telehealth|telehealth
52161|NCT03241589|Dermatology|dermatology
52162|NCT03241589|Telemedicine|telemedicine
52163|NCT03241589|Mobile Application|mobile application
52164|NCT03241550|invasive fungal disease|invasive fungal disease
52165|NCT03241550|Cresemba®|cresemba®
52166|NCT03241550|Hematological malignancy|hematological malignancy
52167|NCT03241550|isavuconazonium sulfate|isavuconazonium sulfate
52168|NCT03241550|ASP9766|asp9766
52169|NCT03241550|isavuconazole|isavuconazole
52170|NCT03241550|pediatric population|pediatric population
52171|NCT03241524|Pelvic Floor muscles|pelvic floor muscles
52172|NCT03241524|Physical Therapy|physical therapy
52173|NCT03241524|Sexual function evaluation|sexual function evaluation
52174|NCT03241511|Periodontitis, End Stage Renal Disease, Periodontal treatment|periodontitis, end stage renal disease, periodontal treatment
52175|NCT03241498|Medicines optimisation|medicines optimisation
52422|NCT03240042|nasotracheal|nasotracheal
52176|NCT03241498|Healthcare resource utilisation|healthcare resource utilisation
52177|NCT03241498|HRQOL|hrqol
52178|NCT03241498|Pharmacist-led|pharmacist-led
52179|NCT03241498|GP based|gp based
52180|NCT03241459|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
52181|NCT03241459|PTA|pta
52182|NCT03241459|Peripheral Artery Disease|peripheral artery disease
52183|NCT03241459|PAD|pad
52184|NCT03241459|Paclitaxel|paclitaxel
52185|NCT03241433|Exercise|exercise
52186|NCT03241394|Monocyte subsets|monocyte subsets
52187|NCT03241394|Obesity|obesity
52188|NCT03241394|Metabolic Syndrome|metabolic syndrome
52189|NCT03241381|observational sample|observational sample
52190|NCT03241368|Irritable Bowel Disease|irritable bowel disease
52191|NCT03241368|IBD|ibd
52192|NCT03241368|Mucosal Disease|mucosal disease
52193|NCT03241329|Endometriosis|endometriosis
52194|NCT03241329|Metabolomics|metabolomics
52195|NCT03241329|Transcriptomics|transcriptomics
52196|NCT03241329|Follicular fluid|follicular fluid
52197|NCT03241329|Cumulus cells|cumulus cells
52198|NCT03241329|Oocyte quality|oocyte quality
52199|NCT03241316|qualitative and survey research|qualitative and survey research
52200|NCT03241303|Glp-1|glp-1
52201|NCT03241303|alpha-glucosidase inhibitor|alpha-glucosidase inhibitor
52202|NCT03241303|acarbose|acarbose
52203|NCT03241290|C-arm|c-arm
52204|NCT03241290|Medical Imaging Device|medical imaging device
52205|NCT03241290|Radiological|radiological
52206|NCT03241277|social phobia|social phobia
52207|NCT03241277|anxiety disorders|anxiety disorders
52208|NCT03241277|DSM-IV TR|dsm-iv tr
52209|NCT03241277|periodontal disease|periodontal disease
52210|NCT03241277|non surgical periodontal treatment|non surgical periodontal treatment
52211|NCT03241251|psychosocial risk|psychosocial risk
52212|NCT03241225|Elder abuse|elder abuse
52213|NCT03241225|Depression|depression
52214|NCT03241225|Mental health|mental health
52215|NCT03241212|adolescent|adolescent
52216|NCT03241212|young adult|young adult
52217|NCT03241212|knowledge|knowledge
52218|NCT03241212|self-care|self-care
52219|NCT03241186|Ipilimumab|ipilimumab
52220|NCT03241186|Nivolumab|nivolumab
52221|NCT03241186|OPDIVO|opdivo
52222|NCT03241186|IgG4 kappa immunoglobulin|igg4 kappa immunoglobulin
52223|NCT03241173|advanced or metastatic cervical cancer|advanced or metastatic cervical cancer
52224|NCT03241173|endometrial cancer|endometrial cancer
52225|NCT03241173|esophageal cancer|esophageal cancer
52226|NCT03241173|hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
52227|NCT03241173|melanoma|melanoma
52228|NCT03241173|Merkel cell carcinoma|merkel cell carcinoma
52229|NCT03241173|mesothelioma|mesothelioma
52230|NCT03241173|microsatellite instability-high colorectal cancer|microsatellite instability-high colorectal cancer
52231|NCT03241173|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
52232|NCT03241173|ovarian cancer|ovarian cancer
52233|NCT03241173|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
52234|NCT03241173|small cell lung cancer (SLCL)|small cell lung cancer (slcl)
52235|NCT03241173|renal cell carcinoma (RCC)|renal cell carcinoma (rcc)
52236|NCT03241173|triple-negative breast cancer|triple-negative breast cancer
52237|NCT03241173|TNBC|tnbc
52238|NCT03241173|urothelial carcinoma|urothelial carcinoma
52239|NCT03241173|OX40 ligand (OX40)|ox40 ligand (ox40)
52240|NCT03241173|SCCHN|scchn
52241|NCT03241173|MSI-H CRC|msi-h crc
52242|NCT03241173|gastric cancer (including stomach and gastroesophageal junction [GEJ])|gastric cancer (including stomach and gastroesophageal junction [gej])
52243|NCT03241134|Dry needling|dry needling
52244|NCT03241134|Sham needling|sham needling
52245|NCT03241134|Office workers|office workers
52246|NCT03241134|Myofascial pain|myofascial pain
52247|NCT03241134|Surface electromyography|surface electromyography
52248|NCT03241121|Time Restricted Feeding|time restricted feeding
52249|NCT03241121|Eating patterns|eating patterns
52250|NCT03241095|Osteopathic Manipulation Treatment|osteopathic manipulation treatment
52251|NCT03241095|Golf|golf
52252|NCT03241069|bio-impedance|bio-impedance
52253|NCT03241069|BIOPAC system|biopac system
52254|NCT03241069|dyspnea|dyspnea
52255|NCT03241069|acute heart failure|acute heart failure
52256|NCT03241043|Pharmacokinetic study|pharmacokinetic study
52257|NCT03241043|Comparing Envarsus versus Advagraf|comparing envarsus versus advagraf
52258|NCT03241017|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
52259|NCT03241017|Double-hit Lymphomas|double-hit lymphomas
52260|NCT03241017|Grey Zone Lymphomas|grey zone lymphomas
52261|NCT03241017|Double or Triple Expressor Lymphomas|double or triple expressor lymphomas
52262|NCT03241017|Unclassifiable Aggressive Lymphoma types|unclassifiable aggressive lymphoma types
52263|NCT03241017|Aggressive Lymphomas|aggressive lymphomas
52264|NCT03240991|bradykinin-mediated angiodema|bradykinin-mediated angiodema
52265|NCT03240991|quality of life|quality of life
52266|NCT03240939|Dutasteride|dutasteride
52267|NCT03240939|Tadalafil|tadalafil
52268|NCT03240926|COPD|copd
52269|NCT03240926|COPD Exacerbation|copd exacerbation
52270|NCT03240926|COPD Asthma|copd asthma
52271|NCT03240926|COPD Bronchitis|copd bronchitis
52272|NCT03240926|COPD, Severe Early-Onset|copd, severe early-onset
52273|NCT03240887|Teen pregnancy prevention|teen pregnancy prevention
52274|NCT03240874|Gestational Diabetes|gestational diabetes
52275|NCT03240874|Diabetes Type 2 in Pregnancy|diabetes type 2 in pregnancy
52276|NCT03240861|T cells|t cells
52277|NCT03240861|stem cells|stem cells
52278|NCT03240861|gene therapy|gene therapy
52279|NCT03240861|NYESO|nyeso
52280|NCT03240848|congenital cataract|congenital cataract
52281|NCT03240848|artificial intelligent clinic|artificial intelligent clinic
52282|NCT03240835|pre-Albumin|pre-albumin
52283|NCT03240835|Retinol Conjugated Protein|retinol conjugated protein
52284|NCT03240835|Transferrin|transferrin
52285|NCT03240835|Locoregionally Advanced Nasopharyngeal Carcinoma|locoregionally advanced nasopharyngeal carcinoma
52286|NCT03240835|nutrition|nutrition
52287|NCT03240822|Penile Trauma|penile trauma
52288|NCT03240822|Allotransplantation|allotransplantation
52289|NCT03240822|Vascularized Composite Allotransplantation|vascularized composite allotransplantation
52290|NCT03240822|VCA|vca
52291|NCT03240822|Genital Trauma|genital trauma
52292|NCT03240822|Penile Transplantation|penile transplantation
52293|NCT03240822|Amputation|amputation
52294|NCT03240822|Penile Injury|penile injury
52295|NCT03240796|dense cataract|dense cataract
52296|NCT03240796|intraocular lens implantation|intraocular lens implantation
52297|NCT03240796|traditional cataract surgery|traditional cataract surgery
52423|NCT03240042|orotracheal|orotracheal
52298|NCT03240783|CT-Fluoroscopic Selective Transforaminal Epidural Steroid|ct-fluoroscopic selective transforaminal epidural steroid
52299|NCT03240783|Oral Dexamethasone|oral dexamethasone
52300|NCT03240783|Acute Lumbar Radiculopathy|acute lumbar radiculopathy
52301|NCT03240783|Sciatic Neuropathy|sciatic neuropathy
52302|NCT03240783|Betamethasone injectable|betamethasone injectable
52303|NCT03240783|Dexamethasone injectable|dexamethasone injectable
52304|NCT03240783|Acute Lumbar radicular pain|acute lumbar radicular pain
52305|NCT03240783|Randomized Controlled Trial (RCT)|randomized controlled trial (rct)
52306|NCT03240783|Comparative Effectiveness Controlled Trial|comparative effectiveness controlled trial
52307|NCT03240770|HFV|hfv
52308|NCT03240770|HFA|hfa
52309|NCT03240770|High Frequency Vibration|high frequency vibration
52310|NCT03240757|meal absorption|meal absorption
52311|NCT03240757|exercise|exercise
52312|NCT03240757|energy balance|energy balance
52313|NCT03240757|lipolysis|lipolysis
52314|NCT03240744|immunogenicity|immunogenicity
52315|NCT03240744|safety|safety
52316|NCT03240744|Hand, Foot and Mouth Disease (HFMD)|hand, foot and mouth disease (hfmd)
52317|NCT03240731|sickle cell disease|sickle cell disease
52318|NCT03240731|haploidentical|haploidentical
52319|NCT03240731|graft|graft
52320|NCT03240731|marrow|marrow
52321|NCT03240705|Stress|stress
52322|NCT03240705|Medical education|medical education
52323|NCT03240692|Major Depressive Disorder|major depressive disorder
52324|NCT03240692|Treatment Resistant Depression|treatment resistant depression
52325|NCT03240692|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
52326|NCT03240692|Theta Burst|theta burst
52327|NCT03240679|Barrett's esophagus|barrett's esophagus
52328|NCT03240679|Endoscopic Mucosal Resection|endoscopic mucosal resection
52329|NCT03240640|Inspiratory muscle training|inspiratory muscle training
52330|NCT03240640|COPD|copd
52331|NCT03240640|Dyspnea|dyspnea
52332|NCT03240640|Balance|balance
52333|NCT03240562|serratus anterior plane block|serratus anterior plane block
52334|NCT03240562|ultrasound-guided|ultrasound-guided
52335|NCT03240562|regional anesthesia|regional anesthesia
52336|NCT03240562|thoracic surgery|thoracic surgery
52337|NCT03240562|postoperative pain|postoperative pain
52338|NCT03240549|advanced pulmonary adenocarcinoma|advanced pulmonary adenocarcinoma
52339|NCT03240549|Bevacizumab|bevacizumab
52340|NCT03240549|First line chemotherapy|first line chemotherapy
52341|NCT03240549|Stable disease|stable disease
52342|NCT03240536|Rheumatology Referral|rheumatology referral
52343|NCT03240536|Choosing Wisely|choosing wisely
52344|NCT03240510|Breast cancer|breast cancer
52345|NCT03240510|Male|male
52346|NCT03240471|Distal radius fracture|distal radius fracture
52347|NCT03240471|Conservative treatment|conservative treatment
52348|NCT03240471|Patient rated outcome (PRO)|patient rated outcome (pro)
52349|NCT03240419|Obesity|obesity
52350|NCT03240419|Inflammation|inflammation
52351|NCT03240419|Pregnancy|pregnancy
52352|NCT03240419|Programming|programming
52353|NCT03240393|Non Small Cell Lung Cancer|non small cell lung cancer
52354|NCT03240393|NSCLC|nsclc
52355|NCT03240393|INC280|inc280
52356|NCT03240393|EGFR wild-type (wt)|egfr wild-type (wt)
52357|NCT03240393|advanced non-small cell lung cancer|advanced non-small cell lung cancer
52358|NCT03240393|advanced/metastatic disease|advanced/metastatic disease
52359|NCT03240393|Non-small cell lung carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
52360|NCT03240393|treatment of lung cancer after first metastasis|treatment of lung cancer after first metastasis
52361|NCT03240393|lung cancer|lung cancer
52362|NCT03240393|lung adenocarcinoma|lung adenocarcinoma
52363|NCT03240393|Non small cell lung carcinoma|non small cell lung carcinoma
52364|NCT03240393|Non-small cell lung cancer|non-small cell lung cancer
52365|NCT03240393|MET exon 14 deletion|met exon 14 deletion
52366|NCT03240393|MET exon 14 skipping|met exon 14 skipping
52367|NCT03240393|MET exon 14 mutation|met exon 14 mutation
52368|NCT03240393|MET mutation|met mutation
52369|NCT03240393|MET amplification|met amplification
52370|NCT03240393|MET inhibitor|met inhibitor
52371|NCT03240393|MET dysregulation|met dysregulation
52372|NCT03240393|MET activation|met activation
52373|NCT03240393|MET signaling|met signaling
52374|NCT03240393|MET pathway|met pathway
52375|NCT03240393|MET|met
52376|NCT03240393|cMET|cmet
52377|NCT03240328|CAR-T HIV therapy|car-t hiv therapy
52378|NCT03240250|VATS|vats
52379|NCT03240250|Pulmonary lobectomy|pulmonary lobectomy
52380|NCT03240250|Uniportal|uniportal
52381|NCT03240250|Postoperative pain|postoperative pain
52382|NCT03240250|Thoracic surgery|thoracic surgery
52383|NCT03240237|HFpEF|hfpef
52384|NCT03240224|Cancer ablation|cancer ablation
52385|NCT03240224|Life information rehabilitation therapy|life information rehabilitation therapy
52386|NCT03240211|Pembrolizumab|pembrolizumab
52387|NCT03240211|Decitabine|decitabine
52388|NCT03240211|Pralatrexate|pralatrexate
52389|NCT03240211|T-cell lymphoma|t-cell lymphoma
52390|NCT03240198|occupational|occupational
52391|NCT03240198|cohort|cohort
52392|NCT03240198|biomarkers|biomarkers
52393|NCT03240185|hemorrhoid|hemorrhoid
52394|NCT03240185|pain|pain
52395|NCT03240185|deep breathing|deep breathing
52396|NCT03240185|multimodal pain control|multimodal pain control
52397|NCT03240133|HAE|hae
52398|NCT03240133|hereditary angioedema|hereditary angioedema
52399|NCT03240133|kallikrein inhibitor|kallikrein inhibitor
52400|NCT03240133|plasma kallikrein|plasma kallikrein
52401|NCT03240107|levator resection|levator resection
52402|NCT03240107|levator tucking|levator tucking
52403|NCT03240107|Fair levator function|fair levator function
52404|NCT03240107|Eyelid contour|eyelid contour
52405|NCT03240094|Ehealth|ehealth
52406|NCT03240094|Older adults|older adults
52407|NCT03240094|Undernutrition|undernutrition
52408|NCT03240081|Post-menopause dyspareunia|post-menopause dyspareunia
52409|NCT03240081|Vulvar vestibular pain|vulvar vestibular pain
52410|NCT03240081|Genitourinary syndrome of menopause|genitourinary syndrome of menopause
52411|NCT03240081|Sexual pain|sexual pain
52412|NCT03240068|Renin-Angiotensin System|renin-angiotensin system
52413|NCT03240068|Inflammation|inflammation
52414|NCT03240068|Cardiovascular|cardiovascular
52415|NCT03240068|Atherosclerosis|atherosclerosis
52416|NCT03240055|spinal anesthesia|spinal anesthesia
52417|NCT03240055|etomidate|etomidate
52418|NCT03240055|median effective dose|median effective dose
52419|NCT03240055|BIS50|bis50
52420|NCT03240042|anterior cervical spine surgery|anterior cervical spine surgery
52421|NCT03240042|cuff pressure|cuff pressure
52424|NCT03240029|children|children
52425|NCT03240029|life quality|life quality
52426|NCT03240029|school reintegration|school reintegration
52427|NCT03240003|Social Anxiety|social anxiety
52428|NCT03240003|Social Anxiety Disorder|social anxiety disorder
52429|NCT03240003|SAD|sad
52430|NCT03239990|Children's mental health|children's mental health
52431|NCT03239990|Conduct disorders|conduct disorders
52432|NCT03239990|Conduct problems|conduct problems
52433|NCT03239990|Externalizing problems|externalizing problems
52434|NCT03239990|Parental Intervention|parental intervention
52435|NCT03239990|Groups based intervention|groups based intervention
52436|NCT03239990|Finland|finland
52437|NCT03239990|Social learning theory|social learning theory
52438|NCT03239990|Cognitive-behavioral theory|cognitive-behavioral theory
52439|NCT03239977|social intelligence|social intelligence
52440|NCT03239977|quality of life|quality of life
52441|NCT03239977|social competence|social competence
52442|NCT03239964|recurrent keloid|recurrent keloid
52443|NCT03239964|surgical excision|surgical excision
52444|NCT03239964|steroids injection|steroids injection
52445|NCT03239938|chronic whiplash associated disorders|chronic whiplash associated disorders
52446|NCT03239938|central sensitization|central sensitization
52447|NCT03239938|electroencephalography|electroencephalography
52448|NCT03239938|physiotherapy|physiotherapy
52449|NCT03239938|chronic pain|chronic pain
52450|NCT03239938|functionality|functionality
52451|NCT03239938|quality of life|quality of life
52452|NCT03239938|stress management|stress management
52453|NCT03239938|randomized controlled trial|randomized controlled trial
52454|NCT03239938|modern neuroscience approach|modern neuroscience approach
52455|NCT03239938|pain neuroscience education|pain neuroscience education
52456|NCT03239938|neck school|neck school
52457|NCT03239938|exercise therapy|exercise therapy
52458|NCT03239938|pain cognitions|pain cognitions
52459|NCT03239925|Cell phones, Electromagnetic Radiation|cell phones, electromagnetic radiation
52460|NCT03239912|Low-level laser|low-level laser
52461|NCT03239912|functional treatment|functional treatment
52462|NCT03239912|twin-block|twin-block
52463|NCT03239912|RCT|rct
52464|NCT03239899|HIV|hiv
52465|NCT03239899|Brain|brain
52466|NCT03239899|Immunotherapy|immunotherapy
52467|NCT03239860|Multiple Sclerosis|multiple sclerosis
52468|NCT03239860|Multiple Sclerosis Relapsing-Remitting|multiple sclerosis relapsing-remitting
52469|NCT03239860|GNbAC1|gnbac1
52470|NCT03239860|MRI|mri
52471|NCT03239860|Monoclonal antibody|monoclonal antibody
52472|NCT03239860|Multiple Sclerosis associated retrovirus MSRV|multiple sclerosis associated retrovirus msrv
52473|NCT03239860|MS|ms
52474|NCT03239860|RRMS|rrms
52475|NCT03239860|HERV-W|herv-w
52476|NCT03239808|once-weekly haemodialysis|once-weekly haemodialysis
52477|NCT03239808|incremental haemodialysis|incremental haemodialysis
52478|NCT03239808|randomized clinical trial|randomized clinical trial
52479|NCT03239795|Posters|posters
52480|NCT03239795|Pamphlets|pamphlets
52481|NCT03239795|Primary Health Care|primary health care
52482|NCT03239795|Health Facilities|health facilities
52483|NCT03239769|Thyroid surgery|thyroid surgery
52484|NCT03239769|Thyroidectomy|thyroidectomy
52485|NCT03239769|Minimally invasive access|minimally invasive access
52486|NCT03239769|Aesthetic principle|aesthetic principle
52487|NCT03239769|POSAS|posas
52488|NCT03239743|virtual reality|virtual reality
52489|NCT03239743|adenoidectomy|adenoidectomy
52490|NCT03239743|induction of anesthesia|induction of anesthesia
52491|NCT03239743|pre-operative anxiety|pre-operative anxiety
52492|NCT03239730|dyspnea|dyspnea
52493|NCT03239730|pH|ph
52494|NCT03239730|blood gas analysis|blood gas analysis
52495|NCT03239730|emergency department|emergency department
52496|NCT03239730|Intensive care unit|intensive care unit
52497|NCT03239704|Inflammatory Bowel Disease|inflammatory bowel disease
52498|NCT03239704|Ulcerative Colitis|ulcerative colitis
52499|NCT03239704|Crohn Disease|crohn disease
52500|NCT03239704|Quality Improvement|quality improvement
52501|NCT03239704|Telemedicine|telemedicine
52502|NCT03239678|Preoxygenation|preoxygenation
52503|NCT03239678|Oxygen Concentration|oxygen concentration
52504|NCT03239665|Vaccine|vaccine
52505|NCT03239665|Educational intervention|educational intervention
52506|NCT03239665|Senior Center Model of Care|senior center model of care
52507|NCT03239665|Older adults|older adults
52508|NCT03239652|Microsphere|microsphere
52509|NCT03239652|Transcatheter Arterial chemo-embolization|transcatheter arterial chemo-embolization
52510|NCT03239639|Substitute decision makers of patient|substitute decision makers of patient
52511|NCT03239600|Anti-IL-7 Receptor-alpha Monoclonal Antibody|anti-il-7 receptor-alpha monoclonal antibody
52512|NCT03239600|Safety|safety
52513|NCT03239600|GSK2618960|gsk2618960
52514|NCT03239600|Primary Sjögren's Syndrome|primary sjögren's syndrome
52515|NCT03239587|Symptoms and signs involving cognition perception emotion & behaviour|symptoms and signs involving cognition perception emotion & behaviour
52516|NCT03239587|Abdominal cancer patients|abdominal cancer patients
52517|NCT03239587|Musical preop intervention|musical preop intervention
52518|NCT03239587|Surveys|surveys
52519|NCT03239587|Questionnaires|questionnaires
52520|NCT03239587|Blood draws|blood draws
52521|NCT03239548|Opinion,|opinion,
52522|NCT03239548|Doctors,|doctors,
52523|NCT03239548|Nurses,|nurses,
52524|NCT03239548|Key informants,|key informants,
52525|NCT03239548|Independent Nurse Midwifery Practitioner|independent nurse midwifery practitioner
52526|NCT03239522|GSK1278863|gsk1278863
52527|NCT03239522|pharmacokinetics|pharmacokinetics
52528|NCT03239522|mass balance|mass balance
52529|NCT03239522|daprodustat|daprodustat
52530|NCT03239509|long-term survival|long-term survival
52531|NCT03239509|bioprosthesis|bioprosthesis
52532|NCT03239509|complications|complications
52533|NCT03239509|anticoagulation|anticoagulation
52534|NCT03239509|mechanichal prosthesis|mechanichal prosthesis
52535|NCT03239470|autologous polyclonal regulatory T cell therapy|autologous polyclonal regulatory t cell therapy
52536|NCT03239470|PolyTregs|polytregs
52537|NCT03239470|open-label|open-label
52538|NCT03239470|Phase 1 (safety)|phase 1 (safety)
52539|NCT03239444|ICE|ice
52540|NCT03239444|Ablation|ablation
52541|NCT03239444|Trans-septal|trans-septal
52542|NCT03239444|Septum|septum
52543|NCT03239444|Echocardiography|echocardiography
52544|NCT03239431|asthma|asthma
52545|NCT03239431|lung function|lung function
52546|NCT03239431|forced oscillometry technique|forced oscillometry technique
52547|NCT03239431|exacerbation|exacerbation
52548|NCT03239418|NMES|nmes
52549|NCT03239405|laparoscopic|laparoscopic
52550|NCT03239405|sleeve|sleeve
52551|NCT03239405|gastrectomy|gastrectomy
52552|NCT03239392|BNZ-1|bnz-1
52553|NCT03239392|Cytokine|cytokine
52554|NCT03239392|IL-2|il-2
52555|NCT03239392|IL-15|il-15
52556|NCT03239379|cytokine inhibitor|cytokine inhibitor
52557|NCT03239379|IL-2|il-2
52558|NCT03239379|IL-9|il-9
52559|NCT03239379|IL-15|il-15
52560|NCT03239366|T2D|t2d
52561|NCT03239340|EGFR, NSCLC, Lung Cancer, Biopsy, Molecular Profiling|egfr, nsclc, lung cancer, biopsy, molecular profiling
52562|NCT03239327|Misoprostol|misoprostol
52563|NCT03239327|neonatal|neonatal
52564|NCT03239327|respiratory distress|respiratory distress
52565|NCT03239327|cesarean section|cesarean section
52566|NCT03239288|Fiber|fiber
52567|NCT03239288|Postprandial glucose|postprandial glucose
52568|NCT03239288|Insulin|insulin
52569|NCT03239288|Resistant Starch Type 4|resistant starch type 4
52570|NCT03239275|en masse retraction|en masse retraction
52571|NCT03239275|biocreative therapy|biocreative therapy
52572|NCT03239275|class II|class ii
52573|NCT03239275|skeletal anchorage|skeletal anchorage
52574|NCT03239262|Atrial Fibrillation|atrial fibrillation
52575|NCT03239262|Left Atrial Cryoablation|left atrial cryoablation
52576|NCT03239262|Ganglionated Plexi|ganglionated plexi
52577|NCT03239262|Open-Heart Surgery|open-heart surgery
52578|NCT03239249|school dropout prevention|school dropout prevention
52579|NCT03239249|intervention study|intervention study
52580|NCT03239249|cluster-randomized|cluster-randomized
52581|NCT03239210|Brain Function|brain function
52582|NCT03239210|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
52583|NCT03239210|Sensory processing|sensory processing
52584|NCT03239210|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
52585|NCT03239210|OCD|ocd
52586|NCT03239184|Cancer ablation|cancer ablation
52587|NCT03239184|Life information rehabilitation therapy|life information rehabilitation therapy
52588|NCT03239171|Cancer ablation|cancer ablation
52589|NCT03239171|Life information rehabilitation therapy|life information rehabilitation therapy
52590|NCT03239158|Cancer ablation|cancer ablation
52591|NCT03239158|Life information rehabilitation therapy|life information rehabilitation therapy
52592|NCT03239145|Advanced Solid Tumor|advanced solid tumor
52593|NCT03239145|Melanoma|melanoma
52594|NCT03239145|Ovarian Cancer|ovarian cancer
52595|NCT03239145|Renal Cancer|renal cancer
52596|NCT03239145|Colorectal Cancer|colorectal cancer
52597|NCT03239119|rE-4|re-4
52598|NCT03239119|Exenatide|exenatide
52599|NCT03239119|Metformin|metformin
52600|NCT03239119|Sulfonylurea|sulfonylurea
52601|NCT03239106|itch|itch
52602|NCT03239106|pruritus|pruritus
52603|NCT03239106|CIP|cip
52604|NCT03239080|Rheumatoid Arthritis|rheumatoid arthritis
52605|NCT03239080|HR-pQCT|hr-pqct
52606|NCT03239080|erosion|erosion
52607|NCT03239080|denosumab|denosumab
52608|NCT03239067|Ticagrelor|ticagrelor
52609|NCT03239067|Clopidogrel|clopidogrel
52610|NCT03239067|Acute Coronary Syndrome|acute coronary syndrome
52611|NCT03239067|Percutaneous Coronary Intervention|percutaneous coronary intervention
52612|NCT03239028|diet quality|diet quality
52613|NCT03239028|pregnancy|pregnancy
52614|NCT03239028|adolescence|adolescence
52615|NCT03239028|longitudinal study|longitudinal study
52616|NCT03239028|food frequency questionnaire|food frequency questionnaire
52617|NCT03238989|Interstitial lung disease|interstitial lung disease
52618|NCT03238976|breast core biopsy|breast core biopsy
52619|NCT03238976|core needle biopsies|core needle biopsies
52620|NCT03238924|posttraumatic stress disorder|posttraumatic stress disorder
52621|NCT03238924|oxytocin|oxytocin
52622|NCT03238924|Prolonged Exposure|prolonged exposure
52623|NCT03238898|muscle cramps|muscle cramps
52624|NCT03238898|diabetic neuropathy|diabetic neuropathy
52625|NCT03238898|botulinum toxin|botulinum toxin
52626|NCT03238872|Anxiety|anxiety
52627|NCT03238872|Depression|depression
52628|NCT03238872|CBT|cbt
52629|NCT03238872|Outcome monitoring|outcome monitoring
52630|NCT03238872|Dissemination|dissemination
52631|NCT03238872|Routine services|routine services
52632|NCT03238833|In vitro fertilization|in vitro fertilization
52633|NCT03238833|Poor ovarian responder|poor ovarian responder
52634|NCT03238833|Luteal ovarian stimulation|luteal ovarian stimulation
52635|NCT03238833|Antagonist protocol|antagonist protocol
52636|NCT03238833|Cumulus cells|cumulus cells
52637|NCT03238820|Gastrointestinal stromal tumors|gastrointestinal stromal tumors
52638|NCT03238820|Robot|robot
52639|NCT03238820|manual suture|manual suture
52640|NCT03238807|hCG|hcg
52641|NCT03238807|Intrauterine hCG|intrauterine hcg
52642|NCT03238807|IVF|ivf
52643|NCT03238807|ICSI|icsi
52644|NCT03238794|Body Mass Index|body mass index
52645|NCT03238794|gastric|gastric
52646|NCT03238794|bypass|bypass
52647|NCT03238794|bariatric surgery|bariatric surgery
52648|NCT03238794|bile acid|bile acid
52649|NCT03238794|weight loss|weight loss
52650|NCT03238794|diet|diet
52651|NCT03238794|low calorie|low calorie
52652|NCT03238781|Migraine|migraine
52653|NCT03238781|Headache|headache
52654|NCT03238781|Prevention|prevention
52655|NCT03238781|Prophylaxis|prophylaxis
52656|NCT03238768|Nutrition|nutrition
52657|NCT03238768|Body Composition|body composition
52658|NCT03238768|Preterm|preterm
52659|NCT03238768|Neonate|neonate
52660|NCT03238755|HIV|hiv
52661|NCT03238755|Diastolic Dysfunction|diastolic dysfunction
52662|NCT03238755|Myocardial fibrosis|myocardial fibrosis
52663|NCT03238755|Statin|statin
52664|NCT03238742|Xuebijing Injection, morality, sepsis|xuebijing injection, morality, sepsis
52665|NCT03238690|LVAD|lvad
52666|NCT03238690|Cardiac Recovery|cardiac recovery
52667|NCT03238677|speech sound disorder|speech sound disorder
52668|NCT03238651|Drug therapy|drug therapy
52669|NCT03238638|Epacadostat|epacadostat
52670|NCT03238638|Pembrolizumab|pembrolizumab
52671|NCT03238638|PD-1|pd-1
52672|NCT03238638|PD-L1|pd-l1
52673|NCT03238612|influenza|influenza
52674|NCT03238612|FFA|ffa
52675|NCT03238612|clarithromycin|clarithromycin
52676|NCT03238612|mortality|mortality
52677|NCT03238612|hospitalisation|hospitalisation
52678|NCT03238586|hiv|hiv
52679|NCT03238586|aids|aids
52680|NCT03238586|alcohol|alcohol
52681|NCT03238586|health|health
52682|NCT03238586|knowledge|knowledge
52683|NCT03238586|motivation|motivation
52684|NCT03238586|skills|skills
52685|NCT03238586|behavior|behavior
52686|NCT03238573|Colorectal Sessile Serrated Adenomas/Polyps optical enhancement endoscopy|colorectal sessile serrated adenomas/polyps optical enhancement endoscopy
52687|NCT03238508|Deferred stenting|deferred stenting
52688|NCT03238508|Microvascular dysfunction|microvascular dysfunction
52689|NCT03238495|Operable breast cancer|operable breast cancer
52690|NCT03238495|Neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
52691|NCT03238469|Microwave Ablation|microwave ablation
52692|NCT03238469|Hair Follicle|hair follicle
52693|NCT03238469|Sweat gland|sweat gland
52694|NCT03238456|Pacific Islander|pacific islander
52695|NCT03238456|Native Hawaiian|native hawaiian
52696|NCT03238456|NHPI|nhpi
52697|NCT03238456|Tobacco Health|tobacco health
52698|NCT03238456|Tobacco Use|tobacco use
52699|NCT03238456|Tobacco Smoking|tobacco smoking
52700|NCT03238456|Tobacco Use Cessation|tobacco use cessation
52701|NCT03238456|Smoking Cessation|smoking cessation
52702|NCT03238456|Smoking|smoking
52703|NCT03238456|Cigarette Use|cigarette use
52704|NCT03238456|Young Adult|young adult
52705|NCT03238443|DSA|dsa
52706|NCT03238430|Intrathecal morphine, continuous wound infiltration|intrathecal morphine, continuous wound infiltration
52707|NCT03238417|women's health|women's health
52708|NCT03238417|primary health care|primary health care
52709|NCT03238417|mental health|mental health
52710|NCT03238417|Veterans|veterans
52711|NCT03238417|quality improvement|quality improvement
52712|NCT03238404|gastric cancer|gastric cancer
52713|NCT03238404|neoadjuvant chemotherapy|neoadjuvant chemotherapy
52714|NCT03238404|enhanced recovery after surgery|enhanced recovery after surgery
52715|NCT03238404|gastrectomy|gastrectomy
52716|NCT03238391|Contrast-induced nephropathy|contrast-induced nephropathy
52717|NCT03238391|Ischemic preconditioning|ischemic preconditioning
52718|NCT03238378|head and neck cancer|head and neck cancer
52719|NCT03238378|Locally recurrent head and neck cancer|locally recurrent head and neck cancer
52720|NCT03238378|Brachytherapy|brachytherapy
52721|NCT03238378|Hyperthermia|hyperthermia
52722|NCT03238339|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
52723|NCT03238339|Respiratory Insufficiency|respiratory insufficiency
52724|NCT03238339|Oxygen Inhalation Therapy|oxygen inhalation therapy
52725|NCT03238339|Noninvasive Ventilation|noninvasive ventilation
52726|NCT03238326|Brexpiprazole|brexpiprazole
52727|NCT03238326|Schizophrenia|schizophrenia
52728|NCT03238300|adolescent|adolescent
52729|NCT03238287|Emergency|emergency
52730|NCT03238287|Mechanical chest compression|mechanical chest compression
52731|NCT03238287|Cerebral oximetry|cerebral oximetry
52732|NCT03238222|Walking|walking
52733|NCT03238222|Six-Minute Walk Distance|six-minute walk distance
52734|NCT03238222|Illness Perceptions|illness perceptions
52735|NCT03238222|Theory of Planned Behaviour|theory of planned behaviour
52736|NCT03238209|neural respiratory drive|neural respiratory drive
52737|NCT03238209|transesophageal diaphragmatic EMG|transesophageal diaphragmatic emg
52738|NCT03238209|surface diaphragmatic EMG|surface diaphragmatic emg
52739|NCT03238209|surface sternocleidomastoid EMG|surface sternocleidomastoid emg
52740|NCT03238209|surface parasternal intercostal muscle EMG|surface parasternal intercostal muscle emg
52741|NCT03238196|FGFR inhibitor|fgfr inhibitor
52742|NCT03238196|ER+ metastatic breast cancer|er+ metastatic breast cancer
52743|NCT03238196|CDK4/6 inhibitor|cdk4/6 inhibitor
52744|NCT03238196|Endocrine therapy|endocrine therapy
52745|NCT03238183|knee osteoarthritis|knee osteoarthritis
52746|NCT03238183|hyaluronic acid|hyaluronic acid
52747|NCT03238183|dextrose|dextrose
52748|NCT03238183|therapeutic effects|therapeutic effects
52749|NCT03238118|irritability|irritability
52750|NCT03238118|severe mood dysregulation|severe mood dysregulation
52751|NCT03238118|disruptive mood dysregulation disorder|disruptive mood dysregulation disorder
52752|NCT03238105|Dark circles|dark circles
52753|NCT03238105|Periorbital hyperchromia|periorbital hyperchromia
52754|NCT03238105|Facial aesthetics|facial aesthetics
52755|NCT03238092|in vitro fertilization|in vitro fertilization
52756|NCT03238092|estradiol|estradiol
52757|NCT03238092|gnrh antagonist|gnrh antagonist
52758|NCT03238092|testosterone|testosterone
52759|NCT03238053|laser treatment, randomized trial, menopause, vaginal symptoms|laser treatment, randomized trial, menopause, vaginal symptoms
52760|NCT03238040|Critical illness|critical illness
52761|NCT03238040|PICU|picu
52762|NCT03238040|biomarkers|biomarkers
52763|NCT03238027|SNDX-6352|sndx-6352
52764|NCT03238027|CSF-1R inhibitor|csf-1r inhibitor
52765|NCT03238027|Colony Stimulating factor 1 receptor inhibitor|colony stimulating factor 1 receptor inhibitor
52766|NCT03238027|Solid Tumor|solid tumor
52767|NCT03238027|Recurrent locally advanced tumor|recurrent locally advanced tumor
52768|NCT03238027|unresectable solid tumor|unresectable solid tumor
52769|NCT03238027|Metastatic tumor|metastatic tumor
52770|NCT03238001|Cognitive assessment|cognitive assessment
52771|NCT03238001|Cognition|cognition
52772|NCT03238001|Clock Test|clock test
52773|NCT03237975|type 2 diabetes|type 2 diabetes
52774|NCT03237975|sense of coherence|sense of coherence
52775|NCT03237975|self-care|self-care
52776|NCT03237975|strengths-based intervention|strengths-based intervention
52777|NCT03237962|High flow nasal cannula|high flow nasal cannula
52778|NCT03237962|Pulmonary rehab|pulmonary rehab
52779|NCT03237962|Pulmonary rehabilitation|pulmonary rehabilitation
52780|NCT03237962|Nasal cannula|nasal cannula
52781|NCT03237962|Exercise endurance|exercise endurance
52782|NCT03237962|Oxygen Therapy|oxygen therapy
52783|NCT03237962|COPD|copd
52784|NCT03237962|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
52785|NCT03237949|Tobacco Use Disorder|tobacco use disorder
52786|NCT03237949|Hospitalized patients|hospitalized patients
52787|NCT03237949|Text message|text message
52788|NCT03237949|Motivational Interview|motivational interview
52789|NCT03237949|Substance-Related Disorders|substance-related disorders
52790|NCT03237949|Behaviors and Mental Disorders|behaviors and mental disorders
52791|NCT03237923|fluid|fluid
52792|NCT03237910|amplitude spectrum area|amplitude spectrum area
52793|NCT03237910|defibrillation|defibrillation
52794|NCT03237910|waveform analysis|waveform analysis
52795|NCT03237910|cardiopulmonary resuscitation|cardiopulmonary resuscitation
52796|NCT03237910|cardiac arrest|cardiac arrest
52797|NCT03237897|ERAS|eras
52798|NCT03237897|Enhanced recovery after surgery|enhanced recovery after surgery
52799|NCT03237884|Palliative Care|palliative care
52800|NCT03237884|Oncology|oncology
52801|NCT03237884|advanced incurable cancer (any type)|advanced incurable cancer (any type)
52802|NCT03237884|integration|integration
52803|NCT03237884|development|development
52804|NCT03237884|palliative care interventions|palliative care interventions
52805|NCT03237884|process indicators|process indicators
52806|NCT03237884|Romania|romania
52807|NCT03237858|heart failure|heart failure
52808|NCT03237858|diagnostics|diagnostics
52809|NCT03237858|heart sounds|heart sounds
52810|NCT03237858|CRT-D|crt-d
52811|NCT03237858|ICD|icd
52812|NCT03237858|remote monitoring|remote monitoring
52813|NCT03237819|Thrombotic Thrombocytopenic Purpura|thrombotic thrombocytopenic purpura
52814|NCT03237819|Intensive care|intensive care
52815|NCT03237806|ARDS,|ards,
52816|NCT03237806|Transpulmonary pressure,|transpulmonary pressure,
52817|NCT03237806|Sedation|sedation
52818|NCT03237754|migraine|migraine
52819|NCT03237754|neurostimulation|neurostimulation
52820|NCT03237754|neuroimaging|neuroimaging
52821|NCT03237754|tDCS|tdcs
52822|NCT03237754|MRI|mri
52823|NCT03237702|prostate cancer|prostate cancer
52824|NCT03237702|prostate biopsy|prostate biopsy
52825|NCT03237702|biomarkers|biomarkers
52826|NCT03237702|metabolomics|metabolomics
52827|NCT03237702|overtreatment|overtreatment
52828|NCT03237702|cancer screening|cancer screening
52829|NCT03237702|urine|urine
52830|NCT03237702|lycopene|lycopene
52831|NCT03237676|cognitive rehabilitation|cognitive rehabilitation
52832|NCT03237676|diffusion tensor imaging|diffusion tensor imaging
52833|NCT03237676|neuropsychology|neuropsychology
52834|NCT03237676|functional outcome|functional outcome
52835|NCT03237650|Painful cutaneous electrical stimulation|painful cutaneous electrical stimulation
52836|NCT03237650|Conditioned Pain Modulation|conditioned pain modulation
52837|NCT03237624|gingivitis|gingivitis
52838|NCT03237611|emesis|emesis
52839|NCT03237611|aprepitant|aprepitant
52840|NCT03237611|carboplatin|carboplatin
52841|NCT03237611|chemotherapy-induced nausea and vomiting|chemotherapy-induced nausea and vomiting
52842|NCT03237585|gender based violence|gender based violence
52843|NCT03237585|violence against women|violence against women
52844|NCT03237585|intimate partner violence|intimate partner violence
52845|NCT03237585|impact assessment|impact assessment
52846|NCT03237585|rural response system|rural response system
52847|NCT03237585|cluster randomised controlled trial|cluster randomised controlled trial
52848|NCT03237572|breast cancer|breast cancer
52849|NCT03237572|pembrolizumab|pembrolizumab
52850|NCT03237572|focused ultrasound|focused ultrasound
52851|NCT03237572|immunotherapy|immunotherapy
52852|NCT03237559|Eugenics|eugenics
52853|NCT03237559|Eligible Couples|eligible couples
52854|NCT03237559|Knowledge|knowledge
52855|NCT03237559|Attitude|attitude
52856|NCT03237559|Practice|practice
52857|NCT03237546|Robotic Cardiac Surgery|robotic cardiac surgery
52858|NCT03237494|Peripheral Nervous System Diseases|peripheral nervous system diseases
52859|NCT03237494|Nervous System Diseases|nervous system diseases
52860|NCT03237494|Metabolism, Inborn Errors|metabolism, inborn errors
52861|NCT03237494|Genetic Diseases, Inborn|genetic diseases, inborn
52862|NCT03237481|inguinal hernia|inguinal hernia
52863|NCT03237481|hernia|hernia
52864|NCT03237481|hernia surgery|hernia surgery
52865|NCT03237481|postoperative pain|postoperative pain
52866|NCT03237481|herniorrhaphy|herniorrhaphy
52867|NCT03237468|concussion|concussion
52868|NCT03237468|football|football
52869|NCT03237468|student|student
52870|NCT03237468|athlete|athlete
52871|NCT03237468|sports|sports
52872|NCT03237429|bioimpedance spectroscopy|bioimpedance spectroscopy
52873|NCT03237429|arterial stiffness|arterial stiffness
52874|NCT03237416|Drug-drug interaction|drug-drug interaction
52875|NCT03237403|Sepsis|sepsis
52876|NCT03237403|Adults|adults
52877|NCT03237403|Pre hospital settings|pre hospital settings
52878|NCT03237403|Triage|triage
52879|NCT03237403|Hospital orientation|hospital orientation
52880|NCT03237403|Outcome|outcome
52881|NCT03237364|deployed in Iraq and/or Afghanistan|deployed in iraq and/or afghanistan
52882|NCT03237351|goal-directed fluid therapy|goal-directed fluid therapy
52883|NCT03237351|thoracic surgery, video-assisted|thoracic surgery, video-assisted
52884|NCT03237351|acute lung injury|acute lung injury
52885|NCT03237325|OM|om
52886|NCT03237325|Head and Neck Cancer|head and neck cancer
52887|NCT03237325|SGX942|sgx942
52888|NCT03237325|Dusquetide|dusquetide
52889|NCT03237325|Squamous Cell Carcinoma|squamous cell carcinoma
52890|NCT03237299|Pharyngitis|pharyngitis
52891|NCT03237299|case-control study|case-control study
52892|NCT03237299|loco-regional complications of pharyngitis|loco-regional complications of pharyngitis
52893|NCT03237286|depression|depression
52894|NCT03237286|ketamine|ketamine
52895|NCT03237286|neurocognitive|neurocognitive
52896|NCT03237286|fMRI|fmri
52897|NCT03237286|cognitive training|cognitive training
52898|NCT03237247|extrahepatic cholestasis, CBC|extrahepatic cholestasis, cbc
52899|NCT03237208|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
52900|NCT03237208|emergency medicine|emergency medicine
52901|NCT03237182|whole genome sequencing;|whole genome sequencing;
52902|NCT03237130|esophagus cancer; radiomics; computed tomograpy|esophagus cancer; radiomics; computed tomograpy
52903|NCT03237104|Adolescent|adolescent
52904|NCT03237104|Athlete|athlete
52905|NCT03237091|non-invasive brain stimulation|non-invasive brain stimulation
52906|NCT03237078|probiotics|probiotics
52907|NCT03237078|major depressive disorder|major depressive disorder
52908|NCT03237078|gut-brain axis|gut-brain axis
52909|NCT03237078|inflammation|inflammation
52910|NCT03237039|Roussouly type|roussouly type
52911|NCT03237039|spine alignment|spine alignment
52912|NCT03237039|fall-risk|fall-risk
52913|NCT03237039|gait cycle analysis|gait cycle analysis
52914|NCT03237026|prostate cancer, prostatectomy, prostate radiotherapy, chemotherapy, immunotherapy, biomarkers, metabolomics, urine|prostate cancer, prostatectomy, prostate radiotherapy, chemotherapy, immunotherapy, biomarkers, metabolomics, urine
52915|NCT03237013|Sunbathing|sunbathing
52916|NCT03237013|Indoor Tanning|indoor tanning
52917|NCT03237013|Facial Morphing|facial morphing
52918|NCT03237013|Skin Cancer Risk|skin cancer risk
52919|NCT03237000|Preeclampsia|preeclampsia
52920|NCT03237000|MgSO4|mgso4
52921|NCT03236987|MAC|mac
52922|NCT03236987|Clarithromycin|clarithromycin
52923|NCT03236987|Azithromycin|azithromycin
52924|NCT03236987|Efficacy|efficacy
52925|NCT03236987|Safety|safety
52926|NCT03236961|uncomplicated acute appendicitis|uncomplicated acute appendicitis
52927|NCT03236961|complicated acute appendicitis|complicated acute appendicitis
52928|NCT03236961|antibiotic therapy|antibiotic therapy
52929|NCT03236922|obstetric fistula, anti-incontinence techniques|obstetric fistula, anti-incontinence techniques
52930|NCT03236896|Menopause|menopause
52931|NCT03236896|Hot Flash|hot flash
52932|NCT03236896|MENQOL|menqol
52933|NCT03236896|Mobile exercise device|mobile exercise device
52934|NCT03236870|psoriasis|psoriasis
52935|NCT03236870|effectiveness|effectiveness
52936|NCT03236870|safety|safety
52937|NCT03236870|adalimumab|adalimumab
52938|NCT03236857|cancer|cancer
52939|NCT03236857|Venetoclax|venetoclax
52940|NCT03236857|pediatric|pediatric
52941|NCT03236857|relapsed or refractory|relapsed or refractory
52942|NCT03236831|Ventricular Assist Device|ventricular assist device
52943|NCT03236818|pulmonary arterial hypertension|pulmonary arterial hypertension
52944|NCT03236818|right ventricle|right ventricle
52945|NCT03236818|MRI|mri
52946|NCT03236818|medical combination therapy|medical combination therapy
52947|NCT03236805|Morphine|morphine
52948|NCT03236805|Ketamine|ketamine
52949|NCT03236805|Acute pain|acute pain
52950|NCT03236805|prehospital|prehospital
52951|NCT03236792|Newly Diagnosed|newly diagnosed
52952|NCT03236792|AL Amyloidosis|al amyloidosis
52953|NCT03236792|Amyloid|amyloid
52954|NCT03236792|Light chain Amyloidosis|light chain amyloidosis
52955|NCT03236753|Thread-Embedding Acupuncture|thread-embedding acupuncture
52956|NCT03236753|Herniated Intervertebral Disc of Lumbar Spine|herniated intervertebral disc of lumbar spine
52957|NCT03236753|Low Back Pain|low back pain
52958|NCT03236753|Radiculopathy|radiculopathy
52959|NCT03236727|Dexmedetomidine, spinal fusion, SSEP|dexmedetomidine, spinal fusion, ssep
52960|NCT03236701|hyperphosphatemia|hyperphosphatemia
52961|NCT03236701|hemodialysis|hemodialysis
52962|NCT03236701|dietary treatment|dietary treatment
52963|NCT03236701|egg white|egg white
52964|NCT03236701|protein energy wasting|protein energy wasting
52965|NCT03236662|BMD|bmd
52966|NCT03236662|Becker muscular dystrophy|becker muscular dystrophy
52967|NCT03236662|epicatechin|epicatechin
52968|NCT03236662|clinical trial|clinical trial
52969|NCT03236662|neuromuscular disease|neuromuscular disease
52970|NCT03236623|Surgical Patient|surgical patient
52971|NCT03236623|Menthol|menthol
52972|NCT03236623|Clinical Study|clinical study
52973|NCT03236571|Marfan syndrome|marfan syndrome
52974|NCT03236571|Personal Training Program|personal training program
52975|NCT03236571|Cardiorespiratory rehabilitation|cardiorespiratory rehabilitation
52976|NCT03236571|Muscular rehabilitation|muscular rehabilitation
52977|NCT03236558|Type 1 diabetes|type 1 diabetes
52978|NCT03236558|Juvenile diabetes|juvenile diabetes
52979|NCT03236558|Immune-tolerance|immune-tolerance
52980|NCT03236558|Regulatory T lymphocyte|regulatory t lymphocyte
52981|NCT03236558|Treg|treg
52982|NCT03236558|TCR|tcr
52983|NCT03236558|Repertoire|repertoire
52984|NCT03236532|HIV/AIDS; Resistance training, supplementation|hiv/aids; resistance training, supplementation
52985|NCT03236506|Illicit drug|illicit drug
52986|NCT03236506|Injecting drug|injecting drug
52987|NCT03236467|Fibromyalgia and PTSD|fibromyalgia and ptsd
52988|NCT03236454|brain stimulation|brain stimulation
52989|NCT03236454|cognitive training|cognitive training
52990|NCT03236454|cognition|cognition
52991|NCT03236454|treatment|treatment
52992|NCT03236441|remote ischemic conditioning|remote ischemic conditioning
52993|NCT03236441|contrast-induced nephropathy|contrast-induced nephropathy
52994|NCT03236441|cardiac catheterization|cardiac catheterization
52995|NCT03236441|coronary artery disease|coronary artery disease
52996|NCT03236428|Smoldering Multiple Myeloma|smoldering multiple myeloma
52997|NCT03236428|Monoclonal Gammopathy|monoclonal gammopathy
52998|NCT03236402|Knowledge|knowledge
52999|NCT03236402|Opinion|opinion
53000|NCT03236402|Adoption|adoption
53001|NCT03236402|Adults|adults
53002|NCT03236402|Cross-Sectional|cross-sectional
53003|NCT03236363|Physical activity|physical activity
53004|NCT03236363|Obesity|obesity
53005|NCT03236363|Children|children
53006|NCT03236363|Cognitive function|cognitive function
53007|NCT03236363|Academic achievement|academic achievement
53008|NCT03236363|Cardiorespiratory fitness|cardiorespiratory fitness
53009|NCT03236363|Adiposity|adiposity
53010|NCT03236363|Cardiovascular fitness|cardiovascular fitness
53011|NCT03236363|Aerobic capacity|aerobic capacity
53012|NCT03236350|Chronic Kidney Disease|chronic kidney disease
53013|NCT03236350|Hypertension|hypertension
53014|NCT03236350|Cardiovascular Disease|cardiovascular disease
53015|NCT03236350|Central Aortic Systolic Pressure|central aortic systolic pressure
53016|NCT03236350|Proteinuria|proteinuria
53017|NCT03236350|Remote Ischemic Conditioning|remote ischemic conditioning
53018|NCT03236350|Left Ventricular Hypertrophy|left ventricular hypertrophy
53019|NCT03236337|Physical activity|physical activity
53020|NCT03236337|Obesity|obesity
53021|NCT03236337|Children|children
53022|NCT03236337|Cognitive function|cognitive function
53023|NCT03236337|Academic achievement|academic achievement
53024|NCT03236337|Cardiorespiratory fitness|cardiorespiratory fitness
53025|NCT03236337|Adiposity|adiposity
53026|NCT03236337|Cardiovascular fitness|cardiovascular fitness
53027|NCT03236337|Atherosclerosis|atherosclerosis
53028|NCT03236337|Aerobic capacity|aerobic capacity
53029|NCT03236298|Epidural|epidural
53030|NCT03236298|Labor analgesia|labor analgesia
53031|NCT03236298|Programmed intermittent epidural bolus|programmed intermittent epidural bolus
53032|NCT03236285|Obesity|obesity
53033|NCT03236285|Microcirculation|microcirculation
53034|NCT03236285|Endothelial function|endothelial function
53035|NCT03236285|Laser speckle imaging|laser speckle imaging
53036|NCT03236285|Capillary density|capillary density
53037|NCT03236272|Biomarkers|biomarkers
53038|NCT03236272|High-Throughput Screening Assays|high-throughput screening assays
53039|NCT03236272|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
53040|NCT03236220|haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
53041|NCT03236220|poor graft function|poor graft function
53042|NCT03236220|prolonged isolated thrombocytopenia|prolonged isolated thrombocytopenia
53043|NCT03236220|bone marrow endothelial cells|bone marrow endothelial cells
53044|NCT03236220|N-acetyl-L-cysteine|n-acetyl-l-cysteine
53045|NCT03236220|Acute leukemia|acute leukemia
53046|NCT03236181|Energy Expenditure|energy expenditure
53047|NCT03236181|Appetite|appetite
53049|NCT03236155|Opioids|opioids
53050|NCT03236142|bariatric|bariatric
53051|NCT03236142|duodenal switch|duodenal switch
53052|NCT03236142|DS|ds
53053|NCT03236142|weight loss surgery|weight loss surgery
53054|NCT03236142|SIPS|sips
53055|NCT03236142|Single Anastomosis|single anastomosis
53056|NCT03236129|DLI|dli
53057|NCT03236129|Regulatory T cells depletion|regulatory t cells depletion
53058|NCT03236129|Hematological malignancies|hematological malignancies
53059|NCT03236129|Relapse|relapse
53060|NCT03236103|Ventricular assist device|ventricular assist device
53061|NCT03236090|Cirrhosis|cirrhosis
53062|NCT03236090|Probiotics|probiotics
53063|NCT03236090|Systemic inflammation|systemic inflammation
53064|NCT03236090|neuroinflammation|neuroinflammation
53065|NCT03236090|Cognitive function|cognitive function
53066|NCT03236090|Bacterial translocation|bacterial translocation
53067|NCT03236077|obesity, women, exercise, physical activity,|obesity, women, exercise, physical activity,
53068|NCT03236051|gastric cancer|gastric cancer
53069|NCT03236051|gastrectomy|gastrectomy
53070|NCT03236051|multimodal analgesia|multimodal analgesia
53071|NCT03236051|parecoxib|parecoxib
53072|NCT03236038|exocrine pancreatic insufficiency|exocrine pancreatic insufficiency
53073|NCT03236038|liver cirrhosis|liver cirrhosis
53074|NCT03236038|decompensated cirrhosis|decompensated cirrhosis
53075|NCT03236038|malnutrition|malnutrition
53076|NCT03236038|prevalence|prevalence
53077|NCT03236025|smoking cessation|smoking cessation
53078|NCT03236025|video|video
53079|NCT03236025|male smoker|male smoker
53080|NCT03235986|RDS|rds
53081|NCT03235973|refractory acute leukemia|refractory acute leukemia
53082|NCT03235973|refractory myelodysplastic syndrome|refractory myelodysplastic syndrome
53083|NCT03235973|cladribine dose escalation|cladribine dose escalation
53084|NCT03235947|Renal transplant|renal transplant
53085|NCT03235947|Antimicrobian prophylaxis|antimicrobian prophylaxis
53086|NCT03235947|Fosfomycin|fosfomycin
53087|NCT03235947|Urinary tract infection|urinary tract infection
53088|NCT03235947|Asymptomatic bacteriuria|asymptomatic bacteriuria
53089|NCT03235934|glucose monitoring|glucose monitoring
53090|NCT03235921|hemorrhagic shock|hemorrhagic shock
53091|NCT03235921|perfusion index|perfusion index
53092|NCT03235921|lactate|lactate
53093|NCT03235921|nitroglycerin|nitroglycerin
53094|NCT03235908|Copeptin|copeptin
53095|NCT03235908|Outcome prediction|outcome prediction
53096|NCT03235882|Lung surfactant|lung surfactant
53097|NCT03235882|Mid-infrared spectroscopy|mid-infrared spectroscopy
53098|NCT03235882|Prematurity|prematurity
53099|NCT03235882|Respiratory distress syndrome|respiratory distress syndrome
53100|NCT03235882|gastric aspirate|gastric aspirate
53101|NCT03235843|Chronotropic Incompetence|chronotropic incompetence
53102|NCT03235843|Rate Adaptive Pacing|rate adaptive pacing
53103|NCT03235843|Minute Ventilation Sensor|minute ventilation sensor
53104|NCT03235843|Primary Prevention ICD Therapy|primary prevention icd therapy
53105|NCT03235843|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
53106|NCT03235843|Heart Failure|heart failure
53107|NCT03235843|Exercise Intolerance|exercise intolerance
53108|NCT03235830|Healthcare utilization|healthcare utilization
53109|NCT03235830|Health literacy|health literacy
53110|NCT03235817|Proseal™ LMA|proseal™ lma
53111|NCT03235817|infants|infants
53112|NCT03235817|ventilation|ventilation
53113|NCT03235817|general anesthesia|general anesthesia
53114|NCT03235817|outpatient surgery|outpatient surgery
53115|NCT03235804|High-protein diet|high-protein diet
53116|NCT03235804|Inflammation|inflammation
53117|NCT03235804|Gut microbiota|gut microbiota
53118|NCT03235804|Energy metabolism|energy metabolism
53119|NCT03235804|Body composition|body composition
53120|NCT03235778|Tolerance; Pharmacokinetic characteristics|tolerance; pharmacokinetic characteristics
53121|NCT03235765|NSCLC|nsclc
53122|NCT03235765|Cancer panel|cancer panel
53123|NCT03235765|NGS|ngs
53124|NCT03235765|Actionable mutation|actionable mutation
53125|NCT03235765|Immune checkpoint inhibitor|immune checkpoint inhibitor
53126|NCT03235752|Randomized|randomized
53127|NCT03235752|Double-blind|double-blind
53128|NCT03235752|Placebo-controlled|placebo-controlled
53129|NCT03235752|Safety|safety
53130|NCT03235752|Efficacy|efficacy
53131|NCT03235752|Active Ulcerative Colitis|active ulcerative colitis
53132|NCT03235726|bystander|bystander
53133|NCT03235726|inhalation powder|inhalation powder
53134|NCT03235726|monodose device|monodose device
53135|NCT03235726|COPD|copd
53136|NCT03235726|pharmacokinetics|pharmacokinetics
53137|NCT03235726|safety|safety
53138|NCT03235726|Healthy|healthy
53139|NCT03235726|CCI15106|cci15106
53140|NCT03235726|tolerability|tolerability
53141|NCT03235713|Ecological momentary assessments|ecological momentary assessments
53142|NCT03235700|heart failure with reduced ejection fraction|heart failure with reduced ejection fraction
53143|NCT03235700|intermediate coronary stenosis|intermediate coronary stenosis
53144|NCT03235700|adenosine|adenosine
53145|NCT03235700|hyperemia|hyperemia
53146|NCT03235674|Cardiac rehabilitation|cardiac rehabilitation
53147|NCT03235674|interval exercise|interval exercise
53148|NCT03235635|microbiome|microbiome
53149|NCT03235635|preterm|preterm
53150|NCT03235635|newborn|newborn
53151|NCT03235635|gut microbiome|gut microbiome
53152|NCT03235635|allergic predisposition|allergic predisposition
53153|NCT03235596|executive functions|executive functions
53154|NCT03235596|tDCS|tdcs
53155|NCT03235583|Energy expenditure|energy expenditure
53156|NCT03235583|physical activity|physical activity
53157|NCT03235583|accelerometer|accelerometer
53158|NCT03235583|magnetometer|magnetometer
53159|NCT03235583|monitoring|monitoring
53160|NCT03235583|free-living conditions|free-living conditions
53161|NCT03235583|doubly labelled water|doubly labelled water
53162|NCT03235570|Solid tumor|solid tumor
53163|NCT03235570|malignancy|malignancy
53164|NCT03235570|fibroblast growth factor receptor (FGFR)|fibroblast growth factor receptor (fgfr)
53165|NCT03235570|fibroblast growth factor (FGF)/FGFR alteration|fibroblast growth factor (fgf)/fgfr alteration
53166|NCT03235557|prostate|prostate
53167|NCT03235557|cancer|cancer
53168|NCT03235557|radiation|radiation
53169|NCT03235557|stereotactic|stereotactic
53170|NCT03235557|CyberKnife|cyberknife
53171|NCT03235557|elderly|elderly
53172|NCT03235544|Mantle cell lymphoma|mantle cell lymphoma
53173|NCT03235544|non-Hodgkin lymphoma|non-hodgkin lymphoma
53174|NCT03235544|Bruton's tyrosine kinase (BTK)|bruton's tyrosine kinase (btk)
53175|NCT03235544|phosphatidylinositol 3-kinase (PI3K)|phosphatidylinositol 3-kinase (pi3k)
53176|NCT03235531|alcohol withdrawal syndrome|alcohol withdrawal syndrome
53177|NCT03235531|trauma|trauma
53178|NCT03235531|alcohol use disorder|alcohol use disorder
53179|NCT03235531|alcohol|alcohol
53180|NCT03235531|lorazepam|lorazepam
53181|NCT03235531|benzodiazepine|benzodiazepine
53182|NCT03235531|valproate|valproate
53183|NCT03235518|HIV Prevention|hiv prevention
53184|NCT03235518|Female sex workers|female sex workers
53185|NCT03235505|Smoking Cessation|smoking cessation
53186|NCT03235505|Electronic cigarette|electronic cigarette
53187|NCT03235505|Adults|adults
53188|NCT03235492|diabetes|diabetes
53189|NCT03235492|salivary glycated albumin|salivary glycated albumin
53190|NCT03235492|HbA1c|hba1c
53191|NCT03235453|Parkinson|parkinson
53192|NCT03235453|Quality of Life|quality of life
53193|NCT03235453|Sleep Disorder|sleep disorder
53194|NCT03235453|Gait Disorders|gait disorders
53195|NCT03235453|Mobility|mobility
53196|NCT03235427|Coronary|coronary
53197|NCT03235427|Coronary Disease|coronary disease
53198|NCT03235427|Coronary Arteriosclerosis|coronary arteriosclerosis
53199|NCT03235427|Heart Disease|heart disease
53200|NCT03235427|Cardiotoxicity|cardiotoxicity
53201|NCT03235427|Breast Cancer|breast cancer
53202|NCT03235427|Carcinoma|carcinoma
53203|NCT03235427|Coronary Vessels|coronary vessels
53204|NCT03235427|Radiation|radiation
53205|NCT03235427|Radiation Therapy|radiation therapy
53206|NCT03235427|Coronary Artery Disease|coronary artery disease
53207|NCT03235427|CAD|cad
53208|NCT03235427|RT|rt
53209|NCT03235427|CT|ct
53210|NCT03235427|Cardiac toxicity|cardiac toxicity
53211|NCT03235427|Cardiac calcium score|cardiac calcium score
53212|NCT03235427|Chest RT|chest rt
53213|NCT03235427|Lung Cancer|lung cancer
53214|NCT03235427|Lymphoma|lymphoma
53215|NCT03235427|Cardiac CT Scan|cardiac ct scan
53216|NCT03235427|Coronary Artery|coronary artery
53217|NCT03235427|Coronary arteries|coronary arteries
53218|NCT03235427|Cardiac Side Effect|cardiac side effect
53219|NCT03235427|Cardiac tissue|cardiac tissue
53220|NCT03235427|Cardiac|cardiac
53221|NCT03235401|Questionnaire|questionnaire
53222|NCT03235401|Disability assessment|disability assessment
53223|NCT03235401|Bothersomeness|bothersomeness
53224|NCT03235401|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
53225|NCT03235401|patient-reported outcome measure|patient-reported outcome measure
53226|NCT03235401|New York Heart Association (NYHA) functional class|new york heart association (nyha) functional class
53227|NCT03235388|Trauma|trauma
53228|NCT03235388|Injury|injury
53229|NCT03235388|Audit filter|audit filter
53230|NCT03235388|Quality improvement|quality improvement
53231|NCT03235388|India|india
53232|NCT03235375|Kidney Failure, Kidney Insufficiency, Renal Failure, Renal Insufficiency, MEDI0382|kidney failure, kidney insufficiency, renal failure, renal insufficiency, medi0382
53233|NCT03235349|Chronic Hepatitis C Virus (HCV)|chronic hepatitis c virus (hcv)
53234|NCT03235349|Genotype 1 to 6|genotype 1 to 6
53235|NCT03235349|Cirrhosis|cirrhosis
53236|NCT03235349|Compensated Cirrhosis|compensated cirrhosis
53237|NCT03235349|Human Immunodeficiency Virus|human immunodeficiency virus
53238|NCT03235349|co-infection|co-infection
53239|NCT03235349|Treatment-naïve|treatment-naïve
53240|NCT03235349|treatment-experienced|treatment-experienced
53241|NCT03235349|interferon|interferon
53242|NCT03235323|Vein Graft Failure|vein graft failure
53243|NCT03235323|Coronary Artery Bypass|coronary artery bypass
53244|NCT03235323|External Counterpulsation|external counterpulsation
53245|NCT03235310|HIV|hiv
53246|NCT03235310|Pregnancy|pregnancy
53247|NCT03235310|Prevention of mother-to-child transmission|prevention of mother-to-child transmission
53248|NCT03235297|Altitude|altitude
53249|NCT03235297|Diffusing capacity for carbon monoxide|diffusing capacity for carbon monoxide
53250|NCT03235297|COPD|copd
53251|NCT03235297|Pulmonary function testing|pulmonary function testing
53252|NCT03235258|HIV Infection|hiv infection
53253|NCT03235258|Adolescent|adolescent
53254|NCT03235245|cutaneous melanoma|cutaneous melanoma
53255|NCT03235245|mucosal melanoma|mucosal melanoma
53256|NCT03235245|BRAF mutation|braf mutation
53257|NCT03235206|Police Officers|police officers
53258|NCT03235154|HCV|hcv
53259|NCT03235154|suboxone|suboxone
53260|NCT03235154|epclusa|epclusa
53261|NCT03235154|psychiatrist|psychiatrist
53262|NCT03235141|Azithromycin eye drops|azithromycin eye drops
53263|NCT03235141|Local Pharmacokinetics|local pharmacokinetics
53264|NCT03235063|Dilated cardiomyopathy|dilated cardiomyopathy
53265|NCT03235063|registry|registry
53266|NCT03235063|heart failure|heart failure
53267|NCT03235063|pregnancy|pregnancy
53268|NCT03234959|Early Intervention|early intervention
53269|NCT03234959|Cerebral Palsy|cerebral palsy
53270|NCT03234959|CareToy Intervention|caretoy intervention
53271|NCT03234959|Infant Massage|infant massage
53272|NCT03234959|Information Communication Technology|information communication technology
53273|NCT03234946|Diabetes|diabetes
53274|NCT03234946|Family|family
53275|NCT03234946|Impaired fasting-glucose|impaired fasting-glucose
53276|NCT03234946|Carbohydrate intolerance|carbohydrate intolerance
53277|NCT03234933|Cancer|cancer
53278|NCT03234920|cirrhosis|cirrhosis
53279|NCT03234920|liver transplantation|liver transplantation
53280|NCT03234920|HMB|hmb
53281|NCT03234907|Drug therapy|drug therapy
53282|NCT03234881|Recurrent Binge Eating|recurrent binge eating
53283|NCT03234881|Cognitive Behavioral Therapist|cognitive behavioral therapist
53284|NCT03234881|Weight reduction|weight reduction
53285|NCT03234842|Esophagus|esophagus
53286|NCT03234842|Proton|proton
53287|NCT03234842|Radiation|radiation
53288|NCT03234829|arch lengths, space analysis, arch prediction|arch lengths, space analysis, arch prediction
53289|NCT03234790|Diesel Exhaust|diesel exhaust
53290|NCT03234790|Air Pollution|air pollution
53291|NCT03234790|Airway Responsiveness|airway responsiveness
53292|NCT03234790|Proteomics|proteomics
53293|NCT03234790|Urine PAH Metabolites|urine pah metabolites
53294|NCT03234764|IgE|ige
53295|NCT03234764|Allergy|allergy
53296|NCT03234764|Tolerance|tolerance
53297|NCT03234764|Immunotherapy|immunotherapy
53298|NCT03234764|Desensitization|desensitization
53299|NCT03234751|human B-type natriuretic peptide|human b-type natriuretic peptide
53300|NCT03234725|Blue light imaging|blue light imaging
53301|NCT03234725|Linked color imaging|linked color imaging
53302|NCT03234725|Optical histology|optical histology
53303|NCT03234725|Adenoma detection rate|adenoma detection rate
53304|NCT03234725|Variable stiffness|variable stiffness
53305|NCT03234725|Deep learning|deep learning
53306|NCT03234712|Advanced Solid Tumors|advanced solid tumors
53307|NCT03234712|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
53308|NCT03234712|EGFR ligands|egfr ligands
53309|NCT03234712|Colorectal carcinoma (CRC)|colorectal carcinoma (crc)
53310|NCT03234712|Squamous cell carcinoma of the head and neck (HNSCC)|squamous cell carcinoma of the head and neck (hnscc)
53311|NCT03234712|Squamous non-small cell lung cancer (sqNSCLC)|squamous non-small cell lung cancer (sqnsclc)
53312|NCT03234712|Glioblastoma (GBM)|glioblastoma (gbm)
53313|NCT03234712|Cancer|cancer
53314|NCT03234712|Overexpression of Epidermal Growth Factor Receptor (EGFR) or EGFR Ligands|overexpression of epidermal growth factor receptor (egfr) or egfr ligands
53315|NCT03234686|Dementia|dementia
53316|NCT03234686|Alzheimer's Disease|alzheimer's disease
53317|NCT03234621|protective ventilation strategy|protective ventilation strategy
53318|NCT03234608|Healthcare services|healthcare services
53319|NCT03234608|Adults|adults
53320|NCT03234595|Cerebraca wafer|cerebraca wafer
53321|NCT03234595|Recurrent high grade glioma|recurrent high grade glioma
53322|NCT03234595|anaplastic astrocytoma|anaplastic astrocytoma
53323|NCT03234595|glioblastoma multiforme|glioblastoma multiforme
53324|NCT03234569|sonohysterosalpingography|sonohysterosalpingography
53325|NCT03234569|hysterosalpingogagraphy|hysterosalpingogagraphy
53326|NCT03234543|Abdominal Surgery|abdominal surgery
53327|NCT03234543|Pre-conditioning|pre-conditioning
53328|NCT03234543|Remote Ischemic Conditioning|remote ischemic conditioning
53329|NCT03234543|Post-Operative Complications|post-operative complications
53330|NCT03234543|Acute Phase Response|acute phase response
53331|NCT03234530|albuminuria|albuminuria
53332|NCT03234530|sleep apnea|sleep apnea
53333|NCT03234530|particulate matter|particulate matter
53334|NCT03234530|renal injury|renal injury
53335|NCT03234491|Diabetes|diabetes
53336|NCT03234491|Insulin|insulin
53337|NCT03234478|deep brain stimulation|deep brain stimulation
53338|NCT03234478|cognition|cognition
53339|NCT03234478|young onset Parkinson disease|young onset parkinson disease
53340|NCT03234452|Lactoflorene plus|lactoflorene plus
53341|NCT03234452|Bifidobacterium animalis subsp. lactis, BB-12®|bifidobacterium animalis subsp. lactis, bb-12®
53342|NCT03234452|Lactobacillus acidophilus, LA-5®|lactobacillus acidophilus, la-5®
53343|NCT03234452|Lactobacillus paracasei subsp. paracasei, L. CASEI 431®|lactobacillus paracasei subsp. paracasei, l. casei 431®
53344|NCT03234452|Inflammation|inflammation
53345|NCT03234452|gut permeability|gut permeability
53346|NCT03234452|disbiosis|disbiosis
53347|NCT03234452|probiotic|probiotic
53348|NCT03234452|IgA|iga
53349|NCT03234452|IL10|il10
53350|NCT03234439|digital behavioral health|digital behavioral health
53351|NCT03234413|Botulinum Toxin-A|botulinum toxin-a
53352|NCT03234374|Pharmacokinetics|pharmacokinetics
53353|NCT03234374|Bioavailability|bioavailability
53354|NCT03234374|Safety|safety
53355|NCT03234374|Bupivacaine|bupivacaine
53356|NCT03234374|Collagen|collagen
53357|NCT03234374|Implant|implant
53358|NCT03234374|Marcaine|marcaine
53359|NCT03234374|Hernioplasty|hernioplasty
53360|NCT03234361|Hypertension|hypertension
53361|NCT03234361|High phosphorus diet|high phosphorus diet
53362|NCT03234361|FGF 23|fgf 23
53363|NCT03234361|24 hour ambulatory blood pressure|24 hour ambulatory blood pressure
53364|NCT03234361|Muscle sympathetic nerve|muscle sympathetic nerve
53365|NCT03234348|biodegradable stent|biodegradable stent
53366|NCT03234348|STEMI|stemi
53367|NCT03234348|Magnesium bioresorbable|magnesium bioresorbable
53368|NCT03234348|Vasomotion|vasomotion
53369|NCT03234335|Multiple Myeloma|multiple myeloma
53370|NCT03234335|Renal Failure|renal failure
53371|NCT03234335|Autologous Hematopoietic Stem Cell Transplantation (ASCT)|autologous hematopoietic stem cell transplantation (asct)
53372|NCT03234335|Melphalan|melphalan
53373|NCT03234322|prevention|prevention
53374|NCT03234322|risk score|risk score
53375|NCT03234322|behaviour|behaviour
53376|NCT03234322|physical activity|physical activity
53377|NCT03234296|uncomplicated acute appendicitis|uncomplicated acute appendicitis
53378|NCT03234296|complicated acute appendicitis|complicated acute appendicitis
53379|NCT03234296|antibiotic therapy|antibiotic therapy
53380|NCT03234296|spontaneous resolution|spontaneous resolution
53381|NCT03234283|Intubation|intubation
53382|NCT03234270|Heat stress, pilots|heat stress, pilots
53383|NCT03234257|Carotid stenosis|carotid stenosis
53384|NCT03234257|stiffness|stiffness
53385|NCT03234257|ultrafast ultrasound imaging|ultrafast ultrasound imaging
53386|NCT03234257|Plaque stability|plaque stability
53387|NCT03234218|vitamin D, liver transplantation|vitamin d, liver transplantation
53388|NCT03234192|extensor carpi radialis brevis|extensor carpi radialis brevis
53389|NCT03234192|Therapeutic Ultrasound|therapeutic ultrasound
53390|NCT03234192|Astym Treatment Technique|astym treatment technique
53391|NCT03234192|Graston Treatment Technique|graston treatment technique
53392|NCT03234179|Non small cell lung cancer|non small cell lung cancer
53393|NCT03234179|Genetic study|genetic study
53394|NCT03234166|Acute necrotizing pancreatitis Acute pancreatitis Pancreas disease Sepsis Infection Drainage Catheters Antibiotics Multiresistant organism|acute necrotizing pancreatitis acute pancreatitis pancreas disease sepsis infection drainage catheters antibiotics multiresistant organism
53395|NCT03234153|Muscle-invasive Bladder Cancer|muscle-invasive bladder cancer
53396|NCT03234153|Ineligible for Cisplatin-based Chemotherapy|ineligible for cisplatin-based chemotherapy
53397|NCT03234153|Durvalumab|durvalumab
53398|NCT03234153|Tremelimumab|tremelimumab
53399|NCT03234114|new generation drug eluting stent (DES)|new generation drug eluting stent (des)
53400|NCT03234114|triple antithrombotic therapy (TT)|triple antithrombotic therapy (tt)
53401|NCT03234114|pragmatic clinical trial (PCT)|pragmatic clinical trial (pct)
53402|NCT03234101|Systematic review and meta-analysis|systematic review and meta-analysis
53403|NCT03234101|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
53404|NCT03234101|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
53405|NCT03234101|Clinical practice guidelines|clinical practice guidelines
53406|NCT03234101|Prospective cohort studies|prospective cohort studies
53407|NCT03234101|Low-risk lifestyle behaviours|low-risk lifestyle behaviours
53408|NCT03234101|Healthy Diet|healthy diet
53409|NCT03234101|Exercise|exercise
53410|NCT03234101|Physical activity|physical activity
53411|NCT03234101|Body weight|body weight
53412|NCT03234101|Sleep|sleep
53413|NCT03234101|alcohol|alcohol
53414|NCT03234101|Smoking|smoking
53415|NCT03234101|Cardiovascular disease|cardiovascular disease
53416|NCT03234101|Coronary heart disease|coronary heart disease
53417|NCT03234101|Stroke|stroke
53418|NCT03234101|Diabetes|diabetes
53419|NCT03234101|Cancer|cancer
53420|NCT03234101|Cardiovascular disease mortality|cardiovascular disease mortality
53421|NCT03234101|Coronary heart disease mortality|coronary heart disease mortality
53422|NCT03234101|Stroke mortality|stroke mortality
53423|NCT03234101|All-cause mortality|all-cause mortality
53424|NCT03234088|Congestive Heart Failure|congestive heart failure
53425|NCT03234088|Heart Failure|heart failure
53426|NCT03234088|Home telemonitoring|home telemonitoring
53427|NCT03234088|Telehealth|telehealth
53428|NCT03234088|HF Disease Management|hf disease management
53429|NCT03234088|Heart failure remote self management|heart failure remote self management
53430|NCT03234049|pediatric|pediatric
53431|NCT03234049|checklist|checklist
53432|NCT03234049|cognitive aid|cognitive aid
53433|NCT03234036|GSK2838232|gsk2838232
53434|NCT03234036|safety|safety
53435|NCT03234036|food effect|food effect
53436|NCT03234036|capsule|capsule
53437|NCT03234036|healthy|healthy
53438|NCT03234036|PK|pk
53439|NCT03234036|tablet|tablet
53440|NCT03233984|bisphenol-A|bisphenol-a
53441|NCT03233984|prevention|prevention
53442|NCT03233984|endocrine disruptors|endocrine disruptors
53443|NCT03233932|CKD-841|ckd-841
53444|NCT03233932|Leuplin|leuplin
53445|NCT03233932|Postmenopausal|postmenopausal
53446|NCT03233919|Remote Ischemic Conditioning|remote ischemic conditioning
53447|NCT03233893|based dentin substitute|based dentin substitute
53448|NCT03233893|dentin bridge|dentin bridge
53449|NCT03233893|tertiary dentin|tertiary dentin
53450|NCT03233893|indirect pulp treatment|indirect pulp treatment
53451|NCT03233880|chlamydia|chlamydia
53452|NCT03233880|prevention|prevention
53453|NCT03233841|Natural History Study|natural history study
53454|NCT03233841|Observational Study|observational study
53455|NCT03233841|Prospective Study|prospective study
53456|NCT03233841|Retrospective Study|retrospective study
53457|NCT03233841|Farber Disease|farber disease
53458|NCT03233841|Farber's Disease|farber's disease
53459|NCT03233841|ASAH1|asah1
53460|NCT03233841|Subcutaneous Nodules|subcutaneous nodules
53461|NCT03233841|Lysosomal Storage Disease|lysosomal storage disease
53462|NCT03233841|Lysosomal Storage Disease, Nervous System|lysosomal storage disease, nervous system
53463|NCT03233841|Metabolic Diseases|metabolic diseases
53464|NCT03233841|Lipid Metabolism Disorders|lipid metabolism disorders
53465|NCT03233841|Lipidoses|lipidoses
53466|NCT03233841|Sphingolipidoses|sphingolipidoses
53467|NCT03233841|Genetic Disease, Inborn|genetic disease, inborn
53468|NCT03233841|Musculoskeletal Diseases|musculoskeletal diseases
53469|NCT03233841|Connective Tissue Diseases|connective tissue diseases
53470|NCT03233841|Central Nervous System Diseases|central nervous system diseases
53471|NCT03233841|Brain Diseases, Metabolic, Inborn|brain diseases, metabolic, inborn
53472|NCT03233841|Brain Diseases, Metabolic|brain diseases, metabolic
53473|NCT03233841|Brain Diseases, Inborn|brain diseases, inborn
53474|NCT03233841|Brain Diseases|brain diseases
53475|NCT03233841|Infant, Newborn Diseases|infant, newborn diseases
53476|NCT03233841|Inborn Errors of Metabolism|inborn errors of metabolism
53477|NCT03233841|Inherited Metabolic Disease|inherited metabolic disease
53478|NCT03233828|Intralesional Injection|intralesional injection
53479|NCT03233828|Immunotherapy|immunotherapy
53480|NCT03233828|Immune Response|immune response
53481|NCT03233828|Interleukin-2 (Aldesleukin)|interleukin-2 (aldesleukin)
53482|NCT03233828|Tumor Infiltration|tumor infiltration
53483|NCT03233828|Metastasis Prevention|metastasis prevention
53484|NCT03233815|Inhaled anesthesia|inhaled anesthesia
53485|NCT03233815|Total intravenous anesthesia|total intravenous anesthesia
53486|NCT03233802|Alcohol Use Disorder|alcohol use disorder
53487|NCT03233802|Treatment|treatment
53488|NCT03233802|Cognitive-Behavioral Treatment|cognitive-behavioral treatment
53489|NCT03233802|Individualized Treatment|individualized treatment
53490|NCT03233776|Anakinra|anakinra
53491|NCT03233776|Mucositis|mucositis
53492|NCT03233776|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
53493|NCT03233776|Febrile neutropenia|febrile neutropenia
53494|NCT03233737|local anesthesia|local anesthesia
53495|NCT03233737|pain tolerance|pain tolerance
53496|NCT03233737|experimental pain|experimental pain
53497|NCT03233724|PD-L1|pd-l1
53498|NCT03233724|Demethylating Agents and Histone Deacetylase (HDAC) Inhibitors|demethylating agents and histone deacetylase (hdac) inhibitors
53499|NCT03233724|DNA Hypomethylating Agent|dna hypomethylating agent
53500|NCT03233724|Cytidine Deaminase|cytidine deaminase
53501|NCT03233724|Checkpoint Inhibitor|checkpoint inhibitor
53502|NCT03233685|Tennis|tennis
53503|NCT03233685|Reaction Time|reaction time
53504|NCT03233685|Visual training|visual training
53505|NCT03233672|adjuvant|adjuvant
53506|NCT03233672|hypofractionation|hypofractionation
53507|NCT03233672|IMRT|imrt
53508|NCT03233672|phase I-II|phase i-ii
53509|NCT03233672|prostate neoplasms|prostate neoplasms
53510|NCT03233672|radiotherapy|radiotherapy
53511|NCT03233659|Allogeneic Stem Cell Transplantation, APCs, GVHD|allogeneic stem cell transplantation, apcs, gvhd
53512|NCT03233646|OCT angiography|oct angiography
53513|NCT03233646|Optical Coherence Tomography|optical coherence tomography
53514|NCT03233646|Vessel Density|vessel density
53515|NCT03233646|Superficial Capillary Plexus|superficial capillary plexus
53516|NCT03233646|retinal microvasculature|retinal microvasculature
53517|NCT03233646|OCTA|octa
53518|NCT03233633|pain management|pain management
53519|NCT03233633|terminally ill|terminally ill
53520|NCT03233620|knee arthroplasty|knee arthroplasty
53521|NCT03233620|working-age|working-age
53522|NCT03233620|patient related outcome measures|patient related outcome measures
53523|NCT03233607|Postpartum|postpartum
53524|NCT03233607|Hemoglobin|hemoglobin
53525|NCT03233594|Chronic Pain Syndrome|chronic pain syndrome
53526|NCT03233594|Chronic Pain|chronic pain
53527|NCT03233594|Chiropractic|chiropractic
53528|NCT03233594|PET|pet
53529|NCT03233594|MRI|mri
53530|NCT03233594|Positron emission tomography|positron emission tomography
53531|NCT03233594|Magnetic resonance imaging|magnetic resonance imaging
53532|NCT03233542|Cognitive biases|cognitive biases
53533|NCT03233542|Associations|associations
53534|NCT03233542|Interpretations|interpretations
53535|NCT03233542|Physiological and biological markers|physiological and biological markers
53536|NCT03233529|atopic dermatitis|atopic dermatitis
53537|NCT03233529|atopic eczema|atopic eczema
53538|NCT03233529|eczema|eczema
53539|NCT03233529|topical treatment|topical treatment
53540|NCT03233529|skin diseases|skin diseases
53541|NCT03233529|phosphodiesterase-4 inhibitor|phosphodiesterase-4 inhibitor
53542|NCT03233529|PDE-4 inhibitor|pde-4 inhibitor
53543|NCT03233529|crisaborole|crisaborole
53544|NCT03233516|Community-acquired pneumonia|community-acquired pneumonia
53545|NCT03233516|Pediatrics|pediatrics
53546|NCT03233516|Etiology|etiology
53547|NCT03233516|Point-of-care test|point-of-care test
53548|NCT03233516|MxA|mxa
53549|NCT03233516|CRP|crp
53550|NCT03233516|Procalcitonin|procalcitonin
53551|NCT03233516|Infectious diseases|infectious diseases
53552|NCT03233516|Respiratory viruses|respiratory viruses
53553|NCT03233516|Pediatric asthma|pediatric asthma
53554|NCT03233490|CPR training|cpr training
53555|NCT03233490|students|students
53556|NCT03233490|willingness|willingness
53557|NCT03233477|Posner Schlossman Syndrome|posner schlossman syndrome
53558|NCT03233477|cytokine expression|cytokine expression
53559|NCT03233477|cytomegalovirus|cytomegalovirus
53560|NCT03233438|Critical Pathways|critical pathways
53561|NCT03233438|Health Facilities|health facilities
53562|NCT03233438|Clinical Protocols|clinical protocols
53563|NCT03233438|Patient Satisfaction|patient satisfaction
53564|NCT03233438|Absenteeism|absenteeism
53565|NCT03233438|Anti-Bacterial Agents|anti-bacterial agents
53566|NCT03233438|Quality of Life|quality of life
53567|NCT03233438|Economics, Medical|economics, medical
53568|NCT03233438|Health Resources|health resources
53569|NCT03233438|Health resource utilization|health resource utilization
53570|NCT03233438|Acute bacterial skin and skin structure infection (ABSSSI)|acute bacterial skin and skin structure infection (absssi)
53571|NCT03233425|Child|child
53572|NCT03233425|adolescent|adolescent
53573|NCT03233425|co-morbidity|co-morbidity
53574|NCT03233425|psychology|psychology
53575|NCT03233425|motivation|motivation
53576|NCT03233425|physical activity|physical activity
53577|NCT03233425|eating disorders|eating disorders
53578|NCT03233425|quality of life|quality of life
53579|NCT03233425|therapy|therapy
53580|NCT03233425|predictors|predictors
53581|NCT03233412|high grade cervical intraepithelial neoplasia|high grade cervical intraepithelial neoplasia
53582|NCT03233412|Immunomodulatory treatment|immunomodulatory treatment
53583|NCT03233399|Electroencephalography|electroencephalography
53584|NCT03233399|Magnetoencephalography|magnetoencephalography
53585|NCT03233399|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
53586|NCT03233373|Nasal Airway Obstruction|nasal airway obstruction
53587|NCT03233373|Devices|devices
53588|NCT03233373|Imaging, Diagnostic|imaging, diagnostic
53589|NCT03233373|Computer-Assisted Image Processing|computer-assisted image processing
53590|NCT03233373|Thermal Analysis, Differential|thermal analysis, differential
53591|NCT03233321|Dry cold application|dry cold application
53592|NCT03233321|Pain|pain
53593|NCT03233321|Bruise|bruise
53594|NCT03233321|Subcutaneous injection|subcutaneous injection
53595|NCT03233243|Rosuvastatin|rosuvastatin
53596|NCT03233243|Sodium fluoride|sodium fluoride
53597|NCT03233243|Positron-emission tomography|positron-emission tomography
53598|NCT03233230|Rheumatoid Arthritis|rheumatoid arthritis
53599|NCT03233230|American College of Rheumatology|american college of rheumatology
53600|NCT03233230|High-sensitivity C-reactive protein|high-sensitivity c-reactive protein
53601|NCT03233230|Bruton's tyrosine kinase|bruton's tyrosine kinase
53602|NCT03233217|Influenza|influenza
53603|NCT03233191|Digital Mammography|digital mammography
53604|NCT03233191|Breast Tomography|breast tomography
53605|NCT03233191|Screening Mammography|screening mammography
53606|NCT03233191|TMIST|tmist
53607|NCT03233165|laser therapy|laser therapy
53608|NCT03233165|recurrence|recurrence
53609|NCT03233165|leukoplakia|leukoplakia
53610|NCT03233165|precancerous lesion|precancerous lesion
53611|NCT03233152|recurrence|recurrence
53612|NCT03233139|Japanese patients|japanese patients
53613|NCT03233113|Exposure therapy|exposure therapy
53614|NCT03233113|Cognitive-behavioral therapy|cognitive-behavioral therapy
53615|NCT03233113|Anxiety disorders|anxiety disorders
53616|NCT03233100|FMT|fmt
53617|NCT03233100|gut microbiota|gut microbiota
53618|NCT03233100|gut-brain disorder|gut-brain disorder
53619|NCT03233100|constipation|constipation
53620|NCT03233100|depression|depression
53621|NCT03233100|anxiety|anxiety
53622|NCT03233074|Myelodysplastic Syndromes|myelodysplastic syndromes
53623|NCT03233074|Acute Myeloid Leukemia|acute myeloid leukemia
53624|NCT03233074|Bone Marrow|bone marrow
53625|NCT03233074|Mesenchymal stromal cell|mesenchymal stromal cell
53626|NCT03233074|Healthy donor|healthy donor
53627|NCT03233061|Obesity; cardiorespiratory fitness; oxygen uptake; household activities; physical activity; sedentary; intensity; obese women|obesity; cardiorespiratory fitness; oxygen uptake; household activities; physical activity; sedentary; intensity; obese women
53628|NCT03233035|Ketamine-Intranasal-Acute pain-Emergency departement|ketamine-intranasal-acute pain-emergency departement
53629|NCT03232996|Balance|balance
53630|NCT03232996|Gait|gait
53631|NCT03232957|Intrathecal morphine, total knee arthroplasty|intrathecal morphine, total knee arthroplasty
53632|NCT03232931|auditory|auditory
53633|NCT03232931|tactile|tactile
53634|NCT03232931|mother's voice|mother's voice
53635|NCT03232931|multisensory|multisensory
53636|NCT03232892|NSCLC|nsclc
53637|NCT03232892|NF-1 mutant|nf-1 mutant
53638|NCT03232879|Motor Imagery|motor imagery
53639|NCT03232879|Action Observation|action observation
53640|NCT03232879|Heart Rate|heart rate
53641|NCT03232879|Respiration Rate|respiration rate
53642|NCT03232879|Electrodermal Activity|electrodermal activity
53643|NCT03232866|Exercise Movement Techniques|exercise movement techniques
53644|NCT03232866|Exercise|exercise
53645|NCT03232866|Monitoring, Physiologic|monitoring, physiologic
53646|NCT03232866|Heart Rate|heart rate
53647|NCT03232866|Autonomic Nervous System|autonomic nervous system
53648|NCT03232866|Heart rate variability|heart rate variability
53649|NCT03232853|medical error in anesthesia|medical error in anesthesia
53650|NCT03232853|drug error in anesthesia|drug error in anesthesia
53651|NCT03232840|wrong site surgery in regional anesthesia|wrong site surgery in regional anesthesia
53652|NCT03232801|hypoactive sexual desire disorder|hypoactive sexual desire disorder
53653|NCT03232801|female sexual dysfunction|female sexual dysfunction
53654|NCT03232801|low libido|low libido
53655|NCT03232801|female sexual interest-arousal disorder|female sexual interest-arousal disorder
53656|NCT03232801|low desire|low desire
53657|NCT03232801|sexual dysfunction|sexual dysfunction
53658|NCT03232788|Periodontal disease|periodontal disease
53659|NCT03232788|Recession|recession
53660|NCT03232788|Black space|black space
53661|NCT03232775|visual pedagogy|visual pedagogy
53662|NCT03232723|Magnetoencephalography|magnetoencephalography
53663|NCT03232723|Whole-cortex MEG System (with optional EEG)|whole-cortex meg system (with optional eeg)
53664|NCT03232554|Iron-Deficiency Anemia|iron-deficiency anemia
53665|NCT03232554|Buxue Yimu Pills|buxue yimu pills
53666|NCT03232554|Ferrous Sulfate|ferrous sulfate
53667|NCT03232554|clinical observations|clinical observations
53668|NCT03232554|adult women|adult women
53669|NCT03232554|Metabonomics|metabonomics
53670|NCT03232515|Bioimpedance Vector Analysis (BIVA)|bioimpedance vector analysis (biva)
53671|NCT03232515|Chronic Renal Failure|chronic renal failure
53672|NCT03232515|Dialysis|dialysis
53673|NCT03232515|Dry weight|dry weight
53674|NCT03232515|Blood Pressure|blood pressure
53675|NCT03232437|HbA1c|hba1c
53676|NCT03232411|prostate disease|prostate disease
53677|NCT03232411|prostatic neoplasm|prostatic neoplasm
53678|NCT03232411|biobank|biobank
53679|NCT03232411|prostate cancer in black males|prostate cancer in black males
53680|NCT03232411|biospecimen|biospecimen
53681|NCT03232411|smoking and the aggressiveness of prostate cancer|smoking and the aggressiveness of prostate cancer
53682|NCT03232372|Bone loss, dental implant desing|bone loss, dental implant desing
53683|NCT03232346|buprenorphine|buprenorphine
53684|NCT03232346|naltrexone|naltrexone
53685|NCT03232346|Vivitrol|vivitrol
53686|NCT03232346|opioid dependence|opioid dependence
53687|NCT03232307|Hematopoietic/Lymphoid Cancer|hematopoietic/lymphoid cancer
53688|NCT03232307|Mantle Cell Lymphoma|mantle cell lymphoma
53689|NCT03232307|MCL|mcl
53690|NCT03232307|Newly-diagnosed|newly-diagnosed
53691|NCT03232307|Ibrutinib|ibrutinib
53692|NCT03232307|PCI-32765|pci-32765
53693|NCT03232307|Imbruvica|imbruvica
53694|NCT03232307|Rituximab|rituximab
53695|NCT03232307|Rituxan|rituxan
53696|NCT03232307|Lenalidomide|lenalidomide
53697|NCT03232307|CC-5013|cc-5013
53698|NCT03232307|Revlimid|revlimid
53699|NCT03232307|Dexamethasone|dexamethasone
53700|NCT03232307|Decadron|decadron
53701|NCT03232294|fetal macrosomia|fetal macrosomia
53702|NCT03232294|fetal abdominal wall thickness|fetal abdominal wall thickness
53703|NCT03232294|subcutaneous adipose tissue|subcutaneous adipose tissue
53704|NCT03232268|Microtransplantation|microtransplantation
53705|NCT03232268|Myeloid Hemopathy|myeloid hemopathy
53706|NCT03232203|Human leukocyte antigen|human leukocyte antigen
53707|NCT03232203|Key Risk Message|key risk message
53708|NCT03232203|ADA-SCID|ada-scid
53709|NCT03232203|Health care providers|health care providers
53710|NCT03232190|prematurity|prematurity
53711|NCT03232190|psychomotor development|psychomotor development
53712|NCT03232190|parent empowerment|parent empowerment
53713|NCT03232190|e-health|e-health
53714|NCT03232190|parental support|parental support
53715|NCT03232190|post discharge follow-up|post discharge follow-up
53716|NCT03232164|Prostate Cancer|prostate cancer
53717|NCT03232164|Prostate neoplasm|prostate neoplasm
53718|NCT03232151|Stroke|stroke
53719|NCT03232138|Sulforaphane|sulforaphane
53720|NCT03232138|Chemoprevention|chemoprevention
53721|NCT03232138|Former Smokers|former smokers
53722|NCT03232112|Alcohol|alcohol
53723|NCT03232112|Addiction|addiction
53724|NCT03232112|Glucagon Like Peptide-1|glucagon like peptide-1
53725|NCT03232112|GLP-1|glp-1
53726|NCT03232099|trimethylamine-N-oxide|trimethylamine-n-oxide
53727|NCT03232099|TMAO|tmao
53728|NCT03232099|Gut Microbiota|gut microbiota
53729|NCT03232099|Gut Flora|gut flora
53730|NCT03232099|Atherosclerosis|atherosclerosis
53731|NCT03232099|Wine|wine
53732|NCT03232099|Red Wine|red wine
53733|NCT03232086|Controlled Human Exposure Study|controlled human exposure study
53734|NCT03232086|Cardiovascular|cardiovascular
53735|NCT03232047|Computerized Working Memory Training|computerized working memory training
53736|NCT03232047|Mild Cognitive Impairment|mild cognitive impairment
53737|NCT03232034|Calcium citrate, dairy product, whey protein, appetite, metabolism|calcium citrate, dairy product, whey protein, appetite, metabolism
53738|NCT03232021|urinary bladder|urinary bladder
53739|NCT03232021|urinary catheters|urinary catheters
53740|NCT03232021|pregabalin|pregabalin
53741|NCT03232008|Blood glucose|blood glucose
53742|NCT03232008|Appetite|appetite
53743|NCT03231995|Severe influenza|severe influenza
53744|NCT03231995|biomarkers|biomarkers
53745|NCT03231995|respiratory microbiome|respiratory microbiome
53746|NCT03231995|prognosis|prognosis
53747|NCT03231943|FTIH|ftih
53748|NCT03231943|Healthy|healthy
53749|NCT03231943|Tolerability|tolerability
53750|NCT03231943|Dose-escalation|dose-escalation
53751|NCT03231943|HIV-1|hiv-1
53752|NCT03231943|Safety|safety
53753|NCT03231943|PK|pk
53754|NCT03231943|GSK3640254|gsk3640254
53755|NCT03231943|Maturation inhibitor|maturation inhibitor
53756|NCT03231930|Diagnosis|diagnosis
53757|NCT03231930|Point of Care Diagnostics|point of care diagnostics
53758|NCT03231930|Hepatitis|hepatitis
53759|NCT03231826|Home monitoring|home monitoring
53760|NCT03231826|ECG|ecg
53761|NCT03231826|Myocardial Infarction|myocardial infarction
53762|NCT03231826|Arrythmia|arrythmia
53763|NCT03231813|irritant contact dermatitis|irritant contact dermatitis
53764|NCT03231813|sodium lauryl sulphate|sodium lauryl sulphate
53765|NCT03231813|emollients|emollients
53766|NCT03231813|transepidermal water loss|transepidermal water loss
53767|NCT03231800|Attention-Deficit Hyperactivity Disorder (ADHD)|attention-deficit hyperactivity disorder (adhd)
53768|NCT03231774|Echocardiography|echocardiography
53769|NCT03231774|Right heart catheterization|right heart catheterization
53770|NCT03231722|mFOLFOXIRI + Panitumumab|mfolfoxiri + panitumumab
53771|NCT03231722|RAS and BRAF wt|ras and braf wt
53772|NCT03231696|nerve block|nerve block
53773|NCT03231696|peripheral nerve stimulation|peripheral nerve stimulation
53774|NCT03231657|preeclampsia|preeclampsia
53775|NCT03231657|intrauterine growth restriction|intrauterine growth restriction
53776|NCT03231657|angiogenic factors|angiogenic factors
53777|NCT03231644|Fibrous Dysplasia|fibrous dysplasia
53778|NCT03231644|McCune-Albright Syndrome|mccune-albright syndrome
53779|NCT03231644|Mazabrauds|mazabrauds
53780|NCT03231644|FD/MAS|fd/mas
53781|NCT03231631|Exercise|exercise
53782|NCT03231631|Education|education
53783|NCT03231631|Stents|stents
53784|NCT03231631|Angioplasty|angioplasty
53785|NCT03231631|Cardiac Rehabilitation|cardiac rehabilitation
53786|NCT03231631|Cholesterol, HDL|cholesterol, hdl
53787|NCT03231631|Metabolic Equivalent|metabolic equivalent
53788|NCT03231618|dietary intake|dietary intake
53789|NCT03231618|cross-over intervention|cross-over intervention
53790|NCT03231618|energy expenditure|energy expenditure
53791|NCT03231540|Critical care|critical care
53792|NCT03231540|nutrition|nutrition
53793|NCT03231540|whey protein|whey protein
53794|NCT03231540|mechanical ventilation|mechanical ventilation
53795|NCT03231540|muscle function|muscle function
53796|NCT03231514|body composition|body composition
53797|NCT03231514|exercise performance|exercise performance
53798|NCT03231514|keto-adaptation|keto-adaptation
53799|NCT03231475|NSCLC|nsclc
53800|NCT03231475|EGFR-TKI|egfr-tki
53801|NCT03231449|routine care, evaluation, Africa, observatory|routine care, evaluation, africa, observatory
53802|NCT03231436|intrathecal bupivacaine|intrathecal bupivacaine
53803|NCT03231436|hyperbaric bupivacaine|hyperbaric bupivacaine
53804|NCT03231436|failed spinal|failed spinal
53805|NCT03231423|Obesity|obesity
53806|NCT03231423|VAS|vas
53807|NCT03231423|Pain|pain
53808|NCT03231423|Laparoscopy|laparoscopy
53809|NCT03231423|Bypass|bypass
53810|NCT03231410|arteriovenous fistula|arteriovenous fistula
53811|NCT03231410|maturation|maturation
53812|NCT03231410|monocyte adhesion|monocyte adhesion
53813|NCT03231410|vascular access|vascular access
53814|NCT03231397|Abdominal Aortic Aneurysm (AAA)|abdominal aortic aneurysm (aaa)
53815|NCT03231371|Orthotopic Heart Transplant|orthotopic heart transplant
53816|NCT03231345|Peripheral IV|peripheral iv
53817|NCT03231345|Internal jugular vein|internal jugular vein
53818|NCT03231345|IJ|ij
53819|NCT03231345|Peripheral IJ|peripheral ij
53820|NCT03231345|Ultrasound-guided IJ|ultrasound-guided ij
53821|NCT03231332|Helicobacter pylori|helicobacter pylori
53822|NCT03231332|Eradication|eradication
53823|NCT03231332|Microbiome|microbiome
53824|NCT03231332|ESBL|esbl
53825|NCT03231332|GIT|git
53826|NCT03231306|Neurofibroma, Plexiform|neurofibroma, plexiform
53827|NCT03231306|Genes, Neurofibromatosis|genes, neurofibromatosis
53828|NCT03231306|Peripheral nerve tumors|peripheral nerve tumors
53829|NCT03231306|Neurofibromatosis 1|neurofibromatosis 1
53830|NCT03231306|Neurofibromas|neurofibromas
53831|NCT03231280|knee|knee
53832|NCT03231267|Multiresistant enterobacteriaceae|multiresistant enterobacteriaceae
53833|NCT03231267|digestive colonization|digestive colonization
53834|NCT03231267|bacteriophages|bacteriophages
53835|NCT03231267|Admission in intensive care unit >72h|admission in intensive care unit >72h
53836|NCT03231267|Presence of at least 2 consecutive stools|presence of at least 2 consecutive stools
53837|NCT03231241|Headaches|headaches
53838|NCT03231241|Tension-Type Headache|tension-type headache
53839|NCT03231241|New Daily Persistent Headache (NDPH)|new daily persistent headache (ndph)
53840|NCT03231241|Migraine|migraine
53841|NCT03231202|Non-operative management|non-operative management
53842|NCT03231202|Splenic Injury|splenic injury
53843|NCT03231202|Blunt|blunt
53844|NCT03231202|Splenic artery embolization|splenic artery embolization
53845|NCT03231202|Trauma|trauma
53846|NCT03231189|Coronary artery disease|coronary artery disease
53847|NCT03231189|cardiac MRI|cardiac mri
53848|NCT03231189|heart failure|heart failure
53849|NCT03231176|Biliary Tract Neoplasms|biliary tract neoplasms
53850|NCT03231176|Bile Duct Neoplasms|bile duct neoplasms
53851|NCT03231176|Gallbladder Neoplasms|gallbladder neoplasms
53852|NCT03231085|Craniosynostosis|craniosynostosis
53853|NCT03231085|hemoglobin|hemoglobin
53854|NCT03231085|iron peros|iron peros
53855|NCT03231085|iron intravenous|iron intravenous
53856|NCT03231072|mechanical ventilation|mechanical ventilation
53857|NCT03231072|pleural effusion|pleural effusion
53858|NCT03231072|EIT|eit
53859|NCT03231059|Coronary artery disease|coronary artery disease
53860|NCT03231059|Percutaneous coronary intervention|percutaneous coronary intervention
53861|NCT03231059|Drug-eluting stent|drug-eluting stent
53862|NCT03231059|Antiplatelet drugs|antiplatelet drugs
53863|NCT03231059|Clinical event committee|clinical event committee
53864|NCT03231020|single ventricle|single ventricle
53865|NCT03231020|pediatric cardiology|pediatric cardiology
53866|NCT03231020|interstage|interstage
53867|NCT03231020|home monitoring|home monitoring
53868|NCT03231020|mHealth|mhealth
53869|NCT03230994|adenomyosis|adenomyosis
53870|NCT03230994|diagnosis|diagnosis
53871|NCT03230994|treatment|treatment
53872|NCT03230994|epidemiology|epidemiology
53873|NCT03230994|Complications|complications
53874|NCT03230981|biomechanics|biomechanics
53875|NCT03230981|cornea|cornea
53876|NCT03230981|optical coherence tomography|optical coherence tomography
53877|NCT03230981|vibrography|vibrography
53878|NCT03230981|brillouin microscopy|brillouin microscopy
53879|NCT03230968|Practical Approach to Lung Health|practical approach to lung health
53880|NCT03230968|Respiratory diseases|respiratory diseases
53881|NCT03230968|Mexico|mexico
53882|NCT03230955|Randomized clinical trial|randomized clinical trial
53883|NCT03230955|Hotlines|hotlines
53884|NCT03230942|patient education|patient education
53885|NCT03230942|arthritis|arthritis
53886|NCT03230942|knee|knee
53887|NCT03230942|arthroplasty|arthroplasty
53888|NCT03230942|gait|gait
53889|NCT03230929|EMG, BIS, phase lag entropy|emg, bis, phase lag entropy
53890|NCT03230903|Multiple Sclerosis|multiple sclerosis
53891|NCT03230903|Telerehabilitation|telerehabilitation
53892|NCT03230903|Physical rehabilitation|physical rehabilitation
53893|NCT03230890|PTSD|ptsd
53894|NCT03230890|military|military
53895|NCT03230890|neurotechnology|neurotechnology
53896|NCT03230890|HIRREM|hirrem
53897|NCT03230890|allostasis|allostasis
53898|NCT03230890|heart rate variability|heart rate variability
53899|NCT03230890|baroreflex sensitivity|baroreflex sensitivity
53900|NCT03230890|closed loop|closed loop
53901|NCT03230890|acoustic stimulation|acoustic stimulation
53902|NCT03230890|neural oscillations|neural oscillations
53903|NCT03230890|autonomic|autonomic
53904|NCT03230890|hyperarousal|hyperarousal
53905|NCT03230864|Treatment-resistant schizophrenia|treatment-resistant schizophrenia
53906|NCT03230864|Lu AF35700|lu af35700
53907|NCT03230851|Light Transmittance Aggregometry|light transmittance aggregometry
53908|NCT03230851|Indobufen|indobufen
53909|NCT03230851|Aspirin|aspirin
53910|NCT03230851|Plasma Thromboxane|plasma thromboxane
53911|NCT03230851|Urine 11-dehydro thromboxane|urine 11-dehydro thromboxane
53912|NCT03230825|incomplete abortion|incomplete abortion
53913|NCT03230825|retained products of conception|retained products of conception
53914|NCT03230825|combined oral contraceptives|combined oral contraceptives
53915|NCT03230825|ultrasound|ultrasound
53916|NCT03230812|Insulin sensitivity|insulin sensitivity
53917|NCT03230812|Metabolic flexibility|metabolic flexibility
53918|NCT03230799|dense cataract|dense cataract
53919|NCT03230799|lens-shell technique|lens-shell technique
53920|NCT03230799|secondary intraocular lens implantation|secondary intraocular lens implantation
53921|NCT03230786|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
53922|NCT03230786|KBP-042|kbp-042
53923|NCT03230760|acupuncture|acupuncture
53924|NCT03230760|breast engorgement|breast engorgement
53925|NCT03230760|lactation|lactation
53926|NCT03230734|prostate cancer|prostate cancer
53927|NCT03230734|castration-resistant prostate cancer|castration-resistant prostate cancer
53928|NCT03230734|metastatic prostate cancer|metastatic prostate cancer
53929|NCT03230734|bone only metastatic prostate cancer|bone only metastatic prostate cancer
53930|NCT03230734|radium-223|radium-223
53931|NCT03230734|Docetaxel|docetaxel
53932|NCT03230721|laser|laser
53933|NCT03230721|HoLEP|holep
53934|NCT03230721|ThuLEP|thulep
53935|NCT03230721|Thulium|thulium
53936|NCT03230721|Thulium-fiber|thulium-fiber
53937|NCT03230721|BPH|bph
53938|NCT03230721|EEP|eep
53939|NCT03230721|monopolar enucleation|monopolar enucleation
53940|NCT03230708|Microparticles|microparticles
53941|NCT03230708|Erythrocytes|erythrocytes
53942|NCT03230708|Methotrexate|methotrexate
53943|NCT03230695|stroke|stroke
53944|NCT03230695|robotic therapy|robotic therapy
53945|NCT03230695|transcranial direct current stimulation|transcranial direct current stimulation
53946|NCT03230682|early improvement|early improvement
53947|NCT03230682|antidepressants|antidepressants
53948|NCT03230682|major depression diorder|major depression diorder
53949|NCT03230682|resting-state fMRI|resting-state fmri
53950|NCT03230669|substance abuse|substance abuse
53951|NCT03230669|addiction|addiction
53952|NCT03230669|etherapy|etherapy
53953|NCT03230591|Fabry's disease|fabry's disease
53954|NCT03230591|Agalsidase Alfa|agalsidase alfa
53955|NCT03230591|Cardiomyopathy|cardiomyopathy
53956|NCT03230591|Enzyme replacement therapy|enzyme replacement therapy
53957|NCT03230591|Diastolic stress echocardiography|diastolic stress echocardiography
53958|NCT03230591|LV vortex flow|lv vortex flow
53959|NCT03230591|Cardiac MRI|cardiac mri
53960|NCT03230578|Pharmacists|pharmacists
53961|NCT03230578|Prescriptions|prescriptions
53962|NCT03230513|vertigo|vertigo
53963|NCT03230513|benign paroxysmal positional vertigo|benign paroxysmal positional vertigo
53964|NCT03230513|particle repositioning manoeuvre|particle repositioning manoeuvre
53965|NCT03230500|computer guided|computer guided
53966|NCT03230500|immediate implant|immediate implant
53967|NCT03230500|patient satisfaction|patient satisfaction
53968|NCT03230461|CPR|cpr
53969|NCT03230461|Basic life support|basic life support
53970|NCT03230448|Acute alcoholism|acute alcoholism
53971|NCT03230435|anorexia nervosa, health-related quality of life|anorexia nervosa, health-related quality of life
53972|NCT03230422|infant, laryngoscopes, pediatrics|infant, laryngoscopes, pediatrics
53973|NCT03230409|Tuberculosis, Latent Tuberculosis Infection, Adherence, Nursing, Pediatrics, Public Health.|tuberculosis, latent tuberculosis infection, adherence, nursing, pediatrics, public health.
53974|NCT03230396|vitamins|vitamins
53975|NCT03230396|dietary supplements|dietary supplements
53976|NCT03230396|chewing gum|chewing gum
53977|NCT03230396|pharmacokinetics|pharmacokinetics
53978|NCT03230396|healthy human subjects|healthy human subjects
53979|NCT03230370|intensity|intensity
53980|NCT03230370|rehabilitation|rehabilitation
53981|NCT03230318|iCCA|icca
53982|NCT03230318|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
53983|NCT03230318|FGFR2 gene fusion|fgfr2 gene fusion
53984|NCT03230318|ARQ 087|arq 087
53985|NCT03230318|biliary cancer|biliary cancer
53986|NCT03230318|bile duct cancer|bile duct cancer
53987|NCT03230318|FGFR2 gene rearrangement|fgfr2 gene rearrangement
53988|NCT03230318|liver cancer|liver cancer
53989|NCT03230318|targeted therapy|targeted therapy
53990|NCT03230318|combined hepatocellular and cholangiocarcinoma|combined hepatocellular and cholangiocarcinoma
53991|NCT03230318|cHCC-CCA|chcc-cca
53992|NCT03230305|Elderly|elderly
53993|NCT03230305|Cancer|cancer
53994|NCT03230305|Ethnographic interview|ethnographic interview
53995|NCT03230305|Social representation|social representation
53996|NCT03230305|Clinical trials|clinical trials
53997|NCT03230305|Reasons of non-participation|reasons of non-participation
53998|NCT03230305|Qualitative method|qualitative method
53999|NCT03230292|Psoriasis|psoriasis
54000|NCT03230292|Chronic Plaque Psoriasis|chronic plaque psoriasis
54001|NCT03230292|Bimekizumab|bimekizumab
54002|NCT03230279|Sacroiliac pain|sacroiliac pain
54003|NCT03230279|Low back pain|low back pain
54004|NCT03230188|asthma|asthma
54005|NCT03230188|neurocircuitry|neurocircuitry
54006|NCT03230188|severe asthma|severe asthma
54007|NCT03230188|mild to moderate asthma|mild to moderate asthma
54008|NCT03230188|neurocircuitry patterns|neurocircuitry patterns
54009|NCT03230149|Fabry|fabry
54010|NCT03230149|Stroke|stroke
54011|NCT03230149|Cerebrovascular Accident|cerebrovascular accident
54012|NCT03230149|small fiber neuropathy|small fiber neuropathy
54013|NCT03230136|Myocardial injury|myocardial injury
54014|NCT03230136|Ischemia reperfusion|ischemia reperfusion
54015|NCT03230136|cardiac surgery|cardiac surgery
54016|NCT03230136|cardioprotection|cardioprotection
54017|NCT03230123|Diabetes Mellitus|diabetes mellitus
54018|NCT03230123|green banana|green banana
54019|NCT03230123|resistant starch|resistant starch
54020|NCT03230123|glucose|glucose
54021|NCT03230123|prebiotics|prebiotics
54022|NCT03230123|insulin|insulin
54023|NCT03230123|incretins|incretins
54024|NCT03230110|Sleep disordered breathing|sleep disordered breathing
54025|NCT03230110|Obstructive sleep apnea|obstructive sleep apnea
54026|NCT03230110|Hypertension|hypertension
54027|NCT03230110|Pregnancy|pregnancy
54028|NCT03230084|Infertility|infertility
54029|NCT03230084|Ovulation|ovulation
54030|NCT03230084|Pregnanediol 3-glucuronide|pregnanediol 3-glucuronide
54031|NCT03230084|Progesterone|progesterone
54032|NCT03230084|Urine dipstick test|urine dipstick test
54233|NCT03228576|Tacrolimus|tacrolimus
54033|NCT03230084|Feasibility study|feasibility study
54034|NCT03230084|Fertile period|fertile period
54035|NCT03230084|Menstrual cycle|menstrual cycle
54036|NCT03230084|Natural family planning|natural family planning
54037|NCT03230084|Fertility awareness methods|fertility awareness methods
54038|NCT03230071|Herbal therapy|herbal therapy
54039|NCT03230071|Randomized controlled trial|randomized controlled trial
54040|NCT03230071|Vascular Dementia|vascular dementia
54041|NCT03230045|acupoint stimulation|acupoint stimulation
54042|NCT03230045|elderly patients|elderly patients
54043|NCT03230045|postoperative pulmonary complications|postoperative pulmonary complications
54044|NCT03230019|wedge resection|wedge resection
54045|NCT03230019|tubeless|tubeless
54046|NCT03229980|myocardial protection|myocardial protection
54047|NCT03229980|potassium cardioplegia|potassium cardioplegia
54048|NCT03229980|tropinin|tropinin
54049|NCT03229980|Custodiol|custodiol
54050|NCT03229967|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
54051|NCT03229967|Microbiome|microbiome
54052|NCT03229967|Microbiota|microbiota
54053|NCT03229967|Premature infant|premature infant
54054|NCT03229967|Observational cohort study|observational cohort study
54055|NCT03229928|Behavior|behavior
54056|NCT03229928|Outcome Measures|outcome measures
54057|NCT03229928|Intellectual/Developmental Disabilities|intellectual/developmental disabilities
54058|NCT03229902|stroke|stroke
54059|NCT03229889|Access Sheath|access sheath
54060|NCT03229889|PCNL|pcnl
54061|NCT03229889|Percutaneous Nephrolithotomy|percutaneous nephrolithotomy
54062|NCT03229889|Ureteroscopy|ureteroscopy
54063|NCT03229889|Alpha Blocker|alpha blocker
54064|NCT03229889|Flomax|flomax
54065|NCT03229889|PDE-5 Inhibitor|pde-5 inhibitor
54066|NCT03229889|Cialis|cialis
54067|NCT03229889|Phosphodiesterase Inhibitor|phosphodiesterase inhibitor
54068|NCT03229863|Breastfeeding|breastfeeding
54069|NCT03229863|First foods|first foods
54070|NCT03229850|Diabetes|diabetes
54071|NCT03229850|Insulin|insulin
54072|NCT03229850|Lipohypertrophy|lipohypertrophy
54073|NCT03229850|Euglycemic Clamp|euglycemic clamp
54074|NCT03229837|Construct validity|construct validity
54075|NCT03229837|Minimally important differences|minimally important differences
54076|NCT03229837|Patient-reported outcomes|patient-reported outcomes
54077|NCT03229837|Pediatric cancer survivors|pediatric cancer survivors
54078|NCT03229837|PROMIS pediatric measures|promis pediatric measures
54079|NCT03229824|Drain antisepsis|drain antisepsis
54080|NCT03229824|Bacterial colonization|bacterial colonization
54081|NCT03229824|Surgical site infection|surgical site infection
54082|NCT03229733|Stroke|stroke
54083|NCT03229733|Kinect|kinect
54084|NCT03229733|Rehabilitation|rehabilitation
54085|NCT03229733|Upper limbs|upper limbs
54086|NCT03229720|Audio Visual Distraction|audio visual distraction
54087|NCT03229681|Baduanjin; CHF; 6MWT; CPET|baduanjin; chf; 6mwt; cpet
54088|NCT03229668|urinary bladder|urinary bladder
54089|NCT03229668|urinary catheters|urinary catheters
54090|NCT03229668|pregabalin|pregabalin
54091|NCT03229642|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
54092|NCT03229642|opioid use disorder|opioid use disorder
54093|NCT03229642|craving|craving
54094|NCT03229642|functional magnetic resonance imaging|functional magnetic resonance imaging
54095|NCT03229642|neuropsychological tests|neuropsychological tests
54096|NCT03229629|Behavior change communication|behavior change communication
54097|NCT03229629|Ethiopia|ethiopia
54098|NCT03229629|Food voucher|food voucher
54099|NCT03229629|complementary feeding practice|complementary feeding practice
54100|NCT03229629|affordability|affordability
54101|NCT03229629|accessibility|accessibility
54102|NCT03229629|gender|gender
54103|NCT03229603|HPV infection and Cervical cancer|hpv infection and cervical cancer
54104|NCT03229564|Burns|burns
54105|NCT03229564|Scar|scar
54106|NCT03229564|Skin|skin
54107|NCT03229564|Wound healing|wound healing
54108|NCT03229564|Tissue Engineering|tissue engineering
54109|NCT03229564|Dermis|dermis
54110|NCT03229564|Epidermis|epidermis
54111|NCT03229564|Thermal Injuries|thermal injuries
54112|NCT03229512|Hand Foot Skin Reaction|hand foot skin reaction
54113|NCT03229512|Sildenafil|sildenafil
54114|NCT03229499|Randomized Controlled Trial|randomized controlled trial
54115|NCT03229499|clinical trial|clinical trial
54116|NCT03229499|anastrozole|anastrozole
54117|NCT03229499|pulmonary hypertension|pulmonary hypertension
54118|NCT03229499|pulmonary arterial hypertension|pulmonary arterial hypertension
54119|NCT03229499|PAH|pah
54120|NCT03229486|emergence delirium|emergence delirium
54121|NCT03229486|tonsillectomy|tonsillectomy
54122|NCT03229473|Balance|balance
54123|NCT03229473|Falls|falls
54124|NCT03229473|Screening|screening
54125|NCT03229473|COPD|copd
54126|NCT03229434|affective responses|affective responses
54127|NCT03229434|stress-related parameters|stress-related parameters
54128|NCT03229434|green exercise|green exercise
54129|NCT03229421|Zika Virus|zika virus
54130|NCT03229408|Inflammation|inflammation
54131|NCT03229408|Hyperandrogenism|hyperandrogenism
54132|NCT03229408|Anovulation|anovulation
54133|NCT03229408|Insulin Resistance|insulin resistance
54134|NCT03229395|skeletal muscle|skeletal muscle
54135|NCT03229395|muscle mass|muscle mass
54136|NCT03229395|glucocorticoids|glucocorticoids
54137|NCT03229395|biomarkers|biomarkers
54138|NCT03229382|MCL, obinutuzumab|mcl, obinutuzumab
54139|NCT03229369|ACL|acl
54140|NCT03229369|ALL|all
54141|NCT03229369|Ligament injury|ligament injury
54142|NCT03229369|Reconstruction|reconstruction
54143|NCT03229343|idiopathic pulmonary fibrosis, palliative care|idiopathic pulmonary fibrosis, palliative care
54144|NCT03229330|Wound Healing|wound healing
54145|NCT03229330|Outcome Assessment (Health Care)|outcome assessment (health care)
54146|NCT03229317|Lung function|lung function
54147|NCT03229317|Children|children
54148|NCT03229317|Vitamin D|vitamin d
54149|NCT03229317|COPD|copd
54150|NCT03229291|SM04755|sm04755
54151|NCT03229291|topical|topical
54152|NCT03229291|Samumed|samumed
54153|NCT03229291|Wnt inhibitor|wnt inhibitor
54154|NCT03229226|Simulation|simulation
54155|NCT03229226|Task Trainer|task trainer
54156|NCT03229213|cystic fibrosis|cystic fibrosis
54157|NCT03229213|video games|video games
54158|NCT03229213|exercise|exercise
54159|NCT03229213|maximal oxygen consumption|maximal oxygen consumption
54160|NCT03229148|Anesthesia or Conscious sedation for Thrombectomy for Stroke|anesthesia or conscious sedation for thrombectomy for stroke
54161|NCT03229148|Thrombectomy|thrombectomy
54162|NCT03229148|Anesthesia|anesthesia
54163|NCT03229148|Conscious sedation|conscious sedation
54164|NCT03229148|Stroke|stroke
54165|NCT03229122|ovarian cancer, gBRCAm|ovarian cancer, gbrcam
54166|NCT03229109|dehydration|dehydration
54167|NCT03229109|spectrophon|spectrophon
54168|NCT03229109|device|device
54169|NCT03229109|perspiration|perspiration
54170|NCT03229096|gastric cancer|gastric cancer
54171|NCT03229096|neoadjuvant chemotherapy|neoadjuvant chemotherapy
54172|NCT03229096|apatinib|apatinib
54173|NCT03229070|Thoracic Surgery|thoracic surgery
54174|NCT03229070|Postoperative Period|postoperative period
54175|NCT03229070|Rehabilitation|rehabilitation
54176|NCT03229070|Early mobilization|early mobilization
54177|NCT03229070|Cycle-ergometer|cycle-ergometer
54178|NCT03229044|adipokine, tetranectin, lipid metabolism, body mass index|adipokine, tetranectin, lipid metabolism, body mass index
54179|NCT03229031|spinal cord, spinal cord injury|spinal cord, spinal cord injury
54180|NCT03229005|soft tissue; implant; abutment;|soft tissue; implant; abutment;
54181|NCT03228966|Pediatric|pediatric
54182|NCT03228953|Pharmacogenomic testing|pharmacogenomic testing
54183|NCT03228953|Depression|depression
54184|NCT03228940|Cardiovascular Disease, Renal Disease|cardiovascular disease, renal disease
54185|NCT03228901|Oxytocin|oxytocin
54186|NCT03228901|Affiliation|affiliation
54187|NCT03228888|Rhythm|rhythm
54188|NCT03228888|Ecological sounds|ecological sounds
54189|NCT03228888|Auditory stimuli|auditory stimuli
54190|NCT03228888|rhythmic auditory stimulation|rhythmic auditory stimulation
54191|NCT03228888|Parkinson's Disease|parkinson's disease
54192|NCT03228888|Gait|gait
54193|NCT03228888|Gait analysis|gait analysis
54194|NCT03228888|Spatio-temporal parameters|spatio-temporal parameters
54195|NCT03228875|pregnancy outcomes, birth outcomes|pregnancy outcomes, birth outcomes
54196|NCT03228849|Bony mallet injury|bony mallet injury
54197|NCT03228849|Anchor suture|anchor suture
54198|NCT03228849|Conservative treatment|conservative treatment
54199|NCT03228849|DIP joint|dip joint
54200|NCT03228823|Premature Ventricular contractions|premature ventricular contractions
54201|NCT03228823|Cardiomyopathy|cardiomyopathy
54202|NCT03228797|pain|pain
54203|NCT03228771|PRGF|prgf
54204|NCT03228771|Statins|statins
54205|NCT03228771|socket augmentation|socket augmentation
54206|NCT03228758|POEM|poem
54207|NCT03228745|mindfulness based stress reduction|mindfulness based stress reduction
54208|NCT03228745|total knee arthroplasty|total knee arthroplasty
54209|NCT03228745|pre-operative|pre-operative
54210|NCT03228719|Total Knee Replacement|total knee replacement
54211|NCT03228719|Physical Therapy|physical therapy
54212|NCT03228706|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
54213|NCT03228706|Medication Adherence|medication adherence
54214|NCT03228706|Malay patients|malay patients
54215|NCT03228706|Structured Group-Based Intervention|structured group-based intervention
54216|NCT03228706|Randomised controlled trial|randomised controlled trial
54217|NCT03228693|Keloid|keloid
54218|NCT03228667|Pembrolizumab|pembrolizumab
54219|NCT03228667|Nivolumab|nivolumab
54220|NCT03228667|Non-Small Cell Lung Cancer|non-small cell lung cancer
54221|NCT03228667|Immunotherapy|immunotherapy
54222|NCT03228667|Interleukin-15|interleukin-15
54223|NCT03228667|PD-1 Checkpoint Inhibitor|pd-1 checkpoint inhibitor
54224|NCT03228667|ALT-803|alt-803
54225|NCT03228641|skin rejuvenation|skin rejuvenation
54226|NCT03228641|wrinkle removal|wrinkle removal
54227|NCT03228641|skin laxity reduction|skin laxity reduction
54228|NCT03228628|Spinal puncture|spinal puncture
54229|NCT03228628|Pain|pain
54230|NCT03228628|Anxiety|anxiety
54231|NCT03228628|Nitrous oxyde|nitrous oxyde
54232|NCT03228615|shared decision making|shared decision making
54234|NCT03228576|Envarsus|envarsus
54235|NCT03228576|Everolimus|everolimus
54236|NCT03228576|kidney|kidney
54237|NCT03228576|Transplant|transplant
54238|NCT03228550|omega-3 fatty acid|omega-3 fatty acid
54239|NCT03228550|B vitamins|b vitamins
54240|NCT03228550|vitamin E|vitamin e
54241|NCT03228550|Phosphatidylserine|phosphatidylserine
54242|NCT03228550|Gingko biloba|gingko biloba
54243|NCT03228550|Gait|gait
54244|NCT03228550|Aerobic Exercise|aerobic exercise
54245|NCT03228550|Memory|memory
54246|NCT03228550|Cognitive function|cognitive function
54247|NCT03228485|Smartphone|smartphone
54248|NCT03228485|Application|application
54249|NCT03228485|Pilot|pilot
54250|NCT03228485|mhealth|mhealth
54251|NCT03228459|Kidney Diseases|kidney diseases
54252|NCT03228459|Subclinical Disease and/or Syndrome|subclinical disease and/or syndrome
54253|NCT03228459|Atherosclerosis|atherosclerosis
54254|NCT03228459|Biomarkers|biomarkers
54255|NCT03228459|Prevention|prevention
54256|NCT03228459|Lung capacity|lung capacity
54257|NCT03228459|Early diagnosis|early diagnosis
54258|NCT03228459|Advanced glycation end products|advanced glycation end products
54259|NCT03228459|Atrial fibrillation|atrial fibrillation
54260|NCT03228459|Diabetes|diabetes
54261|NCT03228459|Arterial ultrasound|arterial ultrasound
54262|NCT03228446|training intervention|training intervention
54263|NCT03228446|filter training|filter training
54264|NCT03228446|distractor inhibition|distractor inhibition
54265|NCT03228433|Drug Therapy|drug therapy
54266|NCT03228394|Postpartum Care|postpartum care
54267|NCT03228394|Postpartum Depression|postpartum depression
54268|NCT03228381|Functional Mitral Regurgitation|functional mitral regurgitation
54269|NCT03228381|Heart Failure|heart failure
54270|NCT03228355|Levcromakalim|levcromakalim
54271|NCT03228342|Rheumatoid Arthritis|rheumatoid arthritis
54272|NCT03228342|Ultrasound|ultrasound
54273|NCT03228342|Impact|impact
54274|NCT03228329|cardiometry|cardiometry
54275|NCT03228329|stroke volume|stroke volume
54276|NCT03228329|liver transplantation|liver transplantation
54277|NCT03228290|Cirrhosis|cirrhosis
54278|NCT03228290|Liver|liver
54279|NCT03228290|Liver Transplant|liver transplant
54280|NCT03228290|Frailty|frailty
54281|NCT03228290|end stage|end stage
54282|NCT03228277|Extracellular vesicles|extracellular vesicles
54283|NCT03228277|Bronchoalveolar lavage fluid|bronchoalveolar lavage fluid
54284|NCT03228277|Liquid biopsy|liquid biopsy
54285|NCT03228277|T790M|t790m
54286|NCT03228277|NSCLC|nsclc
54287|NCT03228277|Exosomes|exosomes
54288|NCT03228277|EGFR mutation testing|egfr mutation testing
54289|NCT03228199|Randomised Control Trial|randomised control trial
54290|NCT03228199|Productivity|productivity
54291|NCT03228199|Agricultural workers|agricultural workers
54292|NCT03228199|India|india
54293|NCT03228199|Vision correction|vision correction
54294|NCT03228173|Cognition|cognition
54295|NCT03228173|Executive functioning|executive functioning
54296|NCT03228173|Depression|depression
54297|NCT03228173|Affect|affect
54298|NCT03228173|adult females|adult females
54299|NCT03228160|Sympathetically Maintained Pain|sympathetically maintained pain
54300|NCT03228160|Linear-Polarized Near-Infrared Irradiation|linear-polarized near-infrared irradiation
54301|NCT03228160|Stellate Ganglion|stellate ganglion
54302|NCT03228160|Heart Rate Variability|heart rate variability
54303|NCT03228160|Autonomic Dysfunction Outcome|autonomic dysfunction outcome
54304|NCT03228134|treatment； bronchial asthma|treatment； bronchial asthma
54305|NCT03228108|Culture-guided|culture-guided
54306|NCT03228108|Targeted prophylaxis|targeted prophylaxis
54307|NCT03228108|Prostate biopsy|prostate biopsy
54308|NCT03228108|Antibiotic prophylaxis|antibiotic prophylaxis
54309|NCT03228095|Volatile Organic Compounds|volatile organic compounds
54310|NCT03228095|Tuberculosis|tuberculosis
54311|NCT03228095|Nano-sensors|nano-sensors
54312|NCT03228095|Electronic nose|electronic nose
54313|NCT03228095|Digestive cancers|digestive cancers
54314|NCT03228082|Patient empowerment|patient empowerment
54315|NCT03228082|Women's Health|women's health
54316|NCT03228082|Home Blood Pressure Monitoring|home blood pressure monitoring
54317|NCT03228069|rabies vaccination|rabies vaccination
54318|NCT03228056|postoperative pain|postoperative pain
54319|NCT03228056|videothoracoscopic surgery|videothoracoscopic surgery
54320|NCT03228056|thoracic epidural analgesia|thoracic epidural analgesia
54321|NCT03228056|lung lobectomy|lung lobectomy
54322|NCT03228043|Apatinib|apatinib
54323|NCT03228043|Outcome, Fatal|outcome, fatal
54324|NCT03228043|Colorectal Cancer|colorectal cancer
54325|NCT03228043|surgery|surgery
54326|NCT03228043|adjuvant chemotherapy|adjuvant chemotherapy
54327|NCT03228030|thiamine|thiamine
54328|NCT03228030|heart failure|heart failure
54329|NCT03228030|heart failure with reduced ejection fraction|heart failure with reduced ejection fraction
54330|NCT03228030|geriatric|geriatric
54331|NCT03228030|thiamin|thiamin
54332|NCT03228030|vitamin b1|vitamin b1
54333|NCT03228030|congestive heart failure|congestive heart failure
54334|NCT03228017|cardiovascular disease|cardiovascular disease
54335|NCT03228017|CVD|cvd
54336|NCT03227991|Suicide|suicide
54337|NCT03227978|pleurodesis|pleurodesis
54338|NCT03227978|PCL|pcl
54339|NCT03227965|cancer|cancer
54340|NCT03227926|RAS|ras
54341|NCT03227926|Panitumumab|panitumumab
54342|NCT03227926|EGFR|egfr
54343|NCT03227926|Clonal evolution|clonal evolution
54344|NCT03227835|contrast-induced nephropathy|contrast-induced nephropathy
54345|NCT03227835|contrast-induced acute kidney injury|contrast-induced acute kidney injury
54346|NCT03227835|prophylaxis|prophylaxis
54347|NCT03227835|intravenous hydration|intravenous hydration
54348|NCT03227809|College student risk behavior prevention|college student risk behavior prevention
54349|NCT03227809|Substance use|substance use
54350|NCT03227809|Alcohol|alcohol
54351|NCT03227809|Marijuana|marijuana
54352|NCT03227809|Illicit drugs|illicit drugs
54353|NCT03227809|Prescription drug misuse|prescription drug misuse
54354|NCT03227809|Risky sexual behaviors|risky sexual behaviors
54355|NCT03227796|osteoarthritis|osteoarthritis
54356|NCT03227796|knee|knee
54357|NCT03227796|healthy|healthy
54358|NCT03227796|volunteer|volunteer
54359|NCT03227796|LEVI-04|levi-04
54360|NCT03227770|Hemoperfusion|hemoperfusion
54361|NCT03227770|Hemodialysis|hemodialysis
54362|NCT03227770|Mortality|mortality
54363|NCT03227757|TRILUMINATE|triluminate
54364|NCT03227757|Percutaneous transcatheter intervention|percutaneous transcatheter intervention
54365|NCT03227757|Tricuspid regurgitation|tricuspid regurgitation
54366|NCT03227757|Tricuspid Valve Repair System|tricuspid valve repair system
54367|NCT03227744|Prostate Cancer, Anxiety|prostate cancer, anxiety
54368|NCT03227731|Preexposure prophylaxis|preexposure prophylaxis
54369|NCT03227731|safety|safety
54370|NCT03227731|HIV prevention|hiv prevention
54371|NCT03227731|pregnant women|pregnant women
54372|NCT03227731|lactating women|lactating women
54373|NCT03227718|VOR|vor
54374|NCT03227705|Preterm birth|preterm birth
54375|NCT03227705|Short cervix|short cervix
54376|NCT03227705|Pessary|pessary
54377|NCT03227705|Progesterone|progesterone
54378|NCT03227679|Personalized Medicine|personalized medicine
54379|NCT03227679|Nicotine Metabolite Ratio (NMR)|nicotine metabolite ratio (nmr)
54380|NCT03227679|Varenicline|varenicline
54381|NCT03227679|Nicotine Replacement Therapy (NRT)|nicotine replacement therapy (nrt)
54382|NCT03227679|Smoking Cessation|smoking cessation
54383|NCT03227679|Pharmacotherapy|pharmacotherapy
54384|NCT03227666|Postural sway|postural sway
54385|NCT03227666|Progressive balance exercise|progressive balance exercise
54386|NCT03227666|RCT|rct
54387|NCT03227666|Functional balance|functional balance
54388|NCT03227653|Efavirenz|efavirenz
54389|NCT03227653|Child Behavior|child behavior
54390|NCT03227653|Cognition|cognition
54391|NCT03227653|Medication Adherence|medication adherence
54392|NCT03227653|Drug-Related Side Effects|drug-related side effects
54393|NCT03227614|abortion|abortion
54394|NCT03227614|social support|social support
54395|NCT03227614|Anxiety|anxiety
54396|NCT03227614|Pain|pain
54397|NCT03227588|Fractional Flow Reserve|fractional flow reserve
54398|NCT03227588|Percutaneous Coronary Intervention|percutaneous coronary intervention
54399|NCT03227562|risperidone|risperidone
54400|NCT03227562|anxiety|anxiety
54401|NCT03227562|cognition|cognition
54402|NCT03227562|stress|stress
54403|NCT03227536|Neonatal asphyxia|neonatal asphyxia
54404|NCT03227536|neonatal acidosis|neonatal acidosis
54405|NCT03227536|fetal ECG|fetal ecg
54406|NCT03227536|umbilical cord acid-base status|umbilical cord acid-base status
54407|NCT03227523|low back pain|low back pain
54408|NCT03227523|respiratory disorders|respiratory disorders
54409|NCT03227523|pulmonary disease, chronic obstructive|pulmonary disease, chronic obstructive
54410|NCT03227523|postural balance|postural balance
54411|NCT03227523|functional laterality|functional laterality
54412|NCT03227523|diaphragm|diaphragm
54413|NCT03227510|Hepatocellular Carcinoma , MicroRNAs, Somalia|hepatocellular carcinoma , micrornas, somalia
54414|NCT03227497|Blood Pressure|blood pressure
54415|NCT03227497|Cholesterol|cholesterol
54416|NCT03227497|Triglycerides|triglycerides
54417|NCT03227497|Walnuts|walnuts
54418|NCT03227458|areal bone mineral density|areal bone mineral density
54419|NCT03227458|dehydroepiandrosterone (DHEA)|dehydroepiandrosterone (dhea)
54420|NCT03227458|postmenopause|postmenopause
54421|NCT03227458|exercise|exercise
54422|NCT03227458|sex hormones|sex hormones
54423|NCT03227445|DISKUS|diskus
54424|NCT03227445|HandiHaler|handihaler
54425|NCT03227445|COPD|copd
54426|NCT03227445|Placebo|placebo
54427|NCT03227445|Cross-over|cross-over
54428|NCT03227445|Dry powder inhaler|dry powder inhaler
54429|NCT03227445|ELLIPTA|ellipta
54430|NCT03227432|Multiple Myeloma|multiple myeloma
54431|NCT03227406|sleep|sleep
54432|NCT03227406|memory|memory
54433|NCT03227406|REM sleep|rem sleep
54434|NCT03227406|slow wave sleep|slow wave sleep
54435|NCT03227406|cognition|cognition
54436|NCT03227406|sleep spindles|sleep spindles
54437|NCT03227393|Heart Failure, Systolic|heart failure, systolic
54534|NCT03226730|West Africa|west africa
54438|NCT03227393|Defibrillators, Implantable|defibrillators, implantable
54439|NCT03227393|Pacemaker, Artificial|pacemaker, artificial
54440|NCT03227367|biomaterials|biomaterials
54441|NCT03227367|apoptosis|apoptosis
54442|NCT03227367|bone regeneration|bone regeneration
54443|NCT03227354|Medical Device|medical device
54444|NCT03227341|asthma control|asthma control
54445|NCT03227341|pulmonary rehabilitation|pulmonary rehabilitation
54446|NCT03227328|luminal B breast cancer|luminal b breast cancer
54447|NCT03227328|metastatic breast cancer|metastatic breast cancer
54448|NCT03227328|First line treatment|first line treatment
54449|NCT03227328|endocrine therapy|endocrine therapy
54450|NCT03227328|chemotherapy|chemotherapy
54451|NCT03227328|randomized phase III trial|randomized phase iii trial
54452|NCT03227328|aromatase inhibitor|aromatase inhibitor
54453|NCT03227276|Litramine|litramine
54454|NCT03227276|Opuntia ficus-indica|opuntia ficus-indica
54455|NCT03227276|weight loss|weight loss
54456|NCT03227263|Hemorrhagic Hereditary Telangiectasia (HHT)|hemorrhagic hereditary telangiectasia (hht)
54457|NCT03227263|VEGF therapy|vegf therapy
54458|NCT03227263|Bevacizumab|bevacizumab
54459|NCT03227250|freezing of gait|freezing of gait
54460|NCT03227250|Parkinson disease|parkinson disease
54461|NCT03227250|GPi|gpi
54462|NCT03227237|Impact, Interpersonal Relationship, Juvenile delinquency|impact, interpersonal relationship, juvenile delinquency
54463|NCT03227211|COPD exacerbated|copd exacerbated
54464|NCT03227211|Readmission|readmission
54465|NCT03227211|Prospective cohort study|prospective cohort study
54466|NCT03227211|Nested case control study|nested case control study
54467|NCT03227211|Clinical prediction rules|clinical prediction rules
54468|NCT03227159|Acute Myocardial Infarction|acute myocardial infarction
54469|NCT03227159|Troponin|troponin
54470|NCT03227159|Emergency department|emergency department
54471|NCT03227146|Burns|burns
54472|NCT03227146|Scar|scar
54473|NCT03227146|Skin|skin
54474|NCT03227146|Wound healing|wound healing
54475|NCT03227146|Tissue Engineering|tissue engineering
54476|NCT03227146|Dermis|dermis
54477|NCT03227146|Epidermis|epidermis
54478|NCT03227146|Thermal Injuries|thermal injuries
54479|NCT03227120|Exercise Therapy|exercise therapy
54480|NCT03227094|Diabetes|diabetes
54481|NCT03227094|Screening test|screening test
54482|NCT03227094|Continuous glucose monitoring|continuous glucose monitoring
54483|NCT03227094|Oral glucose tolerance test|oral glucose tolerance test
54484|NCT03227068|pediatric oncology|pediatric oncology
54485|NCT03227068|parent|parent
54486|NCT03227055|Arterial stiffness, children, chronic kidney disease, hypertension, microRNA|arterial stiffness, children, chronic kidney disease, hypertension, microrna
54487|NCT03227042|Sanfilippo Syndrome Type B|sanfilippo syndrome type b
54488|NCT03227042|MPS IIIB|mps iiib
54489|NCT03227042|MPS 3 B|mps 3 b
54490|NCT03226990|pressure area|pressure area
54491|NCT03226990|polyether elastomeric impression|polyether elastomeric impression
54492|NCT03226990|wax spacer|wax spacer
54493|NCT03226964|endobronchial ultrasound|endobronchial ultrasound
54494|NCT03226964|high flow nasal oxygen|high flow nasal oxygen
54495|NCT03226938|dietary patterns|dietary patterns
54496|NCT03226938|dietary adherence|dietary adherence
54497|NCT03226938|popular diets|popular diets
54498|NCT03226938|Paleo|paleo
54499|NCT03226938|vegan|vegan
54500|NCT03226938|behavior change|behavior change
54501|NCT03226938|adherence|adherence
54502|NCT03226938|compliance|compliance
54503|NCT03226938|vegetarian|vegetarian
54504|NCT03226938|low carb|low carb
54505|NCT03226938|low-carb|low-carb
54506|NCT03226938|whole food plant-based|whole food plant-based
54507|NCT03226938|social ecological model|social ecological model
54508|NCT03226925|thoracic tumors|thoracic tumors
54509|NCT03226925|motion management|motion management
54510|NCT03226925|radiotherapy|radiotherapy
54511|NCT03226925|ventilator|ventilator
54512|NCT03226873|HIV prevention|hiv prevention
54513|NCT03226873|PrEP|prep
54514|NCT03226873|peer navigation|peer navigation
54515|NCT03226873|women|women
54516|NCT03226847|Atrial Fibrillation, Athletes, Pulmonary Vein Isolation|atrial fibrillation, athletes, pulmonary vein isolation
54517|NCT03226821|HIV Lipodystrophy|hiv lipodystrophy
54518|NCT03226821|Tesamorelin|tesamorelin
54519|NCT03226821|Body Composition|body composition
54520|NCT03226821|Visceral Adiposity|visceral adiposity
54521|NCT03226795|Cystic fibrosis|cystic fibrosis
54522|NCT03226795|Therapeutic adherence|therapeutic adherence
54523|NCT03226795|Co-constructed intervention|co-constructed intervention
54524|NCT03226795|Patient involvement|patient involvement
54525|NCT03226743|stepped and collaborative care|stepped and collaborative care
54526|NCT03226743|cluster-randomized controlled trial|cluster-randomized controlled trial
54527|NCT03226743|health services research|health services research
54528|NCT03226743|evidence-based medicine|evidence-based medicine
54529|NCT03226743|complex intervention|complex intervention
54530|NCT03226743|guideline implementation|guideline implementation
54531|NCT03226743|collaborative network|collaborative network
54532|NCT03226730|Female Adolescent|female adolescent
54533|NCT03226730|Married|married
54535|NCT03226730|Family Planning|family planning
54536|NCT03226730|Contraceptive Use|contraceptive use
54537|NCT03226730|Birth Spacing|birth spacing
54538|NCT03226704|CD19|cd19
54539|NCT03226704|CD22|cd22
54540|NCT03226704|CD19/22|cd19/22
54541|NCT03226704|Immunotherapy|immunotherapy
54542|NCT03226704|Apheresis|apheresis
54543|NCT03226691|Plerixafor|plerixafor
54544|NCT03226691|Leukapheresis|leukapheresis
54545|NCT03226691|Mobilization|mobilization
54546|NCT03226691|Stem Cells|stem cells
54547|NCT03226691|Sickle Cell Disease|sickle cell disease
54548|NCT03226665|obstruction|obstruction
54549|NCT03226665|small bowel|small bowel
54550|NCT03226665|ultrasound|ultrasound
54551|NCT03226639|Atrial Fibrillation|atrial fibrillation
54552|NCT03226639|First Ablation|first ablation
54553|NCT03226626|Tumescent|tumescent
54554|NCT03226626|Lidocaine|lidocaine
54555|NCT03226626|Epinephrine|epinephrine
54556|NCT03226626|Cefazolin|cefazolin
54557|NCT03226626|Metronidazole|metronidazole
54558|NCT03226626|Surgical Site Infection|surgical site infection
54559|NCT03226626|Thrombosis|thrombosis
54560|NCT03226626|Sepsis|sepsis
54561|NCT03226626|Prevention|prevention
54562|NCT03226626|Prophylaxis|prophylaxis
54563|NCT03226613|Human Papillomavirus|human papillomavirus
54564|NCT03226613|Oropharyngeal Cancer|oropharyngeal cancer
54565|NCT03226613|Base of Tongue Cancer|base of tongue cancer
54566|NCT03226613|Tonsil Cancer|tonsil cancer
54567|NCT03226600|Gingival Recession|gingival recession
54568|NCT03226600|Connective Tissue Graft|connective tissue graft
54569|NCT03226600|OrACELL|oracell
54570|NCT03226600|Decellularized Dermis|decellularized dermis
54571|NCT03226600|Periodontics|periodontics
54572|NCT03226587|blue light|blue light
54573|NCT03226587|blood pressure|blood pressure
54574|NCT03226587|vascular function|vascular function
54575|NCT03226587|endothelial function|endothelial function
54576|NCT03226587|health volunteers|health volunteers
54577|NCT03226574|Resiniferatoxin|resiniferatoxin
54578|NCT03226574|RTX|rtx
54579|NCT03226574|Cancer pain|cancer pain
54580|NCT03226548|Earned Income Tax Credit (EITC)|earned income tax credit (eitc)
54581|NCT03226548|Tax Credit|tax credit
54582|NCT03226548|Paycheck Plus|paycheck plus
54583|NCT03226535|Computer Assisted Instrument Guidance (CAIG)|computer assisted instrument guidance (caig)
54584|NCT03226535|Ultrasound-CT Fusion|ultrasound-ct fusion
54585|NCT03226535|Image Fusion|image fusion
54586|NCT03226535|Clear Guide SCENERGY|clear guide scenergy
54587|NCT03226535|Needle path|needle path
54588|NCT03226535|Needle Guidance|needle guidance
54589|NCT03226535|CT|ct
54590|NCT03226535|Ultrasound|ultrasound
54591|NCT03226509|cascade of care|cascade of care
54592|NCT03226483|Brain Metastases|brain metastases
54593|NCT03226483|Intraoperative Radiotherapy|intraoperative radiotherapy
54594|NCT03226483|Neurosurgery|neurosurgery
54595|NCT03226470|Transcription Activator-like Effector Nucleases|transcription activator-like effector nucleases
54596|NCT03226470|Human papillomavirus|human papillomavirus
54597|NCT03226470|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
54598|NCT03226457|Heart Failure|heart failure
54599|NCT03226457|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
54600|NCT03226457|Sodium-Glucose co-Transporter 2 (SGLT2) inhibitors|sodium-glucose co-transporter 2 (sglt2) inhibitors
54601|NCT03226457|Natriuresis|natriuresis
54602|NCT03226457|Diuresis|diuresis
54603|NCT03226444|Dry Eye|dry eye
54604|NCT03226444|Primary Sjogren's Syndrome|primary sjogren's syndrome
54605|NCT03226444|Sjogren's Syndrome|sjogren's syndrome
54606|NCT03226405|Cancer|cancer
54607|NCT03226392|QAW039, uncontrolled asthma|qaw039, uncontrolled asthma
54608|NCT03226366|door-to-antibiotic time|door-to-antibiotic time
54609|NCT03226366|emergency department care|emergency department care
54610|NCT03226366|antimicrobial|antimicrobial
54611|NCT03226366|care reorganization|care reorganization
54612|NCT03226366|severe sepsis|severe sepsis
54613|NCT03226366|swarming|swarming
54614|NCT03226314|bacterial multi-resitance|bacterial multi-resitance
54615|NCT03226288|Plantar Fascitis|plantar fascitis
54616|NCT03226288|orthopedic|orthopedic
54617|NCT03226288|3D surface scanning|3d surface scanning
54618|NCT03226275|Concor AM®|concor am®
54619|NCT03226275|Concor®|concor®
54620|NCT03226275|Norvasc®|norvasc®
54621|NCT03226275|Bisoprolol|bisoprolol
54622|NCT03226275|Amlodipine|amlodipine
54623|NCT03226275|Bisoprolol-Amlodipine fixed dose combination|bisoprolol-amlodipine fixed dose combination
54624|NCT03226275|Chinese Subjects|chinese subjects
54625|NCT03226236|Carcinoma, Renal Cell|carcinoma, renal cell
54626|NCT03226236|vaccination|vaccination
54627|NCT03226236|dendritic cells|dendritic cells
54628|NCT03226236|autologous tumor homogenate|autologous tumor homogenate
54629|NCT03226236|High Dose -IL2|high dose -il2
54630|NCT03226236|immunomodulating radiotherapy|immunomodulating radiotherapy
54631|NCT03226236|secondary|secondary
54632|NCT03226210|Diabetes Mellitus|diabetes mellitus
54633|NCT03226210|Rapid-acting insulin analogues|rapid-acting insulin analogues
54634|NCT03226210|Continuous glucose monitoring system (CGMS)|continuous glucose monitoring system (cgms)
54635|NCT03226210|Continuous subcutaneous insulin infusion (CSII)|continuous subcutaneous insulin infusion (csii)
54636|NCT03226184|Er:YAG laser, laser, biofilm removal, biofilm, disinfection, septic revision surgery|er:yag laser, laser, biofilm removal, biofilm, disinfection, septic revision surgery
54637|NCT03226158|Next generation pathogen sequencing (NGPS)|next generation pathogen sequencing (ngps)
54638|NCT03226158|Pediatric|pediatric
54639|NCT03226158|Cancer|cancer
54640|NCT03226158|Bloodstream infection (BSI)|bloodstream infection (bsi)
54641|NCT03226119|HTLV|htlv
54642|NCT03226119|Confirmatory|confirmatory
54643|NCT03226119|Supplemental|supplemental
54644|NCT03226119|Blot|blot
54645|NCT03226119|HTLV-I|htlv-i
54646|NCT03226119|HTLV-II|htlv-ii
54647|NCT03226106|Rehabilitation|rehabilitation
54648|NCT03226106|Total Knee Arthroplasty|total knee arthroplasty
54649|NCT03226106|Telemedicine|telemedicine
54650|NCT03226106|Physical Activity|physical activity
54651|NCT03226054|Proton Pump Inhibitor|proton pump inhibitor
54652|NCT03226041|transcutaneous carbon dioxide|transcutaneous carbon dioxide
54653|NCT03226041|retroperitoneoscopic|retroperitoneoscopic
54654|NCT03226041|urologic surgery|urologic surgery
54655|NCT03226041|anesthesia|anesthesia
54656|NCT03226015|Limbal Stem-cell Deficiency|limbal stem-cell deficiency
54657|NCT03226015|Oral mucosa transplantation|oral mucosa transplantation
54658|NCT03226015|Amniotic membrane|amniotic membrane
54659|NCT03226015|Mesenchymal stem cells|mesenchymal stem cells
54660|NCT03226002|Airtraq NT|airtraq nt
54661|NCT03226002|nasotracheal intubation|nasotracheal intubation
54662|NCT03226002|right|right
54663|NCT03226002|left|left
54664|NCT03225976|Phototherapy|phototherapy
54665|NCT03225976|Athletic Performance|athletic performance
54666|NCT03225976|Muscle Strength|muscle strength
54667|NCT03225976|Fatigue|fatigue
54668|NCT03225963|Glioblastoma|glioblastoma
54669|NCT03225963|Bevacizumab|bevacizumab
54670|NCT03225950|Periodontal disease|periodontal disease
54671|NCT03225950|Periodontitis|periodontitis
54672|NCT03225950|Aggressive periodontitis|aggressive periodontitis
54673|NCT03225950|Dysbiosis|dysbiosis
54674|NCT03225950|Inflammation|inflammation
54675|NCT03225950|Regulation|regulation
54676|NCT03225950|Cytokines|cytokines
54677|NCT03225950|Bacteria|bacteria
54678|NCT03225950|Porphyromonas gingivalis|porphyromonas gingivalis
54679|NCT03225950|Saliva|saliva
54680|NCT03225950|Anti-CCP|anti-ccp
54681|NCT03225950|Peptidyl arginine deiminases|peptidyl arginine deiminases
54682|NCT03225950|Single nucleotide polymorphisms|single nucleotide polymorphisms
54683|NCT03225898|blood flow restriction|blood flow restriction
54684|NCT03225898|resistance exercise|resistance exercise
54685|NCT03225885|gestational age|gestational age
54686|NCT03225885|multi-media|multi-media
54687|NCT03225885|mobile application|mobile application
54688|NCT03225885|anxiety|anxiety
54689|NCT03225885|clinical trial|clinical trial
54690|NCT03225885|random allocation|random allocation
54691|NCT03225872|Osteosarcoma|osteosarcoma
54692|NCT03225872|Bone cancer|bone cancer
54693|NCT03225872|Family-based study|family-based study
54694|NCT03225859|Stress Disorders, Posttraumatic|stress disorders, posttraumatic
54695|NCT03225859|Self-Management|self-management
54696|NCT03225820|pharmacogenomic information|pharmacogenomic information
54697|NCT03225807|Intubated|intubated
54698|NCT03225807|Intubation|intubation
54699|NCT03225807|Ventilator|ventilator
54700|NCT03225807|Ventilator-free days|ventilator-free days
54701|NCT03225807|Ventilator free days|ventilator free days
54702|NCT03225807|Mechanical Ventilation|mechanical ventilation
54703|NCT03225807|Meta-Analysis|meta-analysis
54704|NCT03225807|Tidal Volume|tidal volume
54705|NCT03225807|Tidal Volumes|tidal volumes
54706|NCT03225807|inflammation|inflammation
54707|NCT03225807|cytokines|cytokines
54708|NCT03225807|Pulmonary Infiltrate|pulmonary infiltrate
54709|NCT03225807|Pulmonary Infiltrates|pulmonary infiltrates
54710|NCT03225807|Low Tidal Volumes|low tidal volumes
54711|NCT03225807|Protective Ventilation|protective ventilation
54712|NCT03225794|Retrovirus|retrovirus
54713|NCT03225794|Viral emergence|viral emergence
54714|NCT03225755|Growth Hormone Deficiency|growth hormone deficiency
54715|NCT03225755|Adipose Tissue|adipose tissue
54716|NCT03225755|Inflammation|inflammation
54717|NCT03225716|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
54718|NCT03225703|Exercise|exercise
54719|NCT03225703|Osteoporosis|osteoporosis
54720|NCT03225703|Osteoarthritis|osteoarthritis
54721|NCT03225703|MRI|mri
54722|NCT03225703|DXA|dxa
54723|NCT03225703|High Impact|high impact
54724|NCT03225703|Cartilage|cartilage
54725|NCT03225703|Bone|bone
54726|NCT03225664|Non-Small Cell Lung Cancer|non-small cell lung cancer
54727|NCT03225664|NSCLC|nsclc
54728|NCT03225664|Trametinib|trametinib
54729|NCT03225664|GSK1120212|gsk1120212
54730|NCT03225664|Pembrolizumab|pembrolizumab
54731|NCT03225664|Keytruda|keytruda
54732|NCT03225664|MK-3475|mk-3475
54733|NCT03225664|SCH-900475|sch-900475
54734|NCT03225664|Metastatic|metastatic
54735|NCT03225664|Unresectable|unresectable
54736|NCT03225664|Locally advanced|locally advanced
54737|NCT03225664|Recurrent|recurrent
54738|NCT03225651|Stem cell|stem cell
54739|NCT03225651|Autism|autism
54740|NCT03225651|Psychological|psychological
54741|NCT03225651|Rehabilitation|rehabilitation
54742|NCT03225625|spinal cord injury|spinal cord injury
54743|NCT03225625|spinal cord compression|spinal cord compression
54744|NCT03225625|spinal cord ischemia|spinal cord ischemia
54745|NCT03225625|spinal cord diseases|spinal cord diseases
54746|NCT03225625|spinal paralysis|spinal paralysis
54747|NCT03225625|paraplegia|paraplegia
54748|NCT03225625|paraparesis|paraparesis
54749|NCT03225586|Non-communicable Diseases, Risk Factors|non-communicable diseases, risk factors
54750|NCT03225573|second mesiobuccal canal CBCT prevalence population|second mesiobuccal canal cbct prevalence population
54751|NCT03225560|Smart Phone Application|smart phone application
54752|NCT03225560|Bowel Preparation|bowel preparation
54753|NCT03225560|Colorectal Cancer Screening|colorectal cancer screening
54754|NCT03225547|HER-2 negative breast cancer|her-2 negative breast cancer
54755|NCT03225547|breast cancer|breast cancer
54756|NCT03225547|pembrolizumab|pembrolizumab
54757|NCT03225547|mifepristone|mifepristone
54758|NCT03225534|Asthma|asthma
54759|NCT03225534|Allergy|allergy
54760|NCT03225534|Epidemiology|epidemiology
54761|NCT03225534|Environment|environment
54762|NCT03225534|Exposures|exposures
54763|NCT03225521|Physical Activity|physical activity
54764|NCT03225521|Mobile Health|mobile health
54765|NCT03225521|Self Monitoring|self monitoring
54766|NCT03225521|Wearable Sensors|wearable sensors
54767|NCT03225521|Tailored Health Communication|tailored health communication
54768|NCT03225521|Implementation Intentions|implementation intentions
54769|NCT03225521|Mobile Apps|mobile apps
54770|NCT03225521|Anti-Sedentary Behavior|anti-sedentary behavior
54771|NCT03225521|Opportunistic Physical Activity|opportunistic physical activity
54772|NCT03225521|Health Belief Model|health belief model
54773|NCT03225482|Mild Cognitive Impairment|mild cognitive impairment
54774|NCT03225482|Cognitive rehabilitation|cognitive rehabilitation
54775|NCT03225482|Cognitive training|cognitive training
54776|NCT03225482|Cognitive remediation|cognitive remediation
54777|NCT03225469|Bowel Preparation|bowel preparation
54778|NCT03225469|Colonoscopy|colonoscopy
54779|NCT03225469|Quality|quality
54780|NCT03225469|Family Support|family support
54781|NCT03225469|Education|education
54782|NCT03225456|appetite regulation|appetite regulation
54783|NCT03225456|obesity|obesity
54784|NCT03225456|oxytocin|oxytocin
54785|NCT03225443|Locally advanced cervical cancer|locally advanced cervical cancer
54786|NCT03225443|Particle radiotherapy|particle radiotherapy
54787|NCT03225443|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
54788|NCT03225417|Ixazomib|ixazomib
54789|NCT03225404|Tendinopathy|tendinopathy
54790|NCT03225404|Electrolysis|electrolysis
54791|NCT03225404|Exercise|exercise
54792|NCT03225404|Dry needing|dry needing
54793|NCT03225391|Residents|residents
54794|NCT03225391|Naps|naps
54795|NCT03225391|decision making|decision making
54796|NCT03225378|Fluid responsiveness|fluid responsiveness
54797|NCT03225378|Passive leg raising|passive leg raising
54798|NCT03225378|Pulse pressure variation|pulse pressure variation
54799|NCT03225365|Melanoma|melanoma
54800|NCT03225365|Nivolumab|nivolumab
54801|NCT03225365|Ipilimumab|ipilimumab
54802|NCT03225365|Immune modulation|immune modulation
54803|NCT03225326|articaine|articaine
54804|NCT03225326|local anesthesia|local anesthesia
54805|NCT03225326|AMSA|amsa
54806|NCT03225300|Glioblastoma|glioblastoma
54807|NCT03225300|Chemoradiation|chemoradiation
54808|NCT03225300|Simultaneous integrated boost|simultaneous integrated boost
54809|NCT03225274|Breathing exercises|breathing exercises
54810|NCT03225274|Respiratory status|respiratory status
54811|NCT03225274|Nebulization therapy|nebulization therapy
54812|NCT03225274|lower respiratory tract disorders|lower respiratory tract disorders
54813|NCT03225235|Prostate cancer, SBRT, Ultrafractionation, CyberKnife|prostate cancer, sbrt, ultrafractionation, cyberknife
54814|NCT03225222|Prostate cancer|prostate cancer
54815|NCT03225222|multivariate risk assessment|multivariate risk assessment
54816|NCT03225222|MRI|mri
54817|NCT03225222|biopsy|biopsy
54818|NCT03225222|screening|screening
54819|NCT03225222|multicenter|multicenter
54820|NCT03225209|Roux-en-y gastric bypass|roux-en-y gastric bypass
54821|NCT03225209|GLP-1|glp-1
54822|NCT03225209|Liraglutide|liraglutide
54823|NCT03225209|OPTIFAST|optifast
54824|NCT03225196|Extracellular RNA|extracellular rna
54825|NCT03225196|MicroRNA|microrna
54826|NCT03225183|TOPMed|topmed
54827|NCT03225183|Blood Pressure|blood pressure
54828|NCT03225183|Long Noncoding RNA|long noncoding rna
54829|NCT03225183|Gene Expression|gene expression
54830|NCT03225183|MicroRNA|microrna
54831|NCT03225170|BRCA1|brca1
54832|NCT03225170|BRCA2|brca2
54833|NCT03225170|Clinical Decision-Making|clinical decision-making
54834|NCT03225157|Audiogram|audiogram
54835|NCT03225157|Statins|statins
54836|NCT03225157|Drug Response|drug response
54837|NCT03225157|Cancer Treatment|cancer treatment
54838|NCT03225157|Head and Neck Cancer|head and neck cancer
54839|NCT03225144|Motor Neuron Disease|motor neuron disease
54840|NCT03225144|Frontotemporal Dementia|frontotemporal dementia
54841|NCT03225144|Corticobasal Syndrome|corticobasal syndrome
54842|NCT03225131|Age Related Macular Degeneration|age related macular degeneration
54843|NCT03225131|Dark Adaptation|dark adaptation
54844|NCT03225118|Rebound|rebound
54845|NCT03225118|Reinitiation|reinitiation
54846|NCT03225118|ART|art
54847|NCT03225118|Reservoirs|reservoirs
54848|NCT03225118|Immune Exhaustion|immune exhaustion
54849|NCT03225105|Solid Tumors|solid tumors
54850|NCT03225105|M3541|m3541
54851|NCT03225105|Palliative radiotherapy|palliative radiotherapy
54852|NCT03225105|Adenosine triphosphate-competitive inhibitor|adenosine triphosphate-competitive inhibitor
54853|NCT03225092|Chronic Knee Pain|chronic knee pain
54854|NCT03225092|Status-Post Total Knee Arthroplasty|status-post total knee arthroplasty
54855|NCT03225092|Platelet Rich Plasma|platelet rich plasma
54856|NCT03225079|Pentaglobin® use|pentaglobin® use
54857|NCT03225079|severe bacterial infection|severe bacterial infection
54858|NCT03225053|Percutaneous microelectrolysis|percutaneous microelectrolysis
54859|NCT03225053|Physiotherapy|physiotherapy
54860|NCT03225040|Acromegaly|acromegaly
54861|NCT03225040|Pegvisomant|pegvisomant
54862|NCT03225040|Osteoporosis|osteoporosis
54863|NCT03225027|Emotional prosody, schizophrenia|emotional prosody, schizophrenia
54864|NCT03225001|Sapien XT|sapien xt
54865|NCT03225001|Partner II|partner ii
54866|NCT03225001|cardiovascular disease|cardiovascular disease
54867|NCT03225001|heart disease|heart disease
54868|NCT03225001|aortic disease|aortic disease
54869|NCT03225001|SAVR|savr
54870|NCT03225001|TAVR|tavr
54871|NCT03225001|failing surgical valve|failing surgical valve
54872|NCT03225001|failing valve|failing valve
54873|NCT03225001|failing bioprosthetic valve|failing bioprosthetic valve
54874|NCT03224988|Alzheimer's Disease|alzheimer's disease
54875|NCT03224988|AD|ad
54876|NCT03224988|MCI-AD|mci-ad
54877|NCT03224988|MCI|mci
54878|NCT03224988|Memory|memory
54879|NCT03224988|TMS|tms
54880|NCT03224988|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
54881|NCT03224988|Neuropsychological evaluation|neuropsychological evaluation
54882|NCT03224988|MRI|mri
54883|NCT03224988|DTI|dti
54884|NCT03224988|EEG|eeg
54885|NCT03224975|Pain|pain
54886|NCT03224975|Brain responses|brain responses
54887|NCT03224975|Neuroimaging|neuroimaging
54888|NCT03224975|fMRI|fmri
54889|NCT03224975|Burn|burn
54890|NCT03224975|Memory|memory
54891|NCT03224962|pit and fissure caries|pit and fissure caries
54892|NCT03224936|DISE|dise
54893|NCT03224936|OSAS|osas
54894|NCT03224936|PSI|psi
54895|NCT03224910|FNA, smears, imprints, ROSE|fna, smears, imprints, rose
54896|NCT03224897|Reappraisal|reappraisal
54897|NCT03224897|Emotion Regulation|emotion regulation
54898|NCT03224897|tDCS|tdcs
54899|NCT03224897|Reinterpretation|reinterpretation
54900|NCT03224858|Patient-Centered Care|patient-centered care
54901|NCT03224858|Comorbidity|comorbidity
54902|NCT03224754|Atypia, thyroid, malignancy|atypia, thyroid, malignancy
54903|NCT03224741|Behavioral Economics|behavioral economics
54904|NCT03224702|M6495|m6495
54905|NCT03224702|anti-A disintegrin and metalloproteinase with thrombospondin motifs-5 nanobody|anti-a disintegrin and metalloproteinase with thrombospondin motifs-5 nanobody
54906|NCT03224702|Osteoarthritis|osteoarthritis
54907|NCT03224676|Quality of sleep|quality of sleep
54908|NCT03224676|Perceived sleep distractors|perceived sleep distractors
54909|NCT03224676|Adult patients|adult patients
54910|NCT03224663|Effectiveness|effectiveness
54911|NCT03224663|Module based learning|module based learning
54912|NCT03224663|Mobile application based learning|mobile application based learning
54913|NCT03224663|Facility based newborn care|facility based newborn care
54914|NCT03224663|Knowledge|knowledge
54915|NCT03224663|Practices|practices
54916|NCT03224663|Nursing students|nursing students
54917|NCT03224585|anakinra|anakinra
54918|NCT03224585|Kineret|kineret
54919|NCT03224585|pericarditis|pericarditis
54920|NCT03224572|vitamin C|vitamin c
54921|NCT03224572|quality of life|quality of life
54922|NCT03224572|terminal cancer|terminal cancer
54923|NCT03224533|nut consumption|nut consumption
54924|NCT03224533|NHANES|nhanes
54925|NCT03224533|epidemiology|epidemiology
54926|NCT03224533|plasma glucose|plasma glucose
54927|NCT03224533|hemoglobin A1c|hemoglobin a1c
54928|NCT03224507|multiple myeloma|multiple myeloma
54929|NCT03224507|induction therapy|induction therapy
54930|NCT03224507|autologous hematopoietic cell transplantation|autologous hematopoietic cell transplantation
54931|NCT03224507|KRdD|krdd
54932|NCT03224507|Daratumumab|daratumumab
54933|NCT03224507|Carfilzomib|carfilzomib
54934|NCT03224507|Lenalidomide|lenalidomide
54935|NCT03224468|medical marijuana|medical marijuana
54936|NCT03224468|cannabis|cannabis
54937|NCT03224468|pain|pain
54938|NCT03224468|insomnia|insomnia
54939|NCT03224468|depression|depression
54940|NCT03224468|anxiety|anxiety
54941|NCT03224468|addiction|addiction
54942|NCT03224468|dependence|dependence
54943|NCT03224468|neurocognition|neurocognition
54944|NCT03224468|MRI|mri
54945|NCT03224455|sleep|sleep
54946|NCT03224455|sleep in children|sleep in children
54947|NCT03224455|children and sleep|children and sleep
54948|NCT03224455|environment|environment
54949|NCT03224455|environment and sleep|environment and sleep
54950|NCT03224455|environment and children|environment and children
54951|NCT03224416|Alcohol|alcohol
54952|NCT03224416|Delay Discounting|delay discounting
54953|NCT03224416|Risky Sexual Behavior|risky sexual behavior
54954|NCT03224416|Decision Making|decision making
54955|NCT03224416|MSM|msm
54956|NCT03224390|Contraception|contraception
54957|NCT03224390|Family Planning|family planning
54958|NCT03224390|Digital Health|digital health
54959|NCT03224390|Kenya|kenya
54960|NCT03224390|Unmet Need|unmet need
54961|NCT03224364|Solo surgery|solo surgery
54962|NCT03224364|Camera holder|camera holder
54963|NCT03224364|Laparoscopic Appendectomy|laparoscopic appendectomy
54964|NCT03224325|Drug therapy|drug therapy
54965|NCT03224312|Primary aldosteronism|primary aldosteronism
54966|NCT03224312|cardiovascular events|cardiovascular events
54967|NCT03224312|cerebrovascular events|cerebrovascular events
54968|NCT03224286|Pressure sensitive mat|pressure sensitive mat
54969|NCT03224273|proximal box design preparation|proximal box design preparation
54970|NCT03224247|vertical splitting|vertical splitting
54971|NCT03224247|Cesarean Section Complications|cesarean section complications
54972|NCT03224247|uterine vessels|uterine vessels
54973|NCT03224247|injury|injury
54974|NCT03224234|Uncontrolled Type 2 Diabetes|uncontrolled type 2 diabetes
54975|NCT03224234|Insulclock|insulclock
54976|NCT03224234|Electronic device|electronic device
54977|NCT03224234|Alarm system|alarm system
54978|NCT03224221|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
54979|NCT03224221|apatinib|apatinib
54980|NCT03224208|melanoma|melanoma
54981|NCT03224208|advanced|advanced
54982|NCT03224208|vemurafenib|vemurafenib
54983|NCT03224208|cobimetinib|cobimetinib
54984|NCT03224195|rehabilitation|rehabilitation
54985|NCT03224195|patient perspective|patient perspective
54986|NCT03224195|semi-structured interview|semi-structured interview
54987|NCT03224143|dementia|dementia
54988|NCT03224143|doll therapy|doll therapy
54989|NCT03224143|attachment|attachment
54990|NCT03224130|transitions of care|transitions of care
54991|NCT03224130|reutilization|reutilization
54992|NCT03224130|nurse phone call|nurse phone call
54993|NCT03224104|elderly|elderly
54994|NCT03224104|TG02|tg02
54995|NCT03224104|newly diagnosed|newly diagnosed
54996|NCT03224104|first relapse|first relapse
54997|NCT03224091|Eating disorders|eating disorders
54998|NCT03224091|psychopathology|psychopathology
54999|NCT03224091|pathophysiology|pathophysiology
55000|NCT03224091|prospective|prospective
55001|NCT03224091|longitudinal|longitudinal
55002|NCT03224052|Anti-Bacterial Agents|anti-bacterial agents
55003|NCT03224052|Falciparum|falciparum
55004|NCT03224052|Vivax|vivax
55005|NCT03224000|Malignant neoplasms of lip oral cavity and pharynx|malignant neoplasms of lip oral cavity and pharynx
55006|NCT03224000|Oropharyngeal Cancer|oropharyngeal cancer
55007|NCT03224000|Human papilloma virus positive|human papilloma virus positive
55008|NCT03224000|HPV+|hpv+
55009|NCT03224000|Squamous cell carcinoma of the oropharynx|squamous cell carcinoma of the oropharynx
55010|NCT03224000|Squamous cell carcinoma of the tonsil|squamous cell carcinoma of the tonsil
55011|NCT03224000|Squamous cell carcinoma of the base of tongue|squamous cell carcinoma of the base of tongue
55012|NCT03224000|Squamous cell carcinoma of the soft palate|squamous cell carcinoma of the soft palate
55013|NCT03224000|Squamous cell carcinoma of the oropharyngeal walls|squamous cell carcinoma of the oropharyngeal walls
55014|NCT03224000|Magnetic Resonance Imaging Guided Radiotherapy|magnetic resonance imaging guided radiotherapy
55015|NCT03224000|Standard of Care Radiotherapy Planning|standard of care radiotherapy planning
55016|NCT03224000|Radiation Therapy|radiation therapy
55017|NCT03224000|Intensity modulated radiotherapy|intensity modulated radiotherapy
55018|NCT03224000|IMRT|imrt
55019|NCT03224000|Modified Barium Swallow|modified barium swallow
55020|NCT03224000|MBS|mbs
55021|NCT03224000|Swallowing questionnaire|swallowing questionnaire
55022|NCT03224000|The M.D. Anderson Dysphagia Inventory (MDADI)|the m.d. anderson dysphagia inventory (mdadi)
55023|NCT03224000|Symptom questionnaire|symptom questionnaire
55024|NCT03224000|The M.D. Anderson Symptom Inventory for Head and Neck Cancer (MDASI-HN)|the m.d. anderson symptom inventory for head and neck cancer (mdasi-hn)
55025|NCT03224000|Video-Strobe Procedure|video-strobe procedure
55026|NCT03223987|16S rRNA|16s rrna
55027|NCT03223987|Microbiome|microbiome
55028|NCT03223987|Strath Herbal Yeast Preparation|strath herbal yeast preparation
55029|NCT03223974|Angioplasty|angioplasty
55030|NCT03223974|drug-coated balloon|drug-coated balloon
55031|NCT03223974|bifurcation|bifurcation
55032|NCT03223961|myelodysplastic syndrome|myelodysplastic syndrome
55033|NCT03223961|erythropoetin|erythropoetin
55034|NCT03223922|whole brain radiation therapy|whole brain radiation therapy
55035|NCT03223922|genu of corpus callosum|genu of corpus callosum
55036|NCT03223922|cognitive function|cognitive function
55037|NCT03223909|dry eye|dry eye
55038|NCT03223909|Chondroitin sulfate|chondroitin sulfate
55039|NCT03223909|Ocular lubricants|ocular lubricants
55040|NCT03223896|antagonist|antagonist
55041|NCT03223896|nasal|nasal
55042|NCT03223857|visual outcomes|visual outcomes
55043|NCT03223857|multifocal intraocular lens|multifocal intraocular lens
55044|NCT03223857|patient satisfaction|patient satisfaction
55045|NCT03223857|spectacle independence|spectacle independence
55046|NCT03223844|Dopamine|dopamine
55047|NCT03223844|Amphetamine|amphetamine
55048|NCT03223844|Positron Emission Tomography|positron emission tomography
55049|NCT03223844|Magnetic Resonance Imaging|magnetic resonance imaging
55050|NCT03223844|Schizophrenia|schizophrenia
55051|NCT03223844|Psychosis|psychosis
55052|NCT03223844|[18F]FDOPA|[18f]fdopa
55053|NCT03223844|[11C]-(+)-PHNO|[11c]-(+)-phno
55054|NCT03223831|unresectable malignant gastric outlet obstruction|unresectable malignant gastric outlet obstruction
55055|NCT03223831|Partially covered pyloro-duodenal stents|partially covered pyloro-duodenal stents
55056|NCT03223831|uncovered pyloro-duodenal stents|uncovered pyloro-duodenal stents
55057|NCT03223818|Liver|liver
55058|NCT03223818|Digestive system|digestive system
55059|NCT03223779|Colorectal Cancer|colorectal cancer
55060|NCT03223766|Proton therapy|proton therapy
55061|NCT03223766|Long-term effects|long-term effects
55062|NCT03223727|Radium-223|radium-223
55063|NCT03223714|Conbercept ophthalmic injection|conbercept ophthalmic injection
55064|NCT03223714|ME|me
55065|NCT03223714|CRVO|crvo
55066|NCT03223662|Neoadjuvant Chemoradiotherapy (nCRT)|neoadjuvant chemoradiotherapy (ncrt)
55067|NCT03223662|Esophagectomy|esophagectomy
55068|NCT03223662|Tissue or serologic biomarkers|tissue or serologic biomarkers
55069|NCT03223649|Metabolism|metabolism
55070|NCT03223649|Children|children
55071|NCT03223649|Walking Bouts|walking bouts
55072|NCT03223649|Glucose|glucose
55073|NCT03223649|Insulin|insulin
55074|NCT03223636|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
55075|NCT03223636|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
55076|NCT03223636|Electroencephalogram (EEG)|electroencephalogram (eeg)
55077|NCT03223636|Magnetoencephalogram|magnetoencephalogram
55078|NCT03223636|Transcranial Electrical Stimulation (TES)|transcranial electrical stimulation (tes)
55079|NCT03223623|Complex Regional Pain Syndrome|complex regional pain syndrome
55080|NCT03223623|CRPS|crps
55081|NCT03223623|Dystonia|dystonia
55082|NCT03223610|Monoclonal Antibody|monoclonal antibody
55083|NCT03223610|Dose-Finding|dose-finding
55084|NCT03223597|Radium-223|radium-223
55085|NCT03223597|quality of life|quality of life
55086|NCT03223597|Pain|pain
55087|NCT03223571|stroke|stroke
55088|NCT03223571|Upper arm|upper arm
55089|NCT03223571|Cerebral plasticity|cerebral plasticity
55090|NCT03223571|Functional connectivity|functional connectivity
55091|NCT03223571|Rehabilitation|rehabilitation
55092|NCT03223558|cardiac rehabilitation|cardiac rehabilitation
55093|NCT03223545|mindfulness-based cognitive therapy|mindfulness-based cognitive therapy
55094|NCT03223545|Meditation|meditation
55095|NCT03223519|DOMS|doms
55096|NCT03223519|Exercise|exercise
55097|NCT03223519|Ibuprofen|ibuprofen
55098|NCT03223519|Magnesium|magnesium
55099|NCT03223519|Vitamin C|vitamin c
55100|NCT03223519|Muscle pain|muscle pain
55101|NCT03223467|Obesity|obesity
55102|NCT03223467|Obstructive sleep apnea|obstructive sleep apnea
55103|NCT03223467|Bariatric surgery candidate|bariatric surgery candidate
55104|NCT03223467|Metabolic syndrome|metabolic syndrome
55105|NCT03223441|Pulse wave velocity|pulse wave velocity
55106|NCT03223441|anesthesia|anesthesia
55107|NCT03223415|Clostridium difficile infection|clostridium difficile infection
55108|NCT03223415|Infection Control|infection control
55109|NCT03223415|Prevention|prevention
55110|NCT03223415|Asymptomatic carriage|asymptomatic carriage
55111|NCT03223415|Colonization|colonization
55112|NCT03223415|Pilot Study|pilot study
55113|NCT03223415|Contact Precaution|contact precaution
55114|NCT03223415|Detection|detection
55115|NCT03223363|Birth weight Prediction|birth weight prediction
55116|NCT03223363|Two-dimensional Ultrasonography|two-dimensional ultrasonography
55117|NCT03223363|Three-dimensional Ultrasonography|three-dimensional ultrasonography
55118|NCT03223337|GSK1278863|gsk1278863
55119|NCT03223337|Daprodustat|daprodustat
55120|NCT03223337|Healthy control|healthy control
55121|NCT03223337|Single dose|single dose
55122|NCT03223337|Hepatic Impairment|hepatic impairment
55123|NCT03223324|Threatened Premature Labor|threatened premature labor
55124|NCT03223324|Abdominal Fetal ECG|abdominal fetal ecg
55125|NCT03223298|Myofascial Pain|myofascial pain
55126|NCT03223298|Myofascial Pain Disorder|myofascial pain disorder
55127|NCT03223298|Maxillofacial Pain|maxillofacial pain
55128|NCT03223298|Masseter Muscle|masseter muscle
55129|NCT03223298|Temporalis Muscle|temporalis muscle
55130|NCT03223298|Botulinum Toxin|botulinum toxin
55131|NCT03223285|Cervical spine;|cervical spine;
55132|NCT03223285|Diaphragm;|diaphragm;
55133|NCT03223285|Manual Therapy|manual therapy
55134|NCT03223285|Pain|pain
55135|NCT03223285|Range of Motion|range of motion
55136|NCT03223272|hypertension|hypertension
55137|NCT03223272|sympathetic tone|sympathetic tone
55138|NCT03223272|resperpine|resperpine
55139|NCT03223259|Dance Injuries|dance injuries
55140|NCT03223259|Injury Prevention Workshops|injury prevention workshops
55141|NCT03223259|Motor Skill Theory|motor skill theory
55142|NCT03223259|Gross Motor Skills|gross motor skills
55143|NCT03223220|Stroke, Neuroprotection, Ketamine|stroke, neuroprotection, ketamine
55144|NCT03223194|Crigler-Najjar|crigler-najjar
55145|NCT03223194|CN|cn
55146|NCT03223194|AAV8 Delivered Gene Transfer|aav8 delivered gene transfer
55147|NCT03223194|Adeno Associated Virus|adeno associated virus
55148|NCT03223181|Comiss|comiss
55149|NCT03223155|Small cell lung cancer|small cell lung cancer
55150|NCT03223155|ipilimumab|ipilimumab
55151|NCT03223155|nivolumab|nivolumab
55152|NCT03223155|stereotactic body radiotherapy|stereotactic body radiotherapy
55153|NCT03223129|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
55154|NCT03223129|Impaired glucose tolerance|impaired glucose tolerance
55155|NCT03223129|Metabolomics|metabolomics
55156|NCT03223116|heartburn|heartburn
55157|NCT03223116|regurgitation|regurgitation
55158|NCT03223103|Brain cancer|brain cancer
55159|NCT03223103|Glioblastoma|glioblastoma
55160|NCT03223103|Personalized vaccine|personalized vaccine
55161|NCT03223103|Poly-ICLC|poly-iclc
55162|NCT03223103|Immunotherapy|immunotherapy
55163|NCT03223103|Cancer|cancer
55164|NCT03223103|NovoTTF-200A|novottf-200a
55165|NCT03223103|Optune|optune
55166|NCT03223103|GBM|gbm
55167|NCT03223103|immunogenicity|immunogenicity
55168|NCT03223090|Language|language
55169|NCT03223090|learning|learning
55170|NCT03223090|plasticity|plasticity
55171|NCT03223051|Spinal Muscular Atrophy|spinal muscular atrophy
55172|NCT03223051|Children|children
55173|NCT03223051|Motor assessment|motor assessment
55174|NCT03223051|Space exploration|space exploration
55175|NCT03223051|Upper limbs|upper limbs
55176|NCT03223038|Nutrition|nutrition
55177|NCT03223025|IGHD|ighd
55178|NCT03223025|somatropin|somatropin
55179|NCT03223012|Adalimumab|adalimumab
55180|NCT03223012|Humira®|humira®
55181|NCT03223012|AbbVie patient care support program|abbvie patient care support program
55182|NCT03222999|Out-of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
55183|NCT03222986|sepsis, nanoparticle tracking analysis|sepsis, nanoparticle tracking analysis
55184|NCT03222973|Remyelination|remyelination
55185|NCT03222973|Re-myelination|re-myelination
55186|NCT03222973|DMT|dmt
55187|NCT03222973|LINGO-1|lingo-1
55188|NCT03222973|Anti-LINGO-1|anti-lingo-1
55189|NCT03222973|Opicinumab|opicinumab
55190|NCT03222921|high tibial osteotomy|high tibial osteotomy
55191|NCT03222908|Behavior|behavior
55192|NCT03222908|Perioperative/Postoperative Complications|perioperative/postoperative complications
55193|NCT03222908|contract agreement|contract agreement
55194|NCT03222908|implementation intentions|implementation intentions
55195|NCT03222908|precommitment|precommitment
55196|NCT03222908|smoking cessation|smoking cessation
55197|NCT03222895|Esophageal Neoplasms|esophageal neoplasms
55198|NCT03222895|Lymph node metastases|lymph node metastases
55199|NCT03222895|Esophagectomy|esophagectomy
55200|NCT03222843|ITP|itp
55201|NCT03222804|Infants|infants
55202|NCT03222804|Probiotic|probiotic
55203|NCT03222804|B. Infantis|b. infantis
55204|NCT03222791|Diabetes|diabetes
55205|NCT03222778|fluid responsiveness|fluid responsiveness
55206|NCT03222778|tissue doppler|tissue doppler
55207|NCT03222778|off-pump coronary bypass surgery|off-pump coronary bypass surgery
55208|NCT03222765|prediabetes lifestyle drugs microvascular complications|prediabetes lifestyle drugs microvascular complications
55209|NCT03222752|Alpha-Stim|alpha-stim
55210|NCT03222752|Cranial Electrotherapy Stimulation|cranial electrotherapy stimulation
55211|NCT03222752|CES|ces
55212|NCT03222726|exercise, diabetic kidney disease, complications|exercise, diabetic kidney disease, complications
55213|NCT03222687|tacrolimus, Henoch-Schönlein purpura nephritis, children|tacrolimus, henoch-schönlein purpura nephritis, children
55214|NCT03222674|AML|aml
55215|NCT03222674|CAR T|car t
55216|NCT03222674|Muc1, CD33, CD38, CD56, and/or CD123|muc1, cd33, cd38, cd56, and/or cd123
55217|NCT03222648|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
55218|NCT03222648|Exercise training|exercise training
55219|NCT03222648|Health related quality of life|health related quality of life
55220|NCT03222648|Biomarkers|biomarkers
55221|NCT03222635|Barrett's esophagus|barrett's esophagus
55222|NCT03222635|Submucosal esophageal adenocarcinoma|submucosal esophageal adenocarcinoma
55223|NCT03222635|Endoscopic treatment|endoscopic treatment
55224|NCT03222635|Endoscopic follow-up|endoscopic follow-up
55225|NCT03222622|EGFR inhibitor, topical agent, psoriasis, phase 2|egfr inhibitor, topical agent, psoriasis, phase 2
55226|NCT03222609|Post-polycythemia vera MF (PPV-MF)|post-polycythemia vera mf (ppv-mf)
55227|NCT03222609|Post-essential thrombocythemia (PET-MF)|post-essential thrombocythemia (pet-mf)
55228|NCT03222609|ruxolitinib|ruxolitinib
55229|NCT03222609|navitoclax|navitoclax
55230|NCT03222609|splenic volume|splenic volume
55231|NCT03222609|Primary Myelofibrosis|primary myelofibrosis
55232|NCT03222609|Jakafi|jakafi
55233|NCT03222609|enlarged spleen|enlarged spleen
55234|NCT03222609|splenomegaly|splenomegaly
55235|NCT03222609|ABT 263|abt 263
55236|NCT03222609|bone marrow fibrosis|bone marrow fibrosis
55237|NCT03222596|Quality of Life|quality of life
55238|NCT03222596|Fatigue|fatigue
55239|NCT03222596|Physical Disability|physical disability
55240|NCT03222596|Disabilities Psychological|disabilities psychological
55241|NCT03222596|Pain|pain
55242|NCT03222596|Motivation|motivation
55243|NCT03222596|Multiple sclerosis|multiple sclerosis
55244|NCT03222583|Chronic Hepatitis C Virus (HCV)|chronic hepatitis c virus (hcv)
55245|NCT03222583|Genotype 1 to 6|genotype 1 to 6
55246|NCT03222583|Asian|asian
55247|NCT03222583|non-cirrhotic|non-cirrhotic
55248|NCT03222583|Human Immunodeficiency Virus|human immunodeficiency virus
55249|NCT03222583|co-infection|co-infection
55250|NCT03222583|Treatment-naïve|treatment-naïve
55251|NCT03222583|Treatment-experienced|treatment-experienced
55252|NCT03222583|interferon|interferon
55253|NCT03222544|Indocyanine Green|indocyanine green
55254|NCT03222544|Photodynamics Therapy|photodynamics therapy
55255|NCT03222518|acute pain, trauma, paracetamol, NSAID|acute pain, trauma, paracetamol, nsaid
55256|NCT03222505|Stroke|stroke
55257|NCT03222505|Gait Stride Management Assist|gait stride management assist
55258|NCT03222505|Stroke, post 1 year or longer|stroke, post 1 year or longer
55259|NCT03222492|Diffuse Cutaneous Systemic Sclerosis (dcSSc)|diffuse cutaneous systemic sclerosis (dcssc)
55260|NCT03222492|Phase 1/2 clinical trial|phase 1/2 clinical trial
55261|NCT03222492|dose escalation randomized trial|dose escalation randomized trial
55262|NCT03222492|Brentuximab vedotin|brentuximab vedotin
55263|NCT03222466|Patient educational materials; prostate cancer; co-creation|patient educational materials; prostate cancer; co-creation
55264|NCT03222453|thalassemia|thalassemia
55265|NCT03222453|stem cell|stem cell
55266|NCT03222388|IIEF|iief
55267|NCT03222388|electronic validation|electronic validation
55268|NCT03222375|Yaroshuk's MEGA-DISCOVERY · DIAGNOSTICS · TREATMENT|yaroshuk's mega-discovery · diagnostics · treatment
55269|NCT03222375|Yaroshuk's Scientific Medical School|yaroshuk's scientific medical school
55270|NCT03222375|Center of Synergetics|center of synergetics
55271|NCT03222375|Controlling spatiotemporal chaos/Dr. Synergetic|controlling spatiotemporal chaos/dr. synergetic
55272|NCT03222375|Autowave processes in Medicine|autowave processes in medicine
55273|NCT03222375|Autowave Reverberator|autowave reverberator
55274|NCT03222375|Bifurcation of Dynamic systems on a plane|bifurcation of dynamic systems on a plane
55275|NCT03222375|Spiral Autowaves|spiral autowaves
55276|NCT03222375|Drift of Spiral Autowaves|drift of spiral autowaves
55277|NCT03222375|Excitable medium and Cellular Automata|excitable medium and cellular automata
55278|NCT03222375|Stochastic Resonance and Coherence Resonance|stochastic resonance and coherence resonance
55279|NCT03222375|Autowaves/SQUED|autowaves/squed
55280|NCT03222375|Theory of Semiconducting QUantum Excitonic Device|theory of semiconducting quantum excitonic device
55281|NCT03222362|retinal detachment|retinal detachment
55282|NCT03222362|trauma|trauma
55283|NCT03222362|age related macular degeneration|age related macular degeneration
55284|NCT03222349|interictal state|interictal state
55285|NCT03222349|ictal/peri-ictal state|ictal/peri-ictal state
55286|NCT03222323|volunteers|volunteers
55287|NCT03222284|diabetes|diabetes
55288|NCT03222284|type 2 diabetes|type 2 diabetes
55289|NCT03222284|type ii diabetes|type ii diabetes
55290|NCT03222284|insulin|insulin
55291|NCT03222284|mobile applications|mobile applications
55292|NCT03222284|Diabetes Mellitus|diabetes mellitus
55293|NCT03222284|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
55294|NCT03222284|smartphone application|smartphone application
55295|NCT03222284|health application|health application
55296|NCT03222271|NIV weaning strategy|niv weaning strategy
55297|NCT03222258|Palliative Care|palliative care
55298|NCT03222258|Quality of Life|quality of life
55299|NCT03222258|Prospective Cohort Study|prospective cohort study
55300|NCT03222258|Treatment decision|treatment decision
55301|NCT03222258|Utilization of health care|utilization of health care
55302|NCT03222232|intestinal failure|intestinal failure
55303|NCT03222232|catheter-related bloodstream infections|catheter-related bloodstream infections
55304|NCT03222232|catheter salvage|catheter salvage
55305|NCT03222232|recurrent infections|recurrent infections
55306|NCT03222232|home parenteral support|home parenteral support
55307|NCT03222219|dental implant insertional torque stability|dental implant insertional torque stability
55308|NCT03222206|Hepatokine|hepatokine
55309|NCT03222206|Adipokine|adipokine
55310|NCT03222206|Saccharometabolism|saccharometabolism
55311|NCT03222206|Lipid metabolism|lipid metabolism
55312|NCT03222193|Medical device|medical device
55313|NCT03222193|Retraining|retraining
55314|NCT03222193|Snoring|snoring
55315|NCT03222193|TRP|trp
55316|NCT03222193|Tongue|tongue
55317|NCT03222167|Elbasvir|elbasvir
55318|NCT03222167|Grazoprevir|grazoprevir
55319|NCT03222167|SVR12|svr12
55320|NCT03222167|hepatitis C|hepatitis c
55321|NCT03222167|metabolic syndrome|metabolic syndrome
55322|NCT03222154|High Energy Shock Waves|high energy shock waves
55323|NCT03222154|physiotherapy|physiotherapy
55324|NCT03222141|Sapien 3|sapien 3
55325|NCT03222141|Transfemoral|transfemoral
55326|NCT03222141|Transapical|transapical
55327|NCT03222141|Transaortic|transaortic
55328|NCT03222141|TAVI|tavi
55329|NCT03222141|Aortic Stenosis|aortic stenosis
55330|NCT03222141|THV|thv
55331|NCT03222141|Aortic Valve|aortic valve
55332|NCT03222141|Transcatheter Heart Valve|transcatheter heart valve
55333|NCT03222141|TAVR|tavr
55334|NCT03222128|SAPIEN 3|sapien 3
55335|NCT03222128|Transfemoral|transfemoral
55336|NCT03222128|Transapical|transapical
55337|NCT03222128|Transaortic|transaortic
55338|NCT03222128|NovaFlex|novaflex
55339|NCT03222128|TAVI|tavi
55340|NCT03222128|Aortic Stenosis|aortic stenosis
55341|NCT03222128|THV|thv
55342|NCT03222128|Aortic Valve|aortic valve
55343|NCT03222128|Transcatheter Heart Valve|transcatheter heart valve
55344|NCT03222128|TAVR|tavr
55345|NCT03222076|Hepatocellular carcinoma|hepatocellular carcinoma
55346|NCT03222076|Resectable|resectable
55347|NCT03222076|Potentially resectable|potentially resectable
55348|NCT03222076|Nivolumab|nivolumab
55349|NCT03222076|BMS-936558|bms-936558
55350|NCT03222076|Opdivo|opdivo
55351|NCT03222076|Ipilimumab|ipilimumab
55352|NCT03222076|Yervoy|yervoy
55353|NCT03222076|BMS-734016|bms-734016
55354|NCT03222076|MDX010|mdx010
55355|NCT03222063|Play interventions, anxiety|play interventions, anxiety
55356|NCT03222024|ischaemic stroke|ischaemic stroke
55357|NCT03222024|severe|severe
55358|NCT03222024|malignant|malignant
55359|NCT03222024|courses|courses
55360|NCT03222024|risk factors|risk factors
55361|NCT03222024|clinical course|clinical course
55362|NCT03222024|management|management
55363|NCT03222024|prognosis|prognosis
55364|NCT03222011|Crohn Disease|crohn disease
55365|NCT03222011|Inflammatory Bowel Disease|inflammatory bowel disease
55366|NCT03222011|Intestinal stricture|intestinal stricture
55367|NCT03221998|morbidly obese|morbidly obese
55368|NCT03221998|,elective sleeve|,elective sleeve
55369|NCT03221998|gastrectomy|gastrectomy
55370|NCT03221998|paracetamol|paracetamol
55371|NCT03221998|IV Perfelgan|iv perfelgan
55372|NCT03221985|experience sampling method|experience sampling method
55373|NCT03221972|25 hydroxyvitamin D|25 hydroxyvitamin d
55374|NCT03221972|6-17 years old|6-17 years old
55375|NCT03221972|vitamin D deficiency|vitamin d deficiency
55376|NCT03221959|malignant middle cerebral artery infarction|malignant middle cerebral artery infarction
55377|NCT03221920|Very Low Carbohydrate Diet|very low carbohydrate diet
55378|NCT03221920|Colorectal Adenocarcinoma|colorectal adenocarcinoma
55379|NCT03221894|Complementary therapies|complementary therapies
55380|NCT03221868|motor activity|motor activity
55381|NCT03221868|women|women
55382|NCT03221842|Antibody-mediated kidney transplant rejection|antibody-mediated kidney transplant rejection
55383|NCT03221842|Renal|renal
55384|NCT03221829|spinal anaesthesia|spinal anaesthesia
55385|NCT03221829|elderly patients|elderly patients
55386|NCT03221829|transurethral resection of bladder tumour|transurethral resection of bladder tumour
55387|NCT03221816|Menopause|menopause
55388|NCT03221816|homocysteine|homocysteine
55389|NCT03221816|lipid profile|lipid profile
55390|NCT03221790|Irritable bowel syndrome|irritable bowel syndrome
55391|NCT03221790|Low FODMAP diet|low fodmap diet
55392|NCT03221790|Mucosal Inflammation|mucosal inflammation
55393|NCT03221751|randomized controlled trial|randomized controlled trial
55394|NCT03221738|BDD|bdd
55395|NCT03221725|sacrospinous ligament fixation|sacrospinous ligament fixation
55396|NCT03221725|stress urinary incontinence|stress urinary incontinence
55397|NCT03221712|cardiopulmonary exercise test|cardiopulmonary exercise test
55398|NCT03221712|chronic total occlusion|chronic total occlusion
55399|NCT03221712|cardiac rehabilitation|cardiac rehabilitation
55400|NCT03221673|Exercise|exercise
55401|NCT03221673|Children|children
55402|NCT03221673|Arkansas|arkansas
55403|NCT03221673|Physical activity|physical activity
55404|NCT03221673|Sedentary|sedentary
55405|NCT03221660|filling material, polymerization|filling material, polymerization
55406|NCT03221647|Celiac Disease; P31-43; Loxorubine; TLR7.|celiac disease; p31-43; loxorubine; tlr7.
55407|NCT03221634|Programmed cell death 1 receptor (PD1)|programmed cell death 1 receptor (pd1)
55408|NCT03221634|PD-1|pd-1
55409|NCT03221634|Programmed cell death ligand 1 receptor (PDL1)|programmed cell death ligand 1 receptor (pdl1)
55410|NCT03221634|PD-L1|pd-l1
55411|NCT03221621|Acne inversa|acne inversa
55412|NCT03221621|Adalimumab|adalimumab
55413|NCT03221621|Cost-effectiveness|cost-effectiveness
55414|NCT03221608|Colorectal Cancer|colorectal cancer
55415|NCT03221608|HIPEC|hipec
55416|NCT03221608|Peritoneal Carcinomatosis|peritoneal carcinomatosis
55417|NCT03221608|Lobaplatin|lobaplatin
55418|NCT03221556|Comparative effectiveness research|comparative effectiveness research
55419|NCT03221556|Patient-centered medical home|patient-centered medical home
55420|NCT03221556|Shared decision-making|shared decision-making
55421|NCT03221530|suicidal ideation|suicidal ideation
55422|NCT03221530|mental health|mental health
55423|NCT03221530|adolescent|adolescent
55424|NCT03221530|Latino|latino
55425|NCT03221530|immigrant|immigrant
55426|NCT03221504|urinary tract infections|urinary tract infections
55427|NCT03221504|pyelonephritis|pyelonephritis
55428|NCT03221504|cefuroxime|cefuroxime
55429|NCT03221504|children|children
55430|NCT03221491|Analgesia|analgesia
55431|NCT03221491|Colorectal Surgery|colorectal surgery
55432|NCT03221491|Background Infusion|background infusion
55433|NCT03221439|back pain|back pain
55434|NCT03221439|physiotherapy|physiotherapy
55435|NCT03221439|exercise therapy|exercise therapy
55436|NCT03221439|cognitive functional therapy|cognitive functional therapy
55437|NCT03221439|low back pain|low back pain
55438|NCT03221439|backache|backache
55439|NCT03221439|lower back pain|lower back pain
55440|NCT03221439|lumbago|lumbago
55441|NCT03221439|multidimensional|multidimensional
55442|NCT03221439|biopsychosocial|biopsychosocial
55443|NCT03221426|PD1|pd1
55444|NCT03221426|PD-1|pd-1
55445|NCT03221426|PDL1|pdl1
55446|NCT03221426|PD-L1|pd-l1
55447|NCT03221413|transcranial alternating current stimulation|transcranial alternating current stimulation
55448|NCT03221413|Neuroimaging|neuroimaging
55449|NCT03221413|EEG|eeg
55450|NCT03221387|Therapy|therapy
55451|NCT03221387|Noninvasive Ventilation|noninvasive ventilation
55452|NCT03221335|EUS-guided RFA|eus-guided rfa
55453|NCT03221335|liver|liver
55454|NCT03221335|stomach|stomach
55455|NCT03221335|adrenal|adrenal
55456|NCT03221335|kidney tumour|kidney tumour
55457|NCT03221283|Music therapy|music therapy
55458|NCT03221283|Depression|depression
55459|NCT03221283|Emotion|emotion
55460|NCT03221283|Motivation|motivation
55461|NCT03221270|tACS|tacs
55462|NCT03221270|Sham|sham
55463|NCT03221270|Auditory Hallucinations|auditory hallucinations
55464|NCT03221270|Schizophrenia|schizophrenia
55465|NCT03221270|Schizo Affective Disorder|schizo affective disorder
55466|NCT03221270|EEG|eeg
55467|NCT03221244|Distractibility|distractibility
55468|NCT03221244|Virtual Reality|virtual reality
55469|NCT03221244|Attention|attention
55470|NCT03221244|Child|child
55471|NCT03221244|Pediatric|pediatric
55472|NCT03221205|sleep apnea, obstructive|sleep apnea, obstructive
55473|NCT03221205|obesity|obesity
55474|NCT03221205|DM2|dm2
55475|NCT03221205|TEI index|tei index
55476|NCT03221205|CPAP|cpap
55477|NCT03221192|Real-time data capture|real-time data capture
55478|NCT03221192|Concept elicitation|concept elicitation
55479|NCT03221192|Nasal polyps|nasal polyps
55480|NCT03221192|Cognitive debriefing|cognitive debriefing
55481|NCT03221192|Patient-reported outcomes|patient-reported outcomes
55482|NCT03221192|HRQoL|hrqol
55483|NCT03221166|Children|children
55484|NCT03221166|Crohn disease|crohn disease
55485|NCT03221166|Thalidomide|thalidomide
55486|NCT03221166|Mucosal healing|mucosal healing
55487|NCT03221153|Patient Safety|patient safety
55488|NCT03221153|Quality|quality
55489|NCT03221153|Simulation|simulation
55490|NCT03221153|Undergraduate|undergraduate
55491|NCT03221153|Medical Student|medical student
55492|NCT03221114|Hispanics/Latinos|hispanics/latinos
55493|NCT03221114|Underserved Population|underserved population
55494|NCT03221075|Invasive Aspergillosis|invasive aspergillosis
55495|NCT03221075|Azole resistance|azole resistance
55496|NCT03221075|Aspergillus fumigatus|aspergillus fumigatus
55497|NCT03221075|Efficacy of antifungal therapy|efficacy of antifungal therapy
55498|NCT03221075|Patient registry|patient registry
55499|NCT03221049|diagnosis performance|diagnosis performance
55500|NCT03221049|hepatocellular carcinoma|hepatocellular carcinoma
55501|NCT03221049|liver fibrosis|liver fibrosis
55502|NCT03221049|progression|progression
55503|NCT03221036|Drug therapy|drug therapy
55504|NCT03221023|Vancomycin|vancomycin
55505|NCT03221023|Implantable Neural Stimulator|implantable neural stimulator
55506|NCT03221023|Deep Brain Stimulation|deep brain stimulation
55507|NCT03221023|Surgical Site Infection|surgical site infection
55508|NCT03221010|Smoking|smoking
55509|NCT03221010|Smoking cessation|smoking cessation
55510|NCT03221010|Motivational Interviewing|motivational interviewing
55511|NCT03221010|Primary health care|primary health care
55512|NCT03221010|Randomized clinical trial|randomized clinical trial
55513|NCT03220997|Sequela|sequela
55514|NCT03220997|Ketosis|ketosis
55515|NCT03220971|Lipoprotein and Apolipoproteins metabolism|lipoprotein and apolipoproteins metabolism
55516|NCT03220932|Epithelial Ovarian Cancer - Platinum-resistant - Cytoreductive surgery - HIPEC - Quality of Life|epithelial ovarian cancer - platinum-resistant - cytoreductive surgery - hipec - quality of life
55517|NCT03220919|Insulin|insulin
55518|NCT03220919|Type 2 diabetes|type 2 diabetes
55519|NCT03220880|Dexmedetomidine|dexmedetomidine
55520|NCT03220880|Sedation|sedation
55521|NCT03220880|Pediatric|pediatric
55522|NCT03220841|Crohn Disease|crohn disease
55523|NCT03220841|Inflammatory Bowel Disease|inflammatory bowel disease
55524|NCT03220841|Intestinal stricture|intestinal stricture
55525|NCT03220698|endotracheal intubation|endotracheal intubation
55526|NCT03220698|confirmation|confirmation
55527|NCT03220698|ultrasonography|ultrasonography
55528|NCT03220685|Microbiota|microbiota
55529|NCT03220672|Pelvic floor muscles|pelvic floor muscles
55530|NCT03220672|pelvic floor muscle training|pelvic floor muscle training
55531|NCT03220672|motor control|motor control
55532|NCT03220672|Educational intervention|educational intervention
55533|NCT03220672|menopause|menopause
55534|NCT03220646|Abemaciclib (LY2835219)|abemaciclib (ly2835219)
55535|NCT03220646|17-261|17-261
55536|NCT03220620|fluid therapy|fluid therapy
55537|NCT03220620|perioperative|perioperative
55538|NCT03220620|hemodilution|hemodilution
55539|NCT03220607|uterocervical angle, second trimester abortion|uterocervical angle, second trimester abortion
55540|NCT03220594|hypogastric artery|hypogastric artery
55541|NCT03220594|anti-mullerian hormone|anti-mullerian hormone
55542|NCT03220594|ovarian reserve|ovarian reserve
55543|NCT03220594|postpartum|postpartum
55544|NCT03220555|Buzzy|buzzy
55545|NCT03220555|anesthetic cream|anesthetic cream
55546|NCT03220555|pediatric|pediatric
55547|NCT03220555|pain|pain
55548|NCT03220555|venipuncture|venipuncture
55549|NCT03220555|vaccination|vaccination
55550|NCT03220555|vibration|vibration
55551|NCT03220555|cold|cold
55552|NCT03220555|distraction|distraction
55553|NCT03220555|vaccination center|vaccination center
55554|NCT03220542|Helicobacter Pylori|helicobacter pylori
55555|NCT03220542|Probiotics|probiotics
55556|NCT03220542|Sulforaphane|sulforaphane
55557|NCT03220477|Pembrolizumab|pembrolizumab
55558|NCT03220477|guadecitabine|guadecitabine
55559|NCT03220477|mocetinostat|mocetinostat
55560|NCT03220477|17-241|17-241
55561|NCT03220451|pressure ulcer|pressure ulcer
55562|NCT03220451|pressure sore|pressure sore
55563|NCT03220451|decubitus ulcer|decubitus ulcer
55564|NCT03220451|spinal cord injury|spinal cord injury
55565|NCT03220451|adhesive elastic bandage|adhesive elastic bandage
55566|NCT03220451|taping|taping
55567|NCT03220451|kinesio taping|kinesio taping
55568|NCT03220451|neuro taping|neuro taping
55569|NCT03220412|adolescent|adolescent
55570|NCT03220412|gun|gun
55571|NCT03220412|violence|violence
55572|NCT03220412|media|media
55573|NCT03220386|staphylococcus aureus|staphylococcus aureus
55574|NCT03220386|nosocomial infection|nosocomial infection
55575|NCT03220386|decolonization|decolonization
55576|NCT03220386|emergency department|emergency department
55577|NCT03220373|Neuropsychology|neuropsychology
55578|NCT03220373|Cognition|cognition
55579|NCT03220373|Drop-out|drop-out
55580|NCT03220373|Follow-up|follow-up
55581|NCT03220347|Non-Hodgkin's Lymphomas|non-hodgkin's lymphomas
55582|NCT03220347|Safety|safety
55583|NCT03220347|Efficacy|efficacy
55584|NCT03220347|CC-90010|cc-90010
55585|NCT03220347|Solid Tumors|solid tumors
55586|NCT03220347|Relapsed/Refractory|relapsed/refractory
55587|NCT03220308|Self-control|self-control
55588|NCT03220308|Well-being|well-being
55589|NCT03220269|Utstein|utstein
55590|NCT03220269|Resuscitation|resuscitation
55591|NCT03220269|Epidemiology|epidemiology
55592|NCT03220269|Emergency medicine|emergency medicine
55593|NCT03220269|Resuscitation Registry|resuscitation registry
55594|NCT03220230|Next generation sequencing|next generation sequencing
55595|NCT03220230|Lung cancer|lung cancer
55596|NCT03220230|target therapies|target therapies
55597|NCT03220204|Heart Failure|heart failure
55598|NCT03220204|Positive Psychology|positive psychology
55599|NCT03220204|Adherence to Health Behaviors|adherence to health behaviors
55600|NCT03220178|breast cancer|breast cancer
55601|NCT03220178|HER2 negative|her2 negative
55602|NCT03220178|hormone receptor positive|hormone receptor positive
55603|NCT03220178|advanced|advanced
55604|NCT03220178|metastatic|metastatic
55605|NCT03220113|Migraine|migraine
55606|NCT03220113|Craniofacial Neuralgia|craniofacial neuralgia
55607|NCT03220100|Lung Cancer|lung cancer
55608|NCT03219983|interscalene block|interscalene block
55609|NCT03219983|liposomal bupivacaine|liposomal bupivacaine
55610|NCT03219957|HCV|hcv
55611|NCT03219957|Hepatitis C Virus|hepatitis c virus
55612|NCT03219957|RNA Viruses|rna viruses
55613|NCT03219957|Flavivirus|flavivirus
55614|NCT03219957|Liver Diseases|liver diseases
55615|NCT03219957|Hepatitis, Viral, Human|hepatitis, viral, human
55616|NCT03219957|Flaviviridae Infections|flaviviridae infections
55617|NCT03219931|infant colics|infant colics
55618|NCT03219931|probiotic|probiotic
55619|NCT03219931|gut microbiome|gut microbiome
55620|NCT03219931|bifidobacterium breve|bifidobacterium breve
55621|NCT03219931|crying time|crying time
55622|NCT03219918|Colorectal adenoma|colorectal adenoma
55623|NCT03219918|Colonoscopy|colonoscopy
55624|NCT03219918|Caps|caps
55625|NCT03219918|Adenoma detection rate|adenoma detection rate
55626|NCT03219892|freezing of gait|freezing of gait
55627|NCT03219892|rTMS|rtms
55628|NCT03219892|fMRI|fmri
55629|NCT03219879|Relapse prevention|relapse prevention
55630|NCT03219879|Persistent depressive disorder|persistent depressive disorder
55631|NCT03219879|Recurrent depressive disorder|recurrent depressive disorder
55632|NCT03219879|Telephone-based intervention|telephone-based intervention
55633|NCT03219879|Cognitive behavioral therapy|cognitive behavioral therapy
55634|NCT03219866|Nebulizer|nebulizer
55635|NCT03219866|Inhaler|inhaler
55636|NCT03219840|Cetylpyridium Chloride (CPC)|cetylpyridium chloride (cpc)
55637|NCT03219840|Chewing Gum|chewing gum
55638|NCT03219814|body-image|body-image
55639|NCT03219814|attention|attention
55640|NCT03219814|cognitive dissonance|cognitive dissonance
55641|NCT03219814|eating disorder prevention|eating disorder prevention
55642|NCT03219788|emergence|emergence
55643|NCT03219788|remifentanil|remifentanil
55644|NCT03219788|recovery|recovery
55645|NCT03219788|desflurene|desflurene
55646|NCT03219775|tailored immuno therapy|tailored immuno therapy
55647|NCT03219775|Nivolumab|nivolumab
55648|NCT03219775|Ipilimumab|ipilimumab
55649|NCT03219775|boost|boost
55650|NCT03219749|obstructive sleep apnea|obstructive sleep apnea
55651|NCT03219749|exercise training|exercise training
55652|NCT03219749|vascular function|vascular function
55653|NCT03219710|Chemotherapy induced nausea and vomiting|chemotherapy induced nausea and vomiting
55654|NCT03219710|olanzapine|olanzapine
55655|NCT03219697|Childhood obesity prevention;|childhood obesity prevention;
55656|NCT03219658|Parenting|parenting
55657|NCT03219658|Home visiting|home visiting
55658|NCT03219658|Childhood obesity treatment|childhood obesity treatment
55659|NCT03219606|Systemic sclerosis|systemic sclerosis
55660|NCT03219606|Education|education
55661|NCT03219606|Modified Rodnan skin score|modified rodnan skin score
55662|NCT03219528|Irritable Bowel Syndrome|irritable bowel syndrome
55663|NCT03219528|Diarrhea|diarrhea
55664|NCT03219528|Small Intestinal Bacterial Overgrowth|small intestinal bacterial overgrowth
55665|NCT03219528|Gut Microbiota|gut microbiota
55666|NCT03219502|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
55790|NCT03219034|sleep apnea|sleep apnea
55667|NCT03219502|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
55668|NCT03219502|rTMS|rtms
55669|NCT03219502|Chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
55670|NCT03219502|CIPN|cipn
55671|NCT03219502|Electroencephalogram|electroencephalogram
55673|NCT03219502|Assessment Questionnaires|assessment questionnaires
55674|NCT03219502|Pain Questionnaires|pain questionnaires
55675|NCT03219502|Surveys|surveys
55676|NCT03219489|Electronic Medical Record|electronic medical record
55677|NCT03219489|Progesterone|progesterone
55678|NCT03219476|aromatase inhibitor|aromatase inhibitor
55679|NCT03219476|breast cancer|breast cancer
55680|NCT03219476|estrogen receptor|estrogen receptor
55681|NCT03219476|progesterone receptor|progesterone receptor
55682|NCT03219476|endocrine-targeted therapy|endocrine-targeted therapy
55683|NCT03219476|Anti-estrogen therapy|anti-estrogen therapy
55684|NCT03219476|HR+|hr+
55685|NCT03219476|HER2-negative|her2-negative
55686|NCT03219476|Neoadjuvant Treatment|neoadjuvant treatment
55687|NCT03219450|Leukemia|leukemia
55688|NCT03219450|Lymphocytic Leukemia|lymphocytic leukemia
55689|NCT03219437|ABBV-066|abbv-066
55690|NCT03219437|BI 655066|bi 655066
55691|NCT03219424|Return to work status|return to work status
55692|NCT03219424|Functional outcome|functional outcome
55693|NCT03219424|Quality of life|quality of life
55694|NCT03219398|Living donor laparoscopic nephrectomy|living donor laparoscopic nephrectomy
55695|NCT03219398|Pneumoperitoneum|pneumoperitoneum
55696|NCT03219398|Renal resistive index|renal resistive index
55697|NCT03219398|Syndecan-1|syndecan-1
55698|NCT03219398|soluble VEGF-R2|soluble vegf-r2
55699|NCT03219398|Occludin|occludin
55700|NCT03219398|KIM-1|kim-1
55701|NCT03219398|Interleukin-6|interleukin-6
55702|NCT03219385|uterine leiomyoma|uterine leiomyoma
55703|NCT03219385|uterine fibroid|uterine fibroid
55704|NCT03219385|uterine myoma|uterine myoma
55705|NCT03219385|abnormal menstrual bleeding|abnormal menstrual bleeding
55706|NCT03219385|heavy menstrual bleeding|heavy menstrual bleeding
55707|NCT03219385|menorrhagia|menorrhagia
55708|NCT03219385|high-intensity focused ultrasound|high-intensity focused ultrasound
55709|NCT03219385|ultrasound imaging|ultrasound imaging
55710|NCT03219359|IBD|ibd
55711|NCT03219359|Inflammatory Bowel Diseases|inflammatory bowel diseases
55712|NCT03219359|Gastroenteritis|gastroenteritis
55713|NCT03219359|Crohn's disease|crohn's disease
55714|NCT03219359|Colitis|colitis
55715|NCT03219359|Vedolizumab|vedolizumab
55716|NCT03219346|stroke , swallowing function ,oral health quality of life|stroke , swallowing function ,oral health quality of life
55717|NCT03219333|Enfortumab vedotin|enfortumab vedotin
55718|NCT03219333|Metastatic Urothelial Cancer|metastatic urothelial cancer
55719|NCT03219333|ASG-22CE|asg-22ce
55720|NCT03219333|Locally Advanced Urothelial Cancer|locally advanced urothelial cancer
55721|NCT03219333|Antibody-Drug Conjugate|antibody-drug conjugate
55722|NCT03219333|Nectin-4|nectin-4
55723|NCT03219333|Platinum-naïve|platinum-naïve
55724|NCT03219333|Cisplatin-ineligible|cisplatin-ineligible
55725|NCT03219333|Antineoplastic Agents|antineoplastic agents
55726|NCT03219333|Drug Therapy|drug therapy
55727|NCT03219333|ASG-22ME|asg-22me
55728|NCT03219320|Type 2 Diabetes|type 2 diabetes
55729|NCT03219320|Neuropathic Pain|neuropathic pain
55730|NCT03219320|Peripheral Nervous System|peripheral nervous system
55731|NCT03219307|cartilage repair|cartilage repair
55732|NCT03219307|cartilage regeneration|cartilage regeneration
55733|NCT03219307|cartilage reconstruction|cartilage reconstruction
55734|NCT03219307|cartilage restoration|cartilage restoration
55735|NCT03219307|autologous chondrocyte implantation|autologous chondrocyte implantation
55736|NCT03219307|matrix associated chondrocyte implantation|matrix associated chondrocyte implantation
55737|NCT03219294|neuromuscular blockade|neuromuscular blockade
55738|NCT03219294|sugammadex|sugammadex
55739|NCT03219255|Post-marketing|post-marketing
55740|NCT03219255|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
55741|NCT03219255|Drug use investigation|drug use investigation
55742|NCT03219255|RELVAR 100 ELLIPTA|relvar 100 ellipta
55743|NCT03219242|Advanced ovarian cancer|advanced ovarian cancer
55744|NCT03219229|Fat-free mass|fat-free mass
55745|NCT03219229|Tanner stage 1|tanner stage 1
55746|NCT03219229|Pre-pubertal|pre-pubertal
55747|NCT03219216|Chronic Hepatitis C Virus (HCV)|chronic hepatitis c virus (hcv)
55748|NCT03219216|Genotype 1 - 6|genotype 1 - 6
55749|NCT03219216|Metavir System Fibrosis Score|metavir system fibrosis score
55750|NCT03219216|Glecaprevir|glecaprevir
55751|NCT03219216|Pibrentasvir|pibrentasvir
55752|NCT03219216|Treatment naïve|treatment naïve
55753|NCT03219216|Cirrhosis|cirrhosis
55754|NCT03219216|Compensated cirrhosis|compensated cirrhosis
55755|NCT03219203|HBV vaccination|hbv vaccination
55756|NCT03219203|immunity|immunity
55757|NCT03219138|muscle function tests|muscle function tests
55758|NCT03219125|marrow adipose tissue|marrow adipose tissue
55759|NCT03219125|bone marrow adiposity|bone marrow adiposity
55760|NCT03219112|balance|balance
55761|NCT03219112|rehabilitation|rehabilitation
55762|NCT03219112|exergaming|exergaming
55763|NCT03219112|virtual reality|virtual reality
55764|NCT03219086|combined spinal epidural anesthesia|combined spinal epidural anesthesia
55765|NCT03219086|caesarian section|caesarian section
55766|NCT03219086|prilocaine|prilocaine
55767|NCT03219086|bupivacaine|bupivacaine
55768|NCT03219073|multiple sclerosis|multiple sclerosis
55769|NCT03219073|neuropathic pain|neuropathic pain
55770|NCT03219073|[18F] FDG-PET CT|[18f] fdg-pet ct
55771|NCT03219073|tDCS|tdcs
55772|NCT03219073|transcranial direct current stimulation|transcranial direct current stimulation
55773|NCT03219060|Cognitive dissonance|cognitive dissonance
55774|NCT03219060|Motivational interviewing|motivational interviewing
55775|NCT03219060|Health Professional role|health professional role
55776|NCT03219060|Nurses|nurses
55777|NCT03219060|Health Promotion|health promotion
55778|NCT03219060|Lifestyle|lifestyle
55779|NCT03219060|Smoking cessation|smoking cessation
55780|NCT03219047|Mantle Cell Lymphoma|mantle cell lymphoma
55781|NCT03219047|MCL|mcl
55782|NCT03219047|Relapsed/refractory|relapsed/refractory
55783|NCT03219047|Xenograft|xenograft
55784|NCT03219047|PDX|pdx
55785|NCT03219047|Ibrutinib|ibrutinib
55786|NCT03219047|PCI-32765|pci-32765
55787|NCT03219047|Imbruvica|imbruvica
55788|NCT03219034|oral appliance|oral appliance
55789|NCT03219034|sleep quality|sleep quality
55791|NCT03219021|Cleft lip and Palate|cleft lip and palate
55792|NCT03219021|unilateral cleft lip and palate|unilateral cleft lip and palate
55793|NCT03219021|surgically repaired cleft lip and palate|surgically repaired cleft lip and palate
55794|NCT03219021|arch dimensions|arch dimensions
55795|NCT03219021|arch discrepancies|arch discrepancies
55796|NCT03219021|dental arch dimensions|dental arch dimensions
55797|NCT03219021|arch parameter|arch parameter
55798|NCT03219021|arch circumference|arch circumference
55799|NCT03219021|intercanine width|intercanine width
55800|NCT03219021|first deciduous molar width|first deciduous molar width
55801|NCT03219021|second deciduous molar width|second deciduous molar width
55802|NCT03219021|permanent first molar width|permanent first molar width
55803|NCT03219008|depressive disorder|depressive disorder
55804|NCT03219008|multi-dimensional diagnosis technique|multi-dimensional diagnosis technique
55805|NCT03219008|individualized therapy|individualized therapy
55806|NCT03219008|management technique|management technique
55808|NCT03219008|MBC|mbc
55809|NCT03218995|DMD|dmd
55810|NCT03218995|Duchenne|duchenne
55811|NCT03218995|Eteplirsen|eteplirsen
55812|NCT03218995|dystrophy|dystrophy
55813|NCT03218995|dystrophin|dystrophin
55814|NCT03218995|exon 51|exon 51
55815|NCT03218982|Caregiver|caregiver
55816|NCT03218982|Vietnamese|vietnamese
55817|NCT03218982|Alzheimer's Disease|alzheimer's disease
55818|NCT03218956|Protein requirement|protein requirement
55819|NCT03218943|BiPAP|bipap
55820|NCT03218943|APRV|aprv
55821|NCT03218943|Physiological dead space|physiological dead space
55822|NCT03218943|volumetric capnography|volumetric capnography
55823|NCT03218943|ARDS|ards
55824|NCT03218943|impaired oxygenation|impaired oxygenation
55825|NCT03218943|ICU|icu
55826|NCT03218943|Mechanical ventilation|mechanical ventilation
55827|NCT03218930|General Practice|general practice
55828|NCT03218930|Social Marketing|social marketing
55829|NCT03218930|Behavior Change|behavior change
55830|NCT03218930|Antibiotic Prescribing|antibiotic prescribing
55831|NCT03218917|P aeruginosa|p aeruginosa
55832|NCT03218917|bronchiectasis|bronchiectasis
55833|NCT03218917|active neutrophil elastase|active neutrophil elastase
55834|NCT03218904|Glucose Breath Test|glucose breath test
55835|NCT03218891|Refractory Angina|refractory angina
55836|NCT03218891|Rehabilitation|rehabilitation
55837|NCT03218839|PrePex|prepex
55838|NCT03218839|HIV Seropositivity|hiv seropositivity
55839|NCT03218800|subcutaneous|subcutaneous
55840|NCT03218800|ertapenem|ertapenem
55841|NCT03218800|urinary tract infection|urinary tract infection
55842|NCT03218800|advanced cancer|advanced cancer
55843|NCT03218800|palliative care|palliative care
55844|NCT03218787|Coronary Artery Lesions|coronary artery lesions
55845|NCT03218787|XIENCE|xience
55846|NCT03218787|Dual Antiplatelet Therapy (DAPT)|dual antiplatelet therapy (dapt)
55847|NCT03218787|Reduced DAPT|reduced dapt
55848|NCT03218787|Risk of bleeding|risk of bleeding
55849|NCT03218787|Drug-eluting stents|drug-eluting stents
55850|NCT03218761|norepinephrine|norepinephrine
55851|NCT03218761|norepinephrine transporter|norepinephrine transporter
55852|NCT03218748|Mental illness|mental illness
55853|NCT03218748|Disclosure|disclosure
55854|NCT03218748|stigma|stigma
55855|NCT03218748|soldiers|soldiers
55856|NCT03218748|secrecy|secrecy
55857|NCT03218735|large for gestational age fetal growth|large for gestational age fetal growth
55858|NCT03218722|Acute traumatic coagulopathy|acute traumatic coagulopathy
55859|NCT03218722|Hemostasis|hemostasis
55860|NCT03218722|Severe hemorrhage|severe hemorrhage
55861|NCT03218696|cough|cough
55862|NCT03218696|children|children
55863|NCT03218696|Acute Upper Respiratory Tract Infection|acute upper respiratory tract infection
55864|NCT03218683|relapsed|relapsed
55865|NCT03218683|refractory|refractory
55866|NCT03218683|AZD5991|azd5991
55867|NCT03218683|Non-Hodgkin lymphoma|non-hodgkin lymphoma
55868|NCT03218683|Richter syndrome|richter syndrome
55869|NCT03218683|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
55870|NCT03218683|Small lymphocytic lymphoma|small lymphocytic lymphoma
55871|NCT03218683|T-cell lymphoma, Multiple myeloma|t-cell lymphoma, multiple myeloma
55872|NCT03218657|Aplastic Anemia|aplastic anemia
55873|NCT03218657|levamisole hydrochloride|levamisole hydrochloride
55874|NCT03218657|clinical study|clinical study
55875|NCT03218644|Proprioception|proprioception
55876|NCT03218631|oxandrolone, cardiac|oxandrolone, cardiac
55877|NCT03218605|Achilles tendon|achilles tendon
55878|NCT03218605|Warming-up|warming-up
55879|NCT03218605|Vascularisation|vascularisation
55880|NCT03218605|Physical activity|physical activity
55881|NCT03218605|Oxygen-to-See (O2C)|oxygen-to-see (o2c)
55882|NCT03218592|Adherence|adherence
55883|NCT03218592|Hair|hair
55884|NCT03218579|microbiome|microbiome
55885|NCT03218579|intestinal bacteria|intestinal bacteria
55886|NCT03218566|pulmonary embolism|pulmonary embolism
55887|NCT03218566|clot|clot
55888|NCT03218540|stroke volume variation|stroke volume variation
55889|NCT03218540|central venous pressure|central venous pressure
55890|NCT03218540|serum lactate|serum lactate
55891|NCT03218540|serum creatinine|serum creatinine
55892|NCT03218514|Obesity|obesity
55893|NCT03218514|Venous thromboembolism|venous thromboembolism
55894|NCT03218514|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight
55895|NCT03218514|Body Composition|body composition
55896|NCT03218514|Glomerular filtration rate|glomerular filtration rate
55897|NCT03218514|Bariatric Surgery|bariatric surgery
55898|NCT03218501|Uremic Pruritus|uremic pruritus
55899|NCT03218462|sensory adapted environment|sensory adapted environment
55900|NCT03218462|pediatric dentistry|pediatric dentistry
55901|NCT03218462|oral health|oral health
55902|NCT03218462|Developmental Disability|developmental disability
55903|NCT03218462|Intellectual Disability|intellectual disability
55904|NCT03218462|dental anxiety|dental anxiety
55905|NCT03218462|autism spectrum|autism spectrum
55906|NCT03218423|screening|screening
55907|NCT03218423|plasma|plasma
55908|NCT03218423|DNA methylation|dna methylation
55909|NCT03218410|surgical embolectomy|surgical embolectomy
55910|NCT03218410|catheter-directed therapy|catheter-directed therapy
55911|NCT03218397|Gram-negative Bacteremia|gram-negative bacteremia
55912|NCT03218397|ICU|icu
55913|NCT03218397|Critically ill|critically ill
55914|NCT03218397|Intensive Care Unit|intensive care unit
55915|NCT03218397|Rapid identification|rapid identification
55916|NCT03218397|Rapid susceptibility|rapid susceptibility
55917|NCT03218397|Accelerate PhenoTest™ BC Kit|accelerate phenotest™ bc kit
55918|NCT03218397|Accelerate Pheno™ System (AXDX)|accelerate pheno™ system (axdx)
55919|NCT03218397|Antimicrobial stewardship|antimicrobial stewardship
55920|NCT03218397|Antimicrobial use|antimicrobial use
55921|NCT03218384|Injectafer|injectafer
55922|NCT03218384|ferric carboxymaltose|ferric carboxymaltose
56117|NCT03216902|Glaucoma|glaucoma
55923|NCT03218384|Supplemental Iron|supplemental iron
55924|NCT03218371|scleral indentation|scleral indentation
55925|NCT03218371|chandelier light|chandelier light
55926|NCT03218371|air vitrectomy|air vitrectomy
55927|NCT03218371|rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
55928|NCT03218345|EUS-guided RFA|eus-guided rfa
55929|NCT03218345|pancreatic ca|pancreatic ca
55930|NCT03218345|interventional EUS|interventional eus
55931|NCT03218306|SPI|spi
55932|NCT03218306|Remifentanil|remifentanil
55933|NCT03218306|Target controlled infusion|target controlled infusion
55934|NCT03218280|trauma|trauma
55935|NCT03218280|antioxidant|antioxidant
55936|NCT03218280|oxidative stress|oxidative stress
55937|NCT03218280|Vitamin C|vitamin c
55938|NCT03218280|Ascorbic Acid|ascorbic acid
55939|NCT03218267|total hip replacement|total hip replacement
55940|NCT03218267|static disbalance|static disbalance
55941|NCT03218254|hematological cancer, fatigue, quality of life|hematological cancer, fatigue, quality of life
55942|NCT03218241|Healthy Volunteers|healthy volunteers
55943|NCT03218228|aggressive periodontitis|aggressive periodontitis
55944|NCT03218215|cough assits|cough assits
55945|NCT03218202|Inflammatory Bowel Disease|inflammatory bowel disease
55946|NCT03218202|Crohn Disease|crohn disease
55947|NCT03218202|Ulcerative Colitis|ulcerative colitis
55948|NCT03218202|Intestinal stricture|intestinal stricture
55949|NCT03218189|Essential medicines lists|essential medicines lists
55950|NCT03218163|bone marrow|bone marrow
55951|NCT03218163|bone marrow transplant|bone marrow transplant
55952|NCT03218163|allogeneic|allogeneic
55953|NCT03218163|Medi-551|medi-551
55954|NCT03218137|Subjects|subjects
55955|NCT03218137|diagnosed|diagnosed
55956|NCT03218124|Thyroidectomy|thyroidectomy
55957|NCT03218124|Remifentanil|remifentanil
55958|NCT03218124|Extubation|extubation
55959|NCT03218124|Cough|cough
55960|NCT03218124|Target controlled infusion|target controlled infusion
55961|NCT03218111|Glymphatic network|glymphatic network
55962|NCT03218111|healthy|healthy
55963|NCT03218111|central nervous system|central nervous system
55964|NCT03218085|tenofovir|tenofovir
55965|NCT03218085|prevention|prevention
55966|NCT03218085|microbiome|microbiome
55967|NCT03218085|cervicovaginal|cervicovaginal
55968|NCT03218085|biopsy|biopsy
55969|NCT03218085|swab|swab
55970|NCT03218085|cytokines|cytokines
55971|NCT03218085|inflammation|inflammation
55972|NCT03218085|pharmacology|pharmacology
55973|NCT03218059|Cesarean Scar Pregnancy|cesarean scar pregnancy
55974|NCT03218033|systemic lupus|systemic lupus
55975|NCT03218033|self-management|self-management
55976|NCT03218033|social media|social media
55977|NCT03217942|Muscle soreness|muscle soreness
55978|NCT03217942|NGF-induced pain|ngf-induced pain
55979|NCT03217942|Pain model|pain model
55980|NCT03217942|Long-lasting sensitization|long-lasting sensitization
55981|NCT03217929|vagus nerve|vagus nerve
55982|NCT03217929|obesity|obesity
55983|NCT03217929|craving|craving
55984|NCT03217929|food|food
55985|NCT03217916|podocyte glycoprotein|podocyte glycoprotein
55986|NCT03217916|kidney injury|kidney injury
55987|NCT03217916|preeclampsia|preeclampsia
55988|NCT03217903|Myelodysplastic syndromes|myelodysplastic syndromes
55989|NCT03217877|noninvasive stress testing|noninvasive stress testing
55990|NCT03217877|hign risk|hign risk
55991|NCT03217877|unstable angina|unstable angina
55992|NCT03217864|Cancer|cancer
55993|NCT03217864|palliative care|palliative care
55994|NCT03217864|hospitalization at home|hospitalization at home
55995|NCT03217864|home health care provider|home health care provider
55996|NCT03217851|Plasmodium falciparum|plasmodium falciparum
55997|NCT03217851|Prevalence Survey|prevalence survey
55998|NCT03217851|Antimalarial Drug|antimalarial drug
55999|NCT03217838|AML|aml
56000|NCT03217838|Acute Myeloid Leukaemia|acute myeloid leukaemia
56001|NCT03217838|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
56002|NCT03217838|AZD2811|azd2811
56003|NCT03217838|AZD1152|azd1152
56004|NCT03217838|AZD1152 hQPA|azd1152 hqpa
56005|NCT03217838|barasertib|barasertib
56006|NCT03217786|Macrovascular Disease|macrovascular disease
56007|NCT03217786|Microvascular Coronary Artery Disease|microvascular coronary artery disease
56008|NCT03217786|Cardiac Transplant Rejection|cardiac transplant rejection
56009|NCT03217786|Transplant; Failure, Heart|transplant; failure, heart
56010|NCT03217786|Intravascular ultrasound (IVUS)|intravascular ultrasound (ivus)
56011|NCT03217786|Optical Coherence Tomography|optical coherence tomography
56012|NCT03217786|Index of Microcirculatory Resistance|index of microcirculatory resistance
56013|NCT03217786|Fractional Flow Reserve|fractional flow reserve
56014|NCT03217786|Coronary Flow Reserve|coronary flow reserve
56015|NCT03217786|Positron Emission Tomography|positron emission tomography
56016|NCT03217786|Endomyocardial Biopsies|endomyocardial biopsies
56017|NCT03217760|Induced stress, dental anxiety, endodontic treatment, salivary cortisol, cardiovascular parameters, pain, discomfort.|induced stress, dental anxiety, endodontic treatment, salivary cortisol, cardiovascular parameters, pain, discomfort.
56018|NCT03217747|Metastatic solid tumors|metastatic solid tumors
57208|NCT03210064|Apatinib|apatinib
56019|NCT03217747|Advanced solid tumors|advanced solid tumors
56020|NCT03217747|Avelumab|avelumab
56021|NCT03217747|MSBOO10718C|msboo10718c
56022|NCT03217747|Utomilumab|utomilumab
56023|NCT03217747|PF-05082566|pf-05082566
56024|NCT03217747|Anti-CD137|anti-cd137
56025|NCT03217747|PF-04518600|pf-04518600
56026|NCT03217747|Cisplatin|cisplatin
56027|NCT03217747|Platinol-AQ|platinol-aq
56028|NCT03217747|Platinol|platinol
56029|NCT03217747|CDDP|cddp
56030|NCT03217747|Radiation Therapy|radiation therapy
56031|NCT03217747|XRT|xrt
56032|NCT03217695|Heart rate variability|heart rate variability
56033|NCT03217695|Self-efficacy|self-efficacy
56034|NCT03217695|Pediatrics|pediatrics
56035|NCT03217695|Mindfulness-based yoga|mindfulness-based yoga
56036|NCT03217695|Symptoms|symptoms
56037|NCT03217682|Hospice|hospice
56038|NCT03217682|Palliative Care|palliative care
56039|NCT03217682|Integrative Medicine|integrative medicine
56040|NCT03217682|Massage Therapy|massage therapy
56041|NCT03217682|Music Therapy|music therapy
56042|NCT03217682|Caregivers|caregivers
56043|NCT03217669|epacadostat|epacadostat
56044|NCT03217669|sirolimus|sirolimus
56045|NCT03217617|SCID-X1|scid-x1
56046|NCT03217617|lentiviral vector|lentiviral vector
56047|NCT03217604|PF-06852231|pf-06852231
56048|NCT03217604|Safety|safety
56049|NCT03217604|Tolerability|tolerability
56050|NCT03217604|Pharmacokinetics|pharmacokinetics
56051|NCT03217604|First-in-human|first-in-human
56052|NCT03217604|Healthy subjects|healthy subjects
56053|NCT03217578|Spinal Muscular Atrophy|spinal muscular atrophy
56054|NCT03217578|Newborn Screening|newborn screening
56055|NCT03217526|Burn injury|burn injury
56056|NCT03217526|Gait|gait
56057|NCT03217526|Physical Function|physical function
56058|NCT03217513|osteoporosis|osteoporosis
56059|NCT03217513|osteoarthritis|osteoarthritis
56060|NCT03217513|knee|knee
56061|NCT03217422|Type 1, Type 2, autoimmune hepatitis, AIH,|type 1, type 2, autoimmune hepatitis, aih,
56062|NCT03217396|synaptic plasticity|synaptic plasticity
56063|NCT03217396|neuroinflammation|neuroinflammation
56064|NCT03217396|neurodegeneration|neurodegeneration
56065|NCT03217383|Oral appliance therapy|oral appliance therapy
56066|NCT03217383|mandibular protrusion|mandibular protrusion
56067|NCT03217370|patient blood management|patient blood management
56068|NCT03217370|restrictive transfusion|restrictive transfusion
56069|NCT03217357|tDCS, non invasive brain stimulation|tdcs, non invasive brain stimulation
56070|NCT03217318|ureteral stent|ureteral stent
56071|NCT03217305|EIT. NAVA. Endexpiratory Lung Impedance.|eit. nava. endexpiratory lung impedance.
56072|NCT03217279|stroke-participation|stroke-participation
56073|NCT03217279|restriction-needs-cohort-patients-caregivers|restriction-needs-cohort-patients-caregivers
56074|NCT03217201|Breast Cancer|breast cancer
56075|NCT03217201|Oncology|oncology
56076|NCT03217201|Circadian Rhythm|circadian rhythm
56077|NCT03217201|Light Therapy|light therapy
56078|NCT03217201|Chemotherapy side effects|chemotherapy side effects
56079|NCT03217188|Proton Re-Irradiation|proton re-irradiation
56080|NCT03217188|17-300|17-300
56081|NCT03217175|bionic pancreas|bionic pancreas
56082|NCT03217175|type 1 diabetes|type 1 diabetes
56083|NCT03217123|OCD, DBS, fMRI, Y-BOCS, tractography|ocd, dbs, fmri, y-bocs, tractography
56084|NCT03217110|Cerebellum|cerebellum
56085|NCT03217097|Pancreatic neuroendocrine tumors|pancreatic neuroendocrine tumors
56086|NCT03217097|Broncho-pulmonary neuroendocrine tumors|broncho-pulmonary neuroendocrine tumors
56087|NCT03217097|O6-Methylguanine-DNA methyltransferase (MGMT) methylation|o6-methylguanine-dna methyltransferase (mgmt) methylation
56088|NCT03217097|Alkylating agents|alkylating agents
56089|NCT03217097|Oxaliplatin|oxaliplatin
56090|NCT03217084|White spot lesion ,fluoride varnish|white spot lesion ,fluoride varnish
56091|NCT03217071|non small cell lung cancer, resectable|non small cell lung cancer, resectable
56092|NCT03217058|digital health|digital health
56093|NCT03217058|implementation|implementation
56094|NCT03217058|primary care|primary care
56095|NCT03217032|Hemophilia A|hemophilia a
56096|NCT03217032|Hemophilia B|hemophilia b
56097|NCT03217032|factor VIII|factor viii
56098|NCT03217032|factor IX|factor ix
56099|NCT03217032|Gene therapy|gene therapy
56100|NCT03217032|lentiviral vector|lentiviral vector
56101|NCT03217019|Radial Artery|radial artery
56102|NCT03217019|Vascular Catheters|vascular catheters
56103|NCT03217006|coronary artery bypass surgery|coronary artery bypass surgery
56104|NCT03217006|multiple arterial graft|multiple arterial graft
56105|NCT03217006|radial artery graft|radial artery graft
56106|NCT03216993|feeding protocol|feeding protocol
56107|NCT03216980|cardiovascular disease|cardiovascular disease
56108|NCT03216980|vascular function|vascular function
56109|NCT03216980|PTSD|ptsd
56110|NCT03216941|Psychomotor agitation; Tranquilizing agents|psychomotor agitation; tranquilizing agents
56111|NCT03216928|Reverse Signaling|reverse signaling
56112|NCT03216928|Anti-TNF|anti-tnf
56113|NCT03216915|Heart Rhythm|heart rhythm
56114|NCT03216915|Fingolimod|fingolimod
56115|NCT03216915|autonomic nervous system|autonomic nervous system
56116|NCT03216915|Effects of Medicinal Substance|effects of medicinal substance
56118|NCT03216889|Multiple Sclerosis|multiple sclerosis
56119|NCT03216837|Perinatal stroke|perinatal stroke
56120|NCT03216837|hemiplegia|hemiplegia
56121|NCT03216837|hemiplegic cerebral palsy|hemiplegic cerebral palsy
56122|NCT03216772|Gynecologic Surgery|gynecologic surgery
56123|NCT03216772|larscopy|larscopy
56124|NCT03216772|morcellation|morcellation
56125|NCT03216759|Comprehensive intestinal protection strategy|comprehensive intestinal protection strategy
56126|NCT03216759|Intestinal complications|intestinal complications
56127|NCT03216759|laparotomy|laparotomy
56128|NCT03216746|oral health|oral health
56129|NCT03216746|knowledge|knowledge
56130|NCT03216746|adolescent|adolescent
56131|NCT03216733|DES|des
56132|NCT03216733|Angina pectoris|angina pectoris
56133|NCT03216733|Stent|stent
56134|NCT03216720|Coronary artery bypass grafting|coronary artery bypass grafting
56135|NCT03216720|Miniaturized extracorporeal circulation|miniaturized extracorporeal circulation
56136|NCT03216720|Thrombin generation|thrombin generation
56137|NCT03216655|congenital cataract|congenital cataract
56138|NCT03216655|anxiety|anxiety
56139|NCT03216655|guardian|guardian
56140|NCT03216642|Dacryocystitis|dacryocystitis
56141|NCT03216642|Bacteriology|bacteriology
56142|NCT03216642|Microbial Sensitivity Tests|microbial sensitivity tests
56143|NCT03216629|Pain|pain
56144|NCT03216629|Empathy|empathy
56145|NCT03216629|Dressing change|dressing change
56146|NCT03216616|fatigue|fatigue
56147|NCT03216616|Inflammatory Rheumatism|inflammatory rheumatism
56148|NCT03216616|Coping|coping
56149|NCT03216616|self-efficacy|self-efficacy
56150|NCT03216603|Health literacy|health literacy
56151|NCT03216590|Shoulder Arthroscopy|shoulder arthroscopy
56152|NCT03216590|Soft Tissue Swelling|soft tissue swelling
56153|NCT03216590|Rotator Cuff Repair|rotator cuff repair
56154|NCT03216590|Shoulder Arthroscopy Complications|shoulder arthroscopy complications
56155|NCT03216577|health-related quality of life|health-related quality of life
56156|NCT03216551|selective mediastinal lymphadenectomy|selective mediastinal lymphadenectomy
56157|NCT03216551|minimally invasive surgery|minimally invasive surgery
56158|NCT03216460|T1D, Omnipod|t1d, omnipod
56159|NCT03216447|adherence|adherence
56160|NCT03216447|conversion|conversion
56161|NCT03216447|advagraf|advagraf
56162|NCT03216447|prograf|prograf
56163|NCT03216434|post-traumatic stress disorder|post-traumatic stress disorder
56164|NCT03216434|dopamine|dopamine
56165|NCT03216434|biomarker|biomarker
56166|NCT03216421|DCIS|dcis
56167|NCT03216421|Intraoperative Radiation (IORT)|intraoperative radiation (iort)
56168|NCT03216421|Lumpectomy|lumpectomy
56169|NCT03216421|Breast Conserving Surgery|breast conserving surgery
56170|NCT03216382|High worry|high worry
56171|NCT03216382|Anxiety|anxiety
56172|NCT03216382|Attention Training Technique|attention training technique
56173|NCT03216382|Attention Control|attention control
56174|NCT03216382|Attention|attention
56175|NCT03216382|Mindfulness|mindfulness
56176|NCT03216382|Attention Bias|attention bias
56177|NCT03216382|Worry|worry
56178|NCT03216382|Pathological Worry|pathological worry
56179|NCT03216382|Anxiety Disorder|anxiety disorder
56180|NCT03216369|Arterial Spin Labeling|arterial spin labeling
56181|NCT03216369|MRI|mri
56182|NCT03216369|Perfusion|perfusion
56183|NCT03216369|Carotid artery stenting|carotid artery stenting
56184|NCT03216369|Carotid endarterectomy|carotid endarterectomy
56185|NCT03216330|Quantitative sensory test (QST)|quantitative sensory test (qst)
56186|NCT03216330|Deep dyspareunia|deep dyspareunia
56187|NCT03216330|Electronic Thimble Algometer|electronic thimble algometer
56188|NCT03216317|Hypertension|hypertension
56189|NCT03216317|Hypotension|hypotension
56190|NCT03216317|Cardiovascular system|cardiovascular system
56191|NCT03216278|healthy,|healthy,
56192|NCT03216278|fasted,|fasted,
56193|NCT03216278|fed|fed
56194|NCT03216226|Glucagon|glucagon
56195|NCT03216148|FET PET|fet pet
56196|NCT03216135|Microbiome|microbiome
56197|NCT03216109|Supportive Care|supportive care
56198|NCT03216109|Quality of Life|quality of life
56199|NCT03216083|colpocleisis|colpocleisis
56200|NCT03216083|vaginectomy|vaginectomy
56201|NCT03216083|tranexamic acid|tranexamic acid
56202|NCT03216070|Dasatinib|dasatinib
56203|NCT03216057|hypertriglyceridemia|hypertriglyceridemia
56204|NCT03216057|pediatric obesity|pediatric obesity
56205|NCT03216057|omega 3|omega 3
56206|NCT03216044|childbirth|childbirth
56207|NCT03216044|caesarean delivery|caesarean delivery
56208|NCT03216044|vaginal delivery|vaginal delivery
56209|NCT03216044|chronic pain|chronic pain
56210|NCT03216044|painful sexual intercourse|painful sexual intercourse
56211|NCT03216031|Falls prevention|falls prevention
56212|NCT03216031|Gardening|gardening
56213|NCT03216018|resilience|resilience
56214|NCT03216018|prevention program|prevention program
56215|NCT03216018|body-image|body-image
56216|NCT03216018|self-esteem|self-esteem
56217|NCT03215992|Diffuse Optical Tomography|diffuse optical tomography
56218|NCT03215966|bioequivalence|bioequivalence
56219|NCT03215953|offloading|offloading
56220|NCT03215953|plantar pressure|plantar pressure
56221|NCT03215953|Diabetic Foot Ulcer|diabetic foot ulcer
56222|NCT03215953|cast shoe|cast shoe
56223|NCT03215953|forefoot offloading shoe|forefoot offloading shoe
56224|NCT03215927|ILD|ild
56225|NCT03215914|Closed loop insulin delivery system|closed loop insulin delivery system
56226|NCT03215914|Insulin Pump|insulin pump
56227|NCT03215914|Glycemic control|glycemic control
56228|NCT03215914|Glucose Counterregulation|glucose counterregulation
56229|NCT03215901|Population-based survey|population-based survey
56230|NCT03215901|HIV treatment|hiv treatment
56231|NCT03215901|HIV testing|hiv testing
56232|NCT03215901|Survival expectations|survival expectations
56233|NCT03215901|Condom use|condom use
56234|NCT03215901|Life plans|life plans
56235|NCT03215901|South African young adults|south african young adults
56236|NCT03215862|Post-ERCP Acute Pancreatitis|post-ercp acute pancreatitis
56237|NCT03215862|Normal Saline|normal saline
56238|NCT03215862|Lactated Ringer's|lactated ringer's
56239|NCT03215823|Intubation|intubation
56240|NCT03215823|videolaryngoscope|videolaryngoscope
56241|NCT03215810|Stage IV|stage iv
56242|NCT03215810|NSCLC|nsclc
56243|NCT03215810|Recurrent|recurrent
56244|NCT03215810|TIL|til
56245|NCT03215810|Tumor-infiltrating Lymphocyte Therapy (TIL)|tumor-infiltrating lymphocyte therapy (til)
56246|NCT03215797|svv|svv
56247|NCT03215797|norepinephrine|norepinephrine
56248|NCT03215797|phenylephrine|phenylephrine
56249|NCT03215797|elderly|elderly
56250|NCT03215784|obesity|obesity
56251|NCT03215784|placenta|placenta
56252|NCT03215784|inflammation|inflammation
56253|NCT03215784|fish oil|fish oil
56254|NCT03215784|probiotics|probiotics
56255|NCT03215758|QAW039, uncontrolled asthma|qaw039, uncontrolled asthma
56256|NCT03215745|Delirium|delirium
56257|NCT03215745|Critical Care|critical care
56258|NCT03215745|Prevention & control|prevention & control
56259|NCT03215745|Clinical Trial|clinical trial
56260|NCT03215732|prevalence|prevalence
56261|NCT03215732|vaccine coverage|vaccine coverage
56262|NCT03215732|risk factors|risk factors
56263|NCT03215732|morbidity|morbidity
56264|NCT03215732|mortality|mortality
56265|NCT03215732|quality of life|quality of life
56266|NCT03215732|economic vulnerability|economic vulnerability
56267|NCT03215732|food security|food security
56268|NCT03215732|treatment needs|treatment needs
56269|NCT03215732|decentralized care|decentralized care
56270|NCT03215732|health costs|health costs
56271|NCT03215732|caregivers training|caregivers training
56272|NCT03215719|Radiation Therapy|radiation therapy
56273|NCT03215680|Urinary iodine concentration|urinary iodine concentration
56274|NCT03215654|mental health|mental health
56275|NCT03215654|promotion|promotion
56276|NCT03215654|prevention|prevention
56277|NCT03215654|adolescence|adolescence
56278|NCT03215654|school programs|school programs
56279|NCT03215654|intervention|intervention
56280|NCT03215641|obesity|obesity
56281|NCT03215641|pediatrics|pediatrics
56282|NCT03215641|weight management program|weight management program
56283|NCT03215641|Fitbit|fitbit
56284|NCT03215641|personal activity tracker|personal activity tracker
56285|NCT03215628|CEUS|ceus
56286|NCT03215628|TCEUS|tceus
56287|NCT03215628|contrast enhanced ultrasound|contrast enhanced ultrasound
56288|NCT03215628|perfusion|perfusion
56289|NCT03215628|cerebral perfusion|cerebral perfusion
56290|NCT03215628|sulphur hexafluoride|sulphur hexafluoride
56291|NCT03215628|SonoVue|sonovue
56292|NCT03215602|knee|knee
56293|NCT03215602|osteoarthritis|osteoarthritis
56294|NCT03215602|exercise|exercise
56295|NCT03215602|quadriceps|quadriceps
56296|NCT03215602|strength|strength
56297|NCT03215602|activities of daily living|activities of daily living
56298|NCT03215602|treatment outcome|treatment outcome
56299|NCT03215589|Near-infrared spectroscopy-derived cerebral oximetry|near-infrared spectroscopy-derived cerebral oximetry
56300|NCT03215563|atherosclerosis, imaging|atherosclerosis, imaging
56301|NCT03215550|atherosclerosis, imaging|atherosclerosis, imaging
56302|NCT03215537|physical activity|physical activity
56303|NCT03215537|cardiopulmonary function|cardiopulmonary function
56304|NCT03215537|quality of life|quality of life
56305|NCT03215537|Perioperative management|perioperative management
56306|NCT03215537|comprehensive intervention|comprehensive intervention
56307|NCT03215537|health behavior model|health behavior model
56308|NCT03215511|NTRK Fusion Positive|ntrk fusion positive
56309|NCT03215511|LOXO-195|loxo-195
56310|NCT03215511|Loxo|loxo
56311|NCT03215511|TRK|trk
56312|NCT03215511|TRK Fusion|trk fusion
56313|NCT03215511|NTRK1|ntrk1
56314|NCT03215511|NTRK2|ntrk2
56315|NCT03215511|NTRK3|ntrk3
56316|NCT03215511|TRKA|trka
56317|NCT03215511|TRKB|trkb
56318|NCT03215511|TRKC|trkc
56319|NCT03215511|NTRK|ntrk
56320|NCT03215511|ETV6|etv6
56321|NCT03215511|fusion|fusion
56322|NCT03215511|tumors|tumors
56323|NCT03215511|CNS tumors|cns tumors
56324|NCT03215511|solid tumors|solid tumors
56325|NCT03215511|central nervous system tumors|central nervous system tumors
56326|NCT03215511|advanced cancer|advanced cancer
56327|NCT03215511|primary CNS tumor|primary cns tumor
56328|NCT03215511|Advanced CNS tumor|advanced cns tumor
56329|NCT03215511|Metastatic CNS tumor|metastatic cns tumor
56330|NCT03215511|NTRK1 fusion|ntrk1 fusion
56331|NCT03215511|NTRK2 fusion|ntrk2 fusion
56332|NCT03215511|NTRK3 fusion|ntrk3 fusion
56333|NCT03215511|ETV6-NTRK3|etv6-ntrk3
56334|NCT03215511|ETV6 fusion|etv6 fusion
56335|NCT03215511|Metastatic cancer|metastatic cancer
56336|NCT03215511|Cancer of Unknown Primary Site|cancer of unknown primary site
56337|NCT03215511|Pediatric|pediatric
56338|NCT03215511|NTRK1 gene rearrangement|ntrk1 gene rearrangement
56339|NCT03215511|NTRK2 gene rearrangement|ntrk2 gene rearrangement
56340|NCT03215511|NTRK3 gene rearrangement|ntrk3 gene rearrangement
56341|NCT03215511|ETV6 gene rearrangement|etv6 gene rearrangement
56342|NCT03215511|NTRK gene rearragements|ntrk gene rearragements
56343|NCT03215511|Congenital Nephroma|congenital nephroma
56344|NCT03215511|Metastatic Infantile Fibrosarcoma|metastatic infantile fibrosarcoma
56345|NCT03215511|Advanced Infantile Fibrosarcoma|advanced infantile fibrosarcoma
56346|NCT03215485|adolescent|adolescent
56347|NCT03215485|sports|sports
56348|NCT03215485|nutrition|nutrition
56349|NCT03215485|physical activity|physical activity
56350|NCT03215485|body mass index|body mass index
56351|NCT03215485|virtual world|virtual world
56352|NCT03215459|Cardiopulmonary Exercise Testing|cardiopulmonary exercise testing
56353|NCT03215394|Social ABCs|social abcs
56354|NCT03215394|autism|autism
56355|NCT03215394|autism spectrum disorder|autism spectrum disorder
56356|NCT03215394|Early Intervention|early intervention
56357|NCT03215394|Toddler|toddler
56358|NCT03215394|Early Identification|early identification
56359|NCT03215394|Pivotal Response Treatment|pivotal response treatment
56360|NCT03215394|ASD|asd
56361|NCT03215394|PRT|prt
56362|NCT03215394|Control Group|control group
56363|NCT03215394|treatment Group|treatment group
56364|NCT03215394|At Risk|at risk
56365|NCT03215394|Social Communication|social communication
56366|NCT03215394|Positive Affect|positive affect
56367|NCT03215394|Smiling|smiling
56368|NCT03215394|Social Orienting|social orienting
56369|NCT03215394|Attentional Control|attentional control
56370|NCT03215394|Attentional Disengagement|attentional disengagement
56371|NCT03215394|Naturalistic Developmental Behaviour Intervention|naturalistic developmental behaviour intervention
56372|NCT03215394|NDBI|ndbi
56373|NCT03215381|Healthy Volunteer Male Subjects|healthy volunteer male subjects
56374|NCT03215355|Adaptive radiotherapy|adaptive radiotherapy
56375|NCT03215355|Contrast media|contrast media
56376|NCT03215355|Cone-beam computed tomography|cone-beam computed tomography
56377|NCT03215355|Stereotactic body radiation therapy|stereotactic body radiation therapy
56378|NCT03215342|Child|child
56379|NCT03215342|Rehabilitation|rehabilitation
56380|NCT03215342|Psychotherapy, groups|psychotherapy, groups
56381|NCT03215303|Asthma|asthma
56382|NCT03215303|Continuous positive airway pressure|continuous positive airway pressure
56383|NCT03215303|Oxygen consumption|oxygen consumption
56384|NCT03215277|Ankylosing Spondylitis|ankylosing spondylitis
56385|NCT03215277|Bimekizumab|bimekizumab
56386|NCT03215277|AS|as
56387|NCT03215277|Certolizumab Pegol|certolizumab pegol
56388|NCT03215277|Cimzia|cimzia
56389|NCT03215251|Thirst, Dry Mouth, Intervention Bundle|thirst, dry mouth, intervention bundle
56390|NCT03215225|Endodontology|endodontology
56391|NCT03215225|Endodontics|endodontics
56392|NCT03215212|ear plug|ear plug
56393|NCT03215212|eye mask|eye mask
56394|NCT03215212|ocean sound|ocean sound
56395|NCT03215212|sleep quality|sleep quality
56396|NCT03215212|intensive care unit|intensive care unit
56397|NCT03215186|congenital cataract|congenital cataract
56398|NCT03215186|risk factor|risk factor
56399|NCT03215186|mathematic model|mathematic model
56400|NCT03215160|Mobilization|mobilization
56401|NCT03215160|Manual Therapies|manual therapies
56402|NCT03215160|Exercise|exercise
56403|NCT03215147|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
56404|NCT03215147|Airway Disease|airway disease
56405|NCT03215134|Improving Access to Psychological Therapies (IAPT)|improving access to psychological therapies (iapt)
56406|NCT03215134|Primary mental health service|primary mental health service
56407|NCT03215134|Compassion Focused Therapy (CFT)|compassion focused therapy (cft)
56408|NCT03215095|Radioiodine (RAI)|radioiodine (rai)
56409|NCT03215095|Durvalumab (Medi4736)|durvalumab (medi4736)
56410|NCT03215095|RAI-avid|rai-avid
56411|NCT03215095|17-218|17-218
56412|NCT03215043|Eriocitrin|eriocitrin
56413|NCT03215043|Intermediate hyperglycemia|intermediate hyperglycemia
56414|NCT03215043|Citrus bioflavonoids|citrus bioflavonoids
56415|NCT03215030|Drug therapy|drug therapy
56416|NCT03215004|Volunteer|volunteer
56417|NCT03215004|HIV|hiv
56418|NCT03215004|Leukapheresis|leukapheresis
56419|NCT03214978|thyroid|thyroid
56420|NCT03214965|Kidney transplantation|kidney transplantation
56421|NCT03214965|Facebook|facebook
56422|NCT03214965|Education|education
56423|NCT03214965|Adolescent|adolescent
56424|NCT03214965|Social Networking|social networking
56425|NCT03214939|dendritic cell, IL-12, IL-18, cytotoxicity|dendritic cell, il-12, il-18, cytotoxicity
56426|NCT03214926|Parkinson's disease|parkinson's disease
56427|NCT03214926|Dance|dance
56428|NCT03214926|Google Glass|google glass
56429|NCT03214926|Mobility|mobility
56430|NCT03214926|Balance|balance
56431|NCT03214913|resuscitation|resuscitation
56432|NCT03214913|fluid therapy|fluid therapy
56433|NCT03214887|Hyaluronan|hyaluronan
56434|NCT03214887|Bone marrow mononuclear cells|bone marrow mononuclear cells
56435|NCT03214848|Long-acting reversible contraceptive|long-acting reversible contraceptive
56436|NCT03214848|Post Abortion|post abortion
56437|NCT03214848|Iintrauterine device|iintrauterine device
56438|NCT03214848|Contraceptive implant|contraceptive implant
56439|NCT03214848|LARC|larc
56440|NCT03214848|IUD|iud
56441|NCT03214835|Larynx|larynx
56442|NCT03214835|reflux|reflux
56443|NCT03214835|LPR|lpr
56444|NCT03214835|tumor|tumor
56445|NCT03214835|lesion|lesion
56446|NCT03214822|Microbiome|microbiome
56447|NCT03214809|ultrasound|ultrasound
56448|NCT03214809|MET team|met team
56449|NCT03214809|Concordance|concordance
56450|NCT03214783|artificial intelligence|artificial intelligence
56451|NCT03214783|facial recognition|facial recognition
56452|NCT03214783|facial characteristic|facial characteristic
56453|NCT03214731|artesunate|artesunate
56454|NCT03214705|CT perfusion|ct perfusion
56455|NCT03214705|Subarachnoid hemorrhage|subarachnoid hemorrhage
56456|NCT03214705|Vasospasm|vasospasm
56457|NCT03214705|Delayed cerebral ischemia|delayed cerebral ischemia
56458|NCT03214692|Gum Arabic|gum arabic
56459|NCT03214692|Renal failure|renal failure
56460|NCT03214692|Hemodialysis|hemodialysis
56461|NCT03214692|Antioxidant and anti-inflammatory|antioxidant and anti-inflammatory
56462|NCT03214679|Hepatitis C|hepatitis c
56463|NCT03214679|HCV|hcv
56464|NCT03214679|PWID|pwid
56465|NCT03214679|People who inject drugs|people who inject drugs
56466|NCT03214666|MDS|mds
56467|NCT03214666|AML|aml
56468|NCT03214640|neuraxial analgesia|neuraxial analgesia
56469|NCT03214640|spinal block|spinal block
56470|NCT03214640|epidural block|epidural block
56471|NCT03214588|Drug Therapy|drug therapy
56472|NCT03214575|Central Venous Vascular Access|central venous vascular access
56473|NCT03214575|Intensive Care Unit|intensive care unit
56474|NCT03214575|Needle Navigation Technology|needle navigation technology
56475|NCT03214562|Other diseases of blood and blood-forming organs|other diseases of blood and blood-forming organs
56476|NCT03214562|Acute Myeloid Leukemia|acute myeloid leukemia
56477|NCT03214562|AML|aml
56478|NCT03214562|Newly diagnosed|newly diagnosed
56479|NCT03214562|Relapsed/refractory|relapsed/refractory
56480|NCT03214562|Fludarabine|fludarabine
56481|NCT03214562|Fludarabine phosphate|fludarabine phosphate
56482|NCT03214562|Fludara|fludara
56483|NCT03214562|Cytarabine|cytarabine
56484|NCT03214562|Ara-C|ara-c
56485|NCT03214562|Cytosar|cytosar
56486|NCT03214562|DepoCyt|depocyt
56487|NCT03214562|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
56488|NCT03214562|Idarubicin|idarubicin
56489|NCT03214562|Idamycin|idamycin
56490|NCT03214562|Filgrastim|filgrastim
56491|NCT03214562|G-CSF|g-csf
56492|NCT03214562|Neupogen|neupogen
56493|NCT03214562|Pegylated filgrastim|pegylated filgrastim
56494|NCT03214562|Neulasta|neulasta
56495|NCT03214562|Venetoclax|venetoclax
56496|NCT03214562|ABT-199|abt-199
56497|NCT03214562|GDC-0199|gdc-0199
56498|NCT03214536|spine surgery|spine surgery
56499|NCT03214536|regional anaesthesia|regional anaesthesia
56500|NCT03214536|opioid consumption|opioid consumption
56501|NCT03214536|acute postoperative pain|acute postoperative pain
56502|NCT03214523|sleep|sleep
56503|NCT03214523|actigraphy|actigraphy
56504|NCT03214510|Diseases of liver|diseases of liver
56505|NCT03214510|Thoracic epidural analgesia|thoracic epidural analgesia
56506|NCT03214510|TEA|tea
56507|NCT03214510|Transversus abdominus plane|transversus abdominus plane
56508|NCT03214510|TAP|tap
56509|NCT03214510|Liver resection|liver resection
56510|NCT03214510|Bupivacaine|bupivacaine
56511|NCT03214510|Liposomal Bupivacaine|liposomal bupivacaine
56512|NCT03214510|Hydromorphone|hydromorphone
56513|NCT03214510|Questionnaires|questionnaires
56514|NCT03214510|Surveys|surveys
56515|NCT03214497|laryngeal mask|laryngeal mask
56516|NCT03214497|Supreme|supreme
56517|NCT03214497|Protector|protector
56518|NCT03214471|bariatric surgery|bariatric surgery
56519|NCT03214471|healthy lifestyle|healthy lifestyle
56520|NCT03214458|Therapy|therapy
56521|NCT03214458|Noninvasive Ventilation|noninvasive ventilation
56522|NCT03214432|Mild traumatic brain injury|mild traumatic brain injury
56523|NCT03214432|Concussion|concussion
56524|NCT03214432|Labour market affiliation|labour market affiliation
56525|NCT03214432|Return to work|return to work
56526|NCT03214432|Sickness absence|sickness absence
56527|NCT03214432|Long-term sickness absence|long-term sickness absence
56528|NCT03214432|Disability pension|disability pension
56529|NCT03214419|Breast cancer|breast cancer
56530|NCT03214419|3D Optical scanning|3d optical scanning
56531|NCT03214419|Preoperative MRI|preoperative mri
56532|NCT03214419|Tumor localization|tumor localization
56533|NCT03214354|sickle cell disease|sickle cell disease
56534|NCT03214354|stem cell transplant|stem cell transplant
56535|NCT03214354|red blood cell engraftment|red blood cell engraftment
56536|NCT03214354|nonmyeloablative|nonmyeloablative
56537|NCT03214354|pure red cell aplasia|pure red cell aplasia
56538|NCT03214341|mediastinal masses|mediastinal masses
56539|NCT03214341|MRI diffusion|mri diffusion
56540|NCT03214315|Prostatectomy|prostatectomy
56541|NCT03214302|antiviral treatment|antiviral treatment
56542|NCT03214302|hepatitis B virus|hepatitis b virus
56543|NCT03214302|pregnant woman|pregnant woman
56544|NCT03214302|Postpartum hepatitis|postpartum hepatitis
56545|NCT03214289|Fecal Microbiota Transplantation|fecal microbiota transplantation
56546|NCT03214289|Intestinal Acute Graft Versus Host Disease|intestinal acute graft versus host disease
56547|NCT03214289|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
56548|NCT03214276|polyphenols|polyphenols
56549|NCT03214276|cycling|cycling
56550|NCT03214276|endurance|endurance
56551|NCT03214276|aerobic|aerobic
56552|NCT03214276|pain|pain
56553|NCT03214263|Inflammatory rheumatic diseases|inflammatory rheumatic diseases
56554|NCT03214263|Biomarkers|biomarkers
56555|NCT03214263|Tailored treatment|tailored treatment
56556|NCT03214263|Personalised medicine|personalised medicine
56557|NCT03214263|DANBIO|danbio
56558|NCT03214263|Danish Rheumatologic Biobank|danish rheumatologic biobank
56559|NCT03214263|clinical data|clinical data
56560|NCT03214250|Nivolumab|nivolumab
56561|NCT03214250|APX005M|apx005m
56562|NCT03214250|previously untreated metastatic pancreatic adenocarcinoma|previously untreated metastatic pancreatic adenocarcinoma
56563|NCT03214250|Gemcitabine|gemcitabine
56564|NCT03214250|nab-Paclitaxel|nab-paclitaxel
56565|NCT03214224|Telemedicine|telemedicine
56566|NCT03214224|Pulmonary Function Testing|pulmonary function testing
56567|NCT03214224|Telehealth|telehealth
56568|NCT03214185|unexplained recurrent pregnancy loss|unexplained recurrent pregnancy loss
56569|NCT03214185|infertility, female|infertility, female
56570|NCT03214185|preimplantation genetic screening|preimplantation genetic screening
56571|NCT03214185|in vitro fertilization|in vitro fertilization
56572|NCT03214185|intracytoplasmic sperm injection|intracytoplasmic sperm injection
56573|NCT03214146|ALS|als
56574|NCT03214146|Motor Neuron Disease|motor neuron disease
56575|NCT03214146|Neuromuscular Disease|neuromuscular disease
56576|NCT03214146|Neurodegenerative Disease|neurodegenerative disease
56577|NCT03214146|Central Nervous System Disease|central nervous system disease
56578|NCT03214146|HLA-haplo matched allogenic bone marrow derived stem cells|hla-haplo matched allogenic bone marrow derived stem cells
56579|NCT03214120|thromboelastography, modified ultrafiltration|thromboelastography, modified ultrafiltration
56580|NCT03214107|Exercise|exercise
56581|NCT03214107|Hypoglycemia|hypoglycemia
56582|NCT03214107|Carbohydrates|carbohydrates
56583|NCT03214029|troponin|troponin
56584|NCT03214029|high-sensitivity cardiac troponin|high-sensitivity cardiac troponin
56585|NCT03214029|acute myocardial infarction|acute myocardial infarction
56586|NCT03214016|Pilates Training|pilates training
56587|NCT03214016|Aerobic Exercises|aerobic exercises
56588|NCT03214016|Hypertension|hypertension
56589|NCT03214016|Clinical trial|clinical trial
56590|NCT03214003|small cell lung cancer limited stage|small cell lung cancer limited stage
56591|NCT03214003|twice-daily radiotherapy|twice-daily radiotherapy
56592|NCT03214003|simultaneous integrated boosting technique|simultaneous integrated boosting technique
56593|NCT03213990|Sepsis|sepsis
56594|NCT03213990|Beta-lactam antibiotics|beta-lactam antibiotics
56595|NCT03213977|DLBCL, R-DA-EPOCH, R-CEOP90, auto-HSCT|dlbcl, r-da-epoch, r-ceop90, auto-hsct
56596|NCT03213964|Recurrent|recurrent
56597|NCT03213964|Platinum Resistant|platinum resistant
56598|NCT03213964|Platinum Sensitive|platinum sensitive
56599|NCT03213951|Surgical resection|surgical resection
56600|NCT03213951|Margins of resection|margins of resection
56601|NCT03213951|Beta radiopharmaceutical|beta radiopharmaceutical
56602|NCT03213951|Beta probe device|beta probe device
56603|NCT03213951|Ex-vivo|ex-vivo
56604|NCT03213938|Chronic prostatitis|chronic prostatitis
56605|NCT03213938|chronic pelvic pain syndrome|chronic pelvic pain syndrome
56606|NCT03213938|acupuncture|acupuncture
56607|NCT03213938|randomized controlled trial|randomized controlled trial
56608|NCT03213912|effective concentration|effective concentration
56609|NCT03213899|Subjective Global Assessment|subjective global assessment
56610|NCT03213899|Nutritional Status|nutritional status
56611|NCT03213899|Hospital Mortality|hospital mortality
56612|NCT03213899|Length of Stay|length of stay
56613|NCT03213899|Malnutrition|malnutrition
56614|NCT03213886|hip fracture|hip fracture
56615|NCT03213886|elderly|elderly
56616|NCT03213886|vitamin D|vitamin d
56617|NCT03213886|rehabilitation|rehabilitation
56618|NCT03213873|Balance control|balance control
56619|NCT03213873|Exercise|exercise
56620|NCT03213873|Magnetic Resonance Imaging|magnetic resonance imaging
56621|NCT03213873|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
56622|NCT03213847|Carpal Tunnel Syndrome|carpal tunnel syndrome
56623|NCT03213847|Superb microvascular imaging|superb microvascular imaging
56624|NCT03213847|Doppler ultrasound|doppler ultrasound
56625|NCT03213847|Ultrasound|ultrasound
56626|NCT03213847|Median Nerve Entrapment|median nerve entrapment
56627|NCT03213847|Diagnoses Disease|diagnoses disease
56628|NCT03213808|Allergic diseases|allergic diseases
56629|NCT03213808|hypersensitivity|hypersensitivity
56630|NCT03213808|International Classification of Diseases (ICD)|international classification of diseases (icd)
56631|NCT03213808|World Health Organization (WHO)|world health organization (who)
56632|NCT03213782|Nature Based Sounds|nature based sounds
56633|NCT03213782|Agitation|agitation
56634|NCT03213782|Anxiety|anxiety
56635|NCT03213782|Patients|patients
56636|NCT03213782|Intensive Care Units|intensive care units
56637|NCT03213769|oral minor aphthous ulcer|oral minor aphthous ulcer
56638|NCT03213769|topical Q10 gel|topical q10 gel
56639|NCT03213769|topical antioxidant|topical antioxidant
56640|NCT03213769|oral recurrent aphthous ulcer|oral recurrent aphthous ulcer
56641|NCT03213769|oral aphthous stomatitis|oral aphthous stomatitis
56642|NCT03213756|doppler ultrasound|doppler ultrasound
56643|NCT03213756|physical exercise|physical exercise
56644|NCT03213756|arteriovenous fistula maturation|arteriovenous fistula maturation
56645|NCT03213717|Obesity|obesity
56646|NCT03213717|Loading|loading
56647|NCT03213717|Edema|edema
56648|NCT03213717|Urine|urine
56649|NCT03213613|Teen health|teen health
56650|NCT03213613|Teen development|teen development
56651|NCT03213613|Adolescent development|adolescent development
56652|NCT03213613|Memory|memory
56653|NCT03213613|Attention|attention
56654|NCT03213613|Reward processing|reward processing
56655|NCT03213574|Goal directed fluid therapy|goal directed fluid therapy
56656|NCT03213548|alar base reduction|alar base reduction
56657|NCT03213548|alar facial groove|alar facial groove
56658|NCT03213548|alectomy|alectomy
56659|NCT03213548|Flare|flare
56660|NCT03213548|Nose|nose
56661|NCT03213535|PROM|prom
56662|NCT03213496|clinical trial, non cardiac surgery, walking.|clinical trial, non cardiac surgery, walking.
56663|NCT03213483|gingival recession|gingival recession
56664|NCT03213483|connective tissue graft|connective tissue graft
56665|NCT03213483|deepithelialized free gingival graft|deepithelialized free gingival graft
56666|NCT03213483|free gingival graft|free gingival graft
56667|NCT03213457|Elagolix|elagolix
56668|NCT03213457|Endometriosis associated pain|endometriosis associated pain
56669|NCT03213457|Dysmenorrhea (DYS)|dysmenorrhea (dys)
56670|NCT03213457|Non-menstrual pelvic pain (NMPP)|non-menstrual pelvic pain (nmpp)
56671|NCT03213444|Colon cancer|colon cancer
56672|NCT03213444|adjuvant chemotherapy|adjuvant chemotherapy
56673|NCT03213444|sympathetic nerve activity|sympathetic nerve activity
56674|NCT03213444|peripheral vascular function|peripheral vascular function
56675|NCT03213431|Cancer survivors|cancer survivors
56676|NCT03213431|Instrument development|instrument development
56677|NCT03213431|Neurocognitive functioning|neurocognitive functioning
56678|NCT03213431|Patient-reported outcomes|patient-reported outcomes
56679|NCT03213431|Qualitative interview|qualitative interview
56680|NCT03213405|human Respiratory Syncytial Virus|human respiratory syncytial virus
56681|NCT03213405|Phase I|phase i
56682|NCT03213405|Recombinant BCG vaccine|recombinant bcg vaccine
56683|NCT03213379|actimeter|actimeter
56684|NCT03213379|apomorphin pump|apomorphin pump
56685|NCT03213366|PrEP|prep
56686|NCT03213366|HIV prevention|hiv prevention
56687|NCT03213366|Public Health Social Media Campaign|public health social media campaign
56688|NCT03213366|Peer Intervention|peer intervention
56689|NCT03213327|mental health|mental health
56690|NCT03213327|assessment|assessment
56691|NCT03213327|health promotion|health promotion
56692|NCT03213327|case management|case management
56693|NCT03213327|health insurance|health insurance
56694|NCT03213314|LiverMultiScan|livermultiscan
56695|NCT03213314|multiparameter MRI|multiparameter mri
56696|NCT03213314|functional liver remnant|functional liver remnant
56697|NCT03213314|liver resection|liver resection
56698|NCT03213314|hepatic resection|hepatic resection
56699|NCT03213314|portal vein embolisation|portal vein embolisation
56700|NCT03213314|preoperative liver function|preoperative liver function
56701|NCT03213314|postoperative liver failure|postoperative liver failure
56702|NCT03213301|Progressive Malignant Pleural Mesothelioma|progressive malignant pleural mesothelioma
56703|NCT03213301|Lurbinectedin|lurbinectedin
56704|NCT03213301|Mesothelioma|mesothelioma
56705|NCT03213301|Phase II Trial|phase ii trial
56706|NCT03213275|Extremely premature infants|extremely premature infants
56707|NCT03213275|gut-immune-brain axis|gut-immune-brain axis
56708|NCT03213275|neonatal brain injury|neonatal brain injury
56709|NCT03213275|gut microbiome|gut microbiome
56710|NCT03213275|neurodevelopmental outcome|neurodevelopmental outcome
56711|NCT03213275|neonatal immunity|neonatal immunity
56712|NCT03213223|retention|retention
56713|NCT03213223|attrition|attrition
56714|NCT03213223|PMTCT|pmtct
56715|NCT03213223|elimination of mother to child transmission of HIV|elimination of mother to child transmission of hiv
56716|NCT03213184|Birth cohort|birth cohort
56717|NCT03213184|asthma|asthma
56718|NCT03213184|allergies|allergies
56719|NCT03213171|organ donation|organ donation
56720|NCT03213171|family physician|family physician
56721|NCT03213171|primary care|primary care
56722|NCT03213171|clinical trial|clinical trial
56723|NCT03213171|registry trial|registry trial
56724|NCT03213171|cluster trial|cluster trial
56725|NCT03213171|stepped-wedge|stepped-wedge
56726|NCT03213145|drug-drug interaction|drug-drug interaction
56727|NCT03213132|sleep|sleep
56728|NCT03213132|insomnia|insomnia
56730|NCT03213119|Caloric Vestibular Stimulation Reward|caloric vestibular stimulation reward
56731|NCT03213119|Brain Stimulation|brain stimulation
56732|NCT03213119|Reward|reward
56733|NCT03213119|Vestibular System|vestibular system
56734|NCT03213119|Cingulate Cortex|cingulate cortex
56735|NCT03213119|Cancellation Tasks|cancellation tasks
56736|NCT03213106|TMS|tms
56737|NCT03213106|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
56738|NCT03213106|Cerebellar Ataxia|cerebellar ataxia
56739|NCT03213093|Diabetes|diabetes
56740|NCT03213093|Diabetic Foot Ulcer|diabetic foot ulcer
56741|NCT03213093|Plantar pressure|plantar pressure
56742|NCT03213080|Targeted Lung Denervation|targeted lung denervation
56743|NCT03213080|TLD|tld
56744|NCT03213054|esophageal cancer|esophageal cancer
56745|NCT03213054|OBP-301|obp-301
56746|NCT03213054|radiation|radiation
56747|NCT03213054|Telomelysin|telomelysin
56748|NCT03213054|radiotherapy|radiotherapy
56749|NCT03213054|oncolytic|oncolytic
56750|NCT03213054|virotherapy|virotherapy
56751|NCT03213054|loco regional|loco regional
56752|NCT03213015|confiability|confiability
56753|NCT03213015|ankle|ankle
56754|NCT03213015|patellofemoral pain syndrome|patellofemoral pain syndrome
56755|NCT03212989|HIV|hiv
56756|NCT03212989|HXTC|hxtc
56757|NCT03212989|Antiretroviral Therapy|antiretroviral therapy
56758|NCT03212989|HIV-Infected|hiv-infected
56759|NCT03212989|Vorinostat|vorinostat
56760|NCT03212989|AIDS|aids
56761|NCT03212976|Non-Invasive|non-invasive
56762|NCT03212976|Magnetic Resonance Imaging|magnetic resonance imaging
56763|NCT03212976|Ventricular catheters|ventricular catheters
56764|NCT03212924|cochlear implant|cochlear implant
56765|NCT03212924|Listening effort|listening effort
56766|NCT03212924|pupillometry|pupillometry
56767|NCT03212911|HBV vaccination, HIV, isolated anti-HBc|hbv vaccination, hiv, isolated anti-hbc
56768|NCT03212898|pharmacist interventions, warfarin, elderly rural patients|pharmacist interventions, warfarin, elderly rural patients
56769|NCT03212885|Deep Brain Stimulation|deep brain stimulation
56770|NCT03212872|Ammonia|ammonia
56771|NCT03212872|bleeding risk factors|bleeding risk factors
56772|NCT03212872|endoscopic risk signs for bleeding|endoscopic risk signs for bleeding
56773|NCT03212872|esophageal varices|esophageal varices
56774|NCT03212859|older adults|older adults
56775|NCT03212859|physiotherapy|physiotherapy
56776|NCT03212859|physical activity|physical activity
56777|NCT03212846|hippotherapy|hippotherapy
56778|NCT03212846|cerebral palsy|cerebral palsy
56779|NCT03212846|spasticity|spasticity
56780|NCT03212807|Checkpoint inhibition|checkpoint inhibition
56781|NCT03212807|PDL1|pdl1
56782|NCT03212807|EBV DLBCL|ebv dlbcl
56783|NCT03212807|PCNSL|pcnsl
56784|NCT03212716|Infectiology|infectiology
56785|NCT03212716|Biology of infectious agents|biology of infectious agents
56786|NCT03212716|Flu|flu
56787|NCT03212716|Intensive care|intensive care
56788|NCT03212703|Mindfulness training|mindfulness training
56789|NCT03212703|Parents and families|parents and families
56790|NCT03212703|Pediatric OCD|pediatric ocd
56791|NCT03212690|mechanical ventilation|mechanical ventilation
56792|NCT03212690|echocardiography|echocardiography
56793|NCT03212690|right ventricular function|right ventricular function
56794|NCT03212690|Ang (1-7)|ang (1-7)
56795|NCT03212690|Ang II|ang ii
56796|NCT03212690|Renin-angiotensin system|renin-angiotensin system
56797|NCT03212625|Urea Cream|urea cream
56798|NCT03212625|Sorafenib|sorafenib
56799|NCT03212612|Galectin-3 ,endometrosis|galectin-3 ,endometrosis
56800|NCT03212599|APP-processing|app-processing
56801|NCT03212599|Disulfiram|disulfiram
56802|NCT03212599|ADAM10|adam10
56803|NCT03212599|Alzheimer's disease|alzheimer's disease
56804|NCT03212599|blood|blood
56805|NCT03212560|Exercise capacity|exercise capacity
56806|NCT03212560|Physical activity|physical activity
56807|NCT03212560|Quality of life|quality of life
56808|NCT03212560|Pulmonary functions|pulmonary functions
56809|NCT03212560|Muscle strength|muscle strength
56810|NCT03212560|Respiratory muscle strength|respiratory muscle strength
56811|NCT03212560|Respiratory muscle endurance|respiratory muscle endurance
56812|NCT03212560|Dyspnea|dyspnea
56813|NCT03212560|Anxiety|anxiety
56814|NCT03212560|Fatigue|fatigue
56815|NCT03212547|Social withdrawal|social withdrawal
56816|NCT03212547|Preterm Infant|preterm infant
56817|NCT03212547|Parent's mental health|parent's mental health
56818|NCT03212534|Dascena|dascena
57304|NCT03209258|Stroke|stroke
56819|NCT03212534|patient mortality|patient mortality
56820|NCT03212534|machine learning|machine learning
56821|NCT03212534|algorithm|algorithm
56822|NCT03212534|diagnostic|diagnostic
56823|NCT03212521|chronic hepatitis C virus (HCV)|chronic hepatitis c virus (hcv)
56824|NCT03212521|Hepatitis|hepatitis
56825|NCT03212521|HCV genotype|hcv genotype
56826|NCT03212521|aspartate aminotransferase|aspartate aminotransferase
56827|NCT03212521|platelet|platelet
56828|NCT03212521|Aspartate aminotransferase to Platelet Ratio Index (APRI)|aspartate aminotransferase to platelet ratio index (apri)
56829|NCT03212521|glecaprevir|glecaprevir
56830|NCT03212521|pibrentasvir|pibrentasvir
56831|NCT03212521|Sustained Virologic Response 12 weeks post dosing (SVR12)|sustained virologic response 12 weeks post dosing (svr12)
56832|NCT03212508|Continuous positive airway pressure, preterm|continuous positive airway pressure, preterm
56833|NCT03212495|knee arthroscopy|knee arthroscopy
56834|NCT03212495|dexmedetomidine|dexmedetomidine
56835|NCT03212495|neostigmine|neostigmine
56836|NCT03212482|brain-injured patients, patient-ventilator asychrony|brain-injured patients, patient-ventilator asychrony
56837|NCT03212456|general anesthesia|general anesthesia
56838|NCT03212456|cancer recurrence|cancer recurrence
56839|NCT03212456|opioids analgesics|opioids analgesics
56840|NCT03212456|neoplasm|neoplasm
56841|NCT03212430|L-kynurenine|l-kynurenine
56842|NCT03212430|Cerebral hemodynamic|cerebral hemodynamic
56843|NCT03212430|Headache|headache
56844|NCT03212430|Mohammad Al-Mahdi Al-Karagholi|mohammad al-mahdi al-karagholi
56845|NCT03212404|Cancer|cancer
56846|NCT03212404|PD-L1|pd-l1
56847|NCT03212404|PDL1|pdl1
56848|NCT03212404|PD-1|pd-1
56849|NCT03212404|PD1|pd1
56850|NCT03212404|Solid tumors|solid tumors
56851|NCT03212404|Anti PD-L1|anti pd-l1
56852|NCT03212352|miscarriage|miscarriage
56853|NCT03212352|mifepristone|mifepristone
56854|NCT03212352|misoprostol|misoprostol
56855|NCT03212352|medical treatment|medical treatment
56856|NCT03212352|patient satisfaction|patient satisfaction
56857|NCT03212352|abortifacient agents|abortifacient agents
56858|NCT03212339|parent-child interactions|parent-child interactions
56859|NCT03212339|mental health care|mental health care
56860|NCT03212339|child health services|child health services
56861|NCT03212339|parenting confidence|parenting confidence
56862|NCT03212339|adverse childhood events|adverse childhood events
56863|NCT03212339|dyadic care model|dyadic care model
56864|NCT03212313|Adults|adults
56865|NCT03212313|Liver Disease|liver disease
56866|NCT03212300|aerobic exercise training|aerobic exercise training
56867|NCT03212300|delirium|delirium
56868|NCT03212261|Lymphoma|lymphoma
56869|NCT03212222|screening|screening
56870|NCT03212222|cell phone application|cell phone application
56871|NCT03212209|Sleep Apnea|sleep apnea
56872|NCT03212209|CPAP|cpap
56873|NCT03212196|Pancreaticoduodenectomy|pancreaticoduodenectomy
56874|NCT03212196|Pancreaticogastrostomy|pancreaticogastrostomy
56875|NCT03212196|Pancreaticojejunostomy|pancreaticojejunostomy
56876|NCT03212196|Stent|stent
56877|NCT03212196|Transanastomotic drain|transanastomotic drain
56878|NCT03212183|web-based intervention|web-based intervention
56879|NCT03212183|self-management|self-management
56880|NCT03212183|nursing|nursing
56881|NCT03212183|epilepsy|epilepsy
56882|NCT03212183|seizures|seizures
56883|NCT03212170|Invasive Breast Cancer|invasive breast cancer
56884|NCT03212170|Metastatic Breast Cancer|metastatic breast cancer
56885|NCT03212170|PR Positive Breast Cancer|pr positive breast cancer
56886|NCT03212144|nuts|nuts
56887|NCT03212144|exercise|exercise
56888|NCT03212144|vagal activity|vagal activity
56889|NCT03212144|peanuts|peanuts
56890|NCT03212144|heart rate variability|heart rate variability
56891|NCT03212118|Sick Leave|sick leave
56892|NCT03212118|Return to work|return to work
56893|NCT03212118|Motivational interviewing|motivational interviewing
56894|NCT03212118|Absenteeism|absenteeism
56895|NCT03212118|Occupational Health|occupational health
56896|NCT03212092|Aggression|aggression
56897|NCT03212092|aggressive behavior|aggressive behavior
56898|NCT03212092|nutritional supplements|nutritional supplements
56899|NCT03212092|dietary supplements|dietary supplements
56900|NCT03212092|vitamin, mineral|vitamin, mineral
56901|NCT03212092|omega-3|omega-3
56902|NCT03212092|n-3 fatty acids|n-3 fatty acids
56903|NCT03212092|intellectual disability|intellectual disability
56904|NCT03212079|Cancer Survivors|cancer survivors
56905|NCT03212079|Physical Activities|physical activities
56906|NCT03212079|Baltimore|baltimore
56907|NCT03212079|State of Maryland|state of maryland
56908|NCT03212053|Essential thrombocythemia|essential thrombocythemia
56909|NCT03212053|Multiplate|multiplate
56910|NCT03212053|ROTEM|rotem
56911|NCT03212053|haemorrhage|haemorrhage
56912|NCT03212053|thrombosis|thrombosis
56913|NCT03212053|Vasodilatator Stimulated Phosphoprotein (VASP)|vasodilatator stimulated phosphoprotein (vasp)
56914|NCT03212027|apparent diffusion coefficient|apparent diffusion coefficient
56915|NCT03212027|aquaporins|aquaporins
56916|NCT03212014|Parkinson Disease|parkinson disease
56917|NCT03212014|intelligent|intelligent
56918|NCT03212014|Rehabilitaion|rehabilitaion
56919|NCT03211988|abdominal|abdominal
56920|NCT03211988|neuroendocrine tumor|neuroendocrine tumor
56921|NCT03211988|columbia|columbia
56922|NCT03211988|relapsed|relapsed
56923|NCT03211988|refractory|refractory
56924|NCT03211949|axillary nerve block|axillary nerve block
56925|NCT03211923|muscle relaxation|muscle relaxation
56926|NCT03211923|transcranial magnetic stimulation|transcranial magnetic stimulation
56927|NCT03211923|myopathy|myopathy
56928|NCT03211910|Sacral and trochenteric pressure ulcers|sacral and trochenteric pressure ulcers
56929|NCT03211884|Problem solving therapy|problem solving therapy
56930|NCT03211884|Military family caregivers|military family caregivers
56931|NCT03211884|Cognitive impariment|cognitive impariment
56932|NCT03211884|Traumatic brain injury|traumatic brain injury
56933|NCT03211871|pain management, dexmedetomidine|pain management, dexmedetomidine
56934|NCT03211845|Ehealth|ehealth
56935|NCT03211845|Older adults|older adults
56936|NCT03211845|Undernutrition|undernutrition
56937|NCT03211845|Feasibility study|feasibility study
56938|NCT03211832|Dissemination research|dissemination research
56939|NCT03211832|Public health workforce|public health workforce
56940|NCT03211832|Diabetes prevention|diabetes prevention
56941|NCT03211832|Diabetes control|diabetes control
56942|NCT03211832|Chronic disease prevention|chronic disease prevention
56943|NCT03211832|Evidence-based public health|evidence-based public health
56944|NCT03211832|Public health accreditation|public health accreditation
56945|NCT03211819|immediate|immediate
56946|NCT03211819|esthetics|esthetics
56947|NCT03211793|systemic sclerosis|systemic sclerosis
56948|NCT03211793|scleroderma|scleroderma
56949|NCT03211793|digital ulcer|digital ulcer
56950|NCT03211793|vasculopathy|vasculopathy
56951|NCT03211793|mesenchymal stromal cell|mesenchymal stromal cell
56952|NCT03211793|mesenchymal stem cell|mesenchymal stem cell
56953|NCT03211754|Walnuts|walnuts
56954|NCT03211754|almonds|almonds
56955|NCT03211754|adiponectin|adiponectin
56956|NCT03211754|lipocalin-2|lipocalin-2
56957|NCT03211754|obesity|obesity
56958|NCT03211741|Bevacizumab|bevacizumab
56959|NCT03211702|geriatric assessments|geriatric assessments
56960|NCT03211702|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
56961|NCT03211702|activity of daily living|activity of daily living
56962|NCT03211702|instrumental activity of daily living|instrumental activity of daily living
56963|NCT03211702|Charlson's comorbidity index|charlson's comorbidity index
56964|NCT03211689|Exercise|exercise
56965|NCT03211689|Stress|stress
56966|NCT03211689|Fatigue|fatigue
56967|NCT03211689|Quality of Life|quality of life
56968|NCT03211676|dialyzer|dialyzer
56969|NCT03211676|beta2-microglobilin|beta2-microglobilin
56970|NCT03211676|myoglobin|myoglobin
56971|NCT03211637|nursing care|nursing care
56972|NCT03211637|skin lesions|skin lesions
56973|NCT03211637|wound healing|wound healing
56974|NCT03211637|varicose ulcers|varicose ulcers
56975|NCT03211611|BRCA1/2 Mutation|brca1/2 mutation
56976|NCT03211611|Breast cancer|breast cancer
56977|NCT03211611|General practitionner|general practitionner
56978|NCT03211572|breast|breast
56979|NCT03211559|ankylosing spondylitis|ankylosing spondylitis
56980|NCT03211559|clinical pilates exercise|clinical pilates exercise
56981|NCT03211559|aerobic exercise|aerobic exercise
56982|NCT03211559|functional exercise capacity|functional exercise capacity
56983|NCT03211559|pulmonary function|pulmonary function
56984|NCT03211546|Pediatric femur fracture|pediatric femur fracture
56985|NCT03211546|Spica casting|spica casting
56986|NCT03211546|Traction|traction
56987|NCT03211546|Intramedullary nailing|intramedullary nailing
56988|NCT03211546|Children|children
56989|NCT03211546|Internal fixation|internal fixation
56990|NCT03211546|External fixation|external fixation
56991|NCT03211533|infants at risk of cerebral palsy|infants at risk of cerebral palsy
56993|NCT03211533|general movements|general movements
56994|NCT03211520|Cancer treatment|cancer treatment
56995|NCT03211520|Anthracyclines|anthracyclines
56996|NCT03211520|Cardiac MRI|cardiac mri
56997|NCT03211494|Mechanical ventilation|mechanical ventilation
56998|NCT03211494|Driving pressure|driving pressure
56999|NCT03211494|Closed-loop ventilation|closed-loop ventilation
57000|NCT03211494|Esophageal catheter|esophageal catheter
57001|NCT03211455|bariatric surgery|bariatric surgery
57002|NCT03211455|rehabilitation|rehabilitation
57003|NCT03211455|lidocaine|lidocaine
57004|NCT03211442|Breast cancer|breast cancer
57005|NCT03211442|Radiotherapy|radiotherapy
57006|NCT03211442|Cardiac complications|cardiac complications
57007|NCT03211442|Acute coronary events|acute coronary events
57008|NCT03211442|NTCP model|ntcp model
57009|NCT03211325|Transient Receptor Potential Channels|transient receptor potential channels
57010|NCT03211325|Raynaud's Phenomenon Isolated Primary|raynaud's phenomenon isolated primary
57011|NCT03211325|Raynaud's Phenomenon (Secondary)|raynaud's phenomenon (secondary)
57012|NCT03211286|Hip fracture|hip fracture
57013|NCT03211286|Tranexamic acid|tranexamic acid
57014|NCT03211286|Perioperative blood loss|perioperative blood loss
57403|NCT03208660|seizure|seizure
57015|NCT03211286|Blood Transfusion|blood transfusion
57016|NCT03211260|Parkinson Disease|parkinson disease
57017|NCT03211260|Freezing of gait|freezing of gait
57018|NCT03211260|Equistasi|equistasi
57019|NCT03211247|EPIT|epit
57020|NCT03211247|Epicutaneous|epicutaneous
57021|NCT03211247|Immunotherapy|immunotherapy
57022|NCT03211247|Viaskin|viaskin
57023|NCT03211221|OCD|ocd
57024|NCT03211221|TMS|tms
57025|NCT03211182|lifestyle intervention|lifestyle intervention
57026|NCT03211182|prediabetes|prediabetes
57027|NCT03211156|Amoxicillin|amoxicillin
57028|NCT03211156|Gardnerella vaginalis|gardnerella vaginalis
57029|NCT03211156|Vaginal Colonization|vaginal colonization
57030|NCT03211143|GERD|gerd
57031|NCT03211143|CKD-381|ckd-381
57032|NCT03211143|Nexium|nexium
57033|NCT03211143|Bioequivalence|bioequivalence
57034|NCT03211130|medication adherence|medication adherence
57035|NCT03211130|self-management|self-management
57036|NCT03211130|antithrombotic|antithrombotic
57037|NCT03211104|intermittent androgen deprivation therapy|intermittent androgen deprivation therapy
57038|NCT03211104|curcumin|curcumin
57039|NCT03211078|Early lung cancer|early lung cancer
57040|NCT03211078|Photodynamic therapy|photodynamic therapy
57041|NCT03211078|ENB|enb
57042|NCT03211065|Rituximab|rituximab
57043|NCT03211065|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
57044|NCT03211065|Subcutaneous Immunoglobulin|subcutaneous immunoglobulin
57045|NCT03211039|Rady Children's|rady children's
57046|NCT03211039|Pediatric|pediatric
57047|NCT03211039|Genomic|genomic
57048|NCT03211039|Precision Medicine|precision medicine
57049|NCT03211039|Neonate|neonate
57050|NCT03211026|Urinary tract infection|urinary tract infection
57051|NCT03211026|Multidrug resistant bacteria|multidrug resistant bacteria
57052|NCT03211026|Candiduria|candiduria
57053|NCT03211026|Epidemiology|epidemiology
57054|NCT03211026|Graft rejection|graft rejection
57055|NCT03211026|Solid organ transplantation|solid organ transplantation
57056|NCT03211013|oxytocin|oxytocin
57057|NCT03211013|PTSD|ptsd
57058|NCT03211013|attention bias|attention bias
57059|NCT03211013|startle|startle
57060|NCT03211000|aortic aneurysm|aortic aneurysm
57061|NCT03211000|autophagy|autophagy
57062|NCT03211000|oxidative stress|oxidative stress
57063|NCT03211000|Hippo pathway|hippo pathway
57064|NCT03210987|ward round|ward round
57065|NCT03210987|patient case presentation|patient case presentation
57066|NCT03210987|communication|communication
57067|NCT03210987|patient-centered care|patient-centered care
57068|NCT03210935|Adnexal cutaneous carcinoma|adnexal cutaneous carcinoma
57069|NCT03210935|Merkel cell carcinoma|merkel cell carcinoma
57070|NCT03210935|Advanced basal cell carcinoma requiring systemic treatment|advanced basal cell carcinoma requiring systemic treatment
57071|NCT03210922|cervical collar, nasoendotracheal intubation, glidescope|cervical collar, nasoendotracheal intubation, glidescope
57072|NCT03210870|Maternal health|maternal health
57073|NCT03210870|maternal nutrition|maternal nutrition
57074|NCT03210870|fetal health related to maternal nutrition|fetal health related to maternal nutrition
57075|NCT03210857|apnea|apnea
57076|NCT03210857|neck extension|neck extension
57077|NCT03210857|syncope|syncope
57078|NCT03210857|diving blackout|diving blackout
57079|NCT03210857|right internal carotid arteria|right internal carotid arteria
57080|NCT03210857|pulsatility index|pulsatility index
57081|NCT03210857|healthy trained apnoea divers|healthy trained apnoea divers
57082|NCT03210857|doppler ultrasonography|doppler ultrasonography
57083|NCT03210844|total hip arthroplasty|total hip arthroplasty
57084|NCT03210844|direct anterior|direct anterior
57085|NCT03210844|posterior approach|posterior approach
57086|NCT03210831|NEC, tissue oxygenation, gut inflammation|nec, tissue oxygenation, gut inflammation
57087|NCT03210779|oral wound healing|oral wound healing
57088|NCT03210779|probiotics|probiotics
57089|NCT03210766|Cannabinoids, nabilone, FBSS, THC/CBD, refractory pain|cannabinoids, nabilone, fbss, thc/cbd, refractory pain
57090|NCT03210753|Multiple Myeloma|multiple myeloma
57091|NCT03210753|Peripheral neuropathy|peripheral neuropathy
57092|NCT03210753|Subcutaneous injection|subcutaneous injection
57093|NCT03210753|Bortezomib|bortezomib
57094|NCT03210753|Risk factors|risk factors
57095|NCT03210701|pharmacy|pharmacy
57096|NCT03210701|pharmacist|pharmacist
57097|NCT03210701|POCT|poct
57098|NCT03210701|Implementation science|implementation science
57099|NCT03210688|Prednisolone|prednisolone
57100|NCT03210688|alfacalcidol|alfacalcidol
57101|NCT03210688|Minimal change nephropathy|minimal change nephropathy
57102|NCT03210662|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
57103|NCT03210662|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
57104|NCT03210662|NHL|nhl
57105|NCT03210662|Relapsed|relapsed
57106|NCT03210662|Refractory|refractory
57107|NCT03210662|Pembrolizumab|pembrolizumab
57108|NCT03210662|Keytruda|keytruda
57109|NCT03210662|MK-3475|mk-3475
57110|NCT03210662|SCH-900475|sch-900475
57111|NCT03210662|External Beam Radiotherapy|external beam radiotherapy
57112|NCT03210662|EBRT|ebrt
57113|NCT03210662|Radiation therapy|radiation therapy
57114|NCT03210649|Dyslipidemia|dyslipidemia
57115|NCT03210597|water-base exercise|water-base exercise
57116|NCT03210584|Knee joint|knee joint
57117|NCT03210584|Cartilage degeneration|cartilage degeneration
57118|NCT03210584|Ultrasound imaging|ultrasound imaging
57119|NCT03210584|Full-Field Optical Coherence Tomography|full-field optical coherence tomography
57120|NCT03210584|9,4 Tesla MRI|9,4 tesla mri
57121|NCT03210584|Multimodal evaluation|multimodal evaluation
57122|NCT03210558|female athletes, testosterone, physical performance, body composition|female athletes, testosterone, physical performance, body composition
57123|NCT03210545|Biomarker|biomarker
57124|NCT03210545|Glucocorticoids|glucocorticoids
57125|NCT03210545|Metabolism|metabolism
57126|NCT03210506|chronic hepatitis B|chronic hepatitis b
57127|NCT03210506|hepatitis B virus|hepatitis b virus
57128|NCT03210506|Cytokines|cytokines
57129|NCT03210506|Pegylated Interferon α-2a|pegylated interferon α-2a
57130|NCT03210506|Nucleoside Analogues|nucleoside analogues
57131|NCT03210493|chronic hepatitis B|chronic hepatitis b
57132|NCT03210493|hepatitis B virus|hepatitis b virus
57133|NCT03210493|Treg Cells|treg cells
57134|NCT03210493|Pegylated Interferon α-2a|pegylated interferon α-2a
57135|NCT03210493|Nucleoside Analogues|nucleoside analogues
57136|NCT03210480|Lithium Sulphate|lithium sulphate
57137|NCT03210480|Prolonged release formulation|prolonged release formulation
57138|NCT03210480|Lithium carbonate|lithium carbonate
57139|NCT03210480|Immediate release formulation|immediate release formulation
57140|NCT03210480|Bipolar Disorder|bipolar disorder
57141|NCT03210480|Tremor|tremor
57142|NCT03210467|chronic hepatitis B|chronic hepatitis b
57143|NCT03210467|hepatitis B virus|hepatitis b virus
57144|NCT03210467|Pegylated Interferon α-2a|pegylated interferon α-2a
57145|NCT03210467|entecavir|entecavir
57146|NCT03210467|Plasmacytoid Dendritic Cells|plasmacytoid dendritic cells
57147|NCT03210415|Preterm Labor|preterm labor
57148|NCT03210415|China|china
57149|NCT03210415|Pregnant Women|pregnant women
57150|NCT03210415|≥35 Years Old|≥35 years old
57151|NCT03210389|Recurrent Nasopharyngeal Carcinoma|recurrent nasopharyngeal carcinoma
57152|NCT03210389|lobaptin|lobaptin
57153|NCT03210376|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
57154|NCT03210376|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
57155|NCT03210376|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
57156|NCT03210376|Malignant neoplasms of urinary tract|malignant neoplasms of urinary tract
57157|NCT03210376|Neuromuscular blockade|neuromuscular blockade
57158|NCT03210376|NMB|nmb
57159|NCT03210376|Sugammadex|sugammadex
57160|NCT03210376|Neostigmine|neostigmine
57161|NCT03210376|Pain Assessment|pain assessment
57162|NCT03210376|Survey|survey
57163|NCT03210324|mifepristone antiprogestins|mifepristone antiprogestins
57164|NCT03210298|Pressurized IntraPeritoneal Aerosol Chemotherapy|pressurized intraperitoneal aerosol chemotherapy
57165|NCT03210298|PIPAC|pipac
57166|NCT03210298|Pressurized IntraThoracic Aerosol Chemotherapy|pressurized intrathoracic aerosol chemotherapy
57167|NCT03210298|PITAC|pitac
57168|NCT03210298|Cisplatin|cisplatin
57169|NCT03210298|Oxaliplatin|oxaliplatin
57170|NCT03210298|Gemcitabine|gemcitabine
57171|NCT03210298|Paclitaxel|paclitaxel
57172|NCT03210298|nab-Paclitaxel|nab-paclitaxel
57173|NCT03210298|Doxorubicine|doxorubicine
57174|NCT03210298|Mitomycin|mitomycin
57175|NCT03210285|Whole exome sequencing|whole exome sequencing
57176|NCT03210285|Neurofibromatosis Type 2|neurofibromatosis type 2
57177|NCT03210285|Acoustic Neuroma|acoustic neuroma
57178|NCT03210285|Vestibular schwannoma|vestibular schwannoma
57179|NCT03210194|Inservice Training|inservice training
57180|NCT03210194|Neonatal Resuscitation|neonatal resuscitation
57181|NCT03210194|Randomized Cluster Trial|randomized cluster trial
57182|NCT03210155|Cranial Electrotherapy Stimulation (CES)|cranial electrotherapy stimulation (ces)
57183|NCT03210155|Efficacy|efficacy
57184|NCT03210155|Post Partum|post partum
57185|NCT03210155|Anxiety|anxiety
57186|NCT03210155|Depression|depression
57187|NCT03210155|Insomnia|insomnia
57188|NCT03210155|Sleep Quality|sleep quality
57189|NCT03210155|Maternal Functioning|maternal functioning
57190|NCT03210142|Sleep Apnea, Neural Stimulation|sleep apnea, neural stimulation
57191|NCT03210129|Motivation|motivation
57192|NCT03210129|Behavior|behavior
57193|NCT03210129|Exercise|exercise
57194|NCT03210129|Motivational interview|motivational interview
57195|NCT03210129|Cancer|cancer
57196|NCT03210129|economic evaluation|economic evaluation
57197|NCT03210103|Transoral Surgery|transoral surgery
57198|NCT03210103|Head and Neck Cancer|head and neck cancer
57199|NCT03210090|Stem cells transplantation|stem cells transplantation
57200|NCT03210090|Cytomegalovirus infection|cytomegalovirus infection
57201|NCT03210090|CMV-Specific Immune response|cmv-specific immune response
57202|NCT03210090|Immune reconstitution|immune reconstitution
57203|NCT03210090|Humoral/Cellular mismatch|humoral/cellular mismatch
57204|NCT03210090|Interferon-gamma|interferon-gamma
57205|NCT03210077|general anesthesia|general anesthesia
57206|NCT03210077|Entropy|entropy
57207|NCT03210077|Hypnosis|hypnosis
57209|NCT03210051|Acute ischemic stroke|acute ischemic stroke
57210|NCT03210051|Endovascular treatment|endovascular treatment
57211|NCT03210051|Remote ischemic conditioning|remote ischemic conditioning
57212|NCT03210051|Reperfusion therapy|reperfusion therapy
57213|NCT03210051|Neuroprotection|neuroprotection
57214|NCT03210038|Cystoscopy|cystoscopy
57215|NCT03209986|Liver Cirrhosis|liver cirrhosis
57216|NCT03209986|Mesenchymal Sem Cells|mesenchymal sem cells
57217|NCT03209947|Ulnar Neuropathies|ulnar neuropathies
57218|NCT03209947|Ultrasound|ultrasound
57219|NCT03209934|Bone and Joint Infection|bone and joint infection
57220|NCT03209934|Daptomycin|daptomycin
57221|NCT03209934|Eosinophilic pneumonia|eosinophilic pneumonia
57222|NCT03209921|Bone and Joint Infection|bone and joint infection
57223|NCT03209921|Daptomycin|daptomycin
57224|NCT03209908|antiviral treatment|antiviral treatment
57225|NCT03209908|hepatitis B virus|hepatitis b virus
57226|NCT03209908|mother-to-child transmission|mother-to-child transmission
57227|NCT03209908|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
57228|NCT03209882|Transcranial infrared laser stimulation (TILS)|transcranial infrared laser stimulation (tils)
57229|NCT03209882|Near-infrared spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
57230|NCT03209830|mental fatigue|mental fatigue
57231|NCT03209830|drug therapy|drug therapy
57232|NCT03209830|subarachnoid hemorrhage|subarachnoid hemorrhage
57233|NCT03209830|stroke|stroke
57234|NCT03209804|Intracranial Arteriovenous Malformations|intracranial arteriovenous malformations
57235|NCT03209752|3D analysis|3d analysis
57236|NCT03209752|Brace|brace
57237|NCT03209752|EOS imagind system|eos imagind system
57238|NCT03209752|Anatomical transfer|anatomical transfer
57239|NCT03209713|Mexican|mexican
57240|NCT03209713|Mexican-American|mexican-american
57241|NCT03209713|17-336|17-336
57242|NCT03209674|Cardiac surgery|cardiac surgery
57243|NCT03209674|Thoracic surgery|thoracic surgery
57244|NCT03209661|vascular function|vascular function
57245|NCT03209622|Smoking Cessation|smoking cessation
57246|NCT03209622|Acute Coronary Syndrome|acute coronary syndrome
57247|NCT03209622|Cardiology|cardiology
57248|NCT03209609|Coronary artery bypass|coronary artery bypass
57249|NCT03209596|Athletes|athletes
57250|NCT03209596|Food intake|food intake
57251|NCT03209596|Supplementation|supplementation
57252|NCT03209596|Biochemical biomarkers|biochemical biomarkers
57253|NCT03209596|Soccer Players|soccer players
57254|NCT03209570|urinary incontinence, nursing home|urinary incontinence, nursing home
57255|NCT03209557|Mobile Technology|mobile technology
57256|NCT03209557|Sociobehavioral|sociobehavioral
57257|NCT03209544|Suicidal ideation|suicidal ideation
57258|NCT03209544|Suicide|suicide
57259|NCT03209544|Cognitive behavioral therapy|cognitive behavioral therapy
57260|NCT03209544|Online intervention|online intervention
57261|NCT03209531|Quadriceps activation deficits|quadriceps activation deficits
57262|NCT03209531|ACL|acl
57263|NCT03209531|Surgery|surgery
57264|NCT03209531|Quadrcieps weakness|quadrcieps weakness
57265|NCT03209531|Operant conditioning|operant conditioning
57266|NCT03209531|Cortical excitability|cortical excitability
57267|NCT03209505|Lid Wiper Epitheliopahty|lid wiper epitheliopahty
57268|NCT03209505|Coefficient of Friction|coefficient of friction
57269|NCT03209466|Chlorhexidine gluconate|chlorhexidine gluconate
57270|NCT03209466|Diabetic foot ulcer syndrome|diabetic foot ulcer syndrome
57271|NCT03209466|Wound healing|wound healing
57272|NCT03209453|family work shop|family work shop
57273|NCT03209427|morphine, pruritus, serotonin|morphine, pruritus, serotonin
57274|NCT03209414|Frailty syndrome|frailty syndrome
57275|NCT03209414|Coronary heart disease|coronary heart disease
57276|NCT03209414|Coronary revascularization|coronary revascularization
57277|NCT03209414|Major adverse cardiovascular events|major adverse cardiovascular events
57278|NCT03209414|Arterial stiffness|arterial stiffness
57279|NCT03209414|Applanation tonometry|applanation tonometry
57280|NCT03209414|Lean body mass|lean body mass
57281|NCT03209414|ST2 biomarker|st2 biomarker
57282|NCT03209401|Niraparib|niraparib
57283|NCT03209401|Carboplatin|carboplatin
57284|NCT03209375|triage|triage
57285|NCT03209375|early warning system|early warning system
57286|NCT03209362|Knee|knee
57287|NCT03209362|Osteoarthritis|osteoarthritis
57288|NCT03209362|Intra-articular injection|intra-articular injection
57289|NCT03209349|Sigmoidoscopy|sigmoidoscopy
57290|NCT03209336|Ultra-low rectal cancer|ultra-low rectal cancer
57291|NCT03209336|Intersphincteric resection|intersphincteric resection
57292|NCT03209336|IORT|iort
57293|NCT03209323|Epileptiform patterns|epileptiform patterns
57294|NCT03209323|sevoflurane|sevoflurane
57295|NCT03209323|propofol|propofol
57296|NCT03209323|bispectral index|bispectral index
57297|NCT03209323|state entropy|state entropy
57298|NCT03209323|response entropy|response entropy
57299|NCT03209323|A-line Auto Regressive Index|a-line auto regressive index
57300|NCT03209323|middle latency auditory evoked potentials|middle latency auditory evoked potentials
57301|NCT03209284|maxillary atrophy|maxillary atrophy
57302|NCT03209284|transcrestal sinus floor elevation|transcrestal sinus floor elevation
57303|NCT03209271|Fluid therapy|fluid therapy
57305|NCT03209258|Intracerebral Hemorrhage|intracerebral hemorrhage
57306|NCT03209258|Care Bundle|care bundle
57307|NCT03209258|Clinical Trial|clinical trial
57308|NCT03209258|Stepped-wedge Cluster|stepped-wedge cluster
57309|NCT03209258|Management|management
57310|NCT03209258|Blood Pressure|blood pressure
57311|NCT03209219|effectiveness, safety|effectiveness, safety
57312|NCT03209206|Intravesical Chemotherapy|intravesical chemotherapy
57313|NCT03209206|Docetaxel|docetaxel
57314|NCT03209206|Radical Nephroureterectomy|radical nephroureterectomy
57315|NCT03209193|off-pump coronary artery bypass|off-pump coronary artery bypass
57316|NCT03209193|sevoflurane|sevoflurane
57317|NCT03209193|desflurane|desflurane
57318|NCT03209193|tissue oxygen saturation|tissue oxygen saturation
57319|NCT03209180|HFrEF|hfref
57320|NCT03209180|Carvedilol|carvedilol
57321|NCT03209180|Slow Release|slow release
57322|NCT03209180|NT-proBNP|nt-probnp
57323|NCT03209167|Breast reconstruction; abdominoplasty; patient satisfaction|breast reconstruction; abdominoplasty; patient satisfaction
57324|NCT03209154|Adherence|adherence
57325|NCT03209154|Therapeutic Drug Monitoring|therapeutic drug monitoring
57326|NCT03209154|Patient perspective|patient perspective
57327|NCT03209141|hypertension|hypertension
57328|NCT03209141|Diastolic Dysfunction|diastolic dysfunction
57329|NCT03209141|impedance cardiography|impedance cardiography
57330|NCT03209141|echocardiography|echocardiography
57331|NCT03209076|rectal neoplasms|rectal neoplasms
57332|NCT03209076|sexual dysfunctions|sexual dysfunctions
57333|NCT03209076|Urinary incontinence|urinary incontinence
57334|NCT03209076|Quality of life|quality of life
57335|NCT03209076|robotic surgical procedures|robotic surgical procedures
57336|NCT03209076|laparoscopy|laparoscopy
57337|NCT03209037|chronic hepatitis B|chronic hepatitis b
57338|NCT03209037|hepatitis B virus|hepatitis b virus
57339|NCT03209037|CD8+T Cells|cd8+t cells
57340|NCT03209037|Pegylated Interferon α-2a|pegylated interferon α-2a
57341|NCT03209037|Nucleoside Analogues|nucleoside analogues
57342|NCT03209024|hypertension|hypertension
57343|NCT03209024|home blood pressure monitoring|home blood pressure monitoring
57344|NCT03209024|self blood pressure monitoring|self blood pressure monitoring
57345|NCT03209024|telemedicine|telemedicine
57346|NCT03209024|health apps|health apps
57347|NCT03209024|informatics|informatics
57348|NCT03209024|data collection|data collection
57349|NCT03209024|personal health records|personal health records
57350|NCT03209024|smartphone|smartphone
57351|NCT03209024|self care|self care
57352|NCT03209024|blood pressure monitors|blood pressure monitors
57353|NCT03209011|chronic hepatitis B|chronic hepatitis b
57354|NCT03209011|hepatitis B virus|hepatitis b virus
57355|NCT03209011|CD4+T Cells|cd4+t cells
57356|NCT03209011|Pegylated Interferon α-2a|pegylated interferon α-2a
57357|NCT03209011|Nucleoside Analogues|nucleoside analogues
57358|NCT03208998|hepatitis B virus|hepatitis b virus
57359|NCT03208998|Chronic Hepatitis B Infection|chronic hepatitis b infection
57360|NCT03208998|Pegylated Interferon α-2a|pegylated interferon α-2a
57361|NCT03208998|Nucleoside Analogues|nucleoside analogues
57362|NCT03208998|Natural Killer Cells|natural killer cells
57363|NCT03208985|Emergency contraception|emergency contraception
57364|NCT03208972|IVF|ivf
57365|NCT03208972|ovarian stimulation|ovarian stimulation
57366|NCT03208972|low dose hCG|low dose hcg
57367|NCT03208972|hp-FSH|hp-fsh
57368|NCT03208972|Corifollitropin Alfa|corifollitropin alfa
57369|NCT03208972|costs of IVF|costs of ivf
57370|NCT03208946|Advanced glycation end products|advanced glycation end products
57371|NCT03208946|Absorption|absorption
57372|NCT03208946|Excretion|excretion
57373|NCT03208933|Pirfenidone, UIP, IPF, FVC|pirfenidone, uip, ipf, fvc
57374|NCT03208907|Vivax malaria|vivax malaria
57375|NCT03208907|Radical cure|radical cure
57376|NCT03208907|Elimination|elimination
57377|NCT03208881|Osteoarthritis, Obesity, Liraglutide, Ultrasound|osteoarthritis, obesity, liraglutide, ultrasound
57378|NCT03208855|Cognitive Behavioral Therapy|cognitive behavioral therapy
57379|NCT03208816|pain|pain
57380|NCT03208816|constipation|constipation
57381|NCT03208803|Myelofibrosis|myelofibrosis
57382|NCT03208803|Erythropoiesis-stimulating Agents|erythropoiesis-stimulating agents
57383|NCT03208803|Janus Kinase 2 inhibitors|janus kinase 2 inhibitors
57384|NCT03208803|Ruxolitinib|ruxolitinib
57385|NCT03208725|Malnutrition|malnutrition
57386|NCT03208725|Hospitalization|hospitalization
57387|NCT03208725|Acute Illness|acute illness
57388|NCT03208725|Pediatric|pediatric
57389|NCT03208725|Post-discharge mortality|post-discharge mortality
57390|NCT03208725|Mortality|mortality
57391|NCT03208725|Cohort|cohort
57392|NCT03208725|Nested case control|nested case control
57393|NCT03208725|Antimicrobial resistance|antimicrobial resistance
57394|NCT03208725|Antibiotic|antibiotic
57395|NCT03208725|Feeding|feeding
57396|NCT03208725|Undernutrition|undernutrition
57397|NCT03208699|anorexia|anorexia
57398|NCT03208699|bulimia|bulimia
57399|NCT03208686|Gender|gender
57400|NCT03208686|Men|men
57401|NCT03208686|Black/African American|black/african american
57402|NCT03208686|Self-management|self-management
57404|NCT03208660|Fycompa|fycompa
57405|NCT03208647|case-control study|case-control study
57406|NCT03208647|Multiple risk factors|multiple risk factors
57407|NCT03208634|robotics|robotics
57408|NCT03208634|motor performance|motor performance
57409|NCT03208634|stroke patient|stroke patient
57410|NCT03208634|upper limb|upper limb
57411|NCT03208634|rehabilitation|rehabilitation
57412|NCT03208608|RBANS-H|rbans-h
57413|NCT03208608|Older adults|older adults
57414|NCT03208608|Normal hearing|normal hearing
57415|NCT03208608|Cognition|cognition
57416|NCT03208608|Age-related hearing loss|age-related hearing loss
57417|NCT03208569|anticholinergic|anticholinergic
57418|NCT03208569|alzheimer|alzheimer
57419|NCT03208569|cognition|cognition
57420|NCT03208569|MMSE|mmse
57421|NCT03208569|anticholinergic cognitive burden scale|anticholinergic cognitive burden scale
57422|NCT03208543|thermotherapy|thermotherapy
57423|NCT03208543|Pakistan|pakistan
57424|NCT03208504|Thoracic Aortic Disease|thoracic aortic disease
57425|NCT03208504|Thoracic Aneurysm|thoracic aneurysm
57426|NCT03208465|Empagliflozin|empagliflozin
57427|NCT03208465|Sitagliptin|sitagliptin
57428|NCT03208465|Myocardial perfusion reserve|myocardial perfusion reserve
57429|NCT03208426|Efficacy, Self|efficacy, self
57430|NCT03208413|thalidomide|thalidomide
57431|NCT03208413|radiation-induced brain injury|radiation-induced brain injury
57432|NCT03208387|17-338|17-338
57433|NCT03208387|Cognitive function|cognitive function
57434|NCT03208387|Behavioral function|behavioral function
57435|NCT03208374|Histologically confirmed cancer|histologically confirmed cancer
57436|NCT03208374|IMPACT testing|impact testing
57437|NCT03208374|17-327|17-327
57438|NCT03208335|rh-endostatin|rh-endostatin
57439|NCT03208335|radiotherapy|radiotherapy
57440|NCT03208296|Basal Cell Nevus Syndrome|basal cell nevus syndrome
57441|NCT03208296|Basal Cell Carcinoma|basal cell carcinoma
57442|NCT03208257|esmolol|esmolol
57443|NCT03208257|adrenergic storm|adrenergic storm
57444|NCT03208257|septic shock|septic shock
57445|NCT03208244|Heart Disease|heart disease
57446|NCT03208244|Heart Transplant|heart transplant
57448|NCT03208244|Hepatitis C|hepatitis c
57449|NCT03208218|Evaluation of the pharmacokinetics equivalence|evaluation of the pharmacokinetics equivalence
57450|NCT03208218|Healthy volunteers|healthy volunteers
57451|NCT03208218|Single dose over the period I and II(crossover)|single dose over the period i and ii(crossover)
57452|NCT03208218|Healthy male volunteers|healthy male volunteers
57453|NCT03208192|colorectal liver metastases|colorectal liver metastases
57454|NCT03208192|hepatocellular carcinoma|hepatocellular carcinoma
57455|NCT03208192|intrahepatic cholangiocellular carcinoma|intrahepatic cholangiocellular carcinoma
57456|NCT03208192|tumor of liver|tumor of liver
57457|NCT03208192|focal nodular hyperplasia liver|focal nodular hyperplasia liver
57458|NCT03208192|hemangioma liver|hemangioma liver
57459|NCT03208140|intubation to supraglottic devices|intubation to supraglottic devices
57460|NCT03208140|intubation device|intubation device
57461|NCT03208140|laryngeal vision|laryngeal vision
57462|NCT03208140|success intubation|success intubation
57463|NCT03208140|videolaryngoscope|videolaryngoscope
57464|NCT03208140|direct intubation|direct intubation
57465|NCT03208127|HCV|hcv
57466|NCT03208127|Epclusa|epclusa
57467|NCT03208127|ESLD|esld
57468|NCT03208114|breastfeeding, support, promotion|breastfeeding, support, promotion
57469|NCT03208075|phosphorus,diet|phosphorus,diet
57470|NCT03208075|phosphorus|phosphorus
57471|NCT03208075|healthy subject|healthy subject
57472|NCT03208062|Biobank|biobank
57473|NCT03208062|Waste material|waste material
57474|NCT03208062|Orthopaedic|orthopaedic
57475|NCT03208049|Insomnia|insomnia
57476|NCT03208049|CBT|cbt
57477|NCT03208049|Gulf War Veterans|gulf war veterans
57478|NCT03208036|schizophrenia|schizophrenia
57479|NCT03208036|tdcs|tdcs
57480|NCT03208036|working memory|working memory
57481|NCT03208036|cognitive remediation|cognitive remediation
57482|NCT03208036|cognition|cognition
57483|NCT03207997|Scleroderma|scleroderma
57484|NCT03207997|Pulmonary fibrosis|pulmonary fibrosis
57485|NCT03207997|MRI|mri
57486|NCT03207997|quantification|quantification
57487|NCT03207984|Gingival Recession|gingival recession
57488|NCT03207984|Collagen Matrix|collagen matrix
57489|NCT03207984|Periodontics|periodontics
57490|NCT03207971|Gingival recession|gingival recession
57491|NCT03207971|Laser-Doppler Flowmetry|laser-doppler flowmetry
57492|NCT03207971|Periodontics|periodontics
57493|NCT03207919|maternal-fetal attachment|maternal-fetal attachment
57494|NCT03207919|maternal health|maternal health
57495|NCT03207919|maternal stress|maternal stress
57496|NCT03207919|Lullaby Project|lullaby project
57497|NCT03207880|pregnancy test|pregnancy test
57498|NCT03207867|Immunotherapy, A2aR, PDR001, NIR178, NSCLC, solid tumors|immunotherapy, a2ar, pdr001, nir178, nsclc, solid tumors
57499|NCT03207841|SCI|sci
57500|NCT03207841|High Protein|high protein
57501|NCT03207841|Low Carbohydrate|low carbohydrate
57502|NCT03207841|Metabolic Health|metabolic health
57503|NCT03207841|Microbiome|microbiome
57504|NCT03207828|Behavioral activation|behavioral activation
57505|NCT03207763|Safety|safety
57506|NCT03207763|Reactogenicity|reactogenicity
57507|NCT03207763|Acceptability|acceptability
57508|NCT03207763|Microneedle patch|microneedle patch
57509|NCT03207750|Immunogenicity|immunogenicity
57510|NCT03207750|lyophilized formulation|lyophilized formulation
57511|NCT03207750|United States|united states
57512|NCT03207750|Reactogenicity|reactogenicity
57513|NCT03207750|Safety|safety
57514|NCT03207750|Porcine circovirus -free|porcine circovirus -free
57515|NCT03207750|Human rotavirus vaccine|human rotavirus vaccine
57516|NCT03207750|liquid formulation|liquid formulation
57517|NCT03207750|Healthy infants|healthy infants
57518|NCT03207737|Spinal Cord Injuries|spinal cord injuries
57519|NCT03207737|SCI|sci
57520|NCT03207737|Telehealth|telehealth
57521|NCT03207737|Mindfulness|mindfulness
57522|NCT03207737|Nutrition|nutrition
57523|NCT03207737|Exercise|exercise
57524|NCT03207724|advanced pancreatic cancer|advanced pancreatic cancer
57525|NCT03207724|locally advanced pancreatic cancer|locally advanced pancreatic cancer
57526|NCT03207724|recurrent diagnosis|recurrent diagnosis
57527|NCT03207724|new diagnosis|new diagnosis
57528|NCT03207724|adenocarcinoma|adenocarcinoma
57529|NCT03207685|Epilepsy|epilepsy
57530|NCT03207685|Epilepsy Monitoring Unit|epilepsy monitoring unit
57531|NCT03207685|EMU|emu
57532|NCT03207685|Seizure|seizure
57533|NCT03207685|Seizure Detection|seizure detection
57534|NCT03207672|E7389 liposomal formulation|e7389 liposomal formulation
57535|NCT03207672|dose escalation|dose escalation
57536|NCT03207672|maximum tolerated dose|maximum tolerated dose
57537|NCT03207672|pharmacokinetics|pharmacokinetics
57538|NCT03207646|Cardiac Rehabiliation|cardiac rehabiliation
57539|NCT03207646|Percutaneous Coronary Intervention|percutaneous coronary intervention
57540|NCT03207646|Cardiovascular Risk Factor|cardiovascular risk factor
57541|NCT03207646|Digital Health Solution|digital health solution
57542|NCT03207646|Medication Adherence|medication adherence
57543|NCT03207633|OCD, rTMS, right orbitofrontal cortex|ocd, rtms, right orbitofrontal cortex
57544|NCT03207607|Adults|adults
57545|NCT03207607|Snacks|snacks
57546|NCT03207607|Appetite|appetite
57547|NCT03207607|Blood glucose|blood glucose
57548|NCT03207607|Insulin|insulin
57549|NCT03207555|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
57550|NCT03207555|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
57551|NCT03207555|CLL|cll
57552|NCT03207555|Small Lymphocytic Leukemia|small lymphocytic leukemia
57553|NCT03207555|SLL|sll
57554|NCT03207555|Ibrutinib|ibrutinib
57555|NCT03207555|PCI-32765|pci-32765
57556|NCT03207555|Imbruvica|imbruvica
57557|NCT03207542|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
57558|NCT03207542|B-Cell Precursor Acute Lymphoblastic Leukemia|b-cell precursor acute lymphoblastic leukemia
57559|NCT03207542|T-Cell Precursor Acute Lymphoblastic Leukemia|t-cell precursor acute lymphoblastic leukemia
57560|NCT03207542|ALL|all
57561|NCT03207542|Daratumumab|daratumumab
57562|NCT03207529|Malignant neoplasm of breast|malignant neoplasm of breast
57563|NCT03207529|Metastatic breast cancer|metastatic breast cancer
57564|NCT03207529|Androgen receptor (AR)-positive and PTEN positive|androgen receptor (ar)-positive and pten positive
57565|NCT03207529|Alpelisib|alpelisib
57566|NCT03207529|BY719|by719
57567|NCT03207529|Enzalutamide|enzalutamide
57568|NCT03207529|MDV3100|mdv3100
57569|NCT03207529|XTANDI|xtandi
57570|NCT03207516|sourdough; leavening process; fermentation; brewer's yeast|sourdough; leavening process; fermentation; brewer's yeast
57571|NCT03207490|Hand|hand
57572|NCT03207490|Rehabilitation|rehabilitation
57573|NCT03207490|sEMG|semg
57574|NCT03207477|Infant|infant
57575|NCT03207477|Prematurely born|prematurely born
57576|NCT03207477|maturation|maturation
57577|NCT03207451|Anti-Platelet Therapy|anti-platelet therapy
57578|NCT03207425|Hepatic Impairment|hepatic impairment
57579|NCT03207386|Sexual Violence|sexual violence
57580|NCT03207386|Prevention|prevention
57581|NCT03207386|Mixed-Methods|mixed-methods
57582|NCT03207386|Outcome Evaluation|outcome evaluation
57583|NCT03207386|Process Evaluation|process evaluation
57584|NCT03207386|Adolescence|adolescence
57585|NCT03207347|BAP1|bap1
57586|NCT03207347|niraparib|niraparib
57587|NCT03207347|DNA repair|dna repair
57588|NCT03207347|PARP inhibitor|parp inhibitor
57589|NCT03207347|homologous repair deficiency|homologous repair deficiency
57590|NCT03207347|renal cell carcinoma|renal cell carcinoma
57591|NCT03207347|cholangiocarcinoma|cholangiocarcinoma
57592|NCT03207347|mesothelioma|mesothelioma
57593|NCT03207347|uveal melanoma|uveal melanoma
57594|NCT03207334|acute myeloid leukemia|acute myeloid leukemia
57595|NCT03207334|genomic signatures|genomic signatures
57596|NCT03207334|midostaurin|midostaurin
57597|NCT03207334|relapsed|relapsed
57598|NCT03207334|refractory|refractory
57599|NCT03207334|PKC412|pkc412
57600|NCT03207308|Vitamin A Status|vitamin a status
57601|NCT03207308|Retinol Isotope dilution|retinol isotope dilution
57602|NCT03207308|Total body vitamin A stores|total body vitamin a stores
57603|NCT03207308|Children|children
57604|NCT03207308|Senegal|senegal
57605|NCT03207295|Nesiritide|nesiritide
57606|NCT03207295|Total Cavo-Pulmonary Connection|total cavo-pulmonary connection
57607|NCT03207295|Congenital Heart Disease|congenital heart disease
57608|NCT03207243|Severe asthma|severe asthma
57609|NCT03207243|Safety|safety
57610|NCT03207243|GSK3772847|gsk3772847
57611|NCT03207243|Efficacy|efficacy
57612|NCT03207217|Safety Planning|safety planning
57613|NCT03207217|Access to Lethal Means|access to lethal means
57614|NCT03207217|Zero Suicide|zero suicide
57615|NCT03207204|Dental bleaching|dental bleaching
57616|NCT03207204|Color|color
57617|NCT03207204|Sensitivity|sensitivity
57618|NCT03207204|violet LED|violet led
57619|NCT03207204|Quality of life|quality of life
57620|NCT03207165|Cardiogenic shock|cardiogenic shock
57621|NCT03207165|Inotropes|inotropes
57622|NCT03207165|Low cardiac output syndrome|low cardiac output syndrome
57623|NCT03207139|cancer prostate|cancer prostate
57624|NCT03207139|Ga-68 PSMA Ligand|ga-68 psma ligand
57625|NCT03207139|staging|staging
57626|NCT03207139|biochemical failure|biochemical failure
57627|NCT03207126|Ultrasound|ultrasound
57628|NCT03207126|Biopsy|biopsy
57629|NCT03207126|Endometrial cancer|endometrial cancer
57630|NCT03207113|prostate-specific antigen|prostate-specific antigen
57631|NCT03207113|prostate cancer survivorship|prostate cancer survivorship
57632|NCT03207113|mobile health|mobile health
57633|NCT03207113|realist evaluation|realist evaluation
57634|NCT03207113|case study|case study
57635|NCT03207100|Intracerebral hemorrhage|intracerebral hemorrhage
57636|NCT03207100|Early antihypertensive treatment|early antihypertensive treatment
57637|NCT03207100|Analgesia-first|analgesia-first
57638|NCT03207100|Sedation|sedation
57639|NCT03207074|iKnife|iknife
57640|NCT03207074|Mass Spectrometry|mass spectrometry
57641|NCT03207074|Point-of-care|point-of-care
57642|NCT03207074|Diagnosis|diagnosis
57643|NCT03207074|Endometrial Cancer|endometrial cancer
57644|NCT03207061|endometrial cancer|endometrial cancer
57645|NCT03207061|staging|staging
57646|NCT03207061|3 Dimensional|3 dimensional
57647|NCT03207061|Ultrasound|ultrasound
57648|NCT03207061|Myometrial invasion|myometrial invasion
57649|NCT03206996|autism|autism
57650|NCT03206996|sensory over-responsiveness|sensory over-responsiveness
57651|NCT03206996|auditory hyper-sensitivity|auditory hyper-sensitivity
57652|NCT03206996|auditory processing|auditory processing
57653|NCT03206996|exposure therapy|exposure therapy
57654|NCT03206996|exposure and response prevention|exposure and response prevention
57655|NCT03206996|cognitive behavior therapy|cognitive behavior therapy
57656|NCT03206996|occupational therapy|occupational therapy
57657|NCT03206983|Small pupil|small pupil
57658|NCT03206944|standardized tomato extract|standardized tomato extract
57659|NCT03206944|anti-aggregation|anti-aggregation
57660|NCT03206944|high cardiovascular risk|high cardiovascular risk
57661|NCT03206944|diet supplement|diet supplement
57662|NCT03206892|LESS surgery|less surgery
57663|NCT03206892|conventional multi-port laparoscopy|conventional multi-port laparoscopy
57664|NCT03206892|SILS|sils
57665|NCT03206892|Single-site surgery|single-site surgery
57666|NCT03206892|Covidien|covidien
57667|NCT03206892|laparoscopy|laparoscopy
57668|NCT03206892|minimally invasive surgery|minimally invasive surgery
57669|NCT03206892|ovarian drilling|ovarian drilling
57670|NCT03206892|PCOS|pcos
57671|NCT03206892|Diagnostic laparoscopy|diagnostic laparoscopy
57672|NCT03206879|ESBL|esbl
57673|NCT03206879|Enterobacteriaceae|enterobacteriaceae
57674|NCT03206879|multidrug-resistance|multidrug-resistance
57675|NCT03206840|mindfulness meditation|mindfulness meditation
57676|NCT03206840|hypnosis|hypnosis
57677|NCT03206840|meta-awareness|meta-awareness
57678|NCT03206840|absorption|absorption
57679|NCT03206840|consciousness|consciousness
57680|NCT03206840|self|self
57681|NCT03206827|colorectal cancer|colorectal cancer
57682|NCT03206827|type 2 diabetes|type 2 diabetes
57683|NCT03206827|diet|diet
57684|NCT03206827|plant protein|plant protein
57685|NCT03206827|animal protein|animal protein
57686|NCT03206814|Hypertension|hypertension
57687|NCT03206814|Ambulatory Systolic Blood Pressure|ambulatory systolic blood pressure
57688|NCT03206814|Home Blood Pressure|home blood pressure
57689|NCT03206814|ESH-CARE APP|esh-care app
57690|NCT03206801|Urine biomarker|urine biomarker
57691|NCT03206801|CXCL10 chemokine|cxcl10 chemokine
57692|NCT03206801|Post-transplant monitoring|post-transplant monitoring
57693|NCT03206801|Protocol biopsy|protocol biopsy
57694|NCT03206723|corneal abrasion|corneal abrasion
57695|NCT03206723|contact lens|contact lens
57696|NCT03206723|eye trauma|eye trauma
57697|NCT03206710|vitamin C|vitamin c
57698|NCT03206710|ascorbic acid|ascorbic acid
57699|NCT03206710|wheeze|wheeze
57700|NCT03206710|nicotine|nicotine
57701|NCT03206710|smoke exposure|smoke exposure
57702|NCT03206710|long term follow up|long term follow up
57703|NCT03206710|pulmonary function testing|pulmonary function testing
57704|NCT03206710|forced expiratory flows|forced expiratory flows
57705|NCT03206697|mitochondrial copy, number and energy|mitochondrial copy, number and energy
57706|NCT03206658|acute kidney injury|acute kidney injury
57707|NCT03206658|prevention|prevention
57708|NCT03206658|severity|severity
57709|NCT03206658|biomarker|biomarker
57710|NCT03206619|smoking|smoking
57711|NCT03206619|habit|habit
57712|NCT03206619|preference|preference
57713|NCT03206619|behavior|behavior
57714|NCT03206619|tailoring|tailoring
57715|NCT03206619|cessation|cessation
57716|NCT03206619|engagement|engagement
57717|NCT03206619|digital|digital
57718|NCT03206619|mobile app|mobile app
57719|NCT03206619|recommender system|recommender system
57720|NCT03206606|COPD|copd
57721|NCT03206606|Spirometry|spirometry
57722|NCT03206606|Mobile application|mobile application
57723|NCT03206580|aging|aging
57724|NCT03206580|strength training|strength training
57725|NCT03206580|functionality|functionality
57726|NCT03206567|Hair thinning, Hair loss, Women, Nutraceutical supplement|hair thinning, hair loss, women, nutraceutical supplement
57727|NCT03206541|Neurological syndromes|neurological syndromes
57728|NCT03206541|Arbovirus infection|arbovirus infection
57729|NCT03206515|Renal Pelvic Pressure|renal pelvic pressure
57730|NCT03206476|Food Habits|food habits
57731|NCT03206476|Adolescents|adolescents
57732|NCT03206476|Educative Intervention|educative intervention
57733|NCT03206476|Nutrition Assessment|nutrition assessment
57734|NCT03206476|Behavior Modifications|behavior modifications
57735|NCT03206437|mindfulness|mindfulness
57736|NCT03206437|meditation|meditation
57737|NCT03206359|Unfolded Protein Response|unfolded protein response
57738|NCT03206359|GADD34|gadd34
57739|NCT03206359|Type I IFN|type i ifn
57740|NCT03206359|IFN response genes|ifn response genes
57741|NCT03206359|Type II IFN|type ii ifn
57742|NCT03206359|anti-DNA autoantibodies|anti-dna autoantibodies
57743|NCT03206333|Breast cancer|breast cancer
57744|NCT03206333|Cardiovascular diseases|cardiovascular diseases
57745|NCT03206333|Coronary artery calcium|coronary artery calcium
57746|NCT03206333|Prediction|prediction
57747|NCT03206333|Risk stratification|risk stratification
57748|NCT03206333|Deep learning technique|deep learning technique
57749|NCT03206333|Software development|software development
57750|NCT03206333|Computed tomography scan|computed tomography scan
57751|NCT03206307|Return to work|return to work
57752|NCT03206307|medical rehabilitation|medical rehabilitation
57753|NCT03206281|clinical weight estimation|clinical weight estimation
57754|NCT03206268|retinal nerve fiber layer thickness|retinal nerve fiber layer thickness
57755|NCT03206268|uveitis|uveitis
57756|NCT03206268|SD-OCT|sd-oct
57757|NCT03206268|GDx VCC|gdx vcc
57758|NCT03206255|Human Papilloma Virus 16|human papilloma virus 16
57759|NCT03206255|Human Papilloma Virus 18|human papilloma virus 18
57760|NCT03206255|adolescent girl|adolescent girl
57761|NCT03206255|non-inferiority|non-inferiority
57762|NCT03206255|immuno-persistence|immuno-persistence
57763|NCT03206242|Rehabilitation|rehabilitation
57764|NCT03206242|Physiotherapy|physiotherapy
57765|NCT03206242|Trismus|trismus
57766|NCT03206242|Pain|pain
57767|NCT03206242|Return to work|return to work
57768|NCT03206242|Quality of life|quality of life
57769|NCT03206190|SPG4|spg4
57770|NCT03206190|presymptomatic|presymptomatic
57771|NCT03206190|at risk|at risk
57772|NCT03206190|mutation carriers|mutation carriers
57773|NCT03206190|biomarkers|biomarkers
57774|NCT03206190|longitudinal progression|longitudinal progression
57775|NCT03206164|Health Services Research|health services research
57776|NCT03206138|Investigator trial|investigator trial
57777|NCT03206138|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
57778|NCT03206125|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
57779|NCT03206125|Case-Control Study|case-control study
57780|NCT03206125|Risk Factors|risk factors
57781|NCT03206125|Epidemiology|epidemiology
57782|NCT03206112|Focal Dystonia|focal dystonia
57783|NCT03206112|Healthy Volunteers|healthy volunteers
57784|NCT03206112|Paired Associative Stimulation (PAS)|paired associative stimulation (pas)
57785|NCT03206099|Genetic Disorders and Defects|genetic disorders and defects
57786|NCT03206099|Novel Clinical Phenotypes|novel clinical phenotypes
57787|NCT03206099|Immune Diseases|immune diseases
57788|NCT03206099|Proband|proband
57789|NCT03206099|Mendelian Disorders|mendelian disorders
57790|NCT03206086|DNA Repair|dna repair
57791|NCT03206086|Bone Marrow|bone marrow
57792|NCT03206086|Hematopoiesis|hematopoiesis
57793|NCT03206086|Pancytopenia|pancytopenia
57794|NCT03206086|Thrombocytopenia|thrombocytopenia
57795|NCT03206073|Oncolytic Vaccinia Virus|oncolytic vaccinia virus
57796|NCT03206073|Tumor Cell Death|tumor cell death
57797|NCT03206073|Viral Therapy|viral therapy
57798|NCT03206073|Anti-Tumor Immunity|anti-tumor immunity
57799|NCT03206060|Hypertension|hypertension
57800|NCT03206060|Catecholamine|catecholamine
57801|NCT03206060|Familial Syndromes|familial syndromes
57802|NCT03206060|Somatostatin Receptors|somatostatin receptors
57803|NCT03206060|Ionizing Radiation|ionizing radiation
57804|NCT03206034|Memory|memory
57805|NCT03206034|Cognition|cognition
57806|NCT03205995|TMA|tma
57807|NCT03205995|aHUS|ahus
57808|NCT03205982|Wisepill|wisepill
57809|NCT03205982|ART|art
57810|NCT03205982|PLWH|plwh
57811|NCT03205969|Breast Cancer|breast cancer
57812|NCT03205969|chemotherapy side effect|chemotherapy side effect
57813|NCT03205969|mobile game|mobile game
57814|NCT03205956|Parkinson's disease|parkinson's disease
57815|NCT03205956|PD|pd
57816|NCT03205956|levodopa|levodopa
57817|NCT03205943|ICON|icon
57818|NCT03205904|cystic fibrosis related diabetes|cystic fibrosis related diabetes
57819|NCT03205891|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
57820|NCT03205891|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
57821|NCT03205891|Classical Hodgkin Lymphoma|classical hodgkin lymphoma
57822|NCT03205891|CD30+ peripheral T-cell lymphoma|cd30+ peripheral t-cell lymphoma
57823|NCT03205891|Brentuximab Vedotin|brentuximab vedotin
57824|NCT03205891|SGN-35|sgn-35
57825|NCT03205891|Adcetris|adcetris
57826|NCT03205891|TAK228|tak228
57827|NCT03205891|TAK-228|tak-228
57828|NCT03205891|MLN0128|mln0128
57829|NCT03205891|Glucose Monitor|glucose monitor
57830|NCT03205891|Glucometer|glucometer
57831|NCT03205826|Emphysema|emphysema
57832|NCT03205826|Bronchoscopic intervention|bronchoscopic intervention
57833|NCT03205826|CHARTIS measurement|chartis measurement
57834|NCT03205813|Pain, Postoperative|pain, postoperative
57835|NCT03205813|Cesarean delivery|cesarean delivery
57836|NCT03205813|Intrathecal morphine|intrathecal morphine
57837|NCT03205761|Advanced Breast Cancer|advanced breast cancer
57838|NCT03205761|Triple Negative|triple negative
57839|NCT03205761|olaparib|olaparib
57840|NCT03205761|lynparza|lynparza
57841|NCT03205761|BRCA|brca
57842|NCT03205761|Methylation|methylation
57843|NCT03205709|memory|memory
57844|NCT03205709|computerized training|computerized training
57845|NCT03205709|cognition|cognition
57846|NCT03205709|MRI|mri
57847|NCT03205709|mci|mci
57848|NCT03205709|memory problems|memory problems
57849|NCT03205709|memory complaints|memory complaints
57850|NCT03205670|Autologous Cells|autologous cells
57851|NCT03205670|Buccal Mucosa|buccal mucosa
57852|NCT03205670|Urethroplasty|urethroplasty
57853|NCT03205670|Tissue-engineered Construct|tissue-engineered construct
57854|NCT03205670|Hybrid matrix|hybrid matrix
57855|NCT03205670|Collagen|collagen
57856|NCT03205670|Polylactoglycolide Fibers|polylactoglycolide fibers
57857|NCT03205540|Continuous epidural analgesia|continuous epidural analgesia
57858|NCT03205540|Bilateral single-shot adductor canal blocks|bilateral single-shot adductor canal blocks
57859|NCT03205527|Fall risk|fall risk
57860|NCT03205527|Stroke survivors|stroke survivors
57861|NCT03205527|Perturbation training|perturbation training
57862|NCT03205501|BE|be
57863|NCT03205501|EAC|eac
57864|NCT03205501|HGD|hgd
57865|NCT03205501|Esophagus|esophagus
57866|NCT03205488|Northwestern|northwestern
57867|NCT03205488|Nilotinib|nilotinib
57868|NCT03205488|USA|usa
57869|NCT03205488|NILO-PD|nilo-pd
57870|NCT03205488|Parkinson Disease|parkinson disease
57871|NCT03205475|Training|training
57872|NCT03205475|Intervention|intervention
57873|NCT03205475|Social Communication|social communication
57874|NCT03205475|Play|play
57875|NCT03205462|Pseudomanas Aeruginosa|pseudomanas aeruginosa
57876|NCT03205462|antibiotic resistance|antibiotic resistance
57877|NCT03205462|nosocomial infection|nosocomial infection
57878|NCT03205462|factors of pathogenicity of bacteria|factors of pathogenicity of bacteria
57879|NCT03205462|the system of secretion of type III pathogenic bacteria|the system of secretion of type iii pathogenic bacteria
57880|NCT03205462|chronic infection|chronic infection
57881|NCT03205410|remote ischemic preconditioning|remote ischemic preconditioning
57882|NCT03205410|cardiac surgery-associated acute kidney injury|cardiac surgery-associated acute kidney injury
57883|NCT03205410|neutrophil gelatinase-associated lipocalin|neutrophil gelatinase-associated lipocalin
57884|NCT03205384|Urgent abdominal surgery|urgent abdominal surgery
57885|NCT03205358|Meningitis|meningitis
57886|NCT03205358|Meningococcal Meningitis|meningococcal meningitis
57887|NCT03205358|MenACYW conjugate vaccine|menacyw conjugate vaccine
57888|NCT03205358|NIMENRIX®|nimenrix®
57889|NCT03205345|Cirrhosis|cirrhosis
57890|NCT03205345|NASH Cirrhosis|nash cirrhosis
57891|NCT03205345|Decompensated NASH cirrhosis|decompensated nash cirrhosis
57892|NCT03205345|Cirrhosis, Liver|cirrhosis, liver
57893|NCT03205345|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
57894|NCT03205332|Worry|worry
57895|NCT03205332|Anxiety|anxiety
57896|NCT03205319|Oesophagoduodenoscopy|oesophagoduodenoscopy
57897|NCT03205319|E-learning|e-learning
57898|NCT03205319|Appropriate use of healthcare|appropriate use of healthcare
57899|NCT03205319|Deimplementation|deimplementation
57900|NCT03205306|Myasthenia Gravis|myasthenia gravis
57901|NCT03205306|Psyche|psyche
57902|NCT03205306|Depression|depression
57903|NCT03205306|Anxiety Disorder|anxiety disorder
57904|NCT03205306|Posttraumatic Stress Disorder|posttraumatic stress disorder
57905|NCT03205306|Disease Processing|disease processing
57906|NCT03205293|School-Based Intervention|school-based intervention
57907|NCT03205293|Ecological Model|ecological model
57908|NCT03205293|Participatory Approach|participatory approach
57909|NCT03205293|Palestinian Female Schoolchildren|palestinian female schoolchildren
57910|NCT03205280|Multiple Sclerosis, Relapsing-Remitting, Computer-Assisted Diagnosis, MRI, Diagnosis, Treatment Efficacy|multiple sclerosis, relapsing-remitting, computer-assisted diagnosis, mri, diagnosis, treatment efficacy
57911|NCT03205254|Mediterranean diet|mediterranean diet
57912|NCT03205254|HDL|hdl
57913|NCT03205254|Fast food|fast food
57914|NCT03205254|Gut microbiota|gut microbiota
57915|NCT03205254|Inflammation|inflammation
57916|NCT03205241|Exercise|exercise
57917|NCT03205241|Fish Oil|fish oil
57918|NCT03205241|Cycling|cycling
57919|NCT03205241|Inflammation|inflammation
57920|NCT03205241|Oxidative stress|oxidative stress
57921|NCT03205215|Hyperbaric oxygen|hyperbaric oxygen
57922|NCT03205215|Pressurized oxygen|pressurized oxygen
57923|NCT03205215|Concussion|concussion
57924|NCT03205215|Post concussive syndrome|post concussive syndrome
57925|NCT03205215|Oxygen therapy|oxygen therapy
57926|NCT03205189|postoperative pain|postoperative pain
57927|NCT03205189|ambulatory surgery|ambulatory surgery
57928|NCT03205189|general anesthesia|general anesthesia
57929|NCT03205189|anesthesia consultation|anesthesia consultation
57930|NCT03205189|post-op prescription|post-op prescription
57931|NCT03205176|AZD5153|azd5153
57932|NCT03205176|Malignant solid tumors|malignant solid tumors
57933|NCT03205176|Lymphoma|lymphoma
57934|NCT03205176|Ovarian Cancer|ovarian cancer
57935|NCT03205176|BRD4|brd4
57936|NCT03205150|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
57937|NCT03205150|NASH|nash
57938|NCT03205150|Obese|obese
57939|NCT03205150|Type 2 diabetes mellitus|type 2 diabetes mellitus
57940|NCT03205150|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
57941|NCT03205098|biological markers|biological markers
57942|NCT03205098|mesenteric ischemia|mesenteric ischemia
57943|NCT03205098|ultratrail|ultratrail
57944|NCT03205072|ERCP|ercp
57945|NCT03205072|Per-Oral Cholangioscopy|per-oral cholangioscopy
57946|NCT03205072|Liver Transplantation|liver transplantation
57947|NCT03205072|Spy Glass|spy glass
57948|NCT03205033|Melatonin|melatonin
57949|NCT03205033|Breast cancer|breast cancer
57950|NCT03205033|Chemotherapy|chemotherapy
57951|NCT03205033|Sleep-wake rhytms|sleep-wake rhytms
57952|NCT03205033|Circadian rhythms|circadian rhythms
57953|NCT03205007|Health Promotion|health promotion
57954|NCT03205007|Nutrition|nutrition
57955|NCT03205007|Older Adults|older adults
57956|NCT03204994|Colorectal surgery|colorectal surgery
57957|NCT03204994|Fluorescence guided surgery|fluorescence guided surgery
57958|NCT03204981|intramural needle ablation|intramural needle ablation
57959|NCT03204981|ventricular arrhythmia|ventricular arrhythmia
57960|NCT03204968|vagus nerve|vagus nerve
57961|NCT03204968|Lung lobectomy|lung lobectomy
57962|NCT03204955|Osmolar therapy|osmolar therapy
57963|NCT03204955|Acetate|acetate
57964|NCT03204942|Bone metastasis,Thoracic secondary, Cancer Pain,|bone metastasis,thoracic secondary, cancer pain,
57965|NCT03204903|Dry eye|dry eye
57966|NCT03204903|Laser acupuncture|laser acupuncture
57967|NCT03204903|Traditional Chinese medicine|traditional chinese medicine
57968|NCT03204877|Melatonin|melatonin
57969|NCT03204877|Insulin sensitivity|insulin sensitivity
57970|NCT03204877|Insulin secretion|insulin secretion
57971|NCT03204877|Incretin response|incretin response
57972|NCT03204838|IDH1, IDH2, MUTATION, AML|idh1, idh2, mutation, aml
57973|NCT03204825|Patient education|patient education
57974|NCT03204825|Pain management|pain management
57975|NCT03204825|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
57976|NCT03204825|Physical activity|physical activity
57977|NCT03204825|Feasibility|feasibility
57978|NCT03204812|prostate cancer|prostate cancer
57979|NCT03204812|metastatic disease|metastatic disease
57980|NCT03204812|Immune responses|immune responses
57981|NCT03204812|Immunotherapies|immunotherapies
57982|NCT03204812|PD-L1-dependent immunosuppressive effects|pd-l1-dependent immunosuppressive effects
57983|NCT03204812|cytotoxic activity|cytotoxic activity
57984|NCT03204812|anti-tumor T-cells|anti-tumor t-cells
57985|NCT03204786|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
57986|NCT03204786|Autism|autism
57987|NCT03204747|Gait speed|gait speed
57988|NCT03204747|multiple sclerosis|multiple sclerosis
57989|NCT03204747|lower urinary tract symptoms|lower urinary tract symptoms
57990|NCT03204747|overactive bladder|overactive bladder
57991|NCT03204734|therapy|therapy
57992|NCT03204734|Capecitabine|capecitabine
57993|NCT03204734|breast cancer|breast cancer
57994|NCT03204708|postoperative analgsia|postoperative analgsia
57995|NCT03204708|peripheral block catheter|peripheral block catheter
57996|NCT03204708|modified radical mastectomy|modified radical mastectomy
57997|NCT03204695|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
57998|NCT03204695|Atrial Fibrillation|atrial fibrillation
57999|NCT03204695|Stroke|stroke
58000|NCT03204695|Left Atrial Appendage (LAA)|left atrial appendage (laa)
58001|NCT03204695|LAA Closure|laa closure
58002|NCT03204695|LAA Occlusion|laa occlusion
58003|NCT03204695|WaveCrest|wavecrest
58004|NCT03204682|Endometriosis|endometriosis
58005|NCT03204682|Magnetic transcranial stimulation|magnetic transcranial stimulation
58006|NCT03204682|Chronic pain|chronic pain
58007|NCT03204682|Analgesic|analgesic
58008|NCT03204669|Copper|copper
58009|NCT03204669|Selenium|selenium
58010|NCT03204669|Zinc|zinc
58011|NCT03204669|Continuous renal replacement therapy|continuous renal replacement therapy
58012|NCT03204656|difficult orotracheal intubation|difficult orotracheal intubation
58013|NCT03204656|selective lung intubation|selective lung intubation
58014|NCT03204656|unexpected difficult selective lung intubation|unexpected difficult selective lung intubation
58015|NCT03204630|infant nutrition|infant nutrition
58016|NCT03204630|probiotic|probiotic
58017|NCT03204617|HIV infection|hiv infection
58018|NCT03204617|First in Human|first in human
58019|NCT03204617|Therapeutic Vaccines|therapeutic vaccines
58020|NCT03204617|HTI|hti
58021|NCT03204617|HIV reservoir|hiv reservoir
58022|NCT03204604|Memory|memory
58023|NCT03204604|Dietary Treatment|dietary treatment
58024|NCT03204565|gingival recession, clinical trial(s).|gingival recession, clinical trial(s).
58025|NCT03204539|inhibitor|inhibitor
58026|NCT03204539|Factor VIII inhibitor|factor viii inhibitor
58027|NCT03204513|Prosthesis|prosthesis
58028|NCT03204513|Powered Prosthesis|powered prosthesis
58029|NCT03204500|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
58030|NCT03204500|Dual therapy|dual therapy
58031|NCT03204500|Randomized controlled trial|randomized controlled trial
58032|NCT03204500|ALSFRS-R|alsfrs-r
58033|NCT03204487|tear film thickness|tear film thickness
58034|NCT03204487|ocular surface disease|ocular surface disease
58035|NCT03204487|OCT|oct
58036|NCT03204474|Lacosamide|lacosamide
58037|NCT03204474|Bioequivalence|bioequivalence
58038|NCT03204474|Intravenous solution|intravenous solution
58039|NCT03204474|Tablet|tablet
58040|NCT03204422|urinary sodium excretion|urinary sodium excretion
58041|NCT03204422|24-hout urine|24-hout urine
58042|NCT03204422|salt intakes|salt intakes
58043|NCT03204422|hypertension|hypertension
58044|NCT03204409|CHIKV|chikv
58045|NCT03204409|DENGUE|dengue
58046|NCT03204409|Chikungunya|chikungunya
58047|NCT03204409|DENV|denv
58048|NCT03204357|Cardiac surgery|cardiac surgery
58049|NCT03204344|Gastrointestinal surgery|gastrointestinal surgery
58050|NCT03204344|Preoperative oral carbohydrate|preoperative oral carbohydrate
58051|NCT03204344|Diabetic patients|diabetic patients
58052|NCT03204344|Postoperative recovery|postoperative recovery
58053|NCT03204331|Endometriosis|endometriosis
58054|NCT03204331|Pain|pain
58055|NCT03204331|Dysmenorrhea|dysmenorrhea
58056|NCT03204318|Endometriosis|endometriosis
58057|NCT03204318|Pain|pain
58058|NCT03204318|Dysmenorrhea|dysmenorrhea
58059|NCT03204305|Marijuana|marijuana
58060|NCT03204305|cannabis|cannabis
58061|NCT03204305|cannabinoid receptor|cannabinoid receptor
58062|NCT03204292|Inferior vena cava|inferior vena cava
58063|NCT03204292|Fluid responsiveness|fluid responsiveness
58064|NCT03204292|Central venous pressure|central venous pressure
58065|NCT03204266|urinary tract|urinary tract
58066|NCT03204266|Bladder cancer|bladder cancer
58067|NCT03204266|Radical cystectomy|radical cystectomy
58068|NCT03204266|Omega-3 Fatty Acids|omega-3 fatty acids
58069|NCT03204240|Spinal Cord Injury|spinal cord injury
58070|NCT03204240|Skeletal Muscle|skeletal muscle
58071|NCT03204240|Functional Electrical Stimulation|functional electrical stimulation
58072|NCT03204240|Diabetes|diabetes
58073|NCT03204227|Japanese Encephalitis|japanese encephalitis
58074|NCT03204227|JECEVAX|jecevax
58075|NCT03204227|Vietnam|vietnam
58076|NCT03204214|binge drinking|binge drinking
58077|NCT03204201|Fluorescence|fluorescence
58078|NCT03204188|BTK Inhibitor|btk inhibitor
58079|NCT03204188|Checkpoint Inhibitor|checkpoint inhibitor
58080|NCT03204123|prostate cancer|prostate cancer
58081|NCT03204123|prostatectomy|prostatectomy
58082|NCT03204123|biochemical recurrence|biochemical recurrence
58083|NCT03204123|Ga-HBED-iPSMA|ga-hbed-ipsma
58084|NCT03204123|16-306|16-306
58085|NCT03204110|Reversible cerebral vasoconstriction syndrome|reversible cerebral vasoconstriction syndrome
58086|NCT03204110|Anatomic and morphological retinal network analysis|anatomic and morphological retinal network analysis
58087|NCT03204110|Retinal vessel analyser|retinal vessel analyser
58088|NCT03204110|retinography|retinography
58089|NCT03204110|Prospective analysis|prospective analysis
58090|NCT03204084|pterygium,Low temperature plasma|pterygium,low temperature plasma
58091|NCT03204045|oxycodone, fentanyl, tracheal extubation|oxycodone, fentanyl, tracheal extubation
58092|NCT03204032|Tegafur|tegafur
58093|NCT03204032|Temozolomide|temozolomide
58094|NCT03204032|Thalidomide|thalidomide
58095|NCT03204032|Extrapancreatic Neuroendocrine Tumor|extrapancreatic neuroendocrine tumor
58096|NCT03204019|Tegafur|tegafur
58097|NCT03204019|Temozolomide|temozolomide
58098|NCT03204019|Thalidomide|thalidomide
58099|NCT03204019|Pancreatic Neuroendocrine Tumor|pancreatic neuroendocrine tumor
59596|NCT03194828|Adherence|adherence
58100|NCT03203993|BRCA mutation|brca mutation
58101|NCT03203967|Adults|adults
58102|NCT03203967|Unilateral TKA|unilateral tka
58103|NCT03203967|Single femoral nerve block|single femoral nerve block
58104|NCT03203967|Low-dose epidural morphine|low-dose epidural morphine
58105|NCT03203967|Effect of postoperative analgesia|effect of postoperative analgesia
58106|NCT03203967|Quality of life|quality of life
58107|NCT03203941|Autologous Cord Blood Stem Cells|autologous cord blood stem cells
58108|NCT03203928|ADHD|adhd
58109|NCT03203928|Occupational Therapy|occupational therapy
58110|NCT03203915|cholesterol|cholesterol
58111|NCT03203915|triglyceride|triglyceride
58112|NCT03203915|grape seed extract|grape seed extract
58113|NCT03203915|chardonnay pomace powder|chardonnay pomace powder
58114|NCT03203915|polyphenol|polyphenol
58115|NCT03203915|gut microbiome|gut microbiome
58116|NCT03203902|Therapeutic touch|therapeutic touch
58117|NCT03203902|Post-traumatic Stress Disorder|post-traumatic stress disorder
58118|NCT03203902|Homeless|homeless
58119|NCT03203889|American Indians|american indians
58120|NCT03203889|Native Americans|native americans
58121|NCT03203889|Community Reinforcement Approach and Family Training|community reinforcement approach and family training
58122|NCT03203889|Nar-Anonymous Facilitation|nar-anonymous facilitation
58123|NCT03203889|Treatment Entry|treatment entry
58124|NCT03203889|Cultural adaptations|cultural adaptations
58125|NCT03203889|Spirituality|spirituality
58126|NCT03203850|hereditary hemochromatosis|hereditary hemochromatosis
58127|NCT03203850|ICL670|icl670
58128|NCT03203850|deferasirox FCT|deferasirox fct
58129|NCT03203850|iron overload|iron overload
58130|NCT03203837|Radioembolization|radioembolization
58131|NCT03203837|Y90|y90
58132|NCT03203837|TheraSphere|therasphere
58133|NCT03203837|HCC|hcc
58134|NCT03203837|Biomarker|biomarker
58135|NCT03203837|Prognostic factor|prognostic factor
58136|NCT03203837|Angiogenesis|angiogenesis
58137|NCT03203837|Inflammatory|inflammatory
58138|NCT03203837|Liver|liver
58139|NCT03203811|Healthy Subjects|healthy subjects
58140|NCT03203746|Lycopene|lycopene
58141|NCT03203746|Chronic periodontitis|chronic periodontitis
58142|NCT03203746|Protein carbonyl|protein carbonyl
58143|NCT03203733|Oral Mucositis , cooling, cryotherapy|oral mucositis , cooling, cryotherapy
58144|NCT03203720|adherence|adherence
58145|NCT03203720|adolescent|adolescent
58146|NCT03203720|Motivational Intervention|motivational intervention
58147|NCT03203707|IPSRT|ipsrt
58148|NCT03203707|early intervention|early intervention
58149|NCT03203707|bipolar disorder|bipolar disorder
58150|NCT03203668|Hyperparathyroidism|hyperparathyroidism
58151|NCT03203668|Imaging|imaging
58152|NCT03203668|Scintigraphy|scintigraphy
58153|NCT03203668|18F-choline|18f-choline
58154|NCT03203668|18F-fluorocholine|18f-fluorocholine
58155|NCT03203668|PET|pet
58156|NCT03203668|PET/CT|pet/ct
58157|NCT03203655|Mobile text|mobile text
58158|NCT03203655|Obesity|obesity
58159|NCT03203655|Hispanic|hispanic
58160|NCT03203655|Women|women
58161|NCT03203642|ADPKD|adpkd
58162|NCT03203642|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
58163|NCT03203642|Polycystic Kidney|polycystic kidney
58164|NCT03203642|Tesevatinib|tesevatinib
58165|NCT03203642|Polycystic Kidney Disease|polycystic kidney disease
58166|NCT03203642|PKD|pkd
58167|NCT03203603|asthma|asthma
58168|NCT03203603|pulmonary function testing|pulmonary function testing
58169|NCT03203603|wheeze|wheeze
58170|NCT03203603|vitamin C|vitamin c
58171|NCT03203603|antioxidants|antioxidants
58172|NCT03203603|forced expiratory flows|forced expiratory flows
58173|NCT03203551|Dentures|dentures
58174|NCT03203551|Biofilms|biofilms
58175|NCT03203551|Disinfection|disinfection
58176|NCT03203551|Candidiasis|candidiasis
58177|NCT03203551|Candida|candida
58178|NCT03203538|night work|night work
58179|NCT03203538|shift work|shift work
58180|NCT03203538|light|light
58181|NCT03203538|bright light|bright light
58182|NCT03203538|sleep|sleep
58183|NCT03203538|cognitive performance|cognitive performance
58184|NCT03203538|circadian rhythm|circadian rhythm
58185|NCT03203525|Liver Cancer|liver cancer
58186|NCT03203525|Hepatic metastases|hepatic metastases
58187|NCT03203525|Advanced liver cancer|advanced liver cancer
58188|NCT03203525|Eloxatin|eloxatin
58189|NCT03203525|Oxaliplatin|oxaliplatin
58190|NCT03203525|Leucovorin|leucovorin
58191|NCT03203525|Citrovorum|citrovorum
58192|NCT03203525|Wellcovorin|wellcovorin
58193|NCT03203525|5-fluorouracil|5-fluorouracil
58194|NCT03203525|Fluorouracil|fluorouracil
58195|NCT03203525|5-FU|5-fu
58196|NCT03203525|Adrucil|adrucil
58197|NCT03203525|Efudex|efudex
58198|NCT03203525|Bevacizumab|bevacizumab
58199|NCT03203525|Avastin|avastin
58200|NCT03203525|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
58201|NCT03203525|rhuMab-VEGF|rhumab-vegf
58202|NCT03203525|Liposomal Doxorubicin|liposomal doxorubicin
58203|NCT03203525|Doxil|doxil
58301|NCT03203148|Cardiopulmonary Bypass|cardiopulmonary bypass
58204|NCT03203525|Doxorubicin Hydrochloride (Liposomal)|doxorubicin hydrochloride (liposomal)
58205|NCT03203525|Temsirolimus|temsirolimus
58206|NCT03203525|CCI-779|cci-779
58207|NCT03203525|Torisel|torisel
58208|NCT03203525|NovoTTF-100L System|novottf-100l system
58209|NCT03203512|Fish oil; N-3 polyunsaturated fatty acids|fish oil; n-3 polyunsaturated fatty acids
58210|NCT03203499|Substance abuse disorder|substance abuse disorder
58211|NCT03203486|NAFLD|nafld
58212|NCT03203486|no fibrosis|no fibrosis
58213|NCT03203486|Mediterranean diet|mediterranean diet
58214|NCT03203486|STAT3|stat3
58215|NCT03203486|GCKR|gckr
58216|NCT03203486|visfatin|visfatin
58217|NCT03203486|oxidized LDL|oxidized ldl
58218|NCT03203486|fasting glucose|fasting glucose
58219|NCT03203486|inflammation|inflammation
58220|NCT03203473|Renal Cancer|renal cancer
58221|NCT03203460|Prostate Cancer|prostate cancer
58222|NCT03203460|Active Surveillance|active surveillance
58223|NCT03203460|Exercise|exercise
58224|NCT03203460|High-Intensity Interval Training|high-intensity interval training
58225|NCT03203460|Randomized Controlled Trial|randomized controlled trial
58226|NCT03203447|RVO|rvo
58227|NCT03203447|ME|me
58228|NCT03203447|Microneedle|microneedle
58229|NCT03203447|Microinjection|microinjection
58230|NCT03203447|Triamcinolone|triamcinolone
58231|NCT03203447|Choroid|choroid
58232|NCT03203447|Choroid injection|choroid injection
58233|NCT03203447|Suprachoroidal|suprachoroidal
58234|NCT03203447|Anti-VEGF|anti-vegf
58235|NCT03203447|Subretinal Fluid|subretinal fluid
58236|NCT03203447|Cystoid Macular Edema|cystoid macular edema
58237|NCT03203447|Optical Coherence Tomography|optical coherence tomography
58238|NCT03203447|OCT|oct
58239|NCT03203447|Central Subfield Thickness|central subfield thickness
58240|NCT03203447|Lucentis|lucentis
58241|NCT03203447|Avastin|avastin
58242|NCT03203447|Ranibizumab|ranibizumab
58243|NCT03203447|Bevacizumab|bevacizumab
58244|NCT03203434|Pancreatic cancer|pancreatic cancer
58245|NCT03203434|Esophageal cancer|esophageal cancer
58246|NCT03203434|volatile organic compounds|volatile organic compounds
58247|NCT03203434|Field asymmetric ion mobility spectrometry|field asymmetric ion mobility spectrometry
58248|NCT03203395|Depression|depression
58249|NCT03203395|Anxiety|anxiety
58250|NCT03203395|Panic Attacks|panic attacks
58251|NCT03203395|Collaborative Care|collaborative care
58252|NCT03203395|Heart disease and depression|heart disease and depression
58253|NCT03203395|Heart disease and anxiety|heart disease and anxiety
58254|NCT03203395|Heart disease and panic attacks|heart disease and panic attacks
58255|NCT03203369|Blastic plasmacytoid dendritic cell neoplasm|blastic plasmacytoid dendritic cell neoplasm
58256|NCT03203369|Natural Killer (NK) cell blastic lymphoma|natural killer (nk) cell blastic lymphoma
58257|NCT03203369|Hematologic malignancies|hematologic malignancies
58258|NCT03203369|Cluster of differentiation (CD) CD4+CD56+ hematodermic tumor|cluster of differentiation (cd) cd4+cd56+ hematodermic tumor
58259|NCT03203369|Acute leukemia and myeloid neoplasms|acute leukemia and myeloid neoplasms
58260|NCT03203369|Chimeric Antigen Receptor T-cell (CAR-T) therapy|chimeric antigen receptor t-cell (car-t) therapy
58261|NCT03203369|Allogeneic|allogeneic
58262|NCT03203369|Cluster of differentiation 4 (CD4)|cluster of differentiation 4 (cd4)
58263|NCT03203369|Cluster of differentiation 56 (CD56)|cluster of differentiation 56 (cd56)
58264|NCT03203356|growth hormone|growth hormone
58265|NCT03203356|children|children
58266|NCT03203356|adrenal function|adrenal function
58267|NCT03203343|Inguinal Hernia, Indirect|inguinal hernia, indirect
58268|NCT03203343|Children, Only|children, only
58269|NCT03203343|Inflammatory Response|inflammatory response
58270|NCT03203343|Surgery|surgery
58271|NCT03203343|Interleukin-6|interleukin-6
58272|NCT03203343|Tumor necrosis factor alpha|tumor necrosis factor alpha
58273|NCT03203343|C reactive protein|c reactive protein
58274|NCT03203343|Leukocytes|leukocytes
58275|NCT03203304|hepatocellular carcinoma|hepatocellular carcinoma
58276|NCT03203304|nivolumab|nivolumab
58277|NCT03203304|ipilimumab|ipilimumab
58278|NCT03203304|stereotactic body radiotherapy|stereotactic body radiotherapy
58279|NCT03203304|SBRT|sbrt
58280|NCT03203291|stroke|stroke
58281|NCT03203291|robotic training|robotic training
58282|NCT03203291|gait|gait
58283|NCT03203278|South Asian|south asian
58284|NCT03203265|HIV home testing|hiv home testing
58285|NCT03203239|red light|red light
58286|NCT03203239|vasodilation|vasodilation
58287|NCT03203239|nitric oxide|nitric oxide
58288|NCT03203226|Intellectual Disability|intellectual disability
58289|NCT03203226|Feldenkrais Method|feldenkrais method
58290|NCT03203226|Short Physical Performance Battery|short physical performance battery
58291|NCT03203226|Stabilometry|stabilometry
58292|NCT03203226|Supported employment|supported employment
58293|NCT03203213|Poisoning|poisoning
58294|NCT03203213|Psychoactive substances|psychoactive substances
58295|NCT03203174|microneedle|microneedle
58296|NCT03203174|botulinum toxin|botulinum toxin
58297|NCT03203174|botox|botox
58298|NCT03203174|palmar hyperhidrosis|palmar hyperhidrosis
58299|NCT03203174|sweating|sweating
58300|NCT03203174|hyperhidrosis|hyperhidrosis
58302|NCT03203148|Blood Coagulation Testing|blood coagulation testing
58303|NCT03203148|Point-of-Care Testing|point-of-care testing
58304|NCT03203109|lateropulsion|lateropulsion
58305|NCT03203109|pusher syndrome|pusher syndrome
58306|NCT03203109|posture|posture
58307|NCT03203109|balance|balance
58308|NCT03203109|PASS|pass
58309|NCT03203109|verticality perception|verticality perception
58310|NCT03203109|gait|gait
58311|NCT03203096|magnesium, stress, metabolomics, heart rate variability|magnesium, stress, metabolomics, heart rate variability
58312|NCT03203083|Reproducibility of Results|reproducibility of results
58313|NCT03203083|Clinical Assessment|clinical assessment
58314|NCT03203044|Dietary Intervention|dietary intervention
58315|NCT03203031|pain|pain
58316|NCT03203031|neonate|neonate
58317|NCT03203031|regional anesthesia|regional anesthesia
58318|NCT03203031|postoperative|postoperative
58319|NCT03203018|Cardiovascular Diseases (CVD)|cardiovascular diseases (cvd)
58320|NCT03203018|Community-based intervention|community-based intervention
58321|NCT03203018|Socio-economic status (SES)|socio-economic status (ses)
58322|NCT03203018|Health literacy (HL)|health literacy (hl)
58323|NCT03202979|Trazodone|trazodone
58324|NCT03202979|Placebo|placebo
58325|NCT03202979|Gabapentin|gabapentin
58326|NCT03202979|Neuropathic pain|neuropathic pain
58327|NCT03202940|Lung Cancer|lung cancer
58328|NCT03202901|knee-pain, curcuma, inflammation|knee-pain, curcuma, inflammation
58329|NCT03202862|fulvestrant|fulvestrant
58330|NCT03202862|ESR1|esr1
58331|NCT03202849|hematopoietic stem cell transplant|hematopoietic stem cell transplant
58332|NCT03202849|vitamin a|vitamin a
58333|NCT03202849|vitamin d|vitamin d
58334|NCT03202810|optical imaging technology, loss of heterozygosity, prevention, miRNA, cost-effectiveness|optical imaging technology, loss of heterozygosity, prevention, mirna, cost-effectiveness
58335|NCT03202758|Durvalumab|durvalumab
58336|NCT03202758|Tremelimumab|tremelimumab
58337|NCT03202758|FOLFOX|folfox
58338|NCT03202758|metastatic colorectal cancer|metastatic colorectal cancer
58339|NCT03202732|Self-management|self-management
58340|NCT03202732|Patient Activeted measure|patient activeted measure
58341|NCT03202732|Patient-reported outcome|patient-reported outcome
58342|NCT03202732|Type 1 diabetes Mellitus|type 1 diabetes mellitus
58343|NCT03202732|Non-inferiority study|non-inferiority study
58344|NCT03202719|Inactivated polio vaccine|inactivated polio vaccine
58345|NCT03202719|Polio|polio
58346|NCT03202719|oral polio vaccine|oral polio vaccine
58347|NCT03202693|Tuberculosis, PA-824|tuberculosis, pa-824
58348|NCT03202667|SGLT2-inhibitor|sglt2-inhibitor
58349|NCT03202667|Treatment|treatment
58350|NCT03202641|ARDS|ards
58351|NCT03202641|PEEP titration|peep titration
58352|NCT03202641|Open Lung Strategy|open lung strategy
58353|NCT03202641|Right heart function|right heart function
58354|NCT03202641|Lung recruitment maneuver|lung recruitment maneuver
58355|NCT03202641|Esophageal Pressure|esophageal pressure
58356|NCT03202641|Respiratory system compliance|respiratory system compliance
58357|NCT03202615|lactoferrin|lactoferrin
58358|NCT03202615|iron deficiency anemia in pregnancy|iron deficiency anemia in pregnancy
58359|NCT03202602|Obstructive sleep apnea|obstructive sleep apnea
58360|NCT03202602|Continuous positive airway pressure|continuous positive airway pressure
58361|NCT03202602|Telemoedicine|telemoedicine
58362|NCT03202589|Preoperative assessement for geriatric patients|preoperative assessement for geriatric patients
58363|NCT03202589|FOCUS Echocardiography|focus echocardiography
58364|NCT03202589|Orthopedic|orthopedic
58365|NCT03202589|Surgery|surgery
58366|NCT03202589|Geriatric|geriatric
58367|NCT03202576|nasogastric tube|nasogastric tube
58368|NCT03202576|microbridle|microbridle
58369|NCT03202550|Oral Sedation|oral sedation
58370|NCT03202550|Lorazepam|lorazepam
58371|NCT03202550|Oxycodone|oxycodone
58372|NCT03202524|Paracentesis|paracentesis
58373|NCT03202524|Albumin|albumin
58374|NCT03202524|Plasma|plasma
58375|NCT03202498|Cirrhosis, Liver|cirrhosis, liver
58376|NCT03202498|Fibrosis, Liver|fibrosis, liver
58377|NCT03202498|Hepatic Cirrhosis|hepatic cirrhosis
58378|NCT03202498|Liver Fibrosis|liver fibrosis
58379|NCT03202485|astigmatism|astigmatism
58380|NCT03202485|high myopia|high myopia
58381|NCT03202485|phakic intraocular lens|phakic intraocular lens
58382|NCT03202485|astigmatic keratotomy|astigmatic keratotomy
58383|NCT03202485|toric|toric
58384|NCT03202459|Anesthesia|anesthesia
58385|NCT03202459|Complications|complications
58386|NCT03202459|Nausea|nausea
58387|NCT03202459|Vomiting|vomiting
58388|NCT03202433|Virtual Reality|virtual reality
58389|NCT03202433|Stress Reduction|stress reduction
58390|NCT03202433|Needle Aspiration|needle aspiration
58391|NCT03202433|Blood Donors|blood donors
58392|NCT03202433|Intervention|intervention
58393|NCT03202394|intubation|intubation
58394|NCT03202394|aerosol|aerosol
58395|NCT03202394|sepsis|sepsis
58396|NCT03202394|edema|edema
58397|NCT03202381|Androgen deprivation therapy|androgen deprivation therapy
58398|NCT03202381|GnRH antagonist|gnrh antagonist
58399|NCT03202355|Alignment phase|alignment phase
58400|NCT03202355|Photobiomodulation|photobiomodulation
58401|NCT03202355|Orthodontic treatment|orthodontic treatment
58402|NCT03202355|Malocclusion|malocclusion
58403|NCT03202355|OrthoPulse™|orthopulse™
58404|NCT03202316|Malignant neoplasm of breast|malignant neoplasm of breast
58405|NCT03202316|Metastatic inflammatory breast cancer|metastatic inflammatory breast cancer
58406|NCT03202316|mIBC|mibc
58407|NCT03202316|Cobimetinib|cobimetinib
58408|NCT03202316|Atezolizumab|atezolizumab
58409|NCT03202316|MPDL3280A|mpdl3280a
58410|NCT03202316|Eribulin|eribulin
58411|NCT03202316|E7389|e7389
58412|NCT03202303|Autism|autism
58413|NCT03202303|Irritability|irritability
58414|NCT03202303|cannabinoids|cannabinoids
58415|NCT03202277|physical activity, sleep, sedentary behavior, dietary intake, smartphone|physical activity, sleep, sedentary behavior, dietary intake, smartphone
58416|NCT03202264|Polypharmacy|polypharmacy
58417|NCT03202264|Mobility|mobility
58418|NCT03202264|Multimorbidity|multimorbidity
58419|NCT03202264|Drug Discontinuation|drug discontinuation
58420|NCT03202264|Patient Preference|patient preference
58421|NCT03202264|eHealth|ehealth
58422|NCT03202199|Adenocarcinoma, pancreas, PET/MRI|adenocarcinoma, pancreas, pet/mri
58423|NCT03202173|Probe-based confocal laser endomicroscopy|probe-based confocal laser endomicroscopy
58424|NCT03202173|Optical biopsy|optical biopsy
58425|NCT03202160|Goiter|goiter
58426|NCT03202147|Ischemic stroke, post-stroke cognitive impairment, PSCI|ischemic stroke, post-stroke cognitive impairment, psci
58427|NCT03202108|Ketogenic|ketogenic
58428|NCT03202108|Diet|diet
58429|NCT03202108|Epilepsy|epilepsy
58430|NCT03202108|Glut-1 DS|glut-1 ds
58431|NCT03202108|Krio|krio
58432|NCT03202095|Depression|depression
58433|NCT03202095|Type 2 Diabetes|type 2 diabetes
58434|NCT03202095|Creatine|creatine
58435|NCT03202095|Diabetes|diabetes
58436|NCT03202069|Protein|protein
58437|NCT03202069|Weight Loss|weight loss
58438|NCT03202056|hip osteoarthritis|hip osteoarthritis
58439|NCT03202056|physiotherapy|physiotherapy
58440|NCT03202056|manual therapy|manual therapy
58441|NCT03202030|immediate dentoalveolar restoration|immediate dentoalveolar restoration
58442|NCT03202030|bio-oss|bio-oss
58443|NCT03202030|immediate dental implant|immediate dental implant
58444|NCT03202030|bovine bone|bovine bone
58445|NCT03202004|PGA|pga
58446|NCT03202004|efficacy|efficacy
58447|NCT03202004|PASI|pasi
58448|NCT03202004|GSK2894512|gsk2894512
58449|NCT03202004|NRS|nrs
58450|NCT03202004|Topical|topical
58451|NCT03202004|psoriasis|psoriasis
58452|NCT03201991|ALS|als
58453|NCT03201978|Healthy adults|healthy adults
58454|NCT03201978|GSK2894512|gsk2894512
58455|NCT03201978|Topical|topical
58456|NCT03201978|Psoriasis|psoriasis
58457|NCT03201978|Pharmacokinetics|pharmacokinetics
58458|NCT03201952|Glucose|glucose
58459|NCT03201952|Ileostomy|ileostomy
58460|NCT03201939|HIV/AIDS|hiv/aids
58461|NCT03201939|sub-Saharan Africa|sub-saharan africa
58462|NCT03201939|Kidney disease|kidney disease
58463|NCT03201939|Albuminuria|albuminuria
58464|NCT03201939|Genetic risk|genetic risk
58465|NCT03201900|perampanel|perampanel
58466|NCT03201848|Huaiqihuang granule|huaiqihuang granule
58467|NCT03201848|immune thrombocytopenia|immune thrombocytopenia
58468|NCT03201848|randomized|randomized
58469|NCT03201848|double-blind|double-blind
58470|NCT03201848|placebo-controlled,|placebo-controlled,
58471|NCT03201822|flavanol|flavanol
58472|NCT03201822|ADME|adme
58473|NCT03201822|cocoa flavanols|cocoa flavanols
58474|NCT03201822|polyphenols|polyphenols
58475|NCT03201796|Bacterial prostatitis|bacterial prostatitis
58476|NCT03201796|CBP|cbp
58477|NCT03201796|Levofloxacin|levofloxacin
58478|NCT03201796|Prulifloxacin|prulifloxacin
58479|NCT03201783|frozen-thawed embryo transfer|frozen-thawed embryo transfer
58480|NCT03201783|time interval|time interval
58481|NCT03201770|Uncomplicated Malaria|uncomplicated malaria
58482|NCT03201770|Pyramax|pyramax
58483|NCT03201770|Pyronaridine artesunate|pyronaridine artesunate
58484|NCT03201757|Alkermes|alkermes
58485|NCT03201757|ALKS 3831|alks 3831
58486|NCT03201757|Olanzapine|olanzapine
58487|NCT03201757|Samidorphan|samidorphan
58488|NCT03201757|Schizophrenia|schizophrenia
58489|NCT03201757|Schizophreniform|schizophreniform
58490|NCT03201757|Bipolar I|bipolar i
58491|NCT03201718|Hepatitis C|hepatitis c
58492|NCT03201718|Paritaprevir|paritaprevir
58493|NCT03201718|Ritonavir|ritonavir
58494|NCT03201718|Ombitasvir|ombitasvir
58495|NCT03201718|Dasabuvir|dasabuvir
58496|NCT03201705|Failed Back Surgery Syndrome|failed back surgery syndrome
58497|NCT03201705|Spinal Cord Stimulation|spinal cord stimulation
58498|NCT03201705|Pain Management|pain management
58499|NCT03201705|Implantable Neurostimulator|implantable neurostimulator
58500|NCT03201679|SIRS, systemic inflammatory response syndrome|sirs, systemic inflammatory response syndrome
58501|NCT03201679|Hip Fracture Surgery|hip fracture surgery
58502|NCT03201679|Sepsis|sepsis
58503|NCT03201679|Mortality|mortality
58504|NCT03201666|prenatal diagnosis|prenatal diagnosis
58505|NCT03201666|non-invasive prenatal tests|non-invasive prenatal tests
58506|NCT03201666|chromosome microarray analysis|chromosome microarray analysis
58507|NCT03201653|Distal Pancreatectomy|distal pancreatectomy
58508|NCT03201653|Pancreatic Fistula|pancreatic fistula
58509|NCT03201653|Oxidized Regenerated Cellulose|oxidized regenerated cellulose
58510|NCT03201653|Pancreatectomy|pancreatectomy
58511|NCT03201601|Polycystic ovarian syndrome|polycystic ovarian syndrome
58512|NCT03201601|D-chiro-inositol|d-chiro-inositol
58513|NCT03201601|Fertility|fertility
58514|NCT03201588|Retinopathy of Prematurity|retinopathy of prematurity
58515|NCT03201575|Intensive care|intensive care
58516|NCT03201575|septic shock|septic shock
58517|NCT03201575|multiple organ failure|multiple organ failure
58518|NCT03201575|Ischemia-reperfusion|ischemia-reperfusion
58519|NCT03201575|ischemic conditioning|ischemic conditioning
58520|NCT03201575|remote conditioning|remote conditioning
58521|NCT03201575|SOFA score|sofa score
58522|NCT03201536|ZipLine3 device vs. conventional sutures|zipline3 device vs. conventional sutures
58523|NCT03201523|Community-based Intervention|community-based intervention
58524|NCT03201523|Socio-ecological Model|socio-ecological model
58525|NCT03201523|Participatory Approach|participatory approach
58526|NCT03201523|Ultra-Orthodox Jewish women|ultra-orthodox jewish women
58527|NCT03201432|Vertebral Artery Stenosis|vertebral artery stenosis
58528|NCT03201432|Ischemic Stroke|ischemic stroke
58529|NCT03201432|Stent|stent
58530|NCT03201406|Renal biopsy, Chronic kidney disease,Diabetic nephropathy,Lupus Nephritis|renal biopsy, chronic kidney disease,diabetic nephropathy,lupus nephritis
58531|NCT03201393|Back pain|back pain
58532|NCT03201393|Neuropathic Pain|neuropathic pain
58533|NCT03201393|Radiculopathy|radiculopathy
58534|NCT03201393|Allodynia|allodynia
58535|NCT03201367|Portal vein|portal vein
58536|NCT03201367|thrombosis|thrombosis
58537|NCT03201367|acute|acute
58538|NCT03201367|rivaroxaban|rivaroxaban
58539|NCT03201354|Glaucoma|glaucoma
58540|NCT03201354|Ocular hypertension|ocular hypertension
58541|NCT03201354|Filtration surgery|filtration surgery
58542|NCT03201354|Trabeculectomy with Ex-PRESS|trabeculectomy with ex-press
58543|NCT03201354|Non penetrating deep sclerectomy|non penetrating deep sclerectomy
58544|NCT03201354|Phacoemulsification|phacoemulsification
58545|NCT03201354|Combined surgery|combined surgery
58546|NCT03201341|Stroke|stroke
58547|NCT03201341|Multisensory|multisensory
58548|NCT03201341|Plasticity|plasticity
58549|NCT03201341|Body|body
58550|NCT03201341|Space|space
58551|NCT03201341|MRI|mri
58552|NCT03201315|Fentanyl, opioids|fentanyl, opioids
58553|NCT03201302|bone|bone
58554|NCT03201302|childhood|childhood
58555|NCT03201302|pre-adolescence|pre-adolescence
58556|NCT03201302|bone turnover markers|bone turnover markers
58557|NCT03201302|sclerostin|sclerostin
58558|NCT03201302|sports|sports
58559|NCT03201302|physical activity|physical activity
58560|NCT03201302|nutrition|nutrition
58561|NCT03201276|glucosamine sulfate|glucosamine sulfate
58562|NCT03201276|individual differences|individual differences
58563|NCT03201276|gene polymorphism|gene polymorphism
58564|NCT03201250|carfilzomib|carfilzomib
58565|NCT03201250|cabozantinib|cabozantinib
58566|NCT03201250|proteasome inhibitor|proteasome inhibitor
58567|NCT03201250|resistance|resistance
58568|NCT03201237|Cerebral palsy|cerebral palsy
58569|NCT03201211|Safety|safety
58570|NCT03201211|Immunogenicity|immunogenicity
58571|NCT03201198|physical activity|physical activity
58572|NCT03201198|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
58573|NCT03201185|Cardiovascular events|cardiovascular events
58574|NCT03201185|Ventricular remodeling|ventricular remodeling
58575|NCT03201159|ASH|ash
58576|NCT03201081|elderly|elderly
58577|NCT03201081|motivation|motivation
58578|NCT03201081|adherence|adherence
58579|NCT03201081|resistance-training|resistance-training
58580|NCT03201081|health|health
58581|NCT03201029|center for ethnic skin|center for ethnic skin
58582|NCT03201029|skin of color clinic|skin of color clinic
58583|NCT03201029|ethnic skin center|ethnic skin center
58584|NCT03201016|cirrhosis|cirrhosis
58585|NCT03201003|AR101|ar101
58586|NCT03201003|Characterized Peanut Allergen|characterized peanut allergen
58587|NCT03201003|CPNA (Characterized Peanut Allergen)|cpna (characterized peanut allergen)
58588|NCT03201003|OIT (oral immunotherapy)|oit (oral immunotherapy)
58589|NCT03201003|Peanut Allergy|peanut allergy
58590|NCT03201003|Peanut-Allergic Children|peanut-allergic children
58591|NCT03201003|Desensitization|desensitization
58592|NCT03201003|ARTEMIS|artemis
58593|NCT03201003|Allergy|allergy
58594|NCT03200990|pressure-volume loops|pressure-volume loops
58595|NCT03200990|cardiac mechanics|cardiac mechanics
58596|NCT03200990|high-risk PCI|high-risk pci
58597|NCT03200938|pulpotomy|pulpotomy
58598|NCT03200938|Biological cement|biological cement
58599|NCT03200938|Deciduous tooth|deciduous tooth
58600|NCT03200925|video|video
58601|NCT03200925|skin-to-skin|skin-to-skin
58602|NCT03200925|kangaroo care|kangaroo care
58603|NCT03200925|prenatal education|prenatal education
58604|NCT03200899|cognitive rehabilitation|cognitive rehabilitation
58605|NCT03200886|hyaluronic acid|hyaluronic acid
58606|NCT03200886|intra-articular injections|intra-articular injections
58607|NCT03200886|triamcinolone|triamcinolone
58608|NCT03200886|osteoarthritis of the thumb|osteoarthritis of the thumb
58609|NCT03200873|transcranial magnetic stimulation|transcranial magnetic stimulation
58610|NCT03200873|theta burst stimulation|theta burst stimulation
58611|NCT03200873|impulsivity|impulsivity
58612|NCT03200860|heart failure|heart failure
58613|NCT03200860|diuretic response|diuretic response
58614|NCT03200860|empagliflozin|empagliflozin
58615|NCT03200847|Pembrolizumab|pembrolizumab
58616|NCT03200847|All-Trans Retinoic Acid|all-trans retinoic acid
58617|NCT03200834|Right colon cancer|right colon cancer
58618|NCT03200834|D3 dissection|d3 dissection
58619|NCT03200834|complete mesocolic excision|complete mesocolic excision
58620|NCT03200834|Hemicolectomy|hemicolectomy
58621|NCT03200808|Nonneoplastic Epithelial Disorders|nonneoplastic epithelial disorders
58622|NCT03200808|methylene blue|methylene blue
58623|NCT03200808|treatment|treatment
58624|NCT03200795|Diabetes|diabetes
58625|NCT03200795|Musculoskelatal pain|musculoskelatal pain
58626|NCT03200795|Rebound exercises|rebound exercises
58627|NCT03200795|Depression|depression
58628|NCT03200795|Glucose|glucose
58629|NCT03200795|Quality of life|quality of life
58630|NCT03200782|postprandial hypoglycemia|postprandial hypoglycemia
58631|NCT03200782|bariatric surgery|bariatric surgery
58632|NCT03200782|late dumping syndrome|late dumping syndrome
58633|NCT03200782|anakinra|anakinra
58634|NCT03200782|empagliflozin|empagliflozin
58635|NCT03200782|SGLT2 inhibitor|sglt2 inhibitor
58636|NCT03200782|IL-1Beta|il-1beta
58637|NCT03200782|IL1|il1
58638|NCT03200769|CPAP|cpap
58639|NCT03200769|Sleep Apnea Syndrome|sleep apnea syndrome
58640|NCT03200769|Pharmacoresistant Epilepsy|pharmacoresistant epilepsy
58641|NCT03200769|Apnea Hypopnea-Index|apnea hypopnea-index
58642|NCT03200756|sedentary behavior|sedentary behavior
58643|NCT03200743|Hypertension|hypertension
58644|NCT03200743|Pregnancy|pregnancy
58645|NCT03200743|Catestatin|catestatin
58646|NCT03200730|Family Dignity Intervention|family dignity intervention
58647|NCT03200730|Multicentre Randomized Control Trial|multicentre randomized control trial
58648|NCT03200730|Palliative Care|palliative care
58649|NCT03200730|End-of-Life Care|end-of-life care
58650|NCT03200717|renal cell carcinoma|renal cell carcinoma
58651|NCT03200717|metastatic renal cell|metastatic renal cell
58652|NCT03200717|pazopanib|pazopanib
58653|NCT03200717|checkpoint inhibitor therapy|checkpoint inhibitor therapy
58654|NCT03200717|RCC|rcc
58655|NCT03200717|hypernephroma|hypernephroma
58656|NCT03200717|renal adenocarcinoma|renal adenocarcinoma
58657|NCT03200717|kidney cancer|kidney cancer
58658|NCT03200717|renal cancer|renal cancer
58659|NCT03200717|adult|adult
58660|NCT03200691|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
58661|NCT03200691|PD-1|pd-1
58662|NCT03200691|Neoadjuvant treatment|neoadjuvant treatment
58663|NCT03200678|knee muscle|knee muscle
58664|NCT03200678|strength|strength
58665|NCT03200678|fatigue|fatigue
58666|NCT03200678|MRI|mri
58667|NCT03200678|ACL|acl
58668|NCT03200652|Lysine|lysine
58669|NCT03200652|Adult|adult
58670|NCT03200652|Protein Quality|protein quality
58671|NCT03200639|Breast Cancer Female|breast cancer female
58672|NCT03200639|Gynecologic Cancer|gynecologic cancer
58673|NCT03200639|Menopause|menopause
58674|NCT03200639|Physical Activity|physical activity
58675|NCT03200613|Spinal cord injury|spinal cord injury
58676|NCT03200613|Venous thromboembolism|venous thromboembolism
58677|NCT03200613|Hemorrhage|hemorrhage
58678|NCT03200600|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
58679|NCT03200600|Surgery|surgery
58680|NCT03200600|Dexamethasone|dexamethasone
58681|NCT03200600|Flubiprofen Axetil|flubiprofen axetil
58682|NCT03200600|Delirium|delirium
58683|NCT03200587|Metastatic|metastatic
58684|NCT03200574|Perceval|perceval
58685|NCT03200574|Mitroflow|mitroflow
58686|NCT03200574|CROWN PRT|crown prt
58687|NCT03200574|Freedom Solo|freedom solo
58688|NCT03200574|Solo Smart|solo smart
58689|NCT03200522|Asthma, Diet|asthma, diet
58690|NCT03200509|nonspecific low back pain|nonspecific low back pain
58691|NCT03200509|chronic pain|chronic pain
58692|NCT03200483|Autonomic Nervous System|autonomic nervous system
58693|NCT03200483|Aerobic exercise|aerobic exercise
58694|NCT03200483|Recuperation|recuperation
58695|NCT03200483|Music|music
58696|NCT03200457|Liver iron|liver iron
58697|NCT03200457|Liver steatosis|liver steatosis
58698|NCT03200457|MRI|mri
58699|NCT03200405|umbilical hernia|umbilical hernia
58700|NCT03200405|mesh repair|mesh repair
58701|NCT03200405|MRI-visibility|mri-visibility
58702|NCT03200405|underlay|underlay
58703|NCT03200405|NANEP|nanep
58704|NCT03200405|DynaMeshCICAT|dynameshcicat
58705|NCT03200405|DynaMeshVisible|dynameshvisible
58706|NCT03200405|preperitoneal|preperitoneal
58707|NCT03200392|Er,Cr:YSGG laser|er,cr:ysgg laser
59697|NCT03194308|Women|women
58708|NCT03200392|connective tissue graft|connective tissue graft
58709|NCT03200392|root coverage|root coverage
58710|NCT03200392|mucogingival surgery|mucogingival surgery
58711|NCT03200392|gingival recession|gingival recession
58712|NCT03200366|Cancer Screening Tests|cancer screening tests
58713|NCT03200366|Colonoscopy|colonoscopy
58714|NCT03200275|Legionella urine antigen test|legionella urine antigen test
58715|NCT03200249|dose escalation, chemo-radiation, rectum cancer, phase 2|dose escalation, chemo-radiation, rectum cancer, phase 2
58716|NCT03200236|Lung Cancer Screening|lung cancer screening
58717|NCT03200236|Smoking Cessation|smoking cessation
58718|NCT03200236|Tobacco Use|tobacco use
58719|NCT03200210|Continuous Ambulatory Peritoneal Dialysis (CAPD)|continuous ambulatory peritoneal dialysis (capd)
58720|NCT03200210|Hyperuricemia|hyperuricemia
58721|NCT03200210|Cardiovascular events|cardiovascular events
58722|NCT03200210|Treatment|treatment
58723|NCT03200197|Chewing gum|chewing gum
58724|NCT03200197|Artificial saliva|artificial saliva
58725|NCT03200197|Saliva|saliva
58726|NCT03200197|Mastication|mastication
58727|NCT03200197|Salivary glands|salivary glands
58728|NCT03200197|Xerostomia|xerostomia
58729|NCT03200184|Hepatitis C|hepatitis c
58730|NCT03200184|sofosbuvir|sofosbuvir
58731|NCT03200184|daclatasvir|daclatasvir
58732|NCT03200171|Carcinoma, Hepatocellular|carcinoma, hepatocellular
58733|NCT03200171|Hepatitis C|hepatitis c
58734|NCT03200158|Stress related mucosal disease (SRMD)|stress related mucosal disease (srmd)
58735|NCT03200158|APACHEII score|apacheii score
58736|NCT03200158|C-reactive protein|c-reactive protein
58737|NCT03200158|Malondialdehyde (MDA)|malondialdehyde (mda)
58738|NCT03200158|transforming growth factor (TGF)|transforming growth factor (tgf)
58739|NCT03200158|interleukin (IL)|interleukin (il)
58740|NCT03200093|Clostridium difficile|clostridium difficile
58741|NCT03200093|C diff|c diff
58742|NCT03200093|Oral Vancomycin|oral vancomycin
58743|NCT03200093|Prophylaxis|prophylaxis
58744|NCT03200054|therapy|therapy
58745|NCT03200054|postnatal|postnatal
58746|NCT03200002|Lupus Nephritis, cyclophosphamide, Mycophenolate mofetil|lupus nephritis, cyclophosphamide, mycophenolate mofetil
58747|NCT03199989|colon cancer|colon cancer
58748|NCT03199989|adjuvant chemotherapy|adjuvant chemotherapy
58749|NCT03199989|high risk|high risk
58750|NCT03199976|wheeze|wheeze
58751|NCT03199976|shortness of breath|shortness of breath
58752|NCT03199963|Mammographic|mammographic
58753|NCT03199963|Breast|breast
58754|NCT03199963|Density|density
58755|NCT03199963|BIRADS C or D|birads c or d
58756|NCT03199950|Delirium|delirium
58757|NCT03199950|Haloperidol|haloperidol
58758|NCT03199950|Prophylactic|prophylactic
58759|NCT03199950|High-risk|high-risk
58760|NCT03199937|Autism Spectrum Disorder|autism spectrum disorder
58761|NCT03199937|Executive Functioning|executive functioning
58762|NCT03199937|Intervention|intervention
58763|NCT03199937|Flexible|flexible
58764|NCT03199937|Unstuck|unstuck
58765|NCT03199937|Transition|transition
58766|NCT03199937|Behavior|behavior
58767|NCT03199937|High school|high school
58768|NCT03199937|Problem Solving|problem solving
58769|NCT03199937|Self-Control|self-control
58770|NCT03199937|Coping|coping
58771|NCT03199924|acute pain|acute pain
58772|NCT03199924|Renal colic|renal colic
58773|NCT03199924|Diclofenac|diclofenac
58774|NCT03199924|Lidocain|lidocain
58775|NCT03199924|Magnesium sulfate|magnesium sulfate
58776|NCT03199898|Lung/Growth & Development|lung/growth & development
58777|NCT03199898|Respiration, artificial|respiration, artificial
58778|NCT03199898|Reproducibility of Results|reproducibility of results
58779|NCT03199898|Observer Variation|observer variation
58780|NCT03199859|gastric cancer|gastric cancer
58781|NCT03199859|postoperative|postoperative
58782|NCT03199859|subsyndromal delirium|subsyndromal delirium
58783|NCT03199859|quality of life|quality of life
58784|NCT03199833|rehabilitation|rehabilitation
58785|NCT03199833|orthosis|orthosis
58786|NCT03199833|functional electrical stimulation|functional electrical stimulation
58787|NCT03199833|electrode array|electrode array
58788|NCT03199833|upper limb|upper limb
58789|NCT03199833|sub-acute|sub-acute
58790|NCT03199833|motor relearning|motor relearning
58791|NCT03199807|HCC|hcc
58792|NCT03199807|NRT|nrt
58793|NCT03199807|TOMO radiotherapy|tomo radiotherapy
58794|NCT03199781|cellulits of leg|cellulits of leg
58795|NCT03199781|Motorized power massage|motorized power massage
58796|NCT03199781|massage|massage
58797|NCT03199768|architecture|architecture
58798|NCT03199768|delirium|delirium
58799|NCT03199768|environment|environment
58800|NCT03199768|hospital design and construction|hospital design and construction
58801|NCT03199755|therapeutic|therapeutic
58802|NCT03199755|ACT|act
58803|NCT03199755|gametocyte|gametocyte
58804|NCT03199729|Overground training|overground training
58805|NCT03199729|Dynamic Stability|dynamic stability
58806|NCT03199729|Fall risk|fall risk
58807|NCT03199703|PVI Ablation|pvi ablation
58808|NCT03199703|Cryoballoon|cryoballoon
58809|NCT03199677|apatinib,refractory thyroid cancer|apatinib,refractory thyroid cancer
58810|NCT03199638|Continuous Glucose Monitoring|continuous glucose monitoring
58811|NCT03199638|Children|children
58812|NCT03199638|Exercise|exercise
58813|NCT03199638|Glycated hemoglobin|glycated hemoglobin
58814|NCT03199638|Adolescents|adolescents
58815|NCT03199638|Insulin sensitivity|insulin sensitivity
58816|NCT03199638|Glutamine|glutamine
58817|NCT03199625|cognitive-behavior therapy|cognitive-behavior therapy
58818|NCT03199625|magnetic resonance imaging|magnetic resonance imaging
58819|NCT03199625|Panic Disorder|panic disorder
58820|NCT03199612|Thrombosis during Continuous Flow Pump Support|thrombosis during continuous flow pump support
58821|NCT03199599|PET/CT|pet/ct
58822|NCT03199599|image processing|image processing
58823|NCT03199599|outcome|outcome
58824|NCT03199573|sunscreen|sunscreen
58825|NCT03199534|Pelvic Pain|pelvic pain
58826|NCT03199534|Dyspareunia|dyspareunia
58827|NCT03199534|Pelvic Floor Dysfunction|pelvic floor dysfunction
58828|NCT03199534|Pelvic Floor Physical Therapy|pelvic floor physical therapy
58829|NCT03199534|Chemodenervation|chemodenervation
58830|NCT03199534|Botulinum Toxin A|botulinum toxin a
58831|NCT03199534|Vaginismus|vaginismus
58832|NCT03199521|apixaban|apixaban
58833|NCT03199521|endogenous fibrinolysis|endogenous fibrinolysis
58834|NCT03199521|warfarin|warfarin
58835|NCT03199521|aspirin|aspirin
58836|NCT03199521|thrombotic status|thrombotic status
58837|NCT03199508|Nocturnal Enuresis|nocturnal enuresis
58838|NCT03199508|Voiding Diary|voiding diary
58839|NCT03199495|traditional Chinese medicine|traditional chinese medicine
58840|NCT03199495|electroacupuncture|electroacupuncture
58841|NCT03199495|abdominal pain|abdominal pain
58842|NCT03199469|AAV8-Delivered Gene Therapy|aav8-delivered gene therapy
58843|NCT03199469|XLMTM|xlmtm
58844|NCT03199469|Adeno Associated Virus|adeno associated virus
58845|NCT03199443|Sacral neuromodulation|sacral neuromodulation
58846|NCT03199443|Electromyography|electromyography
58847|NCT03199443|Pelvic floor|pelvic floor
58848|NCT03199430|catecholamines|catecholamines
58849|NCT03199430|Exercise|exercise
58850|NCT03199430|lipid metabolism|lipid metabolism
58851|NCT03199365|Cancer Prevention|cancer prevention
58852|NCT03199365|Latino Families|latino families
58853|NCT03199365|Healthy eating|healthy eating
58854|NCT03199365|Physical activity|physical activity
58855|NCT03199365|PA|pa
58856|NCT03199365|Food inventory|food inventory
58857|NCT03199365|Questionnaires|questionnaires
58858|NCT03199365|Surveys|surveys
58859|NCT03199365|Interviews|interviews
58860|NCT03199365|Accelerometer|accelerometer
58861|NCT03199339|tuberculosis|tuberculosis
58862|NCT03199339|TBA7371|tba7371
58863|NCT03199339|TBA-7371|tba-7371
58864|NCT03199339|TB Alliance|tb alliance
58865|NCT03199339|TB|tb
58866|NCT03199339|Pulmonary Tuberculosis|pulmonary tuberculosis
58867|NCT03199313|tuberculosis|tuberculosis
58868|NCT03199313|TB|tb
58869|NCT03199313|Sutezolid|sutezolid
58870|NCT03199313|pulmonary tuberculosis|pulmonary tuberculosis
58871|NCT03199300|bleomycin|bleomycin
58872|NCT03199300|cisplatin|cisplatin
58873|NCT03199300|trastuzumab|trastuzumab
58874|NCT03199300|anthracyclines|anthracyclines
58875|NCT03199300|toxicity|toxicity
58876|NCT03199287|metagenomics|metagenomics
58877|NCT03199287|next-generation sequencing|next-generation sequencing
58878|NCT03199287|bioinformatics|bioinformatics
58879|NCT03199287|antibiotic susceptibility|antibiotic susceptibility
58880|NCT03199248|Digital Mucous Cyst|digital mucous cyst
58881|NCT03199248|capsulotomy|capsulotomy
58882|NCT03199235|iron intake|iron intake
58883|NCT03199235|iron bioavailability|iron bioavailability
58884|NCT03199222|amputation|amputation
58885|NCT03199222|transtibial|transtibial
58886|NCT03199222|socket|socket
58887|NCT03199222|pressure|pressure
58888|NCT03199209|Physical Activity and Nutrition|physical activity and nutrition
58889|NCT03199209|Latino adults|latino adults
58890|NCT03199209|Questionnaires|questionnaires
58891|NCT03199209|Surveys|surveys
58892|NCT03199209|Community Health Worker|community health worker
58893|NCT03199209|CHW|chw
58894|NCT03199209|Accelerometer|accelerometer
58895|NCT03199196|Cancer Prevention|cancer prevention
58896|NCT03199196|African-American woman|african-american woman
58897|NCT03199196|Hispanic woman|hispanic woman
58898|NCT03199196|Sedentary|sedentary
58899|NCT03199196|Activity Tracker|activity tracker
58900|NCT03199196|Smartphone Application|smartphone application
58901|NCT03199196|Questionnaires|questionnaires
58902|NCT03199196|Surveys|surveys
58903|NCT03199196|Focus Group|focus group
58904|NCT03199196|Electronic Newsletters|electronic newsletters
58905|NCT03199196|Telephone Counseling|telephone counseling
58906|NCT03199183|Takayasu Arteritis|takayasu arteritis
58907|NCT03199183|registry|registry
58908|NCT03199170|Caesarean Section|caesarean section
58909|NCT03199170|Spinal anesthesia|spinal anesthesia
58910|NCT03199170|Quadratus lumborum block|quadratus lumborum block
58911|NCT03199170|Postoperative pain|postoperative pain
58912|NCT03199170|Intrathecal morphine|intrathecal morphine
58913|NCT03199144|Pancreatic Neoplasms|pancreatic neoplasms
58914|NCT03199144|Borderline resectable|borderline resectable
58915|NCT03199144|Neoadjuvant treatment|neoadjuvant treatment
58916|NCT03199144|Chemotherapy|chemotherapy
58917|NCT03199144|Stereotactic radiation|stereotactic radiation
58918|NCT03199118|root coverage|root coverage
58919|NCT03199092|Reading|reading
58920|NCT03199092|Developmental Dyslexia|developmental dyslexia
58921|NCT03199092|Music|music
58922|NCT03199092|Rhythm|rhythm
58923|NCT03199092|Intervention|intervention
58924|NCT03199066|survival|survival
58925|NCT03199066|therapy|therapy
58926|NCT03199066|epidemiology|epidemiology
58927|NCT03199053|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
58928|NCT03199027|Adherence|adherence
58929|NCT03199001|Fabry Disease|fabry disease
58930|NCT03199001|T1 Mapping|t1 mapping
58931|NCT03199001|Cardiovascular Magnetic Resonance|cardiovascular magnetic resonance
58932|NCT03198975|magnetic resonance image features|magnetic resonance image features
58933|NCT03198975|pathological differentiation|pathological differentiation
58934|NCT03198975|machine learning-based model|machine learning-based model
58935|NCT03198962|ATS, Thai MSM TG, Use of amphetamine-type stimulants, HIV, adherence|ats, thai msm tg, use of amphetamine-type stimulants, hiv, adherence
58936|NCT03198923|Non-small Cell Lung Cancer|non-small cell lung cancer
58937|NCT03198897|high cholesterol levels|high cholesterol levels
58938|NCT03198897|low-density lipoprotein|low-density lipoprotein
58939|NCT03198897|xanthelasma palpebrarum|xanthelasma palpebrarum
58940|NCT03198897|atherosclerosis|atherosclerosis
58941|NCT03198897|arcus senilis corneae|arcus senilis corneae
58942|NCT03198897|Primary hyperlipoproteinemia|primary hyperlipoproteinemia
58943|NCT03198871|Post-operative pain|post-operative pain
58944|NCT03198871|Major abdominal surgery|major abdominal surgery
58945|NCT03198871|Colorectal surgery|colorectal surgery
58946|NCT03198871|Gastric surgery|gastric surgery
58947|NCT03198858|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
58948|NCT03198845|knee osteoarthritis|knee osteoarthritis
58949|NCT03198845|video game|video game
58950|NCT03198845|therapeutic effects|therapeutic effects
58951|NCT03198832|Periodontal Disease|periodontal disease
58952|NCT03198832|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
58953|NCT03198832|Z-scan|z-scan
58954|NCT03198832|Atherosclerosis|atherosclerosis
58955|NCT03198819|Topical rifampicin, neural tube defects, infection, newborn|topical rifampicin, neural tube defects, infection, newborn
58956|NCT03198806|Autonomic Nervous System|autonomic nervous system
58957|NCT03198806|Fluid Therapy|fluid therapy
58958|NCT03198806|Heart Rate|heart rate
58959|NCT03198806|Exercise|exercise
58960|NCT03198767|obesity|obesity
58961|NCT03198767|overweight|overweight
58962|NCT03198767|body mass index|body mass index
58963|NCT03198767|BMI|bmi
58964|NCT03198767|diarrhea|diarrhea
58965|NCT03198754|Autologous Stem Cell Transplant|autologous stem cell transplant
58966|NCT03198754|Multiple Myeloma|multiple myeloma
58967|NCT03198754|oncology|oncology
58968|NCT03198754|circadian rhythms|circadian rhythms
58969|NCT03198754|light therapy|light therapy
58970|NCT03198754|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
58971|NCT03198715|Fibrinolysis enhancer|fibrinolysis enhancer
58972|NCT03198715|TAFIa inhibitor|tafia inhibitor
58973|NCT03198715|Developmental Phase I|developmental phase i
58974|NCT03198702|physiotherapy|physiotherapy
58975|NCT03198702|children|children
58976|NCT03198702|shoulder deformation|shoulder deformation
58977|NCT03198702|obstetrical brachial plexus palsy|obstetrical brachial plexus palsy
58978|NCT03198689|systemic sclerosis|systemic sclerosis
58979|NCT03198689|scleroderma|scleroderma
58980|NCT03198689|brentuximab vedotin|brentuximab vedotin
58981|NCT03198689|CD30-directed antibody-drug conjugate|cd30-directed antibody-drug conjugate
58982|NCT03198689|antirheumatic agents|antirheumatic agents
58983|NCT03198689|antineoplastic agents|antineoplastic agents
58984|NCT03198689|connective tissue diseases|connective tissue diseases
58985|NCT03198689|skin diseases|skin diseases
58986|NCT03198689|immunologic factors|immunologic factors
58987|NCT03198637|efficient|efficient
58988|NCT03198637|neuromuscular|neuromuscular
58989|NCT03198637|blockade|blockade
58990|NCT03198572|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
58991|NCT03198559|HIV latency|hiv latency
58992|NCT03198559|Disulfiram|disulfiram
58993|NCT03198559|Vorinostat|vorinostat
58994|NCT03198559|Latency Reversing Agents|latency reversing agents
58995|NCT03198559|Histone Deacetylase Inhibitors (HDACi)|histone deacetylase inhibitors (hdaci)
58996|NCT03198546|Hepatocellular carcinoma|hepatocellular carcinoma
58997|NCT03198546|immunotherapy|immunotherapy
58998|NCT03198546|CAR-T cell therapy|car-t cell therapy
58999|NCT03198546|GPC3 targeting|gpc3 targeting
59000|NCT03198546|Phase I clinical study|phase i clinical study
59001|NCT03198546|squamous cell lung cancer|squamous cell lung cancer
59002|NCT03198546|interventional radiology|interventional radiology
59003|NCT03198533|Knee|knee
59004|NCT03198533|Arthrosis|arthrosis
59005|NCT03198533|Implant|implant
59006|NCT03198481|midurethral sling|midurethral sling
59007|NCT03198481|movie|movie
59008|NCT03198481|preparedness|preparedness
59009|NCT03198481|Video Counseling|video counseling
59010|NCT03198468|Non Small Cell Lung Cancer|non small cell lung cancer
59011|NCT03198468|Metastatic Lung Cancer|metastatic lung cancer
59012|NCT03198468|Lung Cancer|lung cancer
59013|NCT03198468|Vapor Ablation|vapor ablation
59014|NCT03198468|BTVA|btva
59015|NCT03198429|domestic violence|domestic violence
59016|NCT03198429|dyadic mother-child intervention|dyadic mother-child intervention
59017|NCT03198429|fathers|fathers
59018|NCT03198429|parenting|parenting
59019|NCT03198429|young children|young children
59020|NCT03198377|Pain Threshold|pain threshold
59021|NCT03198377|Transcutaneous Electrical Nerve Stimulation|transcutaneous electrical nerve stimulation
59022|NCT03198377|Habituation|habituation
59023|NCT03198325|HIV-1|hiv-1
59024|NCT03198299|therapeutic effects|therapeutic effects
59025|NCT03198299|insoles|insoles
59026|NCT03198299|children|children
59027|NCT03198273|clinical pilates|clinical pilates
59028|NCT03198273|exercise|exercise
59029|NCT03198273|lumbar disc herniation|lumbar disc herniation
59030|NCT03198273|chronic low back pain|chronic low back pain
59031|NCT03198234|Pediatric|pediatric
59032|NCT03198234|GvHD|gvhd
59033|NCT03198234|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
59034|NCT03198234|Stem Cells|stem cells
59035|NCT03198234|Transplant|transplant
59036|NCT03198234|BMT - bone marrow transplant|bmt - bone marrow transplant
59037|NCT03198221|Golytely, Clenpiq, bowel prep|golytely, clenpiq, bowel prep
59038|NCT03198156|Transcranial Direct Current Stimulation|transcranial direct current stimulation
59039|NCT03198156|Without Cataplexy|without cataplexy
59040|NCT03198143|Decision-making|decision-making
59041|NCT03198143|Ghrelin|ghrelin
59042|NCT03198143|Healthy Volunteers|healthy volunteers
59043|NCT03198143|Obese|obese
59044|NCT03198104|Multiparametric MR Imaging|multiparametric mr imaging
59045|NCT03198104|Paediatric|paediatric
59046|NCT03198091|stable angina pectoris|stable angina pectoris
59047|NCT03198091|Dun Ye Guan Xin Ning|dun ye guan xin ning
59048|NCT03198078|Brexpiprazole|brexpiprazole
59049|NCT03198078|Schizophrenia|schizophrenia
59050|NCT03198078|Adolescent|adolescent
59051|NCT03198065|Laparoscopic appendectomy|laparoscopic appendectomy
59052|NCT03198065|Single-incision laparoscopic appendectomy|single-incision laparoscopic appendectomy
59053|NCT03198065|Single-incision laparoscopic surgery setting|single-incision laparoscopic surgery setting
59054|NCT03198065|Simple appendicitis|simple appendicitis
59055|NCT03198065|Complicated appendicitis|complicated appendicitis
59056|NCT03198052|Lung Cancer|lung cancer
59057|NCT03198052|Immunotherapy|immunotherapy
59058|NCT03198052|CAR-T Cell Therapy|car-t cell therapy
59059|NCT03198052|PSCA|psca
59060|NCT03198052|MUC1|muc1
59061|NCT03198052|PD-L1|pd-l1
59062|NCT03198052|CD80/86|cd80/86
59063|NCT03198052|Cancer expressing PSCA,MUC1,PD-L1,or/and CD80/86|cancer expressing psca,muc1,pd-l1,or/and cd80/86
59064|NCT03198039|Meditation|meditation
59065|NCT03198039|Cognitive Dysfunction|cognitive dysfunction
59066|NCT03198039|Postoperative Period|postoperative period
59067|NCT03198039|Cardiac Surgery|cardiac surgery
59068|NCT03198000|Eye Redness|eye redness
59069|NCT03198000|Eye Comfort|eye comfort
59070|NCT03198000|Red Eyes|red eyes
59071|NCT03197987|adenoma detection rate|adenoma detection rate
59072|NCT03197987|cap-assisted colonoscopy|cap-assisted colonoscopy
59073|NCT03197987|endocuff|endocuff
59074|NCT03197974|stage|stage
59075|NCT03197974|online|online
59076|NCT03197974|self-help|self-help
59077|NCT03197974|coaching support|coaching support
59078|NCT03197974|quality of life|quality of life
59079|NCT03197974|mindfulness|mindfulness
59080|NCT03197974|psychoeducation|psychoeducation
59081|NCT03197974|persuasive systems design|persuasive systems design
59082|NCT03197974|psychosocial|psychosocial
59083|NCT03197922|Autism Spectrum Disorder|autism spectrum disorder
59084|NCT03197922|Constipation|constipation
59085|NCT03197909|COPD (Chronic Obstructive Pulmonary Patients)|copd (chronic obstructive pulmonary patients)
59086|NCT03197909|Atrophy|atrophy
59087|NCT03197909|cell cultur|cell cultur
59088|NCT03197909|systemic inflammation|systemic inflammation
59089|NCT03197909|Catabolism|catabolism
59090|NCT03197857|Bariatric surgery|bariatric surgery
59091|NCT03197857|Morbid obesity|morbid obesity
59092|NCT03197857|Physical condition|physical condition
59093|NCT03197857|Muscle|muscle
59094|NCT03197857|6-minute walking test|6-minute walking test
59095|NCT03197857|Protein supplementation|protein supplementation
59096|NCT03197857|Physical activity program|physical activity program
59097|NCT03197831|Medicaid Expansion, Affordable Care Act, Health Care Reform|medicaid expansion, affordable care act, health care reform
59098|NCT03197818|COPD|copd
59099|NCT03197818|Anticholinergics|anticholinergics
59100|NCT03197818|Triple Combination|triple combination
59101|NCT03197805|Equivocal Her 2|equivocal her 2
59102|NCT03197805|Genomic test|genomic test
59103|NCT03197792|Transesophageal ultrasound|transesophageal ultrasound
59104|NCT03197792|TEE|tee
59105|NCT03197792|Portal vein pulsatility|portal vein pulsatility
59106|NCT03197792|Splenic vein pulsatility|splenic vein pulsatility
59107|NCT03197792|Venous congestion|venous congestion
59108|NCT03197792|Strain|strain
59109|NCT03197792|Right ventricular dysfunction|right ventricular dysfunction
59110|NCT03197792|Pulmonary hypertension|pulmonary hypertension
59111|NCT03197792|Venous hypertension|venous hypertension
59112|NCT03197766|Achondroplasia|achondroplasia
59113|NCT03197766|Dwarfism|dwarfism
59114|NCT03197766|Bone Diseases|bone diseases
59115|NCT03197766|Bone Diseases, Developmental|bone diseases, developmental
59116|NCT03197766|ACH|ach
59117|NCT03197766|Natriuretic Peptide, C-Type|natriuretic peptide, c-type
59118|NCT03197766|Musculoskeletal Diseases|musculoskeletal diseases
59119|NCT03197766|Natriuretic Agents|natriuretic agents
59120|NCT03197766|Physiological Effects of Drugs|physiological effects of drugs
59121|NCT03197766|Skeletal Dysplasias|skeletal dysplasias
59122|NCT03197766|Genetic Diseases, Inborn|genetic diseases, inborn
59123|NCT03197766|Osteochondrodysplasias|osteochondrodysplasias
59124|NCT03197753|laryngeal mask airway|laryngeal mask airway
59125|NCT03197753|nasotracheal intubation|nasotracheal intubation
59126|NCT03197753|dental treatment|dental treatment
59127|NCT03197727|Tooth wear, risk factors, saliva, diet, oral hygiene|tooth wear, risk factors, saliva, diet, oral hygiene
59128|NCT03197714|Myeloid Leukemia|myeloid leukemia
59129|NCT03197701|Lung function|lung function
59130|NCT03197701|Inspiratory flow rates|inspiratory flow rates
59131|NCT03197675|Chronic pain|chronic pain
59132|NCT03197675|Acupuncture|acupuncture
59133|NCT03197662|Prader-Willi Syndrome|prader-willi syndrome
59134|NCT03197662|Hyperphagia|hyperphagia
59135|NCT03197636|Vitamin D|vitamin d
59136|NCT03197636|Soluble PD-1|soluble pd-1
59137|NCT03197623|Glucocorticoids|glucocorticoids
59138|NCT03197610|gingival recession|gingival recession
59139|NCT03197610|sub epithelial connective tissue graft|sub epithelial connective tissue graft
59140|NCT03197610|enamel matrix derivatives|enamel matrix derivatives
59141|NCT03197610|root coverage aesthetic score|root coverage aesthetic score
59142|NCT03197597|B. pertussis|b. pertussis
59143|NCT03197597|Acellular vaccination|acellular vaccination
59144|NCT03197597|Strain variation|strain variation
59145|NCT03197532|fertility|fertility
59146|NCT03197532|hormones|hormones
59147|NCT03197532|healthy|healthy
59148|NCT03197532|chemotherapy|chemotherapy
59149|NCT03197532|oncofertility|oncofertility
59150|NCT03197532|alkylating agent|alkylating agent
59151|NCT03197532|fertility after cancer|fertility after cancer
59152|NCT03197532|late effects|late effects
59153|NCT03197532|survivorship|survivorship
59154|NCT03197532|healthy volunteers|healthy volunteers
59155|NCT03197532|perimenopause|perimenopause
59156|NCT03197532|middle age|middle age
59157|NCT03197519|mHealth|mhealth
59158|NCT03197519|Eating Disorders|eating disorders
59159|NCT03197519|Randomised Controlled Trial|randomised controlled trial
59160|NCT03197519|Cognitive Behavioural Therapy|cognitive behavioural therapy
59161|NCT03197519|cost effectiveness|cost effectiveness
59162|NCT03197480|Anti-Vascular Endothelial Growth Factor|anti-vascular endothelial growth factor
59163|NCT03197480|Aflibercept|aflibercept
59164|NCT03197480|Intravitreal injection|intravitreal injection
59165|NCT03197480|Diabetic Macular Edema|diabetic macular edema
59166|NCT03197441|Platelet-rich plasma|platelet-rich plasma
59167|NCT03197441|Osteoarthritis Knee|osteoarthritis knee
59168|NCT03197428|Platelet-Rich Plasma|platelet-rich plasma
59169|NCT03197428|Ankle Injuries|ankle injuries
59170|NCT03197428|Lateral Ligament, Ankle|lateral ligament, ankle
59171|NCT03197415|Platelet-rich plasma|platelet-rich plasma
59172|NCT03197415|Intervertebral Disc Degeneration|intervertebral disc degeneration
59173|NCT03197415|Low Back Pain|low back pain
59174|NCT03197402|Leucine|leucine
59175|NCT03197402|Protein|protein
59176|NCT03197402|Supplementation|supplementation
59177|NCT03197389|Biomarker|biomarker
59178|NCT03197363|Civilization diseases|civilization diseases
59179|NCT03197363|Cardiovascular Risk Factor|cardiovascular risk factor
59180|NCT03197363|Population study|population study
59181|NCT03197363|Intestinal microbiome|intestinal microbiome
59182|NCT03197363|Oral microbiome|oral microbiome
59183|NCT03197350|heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
59184|NCT03197350|Imaging|imaging
59185|NCT03197350|Prognosis|prognosis
59186|NCT03197337|Vulvodynia|vulvodynia
59187|NCT03197337|Localized Provoked Vulvodynia (LPV)|localized provoked vulvodynia (lpv)
59188|NCT03197337|Referred pain|referred pain
59189|NCT03197337|Utero-Sacral ligaments laxity|utero-sacral ligaments laxity
59190|NCT03197311|Oral surgery|oral surgery
59191|NCT03197311|Medication adherence|medication adherence
59192|NCT03197298|Acute Coronary Syndrome|acute coronary syndrome
59193|NCT03197298|Percutaneous Coronary Intervention|percutaneous coronary intervention
59194|NCT03197298|Drug-Eluting Stents|drug-eluting stents
59195|NCT03197298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
59196|NCT03197298|Ticagrelor|ticagrelor
59197|NCT03197298|clopidogrel|clopidogrel
59198|NCT03197298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists
59199|NCT03197285|neck pain|neck pain
59200|NCT03197285|eye|eye
59201|NCT03197285|propioception|propioception
59202|NCT03197285|range of motion|range of motion
59203|NCT03197285|pain|pain
59204|NCT03197272|Myopia|myopia
59205|NCT03197272|corneal Crosslinking|corneal crosslinking
59206|NCT03197259|CLL, del(17p)|cll, del(17p)
59207|NCT03197246|PICC line|picc line
59208|NCT03197246|ECG|ecg
59209|NCT03197246|chest x-ray|chest x-ray
59210|NCT03197246|IVECG|ivecg
59211|NCT03197246|ICECG|icecg
59212|NCT03197194|Central retinal artery occlusion|central retinal artery occlusion
59213|NCT03197194|visual acuity|visual acuity
59214|NCT03197194|visual field|visual field
59215|NCT03197194|mRs|mrs
59216|NCT03197194|NEI-VFQ-25|nei-vfq-25
59217|NCT03197168|stigma|stigma
59218|NCT03197168|psychosocial intervention|psychosocial intervention
59219|NCT03197168|low-and-middle income countries|low-and-middle income countries
59220|NCT03197142|cardiac arrest|cardiac arrest
59221|NCT03197142|resuscitation|resuscitation
59222|NCT03197142|Out-Of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
59223|NCT03197142|CPR|cpr
59224|NCT03197103|Autologous fat grafting|autologous fat grafting
59225|NCT03197103|Breast|breast
59226|NCT03197103|Deformity|deformity
59227|NCT03197103|Asymmetry|asymmetry
59228|NCT03197103|Tuberous breast|tuberous breast
59229|NCT03197103|Acetylcysteine|acetylcysteine
59230|NCT03197090|Screening|screening
59231|NCT03197090|Zenicor|zenicor
59232|NCT03197051|Endothelial glycocalyx|endothelial glycocalyx
59233|NCT03197051|Acute kidney injury|acute kidney injury
59234|NCT03197051|Valvular heart disease|valvular heart disease
59235|NCT03197038|Cognitive function|cognitive function
59236|NCT03197038|Kidney Disease|kidney disease
59237|NCT03197038|Exercise|exercise
59238|NCT03197038|Older adults|older adults
59239|NCT03197025|HPV-16|hpv-16
59240|NCT03197025|premalignancy|premalignancy
59241|NCT03197025|T Cell Therapy|t cell therapy
59242|NCT03197012|neuroendocrine tumor (NET)|neuroendocrine tumor (net)
59243|NCT03197012|Peptide Receptor Radionuclide Therapy (PRRT)|peptide receptor radionuclide therapy (prrt)
59244|NCT03197012|somatostatin receptor (SSTR)|somatostatin receptor (sstr)
59245|NCT03196999|PTSD|ptsd
59246|NCT03196999|Attention bias modification|attention bias modification
59247|NCT03196999|Remote app-based study|remote app-based study
59248|NCT03196999|Digital Health|digital health
59249|NCT03196960|Mobilization Therapy|mobilization therapy
59250|NCT03196960|Critical Illness|critical illness
59251|NCT03196960|Muscle Strength|muscle strength
59252|NCT03196960|Functional Mobility|functional mobility
59253|NCT03196960|Outcome|outcome
59254|NCT03196960|Intensive Care Unit|intensive care unit
59255|NCT03196960|Quality of Life|quality of life
59256|NCT03196947|multiple myeloma|multiple myeloma
59257|NCT03196947|APO010|apo010
59258|NCT03196947|Drug Response Predictor|drug response predictor
59259|NCT03196947|DRP|drp
59260|NCT03196921|amphotericin B|amphotericin b
59261|NCT03196921|cryptococcal|cryptococcal
59262|NCT03196908|ECG|ecg
59263|NCT03196908|Blood Pressure|blood pressure
59264|NCT03196908|Energy Drinks|energy drinks
59265|NCT03196895|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
59266|NCT03196895|Continuous Glucose Monitoring|continuous glucose monitoring
59267|NCT03196895|Lifestyle Modification|lifestyle modification
59268|NCT03196882|pregnancy|pregnancy
59269|NCT03196882|iron|iron
59270|NCT03196882|hemoglobin|hemoglobin
59271|NCT03196882|supplementation|supplementation
59272|NCT03196882|neurodevelopment|neurodevelopment
59273|NCT03196882|newborn|newborn
59274|NCT03196882|anemia|anemia
59275|NCT03196882|clinical trial|clinical trial
59276|NCT03196869|NPC peripheral blood dendritic cell chronic-chemotherap|npc peripheral blood dendritic cell chronic-chemotherap
59277|NCT03196856|Greek Yogurt|greek yogurt
59278|NCT03196856|Muscle Size|muscle size
59279|NCT03196856|Bone Health|bone health
59280|NCT03196856|Body Composition|body composition
59281|NCT03196856|Exercise|exercise
59282|NCT03196843|raltitrexed|raltitrexed
59283|NCT03196843|radiotherapy|radiotherapy
59284|NCT03196843|older patient|older patient
59285|NCT03196843|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
59286|NCT03196830|Relapse/refractory non-Hodgkin lymphoma|relapse/refractory non-hodgkin lymphoma
59287|NCT03196830|CAR - T CD19/CD20/CD22/CD30|car - t cd19/cd20/cd22/cd30
59288|NCT03196817|Random Allocation|random allocation
59289|NCT03196817|Injections|injections
59290|NCT03196817|Orthotic Devices|orthotic devices
59291|NCT03196765|X-ALD|x-ald
59292|NCT03196752|cricothyroid membrane|cricothyroid membrane
59293|NCT03196726|cognitive-behavioral therapy|cognitive-behavioral therapy
59294|NCT03196713|Allegiance|allegiance
59295|NCT03196713|Knowledge|knowledge
59296|NCT03196713|Supervision|supervision
59297|NCT03196713|Early intervention|early intervention
59298|NCT03196713|Autism|autism
59299|NCT03196700|palliative care|palliative care
59300|NCT03196700|head and neck cancer|head and neck cancer
59301|NCT03196700|radiotherapy|radiotherapy
59302|NCT03196700|pain|pain
59303|NCT03196700|quality of life|quality of life
59304|NCT03196687|diastolic dysfunction|diastolic dysfunction
59305|NCT03196661|safety investigation|safety investigation
59306|NCT03196648|Gingivitis|gingivitis
59307|NCT03196648|Periodontal disease|periodontal disease
59308|NCT03196648|Inflammation|inflammation
59309|NCT03196648|Teeth whitening|teeth whitening
59310|NCT03196648|Breath freshening|breath freshening
59311|NCT03196648|Periodontal pathogens|periodontal pathogens
59312|NCT03196648|Bleeding on probing|bleeding on probing
59313|NCT03196622|Sarcopenia|sarcopenia
59314|NCT03196622|Elderly people|elderly people
59315|NCT03196622|Hospitalization|hospitalization
59316|NCT03196609|Intestinal microbiota, microbial genes, oncology|intestinal microbiota, microbial genes, oncology
59317|NCT03196596|TAVI|tavi
59318|NCT03196596|Computer simulation|computer simulation
59319|NCT03196583|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
59320|NCT03196583|video-polysomnography|video-polysomnography
59321|NCT03196583|mandibular advancement device|mandibular advancement device
59322|NCT03196583|oral device|oral device
59323|NCT03196583|cephalometry|cephalometry
59324|NCT03196518|PET Imaging|pet imaging
59325|NCT03196518|18F-TFB|18f-tfb
59326|NCT03196518|17-315|17-315
59327|NCT03196505|Anesthetics, Local|anesthetics, local
59328|NCT03196505|Liposomal Bupivacaine|liposomal bupivacaine
59329|NCT03196505|Bupivacaine|bupivacaine
59330|NCT03196505|Postoperative Complications|postoperative complications
59331|NCT03196505|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
59332|NCT03196505|Sleeve Gastrectomy|sleeve gastrectomy
59333|NCT03196505|Laparoscopic Bariatric Surgery|laparoscopic bariatric surgery
59334|NCT03196466|antiepileptics|antiepileptics
59335|NCT03196466|pharmacokinetics|pharmacokinetics
59336|NCT03196466|children|children
59337|NCT03196453|overweight|overweight
59338|NCT03196453|probiotic|probiotic
59339|NCT03196453|weight management|weight management
59340|NCT03196440|elderly|elderly
59341|NCT03196440|taste|taste
59342|NCT03196440|thresholds|thresholds
59343|NCT03196427|Drug Therapy|drug therapy
59344|NCT03196401|Durvalumb|durvalumb
59345|NCT03196401|Radiation Therapy|radiation therapy
59346|NCT03196401|Clonal Bone Marrow Plasmacytosis|clonal bone marrow plasmacytosis
59347|NCT03196401|MEDI4736|medi4736
59348|NCT03196401|17-269|17-269
59349|NCT03196388|ENZALUTAMIDE|enzalutamide
59350|NCT03196388|External Beam Hypofractionated Radiotherapy Intermediate Risk Prostate Cancer|external beam hypofractionated radiotherapy intermediate risk prostate cancer
59351|NCT03196375|Motor Neuron Disease|motor neuron disease
59352|NCT03196375|Neurodegenerative Diseases|neurodegenerative diseases
59353|NCT03196375|Nervous System Diseases|nervous system diseases
59354|NCT03196375|Neuromuscular Diseases|neuromuscular diseases
59355|NCT03196375|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
59356|NCT03196375|Primary Lateral Sclerosis|primary lateral sclerosis
59357|NCT03196375|Progressive Muscular Atrophy|progressive muscular atrophy
59358|NCT03196375|Muscle cramps|muscle cramps
59359|NCT03196375|Muscle cramping|muscle cramping
59360|NCT03196375|ALS|als
59361|NCT03196375|MND|mnd
59362|NCT03196375|PMA|pma
59363|NCT03196375|PLS|pls
59364|NCT03196375|FLX-787|flx-787
59365|NCT03196362|short-term intensive insulin therapy|short-term intensive insulin therapy
59366|NCT03196362|pioglitazone|pioglitazone
59367|NCT03196362|metformin|metformin
59368|NCT03196362|remission|remission
59369|NCT03196362|sequential therapy|sequential therapy
59370|NCT03196258|fracture|fracture
59371|NCT03196258|persistent pain|persistent pain
59372|NCT03196258|cognitive behavioural therapy|cognitive behavioural therapy
59373|NCT03196258|post surgical pain|post surgical pain
59374|NCT03196258|health-related quality of life|health-related quality of life
59375|NCT03196167|sugammadex|sugammadex
59376|NCT03196167|extubation|extubation
59377|NCT03196167|CABG|cabg
59378|NCT03196154|Homeostasis Model Assessment|homeostasis model assessment
59379|NCT03196154|Insulin Resistance|insulin resistance
59380|NCT03196154|Beta Cell Function|beta cell function
59381|NCT03196154|Liquid Chromatography Tandem Mass Spectrometry|liquid chromatography tandem mass spectrometry
59382|NCT03196115|Autosomal Recessive Disorder|autosomal recessive disorder
59383|NCT03196115|Gingival Hypertrophy|gingival hypertrophy
59384|NCT03196115|Skin and Connective Tissue Diseases|skin and connective tissue diseases
59385|NCT03196102|tobacco prevention; tobacco intervention; military; brief intervention|tobacco prevention; tobacco intervention; military; brief intervention
59386|NCT03196063|Exercise Therapy|exercise therapy
59387|NCT03196063|Heavy Slow Resistance Program|heavy slow resistance program
59388|NCT03196063|Rehabilitation|rehabilitation
59389|NCT03196024|Diabetes; CVD; Lifestyle; Hispanic; Promotora|diabetes; cvd; lifestyle; hispanic; promotora
59390|NCT03196024|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
59391|NCT03196024|Cardiovascular Diseases|cardiovascular diseases
59392|NCT03196024|Risk Reduction Behavior|risk reduction behavior
59393|NCT03196024|Hispanic Americans; Latinos|hispanic americans; latinos
59394|NCT03196024|Community Health Workers|community health workers
59395|NCT03195972|Adherence, Patient, oncology, oral therapy|adherence, patient, oncology, oral therapy
59396|NCT03195959|Pulmonary arterial hypertension|pulmonary arterial hypertension
59495|NCT03195270|Chronic Pain|chronic pain
59397|NCT03195959|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
59398|NCT03195959|Hypoxia|hypoxia
59399|NCT03195959|Hyperoxia|hyperoxia
59400|NCT03195933|Depression|depression
59401|NCT03195933|Childhood Adversity|childhood adversity
59402|NCT03195933|Childhood Abuse|childhood abuse
59403|NCT03195933|Cortisol|cortisol
59404|NCT03195933|Emotional Memory|emotional memory
59405|NCT03195933|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
59406|NCT03195907|Stroke|stroke
59407|NCT03195907|Mortality|mortality
59408|NCT03195907|Intensive care unit|intensive care unit
59409|NCT03195907|Pulmonary rehabilitation|pulmonary rehabilitation
59410|NCT03195894|Alcohol abuse, Alcoholometer, Medical Device, App|alcohol abuse, alcoholometer, medical device, app
59411|NCT03195868|chemotherapy|chemotherapy
59412|NCT03195868|chemo-induced|chemo-induced
59413|NCT03195868|CIPN|cipn
59414|NCT03195829|Mild Cognitive Impairment|mild cognitive impairment
59415|NCT03195829|Computerized Cognitive Stimulation|computerized cognitive stimulation
59416|NCT03195829|Cognition|cognition
59417|NCT03195829|Psychosocial factors|psychosocial factors
59418|NCT03195816|Mild Cognitive Impairment|mild cognitive impairment
59419|NCT03195816|white matter hyperintensities|white matter hyperintensities
59420|NCT03195816|computerized cognitive training|computerized cognitive training
59421|NCT03195816|brain plasticity|brain plasticity
59422|NCT03195751|telemonitoring|telemonitoring
59423|NCT03195738|pediatrics|pediatrics
59424|NCT03195738|case series|case series
59425|NCT03195738|feasibility|feasibility
59427|NCT03195712|Obesity|obesity
59428|NCT03195699|STAT3, cancer, inhibitor, advanced cancer|stat3, cancer, inhibitor, advanced cancer
59429|NCT03195673|Carotid artery stenting|carotid artery stenting
59430|NCT03195673|Silent embolism|silent embolism
59431|NCT03195673|Terazosin|terazosin
59432|NCT03195660|adaptive servo-ventilation|adaptive servo-ventilation
59433|NCT03195660|ASV|asv
59434|NCT03195660|HFpEF|hfpef
59435|NCT03195647|cardiovascular|cardiovascular
59436|NCT03195647|potassium supplementation|potassium supplementation
59437|NCT03195647|coronary artery by pass surgery|coronary artery by pass surgery
59438|NCT03195634|Cirrhosis|cirrhosis
59439|NCT03195634|Portal Hypertension|portal hypertension
59440|NCT03195621|Coronary Artery Disease|coronary artery disease
59441|NCT03195621|Critical lesion|critical lesion
59442|NCT03195608|In-vehicle technologies|in-vehicle technologies
59443|NCT03195608|Parkinson's disease|parkinson's disease
59444|NCT03195608|Driving performance|driving performance
59445|NCT03195569|QL1101 Avastin® Non Small Cell Lung Cancer|ql1101 avastin® non small cell lung cancer
59446|NCT03195543|Blood coagulation disorders|blood coagulation disorders
59447|NCT03195543|Platelets|platelets
59448|NCT03195543|Thrombin|thrombin
59449|NCT03195543|Treatment|treatment
59450|NCT03195517|Osteopenia|osteopenia
59451|NCT03195517|Physical activity|physical activity
59452|NCT03195517|Bone turnover markers|bone turnover markers
59453|NCT03195517|Osteoprogenitor cells|osteoprogenitor cells
59454|NCT03195517|Quality of life|quality of life
59455|NCT03195452|HIV|hiv
59456|NCT03195452|Antiretrovirals|antiretrovirals
59457|NCT03195452|Raltegravir|raltegravir
59458|NCT03195413|Hand blast injury|hand blast injury
59459|NCT03195413|Nerve block|nerve block
59460|NCT03195413|Hand injury|hand injury
59461|NCT03195413|Forearm nerve block|forearm nerve block
59462|NCT03195413|Ultrasound guided nerve block|ultrasound guided nerve block
59463|NCT03195413|Ultrasound nerve block|ultrasound nerve block
59464|NCT03195413|Emergency department|emergency department
59465|NCT03195413|Emergency physician|emergency physician
59466|NCT03195413|Emergency room|emergency room
59467|NCT03195387|malaria, P. falciparum, chemoprotection, Phase Ib|malaria, p. falciparum, chemoprotection, phase ib
59468|NCT03195374|Analgesic opioids|analgesic opioids
59469|NCT03195374|Misuse|misuse
59470|NCT03195374|Use disorder|use disorder
59471|NCT03195374|Pain|pain
59472|NCT03195335|Cerebral Palsy|cerebral palsy
59473|NCT03195335|Participation|participation
59474|NCT03195335|LIFE Habits (life-H)|life habits (life-h)
59475|NCT03195335|Validity|validity
59476|NCT03195335|Reliability|reliability
59477|NCT03195322|Immediate Breast Reconstruction|immediate breast reconstruction
59478|NCT03195322|Pain Control|pain control
59479|NCT03195322|Post Mastectomy Pain Control|post mastectomy pain control
59480|NCT03195322|Acellular Dermal Matrix|acellular dermal matrix
59481|NCT03195309|Cesarean Delivery|cesarean delivery
59482|NCT03195309|Ropivacaine|ropivacaine
59483|NCT03195309|Fentanyl|fentanyl
59484|NCT03195309|Patient-controlled Epidural Analgesia|patient-controlled epidural analgesia
59485|NCT03195283|meal service|meal service
59486|NCT03195283|protein intake|protein intake
59487|NCT03195283|satisfaction|satisfaction
59488|NCT03195283|hospitalized patients|hospitalized patients
59489|NCT03195270|Positron emission tomography|positron emission tomography
59490|NCT03195270|Magnetic Resonance Imaging|magnetic resonance imaging
59491|NCT03195270|PET/MRI|pet/mri
59492|NCT03195270|Fluorodeoxyglucose|fluorodeoxyglucose
59493|NCT03195270|FDG|fdg
59494|NCT03195270|Pain|pain
59496|NCT03195270|Neuropathic Pain|neuropathic pain
59497|NCT03195270|Inflammatory Pain|inflammatory pain
59498|NCT03195270|Nociceptive Pain|nociceptive pain
59499|NCT03195244|aquatic therapy, hydrotherapy|aquatic therapy, hydrotherapy
59500|NCT03195231|Parkinson`s disease|parkinson`s disease
59501|NCT03195231|Depression|depression
59502|NCT03195231|Wuling Powder|wuling powder
59503|NCT03195218|Cancer prevention|cancer prevention
59504|NCT03195218|Diagnosis|diagnosis
59505|NCT03195218|Microendoscope|microendoscope
59506|NCT03195218|High Resolution Microendoscope|high resolution microendoscope
59507|NCT03195179|pelvic fracture urethral injury|pelvic fracture urethral injury
59508|NCT03195179|urethra|urethra
59509|NCT03195179|disruption|disruption
59510|NCT03195179|trauma|trauma
59511|NCT03195166|elderly spinal anesthesia|elderly spinal anesthesia
59512|NCT03195140|Diabetes Mellitus|diabetes mellitus
59513|NCT03195140|Diabetes|diabetes
59514|NCT03195140|Sensor Augmented Pump|sensor augmented pump
59515|NCT03195140|Hypoglycemia|hypoglycemia
59516|NCT03195127|Physical Therapy Modalities|physical therapy modalities
59517|NCT03195127|Rehabilitation|rehabilitation
59518|NCT03195127|Exercise Therapy|exercise therapy
59519|NCT03195127|Critical Illness|critical illness
59520|NCT03195127|Respiration, Artificial|respiration, artificial
59521|NCT03195127|Chronic Disease|chronic disease
59522|NCT03195114|post TAVR quantification|post tavr quantification
59523|NCT03195114|cardiac MRI|cardiac mri
59524|NCT03195114|echocardiography|echocardiography
59525|NCT03195114|biomarkers|biomarkers
59526|NCT03195101|orbital tumors|orbital tumors
59527|NCT03195101|transconjunctival approach|transconjunctival approach
59528|NCT03195062|Fructose|fructose
59529|NCT03195062|Obesity|obesity
59530|NCT03195062|Metabolism|metabolism
59531|NCT03195062|Post-prandial kinetics|post-prandial kinetics
59532|NCT03195049|hyperbilirubinemia|hyperbilirubinemia
59533|NCT03195049|kernicterus|kernicterus
59534|NCT03195036|HIV-exposed|hiv-exposed
59535|NCT03195036|Early Childhood Development|early childhood development
59536|NCT03195036|Cameroon|cameroon
59537|NCT03195023|Renal Insufficiency, Chronic|renal insufficiency, chronic
59538|NCT03194997|Breast Cancer|breast cancer
59539|NCT03194997|Quality of life|quality of life
59540|NCT03194997|Lymphedema|lymphedema
59541|NCT03194997|Fatigue|fatigue
59542|NCT03194997|Depressive symptoms|depressive symptoms
59543|NCT03194997|Body image|body image
59544|NCT03194997|Self Esteem|self esteem
59545|NCT03194997|Optimism|optimism
59546|NCT03194997|Sexual function|sexual function
59547|NCT03194997|Stress|stress
59548|NCT03194997|Sleep quality|sleep quality
59549|NCT03194997|Pain|pain
59550|NCT03194997|Muscular strength|muscular strength
59551|NCT03194997|Postural|postural
59552|NCT03194997|Balance|balance
59553|NCT03194997|Range of motion|range of motion
59554|NCT03194997|Cardiorespiratory fitness|cardiorespiratory fitness
59555|NCT03194984|dental whitening|dental whitening
59556|NCT03194984|Dental office whitening|dental office whitening
59557|NCT03194971|glioblastoma|glioblastoma
59558|NCT03194971|brain tumor autopsy|brain tumor autopsy
59559|NCT03194971|autopsy|autopsy
59560|NCT03194971|Optune therapy|optune therapy
59561|NCT03194971|tumor treatment fields|tumor treatment fields
59562|NCT03194971|TTFields|ttfields
59563|NCT03194971|Recurrent glioblastoma|recurrent glioblastoma
59564|NCT03194971|grade IV|grade iv
59565|NCT03194971|brain tumor|brain tumor
59566|NCT03194971|newly diagnosed glioblastoma|newly diagnosed glioblastoma
59567|NCT03194945|Type 2 diabetes mellitus|type 2 diabetes mellitus
59568|NCT03194945|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
59569|NCT03194945|Metformin|metformin
59570|NCT03194945|Linagliptin|linagliptin
59571|NCT03194919|online intervention|online intervention
59572|NCT03194919|e-Health|e-health
59573|NCT03194919|negotiating quit date|negotiating quit date
59574|NCT03194906|Pediatric oncology|pediatric oncology
59575|NCT03194906|Brain tumor|brain tumor
59576|NCT03194906|Low grade glioma|low grade glioma
59577|NCT03194906|Cognitive late effects|cognitive late effects
59578|NCT03194906|Radiation therapy|radiation therapy
59579|NCT03194906|Neuroprotection|neuroprotection
59580|NCT03194906|Memantine|memantine
59581|NCT03194893|Non−small cell lung cancer (NSCLC)|non−small cell lung cancer (nsclc)
59582|NCT03194893|Anaplastic lymphoma kinase (ALK)|anaplastic lymphoma kinase (alk)
59583|NCT03194893|Rearranged during transfection (RET)|rearranged during transfection (ret)
59584|NCT03194893|Alectinib|alectinib
59585|NCT03194893|Crizotinib|crizotinib
59586|NCT03194854|Well-Being|well-being
59587|NCT03194854|e-Health|e-health
59588|NCT03194854|Randomized Controlled Trial|randomized controlled trial
59589|NCT03194854|Self-Efficacy|self-efficacy
59590|NCT03194854|Interpersonal well-being|interpersonal well-being
59591|NCT03194854|Community well-being|community well-being
59592|NCT03194854|Occupational well-being|occupational well-being
59593|NCT03194854|Physical well-being|physical well-being
59594|NCT03194854|Psychological well-being|psychological well-being
59595|NCT03194854|Economic well-being|economic well-being
59597|NCT03194828|Mobile health|mobile health
59598|NCT03194828|Real-time data|real-time data
59599|NCT03194815|Psychosis|psychosis
59600|NCT03194815|Immunotherapy|immunotherapy
59601|NCT03194815|Autoantibodies|autoantibodies
59602|NCT03194789|FGBMM|fgbmm
59603|NCT03194789|LPSE|lpse
59604|NCT03194789|UDI - 6|udi - 6
59605|NCT03194789|UIQ - 7|uiq - 7
59606|NCT03194776|PAD|pad
59607|NCT03194776|peripheral artery/arterial disease|peripheral artery/arterial disease
59608|NCT03194776|peripheral vascular disease|peripheral vascular disease
59609|NCT03194776|leg pain|leg pain
59610|NCT03194776|claudication|claudication
59611|NCT03194776|leg pain with exercise|leg pain with exercise
59612|NCT03194776|exercise test|exercise test
59613|NCT03194776|walk test|walk test
59614|NCT03194737|Benign prostatic hyperplasia|benign prostatic hyperplasia
59615|NCT03194737|BPH|bph
59616|NCT03194737|Urinary retention|urinary retention
59617|NCT03194737|prostate|prostate
59618|NCT03194737|hypertrophy|hypertrophy
59619|NCT03194711|Percutaneous Coronary Revascularization|percutaneous coronary revascularization
59620|NCT03194711|Optical Coherence Tomography|optical coherence tomography
59621|NCT03194711|Stents, Drug-Eluting|stents, drug-eluting
59622|NCT03194698|Intense Pulsed Light|intense pulsed light
59623|NCT03194685|Acute Myeloid Leukemia|acute myeloid leukemia
59624|NCT03194659|Nutrition|nutrition
59625|NCT03194659|choline|choline
59626|NCT03194659|pregnancy|pregnancy
59627|NCT03194659|docosahexaenoic acid|docosahexaenoic acid
59628|NCT03194659|DHA|dha
59629|NCT03194659|fatty acids|fatty acids
59630|NCT03194646|Uterine Fibroid|uterine fibroid
59631|NCT03194620|Flavanols|flavanols
59632|NCT03194620|Cocoa Flavanols|cocoa flavanols
59633|NCT03194620|Epicatechins|epicatechins
59634|NCT03194620|Polyphenols|polyphenols
59635|NCT03194620|Procyanidins|procyanidins
59636|NCT03194620|EGCG|egcg
59637|NCT03194620|EGC|egc
59638|NCT03194620|ECG|ecg
59639|NCT03194620|Theaflavins|theaflavins
59640|NCT03194620|Thearubigins|thearubigins
59641|NCT03194594|Ketamine, dexamethasone, mood|ketamine, dexamethasone, mood
59642|NCT03194568|Scoliosis|scoliosis
59643|NCT03194568|Idiopathic Scoliosis|idiopathic scoliosis
59644|NCT03194568|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
59645|NCT03194555|Innate Immune System|innate immune system
59646|NCT03194555|Cytokines|cytokines
59647|NCT03194555|Cox-2|cox-2
59648|NCT03194555|Headache|headache
59649|NCT03194555|Migraine|migraine
59650|NCT03194555|Migraine Prevention|migraine prevention
59651|NCT03194542|Luspatercept|luspatercept
59652|NCT03194542|ACE-536|ace-536
59653|NCT03194542|Myeloproliferative Neoplasm-Associated Myelofibrosis|myeloproliferative neoplasm-associated myelofibrosis
59654|NCT03194542|Primary Myelofibrosis|primary myelofibrosis
59655|NCT03194542|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
59656|NCT03194542|Post-Essential Thrombocythemia|post-essential thrombocythemia
59657|NCT03194542|Anemia|anemia
59658|NCT03194542|Red Blood Cell (RBC) Transfusion|red blood cell (rbc) transfusion
59659|NCT03194542|Ruxolitinib|ruxolitinib
59660|NCT03194529|Crohn's Disease|crohn's disease
59661|NCT03194529|PCDAI|pcdai
59662|NCT03194529|16s rRNA|16s rrna
59663|NCT03194529|Fecal Microbiota Transplantation|fecal microbiota transplantation
59664|NCT03194529|Gut Microbiome|gut microbiome
59665|NCT03194529|FMT|fmt
59666|NCT03194516|prostate cancer|prostate cancer
59667|NCT03194516|ketogenic diet|ketogenic diet
59668|NCT03194516|overweight, obese|overweight, obese
59669|NCT03194503|Intubation|intubation
59670|NCT03194503|Video Laryngoscope|video laryngoscope
59671|NCT03194503|Coaching/training|coaching/training
59672|NCT03194477|HIV young Black men who have sex with men substance use|hiv young black men who have sex with men substance use
59673|NCT03194464|hemiparesis|hemiparesis
59674|NCT03194451|bone tissue engineering, dental stem cell differentiation|bone tissue engineering, dental stem cell differentiation
59675|NCT03194438|Pulmonary Hypertension|pulmonary hypertension
59676|NCT03194438|Symptom Management|symptom management
59677|NCT03194438|Behavioral Intervention|behavioral intervention
59678|NCT03194438|Integrative Therapy|integrative therapy
59679|NCT03194438|Quality of Life|quality of life
59680|NCT03194425|Sacral neuromodulation|sacral neuromodulation
59681|NCT03194425|Electromyography|electromyography
59682|NCT03194425|Pelvic floor|pelvic floor
59683|NCT03194412|Frail Elderly|frail elderly
59684|NCT03194412|Geriatric Assessment|geriatric assessment
59685|NCT03194412|Humans|humans
59686|NCT03194412|Aged|aged
59687|NCT03194386|Post-Traumatic Syndrome|post-traumatic syndrome
59688|NCT03194386|Eye-Movement Desensitization and Reprocessing|eye-movement desensitization and reprocessing
59689|NCT03194334|vegetarianism|vegetarianism
59690|NCT03194334|creatine|creatine
59691|NCT03194334|carnosine|carnosine
59692|NCT03194334|carnitine|carnitine
59693|NCT03194308|HIV risk reduction|hiv risk reduction
59694|NCT03194308|Safer Conception|safer conception
59695|NCT03194308|Pre-exposure prophylaxis|pre-exposure prophylaxis
59696|NCT03194308|South Africa|south africa
59698|NCT03194308|Reproductive Health|reproductive health
59699|NCT03194295|Drug-free community support|drug-free community support
59700|NCT03194295|Methadone maintenance|methadone maintenance
59701|NCT03194295|Social networks|social networks
59702|NCT03194256|Smoking|smoking
59703|NCT03194256|Cigarettes|cigarettes
59704|NCT03194256|E-Cigarettes|e-cigarettes
59705|NCT03194243|acute dyspnea|acute dyspnea
59706|NCT03194243|acute heart failure|acute heart failure
59707|NCT03194243|emergency|emergency
59708|NCT03194230|Cervical dilators|cervical dilators
59709|NCT03194230|induction of labor|induction of labor
59710|NCT03194230|cervical ripening|cervical ripening
59711|NCT03194230|medical termination of pregnancy|medical termination of pregnancy
59712|NCT03194230|second-trimester of pregnancy.|second-trimester of pregnancy.
59713|NCT03194191|Insomnia|insomnia
59714|NCT03194191|Pregnancy|pregnancy
59715|NCT03194191|Acupuncture|acupuncture
59716|NCT03194191|Insomnia severity index|insomnia severity index
59717|NCT03194191|Pittsburgh Sleep Quality Index|pittsburgh sleep quality index
59718|NCT03194191|Anxiety|anxiety
59719|NCT03194191|Depression|depression
59720|NCT03194165|antiretroviral|antiretroviral
59721|NCT03194165|children|children
59722|NCT03194165|pharmacokinetics|pharmacokinetics
59723|NCT03194139|Healthy Adult|healthy adult
59724|NCT03194139|Superoxide Dismutase|superoxide dismutase
59725|NCT03194139|First in Human|first in human
59726|NCT03194139|Free Radical Dismutase|free radical dismutase
59727|NCT03194087|Secondary Hyperparathyroidism|secondary hyperparathyroidism
59728|NCT03194087|Low parathyroid hormone|low parathyroid hormone
59729|NCT03194087|Hemodialysis|hemodialysis
59730|NCT03194074|Laser Laryngeal Surgery|laser laryngeal surgery
59731|NCT03194074|Desflurane|desflurane
59732|NCT03194074|Propofol|propofol
59733|NCT03194061|chemotherapy|chemotherapy
59734|NCT03194061|complication|complication
59735|NCT03194048|drooling|drooling
59736|NCT03194048|tongue thrust|tongue thrust
59737|NCT03194035|inflammation|inflammation
59738|NCT03194035|exercise|exercise
59739|NCT03194035|ultra endurance|ultra endurance
59740|NCT03194009|diabetes|diabetes
59741|NCT03194009|prevention|prevention
59742|NCT03194009|metformin|metformin
59743|NCT03194009|Mexico City|mexico city
59744|NCT03193983|occlusive dressing|occlusive dressing
59745|NCT03193970|Bladder Cancer|bladder cancer
59746|NCT03193970|Registry|registry
59747|NCT03193970|Post‐surgical outcomes|post‐surgical outcomes
59748|NCT03193970|Radical cystectomy|radical cystectomy
59749|NCT03193970|MD Anderson Symptom inventory|md anderson symptom inventory
59750|NCT03193970|MDASI|mdasi
59751|NCT03193892|registry|registry
59752|NCT03193892|China|china
59753|NCT03193892|lymphangioleiomyomatosis|lymphangioleiomyomatosis
59754|NCT03193879|Pulmonary function|pulmonary function
59755|NCT03193879|Particulate matter|particulate matter
59756|NCT03193879|COPD|copd
59757|NCT03193879|Asthma|asthma
59758|NCT03193866|Immunomodulating treatment|immunomodulating treatment
59759|NCT03193866|Cohort study|cohort study
59760|NCT03193866|Dimethyl fumarate|dimethyl fumarate
59761|NCT03193866|Fingolimod|fingolimod
59762|NCT03193866|Interferon-beta|interferon-beta
59763|NCT03193866|Natalizumab|natalizumab
59764|NCT03193866|Rituximab|rituximab
59765|NCT03193866|Glatiramer acetate|glatiramer acetate
59766|NCT03193840|old acetabular fracture; posterior wall osteotomy|old acetabular fracture; posterior wall osteotomy
59767|NCT03193827|vip score|vip score
59768|NCT03193827|peripheral venous cannulation|peripheral venous cannulation
59769|NCT03193827|particles|particles
59770|NCT03193801|SAPIEN 3|sapien 3
59771|NCT03193801|PARTNER 3|partner 3
59772|NCT03193801|cardiovascular disease|cardiovascular disease
59773|NCT03193801|TMVR|tmvr
59774|NCT03193801|failing valve|failing valve
59775|NCT03193801|failing bioprosthetic valve|failing bioprosthetic valve
59776|NCT03193775|HBV vaccine|hbv vaccine
59777|NCT03193775|persistent|persistent
59778|NCT03193775|HBsAg|hbsag
59779|NCT03193775|IP-10|ip-10
59780|NCT03193762|pain|pain
59781|NCT03193762|pain management|pain management
59782|NCT03193762|anxiety|anxiety
59783|NCT03193749|Chagas disease, cardiomyopathy, amiodarone, clinical trial|chagas disease, cardiomyopathy, amiodarone, clinical trial
59784|NCT03193723|Hernia|hernia
59785|NCT03193723|Local anesthesia|local anesthesia
59786|NCT03193723|ultrasound|ultrasound
59787|NCT03193710|Intravenous anesthesia|intravenous anesthesia
59788|NCT03193710|Inhalational anesthesia|inhalational anesthesia
59789|NCT03193710|Colorectal cancer resection|colorectal cancer resection
59790|NCT03193710|Lymphocytes|lymphocytes
59791|NCT03193710|Metastasis|metastasis
59792|NCT03193710|Survival|survival
59793|NCT03193710|Molecular mechanism|molecular mechanism
59794|NCT03193671|HE4|he4
59795|NCT03193671|CA125|ca125
59796|NCT03193671|RMI|rmi
59797|NCT03193671|ROMA|roma
59798|NCT03193658|spine surgery|spine surgery
59799|NCT03193658|Thoracolumbar Interfascial Plane block|thoracolumbar interfascial plane block
59800|NCT03193658|regional anesthesia|regional anesthesia
59801|NCT03193658|postoperative analgesia|postoperative analgesia
59802|NCT03193658|opioid consumption|opioid consumption
59803|NCT03193632|lean body mass|lean body mass
59804|NCT03193632|resting energy expenditure|resting energy expenditure
59805|NCT03193632|oxygen consumption|oxygen consumption
59806|NCT03193632|Indirect calorimetry|indirect calorimetry
59807|NCT03193632|carbon dioxide excretion|carbon dioxide excretion
59808|NCT03193632|respiratory quotient|respiratory quotient
59809|NCT03193580|Anodal Stimulation Transcranial Direct Current Stimulation|anodal stimulation transcranial direct current stimulation
59810|NCT03193580|High-Definition Transcranial Direct Current Stimulation|high-definition transcranial direct current stimulation
59811|NCT03193580|tDCS|tdcs
59812|NCT03193580|Non-invasive brain stimulation|non-invasive brain stimulation
59813|NCT03193580|Pediatrics|pediatrics
59814|NCT03193489|Balance|balance
59815|NCT03193489|Posturograpy|posturograpy
59816|NCT03193489|quality of life|quality of life
59817|NCT03193463|Topotecan|topotecan
59818|NCT03193463|Convection-Enhanced Delivery|convection-enhanced delivery
59819|NCT03193450|helicobactor pylori|helicobactor pylori
59820|NCT03193437|Thymus|thymus
59821|NCT03193437|Selinexor|selinexor
59822|NCT03193437|KPT-330|kpt-330
59823|NCT03193398|Major Depressive Disorder|major depressive disorder
59824|NCT03193398|Anhedonia|anhedonia
59825|NCT03193398|antidepressant|antidepressant
59826|NCT03193398|Nociceptin|nociceptin
59827|NCT03193398|NOPR|nopr
59828|NCT03193333|glaucoma|glaucoma
59829|NCT03193333|primary open-angle glaucoma|primary open-angle glaucoma
59830|NCT03193333|Ophthalmic antihypertensives|ophthalmic antihypertensives
59831|NCT03193333|Krytantek Ofteno®.|krytantek ofteno®.
59832|NCT03193333|timolol|timolol
59833|NCT03193333|brimonidine|brimonidine
59834|NCT03193333|dorzolamide|dorzolamide
59835|NCT03193320|plethysmographic variability index|plethysmographic variability index
59837|NCT03193281|Dasatinib|dasatinib
59838|NCT03193281|Imatinib|imatinib
59839|NCT03193268|sensorimotor training|sensorimotor training
59840|NCT03193268|quality of life|quality of life
59841|NCT03193268|posture|posture
59842|NCT03193242|Asthma|asthma
59843|NCT03193242|Asthma Action Plan|asthma action plan
59844|NCT03193216|Barrett's|barrett's
59845|NCT03193216|GERD|gerd
59846|NCT03193216|reflux|reflux
59847|NCT03193216|alginate solution|alginate solution
59848|NCT03193216|proton pump inhibitor|proton pump inhibitor
59849|NCT03193177|fasting-like diet|fasting-like diet
59850|NCT03193177|chronic diseases|chronic diseases
59851|NCT03193177|autoimmune diseases|autoimmune diseases
59852|NCT03193177|metabolic disorder|metabolic disorder
59853|NCT03193164|Electric Stimulation Therapy; Endothelial Progenitor Cells.|electric stimulation therapy; endothelial progenitor cells.
59854|NCT03193151|Liver transplant|liver transplant
59855|NCT03193151|global gene expression|global gene expression
59856|NCT03193151|molecular diagnostics|molecular diagnostics
59857|NCT03193138|Cardiotoxicity|cardiotoxicity
59858|NCT03193138|Androgens|androgens
59859|NCT03193138|Hormone Replacement Therapy|hormone replacement therapy
59860|NCT03193138|Testosterone|testosterone
59861|NCT03193138|Androgen Antagonists|androgen antagonists
59862|NCT03193112|Agomelatine|agomelatine
59863|NCT03193112|Depression|depression
59864|NCT03193112|Intraocular pressure|intraocular pressure
59865|NCT03193086|Multiple Sclerosis|multiple sclerosis
59866|NCT03193086|Blood-Brain-Barrier|blood-brain-barrier
59867|NCT03193086|Treatment response|treatment response
59868|NCT03193086|Metabolism|metabolism
59869|NCT03193086|Alemtuzumab|alemtuzumab
59870|NCT03193086|Perfusion|perfusion
59871|NCT03193086|Oxygen consumption|oxygen consumption
59872|NCT03193047|Cholesterol|cholesterol
59873|NCT03193047|PCSK9|pcsk9
59874|NCT03193047|Repatha|repatha
59875|NCT03193047|evolocumab|evolocumab
59876|NCT03193047|LDL-C|ldl-c
59877|NCT03193034|Arthroplasty|arthroplasty
59878|NCT03193034|replacement|replacement
59879|NCT03193034|Knee|knee
59880|NCT03193034|function|function
59881|NCT03193034|radiographic|radiographic
59882|NCT03193034|survivorship|survivorship
59883|NCT03193021|vessel closure|vessel closure
59884|NCT03193021|venous access site|venous access site
59885|NCT03193021|femoral venotomy|femoral venotomy
59886|NCT03193021|medium bore|medium bore
59887|NCT03193021|multiple access sites|multiple access sites
59888|NCT03193008|Breast Cancer|breast cancer
59889|NCT03193008|Axillary ultrasound|axillary ultrasound
59890|NCT03193008|Sentinel lymph node biopsy|sentinel lymph node biopsy
59891|NCT03193008|Axillary management|axillary management
59892|NCT03192995|HIV|hiv
59893|NCT03192995|sexual behavior|sexual behavior
59894|NCT03192956|Hyperbaric|hyperbaric
59895|NCT03192956|Decompression sickness|decompression sickness
59896|NCT03192956|Decompression injury|decompression injury
59897|NCT03192956|Inflammation|inflammation
59898|NCT03192956|Central nervous injury|central nervous injury
59899|NCT03192956|Hybervaric oxygen therapy|hybervaric oxygen therapy
59900|NCT03192930|Hyperbaric|hyperbaric
59901|NCT03192930|Saturation|saturation
59902|NCT03192930|Decompression injury|decompression injury
59903|NCT03192930|Decompression sickness|decompression sickness
59904|NCT03192930|Inflammation|inflammation
59905|NCT03192930|Central nervous system injury|central nervous system injury
59906|NCT03192930|Diving medicine|diving medicine
59907|NCT03192917|Shock wave therapy|shock wave therapy
59908|NCT03192917|erectile dysfunction|erectile dysfunction
59909|NCT03192904|Lung cancer|lung cancer
59910|NCT03192904|Segmentectomy|segmentectomy
59911|NCT03192904|Postoperative Complication|postoperative complication
59912|NCT03192904|Stapling Device|stapling device
59913|NCT03192904|Energy Device|energy device
59914|NCT03192878|infliximab|infliximab
59915|NCT03192878|biosimilars|biosimilars
59916|NCT03192878|treatment|treatment
59917|NCT03192852|Tooth bleaching color|tooth bleaching color
59918|NCT03192852|dental esthetic|dental esthetic
59919|NCT03192852|Clinical Trial|clinical trial
59920|NCT03192852|Violet LED light|violet led light
59921|NCT03192852|Violet LED|violet led
59922|NCT03192852|color|color
59923|NCT03192852|sensibility|sensibility
59924|NCT03192852|dental aesthetic|dental aesthetic
59925|NCT03192826|Nd-YAG capsulotomy|nd-yag capsulotomy
59926|NCT03192826|ocular hypertension|ocular hypertension
59927|NCT03192826|brimonidine|brimonidine
59928|NCT03192826|brinzolamide|brinzolamide
59929|NCT03192800|clinical outcome|clinical outcome
59930|NCT03192800|prognositic factor|prognositic factor
59931|NCT03192800|spinal dural arteriovenous fistula|spinal dural arteriovenous fistula
59933|NCT03192722|Illumination|illumination
59934|NCT03192722|Low vision|low vision
59935|NCT03192722|Reading|reading
59936|NCT03192709|Sildenafil IVF ICI failure|sildenafil ivf ici failure
59937|NCT03192631|financial incentive|financial incentive
59938|NCT03192579|neoatherosclerosis|neoatherosclerosis
59939|NCT03192566|Acetaminophen|acetaminophen
59940|NCT03192566|Anesthesia|anesthesia
59941|NCT03192566|Adolescent|adolescent
59942|NCT03192566|Obesity|obesity
59943|NCT03192553|donning|donning
59944|NCT03192553|doffing|doffing
59945|NCT03192553|self-contamination|self-contamination
59946|NCT03192553|healthcare workers|healthcare workers
59947|NCT03192540|Exercise|exercise
59948|NCT03192527|KN015|kn015
59949|NCT03192527|Long-acting FSH|long-acting fsh
59950|NCT03192514|Polypharmacy|polypharmacy
59951|NCT03192514|Benzodiazepine use|benzodiazepine use
59952|NCT03192501|lung cancer|lung cancer
59953|NCT03192501|iCAGES|icages
59954|NCT03192501|gene mutation|gene mutation
59955|NCT03192501|precision medicine|precision medicine
59956|NCT03192501|advanced cancers|advanced cancers
59957|NCT03192462|Pancreatic Cancer|pancreatic cancer
59958|NCT03192462|Immune-based therapies|immune-based therapies
59959|NCT03192462|CytotoxicT Lymphocytes|cytotoxict lymphocytes
59960|NCT03192423|Stress|stress
59961|NCT03192423|Performance of procedures|performance of procedures
59962|NCT03192423|Lumbar Puncture|lumbar puncture
59963|NCT03192410|myocardial infarction|myocardial infarction
59964|NCT03192410|cardiovascular diseases|cardiovascular diseases
59965|NCT03192410|mortality|mortality
59966|NCT03192410|post-myocardial infarction patients|post-myocardial infarction patients
59967|NCT03192410|risk prediction|risk prediction
59968|NCT03192410|kidney function|kidney function
59969|NCT03192410|mental well-being|mental well-being
59970|NCT03192410|cardiovascular drug treatment|cardiovascular drug treatment
59971|NCT03192384|Hospital falls|hospital falls
59972|NCT03192371|Zagreb regimen|zagreb regimen
59973|NCT03192371|Encephalitis|encephalitis
59974|NCT03192371|Antibody persistence|antibody persistence
59975|NCT03192371|Essen regimen|essen regimen
59976|NCT03192371|Post-Exposure Prophylaxis (PEP)|post-exposure prophylaxis (pep)
59977|NCT03192371|Rabies|rabies
59978|NCT03192358|Thickened Liquids|thickened liquids
59979|NCT03192358|Dysphagia Management|dysphagia management
59980|NCT03192358|Videofluoroscopy|videofluoroscopy
59981|NCT03192358|Swallowing Physiology|swallowing physiology
59982|NCT03192332|Intravenous thrombolysis|intravenous thrombolysis
59983|NCT03192332|Endovascular treatment|endovascular treatment
59984|NCT03192332|Mechanical thrombectomy|mechanical thrombectomy
59985|NCT03192332|Bridging thrombolysis|bridging thrombolysis
59986|NCT03192332|Acute ischemic stroke|acute ischemic stroke
59987|NCT03192319|Herpes zoster vaccine|herpes zoster vaccine
59988|NCT03192319|Cell-mediated immunity|cell-mediated immunity
59989|NCT03192319|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
59990|NCT03192306|Herpes Labialis|herpes labialis
59991|NCT03192306|Cold Sore|cold sore
59992|NCT03192267|newly diagnosed rheumatoid arthritis|newly diagnosed rheumatoid arthritis
59993|NCT03192267|lung disease|lung disease
59994|NCT03192241|reading|reading
59995|NCT03192228|Diabetes Mellitus, Type 2 +|diabetes mellitus, type 2 +
59996|NCT03192228|Patient Education|patient education
59997|NCT03192215|Atrial Cardiopathy|atrial cardiopathy
59998|NCT03192215|Cryptogenic stroke|cryptogenic stroke
59999|NCT03192215|Ischemic stroke|ischemic stroke
60000|NCT03192215|Apixaban|apixaban
60001|NCT03192215|Aspirin|aspirin
60002|NCT03192202|Lymphoma|lymphoma
60003|NCT03192202|Cutaneous Lymphoma|cutaneous lymphoma
60004|NCT03192202|cutaneous T-cell lymphoma (CTCL)|cutaneous t-cell lymphoma (ctcl)
60005|NCT03192202|CD30-Positive Cutaneous Lymphoma|cd30-positive cutaneous lymphoma
60006|NCT03192176|Menopause|menopause
60007|NCT03192176|Hot flashes|hot flashes
60008|NCT03192176|Perimenopause|perimenopause
60009|NCT03192176|Vasomotor symptoms|vasomotor symptoms
60010|NCT03192124|primary total knee|primary total knee
60011|NCT03192124|infection|infection
60012|NCT03192111|Healthy Volunteers|healthy volunteers
60013|NCT03192111|Mild Renal Impairment|mild renal impairment
60014|NCT03192111|Moderate Renal Impairment|moderate renal impairment
60015|NCT03192111|Severe Renal Impairment|severe renal impairment
60016|NCT03192111|Entinostat|entinostat
60017|NCT03192111|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
60018|NCT03192111|HDAC|hdac
60019|NCT03192059|Immunotherapy|immunotherapy
60020|NCT03192059|Radiotherapy|radiotherapy
60021|NCT03192059|Immune-modulatory cocktail|immune-modulatory cocktail
60022|NCT03192020|Hand dysfunction|hand dysfunction
60023|NCT03192020|Xiapex|xiapex
60024|NCT03192020|Xiaflex|xiaflex
60025|NCT03192020|Aponeurectomy|aponeurectomy
60026|NCT03192020|Aponeurotomy|aponeurotomy
60027|NCT03192020|Dupuytren disease|dupuytren disease
60028|NCT03192020|Joint contracture|joint contracture
60029|NCT03192020|Surgery|surgery
60030|NCT03191968|Behavior change|behavior change
60031|NCT03191968|Prostate cancer|prostate cancer
60032|NCT03191968|Behavioral counseling|behavioral counseling
60033|NCT03191968|Physical Activity|physical activity
60034|NCT03191968|Randomized controlled trial|randomized controlled trial
60035|NCT03191942|Myopia control|myopia control
60036|NCT03191942|Orthokeratology|orthokeratology
60037|NCT03191942|Children|children
60038|NCT03191942|Treatment zone|treatment zone
60039|NCT03191929|Depression|depression
60040|NCT03191929|Post-traumatic Stress Disorder|post-traumatic stress disorder
60041|NCT03191929|Health Information Technology (HIT)|health information technology (hit)
60042|NCT03191929|Primary Care Provider|primary care provider
60043|NCT03191929|Mental Health Screening|mental health screening
60044|NCT03191916|Parkinson's Disease|parkinson's disease
60045|NCT03191916|Mild Cognitive Impairment|mild cognitive impairment
60046|NCT03191916|tDCS|tdcs
60047|NCT03191916|Cognitive function|cognitive function
60048|NCT03191890|in vivo culture|in vivo culture
60049|NCT03191877|coffee consumption|coffee consumption
60050|NCT03191877|Cesarean section|cesarean section
60051|NCT03191877|intestinal motility|intestinal motility
60052|NCT03191864|Esophagitis|esophagitis
60053|NCT03191864|Eosinophilic Esophagitis|eosinophilic esophagitis
60054|NCT03191864|Fluticasone|fluticasone
60055|NCT03191864|Dysphagia|dysphagia
60056|NCT03191864|Safety|safety
60057|NCT03191864|Efficacy|efficacy
60058|NCT03191864|Pharmacokinetics|pharmacokinetics
60059|NCT03191864|Esophageal Diseases|esophageal diseases
60060|NCT03191864|Gastrointestinal Diseases|gastrointestinal diseases
60061|NCT03191864|Digestive System Diseases|digestive system diseases
60062|NCT03191864|Glucocorticoids|glucocorticoids
60063|NCT03191864|Orally Disintegrating Tablet|orally disintegrating tablet
60064|NCT03191825|online intervention|online intervention
60065|NCT03191825|mHealth m-Health|mhealth m-health
60066|NCT03191825|eHealth e-Health|ehealth e-health
60067|NCT03191825|smoking cessation|smoking cessation
60068|NCT03191825|lapse management|lapse management
60069|NCT03191825|relapse prevention|relapse prevention
60070|NCT03191812|Falls|falls
60071|NCT03191812|transcranial Direct Current Stimulation|transcranial direct current stimulation
60072|NCT03191812|Mobility|mobility
60073|NCT03191812|Dual Task|dual task
60074|NCT03191760|Posttraumatic Stress Disorder|posttraumatic stress disorder
60075|NCT03191760|Social Support|social support
60076|NCT03191760|Primary Care|primary care
60077|NCT03191747|Masculine Norms|masculine norms
60078|NCT03191747|Skin Care|skin care
60079|NCT03191747|Gender|gender
60080|NCT03191734|Lower Urinary Tract Symptoms (LUTS)|lower urinary tract symptoms (luts)
60081|NCT03191734|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
60082|NCT03191734|AQUABEAM|aquabeam
60083|NCT03191734|Aquablation|aquablation
60084|NCT03191721|Peri-implantitis|peri-implantitis
60085|NCT03191721|Triclosan|triclosan
60086|NCT03191721|Toothpastes|toothpastes
60087|NCT03191721|Therapeutics|therapeutics
60088|NCT03191721|Periodontal Diseases|periodontal diseases
60089|NCT03191721|Periodontitis|periodontitis
60090|NCT03191721|Dentifrices|dentifrices
60091|NCT03191708|Fractional Flow Reserve|fractional flow reserve
60092|NCT03191708|Quantitative Coronary Angiography|quantitative coronary angiography
60093|NCT03191708|Coronary artery disease|coronary artery disease
60094|NCT03191708|Angina pectoris|angina pectoris
60095|NCT03191708|Quantitative Flow Ratio|quantitative flow ratio
60096|NCT03191695|Participation|participation
60097|NCT03191695|Activity|activity
60098|NCT03191695|Cerebral Palsy|cerebral palsy
60099|NCT03191695|LIFE Habits (life-H)|life habits (life-h)
60100|NCT03191695|Gross Motor Function|gross motor function
60101|NCT03191695|Health-related Quality of Life|health-related quality of life
60102|NCT03191695|Family|family
60103|NCT03191630|Kidney transplant|kidney transplant
60104|NCT03191630|SystemCHANGE|systemchange
60105|NCT03191630|physical activity|physical activity
60106|NCT03191630|smart phone|smart phone
60107|NCT03191630|Fitbit|fitbit
60108|NCT03191630|activity monitor|activity monitor
60109|NCT03191630|step count|step count
60110|NCT03191630|post-surgery|post-surgery
60111|NCT03191630|quality of life|quality of life
60112|NCT03191630|cardiovascular|cardiovascular
60113|NCT03191604|Endoscopy|endoscopy
60114|NCT03191604|Narrow band imaging|narrow band imaging
60115|NCT03191604|Dysplasia|dysplasia
60116|NCT03191591|Overweight|overweight
60117|NCT03191591|Obesity|obesity
60118|NCT03191591|Maternal-child|maternal-child
60119|NCT03191591|Social Determinants of Health|social determinants of health
60120|NCT03191578|NMIBC|nmibc
60121|NCT03191578|Immunotherapy|immunotherapy
60122|NCT03191578|RUTI|ruti
60123|NCT03191578|Non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
60124|NCT03191565|mhealth|mhealth
60125|NCT03191565|self-monitoring|self-monitoring
60126|NCT03191565|Outcome monitoring|outcome monitoring
60127|NCT03191552|Cerebral palsy|cerebral palsy
60128|NCT03191552|lycra garments|lycra garments
60129|NCT03191552|orthosis|orthosis
60130|NCT03191552|suit therapy|suit therapy
60131|NCT03191552|trunk control|trunk control
60132|NCT03191513|Interesterified|interesterified
60133|NCT03191513|Postprandial|postprandial
60134|NCT03191513|Lipid|lipid
60135|NCT03191474|PrEP|prep
60136|NCT03191474|Pre-exposure Prophylaxis|pre-exposure prophylaxis
60137|NCT03191474|Truvada|truvada
60138|NCT03191474|Client-centered case management|client-centered case management
60139|NCT03191474|Transgender|transgender
60140|NCT03191474|Gender non-conforming|gender non-conforming
60141|NCT03191461|Anthracycline-based chemotherapy|anthracycline-based chemotherapy
60142|NCT03191461|Anth-bC|anth-bc
60143|NCT03191461|Chemotherapy|chemotherapy
60144|NCT03191461|Myocardial Perfusion|myocardial perfusion
60145|NCT03191435|Diabetes mellitus, type 2|diabetes mellitus, type 2
60146|NCT03191435|Inspiratory muscle training|inspiratory muscle training
60147|NCT03191435|Glycemic control|glycemic control
60148|NCT03191435|Glucose|glucose
60149|NCT03191435|Exercise|exercise
60150|NCT03191435|Diaphragm exercise|diaphragm exercise
60151|NCT03191435|Inspiratory loading|inspiratory loading
60152|NCT03191422|Rehabilitation|rehabilitation
60153|NCT03191422|Occupational Performance|occupational performance
60154|NCT03191409|cognitive impairment|cognitive impairment
60155|NCT03191409|ESRD|esrd
60156|NCT03191409|functional MRI|functional mri
60157|NCT03191383|Maternal immunization|maternal immunization
60158|NCT03191383|Immunogenicity|immunogenicity
60159|NCT03191383|Vaccines|vaccines
60160|NCT03191383|Safety|safety
60161|NCT03191383|Reactogenicity|reactogenicity
60162|NCT03191383|Respiratory Syncytial Virus|respiratory syncytial virus
60163|NCT03191370|pain during laryngoscopy, Flexible nasal endoscopy|pain during laryngoscopy, flexible nasal endoscopy
60164|NCT03191357|traumatic brain injury,posttraumatic stress,service member|traumatic brain injury,posttraumatic stress,service member
60165|NCT03191344|Intraoperative Parathyroid Scores System|intraoperative parathyroid scores system
60166|NCT03191344|total thyroidectomy|total thyroidectomy
60167|NCT03191344|thyroid cancer|thyroid cancer
60168|NCT03191344|hypoparathyroidism|hypoparathyroidism
60169|NCT03191344|prediction|prediction
60170|NCT03191331|dietary intervention|dietary intervention
60171|NCT03191331|gestational weight gain|gestational weight gain
60172|NCT03191331|gestational diabetes|gestational diabetes
60173|NCT03191331|overweight|overweight
60174|NCT03191331|obesity|obesity
60175|NCT03191318|ERAS|eras
60176|NCT03191318|Enhanced recovery after sugery in bariatric surgery|enhanced recovery after sugery in bariatric surgery
60177|NCT03191318|sleeve gastrectomy|sleeve gastrectomy
60178|NCT03191292|probabilistic antibiotherapy|probabilistic antibiotherapy
60179|NCT03191292|prosthetic joint infection|prosthetic joint infection
60180|NCT03191292|treatment failure|treatment failure
60181|NCT03191279|Wounds and injury|wounds and injury
60182|NCT03191279|Trauma|trauma
60183|NCT03191279|First aid|first aid
60184|NCT03191279|Bystander|bystander
60185|NCT03191279|Laypersons|laypersons
60186|NCT03191266|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
60187|NCT03191266|alcohol use disorder|alcohol use disorder
60188|NCT03191266|neuroimaging|neuroimaging
60189|NCT03191266|relapse|relapse
60190|NCT03191266|Veterans|veterans
60191|NCT03191253|food insecurity|food insecurity
60192|NCT03191253|community-based|community-based
60193|NCT03191253|food assistance|food assistance
60194|NCT03191253|food support|food support
60195|NCT03191253|intervention|intervention
60196|NCT03191253|medically tailored|medically tailored
60197|NCT03191253|nutrition|nutrition
60198|NCT03191240|Out-of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
60199|NCT03191240|Vasopressin|vasopressin
60200|NCT03191214|Infra-red thermography|infra-red thermography
61298|NCT03184337|Women|women
60201|NCT03191201|Metabolomics, Transcriptomics, Ironomics|metabolomics, transcriptomics, ironomics
60202|NCT03191175|HIV|hiv
60203|NCT03191175|Inflammasome|inflammasome
60204|NCT03191162|Benznidazole|benznidazole
60205|NCT03191162|PCR|pcr
60206|NCT03191123|Hepatocellular Carcinoma|hepatocellular carcinoma
60207|NCT03191123|Hepatic Resection|hepatic resection
60208|NCT03191123|TACE|tace
60209|NCT03191123|Solitary Huge Tumor|solitary huge tumor
60210|NCT03191123|Overall Survival|overall survival
60211|NCT03191110|COLON|colon
60212|NCT03191110|colorectal cancer|colorectal cancer
60213|NCT03191110|nutrition|nutrition
60214|NCT03191110|lifestyle|lifestyle
60215|NCT03191110|survival|survival
60216|NCT03191110|recurrence|recurrence
60217|NCT03191110|quality of life|quality of life
60218|NCT03191084|marijuana|marijuana
60219|NCT03191084|THC|thc
60220|NCT03191084|cannabis|cannabis
60221|NCT03191084|driving|driving
60222|NCT03191084|impairment|impairment
60223|NCT03191084|intoxication|intoxication
60224|NCT03191071|pneumonia|pneumonia
60225|NCT03191071|procalcitonin|procalcitonin
60226|NCT03191071|lung ultrassound|lung ultrassound
60227|NCT03191071|point of care testing|point of care testing
60228|NCT03191071|antibiotic prescription|antibiotic prescription
60229|NCT03191071|respiratory pathogens|respiratory pathogens
60230|NCT03191071|host biomarkers|host biomarkers
60231|NCT03191058|Depression|depression
60232|NCT03191058|Unipolar Depression|unipolar depression
60233|NCT03191058|Treatment Resistant Depression|treatment resistant depression
60234|NCT03191058|Magnetic Seizure Therapy|magnetic seizure therapy
60235|NCT03191058|Suicidal Ideation|suicidal ideation
60236|NCT03191058|Electroconvulsive Therapy|electroconvulsive therapy
60237|NCT03191045|MRI|mri
60238|NCT03191045|motility|motility
60239|NCT03191045|perfused manometry|perfused manometry
60240|NCT03191045|stomach|stomach
60241|NCT03191045|bowel|bowel
60242|NCT03191045|water|water
60243|NCT03191032|Peripheral nerves/lesions; hands; rehabilitation; fMRI|peripheral nerves/lesions; hands; rehabilitation; fmri
60244|NCT03191019|Cell phones|cell phones
60245|NCT03191019|Women|women
60246|NCT03191006|effect|effect
60247|NCT03191006|insoles|insoles
60248|NCT03191006|children|children
60249|NCT03190967|Ado-trastuzumab Emtansine|ado-trastuzumab emtansine
60250|NCT03190967|Systemic Control of Disease|systemic control of disease
60251|NCT03190967|Maximum Tolerated Dose|maximum tolerated dose
60252|NCT03190967|Preventing the Formation of a Metastasis|preventing the formation of a metastasis
60253|NCT03190954|C-11 Raclopride|c-11 raclopride
60254|NCT03190954|[11C] NNC-112|[11c] nnc-112
60255|NCT03190954|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
60256|NCT03190954|Dopamine D1 Receptor|dopamine d1 receptor
60257|NCT03190954|D2 Receptors|d2 receptors
60258|NCT03190941|KRAS|kras
60259|NCT03190941|HRAS|hras
60260|NCT03190941|NRAS|nras
60261|NCT03190941|Cell Therapy|cell therapy
60262|NCT03190941|Immunotherapy|immunotherapy
60263|NCT03190928|Disease Monitoring|disease monitoring
60264|NCT03190928|Molecular Monitoring|molecular monitoring
60265|NCT03190928|Novel Biomarker Identification|novel biomarker identification
60266|NCT03190928|Gene Expression Analyses|gene expression analyses
60267|NCT03190928|Watchful-Waiting|watchful-waiting
60268|NCT03190889|ACL Reconstruction|acl reconstruction
60269|NCT03190889|Rehabilitation|rehabilitation
60270|NCT03190889|Sports Injury|sports injury
60271|NCT03190889|Neuromuscular Intervention|neuromuscular intervention
60272|NCT03190889|Knee Injury|knee injury
60273|NCT03190876|Drain usage|drain usage
60274|NCT03190863|Tenodesis grasp|tenodesis grasp
60275|NCT03190863|Neurofeedback|neurofeedback
60276|NCT03190863|Motor imagery|motor imagery
60277|NCT03190863|Reach-to-grasp|reach-to-grasp
60278|NCT03190863|Rehabilitation|rehabilitation
60279|NCT03190863|Physical therapy|physical therapy
60280|NCT03190863|Cervical spinal cord injury|cervical spinal cord injury
60281|NCT03190863|Tetraplegia|tetraplegia
60282|NCT03190863|AIS A|ais a
60283|NCT03190863|AIS B|ais b
60284|NCT03190850|Sleep Apnea|sleep apnea
60285|NCT03190850|Elderly|elderly
60286|NCT03190850|Inspiratory training|inspiratory training
60287|NCT03190837|gaucher|gaucher
60288|NCT03190837|gaucher disease|gaucher disease
60289|NCT03190824|melanoma|melanoma
60290|NCT03190824|immunotherapy|immunotherapy
60291|NCT03190824|immune oncology|immune oncology
60292|NCT03190824|loco regional therapy|loco regional therapy
60293|NCT03190824|adenovirus|adenovirus
60294|NCT03190824|oncolytic virus|oncolytic virus
60295|NCT03190824|unresectable|unresectable
60296|NCT03190824|telomerase|telomerase
60297|NCT03190811|advanced solid tumor|advanced solid tumor
60298|NCT03190811|DC-CIK|dc-cik
60299|NCT03190811|anti-PD-1 antibody|anti-pd-1 antibody
60300|NCT03190811|immunotherapy|immunotherapy
60301|NCT03190785|benzoic acid|benzoic acid
60302|NCT03190785|endocrine disrupting chemicals|endocrine disrupting chemicals
60303|NCT03190785|leptin|leptin
60304|NCT03190785|metabolic rate|metabolic rate
60305|NCT03190733|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
60306|NCT03190733|ATG|atg
60307|NCT03190733|chronic GVHD|chronic gvhd
60308|NCT03190733|leukemia relapse|leukemia relapse
60309|NCT03190694|chronic kidney disease|chronic kidney disease
60310|NCT03190694|non diabetic|non diabetic
60311|NCT03190668|tissue microdialysis|tissue microdialysis
60312|NCT03190668|spinal fusion|spinal fusion
60313|NCT03190668|surgical site infection|surgical site infection
60314|NCT03190642|Orthognathic Surgery|orthognathic surgery
60315|NCT03190642|Swelling|swelling
60316|NCT03190629|body composition|body composition
60317|NCT03190629|bioimpedance|bioimpedance
60318|NCT03190629|hemodialysis|hemodialysis
60319|NCT03190629|hemodiafiltration|hemodiafiltration
60320|NCT03190629|nutritional status|nutritional status
60321|NCT03190629|protein energy wasting|protein energy wasting
60322|NCT03190590|transcranial magnetic stimulation|transcranial magnetic stimulation
60323|NCT03190577|Transthyretin mutation|transthyretin mutation
60324|NCT03190551|infraclavicular brachial plexus block|infraclavicular brachial plexus block
60325|NCT03190551|retroclavicular approach|retroclavicular approach
60326|NCT03190551|costoclavicular approach|costoclavicular approach
60327|NCT03190551|upper limb surgery|upper limb surgery
60328|NCT03190551|needle shaft visibility|needle shaft visibility
60329|NCT03190512|Periodontal disease|periodontal disease
60330|NCT03190512|depression|depression
60331|NCT03190512|body image|body image
60332|NCT03190512|self-esteem|self-esteem
60333|NCT03190499|Cancer|cancer
60334|NCT03190499|Leukemia|leukemia
60335|NCT03190486|Baby cries|baby cries
60336|NCT03190486|pain|pain
60337|NCT03190486|brain responses|brain responses
60338|NCT03190486|neuroimaging|neuroimaging
60339|NCT03190486|fMRI|fmri
60340|NCT03190395|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
60341|NCT03190395|Circumferential Pulmonary Vein Isolation(CPVI)|circumferential pulmonary vein isolation(cpvi)
60342|NCT03190395|Leftatrium Roofline Ablation(LARA)|leftatrium roofline ablation(lara)
60343|NCT03190395|Longterm success rate|longterm success rate
60344|NCT03190317|electronic medical record|electronic medical record
60345|NCT03190317|personal health record|personal health record
60346|NCT03190317|Veteran|veteran
60347|NCT03190317|self-management|self-management
60348|NCT03190278|Acute Myeloid Leukemia|acute myeloid leukemia
60349|NCT03190278|Relapsed/Refractory Acute Myeloid Leukemia|relapsed/refractory acute myeloid leukemia
60350|NCT03190278|Newly diagnosed AML|newly diagnosed aml
60351|NCT03190278|ELN adverse genetic risk group|eln adverse genetic risk group
60352|NCT03190278|Chimeric Antigen Receptor T-Cell (CAR-T) therapy|chimeric antigen receptor t-cell (car-t) therapy
60353|NCT03190278|Allogeneic|allogeneic
60354|NCT03190265|cy|cy
60355|NCT03190265|Cyclophosphamide|cyclophosphamide
60356|NCT03190265|Pancreatic Vaccine|pancreatic vaccine
60357|NCT03190265|GVAX|gvax
60358|NCT03190265|Nivolumab|nivolumab
60359|NCT03190265|Vaccine|vaccine
60360|NCT03190265|Ipilimumab|ipilimumab
60361|NCT03190265|CRS-207|crs-207
60362|NCT03190265|Immunotherapy|immunotherapy
60363|NCT03190265|PD-1|pd-1
60364|NCT03190265|Adenocarcinoma|adenocarcinoma
60365|NCT03190265|Carcinoma|carcinoma
60366|NCT03190265|Neoplasms|neoplasms
60367|NCT03190252|Diving medicine|diving medicine
60368|NCT03190252|Inflammation|inflammation
60369|NCT03190252|Central nervous system injury|central nervous system injury
60370|NCT03190252|Trimix|trimix
60371|NCT03190252|Decompression sickness|decompression sickness
60372|NCT03190252|Venous gas emboli|venous gas emboli
60373|NCT03190226|L-PRF|l-prf
60374|NCT03190226|keratinised tissues|keratinised tissues
60375|NCT03190226|implant|implant
60376|NCT03190226|free gingival graft|free gingival graft
60377|NCT03190213|high grade|high grade
60378|NCT03190161|Schizophrenia|schizophrenia
60379|NCT03190148|GLP-1|glp-1
60380|NCT03190148|Ectopic Lipids|ectopic lipids
60381|NCT03190135|Overweight|overweight
60382|NCT03190135|Obesity|obesity
60383|NCT03190135|School|school
60384|NCT03190135|Physical Activity|physical activity
60385|NCT03190109|bone age measurement|bone age measurement
60386|NCT03190109|skeletal age measurement|skeletal age measurement
60387|NCT03190109|ultrasound|ultrasound
60388|NCT03190109|x-Ray|x-ray
60389|NCT03190083|mastectomy|mastectomy
60390|NCT03190083|lumpectomy|lumpectomy
60391|NCT03190083|3-Dimensional Mammogram|3-dimensional mammogram
60392|NCT03190083|digital breast tomosynthesis|digital breast tomosynthesis
60393|NCT03190070|Renal reserve, physiological study, diagnostic testing|renal reserve, physiological study, diagnostic testing
60394|NCT03190057|BioFreedom|biofreedom
60395|NCT03190057|Drug Eluting Stent|drug eluting stent
60396|NCT03190057|Coronary Artery Disease|coronary artery disease
60397|NCT03190031|training|training
60398|NCT03190031|exercise|exercise
60399|NCT03190031|quality of life|quality of life
60400|NCT03190005|PRU|pru
60401|NCT03190005|P2Y12 receptor|p2y12 receptor
60402|NCT03189979|community based participatory research|community based participatory research
60403|NCT03189979|Childhood obesity|childhood obesity
60404|NCT03189966|transversalis fascia plane block|transversalis fascia plane block
60405|NCT03189966|quadratus lumborum block|quadratus lumborum block
60406|NCT03189966|ultrasound-guided|ultrasound-guided
60407|NCT03189966|Developmental Dysplasia of the Hip|developmental dysplasia of the hip
60408|NCT03189966|postoperative analgesia|postoperative analgesia
60409|NCT03189914|pancreatic cancer|pancreatic cancer
60410|NCT03189914|Abraxane|abraxane
60411|NCT03189914|first line|first line
60412|NCT03189875|Systemic Lupus Erythematosus Disease|systemic lupus erythematosus disease
60413|NCT03189849|Farming environment|farming environment
60414|NCT03189836|CD20+|cd20+
60415|NCT03189836|B cell|b cell
60416|NCT03189836|ACTR|actr
60417|NCT03189836|ACTR707|actr707
60418|NCT03189836|relapsed|relapsed
60419|NCT03189836|refractory|refractory
60420|NCT03189836|T cell|t cell
60421|NCT03189836|T cell product|t cell product
60422|NCT03189836|adoptive T cells|adoptive t cells
60423|NCT03189836|gene therapy|gene therapy
60424|NCT03189810|Sham Repetitive Transcranial Magnetic Stimulation (rTMS)|sham repetitive transcranial magnetic stimulation (rtms)
60425|NCT03189810|Schizophrenia|schizophrenia
60426|NCT03189810|Cannabis Use Disorder|cannabis use disorder
60427|NCT03189810|Cognitive Function|cognitive function
60428|NCT03189758|chronic kidney disease|chronic kidney disease
60429|NCT03189758|hemodialysis|hemodialysis
60430|NCT03189758|sodium restriction|sodium restriction
60431|NCT03189758|MRI|mri
60432|NCT03189732|lipolysis|lipolysis
60433|NCT03189732|adipose tissue|adipose tissue
60434|NCT03189732|exercise|exercise
60435|NCT03189719|PD1|pd1
60436|NCT03189719|PD-1|pd-1
60437|NCT03189719|PDL1|pdl1
60438|NCT03189719|PD-L1|pd-l1
60439|NCT03189706|Hu3F8|hu3f8
60440|NCT03189706|Irinotecan|irinotecan
60441|NCT03189706|Temozolomide|temozolomide
60442|NCT03189706|Sargramostim|sargramostim
60443|NCT03189706|Chemoimmunotherapy|chemoimmunotherapy
60444|NCT03189706|17-251|17-251
60445|NCT03189680|sensorimotor training|sensorimotor training
60446|NCT03189680|exergaming|exergaming
60447|NCT03189680|posture|posture
60448|NCT03189680|quality of life|quality of life
60449|NCT03189641|Drug eluting stents|drug eluting stents
60450|NCT03189641|Coronary artery disease|coronary artery disease
60451|NCT03189641|Coronary artery stenosis|coronary artery stenosis
60452|NCT03189641|Myocardial ischemia|myocardial ischemia
60453|NCT03189641|Angioplasty|angioplasty
60454|NCT03189628|stromal vascular fraction|stromal vascular fraction
60455|NCT03189628|skin regeneration|skin regeneration
60456|NCT03189628|skin texture|skin texture
60457|NCT03189628|anti-aging|anti-aging
60458|NCT03189602|Takayasu Arteritis|takayasu arteritis
60459|NCT03189602|Pulmonary artery hypertension|pulmonary artery hypertension
60460|NCT03189589|Pharmacokinetics|pharmacokinetics
60461|NCT03189589|Healthy|healthy
60462|NCT03189589|ELLIPTA|ellipta
60463|NCT03189589|Safety|safety
60464|NCT03189589|GSK2269557|gsk2269557
60465|NCT03189589|Inhalation|inhalation
60466|NCT03189589|Tolerability|tolerability
60467|NCT03189537|Profilaxis|profilaxis
60468|NCT03189537|Ingavirin|ingavirin
60469|NCT03189511|Brown Adipose Tissue|brown adipose tissue
60470|NCT03189511|Brown Fat|brown fat
60471|NCT03189511|Fluvastatin|fluvastatin
60472|NCT03189511|Prospective Clinical Trial|prospective clinical trial
60473|NCT03189446|Endometrial Cancer|endometrial cancer
60474|NCT03189446|Gynecologic Cancer|gynecologic cancer
60475|NCT03189420|glioma|glioma
60476|NCT03189420|glioblastoma|glioblastoma
60477|NCT03189420|low grade tumor|low grade tumor
60478|NCT03189407|Moringa Oleifera tea|moringa oleifera tea
60479|NCT03189407|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
60480|NCT03189407|Metformin Steady state concentrations|metformin steady state concentrations
60481|NCT03189407|Herb-drug interaction|herb-drug interaction
60482|NCT03189394|HIV|hiv
60483|NCT03189394|gay couples|gay couples
60484|NCT03189394|relationships|relationships
60485|NCT03189394|dyads|dyads
60486|NCT03189381|Whole Brain Radiation|whole brain radiation
60487|NCT03189381|Simultaneous Integrated Boost|simultaneous integrated boost
60488|NCT03189368|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
60489|NCT03189368|Multi-site Pacing|multi-site pacing
60490|NCT03189368|Ventriculoarterial Coupling|ventriculoarterial coupling
60491|NCT03189368|Energy Efficiency|energy efficiency
60492|NCT03189342|Balance|balance
60493|NCT03189342|Dual-task interference|dual-task interference
60494|NCT03189342|Falls|falls
60495|NCT03189342|Gait|gait
60496|NCT03189342|Older Adults|older adults
60497|NCT03189329|NIR spectroscopy, cognitive function, eye, nerve block|nir spectroscopy, cognitive function, eye, nerve block
60498|NCT03189316|Peritoneal fluid|peritoneal fluid
60499|NCT03189316|B cells|b cells
60500|NCT03189316|Regulatory B cells|regulatory b cells
60501|NCT03189316|Human|human
60502|NCT03189264|Percutaneous Nephrolithotomy|percutaneous nephrolithotomy
60503|NCT03189264|Postoperative Complications|postoperative complications
60504|NCT03189264|Renal Stone|renal stone
60505|NCT03189264|Surgical Success|surgical success
60506|NCT03189264|Surgical Complications|surgical complications
60507|NCT03189264|Pneumatic Dilation|pneumatic dilation
60508|NCT03189212|Telemedicine|telemedicine
60509|NCT03189186|Kidney Cancer|kidney cancer
60510|NCT03189186|Immunotherapy|immunotherapy
60511|NCT03189186|Renal Cell Carcinoma|renal cell carcinoma
60512|NCT03189186|Cryoablation|cryoablation
60513|NCT03189186|Metastatic Renal Cancer|metastatic renal cancer
60514|NCT03189173|Obstructive Sleep Apnea|obstructive sleep apnea
60515|NCT03189173|Ventilatory Control Instability|ventilatory control instability
60516|NCT03189173|Complex Sleep Apnea|complex sleep apnea
60517|NCT03189121|Metabolism|metabolism
60518|NCT03189121|Macronutrients|macronutrients
60519|NCT03189121|Obesity|obesity
60520|NCT03189121|Energy Expenditure|energy expenditure
60521|NCT03189121|Glucose|glucose
60522|NCT03189108|Paracentesis|paracentesis
60523|NCT03189108|Thoracentesis|thoracentesis
60524|NCT03189095|exercise|exercise
60525|NCT03189095|physical activity|physical activity
60526|NCT03189095|SCI|sci
60527|NCT03189095|spinal cord injury|spinal cord injury
60528|NCT03189095|online|online
60529|NCT03189056|chronic Chagas disease|chronic chagas disease
60530|NCT03189056|bladder|bladder
60531|NCT03189056|lower urinary tract|lower urinary tract
60532|NCT03189056|urodynamic|urodynamic
60533|NCT03189030|metastatic|metastatic
60534|NCT03189030|microsatellite stable (MSS)|microsatellite stable (mss)
60535|NCT03189004|mHealth, health services, technology, smartphones, Bangladesh|mhealth, health services, technology, smartphones, bangladesh
60536|NCT03188991|pancreatic cystic neoplasm|pancreatic cystic neoplasm
60537|NCT03188991|pancreatic cyst|pancreatic cyst
60538|NCT03188991|pancreatic mucinous cyst|pancreatic mucinous cyst
60539|NCT03188991|pancreatic neoplasms|pancreatic neoplasms
60540|NCT03188991|digestive system neoplasms|digestive system neoplasms
60541|NCT03188991|pancreatic diseases|pancreatic diseases
60542|NCT03188991|mucinous cystic neoplasm|mucinous cystic neoplasm
60543|NCT03188965|First in human|first in human
60544|NCT03188965|Solid tumors|solid tumors
60545|NCT03188965|Lymphomas|lymphomas
60546|NCT03188965|Dose escalation|dose escalation
60547|NCT03188965|Dose expansion|dose expansion
60548|NCT03188913|Burns|burns
60549|NCT03188913|Coagulation|coagulation
60550|NCT03188913|Factor XIII|factor xiii
60551|NCT03188913|Glycocalix|glycocalix
60552|NCT03188913|Cicatrization|cicatrization
60553|NCT03188900|Preeclampsia|preeclampsia
60554|NCT03188900|apheresis|apheresis
60555|NCT03188900|sflt-1|sflt-1
60556|NCT03188887|NIgA|niga
60557|NCT03188887|Kidney biopsy|kidney biopsy
60558|NCT03188887|GFR|gfr
60559|NCT03188887|Corticotherapy|corticotherapy
60560|NCT03188861|mental health conditions in ACSC patients|mental health conditions in acsc patients
60561|NCT03188861|multimorbidity|multimorbidity
60562|NCT03188861|health care utilization|health care utilization
60563|NCT03188809|Postoperative Pain|postoperative pain
60564|NCT03188809|Functional Outcomes|functional outcomes
60565|NCT03188809|Total Knee Arthroplasty|total knee arthroplasty
60566|NCT03188809|Adductor Canal Block|adductor canal block
60567|NCT03188809|Femoral Nerve Block|femoral nerve block
60568|NCT03188796|vitamin D|vitamin d
60569|NCT03188796|critical care|critical care
60570|NCT03188770|Middle-income countries|middle-income countries
60571|NCT03188744|Cervical cancer|cervical cancer
60572|NCT03188744|Pelvic floor muscles|pelvic floor muscles
60573|NCT03188744|Physiotherapy|physiotherapy
60574|NCT03188744|Quality of life|quality of life
60575|NCT03188731|ZIKA|zika
60576|NCT03188731|Dengue|dengue
60577|NCT03188731|Chikungunya|chikungunya
60578|NCT03188731|Pregnant Women|pregnant women
60579|NCT03188731|Pregnant Woman|pregnant woman
60580|NCT03188731|ZIKV|zikv
60581|NCT03188718|Polysomnogram|polysomnogram
60582|NCT03188718|Sleep Disordered Breathing|sleep disordered breathing
60583|NCT03188705|pharmacogenetics|pharmacogenetics
60584|NCT03188705|carboxylesterase|carboxylesterase
60585|NCT03188705|Personalized Medicine|personalized medicine
60586|NCT03188692|Haemophilus influenza type b|haemophilus influenza type b
60587|NCT03188692|Adsorbed Diphtheria-Purified Pertussis-Tetanus-Inactivate|adsorbed diphtheria-purified pertussis-tetanus-inactivate
60588|NCT03188692|poliovirus combined vaccine|poliovirus combined vaccine
60589|NCT03188692|Hib|hib
60590|NCT03188692|DPT-IPV|dpt-ipv
60591|NCT03188692|Intramuscular|intramuscular
60592|NCT03188679|CMV|cmv
60593|NCT03188679|neurological impairment|neurological impairment
60594|NCT03188679|outcome prediction|outcome prediction
60595|NCT03188679|amniotic fluid biomarkers|amniotic fluid biomarkers
60596|NCT03188640|Bariatric surgery|bariatric surgery
60597|NCT03188640|Sex hormones|sex hormones
60598|NCT03188640|Women|women
60599|NCT03188640|Quality of life|quality of life
60600|NCT03188614|shock|shock
60601|NCT03188614|crystalloid|crystalloid
60602|NCT03188614|acute kidney injury|acute kidney injury
60603|NCT03188601|Graft vs Host Disease|graft vs host disease
60604|NCT03188601|Immune System Diseases|immune system diseases
60605|NCT03188601|Protease Inhibitors|protease inhibitors
60606|NCT03188601|Alpha 1-Antitrypsin|alpha 1-antitrypsin
60607|NCT03188601|Enzyme Inhibitors|enzyme inhibitors
60608|NCT03188601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
60609|NCT03188601|Trypsin Inhibitors|trypsin inhibitors
60610|NCT03188601|Serine Proteinase Inhibitors|serine proteinase inhibitors
60611|NCT03188484|Atrial Fibrillation|atrial fibrillation
60612|NCT03188484|Electrocardiography|electrocardiography
60613|NCT03188484|Biological Markers|biological markers
60614|NCT03188484|Risk Assessment|risk assessment
60615|NCT03188458|Infants|infants
60616|NCT03188458|Cord blood sample|cord blood sample
60617|NCT03188458|Acellular pertussis|acellular pertussis
60618|NCT03188458|Boostrix|boostrix
60619|NCT03188458|Colombia|colombia
60620|NCT03188458|Pregnant women|pregnant women
60621|NCT03188419|Prospective Donors|prospective donors
60622|NCT03188419|Immunodeficiency|immunodeficiency
60623|NCT03188406|Intestinal Metaplasia|intestinal metaplasia
60624|NCT03188406|Epidemiology|epidemiology
60625|NCT03188406|Risk Stratification|risk stratification
60626|NCT03188406|Helicobacter Pylori|helicobacter pylori
60627|NCT03188380|nec|nec
60628|NCT03188380|abdominal ultrasound|abdominal ultrasound
60629|NCT03188380|abdominal radiograph|abdominal radiograph
60630|NCT03188380|preterm|preterm
60631|NCT03188367|dose-finding|dose-finding
60632|NCT03188367|extraintestinal symptoms|extraintestinal symptoms
60633|NCT03188367|gluten|gluten
60634|NCT03188367|intestinal symptoms|intestinal symptoms
60635|NCT03188367|placebo|placebo
60636|NCT03188354|Positron-Emission Tomography|positron-emission tomography
60637|NCT03188354|Magnetic Resonance Imaging|magnetic resonance imaging
60638|NCT03188341|vascular surgery|vascular surgery
60639|NCT03188341|repolarization disturbances|repolarization disturbances
60640|NCT03188341|cardiac complications|cardiac complications
60641|NCT03188341|high risk patient|high risk patient
60642|NCT03188341|high risk procedure|high risk procedure
60643|NCT03188302|Stool consistency|stool consistency
60644|NCT03188302|Texture Analyser|texture analyser
60645|NCT03188302|Bristol Stool Form Scale|bristol stool form scale
60646|NCT03188289|chitosan|chitosan
60647|NCT03188289|clorhexidine|clorhexidine
60648|NCT03188289|suture|suture
60649|NCT03188289|bacteria|bacteria
60650|NCT03188289|wisdom|wisdom
60651|NCT03188276|Chronic Hepatitis C|chronic hepatitis c
60652|NCT03188276|direct-acting antiviral agents|direct-acting antiviral agents
60653|NCT03188276|Myeloid-Derived Suppressor Cells|myeloid-derived suppressor cells
60654|NCT03188276|NK cells|nk cells
60655|NCT03188263|diabetes|diabetes
60656|NCT03188263|sleep|sleep
60657|NCT03188263|circadian rhythm|circadian rhythm
60658|NCT03188263|light treatment|light treatment
60659|NCT03188224|Transition|transition
60660|NCT03188224|Improved patient outcomes|improved patient outcomes
60661|NCT03188224|RCT|rct
60662|NCT03188224|Child health|child health
60663|NCT03188224|Empower youth|empower youth
60664|NCT03188185|Alkermes|alkermes
60665|NCT03188185|Major Depressive Disorder|major depressive disorder
60666|NCT03188185|Treatment Refractory MDD|treatment refractory mdd
60667|NCT03188185|ALKS 5461|alks 5461
60668|NCT03188133|Schizophrenia|schizophrenia
60669|NCT03188133|Visual Hallucination|visual hallucination
60670|NCT03188133|False Perception|false perception
60671|NCT03188133|emotional priming|emotional priming
60672|NCT03188107|Risky Infant|risky infant
60673|NCT03188107|Cerebral Palsy|cerebral palsy
60674|NCT03188107|Down Syndrome|down syndrome
60675|NCT03188107|Spina Bifida|spina bifida
60676|NCT03188107|Infant Motor Profile|infant motor profile
60677|NCT03188068|Kaposiform Hemangioendothelioma|kaposiform hemangioendothelioma
60678|NCT03188068|Kasabach Merritt Phenomenon|kasabach merritt phenomenon
60679|NCT03188068|Sirolimus|sirolimus
60680|NCT03188068|Prednisolone|prednisolone
60681|NCT03188055|patient decision making|patient decision making
60682|NCT03188055|surgical decision making|surgical decision making
60683|NCT03188055|shared decision making|shared decision making
60684|NCT03188055|decision support techniques|decision support techniques
60685|NCT03188042|Transorbital Alternating Current Stimulation|transorbital alternating current stimulation
60686|NCT03188042|Glaucoma|glaucoma
60687|NCT03188029|ethomidate adrenocortical insufficiency|ethomidate adrenocortical insufficiency
60688|NCT03188016|"music therapy"|"music therapy"
60689|NCT03188016|"Intensive Interaction"|"intensive interaction"
60690|NCT03188016|"non-verbal communication"|"non-verbal communication"
60691|NCT03188016|"musical improvisation"|"musical improvisation"
60692|NCT03188016|"feasibility study"|"feasibility study"
60693|NCT03188016|"randomised controlled trial"|"randomised controlled trial"
60694|NCT03188003|Exercise Movement Techniques|exercise movement techniques
60695|NCT03188003|Low Back Pain|low back pain
60696|NCT03188003|Exercise|exercise
60697|NCT03187990|PSMA PET/MRI|psma pet/mri
60698|NCT03187990|Guided Biopsy|guided biopsy
60699|NCT03187990|Prostate Cancer|prostate cancer
60700|NCT03187977|Cognitive intervention|cognitive intervention
60701|NCT03187977|Survivors|survivors
60702|NCT03187977|Childhood ALL|childhood all
60703|NCT03187964|People Living with HIV (PLHIV)|people living with hiv (plhiv)
60704|NCT03187964|Xpert HIV-1 Viral Load (Xpert VL)|xpert hiv-1 viral load (xpert vl)
60705|NCT03187964|Xpert Ultra|xpert ultra
60706|NCT03187964|Antiretroviral treatment (ART)|antiretroviral treatment (art)
60707|NCT03187951|Other disorders of glucose regulation and pancreatic internal secretion|other disorders of glucose regulation and pancreatic internal secretion
60708|NCT03187951|Pancreatic cancer|pancreatic cancer
60709|NCT03187951|Questionnaires|questionnaires
60710|NCT03187951|Surveys|surveys
60711|NCT03187951|Nutritional Questionnaire|nutritional questionnaire
60712|NCT03187951|Nutritional Counseling|nutritional counseling
60713|NCT03187951|Booklet|booklet
60714|NCT03187951|Pamphlet|pamphlet
60715|NCT03187951|Educational materials|educational materials
60716|NCT03187951|Aerobic Exercise|aerobic exercise
60717|NCT03187951|Strength Training Exercises|strength training exercises
60718|NCT03187951|Physical Assessments|physical assessments
60719|NCT03187951|Walk Test|walk test
60720|NCT03187938|Alkaline Phosphatase|alkaline phosphatase
60721|NCT03187938|Pregnancy|pregnancy
60722|NCT03187938|Suboptimal fetal growth|suboptimal fetal growth
60723|NCT03187938|Placental insufficiency|placental insufficiency
60724|NCT03187938|Low birth weight|low birth weight
60725|NCT03187938|IUGR|iugr
60726|NCT03187899|cervical plexus block|cervical plexus block
60727|NCT03187899|clavicle fracture|clavicle fracture
60728|NCT03187899|interscalene brachial plexus block|interscalene brachial plexus block
60729|NCT03187886|Cerebral amyloid angiopathy|cerebral amyloid angiopathy
60730|NCT03187886|CAA-RI|caa-ri
60731|NCT03187886|MRI|mri
60732|NCT03187886|Intracerebral hemorrhage|intracerebral hemorrhage
60733|NCT03187873|community participation|community participation
60734|NCT03187873|Maternal and child health|maternal and child health
60735|NCT03187873|Kenya|kenya
60736|NCT03187860|Bronchial epithelial cell|bronchial epithelial cell
60737|NCT03187860|mucus|mucus
60738|NCT03187860|Air Liquid Interface|air liquid interface
60739|NCT03187847|Physical Activity|physical activity
60740|NCT03187847|Fatigue|fatigue
60741|NCT03187847|Rehabilitation|rehabilitation
60742|NCT03187834|infection|infection
60743|NCT03187834|azithromycin|azithromycin
60744|NCT03187834|amoxicillin|amoxicillin
60745|NCT03187834|co-trimoxazole|co-trimoxazole
60746|NCT03187834|trachoma|trachoma
60747|NCT03187834|mass treatment|mass treatment
60748|NCT03187808|Neck pain, Thoracic manipulation, special massage|neck pain, thoracic manipulation, special massage
60749|NCT03187795|Spinal Cord Injuries|spinal cord injuries
60750|NCT03187795|Randomized Controlled Trial|randomized controlled trial
60751|NCT03187795|Neurogenic Bladder|neurogenic bladder
60752|NCT03187795|Rehabilitation|rehabilitation
60753|NCT03187769|Alkermes|alkermes
60754|NCT03187769|ALKS 3831|alks 3831
60755|NCT03187769|Olanzapine|olanzapine
60756|NCT03187769|Samidorphan|samidorphan
60757|NCT03187769|Schizophrenia|schizophrenia
60758|NCT03187769|Schizophreniform|schizophreniform
60759|NCT03187769|Bipolar I|bipolar i
60760|NCT03187756|Hematopoietic Malignancies|hematopoietic malignancies
60761|NCT03187756|Nonmyeloablative Peripheral Blood Stem Cell Transplant|nonmyeloablative peripheral blood stem cell transplant
60762|NCT03187756|Posttransplantation|posttransplantation
60763|NCT03187743|Lupus erythematosus|lupus erythematosus
60764|NCT03187743|Systemic|systemic
60765|NCT03187743|Corticosteroid|corticosteroid
60766|NCT03187743|Prednisone|prednisone
60767|NCT03187743|Pharmacokinetics|pharmacokinetics
60768|NCT03187730|Smoking Cassation|smoking cassation
60769|NCT03187730|Immigrants|immigrants
60770|NCT03187730|Economic Disparity|economic disparity
60771|NCT03187717|Postoperative pain|postoperative pain
60772|NCT03187717|Recovery period|recovery period
60773|NCT03187717|Total intravenous anesthesia|total intravenous anesthesia
60774|NCT03187717|Inhalation anesthesia|inhalation anesthesia
60775|NCT03187704|air filtration, HEPA, In-home,|air filtration, hepa, in-home,
60776|NCT03187678|switch|switch
60777|NCT03187678|intravenous|intravenous
60778|NCT03187678|selexipag|selexipag
60779|NCT03187665|Pediatric|pediatric
60780|NCT03187665|Pulse Oximeter|pulse oximeter
60781|NCT03187665|Wireless|wireless
60782|NCT03187665|Motion|motion
60783|NCT03187665|False Alarm|false alarm
60784|NCT03187639|Coronary artery disease|coronary artery disease
60785|NCT03187639|CT coronary angiography|ct coronary angiography
60786|NCT03187639|FFRct|ffrct
60787|NCT03187639|Rapid access chest pain clinic|rapid access chest pain clinic
60788|NCT03187639|Stable chest pain|stable chest pain
60789|NCT03187639|Resource utilisation|resource utilisation
60790|NCT03187639|Quality of life|quality of life
60791|NCT03187626|Base-of-thumb osteoarthritis|base-of-thumb osteoarthritis
60792|NCT03187626|Botulinum toxin A|botulinum toxin a
60793|NCT03187626|Intra-articular therapy|intra-articular therapy
60794|NCT03187626|Randomized trial|randomized trial
60795|NCT03187613|Retinal shift|retinal shift
60796|NCT03187613|Aniseikonia|aniseikonia
60797|NCT03187613|Metamorphopsia|metamorphopsia
60798|NCT03187613|Autofluorescence|autofluorescence
60799|NCT03187587|Hyperthermia, Induced|hyperthermia, induced
60800|NCT03187587|Laser Coagulation|laser coagulation
60801|NCT03187587|Laser Therapy|laser therapy
60802|NCT03187574|vaginal prolapse, mesh kit, anatomic assessment, quality of life|vaginal prolapse, mesh kit, anatomic assessment, quality of life
60803|NCT03187561|Sleep|sleep
60804|NCT03187561|Parenting|parenting
60805|NCT03187561|Marital relationship|marital relationship
60806|NCT03187561|Parent-child relations|parent-child relations
60807|NCT03187548|WSL|wsl
60808|NCT03187548|CPP-ACP|cpp-acp
60809|NCT03187535|Transcutaneous Electrical Acupoint Stimulation|transcutaneous electrical acupoint stimulation
60810|NCT03187522|AAA|aaa
60811|NCT03187522|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
60812|NCT03187509|Torsemide, loop diuretics, weight-based|torsemide, loop diuretics, weight-based
60813|NCT03187496|drug-drug interaction|drug-drug interaction
60814|NCT03187444|Cardiovascular risk|cardiovascular risk
60815|NCT03187444|Chronic inflammatory rheumatism|chronic inflammatory rheumatism
60816|NCT03187444|Rheumatoid arthritis|rheumatoid arthritis
60817|NCT03187444|Spondyloarthritis|spondyloarthritis
60818|NCT03187444|Inflammation|inflammation
60819|NCT03187431|Stem cell|stem cell
60820|NCT03187431|Therapy|therapy
60821|NCT03187431|IPF|ipf
60822|NCT03187418|Cyclophotocoagulation|cyclophotocoagulation
60823|NCT03187418|Micropulse TSCPC|micropulse tscpc
60824|NCT03187418|Laser ablation|laser ablation
60825|NCT03187418|Laser therapy|laser therapy
60826|NCT03187405|Subarachnoid Hemorrhage|subarachnoid hemorrhage
60827|NCT03187405|Intracranial Aneurysm|intracranial aneurysm
60828|NCT03187405|Cerebral Ischemia|cerebral ischemia
60829|NCT03187405|Ventriculostomy|ventriculostomy
60830|NCT03187405|Tissue Plasminogen Activator|tissue plasminogen activator
60831|NCT03187353|Cognitive complaints|cognitive complaints
60832|NCT03187353|RRSO|rrso
60833|NCT03187353|Oophorectomy|oophorectomy
60834|NCT03187353|Memory|memory
60835|NCT03187353|Cognition|cognition
60836|NCT03187353|Early menopause|early menopause
60837|NCT03187327|prophylactic salpingectomy|prophylactic salpingectomy
60838|NCT03187327|vaginal hysterectomy|vaginal hysterectomy
60839|NCT03187327|p53 expression|p53 expression
60840|NCT03187327|ovarian cancers|ovarian cancers
60841|NCT03187314|Esophageal cancer|esophageal cancer
60842|NCT03187314|Radiation|radiation
60843|NCT03187314|Anti-PD-1 Antibody|anti-pd-1 antibody
60844|NCT03187301|Parkinson's Disease|parkinson's disease
60845|NCT03187301|Off episodes|off episodes
60846|NCT03187275|Cancer Related Fatigue (CRF)|cancer related fatigue (crf)
60847|NCT03187275|Prostate Cancer|prostate cancer
60848|NCT03187275|Swedish Massage Therapy (SMT)|swedish massage therapy (smt)
60849|NCT03187275|Cancer|cancer
60850|NCT03187275|Quality of Life (QOL)|quality of life (qol)
60851|NCT03187262|Waldenström Macroglobulinemia|waldenström macroglobulinemia
60852|NCT03187223|Multiple Myeloma|multiple myeloma
60853|NCT03187223|Bendamustine|bendamustine
60854|NCT03187223|Melphalan|melphalan
60855|NCT03187223|ASCT|asct
60856|NCT03187210|CD30+ Lymphoma|cd30+ lymphoma
60857|NCT03187210|ASCT|asct
60858|NCT03187210|Brentuximab Vedotin|brentuximab vedotin
60859|NCT03187171|Anterior Cervical Spine Fusion|anterior cervical spine fusion
60860|NCT03187132|virtual reality|virtual reality
60861|NCT03187132|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
60862|NCT03187132|analgesia|analgesia
60863|NCT03187119|Pediatric|pediatric
60864|NCT03187119|Education|education
60865|NCT03187119|Technology-supported intervention|technology-supported intervention
60866|NCT03187119|Asthma Action Plan|asthma action plan
60867|NCT03187119|Health literacy|health literacy
60868|NCT03187093|MDD|mdd
60869|NCT03187093|Vortioxetine|vortioxetine
60870|NCT03187093|IGF-1|igf-1
60871|NCT03187093|Cognitive dysfunction|cognitive dysfunction
60872|NCT03187067|pneumonia|pneumonia
60873|NCT03187067|diagnostic|diagnostic
60874|NCT03187067|ultrasound|ultrasound
60875|NCT03187067|Pakistan|pakistan
60876|NCT03187067|Mozambique|mozambique
60877|NCT03187041|blood draw tourniquets|blood draw tourniquets
60878|NCT03187041|skin surface pressure|skin surface pressure
60879|NCT03187041|blood draw band|blood draw band
60880|NCT03187041|elastic tourniquet|elastic tourniquet
60881|NCT03187041|phlebotomy|phlebotomy
60882|NCT03187041|tourniquet pressure|tourniquet pressure
60883|NCT03187028|Cancer of Pancreas|cancer of pancreas
60884|NCT03187028|Neoplasms, Pancreatic|neoplasms, pancreatic
60885|NCT03187028|Pancreas Cancer|pancreas cancer
60886|NCT03187028|Pancreas Neoplasms|pancreas neoplasms
60887|NCT03187028|Cancer of the Pancreas|cancer of the pancreas
60888|NCT03187028|Pancreatic Cancer|pancreatic cancer
60889|NCT03187015|Healthy Volunteers|healthy volunteers
60890|NCT03187015|Entinostat|entinostat
60891|NCT03187015|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
60892|NCT03187015|HDAC|hdac
60893|NCT03186989|Mild Alzheimer's Disease|mild alzheimer's disease
60894|NCT03186989|ISIS 814907|isis 814907
60895|NCT03186976|Risk Factor Modification|risk factor modification
60896|NCT03186976|Catheter ablation|catheter ablation
60897|NCT03186963|distal radius fracture|distal radius fracture
60898|NCT03186963|volar plate|volar plate
60899|NCT03186963|immobilization|immobilization
60900|NCT03186898|hepatocellular carcinoma|hepatocellular carcinoma
60901|NCT03186898|HCC|hcc
60902|NCT03186898|Proton Therapy|proton therapy
60903|NCT03186898|Photon Therapy|photon therapy
60904|NCT03186898|Liver cancer|liver cancer
60905|NCT03186859|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
60906|NCT03186859|bariatric surgery|bariatric surgery
60907|NCT03186846|cognitive decline|cognitive decline
60908|NCT03186846|hemodynamic monitoring|hemodynamic monitoring
60909|NCT03186846|LIDCO|lidco
60910|NCT03186846|INVOS|invos
60911|NCT03186846|BIS|bis
60912|NCT03186846|brain injury biomarkers|brain injury biomarkers
60913|NCT03186820|Endometriosis|endometriosis
60914|NCT03186820|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
60915|NCT03186820|Susceptibility-weighted imaging (SWI)|susceptibility-weighted imaging (swi)
60916|NCT03186807|normogram|normogram
60917|NCT03186807|brain lumination|brain lumination
60918|NCT03186807|fetal cortex|fetal cortex
60919|NCT03186807|ultrasound|ultrasound
60920|NCT03186794|Fatigue|fatigue
60921|NCT03186781|Flu Virus|flu virus
60922|NCT03186781|Flu Shot|flu shot
60923|NCT03186781|H2N2|h2n2
60924|NCT03186781|Protein|protein
60925|NCT03186781|Immune Response|immune response
60926|NCT03186742|Eplerenone|eplerenone
60927|NCT03186742|Concentric hypertrophy|concentric hypertrophy
60928|NCT03186729|Intracerebral hemorrhage|intracerebral hemorrhage
60929|NCT03186716|Colostrum|colostrum
60930|NCT03186716|Enteral Nutrition|enteral nutrition
60931|NCT03186716|Intestinal Permeability|intestinal permeability
60932|NCT03186716|Intensive Care Unit|intensive care unit
60933|NCT03186703|Cancer prevention|cancer prevention
60934|NCT03186703|Knowledge translation|knowledge translation
60935|NCT03186703|Physical activity|physical activity
60936|NCT03186703|Diet|diet
60937|NCT03186703|Alcohol|alcohol
60938|NCT03186703|Smoking|smoking
60939|NCT03186690|vital pulp therapy|vital pulp therapy
60940|NCT03186690|Biodentine|biodentine
60941|NCT03186690|Mineral Trioxide Aggregate|mineral trioxide aggregate
60942|NCT03186677|ISU304|isu304
60943|NCT03186677|previously treated hemophilia B patients|previously treated hemophilia b patients
60944|NCT03186677|FIX|fix
60945|NCT03186677|Factor IX|factor ix
60946|NCT03186677|CB2679d|cb2679d
60947|NCT03186651|Vaginal|vaginal
60948|NCT03186651|Medical Device|medical device
60949|NCT03186651|Female Stress Urinary Incontinence|female stress urinary incontinence
60950|NCT03186625|acute coronary syndrome|acute coronary syndrome
60951|NCT03186625|gut microbiota|gut microbiota
60952|NCT03186625|Trimethylamine N-oxide|trimethylamine n-oxide
60953|NCT03186625|percutaneous coronary intervention|percutaneous coronary intervention
60954|NCT03186612|Video games; Virtual reality; Occupational therapy, Manual dexterity; Multiple sclerosis.|video games; virtual reality; occupational therapy, manual dexterity; multiple sclerosis.
60955|NCT03186599|Medication Event Monitoring System|medication event monitoring system
60956|NCT03186599|adherence|adherence
60957|NCT03186586|Heavy Menstrual Bleeding|heavy menstrual bleeding
60958|NCT03186586|Levonorgestrel relesing intrauterine system|levonorgestrel relesing intrauterine system
60959|NCT03186560|Leg ulcers and use of geko device|leg ulcers and use of geko device
60960|NCT03186508|obesity prevention|obesity prevention
60961|NCT03186508|sleep|sleep
60962|NCT03186508|behavioral intervention|behavioral intervention
60963|NCT03186456|acute cerebral infarction|acute cerebral infarction
60964|NCT03186456|umbilical cord mesenchymal stem cells|umbilical cord mesenchymal stem cells
60965|NCT03186443|herpetic neuralgia|herpetic neuralgia
60966|NCT03186443|post-herpetic neuralgia|post-herpetic neuralgia
60967|NCT03186443|pregabalin|pregabalin
60968|NCT03186430|Vaccine|vaccine
60969|NCT03186430|Vaccination|vaccination
60970|NCT03186430|Behavioral Research|behavioral research
60971|NCT03186430|Adolescent|adolescent
60972|NCT03186430|Health Promotion|health promotion
60973|NCT03186430|Public Health|public health
60974|NCT03186417|Arthritis, Rheumatoid, Stem Cells, Mesenchymal, Autoimmune|arthritis, rheumatoid, stem cells, mesenchymal, autoimmune
60975|NCT03186352|photodynamic therapy|photodynamic therapy
60976|NCT03186352|photoactivated disinfection|photoactivated disinfection
60977|NCT03186352|primary root caries lesion|primary root caries lesion
60978|NCT03186352|cavity disinfection|cavity disinfection
60979|NCT03186352|lasers|lasers
60980|NCT03186352|root caries|root caries
60981|NCT03186339|QoL|qol
60982|NCT03186339|TAVI|tavi
60983|NCT03186339|surgical aortic valve replacement|surgical aortic valve replacement
60984|NCT03186339|Aortic stenosis|aortic stenosis
60985|NCT03186326|immunotherapy|immunotherapy
60986|NCT03186326|second line|second line
60987|NCT03186313|HCV|hcv
60988|NCT03186313|Sofosbuvir|sofosbuvir
60989|NCT03186313|Ribavirin|ribavirin
60990|NCT03186300|bolus advisor|bolus advisor
60991|NCT03186248|Achalasia cardia|achalasia cardia
60992|NCT03186248|myotomy|myotomy
60993|NCT03186248|Per oral endoscopic myotomy|per oral endoscopic myotomy
60994|NCT03186248|laparoscopic fundoplication|laparoscopic fundoplication
60995|NCT03186209|Asthma,|asthma,
60996|NCT03186209|Bronchial Diseases,|bronchial diseases,
61299|NCT03184337|Sleep|sleep
60997|NCT03186209|Respiratory Tract Diseases,|respiratory tract diseases,
60998|NCT03186209|Lung Diseases,|lung diseases,
60999|NCT03186209|Obstructive Lung Diseases|obstructive lung diseases
61000|NCT03186196|Folate|folate
61001|NCT03186196|Polymorphism|polymorphism
61002|NCT03186196|Overweight and Obesity|overweight and obesity
61003|NCT03186196|Inflammatory markers|inflammatory markers
61004|NCT03186183|HIV prevention|hiv prevention
61005|NCT03186183|Sexual health|sexual health
61006|NCT03186183|Motivational interviewing|motivational interviewing
61007|NCT03186183|Information-Motivation-Behavioural skills model|information-motivation-behavioural skills model
61008|NCT03186183|Health promotion|health promotion
61009|NCT03186157|trephined syndrome|trephined syndrome
61010|NCT03186157|sinking skin flap syndrome|sinking skin flap syndrome
61011|NCT03186157|craniectomy|craniectomy
61012|NCT03186157|decompressive craniectomy|decompressive craniectomy
61013|NCT03186157|neurosurgical complications|neurosurgical complications
61014|NCT03186118|pediatric|pediatric
61015|NCT03186118|young adult|young adult
61016|NCT03186118|acute lymphoblastic leukemia|acute lymphoblastic leukemia
61017|NCT03186118|CD 19|cd 19
61018|NCT03186118|leukemia|leukemia
61019|NCT03186118|chimeric antigen receptor|chimeric antigen receptor
61020|NCT03186118|T cell|t cell
61021|NCT03186105|Appendicitis Acute|appendicitis acute
61022|NCT03186105|AMBULATORY|ambulatory
61023|NCT03186092|Respiratory muscle strength|respiratory muscle strength
61024|NCT03186092|Pulmonary hypertension|pulmonary hypertension
61025|NCT03186092|Respiratory muscle training|respiratory muscle training
61026|NCT03186027|chronic fatigue|chronic fatigue
61027|NCT03186027|Sleep problems|sleep problems
61028|NCT03186027|Autonomic dysfunction|autonomic dysfunction
61029|NCT03186027|Health-Related Quality of Life|health-related quality of life
61030|NCT03186027|Coenzyme Q10|coenzyme q10
61031|NCT03186027|NADH|nadh
61032|NCT03186014|Malignant dysphagia|malignant dysphagia
61033|NCT03186014|Stent|stent
61034|NCT03186014|Esophageal neoplasms|esophageal neoplasms
61035|NCT03186014|Brachytherapy|brachytherapy
61036|NCT03186001|frontalis|frontalis
61037|NCT03186001|frontal line|frontal line
61038|NCT03186001|glabellar line|glabellar line
61039|NCT03186001|botulinum toxin|botulinum toxin
61040|NCT03186001|abobotulinum|abobotulinum
61041|NCT03185988|Human epidermal growth factor receptor 2|human epidermal growth factor receptor 2
61042|NCT03185988|Biliary tract cancer|biliary tract cancer
61043|NCT03185988|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
61044|NCT03185988|Targeted therapy|targeted therapy
61045|NCT03185975|HIV|hiv
61046|NCT03185975|transgender|transgender
61047|NCT03185975|trans|trans
61048|NCT03185975|youth|youth
61049|NCT03185975|home testing|home testing
61050|NCT03185936|optic disc pit|optic disc pit
61051|NCT03185936|retinal detachment|retinal detachment
61052|NCT03185936|maculopathy|maculopathy
61053|NCT03185923|Community-Acquired Infections|community-acquired infections
61054|NCT03185923|Humans|humans
61055|NCT03185923|Medicine, Chinese Traditional|medicine, chinese traditional
61056|NCT03185871|Invasive breast carcinoma|invasive breast carcinoma
61057|NCT03185871|breast carcinoma stage T1cN0 to N3N0|breast carcinoma stage t1cn0 to n3n0
61058|NCT03185858|secondary prevention|secondary prevention
61059|NCT03185858|primary healthcare|primary healthcare
61060|NCT03185858|village doctors|village doctors
61061|NCT03185858|rural China|rural china
61062|NCT03185858|medication adherence|medication adherence
61063|NCT03185858|physical activity|physical activity
61064|NCT03185832|Hear failure|hear failure
61065|NCT03185832|Sudden Cardiac Death|sudden cardiac death
61066|NCT03185832|Arrhythmia|arrhythmia
61067|NCT03185832|Implanted device|implanted device
61068|NCT03185832|ICD|icd
61069|NCT03185832|CRT|crt
61070|NCT03185806|severe acute pancreatitis|severe acute pancreatitis
61071|NCT03185806|sterile acute peripancreatic fluid collections|sterile acute peripancreatic fluid collections
61072|NCT03185806|percutaneous catheter drainage|percutaneous catheter drainage
61073|NCT03185793|SHR4640, Phase II, monotherapy, dose-finding|shr4640, phase ii, monotherapy, dose-finding
61074|NCT03185780|complementary/integrative medicine|complementary/integrative medicine
61075|NCT03185780|glioblastoma|glioblastoma
61076|NCT03185780|quality of life|quality of life
61077|NCT03185780|adherence|adherence
61078|NCT03185754|lung cancer|lung cancer
61079|NCT03185754|surgery|surgery
61080|NCT03185754|lobectomy|lobectomy
61081|NCT03185754|sublobar resection|sublobar resection
61082|NCT03185728|Child Abuse|child abuse
61083|NCT03185728|Mandated Reporting|mandated reporting
61084|NCT03185728|Online Learning|online learning
61085|NCT03185728|Child Protection|child protection
61086|NCT03185728|GAMIFICATION|gamification
61087|NCT03185728|Early Childhood Education|early childhood education
61088|NCT03185715|oocyte donation|oocyte donation
61089|NCT03185715|recipient counselling|recipient counselling
61090|NCT03185715|single embryo transfer (SET)|single embryo transfer (set)
61091|NCT03185715|double embryo transfer (DET)|double embryo transfer (det)
61092|NCT03185715|decision-making|decision-making
61093|NCT03185689|Glycemic control|glycemic control
61094|NCT03185689|Diabetes self-management education|diabetes self-management education
61095|NCT03185650|Healthy Volunteers|healthy volunteers
61096|NCT03185637|Outcomes|outcomes
61097|NCT03185637|Mortality|mortality
61098|NCT03185637|Complications|complications
61099|NCT03185637|Neonatal surgery|neonatal surgery
61100|NCT03185637|Paediatric surgery|paediatric surgery
61101|NCT03185637|Childrens surgery|childrens surgery
61102|NCT03185637|Sub-Saharan Africa|sub-saharan africa
61103|NCT03185637|Research Collaboration|research collaboration
61104|NCT03185637|Gastroschisis|gastroschisis
61105|NCT03185637|Anorectal malformation|anorectal malformation
61106|NCT03185637|Appendicitis|appendicitis
61107|NCT03185637|Intussuception|intussuception
61108|NCT03185637|Inguinal hernia|inguinal hernia
61109|NCT03185585|Nutritional screenings|nutritional screenings
61110|NCT03185520|Stroke|stroke
61111|NCT03185520|Ischemic Stroke|ischemic stroke
61112|NCT03185520|Cryptogenic Stroke|cryptogenic stroke
61113|NCT03185520|Embolic stroke of undetermined source|embolic stroke of undetermined source
61114|NCT03185520|ESUS|esus
61115|NCT03185520|Cerebrovascular Disease|cerebrovascular disease
61116|NCT03185481|Parkinson's Disease|parkinson's disease
61117|NCT03185481|Motor Fluctuations|motor fluctuations
61118|NCT03185481|D1 partial agonist|d1 partial agonist
61119|NCT03185468|CAR T|car t
61120|NCT03185468|Bladder|bladder
61121|NCT03185455|Hypertension|hypertension
61122|NCT03185455|Pregnancy|pregnancy
61123|NCT03185455|Text|text
61124|NCT03185442|fMRI|fmri
61125|NCT03185442|PRF|prf
61126|NCT03185416|Quality of Life|quality of life
61127|NCT03185416|Caregiver|caregiver
61128|NCT03185416|Quality Improvement|quality improvement
61129|NCT03185403|hemodynamic effect|hemodynamic effect
61130|NCT03185403|para vertebral block|para vertebral block
61131|NCT03185390|periampullary lesions|periampullary lesions
61132|NCT03185351|midazolam|midazolam
61133|NCT03185351|brachial plexus block|brachial plexus block
61134|NCT03185338|physical activity, promotion, school|physical activity, promotion, school
61135|NCT03185299|Polyp detection rate|polyp detection rate
61136|NCT03185299|Adenoma detection rate|adenoma detection rate
61137|NCT03185299|Boston Bowel Preparation Scale|boston bowel preparation scale
61138|NCT03185286|3D printing, metal implant, bone defect|3d printing, metal implant, bone defect
61139|NCT03185260|Cardio-Pulmonary Resuscitation|cardio-pulmonary resuscitation
61140|NCT03185260|Cardiac Arrest|cardiac arrest
61141|NCT03185260|Training|training
61142|NCT03185247|Transdiagnostic|transdiagnostic
61143|NCT03185247|POTS (Postural Orthostatic Tachycardia Syndrome)|pots (postural orthostatic tachycardia syndrome)
61144|NCT03185247|Therapy|therapy
61145|NCT03185234|tDCS|tdcs
61146|NCT03185221|Stents Coronary Artery Disease|stents coronary artery disease
61147|NCT03185208|Lithium|lithium
61148|NCT03185208|Mild Cognitive Impairment|mild cognitive impairment
61149|NCT03185208|MCI|mci
61150|NCT03185208|Dementia|dementia
61151|NCT03185208|Alzheimer|alzheimer
61152|NCT03185208|Alzheimer's Disease|alzheimer's disease
61153|NCT03185208|Cognition|cognition
61154|NCT03185208|Memory|memory
61155|NCT03185208|Thinking|thinking
61156|NCT03185208|Prevention|prevention
61157|NCT03185208|amyloid|amyloid
61158|NCT03185208|imaging|imaging
61159|NCT03185208|MRI|mri
61160|NCT03185208|PET|pet
61161|NCT03185208|tau|tau
61162|NCT03185208|plaques|plaques
61163|NCT03185208|tangles|tangles
61164|NCT03185182|Diagnosis|diagnosis
61165|NCT03185182|Imaging|imaging
61166|NCT03185169|breast cancer survivor|breast cancer survivor
61167|NCT03185169|postmenopausal|postmenopausal
61168|NCT03185169|dysuria|dysuria
61169|NCT03185169|dyspareunia|dyspareunia
61170|NCT03185169|vaginal dryness|vaginal dryness
61171|NCT03185169|urinary tract infections|urinary tract infections
61172|NCT03185169|urinary frequency|urinary frequency
61173|NCT03185169|urinary urgency|urinary urgency
61174|NCT03185169|genital burning|genital burning
61175|NCT03185169|genital itching|genital itching
61176|NCT03185169|genital dryness|genital dryness
61177|NCT03185156|nausea and vomiting|nausea and vomiting
61178|NCT03185156|hemabate|hemabate
61179|NCT03185156|propofol|propofol
61180|NCT03185130|Headache|headache
61181|NCT03185130|Benign Headache|benign headache
61182|NCT03185117|opioid consumption|opioid consumption
61183|NCT03185117|postdischarge|postdischarge
61184|NCT03185117|major orthopedic surgery|major orthopedic surgery
61185|NCT03185104|removable partial denture|removable partial denture
61186|NCT03185104|silver diamine fluoride|silver diamine fluoride
61187|NCT03185078|physical therapy|physical therapy
61188|NCT03185078|ESWT|eswt
61189|NCT03185026|Psychiatry|psychiatry
61190|NCT03185026|Suicide|suicide
61191|NCT03185026|Psychoeducation|psychoeducation
61192|NCT03185026|Randomized controlled trial|randomized controlled trial
61193|NCT03185026|current suicidal behavior disorder|current suicidal behavior disorder
61194|NCT03185026|DSM-5|dsm-5
61195|NCT03185013|Cervical intraepithelial neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
61196|NCT03185013|Human papillomavirus (HPV)|human papillomavirus (hpv)
61197|NCT03185013|High grade squamous intraepithelial lesion (HSIL)|high grade squamous intraepithelial lesion (hsil)
61198|NCT03185013|CIN 2|cin 2
61199|NCT03185013|CIN 3|cin 3
61200|NCT03185013|papillomavirus|papillomavirus
61201|NCT03184987|fluticasone furoate|fluticasone furoate
61202|NCT03184987|fixed dose combination|fixed dose combination
61203|NCT03184987|Japanese subjects|japanese subjects
61204|NCT03184987|vilanterol|vilanterol
61205|NCT03184987|asthma|asthma
61206|NCT03184987|umeclidinium bromide|umeclidinium bromide
61207|NCT03184987|closed triple therapy|closed triple therapy
61208|NCT03184935|Myelodysplastic Syndromes|myelodysplastic syndromes
61209|NCT03184935|mesenchymal stem cells|mesenchymal stem cells
61210|NCT03184922|femoral suspensory loops|femoral suspensory loops
61211|NCT03184857|maxillary sinus|maxillary sinus
61212|NCT03184857|augmentation|augmentation
61213|NCT03184857|bovine bone|bovine bone
61214|NCT03184857|Nano hydroxy appatite|nano hydroxy appatite
61215|NCT03184844|Thalidomide TI|thalidomide ti
61216|NCT03184831|sinus lift, injectable platelet rich fibrin, sticky bone, bovine bone|sinus lift, injectable platelet rich fibrin, sticky bone, bovine bone
61217|NCT03184792|Spinal electrical stimulation|spinal electrical stimulation
61219|NCT03184779|Snowboard|snowboard
61220|NCT03184779|Snow Sport|snow sport
61221|NCT03184779|Injury|injury
61222|NCT03184779|Injury Prevention|injury prevention
61223|NCT03184779|Safety|safety
61224|NCT03184779|Safety Video|safety video
61225|NCT03184779|Video Intervention|video intervention
61226|NCT03184779|Youth|youth
61227|NCT03184779|Children|children
61228|NCT03184779|Adolescent|adolescent
61229|NCT03184779|Education|education
61230|NCT03184779|Knowledge|knowledge
61231|NCT03184753|Autologous|autologous
61232|NCT03184753|IgT|igt
61233|NCT03184753|Ovarian Cancer|ovarian cancer
61234|NCT03184753|CART|cart
61235|NCT03184701|Telehealth|telehealth
61236|NCT03184701|Quality of Life|quality of life
61237|NCT03184688|platelet rich plasma|platelet rich plasma
61238|NCT03184688|Perineural injection therapy|perineural injection therapy
61239|NCT03184688|hydrodissection|hydrodissection
61240|NCT03184662|High-intensity physical activity|high-intensity physical activity
61241|NCT03184662|Diabetes|diabetes
61242|NCT03184662|Renal function decline|renal function decline
61243|NCT03184636|ACLF|aclf
61244|NCT03184636|SOFA|sofa
61245|NCT03184636|Zagazig university|zagazig university
61246|NCT03184610|Keratoconus|keratoconus
61247|NCT03184610|Optical Coherence Tomography|optical coherence tomography
61248|NCT03184610|Corneal Epithelium Thickness Maps|corneal epithelium thickness maps
61249|NCT03184597|HLA screening|hla screening
61250|NCT03184597|SJS/TEN|sjs/ten
61251|NCT03184597|MPE|mpe
61252|NCT03184597|AEDs|aeds
61253|NCT03184571|bemcentinib|bemcentinib
61254|NCT03184571|NSCLC|nsclc
61255|NCT03184571|pembrolizumab|pembrolizumab
61256|NCT03184571|Keytruda|keytruda
61257|NCT03184571|BGB324|bgb324
61258|NCT03184558|bemcentinib|bemcentinib
61259|NCT03184558|TNBC|tnbc
61260|NCT03184558|pembrolizumab|pembrolizumab
61261|NCT03184558|Keytruda|keytruda
61262|NCT03184558|BGB324|bgb324
61263|NCT03184545|anterior knee pain|anterior knee pain
61264|NCT03184480|Drug Use Investigation|drug use investigation
61265|NCT03184480|GW685698|gw685698
61266|NCT03184480|asthma|asthma
61267|NCT03184480|Post-marketing surveillance|post-marketing surveillance
61268|NCT03184480|ARNUITY ELLIPTA|arnuity ellipta
61269|NCT03184467|GV1001|gv1001
61270|NCT03184467|Alzheimer Disease|alzheimer disease
61271|NCT03184454|OCD|ocd
61272|NCT03184454|deep brain stimulation|deep brain stimulation
61273|NCT03184454|treatment-resistant OCD|treatment-resistant ocd
61274|NCT03184428|YAG-Laser Capsulotomy|yag-laser capsulotomy
61275|NCT03184389|Behavioral Counseling|behavioral counseling
61276|NCT03184389|Cigarette Smoking|cigarette smoking
61277|NCT03184389|Mobile Health|mobile health
61278|NCT03184389|Heart Rate Variability Monitoring|heart rate variability monitoring
61279|NCT03184389|Mindfulness-Based Exercises|mindfulness-based exercises
61280|NCT03184389|Mobile Apps|mobile apps
61281|NCT03184389|Physiological Monitoring|physiological monitoring
61282|NCT03184389|Respiratory Pattern Monitoring|respiratory pattern monitoring
61283|NCT03184389|Stress-Management Interventions|stress-management interventions
61284|NCT03184389|Sensor-Triggered Stress Intervention|sensor-triggered stress intervention
61285|NCT03184389|Smartphone Apps|smartphone apps
61286|NCT03184389|Smoking Cessation|smoking cessation
61287|NCT03184389|Wearable Sensors|wearable sensors
61288|NCT03184389|Eating Behavior|eating behavior
61289|NCT03184389|Stress-Related Eating|stress-related eating
61290|NCT03184376|Gut microbiota|gut microbiota
61291|NCT03184376|Prebiotic|prebiotic
61292|NCT03184376|Liver biopsy|liver biopsy
61293|NCT03184376|Oligofructose|oligofructose
61294|NCT03184350|cervical cancer|cervical cancer
61295|NCT03184350|endometrial cancer|endometrial cancer
61296|NCT03184350|proton therapy|proton therapy
61297|NCT03184337|Weight loss|weight loss
61300|NCT03184337|Intervention|intervention
61301|NCT03184337|Diet|diet
61302|NCT03184337|Physical activity|physical activity
61303|NCT03184337|Fitbit|fitbit
61304|NCT03184311|Iron deficiency|iron deficiency
61305|NCT03184311|Therapy response prediction|therapy response prediction
61306|NCT03184311|Exercise tolerance|exercise tolerance
61307|NCT03184298|Military Personnel|military personnel
61308|NCT03184298|Sexual Assault|sexual assault
61309|NCT03184298|Military Sexual Trauma|military sexual trauma
61310|NCT03184298|Alcohol and Substance Abuse|alcohol and substance abuse
61311|NCT03184285|limitation in conventional monitoring|limitation in conventional monitoring
61312|NCT03184272|limitation in conventional monitoring|limitation in conventional monitoring
61313|NCT03184246|Videolaryngoscopy (GlideScope)|videolaryngoscopy (glidescope)
61314|NCT03184246|Direct laryngoscopy|direct laryngoscopy
61315|NCT03184220|Neck Pain|neck pain
61316|NCT03184220|Physical Therapy Modalities|physical therapy modalities
61317|NCT03184220|Fascia|fascia
61318|NCT03184220|Manual Therapy|manual therapy
61319|NCT03184220|Massage|massage
61320|NCT03184194|daratumumab|daratumumab
61321|NCT03184194|nivolumab|nivolumab
61322|NCT03184194|cyclophosphamide|cyclophosphamide
61323|NCT03184181|tendinopathy|tendinopathy
61324|NCT03184181|electrolysis|electrolysis
61325|NCT03184181|exercise|exercise
61326|NCT03184181|dry needling|dry needling
61327|NCT03184168|healthy volunteers, lorlatinib, PF-06463922, ADME, NSCLC, radiolabel, metabolism|healthy volunteers, lorlatinib, pf-06463922, adme, nsclc, radiolabel, metabolism
61328|NCT03184155|Nicardipine|nicardipine
61329|NCT03184155|Percutaneous Coronary Intervention|percutaneous coronary intervention
61330|NCT03184155|Coronary Artery Disease|coronary artery disease
61331|NCT03184142|Intimidation|intimidation
61332|NCT03184142|Simulation|simulation
61333|NCT03184142|Medical education|medical education
61334|NCT03184142|Surgical education|surgical education
61335|NCT03184077|Postpartum dyspareunia|postpartum dyspareunia
61336|NCT03184077|Obestric laceration|obestric laceration
61337|NCT03184064|Blackcurrant|blackcurrant
61338|NCT03184064|Citrus|citrus
61339|NCT03184064|Polyphenols|polyphenols
61340|NCT03184064|Glucose|glucose
61341|NCT03184064|Postprandial|postprandial
61342|NCT03184064|Metabolism|metabolism
61343|NCT03184051|Knee|knee
61344|NCT03184051|Osteoarthritis|osteoarthritis
61345|NCT03184051|Ultrasonography evaluation/ultrasound|ultrasonography evaluation/ultrasound
61346|NCT03184051|Articular cartilage|articular cartilage
61347|NCT03184051|UltraSound Speed Of Sound (US-SOS)|ultrasound speed of sound (us-sos)
61348|NCT03184051|UltraSound Time of Flight (US-TOF)|ultrasound time of flight (us-tof)
61349|NCT03184012|caries|caries
61350|NCT03184012|full coverage|full coverage
61351|NCT03184012|strip crown|strip crown
61352|NCT03184012|Zirconia crown|zirconia crown
61353|NCT03184012|primary anterior teeth|primary anterior teeth
61354|NCT03184012|crown|crown
61355|NCT03183960|Self-management|self-management
61356|NCT03183960|Quality of Life|quality of life
61357|NCT03183960|Self-efficacy|self-efficacy
61358|NCT03183960|Support|support
61359|NCT03183960|Stroke|stroke
61360|NCT03183960|Older adults|older adults
61361|NCT03183947|fMRI|fmri
61362|NCT03183947|neurofeedback|neurofeedback
61363|NCT03183947|emotion regulation|emotion regulation
61364|NCT03183947|schizophrenia|schizophrenia
61365|NCT03183947|cognitive reappraisal|cognitive reappraisal
61366|NCT03183947|depression|depression
61367|NCT03183934|Epidermolysis Bullosa|epidermolysis bullosa
61368|NCT03183934|Stem cell|stem cell
61369|NCT03183908|influenza vaccine|influenza vaccine
61370|NCT03183908|fever following vaccination|fever following vaccination
61371|NCT03183908|pain following vaccination|pain following vaccination
61372|NCT03183908|quality of life|quality of life
61373|NCT03183869|microbiome|microbiome
61374|NCT03183869|multiple sclerosis|multiple sclerosis
61375|NCT03183869|microbiota|microbiota
61376|NCT03183869|gut|gut
61377|NCT03183843|Atrial Fibrillation|atrial fibrillation
61378|NCT03183843|Mitral Valve Stenosis|mitral valve stenosis
61379|NCT03183843|Mitral Valve Insufficiency|mitral valve insufficiency
61380|NCT03183843|Dabigatran|dabigatran
61381|NCT03183843|Biological Prosthesis|biological prosthesis
61382|NCT03183843|Mitral Valve Replacement|mitral valve replacement
61383|NCT03183843|Cox-Maze Procedure|cox-maze procedure
61384|NCT03183830|Cardiovascular Disease|cardiovascular disease
61385|NCT03183830|Inorganic nitrate|inorganic nitrate
61386|NCT03183830|Nitric Oxide|nitric oxide
61387|NCT03183830|Inflammation|inflammation
61388|NCT03183817|Person-centred care|person-centred care
61389|NCT03183778|Chronic kidney disease, stages 3B-4|chronic kidney disease, stages 3b-4
61390|NCT03183752|thyroid|thyroid
61391|NCT03183752|insulin|insulin
61392|NCT03183752|thyroid nodule|thyroid nodule
61393|NCT03183752|insulin resistance|insulin resistance
61394|NCT03183752|thyroid volume|thyroid volume
61395|NCT03183752|metformin|metformin
61396|NCT03183739|ASP8062|asp8062
61397|NCT03183739|Pharmacokinetics|pharmacokinetics
61398|NCT03183739|Safety|safety
61399|NCT03183700|Screening HPV|screening hpv
61400|NCT03183700|Self sampling|self sampling
61401|NCT03183700|DNA Methylation|dna methylation
61402|NCT03183687|neurosurgery|neurosurgery
61403|NCT03183687|resident wellness|resident wellness
61404|NCT03183687|health|health
61405|NCT03183687|mental health|mental health
61406|NCT03183687|physical activity|physical activity
61407|NCT03183687|physician health|physician health
61408|NCT03183622|Deep Second-Degree Burn Wound|deep second-degree burn wound
61409|NCT03183596|Deep Serratus Block|deep serratus block
61410|NCT03183596|Reconstructive Breast Surgery|reconstructive breast surgery
61411|NCT03183596|Superficial Serratus block|superficial serratus block
61412|NCT03183583|Tissue Adhesive|tissue adhesive
61413|NCT03183492|Israel|israel
61414|NCT03183492|Universal Mass Vaccination|universal mass vaccination
61415|NCT03183492|Havrix®|havrix®
61416|NCT03183492|Hepatitis A|hepatitis a
61417|NCT03183492|Healthy adults|healthy adults
61418|NCT03183492|Long term persistence|long term persistence
61419|NCT03183492|Toddlers|toddlers
61420|NCT03183479|adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
61421|NCT03183479|fibrinogen concentrate|fibrinogen concentrate
61422|NCT03183479|perioperative blood loss|perioperative blood loss
61423|NCT03183479|transfusion|transfusion
61424|NCT03183453|Confabulations|confabulations
61425|NCT03183453|Neuropsychological rehabilitation|neuropsychological rehabilitation
61426|NCT03183453|Memory|memory
61427|NCT03183440|Atopic dermatitis|atopic dermatitis
61428|NCT03183440|Prevention|prevention
61429|NCT03183440|Prebiotics|prebiotics
61430|NCT03183440|Pregnancy|pregnancy
61431|NCT03183414|cardiac surgery|cardiac surgery
61432|NCT03183414|transoesophageal echocardiography|transoesophageal echocardiography
61433|NCT03183401|childhood cancer survivor|childhood cancer survivor
61434|NCT03183388|psychotherapy|psychotherapy
61435|NCT03183362|Barbed sutures,Cesarean Section, adhesions|barbed sutures,cesarean section, adhesions
61436|NCT03183323|hfpef|hfpef
61437|NCT03183323|hfref|hfref
61438|NCT03183323|cardiorenal syndrome|cardiorenal syndrome
61439|NCT03183323|exercise|exercise
61440|NCT03183323|telerehabilitation|telerehabilitation
61441|NCT03183323|rehabilitation|rehabilitation
61442|NCT03183284|dexamethazone|dexamethazone
61443|NCT03183284|prednislone|prednislone
61444|NCT03183284|severe ITP|severe itp
61445|NCT03183232|Immunotherapy, γδ T Cell, Lung Cancer|immunotherapy, γδ t cell, lung cancer
61446|NCT03183219|Immunotherapy, γδ T Cell, Liver Cancer|immunotherapy, γδ t cell, liver cancer
61447|NCT03183206|Immunotherapy, γδ T Cell, Breast Cancer|immunotherapy, γδ t cell, breast cancer
61448|NCT03183193|NAFLD|nafld
61449|NCT03183193|NASH|nash
61450|NCT03183193|Obesity|obesity
61451|NCT03183193|AASLD|aasld
61452|NCT03183193|AHA|aha
61453|NCT03183193|Energy-restricted diet|energy-restricted diet
61454|NCT03183193|Lifestyle intervention|lifestyle intervention
61455|NCT03183193|Mediterranean diet|mediterranean diet
61456|NCT03183193|Weight loss|weight loss
61457|NCT03183193|Liver damage|liver damage
61458|NCT03183193|Inflammation|inflammation
61459|NCT03183193|Oxidative stress|oxidative stress
61460|NCT03183193|Microbiota composition|microbiota composition
61461|NCT03183193|Eating behaviour|eating behaviour
61462|NCT03183193|Satiety|satiety
61463|NCT03183193|Physical activity|physical activity
61464|NCT03183193|Sedentary behaviours|sedentary behaviours
61465|NCT03183193|Sleep quality|sleep quality
61466|NCT03183193|Sleep duration|sleep duration
61467|NCT03183193|Psychological factors|psychological factors
61468|NCT03183193|Nutrigenomics|nutrigenomics
61469|NCT03183193|Nutrigenetics|nutrigenetics
61470|NCT03183193|Transcriptomics|transcriptomics
61471|NCT03183193|Epigenetics|epigenetics
61472|NCT03183193|Metabolomics|metabolomics
61473|NCT03183193|miRNAs|mirnas
61474|NCT03183193|Lipidomics|lipidomics
61475|NCT03183115|Early esophageal squamous cell neoplasm|early esophageal squamous cell neoplasm
61476|NCT03183115|Radiofrequency ablation|radiofrequency ablation
61477|NCT03183115|Endoscopic submucosal dissection|endoscopic submucosal dissection
61478|NCT03183115|Esophageal cancer|esophageal cancer
61479|NCT03183115|Recurrence|recurrence
61480|NCT03183115|Field cancerization|field cancerization
61481|NCT03183076|epilepsy|epilepsy
61482|NCT03183076|Diet, Carbohydrate-Restricted|diet, carbohydrate-restricted
61483|NCT03183076|Drug Resistance|drug resistance
61484|NCT03183037|Acupuncture|acupuncture
61485|NCT03183037|17-298|17-298
61486|NCT03183011|cardiac resynchronization therapy|cardiac resynchronization therapy
61487|NCT03183011|implantable cardioverter defibrillator|implantable cardioverter defibrillator
61488|NCT03183011|heart failure|heart failure
61489|NCT03183011|magnetic resonance imaging|magnetic resonance imaging
61490|NCT03182972|medication reconciliation|medication reconciliation
61491|NCT03182972|implementation|implementation
61492|NCT03182972|pharmacists|pharmacists
61493|NCT03182972|southwestern Nigeria|southwestern nigeria
61494|NCT03182959|Nrf2 pathway|nrf2 pathway
61495|NCT03182959|Oral mucosa|oral mucosa
61496|NCT03182959|HNSCC|hnscc
61497|NCT03182959|Head and Neck Cancer|head and neck cancer
62879|NCT03174197|GBM|gbm
61498|NCT03182959|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
61499|NCT03182959|Avmacol|avmacol
61500|NCT03182959|Tobacco-related Head and Neck Cancer|tobacco-related head and neck cancer
61501|NCT03182959|broccoli sprout powder|broccoli sprout powder
61502|NCT03182959|broccoli seed extract powder|broccoli seed extract powder
61503|NCT03182933|10 meter walk test|10 meter walk test
61504|NCT03182933|Opioid consumption|opioid consumption
61505|NCT03182894|chemo-refractory|chemo-refractory
61506|NCT03182894|pembrolizumab|pembrolizumab
61507|NCT03182894|epacadostat|epacadostat
61508|NCT03182894|azacitidine|azacitidine
61509|NCT03182894|recommended phase 2 dose (RP2D)|recommended phase 2 dose (rp2d)
61510|NCT03182894|microsatellite-stable (MSS) Metastatic Colorectal Cancer|microsatellite-stable (mss) metastatic colorectal cancer
61511|NCT03182881|Myofascial-reléase|myofascial-reléase
61512|NCT03182881|Fibromyalgia|fibromyalgia
61513|NCT03182881|Lymphatic drainage|lymphatic drainage
61514|NCT03182881|Breast cancer|breast cancer
61515|NCT03182855|Acute Coronary Syndrome|acute coronary syndrome
61516|NCT03182855|STEMI|stemi
61517|NCT03182855|Platelet reactivity|platelet reactivity
61518|NCT03182855|Anti-thrombotic therapy|anti-thrombotic therapy
61519|NCT03182829|direct oral anticoagulants|direct oral anticoagulants
61520|NCT03182829|apixaban|apixaban
61521|NCT03182829|dabigatran|dabigatran
61522|NCT03182829|edoxaban|edoxaban
61523|NCT03182829|rivaroxaban|rivaroxaban
61524|NCT03182829|urine|urine
61525|NCT03182829|LC-MS/MS|lc-ms/ms
61526|NCT03182829|evaluation study|evaluation study
61527|NCT03182829|point of care test|point of care test
61528|NCT03182816|epidermal growth factor receptor|epidermal growth factor receptor
61529|NCT03182816|CTLA-4|ctla-4
61530|NCT03182816|PD-1|pd-1
61531|NCT03182816|chimeric antigen receptor T cells|chimeric antigen receptor t cells
61532|NCT03182816|solid tumor|solid tumor
61533|NCT03182803|mesothelin|mesothelin
61534|NCT03182803|CTLA-4|ctla-4
61535|NCT03182803|PD-1|pd-1
61536|NCT03182803|chimeric antigen receptor T cells|chimeric antigen receptor t cells
61537|NCT03182803|solid tumor|solid tumor
61538|NCT03182790|Smoking Cessation|smoking cessation
61539|NCT03182790|Quit to Win|quit to win
61540|NCT03182790|Brief intervention|brief intervention
61541|NCT03182790|Semi-personalized Instant messaging|semi-personalized instant messaging
61542|NCT03182790|Incentives|incentives
61543|NCT03182790|AWARD model|award model
61544|NCT03182790|Smoking Cessation Intervention|smoking cessation intervention
61545|NCT03182790|Regular messages|regular messages
61546|NCT03182777|arrhythmias, cardiac|arrhythmias, cardiac
61547|NCT03182777|channelopathies|channelopathies
61548|NCT03182777|death, sudden|death, sudden
61549|NCT03182777|genetic testing|genetic testing
61550|NCT03182777|electrocardiography, ambulatory|electrocardiography, ambulatory
61551|NCT03182777|anesthesia, local|anesthesia, local
61552|NCT03182777|dentistry|dentistry
61553|NCT03182738|HIV/AIDS Health Management App|hiv/aids health management app
61554|NCT03182738|HIV/AIDS symptoms|hiv/aids symptoms
61555|NCT03182725|POTS|pots
61556|NCT03182725|tachycardia|tachycardia
61557|NCT03182725|ivabradine|ivabradine
61558|NCT03182699|Secondary Hyperparathyroidism|secondary hyperparathyroidism
61559|NCT03182699|Hemodialysis|hemodialysis
61560|NCT03182699|Left Ventricular Hypertrophy|left ventricular hypertrophy
61561|NCT03182699|FGF 23|fgf 23
61562|NCT03182699|Etelcalcetide|etelcalcetide
61563|NCT03182699|Alfacalcidol|alfacalcidol
61564|NCT03182686|osteoarthritis|osteoarthritis
61565|NCT03182686|osteoarthritis of the knee|osteoarthritis of the knee
61566|NCT03182686|OA|oa
61567|NCT03182686|OAK|oak
61568|NCT03182686|Kellgren Lawrence (KL)|kellgren lawrence (kl)
61569|NCT03182673|advanced solid tumor|advanced solid tumor
61570|NCT03182673|Protein Kinase MEK inhibitor (MEKi)|protein kinase mek inhibitor (meki)
61571|NCT03182673|Programmed Death 1(PD-1)|programmed death 1(pd-1)
61572|NCT03182673|Safety|safety
61573|NCT03182673|Pharmacokinetics|pharmacokinetics
61574|NCT03182621|Physical Fitness|physical fitness
61575|NCT03182621|Body Composition|body composition
61576|NCT03182621|Executive Cognitive Function|executive cognitive function
61577|NCT03182582|Laser Debridement|laser debridement
61578|NCT03182582|Debridement|debridement
61579|NCT03182556|Dance Therapy|dance therapy
61580|NCT03182556|Exercise|exercise
61581|NCT03182556|Myofeedback|myofeedback
61582|NCT03182556|Fibromyalgia|fibromyalgia
61583|NCT03182543|Exercise|exercise
61584|NCT03182543|Oxidative stress|oxidative stress
61585|NCT03182543|Antioxidant|antioxidant
61586|NCT03182491|Platelet activating factor|platelet activating factor
61587|NCT03182491|Basophil activation test|basophil activation test
61588|NCT03182491|Anaphylatoxins|anaphylatoxins
61589|NCT03182478|skin picking|skin picking
61590|NCT03182478|SPD|spd
61591|NCT03182478|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
61592|NCT03182478|CBT|cbt
61593|NCT03182478|Group treatment|group treatment
61594|NCT03182478|Rothbaum protocol|rothbaum protocol
61595|NCT03182452|Alarms|alarms
61596|NCT03182452|Alarm Fatigue|alarm fatigue
61597|NCT03182452|Alarm Nuisance|alarm nuisance
61598|NCT03182452|Alarm Reduction|alarm reduction
61599|NCT03182452|Patient Monitoring|patient monitoring
61600|NCT03182452|Intensive Care|intensive care
61601|NCT03182439|WEARABLE HEART RATE MONITORS, ACCURACY|wearable heart rate monitors, accuracy
61602|NCT03182413|modafinil|modafinil
61603|NCT03182413|connexin|connexin
61604|NCT03182413|sleep deprivation|sleep deprivation
61605|NCT03182413|cognitive performance|cognitive performance
61606|NCT03182387|Bronchoalveolar lavage|bronchoalveolar lavage
61607|NCT03182387|amylase assay|amylase assay
61608|NCT03182387|aspiration pneumonia|aspiration pneumonia
61609|NCT03182374|Autologous Protein Solution (APS)|autologous protein solution (aps)
61610|NCT03182374|Intra-articular Injection|intra-articular injection
61611|NCT03182374|Osteoarthritis|osteoarthritis
61612|NCT03182361|Auricular, nasal, orbital, extraoral prostheses, extraoral implants, peri-implant reactions, Holgers|auricular, nasal, orbital, extraoral prostheses, extraoral implants, peri-implant reactions, holgers
61613|NCT03182348|Microvessels|microvessels
61614|NCT03182348|Cardiovascular disease|cardiovascular disease
61615|NCT03182348|OCT|oct
61616|NCT03182322|Type 1 diabetes|type 1 diabetes
61617|NCT03182322|T1D|t1d
61618|NCT03182322|diabetes mellitus|diabetes mellitus
61619|NCT03182322|intranasal insulin|intranasal insulin
61620|NCT03182322|mucosal tolerance|mucosal tolerance
61621|NCT03182322|autoantigen|autoantigen
61622|NCT03182322|self tolerance|self tolerance
61623|NCT03182322|prevention|prevention
61624|NCT03182322|at risk for developing type 1 diabetes|at risk for developing type 1 diabetes
61625|NCT03182322|juvenile diabetes|juvenile diabetes
61626|NCT03182296|beta cell mass|beta cell mass
61627|NCT03182296|exendin|exendin
61628|NCT03182296|GLP-1 PET|glp-1 pet
61629|NCT03182283|Person-centered care|person-centered care
61630|NCT03182283|Psychosis care|psychosis care
61631|NCT03182283|Integrated care|integrated care
61632|NCT03182257|TRK|trk
61633|NCT03182257|TRKA|trka
61634|NCT03182257|TRKB|trkb
61635|NCT03182257|TRKC|trkc
61636|NCT03182257|NTRK1|ntrk1
61637|NCT03182257|NTRK2|ntrk2
61638|NCT03182257|NTRK3|ntrk3
61639|NCT03182257|NTRK fusion positive|ntrk fusion positive
61640|NCT03182257|NTRK1 fusion|ntrk1 fusion
61641|NCT03182257|NTRK2 fusion|ntrk2 fusion
61642|NCT03182257|NTRK3 fusion|ntrk3 fusion
61643|NCT03182257|NTRK1 gene rearrangement|ntrk1 gene rearrangement
61644|NCT03182257|NTRK2 gene rearrangement|ntrk2 gene rearrangement
61645|NCT03182257|NTRK3 gene fusion|ntrk3 gene fusion
61646|NCT03182257|ETV6-NTRK3|etv6-ntrk3
61647|NCT03182257|fusion|fusion
61648|NCT03182257|tumors|tumors
61649|NCT03182257|solid tumors|solid tumors
61650|NCT03182257|CNS tumors|cns tumors
61651|NCT03182257|central nervous system tumors|central nervous system tumors
61652|NCT03182257|TRK fusion|trk fusion
61653|NCT03182257|ETV6|etv6
61654|NCT03182257|ETV6 fusion|etv6 fusion
61655|NCT03182257|solid CNS tumor|solid cns tumor
61656|NCT03182257|advanced CNS tumor|advanced cns tumor
61657|NCT03182257|primary CNS tumor|primary cns tumor
61658|NCT03182244|gilteritinib|gilteritinib
61659|NCT03182244|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
61660|NCT03182244|ASP2215|asp2215
61661|NCT03182231|exendin|exendin
61662|NCT03182231|GLP1|glp1
61663|NCT03182231|beta cell mass|beta cell mass
61664|NCT03182218|Periprocedural|periprocedural
61665|NCT03182218|Anticoagulation|anticoagulation
61666|NCT03182218|Dabigatran|dabigatran
61667|NCT03182218|Rivaroxaban|rivaroxaban
61668|NCT03182218|Apixaban|apixaban
61669|NCT03182218|Edoxaban|edoxaban
61670|NCT03182218|Direct oral anticoagulant|direct oral anticoagulant
61671|NCT03182218|Surgery|surgery
61672|NCT03182218|Anaesthesia|anaesthesia
61673|NCT03182218|Novel oral anticoagulant|novel oral anticoagulant
61674|NCT03182218|Perioperative medicine|perioperative medicine
61675|NCT03182205|Breathing Exercises|breathing exercises
61676|NCT03182205|Autonomic Nervous System|autonomic nervous system
61677|NCT03182205|Hemodynamics|hemodynamics
61678|NCT03182192|Betal cells|betal cells
61679|NCT03182192|Roux- and Y gastic bypass|roux- and y gastic bypass
61680|NCT03182192|exendin|exendin
61681|NCT03182192|GLP1|glp1
61682|NCT03182166|golimumab|golimumab
61683|NCT03182166|clinical response|clinical response
61684|NCT03182166|mayo score|mayo score
61685|NCT03182166|rectosigmoidoscopy|rectosigmoidoscopy
61686|NCT03182166|ulcerative colitis|ulcerative colitis
61687|NCT03182140|long-acting contraception,|long-acting contraception,
61688|NCT03182140|unintended pregnancy|unintended pregnancy
61689|NCT03182140|satisfaction|satisfaction
61690|NCT03182140|bleeding profile|bleeding profile
61691|NCT03182140|amenorrhea|amenorrhea
61692|NCT03182075|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
61693|NCT03182075|OCD|ocd
61694|NCT03182075|Obsessive Personality Disorder|obsessive personality disorder
61695|NCT03182075|Compulsive Behavior|compulsive behavior
61696|NCT03182075|Personality Disorders|personality disorders
61697|NCT03182075|Mental Disorders|mental disorders
61698|NCT03182075|Anxiety Disorders|anxiety disorders
61699|NCT03182075|Impulsive Behavior|impulsive behavior
61700|NCT03182075|Cognition|cognition
61701|NCT03182075|Emotion|emotion
61702|NCT03182075|Emotional Regulation|emotional regulation
61703|NCT03182062|one lung ventilation|one lung ventilation
61704|NCT03182062|postoperative pulmonary complication|postoperative pulmonary complication
61705|NCT03182062|perioperative lung protective ventilation|perioperative lung protective ventilation
61706|NCT03182049|GPA|gpa
61707|NCT03182049|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
61708|NCT03182049|Wegener's granulomatosis|wegener's granulomatosis
61709|NCT03182049|Subglottic Stenosis|subglottic stenosis
61710|NCT03182049|Bronchial Stenosis|bronchial stenosis
61711|NCT03182023|outcome,ECMO,Respiratory Failure,Circulatory Failure|outcome,ecmo,respiratory failure,circulatory failure
61712|NCT03182010|Cesarean section scar, Barbed suture, Conventional suture|cesarean section scar, barbed suture, conventional suture
61713|NCT03181997|Aortic Valve Stenosis|aortic valve stenosis
61714|NCT03181997|Transcatheter Aortic Valve Implantation|transcatheter aortic valve implantation
61715|NCT03181997|Cancer|cancer
61716|NCT03181997|Malignancy|malignancy
61717|NCT03181971|water|water
61718|NCT03181971|sugar-sweetened beverages|sugar-sweetened beverages
61719|NCT03181971|schools|schools
61720|NCT03181958|nasal high frequency oscillation ventilation(NHFOV)|nasal high frequency oscillation ventilation(nhfov)
61721|NCT03181958|nasal continuous positive airway pressure(NCPAP)|nasal continuous positive airway pressure(ncpap)
61722|NCT03181958|nasal intermittent positive pressure ventilation（NIPPV）|nasal intermittent positive pressure ventilation（nippv）
61723|NCT03181958|neonatal respiratory distress syndrome(NRDS)|neonatal respiratory distress syndrome(nrds)
61724|NCT03181958|preterm infants|preterm infants
61725|NCT03181906|medication discrepancy|medication discrepancy
61726|NCT03181906|primary care|primary care
61727|NCT03181906|transition of care|transition of care
61728|NCT03181880|ASTUTE|astute
61729|NCT03181880|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
61730|NCT03181880|Randomised|randomised
61731|NCT03181880|Pragmatic|pragmatic
61732|NCT03181880|Standard of Care|standard of care
61733|NCT03181880|Aclidinium bromide/formoterol fumarate fixed-dose combination|aclidinium bromide/formoterol fumarate fixed-dose combination
61734|NCT03181880|Duaklir|duaklir
61735|NCT03181880|Genuair|genuair
61736|NCT03181867|PET/ CT|pet/ ct
61737|NCT03181867|Endorectal MRI|endorectal mri
61738|NCT03181867|Imaging|imaging
61739|NCT03181867|PSMA|psma
61740|NCT03181867|Prostate Cancer Relapse|prostate cancer relapse
61741|NCT03181854|Integrated Early Palliative Care|integrated early palliative care
61742|NCT03181828|CPSI deficiency|cpsi deficiency
61743|NCT03181828|OTC Deficiency|otc deficiency
61744|NCT03181828|AS Deficiency|as deficiency
61745|NCT03181828|AL Deficiency|al deficiency
61746|NCT03181815|CLADRIBINE|cladribine
61747|NCT03181815|ACUTE MYELOID LEUKEMIA|acute myeloid leukemia
61748|NCT03181789|HIV vaccine|hiv vaccine
61749|NCT03181789|DNA vaccine|dna vaccine
61750|NCT03181789|IL-12|il-12
61751|NCT03181789|Electroporation|electroporation
61752|NCT03181789|p24|p24
61753|NCT03181789|Gag|gag
61754|NCT03181789|Adjuvant|adjuvant
61755|NCT03181789|Healthy|healthy
61756|NCT03181763|MDMA|mdma
61757|NCT03181763|Startle response|startle response
61758|NCT03181763|sleep|sleep
61759|NCT03181750|Palliative Care|palliative care
61760|NCT03181750|Latino|latino
61761|NCT03181750|Patient Navigation|patient navigation
61762|NCT03181737|diabetes mellitus typ 2, adherence, psychological online-intervention, randomized controlled study|diabetes mellitus typ 2, adherence, psychological online-intervention, randomized controlled study
61763|NCT03181711|Dental caries|dental caries
61764|NCT03181711|Tooth, deciduous|tooth, deciduous
61765|NCT03181711|Children|children
61766|NCT03181711|Radiography/bitewing|radiography/bitewing
61767|NCT03181711|diagnostic imaging|diagnostic imaging
61768|NCT03181685|Progesterone supplementation|progesterone supplementation
61769|NCT03181685|IVF|ivf
61770|NCT03181685|Preference expressed by the patient|preference expressed by the patient
61771|NCT03181672|Stellate ganglion block Tourniquet reaction|stellate ganglion block tourniquet reaction
61772|NCT03181659|Musculoskeletal Manipulations|musculoskeletal manipulations
61773|NCT03181659|Exercise|exercise
61774|NCT03181659|Patient Education|patient education
61775|NCT03181659|Low back pain|low back pain
61776|NCT03181633|PNH|pnh
61777|NCT03181633|Paroxysmal|paroxysmal
61778|NCT03181633|Hemoglobinuria|hemoglobinuria
61779|NCT03181633|ACH-0144471|ach-0144471
61780|NCT03181581|ultrasonography|ultrasonography
61781|NCT03181581|ultrasonics|ultrasonics
61782|NCT03181581|brain|brain
61783|NCT03181581|surgery|surgery
61784|NCT03181555|Pregnant|pregnant
61785|NCT03181555|Obese|obese
61786|NCT03181555|Omic|omic
61787|NCT03181490|Pulmonary Nodule|pulmonary nodule
61788|NCT03181490|Solitary|solitary
61789|NCT03181477|Phase II|phase ii
61790|NCT03181477|Radiotherapy with SIB-IMRT|radiotherapy with sib-imrt
61791|NCT03181477|Tomozolomide|tomozolomide
61792|NCT03181438|Renal Transplantation|renal transplantation
61793|NCT03181438|Acute pain|acute pain
61794|NCT03181438|Regional Anesthesia|regional anesthesia
61795|NCT03181438|TAP Block|tap block
61796|NCT03181425|Knee cartilage|knee cartilage
61797|NCT03181425|Early Osteoarthritis|early osteoarthritis
61798|NCT03181425|MRI tractography|mri tractography
61799|NCT03181425|Diffusion Tensor Imaging|diffusion tensor imaging
61800|NCT03181386|Dabigatran|dabigatran
61801|NCT03181386|Rivaroxaban|rivaroxaban
61802|NCT03181386|Apixaban|apixaban
61803|NCT03181386|Warfarin|warfarin
61804|NCT03181386|Tooth Extraction|tooth extraction
61805|NCT03181373|Craniocerebral injury|craniocerebral injury
61806|NCT03181373|Mild and severe brain traumatic injury|mild and severe brain traumatic injury
61807|NCT03181373|Neuropsychological abilities|neuropsychological abilities
61808|NCT03181373|Clinical assessment|clinical assessment
61809|NCT03181373|Anatomical and functional imaging|anatomical and functional imaging
61810|NCT03181360|ischemic stroke|ischemic stroke
61811|NCT03181360|wake-up|wake-up
61812|NCT03181360|thrombolysis|thrombolysis
61813|NCT03181360|tenecteplase|tenecteplase
61814|NCT03181360|computed tomography|computed tomography
61815|NCT03181347|Bariatrics|bariatrics
61816|NCT03181347|Microbiology|microbiology
61817|NCT03181334|colorectal|colorectal
61818|NCT03181334|cancer|cancer
61819|NCT03181334|neoplasm|neoplasm
61820|NCT03181334|CRC screening|crc screening
61821|NCT03181334|FIT|fit
61822|NCT03181334|Fecal Immunochemical Test|fecal immunochemical test
61823|NCT03181321|nutrition|nutrition
61824|NCT03181321|fitness|fitness
61825|NCT03181321|cardiovascular disease|cardiovascular disease
61826|NCT03181321|firefighters|firefighters
61827|NCT03181321|obesity|obesity
61828|NCT03181321|injury|injury
61829|NCT03181295|Family Medicine|family medicine
61830|NCT03181295|Primary Care|primary care
61831|NCT03181295|Exercise prescriptions|exercise prescriptions
61832|NCT03181295|Technology|technology
61833|NCT03181282|Deep brain stimulation|deep brain stimulation
61834|NCT03181282|Balance|balance
61835|NCT03181282|Gait|gait
61836|NCT03181282|Physical Therapy|physical therapy
61837|NCT03181282|Parkinson disease|parkinson disease
61838|NCT03181230|Turner syndrome|turner syndrome
61839|NCT03181230|45,XO|45,xo
61840|NCT03181230|body composition|body composition
61841|NCT03181230|cardiometabolism|cardiometabolism
61842|NCT03181230|quality of life|quality of life
61843|NCT03181230|fitness|fitness
61844|NCT03181178|Complementary food supplement|complementary food supplement
61845|NCT03181178|Protein quality and linear growth|protein quality and linear growth
61846|NCT03181178|Intervention targeting complementary foods and growth|intervention targeting complementary foods and growth
61847|NCT03181165|Low-carbohydrate|low-carbohydrate
61848|NCT03181165|Low calorie|low calorie
61849|NCT03181165|Energy restricted|energy restricted
61850|NCT03181139|Enhanced Recovery after Surgery (ERAS)|enhanced recovery after surgery (eras)
61851|NCT03181139|Fast-track surgery|fast-track surgery
61852|NCT03181139|Pec Blocks|pec blocks
61853|NCT03181139|Mastectomy|mastectomy
61854|NCT03181126|Relapsed of Refractory Acute Lymphoblastic Leukemia|relapsed of refractory acute lymphoblastic leukemia
61855|NCT03181126|Cancer|cancer
61856|NCT03181126|Venetoclax|venetoclax
61857|NCT03181126|Navitoclax|navitoclax
61858|NCT03181113|peginterferon alpha|peginterferon alpha
61859|NCT03181113|HBeAg seroconversion|hbeag seroconversion
61860|NCT03181113|immune control|immune control
61861|NCT03181100|Malignant neoplasms of thyroid and other endocrine glands|malignant neoplasms of thyroid and other endocrine glands
61862|NCT03181100|Anaplastic thyroid carcinoma|anaplastic thyroid carcinoma
61863|NCT03181100|ATC|atc
61864|NCT03181100|Poorly differentiated thyroid cancer|poorly differentiated thyroid cancer
61865|NCT03181100|PDTC|pdtc
61866|NCT03181100|Nab-paclitaxel|nab-paclitaxel
61867|NCT03181100|Paclitaxel (protein bound)|paclitaxel (protein bound)
61868|NCT03181100|Abraxane|abraxane
61869|NCT03181100|ABI-007|abi-007
61870|NCT03181100|Paclitaxel|paclitaxel
61871|NCT03181100|Taxol|taxol
61872|NCT03181100|Vemurafenib|vemurafenib
61873|NCT03181100|PLX4032|plx4032
61874|NCT03181100|R05185426|r05185426
61875|NCT03181100|Cobimetinib|cobimetinib
61876|NCT03181100|Atezolizumab|atezolizumab
61877|NCT03181100|MPDL3280A|mpdl3280a
61878|NCT03181100|Bevacizumab|bevacizumab
61879|NCT03181100|Avastin|avastin
61880|NCT03181100|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
61881|NCT03181100|rhuMAb-VEGF|rhumab-vegf
61882|NCT03181100|BRAF|braf
61883|NCT03181100|BRAF inhibitor|braf inhibitor
61884|NCT03181100|MEK|mek
61885|NCT03181100|MEK inhibitor|mek inhibitor
61886|NCT03181100|Immunotherapy|immunotherapy
61887|NCT03181100|Targeted therapy|targeted therapy
61888|NCT03181087|Mesenchymal Stem Cells|mesenchymal stem cells
61889|NCT03181087|Cesarean Section|cesarean section
61890|NCT03181087|Uterine Scar|uterine scar
61891|NCT03181035|Oral Tongue Cancer|oral tongue cancer
61892|NCT03181035|Tumor Hypoxia|tumor hypoxia
61893|NCT03181022|Patient-Provider Communication|patient-provider communication
61894|NCT03181022|Motivational Interviewing|motivational interviewing
61895|NCT03181022|Medication Adherence|medication adherence
61896|NCT03181009|Oral Immunotherapy|oral immunotherapy
61897|NCT03181009|Omalizumab|omalizumab
61898|NCT03181009|OIT|oit
61899|NCT03181009|Xolair|xolair
61900|NCT03180996|FEVAR|fevar
61901|NCT03180996|Fenestrated|fenestrated
61902|NCT03180996|Endovascular|endovascular
61903|NCT03180996|AAA|aaa
61904|NCT03180996|Custom device|custom device
61905|NCT03180957|Dupuytren|dupuytren
61906|NCT03180957|adalimumab|adalimumab
61907|NCT03180957|anti TNF|anti tnf
61908|NCT03180957|phase II clinical trial|phase ii clinical trial
61909|NCT03180957|randomized controlled trial|randomized controlled trial
61910|NCT03180957|double-blind method|double-blind method
61911|NCT03180957|Dupuytren's|dupuytren's
61912|NCT03180957|Dupuytren's contracture|dupuytren's contracture
61913|NCT03180892|Iodine|iodine
61914|NCT03180892|thyroid peroxidase antibody|thyroid peroxidase antibody
61915|NCT03180840|Enzyme-Replacement Therapy|enzyme-replacement therapy
61916|NCT03180840|pegunigalsidase alfa|pegunigalsidase alfa
61917|NCT03180840|Fabry Disease|fabry disease
61918|NCT03180801|broad|broad
61919|NCT03180801|universal|universal
61920|NCT03180801|vaccine|vaccine
61921|NCT03180801|influenza|influenza
61922|NCT03180801|peptide|peptide
61923|NCT03180801|T cell|t cell
61924|NCT03180801|H1N1|h1n1
61925|NCT03180801|human challenge|human challenge
61926|NCT03180788|ESD|esd
61927|NCT03180788|Traction assisted ESD|traction assisted esd
61928|NCT03180788|Polypectomy|polypectomy
61929|NCT03180788|Clip and thread ESD|clip and thread esd
61930|NCT03180775|Amino acids|amino acids
61931|NCT03180775|Macrophage atherogenicity|macrophage atherogenicity
61932|NCT03180775|Triglycerides|triglycerides
61933|NCT03180775|Cholesterol|cholesterol
61934|NCT03180775|Lipoproteins|lipoproteins
61935|NCT03180697|Amide Proton Transfer|amide proton transfer
61936|NCT03180697|bevacizumab|bevacizumab
61937|NCT03180697|recurrent malignant gliomas|recurrent malignant gliomas
61938|NCT03180697|efficacy|efficacy
61939|NCT03180684|HPV-16|hpv-16
61940|NCT03180684|HPV-18|hpv-18
61941|NCT03180671|anterior deprogrammer|anterior deprogrammer
61942|NCT03180671|muscle pain|muscle pain
61943|NCT03180671|centric relation|centric relation
61944|NCT03180606|Elderly|elderly
61945|NCT03180606|Frail|frail
61946|NCT03180606|Primary care|primary care
61947|NCT03180580|Childhood, Overweight, Obesity|childhood, overweight, obesity
61948|NCT03180554|Vagal nerve stimulation|vagal nerve stimulation
61949|NCT03180554|diaphragmatic breathing|diaphragmatic breathing
61950|NCT03180554|chronic widespread pain|chronic widespread pain
61951|NCT03180554|parasympathetic nervous system|parasympathetic nervous system
61952|NCT03180554|heart rate variability|heart rate variability
61953|NCT03180463|Osteonecrosis of Femoral Head|osteonecrosis of femoral head
61954|NCT03180463|umbilical cord mesenchymal stem cells|umbilical cord mesenchymal stem cells
61955|NCT03180450|Heart Failure|heart failure
61956|NCT03180450|Human Umbilical Cord Mesenchymal Stem Cells|human umbilical cord mesenchymal stem cells
61957|NCT03180437|Immunotherapy|immunotherapy
61958|NCT03180437|γδ T Cell|γδ t cell
61959|NCT03180437|Pancreatic Cancer|pancreatic cancer
61960|NCT03180424|carnitine|carnitine
61961|NCT03180424|elderly|elderly
61962|NCT03180424|functional status|functional status
61963|NCT03180411|Colorectal Cancer|colorectal cancer
61964|NCT03180411|CRC|crc
61965|NCT03180411|Colorectal cancer surveillance|colorectal cancer surveillance
61966|NCT03180411|Decision support tool|decision support tool
61967|NCT03180411|Interviews|interviews
61968|NCT03180411|Questionnaire|questionnaire
61969|NCT03180411|Survey|survey
61970|NCT03180385|NAVA|nava
61971|NCT03180385|BiPAP|bipap
61972|NCT03180385|Pediatrics|pediatrics
61973|NCT03180385|Cardiac Surgery|cardiac surgery
61974|NCT03180359|solid transplant|solid transplant
61975|NCT03180359|grafted children|grafted children
61976|NCT03180359|vaccine recommendation|vaccine recommendation
61977|NCT03180359|immunization efficacy|immunization efficacy
61978|NCT03180359|solid grafted children|solid grafted children
61979|NCT03180359|solid transplant candidate children|solid transplant candidate children
61980|NCT03180333|Chronic Hepatitis B|chronic hepatitis b
61981|NCT03180320|chronic heart failure|chronic heart failure
61982|NCT03180320|exercise-based cardiac rehabilitation|exercise-based cardiac rehabilitation
61983|NCT03180320|Baduanjin|baduanjin
61984|NCT03180203|INTELLiVENT-ASV|intellivent-asv
61985|NCT03180203|Fully closed-loop ventilation|fully closed-loop ventilation
61986|NCT03180203|Wean|wean
61987|NCT03180177|Hyperthermic Intraperitoneal Chemotherapy|hyperthermic intraperitoneal chemotherapy
61988|NCT03180177|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
61989|NCT03180177|Interval Debulking Surgery|interval debulking surgery
61990|NCT03180177|Advanced-Stage Epithelial Ovarian Cancer|advanced-stage epithelial ovarian cancer
61991|NCT03180177|Postoperative Chemotherapy|postoperative chemotherapy
61992|NCT03180151|corticotomy|corticotomy
61993|NCT03180151|enmass retraction|enmass retraction
61994|NCT03180151|mini implant|mini implant
61995|NCT03180138|mobile phone|mobile phone
61996|NCT03180138|Children's Health|children's health
61997|NCT03180125|hydrodissection|hydrodissection
61998|NCT03180125|sodium hyaluorinate|sodium hyaluorinate
61999|NCT03180099|Lumbar Disk Hernia|lumbar disk hernia
62000|NCT03180099|Thoracolumbar Interfascial Plane Block|thoracolumbar interfascial plane block
62001|NCT03180099|Lumbar Disk Surgery|lumbar disk surgery
62002|NCT03180086|Breast cancer risk|breast cancer risk
62003|NCT03180086|Primary Care|primary care
62004|NCT03180086|Women|women
62005|NCT03180060|Likelihood Ratio|likelihood ratio
62006|NCT03180060|Cardiovascular Magnetic Resonance|cardiovascular magnetic resonance
62007|NCT03180060|CMR|cmr
62008|NCT03180060|Myocardial Perfusion|myocardial perfusion
62009|NCT03180060|Predictive Values|predictive values
62010|NCT03180060|Computed Tomography Perfusion|computed tomography perfusion
62011|NCT03180060|CTP|ctp
62012|NCT03180060|SPECT|spect
62013|NCT03180060|PET|pet
62014|NCT03180060|Diagnostic Accuracy|diagnostic accuracy
62015|NCT03180060|Quantitative Coronary Angiography|quantitative coronary angiography
62016|NCT03180060|Area Under the Curve|area under the curve
62017|NCT03180060|ROC Curve|roc curve
62018|NCT03180034|Human Papillomavirus|human papillomavirus
62019|NCT03180034|Cervical Cancer|cervical cancer
62020|NCT03180034|Costa Rica|costa rica
62021|NCT03180034|Fewer Doses|fewer doses
62022|NCT03180034|HPV-Associated Cancers|hpv-associated cancers
62023|NCT03179995|Octreotide, Major Liver Resection|octreotide, major liver resection
62024|NCT03179943|bladder cancer|bladder cancer
62025|NCT03179943|Ureteral Cancer|ureteral cancer
62026|NCT03179943|Urothelial cancer|urothelial cancer
62027|NCT03179943|Urethral cancer|urethral cancer
62028|NCT03179930|Entinostat|entinostat
62029|NCT03179930|Pembrolizumab|pembrolizumab
62030|NCT03179930|17-073|17-073
62031|NCT03179917|Pembrolizumab|pembrolizumab
62032|NCT03179917|Radiation Therapy|radiation therapy
62033|NCT03179917|17-054|17-054
62034|NCT03179891|Interictal Period A|interictal period a
62035|NCT03179891|Icta/peri-ictal Period B|icta/peri-ictal period b
62036|NCT03179839|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
62037|NCT03179813|hydrocortisone|hydrocortisone
62038|NCT03179813|third molar|third molar
62039|NCT03179813|oral surgery|oral surgery
62040|NCT03179813|postoperative pain|postoperative pain
62041|NCT03179813|edema|edema
62042|NCT03179800|Hypertension|hypertension
62043|NCT03179800|Resistant Hypertension|resistant hypertension
62044|NCT03179800|Baroreceptor|baroreceptor
62045|NCT03179800|BAT|bat
62046|NCT03179722|Aging|aging
62047|NCT03179722|Drug-related problems|drug-related problems
62048|NCT03179722|Medication review|medication review
62049|NCT03179722|Community pharmacist|community pharmacist
62050|NCT03179722|Medication use|medication use
62051|NCT03179709|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
62052|NCT03179709|Neuromuscular Blockade|neuromuscular blockade
62053|NCT03179709|Interviews|interviews
62054|NCT03179709|Implementation Science|implementation science
62055|NCT03179696|Schizophrenia|schizophrenia
62056|NCT03179696|CBSST|cbsst
62057|NCT03179696|mobile CBT|mobile cbt
62058|NCT03179696|negative symptoms|negative symptoms
62059|NCT03179683|aluminum step-wedge|aluminum step-wedge
62186|NCT03179007|solid tumor|solid tumor
62060|NCT03179683|demineralized bone matrix|demineralized bone matrix
62061|NCT03179683|dental implant|dental implant
62062|NCT03179683|digital densitometry|digital densitometry
62063|NCT03179683|low level laser therapy|low level laser therapy
62064|NCT03179683|maxillary sinus augmentation.|maxillary sinus augmentation.
62065|NCT03179657|Prospective Cohort study|prospective cohort study
62066|NCT03179657|Nutrition|nutrition
62067|NCT03179657|Diet|diet
62068|NCT03179657|Guangzhou|guangzhou
62069|NCT03179657|Chinese|chinese
62070|NCT03179631|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
62071|NCT03179631|Dystrophinopathy|dystrophinopathy
62072|NCT03179631|Nonsense Mutation|nonsense mutation
62073|NCT03179631|Premature Stop Codon|premature stop codon
62074|NCT03179631|Becker Muscular Dystrophy|becker muscular dystrophy
62075|NCT03179631|DMD/BMD|dmd/bmd
62076|NCT03179631|PTC124|ptc124
62077|NCT03179631|Ataluren|ataluren
62078|NCT03179618|Unstable Angina|unstable angina
62079|NCT03179618|Xuefu Zhuyu Decoction|xuefu zhuyu decoction
62080|NCT03179592|Computed Tomography|computed tomography
62081|NCT03179579|Gastric Cancer|gastric cancer
62082|NCT03179579|Peritoneal Carcinomatosis|peritoneal carcinomatosis
62083|NCT03179579|Hyperthermic Intraperitoneal Chemotherapy|hyperthermic intraperitoneal chemotherapy
62084|NCT03179579|Systemic Chemotherapy|systemic chemotherapy
62085|NCT03179579|Cytoreductive Surgery|cytoreductive surgery
62086|NCT03179566|drug disposal|drug disposal
62087|NCT03179540|Low Rectal Cancer|low rectal cancer
62088|NCT03179540|Complete Clinical Response|complete clinical response
62089|NCT03179540|Non-operative Management|non-operative management
62090|NCT03179527|Unstable Angina|unstable angina
62091|NCT03179527|Shuanghe Decoction|shuanghe decoction
62092|NCT03179514|Unstable Angina|unstable angina
62093|NCT03179514|Gualou Xiebai Banxia Decoction|gualou xiebai banxia decoction
62094|NCT03179514|Danshen Decoction|danshen decoction
62095|NCT03179475|Spinal Cord Injury|spinal cord injury
62096|NCT03179475|Traumatic Spinal Cord Injury|traumatic spinal cord injury
62097|NCT03179475|Targin®|targin®
62098|NCT03179475|Opioids|opioids
62099|NCT03179475|Naloxone|naloxone
62100|NCT03179475|Opioid Induced Constipation|opioid induced constipation
62101|NCT03179475|Oxycodone-Naloxone|oxycodone-naloxone
62102|NCT03179436|PD1|pd1
62103|NCT03179436|PD-1|pd-1
62104|NCT03179436|PDL1|pdl1
62105|NCT03179436|PD-L1|pd-l1
62106|NCT03179423|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
62107|NCT03179423|T1D|t1d
62108|NCT03179423|Monoclonal antibody|monoclonal antibody
62109|NCT03179423|Multiple Sclerosis associated retrovirus MSRV|multiple sclerosis associated retrovirus msrv
62110|NCT03179423|Human Endogenous Retrovirus Type W (HERV-W)|human endogenous retrovirus type w (herv-w)
62111|NCT03179423|GNbAC1|gnbac1
62112|NCT03179410|metastatic castrate-resistant prostate cancer (mCRPC)|metastatic castrate-resistant prostate cancer (mcrpc)
62113|NCT03179410|neuroendocrine prostate cancer (NEPC)|neuroendocrine prostate cancer (nepc)
62114|NCT03179345|Volunteer|volunteer
62115|NCT03179345|Pharmacodynamics|pharmacodynamics
62116|NCT03179345|Pharmacokinetics|pharmacokinetics
62117|NCT03179319|PrEP|prep
62118|NCT03179319|HIV testing|hiv testing
62119|NCT03179319|Sexually transmitted disease (STD) testing|sexually transmitted disease (std) testing
62120|NCT03179319|Mobile app|mobile app
62121|NCT03179319|Young men who have sex with men|young men who have sex with men
62122|NCT03179319|Technology|technology
62123|NCT03179306|Cervix|cervix
62124|NCT03179306|HPV|hpv
62125|NCT03179306|Imaging|imaging
62126|NCT03179306|Costa Rica|costa rica
62127|NCT03179280|Type 1 diabetes|type 1 diabetes
62128|NCT03179280|Dual-wave bolus|dual-wave bolus
62129|NCT03179280|Postprandial euglycaemia|postprandial euglycaemia
62130|NCT03179267|vital signs|vital signs
62131|NCT03179267|monitoring|monitoring
62132|NCT03179267|early warning score|early warning score
62133|NCT03179202|Electrical Stimulation|electrical stimulation
62134|NCT03179202|Neurostimulation|neurostimulation
62135|NCT03179202|Neuromodulation|neuromodulation
62136|NCT03179202|Back Pain|back pain
62137|NCT03179202|Low Back Pain|low back pain
62138|NCT03179163|Hypertension|hypertension
62139|NCT03179163|Blood Pressure|blood pressure
62140|NCT03179163|Cardiovascular Disease|cardiovascular disease
62141|NCT03179163|ACE Inhibitor|ace inhibitor
62142|NCT03179163|Diuretic|diuretic
62143|NCT03179163|Nitric Oxide|nitric oxide
62144|NCT03179163|Hydrogen Sulfide|hydrogen sulfide
62145|NCT03179163|Captopril|captopril
62146|NCT03179163|Enalapril|enalapril
62147|NCT03179163|Hydrochlorothiazide|hydrochlorothiazide
62148|NCT03179163|Microcirculation|microcirculation
62149|NCT03179163|Skin|skin
62150|NCT03179150|computer-aided diagnosis|computer-aided diagnosis
62151|NCT03179150|Web|web
62152|NCT03179150|Cloud computing|cloud computing
62153|NCT03179150|lung cancer|lung cancer
62154|NCT03179124|cerebral palsy|cerebral palsy
62155|NCT03179124|trunk control|trunk control
62156|NCT03179124|upper extremity|upper extremity
62157|NCT03179098|Elbow|elbow
62158|NCT03179098|Stretching|stretching
62159|NCT03179098|Joint amplitude|joint amplitude
62160|NCT03179098|Electromyography|electromyography
62161|NCT03179098|Surface heat|surface heat
62162|NCT03179098|Orthosis|orthosis
62163|NCT03179098|Posttraumatic|posttraumatic
62164|NCT03179085|Diabetes|diabetes
62165|NCT03179085|American Indians|american indians
62166|NCT03179085|Disparity|disparity
62167|NCT03179085|microalbuminuria|microalbuminuria
62168|NCT03179085|Telemedicine|telemedicine
62169|NCT03179085|Community health representative (CHR)|community health representative (chr)
62170|NCT03179085|Patient Activation Measure (PAM)|patient activation measure (pam)
62171|NCT03179085|Home base kidney care|home base kidney care
62172|NCT03179059|Reproductive Health|reproductive health
62173|NCT03179059|Family Planning|family planning
62174|NCT03179059|Randomization Trial|randomization trial
62175|NCT03179059|Uganda|uganda
62176|NCT03179033|LVAD|lvad
62177|NCT03179033|Passive leg raising|passive leg raising
62178|NCT03179020|Intensive Care Units|intensive care units
62179|NCT03179020|Brain Death|brain death
62180|NCT03179020|Organ Donation|organ donation
62181|NCT03179020|Family interview|family interview
62182|NCT03179007|MUC1|muc1
62183|NCT03179007|CTLA-4|ctla-4
62184|NCT03179007|PD-1|pd-1
62185|NCT03179007|chimeric antigen receptor T cells|chimeric antigen receptor t cells
62187|NCT03178994|Post - adolescence acne|post - adolescence acne
62188|NCT03178994|Topical 2% ketoconazole cream|topical 2% ketoconazole cream
62189|NCT03178877|IBS, Rome IV criteria, anxiety|ibs, rome iv criteria, anxiety
62190|NCT03178864|cerebral venous thrombosis|cerebral venous thrombosis
62191|NCT03178864|anticoagulation|anticoagulation
62192|NCT03178799|Fractures|fractures
62193|NCT03178799|Osteoporosis|osteoporosis
62194|NCT03178799|Care management|care management
62195|NCT03178799|cost-effeciveness|cost-effeciveness
62880|NCT03174197|Gliosarcoma|gliosarcoma
62196|NCT03178799|Randomized controlled trial|randomized controlled trial
62197|NCT03178786|Art Therapy|art therapy
62198|NCT03178773|mobile health|mobile health
62199|NCT03178773|social support|social support
62200|NCT03178773|health disparity|health disparity
62201|NCT03178773|Latino|latino
62202|NCT03178760|Optic nerve sheath diameter|optic nerve sheath diameter
62203|NCT03178760|average optic nerve sheath diameter for healthy children|average optic nerve sheath diameter for healthy children
62204|NCT03178747|Methylene blue|methylene blue
62205|NCT03178747|Giemsa|giemsa
62206|NCT03178747|Tzanck smear|tzanck smear
62207|NCT03178695|Infertility|infertility
62208|NCT03178695|Pregnancy|pregnancy
62209|NCT03178695|Menopause|menopause
62210|NCT03178695|Perimenopause|perimenopause
62211|NCT03178695|Premature Ovarian Failure|premature ovarian failure
62212|NCT03178669|Colitis, Ulcerative|colitis, ulcerative
62213|NCT03178669|Gastrointestinal Diseases|gastrointestinal diseases
62214|NCT03178669|Inflammatory Bowel Disease|inflammatory bowel disease
62215|NCT03178669|Immunomodulator Therapy|immunomodulator therapy
62216|NCT03178669|Glucocorticoids|glucocorticoids
62217|NCT03178669|Anti-Inflammatory Agents|anti-inflammatory agents
62218|NCT03178669|Therapeutic uses|therapeutic uses
62219|NCT03178669|Kappaproct|kappaproct
62220|NCT03178669|IDX0150|idx0150
62221|NCT03178669|DIMS0150|dims0150
62222|NCT03178656|sorafenib, operation|sorafenib, operation
62223|NCT03178578|Fluid therapy|fluid therapy
62224|NCT03178565|Respiratory Failure|respiratory failure
62225|NCT03178565|Mechanical Ventilation|mechanical ventilation
62226|NCT03178565|Mechanical insufflation-exsufflation|mechanical insufflation-exsufflation
62227|NCT03178565|Airway mucus clearance|airway mucus clearance
62228|NCT03178539|tonsillectomy|tonsillectomy
62229|NCT03178539|post operative analgesia|post operative analgesia
62230|NCT03178539|diklofanic|diklofanic
62231|NCT03178539|ketorolac|ketorolac
62232|NCT03178500|clomiphene citrate|clomiphene citrate
62233|NCT03178500|stair- step|stair- step
62234|NCT03178500|poly cystic ovary|poly cystic ovary
62235|NCT03178487|Upadacitinib|upadacitinib
62236|NCT03178487|ABT-494|abt-494
62237|NCT03178487|Ankylosing Spondylitis (AS)|ankylosing spondylitis (as)
62238|NCT03178487|Safety|safety
62239|NCT03178487|Efficacy|efficacy
62240|NCT03178474|infant formula|infant formula
62241|NCT03178474|Clinical trial|clinical trial
62242|NCT03178474|Chinese infant|chinese infant
62243|NCT03178474|body growth|body growth
62244|NCT03178474|gut microbiota|gut microbiota
62245|NCT03178474|Stool characteristics|stool characteristics
62246|NCT03178461|Caesarean Section|caesarean section
62247|NCT03178461|Delivery|delivery
62248|NCT03178435|risk score|risk score
62249|NCT03178435|Acute kidney injury|acute kidney injury
62250|NCT03178435|critical care|critical care
62251|NCT03178422|tobacco use cessation|tobacco use cessation
62252|NCT03178422|smoking prevention|smoking prevention
62253|NCT03178422|NRT|nrt
62254|NCT03178370|Gastroparesis|gastroparesis
62255|NCT03178370|Nausea and Vomiting|nausea and vomiting
62256|NCT03178370|Abdominal Pain|abdominal pain
62257|NCT03178370|Gastric Emptying|gastric emptying
62258|NCT03178370|Electrophysiology|electrophysiology
62259|NCT03178370|Hormones|hormones
62260|NCT03178370|Inflammation|inflammation
62261|NCT03178370|Enteric Nervous System|enteric nervous system
62262|NCT03178370|Autonomic Nervous System|autonomic nervous system
62263|NCT03178331|Children|children
62264|NCT03178331|Student|student
62265|NCT03178331|Questionnaires|questionnaires
62266|NCT03178331|Screening|screening
62267|NCT03178331|Health check|health check
62268|NCT03178331|School health services|school health services
62269|NCT03178279|physical health|physical health
62270|NCT03178201|Relapsed follicular lymphoma|relapsed follicular lymphoma
62271|NCT03178201|Refractory follicular lymphoma|refractory follicular lymphoma
62272|NCT03178188|lupus erythematosus, Discoid|lupus erythematosus, discoid
62273|NCT03178188|Pulsed-dye Laser|pulsed-dye laser
62274|NCT03178175|Scalp acupuncture|scalp acupuncture
62275|NCT03178175|Parkinson's disease|parkinson's disease
62276|NCT03178175|Balance|balance
62277|NCT03178162|limitation in conventional monitoring|limitation in conventional monitoring
62278|NCT03178149|Age-related Macular Degeneration|age-related macular degeneration
62279|NCT03178149|ASP7317|asp7317
62280|NCT03178136|HR-HPV opportunistic screening|hr-hpv opportunistic screening
62281|NCT03178136|virus load|virus load
62282|NCT03178136|multi-site|multi-site
62283|NCT03178123|anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
62284|NCT03178123|Mucosal Melanoma|mucosal melanoma
62285|NCT03178123|Interferons|interferons
62286|NCT03178110|physical therapy|physical therapy
62287|NCT03178110|cancer rehabilitation|cancer rehabilitation
62288|NCT03178097|limitation in conventional monitoring|limitation in conventional monitoring
62289|NCT03178084|HIV|hiv
62290|NCT03178084|CD4/CD8 ratio|cd4/cd8 ratio
62291|NCT03178084|immune recovery|immune recovery
62292|NCT03178084|maraviroc|maraviroc
62293|NCT03178084|efavirenz|efavirenz
62294|NCT03178071|NSCLC|nsclc
63179|NCT03172130|CPAP|cpap
62295|NCT03178032|Diffuse intrinsic pontine gliomas|diffuse intrinsic pontine gliomas
62296|NCT03178032|Oncolytic adenovirus|oncolytic adenovirus
62297|NCT03177980|Term infants|term infants
62298|NCT03177980|Analgesia|analgesia
62299|NCT03177980|fentanyl|fentanyl
62300|NCT03177980|clonidine|clonidine
62301|NCT03177980|pharmacokinetics|pharmacokinetics
62302|NCT03177980|sedation|sedation
62303|NCT03177980|pharmacodynamics|pharmacodynamics
62304|NCT03177980|neurophysiology|neurophysiology
62305|NCT03177980|pharmacogenetics|pharmacogenetics
62306|NCT03177980|asphyxia|asphyxia
62307|NCT03177980|hypothermia|hypothermia
62308|NCT03177967|Insomnia|insomnia
62309|NCT03177967|Cognitive behavioral treatment for insomnia (CBT-I)|cognitive behavioral treatment for insomnia (cbt-i)
62310|NCT03177941|Melanoma|melanoma
62311|NCT03177941|Skin Self-Examination|skin self-examination
62312|NCT03177941|First-degree Relative|first-degree relative
62313|NCT03177941|Mobile Application|mobile application
62314|NCT03177876|tenting Hydroxyapetite nano particles implant immediate|tenting hydroxyapetite nano particles implant immediate
62315|NCT03177863|neoplasm|neoplasm
62316|NCT03177863|uterine cervix|uterine cervix
62317|NCT03177850|sleep related breathing disturbances|sleep related breathing disturbances
62318|NCT03177850|respiratory polygraphy|respiratory polygraphy
62319|NCT03177850|airway disease|airway disease
62320|NCT03177850|emphysema|emphysema
62321|NCT03177850|acetazolamide|acetazolamide
62322|NCT03177850|altitude|altitude
62323|NCT03177850|nocturnal pulse oxymetry|nocturnal pulse oxymetry
62324|NCT03177837|exercise performance|exercise performance
62325|NCT03177837|maximal spiroergometry|maximal spiroergometry
62326|NCT03177837|airway disease|airway disease
62327|NCT03177837|emphysema|emphysema
62328|NCT03177837|prevention|prevention
62329|NCT03177837|acetazolamide|acetazolamide
62330|NCT03177837|altitude|altitude
62331|NCT03177811|postural control|postural control
62332|NCT03177811|balance performance|balance performance
62333|NCT03177811|airway disease|airway disease
62334|NCT03177811|altitude|altitude
62335|NCT03177811|prevention|prevention
62336|NCT03177811|acetazolamide|acetazolamide
62337|NCT03177772|caregivers|caregivers
62338|NCT03177772|grief|grief
62339|NCT03177772|dementia|dementia
62340|NCT03177772|long-term care|long-term care
62341|NCT03177772|psychotherapy group|psychotherapy group
62342|NCT03177733|breast surgery|breast surgery
62343|NCT03177733|acute pain|acute pain
62344|NCT03177733|regional anesthesia|regional anesthesia
62345|NCT03177694|cough|cough
62346|NCT03177694|exacerbation|exacerbation
62347|NCT03177694|connected device|connected device
62348|NCT03177681|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
62349|NCT03177681|Gastrointestinal symptoms|gastrointestinal symptoms
62350|NCT03177681|Probiotics|probiotics
62351|NCT03177681|Yogurt|yogurt
62352|NCT03177681|Stool sample|stool sample
62353|NCT03177681|Questionnaires|questionnaires
62354|NCT03177681|Surveys|surveys
62355|NCT03177681|Holter monitor|holter monitor
62356|NCT03177629|Immune Thrombocytopenic Purpura|immune thrombocytopenic purpura
62357|NCT03177629|Helicobacter pylori|helicobacter pylori
62358|NCT03177616|Migraine|migraine
62359|NCT03177616|Women|women
62360|NCT03177616|Adult|adult
62361|NCT03177616|Feasibility|feasibility
62362|NCT03177616|Safety|safety
62363|NCT03177616|Pilot Randomized Trial|pilot randomized trial
62364|NCT03177616|Randomized Control Trial|randomized control trial
62365|NCT03177616|Chiropractic|chiropractic
62366|NCT03177603|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
62367|NCT03177603|Dose-escalation|dose-escalation
62368|NCT03177603|Safety|safety
62369|NCT03177603|Tolerability|tolerability
62370|NCT03177603|GSK2586881|gsk2586881
62371|NCT03177590|autism|autism
62372|NCT03177590|Pervasive Developmental Disorder|pervasive developmental disorder
62373|NCT03177564|driving pressure|driving pressure
62374|NCT03177564|one-lung ventilation|one-lung ventilation
62375|NCT03177551|Prostatic Neoplasms|prostatic neoplasms
62376|NCT03177551|Nomograms|nomograms
62377|NCT03177551|Drug Resistance, Neoplasm|drug resistance, neoplasm
62378|NCT03177538|suboptimal response|suboptimal response
62379|NCT03177538|Corifollitropin alfa|corifollitropin alfa
62380|NCT03177538|IVF|ivf
62381|NCT03177538|Ovarian stimulation|ovarian stimulation
62382|NCT03177525|parent training|parent training
62383|NCT03177525|social skills|social skills
62384|NCT03177512|PrEP|prep
62385|NCT03177512|HIV Testing|hiv testing
62386|NCT03177512|STI Testing|sti testing
62387|NCT03177512|Mobile app|mobile app
62388|NCT03177512|Technology|technology
62389|NCT03177512|Young men who have sex with men|young men who have sex with men
62390|NCT03177499|Portal pressure gradient|portal pressure gradient
62391|NCT03177499|Transjugular intrahepatic portosystemic shunt|transjugular intrahepatic portosystemic shunt
62392|NCT03177499|Virtual imaging-based portal pressure gradient|virtual imaging-based portal pressure gradient
62393|NCT03177486|Syntax score|syntax score
62394|NCT03177486|Frank sign|frank sign
62395|NCT03177486|Coronary angiography|coronary angiography
62396|NCT03177473|degenerative disc disease|degenerative disc disease
62397|NCT03177473|CervicalStim devic|cervicalstim devic
62398|NCT03177473|cervical|cervical
62399|NCT03177473|cervical fusion|cervical fusion
62400|NCT03177460|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
62401|NCT03177460|Prostate Cancer|prostate cancer
62402|NCT03177460|Adenocarcinoma of the Prostate|adenocarcinoma of the prostate
62403|NCT03177460|High-risk|high-risk
62404|NCT03177460|Localized|localized
62405|NCT03177460|Daratumumab|daratumumab
62406|NCT03177460|Prostatectomy|prostatectomy
62407|NCT03177447|Cardiac Failure|cardiac failure
62408|NCT03177447|Congestive Heart Failure|congestive heart failure
62409|NCT03177447|Heart Decompensation|heart decompensation
62410|NCT03177447|Heart Failure, Congestive|heart failure, congestive
62411|NCT03177434|constipation|constipation
62412|NCT03177434|children|children
62413|NCT03177434|polyethylene glycols (PEG)|polyethylene glycols (peg)
62414|NCT03177434|lactulose|lactulose
62415|NCT03177408|Diastolic Dysfunction|diastolic dysfunction
62416|NCT03177408|Hypertension|hypertension
62417|NCT03177408|HMGB1|hmgb1
62418|NCT03177382|Total Neoadjuvant Treatment|total neoadjuvant treatment
62419|NCT03177382|Rectal Cancer|rectal cancer
62420|NCT03177382|High Risk Factors|high risk factors
62421|NCT03177382|Chemoradiotherapy|chemoradiotherapy
62422|NCT03177369|Bone and joint infection|bone and joint infection
62423|NCT03177369|Staphylococcus aureus|staphylococcus aureus
62424|NCT03177369|Teicoplanin|teicoplanin
62425|NCT03177369|Subcutaneous administration|subcutaneous administration
62426|NCT03177356|Platelet rich fibrin,xenograft|platelet rich fibrin,xenograft
62427|NCT03177343|Pristinamycin|pristinamycin
62428|NCT03177343|Staphylococcus aureus|staphylococcus aureus
62429|NCT03177343|Bone and joint infection|bone and joint infection
62430|NCT03177304|Interpersonal Psychotherapy|interpersonal psychotherapy
62431|NCT03177304|Internet|internet
62432|NCT03177304|Training|training
62433|NCT03177304|Depression|depression
62434|NCT03177304|Dissemination|dissemination
62435|NCT03177291|NSCLC|nsclc
62436|NCT03177291|SCLC|sclc
62437|NCT03177265|nicotine dependence|nicotine dependence
62438|NCT03177265|tobacco cessation|tobacco cessation
62439|NCT03177174|locally advanced nasopharyngeal carcinoma|locally advanced nasopharyngeal carcinoma
62440|NCT03177174|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
62441|NCT03177174|Toxic reaction|toxic reaction
62442|NCT03177161|PROM|prom
62443|NCT03177161|Patient Reported Outcome Measure|patient reported outcome measure
62444|NCT03177161|PROMIS|promis
62445|NCT03177161|PROMIS-10|promis-10
62446|NCT03177161|PROMIS Global Health|promis global health
62447|NCT03177161|RiksStroke|riksstroke
62448|NCT03177161|ICHOM|ichom
62449|NCT03177161|International Consortium for Health Outcomes Measurement|international consortium for health outcomes measurement
62450|NCT03177161|Wales|wales
62451|NCT03177161|Administration|administration
62452|NCT03177161|Method|method
62453|NCT03177161|Delivery|delivery
62454|NCT03177122|Polycystic Ovary Syndrome|polycystic ovary syndrome
62455|NCT03177122|Myo-Inositol|myo-inositol
62456|NCT03177122|Assisted Reproductive Technology|assisted reproductive technology
62457|NCT03177122|oocyte performance|oocyte performance
62458|NCT03177122|pregnancy|pregnancy
62459|NCT03177109|Dentine Hypersensitivity|dentine hypersensitivity
62460|NCT03177109|Fluoride varnish|fluoride varnish
62461|NCT03177109|Desensitizing agents|desensitizing agents
62462|NCT03177096|Type 1 diabetes children,School,Childcare facilities,Sensor|type 1 diabetes children,school,childcare facilities,sensor
62463|NCT03177070|Ureteric injury|ureteric injury
62464|NCT03177070|Colorectal Surgery|colorectal surgery
62465|NCT03177044|Inflammatory bowel disease, pelvic floor exercise|inflammatory bowel disease, pelvic floor exercise
62466|NCT03176992|ablation|ablation
62467|NCT03176992|surgicel|surgicel
62468|NCT03176953|PTSD|ptsd
62469|NCT03176953|alcohol use disorder|alcohol use disorder
62470|NCT03176953|Veterans|veterans
62471|NCT03176940|Escalating Dosage|escalating dosage
62472|NCT03176927|magnetogastrogram|magnetogastrogram
62473|NCT03176927|gastroparesis|gastroparesis
62474|NCT03176927|electrogastrogram|electrogastrogram
62475|NCT03176927|gastric slow wave|gastric slow wave
62476|NCT03176914|Community mobilisation|community mobilisation
62477|NCT03176901|urinary urge incontinence|urinary urge incontinence
62478|NCT03176901|urinary incontinence|urinary incontinence
62479|NCT03176901|older adult women|older adult women
62480|NCT03176901|older adults|older adults
62481|NCT03176901|mindfulness-based stress reduction|mindfulness-based stress reduction
62482|NCT03176901|health enhancement program|health enhancement program
62483|NCT03176901|feasibility|feasibility
62484|NCT03176901|randomized controlled trial|randomized controlled trial
62485|NCT03176901|complementary|complementary
62486|NCT03176901|integrative|integrative
62487|NCT03176901|therapies|therapies
62488|NCT03176888|Exercise|exercise
62489|NCT03176888|Aerobic capacity|aerobic capacity
62490|NCT03176888|Rehabilitation|rehabilitation
62491|NCT03176810|percutaneous coronary intervention|percutaneous coronary intervention
62492|NCT03176810|optical coherence tomography|optical coherence tomography
62493|NCT03176797|Liver Fibrosis, multiparametric magnetic resonance imaging|liver fibrosis, multiparametric magnetic resonance imaging
62494|NCT03176784|Varenicline|varenicline
62495|NCT03176784|Nicotine Patch|nicotine patch
62496|NCT03176784|Quit Smoking|quit smoking
62497|NCT03176784|Tobacco|tobacco
62498|NCT03176784|Cigarettes|cigarettes
62499|NCT03176732|Sleep Apnea|sleep apnea
62500|NCT03176732|Hypertension|hypertension
62501|NCT03176732|Positive Airway Pressure|positive airway pressure
62502|NCT03176732|Blood Pressure|blood pressure
62503|NCT03176680|Anesthesia,Esophagectomy,Esophageal cancer,Treatment outcome|anesthesia,esophagectomy,esophageal cancer,treatment outcome
62504|NCT03176667|regional, erector spinae block, lobectomy, video-assisted|regional, erector spinae block, lobectomy, video-assisted
62505|NCT03176641|Platelet-Rich Plasma|platelet-rich plasma
62506|NCT03176641|Meniscus|meniscus
62507|NCT03176641|Knee Injuries|knee injuries
62508|NCT03176628|Pharmacokinetics|pharmacokinetics
62509|NCT03176628|Pharmacodynamics|pharmacodynamics
62510|NCT03176615|Gastric Bypass|gastric bypass
62511|NCT03176602|Subjective Global Assessment|subjective global assessment
62512|NCT03176602|Nutrition Risk in Critically ill Score|nutrition risk in critically ill score
62513|NCT03176602|Critical Illness|critical illness
62514|NCT03176589|positive expiratory pressure|positive expiratory pressure
62515|NCT03176589|oxygen saturation|oxygen saturation
62516|NCT03176589|abdominal surgery|abdominal surgery
62517|NCT03176589|carbon dioxide|carbon dioxide
62518|NCT03176576|cancer among adolescents|cancer among adolescents
62519|NCT03176576|cancer among young adults|cancer among young adults
62520|NCT03176576|adolescents and young adults (AYA)|adolescents and young adults (aya)
62521|NCT03176576|quality of life|quality of life
62522|NCT03176576|reduce stress|reduce stress
62523|NCT03176576|patient navigation|patient navigation
62524|NCT03176576|questionnaire|questionnaire
62525|NCT03176576|supportive care|supportive care
62526|NCT03176576|distress levels|distress levels
62527|NCT03176576|support resources|support resources
62528|NCT03176576|satisfaction survey|satisfaction survey
62529|NCT03176576|teen cancer|teen cancer
62530|NCT03176563|herbal treatment|herbal treatment
62531|NCT03176563|antibiotics|antibiotics
62532|NCT03176563|uncomplicated urinary tract infection|uncomplicated urinary tract infection
62533|NCT03176511|older adults|older adults
62534|NCT03176511|dual task|dual task
62535|NCT03176511|A Matter of Balance|a matter of balance
62536|NCT03176498|cerebral Infarction|cerebral infarction
62537|NCT03176498|umbilical cord mesenchymal stem cells|umbilical cord mesenchymal stem cells
62538|NCT03176485|metastatic|metastatic
62539|NCT03176485|melanoma|melanoma
62540|NCT03176485|cancer|cancer
62541|NCT03176485|colon|colon
62542|NCT03176485|thyroid|thyroid
62543|NCT03176485|Differentiated|differentiated
62544|NCT03176485|Hepatocellular Carcinoma|hepatocellular carcinoma
62545|NCT03176485|HCC|hcc
62546|NCT03176485|RCC|rcc
62547|NCT03176485|Renal Cell Carcinoma|renal cell carcinoma
62548|NCT03176472|Diabetic Neuropathic Pain|diabetic neuropathic pain
62549|NCT03176472|Neuropathic Pain|neuropathic pain
62550|NCT03176472|HDAC6|hdac6
62551|NCT03176472|ricolinostat|ricolinostat
62552|NCT03176459|bupvacaine|bupvacaine
62553|NCT03176459|exparel|exparel
62554|NCT03176459|analgesic|analgesic
62555|NCT03176459|TAP Block|tap block
62556|NCT03176407|sensor capsule|sensor capsule
62557|NCT03176394|Foley, UTI, Biofilm, DNA|foley, uti, biofilm, dna
62558|NCT03176381|Prostatic Neoplasms|prostatic neoplasms
62559|NCT03176381|Abiraterone Acetate|abiraterone acetate
62560|NCT03176381|FK506 binding protein 5|fk506 binding protein 5
62561|NCT03176381|Neurotensin|neurotensin
62562|NCT03176381|yes-associated protein 1|yes-associated protein 1
62563|NCT03176381|AKR1C3 protein|akr1c3 protein
62564|NCT03176381|Proliferating Cell Nuclear Antigen|proliferating cell nuclear antigen
62565|NCT03176368|dry mouth|dry mouth
62566|NCT03176368|coconut oil|coconut oil
62567|NCT03176368|radiation|radiation
62568|NCT03176342|Drug patch tests|drug patch tests
62569|NCT03176329|Full closed-loop ventilation control|full closed-loop ventilation control
62570|NCT03176329|Critical care|critical care
62571|NCT03176316|ileus|ileus
62572|NCT03176316|fusion of spine|fusion of spine
62573|NCT03176277|Leukemia|leukemia
62574|NCT03176277|Leukemia, Myeloid|leukemia, myeloid
62575|NCT03176277|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
62576|NCT03176277|MER|mer
62577|NCT03176277|MERTK|mertk
62578|NCT03176277|TYRO3|tyro3
62579|NCT03176277|AXL|axl
62580|NCT03176277|AML|aml
62581|NCT03176277|de novo AML|de novo aml
62582|NCT03176277|Relapsed/ Refractory AML|relapsed/ refractory aml
62583|NCT03176277|TAM|tam
62584|NCT03176264|PDR001|pdr001
62585|NCT03176264|immunotherapy|immunotherapy
62586|NCT03176264|bevacizumab|bevacizumab
62587|NCT03176264|mFOLFOX6|mfolfox6
62588|NCT03176264|CRC|crc
62589|NCT03176264|MMS|mms
62590|NCT03176264|CMS4|cms4
62591|NCT03176264|ElevatION;CRC-101|elevation;crc-101
62592|NCT03176238|post menopausal|post menopausal
62593|NCT03176238|advanced breast cancer|advanced breast cancer
62594|NCT03176238|metastatic breast cancer|metastatic breast cancer
62595|NCT03176238|everolimus|everolimus
62596|NCT03176238|exemestane|exemestane
62597|NCT03176238|mTor inhibitor|mtor inhibitor
62598|NCT03176238|endocrine therapy|endocrine therapy
62599|NCT03176212|Gut permeability|gut permeability
62600|NCT03176212|Cytokine|cytokine
62601|NCT03176212|Endotoxin|endotoxin
62602|NCT03176199|control-released oxycodone|control-released oxycodone
62603|NCT03176199|immediate-released oxycodone|immediate-released oxycodone
62604|NCT03176199|cancer pain|cancer pain
62605|NCT03176199|opioid-naive|opioid-naive
62606|NCT03176186|ischemic-reperfusion injury|ischemic-reperfusion injury
62607|NCT03176186|out of hospital cardiac arrest|out of hospital cardiac arrest
62608|NCT03176160|LITT|litt
62609|NCT03176160|Fecci|fecci
62610|NCT03176160|Pro00079623|pro00079623
62611|NCT03176160|Glioblastoma|glioblastoma
62612|NCT03176160|Laser Interstitial Thermal Therapy|laser interstitial thermal therapy
62613|NCT03176160|Palliative|palliative
62614|NCT03176147|Anemia|anemia
62615|NCT03176147|Pregnancy|pregnancy
62616|NCT03176147|Hepcidine|hepcidine
62617|NCT03176147|Iron|iron
62618|NCT03176121|Oxycodone|oxycodone
62619|NCT03176121|Cancer Pain|cancer pain
62620|NCT03176121|Long-term use|long-term use
62621|NCT03176082|colorectal cancer screening|colorectal cancer screening
62622|NCT03176082|colorectal cancer|colorectal cancer
62623|NCT03176069|Vaginismus|vaginismus
62624|NCT03176069|Muscle Tone|muscle tone
62625|NCT03176069|Sexual dysfunctions|sexual dysfunctions
62626|NCT03176056|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
62627|NCT03176056|Low carbohydrate diet|low carbohydrate diet
62628|NCT03176017|Transurethral Incision Of The Prostate|transurethral incision of the prostate
62629|NCT03176017|Prostate|prostate
62630|NCT03176017|Holmium Laser|holmium laser
62631|NCT03176017|Ejaculatory Sparing|ejaculatory sparing
62632|NCT03175965|Heart arrest, hypothermia, SEP, prognosis|heart arrest, hypothermia, sep, prognosis
62633|NCT03175939|adjuvant chemotherapy|adjuvant chemotherapy
62634|NCT03175939|NPC|npc
62635|NCT03175926|Asthma|asthma
62636|NCT03175926|inhaler device|inhaler device
62637|NCT03175926|handling|handling
62638|NCT03175900|Migraine|migraine
62639|NCT03175900|Naoan dripping pills|naoan dripping pills
62640|NCT03175900|Traditional Chinese Medicine|traditional chinese medicine
62641|NCT03175900|fMRI|fmri
62642|NCT03175900|Randomized Controlled trial|randomized controlled trial
62643|NCT03175887|depression|depression
62644|NCT03175887|trd|trd
62645|NCT03175887|treatment-resistant depression|treatment-resistant depression
62646|NCT03175887|TMS|tms
62647|NCT03175874|Osteoporosis|osteoporosis
62648|NCT03175874|Alzheimer Disease|alzheimer disease
62649|NCT03175848|Cervical Cancer|cervical cancer
62650|NCT03175848|Radiotherapy|radiotherapy
62651|NCT03175848|Chemotherapy|chemotherapy
62652|NCT03175848|stage IVB cervical cancer|stage ivb cervical cancer
62653|NCT03175835|Dyslipidemia|dyslipidemia
62654|NCT03175835|CKD-519|ckd-519
62655|NCT03175835|Rosuvastatin|rosuvastatin
62656|NCT03175835|Drug-Drug Interaction|drug-drug interaction
62657|NCT03175809|Chronic pelvic pain|chronic pelvic pain
62658|NCT03175809|Pain|pain
62659|NCT03175809|Dry needling|dry needling
62660|NCT03175809|Biofeedback|biofeedback
62661|NCT03175809|Pelvic pain|pelvic pain
62662|NCT03175731|Esophageal and gastric varices|esophageal and gastric varices
62663|NCT03175731|Hemorrhage|hemorrhage
62664|NCT03175718|Sarcoma|sarcoma
62665|NCT03175718|Wound|wound
62666|NCT03175718|Therapy|therapy
62667|NCT03175627|Dental caries|dental caries
62668|NCT03175627|Proximal surfaces|proximal surfaces
62669|NCT03175627|Posterior teeth|posterior teeth
62670|NCT03175627|Carious lesions|carious lesions
62671|NCT03175627|Tooth diseases|tooth diseases
62672|NCT03175627|Dental restorations|dental restorations
62673|NCT03175627|Composite resin|composite resin
62674|NCT03175614|Physical activity|physical activity
62675|NCT03175614|Food Habits|food habits
62676|NCT03175614|Information and communiation Technology|information and communiation technology
62677|NCT03175614|Health education|health education
62678|NCT03175601|Sleep disturbances|sleep disturbances
62679|NCT03175601|Biomarkers|biomarkers
62680|NCT03175601|Prefrailty|prefrailty
62681|NCT03175601|Insulin resistance|insulin resistance
62682|NCT03175601|Olfactory impairment|olfactory impairment
62683|NCT03175601|Multiplex array|multiplex array
62684|NCT03175601|Gait speed|gait speed
62685|NCT03175536|high-deductible health plan|high-deductible health plan
62686|NCT03175536|medication adherence|medication adherence
62687|NCT03175536|out-of-pocket costs|out-of-pocket costs
62688|NCT03175536|preventive drug list|preventive drug list
62689|NCT03175536|value-based insurance design|value-based insurance design
62690|NCT03175523|BioResorbable Scaffold|bioresorbable scaffold
62691|NCT03175523|Quantitative Coronary Angiography|quantitative coronary angiography
62692|NCT03175523|Intravascular Imaging|intravascular imaging
62693|NCT03175510|validity, reliability, low back pain|validity, reliability, low back pain
62694|NCT03175497|Gastric Cancer, VEGFR inhibitor|gastric cancer, vegfr inhibitor
62695|NCT03175484|High Fidelity Simulation|high fidelity simulation
62696|NCT03175484|Cognitive Load|cognitive load
62697|NCT03175484|Simulation Training/methods*|simulation training/methods*
62698|NCT03175484|Task Performance and Analysis*|task performance and analysis*
62699|NCT03175484|Students, Medical|students, medical
62700|NCT03175484|Prospective Studies|prospective studies
62701|NCT03175458|tenting|tenting
62702|NCT03175458|grafting|grafting
62703|NCT03175458|implant placement|implant placement
62704|NCT03175432|Melanoma and other malignant neoplasms of skin|melanoma and other malignant neoplasms of skin
62705|NCT03175432|Untreated Melanoma Brain Metastases|untreated melanoma brain metastases
62706|NCT03175432|Bevacizumab|bevacizumab
62707|NCT03175432|rhuMA-VEGF|rhuma-vegf
62708|NCT03175432|Avastin|avastin
62709|NCT03175432|ANTI-VEGF monoclonal antibody|anti-vegf monoclonal antibody
62710|NCT03175432|Atezolizumab|atezolizumab
62711|NCT03175432|MPDL3280A|mpdl3280a
62712|NCT03175432|Questionnaires|questionnaires
62713|NCT03175432|Surveys|surveys
62714|NCT03175432|Neurocognitive Exam|neurocognitive exam
62715|NCT03175419|laparoscopic liver resection|laparoscopic liver resection
62716|NCT03175341|breast cancer|breast cancer
62717|NCT03175341|ascorbic acid|ascorbic acid
62718|NCT03175341|vitamin C|vitamin c
62719|NCT03175341|vitamin supplementation|vitamin supplementation
62720|NCT03175341|quality of life|quality of life
62721|NCT03175315|psychoeducation|psychoeducation
62722|NCT03175315|treatment and education programme|treatment and education programme
62723|NCT03175315|self-management|self-management
62724|NCT03175315|diabetes education|diabetes education
62725|NCT03175315|flash glucose monitoring|flash glucose monitoring
62726|NCT03175302|cognitive processes|cognitive processes
62727|NCT03175302|perioperative cognition|perioperative cognition
62728|NCT03175302|neurocognitive impairment|neurocognitive impairment
62729|NCT03175276|Delirium|delirium
62730|NCT03175276|Cognitive decline|cognitive decline
62731|NCT03175276|IQCODE|iqcode
62732|NCT03175263|onabotulinumtoxinA, chronic migraine, myofascial pain|onabotulinumtoxina, chronic migraine, myofascial pain
62733|NCT03175224|Advanced Solid Tumor|advanced solid tumor
62734|NCT03175224|Relapsed Solid Tumor|relapsed solid tumor
62735|NCT03175224|Recurrent Solid Tumor|recurrent solid tumor
62736|NCT03175159|Risk Reduction|risk reduction
62737|NCT03175159|Crystal Methamphetamine|crystal methamphetamine
62738|NCT03175159|Cocaine|cocaine
62739|NCT03175159|Stimulant Abuse|stimulant abuse
62740|NCT03175159|HIV|hiv
62741|NCT03175159|Behavioral Activation|behavioral activation
62742|NCT03175133|rehabilitation|rehabilitation
62743|NCT03175133|physical therapy|physical therapy
62744|NCT03175107|exergaming|exergaming
62745|NCT03175107|physiotherapy|physiotherapy
62746|NCT03175107|upper extremities|upper extremities
62747|NCT03175107|telerehabilitation|telerehabilitation
62748|NCT03175094|women|women
62749|NCT03175094|HIV prevention|hiv prevention
62750|NCT03175094|criminal justice|criminal justice
62751|NCT03175081|Intraperitoneal local anesthetic|intraperitoneal local anesthetic
62752|NCT03175081|Ropivacaine|ropivacaine
62753|NCT03175081|Postoperative pain|postoperative pain
62754|NCT03175081|Bariatric surgery|bariatric surgery
62755|NCT03175068|Functional magnetic resonance imaging|functional magnetic resonance imaging
62756|NCT03175068|Electroencephalography|electroencephalography
62757|NCT03175068|Cognitive Behavioral Therapy|cognitive behavioral therapy
62758|NCT03175068|Supportive Therapy|supportive therapy
62759|NCT03175029|Lower Urinary Tract Symptoms|lower urinary tract symptoms
62760|NCT03174990|aspirin|aspirin
62761|NCT03174990|clopidogrel|clopidogrel
62762|NCT03174990|peripheral arterial disease|peripheral arterial disease
62763|NCT03174990|genetics|genetics
62764|NCT03174964|Recurrent Implantation Failure|recurrent implantation failure
62765|NCT03174964|IVIg|ivig
62766|NCT03174964|Pregnancy Rate|pregnancy rate
62767|NCT03174951|Recurrent Pregnancy Loss|recurrent pregnancy loss
62768|NCT03174951|IVIg|ivig
62769|NCT03174951|Pregnancy Rate|pregnancy rate
62770|NCT03174938|Early diagnosis, biomarker, PET, MRI, β-amyloid, tau, CSF, cognitive test|early diagnosis, biomarker, pet, mri, β-amyloid, tau, csf, cognitive test
62771|NCT03174912|EORTC|eortc
62772|NCT03174912|CUETO|cueto
62773|NCT03174912|bladder neoplasm|bladder neoplasm
62774|NCT03174912|disease progression|disease progression
62775|NCT03174912|recurrence|recurrence
62776|NCT03174886|tau|tau
62777|NCT03174886|neurofibrillary|neurofibrillary
62778|NCT03174886|degeneration|degeneration
62779|NCT03174886|primary progressive aphasia|primary progressive aphasia
62780|NCT03174886|agrammatic|agrammatic
62781|NCT03174886|tauopathy|tauopathy
62782|NCT03174886|immunotherapy|immunotherapy
62783|NCT03174886|immunization|immunization
62784|NCT03174860|Pulpitis, irreversible Pulpitis, Hot tooth|pulpitis, irreversible pulpitis, hot tooth
62785|NCT03174860|Cataflam, Diclofenac Potassium, Preoperative, Premedication, Analgesic|cataflam, diclofenac potassium, preoperative, premedication, analgesic
62786|NCT03174860|Local anesthesia, Articaine, Buccal infiltration|local anesthesia, articaine, buccal infiltration
62787|NCT03174847|Primary aldosteronism|primary aldosteronism
62788|NCT03174847|Blood pressure|blood pressure
62789|NCT03174847|Adrenalectomy|adrenalectomy
62790|NCT03174847|Mineralocorticoid-receptor Antagonists|mineralocorticoid-receptor antagonists
62791|NCT03174847|Cardiovascular|cardiovascular
62792|NCT03174847|Endothelial|endothelial
62793|NCT03174847|Renal|renal
62794|NCT03174834|Bladder Stimulation Technique|bladder stimulation technique
62795|NCT03174834|Clean Catch Urine|clean catch urine
62796|NCT03174834|UTI in infants less than 6 months|uti in infants less than 6 months
62797|NCT03174821|Diabetic nephropathy|diabetic nephropathy
62798|NCT03174821|Insulin pump intensive therapy|insulin pump intensive therapy
62799|NCT03174808|cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
62800|NCT03174756|Hypochlorous Acid|hypochlorous acid
62801|NCT03174756|Chlorhexidine|chlorhexidine
62802|NCT03174756|Antiplaque agents|antiplaque agents
62803|NCT03174756|Substantivity|substantivity
62804|NCT03174730|smoking|smoking
62805|NCT03174730|smartphone|smartphone
62806|NCT03174730|technology|technology
62807|NCT03174730|addiction|addiction
62808|NCT03174678|Dexmedetomidine|dexmedetomidine
62809|NCT03174678|child|child
62810|NCT03174678|premedication|premedication
62811|NCT03174678|emergence delirium|emergence delirium
62812|NCT03174678|dental treatment|dental treatment
62813|NCT03174626|caregiver|caregiver
62814|NCT03174626|stress management|stress management
62815|NCT03174600|Stroke|stroke
62816|NCT03174600|Lower urinary tract dysfunction|lower urinary tract dysfunction
62817|NCT03174600|Functional status|functional status
62818|NCT03174600|Mini mental test|mini mental test
62819|NCT03174587|Systemic lupus erythematosus|systemic lupus erythematosus
62820|NCT03174587|HLA-haplo-matching|hla-haplo-matching
62821|NCT03174587|allogenic bone marrow derived mesenchymal stem cell|allogenic bone marrow derived mesenchymal stem cell
62822|NCT03174587|Phase 1 clinical trial|phase 1 clinical trial
62823|NCT03174535|Ischemic Stroke|ischemic stroke
62824|NCT03174535|Secondary Prevention|secondary prevention
62825|NCT03174535|Endpoint Events|endpoint events
62826|NCT03174535|Risk Assessment|risk assessment
62827|NCT03174535|Traditional Chinese Medicine|traditional chinese medicine
62828|NCT03174535|Registry Study|registry study
62829|NCT03174522|Autologous|autologous
62830|NCT03174522|Bone Marrow-derived Mononuclear Cells (BM-MNCs)|bone marrow-derived mononuclear cells (bm-mncs)
62831|NCT03174522|Advanced Therapy Medicinal Product (ATMP)|advanced therapy medicinal product (atmp)
62832|NCT03174522|Tissue-engineered Medicinal Product|tissue-engineered medicinal product
62833|NCT03174522|Revascularization|revascularization
62834|NCT03174522|Angiogenesis|angiogenesis
62835|NCT03174522|Vasculogenesis|vasculogenesis
62836|NCT03174522|Arteriogenesis|arteriogenesis
62837|NCT03174509|airway extubation|airway extubation
62838|NCT03174509|positive-pressure respiration|positive-pressure respiration
62839|NCT03174509|suction|suction
62840|NCT03174509|ventilator weaning|ventilator weaning
62841|NCT03174457|Oesophageal Candidiasis|oesophageal candidiasis
62842|NCT03174457|Paediatric|paediatric
62843|NCT03174457|Invasive Candidiasis|invasive candidiasis
62844|NCT03174457|Prophylaxis of Candida Infections|prophylaxis of candida infections
62845|NCT03174457|Candidemia|candidemia
62846|NCT03174457|Aspergillosis|aspergillosis
62847|NCT03174457|Micafungin|micafungin
62848|NCT03174444|Chinese American|chinese american
62849|NCT03174444|Asian American|asian american
62850|NCT03174444|Colorectal cancer screening|colorectal cancer screening
62851|NCT03174444|Print materials|print materials
62852|NCT03174418|Optical coherence tomography|optical coherence tomography
62853|NCT03174418|Percutaneous coronary interventions|percutaneous coronary interventions
62854|NCT03174418|Coronary atherosclerosis in bifurcations|coronary atherosclerosis in bifurcations
62855|NCT03174392|Exercise|exercise
62856|NCT03174392|Multimodal|multimodal
62857|NCT03174392|Balance|balance
62858|NCT03174392|Resistance|resistance
62859|NCT03174392|Mobility|mobility
62860|NCT03174314|Visual Impairment|visual impairment
62861|NCT03174275|squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
62862|NCT03174275|durvalumab|durvalumab
62863|NCT03174275|neoadjuvant induction|neoadjuvant induction
62864|NCT03174275|post-operative treatment|post-operative treatment
62865|NCT03174262|Ergonomics|ergonomics
62866|NCT03174262|Computer Workstation|computer workstation
62867|NCT03174262|Habit|habit
62868|NCT03174262|Self-efficacy|self-efficacy
62869|NCT03174262|Knowledge|knowledge
62870|NCT03174249|Behavioural therapy|behavioural therapy
62871|NCT03174249|Exposure in vivo|exposure in vivo
62872|NCT03174249|Cortical reorganisation|cortical reorganisation
62873|NCT03174249|Mirror therapy|mirror therapy
62874|NCT03174210|COPD|copd
62875|NCT03174210|supplemental oxygen|supplemental oxygen
62876|NCT03174210|oxygen concentrator|oxygen concentrator
62877|NCT03174197|Malignant neoplasms of eye brain and other parts of central nervous system|malignant neoplasms of eye brain and other parts of central nervous system
62878|NCT03174197|Glioblastoma (GBM)|glioblastoma (gbm)
62881|NCT03174197|Temozolomide|temozolomide
62882|NCT03174197|Temodar|temodar
62883|NCT03174197|TMZ|tmz
62884|NCT03174197|Atezolizumab|atezolizumab
62885|NCT03174197|MPDL3280A|mpdl3280a
62886|NCT03174197|Radiation therapy|radiation therapy
62887|NCT03174197|External beam|external beam
62888|NCT03174197|XRT|xrt
62889|NCT03174171|Everolimus, mTor inhibitor|everolimus, mtor inhibitor
62890|NCT03174158|text messaging|text messaging
62891|NCT03174093|Mobile Health|mobile health
62892|NCT03174080|Positron-Emission|positron-emission
62893|NCT03174080|PET Scan Tomography|pet scan tomography
62894|NCT03174067|buprenorphine|buprenorphine
62895|NCT03174067|emergency department|emergency department
62896|NCT03174054|Men aged 40 and over|men aged 40 and over
62897|NCT03174054|multi parametric MRI|multi parametric mri
62898|NCT03174015|Sanitation|sanitation
62899|NCT03174015|Demand|demand
62900|NCT03174015|Peri-urban|peri-urban
62901|NCT03174015|Behavior Change|behavior change
62902|NCT03174015|Lusaka|lusaka
62903|NCT03174015|Zambia|zambia
62904|NCT03174002|Oxygenation|oxygenation
62905|NCT03174002|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
62906|NCT03174002|Mechanical ventilation|mechanical ventilation
62907|NCT03174002|Critical illness|critical illness
62908|NCT03174002|Critical care|critical care
62909|NCT03173989|osteoarthritis|osteoarthritis
62910|NCT03173989|hand deformities|hand deformities
62911|NCT03173989|hand strength|hand strength
62912|NCT03173989|assistive technology|assistive technology
62913|NCT03173989|exercise|exercise
62914|NCT03173989|health education|health education
62915|NCT03173963|Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitor|sodium glucose co-transporter 2 (sglt2) inhibitor
62916|NCT03173963|Kidney Biopsy|kidney biopsy
62917|NCT03173963|Morphometry|morphometry
62918|NCT03173963|American Indians|american indians
62919|NCT03173963|Glomerular Filtration Rate|glomerular filtration rate
62920|NCT03173950|Immunotherapy|immunotherapy
62921|NCT03173950|Anti-PD-1 Antibody|anti-pd-1 antibody
62922|NCT03173950|Brain Tumors|brain tumors
62923|NCT03173950|MDASI-BT|mdasi-bt
62924|NCT03173950|Spinal Cord Tumors|spinal cord tumors
62925|NCT03173937|Haploidentical|haploidentical
62926|NCT03173937|Nonmyeloablative|nonmyeloablative
62927|NCT03173924|Small Molecule|small molecule
62928|NCT03173924|Radiolabeled|radiolabeled
62929|NCT03173924|PSA|psa
62930|NCT03173924|Diagnostic|diagnostic
62931|NCT03173924|PMSA|pmsa
62932|NCT03173911|Balance|balance
62933|NCT03173911|Postural control|postural control
62934|NCT03173911|Elastic Bandages|elastic bandages
62935|NCT03173911|Force plate|force plate
62936|NCT03173898|PDL Injection; Infiltration; Anesthesia; Extraction|pdl injection; infiltration; anesthesia; extraction
62937|NCT03173872|Reiki|reiki
62938|NCT03173872|Chronic Pain|chronic pain
62939|NCT03173872|Military|military
62940|NCT03173859|prostate cancer, abiraterone, apalutamide|prostate cancer, abiraterone, apalutamide
62941|NCT03173846|neurofeedback|neurofeedback
62942|NCT03173846|episodic memory|episodic memory
62943|NCT03173846|real-time functional MRI|real-time functional mri
62944|NCT03173833|cancer patients, quality of life|cancer patients, quality of life
62945|NCT03173820|tacrolimus|tacrolimus
62946|NCT03173820|transplantation|transplantation
62947|NCT03173820|CYP3A5|cyp3a5
62948|NCT03173820|genotype|genotype
62949|NCT03173768|intravenous antibiotics|intravenous antibiotics
62950|NCT03173768|appropriateness|appropriateness
62951|NCT03173768|outpatient antimicrobial therapy|outpatient antimicrobial therapy
62952|NCT03173716|DEFINITY contrast|definity contrast
62953|NCT03173677|Mononuclear cells|mononuclear cells
62954|NCT03173677|Whey proteins|whey proteins
62955|NCT03173677|Metabolically-Activated Macrophage|metabolically-activated macrophage
62956|NCT03173677|Macrophage Polarization|macrophage polarization
62957|NCT03173677|Macronutrients|macronutrients
62958|NCT03173638|acute non arteritic anterior ischemic optic neuropathy|acute non arteritic anterior ischemic optic neuropathy
62959|NCT03173638|mesenchymal stem cells|mesenchymal stem cells
62960|NCT03173638|intravitreal injection|intravitreal injection
62961|NCT03173638|safety|safety
62962|NCT03173599|Chronic Hepatitis B|chronic hepatitis b
62963|NCT03173586|Sugar sweetened beverage, biomarker|sugar sweetened beverage, biomarker
62964|NCT03173573|Cystic Fibrosis|cystic fibrosis
62965|NCT03173560|Renal Cell Carcinoma|renal cell carcinoma
62966|NCT03173560|lenvatinib|lenvatinib
62967|NCT03173560|everolimus|everolimus
62968|NCT03173560|E7080|e7080
62969|NCT03173560|VEGF-targeted treatment|vegf-targeted treatment
62970|NCT03173508|right ventricular function|right ventricular function
62971|NCT03173508|echocardiography|echocardiography
62972|NCT03173508|obstructive airway disease|obstructive airway disease
62973|NCT03173508|emphysema|emphysema
62974|NCT03173508|acetazolamide|acetazolamide
62975|NCT03173508|altitude|altitude
62976|NCT03173495|fat metabolism|fat metabolism
62977|NCT03173495|fructose|fructose
62978|NCT03173495|exercise|exercise
62979|NCT03173456|acute pain|acute pain
62980|NCT03173456|musculoskeletal pain|musculoskeletal pain
62981|NCT03173456|emergency medicine|emergency medicine
62982|NCT03173456|Emergency Service, Hospital|emergency service, hospital
62983|NCT03173456|analgesics|analgesics
62984|NCT03173456|Acetaminophen|acetaminophen
62985|NCT03173456|Ibuprofen|ibuprofen
62986|NCT03173456|oxycodone|oxycodone
62987|NCT03173456|hydrocodone|hydrocodone
62988|NCT03173456|codeine|codeine
62989|NCT03173456|adult|adult
62990|NCT03173443|Fiberoptic intubation|fiberoptic intubation
62991|NCT03173443|double lumen tube|double lumen tube
62992|NCT03173391|GKA|gka
62993|NCT03173391|T2DM|t2dm
62994|NCT03173391|HMS5552|hms5552
62995|NCT03173391|mono therapy|mono therapy
62996|NCT03173365|Hand-foot Syndrome|hand-foot syndrome
62997|NCT03173365|Brimonidine|brimonidine
62998|NCT03173365|Mirvaso|mirvaso
62999|NCT03173365|palmar-plantar erythrodysesthesia syndrome|palmar-plantar erythrodysesthesia syndrome
63000|NCT03173365|Brimonidine Tartrate|brimonidine tartrate
63001|NCT03173352|Hemangioma|hemangioma
63002|NCT03173339|intubation|intubation
63003|NCT03173339|pharyngitis|pharyngitis
63004|NCT03173339|remifentanil|remifentanil
63005|NCT03173313|Hypothermia|hypothermia
63006|NCT03173313|Acute Myocardial Infarction|acute myocardial infarction
63007|NCT03173313|AMI|ami
63008|NCT03173313|PCI|pci
63009|NCT03173313|Therapeutic Hypothermia|therapeutic hypothermia
63010|NCT03173300|PMM2-CDG|pmm2-cdg
63011|NCT03173300|CDG-Ia|cdg-ia
63012|NCT03173287|Hepatic fibrosis|hepatic fibrosis
63013|NCT03173287|IVIM|ivim
63014|NCT03173287|1.5T MRI|1.5t mri
63015|NCT03173248|Acute Myeloid Leukemia|acute myeloid leukemia
63016|NCT03173248|Leukemia|leukemia
63017|NCT03173248|Azacitidine|azacitidine
63018|NCT03173248|AG-120|ag-120
63019|NCT03173248|ivosidenib|ivosidenib
63020|NCT03173209|school|school
63021|NCT03173196|severe sepsis|severe sepsis
63022|NCT03173196|encephalopathy|encephalopathy
63023|NCT03173170|Drug Therapy|drug therapy
63024|NCT03173144|Life Style|life style
63025|NCT03173144|Diet|diet
63026|NCT03173144|Food|food
63027|NCT03173144|Exercise|exercise
63028|NCT03173144|Treatment Outcome|treatment outcome
63029|NCT03173144|Biomarkers|biomarkers
63030|NCT03173144|Smoking|smoking
63031|NCT03173105|Visually Impaired Persons|visually impaired persons
63032|NCT03173105|Postural Balance|postural balance
63033|NCT03173105|Rehabilitation|rehabilitation
63034|NCT03173105|Transcranial Direct Current Stimulation|transcranial direct current stimulation
63035|NCT03173092|Drug therapy|drug therapy
63036|NCT03173053|S. aureus|s. aureus
63037|NCT03173053|Home Parenteral Nutrition|home parenteral nutrition
63038|NCT03173053|Intestinal failure|intestinal failure
63039|NCT03173053|Eradication|eradication
63040|NCT03173053|Decolonization|decolonization
63041|NCT03173040|Traditional Chinese medicine|traditional chinese medicine
63042|NCT03173040|Niu Bang Zi pill|niu bang zi pill
63043|NCT03173040|methotrexate|methotrexate
63044|NCT03173040|active rheumatoid arthritis|active rheumatoid arthritis
63045|NCT03173001|intestinal helminths; protozoan infections;|intestinal helminths; protozoan infections;
63046|NCT03173001|colorectal cancer; chemotherapy; cancer pathogenesis;|colorectal cancer; chemotherapy; cancer pathogenesis;
63047|NCT03172988|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
63048|NCT03172988|Surgery|surgery
63049|NCT03172988|Dexamethasone|dexamethasone
63050|NCT03172988|Flurbiprofen axetil|flurbiprofen axetil
63051|NCT03172988|Long-term survival|long-term survival
63052|NCT03172975|Controlled infection|controlled infection
63053|NCT03172975|Na-GST-1|na-gst-1
63054|NCT03172975|Hookworm vaccine|hookworm vaccine
63055|NCT03172936|injected lesion|injected lesion
63056|NCT03172936|distal lesion|distal lesion
63057|NCT03172936|abscopal activity|abscopal activity
63058|NCT03172936|intratumoral|intratumoral
63059|NCT03172936|checkpoint inhibitor|checkpoint inhibitor
63060|NCT03172936|cyclic dinucleotide|cyclic dinucleotide
63061|NCT03172936|programmed cell death|programmed cell death
63062|NCT03172910|PER977|per977
63063|NCT03172910|Ciraparantag|ciraparantag
63064|NCT03172910|Whole Blood Clotting Time (WBCT)|whole blood clotting time (wbct)
63065|NCT03172910|Rivaroxaban|rivaroxaban
63066|NCT03172897|Adult|adult
63067|NCT03172897|Intensive care unit|intensive care unit
63068|NCT03172897|Mechanical ventilation|mechanical ventilation
63069|NCT03172897|Delirium|delirium
63070|NCT03172897|Dexmedetomidine|dexmedetomidine
63071|NCT03172884|Renal Impairment|renal impairment
63072|NCT03172884|Pharmacokinetics|pharmacokinetics
63073|NCT03172884|Hepatic impairment|hepatic impairment
63074|NCT03172871|Schizophrenia|schizophrenia
63075|NCT03172871|Aripiprazole Intramuscular Depot|aripiprazole intramuscular depot
63076|NCT03172871|Acute treatment|acute treatment
63077|NCT03172858|cervical ripening|cervical ripening
63078|NCT03172858|term premature rupture of membrane|term premature rupture of membrane
63079|NCT03172858|intracervical balloon catheter|intracervical balloon catheter
63080|NCT03172845|coronary bifurcation lesion|coronary bifurcation lesion
63081|NCT03172845|optical coherence tomography|optical coherence tomography
63384|NCT03170531|17-267|17-267
63082|NCT03172845|vulnerable plaque|vulnerable plaque
63083|NCT03172793|telavancin|telavancin
63084|NCT03172793|lipoglycopeptide|lipoglycopeptide
63085|NCT03172793|MRSA|mrsa
63086|NCT03172793|pharmacokinetics|pharmacokinetics
63087|NCT03172767|Preterm|preterm
63088|NCT03172767|Sensory processing|sensory processing
63089|NCT03172767|School Readiness|school readiness
63090|NCT03172741|Cannabis|cannabis
63091|NCT03172715|Open reduction internal fixation|open reduction internal fixation
63092|NCT03172715|Arthroplasty|arthroplasty
63093|NCT03172715|Surgery|surgery
63094|NCT03172715|Randomized controlled trial|randomized controlled trial
63095|NCT03172663|obesity|obesity
63096|NCT03172624|Nivolumab|nivolumab
63097|NCT03172624|Ipilimumab|ipilimumab
63098|NCT03172624|17-219|17-219
63099|NCT03172572|minimally invasive surgical procedures|minimally invasive surgical procedures
63100|NCT03172572|pancreas surgery|pancreas surgery
63101|NCT03172572|pancreatoduodenectomy|pancreatoduodenectomy
63102|NCT03172559|Stereotactic body radiotherapy|stereotactic body radiotherapy
63103|NCT03172559|SBRT|sbrt
63104|NCT03172559|Radiotherapy|radiotherapy
63105|NCT03172559|Bridging therapy|bridging therapy
63106|NCT03172559|Transplant|transplant
63107|NCT03172546|direct oral anticoagulant|direct oral anticoagulant
63108|NCT03172546|hemorrhagic complication|hemorrhagic complication
63109|NCT03172546|thrombotic complication|thrombotic complication
63110|NCT03172546|genetic polymorphisms|genetic polymorphisms
63111|NCT03172533|anorexia nervosa|anorexia nervosa
63112|NCT03172533|estrogen|estrogen
63113|NCT03172533|psychotherapy|psychotherapy
63114|NCT03172533|cortisol|cortisol
63115|NCT03172533|appetite regulation|appetite regulation
63116|NCT03172533|neurocognitive performance|neurocognitive performance
63117|NCT03172533|eating disorder|eating disorder
63118|NCT03172533|sexual hormone|sexual hormone
63119|NCT03172520|Parotidectomy|parotidectomy
63120|NCT03172507|Hematopoietic Stem Cells|hematopoietic stem cells
63121|NCT03172442|Class III treatment|class iii treatment
63122|NCT03172442|orthodontic removable traction appliance|orthodontic removable traction appliance
63124|NCT03172429|pulmonary hypertension|pulmonary hypertension
63125|NCT03172429|cerebral tissue oxygenation|cerebral tissue oxygenation
63126|NCT03172429|disease progression|disease progression
63127|NCT03172429|hypoxia|hypoxia
63128|NCT03172416|Gastric Cancer|gastric cancer
63129|NCT03172416|Unresectable Peritoneal Carcinomatosis|unresectable peritoneal carcinomatosis
63130|NCT03172416|Oxaliplatin|oxaliplatin
63131|NCT03172416|Pressurized intraperitoneal aerosol chemotherapy|pressurized intraperitoneal aerosol chemotherapy
63132|NCT03172403|Cachexia|cachexia
63133|NCT03172403|Colon cancer|colon cancer
63134|NCT03172403|Myostatin|myostatin
63135|NCT03172403|Skeletal muscle|skeletal muscle
63136|NCT03172390|Ascending aorta aneurysm|ascending aorta aneurysm
63137|NCT03172390|Aortic wall shear stress|aortic wall shear stress
63138|NCT03172390|4D phase contrast Cardiovascular Magnetic Resonance|4d phase contrast cardiovascular magnetic resonance
63139|NCT03172390|Aortic dissection|aortic dissection
63140|NCT03172377|adalimumab|adalimumab
63141|NCT03172377|anti-TNF|anti-tnf
63142|NCT03172377|Humira|humira
63143|NCT03172377|interval lengthening|interval lengthening
63144|NCT03172377|dosing interval|dosing interval
63145|NCT03172377|inflammatory bowel disease|inflammatory bowel disease
63146|NCT03172377|antidrug antibodies|antidrug antibodies
63147|NCT03172377|trough levels|trough levels
63148|NCT03172377|pharmacokinetics|pharmacokinetics
63149|NCT03172377|immunogenicity|immunogenicity
63150|NCT03172377|cost-effectiveness|cost-effectiveness
63151|NCT03172377|dose reduction|dose reduction
63152|NCT03172312|Intraoperative Parathyroid Scores System|intraoperative parathyroid scores system
63153|NCT03172312|total thyroidectomy|total thyroidectomy
63154|NCT03172312|thyroid cancer|thyroid cancer
63155|NCT03172312|hypoparathyroidism|hypoparathyroidism
63156|NCT03172312|prediction|prediction
63157|NCT03172273|Liver Cirrhosis|liver cirrhosis
63158|NCT03172273|Transjugular Intrahepatic Portosystemic shunt|transjugular intrahepatic portosystemic shunt
63159|NCT03172273|Refractory ascites|refractory ascites
63160|NCT03172247|cardiology diabetes|cardiology diabetes
63161|NCT03172234|β-endorphins,laryngoscopy and tracheal intubation|β-endorphins,laryngoscopy and tracheal intubation
63162|NCT03172221|malaria|malaria
63163|NCT03172221|pregnancy|pregnancy
63164|NCT03172221|diagnosis|diagnosis
63165|NCT03172221|low-transmission|low-transmission
63166|NCT03172221|Plasmodium falciparum|plasmodium falciparum
63167|NCT03172221|rapid diagnostic test|rapid diagnostic test
63168|NCT03172195|ulcerative colitis|ulcerative colitis
63169|NCT03172195|inflammation|inflammation
63170|NCT03172195|immunosuppressive drugs|immunosuppressive drugs
63171|NCT03172195|herpesvirus|herpesvirus
63172|NCT03172195|qPCR|qpcr
63173|NCT03172195|colonic mucosa|colonic mucosa
63174|NCT03172156|NSCLC|nsclc
63175|NCT03172156|stage I|stage i
63176|NCT03172156|The next generation of high-throughput gene sequencing (NGS)|the next generation of high-throughput gene sequencing (ngs)
63177|NCT03172156|ctDNA|ctdna
63178|NCT03172130|Obstructive Sleep Apnea|obstructive sleep apnea
63180|NCT03172091|Lung transplant|lung transplant
63181|NCT03172091|Acute resection|acute resection
63182|NCT03172091|Volatile Organic Compounds|volatile organic compounds
63183|NCT03172078|advanced endoscopic procedure|advanced endoscopic procedure
63184|NCT03172078|ERCP|ercp
63185|NCT03172078|EUS|eus
63186|NCT03172078|target-controlled infusion|target-controlled infusion
63187|NCT03172078|sedation|sedation
63188|NCT03172078|propofol|propofol
63189|NCT03172039|hemodialysis|hemodialysis
63190|NCT03172039|antimicrobial stewardship|antimicrobial stewardship
63191|NCT03172039|antimicrobial agents|antimicrobial agents
63192|NCT03172039|bacterial infections|bacterial infections
63193|NCT03172039|ambulatory care|ambulatory care
63194|NCT03172026|Telerehabilitation|telerehabilitation
63195|NCT03172026|Maraviroc|maraviroc
63196|NCT03171987|lidocaine patch|lidocaine patch
63197|NCT03171987|flurbiprofen patch|flurbiprofen patch
63198|NCT03171987|acute back pain|acute back pain
63199|NCT03171974|breast capsular contructure|breast capsular contructure
63200|NCT03171961|weight loss|weight loss
63201|NCT03171961|Diet|diet
63202|NCT03171961|online visit|online visit
63203|NCT03171961|clinic visit|clinic visit
63204|NCT03171948|almond|almond
63205|NCT03171948|weight loss|weight loss
63206|NCT03171948|Weight maintenance|weight maintenance
63207|NCT03171948|hypoenergetic diet|hypoenergetic diet
63208|NCT03171922|weight loss|weight loss
63209|NCT03171922|internet-based diet|internet-based diet
63210|NCT03171922|online dietary coach|online dietary coach
63211|NCT03171922|clinic visit approach|clinic visit approach
63212|NCT03171922|Diet|diet
63213|NCT03171792|Musculoskeletal pain|musculoskeletal pain
63214|NCT03171792|Adolescent|adolescent
63215|NCT03171792|Qualitative research|qualitative research
63216|NCT03171792|Attitude|attitude
63217|NCT03171792|Health professionals|health professionals
63218|NCT03171740|Emergence Delirium|emergence delirium
63219|NCT03171740|Emergence Agitation|emergence agitation
63220|NCT03171740|premedication|premedication
63221|NCT03171740|dexmedetomidine|dexmedetomidine
63222|NCT03171740|midazolam|midazolam
63223|NCT03171714|Drainage Catheter|drainage catheter
63224|NCT03171688|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
63225|NCT03171688|cesarean|cesarean
63226|NCT03171688|risk factors|risk factors
63227|NCT03171675|Chronic Periodontitis|chronic periodontitis
63228|NCT03171675|Preterm Labor|preterm labor
63229|NCT03171675|Preterm Birth|preterm birth
63230|NCT03171675|Interleukin-17|interleukin-17
63231|NCT03171675|IL-17|il-17
63232|NCT03171675|Periodontal Disease|periodontal disease
63233|NCT03171675|Periodontitis|periodontitis
63234|NCT03171675|Periodontal risk factors|periodontal risk factors
63235|NCT03171675|Medical risk factors|medical risk factors
63236|NCT03171649|rehabilitation|rehabilitation
63237|NCT03171649|exoskeleton|exoskeleton
63238|NCT03171649|functional electrical stimulation|functional electrical stimulation
63239|NCT03171649|upper limb|upper limb
63240|NCT03171649|sub-acute|sub-acute
63241|NCT03171649|motor re-learning|motor re-learning
63242|NCT03171623|T2DM|t2dm
63243|NCT03171623|Diabetes|diabetes
63244|NCT03171623|GKA|gka
63245|NCT03171610|laparoscopic nephrectomy|laparoscopic nephrectomy
63246|NCT03171610|Patient-controlled analgesia (PCA)|patient-controlled analgesia (pca)
63247|NCT03171610|sufentanil|sufentanil
63248|NCT03171610|fentanyl|fentanyl
63249|NCT03171597|Unstable Angina|unstable angina
63250|NCT03171597|Traditional Chinese Medicine|traditional chinese medicine
63251|NCT03171571|eating Behavior|eating behavior
63252|NCT03171571|Volunteers|volunteers
63253|NCT03171545|Peer Mentoring|peer mentoring
63254|NCT03171545|Team Training|team training
63255|NCT03171545|Checklist|checklist
63256|NCT03171532|ACL|acl
63257|NCT03171519|Physical activity|physical activity
63258|NCT03171519|Disorders of onset and maintenance of sleep|disorders of onset and maintenance of sleep
63259|NCT03171519|non-pharmacological treatment|non-pharmacological treatment
63260|NCT03171519|Acupuncture|acupuncture
63261|NCT03171506|ketogenic diet|ketogenic diet
63262|NCT03171506|carbohydrate-restricted diet|carbohydrate-restricted diet
63263|NCT03171493|Bladder cancer, Radical cystectomy|bladder cancer, radical cystectomy
63264|NCT03171480|Preeclampsia|preeclampsia
63265|NCT03171480|Induction|induction
63266|NCT03171454|hysteroscopic operation|hysteroscopic operation
63267|NCT03171454|intrauterine balloon|intrauterine balloon
63268|NCT03171454|adhesions|adhesions
63269|NCT03171415|Obesity|obesity
63270|NCT03171415|Overweight|overweight
63271|NCT03171415|Thermogenesis|thermogenesis
63272|NCT03171415|Fat reduction|fat reduction
63273|NCT03171389|GIST|gist
63274|NCT03171389|KIT secondary mutation|kit secondary mutation
63275|NCT03171389|ponatinib|ponatinib
63276|NCT03171376|Root canal treatment|root canal treatment
63277|NCT03171376|Coronal leakage|coronal leakage
63278|NCT03171376|Intraorifice barrier|intraorifice barrier
63279|NCT03171363|Attention bias modification treatment|attention bias modification treatment
63280|NCT03171363|Anxiety disorders|anxiety disorders
63281|NCT03171363|Attention training|attention training
63282|NCT03171337|Chronic tension-type headache|chronic tension-type headache
63283|NCT03171337|Acupuncture|acupuncture
63284|NCT03171337|Fu's subcutaneous needling(FSN)|fu's subcutaneous needling(fsn)
63285|NCT03171337|fMRI|fmri
63286|NCT03171337|Regional homogeneity (ReHo)|regional homogeneity (reho)
63287|NCT03171246|dietary intervention|dietary intervention
63288|NCT03171220|Neoantigen|neoantigen
63289|NCT03171220|Neoantigen Reactive T cells (NRTs)|neoantigen reactive t cells (nrts)
63290|NCT03171220|PD-1 Inhibitor|pd-1 inhibitor
63291|NCT03171220|Advanced Solid Tumor|advanced solid tumor
63292|NCT03171220|Adoptive Cell Therapy(ACT)|adoptive cell therapy(act)
63293|NCT03171220|PD-1 antibody|pd-1 antibody
63294|NCT03171220|SHR1210|shr1210
63295|NCT03171207|Gait Therapy|gait therapy
63296|NCT03171194|Lupus|lupus
63297|NCT03171194|Stem Cell|stem cell
63298|NCT03171194|Systemic Lupus Erythematosus|systemic lupus erythematosus
63299|NCT03171181|Spatial cognition, vestibular system, motor control|spatial cognition, vestibular system, motor control
63300|NCT03171168|Gait Analysis|gait analysis
63301|NCT03171168|WOMAC|womac
63302|NCT03171168|SF-36|sf-36
63303|NCT03171142|Heliox|heliox
63304|NCT03171129|Respiratory Distress|respiratory distress
63305|NCT03171129|Nasal CPAP|nasal cpap
63306|NCT03171129|high flow nasal canula|high flow nasal canula
63307|NCT03171116|ghrelin|ghrelin
63308|NCT03171116|obestatin|obestatin
63309|NCT03171116|children|children
63310|NCT03171064|Exercise|exercise
63311|NCT03171064|Cancer|cancer
63312|NCT03171064|Melanoma|melanoma
63313|NCT03171064|Feasibility|feasibility
63314|NCT03171064|PD-1 antibodies|pd-1 antibodies
63315|NCT03171064|Checkpoint inhibitors|checkpoint inhibitors
63316|NCT03171064|Immune system|immune system
63317|NCT03171038|Telemonitoring|telemonitoring
63318|NCT03171038|Chronic Heart Failure|chronic heart failure
63319|NCT03171038|eHealth|ehealth
63320|NCT03171038|Mortality|mortality
63321|NCT03171025|Muscle Invasive|muscle invasive
63322|NCT03171012|Muscle Stretching Exercises|muscle stretching exercises
63323|NCT03170999|China|china
63324|NCT03170999|Cognitive testing|cognitive testing
63325|NCT03170999|COPD exacerbation|copd exacerbation
63326|NCT03170999|CERT|cert
63327|NCT03170973|Obesity|obesity
63328|NCT03170973|Motor Activity|motor activity
63329|NCT03170973|Fatty acids|fatty acids
63330|NCT03170973|Lipid|lipid
63331|NCT03170960|Kidney|kidney
63332|NCT03170960|Bladder|bladder
63333|NCT03170960|Renal pelvis|renal pelvis
63334|NCT03170960|Ureter|ureter
63335|NCT03170960|Urethra|urethra
63336|NCT03170960|Cancer|cancer
63337|NCT03170960|Prostate|prostate
63338|NCT03170960|Castration-resistant|castration-resistant
63339|NCT03170960|Lung|lung
63340|NCT03170947|Rheumatoid arthritis|rheumatoid arthritis
63341|NCT03170947|Foot|foot
63342|NCT03170947|Insoles|insoles
63343|NCT03170947|Quality of life|quality of life
63344|NCT03170947|Physical Activity|physical activity
63345|NCT03170895|FLT3-ITD (+) Acute Myeloid Leukemia (AML)|flt3-itd (+) acute myeloid leukemia (aml)
63346|NCT03170882|Drug therapy|drug therapy
63347|NCT03170778|Congenital Heart Disease|congenital heart disease
63348|NCT03170778|CHD|chd
63349|NCT03170778|Fontan|fontan
63350|NCT03170752|RCT, Cardiovascular Risk Factors, Screening|rct, cardiovascular risk factors, screening
63351|NCT03170739|dexmedetomidine|dexmedetomidine
63352|NCT03170739|dopamine|dopamine
63353|NCT03170739|surgery|surgery
63354|NCT03170726|Preemptive intravenous ibuprofen|preemptive intravenous ibuprofen
63355|NCT03170726|Intraoperative analgesia|intraoperative analgesia
63356|NCT03170726|Third molar tooth surgery|third molar tooth surgery
63357|NCT03170713|Preemptive intravenous ibuprofen|preemptive intravenous ibuprofen
63358|NCT03170713|trismus|trismus
63359|NCT03170713|edema|edema
63360|NCT03170713|Third molar tooth extraction|third molar tooth extraction
63361|NCT03170713|Antiinflammatory effect|antiinflammatory effect
63362|NCT03170700|preschool|preschool
63363|NCT03170700|eating behaviors|eating behaviors
63364|NCT03170700|family|family
63365|NCT03170648|Acupuncture|acupuncture
63366|NCT03170648|Breast Cancer|breast cancer
63367|NCT03170635|recess, occupational therapy|recess, occupational therapy
63368|NCT03170622|children|children
63369|NCT03170622|paediatrics|paediatrics
63370|NCT03170622|faecal volitile organic compounds|faecal volitile organic compounds
63371|NCT03170622|diagnosis|diagnosis
63372|NCT03170622|pathogenesis|pathogenesis
63373|NCT03170583|bradycardia, pacemaker, MRI scan|bradycardia, pacemaker, mri scan
63374|NCT03170570|recurrent cervical cancer|recurrent cervical cancer
63375|NCT03170570|re-irradiation|re-irradiation
63376|NCT03170570|intensity-modulated raditherapy|intensity-modulated raditherapy
63377|NCT03170557|Persistent pain|persistent pain
63378|NCT03170557|Spinal cord injury|spinal cord injury
63379|NCT03170557|Acupuncture|acupuncture
63380|NCT03170557|Randomized Controlled Trial|randomized controlled trial
63381|NCT03170557|RCT|rct
63382|NCT03170531|MRI|mri
63383|NCT03170531|MR imaging|mr imaging
63385|NCT03170505|cleft palate|cleft palate
63386|NCT03170466|Palliative care|palliative care
63387|NCT03170453|Autism|autism
63388|NCT03170453|Autism Spectrum Disorder|autism spectrum disorder
63389|NCT03170453|Asperger's Syndrome|asperger's syndrome
63390|NCT03170453|Pervasive Developmental Disorder|pervasive developmental disorder
63391|NCT03170453|Cognition|cognition
63392|NCT03170453|Social Cognition|social cognition
63393|NCT03170453|Psychosocial Treatment|psychosocial treatment
63394|NCT03170453|Cognitive Enhancement Therapy|cognitive enhancement therapy
63395|NCT03170453|Enriched Supportive Therapy|enriched supportive therapy
63396|NCT03170453|Therapy|therapy
63397|NCT03170453|Psychotherapy|psychotherapy
63398|NCT03170440|Sleep|sleep
63399|NCT03170440|Vagal nerve stimulation|vagal nerve stimulation
63400|NCT03170414|HIV|hiv
63401|NCT03170414|Kidney Transplant|kidney transplant
63402|NCT03170414|Liver Transplant|liver transplant
63403|NCT03170414|Transplant|transplant
63404|NCT03170414|HOPE Act|hope act
63405|NCT03170375|obesity|obesity
63406|NCT03170375|sodium|sodium
63407|NCT03170375|DASH diet|dash diet
63408|NCT03170375|hypertension|hypertension
63409|NCT03170375|vascular stiffness|vascular stiffness
63410|NCT03170375|diastolic function|diastolic function
63411|NCT03170362|Treatment|treatment
63412|NCT03170362|Pharmacogenetics|pharmacogenetics
63413|NCT03170362|Depression|depression
63414|NCT03170271|Asthma, Bronchial Diseases, Respiratory Tract Diseases, Lung Diseases, Obstructive Lung Diseases|asthma, bronchial diseases, respiratory tract diseases, lung diseases, obstructive lung diseases
63415|NCT03170271|Additional relevant MeSH terms:|additional relevant mesh terms:
63416|NCT03170271|Asthma|asthma
63417|NCT03170271|Inflammation|inflammation
63418|NCT03170271|Bronchial Diseases|bronchial diseases
63419|NCT03170271|Respiratory Tract Diseases|respiratory tract diseases
63420|NCT03170271|Lung Diseases, Obstructive|lung diseases, obstructive
63421|NCT03170271|Lung Diseases Respiratory Hypersensitivity|lung diseases respiratory hypersensitivity
63422|NCT03170271|Hypersensitivity, Immediate|hypersensitivity, immediate
63423|NCT03170271|Hypersensitivity|hypersensitivity
63424|NCT03170271|Immune System Diseases|immune system diseases
63425|NCT03170271|Pathologic Processes|pathologic processes
63426|NCT03170258|real-time fMRI|real-time fmri
63427|NCT03170258|reward|reward
63428|NCT03170258|motivation|motivation
63429|NCT03170258|dopamine|dopamine
63430|NCT03170258|EEG|eeg
63431|NCT03170232|HRQoL|hrqol
63432|NCT03170232|Disease Progression|disease progression
63433|NCT03170232|Danirixin|danirixin
63434|NCT03170232|COPD|copd
63435|NCT03170206|Lung Cancer|lung cancer
63436|NCT03170141|CAR T|car t
63437|NCT03170141|EGFRviii|egfrviii
63438|NCT03170141|GBM|gbm
63439|NCT03170141|PDL1|pdl1
63440|NCT03170141|PD1|pd1
63441|NCT03170141|brain tumor|brain tumor
63442|NCT03170115|Rectal Cancer|rectal cancer
63443|NCT03170115|Total neoadjuvant therapy|total neoadjuvant therapy
63444|NCT03170115|Induction chemotherapy|induction chemotherapy
63445|NCT03170115|Aspirin colorectal cancer|aspirin colorectal cancer
63446|NCT03170102|occupational therapy|occupational therapy
63447|NCT03170089|oral-health-awareness, Diabetes|oral-health-awareness, diabetes
63448|NCT03170076|skin manifestations - hepatitis c virus|skin manifestations - hepatitis c virus
63449|NCT03170063|Parkinson's Disease|parkinson's disease
63450|NCT03170063|Alpha-Synuclein|alpha-synuclein
63451|NCT03170063|Biomarker|biomarker
63452|NCT03170011|Cardiac rehabilitation|cardiac rehabilitation
63453|NCT03170011|Sit to Stand|sit to stand
63454|NCT03170011|Function|function
63455|NCT03169985|Rosuvastatin|rosuvastatin
63456|NCT03169985|Ezetimibe|ezetimibe
63457|NCT03169985|Atherosclerotic plaque|atherosclerotic plaque
63458|NCT03169985|Intravascular ultrasound|intravascular ultrasound
63459|NCT03169959|Anti-diabetic|anti-diabetic
63460|NCT03169959|Anti-hyperglycemic agents|anti-hyperglycemic agents
63461|NCT03169959|Bioequivalence|bioequivalence
63462|NCT03169959|Fixed-Combination Drug Product (FCDP) of saxagliptin / dapagliflozin / metformin extended-release (XR).|fixed-combination drug product (fcdp) of saxagliptin / dapagliflozin / metformin extended-release (xr).
63463|NCT03169959|Fed-state bioequivalence (BE)|fed-state bioequivalence (be)
63464|NCT03169959|XIGDUO® XR|xigduo® xr
63465|NCT03169959|ONGLYZA®|onglyza®
63466|NCT03169933|adjuvant|adjuvant
63467|NCT03169933|androgen suppressive therapy|androgen suppressive therapy
63468|NCT03169933|literature review|literature review
63469|NCT03169933|phase II|phase ii
63470|NCT03169933|prostate neoplasms|prostate neoplasms
63471|NCT03169933|radiotherapy|radiotherapy
63472|NCT03169907|Cardiac functions|cardiac functions
63473|NCT03169907|Intrauterine fetal anemia|intrauterine fetal anemia
63474|NCT03169907|Intrauterine Fetal blood transfusion|intrauterine fetal blood transfusion
63475|NCT03169907|Myocardial performance index|myocardial performance index
63476|NCT03169907|spatiotemporal imaging correlation|spatiotemporal imaging correlation
63477|NCT03169868|clinical decision support|clinical decision support
63478|NCT03169868|drug levels in blood|drug levels in blood
63479|NCT03169868|therapeutic drug monitoring|therapeutic drug monitoring
63480|NCT03169868|medication adherence|medication adherence
63481|NCT03169868|medication therapy management|medication therapy management
63482|NCT03169855|Traffic Ophthalmology|traffic ophthalmology
63483|NCT03169855|Glare|glare
63484|NCT03169855|Cataract|cataract
63485|NCT03169855|Nighttime driving|nighttime driving
63486|NCT03169855|contrast sensitivity|contrast sensitivity
63487|NCT03169855|mesopic vision|mesopic vision
63488|NCT03169829|Hemodialysis|hemodialysis
63489|NCT03169829|Renal Disease|renal disease
63490|NCT03169803|Electrical Stimulation Therapy|electrical stimulation therapy
63491|NCT03169803|Electrodes|electrodes
63492|NCT03169803|Parasympathetic Nervous System|parasympathetic nervous system
63493|NCT03169803|Sympathetic Fibers|sympathetic fibers
63494|NCT03169803|Post Ganglionic|post ganglionic
63495|NCT03169803|Congestive Heart Failure|congestive heart failure
63496|NCT03169803|Heart Failure|heart failure
63497|NCT03169673|Magnetic Resonance Imaging|magnetic resonance imaging
63498|NCT03169673|Pulmonary Function|pulmonary function
63499|NCT03169634|Failed knee replacement|failed knee replacement
63500|NCT03169634|loosening|loosening
63501|NCT03169634|wear|wear
63502|NCT03169634|reoperation|reoperation
63503|NCT03169621|Chronic Endometritis|chronic endometritis
63504|NCT03169621|Endometrial pathogens|endometrial pathogens
63505|NCT03169621|Microbiological diagnosis|microbiological diagnosis
63506|NCT03169621|Next Generation Sequencing|next generation sequencing
63507|NCT03169621|Metagenomics|metagenomics
63508|NCT03169621|Endometrial receptivity|endometrial receptivity
63509|NCT03169608|autonomic nervous system|autonomic nervous system
63510|NCT03169608|atrial fibrillation|atrial fibrillation
63511|NCT03169608|acute kidney injury|acute kidney injury
63512|NCT03169608|baroreflex sensitivity|baroreflex sensitivity
63513|NCT03169608|microcirculation|microcirculation
63514|NCT03169608|coronary artery bypass graft|coronary artery bypass graft
63515|NCT03169569|hemostatic powder|hemostatic powder
63516|NCT03169569|post-ESD bleeding|post-esd bleeding
63517|NCT03169569|antithrombotic therapy|antithrombotic therapy
63518|NCT03169569|high risk of bleeding|high risk of bleeding
63519|NCT03169569|endoscopic submucosal dissection|endoscopic submucosal dissection
63520|NCT03169569|adverse event|adverse event
63521|NCT03169556|Intubation|intubation
63522|NCT03169556|light wand|light wand
63523|NCT03169556|video laryngoscopy|video laryngoscopy
63524|NCT03169556|cervical spine immobilization|cervical spine immobilization
63525|NCT03169530|cardiovascular, alcohol, diabetes|cardiovascular, alcohol, diabetes
63526|NCT03169517|Peripheral nerve block|peripheral nerve block
63527|NCT03169517|laser speckle contrast imaging|laser speckle contrast imaging
63528|NCT03169517|blood flow index|blood flow index
63529|NCT03169504|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
63530|NCT03169504|Acupuncture Therapy|acupuncture therapy
63531|NCT03169504|Humans|humans
63532|NCT03169491|Sleep Apnea, Obstructive|sleep apnea, obstructive
63533|NCT03169491|Child|child
63534|NCT03169491|Continuous Positive Airway Pressure|continuous positive airway pressure
63535|NCT03169491|Perioperative management|perioperative management
63536|NCT03169491|Adenotonsillectomy|adenotonsillectomy
63537|NCT03169491|Acoustic pharyngometry|acoustic pharyngometry
63538|NCT03169478|hysteroscopic myomectomy|hysteroscopic myomectomy
63539|NCT03169478|balloon dilatation|balloon dilatation
63540|NCT03169478|adhesions|adhesions
63541|NCT03169426|remote ischemic conditioning|remote ischemic conditioning
63542|NCT03169426|beta-blocker|beta-blocker
63543|NCT03169400|vascular calcification|vascular calcification
63544|NCT03169400|haemodialysis|haemodialysis
63545|NCT03169400|dialysis membrane|dialysis membrane
63546|NCT03169387|Virtual Reality Exposure Therapy|virtual reality exposure therapy
63547|NCT03169374|Virtual Reality|virtual reality
63548|NCT03169374|Mechanical Ventilation|mechanical ventilation
63549|NCT03169374|Anxiety|anxiety
63550|NCT03169309|complementary and alternative medicine|complementary and alternative medicine
63551|NCT03169309|military|military
63552|NCT03169309|binaural beat technology|binaural beat technology
63553|NCT03169309|brain entrainment technology|brain entrainment technology
63554|NCT03169309|sleep|sleep
63555|NCT03169296|Myelodysplastic syndrome|myelodysplastic syndrome
63556|NCT03169296|Mutations|mutations
63557|NCT03169296|Next-generation sequencing|next-generation sequencing
63558|NCT03169270|Exercise training|exercise training
63559|NCT03169270|Muscle dysfunction|muscle dysfunction
63560|NCT03169270|COPD|copd
63561|NCT03169257|paediatric obesity|paediatric obesity
63562|NCT03169257|cardiovascular dysfunction|cardiovascular dysfunction
63563|NCT03169257|metabolic syndrome|metabolic syndrome
63564|NCT03169257|adipokines|adipokines
63565|NCT03169257|inflammation|inflammation
63566|NCT03169257|oxidative stress|oxidative stress
63567|NCT03169218|Adult|adult
63568|NCT03169218|Chronic pain|chronic pain
63569|NCT03169218|Entrapment neuropathy. Carpal tunnel|entrapment neuropathy. carpal tunnel
63570|NCT03169218|Exercise therapy|exercise therapy
63571|NCT03169218|Humans|humans
63572|NCT03169218|Neuronal plasticity|neuronal plasticity
63573|NCT03169218|Mirror neurons|mirror neurons
63574|NCT03169218|Pain/cognitive aspects|pain/cognitive aspects
63575|NCT03169218|Physiotherapy|physiotherapy
63576|NCT03169218|Somatosensory cortex|somatosensory cortex
63577|NCT03169179|Physical activity|physical activity
63578|NCT03169179|Mobile health|mobile health
63579|NCT03169179|Wearable fitness technology|wearable fitness technology
63580|NCT03169179|Organisational wellness|organisational wellness
63581|NCT03169179|Occupational health|occupational health
63582|NCT03169179|Police force|police force
63583|NCT03169166|GnRH agonist|gnrh agonist
63584|NCT03169166|In Vitro fertilization|in vitro fertilization
63585|NCT03169166|Assisted Reproductive Technology|assisted reproductive technology
63586|NCT03169166|Follicule Maturation|follicule maturation
63587|NCT03169166|Pregnancy|pregnancy
63588|NCT03169153|contact lenses|contact lenses
63589|NCT03169153|lipids|lipids
63590|NCT03169153|deposits|deposits
63591|NCT03169140|pain management|pain management
63592|NCT03169140|topical analgesic|topical analgesic
63593|NCT03169140|acute low back pain|acute low back pain
63594|NCT03169140|kinesiology tape|kinesiology tape
63595|NCT03169127|Ibuprofen|ibuprofen
63596|NCT03169127|Lower third molar|lower third molar
63597|NCT03169127|Oral Surgery|oral surgery
63598|NCT03169114|Appendicitis|appendicitis
63599|NCT03169114|Surgery|surgery
63600|NCT03169114|Antibiotic therapy|antibiotic therapy
63601|NCT03169114|RIPASA Score|ripasa score
63602|NCT03169101|Smoking Cessation|smoking cessation
63603|NCT03169101|HIV|hiv
63604|NCT03169101|Cognition|cognition
63605|NCT03169088|eating Behavior|eating behavior
63606|NCT03169088|Volunteers|volunteers
63607|NCT03169075|Adapted physical ctivity|adapted physical ctivity
63608|NCT03169075|Oral targeted thérapy|oral targeted thérapy
63609|NCT03169075|Advanced cancer|advanced cancer
63610|NCT03169075|Fatigue|fatigue
63611|NCT03169075|Quality of life|quality of life
63612|NCT03169075|Randomized Study|randomized study
63613|NCT03169049|nerve conduction block|nerve conduction block
63614|NCT03169049|high frequency stimulation|high frequency stimulation
63615|NCT03169049|handgrip|handgrip
63616|NCT03169010|registry|registry
63617|NCT03169010|pulmonary hypertension|pulmonary hypertension
63618|NCT03169010|survival|survival
63619|NCT03169010|biomarker|biomarker
63620|NCT03169010|whole genome sequencing|whole genome sequencing
63621|NCT03168997|Alzheimer Disease Memantine|alzheimer disease memantine
63622|NCT03168984|Healthy Japanese subjects|healthy japanese subjects
63623|NCT03168984|Healthy Caucasian subjects|healthy caucasian subjects
63624|NCT03168984|UCB0942|ucb0942
63625|NCT03168971|Cancer|cancer
63626|NCT03168971|Anxiety|anxiety
63627|NCT03168971|Cognitive behavior therapy|cognitive behavior therapy
63628|NCT03168971|Elderly|elderly
63629|NCT03168971|Caregivers|caregivers
63630|NCT03168945|Active Case Finding|active case finding
63631|NCT03168906|Amyloidosis|amyloidosis
63632|NCT03168906|NEOD001|neod001
63633|NCT03168906|RAIN|rain
63634|NCT03168893|deep brain stimulation|deep brain stimulation
63635|NCT03168867|insulin dependent diabetes mellitus|insulin dependent diabetes mellitus
63636|NCT03168867|adolescents/young adults|adolescents/young adults
63637|NCT03168867|e-health intervention|e-health intervention
63638|NCT03168867|parental monitoring|parental monitoring
63639|NCT03168854|Anopheles stephensi|anopheles stephensi
63640|NCT03168854|GAP3KO|gap3ko
63641|NCT03168854|Malaria|malaria
63642|NCT03168854|Mosquitoes|mosquitoes
63643|NCT03168854|Plasmodium falciparum|plasmodium falciparum
63644|NCT03168815|HFNC|hfnc
63645|NCT03168815|Bronchoscopy|bronchoscopy
63646|NCT03168815|Hypoxia|hypoxia
63647|NCT03168815|Immunocompromised|immunocompromised
63648|NCT03168815|Hematological malignancy|hematological malignancy
63649|NCT03168802|Focused ultrasound Ablation|focused ultrasound ablation
63650|NCT03168802|Radiofrequency Ablation|radiofrequency ablation
63651|NCT03168802|Facet joint syndrome|facet joint syndrome
63652|NCT03168802|Chronic low back pain|chronic low back pain
63653|NCT03168789|Breathing Awareness Meditation,|breathing awareness meditation,
63654|NCT03168776|Drug-eluting stent|drug-eluting stent
63655|NCT03168763|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
63656|NCT03168763|Advanced Cancer|advanced cancer
63657|NCT03168763|Videos|videos
63658|NCT03168763|Questionnaires|questionnaires
63659|NCT03168763|Surveys|surveys
63660|NCT03168737|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
63661|NCT03168737|Solid tumors|solid tumors
63662|NCT03168737|PET-CT|pet-ct
63663|NCT03168737|18F-fluoroazomycin arabinoside|18f-fluoroazomycin arabinoside
63664|NCT03168737|18F-FAZA|18f-faza
63665|NCT03168724|Cognition|cognition
63666|NCT03168724|Intervention|intervention
63667|NCT03168724|Self-management|self-management
63668|NCT03168724|Rehabilitation|rehabilitation
63669|NCT03168711|ALS|als
63670|NCT03168711|Inosine|inosine
63671|NCT03168711|Uric acid|uric acid
63672|NCT03168711|Urate|urate
63673|NCT03168711|Glutathione|glutathione
63674|NCT03168711|Biomarker|biomarker
63675|NCT03168711|Oxidative stress|oxidative stress
63676|NCT03168711|Oxidative damage|oxidative damage
63677|NCT03168698|pregnancy|pregnancy
63678|NCT03168698|postpartum hemorrhage|postpartum hemorrhage
63679|NCT03168698|cesarean delivery|cesarean delivery
63680|NCT03168698|carbetocin|carbetocin
63681|NCT03168698|duratocin|duratocin
63682|NCT03168698|oxytocin|oxytocin
63683|NCT03168685|smartphones|smartphones
63684|NCT03168685|clinical trials|clinical trials
63685|NCT03168685|weight|weight
63686|NCT03168685|actigraph|actigraph
63687|NCT03168685|tracking|tracking
63688|NCT03168685|hemophilia|hemophilia
63689|NCT03168633|: Type 2 Diabetes Mellitus|: type 2 diabetes mellitus
63690|NCT03168633|Web-based intervention|web-based intervention
63691|NCT03168633|medication adherence|medication adherence
63692|NCT03168633|lifestyle changes|lifestyle changes
63693|NCT03168607|ORR|orr
63694|NCT03168607|OS|os
63695|NCT03168607|PFS|pfs
63696|NCT03168607|safety|safety
63697|NCT03168594|chemotherapy|chemotherapy
63698|NCT03168594|OS|os
63699|NCT03168594|ORR|orr
63700|NCT03168594|PFS|pfs
63701|NCT03168594|safety|safety
63702|NCT03168529|Acute Heart Failure|acute heart failure
63703|NCT03168529|Observation|observation
63704|NCT03168529|Ivabradine|ivabradine
63705|NCT03168516|Oxygen|oxygen
63706|NCT03168516|closed-loop automatic control|closed-loop automatic control
63707|NCT03168516|Oxygen saturation|oxygen saturation
63708|NCT03168516|preterm infants|preterm infants
63709|NCT03168451|text messaging|text messaging
63710|NCT03168438|Cell Therapy|cell therapy
63711|NCT03168438|Multiple Myeloma|multiple myeloma
63712|NCT03168438|Immuno-oncology|immuno-oncology
63713|NCT03168438|T Cell Therapy|t cell therapy
63714|NCT03168438|Metastatic|metastatic
63715|NCT03168438|SPEAR T Cell|spear t cell
63716|NCT03168438|T Cell Receptor|t cell receptor
63717|NCT03168438|Previously Treated|previously treated
63718|NCT03168438|NY-ESO-1|ny-eso-1
63719|NCT03168425|safe opioid prescribing|safe opioid prescribing
63720|NCT03168412|Hepatitis E|hepatitis e
63721|NCT03168399|Phenylketonuria|phenylketonuria
63722|NCT03168399|PKU|pku
63723|NCT03168399|Metabolism|metabolism
63724|NCT03168399|Metabolic|metabolic
63725|NCT03168399|Control|control
63726|NCT03168399|Acceptability|acceptability
63727|NCT03168347|Decision making|decision making
63728|NCT03168269|CCTA interpretation|ccta interpretation
63729|NCT03168269|technicians|technicians
63730|NCT03168269|experts|experts
63731|NCT03168269|comparison|comparison
63732|NCT03168243|nutrition support, home enteral feeding|nutrition support, home enteral feeding
63733|NCT03168217|Periodontitis|periodontitis
63734|NCT03168217|classification|classification
63735|NCT03168217|Cluster analysis|cluster analysis
63736|NCT03168139|Metastatic colorectal cancer|metastatic colorectal cancer
63737|NCT03168139|Metastatic pancreatic cancer|metastatic pancreatic cancer
63738|NCT03168139|NOX-A12|nox-a12
63739|NCT03168139|Olaptesed pegol|olaptesed pegol
63740|NCT03168139|Spiegelmer|spiegelmer
63741|NCT03168139|Pembrolizumab|pembrolizumab
63742|NCT03168139|PD-1 inhibitor|pd-1 inhibitor
63743|NCT03168139|Stromal cell-derived factor-1 (SDF-1)|stromal cell-derived factor-1 (sdf-1)
63744|NCT03168139|CXCL12|cxcl12
63745|NCT03168139|Tumor microenvironment|tumor microenvironment
63746|NCT03168139|Immunotherapy|immunotherapy
63747|NCT03168139|Checkpoint inhibition|checkpoint inhibition
63748|NCT03168113|skin barrier function|skin barrier function
63749|NCT03168113|microbiome|microbiome
63750|NCT03168113|transepidermal water loss (TEWL)|transepidermal water loss (tewl)
63751|NCT03168113|epidermal transcriptome|epidermal transcriptome
63752|NCT03168113|epidermal lipid composition|epidermal lipid composition
63753|NCT03168061|advanced solid tumor|advanced solid tumor
63754|NCT03168061|unresectable soft tissue sarcoma|unresectable soft tissue sarcoma
63755|NCT03168048|mobile application|mobile application
63756|NCT03168048|radiotherapy|radiotherapy
63757|NCT03168048|patient-care|patient-care
63758|NCT03168048|mhealth|mhealth
63759|NCT03168048|follow-up|follow-up
63760|NCT03168048|patient satisfaction|patient satisfaction
63761|NCT03168048|quality of life|quality of life
63762|NCT03168009|BAT|bat
63763|NCT03168009|Bariatric Surgery|bariatric surgery
63764|NCT03168009|Energy Metabolism|energy metabolism
63765|NCT03167996|South Asian|south asian
63766|NCT03167996|Cardiovascular Risk Reduction|cardiovascular risk reduction
63767|NCT03167996|Metabolic Disorders|metabolic disorders
63768|NCT03167996|Lifestyle modifications|lifestyle modifications
63769|NCT03167957|fluconazole|fluconazole
63770|NCT03167957|fluconazole-resistant|fluconazole-resistant
63771|NCT03167944|Mastectomy|mastectomy
63772|NCT03167944|Seroma|seroma
63773|NCT03167931|non-invasive brain stimulation|non-invasive brain stimulation
63774|NCT03167931|neuromodulation|neuromodulation
63775|NCT03167931|semantic tasks|semantic tasks
63776|NCT03167918|calcium dobesilate|calcium dobesilate
63777|NCT03167918|Xuefuzhuyu Decoction|xuefuzhuyu decoction
63778|NCT03167918|pulmonary function|pulmonary function
63974|NCT03166332|Mindfulness|mindfulness
63779|NCT03167905|Anesthesia, Obstetrical|anesthesia, obstetrical
63780|NCT03167905|Epidural anesthesia|epidural anesthesia
63781|NCT03167905|Postnatal depression|postnatal depression
63782|NCT03167905|Persistent pain|persistent pain
63783|NCT03167879|family planning|family planning
63784|NCT03167879|safer conception|safer conception
63785|NCT03167879|HIV|hiv
63786|NCT03167879|serodiscordant couples|serodiscordant couples
63787|NCT03167879|Uganda|uganda
63788|NCT03167879|contraception|contraception
63789|NCT03167840|falls prevention, older adults, mild cognitive impairment|falls prevention, older adults, mild cognitive impairment
63790|NCT03167827|pelvic floor|pelvic floor
63791|NCT03167827|climateric|climateric
63792|NCT03167827|exercise|exercise
63793|NCT03167827|Supplementation of Isoflavone|supplementation of isoflavone
63794|NCT03167801|tetraplegia|tetraplegia
63795|NCT03167801|spinal cord injury|spinal cord injury
63796|NCT03167801|melatonin|melatonin
63797|NCT03167801|sleep quality|sleep quality
63798|NCT03167801|sleepiness|sleepiness
63799|NCT03167723|Chest tube size|chest tube size
63800|NCT03167723|Hemothorax|hemothorax
63801|NCT03167723|Empyema|empyema
63802|NCT03167697|Phenylketonuria|phenylketonuria
63803|NCT03167697|Hyperphenylalaninaemia|hyperphenylalaninaemia
63804|NCT03167697|Inherited Metabolic Disorders|inherited metabolic disorders
63805|NCT03167671|Oswestry|oswestry
63806|NCT03167671|SF 36|sf 36
63807|NCT03167671|Promis Pain and Function|promis pain and function
63808|NCT03167671|Berg Balance|berg balance
63809|NCT03167658|Wellness|wellness
63810|NCT03167658|Prevention|prevention
63811|NCT03167619|Mestastic|mestastic
63812|NCT03167619|Platinum Sensitive|platinum sensitive
63813|NCT03167619|Advanced|advanced
63814|NCT03167619|PARP inhibitor|parp inhibitor
63815|NCT03167606|myPEEPS|mypeeps
63816|NCT03167606|Mobile Intervention|mobile intervention
63817|NCT03167606|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
63818|NCT03167606|Men who have sex with men (MSM)|men who have sex with men (msm)
63819|NCT03167593|Lactobacillus coryniformis|lactobacillus coryniformis
63820|NCT03167593|Flu|flu
63821|NCT03167593|Vaccine|vaccine
63822|NCT03167528|Pain|pain
63823|NCT03167528|Quality of life|quality of life
63824|NCT03167476|miRNA|mirna
63825|NCT03167476|biomarker|biomarker
63826|NCT03167450|CRISPR|crispr
63827|NCT03167450|Gene Editing|gene editing
63828|NCT03167450|Qualitative|qualitative
63829|NCT03167450|Participation Clinical Trials|participation clinical trials
63830|NCT03167450|Genetic Literacy|genetic literacy
63831|NCT03167437|Reduce Symptoms of Crohn's Disease|reduce symptoms of crohn's disease
63832|NCT03167437|HDAC Inhibitors|hdac inhibitors
63833|NCT03167424|In-stent restenosis|in-stent restenosis
63834|NCT03167424|Bioresorbable vascular scaffold|bioresorbable vascular scaffold
63835|NCT03167424|Coronary angiography|coronary angiography
63836|NCT03167398|fecal microbiota transplantation|fecal microbiota transplantation
63837|NCT03167398|carbapenem-resistant enterobacteriaceae|carbapenem-resistant enterobacteriaceae
63838|NCT03167398|multidrug resistant bacteria|multidrug resistant bacteria
63839|NCT03167398|carrier|carrier
63840|NCT03167385|locally advanced differentiated thyroid carcinoma|locally advanced differentiated thyroid carcinoma
63841|NCT03167385|radioiodine refractory thyroid carcinoma|radioiodine refractory thyroid carcinoma
63842|NCT03167372|Light Therapy|light therapy
63843|NCT03167372|N-of-1|n-of-1
63844|NCT03167359|Psychiatry|psychiatry
63845|NCT03167359|Radiation Therapy|radiation therapy
63846|NCT03167346|stroke|stroke
63847|NCT03167346|core symptoms|core symptoms
63848|NCT03167346|public awareness|public awareness
63849|NCT03167346|FAST|fast
63850|NCT03167307|omega-3 fatty acids|omega-3 fatty acids
63851|NCT03167307|eicosapentaenoic acid|eicosapentaenoic acid
63852|NCT03167307|docosahexaenoic acid|docosahexaenoic acid
63853|NCT03167307|antidepressants|antidepressants
63854|NCT03167307|suicidality|suicidality
63855|NCT03167307|cognition|cognition
63856|NCT03167307|childhood depression|childhood depression
63857|NCT03167307|pediatric depression|pediatric depression
63858|NCT03167294|Aquablation|aquablation
63859|NCT03167294|AQUABEAM|aquabeam
63860|NCT03167294|BPH|bph
63861|NCT03167294|LUTS|luts
63862|NCT03167281|Chest tube|chest tube
63863|NCT03167281|Thoracostomy|thoracostomy
63864|NCT03167281|Pleural Diseases|pleural diseases
63865|NCT03167281|Lung Neoplasms|lung neoplasms
63866|NCT03167281|Pulmonary Embolism|pulmonary embolism
63867|NCT03167281|Pneumothorax|pneumothorax
63868|NCT03167281|Thoracic Surgery|thoracic surgery
63869|NCT03167281|Deoxyribonucleases|deoxyribonucleases
63870|NCT03167281|Fibrinolytic Agents|fibrinolytic agents
63871|NCT03167281|Drainage|drainage
63872|NCT03167281|Pleural Effusion|pleural effusion
63873|NCT03167268|Lycopene|lycopene
63874|NCT03167268|Anti EGFR therapy|anti egfr therapy
63875|NCT03167216|chronic pain|chronic pain
63876|NCT03167216|prostatitis|prostatitis
63877|NCT03167216|pelvic pain|pelvic pain
63878|NCT03167203|hESC-RPE|hesc-rpe
63879|NCT03167203|Macular Degenerative Disease|macular degenerative disease
63880|NCT03167190|Point of Care Ultrasound|point of care ultrasound
63881|NCT03167151|Recurrent intermediate risk NMIBC|recurrent intermediate risk nmibc
63882|NCT03167151|Intravesical Pembrolizumab|intravesical pembrolizumab
63883|NCT03167151|Intravenous Pembrolizumab|intravenous pembrolizumab
63884|NCT03167151|Phase I/II|phase i/ii
63885|NCT03167151|Marker-lesion|marker-lesion
63886|NCT03167151|Non-muscle invasive bladder cancer (NMIBC)|non-muscle invasive bladder cancer (nmibc)
63887|NCT03167138|Shoulder pain|shoulder pain
63888|NCT03167138|Rotator cuff disease|rotator cuff disease
63889|NCT03167138|Spinal cord injuries|spinal cord injuries
63890|NCT03167138|Mesenchymal stromal cells|mesenchymal stromal cells
63891|NCT03167138|Regenerative medicine|regenerative medicine
63892|NCT03167138|Rehabilitation|rehabilitation
63893|NCT03167125|colorectal cancer screening|colorectal cancer screening
63894|NCT03167125|cancer screening|cancer screening
63895|NCT03167125|pragmatic trial|pragmatic trial
63896|NCT03167125|boot camp translation|boot camp translation
63897|NCT03167112|Potentially Curable|potentially curable
63898|NCT03167112|Preoperative|preoperative
63899|NCT03167112|FOLFIRINOX|folfirinox
63900|NCT03167073|smartphone application|smartphone application
63901|NCT03167073|low-income women|low-income women
63902|NCT03167073|breastfeeding|breastfeeding
63903|NCT03167073|health education|health education
63904|NCT03167073|health disparities|health disparities
63905|NCT03167073|postpartum weight loss|postpartum weight loss
63906|NCT03167034|exercise|exercise
63907|NCT03167034|echocardiography|echocardiography
63908|NCT03167034|right ventricular function|right ventricular function
63909|NCT03167034|obstructive airway disease|obstructive airway disease
63910|NCT03167034|emphysema|emphysema
63911|NCT03167034|acetazolamide|acetazolamide
63912|NCT03167034|altitude|altitude
63913|NCT03167021|Cannabis|cannabis
63914|NCT03167021|Community pharmacy|community pharmacy
63915|NCT03167021|Prevention|prevention
63916|NCT03167021|Students|students
63917|NCT03166995|Fibromyalgia,postural exercises|fibromyalgia,postural exercises
63918|NCT03166982|Tubo-ovarian abscess|tubo-ovarian abscess
63919|NCT03166982|Transvaginal drainage|transvaginal drainage
63920|NCT03166982|Laparoscopic treatment|laparoscopic treatment
63921|NCT03166956|Vitamin C|vitamin c
63922|NCT03166956|Glutamine|glutamine
63923|NCT03166956|Interleukin-6|interleukin-6
63924|NCT03166956|Clinical outcomes|clinical outcomes
63925|NCT03166930|Muscle Spasticity|muscle spasticity
63926|NCT03166930|Muscle Stretching Exercises|muscle stretching exercises
63927|NCT03166891|ovarian cancer, relapsed or refractory,chiauranib|ovarian cancer, relapsed or refractory,chiauranib
63928|NCT03166878|CAR-T|car-t
63929|NCT03166878|Cancer treatment|cancer treatment
63930|NCT03166878|Immunotherapy|immunotherapy
63931|NCT03166878|Adoptive cell therapy|adoptive cell therapy
63932|NCT03166878|Chimeric antigen receptor|chimeric antigen receptor
63933|NCT03166878|Universal CAR-T|universal car-t
63934|NCT03166865|osteoarthritis (OA)|osteoarthritis (oa)
63935|NCT03166865|mesenchymal stem cells(MSC)|mesenchymal stem cells(msc)
63936|NCT03166839|maternal health|maternal health
63937|NCT03166839|statistical analysis plan|statistical analysis plan
63938|NCT03166813|remote ischaemic preconditioning|remote ischaemic preconditioning
63939|NCT03166813|childhood cancer|childhood cancer
63940|NCT03166813|cardio-oncology|cardio-oncology
63941|NCT03166813|anthracycline|anthracycline
63942|NCT03166813|myocardial reperfusion injury|myocardial reperfusion injury
63943|NCT03166800|mitoquinone|mitoquinone
63944|NCT03166800|Fatigue|fatigue
63945|NCT03166800|Multiple Sclerosis|multiple sclerosis
63946|NCT03166748|Incomplete lower first molar|incomplete lower first molar
63947|NCT03166748|Immature permanent molar|immature permanent molar
63948|NCT03166748|Potassium nitrate in polycarboxylate|potassium nitrate in polycarboxylate
63949|NCT03166748|Mineral trioxide aggregate .Mineral trioxid|mineral trioxide aggregate .mineral trioxid
63950|NCT03166644|Analgesia Nociception Index (ANI)|analgesia nociception index (ani)
63951|NCT03166644|Postoperative Analgesia|postoperative analgesia
63952|NCT03166644|Postoperative Hypoxemia|postoperative hypoxemia
63953|NCT03166566|glaucoma|glaucoma
63954|NCT03166566|glaucoma surgery|glaucoma surgery
63955|NCT03166566|glaucoma drainage device|glaucoma drainage device
63956|NCT03166566|glaucoma implant|glaucoma implant
63957|NCT03166566|blindness|blindness
63958|NCT03166540|coffee|coffee
63959|NCT03166540|cocoa|cocoa
63960|NCT03166540|bioavailability|bioavailability
63961|NCT03166540|pharmacokinetics|pharmacokinetics
63962|NCT03166540|cardiometabolic risk factors|cardiometabolic risk factors
63963|NCT03166540|caffeoylquinic acids|caffeoylquinic acids
63964|NCT03166540|flavan-3-ol|flavan-3-ol
63965|NCT03166540|caffeine|caffeine
63966|NCT03166540|trigonelline|trigonelline
63967|NCT03166540|diterpene|diterpene
63968|NCT03166449|Traumatic Brain injury|traumatic brain injury
63969|NCT03166449|Immunonutrition|immunonutrition
63970|NCT03166384|electrosurgical bipolar sealing devices, breast cancer|electrosurgical bipolar sealing devices, breast cancer
63971|NCT03166371|Endocrinology|endocrinology
63972|NCT03166371|Nutrition|nutrition
63973|NCT03166371|Aging|aging
63975|NCT03166332|Mediterranean diet|mediterranean diet
63976|NCT03166332|Neurodevelopment|neurodevelopment
63977|NCT03166332|Epigenetics|epigenetics
63978|NCT03166332|Fetal growth restriction|fetal growth restriction
63979|NCT03166306|pulmonary vascular disease|pulmonary vascular disease
63980|NCT03166306|pulmonary vascular imaging|pulmonary vascular imaging
63981|NCT03166293|Cerebral Palsy|cerebral palsy
63982|NCT03166293|Physical Therapy|physical therapy
63983|NCT03166293|Rehabilitation|rehabilitation
63984|NCT03166280|hepatitis C|hepatitis c
63985|NCT03166280|vitamin D|vitamin d
63986|NCT03166280|iron|iron
63987|NCT03166280|hepcidin|hepcidin
63988|NCT03166215|Drug therapy|drug therapy
63989|NCT03166202|age-related macular degeneration|age-related macular degeneration
63990|NCT03166189|Repeated IVF failure|repeated ivf failure
63991|NCT03166189|Stem cell|stem cell
63992|NCT03166163|bleeding on brushing|bleeding on brushing
63993|NCT03166150|Urinary Incontinence, pelvic floor muscle training|urinary incontinence, pelvic floor muscle training
63994|NCT03166137|Warts,Laser,Cryotherapy|warts,laser,cryotherapy
63995|NCT03166098|Psychotic Spectrum Disorders|psychotic spectrum disorders
63996|NCT03166085|HER2-Negative|her2-negative
63997|NCT03166085|PU-H71|pu-h71
63998|NCT03166085|Nab-paclitaxel (Abraxane)|nab-paclitaxel (abraxane)
63999|NCT03166085|17-093|17-093
64000|NCT03166072|Low-vision|low-vision
64001|NCT03166072|health related quality of life|health related quality of life
64002|NCT03166072|visual aids|visual aids
64003|NCT03166072|randomized controlled trial|randomized controlled trial
64004|NCT03166059|Catheter directed thrombolysis (CDT)|catheter directed thrombolysis (cdt)
64005|NCT03166033|Carpal Tunnel Syndrome|carpal tunnel syndrome
64006|NCT03166033|etiology|etiology
64007|NCT03166033|risk factor|risk factor
64008|NCT03166020|Serious Game|serious game
64009|NCT03166020|Stroke|stroke
64010|NCT03166020|Rehabilitation|rehabilitation
64011|NCT03166020|Connected objects|connected objects
64012|NCT03166007|Multiple Sclerosis|multiple sclerosis
64013|NCT03166007|Neurogenic Bowel Dysfunction|neurogenic bowel dysfunction
64014|NCT03166007|Abdominal massage|abdominal massage
64015|NCT03165994|esophagus|esophagus
64016|NCT03165994|gastroesoophageal (GE) junction|gastroesoophageal (ge) junction
64017|NCT03165994|T1-3N0-1|t1-3n0-1
64018|NCT03165981|Influenza vaccine|influenza vaccine
64019|NCT03165981|fever following vaccination|fever following vaccination
64020|NCT03165981|PCV13 vaccine|pcv13 vaccine
64021|NCT03165981|DTaP vaccine|dtap vaccine
64022|NCT03165981|pneumococcal vaccine|pneumococcal vaccine
64023|NCT03165955|breast cancer|breast cancer
64024|NCT03165955|paclitaxel|paclitaxel
64025|NCT03165929|free gingival grafts|free gingival grafts
64026|NCT03165929|connective tissue grafts|connective tissue grafts
64027|NCT03165929|flurbiprofen|flurbiprofen
64028|NCT03165890|cognition|cognition
64029|NCT03165890|visuomotor learning|visuomotor learning
64030|NCT03165890|airway disease|airway disease
64031|NCT03165890|altitude|altitude
64032|NCT03165890|prevention|prevention
64033|NCT03165890|acetazolamide|acetazolamide
64034|NCT03165877|GLYCEMIC INDEX|glycemic index
64035|NCT03165877|NAFLD|nafld
64036|NCT03165877|METABOLIC PARAMETERS|metabolic parameters
64037|NCT03165877|SATIETY|satiety
64038|NCT03165864|Thalassaemia, IONIS TMPRSS6-Lrx|thalassaemia, ionis tmprss6-lrx
64039|NCT03165838|postpartum|postpartum
64040|NCT03165838|pregnancy|pregnancy
64041|NCT03165838|contraception|contraception
64042|NCT03165838|RROP|rrop
64043|NCT03165812|Sleeve Gastrectomy|sleeve gastrectomy
64044|NCT03165812|Duodeno Jejunal Bypass|duodeno jejunal bypass
64045|NCT03165812|Single Anastomosis|single anastomosis
64046|NCT03165812|Intensive Medical Therapy|intensive medical therapy
64047|NCT03165812|Diabetes Mellitus|diabetes mellitus
64048|NCT03165786|fear of hypoglycemia|fear of hypoglycemia
64049|NCT03165786|self-management|self-management
64050|NCT03165786|glycemic control|glycemic control
64051|NCT03165786|glycemic variability|glycemic variability
64052|NCT03165760|protective mechanical ventilation|protective mechanical ventilation
64053|NCT03165747|Probiotics|probiotics
64054|NCT03165747|Menopausal Osteoporosis|menopausal osteoporosis
64055|NCT03165734|myelofibrosis|myelofibrosis
64056|NCT03165734|pacritinib|pacritinib
64057|NCT03165734|Post-polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
64058|NCT03165734|Post-essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
64059|NCT03165734|Ruxolitinib|ruxolitinib
64060|NCT03165734|Bone Marrow Disease|bone marrow disease
64061|NCT03165734|Hematologic Diseases|hematologic diseases
64062|NCT03165734|Blood Platelet Disorders|blood platelet disorders
64063|NCT03165734|Hemorrhagic Disorders|hemorrhagic disorders
64064|NCT03165734|Splenomegaly|splenomegaly
64065|NCT03165734|Anemia|anemia
64066|NCT03165734|Spleen volume|spleen volume
64067|NCT03165734|Spleen|spleen
64068|NCT03165721|Renal Cancer|renal cancer
64069|NCT03165721|DNA Hypermethylation|dna hypermethylation
64070|NCT03165721|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
64071|NCT03165721|DNA Methyltransferase (DNMT) Inhibitor|dna methyltransferase (dnmt) inhibitor
64072|NCT03165721|Succinate Dehydrogenase (SDH) Deficiency|succinate dehydrogenase (sdh) deficiency
64073|NCT03165708|Epidural technique|epidural technique
64074|NCT03165695|Delirium|delirium
64075|NCT03165695|Insomnia|insomnia
64076|NCT03165695|Ramelteon|ramelteon
64077|NCT03165682|fatigue|fatigue
64078|NCT03165682|depression|depression
64079|NCT03165682|cortical excitability|cortical excitability
64080|NCT03165669|education|education
64081|NCT03165669|sleep|sleep
64082|NCT03165669|pillow|pillow
64083|NCT03165669|neck|neck
64084|NCT03165656|Echocardiography|echocardiography
64085|NCT03165656|right ventricular function|right ventricular function
64086|NCT03165656|pulmonary hypertension|pulmonary hypertension
64087|NCT03165656|disease progression|disease progression
64088|NCT03165656|hypoxia|hypoxia
64089|NCT03165617|Influenza vaccine|influenza vaccine
64090|NCT03165604|Physical fitness|physical fitness
64091|NCT03165604|Exercise|exercise
64092|NCT03165604|Childhood Obesity|childhood obesity
64093|NCT03165604|Information|information
64094|NCT03165539|Postoperative|postoperative
64095|NCT03165539|One-lung ventilation|one-lung ventilation
64096|NCT03165539|Cerebral oximetry|cerebral oximetry
64097|NCT03165539|Cerebral desaturation|cerebral desaturation
64098|NCT03165513|Traditional healer|traditional healer
64099|NCT03165513|faith healer|faith healer
64100|NCT03165513|depression|depression
64101|NCT03165513|mhGAP|mhgap
64102|NCT03165513|Kenya|kenya
64103|NCT03165500|Exodontia|exodontia
64104|NCT03165500|Sedation|sedation
64105|NCT03165500|Nitrous Oxide|nitrous oxide
64106|NCT03165500|Benzodiazepines|benzodiazepines
64107|NCT03165487|Triple Negative Breast Cancer|triple negative breast cancer
64108|NCT03165487|microenvironment|microenvironment
64109|NCT03165487|IORT|iort
64110|NCT03165487|Hormone Receptor Positive, HER 2 negative|hormone receptor positive, her 2 negative
64111|NCT03165474|childhood obesity|childhood obesity
64112|NCT03165474|mhealth|mhealth
64113|NCT03165474|digital health|digital health
64114|NCT03165474|nutrition|nutrition
64115|NCT03165474|intervention|intervention
64116|NCT03165461|intubation to supraglottic devices|intubation to supraglottic devices
64117|NCT03165461|intubating laryngeal tube|intubating laryngeal tube
64118|NCT03165448|oral surgery|oral surgery
64119|NCT03165448|psychology|psychology
64120|NCT03165448|fear|fear
64121|NCT03165448|pain|pain
64122|NCT03165448|dentistry|dentistry
64123|NCT03165396|mild cognitive impairment|mild cognitive impairment
64124|NCT03165383|Transverse Abdominis Plane (TAP) Block|transverse abdominis plane (tap) block
64125|NCT03165383|Patient Control Analgesia (PCA)|patient control analgesia (pca)
64126|NCT03165357|Crossfit|crossfit
64127|NCT03165357|Sodium bicarbonate|sodium bicarbonate
64128|NCT03165357|Physical capacity|physical capacity
64129|NCT03165318|Pulsed electromagnetic field|pulsed electromagnetic field
64130|NCT03165318|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
64131|NCT03165318|Muscle|muscle
64132|NCT03165253|Helicobacter pylori infection|helicobacter pylori infection
64133|NCT03165253|Children|children
64134|NCT03165253|Synbiotic|synbiotic
64135|NCT03165253|Standard Triple Therapy|standard triple therapy
64136|NCT03165201|Liver transplantation and Biopsy|liver transplantation and biopsy
64137|NCT03165201|Liver transplantation and LiverMultiScan|liver transplantation and livermultiscan
64138|NCT03165175|prescription drug abuse|prescription drug abuse
64139|NCT03165175|prescription drug misuse|prescription drug misuse
64140|NCT03165175|risk reduction|risk reduction
64141|NCT03165175|education|education
64142|NCT03165175|military|military
64143|NCT03165175|mobile application|mobile application
64144|NCT03165175|substance misuse|substance misuse
64145|NCT03165175|substance abuse|substance abuse
64146|NCT03165162|natural|natural
64147|NCT03165162|Food Label Choices|food label choices
64148|NCT03165136|Unexplained Recurrent Miscarriage|unexplained recurrent miscarriage
64149|NCT03165136|First trimester abortion|first trimester abortion
64150|NCT03165136|Hydroxychloroquine|hydroxychloroquine
64151|NCT03165136|Antiphospholipid antibody|antiphospholipid antibody
64152|NCT03165097|tolerability|tolerability
64153|NCT03165097|safety|safety
64154|NCT03165084|Self-management|self-management
64155|NCT03165084|Primary Health Care|primary health care
64156|NCT03165084|eHealth|ehealth
64157|NCT03165032|exercise|exercise
64158|NCT03165032|echocardiography|echocardiography
64159|NCT03165032|right ventricular function|right ventricular function
64160|NCT03165032|pulmonary hypertension|pulmonary hypertension
64161|NCT03165032|hypoxia|hypoxia
64162|NCT03165019|high altitude illness|high altitude illness
64163|NCT03165019|pulmonary hypertension|pulmonary hypertension
64164|NCT03165019|sleep apnea|sleep apnea
64165|NCT03165019|disease progression|disease progression
64166|NCT03165019|hypoxia|hypoxia
64167|NCT03165006|Breast cancer, screening, survival|breast cancer, screening, survival
64168|NCT03164993|Neoplasms|neoplasms
64169|NCT03164980|Quality of life|quality of life
64170|NCT03164980|ovarian cancer|ovarian cancer
64171|NCT03164980|platinum sensitive|platinum sensitive
64172|NCT03164980|recurrent|recurrent
64173|NCT03164941|selective laser trabeculoplasty|selective laser trabeculoplasty
64174|NCT03164941|practice|practice
64175|NCT03164941|treatment|treatment
64176|NCT03164941|intraocular pressure|intraocular pressure
64177|NCT03164928|Denosumab|denosumab
64178|NCT03164928|Pediatric GIOP|pediatric giop
64179|NCT03164928|Glucocorticoid-induced|glucocorticoid-induced
64180|NCT03164928|Osteoporosis|osteoporosis
64181|NCT03164889|Chronic hepatitis B, antiviral treatment|chronic hepatitis b, antiviral treatment
64182|NCT03164863|Neoadjuvant Chemotherapy, Triple Negative Breast Cancer|neoadjuvant chemotherapy, triple negative breast cancer
64183|NCT03164824|Questionnaire|questionnaire
64184|NCT03164824|Functional Rating Index|functional rating index
64185|NCT03164824|Cross-cultural adaptation|cross-cultural adaptation
64186|NCT03164824|Psychometric properties testing|psychometric properties testing
64187|NCT03164772|mRNA Vaccine|mrna vaccine
64188|NCT03164772|Durvalumab|durvalumab
64189|NCT03164772|MEDI4736|medi4736
64190|NCT03164772|anti-PD-L1|anti-pd-l1
64191|NCT03164772|tremelimumab|tremelimumab
64192|NCT03164772|anti-CTLA-4|anti-ctla-4
64193|NCT03164772|BI 1361849|bi 1361849
64194|NCT03164746|Autism|autism
64195|NCT03164746|Therapeutic body wraps|therapeutic body wraps
64196|NCT03164681|sheerly|sheerly
64197|NCT03164642|Depressive Symptoms|depressive symptoms
64198|NCT03164642|Developmental Disabilities|developmental disabilities
64199|NCT03164642|Early Intervention|early intervention
64200|NCT03164642|Language Development|language development
64201|NCT03164642|Communication|communication
64202|NCT03164642|Maternal Empowerment|maternal empowerment
64203|NCT03164629|BPH|bph
64204|NCT03164629|Lower Urinary Track Infection|lower urinary track infection
64205|NCT03164629|Urine Retention|urine retention
64206|NCT03164616|NSCLC|nsclc
64207|NCT03164616|PD-L1|pd-l1
64208|NCT03164616|Durvalumab|durvalumab
64209|NCT03164616|Tremelimumab|tremelimumab
64210|NCT03164616|PFS|pfs
64211|NCT03164551|GERI+|geri+
64212|NCT03164551|TICON|ticon
64213|NCT03164551|EEVA|eeva
64214|NCT03164551|Embryo culture|embryo culture
64215|NCT03164551|In Vitro Fertilization|in vitro fertilization
64216|NCT03164551|Intracytoplasmic Sperm Injection|intracytoplasmic sperm injection
64217|NCT03164525|Thai version|thai version
64218|NCT03164525|validated|validated
64219|NCT03164525|Critical Care Pain Observation Tool|critical care pain observation tool
64220|NCT03164525|Behavioral Pain Scale|behavioral pain scale
64221|NCT03164525|adult ICU patients|adult icu patients
64222|NCT03164499|Health education|health education
64223|NCT03164499|Life style|life style
64224|NCT03164499|Risk factors|risk factors
64225|NCT03164499|Cardiovascular diseases|cardiovascular diseases
64226|NCT03164499|Cognitive performance|cognitive performance
64227|NCT03164499|Quality of life|quality of life
64228|NCT03164473|Eosinophilic granulomatosis with polyangiitis in remission|eosinophilic granulomatosis with polyangiitis in remission
64229|NCT03164473|double-blind randomized controlled trial|double-blind randomized controlled trial
64230|NCT03164473|maintenance therapy|maintenance therapy
64231|NCT03164473|rituximab versus azathioprine|rituximab versus azathioprine
64232|NCT03164473|vasculitis remission|vasculitis remission
64233|NCT03164473|asthma control|asthma control
64234|NCT03164473|rhinosinusal manifestations control|rhinosinusal manifestations control
64235|NCT03164473|glucocorticoid therapy reduction/withdrawal|glucocorticoid therapy reduction/withdrawal
64236|NCT03164473|steroid sparing effect|steroid sparing effect
64237|NCT03164473|damage|damage
64238|NCT03164460|Head and Neck Cancer|head and neck cancer
64239|NCT03164460|Stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
64240|NCT03164460|SBRT|sbrt
64241|NCT03164460|Intensity modulated radiation therapy|intensity modulated radiation therapy
64242|NCT03164460|IMRT|imrt
64243|NCT03164460|Intensity modulated proton therapy|intensity modulated proton therapy
64244|NCT03164460|IMPT|impt
64245|NCT03164460|Questionnaires|questionnaires
64246|NCT03164460|Surveys|surveys
64247|NCT03164434|intracranial pressure|intracranial pressure
64248|NCT03164434|cerebrospinal fluid drainage|cerebrospinal fluid drainage
64249|NCT03164434|waveform analysis|waveform analysis
64250|NCT03164395|atrial fibrillation|atrial fibrillation
64251|NCT03164395|implantable cardiac defibrillator|implantable cardiac defibrillator
64252|NCT03164395|cardioversion|cardioversion
64253|NCT03164369|epidural block, ultrasound|epidural block, ultrasound
64254|NCT03164356|Limb Fluid Volume Management|limb fluid volume management
64255|NCT03164356|Prosthetic Socket Modification|prosthetic socket modification
64256|NCT03164343|Pain Neuroscience Education|pain neuroscience education
64257|NCT03164330|Health Care|health care
64258|NCT03164330|Workplace Wellness|workplace wellness
64259|NCT03164330|Preventative Health Care|preventative health care
64260|NCT03164330|Health Costs|health costs
64261|NCT03164317|Hypertension|hypertension
64262|NCT03164317|High blood pressure|high blood pressure
64263|NCT03164317|Task shifting|task shifting
64264|NCT03164317|Decision support system|decision support system
64265|NCT03164291|MAC and NTM|mac and ntm
64266|NCT03164278|Wheelchair|wheelchair
64267|NCT03164278|Biomechanics|biomechanics
64268|NCT03164278|Transfer|transfer
64269|NCT03164278|Participation|participation
64270|NCT03164278|Training|training
64271|NCT03164265|Regulatory Dendritic Cells|regulatory dendritic cells
64272|NCT03164252|Third molar;|third molar;
64273|NCT03164252|Third molar surgery;|third molar surgery;
64274|NCT03164252|Laser;|laser;
64275|NCT03164252|Tissue Repair.|tissue repair.
64276|NCT03164226|endothelial function|endothelial function
64277|NCT03164226|acute coronary syndrome|acute coronary syndrome
64278|NCT03164213|tDCS|tdcs
64279|NCT03164213|aphasia|aphasia
64280|NCT03164161|Pain Sensitivity|pain sensitivity
64281|NCT03164161|Measurement|measurement
64282|NCT03164161|Cold Pressor|cold pressor
64283|NCT03164161|β-endorphins|β-endorphins
64284|NCT03164161|saliva|saliva
64285|NCT03164161|oral surgery|oral surgery
64286|NCT03164109|Healthy Adult|healthy adult
64287|NCT03164109|Superoxide Dismutase|superoxide dismutase
64288|NCT03164109|Free Radical Dismutase|free radical dismutase
64289|NCT03164109|Cardiodynamic Assessment|cardiodynamic assessment
64290|NCT03164083|Joint Diseases|joint diseases
64291|NCT03164083|Musculoskeletal Diseases|musculoskeletal diseases
64292|NCT03164083|Arthritis|arthritis
64293|NCT03164070|Osteoarthritis|osteoarthritis
64294|NCT03164070|Flow cytometry|flow cytometry
64295|NCT03164070|Synovial fluid|synovial fluid
64296|NCT03164057|DNA methyltransferase inhibitors|dna methyltransferase inhibitors
64297|NCT03164057|Acute myeloid leukemia|acute myeloid leukemia
64298|NCT03164044|Allergy|allergy
64299|NCT03164044|Drug allergy|drug allergy
64300|NCT03164044|Basophil activation test|basophil activation test
64301|NCT03164044|Flow cytometry|flow cytometry
64302|NCT03164005|VEGF-B|vegf-b
64303|NCT03163979|locally advanced cervical cancer; radiotherapy|locally advanced cervical cancer; radiotherapy
64304|NCT03163953|Physical Activity|physical activity
64305|NCT03163953|Sedentary Lifestyle|sedentary lifestyle
64306|NCT03163953|Office Workers|office workers
64307|NCT03163940|Laughter Yoga|laughter yoga
64308|NCT03163940|Major Depressive Disorder|major depressive disorder
64309|NCT03163940|Anxiety|anxiety
64310|NCT03163940|Stress|stress
64311|NCT03163940|Depression|depression
64312|NCT03163940|Quality of Life|quality of life
64313|NCT03163940|Mood Disorder|mood disorder
64314|NCT03163914|vasopressor|vasopressor
64315|NCT03163914|spinal anaesthesia|spinal anaesthesia
64316|NCT03163901|traumatic brain injury|traumatic brain injury
64317|NCT03163875|erythema|erythema
64318|NCT03163875|wheal formation|wheal formation
64319|NCT03163875|vascular reaction of the skin|vascular reaction of the skin
64320|NCT03163862|IVF|ivf
64321|NCT03163836|Double Valve Replacement|double valve replacement
64322|NCT03163836|Atrial Fibrillation Ablation|atrial fibrillation ablation
64323|NCT03163797|Oropharyngeal cancer|oropharyngeal cancer
64324|NCT03163797|integrated PET/MR|integrated pet/mr
64325|NCT03163797|diffusion-weighted imaging|diffusion-weighted imaging
64326|NCT03163797|perfusion-weighted imaging|perfusion-weighted imaging
64327|NCT03163758|Ischemic stroke|ischemic stroke
64328|NCT03163758|Functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
64329|NCT03163758|Repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
64330|NCT03163758|Brain Reorganization|brain reorganization
64331|NCT03163732|Solid tumor|solid tumor
64332|NCT03163732|Advanced tumor|advanced tumor
64333|NCT03163732|Profiling panel|profiling panel
64334|NCT03163719|Seizure|seizure
64335|NCT03163719|Generalized convulsive seizure|generalized convulsive seizure
64336|NCT03163719|Convulsions|convulsions
64337|NCT03163719|Creatine Kinase|creatine kinase
64338|NCT03163719|Lactate|lactate
64339|NCT03163719|Lactacidaemia|lactacidaemia
64340|NCT03163719|Diagnostic|diagnostic
64341|NCT03163719|Losing consciousness|losing consciousness
64342|NCT03163719|Epilepsy|epilepsy
64343|NCT03163719|Epileptic generalized tonic-clonic seizure|epileptic generalized tonic-clonic seizure
64344|NCT03163706|Schizophrenia|schizophrenia
64345|NCT03163706|Stroop effect|stroop effect
64346|NCT03163706|Semantic conflict|semantic conflict
64347|NCT03163706|Response conflict|response conflict
64348|NCT03163693|Dexmedetomidine|dexmedetomidine
64349|NCT03163693|Cardiac Troponin I|cardiac troponin i
64350|NCT03163693|Glycogen Phosphorylase Isoenzyme BB|glycogen phosphorylase isoenzyme bb
64351|NCT03163680|Gastroduodenal Ulcer|gastroduodenal ulcer
64352|NCT03163680|Marginal Ulcer|marginal ulcer
64353|NCT03163680|Peptic Ulcer Hemorrhage|peptic ulcer hemorrhage
64354|NCT03163680|Peptic Ulcer|peptic ulcer
64355|NCT03163667|advanced, metastatic RCC|advanced, metastatic rcc
64356|NCT03163667|RCC|rcc
64357|NCT03163667|CB-839|cb-839
64358|NCT03163667|Everolimus|everolimus
64359|NCT03163667|CBE|cbe
64360|NCT03163667|Glutaminase Inhibitor|glutaminase inhibitor
64361|NCT03163667|Glutaminase|glutaminase
64362|NCT03163667|Tumor Metabolism|tumor metabolism
64363|NCT03163667|Glutamine|glutamine
64364|NCT03163654|multiple gingival recessions|multiple gingival recessions
64365|NCT03163654|collagen matrix|collagen matrix
64366|NCT03163654|connective tissue graft|connective tissue graft
64367|NCT03163654|tunnel technique|tunnel technique
64368|NCT03163628|severe bacterial infection|severe bacterial infection
64369|NCT03163628|acute infection|acute infection
64370|NCT03163628|infection viral|infection viral
64371|NCT03163628|biomarker combination|biomarker combination
64372|NCT03163628|diagnostic|diagnostic
64373|NCT03163628|child|child
64374|NCT03163602|Peri-Implantitis|peri-implantitis
64375|NCT03163602|Infection|infection
64376|NCT03163602|Bone substitutes|bone substitutes
64377|NCT03163524|family planning|family planning
64378|NCT03163524|reproductive health|reproductive health
64379|NCT03163524|m-health|m-health
64380|NCT03163498|Hypertension|hypertension
64381|NCT03163498|Exercise|exercise
64382|NCT03163498|Sleep|sleep
64383|NCT03163485|epilepsy|epilepsy
64384|NCT03163485|multimodal neuromonitoring|multimodal neuromonitoring
64385|NCT03163485|depth EEG|depth eeg
64386|NCT03163485|microdialysis|microdialysis
64387|NCT03163485|brain injury|brain injury
64388|NCT03163485|brain tissue at risk|brain tissue at risk
64389|NCT03163485|NCSE|ncse
64390|NCT03163485|short time monitoring|short time monitoring
64391|NCT03163485|neurologic ICU|neurologic icu
64392|NCT03163459|mechanical thrombectomy|mechanical thrombectomy
64393|NCT03163459|selective brain cooling|selective brain cooling
64394|NCT03163446|Staphylococcus aureus|staphylococcus aureus
64395|NCT03163446|bacteremia|bacteremia
64396|NCT03163446|staphylococcal endocarditis|staphylococcal endocarditis
64397|NCT03163433|Patient activation measure|patient activation measure
64398|NCT03163433|Self-efficacy|self-efficacy
64399|NCT03163433|Patient participation in research|patient participation in research
64400|NCT03163433|Patient reported outcome measures|patient reported outcome measures
64401|NCT03163420|Anesthetic efficacy|anesthetic efficacy
64402|NCT03163420|Diclofenac|diclofenac
64403|NCT03163420|Irreversible pulpitis|irreversible pulpitis
64404|NCT03163381|first-line treatment failure|first-line treatment failure
64405|NCT03163381|one measurable lesion|one measurable lesion
64406|NCT03163368|metastatic tumor|metastatic tumor
64407|NCT03163368|brain lesion|brain lesion
64408|NCT03163368|stereotactic radiosurgery|stereotactic radiosurgery
64409|NCT03163368|neoadjuvant|neoadjuvant
64410|NCT03163368|maximum tolerated dose|maximum tolerated dose
64411|NCT03163368|dose escalation|dose escalation
64412|NCT03163368|neurosurgical resection|neurosurgical resection
64413|NCT03163355|pureed diet|pureed diet
64414|NCT03163355|dysphasia|dysphasia
64415|NCT03163342|Seasonal|seasonal
64416|NCT03163303|Tobacco|tobacco
64417|NCT03163303|Cigarettes|cigarettes
64418|NCT03163303|Alcohol|alcohol
64419|NCT03163303|Cessation|cessation
64420|NCT03163303|Intervention|intervention
64421|NCT03163303|Young adults|young adults
64422|NCT03163303|Internet|internet
64423|NCT03163303|Social media|social media
64424|NCT03163264|obesity|obesity
64425|NCT03163264|weight loss|weight loss
64426|NCT03163264|weight gain|weight gain
64427|NCT03163264|weight management|weight management
64428|NCT03163264|primary care|primary care
64429|NCT03163264|health coach|health coach
64430|NCT03163251|READ-SG|read-sg
64431|NCT03163251|Burnout|burnout
64432|NCT03163251|Professional identity|professional identity
64433|NCT03163251|Empathy|empathy
64434|NCT03163251|Emotional intelligence|emotional intelligence
64435|NCT03163238|Dexmedetomidine|dexmedetomidine
64436|NCT03163238|Congenital Heart Disease|congenital heart disease
64437|NCT03163238|Cardiopulmonary Bypass|cardiopulmonary bypass
64438|NCT03163238|Interleukin|interleukin
64439|NCT03163225|outpatient care|outpatient care
64440|NCT03163225|emergency department visits|emergency department visits
64441|NCT03163212|Lactoferrin/FOS Supplementation|lactoferrin/fos supplementation
64442|NCT03163173|Healthy Adult|healthy adult
64443|NCT03163173|Superoxide Dismutase|superoxide dismutase
64444|NCT03163173|Absorption|absorption
64445|NCT03163173|Metabolism|metabolism
64446|NCT03163173|Elimination|elimination
64447|NCT03163173|Mass Balance|mass balance
64448|NCT03163173|Male Subjects|male subjects
64449|NCT03163160|pelvic floor muscles|pelvic floor muscles
64450|NCT03163160|pelvic floor myalgia|pelvic floor myalgia
64451|NCT03163160|manual therapy|manual therapy
64452|NCT03163160|electrolysis|electrolysis
64453|NCT03163160|galvanic|galvanic
64454|NCT03163147|frequency|frequency
64455|NCT03163134|Lumbar Drain, CSF Leak|lumbar drain, csf leak
64456|NCT03163121|Plasmodium falciparum|plasmodium falciparum
64457|NCT03163121|PfSPZ Vaccine|pfspz vaccine
64458|NCT03163121|PfSPZ-GA1 Vaccine|pfspz-ga1 vaccine
64459|NCT03163121|Controlled human malaria infection (CHMI)|controlled human malaria infection (chmi)
64460|NCT03163121|Genetically attenuated sporozoites|genetically attenuated sporozoites
64461|NCT03163121|Plasmodium falciparum sporozoites (PfSPZ)|plasmodium falciparum sporozoites (pfspz)
64462|NCT03163108|controller|controller
64463|NCT03163108|hyperoxia|hyperoxia
64464|NCT03163108|hypoxia|hypoxia
64465|NCT03163108|ventilation|ventilation
64466|NCT03163108|cerebral oxygenation|cerebral oxygenation
64467|NCT03163095|sepsis|sepsis
64468|NCT03163095|abdominal infection|abdominal infection
64469|NCT03163095|open abdomen management|open abdomen management
64470|NCT03163095|Negative pressure peritoneal therapy|negative pressure peritoneal therapy
64471|NCT03163082|Coercion theory|coercion theory
64472|NCT03163082|Corrosive Couple Coercion|corrosive couple coercion
64473|NCT03163069|tooth bleaching|tooth bleaching
64474|NCT03163069|dentifrice|dentifrice
64475|NCT03163056|Smoking cessation|smoking cessation
64476|NCT03163056|Depression|depression
64477|NCT03163056|Clinical trial|clinical trial
64478|NCT03163030|Heart Failure|heart failure
64479|NCT03163030|Preserved Ejection Fraction|preserved ejection fraction
64480|NCT03163030|VNS|vns
64481|NCT03163030|Vagus Nerve|vagus nerve
64482|NCT03163030|Autonomic Regulation Therapy|autonomic regulation therapy
64483|NCT03163017|3D Fluoroscopy|3d fluoroscopy
64484|NCT03163004|Sedentary behavior|sedentary behavior
64485|NCT03162978|Exercise|exercise
64486|NCT03162978|behavior economics|behavior economics
64487|NCT03162952|Chronic pain|chronic pain
64488|NCT03162913|Strawberry|strawberry
64489|NCT03162913|Cognition|cognition
64490|NCT03162913|Gait|gait
64491|NCT03162913|Posture|posture
64492|NCT03162900|Glasdegib|glasdegib
64493|NCT03162900|PF-04449913|pf-04449913
64494|NCT03162900|Pharmacokinetics|pharmacokinetics
64495|NCT03162900|QTc|qtc
64496|NCT03162900|TQT|tqt
64497|NCT03162874|Levodopa-Induced Dyskinesia (LID)|levodopa-induced dyskinesia (lid)
64498|NCT03162874|Wearing-off|wearing-off
64499|NCT03162874|Foliglurax|foliglurax
64500|NCT03162874|Parkinson's Disease|parkinson's disease
64501|NCT03162874|mGluR4 PAM|mglur4 pam
64502|NCT03162835|Pain Neuroscience Education|pain neuroscience education
64503|NCT03162822|Caregiver-Child Coercion|caregiver-child coercion
64504|NCT03162822|Early Childhood Caries|early childhood caries
64505|NCT03162809|infertility|infertility
64506|NCT03162809|in vitro fertilization|in vitro fertilization
64507|NCT03162809|Estradiol|estradiol
64508|NCT03162809|Progesterone|progesterone
64509|NCT03162783|Aldeyra|aldeyra
64510|NCT03162770|mindfulness meditation|mindfulness meditation
64511|NCT03162770|hemodialysis|hemodialysis
64512|NCT03162770|quality of life|quality of life
64513|NCT03162770|stress|stress
64514|NCT03162718|lung cancer|lung cancer
64515|NCT03162718|exercise|exercise
64516|NCT03162718|pre-operative exercise program|pre-operative exercise program
64517|NCT03162679|trauma treatment|trauma treatment
64518|NCT03162679|Refugees|refugees
64519|NCT03162679|Emotion regulation|emotion regulation
64520|NCT03162679|Group therapy|group therapy
64521|NCT03162679|randomized controlled|randomized controlled
64522|NCT03162679|PTSD|ptsd
64523|NCT03162653|Allopurinol|allopurinol
64524|NCT03162653|hypothermia therapy|hypothermia therapy
64525|NCT03162653|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
64526|NCT03162653|neonatal oxygen deficiency|neonatal oxygen deficiency
64527|NCT03162653|childbirth outcome|childbirth outcome
64528|NCT03162653|perinatal asphyxia|perinatal asphyxia
64529|NCT03162640|Early onset of cannabis use|early onset of cannabis use
64530|NCT03162640|Addiction|addiction
64531|NCT03162640|Time perception|time perception
64532|NCT03162627|Malignant neoplasm of breast|malignant neoplasm of breast
64533|NCT03162627|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
64534|NCT03162627|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
64535|NCT03162627|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
64536|NCT03162627|Malignant neoplasms of thyroid and other endocrine glands|malignant neoplasms of thyroid and other endocrine glands
64537|NCT03162627|Solid tumors|solid tumors
64538|NCT03162627|Ras Pathway Alterations|ras pathway alterations
64539|NCT03162627|Ovarian Tumors with PARP Resistance|ovarian tumors with parp resistance
64540|NCT03162627|Selumetinib|selumetinib
64541|NCT03162627|AZD6244|azd6244
64542|NCT03162627|Olaparib|olaparib
64543|NCT03162627|Lynparza|lynparza
64544|NCT03162614|healthy volunteers|healthy volunteers
64545|NCT03162614|Malaria|malaria
64546|NCT03162614|malaria vaccine|malaria vaccine
64547|NCT03162614|controlled human challenge|controlled human challenge
64548|NCT03162614|RTS,S/AS01|rts,s/as01
64549|NCT03162536|ARQ 531|arq 531
64550|NCT03162536|Hematologic Malignancies|hematologic malignancies
64551|NCT03162536|SLL|sll
64552|NCT03162536|CLL|cll
64553|NCT03162536|B-cell NHL|b-cell nhl
64554|NCT03162536|WM|wm
64555|NCT03162536|BTK|btk
64556|NCT03162536|cancer|cancer
64557|NCT03162536|refractory|refractory
64558|NCT03162536|relapsed|relapsed
64559|NCT03162510|SOLAR regimen|solar regimen
64560|NCT03162471|Corneal astigmatism|corneal astigmatism
64561|NCT03162471|Cataract surgery|cataract surgery
64562|NCT03162471|Corneal hysteresis|corneal hysteresis
64563|NCT03162471|Corneal resistance factor|corneal resistance factor
64564|NCT03162471|Intraocular pressure|intraocular pressure
64565|NCT03162445|bone mineral density|bone mineral density
64566|NCT03162445|Autism Spectrum Disorder|autism spectrum disorder
64567|NCT03162445|Autism|autism
64568|NCT03162432|IBD|ibd
64569|NCT03162393|brachial plexus; avulsion injury|brachial plexus; avulsion injury
64570|NCT03162380|Bipolar Disorder|bipolar disorder
64571|NCT03162380|occupational stress|occupational stress
64572|NCT03162367|Burn|burn
64573|NCT03162367|Epidermal cell suspension|epidermal cell suspension
64574|NCT03162341|Dual-Energy Computed Tomography|dual-energy computed tomography
64575|NCT03162341|UltraSonography|ultrasonography
64576|NCT03162341|Gout|gout
64577|NCT03162341|Urate deposition|urate deposition
64578|NCT03162302|MRI|mri
64579|NCT03162302|magnetic resonance imaging|magnetic resonance imaging
64580|NCT03162302|fat quantification|fat quantification
64581|NCT03162302|iron quantification|iron quantification
64582|NCT03162289|Fasting|fasting
64583|NCT03162289|Vegan|vegan
64584|NCT03162276|BRCA 1/2 Carriers|brca 1/2 carriers
64585|NCT03162276|The Work|the work
64586|NCT03162276|RCT|rct
64587|NCT03162276|IBSR|ibsr
64588|NCT03162263|Ekso|ekso
64589|NCT03162263|neuroplasticity|neuroplasticity
64590|NCT03162263|functional recovery|functional recovery
64591|NCT03162237|Type1 diabetes|type1 diabetes
64592|NCT03162237|porcine islets|porcine islets
64593|NCT03162237|treg cells|treg cells
64594|NCT03162237|immunosuppress|immunosuppress
64595|NCT03162237|xenotransplantation|xenotransplantation
64596|NCT03162224|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
64597|NCT03162224|Oropharyngeal Cancer|oropharyngeal cancer
64598|NCT03162224|HPV|hpv
64599|NCT03162224|Human Papilloma Virus|human papilloma virus
64600|NCT03162224|Cancer Immunotherapy|cancer immunotherapy
64601|NCT03162224|Check point inhibitors|check point inhibitors
64602|NCT03162224|PD-L1 inhibitor|pd-l1 inhibitor
64603|NCT03162224|Recurrent or Metastatic Cancer|recurrent or metastatic cancer
64604|NCT03162224|Durvalumab|durvalumab
64605|NCT03162224|MEDI0457|medi0457
64606|NCT03162224|Antineoplastic agents|antineoplastic agents
64607|NCT03162224|Neoplasms|neoplasms
64608|NCT03162185|Neuroplasticity|neuroplasticity
64609|NCT03162185|SSRI|ssri
64610|NCT03162185|Motor Learning|motor learning
64611|NCT03162172|congenital adrenal hyperplasia|congenital adrenal hyperplasia
64612|NCT03162172|short stature|short stature
64613|NCT03162172|growth hormone treatment|growth hormone treatment
64614|NCT03162133|Breast Cancer|breast cancer
64615|NCT03162133|Aromatase Inhibitor Therapy|aromatase inhibitor therapy
64616|NCT03162133|Baduanjin Exercise|baduanjin exercise
64617|NCT03162107|adherence|adherence
64618|NCT03162107|HIV|hiv
64619|NCT03162107|MDR/XDR TB|mdr/xdr tb
64620|NCT03162107|Health Care Worker|health care worker
64621|NCT03162081|addiction|addiction
64622|NCT03162081|cognition|cognition
64623|NCT03162081|impulsivity|impulsivity
64624|NCT03162081|neuropsychology|neuropsychology
64625|NCT03162081|prescription drug misuse|prescription drug misuse
64626|NCT03162081|dependence|dependence
64627|NCT03162068|Cushing's syndrome|cushing's syndrome
64628|NCT03162068|Osteoporosis|osteoporosis
64629|NCT03162068|peripheral Quantitative Computed|peripheral quantitative computed
64630|NCT03162068|volumetric Bone Mineral Density|volumetric bone mineral density
64631|NCT03162068|Cortical and trabecular bone|cortical and trabecular bone
64632|NCT03162068|Bone Strength|bone strength
64633|NCT03162055|COPD|copd
64634|NCT03162042|Activin A|activin a
64635|NCT03162042|Myostatin|myostatin
64636|NCT03162042|Follistatin|follistatin
64637|NCT03162042|Cachexia|cachexia
64638|NCT03162042|Squamous cell carcinoma|squamous cell carcinoma
64639|NCT03162029|CBCT|cbct
64640|NCT03162029|Bone quality|bone quality
64641|NCT03162029|Renal failure|renal failure
64642|NCT03161990|DAIR|dair
64643|NCT03161990|Transgluteal approach|transgluteal approach
64644|NCT03161990|Posterior approach|posterior approach
64645|NCT03161964|Hypoglycemia|hypoglycemia
64646|NCT03161964|Impaired Awareness of Hypoglycemia|impaired awareness of hypoglycemia
64647|NCT03161964|Propranolol|propranolol
64648|NCT03161951|acute Infections, flow cytometry, cell activation|acute infections, flow cytometry, cell activation
64649|NCT03161912|Diabetes|diabetes
64650|NCT03161912|Retinal Diseases|retinal diseases
64651|NCT03161912|Diabetic Retinopathy|diabetic retinopathy
64652|NCT03161912|Diabetic macular edema|diabetic macular edema
64653|NCT03161912|Retinal vein occlusion|retinal vein occlusion
64654|NCT03161912|Macular edema secondary to retinal vein occlusion|macular edema secondary to retinal vein occlusion
64655|NCT03161912|Intravitreal anti-VEGF (vascular endothelial growth factor)|intravitreal anti-vegf (vascular endothelial growth factor)
64656|NCT03161912|VEGF inhibitor|vegf inhibitor
64657|NCT03161912|aflibercept|aflibercept
64658|NCT03161912|real world data|real world data
64659|NCT03161912|treatment pattern|treatment pattern
64660|NCT03161899|thalassemia - nutrition -growth|thalassemia - nutrition -growth
64661|NCT03161886|colon capsule endoscopy|colon capsule endoscopy
64662|NCT03161860|Program evaluation|program evaluation
64663|NCT03161860|Cost-effectiveness|cost-effectiveness
64664|NCT03161860|Community participation|community participation
64665|NCT03161860|empowerment|empowerment
64666|NCT03161847|OPMD|opmd
64667|NCT03161834|DNA|dna
64668|NCT03161834|Circulating tumor cells|circulating tumor cells
64669|NCT03161795|Chemical coping|chemical coping
64670|NCT03161795|Long-term opioid therapy|long-term opioid therapy
64671|NCT03161795|Risk factors|risk factors
64672|NCT03161795|Predictive tools|predictive tools
64673|NCT03161795|Frequency|frequency
64674|NCT03161782|pain|pain
64675|NCT03161782|exercise|exercise
64676|NCT03161782|proprioceptive neuromuscular facilitation stretching|proprioceptive neuromuscular facilitation stretching
64677|NCT03161782|static stretching|static stretching
64678|NCT03161743|platelet-rich plasma|platelet-rich plasma
64679|NCT03161743|platelet|platelet
64680|NCT03161730|videolaryngoscope, novice|videolaryngoscope, novice
64681|NCT03161717|electrical stimulation|electrical stimulation
64682|NCT03161717|vaginal delivery|vaginal delivery
64683|NCT03161678|Pharmacogenetics|pharmacogenetics
64684|NCT03161678|Carboxylesterase 1 (CES1)|carboxylesterase 1 (ces1)
64685|NCT03161678|Antiplatelet therapy|antiplatelet therapy
64686|NCT03161652|diabetic retinopathy|diabetic retinopathy
64687|NCT03161652|blindness|blindness
64688|NCT03161652|eye|eye
64689|NCT03161652|macular edema|macular edema
64690|NCT03161652|prolactin|prolactin
64691|NCT03161652|dopamine antagonists|dopamine antagonists
64692|NCT03161652|peptide hormones|peptide hormones
64693|NCT03161639|Pulpectomy|pulpectomy
64694|NCT03161639|Primary teeth|primary teeth
64695|NCT03161639|Working length|working length
64696|NCT03161639|Apex locator|apex locator
64697|NCT03161587|FEV1|fev1
64698|NCT03161587|COPD|copd
64699|NCT03161587|CAT|cat
64700|NCT03161587|treatment modality|treatment modality
64701|NCT03161587|FVC|fvc
64702|NCT03161587|GOLD 2016|gold 2016
64703|NCT03161587|mMRC|mmrc
64704|NCT03161574|neochemotherapy|neochemotherapy
64705|NCT03161574|CRM|crm
64706|NCT03161522|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
64707|NCT03161522|Esophageal Cancer|esophageal cancer
64708|NCT03161522|Gastric Cancer|gastric cancer
64709|NCT03161522|Oligometastatic|oligometastatic
64710|NCT03161522|Chemotherapy|chemotherapy
64711|NCT03161522|Radiation therapy|radiation therapy
64712|NCT03161522|Surgery|surgery
64713|NCT03161522|Questionnaires|questionnaires
64714|NCT03161522|Surveys|surveys
64715|NCT03161483|CC-220|cc-220
64716|NCT03161483|Safety|safety
64717|NCT03161483|Efficacy|efficacy
64718|NCT03161483|Active Systemic Lupus Erythematosus|active systemic lupus erythematosus
64719|NCT03161457|RA|ra
64720|NCT03161457|Moderate RA|moderate ra
64721|NCT03161457|Moderate Rheumatoid Arthritis|moderate rheumatoid arthritis
64722|NCT03161457|Severe RA|severe ra
64723|NCT03161457|Severe Rheumatoid Arthritis|severe rheumatoid arthritis
64724|NCT03161457|Moderate to Severe RA|moderate to severe ra
64725|NCT03161457|Moderate to Severe Rheumatoid Arthritis|moderate to severe rheumatoid arthritis
64726|NCT03161431|Immunotherapy|immunotherapy
64727|NCT03161431|Chemokine receptor blockade|chemokine receptor blockade
64728|NCT03161431|Myeloid-derived suppressor cells|myeloid-derived suppressor cells
64729|NCT03161405|Drug Therapy|drug therapy
64730|NCT03161392|mammography|mammography
64731|NCT03161392|ductal ectasia|ductal ectasia
64732|NCT03161392|breast neoplasm/diagnostic imaging|breast neoplasm/diagnostic imaging
64733|NCT03161392|mammary Glands, Human/pathology|mammary glands, human/pathology
64734|NCT03161392|female|female
64735|NCT03161379|Neoadjuvant therapy|neoadjuvant therapy
64736|NCT03161379|immunotherapy|immunotherapy
64737|NCT03161379|Cytoxan|cytoxan
64738|NCT03161379|Cyclophosphamide|cyclophosphamide
64739|NCT03161379|Pancreatic Vaccine|pancreatic vaccine
64740|NCT03161379|SBRT|sbrt
64741|NCT03161379|GVAX|gvax
64742|NCT03161379|Nivolumab|nivolumab
64743|NCT03161379|borderline resectable|borderline resectable
64744|NCT03161379|Radioimmunotherapy|radioimmunotherapy
64745|NCT03161379|Vaccine|vaccine
64746|NCT03161379|Antibody|antibody
64747|NCT03161379|Anti-PD-1|anti-pd-1
64748|NCT03161366|Ebola Zaire Outbreak|ebola zaire outbreak
64749|NCT03161366|Safety of rVSVΔG-ZEBOV-GP vaccine|safety of rvsvδg-zebov-gp vaccine
64750|NCT03161366|Effectiveness of rVSVΔG-ZEBOV-GP vaccine|effectiveness of rvsvδg-zebov-gp vaccine
64751|NCT03161340|Recurrent Implantation Failure|recurrent implantation failure
64752|NCT03161340|Rapamycin|rapamycin
64753|NCT03161340|Pregnancy Rate|pregnancy rate
64754|NCT03161327|ankle brachial index|ankle brachial index
64755|NCT03161327|peripheral arterial disease|peripheral arterial disease
64756|NCT03161314|Plantar Fasciitis|plantar fasciitis
64757|NCT03161314|Plantar Heel Pain|plantar heel pain
64758|NCT03161314|Multisegment Foot Motion|multisegment foot motion
64759|NCT03161314|EMG|emg
64760|NCT03161314|Gait|gait
64761|NCT03161275|cerebral saturation|cerebral saturation
64762|NCT03161275|epidural anaesthesia|epidural anaesthesia
64763|NCT03161275|Near Infrared Spectroscopy (NIRS)|near infrared spectroscopy (nirs)
64764|NCT03161275|Regional cerebral oxygen saturation|regional cerebral oxygen saturation
64765|NCT03161262|Text-message reminder|text-message reminder
64766|NCT03161262|Post-operative medication|post-operative medication
64767|NCT03161262|Behavioral Research|behavioral research
64768|NCT03161262|Social Research|social research
64769|NCT03161262|Short Message Service (SMS)|short message service (sms)
64770|NCT03161249|first psychotic episode, mobile app intervention|first psychotic episode, mobile app intervention
64771|NCT03161197|CKD, Dialysis, ESRD|ckd, dialysis, esrd
64772|NCT03161197|Mindfulness-Based Stress Reduction (MBSR)|mindfulness-based stress reduction (mbsr)
64773|NCT03161184|maternal health|maternal health
64774|NCT03161184|community health|community health
64775|NCT03161184|health services|health services
64776|NCT03161184|Tanzania|tanzania
64777|NCT03161184|evaluation|evaluation
64778|NCT03161184|cluster randomized trial|cluster randomized trial
64779|NCT03161158|Cardio-Renal Syndrome type 1|cardio-renal syndrome type 1
64780|NCT03161158|Acutely decompensated chronic heart failure|acutely decompensated chronic heart failure
64781|NCT03161158|Ultrafiltration|ultrafiltration
64782|NCT03161067|Tetraplegia|tetraplegia
64783|NCT03161067|Rehabilitation|rehabilitation
64784|NCT03161067|Brain Computer Interface|brain computer interface
64785|NCT03161067|Intracortical Microstimulation|intracortical microstimulation
64786|NCT03161067|Upper extremity prosthetics|upper extremity prosthetics
64787|NCT03161054|Metronomic Chemotherapy|metronomic chemotherapy
64788|NCT03161054|Elderly non-fit patients|elderly non-fit patients
64789|NCT03161054|Aggressive B-Cell lymphomas|aggressive b-cell lymphomas
64790|NCT03161041|Cytoreductive surgery, HIPEC, perioperative chemotherapy, peritoneal carcinomatosis, bevacizumab, colorectal surgery|cytoreductive surgery, hipec, perioperative chemotherapy, peritoneal carcinomatosis, bevacizumab, colorectal surgery
64791|NCT03161028|multiple sclerosis|multiple sclerosis
64792|NCT03161028|magnetic resonance imaging|magnetic resonance imaging
64793|NCT03161028|gait|gait
64794|NCT03161028|neuroprotective agents|neuroprotective agents
64795|NCT03161028|thioctic acid|thioctic acid
64796|NCT03161028|alpha-lipoic acid|alpha-lipoic acid
64797|NCT03161028|mobility|mobility
64798|NCT03161028|chronic progressive multiple sclerosis|chronic progressive multiple sclerosis
64799|NCT03160989|Blood pressure variability|blood pressure variability
64800|NCT03160989|Combined physical exercise|combined physical exercise
64801|NCT03160989|Hypertension|hypertension
64802|NCT03160963|elderly|elderly
64803|NCT03160937|pain|pain
64804|NCT03160924|Enhanced recovery after surgery|enhanced recovery after surgery
64805|NCT03160924|ERAS|eras
64806|NCT03160924|Fast track recovery|fast track recovery
64807|NCT03160924|Laparoscopic gastrectomy|laparoscopic gastrectomy
64808|NCT03160924|Gastric Cancer|gastric cancer
64809|NCT03160911|Over-the-scope clip|over-the-scope clip
64810|NCT03160911|endoscopic haemostasis|endoscopic haemostasis
64811|NCT03160898|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
64812|NCT03160898|ALS|als
64813|NCT03160898|CK-2127107|ck-2127107
64814|NCT03160872|Donor sperm insemination|donor sperm insemination
64815|NCT03160872|Anti Mullerian Hormone|anti mullerian hormone
64816|NCT03160872|Ovarian reserve|ovarian reserve
64817|NCT03160872|Antral follicle count|antral follicle count
64818|NCT03160859|unsedated colonoscopy|unsedated colonoscopy
64819|NCT03160859|water exchange colonoscopy|water exchange colonoscopy
64820|NCT03160859|cap|cap
64821|NCT03160859|colonoscopy pain|colonoscopy pain
64822|NCT03160846|Inotrope|inotrope
64823|NCT03160846|Milrinone|milrinone
64824|NCT03160846|Dopamine|dopamine
64825|NCT03160846|Dobutamine|dobutamine
64826|NCT03160833|HMPL453|hmpl453
64827|NCT03160833|solid tumor|solid tumor
64828|NCT03160833|dose escalation|dose escalation
64829|NCT03160794|Prostate cancer|prostate cancer
64830|NCT03160794|stereotactic ablative radiotherpy|stereotactic ablative radiotherpy
64831|NCT03160794|PET/MR|pet/mr
64832|NCT03160768|p16|p16
64833|NCT03160768|T cell isolation|t cell isolation
64834|NCT03160768|physiologic age|physiologic age
64835|NCT03160703|Dental stain, stannous fluoride, dentifrice|dental stain, stannous fluoride, dentifrice
64836|NCT03160690|Choroidal thickness|choroidal thickness
64837|NCT03160690|Open Angle Glaucoma|open angle glaucoma
64838|NCT03160690|Non penetrating deep sclerectomy|non penetrating deep sclerectomy
64839|NCT03160677|Acute Stroke|acute stroke
64840|NCT03160677|Blood Pressure|blood pressure
64841|NCT03160677|Cerebral Hemorrhage|cerebral hemorrhage
64842|NCT03160664|magnetic seizure therapy|magnetic seizure therapy
64843|NCT03160664|electroconvulsive therapy|electroconvulsive therapy
64844|NCT03160664|bipolar mania|bipolar mania
64845|NCT03160664|cognition|cognition
64846|NCT03160664|randomized controlled trial|randomized controlled trial
64847|NCT03160651|alcoholic hepatitis|alcoholic hepatitis
64848|NCT03160651|spontaneous improvement|spontaneous improvement
64849|NCT03160651|corticosteroids|corticosteroids
64850|NCT03160638|Azithromycin|azithromycin
64851|NCT03160638|Immunomodulation|immunomodulation
64852|NCT03160638|Pharmacokinetics|pharmacokinetics
64853|NCT03160638|Tissue degradation|tissue degradation
64854|NCT03160638|Tissue remodelling|tissue remodelling
64855|NCT03160612|Wheelchair|wheelchair
64856|NCT03160612|Biomechanics|biomechanics
64857|NCT03160612|Transfer|transfer
64858|NCT03160612|Training|training
64859|NCT03160586|Stuttering|stuttering
64860|NCT03160586|Anxiety|anxiety
64861|NCT03160495|PET/MR|pet/mr
64862|NCT03160495|Squamous cell carcinoma|squamous cell carcinoma
64863|NCT03160495|Heterogeneity|heterogeneity
64864|NCT03160482|Thyroid Neoplasm|thyroid neoplasm
64865|NCT03160482|Papillary Carcinoma|papillary carcinoma
64866|NCT03160482|Follicular Carcinoma|follicular carcinoma
64867|NCT03160482|Colloid Nodule|colloid nodule
64868|NCT03160482|Hyperplastic Nodule|hyperplastic nodule
64869|NCT03160482|Adenomatoid Nodule|adenomatoid nodule
64870|NCT03160482|Follicular Adenoma|follicular adenoma
64871|NCT03160482|Thyroid Cancer|thyroid cancer
64872|NCT03160482|Bethesda Classification|bethesda classification
64873|NCT03160482|Biomarkers|biomarkers
64874|NCT03160482|Protein convertase|protein convertase
64875|NCT03160469|obesity|obesity
64876|NCT03160456|upper airway|upper airway
64877|NCT03160456|genioglossus|genioglossus
64878|NCT03160456|CPAP|cpap
64879|NCT03160456|electrical stimulation|electrical stimulation
64880|NCT03160456|sleep|sleep
64881|NCT03160456|sleep disordered breathing|sleep disordered breathing
64882|NCT03160443|Anorexia nervosa|anorexia nervosa
64883|NCT03160443|Bulimia|bulimia
64884|NCT03160443|Binge eating disorders|binge eating disorders
64885|NCT03160443|Neuropsychology|neuropsychology
64886|NCT03160443|Neurocognition|neurocognition
64887|NCT03160443|Daily functioning|daily functioning
64888|NCT03160430|Chronic Kidney Failure|chronic kidney failure
64889|NCT03160430|ESRD|esrd
64890|NCT03160430|End-Stage Kidney Disease|end-stage kidney disease
64891|NCT03160430|End-Stage Renal Disease|end-stage renal disease
64892|NCT03160430|Renal Disease, End-Stage|renal disease, end-stage
64893|NCT03160430|Renal Failure, Chronic|renal failure, chronic
64894|NCT03160430|Renal Failure, End-Stage|renal failure, end-stage
64895|NCT03160404|Exercise|exercise
64896|NCT03160404|Zolpidem|zolpidem
64897|NCT03160404|Sleep|sleep
64898|NCT03160326|chronic kidney disease|chronic kidney disease
64899|NCT03160326|ultrasound|ultrasound
64900|NCT03160326|muscle loss|muscle loss
64901|NCT03160313|Social engagement|social engagement
64902|NCT03160313|Physical Activity|physical activity
64903|NCT03160313|Sleep Quality|sleep quality
64904|NCT03160313|Traumatic Brain Injury|traumatic brain injury
64905|NCT03160313|Veteran|veteran
64906|NCT03160287|mobile, sleep, physical activity, older adults|mobile, sleep, physical activity, older adults
64907|NCT03160274|tumor suppressor gene|tumor suppressor gene
64908|NCT03160274|oncogene|oncogene
64909|NCT03160274|mutation|mutation
64910|NCT03160274|susceptibility gene|susceptibility gene
64911|NCT03160222|reliability|reliability
64912|NCT03160222|bioelectrical impedance analysis|bioelectrical impedance analysis
64913|NCT03160222|computed tomography|computed tomography
64914|NCT03160222|strength|strength
64915|NCT03160222|mobility|mobility
64916|NCT03160209|risk factors|risk factors
64917|NCT03160209|case-control study|case-control study
64918|NCT03160196|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
64919|NCT03160196|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
64920|NCT03160183|initiating chemotherapy|initiating chemotherapy
64921|NCT03160183|prospective, open label, single arm, cohort|prospective, open label, single arm, cohort
64922|NCT03160183|non randomized, non interventional|non randomized, non interventional
64923|NCT03160170|open lumbar spine surgery|open lumbar spine surgery
64924|NCT03160170|operative time and efficiency|operative time and efficiency
64925|NCT03160170|Suction-Integrated Surgical Tissue Elevator and Retractor|suction-integrated surgical tissue elevator and retractor
64926|NCT03160144|laparoscopic resection of colorectal cancer|laparoscopic resection of colorectal cancer
64927|NCT03160144|open lung approach|open lung approach
64928|NCT03160131|Stroke|stroke
64929|NCT03160131|Visual impairment|visual impairment
64930|NCT03160131|Hemianopia|hemianopia
64931|NCT03160131|Neuro Vision Technology|neuro vision technology
64932|NCT03160131|Rehabilitation|rehabilitation
64933|NCT03160079|blinatumomab|blinatumomab
64934|NCT03160079|pembrolizumab|pembrolizumab
64935|NCT03160079|MK-3475|mk-3475
64936|NCT03160079|relapsed|relapsed
64937|NCT03160079|refractory|refractory
64938|NCT03160079|B-lineage acute lymphoblastic leukemia|b-lineage acute lymphoblastic leukemia
64939|NCT03160079|ALL|all
64940|NCT03160066|Psychobiotic|psychobiotic
64941|NCT03160066|Brain-gut axis|brain-gut axis
64942|NCT03160066|Stress|stress
64943|NCT03160066|Cognition|cognition
64944|NCT03160066|EEG|eeg
64945|NCT03160001|Niclosamide|niclosamide
64946|NCT03160001|Rheumatoid arthritis|rheumatoid arthritis
64947|NCT03160001|diseases activity|diseases activity
64948|NCT03160001|Efficacy|efficacy
64949|NCT03160001|Safety|safety
64950|NCT03159975|Tuberculosis|tuberculosis
64951|NCT03159975|DNA vaccine|dna vaccine
64952|NCT03159975|Electroporation|electroporation
64953|NCT03159975|GX-70|gx-70
64954|NCT03159962|Rapid maxillary expansion|rapid maxillary expansion
64955|NCT03159962|Mandibular response|mandibular response
64956|NCT03159962|Class II malocclusion|class ii malocclusion
64957|NCT03159962|Growing subjects|growing subjects
64958|NCT03159949|VO2max, maximal oxygen uptake|vo2max, maximal oxygen uptake
64959|NCT03159910|Shoulder Pain|shoulder pain
64960|NCT03159910|Occupational Exposure|occupational exposure
64961|NCT03159910|Clinical Trial|clinical trial
64962|NCT03159897|advanced stage (IIB-IV)|advanced stage (iib-iv)
64963|NCT03159897|ABVD DD-DI|abvd dd-di
64964|NCT03159897|PET|pet
64965|NCT03159871|Cesarean section|cesarean section
64966|NCT03159871|C- section|c- section
64967|NCT03159871|Suture|suture
64968|NCT03159858|Complex Abdominal Aortic Aneurysm|complex abdominal aortic aneurysm
64969|NCT03159845|zinc|zinc
64970|NCT03159832|Efficacy|efficacy
64971|NCT03159832|PK/PD study|pk/pd study
64972|NCT03159832|Renal Insufficiency|renal insufficiency
64973|NCT03159832|Type 2 Diabetes|type 2 diabetes
64974|NCT03159728|Ability Care|ability care
64975|NCT03159728|Caregiver overload|caregiver overload
64976|NCT03159728|Family caregiver|family caregiver
64977|NCT03159715|Internet, Behavioral Activation, Positive Psychology|internet, behavioral activation, positive psychology
64978|NCT03159702|hematological malignancy|hematological malignancy
64979|NCT03159702|EVOMELA|evomela
64980|NCT03159702|Melphalan HCl|melphalan hcl
64981|NCT03159702|Total Body Irradiation|total body irradiation
64982|NCT03159702|Reduced Intensity Conditioning|reduced intensity conditioning
64983|NCT03159702|Haploidentical Transplantation|haploidentical transplantation
64984|NCT03159702|Fludarabine|fludarabine
64985|NCT03159702|Hematologic Diseases|hematologic diseases
64986|NCT03159702|Neoplasms, Plasma Cell|neoplasms, plasma cell
64987|NCT03159702|Neoplasms by Histologic Type|neoplasms by histologic type
64988|NCT03159702|Lymphoproliferative Disorders|lymphoproliferative disorders
64989|NCT03159676|Prostate cancer|prostate cancer
64990|NCT03159676|Radiation therapy|radiation therapy
64991|NCT03159676|Radiotherapy|radiotherapy
64992|NCT03159676|Proton|proton
64993|NCT03159676|Proton beam|proton beam
64994|NCT03159676|Stereotactic ablative body radiotherapy|stereotactic ablative body radiotherapy
64995|NCT03159676|Stereotactic body radiotherapy|stereotactic body radiotherapy
64996|NCT03159676|SABR|sabr
64997|NCT03159676|SBRT|sbrt
64998|NCT03159676|Localized|localized
64999|NCT03159676|Low risk|low risk
65000|NCT03159676|Intermediate risk|intermediate risk
65001|NCT03159637|Pneumoperitoneum|pneumoperitoneum
65002|NCT03159637|Trendelenburg position|trendelenburg position
65003|NCT03159637|intra-abdominal pressure|intra-abdominal pressure
65004|NCT03159624|nasoseptal flap|nasoseptal flap
65005|NCT03159624|tissue repair|tissue repair
65006|NCT03159624|wound healing|wound healing
65007|NCT03159624|remucosalization|remucosalization
65008|NCT03159624|upper airway|upper airway
65009|NCT03159624|granulation tissue|granulation tissue
65010|NCT03159624|tissue graft|tissue graft
65011|NCT03159598|A-BR|a-br
65012|NCT03159598|Abdominal-based breast reconstruction|abdominal-based breast reconstruction
65013|NCT03159598|Seroma|seroma
65014|NCT03159572|Ovarian cancer|ovarian cancer
65015|NCT03159572|Fallopian tube cancer|fallopian tube cancer
65016|NCT03159572|Primary peritoneal cancer|primary peritoneal cancer
65017|NCT03159572|Germline Breast Cancer Susceptibility Gene (BRCA1/2 gene)|germline breast cancer susceptibility gene (brca1/2 gene)
65018|NCT03159572|Homologous Recombination Deficiency (HRD)|homologous recombination deficiency (hrd)
65019|NCT03159520|Pain|pain
65020|NCT03159507|Omega-3 Index|omega-3 index
65021|NCT03159507|Cellular metabolism|cellular metabolism
65022|NCT03159507|EPA Monoglyceride|epa monoglyceride
65023|NCT03159507|Quality of life|quality of life
65024|NCT03159442|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
65025|NCT03159442|Asthma|asthma
65026|NCT03159442|AZD8871|azd8871
65027|NCT03159442|muscarinic receptor antagonist and β2 adrenoceptor agonist (MABA)|muscarinic receptor antagonist and β2 adrenoceptor agonist (maba)
65028|NCT03159442|Phase I|phase i
65029|NCT03159442|Safety|safety
65030|NCT03159442|Tolerability|tolerability
65031|NCT03159442|Pharmacokinetics|pharmacokinetics
65032|NCT03159442|long-acting muscarinic antagonist (LAMA)|long-acting muscarinic antagonist (lama)
65033|NCT03159442|long-acting β2-agonist (LABA)|long-acting β2-agonist (laba)
65034|NCT03159442|Japanese|japanese
65035|NCT03159390|dietary supplements|dietary supplements
65036|NCT03159377|pulmonary nodule, CT, low dose|pulmonary nodule, ct, low dose
65037|NCT03159364|Virus-CTL|virus-ctl
65038|NCT03159364|EBV|ebv
65039|NCT03159364|CMV|cmv
65040|NCT03159364|ADV|adv
65041|NCT03159364|BKV|bkv
65042|NCT03159325|internet|internet
65043|NCT03159325|chronic disease management|chronic disease management
65044|NCT03159325|technology|technology
65045|NCT03159325|telehealth|telehealth
65046|NCT03159325|application|application
65047|NCT03159312|obesity,bariatric surgery,physical activity|obesity,bariatric surgery,physical activity
65048|NCT03159299|mHealth|mhealth
65049|NCT03159299|Hispanic/Latinos|hispanic/latinos
65050|NCT03159299|Diabetes Self-Management Education|diabetes self-management education
65051|NCT03159273|Dietary nitrate supplementation|dietary nitrate supplementation
65052|NCT03159273|Cold symptoms|cold symptoms
65053|NCT03159273|Stress|stress
65054|NCT03159273|Immunity|immunity
65055|NCT03159273|Exhaled nitric oxide|exhaled nitric oxide
65056|NCT03159273|Lung function|lung function
65057|NCT03159273|Cardiovascular activity|cardiovascular activity
65058|NCT03159260|night-time leg cramps|night-time leg cramps
65059|NCT03159260|topical|topical
65060|NCT03159260|spasm|spasm
65061|NCT03159247|education|education
65062|NCT03159247|counseling|counseling
65063|NCT03159247|motivational interviewing|motivational interviewing
65064|NCT03159247|tailoring|tailoring
65065|NCT03159221|type 2 diabetes in adolescents|type 2 diabetes in adolescents
65066|NCT03159221|obesity in adolescents|obesity in adolescents
65067|NCT03159221|behavioral family systems therapy|behavioral family systems therapy
65068|NCT03159208|Prognosis|prognosis
65069|NCT03159208|Critical Illness|critical illness
65070|NCT03159208|Ventilation, Mechanical|ventilation, mechanical
65071|NCT03159208|Disease Attributes|disease attributes
65072|NCT03159208|Socioeconomic Factors|socioeconomic factors
65073|NCT03159208|Activities of Daily LIving|activities of daily living
65074|NCT03159208|Cognition|cognition
65075|NCT03159195|metastatic breast cancer|metastatic breast cancer
65076|NCT03159195|advanced breast cancer|advanced breast cancer
65077|NCT03159195|HR+/ HER2-|hr+/ her2-
65078|NCT03159182|Hypertrophic scarring|hypertrophic scarring
65079|NCT03159182|Silicone Material|silicone material
65080|NCT03159182|Pressure garments|pressure garments
65081|NCT03159169|Neck Pain|neck pain
65082|NCT03159169|Upper Limb Pain|upper limb pain
65083|NCT03159130|Pain pump catheters|pain pump catheters
65084|NCT03159130|bariatric surgery|bariatric surgery
65085|NCT03159130|OnQ pump|onq pump
65086|NCT03159130|sleeve gastrectomy|sleeve gastrectomy
65087|NCT03159130|continuous infusion catheter|continuous infusion catheter
65088|NCT03159117|GD3 ADC (Pfizer PF-06688992)|gd3 adc (pfizer pf-06688992)
65089|NCT03159117|Stage III Melanoma|stage iii melanoma
65090|NCT03159117|Stage IV Melanoma|stage iv melanoma
65091|NCT03159117|17-165|17-165
65092|NCT03159078|Acinetobacter|acinetobacter
65093|NCT03159078|Polymyxins|polymyxins
65094|NCT03159078|Imipenem|imipenem
65095|NCT03159078|Pseudomona|pseudomona
65096|NCT03159078|Klebsiella|klebsiella
65097|NCT03159026|Amish/Mennonite variant|amish/mennonite variant
65098|NCT03159013|Pyrethroids|pyrethroids
65099|NCT03159013|Lambda-cyhalothrin|lambda-cyhalothrin
65100|NCT03159013|Biomarkers|biomarkers
65101|NCT03159013|Toxicokinetics|toxicokinetics
65102|NCT03158974|External Genital Warts|external genital warts
65103|NCT03158961|Thyroid|thyroid
65104|NCT03158961|Thyroidectomy|thyroidectomy
65105|NCT03158961|Transoral|transoral
65106|NCT03158961|Endoscopic|endoscopic
65107|NCT03158961|Surgery|surgery
65108|NCT03158948|Sepsis|sepsis
65109|NCT03158948|LR12|lr12
65110|NCT03158948|TREM1|trem1
65111|NCT03158948|TREM-1|trem-1
65112|NCT03158935|adoptive cell therapy|adoptive cell therapy
65113|NCT03158935|melanoma|melanoma
65114|NCT03158935|ovarian|ovarian
65115|NCT03158935|cyclophosphamide|cyclophosphamide
65116|NCT03158935|fludarabine|fludarabine
65117|NCT03158935|tumor-infiltrating lymphocytes (TILs)|tumor-infiltrating lymphocytes (tils)
65118|NCT03158935|pembrolizumab|pembrolizumab
65119|NCT03158935|interleukin-2|interleukin-2
65120|NCT03158935|anti-PD-1|anti-pd-1
65121|NCT03158935|immune checkpoint|immune checkpoint
65122|NCT03158909|Eyemask|eyemask
65123|NCT03158909|Earplugs|earplugs
65124|NCT03158896|mesenchymal stem cell|mesenchymal stem cell
65125|NCT03158896|hematopoietic stem cell transplant|hematopoietic stem cell transplant
65126|NCT03158896|Allogeneic hematopoietic stem cell transplant|allogeneic hematopoietic stem cell transplant
65127|NCT03158896|Autologous hematopoietic stem cell transplant|autologous hematopoietic stem cell transplant
65128|NCT03158896|Wharton's jelly|wharton's jelly
65129|NCT03158896|umbilical cord blood|umbilical cord blood
65130|NCT03158896|steroid refractory graft versus host disease|steroid refractory graft versus host disease
65131|NCT03158883|Avelumab|avelumab
65132|NCT03158883|NSCLC|nsclc
65133|NCT03158883|Stereotactic ablative radiotherapy (SAR)|stereotactic ablative radiotherapy (sar)
65134|NCT03158857|Myanmar|myanmar
65135|NCT03158857|HIV|hiv
65136|NCT03158831|Drug Allergy|drug allergy
65137|NCT03158831|Penicillin Allergy|penicillin allergy
65138|NCT03158831|Antibiotic Allergy|antibiotic allergy
65139|NCT03158831|Graded Drug Challenge|graded drug challenge
65140|NCT03158792|Anticoagulation|anticoagulation
65141|NCT03158792|Thromboprophylaxis|thromboprophylaxis
65142|NCT03158792|Anti-Xa levels|anti-xa levels
65143|NCT03158792|Elderly|elderly
65144|NCT03158792|Prevention|prevention
65145|NCT03158792|Enoxaparin|enoxaparin
65146|NCT03158792|Low molecular weight heparin|low molecular weight heparin
65147|NCT03158766|infection|infection
65148|NCT03158766|intervertebral disc|intervertebral disc
65149|NCT03158766|Propionibacterium acnes|propionibacterium acnes
65150|NCT03158766|spine|spine
65151|NCT03158727|intensive care|intensive care
65152|NCT03158701|evaluation|evaluation
65153|NCT03158675|fractional co2 laser, topical steroid,UVB narrow band|fractional co2 laser, topical steroid,uvb narrow band
65154|NCT03158662|Epidermolysis Bullosa|epidermolysis bullosa
65155|NCT03158662|Recessive Dystrophic|recessive dystrophic
65156|NCT03158662|Simplex|simplex
65157|NCT03158662|Junctional Non-Herlitz|junctional non-herlitz
65158|NCT03158649|Pregnancy|pregnancy
65159|NCT03158649|Prenatal well-being|prenatal well-being
65160|NCT03158649|Mental maternal prenatal well-being|mental maternal prenatal well-being
65161|NCT03158649|Positive Psychology|positive psychology
65162|NCT03158649|Positive Psychology Intervention|positive psychology intervention
65163|NCT03158649|Web-based intervention|web-based intervention
65164|NCT03158623|total joint arthroplasty|total joint arthroplasty
65165|NCT03158623|platelet-rich plasma|platelet-rich plasma
65166|NCT03158623|activated collagen|activated collagen
65167|NCT03158571|Gastric Cancer|gastric cancer
65168|NCT03158571|gastric adenocarcinoma|gastric adenocarcinoma
65169|NCT03158571|cancer subtypes|cancer subtypes
65170|NCT03158571|prognosis|prognosis
65171|NCT03158571|survival|survival
65172|NCT03158571|molecular classification|molecular classification
65173|NCT03158571|chemotherapy|chemotherapy
65174|NCT03158571|immunotherapy|immunotherapy
65175|NCT03158519|Physical activity|physical activity
65176|NCT03158480|DC-CIK|dc-cik
65177|NCT03158480|interferon|interferon
65178|NCT03158441|MRI|mri
65179|NCT03158441|Diffusion|diffusion
65181|NCT03158415|mHealth|mhealth
65182|NCT03158402|Inspiratory muscle training|inspiratory muscle training
65183|NCT03158402|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
65184|NCT03158389|MGMT methylation|mgmt methylation
65185|NCT03158389|targeted therapy|targeted therapy
65186|NCT03158389|umbrella protocol|umbrella protocol
65187|NCT03158376|gabapentin|gabapentin
65188|NCT03158376|thoracotomy|thoracotomy
65189|NCT03158376|chronic post-thoracotomy pain|chronic post-thoracotomy pain
65190|NCT03158376|acute post-thoracotomy pain|acute post-thoracotomy pain
65191|NCT03158376|quality of life|quality of life
65192|NCT03158376|neuropathic pain|neuropathic pain
65193|NCT03158363|immobilization|immobilization
65194|NCT03158363|fasting|fasting
65195|NCT03158363|endotoxemia|endotoxemia
65196|NCT03158363|LPS|lps
65197|NCT03158363|metabolism|metabolism
65198|NCT03158363|model of disease|model of disease
65199|NCT03158337|Exercise|exercise
65200|NCT03158337|Physical Activity|physical activity
65201|NCT03158337|Brain blood flow|brain blood flow
65202|NCT03158337|Cognition|cognition
65203|NCT03158337|Fitness|fitness
65204|NCT03158311|QVM149|qvm149
65205|NCT03158311|asthma|asthma
65206|NCT03158311|adult|adult
65207|NCT03158259|IS|is
65208|NCT03158259|ICH|ich
65209|NCT03158259|rtPa|rtpa
65210|NCT03158259|Prehospital|prehospital
65211|NCT03158259|MSU|msu
65212|NCT03158246|zoledronic acid|zoledronic acid
65213|NCT03158246|Yigu|yigu
65214|NCT03158246|Aclasta|aclasta
65215|NCT03158246|Osteoporosis|osteoporosis
65216|NCT03158246|Postmenopausal|postmenopausal
65217|NCT03158246|BMD|bmd
65218|NCT03158246|fracture|fracture
65219|NCT03158246|Biochemical markers|biochemical markers
65220|NCT03158233|Zika virus disease|zika virus disease
65221|NCT03158194|Anxiety|anxiety
65222|NCT03158194|Stress|stress
65223|NCT03158194|Asthma|asthma
65224|NCT03158181|Behavior; Operational block; Monitoring; Social Sciences ; New technologies|behavior; operational block; monitoring; social sciences ; new technologies
65225|NCT03158129|Non-Small Cell Lung Cancer|non-small cell lung cancer
65226|NCT03158129|NSCLC|nsclc
65227|NCT03158129|Nivolumab|nivolumab
65228|NCT03158129|BMS-936558|bms-936558
65229|NCT03158129|Opdivo|opdivo
65230|NCT03158129|Ipilimumab|ipilimumab
65231|NCT03158129|Yervoy|yervoy
65232|NCT03158129|BMS-734016|bms-734016
65233|NCT03158129|MDX010|mdx010
65234|NCT03158129|Amenable For Surgical Resection|amenable for surgical resection
65235|NCT03158116|tracheostomy tube|tracheostomy tube
65236|NCT03158116|Pseudomonas aeruginosa|pseudomonas aeruginosa
65237|NCT03158103|MEK162 (Binimetinib)|mek162 (binimetinib)
65238|NCT03158103|Pexidartinib|pexidartinib
65239|NCT03158103|17-056|17-056
65240|NCT03158090|Acromegaly|acromegaly
65241|NCT03158064|17-160|17-160
65242|NCT03158064|durvalumab|durvalumab
65243|NCT03158064|tremelimumab|tremelimumab
65244|NCT03158064|MEDI4736|medi4736
65245|NCT03158051|Hypertension|hypertension
65246|NCT03158051|Young Adult|young adult
65247|NCT03158051|Self-Management|self-management
65248|NCT03158051|Health coach|health coach
65249|NCT03158038|Trivalent|trivalent
65250|NCT03158038|Influenza|influenza
65251|NCT03158038|FluMist Quadrivalent|flumist quadrivalent
65252|NCT03158038|Vaccine|vaccine
65253|NCT03158038|Prevention|prevention
65254|NCT03158038|Healthy|healthy
65255|NCT03158038|Monovalent|monovalent
65256|NCT03158025|Recreational sedatives|recreational sedatives
65257|NCT03158025|Healthy participants|healthy participants
65258|NCT03158025|Lemborexant|lemborexant
65259|NCT03158025|E2006|e2006
65260|NCT03158025|Zolpidem|zolpidem
65261|NCT03158025|Suvorexant|suvorexant
65262|NCT03157999|Older Adults|older adults
65263|NCT03157999|Transitional Care|transitional care
65264|NCT03157999|Caregiver|caregiver
65364|NCT03157349|Placebo|placebo
65265|NCT03157999|Intervention|intervention
65266|NCT03157986|COPD|copd
65267|NCT03157986|Balance|balance
65268|NCT03157986|Whole Body Vibration Training|whole body vibration training
65269|NCT03157986|pulmonary rehabilitation|pulmonary rehabilitation
65270|NCT03157986|exercise|exercise
65271|NCT03157973|Information Literacy|information literacy
65272|NCT03157973|Nursing Care|nursing care
65273|NCT03157973|Social Support|social support
65274|NCT03157960|Fructose|fructose
65275|NCT03157960|Uric acid|uric acid
65276|NCT03157960|Oxidised LDL|oxidised ldl
65277|NCT03157960|Interleukin 6|interleukin 6
65278|NCT03157947|decision aid|decision aid
65279|NCT03157947|focus group|focus group
65280|NCT03157934|stroke network|stroke network
65281|NCT03157934|acute stroke care|acute stroke care
65282|NCT03157934|emergency medical services|emergency medical services
65283|NCT03157934|integrated care|integrated care
65284|NCT03157908|South Africa|south africa
65285|NCT03157908|Retention in care|retention in care
65286|NCT03157908|Pregnancy|pregnancy
65287|NCT03157908|Mobile health|mobile health
65288|NCT03157895|Foster Families|foster families
65289|NCT03157882|pediatric|pediatric
65290|NCT03157882|children|children
65291|NCT03157882|Faces Pain Scale Revised|faces pain scale revised
65292|NCT03157882|Wong Baker FACES|wong baker faces
65293|NCT03157882|pain scales|pain scales
65294|NCT03157882|BRIGANCE|brigance
65295|NCT03157869|Learning, Automatism, Motor Activity, Electric Stimulation|learning, automatism, motor activity, electric stimulation
65296|NCT03157856|Fluorescence imaging technique|fluorescence imaging technique
65297|NCT03157856|Biopsies from resected prostate|biopsies from resected prostate
65298|NCT03157856|Medical device|medical device
65299|NCT03157830|Multiple Sclerosis|multiple sclerosis
65300|NCT03157830|MS|ms
65301|NCT03157830|ocrelizumab|ocrelizumab
65302|NCT03157830|OCREVUS|ocrevus
65303|NCT03157830|Natalizumab|natalizumab
65304|NCT03157830|Tysabri|tysabri
65305|NCT03157791|simethicone|simethicone
65306|NCT03157778|pregnenolone|pregnenolone
65307|NCT03157778|endocannabinoid|endocannabinoid
65308|NCT03157778|food intake|food intake
65309|NCT03157778|type-1 cannabinoid receptor|type-1 cannabinoid receptor
65310|NCT03157765|recurrent implantation failure|recurrent implantation failure
65311|NCT03157765|frozen embryo transfer|frozen embryo transfer
65312|NCT03157765|IVF|ivf
65313|NCT03157765|endometrial scratch|endometrial scratch
65314|NCT03157765|endometrial injury|endometrial injury
65315|NCT03157739|Migraine|migraine
65316|NCT03157726|benign prostatic hyperplasia|benign prostatic hyperplasia
65317|NCT03157726|multicenter randomized control clinical trial|multicenter randomized control clinical trial
65318|NCT03157726|transurethral plasmakinetic enucleation of prostate|transurethral plasmakinetic enucleation of prostate
65319|NCT03157726|transurethral resection of prostate|transurethral resection of prostate
65320|NCT03157713|Obesity|obesity
65321|NCT03157713|Weight-loss|weight-loss
65322|NCT03157713|Financial Incentives|financial incentives
65323|NCT03157713|Behavioral Economics|behavioral economics
65324|NCT03157648|Shivering temperature|shivering temperature
65325|NCT03157622|Chronic Low Back Pain|chronic low back pain
65326|NCT03157622|Cognitive-Behavioural Therapy|cognitive-behavioural therapy
65327|NCT03157622|Exposure|exposure
65328|NCT03157622|Therapeutic processes|therapeutic processes
65329|NCT03157622|Single-case study|single-case study
65330|NCT03157609|Thermometry|thermometry
65331|NCT03157609|SpotOn|spoton
65332|NCT03157596|disability|disability
65333|NCT03157596|developmental disability|developmental disability
65334|NCT03157596|special healthcare needs|special healthcare needs
65335|NCT03157557|Treatment|treatment
65336|NCT03157557|Sheltered Housing|sheltered housing
65337|NCT03157544|Chronic Neck Pain|chronic neck pain
65338|NCT03157544|Chronic Back Pain|chronic back pain
65339|NCT03157544|non-pharmacological|non-pharmacological
65340|NCT03157544|pain relief|pain relief
65341|NCT03157518|Asthma|asthma
65342|NCT03157518|obesity|obesity
65343|NCT03157518|micorbiome|micorbiome
65344|NCT03157518|probiotics|probiotics
65345|NCT03157492|Adult|adult
65346|NCT03157492|Post-lingual|post-lingual
65347|NCT03157492|Auditory training|auditory training
65348|NCT03157492|Communication strategies|communication strategies
65349|NCT03157492|Speech tracking|speech tracking
65350|NCT03157492|Speech recognition|speech recognition
65351|NCT03157492|Quality of Life|quality of life
65352|NCT03157479|Mechanical ventilation|mechanical ventilation
65353|NCT03157453|Evaluation scale|evaluation scale
65354|NCT03157453|Brain injury|brain injury
65355|NCT03157453|Severity of Brain Injury|severity of brain injury
65356|NCT03157453|Initial Evaluation|initial evaluation
65357|NCT03157427|Solar Lentigo, Cryotherapy, Difluoroethane|solar lentigo, cryotherapy, difluoroethane
65358|NCT03157388|inflammation|inflammation
65359|NCT03157388|Macrophages|macrophages
65360|NCT03157388|CD163|cd163
65361|NCT03157375|IOL, IOL Rotation, Axial Rotation|iol, iol rotation, axial rotation
65362|NCT03157349|Biofreeze|biofreeze
65363|NCT03157349|Acute Neck Pain|acute neck pain
65365|NCT03157349|chiropractic|chiropractic
65366|NCT03157336|Cassava|cassava
65367|NCT03157336|Konzo|konzo
65368|NCT03157336|Cyanide|cyanide
65369|NCT03157336|Cyanate|cyanate
65370|NCT03157336|Thiocyanate|thiocyanate
65371|NCT03157336|Carbamoylation|carbamoylation
65372|NCT03157336|Isoprostanes|isoprostanes
65373|NCT03157336|Oxidative Damage|oxidative damage
65374|NCT03157323|Glycemic Index|glycemic index
65375|NCT03157323|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
65376|NCT03157323|Dietary Change|dietary change
65377|NCT03157323|Pediatric Oncology|pediatric oncology
65378|NCT03157284|Lactobacillus, Probiotics|lactobacillus, probiotics
65379|NCT03157219|Heart failure|heart failure
65380|NCT03157219|Institutional level registry|institutional level registry
65381|NCT03157219|Systolic heart failure|systolic heart failure
65382|NCT03157219|Acute heart failure|acute heart failure
65383|NCT03157219|Heart failure India|heart failure india
65384|NCT03157193|Peri-Implantitis|peri-implantitis
65385|NCT03157193|Dental Implants|dental implants
65386|NCT03157193|Hyaluronic Acid|hyaluronic acid
65387|NCT03157193|Clinical Trial|clinical trial
65388|NCT03157167|Kaposi Sarcoma, KS, HIV|kaposi sarcoma, ks, hiv
65389|NCT03157154|Haemophilia|haemophilia
65390|NCT03157154|Atherosclerosis|atherosclerosis
65391|NCT03157154|Atrial fibrillation|atrial fibrillation
65392|NCT03157154|Antiplatelets|antiplatelets
65393|NCT03157154|Anticoagulant|anticoagulant
65394|NCT03157141|Ankle osteoarthritis|ankle osteoarthritis
65395|NCT03157141|total ankle replacement|total ankle replacement
65396|NCT03157141|ankle arthrodesis|ankle arthrodesis
65397|NCT03157141|kinematics|kinematics
65398|NCT03157141|kinetics|kinetics
65399|NCT03157141|plantar pressure measurements|plantar pressure measurements
65400|NCT03157141|functional compensatory adaptations|functional compensatory adaptations
65401|NCT03157128|LOXO-292|loxo-292
65402|NCT03157128|KIF5B-RET|kif5b-ret
65403|NCT03157128|M918T|m918t
65404|NCT03157128|CCDC6-RET|ccdc6-ret
65405|NCT03157128|RET-PTC1|ret-ptc1
65406|NCT03157128|NCOA4-RET|ncoa4-ret
65407|NCT03157128|RET-PTC|ret-ptc
65408|NCT03157128|RET-PTC3|ret-ptc3
65409|NCT03157128|RET-PTC4|ret-ptc4
65410|NCT03157128|PRKAR1A-RET|prkar1a-ret
65411|NCT03157128|RET-PTC2|ret-ptc2
65412|NCT03157128|GOLGA5-RET|golga5-ret
65413|NCT03157128|RET-PTC5|ret-ptc5
65414|NCT03157128|ERC1-RET|erc1-ret
65415|NCT03157128|KTN1-RET|ktn1-ret
65416|NCT03157128|RET-PTC8|ret-ptc8
65417|NCT03157128|HOOK3-RET|hook3-ret
65418|NCT03157128|PCM1-RET|pcm1-ret
65419|NCT03157128|TRIM24-RET|trim24-ret
65420|NCT03157128|RET-PTC6|ret-ptc6
65421|NCT03157128|TRIM27-RET|trim27-ret
65422|NCT03157128|TRIM33-RET|trim33-ret
65423|NCT03157128|RET-PTC7|ret-ptc7
65424|NCT03157128|AKAP13-RET|akap13-ret
65425|NCT03157128|FKBP15-RET|fkbp15-ret
65426|NCT03157128|SPECC1L-RET|specc1l-ret
65427|NCT03157128|TBL1XR1-RET|tbl1xr1-ret
65428|NCT03157128|BCR-RET|bcr-ret
65429|NCT03157128|FGRF1OP-RET|fgrf1op-ret
65430|NCT03157128|RFG8-RET|rfg8-ret
65431|NCT03157128|RET-PTC9|ret-ptc9
65432|NCT03157128|ACBD5-RET|acbd5-ret
65433|NCT03157128|MYH13-RET|myh13-ret
65434|NCT03157128|CUX1-RET|cux1-ret
65435|NCT03157128|KIAA1468-RET|kiaa1468-ret
65436|NCT03157128|FRMD4A-RET|frmd4a-ret
65437|NCT03157128|SQSTM1-RET|sqstm1-ret
65438|NCT03157128|AFAP1L2-RET|afap1l2-ret
65439|NCT03157128|PPFIBP2-RET|ppfibp2-ret
65440|NCT03157128|EML4-RET|eml4-ret
65441|NCT03157128|PARD3-RET|pard3-ret
65442|NCT03157128|G533C|g533c
65443|NCT03157128|C609F|c609f
65444|NCT03157128|C609G|c609g
65445|NCT03157128|C609R|c609r
65446|NCT03157128|C609S|c609s
65447|NCT03157128|C609Y|c609y
65448|NCT03157128|C611F|c611f
65449|NCT03157128|C611G|c611g
65450|NCT03157128|C611S|c611s
65451|NCT03157128|C611Y|c611y
65452|NCT03157128|C611W|c611w
65453|NCT03157128|C618F|c618f
65454|NCT03157128|C618R|c618r
65455|NCT03157128|C618S|c618s
65456|NCT03157128|C620F|c620f
65457|NCT03157128|C620R|c620r
65458|NCT03157128|C620S|c620s
65459|NCT03157128|C630R|c630r
65460|NCT03157128|C630Y|c630y
65461|NCT03157128|D631Y|d631y
65462|NCT03157128|C634F|c634f
65463|NCT03157128|C634G|c634g
65464|NCT03157128|C634R|c634r
65465|NCT03157128|C634S|c634s
65466|NCT03157128|C634W|c634w
65467|NCT03157128|C634Y|c634y
65468|NCT03157128|K666E|k666e
65469|NCT03157128|E768D|e768d
65470|NCT03157128|L790F|l790f
65471|NCT03157128|V804L|v804l
65472|NCT03157128|V804M|v804m
65473|NCT03157128|A883F|a883f
65474|NCT03157128|S891A|s891a
65475|NCT03157128|R912P|r912p
65476|NCT03157128|CLIP1-RET|clip1-ret
65477|NCT03157128|Y806C|y806c
65478|NCT03157128|RET fusion|ret fusion
65479|NCT03157128|RET alteration|ret alteration
65480|NCT03157128|RET mutation|ret mutation
65481|NCT03157128|RET rearrangement|ret rearrangement
65482|NCT03157128|RET translocation|ret translocation
65483|NCT03157128|Neoplasms by Site|neoplasms by site
65484|NCT03157128|Neoplasms|neoplasms
65485|NCT03157128|Non-Small Cell Lung Cancer|non-small cell lung cancer
65486|NCT03157128|Lung Neoplasms|lung neoplasms
65487|NCT03157128|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
65488|NCT03157128|Cancer of Lung|cancer of lung
65489|NCT03157128|Cancer of the Lung|cancer of the lung
65490|NCT03157128|Lung Cancer|lung cancer
65491|NCT03157128|Neoplasms, Lung|neoplasms, lung
65492|NCT03157128|Neoplasms, Pulmonary|neoplasms, pulmonary
65493|NCT03157128|Pulmonary Cancer|pulmonary cancer
65494|NCT03157128|Pulmonary Neoplasms|pulmonary neoplasms
65495|NCT03157128|Respiratory Tract Neoplasms|respiratory tract neoplasms
65496|NCT03157128|Lung Diseases|lung diseases
65497|NCT03157128|Respiratory Tract Diseases|respiratory tract diseases
65498|NCT03157128|Carcinoma, Bronchogenic|carcinoma, bronchogenic
65499|NCT03157128|Bronchial Neoplasms|bronchial neoplasms
65500|NCT03157128|Medullary Thyroid Cancer|medullary thyroid cancer
65501|NCT03157128|Papillary Thyroid Cancer|papillary thyroid cancer
65502|NCT03157128|Thyroid Diseases|thyroid diseases
65503|NCT03157128|Thyroid Neoplasms|thyroid neoplasms
65504|NCT03157128|Cancer of the Thyroid|cancer of the thyroid
65505|NCT03157128|Cancer of Thyroid|cancer of thyroid
65506|NCT03157128|Neoplasms, Thyroid|neoplasms, thyroid
65507|NCT03157128|Thyroid Ademona|thyroid ademona
65508|NCT03157128|Thyroid Cancer|thyroid cancer
65509|NCT03157128|Thyroid Carcinoma|thyroid carcinoma
65510|NCT03157128|Endocrine System Diseases|endocrine system diseases
65511|NCT03157128|Endocrine Gland Neoplasms|endocrine gland neoplasms
65512|NCT03157128|Head and Neck Neoplasms|head and neck neoplasms
65513|NCT03157128|Thoracic Neoplasms|thoracic neoplasms
65514|NCT03157128|CNS tumor|cns tumor
65515|NCT03157128|Primary CNS tumor|primary cns tumor
65516|NCT03157128|Cancer of Colon|cancer of colon
65517|NCT03157128|Cancer of the Colon|cancer of the colon
65518|NCT03157128|Colon Cancer|colon cancer
65519|NCT03157128|Colon Neoplasms|colon neoplasms
65520|NCT03157128|Colonic Cancer|colonic cancer
65521|NCT03157128|Neoplasms, Colonic|neoplasms, colonic
65522|NCT03157128|Malignant tumor of Breast|malignant tumor of breast
65523|NCT03157128|Mammary Cancer|mammary cancer
65524|NCT03157128|Mammary Carcinoma, Human|mammary carcinoma, human
65525|NCT03157128|Mammary Neoplasm, Human|mammary neoplasm, human
65526|NCT03157128|Neoplasms, Breast|neoplasms, breast
65527|NCT03157128|Tumors, Breast|tumors, breast
65528|NCT03157128|Human Mammary Carcinoma|human mammary carcinoma
65529|NCT03157128|Malignant Neoplasm of Breast|malignant neoplasm of breast
65530|NCT03157128|Breast Carcinoma|breast carcinoma
65531|NCT03157128|Breast Tumors|breast tumors
65532|NCT03157128|Cancer of the Breast|cancer of the breast
65533|NCT03157128|Breast Neoplasms|breast neoplasms
65534|NCT03157128|Breast Cancer|breast cancer
65535|NCT03157115|Kinocardiography|kinocardiography
65536|NCT03157115|Cardiac contractility|cardiac contractility
65537|NCT03157115|Heart kinetic energy|heart kinetic energy
65538|NCT03157102|children|children
65539|NCT03157102|status asthmaticus|status asthmaticus
65540|NCT03157102|HFNC|hfnc
65541|NCT03157011|Primary Sjögren syndrome - Digestive symptoms|primary sjögren syndrome - digestive symptoms
65542|NCT03156998|CARE|care
65543|NCT03156998|Paediatric asthma|paediatric asthma
65544|NCT03156998|Compliance|compliance
65545|NCT03156998|Home nebulizer|home nebulizer
65546|NCT03156959|Eating disorders|eating disorders
65547|NCT03156959|Cognitive Behavioral Therapy|cognitive behavioral therapy
65548|NCT03156959|Eye Movement Desensitization and Processing|eye movement desensitization and processing
65549|NCT03156946|breastfeeding|breastfeeding
65550|NCT03156946|mother-to-mother support|mother-to-mother support
65551|NCT03156946|lactation consultant|lactation consultant
65552|NCT03156946|stepped wedge cluster randomized trial|stepped wedge cluster randomized trial
65553|NCT03156946|peer counseling|peer counseling
65554|NCT03156907|High dosage Buprenorphine (HDB)|high dosage buprenorphine (hdb)
65555|NCT03156907|Chronic pain|chronic pain
65556|NCT03156907|Analgesics opioids|analgesics opioids
65557|NCT03156907|Withdrawal symptoms|withdrawal symptoms
65558|NCT03156894|Graft Dysfunction|graft dysfunction
65559|NCT03156894|Primary Graft Dysfunction|primary graft dysfunction
65560|NCT03156894|heart transplant|heart transplant
65561|NCT03156894|heart failure|heart failure
65562|NCT03156894|Hemodynamic parameters|hemodynamic parameters
65563|NCT03156894|Incidence of PDG|incidence of pdg
65564|NCT03156855|efficacy|efficacy
65565|NCT03156855|safety|safety
65566|NCT03156855|H. pylori eradication|h. pylori eradication
65567|NCT03156842|Hypertension|hypertension
65568|NCT03156842|Dyslipidemia|dyslipidemia
65569|NCT03156842|Fimasartan|fimasartan
65570|NCT03156842|Rosuvastatin|rosuvastatin
65571|NCT03156829|splinting|splinting
65572|NCT03156829|steroid|steroid
65573|NCT03156829|cortisone|cortisone
65574|NCT03156829|trigger digit|trigger digit
65575|NCT03156816|Myocardial Infarction|myocardial infarction
65576|NCT03156816|STEMI|stemi
65577|NCT03156816|Inflammation|inflammation
65578|NCT03156816|Left ventricular remodeling|left ventricular remodeling
65579|NCT03156816|Colchicine|colchicine
65580|NCT03156816|CMR|cmr
65581|NCT03156790|recombinant L-Asparaginase|recombinant l-asparaginase
65582|NCT03156790|Spectrila®|spectrila®
65583|NCT03156790|Lymphoblastic Leukaemia|lymphoblastic leukaemia
65584|NCT03156790|BRALL 2014|brall 2014
65585|NCT03156777|Gastric cancer; Circulating tumor cells; Prognosis|gastric cancer; circulating tumor cells; prognosis
65586|NCT03156764|Qp/Qs ratio|qp/qs ratio
65587|NCT03156764|Pediatric congenital heart disease|pediatric congenital heart disease
65588|NCT03156751|Syphilis screening|syphilis screening
65589|NCT03156751|antenatal care|antenatal care
65590|NCT03156751|prenatal diagnosis|prenatal diagnosis
65591|NCT03156751|rapid diagnosis test|rapid diagnosis test
65592|NCT03156751|Burkina Faso|burkina faso
65593|NCT03156751|feasibility|feasibility
65594|NCT03156725|Iron Bioavailability|iron bioavailability
65595|NCT03156725|hepcidin|hepcidin
65596|NCT03156725|ferritin|ferritin
65597|NCT03156725|iron absorption|iron absorption
65598|NCT03156725|iron status|iron status
65599|NCT03156712|Anemia|anemia
65600|NCT03156712|Iron deficiency anemia|iron deficiency anemia
65601|NCT03156712|Iron fortification|iron fortification
65602|NCT03156712|ferrous sulfate|ferrous sulfate
65603|NCT03156712|aspergillus oryzae|aspergillus oryzae
65604|NCT03156712|iron supplementation|iron supplementation
65605|NCT03156712|AUC|auc
65606|NCT03156686|Acute Heart Failure|acute heart failure
65607|NCT03156686|Chronic Heart Failure|chronic heart failure
65608|NCT03156686|Home care services|home care services
65609|NCT03156686|Cost-Benefit Analysis|cost-benefit analysis
65610|NCT03156686|Quality of life|quality of life
65611|NCT03156634|Patient education|patient education
65612|NCT03156634|Internet|internet
65613|NCT03156608|External Fetal Heart Rate Monitor|external fetal heart rate monitor
65614|NCT03156608|Fetal Heart Rate Monitor|fetal heart rate monitor
65615|NCT03156582|liver transplantation, hepatocellular carcinoma, alpha-foetoproteins, AFP|liver transplantation, hepatocellular carcinoma, alpha-foetoproteins, afp
65616|NCT03156569|saliva , dental , oral health|saliva , dental , oral health
65617|NCT03156530|Acupunture|acupunture
65618|NCT03156530|Acupunture Therapy|acupunture therapy
65619|NCT03156530|Acupunture Points|acupunture points
65620|NCT03156530|Acupunture Ear|acupunture ear
65621|NCT03156530|Postural Balance|postural balance
65622|NCT03156517|Treatment|treatment
65623|NCT03156517|Deep Brain Stimulation|deep brain stimulation
65624|NCT03156517|VIM Nucleus of the Thalamus|vim nucleus of the thalamus
65625|NCT03156517|Posterior Subthalamic Area|posterior subthalamic area
65626|NCT03156517|Zona Incerta|zona incerta
65627|NCT03156517|Efficacy|efficacy
65628|NCT03156517|Safety|safety
65629|NCT03156491|recurrent miscarriages (RM)|recurrent miscarriages (rm)
65630|NCT03156491|recurrent pregnancy loss (RPL)|recurrent pregnancy loss (rpl)
65631|NCT03156491|fetal-maternal interface|fetal-maternal interface
65632|NCT03156491|decidualization|decidualization
65633|NCT03156491|co-culture|co-culture
65634|NCT03156491|implantation|implantation
65635|NCT03156491|immune regulation|immune regulation
65636|NCT03156478|Prevention|prevention
65637|NCT03156478|Digital solutions|digital solutions
65638|NCT03156478|Type 2 diabetes|type 2 diabetes
65639|NCT03156478|Life style modification|life style modification
65640|NCT03156478|Physical activity|physical activity
65641|NCT03156478|Healthy diet|healthy diet
65642|NCT03156478|Health economics|health economics
65643|NCT03156478|Environmental choice architecture|environmental choice architecture
65644|NCT03156478|Socio-economic facilitators|socio-economic facilitators
65645|NCT03156478|Socio-economic barriers|socio-economic barriers
65646|NCT03156478|Wellbeing|wellbeing
65647|NCT03156387|diode laser|diode laser
65648|NCT03156387|scalpel surgery|scalpel surgery
65649|NCT03156387|frenectomy|frenectomy
65650|NCT03156387|postoperative complications|postoperative complications
65651|NCT03156348|Pharmaceutical intervention|pharmaceutical intervention
65652|NCT03156348|Older adult|older adult
65653|NCT03156348|Internal medicine|internal medicine
65654|NCT03156348|Adverse drug event|adverse drug event
65655|NCT03156322|cesarean section|cesarean section
65656|NCT03156322|combined spinal epidural anesthesia|combined spinal epidural anesthesia
65657|NCT03156322|patient controlled epidural analgesia|patient controlled epidural analgesia
65658|NCT03156322|postoperative pain|postoperative pain
65659|NCT03156296|transversus abdominis plane block , Dexmedetomidine|transversus abdominis plane block , dexmedetomidine
65660|NCT03156283|smartphone|smartphone
65661|NCT03156283|obstructive sleep apnea|obstructive sleep apnea
65662|NCT03156283|adherence|adherence
65663|NCT03156270|nasal valve|nasal valve
65664|NCT03156270|nasal airway obstruction|nasal airway obstruction
65665|NCT03156257|Microgravity Effects on Vascular Cells|microgravity effects on vascular cells
65666|NCT03156244|PROMIS|promis
65667|NCT03156231|airway disease|airway disease
65668|NCT03156231|bronchitis|bronchitis
65669|NCT03156231|emphysema|emphysema
65670|NCT03156231|altitude|altitude
65671|NCT03156231|prevention|prevention
65672|NCT03156231|acetazolamide|acetazolamide
66265|NCT03152357|TKA|tka
65673|NCT03156218|PaO2/FiO2 ratio, hyperoxia, mechanical ventilation, ARDS|pao2/fio2 ratio, hyperoxia, mechanical ventilation, ards
65674|NCT03156205|critically ill patients|critically ill patients
65675|NCT03156205|music therapy|music therapy
65676|NCT03156205|sleep|sleep
65677|NCT03156205|delirium|delirium
65678|NCT03156205|melatonin|melatonin
65679|NCT03156205|elderly|elderly
65680|NCT03156192|Caregivers|caregivers
65681|NCT03156192|Family-centered care|family-centered care
65682|NCT03156192|Music use|music use
65683|NCT03156192|Psycho-social benefits of music|psycho-social benefits of music
65684|NCT03156088|Predictors|predictors
65685|NCT03156088|Sacral neuromodulation|sacral neuromodulation
65686|NCT03156088|Outcomes|outcomes
65687|NCT03156088|Overactive bladder|overactive bladder
65688|NCT03156075|hip fracture, intervention, mortality, mobility|hip fracture, intervention, mortality, mobility
65689|NCT03156036|Temozolomide|temozolomide
65690|NCT03156036|Capecitabine|capecitabine
65691|NCT03156036|MGMT|mgmt
65692|NCT03156010|oculomotor testing|oculomotor testing
65693|NCT03155997|early stage breast cancer|early stage breast cancer
65694|NCT03155997|cyclin-dependent kinase (CDK)|cyclin-dependent kinase (cdk)
65695|NCT03155971|Drug-Coated Balloon|drug-coated balloon
65696|NCT03155971|Main Coronary Artery|main coronary artery
65697|NCT03155971|De Novo Lesion|de novo lesion
65698|NCT03155919|taurine|taurine
65699|NCT03155919|triathletes|triathletes
65700|NCT03155919|oxidative stress|oxidative stress
65701|NCT03155919|chocolate milk|chocolate milk
65702|NCT03155906|Chronic hepatitis C|chronic hepatitis c
65703|NCT03155906|Opiate Substitution Treatment|opiate substitution treatment
65704|NCT03155906|Integrated Delivery of Health Care|integrated delivery of health care
65705|NCT03155906|Substance Abuse Treatment Centers|substance abuse treatment centers
65706|NCT03155841|Prevention|prevention
65707|NCT03155841|Internet|internet
65708|NCT03155841|Adolescence|adolescence
65709|NCT03155841|LGBT|lgbt
65710|NCT03155841|Sexuality|sexuality
65711|NCT03155828|PCOS, OSA, CPAP|pcos, osa, cpap
65712|NCT03155763|kidney transplantation|kidney transplantation
65713|NCT03155763|implantation biopsy|implantation biopsy
65714|NCT03155763|histology|histology
65715|NCT03155763|allograft function|allograft function
65716|NCT03155763|allograft survival|allograft survival
65717|NCT03155750|insomnia|insomnia
65718|NCT03155737|Knee Osteoarthritis|knee osteoarthritis
65719|NCT03155685|antipsychotic|antipsychotic
65720|NCT03155685|palliative care|palliative care
65721|NCT03155659|Fish|fish
65722|NCT03155659|Polyunsaturated fatty acids|polyunsaturated fatty acids
65723|NCT03155659|Mortality|mortality
65724|NCT03155659|CHNS|chns
65725|NCT03155659|NHANES|nhanes
65726|NCT03155646|TAP block|tap block
65727|NCT03155646|Dexmedetomidine|dexmedetomidine
65728|NCT03155646|Clonidine|clonidine
65729|NCT03155633|Marathon, runners, biomarkers, recovery|marathon, runners, biomarkers, recovery
65730|NCT03155594|Diabetes|diabetes
65731|NCT03155594|Diabetes Mellitus|diabetes mellitus
65732|NCT03155594|Diabetes Type 1|diabetes type 1
65733|NCT03155594|Diabetes Type 2|diabetes type 2
65734|NCT03155594|CGM|cgm
65735|NCT03155594|Continuous Glucose Monitoring|continuous glucose monitoring
65736|NCT03155594|Inpatient|inpatient
65737|NCT03155594|Outpatient|outpatient
65738|NCT03155594|Transition of care|transition of care
65739|NCT03155594|DM-1|dm-1
65740|NCT03155594|DM-2|dm-2
65741|NCT03155594|Freestyle Libre|freestyle libre
65742|NCT03155555|Fluid Responsiveness|fluid responsiveness
65743|NCT03155555|Pediatric surgery|pediatric surgery
65744|NCT03155555|General endotracheal anaesthesia|general endotracheal anaesthesia
65745|NCT03155542|alcohol|alcohol
65746|NCT03155542|gene polymorphisms|gene polymorphisms
65747|NCT03155542|Colorectal cancer|colorectal cancer
65748|NCT03155529|cervical cancer|cervical cancer
65749|NCT03155529|radical hysterectomy|radical hysterectomy
65750|NCT03155529|Postoperative pelvic floor dysfunction|postoperative pelvic floor dysfunction
65751|NCT03155529|the injure of pelvic floor|the injure of pelvic floor
65752|NCT03155529|Three-dimensional reconstruction|three-dimensional reconstruction
65753|NCT03155529|structural destruction of pelvic organs|structural destruction of pelvic organs
65754|NCT03155529|structural destruction of pelvoic floor|structural destruction of pelvoic floor
65755|NCT03155516|Cancer pain|cancer pain
65756|NCT03155516|GPM|gpm
65757|NCT03155516|pain assessment|pain assessment
65758|NCT03155503|SUVN-911|suvn-911
65759|NCT03155503|Depression|depression
65760|NCT03155503|single dose|single dose
65761|NCT03155503|multiple dose|multiple dose
65762|NCT03155503|alpha4 beta2 receptor|alpha4 beta2 receptor
65763|NCT03155503|first in human|first in human
65764|NCT03155503|safety|safety
65765|NCT03155503|pharmacokinetics|pharmacokinetics
65766|NCT03155503|tolerability|tolerability
65767|NCT03155490|Hospital medical emergency team|hospital medical emergency team
65768|NCT03155490|Leadership|leadership
65769|NCT03155490|Simulation training|simulation training
65770|NCT03155477|SLE, vitamin D, SLEDAI, IL-6, TGF- β1|sle, vitamin d, sledai, il-6, tgf- β1
65771|NCT03155464|indocyanine-green|indocyanine-green
65772|NCT03155464|systemic scerlosis|systemic scerlosis
65773|NCT03155438|Oxidative stress|oxidative stress
65774|NCT03155438|Cumulus cell|cumulus cell
65775|NCT03155438|Controlled ovarian hyperstimulation|controlled ovarian hyperstimulation
65776|NCT03155438|In vitro fertilization|in vitro fertilization
65777|NCT03155438|Low responder|low responder
65778|NCT03155412|Type 2 Diabetes|type 2 diabetes
65779|NCT03155412|adipose tissue|adipose tissue
65780|NCT03155412|preadipocytes|preadipocytes
65781|NCT03155412|expandability|expandability
65782|NCT03155412|hypertrophy|hypertrophy
65783|NCT03155412|hyperplasia|hyperplasia
65784|NCT03155412|lipogenesis|lipogenesis
65785|NCT03155412|adipogenesis|adipogenesis
65786|NCT03155412|insulin sensitivity|insulin sensitivity
65787|NCT03155399|Stroke|stroke
65788|NCT03155399|Neurorehabilitation|neurorehabilitation
65789|NCT03155399|Proprioceptive Training|proprioceptive training
65790|NCT03155399|Bilateral Arm Training|bilateral arm training
65791|NCT03155399|Intracortical Inhibition|intracortical inhibition
65792|NCT03155373|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
65793|NCT03155360|Colics|colics
65794|NCT03155360|infant colics|infant colics
65795|NCT03155360|Migraine equivalent|migraine equivalent
65796|NCT03155360|Migraine|migraine
65797|NCT03155360|Episodic symptoms associated to migraine|episodic symptoms associated to migraine
65798|NCT03155360|Colic|colic
65799|NCT03155334|Multiple Sclerosis; Patient Information Sheet; User Testing|multiple sclerosis; patient information sheet; user testing
65800|NCT03155256|EUS, cyanoacrylate, coils, gastric varices|eus, cyanoacrylate, coils, gastric varices
65801|NCT03155243|Humira®|humira®
65802|NCT03155243|Adalimumab|adalimumab
65803|NCT03155243|Ocular inflammation|ocular inflammation
65804|NCT03155243|Active non-infectious intermediate, posterior and panuveitis|active non-infectious intermediate, posterior and panuveitis
65805|NCT03155230|Inguinal hernia|inguinal hernia
65806|NCT03155217|melanoma|melanoma
65807|NCT03155217|elderly|elderly
65808|NCT03155217|tolerance|tolerance
65809|NCT03155217|adverse effects|adverse effects
65810|NCT03155217|targeted therapies|targeted therapies
65811|NCT03155204|inhalation|inhalation
65812|NCT03155204|LABA|laba
65813|NCT03155204|corticosteroid|corticosteroid
65814|NCT03155191|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
65815|NCT03155191|Leukemia|leukemia
65816|NCT03155191|Lymphoblastic|lymphoblastic
65817|NCT03155191|TBI-1501|tbi-1501
65818|NCT03155191|Anti-CD19 CAR Expressing T cells Therapy|anti-cd19 car expressing t cells therapy
65819|NCT03155191|CD19 CAR Gene-Transduced Lymphocyte|cd19 car gene-transduced lymphocyte
65820|NCT03155191|Adoptive Immunotherapy|adoptive immunotherapy
65821|NCT03155191|Genetically Engineered Lymphocyte Therapy|genetically engineered lymphocyte therapy
65822|NCT03155191|Retroviral Vector|retroviral vector
65823|NCT03155191|Neoplasms by Histologic Type|neoplasms by histologic type
65824|NCT03155191|Neoplasms|neoplasms
65825|NCT03155191|Neoplasms, Experimental|neoplasms, experimental
65826|NCT03155191|Immune System Diseases|immune system diseases
65827|NCT03155191|Chimeric antigen receptor|chimeric antigen receptor
65828|NCT03155165|Colonoscopy, Retroview™ colonoscope, retrofex colonoscopy|colonoscopy, retroview™ colonoscope, retrofex colonoscopy
65829|NCT03155139|prevalence|prevalence
65830|NCT03155139|primary aldosteronism|primary aldosteronism
65831|NCT03155139|hypertension|hypertension
65832|NCT03155139|nationwide|nationwide
65833|NCT03155126|shock|shock
65834|NCT03155126|acute kidney injury|acute kidney injury
65835|NCT03155126|crystalloid|crystalloid
65836|NCT03155113|Chronic infection|chronic infection
65838|NCT03155113|DAA therapy|daa therapy
65839|NCT03155113|immune response|immune response
65840|NCT03155087|T2DM|t2dm
65841|NCT03155087|genetic polymorphism|genetic polymorphism
65842|NCT03155087|diabetic nephropathy|diabetic nephropathy
65843|NCT03155035|deworming|deworming
65844|NCT03155035|STH|sth
65845|NCT03155022|ST-elevation myocardial infarction|st-elevation myocardial infarction
65846|NCT03154996|Gliomas|gliomas
65847|NCT03154996|Recurrent|recurrent
65848|NCT03154996|Chronic Convection|chronic convection
65849|NCT03154996|High Grade Gliomas|high grade gliomas
65850|NCT03154983|Mesylate Apatinib|mesylate apatinib
65851|NCT03154983|The First-line Treatment|the first-line treatment
65852|NCT03154983|Metastatic Gastric Cancer|metastatic gastric cancer
65853|NCT03154970|Physical Therapy Specialty|physical therapy specialty
65854|NCT03154931|PTSD|ptsd
65855|NCT03154931|CBT|cbt
65856|NCT03154931|CFT|cft
65857|NCT03154931|compassion|compassion
65858|NCT03154931|shame|shame
65859|NCT03154931|guilty|guilty
65860|NCT03154931|self-criticism|self-criticism
65861|NCT03154879|Heart arrest|heart arrest
65862|NCT03154879|Hypothermia|hypothermia
65863|NCT03154879|EEG|eeg
65864|NCT03154879|Prognosis|prognosis
65865|NCT03154866|Lactobacillus kefiri LKF01 DSM32079|lactobacillus kefiri lkf01 dsm32079
65866|NCT03154866|Microbial Colonization|microbial colonization
65867|NCT03154853|Electromyography,Excessive Foot Pronation,exercise,neurology,physical therapy|electromyography,excessive foot pronation,exercise,neurology,physical therapy
65868|NCT03154814|ulinastatin|ulinastatin
65869|NCT03154814|cardiopulmonary bypass|cardiopulmonary bypass
65870|NCT03154814|cardiac surgery|cardiac surgery
65871|NCT03154788|Falls prevention|falls prevention
65872|NCT03154788|Community-Based Participatory Research|community-based participatory research
65873|NCT03154749|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
65874|NCT03154749|Triple-Negative Breast Cancer|triple-negative breast cancer
65875|NCT03154736|CVD|cvd
65876|NCT03154736|FDRCV|fdrcv
65877|NCT03154736|Developing countries|developing countries
65878|NCT03154736|Rcih countries|rcih countries
65879|NCT03154710|Web-mediated follow up|web-mediated follow up
65880|NCT03154710|Lymphoma|lymphoma
65881|NCT03154710|Personalized medicine|personalized medicine
65882|NCT03154684|Autonomy|autonomy
65883|NCT03154684|Rehabilitation|rehabilitation
65884|NCT03154684|Falls|falls
65885|NCT03154684|Quality of life|quality of life
65886|NCT03154684|Senior|senior
65887|NCT03154671|older adult;|older adult;
65888|NCT03154671|comprehensive geriatric assessment|comprehensive geriatric assessment
65889|NCT03154671|chemotherapy|chemotherapy
65890|NCT03154671|integrated care|integrated care
65891|NCT03154671|randomized controlled trial|randomized controlled trial
65892|NCT03154632|Myofascial trigger point|myofascial trigger point
65893|NCT03154632|Trapezius Muscle|trapezius muscle
65894|NCT03154632|Diathermy|diathermy
65895|NCT03154632|Ultrasound|ultrasound
65896|NCT03154593|Prevalence|prevalence
65897|NCT03154541|Chronic Rhinosinusitis (CRS), Cystic Fibrosis related CRS|chronic rhinosinusitis (crs), cystic fibrosis related crs
65898|NCT03154515|Respiratory Tract Infections|respiratory tract infections
65899|NCT03154515|Acute Respiratory Viral Infection|acute respiratory viral infection
65900|NCT03154502|Sodium intake|sodium intake
65901|NCT03154502|Urinary sodium excretion|urinary sodium excretion
65902|NCT03154411|ABY-029|aby-029
65903|NCT03154411|Affibody|affibody
65904|NCT03154411|molecular fluorescence-guided surgery|molecular fluorescence-guided surgery
65905|NCT03154411|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
65906|NCT03154398|evaluation of thyroid function in diabetes patients|evaluation of thyroid function in diabetes patients
65907|NCT03154385|ITP|itp
65908|NCT03154346|Baseline|baseline
65909|NCT03154346|Project Baseline|project baseline
65910|NCT03154346|Baseline Study|baseline study
65911|NCT03154346|Project Baseline Study|project baseline study
65912|NCT03154333|Epidermolysis|epidermolysis
65913|NCT03154333|bullosa|bullosa
65914|NCT03154333|simplex|simplex
65915|NCT03154333|blister|blister
65916|NCT03154333|EBS|ebs
65917|NCT03154333|topical|topical
65918|NCT03154333|ointment|ointment
65919|NCT03154333|lesion|lesion
65920|NCT03154281|Breast|breast
65921|NCT03154281|Ovarian|ovarian
65922|NCT03154268|Gestational weight gain|gestational weight gain
65923|NCT03154268|Chinese pregnant women|chinese pregnant women
65924|NCT03154268|Retrospective longitudinal study|retrospective longitudinal study
65925|NCT03154268|China|china
65926|NCT03154268|IOM guideline|iom guideline
65927|NCT03154268|Adverse outcome|adverse outcome
65928|NCT03154268|Model|model
65929|NCT03154255|Obesity|obesity
65930|NCT03154255|Paediatric|paediatric
65931|NCT03154255|Mediterranean diet|mediterranean diet
65932|NCT03154255|Gamification|gamification
65933|NCT03154255|Insulin-resistance|insulin-resistance
65934|NCT03154242|non small cell lung cancer|non small cell lung cancer
65935|NCT03154242|NSCLC|nsclc
65936|NCT03154242|Platinum|platinum
65937|NCT03154151|PTSD|ptsd
65938|NCT03154151|Post-Traumatic Stress Disorder|post-traumatic stress disorder
65939|NCT03154151|Post-Traumatic Stress Disorder symptoms|post-traumatic stress disorder symptoms
65940|NCT03154151|World Trade Center|world trade center
65941|NCT03154151|9/11|9/11
65942|NCT03154151|first responder|first responder
65943|NCT03154151|rescue/recovery/clean-up worker|rescue/recovery/clean-up worker
65944|NCT03154138|Stroke|stroke
65945|NCT03154138|hemiplegia|hemiplegia
65946|NCT03154138|rehabilitation|rehabilitation
65947|NCT03154138|prismatic adaptation|prismatic adaptation
65948|NCT03154138|postural imbalance|postural imbalance
65949|NCT03154138|posture|posture
65950|NCT03154138|spatial cognition|spatial cognition
65951|NCT03154099|CIRCI|circi
65952|NCT03154086|REarranged during Transfection|rearranged during transfection
65953|NCT03154073|Exercise|exercise
65954|NCT03154073|Physical activity|physical activity
65955|NCT03154073|Blood glucose|blood glucose
65956|NCT03154073|Sleep|sleep
65957|NCT03154060|Flash glucose monitoring|flash glucose monitoring
65958|NCT03154060|Accuracy|accuracy
65959|NCT03154060|Precision|precision
65960|NCT03154034|Stress echocardiography|stress echocardiography
65961|NCT03154034|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
65962|NCT03154034|ergospirometry|ergospirometry
65963|NCT03154021|Gingival Index|gingival index
65964|NCT03154021|Plaque Index|plaque index
65965|NCT03154021|Bleeding|bleeding
65966|NCT03154021|Pocket Depth|pocket depth
65967|NCT03154008|reward|reward
65968|NCT03154008|emotion regulation|emotion regulation
66266|NCT03152357|TKR|tkr
65969|NCT03154008|electroencephalogram|electroencephalogram
65970|NCT03154008|event-related potentials|event-related potentials
65971|NCT03154008|cognitive behavior therapy|cognitive behavior therapy
65972|NCT03153995|expander|expander
65973|NCT03153982|HNSCC|hnscc
65974|NCT03153956|AposTherapy® System|apostherapy® system
65975|NCT03153956|Osteoarthritis|osteoarthritis
65976|NCT03153956|Total knee arthroplasties|total knee arthroplasties
65977|NCT03153956|Degenerative joint disease|degenerative joint disease
65978|NCT03153930|sedentary behavior|sedentary behavior
65979|NCT03153930|youth|youth
65980|NCT03153930|moderating factors|moderating factors
65981|NCT03153930|metabolic outcomes|metabolic outcomes
65982|NCT03153917|shift work|shift work
65983|NCT03153917|melatonin|melatonin
65984|NCT03153917|sleep|sleep
65985|NCT03153904|anxiety|anxiety
65986|NCT03153904|depression|depression
65987|NCT03153904|trauma|trauma
65988|NCT03153904|behavior problems|behavior problems
65989|NCT03153904|evidence-based treatments|evidence-based treatments
65990|NCT03153904|manualized treatments|manualized treatments
65991|NCT03153904|cognitive-behavioral therapy|cognitive-behavioral therapy
65992|NCT03153904|youth|youth
65993|NCT03153904|mental health|mental health
65994|NCT03153891|environment|environment
65995|NCT03153891|nature|nature
65996|NCT03153878|Unruptured Intracranial Aneurysm|unruptured intracranial aneurysm
65997|NCT03153878|Benefit-risk|benefit-risk
65998|NCT03153878|Ischemic heart disease|ischemic heart disease
65999|NCT03153878|Ischemic cerebrovascular disease|ischemic cerebrovascular disease
66000|NCT03153878|Antithrombotic|antithrombotic
66001|NCT03153878|Anticoagulant|anticoagulant
66002|NCT03153878|People's Republic of China|people's republic of china
66003|NCT03153878|Multicenter Studies|multicenter studies
66004|NCT03153839|Children|children
66005|NCT03153839|Babies|babies
66006|NCT03153839|Infant|infant
66007|NCT03153839|Swimming pool|swimming pool
66008|NCT03153839|Aquatic physical activity|aquatic physical activity
66009|NCT03153839|Motor development|motor development
66010|NCT03153839|Neurodevelopment|neurodevelopment
66011|NCT03153826|COPD Exacerbation|copd exacerbation
66012|NCT03153826|Muscle atrophy|muscle atrophy
66013|NCT03153826|Inflammation|inflammation
66014|NCT03153826|Oxidative stress|oxidative stress
66015|NCT03153813|pain|pain
66016|NCT03153813|knee osteoarthritis|knee osteoarthritis
66017|NCT03153813|obesity|obesity
66018|NCT03153813|capsaicin|capsaicin
66019|NCT03153787|implantation failure|implantation failure
66020|NCT03153787|fertility|fertility
66021|NCT03153787|microbiome|microbiome
66022|NCT03153787|Assisted reproduction|assisted reproduction
66023|NCT03153774|Sarcopenia|sarcopenia
66024|NCT03153774|Heart failure (HF)|heart failure (hf)
66025|NCT03153774|The trans aortic valvular implantation (TAVI)|the trans aortic valvular implantation (tavi)
66026|NCT03153748|Treatment strategy|treatment strategy
66027|NCT03153735|Hyaluronic acid|hyaluronic acid
66028|NCT03153735|Small Penis|small penis
66029|NCT03153735|Penile Enhancement|penile enhancement
66030|NCT03153722|pediatric|pediatric
66031|NCT03153722|hospital discharge|hospital discharge
66032|NCT03153722|quality improvement|quality improvement
66033|NCT03153722|transition of care|transition of care
66034|NCT03153709|Pregnancy rates|pregnancy rates
66035|NCT03153709|pharmacokinetic interactions|pharmacokinetic interactions
66036|NCT03153709|Women on efavirenz|women on efavirenz
66037|NCT03153709|initiating the Levonorgestrel Implant|initiating the levonorgestrel implant
66038|NCT03153709|initiating the Depot Medroxyprogesterone Acetate Injectable|initiating the depot medroxyprogesterone acetate injectable
66039|NCT03153683|Acute, Ischemic, Stroke, Biomarkers, Proteins, Leukocyte, Inflammatory Cells; Acid/Base Balance|acute, ischemic, stroke, biomarkers, proteins, leukocyte, inflammatory cells; acid/base balance
66040|NCT03153657|Tooth Bleaching|tooth bleaching
66041|NCT03153644|Qualitative Research|qualitative research
66042|NCT03153644|Medical conditions|medical conditions
66043|NCT03153644|Birth control methods|birth control methods
66044|NCT03153644|Intrauterine Devices|intrauterine devices
66045|NCT03153644|Physicians, Primary Care|physicians, primary care
66046|NCT03153644|Long-acting reversible contraceptives (LARC)|long-acting reversible contraceptives (larc)
66047|NCT03153540|Aphasia|aphasia
66048|NCT03153540|Agrammatism|agrammatism
66049|NCT03153540|Frontotemporal Dementia|frontotemporal dementia
66050|NCT03153540|Tauopathies|tauopathies
66051|NCT03153540|Neurodegenerative Diseases|neurodegenerative diseases
66052|NCT03153540|Language Disorders|language disorders
66053|NCT03153540|Frontotemporal Lobar Degeneration|frontotemporal lobar degeneration
66054|NCT03153514|CLL|cll
66055|NCT03153488|ADHD|adhd
66056|NCT03153488|Methylphenidate|methylphenidate
66057|NCT03153488|Amphetamine|amphetamine
66058|NCT03153488|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
66059|NCT03153488|Treatment|treatment
66060|NCT03153475|Revision knee surgery, implant replacement|revision knee surgery, implant replacement
66061|NCT03153449|complex primary, deformity, ligamentous laxity|complex primary, deformity, ligamentous laxity
66062|NCT03153410|Pancreas vaccine|pancreas vaccine
66063|NCT03153410|immunotherapy|immunotherapy
66064|NCT03153410|antibody|antibody
66065|NCT03153410|PD-1|pd-1
66066|NCT03153410|IMC-CS4|imc-cs4
66067|NCT03153410|Pembrolizumab|pembrolizumab
66068|NCT03153410|GVAX|gvax
66069|NCT03153410|Borderline Resectable|borderline resectable
66070|NCT03153397|trauma|trauma
66071|NCT03153397|brain|brain
66072|NCT03153397|neurological|neurological
66073|NCT03153397|injury|injury
66074|NCT03153397|enteral|enteral
66075|NCT03153397|tube|tube
66076|NCT03153397|feeding|feeding
66077|NCT03153397|nutrition|nutrition
66078|NCT03153384|Diagnosis|diagnosis
66079|NCT03153384|Blood Culture|blood culture
66080|NCT03153371|Alzheimer's disease|alzheimer's disease
66081|NCT03153371|Young-onset|young-onset
66082|NCT03153371|variant|variant
66083|NCT03153371|visuospatial|visuospatial
66084|NCT03153371|language|language
66085|NCT03153371|apraxia|apraxia
66086|NCT03153371|control|control
66087|NCT03153371|dementia|dementia
66088|NCT03153371|memory|memory
66089|NCT03153371|MRI|mri
66090|NCT03153371|neurology|neurology
66091|NCT03153371|neuropsychology|neuropsychology
66092|NCT03153371|brain|brain
66093|NCT03153358|EGFR mutation icotinib SBRT|egfr mutation icotinib sbrt
66094|NCT03153306|Albumin|albumin
66095|NCT03153293|LHON,G11778A mutation, rAAV2-ND4，gene therapy|lhon,g11778a mutation, raav2-nd4，gene therapy
66096|NCT03153254|Upper extremity|upper extremity
66097|NCT03153254|Rehabilitation|rehabilitation
66098|NCT03153254|Robot assisted therapy|robot assisted therapy
66099|NCT03153254|Robotics|robotics
66100|NCT03153254|Devices|devices
66101|NCT03153254|Orthosis|orthosis
66102|NCT03153228|E-cigarettes|e-cigarettes
66103|NCT03153202|Ibrutinib|ibrutinib
66104|NCT03153202|Pembrolizumab|pembrolizumab
66105|NCT03153202|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
66106|NCT03153202|Mantle Cell Lymphoma|mantle cell lymphoma
66107|NCT03153189|PA,menatal health,QOL|pa,menatal health,qol
66108|NCT03153176|physical activity|physical activity
66109|NCT03153176|physical fitness|physical fitness
66110|NCT03153176|eating habits|eating habits
66111|NCT03153176|sedentary behavior|sedentary behavior
66112|NCT03153176|sleep quality|sleep quality
66113|NCT03153176|satisfaction personal|satisfaction personal
66114|NCT03153176|school health|school health
66115|NCT03153176|adolescent|adolescent
66116|NCT03153150|Oral anticoagulant|oral anticoagulant
66117|NCT03153150|Factor Xa inhibitors|factor xa inhibitors
66118|NCT03153150|Direct thrombin inhibitor|direct thrombin inhibitor
66119|NCT03153150|Vitamin K antagonist|vitamin k antagonist
66120|NCT03153150|Antiplatelet drug|antiplatelet drug
66121|NCT03153124|Respiratory muscle strength|respiratory muscle strength
66122|NCT03153124|Renal insufficiency|renal insufficiency
66123|NCT03153124|Respiratory muscle training|respiratory muscle training
66124|NCT03153098|physical activity|physical activity
66125|NCT03153098|intervention|intervention
66126|NCT03153098|behaviour change|behaviour change
66127|NCT03153098|inactive adults|inactive adults
66128|NCT03153098|behaviour change techniques|behaviour change techniques
66129|NCT03153098|well-being|well-being
66130|NCT03153085|Unresectable melanoma|unresectable melanoma
66131|NCT03153085|Metastatic melanoma|metastatic melanoma
66132|NCT03153085|Recurrent Melanoma|recurrent melanoma
66133|NCT03153085|TBI-1401(HF10)|tbi-1401(hf10)
66134|NCT03153085|HF10|hf10
66135|NCT03153085|HSV-1|hsv-1
66136|NCT03153085|Oncolytic virus|oncolytic virus
66137|NCT03153085|Oncolytic viral immunotherapy|oncolytic viral immunotherapy
66138|NCT03153085|Ipilimumab|ipilimumab
66139|NCT03153085|Intratumoral administration|intratumoral administration
66140|NCT03153085|canerpaturev|canerpaturev
66141|NCT03153059|gut microbiota|gut microbiota
66142|NCT03153059|stool frequency|stool frequency
66143|NCT03153046|prebiotics|prebiotics
66144|NCT03153046|cognitive impairment|cognitive impairment
66145|NCT03153046|weight gain|weight gain
66146|NCT03153033|Wheelchair propulsion|wheelchair propulsion
66147|NCT03153033|Shoulder|shoulder
66148|NCT03153033|Biomechanics|biomechanics
66149|NCT03152994|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
66150|NCT03152994|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
66151|NCT03152994|neutrophil-lymphocyte ratio|neutrophil-lymphocyte ratio
66152|NCT03152994|platelet-lymphocyte ratio|platelet-lymphocyte ratio
66153|NCT03152994|lymphocyte-monocyte ratio|lymphocyte-monocyte ratio
66154|NCT03152968|FMS|fms
66155|NCT03152955|trigeminal neuralgia|trigeminal neuralgia
66156|NCT03152955|nerve block|nerve block
66157|NCT03152929|Surgery|surgery
66158|NCT03152929|Breast|breast
66159|NCT03152929|Pectoral Never Block|pectoral never block
66160|NCT03152929|Paravertebral Block|paravertebral block
66161|NCT03152929|Analgesia|analgesia
66162|NCT03152929|Mastectomy|mastectomy
66163|NCT03152916|subtalar joint|subtalar joint
66164|NCT03152916|arthrodesis|arthrodesis
66165|NCT03152916|3d printing|3d printing
66166|NCT03152903|Recombinant BCG vaccine|recombinant bcg vaccine
67149|NCT03146585|Glycocalyx|glycocalyx
66167|NCT03152903|Category 1 pulmonary tuberculosis|category 1 pulmonary tuberculosis
66168|NCT03152903|Recurrence|recurrence
66169|NCT03152903|Efficacy|efficacy
66170|NCT03152890|Insulin|insulin
66171|NCT03152890|Liver transplantation|liver transplantation
66172|NCT03152890|Hyperglycemia|hyperglycemia
66173|NCT03152825|myocardial ischaemia|myocardial ischaemia
66174|NCT03152825|myocardial viability|myocardial viability
66175|NCT03152825|coronary chronic total occlusions|coronary chronic total occlusions
66176|NCT03152825|cardiac magnetic resonance|cardiac magnetic resonance
66177|NCT03152825|stress CMR|stress cmr
66178|NCT03152799|remote ischaemic conditioning|remote ischaemic conditioning
66179|NCT03152799|remote ischemic conditioning|remote ischemic conditioning
66180|NCT03152799|cerebral infarction|cerebral infarction
66181|NCT03152799|ischaemia reperfusion injury|ischaemia reperfusion injury
66182|NCT03152799|ischemia reperfusion injury|ischemia reperfusion injury
66183|NCT03152799|anterior circulation stroke|anterior circulation stroke
66184|NCT03152799|mechanical thrombectomy|mechanical thrombectomy
66185|NCT03152773|MRI Catheterization|mri catheterization
66186|NCT03152773|Real-time MRI|real-time mri
66187|NCT03152760|Alcoholism|alcoholism
66188|NCT03152760|Healthy Volunteers|healthy volunteers
66189|NCT03152760|Craving|craving
66190|NCT03152760|Gut|gut
66191|NCT03152734|Elderly patients, Mortality, morbidity, post-intervention|elderly patients, mortality, morbidity, post-intervention
66192|NCT03152721|accelerometry|accelerometry
66193|NCT03152721|home based|home based
66194|NCT03152721|motor complications|motor complications
66195|NCT03152721|Parkinson KinetiGraph|parkinson kinetigraph
66196|NCT03152721|Registry|registry
66197|NCT03152682|glucose|glucose
66198|NCT03152682|glucose homeostasis|glucose homeostasis
66199|NCT03152669|asthma|asthma
66200|NCT03152669|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
66201|NCT03152669|Salford Lung Study|salford lung study
66202|NCT03152656|Familial hypercholesterolemia|familial hypercholesterolemia
66203|NCT03152656|total cholesterol|total cholesterol
66204|NCT03152656|low-density lipoprotein cholesterol|low-density lipoprotein cholesterol
66205|NCT03152656|tendon xanthomas|tendon xanthomas
66206|NCT03152656|premature atherosclerosis|premature atherosclerosis
66207|NCT03152643|Cumulative live birth rates|cumulative live birth rates
66208|NCT03152643|cleavage-stage embryo transfer|cleavage-stage embryo transfer
66209|NCT03152643|blastocyst transfer|blastocyst transfer
66210|NCT03152630|lncRNAs|lncrnas
66211|NCT03152630|Alzheimer's disease|alzheimer's disease
66212|NCT03152630|vascular dementia|vascular dementia
66213|NCT03152617|bariatric surgery|bariatric surgery
66214|NCT03152617|gastric bypass|gastric bypass
66215|NCT03152617|malnutrition|malnutrition
66216|NCT03152617|bone disease|bone disease
66217|NCT03152617|oral health|oral health
66218|NCT03152591|Polycystic ovary syndrome|polycystic ovary syndrome
66219|NCT03152591|PCOS|pcos
66220|NCT03152591|hyperandrogenism|hyperandrogenism
66221|NCT03152591|insulin resistance|insulin resistance
66222|NCT03152591|overweight|overweight
66223|NCT03152591|obesity|obesity
66224|NCT03152552|diabetes type 2|diabetes type 2
66225|NCT03152552|heart failure|heart failure
66226|NCT03152500|IOL|iol
66227|NCT03152500|Stability|stability
66228|NCT03152500|FEMTIS IOL|femtis iol
66229|NCT03152500|Acrysof IOL|acrysof iol
66230|NCT03152500|FLACS|flacs
66231|NCT03152500|Capsulotomy|capsulotomy
66232|NCT03152487|endoscopic ultrasound|endoscopic ultrasound
66233|NCT03152487|celiac plexus neurolysis|celiac plexus neurolysis
66234|NCT03152487|radiofrequency ablation|radiofrequency ablation
66235|NCT03152487|pancreatic cancer|pancreatic cancer
66236|NCT03152461|Viscoelastic testing|viscoelastic testing
66237|NCT03152461|Coagulation|coagulation
66238|NCT03152461|Quantra|quantra
66239|NCT03152461|Hemostasis|hemostasis
66240|NCT03152448|Prolaris|prolaris
66241|NCT03152448|Prostate Cancer|prostate cancer
66242|NCT03152409|Aspirin|aspirin
66243|NCT03152409|Treatment|treatment
66244|NCT03152409|Salicylic acid|salicylic acid
66245|NCT03152409|anti-inflammatory|anti-inflammatory
66246|NCT03152396|modifiable cardiovascular risk factors|modifiable cardiovascular risk factors
66247|NCT03152396|cardiovascular risk factors|cardiovascular risk factors
66248|NCT03152396|blood pressure|blood pressure
66249|NCT03152396|LDL-cholesterol|ldl-cholesterol
66250|NCT03152396|total-cholesterol|total-cholesterol
66251|NCT03152396|HDL-cholesterol|hdl-cholesterol
66252|NCT03152396|hemoglobin A1C|hemoglobin a1c
66253|NCT03152396|tobacco cessation|tobacco cessation
66254|NCT03152396|patient satisfaction|patient satisfaction
66255|NCT03152383|Autism Spectrum Disorder|autism spectrum disorder
66256|NCT03152383|Behavioral Research|behavioral research
66257|NCT03152383|Psychology|psychology
66258|NCT03152383|Cognitive Disorders|cognitive disorders
66259|NCT03152370|E7046|e7046
66260|NCT03152370|Radiotherapy/Chemoradiotherapy|radiotherapy/chemoradiotherapy
66261|NCT03152370|Neoadjuvant therapy|neoadjuvant therapy
66262|NCT03152370|Rectal cancer|rectal cancer
66263|NCT03152357|osteoarthritis|osteoarthritis
66264|NCT03152357|total knee arthroplasty|total knee arthroplasty
66267|NCT03152357|patient specific|patient specific
66268|NCT03152357|Conformis|conformis
66269|NCT03152344|Fall|fall
66270|NCT03152344|Balance control|balance control
66271|NCT03152344|Screening test|screening test
66272|NCT03152344|Oxygen|oxygen
66273|NCT03152344|Skeletal muscle mass|skeletal muscle mass
66274|NCT03152331|Neurofeedback|neurofeedback
66275|NCT03152318|Malignant Glioma|malignant glioma
66276|NCT03152318|Brain Tumor|brain tumor
66277|NCT03152318|Glioblastoma|glioblastoma
66278|NCT03152305|Migraine|migraine
66279|NCT03152305|Intracranial pressure|intracranial pressure
66280|NCT03152305|Headache|headache
66281|NCT03152253|Tobacco, Smoking, Text Message|tobacco, smoking, text message
66282|NCT03152240|Acute Coronary Syndrome|acute coronary syndrome
66283|NCT03152240|Primary Angioplasty|primary angioplasty
66284|NCT03152240|Gender|gender
66285|NCT03152214|Transition out of military|transition out of military
66286|NCT03152188|Hepatic Encephalopathy|hepatic encephalopathy
66287|NCT03152188|Cirrhosis|cirrhosis
66288|NCT03152188|Liver|liver
66289|NCT03152188|Openbiome|openbiome
66290|NCT03152188|FMT Capsule|fmt capsule
66291|NCT03152188|Placebo|placebo
66292|NCT03152175|Memory Reconsolidation|memory reconsolidation
66293|NCT03152175|Propranolol|propranolol
66294|NCT03152175|Police officers|police officers
66295|NCT03152175|911 operators|911 operators
66296|NCT03152175|Efficacy|efficacy
66297|NCT03152175|Cost-effectiveness|cost-effectiveness
66298|NCT03152162|osteoarthritis|osteoarthritis
66299|NCT03152162|patient-specific|patient-specific
66300|NCT03152162|knee replacement|knee replacement
66301|NCT03152162|TKA|tka
66302|NCT03152162|knee arthroplasty|knee arthroplasty
66303|NCT03152162|total knee replacement|total knee replacement
66304|NCT03152162|posterior stabilized|posterior stabilized
66305|NCT03152149|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
66306|NCT03152110|High Intensity Interval Training|high intensity interval training
66307|NCT03152110|HIIT|hiit
66308|NCT03152110|Physical Activity|physical activity
66309|NCT03152071|thoracoscopic surgery|thoracoscopic surgery
66310|NCT03152071|RATS|rats
66311|NCT03152071|VATS|vats
66312|NCT03152071|Robot|robot
66313|NCT03152045|communication between adolescent patients and their clinician|communication between adolescent patients and their clinician
66314|NCT03152032|employment service|employment service
66315|NCT03152032|vocational counseling|vocational counseling
66316|NCT03152032|employment outcome|employment outcome
66317|NCT03152032|schizophrenia|schizophrenia
66318|NCT03152032|bipolar|bipolar
66319|NCT03152032|occupational therapy in mental health|occupational therapy in mental health
66320|NCT03152019|Hemorrhagic Hereditary Telangiectasia (HHT)|hemorrhagic hereditary telangiectasia (hht)
66321|NCT03152019|Antiangiogenic therapy|antiangiogenic therapy
66322|NCT03152019|Tacrolimus|tacrolimus
66323|NCT03152006|Healthcare transition|healthcare transition
66324|NCT03152006|Adolescents|adolescents
66325|NCT03152006|Nigeria|nigeria
66326|NCT03151993|Ischemic Stroke|ischemic stroke
66327|NCT03151993|Fibrinolysis|fibrinolysis
66328|NCT03151993|Fortelyzin|fortelyzin
66329|NCT03151954|nasal epithelium stem cells|nasal epithelium stem cells
66330|NCT03151954|Hippo-YAP pathway|hippo-yap pathway
66331|NCT03151954|proliferation|proliferation
66332|NCT03151954|differentiation|differentiation
66333|NCT03151863|Dexmedetomidine|dexmedetomidine
66334|NCT03151863|Opioids|opioids
66335|NCT03151863|Palliative Care|palliative care
66336|NCT03151863|Elderly people|elderly people
66337|NCT03151863|Nursing care|nursing care
66338|NCT03151863|Analgesia|analgesia
66339|NCT03151863|Sedation|sedation
66340|NCT03151863|Anxiolysis|anxiolysis
66341|NCT03151863|Intranasal|intranasal
66342|NCT03151850|fungal|fungal
66343|NCT03151850|mucosa|mucosa
66344|NCT03151850|diversity|diversity
66345|NCT03151850|Basidiomycete|basidiomycete
66346|NCT03151837|Diabetes|diabetes
66347|NCT03151837|Bitter melon(Momordica charantia)|bitter melon(momordica charantia)
66348|NCT03151837|Insulin sensitivity|insulin sensitivity
66349|NCT03151811|Refractory Multiple Myeloma|refractory multiple myeloma
66350|NCT03151811|Relapsed Multiple Myeloma|relapsed multiple myeloma
66351|NCT03151811|Melflufen|melflufen
66352|NCT03151811|Pomalidomide|pomalidomide
66353|NCT03151811|Dexamethasone|dexamethasone
66354|NCT03151798|Nonalcoholic fatty liver|nonalcoholic fatty liver
66355|NCT03151798|Exercise|exercise
66356|NCT03151798|Weight loss diet|weight loss diet
66357|NCT03151785|CPR|cpr
66358|NCT03151785|Schools|schools
66359|NCT03151785|Education|education
66360|NCT03151785|Lifesaver|lifesaver
66361|NCT03151733|SILS|sils
66362|NCT03151733|colorectal cancer|colorectal cancer
66363|NCT03151694|childhood obesity|childhood obesity
66364|NCT03151694|body weight|body weight
66365|NCT03151694|nutritional risk|nutritional risk
66366|NCT03151681|Reconsolidation|reconsolidation
66367|NCT03151681|Propranolol|propranolol
66368|NCT03151681|Infidelity|infidelity
66369|NCT03151681|Attachment injury|attachment injury
66370|NCT03151681|Romantic relationships|romantic relationships
66371|NCT03151603|Uva Ursi|uva ursi
66372|NCT03151603|fosfomycin|fosfomycin
66373|NCT03151603|uncomplicated urinary tract infection of women|uncomplicated urinary tract infection of women
66374|NCT03151564|Diseases of liver|diseases of liver
66375|NCT03151564|Colon carcinoma|colon carcinoma
66376|NCT03151564|Colorectal carcinoma|colorectal carcinoma
66377|NCT03151564|Liver metastases|liver metastases
66378|NCT03151564|Computed tomography|computed tomography
66379|NCT03151564|CT|ct
66380|NCT03151564|Reduced radiation doses|reduced radiation doses
66381|NCT03151538|Pedography|pedography
66382|NCT03151538|Exercise|exercise
66383|NCT03151538|Play Training|play training
66384|NCT03151538|Pes Planus|pes planus
66385|NCT03151538|Femoral Anteversion|femoral anteversion
66386|NCT03151512|MRI|mri
66387|NCT03151512|distortion correction|distortion correction
66388|NCT03151512|Magnetic Resonance Imaging|magnetic resonance imaging
66389|NCT03151512|prostheses|prostheses
66390|NCT03151447|Breast Cancer|breast cancer
66391|NCT03151447|Anti-PD1 Antibody|anti-pd1 antibody
66392|NCT03151447|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
66393|NCT03151434|VATS|vats
66394|NCT03151434|pain|pain
66395|NCT03151421|air quality feedback|air quality feedback
66396|NCT03151421|second-hand smoke|second-hand smoke
66397|NCT03151421|passive smoking|passive smoking
66398|NCT03151421|exposure to second-hand smoke|exposure to second-hand smoke
66399|NCT03151421|second-hand smoke exposure prevention|second-hand smoke exposure prevention
66400|NCT03151408|AML|aml
66401|NCT03151395|COPD|copd
66402|NCT03151395|AECOPD|aecopd
66403|NCT03151395|GOLD (Global Initiative for Chronic Obstructive Lung Disease)|gold (global initiative for chronic obstructive lung disease)
66404|NCT03151395|Asia Pacific|asia pacific
66405|NCT03151382|Alzheimer Disease|alzheimer disease
66406|NCT03151382|Cognitive Function|cognitive function
66407|NCT03151382|tandospirone|tandospirone
66408|NCT03151304|MDS|mds
66409|NCT03151291|cancer cachexia|cancer cachexia
66410|NCT03151291|WB-EMS|wb-ems
66411|NCT03151291|skeletal muscle mass|skeletal muscle mass
66412|NCT03151291|exercise|exercise
66413|NCT03151291|nutrition|nutrition
66414|NCT03151291|dietary supplements|dietary supplements
66415|NCT03151278|Fluoroscopy|fluoroscopy
66416|NCT03151278|Ablation|ablation
66417|NCT03151278|Three dimensional|three dimensional
66418|NCT03151278|Atrial arrhythmia|atrial arrhythmia
66419|NCT03151278|Radiation|radiation
66420|NCT03151265|Functional Outcome Measures|functional outcome measures
66421|NCT03151265|Wearable Sensors|wearable sensors
66422|NCT03151265|ViMove|vimove
66423|NCT03151265|Low Back Pain|low back pain
66424|NCT03151265|Range of Movement|range of movement
66425|NCT03151265|Muscle Activity|muscle activity
66426|NCT03151265|ThermaCare|thermacare
66427|NCT03151226|obstructive sleep apnea screen negative|obstructive sleep apnea screen negative
66428|NCT03151226|respiratory depression|respiratory depression
66429|NCT03151226|cesarean section|cesarean section
66430|NCT03151200|Amblyopia treatment|amblyopia treatment
66431|NCT03151161|chemotherapy|chemotherapy
66432|NCT03151161|maintenance therapy|maintenance therapy
66433|NCT03151161|icotinib|icotinib
66434|NCT03151148|allogeneic targeted microbiome transplant (TMT)|allogeneic targeted microbiome transplant (tmt)
66435|NCT03151148|dysbiosis in AD|dysbiosis in ad
66436|NCT03151148|Staphylococcus aureus colonized skin|staphylococcus aureus colonized skin
66437|NCT03151148|antimicrobial peptides (AMPs)|antimicrobial peptides (amps)
66438|NCT03151148|randomized trial|randomized trial
66439|NCT03151135|Energy metabolism|energy metabolism
66440|NCT03151109|reverse total shoulder arthroplasty|reverse total shoulder arthroplasty
66441|NCT03151109|glenoid bone loss|glenoid bone loss
66442|NCT03151083|Health Technology|health technology
66443|NCT03151083|Internet-Based Psychotherapy|internet-based psychotherapy
66444|NCT03151083|self-care|self-care
66445|NCT03151083|Primary Care|primary care
66446|NCT03151083|Mental Health|mental health
66447|NCT03151057|Idelalisib|idelalisib
66448|NCT03151057|Zydelig|zydelig
66449|NCT03151057|Gilead|gilead
66450|NCT03151057|allo transplant|allo transplant
66451|NCT03151057|Gladstone|gladstone
66452|NCT03151057|PI3K inhibitor|pi3k inhibitor
66453|NCT03151057|post transplant maintenance therapy|post transplant maintenance therapy
66454|NCT03151044|epirubicin|epirubicin
66455|NCT03151044|high-dose|high-dose
66456|NCT03151044|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
66457|NCT03151044|medium/high-risk|medium/high-risk
66458|NCT03151031|balance|balance
66459|NCT03151031|college students|college students
66460|NCT03151031|star excursion balance test|star excursion balance test
66461|NCT03151018|coronary artery disease|coronary artery disease
66462|NCT03151018|percutaneous coronary intervention|percutaneous coronary intervention
66463|NCT03151018|zotarolimus-eluting stents|zotarolimus-eluting stents
66464|NCT03151005|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
66465|NCT03151005|Overweight|overweight
66466|NCT03151005|Obesity|obesity
66467|NCT03151005|GLP-1 Agonist|glp-1 agonist
66468|NCT03151005|Oral contraceptives (OCs)|oral contraceptives (ocs)
66469|NCT03151005|Metformin|metformin
66470|NCT03151005|Reproductive Disorders|reproductive disorders
66471|NCT03151005|Cardiovascular risk factor|cardiovascular risk factor
66472|NCT03151005|Lipid Metabolism|lipid metabolism
66473|NCT03150992|Feasibility|feasibility
66474|NCT03150992|Elemental Diet|elemental diet
66475|NCT03150992|Quality of life|quality of life
66476|NCT03150992|Palliative|palliative
66477|NCT03150992|Nutrition|nutrition
66478|NCT03150992|Ovarian|ovarian
66479|NCT03150992|Peritoneal|peritoneal
66480|NCT03150992|Advanced|advanced
66481|NCT03150992|Metastatic|metastatic
66482|NCT03150992|Bowel obstruction|bowel obstruction
66483|NCT03150992|Inoperable|inoperable
66484|NCT03150979|Stroke|stroke
66485|NCT03150979|Assistive devices|assistive devices
66486|NCT03150979|Gait|gait
66487|NCT03150979|Rehabilitation|rehabilitation
66488|NCT03150979|Clinical trial|clinical trial
66489|NCT03150966|Multiple sclerosis|multiple sclerosis
66490|NCT03150966|Nanocurcumin|nanocurcumin
66491|NCT03150966|MicroRNAs|micrornas
66492|NCT03150966|Th17 cells|th17 cells
66493|NCT03150953|anesthesia|anesthesia
66494|NCT03150953|MRI|mri
66495|NCT03150953|thermoregulation|thermoregulation
66496|NCT03150862|Adult glioblastoma, adult gian cell glioblastoma, adult gliosarcoma, glioma neoplasms|adult glioblastoma, adult gian cell glioblastoma, adult gliosarcoma, glioma neoplasms
66497|NCT03150862|recurrent adult brain tumor|recurrent adult brain tumor
66498|NCT03150862|neoplasms, central nervous system neoplasms, neoplasms by histologic type, neoplasms by site|neoplasms, central nervous system neoplasms, neoplasms by histologic type, neoplasms by site
66499|NCT03150862|astrocytoma|astrocytoma
66500|NCT03150862|neuroepithelial|neuroepithelial
66501|NCT03150862|neuroectodermal tumors|neuroectodermal tumors
66502|NCT03150862|germ cell and embryonal|germ cell and embryonal
66503|NCT03150862|antineoplastic agents|antineoplastic agents
66504|NCT03150862|glandular and epithelial|glandular and epithelial
66505|NCT03150862|nerve tissue, nervous system diseases|nerve tissue, nervous system diseases
66506|NCT03150862|temozolomide|temozolomide
66507|NCT03150862|BGB-290|bgb-290
66508|NCT03150862|alkylating, alkylating agents|alkylating, alkylating agents
66509|NCT03150862|molecular mechanisms of pharmacological action|molecular mechanisms of pharmacological action
66510|NCT03150862|Poly(ADP-ribose) polymerase inhibitors|poly(adp-ribose) polymerase inhibitors
66511|NCT03150862|enzyme inhibitors|enzyme inhibitors
66512|NCT03150836|bladder cancer|bladder cancer
66513|NCT03150836|urothelial|urothelial
66514|NCT03150823|Direct current|direct current
66515|NCT03150823|Galvanic current|galvanic current
66516|NCT03150823|Handgrip Force|handgrip force
66517|NCT03150823|Palmar Grip|palmar grip
66518|NCT03150823|Dynamometry|dynamometry
66519|NCT03150823|Miofeedback|miofeedback
66520|NCT03150810|Ovarian cancer|ovarian cancer
66521|NCT03150810|Triple negative breast cancer|triple negative breast cancer
66522|NCT03150810|Small cell lung cancer|small cell lung cancer
66523|NCT03150810|Prostate cancer,|prostate cancer,
66524|NCT03150810|Gastric cancer|gastric cancer
66525|NCT03150810|neoplasms|neoplasms
66526|NCT03150810|temozolomide|temozolomide
66527|NCT03150810|BGB-290|bgb-290
66528|NCT03150810|antineoplastic agents|antineoplastic agents
66529|NCT03150810|alkylating, alkylating agents,|alkylating, alkylating agents,
66530|NCT03150810|Poly (ADP-ribose) polymerase inhibitors|poly (adp-ribose) polymerase inhibitors
66531|NCT03150810|enzyme inhibitors|enzyme inhibitors
66532|NCT03150797|UCSF|ucsf
66533|NCT03150797|UCLA|ucla
66534|NCT03150797|melatonin|melatonin
66535|NCT03150797|migraine|migraine
66536|NCT03150797|headache|headache
66537|NCT03150784|Motor Learning|motor learning
66538|NCT03150784|Coordination|coordination
66539|NCT03150784|Children|children
66540|NCT03150784|Motor Skills Disorders|motor skills disorders
66541|NCT03150784|Movement|movement
66542|NCT03150758|Erectile Disfunction|erectile disfunction
66543|NCT03150758|Urinary Function|urinary function
66544|NCT03150706|POLE mutation|pole mutation
66545|NCT03150706|mismatch repair deficient|mismatch repair deficient
66546|NCT03150706|Avelumab|avelumab
66547|NCT03150680|SYNTAX score|syntax score
66548|NCT03150680|SNPs|snps
66549|NCT03150680|Genetics|genetics
66550|NCT03150680|Pharmacogenetics|pharmacogenetics
66551|NCT03150680|Genetic Risk Score|genetic risk score
66552|NCT03150680|Precision Medicine|precision medicine
66553|NCT03150654|macular pigment|macular pigment
66554|NCT03150654|macular pigment optical density|macular pigment optical density
66555|NCT03150654|diabetic retinopathy|diabetic retinopathy
66556|NCT03150654|laser pan-retinal photocoagulation|laser pan-retinal photocoagulation
66557|NCT03150641|Maternal blood loss|maternal blood loss
66558|NCT03150641|Cesarean delivery|cesarean delivery
66559|NCT03150641|Delayed cord clamping|delayed cord clamping
66560|NCT03150641|Neonatal health|neonatal health
66561|NCT03150576|Triple negative breast cancer|triple negative breast cancer
66562|NCT03150576|germline BRCA|germline brca
66563|NCT03150576|platinum and PARP inhibitor|platinum and parp inhibitor
67251|NCT03145896|vitamin D|vitamin d
66564|NCT03150576|neoadjuvant chemotherapy|neoadjuvant chemotherapy
66565|NCT03150576|olaparib|olaparib
66566|NCT03150563|Stretching|stretching
66567|NCT03150563|Stretching sensation|stretching sensation
66568|NCT03150563|Isokinetic dynamometry|isokinetic dynamometry
66569|NCT03150563|Stretching load.|stretching load.
66570|NCT03150550|Mindfulness|mindfulness
66571|NCT03150550|Alcohol|alcohol
66572|NCT03150550|Alcohol Use Disorder|alcohol use disorder
66573|NCT03150550|Relapse|relapse
66574|NCT03150550|Relapse Prevention|relapse prevention
66575|NCT03150550|Cognitive-behavioral therapy|cognitive-behavioral therapy
66576|NCT03150537|jet injector|jet injector
66577|NCT03150537|influenza vaccine|influenza vaccine
66578|NCT03150537|immune response|immune response
66579|NCT03150524|stroke|stroke
66580|NCT03150524|RCVS|rcvs
66581|NCT03150498|Food Effect|food effect
66582|NCT03150498|Pharmacokinetics|pharmacokinetics
66583|NCT03150472|Dental Instruments|dental instruments
66584|NCT03150472|Dental Technology|dental technology
66585|NCT03150446|laparoscopy|laparoscopy
66586|NCT03150446|ureteral catheterization|ureteral catheterization
66587|NCT03150420|calciphylaxis|calciphylaxis
66588|NCT03150420|calcific uremic arteriolopathy, calcinosis|calcific uremic arteriolopathy, calcinosis
66589|NCT03150420|calcium metabolism disorders|calcium metabolism disorders
66590|NCT03150420|metabolic diseases|metabolic diseases
66591|NCT03150420|sodium thiosulfate|sodium thiosulfate
66592|NCT03150342|CZT scanner|czt scanner
66593|NCT03150342|myocardial perfusion imaging|myocardial perfusion imaging
66594|NCT03150342|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
66595|NCT03150303|Periprocedural period|periprocedural period
66596|NCT03150303|Anticoagulant treatment|anticoagulant treatment
66597|NCT03150303|Thromboembolic events|thromboembolic events
66598|NCT03150303|Bleeding events|bleeding events
66599|NCT03150264|lung protective ventilation strategies|lung protective ventilation strategies
66600|NCT03150264|obesity|obesity
66601|NCT03150225|andropause|andropause
66602|NCT03150225|depressive symptoms|depressive symptoms
66603|NCT03150225|stress|stress
66604|NCT03150225|abdominal Obesity|abdominal obesity
66605|NCT03150225|testosterone|testosterone
66606|NCT03150225|erectile dysfunction|erectile dysfunction
66607|NCT03150186|second hand smoke|second hand smoke
66608|NCT03150186|passive smoking|passive smoking
66609|NCT03150186|airborne nicotine|airborne nicotine
66610|NCT03150186|private settings|private settings
66611|NCT03150186|outdoors|outdoors
66612|NCT03150173|opioid use disorder, syringe exchange, HIV risk reduction|opioid use disorder, syringe exchange, hiv risk reduction
66613|NCT03150160|travoprost|travoprost
66614|NCT03150160|brinzolamide 1% / brimonidine 0.2%|brinzolamide 1% / brimonidine 0.2%
66615|NCT03150160|normal tension glaucoma|normal tension glaucoma
66616|NCT03150160|intraocular pressure|intraocular pressure
66617|NCT03150160|efficacy|efficacy
66618|NCT03150160|safety|safety
66619|NCT03150147|Organ preservation|organ preservation
66620|NCT03150147|Survival|survival
66621|NCT03150147|Graft function|graft function
66622|NCT03150147|Reperfusion injury|reperfusion injury
66623|NCT03150147|Heart transplantation|heart transplantation
66624|NCT03150134|Acute Myeloid Leukemia|acute myeloid leukemia
66625|NCT03150134|transplantation|transplantation
66626|NCT03150134|allogeneic transplantation|allogeneic transplantation
66627|NCT03150134|immunosuppressive agents|immunosuppressive agents
66628|NCT03150082|GR37547|gr37547
66629|NCT03150082|Cross-over|cross-over
66630|NCT03150082|Bioequivalence|bioequivalence
66631|NCT03150082|Ciprofloxacin|ciprofloxacin
66632|NCT03150069|Pregnancy|pregnancy
66633|NCT03150056|abiraterone|abiraterone
66634|NCT03150056|castrate-resistant prostate cancer|castrate-resistant prostate cancer
66635|NCT03150056|androgen receptor targeted therapy|androgen receptor targeted therapy
66636|NCT03150056|RP2D|rp2d
66637|NCT03150056|enzalutamide|enzalutamide
66638|NCT03150056|GSK525762|gsk525762
66639|NCT03150043|Hemoglobin|hemoglobin
66640|NCT03150043|Cesarean delivery|cesarean delivery
66641|NCT03150004|Acute myeloid leukemia|acute myeloid leukemia
66642|NCT03150004|AML|aml
66643|NCT03150004|salvage chemotherapy|salvage chemotherapy
66644|NCT03150004|CLAG-M|clag-m
66645|NCT03150004|relapse acute myeloid leukemia|relapse acute myeloid leukemia
66646|NCT03150004|secondary acute myeloid leukemia|secondary acute myeloid leukemia
66647|NCT03150004|phase II|phase ii
66648|NCT03150004|pharmacogenomics|pharmacogenomics
66649|NCT03149991|treatment resistant|treatment resistant
66650|NCT03149991|inadequate response|inadequate response
66651|NCT03149978|Neoadjuvant Chemoradiation|neoadjuvant chemoradiation
66652|NCT03149978|treatment effect prediction|treatment effect prediction
66653|NCT03149978|metabonomics|metabonomics
66654|NCT03149913|below the knee artery|below the knee artery
66655|NCT03149913|endovascular|endovascular
66656|NCT03149913|drug coated balloon|drug coated balloon
66657|NCT03149913|critical limb ischemia|critical limb ischemia
66658|NCT03149848|Tuberculosis|tuberculosis
66659|NCT03149848|Human Immunodeficiency Virus|human immunodeficiency virus
66660|NCT03149848|Rifabutin|rifabutin
66661|NCT03149848|Drug-drug interaction|drug-drug interaction
66662|NCT03149848|Cabotegravir|cabotegravir
66663|NCT03149809|Urinary incontinence|urinary incontinence
66664|NCT03149809|Parkinson disease|parkinson disease
66665|NCT03149809|Overactive urinary bladder|overactive urinary bladder
66666|NCT03149809|Nocturia|nocturia
66667|NCT03149757|Treatment Adherence|treatment adherence
66668|NCT03149757|Alcohol or Drugs|alcohol or drugs
66669|NCT03149757|Behavioral|behavioral
66670|NCT03149757|Internet|internet
66671|NCT03149757|Adolescents|adolescents
66672|NCT03149757|Young Adults|young adults
66673|NCT03149757|Social Support|social support
66674|NCT03149718|Pharmacy|pharmacy
66675|NCT03149718|Intervention|intervention
66676|NCT03149718|Medication Adherence|medication adherence
66677|NCT03149705|Ischemic stroke, stroke, bio-collection, Imaging markers, biomarkers, clinical outcomes|ischemic stroke, stroke, bio-collection, imaging markers, biomarkers, clinical outcomes
66678|NCT03149679|Cyclophosphamide|cyclophosphamide
66679|NCT03149679|Colorectal Cancer Metastatic|colorectal cancer metastatic
66680|NCT03149679|TP53 Gene Mutation|tp53 gene mutation
66681|NCT03149653|lipid emulsion|lipid emulsion
66682|NCT03149653|olive oil|olive oil
66683|NCT03149653|fish oil|fish oil
66684|NCT03149653|intestinal failure|intestinal failure
66685|NCT03149653|home parenteral nutrition|home parenteral nutrition
66686|NCT03149640|Prevention|prevention
66687|NCT03149640|inhaled amikacin|inhaled amikacin
66688|NCT03149640|placebo|placebo
66689|NCT03149614|mobilization|mobilization
66690|NCT03149614|resonant oscillation|resonant oscillation
66691|NCT03149575|Glioma|glioma
66692|NCT03149575|Glioblastoma|glioblastoma
66693|NCT03149575|Glioblastoma multiforme|glioblastoma multiforme
66694|NCT03149575|GBM|gbm
66695|NCT03149575|brain tumor|brain tumor
66696|NCT03149575|brain cancer|brain cancer
66697|NCT03149575|recurrent brain tumor|recurrent brain tumor
66698|NCT03149575|recurrent brain cancer|recurrent brain cancer
66699|NCT03149575|refractory brain tumor|refractory brain tumor
66700|NCT03149575|refractory brain cancer|refractory brain cancer
66701|NCT03149575|recurrent GBM|recurrent gbm
66702|NCT03149575|refractory GBM|refractory gbm
66703|NCT03149575|recurrent glioma|recurrent glioma
66704|NCT03149575|refractory glioma|refractory glioma
66705|NCT03149575|recurrent glioblastoma|recurrent glioblastoma
66706|NCT03149575|refractory glioblastoma|refractory glioblastoma
66707|NCT03149575|recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
66708|NCT03149575|refractory glioblastoma multiforme|refractory glioblastoma multiforme
66709|NCT03149575|failed temodar|failed temodar
66710|NCT03149575|failed temozolomide|failed temozolomide
66711|NCT03149575|temodar refractory|temodar refractory
66712|NCT03149575|temozolomide refractory|temozolomide refractory
66713|NCT03149575|failed avastin|failed avastin
66714|NCT03149575|avastin refractory|avastin refractory
66715|NCT03149575|failed bevacizumab|failed bevacizumab
66716|NCT03149575|bevacizumab refractory|bevacizumab refractory
66717|NCT03149575|avastin failure|avastin failure
66718|NCT03149575|bevacizumab failure|bevacizumab failure
66719|NCT03149575|STAR-3|star-3
66720|NCT03149549|cancer|cancer
66721|NCT03149549|solid tumor|solid tumor
66722|NCT03149549|PROCLAIM|proclaim
66723|NCT03149549|CX-2009|cx-2009
66724|NCT03149549|PROBODY™ Therapeutic|probody™ therapeutic
66725|NCT03149549|Drug Conjugate|drug conjugate
66726|NCT03149549|Antibody drug conjugate|antibody drug conjugate
66727|NCT03149549|CD166|cd166
66728|NCT03149536|pharmacogenetic|pharmacogenetic
66729|NCT03149536|pharmacogenomic|pharmacogenomic
66730|NCT03149536|polymorphism|polymorphism
66731|NCT03149536|individualized controlled ovarian stimulation|individualized controlled ovarian stimulation
66732|NCT03149536|algorithm|algorithm
66733|NCT03149536|assisted reproduction|assisted reproduction
66734|NCT03149523|exhaustive genetic and immunological analyses|exhaustive genetic and immunological analyses
66735|NCT03149523|targeted therapies|targeted therapies
66736|NCT03149523|colon cancer|colon cancer
66737|NCT03149523|kidney cancer|kidney cancer
66738|NCT03149523|liver cancer|liver cancer
66739|NCT03149523|immunological tumor microenvironment|immunological tumor microenvironment
66740|NCT03149523|tumor microenvironment heterogeneity|tumor microenvironment heterogeneity
66741|NCT03149510|mobile application|mobile application
66742|NCT03149510|mHealth|mhealth
66743|NCT03149458|stroke|stroke
66744|NCT03149458|balance|balance
66745|NCT03149458|dance|dance
66746|NCT03149432|mirror therapy|mirror therapy
66747|NCT03149432|amputation|amputation
66748|NCT03149432|phantom pain|phantom pain
66749|NCT03149419|postmenopause|postmenopause
66750|NCT03149419|paroxetine|paroxetine
66751|NCT03149419|endothelial dysfunction|endothelial dysfunction
66752|NCT03149419|blood pressure|blood pressure
66753|NCT03149419|heart rate variability|heart rate variability
66754|NCT03149419|sleep quality|sleep quality
66755|NCT03149419|perceived stress|perceived stress
66756|NCT03149419|sleepiness|sleepiness
66757|NCT03149393|Functional Dyspepsia|functional dyspepsia
66758|NCT03149393|Qizhi Weitong Granules|qizhi weitong granules
66759|NCT03149393|Traditional Chinese Medicine|traditional chinese medicine
66760|NCT03149328|Home Dialysis|home dialysis
66761|NCT03149328|Person-Centred Care|person-centred care
66762|NCT03149328|Patient-Reported Outcome Measures|patient-reported outcome measures
66763|NCT03149328|Process Evaluation|process evaluation
66764|NCT03149328|Educational Support|educational support
66765|NCT03149328|Electronic Patient-Reported Outcome Measures|electronic patient-reported outcome measures
66766|NCT03149328|Patient-Reported Experience Measures|patient-reported experience measures
66767|NCT03149302|Manual therapy|manual therapy
66768|NCT03149302|Sensorimotor exercises|sensorimotor exercises
66769|NCT03149302|Balance exercises|balance exercises
66770|NCT03149302|Cervical mobilization|cervical mobilization
66771|NCT03149302|Specific neck muscle exercises|specific neck muscle exercises
66772|NCT03149263|botulinum toxin|botulinum toxin
66773|NCT03149263|anxiety reduction|anxiety reduction
66774|NCT03149263|pain reduction|pain reduction
66775|NCT03149263|medical clowns|medical clowns
66776|NCT03149263|distraction|distraction
66777|NCT03149250|Aggregometry|aggregometry
66778|NCT03149237|Mozambique|mozambique
66779|NCT03149237|Couples-based services|couples-based services
66780|NCT03149237|HIV/AIDS|hiv/aids
66781|NCT03149237|Ante-natal Care|ante-natal care
66782|NCT03149198|Fibromyalgia, pilates, exercises|fibromyalgia, pilates, exercises
66783|NCT03149185|prostate cancer|prostate cancer
66784|NCT03149185|advanced prostate cancer|advanced prostate cancer
66785|NCT03149185|technology based|technology based
66786|NCT03149146|Clinical Decision Making|clinical decision making
66787|NCT03149146|Myanmar Physical therapists|myanmar physical therapists
66788|NCT03149146|Educational workshop|educational workshop
66789|NCT03149133|Biomechanics|biomechanics
66790|NCT03149133|Strength training|strength training
66791|NCT03149133|Elastography|elastography
66792|NCT03149133|Ultrasound|ultrasound
66793|NCT03149120|Metastatic|metastatic
66794|NCT03149120|Unresectable|unresectable
66795|NCT03149120|anthracycline|anthracycline
66796|NCT03149120|chemotherapy|chemotherapy
66797|NCT03149120|systemic therapy|systemic therapy
66798|NCT03149107|Prodrome, CHR, Schizophrenia, prevention, N-acetylcysteine|prodrome, chr, schizophrenia, prevention, n-acetylcysteine
66799|NCT03149094|Self-Management|self-management
66800|NCT03149094|mHealth|mhealth
66801|NCT03149042|FFR|ffr
66802|NCT03149042|Fractional Flow Reserve|fractional flow reserve
66803|NCT03149042|Atherosclerosis|atherosclerosis
66804|NCT03149042|Coronary|coronary
66805|NCT03149042|stenosis|stenosis
66806|NCT03149029|Metastatic Melanoma|metastatic melanoma
66807|NCT03149003|Glioblastoma|glioblastoma
66808|NCT03149003|Wilms Tumor 1|wilms tumor 1
66809|NCT03149003|Cancer Vaccines|cancer vaccines
66810|NCT03149003|Neoplasms|neoplasms
66811|NCT03148990|Double Viral Vaccine Measles and Rubella|double viral vaccine measles and rubella
66812|NCT03148990|Safety Efficacy Imunogenicity|safety efficacy imunogenicity
66813|NCT03148977|Matrix Metalloproteinases|matrix metalloproteinases
66814|NCT03148951|MPV|mpv
66815|NCT03148951|NLR|nlr
66816|NCT03148951|Postoperative pain|postoperative pain
66817|NCT03148938|DAM|dam
66818|NCT03148938|multiple sclerosis|multiple sclerosis
66819|NCT03148938|MSFC|msfc
66820|NCT03148938|application|application
66821|NCT03148938|mobile|mobile
66822|NCT03148925|nicotine vaccine|nicotine vaccine
66823|NCT03148925|smoking vaccine|smoking vaccine
66824|NCT03148925|smoking cessation|smoking cessation
66825|NCT03148925|SELA-070|sela-070
66826|NCT03148899|Sleep Apnea|sleep apnea
66827|NCT03148899|Oxytocin Nasal Spray|oxytocin nasal spray
66828|NCT03148886|Physical activity|physical activity
66829|NCT03148860|Psoriatic Arthritis|psoriatic arthritis
66830|NCT03148860|Ustekinumab|ustekinumab
66831|NCT03148860|Methotrexate|methotrexate
66832|NCT03148860|DAS28|das28
66833|NCT03148834|Acute Myocardial Infarction Reperfusion Injury|acute myocardial infarction reperfusion injury
66834|NCT03148821|pressure ulcer|pressure ulcer
66835|NCT03148821|pressure sore|pressure sore
66836|NCT03148821|patient positioning|patient positioning
66837|NCT03148769|Bloodstream infections, epidemiology|bloodstream infections, epidemiology
66838|NCT03148678|Emotional reactivity|emotional reactivity
66839|NCT03148678|Cognitive flexibility|cognitive flexibility
66840|NCT03148665|Oral Cancer|oral cancer
66841|NCT03148665|Head and Neck Cancer|head and neck cancer
66842|NCT03148639|auditory hallucination|auditory hallucination
66843|NCT03148639|schizophrenia|schizophrenia
66844|NCT03148639|treatment-resistant|treatment-resistant
66845|NCT03148639|psychotherapy|psychotherapy
66846|NCT03148639|virtual reality|virtual reality
66847|NCT03148639|avatar|avatar
66848|NCT03148626|mindfulness curriculum|mindfulness curriculum
66849|NCT03148600|Ileoanal pouch, pelvic floor exercise|ileoanal pouch, pelvic floor exercise
66850|NCT03148587|abortion|abortion
66851|NCT03148587|medical abortion|medical abortion
66852|NCT03148587|mifepristone|mifepristone
66853|NCT03148587|pregnancy test|pregnancy test
66854|NCT03148548|VTE|vte
66855|NCT03148548|thrombophilia screening|thrombophilia screening
66856|NCT03148548|patients|patients
66857|NCT03148548|risk factors|risk factors
66858|NCT03148548|post-thrombotic syndrome|post-thrombotic syndrome
66859|NCT03148496|abdominal surgery|abdominal surgery
66860|NCT03148496|wound complication|wound complication
66861|NCT03148483|Pregnancy outcome|pregnancy outcome
66862|NCT03148483|Feasibility|feasibility
66863|NCT03148483|Milk Fortification|milk fortification
66864|NCT03148483|Periodontitis|periodontitis
66865|NCT03148483|Pregnant women|pregnant women
66866|NCT03148483|Periodontal Therapy|periodontal therapy
66867|NCT03148470|theta burst stimulation|theta burst stimulation
66868|NCT03148470|Language switching|language switching
66869|NCT03148470|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
66870|NCT03148457|Stroke|stroke
66871|NCT03148457|Direct oral anticoagulation|direct oral anticoagulation
66872|NCT03148457|Apixaban|apixaban
66873|NCT03148457|Dabigatran|dabigatran
66874|NCT03148457|Rivaroxaban|rivaroxaban
66875|NCT03148457|Edoxaban|edoxaban
66876|NCT03148457|Therapy initiation|therapy initiation
66877|NCT03148457|Major bleeding|major bleeding
66878|NCT03148457|Atrial fibrillation|atrial fibrillation
66879|NCT03148379|Total Knee Replacement|total knee replacement
66880|NCT03148366|Self Efficacy|self efficacy
66881|NCT03148353|ultrasonography, corticosteroid, subacromial impingement syndrome, shoulder pain|ultrasonography, corticosteroid, subacromial impingement syndrome, shoulder pain
66882|NCT03148249|Randomized control trial|randomized control trial
66883|NCT03148249|Charles Bonnet syndrome|charles bonnet syndrome
66884|NCT03148249|visual hallucinations|visual hallucinations
66885|NCT03148249|age related macular degeneration|age related macular degeneration
66886|NCT03148249|patient education|patient education
66887|NCT03148223|Dysmenorrhea|dysmenorrhea
66888|NCT03148223|acupuncture|acupuncture
66889|NCT03148223|auriculotherapy|auriculotherapy
66890|NCT03148197|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
66891|NCT03148197|Graft-versus-host-disease|graft-versus-host-disease
66892|NCT03148197|Acute Myeloid Leukemia|acute myeloid leukemia
66893|NCT03148184|reverse total shoulder arthroplasty|reverse total shoulder arthroplasty
66894|NCT03148184|60 years old or younger|60 years old or younger
66895|NCT03148184|outcomes|outcomes
66896|NCT03148171|Pre-Exposure Prophylaxis (PrEP); Retention in PrEP Care|pre-exposure prophylaxis (prep); retention in prep care
66897|NCT03148158|Bladder Cancer|bladder cancer
66898|NCT03148158|Flexible cystoscopy|flexible cystoscopy
66899|NCT03148158|Diagnosis|diagnosis
66900|NCT03148132|Retinopathy of Prematurity|retinopathy of prematurity
66901|NCT03148132|VEGF|vegf
66902|NCT03148132|Bevacizumab|bevacizumab
66903|NCT03148132|Ranibizumab|ranibizumab
66904|NCT03148093|Metastatic Colorectal Cancer|metastatic colorectal cancer
66905|NCT03148093|Registry|registry
66906|NCT03148093|Patient Reported Outcomes|patient reported outcomes
66907|NCT03148093|Treatment Patterns|treatment patterns
66908|NCT03148093|Prescription Use|prescription use
66909|NCT03148067|Risk Factors|risk factors
66910|NCT03148067|Incidence|incidence
66911|NCT03148067|Epidemiology|epidemiology
66912|NCT03148054|Anastomosis|anastomosis
66913|NCT03148054|Colon|colon
66914|NCT03148054|CT|ct
66915|NCT03148054|Endoscopy|endoscopy
66916|NCT03148054|Enema|enema
66917|NCT03148054|Detection leak|detection leak
66918|NCT03148054|Anastomotic leak|anastomotic leak
66919|NCT03147989|MultiHance|multihance
66920|NCT03147989|MRI|mri
66921|NCT03147989|CNS|cns
66922|NCT03147989|Gadobenate Dimeglumine|gadobenate dimeglumine
66923|NCT03147963|therapy|therapy
66924|NCT03147963|breast cancer|breast cancer
66925|NCT03147963|docetaxel|docetaxel
66926|NCT03147963|metastasis|metastasis
66927|NCT03147950|Prone-Flexed Position|prone-flexed position
66928|NCT03147950|Percutaneous Nephrolithotomy (PCNL)|percutaneous nephrolithotomy (pcnl)
66929|NCT03147950|Clavien-Dindo Classification Score|clavien-dindo classification score
66930|NCT03147911|Stroke or systemic embolism|stroke or systemic embolism
66931|NCT03147911|CHA2DS2-VASc score|cha2ds2-vasc score
66932|NCT03147898|Whooping cough|whooping cough
66933|NCT03147898|Pertussis|pertussis
66934|NCT03147807|Carbapenems de-escalation, rapid diagnostic test,|carbapenems de-escalation, rapid diagnostic test,
66935|NCT03147807|Carbapenem-antimicrobial de-escalation-rapid diagnostic test|carbapenem-antimicrobial de-escalation-rapid diagnostic test
66936|NCT03147781|auriculotherapy, human milk, breastfeeding, lactogenesis|auriculotherapy, human milk, breastfeeding, lactogenesis
66937|NCT03147768|Laser Tissue Welding|laser tissue welding
66938|NCT03147768|Pancreatic Sealing|pancreatic sealing
66939|NCT03147768|Hemostasis|hemostasis
66940|NCT03147768|Pancreatic Tumors|pancreatic tumors
66941|NCT03147768|Pancreatic Resection|pancreatic resection
66942|NCT03147768|Pancreatic leakage|pancreatic leakage
66943|NCT03147768|LTW|ltw
66944|NCT03147755|stroke|stroke
66945|NCT03147742|ruxolitinib|ruxolitinib
66946|NCT03147742|acute or chronic steroid-refractory GVHD|acute or chronic steroid-refractory gvhd
66947|NCT03147742|hematopoietic stem cell transplantation (allo-HSCT)|hematopoietic stem cell transplantation (allo-hsct)
66948|NCT03147729|Radiofrequency|radiofrequency
66949|NCT03147729|Anal incontinence|anal incontinence
66950|NCT03147729|Fecal incontinence|fecal incontinence
66951|NCT03147729|Women sexual function|women sexual function
66952|NCT03147729|Sexuality|sexuality
66953|NCT03147703|Microbiota|microbiota
66954|NCT03147703|Food timing|food timing
66955|NCT03147703|Obesity|obesity
66956|NCT03147690|Solid Organ Injury|solid organ injury
66957|NCT03147677|Type 2 diabetic nephropathy|type 2 diabetic nephropathy
66958|NCT03147677|Alfacalcidol|alfacalcidol
66959|NCT03147664|pompe disease|pompe disease
66960|NCT03147664|exercise capacity|exercise capacity
66961|NCT03147664|cardiopulmonary exercise testing|cardiopulmonary exercise testing
66962|NCT03147651|Cystic fibrosis|cystic fibrosis
66963|NCT03147651|exercise capacity|exercise capacity
66964|NCT03147651|non-cystic fibrosis|non-cystic fibrosis
66965|NCT03147651|bronchiectasis|bronchiectasis
66966|NCT03147625|Aged|aged
66967|NCT03147625|Independent living|independent living
66968|NCT03147625|Health Promotion|health promotion
66969|NCT03147625|Residence Characteristics|residence characteristics
66970|NCT03147625|Elderly-only household|elderly-only household
66971|NCT03147612|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
66972|NCT03147612|ALL|all
66973|NCT03147612|Philadelphia Chromosome (Ph)-Positive|philadelphia chromosome (ph)-positive
66974|NCT03147612|BCR-ABL Positive|bcr-abl positive
66975|NCT03147612|Ponatinib|ponatinib
66976|NCT03147612|Iclusig|iclusig
66977|NCT03147612|AP24534|ap24534
66978|NCT03147612|Cyclophosphamide|cyclophosphamide
66979|NCT03147612|Cytoxan|cytoxan
66980|NCT03147612|Neosar|neosar
66981|NCT03147612|Mesna|mesna
66982|NCT03147612|Mesnex|mesnex
66983|NCT03147612|Rituximab|rituximab
66984|NCT03147612|Rituxan|rituxan
66985|NCT03147612|Vincristine|vincristine
66986|NCT03147612|Dexamethasone|dexamethasone
66987|NCT03147612|Decadron|decadron
66988|NCT03147612|G-CSF|g-csf
66989|NCT03147612|Filgrastim|filgrastim
66990|NCT03147612|Neupogen|neupogen
66991|NCT03147612|Methotrexate|methotrexate
66992|NCT03147612|Cytarabine|cytarabine
66993|NCT03147612|Ara-C|ara-c
66994|NCT03147612|Cytosar|cytosar
66995|NCT03147612|DepoCyt|depocyt
66996|NCT03147612|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
66997|NCT03147612|Prednisone|prednisone
66998|NCT03147599|Mebeverine|mebeverine
66999|NCT03147599|Incontinence|incontinence
67000|NCT03147599|Orthotopic Neobladder|orthotopic neobladder
67001|NCT03147586|Immune Nutrition|immune nutrition
67002|NCT03147586|Morbidity|morbidity
67003|NCT03147573|Hypertension|hypertension
67004|NCT03147573|Blood pressure monitoring|blood pressure monitoring
67005|NCT03147560|Immunogenicity|immunogenicity
67006|NCT03147560|Safety|safety
67007|NCT03147560|Sabin IPV|sabin ipv
67008|NCT03147560|bOPV|bopv
67009|NCT03147508|Diagnostics, clinical criteria, clincal reasoning, neck pain|diagnostics, clinical criteria, clincal reasoning, neck pain
67010|NCT03147456|bariatric|bariatric
67011|NCT03147456|obesity|obesity
67012|NCT03147456|protein supplements|protein supplements
67013|NCT03147443|traditional Chinese medicine|traditional chinese medicine
67014|NCT03147443|Drugs, Chinese Herbal|drugs, chinese herbal
67015|NCT03147443|N-of-1 trials|n-of-1 trials
67016|NCT03147443|sputum|sputum
67017|NCT03147443|symptoms|symptoms
67018|NCT03147443|individualized treatment|individualized treatment
67019|NCT03147443|stable bronchiectasis|stable bronchiectasis
67020|NCT03147391|Atrial Fibrillation|atrial fibrillation
67021|NCT03147391|Left Atrial Appendage Closure|left atrial appendage closure
67022|NCT03147391|LAmbre device|lambre device
67023|NCT03147391|Stroke|stroke
67024|NCT03147352|Fasciitis|fasciitis
67025|NCT03147352|Gangrene|gangrene
67026|NCT03147352|Fasciitis, Necrotizing|fasciitis, necrotizing
67027|NCT03147352|Soft Tissue Infections|soft tissue infections
67028|NCT03147352|Fournier's Gangrene|fournier's gangrene
67029|NCT03147352|Streptococcal septic shock syndrome|streptococcal septic shock syndrome
67030|NCT03147352|Flesh eating bacteria|flesh eating bacteria
67031|NCT03147352|Meleneys ulcer|meleneys ulcer
67032|NCT03147352|Wounds and Injuries|wounds and injuries
67033|NCT03147352|Streptococcus pyogenes|streptococcus pyogenes
67034|NCT03147352|Staphylococcus aureus|staphylococcus aureus
67035|NCT03147352|Soft Tissue Infections/blood|soft tissue infections/blood
67036|NCT03147352|Necrosis/blood|necrosis/blood
67037|NCT03147352|Necrosis/diagnosis|necrosis/diagnosis
67038|NCT03147352|Necrosis/mortality|necrosis/mortality
67039|NCT03147352|Necrosis/surgery|necrosis/surgery
67040|NCT03147352|Prognosis|prognosis
67041|NCT03147352|Risk Factors|risk factors
67042|NCT03147352|Bacterial Infections|bacterial infections
67043|NCT03147352|Infection|infection
67044|NCT03147352|Skin Diseases, Bacterial|skin diseases, bacterial
67045|NCT03147352|Observational study|observational study
67046|NCT03147352|Biological markers|biological markers
67047|NCT03147352|Endothelium|endothelium
67048|NCT03147352|suPAR|supar
67049|NCT03147352|sTM|stm
67050|NCT03147352|syndecan-1|syndecan-1
67051|NCT03147352|sE-selectin|se-selectin
67052|NCT03147352|VE-cadherin|ve-cadherin
67053|NCT03147352|protein C|protein c
67054|NCT03147352|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
67055|NCT03147352|HBOT|hbot
67056|NCT03147339|AGEs( Advanced glycation end products)|ages( advanced glycation end products)
67057|NCT03147313|extracorporeal shock wave|extracorporeal shock wave
67058|NCT03147313|microsurgical nerve coaptation|microsurgical nerve coaptation
67059|NCT03147313|nerve regeneration|nerve regeneration
67060|NCT03147300|Low back pain|low back pain
67061|NCT03147300|Model of care|model of care
67062|NCT03147300|Primary health care|primary health care
67063|NCT03147300|Implementation|implementation
67064|NCT03147300|Patient-rated outcome|patient-rated outcome
67065|NCT03147300|Clinician-rated outcome|clinician-rated outcome
67066|NCT03147300|Cost-effectiveness|cost-effectiveness
67067|NCT03147287|Breast Cancer|breast cancer
67068|NCT03147274|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
67069|NCT03147274|Adolescence|adolescence
67070|NCT03147222|hip fracture|hip fracture
67071|NCT03147222|dementia|dementia
67072|NCT03147222|intervention|intervention
67073|NCT03147157|tacrolimus|tacrolimus
67074|NCT03147157|histocompatibility antigens|histocompatibility antigens
67075|NCT03147131|Total Hip Arthroplasty|total hip arthroplasty
67076|NCT03147131|Short Stem|short stem
67077|NCT03147131|DEXA|dexa
67078|NCT03147118|trapeziometacarpal arthritis|trapeziometacarpal arthritis
67079|NCT03147105|chronic progressive multiple sclerosis, mobility, arm ergometry, rehabilitation|chronic progressive multiple sclerosis, mobility, arm ergometry, rehabilitation
67080|NCT03147079|obesity|obesity
67081|NCT03147079|pregnancy|pregnancy
67082|NCT03147079|lifestyle|lifestyle
67083|NCT03147079|gestational weight gain|gestational weight gain
67084|NCT03147079|weight of offspring|weight of offspring
67085|NCT03147079|antenatal care|antenatal care
67086|NCT03147079|health behavior|health behavior
67087|NCT03147079|physical activity|physical activity
67088|NCT03147079|diet|diet
67089|NCT03147079|programme evaluation|programme evaluation
67090|NCT03147079|costs and costs analysis|costs and costs analysis
67091|NCT03147066|Dezocine|dezocine
67092|NCT03147066|CRBD|crbd
67093|NCT03147066|General anesthesia|general anesthesia
67094|NCT03147066|Urinary catheter|urinary catheter
67095|NCT03147040|Lobular|lobular
67096|NCT03147040|Metastatic or incurable locally advanced cancer|metastatic or incurable locally advanced cancer
67097|NCT03147040|Disease progression on endocrine therapy in advanced setting|disease progression on endocrine therapy in advanced setting
67098|NCT03147027|ischemic cardiomyopathy|ischemic cardiomyopathy
67099|NCT03147027|prophylactic ablation|prophylactic ablation
67100|NCT03147014|Echocardiography|echocardiography
67101|NCT03147014|Congenital Heart Disease|congenital heart disease
67102|NCT03147014|Maternal hyperoxygenation|maternal hyperoxygenation
67103|NCT03147001|Endurance exercise|endurance exercise
67104|NCT03147001|Dietary protein|dietary protein
67105|NCT03146975|Beta-defensins|beta-defensins
67106|NCT03146975|Chronic periodontitis|chronic periodontitis
67107|NCT03146975|Diabetes mellitus|diabetes mellitus
67108|NCT03146975|Non-surgical periodontal therapy|non-surgical periodontal therapy
67109|NCT03146897|Food Aid, Malnutrition, RUSF, FBF, Supplementary Food|food aid, malnutrition, rusf, fbf, supplementary food
67110|NCT03146845|Diabetic Foot Ulcer|diabetic foot ulcer
67111|NCT03146845|Pressure Ulcer|pressure ulcer
67112|NCT03146845|Leg Ulcer|leg ulcer
67113|NCT03146819|osteoarthritis|osteoarthritis
67114|NCT03146819|osteoarthritis knee|osteoarthritis knee
67115|NCT03146819|total knee replacement|total knee replacement
67116|NCT03146819|patient specific|patient specific
67117|NCT03146819|total knee arthroplasty|total knee arthroplasty
67118|NCT03146819|orthopedics|orthopedics
67119|NCT03146806|Cancer pain|cancer pain
67120|NCT03146806|Anesthesiology|anesthesiology
67121|NCT03146806|Opiates|opiates
67122|NCT03146806|Intranasal ketamine|intranasal ketamine
67123|NCT03146793|Calciphylaxis/complications|calciphylaxis/complications
67124|NCT03146793|Kidney Failure, Chronic/complications|kidney failure, chronic/complications
67125|NCT03146793|Renal Dialysis|renal dialysis
67126|NCT03146793|Thiosulfates/therapeutic use|thiosulfates/therapeutic use
67127|NCT03146793|Time Factors|time factors
67128|NCT03146741|Heart Failure|heart failure
67129|NCT03146702|Quality of Life|quality of life
67130|NCT03146689|osteoarthritis|osteoarthritis
67131|NCT03146689|n-of-1|n-of-1
67132|NCT03146689|ibuprofen|ibuprofen
67133|NCT03146689|capsaicin|capsaicin
67134|NCT03146689|NSAID|nsaid
67135|NCT03146689|topical|topical
67136|NCT03146663|Platinum-resistant|platinum-resistant
67137|NCT03146663|ovarian neoplasm|ovarian neoplasm
67138|NCT03146663|antineoplastic agents|antineoplastic agents
67139|NCT03146663|ovarian diseases|ovarian diseases
67140|NCT03146663|cancer of the ovary|cancer of the ovary
67141|NCT03146637|PD-1 activated CIK|pd-1 activated cik
67142|NCT03146637|MUC1|muc1
67143|NCT03146637|Bispecfic antibody|bispecfic antibody
67144|NCT03146637|liver cancer|liver cancer
67145|NCT03146598|Foot deformity|foot deformity
67146|NCT03146598|Orthopaedic management|orthopaedic management
67147|NCT03146598|prevention|prevention
67148|NCT03146598|side pole static ankle foot orthosis|side pole static ankle foot orthosis
67150|NCT03146559|Cross education|cross education
67151|NCT03146559|EMG|emg
67152|NCT03146520|Syndecan 2|syndecan 2
67153|NCT03146520|Methylation biomarker|methylation biomarker
67154|NCT03146520|Colorectal cancer|colorectal cancer
67155|NCT03146520|EarlyTect Colon Cancer test|earlytect colon cancer test
67156|NCT03146481|Anesthetic efficacy, Irriversible pulpitis, Aceclofenac|anesthetic efficacy, irriversible pulpitis, aceclofenac
67157|NCT03146455|Thrombelastograghy|thrombelastograghy
67158|NCT03146455|reference ranges|reference ranges
67159|NCT03146455|racial|racial
67160|NCT03146455|geographic|geographic
67161|NCT03146455|Blood Transfusion|blood transfusion
67162|NCT03146442|increased dietary protein|increased dietary protein
67163|NCT03146442|breakfast|breakfast
67164|NCT03146442|weight management|weight management
67165|NCT03146442|satiety|satiety
67166|NCT03146442|glucose control|glucose control
67167|NCT03146442|fMRI|fmri
67168|NCT03146442|cognitive performance|cognitive performance
67169|NCT03146442|memory|memory
67170|NCT03146442|attention|attention
67171|NCT03146442|executive function|executive function
67172|NCT03146442|structural MRI|structural mri
67173|NCT03146442|sleep quality|sleep quality
67174|NCT03146403|HSV|hsv
67175|NCT03146403|Herpes|herpes
67176|NCT03146403|Genital Herpes|genital herpes
67177|NCT03146403|Vaccine|vaccine
67178|NCT03146390|biofilms|biofilms
67179|NCT03146390|essential oils|essential oils
67180|NCT03146390|microscopy, confocal|microscopy, confocal
67181|NCT03146390|mouthwashes|mouthwashes
67182|NCT03146364|Virtual Reality|virtual reality
67183|NCT03146351|preterm|preterm
67184|NCT03146351|infant|infant
67185|NCT03146351|physiotherapy|physiotherapy
67186|NCT03146338|Anti-EGFR|anti-egfr
67187|NCT03146338|Hypomagnesemia|hypomagnesemia
67188|NCT03146338|Magnesium-rich mineral water|magnesium-rich mineral water
67189|NCT03146338|Metastatic colorectal or head and neck cancers|metastatic colorectal or head and neck cancers
67190|NCT03146325|H. pylori infection|h. pylori infection
67191|NCT03146312|gene expression|gene expression
67192|NCT03146312|gene array|gene array
67193|NCT03146312|epigenetics|epigenetics
67194|NCT03146312|DNA methylation|dna methylation
67195|NCT03146260|TESE|tese
67196|NCT03146260|Sperm retreival|sperm retreival
67197|NCT03146260|Azoospermia|azoospermia
67198|NCT03146260|FSH|fsh
67199|NCT03146260|LH|lh
67200|NCT03146208|Growth differentiation factor-15|growth differentiation factor-15
67201|NCT03146208|Dipeptidyl-peptidase inhibitors (DPP4 -I)|dipeptidyl-peptidase inhibitors (dpp4 -i)
67202|NCT03146208|Coronroy artery diseases|coronroy artery diseases
67203|NCT03146195|pelvic organ prolapse|pelvic organ prolapse
67204|NCT03146195|dynamic magnetic resonance imaging|dynamic magnetic resonance imaging
67205|NCT03146195|three-dimensional reconstruction|three-dimensional reconstruction
67206|NCT03146195|space coordinates|space coordinates
67207|NCT03146182|C-reactive protein|c-reactive protein
67208|NCT03146182|Procalcitonin|procalcitonin
67209|NCT03146182|Community-acquired pneumonia|community-acquired pneumonia
67210|NCT03146182|Antibiotic stewardship|antibiotic stewardship
67211|NCT03146156|obesity|obesity
67212|NCT03146156|overweight|overweight
67213|NCT03146156|lifestyle intervention|lifestyle intervention
67214|NCT03146156|fetal growth/adiposity|fetal growth/adiposity
67215|NCT03146156|Mediterranean diet|mediterranean diet
67216|NCT03146117|PET CT|pet ct
67217|NCT03146091|Antibiotics|antibiotics
67218|NCT03146052|Colon cleansing|colon cleansing
67219|NCT03146013|HTLV|htlv
67220|NCT03146013|Confirmatory|confirmatory
67221|NCT03146013|Supplemental|supplemental
67222|NCT03146013|Blot|blot
67223|NCT03146013|HTLV-I|htlv-i
67224|NCT03146013|HTLV-II|htlv-ii
67225|NCT03145987|Cognitive functioning|cognitive functioning
67226|NCT03145987|Neuropsychological status|neuropsychological status
67227|NCT03145987|Vitis vinifera|vitis vinifera
67228|NCT03145974|respiratory failure|respiratory failure
67229|NCT03145974|mechanical ventilation|mechanical ventilation
67230|NCT03145961|Breast cancer early stage|breast cancer early stage
67231|NCT03145961|circulating tumour DNA|circulating tumour dna
67232|NCT03145961|pembrolizumab|pembrolizumab
67233|NCT03145961|targeted therapy|targeted therapy
67234|NCT03145961|randomised clinical trial|randomised clinical trial
67235|NCT03145961|phase II|phase ii
67236|NCT03145961|mutation screening|mutation screening
67237|NCT03145961|intermediate endpoint|intermediate endpoint
67238|NCT03145948|Tolerability|tolerability
67239|NCT03145948|Psoriasis|psoriasis
67240|NCT03145948|Pharmacokinetics|pharmacokinetics
67241|NCT03145948|Safety|safety
67242|NCT03145948|Healthy Volunteers|healthy volunteers
67243|NCT03145909|Cancer|cancer
67244|NCT03145909|Metastatic|metastatic
67245|NCT03145909|Prolactin Receptor (PRLR)|prolactin receptor (prlr)
67246|NCT03145909|Breast cancer|breast cancer
67247|NCT03145909|Colorectal cancer|colorectal cancer
67248|NCT03145909|Adrenocortical carcinoma,|adrenocortical carcinoma,
67249|NCT03145909|Chromophobe renal cell carcinoma|chromophobe renal cell carcinoma
67250|NCT03145909|Hepatocellular carcinoma|hepatocellular carcinoma
67252|NCT03145896|Anemia|anemia
67253|NCT03145896|IBD|ibd
67254|NCT03145857|Gallium-68|gallium-68
67255|NCT03145857|Positron Emission Tomography|positron emission tomography
67256|NCT03145844|DAA|daa
67257|NCT03145844|Hepatitis|hepatitis
67258|NCT03145831|Pediatrics|pediatrics
67259|NCT03145818|dissemination|dissemination
67260|NCT03145805|blood chemical analysis|blood chemical analysis
67261|NCT03145805|bupivacaine|bupivacaine
67262|NCT03145805|local anesthetic toxicity|local anesthetic toxicity
67263|NCT03145805|Drug-Related Side Effects and Adverse Reactions|drug-related side effects and adverse reactions
67264|NCT03145766|Rabies virus|rabies virus
67265|NCT03145753|HIV testing program|hiv testing program
67266|NCT03145753|HCV testing program|hcv testing program
67267|NCT03145753|education|education
67268|NCT03145727|Chemotherapy|chemotherapy
67269|NCT03145727|nausea|nausea
67270|NCT03145727|vomiting|vomiting
67271|NCT03145727|transcutaneous electrical acupoint stimulation|transcutaneous electrical acupoint stimulation
67272|NCT03145714|POCD|pocd
67273|NCT03145714|Elderly|elderly
67274|NCT03145688|Behavioural|behavioural
67275|NCT03145688|Family physical activity habit|family physical activity habit
67276|NCT03145675|Anticoagulation|anticoagulation
67277|NCT03145675|Enoxaparin|enoxaparin
67278|NCT03145675|Dose|dose
67279|NCT03145649|Breast milk|breast milk
67280|NCT03145649|Hormone|hormone
67281|NCT03145649|Infant growth|infant growth
67282|NCT03145649|Gestational diabetes mellitus|gestational diabetes mellitus
67283|NCT03145636|Obesity|obesity
67284|NCT03145636|Bariatric surgery|bariatric surgery
67285|NCT03145636|Vagal blocking|vagal blocking
67286|NCT03145636|vBloc therapy|vbloc therapy
67287|NCT03145636|Vagus Nerve|vagus nerve
67288|NCT03145636|Percent excess weight loss|percent excess weight loss
67289|NCT03145636|Percent total body weight loss|percent total body weight loss
67290|NCT03145597|facings|facings
67291|NCT03145597|veneers|veneers
67292|NCT03145597|laminates|laminates
67293|NCT03145597|existing|existing
67294|NCT03145597|restorations|restorations
67295|NCT03145597|esthetics|esthetics
67296|NCT03145597|dental|dental
67297|NCT03145584|Total Knee Arthroplasty|total knee arthroplasty
67298|NCT03145584|Physiotherapy|physiotherapy
67299|NCT03145558|Tirapazamine, embolization, TACE, Hepatocellular carcinoma|tirapazamine, embolization, tace, hepatocellular carcinoma
67300|NCT03145493|Drainage, Suction|drainage, suction
67301|NCT03145493|tranexamic acid|tranexamic acid
67302|NCT03145480|leukemia|leukemia
67303|NCT03145480|richter|richter
67304|NCT03145467|Migraine|migraine
67305|NCT03145467|Paracetamol|paracetamol
67306|NCT03145467|Zolmitriptan|zolmitriptan
67307|NCT03145467|Emergency services|emergency services
67308|NCT03145454|Pain|pain
67309|NCT03145454|children|children
67310|NCT03145454|emergency|emergency
67311|NCT03145454|electroencephalography|electroencephalography
67312|NCT03145454|heart rate|heart rate
67313|NCT03145454|skin conductance|skin conductance
67314|NCT03145454|pupillary diameter|pupillary diameter
67315|NCT03145415|pudendal nerve block|pudendal nerve block
67316|NCT03145415|hypospadias|hypospadias
67317|NCT03145415|caudal block|caudal block
67318|NCT03145376|TAVI|tavi
67319|NCT03145376|MitraClip|mitraclip
67320|NCT03145376|geriatric assessment|geriatric assessment
67321|NCT03145376|heart rate variability|heart rate variability
67322|NCT03145376|elderly|elderly
67323|NCT03145350|NAFLD|nafld
67324|NCT03145350|Fat intake|fat intake
67325|NCT03145350|Sugar intake|sugar intake
67326|NCT03145311|Repetitive transcranial magnetic stimulation, Drug Induced Tardive Syndrome|repetitive transcranial magnetic stimulation, drug induced tardive syndrome
67327|NCT03145298|HPAH (heritable)|hpah (heritable)
67328|NCT03145298|IPAH (idiopathic)|ipah (idiopathic)
67329|NCT03145298|PAH-CTD (connective tissue diseases)|pah-ctd (connective tissue diseases)
67330|NCT03145298|PAH-HIV (human immunodeficiency virus)|pah-hiv (human immunodeficiency virus)
67331|NCT03145285|Abiraterone Acetate|abiraterone acetate
67332|NCT03145285|Cushing Syndrome|cushing syndrome
67333|NCT03145285|Adrenocortical Carcinoma|adrenocortical carcinoma
67334|NCT03145272|Pharmacogenomics|pharmacogenomics
67335|NCT03145272|Pharmacokinetics|pharmacokinetics
67336|NCT03145272|Oxycodone|oxycodone
67337|NCT03145246|intrabony defect|intrabony defect
67338|NCT03145246|periodontal regeneration|periodontal regeneration
67339|NCT03145233|physiotherapy|physiotherapy
67340|NCT03145220|EA-230|ea-230
67341|NCT03145220|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
67342|NCT03145220|Acute Kidney Injury|acute kidney injury
67343|NCT03145220|Interleukin-6|interleukin-6
67344|NCT03145220|Safety|safety
67345|NCT03145220|Tolerability|tolerability
67346|NCT03145220|Phase II|phase ii
67347|NCT03145220|Randomized clinical trial|randomized clinical trial
67348|NCT03145155|continuum of care|continuum of care
67349|NCT03145155|maternal|maternal
67350|NCT03145155|newborn|newborn
67351|NCT03145155|child health|child health
67352|NCT03145155|noncommunicable diseases|noncommunicable diseases
67353|NCT03145142|Near-Infrared Spectroscopy|near-infrared spectroscopy
67354|NCT03145129|Intraocular pressure|intraocular pressure
67355|NCT03145129|IOP|iop
67356|NCT03145129|CPAP|cpap
67357|NCT03145090|bone scintigraphy|bone scintigraphy
67358|NCT03145090|knee arthroplasty|knee arthroplasty
67359|NCT03145090|spect-ct|spect-ct
67360|NCT03145090|quantification|quantification
67361|NCT03145077|Head and Neck Cancer|head and neck cancer
67362|NCT03145077|Osteoradionecrosis|osteoradionecrosis
67363|NCT03145077|ORN|orn
67364|NCT03145077|Dynamic contrast-enhanced magnetic resonance imaging|dynamic contrast-enhanced magnetic resonance imaging
67365|NCT03145077|DCE-MRI|dce-mri
67366|NCT03145077|Questionnaires|questionnaires
67367|NCT03145077|Surveys|surveys
67368|NCT03145064|relapsed/refractory non-GCB type|relapsed/refractory non-gcb type
67369|NCT03145051|saline solution|saline solution
67370|NCT03145051|minerals|minerals
67371|NCT03145051|cystic fibrosis|cystic fibrosis
67372|NCT03145051|chronic rhinosinusitis|chronic rhinosinusitis
67373|NCT03145051|nasal irrigation|nasal irrigation
67374|NCT03145012|Cancer|cancer
67375|NCT03145012|Immunity|immunity
67376|NCT03145012|Peripheral Blood Mononuclear Cells|peripheral blood mononuclear cells
67377|NCT03145012|Ranitidine|ranitidine
67378|NCT03144999|Dry AMD|dry amd
67379|NCT03144999|Dry Age-related Macular Degeneration|dry age-related macular degeneration
67380|NCT03144999|Gene Therapy|gene therapy
67381|NCT03144999|Complement|complement
67382|NCT03144999|Intravitreal Injection|intravitreal injection
67383|NCT03144999|Geographic Atrophy|geographic atrophy
67384|NCT03144999|Drusen|drusen
67385|NCT03144999|Membrane Attack Complex|membrane attack complex
67386|NCT03144999|CD59|cd59
67387|NCT03144934|HPV|hpv
67388|NCT03144921|Early-stage Dementia|early-stage dementia
67389|NCT03144921|Early-stage Alzheimer's disease|early-stage alzheimer's disease
67390|NCT03144921|Care partner|care partner
67391|NCT03144921|Caregivers|caregivers
67392|NCT03144921|Caregiving|caregiving
67393|NCT03144869|type 1 diabetes mellitus|type 1 diabetes mellitus
67394|NCT03144869|physical activity|physical activity
67395|NCT03144869|children|children
67396|NCT03144869|constant glucose monitoring|constant glucose monitoring
67397|NCT03144856|Biliary Tract Cancer|biliary tract cancer
67398|NCT03144856|Second line thrapy|second line thrapy
67399|NCT03144856|Apatinib|apatinib
67400|NCT03144843|Gastric cancer|gastric cancer
67401|NCT03144843|Peritoneal metastasis|peritoneal metastasis
67402|NCT03144843|Paclitaxol|paclitaxol
67403|NCT03144843|Apatinib|apatinib
67404|NCT03144843|Second-line chemotherapy|second-line chemotherapy
67405|NCT03144817|hemodialysis|hemodialysis
67406|NCT03144817|fluid overload|fluid overload
67407|NCT03144817|dialysis disequilibrium|dialysis disequilibrium
67408|NCT03144817|intra-dialytic hypotension|intra-dialytic hypotension
67409|NCT03144817|dialysate sodium lowering|dialysate sodium lowering
67410|NCT03144804|Colorectal Cancer|colorectal cancer
67411|NCT03144778|Malignant Neoplasms of Oropharynx|malignant neoplasms of oropharynx
67412|NCT03144778|CD8+ tumor infiltrating lymphocytes|cd8+ tumor infiltrating lymphocytes
67413|NCT03144778|Biomarkers|biomarkers
67414|NCT03144778|Durvalumab|durvalumab
67415|NCT03144778|MEDI4736|medi4736
67416|NCT03144778|Tremelimumab|tremelimumab
67417|NCT03144778|Ticilimumab|ticilimumab
67418|NCT03144778|CP-675,206|cp-675,206
67419|NCT03144765|taTME|tatme
67420|NCT03144765|Transanal|transanal
67421|NCT03144765|Rectal cancer|rectal cancer
67422|NCT03144765|Colorectal|colorectal
67423|NCT03144765|Total mesorectal excision|total mesorectal excision
67424|NCT03144765|TME|tme
67425|NCT03144687|Myelofibrosis|myelofibrosis
67426|NCT03144687|Janus kinase (JAK) inhibitor|janus kinase (jak) inhibitor
67427|NCT03144687|itacitinib|itacitinib
67428|NCT03144687|ruxolitinib|ruxolitinib
67429|NCT03144674|Marginal zone lymphoma|marginal zone lymphoma
67430|NCT03144674|phosphatidylinositol 3-kinase (PI3K)δ inhibitor|phosphatidylinositol 3-kinase (pi3k)δ inhibitor
67431|NCT03144674|indolent (slow-growing) non-Hodgkin lymphoma B-cell lymphoma|indolent (slow-growing) non-hodgkin lymphoma b-cell lymphoma
67432|NCT03144661|hepatocellular carcinoma|hepatocellular carcinoma
67433|NCT03144661|cholangiocarcinoma|cholangiocarcinoma
67434|NCT03144661|esophageal|esophageal
67435|NCT03144661|nasopharyngeal|nasopharyngeal
67436|NCT03144661|serous ovarian|serous ovarian
67437|NCT03144661|solid tumors|solid tumors
67438|NCT03144661|fibroblast growth factor (FGF)|fibroblast growth factor (fgf)
67565|NCT03143855|oxycodone|oxycodone
67439|NCT03144661|fibroblast growth factor receptor (FGFR)|fibroblast growth factor receptor (fgfr)
67440|NCT03144635|Direct Acting Antivirals|direct acting antivirals
67441|NCT03144635|Grazoprevir|grazoprevir
67442|NCT03144635|Elbasvir|elbasvir
67443|NCT03144622|(4S)-4-(3-[18F]fluoropropyl-)-L-glutamate|(4s)-4-(3-[18f]fluoropropyl-)-l-glutamate
67444|NCT03144622|18F-FSPG|18f-fspg
67445|NCT03144622|PET/CT|pet/ct
67446|NCT03144622|system xC-transporter|system xc-transporter
67447|NCT03144609|mechanical ventilation, obesity, oral-surgical procedures|mechanical ventilation, obesity, oral-surgical procedures
67448|NCT03144583|CART19|cart19
67449|NCT03144570|ICU, encephalitis, meningo-encephalitis, seizures|icu, encephalitis, meningo-encephalitis, seizures
67450|NCT03144557|Education|education
67451|NCT03144557|COPD|copd
67452|NCT03144557|Inhalation Devices|inhalation devices
67453|NCT03144544|Similarity|similarity
67454|NCT03144544|Diversity|diversity
67455|NCT03144531|School-age child|school-age child
67456|NCT03144518|Positive Affect|positive affect
67457|NCT03144518|Positive Mood|positive mood
67458|NCT03144518|Influenza Vaccination|influenza vaccination
67459|NCT03144518|Vaccination|vaccination
67460|NCT03144518|Randomised Controlled Trial|randomised controlled trial
67461|NCT03144505|Type 2 Diabetes|type 2 diabetes
67462|NCT03144505|Exercise|exercise
67463|NCT03144505|High Intensity Interval Training|high intensity interval training
67464|NCT03144505|Glycemic Control|glycemic control
67465|NCT03144492|Cell Culture|cell culture
67466|NCT03144492|Microgravity co-culture|microgravity co-culture
67467|NCT03144453|Curare|curare
67468|NCT03144453|Robotic surgery|robotic surgery
67469|NCT03144440|ZEPATIER|zepatier
67470|NCT03144427|albumin|albumin
67471|NCT03144427|resuscitation|resuscitation
67472|NCT03144427|burns|burns
67473|NCT03144427|shock|shock
67474|NCT03144427|fluid creep|fluid creep
67475|NCT03144401|cesarean section|cesarean section
67476|NCT03144401|Misoprostol|misoprostol
67477|NCT03144401|sublingual|sublingual
67478|NCT03144401|uterotonics|uterotonics
67479|NCT03144323|Intraoral elastics|intraoral elastics
67480|NCT03144258|congenital heart defects|congenital heart defects
67481|NCT03144258|systemic microcirculation|systemic microcirculation
67482|NCT03144258|laser Doppler perfusion imaging|laser doppler perfusion imaging
67483|NCT03144258|cardiac corrective surgery|cardiac corrective surgery
67484|NCT03144245|AML|aml
67485|NCT03144245|treatment|treatment
67486|NCT03144245|relapsed|relapsed
67487|NCT03144245|refractory|refractory
67488|NCT03144245|phase 1|phase 1
67489|NCT03144219|intracranial pressure|intracranial pressure
67490|NCT03144219|transcranial Doppler|transcranial doppler
67491|NCT03144219|jugular compression|jugular compression
67492|NCT03144219|cerebral compliance|cerebral compliance
67493|NCT03144193|topical treatment|topical treatment
67494|NCT03144193|wrinkles|wrinkles
67495|NCT03144193|extracellular matrix|extracellular matrix
67496|NCT03144180|pregnant|pregnant
67497|NCT03144180|third trimester|third trimester
67498|NCT03144180|umbilical cord blood collection|umbilical cord blood collection
67499|NCT03144154|Cancer|cancer
67500|NCT03144154|Fatigue|fatigue
67501|NCT03144154|Hypnosis|hypnosis
67502|NCT03144154|Self-hypnosis|self-hypnosis
67503|NCT03144154|Self-care|self-care
67504|NCT03144154|Emotional distress|emotional distress
67505|NCT03144154|Cancer survivors|cancer survivors
67506|NCT03144128|vitamin D|vitamin d
67507|NCT03144128|muscle|muscle
67508|NCT03144128|metabolism|metabolism
67509|NCT03144128|cancer cachexia|cancer cachexia
67510|NCT03144115|oxytocin|oxytocin
67511|NCT03144115|sex hormone|sex hormone
67512|NCT03144115|verbal reward|verbal reward
67513|NCT03144115|mate selection|mate selection
67514|NCT03144115|metaphorical language|metaphorical language
67515|NCT03144089|Morbid obesity|morbid obesity
67516|NCT03144089|Obstructive sleep apnea|obstructive sleep apnea
67517|NCT03144089|Mask ventilation|mask ventilation
67518|NCT03144089|Upper airway obstruction|upper airway obstruction
67519|NCT03144076|healthcare|healthcare
67520|NCT03144076|India|india
67521|NCT03144076|health insurance|health insurance
67522|NCT03144076|RSBY|rsby
67523|NCT03144076|free health insurance|free health insurance
67524|NCT03144076|inpatient insurance|inpatient insurance
67525|NCT03144076|wealth transfer|wealth transfer
67526|NCT03144063|Disease Activity|disease activity
67527|NCT03144063|SLEDAI-2K|sledai-2k
67528|NCT03144024|Tricuspid Regurgitation|tricuspid regurgitation
67529|NCT03144024|Insufficiency, Tricuspid Valve|insufficiency, tricuspid valve
67530|NCT03144024|Valvular Annuloplasty|valvular annuloplasty
67531|NCT03144024|Cardiac Valve Annulus Repair|cardiac valve annulus repair
67532|NCT03144011|acute kidney injury, cardiosurgery|acute kidney injury, cardiosurgery
67533|NCT03143985|TEW-7197|tew-7197
67534|NCT03143985|Pomalidomide|pomalidomide
67535|NCT03143972|Dexmedetomidine|dexmedetomidine
67536|NCT03143972|Remifentanil|remifentanil
67537|NCT03143972|Pharmacodynamics|pharmacodynamics
67538|NCT03143972|Interaction|interaction
67539|NCT03143946|neuroendocrine tumor|neuroendocrine tumor
67540|NCT03143946|vitamin|vitamin
67541|NCT03143946|diet|diet
67542|NCT03143933|propofol, BIS, general anesthesia|propofol, bis, general anesthesia
67543|NCT03143920|hyperbaric oxygen|hyperbaric oxygen
67544|NCT03143920|inflammation|inflammation
67545|NCT03143920|chronic disease|chronic disease
67546|NCT03143920|urinary bladder|urinary bladder
67547|NCT03143920|urinary tract infection|urinary tract infection
67548|NCT03143920|recurrent urinary tract infection|recurrent urinary tract infection
67549|NCT03143920|painful bladder syndrome|painful bladder syndrome
67550|NCT03143920|chronic pain|chronic pain
67551|NCT03143920|hypoxia|hypoxia
67552|NCT03143920|bacterial infection|bacterial infection
67553|NCT03143907|Mindfulness|mindfulness
67554|NCT03143907|Group Therapy|group therapy
67555|NCT03143894|Breast Cancer|breast cancer
67556|NCT03143894|Cognition|cognition
67557|NCT03143894|Fatigue|fatigue
67558|NCT03143894|Cancer-related Cognitive Impairment|cancer-related cognitive impairment
67559|NCT03143894|Transcranial Direct Current Stimulation|transcranial direct current stimulation
67560|NCT03143868|acute exercise|acute exercise
67561|NCT03143868|resistance exercise|resistance exercise
67562|NCT03143868|aerobic exercise|aerobic exercise
67563|NCT03143868|appetite|appetite
67564|NCT03143868|energy intake|energy intake
67566|NCT03143855|lorcaserin|lorcaserin
67568|NCT03143842|VNS|vns
67569|NCT03143842|accelerate learning|accelerate learning
67570|NCT03143842|memory|memory
67571|NCT03143829|gerontology|gerontology
67572|NCT03143829|symptom self-management|symptom self-management
67573|NCT03143829|Chemotherapy-induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
67574|NCT03143816|diabetes|diabetes
67575|NCT03143816|time in range|time in range
67576|NCT03143816|inhaled insulin|inhaled insulin
67577|NCT03143816|continuous glucose monitoring|continuous glucose monitoring
67578|NCT03143816|type 1 diabetes|type 1 diabetes
67579|NCT03143816|hypoglycemia|hypoglycemia
67580|NCT03143816|post prandial hypergylcemia|post prandial hypergylcemia
67581|NCT03143790|Erectile Function|erectile function
67582|NCT03143790|Prostatectomy|prostatectomy
67583|NCT03143790|Extracorporeal Shock Wave Therapy|extracorporeal shock wave therapy
67584|NCT03143790|IIEF-5|iief-5
67585|NCT03143777|physiotherapy|physiotherapy
67586|NCT03143777|rehabilitation|rehabilitation
67587|NCT03143777|critical care|critical care
67588|NCT03143777|seating|seating
67589|NCT03143738|regional anesthesia|regional anesthesia
67590|NCT03143738|knee replacement|knee replacement
67591|NCT03143738|pain treatment|pain treatment
67592|NCT03143738|rehabilitation|rehabilitation
67593|NCT03143686|Severe symptomatic Aortic Stenosis|severe symptomatic aortic stenosis
67594|NCT03143673|Severe Symptomatic Aortic Valve Stenosis|severe symptomatic aortic valve stenosis
67595|NCT03143660|obesity|obesity
67596|NCT03143608|GERD|gerd
67597|NCT03143608|Hiatal hernia repair|hiatal hernia repair
67598|NCT03143608|Transoral Incision less fundoplication|transoral incision less fundoplication
67599|NCT03143595|Preexisting cognitive impairment|preexisting cognitive impairment
67600|NCT03143595|Elderly|elderly
67601|NCT03143595|Outcomes|outcomes
67602|NCT03143556|renal transplant|renal transplant
67603|NCT03143556|magnetic ureteral stent|magnetic ureteral stent
67604|NCT03143556|Black-Star®|black-star®
67605|NCT03143543|cocaine disorder|cocaine disorder
67606|NCT03143543|opioid disorder|opioid disorder
67607|NCT03143543|lorcaserin|lorcaserin
67608|NCT03143543|MRI|mri
67609|NCT03143543|fMRI|fmri
67610|NCT03143530|Ropivacaine|ropivacaine
67611|NCT03143517|Inflammatory Bowel Diseases|inflammatory bowel diseases
67612|NCT03143517|Irritable Bowel Syndrome|irritable bowel syndrome
67613|NCT03143517|Ulcerative Colitis|ulcerative colitis
67614|NCT03143517|Crohn Disease|crohn disease
67615|NCT03143517|Indeterminate Colitis|indeterminate colitis
67616|NCT03143426|3D laparoscopic cholecystectomy|3d laparoscopic cholecystectomy
67617|NCT03143426|Junior surgeons|junior surgeons
67618|NCT03143426|Complication|complication
67619|NCT03143426|Conversion|conversion
67620|NCT03143413|Salivary glands ultrasonography|salivary glands ultrasonography
67621|NCT03143413|Systemic sclerosis|systemic sclerosis
67622|NCT03143413|Gougerot Sjogren syndrome|gougerot sjogren syndrome
67623|NCT03143413|Sicca syndrome|sicca syndrome
67624|NCT03143400|Probiotics|probiotics
67625|NCT03143400|Galenic form|galenic form
67626|NCT03143400|Digestive tract|digestive tract
67627|NCT03143400|Intestinal microbiota|intestinal microbiota
67628|NCT03143400|Lactobacillus salivarius|lactobacillus salivarius
67629|NCT03143361|aortic valve stenosis|aortic valve stenosis
67630|NCT03143361|heart valves|heart valves
67631|NCT03143361|heart surgery|heart surgery
67632|NCT03143335|Breast; Reconstruction; BAD; Implant; ADM|breast; reconstruction; bad; implant; adm
67633|NCT03143322|Bone-only metastases|bone-only metastases
67634|NCT03143322|solid tumors|solid tumors
67635|NCT03143322|SBRT|sbrt
67636|NCT03143283|suicide|suicide
67637|NCT03143283|lethal means|lethal means
67638|NCT03143283|counseling|counseling
67639|NCT03143283|youth|youth
67640|NCT03143283|parents|parents
67641|NCT03143283|firearms|firearms
67642|NCT03143283|medication|medication
67643|NCT03143283|suicidal|suicidal
67644|NCT03143283|emergency department|emergency department
67645|NCT03143270|nivolumab|nivolumab
67646|NCT03143270|deb-TACE|deb-tace
67647|NCT03143270|17-087|17-087
67648|NCT03143218|Malaria|malaria
67649|NCT03143218|Seasonal vaccination|seasonal vaccination
67650|NCT03143218|Seasonal chemoprevention|seasonal chemoprevention
67651|NCT03143192|DME, Micropulse Laser, Anti-VEGF|dme, micropulse laser, anti-vegf
67652|NCT03143140|Ablation Techniques|ablation techniques
67653|NCT03143101|FluMist Quadrivalent|flumist quadrivalent
67654|NCT03143101|Trivalent|trivalent
67655|NCT03143101|Influenza|influenza
67656|NCT03143101|Vaccine|vaccine
67657|NCT03143101|Prevention|prevention
67658|NCT03143088|Blood pressure|blood pressure
67659|NCT03143088|Medical clown|medical clown
67660|NCT03143088|Pediatric|pediatric
67661|NCT03143062|National Early Warning Score|national early warning score
67662|NCT03143062|Rapid response system|rapid response system
67663|NCT03143049|Pomalidomide|pomalidomide
67664|NCT03143036|daratumumab|daratumumab
67665|NCT03142971|Shock waves|shock waves
67666|NCT03142971|Greater trochanteric pain syndrome|greater trochanteric pain syndrome
67667|NCT03142932|smoking|smoking
67668|NCT03142919|Mood Disorder|mood disorder
67669|NCT03142919|MDD|mdd
67670|NCT03142919|Endotoxin|endotoxin
67671|NCT03142919|MRI|mri
67672|NCT03142919|CRP|crp
67673|NCT03142906|preoperative, perioperative, point-of-care ultrasound|preoperative, perioperative, point-of-care ultrasound
67674|NCT03142893|testosterone|testosterone
67675|NCT03142893|cortisol|cortisol
67676|NCT03142880|marginally hyperbaric|marginally hyperbaric
67677|NCT03142880|ropivacaine|ropivacaine
67678|NCT03142880|cesarean|cesarean
67679|NCT03142867|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
67680|NCT03142867|Non Alcoholic Steatohepatitis|non alcoholic steatohepatitis
67681|NCT03142867|Prevalence|prevalence
67682|NCT03142867|Coronary Artery Disease|coronary artery disease
67683|NCT03142867|PDFF|pdff
67684|NCT03142854|bowel preparation|bowel preparation
67685|NCT03142854|colonoscopy|colonoscopy
67686|NCT03142854|predictive model|predictive model
67687|NCT03142841|Depression|depression
67688|NCT03142841|Burden|burden
67689|NCT03142841|Problem Solving Ability|problem solving ability
67690|NCT03142841|Caregivers|caregivers
67691|NCT03142841|Stroke|stroke
67692|NCT03142841|Veterans|veterans
67693|NCT03142828|chlorhexidine, dental implant, in-situ drug delivery,|chlorhexidine, dental implant, in-situ drug delivery,
67694|NCT03142815|Coronary Artery Bypass Graft (CABG), Arterial stiffness|coronary artery bypass graft (cabg), arterial stiffness
67695|NCT03142802|Testicular cancer|testicular cancer
67696|NCT03142802|low-dose CT|low-dose ct
67697|NCT03142802|CT scan|ct scan
67698|NCT03142789|Pain|pain
67699|NCT03142789|Total knee arthroplasty|total knee arthroplasty
67700|NCT03142789|Regional anesthesia|regional anesthesia
67701|NCT03142776|clarithromycin|clarithromycin
67702|NCT03142776|photodynamic therapy|photodynamic therapy
67703|NCT03142776|Antimicrobial therapy|antimicrobial therapy
67704|NCT03142776|Periodontal pocket|periodontal pocket
67705|NCT03142724|HV|hv
67706|NCT03142698|hepatic steatosis|hepatic steatosis
67707|NCT03142698|MRImaging|mrimaging
67708|NCT03142685|NEC|nec
67709|NCT03142685|Bowel Ultrasound|bowel ultrasound
67710|NCT03142685|CHD|chd
67711|NCT03142672|Postoperative pain|postoperative pain
67712|NCT03142672|child|child
67713|NCT03142672|pulpotomy|pulpotomy
67714|NCT03142672|general anesthesia|general anesthesia
67715|NCT03142620|Drug resistant H.pylori infection|drug resistant h.pylori infection
67716|NCT03142620|vitamin D|vitamin d
67717|NCT03142620|gastritis|gastritis
67718|NCT03142529|Non dialysis|non dialysis
67719|NCT03142516|Clinical Trial, Phase II|clinical trial, phase ii
67720|NCT03142516|Elderly|elderly
67721|NCT03142516|Aged|aged
67722|NCT03142516|Disease-Free Survival|disease-free survival
67723|NCT03142516|Safety|safety
67724|NCT03142516|Tolerability|tolerability
67725|NCT03142516|Chemotherapy regimen|chemotherapy regimen
67726|NCT03142516|Monoclonal antibody|monoclonal antibody
67727|NCT03142516|FOLFIRI|folfiri
67728|NCT03142516|Panitumumab|panitumumab
67729|NCT03142516|RAS/BRAF Wild-type|ras/braf wild-type
67730|NCT03142503|psoriatic arthritis|psoriatic arthritis
67731|NCT03142503|psoriasis|psoriasis
67732|NCT03142503|body composition|body composition
67733|NCT03142503|DXA measurements|dxa measurements
67734|NCT03142503|spondyloarthritis|spondyloarthritis
67735|NCT03142503|diet therapy|diet therapy
67736|NCT03142503|adipose tissue|adipose tissue
67737|NCT03142490|Acupuncture|acupuncture
67738|NCT03142490|Infertility|infertility
67739|NCT03142490|In vitro fertilization|in vitro fertilization
67740|NCT03142490|Quality of life|quality of life
67741|NCT03142490|Stress|stress
67742|NCT03142490|Anxiety|anxiety
67743|NCT03142477|Therapeutic touch|therapeutic touch
67744|NCT03142477|Reiki|reiki
67745|NCT03142477|Laying-on-of-Hands|laying-on-of-hands
67746|NCT03142477|Spiritual Therapies|spiritual therapies
67747|NCT03142464|saline solution|saline solution
67748|NCT03142464|laparoscopy|laparoscopy
67749|NCT03142464|cholecystectomy|cholecystectomy
67750|NCT03142464|outcomes|outcomes
67751|NCT03142412|Lupus|lupus
67752|NCT03142412|SLE|sle
67753|NCT03142412|Systemic Lupus Erythematosus|systemic lupus erythematosus
67754|NCT03142399|heart failure|heart failure
67755|NCT03142399|cardiac reabilitation|cardiac reabilitation
67756|NCT03142399|nutritional status|nutritional status
67859|NCT03141723|Bag|bag
67757|NCT03142399|quality of life|quality of life
67758|NCT03142399|milk protein|milk protein
67759|NCT03142386|geriatric oncology|geriatric oncology
67760|NCT03142386|pain|pain
67761|NCT03142386|osteopathic manipulative treatment|osteopathic manipulative treatment
67762|NCT03142386|quality of life|quality of life
67763|NCT03142373|heart rate variability|heart rate variability
67764|NCT03142373|autonomic nervous system|autonomic nervous system
67765|NCT03142373|osteopathic manipulative treatment|osteopathic manipulative treatment
67766|NCT03142373|skin conductance|skin conductance
67767|NCT03142347|remote endarterectomy|remote endarterectomy
67768|NCT03142347|DCB balloon|dcb balloon
67769|NCT03142334|PD1|pd1
67770|NCT03142334|PD-1|pd-1
67771|NCT03142334|PDL1|pdl1
67772|NCT03142334|PD-L1|pd-l1
67773|NCT03142334|Adjuvant|adjuvant
67774|NCT03142308|Satisfaction|satisfaction
67775|NCT03142308|Training program|training program
67776|NCT03142308|Egypt|egypt
67777|NCT03142308|Cross-sectional|cross-sectional
67778|NCT03142308|Multi-center|multi-center
67779|NCT03142295|Urine transfusion|urine transfusion
67780|NCT03142295|Recurrent urinary tract infection|recurrent urinary tract infection
67781|NCT03142295|Urinary microbiota|urinary microbiota
67782|NCT03142282|maintenance treatment|maintenance treatment
67783|NCT03142243|Tennis|tennis
67784|NCT03142243|Asymmetry|asymmetry
67785|NCT03142243|Morphological|morphological
67786|NCT03142230|feeding tube|feeding tube
67787|NCT03142230|gastric|gastric
67788|NCT03142230|newborn infant|newborn infant
67789|NCT03142230|nursing|nursing
67790|NCT03142230|pain|pain
67791|NCT03142191|Idiopathic Pulmonary Fibrosis (IPF)|idiopathic pulmonary fibrosis (ipf)
67792|NCT03142191|Pulmonary Fibrosis|pulmonary fibrosis
67793|NCT03142191|CC-90001|cc-90001
67794|NCT03142191|Safety|safety
67795|NCT03142191|Efficacy|efficacy
67796|NCT03142191|IPF|ipf
67797|NCT03142191|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
67798|NCT03142178|osteoarthritis|osteoarthritis
67799|NCT03142178|pain|pain
67800|NCT03142178|knee|knee
67801|NCT03142152|Functional Mitral Regurgitation|functional mitral regurgitation
67802|NCT03142152|Percutaneous Mitral Valve Repair|percutaneous mitral valve repair
67803|NCT03142152|Percutaneous Mitral Valve Annuloplasty|percutaneous mitral valve annuloplasty
67804|NCT03142152|Coronary sinus Annuloplasty|coronary sinus annuloplasty
67805|NCT03142152|Secondary Mitral Regurgitation|secondary mitral regurgitation
67806|NCT03142152|Functional MR|functional mr
67807|NCT03142152|FMR|fmr
67808|NCT03142139|Observational study; DTaP-IPV-Hib; Atopic Dermatitis; AD; Heterologous immunity; Non-specific effects; Non-targeted effects; Immunization;|observational study; dtap-ipv-hib; atopic dermatitis; ad; heterologous immunity; non-specific effects; non-targeted effects; immunization;
67809|NCT03142113|optimization|optimization
67810|NCT03142113|adalimumab|adalimumab
67811|NCT03142087|balance|balance
67812|NCT03142087|brain tumor|brain tumor
67813|NCT03142087|virtual reality|virtual reality
67814|NCT03142074|Improve diagnosis|improve diagnosis
67815|NCT03142009|Community-Based Participatory Research|community-based participatory research
67816|NCT03141996|vibration|vibration
67817|NCT03141996|stroke|stroke
67818|NCT03141996|activities of daily living|activities of daily living
67819|NCT03141983|ESRD|esrd
67820|NCT03141983|End-Stage Kidney Disease|end-stage kidney disease
67821|NCT03141970|Proteinuria Hypoproteinemia Edema Hypoalbuminemia Prednisone|proteinuria hypoproteinemia edema hypoalbuminemia prednisone
67822|NCT03141957|Aging|aging
67823|NCT03141957|Hypermetabolism|hypermetabolism
67824|NCT03141944|non motor symptoms|non motor symptoms
67825|NCT03141931|Nutraceutical supplement|nutraceutical supplement
67826|NCT03141905|patient safety|patient safety
67827|NCT03141905|self-management|self-management
67828|NCT03141905|remote monitoring|remote monitoring
67829|NCT03141879|Frailty|frailty
67830|NCT03141879|Physical Activity|physical activity
67831|NCT03141879|Resistance training|resistance training
67832|NCT03141853|Randomized Controlled Trial|randomized controlled trial
67833|NCT03141853|Intervention Study|intervention study
67834|NCT03141827|Lipoprotein|lipoprotein
67835|NCT03141827|Apolipoprotein|apolipoprotein
67836|NCT03141827|Pancreatic clamp|pancreatic clamp
67837|NCT03141827|Insulin|insulin
67838|NCT03141827|Nasal|nasal
67839|NCT03141801|ACL|acl
67840|NCT03141801|Knee|knee
67841|NCT03141801|Muscle|muscle
67842|NCT03141788|Aligners|aligners
67843|NCT03141775|Clostridium difficile associated diarrhea (CDAD)|clostridium difficile associated diarrhea (cdad)
67844|NCT03141762|Falls|falls
67845|NCT03141762|Intensive care|intensive care
67846|NCT03141736|Infant|infant
67847|NCT03141736|Newborn|newborn
67848|NCT03141736|Preterm|preterm
67849|NCT03141736|Hypothermia|hypothermia
67850|NCT03141736|Kangaroo|kangaroo
67851|NCT03141736|Plastic|plastic
67852|NCT03141736|Bag|bag
67853|NCT03141723|Infant|infant
67854|NCT03141723|Newborn|newborn
67855|NCT03141723|Preterm|preterm
67856|NCT03141723|Hypothermia|hypothermia
67857|NCT03141723|Kangaroo|kangaroo
67858|NCT03141723|Plastic|plastic
67860|NCT03141697|Carbon Dioxide|carbon dioxide
67861|NCT03141697|Coloboscopy|coloboscopy
67862|NCT03141671|Prostate Cancer|prostate cancer
67863|NCT03141658|TS-134|ts-134
67864|NCT03141658|ketamine|ketamine
67865|NCT03141658|fMRI|fmri
67866|NCT03141619|cerebral oximetry|cerebral oximetry
67867|NCT03141619|near-infrared spectroscopy|near-infrared spectroscopy
67868|NCT03141619|neurocognitive|neurocognitive
67869|NCT03141619|post-ICU syndrome|post-icu syndrome
67870|NCT03141593|adherence to medication|adherence to medication
67871|NCT03141593|electronic monitoring|electronic monitoring
67872|NCT03141567|Lymphangiogenesis|lymphangiogenesis
67873|NCT03141567|Heart Failure|heart failure
67874|NCT03141541|low back pain|low back pain
67875|NCT03141541|cognitive behavioural therapy|cognitive behavioural therapy
67876|NCT03141541|randomised controlled trial|randomised controlled trial
67877|NCT03141528|Self-learning|self-learning
67878|NCT03141528|Instructor-led learning|instructor-led learning
67879|NCT03141528|Long-term retention|long-term retention
67880|NCT03141515|lung ultrasound|lung ultrasound
67881|NCT03141515|recruitment maneuver|recruitment maneuver
67882|NCT03141515|atelectasis|atelectasis
67883|NCT03141515|children|children
67884|NCT03141502|tension wound|tension wound
67885|NCT03141502|skin stretching device|skin stretching device
67886|NCT03141502|skin grafting|skin grafting
67887|NCT03141476|Surgery|surgery
67888|NCT03141476|Obesity|obesity
67889|NCT03141476|Drug|drug
67890|NCT03141476|Antibiotics|antibiotics
67891|NCT03141476|Cefuroxime|cefuroxime
67892|NCT03141463|Therapeutic vaccination|therapeutic vaccination
67893|NCT03141437|Malignant Neoplasm of Breast|malignant neoplasm of breast
67894|NCT03141437|Malignant Neoplasm of Female Genital Organs|malignant neoplasm of female genital organs
67895|NCT03141437|Lymphoma|lymphoma
67896|NCT03141437|Myeloma|myeloma
67897|NCT03141437|Decision Aid Website|decision aid website
67898|NCT03141437|DA|da
67899|NCT03141437|Fertility preservation support|fertility preservation support
67900|NCT03141437|Questionnaires|questionnaires
67901|NCT03141437|Surveys|surveys
67902|NCT03141437|Educational materials|educational materials
67903|NCT03141372|Total Laparoscopic Hysterectomy|total laparoscopic hysterectomy
67904|NCT03141372|Urinary Retention|urinary retention
67905|NCT03141372|Backfill Void Trial|backfill void trial
67906|NCT03141372|Autofill Void Trial|autofill void trial
67907|NCT03141307|Neonatal screening|neonatal screening
67908|NCT03141307|Biobank|biobank
67909|NCT03141307|Broad Consent|broad consent
67910|NCT03141294|tracheostomy，fascia，force gauge|tracheostomy，fascia，force gauge
67911|NCT03141281|aging|aging
67912|NCT03141281|cognitive ability|cognitive ability
67913|NCT03141281|IADL|iadl
67914|NCT03141281|driving|driving
67915|NCT03141281|financial fraud|financial fraud
67916|NCT03141281|perception|perception
67917|NCT03141281|attention|attention
67918|NCT03141281|memory|memory
67919|NCT03141255|Therapeutic Hypothermia (TH)|therapeutic hypothermia (th)
67920|NCT03141242|Advance Care Planning|advance care planning
67921|NCT03141242|Group Medial Visit|group medial visit
67922|NCT03141242|Shared Medical Appointment|shared medical appointment
67923|NCT03141229|MBSR|mbsr
67924|NCT03141229|Children|children
67925|NCT03141229|Teacher|teacher
67926|NCT03141229|School|school
67927|NCT03141229|Burnout|burnout
67928|NCT03141229|Classroom behavior|classroom behavior
67929|NCT03141125|Erythrocyte sedimentation rate|erythrocyte sedimentation rate
67930|NCT03141125|Modified Rodnan Skin Score|modified rodnan skin score
67931|NCT03141125|B-cell Activating Factor|b-cell activating factor
67932|NCT03141125|soluble-CD40Ligand|soluble-cd40ligand
67933|NCT03141125|Procollagen Type-1 N-terminal Propeptide|procollagen type-1 n-terminal propeptide
67934|NCT03141125|Scleroderma|scleroderma
67935|NCT03141099|OHCA|ohca
67936|NCT03141099|Hemodynamic|hemodynamic
67937|NCT03141099|TTM|ttm
67938|NCT03141099|post-rescusitation care|post-rescusitation care
67939|NCT03141099|Blood pressure targets|blood pressure targets
67940|NCT03141099|Oxygenation targets|oxygenation targets
67941|NCT03141086|shift work disorder|shift work disorder
67942|NCT03141073|GKA|gka
67943|NCT03141073|T2DM|t2dm
67944|NCT03141073|HMS5552|hms5552
67945|NCT03141073|Add on therapy|add on therapy
67946|NCT03141073|Metformin|metformin
67947|NCT03141047|Sexual trauma, Lifespan Integration|sexual trauma, lifespan integration
67948|NCT03141008|Ketosis|ketosis
67949|NCT03141008|NAFLD|nafld
67950|NCT03141008|Obesity|obesity
67951|NCT03140995|Exercise|exercise
67952|NCT03140995|Sleep|sleep
67953|NCT03140982|propofol|propofol
67954|NCT03140982|pharmacology|pharmacology
67955|NCT03140982|anesthesic induction|anesthesic induction
67956|NCT03140982|drug titration|drug titration
67957|NCT03140969|CEP290|cep290
67958|NCT03140969|p.Cys998X|p.cys998x
67959|NCT03140969|c.2991+1655A>G|c.2991+1655a>g
67960|NCT03140969|RNA therapy|rna therapy
67961|NCT03140969|Antisense oligonucleotide|antisense oligonucleotide
67962|NCT03140969|Leber's congenital amaurosis|leber's congenital amaurosis
67963|NCT03140943|carfilzomib|carfilzomib
67964|NCT03140917|Liver function|liver function
67965|NCT03140917|Future liver remnant|future liver remnant
67966|NCT03140917|Chemotherapy|chemotherapy
67967|NCT03140891|preterm infant|preterm infant
67968|NCT03140891|respiratory distress syndrome|respiratory distress syndrome
67969|NCT03140891|nasal high frequence oscillation ventilation|nasal high frequence oscillation ventilation
67970|NCT03140865|Alzheimer's|alzheimer's
67971|NCT03140865|observational|observational
67972|NCT03140865|prediabetes|prediabetes
67973|NCT03140865|mild cognitive impairment|mild cognitive impairment
67974|NCT03140774|Ebola vaccine|ebola vaccine
67975|NCT03140774|immunogenicity|immunogenicity
67976|NCT03140774|persistence|persistence
67977|NCT03140722|anemia|anemia
67978|NCT03140722|kidney|kidney
67979|NCT03140722|dialysis-dependent chronic kidney disease|dialysis-dependent chronic kidney disease
67980|NCT03140722|CKD|ckd
67981|NCT03140722|DD-CKD|dd-ckd
67982|NCT03140722|renal|renal
67983|NCT03140722|vadadustat|vadadustat
67984|NCT03140722|AKB-6548|akb-6548
67985|NCT03140722|hypoxia-inducible factor|hypoxia-inducible factor
67986|NCT03140722|HIF|hif
67987|NCT03140722|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
67988|NCT03140722|HIF-PHI|hif-phi
67989|NCT03140722|hyporesponder|hyporesponder
67990|NCT03140722|hyporesponsive|hyporesponsive
67991|NCT03140722|epoetin alfa|epoetin alfa
67992|NCT03140722|hemoglobin|hemoglobin
67993|NCT03140722|erythropoiesis stimulating agent|erythropoiesis stimulating agent
67994|NCT03140722|ESA|esa
67995|NCT03140709|Salivary|salivary
67996|NCT03140709|Oxytocin|oxytocin
67997|NCT03140709|Induction|induction
67998|NCT03140709|Labor|labor
67999|NCT03140657|Ankylosing spondylitis, Nanocurcumin, MicroRNA, Th17 cells|ankylosing spondylitis, nanocurcumin, microrna, th17 cells
68000|NCT03140644|thoracic sarcoidosis|thoracic sarcoidosis
68001|NCT03140644|ultra-low dose computed tomography|ultra-low dose computed tomography
68002|NCT03140644|Magnetic resonance imaging using Ultrashort echo time|magnetic resonance imaging using ultrashort echo time
68003|NCT03140631|atrial fibrillation|atrial fibrillation
68004|NCT03140631|catheter ablation|catheter ablation
68005|NCT03140631|protamine sulfate|protamine sulfate
68006|NCT03140631|anticoagulation reversal|anticoagulation reversal
68007|NCT03140618|single-system-design|single-system-design
68008|NCT03140618|mixed methods|mixed methods
68009|NCT03140618|psychiatric inpatient care|psychiatric inpatient care
68010|NCT03140618|work environment|work environment
68011|NCT03140618|rebuilding|rebuilding
68012|NCT03140579|recruitment|recruitment
68013|NCT03140579|lung homogeneity|lung homogeneity
68014|NCT03140579|airway pressure release ventilation|airway pressure release ventilation
68015|NCT03140566|heart failure|heart failure
68016|NCT03140566|acute decompensated heart failure|acute decompensated heart failure
68017|NCT03140566|congestion|congestion
68018|NCT03140566|inferior vena cava|inferior vena cava
68019|NCT03140553|Neoadjuvant Treatment|neoadjuvant treatment
68020|NCT03140553|HER2-Positive Breast Cancer|her2-positive breast cancer
68021|NCT03140540|Fluid management|fluid management
68022|NCT03140540|goal-directed therapy|goal-directed therapy
68023|NCT03140540|transesophageal echocardiography|transesophageal echocardiography
68024|NCT03140514|Urine chemokine monitoring|urine chemokine monitoring
68025|NCT03140488|Induction of labor|induction of labor
68026|NCT03140488|Pitocin|pitocin
68027|NCT03140488|BMI|bmi
68028|NCT03140475|Metacognition|metacognition
68029|NCT03140475|Mousetracking|mousetracking
68030|NCT03140475|EEG|eeg
68031|NCT03140475|Event related potentials|event related potentials
68032|NCT03140475|Frequency analysis|frequency analysis
68033|NCT03140475|Depression|depression
68034|NCT03140462|Tacrolimus|tacrolimus
68035|NCT03140462|Pharmacokinetics|pharmacokinetics
68036|NCT03140462|Genetic polymorphisms|genetic polymorphisms
68037|NCT03140449|Tuberous sclerosis complex|tuberous sclerosis complex
68038|NCT03140449|facial angiofibroma|facial angiofibroma
68039|NCT03140449|rapamycin|rapamycin
68040|NCT03140449|calcitriol|calcitriol
68041|NCT03140436|stain removal efficacy, air polishing powder|stain removal efficacy, air polishing powder
68042|NCT03140423|MRSA|mrsa
68043|NCT03140423|healthcare-associated infections|healthcare-associated infections
68044|NCT03140423|mupirocin|mupirocin
68045|NCT03140423|iodophor|iodophor
68046|NCT03140423|resistance|resistance
68047|NCT03140410|Staphylococci|staphylococci
68048|NCT03140410|Blood-stream infections|blood-stream infections
68049|NCT03140410|Linezolid|linezolid
68050|NCT03140397|Bioavailability|bioavailability
68051|NCT03140397|Pharmacokinetics|pharmacokinetics
68052|NCT03140397|8-prenylnaringenin|8-prenylnaringenin
68053|NCT03140397|6-prenylnaringenin|6-prenylnaringenin
68054|NCT03140397|Prenylflavonoids|prenylflavonoids
68055|NCT03140397|PBMC|pbmc
68056|NCT03140371|Enteral feeding|enteral feeding
68057|NCT03140371|Oral nutritional supplements|oral nutritional supplements
68058|NCT03140371|Peptide-based feed|peptide-based feed
68059|NCT03140371|Hydrolysed feed|hydrolysed feed
68060|NCT03140371|Semi-elemental feed|semi-elemental feed
68061|NCT03140345|Hemodialysis|hemodialysis
68062|NCT03140345|Microcirculation|microcirculation
68063|NCT03140345|Traditional Chinese Medicine|traditional chinese medicine
68064|NCT03140345|Hemodialysis vascular access|hemodialysis vascular access
68065|NCT03140319|Fibroblast|fibroblast
68066|NCT03140319|Cell transplantation|cell transplantation
68067|NCT03140306|Computed tomography|computed tomography
68068|NCT03140306|Model based iterative reconstruction|model based iterative reconstruction
68069|NCT03140306|Low dose CT|low dose ct
68070|NCT03140293|Chorionic villus sampling|chorionic villus sampling
68071|NCT03140293|Pain|pain
68072|NCT03140293|Anxiety|anxiety
68073|NCT03140280|Black raspberries|black raspberries
68074|NCT03140280|MDS|mds
68075|NCT03140280|Myelodysplastic Syndromes|myelodysplastic syndromes
68076|NCT03140280|hypomethylating effects|hypomethylating effects
68077|NCT03140280|chemopreventive agent|chemopreventive agent
68078|NCT03140280|BRB|brb
68079|NCT03140280|pharmokinetics|pharmokinetics
68080|NCT03140267|Ventilated induced diaphragmatic dysfunction|ventilated induced diaphragmatic dysfunction
68081|NCT03140267|Weaning|weaning
68082|NCT03140267|Inspiratory muscle training|inspiratory muscle training
68083|NCT03140215|Baska|baska
68084|NCT03140215|seal pressure|seal pressure
68085|NCT03140215|I-Gel|i-gel
68086|NCT03140215|Supraglottic airway device|supraglottic airway device
68087|NCT03140189|Esophageal cancer|esophageal cancer
68088|NCT03140189|Robotic|robotic
68089|NCT03140189|Ivor-Lewis esophagectomy|ivor-lewis esophagectomy
68090|NCT03140176|Sunitinib|sunitinib
68091|NCT03140176|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
68092|NCT03140176|Africa Middle East|africa middle east
68093|NCT03140098|Collagen membrane|collagen membrane
68094|NCT03140098|Cardiac surgery|cardiac surgery
68095|NCT03140098|Postoperative complication|postoperative complication
68096|NCT03140072|Asthma, Single Ascending Dose (SAD), Multiple Ascending Dose (MAD), AZD9898|asthma, single ascending dose (sad), multiple ascending dose (mad), azd9898
68097|NCT03140059|surgical procedure|surgical procedure
68098|NCT03140059|residual pockets|residual pockets
68099|NCT03140059|agressive periodontitis|agressive periodontitis
68100|NCT03140059|antimicrobial photodynamic therapy|antimicrobial photodynamic therapy
68101|NCT03140020|aneurysm|aneurysm
68102|NCT03140020|cognition|cognition
68103|NCT03140020|functional connectivity|functional connectivity
68104|NCT03140020|frontal lobe function|frontal lobe function
68105|NCT03140020|neuropsychological testing|neuropsychological testing
68106|NCT03140020|coiling|coiling
68107|NCT03140020|clipping|clipping
68108|NCT03140007|ERCP|ercp
68109|NCT03140007|cholangioscopy|cholangioscopy
68110|NCT03139994|occlusion|occlusion
68111|NCT03139994|pain|pain
68112|NCT03139981|eczema|eczema
68113|NCT03139955|Feasibility Study|feasibility study
68114|NCT03139955|Pre/Post-Operative Patient Monitoring|pre/post-operative patient monitoring
68115|NCT03139955|Continuous Patient Monitoring|continuous patient monitoring
68116|NCT03139955|Patient Deterioration Identification|patient deterioration identification
68117|NCT03139955|Bodytrak|bodytrak
68118|NCT03139955|National Early Warning System|national early warning system
68119|NCT03139955|Patient Safety|patient safety
68120|NCT03139942|Endoscopy|endoscopy
68121|NCT03139942|Colonoscopy|colonoscopy
68122|NCT03139942|Hyperspectral imaging|hyperspectral imaging
68123|NCT03139942|Tissue classification|tissue classification
68124|NCT03139942|Tissue autofluorescence|tissue autofluorescence
68125|NCT03139942|Advanced imaging techniques|advanced imaging techniques
68126|NCT03139916|Glioblastoma|glioblastoma
68127|NCT03139903|Seckel Syndrome|seckel syndrome
68128|NCT03139903|Microcephalic Osteodysplastic Primordial Dwarfism Type II|microcephalic osteodysplastic primordial dwarfism type ii
68129|NCT03139864|Type 1 diabetes|type 1 diabetes
68130|NCT03139864|Control|control
68131|NCT03139864|Physical activity|physical activity
68132|NCT03139864|Substrate utilization|substrate utilization
68133|NCT03139864|Hormonal regulation|hormonal regulation
68134|NCT03139851|Solid tumor|solid tumor
68135|NCT03139851|Breast cancer|breast cancer
68136|NCT03139851|Metastatic cancer|metastatic cancer
68137|NCT03139851|Pembrolizumab|pembrolizumab
68138|NCT03139851|Metronomic cyclophosphamide|metronomic cyclophosphamide
68139|NCT03139838|Palliative Care|palliative care
68140|NCT03139838|Pragmatic Clinical Trial|pragmatic clinical trial
68141|NCT03139838|Electronic Health Records|electronic health records
68142|NCT03139838|Economics, Behavioral|economics, behavioral
68143|NCT03139812|continuous contact lens wear|continuous contact lens wear
68144|NCT03139812|silicone hydrogel contact lenses|silicone hydrogel contact lenses
68145|NCT03139812|irrigation|irrigation
68146|NCT03139812|corneal epithelial permeability|corneal epithelial permeability
68147|NCT03139812|contact lens-related adverse events|contact lens-related adverse events
68148|NCT03139734|Sacral Nerve Modulation|sacral nerve modulation
68149|NCT03139708|Mydriasis|mydriasis
68150|NCT03139708|Cycloplegics|cycloplegics
68151|NCT03139630|HIV, Dyslipidemia|hiv, dyslipidemia
68152|NCT03139630|Dyslipidemia|dyslipidemia
68153|NCT03139630|Protease Inhibitor|protease inhibitor
68154|NCT03139630|Ritonavir|ritonavir
68155|NCT03139630|PCSK9|pcsk9
68156|NCT03139630|Observational|observational
68157|NCT03139617|Fascia Iliaca Block|fascia iliaca block
68158|NCT03139617|Femoral 3-in-1 block|femoral 3-in-1 block
68159|NCT03139617|Fracture femur|fracture femur
68160|NCT03139617|Spinal anesthesia|spinal anesthesia
68161|NCT03139604|Acute graft-versus-host disease|acute graft-versus-host disease
68162|NCT03139604|Janus kinase (JAK) inhibitor|janus kinase (jak) inhibitor
68163|NCT03139604|itacitinib|itacitinib
68164|NCT03139604|corticosteroids|corticosteroids
68165|NCT03139604|allogeneic hematopoietic stem cell transplant (allo-HSCT)|allogeneic hematopoietic stem cell transplant (allo-hsct)
68166|NCT03139565|Influenza|influenza
68167|NCT03139565|Solid Organ Transplant|solid organ transplant
68168|NCT03139565|Infection|infection
68169|NCT03139565|Vaccine|vaccine
68170|NCT03139565|Immunogenicity|immunogenicity
68171|NCT03139552|Taste Test|taste test
68172|NCT03139552|Spices|spices
68173|NCT03139552|Reduced sugar|reduced sugar
68174|NCT03139552|Food liking|food liking
68175|NCT03139526|Craniopharyngioma|craniopharyngioma
68176|NCT03139526|Children|children
68177|NCT03139526|Social participation|social participation
68178|NCT03139526|Life-H questionnaire|life-h questionnaire
68179|NCT03139487|Anticoagulant Adverse Reaction|anticoagulant adverse reaction
68180|NCT03139487|Cancer-associated Thrombosis|cancer-associated thrombosis
68181|NCT03139487|Low molecular weight heparin|low molecular weight heparin
68182|NCT03139487|Direct oral anticoagulant|direct oral anticoagulant
68183|NCT03139461|Physical Therapy|physical therapy
68184|NCT03139461|Capacity Building|capacity building
68185|NCT03139461|Clinical-Community Linkages|clinical-community linkages
68186|NCT03139396|inlay bridge, tub shaped design|inlay bridge, tub shaped design
68187|NCT03139383|postoperative nausea|postoperative nausea
68188|NCT03139383|postoperative vomiting|postoperative vomiting
68189|NCT03139383|gynecologic laparoscopic surgery|gynecologic laparoscopic surgery
68190|NCT03139344|metabolism|metabolism
68191|NCT03139344|exercise|exercise
68192|NCT03139344|glucose|glucose
68193|NCT03139344|secondary health conditions|secondary health conditions
68194|NCT03139344|quality of life|quality of life
68195|NCT03139305|glucagon|glucagon
68196|NCT03139266|cystic fibrosis|cystic fibrosis
68197|NCT03139266|mindfulness|mindfulness
68198|NCT03139266|cognitive behavioral therapy|cognitive behavioral therapy
68199|NCT03139266|UPLIFT|uplift
68200|NCT03139266|anxiety|anxiety
68201|NCT03139266|depression|depression
68202|NCT03139266|web based intervention|web based intervention
68203|NCT03139253|Helicobacter Pylori Infection|helicobacter pylori infection
68204|NCT03139253|Antimicrobial susceptibility testing (AST)|antimicrobial susceptibility testing (ast)
68205|NCT03139253|Triple Therapy|triple therapy
68206|NCT03139201|silicone hydrogel soft contact lens|silicone hydrogel soft contact lens
68207|NCT03139188|Cancer|cancer
68208|NCT03139188|incurable pathologies|incurable pathologies
68209|NCT03139188|palliative care|palliative care
68210|NCT03139162|Home Care Services|home care services
68211|NCT03139162|Aging|aging
68212|NCT03139162|Frailty|frailty
68213|NCT03139162|Complexity|complexity
68214|NCT03139162|Nursing|nursing
68215|NCT03139149|conservative treatment|conservative treatment
68216|NCT03139149|laparoscopic adhesiolysis|laparoscopic adhesiolysis
68217|NCT03139149|strangulation|strangulation
68218|NCT03139071|coffee consumption|coffee consumption
68219|NCT03139071|cardiovascular diseases|cardiovascular diseases
68220|NCT03139071|coronary artery calcium|coronary artery calcium
68221|NCT03139071|subclinical atherosclerosis|subclinical atherosclerosis
68222|NCT03139019|Diabetes prevention|diabetes prevention
68223|NCT03139019|Weight loss|weight loss
68224|NCT03139019|Lifestyle change|lifestyle change
68225|NCT03138967|Malignant neoplasms of urinary tract|malignant neoplasms of urinary tract
68226|NCT03138967|Bladder cancer|bladder cancer
68227|NCT03138967|Outpatient bladder procedures|outpatient bladder procedures
68228|NCT03138967|Outpatient cystoscopy procedure|outpatient cystoscopy procedure
68229|NCT03138967|Transurethral resection of the bladder|transurethral resection of the bladder
68230|NCT03138967|TURB|turb
68231|NCT03138967|Rocuronium|rocuronium
68232|NCT03138967|Rocuronium Bromide|rocuronium bromide
68233|NCT03138967|Zemuron|zemuron
68234|NCT03138967|Sugammadex|sugammadex
68235|NCT03138967|Neostigmine|neostigmine
68236|NCT03138967|Glycopyrrolate|glycopyrrolate
68237|NCT03138928|glaucoma|glaucoma
68238|NCT03138928|trabeculectomy|trabeculectomy
68239|NCT03138928|minimally invasive glaucoma surgery|minimally invasive glaucoma surgery
68240|NCT03138928|XEN45 gel stent|xen45 gel stent
68241|NCT03138915|clinically significant portal hypertension|clinically significant portal hypertension
68242|NCT03138915|hepatic venous pressure gradient|hepatic venous pressure gradient
68243|NCT03138915|radiomics|radiomics
68244|NCT03138889|NKTR-214|nktr-214
68245|NCT03138889|Atezolizumab|atezolizumab
68246|NCT03138889|Tecentriq®|tecentriq®
68247|NCT03138889|Metastatic Urothelial Bladder Cancer|metastatic urothelial bladder cancer
68248|NCT03138889|Metastatic Non-Small Cell Lung Cancer|metastatic non-small cell lung cancer
68249|NCT03138889|Pembrolizumab|pembrolizumab
68250|NCT03138889|Keytruda®|keytruda®
68251|NCT03138889|Melanoma|melanoma
68252|NCT03138889|Bladder|bladder
68253|NCT03138889|NSCLC|nsclc
68254|NCT03138850|intravenous sedation|intravenous sedation
68255|NCT03138850|esophagogastroduodenalscopy|esophagogastroduodenalscopy
68256|NCT03138850|upper airway|upper airway
68257|NCT03138850|mandibular advancement device|mandibular advancement device
68258|NCT03138850|high flow nasal cannula|high flow nasal cannula
68259|NCT03138837|Bladder cancer|bladder cancer
68260|NCT03138837|Magnetic Resonance Imaging|magnetic resonance imaging
68261|NCT03138837|Bladder Cancer Superficial|bladder cancer superficial
68262|NCT03138824|Bladder Urothelial Carcinoma|bladder urothelial carcinoma
68263|NCT03138824|TURBT|turbt
68264|NCT03138824|Recurrence|recurrence
68265|NCT03138824|Progression|progression
68266|NCT03138811|asthma|asthma
68267|NCT03138811|allergen bronchoprovocation|allergen bronchoprovocation
68268|NCT03138811|pharmacodynamics|pharmacodynamics
68269|NCT03138811|pharmacokinetics|pharmacokinetics
68270|NCT03138811|safety|safety
68271|NCT03138811|tolerability|tolerability
68272|NCT03138798|Labor|labor
68273|NCT03138798|Second stage|second stage
68274|NCT03138798|Dental device|dental device
68275|NCT03138746|hyperbaric oxygenation|hyperbaric oxygenation
68276|NCT03138746|insulin sensitivity|insulin sensitivity
68277|NCT03138746|human|human
68278|NCT03138746|inflammation|inflammation
68279|NCT03138655|Drug therapy|drug therapy
68280|NCT03138642|mucosal melanoma|mucosal melanoma
68281|NCT03138642|radiotherapy|radiotherapy
68282|NCT03138616|Gestational diabetes mellitus|gestational diabetes mellitus
68283|NCT03138616|vitamin D|vitamin d
68284|NCT03138616|postpartum|postpartum
68285|NCT03138603|surgery|surgery
68286|NCT03138603|heart disease|heart disease
68287|NCT03138603|metoprolol|metoprolol
68288|NCT03138603|myocardial injury|myocardial injury
68289|NCT03138590|transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
68290|NCT03138590|accelerate learning|accelerate learning
68291|NCT03138590|memory|memory
68292|NCT03138564|Nursing|nursing
68293|NCT03138564|Nephrology|nephrology
68294|NCT03138564|Behavioral Research|behavioral research
68295|NCT03138564|Social Research|social research
68296|NCT03138551|Sensory Food Aversions|sensory food aversions
68297|NCT03138538|Advanced Solid Tumors|advanced solid tumors
68298|NCT03138538|M8891|m8891
68299|NCT03138538|Methionine Aminopeptidase 2 Inhibitor|methionine aminopeptidase 2 inhibitor
68300|NCT03138512|localized; resected; adjuvant|localized; resected; adjuvant
68301|NCT03138473|SYNTAX Score|syntax score
68302|NCT03138473|residual SYNTAX score|residual syntax score
68303|NCT03138473|SYNTAX Revascularization Index|syntax revascularization index
68304|NCT03138447|insulin|insulin
68305|NCT03138447|basal|basal
68306|NCT03138447|titration|titration
68307|NCT03138447|digital health|digital health
68308|NCT03138434|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
68309|NCT03138434|4D flow MRI|4d flow mri
68310|NCT03138434|DCE-MRI|dce-mri
68311|NCT03138434|T1 and T2 mapping|t1 and t2 mapping
68312|NCT03138408|Cancer|cancer
68313|NCT03138408|Solid tumor cancers|solid tumor cancers
68314|NCT03138408|Ovarian cancer|ovarian cancer
68315|NCT03138408|Endometrial cancer|endometrial cancer
68316|NCT03138408|SC-004|sc-004
68317|NCT03138408|Maximum tolerated dose (MTD)|maximum tolerated dose (mtd)
68318|NCT03138395|acute myeloid leukemia|acute myeloid leukemia
68319|NCT03138395|myelodysplastic syndrome|myelodysplastic syndrome
68320|NCT03138395|relapse|relapse
68321|NCT03138395|PCR|pcr
68322|NCT03138395|droplet digital|droplet digital
68323|NCT03138395|polymerase chain reaction|polymerase chain reaction
68324|NCT03138382|obesity|obesity
68325|NCT03138382|metabolic syndrome|metabolic syndrome
68326|NCT03138369|Obesity|obesity
68327|NCT03138369|Metabolic Syndrome|metabolic syndrome
68328|NCT03138369|Prediabetes|prediabetes
68329|NCT03138369|Glycemic control|glycemic control
68330|NCT03138369|Hypercholesterolemia|hypercholesterolemia
68331|NCT03138369|Abdominal obesity|abdominal obesity
68332|NCT03138369|Weight Loss|weight loss
68333|NCT03138356|Type 2 diabetes mellitus, saxagliptin, dapagliflozin, metformin XR, fixed-dose combination, healthy subjects, crossover, cohorts.|type 2 diabetes mellitus, saxagliptin, dapagliflozin, metformin xr, fixed-dose combination, healthy subjects, crossover, cohorts.
68334|NCT03138304|decision making|decision making
68335|NCT03138304|heuristics|heuristics
68336|NCT03138226|uterus, transplantation, infertility, twin|uterus, transplantation, infertility, twin
68337|NCT03138213|pancreaticoduodenectomy|pancreaticoduodenectomy
68338|NCT03138213|surgical outcome|surgical outcome
68339|NCT03138200|Transfusion|transfusion
68340|NCT03138200|ScvO2|scvo2
68341|NCT03138200|Hemoglobin|hemoglobin
68342|NCT03138187|spontaneous physical activity|spontaneous physical activity
68343|NCT03138187|caloric intake|caloric intake
68344|NCT03138174|Blood Glucose Monitor System Accuracy|blood glucose monitor system accuracy
68345|NCT03138161|cancer immunotherapy, combination chemo-/immunotherapy|cancer immunotherapy, combination chemo-/immunotherapy
68346|NCT03138148|intensive care|intensive care
68347|NCT03138135|PrEP|prep
68348|NCT03138135|HIV prevention|hiv prevention
68349|NCT03138135|Risk reduction|risk reduction
68350|NCT03138135|STI prevention|sti prevention
68351|NCT03138135|Home HIV testing|home hiv testing
68352|NCT03138135|HIV testing|hiv testing
68353|NCT03138135|STI testing|sti testing
68354|NCT03138109|non-cardiac surgery|non-cardiac surgery
68355|NCT03138109|major adverse cardiac event|major adverse cardiac event
68356|NCT03138083|Mesenchymal-epithelial transition factor (MET) inhibitor|mesenchymal-epithelial transition factor (met) inhibitor
68357|NCT03138044|Hepatocellular Carcinoma|hepatocellular carcinoma
68358|NCT03138044|Ipsilateral Liver Lobe Devascularization|ipsilateral liver lobe devascularization
68359|NCT03138044|Alcohol Treatment|alcohol treatment
68360|NCT03138044|CILDAT|cildat
68361|NCT03138031|Percutaneuos Ethanol alcohol injection|percutaneuos ethanol alcohol injection
68362|NCT03138005|Emergency Care, Prehospital|emergency care, prehospital
68363|NCT03138005|Resuscitation|resuscitation
68364|NCT03138005|Oxygen|oxygen
68365|NCT03138005|Cardiac Arrest|cardiac arrest
68366|NCT03138005|Heart Arrest|heart arrest
68367|NCT03137992|COPD|copd
68368|NCT03137979|Periodontitis|periodontitis
68369|NCT03137979|Gingiva mesenchymal stem cells|gingiva mesenchymal stem cells
68370|NCT03137966|Diabetes mellitus, foot ulcer, deferoxamine|diabetes mellitus, foot ulcer, deferoxamine
68371|NCT03137940|Unilateral Cerebral Palsy|unilateral cerebral palsy
68372|NCT03137940|tDCS|tdcs
68373|NCT03137940|Safety|safety
68374|NCT03137940|Upper Limb functions|upper limb functions
68375|NCT03137927|bordetella pertussis|bordetella pertussis
68376|NCT03137927|vaccine|vaccine
68377|NCT03137927|Immunologic Factors|immunologic factors
68378|NCT03137927|whooping cough|whooping cough
68379|NCT03137914|orthognathic surgery|orthognathic surgery
68380|NCT03137914|TMJ|tmj
68381|NCT03137914|osteoarthritis|osteoarthritis
68382|NCT03137875|Tuberculosis|tuberculosis
68383|NCT03137875|TB|tb
68384|NCT03137875|MDR-TB|mdr-tb
68385|NCT03137875|LIPA|lipa
68386|NCT03137875|filter paper|filter paper
68387|NCT03137875|slides|slides
68388|NCT03137875|MTBDR Plus|mtbdr plus
68389|NCT03137849|Yoga|yoga
68390|NCT03137849|Hypertension|hypertension
68391|NCT03137849|Post-Menopausal Women|post-menopausal women
68392|NCT03137849|Heart Rate Variability|heart rate variability
68393|NCT03137823|diagnosis, tonsillitis, streptococcus, GABHS|diagnosis, tonsillitis, streptococcus, gabhs
68394|NCT03137784|asthma,|asthma,
68395|NCT03137784|NVA237,|nva237,
68396|NCT03137784|glycopyrronium bromide|glycopyrronium bromide
68397|NCT03137784|allergic asthma,|allergic asthma,
68398|NCT03137784|allergy triggered asthma,|allergy triggered asthma,
68399|NCT03137784|reactive asthma,|reactive asthma,
68400|NCT03137784|asthma attack,|asthma attack,
68401|NCT03137784|difficulty breathing|difficulty breathing
68402|NCT03137745|Thromboelastography, chemotherapy,hyperthermic|thromboelastography, chemotherapy,hyperthermic
68403|NCT03137693|histologically proven|histologically proven
68404|NCT03137693|invasive adenocarcinoma of breast|invasive adenocarcinoma of breast
68405|NCT03137693|node negative (N0)|node negative (n0)
68406|NCT03137693|breast-conserving surgery|breast-conserving surgery
68407|NCT03137693|negative for Her-2 amplification|negative for her-2 amplification
68408|NCT03137693|estrogen receptor (ER) positive|estrogen receptor (er) positive
68409|NCT03137693|progesterone receptor (PR) positive|progesterone receptor (pr) positive
68410|NCT03137680|Arteriovenous Fistula|arteriovenous fistula
68411|NCT03137680|Pre-operative Exercise|pre-operative exercise
68412|NCT03137680|Fistula Maturation|fistula maturation
68413|NCT03137667|Influenza Vaccination Rates|influenza vaccination rates
68414|NCT03137654|Cognitive Training|cognitive training
68415|NCT03137654|Emotion Processing|emotion processing
68416|NCT03137641|occupational exposure|occupational exposure
68417|NCT03137641|antineoplastic drugs|antineoplastic drugs
68418|NCT03137641|biomonitoring|biomonitoring
68419|NCT03137628|general anesthesia,mechanical ventilation,colectomy|general anesthesia,mechanical ventilation,colectomy
68420|NCT03137589|Telemedicine|telemedicine
68421|NCT03137576|Awake Thoracic Surgery, Erector Spinae Plane Block|awake thoracic surgery, erector spinae plane block
68422|NCT03137563|Women|women
68423|NCT03137563|25-65 years|25-65 years
68424|NCT03137537|Lymphoma|lymphoma
68425|NCT03137537|Abnormal resting heart rate|abnormal resting heart rate
68426|NCT03137537|Autonomic imbalance|autonomic imbalance
68427|NCT03137537|Cancer survivorship|cancer survivorship
68428|NCT03137524|Fan or Air Therapy|fan or air therapy
68429|NCT03137511|Public Health|public health
68430|NCT03137511|General Medicine|general medicine
68431|NCT03137511|Dermatology|dermatology
68432|NCT03137498|renal colic|renal colic
68433|NCT03137498|lidocaine|lidocaine
68434|NCT03137498|ketorolac|ketorolac
68435|NCT03137498|acute pain|acute pain
68436|NCT03137472|TMS, CRPS, Sham|tms, crps, sham
68437|NCT03137459|Transtheoretical Model (TTM)|transtheoretical model (ttm)
68438|NCT03137446|Intravenous fluid resuscitation|intravenous fluid resuscitation
68439|NCT03137446|Septic shock|septic shock
68440|NCT03137446|Severe sepsis|severe sepsis
68441|NCT03137446|Fluid restriction|fluid restriction
68442|NCT03137433|Weight loss|weight loss
68443|NCT03137433|Cardiometabolic|cardiometabolic
68444|NCT03137433|Meal-replacement therapy|meal-replacement therapy
68445|NCT03137407|heel pain|heel pain
68446|NCT03137394|spinal cord injury|spinal cord injury
68447|NCT03137394|shoulder pain|shoulder pain
68448|NCT03137394|psychosocial|psychosocial
68449|NCT03137368|ovarian function suppression/ablation|ovarian function suppression/ablation
68450|NCT03137368|breast cancer|breast cancer
68451|NCT03137368|Exemestane|exemestane
68452|NCT03137368|Tamoxifen|tamoxifen
68453|NCT03137368|CYP2D6*10 mutations|cyp2d6*10 mutations
68454|NCT03137355|Leigh Syndrome|leigh syndrome
68455|NCT03137355|Leigh Disease|leigh disease
68456|NCT03137355|Leigh's Necrotizing Encephalopathy|leigh's necrotizing encephalopathy
68457|NCT03137355|Subacute Necrotizing Encephalomyelopathy|subacute necrotizing encephalomyelopathy
68458|NCT03137355|Subacute Necrotizing Encephalomyopathy|subacute necrotizing encephalomyopathy
68459|NCT03137342|PrEP|prep
68460|NCT03137342|Adherence|adherence
68461|NCT03137342|Risk Reduction|risk reduction
68462|NCT03137342|Stimulant Use|stimulant use
68463|NCT03137290|Paediatric general anaesthesia|paediatric general anaesthesia
68464|NCT03137290|Rocuronium|rocuronium
68465|NCT03137290|Neostigmine|neostigmine
68466|NCT03137290|Sugammadex|sugammadex
68467|NCT03137277|Colonoscopy|colonoscopy
68468|NCT03137277|ADR|adr
68469|NCT03137277|Adenoma detection rate|adenoma detection rate
68470|NCT03137277|colonoscopic imaging feature improvement|colonoscopic imaging feature improvement
68471|NCT03137277|Olympus colonoscopes|olympus colonoscopes
68472|NCT03137264|T790M mutation|t790m mutation
68473|NCT03137264|EGFR epidermal growth factor receptor|egfr epidermal growth factor receptor
68474|NCT03137264|non-invasive testing|non-invasive testing
68475|NCT03137264|lung cancer|lung cancer
68476|NCT03137251|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
68477|NCT03137251|TENS|tens
68478|NCT03137251|Analgesia|analgesia
68479|NCT03137251|Labour pain|labour pain
68480|NCT03137251|Physical therapy modality|physical therapy modality
68481|NCT03137238|Self-motion perception|self-motion perception
68482|NCT03137238|Optic flow|optic flow
68483|NCT03137238|Vestibular system|vestibular system
68484|NCT03137238|Multisensory integration|multisensory integration
68485|NCT03137238|Parkinson's disease|parkinson's disease
68486|NCT03137212|Percutaneous Coronary Intervention|percutaneous coronary intervention
68487|NCT03137212|STEMI|stemi
68488|NCT03137212|Thrombosis|thrombosis
68489|NCT03137199|stem cell|stem cell
68490|NCT03137199|mesenchymal stem cell|mesenchymal stem cell
68491|NCT03137199|lung|lung
68492|NCT03137199|asthma|asthma
68493|NCT03137186|Metformin, prostate cancer|metformin, prostate cancer
68494|NCT03137147|pediatric|pediatric
68495|NCT03137147|children|children
68496|NCT03137147|adolescent|adolescent
68497|NCT03137147|sleep|sleep
68498|NCT03137147|pain|pain
68499|NCT03137147|cognitive-behavioral therapy|cognitive-behavioral therapy
68500|NCT03137121|nausea|nausea
68501|NCT03137121|vomiting|vomiting
68502|NCT03137121|olanzapine|olanzapine
68503|NCT03137082|Alcohol Use Disorder|alcohol use disorder
68504|NCT03137082|Guanfacine|guanfacine
68505|NCT03137082|Stress|stress
68506|NCT03137082|Craving|craving
68507|NCT03137082|Gender|gender
68508|NCT03137082|Relapse|relapse
68509|NCT03137056|Hemodialysis|hemodialysis
68510|NCT03137056|Membrane|membrane
68511|NCT03137056|Albumin|albumin
68512|NCT03137056|Proteomics|proteomics
68513|NCT03137043|GINA guidelines|gina guidelines
68514|NCT03137043|Prevalence|prevalence
68515|NCT03137043|Mepolizumab|mepolizumab
68516|NCT03137043|severe asthma|severe asthma
68517|NCT03137043|Spain|spain
68518|NCT03137030|Abuse deterrent formulation|abuse deterrent formulation
68519|NCT03137030|Hydrocodone|hydrocodone
68520|NCT03137030|Analgesics, Opioid|analgesics, opioid
68521|NCT03137030|Narcotics|narcotics
68522|NCT03137017|Abuse deterrent formulation|abuse deterrent formulation
68523|NCT03137017|Hydrocodone|hydrocodone
68524|NCT03137017|Analgesics, Opioid|analgesics, opioid
68525|NCT03137017|Narcotics|narcotics
68526|NCT03136991|Oral myeloperoxidase inhibitor|oral myeloperoxidase inhibitor
68527|NCT03136978|Macrophages|macrophages
68528|NCT03136978|Macrophages, Peritoneal|macrophages, peritoneal
68529|NCT03136978|Endometriosis|endometriosis
68530|NCT03136952|NIRS|nirs
68531|NCT03136952|Monitoring|monitoring
68532|NCT03136952|Pediatric|pediatric
68533|NCT03136874|donors|donors
68534|NCT03136874|gametes|gametes
68535|NCT03136874|motivation|motivation
68536|NCT03136874|psychological|psychological
68537|NCT03136861|axial spondyloarthritis|axial spondyloarthritis
68538|NCT03136861|ankylosing spondylitis|ankylosing spondylitis
68539|NCT03136861|non-radiographic axial spondyloarthritis|non-radiographic axial spondyloarthritis
68540|NCT03136861|inflammatory back pain|inflammatory back pain
68541|NCT03136861|spinal pain|spinal pain
68542|NCT03136861|secukinumab|secukinumab
68543|NCT03136861|AIN457|ain457
68544|NCT03136848|perfusion|perfusion
68545|NCT03136822|Diabetic Foot|diabetic foot
68546|NCT03136744|Sedentary behaviour|sedentary behaviour
68547|NCT03136744|Co-morbidity|co-morbidity
68548|NCT03136744|Intervention|intervention
68549|NCT03136731|Celiac disease, Gluten, Microbiome, Genetic|celiac disease, gluten, microbiome, genetic
68550|NCT03136718|mHealth|mhealth
68551|NCT03136718|Hearing aids|hearing aids
68552|NCT03136718|Auditory rehabilitation|auditory rehabilitation
68553|NCT03136718|Adult|adult
68554|NCT03136718|Reusable Learning Object|reusable learning object
68555|NCT03136718|Education|education
68556|NCT03136718|Personalised|personalised
68557|NCT03136718|Telehealth|telehealth
68558|NCT03136718|Teleaudiology|teleaudiology
68559|NCT03136705|Phosphorus Homeostasis|phosphorus homeostasis
68560|NCT03136705|FGF23|fgf23
68561|NCT03136705|Vitamin D|vitamin d
68562|NCT03136692|app|app
68563|NCT03136692|weight loss|weight loss
68564|NCT03136692|diet|diet
68565|NCT03136692|behavior|behavior
68566|NCT03136653|DARPin|darpin
68567|NCT03136653|MP0250|mp0250
68568|NCT03136653|VEGF|vegf
68569|NCT03136653|HGF|hgf
68570|NCT03136653|RRMM|rrmm
68828|NCT03134937|Gastric Distension|gastric distension
68571|NCT03136627|RCC, Tivozanib, Nivolumab, Metastatic Renal Cell Cancer|rcc, tivozanib, nivolumab, metastatic renal cell cancer
68572|NCT03136588|Information and Communication Technology|information and communication technology
68573|NCT03136588|Adherence|adherence
68574|NCT03136588|Kidney transplantation|kidney transplantation
68575|NCT03136523|NSCLC|nsclc
68576|NCT03136523|SCLC|sclc
68577|NCT03136523|MOLECULAR BIOMARKERS|molecular biomarkers
68578|NCT03136523|EGFR|egfr
68579|NCT03136523|PD-L1|pd-l1
68580|NCT03136523|ALK|alk
68581|NCT03136523|KRAS|kras
68582|NCT03136458|contrast media|contrast media
68583|NCT03136458|nephropathy|nephropathy
68584|NCT03136458|ischemic preconditioning|ischemic preconditioning
68585|NCT03136445|Tranexamic acid|tranexamic acid
68586|NCT03136445|Platelet transfusion|platelet transfusion
68587|NCT03136432|Cerebral Palsy|cerebral palsy
68588|NCT03136432|Functional Exercise Capacity|functional exercise capacity
68589|NCT03136432|Quality of Life|quality of life
68590|NCT03136419|microbiota|microbiota
68591|NCT03136419|innate immunity|innate immunity
68592|NCT03136393|nutrition|nutrition
68593|NCT03136393|pregnancy|pregnancy
68594|NCT03136393|birth weight|birth weight
68595|NCT03136380|healthy Japanese subjects|healthy japanese subjects
68596|NCT03136380|CXCR2 inhibitor|cxcr2 inhibitor
68597|NCT03136380|Danirixin|danirixin
68598|NCT03136367|encounter decision aids|encounter decision aids
68599|NCT03136367|shared decision making|shared decision making
68600|NCT03136367|socioeconomic status|socioeconomic status
68601|NCT03136367|disparities|disparities
68602|NCT03136367|decision quality|decision quality
68603|NCT03136341|Upper Limb|upper limb
68604|NCT03136341|Tremor|tremor
68605|NCT03136341|task-dependent|task-dependent
68606|NCT03136315|Renal failure|renal failure
68607|NCT03136315|athlete|athlete
68608|NCT03136315|ultra endurance|ultra endurance
68609|NCT03136263|Attention|attention
68610|NCT03136263|Attention deficit/hyperactivity disorder|attention deficit/hyperactivity disorder
68611|NCT03136263|Cognitive control|cognitive control
68612|NCT03136263|Executive control|executive control
68613|NCT03136263|Executive functions|executive functions
68614|NCT03136263|Impulse control|impulse control
68615|NCT03136263|Impulsivity|impulsivity
68616|NCT03136263|Oxytocin|oxytocin
68617|NCT03136250|Muscle Energy Techniques|muscle energy techniques
68618|NCT03136250|Autogenic Inhibition|autogenic inhibition
68619|NCT03136250|Reciprocal Inhibition|reciprocal inhibition
68620|NCT03136250|Stretching|stretching
68621|NCT03136250|Range of Motion|range of motion
68622|NCT03136250|Muscle Strength|muscle strength
68623|NCT03136250|VAS|vas
68624|NCT03136250|Neck Disability Index|neck disability index
68625|NCT03136250|NDI|ndi
68626|NCT03136224|circumcision|circumcision
68627|NCT03136224|Thermocautery|thermocautery
68628|NCT03136224|Clamp|clamp
68629|NCT03136224|Surgical Circumcision|surgical circumcision
68630|NCT03136198|Heart Failure|heart failure
68631|NCT03136198|Acute Heart Failure|acute heart failure
68632|NCT03136198|Pulmonary Edema|pulmonary edema
68633|NCT03136198|Lung ultrasound|lung ultrasound
68634|NCT03136198|Extra vascular lung water|extra vascular lung water
68635|NCT03136198|B-lines|b-lines
68636|NCT03136185|LSD1|lsd1
68637|NCT03136159|pregnancy|pregnancy
68638|NCT03136159|delivery|delivery
68639|NCT03136159|cesarean section|cesarean section
68640|NCT03136159|wound healing|wound healing
68641|NCT03136159|silver-containing dressing|silver-containing dressing
68642|NCT03136146|Hematopoietic/Lymphoid Cancer|hematopoietic/lymphoid cancer
68643|NCT03136146|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
68644|NCT03136146|ALL|all
68645|NCT03136146|Lymphoblastic Lymphoma|lymphoblastic lymphoma
68646|NCT03136146|LL|ll
68647|NCT03136146|Relapsed/Refractory|relapsed/refractory
68648|NCT03136146|Clofarabine|clofarabine
68649|NCT03136146|Clofarex|clofarex
68650|NCT03136146|Clolar|clolar
68651|NCT03136146|Etoposide|etoposide
68652|NCT03136146|VePesid|vepesid
68653|NCT03136146|Cyclophosphamide|cyclophosphamide
68654|NCT03136146|Cytoxan|cytoxan
68655|NCT03136146|Neosar|neosar
68656|NCT03136146|Liposomal Vincristine|liposomal vincristine
68657|NCT03136146|Vincristine Sulfate Liposomes Injection|vincristine sulfate liposomes injection
68658|NCT03136146|VSLI|vsli
68659|NCT03136146|Marqibo|marqibo
68660|NCT03136146|Bortezomib|bortezomib
68661|NCT03136146|Velcade|velcade
68662|NCT03136146|LDP-341|ldp-341
68663|NCT03136146|MLN341|mln341
68664|NCT03136146|PS-341|ps-341
68665|NCT03136146|Ofatumumab|ofatumumab
68666|NCT03136146|Arzerra|arzerra
68667|NCT03136146|Rituximab|rituximab
68668|NCT03136146|Rituxan|rituxan
68669|NCT03136146|Pegfilgrastim|pegfilgrastim
68670|NCT03136146|Neulasta|neulasta
68671|NCT03136146|PEG-G-CSF|peg-g-csf
68672|NCT03136120|Ipratropium bromide|ipratropium bromide
68673|NCT03136120|Cryobiopsy|cryobiopsy
68674|NCT03136120|TBCB|tbcb
68675|NCT03136120|IPF|ipf
68676|NCT03136120|Transbronchial cryobiopsy|transbronchial cryobiopsy
68677|NCT03136120|Interstitial lung disease|interstitial lung disease
68678|NCT03136094|American Indian|american indian
68679|NCT03136094|Alaska Native|alaska native
68680|NCT03136094|Youth and Young Adult|youth and young adult
68681|NCT03136094|SBIRT|sbirt
68682|NCT03136081|Septic shock|septic shock
68683|NCT03136081|Candidiasis|candidiasis
68684|NCT03136081|Candidemia|candidemia
68685|NCT03136081|Bacteremia|bacteremia
68686|NCT03136081|Immunoparalysis|immunoparalysis
68687|NCT03136055|NEC|nec
68688|NCT03136029|HFrEF|hfref
68689|NCT03136029|Exercise Intolerance|exercise intolerance
68690|NCT03136029|Nitric Oxide|nitric oxide
68691|NCT03135990|Virtual Reality|virtual reality
68692|NCT03135990|Exposure Therapy|exposure therapy
68693|NCT03135990|Cognitive Behavioral Therapy|cognitive behavioral therapy
68694|NCT03135990|Extinction Learning|extinction learning
68695|NCT03135964|NPWT|npwt
68696|NCT03135964|foam|foam
68697|NCT03135964|gauze|gauze
68698|NCT03135951|Breast Cancer|breast cancer
68699|NCT03135951|Pharmacokinetics|pharmacokinetics
68700|NCT03135951|Long-acting Myeloid Growth Factor|long-acting myeloid growth factor
68701|NCT03135951|Early Stage Breast Cancer|early stage breast cancer
68702|NCT03135951|Docetaxel + Cyclophosphamide (TC) Chemotherapy|docetaxel + cyclophosphamide (tc) chemotherapy
68703|NCT03135912|Tinea Pedis|tinea pedis
68704|NCT03135912|Athlete's Foot|athlete's foot
68705|NCT03135886|HIV|hiv
68706|NCT03135886|HIV Testing|hiv testing
68707|NCT03135886|Hepatitis C Virus Testing|hepatitis c virus testing
68708|NCT03135886|Opioid Use Disorder Treatment|opioid use disorder treatment
68709|NCT03135886|Substance Use Disorders Treatment|substance use disorders treatment
68710|NCT03135886|Hepatitis C Virus|hepatitis c virus
68711|NCT03135886|Practice Coaching|practice coaching
68712|NCT03135860|Inhaled Nitric Oxide|inhaled nitric oxide
68713|NCT03135860|COPD|copd
68714|NCT03135860|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
68715|NCT03135860|Idopathic Pulmonary Fibrosis|idopathic pulmonary fibrosis
68716|NCT03135860|Long Term Oxygen Therapy (LTOT)|long term oxygen therapy (ltot)
68717|NCT03135808|MRI|mri
68718|NCT03135808|Imaging,|imaging,
68719|NCT03135808|Anatomy|anatomy
68720|NCT03135808|Tissue|tissue
68721|NCT03135808|Colorectal|colorectal
68722|NCT03135808|Sigmoid|sigmoid
68723|NCT03135808|Colon|colon
68724|NCT03135808|Pathology|pathology
68725|NCT03135795|sufentanil|sufentanil
68726|NCT03135795|DNA methylation|dna methylation
68727|NCT03135769|avelumab|avelumab
68728|NCT03135769|PDL1|pdl1
68729|NCT03135769|Gestational Trophoblastic Neoplasias|gestational trophoblastic neoplasias
68730|NCT03135769|GTN|gtn
68731|NCT03135769|Hydatiform mole|hydatiform mole
68732|NCT03135769|hCG|hcg
68733|NCT03135717|Chronic kidney disease|chronic kidney disease
68734|NCT03135717|Enteral nutrition|enteral nutrition
68735|NCT03135717|Oral nutritional supplements|oral nutritional supplements
68736|NCT03135717|Parenteral nutrition|parenteral nutrition
68737|NCT03135717|Refeeding|refeeding
68738|NCT03135717|Wasting|wasting
68739|NCT03135652|Radiotherapy|radiotherapy
68740|NCT03135652|Colorectal Cancer|colorectal cancer
68741|NCT03135652|Liver Metastases|liver metastases
68742|NCT03135639|tACS|tacs
68743|NCT03135639|transcranial alternating current stimulation|transcranial alternating current stimulation
68744|NCT03135639|stimulation|stimulation
68745|NCT03135639|healthy control|healthy control
68746|NCT03135639|alpha oscillations|alpha oscillations
68747|NCT03135639|heart rate variability|heart rate variability
68748|NCT03135626|Pulpotomy|pulpotomy
68749|NCT03135626|Primary molars|primary molars
68750|NCT03135613|Knee tumor|knee tumor
68751|NCT03135613|Microwave|microwave
68752|NCT03135613|Gait|gait
68753|NCT03135600|Knee|knee
68754|NCT03135600|ACL Injury|acl injury
68755|NCT03135600|Kinematics|kinematics
68756|NCT03135587|Knee|knee
68757|NCT03135587|Loading|loading
68758|NCT03135587|Kinematics|kinematics
68759|NCT03135522|Chronic cough|chronic cough
68760|NCT03135522|Refractory cough|refractory cough
68761|NCT03135522|Chronic refractory cough|chronic refractory cough
68762|NCT03135522|Zinc|zinc
68763|NCT03135522|Zinc acetate|zinc acetate
68764|NCT03135509|Healthy Subjects|healthy subjects
68765|NCT03135509|CC-220 Capsules|cc-220 capsules
68766|NCT03135509|Relative Bioavailability|relative bioavailability
68767|NCT03135509|Phase 1|phase 1
68768|NCT03135470|pain|pain
68769|NCT03135470|ambulatory surgery|ambulatory surgery
68770|NCT03135470|oxycodone|oxycodone
68771|NCT03135470|adverse effect|adverse effect
68772|NCT03135444|Screening|screening
68773|NCT03135444|Shared Decision Making|shared decision making
68774|NCT03135418|Virtual Reality|virtual reality
68775|NCT03135392|Breast Cancer|breast cancer
68776|NCT03135392|sensation recovery|sensation recovery
68777|NCT03135392|Neurotization|neurotization
68778|NCT03135366|Tuberculosis|tuberculosis
68779|NCT03135366|TB|tb
68780|NCT03135366|Adherence|adherence
68781|NCT03135366|Mobile Health|mobile health
68782|NCT03135366|mHealth|mhealth
68783|NCT03135366|Behavior change|behavior change
68784|NCT03135366|Social and Behavior Change Communication (SBCC)|social and behavior change communication (sbcc)
68785|NCT03135366|Drug-Resistance|drug-resistance
68786|NCT03135366|Keheala|keheala
68787|NCT03135275|ST-elevation Myocardial Infarction|st-elevation myocardial infarction
68788|NCT03135275|Multivessel coronary disease|multivessel coronary disease
68789|NCT03135275|Immediate complete coronary revascularization|immediate complete coronary revascularization
68790|NCT03135275|Staged complete coronary revascularization|staged complete coronary revascularization
68791|NCT03135275|Percutaneous coronary intervention|percutaneous coronary intervention
68792|NCT03135275|Biodegradable-polymer everolimus-eluting stent|biodegradable-polymer everolimus-eluting stent
68793|NCT03135236|Parent training|parent training
68794|NCT03135236|Family education|family education
68795|NCT03135236|Young adults|young adults
68796|NCT03135236|Down syndrome|down syndrome
68797|NCT03135236|sexuality|sexuality
68798|NCT03135223|Physical activity|physical activity
68799|NCT03135145|Single Event Multilevel Lower Extremity Orthopedic Surgery (SEMLS)|single event multilevel lower extremity orthopedic surgery (semls)
68800|NCT03135145|Physical Therapy|physical therapy
68801|NCT03135145|Gait Training|gait training
68802|NCT03135145|Functional Walking|functional walking
68803|NCT03135145|Selective Dorsal Rhizotomy (SDR)|selective dorsal rhizotomy (sdr)
68804|NCT03135132|High visceral fat|high visceral fat
68805|NCT03135132|Low calorie diet|low calorie diet
68806|NCT03135132|Mild weight loss|mild weight loss
68807|NCT03135132|Metabolomics|metabolomics
68808|NCT03135132|Metabolites|metabolites
68809|NCT03135132|Acylcarnitines|acylcarnitines
68810|NCT03135093|synergies|synergies
68811|NCT03135093|upper limb|upper limb
68812|NCT03135093|vision|vision
68813|NCT03135067|HIV self-testing|hiv self-testing
68814|NCT03135067|female sex workers|female sex workers
68815|NCT03135067|partner testing|partner testing
68816|NCT03135067|couples testing|couples testing
68817|NCT03135067|transactional sex|transactional sex
68818|NCT03135054|FLT3-ITD (+) AML; Quizartinib, Omacetaxine mepesuccinate|flt3-itd (+) aml; quizartinib, omacetaxine mepesuccinate
68819|NCT03135041|Prebiotics|prebiotics
68820|NCT03135041|Microbiome|microbiome
68821|NCT03135041|Glucose metabolism|glucose metabolism
68822|NCT03134976|Salvage surgery|salvage surgery
68823|NCT03134976|Head and neck cancer|head and neck cancer
68824|NCT03134976|Wound healing|wound healing
68825|NCT03134976|Hypothyroidism|hypothyroidism
68826|NCT03134976|Levothyroxine|levothyroxine
68827|NCT03134937|Gastric Ultrasound|gastric ultrasound
68829|NCT03134937|Gastric Volume|gastric volume
68830|NCT03134937|Gastric Fluid Volume|gastric fluid volume
68831|NCT03134937|High-flow oxygen therapy|high-flow oxygen therapy
68832|NCT03134937|HFHHNO|hfhhno
68833|NCT03134937|Healthy volunteer|healthy volunteer
68834|NCT03134924|Bacterial Vaginosis|bacterial vaginosis
68835|NCT03134885|suicide|suicide
68836|NCT03134885|suicidal conducts|suicidal conducts
68837|NCT03134885|post discharge monitoring system|post discharge monitoring system
68838|NCT03134872|PD-1|pd-1
68839|NCT03134872|PD-L1|pd-l1
68840|NCT03134872|SHR-1210|shr-1210
68841|NCT03134872|Carboplatin|carboplatin
68842|NCT03134872|Pemetrexed|pemetrexed
68843|NCT03134859|motor development|motor development
68844|NCT03134846|Intraoperative fluorescence imaging|intraoperative fluorescence imaging
68845|NCT03134846|Cetuximab-IRDye800CW|cetuximab-irdye800cw
68846|NCT03134846|Molecular imaging|molecular imaging
68847|NCT03134833|HIV|hiv
68848|NCT03134833|STI|sti
68849|NCT03134833|Mental Health|mental health
68850|NCT03134833|Substance Use|substance use
68851|NCT03134833|Peer Support|peer support
68852|NCT03134820|Low molecular weight heparins|low molecular weight heparins
68853|NCT03134820|Procoagulants|procoagulants
68854|NCT03134820|Phospholipid-dependent Microparticles|phospholipid-dependent microparticles
68855|NCT03134794|neuroeconomics|neuroeconomics
68856|NCT03134794|multiple sclerosis|multiple sclerosis
68857|NCT03134794|educational intervention|educational intervention
68858|NCT03134794|traffic light system|traffic light system
68859|NCT03134794|aversion to ambiguity|aversion to ambiguity
68860|NCT03134794|risk|risk
68861|NCT03134794|outcomes|outcomes
68862|NCT03134794|knowledge|knowledge
68863|NCT03134794|action|action
68864|NCT03134794|gaps|gaps
68865|NCT03134794|disease modifying agents|disease modifying agents
68866|NCT03134755|Asthma|asthma
68867|NCT03134755|Children|children
68868|NCT03134755|Stress|stress
68869|NCT03134755|Puerto Rican|puerto rican
68870|NCT03134755|Health disparities|health disparities
68871|NCT03134755|Treatment response|treatment response
68872|NCT03134742|soft tissue sarcoma extremities|soft tissue sarcoma extremities
68873|NCT03134729|Serratus Block, Pain Management, lung lobectomy|serratus block, pain management, lung lobectomy
68874|NCT03134690|Poor ovarian response gonadotropins antagonist|poor ovarian response gonadotropins antagonist
68875|NCT03134677|Spinal anesthesia|spinal anesthesia
68876|NCT03134677|General anesthesia|general anesthesia
68877|NCT03134677|P wave dispersion|p wave dispersion
68878|NCT03134651|Anxiety|anxiety
68879|NCT03134651|Oocyte retrieval|oocyte retrieval
68880|NCT03134651|Monitoring of brain function|monitoring of brain function
68881|NCT03134625|metabolomics|metabolomics
68882|NCT03134625|biomarker|biomarker
68883|NCT03134625|acute rejection|acute rejection
68884|NCT03134612|lidocain|lidocain
68885|NCT03134612|ondansetron|ondansetron
68886|NCT03134612|pain|pain
68887|NCT03134612|propofol|propofol
68888|NCT03134586|Capsule endoscopy|capsule endoscopy
68889|NCT03134586|Crohn's disease|crohn's disease
68890|NCT03134586|Magnetic resonance enterography|magnetic resonance enterography
68891|NCT03134586|Ileocolonoscopy|ileocolonoscopy
68892|NCT03134586|Bowel Ultrasound|bowel ultrasound
68893|NCT03134586|diagnostic imaging|diagnostic imaging
68894|NCT03134573|Relapsing Remitting Multiple Sclerosis (RRMS),|relapsing remitting multiple sclerosis (rrms),
68895|NCT03134573|Clinically isolated Syndrome (CIS),|clinically isolated syndrome (cis),
68896|NCT03134573|Secondary Progressive Multiple Sclerosis (SPMS)|secondary progressive multiple sclerosis (spms)
68897|NCT03134560|vein display instrument|vein display instrument
68898|NCT03134560|pediatric|pediatric
68899|NCT03134560|vein access|vein access
68900|NCT03134560|vein cannulation|vein cannulation
68901|NCT03134547|emergence agitation|emergence agitation
68902|NCT03134547|sevoflurane|sevoflurane
68903|NCT03134547|children|children
68904|NCT03134534|lobectomy|lobectomy
68905|NCT03134534|robot-assisted thoracoscopic surgery|robot-assisted thoracoscopic surgery
68906|NCT03134534|lung cancer|lung cancer
68907|NCT03134521|bone and joint infection|bone and joint infection
68908|NCT03134521|daptomycin|daptomycin
68909|NCT03134521|population pharmacokinetics|population pharmacokinetics
68910|NCT03134521|Glycoprotein-P (PgP)|glycoprotein-p (pgp)
68911|NCT03134482|in vitro maturation (IVM)|in vitro maturation (ivm)
68912|NCT03134482|polycystic ovarian syndrome (PCOS)|polycystic ovarian syndrome (pcos)
68913|NCT03134482|ovarian hyperstimulation syndrome (OHSS)|ovarian hyperstimulation syndrome (ohss)
68914|NCT03134482|assisted reproductive technology (ART)|assisted reproductive technology (art)
68915|NCT03134430|Regional nerve block|regional nerve block
68916|NCT03134430|cancer recurrence|cancer recurrence
68917|NCT03134404|RAMP|ramp
68918|NCT03134404|Rapid Access|rapid access
68919|NCT03134404|Metastasis to Bone|metastasis to bone
68920|NCT03134404|Cancer|cancer
68921|NCT03134378|Helicobacter pylori|helicobacter pylori
68922|NCT03134378|triple therapy|triple therapy
68923|NCT03134378|eradication|eradication
68924|NCT03134365|meal ingestion|meal ingestion
68925|NCT03134365|palatability|palatability
68926|NCT03134365|postprandial responses|postprandial responses
68927|NCT03134365|hedonic response|hedonic response
68928|NCT03134352|subacute|subacute
68929|NCT03134339|nicotine, smoking|nicotine, smoking
68930|NCT03134209|Monocryl|monocryl
68931|NCT03134209|Dermabond|dermabond
68932|NCT03134209|Polyester mesh|polyester mesh
68933|NCT03134209|Joint Disease|joint disease
68934|NCT03134209|Arthropathy|arthropathy
68935|NCT03134209|Joint Replacement|joint replacement
68936|NCT03134196|Herpes Zoster Ophthalmicus|herpes zoster ophthalmicus
68937|NCT03134196|Zoster Eye Disease Study|zoster eye disease study
68938|NCT03134196|Varicella Zoster Virus|varicella zoster virus
68939|NCT03134196|Zoster|zoster
68940|NCT03134196|Shingles|shingles
68941|NCT03134183|D&E|d&e
68942|NCT03134183|dilation and evacuation|dilation and evacuation
68943|NCT03134183|abortion|abortion
68944|NCT03134183|second trimester|second trimester
68945|NCT03134183|mifepristone|mifepristone
68946|NCT03134183|misoprostol|misoprostol
68947|NCT03134170|pharmacist|pharmacist
68948|NCT03134170|diabetes|diabetes
68949|NCT03134170|Preventative Care|preventative care
68950|NCT03134170|Quality of Life|quality of life
68951|NCT03134157|Leiomyoma simvastatin infertility|leiomyoma simvastatin infertility
68952|NCT03134144|Exoskeleton|exoskeleton
68953|NCT03134144|Manual materials handling|manual materials handling
68954|NCT03134144|Musculoskeletal disorders|musculoskeletal disorders
68955|NCT03134144|Posture|posture
68956|NCT03134144|Standing work|standing work
68957|NCT03134144|Muscle activity|muscle activity
68958|NCT03134118|Thymoma|thymoma
68959|NCT03134118|Phase II|phase ii
68960|NCT03134118|nivolumab|nivolumab
68961|NCT03134118|Thymic carcinoma|thymic carcinoma
68962|NCT03134079|Taste Testing|taste testing
68963|NCT03134079|Spices|spices
68964|NCT03134079|Reduced sugar|reduced sugar
68965|NCT03134079|Food liking|food liking
68966|NCT03134053|hypertrophy scar|hypertrophy scar
68967|NCT03134053|burn|burn
68968|NCT03134040|Incentives|incentives
68969|NCT03134040|Motivation|motivation
68970|NCT03133975|high dose vitamin D|high dose vitamin d
68971|NCT03133975|dyslipidemia|dyslipidemia
68972|NCT03133975|premenopausal women|premenopausal women
68973|NCT03133923|Attenuated Mumps Vaccine(F-genotype，Human Diploid Cell, KMB-17), safety, immunogenecity|attenuated mumps vaccine(f-genotype，human diploid cell, kmb-17), safety, immunogenecity
68974|NCT03133910|Pharmacokinetics|pharmacokinetics
68975|NCT03133910|Ceftazidime|ceftazidime
68976|NCT03133897|dexamethasone|dexamethasone
68977|NCT03133897|prednisone|prednisone
68978|NCT03133897|inpatient|inpatient
68979|NCT03133897|paediatrics|paediatrics
68980|NCT03133884|chronic tension-type headache|chronic tension-type headache
68981|NCT03133884|acupuncture|acupuncture
68982|NCT03133884|Deqi|deqi
68983|NCT03133845|delirium|delirium
68984|NCT03133845|elderly|elderly
68985|NCT03133845|lumbar|lumbar
68986|NCT03133845|surgery|surgery
68987|NCT03133832|Schistosomiasis haematobium|schistosomiasis haematobium
68988|NCT03133832|Praziquantel|praziquantel
68989|NCT03133832|A randomized controlled trial|a randomized controlled trial
68990|NCT03133806|Percutaneous Occlusion|percutaneous occlusion
68991|NCT03133793|heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
68992|NCT03133767|Normal saline|normal saline
68993|NCT03133767|Lactated ringers|lactated ringers
68994|NCT03133767|Emergency department|emergency department
68995|NCT03133741|GIP|gip
68996|NCT03133741|GIP receptor antagonist|gip receptor antagonist
68997|NCT03133728|EID HIV|eid hiv
68998|NCT03133728|Early Infant Diagnosis|early infant diagnosis
68999|NCT03133728|Point of Care|point of care
69000|NCT03133728|Infant|infant
69001|NCT03133728|HIV|hiv
69002|NCT03133715|robot-assisted|robot-assisted
69003|NCT03133689|Alcohol|alcohol
69004|NCT03133689|Coronary heart disease|coronary heart disease
69005|NCT03133689|Ischemic heart disease|ischemic heart disease
69006|NCT03133689|Cardiovascular health|cardiovascular health
69007|NCT03133689|Individual participant data meta-analysis|individual participant data meta-analysis
69008|NCT03133689|Longitudinal|longitudinal
69009|NCT03133676|Osteoarthritis|osteoarthritis
69010|NCT03133676|Arthritis|arthritis
69011|NCT03133676|Joint Disease|joint disease
69012|NCT03133676|Osteoarthritis, Knee|osteoarthritis, knee
69013|NCT03133663|electrocardiogram|electrocardiogram
69014|NCT03133663|premature|premature
69015|NCT03133663|resuscitation|resuscitation
69016|NCT03133650|Vascular-Targeted Photodynamic Therapy (VTP)|vascular-targeted photodynamic therapy (vtp)
69017|NCT03133650|15-319|15-319
69018|NCT03133624|unruptured intracranial aneurysms|unruptured intracranial aneurysms
69019|NCT03133624|rupture risk|rupture risk
69020|NCT03133624|computational fluid dynamic|computational fluid dynamic
69021|NCT03133624|high resolution magnetic resonance images|high resolution magnetic resonance images
69022|NCT03133624|gene|gene
69023|NCT03133624|multi dimensional prediction model|multi dimensional prediction model
69024|NCT03133624|clinical features|clinical features
69025|NCT03133624|risk factors|risk factors
69026|NCT03133624|registry study|registry study
69027|NCT03133624|china|china
69028|NCT03133624|biomarkers|biomarkers
69029|NCT03133611|Speech disorder|speech disorder
69030|NCT03133611|Acoustic analysis|acoustic analysis
69031|NCT03133611|Dysarthria|dysarthria
69032|NCT03133598|Un-ruptured intracranial aneurysm|un-ruptured intracranial aneurysm
69033|NCT03133598|Interventional therapy and craniotomy|interventional therapy and craniotomy
69034|NCT03133598|Prospective cohort study|prospective cohort study
69035|NCT03133598|China|china
69036|NCT03133546|NSCLC|nsclc
69037|NCT03133546|EGFR|egfr
69038|NCT03133546|TKI|tki
69039|NCT03133546|EGFRm|egfrm
69040|NCT03133546|T790M|t790m
69041|NCT03133533|robot-assisted|robot-assisted
69042|NCT03133520|Respiratory failure|respiratory failure
69043|NCT03133520|immuncompromise patients|immuncompromise patients
69044|NCT03133520|high flow oxygen|high flow oxygen
69045|NCT03133507|cancer|cancer
69046|NCT03133507|salivary alpha amylase|salivary alpha amylase
69047|NCT03133507|pain|pain
69048|NCT03133507|positive affect|positive affect
69049|NCT03133507|emotion regulation strategies|emotion regulation strategies
69050|NCT03133481|Adductor Canal Block|adductor canal block
69051|NCT03133481|Femoral Canal Block|femoral canal block
69052|NCT03133468|AJM347|ajm347
69053|NCT03133468|pharmacokinetics|pharmacokinetics
69256|NCT03132233|Prevention|prevention
69054|NCT03133468|food effect study|food effect study
69055|NCT03133468|pharmacodynamics|pharmacodynamics
69056|NCT03133455|Rumination|rumination
69057|NCT03133429|carotid artery|carotid artery
69058|NCT03133429|stroke|stroke
69059|NCT03133429|stent|stent
69060|NCT03133416|rotator cuff tendinopathy|rotator cuff tendinopathy
69061|NCT03133416|rotator cuff tear|rotator cuff tear
69062|NCT03133416|platelet-rich plasma|platelet-rich plasma
69063|NCT03133416|physiotherapy|physiotherapy
69064|NCT03133416|exercise|exercise
69065|NCT03133377|Early activity and mobilization, rehabilitation, intensive care|early activity and mobilization, rehabilitation, intensive care
69066|NCT03133325|Hyaluronic Acid, Lidocaine|hyaluronic acid, lidocaine
69067|NCT03133286|Anal Cancer|anal cancer
69068|NCT03133286|Bladder|bladder
69069|NCT03133286|Cervical|cervical
69070|NCT03133286|Colorectal|colorectal
69071|NCT03133286|Esophageal|esophageal
69072|NCT03133286|Gallbladder|gallbladder
69073|NCT03133286|Liver|liver
69074|NCT03133286|Ovarian|ovarian
69075|NCT03133286|Pancreas|pancreas
69076|NCT03133286|Pancreatic|pancreatic
69077|NCT03133286|Prostate|prostate
69078|NCT03133286|Rectal|rectal
69079|NCT03133286|Renal|renal
69080|NCT03133286|Kidney|kidney
69081|NCT03133286|Stomach|stomach
69082|NCT03133286|Testicular|testicular
69083|NCT03133286|Uterine|uterine
69084|NCT03133286|Cancer|cancer
69085|NCT03133286|Radiation Therapy|radiation therapy
69086|NCT03133286|Radiation Treatment|radiation treatment
69087|NCT03133273|Colorectal Cancer Metastatic|colorectal cancer metastatic
69088|NCT03133273|Chemosensitivity|chemosensitivity
69089|NCT03133221|NHL|nhl
69090|NCT03133221|indolent NHL|indolent nhl
69091|NCT03133221|Zydelig|zydelig
69092|NCT03133221|Idelalisib|idelalisib
69093|NCT03133221|B-cell NHL|b-cell nhl
69094|NCT03133221|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
69095|NCT03133221|Maintenance|maintenance
69096|NCT03133221|Transformed B-cell Non-Hodgkin's lymphoma|transformed b-cell non-hodgkin's lymphoma
69097|NCT03133221|Autologous Stem Cell Transplantation|autologous stem cell transplantation
69098|NCT03133208|sepsis|sepsis
69099|NCT03133208|sepsis associated encephalopathy|sepsis associated encephalopathy
69100|NCT03133208|sepsis associated delirium|sepsis associated delirium
69101|NCT03133208|altered mental status|altered mental status
69102|NCT03133195|Terriparatide, bone fracture healing, PFNA|terriparatide, bone fracture healing, pfna
69103|NCT03133169|Thalassemia|thalassemia
69104|NCT03133169|Glutamine/glutamate ratio|glutamine/glutamate ratio
69105|NCT03133169|Pulmonary hypertension|pulmonary hypertension
69106|NCT03133156|Exercise|exercise
69107|NCT03133156|Training|training
69108|NCT03133156|Type 2 Diabetes|type 2 diabetes
69109|NCT03133156|Mellitus|mellitus
69110|NCT03133143|Cognitive Function|cognitive function
69111|NCT03133143|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
69112|NCT03133143|Computers, Digital|computers, digital
69113|NCT03133130|Scar|scar
69114|NCT03133130|Scar prevention|scar prevention
69115|NCT03133130|siRNA|sirna
69116|NCT03133091|PIEB|pieb
69117|NCT03133091|PCEA|pcea
69118|NCT03133091|LEVOBUPIVACAINE|levobupivacaine
69119|NCT03133078|Side Hop|side hop
69120|NCT03133078|Forward Hop|forward hop
69121|NCT03133078|Step test|step test
69122|NCT03133078|Vertical Jump|vertical jump
69123|NCT03133052|cognitive control training|cognitive control training
69124|NCT03133052|aMCI|amci
69125|NCT03133052|MRI|mri
69126|NCT03133052|RCT|rct
69127|NCT03133026|obstructive Jaundice|obstructive jaundice
69128|NCT03133026|Self Expandable Metal Stents (SEMS)|self expandable metal stents (sems)
69129|NCT03133026|Cholangitis|cholangitis
69130|NCT03133000|Recurrent abdominal wall hernia|recurrent abdominal wall hernia
69131|NCT03133000|Incisional hernia|incisional hernia
69132|NCT03132987|quadriceps strength|quadriceps strength
69133|NCT03132987|quadriceps voluntary activation|quadriceps voluntary activation
69134|NCT03132987|progressive strength program|progressive strength program
69135|NCT03132961|Vestibular evoked myogenic potentials|vestibular evoked myogenic potentials
69136|NCT03132961|Electrocochleography|electrocochleography
69137|NCT03132961|Infrasound|infrasound
69138|NCT03132948|ALL Cancer Patients|all cancer patients
69139|NCT03132948|Quality of Life|quality of life
69140|NCT03132948|Fitness|fitness
69141|NCT03132935|Non-STEMI Acute Coronary Syndrome|non-stemi acute coronary syndrome
69142|NCT03132935|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
69143|NCT03132935|Telemedicine|telemedicine
69144|NCT03132922|Cell Therapy|cell therapy
69145|NCT03132922|T Cell Therapy|t cell therapy
69146|NCT03132922|SPEAR T Cell|spear t cell
69147|NCT03132922|MAGE-A4|mage-a4
69148|NCT03132922|Immuno-oncology|immuno-oncology
69149|NCT03132922|Metastatic|metastatic
69150|NCT03132922|Urothelial Cancer|urothelial cancer
69151|NCT03132922|Previously Treated|previously treated
69152|NCT03132922|T Cell Receptor|t cell receptor
69153|NCT03132922|Squamous, adenosquamous, or large cell NSCLC|squamous, adenosquamous, or large cell nsclc
69257|NCT03132233|Prophylaxis|prophylaxis
69154|NCT03132922|Squamous or adenocarcinoma esophageal cancer|squamous or adenocarcinoma esophageal cancer
69155|NCT03132922|Sarcoma|sarcoma
69156|NCT03132922|Melanoma|melanoma
69157|NCT03132922|Bladder|bladder
69158|NCT03132922|Ovarian|ovarian
69159|NCT03132818|Procreation with donation|procreation with donation
69160|NCT03132792|Alpha-fetoprotein|alpha-fetoprotein
69161|NCT03132792|Cell Therapy|cell therapy
69162|NCT03132792|T Cell Therapy|t cell therapy
69163|NCT03132792|SPEAR T Cell|spear t cell
69164|NCT03132792|Immuno-oncology|immuno-oncology
69165|NCT03132792|Metastatic|metastatic
69166|NCT03132792|Previously treated|previously treated
69167|NCT03132792|T Cell Receptor|t cell receptor
69168|NCT03132779|Intralipid|intralipid
69169|NCT03132779|NK cells|nk cells
69170|NCT03132779|Recurrent miscarriage|recurrent miscarriage
69171|NCT03132740|Hepatic Carcinoma,Three-dimensional Visualization|hepatic carcinoma,three-dimensional visualization
69172|NCT03132714|Full-mouth ultrasonic debridement|full-mouth ultrasonic debridement
69173|NCT03132714|Clarithromycin|clarithromycin
69174|NCT03132714|Amoxicillin|amoxicillin
69175|NCT03132714|Metronidazole|metronidazole
69176|NCT03132714|Antimicrobial therapy|antimicrobial therapy
69177|NCT03132714|Photodynamic therapy|photodynamic therapy
69178|NCT03132714|Low-level laser therapy|low-level laser therapy
69179|NCT03132675|Melanoma|melanoma
69180|NCT03132675|pIL-12|pil-12
69181|NCT03132675|pembrolizumab|pembrolizumab
69182|NCT03132649|Three dimensional visualization|three dimensional visualization
69183|NCT03132649|Operation strategy|operation strategy
69184|NCT03132597|stress|stress
69185|NCT03132597|anxiety|anxiety
69186|NCT03132597|depression|depression
69187|NCT03132597|quality of life|quality of life
69188|NCT03132597|Mindfulness|mindfulness
69189|NCT03132584|Non Hodgkin Lymphoma|non hodgkin lymphoma
69190|NCT03132571|Schizophrenia|schizophrenia
69191|NCT03132571|Diabetes|diabetes
69192|NCT03132571|Obesity|obesity
69193|NCT03132519|Cough|cough
69194|NCT03132519|Hypertension|hypertension
69195|NCT03132519|Remifentanil|remifentanil
69196|NCT03132519|Sevoflurane|sevoflurane
69197|NCT03132519|Desflurane|desflurane
69198|NCT03132467|Breast Cancer|breast cancer
69199|NCT03132467|Hormone Receptor Positive, HER2 Negative Breast Cancer|hormone receptor positive, her2 negative breast cancer
69200|NCT03132467|Tremelimumab|tremelimumab
69201|NCT03132467|Ticilimumab|ticilimumab
69202|NCT03132467|CP-675,206|cp-675,206
69203|NCT03132467|Durvalumab|durvalumab
69204|NCT03132467|MEDI4736|medi4736
69205|NCT03132454|Hematopoietic/Lymphoid Cancer|hematopoietic/lymphoid cancer
69206|NCT03132454|Acute myeloid leukemia|acute myeloid leukemia
69207|NCT03132454|AML|aml
69208|NCT03132454|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
69209|NCT03132454|ALL|all
69210|NCT03132454|Relapsed or refractory|relapsed or refractory
69211|NCT03132454|R/R|r/r
69212|NCT03132454|Palbociclib|palbociclib
69213|NCT03132454|PD-0332991|pd-0332991
69214|NCT03132454|Ibrance|ibrance
69215|NCT03132454|Sorafenib|sorafenib
69216|NCT03132454|Nexavar|nexavar
69217|NCT03132454|BAY 43-9006|bay 43-9006
69218|NCT03132454|Decitabine|decitabine
69219|NCT03132454|Dacogen|dacogen
69220|NCT03132454|Dexamethasone|dexamethasone
69221|NCT03132454|Decadron|decadron
69222|NCT03132441|advanced heart failure|advanced heart failure
69223|NCT03132441|NYHA Class III-IV|nyha class iii-iv
69224|NCT03132441|frailty|frailty
69225|NCT03132441|cardiac rehabilitation|cardiac rehabilitation
69226|NCT03132415|Prevention & Control|prevention & control
69227|NCT03132415|Internet|internet
69228|NCT03132415|Adolescents|adolescents
69229|NCT03132415|Young adults|young adults
69230|NCT03132402|Elisa|elisa
69231|NCT03132402|Plasmodium Falciparum|plasmodium falciparum
69232|NCT03132389|Sexual assault|sexual assault
69233|NCT03132389|Sexually transmitted diseases|sexually transmitted diseases
69234|NCT03132389|Chlamydia trachomatis|chlamydia trachomatis
69235|NCT03132389|Mycoplasma genitalium|mycoplasma genitalium
69236|NCT03132389|Neisseria gonorrhoeae|neisseria gonorrhoeae
69237|NCT03132389|Hepatitis B and C|hepatitis b and c
69238|NCT03132389|HIV|hiv
69239|NCT03132389|Syphilis|syphilis
69240|NCT03132389|Follow up visits after sexual assault|follow up visits after sexual assault
69241|NCT03132324|Sickle cell disease (SCD)|sickle cell disease (scd)
69242|NCT03132324|sickle cell SS|sickle cell ss
69243|NCT03132324|lysine demethylase 1 (LSD1) inhibition|lysine demethylase 1 (lsd1) inhibition
69244|NCT03132311|yellow fever vaccine|yellow fever vaccine
69245|NCT03132311|hiv|hiv
69246|NCT03132272|ADAsorb apheresis|adasorb apheresis
69247|NCT03132272|Globaffin adsorber|globaffin adsorber
69248|NCT03132272|Agonistic Autoantibodies|agonistic autoantibodies
69249|NCT03132272|Immunoadsorption|immunoadsorption
69250|NCT03132272|Alzheimer Dementia|alzheimer dementia
69251|NCT03132259|Dexmedethomidine|dexmedethomidine
69252|NCT03132246|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
69253|NCT03132246|Infection|infection
69254|NCT03132246|Biofilm Assay|biofilm assay
69255|NCT03132233|Migraine|migraine
69258|NCT03132233|Ketone bodies|ketone bodies
69259|NCT03132233|Beta-hydroxybutyrate|beta-hydroxybutyrate
69260|NCT03132233|Double-blind|double-blind
69261|NCT03132233|Randomised|randomised
69262|NCT03132233|Placebo controlled|placebo controlled
69263|NCT03132233|Mitochondrial functioning|mitochondrial functioning
69264|NCT03132233|Energy metabolism|energy metabolism
69265|NCT03132233|Intervention|intervention
69266|NCT03132233|Dietary Supplement|dietary supplement
69267|NCT03132220|critical care nurses|critical care nurses
69268|NCT03132220|mindfulness-based cognitive therapy|mindfulness-based cognitive therapy
69269|NCT03132220|Burn-out Syndrome|burn-out syndrome
69270|NCT03132220|Post-traumatic Stress Disorder|post-traumatic stress disorder
69271|NCT03132220|Cognitive Behavioral Therapy|cognitive behavioral therapy
69272|NCT03132207|Oral Health|oral health
69273|NCT03132207|Pregnancy|pregnancy
69274|NCT03132207|Prevention|prevention
69275|NCT03132207|adverse pregnancy outcomes|adverse pregnancy outcomes
69276|NCT03132181|Empagliflozin|empagliflozin
69277|NCT03132181|Diabetes|diabetes
69278|NCT03132181|Systemic vascular resistance|systemic vascular resistance
69279|NCT03132181|Cardiac output|cardiac output
69280|NCT03132181|Blood pressure|blood pressure
69281|NCT03132168|cystectomy|cystectomy
69282|NCT03132168|urology|urology
69283|NCT03132168|surgery|surgery
69284|NCT03132129|Type 2 diabetes|type 2 diabetes
69285|NCT03132129|Diabetic cardiomyopathy|diabetic cardiomyopathy
69286|NCT03132129|Cardiovascular magnetic resonance|cardiovascular magnetic resonance
69287|NCT03132116|Cat Scratch Disease's lymphadenitis|cat scratch disease's lymphadenitis
69288|NCT03132116|Infectious Diseases|infectious diseases
69289|NCT03132103|Vitamin D deficiency|vitamin d deficiency
69290|NCT03132103|Simulated sunlight radiation|simulated sunlight radiation
69291|NCT03132103|Oral vitamin D3|oral vitamin d3
69292|NCT03132051|carpal tunnel syndrome|carpal tunnel syndrome
69293|NCT03132025|Metastatic Colorectal Cancer|metastatic colorectal cancer
69294|NCT03132025|Apatinib|apatinib
69295|NCT03132025|Capecitabine|capecitabine
69296|NCT03131999|VEGF-D|vegf-d
69297|NCT03131999|Imatinib mesylate|imatinib mesylate
69298|NCT03131999|Sirolimus|sirolimus
69299|NCT03131921|Energy expenditure|energy expenditure
69300|NCT03131921|Nutrition|nutrition
69301|NCT03131921|Colorectal cancer|colorectal cancer
69302|NCT03131921|Dietary needs|dietary needs
69303|NCT03131921|Breast cancer|breast cancer
69304|NCT03131908|Melanoma and other malignant neoplasms of skin|melanoma and other malignant neoplasms of skin
69305|NCT03131908|Metastatic Melanoma|metastatic melanoma
69306|NCT03131908|GSK2633771|gsk2633771
69307|NCT03131908|Pembrolizumab|pembrolizumab
69308|NCT03131908|Keytruda|keytruda
69309|NCT03131908|MK-3475|mk-3475
69310|NCT03131908|SCH-900475|sch-900475
69311|NCT03131895|Drug therapy|drug therapy
69312|NCT03131882|trigger finger|trigger finger
69313|NCT03131882|trigger thumb|trigger thumb
69314|NCT03131882|ultrasound guided|ultrasound guided
69315|NCT03131882|hyaluronic acid|hyaluronic acid
69316|NCT03131856|Geriatrics|geriatrics
69317|NCT03131856|Nutritional risk|nutritional risk
69318|NCT03131856|Multi-disciplinary intervention|multi-disciplinary intervention
69319|NCT03131856|Randomized Controlled Trial|randomized controlled trial
69320|NCT03131843|skin infection|skin infection
69321|NCT03131843|vaccination|vaccination
69322|NCT03131843|children|children
69323|NCT03131843|alcohol swab|alcohol swab
69324|NCT03131843|skin preparation|skin preparation
69325|NCT03131804|Aerobic|aerobic
69326|NCT03131804|Intradialytic|intradialytic
69327|NCT03131804|Cardio-metabolic markers|cardio-metabolic markers
69328|NCT03131804|Dialysis Adequacy|dialysis adequacy
69329|NCT03131804|Quality of Life|quality of life
69330|NCT03131804|Cost Effectiveness|cost effectiveness
69331|NCT03131791|Extracorporeal Shock Wave|extracorporeal shock wave
69332|NCT03131791|Spasticity in stokes|spasticity in stokes
69333|NCT03131791|Botulinum toxin|botulinum toxin
69334|NCT03131752|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
69335|NCT03131752|muscle strength|muscle strength
69336|NCT03131752|physical activity|physical activity
69337|NCT03131739|Resilience|resilience
69338|NCT03131739|Alaska Native|alaska native
69339|NCT03131739|Community Based Participatory Research|community based participatory research
69340|NCT03131739|Culture and Community Factors|culture and community factors
69341|NCT03131739|Protective Factors|protective factors
69342|NCT03131739|Risk Factors|risk factors
69343|NCT03131726|simvastatin|simvastatin
69344|NCT03131726|diclofenac|diclofenac
69345|NCT03131713|Mohs micrographic surgery|mohs micrographic surgery
69346|NCT03131713|pain|pain
69347|NCT03131713|functional status|functional status
69348|NCT03131700|RPH101|rph101
69349|NCT03131700|RPH-101|rph-101
69350|NCT03131700|Biosimilar|biosimilar
69351|NCT03131700|Bevacizumab|bevacizumab
69352|NCT03131700|Safety|safety
69353|NCT03131674|Somatic tinnitus|somatic tinnitus
69354|NCT03131635|Developmental|developmental
69355|NCT03131596|intrauterine balloon|intrauterine balloon
69356|NCT03131596|hysteroscopy|hysteroscopy
69357|NCT03131583|SHR4640 Febuxostat Colchicine pharmacodynamics|shr4640 febuxostat colchicine pharmacodynamics
69358|NCT03131570|Psoriasis|psoriasis
69359|NCT03131570|Chronic Plaque Psoriasis|chronic plaque psoriasis
69360|NCT03131570|Secukinumab|secukinumab
69361|NCT03131544|BPH|bph
69362|NCT03131544|Benign Prostatic Hypertrophy|benign prostatic hypertrophy
69363|NCT03131544|MRI|mri
69364|NCT03131544|Prostate|prostate
69365|NCT03131544|Lower Urinary Tract Symptoms|lower urinary tract symptoms
69366|NCT03131544|Nocturia|nocturia
69367|NCT03131544|Incomplete bladder emptying|incomplete bladder emptying
69368|NCT03131479|renal function|renal function
69369|NCT03131479|sodium-glucose co-transporter|sodium-glucose co-transporter
69370|NCT03131479|pharmacokinetics|pharmacokinetics
69371|NCT03131479|decreased renal function|decreased renal function
69372|NCT03131479|decreased kidney function|decreased kidney function
69373|NCT03131479|kidney disease|kidney disease
69374|NCT03131479|urinary glucose excretion|urinary glucose excretion
69375|NCT03131479|UGE|uge
69376|NCT03131466|Trigeminal Neuralgia|trigeminal neuralgia
69377|NCT03131466|Pulsed Radiofrequency|pulsed radiofrequency
69378|NCT03131466|Gasserian Ganglion|gasserian ganglion
69379|NCT03131453|Placebo controlled,|placebo controlled,
69380|NCT03131453|APOE4 carriers,|apoe4 carriers,
69381|NCT03131453|Homozygotes,|homozygotes,
69382|NCT03131453|Heterozygotes,|heterozygotes,
69383|NCT03131453|Brain Amyloid,|brain amyloid,
69384|NCT03131453|Preclinical Alzheimer's Disease (AD),|preclinical alzheimer's disease (ad),
69385|NCT03131453|Aβ lowering,|aβ lowering,
69386|NCT03131453|BACE-1 inhibitor|bace-1 inhibitor
69387|NCT03131427|Wilson's Disease|wilson's disease
69388|NCT03131427|Hereditary Hemochromatosis|hereditary hemochromatosis
69389|NCT03131427|Hereditary Hyperbilirubinemias|hereditary hyperbilirubinemias
69390|NCT03131427|Inherited Cholestatic Liver Disease|inherited cholestatic liver disease
69391|NCT03131427|Genetic Testing|genetic testing
69392|NCT03131375|dexmedetomidine|dexmedetomidine
69393|NCT03131375|emergence delirium|emergence delirium
69394|NCT03131375|anesthesia|anesthesia
69395|NCT03131375|propofol|propofol
69396|NCT03131375|children|children
69397|NCT03131362|COPD|copd
69398|NCT03131323|delineate the prevalence of abnormal nasal finding in wheezy child|delineate the prevalence of abnormal nasal finding in wheezy child
69399|NCT03131297|anal fistulas|anal fistulas
69400|NCT03131297|evaluation of radiofrequency|evaluation of radiofrequency
69401|NCT03131271|Percutaneous coronary intervention|percutaneous coronary intervention
69402|NCT03131271|Femoral arterial catheter|femoral arterial catheter
69403|NCT03131271|Pain|pain
69404|NCT03131271|Cold application|cold application
69405|NCT03131271|Nursing|nursing
69406|NCT03131206|Non-small cell lung cancer|non-small cell lung cancer
69407|NCT03131206|NSCLC|nsclc
69408|NCT03131206|ALK|alk
69409|NCT03131206|RET|ret
69410|NCT03131206|alectinib|alectinib
69411|NCT03131206|Thyroid cancer|thyroid cancer
69412|NCT03131128|Mindfulness-based intervention|mindfulness-based intervention
69413|NCT03131128|Weight loss|weight loss
69414|NCT03131128|Workplace health promotion|workplace health promotion
69415|NCT03131128|Obesity|obesity
69416|NCT03131063|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
69417|NCT03131063|Sepsis|sepsis
69418|NCT03131063|Antibiotics|antibiotics
69419|NCT03131063|Pharmacokinetic|pharmacokinetic
69420|NCT03131063|Intensive Care Unit|intensive care unit
69421|NCT03131050|Scopolamine|scopolamine
69422|NCT03131037|immunotherapy|immunotherapy
69423|NCT03131037|immuno-oncology|immuno-oncology
69424|NCT03131037|tumor vaccine|tumor vaccine
69425|NCT03131024|anthracyclines|anthracyclines
69426|NCT03130998|smoking cessation|smoking cessation
69427|NCT03130998|depression|depression
69428|NCT03130998|mental health|mental health
69429|NCT03130998|mood management|mood management
69430|NCT03130998|primary care|primary care
69431|NCT03130998|screening|screening
69432|NCT03130998|brief intervention|brief intervention
69433|NCT03130998|referral to treatment|referral to treatment
69434|NCT03130985|microRNA|microrna
69435|NCT03130985|biomarker|biomarker
69436|NCT03130946|breast neoplasms|breast neoplasms
69437|NCT03130946|Ultrasonography, Interventional|ultrasonography, interventional
69438|NCT03130946|Biopsy, Large-Core Needle|biopsy, large-core needle
69439|NCT03130946|Biopsy, Fine-Needle|biopsy, fine-needle
69440|NCT03130933|third molar|third molar
69441|NCT03130933|oral surgical procedures|oral surgical procedures
69442|NCT03130933|antibiotic prophylaxis|antibiotic prophylaxis
69443|NCT03130933|placebo effect|placebo effect
69444|NCT03130920|preconditioning, resection|preconditioning, resection
69445|NCT03130894|trimethylamine-N-oxide|trimethylamine-n-oxide
69446|NCT03130894|type2 Diabetes|type2 diabetes
69447|NCT03130894|enzyme flavin monooxygenase 3 polymorphisms|enzyme flavin monooxygenase 3 polymorphisms
69448|NCT03130855|pediatric patients|pediatric patients
69449|NCT03130855|articaine local anesthesia|articaine local anesthesia
69450|NCT03130829|NSCLC|nsclc
69451|NCT03130829|QoL|qol
69452|NCT03130829|Fucoidan|fucoidan
69453|NCT03130816|Umbilical cord blood transplantation|umbilical cord blood transplantation
69454|NCT03130816|Cytokine changes|cytokine changes
69455|NCT03130764|Non-small Cell Lung Cancer|non-small cell lung cancer
69456|NCT03130712|immunotherapy|immunotherapy
69457|NCT03130712|GPC3-CART|gpc3-cart
69458|NCT03130712|HCC|hcc
69459|NCT03130699|Diabetes|diabetes
69460|NCT03130699|mHealth|mhealth
69461|NCT03130699|Medical Assistant|medical assistant
69462|NCT03130699|Automated|automated
69463|NCT03130699|Adaptive Feedback|adaptive feedback
69464|NCT03130699|Self-Management Support|self-management support
69465|NCT03130699|Hispanics|hispanics
69466|NCT03130699|HbA1c|hba1c
69467|NCT03130699|Cyberinfrastructure|cyberinfrastructure
69468|NCT03130699|Federally-Qualified Health Centers|federally-qualified health centers
69469|NCT03130699|Cost-Effectiveness|cost-effectiveness
69470|NCT03130699|T2DM|t2dm
69471|NCT03130699|Pay-for-Performance|pay-for-performance
69472|NCT03130699|Medication Adherence|medication adherence
69473|NCT03130699|LDL-C|ldl-c
69474|NCT03130699|Systolic Blood Pressure|systolic blood pressure
69475|NCT03130699|Text Messaging|text messaging
69476|NCT03130673|hip fracture|hip fracture
69477|NCT03130673|trochanteric fracure|trochanteric fracure
69478|NCT03130673|subtrocantheric fracture|subtrocantheric fracture
69479|NCT03130673|femoral head fracture|femoral head fracture
69480|NCT03130673|epidemiology|epidemiology
69481|NCT03130660|central line|central line
69482|NCT03130660|Central Line Complication|central line complication
69483|NCT03130634|CPT-11(irinotecan)|cpt-11(irinotecan)
69484|NCT03130634|silymarin|silymarin
69485|NCT03130634|GI toxicity|gi toxicity
69486|NCT03130608|liver disease|liver disease
69487|NCT03130608|transplant|transplant
69488|NCT03130608|muscle wasting|muscle wasting
69489|NCT03130608|breathing exercise|breathing exercise
69490|NCT03130595|accelerometry|accelerometry
69491|NCT03130595|Parkinson Kinetigraph|parkinson kinetigraph
69492|NCT03130582|high-dose etoposide,autologous peripheral blood stem cell transplantation|high-dose etoposide,autologous peripheral blood stem cell transplantation
69493|NCT03130569|Risk Assessment|risk assessment
69494|NCT03130569|Personal Genomic Testing|personal genomic testing
69495|NCT03130569|Skin Cancer|skin cancer
69496|NCT03130569|Primary Care|primary care
69497|NCT03130556|Glasdegib|glasdegib
69498|NCT03130556|PF-04449913|pf-04449913
69499|NCT03130556|Pharmacokinetics|pharmacokinetics
69500|NCT03130556|Bioavailability|bioavailability
69501|NCT03130543|Brief resolved unexplained event|brief resolved unexplained event
69502|NCT03130530|robotic|robotic
69503|NCT03130530|colorectal|colorectal
69504|NCT03130530|surgery|surgery
69505|NCT03130517|hemolysis,newborn|hemolysis,newborn
69506|NCT03130478|long-acting injectable antipsychotic|long-acting injectable antipsychotic
69507|NCT03130478|persistence|persistence
69508|NCT03130465|adherence|adherence
69509|NCT03130465|long-acting injectable antipsychotic|long-acting injectable antipsychotic
69510|NCT03130465|all-cause treatment discontinuation|all-cause treatment discontinuation
69511|NCT03130465|recent-onset schizophrenia|recent-onset schizophrenia
69512|NCT03130465|daily oral atypical antipsychotic|daily oral atypical antipsychotic
69513|NCT03130439|Breast Cancer|breast cancer
69514|NCT03130426|Diabetes|diabetes
69515|NCT03130426|iGlarLixi|iglarlixi
69516|NCT03130426|Metformin|metformin
69517|NCT03130426|Insulin|insulin
69518|NCT03130426|Diet|diet
69519|NCT03130426|Exercise|exercise
69520|NCT03130426|Lifestyle|lifestyle
69521|NCT03130413|Ambu Aura Gain|ambu aura gain
69522|NCT03130413|Air-Q intubating laryngeal airway|air-q intubating laryngeal airway
69523|NCT03130413|Paediatric surgery|paediatric surgery
69524|NCT03130400|Knee|knee
69525|NCT03130400|Gait|gait
69526|NCT03130400|Injuries|injuries
69527|NCT03130400|Arthritis|arthritis
69528|NCT03130387|Hytsteroscopy|hytsteroscopy
69529|NCT03130374|mesenchymal stem cells|mesenchymal stem cells
69530|NCT03130374|Tracheal Stenosis|tracheal stenosis
69531|NCT03130374|Laryngeal Stenosis|laryngeal stenosis
69532|NCT03130374|cell therapy|cell therapy
69533|NCT03130309|Knee|knee
69534|NCT03130309|Replacement|replacement
69535|NCT03130309|Mobile-bearing|mobile-bearing
69536|NCT03130309|unicompartmental prosthesis|unicompartmental prosthesis
69537|NCT03130296|HIV infection|hiv infection
69538|NCT03130296|Fc receptor polymorphism (FcR)|fc receptor polymorphism (fcr)
69539|NCT03130283|Acute patients|acute patients
69540|NCT03130283|Exacerbated chronic patients|exacerbated chronic patients
69541|NCT03130270|nasopharyngeal carcinoma|nasopharyngeal carcinoma
69542|NCT03130270|disease-free survival|disease-free survival
69543|NCT03130270|adverse reaction|adverse reaction
69544|NCT03130257|blood pressure measurement|blood pressure measurement
69545|NCT03130231|Delirium β2-microspheres|delirium β2-microspheres
69546|NCT03130179|Bioequivalence|bioequivalence
69547|NCT03130166|Postoperative pain|postoperative pain
69548|NCT03130166|Postoperative recovery|postoperative recovery
69549|NCT03130166|Intracorporeal anastomosis|intracorporeal anastomosis
69550|NCT03130166|Robotic right colectomy|robotic right colectomy
69551|NCT03130114|Mortality|mortality
69552|NCT03130114|Infant|infant
69553|NCT03130114|Antibiotics|antibiotics
69554|NCT03130114|Linear Growth|linear growth
69555|NCT03130101|Type 1 Diabetes|type 1 diabetes
69556|NCT03130101|Exercise|exercise
69557|NCT03130101|Basal insulin|basal insulin
69558|NCT03130101|CSII|csii
69559|NCT03130101|OmniPod|omnipod
69560|NCT03130101|CGM|cgm
69561|NCT03130088|Out-Of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
69562|NCT03130088|Resuscitation Registry|resuscitation registry
69563|NCT03130088|EuReCa TWO|eureca two
69564|NCT03130062|Resistance Exercise|resistance exercise
69565|NCT03130062|Functional Fitness|functional fitness
69566|NCT03130062|Actigraphy|actigraphy
69567|NCT03130062|Primary Sjögren Syndrome|primary sjögren syndrome
69568|NCT03130049|Peripheral nerve block|peripheral nerve block
69569|NCT03130049|Ultrasound|ultrasound
69570|NCT03130036|Memory|memory
69571|NCT03130036|Cognitive|cognitive
69572|NCT03129984|mandibular movements|mandibular movements
69573|NCT03129958|NECK PAIN, OFFICE WORKERS|neck pain, office workers
69574|NCT03129945|Obstetric Labor, Premature|obstetric labor, premature
69575|NCT03129945|Tocolytic Agents|tocolytic agents
69576|NCT03129932|gluten|gluten
69577|NCT03129932|adipokine|adipokine
69578|NCT03129932|obesity|obesity
69579|NCT03129932|diet|diet
69580|NCT03129906|Fibromyalgia; non-celiac gluten sensitivity|fibromyalgia; non-celiac gluten sensitivity
69581|NCT03129880|Voice disorder|voice disorder
69582|NCT03129880|Hoarseness|hoarseness
69583|NCT03129880|Phonation Disorders|phonation disorders
69584|NCT03129880|Speech Disorders|speech disorders
69585|NCT03129854|prostate cancer|prostate cancer
69586|NCT03129854|metastatic|metastatic
69587|NCT03129854|cryotherapy|cryotherapy
69588|NCT03129854|ADT|adt
69589|NCT03129841|weight loss|weight loss
69590|NCT03129841|dietary pattern|dietary pattern
69591|NCT03129841|late dinner|late dinner
69592|NCT03129841|early dinner|early dinner
69593|NCT03129828|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
69594|NCT03129828|Ibrutinib|ibrutinib
69595|NCT03129828|Bortezomib|bortezomib
69596|NCT03129815|extubation|extubation
69597|NCT03129815|pediatric resuscitation|pediatric resuscitation
69598|NCT03129815|reintubation|reintubation
69599|NCT03129815|failures of extubation.|failures of extubation.
69600|NCT03129802|extubation|extubation
69601|NCT03129802|pediatric resuscitation|pediatric resuscitation
69602|NCT03129802|reintubation|reintubation
69603|NCT03129802|failures of extubation.|failures of extubation.
69604|NCT03129802|Respiratory Insufficiency|respiratory insufficiency
69605|NCT03129763|SPY-ICG Angiography|spy-icg angiography
69606|NCT03129763|Tissue Expander|tissue expander
69607|NCT03129763|Capsule Pressure|capsule pressure
69608|NCT03129763|Blood Supply|blood supply
69609|NCT03129724|Kidney Neoplasms|kidney neoplasms
69610|NCT03129724|Kidney|kidney
69611|NCT03129724|Neoplasms|neoplasms
69612|NCT03129724|TKI|tki
69613|NCT03129724|Axitinib|axitinib
69614|NCT03129724|VEGF|vegf
69615|NCT03129724|mTORi|mtori
69616|NCT03129685|Hepatocellular carcinoma|hepatocellular carcinoma
69617|NCT03129685|Devascularization|devascularization
69618|NCT03129672|allograft|allograft
69619|NCT03129672|distal tibia sarcoma|distal tibia sarcoma
69620|NCT03129659|Coronary CT Angiography|coronary ct angiography
69621|NCT03129659|High-sensitivity Troponin|high-sensitivity troponin
69622|NCT03129659|Diagnosis|diagnosis
69623|NCT03129620|Ampicillin|ampicillin
69624|NCT03129607|POPF|popf
69625|NCT03129607|Classification system|classification system
69626|NCT03129581|obesity, diet, sleep activity|obesity, diet, sleep activity
69627|NCT03129555|Non-vitamin K antagonist oral anticoagulation|non-vitamin k antagonist oral anticoagulation
69628|NCT03129555|Non-vitamin K Antagonist Oral Anticoagulants|non-vitamin k antagonist oral anticoagulants
69629|NCT03129555|Direct-acting Oral Anticoagulants|direct-acting oral anticoagulants
69630|NCT03129555|Novel oral anticoagulant drugs|novel oral anticoagulant drugs
69631|NCT03129516|imaginary|imaginary
69632|NCT03129516|Turkish version|turkish version
69633|NCT03129516|motor imagery|motor imagery
69634|NCT03129516|reliability|reliability
69635|NCT03129503|Optical coherence tomography (OCT)|optical coherence tomography (oct)
69636|NCT03129490|Atrial Fibrillation|atrial fibrillation
69637|NCT03129490|Non-vitamin K antagonist oral anticoagulation|non-vitamin k antagonist oral anticoagulation
69638|NCT03129490|Direct-acting oral anticoagulants|direct-acting oral anticoagulants
69639|NCT03129490|Novel oral anticoagulant drugs|novel oral anticoagulant drugs
69640|NCT03129490|Non-vitamin K antagonist oral anticoagulants|non-vitamin k antagonist oral anticoagulants
69641|NCT03129477|Non invasive ventilation in COPD|non invasive ventilation in copd
69642|NCT03129477|Noninvasive ventilation|noninvasive ventilation
69643|NCT03129477|Tele-monitoring|tele-monitoring
69644|NCT03129438|continuous EEG|continuous eeg
69645|NCT03129438|routine EEG|routine eeg
69646|NCT03129438|prognosis|prognosis
69647|NCT03129425|Patient|patient
69648|NCT03129425|Caregiver|caregiver
69649|NCT03129425|Coping|coping
69650|NCT03129425|Psychosocial adaptation|psychosocial adaptation
69651|NCT03129399|anesthesia|anesthesia
69652|NCT03129399|King Vision|king vision
69653|NCT03129399|videolaryngoscope|videolaryngoscope
69654|NCT03129399|nasotracheal|nasotracheal
69655|NCT03129360|Early Psychosis|early psychosis
69656|NCT03129360|Levetiracetam|levetiracetam
69657|NCT03129308|HIV|hiv
69658|NCT03129308|Cutaneous Autoantibodies|cutaneous autoantibodies
69659|NCT03129308|Indirect Immunofluorescence|indirect immunofluorescence
69660|NCT03129269|Cognitive decline|cognitive decline
69661|NCT03129269|frailty|frailty
69662|NCT03129269|mild cognitive impairment|mild cognitive impairment
69663|NCT03129269|Positron Emission Tomography, PET|positron emission tomography, pet
69664|NCT03129269|Alzheimer disease|alzheimer disease
69665|NCT03129269|amyloid load|amyloid load
69666|NCT03129269|Magnetic resonance imaging, MRI|magnetic resonance imaging, mri
69667|NCT03129256|non-small cell lung cancer|non-small cell lung cancer
69668|NCT03129256|Apatinib|apatinib
69669|NCT03129256|S1|s1
69670|NCT03129217|Diaphragm function|diaphragm function
69671|NCT03129217|Acute respiratory failure|acute respiratory failure
69672|NCT03129217|Weaning|weaning
69673|NCT03129204|intensive care unit|intensive care unit
69674|NCT03129204|critical care|critical care
69675|NCT03129204|family|family
69676|NCT03129204|caregiver|caregiver
69677|NCT03129204|actigraphy|actigraphy
69678|NCT03129178|Nitrate|nitrate
69679|NCT03129178|Nitric oxide|nitric oxide
69680|NCT03129178|Microvascular|microvascular
69681|NCT03129165|Cardiovascular diseases|cardiovascular diseases
69682|NCT03129165|Public Health|public health
69683|NCT03129165|Hypertension|hypertension
69684|NCT03129165|Smoking|smoking
69685|NCT03129165|Hypercholesterolemia|hypercholesterolemia
69686|NCT03129165|Food Habits|food habits
69687|NCT03129165|Exercise|exercise
69688|NCT03129165|Anxiety|anxiety
69689|NCT03129165|Depression|depression
69690|NCT03129165|Obesity|obesity
69691|NCT03129165|Diabetes|diabetes
69692|NCT03129139|Metastatic|metastatic
69693|NCT03128996|Bone marrow transplant|bone marrow transplant
69694|NCT03128996|Transplant|transplant
69695|NCT03128996|Transplantation|transplantation
69696|NCT03128996|Reduced Intensity|reduced intensity
69697|NCT03128996|Familial HLA mismatched|familial hla mismatched
69698|NCT03128905|Colchicine|colchicine
69699|NCT03128905|Corticoids|corticoids
69700|NCT03128905|Prednisone|prednisone
69701|NCT03128905|CPPD|cppd
69702|NCT03128905|Calcium Pyrophosphate Deposition Disease|calcium pyrophosphate deposition disease
69703|NCT03128879|Primary lymphoid haematopoietic neoplasms|primary lymphoid haematopoietic neoplasms
69704|NCT03128879|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
69705|NCT03128879|CLL|cll
69706|NCT03128879|Small lymphocytic lymphoma|small lymphocytic lymphoma
69707|NCT03128879|SLL|sll
69708|NCT03128879|High risk|high risk
69709|NCT03128879|Venetoclax|venetoclax
69710|NCT03128879|ABT-199|abt-199
69711|NCT03128879|GDC-0199|gdc-0199
69712|NCT03128879|Ibrutinib|ibrutinib
69713|NCT03128879|PCI-32765|pci-32765
69714|NCT03128879|Imbruvica|imbruvica
69715|NCT03128879|Allopurinol|allopurinol
69716|NCT03128879|Lopurin|lopurin
69717|NCT03128879|Zurinol|zurinol
69718|NCT03128879|Zyloprim|zyloprim
69719|NCT03128866|Malignant neoplasms of bone and articular cartilage|malignant neoplasms of bone and articular cartilage
69720|NCT03128866|Pelvic Tumor|pelvic tumor
69721|NCT03128866|Tranexamic acid|tranexamic acid
69722|NCT03128814|Tennis|tennis
69723|NCT03128814|Asymmetry|asymmetry
69724|NCT03128814|Structural|structural
69725|NCT03128814|Functional|functional
69726|NCT03128801|Low Back Pain|low back pain
69727|NCT03128801|Back Pain|back pain
69728|NCT03128801|Muscle Stretching Exercises|muscle stretching exercises
69729|NCT03128801|Stabilization Exercise|stabilization exercise
69730|NCT03128801|Exercise Therapy|exercise therapy
69731|NCT03128801|Exercise Movement|exercise movement
69732|NCT03128801|Exercise Movement Tecniques|exercise movement tecniques
69733|NCT03128801|Pain|pain
69734|NCT03128801|Disability|disability
69735|NCT03128788|epidurography epidural pressure patient posture|epidurography epidural pressure patient posture
69736|NCT03128749|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
69737|NCT03128749|Mindfulness Based Intervention|mindfulness based intervention
69738|NCT03128749|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
69739|NCT03128749|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
69740|NCT03128749|Neuropsychology|neuropsychology
69741|NCT03128749|Childhood Maltreatment|childhood maltreatment
69742|NCT03128723|Acne|acne
69743|NCT03128710|Survey|survey
69744|NCT03128710|Focus Group|focus group
69745|NCT03128710|Treatment Preferences|treatment preferences
69746|NCT03128697|Obesity|obesity
69747|NCT03128697|Satiety quotient|satiety quotient
69748|NCT03128697|Appetite control|appetite control
69749|NCT03128697|Weight loss|weight loss
69750|NCT03128697|Satiety phenotype|satiety phenotype
69751|NCT03128697|Functional food|functional food
69752|NCT03128684|lentils|lentils
69753|NCT03128684|satiety|satiety
69754|NCT03128684|appetite|appetite
69755|NCT03128684|food intake|food intake
69953|NCT03127358|Reinfection|reinfection
69756|NCT03128684|24-hour energy intake|24-hour energy intake
69757|NCT03128671|intensive care unit|intensive care unit
69758|NCT03128671|critical care|critical care
69759|NCT03128671|mechanical ventilation|mechanical ventilation
69760|NCT03128671|confusion|confusion
69761|NCT03128671|polysomnography|polysomnography
69762|NCT03128671|delirium|delirium
69763|NCT03128671|adult|adult
69764|NCT03128658|Trauma induced coagulopathy|trauma induced coagulopathy
69765|NCT03128554|Not Ready to Quit|not ready to quit
69766|NCT03128554|Primary Care|primary care
69767|NCT03128554|Tobacco|tobacco
69768|NCT03128554|Reduce to Quit|reduce to quit
69769|NCT03128554|Smoking Reduction|smoking reduction
69770|NCT03128528|SGLT-2 inhibitor, Chronic heart failure, tissue sodium,|sglt-2 inhibitor, chronic heart failure, tissue sodium,
69771|NCT03128515|Hydroxyurea|hydroxyurea
69772|NCT03128502|saliva|saliva
69773|NCT03128502|GCF|gcf
69774|NCT03128502|pentraxin-3|pentraxin-3
69775|NCT03128489|Safety|safety
69776|NCT03128489|Infanrix™-IPV/Hib|infanrix™-ipv/hib
69777|NCT03128489|Immunogenicity|immunogenicity
69778|NCT03128489|Indian infants|indian infants
69779|NCT03128489|Combined vaccine|combined vaccine
69780|NCT03128463|Age-Related Macular Degeneration|age-related macular degeneration
69781|NCT03128463|Polypoidal Choroidal Vasculopathy|polypoidal choroidal vasculopathy
69782|NCT03128463|Pathological Myopia|pathological myopia
69783|NCT03128463|Conbercept|conbercept
69784|NCT03128450|Parkinson Disease|parkinson disease
69785|NCT03128450|Neural stem cell|neural stem cell
69786|NCT03128450|Nasal delivery|nasal delivery
69787|NCT03128437|Anxiety|anxiety
69788|NCT03128437|Young Adults|young adults
69789|NCT03128437|Health Behaviors|health behaviors
69790|NCT03128411|Leukemia, Chronic Myelogenous|leukemia, chronic myelogenous
69791|NCT03128398|Gastroparesis|gastroparesis
69792|NCT03128385|Upper limb neurorehabilitation|upper limb neurorehabilitation
69793|NCT03128385|Neurological rehabilitation|neurological rehabilitation
69794|NCT03128385|Upper extremity|upper extremity
69795|NCT03128281|Malignant Neoplasms of Female Genital Organs|malignant neoplasms of female genital organs
69796|NCT03128281|Laparoscopic gynecologic surgery|laparoscopic gynecologic surgery
69797|NCT03128281|Robotic gynecologic surgery|robotic gynecologic surgery
69798|NCT03128281|AirSeal® Insufflation System|airseal® insufflation system
69799|NCT03128281|AIS|ais
69800|NCT03128281|Conventional Insufflation System|conventional insufflation system
69801|NCT03128281|CIS|cis
69802|NCT03128281|Questionnaires|questionnaires
69803|NCT03128281|Surveys|surveys
69804|NCT03128255|Fusion|fusion
69805|NCT03128255|Hybrid Imaging|hybrid imaging
69806|NCT03128255|Mapping|mapping
69807|NCT03128255|Iodine|iodine
69808|NCT03128255|Ultrasound|ultrasound
69809|NCT03128242|oxytocin|oxytocin
69810|NCT03128242|attention bias|attention bias
69811|NCT03128242|attention training|attention training
69812|NCT03128242|eye-tracking|eye-tracking
69813|NCT03128203|Oxytocin|oxytocin
69814|NCT03128203|Resting-state|resting-state
69815|NCT03128203|Functional connectivity|functional connectivity
69816|NCT03128203|BOLD|bold
69817|NCT03128190|high-risk surgery|high-risk surgery
69818|NCT03128190|pulse-pressure variation|pulse-pressure variation
69819|NCT03128190|monitoring|monitoring
69820|NCT03128190|Postoperative Complications|postoperative complications
69821|NCT03128177|nocturnal hypertension|nocturnal hypertension
69822|NCT03128177|non-dipping blood pressure|non-dipping blood pressure
69823|NCT03128177|obstructive sleep apnea|obstructive sleep apnea
69824|NCT03128151|NMB (Neuromuscular Blockade)|nmb (neuromuscular blockade)
69825|NCT03128151|Anesthesia|anesthesia
69826|NCT03128151|Curarization|curarization
69827|NCT03128151|TOFr (train of four)|tofr (train of four)
69828|NCT03128151|PACU (postanesthesia care unit)|pacu (postanesthesia care unit)
69829|NCT03128151|Monitorization|monitorization
69830|NCT03128112|Parental perception, obesity, overweight|parental perception, obesity, overweight
69831|NCT03128099|Social Skills|social skills
69832|NCT03128099|Social attention|social attention
69833|NCT03128099|Virtual reality|virtual reality
69834|NCT03128099|Eye tracking|eye tracking
69835|NCT03128073|Heart failure, Cardio-Renal Syndrome|heart failure, cardio-renal syndrome
69836|NCT03128047|pediatric cancer|pediatric cancer
69837|NCT03128047|brain tumor|brain tumor
69838|NCT03128047|glioblastoma|glioblastoma
69839|NCT03128047|high grade brain tumor|high grade brain tumor
69840|NCT03128047|malignant brain tumor|malignant brain tumor
69841|NCT03128021|Depression|depression
69842|NCT03128021|fMRI|fmri
69843|NCT03128021|Escitalopram|escitalopram
69844|NCT03128021|Lexapro|lexapro
69845|NCT03128021|Randomized Clinical Trial|randomized clinical trial
69846|NCT03128021|Levomilnacipran|levomilnacipran
69847|NCT03128021|Fetzima|fetzima
69848|NCT03127995|Breast Cancer pT1-3, pN0-N3, M0|breast cancer pt1-3, pn0-n3, m0
69849|NCT03127995|Lymph Node Irradiation|lymph node irradiation
69850|NCT03127982|Anxiety Depression Emotion PTSD Randomized Clinical Trial|anxiety depression emotion ptsd randomized clinical trial
69851|NCT03127969|Rheumatoid hand|rheumatoid hand
69852|NCT03127969|Fluidotherapy|fluidotherapy
70240|NCT03125577|CD70|cd70
69853|NCT03127969|Rehabilitation|rehabilitation
69854|NCT03127943|lidocaine, mandible|lidocaine, mandible
69855|NCT03127930|Cognitive Impairment|cognitive impairment
69856|NCT03127930|Memory loss|memory loss
69857|NCT03127930|Caregivers|caregivers
69858|NCT03127930|Medication adherence|medication adherence
69859|NCT03127930|Medication compliance|medication compliance
69860|NCT03127930|Medication management|medication management
69861|NCT03127930|Problem solving|problem solving
69862|NCT03127930|Quality of Life|quality of life
69863|NCT03127930|Health resource utilization|health resource utilization
69864|NCT03127930|Community dwelling|community dwelling
69865|NCT03127917|Gait Speed|gait speed
69866|NCT03127917|Cognitive Function|cognitive function
69867|NCT03127904|Varicose ulcer|varicose ulcer
69868|NCT03127904|Compressive therapy|compressive therapy
69869|NCT03127904|Venous ulcer|venous ulcer
69870|NCT03127904|Chronic venous disease|chronic venous disease
69871|NCT03127891|pranayama yoga|pranayama yoga
69872|NCT03127878|Exercise|exercise
69873|NCT03127878|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
69874|NCT03127878|Activities of Daily Living|activities of daily living
69875|NCT03127878|Upper Extremity|upper extremity
69876|NCT03127878|Motor Activity|motor activity
69877|NCT03127839|Exercise|exercise
69878|NCT03127839|Pain Neuroscience Education|pain neuroscience education
69879|NCT03127839|Physical Therapy|physical therapy
69880|NCT03127839|Subacromial Pain|subacromial pain
69881|NCT03127839|Rotator Cuff|rotator cuff
69882|NCT03127826|Low Back Pain|low back pain
69883|NCT03127826|Risk-Stratified Care|risk-stratified care
69884|NCT03127813|glaucoma|glaucoma
69885|NCT03127813|OSA|osa
69886|NCT03127813|apnoea|apnoea
69887|NCT03127813|intraocular|intraocular
69888|NCT03127813|CPAP|cpap
69889|NCT03127813|airway|airway
69890|NCT03127813|pressure|pressure
69891|NCT03127813|blindness|blindness
69892|NCT03127800|Obstructive Sleep Apnoea|obstructive sleep apnoea
69893|NCT03127800|Morphine sulphate|morphine sulphate
69894|NCT03127800|Sleep Disordered Breathing|sleep disordered breathing
69895|NCT03127800|Central Sleep Apnoea|central sleep apnoea
69896|NCT03127800|Hypoxaemia|hypoxaemia
69897|NCT03127800|Hypercapnia|hypercapnia
69898|NCT03127800|Cheyne-Stokes Respiration|cheyne-stokes respiration
69899|NCT03127800|Analgesia|analgesia
69900|NCT03127800|Respiration|respiration
69901|NCT03127800|Apnoea-Hypopnea Index|apnoea-hypopnea index
69902|NCT03127800|Oxygen Desaturation Index|oxygen desaturation index
69903|NCT03127800|Oximetry|oximetry
69904|NCT03127800|Respiratory Polygraphy|respiratory polygraphy
69905|NCT03127800|Polysomnography|polysomnography
69906|NCT03127774|Cisplatin|cisplatin
69907|NCT03127774|Heated Cisplatin|heated cisplatin
69908|NCT03127761|Multiple Myeloma|multiple myeloma
69909|NCT03127748|ventricular septal defect,transcatheter closure|ventricular septal defect,transcatheter closure
69910|NCT03127735|Phase 1|phase 1
69911|NCT03127735|mIDH1|midh1
69912|NCT03127735|IDH1 mutation|idh1 mutation
69913|NCT03127735|mIDH1 inhibitor|midh1 inhibitor
69914|NCT03127709|17-199|17-199
69915|NCT03127709|histiocytosis|histiocytosis
69916|NCT03127696|Fecal Microbiota Transplant|fecal microbiota transplant
69917|NCT03127631|Androgen Deprivation Therapy|androgen deprivation therapy
69918|NCT03127553|salt intake|salt intake
69919|NCT03127553|functional food|functional food
69920|NCT03127553|low-salt bread|low-salt bread
69921|NCT03127553|blood pressure|blood pressure
69922|NCT03127514|Randomized|randomized
69923|NCT03127514|Double-blind|double-blind
69924|NCT03127514|Placebo-controlled|placebo-controlled
69925|NCT03127514|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
69926|NCT03127514|Sodium Phenylbutyrate|sodium phenylbutyrate
69927|NCT03127514|Tauroursodeoxycholic Acid|tauroursodeoxycholic acid
69928|NCT03127475|Parkinson's disease|parkinson's disease
69929|NCT03127475|freezing of gait|freezing of gait
69930|NCT03127475|electrophysiology|electrophysiology
69931|NCT03127475|magnetic resonance image|magnetic resonance image
69932|NCT03127475|direct current stimulation|direct current stimulation
69933|NCT03127423|Hybrid ablation|hybrid ablation
69934|NCT03127423|Thoracoscope|thoracoscope
69935|NCT03127397|antiretroviral therapy|antiretroviral therapy
69936|NCT03127397|HIV/AIDS|hiv/aids
69937|NCT03127397|ART adherence|art adherence
69938|NCT03127371|Nitrous Oxide|nitrous oxide
69939|NCT03127371|Abscess|abscess
69940|NCT03127371|Incision and drainage|incision and drainage
69941|NCT03127358|Addiction|addiction
69942|NCT03127358|Sustained Viral Response|sustained viral response
69943|NCT03127358|Adherence|adherence
69944|NCT03127358|Adverse Effects|adverse effects
69945|NCT03127358|Direct Acting Antiviral Agent|direct acting antiviral agent
69946|NCT03127358|Chronic Hepatitis C|chronic hepatitis c
69947|NCT03127358|Resistance Development|resistance development
69948|NCT03127358|Methadone Clinic|methadone clinic
69949|NCT03127358|Primary Care|primary care
69950|NCT03127358|Directly Observed Therapy|directly observed therapy
69951|NCT03127358|Randomized Controlled Trial|randomized controlled trial
69952|NCT03127358|Resistance|resistance
69954|NCT03127358|Treatment Outcome|treatment outcome
69955|NCT03127358|Patient Navigation|patient navigation
69956|NCT03127358|Multi-Site|multi-site
69957|NCT03127358|Liver Disease|liver disease
69958|NCT03127358|Intervention|intervention
69959|NCT03127332|Treatment care planning|treatment care planning
69960|NCT03127306|Pain|pain
69961|NCT03127306|Behavioural Pain Scale|behavioural pain scale
69962|NCT03127306|BPS|bps
69963|NCT03127306|NRS|nrs
69964|NCT03127306|Delirium|delirium
69965|NCT03127306|CAM-ICU|cam-icu
69966|NCT03127280|urinary tract infections|urinary tract infections
69967|NCT03127280|postoperative voiding dysfunction|postoperative voiding dysfunction
69968|NCT03127280|foley removal|foley removal
69969|NCT03127280|patient satisfaction|patient satisfaction
69970|NCT03127254|Video Narrative|video narrative
69971|NCT03127241|Assistive devices|assistive devices
69972|NCT03127241|Randomized controlled trial (RCT)|randomized controlled trial (rct)
69973|NCT03127241|Upper limbs|upper limbs
69974|NCT03127241|Robotic devices|robotic devices
69975|NCT03127228|Laser|laser
69976|NCT03127202|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
69977|NCT03127150|Chylous leakage|chylous leakage
69978|NCT03127150|Diagnostic criteria|diagnostic criteria
69979|NCT03127150|Pancreas surgery|pancreas surgery
69980|NCT03127150|Therapy|therapy
69981|NCT03127098|locally advanced or metastatic|locally advanced or metastatic
69982|NCT03127098|carcinoembryonic antigen (CEA)-expressing|carcinoembryonic antigen (cea)-expressing
69983|NCT03127098|CEA|cea
69984|NCT03127098|carcinoembryonic antigen|carcinoembryonic antigen
69985|NCT03127072|colorectal cancer|colorectal cancer
69986|NCT03127072|liver metastasis|liver metastasis
69987|NCT03127072|Radiofrequency Ablation|radiofrequency ablation
69988|NCT03127072|chemotherapy|chemotherapy
69989|NCT03127072|target therapy|target therapy
69990|NCT03127059|Dysfunctional Breathing|dysfunctional breathing
69991|NCT03127059|Uncontrolled Asthma|uncontrolled asthma
69992|NCT03127059|Breathing Exercises|breathing exercises
69993|NCT03127059|Adults|adults
69994|NCT03127007|immunotherapy|immunotherapy
69995|NCT03127007|anti-PD-L1|anti-pd-l1
69996|NCT03126955|microvascular decompression, Xth nerve|microvascular decompression, xth nerve
69997|NCT03126942|Aged patients|aged patients
69998|NCT03126942|Cost Estimates|cost estimates
69999|NCT03126942|Complete Denture|complete denture
70000|NCT03126942|Dental Economics|dental economics
70001|NCT03126942|Dental Implants|dental implants
70002|NCT03126942|Dental Prosthesis, Implant-Supported|dental prosthesis, implant-supported
70003|NCT03126942|Denture Retention|denture retention
70004|NCT03126942|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
70005|NCT03126942|Oral Health-Related Quality of Life|oral health-related quality of life
70006|NCT03126942|Overdenture|overdenture
70007|NCT03126942|Patient Acceptance of Health Care|patient acceptance of health care
70008|NCT03126942|Quality of Healthcare|quality of healthcare
70009|NCT03126942|Quality of Life|quality of life
70010|NCT03126942|Patient Satisfaction|patient satisfaction
70011|NCT03126942|Single implant overdenture|single implant overdenture
70012|NCT03126929|disorders of consciousness|disorders of consciousness
70013|NCT03126929|Vegetative state|vegetative state
70014|NCT03126929|Minimally conscious state|minimally conscious state
70015|NCT03126929|Emergence from MCS|emergence from mcs
70016|NCT03126929|Coma Recovery Scale-Revised|coma recovery scale-revised
70017|NCT03126890|Pharmacokinetics,adverse events|pharmacokinetics,adverse events
70018|NCT03126890|Linezolid|linezolid
70019|NCT03126890|Therapeutic drug monitoring|therapeutic drug monitoring
70020|NCT03126890|Myelosuppression|myelosuppression
70021|NCT03126890|Lactic acidosis|lactic acidosis
70022|NCT03126890|Peripheral neuropathy|peripheral neuropathy
70023|NCT03126864|Hematopoietic/Lymphoid Cancer|hematopoietic/lymphoid cancer
70024|NCT03126864|Acute Myeloid Leukemia|acute myeloid leukemia
70025|NCT03126864|AML|aml
70026|NCT03126864|Relapsed or Refractory CD33-Positive|relapsed or refractory cd33-positive
70027|NCT03126864|CD33-CAR-T cells|cd33-car-t cells
70028|NCT03126864|Fludarabine|fludarabine
70029|NCT03126864|Fludarabine phosphate|fludarabine phosphate
70030|NCT03126864|Fludara|fludara
70031|NCT03126864|Cyclophosphamide|cyclophosphamide
70032|NCT03126864|Cytoxan|cytoxan
70033|NCT03126864|Neosar|neosar
70034|NCT03126838|diaphragm|diaphragm
70035|NCT03126838|ultrasound|ultrasound
70036|NCT03126838|dysfunction|dysfunction
70037|NCT03126838|cardiac surgery|cardiac surgery
70038|NCT03126838|weaning|weaning
70039|NCT03126812|Primary stage 4|primary stage 4
70040|NCT03126812|Neo adjuvant|neo adjuvant
70041|NCT03126786|Diabetes Mellitus|diabetes mellitus
70042|NCT03126786|Diabetic Retinopathy|diabetic retinopathy
70043|NCT03126786|Microneedle|microneedle
70044|NCT03126786|Mircoinjection|mircoinjection
70045|NCT03126786|Triamcinolone|triamcinolone
70046|NCT03126786|Choroid|choroid
70047|NCT03126786|Choroid Injection|choroid injection
70048|NCT03126786|Aflibercept|aflibercept
70049|NCT03126786|Suprachoroidal|suprachoroidal
70050|NCT03126773|non-interventional|non-interventional
70051|NCT03126773|cohort|cohort
70052|NCT03126773|Angeliq Micro|angeliq micro
70053|NCT03126773|menopause|menopause
70054|NCT03126773|Russia|russia
70055|NCT03126734|Down Syndrome|down syndrome
70056|NCT03126734|Acceptance|acceptance
70057|NCT03126734|Commitment|commitment
70058|NCT03126734|Concience of influence|concience of influence
70059|NCT03126721|drug interaction|drug interaction
70060|NCT03126721|PF-06751979|pf-06751979
70061|NCT03126721|oral midazolam|oral midazolam
70062|NCT03126695|Abnormal hemoglobin (called hemoglobin S or sickle hemoglobin) in the red blood cells|abnormal hemoglobin (called hemoglobin s or sickle hemoglobin) in the red blood cells
70063|NCT03126695|Thrombotic cardiovascular events|thrombotic cardiovascular events
70064|NCT03126695|Acute coronary syndrome|acute coronary syndrome
70065|NCT03126695|P2Y12 platelet inhibitor|p2y12 platelet inhibitor
70066|NCT03126695|Brilinta|brilinta
70067|NCT03126682|Wellbutrin|wellbutrin
70068|NCT03126682|Electroconvulsive therapy|electroconvulsive therapy
70069|NCT03126682|Right Unilateral Ultra Brief|right unilateral ultra brief
70070|NCT03126669|Hyperbaric oxygen|hyperbaric oxygen
70071|NCT03126669|multitasking performance|multitasking performance
70072|NCT03126669|cognitive funcitons|cognitive funcitons
70073|NCT03126656|testosterone|testosterone
70074|NCT03126656|chronic heart failure|chronic heart failure
70075|NCT03126552|hookworm|hookworm
70076|NCT03126552|controlled human infection model|controlled human infection model
70077|NCT03126539|aging|aging
70078|NCT03126539|ultraviolet exposure|ultraviolet exposure
70079|NCT03126539|skin fragility|skin fragility
70080|NCT03126539|sulforaphane|sulforaphane
70081|NCT03126513|G-POEM|g-poem
70082|NCT03126513|Safety|safety
70083|NCT03126513|Efficacy|efficacy
70084|NCT03126500|Malnutrition|malnutrition
70085|NCT03126500|Disease-related malnutrition|disease-related malnutrition
70086|NCT03126500|Frailty|frailty
70087|NCT03126500|Sarcopenia|sarcopenia
70088|NCT03126500|Hospital discharge|hospital discharge
70089|NCT03126500|Geriatrics|geriatrics
70090|NCT03126461|metastatic melanoma|metastatic melanoma
70091|NCT03126448|Infection|infection
70092|NCT03126448|Nonunion|nonunion
70093|NCT03126448|Fracture healing|fracture healing
70094|NCT03126435|FOLFIRINOX|folfirinox
70095|NCT03126435|5-Fluorouracil|5-fluorouracil
70096|NCT03126435|folinic acid|folinic acid
70097|NCT03126435|irinotecan|irinotecan
70098|NCT03126435|oxaliplatin|oxaliplatin
70099|NCT03126435|Gemcitabine|gemcitabine
70100|NCT03126409|coronary artery disease|coronary artery disease
70101|NCT03126409|coronary artery bypass graft|coronary artery bypass graft
70102|NCT03126344|King Vision|king vision
70103|NCT03126331|Kidney Cancer|kidney cancer
70104|NCT03126331|Metastatic|metastatic
70105|NCT03126331|Nivolumab|nivolumab
70106|NCT03126305|exposure|exposure
70107|NCT03126305|response prevention|response prevention
70108|NCT03126305|web-based application|web-based application
70109|NCT03126292|Medical home|medical home
70110|NCT03126292|Primary care|primary care
70111|NCT03126292|Children|children
70112|NCT03126292|Development|development
70113|NCT03126279|Osteoarthritis|osteoarthritis
70114|NCT03126279|Pain|pain
70115|NCT03126279|Postoperative Pain|postoperative pain
70116|NCT03126253|childhood anemia, socioeconomic status|childhood anemia, socioeconomic status
70117|NCT03126227|AR101|ar101
70118|NCT03126227|Characterized Peanut Allergen|characterized peanut allergen
70119|NCT03126227|CPNA (Characterized Peanut Allergen)|cpna (characterized peanut allergen)
70120|NCT03126227|OIT (oral immunotherapy)|oit (oral immunotherapy)
70121|NCT03126227|Peanut Allergy|peanut allergy
70122|NCT03126227|Peanut-Allergic Children|peanut-allergic children
70123|NCT03126227|Desensitization|desensitization
70124|NCT03126227|ARC007|arc007
70125|NCT03126227|Characterized Oral Desensitization Immunotherapy (CODIT™)|characterized oral desensitization immunotherapy (codit™)
70126|NCT03126214|atrial fibrillation|atrial fibrillation
70127|NCT03126214|stroke|stroke
70128|NCT03126214|oral anticoagulation therapy|oral anticoagulation therapy
70129|NCT03126214|pharmacist case management|pharmacist case management
70130|NCT03126201|focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
70131|NCT03126201|disease progression|disease progression
70132|NCT03126175|conservative treatment, treatment outcome|conservative treatment, treatment outcome
70133|NCT03126162|minimally invasive gynecologic surgery|minimally invasive gynecologic surgery
70134|NCT03126162|same-day discharge|same-day discharge
70135|NCT03126162|bladder testing|bladder testing
70136|NCT03126136|Fetal heart rate abnormalities|fetal heart rate abnormalities
70137|NCT03126136|Pregnancy|pregnancy
70138|NCT03126136|Epidural analgesia|epidural analgesia
70139|NCT03126136|Pulse pressure|pulse pressure
70140|NCT03126123|Anal condylomatosis|anal condylomatosis
70141|NCT03126123|surgery|surgery
70142|NCT03126123|acetic acid|acetic acid
70143|NCT03126123|dysplastic areas|dysplastic areas
70144|NCT03126110|cervical cancer|cervical cancer
70145|NCT03126110|endometrial cancer|endometrial cancer
70146|NCT03126110|gastric cancer (stomach, esophageal, and gastroesophageal junction [GEJ])|gastric cancer (stomach, esophageal, and gastroesophageal junction [gej])
70442|NCT03123835|endoscopic|endoscopic
70147|NCT03126110|hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
70148|NCT03126110|melanoma|melanoma
70149|NCT03126110|Merkel cell carcinoma|merkel cell carcinoma
70150|NCT03126110|mesothelioma|mesothelioma
70151|NCT03126110|microsatellite instability-high (MSI-H) colorectal cancer (CRC)|microsatellite instability-high (msi-h) colorectal cancer (crc)
70152|NCT03126110|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
70153|NCT03126110|ovarian cancer|ovarian cancer
70154|NCT03126110|squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
70155|NCT03126110|small cell lung cancer (SCLC)|small cell lung cancer (sclc)
70156|NCT03126110|renal cell carcinoma (RCC)|renal cell carcinoma (rcc)
70157|NCT03126110|triple-negative breast cancer (TNBC)|triple-negative breast cancer (tnbc)
70158|NCT03126110|urothelial carcinoma|urothelial carcinoma
70159|NCT03126110|glucocorticoid-induced tumor necrosis factor receptor (GITR)|glucocorticoid-induced tumor necrosis factor receptor (gitr)
70160|NCT03126058|enhanced recovery after surgery|enhanced recovery after surgery
70161|NCT03126058|colorectal cancer|colorectal cancer
70162|NCT03126045|Lumbar puncture|lumbar puncture
70163|NCT03126045|Post lumbar puncture headache|post lumbar puncture headache
70164|NCT03126045|Atraumatic needle|atraumatic needle
70165|NCT03126045|Haematology|haematology
70166|NCT03126032|Sepsis|sepsis
70167|NCT03126032|SIRS|sirs
70168|NCT03126032|Glycocalyx|glycocalyx
70169|NCT03126032|Glycocheck™-System|glycocheck™-system
70170|NCT03126032|Infection|infection
70171|NCT03126019|Follicular lymphoma|follicular lymphoma
70172|NCT03126019|non-Hodgkin lymphoma (NHL)|non-hodgkin lymphoma (nhl)
70173|NCT03126019|phosphatidylinositol 3-kinase (PI3K) δ inhibitor|phosphatidylinositol 3-kinase (pi3k) δ inhibitor
70174|NCT03125993|obesity; brisk walking|obesity; brisk walking
70175|NCT03125928|Atezolizumab|atezolizumab
70176|NCT03125928|PD-L1|pd-l1
70177|NCT03125915|couples HIV testing; drug intervention; communication skills|couples hiv testing; drug intervention; communication skills
70178|NCT03125889|Image-guided|image-guided
70179|NCT03125889|BPH|bph
70180|NCT03125889|Aquablation|aquablation
70181|NCT03125889|AQUABEAM|aquabeam
70182|NCT03125889|LUTS|luts
70183|NCT03125889|Tissue resection|tissue resection
70184|NCT03125889|Robotics|robotics
70185|NCT03125863|Image-guided|image-guided
70186|NCT03125863|BPH|bph
70187|NCT03125863|Aquablation|aquablation
70188|NCT03125863|AQUABEAM|aquabeam
70189|NCT03125863|LUTS|luts
70190|NCT03125863|Tissue resection|tissue resection
70191|NCT03125863|Robotics|robotics
70192|NCT03125850|day-ward|day-ward
70193|NCT03125850|inpatient|inpatient
70194|NCT03125811|Isopropyl alcohol|isopropyl alcohol
70195|NCT03125811|Zofran|zofran
70196|NCT03125811|antiemetics|antiemetics
70197|NCT03125798|video-assisted thoracic surgery|video-assisted thoracic surgery
70198|NCT03125798|LigaSure|ligasure
70199|NCT03125798|mediastinal lymph node dissection|mediastinal lymph node dissection
70200|NCT03125785|congenital cataract, contact lens|congenital cataract, contact lens
70201|NCT03125772|coronary artery disease|coronary artery disease
70202|NCT03125772|diabetes mellitus|diabetes mellitus
70203|NCT03125772|everolimus|everolimus
70204|NCT03125772|paclitaxel stents|paclitaxel stents
70205|NCT03125759|Ischemic Stroke|ischemic stroke
70207|NCT03125733|Endoscopy, Digestive system|endoscopy, digestive system
70208|NCT03125733|Natural orifice transluminal endoscopic surgery|natural orifice transluminal endoscopic surgery
70209|NCT03125733|Therapeutic|therapeutic
70210|NCT03125733|Complications|complications
70211|NCT03125720|cardiac resynchronization therapy|cardiac resynchronization therapy
70212|NCT03125720|chronic heart failure|chronic heart failure
70213|NCT03125720|image fusion-guided implantation|image fusion-guided implantation
70214|NCT03125720|SPECT|spect
70215|NCT03125720|venogram|venogram
70216|NCT03125681|remote ischemic conditioning|remote ischemic conditioning
70217|NCT03125681|off-pump coronary artery bypass surgery|off-pump coronary artery bypass surgery
70218|NCT03125655|cytokines|cytokines
70219|NCT03125642|Lymphoblastic Lymphoma|lymphoblastic lymphoma
70220|NCT03125642|Mature B-cell Lymphomas|mature b-cell lymphomas
70221|NCT03125642|Follicular Lymphoma|follicular lymphoma
70222|NCT03125642|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
70223|NCT03125642|Mantle Cell Lymphoma|mantle cell lymphoma
70224|NCT03125642|Burkitt's/Burkitt's like|burkitt's/burkitt's like
70225|NCT03125642|Mature T-Cell Lymphoma|mature t-cell lymphoma
70226|NCT03125616|Prematurity|prematurity
70227|NCT03125616|Vaccination|vaccination
70228|NCT03125603|Immunotherapy|immunotherapy
70229|NCT03125603|Anti-PD-(L)-1|anti-pd-(l)-1
70230|NCT03125603|Anti-CTLA-4|anti-ctla-4
70231|NCT03125590|Osteoporosis, osteopenia, test-retest, validity, PEQ, questionnaire, facilitators, barriers, exercise, physical activity|osteoporosis, osteopenia, test-retest, validity, peq, questionnaire, facilitators, barriers, exercise, physical activity
70232|NCT03125577|4S CAR-T|4s car-t
70233|NCT03125577|CD19|cd19
70234|NCT03125577|CD20|cd20
70235|NCT03125577|CD22|cd22
70236|NCT03125577|CD38|cd38
70237|NCT03125577|CD123|cd123
70238|NCT03125577|B cell leukemia|b cell leukemia
70239|NCT03125577|B-ALL|b-all
70241|NCT03125551|Dietary supplements|dietary supplements
70242|NCT03125551|Bleeding tendency|bleeding tendency
70243|NCT03125538|Motor Imagery|motor imagery
70244|NCT03125538|Amputation|amputation
70245|NCT03125538|Functional rehabilitation|functional rehabilitation
70246|NCT03125538|Locomotion|locomotion
70247|NCT03125538|Phantom-limb pain|phantom-limb pain
70248|NCT03125525|migraine|migraine
70249|NCT03125525|transcutaneous|transcutaneous
70250|NCT03125525|supraorbital|supraorbital
70251|NCT03125525|nerve|nerve
70252|NCT03125525|stimulation|stimulation
70253|NCT03125512|Sleep Apnea Syndromes|sleep apnea syndromes
70254|NCT03125512|Positional sleep apnea|positional sleep apnea
70255|NCT03125512|CPAP|cpap
70256|NCT03125512|Night Shift|night shift
70257|NCT03125486|subcutaneous Belimumab|subcutaneous belimumab
70258|NCT03125486|Individual Patient Compassionate Use|individual patient compassionate use
70259|NCT03125486|SLE|sle
70260|NCT03125486|GSK1550188|gsk1550188
70261|NCT03125447|Prematurely born children|prematurely born children
70262|NCT03125447|Attention function|attention function
70263|NCT03125447|Posture|posture
70264|NCT03125447|Mobility|mobility
70265|NCT03125356|diet soda|diet soda
70266|NCT03125356|low-calorie sweeteners|low-calorie sweeteners
70267|NCT03125356|obesity|obesity
70268|NCT03125343|radiotherapy|radiotherapy
70269|NCT03125343|chemotherapy|chemotherapy
70270|NCT03125343|complete response|complete response
70271|NCT03125330|Coaching|coaching
70272|NCT03125330|Professional coaching|professional coaching
70273|NCT03125330|Emergency physicians|emergency physicians
70274|NCT03125330|Emergency medicine|emergency medicine
70275|NCT03125330|Goal attainment|goal attainment
70276|NCT03125330|Leadership strengths|leadership strengths
70277|NCT03125330|Well-being|well-being
70278|NCT03125330|Burnout|burnout
70279|NCT03125330|Adult level of development|adult level of development
70280|NCT03125330|Group coaching|group coaching
70281|NCT03125330|Instructor|instructor
70282|NCT03125330|Assistant professor|assistant professor
70283|NCT03125330|Academic faculty|academic faculty
70284|NCT03125330|Subject-Object Interview|subject-object interview
70285|NCT03125304|Endometriosis|endometriosis
70286|NCT03125304|acupuncture|acupuncture
70287|NCT03125304|pain|pain
70288|NCT03125304|dysmenorrhea|dysmenorrhea
70289|NCT03125291|Substance Use and Abuse|substance use and abuse
70290|NCT03125291|Risky Sexual Behavior|risky sexual behavior
70291|NCT03125291|Behavior Problems|behavior problems
70292|NCT03125291|Academic Achievement|academic achievement
70293|NCT03125265|nutrition|nutrition
70294|NCT03125265|hemodialysis|hemodialysis
70295|NCT03125265|mortality|mortality
70296|NCT03125265|omega 3|omega 3
70297|NCT03125252|Delirium|delirium
70298|NCT03125252|Reanimation|reanimation
70299|NCT03125252|Conversational hypnosis|conversational hypnosis
70300|NCT03125239|Refractory Adult Acute Myeloid Leukemia|refractory adult acute myeloid leukemia
70301|NCT03125239|Relapsed Adult Acute Myeloid Leukemia|relapsed adult acute myeloid leukemia
70302|NCT03125187|Sodium Heparin|sodium heparin
70303|NCT03125187|Intravenous administration|intravenous administration
70304|NCT03125187|Pharmacokinetics|pharmacokinetics
70305|NCT03125187|Coagulation factor|coagulation factor
70306|NCT03125174|sputum|sputum
70307|NCT03125174|bronchiectasis|bronchiectasis
70308|NCT03125174|lung disease|lung disease
70309|NCT03125161|colorectal cancer|colorectal cancer
70310|NCT03125161|liver metastasis|liver metastasis
70311|NCT03125161|hepatic arterial infusion|hepatic arterial infusion
70312|NCT03125161|chemotherapy|chemotherapy
70313|NCT03125161|target therapy|target therapy
70314|NCT03125161|conversional resection rates|conversional resection rates
70315|NCT03125083|Skin restricted lupus|skin restricted lupus
70316|NCT03125083|Psychiatric disorders|psychiatric disorders
70317|NCT03125083|Inflammation|inflammation
70318|NCT03125083|Kynurenine pathway|kynurenine pathway
70319|NCT03124667|adherence|adherence
70320|NCT03124667|cognition|cognition
70321|NCT03124667|exercise|exercise
70322|NCT03124667|aging|aging
70323|NCT03124667|brain training|brain training
70324|NCT03124667|cognitive training|cognitive training
70325|NCT03124667|executive function|executive function
70326|NCT03124641|Hypothermic oxygenated machine perfusion|hypothermic oxygenated machine perfusion
70327|NCT03124641|Orthotopic liver transplantation|orthotopic liver transplantation
70328|NCT03124641|Extended criteria donation|extended criteria donation
70329|NCT03124641|Donation after brain death|donation after brain death
70330|NCT03124641|HOPE|hope
70331|NCT03124563|Exercise|exercise
70332|NCT03124563|Health Behavior|health behavior
70333|NCT03124563|Aging|aging
70334|NCT03124550|Caregivers|caregivers
70335|NCT03124550|Exercise|exercise
70336|NCT03124550|Behavior Change|behavior change
70337|NCT03124537|Physical Exercise|physical exercise
70338|NCT03124537|Behavior Change|behavior change
70339|NCT03124524|estradiol valerate/dienogest|estradiol valerate/dienogest
70340|NCT03124524|ethinylestradiol/ drospirenone|ethinylestradiol/ drospirenone
70341|NCT03124524|pelvic pain|pelvic pain
70342|NCT03124524|primary dysmenorrhea|primary dysmenorrhea
70343|NCT03124524|uterine artery doppler indices|uterine artery doppler indices
70344|NCT03124498|Hepatocellular Carcinoma, Autologous Cytokine-Induced Killer|hepatocellular carcinoma, autologous cytokine-induced killer
70345|NCT03124459|CMT1 / CMTX|cmt1 / cmtx
70346|NCT03124446|mindfulness|mindfulness
70347|NCT03124433|prostate cancer|prostate cancer
70348|NCT03124433|prostatectomy, retropubic|prostatectomy, retropubic
70349|NCT03124433|Androgen Receptor Antagonists|androgen receptor antagonists
70350|NCT03124420|Helicobacter Infection|helicobacter infection
70351|NCT03124420|Eradication therapy|eradication therapy
70352|NCT03124420|Antibiotics|antibiotics
70353|NCT03124355|vagal stimulation|vagal stimulation
70354|NCT03124355|POTS|pots
70355|NCT03124355|galantamine|galantamine
70356|NCT03124355|pyridostigmine|pyridostigmine
70357|NCT03124238|massage|massage
70358|NCT03124212|mutation carrier|mutation carrier
70359|NCT03124212|blood relative|blood relative
70360|NCT03124212|genetic testing|genetic testing
70361|NCT03124212|family-based cohort|family-based cohort
70362|NCT03124199|Eradication|eradication
70363|NCT03124199|Helicobacter pylori|helicobacter pylori
70364|NCT03124199|rifaximin|rifaximin
70365|NCT03124199|therapy|therapy
70366|NCT03124199|standard triple therapy|standard triple therapy
70367|NCT03124186|motor recovery|motor recovery
70368|NCT03124186|neuroplasticity|neuroplasticity
70369|NCT03124186|subacute|subacute
70370|NCT03124186|human|human
70371|NCT03124186|sensory|sensory
70372|NCT03124186|nerve stimulation|nerve stimulation
70373|NCT03124173|fMRI|fmri
70374|NCT03124173|cingulate cortex|cingulate cortex
70375|NCT03124173|adaptation|adaptation
70376|NCT03124173|frontal cortex|frontal cortex
70377|NCT03124160|Healthy Women|healthy women
70378|NCT03124160|Female Contraception|female contraception
70380|NCT03124147|motor recovery|motor recovery
70381|NCT03124147|neuroplasticity|neuroplasticity
70382|NCT03124147|chronic|chronic
70383|NCT03124147|human|human
70384|NCT03124147|noninvasive brain stimulation|noninvasive brain stimulation
70385|NCT03124147|neuromodulation|neuromodulation
70386|NCT03124108|Elafibranor|elafibranor
70387|NCT03124108|Primary Biliary Cholangitis|primary biliary cholangitis
70388|NCT03124108|Alkaline phosphatase|alkaline phosphatase
70389|NCT03124095|physical exercise|physical exercise
70390|NCT03124095|combined training|combined training
70391|NCT03124095|physical activity|physical activity
70392|NCT03124095|physical fitness|physical fitness
70393|NCT03124056|Extracorporeal photopheresis|extracorporeal photopheresis
70394|NCT03124056|Biomarker of response|biomarker of response
70395|NCT03124056|Steroid resistant|steroid resistant
70396|NCT03124030|direct oral anticoagulant|direct oral anticoagulant
70397|NCT03124030|oral anticoagulant therapy|oral anticoagulant therapy
70398|NCT03124030|dental extraction|dental extraction
70399|NCT03124030|bleeding complication|bleeding complication
70400|NCT03124030|atrial fibrillation|atrial fibrillation
70401|NCT03124030|deep venous thrombosis|deep venous thrombosis
70402|NCT03124004|direct oral anticoagulant|direct oral anticoagulant
70403|NCT03124004|oral anticoagulant therapy|oral anticoagulant therapy
70404|NCT03124004|periodontal disease|periodontal disease
70405|NCT03124004|periodontal debridement|periodontal debridement
70406|NCT03124004|ultrasonic periodontal debridement|ultrasonic periodontal debridement
70407|NCT03124004|ultrasonic scaling|ultrasonic scaling
70408|NCT03124004|periodontal scaling|periodontal scaling
70409|NCT03124004|subgingival scaling|subgingival scaling
70410|NCT03123978|castration resistant prostate cancer|castration resistant prostate cancer
70411|NCT03123965|Special Access Scheme|special access scheme
70412|NCT03123965|Expanded Access|expanded access
70413|NCT03123965|Pre-approval Access|pre-approval access
70414|NCT03123965|Compassionate Use|compassionate use
70415|NCT03123965|Special Access Program|special access program
70416|NCT03123965|Named Patient Basis|named patient basis
70417|NCT03123952|Expanded Access|expanded access
70418|NCT03123952|Pre-approval Access|pre-approval access
70419|NCT03123952|Compassionate Use|compassionate use
70420|NCT03123952|Special Access Program|special access program
70421|NCT03123952|Named Patient Basis|named patient basis
70422|NCT03123952|Special Access Scheme|special access scheme
70423|NCT03123939|ALL|all
70424|NCT03123926|spontaneous preterm birth|spontaneous preterm birth
70425|NCT03123926|lipids|lipids
70426|NCT03123926|biomarkers|biomarkers
70427|NCT03123874|human milk|human milk
70428|NCT03123874|breast milk|breast milk
70429|NCT03123874|expressed human milk|expressed human milk
70430|NCT03123874|bacterial communities|bacterial communities
70431|NCT03123874|microbiome|microbiome
70432|NCT03123874|breast pump|breast pump
70433|NCT03123874|bacterial growth|bacterial growth
70434|NCT03123861|Pelvic Organ Prolapse|pelvic organ prolapse
70435|NCT03123861|postoperative gluteal pain|postoperative gluteal pain
70436|NCT03123861|opioid use|opioid use
70437|NCT03123835|Achalasia|achalasia
70438|NCT03123835|Fistula|fistula
70439|NCT03123835|Obesity|obesity
70440|NCT03123835|POEM|poem
70441|NCT03123835|GERD|gerd
70443|NCT03123835|treatments|treatments
70444|NCT03123835|post bariatric surger weight gain|post bariatric surger weight gain
70445|NCT03123835|endoluminal|endoluminal
70446|NCT03123835|Bariatric Surgery|bariatric surgery
70447|NCT03123835|Barretts|barretts
70448|NCT03123809|Diabetes Mellitus|diabetes mellitus
70449|NCT03123809|gastroparesis|gastroparesis
70450|NCT03123809|gastric electrical stimulation|gastric electrical stimulation
70451|NCT03123809|pyloroplasty|pyloroplasty
70452|NCT03123809|Idiopathic -unknown etiology|idiopathic -unknown etiology
70453|NCT03123796|chronic rejection|chronic rejection
70454|NCT03123796|transplant outcome|transplant outcome
70455|NCT03123783|CD40|cd40
70456|NCT03123783|Immunotherapy|immunotherapy
70457|NCT03123783|Nivolumab|nivolumab
70458|NCT03123783|APX005M|apx005m
70459|NCT03123783|PD-1|pd-1
70460|NCT03123770|Breast cancer|breast cancer
70461|NCT03123770|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
70462|NCT03123770|Pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
70463|NCT03123770|PLD|pld
70464|NCT03123744|Palbociclib|palbociclib
70465|NCT03123744|Cyclin Pathway|cyclin pathway
70466|NCT03123744|kinase inhibitor|kinase inhibitor
70467|NCT03123731|physical activity|physical activity
70468|NCT03123731|diet|diet
70469|NCT03123731|mHealth|mhealth
70470|NCT03123731|Fitbit|fitbit
70471|NCT03123731|neurocognition|neurocognition
70472|NCT03123731|text messaging|text messaging
70473|NCT03123718|methotrexate|methotrexate
70474|NCT03123640|Medication reconciliation|medication reconciliation
70475|NCT03123640|Medication review|medication review
70476|NCT03123640|Drug related admission|drug related admission
70477|NCT03123627|Cytomegalovirus, Seropositive|cytomegalovirus, seropositive
70478|NCT03123614|Photorefractive keratectomy|photorefractive keratectomy
70479|NCT03123601|Nursing home|nursing home
70480|NCT03123601|Falls|falls
70481|NCT03123601|Dysphasia|dysphasia
70482|NCT03123601|Choking|choking
70483|NCT03123601|Dehydration|dehydration
70484|NCT03123588|Essential thrombocythemia|essential thrombocythemia
70485|NCT03123588|hydroxyurea-resistant|hydroxyurea-resistant
70486|NCT03123588|hydroxyurea-intolerant|hydroxyurea-intolerant
70487|NCT03123588|ruxolitinib|ruxolitinib
70488|NCT03123588|anagrelide|anagrelide
70489|NCT03123562|Cerebral palsy|cerebral palsy
70490|NCT03123562|Stem cells|stem cells
70491|NCT03123562|Neonatal icterus|neonatal icterus
70492|NCT03123536|high risk|high risk
70493|NCT03123536|complication|complication
70494|NCT03123536|Ultrasonography|ultrasonography
70495|NCT03123510|probiotics|probiotics
70496|NCT03123510|prebiotics|prebiotics
70497|NCT03123510|synbiotics|synbiotics
70498|NCT03123510|obesity|obesity
70499|NCT03123497|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
70500|NCT03123484|beta-elemene|beta-elemene
70501|NCT03123471|Plaque Psoriasis|plaque psoriasis
70502|NCT03123471|Scalp|scalp
70503|NCT03123471|Double-Blind|double-blind
70504|NCT03123471|Efficacy|efficacy
70505|NCT03123471|Safety|safety
70506|NCT03123471|CC-10004|cc-10004
70507|NCT03123471|Apremilast|apremilast
70508|NCT03123471|Otezla|otezla
70509|NCT03123471|Itch|itch
70510|NCT03123471|Head|head
70511|NCT03123458|MSC|msc
70512|NCT03123458|GVHDs|gvhds
70513|NCT03123458|transplantation|transplantation
70514|NCT03123445|endostar|endostar
70515|NCT03123432|immunomodulating nutrients|immunomodulating nutrients
70516|NCT03123406|cinacalcet|cinacalcet
70517|NCT03123406|secondary hyperparathyroidism|secondary hyperparathyroidism
70518|NCT03123406|calcimimetics|calcimimetics
70519|NCT03123406|CKD-MBD|ckd-mbd
70520|NCT03123393|Drug therapy|drug therapy
70521|NCT03123315|hysterectomy|hysterectomy
70522|NCT03123315|ureter|ureter
70523|NCT03123302|MRI scan, sedation, epilepsia|mri scan, sedation, epilepsia
70524|NCT03123289|PET/CT|pet/ct
70525|NCT03123289|68Gallium Citrate|68gallium citrate
70526|NCT03123289|Orthopedic Hardware infection|orthopedic hardware infection
70527|NCT03123250|Lower Urinary Tract Symptoms (LUTS)|lower urinary tract symptoms (luts)
70528|NCT03123250|AQUABEAM|aquabeam
70529|NCT03123250|Aquablation|aquablation
70530|NCT03123250|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
70531|NCT03123224|Caregiver|caregiver
70532|NCT03123224|Caregiving|caregiving
70533|NCT03123224|TBI|tbi
70534|NCT03123224|dementia|dementia
70535|NCT03123224|Alzheimer's disease|alzheimer's disease
70536|NCT03123224|physical exercise|physical exercise
70537|NCT03123224|physical activity|physical activity
70538|NCT03123224|psychosocial|psychosocial
70539|NCT03123224|caregiver skills training|caregiver skills training
70540|NCT03123211|Expanded Access|expanded access
70541|NCT03123211|Pre-approval Access|pre-approval access
70542|NCT03123211|Compassionate Use|compassionate use
70543|NCT03123211|Special Access Program|special access program
70544|NCT03123211|Named Patient Basis|named patient basis
70545|NCT03123211|Special Access Scheme|special access scheme
70644|NCT03122548|digestive system diseases|digestive system diseases
70546|NCT03123198|borderline personality disorder, dialectical behavior therapy, suicidal behaviors|borderline personality disorder, dialectical behavior therapy, suicidal behaviors
70547|NCT03123172|co2 gap|co2 gap
70548|NCT03123172|PPV|ppv
70549|NCT03123172|resuscitation|resuscitation
70550|NCT03123172|liver transplantation|liver transplantation
70551|NCT03123146|Cognitive Behavioral Therapy|cognitive behavioral therapy
70552|NCT03123107|Vitamin C|vitamin c
70553|NCT03123107|Postoperative atrial fibrillation|postoperative atrial fibrillation
70554|NCT03123107|coronary artery bypass graft|coronary artery bypass graft
70555|NCT03123107|ascorbic acid|ascorbic acid
70556|NCT03123055|Urothelial Cell Carcinoma|urothelial cell carcinoma
70557|NCT03123055|UCC|ucc
70558|NCT03123055|bladder cancer|bladder cancer
70559|NCT03123055|B-701|b-701
70560|NCT03123055|FGFR3|fgfr3
70561|NCT03123055|invasive bladder cancer|invasive bladder cancer
70562|NCT03123055|Transitional Cell Carcinoma|transitional cell carcinoma
70563|NCT03123055|TCC|tcc
70564|NCT03123055|second line therapy|second line therapy
70565|NCT03123055|monoclonal antibody|monoclonal antibody
70566|NCT03123055|combination therapy|combination therapy
70567|NCT03123055|Phase 1b|phase 1b
70568|NCT03123055|pembrolizumab|pembrolizumab
70569|NCT03123055|checkpoint inhibitor|checkpoint inhibitor
70570|NCT03123055|Phase 2|phase 2
70571|NCT03123055|Urothelial Carcinoma|urothelial carcinoma
70572|NCT03123042|Sentinel lymph node|sentinel lymph node
70573|NCT03123042|Early gastric cancer|early gastric cancer
70574|NCT03123042|Non-curative endoscopic resection|non-curative endoscopic resection
70575|NCT03123029|Expanded Access|expanded access
70576|NCT03123029|Pre-approval Access|pre-approval access
70577|NCT03123029|Compassionate Use|compassionate use
70578|NCT03123029|Special Access Program|special access program
70579|NCT03123029|Named Patient Basis|named patient basis
70580|NCT03123029|Special Access Scheme|special access scheme
70581|NCT03123016|Vitiligo|vitiligo
70582|NCT03123003|Bone age,|bone age,
70583|NCT03123003|Height prediction|height prediction
70584|NCT03123003|Growth|growth
70585|NCT03122938|lactoferrin|lactoferrin
70586|NCT03122938|Iron Metabolism|iron metabolism
70587|NCT03122938|iron-deficiency anemia|iron-deficiency anemia
70588|NCT03122938|pregnant women|pregnant women
70589|NCT03122938|fetal development|fetal development
70590|NCT03122912|fish oil|fish oil
70591|NCT03122899|SI-BONE|si-bone
70592|NCT03122899|sacroiliac joint|sacroiliac joint
70593|NCT03122899|degenerative sacroiliitis|degenerative sacroiliitis
70594|NCT03122899|sacroiliac joint disruption|sacroiliac joint disruption
70595|NCT03122899|iFuse|ifuse
70596|NCT03122860|SM04690|sm04690
70597|NCT03122860|Wnt pathway inhibitor|wnt pathway inhibitor
70598|NCT03122860|osteoarthritis|osteoarthritis
70599|NCT03122860|Samumed|samumed
70600|NCT03122834|Heart Failure|heart failure
70601|NCT03122834|Genetic Polymorphism|genetic polymorphism
70602|NCT03122834|RAAS|raas
70603|NCT03122834|Cardiac Fibrosis|cardiac fibrosis
70604|NCT03122834|Remodeling|remodeling
70605|NCT03122808|Tachysystole|tachysystole
70606|NCT03122808|Excessive Uterine Activity|excessive uterine activity
70607|NCT03122769|Metformin|metformin
70608|NCT03122769|Heart Failure|heart failure
70609|NCT03122769|Organic cation transporter|organic cation transporter
70610|NCT03122769|Pharmacogenetics|pharmacogenetics
70611|NCT03122769|Pharmacokinetics|pharmacokinetics
70612|NCT03122769|Positron Emission Tomography|positron emission tomography
70613|NCT03122756|Intravenous Dexamethasone|intravenous dexamethasone
70614|NCT03122756|Spinal Anesthesia|spinal anesthesia
70615|NCT03122756|Post-cesarean Section Pain|post-cesarean section pain
70616|NCT03122730|Cardiac surgery|cardiac surgery
70617|NCT03122730|Cardiopulmonary bypass|cardiopulmonary bypass
70618|NCT03122730|Epoprostenol|epoprostenol
70619|NCT03122717|Non-Small Cell Lung Cancer|non-small cell lung cancer
70620|NCT03122665|Nefopam|nefopam
70621|NCT03122665|Pharmacokinetics|pharmacokinetics
70622|NCT03122665|Shivering,|shivering,
70623|NCT03122665|Thermoregulation|thermoregulation
70624|NCT03122665|Anesthesia|anesthesia
70625|NCT03122626|stroke|stroke
70626|NCT03122626|community-based exercise program|community-based exercise program
70627|NCT03122626|task-oriented exercise|task-oriented exercise
70628|NCT03122626|group exercise program|group exercise program
70629|NCT03122626|healthcare-recreation partnership|healthcare-recreation partnership
70630|NCT03122626|randomized controlled pilot trial|randomized controlled pilot trial
70631|NCT03122626|mixed methods|mixed methods
70632|NCT03122587|tACS|tacs
70633|NCT03122587|Brain Stimulation|brain stimulation
70634|NCT03122587|Transcranial Alternating Current Stimulation|transcranial alternating current stimulation
70635|NCT03122587|Substance Use|substance use
70636|NCT03122574|aromatherapy|aromatherapy
70637|NCT03122574|pediatric|pediatric
70638|NCT03122574|venipuncture|venipuncture
70639|NCT03122574|lavender|lavender
70640|NCT03122574|pain management|pain management
70641|NCT03122548|stomach cancer|stomach cancer
70642|NCT03122548|gastric cancer|gastric cancer
70643|NCT03122548|esophageal cancer|esophageal cancer
70645|NCT03122548|gastrointestinal diseases|gastrointestinal diseases
70646|NCT03122548|stomach diseases|stomach diseases
70647|NCT03122535|Femtosecond LASIK (FS--LASIK)|femtosecond lasik (fs--lasik)
70648|NCT03122535|Visual acuity|visual acuity
70649|NCT03122535|Refractive errors|refractive errors
70650|NCT03122535|Side-cut angles|side-cut angles
70651|NCT03122522|unresectable|unresectable
70652|NCT03122522|III or stage IV|iii or stage iv
70653|NCT03122522|Ipilimumab|ipilimumab
70654|NCT03122522|Nivolumab|nivolumab
70655|NCT03122522|17-162|17-162
70656|NCT03122509|Durvalumab|durvalumab
70657|NCT03122509|Tremelimumab|tremelimumab
70658|NCT03122509|Radiation Therapy|radiation therapy
70659|NCT03122509|Ablation|ablation
70660|NCT03122509|17-139|17-139
70661|NCT03122496|Durvalumab (Medi4736)|durvalumab (medi4736)
70662|NCT03122496|Tremelimumab|tremelimumab
70663|NCT03122496|Image Guided Stereotactic Body Radiotherapy (SBRT)|image guided stereotactic body radiotherapy (sbrt)
70664|NCT03122496|17-108|17-108
70665|NCT03122470|TRUS biopsy|trus biopsy
70666|NCT03122470|Pelvic MRI|pelvic mri
70667|NCT03122457|Actinic Keratosis|actinic keratosis
70668|NCT03122366|single nucleotide polymorphisms|single nucleotide polymorphisms
70669|NCT03122366|Toll-like receptor-4|toll-like receptor-4
70670|NCT03122340|Acute Coronary Syndrome|acute coronary syndrome
70671|NCT03122340|Polyprenols|polyprenols
70672|NCT03122340|Cholesterol|cholesterol
70673|NCT03122314|paracetamol|paracetamol
70674|NCT03122314|dexketoprofen|dexketoprofen
70675|NCT03122314|emergency department|emergency department
70676|NCT03122314|musculoskeletal pain|musculoskeletal pain
70677|NCT03122275|Adherence|adherence
70678|NCT03122275|Directive Counseling|directive counseling
70679|NCT03122262|Antiretroviral Agents, first-line antiretroviral therapy|antiretroviral agents, first-line antiretroviral therapy
70680|NCT03122262|dolutegravir|dolutegravir
70681|NCT03122262|Tenofovir alafenamide|tenofovir alafenamide
70682|NCT03122249|Palliative care|palliative care
70683|NCT03122249|Symptom management|symptom management
70684|NCT03122249|Self-management|self-management
70685|NCT03122249|Rural area|rural area
70686|NCT03122249|eHealth|ehealth
70687|NCT03122249|telehealth|telehealth
70688|NCT03122223|HIV|hiv
70689|NCT03122158|major depressive disorder|major depressive disorder
70690|NCT03122158|anxiety disorders|anxiety disorders
70691|NCT03122158|adolescent|adolescent
70692|NCT03122158|child|child
70693|NCT03122145|healthy|healthy
70694|NCT03122145|volunteer|volunteer
70695|NCT03122132|Hepatitis C Infection|hepatitis c infection
70696|NCT03122132|Ombitasvir/Paritaprevir/Ritonavir+dasabuvir|ombitasvir/paritaprevir/ritonavir+dasabuvir
70697|NCT03122119|Sacroiliac|sacroiliac
70698|NCT03122119|Joint Injection|joint injection
70699|NCT03122119|Platelet Rich Plasma|platelet rich plasma
70700|NCT03122119|Ultrasound|ultrasound
70701|NCT03122119|Low Back Pain|low back pain
70702|NCT03122119|Corticosteroid|corticosteroid
70703|NCT03122093|pediatric|pediatric
70704|NCT03122093|dietary treatment|dietary treatment
70705|NCT03122093|celiac disease|celiac disease
70706|NCT03122093|T1D|t1d
70707|NCT03122080|acupuncture|acupuncture
70708|NCT03122080|insomnia|insomnia
70709|NCT03122080|depression|depression
70710|NCT03122080|antidepressants|antidepressants
70711|NCT03122067|oxytocin|oxytocin
70712|NCT03122067|social cognition|social cognition
70714|NCT03122067|empathy|empathy
70715|NCT03122054|Laparoscopic Cholecystectomy, Delayed Cholecystectomy|laparoscopic cholecystectomy, delayed cholecystectomy
70716|NCT03122041|metformin intolerance|metformin intolerance
70717|NCT03122041|PCOS|pcos
70718|NCT03122041|Sitagliptin|sitagliptin
70719|NCT03122041|beta cell function|beta cell function
70720|NCT03122028|LAmbre|lambre
70721|NCT03122002|Ischemic Stroke|ischemic stroke
70722|NCT03122002|Cerebral Infarction|cerebral infarction
70723|NCT03122002|Cerebrovascular Disorders|cerebrovascular disorders
70724|NCT03121950|dementia|dementia
70725|NCT03121924|oocyte denudation|oocyte denudation
70726|NCT03121924|preincubation|preincubation
70727|NCT03121924|icsi|icsi
70728|NCT03121924|oocyte donation|oocyte donation
70729|NCT03121911|Recent Myocardial Infarction|recent myocardial infarction
70730|NCT03121911|Interval Physical Training|interval physical training
70731|NCT03121911|Inspiratory Muscle Training|inspiratory muscle training
70732|NCT03121911|Expiratory Flow Limitation|expiratory flow limitation
70733|NCT03121911|Ventilatory Efficiency|ventilatory efficiency
70734|NCT03121911|Inflammatory Markers|inflammatory markers
70735|NCT03121911|Heart Rate Variability|heart rate variability
70736|NCT03121859|TENS|tens
70737|NCT03121859|interferential current therapy|interferential current therapy
70738|NCT03121859|Chronic neck pain|chronic neck pain
70739|NCT03121846|Apatinib|apatinib
70740|NCT03121846|Soft Tissue Sarcoma|soft tissue sarcoma
70741|NCT03121833|Endostar|endostar
70742|NCT03121833|Soft Tissue Sarcoma|soft tissue sarcoma
70743|NCT03121833|Chemotherapy|chemotherapy
70744|NCT03121807|home parenteral nutrition|home parenteral nutrition
70745|NCT03121794|ultrasonography|ultrasonography
70945|NCT03120507|IHCA|ihca
70746|NCT03121794|Intraosseous Vascular access|intraosseous vascular access
70747|NCT03121794|humerus|humerus
70748|NCT03121794|anatomic landmark|anatomic landmark
70749|NCT03121768|Prognostic Model|prognostic model
70750|NCT03121768|Bladder Cancer|bladder cancer
70751|NCT03121768|Superficial Bladder Cancer|superficial bladder cancer
70752|NCT03121768|Recurrence|recurrence
70753|NCT03121768|Progression|progression
70754|NCT03121768|BCG|bcg
70755|NCT03121742|Suicide|suicide
70756|NCT03121729|enhanced recovery after surgery|enhanced recovery after surgery
70757|NCT03121729|gastric cancer|gastric cancer
70758|NCT03121664|Drug drug interaction, CYP3A4, itraconazole|drug drug interaction, cyp3a4, itraconazole
70759|NCT03121651|Mobile technology|mobile technology
70760|NCT03121651|Reinforcement-learning|reinforcement-learning
70761|NCT03121651|Medication management|medication management
70762|NCT03121638|Varicella Vaccine|varicella vaccine
70763|NCT03121638|Herpes Zoster Vaccine|herpes zoster vaccine
70764|NCT03121612|RDS|rds
70765|NCT03121573|near infrared spectroscopy, NIRS, duloxetine|near infrared spectroscopy, nirs, duloxetine
70766|NCT03121560|Hysteroscopy|hysteroscopy
70767|NCT03121560|Saline infusion hysterosonography|saline infusion hysterosonography
70768|NCT03121534|Hematopoietic/Lymphoid Cancer|hematopoietic/lymphoid cancer
70769|NCT03121534|Richter's transformation|richter's transformation
70770|NCT03121534|RT|rt
70771|NCT03121534|Blinatumomab|blinatumomab
70772|NCT03121534|Dexamethasone|dexamethasone
70773|NCT03121534|Decadron|decadron
70774|NCT03121521|statins liver enzymes melatonin|statins liver enzymes melatonin
70775|NCT03121430|peripheral arterial disease|peripheral arterial disease
70776|NCT03121430|Drug eluting peripheral vascular stent system|drug eluting peripheral vascular stent system
70777|NCT03121430|primary patency|primary patency
70778|NCT03121378|Hip Joint Alloplasty|hip joint alloplasty
70779|NCT03121378|Bone Cements|bone cements
70780|NCT03121378|Impedance Aggregometry|impedance aggregometry
70781|NCT03121378|Platelet Activation|platelet activation
70782|NCT03121365|Digital literacy|digital literacy
70783|NCT03121365|Reading|reading
70784|NCT03121352|Carboplatin|carboplatin
70785|NCT03121352|Nab-Paclitaxel|nab-paclitaxel
70786|NCT03121352|Pembrolizumab|pembrolizumab
70787|NCT03121326|Sarcopenia|sarcopenia
70788|NCT03121326|Aging|aging
70789|NCT03121326|Biomarkers|biomarkers
70790|NCT03121326|Metabolomics|metabolomics
70791|NCT03121313|Tegafur-uracil|tegafur-uracil
70792|NCT03121313|distant metastasis|distant metastasis
70793|NCT03121313|oral cavity cancer|oral cavity cancer
70794|NCT03121261|levobupivacaine|levobupivacaine
70795|NCT03121261|nerve fibers|nerve fibers
70796|NCT03121261|clonidine|clonidine
70797|NCT03121248|Accelerated radiotherapy|accelerated radiotherapy
70798|NCT03121248|Older women|older women
70799|NCT03121248|Hypo-fractonation|hypo-fractonation
70800|NCT03121235|aspergillosis|aspergillosis
70801|NCT03121235|mycosis|mycosis
70802|NCT03121235|neutropenia|neutropenia
70803|NCT03121235|hematologic diseases|hematologic diseases
70804|NCT03121235|AsperGenius PCR|aspergenius pcr
70805|NCT03121235|Ambisome|ambisome
70806|NCT03121235|Voriconazole|voriconazole
70807|NCT03121196|Social deprivation|social deprivation
70808|NCT03121196|Adverse perinatal outcomes|adverse perinatal outcomes
70809|NCT03121183|Cardiology|cardiology
70810|NCT03121183|Device Removal|device removal
70811|NCT03121183|Pacemaker|pacemaker
70812|NCT03121183|Defibrillators|defibrillators
70813|NCT03121183|Catheterization|catheterization
70814|NCT03121183|Laser Therapy|laser therapy
70815|NCT03121183|Cost-Benefit Analysis|cost-benefit analysis
70816|NCT03121170|primary dysmenorrhea|primary dysmenorrhea
70817|NCT03121170|extracorporeal shock wave therapy|extracorporeal shock wave therapy
70818|NCT03121170|traditional Chinese medicine|traditional chinese medicine
70819|NCT03121157|African Americans|african americans
70820|NCT03121157|Emerging adults|emerging adults
70821|NCT03121157|Medication adherence|medication adherence
70822|NCT03121157|eHealth|ehealth
70823|NCT03121118|Mild Cognitive Impairment|mild cognitive impairment
70824|NCT03121118|Amyvid|amyvid
70825|NCT03121118|Amyloid Imaging|amyloid imaging
70826|NCT03121118|PET Brain Scan|pet brain scan
70827|NCT03121118|Amyloid Plaque|amyloid plaque
70828|NCT03121118|Ethics|ethics
70829|NCT03121118|Results disclosure|results disclosure
70830|NCT03121105|Idiopathic Inflammatory demyelinating disorders of the central nervous system|idiopathic inflammatory demyelinating disorders of the central nervous system
70831|NCT03121105|Multiple Sclerosis|multiple sclerosis
70832|NCT03121105|Neuromyelitis Optica|neuromyelitis optica
70833|NCT03121105|MRI|mri
70834|NCT03121105|pahtological|pahtological
70835|NCT03121079|Interferon-alpha|interferon-alpha
70836|NCT03121079|Relapse|relapse
70837|NCT03121079|prevention|prevention
70838|NCT03121079|hematopietic stem cell transplantation|hematopietic stem cell transplantation
70839|NCT03121079|acute myeloid leukemia|acute myeloid leukemia
70840|NCT03121066|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
70841|NCT03121066|Non invasive brain stimulation|non invasive brain stimulation
70842|NCT03121066|Theta Burst Protocol|theta burst protocol
70843|NCT03121066|Brain connectivity|brain connectivity
70844|NCT03121066|Dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
70845|NCT03121066|Parietal cortex|parietal cortex
70846|NCT03121053|transcatheter aortic valve implantation|transcatheter aortic valve implantation
70847|NCT03121053|transcatheter aortic valve replacement|transcatheter aortic valve replacement
70848|NCT03121040|Vespa amino acid mixture (VAAM®)|vespa amino acid mixture (vaam®)
70849|NCT03121040|Young athletes|young athletes
70850|NCT03121040|Nutrition|nutrition
70851|NCT03121040|lactic acid accumulation|lactic acid accumulation
70852|NCT03121040|Anaerobic metabolism|anaerobic metabolism
70853|NCT03121040|ATP|atp
70854|NCT03121040|Sports damage|sports damage
70855|NCT03121027|Anemia|anemia
70856|NCT03121027|Ever married women|ever married women
70857|NCT03121027|Economic inequality|economic inequality
70858|NCT03121027|Diabetes|diabetes
70859|NCT03121027|Maternity|maternity
70860|NCT03121027|BMI|bmi
70861|NCT03120988|Knee OA|knee oa
70862|NCT03120988|lavage|lavage
70863|NCT03120988|Platelet Poor Plasma (PPP)|platelet poor plasma (ppp)
70864|NCT03120975|Anti-Infective Agents|anti-infective agents
70865|NCT03120975|Decision Support Systems, Clinical|decision support systems, clinical
70866|NCT03120975|Quality Improvement|quality improvement
70867|NCT03120949|Rheumatoid Arthritis|rheumatoid arthritis
70868|NCT03120949|moderate|moderate
70869|NCT03120949|severe|severe
70870|NCT03120949|subcutaneous|subcutaneous
70871|NCT03120949|Olokizumab|olokizumab
70872|NCT03120949|open-label|open-label
70873|NCT03120936|Adherence|adherence
70874|NCT03120936|Transgender|transgender
70875|NCT03120936|PrEP|prep
70876|NCT03120936|HIV Prevention|hiv prevention
70877|NCT03120936|Truvada|truvada
70878|NCT03120936|HIV Risk Reduction|hiv risk reduction
70879|NCT03120923|subacromial injection|subacromial injection
70880|NCT03120871|Beta cell failure|beta cell failure
70881|NCT03120871|Puberty|puberty
70882|NCT03120871|Microbiome|microbiome
70883|NCT03120871|Insulin Sensitivity|insulin sensitivity
70884|NCT03120858|motor imagery|motor imagery
70885|NCT03120858|kinesthetic imagery|kinesthetic imagery
70886|NCT03120858|reliability|reliability
70887|NCT03120858|Turkish version|turkish version
70888|NCT03120845|Pain,|pain,
70889|NCT03120845|one-visit|one-visit
70890|NCT03120845|two visits|two visits
70891|NCT03120819|exercise|exercise
70892|NCT03120819|fatigue|fatigue
70893|NCT03120819|physical activity|physical activity
70894|NCT03120754|ERAS|eras
70895|NCT03120754|Peritoneal drainage|peritoneal drainage
70896|NCT03120754|Primary Closure|primary closure
70897|NCT03120741|Healthcare Quality|healthcare quality
70898|NCT03120728|Emergency contraception|emergency contraception
70899|NCT03120728|Contraceptive vaginal ring|contraceptive vaginal ring
70900|NCT03120728|NuvaRing|nuvaring
70901|NCT03120728|Contraception|contraception
70902|NCT03120715|low molecular weight heparin (LMWH)|low molecular weight heparin (lmwh)
70903|NCT03120715|frozen embryo transfer (FET)|frozen embryo transfer (fet)
70904|NCT03120715|pregnancy|pregnancy
70905|NCT03120689|VITOM|vitom
70906|NCT03120689|Adult learners|adult learners
70907|NCT03120689|Medical students|medical students
70908|NCT03120689|Residents|residents
70909|NCT03120689|Vaginal surgery|vaginal surgery
70910|NCT03120689|Medical education|medical education
70911|NCT03120676|Relapsed|relapsed
70912|NCT03120676|Refractory|refractory
70913|NCT03120676|Atezolizumab|atezolizumab
70914|NCT03120676|17-191|17-191
70915|NCT03120663|antimicrobials|antimicrobials
70916|NCT03120663|pharmacokinetics|pharmacokinetics
70917|NCT03120663|augmented renal clearance|augmented renal clearance
70918|NCT03120663|non critically ill|non critically ill
70919|NCT03120637|Methylene Blue|methylene blue
70920|NCT03120637|Septic Shock|septic shock
70921|NCT03120637|Vasoplegia|vasoplegia
70922|NCT03120637|Cirrhosis|cirrhosis
70923|NCT03120611|Exercise|exercise
70924|NCT03120611|Hemodialysis|hemodialysis
70925|NCT03120611|Virtual Reality|virtual reality
70926|NCT03120598|preparation strategies|preparation strategies
70927|NCT03120598|implementation strategies|implementation strategies
70928|NCT03120598|sustainment strategies|sustainment strategies
70929|NCT03120585|Respiratory Distress Syndrome, Newborn|respiratory distress syndrome, newborn
70930|NCT03120585|fluid restriction|fluid restriction
70931|NCT03120572|Respiratory muscle strength|respiratory muscle strength
70932|NCT03120572|Diaphragmatic surface electromyography|diaphragmatic surface electromyography
70933|NCT03120572|Functional capacity|functional capacity
70934|NCT03120559|Gingivitis|gingivitis
70935|NCT03120559|SMS|sms
70936|NCT03120559|Dental floss|dental floss
70937|NCT03120559|behavior change|behavior change
70938|NCT03120559|HAPA|hapa
70939|NCT03120546|cervical spine motion|cervical spine motion
70940|NCT03120546|video laryngoscope|video laryngoscope
70941|NCT03120546|rigid video stylet|rigid video stylet
70942|NCT03120533|iontophoresis|iontophoresis
70943|NCT03120533|treprostinil|treprostinil
70944|NCT03120507|in-hospital cardiac arrest|in-hospital cardiac arrest
70946|NCT03120507|quality of life|quality of life
70947|NCT03120507|QoL|qol
70948|NCT03120507|patient-reported outcomes|patient-reported outcomes
70949|NCT03120494|HIV prevention, high risk MSM, sero-discordant couples, PrEP|hiv prevention, high risk msm, sero-discordant couples, prep
70950|NCT03120468|alcohol, alcohol dependence, addiction, alcohol use disorder|alcohol, alcohol dependence, addiction, alcohol use disorder
70951|NCT03120455|weight loss|weight loss
70952|NCT03120455|Almond|almond
70953|NCT03120455|Pistachio|pistachio
70954|NCT03120455|hypoenergetic diet|hypoenergetic diet
70955|NCT03120455|Nut|nut
70956|NCT03120442|postoperative delirium|postoperative delirium
70957|NCT03120442|total knee arthroplasty|total knee arthroplasty
70958|NCT03120442|propofol|propofol
70959|NCT03120442|dexmedetomidine|dexmedetomidine
70960|NCT03120442|fentanyl|fentanyl
70961|NCT03120442|inflammatory response|inflammatory response
70962|NCT03120442|interleukins|interleukins
70963|NCT03120442|CAM-ICU|cam-icu
70964|NCT03120429|lean fish|lean fish
70965|NCT03120429|weight loss|weight loss
70966|NCT03120429|Diet|diet
70967|NCT03120364|Herpes Zoster Vaccine|herpes zoster vaccine
70968|NCT03120364|Prevention of Herpes Zoster|prevention of herpes zoster
70969|NCT03120338|Child and Adolescent|child and adolescent
70970|NCT03120338|Randomised Controlled Trial|randomised controlled trial
70971|NCT03120338|Paediatrics|paediatrics
70972|NCT03120338|DAWBA|dawba
70973|NCT03120338|eHealth Services|ehealth services
70974|NCT03120312|outcome|outcome
70975|NCT03120286|OBESITY|obesity
70976|NCT03120286|In Vitro Fertilization (IVF)|in vitro fertilization (ivf)
70977|NCT03120286|Polycystic ovary syndrome (PCOS)|polycystic ovary syndrome (pcos)
70978|NCT03120260|Caloric Restriction|caloric restriction
70979|NCT03120260|weight loss|weight loss
70980|NCT03120260|sleep|sleep
70981|NCT03120221|Pregnancy|pregnancy
70982|NCT03120221|Iodine deficiency|iodine deficiency
70983|NCT03120221|Thyroid|thyroid
70984|NCT03120208|Postpartum psychological disorders|postpartum psychological disorders
70985|NCT03120208|immediate postpartum hemorrhage.|immediate postpartum hemorrhage.
70986|NCT03120182|aspirin|aspirin
70987|NCT03120182|bleeding risk|bleeding risk
70988|NCT03120182|intracranial bleeding|intracranial bleeding
70989|NCT03120182|burr-hole drainage|burr-hole drainage
70990|NCT03120182|chronic subdural hematoma|chronic subdural hematoma
70991|NCT03120182|anticoagulation|anticoagulation
70992|NCT03120169|COPD|copd
70993|NCT03120169|exercise|exercise
70994|NCT03120169|training|training
70995|NCT03120169|cycling|cycling
70996|NCT03120169|treadmill|treadmill
70997|NCT03120169|walking|walking
70998|NCT03120169|pulmonary rehabilitation|pulmonary rehabilitation
70999|NCT03120156|sensomotoric insoles|sensomotoric insoles
71000|NCT03120156|postural control|postural control
71001|NCT03120156|proprioceptive insoles|proprioceptive insoles
71002|NCT03120156|insoles|insoles
71003|NCT03120143|Small-sided ball games|small-sided ball games
71004|NCT03120143|Aging|aging
71005|NCT03120143|Muscle mass|muscle mass
71006|NCT03120143|Health|health
71007|NCT03120143|Training|training
71008|NCT03120143|Protein intake|protein intake
71009|NCT03120143|Physical function|physical function
71010|NCT03120143|Physiological adaptations|physiological adaptations
71011|NCT03120130|Phase I,|phase i,
71012|NCT03120117|Midurethral Slings|midurethral slings
71013|NCT03120078|Ultrasound|ultrasound
71014|NCT03120065|adherence|adherence
71015|NCT03120013|Transcranial direct current stimulation|transcranial direct current stimulation
71016|NCT03120013|Transcranial magnetic stimulation|transcranial magnetic stimulation
71017|NCT03120013|Spinocerebellar ataxia|spinocerebellar ataxia
71018|NCT03120013|Cerebellar ataxia|cerebellar ataxia
71019|NCT03120000|DLBCL|dlbcl
71020|NCT03119987|Red cell Distribution Width|red cell distribution width
71021|NCT03119987|Risk|risk
71022|NCT03119987|Mortality|mortality
71023|NCT03119987|Hemorrhage|hemorrhage
71024|NCT03119974|ITP|itp
71025|NCT03119974|TPO-RAS|tpo-ras
71026|NCT03119974|Thrombopoietin-receptor agonists|thrombopoietin-receptor agonists
71027|NCT03119961|Amyloid Amyloid Plaque|amyloid amyloid plaque
71028|NCT03119961|Tau Protein|tau protein
71029|NCT03119961|Sonication|sonication
71030|NCT03119948|Muscle spasticity|muscle spasticity
71031|NCT03119948|Botulinum toxin|botulinum toxin
71032|NCT03119935|ambu bag, ventilation, tidal volume|ambu bag, ventilation, tidal volume
71033|NCT03119922|major sickle cell disease (SCD)|major sickle cell disease (scd)
71034|NCT03119922|children|children
71035|NCT03119922|pneumococcal preventive measures|pneumococcal preventive measures
71036|NCT03119909|fMRI|fmri
71037|NCT03119909|cingulate cortex|cingulate cortex
71038|NCT03119909|adaptation|adaptation
71039|NCT03119909|frontal cortex|frontal cortex
71040|NCT03119896|chronic pain|chronic pain
71041|NCT03119896|self-management|self-management
71042|NCT03119896|pain management|pain management
71043|NCT03119896|doctor patient communication|doctor patient communication
71044|NCT03119896|primary care|primary care
71045|NCT03119883|Myeloma|myeloma
71046|NCT03119883|Metabolism|metabolism
71047|NCT03119883|Glutamine|glutamine
71048|NCT03119870|fMRI|fmri
71049|NCT03119870|EEG|eeg
71050|NCT03119870|behavior|behavior
71051|NCT03119870|cingulate cortex|cingulate cortex
71052|NCT03119857|Non-metastatic Prostate Cancer|non-metastatic prostate cancer
71053|NCT03119831|chlorhexidine|chlorhexidine
71054|NCT03119831|alcohol|alcohol
71055|NCT03119831|C31G|c31g
71056|NCT03119831|Mouthrinses|mouthrinses
71057|NCT03119831|Early postsurgical wound healing|early postsurgical wound healing
71058|NCT03119818|ESRD|esrd
71059|NCT03119818|hemodialysis|hemodialysis
71060|NCT03119818|phosphate|phosphate
71061|NCT03119818|ATP|atp
71062|NCT03119818|magnetic resonance spectroscopy|magnetic resonance spectroscopy
71063|NCT03119805|composite scores|composite scores
71064|NCT03119805|patient reported outcomes|patient reported outcomes
71065|NCT03119805|patient perpective|patient perpective
71066|NCT03119805|physician perspective|physician perspective
71067|NCT03119805|cut-off values|cut-off values
71068|NCT03119805|flare|flare
71069|NCT03119805|remission|remission
71070|NCT03119805|minimal disease activity|minimal disease activity
71071|NCT03119805|low disease activity|low disease activity
71072|NCT03119792|Behavioral Modification|behavioral modification
71073|NCT03119792|Health Community|health community
71074|NCT03119792|Community Intervention|community intervention
71075|NCT03119792|Prevention|prevention
71076|NCT03119792|Cardiovascular Health|cardiovascular health
71077|NCT03119792|Education Intervention|education intervention
71078|NCT03119792|Colombia|colombia
71079|NCT03119779|pulpotomy|pulpotomy
71080|NCT03119779|deep caries|deep caries
71081|NCT03119779|permanent molars|permanent molars
71082|NCT03119779|MTA|mta
71083|NCT03119753|Rapid Prototyping technique|rapid prototyping technique
71084|NCT03119753|complete denture|complete denture
71085|NCT03119714|bronchoprovocation|bronchoprovocation
71086|NCT03119714|early-late asthmatic reaction|early-late asthmatic reaction
71087|NCT03119714|mast cell stabilizer|mast cell stabilizer
71088|NCT03119714|mast cell mediators|mast cell mediators
71089|NCT03119714|sputum eosinophils|sputum eosinophils
71090|NCT03119701|Patients Surviving Open Surgery|patients surviving open surgery
71091|NCT03119701|Ruptured Abdominal Aortic Aneurysm|ruptured abdominal aortic aneurysm
71092|NCT03119675|Myopia|myopia
71093|NCT03119675|Hyperopia|hyperopia
71094|NCT03119675|Anisometropia|anisometropia
71095|NCT03119675|Amblyopia Risk Factors|amblyopia risk factors
71096|NCT03119675|Risk Factors|risk factors
71097|NCT03119675|Smartphone Application (App)|smartphone application (app)
71098|NCT03119675|Photoscreening|photoscreening
71099|NCT03119675|Vision Screening|vision screening
71100|NCT03119675|Mobile Vision Screening|mobile vision screening
71101|NCT03119662|Acute kidney injury (AKI)|acute kidney injury (aki)
71102|NCT03119662|Acute kidney injury network (AKIN)|acute kidney injury network (akin)
71103|NCT03119662|Chronic kidney disease (CKD)|chronic kidney disease (ckd)
71104|NCT03119662|Contrast-enhanced computed tomography (CECT)|contrast-enhanced computed tomography (cect)
71105|NCT03119662|Endovascular Aneurysm Repair (EVAR)|endovascular aneurysm repair (evar)
71106|NCT03119662|Iodixanol|iodixanol
71107|NCT03119662|Non-enhanced computed tomography (NECT)|non-enhanced computed tomography (nect)
71108|NCT03119662|Serum creatinine (SCr)|serum creatinine (scr)
71109|NCT03119623|Heart Failure|heart failure
71110|NCT03119623|Endothelial function|endothelial function
71111|NCT03119623|Brachial Artery Reactivity Test|brachial artery reactivity test
71112|NCT03119623|Sacubitril/Valsartan|sacubitril/valsartan
71113|NCT03119623|Enalapril|enalapril
71114|NCT03119623|HFREF|hfref
71115|NCT03119597|low mood, depression|low mood, depression
71116|NCT03119584|chronic constipation|chronic constipation
71117|NCT03119584|diabetes|diabetes
71118|NCT03119571|Cardiac arrest|cardiac arrest
71119|NCT03119571|Ventricular fibrillation|ventricular fibrillation
71120|NCT03119571|coronary artery disease|coronary artery disease
71121|NCT03119545|intervention|intervention
71122|NCT03119545|support program|support program
71123|NCT03119545|family centered|family centered
71124|NCT03119545|parental death|parental death
71125|NCT03119519|NSCLC|nsclc
71126|NCT03119519|Oligometastases|oligometastases
71127|NCT03119519|radiotherapy|radiotherapy
71128|NCT03119493|Metabolic syndrome X|metabolic syndrome x
71129|NCT03119493|Autonomic nervous system|autonomic nervous system
71130|NCT03119493|Aerobic exercise|aerobic exercise
71131|NCT03119493|Exercise|exercise
71132|NCT03119493|Heart rate|heart rate
71133|NCT03119480|Acute Kidney Injury|acute kidney injury
71134|NCT03119480|Electronic alerts|electronic alerts
71135|NCT03119402|Reading|reading
71136|NCT03119402|Developmental Dyslexia|developmental dyslexia
71137|NCT03119402|Music|music
71138|NCT03119402|Rhythm|rhythm
71139|NCT03119402|transcranial electrical stimulation|transcranial electrical stimulation
71140|NCT03119402|transcranial direct current stimulation|transcranial direct current stimulation
71141|NCT03119389|Hand Hygiene|hand hygiene
71142|NCT03119389|Non-sterile glove use|non-sterile glove use
71143|NCT03119376|peer review|peer review
71144|NCT03119376|online tool|online tool
71145|NCT03119376|Randomized Controlled Trial|randomized controlled trial
71146|NCT03119363|cancer-related fatigue|cancer-related fatigue
71147|NCT03119363|circadian rhythms|circadian rhythms
71148|NCT03119363|light therapy|light therapy
71149|NCT03119363|systematic light exposure|systematic light exposure
71150|NCT03119363|cancer survivors|cancer survivors
71151|NCT03119363|oncology|oncology
71152|NCT03119363|Multiple Myeloma|multiple myeloma
71153|NCT03119363|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
71154|NCT03119363|Autologous stem cell transplantation|autologous stem cell transplantation
71155|NCT03119337|male circumcision, text-based follow-up, Zimbabwe,|male circumcision, text-based follow-up, zimbabwe,
71156|NCT03119324|Biomodulation|biomodulation
71157|NCT03119324|LLLT|lllt
71158|NCT03119324|Temporomandibular Joint Disorders|temporomandibular joint disorders
71159|NCT03119324|Pain management|pain management
71160|NCT03119285|ovarian cancer|ovarian cancer
71161|NCT03119285|BRCA1|brca1
71162|NCT03119285|BRCA2|brca2
71163|NCT03119285|BROCA|broca
71164|NCT03119246|beta testing|beta testing
71165|NCT03119246|assessment battery|assessment battery
71166|NCT03119246|HD|hd
71167|NCT03119207|ICU|icu
71168|NCT03119168|screening|screening
71169|NCT03119168|adenoma detection rate|adenoma detection rate
71170|NCT03119168|simethicone|simethicone
71171|NCT03119155|Congenital Heart Disease|congenital heart disease
71172|NCT03119155|Echocardiography|echocardiography
71173|NCT03119155|Diagnosis|diagnosis
71174|NCT03119129|prevention|prevention
71175|NCT03119129|health disparities|health disparities
71176|NCT03119129|Native Hawaiians and other Pacific Islanders|native hawaiians and other pacific islanders
71177|NCT03119116|Stroke Prevention in NVAF patients|stroke prevention in nvaf patients
71178|NCT03119103|respiratory pattern|respiratory pattern
71179|NCT03119103|sensor data|sensor data
71180|NCT03119103|bed sheet|bed sheet
71181|NCT03119103|pressure|pressure
71182|NCT03119103|respiration rate|respiration rate
71183|NCT03119090|biomarkers|biomarkers
71184|NCT03119090|Fontan operation|fontan operation
71185|NCT03119090|Single ventricle|single ventricle
71186|NCT03119090|congenital heart disease|congenital heart disease
71187|NCT03119077|PCOS|pcos
71188|NCT03119051|mild cognitive impairment|mild cognitive impairment
71189|NCT03119038|total hip|total hip
71190|NCT03119038|degenerative joint disease|degenerative joint disease
71191|NCT03119038|osteoarthritis|osteoarthritis
71192|NCT03119025|Dendritic Cells|dendritic cells
71193|NCT03119025|DC-based Vaccines|dc-based vaccines
71194|NCT03119025|Chronic HCV Infection|chronic hcv infection
71195|NCT03119025|Antigen-Specific T cell response|antigen-specific t cell response
71196|NCT03119025|Recombinant HCV-Core antigen|recombinant hcv-core antigen
71197|NCT03119025|Recombinant HCV-NS3 antigen|recombinant hcv-ns3 antigen
71198|NCT03119012|Bioresorbable scaffold|bioresorbable scaffold
71199|NCT03119012|Dual antiplatelet therapy|dual antiplatelet therapy
71200|NCT03119012|P2Y12 receptor inhibitor|p2y12 receptor inhibitor
71201|NCT03119012|Coronary artery disease|coronary artery disease
71202|NCT03118986|olanzapine|olanzapine
71203|NCT03118986|vomiting|vomiting
71204|NCT03118986|children|children
71205|NCT03118986|adolescents|adolescents
71206|NCT03118986|bone marrow transplant|bone marrow transplant
71207|NCT03118986|supportive care|supportive care
71208|NCT03118934|contact lenses|contact lenses
71209|NCT03118934|presbyopia|presbyopia
71210|NCT03118934|multifocal|multifocal
71211|NCT03118908|Succinate|succinate
71212|NCT03118908|B complex vitamins|b complex vitamins
71213|NCT03118908|menopause|menopause
71214|NCT03118882|Breast cancer screening|breast cancer screening
71215|NCT03118882|Colorectal Cancer screening|colorectal cancer screening
71216|NCT03118882|Primary prevention|primary prevention
71217|NCT03118882|Lifestyles|lifestyles
71218|NCT03118882|Teachable moment|teachable moment
71219|NCT03118869|Asthma|asthma
71220|NCT03118869|B2 adrenergic receptors|b2 adrenergic receptors
71221|NCT03118869|Polymorphism|polymorphism
71222|NCT03118804|Weaning|weaning
71223|NCT03118804|Mechanical ventilation|mechanical ventilation
71224|NCT03118804|Electrical impedance tomography|electrical impedance tomography
71225|NCT03118804|Tidal distribution|tidal distribution
71226|NCT03118778|Stress Ulcer Prevention|stress ulcer prevention
71227|NCT03118726|LARC|larc
71228|NCT03118726|New Mexico|new mexico
71229|NCT03118726|Contraception|contraception
71230|NCT03118713|Glimepride|glimepride
71231|NCT03118713|Metformin|metformin
71232|NCT03118713|Ipragliflozin|ipragliflozin
71233|NCT03118713|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
71234|NCT03118713|ASP1941|asp1941
71235|NCT03118687|Immune system|immune system
71236|NCT03118674|Interventional, Open-label, PCT, Hepatitis C|interventional, open-label, pct, hepatitis c
71237|NCT03118648|upper limb|upper limb
71238|NCT03118648|functional recovery|functional recovery
71239|NCT03118648|activities of daily living|activities of daily living
71240|NCT03118635|Summer|summer
71241|NCT03118635|Diet|diet
71642|NCT03116334|BMI|bmi
71242|NCT03118635|Physical Activity|physical activity
71243|NCT03118635|Sedentary behavior|sedentary behavior
71244|NCT03118635|Low-income|low-income
71245|NCT03118609|Caregivers|caregivers
71246|NCT03118609|Chronic Pain|chronic pain
71247|NCT03118596|intubation|intubation
71248|NCT03118596|tracheal|tracheal
71249|NCT03118596|airway device|airway device
71250|NCT03118596|supra-glottic airway device|supra-glottic airway device
71251|NCT03118596|fibreoptic scope|fibreoptic scope
71252|NCT03118570|Osteogenesis Imperfecta|osteogenesis imperfecta
71253|NCT03118570|Brittle Bone Disease|brittle bone disease
71254|NCT03118557|pelvic floor|pelvic floor
71255|NCT03118557|strengthening|strengthening
71256|NCT03118557|Stress|stress
71257|NCT03118557|urinary|urinary
71258|NCT03118557|incontinence|incontinence
71259|NCT03118544|Chronic Total Occlusion|chronic total occlusion
71260|NCT03118544|Coronary Artery Disease|coronary artery disease
71261|NCT03118544|Percutaneous Coronary Intervention|percutaneous coronary intervention
71262|NCT03118544|CTO|cto
71263|NCT03118544|PCI|pci
71264|NCT03118531|Long Lesion|long lesion
71265|NCT03118531|In-stent Late Lumen Loss (LLL)|in-stent late lumen loss (lll)
71266|NCT03118531|Major Adverse Cardiac Events (MACE)|major adverse cardiac events (mace)
71267|NCT03118531|MYOCARDIAL INFARCTION (MI)|myocardial infarction (mi)
71268|NCT03118531|TARGET VESSEL REVASCULARIZATION (TVR)|target vessel revascularization (tvr)
71269|NCT03118531|TARGET LESION REVASCULARIZATION (TLR)|target lesion revascularization (tlr)
71270|NCT03118531|Target Vessel Failure (TVF)|target vessel failure (tvf)
71271|NCT03118531|Target Lesion Failure (TLF)|target lesion failure (tlf)
71272|NCT03118531|Stent Thrombosis (ST)|stent thrombosis (st)
71273|NCT03118479|IHH|ihh
71274|NCT03118479|KS|ks
71275|NCT03118479|Idiopathic hypogonadotropic hypogonadism|idiopathic hypogonadotropic hypogonadism
71276|NCT03118479|GnRH deficiency|gnrh deficiency
71277|NCT03118466|AML|aml
71278|NCT03118453|Musculoskeletal pain/*therapy|musculoskeletal pain/*therapy
71279|NCT03118453|Behavioral medicine|behavioral medicine
71280|NCT03118453|Physical therapy|physical therapy
71281|NCT03118453|Cost-benefit analyses|cost-benefit analyses
71282|NCT03118453|Treatment outcome|treatment outcome
71283|NCT03118453|Adults|adults
71284|NCT03118440|Fluoroscopy|fluoroscopy
71285|NCT03118440|Pacemaker|pacemaker
71286|NCT03118440|Three dimensional|three dimensional
71287|NCT03118440|Radiation|radiation
71288|NCT03118440|Imaging|imaging
71289|NCT03118427|Fluoroscopy|fluoroscopy
71290|NCT03118427|Pacemaker|pacemaker
71291|NCT03118427|Three dimensional|three dimensional
71292|NCT03118427|Radiation|radiation
71293|NCT03118427|Imaging|imaging
71294|NCT03118414|Balance|balance
71295|NCT03118414|Cognition|cognition
71296|NCT03118414|Exercise|exercise
71297|NCT03118362|Burns|burns
71298|NCT03118362|Critically ill|critically ill
71299|NCT03118362|Acid-Base status|acid-base status
71300|NCT03118349|CA19-9 Positive Malignancies|ca19-9 positive malignancies
71301|NCT03118323|willingness topay|willingness topay
71302|NCT03118323|WTP|wtp
71303|NCT03118323|health economic|health economic
71304|NCT03118323|preference-based measures|preference-based measures
71305|NCT03118310|Reduction of liver fat|reduction of liver fat
71306|NCT03118297|Etonogestrel Implant|etonogestrel implant
71307|NCT03118284|Foley catheter|foley catheter
71308|NCT03118271|lumbar disc herniation|lumbar disc herniation
71309|NCT03118271|lumbar traction|lumbar traction
71310|NCT03118271|spinal manipulation|spinal manipulation
71311|NCT03118271|lumbar surgery|lumbar surgery
71312|NCT03118258|Vaginal HPV self-sampling|vaginal hpv self-sampling
71313|NCT03118258|Pap test smear|pap test smear
71314|NCT03118258|cervical cancer screening|cervical cancer screening
71315|NCT03118258|deprivation|deprivation
71316|NCT03118258|sexual and reproductive health|sexual and reproductive health
71317|NCT03118258|Precariousness|precariousness
71318|NCT03118232|Nursing Homes|nursing homes
71319|NCT03118232|Health Facilities|health facilities
71320|NCT03118232|Infections|infections
71321|NCT03118232|Readmissions|readmissions
71322|NCT03118232|Multi-Drug resistance|multi-drug resistance
71323|NCT03118232|Antibiotic Use|antibiotic use
71324|NCT03118219|assisted reproductive technology|assisted reproductive technology
71325|NCT03118219|embryo transfer|embryo transfer
71326|NCT03118219|online intervention|online intervention
71327|NCT03118219|rct|rct
71328|NCT03118206|Lumbar spinal stenosis|lumbar spinal stenosis
71329|NCT03118206|spinal manipulation|spinal manipulation
71330|NCT03118206|physical therapy|physical therapy
71331|NCT03118206|surgery|surgery
71332|NCT03118193|depression|depression
71333|NCT03118193|antidepressant|antidepressant
71334|NCT03118193|resistance|resistance
71335|NCT03118167|Acrylamide|acrylamide
71336|NCT03118167|Tea polyphenols|tea polyphenols
71337|NCT03118167|Water-soluble antioxidant of bamboo leaves|water-soluble antioxidant of bamboo leaves
71338|NCT03118154|endometriosis|endometriosis
71339|NCT03118154|pelvic pain|pelvic pain
71340|NCT03118154|dysmenorrhea|dysmenorrhea
71341|NCT03118141|preimplantation genetic screening|preimplantation genetic screening
71342|NCT03118141|single embryo transfer|single embryo transfer
71343|NCT03118141|frozen embryo transfer|frozen embryo transfer
71344|NCT03118141|cumulative live birth rate|cumulative live birth rate
71345|NCT03118128|Acute Lymphoblastic Leukemia (ALL), ABCB1, Metformin|acute lymphoblastic leukemia (all), abcb1, metformin
71346|NCT03118115|bioimpedance|bioimpedance
71347|NCT03118115|thrombosis|thrombosis
71348|NCT03118115|free flap|free flap
71349|NCT03118115|microsurgerie|microsurgerie
71350|NCT03118115|breast reconstruction|breast reconstruction
71351|NCT03118089|Oral nutritional supplements|oral nutritional supplements
71352|NCT03118050|exercise|exercise
71353|NCT03118050|bed rest|bed rest
71354|NCT03118050|muscle|muscle
71355|NCT03118050|nutrition|nutrition
71356|NCT03118050|amino acids|amino acids
71357|NCT03118037|Radiofrequency Ablation|radiofrequency ablation
71358|NCT03118024|deep inferior epigastric perforator flap|deep inferior epigastric perforator flap
71359|NCT03118024|fluid restriction|fluid restriction
71360|NCT03118024|catecholamine restriction|catecholamine restriction
71361|NCT03118011|Tobacco use, withdrawal symptoms|tobacco use, withdrawal symptoms
71362|NCT03117985|HIV reservoirs|hiv reservoirs
71363|NCT03117985|HIV persistence|hiv persistence
71364|NCT03117985|Viral rebound|viral rebound
71365|NCT03117972|Metastatic colorectal cancer|metastatic colorectal cancer
71366|NCT03117972|Biomarker|biomarker
71367|NCT03117972|Chemotherapy intensification|chemotherapy intensification
71368|NCT03117972|Syndecan1|syndecan1
71369|NCT03117972|LDH|ldh
71370|NCT03117972|CD138|cd138
71371|NCT03117946|immunomonitoring|immunomonitoring
71372|NCT03117946|immune checkpoint|immune checkpoint
71373|NCT03117946|chemoradiation|chemoradiation
71374|NCT03117946|T cells|t cells
71375|NCT03117933|BRCA1/2 mutation|brca1/2 mutation
71376|NCT03117933|Platinum resistance|platinum resistance
71377|NCT03117920|Refractory pancreatic cancer|refractory pancreatic cancer
71378|NCT03117920|Minnelide|minnelide
71379|NCT03117920|Minnelide002|minnelide002
71380|NCT03117920|2017-000126-36|2017-000126-36
71381|NCT03117881|Multiple Sclerosis|multiple sclerosis
71382|NCT03117881|Yoga|yoga
71383|NCT03117881|Pilates|pilates
71384|NCT03117881|Telerehabilitation|telerehabilitation
71385|NCT03117881|Physical activity|physical activity
71386|NCT03117842|Female entertainment workers|female entertainment workers
71387|NCT03117842|mHealth|mhealth
71388|NCT03117842|HIV testing|hiv testing
71389|NCT03117842|Cambodia|cambodia
71390|NCT03117816|deep molecular remission of MR4 or better|deep molecular remission of mr4 or better
71391|NCT03117803|Aneurysm, Intracranial|aneurysm, intracranial
71392|NCT03117803|Registries|registries
71393|NCT03117803|Multicenter Studies|multicenter studies
71394|NCT03117803|People's Republic of China|people's republic of china
71395|NCT03117790|elderly|elderly
71396|NCT03117790|surgery|surgery
71397|NCT03117790|analgesia|analgesia
71398|NCT03117790|dexmedetomidine|dexmedetomidine
71399|NCT03117790|sleep quality|sleep quality
71400|NCT03117751|Leukemia|leukemia
71401|NCT03117751|Lymphoma|lymphoma
71402|NCT03117751|Pediatric|pediatric
71403|NCT03117751|B-Cell|b-cell
71404|NCT03117751|T-Cell|t-cell
71405|NCT03117725|oxidative stress|oxidative stress
71406|NCT03117725|antioxidants|antioxidants
71407|NCT03117725|diminished ovarian reserve|diminished ovarian reserve
71408|NCT03117712|cerebral blood supply|cerebral blood supply
71409|NCT03117712|cardiopulmonary bypass|cardiopulmonary bypass
71410|NCT03117712|open-heart cardiac surgery|open-heart cardiac surgery
71411|NCT03117699|Hemiplegia|hemiplegia
71412|NCT03117699|transport device|transport device
71413|NCT03117673|right ventricular systolic pressure (RVSP)|right ventricular systolic pressure (rvsp)
71414|NCT03117673|Transesophageal echocardiography|transesophageal echocardiography
71415|NCT03117634|anti vegf|anti vegf
71416|NCT03117634|aflibercept|aflibercept
71417|NCT03117634|treat and extend|treat and extend
71418|NCT03117621|Blincyto|blincyto
71419|NCT03117608|OA|oa
71420|NCT03117608|aMAT|amat
71421|NCT03117608|PRP|prp
71422|NCT03117595|Single Shot Spinal|single shot spinal
71423|NCT03117595|Intrathecal narcotics|intrathecal narcotics
71424|NCT03117595|Morphine|morphine
71425|NCT03117595|Fentanyl|fentanyl
71426|NCT03117595|Labour Analgesia|labour analgesia
71427|NCT03117582|C. diff|c. diff
71428|NCT03117582|CDI|cdi
71429|NCT03117582|Clostridium Difficile Infection|clostridium difficile infection
71430|NCT03117582|Diarrhea|diarrhea
71431|NCT03117582|Fecal microbiota transplantation|fecal microbiota transplantation
71432|NCT03117582|FMT|fmt
71433|NCT03117543|Screening|screening
71434|NCT03117530|minocycline|minocycline
71435|NCT03117530|brain inflammation|brain inflammation
71436|NCT03117530|microglia|microglia
71437|NCT03117530|cognition|cognition
71438|NCT03117517|PCOS|pcos
71439|NCT03117504|Stress urinary incontinence|stress urinary incontinence
71440|NCT03117504|SUI|sui
71441|NCT03117491|Gow-Gates nerve block|gow-gates nerve block
71442|NCT03117491|Inferior alveolar nerve block|inferior alveolar nerve block
71443|NCT03117491|local anesthesia|local anesthesia
71444|NCT03117491|molar|molar
71445|NCT03117491|pulpitis|pulpitis
71446|NCT03117452|schizophrenia|schizophrenia
71447|NCT03117452|visual processing|visual processing
71448|NCT03117452|cognitive training|cognitive training
71449|NCT03117452|visual training|visual training
71450|NCT03117426|Symfony Extended Range of Vision IOL|symfony extended range of vision iol
71451|NCT03117426|AT LISA tri 839MP IOL|at lisa tri 839mp iol
71452|NCT03117426|Trifocal IOL|trifocal iol
71453|NCT03117426|Extended depth of focus IOLs|extended depth of focus iols
71454|NCT03117413|Cochlear implantation|cochlear implantation
71455|NCT03117413|Deafness|deafness
71456|NCT03117413|Auditory cortex|auditory cortex
71457|NCT03117413|Auditory plasticity|auditory plasticity
71458|NCT03117413|Tinnitus|tinnitus
71459|NCT03117361|multiple myeloma|multiple myeloma
71460|NCT03117361|plitidepsin|plitidepsin
71461|NCT03117361|Aplidin|aplidin
71462|NCT03117348|Enteral Nutrition|enteral nutrition
71463|NCT03117348|Digestive System Neoplasms|digestive system neoplasms
71464|NCT03117348|Randomized Controlled Trial|randomized controlled trial
71465|NCT03117348|Clinical Outcomes|clinical outcomes
71466|NCT03117335|Non-small Cell Lung Cancer|non-small cell lung cancer
71467|NCT03117335|Sulijia|sulijia
71468|NCT03117335|Recombinant endostatin|recombinant endostatin
71469|NCT03117335|Vinorelbine|vinorelbine
71470|NCT03117335|Cisplatin|cisplatin
71471|NCT03117322|cerebral palsy|cerebral palsy
71472|NCT03117322|children|children
71473|NCT03117322|chronic constipation|chronic constipation
71474|NCT03117322|synbiotic|synbiotic
71475|NCT03117322|prebiotics|prebiotics
71476|NCT03117322|probiotics|probiotics
71477|NCT03117322|agave inulin|agave inulin
71478|NCT03117322|microbiota|microbiota
71479|NCT03117309|Nivolumab|nivolumab
71480|NCT03117309|Ipilimumab|ipilimumab
71481|NCT03117309|OPDIVO|opdivo
71482|NCT03117309|IgG1 kappa immunoglobulin|igg1 kappa immunoglobulin
71483|NCT03117296|physical therapy|physical therapy
71484|NCT03117296|occupational therapy|occupational therapy
71485|NCT03117296|tAVR|tavr
71486|NCT03117283|Laparoscopic surgery|laparoscopic surgery
71487|NCT03117283|Radical total gastrectomy|radical total gastrectomy
71488|NCT03117283|Bursectomy|bursectomy
71489|NCT03117283|Advanced posterior gastric wall cancer|advanced posterior gastric wall cancer
71490|NCT03117257|Lobaplatin|lobaplatin
71491|NCT03117257|head and neck cancer|head and neck cancer
71492|NCT03117257|chronic-chemotherapy|chronic-chemotherapy
71493|NCT03117231|osteoarthritis|osteoarthritis
71494|NCT03117231|elderly|elderly
71495|NCT03117231|musculoskeletal pain|musculoskeletal pain
71496|NCT03117231|transcranial direct current stimulation|transcranial direct current stimulation
71497|NCT03117192|zinc supplementation|zinc supplementation
71498|NCT03117192|immunity|immunity
71499|NCT03117192|thalassemia|thalassemia
71500|NCT03117166|lidocaine implantation ICD|lidocaine implantation icd
71501|NCT03117140|Brachial Plexus Block|brachial plexus block
71502|NCT03117140|Clonidine|clonidine
71503|NCT03117140|Dexamethasone|dexamethasone
71504|NCT03117140|Buprenorphine|buprenorphine
71505|NCT03117114|colonoscopy|colonoscopy
71506|NCT03117114|polyp|polyp
71507|NCT03117114|resection|resection
71508|NCT03117101|Tolerability Pharmacokinetics|tolerability pharmacokinetics
71509|NCT03117088|Standardized handover|standardized handover
71510|NCT03117088|Online-based|online-based
71511|NCT03117088|SOFA-Score|sofa-score
71512|NCT03117088|ICU|icu
71513|NCT03117088|ISBAR3|isbar3
71514|NCT03117075|cancer pain, wearable device|cancer pain, wearable device
71515|NCT03117036|lymphoma|lymphoma
71516|NCT03117036|cohort|cohort
71517|NCT03117036|serum|serum
71518|NCT03117036|cell-free DNA|cell-free dna
71519|NCT03117023|dexmedetomidine|dexmedetomidine
71520|NCT03117023|sleep deprivation|sleep deprivation
71521|NCT03117023|gastric cancer|gastric cancer
71522|NCT03117023|middle-aged and elderly patient|middle-aged and elderly patient
71523|NCT03117010|Hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
71524|NCT03116997|neuromuscular blockade|neuromuscular blockade
71525|NCT03116997|sugammadex|sugammadex
71526|NCT03116997|SUG|sug
71527|NCT03116997|neostigmine|neostigmine
71528|NCT03116997|NEO/GLYCO|neo/glyco
71529|NCT03116997|17-207|17-207
71530|NCT03116984|Hepatocellular Carcinoma|hepatocellular carcinoma
71531|NCT03116984|external- beam radiotherapy (EBRT)|external- beam radiotherapy (ebrt)
71532|NCT03116984|transarterial chemoembolization (TACE)|transarterial chemoembolization (tace)
71533|NCT03116971|M3814, Small Cell Lung Cancer (SCLC), Deoxyribonucleic acid-dependent protein kinase inhibitor, Chemotherapy|m3814, small cell lung cancer (sclc), deoxyribonucleic acid-dependent protein kinase inhibitor, chemotherapy
71534|NCT03116958|CPAP compliance|cpap compliance
71535|NCT03116958|Telemedicine integrated platform|telemedicine integrated platform
71536|NCT03116958|Standard management|standard management
71537|NCT03116958|Cost-effectiveness|cost-effectiveness
71538|NCT03116945|PET/CT|pet/ct
71539|NCT03116945|68Gallium Citrate|68gallium citrate
71540|NCT03116945|Hepatocellular carcinoma|hepatocellular carcinoma
71541|NCT03116932|HIV prevention, high risk MSM, PrEP|hiv prevention, high risk msm, prep
71542|NCT03116919|nutrition|nutrition
71543|NCT03116919|Potatoes|potatoes
71544|NCT03116919|endothelial function|endothelial function
71545|NCT03116919|feeding trial|feeding trial
71546|NCT03116880|Aorta, Abdominal/surgery|aorta, abdominal/surgery
71547|NCT03116880|Endovascular Procedures|endovascular procedures
71548|NCT03116854|Acute Coronary Syndrome|acute coronary syndrome
71549|NCT03116854|Beta Blockers|beta blockers
71550|NCT03116854|Prognosis|prognosis
71551|NCT03116828|epilepsy|epilepsy
71552|NCT03116828|seizures|seizures
71553|NCT03116828|partial on-set seizures|partial on-set seizures
71554|NCT03116815|blood pressure|blood pressure
71555|NCT03116815|monitoring|monitoring
71556|NCT03116815|hypertension|hypertension
71557|NCT03116815|patient reported outcomes|patient reported outcomes
71558|NCT03116776|walnut shell glasses moxibustion|walnut shell glasses moxibustion
71559|NCT03116776|dry eye|dry eye
71560|NCT03116776|randomized controlled trial|randomized controlled trial
71561|NCT03116750|mechanical thrombectomy|mechanical thrombectomy
71562|NCT03116737|AOM|aom
71563|NCT03116724|catheterization, central venous|catheterization, central venous
71564|NCT03116724|jugular veins|jugular veins
71565|NCT03116724|echocardiography, transesophageal|echocardiography, transesophageal
71566|NCT03116672|pain|pain
71567|NCT03116672|Diclofenac|diclofenac
71568|NCT03116672|NSAID|nsaid
71569|NCT03116672|Ketorolac|ketorolac
71570|NCT03116646|mastication|mastication
71571|NCT03116646|cerebral palsy|cerebral palsy
71572|NCT03116646|family|family
71573|NCT03116633|lung cancer|lung cancer
71574|NCT03116633|biopsy|biopsy
71575|NCT03116620|mastication|mastication
71576|NCT03116620|children with neuromuscular disorders|children with neuromuscular disorders
71577|NCT03116607|User satisfaction|user satisfaction
71578|NCT03116607|Readmission|readmission
71579|NCT03116607|Emergency department|emergency department
71580|NCT03116607|Pharmaceutical intervention|pharmaceutical intervention
71581|NCT03116594|Herpes Zoster Vaccine|herpes zoster vaccine
71582|NCT03116594|Prevention of Herpes Zoster|prevention of herpes zoster
71583|NCT03116581|Perceptual Decision|perceptual decision
71584|NCT03116581|Social Cognition|social cognition
71585|NCT03116581|Motivation|motivation
71586|NCT03116568|IBD|ibd
71587|NCT03116568|Meconium|meconium
71588|NCT03116568|Pregnancy|pregnancy
71589|NCT03116568|Microbiota|microbiota
71590|NCT03116568|Newborn|newborn
71591|NCT03116555|Apatinib|apatinib
71592|NCT03116555|Irinotecan|irinotecan
71593|NCT03116555|Second-line|second-line
71594|NCT03116555|Metastatic Gastric Adenocarcinoma|metastatic gastric adenocarcinoma
71595|NCT03116529|Neoadjuvant|neoadjuvant
71596|NCT03116529|Soft Tissue Sarcoma|soft tissue sarcoma
71597|NCT03116529|Immunotherapy|immunotherapy
71598|NCT03116529|Checkpoint Inhibitor|checkpoint inhibitor
71599|NCT03116529|PD-1 (Programmed Cell Death Protein 1)|pd-1 (programmed cell death protein 1)
71600|NCT03116529|PD-L1 (Programmed Death Ligand 1)|pd-l1 (programmed death ligand 1)
71601|NCT03116529|CTLA-4 (Cytotoxic T-Lymphocyte-Associated Protein 4)|ctla-4 (cytotoxic t-lymphocyte-associated protein 4)
71602|NCT03116529|Radiotherapy|radiotherapy
71603|NCT03116529|Durvalumab|durvalumab
71604|NCT03116529|Tremelimumab|tremelimumab
71605|NCT03116529|Surgery|surgery
71606|NCT03116529|Radiation|radiation
71607|NCT03116529|Combined|combined
71608|NCT03116529|Preoperative|preoperative
71609|NCT03116503|Suicide|suicide
71610|NCT03116490|morbidity|morbidity
71611|NCT03116490|mortality|mortality
71612|NCT03116490|hip fracture|hip fracture
71613|NCT03116490|anesthesia type|anesthesia type
71614|NCT03116490|POSSUM|possum
71615|NCT03116451|foot health|foot health
71616|NCT03116451|nurses|nurses
71617|NCT03116451|work well-being|work well-being
71618|NCT03116438|Coronary Artery Disease|coronary artery disease
71619|NCT03116438|Nuclear Stress Test|nuclear stress test
71620|NCT03116438|CT Angiography|ct angiography
71621|NCT03116438|Angiography|angiography
71622|NCT03116425|Precision Medicine|precision medicine
71623|NCT03116425|Functional Neuroimaging|functional neuroimaging
71624|NCT03116425|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
71625|NCT03116425|Transcranial Direct Current Stimulation|transcranial direct current stimulation
71626|NCT03116425|Monocentric|monocentric
71627|NCT03116425|Comparative balanced, randomized|comparative balanced, randomized
71628|NCT03116425|double-blind cross-over 3 Arms Study|double-blind cross-over 3 arms study
71629|NCT03116412|Malignant melanoma|malignant melanoma
71630|NCT03116412|Follow up|follow up
71631|NCT03116412|Radiology|radiology
71632|NCT03116412|Survival|survival
71633|NCT03116399|Older adults|older adults
71634|NCT03116399|Social Support|social support
71635|NCT03116399|Technology uptake|technology uptake
71636|NCT03116373|Posture|posture
71637|NCT03116373|Physiology|physiology
71638|NCT03116373|Head|head
71639|NCT03116373|Intubation|intubation
71640|NCT03116373|Intratracheal methods|intratracheal methods
71641|NCT03116334|Obesity|obesity
71643|NCT03116334|executive functioning|executive functioning
71644|NCT03116334|general cognitive ability|general cognitive ability
71645|NCT03116334|twin study|twin study
71646|NCT03116334|heritability|heritability
71647|NCT03116334|cognition|cognition
71648|NCT03116334|GCTA|gcta
71649|NCT03116243|migrant and seasonal head start|migrant and seasonal head start
71650|NCT03116243|early childhood education|early childhood education
71651|NCT03116243|head start|head start
71652|NCT03116230|Knee pathology|knee pathology
71653|NCT03116217|renal function|renal function
71654|NCT03116217|post natal|post natal
71655|NCT03116217|peptidome|peptidome
71656|NCT03116204|Dependency|dependency
71657|NCT03116204|FRC department|frc department
71658|NCT03116204|scale validation|scale validation
71659|NCT03116204|validity|validity
71660|NCT03116204|reliability|reliability
71661|NCT03116178|Fluid therapy|fluid therapy
71662|NCT03116178|oximetry|oximetry
71663|NCT03116178|thromboelastography|thromboelastography
71664|NCT03116178|intraoperative/method|intraoperative/method
71665|NCT03116178|monitoring|monitoring
71666|NCT03116139|Computed tomography scan|computed tomography scan
71667|NCT03116139|Ventilation-perfusion lung scan|ventilation-perfusion lung scan
71668|NCT03116139|Acute kidney injury|acute kidney injury
71669|NCT03116139|Pulmonary embolism|pulmonary embolism
71670|NCT03116139|Contrast-induced nephropathy|contrast-induced nephropathy
71671|NCT03116087|Postmenopausal women|postmenopausal women
71672|NCT03116061|Multimorbidity|multimorbidity
71673|NCT03116061|Family Medicine|family medicine
71674|NCT03116061|decompensation|decompensation
71675|NCT03116061|predictive value|predictive value
71676|NCT03116022|menopause|menopause
71677|NCT03116022|sexual dysfunction|sexual dysfunction
71678|NCT03116022|coital pain|coital pain
71679|NCT03116022|vagina|vagina
71680|NCT03116009|Obesity|obesity
71681|NCT03116009|Pregnancy|pregnancy
71682|NCT03116009|Diabetes Mellitus|diabetes mellitus
71683|NCT03116009|Perinatal Outcomes|perinatal outcomes
71684|NCT03115957|Parenteral Nutrition|parenteral nutrition
71685|NCT03115957|Digestive System Neoplasms|digestive system neoplasms
71686|NCT03115957|Randomized Controlled Trials|randomized controlled trials
71687|NCT03115957|Clinical Outcomes|clinical outcomes
71688|NCT03115957|Postoperative Period|postoperative period
71689|NCT03115905|Aneurysmal Subarachnoid Hemorrhage|aneurysmal subarachnoid hemorrhage
71690|NCT03115905|Emergency Medical Services|emergency medical services
71691|NCT03115905|Registry Study|registry study
71692|NCT03115905|China|china
71693|NCT03115866|Healthy Diet|healthy diet
71694|NCT03115866|Fruits and Vegetables|fruits and vegetables
71695|NCT03115866|Metabolome|metabolome
71696|NCT03115866|Microbiome|microbiome
71697|NCT03115866|Young Adults|young adults
71698|NCT03115788|Thermal|thermal
71699|NCT03115762|ASKB1202|askb1202
71700|NCT03115749|Crohn's disease|crohn's disease
71701|NCT03115749|ulcerative colitis|ulcerative colitis
71702|NCT03115749|mesenchymal stem cells|mesenchymal stem cells
71703|NCT03115749|intestinal inflammation|intestinal inflammation
71704|NCT03115736|HIV|hiv
71705|NCT03115736|Hepatitis B|hepatitis b
71706|NCT03115736|Renal dysfunction|renal dysfunction
71707|NCT03115736|tenofovir alafenamide|tenofovir alafenamide
71708|NCT03115723|Hospitalization|hospitalization
71709|NCT03115723|Health Care Economics and Organizations|health care economics and organizations
71710|NCT03115710|Keratoconus|keratoconus
71711|NCT03115710|Prevalence|prevalence
71712|NCT03115671|Phosphatidylserine|phosphatidylserine
71713|NCT03115671|Omega-3|omega-3
71714|NCT03115606|videolaryngoscope|videolaryngoscope
71715|NCT03115606|Fastrach LMA|fastrach lma
71716|NCT03115606|cervical motion|cervical motion
71717|NCT03115593|hysteroscopy|hysteroscopy
71718|NCT03115593|pipette|pipette
71719|NCT03115593|biopsy|biopsy
71720|NCT03115593|endometrial cancer|endometrial cancer
71721|NCT03115541|venous thromboembolism prophylaxis|venous thromboembolism prophylaxis
71722|NCT03115541|deep vein thrombosis|deep vein thrombosis
71723|NCT03115541|pulmonary embolus|pulmonary embolus
71724|NCT03115541|esophageal resection|esophageal resection
71725|NCT03115541|incidence|incidence
71726|NCT03115528|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
71727|NCT03115528|Medical oncologists|medical oncologists
71728|NCT03115528|Palliative care physicians|palliative care physicians
71729|NCT03115528|Questionnaire|questionnaire
71730|NCT03115528|Survey|survey
71731|NCT03115515|Thyroid Stimulating Hormone|thyroid stimulating hormone
71732|NCT03115489|seizure|seizure
71733|NCT03115489|glutamate activation|glutamate activation
71734|NCT03115489|N-Methyl D-Aspartate|n-methyl d-aspartate
71735|NCT03115489|GABA receptor|gaba receptor
71736|NCT03115489|Ketamine|ketamine
71737|NCT03115463|Neonatal Resuscitation|neonatal resuscitation
71738|NCT03115463|Prematurity|prematurity
71739|NCT03115463|Oxygen|oxygen
71740|NCT03115450|External ventricular drain (EVD)|external ventricular drain (evd)
71741|NCT03115450|Placement of Bolt|placement of bolt
71742|NCT03115437|Body mass|body mass
71743|NCT03115437|Running-related injury|running-related injury
71744|NCT03115437|Sports injury prevention|sports injury prevention
71745|NCT03115437|Impact forces|impact forces
71746|NCT03115437|Epidemiology|epidemiology
71747|NCT03115437|Running biomechanics|running biomechanics
71748|NCT03115437|Sports footwear|sports footwear
71749|NCT03115437|Shoe cushioning|shoe cushioning
71750|NCT03115424|Weight Loss|weight loss
71751|NCT03115424|Bariatric Surgery|bariatric surgery
71752|NCT03115398|Fitness Tracker|fitness tracker
71753|NCT03115398|Activity Monitoring|activity monitoring
71754|NCT03115398|Chemotherapy|chemotherapy
71755|NCT03115398|Radiation Therapy|radiation therapy
71756|NCT03115398|Chemoradiotherapy|chemoradiotherapy
71757|NCT03115359|Chronic Low Back Pain|chronic low back pain
71758|NCT03115359|Opioid Therapy|opioid therapy
71759|NCT03115359|Chronic Pain|chronic pain
71760|NCT03115359|Mindfulness Meditation|mindfulness meditation
71761|NCT03115359|Cognitive Behavioral Therapy|cognitive behavioral therapy
71762|NCT03115359|Opioid-treated Chronic Low Back Pain|opioid-treated chronic low back pain
71763|NCT03115359|CLBP|clbp
71764|NCT03115307|Insemination|insemination
71765|NCT03115307|Luteal phase support|luteal phase support
71766|NCT03115307|Gonadotropin-releasing hormone agonist|gonadotropin-releasing hormone agonist
71767|NCT03115307|Triptoreline|triptoreline
71768|NCT03115268|social support|social support
71769|NCT03115255|retinopathy of prematurity|retinopathy of prematurity
71770|NCT03115255|ranibizumab|ranibizumab
71771|NCT03115255|vascular endothelial growth factor|vascular endothelial growth factor
71772|NCT03115229|Obesity|obesity
71773|NCT03115229|Overweight|overweight
71774|NCT03115229|Physical Activity|physical activity
71775|NCT03115229|Nutrition|nutrition
71776|NCT03115229|Nursing|nursing
71777|NCT03115203|muscle skin|muscle skin
71778|NCT03115203|IRM 3 tesla|irm 3 tesla
71779|NCT03115138|Biopsy|biopsy
71780|NCT03115125|B lymphocyte|b lymphocyte
71781|NCT03115086|Bile Acid Synthesis Disorder|bile acid synthesis disorder
71782|NCT03115086|Zellweger Spectrum Disorder|zellweger spectrum disorder
71783|NCT03115086|Peroxisomal Disorder|peroxisomal disorder
71784|NCT03115086|Cholic Acid|cholic acid
71785|NCT03115086|Cholbam|cholbam
71786|NCT03115086|Kolbam|kolbam
71787|NCT03115086|The Replace Registry|the replace registry
71788|NCT03115073|Vulvovaginal candidiasis|vulvovaginal candidiasis
71789|NCT03115073|Candiplus|candiplus
71790|NCT03115073|Clotrimazole|clotrimazole
71791|NCT03115073|Safety|safety
71792|NCT03115073|Tolerability|tolerability
71793|NCT03115073|Clinical efficacy|clinical efficacy
71794|NCT03115034|carotid stenosis|carotid stenosis
71795|NCT03115034|melatonin|melatonin
71796|NCT03115034|vascular injury|vascular injury
71797|NCT03115034|ischemia reperfusion|ischemia reperfusion
71798|NCT03114995|Tirofiban|tirofiban
71799|NCT03114995|Resistance to antiplatelet agents|resistance to antiplatelet agents
71800|NCT03114982|Prevention of varicella|prevention of varicella
71801|NCT03114982|Varicella-zoster vaccine|varicella-zoster vaccine
71802|NCT03114969|Overall error|overall error
71803|NCT03114969|Error rate|error rate
71804|NCT03114969|Critical error|critical error
71805|NCT03114969|COPD|copd
71806|NCT03114969|ELLIPTA|ellipta
71807|NCT03114969|Dry powder inhaler|dry powder inhaler
71808|NCT03114943|prevention of varicella|prevention of varicella
71809|NCT03114943|Varicella-zoster vaccine|varicella-zoster vaccine
71810|NCT03114917|Suicide|suicide
71811|NCT03114917|Self-harm|self-harm
71812|NCT03114917|Psychosis|psychosis
71813|NCT03114917|Community|community
71814|NCT03114917|Suicide Prevention|suicide prevention
71815|NCT03114917|CBT|cbt
71816|NCT03114917|CARMS|carms
71817|NCT03114917|Randomised controlled trial|randomised controlled trial
71818|NCT03114891|post-traumatic stress|post-traumatic stress
71819|NCT03114891|depression|depression
71820|NCT03114865|bone marrow|bone marrow
71821|NCT03114865|bone marrow transplant|bone marrow transplant
71822|NCT03114865|allogeneic|allogeneic
71823|NCT03114865|tacrolimus|tacrolimus
71824|NCT03114865|cyclophosphamide|cyclophosphamide
71825|NCT03114865|Blinatumomab|blinatumomab
71826|NCT03114839|Lactobacillus casei strain Shirota|lactobacillus casei strain shirota
71827|NCT03114839|Yakult|yakult
71828|NCT03114839|IntelliCap|intellicap
71829|NCT03114761|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
71830|NCT03114761|Internal Herniation|internal herniation
71831|NCT03114761|Computed Tomography|computed tomography
71832|NCT03114748|deep brain stimulation|deep brain stimulation
71833|NCT03114748|EEG|eeg
71834|NCT03114709|Mindfulness|mindfulness
71835|NCT03114709|Exercise|exercise
71836|NCT03114709|Physical activity|physical activity
71837|NCT03114709|Behavior change|behavior change
71838|NCT03114709|Aging|aging
71839|NCT03114709|Randomized controlled trial|randomized controlled trial
71840|NCT03114709|Pilot|pilot
71841|NCT03114670|Leukemia|leukemia
71842|NCT03114670|Leukemia, Myeloid|leukemia, myeloid
71843|NCT03114670|Recurrence|recurrence
71844|NCT03114670|Neoplasms by Histologic Type|neoplasms by histologic type
71845|NCT03114670|Disease Attributes|disease attributes
71846|NCT03114670|Cyclophosphamide|cyclophosphamide
71847|NCT03114670|Fludarabine|fludarabine
71848|NCT03114670|CD123|cd123
71849|NCT03114670|Chimeric Antigen Receptor modified T-cells|chimeric antigen receptor modified t-cells
71850|NCT03114631|dendritic cells, pancreatic cancer, immunotherapy|dendritic cells, pancreatic cancer, immunotherapy
71851|NCT03114566|transplant donor|transplant donor
71852|NCT03114566|HLA typed|hla typed
71853|NCT03114566|17-211|17-211
71854|NCT03114553|family health history|family health history
71855|NCT03114553|prevention|prevention
71856|NCT03114553|genetic risk|genetic risk
71857|NCT03114553|clinical decision support|clinical decision support
71858|NCT03114527|Dedifferentiated liposarcoma|dedifferentiated liposarcoma
71859|NCT03114527|DDL|ddl
71860|NCT03114527|Leiomyosarcoma|leiomyosarcoma
71861|NCT03114527|LMS|lms
71862|NCT03114527|Ribociclib|ribociclib
71863|NCT03114501|Malignant neoplasms of lip oral cavity and pharynx|malignant neoplasms of lip oral cavity and pharynx
71864|NCT03114501|Head and Neck Cancer|head and neck cancer
71865|NCT03114501|Yoga|yoga
71866|NCT03114501|Questionnaires|questionnaires
71867|NCT03114501|Surveys|surveys
71868|NCT03114462|Malignant neoplasms of respiratory and intrathoracic organs|malignant neoplasms of respiratory and intrathoracic organs
71869|NCT03114462|Squamous cell carcinoma of the larynx|squamous cell carcinoma of the larynx
71870|NCT03114462|Stereotactic hypofractionated radioablation|stereotactic hypofractionated radioablation
71871|NCT03114462|HYDRA|hydra
71872|NCT03114462|Questionnaires|questionnaires
71873|NCT03114462|Surveys|surveys
71874|NCT03114423|EMDR|emdr
71875|NCT03114423|Psychotherapy|psychotherapy
71876|NCT03114423|Substance Use Disorders|substance use disorders
71877|NCT03114423|Eye Movement Desensitization and Reprocessing|eye movement desensitization and reprocessing
71878|NCT03114371|Prader-Willi syndrome|prader-willi syndrome
71879|NCT03114371|Oxytocin|oxytocin
71880|NCT03114371|Behavioural troubles|behavioural troubles
71881|NCT03114358|De-escalation|de-escalation
71882|NCT03114358|Carbapenems|carbapenems
71883|NCT03114358|Antimicrobial stewardship|antimicrobial stewardship
71884|NCT03114345|Pressure ulcer|pressure ulcer
71885|NCT03114345|Interface pressure|interface pressure
71886|NCT03114345|Pressure mapping device|pressure mapping device
71887|NCT03114345|Monitoring|monitoring
71888|NCT03114345|Microvascularization|microvascularization
71889|NCT03114319|TNO155|tno155
71890|NCT03114319|SHP2|shp2
71891|NCT03114319|advanced solid tumor|advanced solid tumor
71892|NCT03114319|NSCLC|nsclc
71893|NCT03114319|HNSCC|hnscc
71894|NCT03114319|EGFR|egfr
71895|NCT03114319|GIST|gist
71896|NCT03114319|PTPN11|ptpn11
71897|NCT03114319|cancers with a mass|cancers with a mass
71898|NCT03114319|bulky tumor|bulky tumor
71899|NCT03114319|nodule|nodule
71900|NCT03114319|lump|lump
71901|NCT03114319|advanced solid malignancies|advanced solid malignancies
71902|NCT03114306|ERAS|eras
71903|NCT03114306|pain|pain
71904|NCT03114306|knee arthroplasty|knee arthroplasty
71905|NCT03114306|joint pain|joint pain
71906|NCT03114306|regional anaesthesia|regional anaesthesia
71907|NCT03114293|Physical activity|physical activity
71908|NCT03114293|Mobility|mobility
71909|NCT03114254|Recurrent|recurrent
71910|NCT03114254|Locally advanced|locally advanced
71911|NCT03114254|Metastatic|metastatic
71912|NCT03114241|COPD|copd
71913|NCT03114241|Physical activity|physical activity
71914|NCT03114241|Endothelial function|endothelial function
71915|NCT03114228|myeloid|myeloid
71916|NCT03114228|leukemia|leukemia
71917|NCT03114228|FLT3-mutated|flt3-mutated
71918|NCT03114228|PKC412|pkc412
71919|NCT03114228|midostaurin|midostaurin
71920|NCT03114228|adult|adult
71921|NCT03114228|AML|aml
71922|NCT03114228|ETP|etp
71923|NCT03114228|FMS-like tyrosine kinase receptor|fms-like tyrosine kinase receptor
71924|NCT03114228|Acute myeloid leukemia|acute myeloid leukemia
71925|NCT03114215|Biotin|biotin
71926|NCT03114215|MD1003|md1003
71927|NCT03114215|ALSFRS-R|alsfrs-r
71928|NCT03114189|Sleep disturbance|sleep disturbance
71929|NCT03114189|footbath|footbath
71930|NCT03114189|Kneipp|kneipp
71931|NCT03114189|care of sleep|care of sleep
71932|NCT03114189|sleep|sleep
71933|NCT03114150|physical activity|physical activity
71934|NCT03114150|aging|aging
71935|NCT03114150|learning and memory|learning and memory
71936|NCT03114150|exercise|exercise
71937|NCT03114150|brain|brain
71938|NCT03114137|Sub-Saharan Africa|sub-saharan africa
71939|NCT03114137|Sickle Cell Disease|sickle cell disease
71940|NCT03114137|Vasculopathy|vasculopathy
71941|NCT03114137|Nephropathy|nephropathy
71942|NCT03114137|Pulmonary hypertension|pulmonary hypertension
71943|NCT03114137|cardiac disease|cardiac disease
71944|NCT03114137|hemolysis|hemolysis
71945|NCT03114137|pulse wave velocity|pulse wave velocity
71946|NCT03114137|blood viscosity|blood viscosity
71947|NCT03114124|ablation|ablation
71948|NCT03114124|atrioventricular node|atrioventricular node
71949|NCT03114124|microfidelity|microfidelity
71950|NCT03114098|Drug Resistance|drug resistance
71951|NCT03114098|CYP2D6|cyp2d6
71952|NCT03114098|cytochrom P450|cytochrom p450
71953|NCT03114072|Pregnancy|pregnancy
71954|NCT03114072|Blue-blockers|blue-blockers
71955|NCT03114072|Sleep quality|sleep quality
71956|NCT03114072|Melatonin|melatonin
71957|NCT03114059|Late Effects of Surgery|late effects of surgery
71958|NCT03114033|Cardiac Arrest|cardiac arrest
71959|NCT03114033|Intensive Care Unit|intensive care unit
71960|NCT03114033|Therapeutic Mild Hypercapnia|therapeutic mild hypercapnia
71961|NCT03114033|Normocapnia|normocapnia
71962|NCT03114033|Mortality|mortality
71963|NCT03114033|Neurological function|neurological function
71964|NCT03114020|Emphysema|emphysema
71965|NCT03114020|COPD|copd
71966|NCT03114020|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
71967|NCT03114007|Mental health problems|mental health problems
71968|NCT03114007|Substance misuse|substance misuse
71969|NCT03114007|Psychosocial difficulties|psychosocial difficulties
71970|NCT03114007|Youth|youth
71971|NCT03113994|Spinal Cord Injury|spinal cord injury
71972|NCT03113994|Osteoporosis|osteoporosis
71973|NCT03113994|Cardiometabolic Syndrome|cardiometabolic syndrome
71974|NCT03113916|Culturally-tailored|culturally-tailored
71975|NCT03113916|Weight Loss|weight loss
71976|NCT03113916|Diabetes|diabetes
71977|NCT03113916|Women|women
71978|NCT03113916|Hispanic|hispanic
71979|NCT03113916|Obesity|obesity
71980|NCT03113903|Pain|pain
71981|NCT03113903|psychophysics|psychophysics
71982|NCT03113903|Nociception|nociception
71983|NCT03113903|Sensitivity|sensitivity
71984|NCT03113903|Senses|senses
71985|NCT03113903|Phenotyping|phenotyping
71986|NCT03113903|Questionnaire|questionnaire
71987|NCT03113903|Anxiety|anxiety
71988|NCT03113903|Depression|depression
71989|NCT03113903|Catastrophizing|catastrophizing
71990|NCT03113890|pharmacogenetic testing|pharmacogenetic testing
71991|NCT03113890|genomic|genomic
71992|NCT03113890|assay|assay
71993|NCT03113890|PTSD|ptsd
71994|NCT03113890|pharmacodynamic|pharmacodynamic
71995|NCT03113890|pharmacokinetic|pharmacokinetic
71996|NCT03113890|psychiatric disorders|psychiatric disorders
71997|NCT03113864|Vision|vision
71998|NCT03113864|Eye Health|eye health
71999|NCT03113864|Lutein|lutein
72000|NCT03113864|Carotenoids|carotenoids
72001|NCT03113838|Drug-Induced Liver Injury|drug-induced liver injury
72002|NCT03113825|breast carcinoma|breast carcinoma
72003|NCT03113825|DCIS|dcis
72004|NCT03113786|Discectomy|discectomy
72005|NCT03113786|Lumbar discectomy|lumbar discectomy
72006|NCT03113786|Protruding disc|protruding disc
72007|NCT03113747|Allogeneic adipose-derived stem cells|allogeneic adipose-derived stem cells
72008|NCT03113747|burn wounds|burn wounds
72009|NCT03113747|wound healing|wound healing
72010|NCT03113747|regeneration|regeneration
72011|NCT03113747|repair|repair
72012|NCT03113747|skin tissue engineering|skin tissue engineering
72013|NCT03113708|heparin|heparin
72014|NCT03113708|heparin antagonists|heparin antagonists
72015|NCT03113708|cardiac surgery|cardiac surgery
72016|NCT03113708|active clotting time|active clotting time
72017|NCT03113695|Richter's Syndrome|richter's syndrome
72018|NCT03113695|CLL|cll
72019|NCT03113695|Chronic Lumphocytic Leukemia|chronic lumphocytic leukemia
72020|NCT03113695|obinutuzumab|obinutuzumab
72021|NCT03113695|HDMP|hdmp
72022|NCT03113695|lenalidomide|lenalidomide
72023|NCT03113695|cancer|cancer
72024|NCT03113695|methylprednisolone|methylprednisolone
72025|NCT03113643|Acute Myeloid Leukemia|acute myeloid leukemia
72026|NCT03113643|Myelodysplastic Syndrome|myelodysplastic syndrome
72027|NCT03113630|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
72028|NCT03113630|Virtual Reality Exposure Therapy|virtual reality exposure therapy
72029|NCT03113630|User-Computer Interface|user-computer interface
72030|NCT03113630|Rehabilitation|rehabilitation
72031|NCT03113630|Motor Activity|motor activity
72032|NCT03113591|total hip arthroplasty|total hip arthroplasty
72033|NCT03113591|minimal invasive|minimal invasive
72034|NCT03113578|Balloon enteroscopy|balloon enteroscopy
72035|NCT03113578|colonoscopy|colonoscopy
72036|NCT03113578|polyps|polyps
72037|NCT03113461|cognitive impairment|cognitive impairment
72038|NCT03113461|sleep apnea|sleep apnea
72039|NCT03113461|positive airway pressure therapy|positive airway pressure therapy
72040|NCT03113448|capsaicin|capsaicin
72041|NCT03113448|neuropathic pain|neuropathic pain
72042|NCT03113448|diabetic neuropathy|diabetic neuropathy
72043|NCT03113448|topical lotion|topical lotion
72044|NCT03113435|CO2 gap|co2 gap
72045|NCT03113435|oxygen consumption|oxygen consumption
72046|NCT03113435|Stroke volume optimization|stroke volume optimization
72047|NCT03113422|High Tumor Burden Follicular Lymphoma|high tumor burden follicular lymphoma
72048|NCT03113422|Venetoclax|venetoclax
72049|NCT03113422|Obinutuzumab|obinutuzumab
72050|NCT03113422|Bendamustine|bendamustine
72051|NCT03113422|Bcl-2 Family Protein Inhibitor|bcl-2 family protein inhibitor
72052|NCT03113422|Monoclonal Antibody|monoclonal antibody
72053|NCT03113409|Outpatient detoxification|outpatient detoxification
72054|NCT03113409|Opioid dependence|opioid dependence
72055|NCT03113409|Naltrexone|naltrexone
72056|NCT03113409|Vivitrol|vivitrol
72057|NCT03113409|Buprenorphine|buprenorphine
72058|NCT03113383|Thoracoabdominal Aortic Aneurysm|thoracoabdominal aortic aneurysm
72059|NCT03113383|Endovascular Aneurysm Repair|endovascular aneurysm repair
72060|NCT03113383|Stent-Graft|stent-graft
72061|NCT03113370|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
72062|NCT03113370|tobacco use|tobacco use
72063|NCT03113370|postpartum|postpartum
72064|NCT03113357|myofascial release|myofascial release
72065|NCT03113357|cervicogenic headache|cervicogenic headache
72066|NCT03113357|pain intensity|pain intensity
72067|NCT03113357|exercise therapy|exercise therapy
72068|NCT03113357|pressure pain threshold|pressure pain threshold
72069|NCT03113331|Intrauterine growth restriction|intrauterine growth restriction
72070|NCT03113331|Preterm birth|preterm birth
72071|NCT03113331|Birth defect|birth defect
72072|NCT03113331|Infant growth|infant growth
72073|NCT03113331|Neurodevelopmental outcomes|neurodevelopmental outcomes
72074|NCT03113318|Pulmonary neoplasm|pulmonary neoplasm
72075|NCT03113318|Metastasis|metastasis
72076|NCT03113318|colorectal neoplasm|colorectal neoplasm
72077|NCT03113305|Gastric bypass|gastric bypass
72078|NCT03113305|Morbid obesity|morbid obesity
72079|NCT03113305|Food choice|food choice
72080|NCT03113305|Ingestive behaviour|ingestive behaviour
72081|NCT03113292|physical therapy|physical therapy
72082|NCT03113292|therapeutic exercises|therapeutic exercises
72083|NCT03113292|low back pain|low back pain
72084|NCT03113266|anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
72085|NCT03113266|Metastatic|metastatic
72086|NCT03113266|Advanced|advanced
72087|NCT03113266|Bladder Urothelial Carcinoma|bladder urothelial carcinoma
72088|NCT03113253|Tranexamic Acid|tranexamic acid
72089|NCT03113253|Burn|burn
72090|NCT03113253|Surgery|surgery
72091|NCT03113253|Excision|excision
72092|NCT03113240|Glutamin|glutamin
72093|NCT03113240|Enteral Nutrition|enteral nutrition
72094|NCT03113240|Intensive Care Unit|intensive care unit
72095|NCT03113240|Intestinal Permeability|intestinal permeability
72096|NCT03113227|induction of labor|induction of labor
72097|NCT03113227|Bishop score|bishop score
72098|NCT03113227|posterior cervical angle|posterior cervical angle
72099|NCT03113227|cervical length|cervical length
72100|NCT03113201|Depression|depression
72101|NCT03113201|Collaborative care|collaborative care
72102|NCT03113201|Care manager|care manager
72103|NCT03113201|Anxiety|anxiety
72104|NCT03113201|Psychiatry|psychiatry
72105|NCT03113201|Consultation-liaison|consultation-liaison
72106|NCT03113201|General practitioner|general practitioner
72107|NCT03113175|Anxiety|anxiety
72108|NCT03113175|Collaborative care|collaborative care
72109|NCT03113175|Consultation-liaison|consultation-liaison
72110|NCT03113175|General practitioner|general practitioner
72111|NCT03113175|Psychiatry|psychiatry
72112|NCT03113162|multiple sclerosis|multiple sclerosis
72113|NCT03113162|HSCT|hsct
72114|NCT03113149|Physical Therapy Modalities|physical therapy modalities
72115|NCT03113149|Recovery of Function|recovery of function
72116|NCT03113149|Predictive Value of Tests|predictive value of tests
72117|NCT03113149|Cohort Studies|cohort studies
72118|NCT03113123|Adherence|adherence
72119|NCT03113123|Prevention|prevention
72120|NCT03113123|Tenofovir|tenofovir
72121|NCT03113123|Emtricitabine|emtricitabine
72122|NCT03113123|Antiretroviral|antiretroviral
72123|NCT03113123|Prophylaxis|prophylaxis
72124|NCT03113123|Men who have sex with men|men who have sex with men
72125|NCT03113110|Empagliflozin|empagliflozin
72126|NCT03113110|SGLT-2 Inhibition|sglt-2 inhibition
72127|NCT03113110|Glucose Metabolism|glucose metabolism
72128|NCT03113084|Sodium Heparin|sodium heparin
72129|NCT03113084|Pharmacokinetics|pharmacokinetics
72130|NCT03113084|Coagulation factor|coagulation factor
72131|NCT03113058|HBV infection,γδT cells,Adoptive treatment|hbv infection,γδt cells,adoptive treatment
72132|NCT03113032|total knee replacement|total knee replacement
72133|NCT03113032|sensorimotor training|sensorimotor training
72134|NCT03113032|pre-surgery exercise|pre-surgery exercise
72135|NCT03113032|sensorimotor function|sensorimotor function
72136|NCT03113032|neuromuscular|neuromuscular
72137|NCT03113019|dendritic cell, IL-12, IL-18, сytotoxicity|dendritic cell, il-12, il-18, сytotoxicity
72138|NCT03112993|spine surgery|spine surgery
72139|NCT03112993|neuromuscular blockade|neuromuscular blockade
72140|NCT03112993|sugammadex|sugammadex
72141|NCT03112993|elderly|elderly
72142|NCT03112993|reversal|reversal
72143|NCT03112993|neostigmine|neostigmine
72144|NCT03112993|recovery|recovery
72145|NCT03112980|Aortic Valve Stenosis|aortic valve stenosis
72146|NCT03112980|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
72147|NCT03112980|Surgical aortic valve replacement|surgical aortic valve replacement
72148|NCT03112980|Intermediate operative risk|intermediate operative risk
72149|NCT03112915|postoperative pain|postoperative pain
72150|NCT03112915|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
72151|NCT03112915|Quadratus lumborum block|quadratus lumborum block
72152|NCT03112915|transversus abdominis plan block|transversus abdominis plan block
72153|NCT03112889|McArdle Disease|mcardle disease
72154|NCT03112889|McArdle's Disease|mcardle's disease
72155|NCT03112889|Glycogen Storage Disease Type V|glycogen storage disease type v
72156|NCT03112889|GSDV|gsdv
72157|NCT03112889|Sodium Valproate|sodium valproate
72158|NCT03112889|Valproic Acid|valproic acid
72159|NCT03112889|Myophosphorylase Deficiency|myophosphorylase deficiency
72160|NCT03112889|Muscle Phosphorylase Deficiency|muscle phosphorylase deficiency
72161|NCT03112889|Glycogenosis|glycogenosis
72162|NCT03112889|Glycogen Storage Disorder|glycogen storage disorder
72163|NCT03112876|younger age|younger age
72164|NCT03112876|older age|older age
72165|NCT03112876|atopic dermatitis|atopic dermatitis
72166|NCT03112876|acne|acne
72167|NCT03112876|smoker|smoker
72168|NCT03112850|Crossover design|crossover design
72169|NCT03112850|Randomized controlled trial|randomized controlled trial
72170|NCT03112850|Aural rehabilitation intervention|aural rehabilitation intervention
72171|NCT03112798|tracheal intubation|tracheal intubation
72172|NCT03112798|Macintosh blade|macintosh blade
72173|NCT03112798|Miller blade|miller blade
72174|NCT03112785|Hip|hip
72175|NCT03112785|Arthroplasty|arthroplasty
72176|NCT03112785|Stem|stem
72177|NCT03112785|Outcome|outcome
72178|NCT03112746|child|child
72179|NCT03112746|goal|goal
72180|NCT03112746|intervention|intervention
72181|NCT03112746|motor skills disorder|motor skills disorder
72182|NCT03112746|occupational therapy|occupational therapy
72183|NCT03112655|diagnosis|diagnosis
72184|NCT03112655|sensitivity|sensitivity
72185|NCT03112655|specificity|specificity
72186|NCT03112655|therapeutic outcome|therapeutic outcome
72187|NCT03112655|cerebrospinal fluid|cerebrospinal fluid
72188|NCT03112629|Quality of Care|quality of care
72189|NCT03112629|aortic stenosis|aortic stenosis
72190|NCT03112629|transcatheter aortic valve implantation|transcatheter aortic valve implantation
72191|NCT03112629|surgical aortic valve replacement|surgical aortic valve replacement
72192|NCT03112629|facilitated data relay|facilitated data relay
72193|NCT03112603|Graft-versus-host disease (GvHD)|graft-versus-host disease (gvhd)
72194|NCT03112603|Chronic GvHD (cGvHD)|chronic gvhd (cgvhd)
72195|NCT03112603|steroid-refractory|steroid-refractory
72196|NCT03112603|ruxolitinib|ruxolitinib
72197|NCT03112603|Janus kinase inhibitor|janus kinase inhibitor
72198|NCT03112590|Histologically confirmed HER2 positive breast cancer|histologically confirmed her2 positive breast cancer
72199|NCT03112590|Unresectable breast cancer|unresectable breast cancer
72200|NCT03112590|Locally advanced breast cancer|locally advanced breast cancer
72201|NCT03112590|Metastatic breast cancer|metastatic breast cancer
72202|NCT03112590|Clinical stage 2-3 early stage breast cancer|clinical stage 2-3 early stage breast cancer
72203|NCT03112564|Endotracheal intubation|endotracheal intubation
72204|NCT03112564|muscle relaxants|muscle relaxants
72205|NCT03112564|inhalational anesthesia|inhalational anesthesia
72206|NCT03112538|insulin pump|insulin pump
72207|NCT03112538|basal bolus insulin|basal bolus insulin
72208|NCT03112525|rivaroxaban|rivaroxaban
72209|NCT03112525|apixaban|apixaban
72210|NCT03112525|cytochrome|cytochrome
72211|NCT03112525|anticoagulant|anticoagulant
72212|NCT03112525|transporter|transporter
72213|NCT03112525|polymorphism|polymorphism
72214|NCT03112525|genotyping|genotyping
72215|NCT03112525|phenotyping|phenotyping
72216|NCT03112512|optimal positive end-expiratory pressure determination|optimal positive end-expiratory pressure determination
72217|NCT03112512|Electrical impedance tomography|electrical impedance tomography
72218|NCT03112499|Acute Kidney Injury|acute kidney injury
72219|NCT03112499|PCNL|pcnl
72220|NCT03112499|mini-PCNL|mini-pcnl
72221|NCT03112499|RIRS|rirs
72222|NCT03112499|urine biomarkers|urine biomarkers
72223|NCT03112486|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
72224|NCT03112486|neurological outcome|neurological outcome
72225|NCT03112486|prognostication|prognostication
72226|NCT03112486|cerebral performance category|cerebral performance category
72227|NCT03112486|hypoxic-ischemic brain injury|hypoxic-ischemic brain injury
72228|NCT03112486|biomarkers|biomarkers
72229|NCT03112460|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
72230|NCT03112447|medial epicondyle humerus|medial epicondyle humerus
72231|NCT03112447|absorbable cartilage nail|absorbable cartilage nail
72232|NCT03112421|IVD|ivd
72233|NCT03112408|cerebellar lesion|cerebellar lesion
72234|NCT03112408|saccadic adaptation|saccadic adaptation
72235|NCT03112408|spatial localization|spatial localization
72236|NCT03112408|visuo spatial perception|visuo spatial perception
72237|NCT03112408|eye movements|eye movements
72238|NCT03112369|American Indian / Alaska Native|american indian / alaska native
72239|NCT03112369|HIV Prevention|hiv prevention
72240|NCT03112369|Sexual Risk Behavior|sexual risk behavior
72241|NCT03112369|Trauma|trauma
72242|NCT03112369|Substance Use|substance use
72243|NCT03112356|infectious endocarditis|infectious endocarditis
72244|NCT03112356|prosthetic valve infection|prosthetic valve infection
72939|NCT03108482|Tramadol|tramadol
72245|NCT03112356|implantable cardiac device infection|implantable cardiac device infection
72246|NCT03112356|99mTc-Leukoscan® scintigraphy|99mtc-leukoscan® scintigraphy
72247|NCT03112343|ICT based clinical trial|ict based clinical trial
72248|NCT03112343|Contract research organization (CRO)|contract research organization (cro)
72249|NCT03112343|eCRF|ecrf
72250|NCT03112343|Joint Electronic-institutional review board (eIRB)|joint electronic-institutional review board (eirb)
72251|NCT03112343|Centralized monitoring|centralized monitoring
72252|NCT03112330|atrophic rhinitis|atrophic rhinitis
72253|NCT03112317|Surgery|surgery
72254|NCT03112317|Hypothermia|hypothermia
72255|NCT03112317|Prevention|prevention
72256|NCT03112317|Surgical Site Infection|surgical site infection
72257|NCT03112317|Bleeding|bleeding
72258|NCT03112304|children|children
72259|NCT03112304|youth|youth
72260|NCT03112304|adolescents|adolescents
72261|NCT03112304|anxiety|anxiety
72262|NCT03112304|depression|depression
72263|NCT03112304|trauma|trauma
72264|NCT03112304|behavior problems|behavior problems
72265|NCT03112304|evidence-based treatments|evidence-based treatments
72266|NCT03112304|manualized|manualized
72267|NCT03112304|cognitive-behavioral therapy|cognitive-behavioral therapy
72268|NCT03112304|mental health|mental health
72269|NCT03112291|anti-microbial agents|anti-microbial agents
72270|NCT03112291|apexification|apexification
72271|NCT03112291|dental pulp|dental pulp
72272|NCT03112291|endodontics|endodontics
72273|NCT03112291|root canal therapy|root canal therapy
72274|NCT03112291|dental trauma|dental trauma
72275|NCT03112278|tooth erosion|tooth erosion
72276|NCT03112278|Computer-Aided Design|computer-aided design
72277|NCT03112278|occlusal veneers|occlusal veneers
72278|NCT03112278|dental veneers|dental veneers
72279|NCT03112265|anxiety|anxiety
72280|NCT03112265|depression|depression
72281|NCT03112265|trauma|trauma
72282|NCT03112265|behavior problems|behavior problems
72283|NCT03112265|evidence-based treatments|evidence-based treatments
72284|NCT03112265|manualized treatments|manualized treatments
72285|NCT03112265|cognitive-behavioral therapy|cognitive-behavioral therapy
72286|NCT03112265|youth|youth
72287|NCT03112265|mental health|mental health
72288|NCT03112265|self-regulation|self-regulation
72289|NCT03112265|neuroimaging|neuroimaging
72290|NCT03112252|Immunotherapy|immunotherapy
72291|NCT03112239|Asthma|asthma
72292|NCT03112239|Photobiomodulation|photobiomodulation
72293|NCT03112239|Resistance Training|resistance training
72294|NCT03112226|cognitive impairment|cognitive impairment
72295|NCT03112226|menopause|menopause
72296|NCT03112226|estrogen|estrogen
72297|NCT03112226|functional MRI|functional mri
72298|NCT03112226|executive function|executive function
72299|NCT03112226|endothelial function|endothelial function
72300|NCT03112226|arterial stiffness|arterial stiffness
72301|NCT03112200|Subchondroplasty|subchondroplasty
72302|NCT03112200|Arthroscopy|arthroscopy
72303|NCT03112200|Bone Substitute Material|bone substitute material
72304|NCT03112200|Subchondral Bone Defect|subchondral bone defect
72305|NCT03112200|AccuFill|accufill
72306|NCT03112200|Bone Marrow Lesion|bone marrow lesion
72307|NCT03112187|IDA|ida
72308|NCT03112187|iron deficiency anemia|iron deficiency anemia
72309|NCT03112187|iron supplements|iron supplements
72310|NCT03112187|Pakistan|pakistan
72311|NCT03112187|Liposomal iron|liposomal iron
72312|NCT03112174|PCYC|pcyc
72313|NCT03112174|MCL|mcl
72314|NCT03112174|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
72315|NCT03112174|NHL|nhl
72316|NCT03112174|ibrutinib|ibrutinib
72317|NCT03112174|venetoclax|venetoclax
72318|NCT03112174|Pharmacyclics|pharmacyclics
72319|NCT03112122|Bone Marrow Edema|bone marrow edema
72320|NCT03112122|Mesenchymal Stem Cells|mesenchymal stem cells
72321|NCT03112096|Tau|tau
72322|NCT03112096|neurodegeneration|neurodegeneration
72323|NCT03112096|positron emission tomography|positron emission tomography
72324|NCT03112083|krill powder|krill powder
72325|NCT03112083|krill oil|krill oil
72326|NCT03112083|safety|safety
72327|NCT03112083|tolerability|tolerability
72328|NCT03112083|adverse event|adverse event
72329|NCT03112083|omega-3 fatty acids|omega-3 fatty acids
72330|NCT03112083|eicosapentaenoic acid|eicosapentaenoic acid
72331|NCT03112083|docosahexaenoic acid|docosahexaenoic acid
72332|NCT03112044|Lung|lung
72333|NCT03112044|Transplant|transplant
72334|NCT03112044|Hepatitis C|hepatitis c
72335|NCT03112044|DAAs|daas
72336|NCT03112044|Epclusa|epclusa
72337|NCT03112031|Tamoxifen|tamoxifen
72338|NCT03112031|Cryptococcal meningitis|cryptococcal meningitis
72339|NCT03112031|Cryptococcus neoformans|cryptococcus neoformans
72340|NCT03112031|Human immunodeficiency virus|human immunodeficiency virus
72341|NCT03112018|premature birth|premature birth
72342|NCT03112018|neonatal mortality|neonatal mortality
72343|NCT03112018|premature infant|premature infant
72344|NCT03112005|Diabetic Eye Disease|diabetic eye disease
72345|NCT03111992|Myeloma,|myeloma,
72346|NCT03111992|Multiple Myeloma,|multiple myeloma,
72940|NCT03108482|Celecoxib|celecoxib
72347|NCT03111992|Hematologic Diseases,|hematologic diseases,
72348|NCT03111992|Myeloma, Multiple,|myeloma, multiple,
72349|NCT03111992|Myeloma-Multiple,|myeloma-multiple,
72350|NCT03111992|Programmed Cell Death 1 Receptor|programmed cell death 1 receptor
72351|NCT03111979|beta-alanine|beta-alanine
72352|NCT03111979|Carnosine|carnosine
72353|NCT03111979|Neuromuscular|neuromuscular
72354|NCT03111979|Stimulation|stimulation
72355|NCT03111979|Skeletal muscle|skeletal muscle
72356|NCT03111966|Hepatitis C|hepatitis c
72357|NCT03111953|Bariatric Surgery|bariatric surgery
72358|NCT03111953|Roux-en-Y gastric bypass|roux-en-y gastric bypass
72359|NCT03111953|Biliopancreatic Diversion|biliopancreatic diversion
72360|NCT03111927|Nutrition, Brain Development, Cognition, Heathy Infants|nutrition, brain development, cognition, heathy infants
72361|NCT03111901|pembrolizumab|pembrolizumab
72362|NCT03111901|IL-2|il-2
72363|NCT03111901|interleukin-2|interleukin-2
72364|NCT03111901|MK-3475|mk-3475
72365|NCT03111875|Hypothermia|hypothermia
72366|NCT03111875|Intraoperative warming|intraoperative warming
72367|NCT03111875|non-cardiac surgery|non-cardiac surgery
72368|NCT03111875|myocardial injury|myocardial injury
72369|NCT03111849|COPD|copd
72370|NCT03111849|Sarcopenia|sarcopenia
72371|NCT03111849|Prevalence|prevalence
72372|NCT03111849|Mortality|mortality
72373|NCT03111849|Malnutrition|malnutrition
72374|NCT03111849|Nutritional assessment|nutritional assessment
72375|NCT03111849|Body composition|body composition
72376|NCT03111849|Pulmonary cachexia|pulmonary cachexia
72377|NCT03111810|Corticosteroids|corticosteroids
72378|NCT03111810|Prednisolone|prednisolone
72379|NCT03111810|11 beta-Hydroxysteroid dehydrogenase1 inhibitor|11 beta-hydroxysteroid dehydrogenase1 inhibitor
72380|NCT03111810|Iatrogenic Cushing's disease|iatrogenic cushing's disease
72381|NCT03111810|AZD4017|azd4017
72382|NCT03111784|Fish Consumption, Fatty acid composition, Lipid Profile, Tocopherol, Sociodemographics|fish consumption, fatty acid composition, lipid profile, tocopherol, sociodemographics
72383|NCT03111771|Cancer|cancer
72384|NCT03111771|Cachexia|cachexia
72385|NCT03111771|Myosteatosis|myosteatosis
72386|NCT03111771|Mitochondrial activity|mitochondrial activity
72387|NCT03111771|Upper aerodigestive pathways|upper aerodigestive pathways
72388|NCT03111771|Lipotoxicity|lipotoxicity
72389|NCT03111745|Reactivation or Proliferation of Latent Viral Infections.|reactivation or proliferation of latent viral infections.
72390|NCT03111745|VIRAL INFECTION|viral infection
72391|NCT03111745|Lymphoproliferation|lymphoproliferation
72392|NCT03111732|Immune-Based Strategies|immune-based strategies
72393|NCT03111732|Anti-PD1 Therapy|anti-pd1 therapy
72394|NCT03111732|Chronic Inflammation|chronic inflammation
72395|NCT03111732|Combination Chemotherapy|combination chemotherapy
72396|NCT03111693|Epicardial fat|epicardial fat
72397|NCT03111693|Obesity|obesity
72398|NCT03111693|Cardiovascular risks markers|cardiovascular risks markers
72399|NCT03111693|Metabolic syndrome|metabolic syndrome
72400|NCT03111693|Low dose computed tomography|low dose computed tomography
72401|NCT03111667|Marijuana|marijuana
72402|NCT03111667|Motivational Enhancement Therapy|motivational enhancement therapy
72403|NCT03111667|Adolescents|adolescents
72404|NCT03111615|Aromatase inhibitors|aromatase inhibitors
72405|NCT03111615|Luminal Breast Cancer neoadjuvant hormone therapy|luminal breast cancer neoadjuvant hormone therapy
72406|NCT03111602|polyphenols|polyphenols
72407|NCT03111602|pregnant|pregnant
72408|NCT03111602|fetal ductal constriction|fetal ductal constriction
72409|NCT03111602|prostaglandin E2|prostaglandin e2
72410|NCT03111589|Sickle Cell Disease|sickle cell disease
72411|NCT03111589|Heme oxidase-1 (HO-1)|heme oxidase-1 (ho-1)
72412|NCT03111537|cigarette|cigarette
72413|NCT03111537|smoking|smoking
72414|NCT03111537|e-cigarette|e-cigarette
72415|NCT03111537|nicotine replacement therapy|nicotine replacement therapy
72416|NCT03111537|nrt|nrt
72417|NCT03111537|tobacco|tobacco
72418|NCT03111524|stuttering|stuttering
72419|NCT03111524|children who stutter|children who stutter
72420|NCT03111524|peer attitudes|peer attitudes
72421|NCT03111524|classroom-based intervention|classroom-based intervention
72422|NCT03111524|teasing|teasing
72423|NCT03111524|bullying|bullying
72424|NCT03111498|Vacuum assisted delivery|vacuum assisted delivery
72425|NCT03111498|technical skills|technical skills
72426|NCT03111498|training|training
72427|NCT03111459|endograft repair,|endograft repair,
72428|NCT03111433|Type 1 Diabetes mellitus|type 1 diabetes mellitus
72429|NCT03111433|Coenzyme Q10|coenzyme q10
72430|NCT03111433|endothelial dysfunction|endothelial dysfunction
72431|NCT03111433|pediatric patients|pediatric patients
72432|NCT03111407|primary total knee arthroplasty|primary total knee arthroplasty
72433|NCT03111394|MS|ms
72434|NCT03111394|23andMe|23andme
72435|NCT03111394|MRI|mri
72436|NCT03111394|Genome-wide association studies|genome-wide association studies
72437|NCT03111368|eus-fna|eus-fna
72438|NCT03111368|pancreatic neoplasm|pancreatic neoplasm
72439|NCT03111368|slow-pull|slow-pull
72440|NCT03111368|negative pressure|negative pressure
72441|NCT03111355|nuts|nuts
72442|NCT03111355|micronutrients|micronutrients
72443|NCT03111355|nutrigenomics|nutrigenomics
72444|NCT03111355|nutrigenetics|nutrigenetics
72445|NCT03111342|Intrauterine contraception|intrauterine contraception
72446|NCT03111342|Pain|pain
72447|NCT03111342|Anesthesia|anesthesia
72448|NCT03111342|LNG-IUD|lng-iud
72449|NCT03111342|nulligravida|nulligravida
72450|NCT03111329|Gastric residuals assessment|gastric residuals assessment
72451|NCT03111329|Prematurity|prematurity
72452|NCT03111329|Necrotizing Enterocolitis of Newborn|necrotizing enterocolitis of newborn
72453|NCT03111329|Sepsis Newborn|sepsis newborn
72454|NCT03111329|Nutrition of newborn|nutrition of newborn
72455|NCT03111329|feeding tolerance of newborn|feeding tolerance of newborn
72456|NCT03111316|Cervical Ripening|cervical ripening
72457|NCT03111316|Induction of Labor|induction of labor
72458|NCT03111290|Facial recognition|facial recognition
72459|NCT03111277|neuropathic pain|neuropathic pain
72460|NCT03111264|Overweight|overweight
72461|NCT03111264|Obesity|obesity
72462|NCT03111264|Prevention|prevention
72463|NCT03111264|Children|children
72464|NCT03111264|Childcare|childcare
72465|NCT03111264|Physical Activity|physical activity
72466|NCT03111264|Nutrition|nutrition
72467|NCT03111264|Wellness|wellness
72468|NCT03111264|Environment|environment
72469|NCT03111264|Intervention|intervention
72470|NCT03111264|Feeding|feeding
72471|NCT03111238|Autologous|autologous
72472|NCT03111238|Bone Marrow-derived Mononuclear Cells (BM-MNCs)|bone marrow-derived mononuclear cells (bm-mncs)
72473|NCT03111238|Advanced Therapy Medicinal Product (ATMP)|advanced therapy medicinal product (atmp)
72474|NCT03111238|Tissue-engineered Medicinal Product|tissue-engineered medicinal product
72475|NCT03111238|Revascularization|revascularization
72476|NCT03111238|Angiogenesis|angiogenesis
72477|NCT03111238|Vasculogenesis|vasculogenesis
72478|NCT03111238|Arteriogenesis|arteriogenesis
72479|NCT03111212|Acute respiratory distress syndrome|acute respiratory distress syndrome
72480|NCT03111199|Low back pain|low back pain
72481|NCT03111199|Analgesia|analgesia
72482|NCT03111199|Physical therapy|physical therapy
72483|NCT03111186|oxycodone|oxycodone
72484|NCT03111186|ibuprofen|ibuprofen
72485|NCT03111186|acetaminophen|acetaminophen
72486|NCT03111186|soft-tissue hand surgery|soft-tissue hand surgery
72487|NCT03111186|carpal tunnel release|carpal tunnel release
72488|NCT03111186|Dupuytren contracture release|dupuytren contracture release
72489|NCT03111186|Trigger digit release|trigger digit release
72490|NCT03111186|Ganglion cyst removal|ganglion cyst removal
72491|NCT03111186|De Quervain's release|de quervain's release
72492|NCT03111173|ECG|ecg
72493|NCT03111173|Fetus|fetus
72494|NCT03111173|R peak extraction|r peak extraction
72495|NCT03111160|Small-incision lenticule extraction|small-incision lenticule extraction
72496|NCT03111160|femtosecond laser|femtosecond laser
72497|NCT03111160|lower laser energy level|lower laser energy level
72498|NCT03111160|early visual recovery|early visual recovery
72499|NCT03111134|abdominal wound closure techniques|abdominal wound closure techniques
72500|NCT03111134|layered closure|layered closure
72501|NCT03111134|component separation technique|component separation technique
72502|NCT03111121|deeply anesthetized|deeply anesthetized
72503|NCT03111121|ideal surgical exposure|ideal surgical exposure
72504|NCT03111121|muscle relaxation|muscle relaxation
72505|NCT03111121|Adults|adults
72506|NCT03111069|Malignant neoplasms of mesothelial and soft tissue|malignant neoplasms of mesothelial and soft tissue
72507|NCT03111069|Pelvic and Abdominal Rhabdomyosarcoma|pelvic and abdominal rhabdomyosarcoma
72508|NCT03111069|Undifferentiated Sarcomas|undifferentiated sarcomas
72509|NCT03111069|Unresectable or Refractory|unresectable or refractory
72510|NCT03111069|Abdominal tumors|abdominal tumors
72511|NCT03111069|Hyperthermic intra-peritoneal chemotherapy|hyperthermic intra-peritoneal chemotherapy
72512|NCT03111069|HIPEC|hipec
72513|NCT03111069|Abdominal surgery|abdominal surgery
72514|NCT03111069|Doxorubicin|doxorubicin
72515|NCT03111069|Doxorubicin Hydrochloride|doxorubicin hydrochloride
72516|NCT03111069|Adriamycin PFS|adriamycin pfs
72517|NCT03111069|Adriamycin RDF|adriamycin rdf
72518|NCT03111069|Adriamycin|adriamycin
72519|NCT03111069|Rubex|rubex
72520|NCT03111069|Intra-operative radiation|intra-operative radiation
72521|NCT03111069|IORT|iort
72522|NCT03111069|Brachytherapy|brachytherapy
72523|NCT03111043|computed tomography|computed tomography
72524|NCT03111043|Sudden cardiac arrest|sudden cardiac arrest
72525|NCT03111043|Cardiac computed tomography|cardiac computed tomography
72526|NCT03111043|Diagnostic accuracy|diagnostic accuracy
72527|NCT03111043|Clinical outcome|clinical outcome
72528|NCT03111017|muscle sympathetic nerve activity|muscle sympathetic nerve activity
72529|NCT03111017|exercise tolerance|exercise tolerance
72530|NCT03111017|exercise training|exercise training
72531|NCT03111017|peak oxygen uptake|peak oxygen uptake
72532|NCT03111004|information technology|information technology
72533|NCT03111004|telemedicine|telemedicine
72534|NCT03111004|integrated care|integrated care
72535|NCT03111004|MAST framework|mast framework
72536|NCT03111004|organizational change|organizational change
72537|NCT03111004|social care|social care
72941|NCT03108469|migraine|migraine
72538|NCT03111004|elderly patients|elderly patients
72539|NCT03110991|Depression|depression
72540|NCT03110991|Depressive symptoms|depressive symptoms
72541|NCT03110991|Prevention|prevention
72542|NCT03110991|Non-professional caregivers|non-professional caregivers
72543|NCT03110991|App|app
72544|NCT03110978|Malignant neoplasms of respiratory and intrathoracic organs|malignant neoplasms of respiratory and intrathoracic organs
72545|NCT03110978|Non-small Cell Lung Cancer|non-small cell lung cancer
72546|NCT03110978|NSCLC|nsclc
72547|NCT03110978|Squamous cell carcinoma|squamous cell carcinoma
72548|NCT03110978|Adenocarcinoma|adenocarcinoma
72549|NCT03110978|Large cell carcinoma|large cell carcinoma
72550|NCT03110978|Bronchioloalveolar cell carcinoma|bronchioloalveolar cell carcinoma
72551|NCT03110978|Stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
72552|NCT03110978|SABR|sabr
72553|NCT03110978|Nivolumab|nivolumab
72554|NCT03110978|BMS-936558|bms-936558
72555|NCT03110978|Opdivo|opdivo
72556|NCT03110978|Immunotherapy|immunotherapy
72557|NCT03110913|Healthy|healthy
72558|NCT03110913|Men|men
72559|NCT03110913|Adults|adults
72560|NCT03110913|Methionine|methionine
72561|NCT03110887|Dynamic prediction model|dynamic prediction model
72562|NCT03110822|Ruxolitinib|ruxolitinib
72563|NCT03110822|Steroids|steroids
72564|NCT03110822|Lenalidomide|lenalidomide
72565|NCT03110822|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
72566|NCT03110809|obesity|obesity
72567|NCT03110809|brown|brown
72568|NCT03110809|fat|fat
72569|NCT03110809|weight|weight
72570|NCT03110809|loss|loss
72571|NCT03110783|Bioseal as an Adjunct to Sutured Dural Repair|bioseal as an adjunct to sutured dural repair
72572|NCT03110783|elective posterior fossa|elective posterior fossa
72573|NCT03110783|supratentorial procedure|supratentorial procedure
72574|NCT03110770|Flavivirus|flavivirus
72575|NCT03110770|Zika|zika
72576|NCT03110770|Vaccine|vaccine
72577|NCT03110770|Physiological Effects of Drugs|physiological effects of drugs
72578|NCT03110770|Immunologic Factors|immunologic factors
72579|NCT03110770|Virus-like Particles|virus-like particles
72580|NCT03110770|Zika vaccine|zika vaccine
72581|NCT03110757|AP 10-701|ap 10-701
72582|NCT03110757|healthy adults|healthy adults
72583|NCT03110757|Immunogenicity|immunogenicity
72584|NCT03110757|Phase Ib|phase ib
72585|NCT03110757|Reactogenicity|reactogenicity
72586|NCT03110757|Safety|safety
72587|NCT03110757|Schistosomiasis|schistosomiasis
72588|NCT03110757|Sm-TSP-2/Alhydrogel®|sm-tsp-2/alhydrogel®
72589|NCT03110718|robotic rehabilitation|robotic rehabilitation
72590|NCT03110718|muscle vibration|muscle vibration
72591|NCT03110718|combined approach|combined approach
72592|NCT03110679|osteoarthritis|osteoarthritis
72593|NCT03110679|autologous bone marrow concentrate|autologous bone marrow concentrate
72594|NCT03110666|knee osteoarthritis ,|knee osteoarthritis ,
72595|NCT03110666|bone marrow aspirate|bone marrow aspirate
72596|NCT03110666|injections|injections
72597|NCT03110627|Single-chamber ICD (implantable cardioverter-defibrillator)|single-chamber icd (implantable cardioverter-defibrillator)
72598|NCT03110627|Cardiac Arrhythmias|cardiac arrhythmias
72599|NCT03110627|Atrial fibrillation|atrial fibrillation
72600|NCT03110627|Atrial flutter|atrial flutter
72601|NCT03110627|Stroke|stroke
72602|NCT03110614|COPD|copd
72603|NCT03110614|acute|acute
72604|NCT03110614|exacerbation|exacerbation
72605|NCT03110614|lung ultrasound|lung ultrasound
72606|NCT03110588|metastatic prostate cancer|metastatic prostate cancer
72607|NCT03110588|castration-resistant prostate cancer|castration-resistant prostate cancer
72608|NCT03110588|PACE (Prednisone, Abiraterone, Cabazitaxel, and Enzalutamide)|pace (prednisone, abiraterone, cabazitaxel, and enzalutamide)
72609|NCT03110575|TNX-102 SL|tnx-102 sl
72610|NCT03110575|Bedtime|bedtime
72611|NCT03110575|Sublingual|sublingual
72612|NCT03110575|3-month|3-month
72613|NCT03110575|Safety|safety
72614|NCT03110575|Efficacy|efficacy
72615|NCT03110575|PTSD|ptsd
72616|NCT03110562|Relapsed or Refractory Multiple Myeloma|relapsed or refractory multiple myeloma
72617|NCT03110562|RRMM|rrmm
72618|NCT03110562|Bortezomib|bortezomib
72619|NCT03110562|Dexamethasone|dexamethasone
72620|NCT03110536|Burnout syndrome|burnout syndrome
72621|NCT03110536|Triage|triage
72622|NCT03110536|Nurse|nurse
72623|NCT03110536|Emergency Department|emergency department
72624|NCT03110536|Romania|romania
72625|NCT03110497|Cervical cancer|cervical cancer
72626|NCT03110497|Image guided Brachytherapy|image guided brachytherapy
72627|NCT03110497|single application|single application
72628|NCT03110471|Cognitive impairment|cognitive impairment
72629|NCT03110471|antipsychotics|antipsychotics
72630|NCT03110471|antidepressants|antidepressants
72631|NCT03110458|Acute unilateral vestibulopathy, AUV|acute unilateral vestibulopathy, auv
72632|NCT03110419|Elderly|elderly
72633|NCT03110419|Frailty|frailty
72634|NCT03110419|Multicomponent training|multicomponent training
72635|NCT03110419|Physical exercise|physical exercise
72636|NCT03110419|Functional capacity|functional capacity
72637|NCT03110419|Complexity|complexity
72942|NCT03108456|atherectomy|atherectomy
72638|NCT03110419|Physical Therapy|physical therapy
72639|NCT03110406|renal transplant recipients|renal transplant recipients
72640|NCT03110406|exercise|exercise
72641|NCT03110406|heart rate variability|heart rate variability
72642|NCT03110406|Cardiovascular mortality|cardiovascular mortality
72643|NCT03110393|Obese|obese
72644|NCT03110393|Laryngeal Mask Airway|laryngeal mask airway
72645|NCT03110393|Anaesthesia|anaesthesia
72646|NCT03110354|AML|aml
72647|NCT03110354|ALL|all
72648|NCT03110354|Enhancer of zeste homolog (EZH) inhibitor|enhancer of zeste homolog (ezh) inhibitor
72649|NCT03110354|DS-3201b|ds-3201b
72650|NCT03110315|Multiple Sclerosis|multiple sclerosis
72651|NCT03110315|Fatigue|fatigue
72652|NCT03110315|Insomnia|insomnia
72653|NCT03110315|Suvorexant|suvorexant
72654|NCT03110315|Belsomra|belsomra
72655|NCT03110315|Sleep disorder|sleep disorder
72656|NCT03110315|Sleep|sleep
72657|NCT03110302|Posttraumatic Stress Disorder|posttraumatic stress disorder
72658|NCT03110302|Telehealth|telehealth
72659|NCT03110302|Video teleconferencing|video teleconferencing
72660|NCT03110302|In home therapy|in home therapy
72661|NCT03110302|Prolonged Exposure|prolonged exposure
72662|NCT03110289|Fecal microbiota transplantation|fecal microbiota transplantation
72663|NCT03110250|Familial Hypercholesterolemia|familial hypercholesterolemia
72664|NCT03110250|registry|registry
72665|NCT03110250|Turkey|turkey
72666|NCT03110250|Lipid lowering therapy|lipid lowering therapy
72667|NCT03110224|Subchondroplasty|subchondroplasty
72668|NCT03110224|Bone Marrow Lesion|bone marrow lesion
72669|NCT03110224|Arthroscopy|arthroscopy
72670|NCT03110224|Bone Substitute Material|bone substitute material
72671|NCT03110224|AccuFill|accufill
72672|NCT03110224|Subchondral Bone Defect|subchondral bone defect
72673|NCT03110198|Mesalazine|mesalazine
72674|NCT03110198|Ulcerative Colitis(UC)|ulcerative colitis(uc)
72675|NCT03110198|Enema|enema
72676|NCT03110172|Osteoarthritis|osteoarthritis
72677|NCT03110172|Depression|depression
72678|NCT03110172|Pain|pain
72679|NCT03110159|Photodynamic therapy|photodynamic therapy
72680|NCT03110159|Prevention|prevention
72681|NCT03110159|Actinic Keratosis|actinic keratosis
72682|NCT03110159|Skin Cancer|skin cancer
72683|NCT03110159|Non-melanoma Skin Cancer|non-melanoma skin cancer
72684|NCT03110159|Sun Damaged Skin|sun damaged skin
72685|NCT03110159|Solid Organ Transplant|solid organ transplant
72686|NCT03110159|PDT|pdt
72687|NCT03110133|Clostridium Difficile Infection|clostridium difficile infection
72688|NCT03110133|CP101|cp101
72689|NCT03110133|Crestovo|crestovo
72690|NCT03110133|FMT|fmt
72691|NCT03110133|CDI|cdi
72692|NCT03110133|C. difficile|c. difficile
72693|NCT03110133|C. diff|c. diff
72694|NCT03110133|Recurrenct Clostridium Difficile Infection|recurrenct clostridium difficile infection
72695|NCT03110133|Recurrent C. diff|recurrent c. diff
72696|NCT03110133|Recurrent CDI|recurrent cdi
72697|NCT03110133|Finch|finch
72698|NCT03110068|microvascular invasion|microvascular invasion
72699|NCT03110068|serum biomarker|serum biomarker
72700|NCT03110068|radiological feature|radiological feature
72701|NCT03110068|pathological differentiation|pathological differentiation
72702|NCT03110003|Neuraxial epidural techniques|neuraxial epidural techniques
72703|NCT03110003|Combined spinal epidural|combined spinal epidural
72704|NCT03110003|Epidural volume extension|epidural volume extension
72705|NCT03110003|Transient Neurologic Symptoms (TNS)|transient neurologic symptoms (tns)
72706|NCT03109977|17-059|17-059
72707|NCT03109977|Zr-DFO-pertuzumab|zr-dfo-pertuzumab
72708|NCT03109951|Type 2 diabetes|type 2 diabetes
72709|NCT03109951|colonoscopy|colonoscopy
72710|NCT03109951|hypoglycemia|hypoglycemia
72711|NCT03109951|hyperglycemia|hyperglycemia
72712|NCT03109951|polyethylene glycol|polyethylene glycol
72713|NCT03109925|PAE|pae
72714|NCT03109925|embolization|embolization
72715|NCT03109925|non-surgical|non-surgical
72716|NCT03109925|prostate artery embolization|prostate artery embolization
72717|NCT03109925|radio-opaque embolic|radio-opaque embolic
72718|NCT03109899|mHealth|mhealth
72719|NCT03109899|HIV Prevention|hiv prevention
72720|NCT03109886|Unresectable Hepatocellular Carcinoma|unresectable hepatocellular carcinoma
72721|NCT03109886|Metastatic Hepatocellular Carcinoma|metastatic hepatocellular carcinoma
72722|NCT03109886|Child-Pugh Class A|child-pugh class a
72723|NCT03109860|Chronic neuropathic pain|chronic neuropathic pain
72724|NCT03109834|Weight Management Programs|weight management programs
72725|NCT03109834|Weight loss stabilization|weight loss stabilization
72726|NCT03109834|Cardiometabolic risk|cardiometabolic risk
72727|NCT03109821|Exercise Therapy|exercise therapy
72728|NCT03109821|Rehabilitation|rehabilitation
72729|NCT03109782|Spinal Cord Injury|spinal cord injury
72730|NCT03109782|Spine Surgery|spine surgery
72731|NCT03109782|Patient Registry|patient registry
72732|NCT03109782|Trauma|trauma
72733|NCT03109743|HIV treatment|hiv treatment
72734|NCT03109743|Adherence Group Treatment|adherence group treatment
72735|NCT03109717|Treatment Resistant Depression|treatment resistant depression
72736|NCT03109704|scapular kinematics|scapular kinematics
72737|NCT03109704|thoracic spine|thoracic spine
72738|NCT03109704|thrust manipulation|thrust manipulation
72739|NCT03109652|total knee replacement arthroplasty|total knee replacement arthroplasty
72740|NCT03109652|total knee arthroplasty|total knee arthroplasty
72741|NCT03109652|tranexamic acid|tranexamic acid
72742|NCT03109652|oral tranexamic acid|oral tranexamic acid
72743|NCT03109652|transfusion|transfusion
72744|NCT03109652|blood loss|blood loss
72745|NCT03109639|EUS|eus
72746|NCT03109639|FNA|fna
72747|NCT03109639|FNB|fnb
72748|NCT03109639|Core Histology|core histology
72749|NCT03109626|DHA, replacement, treatment, brain PET-FDG, ataxia|dha, replacement, treatment, brain pet-fdg, ataxia
72750|NCT03109613|Positive end-expiratory pressure|positive end-expiratory pressure
72751|NCT03109613|PEEP|peep
72752|NCT03109613|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
72753|NCT03109613|Ventilator Induced Lung Injury|ventilator induced lung injury
72754|NCT03109613|V/Q mismatch|v/q mismatch
72755|NCT03109522|axillary reverse mapping (ARM)|axillary reverse mapping (arm)
72756|NCT03109522|sentinel lymph node biopsy (SLNB)|sentinel lymph node biopsy (slnb)
72757|NCT03109522|axillary lymph node dissection (ALND)|axillary lymph node dissection (alnd)
72758|NCT03109522|lymphedema|lymphedema
72759|NCT03109522|breast cancer|breast cancer
72760|NCT03109522|surgery|surgery
72761|NCT03109496|OME|ome
72762|NCT03109496|Otitis Media with Effusion|otitis media with effusion
72763|NCT03109496|Microbiota|microbiota
72764|NCT03109496|Microbiome|microbiome
72765|NCT03109496|URT|urt
72766|NCT03109496|Upper Respiratory Tract|upper respiratory tract
72767|NCT03109496|Healthy URT microbiota|healthy urt microbiota
72768|NCT03109483|geriatric patients|geriatric patients
72769|NCT03109483|elderly|elderly
72770|NCT03109483|multicomponent physical therapy|multicomponent physical therapy
72771|NCT03109470|Tocilizumab|tocilizumab
72772|NCT03109470|Early Rheumatoid Arthritis|early rheumatoid arthritis
72773|NCT03109470|Observational|observational
72774|NCT03109470|Canadian|canadian
72775|NCT03109457|Hepatitis C Virus|hepatitis c virus
72776|NCT03109457|Oral squamous cell carcinoma|oral squamous cell carcinoma
72777|NCT03109444|Hip Growth Chart|hip growth chart
72778|NCT03109431|HIV Treatment Continuum|hiv treatment continuum
72779|NCT03109431|HIV Disease Progression|hiv disease progression
72780|NCT03109431|Mental Health|mental health
72781|NCT03109431|Substance Use|substance use
72782|NCT03109431|ARV Adherence|arv adherence
72783|NCT03109431|Retention in Care|retention in care
72784|NCT03109431|STI|sti
72785|NCT03109418|Ketamine|ketamine
72786|NCT03109418|Postoperative morbidity|postoperative morbidity
72787|NCT03109353|Photopheresis|photopheresis
72788|NCT03109353|5-aminolevulinic acid|5-aminolevulinic acid
72789|NCT03109353|Extracorporeal Circulation|extracorporeal circulation
72790|NCT03109340|abdominal obesity|abdominal obesity
72791|NCT03109340|walking|walking
72792|NCT03109340|aerobic exercise|aerobic exercise
72793|NCT03109314|amblyopia|amblyopia
72794|NCT03109314|donepezil|donepezil
72795|NCT03109314|perceptual learning|perceptual learning
72796|NCT03109314|crowding|crowding
72797|NCT03109314|contrast sensitivity|contrast sensitivity
72798|NCT03109314|visual acuity|visual acuity
72799|NCT03109301|Mesenchymal Neoplasm|mesenchymal neoplasm
72800|NCT03109301|Neurofibromatosis 1|neurofibromatosis 1
72801|NCT03109301|Plexiform Neurofibromas|plexiform neurofibromas
72802|NCT03109288|Targeted Therapy|targeted therapy
72803|NCT03109288|Multiple Sclerosis|multiple sclerosis
72804|NCT03109288|Biomarkers|biomarkers
72805|NCT03109288|Combination Therapy|combination therapy
72806|NCT03109184|Dating violence prevention|dating violence prevention
72807|NCT03109184|Adolescent boys|adolescent boys
72808|NCT03109184|Middle school|middle school
72809|NCT03109184|Web-based prevention|web-based prevention
72810|NCT03109171|Endoscopy|endoscopy
72811|NCT03109171|Lasers|lasers
72812|NCT03109171|Fiber Optic Technology|fiber optic technology
72813|NCT03109171|Bronchoscopy|bronchoscopy
72814|NCT03109171|Esthesiometer|esthesiometer
72815|NCT03109171|Mechanoreceptors|mechanoreceptors
72816|NCT03109171|Diagnosis|diagnosis
72817|NCT03109171|Reflex|reflex
72818|NCT03109171|Reproducibility of Results|reproducibility of results
72819|NCT03109171|Reliability of Results|reliability of results
72820|NCT03109171|Validity of Results|validity of results
72821|NCT03109171|Sensory Thresholds|sensory thresholds
72822|NCT03109158|squamous cell carcinoma|squamous cell carcinoma
72823|NCT03109158|head|head
72824|NCT03109158|neck|neck
72825|NCT03109145|Shared decision making|shared decision making
72826|NCT03109145|Knowledge|knowledge
72827|NCT03109145|Patient portal|patient portal
72828|NCT03109145|Secure messaging|secure messaging
72829|NCT03109119|genomic instability|genomic instability
72830|NCT03109119|Sevoflurane|sevoflurane
72831|NCT03109119|General anaesthesia|general anaesthesia
72832|NCT03109106|MICU|micu
72833|NCT03109106|CICU|cicu
72834|NCT03109106|PCT - Procalcitonin|pct - procalcitonin
72835|NCT03109106|B·R·A·H·M·S PCT sensitive Kryptor®|b·r·a·h·m·s pct sensitive kryptor®
72836|NCT03109106|Antibiotic initiation|antibiotic initiation
72837|NCT03109106|Antibiotic de-escalation|antibiotic de-escalation
72838|NCT03109093|ALL|all
72839|NCT03109093|acute lymphoblastic leukemia|acute lymphoblastic leukemia
72840|NCT03109093|MRD positive|mrd positive
72841|NCT03109093|minimal residual disease|minimal residual disease
72842|NCT03109093|blinatumomab|blinatumomab
72843|NCT03109067|Cholesterol, HDL, Postprandial Period, Polymorphism, Genetic|cholesterol, hdl, postprandial period, polymorphism, genetic
72844|NCT03109054|Melatonin|melatonin
72845|NCT03109054|Anxiety|anxiety
72846|NCT03109041|Whipple|whipple
72847|NCT03109041|brachytherapy|brachytherapy
72848|NCT03109041|CivaSheet|civasheet
72849|NCT03109041|CivaTech Oncology|civatech oncology
72850|NCT03109041|radiation|radiation
72851|NCT03109041|intraoperative radiation|intraoperative radiation
72852|NCT03109041|IORT|iort
72853|NCT03109041|resectable pancreatic cancer|resectable pancreatic cancer
72854|NCT03109041|Pd-103|pd-103
72855|NCT03109015|metastatic renal cell carcinoma|metastatic renal cell carcinoma
72856|NCT03109015|sunitinib|sunitinib
72857|NCT03109015|Sutent|sutent
72858|NCT03109015|cardiopulmonary function|cardiopulmonary function
72859|NCT03108976|Autism|autism
72860|NCT03108976|Sensori-motor learning|sensori-motor learning
72861|NCT03108976|Development|development
72862|NCT03108976|Neuroimaging|neuroimaging
72863|NCT03108872|Anticoagulants|anticoagulants
72864|NCT03108872|Atrial Appendage|atrial appendage
72865|NCT03108872|Stroke|stroke
72866|NCT03108846|Alzheimer's Disease|alzheimer's disease
72867|NCT03108846|Agitation|agitation
72868|NCT03108807|Emergency Department|emergency department
72869|NCT03108807|Medical patients|medical patients
72870|NCT03108807|D-dimer|d-dimer
72871|NCT03108807|National Early Warning Score|national early warning score
72872|NCT03108807|NEWS|news
72873|NCT03108807|30-days mortality|30-days mortality
72874|NCT03108807|Mortality|mortality
72875|NCT03108794|hepatitis B，registry,cirrhosis, HCC|hepatitis b，registry,cirrhosis, hcc
72876|NCT03108781|Dementia|dementia
72877|NCT03108781|Behavioral Psychiatric symptoms|behavioral psychiatric symptoms
72878|NCT03108781|Treatment|treatment
72879|NCT03108755|ASP7713|asp7713
72880|NCT03108729|epilepsy|epilepsy
72881|NCT03108729|Partial-onset seizures|partial-onset seizures
72882|NCT03108729|Focal epilepsy|focal epilepsy
72883|NCT03108729|Focal seizures|focal seizures
72884|NCT03108729|Partial onset seizures|partial onset seizures
72885|NCT03108729|Pediatric|pediatric
72886|NCT03108729|Partial seizures|partial seizures
72887|NCT03108703|RCC|rcc
72888|NCT03108703|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
72889|NCT03108703|SBRT|sbrt
72890|NCT03108703|Stereotactic Ablative Radiotherapy|stereotactic ablative radiotherapy
72891|NCT03108703|SABR|sabr
72892|NCT03108690|Therapeutic drug monitoring|therapeutic drug monitoring
72893|NCT03108690|Continuous infusion|continuous infusion
72894|NCT03108690|Beta-lactam|beta-lactam
72895|NCT03108690|Antibiotics|antibiotics
72896|NCT03108690|Bacteraemia|bacteraemia
72897|NCT03108677|RNA profiling|rna profiling
72898|NCT03108677|Exosome|exosome
72899|NCT03108677|Lung Metastases|lung metastases
72900|NCT03108677|Osteosarcoma|osteosarcoma
72901|NCT03108664|SYL1001|syl1001
72902|NCT03108664|siRNA|sirna
72903|NCT03108625|children|children
72904|NCT03108625|adolescent|adolescent
72905|NCT03108612|diagnostic accuracy|diagnostic accuracy
72906|NCT03108612|upper limb|upper limb
72907|NCT03108599|Health Promotion|health promotion
72908|NCT03108599|Injury Prevention|injury prevention
72909|NCT03108599|Safety|safety
72910|NCT03108599|Wellbeing|wellbeing
72911|NCT03108599|Physical Activity|physical activity
72912|NCT03108599|Sleep|sleep
72913|NCT03108599|Whole Body Vibration|whole body vibration
72914|NCT03108599|Self-Monitoring|self-monitoring
72915|NCT03108586|restorations|restorations
72916|NCT03108586|diagnosis|diagnosis
72917|NCT03108586|secondary caries|secondary caries
72918|NCT03108586|treatment decision|treatment decision
72919|NCT03108560|sublobar resection|sublobar resection
72920|NCT03108560|lobectomy|lobectomy
72921|NCT03108547|Sarcoidosis|sarcoidosis
72922|NCT03108547|Scalp hair cortisol and testosterone|scalp hair cortisol and testosterone
72923|NCT03108547|Fatigue|fatigue
72924|NCT03108547|Biomarker|biomarker
72925|NCT03108547|Psychological distress|psychological distress
72926|NCT03108521|DPP - 4; GLP1R ; gene polymorphism research; diabetes|dpp - 4; glp1r ; gene polymorphism research; diabetes
72927|NCT03108495|LN-145|ln-145
72928|NCT03108495|Cell Therapy|cell therapy
72929|NCT03108495|Autologous Adoptive Cell Transfer|autologous adoptive cell transfer
72930|NCT03108495|Autologous Adoptive Cell Therapy|autologous adoptive cell therapy
72931|NCT03108495|Cellular Immuno-therapy|cellular immuno-therapy
72932|NCT03108495|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
72933|NCT03108495|TIL|til
72934|NCT03108495|IL-2|il-2
72935|NCT03108482|Acute Pain|acute pain
72936|NCT03108482|Post-surgical Pain|post-surgical pain
72937|NCT03108482|Bunionectomy|bunionectomy
72938|NCT03108482|Co-crystal|co-crystal
72943|NCT03108456|CAD|cad
72944|NCT03108456|severe calcium|severe calcium
72945|NCT03108456|orbital atherectomy|orbital atherectomy
72946|NCT03108456|minimum stent area|minimum stent area
72947|NCT03108404|predictive score|predictive score
72948|NCT03108378|Gadolinium|gadolinium
72949|NCT03108378|Bone|bone
72950|NCT03108378|Skin|skin
72951|NCT03108300|efficacy|efficacy
72952|NCT03108300|propranolol hydrochloride|propranolol hydrochloride
72953|NCT03108300|sts|sts
72954|NCT03108274|Midazolam|midazolam
72955|NCT03108274|Fexofenadine|fexofenadine
72956|NCT03108274|Mycophenolate Mofetil|mycophenolate mofetil
72957|NCT03108248|transarterial chemoembolization|transarterial chemoembolization
72958|NCT03108248|stent|stent
72959|NCT03108248|irradiation|irradiation
72960|NCT03108248|survival|survival
72961|NCT03108248|decompensation|decompensation
72962|NCT03108248|tumor response|tumor response
72963|NCT03108222|chronic kidney disease|chronic kidney disease
72964|NCT03108222|CKD|ckd
72965|NCT03108222|renal failure|renal failure
72966|NCT03108222|phosphorus|phosphorus
72967|NCT03108222|phosphate|phosphate
72968|NCT03108222|intestinal absorption|intestinal absorption
72969|NCT03108196|bladder cancer， neobladder, detaenial sigmoid, ileal|bladder cancer， neobladder, detaenial sigmoid, ileal
72970|NCT03108157|IVF|ivf
72971|NCT03108157|DONOR EGGS|donor eggs
72972|NCT03108157|ENDOMETRIAL SCRATCH|endometrial scratch
72973|NCT03108157|PIPELLE|pipelle
72974|NCT03108157|ONGOING PREGNANCY|ongoing pregnancy
72975|NCT03108144|smoking cessation|smoking cessation
72976|NCT03108144|alcohol|alcohol
72977|NCT03108144|primary care|primary care
72978|NCT03108144|screening|screening
72979|NCT03108144|brief intervention|brief intervention
72980|NCT03108144|referral to treatment|referral to treatment
72981|NCT03108144|cancer risk|cancer risk
72982|NCT03108131|Malignant Neoplasms of Digestive Organs|malignant neoplasms of digestive organs
72983|NCT03108131|Melanoma and Other Malignant Neoplasms of Skin|melanoma and other malignant neoplasms of skin
72984|NCT03108131|Appendiceal Adenocarcinoma|appendiceal adenocarcinoma
72985|NCT03108131|Cutaneous Squamous Cell Carcinoma|cutaneous squamous cell carcinoma
72986|NCT03108131|Small Bowel Adenocarcinoma|small bowel adenocarcinoma
72987|NCT03108131|Advanced rare tumors|advanced rare tumors
72988|NCT03108131|Cobimetinib|cobimetinib
72989|NCT03108131|Atezolizumab|atezolizumab
72990|NCT03108131|MPDL3280A|mpdl3280a
72991|NCT03108118|Diaphragm dysfunction|diaphragm dysfunction
72992|NCT03108118|Acute respiratory failure|acute respiratory failure
72993|NCT03108118|Weaning|weaning
72994|NCT03108092|Drug Utilization Review|drug utilization review
72995|NCT03108092|Older people|older people
72996|NCT03108092|Health economics|health economics
72997|NCT03108079|Urologic Injuries|urologic injuries
72998|NCT03108079|Urologic Diseases|urologic diseases
72999|NCT03108079|Bladder Infection|bladder infection
73000|NCT03108079|Urinary Tract Infections|urinary tract infections
73001|NCT03108079|Mucosal Inflammation|mucosal inflammation
73002|NCT03108079|Mucosal Infection|mucosal infection
73003|NCT03108079|Bladder Injury|bladder injury
73004|NCT03108079|Catheter Related Infections|catheter related infections
73005|NCT03108079|Catheter Complications|catheter complications
73006|NCT03108079|Catheter Infection|catheter infection
73007|NCT03108079|Indwelling Catheter|indwelling catheter
73008|NCT03108079|Pelvic Floor Disorders|pelvic floor disorders
73009|NCT03108079|Urinary Incontinence|urinary incontinence
73010|NCT03108053|urinary stones|urinary stones
73011|NCT03108053|semirigid ureteroscopy|semirigid ureteroscopy
73012|NCT03108053|guidewire|guidewire
73013|NCT03108027|QVM149,|qvm149,
73014|NCT03108027|asthma,|asthma,
73015|NCT03108027|allergic asthma,|allergic asthma,
73016|NCT03108027|allergy triggered asthma,|allergy triggered asthma,
73017|NCT03108027|reactive asthma,|reactive asthma,
73018|NCT03108027|asthma attack,|asthma attack,
73019|NCT03108027|difficulty breathing|difficulty breathing
73020|NCT03107962|NK/T cell lymphoma|nk/t cell lymphoma
73021|NCT03107962|immunotherapy|immunotherapy
73022|NCT03107962|clinical trial|clinical trial
73023|NCT03107962|RR|rr
73024|NCT03107962|PFS|pfs
73025|NCT03107962|OS|os
73026|NCT03107949|Diaphragm atrophy|diaphragm atrophy
73027|NCT03107949|VIDD|vidd
73028|NCT03107949|weaning failure|weaning failure
73029|NCT03107949|SBT|sbt
73030|NCT03107923|Myocardial fibrosis|myocardial fibrosis
73031|NCT03107923|Aortic Valve Stenosis|aortic valve stenosis
73032|NCT03107923|TAVI|tavi
73033|NCT03107923|Outcome|outcome
73034|NCT03107897|TAVR|tavr
73035|NCT03107897|elevated frailty score|elevated frailty score
73036|NCT03107897|Transcatheter Valve Replacement|transcatheter valve replacement
73037|NCT03107871|valganciclovir|valganciclovir
73038|NCT03107845|CBT|cbt
73039|NCT03107845|Psychometric Feedback|psychometric feedback
73040|NCT03107845|Clinical Support Tools|clinical support tools
73041|NCT03107845|Personalized Mental Health|personalized mental health
73042|NCT03107819|Plasma metabolomics|plasma metabolomics
73043|NCT03107819|Urinary metabolomics|urinary metabolomics
73239|NCT03106610|BMS-936558|bms-936558
73044|NCT03107819|Metabonomics|metabonomics
73045|NCT03107819|Biomarker discovery|biomarker discovery
73046|NCT03107806|acute coronary syndromes|acute coronary syndromes
73047|NCT03107806|hyperglycemia|hyperglycemia
73048|NCT03107806|hypoglycemia|hypoglycemia
73049|NCT03107806|continuous glucose monitoring|continuous glucose monitoring
73050|NCT03107741|Metabolic Syndrome|metabolic syndrome
73051|NCT03107741|Waist circumference|waist circumference
73052|NCT03107741|Blood pressure|blood pressure
73053|NCT03107741|Triglyceride|triglyceride
73054|NCT03107741|HDL cholesterol|hdl cholesterol
73055|NCT03107728|orthotics|orthotics
73056|NCT03107728|high-energy lower extremity trauma|high-energy lower extremity trauma
73057|NCT03107728|physical therapy|physical therapy
73058|NCT03107728|bracing|bracing
73059|NCT03107728|functional performance|functional performance
73060|NCT03107728|performance assessment|performance assessment
73061|NCT03107715|exclusive breastfeeding|exclusive breastfeeding
73062|NCT03107715|health disparity|health disparity
73063|NCT03107715|prenatal intervention|prenatal intervention
73064|NCT03107689|ILE|ile
73065|NCT03107689|lipid|lipid
73066|NCT03107689|overdose|overdose
73067|NCT03107689|resuscitation|resuscitation
73068|NCT03107676|trunk extensors; endurance, peak torque, power, work|trunk extensors; endurance, peak torque, power, work
73069|NCT03107663|PET/CT|pet/ct
73070|NCT03107663|Imaging|imaging
73071|NCT03107663|⁸⁹Zr-Df-IAB22M2C|⁸⁹zr-df-iab22m2c
73072|NCT03107663|CD8 + T Cells|cd8 + t cells
73073|NCT03107663|Standard of Care|standard of care
73074|NCT03107637|Embolic Stroke of Undetermined Source|embolic stroke of undetermined source
73075|NCT03107637|transesophageal echocardiography|transesophageal echocardiography
73076|NCT03107637|cardiac source of embolism|cardiac source of embolism
73077|NCT03107637|ischemic stroke|ischemic stroke
73078|NCT03107598|spinal anesthesia|spinal anesthesia
73079|NCT03107598|neonatal outcome|neonatal outcome
73080|NCT03107598|Caesarean Section|caesarean section
73081|NCT03107585|cervical plexus block|cervical plexus block
73082|NCT03107585|thyroidectomy|thyroidectomy
73083|NCT03107585|opioid consumption|opioid consumption
73084|NCT03107559|perfüsion index|perfüsion index
73085|NCT03107559|epidural analgesia|epidural analgesia
73086|NCT03107559|labor|labor
73087|NCT03107546|Syndactyly|syndactyly
73088|NCT03107546|Syndactyly release surgery|syndactyly release surgery
73089|NCT03107546|Full thickness skin graft|full thickness skin graft
73090|NCT03107546|Hyalomatrix|hyalomatrix
73091|NCT03107546|Scar formation|scar formation
73092|NCT03107520|contrast-enhanced ultrasound|contrast-enhanced ultrasound
73093|NCT03107520|Lumason|lumason
73094|NCT03107520|developmental dysplasia of the hip (DDH)|developmental dysplasia of the hip (ddh)
73095|NCT03107520|avascular necrosis|avascular necrosis
73096|NCT03107507|EEG with Periodic Abnormalities|eeg with periodic abnormalities
73097|NCT03107507|Levetiracetam|levetiracetam
73098|NCT03107507|Phenobarbitone|phenobarbitone
73099|NCT03107507|neonatal seizures|neonatal seizures
73100|NCT03107507|Neurodevelopmental Abnormality|neurodevelopmental abnormality
73101|NCT03107481|Acetaminophen|acetaminophen
73102|NCT03107481|Hydromorphone|hydromorphone
73103|NCT03107481|Emergency Department|emergency department
73104|NCT03107481|Narcotics|narcotics
73105|NCT03107481|Analgesics, Opioid|analgesics, opioid
73106|NCT03107481|Analgesics, Non-Narcotic|analgesics, non-narcotic
73107|NCT03107468|Non-surgical treatment|non-surgical treatment
73108|NCT03107468|Acupuncture|acupuncture
73109|NCT03107468|Chuna|chuna
73110|NCT03107468|Physiotherapy|physiotherapy
73111|NCT03107468|Epidural steroid injection|epidural steroid injection
73112|NCT03107455|MitraClip|mitraclip
73113|NCT03107455|Acute mitral regurgitation|acute mitral regurgitation
73114|NCT03107455|Acute myocardial infarction|acute myocardial infarction
73115|NCT03107442|Arterial stiffness|arterial stiffness
73116|NCT03107442|Markers of Inflammation|markers of inflammation
73117|NCT03107442|Exercise|exercise
73118|NCT03107442|Physical fitness|physical fitness
73119|NCT03107442|Cardiovascular risk|cardiovascular risk
73120|NCT03107442|Autoimmune diseases|autoimmune diseases
73121|NCT03107429|Trendelenburg|trendelenburg
73122|NCT03107429|Laparoscopic colorectal surgery|laparoscopic colorectal surgery
73123|NCT03107429|POVL|povl
73124|NCT03107416|Bumetanide|bumetanide
73125|NCT03107416|Diuretic|diuretic
73126|NCT03107416|Transarterial Embolization (TAE)|transarterial embolization (tae)
73127|NCT03107416|17-141|17-141
73128|NCT03107403|dreams bereavement|dreams bereavement
73129|NCT03107403|emotional|emotional
73130|NCT03107403|regulation|regulation
73131|NCT03107403|bereavement|bereavement
73132|NCT03107338|Pre-emptive analgesia; Dexketoprofen trometamol|pre-emptive analgesia; dexketoprofen trometamol
73133|NCT03107208|DKA|dka
73134|NCT03107208|type 1 diabetes|type 1 diabetes
73135|NCT03107208|children|children
73136|NCT03107208|continuous glucose monitoring|continuous glucose monitoring
73137|NCT03107182|HPV- positive HNSCC|hpv- positive hnscc
73138|NCT03107182|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
73139|NCT03107156|Treatment care planning|treatment care planning
73140|NCT03107143|Pressure ulcer prevention|pressure ulcer prevention
73141|NCT03107143|Pressure injury|pressure injury
73142|NCT03107091|Terlipressin|terlipressin
73143|NCT03107091|Terlipressin acetate|terlipressin acetate
73144|NCT03107065|Sweating|sweating
73145|NCT03107026|Binge eating Disorder|binge eating disorder
73146|NCT03107026|dasotraline|dasotraline
73147|NCT03107013|Mass Balance|mass balance
73148|NCT03107013|Phase 1|phase 1
73149|NCT03106987|polymerisation inhibitor (PARPi)|polymerisation inhibitor (parpi)
73150|NCT03106987|PARPi re-treatment|parpi re-treatment
73151|NCT03106987|BRCA1/2 (+ve)|brca1/2 (+ve)
73152|NCT03106987|BRCA1/2 (-ve)|brca1/2 (-ve)
73153|NCT03106987|Olaparib|olaparib
73154|NCT03106987|ovarian cancer|ovarian cancer
73155|NCT03106987|progression free survival (PFS)|progression free survival (pfs)
73156|NCT03106935|recurrent pregnancy loss|recurrent pregnancy loss
73157|NCT03106935|Clinical hypothyroidism|clinical hypothyroidism
73158|NCT03106935|Subclinical hypothyroidism|subclinical hypothyroidism
73159|NCT03106935|thyroid stimulating hormone|thyroid stimulating hormone
73160|NCT03106935|thyroid peroxidase antibody|thyroid peroxidase antibody
73161|NCT03106935|Levothyroxine|levothyroxine
73162|NCT03106922|Polyethylene glycol|polyethylene glycol
73163|NCT03106922|Bowel cleansing|bowel cleansing
73164|NCT03106922|Colonoscopy|colonoscopy
73165|NCT03106909|stroke|stroke
73166|NCT03106909|pneumonia|pneumonia
73167|NCT03106909|biomarkers|biomarkers
73168|NCT03106909|pulmonary CT|pulmonary ct
73169|NCT03106883|Attention bias modification|attention bias modification
73170|NCT03106883|Cognitive bias modification|cognitive bias modification
73171|NCT03106883|Eye-tracking|eye-tracking
73172|NCT03106883|Treatment|treatment
73173|NCT03106844|FMT|fmt
73174|NCT03106844|IBD|ibd
73175|NCT03106805|intrauterine device|intrauterine device
73176|NCT03106779|Phase 3|phase 3
73177|NCT03106779|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
73178|NCT03106779|CML|cml
73179|NCT03106779|bosutinib|bosutinib
73180|NCT03106779|ABL001|abl001
73181|NCT03106779|tyrosine kinase inhibitor|tyrosine kinase inhibitor
73182|NCT03106779|Chronic myelogenous leukemia (CML)|chronic myelogenous leukemia (cml)
73183|NCT03106779|chronic myeloid leukemia (CML)|chronic myeloid leukemia (cml)
73184|NCT03106779|chronic myelocytic leukemia (CML)|chronic myelocytic leukemia (cml)
73185|NCT03106779|chronic granulocytic leukemia (CGL)|chronic granulocytic leukemia (cgl)
73186|NCT03106779|cancer of the white blood cells|cancer of the white blood cells
73187|NCT03106779|clonal bone marrow stem cell disorder|clonal bone marrow stem cell disorder
73188|NCT03106779|proliferation of mature granulocytes|proliferation of mature granulocytes
73189|NCT03106753|External Cephalic Version|external cephalic version
73190|NCT03106753|neuraxial analgesia|neuraxial analgesia
73191|NCT03106740|Microglia|microglia
73192|NCT03106740|Minocycline|minocycline
73193|NCT03106740|Magnetic Resonance Imaging|magnetic resonance imaging
73194|NCT03106740|Positron Emission Tomography|positron emission tomography
73195|NCT03106740|Pain|pain
73196|NCT03106740|Astrocytes|astrocytes
73197|NCT03106740|Glia|glia
73198|NCT03106740|Human|human
73199|NCT03106740|Back Pain|back pain
73200|NCT03106727|Community Health Workers|community health workers
73201|NCT03106727|Maternal and Child Health|maternal and child health
73202|NCT03106727|Integrated Care|integrated care
73203|NCT03106727|Malawi|malawi
73204|NCT03106727|NCD|ncd
73205|NCT03106714|persistence|persistence
73206|NCT03106714|body fluids|body fluids
73207|NCT03106688|PET imaging|pet imaging
73208|NCT03106688|Cannabinoid receptor|cannabinoid receptor
73209|NCT03106688|Opioid receptor|opioid receptor
73210|NCT03106688|Addiction|addiction
73211|NCT03106688|fMRI imaging|fmri imaging
73212|NCT03106675|HIFU|hifu
73213|NCT03106675|MR-HIFU|mr-hifu
73214|NCT03106675|MRgFUs|mrgfus
73215|NCT03106675|MRI-intervention|mri-intervention
73216|NCT03106675|Palliation|palliation
73217|NCT03106662|Mesenchymal stem cell|mesenchymal stem cell
73218|NCT03106662|haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
73219|NCT03106662|graft-versus-host disease|graft-versus-host disease
73220|NCT03106662|engraftment|engraftment
73221|NCT03106636|Preschool-aged|preschool-aged
73222|NCT03106636|Foster children|foster children
73223|NCT03106636|child welfare|child welfare
73224|NCT03106636|Fostercare|fostercare
73225|NCT03106636|Parent training|parent training
73226|NCT03106636|early adversity|early adversity
73227|NCT03106636|curriculum based|curriculum based
73228|NCT03106636|early intervention|early intervention
73229|NCT03106636|preschool|preschool
73230|NCT03106636|foster placement disruptions|foster placement disruptions
73231|NCT03106636|manualized intervention|manualized intervention
73232|NCT03106636|group based intervention|group based intervention
73233|NCT03106636|high-risk children|high-risk children
73234|NCT03106610|Bladder cancer|bladder cancer
73235|NCT03106610|Cancer of urothelium|cancer of urothelium
73236|NCT03106610|Transitional cell carcinoma|transitional cell carcinoma
73237|NCT03106610|Carcinoma in situ|carcinoma in situ
73238|NCT03106610|Nivolumab|nivolumab
73240|NCT03106610|Opdivo|opdivo
73241|NCT03106610|Questionnaires|questionnaires
73242|NCT03106610|Surveys|surveys
73243|NCT03106597|Peripheral Edema|peripheral edema
73244|NCT03106597|Bioimpedance Analysis|bioimpedance analysis
73245|NCT03106584|Knee pain|knee pain
73246|NCT03106584|Glucosamine|glucosamine
73247|NCT03106584|WOMAC|womac
73248|NCT03106584|Osteoarthritis|osteoarthritis
73249|NCT03106571|Phase 1 clinical trial|phase 1 clinical trial
73250|NCT03106506|Implants|implants
73251|NCT03106506|Conjunctive tissue graft|conjunctive tissue graft
73252|NCT03106506|Prospective study|prospective study
73253|NCT03106480|Pre-diabetes|pre-diabetes
73254|NCT03106480|Diabetes Mellitus|diabetes mellitus
73255|NCT03106480|HIV|hiv
73256|NCT03106480|ART|art
73257|NCT03106480|Body composition|body composition
73258|NCT03106480|Inflammation|inflammation
73259|NCT03106480|Insulin resistance|insulin resistance
73260|NCT03106480|Beta-cell function|beta-cell function
73261|NCT03106480|Pre-Hypertension|pre-hypertension
73262|NCT03106480|Hypertension|hypertension
73263|NCT03106467|appendectomy|appendectomy
73264|NCT03106467|laparoscopic|laparoscopic
73265|NCT03106467|single port|single port
73266|NCT03106467|randomized|randomized
73267|NCT03106389|misoprostol|misoprostol
73268|NCT03106389|transcervical balloon catheter|transcervical balloon catheter
73269|NCT03106389|second trimester|second trimester
73270|NCT03106389|induced abortion|induced abortion
73271|NCT03106337|Thyroid|thyroid
73272|NCT03106337|Follicular Neoplasms|follicular neoplasms
73273|NCT03106337|Bethesda System|bethesda system
73274|NCT03106337|Elastography|elastography
73275|NCT03106337|Doppler ultrasound|doppler ultrasound
73276|NCT03106337|Thyroidectomy|thyroidectomy
73277|NCT03106324|Multiple Myeloma|multiple myeloma
73278|NCT03106324|Non transplant eligible|non transplant eligible
73279|NCT03106324|Revlimid|revlimid
73280|NCT03106324|PASS|pass
73281|NCT03106324|Non-interventional|non-interventional
73282|NCT03106324|Lenalidomide|lenalidomide
73283|NCT03106298|Iron Deficiency|iron deficiency
73284|NCT03106298|Fibroblast Growth Factor 23|fibroblast growth factor 23
73285|NCT03106298|Phosphate|phosphate
73286|NCT03106259|FURESTEM-RA|furestem-ra
73287|NCT03106246|Extracellular vesicles|extracellular vesicles
73288|NCT03106246|Autoimmunity|autoimmunity
73289|NCT03106246|Beta-cell injury|beta-cell injury
73290|NCT03106233|Breast reconstruction|breast reconstruction
73291|NCT03106233|Perforator flap|perforator flap
73292|NCT03106233|Microsurgery|microsurgery
73293|NCT03106168|Extraction|extraction
73294|NCT03106168|Local Anesthetic|local anesthetic
73295|NCT03106168|Mepivacaine|mepivacaine
73296|NCT03106168|Mandibular Molar|mandibular molar
73297|NCT03106142|intervention, improvement strategy|intervention, improvement strategy
73298|NCT03106116|Coronary Heart Disease|coronary heart disease
73299|NCT03106116|Ventricular Function|ventricular function
73300|NCT03106116|Vascular Endothelium|vascular endothelium
73301|NCT03106116|Counterpulsation, External|counterpulsation, external
73302|NCT03106103|urodynamics|urodynamics
73303|NCT03106103|cystitis|cystitis
73304|NCT03106103|prophylactic antibiotics|prophylactic antibiotics
73305|NCT03106103|bacteriuria|bacteriuria
73306|NCT03106090|survivorship care plan|survivorship care plan
73307|NCT03106090|head and neck cancer|head and neck cancer
73308|NCT03106090|survivorship|survivorship
73309|NCT03106077|Malignant neoplasm of breast|malignant neoplasm of breast
73310|NCT03106077|Triple-Negative Breast Cancer|triple-negative breast cancer
73311|NCT03106077|TNBC|tnbc
73312|NCT03106077|Metastatic Triple-Negative Breast Cancer|metastatic triple-negative breast cancer
73313|NCT03106077|Newly Diagnosed Triple-Negative Breast Cancer|newly diagnosed triple-negative breast cancer
73314|NCT03106077|Mirvetuximab Soravtansine|mirvetuximab soravtansine
73315|NCT03106077|IMGN853|imgn853
73316|NCT03106051|Arthritis|arthritis
73317|NCT03106051|Psoriatic|psoriatic
73318|NCT03106051|Observational|observational
73319|NCT03106051|Apremilast|apremilast
73320|NCT03106038|contrast agent|contrast agent
73321|NCT03106038|ureter imaging|ureter imaging
73322|NCT03106038|intraoperative monitoring|intraoperative monitoring
73323|NCT03106038|intraoperative procedures|intraoperative procedures
73324|NCT03106038|near infrared fluorescence|near infrared fluorescence
73325|NCT03106038|minimally invasive|minimally invasive
73326|NCT03105973|jail|jail
73327|NCT03105973|prison|prison
73328|NCT03105973|technology|technology
73329|NCT03105973|depression|depression
73330|NCT03105973|CBT|cbt
73331|NCT03105947|lipids|lipids
73332|NCT03105947|dietary fats|dietary fats
73333|NCT03105921|Locally advanced pancreatic carcinoma|locally advanced pancreatic carcinoma
73334|NCT03105921|Irreversible electroporation|irreversible electroporation
73335|NCT03105921|Interventional radiology|interventional radiology
73336|NCT03105895|Incisional hernia|incisional hernia
73337|NCT03105895|Mesh prevention|mesh prevention
73338|NCT03105895|Mesh augmentation|mesh augmentation
73339|NCT03105882|Spinal Cord Injury|spinal cord injury
73340|NCT03105882|SCI|sci
73341|NCT03105882|Complete (AIS A) Traumatic Acute Spinal Cord Injury|complete (ais a) traumatic acute spinal cord injury
73342|NCT03105869|repeatability|repeatability
73343|NCT03105869|positron emission tomography (PET)|positron emission tomography (pet)
73344|NCT03105869|fluorocholine|fluorocholine
73345|NCT03105856|Mass screening|mass screening
73346|NCT03105856|Vaccination|vaccination
73347|NCT03105856|Mexico|mexico
73348|NCT03105843|Asthma|asthma
73349|NCT03105843|Cough|cough
73350|NCT03105843|Eucapneic Voluntary Hyperventilation|eucapneic voluntary hyperventilation
73351|NCT03105843|Hypertonic Saline|hypertonic saline
73352|NCT03105817|Asymmetric cellulose triacetate|asymmetric cellulose triacetate
73353|NCT03105817|Biocompatibility|biocompatibility
73354|NCT03105817|Hemodiafiltration on-line|hemodiafiltration on-line
73355|NCT03105817|Convective volume|convective volume
73356|NCT03105817|Adequacy|adequacy
73357|NCT03105778|BNP|bnp
73358|NCT03105778|IVD|ivd
73359|NCT03105765|Neuropathic Pain|neuropathic pain
73360|NCT03105765|Chronic Pain|chronic pain
73361|NCT03105765|Posterolateral thoracotomy|posterolateral thoracotomy
73362|NCT03105752|Outcome Assessments (Health Care)|outcome assessments (health care)
73363|NCT03105752|Volunteers|volunteers
73364|NCT03105752|Informed consent|informed consent
73365|NCT03105752|Comprehension|comprehension
73366|NCT03105752|Language tests|language tests
73367|NCT03105726|End Stage Heart Failure|end stage heart failure
73368|NCT03105726|New York Heart Association functional class III or IV|new york heart association functional class iii or iv
73369|NCT03105726|Heart transplantation|heart transplantation
73370|NCT03105726|Ventricular assisted devices|ventricular assisted devices
73371|NCT03105726|Cardiogenic shock|cardiogenic shock
73372|NCT03105713|Checklist|checklist
73373|NCT03105713|Patient Checklist|patient checklist
73374|NCT03105713|Surgery|surgery
73375|NCT03105713|Safety|safety
73376|NCT03105713|Patient Involvement|patient involvement
73377|NCT03105700|epilepsy|epilepsy
73378|NCT03105700|depression|depression
73379|NCT03105700|refractory|refractory
73380|NCT03105700|temporal lobe|temporal lobe
73381|NCT03105700|TMS|tms
73382|NCT03105700|biomarker|biomarker
73383|NCT03105687|mHealth|mhealth
73384|NCT03105687|SMS reminders|sms reminders
73385|NCT03105687|adherence|adherence
73386|NCT03105687|antihypertensive drugs|antihypertensive drugs
73387|NCT03105687|pharmacists|pharmacists
73388|NCT03105687|cost-effectiveness|cost-effectiveness
73389|NCT03105674|analgesia|analgesia
73390|NCT03105674|peri-anal procedure|peri-anal procedure
73391|NCT03105674|peri-anal block|peri-anal block
73392|NCT03105674|anal surgery|anal surgery
73393|NCT03105635|Community Resources|community resources
73394|NCT03105635|Health Navigator|health navigator
73395|NCT03105622|Exercise|exercise
73396|NCT03105622|Screen|screen
73397|NCT03105622|Music|music
73398|NCT03105622|Energy compensation|energy compensation
73399|NCT03105622|Adolescents|adolescents
73400|NCT03105622|Running+screen|running+screen
73401|NCT03105622|Running+music|running+music
73402|NCT03105622|Running without stimulus (control condition)|running without stimulus (control condition)
73403|NCT03105609|hyperspectral imaging, Ranibizumab|hyperspectral imaging, ranibizumab
73404|NCT03105583|Medication beliefs|medication beliefs
73405|NCT03105583|Information desire|information desire
73406|NCT03105583|Vitamin deficiencies|vitamin deficiencies
73407|NCT03105570|breast neoplasms|breast neoplasms
73408|NCT03105570|Mastectomy, Subcutaneous|mastectomy, subcutaneous
73409|NCT03105570|Areola|areola
73410|NCT03105557|Prematurely born newborns|prematurely born newborns
73411|NCT03105557|Urine|urine
73412|NCT03105557|Collecting device|collecting device
73413|NCT03105544|simulation-based training|simulation-based training
73414|NCT03105544|obstetric ultrasound|obstetric ultrasound
73415|NCT03105544|intrauterine growth restriction|intrauterine growth restriction
73416|NCT03105544|ultrasound simulation|ultrasound simulation
73417|NCT03105531|primary aldosteronism|primary aldosteronism
73418|NCT03105531|hypertension|hypertension
73419|NCT03105531|screening|screening
73420|NCT03105531|secondary hypertension|secondary hypertension
73421|NCT03105518|assisted reproduction|assisted reproduction
73422|NCT03105518|postoperative pain|postoperative pain
73423|NCT03105518|opioid|opioid
73424|NCT03105492|Prenatal Testing|prenatal testing
73425|NCT03105492|Whole Genome Sequencing|whole genome sequencing
73426|NCT03105479|vancomycin|vancomycin
73427|NCT03105479|children|children
73428|NCT03105479|cadazolid|cadazolid
73429|NCT03105479|clostridium difficile associated diarrhea|clostridium difficile associated diarrhea
73430|NCT03105466|Corneal Transplantation|corneal transplantation
73431|NCT03105466|Xenotransplantation|xenotransplantation
73432|NCT03105466|Bioegineered cornea|bioegineered cornea
73433|NCT03105453|Assisted reproductive technologies|assisted reproductive technologies
73434|NCT03105453|Microbiome|microbiome
73435|NCT03105440|breast cancer|breast cancer
73436|NCT03105440|lymphedema|lymphedema
73437|NCT03105440|pain|pain
73438|NCT03105440|range of motion|range of motion
73439|NCT03105440|technologic innovation|technologic innovation
73440|NCT03105440|rehabilitation|rehabilitation
73441|NCT03105414|Mechanical ventilation|mechanical ventilation
73442|NCT03105414|Pediatrics|pediatrics
73443|NCT03105414|Cross infection|cross infection
73444|NCT03105414|Intensive care|intensive care
73445|NCT03105414|Diagnosis|diagnosis
73446|NCT03105375|Potassium competitive acid blocker|potassium competitive acid blocker
73447|NCT03105375|X842|x842
73448|NCT03105375|Gastroesophageal reflux disease|gastroesophageal reflux disease
73449|NCT03105375|Esophagitis|esophagitis
73450|NCT03105375|Intragastric pH|intragastric ph
73451|NCT03105375|Acid inhibition|acid inhibition
73452|NCT03105362|Oral Rehydration Solutions|oral rehydration solutions
73453|NCT03105310|Hepatitis D|hepatitis d
73454|NCT03105310|Ezetimibe|ezetimibe
73455|NCT03105310|Pegylated interferon|pegylated interferon
73456|NCT03105297|Nasal dilator strip|nasal dilator strip
73457|NCT03105297|Sleep disordered breathing|sleep disordered breathing
73458|NCT03105284|stem cell|stem cell
73459|NCT03105284|liposuction|liposuction
73460|NCT03105284|regenerative medicine|regenerative medicine
73461|NCT03105245|electroconvulsive therapy|electroconvulsive therapy
73462|NCT03105245|anaesthesia|anaesthesia
73463|NCT03105206|lowl pole renal calculus|lowl pole renal calculus
73464|NCT03105206|anatomical parameters|anatomical parameters
73465|NCT03105206|flexible ureteroscopy|flexible ureteroscopy
73466|NCT03105193|Colon surgery|colon surgery
73467|NCT03105193|Lignocaine|lignocaine
73468|NCT03105193|Lidocaine|lidocaine
73469|NCT03105193|Analgesia|analgesia
73470|NCT03105193|Local anaesthetic|local anaesthetic
73471|NCT03105167|CBT|cbt
73472|NCT03105167|RCT|rct
73473|NCT03105167|TLIF|tlif
73474|NCT03105141|Intracranial atherosclerotic stenosis|intracranial atherosclerotic stenosis
73475|NCT03105141|Remote ischemic conditioning|remote ischemic conditioning
73476|NCT03105141|Stroke|stroke
73477|NCT03105115|fentanyl|fentanyl
73478|NCT03105115|dexmedetomidine|dexmedetomidine
73479|NCT03105102|risankizumab|risankizumab
73480|NCT03105102|ABBV-066|abbv-066
73481|NCT03105102|BI 655066|bi 655066
73482|NCT03105050|access|access
73483|NCT03105050|policy|policy
73484|NCT03105024|specific phobia|specific phobia
73485|NCT03105024|height phobia|height phobia
73486|NCT03105024|exposure|exposure
73487|NCT03105024|virtual reality|virtual reality
73488|NCT03105024|extinction|extinction
73489|NCT03105024|self-efficacy|self-efficacy
73490|NCT03105011|Type 2 diabetes|type 2 diabetes
73491|NCT03104998|Idiopathic|idiopathic
73492|NCT03104998|Infertility|infertility
73493|NCT03104998|coenzyme q10|coenzyme q10
73494|NCT03104998|Pakistan|pakistan
73495|NCT03104985|Trophic ulcer; low level laser therapy; Chronic Venous Insufficiency|trophic ulcer; low level laser therapy; chronic venous insufficiency
73496|NCT03104972|ADHD|adhd
73497|NCT03104972|TRANS CRANIAL ELECTRIC STIMULATION|trans cranial electric stimulation
73498|NCT03104959|hangovers|hangovers
73499|NCT03104959|N-acetyl cysteine|n-acetyl cysteine
73500|NCT03104959|alcohol|alcohol
73501|NCT03104933|Proadrenomedullin|proadrenomedullin
73502|NCT03104933|Copeptin|copeptin
73503|NCT03104933|Vasopressors|vasopressors
73504|NCT03104933|Septic Shock|septic shock
73505|NCT03104920|ERAS|eras
73506|NCT03104920|Time to ready for discharge|time to ready for discharge
73507|NCT03104907|IPSS|ipss
73508|NCT03104907|Quality of Life|quality of life
73509|NCT03104907|DAN-PSS|dan-pss
73510|NCT03104907|Complications|complications
73511|NCT03104907|Prostate cancer|prostate cancer
73512|NCT03104881|stroke|stroke
73513|NCT03104855|cystic fibrosis|cystic fibrosis
73514|NCT03104855|vitamin d catabolism|vitamin d catabolism
73515|NCT03104816|Acetaminophen po|acetaminophen po
73516|NCT03104816|Acetaminophen IV|acetaminophen iv
73517|NCT03104816|Pain management|pain management
73518|NCT03104816|minimally invasive lumbar fusions|minimally invasive lumbar fusions
73519|NCT03104816|Ofirmev|ofirmev
73520|NCT03104816|Analgesics|analgesics
73521|NCT03104816|Opioid|opioid
73522|NCT03104816|Pain|pain
73523|NCT03104816|Postoperative|postoperative
73524|NCT03104816|Spinal|spinal
73525|NCT03104764|labial frenulum|labial frenulum
73526|NCT03104764|surgery|surgery
73527|NCT03104764|scalpel technique|scalpel technique
73528|NCT03104764|Er:YAG laser|er:yag laser
73529|NCT03104751|Complex Congenital Heart Defect|complex congenital heart defect
73530|NCT03104751|Infants|infants
73531|NCT03104725|5-S-Cysteinyldopamine|5-s-cysteinyldopamine
73532|NCT03104725|Cerebrospinal Fluid|cerebrospinal fluid
73533|NCT03104725|PARKINSONS DISEASE|parkinsons disease
73534|NCT03104725|MONOAMINE OXIDASE INHIBITOR|monoamine oxidase inhibitor
73535|NCT03104712|glycemic index|glycemic index
73536|NCT03104699|Antibodies|antibodies
73537|NCT03104699|Immunologic effects|immunologic effects
73538|NCT03104699|Physiological Effects of Drugs|physiological effects of drugs
73539|NCT03104673|Molecular signature|molecular signature
73540|NCT03104673|Thailand-Myanmar border|thailand-myanmar border
73541|NCT03104621|preservative-free, tafluprost|preservative-free, tafluprost
73643|NCT03104231|oral anticoagulantion|oral anticoagulantion
73542|NCT03104595|EC-18, febrile neutropenia, breast cancer, chemotherapy|ec-18, febrile neutropenia, breast cancer, chemotherapy
73543|NCT03104582|ERCP|ercp
73544|NCT03104582|PTBD|ptbd
73545|NCT03104582|EBD|ebd
73546|NCT03104582|Cholangitis|cholangitis
73547|NCT03104582|Complication|complication
73548|NCT03104582|Klatskin tumor|klatskin tumor
73549|NCT03104569|ERCP|ercp
73550|NCT03104569|Contrast agent|contrast agent
73551|NCT03104569|Hilar cholangiocarcinoma|hilar cholangiocarcinoma
73552|NCT03104569|Cholangitis|cholangitis
73553|NCT03104569|Nonionic|nonionic
73554|NCT03104543|survivor|survivor
73555|NCT03104543|undertreatment|undertreatment
73556|NCT03104543|adherence|adherence
73557|NCT03104543|self-efficacy|self-efficacy
73558|NCT03104530|Crab|crab
73559|NCT03104530|Brown meat|brown meat
73560|NCT03104530|Cadmium body burden|cadmium body burden
73561|NCT03104530|Ferritin|ferritin
73562|NCT03104530|Zinc|zinc
73563|NCT03104530|Selenium|selenium
73564|NCT03104530|Creatinine|creatinine
73565|NCT03104530|B2-Microglobulin|b2-microglobulin
73566|NCT03104517|Urinary Incontinence|urinary incontinence
73567|NCT03104517|Urinary Stress Incontinence|urinary stress incontinence
73568|NCT03104517|Lower Urinary Tract Symptoms|lower urinary tract symptoms
73569|NCT03104517|Urinary Bladder|urinary bladder
73570|NCT03104517|Urinary Tract Diseases|urinary tract diseases
73571|NCT03104517|Bladder|bladder
73572|NCT03104517|Urinary Leak|urinary leak
73573|NCT03104517|Urine Leak|urine leak
73574|NCT03104517|Bladder Leak|bladder leak
73575|NCT03104517|Urethra|urethra
73576|NCT03104517|Urethral Sphincter|urethral sphincter
73577|NCT03104504|Suicide Screening|suicide screening
73578|NCT03104504|Safety Planning|safety planning
73579|NCT03104491|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
73580|NCT03104491|donor chimerism|donor chimerism
73581|NCT03104478|DLBCL|dlbcl
73582|NCT03104478|Real time molecular characterization|real time molecular characterization
73583|NCT03104465|Chronic Pain|chronic pain
73584|NCT03104465|Mindfulness|mindfulness
73585|NCT03104465|Behavioral Health|behavioral health
73586|NCT03104465|Quality of Life|quality of life
73587|NCT03104439|Pancreatic Cancer|pancreatic cancer
73588|NCT03104439|Microsatellite Stable Colorectal Cancer|microsatellite stable colorectal cancer
73589|NCT03104426|Hemolytic disease of the fetus and newborn|hemolytic disease of the fetus and newborn
73590|NCT03104426|HDFN|hdfn
73591|NCT03104426|Red blood cell alloimmunization|red blood cell alloimmunization
73592|NCT03104413|ABBV-066|abbv-066
73593|NCT03104413|BI 655066|bi 655066
73594|NCT03104400|Arthritis|arthritis
73595|NCT03104400|Psoriasis|psoriasis
73596|NCT03104400|Anti-inflammatory|anti-inflammatory
73597|NCT03104400|Joint disease|joint disease
73598|NCT03104400|Musculoskeletal disease|musculoskeletal disease
73599|NCT03104400|Anti-Rheumatic|anti-rheumatic
73600|NCT03104387|Air pollution|air pollution
73601|NCT03104387|Diesel exhaust|diesel exhaust
73602|NCT03104387|Ultrafine particles|ultrafine particles
73603|NCT03104387|Vascular function|vascular function
73604|NCT03104387|Endothelium function|endothelium function
73605|NCT03104387|Heart rate variability|heart rate variability
73606|NCT03104387|DNA damage|dna damage
73607|NCT03104374|Arthritis|arthritis
73608|NCT03104374|Psoriasis|psoriasis
73609|NCT03104374|Anti-Rheumatic|anti-rheumatic
73610|NCT03104374|Anti-inflammatory|anti-inflammatory
73611|NCT03104374|Joint disease|joint disease
73612|NCT03104374|Musculoskeletal disease|musculoskeletal disease
73613|NCT03104361|intersitial cystitis|intersitial cystitis
73614|NCT03104361|Bladder pain syndrome|bladder pain syndrome
73615|NCT03104361|Intravesical treatment|intravesical treatment
73616|NCT03104348|COPD|copd
73617|NCT03104348|Primary care|primary care
73618|NCT03104335|soft tissue sarcoma|soft tissue sarcoma
73619|NCT03104335|advanced|advanced
73620|NCT03104335|apatinib|apatinib
73621|NCT03104335|tyrosine-kinase inhibitors|tyrosine-kinase inhibitors
73622|NCT03104322|digital health|digital health
73623|NCT03104322|home spirometry|home spirometry
73624|NCT03104322|patient reported outcome measure|patient reported outcome measure
73625|NCT03104322|e-health|e-health
73626|NCT03104322|pirfenidone|pirfenidone
73627|NCT03104322|nintedanib|nintedanib
73628|NCT03104322|FVC|fvc
73629|NCT03104322|antifibrotic|antifibrotic
73630|NCT03104296|NIRS|nirs
73631|NCT03104296|Griffiths Mental Development Scales|griffiths mental development scales
73632|NCT03104296|prematurity|prematurity
73633|NCT03104283|apatinib|apatinib
73634|NCT03104283|gastric cancer|gastric cancer
73635|NCT03104283|elderly patients|elderly patients
73636|NCT03104270|Elotuzumab, Multiple Myeloma, Phase 2|elotuzumab, multiple myeloma, phase 2
73637|NCT03104257|Healthy Control, Cannabis, Dependence|healthy control, cannabis, dependence
73638|NCT03104244|concussion|concussion
73639|NCT03104244|subconcussive impacts|subconcussive impacts
73640|NCT03104244|brain function|brain function
73641|NCT03104244|football|football
73642|NCT03104231|atrial fibrillation|atrial fibrillation
73644|NCT03104231|stroke prevention|stroke prevention
73645|NCT03104231|education|education
73646|NCT03104231|e-medicine|e-medicine
73647|NCT03104205|frail elderly|frail elderly
73648|NCT03104205|telemedicine|telemedicine
73649|NCT03104205|obesity|obesity
73650|NCT03104205|rural health|rural health
73651|NCT03104205|health promotion|health promotion
73652|NCT03104205|weight loss|weight loss
73653|NCT03104192|frail elderly|frail elderly
73654|NCT03104192|telemedicine|telemedicine
73655|NCT03104192|obesity|obesity
73656|NCT03104192|rural health|rural health
73657|NCT03104192|health promotion|health promotion
73658|NCT03104192|weight loss|weight loss
73659|NCT03104127|Lower-limb robotic device|lower-limb robotic device
73660|NCT03104127|Gait|gait
73661|NCT03104127|Balance|balance
73662|NCT03104127|Pressure|pressure
73663|NCT03104127|Chronic stroke|chronic stroke
73664|NCT03104127|Blood pressure|blood pressure
73665|NCT03104127|Blood velocity|blood velocity
73666|NCT03104127|Aerobic fitness|aerobic fitness
73667|NCT03104127|Strength|strength
73668|NCT03104101|PTNS|ptns
73669|NCT03104101|Neuromodulation|neuromodulation
73670|NCT03104101|TPTNS|tptns
73671|NCT03104101|Trospium chloride|trospium chloride
73672|NCT03104075|Genomics|genomics
73673|NCT03104075|Epigenomics|epigenomics
73674|NCT03104075|Pneumococcal vaccine|pneumococcal vaccine
73675|NCT03104075|Elderly|elderly
73676|NCT03104049|Parkinson's Disease|parkinson's disease
73677|NCT03104049|Neuromuscular taping|neuromuscular taping
73678|NCT03104049|Trunk|trunk
73679|NCT03104049|Posture|posture
73680|NCT03104049|Kinematic|kinematic
73681|NCT03104049|rehabilitation|rehabilitation
73682|NCT03104036|Feacal bacterial transplantation|feacal bacterial transplantation
73683|NCT03104036|Left-sided ulcerative colitis|left-sided ulcerative colitis
73684|NCT03103997|Liver|liver
73685|NCT03103997|EUS|eus
73686|NCT03103997|Biopsy|biopsy
73687|NCT03103997|Heparin|heparin
73688|NCT03103984|Obesity|obesity
73689|NCT03103984|Liver transplantation|liver transplantation
73690|NCT03103984|weight loss diet|weight loss diet
73691|NCT03103984|immunosuppression|immunosuppression
73692|NCT03103958|probiotic|probiotic
73693|NCT03103958|metagenomic|metagenomic
73694|NCT03103958|constipation|constipation
73695|NCT03103945|Atrial Fibrillation|atrial fibrillation
73696|NCT03103945|Atrial Arrhythmia|atrial arrhythmia
73697|NCT03103945|Arrhythmias, Cardiac|arrhythmias, cardiac
73698|NCT03103945|Cardiac Diseases|cardiac diseases
73699|NCT03103945|Electrophysiologic Techniques, Cardiac|electrophysiologic techniques, cardiac
73700|NCT03103945|Electrophysiology|electrophysiology
73701|NCT03103945|Remote Magnetic Navigation|remote magnetic navigation
73702|NCT03103945|Contact Detection System|contact detection system
73703|NCT03103932|biomarkers|biomarkers
73704|NCT03103932|heart failure|heart failure
73705|NCT03103932|hospital admission|hospital admission
73706|NCT03103919|Parkinson´s Disease|parkinson´s disease
73707|NCT03103919|Kinesia-360™|kinesia-360™
73708|NCT03103919|Kinesia-ONE™|kinesia-one™
73709|NCT03103919|Biosensor|biosensor
73710|NCT03103880|Patient Adherence|patient adherence
73711|NCT03103880|Mobile Applications|mobile applications
73712|NCT03103880|Mobile Health|mobile health
73713|NCT03103854|Exercise|exercise
73714|NCT03103854|Secondary Prevention|secondary prevention
73715|NCT03103854|Diabetes|diabetes
73716|NCT03103854|Rehabilitation|rehabilitation
73717|NCT03103841|Children|children
73718|NCT03103815|Amyotrophic lateral sclerosis, survival, adverse event|amyotrophic lateral sclerosis, survival, adverse event
73719|NCT03103763|Elderly|elderly
73720|NCT03103763|Anticoagulation|anticoagulation
73721|NCT03103763|Risk Assessment|risk assessment
73722|NCT03103750|Vitamin D|vitamin d
73723|NCT03103737|Well-being|well-being
73724|NCT03103737|Information and communication technologies|information and communication technologies
73725|NCT03103737|Hospital|hospital
73726|NCT03103711|Virtual reality|virtual reality
73727|NCT03103711|Well-being|well-being
73728|NCT03103711|Hospital|hospital
73729|NCT03103698|analgesia per-operative|analgesia per-operative
73730|NCT03103685|Dual antiplatelet therapy|dual antiplatelet therapy
73731|NCT03103685|Dental procedure|dental procedure
73732|NCT03103672|quality of anesthesia|quality of anesthesia
73733|NCT03103672|reduce recovery time|reduce recovery time
73734|NCT03103633|oxygen dynamics|oxygen dynamics
73735|NCT03103633|Prognosis|prognosis
73736|NCT03103555|Anti-interferon gamma autoantibody|anti-interferon gamma autoantibody
73737|NCT03103542|ITI|iti
73738|NCT03103542|rFVIIIFc|rfviiifc
73739|NCT03103542|Immune Tolerance Induction|immune tolerance induction
73740|NCT03103490|PET/MR|pet/mr
73741|NCT03103425|New onset seizures|new onset seizures
73742|NCT03103412|Active Mild Ulcerative Colitis, Active Moderate Ulcerative Colitis, Healthy Subjects|active mild ulcerative colitis, active moderate ulcerative colitis, healthy subjects
73743|NCT03103386|fermented rye bran|fermented rye bran
73744|NCT03103386|H. pylori infections|h. pylori infections
73745|NCT03103386|non-communicable diseases|non-communicable diseases
73746|NCT03103373|Echocardiography|echocardiography
73747|NCT03103373|anesthesia|anesthesia
73748|NCT03103373|general surgery|general surgery
73749|NCT03103347|EEG|eeg
73750|NCT03103347|Parkinson Disease|parkinson disease
73751|NCT03103347|Beta Oscillations|beta oscillations
73752|NCT03103308|Cancer|cancer
73753|NCT03103308|Exercise|exercise
73754|NCT03103308|Physical Function|physical function
73755|NCT03103295|tissue engineering,|tissue engineering,
73756|NCT03103295|regeneration,|regeneration,
73757|NCT03103295|repair,|repair,
73758|NCT03103295|traumatic bone defects,|traumatic bone defects,
73759|NCT03103295|regenerative therapy|regenerative therapy
73760|NCT03103269|Overweight|overweight
73761|NCT03103269|Obesity|obesity
73762|NCT03103269|Prevention|prevention
73763|NCT03103269|Diet|diet
73764|NCT03103269|Physical activity|physical activity
73765|NCT03103269|Depression|depression
73766|NCT03103269|Anxiety|anxiety
73767|NCT03103269|Stages of change|stages of change
73768|NCT03103269|Barriers|barriers
73769|NCT03103269|Perceptions|perceptions
73770|NCT03103269|Environment|environment
73771|NCT03103269|Eating Disorder|eating disorder
73772|NCT03103269|Self efficacy|self efficacy
73773|NCT03103243|Lupus|lupus
73774|NCT03103243|SLE|sle
73775|NCT03103243|Erythematosus|erythematosus
73776|NCT03103230|Motor evoked potentials|motor evoked potentials
73777|NCT03103230|aphasia|aphasia
73778|NCT03103230|prognosis|prognosis
73779|NCT03103230|stroke|stroke
73780|NCT03103204|Obesity|obesity
73781|NCT03103204|Periodontitis|periodontitis
73782|NCT03103204|Therapeutics|therapeutics
73783|NCT03103204|Chlorhexidine|chlorhexidine
73784|NCT03103152|Prostate Cancer|prostate cancer
73785|NCT03103152|Active Surveillance|active surveillance
73786|NCT03103152|Chemo-prevention|chemo-prevention
73787|NCT03103126|pedometer-determined walking|pedometer-determined walking
73788|NCT03103126|resistance exercise|resistance exercise
73789|NCT03103100|Local anesthetic|local anesthetic
73790|NCT03103100|Labor epidural|labor epidural
73791|NCT03103074|botulinum toxin|botulinum toxin
73792|NCT03103061|Computed Tomography|computed tomography
73793|NCT03102996|Alkali|alkali
73794|NCT03102996|Graft|graft
73795|NCT03102996|Acid base|acid base
73796|NCT03102996|Metabolic acidosis|metabolic acidosis
73797|NCT03102996|Chronic kidney disease|chronic kidney disease
73798|NCT03102983|MRI, Functional|mri, functional
73799|NCT03102970|COPD, Pain, Exacerbation|copd, pain, exacerbation
73800|NCT03102918|Cannabidiol|cannabidiol
73801|NCT03102879|mesenchymal stem cells|mesenchymal stem cells
73802|NCT03102879|regenerative procedures|regenerative procedures
73803|NCT03102879|tissue engineering|tissue engineering
73804|NCT03102879|regenerative endodontic|regenerative endodontic
73805|NCT03102879|scaffold|scaffold
73806|NCT03102879|cell encapsulation|cell encapsulation
73807|NCT03102879|dental pulp|dental pulp
73808|NCT03102879|pulp regeneration|pulp regeneration
73809|NCT03102879|plasma-derived biomaterial|plasma-derived biomaterial
73810|NCT03102879|allogenic stem cells|allogenic stem cells
73811|NCT03102879|mesenchymal stromal cells|mesenchymal stromal cells
73812|NCT03102879|adult stem cells|adult stem cells
73813|NCT03102879|umbilical cord stem cells|umbilical cord stem cells
73814|NCT03102840|Carriage|carriage
73815|NCT03102840|Immunogenicity|immunogenicity
73816|NCT03102840|Pneumococcal conjugate vaccine 13 (PCV 13)|pneumococcal conjugate vaccine 13 (pcv 13)
73817|NCT03102840|Children|children
73818|NCT03102840|Pneumococcus|pneumococcus
73819|NCT03102775|poverty|poverty
73820|NCT03102775|unemployment|unemployment
73821|NCT03102775|cluster-randomized|cluster-randomized
73822|NCT03102775|family-project|family-project
73823|NCT03102762|Erectile dysfunction|erectile dysfunction
73824|NCT03102762|Botulinum toxin A|botulinum toxin a
73825|NCT03102762|Botox|botox
73826|NCT03102749|Airways|airways
73827|NCT03102749|asthma|asthma
73828|NCT03102749|overweight|overweight
73829|NCT03102736|depression|depression
73830|NCT03102736|ketamine|ketamine
73831|NCT03102736|nitroprusside|nitroprusside
73832|NCT03102723|STEMI|stemi
73833|NCT03102723|primary percutaneous coronary intervention (PPCI)|primary percutaneous coronary intervention (ppci)
73834|NCT03102723|cangrelor|cangrelor
73835|NCT03102723|reperfusion|reperfusion
73836|NCT03102697|Intragastric balloon|intragastric balloon
73837|NCT03102697|obesity|obesity
73838|NCT03102697|metabolic syndrome|metabolic syndrome
73839|NCT03102697|bariatric surgery|bariatric surgery
73840|NCT03102684|e-cigarette|e-cigarette
73841|NCT03102684|electronic cigarette|electronic cigarette
73842|NCT03102684|passive exposure|passive exposure
73843|NCT03102684|secondhand exposure|secondhand exposure
73844|NCT03102684|smoking|smoking
73845|NCT03102684|respiratory system|respiratory system
73846|NCT03102619|Wireless monitoring|wireless monitoring
73847|NCT03102619|Postoperative complications|postoperative complications
73848|NCT03102619|Vital parameters|vital parameters
73849|NCT03102619|Continuous monitoring|continuous monitoring
73850|NCT03102606|Plinabulin|plinabulin
73851|NCT03102606|Pegfilgrastim|pegfilgrastim
73852|NCT03102606|Duration of Severe Neutropenia|duration of severe neutropenia
73853|NCT03102606|Bone Pain|bone pain
73854|NCT03102580|Shared Decision Making|shared decision making
73855|NCT03102554|Exome Sequencing|exome sequencing
73856|NCT03102502|Coronary Heart Disease|coronary heart disease
73857|NCT03102502|Atherosclerosis|atherosclerosis
73858|NCT03102502|Vascular Endothelium|vascular endothelium
73859|NCT03102502|Counterpulsation, External|counterpulsation, external
73860|NCT03102463|Insulin sensitivity|insulin sensitivity
73861|NCT03102463|Obesity|obesity
73862|NCT03102463|Insulin resistance|insulin resistance
73863|NCT03102463|Milk derived hydrolysate|milk derived hydrolysate
73864|NCT03102463|Hyperinsulinemic-euglycaemic clamp|hyperinsulinemic-euglycaemic clamp
73865|NCT03102437|Cardiac Contractility Modulation|cardiac contractility modulation
73866|NCT03102437|CCM|ccm
73867|NCT03102437|FIX-HF-5CA|fix-hf-5ca
73868|NCT03102437|Continued Access|continued access
73869|NCT03102398|Erectile Dysfunction|erectile dysfunction
73870|NCT03102398|PDE5 inhibitor|pde5 inhibitor
73871|NCT03102398|Sexual Dysfunction|sexual dysfunction
73872|NCT03102385|blood donation|blood donation
73873|NCT03102385|motivation|motivation
73874|NCT03102385|donor retention|donor retention
73875|NCT03102372|FFM|ffm
73876|NCT03102372|VLCD|vlcd
73877|NCT03102372|exercise|exercise
73878|NCT03102372|Protein|protein
73879|NCT03102372|Obesity|obesity
73880|NCT03102346|cardiorespiratory fitness|cardiorespiratory fitness
73881|NCT03102346|coronary artery disease|coronary artery disease
73882|NCT03102346|cardiac rehabilitation|cardiac rehabilitation
73883|NCT03102346|remote control|remote control
73884|NCT03102346|major adverse cardiac and cerebrovascular events|major adverse cardiac and cerebrovascular events
73885|NCT03102320|cholangiocarcinoma|cholangiocarcinoma
73886|NCT03102320|pancreatic cancer|pancreatic cancer
73887|NCT03102320|triple-negative breast cancer|triple-negative breast cancer
73888|NCT03102320|non-small cell lung cancer|non-small cell lung cancer
73889|NCT03102320|thymic carcinoma|thymic carcinoma
73890|NCT03102320|gastric including gastroesophageal junction cancer|gastric including gastroesophageal junction cancer
73891|NCT03102307|Targeted axillary dissection|targeted axillary dissection
73892|NCT03102307|Sentinel node biopsy|sentinel node biopsy
73893|NCT03102307|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
73894|NCT03102255|Nasotracheal intubation|nasotracheal intubation
73895|NCT03102229|Activity Monitoring|activity monitoring
73896|NCT03102229|Chemotherapy|chemotherapy
73897|NCT03102229|Radiotherapy|radiotherapy
73898|NCT03102164|heart failure|heart failure
73899|NCT03102164|decompensation|decompensation
73900|NCT03102125|heart transplant, acute graft rejection, chronic graft rejection|heart transplant, acute graft rejection, chronic graft rejection
73901|NCT03102112|Glioma APT MRI|glioma apt mri
73902|NCT03102073|Reading speed|reading speed
73903|NCT03102047|microsatellite stable|microsatellite stable
73904|NCT03102047|MSS|mss
73905|NCT03102047|durvalumab|durvalumab
73906|NCT03102047|NSABP|nsabp
73907|NCT03102008|Transdiagnostic Treatment|transdiagnostic treatment
73908|NCT03102008|Emotional Disorders|emotional disorders
73909|NCT03102008|Adolescence|adolescence
73910|NCT03102008|Psychotherapy|psychotherapy
73911|NCT03101995|Treatment|treatment
73912|NCT03101995|Locally advanced cervical cancer|locally advanced cervical cancer
73913|NCT03101995|Renal failure|renal failure
73914|NCT03101995|Gemcitabine|gemcitabine
73915|NCT03101969|language|language
73916|NCT03101969|scheduled|scheduled
73917|NCT03101969|appointment|appointment
73918|NCT03101956|Spine Manipulation|spine manipulation
73919|NCT03101943|Sugar|sugar
73920|NCT03101943|Sweetened|sweetened
73921|NCT03101943|Beverages|beverages
73922|NCT03101891|Amnioinfusion|amnioinfusion
73923|NCT03101891|Fetal therapy|fetal therapy
73924|NCT03101878|Healthy Volunteers, IONIS AGT-Lrx|healthy volunteers, ionis agt-lrx
73925|NCT03101865|Type 1 diabetes|type 1 diabetes
73926|NCT03101865|Artificial Pancreas|artificial pancreas
73927|NCT03101865|Closed-loop glucose control|closed-loop glucose control
73928|NCT03101865|Very young children|very young children
73929|NCT03101865|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
73930|NCT03101865|Continuous glucose monitoring|continuous glucose monitoring
73931|NCT03101852|severe acute malnutrition|severe acute malnutrition
73932|NCT03101852|moderate acute malnutrition|moderate acute malnutrition
73933|NCT03101852|HIV-infection|hiv-infection
73934|NCT03101852|adolescents|adolescents
73935|NCT03101852|antiretroviral|antiretroviral
73936|NCT03101852|Africa|africa
73937|NCT03101852|ready-to-use food|ready-to-use food
73938|NCT03101852|outpatient care|outpatient care
73939|NCT03101839|AZD4785|azd4785
73940|NCT03101839|KRAS|kras
73941|NCT03101839|KRAS mutations|kras mutations
73942|NCT03101839|Non-small cell lung cancer|non-small cell lung cancer
73943|NCT03101839|Advanced solid tumours|advanced solid tumours
73944|NCT03101826|Polyvagal Theory|polyvagal theory
73945|NCT03101826|Respiratory Sinus Arrhythmia|respiratory sinus arrhythmia
73946|NCT03101826|Heart rate|heart rate
73947|NCT03101826|Social Behavior|social behavior
73948|NCT03101826|Arginine Vasopressin|arginine vasopressin
73949|NCT03101826|Dichotic Listening Tests|dichotic listening tests
73950|NCT03101826|Oxytocin|oxytocin
73951|NCT03101826|Hyperacusis|hyperacusis
73952|NCT03101826|Affect|affect
73953|NCT03101826|Auditory perception|auditory perception
73954|NCT03101826|Sound spectrography|sound spectrography
73955|NCT03101800|Azathioprine|azathioprine
73956|NCT03101800|Allopurinol|allopurinol
73957|NCT03101800|Antimetabolites|antimetabolites
73958|NCT03101800|Ulcerative Colitis|ulcerative colitis
73959|NCT03101787|ECPR|ecpr
73960|NCT03101787|Extracorporeal CardioPulmonary Resuscitation|extracorporeal cardiopulmonary resuscitation
73961|NCT03101787|OHCA|ohca
73962|NCT03101787|Out-of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
73963|NCT03101787|CPR|cpr
73964|NCT03101787|CardioPulmonary Resuscitation|cardiopulmonary resuscitation
73965|NCT03101787|ECMO|ecmo
73966|NCT03101787|ExtraCorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
73967|NCT03101787|Refractory Cardiac Arrest|refractory cardiac arrest
73968|NCT03101774|inspiratory muscle training|inspiratory muscle training
73969|NCT03101748|Malignant neoplasm of breast|malignant neoplasm of breast
73970|NCT03101748|Metastatic breast cancer|metastatic breast cancer
73971|NCT03101748|Locally advanced breast cancer|locally advanced breast cancer
73972|NCT03101748|HER2-positive|her2-positive
73973|NCT03101748|HER2+|her2+
73974|NCT03101748|HER2-negative/ER-positive|her2-negative/er-positive
73975|NCT03101748|HER2-/ER+|her2-/er+
73976|NCT03101748|Locally advanced inflammatory breast cancer|locally advanced inflammatory breast cancer
73977|NCT03101748|IBC|ibc
73978|NCT03101748|Neratinib|neratinib
73979|NCT03101748|Paclitaxel|paclitaxel
73980|NCT03101748|Taxol|taxol
73981|NCT03101748|Doxorubicin|doxorubicin
73982|NCT03101748|Doxorubicin Hydrochloride|doxorubicin hydrochloride
73983|NCT03101748|Adriamycin PFS|adriamycin pfs
73984|NCT03101748|Adriamycin RDF|adriamycin rdf
73985|NCT03101748|Adriamycin|adriamycin
73986|NCT03101748|Rubex|rubex
73987|NCT03101748|Pertuzumab|pertuzumab
73988|NCT03101748|Perjeta|perjeta
73989|NCT03101748|Trastuzumab|trastuzumab
73990|NCT03101748|Herceptin|herceptin
73991|NCT03101748|Cyclophosphamide|cyclophosphamide
73992|NCT03101748|Cytoxan|cytoxan
73993|NCT03101748|Neosar|neosar
73994|NCT03101722|presbycusis|presbycusis
73995|NCT03101722|tinnitus|tinnitus
73996|NCT03101722|cognitive impairment|cognitive impairment
73997|NCT03101722|Huperzine A|huperzine a
73998|NCT03101722|hearing aid|hearing aid
73999|NCT03101722|age-related hearing impairment|age-related hearing impairment
74000|NCT03101696|coronary angiography|coronary angiography
74001|NCT03101696|coronary conductance|coronary conductance
74002|NCT03101696|hyperemia|hyperemia
74003|NCT03101696|regadenoson|regadenoson
74004|NCT03101696|fractional flow reserve|fractional flow reserve
74005|NCT03101696|coronary flow reserve|coronary flow reserve
74006|NCT03101696|index of microcirculatory resistance|index of microcirculatory resistance
74007|NCT03101631|Elderly population with cancer|elderly population with cancer
74008|NCT03101631|Toxicity risk|toxicity risk
74009|NCT03101631|Mortality risk|mortality risk
74010|NCT03101631|Frailty conditions in elderly population|frailty conditions in elderly population
74011|NCT03101631|Chemotherapy in elderly population|chemotherapy in elderly population
74012|NCT03101618|allergen|allergen
74013|NCT03101618|allergy|allergy
74014|NCT03101618|pet|pet
74015|NCT03101592|antiretroviral therapy|antiretroviral therapy
74016|NCT03101592|retention|retention
74017|NCT03101592|ART|art
74018|NCT03101592|cost-effectiveness|cost-effectiveness
74019|NCT03101592|virologic suppression|virologic suppression
74020|NCT03101579|Leptomeningeal metastasis|leptomeningeal metastasis
74021|NCT03101579|Recurrence|recurrence
74022|NCT03101579|Intrathecal chemotherapy|intrathecal chemotherapy
74023|NCT03101579|Pemetrexed|pemetrexed
74024|NCT03101540|Major Depressive Disorder,|major depressive disorder,
74025|NCT03101540|omega-3 polyunsaturated fatty acid|omega-3 polyunsaturated fatty acid
74026|NCT03101540|PUFA|pufa
74027|NCT03101540|Pregnancy|pregnancy
74028|NCT03101540|eicosapentaenoic acid (EPA) supplementation|eicosapentaenoic acid (epa) supplementation
74029|NCT03101540|cytokine|cytokine
74030|NCT03101540|docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
74031|NCT03101527|Major Depressive Disorder|major depressive disorder
74032|NCT03101527|omega-3 polyunsaturated fatty acid|omega-3 polyunsaturated fatty acid
74033|NCT03101527|PUFA|pufa
74034|NCT03101527|Pregnancy|pregnancy
74035|NCT03101527|eicosapentaenoic acid (EPA) supplementation|eicosapentaenoic acid (epa) supplementation
74036|NCT03101514|head and neck|head and neck
74037|NCT03101514|tumor|tumor
74038|NCT03101514|radiotherapy|radiotherapy
74039|NCT03101514|mucositis|mucositis
74040|NCT03101514|toxicity|toxicity
74041|NCT03101514|Kanglaite injection|kanglaite injection
74042|NCT03101488|KN035|kn035
74043|NCT03101488|phase 1|phase 1
74044|NCT03101475|Colorectal Cancer|colorectal cancer
74045|NCT03101475|Liver Metastases|liver metastases
74046|NCT03101475|Durvalumab|durvalumab
74047|NCT03101475|Tremelimumab|tremelimumab
74048|NCT03101436|Insulin Resistance|insulin resistance
74049|NCT03101436|Extra Virgin Olive Oil|extra virgin olive oil
74050|NCT03101436|Red Wine|red wine
74051|NCT03101436|Diet|diet
74052|NCT03101436|Microbiota|microbiota
74053|NCT03101423|thalassemia|thalassemia
74054|NCT03101423|transplantation|transplantation
74055|NCT03101423|chimerism|chimerism
74056|NCT03101423|donor ymphocytes|donor ymphocytes
74057|NCT03101410|Gluten|gluten
74058|NCT03101410|sport performance|sport performance
74059|NCT03101397|serum KL-6|serum kl-6
74060|NCT03101397|pulmonary function test|pulmonary function test
74061|NCT03101397|CT score|ct score
74062|NCT03101397|evaluation|evaluation
74063|NCT03101358|cutaneous metastases|cutaneous metastases
74064|NCT03101358|cutaneous metastasis|cutaneous metastasis
74065|NCT03101358|skin metastases|skin metastases
74066|NCT03101358|skin metastasis|skin metastasis
74067|NCT03101306|cervix, radiotherapy, magnetic resonance imaging|cervix, radiotherapy, magnetic resonance imaging
74068|NCT03101293|Drug therapy|drug therapy
74069|NCT03101267|Cedar pollinosis|cedar pollinosis
74070|NCT03101267|ASP4070|asp4070
74071|NCT03101267|DNA plasmid vaccine|dna plasmid vaccine
74072|NCT03101254|Melanoma|melanoma
74073|NCT03101241|Essential Tremor|essential tremor
74074|NCT03101241|Movement Disorders|movement disorders
74075|NCT03101241|thalamocortical dysrhythmias|thalamocortical dysrhythmias
74076|NCT03101228|Physical Activity|physical activity
74077|NCT03101228|Metabolic Syndrome|metabolic syndrome
74078|NCT03101228|Insulin Sensitivity|insulin sensitivity
74079|NCT03101228|Cardiovascular Risk Factor|cardiovascular risk factor
74080|NCT03101228|Sedentary Lifestyle|sedentary lifestyle
74081|NCT03101228|Accelerometry|accelerometry
74082|NCT03101189|safety|safety
74083|NCT03101189|Japanese|japanese
74084|NCT03101189|pharmacokinetics|pharmacokinetics
74085|NCT03101176|multiparametric ultrasound|multiparametric ultrasound
74086|NCT03101176|prostate cancer|prostate cancer
74087|NCT03101176|contrast ultrasound|contrast ultrasound
74088|NCT03101176|CEUS|ceus
74089|NCT03101176|radical prostatectomy|radical prostatectomy
74090|NCT03101150|Maternal vitamin D|maternal vitamin d
74091|NCT03101150|Deficiency|deficiency
74092|NCT03101150|Insufficiency|insufficiency
74093|NCT03101150|Pregnancy|pregnancy
74094|NCT03101150|Pre-eclampsia|pre-eclampsia
74095|NCT03101150|IUGR|iugr
74096|NCT03101124|Hemostasis, Surgical|hemostasis, surgical
74097|NCT03101124|Tranexamic Acid|tranexamic acid
74098|NCT03101124|Antifibrinolytic Agents|antifibrinolytic agents
74099|NCT03101124|Administration, Cutaneous|administration, cutaneous
74100|NCT03101124|Administration, Intravenous|administration, intravenous
74101|NCT03101124|Administration, Topical|administration, topical
74102|NCT03101072|Gram-negative bacteremia|gram-negative bacteremia
74103|NCT03101072|antibiotic durations|antibiotic durations
74104|NCT03101072|point-of-care randomization|point-of-care randomization
74105|NCT03101059|Tracheal|tracheal
74106|NCT03101059|Bronchial|bronchial
74107|NCT03101059|Tracheobronchiomegaly|tracheobronchiomegaly
74108|NCT03101059|Collapse|collapse
74109|NCT03101059|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
74110|NCT03101059|Computer Tomography|computer tomography
74111|NCT03101059|Impedance Tomography|impedance tomography
74112|NCT03101046|Docetaxel|docetaxel
74113|NCT03101046|Cabazitaxel|cabazitaxel
74114|NCT03101033|Herniated lumbar disc|herniated lumbar disc
74115|NCT03101033|Epidural neuroplasty|epidural neuroplasty
74116|NCT03101033|Epidural injection|epidural injection
74117|NCT03101020|Visceral Manipulation|visceral manipulation
74118|NCT03101007|Comparative study|comparative study
74119|NCT03101007|Knee Prosthesis|knee prosthesis
74120|NCT03101007|Prosthesis Design|prosthesis design
74121|NCT03101007|Treatment Outcome|treatment outcome
74122|NCT03101007|Follow-up studies|follow-up studies
74123|NCT03101007|Arthroplast, Replacement, Knee/methods|arthroplast, replacement, knee/methods
74124|NCT03100981|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
74125|NCT03100981|Internet-delivered|internet-delivered
74126|NCT03100981|Breast cancer|breast cancer
74127|NCT03100981|Prostate cancer|prostate cancer
74128|NCT03100981|Survivors|survivors
74129|NCT03100981|Depression|depression
74130|NCT03100981|Anxiety|anxiety
74131|NCT03100981|Stress|stress
74132|NCT03100838|Proton Pump Inhibitor|proton pump inhibitor
74133|NCT03100838|Bioequivalence|bioequivalence
74134|NCT03100838|Drug-Drug Interaction|drug-drug interaction
74135|NCT03100838|Modified Release|modified release
74136|NCT03100838|Nifedipine|nifedipine
74137|NCT03100825|QVM149,|qvm149,
74138|NCT03100825|Asthma,|asthma,
74139|NCT03100825|Japanese,|japanese,
74140|NCT03100825|Allergic asthma,|allergic asthma,
74141|NCT03100825|Allergy triggered asthma,|allergy triggered asthma,
74142|NCT03100825|Reactive asthma,|reactive asthma,
74143|NCT03100825|Asthma attack,|asthma attack,
74144|NCT03100825|Difficulty breathing|difficulty breathing
74145|NCT03100812|Hypertensive|hypertensive
74146|NCT03100812|Hypertension|hypertension
74147|NCT03100812|Filipino|filipino
74148|NCT03100799|Osteoarthritis|osteoarthritis
74149|NCT03100799|Senescence|senescence
74150|NCT03100799|Magnetic resonance imaging|magnetic resonance imaging
74151|NCT03100799|Arthroscopy|arthroscopy
74152|NCT03100799|Arthrocentesis|arthrocentesis
74153|NCT03100799|Biomarker|biomarker
74154|NCT03100786|Tuberculosis|tuberculosis
74155|NCT03100786|tuberculous meningitis|tuberculous meningitis
74156|NCT03100786|drug induced liver injury|drug induced liver injury
74157|NCT03100786|dexamethasone|dexamethasone
74158|NCT03100786|LTA4H|lta4h
74159|NCT03100786|host genotype|host genotype
74160|NCT03100786|personalized medicine|personalized medicine
74161|NCT03100773|alpha-amylases|alpha-amylases
74162|NCT03100773|child|child
74163|NCT03100773|cortisol|cortisol
74164|NCT03100773|dental anxiety|dental anxiety
74165|NCT03100773|dental atraumatic restorative treatment|dental atraumatic restorative treatment
74166|NCT03100773|health education|health education
74167|NCT03100773|microbiota|microbiota
74168|NCT03100773|oral hygiene|oral hygiene
74169|NCT03100773|quality of life|quality of life
74170|NCT03100773|saliva|saliva
74171|NCT03100734|Rheumatoid arthritis|rheumatoid arthritis
74172|NCT03100734|Axial spondyloarthritis|axial spondyloarthritis
74173|NCT03100734|Observational|observational
74174|NCT03100734|Biosimilar|biosimilar
74175|NCT03100734|Etanercept|etanercept
74176|NCT03100734|Benepali|benepali
74177|NCT03100734|Enbrel|enbrel
74178|NCT03100721|Chronic pain|chronic pain
74179|NCT03100721|Musculoskeletal diseases|musculoskeletal diseases
74180|NCT03100721|Pain Neuroscience Education|pain neuroscience education
74181|NCT03100721|Physiotherapy|physiotherapy
74182|NCT03100656|psychopathology|psychopathology
74183|NCT03100656|treatment|treatment
74184|NCT03100656|epoxide hydrolases|epoxide hydrolases
74185|NCT03100656|polyunsaturated fatty acids|polyunsaturated fatty acids
74186|NCT03100656|eicosanoids|eicosanoids
74187|NCT03100643|HIV/AIDS, mHealth, intervention development, African American men|hiv/aids, mhealth, intervention development, african american men
74188|NCT03100617|Family caregiver|family caregiver
74189|NCT03100604|middle ear pressure|middle ear pressure
74190|NCT03100604|sevoflurane|sevoflurane
74191|NCT03100604|desflurane|desflurane
74192|NCT03100578|PANCREAS|pancreas
74193|NCT03100578|ENDOSCOPIC INTERVENTION|endoscopic intervention
74194|NCT03100578|PLASTIC STENT|plastic stent
74195|NCT03100578|SELF EXPANDING METALLIC STENT|self expanding metallic stent
74196|NCT03100578|ENDOSCOPIC TRANSMURAL DRAINAGE|endoscopic transmural drainage
74197|NCT03100578|WALLED OFF PANCREATIC NECROSIS|walled off pancreatic necrosis
74198|NCT03100565|colposcopy|colposcopy
74199|NCT03100565|pain|pain
74200|NCT03100565|coughing|coughing
74201|NCT03100565|anesthetic spray|anesthetic spray
74202|NCT03100552|Colonoscopy|colonoscopy
74203|NCT03100552|Endoscopic resection|endoscopic resection
74204|NCT03100552|Sessile serrated adenoma|sessile serrated adenoma
74205|NCT03100539|Massage|massage
74206|NCT03100539|Caregiver|caregiver
74207|NCT03100539|Fascia|fascia
74208|NCT03100526|High-Risk Patients|high-risk patients
74209|NCT03100500|QVM149,|qvm149,
74210|NCT03100500|Asthma,|asthma,
74211|NCT03100500|Japanese,|japanese,
74212|NCT03100500|Allergic asthma,|allergic asthma,
74213|NCT03100500|Allergy triggered asthma,|allergy triggered asthma,
74214|NCT03100500|Reactive asthma,|reactive asthma,
74215|NCT03100500|Asthma attack,|asthma attack,
74216|NCT03100500|Difficulty breathing|difficulty breathing
74217|NCT03100474|tremor|tremor
74218|NCT03100474|Parkinson's|parkinson's
74219|NCT03100474|movement|movement
74220|NCT03100474|neuropathic|neuropathic
74221|NCT03100474|pain|pain
74222|NCT03100461|Cancer Screening|cancer screening
74223|NCT03100461|Colon Cancer|colon cancer
74224|NCT03100461|Colon Cancer Screening|colon cancer screening
74225|NCT03100409|Cervical cancer|cervical cancer
74226|NCT03100383|gestational diabetes|gestational diabetes
74227|NCT03100383|Type2 Diabetes|type2 diabetes
74228|NCT03100331|neuropsychological outcomes|neuropsychological outcomes
74229|NCT03100331|HIV/AIDS|hiv/aids
74230|NCT03100331|international adoption|international adoption
74231|NCT03100331|perinatal infection|perinatal infection
74232|NCT03100292|primary bariatric surgery|primary bariatric surgery
74233|NCT03100292|morbid obesity|morbid obesity
74234|NCT03100292|South Korea|south korea
74235|NCT03100292|sleeve gastrectomy|sleeve gastrectomy
74236|NCT03100292|Roux-en Y gastric bypass|roux-en y gastric bypass
74237|NCT03100279|cognitive behavioral therapy|cognitive behavioral therapy
74238|NCT03100279|treatment mediators|treatment mediators
74239|NCT03100279|trajectories of change|trajectories of change
74240|NCT03100253|Rheumatoid Arthritis|rheumatoid arthritis
74241|NCT03100253|Tocilizumab|tocilizumab
74242|NCT03100253|anti-TNF treatment|anti-tnf treatment
74243|NCT03100201|robotic-assisted rehabilitation|robotic-assisted rehabilitation
74244|NCT03100201|humeral fracture|humeral fracture
74245|NCT03100201|randomised controlled study|randomised controlled study
74246|NCT03100188|peritoneal dialysis|peritoneal dialysis
74247|NCT03100188|incremental peritoneal dialysis|incremental peritoneal dialysis
74248|NCT03100188|quality of life|quality of life
74249|NCT03100188|end stage renal disease|end stage renal disease
74250|NCT03100188|adequacy|adequacy
74251|NCT03100162|probiotics|probiotics
74252|NCT03100162|metabolic syndrome|metabolic syndrome
74253|NCT03100162|obesity|obesity
74254|NCT03100162|microbiome|microbiome
74255|NCT03100136|PET|pet
74256|NCT03100136|[11C]PF-06809247|[11c]pf-06809247
74257|NCT03100136|Reliability|reliability
74258|NCT03100136|Scan, Safety|scan, safety
74259|NCT03100110|Brain-Computer Interface|brain-computer interface
74260|NCT03100110|Brain-Machine Interface|brain-machine interface
74261|NCT03100110|Prefrontal Cortex|prefrontal cortex
74262|NCT03100084|Preeclampsia|preeclampsia
74263|NCT03100084|Diabetes in Pregnancy|diabetes in pregnancy
74264|NCT03100084|Fetal Growth Restriction|fetal growth restriction
74265|NCT03100084|Reduced Fetal Movements|reduced fetal movements
74266|NCT03100058|Obesity|obesity
74267|NCT03100058|Overweight|overweight
74268|NCT03100045|HPV|hpv
74269|NCT03100045|suppository|suppository
74270|NCT03100045|Artesunate|artesunate
74271|NCT03100045|artemisinin|artemisinin
74272|NCT03100045|anal dysplasia|anal dysplasia
74273|NCT03100045|treatment|treatment
74274|NCT03100045|alternative treatment|alternative treatment
74275|NCT03100045|anal precancer|anal precancer
74276|NCT03100045|Johns Hopkins|johns hopkins
74277|NCT03100045|Sandy Fang|sandy fang
74278|NCT03100045|Frantz Viral Therapeutics|frantz viral therapeutics
74279|NCT03100032|Spinal Fusion|spinal fusion
74280|NCT03100032|Lumbar Interbody Fusion|lumbar interbody fusion
74281|NCT03100032|Autologous Stem Cell Therapy|autologous stem cell therapy
74282|NCT03100032|Bone Graft|bone graft
74283|NCT03100032|Demineralized Bone Matrix|demineralized bone matrix
74284|NCT03100032|Polyetheretherketone (PEEK) cage|polyetheretherketone (peek) cage
74285|NCT03100019|Resveratrol|resveratrol
74286|NCT03100019|Cerebral blood flow|cerebral blood flow
74287|NCT03100019|Cognition|cognition
74288|NCT03099993|Unilateral cerebral palsy|unilateral cerebral palsy
74289|NCT03099993|kinematics|kinematics
74290|NCT03099993|electromyography|electromyography
74291|NCT03099993|constraint-induced therapy|constraint-induced therapy
74292|NCT03099993|muscle activation|muscle activation
74293|NCT03099993|upper limb|upper limb
74294|NCT03099993|child|child
74295|NCT03099941|Low Back Pain, Mechanical, Biofeedback, Pain, Chronic|low back pain, mechanical, biofeedback, pain, chronic
74296|NCT03099902|Asthma|asthma
74297|NCT03099902|Wheezing|wheezing
74298|NCT03099902|GSTP1|gstp1
74299|NCT03099902|TNFa|tnfa
74300|NCT03099902|Secondhand smoking|secondhand smoking
74301|NCT03099902|Passive smoking|passive smoking
74302|NCT03099902|Intrauterine smoking|intrauterine smoking
74303|NCT03099850|Chronic Pancreatitis|chronic pancreatitis
74304|NCT03099850|Data management|data management
74305|NCT03099850|Regulatory compliance|regulatory compliance
74306|NCT03099850|Protocol monitoring|protocol monitoring
74307|NCT03099824|Healthy Adult|healthy adult
74308|NCT03099824|Oral Capsule|oral capsule
74309|NCT03099824|Superoxide Dismutase|superoxide dismutase
74310|NCT03099824|Free Radical Oxygen|free radical oxygen
74311|NCT03099824|Single Ascending Dose|single ascending dose
74312|NCT03099824|GC4702 Oral Form Capsule|gc4702 oral form capsule
74313|NCT03099824|Food Effect Cohort|food effect cohort
74314|NCT03099772|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
74315|NCT03099759|Vitamin D Dosing Regimens|vitamin d dosing regimens
74316|NCT03099759|Blood Serum 25(OH)D3 Levels|blood serum 25(oh)d3 levels
74317|NCT03099746|chronically critically ill|chronically critically ill
74318|NCT03099746|surrogate decision maker|surrogate decision maker
74319|NCT03099707|Treatment|treatment
74320|NCT03099707|ART|art
74321|NCT03099707|South Africa|south africa
74322|NCT03099694|NRDS|nrds
74323|NCT03099694|nHFOV|nhfov
74324|NCT03099694|nCPAP|ncpap
74325|NCT03099694|preterm infants|preterm infants
74326|NCT03099655|Heart Failure|heart failure
74327|NCT03099655|Cardiac Pacing|cardiac pacing
74328|NCT03099655|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
74329|NCT03099655|Left Ventricular Lead|left ventricular lead
74330|NCT03099642|lumbar puncture|lumbar puncture
74331|NCT03099642|Point of care ultrasound|point of care ultrasound
74332|NCT03099642|children|children
74333|NCT03099629|Inspiratory muscle training|inspiratory muscle training
74334|NCT03099629|Diaphragmatic surface electromyography|diaphragmatic surface electromyography
74335|NCT03099629|Respiratory muscle strength|respiratory muscle strength
74336|NCT03099629|Functional capacity|functional capacity
74337|NCT03099616|propofol|propofol
74338|NCT03099616|CLADS|clads
74339|NCT03099616|Desflurane|desflurane
74340|NCT03099616|Obesity|obesity
74341|NCT03099564|Pembrolizumab|pembrolizumab
74342|NCT03099564|Y90 Radioembolization|y90 radioembolization
74343|NCT03099564|KEYTRUDA®|keytruda®
74344|NCT03099564|TheraSphere®|therasphere®
74345|NCT03099564|PD-1|pd-1
74346|NCT03099564|IgG4/kappa isotype|igg4/kappa isotype
74347|NCT03099551|Plaque|plaque
74348|NCT03099551|oral hygiene|oral hygiene
74349|NCT03099551|gingivitis|gingivitis
74350|NCT03099551|sonic toothbrush|sonic toothbrush
74351|NCT03099551|manual toothbrush|manual toothbrush
74352|NCT03099538|Ixekizumab|ixekizumab
74353|NCT03099538|Bullous Pemphigoid|bullous pemphigoid
74354|NCT03099538|Pemphigoid|pemphigoid
74355|NCT03099538|IL17|il17
74356|NCT03099538|IL-17|il-17
74357|NCT03099538|Interleukin 17|interleukin 17
74358|NCT03099512|Patellofemoral pain|patellofemoral pain
74359|NCT03099512|foot deformity|foot deformity
74360|NCT03099512|foot pronation|foot pronation
74361|NCT03099512|short foot exercise|short foot exercise
74362|NCT03099473|electroacupuncture|electroacupuncture
74363|NCT03099473|trochlear nerve palsy|trochlear nerve palsy
74364|NCT03099473|eyeball movement|eyeball movement
74365|NCT03099473|diplopia|diplopia
74366|NCT03099473|ocular motility disorder|ocular motility disorder
74367|NCT03099460|electroacupuncture|electroacupuncture
74368|NCT03099460|abducens nerve palsy|abducens nerve palsy
74369|NCT03099460|eyeball movement|eyeball movement
74370|NCT03099460|diplopia|diplopia
74371|NCT03099460|ocular motility disorder|ocular motility disorder
74372|NCT03099447|electroacupuncture|electroacupuncture
74373|NCT03099447|oculomotor nerve palsy|oculomotor nerve palsy
74374|NCT03099447|rehabilitation|rehabilitation
74375|NCT03099447|diplopia|diplopia
74376|NCT03099447|ocular motility disorder|ocular motility disorder
74377|NCT03099434|Live Donor Transplant, Social Media, Education, Advocacy, Live Donor|live donor transplant, social media, education, advocacy, live donor
74378|NCT03099421|Benign prostatic obstruction|benign prostatic obstruction
74379|NCT03099421|benign prostatic enlargement|benign prostatic enlargement
74380|NCT03099421|benign prostatic hyperplasia|benign prostatic hyperplasia
74381|NCT03099421|prostatic artery embolization|prostatic artery embolization
74382|NCT03099421|Quality of Life|quality of life
74383|NCT03099421|IPSS|ipss
74384|NCT03099421|DAN-PSS|dan-pss
74385|NCT03099421|Complications|complications
74386|NCT03099408|Recurrence|recurrence
74387|NCT03099408|Lactobacillus Vaginal Suppositories|lactobacillus vaginal suppositories
74388|NCT03099395|myocardial infarction|myocardial infarction
74389|NCT03099369|Peripheral Artery Disease|peripheral artery disease
74390|NCT03099369|Peripheral Arterial Disease|peripheral arterial disease
74391|NCT03099369|Exercise|exercise
74392|NCT03099369|Step Count|step count
74393|NCT03099369|Fitness Monitor|fitness monitor
74394|NCT03099369|Mobile Health|mobile health
74395|NCT03099369|Walking Ability|walking ability
74396|NCT03099369|Quality of Life|quality of life
74397|NCT03099343|sodium|sodium
74398|NCT03099343|salt|salt
74399|NCT03099343|diet|diet
74400|NCT03099343|tailored messaging|tailored messaging
74401|NCT03099343|mobile application|mobile application
74402|NCT03099317|Knee Osteoarthritis|knee osteoarthritis
74403|NCT03099317|Sinew Acupuncture|sinew acupuncture
74404|NCT03099317|Pain|pain
74405|NCT03099304|Vitiligo|vitiligo
74406|NCT03099304|depigmenting disorder|depigmenting disorder
74407|NCT03099304|topical JAK inhibitor|topical jak inhibitor
74408|NCT03099278|hepatitis D|hepatitis d
74409|NCT03099278|Ezetimibe|ezetimibe
74410|NCT03099278|HDV RNA|hdv rna
74411|NCT03099161|Advanced Solid Tumor|advanced solid tumor
74412|NCT03099161|Programmed Cell Death Receptor 1 (PD-1)|programmed cell death receptor 1 (pd-1)
74413|NCT03099161|Programmed Cell Death Receptor Ligand 1 (PD-L1)|programmed cell death receptor ligand 1 (pd-l1)
74415|NCT03099161|PD-1|pd-1
74416|NCT03099161|PDL1|pdl1
74417|NCT03099161|PD-L1|pd-l1
74418|NCT03099109|TIM-3|tim-3
74419|NCT03099109|PD-L1|pd-l1
74420|NCT03099096|SB240563|sb240563
74421|NCT03099096|Mepolizumab|mepolizumab
74422|NCT03099096|self-administration|self-administration
74423|NCT03099096|eosinophilic asthma|eosinophilic asthma
74424|NCT03099096|autoinjector|autoinjector
74425|NCT03099083|Psoriasis|psoriasis
74426|NCT03099083|Adalimumab|adalimumab
74427|NCT03099083|Humira|humira
74428|NCT03099083|Korea|korea
74429|NCT03099070|Stress|stress
74430|NCT03099070|Fasting|fasting
74431|NCT03099070|Migraine|migraine
74432|NCT03099031|Ottawa score|ottawa score
74433|NCT03099031|tinzaparin|tinzaparin
74434|NCT03099031|low-molecular weight heparin|low-molecular weight heparin
74435|NCT03099031|anticoagulants|anticoagulants
74436|NCT03099031|venous thrombosis|venous thrombosis
74437|NCT03099031|thromboembolism|thromboembolism
74438|NCT03099031|hemostatic disorders|hemostatic disorders
74439|NCT03099031|vascular disease|vascular disease
74440|NCT03099031|neoplasms|neoplasms
74441|NCT03099031|breast neoplasms|breast neoplasms
74442|NCT03099031|lung neoplasms|lung neoplasms
74443|NCT03099031|prostatic neoplasms|prostatic neoplasms
74444|NCT03099031|colorectal neoplasms|colorectal neoplasms
74445|NCT03099031|genital neoplasms|genital neoplasms
74446|NCT03099031|urogenital neoplasms|urogenital neoplasms
74447|NCT03099031|intestinal neoplasms|intestinal neoplasms
74448|NCT03099031|digestive system neoplasms|digestive system neoplasms
74449|NCT03099031|lymphoma|lymphoma
74450|NCT03099031|leukemia|leukemia
74451|NCT03099031|multiple myeloma|multiple myeloma
74452|NCT03099031|lymphoproliferative disorders|lymphoproliferative disorders
74453|NCT03099031|myeloproliferative disorders|myeloproliferative disorders
74454|NCT03099031|lymphatic disease|lymphatic disease
74455|NCT03099018|GAS|gas
74456|NCT03099018|pharyngitis|pharyngitis
74457|NCT03099018|children|children
74458|NCT03099018|RADT|radt
74459|NCT03099005|neuropathic pain|neuropathic pain
74460|NCT03099005|human immunovirus|human immunovirus
74461|NCT03099005|vaporized cannabis|vaporized cannabis
74462|NCT03098979|Chronic Heart Failure|chronic heart failure
74463|NCT03098979|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
74464|NCT03098953|Ocular Installation|ocular installation
74465|NCT03098927|Motor Imagery|motor imagery
74466|NCT03098927|Spinal Cord Injury|spinal cord injury
74467|NCT03098927|Motor Function Improvement|motor function improvement
74468|NCT03098914|Pathogen|pathogen
74469|NCT03098914|Mortality|mortality
74470|NCT03098914|Community-acquired Pneumonia|community-acquired pneumonia
74471|NCT03098914|Risk factors|risk factors
74472|NCT03098901|TTR Amyloidosis|ttr amyloidosis
74473|NCT03098901|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
74474|NCT03098901|Ventricular arrhythmia|ventricular arrhythmia
74475|NCT03098901|Cardiac Conduction Disturbances|cardiac conduction disturbances
74476|NCT03098888|side effects|side effects
74477|NCT03098888|decision making|decision making
74478|NCT03098888|indications|indications
74479|NCT03098888|risk factors|risk factors
74480|NCT03098862|Ebola Virus|ebola virus
74481|NCT03098862|Genome-Wide Association Study|genome-wide association study
74482|NCT03098862|Liberia|liberia
74483|NCT03098862|Ebola Survivors|ebola survivors
74484|NCT03098862|Ebola Contacts|ebola contacts
74485|NCT03098849|Buteyko-based breathing technique training|buteyko-based breathing technique training
74486|NCT03098836|metastatic|metastatic
74487|NCT03098836|castrate resistant|castrate resistant
74488|NCT03098797|Barth Syndrome|barth syndrome
74489|NCT03098797|elamipretide|elamipretide
74490|NCT03098797|MTP-131|mtp-131
74491|NCT03098797|Stealth|stealth
74492|NCT03098797|Stealth BT|stealth bt
74493|NCT03098797|BTHS|bths
74494|NCT03098784|airport environment|airport environment
74495|NCT03098784|Air France|air france
74496|NCT03098784|flightline employees|flightline employees
74497|NCT03098784|administrative employees|administrative employees
74498|NCT03098758|Polymerase Chain Reaction|polymerase chain reaction
74499|NCT03098758|gastric cancer|gastric cancer
74500|NCT03098758|citology|citology
74501|NCT03098758|peritoneal washing|peritoneal washing
74502|NCT03098758|CK20|ck20
74503|NCT03098758|CEA|cea
74504|NCT03098758|BER-EP4|ber-ep4
74505|NCT03098732|Stroke|stroke
74506|NCT03098732|Ischemic|ischemic
74507|NCT03098732|Tissue Plasminogen Activator|tissue plasminogen activator
74508|NCT03098732|Thrombolysis|thrombolysis
74509|NCT03098732|Vascular Diseases|vascular diseases
74510|NCT03098732|Cerebrovascular Disorders|cerebrovascular disorders
74511|NCT03098732|Fibrinolytic Agents|fibrinolytic agents
74512|NCT03098732|Plasminogen|plasminogen
74513|NCT03098693|Serodiscordant|serodiscordant
74514|NCT03098693|Pre-exposure Prophylaxis|pre-exposure prophylaxis
74515|NCT03098693|Self-testing|self-testing
74516|NCT03098693|Tanzania|tanzania
74517|NCT03098680|Adverse reactions|adverse reactions
74518|NCT03098680|Cardiovascular|cardiovascular
74519|NCT03098680|Translation|translation
74520|NCT03098680|Modelling|modelling
74521|NCT03098680|Pharmacokinetics|pharmacokinetics
74522|NCT03098680|Pharmacodynamics|pharmacodynamics
74523|NCT03098654|Human Immunodeficiency Virus|human immunodeficiency virus
74524|NCT03098654|Community Health Services|community health services
74525|NCT03098654|Chronic Disease|chronic disease
74526|NCT03098654|Integrated Delivery of Health Care|integrated delivery of health care
74527|NCT03098654|Tanzania|tanzania
74528|NCT03098589|Adult T-cell Leukemia Lymphoma|adult t-cell leukemia lymphoma
74529|NCT03098589|Teratogenicity|teratogenicity
74530|NCT03098589|Myelosuppression|myelosuppression
74531|NCT03098589|Haemorrhage|haemorrhage
74532|NCT03098589|Infection|infection
74533|NCT03098589|Thromboembolism|thromboembolism
74534|NCT03098589|Hypersensitivity|hypersensitivity
74535|NCT03098589|Tumor lysis syndrome|tumor lysis syndrome
74536|NCT03098589|Peripheral neuropathy|peripheral neuropathy
74537|NCT03098589|Ischaemic heart disease|ischaemic heart disease
74538|NCT03098589|Cardiac failure|cardiac failure
74539|NCT03098589|Arrhythmia|arrhythmia
74540|NCT03098589|Renal failure|renal failure
74541|NCT03098589|Interstitial lung disease|interstitial lung disease
74542|NCT03098589|Hepatic disorder|hepatic disorder
74543|NCT03098589|Hypothyroidism|hypothyroidism
74544|NCT03098589|Gastrointestinal perforation|gastrointestinal perforation
74545|NCT03098589|Orthostatic hypotension|orthostatic hypotension
74546|NCT03098589|Convulsion|convulsion
74547|NCT03098589|Somnolence|somnolence
74548|NCT03098589|Confusion|confusion
74549|NCT03098589|Fatigue|fatigue
74550|NCT03098589|Dizziness|dizziness
74551|NCT03098589|Blurred vision|blurred vision
74552|NCT03098589|Second primary cancer|second primary cancer
74553|NCT03098589|Cataract|cataract
74554|NCT03098589|Revlimid capsules|revlimid capsules
74555|NCT03098576|advanced|advanced
74556|NCT03098576|metastatic solid tumors|metastatic solid tumors
74557|NCT03098563|Clinical Trial|clinical trial
74558|NCT03098563|Phase II|phase ii
74559|NCT03098550|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
74560|NCT03098550|Triple Negative Breast Cancer (TNBC)|triple negative breast cancer (tnbc)
74561|NCT03098550|Pancreatic Cancer (PAC)|pancreatic cancer (pac)
74562|NCT03098524|Cardiac surgery|cardiac surgery
74563|NCT03098524|Mechanical ventilation|mechanical ventilation
74564|NCT03098524|Cardiopulmonary bypass|cardiopulmonary bypass
74565|NCT03098524|Pneumonia|pneumonia
74566|NCT03098524|Atelectasis|atelectasis
74567|NCT03098511|Neurological Determination of Death|neurological determination of death
74568|NCT03098511|Determination of Death|determination of death
74569|NCT03098511|CT-Perfusion scan|ct-perfusion scan
74570|NCT03098511|Ancillary Test|ancillary test
74571|NCT03098511|Organ Donation|organ donation
74572|NCT03098498|periodontitis|periodontitis
74573|NCT03098498|scaling|scaling
74574|NCT03098498|attachment gain|attachment gain
74575|NCT03098498|air polishing|air polishing
74576|NCT03098498|periodontal lesion|periodontal lesion
74577|NCT03098459|Delirium|delirium
74578|NCT03098459|Cognitive Impairment|cognitive impairment
74579|NCT03098459|Alzheimer's Disease|alzheimer's disease
74580|NCT03098459|Encephalopathy|encephalopathy
74581|NCT03098459|Trauma|trauma
74582|NCT03098459|Polytrauma|polytrauma
74583|NCT03098459|ICU|icu
74584|NCT03098459|Critical Illness|critical illness
74585|NCT03098459|Traumatic Brain Injury|traumatic brain injury
74586|NCT03098459|INSIGHT-ICU|insight-icu
74587|NCT03098459|INSIGHT|insight
74588|NCT03098459|Intracerebral hemorrhage|intracerebral hemorrhage
74589|NCT03098459|Subarachnoid hemorrhage|subarachnoid hemorrhage
74590|NCT03098459|Neurotrauma|neurotrauma
74591|NCT03098459|Neuropsychology|neuropsychology
74592|NCT03098459|Dementia|dementia
74593|NCT03098459|Critical Care|critical care
74594|NCT03098459|Subdural hemorrhage|subdural hemorrhage
74595|NCT03098459|Cognition|cognition
74596|NCT03098459|Neuropsychological Outcomes|neuropsychological outcomes
74597|NCT03098459|Neuropsychology Dysfunction|neuropsychology dysfunction
74598|NCT03098459|Inflammation|inflammation
74599|NCT03098459|Neuroinflammation|neuroinflammation
74600|NCT03098459|Inflammatory Mechanisms|inflammatory mechanisms
74601|NCT03098459|Burn|burn
74602|NCT03098459|Critically Injured|critically injured
74603|NCT03098459|Injury|injury
74604|NCT03098459|Head Injury|head injury
74605|NCT03098459|Long-term Cognitive Impairment|long-term cognitive impairment
74606|NCT03098459|ICU-related Dementia|icu-related dementia
74607|NCT03098459|Employment|employment
74608|NCT03098459|Return to Work|return to work
74609|NCT03098394|Rapid turnaround test|rapid turnaround test
74610|NCT03098394|RTAT|rtat
74611|NCT03098394|Gonorrhea|gonorrhea
74612|NCT03098394|Chlamydia|chlamydia
74613|NCT03098394|STI|sti
74614|NCT03098368|Parkinson's disease|parkinson's disease
74615|NCT03098368|Rotigotine transdermal patch|rotigotine transdermal patch
74616|NCT03098368|Nocturnal hypokinesia|nocturnal hypokinesia
74617|NCT03098355|CART|cart
74618|NCT03098355|CD19|cd19
74619|NCT03098355|CD22|cd22
74620|NCT03098355|Interleukin-2|interleukin-2
74621|NCT03098342|Onychomycosis|onychomycosis
74622|NCT03098342|photodynamic therapy|photodynamic therapy
74623|NCT03098342|methylene blue|methylene blue
74624|NCT03098342|amorolfine, nail lacquer|amorolfine, nail lacquer
74625|NCT03098342|Asians|asians
74626|NCT03098329|Screening|screening
74627|NCT03098329|men|men
74628|NCT03098329|expedited treatment|expedited treatment
74629|NCT03098316|Cross sectional studies|cross sectional studies
74630|NCT03098316|Metabolomics|metabolomics
74631|NCT03098316|Glaucoma|glaucoma
74632|NCT03098316|Low tension glaucoma|low tension glaucoma
74633|NCT03098316|Ophthalmologic surgical procedures|ophthalmologic surgical procedures
74634|NCT03098290|GermanVasc|germanvasc
74635|NCT03098290|Peripheral Arterial Disease|peripheral arterial disease
74636|NCT03098290|IDOMENEO|idomeneo
74637|NCT03098290|Routine Data|routine data
74638|NCT03098290|Registry Data|registry data
74639|NCT03098290|Data Validity|data validity
74640|NCT03098199|Antimullerian Hormone|antimullerian hormone
74641|NCT03098199|In vitro fertilization|in vitro fertilization
74642|NCT03098199|Medications|medications
74643|NCT03098199|Dosing|dosing
74644|NCT03098186|Medication adherence|medication adherence
74645|NCT03098186|mHealth|mhealth
74646|NCT03098173|Early colonoscopy|early colonoscopy
74647|NCT03098173|Stigmata of recent hemorrhage|stigmata of recent hemorrhage
74648|NCT03098173|Rebleeding|rebleeding
74649|NCT03098160|Immunotherapy|immunotherapy
74650|NCT03098160|Hypoxia|hypoxia
74651|NCT03098160|Evofosfamide|evofosfamide
74652|NCT03098160|Ipilimumab|ipilimumab
74653|NCT03098160|TH-302|th-302
74654|NCT03098069|Kangaroo Mother Care|kangaroo mother care
74655|NCT03098069|Low Birth Weight|low birth weight
74656|NCT03098069|Implementation research|implementation research
74657|NCT03098043|Hypothermic machine perfusion|hypothermic machine perfusion
74658|NCT03098043|Donation after circulatory death|donation after circulatory death
74659|NCT03098043|Extended criteria liver grafts|extended criteria liver grafts
74660|NCT03098030|Dinutuximab|dinutuximab
74661|NCT03098030|Irinotecan|irinotecan
74662|NCT03098030|Topotecan|topotecan
74663|NCT03097991|Coparenting Unmarried African-American Prenatal|coparenting unmarried african-american prenatal
74664|NCT03097913|nasotracheal intubation|nasotracheal intubation
74665|NCT03097913|video-stylet|video-stylet
74666|NCT03097913|nasal cavity injury|nasal cavity injury
74667|NCT03097900|Postoperative Ileus|postoperative ileus
74668|NCT03097900|Caffeine Citrate|caffeine citrate
74669|NCT03097887|Omega Loop Gastric Bypass|omega loop gastric bypass
74670|NCT03097887|Reflux|reflux
74671|NCT03097887|Mini Gastric Bypass|mini gastric bypass
74672|NCT03097874|anorexia|anorexia
74673|NCT03097874|anorexia nervosa|anorexia nervosa
74674|NCT03097874|eating disorder|eating disorder
74675|NCT03097874|weight|weight
74676|NCT03097874|eating|eating
74677|NCT03097874|weight loss|weight loss
74678|NCT03097874|family based treatment|family based treatment
74679|NCT03097874|FBT|fbt
74680|NCT03097874|family treatment|family treatment
74681|NCT03097874|therapy|therapy
74682|NCT03097874|Maudsley method|maudsley method
74683|NCT03097783|hyaluronic acid, midface|hyaluronic acid, midface
74684|NCT03097757|Ultrasound|ultrasound
74685|NCT03097757|Forearm Fracture Reduction|forearm fracture reduction
74686|NCT03097757|Pediatric Emergency Department|pediatric emergency department
74687|NCT03097744|Lateral Meniscus Tear|lateral meniscus tear
74688|NCT03097744|Medial Meniscus Tear|medial meniscus tear
74689|NCT03097731|interleukin-10|interleukin-10
74690|NCT03097731|inflammatory bowel disease|inflammatory bowel disease
74691|NCT03097692|cardiac preconditioning|cardiac preconditioning
74692|NCT03097692|open heart surgery|open heart surgery
74693|NCT03097692|createnine|createnine
74694|NCT03097692|inflammation|inflammation
74695|NCT03097653|breast cancer screening|breast cancer screening
74696|NCT03097653|mammography|mammography
74697|NCT03097653|decision-aid|decision-aid
74698|NCT03097653|informed choice|informed choice
74699|NCT03097653|National Cancer Screening Program|national cancer screening program
74700|NCT03097627|Indocyanine Green|indocyanine green
74701|NCT03097627|Near-infrared imaging|near-infrared imaging
74702|NCT03097575|Lung lesions|lung lesions
74703|NCT03097575|Navigational bronchoscopy|navigational bronchoscopy
74704|NCT03097575|Near infrared imaging|near infrared imaging
74705|NCT03097575|Lymphadenectomy|lymphadenectomy
74706|NCT03097562|Cataract|cataract
74707|NCT03097562|Femtosecond laser|femtosecond laser
74708|NCT03097562|Cornea|cornea
74709|NCT03097562|Anatomy|anatomy
74710|NCT03097562|FSL|fsl
74711|NCT03097562|surgery|surgery
74712|NCT03097549|urinary incontinence|urinary incontinence
74713|NCT03097549|urgency urinary incontinence|urgency urinary incontinence
74714|NCT03097549|mixed urinary incontinence|mixed urinary incontinence
74715|NCT03097549|smartphone application|smartphone application
74716|NCT03097549|ehealth|ehealth
74717|NCT03097549|mhealth|mhealth
74718|NCT03097549|randomized controlled trial|randomized controlled trial
74719|NCT03097549|self management|self management
74720|NCT03097549|treatment|treatment
74721|NCT03097536|Blood Sugar|blood sugar
74722|NCT03097523|NSBRI|nsbri
74723|NCT03097510|Perceived stress|perceived stress
74724|NCT03097510|Leadership|leadership
74725|NCT03097510|Transcendental Meditation|transcendental meditation
74726|NCT03097497|Chronic Non-specific Low-Back Pain|chronic non-specific low-back pain
74727|NCT03097497|Chronic Low-Back Pain|chronic low-back pain
74728|NCT03097497|Physiotherapy|physiotherapy
74729|NCT03097497|Therapeutic Exercise|therapeutic exercise
74730|NCT03097497|Primary Care|primary care
74731|NCT03097497|Transverse Abdominal Muscle|transverse abdominal muscle
74732|NCT03097458|Counselling for Families|counselling for families
74733|NCT03097458|Parental cancer|parental cancer
74734|NCT03097458|Psychological distress and adjustment|psychological distress and adjustment
74735|NCT03097445|Smoking|smoking
74736|NCT03097445|Nicotine|nicotine
74737|NCT03097445|Nicotine Replacement Therapy|nicotine replacement therapy
74738|NCT03097445|Nicotine Patch|nicotine patch
74739|NCT03097445|Mass Distribution|mass distribution
74740|NCT03097445|Tobacco Control|tobacco control
74741|NCT03097445|Cancer Prevention|cancer prevention
74742|NCT03097445|Randomized Controlled Trial|randomized controlled trial
74743|NCT03097419|non-ST segment elevation myocardial infarction|non-st segment elevation myocardial infarction
74744|NCT03097419|myocardial infarction|myocardial infarction
74745|NCT03097419|remote ischemic conditioning|remote ischemic conditioning
74746|NCT03097419|ischemic conditioning|ischemic conditioning
74747|NCT03097419|sphygmomanometer|sphygmomanometer
74748|NCT03097419|metabolomics|metabolomics
74749|NCT03097380|Healthy volunteer study|healthy volunteer study
74750|NCT03097367|laparoscopic radical prostatectomy|laparoscopic radical prostatectomy
74751|NCT03097367|urinary incontinence|urinary incontinence
74752|NCT03097367|prostate cancer|prostate cancer
74753|NCT03097367|bladder neck level|bladder neck level
74754|NCT03097367|urodynamics|urodynamics
74755|NCT03097354|alcohol use|alcohol use
74756|NCT03097354|consumption measure|consumption measure
74757|NCT03097354|Composite International Diagnostic Interview (CIDI)|composite international diagnostic interview (cidi)
74758|NCT03097354|internet survey|internet survey
74759|NCT03097354|standardized assessment|standardized assessment
74760|NCT03097328|Renal Cell Carcinoma|renal cell carcinoma
74761|NCT03097315|Uveitis|uveitis
74762|NCT03097315|UME|ume
74763|NCT03097315|Posterior Uveitis|posterior uveitis
74764|NCT03097315|Anterior Uveitis|anterior uveitis
74765|NCT03097315|Intermediate Uveitis|intermediate uveitis
74766|NCT03097315|Panuveitis|panuveitis
74767|NCT03097315|Non-infectious Uveitis|non-infectious uveitis
74768|NCT03097315|Triamcinolone|triamcinolone
74769|NCT03097315|Choroid|choroid
74770|NCT03097315|Choroidal Injection|choroidal injection
74771|NCT03097315|Suprachoroidal|suprachoroidal
74772|NCT03097315|Microneedle|microneedle
74773|NCT03097315|Microinjection|microinjection
74774|NCT03097302|laser-assisted keratotomy|laser-assisted keratotomy
74775|NCT03097302|anterior astigmatism|anterior astigmatism
74776|NCT03097302|posterior astigmatism|posterior astigmatism
74777|NCT03097302|total corneal refractive power|total corneal refractive power
74778|NCT03097302|nomogram|nomogram
74779|NCT03097289|Healthy Adults|healthy adults
74780|NCT03097250|PKU|pku
74781|NCT03097250|Neuropsychology|neuropsychology
74782|NCT03097250|MRI|mri
74783|NCT03097198|Juvenile|juvenile
74784|NCT03097198|Traditional Chinese Medicine|traditional chinese medicine
74785|NCT03097198|Plum-blossom needle|plum-blossom needle
74786|NCT03097185|pancreatitis|pancreatitis
74787|NCT03097185|islet cell|islet cell
74788|NCT03097172|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
74789|NCT03097172|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
74790|NCT03097172|Cardiac MRI|cardiac mri
74791|NCT03097172|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
74792|NCT03097172|Doppler Flow Velocity|doppler flow velocity
74793|NCT03097172|Cardiovascular Disease|cardiovascular disease
74794|NCT03097172|Atherosclerosis|atherosclerosis
74795|NCT03097172|Hydrostatic Pressure|hydrostatic pressure
74796|NCT03097159|costoclavicular block|costoclavicular block
74797|NCT03097146|Stroke|stroke
74798|NCT03097146|Aftercare|aftercare
74799|NCT03097146|Comprehensive Care|comprehensive care
74800|NCT03097107|hypertriglyceridemia|hypertriglyceridemia
74801|NCT03097107|dyslipidemia|dyslipidemia
74802|NCT03097107|saroglitazar magnesium|saroglitazar magnesium
74803|NCT03097107|lipid disorder|lipid disorder
74804|NCT03097094|Dog allergy|dog allergy
74805|NCT03097094|Can f 5|can f 5
74806|NCT03097094|Male dog|male dog
74807|NCT03097094|Female dog|female dog
74808|NCT03097094|Allergen components|allergen components
74809|NCT03097055|Stroke|stroke
74810|NCT03097055|Acupuncture|acupuncture
74811|NCT03097055|antiinflammatory|antiinflammatory
74812|NCT03097055|NIHSS|nihss
74813|NCT03097029|pancreatic enzymes|pancreatic enzymes
74814|NCT03097016|Renal Impairment|renal impairment
74815|NCT03097016|Pharmacokinetics|pharmacokinetics
74816|NCT03097016|CC-122|cc-122
74817|NCT03097016|Mild|mild
74818|NCT03097016|Moderate|moderate
74819|NCT03097016|Severe|severe
74820|NCT03097003|Proriasis|proriasis
74821|NCT03097003|Real-life management|real-life management
74822|NCT03097003|Observational|observational
74823|NCT03097003|Otezla|otezla
74824|NCT03097003|CC-10004|cc-10004
74825|NCT03097003|Apremilast|apremilast
74826|NCT03097003|Belgium|belgium
74827|NCT03097003|OTELO|otelo
74828|NCT03096990|Psoriatic Arthritis|psoriatic arthritis
74829|NCT03096990|Observational|observational
74830|NCT03096990|Otezla|otezla
74831|NCT03096990|Apremilast|apremilast
74832|NCT03096990|Real-Life management|real-life management
74833|NCT03096990|Belgium|belgium
74834|NCT03096990|APOLO|apolo
74835|NCT03096990|CC-10004|cc-10004
74836|NCT03096977|Hand dexterity|hand dexterity
74837|NCT03096977|Multiple sclerosis|multiple sclerosis
74838|NCT03096977|Nine Holes Peg|nine holes peg
74839|NCT03096964|Elderly training|elderly training
74840|NCT03096964|Pole walking|pole walking
74841|NCT03096964|Locomotor Rehabilitation Index|locomotor rehabilitation index
74842|NCT03096964|Self-selected speed of walking|self-selected speed of walking
74843|NCT03096964|Recovery|recovery
74844|NCT03096938|cell-free DNA|cell-free dna
74845|NCT03096938|methylation|methylation
74846|NCT03096938|markers|markers
74847|NCT03096938|cancer|cancer
74848|NCT03096938|screening|screening
74849|NCT03096925|non-cardiac chest pain|non-cardiac chest pain
74850|NCT03096925|anxiety|anxiety
74851|NCT03096912|CDK4 inhibitor|cdk4 inhibitor
74852|NCT03096912|LEE011|lee011
74853|NCT03096912|ribociclib|ribociclib
74854|NCT03096912|liposarcoma dedifferentiated|liposarcoma dedifferentiated
74855|NCT03096912|liposarcoma well differentiated|liposarcoma well differentiated
74856|NCT03096886|Cognitive Behavioral Therapy|cognitive behavioral therapy
74857|NCT03096886|Computer-Assisted Cognitive Behavioral Therapy|computer-assisted cognitive behavioral therapy
74858|NCT03096886|Computer-Augmented Cognitive Behavioral Therapy|computer-augmented cognitive behavioral therapy
74859|NCT03096886|CBT|cbt
74860|NCT03096886|Computer-Assisted CBT|computer-assisted cbt
74861|NCT03096886|Computer-Augmented CBT|computer-augmented cbt
74862|NCT03096847|ribociclib|ribociclib
74863|NCT03096847|LEE011|lee011
74864|NCT03096847|RIBECCA|ribecca
74865|NCT03096847|breast cancer|breast cancer
74866|NCT03096847|breast carcinoma|breast carcinoma
74867|NCT03096847|HR-positive|hr-positive
74868|NCT03096847|HER2-negative|her2-negative
74869|NCT03096847|advanced breast cancer|advanced breast cancer
74870|NCT03096847|Letrozole|letrozole
74871|NCT03096847|CDK4/6|cdk4/6
74872|NCT03096834|Migraine|migraine
74873|NCT03096834|attack|attack
74874|NCT03096834|headache|headache
74875|NCT03096834|episodic|episodic
74876|NCT03096834|aura|aura
74877|NCT03096834|AMG 334|amg 334
74878|NCT03096834|CGRP receptor agonist|cgrp receptor agonist
74879|NCT03096834|erenumab|erenumab
74880|NCT03096808|adaptive radiotherapy|adaptive radiotherapy
74881|NCT03096808|ART|art
74882|NCT03096808|intensity modulated radiation therapy|intensity modulated radiation therapy
74883|NCT03096808|IMRT|imrt
74884|NCT03096795|MEDI3506|medi3506
74885|NCT03096795|Safety|safety
74886|NCT03096795|Tolerability|tolerability
74887|NCT03096795|Pharmacokinetics|pharmacokinetics
74888|NCT03096795|Immunogenicity|immunogenicity
74889|NCT03096782|Acute Myelogenous Leukemia|acute myelogenous leukemia
74890|NCT03096782|AML|aml
74891|NCT03096782|Myelodysplastic Syndrome|myelodysplastic syndrome
74892|NCT03096782|MDS|mds
74893|NCT03096782|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
74894|NCT03096782|ALL|all
74895|NCT03096782|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
74896|NCT03096782|NHL|nhl
74897|NCT03096782|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
74898|NCT03096782|SLL|sll
74899|NCT03096782|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
74900|NCT03096782|CLL|cll
74901|NCT03096782|Hodgkin's Disease|hodgkin's disease
74902|NCT03096782|HD|hd
74903|NCT03096782|Busulfan|busulfan
74904|NCT03096782|Busulfex|busulfex
74905|NCT03096782|Myleran|myleran
74906|NCT03096782|Rituximab|rituximab
74907|NCT03096782|Rituxan|rituxan
74908|NCT03096782|ATG|atg
74909|NCT03096782|ATG(rabbit)|atg(rabbit)
74910|NCT03096782|Rabbit Antithymocyte Globulin|rabbit antithymocyte globulin
74911|NCT03096782|Rabbit Antilymphocyte Globulin|rabbit antilymphocyte globulin
74912|NCT03096782|Rabbit ATG|rabbit atg
74913|NCT03096782|rATg|ratg
74914|NCT03096782|Thymoglobulin|thymoglobulin
74915|NCT03096782|Fludarabine|fludarabine
74916|NCT03096782|Fludarabine Phosphate|fludarabine phosphate
74917|NCT03096782|Fludara|fludara
74918|NCT03096782|Clofarabine|clofarabine
74919|NCT03096782|Clofarex|clofarex
74920|NCT03096782|Clolar|clolar
74921|NCT03096782|Total Body Irradiation|total body irradiation
74922|NCT03096782|TBI|tbi
74923|NCT03096782|XRT|xrt
74924|NCT03096782|External Beam Radiotherapy|external beam radiotherapy
74925|NCT03096782|Mycophenolate Mofetil|mycophenolate mofetil
74926|NCT03096782|MMF|mmf
74927|NCT03096782|CellCept|cellcept
74928|NCT03096782|Tacrolimus|tacrolimus
74929|NCT03096782|Prograf|prograf
74930|NCT03096782|G-CSF|g-csf
74931|NCT03096782|Filgrastim|filgrastim
74932|NCT03096782|Neupogen|neupogen
74933|NCT03096782|Melphalan|melphalan
74934|NCT03096782|Alkeran|alkeran
74935|NCT03096782|Cyclophosphamide|cyclophosphamide
74936|NCT03096782|Cytoxan|cytoxan
74937|NCT03096782|Neosar|neosar
74938|NCT03096782|Mesna|mesna
74939|NCT03096782|Mesnex|mesnex
74940|NCT03096782|Cord Blood Transplantation|cord blood transplantation
74941|NCT03096782|Stem Cell Transplant|stem cell transplant
74942|NCT03096756|Oral Formulation|oral formulation
74943|NCT03096756|Food Effect|food effect
74944|NCT03096756|Superoxide Dismutase|superoxide dismutase
74945|NCT03096756|Single Ascending Dose|single ascending dose
74946|NCT03096756|GC4702|gc4702
74947|NCT03096756|Bioavailability|bioavailability
74948|NCT03096756|Pharmacokinetics|pharmacokinetics
74949|NCT03096756|Active Comparator|active comparator
74950|NCT03096730|Remifentanil|remifentanil
74951|NCT03096730|Opioid-induced hyperalgesia|opioid-induced hyperalgesia
74952|NCT03096730|Postoperative pain|postoperative pain
74953|NCT03096730|pain intensity|pain intensity
74954|NCT03096691|cervical pessary|cervical pessary
74955|NCT03096691|preterm labor|preterm labor
74956|NCT03096691|Cervical insufficiency|cervical insufficiency
74957|NCT03096678|Left Bundle Branch Block|left bundle branch block
74958|NCT03096678|Regional/Globle cardiac function|regional/globle cardiac function
74959|NCT03096678|Mechanical asynchrony|mechanical asynchrony
74960|NCT03096678|Cardiovascular Magnetic Resonance|cardiovascular magnetic resonance
74961|NCT03096678|Outcome|outcome
74962|NCT03096678|Cardiovascular events|cardiovascular events
74963|NCT03096665|venous blood|venous blood
74964|NCT03096665|arterial blood|arterial blood
74965|NCT03096665|capillary blood|capillary blood
74966|NCT03096652|gynecologic cancer - panniculectomy|gynecologic cancer - panniculectomy
74967|NCT03096639|Diaphragm atrophy|diaphragm atrophy
74968|NCT03096639|VIDD|vidd
74969|NCT03096639|Weaning failure|weaning failure
74970|NCT03096626|Depression|depression
74971|NCT03096613|heart failure|heart failure
74972|NCT03096613|Subclinical Hypothyroidism|subclinical hypothyroidism
74973|NCT03096613|levothyroxine|levothyroxine
74974|NCT03096613|6-minute walk test|6-minute walk test
74975|NCT03096600|spine|spine
74976|NCT03096587|XP Endo Finisher|xp endo finisher
74977|NCT03096587|ultrasonic activated irrigation|ultrasonic activated irrigation
74978|NCT03096587|postoperative pain|postoperative pain
74979|NCT03096574|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
74980|NCT03096574|Maternal vaccination|maternal vaccination
74981|NCT03096574|Attitudes|attitudes
74982|NCT03096574|Pregnancy|pregnancy
74983|NCT03096548|Skin Cancer|skin cancer
74984|NCT03096548|Tattoo|tattoo
74985|NCT03096496|Quality of life|quality of life
74986|NCT03096496|acute promyelocytic leukemia|acute promyelocytic leukemia
74987|NCT03096496|ATO|ato
74988|NCT03096457|leishmaniasis|leishmaniasis
74989|NCT03096457|L.braziliensis|l.braziliensis
74990|NCT03096457|paromomycin cream|paromomycin cream
74991|NCT03096457|intralesional pentamidine|intralesional pentamidine
74992|NCT03096457|leishmaniasis local therapy|leishmaniasis local therapy
74993|NCT03096431|whole-brain radiation therapy|whole-brain radiation therapy
74994|NCT03096431|sterotactic radiosurgery|sterotactic radiosurgery
74995|NCT03096431|cognitive rehabilitation|cognitive rehabilitation
74996|NCT03096431|physical activity|physical activity
74997|NCT03096379|TB|tb
74998|NCT03096379|CD|cd
74999|NCT03096379|MRE|mre
75000|NCT03096379|ileocecal|ileocecal
75001|NCT03096366|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
75002|NCT03096353|NALOXONE|naloxone
75003|NCT03096353|fMRI|fmri
75004|NCT03096353|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
75005|NCT03096340|SN-38|sn-38
75006|NCT03096340|irinotecan|irinotecan
75007|NCT03096327|Quality of Life|quality of life
75008|NCT03096327|Asthma control test|asthma control test
75009|NCT03096327|Montelukast|montelukast
75010|NCT03096327|Asthma|asthma
75011|NCT03096314|ARDS|ards
75012|NCT03096314|Vitamin D|vitamin d
75013|NCT03096301|temporomandibular disorder|temporomandibular disorder
75014|NCT03096301|photobiomodulation|photobiomodulation
75015|NCT03096301|pain|pain
75016|NCT03096275|Mycophenolate mofetil|mycophenolate mofetil
75017|NCT03096275|Methotrexate|methotrexate
75018|NCT03096275|cyclophosphamide|cyclophosphamide
75019|NCT03096262|cognitive skills|cognitive skills
75020|NCT03096262|technical|technical
75021|NCT03096262|internet platform|internet platform
75022|NCT03096262|Stroke|stroke
75023|NCT03096262|Hemiparesis|hemiparesis
75024|NCT03096249|oxytocin|oxytocin
75025|NCT03096249|emotion recognition|emotion recognition
75026|NCT03096249|emotion processing|emotion processing
75027|NCT03096249|social salience|social salience
75028|NCT03096249|face processing|face processing
75029|NCT03096249|Electroencephalography (EEG)|electroencephalography (eeg)
75030|NCT03096210|Maxillar sinus|maxillar sinus
75031|NCT03096210|Titanium-Prepared Platelet Rich Fibrin|titanium-prepared platelet rich fibrin
75032|NCT03096210|Allograft|allograft
75033|NCT03096210|implant|implant
75034|NCT03096197|Spinal Cord injury (SCI)|spinal cord injury (sci)
75035|NCT03096197|Transcutaneous lumbosacral stimulation (TLS)|transcutaneous lumbosacral stimulation (tls)
75036|NCT03096197|Exoskeleton-Assisted Walking (EAW)|exoskeleton-assisted walking (eaw)
75037|NCT03096184|head and neck cancer|head and neck cancer
75038|NCT03096184|Apatinib|apatinib
75039|NCT03096184|Tegafur Gimeracil Oteracil|tegafur gimeracil oteracil
75040|NCT03096171|Stress|stress
75041|NCT03096171|Well-being|well-being
75042|NCT03096171|Positive Psychology|positive psychology
75043|NCT03096158|Coronary artery bypass grafting|coronary artery bypass grafting
75044|NCT03096158|Cardiorespiratory rehabilitation|cardiorespiratory rehabilitation
75045|NCT03096158|Functional electrical stimulation|functional electrical stimulation
75046|NCT03096158|Inspiratory muscle training|inspiratory muscle training
75047|NCT03096158|Aerobic training|aerobic training
75048|NCT03096158|Isometric handgrip training|isometric handgrip training
75049|NCT03096158|Functional capacity|functional capacity
75050|NCT03096158|Endothelial function|endothelial function
75051|NCT03096158|Cardiac function|cardiac function
75052|NCT03096145|tobacco|tobacco
75053|NCT03096145|quitlines|quitlines
75054|NCT03096145|social support|social support
75055|NCT03096145|mobile support|mobile support
75056|NCT03096132|Obesity|obesity
75057|NCT03096132|Overweight|overweight
75058|NCT03096132|Overeating|overeating
75059|NCT03096132|Body Mass Index|body mass index
75060|NCT03096132|Treatment|treatment
75061|NCT03096132|Intervention|intervention
75062|NCT03096132|Family Based Therapy|family based therapy
75063|NCT03096132|Weight|weight
75064|NCT03096132|Children|children
75065|NCT03096119|blood pressure monitoring, home|blood pressure monitoring, home
75066|NCT03096119|Asia|asia
75067|NCT03096093|Pancreatic|pancreatic
75068|NCT03096093|Late stage cancer|late stage cancer
75069|NCT03096093|Immunotherapy|immunotherapy
75070|NCT03096093|Phase I|phase i
75071|NCT03096093|Vaccination|vaccination
75072|NCT03096080|ARPKD|arpkd
75073|NCT03096080|Autosomal Recessive Polycystic Kidney Disease|autosomal recessive polycystic kidney disease
75074|NCT03096080|Pediatric Polycystic Kidney|pediatric polycystic kidney
75075|NCT03096080|Tesevatinib|tesevatinib
75076|NCT03096080|Polycystic Kidney Disease|polycystic kidney disease
75077|NCT03096041|auriculotherapy|auriculotherapy
75078|NCT03096041|aromatase inhibitors|aromatase inhibitors
75079|NCT03096041|adjuvant treatment|adjuvant treatment
75080|NCT03096028|maternal nutrition|maternal nutrition
75081|NCT03096028|neurocognitive development|neurocognitive development
75082|NCT03096028|brain volume|brain volume
75083|NCT03096002|PreDiabetes, Lifestyle intervention, Exercise Behavior, Adherence|prediabetes, lifestyle intervention, exercise behavior, adherence
75084|NCT03095989|mindfulness|mindfulness
75085|NCT03095976|Guided Tissue Regeneration,|guided tissue regeneration,
75086|NCT03095976|Amnion-Chorion,|amnion-chorion,
75087|NCT03095976|Intrabony defects,|intrabony defects,
75088|NCT03095976|furcation|furcation
75089|NCT03095950|Spin|spin
75090|NCT03095950|Misleading reporting|misleading reporting
75091|NCT03095950|Misleading interpretation|misleading interpretation
75092|NCT03095950|Misleading extrapolation|misleading extrapolation
75093|NCT03095950|Randomized controlled trials|randomized controlled trials
75094|NCT03095950|Patients|patients
75095|NCT03095924|Spin|spin
75096|NCT03095924|Misleading reporting|misleading reporting
75097|NCT03095924|Misleading interpretation|misleading interpretation
75098|NCT03095924|Misleading extrapolation|misleading extrapolation
75099|NCT03095924|Randomized controlled trials|randomized controlled trials
75100|NCT03095924|Patients|patients
75101|NCT03095911|Spin|spin
75102|NCT03095911|Misleading reporting|misleading reporting
75103|NCT03095911|Misleading interpretation|misleading interpretation
75104|NCT03095911|Misleading extrapolation|misleading extrapolation
75105|NCT03095911|Randomized controlled trials|randomized controlled trials
75106|NCT03095911|Patients|patients
75107|NCT03095898|Colonoscopy|colonoscopy
75108|NCT03095898|Acupuncture|acupuncture
75109|NCT03095885|Urine Oxalate|urine oxalate
75110|NCT03095885|Nephrolithiasis|nephrolithiasis
75111|NCT03095885|Kidney Stones|kidney stones
75112|NCT03095885|Hyperoxaluria|hyperoxaluria
75113|NCT03095885|Enteric Hyperoxaluria|enteric hyperoxaluria
75114|NCT03095885|urological Diseases|urological diseases
75115|NCT03095885|Kidney Diseases|kidney diseases
75116|NCT03095885|Dietary Oxalate|dietary oxalate
75117|NCT03095885|Idiopathic Hyperoxaluria|idiopathic hyperoxaluria
75118|NCT03095885|Oxalate Absorption|oxalate absorption
75119|NCT03095872|photodamaged skin|photodamaged skin
75120|NCT03095872|wound healing|wound healing
75121|NCT03095872|CO2 laser|co2 laser
75122|NCT03095820|Community|community
75123|NCT03095820|Depressive Symptoms|depressive symptoms
75124|NCT03095820|Mental Health Program|mental health program
75125|NCT03095820|Older adults|older adults
75126|NCT03095768|Lifestyle|lifestyle
75127|NCT03095768|Nutrition|nutrition
75128|NCT03095768|Cooking|cooking
75129|NCT03095742|Microdialysis|microdialysis
75130|NCT03095742|Cerebral metabolism|cerebral metabolism
75131|NCT03095742|Cardiac arrest|cardiac arrest
75132|NCT03095742|Intravenous|intravenous
75133|NCT03095742|Neurological prognosis|neurological prognosis
75134|NCT03095716|Carbon dioxide pneumoperitoneum|carbon dioxide pneumoperitoneum
75135|NCT03095716|Intraperitoneal pressure|intraperitoneal pressure
75136|NCT03095716|Post-operative recovery|post-operative recovery
75137|NCT03095716|Laparoscopic Humidification System|laparoscopic humidification system
75138|NCT03095703|Sirolimus|sirolimus
75139|NCT03095703|Intestinal adenomas|intestinal adenomas
75140|NCT03095690|Osteoporosis|osteoporosis
75141|NCT03095690|Parkinson|parkinson
75142|NCT03095690|HR-pQCT|hr-pqct
75143|NCT03095690|bone microstructure|bone microstructure
75144|NCT03095690|fracture risk|fracture risk
75145|NCT03095677|dynamic apnea|dynamic apnea
75146|NCT03095677|muscle oxygenation|muscle oxygenation
75147|NCT03095677|physical performance|physical performance
75148|NCT03095664|lifestyle intervention|lifestyle intervention
75149|NCT03095664|endometrial cancer|endometrial cancer
75150|NCT03095664|survival|survival
75151|NCT03095638|Dispersible tablets|dispersible tablets
75152|NCT03095638|Bioavailability|bioavailability
75153|NCT03095638|Dolutegravir|dolutegravir
75154|NCT03095638|Healthy|healthy
75155|NCT03095638|Conventional tablets|conventional tablets
75156|NCT03095625|Sepsis|sepsis
75157|NCT03095625|Bleeding disorder|bleeding disorder
75158|NCT03095625|Viscoelastic tests|viscoelastic tests
75159|NCT03095599|Influenza|influenza
75160|NCT03095599|Vaccine|vaccine
75161|NCT03095586|Spin|spin
75162|NCT03095586|Misleading reporting|misleading reporting
75163|NCT03095586|Misleading interpretation|misleading interpretation
75164|NCT03095586|Misleading extrapolation|misleading extrapolation
75165|NCT03095586|Randomized controlled trials|randomized controlled trials
75166|NCT03095586|Patients|patients
75167|NCT03095573|Celiac disease|celiac disease
75168|NCT03095573|Enteropathy associated T cell lymphoma|enteropathy associated t cell lymphoma
75169|NCT03095573|Refractory celiac disease|refractory celiac disease
75170|NCT03095573|Small bowel adenocarcinoma|small bowel adenocarcinoma
75171|NCT03095534|Occupational Therapy|occupational therapy
75172|NCT03095534|Aging in place|aging in place
75173|NCT03095534|Activities of daily living|activities of daily living
75174|NCT03095534|Community program|community program
75175|NCT03095521|Angal|angal
75176|NCT03095521|ANTI-ANGIN® FORMULA|anti-angin® formula
75177|NCT03095521|sore throat|sore throat
75178|NCT03095521|no less therapeutic efficacy|no less therapeutic efficacy
75179|NCT03095508|Angal S|angal s
75180|NCT03095508|ANTI-ANGIN FORMULA|anti-angin formula
75181|NCT03095508|Sore Throat|sore throat
75182|NCT03095508|no less therapeutic efficacy|no less therapeutic efficacy
75183|NCT03095495|Heated Humidified High Flow Nasal Cannula (HHHFNC)|heated humidified high flow nasal cannula (hhhfnc)
75184|NCT03095495|Low Flow Nasal Cannula|low flow nasal cannula
75185|NCT03095495|Bronchiolitis|bronchiolitis
75186|NCT03095495|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
75187|NCT03095495|Respiratory Failure|respiratory failure
75188|NCT03095495|High Flow Nasal Cannula (HFNC)|high flow nasal cannula (hfnc)
75189|NCT03095495|Lung Diseases, Obstructive|lung diseases, obstructive
75190|NCT03095482|Arachnophobia (fear of spiders)|arachnophobia (fear of spiders)
75191|NCT03095482|Ophidophobia (fear of snakes)|ophidophobia (fear of snakes)
75192|NCT03095482|Claustrophobia (fear of tightly enclosed spaces)|claustrophobia (fear of tightly enclosed spaces)
75193|NCT03095482|Germaphobia (fear of germs, dirtiness, and contamination)|germaphobia (fear of germs, dirtiness, and contamination)
75194|NCT03095456|Chronic Obstructive Pulmonary Disease, COPD, Low Peak Inspiratory Flow Rate|chronic obstructive pulmonary disease, copd, low peak inspiratory flow rate
75195|NCT03095443|Delirium|delirium
75196|NCT03095443|Critical Illness|critical illness
75197|NCT03095443|Music Therapy|music therapy
75198|NCT03095430|Trauma|trauma
75199|NCT03095430|General Anesthesia|general anesthesia
75200|NCT03095430|Surgical Pleth Index|surgical pleth index
75201|NCT03095430|Entropy|entropy
75202|NCT03095417|Delirium|delirium
75203|NCT03095417|Alzheimer's Disease|alzheimer's disease
75204|NCT03095417|Aging|aging
75205|NCT03095417|Exercise Therapy|exercise therapy
75206|NCT03095417|Cognitive Training|cognitive training
75207|NCT03095378|gingival recession|gingival recession
75208|NCT03095339|Burkina Faso|burkina faso
75209|NCT03095339|Community-based randomized controlled trial|community-based randomized controlled trial
75210|NCT03095339|Cysticercosis|cysticercosis
75211|NCT03095339|Implementation Research|implementation research
75212|NCT03095339|Effectiveness|effectiveness
75213|NCT03095313|Transcatheter Aortic Valve Replacement (TAVR).|transcatheter aortic valve replacement (tavr).
75214|NCT03095313|Surgical bioprosthetic aortic valve replacement|surgical bioprosthetic aortic valve replacement
75215|NCT03095300|Prone Position|prone position
75216|NCT03095300|High-flow oxygen therapy|high-flow oxygen therapy
75217|NCT03095287|Factor VIII|factor viii
75218|NCT03095287|von Willebrand Factor|von willebrand factor
75219|NCT03095287|Plasma-derived|plasma-derived
75220|NCT03095287|Inhibitors|inhibitors
75221|NCT03095287|Immune tolerance induction|immune tolerance induction
75223|NCT03095287|Antibodies|antibodies
75224|NCT03095287|Hemophilia A|hemophilia a
75225|NCT03095261|Cardiovascular Disease|cardiovascular disease
75226|NCT03095261|Cardiac Rehabilitation|cardiac rehabilitation
75227|NCT03095261|Financial Incentives|financial incentives
75228|NCT03095261|Outpatient (Phase II) Cardiac Rehabilitation Exercise Adherence|outpatient (phase ii) cardiac rehabilitation exercise adherence
75229|NCT03095235|keratoconus|keratoconus
75230|NCT03095235|cornea ectasia|cornea ectasia
75231|NCT03095183|Posterior oropharynx exam|posterior oropharynx exam
75232|NCT03095183|Pediatric|pediatric
75233|NCT03095183|Tongue Depressor|tongue depressor
75234|NCT03095183|Flavored Tongue Depressor|flavored tongue depressor
75235|NCT03095144|pyloromyotomy|pyloromyotomy
75236|NCT03095144|spinal anaesthesia|spinal anaesthesia
75237|NCT03095144|surgical outcomes|surgical outcomes
75238|NCT03095144|general anaesthesia|general anaesthesia
75240|NCT03095131|Heart Spectrum Blood Pressure MonitorHeart Spectrum|heart spectrum blood pressure monitorheart spectrum
75241|NCT03095079|endostar|endostar
75242|NCT03095079|dacarbazine|dacarbazine
75243|NCT03095079|cisplatin|cisplatin
75244|NCT03095066|aggression|aggression
75245|NCT03095066|agitation|agitation
75246|NCT03095066|irritability|irritability
75247|NCT03095066|non-penetrating brain injury|non-penetrating brain injury
75248|NCT03095066|traumatic brain injury|traumatic brain injury
75249|NCT03095066|TBI|tbi
75250|NCT03095066|AVP-786|avp-786
75251|NCT03095053|blastocyst|blastocyst
75252|NCT03095053|comprehensive chromosome screening|comprehensive chromosome screening
75253|NCT03095053|euploidy|euploidy
75254|NCT03095053|frozen embryo transfer|frozen embryo transfer
75255|NCT03095001|bevacizumab|bevacizumab
75256|NCT03095001|Intraperitoneal administration|intraperitoneal administration
75257|NCT03095001|Ovarian Cancer|ovarian cancer
75258|NCT03095001|Peritoneal Adhesion|peritoneal adhesion
75259|NCT03094962|Kinematics|kinematics
75260|NCT03094962|MRI Scans|mri scans
75261|NCT03094962|CT Scan, Single-Photon Emission|ct scan, single-photon emission
75262|NCT03094962|finger interphalangeal joint|finger interphalangeal joint
75263|NCT03094949|microwave ablation|microwave ablation
75264|NCT03094949|partial nephrectomy|partial nephrectomy
75265|NCT03094910|Raynaud Phenomenon|raynaud phenomenon
75266|NCT03094910|Hand and Arm Vibration Syndrome|hand and arm vibration syndrome
75267|NCT03094910|Autonomic Imbalance|autonomic imbalance
75268|NCT03094910|Thermography|thermography
75269|NCT03094897|Breast Neoplasms,Prostatic Neoplasms|breast neoplasms,prostatic neoplasms
75270|NCT03094858|Smartphone, sedentary behavior, smartphone intervention|smartphone, sedentary behavior, smartphone intervention
75271|NCT03094832|ARQ 092|arq 092
75272|NCT03094832|ArQule|arqule
75273|NCT03094832|AKT|akt
75274|NCT03094832|PIK3CA|pik3ca
75275|NCT03094832|Overgrowth|overgrowth
75276|NCT03094832|Congenital malformations|congenital malformations
75277|NCT03094793|abnormal EEGs (AIC)|abnormal eegs (aic)
75278|NCT03094767|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
75279|NCT03094767|Heart Rate Variability|heart rate variability
75280|NCT03094767|Rehabilitation|rehabilitation
75281|NCT03094767|Hemoglobin Glycated|hemoglobin glycated
75282|NCT03094715|Mechanical thrombectomy|mechanical thrombectomy
75283|NCT03094715|Endovascular thrombectomy|endovascular thrombectomy
75284|NCT03094689|Physical activity|physical activity
75285|NCT03094689|Muscle pain|muscle pain
75286|NCT03094689|Cryotherapy|cryotherapy
75287|NCT03094676|Massage|massage
75288|NCT03094676|Autonomic nervous system|autonomic nervous system
75289|NCT03094676|Recovery of Physiological Function|recovery of physiological function
75290|NCT03094676|Heart Rate|heart rate
75291|NCT03094663|IPACK|ipack
75292|NCT03094663|PAI|pai
75293|NCT03094650|stroke|stroke
75294|NCT03094650|neurorehabilitation|neurorehabilitation
75295|NCT03094650|virtual reality|virtual reality
75296|NCT03094650|rehabilitation dose|rehabilitation dose
75297|NCT03094650|motor rehabilitation|motor rehabilitation
75298|NCT03094637|Hematopoietic/Lymphoid Cancer|hematopoietic/lymphoid cancer
75299|NCT03094637|Myelodysplastic Syndrome|myelodysplastic syndrome
75300|NCT03094637|MDS|mds
75301|NCT03094637|Higher risk|higher risk
75302|NCT03094637|Azacitidine|azacitidine
75303|NCT03094637|5-azacytidine|5-azacytidine
75304|NCT03094637|5-aza|5-aza
75305|NCT03094637|Vidaza|vidaza
75306|NCT03094637|5-AZC|5-azc
75307|NCT03094637|AZA-CR|aza-cr
75308|NCT03094637|Ladakamycin|ladakamycin
75309|NCT03094637|NSC-102816|nsc-102816
75310|NCT03094637|Azacytidine|azacytidine
75311|NCT03094637|Pembrolizumab|pembrolizumab
75312|NCT03094637|Keytruda|keytruda
75313|NCT03094637|MK-3475|mk-3475
75314|NCT03094637|SCH-900475|sch-900475
75315|NCT03094624|Amusia|amusia
75316|NCT03094624|Audition|audition
75317|NCT03094624|Short-term memory|short-term memory
75318|NCT03094624|Emotions|emotions
75319|NCT03094624|EEG|eeg
75320|NCT03094624|MEG|meg
75321|NCT03094624|MRI|mri
75322|NCT03094611|Acute lymphocytic leukemia|acute lymphocytic leukemia
75323|NCT03094611|ALL|all
75324|NCT03094611|CD22-positive|cd22-positive
75325|NCT03094611|Inotuzumab Ozogamicin|inotuzumab ozogamicin
75326|NCT03094611|CMC-544|cmc-544
75327|NCT03094585|Healthy nurses|healthy nurses
75328|NCT03094572|spinal cord circuitry|spinal cord circuitry
75329|NCT03094572|hemiplegia|hemiplegia
75330|NCT03094572|rhythmic task|rhythmic task
75331|NCT03094559|peripheral arterial disease|peripheral arterial disease
75332|NCT03094546|subjective cognitive decline|subjective cognitive decline
75333|NCT03094546|Alzheimer's disease, dementia|alzheimer's disease, dementia
75334|NCT03094546|dietary supplement|dietary supplement
75335|NCT03094546|polyamine|polyamine
75336|NCT03094546|prevention|prevention
75337|NCT03094546|treatment|treatment
75338|NCT03094546|lifestyle|lifestyle
75339|NCT03094546|memory|memory
75340|NCT03094546|autophagy|autophagy
75341|NCT03094533|Anesthesia, intravenous|anesthesia, intravenous
75342|NCT03094533|Anesthesia, inhalation|anesthesia, inhalation
75343|NCT03094533|propofol|propofol
75344|NCT03094533|sevoflurane|sevoflurane
75345|NCT03094533|glucose|glucose
75346|NCT03094468|terbinafine nail solution|terbinafine nail solution
75347|NCT03094468|nail fungal infection|nail fungal infection
75348|NCT03094468|topical antifungal drug|topical antifungal drug
75349|NCT03094455|Tele-rehabilitation|tele-rehabilitation
75350|NCT03094455|Action Observation|action observation
75351|NCT03094455|Mirror neurons|mirror neurons
75352|NCT03094455|ICT|ict
75353|NCT03094442|Quality of Recovery|quality of recovery
75354|NCT03094442|Minimally Invasive Sacrocolpopexy|minimally invasive sacrocolpopexy
75355|NCT03094442|Dexamethasone|dexamethasone
75356|NCT03094377|Multisensory stimulation; motor recovery|multisensory stimulation; motor recovery
75357|NCT03094364|Constraint-induced movement therapy|constraint-induced movement therapy
75358|NCT03094364|video game|video game
75359|NCT03094364|virtual reality|virtual reality
75360|NCT03094364|upper extremity|upper extremity
75361|NCT03094364|CI therapy|ci therapy
75362|NCT03094364|rehabilitation|rehabilitation
75363|NCT03094364|hemiparesis|hemiparesis
75364|NCT03094364|MS|ms
75365|NCT03094364|multiple sclerosis|multiple sclerosis
75366|NCT03094364|progressive multiple sclerosis|progressive multiple sclerosis
75367|NCT03094364|primary progressive multiple sclerosis|primary progressive multiple sclerosis
75368|NCT03094364|secondary progressive multiple sclerosis|secondary progressive multiple sclerosis
75369|NCT03094364|motor|motor
75370|NCT03094364|physical therapy|physical therapy
75371|NCT03094364|physiotherapy|physiotherapy
75372|NCT03094364|occupational therapy|occupational therapy
75373|NCT03094364|arm|arm
75374|NCT03094364|hand|hand
75375|NCT03094351|robot assisted esophagectomy|robot assisted esophagectomy
75376|NCT03094351|minimally invasive esophagectomy|minimally invasive esophagectomy
75377|NCT03094351|esophageal cancer|esophageal cancer
75378|NCT03094338|Psychology, Educational [F02.784.629]|psychology, educational [f02.784.629]
75379|NCT03094325|Septal Myectomy|septal myectomy
75380|NCT03094312|SEEG|seeg
75381|NCT03094312|ISD|isd
75382|NCT03094312|cognitive disorder|cognitive disorder
75383|NCT03094312|epilepsy surgery|epilepsy surgery
75384|NCT03094286|HIV|hiv
75385|NCT03094286|HIV with cancer patient|hiv with cancer patient
75386|NCT03094286|D006678|d006678
75387|NCT03094273|Melanocytic neoplasm|melanocytic neoplasm
75388|NCT03094273|Biopsy|biopsy
75389|NCT03094273|Saucerization biopsy|saucerization biopsy
75390|NCT03094273|Skin lesion|skin lesion
75391|NCT03094247|Malnutrition|malnutrition
75392|NCT03094247|Micronutrients|micronutrients
75393|NCT03094247|Polyunsaturated fatty acids|polyunsaturated fatty acids
75394|NCT03094247|Ready-to-use therapeutic foods|ready-to-use therapeutic foods
75395|NCT03094247|Omega-3 fatty acids|omega-3 fatty acids
75396|NCT03094247|Peanuts|peanuts
75397|NCT03094195|post-herpetic neuralgia|post-herpetic neuralgia
75398|NCT03094195|neuropathic pain|neuropathic pain
75399|NCT03094195|angiotensin II type 2 receptor antagonist|angiotensin ii type 2 receptor antagonist
75400|NCT03094195|dose ranging|dose ranging
75401|NCT03094130|Spin|spin
75402|NCT03094130|Misleading reporting|misleading reporting
75403|NCT03094130|Misleading interpretation|misleading interpretation
75404|NCT03094130|Misleading extrapolation|misleading extrapolation
75405|NCT03094130|phase I/II trials|phase i/ii trials
75406|NCT03094130|non-randomized trials|non-randomized trials
75407|NCT03094130|Patients|patients
75408|NCT03094117|Spin|spin
75409|NCT03094117|Misleading reporting|misleading reporting
75410|NCT03094117|Misleading interpretation|misleading interpretation
75411|NCT03094117|Misleading extrapolation|misleading extrapolation
75412|NCT03094117|phase I/II trials|phase i/ii trials
75413|NCT03094117|non-randomized trials|non-randomized trials
75414|NCT03094117|Patients|patients
75415|NCT03094104|Spin|spin
75416|NCT03094104|Misleading reporting|misleading reporting
75417|NCT03094104|Misleading interpretation|misleading interpretation
75418|NCT03094104|Misleading extrapolation|misleading extrapolation
75419|NCT03094104|phase I/II trials|phase i/ii trials
75420|NCT03094104|non-randomized trials|non-randomized trials
75421|NCT03094104|Patients|patients
75422|NCT03094091|Spin|spin
75423|NCT03094091|Misleading reporting|misleading reporting
75424|NCT03094091|Misleading interpretation|misleading interpretation
75425|NCT03094091|Misleading extrapolation|misleading extrapolation
75426|NCT03094091|phase I/II trials|phase i/ii trials
75427|NCT03094091|non-randomized trials|non-randomized trials
75428|NCT03094091|Patients|patients
75429|NCT03094078|Spin|spin
75430|NCT03094078|Misleading reporting|misleading reporting
75431|NCT03094078|Misleading interpretation|misleading interpretation
75432|NCT03094078|Misleading extrapolation|misleading extrapolation
75433|NCT03094078|Animal studies|animal studies
75434|NCT03094078|Cell culture studies|cell culture studies
75435|NCT03094078|Pre-clinical studies|pre-clinical studies
75436|NCT03094065|Spin|spin
75437|NCT03094065|Misleading reporting|misleading reporting
75438|NCT03094065|Misleading interpretation|misleading interpretation
75439|NCT03094065|Misleading extrapolation|misleading extrapolation
75440|NCT03094065|Animal studies|animal studies
75441|NCT03094065|Cell culture studies|cell culture studies
75442|NCT03094065|Pre-clinical studies|pre-clinical studies
75443|NCT03094052|neratinib|neratinib
75444|NCT03094052|trastuzumab|trastuzumab
75445|NCT03094052|crofelemer|crofelemer
75544|NCT03093376|Preschool|preschool
75446|NCT03094026|Hematologic cancers|hematologic cancers
75447|NCT03094026|Hematopoietic cell transplantation|hematopoietic cell transplantation
75448|NCT03094026|cognitive training|cognitive training
75449|NCT03094026|genetic knowledge|genetic knowledge
75450|NCT03094026|genetic attitude|genetic attitude
75451|NCT03094026|adult cancer survivors|adult cancer survivors
75452|NCT03094013|psycho-social factors, psychological symptoms|psycho-social factors, psychological symptoms
75453|NCT03094000|Bulimia Nervosa|bulimia nervosa
75454|NCT03094000|Binge-Eating|binge-eating
75455|NCT03094000|Self monitoring|self monitoring
75456|NCT03094000|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
75457|NCT03094000|Mindfulness|mindfulness
75458|NCT03093987|Shock|shock
75459|NCT03093987|Critical Care Ultrasound|critical care ultrasound
75460|NCT03093987|Lactate|lactate
75461|NCT03093987|Mortality|mortality
75462|NCT03093987|Prognosis|prognosis
75463|NCT03093935|Post-Stroke|post-stroke
75464|NCT03093935|Neuromodulation|neuromodulation
75465|NCT03093935|Axillary nerve|axillary nerve
75466|NCT03093935|Peripheral Nerve Stimulation|peripheral nerve stimulation
75467|NCT03093922|Gemcitabine|gemcitabine
75468|NCT03093922|Atezolizumab|atezolizumab
75469|NCT03093922|Cisplatin|cisplatin
75470|NCT03093922|16-1621|16-1621
75471|NCT03093909|Solid Tumors and Pulmonary Metastases|solid tumors and pulmonary metastases
75472|NCT03093909|aerosol gemcitabine|aerosol gemcitabine
75473|NCT03093909|aerosol GCB|aerosol gcb
75474|NCT03093909|Lung metastases|lung metastases
75475|NCT03093909|osteosarcoma|osteosarcoma
75476|NCT03093896|almonds|almonds
75477|NCT03093896|cereal snack|cereal snack
75478|NCT03093870|Neoplasms|neoplasms
75479|NCT03093870|Biliary Tract Neoplasms|biliary tract neoplasms
75480|NCT03093870|Bile Duct Neoplasms|bile duct neoplasms
75481|NCT03093870|Gallbladder Neoplasms|gallbladder neoplasms
75482|NCT03093844|Stem Cell Transplant|stem cell transplant
75483|NCT03093844|Umbilical Cord Blood Transplant|umbilical cord blood transplant
75484|NCT03093844|Haploidentical CD34+ Selected Cells|haploidentical cd34+ selected cells
75485|NCT03093805|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
75486|NCT03093805|Graft Versus Host Disease|graft versus host disease
75487|NCT03093779|Hearing Loss|hearing loss
75488|NCT03093779|Deaf|deaf
75489|NCT03093779|Health Literacy|health literacy
75490|NCT03093779|Health Information|health information
75491|NCT03093779|Visual Learning|visual learning
75492|NCT03093766|Aetiology|aetiology
75493|NCT03093740|hemodialysis|hemodialysis
75494|NCT03093740|renal failure|renal failure
75495|NCT03093740|kidney transplant|kidney transplant
75496|NCT03093714|Cystic Fibrosis|cystic fibrosis
75497|NCT03093636|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
75498|NCT03093636|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
75499|NCT03093636|Multiple Daily Injections (MDI)|multiple daily injections (mdi)
75500|NCT03093636|Insulin Pen|insulin pen
75501|NCT03093636|inControl Advice|incontrol advice
75502|NCT03093636|Decision Support System (DSS)|decision support system (dss)
75503|NCT03093623|physical activity|physical activity
75504|NCT03093623|abstain from smoking|abstain from smoking
75505|NCT03093623|human papillomavirus (HPV)|human papillomavirus (hpv)
75506|NCT03093623|cervical intraepithelial neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
75507|NCT03093558|adherence|adherence
75508|NCT03093558|quality of life|quality of life
75509|NCT03093558|health literacy|health literacy
75510|NCT03093545|rabies|rabies
75511|NCT03093545|obese|obese
75512|NCT03093545|immunoglobulin|immunoglobulin
75513|NCT03093545|rabies vaccine|rabies vaccine
75514|NCT03093545|post-exposure|post-exposure
75515|NCT03093545|immunogenicity|immunogenicity
75516|NCT03093532|emergency department|emergency department
75517|NCT03093532|stage 2 hypertension|stage 2 hypertension
75518|NCT03093532|minorities|minorities
75519|NCT03093506|Erythropoietin|erythropoietin
75520|NCT03093506|Randomized controlled trial|randomized controlled trial
75521|NCT03093506|Human volunteers|human volunteers
75522|NCT03093506|Mitochondrial function|mitochondrial function
75523|NCT03093506|Cognitive performance|cognitive performance
75524|NCT03093467|Internet|internet
75525|NCT03093467|Mental Health|mental health
75526|NCT03093441|High-intensity interval training|high-intensity interval training
75527|NCT03093441|cardiometabolic|cardiometabolic
75528|NCT03093441|physical performance|physical performance
75529|NCT03093441|psychosocial adaptation|psychosocial adaptation
75530|NCT03093428|Prostate Cancer|prostate cancer
75531|NCT03093415|Hepatitis C|hepatitis c
75533|NCT03093415|People Who Inject Drugs|people who inject drugs
75534|NCT03093415|PWID|pwid
75535|NCT03093415|Medication Assisted Therapy|medication assisted therapy
75536|NCT03093415|MAT|mat
75537|NCT03093415|Needle Exchange Program|needle exchange program
75538|NCT03093402|JBT-101 (also known as lenabasum)|jbt-101 (also known as lenabasum)
75539|NCT03093402|efficacy|efficacy
75540|NCT03093402|musculoskeletal disease|musculoskeletal disease
75541|NCT03093402|randomized trial|randomized trial
75542|NCT03093376|Anxiety|anxiety
75543|NCT03093376|Effortful Control|effortful control
75545|NCT03093376|ERN|ern
75546|NCT03093350|Breast Cancer|breast cancer
75547|NCT03093350|Tumor Associated Antigen Specific T cells|tumor associated antigen specific t cells
75548|NCT03093337|Neuromotor sequelae|neuromotor sequelae
75549|NCT03093337|Cognitive disorders|cognitive disorders
75550|NCT03093337|Cerebral development|cerebral development
75551|NCT03093337|Psychomotoricity|psychomotoricity
75552|NCT03093337|Postural management|postural management
75553|NCT03093337|Motor coordination|motor coordination
75554|NCT03093337|Parenthood|parenthood
75555|NCT03093324|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
75556|NCT03093324|RRMS|rrms
75557|NCT03093324|Multiple Sclerosis|multiple sclerosis
75558|NCT03093324|MS|ms
75559|NCT03093324|Alkermes|alkermes
75560|NCT03093324|ALKS 8700|alks 8700
75561|NCT03093324|Dimethyl Fumarate|dimethyl fumarate
75562|NCT03093324|DMF|dmf
75563|NCT03093324|Tecfidera|tecfidera
75564|NCT03093311|Near-Infrared Spectroscopy|near-infrared spectroscopy
75565|NCT03093311|Neurosurgical Procedures|neurosurgical procedures
75566|NCT03093311|Cognitive Dysfunction|cognitive dysfunction
75567|NCT03093272|Prostate Cancer|prostate cancer
75568|NCT03093259|ABX464|abx464
75569|NCT03093259|Ulcerative Colitis|ulcerative colitis
75570|NCT03093259|Refractory|refractory
75571|NCT03093246|Full-mouth ultrasonic debridement|full-mouth ultrasonic debridement
75572|NCT03093246|Aspirin|aspirin
75573|NCT03093246|Omega-3 polyunsaturated fatty acids|omega-3 polyunsaturated fatty acids
75574|NCT03093246|Non-surgical therapy|non-surgical therapy
75575|NCT03093207|Aggressive periodontitis|aggressive periodontitis
75576|NCT03093207|Aspirin|aspirin
75577|NCT03093207|Omega-3 polyunsaturated fatty acids|omega-3 polyunsaturated fatty acids
75578|NCT03093207|Surgical therapy|surgical therapy
75579|NCT03093142|transcranial direct current stimulation (tDCs)|transcranial direct current stimulation (tdcs)
75580|NCT03093142|neurofeedback|neurofeedback
75581|NCT03093116|ALK Gene Rearrangement|alk gene rearrangement
75582|NCT03093116|ROS1 Gene Rearrangement|ros1 gene rearrangement
75583|NCT03093116|NTRK 1/2/3 Gene Rearrangement|ntrk 1/2/3 gene rearrangement
75584|NCT03093103|empagliflozin|empagliflozin
75585|NCT03093103|kidney|kidney
75586|NCT03093103|BOLD-MRI|bold-mri
75587|NCT03093090|furosemide|furosemide
75588|NCT03093051|Termination|termination
75589|NCT03093051|Unpinning|unpinning
75590|NCT03093051|Therapy|therapy
75591|NCT03093025|Major Depressive Disorder|major depressive disorder
75592|NCT03093025|Adjunctive Treatment|adjunctive treatment
75593|NCT03092999|Pharmacokinetics|pharmacokinetics
75594|NCT03092960|Latino|latino
75595|NCT03092960|Male|male
75596|NCT03092934|Small Cell Lung Carcinoma|small cell lung carcinoma
75597|NCT03092908|calcium oxalate|calcium oxalate
75598|NCT03092908|nephrolithiasis|nephrolithiasis
75599|NCT03092908|Mature vinegar|mature vinegar
75600|NCT03092908|prophylaxis|prophylaxis
75601|NCT03092869|Feet|feet
75602|NCT03092869|Ankle|ankle
75603|NCT03092869|Balance|balance
75604|NCT03092869|Manual Therapy|manual therapy
75605|NCT03092869|Older Adult|older adult
75606|NCT03092830|SCC|scc
75607|NCT03092830|BCC|bcc
75608|NCT03092830|DNA|dna
75609|NCT03092830|RNA|rna
75610|NCT03092830|HEDGE HOG|hedge hog
75611|NCT03092830|epidermal growth factor receptor|epidermal growth factor receptor
75612|NCT03092817|Tuberculosis|tuberculosis
75613|NCT03092817|tuberculous meningitis|tuberculous meningitis
75614|NCT03092817|drug induced liver injury|drug induced liver injury
75616|NCT03092817|IRIS|iris
75617|NCT03092817|randomized controlled trial|randomized controlled trial
75618|NCT03092817|dexamethasone|dexamethasone
75619|NCT03092804|Shunting|shunting
75620|NCT03092804|Brain constructure|brain constructure
75621|NCT03092804|Neural network|neural network
75622|NCT03092791|Drug Therapy|drug therapy
75623|NCT03092778|Cryoablation|cryoablation
75624|NCT03092778|Radiology|radiology
75625|NCT03092765|E6011|e6011
75626|NCT03092765|Ursodeoxycholic acid|ursodeoxycholic acid
75627|NCT03092765|Japan|japan
75628|NCT03092726|ASP8062|asp8062
75629|NCT03092726|Fibromyalgia|fibromyalgia
75630|NCT03092713|Cognitive Rehabilitation|cognitive rehabilitation
75631|NCT03092713|Supported employment|supported employment
75632|NCT03092713|Mild and moderate TBI|mild and moderate tbi
75633|NCT03092713|Return to work|return to work
75634|NCT03092713|Randomized Controlled Trial|randomized controlled trial
75635|NCT03092687|Mental Illness|mental illness
75636|NCT03092687|Aging|aging
75637|NCT03092687|Normal Development|normal development
75638|NCT03092661|Oxygen saturation|oxygen saturation
75639|NCT03092661|Pulse oximetry|pulse oximetry
75640|NCT03092661|Neonate|neonate
75641|NCT03092661|Infant|infant
75642|NCT03092622|Exercise Therapy|exercise therapy
75643|NCT03092609|Attentional Bias to Threat|attentional bias to threat
75644|NCT03092596|HIV infection|hiv infection
75645|NCT03092596|drug abuse|drug abuse
75646|NCT03092596|substance use|substance use
75647|NCT03092596|alcohol abuse|alcohol abuse
75648|NCT03092596|screening|screening
75649|NCT03092596|treatment|treatment
75650|NCT03092596|primary care|primary care
75651|NCT03092596|motivational interviewing|motivational interviewing
75652|NCT03092570|Motor learning|motor learning
75653|NCT03092570|stroke|stroke
75654|NCT03092570|tDCS|tdcs
75655|NCT03092570|upper limb|upper limb
75656|NCT03092531|HIV|hiv
75657|NCT03092531|ART Adherence|art adherence
75658|NCT03092531|Adolescents|adolescents
75659|NCT03092518|Surgical Resection|surgical resection
75660|NCT03092518|Progression Free Survival|progression free survival
75661|NCT03092518|Gastroesophageal Junction (Siewert III) Adenocarcinoma|gastroesophageal junction (siewert iii) adenocarcinoma
75662|NCT03092505|Herpes|herpes
75663|NCT03092505|Uganda|uganda
75664|NCT03092505|HSV|hsv
75665|NCT03092505|Sample|sample
75666|NCT03092492|Age Related Macular Degeneration|age related macular degeneration
75667|NCT03092492|Age Related Macular Degeneration (AMD)|age related macular degeneration (amd)
75668|NCT03092492|Reticular Pseudodrusen|reticular pseudodrusen
75669|NCT03092466|femoral nerve block|femoral nerve block
75670|NCT03092466|elderly patient|elderly patient
75671|NCT03092466|cognitive impairment|cognitive impairment
75672|NCT03092466|hip fracture|hip fracture
75673|NCT03092466|regional anesthesia|regional anesthesia
75674|NCT03092440|Medical Education|medical education
75675|NCT03092440|simulation|simulation
75676|NCT03092440|serious game|serious game
75677|NCT03092440|validity|validity
75678|NCT03092401|Liver transplantation|liver transplantation
75679|NCT03092401|Hepatopulmonary Syndrome|hepatopulmonary syndrome
75680|NCT03092401|Liver Cirrhosis|liver cirrhosis
75681|NCT03092388|Sleep-Disordered Breathing|sleep-disordered breathing
75682|NCT03092388|Heart Failure|heart failure
75683|NCT03092388|Leg Fluid Shift|leg fluid shift
75684|NCT03092375|HCV|hcv
75685|NCT03092375|Previously treated|previously treated
75686|NCT03092362|persistent atrial fibrillation|persistent atrial fibrillation
75687|NCT03092362|Heart rate variability|heart rate variability
75688|NCT03092362|quality of life|quality of life
75689|NCT03092336|Peripheral Arterial Disease, training|peripheral arterial disease, training
75690|NCT03092310|Artificial Pancreas|artificial pancreas
75691|NCT03092271|suicide|suicide
75692|NCT03092271|suicide attempt|suicide attempt
75693|NCT03092271|self harm|self harm
75694|NCT03092271|depression|depression
75695|NCT03092193|Naproxen|naproxen
75696|NCT03092193|Association of naproxen-esomeprazole|association of naproxen-esomeprazole
75697|NCT03092193|High pressure liquid chromatography|high pressure liquid chromatography
75698|NCT03092193|Cytochrome P450|cytochrome p450
75699|NCT03092180|Dermatomyositis|dermatomyositis
75700|NCT03092180|Immunomodulation|immunomodulation
75701|NCT03092180|Immunosuppressive agents|immunosuppressive agents
75702|NCT03092180|Myositis|myositis
75703|NCT03092180|Polymyositis|polymyositis
75704|NCT03092180|Necrotizing myopathies|necrotizing myopathies
75705|NCT03092180|Antisynthetase syndrome|antisynthetase syndrome
75706|NCT03092128|Gastrointestinal stromal tumor (GIST)|gastrointestinal stromal tumor (gist)
75707|NCT03092128|Imatinib|imatinib
75708|NCT03092128|Pharmacogenetics|pharmacogenetics
75709|NCT03092128|Pharmacokinetics|pharmacokinetics
75710|NCT03092128|Precision medicine|precision medicine
75711|NCT03092128|Somatic and germ-line mutations|somatic and germ-line mutations
75712|NCT03092115|Men who have sex with men (MSM)|men who have sex with men (msm)
75713|NCT03092115|mHealth|mhealth
75714|NCT03092115|antiretroviral therapy (ART)|antiretroviral therapy (art)
75715|NCT03092115|native android app|native android app
75716|NCT03092089|Sonothrombolysis, STEMI, PPCI, Microbubbles|sonothrombolysis, stemi, ppci, microbubbles
75717|NCT03092076|pharmacokinetics|pharmacokinetics
75718|NCT03092076|antiplatelet effects|antiplatelet effects
75719|NCT03092076|single nucleotide polymorphism (SNP)|single nucleotide polymorphism (snp)
75720|NCT03092024|Systemic Sclerosis|systemic sclerosis
75721|NCT03092024|Scleroderma|scleroderma
75722|NCT03092024|Hand|hand
75723|NCT03092024|Intervention|intervention
75724|NCT03092024|Exercise|exercise
75725|NCT03091985|Breastshield|breastshield
75726|NCT03091985|Breastpump|breastpump
75727|NCT03091985|Breastfeeding|breastfeeding
75728|NCT03091972|Persistent Atrial Fibrillation|persistent atrial fibrillation
75729|NCT03091972|Linear ablation|linear ablation
75730|NCT03091972|Catheter ablation|catheter ablation
75731|NCT03091972|Contact force|contact force
75732|NCT03091946|Oatmeal; Post-prandial glycemic response ; Post-prandial insulin response; Post-prandial hunger|oatmeal; post-prandial glycemic response ; post-prandial insulin response; post-prandial hunger
75733|NCT03091933|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
75734|NCT03091933|relapsed hematopoietic malignancy|relapsed hematopoietic malignancy
75735|NCT03091933|HLA matched donor|hla matched donor
75736|NCT03091933|minor histocompatibilty antigen (MiHA)|minor histocompatibilty antigen (miha)
75737|NCT03091907|Necrotizing enterocolitis|necrotizing enterocolitis
75738|NCT03091907|Followup|followup
75739|NCT03091907|Neurodevelopmental impairments|neurodevelopmental impairments
75740|NCT03091907|Growth impairments|growth impairments
75741|NCT03091907|Gut function|gut function
75742|NCT03091907|Behavioural impairments|behavioural impairments
75743|NCT03091894|Dexmedetomidine|dexmedetomidine
75744|NCT03091894|Sleep|sleep
75745|NCT03091894|Endoscopy|endoscopy
75746|NCT03091894|Propofol|propofol
75747|NCT03091881|Granisetron|granisetron
75748|NCT03091881|Spinal induced hypotension|spinal induced hypotension
75749|NCT03091790|ventral hernia|ventral hernia
75750|NCT03091790|mesh|mesh
75751|NCT03091777|bacterial vaginosis|bacterial vaginosis
75752|NCT03091777|vaginal infection|vaginal infection
75753|NCT03091777|BV|bv
75754|NCT03091764|NMIBC|nmibc
75755|NCT03091764|non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
75756|NCT03091764|Patient reported outcome|patient reported outcome
75757|NCT03091764|Symptom burden|symptom burden
75758|NCT03091764|Questionnaire|questionnaire
75759|NCT03091751|Factor IX (FIX)|factor ix (fix)
75760|NCT03091738|sleep|sleep
75761|NCT03091725|Obesity|obesity
75762|NCT03091725|Roux-en-Y gastric bypass (RYGB)|roux-en-y gastric bypass (rygb)
75763|NCT03091725|Very low calorie diet|very low calorie diet
75764|NCT03091725|Fibroblast growth factor 21 (FGF21)|fibroblast growth factor 21 (fgf21)
75765|NCT03091712|Degludec|degludec
75766|NCT03091712|MIDS|mids
75767|NCT03091712|Mobile Insulin Dosing System|mobile insulin dosing system
75768|NCT03091712|Glooko|glooko
75769|NCT03091712|Tresiba|tresiba
75770|NCT03091712|Tresiba® U-200 FlexTouch®|tresiba® u-200 flextouch®
75771|NCT03091699|Smoking|smoking
75772|NCT03091699|Nicotine|nicotine
75773|NCT03091699|Exercise|exercise
75774|NCT03091699|Cognition|cognition
75775|NCT03091686|Sedentary Behaviour|sedentary behaviour
75776|NCT03091686|Health Behaviour Change|health behaviour change
75777|NCT03091686|Health Action Process Approach|health action process approach
75778|NCT03091686|Intervention|intervention
75779|NCT03091686|Prolonged Sitting|prolonged sitting
75780|NCT03091686|Light Intensity Physical Activity|light intensity physical activity
75781|NCT03091686|Motivational Factors|motivational factors
75782|NCT03091686|Intentions|intentions
75783|NCT03091686|Diabetes|diabetes
75784|NCT03091686|Self-Efficacy|self-efficacy
75785|NCT03091686|Risk Perception|risk perception
75786|NCT03091686|Outcome Expectancies|outcome expectancies
75787|NCT03091647|Chinese women|chinese women
75788|NCT03091647|Cancer-related fatigue|cancer-related fatigue
75789|NCT03091647|Acupressure|acupressure
75790|NCT03091634|Xue-Fu-Zhu-Yu Capsule|xue-fu-zhu-yu capsule
75791|NCT03091634|Qi Stagnation and Blood Stasis syndrome|qi stagnation and blood stasis syndrome
75792|NCT03091634|National Center for Complementary and Integrative Health|national center for complementary and integrative health
75793|NCT03091621|Deep Vein Thrombosis|deep vein thrombosis
75794|NCT03091621|pulmonary embolism|pulmonary embolism
75795|NCT03091608|Drug-Induced Liver Injury|drug-induced liver injury
75796|NCT03091582|Psychological Therapy|psychological therapy
75797|NCT03091556|Drug-Induced Liver Injury|drug-induced liver injury
75798|NCT03091530|Throwing|throwing
75799|NCT03091530|Sleeper Stretch|sleeper stretch
75800|NCT03091530|Balloon Blow|balloon blow
75801|NCT03091530|GIRD (Glenohumeral internal rotation deficit)|gird (glenohumeral internal rotation deficit)
75802|NCT03091517|Online lifestyle modification|online lifestyle modification
75803|NCT03091517|Self-management|self-management
75804|NCT03091517|HbA1c|hba1c
75805|NCT03091439|Osteomyelitis|osteomyelitis
75806|NCT03091439|dalbavancin|dalbavancin
75807|NCT03091439|antibiotic|antibiotic
75808|NCT03091400|Memory Disorders|memory disorders
75809|NCT03091400|Multiple Sclerosis|multiple sclerosis
75810|NCT03091400|Atomoxetine Hydrochloride|atomoxetine hydrochloride
75811|NCT03091387|neonates, extubation|neonates, extubation
75812|NCT03091361|Bacterial imaging|bacterial imaging
75813|NCT03091361|PPV|ppv
75814|NCT03091361|Chronic wounds|chronic wounds
75815|NCT03091309|Inflammatory Bowel Diseases|inflammatory bowel diseases
75816|NCT03091309|Medication Adherence|medication adherence
75817|NCT03091309|Crohn Disease|crohn disease
75818|NCT03091309|Ulcerative Colitis|ulcerative colitis
75819|NCT03091309|Pregnancy|pregnancy
75820|NCT03091309|Counselling|counselling
75821|NCT03091309|Patient Education|patient education
75822|NCT03091283|time management, anaesthesia training program|time management, anaesthesia training program
75823|NCT03091270|gliomas|gliomas
75824|NCT03091270|motor functional cortex|motor functional cortex
75825|NCT03091270|ZOOMit-fMRI|zoomit-fmri
75826|NCT03091270|BOLD-fMRI|bold-fmri
75827|NCT03091257|Multiple Myeloma|multiple myeloma
75828|NCT03091244|Drug-Induced Liver Injury|drug-induced liver injury
75829|NCT03091218|Drug-Induced Liver Injury|drug-induced liver injury
75830|NCT03091192|Papillary Renal Cell Cancer|papillary renal cell cancer
75831|NCT03091192|AZD6094|azd6094
75832|NCT03091192|Savolitinib|savolitinib
75833|NCT03091179|airway management|airway management
75834|NCT03091179|high flow nasal oxygen|high flow nasal oxygen
75835|NCT03091179|high flow nasal cannula|high flow nasal cannula
75836|NCT03091179|THRIVE|thrive
75837|NCT03091140|Parathyroidectomy|parathyroidectomy
75838|NCT03091140|Muscular Functional Characteristics|muscular functional characteristics
76239|NCT03088891|diet|diet
75839|NCT03091140|Parathyroid Glands|parathyroid glands
75840|NCT03091114|fractures, risk prediction|fractures, risk prediction
75841|NCT03091101|keratoconus|keratoconus
75842|NCT03091101|corneal innervation|corneal innervation
75843|NCT03091101|scleral contact lenses|scleral contact lenses
75844|NCT03091075|Rotator Cuff Tear|rotator cuff tear
75845|NCT03091075|Rotator Cuff|rotator cuff
75846|NCT03091075|Anabolic Steroid|anabolic steroid
75847|NCT03091075|Testosterone|testosterone
75848|NCT03091075|Oxandrolone|oxandrolone
75849|NCT03091049|coronary|coronary
75850|NCT03091049|catheterization|catheterization
75851|NCT03091049|transradial|transradial
75852|NCT03091049|anesthesia|anesthesia
75853|NCT03091036|Chronic|chronic
75854|NCT03091036|Complex|complex
75855|NCT03091023|Endometrial receptivity|endometrial receptivity
75856|NCT03091023|Transcriptomic|transcriptomic
75857|NCT03091023|Single cell|single cell
75858|NCT03091023|Endometrial fluid|endometrial fluid
75859|NCT03090997|resveratrol, vitamin C, antioxidant therapy, antioxidant capacity|resveratrol, vitamin c, antioxidant therapy, antioxidant capacity
75860|NCT03090984|Hemodialysis|hemodialysis
75861|NCT03090984|Coagulation activation|coagulation activation
75862|NCT03090958|technology|technology
75863|NCT03090958|app|app
75864|NCT03090958|YMSM|ymsm
75865|NCT03090958|HIV|hiv
75866|NCT03090945|Endoscopy|endoscopy
75867|NCT03090945|GI Bleeding|gi bleeding
75868|NCT03090945|Pediatrics|pediatrics
75869|NCT03090945|Upper Gastrointestinal Bleeding|upper gastrointestinal bleeding
75870|NCT03090945|Gastro Intestinal Bleeding|gastro intestinal bleeding
75871|NCT03090906|volume gain|volume gain
75872|NCT03090906|soft tissue augmentation|soft tissue augmentation
75873|NCT03090906|dental implants|dental implants
75874|NCT03090906|histology|histology
75875|NCT03090880|Low-molecular-weight Heparin|low-molecular-weight heparin
75876|NCT03090880|Tinzaparin|tinzaparin
75877|NCT03090867|Clinical Practice Guideline|clinical practice guideline
75878|NCT03090867|Critical care|critical care
75879|NCT03090867|Family-centered care|family-centered care
75880|NCT03090867|Professional-family relations|professional-family relations
75881|NCT03090867|Family nursing|family nursing
75882|NCT03090867|Anxiety|anxiety
75883|NCT03090867|Depression|depression
75884|NCT03090867|Participation in care|participation in care
75885|NCT03090854|Alzheimer's Disease|alzheimer's disease
75886|NCT03090854|Cognition|cognition
75887|NCT03090854|Cholinergic target|cholinergic target
75888|NCT03090841|Cytomegalovirus Congenital|cytomegalovirus congenital
75889|NCT03090841|Non-invasive diagnosis|non-invasive diagnosis
75890|NCT03090841|Omics|omics
75891|NCT03090841|Biomarkers|biomarkers
75892|NCT03090828|economic evaluation|economic evaluation
75893|NCT03090828|e health|e health
75894|NCT03090815|Circulating Tumor DNA|circulating tumor dna
75895|NCT03090815|Prognostic|prognostic
75896|NCT03090815|Molecular tests|molecular tests
75897|NCT03090802|Human Immunodeficiency Virus|human immunodeficiency virus
75898|NCT03090802|resilience|resilience
75899|NCT03090802|adolescent mothers|adolescent mothers
75900|NCT03090802|Sub-Saharan Africa|sub-saharan africa
75901|NCT03090802|intimate partner violence|intimate partner violence
75902|NCT03090802|postpartum period|postpartum period
75903|NCT03090789|Friedreich Ataxia|friedreich ataxia
75904|NCT03090789|Neuro-degenerative disease|neuro-degenerative disease
75905|NCT03090698|osteoarthritis|osteoarthritis
75906|NCT03090698|knee|knee
75907|NCT03090698|treatment|treatment
75908|NCT03090685|Chikungunya Fever|chikungunya fever
75909|NCT03090685|Pain|pain
75910|NCT03090685|Mobility Limitation|mobility limitation
75911|NCT03090685|Auriculotherapy|auriculotherapy
75912|NCT03090685|Complementary Therapies|complementary therapies
75913|NCT03090685|Physical Therapy|physical therapy
75914|NCT03090672|Arthritis|arthritis
75915|NCT03090672|Degenerative|degenerative
75916|NCT03090672|Tendinosis|tendinosis
75917|NCT03090672|Jont disease|jont disease
75918|NCT03090672|Low back pain|low back pain
75919|NCT03090659|multiple myeloma|multiple myeloma
75920|NCT03090659|BCMA|bcma
75921|NCT03090659|CAR-T|car-t
75922|NCT03090646|social behavioral|social behavioral
75923|NCT03090646|living donor kidney transplant|living donor kidney transplant
75924|NCT03090646|follow-up|follow-up
75925|NCT03090646|health utilization|health utilization
75926|NCT03090646|incentives|incentives
75927|NCT03090633|Fetoscopy|fetoscopy
75928|NCT03090633|Fetal surgery|fetal surgery
75929|NCT03090633|Fetal spina bifida|fetal spina bifida
75930|NCT03090594|Cryoprobe|cryoprobe
75931|NCT03090594|Bronchoscopy|bronchoscopy
75932|NCT03090594|Acute cellular rejection|acute cellular rejection
75933|NCT03090581|Graft Rejection/diagnosis|graft rejection/diagnosis
75934|NCT03090581|Lung Transplantation|lung transplantation
75935|NCT03090581|Cryoprobe|cryoprobe
75936|NCT03090555|adhesive capsulitis|adhesive capsulitis
75937|NCT03090555|clinical trial|clinical trial
75938|NCT03090555|manipulation|manipulation
75939|NCT03090529|Exercise training|exercise training
75940|NCT03090529|Ambulatory blood pressure|ambulatory blood pressure
75941|NCT03090529|Resistant Hypertension|resistant hypertension
75942|NCT03090529|Nitric Oxide|nitric oxide
75943|NCT03090516|Ginkgo biloba dispersible tablets|ginkgo biloba dispersible tablets
75944|NCT03090516|Alzheimer's|alzheimer's
75945|NCT03090503|Antipsychotic agents|antipsychotic agents
75946|NCT03090503|Treatment|treatment
75947|NCT03090503|Effectiveness|effectiveness
75948|NCT03090503|Aripiprazole|aripiprazole
75949|NCT03090503|Risperidone|risperidone
75950|NCT03090490|Treatment|treatment
75951|NCT03090490|Maintenance|maintenance
75952|NCT03090464|Type 2 diabetes mellitus|type 2 diabetes mellitus
75953|NCT03090464|Digital disease management|digital disease management
75954|NCT03090464|T2DM|t2dm
75955|NCT03090464|Hyperglycemia|hyperglycemia
75956|NCT03090464|Diabetes mellitus|diabetes mellitus
75957|NCT03090451|Insulin|insulin
75958|NCT03090451|Glucose Clamp|glucose clamp
75959|NCT03090451|Glucose Tracer|glucose tracer
75960|NCT03090451|Artificial Pancreas|artificial pancreas
75961|NCT03090451|Exercise|exercise
75962|NCT03090451|Aerobic|aerobic
75963|NCT03090399|Goal Directed Fluid Therapy|goal directed fluid therapy
75964|NCT03090373|Catheter|catheter
75965|NCT03090373|UTI's|uti's
75966|NCT03090360|Healthy babies|healthy babies
75967|NCT03090360|Infant formula|infant formula
75968|NCT03090360|Growth|growth
75969|NCT03090334|beta-d-glucan|beta-d-glucan
75970|NCT03090334|abdominal candidiasis|abdominal candidiasis
75971|NCT03090321|fitness|fitness
75972|NCT03090321|health|health
75973|NCT03090321|activity|activity
75974|NCT03090321|heart risk|heart risk
75975|NCT03090321|wellness|wellness
75976|NCT03090282|mechanical treatment|mechanical treatment
75977|NCT03090282|implant|implant
75978|NCT03090269|cocaine|cocaine
75979|NCT03090269|methylphenidate|methylphenidate
75980|NCT03090269|psychostimulant|psychostimulant
75981|NCT03090269|ADHD|adhd
75982|NCT03090269|effective dose|effective dose
75983|NCT03090269|pharmacokinetics|pharmacokinetics
75984|NCT03090269|crack|crack
75985|NCT03090243|Glaucoma|glaucoma
75986|NCT03090243|Intraocular pressure|intraocular pressure
75987|NCT03090243|Colonoscopy|colonoscopy
75988|NCT03090243|Virtual Colonoscopy|virtual colonoscopy
75989|NCT03090243|Valsalva|valsalva
75990|NCT03090230|Descending Thoracic Aorta|descending thoracic aorta
75992|NCT03090230|Transection|transection
75993|NCT03090230|Traumatic Injury of the Descending Thoracic Aorta|traumatic injury of the descending thoracic aorta
75994|NCT03090217|Radiotherapy|radiotherapy
75995|NCT03090217|Brachytherapy|brachytherapy
75996|NCT03090217|Physiotherapy|physiotherapy
75997|NCT03090217|Vaginal dilators|vaginal dilators
75998|NCT03090217|Pelvic floor exercises|pelvic floor exercises
75999|NCT03090217|Vaginal Stenosis|vaginal stenosis
76000|NCT03090204|strain|strain
76001|NCT03090204|myocarditic deformation imaging|myocarditic deformation imaging
76002|NCT03090204|right ventricle (RV)|right ventricle (rv)
76003|NCT03090204|systolic RV function|systolic rv function
76004|NCT03090204|preload dependence|preload dependence
76005|NCT03090204|contractility|contractility
76006|NCT03090204|intermittent hemodialysis (HDI)|intermittent hemodialysis (hdi)
76007|NCT03090165|Triple Negative Breast Neoplasms|triple negative breast neoplasms
76008|NCT03090165|ribociclib|ribociclib
76009|NCT03090165|LEE011|lee011
76010|NCT03090165|CDK 4/6 inhibitor|cdk 4/6 inhibitor
76011|NCT03090165|bicalutamide|bicalutamide
76012|NCT03090152|Total Hip Replacement|total hip replacement
76013|NCT03090152|Total Hip Arthroplasty|total hip arthroplasty
76014|NCT03090139|Drug therapy|drug therapy
76015|NCT03090113|Stroke|stroke
76016|NCT03090113|Embolic Stroke|embolic stroke
76017|NCT03090113|Shuxuetong|shuxuetong
76018|NCT03090113|Recurrence|recurrence
76019|NCT03090113|Symptomatic New Cerebral Infarction|symptomatic new cerebral infarction
76020|NCT03090113|Asymptomatic New Cerebral Infarction|asymptomatic new cerebral infarction
76021|NCT03090087|Diameter of retinal arteries|diameter of retinal arteries
76022|NCT03090087|Adenosine|adenosine
76023|NCT03090087|Hypoxia|hypoxia
76024|NCT03090035|HCV genotype 2, HCV genotype 3, IL-28B, PEG-INF.|hcv genotype 2, hcv genotype 3, il-28b, peg-inf.
76025|NCT03090009|Peri-implant Mucositis|peri-implant mucositis
76026|NCT03090009|NSAID|nsaid
76027|NCT03090009|Microbiome|microbiome
76028|NCT03090009|16s Ribosomal Pyro-sequencing|16s ribosomal pyro-sequencing
76029|NCT03089996|piezocision|piezocision
76030|NCT03089996|corticotomy|corticotomy
76031|NCT03089996|Gingival Crevicular Fluid|gingival crevicular fluid
76032|NCT03089983|prison|prison
76033|NCT03089957|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
76034|NCT03089957|Critical Illness|critical illness
76035|NCT03089957|Randomized Controlled Trial|randomized controlled trial
76036|NCT03089957|Ulinastatin|ulinastatin
76037|NCT03089944|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
76038|NCT03089944|Glecaprevir|glecaprevir
76039|NCT03089944|Pibrentasvir|pibrentasvir
76040|NCT03089944|Treatment Naïve|treatment naïve
76041|NCT03089944|Cirrhosis|cirrhosis
76042|NCT03089944|Compensated Cirrhosis|compensated cirrhosis
76043|NCT03089944|Genotype (GT) 1, 2, 4, 5 or 6|genotype (gt) 1, 2, 4, 5 or 6
76044|NCT03089944|Pangenotypic|pangenotypic
76045|NCT03089879|Immunogenicity, Vaccine|immunogenicity, vaccine
76046|NCT03089879|Immunologic Memory|immunologic memory
76047|NCT03089879|GMMA|gmma
76048|NCT03089879|Shigella Vaccines|shigella vaccines
76049|NCT03089879|Shigellosis|shigellosis
76050|NCT03089879|Dysentery, Bacillary|dysentery, bacillary
76051|NCT03089879|Healthy Volunteers|healthy volunteers
76052|NCT03089879|Safety|safety
76053|NCT03089879|Bacteria|bacteria
76054|NCT03089879|Clinical Trials, Phase 1|clinical trials, phase 1
76055|NCT03089879|Shigella sonnei|shigella sonnei
76056|NCT03089866|Central nervous System|central nervous system
76057|NCT03089866|Memory functions|memory functions
76058|NCT03089866|Executive functions|executive functions
76059|NCT03089866|Cognitive impairment|cognitive impairment
76060|NCT03089853|COPD|copd
76061|NCT03089853|pulmonary rehabilitation|pulmonary rehabilitation
76062|NCT03089853|telehealth|telehealth
76063|NCT03089853|smart|smart
76064|NCT03089853|technology|technology
76065|NCT03089853|NEMS|nems
76066|NCT03089853|acute exacerbation|acute exacerbation
76067|NCT03089840|normothermic perfusion|normothermic perfusion
76068|NCT03089840|liver transplantation|liver transplantation
76069|NCT03089827|Memory|memory
76070|NCT03089814|tissue oxygen saturation, ischemic conditioning|tissue oxygen saturation, ischemic conditioning
76071|NCT03089801|health care access|health care access
76072|NCT03089801|eHealth|ehealth
76073|NCT03089801|telehealth|telehealth
76074|NCT03089775|Contact|contact
76075|NCT03089775|Treatment|treatment
76076|NCT03089775|Prevention|prevention
76077|NCT03089775|BBI-2000|bbi-2000
76078|NCT03089775|Dermatitis|dermatitis
76079|NCT03089775|Allergic|allergic
76080|NCT03089736|Pain|pain
76081|NCT03089736|Head and neck cancer|head and neck cancer
76082|NCT03089736|depression|depression
76083|NCT03089736|anxiety|anxiety
76084|NCT03089736|health|health
76085|NCT03089736|catastrophizing|catastrophizing
76086|NCT03089723|carpometacarpal joint ostearthritis|carpometacarpal joint ostearthritis
76087|NCT03089723|hyaluronic acid|hyaluronic acid
76088|NCT03089723|Rhizarthrosis|rhizarthrosis
76089|NCT03089697|N-Rephasin SAL200|n-rephasin sal200
76090|NCT03089697|Methicillin-Sensitive Staphylococcus aureus|methicillin-sensitive staphylococcus aureus
76091|NCT03089697|Methicillin Resistant Staphylococcus Aureus|methicillin resistant staphylococcus aureus
76092|NCT03089684|NHANES|nhanes
76093|NCT03089684|Folate|folate
76094|NCT03089684|Folic Acid|folic acid
76095|NCT03089671|Vitamin B|vitamin b
76096|NCT03089671|5% Dextrose in Water|5% dextrose in water
76097|NCT03089671|Cystoscopy|cystoscopy
76098|NCT03089671|Ureter|ureter
76099|NCT03089658|Metastatic Merkel Cell Carcinoma|metastatic merkel cell carcinoma
76100|NCT03089658|Expanded Access Program|expanded access program
76101|NCT03089658|Temporary Authorisation for Use|temporary authorisation for use
76102|NCT03089658|Avelumab|avelumab
76103|NCT03089632|gluten-free diet|gluten-free diet
76104|NCT03089632|gluten sensitivity|gluten sensitivity
76105|NCT03089632|dyspepsia|dyspepsia
76106|NCT03089632|diabetes mellitus, type 1|diabetes mellitus, type 1
76107|NCT03089632|gastroparesis|gastroparesis
76108|NCT03089632|motility|motility
76109|NCT03089619|Alveolar bone|alveolar bone
76110|NCT03089619|Bone resorption|bone resorption
76111|NCT03089619|dental implants|dental implants
76112|NCT03089593|Thermic Effect of Food|thermic effect of food
76113|NCT03089593|Energy Expenditure|energy expenditure
76114|NCT03089593|Ginger|ginger
76115|NCT03089567|Silver diamine Fluoride|silver diamine fluoride
76116|NCT03089567|Streptococcus mutans|streptococcus mutans
76117|NCT03089567|Caries prevention|caries prevention
76118|NCT03089567|Fluoride|fluoride
76119|NCT03089528|Direct laryngoscopy|direct laryngoscopy
76120|NCT03089528|Videolaryngoscopy|videolaryngoscopy
76121|NCT03089528|Diabetes Mellitus|diabetes mellitus
76122|NCT03089528|Intubation|intubation
76123|NCT03089528|Anesthesia|anesthesia
76124|NCT03089515|World Trade Center|world trade center
76125|NCT03089515|World Trade Center Survivors|world trade center survivors
76126|NCT03089502|Exercise|exercise
76127|NCT03089502|Cardiac Rehabilitation|cardiac rehabilitation
76128|NCT03089502|Breast Caner|breast caner
76129|NCT03089502|Left Ventricular Dysfunction|left ventricular dysfunction
76130|NCT03089502|Trastuzumab|trastuzumab
76131|NCT03089502|Anthracyclines|anthracyclines
76132|NCT03089489|Primary graft dysfunction|primary graft dysfunction
76133|NCT03089489|Lung transplantation|lung transplantation
76134|NCT03089489|Surfactant Protein|surfactant protein
76135|NCT03089489|inflammation|inflammation
76136|NCT03089476|Prevention|prevention
76137|NCT03089476|Predictors|predictors
76138|NCT03089463|Diabetes|diabetes
76139|NCT03089463|Diabetic Foot|diabetic foot
76140|NCT03089463|Biomechanics|biomechanics
76141|NCT03089463|Stratification|stratification
76142|NCT03089463|Diabetes Complications|diabetes complications
76143|NCT03089463|Diabetes; Neuropathic (Manifestation)|diabetes; neuropathic (manifestation)
76144|NCT03089463|Risk Factors|risk factors
76145|NCT03089463|Prospective Studies|prospective studies
76146|NCT03089424|low back pain, photobiomodulation therapy, LLLT|low back pain, photobiomodulation therapy, lllt
76147|NCT03089411|myeloma multiple|myeloma multiple
76148|NCT03089411|newly diagnosed|newly diagnosed
76149|NCT03089398|Hybrid Coronary Revascularization|hybrid coronary revascularization
76150|NCT03089398|Coronary Artery Bypass Grafting|coronary artery bypass grafting
76151|NCT03089398|Percutaneous Coronary Intervention|percutaneous coronary intervention
76152|NCT03089372|Erectile Dysfunction|erectile dysfunction
76153|NCT03089372|Low intensity extracorporeal shock wave treatment|low intensity extracorporeal shock wave treatment
76154|NCT03089359|Unspecific symptoms|unspecific symptoms
76155|NCT03089359|Soluvent urokinase plasminogen activator receptor|soluvent urokinase plasminogen activator receptor
76156|NCT03089359|Lactate|lactate
76157|NCT03089359|Emergency Medical Services|emergency medical services
76158|NCT03089346|Imaging|imaging
76159|NCT03089346|Bronchial Remodeling|bronchial remodeling
76160|NCT03089320|HIV, Heavy drinking, Alcohol Abuse, AIDS|hiv, heavy drinking, alcohol abuse, aids
76161|NCT03089307|Erectile Dysfunction|erectile dysfunction
76162|NCT03089307|Low intensity extracorporeal shock wave treatment|low intensity extracorporeal shock wave treatment
76163|NCT03089294|Erectile Dysfunction|erectile dysfunction
76164|NCT03089294|Low intensity extracorporeal shock wave treatment|low intensity extracorporeal shock wave treatment
76165|NCT03089268|sessile serrated polyp|sessile serrated polyp
76166|NCT03089268|prevalence|prevalence
76167|NCT03089268|colorectal cancer|colorectal cancer
76168|NCT03089268|molecular biology|molecular biology
76169|NCT03089255|Thrombophylaxis|thrombophylaxis
76170|NCT03089255|Deep Venous Thrombosis|deep venous thrombosis
76171|NCT03089255|Pulmonary Embolism|pulmonary embolism
76172|NCT03089255|Lower Leg Trauma|lower leg trauma
76173|NCT03089229|Topical Cream|topical cream
76174|NCT03089229|Novel|novel
76175|NCT03089190|Appetite|appetite
76176|NCT03089190|Satiety|satiety
76177|NCT03089190|Energy intake|energy intake
76178|NCT03089190|Hunger|hunger
76179|NCT03089190|Peptide|peptide
76180|NCT03089190|Encapsulation|encapsulation
76181|NCT03089177|Randomized Controlled Trial|randomized controlled trial
76182|NCT03089177|Community Gardening|community gardening
76183|NCT03089177|Health Behavior Change|health behavior change
76184|NCT03089177|Physical Activity|physical activity
76185|NCT03089177|Diet|diet
76186|NCT03089177|Obesity|obesity
76187|NCT03089177|Cancer Prevention|cancer prevention
76188|NCT03089177|Neighborhood|neighborhood
76189|NCT03089151|Pilot Randomized Controlled Trial|pilot randomized controlled trial
76190|NCT03089151|Community Garden|community garden
76191|NCT03089151|Health Behavior Change|health behavior change
76192|NCT03089151|Physical Activity|physical activity
76193|NCT03089151|Diet|diet
76194|NCT03089151|Obesity|obesity
76195|NCT03089151|Neighborhood|neighborhood
76196|NCT03089151|Microbiome|microbiome
76197|NCT03089151|Inflammatory biomarkers|inflammatory biomarkers
76198|NCT03089125|Lung Cancer|lung cancer
76199|NCT03089099|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
76200|NCT03089099|circulating tumor cells|circulating tumor cells
76201|NCT03089099|Prognosis|prognosis
76202|NCT03089099|Liquid biopsy|liquid biopsy
76203|NCT03089086|meningococcal B vaccine|meningococcal b vaccine
76204|NCT03089086|herd immunity|herd immunity
76205|NCT03089086|adolescents|adolescents
76206|NCT03089086|young adults|young adults
76207|NCT03089086|south australia|south australia
76208|NCT03089060|Fingertip Amputation|fingertip amputation
76209|NCT03089060|Fingertip Regeneration|fingertip regeneration
76210|NCT03089060|Infection|infection
76211|NCT03089060|Occlusive Dressings|occlusive dressings
76212|NCT03089060|Pediatric Surgery|pediatric surgery
76213|NCT03089060|Silicone Finger Cap|silicone finger cap
76214|NCT03089021|neck pain,|neck pain,
76215|NCT03088982|Family Medicine|family medicine
76216|NCT03088982|multimorbidity|multimorbidity
76217|NCT03088982|prevention|prevention
76218|NCT03088969|Chronic Low Back Pain|chronic low back pain
76219|NCT03088969|Function|function
76220|NCT03088969|Self-efficacy|self-efficacy
76221|NCT03088969|Return to work|return to work
76222|NCT03088969|Questionnaire|questionnaire
76223|NCT03088956|Longitudinal|longitudinal
76224|NCT03088956|Caregiver|caregiver
76225|NCT03088956|Cognitive assessments|cognitive assessments
76226|NCT03088956|Behavioral assessments|behavioral assessments
76227|NCT03088956|Functional assessments|functional assessments
76228|NCT03088904|Inactivated influenza vaccine quadrivalent|inactivated influenza vaccine quadrivalent
76229|NCT03088904|Live, attenuated influenza vaccine quadrivalent|live, attenuated influenza vaccine quadrivalent
76230|NCT03088904|Monozygotic twins|monozygotic twins
76231|NCT03088904|Dizygotic twins|dizygotic twins
76232|NCT03088904|Adults|adults
76233|NCT03088904|Adolescents|adolescents
76234|NCT03088891|altitude training|altitude training
76235|NCT03088891|antioxidants|antioxidants
76236|NCT03088891|oxidative stress|oxidative stress
76237|NCT03088891|elite athletes|elite athletes
76238|NCT03088891|inflammation|inflammation
76240|NCT03088878|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
76241|NCT03088878|Small lymphocytic lymphoma|small lymphocytic lymphoma
76242|NCT03088878|Mantle cell lymphoma|mantle cell lymphoma
76243|NCT03088878|Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1)|receptor tyrosine kinase-like orphan receptor 1 (ror1)
76244|NCT03088878|Bruton Tyrosine Kinase (BTK)|bruton tyrosine kinase (btk)
76245|NCT03088774|Low back pain|low back pain
76246|NCT03088761|tracheal tube|tracheal tube
76247|NCT03088761|cuff pressure|cuff pressure
76248|NCT03088748|total knee arthroplasty|total knee arthroplasty
76249|NCT03088722|Contraceptive implant|contraceptive implant
76250|NCT03088722|Task sharing|task sharing
76251|NCT03088722|Nigeria|nigeria
76252|NCT03088709|NHL|nhl
76253|NCT03088709|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
76254|NCT03088709|Haploidentical|haploidentical
76255|NCT03088709|Bone Marrow Transplant|bone marrow transplant
76256|NCT03088709|Stem Cell Transplant|stem cell transplant
76257|NCT03088709|Acute Myeloid Leukemia|acute myeloid leukemia
76258|NCT03088709|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
76259|NCT03088709|Myelodysplastic Syndrome|myelodysplastic syndrome
76260|NCT03088709|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
76261|NCT03088709|GVHD|gvhd
76262|NCT03088696|laparoscopic|laparoscopic
76263|NCT03088696|acupuncture|acupuncture
76264|NCT03088683|sleeve gastrectomy|sleeve gastrectomy
76265|NCT03088683|liver retractor|liver retractor
76266|NCT03088683|nathanson|nathanson
76267|NCT03088683|reveel|reveel
76268|NCT03088683|liver trauma|liver trauma
76269|NCT03088657|Cohort study|cohort study
76270|NCT03088657|early-onset mood disorders|early-onset mood disorders
76271|NCT03088618|Nasal obstruction|nasal obstruction
76272|NCT03088618|Septal deformity|septal deformity
76273|NCT03088618|Septoplasty|septoplasty
76274|NCT03088618|TnR Mesh|tnr mesh
76275|NCT03088618|polycaprolactone|polycaprolactone
76276|NCT03088592|Deep Brain Stimulation|deep brain stimulation
76277|NCT03088579|radiation shielding|radiation shielding
76278|NCT03088553|Ganciclovir|ganciclovir
76279|NCT03088553|trough concentrations|trough concentrations
76280|NCT03088553|CMV viral load|cmv viral load
76281|NCT03088553|safety|safety
76282|NCT03088553|Solid organ transplantation (heart, kidney or liver)|solid organ transplantation (heart, kidney or liver)
76283|NCT03088514|Hypertension|hypertension
76284|NCT03088514|Left Ventricular Hypertrophy|left ventricular hypertrophy
76285|NCT03088514|Endothelial Dysfunction|endothelial dysfunction
76286|NCT03088514|Nitrate|nitrate
76287|NCT03088501|Birth cohort, follow-up, IVRS|birth cohort, follow-up, ivrs
76288|NCT03088488|25-OH vitamin D|25-oh vitamin d
76289|NCT03088488|RANKL|rankl
76290|NCT03088488|Osteoprotogerin|osteoprotogerin
76291|NCT03088488|TNF-α|tnf-α
76292|NCT03088462|Bipolar Disorder|bipolar disorder
76293|NCT03088462|Smartphone|smartphone
76294|NCT03088462|Behavior Therapy|behavior therapy
76295|NCT03088449|Crohns disease|crohns disease
76296|NCT03088449|primary non response|primary non response
76297|NCT03088449|lose of response|lose of response
76298|NCT03088449|personalising anti-TNF therapy|personalising anti-tnf therapy
76299|NCT03088449|Anti-TNF|anti-tnf
76300|NCT03088449|PANTS|pants
76301|NCT03088449|Biosimilars|biosimilars
76302|NCT03088436|MRI|mri
76303|NCT03088436|Breast|breast
76304|NCT03088423|MRI|mri
76305|NCT03088423|Stereotactic body radiation therapy|stereotactic body radiation therapy
76306|NCT03088384|Post Traumatic Stress Disorder|post traumatic stress disorder
76307|NCT03088384|PTSD|ptsd
76308|NCT03088384|Combat Trauma|combat trauma
76309|NCT03088371|Total knee replacement|total knee replacement
76310|NCT03088371|Psoas Sciatic block|psoas sciatic block
76311|NCT03088371|Epidural anaesthesia|epidural anaesthesia
76312|NCT03088345|Fontan Palliation Surgery|fontan palliation surgery
76313|NCT03088345|Post-Operative Care|post-operative care
76314|NCT03088319|postnatal depression stress mindfulness allostatic load|postnatal depression stress mindfulness allostatic load
76315|NCT03088293|idiopathic refractory scleritis|idiopathic refractory scleritis
76316|NCT03088293|infliximab|infliximab
76317|NCT03088293|cyclophosphamide|cyclophosphamide
76318|NCT03088241|randomized clinical trial|randomized clinical trial
76319|NCT03088241|low level viremia|low level viremia
76320|NCT03088241|lesotho|lesotho
76321|NCT03088241|resource-limited setting|resource-limited setting
76322|NCT03088241|ART first-line failure|art first-line failure
76323|NCT03088215|Trigger Point Pain, Myofascial|trigger point pain, myofascial
76324|NCT03088215|shock-waves|shock-waves
76325|NCT03088215|extracorporeal shock-wave treatment (ESWT)|extracorporeal shock-wave treatment (eswt)
76326|NCT03088215|pain|pain
76327|NCT03088215|trigger point|trigger point
76328|NCT03088215|referred pain|referred pain
76329|NCT03088202|cancer|cancer
76330|NCT03088202|palliative care|palliative care
76331|NCT03088202|PROMs|proms
76332|NCT03088202|survival|survival
76333|NCT03088202|QoL|qol
76334|NCT03088202|referral|referral
76335|NCT03088189|maternal nutrition|maternal nutrition
76336|NCT03088189|periconceptional|periconceptional
76816|NCT03085147|Mouth|mouth
76337|NCT03088189|neurocognitive development|neurocognitive development
76338|NCT03088176|Melanoma|melanoma
76339|NCT03088176|BRAF inhibitor|braf inhibitor
76340|NCT03088176|Intratumoral injection|intratumoral injection
76341|NCT03088176|Talimogene laherparepvec|talimogene laherparepvec
76342|NCT03088176|MEK inhibitor|mek inhibitor
76343|NCT03088176|dabrafenib|dabrafenib
76344|NCT03088176|trametinib|trametinib
76345|NCT03088150|Hepatic resection|hepatic resection
76346|NCT03088150|Liver surgery|liver surgery
76347|NCT03088150|Thermal ablation|thermal ablation
76348|NCT03088150|Radiofrequency ablation|radiofrequency ablation
76349|NCT03088150|Microwave ablation|microwave ablation
76350|NCT03088150|RFA|rfa
76351|NCT03088150|MWA|mwa
76352|NCT03088137|in vitro fertilization|in vitro fertilization
76353|NCT03088111|Anthim®|anthim®
76354|NCT03088111|Obiltoxaximab|obiltoxaximab
76355|NCT03088111|anthrax|anthrax
76356|NCT03088111|anti-toxin|anti-toxin
76357|NCT03088098|left atrial appendage occlusion|left atrial appendage occlusion
76358|NCT03088098|transcatheter aortic valve implantation|transcatheter aortic valve implantation
76359|NCT03088098|atrial fibrillation|atrial fibrillation
76360|NCT03088072|Edoxaban|edoxaban
76361|NCT03088072|WATCHMAN device|watchman device
76362|NCT03088020|CCHS|cchs
76363|NCT03088020|PHOX2B|phox2b
76364|NCT03088020|Paired-like Homeobox gene PHOX2B|paired-like homeobox gene phox2b
76365|NCT03088020|autonomic nervous system dysregulation|autonomic nervous system dysregulation
76366|NCT03088020|control of breathing|control of breathing
76367|NCT03088020|Hirschsprung disease|hirschsprung disease
76368|NCT03088020|neural crest tumors|neural crest tumors
76369|NCT03088020|neuroblastoma|neuroblastoma
76370|NCT03088020|ganglioneuroma|ganglioneuroma
76371|NCT03088020|ganglioneuroblastoma|ganglioneuroblastoma
76372|NCT03088020|artificial ventilation|artificial ventilation
76373|NCT03088020|diaphragm pacing|diaphragm pacing
76374|NCT03088007|Intellectual Deficiency|intellectual deficiency
76375|NCT03088007|cognitive, adaptive|cognitive, adaptive
76376|NCT03088007|behavioral and academic profile|behavioral and academic profile
76377|NCT03088007|regular and special schools|regular and special schools
76378|NCT03087942|end stage renal disase ESRD|end stage renal disase esrd
76379|NCT03087942|dialysis effect on pharmacokinetics PK|dialysis effect on pharmacokinetics pk
76380|NCT03087942|renal impairment|renal impairment
76381|NCT03087903|Prostate Specific Antigen (PSA)|prostate specific antigen (psa)
76382|NCT03087903|Non-Metastatic Prostate Cancer|non-metastatic prostate cancer
76383|NCT03087890|Microbial drug resistance|microbial drug resistance
76384|NCT03087890|Beta-lactamase|beta-lactamase
76385|NCT03087890|Cotrimoxazole|cotrimoxazole
76386|NCT03087890|Trimethoprim-sulfamethoxazole|trimethoprim-sulfamethoxazole
76387|NCT03087890|Tanzania|tanzania
76388|NCT03087864|esophageal cancer|esophageal cancer
76389|NCT03087864|PD-L1 inhibition|pd-l1 inhibition
76390|NCT03087864|chemoradiation|chemoradiation
76391|NCT03087851|Denosumab|denosumab
76392|NCT03087851|Bone Turnover markers|bone turnover markers
76393|NCT03087851|Drug Holiday|drug holiday
76394|NCT03087812|Microbiological burden|microbiological burden
76395|NCT03087812|kidney|kidney
76396|NCT03087812|stone|stone
76397|NCT03087812|durability of flexible endoscopes|durability of flexible endoscopes
76398|NCT03087734|Prostheses and Implants|prostheses and implants
76399|NCT03087721|Metabolic Syndrome|metabolic syndrome
76400|NCT03087721|Exercise Training|exercise training
76401|NCT03087721|Interval Training|interval training
76402|NCT03087721|Skeletal Muscle|skeletal muscle
76403|NCT03087721|Risk Factors|risk factors
76404|NCT03087721|Insulin Resistance|insulin resistance
76405|NCT03087695|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
76406|NCT03087695|EBV DNA|ebv dna
76407|NCT03087695|Chemoradiotherapy|chemoradiotherapy
76408|NCT03087669|Left Ventricular Assist Device|left ventricular assist device
76409|NCT03087669|Hemodynamic monitoring|hemodynamic monitoring
76410|NCT03087656|levofloxacin|levofloxacin
76411|NCT03087656|Ceftriaxone|ceftriaxone
76412|NCT03087656|Cholangitis|cholangitis
76413|NCT03087656|ERCP|ercp
76414|NCT03087643|Flow-mediated dilation|flow-mediated dilation
76415|NCT03087643|Passive limb movement|passive limb movement
76416|NCT03087604|epidural catheter placement|epidural catheter placement
76417|NCT03087578|overactive bladder, acupuncture|overactive bladder, acupuncture
76418|NCT03087526|Non Invasive Prenatal Diagnosis (NIPD)|non invasive prenatal diagnosis (nipd)
76419|NCT03087526|Circulating Fetal Trophoblastic Cells (CFTC)|circulating fetal trophoblastic cells (cftc)
76420|NCT03087526|Triplet repeat diseases|triplet repeat diseases
76421|NCT03087526|Huntington Disease - Myotonic Dystrophy Type 1 - Spinocerebellar Ataxia 1, 2 and 3|huntington disease - myotonic dystrophy type 1 - spinocerebellar ataxia 1, 2 and 3
76422|NCT03087500|Down Syndrome|down syndrome
76423|NCT03087500|Typically Developing Participants|typically developing participants
76424|NCT03087500|Children|children
76425|NCT03087500|Adolescents|adolescents
76426|NCT03087500|Adults|adults
76427|NCT03087448|ALK rearranged|alk rearranged
76428|NCT03087448|Stage IIIB NSCLC|stage iiib nsclc
76429|NCT03087448|Stage IV NSCLC|stage iv nsclc
76430|NCT03087448|ROS-1 rearranged NSCLC|ros-1 rearranged nsclc
76431|NCT03087396|bone marrow defect|bone marrow defect
76432|NCT03087396|bone marrow lesion|bone marrow lesion
76433|NCT03087396|stress fracture|stress fracture
76434|NCT03087396|calcium phosphate|calcium phosphate
76435|NCT03087396|bone substitute material|bone substitute material
76436|NCT03087370|CXCR4 Mutation|cxcr4 mutation
76437|NCT03087370|Primary immunodeficiency disorder|primary immunodeficiency disorder
76438|NCT03087370|Warts|warts
76439|NCT03087370|Hypogammaglobulinemia|hypogammaglobulinemia
76440|NCT03087370|Infections|infections
76441|NCT03087370|Myelokathexis|myelokathexis
76442|NCT03087370|Human papillomavirus (HPV)|human papillomavirus (hpv)
76443|NCT03087370|Neutropenia|neutropenia
76444|NCT03087370|Herpes|herpes
76445|NCT03087344|Postprandial liver and spleen stiffness measurements|postprandial liver and spleen stiffness measurements
76446|NCT03087344|Transient elastography|transient elastography
76447|NCT03087344|Cirrhosis|cirrhosis
76448|NCT03087344|Acoustic radiation force impulse|acoustic radiation force impulse
76449|NCT03087318|Obstructive sleep apnea (OSA)|obstructive sleep apnea (osa)
76450|NCT03087318|Overweight and moderate obesity|overweight and moderate obesity
76451|NCT03087318|Sport prescription|sport prescription
76452|NCT03087318|Physical activity|physical activity
76453|NCT03087305|Interventional Pulmonary|interventional pulmonary
76454|NCT03087305|EBUS-TBNA|ebus-tbna
76455|NCT03087305|Lung cancer staging|lung cancer staging
76456|NCT03087292|blood flow restriction|blood flow restriction
76457|NCT03087292|resistance training|resistance training
76458|NCT03087292|coronary heart disease|coronary heart disease
76459|NCT03087240|Disease Activity Score 28 (DAS28)|disease activity score 28 (das28)
76460|NCT03087240|Health Assessment Questionnaire (HAQ)|health assessment questionnaire (haq)
76461|NCT03087240|Dental Scaling|dental scaling
76462|NCT03087240|Dental Polishing|dental polishing
76463|NCT03087240|Oral Health|oral health
76464|NCT03087240|Gingival Crevicular Fluid|gingival crevicular fluid
76465|NCT03087240|Inflammatory Cytokine Profile|inflammatory cytokine profile
76466|NCT03087240|Biofilm|biofilm
76467|NCT03087240|Oral Microbiome|oral microbiome
76468|NCT03087240|Intestinal Microbiome|intestinal microbiome
76469|NCT03087227|mHealth|mhealth
76470|NCT03087227|febrile neutropenia|febrile neutropenia
76471|NCT03087227|neutropenia/chemically induced/*complications|neutropenia/chemically induced/*complications
76472|NCT03087227|antineoplastic agents/*adverse events|antineoplastic agents/*adverse events
76473|NCT03087227|Patient readmission|patient readmission
76474|NCT03087227|disease management|disease management
76475|NCT03087201|Chronic tic disorders|chronic tic disorders
76476|NCT03087201|Tourette syndrome|tourette syndrome
76477|NCT03087149|vitamin D|vitamin d
76478|NCT03087149|supplementation|supplementation
76479|NCT03087149|hydroxyvitamin D|hydroxyvitamin d
76480|NCT03087149|pretrem infants|pretrem infants
76481|NCT03087149|osteopenia|osteopenia
76482|NCT03087136|multiple sclerosis|multiple sclerosis
76483|NCT03087136|pediatric|pediatric
76484|NCT03087123|single-case design|single-case design
76485|NCT03087123|children|children
76486|NCT03087123|health equity|health equity
76487|NCT03087123|mobile health|mobile health
76488|NCT03087071|Colorectal cancer|colorectal cancer
76489|NCT03087071|Colorectal adenocarcinoma|colorectal adenocarcinoma
76490|NCT03087071|EGFR S492R or other ectodomain mutations in circulating free tumor DNA|egfr s492r or other ectodomain mutations in circulating free tumor dna
76491|NCT03087071|Detectable KRAS or NRAS mutations in exons 2, 3, or 4; or BRAF codon 600 mutations in circulating free tumor DNA|detectable kras or nras mutations in exons 2, 3, or 4; or braf codon 600 mutations in circulating free tumor dna
76492|NCT03087071|No detectable mutations in circulating free tumor DNA|no detectable mutations in circulating free tumor dna
76493|NCT03087071|Panitumumab|panitumumab
76494|NCT03087071|Vectibix|vectibix
76495|NCT03087071|Trametinib|trametinib
76496|NCT03087071|GSK1120212|gsk1120212
76497|NCT03087058|Treatment of Hyperkalemia|treatment of hyperkalemia
76498|NCT03087058|Hyperkalemia|hyperkalemia
76499|NCT03087058|Potassium|potassium
76500|NCT03087058|Chronic Kidney Disease|chronic kidney disease
76501|NCT03087032|Liraglutide|liraglutide
76502|NCT03087032|Insulin Glargine|insulin glargine
76503|NCT03087032|Prandial Insulin|prandial insulin
76504|NCT03087019|adenoid cystic carcinoma|adenoid cystic carcinoma
76505|NCT03086980|health related quality of life|health related quality of life
76506|NCT03086980|utility|utility
76507|NCT03086980|regression|regression
76508|NCT03086967|cervical ripening|cervical ripening
76509|NCT03086967|double lumen catheter|double lumen catheter
76510|NCT03086954|CD19 positive lymphoma|cd19 positive lymphoma
76511|NCT03086915|neuromuscular blockade|neuromuscular blockade
76512|NCT03086915|muscle relaxation|muscle relaxation
76513|NCT03086915|muscle relaxant|muscle relaxant
76514|NCT03086902|Ablation; Cryo Energy; Radofrequency Ablation|ablation; cryo energy; radofrequency ablation
76515|NCT03086863|electroacupuncture|electroacupuncture
76516|NCT03086863|randomized controlled trial|randomized controlled trial
76517|NCT03086824|Bone Metastasis|bone metastasis
76518|NCT03086811|feeding interaction, infant eating habits, hunger satiety cues, childhood obesity|feeding interaction, infant eating habits, hunger satiety cues, childhood obesity
76519|NCT03086798|Magill forceps|magill forceps
76520|NCT03086798|cuff inflation|cuff inflation
76521|NCT03086798|Nasotracheal Intubation|nasotracheal intubation
76522|NCT03086746|Remodeling|remodeling
76523|NCT03086733|Lung Cancer|lung cancer
76524|NCT03086733|Non small cell lung cancer|non small cell lung cancer
76525|NCT03086733|Metformin|metformin
76526|NCT03086733|Pre-operative treatment|pre-operative treatment
76527|NCT03086733|Neoadjuvant treatments|neoadjuvant treatments
76528|NCT03086733|Cancer|cancer
76529|NCT03086733|Phase II|phase ii
76530|NCT03086720|Adhesive system|adhesive system
76531|NCT03086720|Controlled clinical trial|controlled clinical trial
76532|NCT03086720|Dental restoration|dental restoration
76533|NCT03086720|Noncarious cervical lesions|noncarious cervical lesions
76534|NCT03086720|Dental restoration failure|dental restoration failure
76535|NCT03086720|Sodium hypochlorite|sodium hypochlorite
76536|NCT03086707|nasal mucociliary clearance|nasal mucociliary clearance
76537|NCT03086707|saccharine transit time|saccharine transit time
76538|NCT03086694|oromaxillofacial surgery|oromaxillofacial surgery
76539|NCT03086694|nasotracheal intubation|nasotracheal intubation
76540|NCT03086694|stroke volume variation|stroke volume variation
76541|NCT03086681|Cervical carcinoma|cervical carcinoma
76542|NCT03086681|endostar|endostar
76543|NCT03086681|concurrent chemoradiotherapy|concurrent chemoradiotherapy
76544|NCT03086668|Nasotracheal Intubation|nasotracheal intubation
76545|NCT03086668|jaw thrust|jaw thrust
76546|NCT03086668|hook-finger|hook-finger
76547|NCT03086655|biological markers|biological markers
76548|NCT03086655|monitoring device|monitoring device
76549|NCT03086655|wireless technology|wireless technology
76550|NCT03086642|locally advanced pancreatic cancer|locally advanced pancreatic cancer
76551|NCT03086642|locally advanced pancreas cancer|locally advanced pancreas cancer
76552|NCT03086642|metastatic pancreatic cancer|metastatic pancreatic cancer
76553|NCT03086642|metastatic pancreas cancer|metastatic pancreas cancer
76554|NCT03086642|refractory|refractory
76555|NCT03086642|refractory pancreatic cancer|refractory pancreatic cancer
76556|NCT03086642|refractory pancreas cancer|refractory pancreas cancer
76557|NCT03086642|T-Vec|t-vec
76558|NCT03086642|T Vec|t vec
76559|NCT03086616|DIPG|dipg
76560|NCT03086616|CED|ced
76561|NCT03086616|glioma|glioma
76562|NCT03086590|Body composition|body composition
76563|NCT03086590|Ultrasound|ultrasound
76564|NCT03086590|Chronic Pulmonary Obstructive Disease|chronic pulmonary obstructive disease
76565|NCT03086590|Respiratory muscles|respiratory muscles
76566|NCT03086564|HCC|hcc
76567|NCT03086564|ADCC|adcc
76568|NCT03086564|TACE|tace
76569|NCT03086564|immuno therapy|immuno therapy
76570|NCT03086551|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
76571|NCT03086551|Motor Impairment|motor impairment
76572|NCT03086551|Rehabilitation|rehabilitation
76573|NCT03086551|Motor Learning|motor learning
76574|NCT03086525|Chronic pain|chronic pain
76575|NCT03086525|Psychological factors|psychological factors
76576|NCT03086525|Musculoskeletal pain|musculoskeletal pain
76577|NCT03086525|Prognosis|prognosis
76578|NCT03086499|pectus excavatum|pectus excavatum
76579|NCT03086486|Tuberculosis|tuberculosis
76580|NCT03086486|Multi Drug-Resistant Tuberculosis|multi drug-resistant tuberculosis
76581|NCT03086486|Extensively Drug-Resistant Tuberculosis|extensively drug-resistant tuberculosis
76582|NCT03086486|Drug-Resistant Tuberculosis|drug-resistant tuberculosis
76583|NCT03086486|Pretomanid|pretomanid
76584|NCT03086486|PA-824|pa-824
76585|NCT03086486|Bedaquiline|bedaquiline
76586|NCT03086486|Linezolid|linezolid
76587|NCT03086486|NC-007|nc-007
76588|NCT03086486|TB Alliance|tb alliance
76589|NCT03086486|pre-XDR-TB|pre-xdr-tb
76590|NCT03086473|caffeine|caffeine
76591|NCT03086473|intubation|intubation
76592|NCT03086473|hemodynamics|hemodynamics
76593|NCT03086473|mechanical ventilation|mechanical ventilation
76594|NCT03086473|cardiac output|cardiac output
76595|NCT03086473|near infrared spectroscopy|near infrared spectroscopy
76596|NCT03086473|functional echocardiography|functional echocardiography
76597|NCT03086434|Culturally tailored intervention|culturally tailored intervention
76598|NCT03086434|American Indian early adolescents|american indian early adolescents
76599|NCT03086434|Prevention of substance use|prevention of substance use
76600|NCT03086421|Childhood cancer|childhood cancer
76601|NCT03086421|Social functioning|social functioning
76602|NCT03086421|Social development|social development
76603|NCT03086408|airway management|airway management
76604|NCT03086408|high flow nasal oxygen|high flow nasal oxygen
76605|NCT03086408|high flow nasal cannula|high flow nasal cannula
76606|NCT03086408|THRIVE|thrive
76607|NCT03086395|relapsed|relapsed
76608|NCT03086395|refractory|refractory
76609|NCT03086382|Lacosamide|lacosamide
76610|NCT03086382|Syrup|syrup
76611|NCT03086382|Bioequivalence|bioequivalence
76612|NCT03086382|Tablet|tablet
76613|NCT03086343|Musculoskeletal Disease|musculoskeletal disease
76614|NCT03086343|Arthritis|arthritis
76615|NCT03086343|Joint Disease|joint disease
76616|NCT03086343|Anti-inflammatory agents|anti-inflammatory agents
76617|NCT03086343|Antirheumatic agents|antirheumatic agents
76618|NCT03086317|Pulmonary Medicine|pulmonary medicine
76619|NCT03086317|Therapy Evaluation|therapy evaluation
76620|NCT03086304|postoperative intestinal obstruction;TEAS|postoperative intestinal obstruction;teas
76621|NCT03086265|airway management|airway management
76622|NCT03086265|high flow nasal oxygen high flow nasal cannula THRIVE|high flow nasal oxygen high flow nasal cannula thrive
76623|NCT03086265|high flow nasal cannula THRIVE|high flow nasal cannula thrive
76624|NCT03086265|THRIVE|thrive
76625|NCT03086239|Advanced, Recurrent Small Cell Lung Cancer|advanced, recurrent small cell lung cancer
76626|NCT03086239|Small Cell Lung Cancer|small cell lung cancer
76627|NCT03086239|Rovalpituzumab tesirine|rovalpituzumab tesirine
76628|NCT03086239|Cancer|cancer
76629|NCT03086226|Mycetoma Fosravuconazole Itraconazole Surgery Sudan|mycetoma fosravuconazole itraconazole surgery sudan
76630|NCT03086213|nonintubated uniport thoracoscopic surgery|nonintubated uniport thoracoscopic surgery
76631|NCT03086213|paravertebral nerve block|paravertebral nerve block
76632|NCT03086213|intercostal nerve block|intercostal nerve block
76633|NCT03086213|peripheral solitary pulmonary nodule|peripheral solitary pulmonary nodule
76634|NCT03086200|PrEP|prep
76635|NCT03086200|Pre-exposure Prophylaxis|pre-exposure prophylaxis
76636|NCT03086200|Text messaging|text messaging
76637|NCT03086200|Truvada|truvada
76638|NCT03086200|Motivational interviewing|motivational interviewing
76639|NCT03086200|Transgender|transgender
76640|NCT03086200|Gender Non-conforming|gender non-conforming
76641|NCT03086187|weight bearing|weight bearing
76642|NCT03086187|muscle unloading|muscle unloading
76643|NCT03086187|bone loss|bone loss
76644|NCT03086187|arterial adaptation|arterial adaptation
76645|NCT03086187|muscular adaptation|muscular adaptation
76646|NCT03086174|anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
76647|NCT03086174|advanced|advanced
76648|NCT03086174|melanoma|melanoma
76649|NCT03086174|kidney cancer|kidney cancer
76650|NCT03086122|OSA|osa
76651|NCT03086122|Erectile Dysfunction|erectile dysfunction
76652|NCT03086122|CPAP treatment|cpap treatment
76653|NCT03086122|Endothelial Dysfunction|endothelial dysfunction
76654|NCT03086122|Cardiovascular risk|cardiovascular risk
76655|NCT03086109|prevalence|prevalence
76656|NCT03086109|Bone Degenerative Disease|bone degenerative disease
76657|NCT03086083|Traumatic memories|traumatic memories
76658|NCT03086083|comparative study|comparative study
76659|NCT03086083|single session|single session
76660|NCT03086083|EMDR|emdr
76661|NCT03086083|Beck inventory|beck inventory
76662|NCT03086070|omeprazole|omeprazole
76663|NCT03086070|placebo|placebo
76664|NCT03086070|treatment|treatment
76665|NCT03086070|adults|adults
76666|NCT03086057|PrEP|prep
76667|NCT03086057|Prevention|prevention
76668|NCT03086057|Male Sex Workers (MSW)|male sex workers (msw)
76669|NCT03086031|Traumatic brain injury, Vocational rehabilitation, Caregiver intervention,|traumatic brain injury, vocational rehabilitation, caregiver intervention,
76670|NCT03086005|Metformin|metformin
76671|NCT03085992|rectal cancer|rectal cancer
76672|NCT03085992|FOLFOXIRI|folfoxiri
76673|NCT03085992|bevacizumab|bevacizumab
76674|NCT03085992|trust|trust
76675|NCT03085966|central memory T cell|central memory t cell
76676|NCT03085966|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
76677|NCT03085953|Psychological health|psychological health
76678|NCT03085953|Well-being|well-being
76679|NCT03085953|Employee|employee
76680|NCT03085927|music therapy|music therapy
76681|NCT03085927|neoplasms|neoplasms
76682|NCT03085927|play|play
76683|NCT03085927|children|children
76684|NCT03085927|parents|parents
76685|NCT03085914|solid tumors|solid tumors
76686|NCT03085914|colorectal cancer|colorectal cancer
76687|NCT03085914|pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
76688|NCT03085914|non-small cell lung cancer|non-small cell lung cancer
76689|NCT03085914|PD-1|pd-1
76690|NCT03085914|PD-L1|pd-l1
76691|NCT03085914|epacadostat|epacadostat
76692|NCT03085914|IDO inhibitor|ido inhibitor
76693|NCT03085888|Cancer Screening|cancer screening
76694|NCT03085888|Next Generation Sequencing|next generation sequencing
76695|NCT03085888|Circulating cell-free nucleic acid|circulating cell-free nucleic acid
76696|NCT03085888|Circulating cell-free tumor DNA|circulating cell-free tumor dna
76697|NCT03085888|Deep sequencing|deep sequencing
76698|NCT03085875|Weight Change|weight change
76699|NCT03085875|Healthy Pregnancy|healthy pregnancy
76700|NCT03085875|Physiologic Sensors|physiologic sensors
76701|NCT03085862|Ultrasonography|ultrasonography
76702|NCT03085862|Extravascular lung water|extravascular lung water
76703|NCT03085862|PaO2/FiO2 ratio|pao2/fio2 ratio
76704|NCT03085836|Drug Therapy|drug therapy
76705|NCT03085797|SB240563|sb240563
76706|NCT03085797|Nasal Polyps|nasal polyps
76707|NCT03085797|Mepolizumab|mepolizumab
76708|NCT03085797|Phase 3|phase 3
76709|NCT03085797|Parallel group|parallel group
76710|NCT03085797|Efficacy|efficacy
76711|NCT03085758|Early Septic Shock|early septic shock
76712|NCT03085745|Writer's cramp|writer's cramp
76713|NCT03085745|Sensorimotor plasticity|sensorimotor plasticity
76714|NCT03085745|TMS|tms
76715|NCT03085745|Afferent inhibition|afferent inhibition
76716|NCT03085745|Motor mapping|motor mapping
76717|NCT03085745|Sensory mapping|sensory mapping
76718|NCT03085745|adaptive sensorimotor synergies|adaptive sensorimotor synergies
76719|NCT03085745|fine motor control|fine motor control
76720|NCT03085732|saline irrigation|saline irrigation
76721|NCT03085732|abdominal hysterectomy|abdominal hysterectomy
76722|NCT03085732|postoperative infectious morbidities|postoperative infectious morbidities
76723|NCT03085732|gastrointestinal disturbances|gastrointestinal disturbances
76724|NCT03085719|Head and Neck Cancer|head and neck cancer
76725|NCT03085680|Curcumin, physical function, cognitive function|curcumin, physical function, cognitive function
76726|NCT03085667|Left atrial appendage occluder|left atrial appendage occluder
76727|NCT03085667|Watchman device|watchman device
76728|NCT03085667|Atrial fibrillation|atrial fibrillation
76729|NCT03085667|atrial natriureitc peptide|atrial natriureitc peptide
76730|NCT03085667|brain natriuretic peptide|brain natriuretic peptide
76731|NCT03085654|multiple doses|multiple doses
76732|NCT03085654|oxytocin|oxytocin
76733|NCT03085654|trait anxiety|trait anxiety
76734|NCT03085641|High flow oxygen therapy|high flow oxygen therapy
76735|NCT03085628|social sharing|social sharing
76736|NCT03085628|social reward|social reward
76737|NCT03085628|functional magnetic resonance imaging|functional magnetic resonance imaging
76738|NCT03085628|reward circuit|reward circuit
76739|NCT03085589|elderly|elderly
76740|NCT03085589|telemedicine|telemedicine
76741|NCT03085589|obesity|obesity
76742|NCT03085589|rural health|rural health
76743|NCT03085589|health promotion|health promotion
76744|NCT03085576|Atrial Fibrillation|atrial fibrillation
76745|NCT03085576|Anticoagulation|anticoagulation
76746|NCT03085576|Stroke|stroke
76747|NCT03085576|Vitamin K antagonist|vitamin k antagonist
76748|NCT03085576|Cardioversion|cardioversion
76749|NCT03085576|INR (International Normalized Ratio)|inr (international normalized ratio)
76750|NCT03085550|diabetic foot ulcer|diabetic foot ulcer
76751|NCT03085550|diabetes mellitus|diabetes mellitus
76752|NCT03085550|fat grafting|fat grafting
76753|NCT03085550|platelet rich plasma|platelet rich plasma
76754|NCT03085550|wound healing|wound healing
76755|NCT03085537|home monitoring|home monitoring
76756|NCT03085537|Non-invasive mechanical ventilation|non-invasive mechanical ventilation
76757|NCT03085511|Egg breakfast|egg breakfast
76758|NCT03085511|Weight loss|weight loss
76759|NCT03085511|Satiety|satiety
76760|NCT03085511|Insulin|insulin
76761|NCT03085511|Glucagon-Like Peptide 1|glucagon-like peptide 1
76762|NCT03085511|PYY (3-36) peptide|pyy (3-36) peptide
76763|NCT03085511|Ghrelin|ghrelin
76764|NCT03085511|Glucose|glucose
76765|NCT03085511|Protein quality|protein quality
76766|NCT03085498|retinal vessels|retinal vessels
76767|NCT03085498|physical activity|physical activity
76768|NCT03085498|children|children
76769|NCT03085498|psychosocial health|psychosocial health
76770|NCT03085485|COPD|copd
76771|NCT03085485|CFTR|cftr
76772|NCT03085485|ivacaftor|ivacaftor
76773|NCT03085485|topic trial|topic trial
76774|NCT03085472|intracerebral hemrrohage|intracerebral hemrrohage
76775|NCT03085472|stroke|stroke
76776|NCT03085472|China|china
76777|NCT03085472|hematoma|hematoma
76778|NCT03085472|CT|ct
76779|NCT03085472|predictor|predictor
76780|NCT03085472|prognosis|prognosis
76781|NCT03085472|outcome|outcome
76782|NCT03085420|Burns|burns
76783|NCT03085420|Pediatrics|pediatrics
76784|NCT03085420|Cardiac Arrhythmia|cardiac arrhythmia
76785|NCT03085394|Morbid Obesity|morbid obesity
76786|NCT03085394|Sleeve gastrectomy|sleeve gastrectomy
76787|NCT03085368|breast cancer|breast cancer
76788|NCT03085368|her-2 positive|her-2 positive
76789|NCT03085368|lapatinib|lapatinib
76790|NCT03085368|herceptin|herceptin
76791|NCT03085355|neck pain|neck pain
76792|NCT03085342|liver|liver
76793|NCT03085342|fibrosis|fibrosis
76794|NCT03085342|MRI|mri
76795|NCT03085329|bubble nasal continuous positive airway pressure|bubble nasal continuous positive airway pressure
76796|NCT03085329|respiratory support|respiratory support
76797|NCT03085290|dry eye syndrome|dry eye syndrome
76798|NCT03085290|serum eye drops|serum eye drops
76799|NCT03085277|Bovine colostrum|bovine colostrum
76800|NCT03085277|Preterm formula|preterm formula
76801|NCT03085277|Very preterm infants|very preterm infants
76802|NCT03085277|Enteral feeding|enteral feeding
76803|NCT03085225|Advanced tumor|advanced tumor
76804|NCT03085225|Pretreated tumor|pretreated tumor
76805|NCT03085225|Soft Tissue Sarcomas|soft tissue sarcomas
76806|NCT03085225|Ovarian Carcinomas|ovarian carcinomas
76807|NCT03085225|Phase Ib|phase ib
76808|NCT03085225|Circulating DNA|circulating dna
76809|NCT03085199|gastric cancer|gastric cancer
76810|NCT03085199|laparoscopic gastrectomy|laparoscopic gastrectomy
76811|NCT03085199|laparoscopic reinforcement suture (LARS)|laparoscopic reinforcement suture (lars)
76812|NCT03085173|CAR T Cells Targeting CD19|car t cells targeting cd19
76813|NCT03085173|EGFRt/19-28z/4-1BBL|egfrt/19-28z/4-1bbl
76814|NCT03085173|16-1570|16-1570
76815|NCT03085147|Tongue|tongue
76817|NCT03085147|Fluorescent PARP1 Binding Imaging Agent|fluorescent parp1 binding imaging agent
76818|NCT03085147|PARPi-FL|parpi-fl
76819|NCT03085147|15-336|15-336
76820|NCT03085121|extramedullary|extramedullary
76821|NCT03085121|intramedullary|intramedullary
76822|NCT03085121|total knee arthroplasty (TKA)|total knee arthroplasty (tka)
76823|NCT03085069|PD-1|pd-1
76824|NCT03085069|PD-L1|pd-l1
76825|NCT03085069|shr-1210|shr-1210
76826|NCT03085056|Trametinib|trametinib
76827|NCT03085056|Paclitaxel|paclitaxel
76828|NCT03085056|15-055|15-055
76829|NCT03085043|Prostate Cancer|prostate cancer
76830|NCT03085043|Whole body MRI|whole body mri
76831|NCT03085043|MRI of the pelvis|mri of the pelvis
76832|NCT03085043|Magnetic resonance imaging|magnetic resonance imaging
76833|NCT03085043|Bone scan|bone scan
76834|NCT03085043|Computed tomography scan of abdomen and pelvis|computed tomography scan of abdomen and pelvis
76835|NCT03085043|CT|ct
76836|NCT03085030|infertility|infertility
76837|NCT03085030|IVF|ivf
76838|NCT03085030|ICSI|icsi
76839|NCT03085030|poor responders in IVF/ICSI cycles|poor responders in ivf/icsi cycles
76840|NCT03085030|antioxidant|antioxidant
76841|NCT03085004|Pancreatic cyst|pancreatic cyst
76842|NCT03085004|Cyst Ablation|cyst ablation
76843|NCT03085004|Eus-FNA (fine-needle aspiration )|eus-fna (fine-needle aspiration )
76844|NCT03085004|Chemotherapy|chemotherapy
76845|NCT03084952|safety|safety
76846|NCT03084952|pharmacokynetics|pharmacokynetics
76847|NCT03084952|leishmaniasis treatment|leishmaniasis treatment
76848|NCT03084913|dietary treatment|dietary treatment
76849|NCT03084887|Tissue Expansion Devices|tissue expansion devices
76850|NCT03084887|Tissue Expansion|tissue expansion
76851|NCT03084887|common complications|common complications
76852|NCT03084887|intervention study|intervention study
76853|NCT03084874|COPD|copd
76854|NCT03084874|Physical Activity|physical activity
76855|NCT03084874|Sedentary behaviour|sedentary behaviour
76856|NCT03084874|Hospitalization|hospitalization
76857|NCT03084848|brain/cognitive measures|brain/cognitive measures
76858|NCT03084848|condition|condition
76859|NCT03084848|inhibitor control|inhibitor control
76860|NCT03084848|training at adolescence|training at adolescence
76861|NCT03084835|tobacco|tobacco
76862|NCT03084835|smoking|smoking
76863|NCT03084835|low dose computed tomography|low dose computed tomography
76864|NCT03084835|lung screening|lung screening
76865|NCT03084835|text messaging|text messaging
76866|NCT03084783|dexamethasone|dexamethasone
76867|NCT03084783|HSV encephalitis|hsv encephalitis
76868|NCT03084770|NF-PNEN|nf-pnen
76869|NCT03084731|Microbiota|microbiota
76870|NCT03084731|Complementary Food|complementary food
76871|NCT03084692|caregiver|caregiver
76872|NCT03084692|lung cancer|lung cancer
76873|NCT03084692|yoga|yoga
76874|NCT03084692|resistance exercise|resistance exercise
76875|NCT03084679|Heart Failure|heart failure
76876|NCT03084679|Hypertrophy|hypertrophy
76877|NCT03084679|Fibrosis|fibrosis
76878|NCT03084679|Magnetic Resonance|magnetic resonance
76879|NCT03084653|Trocar entery|trocar entery
76880|NCT03084653|Surgery, Laparoscopic|surgery, laparoscopic
76881|NCT03084627|tailored dietary advice|tailored dietary advice
76882|NCT03084627|nutrient adequacy|nutrient adequacy
76883|NCT03084627|dietary modifications|dietary modifications
76884|NCT03084614|Infectious Diseases|infectious diseases
76885|NCT03084614|Dendritic Cells|dendritic cells
76886|NCT03084614|Pathogens|pathogens
76887|NCT03084614|Passive Cellular Immunity|passive cellular immunity
76888|NCT03084614|Immune-Modulating|immune-modulating
76889|NCT03084575|neuroaxial rhizolysis -selective rhizolysis-thermal radiofrequency|neuroaxial rhizolysis -selective rhizolysis-thermal radiofrequency
76890|NCT03084510|High risk for surgical valve replacement|high risk for surgical valve replacement
76891|NCT03084510|transcatheter aortic valve replacement|transcatheter aortic valve replacement
76892|NCT03084497|Massage|massage
76893|NCT03084497|Development|development
76894|NCT03084471|Programmed death ligand 1 (PD-L1)|programmed death ligand 1 (pd-l1)
76895|NCT03084471|Cytotoxic T-lymphocyte antigen-4 (CTLA-4)|cytotoxic t-lymphocyte antigen-4 (ctla-4)
76896|NCT03084471|Durvalumab in combination with tremelimumab|durvalumab in combination with tremelimumab
76897|NCT03084458|Increasing daily physical activity|increasing daily physical activity
76898|NCT03084445|Brominated Flame Retardants (BFRs)|brominated flame retardants (bfrs)
76899|NCT03084445|Phthalates|phthalates
76900|NCT03084445|pregnant women|pregnant women
76901|NCT03084445|newborn|newborn
76902|NCT03084445|Heavy Metals|heavy metals
76903|NCT03084445|Volatile Organic Compounds|volatile organic compounds
76904|NCT03084432|caffeine|caffeine
76905|NCT03084432|bone mineral content|bone mineral content
76906|NCT03084419|Rheumatoid Arthritis|rheumatoid arthritis
76907|NCT03084419|Interstitial Lung Disease|interstitial lung disease
76908|NCT03084419|RA-ILD|ra-ild
76909|NCT03084419|Abatacept|abatacept
76910|NCT03084406|Substance Abuse|substance abuse
76911|NCT03084406|Implementation Science|implementation science
76912|NCT03084406|Evidence-based Practices|evidence-based practices
76913|NCT03084393|non-cardiac surgery|non-cardiac surgery
77113|NCT03082963|ablation|ablation
76914|NCT03084393|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
76915|NCT03084354|pelvic floor|pelvic floor
76916|NCT03084354|women's experiences|women's experiences
76917|NCT03084354|bladder care|bladder care
76918|NCT03084354|pregnancy|pregnancy
76919|NCT03084354|labour|labour
76920|NCT03084354|postpartum|postpartum
76921|NCT03084341|Elasticity|elasticity
76922|NCT03084341|Electric Stimulation|electric stimulation
76923|NCT03084341|Muscle Stretching Exercises|muscle stretching exercises
76924|NCT03084315|smoking|smoking
76925|NCT03084315|electronic cigarettes|electronic cigarettes
76926|NCT03084315|nicotine|nicotine
76927|NCT03084302|sedentary behavior|sedentary behavior
76928|NCT03084302|physical activity|physical activity
76929|NCT03084276|meal ingestion|meal ingestion
76930|NCT03084276|meal composition|meal composition
76931|NCT03084276|postprandial responses|postprandial responses
76932|NCT03084276|hedonic sensations|hedonic sensations
76933|NCT03084276|homeostatic sensations|homeostatic sensations
76934|NCT03084276|new composition|new composition
76935|NCT03084211|emergency department|emergency department
76936|NCT03084211|concussion|concussion
76937|NCT03084211|head injury|head injury
76938|NCT03084198|Bioartificial Liver|bioartificial liver
76939|NCT03084198|Acute Liver Failure|acute liver failure
76940|NCT03084185|decompensation|decompensation
76941|NCT03084185|deficit|deficit
76942|NCT03084185|metabolomics|metabolomics
76943|NCT03084185|portal hypertension|portal hypertension
76944|NCT03084133|Therapeutic education strategy|therapeutic education strategy
76945|NCT03084107|Elder care|elder care
76946|NCT03084107|Active aging|active aging
76947|NCT03084107|Intelligent Care Facilities for Elders|intelligent care facilities for elders
76948|NCT03084094|Fibromyalgia|fibromyalgia
76949|NCT03084094|tDCS|tdcs
76950|NCT03084081|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
76951|NCT03084081|Cryotherapy|cryotherapy
76952|NCT03084081|Thermoablation|thermoablation
76953|NCT03084081|Thermocoagulation|thermocoagulation
76954|NCT03084081|Low and Middle Income Countries (LMICs)|low and middle income countries (lmics)
76955|NCT03084042|emotional impairments|emotional impairments
76956|NCT03084042|cognitive impairments|cognitive impairments
76957|NCT03084029|oxytocin|oxytocin
76958|NCT03084029|fMRI|fmri
76959|NCT03084029|empathy|empathy
76960|NCT03083964|Middle aged women|middle aged women
76961|NCT03083964|35-64yrs|35-64yrs
76962|NCT03083964|BMI= >30|bmi= >30
76963|NCT03083951|Complete mesocolon excision|complete mesocolon excision
76964|NCT03083951|Sigmoid cancer|sigmoid cancer
76965|NCT03083951|Colorectal cancer|colorectal cancer
76966|NCT03083938|Pancreatoduodenectomy|pancreatoduodenectomy
76967|NCT03083938|Omentum|omentum
76968|NCT03083938|Wrapping|wrapping
76969|NCT03083938|Roll-up|roll-up
76970|NCT03083938|Whipple|whipple
76971|NCT03083912|Malnutrition|malnutrition
76972|NCT03083912|Disability|disability
76973|NCT03083912|Oral Nutritional Supplementation|oral nutritional supplementation
76974|NCT03083899|Diabetes|diabetes
76975|NCT03083899|Organization|organization
76976|NCT03083899|Out-patient control|out-patient control
76977|NCT03083873|LN-145|ln-145
76978|NCT03083873|Cell Therapy|cell therapy
76979|NCT03083873|Autologous Adoptive Cell Transfer|autologous adoptive cell transfer
76980|NCT03083873|Autologous Adoptive Cell Therapy|autologous adoptive cell therapy
76981|NCT03083873|Cellular Immuno-therapy|cellular immuno-therapy
76982|NCT03083873|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
76983|NCT03083873|TIL|til
76984|NCT03083873|IL-2|il-2
76985|NCT03083847|Malaria|malaria
76986|NCT03083847|Parasitemia|parasitemia
76987|NCT03083847|Immune|immune
76988|NCT03083847|Responses|responses
76989|NCT03083847|Sporozoites|sporozoites
76990|NCT03083834|cosyntropin|cosyntropin
76991|NCT03083834|salivary free cortisol|salivary free cortisol
76992|NCT03083834|mitotane|mitotane
76993|NCT03083808|PD-1|pd-1
76994|NCT03083808|PD-L1 Inhibitor|pd-l1 inhibitor
76995|NCT03083808|Pembrolizumab|pembrolizumab
76996|NCT03083808|Docetaxel|docetaxel
76997|NCT03083808|Pemetrexed|pemetrexed
76998|NCT03083808|Gemcitabine|gemcitabine
76999|NCT03083795|Social relationships|social relationships
77000|NCT03083795|Vulnerable connections|vulnerable connections
77001|NCT03083795|Diabetes Distress|diabetes distress
77002|NCT03083795|Support group|support group
77003|NCT03083782|Apixaban|apixaban
77004|NCT03083782|Cyclosporine|cyclosporine
77005|NCT03083782|Tacrolimus|tacrolimus
77006|NCT03083782|Cytochrome P450 CYP3A4|cytochrome p450 cyp3a4
77007|NCT03083782|Permeability Glycoprotein P-gp|permeability glycoprotein p-gp
77008|NCT03083782|Breast cancer resistance protein BCRP|breast cancer resistance protein bcrp
77009|NCT03083782|Factor Xa Inhibitors|factor xa inhibitors
77010|NCT03083782|Anticoagulants|anticoagulants
77011|NCT03083782|Enzyme Inhibitors|enzyme inhibitors
77012|NCT03083769|tacrolimus|tacrolimus
77013|NCT03083769|genetic variants|genetic variants
77014|NCT03083769|side effects|side effects
77015|NCT03083743|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
77016|NCT03083743|Carcinoma, Bronchogenic|carcinoma, bronchogenic
77017|NCT03083743|Bronchial Neoplasms|bronchial neoplasms
77018|NCT03083743|Lung Neoplasms|lung neoplasms
77019|NCT03083743|Thoracic Neoplasms|thoracic neoplasms
77020|NCT03083743|Neoplasms|neoplasms
77021|NCT03083743|Lung Diseases|lung diseases
77022|NCT03083743|Antineoplastic Agents, Cytokines|antineoplastic agents, cytokines
77023|NCT03083743|Antineoplastic Agents|antineoplastic agents
77024|NCT03083743|Biological activity factor|biological activity factor
77025|NCT03083743|Genetic Engineering|genetic engineering
77026|NCT03083743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
77027|NCT03083743|Physiological Effects of Drugs|physiological effects of drugs
77028|NCT03083730|Atopic Dermatitis|atopic dermatitis
77029|NCT03083730|Eczema|eczema
77030|NCT03083730|Systemic Inflammation|systemic inflammation
77031|NCT03083730|UVB Phototherapy|uvb phototherapy
77032|NCT03083691|Nivolumab|nivolumab
77033|NCT03083691|Ipilimumab|ipilimumab
77034|NCT03083678|EGFR|egfr
77035|NCT03083678|Afatinib|afatinib
77036|NCT03083665|Epilepsy|epilepsy
77037|NCT03083665|Partial seizures with or without secondary generalization|partial seizures with or without secondary generalization
77038|NCT03083665|Brivaracetam|brivaracetam
77039|NCT03083665|Asian subjects|asian subjects
77040|NCT03083652|physiotherapy|physiotherapy
77041|NCT03083652|neuromuscular electrical stimulation|neuromuscular electrical stimulation
77042|NCT03083652|exercise capacity|exercise capacity
77043|NCT03083639|Drug Therapy|drug therapy
77044|NCT03083626|Chronic pain|chronic pain
77045|NCT03083626|Narcotic abuse|narcotic abuse
77046|NCT03083626|Opioid related disorders|opioid related disorders
77047|NCT03083626|Opiate substitution treatment|opiate substitution treatment
77048|NCT03083626|Buprenorphine|buprenorphine
77049|NCT03083626|Pregabalin|pregabalin
77050|NCT03083626|Methadone|methadone
77051|NCT03083613|Raltitrexed|raltitrexed
77052|NCT03083613|Paclitaxel|paclitaxel
77053|NCT03083613|chemotherapy|chemotherapy
77054|NCT03083613|Gastric cancer|gastric cancer
77055|NCT03083613|Gastroesophageal Junction Adenocarcinoma|gastroesophageal junction adenocarcinoma
77056|NCT03083600|protein hydrolysates|protein hydrolysates
77057|NCT03083600|HbA1c|hba1c
77058|NCT03083600|prediabetes|prediabetes
77059|NCT03083574|Hematology|hematology
77060|NCT03083574|Chronic graft versus host disease (cGVHD)|chronic graft versus host disease (cgvhd)
77061|NCT03083574|Extracorporeal photopheresis|extracorporeal photopheresis
77062|NCT03083574|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
77063|NCT03083574|Donor lymphocyte infusion|donor lymphocyte infusion
77064|NCT03083522|Cold Hypersensitivity|cold hypersensitivity
77065|NCT03083522|Korean medicine|korean medicine
77066|NCT03083522|Ojeok-san|ojeok-san
77067|NCT03083522|Cold intolerance|cold intolerance
77068|NCT03083418|AECOPD|aecopd
77069|NCT03083418|EDP|edp
77070|NCT03083418|Neural Respiratory Drive|neural respiratory drive
77071|NCT03083418|Surface EMGdi|surface emgdi
77072|NCT03083392|DIVA|diva
77073|NCT03083392|sinusitis|sinusitis
77074|NCT03083392|maxillary|maxillary
77075|NCT03083379|Incentive spirometry|incentive spirometry
77076|NCT03083379|EzPAP|ezpap
77077|NCT03083379|Electrical impedance tomography|electrical impedance tomography
77078|NCT03083366|spinal cord injury|spinal cord injury
77079|NCT03083366|Neurogenic|neurogenic
77080|NCT03083366|bladder|bladder
77081|NCT03083366|electrical stimulation|electrical stimulation
77082|NCT03083366|neuromodulation|neuromodulation
77083|NCT03083301|Cardiac resynchronisation|cardiac resynchronisation
77084|NCT03083223|patient positioning|patient positioning
77085|NCT03083223|lung diseases|lung diseases
77086|NCT03083223|oxygenation|oxygenation
77087|NCT03083223|hemodynamic parameters|hemodynamic parameters
77088|NCT03083223|vital signs|vital signs
77089|NCT03083197|Scrub Typhus|scrub typhus
77090|NCT03083197|Antibiotic Resistance|antibiotic resistance
77091|NCT03083184|Hemodialysis|hemodialysis
77092|NCT03083184|hemodiafiltration|hemodiafiltration
77093|NCT03083184|tunnelled dialysis catheter|tunnelled dialysis catheter
77094|NCT03083184|interdialytic lock solution|interdialytic lock solution
77095|NCT03083184|preventing tunnelled catheter infection|preventing tunnelled catheter infection
77096|NCT03083171|Adrecizumab|adrecizumab
77097|NCT03083171|Adrenomedullin|adrenomedullin
77098|NCT03083171|Healthy volunteers|healthy volunteers
77099|NCT03083171|LPS|lps
77100|NCT03083171|Monoclonal recombinant antibody|monoclonal recombinant antibody
77101|NCT03083132|freezing of gait|freezing of gait
77102|NCT03083067|AECOPD|aecopd
77103|NCT03083067|air pollution|air pollution
77104|NCT03083067|COPD|copd
77105|NCT03083067|salvational Intervention|salvational intervention
77106|NCT03083041|SHR-1210|shr-1210
77107|NCT03083041|Apatinib|apatinib
77108|NCT03083041|NSCLC|nsclc
77109|NCT03083028|Ankle Fracture|ankle fracture
77110|NCT03083015|regeneration, MTA apexification and TAP|regeneration, mta apexification and tap
77111|NCT03083015|revascularization|revascularization
77112|NCT03082963|atrial fibrillation|atrial fibrillation
77114|NCT03082950|hpv prevalence|hpv prevalence
77115|NCT03082950|recurrence rate|recurrence rate
77116|NCT03082950|survival|survival
77117|NCT03082924|surface EMGdi|surface emgdi
77118|NCT03082924|pulmonary rehabilitation|pulmonary rehabilitation
77119|NCT03082924|inspiratory muscle training|inspiratory muscle training
77120|NCT03082924|exercise training|exercise training
77121|NCT03082911|screening|screening
77122|NCT03082911|early detection|early detection
77123|NCT03082911|participation|participation
77124|NCT03082872|Reduction, Fracture|reduction, fracture
77125|NCT03082859|Exercise|exercise
77126|NCT03082859|Interval Training|interval training
77127|NCT03082859|Glycaemic Control|glycaemic control
77128|NCT03082859|Type 2 Diabetes|type 2 diabetes
77129|NCT03082846|malignant glioma|malignant glioma
77130|NCT03082846|intensity modulated radiation therapy|intensity modulated radiation therapy
77131|NCT03082846|simultaneous integrated boost|simultaneous integrated boost
77132|NCT03082846|hypofractionation|hypofractionation
77133|NCT03082846|temozolomide|temozolomide
77134|NCT03082846|maximum tolerated dose|maximum tolerated dose
77135|NCT03082807|Caloric Restriction|caloric restriction
77136|NCT03082807|Diet|diet
77137|NCT03082807|Exercise|exercise
77138|NCT03082807|Obesity|obesity
77139|NCT03082807|Overweight|overweight
77140|NCT03082807|Sedentary lifestyle|sedentary lifestyle
77141|NCT03082807|weight loss|weight loss
77142|NCT03082807|Men|men
77143|NCT03082794|Dietary Formulations|dietary formulations
77144|NCT03082794|Lifestyle|lifestyle
77145|NCT03082794|Obesity|obesity
77146|NCT03082794|Overweight|overweight
77147|NCT03082794|weight loss|weight loss
77148|NCT03082781|Diet|diet
77149|NCT03082781|Exercise|exercise
77150|NCT03082781|Obesity|obesity
77151|NCT03082781|Overweight|overweight
77152|NCT03082781|Weight loss|weight loss
77153|NCT03082768|HV|hv
77154|NCT03082742|diuretics|diuretics
77155|NCT03082742|furosemide|furosemide
77156|NCT03082742|hydrochlorothiazide|hydrochlorothiazide
77157|NCT03082742|CKD-MBD|ckd-mbd
77158|NCT03082742|HRpQCT|hrpqct
77159|NCT03082742|parathyroid hormone|parathyroid hormone
77160|NCT03082716|cardioplegia|cardioplegia
77161|NCT03082716|myocardial protection|myocardial protection
77162|NCT03082716|custodiol|custodiol
77163|NCT03082716|htk|htk
77164|NCT03082677|Ixazomib|ixazomib
77165|NCT03082677|Graft-versus-Host Disease|graft-versus-host disease
77166|NCT03082677|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
77167|NCT03082677|16-076|16-076
77168|NCT03082651|Running injuries, footwear, alternating load|running injuries, footwear, alternating load
77169|NCT03082612|Behavioral research|behavioral research
77170|NCT03082612|Social research|social research
77171|NCT03082612|Spirituality|spirituality
77172|NCT03082612|Late stage cancer|late stage cancer
77173|NCT03082547|Headache|headache
77174|NCT03082547|Neuropsychological tests|neuropsychological tests
77175|NCT03082547|Myofascial trigger points|myofascial trigger points
77176|NCT03082547|electrophysiology|electrophysiology
77177|NCT03082534|Head and Neck Cancer|head and neck cancer
77178|NCT03082534|Pembrolizumab|pembrolizumab
77179|NCT03082534|Keytruda®|keytruda®
77180|NCT03082534|Cetuximab|cetuximab
77181|NCT03082534|Erbitux®|erbitux®
77182|NCT03082534|Recurrent|recurrent
77183|NCT03082534|Metastatic|metastatic
77184|NCT03082534|PD-1|pd-1
77185|NCT03082534|PD-L1|pd-l1
77186|NCT03082534|non-EBV related Nasopharynx|non-ebv related nasopharynx
77187|NCT03082521|After hours care; Primary care; Antibiotics; Action Research|after hours care; primary care; antibiotics; action research
77188|NCT03082508|Algisyl|algisyl
77189|NCT03082508|Heart Failure|heart failure
77190|NCT03082508|Dilated Cardiomyopathy|dilated cardiomyopathy
77191|NCT03082508|Alginate Hydrogel|alginate hydrogel
77192|NCT03082508|Heart Failure with Reduced Ejection Fraction|heart failure with reduced ejection fraction
77193|NCT03082508|Congestive Heart Failure|congestive heart failure
77194|NCT03082495|Exercise|exercise
77195|NCT03082495|Cancer|cancer
77196|NCT03082495|Symptom management|symptom management
77197|NCT03082495|Quality of life|quality of life
77198|NCT03082495|presurgical|presurgical
77199|NCT03082495|chemoradiotherapy|chemoradiotherapy
77200|NCT03082495|Physical Fitness|physical fitness
77201|NCT03082482|Smoking Cessation|smoking cessation
77202|NCT03082482|HIV|hiv
77203|NCT03082482|AIDS|aids
77204|NCT03082469|Severe acute pancreatitis|severe acute pancreatitis
77205|NCT03082469|Haemodynamic monitoring|haemodynamic monitoring
77206|NCT03082469|Cytokine removal|cytokine removal
77207|NCT03082469|Vasopressor dependency index|vasopressor dependency index
77208|NCT03082456|molecuiar breast imaging|molecuiar breast imaging
77209|NCT03082456|MBI|mbi
77210|NCT03082456|breast cancer|breast cancer
77211|NCT03082456|mammography|mammography
77212|NCT03082456|sonography|sonography
77213|NCT03082456|recall rate|recall rate
77214|NCT03082456|diagnostic accuracy|diagnostic accuracy
77215|NCT03082456|breast echo|breast echo
77216|NCT03082456|female population|female population
77217|NCT03082443|Cardiac rehabilitation|cardiac rehabilitation
77218|NCT03082443|psychology|psychology
77219|NCT03082443|nutrition|nutrition
77220|NCT03082443|stress|stress
77221|NCT03082443|quality of life|quality of life
77222|NCT03082417|Bone Fracture|bone fracture
77223|NCT03082417|75 years old|75 years old
77224|NCT03082417|Elderly|elderly
77225|NCT03082417|Older adults|older adults
77226|NCT03082417|Pain scale|pain scale
77227|NCT03082417|Pain documentation|pain documentation
77228|NCT03082417|Analgesics|analgesics
77229|NCT03082417|Acetaminophen|acetaminophen
77230|NCT03082417|Opioid|opioid
77231|NCT03082417|Nonsteroidal anti-inflammatory drugs|nonsteroidal anti-inflammatory drugs
77232|NCT03082417|Emergency Department|emergency department
77233|NCT03082404|Chronic kidney disease|chronic kidney disease
77234|NCT03082404|Inspiratory muscle training|inspiratory muscle training
77235|NCT03082391|Ventral Hernia Repair|ventral hernia repair
77236|NCT03082391|Heavyweight Mesh|heavyweight mesh
77237|NCT03082391|Mediumweight Mesh|mediumweight mesh
77238|NCT03082365|oral findings or oral manifestations|oral findings or oral manifestations
77239|NCT03082365|pre-dialysis or end stage renal disease|pre-dialysis or end stage renal disease
77240|NCT03082326|shock|shock
77241|NCT03082326|critical care ultrasound|critical care ultrasound
77242|NCT03082326|hemodynamics|hemodynamics
77243|NCT03082326|lung pathology|lung pathology
77244|NCT03082326|epidemic|epidemic
77245|NCT03082326|prognosis|prognosis
77246|NCT03082313|infant|infant
77247|NCT03082313|leg movement|leg movement
77248|NCT03082313|wearable sensors|wearable sensors
77249|NCT03082313|early intervention|early intervention
77250|NCT03082300|ASP8273|asp8273
77251|NCT03082300|Epidermal growth factor receptor (EGFR) mutations|epidermal growth factor receptor (egfr) mutations
77252|NCT03082300|naquotinib|naquotinib
77253|NCT03082300|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
77254|NCT03082300|Bioequivalence|bioequivalence
77255|NCT03082261|Failed Back Surgery Syndrome|failed back surgery syndrome
77256|NCT03082261|Radiculopathy|radiculopathy
77257|NCT03082261|Post Laminectomy Syndrome|post laminectomy syndrome
77258|NCT03082248|Low Back Pain|low back pain
77259|NCT03082248|Surgery|surgery
77260|NCT03082248|Lumbar Spine|lumbar spine
77261|NCT03082248|Physical Therapy Modalities|physical therapy modalities
77262|NCT03082248|Rehabilitation|rehabilitation
77263|NCT03082235|Healthy participants|healthy participants
77264|NCT03082235|E6742|e6742
77265|NCT03082235|pharmacokinetics|pharmacokinetics
77266|NCT03082222|partial onset seizures with or without secondary generalization|partial onset seizures with or without secondary generalization
77267|NCT03082209|Solid Tumors|solid tumors
77268|NCT03082209|Hematologic Malignancies|hematologic malignancies
77269|NCT03082209|Cancer|cancer
77270|NCT03082209|non-Hodgkin lymphoma|non-hodgkin lymphoma
77271|NCT03082209|acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
77272|NCT03082209|colorectal cancer (CRC)|colorectal cancer (crc)
77273|NCT03082209|Diffuse Large B-Cell Lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
77274|NCT03082196|sodium fluoride|sodium fluoride
77275|NCT03082196|povidone iodine|povidone iodine
77276|NCT03082196|varnish|varnish
77277|NCT03082170|sleep apnea|sleep apnea
77278|NCT03082170|robotic surgery for base of tongue|robotic surgery for base of tongue
77279|NCT03082170|soft palate surgery|soft palate surgery
77280|NCT03082170|post operative swallowing evaluation|post operative swallowing evaluation
77281|NCT03082170|dysphagia|dysphagia
77282|NCT03082131|Gut Microbiota|gut microbiota
77283|NCT03082131|Glycemic Response|glycemic response
77284|NCT03082131|Resistant Starch|resistant starch
77285|NCT03082131|Fiber|fiber
77286|NCT03082092|Knee|knee
77287|NCT03082092|Pain|pain
77288|NCT03082092|Recovery|recovery
77289|NCT03082092|Steroid|steroid
77290|NCT03082092|Replacement|replacement
77291|NCT03082092|Arthroplasty|arthroplasty
77292|NCT03082079|GIST|gist
77293|NCT03082079|ESD|esd
77294|NCT03082066|bone access|bone access
77295|NCT03082066|intraosseus needle|intraosseus needle
77296|NCT03082066|resuscitation|resuscitation
77297|NCT03082066|infusion|infusion
77298|NCT03082066|volume therapy|volume therapy
77299|NCT03082066|emergency|emergency
77300|NCT03082027|ultrasonography|ultrasonography
77301|NCT03082027|carpal tunnel syndrome|carpal tunnel syndrome
77302|NCT03082014|Hypertension|hypertension
77303|NCT03082014|Cerebrovascular Reactivity|cerebrovascular reactivity
77304|NCT03082014|Blood Pressure Variability|blood pressure variability
77305|NCT03082001|Neonate|neonate
77306|NCT03082001|Pain|pain
77307|NCT03082001|ELBW|elbw
77308|NCT03081988|Esophageal Cancer|esophageal cancer
77309|NCT03081988|chemoradiotherapy response|chemoradiotherapy response
77310|NCT03081988|molecular factors|molecular factors
77311|NCT03081975|adenoma detection rate|adenoma detection rate
77312|NCT03081975|narrow band imaging|narrow band imaging
77313|NCT03081949|peripartum cardiomyopathy|peripartum cardiomyopathy
77314|NCT03081949|Ventricular remodelling|ventricular remodelling
77315|NCT03081949|Survival|survival
77316|NCT03081949|Selenium|selenium
77317|NCT03081949|Oxidative stress|oxidative stress
77318|NCT03081949|Nigeria|nigeria
77319|NCT03081923|Immunotherapy|immunotherapy
77320|NCT03081923|Durvalumab|durvalumab
77321|NCT03081923|Tremelimumab|tremelimumab
77322|NCT03081923|Combination therapy|combination therapy
77323|NCT03081923|Testicular cancer|testicular cancer
77324|NCT03081910|Autologous CAR T cells|autologous car t cells
77325|NCT03081910|T-cell acute lymphoblastic lymphoma|t-cell acute lymphoblastic lymphoma
77326|NCT03081910|T-non-Hodgkin Lymphoma|t-non-hodgkin lymphoma
77327|NCT03081910|T-cell Acute Lymphoblastic Leukemia|t-cell acute lymphoblastic leukemia
77328|NCT03081884|Prostate cancer|prostate cancer
77329|NCT03081884|Metastatic cancer|metastatic cancer
77330|NCT03081884|Urogenital disorders|urogenital disorders
77331|NCT03081884|Oncology|oncology
77332|NCT03081884|Radiology|radiology
77333|NCT03081858|NMIBC|nmibc
77334|NCT03081858|Paclitaxel|paclitaxel
77335|NCT03081858|Antineoplastic Agents|antineoplastic agents
77336|NCT03081832|Prader-Willi|prader-willi
77337|NCT03081832|Oxytocin|oxytocin
77338|NCT03081832|Communication skills|communication skills
77339|NCT03081832|Oral skills|oral skills
77340|NCT03081832|Brain activity|brain activity
77341|NCT03081832|Hormonal disease|hormonal disease
77342|NCT03081806|Phase 3|phase 3
77343|NCT03081806|Efficacy|efficacy
77344|NCT03081806|Safety|safety
77345|NCT03081806|Osteoarthritis, Knee|osteoarthritis, knee
77346|NCT03081793|postoperative monitoring|postoperative monitoring
77347|NCT03081793|plethysmography|plethysmography
77348|NCT03081793|monitoring|monitoring
77349|NCT03081780|AML|aml
77350|NCT03081767|PET/CT|pet/ct
77351|NCT03081767|digital PET/CT|digital pet/ct
77352|NCT03081715|esophageal cancer|esophageal cancer
77353|NCT03081715|immune checkpoint|immune checkpoint
77354|NCT03081715|PD-1|pd-1
77355|NCT03081715|CRISPER|crisper
77356|NCT03081715|autologous cell infusion|autologous cell infusion
77357|NCT03081676|Maturity-Onset Diabetes of the Young, Type 3|maturity-onset diabetes of the young, type 3
77358|NCT03081676|Glucose-dependent insulinotropic peptide|glucose-dependent insulinotropic peptide
77359|NCT03081676|Glucagon-like-peptide 1|glucagon-like-peptide 1
77360|NCT03081676|Dipeptidyl peptidase 4|dipeptidyl peptidase 4
77361|NCT03081676|Glimepiride|glimepiride
77362|NCT03081676|Sulphonylurea|sulphonylurea
77363|NCT03081676|Glucose clamp|glucose clamp
77364|NCT03081676|Hepatocyte nuclear factor 1 alpha|hepatocyte nuclear factor 1 alpha
77365|NCT03081663|total knee arthroplasty|total knee arthroplasty
77366|NCT03081663|quadriceps sparing mid-vastus|quadriceps sparing mid-vastus
77367|NCT03081663|medial para-patellar|medial para-patellar
77368|NCT03081624|preterm|preterm
77369|NCT03081624|neurological status|neurological status
77370|NCT03081624|School Readiness|school readiness
77371|NCT03081585|fmri|fmri
77372|NCT03081585|neuronal reward processing|neuronal reward processing
77373|NCT03081585|hormonal satiety signalling|hormonal satiety signalling
77374|NCT03081585|fasting|fasting
77375|NCT03081559|transgender|transgender
77376|NCT03081559|women|women
77377|NCT03081533|Circular dance|circular dance
77378|NCT03081533|Older caregiver|older caregiver
77379|NCT03081533|Dance Therapy|dance therapy
77380|NCT03081507|Muslim Americans|muslim americans
77381|NCT03081507|Patient Navigation|patient navigation
77382|NCT03081507|Breast Cancer|breast cancer
77383|NCT03081507|Cervical Cancer|cervical cancer
77384|NCT03081494|PDR001|pdr001
77385|NCT03081494|immunotherapy|immunotherapy
77386|NCT03081494|regorafenib|regorafenib
77387|NCT03081494|CRC|crc
77388|NCT03081494|MMS|mms
77389|NCT03081494|CMS4|cms4
77390|NCT03081494|ElevatION:CRC-102|elevation:crc-102
77391|NCT03081481|Intraprostatic|intraprostatic
77392|NCT03081481|MRI lesion|mri lesion
77393|NCT03081481|Prostate biopsies|prostate biopsies
77394|NCT03081468|Optical coherence tomography|optical coherence tomography
77395|NCT03081468|Pupillometry|pupillometry
77396|NCT03081468|Automated|automated
77397|NCT03081468|Binocular|binocular
77398|NCT03081455|Screening|screening
77399|NCT03081455|Hereditary Cancer|hereditary cancer
77400|NCT03081403|Sensitive skin|sensitive skin
77401|NCT03081403|Quantitative Sensory Testing|quantitative sensory testing
77402|NCT03081364|Cardiac Implanted Device|cardiac implanted device
77403|NCT03081351|Extended retroperitoneal lymphadenectomy, Nerve plexus clearance, Survival benefit|extended retroperitoneal lymphadenectomy, nerve plexus clearance, survival benefit
77404|NCT03081338|ALS, MND, Care, Patient journey|als, mnd, care, patient journey
77405|NCT03081325|uRM|urm
77406|NCT03081325|RIF|rif
77407|NCT03081325|Th1|th1
77408|NCT03081325|Th2|th2
77409|NCT03081325|Treg|treg
77410|NCT03081325|lymphocyte immunotherapy|lymphocyte immunotherapy
77411|NCT03081312|Family Cancer Caregivers,|family cancer caregivers,
77412|NCT03081312|Needs|needs
77413|NCT03081312|Burden of Care|burden of care
77414|NCT03081312|Quality of Life|quality of life
77415|NCT03081273|Antimicrobial susceptibility|antimicrobial susceptibility
77416|NCT03081273|Biofilm formation|biofilm formation
77417|NCT03081273|Bone and joint infection|bone and joint infection
77418|NCT03081273|Corynebacterium spp|corynebacterium spp
77419|NCT03081273|Osteoblast|osteoblast
77420|NCT03081273|Outcome|outcome
77421|NCT03081273|Prosthetic joint infection|prosthetic joint infection
77422|NCT03081260|Total Knee Arthroplasty|total knee arthroplasty
77423|NCT03081260|Patella|patella
77424|NCT03081260|Resurfacing|resurfacing
77425|NCT03081260|IKS score|iks score
77426|NCT03081234|Hormone receptor-positive|hormone receptor-positive
77427|NCT03081234|Estrogen and/or progesterone receptor-positive|estrogen and/or progesterone receptor-positive
77428|NCT03081234|HER2-negative|her2-negative
77429|NCT03081234|Intermediate risk early breast cancer|intermediate risk early breast cancer
77430|NCT03081234|Adjuvant|adjuvant
77431|NCT03081234|Ribociclib|ribociclib
77432|NCT03081234|LEE011|lee011
77433|NCT03081234|CDK4/6 inhibitor|cdk4/6 inhibitor
77434|NCT03081234|Endocrine therapy|endocrine therapy
77435|NCT03081234|Phase III|phase iii
77436|NCT03081234|breast carcinoma|breast carcinoma
77437|NCT03081234|breast cancer|breast cancer
77438|NCT03081208|IVF|ivf
77439|NCT03081208|ICSI|icsi
77440|NCT03081195|child behavior|child behavior
77441|NCT03081195|intervention|intervention
77442|NCT03081195|multiple family group|multiple family group
77443|NCT03081195|Sub Saharan Africa|sub saharan africa
77444|NCT03081195|caregivers|caregivers
77445|NCT03081182|Pediatric Chronic Pancreatitis|pediatric chronic pancreatitis
77446|NCT03081182|Data management|data management
77447|NCT03081182|Regulatory compliance|regulatory compliance
77448|NCT03081182|Protocol monitoring|protocol monitoring
77449|NCT03081156|chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
77450|NCT03081156|exercise intolerance|exercise intolerance
77451|NCT03081156|dynamic hyperinflation|dynamic hyperinflation
77452|NCT03081117|HIV-Associated Neurocognitive Disorder (HAND)|hiv-associated neurocognitive disorder (hand)
77453|NCT03081117|Intranasal|intranasal
77454|NCT03081052|Heart and Lung transplantation surgery|heart and lung transplantation surgery
77455|NCT03081052|Pulmonary vasodilation therapy|pulmonary vasodilation therapy
77456|NCT03081039|cholangiocarcinoma|cholangiocarcinoma
77457|NCT03081039|gemcitabine|gemcitabine
77458|NCT03081039|carboplatin|carboplatin
77459|NCT03081039|cisplatin|cisplatin
77460|NCT03081026|surgery|surgery
77461|NCT03081026|ages 6-16|ages 6-16
77462|NCT03081013|adolescents|adolescents
77463|NCT03081013|social norms|social norms
77464|NCT03080974|irreversible electroporation|irreversible electroporation
77465|NCT03080974|Nivolumab|nivolumab
77466|NCT03080961|Barrier cream|barrier cream
77467|NCT03080922|Acute Myeloid Leukemia|acute myeloid leukemia
77468|NCT03080922|Relapsed|relapsed
77469|NCT03080922|Refractory|refractory
77470|NCT03080922|hematopoietic stem cell|hematopoietic stem cell
77471|NCT03080909|Satiety|satiety
77472|NCT03080909|Nutrient|nutrient
77473|NCT03080909|Appetite|appetite
77474|NCT03080909|Encapsulation|encapsulation
77475|NCT03080909|Lipid|lipid
77476|NCT03080909|Amino acid|amino acid
77477|NCT03080909|Probiotic bacteria|probiotic bacteria
77478|NCT03080870|Art intervention|art intervention
77479|NCT03080870|Quality of Life|quality of life
77480|NCT03080870|Well-being|well-being
77481|NCT03080870|Physical performance|physical performance
77482|NCT03080870|Family caregivers|family caregivers
77483|NCT03080870|Older adults|older adults
77484|NCT03080831|Maintenance Fluid Therapy|maintenance fluid therapy
77485|NCT03080818|Probiotic, Cognitive Function, Mood|probiotic, cognitive function, mood
77486|NCT03080792|stem cell transplantation|stem cell transplantation
77487|NCT03080792|exercise|exercise
77488|NCT03080792|high intensity interval training|high intensity interval training
77489|NCT03080792|resistance training|resistance training
77490|NCT03080792|physical fitness|physical fitness
77491|NCT03080792|cancer|cancer
77492|NCT03080753|Sphinkeeper|sphinkeeper
77493|NCT03080753|Intersphincteric implants|intersphincteric implants
77494|NCT03080753|Gatekeeper|gatekeeper
77495|NCT03080714|no known ocular pathology|no known ocular pathology
77496|NCT03080714|Glaucoma|glaucoma
77497|NCT03080714|Retinal Disease|retinal disease
77498|NCT03080701|Behavioral: Automated Mailing|behavioral: automated mailing
77499|NCT03080675|Aging population|aging population
77500|NCT03080649|dental caries, Er:YAG laser, rotary bur|dental caries, er:yag laser, rotary bur
77501|NCT03080636|Post-exercise hypotension|post-exercise hypotension
77502|NCT03080636|Aerobic Exercise|aerobic exercise
77503|NCT03080636|Resistance Exercise|resistance exercise
77504|NCT03080636|Autonomic Stress|autonomic stress
77505|NCT03080636|Heart Rate Variability|heart rate variability
77506|NCT03080636|Sex difference|sex difference
77507|NCT03080610|Post-Dural Puncture Headache [C10.228.140.546.699.124]|post-dural puncture headache [c10.228.140.546.699.124]
77508|NCT03080610|Blood Patch, Epidural [E02.319.267.530.580.300.145]|blood patch, epidural [e02.319.267.530.580.300.145]
77509|NCT03080584|acupuncture|acupuncture
77510|NCT03080584|IVF|ivf
77511|NCT03080584|AMH|amh
77512|NCT03080584|ovarian reserve|ovarian reserve
77513|NCT03080558|Indocyanine green fluorescence|indocyanine green fluorescence
77514|NCT03080558|Rectal vascularisation|rectal vascularisation
77515|NCT03080558|Vaginal vascularisation|vaginal vascularisation
77516|NCT03080558|Laparoscopic surgery|laparoscopic surgery
77517|NCT03080558|Rectal shaving|rectal shaving
77518|NCT03080558|Recto vaginal node|recto vaginal node
77519|NCT03080558|Deep Endometriosis|deep endometriosis
77520|NCT03080532|Microbiome|microbiome
77521|NCT03080532|Mediterranean diet|mediterranean diet
77522|NCT03080519|renal artery stenosis|renal artery stenosis
77523|NCT03080519|balloon angioplasty|balloon angioplasty
77524|NCT03080519|stents|stents
77525|NCT03080493|Abortion|abortion
77526|NCT03080493|Osmotic dilators|osmotic dilators
77527|NCT03080493|Gabapentin|gabapentin
77528|NCT03080493|Text message|text message
77529|NCT03080480|Chronic Granulomatous Disease|chronic granulomatous disease
77530|NCT03080480|Severe Infection|severe infection
77531|NCT03080480|PPARγ|pparγ
77532|NCT03080480|Pioglitazone|pioglitazone
77533|NCT03080480|phagocytes|phagocytes
77534|NCT03080467|Trauma|trauma
77535|NCT03080467|Laceration|laceration
77536|NCT03080467|Suture|suture
77537|NCT03080467|Cosmesis|cosmesis
77538|NCT03080467|Ethyl-2-Cyanoacrylate|ethyl-2-cyanoacrylate
77539|NCT03080467|Tissue adhesive|tissue adhesive
77540|NCT03080467|Lip lacerations|lip lacerations
77541|NCT03080467|Skalp lacerations|skalp lacerations
77542|NCT03080467|Facial injuries|facial injuries
77543|NCT03080454|stroke|stroke
77544|NCT03080454|CVA|cva
77545|NCT03080454|Spasticity|spasticity
77546|NCT03080454|hemiparesis|hemiparesis
77547|NCT03080454|rehabilitation|rehabilitation
77548|NCT03080454|tsDCS|tsdcs
77549|NCT03080454|non-invasive stimulation|non-invasive stimulation
77550|NCT03080428|Breast cancer|breast cancer
77551|NCT03080428|ER-positive|er-positive
77552|NCT03080428|Her-2 negative|her-2 negative
77553|NCT03080428|genomic test|genomic test
77554|NCT03080402|Anterior Cruciate Ligament|anterior cruciate ligament
77555|NCT03080402|ACL injury|acl injury
77556|NCT03080402|Injury prevention|injury prevention
77557|NCT03080402|Perturbation training|perturbation training
77558|NCT03080402|Risk factors|risk factors
77559|NCT03080389|overactive bladder|overactive bladder
77560|NCT03080389|overactive detrusor|overactive detrusor
77561|NCT03080389|urgency-frequency|urgency-frequency
77562|NCT03080389|urinary tract infection|urinary tract infection
77563|NCT03080376|Exercise|exercise
77564|NCT03080376|Web-based intervention|web-based intervention
77565|NCT03080363|Extracorporeal Shockwave Lithotripsy|extracorporeal shockwave lithotripsy
77566|NCT03080363|Quadratus Lumborum Block|quadratus lumborum block
77567|NCT03080363|bupivacaine|bupivacaine
77568|NCT03080363|lidocaine|lidocaine
77569|NCT03080350|Fentanyl|fentanyl
77570|NCT03080350|Transmucosal administration|transmucosal administration
77571|NCT03080350|Endovenous administration|endovenous administration
77572|NCT03080350|Pain therapy|pain therapy
77573|NCT03080350|Mountain emergency medicine|mountain emergency medicine
77574|NCT03080324|Fentanyl|fentanyl
77575|NCT03080324|Transmucosal administration|transmucosal administration
77576|NCT03080324|Endovenous administration|endovenous administration
77577|NCT03080324|Pain therapy|pain therapy
77578|NCT03080311|Bcl-2/Bcl-xL dual inhibitor|bcl-2/bcl-xl dual inhibitor
77579|NCT03080272|individual patient|individual patient
77580|NCT03080259|ADHD|adhd
77581|NCT03080259|Stimulant Misuse|stimulant misuse
77582|NCT03080259|Stimulant Diversion|stimulant diversion
77583|NCT03080233|stroke|stroke
77584|NCT03080233|Validation|validation
77585|NCT03080233|Clinical decision support tool|clinical decision support tool
77586|NCT03080207|Lower Extremity Lymphedema|lower extremity lymphedema
77587|NCT03080207|Physiotherapy|physiotherapy
77588|NCT03080207|Complex Decongestive Physiotherapy|complex decongestive physiotherapy
77589|NCT03080207|Low Level Laser|low level laser
77590|NCT03080207|Platelet rich plasma|platelet rich plasma
77591|NCT03080194|schizophrenia|schizophrenia
77592|NCT03080194|violence risk|violence risk
77593|NCT03080194|long-acting antipsychotics|long-acting antipsychotics
77594|NCT03080194|community-based|community-based
77595|NCT03080168|suicidal ideation|suicidal ideation
77596|NCT03080168|suicidal behavior|suicidal behavior
77597|NCT03080168|Veterans|veterans
77598|NCT03080168|inpatients|inpatients
77599|NCT03080168|Actigraphy|actigraphy
77600|NCT03080168|implicit associations|implicit associations
77601|NCT03080168|risk factors|risk factors
77602|NCT03080129|Liver cirrhosis|liver cirrhosis
77603|NCT03080129|Sarcopenia|sarcopenia
77604|NCT03080129|Microbiome|microbiome
77605|NCT03080116|Randomized|randomized
77606|NCT03080116|Placebo-controlled|placebo-controlled
77607|NCT03080116|Neoadjuvant|neoadjuvant
77608|NCT03080116|Androgen deprivation|androgen deprivation
77609|NCT03080116|Antiandrogen|antiandrogen
77610|NCT03080116|Radical Prostatectomy|radical prostatectomy
77611|NCT03080103|Acute Appendicitis|acute appendicitis
77612|NCT03080103|Uncomplicated Acute Appendicitis|uncomplicated acute appendicitis
77613|NCT03080103|Appendectomy|appendectomy
77614|NCT03080103|Conservative Treatment|conservative treatment
77615|NCT03080103|Antibiotic-first Treatment|antibiotic-first treatment
77616|NCT03080103|Recurrent Appendicitis|recurrent appendicitis
77617|NCT03080103|Prospective Study|prospective study
77618|NCT03080051|PSP|psp
77619|NCT03080051|AD|ad
77620|NCT03080051|HV|hv
77621|NCT03080038|Sepsis|sepsis
77622|NCT03080038|Shock|shock
77623|NCT03080038|Septic Shock|septic shock
77624|NCT03080038|Fluid Therapy|fluid therapy
77625|NCT03080038|Resuscitation|resuscitation
77626|NCT03080038|Pediatrics|pediatrics
77627|NCT03080038|Emergency Medicine|emergency medicine
77628|NCT03080038|Critical Care|critical care
77629|NCT03080025|CBCT® (Cognitively Based Compassion-Training)|cbct® (cognitively based compassion-training)
77630|NCT03080025|Psychobiological Evaluation|psychobiological evaluation
77631|NCT03080025|Real Time Social Interaction|real time social interaction
77632|NCT03080025|Eye-Tracking|eye-tracking
77633|NCT03080025|Heart Rate Variability|heart rate variability
77634|NCT03080025|IL-6|il-6
77635|NCT03080025|IL-1b|il-1b
77636|NCT03080025|Cortisol|cortisol
77637|NCT03080025|Alpha-Amylase|alpha-amylase
77638|NCT03080025|Randomised Controlled Trial|randomised controlled trial
77639|NCT03080025|Compassion|compassion
77640|NCT03080025|Empathy|empathy
77641|NCT03080025|Relationship Quality|relationship quality
77642|NCT03080025|Interpersonal Relations|interpersonal relations
77643|NCT03080025|Stress|stress
77644|NCT03079986|Pancreatic surgery|pancreatic surgery
77645|NCT03079986|Chylous ascites|chylous ascites
77646|NCT03079973|Calcipotriene|calcipotriene
77647|NCT03079960|Parkinson|parkinson
77648|NCT03079960|DBS|dbs
77649|NCT03079960|Deep Brain Stimulation|deep brain stimulation
77650|NCT03079960|LFP|lfp
77651|NCT03079960|Local Field Potentials|local field potentials
77652|NCT03079960|EEG|eeg
77653|NCT03079960|Electroencephalogram|electroencephalogram
77654|NCT03079947|Circulating DNA|circulating dna
77655|NCT03079947|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
77656|NCT03079947|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
77657|NCT03079947|prognosis|prognosis
77658|NCT03079934|Bioresorbable vascular scaffold|bioresorbable vascular scaffold
77659|NCT03079934|Optical coherence tomography|optical coherence tomography
77660|NCT03079934|strut coverage|strut coverage
77661|NCT03079934|acute coronary syndrome|acute coronary syndrome
77662|NCT03079921|Islet Graft Function|islet graft function
77663|NCT03079921|Islet Cell transplantation|islet cell transplantation
77664|NCT03079921|Auto-islet transplantation|auto-islet transplantation
77665|NCT03079921|Intra-hepatic islets|intra-hepatic islets
77666|NCT03079921|Extra-hepatic islets|extra-hepatic islets
77667|NCT03079908|Laparoscopy|laparoscopy
77668|NCT03079908|Surgery|surgery
77669|NCT03079908|Training|training
77670|NCT03079908|Virtual reality|virtual reality
77671|NCT03079908|Simulation|simulation
77672|NCT03079908|Robotic Surgery|robotic surgery
77673|NCT03079908|Da Vinci|da vinci
77674|NCT03079895|Depression|depression
77675|NCT03079895|internet|internet
77676|NCT03079895|Cognitive Behavioral Therapy|cognitive behavioral therapy
77677|NCT03079895|CBT|cbt
77678|NCT03079895|computer|computer
77679|NCT03079895|Primary Care|primary care
77680|NCT03079895|Psychiatry|psychiatry
77681|NCT03079895|treatment|treatment
77682|NCT03079895|self-help|self-help
77683|NCT03079895|managed care|managed care
77684|NCT03079882|Ultrasound|ultrasound
77685|NCT03079882|Viscoelasticity|viscoelasticity
77686|NCT03079882|Viscoelastic Response (VisR) Ultrasound|viscoelastic response (visr) ultrasound
77687|NCT03079856|Emerging adults|emerging adults
77688|NCT03079856|Drugs|drugs
77689|NCT03079856|HIV|hiv
77690|NCT03079856|Risky Sex Behaviors|risky sex behaviors
77691|NCT03079830|aortic valve surgery|aortic valve surgery
77692|NCT03079830|postoperative pain|postoperative pain
77693|NCT03079791|OCT|oct
77694|NCT03079791|cardiac allograft vasculopathy|cardiac allograft vasculopathy
77695|NCT03079791|CAV|cav
77696|NCT03079791|intravascular imaging|intravascular imaging
77697|NCT03079765|Telehealth|telehealth
77698|NCT03079765|Functional behavior assessment|functional behavior assessment
77699|NCT03079713|pain|pain
77700|NCT03079713|anesthesia|anesthesia
77701|NCT03079713|vibrator|vibrator
77702|NCT03079713|intravitreal|intravitreal
77703|NCT03079713|injection|injection
77704|NCT03079687|Ovarian cancer|ovarian cancer
77705|NCT03079687|gynaecological cancer|gynaecological cancer
77706|NCT03079687|platinum-sensitive disease|platinum-sensitive disease
77707|NCT03079687|platinum-sensitive relapsed|platinum-sensitive relapsed
77708|NCT03079687|Olaparib|olaparib
77709|NCT03079687|Ovarian Neoplasms|ovarian neoplasms
77710|NCT03079687|Neoplasms|neoplasms
77711|NCT03079687|Ovarian Disease|ovarian disease
77712|NCT03079687|fallopean tube cancer|fallopean tube cancer
77713|NCT03079687|primary peritoneal cancer|primary peritoneal cancer
77714|NCT03079687|epithelial ovarian cancer|epithelial ovarian cancer
77715|NCT03079687|PARP inhibitors|parp inhibitors
77716|NCT03079687|Poly (ADP-ribose) polymerase inhibitors.|poly (adp-ribose) polymerase inhibitors.
77717|NCT03079674|transient Ischemic Attack|transient ischemic attack
77718|NCT03079674|minor Stroke|minor stroke
77719|NCT03079674|non-disabling ischemic cerebrovascular events|non-disabling ischemic cerebrovascular events
77720|NCT03079674|biomarker|biomarker
77721|NCT03079674|epidemiology|epidemiology
77722|NCT03079674|prognosis|prognosis
77723|NCT03079661|pollution|pollution
77724|NCT03079661|ozone|ozone
77725|NCT03079661|Copd|copd
77726|NCT03079661|particles|particles
77727|NCT03079648|Angelica gigas N. extract|angelica gigas n. extract
77728|NCT03079648|Hyperlipidemia|hyperlipidemia
77729|NCT03079648|Clinical Trial|clinical trial
77730|NCT03079596|gastric cancer|gastric cancer
77731|NCT03079596|ERAS (early recovery after surgery)|eras (early recovery after surgery)
77732|NCT03079596|laparoscopic total gastrectomy|laparoscopic total gastrectomy
77733|NCT03079557|Adolescent|adolescent
77734|NCT03079557|Injections, intraperitoneal|injections, intraperitoneal
77735|NCT03079557|Endoscopy|endoscopy
77736|NCT03079557|Botulinum Toxins, Type A|botulinum toxins, type a
77737|NCT03079557|OnabotulinumtoxinA|onabotulinumtoxina
77738|NCT03079518|iron deficiency|iron deficiency
77739|NCT03079518|HFREF|hfref
77740|NCT03079518|FGF23|fgf23
77741|NCT03079518|ferric carboxymaltose|ferric carboxymaltose
77742|NCT03079479|Arthoplasty|arthoplasty
77743|NCT03079479|Gait|gait
77744|NCT03079479|muscle strenght|muscle strenght
77745|NCT03079479|Quality of life|quality of life
77746|NCT03079466|Sleep apnea|sleep apnea
77747|NCT03079466|Elderly|elderly
77748|NCT03079466|CPAP|cpap
77749|NCT03079453|Dexamethasone|dexamethasone
77750|NCT03079453|Tonsillectomy|tonsillectomy
77751|NCT03079453|Uvula|uvula
77752|NCT03079453|Edema|edema
77753|NCT03079453|Uvula edema|uvula edema
77754|NCT03079453|Post-tonsillectomy|post-tonsillectomy
77755|NCT03079440|Neuroendocrine tumors|neuroendocrine tumors
77756|NCT03079440|Neuroendocrine Carcinoma|neuroendocrine carcinoma
77757|NCT03079440|Capecitabine|capecitabine
77758|NCT03079440|Temozolomide|temozolomide
77759|NCT03079427|Cholangiocarcinoma|cholangiocarcinoma
77760|NCT03079427|Adjuvant chemotherapy|adjuvant chemotherapy
77761|NCT03079414|Sudden Cardiac Death|sudden cardiac death
77762|NCT03079414|Cardiac Arrhythmia|cardiac arrhythmia
77763|NCT03079414|Electrophysiology Study|electrophysiology study
77764|NCT03079414|Genetics|genetics
77765|NCT03079401|biventricular conversion|biventricular conversion
77766|NCT03079375|cross sectional|cross sectional
77767|NCT03079375|medication review|medication review
77768|NCT03079375|readmissions|readmissions
77769|NCT03079375|follow-up|follow-up
77770|NCT03079336|Randomized controlled design development|randomized controlled design development
77771|NCT03079336|Translational Research|translational research
77772|NCT03079336|Psychological Interventions|psychological interventions
77773|NCT03079336|Contextual Model of Psychotherapy|contextual model of psychotherapy
77774|NCT03079323|External beam radiotherapy|external beam radiotherapy
77775|NCT03079323|Prostate cancer|prostate cancer
77776|NCT03079323|Elective para-aortic radiation therapy|elective para-aortic radiation therapy
77777|NCT03079323|PART|part
77778|NCT03079310|spinal cord stimulation|spinal cord stimulation
77779|NCT03079310|gait analysis|gait analysis
77780|NCT03079310|whole-body kinematics|whole-body kinematics
77781|NCT03079310|Parkinson's disease|parkinson's disease
77782|NCT03079310|Neuromodulation|neuromodulation
77783|NCT03079310|Feature extraction|feature extraction
77784|NCT03079297|Antidepressant|antidepressant
77785|NCT03079297|Inflammation|inflammation
77786|NCT03079297|Biomarker|biomarker
77787|NCT03079297|Depression|depression
77788|NCT03079297|Treatment Resistant Depression|treatment resistant depression
77789|NCT03079297|Leucine|leucine
77790|NCT03079258|vascular structure|vascular structure
77791|NCT03079258|vascular function|vascular function
77792|NCT03079258|cerebrovascular reactivity|cerebrovascular reactivity
77793|NCT03079258|physical activity|physical activity
77794|NCT03079258|sedentary behaviour|sedentary behaviour
77795|NCT03079258|offspring health|offspring health
77796|NCT03079258|maternal health|maternal health
77797|NCT03079245|Neonatal ICU|neonatal icu
77798|NCT03079245|antimicrobial stewardship|antimicrobial stewardship
77799|NCT03079232|Optical biopsy|optical biopsy
77800|NCT03079232|Skin cancer|skin cancer
77801|NCT03079232|Diagnostic performance|diagnostic performance
77802|NCT03079206|hazelnut|hazelnut
77803|NCT03079206|allergens|allergens
77804|NCT03079206|basophile-activation-test|basophile-activation-test
77805|NCT03079206|food|food
77806|NCT03079206|allergy|allergy
77807|NCT03079193|post thyroidectomy|post thyroidectomy
77808|NCT03079193|laryngeoscopic examination|laryngeoscopic examination
77809|NCT03079180|Tendon|tendon
77810|NCT03079180|Ageing|ageing
77811|NCT03079180|Training|training
77812|NCT03079180|Achilles tendon|achilles tendon
77813|NCT03079180|Patella tendon|patella tendon
77814|NCT03079180|Skeletal muscle|skeletal muscle
77815|NCT03079180|Adaptation|adaptation
77816|NCT03079180|Triceps Surae|triceps surae
77817|NCT03079180|Quadriceps|quadriceps
77818|NCT03079115|Atorvastatin|atorvastatin
77819|NCT03079089|Allogenic cell stem transplant|allogenic cell stem transplant
77820|NCT03079089|Sequential chemotherapy|sequential chemotherapy
77821|NCT03079089|Haploidentical transplant|haploidentical transplant
77822|NCT03079076|Postoperative Analgesia|postoperative analgesia
77823|NCT03079076|Ultrasound guided thoracolumbar interfascial plane block|ultrasound guided thoracolumbar interfascial plane block
77824|NCT03079011|ESR1 mutation detection, ctDNA|esr1 mutation detection, ctdna
77825|NCT03078998|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
77826|NCT03078998|Cerebral Palsy|cerebral palsy
77827|NCT03078998|Obstetric Brachial Plexus Palsy|obstetric brachial plexus palsy
77828|NCT03078998|Human Computer Interaction|human computer interaction
77829|NCT03078998|Leap Motion|leap motion
77830|NCT03078998|Video Game Based Rehabilitation|video game based rehabilitation
77831|NCT03078985|real-time MRI|real-time mri
77832|NCT03078985|electrophysiology study|electrophysiology study
77833|NCT03078985|atrial flutter ablation|atrial flutter ablation
77834|NCT03078985|active tracking|active tracking
77835|NCT03078946|Cardiac surgery|cardiac surgery
77836|NCT03078946|delirium|delirium
77837|NCT03078946|dexmedetomidine|dexmedetomidine
77838|NCT03078946|morphine|morphine
77839|NCT03078946|midazolam|midazolam
77840|NCT03078933|DFU|dfu
77841|NCT03078907|daily life|daily life
77842|NCT03078907|physical activity|physical activity
77843|NCT03078907|actigraphy|actigraphy
77844|NCT03078907|PAH-SYMPACT|pah-sympact
77845|NCT03078894|Zika|zika
77846|NCT03078894|Dengue|dengue
77847|NCT03078894|Chikagunya|chikagunya
77848|NCT03078894|Peru|peru
77849|NCT03078829|gender identity|gender identity
77850|NCT03078829|trans female|trans female
77851|NCT03078829|GnRH agonists|gnrh agonists
77852|NCT03078829|QTc interval|qtc interval
77853|NCT03078803|fecal transplant|fecal transplant
77854|NCT03078803|inflammatory bowel disease|inflammatory bowel disease
77855|NCT03078777|Pharmacokinetics|pharmacokinetics
77856|NCT03078764|Mobile health (mHealth)|mobile health (mhealth)
77857|NCT03078751|Hormone receptor-positive|hormone receptor-positive
77858|NCT03078751|Estrogen and/or progesterone receptor-positive|estrogen and/or progesterone receptor-positive
77859|NCT03078751|HER2-negative|her2-negative
77860|NCT03078751|High risk early breast cancer|high risk early breast cancer
77861|NCT03078751|Adjuvant|adjuvant
77862|NCT03078751|Ribociclib|ribociclib
77864|NCT03078751|CDK4/6 inhibitor|cdk4/6 inhibitor
77865|NCT03078751|Endocrine therapy|endocrine therapy
77866|NCT03078751|Phase III|phase iii
77867|NCT03078751|Breast carcinoma|breast carcinoma
77868|NCT03078751|Breast cancer|breast cancer
77869|NCT03078738|OMT-28|omt-28
77870|NCT03078738|Atrial Fibrillation|atrial fibrillation
77871|NCT03078738|SAD|sad
77872|NCT03078738|MAD|mad
77873|NCT03078738|First-in-Man|first-in-man
77874|NCT03078738|Cardiovascular|cardiovascular
77875|NCT03078725|gestational diabetes|gestational diabetes
77876|NCT03078725|glyburide|glyburide
77877|NCT03078725|metformin|metformin
77878|NCT03078725|failure rate|failure rate
77879|NCT03078712|Septic Shock|septic shock
77880|NCT03078712|Lactate|lactate
77881|NCT03078712|Capillary Refill Time|capillary refill time
77882|NCT03078712|Fluid Responsiveness|fluid responsiveness
77883|NCT03078712|Mortality|mortality
77884|NCT03078699|Thymoma|thymoma
77885|NCT03078699|Thymic tumor|thymic tumor
77886|NCT03078699|Stereotactic body radiotherapy|stereotactic body radiotherapy
77887|NCT03078686|Stem Cells,PRP, tSVF,cSVF,Alopecia Areata,Scarring Alopecia|stem cells,prp, tsvf,csvf,alopecia areata,scarring alopecia
77888|NCT03078673|Cross country poling, motor skill, strength training|cross country poling, motor skill, strength training
77889|NCT03078634|Irritable bowel syndrome|irritable bowel syndrome
77890|NCT03078634|Constipation|constipation
77891|NCT03078634|Functional dyspepsia|functional dyspepsia
77892|NCT03078634|Multi-disciplinary treatment|multi-disciplinary treatment
77893|NCT03078621|stem cells|stem cells
77894|NCT03078608|anxiety|anxiety
77895|NCT03078608|quality of life|quality of life
77896|NCT03078608|mindfulness|mindfulness
77897|NCT03078608|meditation|meditation
77898|NCT03078608|depression|depression
77899|NCT03078595|periodontal disease|periodontal disease
77900|NCT03078595|plaque-induced gingivitis|plaque-induced gingivitis
77901|NCT03078595|bleeding on probing|bleeding on probing
77902|NCT03078595|von willebrand disease|von willebrand disease
77903|NCT03078595|gingival bleeding|gingival bleeding
77904|NCT03078582|PNH|pnh
77905|NCT03078569|Poor responders|poor responders
77906|NCT03078556|FDC|fdc
77907|NCT03078556|Lamivudine|lamivudine
77908|NCT03078556|Bio-equivalence|bio-equivalence
77909|NCT03078556|Dolutegravir|dolutegravir
77910|NCT03078556|HIV|hiv
77911|NCT03078530|GWI|gwi
77912|NCT03078530|IBS|ibs
77913|NCT03078530|Irritable Bowel Syndrome|irritable bowel syndrome
77914|NCT03078530|Gulf War Illness|gulf war illness
77915|NCT03078530|Probiotics|probiotics
77916|NCT03078517|I-gel|i-gel
77917|NCT03078517|Laryngeal mask airway protector|laryngeal mask airway protector
77918|NCT03078491|type 1 diabetes|type 1 diabetes
77919|NCT03078491|geriatrics|geriatrics
77920|NCT03078491|older adults|older adults
77921|NCT03078491|technology|technology
77922|NCT03078491|CGM|cgm
77923|NCT03078491|clinical decision support|clinical decision support
77924|NCT03078491|hypoglycemia|hypoglycemia
77925|NCT03078439|very preterm birth|very preterm birth
77926|NCT03078439|developmental disorders|developmental disorders
77927|NCT03078439|health problems|health problems
77928|NCT03078439|prospective population-based cohort|prospective population-based cohort
77929|NCT03078426|Lung|lung
77930|NCT03078426|MRI|mri
77931|NCT03078426|CT|ct
77932|NCT03078426|Usual interstitial pneumonia|usual interstitial pneumonia
77933|NCT03078426|Ultra-short echo time|ultra-short echo time
77934|NCT03078413|Mustard Procedure|mustard procedure
77935|NCT03078374|Reduced anti-coagulation, mechanical circulatory support.|reduced anti-coagulation, mechanical circulatory support.
77936|NCT03078361|cancer screening|cancer screening
77937|NCT03078361|colon|colon
77938|NCT03078348|cancer screening|cancer screening
77939|NCT03078335|Late onset sepsis|late onset sepsis
77940|NCT03078335|glove based care|glove based care
77941|NCT03078335|NICU|nicu
77942|NCT03078335|Non sterile gloves|non sterile gloves
77943|NCT03078335|infection control|infection control
77944|NCT03078309|retinitis pigmentosa|retinitis pigmentosa
77945|NCT03078309|retinal degeneration|retinal degeneration
77946|NCT03078309|cannabis|cannabis
77947|NCT03078309|THC|thc
77948|NCT03078309|CBD|cbd
77949|NCT03078309|electrophysiology|electrophysiology
77950|NCT03078309|visual functions|visual functions
77951|NCT03078309|eye|eye
77952|NCT03078309|retina|retina
77953|NCT03078270|social anxiety|social anxiety
77954|NCT03078270|botulinum toxin|botulinum toxin
77955|NCT03078270|botox|botox
77956|NCT03078257|Platelet Activities|platelet activities
77957|NCT03078257|light aggregometry|light aggregometry
77958|NCT03078257|VerifyNow P2Y12-assay|verifynow p2y12-assay
77959|NCT03078257|peripheral vein|peripheral vein
77960|NCT03078257|peripheral artery|peripheral artery
77961|NCT03078257|intracoronary artery|intracoronary artery
77962|NCT03078257|tirofiban|tirofiban
77963|NCT03078257|antiplatelet thrombolysin|antiplatelet thrombolysin
77964|NCT03078218|Pulse oximetry|pulse oximetry
77965|NCT03078218|Asymptomatic newborns|asymptomatic newborns
77966|NCT03078205|TCM multi-channel therapy|tcm multi-channel therapy
77967|NCT03078205|ART failure|art failure
77968|NCT03078179|Probiotic|probiotic
77969|NCT03078179|Child|child
77970|NCT03078179|Care, dental|care, dental
77971|NCT03078166|Cardiac Failure|cardiac failure
77972|NCT03078166|Congestive Heart Failure|congestive heart failure
77973|NCT03078166|Heart Decompensation|heart decompensation
77974|NCT03078166|Heart Failure, Congestive|heart failure, congestive
77975|NCT03078166|Heart Failure, Left-Sided|heart failure, left-sided
77976|NCT03078166|Heart Failure, Right-Sided|heart failure, right-sided
77977|NCT03078166|Left-Sided Heart Failure|left-sided heart failure
77978|NCT03078166|Myocardial Failure|myocardial failure
77979|NCT03078166|Right-Sided Heart Failure|right-sided heart failure
77980|NCT03078166|Outcomes|outcomes
77981|NCT03078166|Co-morbidities|co-morbidities
77982|NCT03078166|Biomarkers|biomarkers
77983|NCT03078101|Empagliflozin|empagliflozin
77984|NCT03078101|SGLT-2 Inhibiton and RAS in CKD|sglt-2 inhibiton and ras in ckd
77985|NCT03078075|Methamphetamine|methamphetamine
77986|NCT03078075|Methamphetamine Use Disorder|methamphetamine use disorder
77987|NCT03078075|Naltrexone|naltrexone
77988|NCT03078075|Bupropion|bupropion
77989|NCT03078075|Vivitrol®|vivitrol®
77990|NCT03078062|Spinal anesthesia|spinal anesthesia
77991|NCT03078062|Motor block|motor block
77992|NCT03078062|Sensory block|sensory block
77993|NCT03078062|Dexamethasone|dexamethasone
77994|NCT03078036|HER2-ve metastatic breast cancer|her2-ve metastatic breast cancer
77995|NCT03078036|gBRCA, sBRCA and HRR gene mutations|gbrca, sbrca and hrr gene mutations
77996|NCT03078023|EoE|eoe
77997|NCT03078010|Antibiotic|antibiotic
77998|NCT03078010|piperacillin-tazobactam|piperacillin-tazobactam
77999|NCT03078010|cefepime|cefepime
78000|NCT03078010|aztreonam|aztreonam
78001|NCT03078010|17-097|17-097
78002|NCT03077997|Diabetes|diabetes
78003|NCT03077997|Diabetes distress|diabetes distress
78004|NCT03077971|Carers of People with Multiple Sclerosis|carers of people with multiple sclerosis
78005|NCT03077971|Carer Strain|carer strain
78006|NCT03077971|Acceptance and Commitment Therapy|acceptance and commitment therapy
78007|NCT03077945|biofeedback|biofeedback
78008|NCT03077945|heart rate variability|heart rate variability
78009|NCT03077945|HRV|hrv
78010|NCT03077945|psychophysiology|psychophysiology
78011|NCT03077945|reappraisal|reappraisal
78012|NCT03077945|cognitive reappraisal|cognitive reappraisal
78013|NCT03077945|arousal reappraisal|arousal reappraisal
78014|NCT03077945|woman|woman
78015|NCT03077945|women|women
78016|NCT03077945|female|female
78017|NCT03077945|smoker|smoker
78018|NCT03077945|relapse|relapse
78019|NCT03077945|cigarette|cigarette
78020|NCT03077945|craving|craving
78021|NCT03077945|self regulation|self regulation
78022|NCT03077945|emotion regulation|emotion regulation
78023|NCT03077945|stress response|stress response
78024|NCT03077945|cognitive behavioral intervention|cognitive behavioral intervention
78025|NCT03077945|respiratory sinus arrhythmia|respiratory sinus arrhythmia
78026|NCT03077945|smoking cessation intervention|smoking cessation intervention
78027|NCT03077919|Posttraumatic Stress Disorder|posttraumatic stress disorder
78028|NCT03077919|Generalized Anxiety Disorder|generalized anxiety disorder
78029|NCT03077919|Depression|depression
78030|NCT03077919|Distress|distress
78031|NCT03077919|Alcohol Use|alcohol use
78032|NCT03077919|Pain|pain
78033|NCT03077906|Gastroœsophageal Reflux|gastroœsophageal reflux
78034|NCT03077906|Sleeve Gastrectomy|sleeve gastrectomy
78035|NCT03077880|implant insertion|implant insertion
78036|NCT03077880|bone resorption|bone resorption
78037|NCT03077880|soft tissue|soft tissue
78038|NCT03077867|sinus lift|sinus lift
78039|NCT03077867|synthetic hydroxyapatite|synthetic hydroxyapatite
78040|NCT03077867|bone graft|bone graft
78041|NCT03077854|Lung Cancer|lung cancer
78042|NCT03077854|Radiotherapy|radiotherapy
78043|NCT03077854|Biomarkers|biomarkers
78044|NCT03077854|Radiation Lung Injury|radiation lung injury
78045|NCT03077854|Quality of Life|quality of life
78046|NCT03077841|Malignant neoplasm of breast|malignant neoplasm of breast
78047|NCT03077841|Breast cancer|breast cancer
78048|NCT03077841|Radiation therapy|radiation therapy
78049|NCT03077841|XRT|xrt
78050|NCT03077841|External beam radiation therapy|external beam radiation therapy
78051|NCT03077841|Shorter course|shorter course
78052|NCT03077841|Questionnaires|questionnaires
78053|NCT03077841|Surveys|surveys
78054|NCT03077802|Seldinger technique|seldinger technique
78055|NCT03077802|Modified Seldinger technique|modified seldinger technique
78056|NCT03077802|Complication|complication
78057|NCT03077802|Success rate|success rate
78058|NCT03077789|visual acuity|visual acuity
78059|NCT03077789|prognosis epidemiology|prognosis epidemiology
78060|NCT03077763|nitrite|nitrite
78061|NCT03077763|haemoglobin|haemoglobin
78062|NCT03077763|normoxia|normoxia
78063|NCT03077763|hypoxia|hypoxia
78064|NCT03077763|vasodilatation|vasodilatation
78065|NCT03077763|blood|blood
78066|NCT03077750|viral skin disease|viral skin disease
78067|NCT03077737|Treatment access|treatment access
78068|NCT03077737|Treatment utilization|treatment utilization
78069|NCT03077737|Smoking cessation|smoking cessation
78070|NCT03077737|Low income|low income
78071|NCT03077737|Electronic health record system|electronic health record system
78072|NCT03077737|Electronic referral|electronic referral
78073|NCT03077724|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
78074|NCT03077724|tobacco use|tobacco use
78075|NCT03077724|pregnancy|pregnancy
78076|NCT03077698|Endometrial cancer|endometrial cancer
78077|NCT03077698|Recurrent or persistent endometrial carcinoma|recurrent or persistent endometrial carcinoma
78078|NCT03077698|Progesterone Receptor Negative|progesterone receptor negative
78079|NCT03077698|Sodium Cridanimod|sodium cridanimod
78080|NCT03077685|pancreatic neoplasms|pancreatic neoplasms
78081|NCT03077685|digestive system neoplasms|digestive system neoplasms
78082|NCT03077685|pancreatic diseases|pancreatic diseases
78083|NCT03077685|digestive system diseases|digestive system diseases
78084|NCT03077685|pancreatic adenocarcinoma|pancreatic adenocarcinoma
78085|NCT03077685|pancreatic cancer|pancreatic cancer
78086|NCT03077672|Mitochondrial DNA|mitochondrial dna
78087|NCT03077672|Lactate|lactate
78088|NCT03077672|Mortality|mortality
78089|NCT03077672|Emergency Department|emergency department
78090|NCT03077672|Intensive Care Unit|intensive care unit
78091|NCT03077672|Triage|triage
78092|NCT03077672|Organ Dysfunction|organ dysfunction
78093|NCT03077672|Biomarker|biomarker
78094|NCT03077672|Prognosis|prognosis
78095|NCT03077659|prostate cancer|prostate cancer
78096|NCT03077659|prostatic neoplasms|prostatic neoplasms
78097|NCT03077659|genital neoplasms, male|genital neoplasms, male
78098|NCT03077659|urogenital neoplasms|urogenital neoplasms
78099|NCT03077659|prostatic diseases|prostatic diseases
78100|NCT03077646|firearm|firearm
78101|NCT03077646|gun|gun
78102|NCT03077646|safety|safety
78103|NCT03077646|pediatric|pediatric
78104|NCT03077646|inpatient|inpatient
78105|NCT03077633|Cerclage|cerclage
78106|NCT03077633|Cervical shortening|cervical shortening
78107|NCT03077633|Twins|twins
78108|NCT03077633|Progesterone|progesterone
78109|NCT03077568|internet|internet
78110|NCT03077568|web-based|web-based
78111|NCT03077568|behavior change|behavior change
78112|NCT03077568|stress-management|stress-management
78113|NCT03077555|quick starting contraception|quick starting contraception
78114|NCT03077542|Peripheral Blood Stem Cells|peripheral blood stem cells
78115|NCT03077542|Host-Donor Chimerism|host-donor chimerism
78116|NCT03077542|Graft Versus Host Disease|graft versus host disease
78117|NCT03077542|Haploidentical|haploidentical
78118|NCT03077542|Donor Apheresis|donor apheresis
78119|NCT03077503|Hemodynamic response|hemodynamic response
78120|NCT03077503|Skull pins application|skull pins application
78121|NCT03077503|Dexmedetomidine|dexmedetomidine
78122|NCT03077503|Fentanyl|fentanyl
78123|NCT03077490|Pelvic organ prolapse|pelvic organ prolapse
78124|NCT03077490|transvaginal mesh|transvaginal mesh
78125|NCT03077490|complications|complications
78126|NCT03077464|nutrition education|nutrition education
78127|NCT03077464|Vegetables|vegetables
78128|NCT03077464|Fruit|fruit
78129|NCT03077438|Meningitis|meningitis
78130|NCT03077438|Meningococcal Meningitis|meningococcal meningitis
78131|NCT03077438|MenACYW conjugate vaccine|menacyw conjugate vaccine
78132|NCT03077438|MENVEO®|menveo®
78133|NCT03077399|lateropulsion|lateropulsion
78134|NCT03077399|stroke|stroke
78135|NCT03077399|Pusher syndrome|pusher syndrome
78136|NCT03077386|patient navigator|patient navigator
78137|NCT03077386|community health worker|community health worker
78138|NCT03077386|multi-morbidity|multi-morbidity
78139|NCT03077386|primary care|primary care
78140|NCT03077386|social determinants of health|social determinants of health
78141|NCT03077373|systolic blood pressure|systolic blood pressure
78142|NCT03077373|physical activity|physical activity
78143|NCT03077373|sedentary time|sedentary time
78144|NCT03077373|smoking|smoking
78145|NCT03077347|Schizophrenia|schizophrenia
78146|NCT03077347|Transcranial Direct Current Stimulation|transcranial direct current stimulation
78147|NCT03077347|tDCS|tdcs
78148|NCT03077347|Cognitive Control|cognitive control
78149|NCT03077347|fMRI|fmri
78150|NCT03077347|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
78151|NCT03077308|Auditory ERP, Visual ERP, EEG|auditory erp, visual erp, eeg
78152|NCT03077282|Prasaprohyai extract, Healthy volunteers|prasaprohyai extract, healthy volunteers
78153|NCT03077269|burn|burn
78154|NCT03077269|coagulation|coagulation
78155|NCT03077269|inflammation|inflammation
78156|NCT03077256|Ankle Arthrodesis|ankle arthrodesis
78157|NCT03077256|Cellular Allograft|cellular allograft
78158|NCT03077243|Human Papillomavirus|human papillomavirus
78159|NCT03077243|Oropharynx|oropharynx
78160|NCT03077243|Oropharyngeal Squamous Cell Carcinoma|oropharyngeal squamous cell carcinoma
78161|NCT03077243|Squamous Cell Carcinoma|squamous cell carcinoma
78162|NCT03077243|Radiation Therapy|radiation therapy
78163|NCT03077243|Chemotherapy|chemotherapy
78164|NCT03077243|p16|p16
78165|NCT03077217|covert hepatic encephalopathy|covert hepatic encephalopathy
78166|NCT03077217|low-dose rifaximin|low-dose rifaximin
78167|NCT03077204|Total cervical vertebrectomy|total cervical vertebrectomy
78168|NCT03077204|Partial cervical vertebrectomy|partial cervical vertebrectomy
78169|NCT03077204|Failed previous fusion|failed previous fusion
78170|NCT03077204|Spinal stenosis|spinal stenosis
78171|NCT03077204|Tumor|tumor
78172|NCT03077204|Decompression of the spinal cord|decompression of the spinal cord
78173|NCT03077204|Pseudoarthrosis|pseudoarthrosis
78174|NCT03077204|Curvatures|curvatures
78175|NCT03077204|Deformities|deformities
78176|NCT03077191|hypofractionated whole breast radiotherapy|hypofractionated whole breast radiotherapy
78177|NCT03077191|breast cancer|breast cancer
78178|NCT03077191|conservative treatment|conservative treatment
78179|NCT03077191|quality of life|quality of life
78180|NCT03077178|Soft Tissue Sarcoma|soft tissue sarcoma
78181|NCT03077178|Surgery|surgery
78182|NCT03077178|Functional Impact|functional impact
78183|NCT03077178|Elderly Patient|elderly patient
78184|NCT03077178|Geriatrics|geriatrics
78185|NCT03077152|copd, aecopd, antibiotic use|copd, aecopd, antibiotic use
78186|NCT03077126|elastography|elastography
78187|NCT03077126|ultrasound|ultrasound
78188|NCT03077126|prostate|prostate
78189|NCT03077126|cancer screening|cancer screening
78190|NCT03077113|lung cancer|lung cancer
78191|NCT03077113|radiation therapy|radiation therapy
78192|NCT03077048|CKD|ckd
78193|NCT03077048|Ketosteril|ketosteril
78194|NCT03077048|keto-acids|keto-acids
78195|NCT03077048|ketoanalogues|ketoanalogues
78196|NCT03077048|Chronic kidney disease|chronic kidney disease
78197|NCT03077035|ICDAS|icdas
78198|NCT03077035|DIAGNOdent|diagnodent
78199|NCT03077035|glass ionomer sealant|glass ionomer sealant
78200|NCT03077035|resin-based sealant|resin-based sealant
78201|NCT03077035|pit and fissure sealants|pit and fissure sealants
78202|NCT03077035|effectiveness of preventing caries|effectiveness of preventing caries
78203|NCT03076983|Ventilation Monitoring|ventilation monitoring
78204|NCT03076983|Electrical Impedance Tomography|electrical impedance tomography
78205|NCT03076931|Voice|voice
78206|NCT03076931|Biomarker|biomarker
78207|NCT03076931|Airway Reconstruction|airway reconstruction
78208|NCT03076918|PDT, Methyl Aminolevulinate, Light Emitting Textile|pdt, methyl aminolevulinate, light emitting textile
78209|NCT03076892|PDT|pdt
78210|NCT03076892|Methyl Aminolevulinate|methyl aminolevulinate
78211|NCT03076892|light emitting textile|light emitting textile
78212|NCT03076879|Cervical Cancer|cervical cancer
78213|NCT03076879|Pap smear|pap smear
78214|NCT03076879|Screening|screening
78215|NCT03076879|Beliefs|beliefs
78216|NCT03076879|Attitude|attitude
78217|NCT03076879|Nursing|nursing
78218|NCT03076840|hamstring tightness|hamstring tightness
78219|NCT03076801|Choral Singing|choral singing
78220|NCT03076801|Music|music
78221|NCT03076801|Quality of Life|quality of life
78222|NCT03076801|Psychosocial Stress|psychosocial stress
78223|NCT03076801|Cardiac Rehabilitation|cardiac rehabilitation
78224|NCT03076788|echocardiography|echocardiography
78225|NCT03076788|intraventricular pressure gradients|intraventricular pressure gradients
78226|NCT03076788|cardiac remodeling|cardiac remodeling
78227|NCT03076788|athletes|athletes
78228|NCT03076775|Betamethasone|betamethasone
78229|NCT03076775|Late preterm|late preterm
78230|NCT03076775|Steroids|steroids
78231|NCT03076762|interstitial cystitis|interstitial cystitis
78232|NCT03076762|pain|pain
78233|NCT03076762|intravesical injection|intravesical injection
78234|NCT03076762|therapy|therapy
78235|NCT03076762|bladder|bladder
78236|NCT03076749|Betalactam|betalactam
78237|NCT03076749|Decision tree|decision tree
78238|NCT03076749|Drug hypersensitivity|drug hypersensitivity
78239|NCT03076749|Logistic regression|logistic regression
78240|NCT03076749|Predictive modelling|predictive modelling
78241|NCT03076710|spine surgery|spine surgery
78242|NCT03076710|post-operative pain|post-operative pain
78243|NCT03076710|patient controlled analgesia|patient controlled analgesia
78244|NCT03076710|Exparel®|exparel®
78245|NCT03076710|bupivacaine|bupivacaine
78246|NCT03076697|fundus photography|fundus photography
78247|NCT03076697|smartphone-based photography|smartphone-based photography
78248|NCT03076671|Palliative Care|palliative care
78249|NCT03076671|Supportive Care|supportive care
78250|NCT03076671|Movement Disorders|movement disorders
78251|NCT03076671|Brain Disease|brain disease
78252|NCT03076671|Neurodegeneration|neurodegeneration
78253|NCT03076671|Parkinson's Disease|parkinson's disease
78254|NCT03076632|transcranial magnetic stimulation|transcranial magnetic stimulation
78255|NCT03076632|neurostimulation|neurostimulation
78256|NCT03076632|non-invasive stimulation|non-invasive stimulation
78257|NCT03076632|closed-loop stimulation|closed-loop stimulation
78258|NCT03076619|pregnancy induced hypertension|pregnancy induced hypertension
78259|NCT03076619|ophthalmoscopy|ophthalmoscopy
78260|NCT03076593|geriatric|geriatric
78261|NCT03076567|Epidemiology|epidemiology
78262|NCT03076567|Cancer|cancer
78263|NCT03076567|Methylation|methylation
78264|NCT03076567|Genetics|genetics
78265|NCT03076567|Screening|screening
78266|NCT03076554|Programmed Death 1 (PD-1)|programmed death 1 (pd-1)
78267|NCT03076554|Immune Checkpoint Blockade|immune checkpoint blockade
78268|NCT03076541|Restless legs syndrome|restless legs syndrome
78269|NCT03076541|Periodic leg movements|periodic leg movements
78270|NCT03076541|Heart rate|heart rate
78271|NCT03076541|Heart rate variability|heart rate variability
78272|NCT03076541|Microarousals|microarousals
78273|NCT03076541|Autonomic nervous system activity|autonomic nervous system activity
78274|NCT03076528|exercise|exercise
78275|NCT03076528|exergame|exergame
78276|NCT03076528|hemodialysis|hemodialysis
78277|NCT03076528|balance|balance
78278|NCT03076502|ctDNA|ctdna
78279|NCT03076502|Gastrointestinal Cancer|gastrointestinal cancer
78280|NCT03076502|ROS|ros
78281|NCT03076502|Hepatobiliary Pancreatic Cancer|hepatobiliary pancreatic cancer
78282|NCT03076476|Coronary Stent|coronary stent
78283|NCT03076476|PCI|pci
78284|NCT03076476|BVS|bvs
78285|NCT03076476|Index of microcirculatory resistance|index of microcirculatory resistance
78286|NCT03076463|Polyphenols|polyphenols
78287|NCT03076463|Metabolic syndrome|metabolic syndrome
78288|NCT03076463|Cardiometabolic risk|cardiometabolic risk
78289|NCT03076463|Grape pomace|grape pomace
78290|NCT03076463|Postprandial glucose|postprandial glucose
78291|NCT03076463|Insulin resistance|insulin resistance
78292|NCT03076463|Obesity|obesity
78293|NCT03076450|Acute respiratory distress syndrome, ARDS|acute respiratory distress syndrome, ards
78294|NCT03076450|Point-of-care lung ultrasound,POC-LUS|point-of-care lung ultrasound,poc-lus
78295|NCT03076450|Pressure-volume curve, PVC|pressure-volume curve, pvc
78296|NCT03076450|Positive end-expiratory pressure, PEEP|positive end-expiratory pressure, peep
78297|NCT03076450|Ultrasound re-aeration score, US-RAS|ultrasound re-aeration score, us-ras
78298|NCT03076411|Dyspepsia|dyspepsia
78299|NCT03076411|Observational trial|observational trial
78300|NCT03076411|Enzyme therapy|enzyme therapy
78301|NCT03076411|Pepsin|pepsin
78302|NCT03076385|VAL-506440|val-506440
78303|NCT03076385|H10N8 antigen mRNA|h10n8 antigen mrna
78304|NCT03076385|Influenza vaccine|influenza vaccine
78305|NCT03076372|Cancer|cancer
78306|NCT03076372|Oncology|oncology
78307|NCT03076372|Phase I|phase i
78308|NCT03076372|Gemcitabine|gemcitabine
78309|NCT03076372|Carboplatin|carboplatin
78310|NCT03076372|MM-310|mm-310
78311|NCT03076372|EphA2|epha2
78312|NCT03076372|Ephrin A2|ephrin a2
78313|NCT03076372|Solid tumors|solid tumors
78314|NCT03076372|urothelial carcinoma|urothelial carcinoma
78315|NCT03076372|gastric carcinoma|gastric carcinoma
78316|NCT03076372|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
78317|NCT03076372|ovarian cancer|ovarian cancer
78318|NCT03076372|pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
78319|NCT03076372|prostate adenocarcinoma|prostate adenocarcinoma
78320|NCT03076372|non-small cell lung cancer|non-small cell lung cancer
78321|NCT03076372|small cell lung cancer|small cell lung cancer
78322|NCT03076372|triple negative breast cancer|triple negative breast cancer
78323|NCT03076372|endometrial carcinoma|endometrial carcinoma
78324|NCT03076372|soft tissue sarcoma|soft tissue sarcoma
78325|NCT03076372|Merrimack|merrimack
78326|NCT03076320|Modified diallyl disulfide oxide (M-DDO)|modified diallyl disulfide oxide (m-ddo)
78327|NCT03076320|Pirfenidone (PFD)|pirfenidone (pfd)
78328|NCT03076320|Adapalene + Benzoyl peroxide (A-BPO)|adapalene + benzoyl peroxide (a-bpo)
78329|NCT03076294|knee ostearthritis|knee ostearthritis
78330|NCT03076294|transcranial magnetic stimulation|transcranial magnetic stimulation
78331|NCT03076294|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
78332|NCT03076294|chronic pain|chronic pain
78333|NCT03076294|musculoskeletal manipulations|musculoskeletal manipulations
78334|NCT03076216|Pancreatic Cancer|pancreatic cancer
78335|NCT03076216|Pancreas|pancreas
78336|NCT03076216|metastases|metastases
78337|NCT03076216|pancreatic tumour|pancreatic tumour
78338|NCT03076216|unresectable|unresectable
78339|NCT03076216|locally advanced|locally advanced
78340|NCT03076216|implantable|implantable
78341|NCT03076216|radiographic|radiographic
78342|NCT03076216|device|device
78343|NCT03076216|Phosphorous-32 (P32)|phosphorous-32 (p32)
78344|NCT03076216|OncoSil™|oncosil™
78345|NCT03076216|brachytherapy|brachytherapy
78346|NCT03076216|gemcitabine|gemcitabine
78347|NCT03076216|nab-paclitaxel|nab-paclitaxel
78348|NCT03076216|Abraxane|abraxane
78349|NCT03076190|psychology|psychology
78350|NCT03076190|pain|pain
78351|NCT03076190|surgery|surgery
78352|NCT03076190|treatment|treatment
78353|NCT03076190|catastrophizing|catastrophizing
78354|NCT03076190|cancer|cancer
78355|NCT03076177|knee osteoarthritis, kinesio taping, knee function, pain|knee osteoarthritis, kinesio taping, knee function, pain
78356|NCT03076164|erlotinib|erlotinib
78357|NCT03076164|trametinib|trametinib
78358|NCT03076164|15-098|15-098
78359|NCT03076151|Transplantation|transplantation
78360|NCT03076151|Kidney|kidney
78361|NCT03076151|pharmacokinetic|pharmacokinetic
78362|NCT03076151|bayesian estimators|bayesian estimators
78363|NCT03076138|Gene-activated matrix|gene-activated matrix
78364|NCT03076138|Bone substitute|bone substitute
78365|NCT03076138|Bone grafting|bone grafting
78366|NCT03076138|Dental implantation|dental implantation
78367|NCT03076138|gene therapy|gene therapy
78368|NCT03076138|plasmid DNA|plasmid dna
78369|NCT03076138|VEGF gene|vegf gene
78370|NCT03076138|octacalcium phosphate|octacalcium phosphate
78371|NCT03076125|Primary Stroke Prevention, Risk Factors for Stroke|primary stroke prevention, risk factors for stroke
78372|NCT03076112|Ipragliflozin|ipragliflozin
78373|NCT03076112|Sitagliptin|sitagliptin
78374|NCT03076099|Dexmedetomidine|dexmedetomidine
78375|NCT03076099|brain arteriovenous malformation|brain arteriovenous malformation
78376|NCT03076099|embolization|embolization
78377|NCT03076099|post-operative hypertension|post-operative hypertension
78378|NCT03076073|Ultrasound|ultrasound
78379|NCT03076073|Achilles tendon|achilles tendon
78380|NCT03076073|Patellar tendon|patellar tendon
78381|NCT03076073|obesity|obesity
78382|NCT03076060|Ketogenic Diet|ketogenic diet
78383|NCT03076060|Very low calories diet|very low calories diet
78384|NCT03076060|ketone bodies|ketone bodies
78385|NCT03075995|lapatinib|lapatinib
78386|NCT03075995|steady state plasma concentration|steady state plasma concentration
78387|NCT03075995|high-fat breakfast|high-fat breakfast
78388|NCT03075969|Chronic myeloid leukemia; quality of life|chronic myeloid leukemia; quality of life
78389|NCT03075930|Atrial fibrillation|atrial fibrillation
78390|NCT03075930|ECG|ecg
78391|NCT03075930|Body surface potential map|body surface potential map
78392|NCT03075930|Recurrence of AF|recurrence of af
78393|NCT03075917|Allergic rhinitis|allergic rhinitis
78394|NCT03075865|intermaxillary fixation|intermaxillary fixation
78395|NCT03075865|maxillo-mandibular fixation|maxillo-mandibular fixation
78396|NCT03075852|Heads-up display, NGENUITY, Vitreoretinal surgery|heads-up display, ngenuity, vitreoretinal surgery
78397|NCT03075800|Assertive Community Treatment (ACT) Only|assertive community treatment (act) only
78398|NCT03075800|Assertive Community Treatment (ACT) + Illness Management and Recovery (IMR)|assertive community treatment (act) + illness management and recovery (imr)
78399|NCT03075787|Obstructive sleep apnea|obstructive sleep apnea
78400|NCT03075787|Heart rate|heart rate
78401|NCT03075787|Heart rate variability|heart rate variability
78402|NCT03075787|Microarousals|microarousals
78403|NCT03075787|Autonomic nervous system activity|autonomic nervous system activity
78404|NCT03075761|Venous thromboembolism|venous thromboembolism
78405|NCT03075761|Deep Vein Thrombosis|deep vein thrombosis
78406|NCT03075761|Lower Extremity|lower extremity
78407|NCT03075761|Blood clot|blood clot
78408|NCT03075761|Anticoagulation|anticoagulation
78409|NCT03075761|Physical Activity|physical activity
78410|NCT03075761|Fitbit|fitbit
78411|NCT03075761|Post-thrombotic syndrome|post-thrombotic syndrome
78412|NCT03075761|Post-phlebitic syndrome|post-phlebitic syndrome
78413|NCT03075761|Thrombosis|thrombosis
78414|NCT03075748|Vascular|vascular
78415|NCT03075748|Stent|stent
78416|NCT03075748|Graft|graft
78417|NCT03075735|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
78418|NCT03075735|DNA-repair|dna-repair
78419|NCT03075735|BRCA1|brca1
78420|NCT03075735|BRCA2|brca2
78421|NCT03075735|ATM|atm
78422|NCT03075735|PALB2|palb2
78423|NCT03075709|Clinical Pathway|clinical pathway
78424|NCT03075709|CPW|cpw
78425|NCT03075709|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
78426|NCT03075709|COPD|copd
78427|NCT03075709|Protocol|protocol
78428|NCT03075709|Adherence|adherence
78429|NCT03075709|Readmission|readmission
78430|NCT03075709|Length of Stay|length of stay
78431|NCT03075709|Cost|cost
78432|NCT03075683|Cognitive behavioural therapy|cognitive behavioural therapy
78433|NCT03075683|Non-pharmacological treatment|non-pharmacological treatment
78434|NCT03075683|Internet mediated|internet mediated
78435|NCT03075579|ADHD, cortisol, α-amylase, actometer|adhd, cortisol, α-amylase, actometer
78436|NCT03075566|coronary artery disease|coronary artery disease
78437|NCT03075566|risk factors|risk factors
78438|NCT03075566|inflammation|inflammation
78439|NCT03075566|biomarkers|biomarkers
78440|NCT03075566|atherosclerosis|atherosclerosis
78441|NCT03075540|Latinas|latinas
78442|NCT03075527|Mesothelioma|mesothelioma
78443|NCT03075514|ketogenic|ketogenic
78444|NCT03075501|drug cues|drug cues
78445|NCT03075475|Child|child
78446|NCT03075475|Adolescent|adolescent
78447|NCT03075475|Mental Health|mental health
78448|NCT03075475|Randomized Controlled Trial|randomized controlled trial
78449|NCT03075462|PARP inhibitor|parp inhibitor
78450|NCT03075462|VEGFR inhibitor|vegfr inhibitor
78451|NCT03075462|Combination therapy|combination therapy
78452|NCT03075462|Ovarian Cancer|ovarian cancer
78453|NCT03075462|Triple Negative Breast Cancer|triple negative breast cancer
78454|NCT03075436|Sanitation|sanitation
78455|NCT03075436|Hygiene|hygiene
78456|NCT03075436|Public Health|public health
78457|NCT03075436|Behavior change|behavior change
78458|NCT03075436|Neglected tropical diseases|neglected tropical diseases
78459|NCT03075436|Demand-side sanitation and hygiene|demand-side sanitation and hygiene
78460|NCT03075436|Mental well-being|mental well-being
78461|NCT03075436|Water insecurity|water insecurity
78462|NCT03075436|Sanitation insecurity|sanitation insecurity
78463|NCT03075436|Collective efficacy|collective efficacy
78464|NCT03075410|ascending dose|ascending dose
78465|NCT03075410|Pharmacokinetics|pharmacokinetics
78466|NCT03075410|GSK3036656|gsk3036656
78467|NCT03075410|FTIH|ftih
78468|NCT03075410|Safety|safety
78469|NCT03075397|HIV-1|hiv-1
78470|NCT03075397|Colo-rectal transmission|colo-rectal transmission
78471|NCT03075397|seminal plasma|seminal plasma
78472|NCT03075384|computer-assisted navigation system|computer-assisted navigation system
78473|NCT03075332|Detraining|detraining
78474|NCT03075332|Physical aptitude|physical aptitude
78475|NCT03075332|HIV|hiv
78476|NCT03075280|ERCP|ercp
78477|NCT03075280|ERAS|eras
78478|NCT03075280|complication|complication
78479|NCT03075280|fatigue|fatigue
78480|NCT03075280|high carbohydrate diet|high carbohydrate diet
78481|NCT03075254|Pain|pain
78482|NCT03075254|Fatigue|fatigue
78483|NCT03075241|Sleep Disturbances|sleep disturbances
78484|NCT03075241|Alzheimer Disease|alzheimer disease
78485|NCT03075241|Insomnia|insomnia
78486|NCT03075241|Z-Drugs|z-drugs
78487|NCT03075241|Treatment|treatment
78488|NCT03075228|microbiota|microbiota
78489|NCT03075228|small intestine|small intestine
78490|NCT03075228|metabolic disease|metabolic disease
78491|NCT03075202|Schizophrenia|schizophrenia
78492|NCT03075202|Smoking|smoking
78493|NCT03075202|E-cigarette|e-cigarette
78494|NCT03075189|Frailty|frailty
78495|NCT03075189|geriatric|geriatric
78496|NCT03075189|hospitalized|hospitalized
78497|NCT03075189|enrichment|enrichment
78498|NCT03075189|whey protein|whey protein
78499|NCT03075189|protein intake|protein intake
78500|NCT03075189|sarcopenia|sarcopenia
78501|NCT03075189|dietary counseling|dietary counseling
78502|NCT03075176|Photorefractive keratectomy|photorefractive keratectomy
78503|NCT03075176|Laser-assisted in situ keratomileusis|laser-assisted in situ keratomileusis
78504|NCT03075163|PONV|ponv
78505|NCT03075163|Nausea|nausea
78506|NCT03075163|Vomiting|vomiting
78507|NCT03075163|Acupressure|acupressure
78509|NCT03075150|Dynamic Cardiac Monitors|dynamic cardiac monitors
78510|NCT03075150|SVV|svv
78511|NCT03075150|PPV|ppv
78512|NCT03075137|ischemic stroke|ischemic stroke
78513|NCT03075137|external counter pulsation|external counter pulsation
78514|NCT03075137|mRS|mrs
78515|NCT03075124|Coronary Artery Disease|coronary artery disease
78516|NCT03075124|external counter pulsation|external counter pulsation
78517|NCT03075124|major adverse cardiovascular events|major adverse cardiovascular events
78518|NCT03075098|Colposcopy|colposcopy
78519|NCT03075098|oral epithelial dysplasia|oral epithelial dysplasia
78520|NCT03075098|diagnostic accuracy|diagnostic accuracy
78521|NCT03075072|Brain metastases|brain metastases
78522|NCT03075072|Brain metastasis|brain metastasis
78523|NCT03075072|Lung cancer|lung cancer
78524|NCT03075072|Melanoma|melanoma
78525|NCT03075072|Breast cancer|breast cancer
78526|NCT03075072|Kidney cancer|kidney cancer
78527|NCT03075072|Renal cell carcinoma|renal cell carcinoma
78528|NCT03075072|Stereotactic radiation|stereotactic radiation
78529|NCT03075072|Stereotactic radiosurgery|stereotactic radiosurgery
78530|NCT03075072|SRS|srs
78531|NCT03075072|Stereotactic|stereotactic
78532|NCT03075072|Whole brain radiation|whole brain radiation
78533|NCT03075072|WBRT|wbrt
78534|NCT03075072|Hippocampal avoidance|hippocampal avoidance
78535|NCT03075072|Hippocampal sparing|hippocampal sparing
78536|NCT03075072|Hippocampal|hippocampal
78537|NCT03075072|Hippocampus|hippocampus
78538|NCT03075072|Radiation|radiation
78539|NCT03075072|Quality of Life|quality of life
78540|NCT03075072|Neurocognitive|neurocognitive
78541|NCT03075072|Neurocognition|neurocognition
78542|NCT03075072|Survival|survival
78543|NCT03075072|Salvage|salvage
78544|NCT03075072|MDASI|mdasi
78545|NCT03075072|Chemotherapy|chemotherapy
78546|NCT03075072|Recurrence|recurrence
78547|NCT03075046|Blue Light Emitting Diode|blue light emitting diode
78548|NCT03075046|Women|women
78549|NCT03075033|Shikani optical stylet, rigid optical stylets, awake, fiber-optic intubation, and cervical spine injury.|shikani optical stylet, rigid optical stylets, awake, fiber-optic intubation, and cervical spine injury.
78550|NCT03075007|Alzheimer Disease|alzheimer disease
78551|NCT03075007|Aging|aging
78552|NCT03075007|Dementia|dementia
78553|NCT03075007|PET|pet
78554|NCT03074994|Tranexamic acid|tranexamic acid
78555|NCT03074994|Peri-articular injection|peri-articular injection
78556|NCT03074994|Intraarticular injection|intraarticular injection
78557|NCT03074994|Total knee arthroplasty|total knee arthroplasty
78558|NCT03074994|Blood loss|blood loss
78559|NCT03074955|Hypotension|hypotension
78560|NCT03074955|Propofol|propofol
78561|NCT03074955|Trendelenburg|trendelenburg
78562|NCT03074955|leg wrapping|leg wrapping
78563|NCT03074929|risk communication|risk communication
78564|NCT03074903|intrauterine device|intrauterine device
78565|NCT03074903|bleeding|bleeding
78566|NCT03074877|Substance Use|substance use
78567|NCT03074864|Activating mutations,lung cancer,radiotherapy|activating mutations,lung cancer,radiotherapy
78568|NCT03074851|low sodium salt|low sodium salt
78569|NCT03074851|blood pressure|blood pressure
78570|NCT03074851|reporter|reporter
78571|NCT03074838|Cardiac surgery|cardiac surgery
78572|NCT03074838|TAVI|tavi
78573|NCT03074825|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
78574|NCT03074825|Relapsed/Refractory|relapsed/refractory
78575|NCT03074825|Aurora kinase B|aurora kinase b
78576|NCT03074734|secondhand smoke|secondhand smoke
78577|NCT03074734|passive smoking|passive smoking
78578|NCT03074734|respiratory diseases|respiratory diseases
78579|NCT03074734|COPD|copd
78580|NCT03074734|asthma|asthma
78581|NCT03074734|SHS health effect|shs health effect
78582|NCT03074708|Three-Dimensional Image|three-dimensional image
78583|NCT03074708|Three Dimensional Printing|three dimensional printing
78584|NCT03074682|Resuscitation|resuscitation
78585|NCT03074669|Anxiety symptoms/disorders (OCD, PTSD, GAD, SAD, Panic)|anxiety symptoms/disorders (ocd, ptsd, gad, sad, panic)
78586|NCT03074656|infliximab|infliximab
78587|NCT03074656|therapeutic drug monitoring|therapeutic drug monitoring
78588|NCT03074656|anti drug antibodies|anti drug antibodies
78589|NCT03074604|Brain Injuries|brain injuries
78590|NCT03074604|Neurological Injury|neurological injury
78591|NCT03074604|Stroke|stroke
78592|NCT03074604|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
78593|NCT03074604|Postoperative Delirium|postoperative delirium
78594|NCT03074604|Coronary Artery Disease|coronary artery disease
78595|NCT03074604|Coronary Artery Bypass Grafting|coronary artery bypass grafting
78596|NCT03074604|Coronary Artery Bypass Surgery|coronary artery bypass surgery
78597|NCT03074604|Bypass surgery|bypass surgery
78598|NCT03074604|Beating Heart Coronary Artery Bypass|beating heart coronary artery bypass
78599|NCT03074604|Off-Pump Coronary Artery Bypass|off-pump coronary artery bypass
78600|NCT03074591|Iron deficiency|iron deficiency
78601|NCT03074591|Heart failure|heart failure
78602|NCT03074578|sleep|sleep
78603|NCT03074578|verbal abuse|verbal abuse
78604|NCT03074578|polysomnography|polysomnography
78605|NCT03074578|perception|perception
78606|NCT03074578|neuropsychological tests|neuropsychological tests
78607|NCT03074565|Sanative Therapy|sanative therapy
78608|NCT03074565|Ultrasonic Therapy|ultrasonic therapy
78609|NCT03074565|Deep Scaling|deep scaling
78610|NCT03074565|Hand Scaling|hand scaling
78611|NCT03074552|probiotics|probiotics
78612|NCT03074552|VAP|vap
78613|NCT03074552|microbiome|microbiome
78614|NCT03074552|trauma|trauma
78615|NCT03074552|infections|infections
78616|NCT03074513|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
78617|NCT03074513|Malignant neoplasms of lip oral cavity and pharynx|malignant neoplasms of lip oral cavity and pharynx
78618|NCT03074513|Malignant neoplasms of mesothelial and soft tissue|malignant neoplasms of mesothelial and soft tissue
78619|NCT03074513|Malignant neoplasms of respiratory and intrathoracic organs|malignant neoplasms of respiratory and intrathoracic organs
78620|NCT03074513|Rare Solid Tumors|rare solid tumors
78621|NCT03074513|Atezolizumab|atezolizumab
78622|NCT03074513|MPDL3280A|mpdl3280a
78623|NCT03074513|Bevacizumab|bevacizumab
78624|NCT03074513|Avastin|avastin
78625|NCT03074513|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
78626|NCT03074513|rhuMAb-VEGF|rhumab-vegf
78627|NCT03074513|Phone call|phone call
78628|NCT03074500|Kinesio taping|kinesio taping
78629|NCT03074500|lateral epicondylitis|lateral epicondylitis
78630|NCT03074500|tennis elbow|tennis elbow
78631|NCT03074500|treatment|treatment
78632|NCT03074487|Spinal cord ischemia|spinal cord ischemia
78633|NCT03074487|Postoperative|postoperative
78634|NCT03074487|Thoracoabdominal Aneurysm|thoracoabdominal aneurysm
78635|NCT03074487|Monitoring|monitoring
78636|NCT03074474|use of mesh|use of mesh
78637|NCT03074461|Rectal Cancer|rectal cancer
78638|NCT03074461|Low Anterior Resection|low anterior resection
78639|NCT03074461|Coloplasty Pouch|coloplasty pouch
78640|NCT03074461|Side-to-end Anastomosis|side-to-end anastomosis
78641|NCT03074461|Continence|continence
78642|NCT03074461|Quality of Life|quality of life
78643|NCT03074448|Colonoscopy|colonoscopy
78644|NCT03074448|Intestinal Cleaning|intestinal cleaning
78645|NCT03074448|Picoprep|picoprep
78646|NCT03074448|Aquanet|aquanet
78647|NCT03074422|Functional neurosurgery|functional neurosurgery
78648|NCT03074422|Pain management|pain management
78649|NCT03074422|Hypnosis|hypnosis
78650|NCT03074422|Stereotaxy|stereotaxy
78651|NCT03074422|Parkinson disease|parkinson disease
78652|NCT03074422|Essential tremor|essential tremor
78653|NCT03074422|Dystonia|dystonia
78654|NCT03074422|Invasive monitoring of epilepsy|invasive monitoring of epilepsy
78655|NCT03074409|Oxytocin|oxytocin
78656|NCT03074344|Dry Eye Syndrome|dry eye syndrome
78657|NCT03074344|artificial tear|artificial tear
78658|NCT03074344|CoQ10|coq10
78659|NCT03074344|Hyaluronic acid|hyaluronic acid
78660|NCT03074305|In-bioresorbable vascular scaffold restenosis|in-bioresorbable vascular scaffold restenosis
78661|NCT03074305|drug-eluting stent|drug-eluting stent
78662|NCT03074305|drug-eluting balloon|drug-eluting balloon
78663|NCT03074305|bioresorbable scaffold|bioresorbable scaffold
78664|NCT03074279|Epilepsy|epilepsy
78665|NCT03074279|SUDEP|sudep
78666|NCT03074279|case-control study|case-control study
78667|NCT03074279|risks factors|risks factors
78668|NCT03074240|Truncal block|truncal block
78669|NCT03074240|Surgical anesthesia|surgical anesthesia
78670|NCT03074240|Postoperative pain control|postoperative pain control
78671|NCT03074214|copeptin|copeptin
78672|NCT03074214|myocardial infarct size|myocardial infarct size
78673|NCT03074214|prognosis|prognosis
78674|NCT03074214|ST-elevation myocardial infarction|st-elevation myocardial infarction
78675|NCT03074214|percutaneous coronary intervention|percutaneous coronary intervention
78676|NCT03074201|ERCP, choledocholithiasis, cholangioscopy|ercp, choledocholithiasis, cholangioscopy
78677|NCT03074188|oral findings or oral manifestation|oral findings or oral manifestation
78678|NCT03074188|pre-dialysis stage or end stage renal disease|pre-dialysis stage or end stage renal disease
78679|NCT03074136|photodynamic therapy|photodynamic therapy
78680|NCT03074136|diode laser|diode laser
78681|NCT03074136|immature permanent teeth|immature permanent teeth
78682|NCT03074136|endodontic therapy|endodontic therapy
78683|NCT03074123|cosyntropin stimulation test|cosyntropin stimulation test
78684|NCT03074123|low-dose|low-dose
78685|NCT03074110|Inhalation Anaesthetics, Sevoflurane|inhalation anaesthetics, sevoflurane
78686|NCT03074110|Carbon Dioxide|carbon dioxide
78687|NCT03074110|Hyperventilation|hyperventilation
78688|NCT03074110|Anaesthesia Recovery Period|anaesthesia recovery period
78689|NCT03074110|Ventilators|ventilators
78690|NCT03074097|Rectus sheath block, Postoperative pain,TNF alpha and IL-6|rectus sheath block, postoperative pain,tnf alpha and il-6
78691|NCT03074084|abdominal pain|abdominal pain
78692|NCT03074084|adult|adult
78693|NCT03074084|emergency department|emergency department
78694|NCT03074084|electronic nose|electronic nose
78695|NCT03074084|celiac disease|celiac disease
78696|NCT03074071|Disambiguation, Depression, Burnout|disambiguation, depression, burnout
78697|NCT03074045|Intrauterine|intrauterine
78698|NCT03074045|Birth control|birth control
78699|NCT03073993|nasogastric|nasogastric
78700|NCT03073993|orogastric|orogastric
78701|NCT03073993|nutrition|nutrition
78702|NCT03073993|preterm|preterm
78703|NCT03073993|feeding tube|feeding tube
78704|NCT03073993|insertion|insertion
78705|NCT03073993|episodes|episodes
78706|NCT03073993|bradycardia|bradycardia
78707|NCT03073993|desaturation|desaturation
78708|NCT03073980|in vitro fertilization|in vitro fertilization
78709|NCT03073980|oocyte retrieval|oocyte retrieval
78710|NCT03073980|acetaminophen|acetaminophen
78711|NCT03073980|postoperative pain control|postoperative pain control
78712|NCT03073954|Health Behavior|health behavior
78713|NCT03073954|Executive function|executive function
78714|NCT03073954|Working-memory training|working-memory training
78715|NCT03073954|Feasibility|feasibility
78716|NCT03073954|Impulsivity|impulsivity
78717|NCT03073941|Knee arthroplasty|knee arthroplasty
78718|NCT03073941|Knee function|knee function
78719|NCT03073941|Total knee replacement|total knee replacement
78720|NCT03073941|Persona total knee system|persona total knee system
78721|NCT03073941|NexGen total knee system|nexgen total knee system
78722|NCT03073928|Nerve block|nerve block
78723|NCT03073928|Diaphragm function|diaphragm function
78724|NCT03073889|Aneurysm Clipping|aneurysm clipping
78725|NCT03073889|Scalp nerve block|scalp nerve block
78726|NCT03073889|Scalp infiltration|scalp infiltration
78727|NCT03073889|Ropivacaine|ropivacaine
78728|NCT03073876|Alzheimer Disease|alzheimer disease
78729|NCT03073876|Attention|attention
78730|NCT03073876|Donepezil hydrochloride|donepezil hydrochloride
78731|NCT03073863|LDL Cholesterol|ldl cholesterol
78732|NCT03073863|Statin intensity|statin intensity
78733|NCT03073863|post hoc analysis|post hoc analysis
78734|NCT03073863|Achieved LDL Cholesterol level|achieved ldl cholesterol level
78735|NCT03073811|protein supplementation|protein supplementation
78736|NCT03073811|older adults|older adults
78737|NCT03073811|nutrition perihabilitation|nutrition perihabilitation
78738|NCT03073811|perioperative optimization|perioperative optimization
78739|NCT03073811|Veterans|veterans
78740|NCT03073798|Lung Disease|lung disease
78741|NCT03073798|Breathing Difficulty|breathing difficulty
78742|NCT03073798|Smoking|smoking
78743|NCT03073798|Mucociliary|mucociliary
78744|NCT03073746|Google|google
78745|NCT03073746|Knowledge Panels|knowledge panels
78746|NCT03073746|Health Search|health search
78747|NCT03073746|Online|online
78748|NCT03073746|Internet|internet
78749|NCT03073746|Smartphone|smartphone
78750|NCT03073746|Tablet|tablet
78751|NCT03073746|Digital|digital
78752|NCT03073746|Mobile|mobile
78753|NCT03073746|Symptoms|symptoms
78754|NCT03073746|Differential diagnosis|differential diagnosis
78755|NCT03073746|Diagnosis|diagnosis
78756|NCT03073746|Anxiety|anxiety
78757|NCT03073707|Non-Typhoid Salmonella|non-typhoid salmonella
78758|NCT03073707|Invasive blood stream infections|invasive blood stream infections
78759|NCT03073707|Reservoir|reservoir
78760|NCT03073707|Household environment|household environment
78761|NCT03073707|Children|children
78762|NCT03073694|Peritoneal Surface Disease|peritoneal surface disease
78763|NCT03073694|mitomycin-c|mitomycin-c
78764|NCT03073694|melphalan|melphalan
78765|NCT03073694|Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC)|cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (crs-hipec)
78766|NCT03073694|Peritoneal Carcinomatosis|peritoneal carcinomatosis
78767|NCT03073681|cataract|cataract
78768|NCT03073655|shoulder pain|shoulder pain
78769|NCT03073655|shoulder function|shoulder function
78770|NCT03073642|Hydrotherapy|hydrotherapy
78771|NCT03073642|Pain education|pain education
78772|NCT03073577|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
78773|NCT03073577|Islet Transplantation|islet transplantation
78774|NCT03073577|Diabetes|diabetes
78775|NCT03073577|Diabetes Treatment|diabetes treatment
78776|NCT03073564|Dyspnea|dyspnea
78777|NCT03073564|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
78778|NCT03073564|Positive-Pressure Respiration|positive-pressure respiration
78779|NCT03073525|Stage IIIb|stage iiib
78780|NCT03073525|Stage IV|stage iv
78781|NCT03073525|Ovarian Cancer|ovarian cancer
78782|NCT03073525|Cervical Cancer|cervical cancer
78783|NCT03073525|Uterine Cancer|uterine cancer
78784|NCT03073525|Immunotherapy|immunotherapy
78785|NCT03073447|Myocardial infarction|myocardial infarction
78786|NCT03073447|Women|women
78787|NCT03073447|Young|young
78788|NCT03073447|Primary PCI|primary pci
78789|NCT03073447|Hormone|hormone
78790|NCT03073408|Propofol|propofol
78791|NCT03073408|Bispectral index (BIS)|bispectral index (bis)
78792|NCT03073408|Closed loop|closed loop
78793|NCT03073356|Myocardial metabolism|myocardial metabolism
78794|NCT03073356|Positron emission tomography|positron emission tomography
78795|NCT03073356|Echocardiography|echocardiography
78796|NCT03073356|Right sided heart catheterization|right sided heart catheterization
78797|NCT03073317|Preterm Infants|preterm infants
78798|NCT03073317|Premature Birth|premature birth
78799|NCT03073317|Placenta growth factor|placenta growth factor
78800|NCT03073317|Prenatal Care|prenatal care
78801|NCT03073317|PERINATAL MORTALITY|perinatal mortality
78802|NCT03073317|Pre-Eclampsia|pre-eclampsia
78803|NCT03073304|isolated limb perfusion|isolated limb perfusion
78804|NCT03073291|cannabis|cannabis
78805|NCT03073291|commerce|commerce
78806|NCT03073265|DOAC|doac
78807|NCT03073265|apixaban|apixaban
78808|NCT03073265|IVD|ivd
78809|NCT03073239|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
78810|NCT03073239|Bulbar disfunction|bulbar disfunction
78811|NCT03073239|Rik factors ALS|rik factors als
78812|NCT03073200|children|children
78813|NCT03073200|psoriasis treatment|psoriasis treatment
78814|NCT03073200|adolescents|adolescents
78815|NCT03073187|Asthma|asthma
78816|NCT03073187|Sleep|sleep
78817|NCT03073187|Adolescents|adolescents
78818|NCT03073187|Urban|urban
78819|NCT03073187|Intervention|intervention
78820|NCT03073187|High school|high school
78821|NCT03073174|dietary intake|dietary intake
78822|NCT03073174|nutritional supplements|nutritional supplements
78823|NCT03073174|sanative therapy|sanative therapy
78824|NCT03073174|healing|healing
78825|NCT03073174|flavonoids|flavonoids
78826|NCT03073174|tea|tea
78827|NCT03073161|flavonoids|flavonoids
78828|NCT03073161|tea|tea
78829|NCT03073161|dietary intake|dietary intake
78830|NCT03073161|nutritional supplements|nutritional supplements
78831|NCT03073161|periodontal disease|periodontal disease
78832|NCT03073161|healing|healing
78833|NCT03073161|sanative therapy|sanative therapy
78834|NCT03073096|axillary nodal dissection|axillary nodal dissection
78835|NCT03073096|groin nodal dissection|groin nodal dissection
78836|NCT03073083|autograft|autograft
78837|NCT03073070|diabetic children|diabetic children
78838|NCT03073070|RBC lifespan|rbc lifespan
78839|NCT03073044|Quality of life|quality of life
78840|NCT03073044|psychosocial and psychological problems|psychosocial and psychological problems
78841|NCT03073005|ventricular assist device (VAD)|ventricular assist device (vad)
78842|NCT03073005|heart failure|heart failure
78843|NCT03073005|simulation|simulation
78844|NCT03072966|Distress|distress
78845|NCT03072966|Exercise|exercise
78846|NCT03072966|Wearable device|wearable device
78847|NCT03072966|Smartphone|smartphone
78848|NCT03072927|Lumbar Spinal Stenosis|lumbar spinal stenosis
78849|NCT03072927|Interspinous process decompression|interspinous process decompression
78850|NCT03072927|MILD|mild
78851|NCT03072927|Medicare|medicare
78852|NCT03072888|acute pain|acute pain
78853|NCT03072888|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
78854|NCT03072888|Anesthesia Recovery Period|anesthesia recovery period
78855|NCT03072875|Suicidality|suicidality
78856|NCT03072875|Collaborative Assessment and Management of Suicidality|collaborative assessment and management of suicidality
78857|NCT03072875|Technology|technology
78858|NCT03072875|Suicide Prevention|suicide prevention
78859|NCT03072875|Suicide Intervention|suicide intervention
78860|NCT03072862|Cochlear implant treatment, aging adults|cochlear implant treatment, aging adults
78861|NCT03072849|Pediatrics|pediatrics
78862|NCT03072849|Airflow obstruction|airflow obstruction
78863|NCT03072849|Chronic graft-vs-host disease|chronic graft-vs-host disease
78864|NCT03072849|Bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
78865|NCT03072823|CVDs|cvds
78866|NCT03072823|cardiovascular diseases|cardiovascular diseases
78867|NCT03072823|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
78868|NCT03072823|depression|depression
78869|NCT03072810|Positive psychology|positive psychology
78870|NCT03072810|Wellbeing|wellbeing
78871|NCT03072810|Chronic pain|chronic pain
78872|NCT03072810|Mindfulness|mindfulness
78873|NCT03072797|Atherosclerosis|atherosclerosis
78874|NCT03072797|Longitudinal|longitudinal
78875|NCT03072797|Biomarker|biomarker
78876|NCT03072797|Coronary angiography|coronary angiography
78877|NCT03072797|Follow-up|follow-up
78878|NCT03072797|Metabolomics|metabolomics
78879|NCT03072797|Risk factor|risk factor
78880|NCT03072758|Male partner involvement|male partner involvement
78881|NCT03072745|Cognitive Impairment|cognitive impairment
78882|NCT03072732|Heart Failure|heart failure
78883|NCT03072732|Hemodialysis|hemodialysis
78884|NCT03072706|hip replacement|hip replacement
78885|NCT03072706|acetabulum|acetabulum
78886|NCT03072706|anteversion|anteversion
78887|NCT03072706|position|position
78888|NCT03072706|guide|guide
78889|NCT03072667|prematurity|prematurity
78890|NCT03072667|bowel atresia|bowel atresia
78891|NCT03072667|necrotizing entercolitis|necrotizing entercolitis
78892|NCT03072667|parenteral nutrition associated liver disease (PNALD)|parenteral nutrition associated liver disease (pnald)
78893|NCT03072667|intestinal failure|intestinal failure
78894|NCT03072667|parenteral nutrition associated cholestasis|parenteral nutrition associated cholestasis
78895|NCT03072667|fish oil|fish oil
78896|NCT03072641|Probiotics|probiotics
78897|NCT03072641|Epigenetics|epigenetics
78898|NCT03072641|Microbiota|microbiota
78899|NCT03072628|nicotine|nicotine
78900|NCT03072628|sympathetic nerve activity|sympathetic nerve activity
78901|NCT03072628|oxidative stress|oxidative stress
78902|NCT03072602|Racial differences|racial differences
78903|NCT03072576|Diagnosis|diagnosis
78904|NCT03072576|Xpert MTB/RIF|xpert mtb/rif
78905|NCT03072576|Ultra Xpert MTB/RIF|ultra xpert mtb/rif
78906|NCT03072550|fungal nail|fungal nail
78907|NCT03072550|toenail fungus|toenail fungus
78908|NCT03072537|growth, BMI, obesity, overweight, weight, height, childhood, adolescence, development|growth, bmi, obesity, overweight, weight, height, childhood, adolescence, development
78909|NCT03072524|pre-hospital stroke scale test|pre-hospital stroke scale test
78910|NCT03072524|severe hemiparesis|severe hemiparesis
78911|NCT03072524|large vessel occlusion|large vessel occlusion
78912|NCT03072524|mechanical thrombectomy|mechanical thrombectomy
78913|NCT03072485|aging|aging
78914|NCT03072472|Colorectal Cancer|colorectal cancer
78915|NCT03072472|Endoscopy|endoscopy
78916|NCT03072472|Screening|screening
78917|NCT03072472|Colonic Adenoma|colonic adenoma
78918|NCT03072472|Adenoma Detection Rate|adenoma detection rate
78919|NCT03072472|Endocuff|endocuff
78920|NCT03072472|Endocuff Vision|endocuff vision
78921|NCT03072446|Uterine Fibroid|uterine fibroid
78922|NCT03072446|Embolization|embolization
78923|NCT03072446|symptoms|symptoms
78924|NCT03072446|Gel-Beads|gel-beads
78925|NCT03072433|child malnutrition|child malnutrition
78926|NCT03072433|child development|child development
78927|NCT03072433|counseling|counseling
78928|NCT03072420|MRI, fingers compression|mri, fingers compression
78929|NCT03072381|CLE|cle
78930|NCT03072381|epicondylosis|epicondylosis
78931|NCT03072381|platelet rich plasma|platelet rich plasma
78932|NCT03072381|PRP|prp
78933|NCT03072381|ultrasound|ultrasound
78934|NCT03072381|shear wave ultrasound|shear wave ultrasound
78935|NCT03072381|tendinopathy|tendinopathy
78936|NCT03072381|elbow|elbow
78937|NCT03072381|tenis elbow|tenis elbow
78938|NCT03072381|plasma|plasma
78939|NCT03072381|plasma injection|plasma injection
78940|NCT03072381|tendinosis|tendinosis
78941|NCT03072381|tendinitis|tendinitis
78942|NCT03072355|fatigue|fatigue
78943|NCT03072355|resistance test|resistance test
78944|NCT03072316|breast cancer|breast cancer
78945|NCT03072316|mastectomy|mastectomy
78946|NCT03072316|deep inferior perforator flap reconstruction|deep inferior perforator flap reconstruction
78947|NCT03072316|post mastectomy radiotherapy|post mastectomy radiotherapy
78948|NCT03072303|Brittle Bone|brittle bone
78949|NCT03072303|Osteogenesis Imperfecta|osteogenesis imperfecta
78950|NCT03072303|BBD|bbd
78951|NCT03072303|OI|oi
78952|NCT03072303|Congenital Abnormalities|congenital abnormalities
78953|NCT03072303|Congenital Bone Disorder|congenital bone disorder
78954|NCT03072303|Lobstein Syndrome|lobstein syndrome
78955|NCT03072277|DHA|dha
78956|NCT03072277|Docosa Hexaenoic Acid|docosa hexaenoic acid
78957|NCT03072277|Omega 3 fatty acid|omega 3 fatty acid
78958|NCT03072277|Newborn Outcome|newborn outcome
78959|NCT03072277|Birth Size|birth size
78960|NCT03072277|Gestational Age|gestational age
78961|NCT03072277|DASII|dasii
78962|NCT03072277|Prenatal Supplementation|prenatal supplementation
78963|NCT03072277|Randomized Controlled Trial|randomized controlled trial
78964|NCT03072277|Neurodevelopment|neurodevelopment
78965|NCT03072264|Generalized Anxiety Disorder, GAD, mindfulness, anxiety|generalized anxiety disorder, gad, mindfulness, anxiety
78966|NCT03072238|Metastatic Castrate-Resistant Prostate Cancer|metastatic castrate-resistant prostate cancer
78967|NCT03072225|herbal medicine|herbal medicine
78968|NCT03072225|stroke|stroke
78969|NCT03072225|vulnerable plaques of carotid artery|vulnerable plaques of carotid artery
78970|NCT03072212|HIV|hiv
78971|NCT03072212|Stroke|stroke
78972|NCT03072212|Cerebral vascular accident|cerebral vascular accident
78973|NCT03072212|Uganda|uganda
78974|NCT03072199|Rituximab|rituximab
78975|NCT03072199|B cells|b cells
78976|NCT03072160|Anti-PD1/PDL1|anti-pd1/pdl1
78977|NCT03072160|Vaccine Therapy|vaccine therapy
78978|NCT03072160|TKI-Naive|tki-naive
78979|NCT03072134|Glioma|glioma
78980|NCT03072134|Glioblastoma|glioblastoma
78981|NCT03072134|Astrocytoma|astrocytoma
78982|NCT03072134|Brain Cancer|brain cancer
78983|NCT03072134|New Diagnosed Glioma|new diagnosed glioma
78984|NCT03072134|Temozolomide|temozolomide
78985|NCT03072134|Radiation|radiation
78986|NCT03072134|Neural Stem Cells|neural stem cells
78987|NCT03072134|Virotherapy|virotherapy
78988|NCT03072134|Adenovirus|adenovirus
78989|NCT03072134|Oncolytic virotherapy|oncolytic virotherapy
78990|NCT03072121|coronary artery disease|coronary artery disease
78991|NCT03072121|revascularization|revascularization
78992|NCT03072121|Shexiang Baoxin Pill|shexiang baoxin pill
78993|NCT03072095|Colorectal Neoplasms|colorectal neoplasms
78994|NCT03072095|Colonic Neoplasms|colonic neoplasms
78995|NCT03072095|Gastrointestinal Neoplasms|gastrointestinal neoplasms
78996|NCT03072095|Digestive System Neoplasms|digestive system neoplasms
78997|NCT03072095|Neoplasms|neoplasms
78998|NCT03072095|Digestive System Diseases|digestive system diseases
78999|NCT03072095|Gastrointestinal Diseases|gastrointestinal diseases
79000|NCT03072095|Colonic Diseases|colonic diseases
79001|NCT03072095|Rectal Diseases|rectal diseases
79002|NCT03072082|coronary artery disease|coronary artery disease
79003|NCT03072082|revascularization|revascularization
79004|NCT03072082|Danlou Tablet|danlou tablet
79005|NCT03072043|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
79006|NCT03072043|TP53 mutant myelodysplastic syndrome|tp53 mutant myelodysplastic syndrome
79007|NCT03072043|MDS/myeloproliferative neoplasm (MPN)|mds/myeloproliferative neoplasm (mpn)
79008|NCT03072043|chronic myelomonocytic leukemia (CMML)|chronic myelomonocytic leukemia (cmml)
79009|NCT03072043|acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
79010|NCT03072030|Ebola Virus Disease|ebola virus disease
79011|NCT03072030|Hemorrhagic Fever, Ebola|hemorrhagic fever, ebola
79012|NCT03072030|Vaccines|vaccines
79013|NCT03072030|GP protein, Ebola virus|gp protein, ebola virus
79014|NCT03072030|Ebola Virus Vaccines|ebola virus vaccines
79015|NCT03072004|Leprosy|leprosy
79016|NCT03072004|Neuropathy|neuropathy
79017|NCT03072004|LLLT|lllt
79018|NCT03071991|preinsicional bupivacain|preinsicional bupivacain
79019|NCT03071991|laparoscopic bariatric surgery|laparoscopic bariatric surgery
79020|NCT03071991|postoperative pain|postoperative pain
79021|NCT03071978|Heart Failure|heart failure
79022|NCT03071978|LV-fusion pacing|lv-fusion pacing
79023|NCT03071978|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
79024|NCT03071952|Heart Failure|heart failure
79025|NCT03071952|Chronotropic Incompetence|chronotropic incompetence
79026|NCT03071952|Rate Response|rate response
79027|NCT03071952|Exercise Test|exercise test
79028|NCT03071874|Meningioma|meningioma
79029|NCT03071861|darbepoetin|darbepoetin
79030|NCT03071861|Brain Diseases|brain diseases
79031|NCT03071835|Stem Cells|stem cells
79032|NCT03071835|Cardiovascular|cardiovascular
79033|NCT03071835|Quality of Life|quality of life
79034|NCT03071835|Cardiomyopathy|cardiomyopathy
79035|NCT03071822|PTCLs|ptcls
79036|NCT03071809|Solid tumor|solid tumor
79037|NCT03071809|carcinoma|carcinoma
79038|NCT03071809|sarcoma|sarcoma
79039|NCT03071809|stage I|stage i
79040|NCT03071809|stage II|stage ii
79041|NCT03071809|stage III|stage iii
79042|NCT03071770|Healthy Volunteers|healthy volunteers
79043|NCT03071770|Japanese|japanese
79044|NCT03071770|Caucasian|caucasian
79045|NCT03071757|Solid Tumors|solid tumors
79046|NCT03071757|Cancer|cancer
79047|NCT03071757|Metastatic Solid Tumors|metastatic solid tumors
79048|NCT03071757|Advanced Solid Tumors|advanced solid tumors
79049|NCT03071757|Triple negative breast cancer|triple negative breast cancer
79050|NCT03071757|Ovarian cancer|ovarian cancer
79051|NCT03071757|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
79052|NCT03071757|Gastric cancer|gastric cancer
79053|NCT03071757|Mesothelioma|mesothelioma
79054|NCT03071757|Small cell lung cancer (SCLC)|small cell lung cancer (sclc)
79055|NCT03071757|Cholangiocarcinoma|cholangiocarcinoma
79056|NCT03071757|Merkel cell carcinoma|merkel cell carcinoma
79057|NCT03071757|Melanoma|melanoma
79058|NCT03071757|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
79059|NCT03071731|Glittre|glittre
79060|NCT03071731|COPD|copd
79061|NCT03071731|sit-to-stand|sit-to-stand
79062|NCT03071731|responsiveness|responsiveness
79063|NCT03071731|bronchodilation|bronchodilation
79064|NCT03071718|cardiovascular diseases|cardiovascular diseases
79065|NCT03071718|gut microbiota|gut microbiota
79066|NCT03071718|Mediterranean diet|mediterranean diet
79067|NCT03071705|NSCLC|nsclc
79068|NCT03071705|metformin|metformin
79069|NCT03071705|metformin plus TKI|metformin plus tki
79070|NCT03071705|EGFR positive status|egfr positive status
79071|NCT03071666|Nepal|nepal
79072|NCT03071666|South Asia|south asia
79073|NCT03071666|Nutrition|nutrition
79074|NCT03071666|Pregnancy|pregnancy
79075|NCT03071666|Neurodevelopment|neurodevelopment
79076|NCT03071666|Growth|growth
79077|NCT03071653|Cardiomyopathy|cardiomyopathy
79078|NCT03071653|Left Cardiac Sympathetic Denervation|left cardiac sympathetic denervation
79079|NCT03071640|old|old
79080|NCT03071640|elderly|elderly
79081|NCT03071640|radiotherapy|radiotherapy
79082|NCT03071640|geriatric assessment|geriatric assessment
79083|NCT03071627|Spin|spin
79084|NCT03071627|Misleading reporting|misleading reporting
79085|NCT03071627|Misleading interpretation|misleading interpretation
79086|NCT03071627|Misleading extrapolation|misleading extrapolation
79087|NCT03071627|Animal studies|animal studies
79088|NCT03071627|Cell culture studies|cell culture studies
79089|NCT03071627|Pre-clinical studies|pre-clinical studies
79090|NCT03071614|Spin, misleading reporting, misleading interpretation, misleading extrapolation, animal studies, cell culture studies, pre-clinical studies|spin, misleading reporting, misleading interpretation, misleading extrapolation, animal studies, cell culture studies, pre-clinical studies
79091|NCT03071614|Misleading reporting|misleading reporting
79092|NCT03071614|Misleading interpretation|misleading interpretation
79093|NCT03071614|Misleading extrapolation|misleading extrapolation
79094|NCT03071614|Animal studies|animal studies
79095|NCT03071614|Cell culture studies|cell culture studies
79096|NCT03071614|Pre-clinical studies|pre-clinical studies
79097|NCT03071601|Laceration|laceration
79098|NCT03071601|Suture|suture
79099|NCT03071601|Topical anesthesia|topical anesthesia
79100|NCT03071601|Lidocaine|lidocaine
79101|NCT03071575|measles|measles
79102|NCT03071575|rubella|rubella
79103|NCT03071575|immunogenicity|immunogenicity
79104|NCT03071575|congenital rubella syndrome|congenital rubella syndrome
79105|NCT03071575|measles-rubella vaccine|measles-rubella vaccine
79106|NCT03071562|HIV|hiv
79107|NCT03071562|Cognitive impairment|cognitive impairment
79108|NCT03071562|Aging|aging
79109|NCT03071562|Physical Activity|physical activity
79110|NCT03071562|Exercise|exercise
79111|NCT03071562|Yoga|yoga
79112|NCT03071562|Neuroplasticity|neuroplasticity
79113|NCT03071549|Acne vulgaris|acne vulgaris
79114|NCT03071549|Chemical peeling|chemical peeling
79115|NCT03071549|Dermoscopy|dermoscopy
79116|NCT03071536|furosemide stress test|furosemide stress test
79117|NCT03071536|kidney transplantation|kidney transplantation
79118|NCT03071536|urine output|urine output
79119|NCT03071536|perioperation|perioperation
79120|NCT03071536|delayed graft function|delayed graft function
79121|NCT03071497|Iron-deficiency|iron-deficiency
79122|NCT03071497|Anemia|anemia
79123|NCT03071497|Iron-deficiency Anemia|iron-deficiency anemia
79124|NCT03071497|Zinc protoporphyrin|zinc protoporphyrin
79125|NCT03071484|Early Stages of Psychosis|early stages of psychosis
79126|NCT03071484|Schizophrenia|schizophrenia
79127|NCT03071484|Transcranial Direct Current Stimulation|transcranial direct current stimulation
79128|NCT03071484|Cognitive Symptomatology|cognitive symptomatology
79129|NCT03071484|Double-blind Randomized Controlled Trial|double-blind randomized controlled trial
79130|NCT03071419|fathers|fathers
79131|NCT03071406|Merkel cell carcinoma (MCC)|merkel cell carcinoma (mcc)
79132|NCT03071406|Metastatic|metastatic
79133|NCT03071406|Metastasis|metastasis
79134|NCT03071406|Stereotactic body radiation therapy (SBRT)|stereotactic body radiation therapy (sbrt)
79135|NCT03071406|Immunology|immunology
79136|NCT03071406|Antibody|antibody
79137|NCT03071406|Nivolumab|nivolumab
79138|NCT03071406|Ipilimumab|ipilimumab
79139|NCT03071406|Metastatic skin cancer|metastatic skin cancer
79140|NCT03071406|Cutaneous|cutaneous
79141|NCT03071393|acute intermittent hypoxia|acute intermittent hypoxia
79142|NCT03071393|walking|walking
79143|NCT03071393|breathing|breathing
79144|NCT03071393|standing|standing
79145|NCT03071393|sitting|sitting
79146|NCT03071393|spinal cord injury|spinal cord injury
79147|NCT03071367|Airway Management|airway management
79148|NCT03071367|Medical students|medical students
79149|NCT03071367|Intratracheal intubation|intratracheal intubation
79150|NCT03071367|Educational Technology|educational technology
79151|NCT03071354|ICU-acquired weakness|icu-acquired weakness
79152|NCT03071341|MPS I; Hurler Syndrome|mps i; hurler syndrome
79153|NCT03071315|Economic evaluation|economic evaluation
79154|NCT03071315|Heroin dependence|heroin dependence
79155|NCT03071315|Compulsory treatment|compulsory treatment
79156|NCT03071315|Methadone treatment|methadone treatment
79157|NCT03071315|Vietnam|vietnam
79158|NCT03071315|East and Southeast Asia|east and southeast asia
79159|NCT03071315|Cost-effectiveness|cost-effectiveness
79160|NCT03071302|Keratoconus,Corneal Dystrophies, corneal Tomography, topography|keratoconus,corneal dystrophies, corneal tomography, topography
79161|NCT03071263|Treatment of Hyperkalemia|treatment of hyperkalemia
79162|NCT03071263|Hyperkalemia|hyperkalemia
79163|NCT03071263|Potassium|potassium
79164|NCT03071263|Chronic Kidney Disease|chronic kidney disease
79165|NCT03071263|Hypertension|hypertension
79166|NCT03071263|Resistant Hypertension|resistant hypertension
79167|NCT03071263|Spironolactone|spironolactone
79168|NCT03071237|infrapyloric artery|infrapyloric artery
79169|NCT03071237|gastric cancer|gastric cancer
79170|NCT03071224|AD|ad
79171|NCT03071224|HV|hv
79172|NCT03071211|pelvic organ prolapse|pelvic organ prolapse
79173|NCT03071211|urinary catheters|urinary catheters
79174|NCT03071198|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
79175|NCT03071185|free flap|free flap
79176|NCT03071185|nerve block|nerve block
79177|NCT03071185|elective reconstructive surgery|elective reconstructive surgery
79178|NCT03071185|free fibular|free fibular
79179|NCT03071185|anterolateral thigh flaps|anterolateral thigh flaps
79180|NCT03071159|Flash Glucose Monitoring|flash glucose monitoring
79181|NCT03071159|Usability|usability
79182|NCT03071159|Metabolic control|metabolic control
79183|NCT03071055|Macular Degeneration|macular degeneration
79184|NCT03071055|AMD|amd
79185|NCT03071055|Wet AMD|wet amd
79186|NCT03071055|Lucentis|lucentis
79187|NCT03071029|family planning|family planning
79188|NCT03071029|reproductive health|reproductive health
79189|NCT03071029|abortion|abortion
79190|NCT03071029|health providers|health providers
79191|NCT03071016|T2D,|t2d,
79192|NCT03071016|Type 2 Diabetes,|type 2 diabetes,
79193|NCT03071016|T2DM|t2dm
79194|NCT03071003|Pharmacokinetics|pharmacokinetics
79195|NCT03071003|Healthy Volunteer Study|healthy volunteer study
79196|NCT03070990|Enfortumab vedotin|enfortumab vedotin
79197|NCT03070990|ASG-22CE|asg-22ce
79198|NCT03070990|ASG-22ME|asg-22me
79199|NCT03070990|Metastatic Urothelial Cancer|metastatic urothelial cancer
79200|NCT03070977|Interprofessional education|interprofessional education
79201|NCT03070977|study unit|study unit
79202|NCT03070977|Psychiatry|psychiatry
79203|NCT03070951|Uterine Fibroid|uterine fibroid
79204|NCT03070951|Leiomyomata|leiomyomata
79205|NCT03070951|Heavy Menstrual Bleeding|heavy menstrual bleeding
79206|NCT03070951|HMB|hmb
79207|NCT03070951|Heavy Uterine Bleeding|heavy uterine bleeding
79208|NCT03070951|Menorrhagia|menorrhagia
79209|NCT03070951|OBE2109 + Add-back|obe2109 + add-back
79210|NCT03070938|Chronic wounds|chronic wounds
79211|NCT03070938|Acute Wounds|acute wounds
79212|NCT03070938|PHMB|phmb
79213|NCT03070938|Wound Management|wound management
79214|NCT03070938|Bioburden|bioburden
79215|NCT03070938|Collagen|collagen
79216|NCT03070925|Antimicrobial|antimicrobial
79217|NCT03070925|Collagen|collagen
79218|NCT03070925|Bioburden|bioburden
79219|NCT03070925|Biofilm|biofilm
79220|NCT03070925|PHMB|phmb
79221|NCT03070925|Chronic wounds|chronic wounds
79222|NCT03070925|Acute wounds|acute wounds
79223|NCT03070912|mechanical circulatory support|mechanical circulatory support
79224|NCT03070912|bleeding, acquired von willebrand disease|bleeding, acquired von willebrand disease
79225|NCT03070912|acquired von willebrand disease|acquired von willebrand disease
79226|NCT03070899|Uterine Fibroid|uterine fibroid
79227|NCT03070899|Leiomyomata|leiomyomata
79228|NCT03070899|Heavy Menstrual Bleeding|heavy menstrual bleeding
79229|NCT03070899|HMB|hmb
79230|NCT03070899|Heavy Uterine Bleeding|heavy uterine bleeding
79231|NCT03070899|Menorrhagia|menorrhagia
79232|NCT03070899|OBE2109 + Add-back|obe2109 + add-back
79233|NCT03070873|Quality of life|quality of life
79234|NCT03070873|Vaginal mesh|vaginal mesh
79235|NCT03070873|Mesh complications|mesh complications
79236|NCT03070860|Low Grade Chronic vascular and skin Inflammation|low grade chronic vascular and skin inflammation
79237|NCT03070860|Molecular vascular and skin Calcification|molecular vascular and skin calcification
79238|NCT03070860|Calcium Score|calcium score
79239|NCT03070847|tranexamic acid|tranexamic acid
79240|NCT03070847|rhinoplasty|rhinoplasty
79241|NCT03070847|bleeding reduction|bleeding reduction
79242|NCT03070821|neurofeedback|neurofeedback
79243|NCT03070821|real-time functional MRI|real-time functional mri
79244|NCT03070821|parahippocampus|parahippocampus
79245|NCT03070808|obesity|obesity
79246|NCT03070808|voice|voice
79247|NCT03070795|post-operative ileus|post-operative ileus
79248|NCT03070795|early feeding|early feeding
79249|NCT03070795|delayed feeding|delayed feeding
79250|NCT03070782|IONIS-APO(a)-LRx|ionis-apo(a)-lrx
79251|NCT03070782|AKCEA-APO(a)-LRx|akcea-apo(a)-lrx
79252|NCT03070782|Dyslipidemia|dyslipidemia
79253|NCT03070782|Dyslipoproteinemia|dyslipoproteinemia
79254|NCT03070782|Hyperlipidemia|hyperlipidemia
79255|NCT03070782|Hyperlipoproteinemia|hyperlipoproteinemia
79256|NCT03070782|Hyperlipoproteinemia(a)|hyperlipoproteinemia(a)
79257|NCT03070782|Hyperlipoproteinemia a|hyperlipoproteinemia a
79258|NCT03070782|Lipoprotein|lipoprotein
79259|NCT03070782|Lipoprotein(a)|lipoprotein(a)
79260|NCT03070782|Lipoprotein a|lipoprotein a
79261|NCT03070782|Lp(a)|lp(a)
79262|NCT03070782|Lp a|lp a
79263|NCT03070756|auto-CPAP|auto-cpap
79264|NCT03070756|forced oscillation technique|forced oscillation technique
79265|NCT03070756|obstructive sleep apnea|obstructive sleep apnea
79266|NCT03070743|basilar invagination|basilar invagination
79267|NCT03070743|atlantoaxial dislocation|atlantoaxial dislocation
79268|NCT03070743|surgery|surgery
79269|NCT03070743|restoration technique|restoration technique
79270|NCT03070730|Tachycardia|tachycardia
79271|NCT03070730|orthostatic symptoms|orthostatic symptoms
79272|NCT03070730|autonomic reflex|autonomic reflex
79273|NCT03070717|High myopia, shortsightedness, retinal changes|high myopia, shortsightedness, retinal changes
79274|NCT03070691|Basal cell carcinoma|basal cell carcinoma
79275|NCT03070691|Nevoid Basal Cell Carcinoma Syndrome|nevoid basal cell carcinoma syndrome
79276|NCT03070691|NBCCS, Gorlin syndrome|nbccs, gorlin syndrome
79277|NCT03070691|Gorlin-Goltz Syndrome|gorlin-goltz syndrome
79278|NCT03070691|Basal Cell Nevus Syndrome|basal cell nevus syndrome
79279|NCT03070691|BCNS, Hedgehog pathway inhibitor|bcns, hedgehog pathway inhibitor
79280|NCT03070691|topical|topical
79281|NCT03070691|Smoothened|smoothened
79282|NCT03070665|endoscopic submucosal dissection|endoscopic submucosal dissection
79283|NCT03070665|postoperation bleeding|postoperation bleeding
79284|NCT03070652|attachment|attachment
79285|NCT03070652|bonding psychological|bonding psychological
79286|NCT03070626|General Surgery|general surgery
79287|NCT03070626|Carbohydrates|carbohydrates
79288|NCT03070626|Perioperative|perioperative
79289|NCT03070613|Colonoscopy|colonoscopy
79290|NCT03070613|Fluorescence guided surgery|fluorescence guided surgery
79291|NCT03070600|PrEP|prep
79292|NCT03070574|Lynch Syndrome|lynch syndrome
79293|NCT03070574|Chemoprevention|chemoprevention
79294|NCT03070574|Mesalazine|mesalazine
79295|NCT03070535|APOE E4; cognition; metabolic markers; beta-amyloid|apoe e4; cognition; metabolic markers; beta-amyloid
79296|NCT03070496|Myocardial infarction|myocardial infarction
79297|NCT03070496|bio-collection|bio-collection
79298|NCT03070496|Imaging markers|imaging markers
79299|NCT03070496|biomarkers|biomarkers
79300|NCT03070496|STEMI|stemi
79301|NCT03070496|clinical outcomes|clinical outcomes
79302|NCT03070457|bariatric surgery|bariatric surgery
79303|NCT03070457|sleeve gastrectomy|sleeve gastrectomy
79304|NCT03070457|eras|eras
79305|NCT03070444|Essix retainer|essix retainer
79306|NCT03070444|Cuspid-to-cuspid retainer|cuspid-to-cuspid retainer
79307|NCT03070431|spinal cord compression, radiotherapy|spinal cord compression, radiotherapy
79308|NCT03070418|DHS|dhs
79309|NCT03070418|DCS|dcs
79310|NCT03070418|Boyd and Griffin Classification|boyd and griffin classification
79311|NCT03070405|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
79312|NCT03070405|4-Aminosalicylic Acid|4-aminosalicylic acid
79313|NCT03070405|Tuberculosis|tuberculosis
79314|NCT03070405|HIV|hiv
79315|NCT03070392|Melanoma|melanoma
79316|NCT03070392|Uveal Cancer|uveal cancer
79317|NCT03070392|IMCgp100|imcgp100
79318|NCT03070392|Immunotherapy|immunotherapy
79319|NCT03070366|Oligometastasis|oligometastasis
79320|NCT03070366|stereotactic irradiation|stereotactic irradiation
79321|NCT03070353|Cirrhosis|cirrhosis
79322|NCT03070353|AKI|aki
79323|NCT03070353|Albumin|albumin
79324|NCT03070353|Dextran|dextran
79325|NCT03070340|mastectomy|mastectomy
79326|NCT03070340|breast MRI|breast mri
79327|NCT03070340|contrast enhanced mammography|contrast enhanced mammography
79328|NCT03070340|CEDM|cedm
79329|NCT03070340|17-045|17-045
79330|NCT03070327|B-cell Maturation Antigen (BCMA)|b-cell maturation antigen (bcma)
79331|NCT03070327|Targeted EGFRt/BCMA-41BBz|targeted egfrt/bcma-41bbz
79332|NCT03070327|Chimeric antigen receptor (CAR)|chimeric antigen receptor (car)
79333|NCT03070327|Lenalidomide|lenalidomide
79334|NCT03070327|17-025|17-025
79335|NCT03070314|Echinacea|echinacea
79336|NCT03070314|bioavailability|bioavailability
79337|NCT03070314|children|children
79338|NCT03070301|LEE011|lee011
79339|NCT03070301|Everolimus|everolimus
79340|NCT03070301|16-1535|16-1535
79341|NCT03070288|RGB|rgb
79342|NCT03070288|red-green-blue|red-green-blue
79343|NCT03070288|rhinitis|rhinitis
79344|NCT03070288|allergic rhinitis|allergic rhinitis
79345|NCT03070288|nasal mucosa|nasal mucosa
79346|NCT03070275|surgical implant placement|surgical implant placement
79347|NCT03070275|crestal bone|crestal bone
79348|NCT03070275|mucosa thickness|mucosa thickness
79349|NCT03070275|stem cells|stem cells
79350|NCT03070275|fibrin glue|fibrin glue
79351|NCT03070275|collagen fleece|collagen fleece
79352|NCT03070262|esophageal cancer|esophageal cancer
79353|NCT03070262|caffeic acid|caffeic acid
79354|NCT03070249|Emergency Department|emergency department
79355|NCT03070236|Breast Cancer|breast cancer
79356|NCT03070184|Racial differences|racial differences
79357|NCT03070158|Premature Infant|premature infant
79358|NCT03070158|Mother-Infant Interaction|mother-infant interaction
79359|NCT03070158|Acoustic stimulation/methods|acoustic stimulation/methods
79360|NCT03070158|Touch|touch
79361|NCT03070158|Visual Stimulation|visual stimulation
79362|NCT03070158|Vestibule, Labyrinth/physiology|vestibule, labyrinth/physiology
79363|NCT03070145|Prostate Cancer|prostate cancer
79364|NCT03070093|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
79365|NCT03070093|FMS-like Tyrosine kinase-3 (FLT3) mutations|fms-like tyrosine kinase-3 (flt3) mutations
79366|NCT03070093|gilteritinib|gilteritinib
79367|NCT03070093|Expanded access|expanded access
79368|NCT03070093|ASP2215|asp2215
79369|NCT03070015|Weight Loss|weight loss
79370|NCT03070015|Obesity|obesity
79371|NCT03070015|Overweight|overweight
79372|NCT03069989|Tolerability|tolerability
79373|NCT03069989|IPF|ipf
79374|NCT03069989|PET imaging|pet imaging
79375|NCT03069989|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
79376|NCT03069989|Safety|safety
79377|NCT03069989|Pharmacokinetics|pharmacokinetics
79378|NCT03069989|Double-blind|double-blind
79379|NCT03069950|Hepatic Arterial Infusion|hepatic arterial infusion
79380|NCT03069950|Floxuridine (FUDR)|floxuridine (fudr)
79381|NCT03069950|Irinotecan (CPT-11)|irinotecan (cpt-11)
79382|NCT03069950|FLUOROURACIL|fluorouracil
79383|NCT03069950|PANITUMUMAB|panitumumab
79384|NCT03069950|16-1341|16-1341
79385|NCT03069911|Parkinson Disease|parkinson disease
79386|NCT03069911|Parkinsonism|parkinsonism
79387|NCT03069911|Depression|depression
79388|NCT03069911|OnabotulinumtoxinA|onabotulinumtoxina
79389|NCT03069911|BOTOX|botox
79390|NCT03069898|Marital relationship|marital relationship
79391|NCT03069872|Transvaginal ultrasound|transvaginal ultrasound
79392|NCT03069872|General practice|general practice
79393|NCT03069872|Early diagnosis|early diagnosis
79394|NCT03069872|Symptoms|symptoms
79395|NCT03069859|Post partum hemorrhage|post partum hemorrhage
79396|NCT03069859|Tranexamic acid|tranexamic acid
79397|NCT03069859|Spontaneous vaginal delivery|spontaneous vaginal delivery
79398|NCT03069859|C-section|c-section
79399|NCT03069846|skin cancer|skin cancer
79400|NCT03069846|laser spectroscopy|laser spectroscopy
79401|NCT03069846|non-invasive diagnostics|non-invasive diagnostics
79402|NCT03069781|estrogen|estrogen
79403|NCT03069768|Nicotine addiction|nicotine addiction
79404|NCT03069768|Cigarette smoking|cigarette smoking
79405|NCT03069768|Smoking cessation|smoking cessation
79406|NCT03069768|Quit smoking|quit smoking
79407|NCT03069755|India|india
79408|NCT03069755|Perioperative mortality|perioperative mortality
79409|NCT03069755|Trauma|trauma
79410|NCT03069755|Surgery|surgery
79411|NCT03069742|Breast Cancer Prevention|breast cancer prevention
79412|NCT03069742|Risk Assessment|risk assessment
79413|NCT03069742|Chemoprevention|chemoprevention
79414|NCT03069742|Decision Making|decision making
79415|NCT03069729|screen|screen
79416|NCT03069716|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
79417|NCT03069703|Vaccine|vaccine
79418|NCT03069703|ANCA- associated vasculitides|anca- associated vasculitides
79419|NCT03069703|pneumovax|pneumovax
79420|NCT03069703|prevenar|prevenar
79421|NCT03069703|pneumovas|pneumovas
79422|NCT03069677|midazolam|midazolam
79423|NCT03069664|Pancreatic Cancer|pancreatic cancer
79424|NCT03069664|Pancreatic Duct Stricture|pancreatic duct stricture
79425|NCT03069664|Endoscopic treatment|endoscopic treatment
79426|NCT03069638|sedation|sedation
79427|NCT03069638|pediatrics|pediatrics
79428|NCT03069638|intranasal sedation|intranasal sedation
79429|NCT03069638|dexmedetomidine|dexmedetomidine
79430|NCT03069638|dinitrous oxide|dinitrous oxide
79431|NCT03069638|intra-articular joint injection|intra-articular joint injection
79432|NCT03069625|Cystic Fibrosis|cystic fibrosis
79433|NCT03069625|Exercise Testing|exercise testing
79434|NCT03069625|Muscular strength|muscular strength
79435|NCT03069625|Pediatrics|pediatrics
79436|NCT03069625|Quality of life|quality of life
79437|NCT03069612|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
79438|NCT03069612|working memory|working memory
79439|NCT03069612|gamma oscillations|gamma oscillations
79440|NCT03069612|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
79441|NCT03069573|Eosinophilic Esophagitis|eosinophilic esophagitis
79442|NCT03069573|Gastroesophageal Reflux|gastroesophageal reflux
79443|NCT03069573|Diagnose|diagnose
79444|NCT03069573|Biomarker|biomarker
79445|NCT03069560|suicide attempt|suicide attempt
79446|NCT03069560|SMS monitoring|sms monitoring
79447|NCT03069560|Phone|phone
79448|NCT03069560|Prevention control|prevention control
79449|NCT03069560|tertiary healthcare|tertiary healthcare
79450|NCT03069534|MDR-TB|mdr-tb
79451|NCT03069534|rhIL-2|rhil-2
79452|NCT03069534|immunotherapy|immunotherapy
79453|NCT03069495|Allergy|allergy
79454|NCT03069495|Asthma|asthma
79455|NCT03069495|Urticaria|urticaria
79456|NCT03069482|Smoking|smoking
79457|NCT03069482|mHealth|mhealth
79458|NCT03069482|Serious Mental Illness|serious mental illness
79459|NCT03069482|Acceptance and Commitment Therapy|acceptance and commitment therapy
79460|NCT03069482|US DHHS Clinical Practice Guidelines|us dhhs clinical practice guidelines
79461|NCT03069469|CSF1R|csf1r
79462|NCT03069469|ALL|all
79463|NCT03069469|CML|cml
79464|NCT03069469|AML|aml
79465|NCT03069469|MDS|mds
79466|NCT03069456|sevoflurane|sevoflurane
79467|NCT03069456|Bistpectral index|bistpectral index
79468|NCT03069456|Anesthetic Depth Monitoring System|anesthetic depth monitoring system
79469|NCT03069456|population pharmacodynamics|population pharmacodynamics
79470|NCT03069443|Isometric handgrip training|isometric handgrip training
79471|NCT03069443|home training|home training
79472|NCT03069443|older adults|older adults
79473|NCT03069443|Hypertension|hypertension
79474|NCT03069417|HIV|hiv
79475|NCT03069417|Medication adherence|medication adherence
79476|NCT03069417|PMTCT|pmtct
79477|NCT03069417|Depression|depression
79478|NCT03069391|exercise|exercise
79479|NCT03069391|exergame|exergame
79480|NCT03069378|Metastatic|metastatic
79481|NCT03069378|Locally Advanced|locally advanced
79482|NCT03069378|Talimogene Laherparepvec (T-VEC)|talimogene laherparepvec (t-vec)
79483|NCT03069378|Pembrolizumab|pembrolizumab
79484|NCT03069378|16-1534|16-1534
79485|NCT03069365|Chronic Hepatitis C Virus|chronic hepatitis c virus
79486|NCT03069365|Chronic Kidney Disease|chronic kidney disease
79487|NCT03069365|Glecaprevir|glecaprevir
79488|NCT03069365|Pibrentasvir|pibrentasvir
79489|NCT03069365|Hepatitis C Virus Genotype|hepatitis c virus genotype
79490|NCT03069365|compensated cirrhosis|compensated cirrhosis
79491|NCT03069365|non-cirrhotic|non-cirrhotic
79492|NCT03069365|interferon (IFN)|interferon (ifn)
79493|NCT03069365|treatment naïve|treatment naïve
79494|NCT03069365|sofosbuvir (SOF)|sofosbuvir (sof)
79495|NCT03069365|pegylated interferon (pegIFN)|pegylated interferon (pegifn)
79496|NCT03069365|ribavirin (RBV)|ribavirin (rbv)
79497|NCT03069352|Acute Myeloid Leukemia|acute myeloid leukemia
79498|NCT03069352|Leukemia|leukemia
79499|NCT03069352|Treatment naïve|treatment naïve
79500|NCT03069352|Venetoclax|venetoclax
79501|NCT03069352|Cytarabine|cytarabine
79502|NCT03069326|Ruxolitinib|ruxolitinib
79503|NCT03069326|Thalidomide|thalidomide
79504|NCT03069326|16-1498|16-1498
79505|NCT03069313|Aromatase Inhibitor|aromatase inhibitor
79506|NCT03069313|Breast Cancer|breast cancer
79507|NCT03069313|Arthralgia|arthralgia
79508|NCT03069313|Musculoskeletal symptoms|musculoskeletal symptoms
79509|NCT03069313|Joint pain|joint pain
79510|NCT03069261|Breast reconstruction|breast reconstruction
79511|NCT03069261|Autologous tissue flaps|autologous tissue flaps
79512|NCT03069261|Indocyanine green angiography|indocyanine green angiography
79513|NCT03069261|Breast cancer|breast cancer
79514|NCT03069235|HIV|hiv
79515|NCT03069235|Breast Feeding|breast feeding
79516|NCT03069222|diffusion tensor imaging|diffusion tensor imaging
79517|NCT03069196|Prevalence|prevalence
79518|NCT03069196|Incidence|incidence
79519|NCT03069196|Type 1 diabetes and its Micro-vascular complications|type 1 diabetes and its micro-vascular complications
79520|NCT03069196|Type 1 diabetes and its Macro-vascular complications|type 1 diabetes and its macro-vascular complications
79521|NCT03069196|Type 1 Diabetes and its complications in India|type 1 diabetes and its complications in india
79522|NCT03069183|Fascia Iliaca Block|fascia iliaca block
79523|NCT03069183|Total Hip Arthroplasty|total hip arthroplasty
79524|NCT03069183|Total Hip Replacement|total hip replacement
79525|NCT03069183|Ultrasound|ultrasound
79526|NCT03069144|Psoriasis|psoriasis
79527|NCT03069144|Topical|topical
79528|NCT03069131|primary prophylaxis|primary prophylaxis
79529|NCT03069131|rifaximin|rifaximin
79530|NCT03069118|Telemedicine|telemedicine
79531|NCT03069118|Online Treatment|online treatment
79532|NCT03069118|Digital Intervention|digital intervention
79533|NCT03069079|primary immunodeficiency|primary immunodeficiency
79534|NCT03069079|dental health|dental health
79535|NCT03069079|neutrophil defect|neutrophil defect
79536|NCT03069079|periodontitis|periodontitis
79537|NCT03069066|In-stent restenosis|in-stent restenosis
79538|NCT03069066|Bioresorbable vascular scaffold|bioresorbable vascular scaffold
79539|NCT03069066|Stent|stent
79540|NCT03069066|Drug-eluting stent|drug-eluting stent
79541|NCT03069066|Coronary angiography|coronary angiography
79542|NCT03069066|Scoring balloon|scoring balloon
79543|NCT03069040|cervical cancer|cervical cancer
79544|NCT03069040|NSRH|nsrh
79545|NCT03069040|RH|rh
79546|NCT03069040|urine flow mechanics|urine flow mechanics
79547|NCT03069040|anorectal dynamics|anorectal dynamics
79548|NCT03069027|Nasal surgery|nasal surgery
79549|NCT03069027|external nasal nerve block|external nasal nerve block
79550|NCT03069027|postoperative agitation|postoperative agitation
79551|NCT03069001|HCV treatment|hcv treatment
79552|NCT03068988|bone marrow stem cells|bone marrow stem cells
79553|NCT03068988|rotator cuff lesion|rotator cuff lesion
79554|NCT03068936|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
79555|NCT03068936|Intensity modulated radiotherapy|intensity modulated radiotherapy
79556|NCT03068936|Cisplatin|cisplatin
79557|NCT03068923|Blood clot|blood clot
79558|NCT03068923|Deep Vein Thrombosis|deep vein thrombosis
79559|NCT03068923|Pulmonary Embolism|pulmonary embolism
79560|NCT03068923|Lower Extremity|lower extremity
79561|NCT03068923|Upper Extremity|upper extremity
79562|NCT03068923|Cerebral sinus|cerebral sinus
79563|NCT03068923|Renal vein|renal vein
79564|NCT03068923|Portal vein|portal vein
79565|NCT03068923|thrombin|thrombin
79566|NCT03068923|fibrinolysis|fibrinolysis
79567|NCT03068923|coagulation|coagulation
79568|NCT03068923|anticoagulation|anticoagulation
79569|NCT03068923|Post trombotic syndrome|post trombotic syndrome
79570|NCT03068923|Post pulmonary embolism syndrome|post pulmonary embolism syndrome
79571|NCT03068923|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
79572|NCT03068910|PCOS|pcos
79573|NCT03068845|non-maturing arteriovenous fistula|non-maturing arteriovenous fistula
79574|NCT03068845|stenosis of arteriovenous fistula|stenosis of arteriovenous fistula
79575|NCT03068845|drug-eluting balloon|drug-eluting balloon
79576|NCT03068767|HBV DNA, qHBsAg|hbv dna, qhbsag
79577|NCT03068754|ALS|als
79578|NCT03068728|bilateral chronic rhino sinusitis|bilateral chronic rhino sinusitis
79579|NCT03068715|transcranial magnetic stimulation|transcranial magnetic stimulation
79580|NCT03068715|theta burst|theta burst
79581|NCT03068689|Partial nephrectomy, RIPC, Reperfusion Injury|partial nephrectomy, ripc, reperfusion injury
79582|NCT03068676|Depression|depression
79583|NCT03068676|Anxiety|anxiety
79584|NCT03068676|Internet-delivered|internet-delivered
79585|NCT03068676|CBT|cbt
79586|NCT03068676|Primary Care|primary care
79587|NCT03068663|lung cancer|lung cancer
79588|NCT03068663|intestinal microbiota|intestinal microbiota
79589|NCT03068663|lung microbiota|lung microbiota
79590|NCT03068663|surgery|surgery
79591|NCT03068663|chemotherapy|chemotherapy
79592|NCT03068624|Melanoma and Other Malignant Neoplasms of Skin|melanoma and other malignant neoplasms of skin
79593|NCT03068624|Metastatic uveal melanoma|metastatic uveal melanoma
79594|NCT03068624|Autologous CD8+ T cells|autologous cd8+ t cells
79595|NCT03068624|Cyclophosphamide|cyclophosphamide
79596|NCT03068624|Cytoxan|cytoxan
79597|NCT03068624|Neosar|neosar
79598|NCT03068624|Interleukin-2|interleukin-2
79599|NCT03068624|IL-2|il-2
79600|NCT03068624|Aldesleukin|aldesleukin
79601|NCT03068624|Proleukin|proleukin
79602|NCT03068624|Ipilimumab|ipilimumab
79603|NCT03068624|Yervoy|yervoy
79604|NCT03068624|BMS-734016|bms-734016
79605|NCT03068624|MDX010|mdx010
79606|NCT03068585|PAD|pad
79607|NCT03068585|CLI|cli
79608|NCT03068585|stage 2a-3 of Pokrovsky-Fonteine|stage 2a-3 of pokrovsky-fonteine
79609|NCT03068572|minimal change esophageal reflux disease diagnosis|minimal change esophageal reflux disease diagnosis
79610|NCT03068572|Linked Color imaging|linked color imaging
79611|NCT03068572|non-erosive reflux disease|non-erosive reflux disease
79918|NCT03066804|6 MWT|6 mwt
79612|NCT03068546|Oral Microbiota|oral microbiota
79613|NCT03068533|DH, dentin hypersensitivity, chronic periodontitis|dh, dentin hypersensitivity, chronic periodontitis
79614|NCT03068520|PET|pet
79615|NCT03068520|MRI|mri
79616|NCT03068520|BRAIN METASTASIS|brain metastasis
79617|NCT03068520|BRAIN PRIMARY TUMOR|brain primary tumor
79618|NCT03068520|RESPONSE TO TREATMENT|response to treatment
79619|NCT03068507|Perioperative|perioperative
79620|NCT03068507|functional capability|functional capability
79621|NCT03068507|Prehabilitation|prehabilitation
79622|NCT03068507|thoracoscopic lobectomy|thoracoscopic lobectomy
79623|NCT03068507|Lung Cancer|lung cancer
79624|NCT03068494|Coronary Bifurcation Lesion|coronary bifurcation lesion
79625|NCT03068494|2nd generation drug-eluting stent|2nd generation drug-eluting stent
79626|NCT03068442|Carotid artery|carotid artery
79627|NCT03068442|MRI|mri
79628|NCT03068442|PET|pet
79629|NCT03068442|Intraplaque hemorrhage|intraplaque hemorrhage
79630|NCT03068429|obsessive-compulsive disorder|obsessive-compulsive disorder
79631|NCT03068429|fear conditioning|fear conditioning
79632|NCT03068429|functional neuroimaging|functional neuroimaging
79633|NCT03068429|sertraline|sertraline
79634|NCT03068403|CEUS Perfusion|ceus perfusion
79635|NCT03068403|Rectal Cancer|rectal cancer
79636|NCT03068403|Tumor Perfusion|tumor perfusion
79637|NCT03068403|Radiochemotherapy|radiochemotherapy
79638|NCT03068377|lycopene|lycopene
79639|NCT03068377|eye|eye
79640|NCT03068377|vessel function|vessel function
79641|NCT03068364|Mortality|mortality
79642|NCT03068364|Hypertension|hypertension
79643|NCT03068364|Left ventricular hypertrophy|left ventricular hypertrophy
79644|NCT03068364|NT-proBNP|nt-probnp
79645|NCT03068364|ECG|ecg
79646|NCT03068364|Transthoracic echocardiography|transthoracic echocardiography
79647|NCT03068299|Prevention|prevention
79648|NCT03068299|Cognition|cognition
79649|NCT03068299|Aged care|aged care
79650|NCT03068299|Caregivers|caregivers
79651|NCT03068299|Frail elderly|frail elderly
79652|NCT03068299|Dancing therapy|dancing therapy
79653|NCT03068299|Rural population|rural population
79654|NCT03068273|Hospitalization|hospitalization
79655|NCT03068260|caesarean section|caesarean section
79656|NCT03068260|postoperative pain|postoperative pain
79657|NCT03068260|transmuscular quadratus lumborum block|transmuscular quadratus lumborum block
79658|NCT03068260|reduction of opioid consumption|reduction of opioid consumption
79659|NCT03068208|Methylene blue|methylene blue
79660|NCT03068208|photodynamic therapy|photodynamic therapy
79661|NCT03068208|primary cutaneous localized amyloidosis|primary cutaneous localized amyloidosis
79662|NCT03068208|lichen amyloidosis|lichen amyloidosis
79663|NCT03068195|laparoscopy|laparoscopy
79664|NCT03068195|microwave|microwave
79665|NCT03068195|ablation technique|ablation technique
79666|NCT03068182|Exercise ,Autonomic cardiac function ,Adult subjects|exercise ,autonomic cardiac function ,adult subjects
79667|NCT03068169|remote ECG|remote ecg
79668|NCT03068169|atrial fibrillation|atrial fibrillation
79669|NCT03068169|cardiac rehabilitation|cardiac rehabilitation
79670|NCT03068169|cardiac resynchronization therapy|cardiac resynchronization therapy
79671|NCT03068169|supraventricular tachycardia|supraventricular tachycardia
79672|NCT03068156|308-nm excimer laser|308-nm excimer laser
79673|NCT03068156|primary localized cutaneous amyloidosis|primary localized cutaneous amyloidosis
79674|NCT03068156|lichen amyloidosis|lichen amyloidosis
79675|NCT03068156|Asians|asians
79676|NCT03068130|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
79677|NCT03068130|Pulmonary Hypertension|pulmonary hypertension
79678|NCT03068130|PH|ph
79679|NCT03068130|PAH|pah
79680|NCT03068130|Bardoxolone methyl|bardoxolone methyl
79681|NCT03068130|6-minute walk distance|6-minute walk distance
79682|NCT03068130|CDDO-ME|cddo-me
79683|NCT03068130|RTA 402|rta 402
79684|NCT03068130|LARIAT|lariat
79685|NCT03068130|CATALYST|catalyst
79686|NCT03068130|RANGER|ranger
79687|NCT03068117|Specialist Palliative Care|specialist palliative care
79688|NCT03068117|Symptom Control|symptom control
79689|NCT03068117|Early Referral|early referral
79690|NCT03068117|Quality of Life|quality of life
79691|NCT03068117|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
79692|NCT03068117|Mesothelioma|mesothelioma
79693|NCT03068104|Trauma|trauma
79694|NCT03068104|Haemorrhage|haemorrhage
79695|NCT03068104|Massive transfusion|massive transfusion
79696|NCT03068104|India|india
79697|NCT03068091|Interstitial Lung Disease|interstitial lung disease
79698|NCT03068091|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
79699|NCT03068065|Liraglutide|liraglutide
79700|NCT03068065|Metformin|metformin
79701|NCT03068065|Gliclazide|gliclazide
79702|NCT03068039|MRI|mri
79703|NCT03068039|blood glucose|blood glucose
79704|NCT03068039|porridge|porridge
79705|NCT03068039|breakfast|breakfast
79706|NCT03068039|satiety|satiety
79707|NCT03068039|plasma peptides|plasma peptides
79708|NCT03068026|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
79709|NCT03068026|Non-invasive ventilation|non-invasive ventilation
79710|NCT03068013|CALM|calm
79711|NCT03068013|Depression|depression
79712|NCT03068013|Demoralization|demoralization
79713|NCT03068013|Cancer|cancer
79714|NCT03068013|Spirituality|spirituality
79715|NCT03068013|Psychotherapy|psychotherapy
79716|NCT03068013|Quality of Life|quality of life
79717|NCT03068013|Anxiety|anxiety
79718|NCT03068013|Post-Traumatic Growth|post-traumatic growth
79719|NCT03068000|Martial arts|martial arts
79720|NCT03068000|Judo|judo
79721|NCT03068000|Motor skills|motor skills
79722|NCT03068000|Physical fitness|physical fitness
79723|NCT03068000|Cardiovascular parameters|cardiovascular parameters
79724|NCT03068000|Quality of life|quality of life
79725|NCT03068000|Physical Activity|physical activity
79726|NCT03067974|ketamine|ketamine
79727|NCT03067974|pediatric|pediatric
79728|NCT03067974|procedural sedation|procedural sedation
79729|NCT03067961|Enteric fever|enteric fever
79730|NCT03067961|Typhoid|typhoid
79731|NCT03067961|Salmonella Typhi|salmonella typhi
79732|NCT03067961|Challenge study|challenge study
79733|NCT03067961|Human model of infection|human model of infection
79734|NCT03067961|Typhoid toxin|typhoid toxin
79735|NCT03067922|Mastectomy|mastectomy
79736|NCT03067922|Pain|pain
79737|NCT03067922|Severity|severity
79738|NCT03067922|Life quality|life quality
79739|NCT03067896|spinal block|spinal block
79740|NCT03067896|stress response|stress response
79741|NCT03067896|dexmedetomidine|dexmedetomidine
79742|NCT03067896|intrathecally|intrathecally
79743|NCT03067870|Stem cells|stem cells
79744|NCT03067870|Rheumatoid arthritis|rheumatoid arthritis
79745|NCT03067831|stem cells|stem cells
79746|NCT03067818|arm|arm
79747|NCT03067818|rehabilitation|rehabilitation
79748|NCT03067818|non-invasive brain stimulation|non-invasive brain stimulation
79749|NCT03067818|transcranial magnetic stimulation|transcranial magnetic stimulation
79750|NCT03067818|upper extremity|upper extremity
79751|NCT03067805|Oxytocin effect|oxytocin effect
79752|NCT03067805|romantic jealousy|romantic jealousy
79753|NCT03067805|Arousal Rating|arousal rating
79754|NCT03067805|Jealousy Rating|jealousy rating
79755|NCT03067792|inoperable gastric cancer|inoperable gastric cancer
79756|NCT03067792|palliative chemotherapy|palliative chemotherapy
79757|NCT03067740|appendicectomy|appendicectomy
79758|NCT03067740|children|children
79759|NCT03067740|local anesthetics|local anesthetics
79760|NCT03067740|laparoscopy|laparoscopy
79761|NCT03067740|peritoneum|peritoneum
79762|NCT03067675|no known ocular pathology|no known ocular pathology
79763|NCT03067623|Thin endometrium|thin endometrium
79764|NCT03067623|Endometrial thickness|endometrial thickness
79765|NCT03067584|Familial cancer|familial cancer
79766|NCT03067584|Genetic predisposition|genetic predisposition
79767|NCT03067584|Heritable disease|heritable disease
79768|NCT03067584|Cancer risk|cancer risk
79769|NCT03067584|Genome analysis|genome analysis
79770|NCT03067584|Genetic modifiers|genetic modifiers
79771|NCT03067584|Next generation sequencing (NGS)|next generation sequencing (ngs)
79772|NCT03067584|Genetic counseling|genetic counseling
79773|NCT03067584|DNA|dna
79774|NCT03067571|Hematopoietic/Lymphoid Cancer|hematopoietic/lymphoid cancer
79775|NCT03067571|Acute Myelogenous Leukemia|acute myelogenous leukemia
79776|NCT03067571|AML|aml
79777|NCT03067571|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
79778|NCT03067571|MDA|mda
79779|NCT03067571|Daratumumab|daratumumab
79780|NCT03067558|Pneumonia|pneumonia
79781|NCT03067558|Diagnostics|diagnostics
79782|NCT03067558|Childhood|childhood
79783|NCT03067558|Respiratory rate|respiratory rate
79784|NCT03067558|Ethiopia|ethiopia
79785|NCT03067506|Drug Therapy|drug therapy
79786|NCT03067454|early mobilisation|early mobilisation
79787|NCT03067454|metacarpal fracture|metacarpal fracture
79788|NCT03067454|operation|operation
79789|NCT03067441|hyperlipidemia|hyperlipidemia
79790|NCT03067441|cholesterol|cholesterol
79791|NCT03067441|heterozygous familial hypercholesterolemia|heterozygous familial hypercholesterolemia
79792|NCT03067441|atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease
79793|NCT03067441|ASCVD|ascvd
79794|NCT03067441|HeFH|hefh
79795|NCT03067441|LDL|ldl
79796|NCT03067428|Fructose|fructose
79797|NCT03067428|Diet|diet
79798|NCT03067415|Glaucoma, Primary Open Angle|glaucoma, primary open angle
79799|NCT03067415|Ocular hypertension|ocular hypertension
79800|NCT03067415|CKD-351|ckd-351
79801|NCT03067402|Myocardial Infarction|myocardial infarction
79802|NCT03067402|Physiological Stress Test|physiological stress test
79803|NCT03067402|Nuclear Image Perfusion|nuclear image perfusion
79804|NCT03067402|Angioplasty|angioplasty
79805|NCT03067402|Coronary Artery Bypass Graft|coronary artery bypass graft
79806|NCT03067402|Percutaneous Coronary Intervention|percutaneous coronary intervention
79807|NCT03067402|Angina|angina
79808|NCT03067402|Ischemia|ischemia
79809|NCT03067376|ADME|adme
79810|NCT03067376|Metabolism|metabolism
79811|NCT03067376|Metabolite Profiling|metabolite profiling
79812|NCT03067376|Excretion|excretion
79813|NCT03067350|voriconazole|voriconazole
79814|NCT03067350|pharmacogenetics|pharmacogenetics
79815|NCT03067350|pharmacokinetics|pharmacokinetics
79816|NCT03067350|therapeutic drug monitoring|therapeutic drug monitoring
79817|NCT03067337|Stainless Steel Crowns|stainless steel crowns
79818|NCT03067337|Zirconia Crowns|zirconia crowns
79819|NCT03067337|Aesthetic restorations|aesthetic restorations
79820|NCT03067324|Islet Transplantation|islet transplantation
79821|NCT03067298|pregnancy|pregnancy
79822|NCT03067298|screening|screening
79823|NCT03067298|doppler|doppler
79824|NCT03067298|markers|markers
79825|NCT03067298|PlGF|plgf
79826|NCT03067298|sFlt-1|sflt-1
79827|NCT03067298|placenta|placenta
79828|NCT03067272|Permanent contraception|permanent contraception
79829|NCT03067272|Birth control|birth control
79830|NCT03067259|eldery patients|eldery patients
79831|NCT03067259|cognitive impairment|cognitive impairment
79832|NCT03067246|Supraglottic device|supraglottic device
79833|NCT03067246|Fibre optic scope|fibre optic scope
79834|NCT03067246|Endotracheal intubation|endotracheal intubation
79835|NCT03067220|outpatients|outpatients
79836|NCT03067220|general surgery|general surgery
79837|NCT03067220|virtual clinic|virtual clinic
79838|NCT03067220|patient satisfaction|patient satisfaction
79839|NCT03067207|mindfulness meditation|mindfulness meditation
79840|NCT03067207|Adolescent|adolescent
79841|NCT03067207|eHealth|ehealth
79842|NCT03067207|randomized trial|randomized trial
79843|NCT03067194|Osteoarthritis Hand|osteoarthritis hand
79844|NCT03067155|allogeneic stem cell transplantation|allogeneic stem cell transplantation
79845|NCT03067155|CMV reactivation|cmv reactivation
79846|NCT03067129|Chronic Hepatitis C Virus|chronic hepatitis c virus
79847|NCT03067129|Glecaprevir|glecaprevir
79848|NCT03067129|Pibrentasvir|pibrentasvir
79849|NCT03067129|Pharmacokinetic|pharmacokinetic
79850|NCT03067129|Treatment naïve|treatment naïve
79851|NCT03067129|Treatment experienced|treatment experienced
79852|NCT03067129|Interferon (IFN)|interferon (ifn)
79853|NCT03067129|pegylated interferon (pegIFN)|pegylated interferon (pegifn)
79854|NCT03067129|Ribavirin (RBV)|ribavirin (rbv)
79855|NCT03067129|sofosbuvir|sofosbuvir
79856|NCT03067129|Non-cirrhotic cirrhosis|non-cirrhotic cirrhosis
79857|NCT03067129|Compensated (Child-Pugh A) cirrhosis|compensated (child-pugh a) cirrhosis
79858|NCT03067116|balance, postural|balance, postural
79859|NCT03067116|fall risk|fall risk
79860|NCT03067116|anthropometrics|anthropometrics
79861|NCT03067116|blood pressure|blood pressure
79862|NCT03067116|SpO2|spo2
79863|NCT03067116|heart rate|heart rate
79864|NCT03067116|heart rate variability|heart rate variability
79865|NCT03067116|stance width|stance width
79866|NCT03067103|Adenotonsillectomy|adenotonsillectomy
79867|NCT03067103|pain|pain
79868|NCT03067103|topic analgesia|topic analgesia
79869|NCT03067103|child|child
79870|NCT03067077|SMILE|smile
79871|NCT03067077|LASIK|lasik
79872|NCT03067077|Myopia|myopia
79873|NCT03067077|Wavefront-guided|wavefront-guided
79874|NCT03067012|Oncometabolic surgery|oncometabolic surgery
79875|NCT03067012|Long limb uncut Roux-en-Y gastrojejunostomy|long limb uncut roux-en-y gastrojejunostomy
79876|NCT03067012|Obesity|obesity
79877|NCT03067012|Diabetes|diabetes
79878|NCT03067012|Early gastric cancer|early gastric cancer
79879|NCT03066986|Venom anaphylaxis|venom anaphylaxis
79880|NCT03066986|Myrmecia piluosa|myrmecia piluosa
79881|NCT03066986|Immunological adjuvant|immunological adjuvant
79882|NCT03066986|Immunotherapy|immunotherapy
79883|NCT03066986|Jack jumper ant|jack jumper ant
79884|NCT03066973|breath exercises|breath exercises
79885|NCT03066973|labor pain|labor pain
79886|NCT03066973|labor duration|labor duration
79887|NCT03066973|VAS|vas
79888|NCT03066934|Noninvasive Positive Pressure Ventilation|noninvasive positive pressure ventilation
79889|NCT03066934|Nasal high flow|nasal high flow
79890|NCT03066934|Respiratory Failure|respiratory failure
79891|NCT03066934|Childhood|childhood
79892|NCT03066921|Lactic acid bacteria|lactic acid bacteria
79893|NCT03066921|dyslipidemia uremic toxins|dyslipidemia uremic toxins
79894|NCT03066921|Hemodialysis|hemodialysis
79895|NCT03066908|Chronic Rhinosinusitis|chronic rhinosinusitis
79896|NCT03066882|Caloric Restriction|caloric restriction
79897|NCT03066882|Diet|diet
79898|NCT03066882|Obesity|obesity
79899|NCT03066882|Overweight|overweight
79900|NCT03066882|Sedentary Lifestyle|sedentary lifestyle
79901|NCT03066882|Weight loss|weight loss
79902|NCT03066882|Women|women
79903|NCT03066856|BRCA genes|brca genes
79904|NCT03066856|Mutation carriers|mutation carriers
79905|NCT03066856|IGF-I|igf-i
79906|NCT03066856|Diet|diet
79907|NCT03066817|Vitamin D|vitamin d
79908|NCT03066817|Deficiency|deficiency
79909|NCT03066817|Insufficiency|insufficiency
79910|NCT03066817|Bone turnover|bone turnover
79911|NCT03066817|Bone healing|bone healing
79912|NCT03066817|Polytrauma|polytrauma
79913|NCT03066804|Cardiovascular Diseases|cardiovascular diseases
79914|NCT03066804|Heart Failure|heart failure
79915|NCT03066804|Heart failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
79916|NCT03066804|NT-proBNP|nt-probnp
79917|NCT03066804|KCCQ|kccq
79919|NCT03066804|SF-36|sf-36
79920|NCT03066804|NYHA Class|nyha class
79921|NCT03066804|LCZ696|lcz696
79922|NCT03066804|Enalapril|enalapril
79923|NCT03066804|Valsartan|valsartan
79924|NCT03066804|Angiotensin-Converting Enzyme Inhibitors (ACEi)|angiotensin-converting enzyme inhibitors (acei)
79925|NCT03066804|Angiotensin II Type 1 Receptor Blockers (ARB)|angiotensin ii type 1 receptor blockers (arb)
79926|NCT03066804|Renin Angiotensin System Inhibitors (RASi)|renin angiotensin system inhibitors (rasi)
79927|NCT03066778|Extensive stage small cell lung cancer (ES-SCLC)|extensive stage small cell lung cancer (es-sclc)
79928|NCT03066778|Programmed cell death protein-1 (PD-1)|programmed cell death protein-1 (pd-1)
79929|NCT03066778|Programmed cell death-ligand 1 (PD-L1)|programmed cell death-ligand 1 (pd-l1)
79930|NCT03066778|PD1|pd1
79931|NCT03066778|PDL1|pdl1
79932|NCT03066726|Biophysical profile|biophysical profile
79933|NCT03066726|Cesarean section|cesarean section
79934|NCT03066726|Estimated fetal weight|estimated fetal weight
79935|NCT03066726|Middle cerebral artery|middle cerebral artery
79936|NCT03066726|Umbilical artery|umbilical artery
79937|NCT03066726|Fetal growth restriction|fetal growth restriction
79938|NCT03066726|Pulsatility index|pulsatility index
79939|NCT03066726|Estimated gestational age|estimated gestational age
79940|NCT03066726|Doppler|doppler
79941|NCT03066648|Acute Myeloid Leukemia|acute myeloid leukemia
79942|NCT03066648|Myelodysplastic syndromes|myelodysplastic syndromes
79943|NCT03066635|Nerve block|nerve block
79944|NCT03066635|Ganglia, Parasympathetic|ganglia, parasympathetic
79945|NCT03066635|Botulinum Toxins, Type A|botulinum toxins, type a
79946|NCT03066635|Injection|injection
79947|NCT03066609|Plaque psoriasis, Secukinumab, Skin condition, skin disease, itching, psoriasis vulgaris, immune-mediated systemic disease, skin lesions, scaly patches, papules|plaque psoriasis, secukinumab, skin condition, skin disease, itching, psoriasis vulgaris, immune-mediated systemic disease, skin lesions, scaly patches, papules
79948|NCT03066583|meniscus repair|meniscus repair
79949|NCT03066583|platelet rich plasma|platelet rich plasma
79950|NCT03066570|Graded Exposure|graded exposure
79951|NCT03066570|Quality of Life|quality of life
79952|NCT03066570|Physical Activity|physical activity
79953|NCT03066570|Anxiety|anxiety
79954|NCT03066557|Hepatocellular Carcinoma|hepatocellular carcinoma
79955|NCT03066557|Apatinib|apatinib
79956|NCT03066544|migraine|migraine
79957|NCT03066544|responder|responder
79958|NCT03066544|non-responder|non-responder
79959|NCT03066544|treatment|treatment
79960|NCT03066531|ACT|act
79961|NCT03066531|CBT obesity|cbt obesity
79962|NCT03066531|Eating disorders|eating disorders
79963|NCT03066531|Health psychology|health psychology
79964|NCT03066518|melatonin|melatonin
79965|NCT03066518|sleep|sleep
79966|NCT03066518|dementia|dementia
79967|NCT03066518|cognition|cognition
79968|NCT03066492|Tertiary Care Center|tertiary care center
79969|NCT03066492|Patient Readmission|patient readmission
79970|NCT03066492|Health Services Research|health services research
79971|NCT03066492|Hospital Readmissions|hospital readmissions
79972|NCT03066466|Acute Myeloid Leukemia|acute myeloid leukemia
79973|NCT03066466|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
79974|NCT03066466|Myelodysplastic Syndrome|myelodysplastic syndrome
79975|NCT03066466|BMT|bmt
79976|NCT03066466|Matched unrelated donor transplant|matched unrelated donor transplant
79977|NCT03066466|Graft versus Host Disease|graft versus host disease
79978|NCT03066466|GVHD|gvhd
79979|NCT03066453|cystic fibrosis, tobramycin, antibiotic courses, FEV1|cystic fibrosis, tobramycin, antibiotic courses, fev1
79980|NCT03066440|diabetic ketoacidosis|diabetic ketoacidosis
79981|NCT03066440|fluid management|fluid management
79982|NCT03066440|hyperchloremia|hyperchloremia
79983|NCT03066427|Clear Cell Renal Carcinoma|clear cell renal carcinoma
79984|NCT03066427|Sunitinib|sunitinib
79985|NCT03066414|hemochromatosis|hemochromatosis
79986|NCT03066414|blood withdrawal|blood withdrawal
79987|NCT03066414|respiratory variations|respiratory variations
79988|NCT03066414|inferior vena cava|inferior vena cava
79989|NCT03066414|internal jugular vein|internal jugular vein
79990|NCT03066414|ultrasound|ultrasound
79991|NCT03066414|ultrasonography|ultrasonography
79992|NCT03066414|echography|echography
79993|NCT03066401|hyperferritinemia|hyperferritinemia
79994|NCT03066401|dysmetabolic hyperferritinemia|dysmetabolic hyperferritinemia
79995|NCT03066401|obese|obese
79996|NCT03066401|blood withdrawal|blood withdrawal
79997|NCT03066401|respiratory variations|respiratory variations
79998|NCT03066401|inferior vena cava|inferior vena cava
79999|NCT03066401|internal jugular vein|internal jugular vein
80000|NCT03066401|ultrasound|ultrasound
80001|NCT03066401|ultrasonography|ultrasonography
80002|NCT03066401|echography|echography
80003|NCT03066388|fluid|fluid
80004|NCT03066388|fluid responsiveness|fluid responsiveness
80005|NCT03066388|pulse pressure|pulse pressure
80006|NCT03066388|noninvasive monitoring|noninvasive monitoring
80007|NCT03066388|pulse pressure variations|pulse pressure variations
80008|NCT03066388|volume expansion|volume expansion
80009|NCT03066388|SIRS|sirs
80010|NCT03066388|systemic inflammatory response syndrome|systemic inflammatory response syndrome
80011|NCT03066375|vena cava|vena cava
80012|NCT03066375|fluid|fluid
80013|NCT03066375|sepsis|sepsis
80014|NCT03066375|echocardiography|echocardiography
80015|NCT03066375|ultrasound|ultrasound
80016|NCT03066375|ultrasonography|ultrasonography
80017|NCT03066375|collapsibility index|collapsibility index
80018|NCT03066375|circulatory failure|circulatory failure
80019|NCT03066375|irregular cardiac rhythm|irregular cardiac rhythm
80020|NCT03066375|fluid responsiveness|fluid responsiveness
80021|NCT03066375|Spontaneous breathing|spontaneous breathing
80022|NCT03066362|Spontaneous ventilation|spontaneous ventilation
80023|NCT03066323|Blood glucose|blood glucose
80024|NCT03066310|Bladder cancer|bladder cancer
80025|NCT03066310|Urine|urine
80026|NCT03066310|DNA biomarker|dna biomarker
80027|NCT03066310|Diagnosis|diagnosis
80028|NCT03066297|Clinical stage IA non-small cell lung cancer|clinical stage ia non-small cell lung cancer
80029|NCT03066297|Lobectomy|lobectomy
80030|NCT03066297|Segmentectomy|segmentectomy
80031|NCT03066297|Wedge resection|wedge resection
80032|NCT03066297|Sublobar resection|sublobar resection
80033|NCT03066297|Limited resection|limited resection
80034|NCT03066284|Children|children
80035|NCT03066284|Adolescents|adolescents
80036|NCT03066284|Parents|parents
80037|NCT03066284|Insulin Pump Therapy|insulin pump therapy
80038|NCT03066271|Aerobic exercise|aerobic exercise
80039|NCT03066271|Lung Cancer|lung cancer
80040|NCT03066258|nAMD|namd
80041|NCT03066258|wet AMD|wet amd
80042|NCT03066258|gene therapy|gene therapy
80043|NCT03066245|Aneurysmal bone cysts|aneurysmal bone cysts
80044|NCT03066245|PLGA|plga
80045|NCT03066245|Platelet Lysate|platelet lysate
80046|NCT03066245|Bone marrow|bone marrow
80047|NCT03066245|Mesenchymal stem cells|mesenchymal stem cells
80048|NCT03066232|Delirium|delirium
80049|NCT03066232|Dementia|dementia
80050|NCT03066232|Physical function|physical function
80051|NCT03066206|Malignant Neoplasm of Respiratory and Intrathoracic Organ|malignant neoplasm of respiratory and intrathoracic organ
80052|NCT03066206|Non-Small Cell Lung Cancer|non-small cell lung cancer
80053|NCT03066206|NSCLC|nsclc
80054|NCT03066206|Advanced|advanced
80055|NCT03066206|EGFR exon 20 mutation|egfr exon 20 mutation
80056|NCT03066206|EGFR-positive|egfr-positive
80057|NCT03066206|Poziotinib|poziotinib
80058|NCT03066193|Motor tics|motor tics
80059|NCT03066193|Vocal tics|vocal tics
80060|NCT03066193|Cannabinoids|cannabinoids
80061|NCT03066193|Dronabinol|dronabinol
80063|NCT03066193|Palmitoylethanolamide|palmitoylethanolamide
80064|NCT03066193|Tourettes|tourettes
80065|NCT03066193|TS|ts
80066|NCT03066167|Cancer of the gastro-esophageal junction|cancer of the gastro-esophageal junction
80067|NCT03066167|Watson score|watson score
80068|NCT03066167|Ogilvie score|ogilvie score
80069|NCT03066167|Goldschmid score|goldschmid score
80070|NCT03066167|Validation|validation
80071|NCT03066167|Quality of Life|quality of life
80072|NCT03066154|High risk prostate cancer|high risk prostate cancer
80073|NCT03066154|>T2cN+M0|>t2cn+m0
80074|NCT03066128|Task shifting|task shifting
80075|NCT03066128|HIV care|hiv care
80076|NCT03066115|Cerebral blood flow|cerebral blood flow
80077|NCT03066115|Cyclooxygenase|cyclooxygenase
80078|NCT03066115|Nitric oxide synthase|nitric oxide synthase
80079|NCT03066115|Reactive Oxygen Species|reactive oxygen species
80080|NCT03066102|sensorimotor system|sensorimotor system
80081|NCT03066102|scapular joint position sense|scapular joint position sense
80082|NCT03066102|fatigue|fatigue
80083|NCT03066089|FBS,HbA1C, PPBS|fbs,hba1c, ppbs
80084|NCT03066050|Ischemic Mitral Regurgitation|ischemic mitral regurgitation
80085|NCT03066050|Mitral Valve Disease|mitral valve disease
80086|NCT03066050|Moderate Mitral Regurgitation|moderate mitral regurgitation
80087|NCT03066050|Severe Mitral Regurgitation|severe mitral regurgitation
80088|NCT03066037|regional-anaesthesiological infiltration|regional-anaesthesiological infiltration
80089|NCT03066037|block series|block series
80090|NCT03066037|invasive pain treatment|invasive pain treatment
80091|NCT03066011|mold-active triazoles|mold-active triazoles
80092|NCT03065972|kidney disease|kidney disease
80093|NCT03065972|vascular access|vascular access
80094|NCT03065972|graft|graft
80095|NCT03065972|fistula|fistula
80096|NCT03065972|hemodialysis|hemodialysis
80097|NCT03065972|dialysis|dialysis
80098|NCT03065959|CK-2127107|ck-2127107
80099|NCT03065959|Mobility Limitation|mobility limitation
80100|NCT03065959|Phase 1b|phase 1b
80101|NCT03065959|skeletal muscle fatigue|skeletal muscle fatigue
80102|NCT03065946|Therapeutic hypothermia|therapeutic hypothermia
80103|NCT03065946|Electroencephalogram|electroencephalogram
80104|NCT03065946|Neuron-Specific Enolase|neuron-specific enolase
80105|NCT03065946|Return of Spontaneous Circulation|return of spontaneous circulation
80106|NCT03065946|S-100B|s-100b
80107|NCT03065933|mania|mania
80108|NCT03065933|clonidine|clonidine
80109|NCT03065933|bipolar disorder|bipolar disorder
80110|NCT03065894|stratified care|stratified care
80111|NCT03065894|psychologically informed practice|psychologically informed practice
80112|NCT03065894|matched care|matched care
80113|NCT03065868|gastric polyp|gastric polyp
80114|NCT03065868|Helicobacter pylori eradication|helicobacter pylori eradication
80115|NCT03065855|laparoscopic mesorectal excision|laparoscopic mesorectal excision
80116|NCT03065855|rectal cancer|rectal cancer
80117|NCT03065855|urinary distention|urinary distention
80118|NCT03065842|Stigma|stigma
80119|NCT03065842|Pregnancy|pregnancy
80120|NCT03065842|Abortion|abortion
80121|NCT03065842|Contraception|contraception
80122|NCT03065842|Adolescence|adolescence
80123|NCT03065829|caregiver|caregiver
80124|NCT03065829|chronically critically ill|chronically critically ill
80125|NCT03065777|single file.|single file.
80126|NCT03065777|ONE ENDO.|one endo.
80127|NCT03065777|F6 SkyTaper.|f6 skytaper.
80128|NCT03065777|ProTaper Universal.|protaper universal.
80129|NCT03065777|irreversible pulpitis.|irreversible pulpitis.
80130|NCT03065777|postoperative pain.|postoperative pain.
80131|NCT03065764|Pembrolizumab|pembrolizumab
80132|NCT03065764|89Zirconium|89zirconium
80133|NCT03065738|reduction osteotomy|reduction osteotomy
80134|NCT03065738|knee arthroplasty|knee arthroplasty
80135|NCT03065712|Breast Cancer|breast cancer
80136|NCT03065712|PET/CT|pet/ct
80137|NCT03065712|FES|fes
80138|NCT03065712|18F Fluoroestradiol|18f fluoroestradiol
80139|NCT03065712|Breast|breast
80140|NCT03065699|Medical device|medical device
80141|NCT03065699|Liver dialysis|liver dialysis
80142|NCT03065699|Haemofilter|haemofilter
80143|NCT03065699|ACLF|aclf
80144|NCT03065686|Cleft Lip and Palate|cleft lip and palate
80145|NCT03065686|CL/P|cl/p
80146|NCT03065686|WES|wes
80147|NCT03065673|Tooth bleaching|tooth bleaching
80148|NCT03065673|Tooth sensitivity|tooth sensitivity
80149|NCT03065660|Missed miscarriage|missed miscarriage
80150|NCT03065660|Mifepristone|mifepristone
80151|NCT03065660|Misoprostol|misoprostol
80152|NCT03065660|Medical management|medical management
80153|NCT03065647|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
80154|NCT03065647|Cardiac Arrest|cardiac arrest
80155|NCT03065647|Heart Arrest|heart arrest
80156|NCT03065647|Sudden Cardiac Arrest|sudden cardiac arrest
80157|NCT03065647|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
80158|NCT03065647|Extracorporeal Cardiopulmonary Resuscitation|extracorporeal cardiopulmonary resuscitation
80159|NCT03065647|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
80160|NCT03065647|CPR|cpr
80161|NCT03065647|ECPR|ecpr
80162|NCT03065647|ECMO|ecmo
80163|NCT03065647|Emergency Medical Services|emergency medical services
80164|NCT03065647|EMS|ems
80165|NCT03065647|OHCA|ohca
80166|NCT03065621|Breast|breast
80167|NCT03065595|Ophiocephalus striatus|ophiocephalus striatus
80168|NCT03065595|IGF-1|igf-1
80169|NCT03065595|hypoalbuminemia|hypoalbuminemia
80170|NCT03065595|MNA score|mna score
80171|NCT03065595|elderly|elderly
80172|NCT03065543|Hyperlipidemias|hyperlipidemias
80173|NCT03065543|Secondary prevention|secondary prevention
80174|NCT03065543|high risk patients|high risk patients
80175|NCT03065543|very high risk patients|very high risk patients
80176|NCT03065530|Dexmedetomidine|dexmedetomidine
80177|NCT03065530|Butorphanol tartrate|butorphanol tartrate
80178|NCT03065530|Analgesia|analgesia
80179|NCT03065530|Breastfeeding|breastfeeding
80180|NCT03065530|Relative infant dose|relative infant dose
80181|NCT03065517|Criminal Justice|criminal justice
80182|NCT03065517|Juvenile Delinquency|juvenile delinquency
80183|NCT03065491|Red yeast rice|red yeast rice
80184|NCT03065491|Phytosterols|phytosterols
80185|NCT03065491|L-Tyrosol|l-tyrosol
80186|NCT03065491|Lipids|lipids
80187|NCT03065491|LDL-cholesterol|ldl-cholesterol
80188|NCT03065491|Endothelial function|endothelial function
80189|NCT03065478|Peripheral Neuropathy|peripheral neuropathy
80190|NCT03065478|Chemotherapy induced|chemotherapy induced
80191|NCT03065478|CIPN|cipn
80192|NCT03065465|Upper GI hemorrhage|upper gi hemorrhage
80193|NCT03065465|Stigmata of recent hemorrhage|stigmata of recent hemorrhage
80194|NCT03065465|Diverticular Hemorrhage|diverticular hemorrhage
80195|NCT03065465|Ulcers|ulcers
80196|NCT03065400|Myelofibrosis|myelofibrosis
80197|NCT03065400|Acute Leukemia|acute leukemia
80198|NCT03065387|Metastatic solid tumors|metastatic solid tumors
80199|NCT03065387|Genetic mutation|genetic mutation
80200|NCT03065387|Biomarkers|biomarkers
80201|NCT03065387|Neratinib|neratinib
80202|NCT03065387|Everolimus|everolimus
80203|NCT03065387|Afinitor|afinitor
80204|NCT03065387|Zortress|zortress
80205|NCT03065387|RAD001|rad001
80206|NCT03065387|Palbociclib|palbociclib
80207|NCT03065387|PD-0332991|pd-0332991
80208|NCT03065387|Ibrance|ibrance
80209|NCT03065387|Trametinib|trametinib
80210|NCT03065361|Chronic Kidney Disease|chronic kidney disease
80211|NCT03065361|Handgrip Strength|handgrip strength
80212|NCT03065361|Fine Motor Skills|fine motor skills
80213|NCT03065361|Sensitivity|sensitivity
80214|NCT03065348|prehabilitation|prehabilitation
80215|NCT03065348|nutrition|nutrition
80216|NCT03065348|hydration|hydration
80323|NCT03064724|patients|patients
80217|NCT03065348|cystectomy and urinary diversion|cystectomy and urinary diversion
80218|NCT03065348|regional anesthesia|regional anesthesia
80219|NCT03065348|cognition|cognition
80220|NCT03065335|Magnetic Resonance Imaging|magnetic resonance imaging
80221|NCT03065335|Magnetoencephalography|magnetoencephalography
80222|NCT03065335|Major Depressive Disorder|major depressive disorder
80223|NCT03065335|Ketamine|ketamine
80224|NCT03065335|NEUROPHARMACOLOGY|neuropharmacology
80225|NCT03065322|PCOS|pcos
80226|NCT03065322|OSA|osa
80227|NCT03065296|Behavior|behavior
80228|NCT03065296|education|education
80229|NCT03065296|medical residents|medical residents
80230|NCT03065296|knowledge|knowledge
80231|NCT03065296|confidence|confidence
80232|NCT03065296|skills assessment|skills assessment
80233|NCT03065257|EMR|emr
80234|NCT03065257|ESD|esd
80235|NCT03065257|Resection|resection
80236|NCT03065257|STER|ster
80237|NCT03065257|EFTR|eftr
80238|NCT03065257|Submucosal dissection|submucosal dissection
80239|NCT03065257|Endoscopic resection|endoscopic resection
80240|NCT03065244|Kawasaki disease|kawasaki disease
80241|NCT03065218|Thyroid|thyroid
80242|NCT03065218|sestamibi|sestamibi
80243|NCT03065192|Gene Therapy|gene therapy
80244|NCT03065192|PD|pd
80245|NCT03065192|Parkinson's Disease|parkinson's disease
80246|NCT03065192|Aromatic L- Amino Acid Decarboxylase|aromatic l- amino acid decarboxylase
80247|NCT03065192|AADC|aadc
80248|NCT03065192|AAV2-AADC|aav2-aadc
80249|NCT03065192|AAV2|aav2
80250|NCT03065192|Viral Vector|viral vector
80251|NCT03065192|Gene Transfer|gene transfer
80253|NCT03065192|PET|pet
80254|NCT03065192|VY-AADC01|vy-aadc01
80255|NCT03065153|Torso|torso
80256|NCT03065153|Trunk|trunk
80257|NCT03065088|Exercise|exercise
80258|NCT03065088|Feasibility Studies|feasibility studies
80259|NCT03065088|Healthy Lifestyle|healthy lifestyle
80260|NCT03065088|Health Promotion|health promotion
80261|NCT03065088|Health Behavior|health behavior
80262|NCT03065088|Aging|aging
80263|NCT03065088|Activities of Daily Living|activities of daily living
80264|NCT03065088|Mobile Applications|mobile applications
80265|NCT03065062|Lung Cancer Squamous Cell|lung cancer squamous cell
80266|NCT03065062|Head & Neck Cancer|head & neck cancer
80267|NCT03065062|Neoplasms|neoplasms
80268|NCT03065062|Endometrial Cancer|endometrial cancer
80269|NCT03065049|Physical Activity|physical activity
80270|NCT03065049|Peer-facilitation|peer-facilitation
80271|NCT03065049|Methadone Maintenance Therapy|methadone maintenance therapy
80272|NCT03065036|Primary Open Angle Glaucoma|primary open angle glaucoma
80273|NCT03065036|POAG|poag
80274|NCT03065023|advanced tumor|advanced tumor
80275|NCT03065023|intratumoral injection|intratumoral injection
80276|NCT03065023|intralesional injection|intralesional injection
80277|NCT03064997|prebiotic|prebiotic
80278|NCT03064997|pediatric patients|pediatric patients
80279|NCT03064997|health status|health status
80280|NCT03064997|intestine permeability|intestine permeability
80281|NCT03064971|Quitline|quitline
80282|NCT03064971|culturally specific|culturally specific
80283|NCT03064958|glucose regulation|glucose regulation
80284|NCT03064958|lipids|lipids
80285|NCT03064958|Immune markers|immune markers
80286|NCT03064958|Endothelium, Vascular|endothelium, vascular
80287|NCT03064945|Livia TENS|livia tens
80288|NCT03064945|safety and efficacy|safety and efficacy
80289|NCT03064945|menstruating women|menstruating women
80290|NCT03064919|hunger and fullness|hunger and fullness
80291|NCT03064919|regulation of energy intake|regulation of energy intake
80292|NCT03064919|energy compensation|energy compensation
80293|NCT03064919|nutrition knowledge|nutrition knowledge
80294|NCT03064906|T1D, Omnipod|t1d, omnipod
80295|NCT03064880|Thoracic surgery|thoracic surgery
80296|NCT03064880|Fluid responsiveness|fluid responsiveness
80297|NCT03064880|Hemodynamics|hemodynamics
80298|NCT03064880|Oxidative stress|oxidative stress
80299|NCT03064880|Goal-directed fluid therapy|goal-directed fluid therapy
80300|NCT03064867|venetoclax|venetoclax
80301|NCT03064867|rituximab|rituximab
80302|NCT03064867|ifosfamide|ifosfamide
80303|NCT03064867|carboplatin|carboplatin
80304|NCT03064867|etoposide|etoposide
80305|NCT03064854|PDR001|pdr001
80306|NCT03064854|immunotherapy|immunotherapy
80307|NCT03064854|Non-small cell lung cancer|non-small cell lung cancer
80308|NCT03064854|lung|lung
80309|NCT03064854|NSCLC|nsclc
80310|NCT03064802|BioBurst|bioburst
80311|NCT03064802|Spinal Fusion|spinal fusion
80312|NCT03064802|Cellular Allograft|cellular allograft
80313|NCT03064789|Candidiases|candidiases
80314|NCT03064789|Vaginal Infections|vaginal infections
80315|NCT03064776|telemedicine|telemedicine
80316|NCT03064763|Unresectable Stage IIIB-IV Malignant Melanoma|unresectable stage iiib-iv malignant melanoma
80317|NCT03064750|Exercise Therapy|exercise therapy
80318|NCT03064750|Pelvic Floor|pelvic floor
80319|NCT03064750|Preoperative Care|preoperative care
80320|NCT03064724|smoking|smoking
80321|NCT03064724|tobacco use|tobacco use
80322|NCT03064724|Asian|asian
80324|NCT03064724|provider advice|provider advice
80325|NCT03064724|digital health intervention|digital health intervention
80326|NCT03064685|Pyogenic Liver abscess|pyogenic liver abscess
80327|NCT03064685|Liver transplantation|liver transplantation
80328|NCT03064685|Biliary disease|biliary disease
80329|NCT03064659|Postoperative pulmonary complications|postoperative pulmonary complications
80330|NCT03064659|Driving Pressure|driving pressure
80331|NCT03064659|Limitation of Expiratory Flow|limitation of expiratory flow
80332|NCT03064659|Cardiac Surgery|cardiac surgery
80333|NCT03064659|Cardio-pulmonary bypass|cardio-pulmonary bypass
80334|NCT03064646|ORGAN PRESERVATION|organ preservation
80335|NCT03064646|WATCH AND WAIT|watch and wait
80336|NCT03064646|TRANSANAL ENDOSCOPIC MICROSURGERY|transanal endoscopic microsurgery
80337|NCT03064633|Dexamethasone|dexamethasone
80338|NCT03064633|Dexmedetomidine|dexmedetomidine
80339|NCT03064633|Transversus abdominis plane block|transversus abdominis plane block
80340|NCT03064633|Local anesthetic adjuvants|local anesthetic adjuvants
80341|NCT03064633|postoperative pain|postoperative pain
80342|NCT03064620|PCV effects|pcv effects
80343|NCT03064620|S. pneumoniae carriage|s. pneumoniae carriage
80344|NCT03064620|S. aureus carriage|s. aureus carriage
80345|NCT03064620|Indirect vaccination effects|indirect vaccination effects
80346|NCT03064620|Palestinian-Israeli Collaborative Research (PICR)|palestinian-israeli collaborative research (picr)
80347|NCT03064607|Neonates|neonates
80348|NCT03064607|biomarkers|biomarkers
80349|NCT03064607|EXIT procedure|exit procedure
80350|NCT03064607|Cesarean Section|cesarean section
80351|NCT03064581|Cervical Cancer|cervical cancer
80352|NCT03064581|Screening|screening
80353|NCT03064581|Pap Test|pap test
80354|NCT03064581|Pacific Islander Americans|pacific islander americans
80355|NCT03064568|Myomectomy, Misoprostol, Vasopressin, Blood loss|myomectomy, misoprostol, vasopressin, blood loss
80356|NCT03064555|Renal|renal
80357|NCT03064555|Acute|acute
80358|NCT03064555|Exercise|exercise
80359|NCT03064555|Dialysis|dialysis
80360|NCT03064555|Hemodialysis|hemodialysis
80361|NCT03064555|End stage renal disease|end stage renal disease
80362|NCT03064555|Aerobic|aerobic
80363|NCT03064503|myocardial fibrosis|myocardial fibrosis
80364|NCT03064503|cardiac function|cardiac function
80365|NCT03064503|ageing|ageing
80366|NCT03064477|Unified Protocol|unified protocol
80367|NCT03064477|Transdiagnostic approach|transdiagnostic approach
80368|NCT03064477|Public health|public health
80369|NCT03064464|methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
80370|NCT03064451|persistent atrial fibrillation - ablation procedure|persistent atrial fibrillation - ablation procedure
80371|NCT03064373|S. aureus|s. aureus
80372|NCT03064373|carriage|carriage
80373|NCT03064373|mother-neonatal transmission|mother-neonatal transmission
80374|NCT03064373|microbiome|microbiome
80375|NCT03064347|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
80376|NCT03064347|Obesity|obesity
80377|NCT03064347|Nutrient|nutrient
80378|NCT03064321|cognitive behavioral treatment|cognitive behavioral treatment
80379|NCT03064308|Frailty|frailty
80380|NCT03064308|Surgery|surgery
80381|NCT03064308|Physical function|physical function
80382|NCT03064308|Cognitive function|cognitive function
80383|NCT03064308|Quality of life|quality of life
80384|NCT03064308|Exercise|exercise
80385|NCT03064308|Rehabilitation|rehabilitation
80386|NCT03064308|Delirium|delirium
80387|NCT03064308|Morbidity|morbidity
80388|NCT03064308|Mortality|mortality
80389|NCT03064308|Length of stay|length of stay
80390|NCT03064308|Well-being|well-being
80391|NCT03064308|Elderly|elderly
80392|NCT03064308|Older surgical patient|older surgical patient
80393|NCT03064308|Radical prostatectomy|radical prostatectomy
80394|NCT03064308|Radical cystectomy|radical cystectomy
80395|NCT03064308|Radical cystoprostatectomy|radical cystoprostatectomy
80396|NCT03064308|Aortic Aneurysm Repair|aortic aneurysm repair
80397|NCT03064308|Major Cavity Surgery|major cavity surgery
80398|NCT03064308|Abdominal Surgery|abdominal surgery
80399|NCT03064308|Recovery|recovery
80400|NCT03064308|Nephrectomy|nephrectomy
80401|NCT03064269|CNS B cell acute lymphocytic leukemia|cns b cell acute lymphocytic leukemia
80402|NCT03064256|Exercisy therapy|exercisy therapy
80403|NCT03064256|Hypertension|hypertension
80404|NCT03064256|Physiopathology|physiopathology
80405|NCT03064256|Heart rate|heart rate
80406|NCT03064256|Nonlinear dynamics|nonlinear dynamics
80407|NCT03064217|Clinical crown lengthening|clinical crown lengthening
80408|NCT03064217|intraoral imaging|intraoral imaging
80409|NCT03064217|Emax crown|emax crown
80410|NCT03064191|intra-canal medications|intra-canal medications
80411|NCT03064178|periodontal therapy|periodontal therapy
80412|NCT03064178|anticipated pain|anticipated pain
80413|NCT03064178|experienced pain|experienced pain
80414|NCT03064178|pain medication use|pain medication use
80415|NCT03064139|physical activity|physical activity
80416|NCT03064139|gait|gait
80417|NCT03064139|biomechanics|biomechanics
80418|NCT03064126|Artery|artery
80419|NCT03064126|Atherosclerosis|atherosclerosis
80420|NCT03064126|Arterial|arterial
80421|NCT03064126|Peripheral|peripheral
80422|NCT03064126|Plaque|plaque
80423|NCT03064126|Angioplasty|angioplasty
80424|NCT03064126|PTA|pta
80425|NCT03064113|Chronic Obstructive Pulmonary Disease, COPD|chronic obstructive pulmonary disease, copd
80426|NCT03064087|Self-Sampling|self-sampling
80427|NCT03064087|HPV Testing|hpv testing
80428|NCT03064087|Diagnostic Test Accuracy|diagnostic test accuracy
80429|NCT03064087|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
80430|NCT03064087|Urine|urine
80431|NCT03064087|Cervical Cancer Screening|cervical cancer screening
80432|NCT03064048|Argininosuccinate Lyase Deficiency|argininosuccinate lyase deficiency
80433|NCT03064048|Urea Cycle Disorder|urea cycle disorder
80434|NCT03064022|weight gain|weight gain
80435|NCT03064022|head circumference|head circumference
80436|NCT03064022|length|length
80437|NCT03064022|neurodevelopment|neurodevelopment
80438|NCT03063983|osteosarcoma|osteosarcoma
80439|NCT03063983|metastatic|metastatic
80440|NCT03063983|metronomic therapy|metronomic therapy
80441|NCT03063970|Upper extremity|upper extremity
80442|NCT03063970|Rehabilitation|rehabilitation
80443|NCT03063931|Breast cancer|breast cancer
80444|NCT03063931|Mastectomy|mastectomy
80445|NCT03063931|Pain|pain
80446|NCT03063931|Anxiety and Depression|anxiety and depression
80447|NCT03063931|Cognition|cognition
80448|NCT03063931|Quality of life|quality of life
80449|NCT03063905|Opioid related disorders|opioid related disorders
80450|NCT03063905|Narcotic abuse|narcotic abuse
80451|NCT03063879|hepatitis C|hepatitis c
80452|NCT03063879|renal failure|renal failure
80453|NCT03063879|sofosbuvir|sofosbuvir
80454|NCT03063879|daclatasvir|daclatasvir
80455|NCT03063840|hepatocellular carcinoma|hepatocellular carcinoma
80456|NCT03063840|microwave ablation|microwave ablation
80457|NCT03063840|liver cancer|liver cancer
80458|NCT03063801|Congenital Heart Disease|congenital heart disease
80459|NCT03063801|Blood products transfusion|blood products transfusion
80460|NCT03063762|Renal Cell Carcinoma|renal cell carcinoma
80461|NCT03063762|RO6874281|ro6874281
80462|NCT03063762|Atezolizumab|atezolizumab
80463|NCT03063762|Bevacizumab|bevacizumab
80464|NCT03063723|Chronic Hepatitis C|chronic hepatitis c
80465|NCT03063723|Monocytes|monocytes
80466|NCT03063723|Nk cells|nk cells
80467|NCT03063723|direct-acting antiviral agents|direct-acting antiviral agents
80468|NCT03063697|Carvedilol SR Cap|carvedilol sr cap
80469|NCT03063697|Essential hypertension|essential hypertension
80470|NCT03063697|Chronic stable angina|chronic stable angina
80471|NCT03063697|Congestive heart failure|congestive heart failure
80472|NCT03063671|postmastectomy pain|postmastectomy pain
80473|NCT03063658|Ibuprofen|ibuprofen
80474|NCT03063658|Paracetamol|paracetamol
80475|NCT03063658|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
80476|NCT03063658|Morphine|morphine
80477|NCT03063658|Visual analog scale|visual analog scale
80478|NCT03063645|Healthy volunteer|healthy volunteer
80479|NCT03063645|AC-1202|ac-1202
80480|NCT03063645|AC-SD-01|ac-sd-01
80481|NCT03063645|Pharacokinetic|pharacokinetic
80482|NCT03063645|ketone body|ketone body
80483|NCT03063554|Endoscopy|endoscopy
80484|NCT03063554|Pancreatic Cancer|pancreatic cancer
80485|NCT03063554|Bile duct|bile duct
80486|NCT03063554|Periampullary|periampullary
80487|NCT03063554|ERCP|ercp
80488|NCT03063554|Biliary drainage|biliary drainage
80489|NCT03063554|Biliary obstruction|biliary obstruction
80490|NCT03063554|EUSBD|eusbd
80491|NCT03063554|TEUS|teus
80492|NCT03063554|EUS|eus
80493|NCT03063554|Endoscopic Ultrasound|endoscopic ultrasound
80494|NCT03063528|Pregnancy|pregnancy
80495|NCT03063528|Weight|weight
80496|NCT03063528|Gestational weight gain|gestational weight gain
80497|NCT03063528|Stress reduction|stress reduction
80498|NCT03063528|Exercise|exercise
80499|NCT03063515|Insulin secretion|insulin secretion
80500|NCT03063450|anti PD-L1|anti pd-l1
80501|NCT03063450|nivolumab|nivolumab
80502|NCT03063450|immunotherapy|immunotherapy
80503|NCT03063450|RECIST|recist
80504|NCT03063450|quality of life|quality of life
80505|NCT03063450|survival|survival
80506|NCT03063450|immune checkpoint inhibition|immune checkpoint inhibition
80507|NCT03063437|vancomycin resistant enterococcus|vancomycin resistant enterococcus
80508|NCT03063437|VRE|vre
80509|NCT03063437|decolonization|decolonization
80510|NCT03063437|VRE colonization|vre colonization
80511|NCT03063437|fecal microbiota transplantation|fecal microbiota transplantation
80512|NCT03063437|FMT|fmt
80513|NCT03063437|FMT capsule|fmt capsule
80514|NCT03063437|capsule|capsule
80515|NCT03063437|antimicrobial resistance|antimicrobial resistance
80516|NCT03063437|antibiotic resistance|antibiotic resistance
80517|NCT03063437|MDRO|mdro
80518|NCT03063437|multidrug-resistant organism|multidrug-resistant organism
80519|NCT03063437|OpenBiome|openbiome
80520|NCT03063424|isocapnic voluntary hyperventilation|isocapnic voluntary hyperventilation
80521|NCT03063424|eucapnic voluntary hyperventilation|eucapnic voluntary hyperventilation
80522|NCT03063424|exercise induced bronchoconstriction|exercise induced bronchoconstriction
80523|NCT03063424|exercise challenge cycle ergometer|exercise challenge cycle ergometer
80524|NCT03063411|Maths reasoning|maths reasoning
80525|NCT03063411|Working memory|working memory
80526|NCT03063411|Executive Functions|executive functions
80527|NCT03063411|Cognitive Control|cognitive control
80528|NCT03063411|Academic Skills|academic skills
80529|NCT03063411|Randomised Control Trial|randomised control trial
80530|NCT03063385|Adolescents|adolescents
80531|NCT03063385|Parents|parents
80532|NCT03063385|Web-based|web-based
80533|NCT03063385|Puerto Rico|puerto rico
80534|NCT03063385|Latino|latino
80535|NCT03063385|Sexual communication|sexual communication
80536|NCT03063385|Stigma|stigma
80537|NCT03063385|Randomized controlled trial|randomized controlled trial
80538|NCT03063385|STD|std
80539|NCT03063385|Intercourse|intercourse
80540|NCT03063385|Sexual behavior|sexual behavior
80541|NCT03063385|HIV/AIDS|hiv/aids
80542|NCT03063372|Pomegranate|pomegranate
80543|NCT03063372|Burnout|burnout
80544|NCT03063372|Psychological Distress|psychological distress
80545|NCT03063372|Antioxidant|antioxidant
80546|NCT03063359|traumatic pain|traumatic pain
80547|NCT03063359|children|children
80548|NCT03063359|fentanyl|fentanyl
80549|NCT03063359|intranasal use|intranasal use
80550|NCT03063333|spinal cord injury|spinal cord injury
80551|NCT03063333|hypnosis|hypnosis
80552|NCT03063333|pain|pain
80553|NCT03063333|pain catastrophizing|pain catastrophizing
80554|NCT03063333|coping|coping
80555|NCT03063307|Tooth, Deciduous|tooth, deciduous
80556|NCT03063307|Dental Caries|dental caries
80557|NCT03063307|Glass Ionomer Cements|glass ionomer cements
80558|NCT03063307|Dental Atraumatic Restorative Treatment|dental atraumatic restorative treatment
80559|NCT03063307|Cariostatic Agents|cariostatic agents
80560|NCT03063307|Fluorides|fluorides
80561|NCT03063294|Coordination, Administrative|coordination, administrative
80562|NCT03063294|Coaching|coaching
80563|NCT03063294|Primary Care|primary care
80564|NCT03063294|Quality Improvement|quality improvement
80565|NCT03063281|ficolin-2|ficolin-2
80566|NCT03063281|anti-ficolin-2 antibodies|anti-ficolin-2 antibodies
80567|NCT03063281|lupus nephritis|lupus nephritis
80568|NCT03063281|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
80569|NCT03063281|biomarker|biomarker
80570|NCT03063281|ficolin-3|ficolin-3
80571|NCT03063281|anti-ficolin-3 antibodies|anti-ficolin-3 antibodies
80572|NCT03063268|Electronic Consent|electronic consent
80573|NCT03063268|Human Behavior|human behavior
80574|NCT03063268|Bioethics|bioethics
80575|NCT03063268|Research Ethics|research ethics
80576|NCT03063268|Electronic Medical Records (EMR)|electronic medical records (emr)
80577|NCT03063268|Electronic Health Records (EHR)|electronic health records (ehr)
80578|NCT03063268|Informed Consent Form|informed consent form
80579|NCT03063268|Interactive Consent|interactive consent
80580|NCT03063268|Health Record Data|health record data
80581|NCT03063242|Sargramostim|sargramostim
80582|NCT03063229|Insulin Pump Therapy|insulin pump therapy
80583|NCT03063229|Islet Cell Transplant|islet cell transplant
80584|NCT03063229|Energy Expenditure|energy expenditure
80585|NCT03063177|chronic thoracic pain|chronic thoracic pain
80586|NCT03063177|spine stiffness|spine stiffness
80587|NCT03063177|spinal manipulation|spinal manipulation
80588|NCT03063177|spinal manipulative therapy|spinal manipulative therapy
80589|NCT03063164|Femtosecond laser|femtosecond laser
80590|NCT03063164|Visumax|visumax
80591|NCT03063164|Intralase IFS150|intralase ifs150
80592|NCT03063164|LASIK|lasik
80593|NCT03063138|Diabetic foot ulcer|diabetic foot ulcer
80594|NCT03063138|Measurement|measurement
80595|NCT03063138|Wound healing|wound healing
80596|NCT03063138|Measurement device|measurement device
80597|NCT03063138|Three-dimensional measurements|three-dimensional measurements
80598|NCT03063125|radical cystectomy|radical cystectomy
80599|NCT03063125|hypogonadism|hypogonadism
80600|NCT03063008|Lumbar spine; Fusion; Titanium; PEEK|lumbar spine; fusion; titanium; peek
80601|NCT03062930|stroke|stroke
80602|NCT03062930|hemiparesis|hemiparesis
80603|NCT03062930|lesion hemisphere|lesion hemisphere
80604|NCT03062930|ipsilesional deficits|ipsilesional deficits
80605|NCT03062930|contralesional deficits|contralesional deficits
80606|NCT03062930|rehabilitation|rehabilitation
80607|NCT03062930|remediation|remediation
80608|NCT03062930|paretic arm|paretic arm
80609|NCT03062904|healthy|healthy
80610|NCT03062904|respiratory system|respiratory system
80611|NCT03062904|ventilation|ventilation
80612|NCT03062904|paradoxical effect|paradoxical effect
80613|NCT03062904|methacholine|methacholine
80614|NCT03062904|bronchodilator|bronchodilator
80615|NCT03062904|NEP|nep
80616|NCT03062904|EFL|efl
80617|NCT03062865|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
80618|NCT03062865|TNF-alpha inhibitors|tnf-alpha inhibitors
80619|NCT03062852|Medication Errors/prevention & control|medication errors/prevention & control
80620|NCT03062852|Nursing Staff, Hospital/organization & administration|nursing staff, hospital/organization & administration
80621|NCT03062852|Drug Therapy/nursing|drug therapy/nursing
80622|NCT03062852|Safety Management|safety management
80623|NCT03062852|Medication Systems, Hospital/organization & administration|medication systems, hospital/organization & administration
80624|NCT03062826|OCT|oct
80625|NCT03062826|STEMI|stemi
80752|NCT03061968|behavioral state|behavioral state
80626|NCT03062813|Hepatitis B virus, tacrolimus,membranous nephropathy|hepatitis b virus, tacrolimus,membranous nephropathy
80627|NCT03062800|thalidomide|thalidomide
80628|NCT03062800|pemetrexed|pemetrexed
80629|NCT03062800|nsclc|nsclc
80630|NCT03062800|maintenance treatment|maintenance treatment
80631|NCT03062722|microsurgical treatment|microsurgical treatment
80632|NCT03062722|pain|pain
80633|NCT03062722|dexterity|dexterity
80634|NCT03062722|Phalen sign|phalen sign
80635|NCT03062722|functional status|functional status
80636|NCT03062709|tobacco cessation|tobacco cessation
80637|NCT03062709|bronchiolitis|bronchiolitis
80638|NCT03062709|pneumonia|pneumonia
80639|NCT03062709|pediatric|pediatric
80640|NCT03062709|environmental tobacco smoke|environmental tobacco smoke
80641|NCT03062709|secondhand tobacco smoke|secondhand tobacco smoke
80642|NCT03062709|thirdhand tobacco smoke|thirdhand tobacco smoke
80643|NCT03062709|tobacco smoke|tobacco smoke
80644|NCT03062709|asthma|asthma
80645|NCT03062709|reactive airway disease|reactive airway disease
80646|NCT03062709|bronchopulmonary dysplasia|bronchopulmonary dysplasia
80647|NCT03062683|lactate|lactate
80648|NCT03062683|syncope|syncope
80649|NCT03062644|Open Total or Subtotal Abdominal Hysterectomy|open total or subtotal abdominal hysterectomy
80650|NCT03062631|Congenital Myasthenic Syndrome|congenital myasthenic syndrome
80651|NCT03062631|Lambert-Eaton Myasthenic Syndrome|lambert-eaton myasthenic syndrome
80652|NCT03062631|3,4 DAP|3,4 dap
80653|NCT03062631|3,4 Diaminopyridine|3,4 diaminopyridine
80654|NCT03062592|incretin|incretin
80655|NCT03062592|insulin|insulin
80656|NCT03062592|glucose|glucose
80657|NCT03062566|biomarkers|biomarkers
80658|NCT03062566|point-of-care analysis|point-of-care analysis
80659|NCT03062540|PTSD|ptsd
80660|NCT03062540|Military-related PTSD|military-related ptsd
80661|NCT03062527|Nutrition|nutrition
80662|NCT03062527|Training support|training support
80663|NCT03062527|Low Glycemic Index|low glycemic index
80664|NCT03062527|Moderate Glycemic Index|moderate glycemic index
80665|NCT03062527|Endurance|endurance
80666|NCT03062527|Running|running
80667|NCT03062449|L-Serine, Alzheimer's Disease, AD, Memory,|l-serine, alzheimer's disease, ad, memory,
80668|NCT03062436|CML, treatment free remission|cml, treatment free remission
80669|NCT03062410|Health Related Quality of Life|health related quality of life
80670|NCT03062410|Routine clinical practice|routine clinical practice
80671|NCT03062410|Electronic Patient Reported Outcome|electronic patient reported outcome
80672|NCT03062410|EORTC QLQ-C30|eortc qlq-c30
80673|NCT03062410|Pazopanib|pazopanib
80674|NCT03062410|Sunitinib|sunitinib
80675|NCT03062410|Tyrosine Kinase Inhibitor anti-VEGF|tyrosine kinase inhibitor anti-vegf
80676|NCT03062410|Patient Reported Outcome|patient reported outcome
80677|NCT03062410|Supportive Care|supportive care
80678|NCT03062410|Quality of Life|quality of life
80679|NCT03062384|brain|brain
80680|NCT03062384|health|health
80681|NCT03062358|Programmed Cell Death Receptor 1 (PD-1)|programmed cell death receptor 1 (pd-1)
80682|NCT03062358|Programmed Cell Death Receptor Ligand 1 (PD-L1)|programmed cell death receptor ligand 1 (pd-l1)
80683|NCT03062358|Programmed Cell Death Receptor Ligand 2 (PD-L2)|programmed cell death receptor ligand 2 (pd-l2)
80684|NCT03062358|PD1|pd1
80685|NCT03062358|PD-1|pd-1
80686|NCT03062358|PDL1|pdl1
80687|NCT03062358|PD-L1|pd-l1
80688|NCT03062358|PDL2|pdl2
80689|NCT03062345|Stroke|stroke
80690|NCT03062345|Virtual Reality Therapy|virtual reality therapy
80691|NCT03062345|Rehabilitation|rehabilitation
80692|NCT03062345|Upper Extremity|upper extremity
80693|NCT03062345|Arm|arm
80694|NCT03062345|Telerehabilitation|telerehabilitation
80695|NCT03062319|anticoagulant|anticoagulant
80696|NCT03062319|antiplatelet|antiplatelet
80697|NCT03062306|Cerebral Oxygenation|cerebral oxygenation
80698|NCT03062306|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
80699|NCT03062306|Chest Compression|chest compression
80700|NCT03062293|Lumbo-pelvic muscles|lumbo-pelvic muscles
80701|NCT03062293|Rehabilitation|rehabilitation
80702|NCT03062293|Exercise|exercise
80703|NCT03062293|Low back pain|low back pain
80704|NCT03062293|Functional Re-adaptive Exercise Device|functional re-adaptive exercise device
80705|NCT03062280|Extension study|extension study
80706|NCT03062267|mhealth|mhealth
80707|NCT03062267|texting intervention|texting intervention
80708|NCT03062267|mobile health|mobile health
80709|NCT03062267|mobile mental health|mobile mental health
80710|NCT03062254|PSMA|psma
80711|NCT03062241|cryoablation|cryoablation
80712|NCT03062241|conventional treatment of heart failure|conventional treatment of heart failure
80713|NCT03062228|stillbirth|stillbirth
80714|NCT03062228|sleep|sleep
80715|NCT03062228|low birth weight|low birth weight
80716|NCT03062228|pregnancy|pregnancy
80717|NCT03062228|supine|supine
80718|NCT03062228|small for gestational age|small for gestational age
80719|NCT03062215|Culturally adapted psychotherapy|culturally adapted psychotherapy
80720|NCT03062215|Internet-delivered treatment|internet-delivered treatment
80721|NCT03062215|Depression|depression
80722|NCT03062215|Latin America|latin america
80723|NCT03062202|Depression|depression
80724|NCT03062202|Anxiety|anxiety
80725|NCT03062202|Online interventions|online interventions
80726|NCT03062202|CBT|cbt
80727|NCT03062202|IAPT|iapt
80728|NCT03062176|Heart failure|heart failure
80729|NCT03062176|End-stage renal disease|end-stage renal disease
80730|NCT03062176|Interleukin-1|interleukin-1
80731|NCT03062176|Interleukin-1 receptor antagonist|interleukin-1 receptor antagonist
80732|NCT03062176|Metabolomics|metabolomics
80733|NCT03062176|Lipidomics|lipidomics
80734|NCT03062176|Chronic kidney disease|chronic kidney disease
80735|NCT03062137|bronchoscopy|bronchoscopy
80736|NCT03062137|saturation|saturation
80737|NCT03062124|SpyGlass|spyglass
80738|NCT03062124|Pancreatoscopy|pancreatoscopy
80739|NCT03062072|normoglycemia|normoglycemia
80740|NCT03062072|cancer|cancer
80741|NCT03062072|chemotherapy|chemotherapy
80742|NCT03062072|Hyperglycemia Drug Induced|hyperglycemia drug induced
80743|NCT03062046|Atrial Fibrillation|atrial fibrillation
80744|NCT03062020|Preterm Birth|preterm birth
80745|NCT03062020|Asymptomatic high-risk women|asymptomatic high-risk women
80746|NCT03062020|QUIPP|quipp
80747|NCT03062020|Quantitative fetal fibronectin|quantitative fetal fibronectin
80748|NCT03062020|Cervical length|cervical length
80749|NCT03061968|acupressure|acupressure
80750|NCT03061968|very-low- birth-weight premature|very-low- birth-weight premature
80751|NCT03061968|body weight|body weight
80753|NCT03061968|developmental status|developmental status
80754|NCT03061903|total hip arthroplasty|total hip arthroplasty
80755|NCT03061903|direct anterior approach|direct anterior approach
80756|NCT03061903|wound complication|wound complication
80757|NCT03061890|children's environmental health|children's environmental health
80758|NCT03061890|prematurity|prematurity
80759|NCT03061890|preterm birth|preterm birth
80760|NCT03061890|phthalates|phthalates
80761|NCT03061890|NICU|nicu
80762|NCT03061890|stress|stress
80763|NCT03061890|lung health|lung health
80764|NCT03061890|neurodevelopment|neurodevelopment
80765|NCT03061890|growth|growth
80766|NCT03061877|Rheumatoid arthritis|rheumatoid arthritis
80767|NCT03061877|Anxiety|anxiety
80768|NCT03061877|Depression|depression
80769|NCT03061825|Aneurysm|aneurysm
80770|NCT03061825|Aortic Aneurysm|aortic aneurysm
80771|NCT03061825|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
80772|NCT03061825|Iliac Aneurysm|iliac aneurysm
80773|NCT03061825|Vascular Diseases|vascular diseases
80774|NCT03061825|Cardiovascular Diseases|cardiovascular diseases
80775|NCT03061825|Aortic Diseases|aortic diseases
80776|NCT03061812|Small cell lung cancer (SCLC)|small cell lung cancer (sclc)
80777|NCT03061812|Delta-like protein 3 (DLL3)|delta-like protein 3 (dll3)
80778|NCT03061812|rovalpituzumab tesirine|rovalpituzumab tesirine
80779|NCT03061812|topotecan|topotecan
80780|NCT03061812|metastatic|metastatic
80781|NCT03061760|Prostate cancer|prostate cancer
80782|NCT03061760|Incontinence|incontinence
80783|NCT03061760|Radical prostatectomy|radical prostatectomy
80784|NCT03061760|Urge urinary incontinence|urge urinary incontinence
80785|NCT03061734|Migraine Disorders|migraine disorders
80786|NCT03061734|Headache Disorders|headache disorders
80787|NCT03061734|Migraine with Aura|migraine with aura
80788|NCT03061734|Migraine without Aura|migraine without aura
80789|NCT03061721|NASH|nash
80790|NCT03061721|NAFLD|nafld
80791|NCT03061721|Saroglitazar|saroglitazar
80792|NCT03061669|heart failure|heart failure
80793|NCT03061669|pulmonary hypertension|pulmonary hypertension
80794|NCT03061669|right heart catheterization|right heart catheterization
80795|NCT03061591|Turmeric|turmeric
80796|NCT03061591|Curcumin|curcumin
80797|NCT03061591|colorectal polyps|colorectal polyps
80798|NCT03061591|colorectal neoplasia|colorectal neoplasia
80799|NCT03061591|mutyh mutation|mutyh mutation
80800|NCT03061591|apc mutation|apc mutation
80801|NCT03061578|Tear Film|tear film
80802|NCT03061578|Hyperspectral imaging|hyperspectral imaging
80803|NCT03061578|Low Humidity Environmental Exposure Chamber|low humidity environmental exposure chamber
80804|NCT03061565|erythropoietin|erythropoietin
80805|NCT03061565|traumatic brain injury|traumatic brain injury
80806|NCT03061539|Immunogenic signature|immunogenic signature
80807|NCT03061513|Parkinson Disease|parkinson disease
80808|NCT03061513|ubiquinol|ubiquinol
80809|NCT03061513|CoQ10|coq10
80810|NCT03061513|magnetic resonance spectroscopy|magnetic resonance spectroscopy
80811|NCT03061513|lactate|lactate
80812|NCT03061513|glutathione|glutathione
80813|NCT03061500|Proadrenomedullin|proadrenomedullin
80814|NCT03061500|Sepsis|sepsis
80815|NCT03061500|Intraabdominal Infections|intraabdominal infections
80816|NCT03061500|prognosis|prognosis
80817|NCT03061474|Mild Cognitive Impairment|mild cognitive impairment
80818|NCT03061474|Alzheimer's Disease|alzheimer's disease
80819|NCT03061474|Nicotinamide|nicotinamide
80820|NCT03061474|Niacinamide|niacinamide
80821|NCT03061474|Niacin|niacin
80822|NCT03061474|Nicotinic Acids|nicotinic acids
80823|NCT03061474|Vitamin|vitamin
80824|NCT03061474|Neurodegenerative Diseases|neurodegenerative diseases
80825|NCT03061474|Tauopathies|tauopathies
80826|NCT03061474|Dementia|dementia
80827|NCT03061461|Extracorporeal shock wave therapy|extracorporeal shock wave therapy
80828|NCT03061461|ESWT|eswt
80829|NCT03061461|Radial extracorporeal shock wave therapy|radial extracorporeal shock wave therapy
80830|NCT03061461|rESWT|reswt
80831|NCT03061461|Diabetes|diabetes
80832|NCT03061435|Vulvar Cancer|vulvar cancer
80833|NCT03061435|Cervical Cancer|cervical cancer
80834|NCT03061435|Vulvar Dysplasia|vulvar dysplasia
80835|NCT03061435|Cervical Dysplasia|cervical dysplasia
80836|NCT03061435|Anal Cancer|anal cancer
80837|NCT03061435|Anal Dysplasia|anal dysplasia
80838|NCT03061435|HPV|hpv
80839|NCT03061357|activity tracker|activity tracker
80840|NCT03061357|behavior change|behavior change
80841|NCT03061318|Fine Needle Aspiration, Genetic Classifier|fine needle aspiration, genetic classifier
80842|NCT03061279|Medial Malleolus fractures|medial malleolus fractures
80843|NCT03061279|headless screws|headless screws
80844|NCT03061279|headed screws|headed screws
80845|NCT03061266|type 2 diabetes mellitus, application, e-health education|type 2 diabetes mellitus, application, e-health education
80846|NCT03061253|Electronic Cigarettes|electronic cigarettes
80847|NCT03061253|Laser Doppler Flowmetry|laser doppler flowmetry
80848|NCT03061253|Ultrasound|ultrasound
80849|NCT03061253|Nicotine Replacement Therapy|nicotine replacement therapy
80850|NCT03061240|Internet of Things|internet of things
80851|NCT03061136|Cognition|cognition
80852|NCT03061136|Gamma oscillations|gamma oscillations
80853|NCT03061136|EEG|eeg
80854|NCT03061136|Executive function|executive function
80855|NCT03061136|Benzodiazepine|benzodiazepine
80856|NCT03061136|GABA|gaba
80857|NCT03061097|Autologous Fecal Microbiota Transplantation|autologous fecal microbiota transplantation
80858|NCT03061084|Spina Bifida,Neurogenic bladder, Myelomeningocele, Meningocele|spina bifida,neurogenic bladder, myelomeningocele, meningocele
80859|NCT03061071|Positional Sleep Apnea|positional sleep apnea
80860|NCT03061071|Positional Obstructive Sleep Apnea|positional obstructive sleep apnea
80861|NCT03061071|POSA|posa
80862|NCT03061071|OSA|osa
80863|NCT03061071|Obstructive Sleep Apnea|obstructive sleep apnea
80864|NCT03061071|Sleep Apnea|sleep apnea
80865|NCT03061019|child|child
80866|NCT03061019|myofunctional therapy|myofunctional therapy
80867|NCT03061019|adenotonsillectomy|adenotonsillectomy
80868|NCT03061019|randomized controlled trial|randomized controlled trial
80869|NCT03060993|Cannabis|cannabis
80870|NCT03060993|Marijuana|marijuana
80871|NCT03060967|motivation, instrumental tasks, food-related stimuli, size/time discrimination, major depression|motivation, instrumental tasks, food-related stimuli, size/time discrimination, major depression
80872|NCT03060954|Visual Disorder|visual disorder
80873|NCT03060928|Rotator Cuff Tear|rotator cuff tear
80874|NCT03060928|Artelon®|artelon®
80875|NCT03060915|Actigraphy|actigraphy
80876|NCT03060915|Polysomnography|polysomnography
80877|NCT03060915|Obstructive Sleep Apnea|obstructive sleep apnea
80878|NCT03060889|Cesarean section|cesarean section
80879|NCT03060889|placenta previa|placenta previa
80880|NCT03060889|Tranexamic acid|tranexamic acid
80881|NCT03060876|shoulder fractures|shoulder fractures
80882|NCT03060876|humeral fractures|humeral fractures
80883|NCT03060876|operative therapy|operative therapy
80884|NCT03060876|conservative therapy|conservative therapy
80885|NCT03060876|range of motion, articular|range of motion, articular
80886|NCT03060876|quality of life|quality of life
80887|NCT03060876|proximal|proximal
80888|NCT03060863|children|children
80889|NCT03060837|RIRS|rirs
80890|NCT03060837|Kidney Stone|kidney stone
80891|NCT03060837|Single lung ventilation|single lung ventilation
80892|NCT03060837|Simultaneous normal ventilation|simultaneous normal ventilation
80893|NCT03060824|Osmolality|osmolality
80894|NCT03060824|Sodium|sodium
80895|NCT03060824|CABG|cabg
80896|NCT03060824|Cardiovascular Diseases|cardiovascular diseases
80897|NCT03060824|Cardiopulmonary bypass|cardiopulmonary bypass
80898|NCT03060772|Pulmonary Medicine|pulmonary medicine
80899|NCT03060772|Oxidative Stress|oxidative stress
80900|NCT03060772|Pioglitazone|pioglitazone
80901|NCT03060772|Immunology|immunology
80902|NCT03060772|Addictive/Compulsive Behavior|addictive/compulsive behavior
80903|NCT03060759|Multiple Sclerosis|multiple sclerosis
80904|NCT03060759|Relapsing-Remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
80905|NCT03060759|Fatigue|fatigue
80906|NCT03060759|Light Therapy|light therapy
80907|NCT03060720|Pancreatic Cancer|pancreatic cancer
80908|NCT03060694|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
80909|NCT03060694|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
80910|NCT03060668|Critical Illness|critical illness
80911|NCT03060668|Indirect Calorimetry|indirect calorimetry
80912|NCT03060668|Dietary Proteins|dietary proteins
80913|NCT03060655|PLGA-Mg|plga-mg
80914|NCT03060655|fracture|fracture
80915|NCT03060655|fixation|fixation
80916|NCT03060655|union|union
80917|NCT03060642|Microenvironment|microenvironment
80918|NCT03060642|Microbiome|microbiome
80919|NCT03060642|Screening|screening
80920|NCT03060642|Barrett Esophagus|barrett esophagus
80921|NCT03060642|Esophageal Adenocarcinoma|esophageal adenocarcinoma
80922|NCT03060603|Erythropoietin|erythropoietin
80923|NCT03060603|Endometrium|endometrium
80924|NCT03060603|Doppler Ultrasonography|doppler ultrasonography
80925|NCT03060590|sarcopenia, uremic toxins|sarcopenia, uremic toxins
80926|NCT03060564|shoulder|shoulder
80927|NCT03060564|orthopaedics|orthopaedics
80928|NCT03060525|Deaf|deaf
80929|NCT03060525|American Sign Language|american sign language
80930|NCT03060525|Overweight|overweight
80931|NCT03060525|Obese|obese
80932|NCT03060512|Opioid Induced constipation,|opioid induced constipation,
80933|NCT03060512|constipation,|constipation,
80934|NCT03060512|laxative,|laxative,
80935|NCT03060512|bowel movement,|bowel movement,
80936|NCT03060512|Movantik,|movantik,
80937|NCT03060512|Naloxegol|naloxegol
80938|NCT03060499|Thyroidectomy|thyroidectomy
80939|NCT03060499|Myocardial Function|myocardial function
80940|NCT03060499|Thyroid gland|thyroid gland
80941|NCT03060499|Heart|heart
80942|NCT03060473|PPROM|pprom
80943|NCT03060473|Azithromycin|azithromycin
80944|NCT03060473|Erythromycin|erythromycin
80945|NCT03060434|pentoxifylline|pentoxifylline
80946|NCT03060434|Disc hernia|disc hernia
80947|NCT03060434|sciatica|sciatica
80948|NCT03060434|lumbar radiculopathy|lumbar radiculopathy
80949|NCT03060408|Fluid Therapy|fluid therapy
80950|NCT03060408|Laparoscopy|laparoscopy
80951|NCT03060369|Tissue Perfusion|tissue perfusion
80952|NCT03060369|Noninvasive Monitoring|noninvasive monitoring
80953|NCT03060369|Near-infrared spectroscopy|near-infrared spectroscopy
80954|NCT03060369|CareGuide|careguide
80955|NCT03060317|Disorders of consciousness|disorders of consciousness
80956|NCT03060317|validation studies|validation studies
80957|NCT03060317|coma|coma
80958|NCT03060317|vegetative state|vegetative state
80959|NCT03060304|tamoxifen|tamoxifen
80960|NCT03060304|thin endometrium|thin endometrium
80961|NCT03060304|frozen embryo transfer|frozen embryo transfer
80962|NCT03060304|pregnancy rate|pregnancy rate
80963|NCT03060291|Family Check-up|family check-up
80964|NCT03060278|smoking cessation, food pantry|smoking cessation, food pantry
80965|NCT03060265|multimodal analgesia|multimodal analgesia
80966|NCT03060265|paracetamol|paracetamol
80967|NCT03060265|cesarean section|cesarean section
80968|NCT03060252|Drug-Induced Liver Injury|drug-induced liver injury
80969|NCT03060239|Parkinson Disease|parkinson disease
80970|NCT03060239|Near infrared Spectroscopy|near infrared spectroscopy
80971|NCT03060239|REM sleep behaviour disorder|rem sleep behaviour disorder
80972|NCT03060239|Supplementary motor area|supplementary motor area
80973|NCT03060213|Well-Being|well-being
80974|NCT03060213|e-Health|e-health
80975|NCT03060213|Randomized Controlled Trial|randomized controlled trial
80976|NCT03060213|Self-Efficacy|self-efficacy
80977|NCT03060213|Interpersonal well-being|interpersonal well-being
80978|NCT03060213|Community well-being|community well-being
80979|NCT03060213|Occupational well-being|occupational well-being
80980|NCT03060213|Physical well-being|physical well-being
80981|NCT03060213|Psychological well-being|psychological well-being
80982|NCT03060213|Economic well-being|economic well-being
80983|NCT03060200|depression|depression
80984|NCT03060200|treatment|treatment
80986|NCT03060200|online|online
80987|NCT03060200|app|app
80988|NCT03060161|Health promotion|health promotion
80989|NCT03060161|Healthy Diet|healthy diet
80990|NCT03060161|Exercise|exercise
80991|NCT03060148|Heart failure|heart failure
80992|NCT03060148|Spinal cord stimulation|spinal cord stimulation
80993|NCT03060109|Traumatic brain injury|traumatic brain injury
80994|NCT03060109|Head injury|head injury
80995|NCT03060031|Oxytocin|oxytocin
80996|NCT03060005|Sjögren's syndrome|sjögren's syndrome
80997|NCT03060005|meibomian gland dysfunction|meibomian gland dysfunction
80998|NCT03060005|dry eye disease|dry eye disease
80999|NCT03059940|Smoking Cessation|smoking cessation
81000|NCT03059940|Low Dose computed tomography|low dose computed tomography
81001|NCT03059940|LDCT|ldct
81002|NCT03059940|Quitline|quitline
81003|NCT03059940|Questionnaires|questionnaires
81004|NCT03059940|Surveys|surveys
81005|NCT03059940|Counseling|counseling
81006|NCT03059940|Smoking cessation drugs|smoking cessation drugs
81007|NCT03059940|Anti-Smoking Drug|anti-smoking drug
81008|NCT03059940|Nicotine replacement therapy|nicotine replacement therapy
81010|NCT03059940|Nicotine Patch|nicotine patch
81011|NCT03059927|Cruciate retaining|cruciate retaining
81012|NCT03059927|Anterior stabilized|anterior stabilized
81013|NCT03059927|Posterior stabilized|posterior stabilized
81014|NCT03059927|Posterior cruciate ligament|posterior cruciate ligament
81015|NCT03059927|Degenerative knee joint disease|degenerative knee joint disease
81016|NCT03059927|Knee injury and Osteoarthritis Outcome Score|knee injury and osteoarthritis outcome score
81017|NCT03059927|Kinematic radiostereometry|kinematic radiostereometry
81018|NCT03059901|Physical Activity|physical activity
81019|NCT03059901|Latina Women|latina women
81020|NCT03059901|Minority Health|minority health
81021|NCT03059901|Mobile Technology|mobile technology
81022|NCT03059901|Social Support|social support
81023|NCT03059875|Breastcancer|breastcancer
81024|NCT03059875|Standardized Geriatric Evaluation|standardized geriatric evaluation
81025|NCT03059875|Onco-Geriatric Filter|onco-geriatric filter
81026|NCT03059862|immunity|immunity
81027|NCT03059862|Aryl-hydrocarbon receptor|aryl-hydrocarbon receptor
81028|NCT03059862|immune homeostasis|immune homeostasis
81029|NCT03059862|microbiota|microbiota
81030|NCT03059862|tryptophan|tryptophan
81031|NCT03059836|n3 PUFA|n3 pufa
81032|NCT03059823|Solid tumors|solid tumors
81033|NCT03059823|Metastatic cancer|metastatic cancer
81034|NCT03059745|Cholecystitis|cholecystitis
81035|NCT03059745|Cholelithiasis|cholelithiasis
81036|NCT03059732|Gastric cancer|gastric cancer
81037|NCT03059732|Thailand|thailand
81038|NCT03059732|Japan|japan
81039|NCT03059719|safety|safety
81040|NCT03059719|pharmacokinetics|pharmacokinetics
81041|NCT03059719|pharmacodynamics|pharmacodynamics
81042|NCT03059693|Eczema|eczema
81043|NCT03059693|Topical|topical
81044|NCT03059680|Potassium|potassium
81045|NCT03059680|Nutrition|nutrition
81046|NCT03059667|Small Cell Lun cancer|small cell lun cancer
81047|NCT03059667|IFCT|ifct
81048|NCT03059667|immune therapy|immune therapy
81049|NCT03059654|Percutaneous tracheostomy|percutaneous tracheostomy
81050|NCT03059654|surgical tracheostomy|surgical tracheostomy
81051|NCT03059654|airway ultrasound|airway ultrasound
81052|NCT03059654|intensive care|intensive care
81053|NCT03059641|Next Generation Sequencing (NGS)|next generation sequencing (ngs)
81054|NCT03059641|Tyrosine Kinase Inhibitor (TKI)|tyrosine kinase inhibitor (tki)
81055|NCT03059641|liquid biopsy|liquid biopsy
81056|NCT03059641|EGFR Gene mutation|egfr gene mutation
81057|NCT03059589|food anaphylaxis|food anaphylaxis
81058|NCT03059589|peanut anaphylaxis|peanut anaphylaxis
81059|NCT03059589|food oral immunotherapy|food oral immunotherapy
81060|NCT03059589|food allergy|food allergy
81061|NCT03059589|food allergy treatment|food allergy treatment
81062|NCT03059576|Chronobiology|chronobiology
81063|NCT03059576|Circadian rhythms|circadian rhythms
81064|NCT03059576|Heritability|heritability
81065|NCT03059576|Twins|twins
81066|NCT03059563|Varenicline|varenicline
81067|NCT03059563|Positron Emission Tomography|positron emission tomography
81068|NCT03059563|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
81069|NCT03059563|Methamphetamine Abuse|methamphetamine abuse
81070|NCT03059550|cardiac rehabilitation|cardiac rehabilitation
81071|NCT03059550|prediabetes|prediabetes
81072|NCT03059524|microRNA|microrna
81073|NCT03059498|PECS I and II|pecs i and ii
81074|NCT03059498|PECS blocks|pecs blocks
81075|NCT03059485|Leukemia|leukemia
81076|NCT03059472|physical activity|physical activity
81077|NCT03059472|nutrition|nutrition
81078|NCT03059472|social network|social network
81079|NCT03059472|civic engagement|civic engagement
81080|NCT03059459|Lung Diseases, Obstructive|lung diseases, obstructive
81081|NCT03059459|Air Pollution|air pollution
81082|NCT03059459|Particulate Matter|particulate matter
81083|NCT03059433|Substance use|substance use
81084|NCT03059433|adolescent|adolescent
81085|NCT03059433|health|health
81086|NCT03059433|social network|social network
81087|NCT03059420|CFEOM (Congenital Fibrosis of Extraocular Muscles)|cfeom (congenital fibrosis of extraocular muscles)
81088|NCT03059420|CCDD (Congenital Cranial Dysinnervation Disorders)|ccdd (congenital cranial dysinnervation disorders)
81089|NCT03059420|DRS (Duane Retraction Syndrome)|drs (duane retraction syndrome)
81090|NCT03059420|DRRS (Duane Radial Ray Syndrome)|drrs (duane radial ray syndrome)
81091|NCT03059420|Strabismus|strabismus
81092|NCT03059420|MGJWS (Marcus Gunn Jaw Winking Syndrome)|mgjws (marcus gunn jaw winking syndrome)
81093|NCT03059420|HGP (Horizontal Gaze Palsy)|hgp (horizontal gaze palsy)
81094|NCT03059420|HGPPS (Horizontal Gaze Palsy with Progressive Scoliosis)|hgpps (horizontal gaze palsy with progressive scoliosis)
81095|NCT03059420|Moebius|moebius
81096|NCT03059394|reliability|reliability
81097|NCT03059394|validity|validity
81098|NCT03059394|measurement error|measurement error
81099|NCT03059381|adolescent epilepsy participants|adolescent epilepsy participants
81100|NCT03059381|partial seizures|partial seizures
81101|NCT03059381|primary generalized Tonic-clonic seizures|primary generalized tonic-clonic seizures
81102|NCT03059342|spastic diplegic CP|spastic diplegic cp
81103|NCT03059342|self-care|self-care
81104|NCT03059342|functional mobility|functional mobility
81105|NCT03059342|multilevel surgery|multilevel surgery
81106|NCT03059329|adult epilepsy participants|adult epilepsy participants
81107|NCT03059329|partial seizures|partial seizures
81108|NCT03059329|primary generalized Tonic-clonic seizures|primary generalized tonic-clonic seizures
81109|NCT03059316|controlled hypotension, perfusion|controlled hypotension, perfusion
81110|NCT03059290|post operative pain|post operative pain
81111|NCT03059290|Post operative flare ups|post operative flare ups
81112|NCT03059290|Post endodontic pain|post endodontic pain
81113|NCT03059290|Post endodontic flare ups|post endodontic flare ups
81114|NCT03059290|Necrotic teeth|necrotic teeth
81115|NCT03059290|Non vital teeth|non vital teeth
81116|NCT03059290|Neolix file|neolix file
81117|NCT03059290|Single rotating file|single rotating file
81118|NCT03059290|Protaper next file|protaper next file
81119|NCT03059290|Multiple rotating file|multiple rotating file
81120|NCT03059290|Single visit|single visit
81121|NCT03059277|Diabetic Macular Edema|diabetic macular edema
81122|NCT03059277|Diabetes|diabetes
81123|NCT03059277|reduced treatment frequency|reduced treatment frequency
81124|NCT03059251|CLL, obinutuzumab, treatment|cll, obinutuzumab, treatment
81125|NCT03059238|Pain control|pain control
81126|NCT03059238|TACE|tace
81127|NCT03059238|Opioids|opioids
81128|NCT03059238|NSAIDs|nsaids
81129|NCT03059225|Stroke|stroke
81130|NCT03059225|Aphasia|aphasia
81131|NCT03059225|rTMS|rtms
81132|NCT03059225|Functional MRI|functional mri
81133|NCT03059225|Speech training|speech training
81134|NCT03059212|working memory|working memory
81135|NCT03059212|parkinson's disease|parkinson's disease
81136|NCT03059199|Prospective/Retrospective|prospective/retrospective
81137|NCT03059173|Polycystic ovary syndrome|polycystic ovary syndrome
81138|NCT03059173|Reproductive medicine|reproductive medicine
81139|NCT03059160|Rett syndrome, Triheptanoic acid, Walking, EEG|rett syndrome, triheptanoic acid, walking, eeg
81140|NCT03059134|Overactive bladder|overactive bladder
81141|NCT03059134|Pharmacotherapy|pharmacotherapy
81142|NCT03059134|Adverse event|adverse event
81143|NCT03059121|HIV|hiv
81144|NCT03059121|Lipodystrophy|lipodystrophy
81145|NCT03059043|Phakic Intraocular Lenses|phakic intraocular lenses
81146|NCT03059043|viscoelastic|viscoelastic
81147|NCT03059030|Thrombocytopenia|thrombocytopenia
81148|NCT03059030|cirrhosis|cirrhosis
81149|NCT03059030|Therasphere®|therasphere®
81150|NCT03059030|Y90|y90
81151|NCT03059030|Radioembolization|radioembolization
81152|NCT03059004|physical therapy|physical therapy
81153|NCT03058965|AD|ad
81154|NCT03058965|HV|hv
81155|NCT03058965|PSP|psp
81156|NCT03058952|pain management|pain management
81157|NCT03058952|fatigue|fatigue
81158|NCT03058952|mindfulness|mindfulness
81159|NCT03058952|Gulf War|gulf war
81160|NCT03058939|Breast Cancer|breast cancer
81161|NCT03058939|Breast Cancer Stage II|breast cancer stage ii
81162|NCT03058939|Breast Cancer Stage III|breast cancer stage iii
81163|NCT03058939|Paclitaxel|paclitaxel
81164|NCT03058939|Taxol|taxol
81165|NCT03058926|Chronic Pancreatitis|chronic pancreatitis
81166|NCT03058926|Diabetes|diabetes
81167|NCT03058926|Pancreatic Cancer|pancreatic cancer
81168|NCT03058926|Data Management|data management
81169|NCT03058926|Protocol compliance|protocol compliance
81170|NCT03058926|Regulatory compliance|regulatory compliance
81171|NCT03058926|Consortium studies|consortium studies
81172|NCT03058900|Fecal Microbiota Transplantation|fecal microbiota transplantation
81173|NCT03058900|FMT|fmt
81174|NCT03058900|Randomized Controlled Trial|randomized controlled trial
81175|NCT03058900|Intestinal microbiome|intestinal microbiome
81176|NCT03058900|RCT|rct
81177|NCT03058887|High Intensity Interval Training|high intensity interval training
81178|NCT03058887|Exercise|exercise
81179|NCT03058887|Microcirculation|microcirculation
81180|NCT03058874|Chronic Kidney Disease|chronic kidney disease
81181|NCT03058874|Hemodialysis|hemodialysis
81182|NCT03058874|Hypertension|hypertension
81183|NCT03058874|Arterial Stifness|arterial stifness
81184|NCT03058874|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
81185|NCT03058848|Phenylketonuria|phenylketonuria
81186|NCT03058848|PKU|pku
81187|NCT03058848|Metabolism|metabolism
81188|NCT03058848|Metabolic|metabolic
81189|NCT03058848|Control|control
81190|NCT03058848|Acceptability|acceptability
81191|NCT03058835|HIV|hiv
81192|NCT03058835|Truvada|truvada
81193|NCT03058796|stroke|stroke
81194|NCT03058796|rehabilitation|rehabilitation
81195|NCT03058796|Hemipelegia|hemipelegia
81196|NCT03058770|chronic stroke, sensorimotor retraining|chronic stroke, sensorimotor retraining
81197|NCT03058692|Immunogenicity|immunogenicity
81198|NCT03058692|Influenza Vaccine|influenza vaccine
81199|NCT03058692|M-001 vaccine|m-001 vaccine
81200|NCT03058692|Reactogenicity|reactogenicity
81201|NCT03058692|Safety|safety
81202|NCT03058679|diet|diet
81203|NCT03058679|specific carbohydrate diet|specific carbohydrate diet
81204|NCT03058679|Mediterranean style diet|mediterranean style diet
81205|NCT03058679|randomized controlled trial|randomized controlled trial
81206|NCT03058666|Aerosol|aerosol
81207|NCT03058666|surfactant|surfactant
81208|NCT03058666|calfactant|calfactant
81209|NCT03058666|Infasurf|infasurf
81210|NCT03058666|Respiratory Distress Syndrome|respiratory distress syndrome
81211|NCT03058666|RDS|rds
81212|NCT03058666|Premature|premature
81213|NCT03058666|Neonates|neonates
81214|NCT03058614|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
81215|NCT03058614|Percutaneous nephrolithotomy|percutaneous nephrolithotomy
81216|NCT03058575|Microbiome|microbiome
81217|NCT03058575|Gut|gut
81218|NCT03058575|Skin|skin
81219|NCT03058575|Fiber|fiber
81220|NCT03058575|Starch|starch
81221|NCT03058549|Expectant parents|expectant parents
81222|NCT03058549|Relationship education|relationship education
81223|NCT03058536|twin short cervix pessary progesterone preterm birth|twin short cervix pessary progesterone preterm birth
81224|NCT03058523|Flavour|flavour
81225|NCT03058523|Infants|infants
81226|NCT03058523|Taste|taste
81227|NCT03058523|Pregnancy|pregnancy
81228|NCT03058523|Programming|programming
81229|NCT03058523|Fruit|fruit
81230|NCT03058523|Vegetables|vegetables
81231|NCT03058523|Bitter profile|bitter profile
81232|NCT03058523|Food preferences|food preferences
81233|NCT03058510|bifurcation lesion|bifurcation lesion
81234|NCT03058510|atherectomy|atherectomy
81235|NCT03058510|calcification|calcification
81236|NCT03058510|stent|stent
81237|NCT03058445|Central venous catheter|central venous catheter
81238|NCT03058445|MMode echocardiography|mmode echocardiography
81239|NCT03058406|Sarcoma, Soft Tissue|sarcoma, soft tissue
81240|NCT03058406|Halaven Injection|halaven injection
81241|NCT03058406|E7389|e7389
81242|NCT03058341|postoperative pain|postoperative pain
81243|NCT03058341|propofol|propofol
81244|NCT03058341|TIVA|tiva
81245|NCT03058328|Inflammation/physiopathology, Immune System/immunology,|inflammation/physiopathology, immune system/immunology,
81246|NCT03058328|Neuroimmunomodulation/physiology, General Surgery|neuroimmunomodulation/physiology, general surgery
81247|NCT03058328|Heart Rate/physiology*Vagus Nerve/physiology*|heart rate/physiology*vagus nerve/physiology*
81248|NCT03058315|Physical activity|physical activity
81249|NCT03058315|Disease perception|disease perception
81250|NCT03058315|Pain beliefs|pain beliefs
81251|NCT03058315|Disability|disability
81252|NCT03058315|Advice|advice
81253|NCT03058289|Neoplasm|neoplasm
81254|NCT03058289|Malignancy|malignancy
81255|NCT03058289|Intratumoral|intratumoral
81256|NCT03058289|Intralesional|intralesional
81257|NCT03058289|anti-PD-1 antibodies|anti-pd-1 antibodies
81258|NCT03058289|Immuno therapy|immuno therapy
81259|NCT03058289|Dose escalation|dose escalation
81260|NCT03058289|Platinum|platinum
81261|NCT03058289|Intensity Therapeutics|intensity therapeutics
81262|NCT03058289|INT230-6|int230-6
81263|NCT03058289|cisplatin|cisplatin
81264|NCT03058289|vinblastine|vinblastine
81265|NCT03058289|PD-1|pd-1
81266|NCT03058276|rTMS|rtms
81268|NCT03058276|Alcohol-Dependence|alcohol-dependence
81269|NCT03058276|Relapses|relapses
81270|NCT03058224|Pain, Symptom Severity|pain, symptom severity
81271|NCT03058224|Immunoglobulin IgY|immunoglobulin igy
81272|NCT03058224|Fibromyalgia|fibromyalgia
81273|NCT03058224|Widespread Pain Index|widespread pain index
81274|NCT03058224|Eggyolk|eggyolk
81275|NCT03058224|FIQ-R|fiq-r
81276|NCT03058224|SF-36v2TM|sf-36v2tm
81277|NCT03058224|MOS-SS|mos-ss
81278|NCT03058224|FSS|fss
81279|NCT03058224|PGIC|pgic
81280|NCT03058224|Quality of life|quality of life
81281|NCT03058211|Pneumococcal pneumonia|pneumococcal pneumonia
81282|NCT03058211|Acute cardiovascular events|acute cardiovascular events
81283|NCT03058198|Glioma|glioma
81284|NCT03058198|PET|pet
81285|NCT03058198|EGFR vIII|egfr viii
81286|NCT03058198|Multimodal neuronavigation|multimodal neuronavigation
81287|NCT03058198|Molecular pathology|molecular pathology
81288|NCT03058198|PET-CT|pet-ct
81289|NCT03058198|Neuronavigation|neuronavigation
81290|NCT03058185|Lamin A/C|lamin a/c
81291|NCT03058185|Emerin|emerin
81292|NCT03058146|Exercise|exercise
81293|NCT03058146|Fitness|fitness
81294|NCT03058146|Physical Activity|physical activity
81295|NCT03058146|Cognitive Aging|cognitive aging
81296|NCT03058146|Cerebral Blood Flow|cerebral blood flow
81297|NCT03058146|Brain Imaging|brain imaging
81298|NCT03058146|Unsupervised Intervention|unsupervised intervention
81299|NCT03058146|Mobile Health|mobile health
81300|NCT03058146|Free-living exercise intervention|free-living exercise intervention
81301|NCT03058133|fMRI, perception, face-voice processing|fmri, perception, face-voice processing
81302|NCT03058107|Nutrition Therapy|nutrition therapy
81303|NCT03058081|COPD|copd
81304|NCT03058081|Exercise|exercise
81305|NCT03058081|High Flow Nasal|high flow nasal
81306|NCT03058081|Muscle Oxygenation|muscle oxygenation
81307|NCT03058081|Pulmonary Rehabilitation|pulmonary rehabilitation
81308|NCT03058042|Urinary Incontinence, Stress|urinary incontinence, stress
81309|NCT03058042|Pelvic Floor; Exercise|pelvic floor; exercise
81310|NCT03058042|Physical Therapy Modalities|physical therapy modalities
81311|NCT03058003|balance, postural|balance, postural
81312|NCT03058003|postural equilibrium|postural equilibrium
81313|NCT03058003|chronic pain|chronic pain
81314|NCT03058003|Chronic nonspecific low back pain|chronic nonspecific low back pain
81315|NCT03058003|Fibromyalgia|fibromyalgia
81316|NCT03058003|Cervicogenic headache|cervicogenic headache
81317|NCT03058003|Chronic tension type headache|chronic tension type headache
81318|NCT03058003|Irritable bowel syndrome|irritable bowel syndrome
81319|NCT03058003|Whiplash associated disorder|whiplash associated disorder
81320|NCT03058003|Temporomandibular disorder|temporomandibular disorder
81321|NCT03057990|Pyrimethamine|pyrimethamine
81322|NCT03057990|Myelodysplastic Syndromes (MDS)|myelodysplastic syndromes (mds)
81323|NCT03057990|Refractory|refractory
81324|NCT03057990|Relapsed|relapsed
81325|NCT03057938|Alzheimer|alzheimer
81326|NCT03057938|Subjective Cognitive Decline|subjective cognitive decline
81327|NCT03057938|Florbetaben|florbetaben
81328|NCT03057925|thyroid nodule|thyroid nodule
81329|NCT03057925|microwave ablation|microwave ablation
81330|NCT03057912|Cervical intraepithelial neoplasiaⅠ|cervical intraepithelial neoplasiaⅰ
81331|NCT03057912|TALEN|talen
81332|NCT03057912|CRISPR/Cas9|crispr/cas9
81333|NCT03057899|Herbal medicine|herbal medicine
81334|NCT03057899|phytotherapy|phytotherapy
81335|NCT03057899|testosterone|testosterone
81336|NCT03057873|protein|protein
81337|NCT03057873|fiber|fiber
81338|NCT03057873|weight loss|weight loss
81339|NCT03057873|fat loss|fat loss
81340|NCT03057821|hydrogen peroxide|hydrogen peroxide
81341|NCT03057821|Propionibacterium Acnes|propionibacterium acnes
81342|NCT03057821|shoulder arthroplasty|shoulder arthroplasty
81343|NCT03057808|Pregnancy|pregnancy
81344|NCT03057808|Postpartum|postpartum
81345|NCT03057782|Pain|pain
81346|NCT03057782|Sedation|sedation
81347|NCT03057782|Surgery|surgery
81348|NCT03057769|ERCP, post-ERCP pancreatitis, indomethacin, epinephrine|ercp, post-ercp pancreatitis, indomethacin, epinephrine
81349|NCT03057756|Multi-drug Resistant Tuberculosis|multi-drug resistant tuberculosis
81350|NCT03057756|short course regimen protocol|short course regimen protocol
81351|NCT03057730|acellular dermal matrix|acellular dermal matrix
81352|NCT03057704|Propofol|propofol
81353|NCT03057704|lidocaine|lidocaine
81354|NCT03057704|pain|pain
81355|NCT03057691|Acute Coronary Syndrome|acute coronary syndrome
81356|NCT03057691|Major Depressive Disorder|major depressive disorder
81357|NCT03057691|Generalized Anxiety Disorder|generalized anxiety disorder
81358|NCT03057691|Percutaneous Coronary Intervention|percutaneous coronary intervention
81359|NCT03057691|Major Adverse Cardiovascular Events|major adverse cardiovascular events
81360|NCT03057613|radiation|radiation
81361|NCT03057613|resected|resected
81362|NCT03057600|African ancestry|african ancestry
81363|NCT03057600|African American|african american
81364|NCT03057600|CB-839|cb-839
81365|NCT03057600|Glutaminase Inhibitor|glutaminase inhibitor
81366|NCT03057600|Glutaminase|glutaminase
81367|NCT03057600|TNBC|tnbc
81368|NCT03057600|Tumor Metabolism|tumor metabolism
81369|NCT03057600|Glutamine|glutamine
81370|NCT03057561|CAD|cad
81371|NCT03057548|Atrial Fibrillation|atrial fibrillation
81372|NCT03057548|Long-Standing Atrial Fibrillation|long-standing atrial fibrillation
81373|NCT03057548|Posterior Left Atrial Wall Ablation|posterior left atrial wall ablation
81374|NCT03057535|Exercise|exercise
81375|NCT03057535|Sodium Bicarbonate|sodium bicarbonate
81376|NCT03057535|Ventilatory equivalent for carbon dioxide|ventilatory equivalent for carbon dioxide
81377|NCT03057522|Run|run
81378|NCT03057522|Cadence|cadence
81379|NCT03057522|Home exercise|home exercise
81380|NCT03057509|Carcinoid Tumors|carcinoid tumors
81381|NCT03057470|Diabetes|diabetes
81382|NCT03057470|Exercise|exercise
81383|NCT03057470|Insulin|insulin
81384|NCT03057444|resistant starch type III|resistant starch type iii
81385|NCT03057444|butyrate-producing gut bacteria|butyrate-producing gut bacteria
81386|NCT03057444|diabetes mellitus type 2|diabetes mellitus type 2
81387|NCT03057444|prediabetes|prediabetes
81388|NCT03057431|kidney stones|kidney stones
81389|NCT03057431|hydrochlorothiazide|hydrochlorothiazide
81390|NCT03057405|intra-operative navigation|intra-operative navigation
81391|NCT03057405|3D virtual planning|3d virtual planning
81392|NCT03057405|intra-operative cone beam computed tomography (CBCT)|intra-operative cone beam computed tomography (cbct)
81393|NCT03057392|immersion|immersion
81394|NCT03057392|ultrafiltration|ultrafiltration
81395|NCT03057392|dialysis|dialysis
81396|NCT03057379|HPV vaccine|hpv vaccine
81397|NCT03057379|Immunization registry|immunization registry
81398|NCT03057379|Reminder recall|reminder recall
81399|NCT03057366|Drug therapy|drug therapy
81400|NCT03057340|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
81401|NCT03057340|Dribbles|dribbles
81402|NCT03057275|Threatened Premature Labor|threatened premature labor
81403|NCT03057275|Abdominal Fetal ECG|abdominal fetal ecg
81404|NCT03057262|temporomandibular joint disorders|temporomandibular joint disorders
81405|NCT03057262|disc displacement with reduction|disc displacement with reduction
81406|NCT03057262|anterior repositioning splint|anterior repositioning splint
81407|NCT03057249|Surgery|surgery
81408|NCT03057249|Thermography|thermography
81409|NCT03057249|Perfusion|perfusion
81410|NCT03057249|Imaging|imaging
81411|NCT03057236|psychological, behavioral, psychosocial, antiviral, liver|psychological, behavioral, psychosocial, antiviral, liver
81412|NCT03057223|3D printing|3d printing
81413|NCT03057223|patient-specific titanium plate|patient-specific titanium plate
81414|NCT03057223|mandibular malignancy|mandibular malignancy
81415|NCT03057223|dento-maxillofacial deformity|dento-maxillofacial deformity
81416|NCT03057223|orthognathic surgery|orthognathic surgery
81417|NCT03057223|mandibular reconstruction|mandibular reconstruction
81418|NCT03057210|Exercise|exercise
81419|NCT03057210|Massage|massage
81420|NCT03057210|Post-exercise recovery|post-exercise recovery
81421|NCT03057210|Athletic performance|athletic performance
81422|NCT03057184|Adult Day Care Center|adult day care center
81423|NCT03057184|behavioral problems|behavioral problems
81424|NCT03057184|caregivers|caregivers
81425|NCT03057171|Helicobacter pylori|helicobacter pylori
81426|NCT03057171|long non-coding RNA|long non-coding rna
81427|NCT03057171|THRIL|thril
81428|NCT03057171|PACER|pacer
81429|NCT03057171|cagA|caga
81430|NCT03057158|OAB|oab
81431|NCT03057158|Insulin resistance|insulin resistance
81432|NCT03057158|diabetes|diabetes
81433|NCT03057158|pre-diabetes|pre-diabetes
81434|NCT03057145|Solid Tumor|solid tumor
81435|NCT03057093|NSTEMI, ECG|nstemi, ecg
81436|NCT03057067|Embolization, Therapeutic|embolization, therapeutic
81437|NCT03057067|Pelvis|pelvis
81438|NCT03056976|Overdenture|overdenture
81439|NCT03056976|Dental implant|dental implant
81440|NCT03056976|Complete denture|complete denture
81441|NCT03056976|Cost analysis|cost analysis
81442|NCT03056963|Guided Imagery|guided imagery
81443|NCT03056950|Blood Flow Restriciton|blood flow restriciton
81444|NCT03056950|Occlusion training|occlusion training
81445|NCT03056950|Distal radius fracture|distal radius fracture
81446|NCT03056911|ozone therapy|ozone therapy
81447|NCT03056911|percutaneous treatment|percutaneous treatment
81448|NCT03056911|Oswestry Disability Index (ODI)|oswestry disability index (odi)
81449|NCT03056911|Visual analog Scale (VAS)|visual analog scale (vas)
81450|NCT03056911|Neuropathic Pain Questionnaire (DN-4)|neuropathic pain questionnaire (dn-4)
81451|NCT03056911|cervical|cervical
81452|NCT03056898|eicosapentaenoic acid|eicosapentaenoic acid
81453|NCT03056898|EPA|epa
81454|NCT03056898|docosahexaenoic acid|docosahexaenoic acid
81455|NCT03056898|DHA|dha
81456|NCT03056898|omega-3 index|omega-3 index
81457|NCT03056885|one-lung ventilation|one-lung ventilation
81458|NCT03056885|broncho-alveolar lavage|broncho-alveolar lavage
81459|NCT03056885|protective ventilation|protective ventilation
81460|NCT03056885|cytokines|cytokines
81461|NCT03056885|thoracic surgery|thoracic surgery
81462|NCT03056859|Operator satisfaction with device|operator satisfaction with device
81463|NCT03056846|probiotic|probiotic
81464|NCT03056846|gastrointestinal|gastrointestinal
81465|NCT03056846|stress|stress
81466|NCT03056846|student|student
81467|NCT03056820|tracheal intubation|tracheal intubation
81468|NCT03056807|tolerable apneic time|tolerable apneic time
81469|NCT03056807|bariatric surgery|bariatric surgery
81470|NCT03056807|gastric band surgery|gastric band surgery
81471|NCT03056807|intubation|intubation
81472|NCT03056794|pyruvate|pyruvate
81473|NCT03056794|pyruvate dehydrogenase|pyruvate dehydrogenase
81474|NCT03056794|PDC|pdc
81475|NCT03056794|PDCD|pdcd
81476|NCT03056755|advanced breast cancer|advanced breast cancer
81477|NCT03056755|PIK3CA|pik3ca
81478|NCT03056755|CDK 4/6 inhibitor|cdk 4/6 inhibitor
81479|NCT03056755|fulvestrant|fulvestrant
81480|NCT03056755|letrozole|letrozole
81481|NCT03056755|HR+|hr+
81482|NCT03056755|HER-negative|her-negative
81483|NCT03056755|post menopausal|post menopausal
81484|NCT03056755|pre-menopausal|pre-menopausal
81485|NCT03056716|thoracic surgery|thoracic surgery
81486|NCT03056716|silastic drains|silastic drains
81487|NCT03056716|conventional drains|conventional drains
81488|NCT03056690|ASP0819|asp0819
81489|NCT03056690|Fibromyalgia|fibromyalgia
81490|NCT03056677|Whey protein|whey protein
81491|NCT03056677|Dietary supplementation|dietary supplementation
81492|NCT03056677|Glucose|glucose
81493|NCT03056677|GLP-1|glp-1
81494|NCT03056677|Satiety|satiety
81495|NCT03056651|heart failure|heart failure
81496|NCT03056651|day care|day care
81497|NCT03056651|prognosis|prognosis
81498|NCT03056638|Androgen Deprivation Therapy|androgen deprivation therapy
81499|NCT03056638|Ultra-Hypofractionated SBRT|ultra-hypofractionated sbrt
81500|NCT03056638|16-1686|16-1686
81501|NCT03056625|fortified rice|fortified rice
81502|NCT03056625|lactating women|lactating women
81503|NCT03056625|13C2-retinol isotope dilution|13c2-retinol isotope dilution
81504|NCT03056625|vitamin A liver store|vitamin a liver store
81505|NCT03056599|in vivo drug sensitivity|in vivo drug sensitivity
81506|NCT03056599|personalized medicine|personalized medicine
81507|NCT03056599|precision oncology|precision oncology
81508|NCT03056599|in vivo oncology|in vivo oncology
81509|NCT03056599|soft tissue sarcoma|soft tissue sarcoma
81510|NCT03056599|chemotherapy|chemotherapy
81511|NCT03056599|microinjection|microinjection
81512|NCT03056599|microdosing|microdosing
81513|NCT03056573|TAVI|tavi
81514|NCT03056573|Valvular heart disease|valvular heart disease
81515|NCT03056573|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
81516|NCT03056534|Primary Total Hip Arthroplasty|primary total hip arthroplasty
81517|NCT03056534|Non-Inflammatory Arthritis|non-inflammatory arthritis
81518|NCT03056534|Degenerative Joint Disease|degenerative joint disease
81519|NCT03056534|R3 Delta Ceramic Acetabular Insert|r3 delta ceramic acetabular insert
81520|NCT03056508|diet|diet
81521|NCT03056508|nutrition|nutrition
81522|NCT03056508|aerobic exercise|aerobic exercise
81523|NCT03056508|cognition|cognition
81524|NCT03056508|grey matter|grey matter
81525|NCT03056508|cerebral blood flow|cerebral blood flow
81526|NCT03056508|neural activity|neural activity
81527|NCT03056508|resting state connectivity|resting state connectivity
81528|NCT03056482|cannabis|cannabis
81529|NCT03056482|haloperidol|haloperidol
81530|NCT03056482|ondansetron|ondansetron
81531|NCT03056482|hyperemesis|hyperemesis
81532|NCT03056482|cyclic vomiting syndrome|cyclic vomiting syndrome
81533|NCT03056469|patient-reported outcomes|patient-reported outcomes
81534|NCT03056469|supportive care|supportive care
81535|NCT03056469|clinical practice|clinical practice
81536|NCT03056469|hematological cancer|hematological cancer
81537|NCT03056430|MRI, Neuroplasticity, Balance, Spatial orientation, Hippocampus, Slacklining|mri, neuroplasticity, balance, spatial orientation, hippocampus, slacklining
81538|NCT03056417|chronic pain|chronic pain
81539|NCT03056417|telomere|telomere
81540|NCT03056417|telomerase|telomerase
81541|NCT03056417|life style|life style
81542|NCT03056391|knowlesi malaria|knowlesi malaria
81543|NCT03056391|paracetamol|paracetamol
81544|NCT03056391|renal function|renal function
81545|NCT03056391|haemolysis|haemolysis
81546|NCT03056391|oxidative stress|oxidative stress
81547|NCT03056365|Detoxification|detoxification
81548|NCT03056365|Outpatient|outpatient
81549|NCT03056365|Advanced Nursing|advanced nursing
81550|NCT03056365|Health Services|health services
81551|NCT03056339|B-Lymphoid Malignancies|b-lymphoid malignancies
81552|NCT03056339|Relapsed/Refractory|relapsed/refractory
81553|NCT03056339|Acute lymphocytic leukemia|acute lymphocytic leukemia
81555|NCT03056339|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
81556|NCT03056339|CLL|cll
81557|NCT03056339|Non-Hodgkin lymphoma|non-hodgkin lymphoma
81558|NCT03056339|NHL|nhl
81559|NCT03056339|(CAR).CD19-CD28-zeta-2A-iCasp9-IL15-transduced cord blood natural killer cells|(car).cd19-cd28-zeta-2a-icasp9-il15-transduced cord blood natural killer cells
81560|NCT03056339|CB-NK cells|cb-nk cells
81561|NCT03056339|Fludarabine|fludarabine
81562|NCT03056339|Fludarabine phosphate|fludarabine phosphate
81563|NCT03056339|Fludara|fludara
81564|NCT03056339|Cyclophosphamide|cyclophosphamide
81565|NCT03056339|Cytoxan|cytoxan
81566|NCT03056339|Neosar|neosar
81567|NCT03056339|AP1903|ap1903
81568|NCT03056339|Mesna|mesna
81569|NCT03056339|Mesnex|mesnex
81570|NCT03056313|Delivery, Obstetric|delivery, obstetric
81571|NCT03056313|Uterine Contraction|uterine contraction
81572|NCT03056313|Cervix Uteri|cervix uteri
81573|NCT03056274|Metformin|metformin
81574|NCT03056274|Ursodeoxycholic acid|ursodeoxycholic acid
81575|NCT03056274|Outcomes|outcomes
81576|NCT03056261|Combined general-epidural anesthesia intestinal recovery|combined general-epidural anesthesia intestinal recovery
81577|NCT03056235|Atrophic acne scar|atrophic acne scar
81578|NCT03056209|Mitochondrial DNA tRNALeu(UUR) m.3243A<G Mutation|mitochondrial dna trnaleu(uur) m.3243a<g mutation
81579|NCT03056157|Moral Injury|moral injury
81580|NCT03056157|Post-traumatic Stress Disorder|post-traumatic stress disorder
81581|NCT03056157|Traumatic Loss|traumatic loss
81582|NCT03056157|Adaptive Disclosure|adaptive disclosure
81583|NCT03056157|Veterans|veterans
81584|NCT03056144|spinal muscular atrophy|spinal muscular atrophy
81585|NCT03056144|total body vibration|total body vibration
81586|NCT03056144|children|children
81587|NCT03056118|OPTIMA-C|optima-c
81588|NCT03056105|Well-being, affiliation, inflammation|well-being, affiliation, inflammation
81589|NCT03056092|ranibizumab|ranibizumab
81590|NCT03056092|aqueous cytokine|aqueous cytokine
81591|NCT03056092|age related macular degeneration|age related macular degeneration
81592|NCT03056092|diabetic macular edema|diabetic macular edema
81593|NCT03056092|retinal vein occlusion|retinal vein occlusion
81594|NCT03056079|neovascular age related macular degeneration|neovascular age related macular degeneration
81595|NCT03056079|diabetic macular edema|diabetic macular edema
81596|NCT03056079|retinal vein occlusion|retinal vein occlusion
81597|NCT03056079|aflibercept|aflibercept
81598|NCT03056079|aqueous humor cytokine|aqueous humor cytokine
81599|NCT03056053|insomnia|insomnia
81600|NCT03055975|Bacteria|bacteria
81601|NCT03055975|Root canal treatment|root canal treatment
81602|NCT03055975|Endodontics|endodontics
81603|NCT03055962|Healthy Participants|healthy participants
81604|NCT03055962|E2609|e2609
81605|NCT03055962|Pharmacokinetics|pharmacokinetics
81606|NCT03055962|Japan|japan
81607|NCT03055949|early rehabilitation|early rehabilitation
81608|NCT03055949|early mobilization|early mobilization
81609|NCT03055949|surgical intensive care unit|surgical intensive care unit
81610|NCT03055884|transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
81611|NCT03055884|accelerated learning|accelerated learning
81612|NCT03055884|memory|memory
81613|NCT03055871|Behavioural: Family physical activity habit|behavioural: family physical activity habit
81614|NCT03055858|PDA, ADO II AS|pda, ado ii as
81615|NCT03055819|Brow Lift|brow lift
81616|NCT03055819|Brow Ptosis|brow ptosis
81617|NCT03055806|Sex|sex
81618|NCT03055806|Sexual Dysfunction|sexual dysfunction
81619|NCT03055806|IX-01|ix-01
81620|NCT03055741|Alzheimer's disease|alzheimer's disease
81621|NCT03055728|streptococcal infections|streptococcal infections
81622|NCT03055728|rapid strep testing|rapid strep testing
81623|NCT03055728|rapid antigen detection test|rapid antigen detection test
81624|NCT03055715|NSCLC|nsclc
81625|NCT03055715|Radiotherapy|radiotherapy
81626|NCT03055715|young DEGRO|young degro
81627|NCT03055715|tumor volume|tumor volume
81628|NCT03055715|lung cancer|lung cancer
81629|NCT03055715|radiochemotherapy|radiochemotherapy
81630|NCT03055715|prognostic factors|prognostic factors
81631|NCT03055702|Short Message Service|short message service
81632|NCT03055702|appointment reminder|appointment reminder
81633|NCT03055702|Attendance rate|attendance rate
81634|NCT03055689|Colonoscopy|colonoscopy
81635|NCT03055689|Educational intervention|educational intervention
81636|NCT03055676|Pancreaticoduodenectomy|pancreaticoduodenectomy
81637|NCT03055676|Time of drain removal|time of drain removal
81638|NCT03055624|prostate artery embolization (PAE)|prostate artery embolization (pae)
81639|NCT03055624|benign prostatic hyperplasia (BPH)|benign prostatic hyperplasia (bph)
81640|NCT03055624|lower urinary tract symptoms (LUTS)|lower urinary tract symptoms (luts)
81641|NCT03055611|Blood Coagulation Disorder|blood coagulation disorder
81642|NCT03055611|Hematologic Diseases|hematologic diseases
81643|NCT03055611|Coagulation Protein Disorder|coagulation protein disorder
81644|NCT03055611|Hemorrhagic Disorder|hemorrhagic disorder
81645|NCT03055611|Genetic Diseases, Inborn|genetic diseases, inborn
81646|NCT03055585|Wolbachia; Aedes aegypti; Indonesia; Dengue; Cluster-randomised trial|wolbachia; aedes aegypti; indonesia; dengue; cluster-randomised trial
81647|NCT03055572|Rhinitis|rhinitis
81648|NCT03055572|Chronic Rhinosinusitis|chronic rhinosinusitis
81649|NCT03055572|Olfactory Training|olfactory training
81650|NCT03055559|Iron, Hemoglobin, Feritin, erytrocyty. transferin|iron, hemoglobin, feritin, erytrocyty. transferin
81651|NCT03055546|oxytocin|oxytocin
81652|NCT03055546|emotion regulation|emotion regulation
81653|NCT03055533|Behavioral|behavioral
81655|NCT03055533|Headsprout reading program|headsprout reading program
81656|NCT03055520|schizophrenia|schizophrenia
81657|NCT03055520|cognition|cognition
81658|NCT03055520|arithmetic training|arithmetic training
81659|NCT03055520|Kumon method|kumon method
81660|NCT03055481|neonatal jaundice|neonatal jaundice
81661|NCT03055481|phototherapy|phototherapy
81662|NCT03055481|neonate|neonate
81663|NCT03055429|Prisoners|prisoners
81664|NCT03055429|End-of-life care|end-of-life care
81665|NCT03055429|Geriatric care|geriatric care
81666|NCT03055429|Palliative care|palliative care
81667|NCT03055429|Hospice care|hospice care
81668|NCT03055416|Overweight|overweight
81669|NCT03055416|Obesity|obesity
81670|NCT03055416|Physical Activity|physical activity
81671|NCT03055416|African-American Men|african-american men
81672|NCT03055416|mHealth|mhealth
81673|NCT03055416|Mobile Health|mobile health
81674|NCT03055390|hyoscine butylbromide|hyoscine butylbromide
81675|NCT03055390|progress of labor|progress of labor
81676|NCT03055390|duration of labor|duration of labor
81677|NCT03055377|cannabis|cannabis
81678|NCT03055377|marijuana|marijuana
81679|NCT03055377|youth|youth
81680|NCT03055377|adolescent|adolescent
81681|NCT03055377|pharmacotherapy|pharmacotherapy
81682|NCT03055377|medication|medication
81683|NCT03055377|n-acetylcysteine|n-acetylcysteine
81684|NCT03055377|trial|trial
81685|NCT03055351|Exercise motivation|exercise motivation
81686|NCT03055351|Psychological well-being|psychological well-being
81687|NCT03055351|Healthy living|healthy living
81688|NCT03055351|Physical activity|physical activity
81689|NCT03055351|Autonomy support|autonomy support
81690|NCT03055351|Self-determination theory|self-determination theory
81691|NCT03055338|Schizophrenia, acute episode|schizophrenia, acute episode
81692|NCT03055338|Schizophrenia Spectrum and Other Psychotic Disorders|schizophrenia spectrum and other psychotic disorders
81693|NCT03055338|Mental Disorders|mental disorders
81694|NCT03055247|Chronic granulomatous disease X-linked|chronic granulomatous disease x-linked
81695|NCT03055247|Ibuprofen|ibuprofen
81696|NCT03055247|Mobilization regimen|mobilization regimen
81697|NCT03055247|Gene Therapy|gene therapy
81698|NCT03055234|Oral treprostinil|oral treprostinil
81699|NCT03055234|6-Minute Walk Distance|6-minute walk distance
81700|NCT03055234|PH|ph
81701|NCT03055234|sickle cell|sickle cell
81702|NCT03055221|Remodulin|remodulin
81703|NCT03055221|6-Minute Walk Test|6-minute walk test
81704|NCT03055208|Glioblastoma|glioblastoma
81705|NCT03055208|Radiosurgery|radiosurgery
81706|NCT03055208|Gamma Knife|gamma knife
81707|NCT03055195|subcutaneous|subcutaneous
81708|NCT03055195|safety|safety
81709|NCT03055195|mepolizumab|mepolizumab
81710|NCT03055195|efficacy|efficacy
81711|NCT03055195|atopic dermatitis|atopic dermatitis
81712|NCT03055182|Isokinetic|isokinetic
81713|NCT03055182|oxygenation|oxygenation
81714|NCT03055182|deoxygenation|deoxygenation
81715|NCT03055182|aerobic metabolism|aerobic metabolism
81716|NCT03055169|hyperglycemia|hyperglycemia
81717|NCT03055169|Multiple Organ Failure|multiple organ failure
81718|NCT03055169|biobank|biobank
81719|NCT03055169|diabetes|diabetes
81720|NCT03055156|Sleep Apnea|sleep apnea
81721|NCT03055156|Insomnia|insomnia
81722|NCT03055156|sleep disorders|sleep disorders
81723|NCT03055156|sleep environment|sleep environment
81724|NCT03055156|core body temperature|core body temperature
81725|NCT03055117|Shoulder pain|shoulder pain
81726|NCT03055117|Physiotherapy|physiotherapy
81727|NCT03055117|Rehabilitation|rehabilitation
81728|NCT03055117|Exercise|exercise
81729|NCT03055104|severe malnutrition|severe malnutrition
81730|NCT03055104|Critically Ill|critically ill
81731|NCT03055104|refeeding syndrome|refeeding syndrome
81732|NCT03055104|guideline|guideline
81733|NCT03055065|Adenoviral conjunctivitis diagnosed with AdenoPlus™ Test|adenoviral conjunctivitis diagnosed with adenoplus™ test
81734|NCT03055000|Mosquito-Borne Diseases|mosquito-borne diseases
81735|NCT03055000|Universal Mosquito Vaccine|universal mosquito vaccine
81736|NCT03055000|Mosquito Transmission|mosquito transmission
81737|NCT03055000|Vector Borne Viruses|vector borne viruses
81738|NCT03055000|Vaccine|vaccine
81739|NCT03054974|Stroke|stroke
81740|NCT03054974|Traditional Chinese Medicine|traditional chinese medicine
81741|NCT03054974|Rehabilitation|rehabilitation
81742|NCT03054961|epilepsy|epilepsy
81743|NCT03054961|cytochrome oxidase redox state|cytochrome oxidase redox state
81744|NCT03054961|childhood epilepsy|childhood epilepsy
81745|NCT03054961|partial epilepsy|partial epilepsy
81746|NCT03054961|NIRS|nirs
81747|NCT03054961|near-infrared spectroscopy|near-infrared spectroscopy
81748|NCT03054961|regional cerebral oxygen saturation|regional cerebral oxygen saturation
81749|NCT03054935|Energy Expenditure|energy expenditure
81750|NCT03054935|Body Composition|body composition
81751|NCT03054935|Food Intake|food intake
81752|NCT03054896|Richter Syndrome|richter syndrome
81753|NCT03054883|Mantle Cell Lymphoma|mantle cell lymphoma
81754|NCT03054883|minimal residual disease|minimal residual disease
81755|NCT03054883|cytosine arabinoside|cytosine arabinoside
81756|NCT03054870|pulmonary ventilation|pulmonary ventilation
81757|NCT03054870|ventilation scintigraphy|ventilation scintigraphy
81758|NCT03054844|Intranasal|intranasal
81759|NCT03054844|Pain|pain
81760|NCT03054844|Lidocaine|lidocaine
81761|NCT03054844|Midazolam|midazolam
81762|NCT03054844|Emergency department|emergency department
81763|NCT03054766|Laser Photocoagulation|laser photocoagulation
81764|NCT03054766|Ranibizumab|ranibizumab
81765|NCT03054766|Branch Retinal Vein Occlusion|branch retinal vein occlusion
81766|NCT03054766|Vascular Endothecial Growth Factor|vascular endothecial growth factor
81767|NCT03054753|Abduction brace|abduction brace
81768|NCT03054753|Compliance|compliance
81769|NCT03054753|Rotator cuff tear|rotator cuff tear
81770|NCT03054753|Rotator cuff repair|rotator cuff repair
81771|NCT03054740|Vapocoolant applied prior to IV access|vapocoolant applied prior to iv access
81772|NCT03054727|Post Thrombotic Syndrome|post thrombotic syndrome
81773|NCT03054727|Venous Thromboembolism|venous thromboembolism
81774|NCT03054727|Incidence|incidence
81775|NCT03054727|Risk factors|risk factors
81776|NCT03054727|Venous ulcer|venous ulcer
81777|NCT03054701|Patellofemoral pain|patellofemoral pain
81779|NCT03054701|PFPS|pfps
81780|NCT03054675|lung resection|lung resection
81781|NCT03054675|lung function|lung function
81782|NCT03054675|VATS|vats
81783|NCT03054675|Thoracotomy|thoracotomy
81784|NCT03054662|Haemophilia|haemophilia
81785|NCT03054610|plantar fascitis|plantar fascitis
81786|NCT03054610|Botulinum toxin A|botulinum toxin a
81787|NCT03054610|Betamethason Sodium Phosphate|betamethason sodium phosphate
81788|NCT03054610|infiltration|infiltration
81789|NCT03054610|plantar fascia|plantar fascia
81790|NCT03054558|Junctional zone|junctional zone
81791|NCT03054558|recurrent pregnancy loss|recurrent pregnancy loss
81792|NCT03054558|3D power Doppler|3d power doppler
81793|NCT03054480|Fractional Micro-Needle Radiofrequency|fractional micro-needle radiofrequency
81794|NCT03054480|Intradermal Botulinum Toxin A|intradermal botulinum toxin a
81795|NCT03054441|Upper limb|upper limb
81796|NCT03054441|Inertial sensors|inertial sensors
81797|NCT03054415|neuronal-glial-epithelial unit, anorectal function|neuronal-glial-epithelial unit, anorectal function
81798|NCT03054376|Immobilization|immobilization
81799|NCT03054376|Angiogenesis|angiogenesis
81800|NCT03054376|Skeletal muscle|skeletal muscle
81801|NCT03054376|Exercise training|exercise training
81802|NCT03054376|Vascular function|vascular function
81803|NCT03054363|Metastatic Breast Cancer|metastatic breast cancer
81804|NCT03054363|Tucatinib|tucatinib
81805|NCT03054363|Palbociclib|palbociclib
81806|NCT03054363|Letrozole|letrozole
81807|NCT03054363|HR-positive|hr-positive
81808|NCT03054363|HER2-positive|her2-positive
81809|NCT03054363|ER-positive|er-positive
81810|NCT03054363|PR-positive|pr-positive
81811|NCT03054363|HER2-targeted therapy|her2-targeted therapy
81812|NCT03054363|CDK4/6 inhibitor|cdk4/6 inhibitor
81813|NCT03054363|ONT-380|ont-380
81814|NCT03054363|Ibrance|ibrance
81815|NCT03054350|Anemia|anemia
81816|NCT03054350|kidney|kidney
81817|NCT03054350|dialysis-dependent chronic kidney disease|dialysis-dependent chronic kidney disease
81818|NCT03054350|CKD|ckd
81819|NCT03054350|DD-CKD|dd-ckd
81820|NCT03054350|renal|renal
81821|NCT03054350|vadadustat|vadadustat
81822|NCT03054350|AKB-6548|akb-6548
81823|NCT03054350|hypoxia-inducible factor|hypoxia-inducible factor
81824|NCT03054350|HIF|hif
81825|NCT03054350|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
81826|NCT03054350|HIF-PHI|hif-phi
81827|NCT03054350|Japan|japan
81828|NCT03054350|Japanese|japanese
81829|NCT03054337|Anemia|anemia
81830|NCT03054337|kidney|kidney
81831|NCT03054337|non-dialysis dependent chronic kidney disease|non-dialysis dependent chronic kidney disease
81832|NCT03054337|CKD|ckd
81833|NCT03054337|NDD-CKD|ndd-ckd
81834|NCT03054337|renal|renal
81835|NCT03054337|vadadustat|vadadustat
81836|NCT03054337|AKB-6548|akb-6548
81837|NCT03054337|hypoxia-inducible factor|hypoxia-inducible factor
81838|NCT03054337|HIF|hif
81839|NCT03054337|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
81840|NCT03054337|HIF-PHI|hif-phi
81841|NCT03054337|Japan|japan
81842|NCT03054337|Japanese|japanese
81843|NCT03054324|Cardiovascular Diseases|cardiovascular diseases
81844|NCT03054324|Fractional Flow Reserve|fractional flow reserve
81845|NCT03054324|Ischemic Heart Disease|ischemic heart disease
81846|NCT03054324|CT Angiogram|ct angiogram
81847|NCT03054285|Seizures|seizures
81848|NCT03054285|Traumatic Brain Injury|traumatic brain injury
81849|NCT03054285|Prophylaxis|prophylaxis
81850|NCT03054285|Levetiracetam|levetiracetam
81851|NCT03054272|High-fidelity simulation|high-fidelity simulation
81852|NCT03054272|Eye-tracking|eye-tracking
81853|NCT03054272|Difficult intubation|difficult intubation
81854|NCT03054233|spinal anesthesia|spinal anesthesia
81855|NCT03054233|spinal-bone contact|spinal-bone contact
81856|NCT03054233|caesarian section|caesarian section
81857|NCT03054233|crossed leg sitting position|crossed leg sitting position
81858|NCT03054194|Healthy participants|healthy participants
81859|NCT03054194|E2730|e2730
81860|NCT03054194|Pharmacokinetics|pharmacokinetics
81861|NCT03054181|Observational|observational
81862|NCT03054181|Infection|infection
81863|NCT03054181|Utilisation|utilisation
81864|NCT03054181|Safety|safety
81865|NCT03054181|Tolerability|tolerability
81866|NCT03054181|Infusion|infusion
81867|NCT03054181|chronic|chronic
81868|NCT03054168|Protein Synthesis|protein synthesis
81869|NCT03054168|Hypertrophy|hypertrophy
81870|NCT03054168|Testosterone|testosterone
81871|NCT03054155|hidradenitis suppurativa|hidradenitis suppurativa
81872|NCT03054155|hidradenitis|hidradenitis
81873|NCT03054155|laser|laser
81874|NCT03054103|ketamine|ketamine
81875|NCT03054103|midazolam|midazolam
81876|NCT03054103|sedation|sedation
81877|NCT03054090|Cardiovascular Diseases|cardiovascular diseases
81878|NCT03054090|Primary Care|primary care
81879|NCT03054077|pre-procedural anxiety|pre-procedural anxiety
81880|NCT03054077|children|children
81881|NCT03054077|pediatric sedation|pediatric sedation
81882|NCT03054051|HIV prevention|hiv prevention
81883|NCT03054051|Preadolescence|preadolescence
81884|NCT03054051|Mobile phone game|mobile phone game
81885|NCT03054051|Feasibility|feasibility
81886|NCT03054012|CAD-CAM software|cad-cam software
81887|NCT03054012|accuracy|accuracy
81888|NCT03054012|head and neck region|head and neck region
81889|NCT03054012|mandibular reconstruction|mandibular reconstruction
81890|NCT03053999|Multiple Endocrine Neoplasia|multiple endocrine neoplasia
81891|NCT03053999|Pancreatic Neuroendocrine Tumors|pancreatic neuroendocrine tumors
81892|NCT03053999|Hyperparathyroidism|hyperparathyroidism
81893|NCT03053999|HPTH|hpth
81894|NCT03053999|PNET|pnet
81895|NCT03053999|Biomarkers|biomarkers
81896|NCT03053999|Parathyroidectomy|parathyroidectomy
81897|NCT03053999|Genome sequencing|genome sequencing
81898|NCT03053999|Data review|data review
81899|NCT03053973|COPD|copd
81900|NCT03053973|airway inflammation|airway inflammation
81901|NCT03053973|airway remodeling|airway remodeling
81902|NCT03053973|health-related auality of life|health-related auality of life
81903|NCT03053973|forced expiratory volume 1 second|forced expiratory volume 1 second
81904|NCT03053947|Intranasal Ketamine|intranasal ketamine
81905|NCT03053947|Pain Management|pain management
81906|NCT03053934|Online counselling|online counselling
81907|NCT03053921|gingival recession|gingival recession
81908|NCT03053921|Zuchellis technique,|zuchellis technique,
81909|NCT03053921|placental membrane|placental membrane
81910|NCT03053908|Orexin|orexin
81911|NCT03053908|Core Body Temperature|core body temperature
81912|NCT03053882|mouth wash , green tea , peppermint , bad breath|mouth wash , green tea , peppermint , bad breath
81913|NCT03053856|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
81914|NCT03053856|Adjuvant pembrolizumab|adjuvant pembrolizumab
81915|NCT03053843|Atrial fibrillation|atrial fibrillation
81916|NCT03053843|Mediterranean Diet|mediterranean diet
81917|NCT03053843|Extra Virgin Olive Oil|extra virgin olive oil
81918|NCT03053843|Ablation|ablation
81919|NCT03053830|Ketamine|ketamine
81920|NCT03053830|Major Depressive Disorder|major depressive disorder
81921|NCT03053804|MR/PET|mr/pet
81922|NCT03053804|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
81923|NCT03053791|Deep brain stimulation|deep brain stimulation
81924|NCT03053791|DBS|dbs
81925|NCT03053791|Spinal cord injury|spinal cord injury
81926|NCT03053791|SCI|sci
81927|NCT03053791|Paraplegia|paraplegia
81928|NCT03053791|Mesencephalic locomotor region|mesencephalic locomotor region
81929|NCT03053791|MLR|mlr
81930|NCT03053791|Pedunculopontine nucleus|pedunculopontine nucleus
81931|NCT03053791|PPN|ppn
81932|NCT03053778|Readmission|readmission
81933|NCT03053778|Early follow-up|early follow-up
81934|NCT03053778|Heart valves|heart valves
81935|NCT03053778|Heart valve surgery|heart valve surgery
81936|NCT03053739|Systemic sclerosis, Associated Pulmonary Arterial Hypertension|systemic sclerosis, associated pulmonary arterial hypertension
81937|NCT03053726|Variable Frequency Stimulation|variable frequency stimulation
81938|NCT03053713|Mediterranean diet pattern|mediterranean diet pattern
81939|NCT03053713|nutrition|nutrition
81940|NCT03053713|diet intervention|diet intervention
81941|NCT03053713|disease activity|disease activity
81942|NCT03053713|intestinal microbiome|intestinal microbiome
81943|NCT03053713|inflammatory bowel disease|inflammatory bowel disease
81944|NCT03053700|Rosacea, Bromonidine, intensed pulse light|rosacea, bromonidine, intensed pulse light
81945|NCT03053661|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
81946|NCT03053661|cancer-specific immunity|cancer-specific immunity
81947|NCT03053661|cancer immunology|cancer immunology
81948|NCT03053661|cancer-testis antigens|cancer-testis antigens
81949|NCT03053661|human papilloma virus|human papilloma virus
81950|NCT03053661|immune modulatory cells|immune modulatory cells
81951|NCT03053648|Insomnia|insomnia
81952|NCT03053648|Randomized controlled trial|randomized controlled trial
81953|NCT03053648|Acupressure|acupressure
81954|NCT03053648|Self-help|self-help
81955|NCT03053635|Photodynamic Therapy|photodynamic therapy
81956|NCT03053635|Non-muscle invasive bladder cancer (NMIBC)|non-muscle invasive bladder cancer (nmibc)
81957|NCT03053635|Urothelial carcinoma|urothelial carcinoma
81958|NCT03053635|Ta bladder cancer|ta bladder cancer
81959|NCT03053635|T1 bladder cancer|t1 bladder cancer
81960|NCT03053635|Refractory to BCG|refractory to bcg
81961|NCT03053609|gastroesophageal reflux|gastroesophageal reflux
81962|NCT03053609|apnea|apnea
81963|NCT03053609|bradycardia|bradycardia
81964|NCT03053609|desaturation|desaturation
81965|NCT03053609|impedance|impedance
81966|NCT03053596|HCC|hcc
81967|NCT03053596|LifePearl|lifepearl
81968|NCT03053583|larynx, laryngoscopy|larynx, laryngoscopy
81969|NCT03053583|vocal cords, laryngoscopy|vocal cords, laryngoscopy
81970|NCT03053583|airway|airway
81971|NCT03053583|pediatric|pediatric
81972|NCT03053570|Cryoballoon|cryoballoon
81973|NCT03053570|Contact Force|contact force
81974|NCT03053570|Persistent Atrial Fibrillation|persistent atrial fibrillation
81975|NCT03053557|mental health consumers|mental health consumers
81976|NCT03053544|rectal cancer|rectal cancer
81977|NCT03053544|adenocarcinoma of the rectum|adenocarcinoma of the rectum
81978|NCT03053544|node positive rectal tumors|node positive rectal tumors
81979|NCT03053544|metformin|metformin
81980|NCT03053544|neoadjuvant chemoradiation|neoadjuvant chemoradiation
81981|NCT03053518|Type 2 Diabetes|type 2 diabetes
81982|NCT03053518|Hyperglycemia|hyperglycemia
81983|NCT03053518|Personal Nutrition Project|personal nutrition project
81984|NCT03053505|fecal microbiota transplantation (FMT)|fecal microbiota transplantation (fmt)
81985|NCT03053505|Clostridium difficile infection|clostridium difficile infection
81986|NCT03053505|gut flora|gut flora
81987|NCT03053505|human microbiome|human microbiome
81988|NCT03053505|colitis|colitis
81989|NCT03053492|Video Games|video games
81990|NCT03053479|surgery|surgery
81991|NCT03053479|native tissue prolapse repair|native tissue prolapse repair
81992|NCT03053479|laparoscopic sacrocolpopexy|laparoscopic sacrocolpopexy
81993|NCT03053479|vaginal mesh|vaginal mesh
81994|NCT03053466|Advanced Solid Tumor|advanced solid tumor
81995|NCT03053466|Relapsed Solid Tumor|relapsed solid tumor
81996|NCT03053466|Recurrent Solid Tumor|recurrent solid tumor
81997|NCT03053453|Total Knee Replacement Arthroplasty|total knee replacement arthroplasty
81998|NCT03053427|Restless Legs Syndrome|restless legs syndrome
81999|NCT03053427|Gabapentin enacarbil|gabapentin enacarbil
82000|NCT03053401|Quadriceps muscle strength|quadriceps muscle strength
82001|NCT03053401|Anterior cruciate ligament repair|anterior cruciate ligament repair
82002|NCT03053401|Femoral nerve block|femoral nerve block
82003|NCT03053401|Adductor Canal block|adductor canal block
82004|NCT03053401|Saphenous nerve block in the Adductor Canal|saphenous nerve block in the adductor canal
82005|NCT03053401|Pediatrics|pediatrics
82006|NCT03053401|Postoperative analgesia|postoperative analgesia
82007|NCT03053401|Ultrasound guided nerve block|ultrasound guided nerve block
82008|NCT03053323|Preconception|preconception
82009|NCT03053323|Pregnancy|pregnancy
82010|NCT03053323|Lifestyle|lifestyle
82011|NCT03053310|surgery|surgery
82012|NCT03053310|curative intent|curative intent
82013|NCT03053310|geriatric assessment|geriatric assessment
82014|NCT03053310|30-day postoperative morbidity|30-day postoperative morbidity
82015|NCT03053297|EGFR|egfr
82016|NCT03053297|EGFR mutation|egfr mutation
82017|NCT03053297|EGFRm|egfrm
82018|NCT03053297|EGFR-TKI|egfr-tki
82019|NCT03053297|Health care resource utilization|health care resource utilization
82020|NCT03053297|Health-Related Quality of Life|health-related quality of life
82021|NCT03053297|Locally advanced or metastatic lung cancer|locally advanced or metastatic lung cancer
82022|NCT03053297|NSCLC|nsclc
82023|NCT03053297|Non-Small Cell Lung Cancer|non-small cell lung cancer
82024|NCT03053297|Observational study|observational study
82025|NCT03053297|Osimertinib|osimertinib
82026|NCT03053297|Personalized medicine|personalized medicine
82027|NCT03053297|PRO|pro
82028|NCT03053297|Patient Reported Outcome|patient reported outcome
82029|NCT03053297|Resistance|resistance
82030|NCT03053297|T790M|t790m
82031|NCT03053297|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
82032|NCT03053297|Carcinoma, Bronchogenic|carcinoma, bronchogenic
82033|NCT03053297|Bronchial Neoplasms|bronchial neoplasms
82034|NCT03053297|Lung Neoplasms|lung neoplasms
82035|NCT03053297|Respiratory Tract Neoplasms|respiratory tract neoplasms
82036|NCT03053297|Thoracic neoplasms, Neoplasms by site|thoracic neoplasms, neoplasms by site
82037|NCT03053297|Lung diseases|lung diseases
82038|NCT03053297|Respiratory Tract diseases|respiratory tract diseases
82039|NCT03053297|Cancer Chemotherapy|cancer chemotherapy
82040|NCT03053297|Combination Chemotherapy|combination chemotherapy
82041|NCT03053297|Immunotherapy|immunotherapy
82042|NCT03053297|Radiation|radiation
82043|NCT03053271|Endogenous Cushing's Syndrome|endogenous cushing's syndrome
82044|NCT03053271|ATR-101|atr-101
82045|NCT03053271|CS|cs
82046|NCT03053245|Collaborative Care Model|collaborative care model
82047|NCT03053245|Intensive Care Unit|intensive care unit
82048|NCT03053193|breast cancer|breast cancer
82049|NCT03053193|stage I|stage i
82050|NCT03053193|stage II|stage ii
82051|NCT03053193|stage III|stage iii
82052|NCT03053180|Paritaprevir|paritaprevir
82053|NCT03053180|Dasabuvir|dasabuvir
82054|NCT03053180|Ombitasvir|ombitasvir
82055|NCT03053180|Ritonavir|ritonavir
82056|NCT03053180|Ribavirin free|ribavirin free
82057|NCT03053180|Chronic Hepatitis C genotype 1b (GT1b)|chronic hepatitis c genotype 1b (gt1b)
82058|NCT03053180|Cirrhosis|cirrhosis
82059|NCT03053180|Compensated liver cirrhosis|compensated liver cirrhosis
82060|NCT03053180|Hepatitis|hepatitis
82061|NCT03053167|Raltitrexed|raltitrexed
82062|NCT03053167|Irinotecan|irinotecan
82063|NCT03053167|Second-line Treatment|second-line treatment
82064|NCT03053167|Advanced Colorectal Cancer(ACC)|advanced colorectal cancer(acc)
82065|NCT03053154|Pelvic Inclination|pelvic inclination
82066|NCT03053154|Sit to Stand|sit to stand
82067|NCT03053154|Stroke|stroke
82068|NCT03053154|Anterior pelvic tilt|anterior pelvic tilt
82069|NCT03053154|Posterior pelvic tilt|posterior pelvic tilt
82070|NCT03053128|cardiac ischemia|cardiac ischemia
82071|NCT03053102|PNH|pnh
82072|NCT03053102|Paroxysmal|paroxysmal
82073|NCT03053102|Hemoglobinuria|hemoglobinuria
82074|NCT03053089|MPS I; Hurler Syndrome|mps i; hurler syndrome
82075|NCT03053076|cord blood mononuclear cells|cord blood mononuclear cells
82076|NCT03053076|safety|safety
82077|NCT03053076|effect|effect
82078|NCT03053076|neonates|neonates
82079|NCT03053037|apical size|apical size
82080|NCT03053037|root canal treatment success|root canal treatment success
82081|NCT03053037|micro biome analysis|micro biome analysis
82082|NCT03053037|pulp necrosis|pulp necrosis
82083|NCT03052985|medical devices (meshes)|medical devices (meshes)
82084|NCT03052985|surgery|surgery
82085|NCT03052946|fecal incontinence, anorectal manometry, bulking agents|fecal incontinence, anorectal manometry, bulking agents
82086|NCT03052933|copanlisib|copanlisib
82087|NCT03052933|gemcitabine|gemcitabine
82088|NCT03052933|peripheral T-cell lymphoma|peripheral t-cell lymphoma
82089|NCT03052933|extranodal NK/T-cell lymphoma|extranodal nk/t-cell lymphoma
82090|NCT03052920|cochlear implant|cochlear implant
82091|NCT03052920|asymmetric hearing loss|asymmetric hearing loss
82092|NCT03052894|anesthesiology|anesthesiology
82093|NCT03052894|neuromuscular blockade|neuromuscular blockade
82094|NCT03052894|monitoring device|monitoring device
82095|NCT03052855|Psychiatry|psychiatry
82096|NCT03052855|Suicidal behaviour|suicidal behaviour
82097|NCT03052855|Cerebral metabolites|cerebral metabolites
82098|NCT03052855|MRI|mri
82099|NCT03052855|Inflammatory markers|inflammatory markers
82100|NCT03052803|coronary stenosis|coronary stenosis
82101|NCT03052803|fractional flow reserve|fractional flow reserve
82102|NCT03052751|UCB7665|ucb7665
82103|NCT03052751|Myasthenia Gravis|myasthenia gravis
82104|NCT03052738|central nervous system (brain or spinal) tumor|central nervous system (brain or spinal) tumor
82105|NCT03052712|Disorders of socio-emotional|disorders of socio-emotional
82106|NCT03052712|Alzheimer|alzheimer
82107|NCT03052712|frontal temporal dementia|frontal temporal dementia
82108|NCT03052712|Parkinson|parkinson
82109|NCT03052712|Huntington|huntington
82110|NCT03052712|traumatic brain injury|traumatic brain injury
82111|NCT03052712|stroke|stroke
82112|NCT03052712|focal lesions|focal lesions
82113|NCT03052699|Complications; Cesarean Section|complications; cesarean section
82114|NCT03052686|Uterine rupture|uterine rupture
82115|NCT03052673|ketamine|ketamine
82116|NCT03052673|fentanyl|fentanyl
82117|NCT03052673|postoperative pain|postoperative pain
82118|NCT03052660|Midazolam|midazolam
82119|NCT03052660|Anxiety|anxiety
82120|NCT03052660|Clinical trial|clinical trial
82121|NCT03052660|Patient Satisfaction|patient satisfaction
82122|NCT03052647|dermaclip|dermaclip
82123|NCT03052647|subcuticular|subcuticular
82124|NCT03052647|cesarean section|cesarean section
82125|NCT03052647|staples|staples
82126|NCT03052647|adhesive latch|adhesive latch
82127|NCT03052647|rousseau|rousseau
82128|NCT03052608|ALK; anaplastic lymphoma kinase; Non-Small-Cell Lung cancer; NSCLC|alk; anaplastic lymphoma kinase; non-small-cell lung cancer; nsclc
82129|NCT03052556|cystic Fibrosis|cystic fibrosis
82130|NCT03052556|cervical cancer|cervical cancer
82131|NCT03052556|screening|screening
82132|NCT03052556|human papilloma virus (HPV)|human papilloma virus (hpv)
82133|NCT03052556|pap smear test|pap smear test
82134|NCT03052517|Asthma, QAW039|asthma, qaw039
82135|NCT03052465|Motility|motility
82136|NCT03052413|thinning hair|thinning hair
82137|NCT03052413|female pattern hair loss|female pattern hair loss
82138|NCT03052400|type 2 diabetes mellitus|type 2 diabetes mellitus
82139|NCT03052400|insulin resistance|insulin resistance
82140|NCT03052400|mifepristone|mifepristone
82141|NCT03052400|glucocorticoids|glucocorticoids
82142|NCT03052374|Video-Feedback Interaction Guidance|video-feedback interaction guidance
82143|NCT03052374|Depressed Mothers and their Infants|depressed mothers and their infants
82144|NCT03052361|Children|children
82145|NCT03052361|emergency department|emergency department
82146|NCT03052361|ondansetron|ondansetron
82147|NCT03052348|Topical Antibiotics|topical antibiotics
82148|NCT03052348|Fusidic Acid|fusidic acid
82149|NCT03052348|Atopic Dermatitis|atopic dermatitis
82150|NCT03052348|Eczema|eczema
82151|NCT03052335|colorectal cancer|colorectal cancer
82152|NCT03052335|screening|screening
82153|NCT03052335|colon capsule|colon capsule
82154|NCT03052335|colonoscopy|colonoscopy
82155|NCT03052283|Cystic fibrosis|cystic fibrosis
82156|NCT03052283|Abdomen|abdomen
82157|NCT03052283|Pancreas|pancreas
82158|NCT03052283|Liver|liver
82159|NCT03052283|Gut|gut
82160|NCT03052283|Symptom Score|symptom score
82161|NCT03052283|Patient reported outcome measure (PROM)|patient reported outcome measure (prom)
82162|NCT03052257|Glaucoma|glaucoma
82163|NCT03052257|Disease management|disease management
82164|NCT03052257|Smart bottle|smart bottle
82165|NCT03052244|tDCS (trans cranial direct current stimulation)|tdcs (trans cranial direct current stimulation)
82166|NCT03052244|Visual illusion|visual illusion
82167|NCT03052244|Neuropathic pain|neuropathic pain
82168|NCT03052244|Spinal cord Injury|spinal cord injury
82169|NCT03052231|adherence|adherence
82170|NCT03052231|cystic fibrosis|cystic fibrosis
82171|NCT03052218|children|children
82172|NCT03052218|pain|pain
82173|NCT03052218|Cytochrome P450 CYP2D6 genotype|cytochrome p450 cyp2d6 genotype
82174|NCT03052218|Cytochrome P450 CYP2D6 phenotype|cytochrome p450 cyp2d6 phenotype
82175|NCT03052218|Pupillometry|pupillometry
82176|NCT03052205|ILLUMINATE-101|illuminate-101
82177|NCT03052205|melanoma|melanoma
82178|NCT03052127|Uveal melanoma|uveal melanoma
82179|NCT03052127|Eye cancer|eye cancer
82180|NCT03052127|Ocular melanoma|ocular melanoma
82181|NCT03052127|Choroidal melanoma|choroidal melanoma
82182|NCT03052114|Electrical Impedance Tomography|electrical impedance tomography
82183|NCT03052114|EIT|eit
82184|NCT03052114|Stroke|stroke
82185|NCT03052114|Craniocerebral Injury|craniocerebral injury
82186|NCT03052114|Head Injury|head injury
82187|NCT03052101|PLCH|plch
82188|NCT03052101|Air travel|air travel
82189|NCT03052101|pneumothorax|pneumothorax
82190|NCT03052101|pleurodesis|pleurodesis
82191|NCT03052075|Primary Hyperparathyroidism|primary hyperparathyroidism
82192|NCT03052075|Parathyroidectomy|parathyroidectomy
82193|NCT03052075|Bone mineral density|bone mineral density
82194|NCT03052075|BMD|bmd
82195|NCT03052075|Data Review|data review
82196|NCT03052049|Prostate Artery Embolization|prostate artery embolization
82197|NCT03052036|Acute Coronory Syndrome|acute coronory syndrome
82198|NCT03052023|dual approach|dual approach
82199|NCT03052023|laparoscopic hernioplasty|laparoscopic hernioplasty
82200|NCT03052010|HIV-1 serodiscordant couples|hiv-1 serodiscordant couples
82201|NCT03052010|PrEP as Bridge to ART|prep as bridge to art
82202|NCT03051919|Laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
82203|NCT03051919|reinforcement|reinforcement
82204|NCT03051919|leak|leak
82205|NCT03051906|Carcinoma, squamous cell|carcinoma, squamous cell
82206|NCT03051906|Head and Neck Neoplasms|head and neck neoplasms
82207|NCT03051906|Radiotherapy|radiotherapy
82208|NCT03051906|Immunotherapy|immunotherapy
82209|NCT03051880|Epidermal Growth Factor|epidermal growth factor
82210|NCT03051854|Violence|violence
82211|NCT03051854|Children|children
82212|NCT03051854|Prevalence|prevalence
82213|NCT03051854|Abuse|abuse
82214|NCT03051854|Prevention|prevention
82215|NCT03051828|fencing, cancer|fencing, cancer
82216|NCT03051815|obstructive sleep apnea|obstructive sleep apnea
82217|NCT03051802|Endoscopy|endoscopy
82218|NCT03051802|HDR Brachytherapy|hdr brachytherapy
82219|NCT03051802|navigation|navigation
82220|NCT03051789|Menstrual hygiene management|menstrual hygiene management
82221|NCT03051789|Sexual and Reproductive Health|sexual and reproductive health
82222|NCT03051789|Adolescent schoolgirls|adolescent schoolgirls
82223|NCT03051789|School dropoout|school dropoout
82224|NCT03051789|sub-Saharan Africa|sub-saharan africa
82225|NCT03051789|Kenya|kenya
82226|NCT03051776|Compression garments|compression garments
82227|NCT03051776|Kinesio Taping|kinesio taping
82228|NCT03051776|Breast Cancer-Related Lymphedema|breast cancer-related lymphedema
82229|NCT03051763|pulmonary hypertension|pulmonary hypertension
82230|NCT03051763|commercial air travel|commercial air travel
82231|NCT03051750|Breast Cancer-Related Lymphedema|breast cancer-related lymphedema
82232|NCT03051750|Complex Physical Therapy|complex physical therapy
82233|NCT03051750|Pressotherapy|pressotherapy
82234|NCT03051750|Kinesio Taping|kinesio taping
82235|NCT03051750|Physiotherapy|physiotherapy
82236|NCT03051750|Manual Lymph Drainage|manual lymph drainage
82237|NCT03051750|Multilayer Bandage|multilayer bandage
82238|NCT03051750|TTDL questionnaire|ttdl questionnaire
82239|NCT03051737|Multi-scale|multi-scale
82240|NCT03051737|Prediction|prediction
82241|NCT03051737|Patient Flow|patient flow
82242|NCT03051737|Emergency Department|emergency department
82243|NCT03051737|Hospitalization|hospitalization
82244|NCT03051737|Ile-de-France|ile-de-france
82245|NCT03051724|OSA|osa
82246|NCT03051724|CPAP management|cpap management
82247|NCT03051724|Telemedicine|telemedicine
82248|NCT03051698|C1-inhibitor|c1-inhibitor
82249|NCT03051698|house dust mite|house dust mite
82250|NCT03051698|complement system|complement system
82251|NCT03051672|Breast Cancer|breast cancer
82252|NCT03051659|Breast Cancer|breast cancer
82253|NCT03051646|Exercise|exercise
82254|NCT03051646|Time to Exhaustion|time to exhaustion
82255|NCT03051620|Bone turnover markers|bone turnover markers
82256|NCT03051620|Alendronate|alendronate
82257|NCT03051620|Drug Holiday|drug holiday
82258|NCT03051607|Motor Fluctuations|motor fluctuations
82259|NCT03051607|Off time|off time
82260|NCT03051607|On time|on time
82261|NCT03051607|Dyskinesia|dyskinesia
82262|NCT03051581|Lymphoma, T-Cell, Peripheral|lymphoma, t-cell, peripheral
82263|NCT03051581|Positron-Emission Tomography|positron-emission tomography
82264|NCT03051581|Prognosis|prognosis
82265|NCT03051568|Lymphoma, T-Cell, Peripheral|lymphoma, t-cell, peripheral
82266|NCT03051568|Positron-Emission Tomography|positron-emission tomography
82267|NCT03051568|Prognosis|prognosis
82268|NCT03051555|Lymphoma, Extranodal NK-T-Cell|lymphoma, extranodal nk-t-cell
82269|NCT03051555|Positron-Emission Tomography|positron-emission tomography
82270|NCT03051555|Prognosis|prognosis
82271|NCT03051542|Lymphoma, Extranodal NK-T-Cell|lymphoma, extranodal nk-t-cell
82272|NCT03051542|Positron-Emission Tomography|positron-emission tomography
82273|NCT03051542|Prognosis|prognosis
82274|NCT03051451|Hydrochloride of Metformin / Fluoxetine|hydrochloride of metformin / fluoxetine
82275|NCT03051451|Placebo|placebo
82276|NCT03051451|Obesity|obesity
82277|NCT03051425|Probiotics|probiotics
82278|NCT03051425|Immune function|immune function
82279|NCT03051425|Natural killer cell activity|natural killer cell activity
82280|NCT03051425|Interleukin-12|interleukin-12
82281|NCT03051425|Interferon-gamma|interferon-gamma
82282|NCT03051425|Immunoglobulin|immunoglobulin
82283|NCT03051399|Constipation|constipation
82284|NCT03051399|Gastrointestinal symptoms of discomfort|gastrointestinal symptoms of discomfort
82285|NCT03051399|Quality of life|quality of life
82286|NCT03051399|Saccharomyces cerevisiae|saccharomyces cerevisiae
82287|NCT03051399|Gut microbiome|gut microbiome
82288|NCT03051360|aortic valve stenosis|aortic valve stenosis
82289|NCT03051360|PCSK9 inhibitor|pcsk9 inhibitor
82290|NCT03051308|Parathyroid cell viability|parathyroid cell viability
82291|NCT03051308|Ischemia|ischemia
82292|NCT03051308|Parathyroid allotransplantation|parathyroid allotransplantation
82293|NCT03051308|Vitamin D Receptor|vitamin d receptor
82294|NCT03051308|Calcium Sensing Receptor|calcium sensing receptor
82295|NCT03051295|Communication Barriers|communication barriers
82296|NCT03051295|Persuasive Communication|persuasive communication
82297|NCT03051295|Risk|risk
82298|NCT03051269|Electroporation|electroporation
82299|NCT03051269|Calcium|calcium
82300|NCT03051269|Head and Neck cancer|head and neck cancer
82301|NCT03051256|REL-1017|rel-1017
82302|NCT03051256|d-Methadone|d-methadone
82303|NCT03051256|Methadone|methadone
82304|NCT03051256|Depression|depression
82305|NCT03051256|Refractory Depression|refractory depression
82306|NCT03051256|Antidepressant|antidepressant
82404|NCT03050736|brain tumor|brain tumor
82307|NCT03051256|Adjunctive Treatment|adjunctive treatment
82308|NCT03051256|NMDA Receptor Antagonist|nmda receptor antagonist
82309|NCT03051256|Excitatory Amino Acid Antagonist|excitatory amino acid antagonist
82310|NCT03051256|Glutamate Antagonist|glutamate antagonist
82311|NCT03051230|Blood Coagulation Disorders|blood coagulation disorders
82312|NCT03051230|Cell-Derived Microparticles|cell-derived microparticles
82313|NCT03051230|Superovulation|superovulation
82314|NCT03051230|Fertilization in Vitro|fertilization in vitro
82315|NCT03051230|Biomarkers|biomarkers
82316|NCT03051217|Psoriasis|psoriasis
82317|NCT03051217|PSO|pso
82318|NCT03051217|Chronic plaque psoriasis|chronic plaque psoriasis
82319|NCT03051217|Certolizumb Pegol|certolizumb pegol
82320|NCT03051217|Cimzia|cimzia
82321|NCT03051217|Generalized pustular psoriasis and erythrodermic psoriasis|generalized pustular psoriasis and erythrodermic psoriasis
82322|NCT03051191|atherosclerotic cardiovascular diseases|atherosclerotic cardiovascular diseases
82323|NCT03051191|nonischemic heart failure|nonischemic heart failure
82324|NCT03051191|cancer|cancer
82325|NCT03051165|Cardiovascular Disease|cardiovascular disease
82326|NCT03051165|Pulmonary Medicine|pulmonary medicine
82327|NCT03051165|Hypoglossal Nerve Stimulation|hypoglossal nerve stimulation
82328|NCT03051139|Implementation Science|implementation science
82329|NCT03051139|Low Tidal Volume Ventilation (LTVV)|low tidal volume ventilation (ltvv)
82330|NCT03051126|Parathyroid disease|parathyroid disease
82331|NCT03051126|Parathyroid Tissue Bank|parathyroid tissue bank
82332|NCT03051126|Database|database
82333|NCT03051126|Blood samples|blood samples
82334|NCT03051100|hyperlididemia|hyperlididemia
82335|NCT03051100|LDL|ldl
82336|NCT03051100|cholesterol|cholesterol
82337|NCT03051074|Anxiety|anxiety
82338|NCT03051074|Floating|floating
82339|NCT03051061|Atrial Fibrillation|atrial fibrillation
82340|NCT03051061|Coronary Heart Disease|coronary heart disease
82341|NCT03051061|antithrombotic treatment|antithrombotic treatment
82342|NCT03051061|clinical prognosis|clinical prognosis
82343|NCT03051048|Acute Myocardial Infarction|acute myocardial infarction
82344|NCT03051035|non-hematological malignancies|non-hematological malignancies
82345|NCT03051035|non-squamous|non-squamous
82346|NCT03051035|squamous|squamous
82347|NCT03051035|BRAF|braf
82348|NCT03051035|KRAS|kras
82349|NCT03051035|NRAS|nras
82350|NCT03051022|Bupivacaine|bupivacaine
82351|NCT03051022|adjuvant|adjuvant
82352|NCT03051022|regional anesthesia|regional anesthesia
82353|NCT03051022|dexamethasone|dexamethasone
82354|NCT03051022|morphine|morphine
82355|NCT03050983|Respiratory Compromise|respiratory compromise
82356|NCT03050970|minor head trauma|minor head trauma
82357|NCT03050970|child|child
82358|NCT03050970|age less than 2 years|age less than 2 years
82359|NCT03050970|Clinically-important traumatic brain injury (ciTBI)|clinically-important traumatic brain injury (citbi)
82360|NCT03050970|Computed tomography scan|computed tomography scan
82361|NCT03050970|Radiation exposure from CT scans|radiation exposure from ct scans
82362|NCT03050944|Fertility|fertility
82363|NCT03050944|Infertility|infertility
82364|NCT03050944|Dietary Patterns|dietary patterns
82365|NCT03050944|Mediterranean diet|mediterranean diet
82366|NCT03050944|Adiponectin|adiponectin
82367|NCT03050944|Follistatin|follistatin
82368|NCT03050944|Assisted Reproduction|assisted reproduction
82369|NCT03050944|In Vitro Fertilization|in vitro fertilization
82370|NCT03050944|Semen quality|semen quality
82371|NCT03050944|Diet|diet
82372|NCT03050944|IVF|ivf
82373|NCT03050931|Electrical Impedance Tomography|electrical impedance tomography
82374|NCT03050931|EIT|eit
82375|NCT03050931|Epilepsy|epilepsy
82376|NCT03050879|Stomach Neoplasms|stomach neoplasms
82377|NCT03050879|Indocyanine Green Tracer|indocyanine green tracer
82378|NCT03050879|Laparoscopic Gastrectomy|laparoscopic gastrectomy
82379|NCT03050879|Lymph Node Dissection|lymph node dissection
82380|NCT03050866|Androgen Receptor|androgen receptor
82381|NCT03050866|AR-V7|ar-v7
82382|NCT03050866|Predictive Factor|predictive factor
82383|NCT03050814|Anti-PDL1 Antibody|anti-pdl1 antibody
82384|NCT03050814|Therapeutic Cancer Vaccine|therapeutic cancer vaccine
82385|NCT03050814|Mismatch Repair Deficiency|mismatch repair deficiency
82386|NCT03050814|Progression Free Survival|progression free survival
82387|NCT03050814|Adenovirus Based, CEA-Targeting Vaccine|adenovirus based, cea-targeting vaccine
82388|NCT03050801|Explicit Memory|explicit memory
82389|NCT03050801|Implicit Memory|implicit memory
82390|NCT03050801|Memory Disorder|memory disorder
82391|NCT03050788|Smartphone confocal microscopy|smartphone confocal microscopy
82392|NCT03050788|Kaposi Sarcoma|kaposi sarcoma
82393|NCT03050788|Point of care diagnosis|point of care diagnosis
82394|NCT03050762|Endocrine Disease|endocrine disease
82395|NCT03050762|Thyroid disease|thyroid disease
82396|NCT03050762|Parathyroid disease|parathyroid disease
82397|NCT03050762|Adrenal disease|adrenal disease
82398|NCT03050762|Data Review|data review
82399|NCT03050762|Database|database
82400|NCT03050736|Glioma|glioma
82401|NCT03050736|Glioblastoma|glioblastoma
82402|NCT03050736|Glioblastoma multiforme|glioblastoma multiforme
82403|NCT03050736|GBM|gbm
82405|NCT03050736|brain cancer|brain cancer
82406|NCT03050632|working memory|working memory
82407|NCT03050632|adherence|adherence
82408|NCT03050606|Exercise Therapy|exercise therapy
82409|NCT03050606|Exercise Movement Techniques|exercise movement techniques
82410|NCT03050606|Pilates-Based Exercises|pilates-based exercises
82411|NCT03050606|Cost-effectiveness|cost-effectiveness
82412|NCT03050593|HFpEF|hfpef
82413|NCT03050593|HFrEF|hfref
82414|NCT03050580|Abused women|abused women
82415|NCT03050580|treatment group|treatment group
82416|NCT03050580|family violence|family violence
82417|NCT03050567|Microemboli|microemboli
82418|NCT03050554|cancer|cancer
82419|NCT03050554|Non-Small Cell Lung Cancer|non-small cell lung cancer
82420|NCT03050554|SBRT|sbrt
82421|NCT03050554|Avelumab|avelumab
82422|NCT03050554|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
82423|NCT03050554|radiation|radiation
82424|NCT03050554|NSCLC|nsclc
82425|NCT03050554|PD-1|pd-1
82426|NCT03050554|PD-L1|pd-l1
82427|NCT03050554|Immunotherapy|immunotherapy
82428|NCT03050554|Lung|lung
82429|NCT03050541|MDMA|mdma
82430|NCT03050541|adult|adult
82431|NCT03050528|Acceptance and Commitment Therapy|acceptance and commitment therapy
82432|NCT03050528|Exercise|exercise
82433|NCT03050528|Psychology|psychology
82434|NCT03050528|Psychological therapy|psychological therapy
82435|NCT03050528|Physiotherapy|physiotherapy
82436|NCT03050528|Physical therapy|physical therapy
82437|NCT03050502|Hemothorax|hemothorax
82438|NCT03050502|Management|management
82439|NCT03050489|CABG|cabg
82440|NCT03050489|Off-Pump CABG|off-pump cabg
82441|NCT03050489|On-Pump CABG|on-pump cabg
82442|NCT03050489|ischemic-reperfusion injury during CABG|ischemic-reperfusion injury during cabg
82443|NCT03050489|comparison of On- and Off- Pump CABG|comparison of on- and off- pump cabg
82444|NCT03050489|Ischemic Heart Disease|ischemic heart disease
82445|NCT03050489|Myocardial ischemia-reperfusion and myeloperoxidase|myocardial ischemia-reperfusion and myeloperoxidase
82446|NCT03050489|Myocardial ischemia-reperfusion biomarkers|myocardial ischemia-reperfusion biomarkers
82447|NCT03050476|side-effects|side-effects
82448|NCT03050476|heart-lung machine|heart-lung machine
82449|NCT03050476|alkaline phosphatase|alkaline phosphatase
82450|NCT03050437|Failed in First Line EGFR-TKI|failed in first line egfr-tki
82451|NCT03050437|EGFR Activating Mutation|egfr activating mutation
82452|NCT03050437|Pemetrexed|pemetrexed
82453|NCT03050424|COPD|copd
82454|NCT03050424|Iron|iron
82455|NCT03050424|Exercise Capacity|exercise capacity
82456|NCT03050424|Non-anaemic iron deficiency|non-anaemic iron deficiency
82457|NCT03050411|Non Small Cell Lung Cancer|non small cell lung cancer
82458|NCT03050411|EGFR-TKI resistance|egfr-tki resistance
82459|NCT03050411|Apatinib|apatinib
82460|NCT03050411|anti-angiogenesis drugs|anti-angiogenesis drugs
82461|NCT03050398|HR-positive|hr-positive
82462|NCT03050398|HER2-negative|her2-negative
82463|NCT03050398|Advanced breast cancer|advanced breast cancer
82464|NCT03050398|LEE011|lee011
82465|NCT03050398|ribociclib|ribociclib
82466|NCT03050398|letrozole|letrozole
82467|NCT03050398|femara|femara
82468|NCT03050398|CDK|cdk
82469|NCT03050398|CDK4|cdk4
82470|NCT03050398|CDK6|cdk6
82471|NCT03050398|CDK4/6|cdk4/6
82472|NCT03050398|CDK4/6 inhibitor|cdk4/6 inhibitor
82473|NCT03050398|Phase III|phase iii
82474|NCT03050398|Phase IIIb|phase iiib
82475|NCT03050398|ER-positive|er-positive
82476|NCT03050398|PR-positive|pr-positive
82477|NCT03050398|Postmenopausal|postmenopausal
82478|NCT03050398|Premenopausal|premenopausal
82479|NCT03050398|Men|men
82480|NCT03050385|cognitive rehabilitation|cognitive rehabilitation
82481|NCT03050359|Drug therapy|drug therapy
82482|NCT03050359|Gastrointestinal Diseases|gastrointestinal diseases
82483|NCT03050359|Digestive System Diseases|digestive system diseases
82484|NCT03050359|Lansoprazole|lansoprazole
82485|NCT03050359|Anti-Ulcer Agents|anti-ulcer agents
82486|NCT03050359|Gastrointestinal Agents|gastrointestinal agents
82487|NCT03050359|Proton Pump Inhibitors|proton pump inhibitors
82488|NCT03050359|Enzyme Inhibitors|enzyme inhibitors
82489|NCT03050359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
82490|NCT03050346|Magnetic Resonance Imaging|magnetic resonance imaging
82491|NCT03050346|Coronary Artery Disease|coronary artery disease
82492|NCT03050346|Apnea|apnea
82493|NCT03050346|Hyperventilation|hyperventilation
82494|NCT03050346|BOLD|bold
82495|NCT03050346|Breathing Maneuvers|breathing maneuvers
82496|NCT03050346|Myocardial Oxygenation|myocardial oxygenation
82497|NCT03050320|Resilience|resilience
82498|NCT03050320|Exercise in the workplace|exercise in the workplace
82499|NCT03050307|Drug therapy|drug therapy
82500|NCT03050268|Familial cancer|familial cancer
82501|NCT03050268|Genetic predisposition|genetic predisposition
82502|NCT03050268|Heritable disease|heritable disease
82503|NCT03050268|Cancer risk|cancer risk
82504|NCT03050268|Genome analysis|genome analysis
82505|NCT03050268|Genetic modifiers|genetic modifiers
83293|NCT03044977|theranostic|theranostic
82506|NCT03050268|Next generation sequencing (NGS)|next generation sequencing (ngs)
82507|NCT03050268|Genetic counseling|genetic counseling
82508|NCT03050268|DNA|dna
82509|NCT03050255|supplemental oxygen|supplemental oxygen
82510|NCT03050255|walking capacity|walking capacity
82511|NCT03050255|exercise capacity|exercise capacity
82512|NCT03050255|endurance shuttle walk test|endurance shuttle walk test
82513|NCT03050190|4s CAR-T|4s car-t
82514|NCT03050190|CD19|cd19
82515|NCT03050190|B cell leukemia|b cell leukemia
82516|NCT03050190|B-ALL|b-all
82517|NCT03050177|Bioequivalence Study|bioequivalence study
82518|NCT03050138|Postthrombotic Syndrome|postthrombotic syndrome
82519|NCT03050138|Venous Thrombosis|venous thrombosis
82520|NCT03050138|Quality of Life|quality of life
82521|NCT03050138|Hemorrhage|hemorrhage
82522|NCT03050138|Recurrence|recurrence
82523|NCT03050112|MacNew questionnaire|macnew questionnaire
82524|NCT03050112|Quality of life|quality of life
82525|NCT03050034|Wireless monitoring system|wireless monitoring system
82526|NCT03050034|Acute Medicine|acute medicine
82527|NCT03050034|Poly-pathological patients|poly-pathological patients
82528|NCT03050034|Internal Medicine core competencies|internal medicine core competencies
82529|NCT03050034|Acute Complex Care Model|acute complex care model
82530|NCT03050021|Delirium|delirium
82531|NCT03050021|Intensive care unit|intensive care unit
82532|NCT03050008|Cataract Surgery|cataract surgery
82533|NCT03049995|effectiveness; imaging; prognosis; stress echocardiography|effectiveness; imaging; prognosis; stress echocardiography
82534|NCT03049982|Oral appliance therapy|oral appliance therapy
82535|NCT03049969|Working Memory|working memory
82536|NCT03049969|Cognitive Training|cognitive training
82537|NCT03049969|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
82538|NCT03049956|Ocular Vestibular Evoked Myogenic Potentials|ocular vestibular evoked myogenic potentials
82539|NCT03049943|low level laser therapy|low level laser therapy
82540|NCT03049943|hyposalivation|hyposalivation
82541|NCT03049930|Burns|burns
82542|NCT03049930|Ketamine|ketamine
82543|NCT03049930|Anesthesia|anesthesia
82544|NCT03049917|financial incentive|financial incentive
82545|NCT03049917|pediatric HIV testing|pediatric hiv testing
82546|NCT03049904|Indian, North America|indian, north america
82547|NCT03049904|Male, Two-Spirit|male, two-spirit
82548|NCT03049904|HIV Prevention|hiv prevention
82549|NCT03049904|MSM|msm
82550|NCT03049891|Antiretroviral Therapy|antiretroviral therapy
82551|NCT03049891|Retention|retention
82552|NCT03049891|Loss to Follow Up|loss to follow up
82553|NCT03049878|postoperative pain|postoperative pain
82554|NCT03049878|paracetamol|paracetamol
82555|NCT03049878|codeine|codeine
82556|NCT03049878|tooth extractions|tooth extractions
82557|NCT03049878|analgesia|analgesia
82558|NCT03049878|premedication|premedication
82559|NCT03049826|nutrient|nutrient
82560|NCT03049800|Recent onset psychotic illness|recent onset psychotic illness
82561|NCT03049800|Healthy controls|healthy controls
82562|NCT03049800|Cognitive training|cognitive training
82563|NCT03049800|7T Magnetic Resonance Imaging|7t magnetic resonance imaging
82564|NCT03049787|physical therapy|physical therapy
82565|NCT03049787|home exercise|home exercise
82566|NCT03049787|adhesive capsulitis|adhesive capsulitis
82567|NCT03049748|Heart-Assist Devices, Self-care, Quality of Life|heart-assist devices, self-care, quality of life
82568|NCT03049709|central blood pressure|central blood pressure
82569|NCT03049709|measurement|measurement
82570|NCT03049709|oscillometric radial pulse wave analysis|oscillometric radial pulse wave analysis
82571|NCT03049696|Roux-En-Y Gastric Bypass|roux-en-y gastric bypass
82572|NCT03049696|Bariatric Surgery|bariatric surgery
82573|NCT03049696|Pre-Operative Physical Activity and Education Program|pre-operative physical activity and education program
82574|NCT03049696|Obesity|obesity
82575|NCT03049696|Exercise|exercise
82576|NCT03049696|Behaviour Modification|behaviour modification
82577|NCT03049696|Surgical Outcomes|surgical outcomes
82578|NCT03049696|Quality of Life|quality of life
82579|NCT03049683|Vestibular evoked myogenic potentials|vestibular evoked myogenic potentials
82580|NCT03049670|Safety Issue|safety issue
82581|NCT03049644|chronic lower back pain|chronic lower back pain
82582|NCT03049644|Manual Therapy|manual therapy
82583|NCT03049644|Mechanical Diagnosis and Treatment|mechanical diagnosis and treatment
82584|NCT03049631|Pre-diabetes|pre-diabetes
82585|NCT03049631|red raspberry|red raspberry
82586|NCT03049631|fructooligosaccharide|fructooligosaccharide
82587|NCT03049631|metagenomics|metagenomics
82588|NCT03049631|polyphenol bioavailability|polyphenol bioavailability
82589|NCT03049631|glycemic response|glycemic response
82590|NCT03049631|insulin response|insulin response
82591|NCT03049605|Neuropathies laser and magnetic therapy|neuropathies laser and magnetic therapy
82592|NCT03049592|Diabetes|diabetes
82593|NCT03049592|Contraception|contraception
82594|NCT03049592|Prenatal Counseling|prenatal counseling
82595|NCT03049566|Bleeding|bleeding
82596|NCT03049566|Adverse Cardiac Events|adverse cardiac events
82597|NCT03049566|Adherence, Medication|adherence, medication
82598|NCT03049566|Aspirin|aspirin
82599|NCT03049566|Acetylsalicylic acid|acetylsalicylic acid
82600|NCT03049553|Cervical screening|cervical screening
82601|NCT03049553|Human papillomavirus (HPV)|human papillomavirus (hpv)
82602|NCT03049553|Cytology|cytology
82603|NCT03049553|HPV-test|hpv-test
82604|NCT03049553|Cervical intraepithelial neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
82605|NCT03049527|Chronic Kidney Disease|chronic kidney disease
82606|NCT03049527|Unknown Origin|unknown origin
82607|NCT03049514|Thrombolysis|thrombolysis
82608|NCT03049514|Recanalization|recanalization
82609|NCT03049514|Dynamic retinal angiography|dynamic retinal angiography
82610|NCT03049501|Alzheimer's caregivers|alzheimer's caregivers
82611|NCT03049501|Technology-based intervention|technology-based intervention
82612|NCT03049501|Culturally-tailored intervention|culturally-tailored intervention
82613|NCT03049488|Immune Response|immune response
82614|NCT03049488|Respiratory Syncytial Virus|respiratory syncytial virus
82615|NCT03049488|Vaccine-Mediated Protection|vaccine-mediated protection
82616|NCT03049488|Neutralizing Antibody|neutralizing antibody
82617|NCT03049488|Antibody Response|antibody response
82618|NCT03049475|Pain|pain
82619|NCT03049475|Cell Free DNA|cell free dna
82620|NCT03049475|Inflammatory Markers|inflammatory markers
82621|NCT03049475|Microparticles|microparticles
82622|NCT03049475|NETosis|netosis
82623|NCT03049462|Brown Adipose Tissue|brown adipose tissue
82624|NCT03049462|Energy Expenditure|energy expenditure
82625|NCT03049462|Energy Metabolism|energy metabolism
82626|NCT03049462|Obesity|obesity
82627|NCT03049449|Gene Therapy|gene therapy
82628|NCT03049449|Adoptive T Cell Therapy|adoptive t cell therapy
82629|NCT03049449|T-cell infusion|t-cell infusion
82630|NCT03049449|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
82631|NCT03049449|Immunohistochemistry|immunohistochemistry
82632|NCT03049436|Physical activity|physical activity
82633|NCT03049436|cancer|cancer
82634|NCT03049436|chemotherapy|chemotherapy
82635|NCT03049436|daily care unit|daily care unit
82636|NCT03049410|Cystectomy|cystectomy
82637|NCT03049332|Quality of Life|quality of life
82638|NCT03049306|Obstructive sleep apnea|obstructive sleep apnea
82639|NCT03049306|CPAP|cpap
82640|NCT03049306|Propranolol|propranolol
82641|NCT03049306|Metabolism|metabolism
82642|NCT03049293|COPD,IVF|copd,ivf
82643|NCT03049267|acne inversa|acne inversa
82644|NCT03049241|Children|children
82645|NCT03049241|Neuromuscular fatigue|neuromuscular fatigue
82646|NCT03049241|Muscle group|muscle group
82647|NCT03049241|Magnetic Nerve stimulation|magnetic nerve stimulation
82648|NCT03049241|Muscle length|muscle length
82649|NCT03049241|Stiffness|stiffness
82650|NCT03049241|prepubertal children|prepubertal children
82651|NCT03049241|adults|adults
82652|NCT03049228|Spectrum Analysis|spectrum analysis
82653|NCT03049228|Mitochondria|mitochondria
82654|NCT03049228|Peroxisome Proliferator-Activated Receptors|peroxisome proliferator-activated receptors
82655|NCT03049228|Respirometry|respirometry
82656|NCT03049228|Human|human
82657|NCT03049228|Heart|heart
82658|NCT03049189|non-functional and functional P-NET|non-functional and functional p-net
82659|NCT03049189|non-functional GE-NET|non-functional ge-net
82660|NCT03049176|HIV-discordant couple|hiv-discordant couple
82662|NCT03049176|PrEP|prep
82663|NCT03049176|semen washing|semen washing
82664|NCT03049176|artificial vaginal insemination|artificial vaginal insemination
82665|NCT03049176|safer conception|safer conception
82666|NCT03049176|pregnancy|pregnancy
82667|NCT03049150|Urine|urine
82668|NCT03049150|Mass Spectometry|mass spectometry
82669|NCT03049150|Observational|observational
82670|NCT03049124|Exercise|exercise
82671|NCT03049124|Feasibility trial|feasibility trial
82672|NCT03049124|Cancer|cancer
82673|NCT03049124|Chemoradiation|chemoradiation
82674|NCT03049111|Der F (House Dust Mite)|der f (house dust mite)
82675|NCT03049098|Eye-tracking|eye-tracking
82676|NCT03049098|High Fidelity Simulation Training|high fidelity simulation training
82677|NCT03049098|Visual Perception|visual perception
82678|NCT03049085|OPCAB|opcab
82679|NCT03049085|ASA|asa
82680|NCT03049085|Aspirin|aspirin
82681|NCT03049020|pelvic organ prolapse|pelvic organ prolapse
82682|NCT03049020|sacrocolpopexy|sacrocolpopexy
82683|NCT03049020|pelvic floor ultrasound|pelvic floor ultrasound
82684|NCT03049007|bereavement|bereavement
82685|NCT03049007|natural grief|natural grief
82686|NCT03049007|prolonged grief|prolonged grief
82687|NCT03049007|complicated grief|complicated grief
82688|NCT03048994|Glutamine|glutamine
82689|NCT03048994|Severe sepsis|severe sepsis
82690|NCT03048981|Thrombocyte aggregation|thrombocyte aggregation
82691|NCT03048981|Fish oil|fish oil
82692|NCT03048981|Alternative medicine|alternative medicine
82693|NCT03048981|Point of care testing|point of care testing
82694|NCT03048981|Coagulation monitoring|coagulation monitoring
82695|NCT03048968|Exoskeleton Device|exoskeleton device
82696|NCT03048968|elderly|elderly
82697|NCT03048968|stroke|stroke
82698|NCT03048942|Breast cancer|breast cancer
82699|NCT03048942|HER2 negative|her2 negative
82700|NCT03048942|Cabazitaxel|cabazitaxel
82701|NCT03048942|Paclitaxel|paclitaxel
82702|NCT03048942|Chemotherapy|chemotherapy
82703|NCT03048916|dysphagia|dysphagia
82704|NCT03048916|stroke|stroke
82705|NCT03048916|magnetic resonance imaging|magnetic resonance imaging
82706|NCT03048916|videofluoroscopy|videofluoroscopy
82707|NCT03048903|Gastrointestinal dysfunction|gastrointestinal dysfunction
82708|NCT03048903|sepsis|sepsis
82709|NCT03048903|trauma|trauma
82710|NCT03048890|PAD|pad
82711|NCT03048877|Radioactive iodine-refractory|radioactive iodine-refractory
82712|NCT03048877|differentiated thyroid cancer|differentiated thyroid cancer
82713|NCT03048877|Apatinib|apatinib
82714|NCT03048877|anti-angiogenesis drugs|anti-angiogenesis drugs
82715|NCT03048864|Metabolic Screening|metabolic screening
82716|NCT03048864|24 hour urine|24 hour urine
82717|NCT03048851|Cerebral palsy|cerebral palsy
82718|NCT03048851|sensory electrical stimulation|sensory electrical stimulation
82719|NCT03048851|virtual reality constraint-induced therapy|virtual reality constraint-induced therapy
82720|NCT03048812|Dental implant|dental implant
82721|NCT03048812|Mandibular overdenture|mandibular overdenture
82722|NCT03048812|Cross-over study|cross-over study
82723|NCT03048786|Peer mentoring|peer mentoring
82724|NCT03048786|social support|social support
82725|NCT03048786|text messaging|text messaging
82726|NCT03048786|smoking cessation|smoking cessation
82727|NCT03048773|shockwave therapy|shockwave therapy
82728|NCT03048773|knee osteoarthritis|knee osteoarthritis
82729|NCT03048760|MRI scan|mri scan
82730|NCT03048760|Organs at Risk|organs at risk
82731|NCT03048708|Bariatric surgery|bariatric surgery
82732|NCT03048708|Leptin|leptin
82733|NCT03048708|Thyroid function tests|thyroid function tests
82734|NCT03048617|Primary Mitochondrial Disease|primary mitochondrial disease
82735|NCT03048617|Stealth|stealth
82736|NCT03048617|Myopathy|myopathy
82737|NCT03048617|exercise intolerance|exercise intolerance
82738|NCT03048617|muscle pain|muscle pain
82739|NCT03048617|Mitochondrial Myopathy|mitochondrial myopathy
82740|NCT03048617|Primary Mitochondrial Myopathy|primary mitochondrial myopathy
82741|NCT03048578|Roux-en-Y gastric bypass (RYGB)|roux-en-y gastric bypass (rygb)
82742|NCT03048565|mindfulness|mindfulness
82743|NCT03048565|caregivers|caregivers
82744|NCT03048552|drug use|drug use
82745|NCT03048552|drug addiction|drug addiction
82746|NCT03048552|drug habituation|drug habituation
82747|NCT03048552|drug use disorders|drug use disorders
82748|NCT03048552|organic mental disorders|organic mental disorders
82749|NCT03048552|substance-induced|substance-induced
82750|NCT03048552|substance abuse|substance abuse
82751|NCT03048552|substance addiction|substance addiction
82752|NCT03048552|substance dependence|substance dependence
82753|NCT03048552|substance use disorders|substance use disorders
82754|NCT03048539|Endoscopic surgery|endoscopic surgery
82755|NCT03048539|Thyroidectomy|thyroidectomy
82756|NCT03048539|Quality of life|quality of life
82757|NCT03048513|Melioidosis|melioidosis
82758|NCT03048513|Head and Neck|head and neck
82759|NCT03048513|Clinical|clinical
82760|NCT03048474|progressive disease after at least 1 course of chemotherapy|progressive disease after at least 1 course of chemotherapy
82761|NCT03048448|Hepatic impairment,|hepatic impairment,
82762|NCT03048448|Fevipiprant,|fevipiprant,
82763|NCT03048448|adults,|adults,
82764|NCT03048448|pharmacokinetics|pharmacokinetics
82765|NCT03048435|Cervical Cancer|cervical cancer
82766|NCT03048435|Patient Reported Outcomes|patient reported outcomes
82767|NCT03048435|Radiation Therapy|radiation therapy
82768|NCT03048435|EORTC QLQ-CX24|eortc qlq-cx24
82769|NCT03048435|Quality of Life|quality of life
82770|NCT03048383|Facial paralysis|facial paralysis
82771|NCT03048383|Facial synkinesis|facial synkinesis
82772|NCT03048383|Botulinum toxin|botulinum toxin
82773|NCT03048344|acute promyelocytic leukemia|acute promyelocytic leukemia
82774|NCT03048344|APL|apl
82775|NCT03048344|arsenic trioxide|arsenic trioxide
82776|NCT03048331|Functional Electrical Stimulation|functional electrical stimulation
82777|NCT03048331|Tetraplegia|tetraplegia
82778|NCT03048331|Reconstructive Hand Surgery|reconstructive hand surgery
82779|NCT03048292|Embolectomy|embolectomy
82780|NCT03048292|Embolus|embolus
82781|NCT03048292|Thrombectomy|thrombectomy
82782|NCT03048292|Thrombolysis|thrombolysis
82783|NCT03048292|Thrombus|thrombus
82784|NCT03048292|Mobile|mobile
82785|NCT03048292|Interventional|interventional
82786|NCT03048292|Neurointervention|neurointervention
82787|NCT03048292|Stroke|stroke
82788|NCT03048292|Ischemic|ischemic
82789|NCT03048292|Acute|acute
82790|NCT03048292|Endovascular|endovascular
82791|NCT03048292|Cerebrovascular|cerebrovascular
82792|NCT03048292|Clot|clot
82793|NCT03048292|Stent Retriever|stent retriever
82794|NCT03048292|Tissue Plasminogen Activator|tissue plasminogen activator
82795|NCT03048292|Drip and Ship|drip and ship
82796|NCT03048292|Mothership|mothership
82797|NCT03048292|Trip and Treat|trip and treat
82798|NCT03048279|Multiple Endocrine Neoplasia Syndromes|multiple endocrine neoplasia syndromes
82799|NCT03048279|MEN1|men1
82800|NCT03048279|MEN2|men2
82801|NCT03048279|Relatives|relatives
82802|NCT03048279|Database|database
82803|NCT03048279|Questionnaires|questionnaires
82804|NCT03048279|Surveys|surveys
82805|NCT03048266|Multiple endocrine neoplasia|multiple endocrine neoplasia
82806|NCT03048266|MEN1|men1
82807|NCT03048266|Aggressive pancreatic neuroendocrine tumors|aggressive pancreatic neuroendocrine tumors
82808|NCT03048266|PNET|pnet
82809|NCT03048266|Non-aggressive pancreatic neuroendocrine tumors|non-aggressive pancreatic neuroendocrine tumors
82810|NCT03048266|Metabolomics|metabolomics
82811|NCT03048266|Genetics|genetics
82812|NCT03048266|Biomarkers|biomarkers
82813|NCT03048240|Glioblastoma|glioblastoma
82814|NCT03048227|TIDM|tidm
82815|NCT03048227|Type1diabetes|type1diabetes
82816|NCT03048227|Implantable Pump|implantable pump
82817|NCT03048227|CGM|cgm
82818|NCT03048214|Nerve block; Infraclavicular; Acute pain|nerve block; infraclavicular; acute pain
82819|NCT03048201|Physica KR|physica kr
82820|NCT03048201|Physica CR|physica cr
82821|NCT03048201|Physica PS|physica ps
82822|NCT03048201|Kinematic Retaining|kinematic retaining
82823|NCT03048201|Cruciate Retaining|cruciate retaining
82824|NCT03048201|Posterior Stabilized|posterior stabilized
82825|NCT03048201|Physica System|physica system
82826|NCT03048175|C-reactive protein|c-reactive protein
82827|NCT03048175|Systemic inflammation|systemic inflammation
82828|NCT03048175|Third molar|third molar
82829|NCT03048175|Wisdom tooth|wisdom tooth
82830|NCT03048149|hazelnut allergy|hazelnut allergy
82831|NCT03048123|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
82832|NCT03048123|Transarterial Chemoembolization|transarterial chemoembolization
82833|NCT03048123|Large and unresectable HCC|large and unresectable hcc
82834|NCT03048071|Contegra|contegra
82835|NCT03048071|Homograft|homograft
82836|NCT03048045|chronic periodontitis|chronic periodontitis
82837|NCT03048045|aggressive periodontitis|aggressive periodontitis
82838|NCT03048045|supportive periodontal treatment|supportive periodontal treatment
82839|NCT03048032|acute heart failure|acute heart failure
82840|NCT03048032|right ventricular failure|right ventricular failure
82841|NCT03048032|cardiac biomarkers|cardiac biomarkers
82842|NCT03048032|echocardiography|echocardiography
82843|NCT03048032|diagnosis|diagnosis
82844|NCT03048032|prognosis|prognosis
82845|NCT03047993|Myelodysplastic syndrome|myelodysplastic syndrome
82846|NCT03047993|MDS|mds
82847|NCT03047993|Other diseases of blood and blood-forming organs|other diseases of blood and blood-forming organs
82848|NCT03047993|CB-839|cb-839
82849|NCT03047993|Azacitidine|azacitidine
82850|NCT03047993|5-azacytidine|5-azacytidine
82851|NCT03047993|5-aza|5-aza
82852|NCT03047993|Vidaza|vidaza
82853|NCT03047993|5-AZC|5-azc
82854|NCT03047993|AZA-CR|aza-cr
82855|NCT03047993|Ladakamycin|ladakamycin
82856|NCT03047993|NSC-102816|nsc-102816
82857|NCT03047993|Azacytidine|azacytidine
82858|NCT03047993|Pharmacokinetic testing|pharmacokinetic testing
82859|NCT03047993|Pharmacodynamic testing|pharmacodynamic testing
82860|NCT03047980|SWS|sws
82861|NCT03047980|Cognitive impairment|cognitive impairment
82862|NCT03047980|sirolimus|sirolimus
82863|NCT03047915|Anxiety|anxiety
82864|NCT03047915|Music intervention|music intervention
82865|NCT03047915|Emergency department (ED)|emergency department (ed)
82866|NCT03047902|Adolescent Smoking Cessation Asthma Carbon Monoxide.|adolescent smoking cessation asthma carbon monoxide.
82867|NCT03047876|cardiac|cardiac
82868|NCT03047876|aortic arch surgery|aortic arch surgery
82869|NCT03047876|Brain vascular reactivity|brain vascular reactivity
82870|NCT03047876|neonates|neonates
82871|NCT03047876|infants|infants
82872|NCT03047863|Epidermal Growth Factor|epidermal growth factor
82873|NCT03047850|Sternotomy|sternotomy
82874|NCT03047837|Colorectal cancer|colorectal cancer
82875|NCT03047837|aspirin|aspirin
82876|NCT03047837|metformin|metformin
82877|NCT03047837|chemoprevention|chemoprevention
82878|NCT03047798|centella asiatica|centella asiatica
82879|NCT03047798|bamboo salt|bamboo salt
82880|NCT03047798|magnolia bark|magnolia bark
82881|NCT03047798|gingivitis|gingivitis
82882|NCT03047798|dental plaque|dental plaque
82883|NCT03047798|mouthrinse|mouthrinse
82884|NCT03047785|Myocardial Infarction|myocardial infarction
82885|NCT03047785|Highly sensitive troponin|highly sensitive troponin
82886|NCT03047785|Hospital population|hospital population
82887|NCT03047785|99th percentile|99th percentile
82888|NCT03047785|Upper limit of normal|upper limit of normal
82889|NCT03047733|Vitiligo|vitiligo
82890|NCT03047733|308 nm excimer laser|308 nm excimer laser
82891|NCT03047720|bedwetting|bedwetting
82892|NCT03047707|ultrasound elastography|ultrasound elastography
82893|NCT03047707|S-Shearwave|s-shearwave
82894|NCT03047707|liver|liver
82895|NCT03047707|fibrosis|fibrosis
82896|NCT03047694|Lexico-semantic stimulation|lexico-semantic stimulation
82897|NCT03047694|tactile tablet|tactile tablet
82898|NCT03047681|TAVR|tavr
82899|NCT03047681|tryptse|tryptse
82900|NCT03047681|mast|mast
82901|NCT03047642|biomarker|biomarker
82902|NCT03047642|low and middle income countries|low and middle income countries
82903|NCT03047642|fever|fever
83494|NCT03043729|neoadjuvant|neoadjuvant
82904|NCT03047642|antimicrobial resistance|antimicrobial resistance
82905|NCT03047642|diagnostic|diagnostic
82906|NCT03047629|non-motor symptoms|non-motor symptoms
82907|NCT03047603|Hepatocellular carcinoma|hepatocellular carcinoma
82908|NCT03047603|Protein induced by vitamin K absence or antagonist-II|protein induced by vitamin k absence or antagonist-ii
82909|NCT03047603|Differential diagnosis|differential diagnosis
82910|NCT03047603|Des-γ-carboxy prothrombin|des-γ-carboxy prothrombin
82911|NCT03047603|Alpha-fetoprotein|alpha-fetoprotein
82912|NCT03047603|Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein-fetoprotein|lens culinaris agglutinin-reactive fraction of alpha-fetoprotein-fetoprotein
82913|NCT03047590|exercise behavior|exercise behavior
82914|NCT03047590|exercise prescription|exercise prescription
82915|NCT03047590|affect-based exercise|affect-based exercise
82916|NCT03047590|affect-guided exercise|affect-guided exercise
82917|NCT03047590|self-paced exercise|self-paced exercise
82918|NCT03047590|self-selected exercise|self-selected exercise
82919|NCT03047577|Brief intervention|brief intervention
82920|NCT03047577|Alcohol|alcohol
82921|NCT03047577|Alcohol use disorder|alcohol use disorder
82922|NCT03047577|Intensive care unit|intensive care unit
82923|NCT03047577|Critically ill|critically ill
82924|NCT03047577|Audit|audit
82925|NCT03047564|Total Knee Arthroplasty|total knee arthroplasty
82926|NCT03047564|Total Knee Replacement|total knee replacement
82927|NCT03047564|Outcome|outcome
82928|NCT03047564|Metal ion concentration|metal ion concentration
82929|NCT03047564|Results|results
82930|NCT03047551|Abortion, induced|abortion, induced
82931|NCT03047551|Ultrasonography|ultrasonography
82932|NCT03047551|Health Services accessibility|health services accessibility
82933|NCT03047551|Pragmatic Clinical Trial|pragmatic clinical trial
82934|NCT03047551|Randomized controlled trial as topic|randomized controlled trial as topic
82935|NCT03047538|Arterial hypertension|arterial hypertension
82936|NCT03047538|Dyslipidemia|dyslipidemia
82937|NCT03047538|Blood pressure control|blood pressure control
82938|NCT03047538|Fixed combination|fixed combination
82939|NCT03047525|cytokine-induced killer cell|cytokine-induced killer cell
82940|NCT03047525|dendritic and cytokine-induced killer cells|dendritic and cytokine-induced killer cells
82941|NCT03047512|Depression in adolescents|depression in adolescents
82942|NCT03047512|Mental Health|mental health
82943|NCT03047512|E-mental health|e-mental health
82944|NCT03047512|Prevention and Early intervention|prevention and early intervention
82945|NCT03047486|insulin pump|insulin pump
82946|NCT03047486|continuous glucose monitoring sensor|continuous glucose monitoring sensor
82947|NCT03047486|predictive low glucose suspend|predictive low glucose suspend
82948|NCT03047473|newly diagnosed|newly diagnosed
82949|NCT03047460|motor evoked potential|motor evoked potential
82950|NCT03047460|somatosensory evoked potentials|somatosensory evoked potentials
82951|NCT03047460|biomarker|biomarker
82952|NCT03047408|REM Sleep Behavior Disorder|rem sleep behavior disorder
82953|NCT03047408|Parkinson's Disease|parkinson's disease
82954|NCT03047408|REM sleep without Atonia|rem sleep without atonia
82955|NCT03047395|ABBV-066|abbv-066
82956|NCT03047395|BI 655066|bi 655066
82957|NCT03047369|leukodystrophy|leukodystrophy
82958|NCT03047369|white matter disease|white matter disease
82959|NCT03047369|leukoencephalopathy|leukoencephalopathy
82960|NCT03047369|myelin|myelin
82961|NCT03047369|demyelinating|demyelinating
82962|NCT03047369|mdbp|mdbp
82963|NCT03047343|pulmonary artery strapping|pulmonary artery strapping
82964|NCT03047330|menopause|menopause
82965|NCT03047330|sleep fragmentation|sleep fragmentation
82966|NCT03047330|leuprolide|leuprolide
82967|NCT03047330|adipokine|adipokine
82968|NCT03047330|weight gain|weight gain
82969|NCT03047330|leptin|leptin
82970|NCT03047317|pharmacokinetics|pharmacokinetics
82971|NCT03047291|mucositis, periimplantitis, probiotic|mucositis, periimplantitis, probiotic
82972|NCT03047226|Lynch Syndrome|lynch syndrome
82973|NCT03047226|mismatch repair|mismatch repair
82974|NCT03047226|microsatellite instability|microsatellite instability
82975|NCT03047226|next-generation sequencing|next-generation sequencing
82976|NCT03047226|immunohistochemistry|immunohistochemistry
82977|NCT03047200|Diabetes Mellitus|diabetes mellitus
82978|NCT03047200|Hypoglycemia|hypoglycemia
82979|NCT03047200|Hyperglycemia|hyperglycemia
82980|NCT03047200|Type 1 Diabetes|type 1 diabetes
82981|NCT03047200|Islet Cell Transplantation|islet cell transplantation
82982|NCT03047174|Head and Neck Neoplasms, Radio(chemo)therapy|head and neck neoplasms, radio(chemo)therapy
82983|NCT03047161|magnetocardiography|magnetocardiography
82984|NCT03047135|high-risk biochemically-recurrent|high-risk biochemically-recurrent
82985|NCT03047122|Breast|breast
82986|NCT03047122|ultrasonography|ultrasonography
82987|NCT03047109|Ephedrine|ephedrine
82988|NCT03047109|Phenylephrine|phenylephrine
82989|NCT03047109|Spinal Hypotension|spinal hypotension
82990|NCT03047109|Cesarean Section|cesarean section
82991|NCT03047109|Maternal Cardiodynamics|maternal cardiodynamics
82992|NCT03047083|Retrospective|retrospective
82993|NCT03047083|Non-interventional Study|non-interventional study
82994|NCT03047083|FMS-like tyrosine kinase-3 (FLT3) mutations|fms-like tyrosine kinase-3 (flt3) mutations
82995|NCT03047044|lumbar fusion surgery|lumbar fusion surgery
82996|NCT03047044|Patient Controlled Analgesia|patient controlled analgesia
82997|NCT03047044|Optimizing Basal Infusion Mode|optimizing basal infusion mode
82998|NCT03047018|Nutrition|nutrition
82999|NCT03046992|EGFR|egfr
83000|NCT03046992|Non-Small Cell Lung Cancer|non-small cell lung cancer
83001|NCT03046992|T790M|t790m
83002|NCT03046992|Brain Metastasis|brain metastasis
83003|NCT03046979|apatinib|apatinib
83004|NCT03046979|advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
83005|NCT03046953|Lymphoma|lymphoma
83006|NCT03046927|Type 1 diabetes|type 1 diabetes
83007|NCT03046927|vitamin D|vitamin d
83008|NCT03046927|honeymoon phase|honeymoon phase
83009|NCT03046901|Vancomycin|vancomycin
83010|NCT03046901|Primary Sclerosing cholangitis|primary sclerosing cholangitis
83011|NCT03046901|Post-liver transplantation|post-liver transplantation
83012|NCT03046849|Lynch Syndrome|lynch syndrome
83013|NCT03046849|next-generation sequencing|next-generation sequencing
83014|NCT03046849|germline mutation|germline mutation
83015|NCT03046836|Couples|couples
83016|NCT03046836|Oxytocin|oxytocin
83017|NCT03046836|Aggression|aggression
83018|NCT03046836|Alcohol|alcohol
83019|NCT03046771|falls|falls
83020|NCT03046771|readmissions|readmissions
83021|NCT03046771|emergency department visits|emergency department visits
83022|NCT03046771|transitions of care|transitions of care
83023|NCT03046745|Gastric cancer, endoscopy, pepsinogen, TFF3, biomarker|gastric cancer, endoscopy, pepsinogen, tff3, biomarker
83024|NCT03046732|Kidney Transplant Education|kidney transplant education
83025|NCT03046732|Transplant Readiness|transplant readiness
83026|NCT03046732|Living Donor Kidney Transplant|living donor kidney transplant
83027|NCT03046732|Chronic Kidney Disease|chronic kidney disease
83028|NCT03046732|End Stage Kidney Disease|end stage kidney disease
83029|NCT03046732|Renal Replacement Therapy|renal replacement therapy
83030|NCT03046719|bupivacaine|bupivacaine
83031|NCT03046719|intravitreal|intravitreal
83032|NCT03046719|analgesia|analgesia
83033|NCT03046719|silicone oil removal|silicone oil removal
83034|NCT03046719|retinal detachment|retinal detachment
83035|NCT03046719|subconjunctival|subconjunctival
83036|NCT03046706|voice rest|voice rest
83037|NCT03046706|laryngeal surgery|laryngeal surgery
83038|NCT03046706|glottic polyp|glottic polyp
83039|NCT03046706|glottic cyst|glottic cyst
83040|NCT03046693|Non-arteritic anterior ischemic optic neuropathy|non-arteritic anterior ischemic optic neuropathy
83041|NCT03046693|pattern electroretinography|pattern electroretinography
83042|NCT03046693|citicoline|citicoline
83043|NCT03046693|retinal ganglion cell|retinal ganglion cell
83044|NCT03046693|visual field|visual field
83045|NCT03046667|Beta glucans|beta glucans
83046|NCT03046667|Barley|barley
83047|NCT03046667|SCFA|scfa
83048|NCT03046667|Calprotectin|calprotectin
83049|NCT03046667|Microbiota|microbiota
83050|NCT03046667|Hydrogene|hydrogene
83051|NCT03046667|Methane|methane
83052|NCT03046667|Metabolomics|metabolomics
83053|NCT03046667|Stool volume|stool volume
83054|NCT03046667|Stool frequency|stool frequency
83055|NCT03046641|Caloric Restriction|caloric restriction
83056|NCT03046641|Dietary Formulations|dietary formulations
83057|NCT03046641|Exercise|exercise
83058|NCT03046641|Men|men
83059|NCT03046615|EEG electrodes|eeg electrodes
83060|NCT03046563|acupressure|acupressure
83061|NCT03046563|abdominal massage|abdominal massage
83062|NCT03046563|constipation|constipation
83063|NCT03046563|stroke patients|stroke patients
83064|NCT03046563|Traditional Chinese medicine|traditional chinese medicine
83065|NCT03046524|Parathyroid Carcinoma|parathyroid carcinoma
83066|NCT03046524|Parathyroid Neoplasm|parathyroid neoplasm
83067|NCT03046524|Chart Review|chart review
83068|NCT03046485|AMD|amd
83069|NCT03046485|vision loss|vision loss
83070|NCT03046485|self-management strategies|self-management strategies
83071|NCT03046485|low-vision rehabilitation|low-vision rehabilitation
83072|NCT03046485|IVI|ivi
83073|NCT03046472|thorax curve angle|thorax curve angle
83074|NCT03046459|cytokines|cytokines
83075|NCT03046459|interleukin-2|interleukin-2
83076|NCT03046459|Safety Issues|safety issues
83077|NCT03046446|Osteoarthritis|osteoarthritis
83078|NCT03046446|Knee|knee
83079|NCT03046446|Pain|pain
83080|NCT03046446|Steroid|steroid
83081|NCT03046446|Intra-articular|intra-articular
83082|NCT03046446|Injection|injection
83083|NCT03046433|children|children
83084|NCT03046433|asthma|asthma
83085|NCT03046433|China|china
83086|NCT03046394|prosthetic feet|prosthetic feet
83087|NCT03046394|gait pattern|gait pattern
83088|NCT03046394|one leg standing|one leg standing
83089|NCT03046394|walking speed|walking speed
83090|NCT03046342|Gastroenteritis, Polymerase chain reaction|gastroenteritis, polymerase chain reaction
83091|NCT03046329|patient care planning|patient care planning
83092|NCT03046316|Therapeutics|therapeutics
83093|NCT03046303|ERAS,gastric cancer|eras,gastric cancer
83094|NCT03046264|central blood pressure|central blood pressure
83095|NCT03046264|measurement|measurement
83096|NCT03046264|oscillometric radial pulse wave analysis|oscillometric radial pulse wave analysis
83097|NCT03046186|Gastric sleeve|gastric sleeve
83098|NCT03046186|Gastric bypass|gastric bypass
83099|NCT03046160|PPT|ppt
83100|NCT03046160|Scapula|scapula
83101|NCT03046160|Intervention|intervention
83102|NCT03046160|Manual therapy|manual therapy
83103|NCT03046160|mobilization|mobilization
83104|NCT03046121|dementia|dementia
83105|NCT03046121|acute care|acute care
83106|NCT03046121|post-acute recovery|post-acute recovery
83107|NCT03046121|family caregivers|family caregivers
83108|NCT03046095|Muscle Hypertrophy|muscle hypertrophy
83109|NCT03046095|Muscle Atrophy|muscle atrophy
83110|NCT03046095|Resistance Training|resistance training
83111|NCT03046095|Immobilization|immobilization
83112|NCT03046069|Triple therapy|triple therapy
83113|NCT03046069|COPD|copd
83114|NCT03046069|DCE|dce
83115|NCT03046069|Qualitative|qualitative
83116|NCT03046004|breast cancer|breast cancer
83117|NCT03046004|screening|screening
83118|NCT03046004|decision aid|decision aid
83119|NCT03046004|informed choice|informed choice
83120|NCT03046004|decisional conflict|decisional conflict
83121|NCT03045965|Salpingectomy|salpingectomy
83122|NCT03045965|Hysterectomy|hysterectomy
83123|NCT03045965|Ovarian cancer|ovarian cancer
83124|NCT03045952|Multicenter study|multicenter study
83125|NCT03045952|microwave|microwave
83126|NCT03045939|cervical ripening|cervical ripening
83127|NCT03045939|labor induction|labor induction
83128|NCT03045939|double balloon device|double balloon device
83129|NCT03045939|cervical ripening device|cervical ripening device
83130|NCT03045939|unfavorable cervix|unfavorable cervix
83131|NCT03045913|Observational registry|observational registry
83132|NCT03045913|All-comers open label registry|all-comers open label registry
83133|NCT03045913|Genoss DES|genoss des
83134|NCT03045913|Multicenter|multicenter
83135|NCT03045913|Stenting|stenting
83136|NCT03045913|Coronary Artery Disease|coronary artery disease
83137|NCT03045913|Coronary revascularization|coronary revascularization
83138|NCT03045913|Percutaneous Coronary Intervention|percutaneous coronary intervention
83139|NCT03045887|repeat dose|repeat dose
83140|NCT03045887|GSK2292767|gsk2292767
83141|NCT03045887|smoke|smoke
83142|NCT03045887|tolerability|tolerability
83143|NCT03045887|safety|safety
83144|NCT03045887|dry powder inhalation|dry powder inhalation
83145|NCT03045887|pharmacokinetics|pharmacokinetics
83146|NCT03045887|single dose|single dose
83147|NCT03045848|Observational registry|observational registry
83148|NCT03045848|All-comers open label registry|all-comers open label registry
83149|NCT03045848|Drug coated stent|drug coated stent
83150|NCT03045848|Multicenter|multicenter
83151|NCT03045848|Stenting|stenting
83152|NCT03045848|Coronary Artery Disease|coronary artery disease
83153|NCT03045848|Coronary revascularization|coronary revascularization
83154|NCT03045848|Percutaneous Coronary Intervention|percutaneous coronary intervention
83155|NCT03045835|laparoscopic cholecystectomy BASKA mask Endotracheal tube|laparoscopic cholecystectomy baska mask endotracheal tube
83156|NCT03045822|Bioimpedance analysis|bioimpedance analysis
83157|NCT03045822|implantable cardioverter-defibrillators|implantable cardioverter-defibrillators
83158|NCT03045822|pacemakers|pacemakers
83159|NCT03045809|Syndromic management|syndromic management
83160|NCT03045809|Point of care testing|point of care testing
83161|NCT03045783|gastric varices|gastric varices
83162|NCT03045783|endoscopic injection of tissue adhesive|endoscopic injection of tissue adhesive
83163|NCT03045731|kidney transplantation|kidney transplantation
83164|NCT03045731|ultrasound|ultrasound
83165|NCT03045731|mathematical model|mathematical model
83166|NCT03045718|Horticultural Therapy|horticultural therapy
83167|NCT03045718|Dementia|dementia
83168|NCT03045718|Randomized Controlled Trial|randomized controlled trial
83169|NCT03045718|Elderly|elderly
83170|NCT03045718|Prevention|prevention
83171|NCT03045692|drug dosing, eGFR, CCr|drug dosing, egfr, ccr
83172|NCT03045679|Roux-en Y gastric bypass|roux-en y gastric bypass
83173|NCT03045679|One-anastomosis gastric bypass|one-anastomosis gastric bypass
83174|NCT03045679|Mini-gastric bypass|mini-gastric bypass
83175|NCT03045679|metabolic surgery|metabolic surgery
83176|NCT03045653|Breast Cancer|breast cancer
83177|NCT03045653|high dose Tamoxifen|high dose tamoxifen
83178|NCT03045653|endocrine therapy|endocrine therapy
83179|NCT03045653|Hormone Receptor Positive Malignant Neoplasm of Breast|hormone receptor positive malignant neoplasm of breast
83180|NCT03045653|Tamoxifen|tamoxifen
83181|NCT03045653|Breast Cancer Metastatic|breast cancer metastatic
83182|NCT03045640|ECD|ecd
83183|NCT03045640|parenting program|parenting program
83184|NCT03045640|home visiting|home visiting
83185|NCT03045627|Acute Myeloid Leukemia|acute myeloid leukemia
83186|NCT03045627|PEG-G-CSF|peg-g-csf
83187|NCT03045601|Diagnostic Techniques, Cardiovascular|diagnostic techniques, cardiovascular
83188|NCT03045601|Coronary Angiography|coronary angiography
83189|NCT03045601|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
83190|NCT03045601|Echocardiography, Stress|echocardiography, stress
83191|NCT03045510|Decitabine Myelodysplastic syndrome|decitabine myelodysplastic syndrome
83192|NCT03045484|nasopharyngeal carcinoma|nasopharyngeal carcinoma
83193|NCT03045484|Oral Mucositis Pain|oral mucositis pain
83194|NCT03045484|Oxycodone|oxycodone
83195|NCT03045458|one stage dental implant|one stage dental implant
83196|NCT03045458|two stage dental implant|two stage dental implant
83197|NCT03045458|Interleukin-1β|interleukin-1β
83198|NCT03045445|CT|ct
83199|NCT03045445|dual energy|dual energy
83200|NCT03045445|low dose|low dose
83201|NCT03045432|Stroke|stroke
83202|NCT03045432|Hemiplegia|hemiplegia
83203|NCT03045432|Rotator Cuff Injury|rotator cuff injury
83204|NCT03045419|MRI|mri
83205|NCT03045419|gadoxetic acid|gadoxetic acid
83206|NCT03045419|CT|ct
83207|NCT03045393|Neoadjuvant|neoadjuvant
83208|NCT03045393|Breast Cancer|breast cancer
83209|NCT03045393|Folate Receptor Alpha|folate receptor alpha
83210|NCT03045393|FRa|fra
83211|NCT03045393|TNBC|tnbc
83212|NCT03045393|Triple Negative Breast Cancer|triple negative breast cancer
83213|NCT03045393|Preoperative|preoperative
83214|NCT03045393|Presurgery|presurgery
83215|NCT03045393|Mirvetuximab Soravtansine|mirvetuximab soravtansine
83216|NCT03045393|IMGN853|imgn853
83217|NCT03045367|Metamorphopsia|metamorphopsia
83218|NCT03045367|Epiretinal membrane|epiretinal membrane
83219|NCT03045367|Vitrectomy|vitrectomy
83220|NCT03045354|children|children
83221|NCT03045354|dietary carbohydrates|dietary carbohydrates
83222|NCT03045354|satiety|satiety
83223|NCT03045354|appetite|appetite
83224|NCT03045354|blood glucose|blood glucose
83225|NCT03045354|solanum tuberosum|solanum tuberosum
83226|NCT03045354|obesity|obesity
83227|NCT03045354|breakfast|breakfast
83228|NCT03045276|Spina Bifida|spina bifida
83229|NCT03045276|Kidney Transplant|kidney transplant
83230|NCT03045263|ASD|asd
83231|NCT03045237|Pregnancy|pregnancy
83232|NCT03045237|Physical activity|physical activity
83233|NCT03045237|Newborn|newborn
83234|NCT03045237|Depressive Symptoms|depressive symptoms
83235|NCT03045237|Dietary habits|dietary habits
83236|NCT03045237|Healthy lifestyles|healthy lifestyles
83237|NCT03045224|PAD, PTA, mortality, morbidity, amputation rate, quality of life|pad, pta, mortality, morbidity, amputation rate, quality of life
83238|NCT03045224|Percutaneous transluminal angioplasty (PTA), Stenting, balloon angioplasty|percutaneous transluminal angioplasty (pta), stenting, balloon angioplasty
83239|NCT03045198|cystic fibrosis|cystic fibrosis
83240|NCT03045185|Non Vital teeth|non vital teeth
83241|NCT03045185|Traumatised teeth|traumatised teeth
83242|NCT03045185|Immature teeth|immature teeth
83243|NCT03045185|Regenerative Endodontics|regenerative endodontics
83244|NCT03045172|Lichen Sclerosus|lichen sclerosus
83245|NCT03045172|Platelet Rich Plasma|platelet rich plasma
83246|NCT03045172|Vulvar|vulvar
83247|NCT03045172|Vulva|vulva
83248|NCT03045159|deployment cycle|deployment cycle
83249|NCT03045159|military family|military family
83250|NCT03045159|prevention|prevention
83251|NCT03045159|stress|stress
83252|NCT03045159|military child|military child
83253|NCT03045159|parenting|parenting
83254|NCT03045159|coparenting|coparenting
83255|NCT03045146|Acute Ischemic Stroke, Thrombectomy|acute ischemic stroke, thrombectomy
83256|NCT03045133|Postoperative pain|postoperative pain
83257|NCT03045133|Postoperative nausea and vomiting|postoperative nausea and vomiting
83258|NCT03045133|Quality of recovery|quality of recovery
83259|NCT03045133|QoR-40|qor-40
83260|NCT03045133|Total intravenous anesthesia|total intravenous anesthesia
83261|NCT03045107|right colon|right colon
83262|NCT03045107|laparoscopic right colectomy|laparoscopic right colectomy
83263|NCT03045107|intracorporeal anastomosis|intracorporeal anastomosis
83264|NCT03045107|extracorporeal anastomosis|extracorporeal anastomosis
83265|NCT03045107|hospital stay|hospital stay
83266|NCT03045107|quality of life|quality of life
83267|NCT03045107|costs|costs
83268|NCT03045094|pediatric|pediatric
83269|NCT03045094|intubation|intubation
83270|NCT03045094|neck movement|neck movement
83271|NCT03045055|Acute ischemic stroke|acute ischemic stroke
83272|NCT03045055|Endovascular treatment|endovascular treatment
83273|NCT03045055|Remote ischemic conditioning|remote ischemic conditioning
83274|NCT03045042|Pompe|pompe
83275|NCT03045042|microRNA|microrna
83276|NCT03045042|biomarker|biomarker
83277|NCT03045042|muscle MRI|muscle mri
83278|NCT03045042|glycogenosis|glycogenosis
83279|NCT03045029|PAH|pah
83280|NCT03045029|Oral Treprostiinil|oral treprostiinil
83281|NCT03045029|Orenitram|orenitram
83282|NCT03045016|Acute stress Disorder|acute stress disorder
83283|NCT03045016|Post Traumatic Stress Disorder|post traumatic stress disorder
83284|NCT03045016|Prevention|prevention
83285|NCT03045016|trauma|trauma
83286|NCT03045016|prazosin|prazosin
83287|NCT03045003|Resilience, Supportive Care, Psychosocial Care, Nursing|resilience, supportive care, psychosocial care, nursing
83288|NCT03044990|Acute coronary syndrome|acute coronary syndrome
83289|NCT03044990|renal insufficiency|renal insufficiency
83290|NCT03044990|mortality|mortality
83291|NCT03044977|3-Iodobenzylguanidine|3-iodobenzylguanidine
83292|NCT03044977|dose-response relationship, radiation|dose-response relationship, radiation
83294|NCT03044977|radionuclide|radionuclide
83295|NCT03044977|MIBG|mibg
83296|NCT03044977|DOTA|dota
83297|NCT03044964|Angina, Chest Pain|angina, chest pain
83298|NCT03044951|atrial fibrillation|atrial fibrillation
83299|NCT03044951|cryoablation|cryoablation
83300|NCT03044951|irrigated radiofrequency ablation|irrigated radiofrequency ablation
83301|NCT03044951|pulmonary vein isolation|pulmonary vein isolation
83302|NCT03044938|Asthma|asthma
83303|NCT03044938|Salbutamol|salbutamol
83304|NCT03044938|Exercise|exercise
83305|NCT03044938|Heart Rate|heart rate
83306|NCT03044938|Blood pressure|blood pressure
83307|NCT03044925|persistent atrial fibrillation|persistent atrial fibrillation
83308|NCT03044925|remote magnetic navigation|remote magnetic navigation
83309|NCT03044925|cryoablation|cryoablation
83310|NCT03044899|Surgery|surgery
83311|NCT03044899|Complications|complications
83312|NCT03044899|Mortality|mortality
83313|NCT03044886|Vitamin D|vitamin d
83314|NCT03044821|Neural Tube Defect|neural tube defect
83315|NCT03044795|homologous recombination deficiency|homologous recombination deficiency
83316|NCT03044795|veliparib|veliparib
83317|NCT03044795|PARP inhibitor|parp inhibitor
83318|NCT03044795|biomarker|biomarker
83319|NCT03044769|Congenital Lung Anomalies|congenital lung anomalies
83320|NCT03044756|GnRH antagonist|gnrh antagonist
83321|NCT03044756|Pituitary downregulation|pituitary downregulation
83322|NCT03044756|IVF|ivf
83323|NCT03044756|ICSI|icsi
83324|NCT03044743|PD-1|pd-1
83325|NCT03044743|CRISPR Cas9|crispr cas9
83326|NCT03044743|EBV|ebv
83327|NCT03044743|advanced stage malignancies|advanced stage malignancies
83328|NCT03044717|Nutrition Education|nutrition education
83329|NCT03044717|Cardiology Fellows|cardiology fellows
83330|NCT03044652|Vulvovaginal Dryness|vulvovaginal dryness
83331|NCT03044626|Nivolumab|nivolumab
83332|NCT03044626|Radiotherapy|radiotherapy
83333|NCT03044600|Parathyroid disease|parathyroid disease
83334|NCT03044600|Hyperparathyroidism|hyperparathyroidism
83335|NCT03044600|Chart review|chart review
83336|NCT03044600|MEN1-negative|men1-negative
83337|NCT03044600|HRPT2 mutations|hrpt2 mutations
83338|NCT03044587|Biliary Tract Cancer|biliary tract cancer
83339|NCT03044587|NaI-IRI|nai-iri
83340|NCT03044574|venous thromboembolism|venous thromboembolism
83341|NCT03044574|deep vein thrombosis|deep vein thrombosis
83342|NCT03044574|pulmonary embolism|pulmonary embolism
83343|NCT03044574|prevention|prevention
83344|NCT03044574|intermittent pneumatic compression|intermittent pneumatic compression
83345|NCT03044574|sequential pneumatic compression|sequential pneumatic compression
83346|NCT03044574|surgery|surgery
83347|NCT03044574|elastic compression|elastic compression
83348|NCT03044574|low-molecular weight heparin|low-molecular weight heparin
83349|NCT03044574|prophylaxis|prophylaxis
83350|NCT03044535|quality of life|quality of life
83351|NCT03044535|mechanical circulatory support|mechanical circulatory support
83352|NCT03044509|Immunodiagnostics tests|immunodiagnostics tests
83353|NCT03044509|TB exposure|tb exposure
83354|NCT03044509|Latent TB|latent tb
83355|NCT03044509|TB disease|tb disease
83356|NCT03044509|Biomarkers|biomarkers
83357|NCT03044496|NIR Spectroscopy|nir spectroscopy
83358|NCT03044496|Nerve Blockade|nerve blockade
83359|NCT03044496|Surgical Arteriovenous Shunt|surgical arteriovenous shunt
83360|NCT03044483|Sepsis|sepsis
83361|NCT03044483|Microcirculatory function|microcirculatory function
83362|NCT03044444|performance|performance
83363|NCT03044444|polyphenols|polyphenols
83364|NCT03044444|nutrition|nutrition
83365|NCT03044444|sports|sports
83366|NCT03044431|Shortness of breath|shortness of breath
83367|NCT03044431|Breathlessness|breathlessness
83368|NCT03044431|Stem cells|stem cells
83369|NCT03044431|Platelet rich plasma|platelet rich plasma
83370|NCT03044431|Quality of life|quality of life
83371|NCT03044431|Pulmonary Function|pulmonary function
83372|NCT03044418|laser|laser
83373|NCT03044418|endotracheal tube|endotracheal tube
83374|NCT03044418|total intravenous anesthesia|total intravenous anesthesia
83375|NCT03044418|side effect|side effect
83376|NCT03044418|endolaryngeal surgery|endolaryngeal surgery
83377|NCT03044405|fluid responsiveness|fluid responsiveness
83378|NCT03044405|focused echocardiography|focused echocardiography
83379|NCT03044405|major surgery|major surgery
83380|NCT03044392|Programmed Intermittent Epidural Bolus|programmed intermittent epidural bolus
83381|NCT03044392|Labour Analgesia|labour analgesia
83382|NCT03044392|Pain|pain
83383|NCT03044353|echocardiography (ECHO)|echocardiography (echo)
83384|NCT03044353|skin biopsy|skin biopsy
83385|NCT03044353|monoclonal anti-serum amyloid p component antibody (anti-SAP mAb)|monoclonal anti-serum amyloid p component antibody (anti-sap mab)
83386|NCT03044353|Amyloidosis|amyloidosis
83387|NCT03044353|cardiac magnetic resonance imaging (CMR)|cardiac magnetic resonance imaging (cmr)
83388|NCT03044353|biomarkers|biomarkers
83389|NCT03044353|cardiac functional measures|cardiac functional measures
83390|NCT03044353|left ventricular mass|left ventricular mass
83391|NCT03044314|pulmonary hypertension|pulmonary hypertension
83392|NCT03044314|vasodilator challenge|vasodilator challenge
83393|NCT03044314|echocardiography|echocardiography
83394|NCT03044314|outcomes|outcomes
83395|NCT03044314|iloprost|iloprost
83396|NCT03044314|inhaled nitric oxide|inhaled nitric oxide
83397|NCT03044249|Psychotic Disorders|psychotic disorders
83398|NCT03044223|pseudomonas aeruginosa|pseudomonas aeruginosa
83399|NCT03044223|critically ill patient|critically ill patient
83400|NCT03044223|sepsis|sepsis
83401|NCT03044223|monocyte|monocyte
83402|NCT03044223|macrophage|macrophage
83403|NCT03044223|cytokine|cytokine
83404|NCT03044223|severity of disease|severity of disease
83405|NCT03044210|Rest energetic cost measured by indirect calorimetry|rest energetic cost measured by indirect calorimetry
83406|NCT03044210|Hormonal axis|hormonal axis
83407|NCT03044210|Mitochondrial oxidative phosphorylation|mitochondrial oxidative phosphorylation
83408|NCT03044210|Basal metabolism|basal metabolism
83409|NCT03044197|prostate cancer|prostate cancer
83410|NCT03044197|magnetic resonance imaging|magnetic resonance imaging
83411|NCT03044197|transperineal biopsy|transperineal biopsy
83412|NCT03044197|target lesion|target lesion
83413|NCT03044197|fusion biopsy|fusion biopsy
83414|NCT03044184|Tranexamic Acid|tranexamic acid
83415|NCT03044184|Antifibrinolytic|antifibrinolytic
83416|NCT03044158|tuberculosis|tuberculosis
83417|NCT03044158|implementation science|implementation science
83418|NCT03044158|point-of-care|point-of-care
83419|NCT03044158|diagnostics|diagnostics
83420|NCT03044158|GeneXpert|genexpert
83421|NCT03044158|Uganda|uganda
83422|NCT03044145|Cultural Competence|cultural competence
83423|NCT03044145|Patient-Clinician communication|patient-clinician communication
83424|NCT03044132|Diabetic Foot Ulcer|diabetic foot ulcer
83425|NCT03044132|DFU|dfu
83426|NCT03044132|Lower Extremity Wound|lower extremity wound
83427|NCT03044132|Skin Substitute|skin substitute
83428|NCT03044106|hamstrings|hamstrings
83429|NCT03044106|flexibility|flexibility
83430|NCT03044106|strength|strength
83431|NCT03044106|pain pressure threshold|pain pressure threshold
83432|NCT03044106|lllt|lllt
83433|NCT03044106|photobiomodulation|photobiomodulation
83434|NCT03044106|cranial reflex|cranial reflex
83435|NCT03044106|cranial laser reflex technique|cranial laser reflex technique
83436|NCT03044106|CLRT|clrt
83437|NCT03044080|Walking Disorder|walking disorder
83438|NCT03044080|Stroke|stroke
83439|NCT03044080|Botulinum Toxin|botulinum toxin
83440|NCT03044080|Spasticity|spasticity
83441|NCT03044067|Chronic pain|chronic pain
83442|NCT03044067|Fibromyalgia|fibromyalgia
83443|NCT03044067|Pain neuroscience education|pain neuroscience education
83444|NCT03044067|Exercise|exercise
83445|NCT03044054|HIFU|hifu
83446|NCT03044041|Blood loss|blood loss
83447|NCT03044041|Tranexamic acid|tranexamic acid
83448|NCT03044041|Total knee arthroplasty|total knee arthroplasty
83449|NCT03044041|Topical administration|topical administration
83450|NCT03043989|docetaxel|docetaxel
83451|NCT03043989|cabazitaxel|cabazitaxel
83452|NCT03043989|phase 1b|phase 1b
83453|NCT03043989|castration-resistant|castration-resistant
83454|NCT03043989|bone metastasis|bone metastasis
83455|NCT03043976|Physical activity|physical activity
83456|NCT03043976|Steps count|steps count
83457|NCT03043950|mCRC|mcrc
83458|NCT03043950|First line|first line
83459|NCT03043950|Panitumumab|panitumumab
83460|NCT03043950|mCCS Prognostic Score|mccs prognostic score
83461|NCT03043950|Prognosis|prognosis
83462|NCT03043950|Ras wild type|ras wild type
83463|NCT03043924|hypothalamus|hypothalamus
83464|NCT03043924|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
83465|NCT03043924|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
83466|NCT03043911|early detection|early detection
83467|NCT03043911|respiratory events|respiratory events
83468|NCT03043911|sepsis|sepsis
83469|NCT03043872|Carcinoma, Small Cell Lung|carcinoma, small cell lung
83470|NCT03043872|Oat Cell Carcinoma of Lung|oat cell carcinoma of lung
83471|NCT03043872|Oat Cell Lung Cancer|oat cell lung cancer
83472|NCT03043872|Small Cell Cancer Of The Lung|small cell cancer of the lung
83473|NCT03043872|Small Cell Lung Cancer|small cell lung cancer
83474|NCT03043846|Treat to Target approach|treat to target approach
83475|NCT03043820|raloxifene|raloxifene
83476|NCT03043820|selective estrogen receptor modulator (SERM)|selective estrogen receptor modulator (serm)
83477|NCT03043820|schizophrenia|schizophrenia
83478|NCT03043820|psychosis|psychosis
83479|NCT03043820|cognition|cognition
83480|NCT03043820|negative symptoms|negative symptoms
83481|NCT03043807|prostatectomy|prostatectomy
83482|NCT03043807|androgen deprivation|androgen deprivation
83483|NCT03043807|chemotherapy|chemotherapy
83484|NCT03043807|radiation|radiation
83485|NCT03043794|early stage|early stage
83486|NCT03043794|low risk|low risk
83487|NCT03043768|Parkinson's disease|parkinson's disease
83488|NCT03043768|Autonomic|autonomic
83489|NCT03043768|Diagnosis|diagnosis
83490|NCT03043768|Pilomotor|pilomotor
83491|NCT03043768|Alpha-synuclein|alpha-synuclein
83492|NCT03043768|Axon-reflex|axon-reflex
83493|NCT03043768|Peripheral nerve fibers|peripheral nerve fibers
83495|NCT03043729|MRI-defined T3|mri-defined t3
83496|NCT03043729|mFOLFOX6|mfolfox6
83497|NCT03043729|Aflibercept|aflibercept
83498|NCT03043690|menopause|menopause
83499|NCT03043690|ammonium succinate|ammonium succinate
83500|NCT03043664|GEP-NET|gep-net
83501|NCT03043664|Pembrolizumab|pembrolizumab
83502|NCT03043664|Lanreotide depot|lanreotide depot
83503|NCT03043664|PD-1|pd-1
83504|NCT03043651|Pulmonary Hypertension|pulmonary hypertension
83505|NCT03043651|HFpEF|hfpef
83506|NCT03043651|6-Minute Walk Test|6-minute walk test
83507|NCT03043651|Oral Treprostinil|oral treprostinil
83508|NCT03043638|multiple adjacent gingival recessions|multiple adjacent gingival recessions
83509|NCT03043638|platelet rich plasma|platelet rich plasma
83510|NCT03043638|acellular dermal matrix|acellular dermal matrix
83511|NCT03043638|coronally advanced flap|coronally advanced flap
83512|NCT03043638|gingival recession|gingival recession
83513|NCT03043638|root coverage|root coverage
83514|NCT03043638|clinical attachment level|clinical attachment level
83515|NCT03043625|Neck pain|neck pain
83516|NCT03043625|visceral manipulation|visceral manipulation
83517|NCT03043625|functional dyspepsia|functional dyspepsia
83518|NCT03043625|electromyography|electromyography
83519|NCT03043625|pain|pain
83520|NCT03043612|Ureteroscopy for urolithiasis|ureteroscopy for urolithiasis
83521|NCT03043599|Thoracic|thoracic
83522|NCT03043599|Radiotherapy|radiotherapy
83523|NCT03043599|Platinum Based Chemotherapy|platinum based chemotherapy
83524|NCT03043599|Immunotherapy|immunotherapy
83525|NCT03043599|Ipilimumab|ipilimumab
83526|NCT03043599|Nivolumab|nivolumab
83527|NCT03043599|Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC)|extensive-stage disease small cell lung cancer (ed-sclc)
83528|NCT03043586|Acromegaly|acromegaly
83529|NCT03043560|depression|depression
83530|NCT03043560|anhedonia|anhedonia
83531|NCT03043560|reward|reward
83532|NCT03043547|nal-IRI|nal-iri
83533|NCT03043547|5-Fluorouracil|5-fluorouracil
83534|NCT03043508|Genetic mutation|genetic mutation
83535|NCT03043508|MEN1|men1
83536|NCT03043508|Pancreatic neuroendocrine tumor|pancreatic neuroendocrine tumor
83537|NCT03043508|PNET|pnet
83538|NCT03043508|Chart review|chart review
83539|NCT03043508|Questionnaire|questionnaire
83540|NCT03043508|Survey|survey
83541|NCT03043495|dexamethasone|dexamethasone
83542|NCT03043495|supraclavicular brachial plexus block|supraclavicular brachial plexus block
83543|NCT03043495|ultrasound|ultrasound
83544|NCT03043482|VS-105|vs-105
83545|NCT03043482|Renal Insufficiency, Chronic|renal insufficiency, chronic
83546|NCT03043482|Secondary hyperparathyroidism|secondary hyperparathyroidism
83547|NCT03043469|dysfunctional breathing|dysfunctional breathing
83548|NCT03043443|sleep|sleep
83549|NCT03043443|Alcohol dependence|alcohol dependence
83550|NCT03043443|Melatonin|melatonin
83551|NCT03043417|Stigma|stigma
83552|NCT03043417|Primary Health Care|primary health care
83553|NCT03043417|Recovery|recovery
83554|NCT03043391|Pediatric Malignant Glioma|pediatric malignant glioma
83555|NCT03043391|PVSRIPO|pvsripo
83556|NCT03043391|Pro00071228|pro00071228
83557|NCT03043391|Eric Thompson|eric thompson
83558|NCT03043391|Darell Bigner|darell bigner
83559|NCT03043391|Oncolytic Poliovirus|oncolytic poliovirus
83560|NCT03043391|David Ashley|david ashley
83561|NCT03043378|Malignant Neoplasms of Independent (Primary) Multiple Sites|malignant neoplasms of independent (primary) multiple sites
83562|NCT03043378|Non-malignant pain|non-malignant pain
83563|NCT03043378|Supportive care|supportive care
83564|NCT03043378|Questionnaires|questionnaires
83565|NCT03043378|Surveys|surveys
83566|NCT03043378|Chronic non-malignant pain|chronic non-malignant pain
83567|NCT03043365|Fish Oils|fish oils
83568|NCT03043365|Long Chain Monounsaturated Fatty Acids|long chain monounsaturated fatty acids
83569|NCT03043365|Lipoproteins|lipoproteins
83570|NCT03043365|Cardiovascular Disease|cardiovascular disease
83571|NCT03043352|SAM|sam
83572|NCT03043352|Malnutrition|malnutrition
83573|NCT03043352|LHW|lhw
83574|NCT03043352|CMAM|cmam
83575|NCT03043339|Microbiota composition|microbiota composition
83576|NCT03043339|Kidney transplant recipient|kidney transplant recipient
83577|NCT03043339|Kidney transplant donor|kidney transplant donor
83578|NCT03043339|Antibiotics|antibiotics
83579|NCT03043339|Drug resistance|drug resistance
83580|NCT03043339|Transplantation surgery|transplantation surgery
83581|NCT03043326|Pre-exposure Prophylaxis|pre-exposure prophylaxis
83582|NCT03043326|MSM and transgender women|msm and transgender women
83583|NCT03043313|Tucatinib|tucatinib
83584|NCT03043313|Trastuzumab|trastuzumab
83585|NCT03043313|HER2|her2
83586|NCT03043313|ERBB2|erbb2
83587|NCT03043313|Colorectal cancer|colorectal cancer
83588|NCT03043300|Travelers' diarrhea|travelers' diarrhea
83589|NCT03043300|Intestinal microbiota|intestinal microbiota
83590|NCT03043300|Antibiotic resistance|antibiotic resistance
83591|NCT03043300|Antibiotics|antibiotics
83592|NCT03043300|Gastrointestinal disorders|gastrointestinal disorders
83593|NCT03043300|Infectious diseases|infectious diseases
83594|NCT03043300|International Travel|international travel
83595|NCT03043300|Travel Medicine|travel medicine
83596|NCT03043300|Resistome|resistome
83597|NCT03043300|Microbiome|microbiome
83598|NCT03043261|CHF|chf
83599|NCT03043248|TRK-700|trk-700
83600|NCT03043248|PK|pk
83601|NCT03043248|Digoxin|digoxin
83602|NCT03043248|Midazolam|midazolam
83603|NCT03043248|Drug-Drug interaction|drug-drug interaction
83604|NCT03043248|P-glycoprotein|p-glycoprotein
83605|NCT03043248|CYP3A4|cyp3a4
83606|NCT03043248|MDR1|mdr1
83607|NCT03043248|pharmacokinetics|pharmacokinetics
83608|NCT03043248|multidrug resistance 1|multidrug resistance 1
83609|NCT03043222|prostate artery embolization|prostate artery embolization
83610|NCT03043222|Prostatic Urethral Lift, Urolift|prostatic urethral lift, urolift
83611|NCT03043222|Minimally invasive|minimally invasive
83612|NCT03043222|non-surgical|non-surgical
83613|NCT03043222|maintenance of sexual function|maintenance of sexual function
83614|NCT03043222|complications of TURP , surgery|complications of turp , surgery
83615|NCT03043183|gastric cancer|gastric cancer
83616|NCT03043183|Enhanced recovery after surgery|enhanced recovery after surgery
83617|NCT03043170|Adults|adults
83618|NCT03043170|Emergency Department|emergency department
83619|NCT03043170|Haemodynamics|haemodynamics
83620|NCT03043170|Resuscitation|resuscitation
83621|NCT03043170|Shock|shock
83622|NCT03043170|Uscom|uscom
83623|NCT03043131|Cardiopulmonary bypass prime|cardiopulmonary bypass prime
83624|NCT03043131|Plasma Lyte - A|plasma lyte - a
83625|NCT03043131|Ringer;s lactate|ringer;s lactate
83626|NCT03043131|Acidosis|acidosis
83627|NCT03043118|Eating Behaviors|eating behaviors
83628|NCT03043118|Preschool|preschool
83629|NCT03043118|Vegetable Intake|vegetable intake
83630|NCT03043105|Multicentric Castleman's Disease|multicentric castleman's disease
83631|NCT03043105|Thalidomide, cyclophosphamide and prednisone (TCP regimen)|thalidomide, cyclophosphamide and prednisone (tcp regimen)
83632|NCT03043105|Efficacy|efficacy
83633|NCT03043105|Safety|safety
83634|NCT03043092|ultrasound, transcranial Doppler, arterial diseases|ultrasound, transcranial doppler, arterial diseases
83635|NCT03043066|Chronic Periodontitis|chronic periodontitis
83636|NCT03043066|TRAP-5b|trap-5b
83637|NCT03043066|Non-surgical periodontal therapy|non-surgical periodontal therapy
83638|NCT03043066|Systemic antibiotics|systemic antibiotics
83639|NCT03043053|weight loss|weight loss
83640|NCT03043053|body mass index|body mass index
83641|NCT03043053|oxytocin|oxytocin
83642|NCT03043053|magnetic resonance imaging|magnetic resonance imaging
83643|NCT03043040|suicide, attempted|suicide, attempted
83644|NCT03043040|prevention|prevention
83645|NCT03043040|telemedicine|telemedicine
83646|NCT03042988|supine hypertension|supine hypertension
83647|NCT03042988|autonomic failure|autonomic failure
83648|NCT03042988|heat stress|heat stress
83649|NCT03042988|orthostatic hypotension|orthostatic hypotension
83650|NCT03042975|spasmodic dysphonia|spasmodic dysphonia
83651|NCT03042975|dystonia|dystonia
83652|NCT03042975|laryngeal dystonia|laryngeal dystonia
83653|NCT03042975|imaging|imaging
83654|NCT03042975|genetics|genetics
83655|NCT03042962|dystonia|dystonia
83656|NCT03042962|imaging|imaging
83657|NCT03042962|genetics|genetics
83658|NCT03042962|neuropathology|neuropathology
83659|NCT03042936|Children|children
83660|NCT03042936|Teens|teens
83661|NCT03042936|Adolescents|adolescents
83662|NCT03042936|Type 2 diabetes|type 2 diabetes
83663|NCT03042936|Impaired glucose tolerance|impaired glucose tolerance
83664|NCT03042936|Exercise|exercise
83665|NCT03042936|Nutrition|nutrition
83666|NCT03042936|Education|education
83667|NCT03042923|Intestinal permeability|intestinal permeability
83668|NCT03042884|Benign Neoplasms|benign neoplasms
83669|NCT03042884|In Situ Neoplasms|in situ neoplasms
83670|NCT03042884|Malignant Neoplasms of Independent (Primary) Multiple Sites|malignant neoplasms of independent (primary) multiple sites
83671|NCT03042884|Wearable exercise trackers|wearable exercise trackers
83672|NCT03042884|Questionnaires|questionnaires
83673|NCT03042884|Surveys|surveys
83674|NCT03042871|PM-CNV ,Ranibizumab, Dosing Strategy|pm-cnv ,ranibizumab, dosing strategy
83675|NCT03042858|PPV|ppv
83676|NCT03042858|patent processus vaginalis|patent processus vaginalis
83677|NCT03042858|inguinal hernia|inguinal hernia
83678|NCT03042832|Leadership|leadership
83679|NCT03042832|Organizational Climate|organizational climate
83680|NCT03042832|Implementation|implementation
83681|NCT03042832|Implementation Climate|implementation climate
83682|NCT03042832|Motivational Interviewing|motivational interviewing
83683|NCT03042832|Fidelity|fidelity
83684|NCT03042806|Physical Activity|physical activity
83685|NCT03042806|Questionnaire|questionnaire
83686|NCT03042793|myeloma|myeloma
83687|NCT03042793|vaccination|vaccination
83688|NCT03042793|PD-L1|pd-l1
83689|NCT03042793|peptide vaccine|peptide vaccine
83690|NCT03042793|cancer vaccine|cancer vaccine
83691|NCT03042793|immunotherapy|immunotherapy
83692|NCT03042780|Gastroenteropancreatic neuroendocrine carcinomas (GEP-NECs)|gastroenteropancreatic neuroendocrine carcinomas (gep-necs)
83693|NCT03042780|Metastatic|metastatic
83694|NCT03042780|High grade|high grade
83695|NCT03042780|Pancreas|pancreas
83696|NCT03042780|Neuroendocrine carcinoma of gastrointestinal tract|neuroendocrine carcinoma of gastrointestinal tract
83697|NCT03042754|LAM|lam
83698|NCT03042754|XpertMTB/RIF|xpertmtb/rif
83699|NCT03042754|treatment outcome|treatment outcome
83700|NCT03042754|Microbacterial tuberculosis|microbacterial tuberculosis
83701|NCT03042715|Supportive Care|supportive care
83702|NCT03042689|AML|aml
83703|NCT03042676|anti-T lymphocytic globulin (ATG)|anti-t lymphocytic globulin (atg)
83704|NCT03042676|allogeneic stem cell transplant|allogeneic stem cell transplant
83705|NCT03042676|prophylaxis of GVHD|prophylaxis of gvhd
83706|NCT03042663|stellate ganglion block|stellate ganglion block
83707|NCT03042663|arterial cannula|arterial cannula
83708|NCT03042663|ischemia|ischemia
83709|NCT03042663|septic shock|septic shock
83710|NCT03042611|Gastric Cancer|gastric cancer
83711|NCT03042611|Gastric Adenocarcinoma|gastric adenocarcinoma
83712|NCT03042611|Gastro-esophageal Cancer|gastro-esophageal cancer
83713|NCT03042611|Gastro-esophageal junction Cancer|gastro-esophageal junction cancer
83714|NCT03042611|Stomach Cancer|stomach cancer
83715|NCT03042611|Tumor|tumor
83716|NCT03042611|Oncology|oncology
83717|NCT03042611|Antiangiogenesis|antiangiogenesis
83718|NCT03042611|Metastatic|metastatic
83719|NCT03042598|Safe Apneic Period|safe apneic period
83720|NCT03042598|Emergency Intubation|emergency intubation
83721|NCT03042598|Biphasic Cuirass Ventilation (BCV)|biphasic cuirass ventilation (bcv)
83722|NCT03042598|Non-invasive ventilation|non-invasive ventilation
83723|NCT03042598|Peri-intubation Hemodynamic instability|peri-intubation hemodynamic instability
83724|NCT03042598|desaturation|desaturation
83725|NCT03042598|waveform capnography|waveform capnography
83726|NCT03042598|Patient safety|patient safety
83727|NCT03042585|BMT|bmt
83728|NCT03042585|NHL|nhl
83729|NCT03042585|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
83730|NCT03042585|Relapsed Non-Hodgkin Lymphoma|relapsed non-hodgkin lymphoma
83731|NCT03042585|Refractory Non-Hodgkin Lymphoma|refractory non-hodgkin lymphoma
83732|NCT03042585|autologous stem cell transplantation|autologous stem cell transplantation
83733|NCT03042572|Critical Limb Ischemia (CLI)|critical limb ischemia (cli)
83734|NCT03042572|Severe Limb Ischemia (SLI)|severe limb ischemia (sli)
83735|NCT03042572|Peripheral Artery Disease (PAD)|peripheral artery disease (pad)
83736|NCT03042572|Peripheral Artery Occlusive Disease (PAOD)|peripheral artery occlusive disease (paod)
83737|NCT03042572|Cardiovascular disease|cardiovascular disease
83738|NCT03042572|Mesenchymal stromal cell (MSC)|mesenchymal stromal cell (msc)
83739|NCT03042572|Mesenchymal stem cell (MSC)|mesenchymal stem cell (msc)
83740|NCT03042494|Prebiotic|prebiotic
83741|NCT03042494|Gut microbiota|gut microbiota
83742|NCT03042494|Dietary fiber|dietary fiber
83743|NCT03042494|Gastrointestinal tolerance|gastrointestinal tolerance
83744|NCT03042481|chronic hepatitis B|chronic hepatitis b
83745|NCT03042481|entecavir|entecavir
83746|NCT03042481|tenofovir|tenofovir
83747|NCT03042481|off-therapy|off-therapy
83749|NCT03042442|pancreatic cancer|pancreatic cancer
83750|NCT03042442|cachexia|cachexia
83751|NCT03042442|perineural invasion|perineural invasion
83752|NCT03042442|pain|pain
83753|NCT03042442|diabetes|diabetes
83754|NCT03042429|neuroblastoma|neuroblastoma
83755|NCT03042429|chemotherapy|chemotherapy
83756|NCT03042429|autologous stem cell transplantation|autologous stem cell transplantation
83757|NCT03042429|radiotherapy|radiotherapy
83758|NCT03042429|mIBG|mibg
83759|NCT03042429|tumor resection|tumor resection
83760|NCT03042416|18F-DOPA PET/CT|18f-dopa pet/ct
83761|NCT03042403|hemodynamics|hemodynamics
83762|NCT03042403|physiotherapy|physiotherapy
83763|NCT03042403|breath stacking|breath stacking
83764|NCT03042377|Endodontics|endodontics
83765|NCT03042377|Retreatment|retreatment
83766|NCT03042377|Postoperative Pain|postoperative pain
83767|NCT03042377|Visual Analogue Pain Scale|visual analogue pain scale
83768|NCT03042364|Endometrium, Cytokines, Endometrial secretion, Implantation, Endometrial scratching|endometrium, cytokines, endometrial secretion, implantation, endometrial scratching
83769|NCT03042351|Urinary Incontinence|urinary incontinence
83770|NCT03042351|Pelvic Floor|pelvic floor
83771|NCT03042325|Drug therapy|drug therapy
83772|NCT03042286|statin|statin
83773|NCT03042286|myalgia|myalgia
83774|NCT03042286|myopathy|myopathy
83775|NCT03042286|adverse drug reactions (ADRs)|adverse drug reactions (adrs)
83776|NCT03042286|pharmacokinetics and pharmacogenetics|pharmacokinetics and pharmacogenetics
83777|NCT03042273|recurrent|recurrent
83778|NCT03042260|trimethoprim, sulfamethoxazole drug combination|trimethoprim, sulfamethoxazole drug combination
83779|NCT03042260|Infection|infection
83780|NCT03042260|Prophylaxis|prophylaxis
83781|NCT03042234|Obesity|obesity
83782|NCT03042234|Exercise|exercise
83783|NCT03042234|Fat oxidation|fat oxidation
83784|NCT03042234|Adolescent|adolescent
83785|NCT03042234|Insulin resistance|insulin resistance
83786|NCT03042195|Supplementary Parenteral Nutrition|supplementary parenteral nutrition
83787|NCT03042195|Postoperative Nutrition|postoperative nutrition
83788|NCT03042195|Postoperative complications|postoperative complications
83789|NCT03042169|Stage IV gastric cancer|stage iv gastric cancer
83790|NCT03042169|palliative surgery|palliative surgery
83791|NCT03042169|chemotherapy|chemotherapy
83792|NCT03042169|survival|survival
83793|NCT03042169|quality of life|quality of life
83794|NCT03042143|Acute respiratory distress syndrome|acute respiratory distress syndrome
83795|NCT03042143|Human umbilical cord-derived mesenchymal stem cells|human umbilical cord-derived mesenchymal stem cells
83796|NCT03042104|Stenosis|stenosis
83797|NCT03042104|Heart Disease|heart disease
83798|NCT03042104|Valve|valve
83799|NCT03042104|Tricuspid|tricuspid
83800|NCT03042104|Aortic Valve|aortic valve
83801|NCT03042104|Asymptomatic|asymptomatic
83802|NCT03042078|Fluoroscopy|fluoroscopy
83803|NCT03042078|Ablation|ablation
83804|NCT03042078|Three dimensional|three dimensional
83805|NCT03042078|Paroxysmal supraventricular tachycardia|paroxysmal supraventricular tachycardia
83806|NCT03042078|Radiation|radiation
83807|NCT03042065|pediatrics|pediatrics
83808|NCT03042065|asthma|asthma
83809|NCT03042065|nebulization|nebulization
83810|NCT03042065|vibrating mesh|vibrating mesh
83811|NCT03042065|salbutamol|salbutamol
83812|NCT03042065|Efficiency|efficiency
83813|NCT03042013|ASP8273|asp8273
83814|NCT03042013|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
83815|NCT03042013|EGFR mutations|egfr mutations
83816|NCT03042013|Oncology|oncology
83817|NCT03042000|rectal cancer|rectal cancer
83818|NCT03042000|neoadjuvant chemoradiation|neoadjuvant chemoradiation
83819|NCT03042000|circulating tumor DNA|circulating tumor dna
83820|NCT03042000|local recurrence|local recurrence
83821|NCT03042000|long-term survival|long-term survival
83822|NCT03041987|Cohort studies|cohort studies
83823|NCT03041987|Prognosis|prognosis
83824|NCT03041974|Red Blood Cell Transfusion|red blood cell transfusion
83825|NCT03041974|Cell-Derived Microparticles|cell-derived microparticles
83826|NCT03041961|Vascular function|vascular function
83827|NCT03041961|Endothelial function|endothelial function
83828|NCT03041961|(Poly)phenols|(poly)phenols
83829|NCT03041948|Inguinal hernia|inguinal hernia
83830|NCT03041948|Caudal nerve block|caudal nerve block
83831|NCT03041948|Ilioinguinal nerve block|ilioinguinal nerve block
83832|NCT03041948|Pain|pain
83833|NCT03041935|Testicle|testicle
83834|NCT03041935|Pain|pain
83835|NCT03041935|Orchiopexy|orchiopexy
83836|NCT03041935|Caudal nerve block|caudal nerve block
83837|NCT03041935|Ilioinguinal nerve block|ilioinguinal nerve block
83838|NCT03041922|Elastography|elastography
83839|NCT03041922|Buttocks|buttocks
83840|NCT03041922|Ultrasound|ultrasound
83841|NCT03041922|Soft tissue|soft tissue
83842|NCT03041870|PET-fMRI|pet-fmri
83843|NCT03041870|dominance|dominance
83844|NCT03041870|5HT transporter|5ht transporter
83845|NCT03041857|Videofluoroscopy|videofluoroscopy
83846|NCT03041857|GMK Sphere|gmk sphere
83847|NCT03041857|GMK PS Fixed Bearing|gmk ps fixed bearing
83848|NCT03041857|GMK UC Mobile Bearing|gmk uc mobile bearing
83849|NCT03041844|therapeutic ultrasound|therapeutic ultrasound
83850|NCT03041844|quality of life|quality of life
83851|NCT03041831|frail elderly|frail elderly
83852|NCT03041831|telemedicine|telemedicine
83853|NCT03041831|obesity|obesity
83854|NCT03041831|rural health|rural health
83855|NCT03041831|health promotion|health promotion
83856|NCT03041818|cerebral palsy|cerebral palsy
83857|NCT03041818|horseback riding|horseback riding
83858|NCT03041805|venous thromboembolism|venous thromboembolism
83859|NCT03041805|deep vein thrombosis|deep vein thrombosis
83860|NCT03041805|pulmonary embolism|pulmonary embolism
83861|NCT03041805|varicose veins|varicose veins
83862|NCT03041805|surgery|surgery
83863|NCT03041805|endovenous laser treatment|endovenous laser treatment
83864|NCT03041805|radiofrequency ablation|radiofrequency ablation
83865|NCT03041805|ultrasound-guided foam sclerotherapy|ultrasound-guided foam sclerotherapy
83866|NCT03041805|register|register
83867|NCT03041805|anticoagulation|anticoagulation
83868|NCT03041766|Schistosomiasis|schistosomiasis
83869|NCT03041766|Recombinant vaccine|recombinant vaccine
83870|NCT03041766|rSm14|rsm14
83871|NCT03041766|GLA-SE|gla-se
83872|NCT03041766|Fatty acid-binding protein (FABP)|fatty acid-binding protein (fabp)
83873|NCT03041766|Phase II Clinical Trial|phase ii clinical trial
83874|NCT03041766|Senegal|senegal
83875|NCT03041753|stroke|stroke
83876|NCT03041753|thrombolysis|thrombolysis
83877|NCT03041753|metalloproteinases|metalloproteinases
83878|NCT03041753|blood brain barrier|blood brain barrier
83879|NCT03041740|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
83880|NCT03041740|Neonates|neonates
83881|NCT03041714|Essential Tremor|essential tremor
83882|NCT03041714|Cervical Dystonia|cervical dystonia
83883|NCT03041714|Hand Dystonia|hand dystonia
83884|NCT03041714|Neurophysiology|neurophysiology
83885|NCT03041714|Dystonic Tremor|dystonic tremor
83886|NCT03041701|ERMS|erms
83887|NCT03041701|ARMS|arms
83888|NCT03041701|Monoclonal Antibody|monoclonal antibody
83889|NCT03041701|YES|yes
83890|NCT03041701|RMS|rms
83891|NCT03041675|Lacer Acupuncture|lacer acupuncture
83892|NCT03041675|Paralytic ileus|paralytic ileus
83893|NCT03041649|Gastroesophageal Reflux|gastroesophageal reflux
83894|NCT03041649|Feeding Disorder|feeding disorder
83895|NCT03041649|Gastrostomy tube|gastrostomy tube
83896|NCT03041649|Family Satisfaction|family satisfaction
83897|NCT03041649|GT button|gt button
83898|NCT03041649|Enteral nutrition|enteral nutrition
83899|NCT03041649|Gastrostomy button|gastrostomy button
83900|NCT03041636|Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
83901|NCT03041636|Other Diseases of Blood and Blood-Forming Organs|other diseases of blood and blood-forming organs
83902|NCT03041636|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
83903|NCT03041636|CLL|cll
83904|NCT03041636|Ruxolitinib|ruxolitinib
83905|NCT03041636|Jakafi|jakafi
83906|NCT03041636|INCB018424|incb018424
83907|NCT03041636|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
83908|NCT03041636|SLL|sll
83909|NCT03041623|IIPs|iips
83910|NCT03041558|healthy relationships|healthy relationships
83911|NCT03041558|interpersonal relations|interpersonal relations
83912|NCT03041558|domestic violence|domestic violence
83913|NCT03041532|retroflexion proximal|retroflexion proximal
83914|NCT03041532|colorectal cancer screening programme|colorectal cancer screening programme
83915|NCT03041532|adenoma detection rate|adenoma detection rate
83916|NCT03041532|right colon|right colon
83917|NCT03041519|Fluoroscopy|fluoroscopy
83918|NCT03041519|Ablation|ablation
83919|NCT03041519|Three dimensional|three dimensional
83920|NCT03041519|Ventricular arrhythmias|ventricular arrhythmias
83921|NCT03041519|Radiation|radiation
83922|NCT03041506|Shoulder dislocation reduction|shoulder dislocation reduction
83923|NCT03041506|Ultrasound guided interscalene block (ISCB)|ultrasound guided interscalene block (iscb)
83924|NCT03041506|Sedation|sedation
83925|NCT03041493|Electronic Cigarettes|electronic cigarettes
83926|NCT03041493|17-071|17-071
83927|NCT03041480|chronic periodontitis|chronic periodontitis
83928|NCT03041480|lipids|lipids
83929|NCT03041480|Lp-PLA2|lp-pla2
83930|NCT03041402|non-invasive ventilation|non-invasive ventilation
83931|NCT03041402|Pressure Support Ventilation|pressure support ventilation
83932|NCT03041402|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
83933|NCT03041402|patient-ventilator interaction|patient-ventilator interaction
83934|NCT03041402|ventilator performance|ventilator performance
83935|NCT03041402|asynchrony|asynchrony
83936|NCT03041389|Computerized Cognitive Behavioral Therapy|computerized cognitive behavioral therapy
83937|NCT03041350|Emergency Medical Services|emergency medical services
83938|NCT03041350|Smartphone|smartphone
83939|NCT03041350|Survival|survival
83940|NCT03041324|MPS ll|mps ll
83941|NCT03041324|Mucopolysaccharidosis|mucopolysaccharidosis
83942|NCT03041324|Hunter syndrome|hunter syndrome
83943|NCT03041324|gene editing|gene editing
83944|NCT03041324|gene therapy|gene therapy
83945|NCT03041324|zinc finger|zinc finger
83946|NCT03041324|ZFN|zfn
83947|NCT03041324|SB-913|sb-913
83948|NCT03041324|rare|rare
83949|NCT03041324|genetic|genetic
83950|NCT03041324|DNA|dna
83951|NCT03041324|Sangamo|sangamo
83952|NCT03041324|Genomic editing|genomic editing
83953|NCT03041324|Champions|champions
83954|NCT03041324|Hunter|hunter
83955|NCT03041311|Small Cell Lung Cancer|small cell lung cancer
83956|NCT03041311|CDK 4/6 Inhibitor|cdk 4/6 inhibitor
83957|NCT03041311|Immune Checkpoint Inhibitor|immune checkpoint inhibitor
83958|NCT03041246|pelvic floor|pelvic floor
83959|NCT03041207|ventilator associated infection|ventilator associated infection
83960|NCT03041207|ventilator associated pneumonia|ventilator associated pneumonia
83961|NCT03041207|ventilator associated tracheitis|ventilator associated tracheitis
83962|NCT03041207|Lower respiratory infection|lower respiratory infection
83963|NCT03041181|Nivolumab|nivolumab
83964|NCT03041181|BMS-936558-01|bms-936558-01
83965|NCT03041181|Anti-PD-1 Antibody|anti-pd-1 antibody
83966|NCT03041181|Docetaxel|docetaxel
83967|NCT03041181|Pemetrexed|pemetrexed
83968|NCT03041181|Gemcitabine|gemcitabine
83969|NCT03041142|Obesity|obesity
83970|NCT03041142|Cardiovascular risk factors|cardiovascular risk factors
83971|NCT03041142|Interdisciplinary intervention|interdisciplinary intervention
83972|NCT03041129|hepatic de novo lipogenesis|hepatic de novo lipogenesis
83973|NCT03041116|PKAN|pkan
83974|NCT03041090|infiltration|infiltration
83975|NCT03041090|extravasation|extravasation
83976|NCT03041090|PET/CT|pet/ct
83977|NCT03041090|PET|pet
83978|NCT03041090|PET-CT|pet-ct
83979|NCT03041025|Systemic Sclerosis|systemic sclerosis
83980|NCT03041025|Repeat-dose|repeat-dose
83981|NCT03041025|Phase IIA|phase iia
83982|NCT03041025|GSK2330811|gsk2330811
83983|NCT03041025|Pharmacodynamics|pharmacodynamics
83984|NCT03041025|Pharmacokinetics|pharmacokinetics
83985|NCT03041025|Proof of mechanism study|proof of mechanism study
83986|NCT03041012|HIV-1|hiv-1
83987|NCT03041012|Latency Reversal Agent|latency reversal agent
83988|NCT03041012|Immunotherapy|immunotherapy
83989|NCT03040999|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
83990|NCT03040999|Programmed Cell Death Receptor 1 (PD-1)|programmed cell death receptor 1 (pd-1)
83991|NCT03040999|Programmed Cell Death Receptor Ligand 1 (PD-L1)|programmed cell death receptor ligand 1 (pd-l1)
83992|NCT03040999|Programmed Cell Death Receptor Ligand 2 (PD-L2)|programmed cell death receptor ligand 2 (pd-l2)
83993|NCT03040999|PD1|pd1
83994|NCT03040999|PD-1|pd-1
83995|NCT03040999|PDL1|pdl1
83996|NCT03040999|PD-L1|pd-l1
83997|NCT03040999|PDL2|pdl2
83998|NCT03040973|capmatinib|capmatinib
83999|NCT03040973|cMET|cmet
84000|NCT03040973|advanced solid tumor|advanced solid tumor
84001|NCT03040973|cancer|cancer
84002|NCT03040960|infection|infection
84003|NCT03040960|wound infection|wound infection
84004|NCT03040960|surgical wound infection|surgical wound infection
84005|NCT03040960|Staphylococcal infections|staphylococcal infections
84006|NCT03040960|wound and injuries|wound and injuries
84007|NCT03040960|postoperative complications|postoperative complications
84008|NCT03040960|Gram-positive bacterial infections|gram-positive bacterial infections
84009|NCT03040960|bacterial infections|bacterial infections
84010|NCT03040895|Parenting practices|parenting practices
84011|NCT03040856|Omega 3|omega 3
84012|NCT03040856|Supplements|supplements
84013|NCT03040856|Alpha Linolenic Acid|alpha linolenic acid
84014|NCT03040843|documentation|documentation
84015|NCT03040843|altered mental status|altered mental status
84016|NCT03040843|definition|definition
84017|NCT03040843|clinically|clinically
84018|NCT03040804|hidradenitis suppurativa|hidradenitis suppurativa
84019|NCT03040804|HS|hs
84020|NCT03040804|radiotherapy|radiotherapy
84021|NCT03040791|prostate cancer|prostate cancer
84022|NCT03040778|MRONJ|mronj
84023|NCT03040778|BRONJ|bronj
84024|NCT03040765|Osteoporosis|osteoporosis
84025|NCT03040765|Beta-Thalassemia Major|beta-thalassemia major
84026|NCT03040765|Denosumab|denosumab
84027|NCT03040765|Zoledronic Acid|zoledronic acid
84028|NCT03040739|O'ARM|o'arm
84029|NCT03040726|In situ neoplasm|in situ neoplasm
84030|NCT03040726|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
84031|NCT03040726|Symptoms and signs involving the digestive system and abdomen|symptoms and signs involving the digestive system and abdomen
84032|NCT03040726|Chronic nausea and vomiting|chronic nausea and vomiting
84033|NCT03040726|Netupitant/Palonosetron|netupitant/palonosetron
84034|NCT03040726|NEPA|nepa
84035|NCT03040726|Placebo|placebo
84036|NCT03040726|Sugar pill|sugar pill
84037|NCT03040726|Symptom questionnaires|symptom questionnaires
84038|NCT03040726|Surveys|surveys
84039|NCT03040726|Pill diary|pill diary
84040|NCT03040726|Akynzeo|akynzeo
84041|NCT03040700|coronary artery disease|coronary artery disease
84042|NCT03040700|surgery|surgery
84043|NCT03040700|angina|angina
84044|NCT03040700|myocardial ischemia|myocardial ischemia
84045|NCT03040700|non-invasive testing|non-invasive testing
84046|NCT03040687|ETEC|etec
84047|NCT03040687|Escherichia coli|escherichia coli
84048|NCT03040687|enteritis|enteritis
84049|NCT03040687|challenge|challenge
84050|NCT03040687|CS6|cs6
84051|NCT03040687|B7A|b7a
84052|NCT03040674|Shortness of breath|shortness of breath
84053|NCT03040674|Breathlessness|breathlessness
84054|NCT03040674|Stem cells|stem cells
84055|NCT03040674|Platelet rich plasma|platelet rich plasma
84056|NCT03040674|Quality of life|quality of life
84057|NCT03040674|Pulmonary function|pulmonary function
84058|NCT03040622|WATCHMAN|watchman
84059|NCT03040622|Left Atrial Appendage Closure|left atrial appendage closure
84060|NCT03040622|Thrombosis|thrombosis
84061|NCT03040622|Platelet Function|platelet function
84062|NCT03040609|Profound Multiple Intellectual Disabilities|profound multiple intellectual disabilities
84063|NCT03040609|Visual-Behavioral Scale|visual-behavioral scale
84064|NCT03040596|vocal fold nodules|vocal fold nodules
84065|NCT03040596|inhaled steroid|inhaled steroid
84066|NCT03040596|steroid|steroid
84067|NCT03040596|children|children
84068|NCT03040596|nodules|nodules
84069|NCT03040583|Primary Sjögren's syndrome (PSS)|primary sjögren's syndrome (pss)
84070|NCT03040583|auto-immune diseases|auto-immune diseases
84071|NCT03040557|plantar fasciitis|plantar fasciitis
84072|NCT03040557|shoes|shoes
84073|NCT03040557|insoles|insoles
84074|NCT03040557|pain|pain
84075|NCT03040557|foot|foot
84076|NCT03040544|minimally invasive surgery|minimally invasive surgery
84077|NCT03040544|video-based trainer|video-based trainer
84078|NCT03040531|glucocorticoid|glucocorticoid
84079|NCT03040531|genistein|genistein
84080|NCT03040531|alendronate|alendronate
84081|NCT03040518|Behaviour change|behaviour change
84082|NCT03040518|Male obesity|male obesity
84083|NCT03040518|SMS|sms
84084|NCT03040518|Financial Incentive|financial incentive
84085|NCT03040518|Endowment incentive|endowment incentive
84086|NCT03040466|ureteroscopy|ureteroscopy
84087|NCT03040466|flexible ureteroscope|flexible ureteroscope
84088|NCT03040466|randomized controlled trial|randomized controlled trial
84089|NCT03040453|Irreversible electroporation|irreversible electroporation
84090|NCT03040453|Microwave ablation|microwave ablation
84091|NCT03040427|F-18 florbetapir|f-18 florbetapir
84092|NCT03040427|Amyvid|amyvid
84093|NCT03040427|PET scan|pet scan
84094|NCT03040427|Early detection|early detection
84095|NCT03040414|Hybrid closed loop|hybrid closed loop
84096|NCT03040414|Closed loop|closed loop
84097|NCT03040414|Artificial pancreas|artificial pancreas
84098|NCT03040401|CMML|cmml
84099|NCT03040401|Ceplene|ceplene
84100|NCT03040401|Interleukin-2|interleukin-2
84101|NCT03040388|Electroconvulsive therapy|electroconvulsive therapy
84102|NCT03040388|Depressive Disorder|depressive disorder
84103|NCT03040388|Magnetic Resonance Imaging|magnetic resonance imaging
84104|NCT03040388|Hippocampus|hippocampus
84105|NCT03040388|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
84106|NCT03040388|Vascular Endothelial Growth Factor|vascular endothelial growth factor
84107|NCT03040388|Blood-Brain Barrier|blood-brain barrier
84108|NCT03040349|primary care|primary care
84109|NCT03040349|greece|greece
84110|NCT03040349|cyprus|cyprus
84111|NCT03040349|tobacco use treatment|tobacco use treatment
84112|NCT03040349|evidence-based guidelines|evidence-based guidelines
84113|NCT03040336|surgery|surgery
84114|NCT03040336|prehabilitation|prehabilitation
84115|NCT03040336|exercise therapy|exercise therapy
84116|NCT03040336|nutrition support|nutrition support
84117|NCT03040297|Weaning from mechanical ventilation|weaning from mechanical ventilation
84118|NCT03040297|tracheostomized patients|tracheostomized patients
84119|NCT03040297|Tracheal gas insufflation|tracheal gas insufflation
84120|NCT03040284|noninvasive monitoring|noninvasive monitoring
84121|NCT03040284|intracranial pressure|intracranial pressure
84122|NCT03040284|cochlear electrophysiology|cochlear electrophysiology
84123|NCT03040284|aneurysmal subarachnoid haemorrhage|aneurysmal subarachnoid haemorrhage
84124|NCT03040284|cerebrovascular disorders|cerebrovascular disorders
84125|NCT03040284|brain diseases|brain diseases
84126|NCT03040271|School-based intervention|school-based intervention
84127|NCT03040258|School-based intervention|school-based intervention
84128|NCT03040245|Emergency physician|emergency physician
84129|NCT03040245|Whiplash Book|whiplash book
84130|NCT03040245|Whiplash trauma|whiplash trauma
84131|NCT03040245|Fears|fears
84132|NCT03040245|Beliefs|beliefs
84133|NCT03040193|Lignocaine|lignocaine
84134|NCT03040180|Neoplasms|neoplasms
84135|NCT03040180|Neoplasms, primary|neoplasms, primary
84136|NCT03040180|Cancer|cancer
84137|NCT03040180|Colorectal cancer|colorectal cancer
84138|NCT03040180|rectal cancer|rectal cancer
84139|NCT03040180|rectal cancer, locally advanced|rectal cancer, locally advanced
84140|NCT03040180|Electrochemotherapy|electrochemotherapy
84141|NCT03040180|Electroporation|electroporation
84142|NCT03040180|Neoadjuvant therapy|neoadjuvant therapy
84143|NCT03040180|Antineoplastic, antibodies|antineoplastic, antibodies
84144|NCT03040180|Bleomycin|bleomycin
84145|NCT03040180|Pathologic processes|pathologic processes
84146|NCT03040180|Neoplastic processes|neoplastic processes
84147|NCT03040154|Filipino|filipino
84148|NCT03040102|Advanced Cancer|advanced cancer
84149|NCT03040063|aneurysm, poplietl artery, acute limb ischemia|aneurysm, poplietl artery, acute limb ischemia
84150|NCT03040024|Anesthesiology|anesthesiology
84151|NCT03040011|Vaginal Surgery|vaginal surgery
84152|NCT03040011|Pelvic Organ Prolapse|pelvic organ prolapse
84153|NCT03040011|Postoperative Pain|postoperative pain
84154|NCT03039959|Chronic Kidney Disease|chronic kidney disease
84155|NCT03039946|Fluid therapy|fluid therapy
84156|NCT03039946|Hemodynamic flow monitoring|hemodynamic flow monitoring
84157|NCT03039946|Closed-loop system|closed-loop system
84158|NCT03039946|Goal-directed fluid therapy|goal-directed fluid therapy
84159|NCT03039946|Anesthesiology|anesthesiology
84160|NCT03039907|Knee|knee
84161|NCT03039907|Replacement|replacement
84162|NCT03039894|school-based, evaluation, interrupted time series|school-based, evaluation, interrupted time series
84163|NCT03039881|Minute ventilation, ExSpiron monitor|minute ventilation, exspiron monitor
84164|NCT03039855|Mitral|mitral
84165|NCT03039855|Regurgitation|regurgitation
84166|NCT03039855|Heart valve|heart valve
84167|NCT03039855|Transcatheter|transcatheter
84168|NCT03039855|Transapical|transapical
84169|NCT03039855|Functional|functional
84170|NCT03039855|Degenerative|degenerative
84171|NCT03039855|TMVR|tmvr
84172|NCT03039842|dextromethorphan; memantine; treatment response|dextromethorphan; memantine; treatment response
84173|NCT03039790|Immunogenicity, Norovirus vaccination|immunogenicity, norovirus vaccination
84174|NCT03039686|muscular dystrophy|muscular dystrophy
84175|NCT03039686|Duchenne's Muscular Dystrophy|duchenne's muscular dystrophy
84176|NCT03039686|DMD|dmd
84177|NCT03039673|interleukin-2|interleukin-2
84178|NCT03039673|low-dose interleukin-2|low-dose interleukin-2
84179|NCT03039608|esophageal stricture|esophageal stricture
84180|NCT03039608|endoscopic submucosal dissection|endoscopic submucosal dissection
84181|NCT03039608|prevention|prevention
84182|NCT03039595|Early rectal cancer|early rectal cancer
84183|NCT03039595|Ploidy|ploidy
84184|NCT03039595|Tumour:stroma ratio|tumour:stroma ratio
84185|NCT03039582|perineal tear|perineal tear
84186|NCT03039582|bidigital palpation|bidigital palpation
84187|NCT03039582|perineal ultrasound|perineal ultrasound
84188|NCT03039582|post partum diagnostics|post partum diagnostics
84189|NCT03039569|Type 2 diabetes patients|type 2 diabetes patients
84190|NCT03039569|Diabetes self-management|diabetes self-management
84191|NCT03039569|Cardiovascular diseases awareness|cardiovascular diseases awareness
84192|NCT03039569|Home food environment|home food environment
84193|NCT03039569|Text message|text message
84194|NCT03039530|Postpartum Depression|postpartum depression
84195|NCT03039530|Cognitive Behavioral Therapy|cognitive behavioral therapy
84196|NCT03039530|Public Health|public health
84197|NCT03039530|Mother|mother
84198|NCT03039530|Infant|infant
84199|NCT03039530|Emotion|emotion
84200|NCT03039517|Adaptive Compression Therapy Delivery System|adaptive compression therapy delivery system
84201|NCT03039504|Succinates|succinates
84202|NCT03039504|Dietary supplement|dietary supplement
84203|NCT03039491|pneumococcal vaccination|pneumococcal vaccination
84204|NCT03039465|Indwelling Trachea-oesophageal Prosthesis|indwelling trachea-oesophageal prosthesis
84205|NCT03039465|Voice Rehabilitation|voice rehabilitation
84206|NCT03039465|Total Laryngectomy|total laryngectomy
84207|NCT03039439|Immunohistochemical profiling of tumors|immunohistochemical profiling of tumors
84208|NCT03039439|Biomarkers|biomarkers
84209|NCT03039374|OASI|oasi
84210|NCT03039374|Faecal incontinence|faecal incontinence
84211|NCT03039374|Obstetric anal sphincter injury|obstetric anal sphincter injury
84212|NCT03039374|MRI|mri
84213|NCT03039348|Breast Cancer Female|breast cancer female
84214|NCT03039348|Mastectomy|mastectomy
84215|NCT03039348|Breast Reconstruction|breast reconstruction
84216|NCT03039348|questionnaire|questionnaire
84217|NCT03039309|Endoscopic Submucosal Dissection|endoscopic submucosal dissection
84218|NCT03039296|Low back pain|low back pain
84219|NCT03039296|Facet joints|facet joints
84220|NCT03039296|Endoscopic rhizotomy|endoscopic rhizotomy
84221|NCT03039283|Moderate to profound sensorineural hearing loss|moderate to profound sensorineural hearing loss
84222|NCT03039270|Tooth Sensitivity|tooth sensitivity
84223|NCT03039270|Tooth Bleaching|tooth bleaching
84224|NCT03039270|Desensitizing agent|desensitizing agent
84225|NCT03039270|Sonic vibration|sonic vibration
84226|NCT03039257|hematopoietic stem cell transplant|hematopoietic stem cell transplant
84227|NCT03039257|vitamin a|vitamin a
84228|NCT03039244|Photochemotherapy|photochemotherapy
84229|NCT03039244|Photosensitizing agents|photosensitizing agents
84230|NCT03039244|Smokers|smokers
84231|NCT03039231|PTSD|ptsd
84232|NCT03039218|erectile dysfunction|erectile dysfunction
84233|NCT03039218|shockwave|shockwave
84234|NCT03039218|Dornier|dornier
84235|NCT03039205|Platelet aggregation|platelet aggregation
84236|NCT03039205|Adenosine|adenosine
84237|NCT03039205|Coronary artery disease|coronary artery disease
84238|NCT03039205|Kidney dysfunction|kidney dysfunction
84239|NCT03039205|Ticagrelor|ticagrelor
84240|NCT03039205|Clopidogrel|clopidogrel
84241|NCT03039127|Hyperthermia|hyperthermia
84242|NCT03039127|Laser Coagulation|laser coagulation
84243|NCT03039127|Laser Therapy|laser therapy
84244|NCT03039127|Induced|induced
84245|NCT03039114|Follicular lymphoma|follicular lymphoma
84246|NCT03039114|relapsed|relapsed
84247|NCT03039114|refractory|refractory
84248|NCT03039114|non-Hodgkin lymphoma|non-hodgkin lymphoma
84249|NCT03039114|phosphatidylinositol 3-kinase (PI3K)|phosphatidylinositol 3-kinase (pi3k)
84250|NCT03039101|allergen|allergen
84251|NCT03039101|neutrophils|neutrophils
84252|NCT03039101|allergy|allergy
84253|NCT03039062|Serum miR-122|serum mir-122
84254|NCT03039062|drug-induced liver injury by chemotherapy|drug-induced liver injury by chemotherapy
84255|NCT03039062|malignant tumor patients|malignant tumor patients
84256|NCT03039049|GnRH agonist trigger|gnrh agonist trigger
84257|NCT03039049|IVF|ivf
84258|NCT03039049|Luteal phase support|luteal phase support
84259|NCT03039049|Mid-luteal GnRH agonist|mid-luteal gnrh agonist
84260|NCT03039036|Labor Induction|labor induction
84261|NCT03039036|Early Amniotomy|early amniotomy
84262|NCT03039036|Foley catheter|foley catheter
84263|NCT03039023|TMAO|tmao
84264|NCT03039023|choline|choline
84265|NCT03039023|eggs|eggs
84266|NCT03039023|gastrointestinal microbiome|gastrointestinal microbiome
84267|NCT03039023|healthy volunteers|healthy volunteers
84268|NCT03038984|IBD|ibd
84269|NCT03038984|Telemedicine|telemedicine
84270|NCT03038984|At-home monitoring|at-home monitoring
84271|NCT03038984|Disease activity|disease activity
84272|NCT03038984|fecal calprotectin|fecal calprotectin
84273|NCT03038984|Total inflammation burden|total inflammation burden
84274|NCT03038984|11 years follow up|11 years follow up
84275|NCT03038958|Local Anaesthetic|local anaesthetic
84276|NCT03038958|spinal anesthesia|spinal anesthesia
84277|NCT03038958|Knee arthroscopy|knee arthroscopy
84278|NCT03038945|Laparoscopy|laparoscopy
84279|NCT03038945|Hysterectomy|hysterectomy
84280|NCT03038945|Suture Techniques|suture techniques
84281|NCT03038932|whole genome sequencing (WGS)|whole genome sequencing (wgs)
84282|NCT03038919|prolonged mechanical ventilation|prolonged mechanical ventilation
84283|NCT03038919|critically ill patients|critically ill patients
84284|NCT03038919|anabolic steroid|anabolic steroid
84285|NCT03038893|Ultrasonography|ultrasonography
84286|NCT03038893|Point-of-care systems|point-of-care systems
84287|NCT03038893|Deep venous thrombosis|deep venous thrombosis
84288|NCT03038893|Hospitalization|hospitalization
84289|NCT03038776|vaccine|vaccine
84290|NCT03038750|Healthy Volunteers|healthy volunteers
84291|NCT03038750|Genetic Risk Markers for Cardiovascular Disease|genetic risk markers for cardiovascular disease
84292|NCT03038750|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
84293|NCT03038750|Coronary Disease|coronary disease
84294|NCT03038750|Hypertension|hypertension
84295|NCT03038750|Venous Thromboses|venous thromboses
84296|NCT03038750|Venous Thromboembolism|venous thromboembolism
84297|NCT03038750|Coronary Heart Disease|coronary heart disease
84298|NCT03038750|Coronary Artery Disease|coronary artery disease
84299|NCT03038737|nylon|nylon
84300|NCT03038737|polyamide|polyamide
84301|NCT03038737|PEEK|peek
84302|NCT03038737|partial denture|partial denture
84303|NCT03038724|HIV testing|hiv testing
84304|NCT03038698|spirometry|spirometry
84305|NCT03038698|normative values|normative values
84306|NCT03038698|health|health
84307|NCT03038698|south africa|south africa
84308|NCT03038698|children|children
84309|NCT03038685|Secondary prevention|secondary prevention
84310|NCT03038685|Web-based intervention|web-based intervention
84311|NCT03038685|Strokecoach|strokecoach
84312|NCT03038646|Pharmacokinetics|pharmacokinetics
84313|NCT03038646|Food Effect|food effect
84314|NCT03038620|Obesity|obesity
84315|NCT03038620|Visceral|visceral
84316|NCT03038620|Cardiovascular Disease|cardiovascular disease
84317|NCT03038620|Fat|fat
84318|NCT03038594|Burns|burns
84319|NCT03038594|Growth Hormone|growth hormone
84320|NCT03038594|Lean Body Mass|lean body mass
84321|NCT03038594|Strength|strength
84322|NCT03038594|Exercise Endurance|exercise endurance
84323|NCT03038581|Deep wrist injury|deep wrist injury
84324|NCT03038581|Self inflicted|self inflicted
84325|NCT03038581|Traumatic wrist injury|traumatic wrist injury
84326|NCT03038568|colorectal liver metastases|colorectal liver metastases
84327|NCT03038568|CT scan|ct scan
84328|NCT03038568|17-010|17-010
84329|NCT03038555|Medical staff|medical staff
84330|NCT03038555|preeclampsia|preeclampsia
84331|NCT03038555|cohort study|cohort study
84332|NCT03038555|further effect|further effect
84333|NCT03038529|low back pain , Ozone|low back pain , ozone
84334|NCT03038503|refractory septic shock|refractory septic shock
84335|NCT03038503|catecholamine resistance septic shock|catecholamine resistance septic shock
84336|NCT03038503|terlipressin|terlipressin
84337|NCT03038503|methylene blue|methylene blue
84338|NCT03038477|Borderline Resectable Pancreatic Ductal Adenocarcinoma|borderline resectable pancreatic ductal adenocarcinoma
84339|NCT03038477|Durvalumab|durvalumab
84340|NCT03038399|Duchenne muscular dystrophy|duchenne muscular dystrophy
84341|NCT03038399|vamorolone|vamorolone
84342|NCT03038347|cross-cultural competencies|cross-cultural competencies
84343|NCT03038347|internet-based training|internet-based training
84344|NCT03038347|cognitive-behavioural therapy (CBT)|cognitive-behavioural therapy (cbt)
84345|NCT03038347|psychotherapy training|psychotherapy training
84346|NCT03038347|competence training|competence training
84347|NCT03038321|BCG Cystitis|bcg cystitis
84348|NCT03038321|Bladder Cancer|bladder cancer
84349|NCT03038321|Levofloxacin|levofloxacin
84350|NCT03038321|Solifenacin|solifenacin
84351|NCT03038321|Lornoxicam|lornoxicam
84352|NCT03038308|ropinirole|ropinirole
84353|NCT03038308|hyperprolactinemia|hyperprolactinemia
84354|NCT03038308|prolactin|prolactin
84355|NCT03038295|Retinopathy of Prematurity|retinopathy of prematurity
84356|NCT03038295|propranolol|propranolol
84357|NCT03038295|ROP|rop
84358|NCT03038269|Robotics|robotics
84359|NCT03038269|Upper Extremity|upper extremity
84360|NCT03038256|High Risk Rectal Cancer|high risk rectal cancer
84361|NCT03038256|Total neoadjuvant chemoradiotherapy|total neoadjuvant chemoradiotherapy
84362|NCT03038256|Lengthening interval between radiotherapy and surgery|lengthening interval between radiotherapy and surgery
84363|NCT03038243|Shigella|shigella
84364|NCT03038243|vaccine|vaccine
84365|NCT03038243|shigellosis|shigellosis
84366|NCT03038243|dysentery|dysentery
84367|NCT03038243|whole cell|whole cell
84368|NCT03038230|human bispecific full length IgG antibody, CLEC12A, CD3|human bispecific full length igg antibody, clec12a, cd3
84369|NCT03038230|MCLA-117|mcla-117
84370|NCT03038230|First in Human|first in human
84371|NCT03038230|Antibodies, Bispecific|antibodies, bispecific
84372|NCT03038230|Immunologic Factors|immunologic factors
84373|NCT03038230|relapsed, refractory patient|relapsed, refractory patient
84374|NCT03038230|AML, minimal residual disease (MRD)|aml, minimal residual disease (mrd)
84375|NCT03038230|Acute Myelogenous Leukemia|acute myelogenous leukemia
84376|NCT03038230|Acute Myeloid Leukemia|acute myeloid leukemia
84377|NCT03038230|CD34+CD38|cd34+cd38
84378|NCT03038230|T-cell recruiting|t-cell recruiting
84379|NCT03038217|rectal cancer|rectal cancer
84380|NCT03038217|neoajuvant chemoradiation|neoajuvant chemoradiation
84381|NCT03038217|circulating tumor DNA|circulating tumor dna
84382|NCT03038204|Papillary muscles approximation|papillary muscles approximation
84485|NCT03037437|Sorafenib|sorafenib
84383|NCT03038178|Mycobacterium Infections, Nontuberculous|mycobacterium infections, nontuberculous
84384|NCT03038178|Mycobacteria, Atypical|mycobacteria, atypical
84385|NCT03038178|Amikacin|amikacin
84386|NCT03038178|Inhalation|inhalation
84387|NCT03038165|Hemodialysis|hemodialysis
84388|NCT03038165|Intradialytic hypertension|intradialytic hypertension
84389|NCT03038165|Hemodynamics changes|hemodynamics changes
84390|NCT03038152|Disorder of breast|disorder of breast
84391|NCT03038152|Breast Cancer|breast cancer
84392|NCT03038152|Lymph node metastasis|lymph node metastasis
84393|NCT03038152|Magseed marker|magseed marker
84394|NCT03038152|Lymph node removal|lymph node removal
84395|NCT03038139|forward head posture|forward head posture
84396|NCT03038139|postural correction|postural correction
84397|NCT03038139|spinal muscles|spinal muscles
84398|NCT03038126|chronic kidney disease|chronic kidney disease
84399|NCT03038126|patient safety|patient safety
84400|NCT03038126|home telehealth|home telehealth
84401|NCT03038061|Diaphragm|diaphragm
84402|NCT03038061|EIT|eit
84403|NCT03038061|Laparoscopy|laparoscopy
84404|NCT03038009|Coronary Artery Bypass Graft|coronary artery bypass graft
84405|NCT03038009|Dual Antiplatelet Therapy|dual antiplatelet therapy
84406|NCT03038009|Gastrointestinal|gastrointestinal
84407|NCT03038009|Mucosal Injury|mucosal injury
84408|NCT03038009|Proton Pump Inhibitor|proton pump inhibitor
84409|NCT03037996|anesthesia|anesthesia
84410|NCT03037996|satisfaction|satisfaction
84411|NCT03037983|Schizophrenia|schizophrenia
84412|NCT03037983|Transcranial magnetic stimulation|transcranial magnetic stimulation
84413|NCT03037983|Electroencephalography|electroencephalography
84414|NCT03037944|Adenomyosis|adenomyosis
84415|NCT03037944|Contraceptive pills|contraceptive pills
84416|NCT03037944|Levonorgestrel-releasing Intrauterine System|levonorgestrel-releasing intrauterine system
84417|NCT03037918|Gut Microbiota|gut microbiota
84418|NCT03037918|High Fat Diets|high fat diets
84419|NCT03037918|Probiotics|probiotics
84420|NCT03037918|Glycaemic Control|glycaemic control
84421|NCT03037853|Atlas|atlas
84422|NCT03037853|Full human Body|full human body
84423|NCT03037853|MRI|mri
84424|NCT03037840|RF EMF|rf emf
84425|NCT03037840|In Vivo|in vivo
84426|NCT03037840|tumor specific frequencies|tumor specific frequencies
84427|NCT03037827|endovenous laser ablation|endovenous laser ablation
84428|NCT03037827|radial fiber|radial fiber
84429|NCT03037827|linear endovenous energy density|linear endovenous energy density
84430|NCT03037827|1470 nm|1470 nm
84431|NCT03037827|occlusion rate|occlusion rate
84432|NCT03037814|restorative materials|restorative materials
84433|NCT03037814|primary teeth|primary teeth
84434|NCT03037814|children|children
84435|NCT03037788|Excessive sweating|excessive sweating
84436|NCT03037775|tobacco|tobacco
84437|NCT03037775|cardiovascular system|cardiovascular system
84438|NCT03037775|sympathetic nervous system|sympathetic nervous system
84439|NCT03037684|neuropathic pain|neuropathic pain
84440|NCT03037684|chronic postoperative pain|chronic postoperative pain
84441|NCT03037671|Malglycemia|malglycemia
84442|NCT03037658|physical activity|physical activity
84443|NCT03037658|walking|walking
84444|NCT03037658|incentive|incentive
84445|NCT03037658|step count|step count
84446|NCT03037645|CLL|cll
84447|NCT03037645|hematological diseases|hematological diseases
84448|NCT03037645|relapsed|relapsed
84449|NCT03037645|cancer|cancer
84450|NCT03037645|malignancy|malignancy
84451|NCT03037645|SNS-062|sns-062
84452|NCT03037645|B-lymphoid|b-lymphoid
84453|NCT03037645|chronic lymphocytic leukemia|chronic lymphocytic leukemia
84454|NCT03037645|small lymphocytic lymphoma|small lymphocytic lymphoma
84455|NCT03037645|lymphoplasmacytoid lymphoma|lymphoplasmacytoid lymphoma
84456|NCT03037645|Waldenström's macrogloulinemia|waldenström's macrogloulinemia
84457|NCT03037645|mantle cell lymphoma|mantle cell lymphoma
84458|NCT03037645|SLL|sll
84459|NCT03037645|LPL|lpl
84460|NCT03037645|WM|wm
84461|NCT03037645|MCL|mcl
84462|NCT03037645|refractory|refractory
84463|NCT03037645|DLBCL-ABC|dlbcl-abc
84464|NCT03037645|DLBCL|dlbcl
84465|NCT03037645|follicular lymphoma|follicular lymphoma
84466|NCT03037645|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
84467|NCT03037593|Pregnancy|pregnancy
84468|NCT03037593|Gestational Diabetes|gestational diabetes
84469|NCT03037580|Pulmonary Hypertension|pulmonary hypertension
84470|NCT03037580|6-Minute Walk Test|6-minute walk test
84471|NCT03037580|HFpEF|hfpef
84472|NCT03037580|Oral Treprostinil|oral treprostinil
84473|NCT03037554|Skin Temperature|skin temperature
84474|NCT03037554|Hot Flashes|hot flashes
84475|NCT03037554|Sleep Disturbance|sleep disturbance
84476|NCT03037541|Wake Forest|wake forest
84477|NCT03037541|Actinic Keratosis|actinic keratosis
84478|NCT03037541|Cryosurgery|cryosurgery
84479|NCT03037541|Cream|cream
84480|NCT03037502|Men's Health|men's health
84481|NCT03037502|weight loss|weight loss
84482|NCT03037502|African American men|african american men
84483|NCT03037502|Latino men|latino men
84484|NCT03037437|Hepatocellular Cancer|hepatocellular cancer
84486|NCT03037437|Hydroxychloroquine|hydroxychloroquine
84487|NCT03037424|Cyroprecipitate|cyroprecipitate
84488|NCT03037424|Fibrinogen|fibrinogen
84489|NCT03037424|Cardiac Surgery|cardiac surgery
84490|NCT03037411|Atherosclerosis|atherosclerosis
84491|NCT03037411|Superficial Femoral Artery (SFA)|superficial femoral artery (sfa)
84492|NCT03037411|Proximal Popliteal Artery (PPA)|proximal popliteal artery (ppa)
84493|NCT03037411|Stenting|stenting
84494|NCT03037411|Paclitaxel|paclitaxel
84495|NCT03037411|Health Economics|health economics
84496|NCT03037385|RET Lung|ret lung
84497|NCT03037385|RET Thyroid|ret thyroid
84498|NCT03037385|RET fusion|ret fusion
84499|NCT03037385|RET alteration|ret alteration
84500|NCT03037385|RET mutation|ret mutation
84501|NCT03037385|RET positive|ret positive
84502|NCT03037385|RET inhibitor|ret inhibitor
84503|NCT03037385|RET altered|ret altered
84504|NCT03037385|RET rearrangement|ret rearrangement
84505|NCT03037385|RET NSCLC|ret nsclc
84506|NCT03037385|RET medullary thyroid cancer|ret medullary thyroid cancer
84507|NCT03037385|RET-rearranged NSCLC|ret-rearranged nsclc
84508|NCT03037385|RET-rearranged thyroid|ret-rearranged thyroid
84509|NCT03037385|M918T|m918t
84510|NCT03037385|TRIM33-RET|trim33-ret
84511|NCT03037385|RET fusion lung cancer|ret fusion lung cancer
84512|NCT03037385|RET fusion thyroid cancer|ret fusion thyroid cancer
84513|NCT03037385|lung cancer mutation|lung cancer mutation
84514|NCT03037385|BLUE 667|blue 667
84515|NCT03037385|RET tyrosine kinase|ret tyrosine kinase
84516|NCT03037385|RET gene mutation|ret gene mutation
84517|NCT03037385|RET kinase|ret kinase
84518|NCT03037385|RET MTC|ret mtc
84519|NCT03037385|advanced lung cancer|advanced lung cancer
84520|NCT03037385|advanced non small cell lung cancer|advanced non small cell lung cancer
84521|NCT03037385|metastatic lung cancer|metastatic lung cancer
84522|NCT03037385|KIF5B-RET|kif5b-ret
84523|NCT03037385|CCDC6-RET|ccdc6-ret
84524|NCT03037385|NCOA4-RET|ncoa4-ret
84525|NCT03037385|advance solid tumor|advance solid tumor
84526|NCT03037385|V804L|v804l
84527|NCT03037385|V804M|v804m
84528|NCT03037385|thyroid cancer RET inhibitor|thyroid cancer ret inhibitor
84529|NCT03037385|lung cancer RET inhibitor|lung cancer ret inhibitor
84530|NCT03037385|RET PTC|ret ptc
84531|NCT03037385|rearranged during transfection|rearranged during transfection
84532|NCT03037372|adults|adults
84533|NCT03037372|antiretroviral therapy|antiretroviral therapy
84534|NCT03037359|PID|pid
84535|NCT03037346|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
84536|NCT03037346|Invasive gynecologic malignancy|invasive gynecologic malignancy
84537|NCT03037346|Medical Power of Attorney Documents|medical power of attorney documents
84538|NCT03037346|MPOAD|mpoad
84539|NCT03037346|Questionnaires|questionnaires
84540|NCT03037346|Surveys|surveys
84541|NCT03037333|echocardiogram|echocardiogram
84542|NCT03037333|Electrocardiogram: Electrical Alternans|electrocardiogram: electrical alternans
84543|NCT03037333|fluoroscopy|fluoroscopy
84544|NCT03037229|Myocardial Infarction|myocardial infarction
84545|NCT03037229|Ischemia|ischemia
84546|NCT03037229|Myocardial Ischemia|myocardial ischemia
84547|NCT03037229|Heart Diseases|heart diseases
84548|NCT03037229|Cardiovascular Diseases|cardiovascular diseases
84549|NCT03037229|Vascular Diseases|vascular diseases
84550|NCT03037216|Exercise|exercise
84551|NCT03037164|INTERCEPT|intercept
84552|NCT03037164|Red Blood Cells|red blood cells
84553|NCT03037164|RBC|rbc
84554|NCT03037164|Pathogen Inactivation|pathogen inactivation
84555|NCT03037164|Zika|zika
84556|NCT03037164|Cerus|cerus
84557|NCT03037164|Pathogen Reduction|pathogen reduction
84558|NCT03037151|Safety|safety
84559|NCT03037151|Efficacy|efficacy
84560|NCT03037151|grazoprevir|grazoprevir
84561|NCT03037151|elbasvir|elbasvir
84562|NCT03037151|compensated cirrhosis|compensated cirrhosis
84563|NCT03037151|genotype 1 (GT1)|genotype 1 (gt1)
84564|NCT03037151|genotype 6 (GT6)|genotype 6 (gt6)
84565|NCT03037151|hepatitis virus C (HCV)|hepatitis virus c (hcv)
84566|NCT03037151|human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
84567|NCT03037138|postdialysis washed-out|postdialysis washed-out
84568|NCT03037099|Glycemic index|glycemic index
84569|NCT03037099|dietary intakes|dietary intakes
84570|NCT03037086|NSCLC|nsclc
84571|NCT03037073|Duloxetine|duloxetine
84572|NCT03037073|Succinylcholine|succinylcholine
84573|NCT03037073|Postoperative Myalgia|postoperative myalgia
84574|NCT03037073|Microlaryngoscopy|microlaryngoscopy
84575|NCT03037060|Alcohol use, problem|alcohol use, problem
84576|NCT03037021|Sickle Cell Disease|sickle cell disease
84577|NCT03037021|Needs Assessment|needs assessment
84578|NCT03037021|Barriers to care|barriers to care
84579|NCT03037021|Access to care|access to care
84580|NCT03037021|Primary care|primary care
84581|NCT03037008|perineal sonography|perineal sonography
84582|NCT03037008|male sling|male sling
84583|NCT03037008|post prostatectomy incontinence|post prostatectomy incontinence
84584|NCT03037008|ultrasonography|ultrasonography
84585|NCT03036956|subclinical hypothyroidism in pregnancy|subclinical hypothyroidism in pregnancy
84586|NCT03036904|venetoclax|venetoclax
84587|NCT03036904|dose-adjusted EPOCH-R|dose-adjusted epoch-r
84588|NCT03036904|aggressive B-Cell lymphoma|aggressive b-cell lymphoma
84589|NCT03036904|Lymphoma|lymphoma
84590|NCT03036904|Non-Hodgkin lymphoma|non-hodgkin lymphoma
84591|NCT03036904|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
84592|NCT03036904|Double hit lymphoma|double hit lymphoma
84593|NCT03036891|Gastroparesis|gastroparesis
84594|NCT03036891|Opioid-Induced|opioid-induced
84595|NCT03036891|Delayed Gastric Emptying|delayed gastric emptying
84596|NCT03036878|Osteochondral|osteochondral
84597|NCT03036878|Marrow Stimulation|marrow stimulation
84598|NCT03036878|ReNu|renu
84599|NCT03036865|Healthy participants|healthy participants
84600|NCT03036865|BOS161721|bos161721
84601|NCT03036865|Pharmacokinetics|pharmacokinetics
84602|NCT03036865|Pharmacodynamics|pharmacodynamics
84603|NCT03036826|renal replacement therapy|renal replacement therapy
84604|NCT03036787|Premature Baby|premature baby
84605|NCT03036787|motor development|motor development
84606|NCT03036787|cognitive development|cognitive development
84607|NCT03036774|Gastric contents|gastric contents
84608|NCT03036774|Ultrasound|ultrasound
84609|NCT03036774|Diabetes|diabetes
84610|NCT03036761|Auriculotherapy|auriculotherapy
84611|NCT03036696|Retention|retention
84612|NCT03036696|Lactation|lactation
84613|NCT03036696|Human milk|human milk
84614|NCT03036696|Pregnancy|pregnancy
84615|NCT03036696|Clinical Research Studies|clinical research studies
84616|NCT03036696|BEACH|beach
84617|NCT03036657|Acupuncture|acupuncture
84618|NCT03036657|Electroacupuncture|electroacupuncture
84619|NCT03036657|Nerve Conduction Studies|nerve conduction studies
84620|NCT03036657|Quantitative Sensory Testing|quantitative sensory testing
84621|NCT03036644|electronic cigarette|electronic cigarette
84622|NCT03036644|e-cigarette|e-cigarette
84623|NCT03036644|oxidative stress|oxidative stress
84624|NCT03036644|tobacco smoking|tobacco smoking
84625|NCT03036618|BMI|bmi
84626|NCT03036618|Blood Cholesterol|blood cholesterol
84627|NCT03036618|Glucose|glucose
84628|NCT03036618|Insulin|insulin
84629|NCT03036618|Gut health|gut health
84630|NCT03036605|dexamethasone|dexamethasone
84631|NCT03036605|bupivacaine|bupivacaine
84632|NCT03036605|nasal surgery|nasal surgery
84633|NCT03036605|nasal packing|nasal packing
84634|NCT03036592|Glucose tolerance test, MTNR1B, nutrigenomics, food timing|glucose tolerance test, mtnr1b, nutrigenomics, food timing
84635|NCT03036579|CAD/CAM|cad/cam
84636|NCT03036579|Ceramic|ceramic
84637|NCT03036579|Crown|crown
84638|NCT03036553|Chronic pain|chronic pain
84639|NCT03036553|Psychological factors|psychological factors
84640|NCT03036553|Musculoskeletal pain|musculoskeletal pain
84641|NCT03036553|Prognosis|prognosis
84642|NCT03036540|upper limb thrombosis, midline catheter|upper limb thrombosis, midline catheter
84643|NCT03036527|Bladder|bladder
84644|NCT03036527|Sexual Function|sexual function
84645|NCT03036514|numeric rating scale|numeric rating scale
84646|NCT03036514|opioid side effects|opioid side effects
84647|NCT03036488|PD1|pd1
84648|NCT03036488|PD-1|pd-1
84649|NCT03036488|PDL1|pdl1
84650|NCT03036488|PD-L1|pd-l1
84651|NCT03036462|intravenous iron|intravenous iron
84652|NCT03036462|systolic heart failure|systolic heart failure
84653|NCT03036462|iron deficiency|iron deficiency
84654|NCT03036462|morbidity|morbidity
84655|NCT03036462|mortality|mortality
84656|NCT03036449|Medication errors|medication errors
84657|NCT03036449|Patient safety|patient safety
84658|NCT03036436|Cancer|cancer
84659|NCT03036436|EHealth|ehealth
84660|NCT03036436|Cancer Survivor|cancer survivor
84661|NCT03036436|Rehabilitation|rehabilitation
84662|NCT03036410|Hearing Aid Usage (monaural, binaural)|hearing aid usage (monaural, binaural)
84663|NCT03036410|Cochlear Implant Usage (monaural, binaural)|cochlear implant usage (monaural, binaural)
84664|NCT03036410|Hearing Aid and Cochlear Implant Usage (monaural)|hearing aid and cochlear implant usage (monaural)
84665|NCT03036397|Anxiety|anxiety
84666|NCT03036397|Vasopressin|vasopressin
84667|NCT03036397|Fear-Potentiated Startle|fear-potentiated startle
84668|NCT03036397|Shock Threat|shock threat
84669|NCT03036397|Emotion Recognition|emotion recognition
84670|NCT03036384|scheduled cesarean delivery|scheduled cesarean delivery
84671|NCT03036384|spinal anesthesia|spinal anesthesia
84672|NCT03036384|local anesthesia|local anesthesia
84673|NCT03036371|Neurogenesis|neurogenesis
84674|NCT03036371|Memory|memory
84675|NCT03036371|Spatial Processing|spatial processing
84676|NCT03036371|Hippocampus|hippocampus
84677|NCT03036371|Cognition|cognition
84678|NCT03036371|Aerobic Exercise|aerobic exercise
84679|NCT03036332|aerobic interval training|aerobic interval training
84680|NCT03036332|biomarkers|biomarkers
84681|NCT03036306|scar|scar
84682|NCT03036306|nefopam|nefopam
84683|NCT03036306|cicatrix|cicatrix
84684|NCT03036280|E2609|e2609
84685|NCT03036280|elenbecestat|elenbecestat
84686|NCT03036280|Alzheimer's Disease|alzheimer's disease
84687|NCT03036280|Early Alzheimer's Disease|early alzheimer's disease
84688|NCT03036280|Prodromal Alzheimer's Disease|prodromal alzheimer's disease
84689|NCT03036280|Dementia|dementia
84690|NCT03036280|Dementia, Alzheimer's type|dementia, alzheimer's type
84691|NCT03036280|mild cognitive impairment|mild cognitive impairment
84692|NCT03036280|MissionAD2|missionad2
84693|NCT03036267|health disparity|health disparity
84694|NCT03036267|motivational interviewing|motivational interviewing
84695|NCT03036267|African American adults|african american adults
84696|NCT03036267|Federally Qualified Health Centers|federally qualified health centers
84697|NCT03036267|adherence|adherence
84698|NCT03036267|health beliefs|health beliefs
84699|NCT03036267|self-management|self-management
84700|NCT03036267|asthma control|asthma control
84701|NCT03036254|Diabetes Mellitus|diabetes mellitus
84702|NCT03036254|Cognition|cognition
84703|NCT03036241|drug-eluting balloon,|drug-eluting balloon,
84704|NCT03036241|target lesion revascularization (TLR)|target lesion revascularization (tlr)
84705|NCT03036241|restenosis|restenosis
84706|NCT03036228|Solid tumours|solid tumours
84707|NCT03036202|epinephrine|epinephrine
84708|NCT03036163|Tuberculosis|tuberculosis
84709|NCT03036150|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
84710|NCT03036150|Cardiovascular Events (CV)|cardiovascular events (cv)
84711|NCT03036150|Phase III outcome trial|phase iii outcome trial
84712|NCT03036137|Tinnitus|tinnitus
84713|NCT03036137|Electroencephalogram|electroencephalogram
84714|NCT03036137|Transcranial Direct Current Stimulation|transcranial direct current stimulation
84715|NCT03036124|HFrEF|hfref
84716|NCT03036124|Heart Failure (HF)|heart failure (hf)
84717|NCT03036124|Cardiovascular Events (CV)|cardiovascular events (cv)
84718|NCT03036124|Phase III outcome trial|phase iii outcome trial
84719|NCT03036085|postoperative pain|postoperative pain
84720|NCT03036085|video-assisted thoracoscopic surgery (VATS)|video-assisted thoracoscopic surgery (vats)
84721|NCT03036085|opioids|opioids
84722|NCT03036085|bupivacaine|bupivacaine
84723|NCT03036085|liposomal bupivacaine|liposomal bupivacaine
84724|NCT03036085|analgesia|analgesia
84725|NCT03036085|local anesthetics|local anesthetics
84726|NCT03036072|Therapeutic Hypothermia|therapeutic hypothermia
84727|NCT03036059|Twice a year treatment|twice a year treatment
84728|NCT03036059|Biannual treatment|biannual treatment
84729|NCT03036059|Wuchereria bancrofti|wuchereria bancrofti
84730|NCT03036007|Spine, Disc, Neck pain, Rehabilitation, Exercise Therapy, Internet|spine, disc, neck pain, rehabilitation, exercise therapy, internet
84731|NCT03035968|Vojta therapy|vojta therapy
84732|NCT03035968|reflex locomotion|reflex locomotion
84733|NCT03035968|stroke rehabilitation|stroke rehabilitation
84734|NCT03035968|stroke|stroke
84735|NCT03035968|physiotherapy|physiotherapy
84736|NCT03035955|Rosacea|rosacea
84737|NCT03035955|Wake Forest|wake forest
84738|NCT03035955|Demodex|demodex
84739|NCT03035955|Finacea Gel|finacea gel
84740|NCT03035942|Intrathecal morphine|intrathecal morphine
84741|NCT03035942|Nausea and vomiting|nausea and vomiting
84742|NCT03035942|Quality of recovery|quality of recovery
84743|NCT03035942|Patient satisfaction|patient satisfaction
84744|NCT03035942|Pruritus|pruritus
84745|NCT03035942|Postoperative pain|postoperative pain
84746|NCT03035916|transversus abdominal plane block|transversus abdominal plane block
84747|NCT03035916|epidural anesthesia|epidural anesthesia
84748|NCT03035916|stress response|stress response
84749|NCT03035916|anesthetic recovery|anesthetic recovery
84750|NCT03035890|NSCLC|nsclc
84751|NCT03035890|Lung Cancer|lung cancer
84752|NCT03035890|Non Small Cell Lung Cancer|non small cell lung cancer
84753|NCT03035877|Antisocial Behavior|antisocial behavior
84754|NCT03035877|Alcohol Abuse|alcohol abuse
84755|NCT03035877|Drug Abuse|drug abuse
84756|NCT03035877|Young Adults|young adults
84757|NCT03035864|Ocular discomfort after cataract and refractive surgery|ocular discomfort after cataract and refractive surgery
84758|NCT03035864|cataract surgery|cataract surgery
84759|NCT03035864|refractive surgery|refractive surgery
84760|NCT03035851|Alzheimer Disease|alzheimer disease
84761|NCT03035851|Dementia|dementia
84762|NCT03035851|Exercise|exercise
84763|NCT03035851|Physical Activity|physical activity
84764|NCT03035851|Brain blood flow|brain blood flow
84765|NCT03035851|Cognition|cognition
84766|NCT03035851|Fitness|fitness
84767|NCT03035812|Bicarbonate|bicarbonate
84768|NCT03035773|Cancer|cancer
84769|NCT03035773|Oncology|oncology
84770|NCT03035773|Survivorship|survivorship
84771|NCT03035760|Helminths|helminths
84772|NCT03035760|Oxfendazole|oxfendazole
84773|NCT03035760|Pharmacokinetics|pharmacokinetics
84774|NCT03035760|Safety|safety
84775|NCT03035747|registry|registry
84776|NCT03035747|varicose veins|varicose veins
84777|NCT03035747|conventional surgery|conventional surgery
84778|NCT03035747|thermal ablation|thermal ablation
84779|NCT03035747|radiofrequency|radiofrequency
84780|NCT03035747|laser|laser
84781|NCT03035747|sclerotherapy|sclerotherapy
84782|NCT03035721|Full term healthy infants|full term healthy infants
84783|NCT03035721|Low protein content formula|low protein content formula
84784|NCT03035721|Safety|safety
84785|NCT03035721|Growth|growth
84786|NCT03035721|Body composition|body composition
84787|NCT03035695|Trauma|trauma
84788|NCT03035695|Scalp injuries|scalp injuries
84789|NCT03035695|Profused Bleeding|profused bleeding
84790|NCT03035695|Accident|accident
84791|NCT03035656|Pain|pain
84792|NCT03035656|analgesic|analgesic
84793|NCT03035656|spinal fusion|spinal fusion
84794|NCT03035630|Avelumab|avelumab
84795|NCT03035630|Sunitinib|sunitinib
84796|NCT03035630|MSB0010718C|msb0010718c
84797|NCT03035630|Sutent|sutent
84798|NCT03035630|IgG1 antibody|igg1 antibody
84799|NCT03035630|Anti-PD-L1|anti-pd-l1
84800|NCT03035630|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
84801|NCT03035617|Bupivacaine|bupivacaine
84802|NCT03035604|Malnutrition|malnutrition
84803|NCT03035604|Nutritional status|nutritional status
84804|NCT03035604|Mini Nutritional Assessment|mini nutritional assessment
84805|NCT03035604|MNA|mna
84806|NCT03035604|Weight loss|weight loss
84807|NCT03035604|Body Mass Index|body mass index
84808|NCT03035604|BMI|bmi
84809|NCT03035604|Lean muscle mas|lean muscle mas
84810|NCT03035604|American Society for Parenteral and Enteral Nutrition|american society for parenteral and enteral nutrition
84811|NCT03035604|ASPEN|aspen
84812|NCT03035578|Pharmacokinetics|pharmacokinetics
84813|NCT03035578|Pharmacodynamics|pharmacodynamics
84814|NCT03035578|Morphine|morphine
84815|NCT03035578|Neonatal|neonatal
84816|NCT03035565|Heart Failure|heart failure
84817|NCT03035565|Cognition in Heart Failure|cognition in heart failure
84818|NCT03035552|Congenital heart disease (CCHD)|congenital heart disease (cchd)
84819|NCT03035552|Non-Nutritive Suck|non-nutritive suck
84820|NCT03035539|Rehabilitation|rehabilitation
84821|NCT03035513|Continuous spikes|continuous spikes
84822|NCT03035513|Epilepsy|epilepsy
84823|NCT03035513|Nervous system disease|nervous system disease
84824|NCT03035513|Neuronal plasticity|neuronal plasticity
84825|NCT03035513|Diffusion MRI|diffusion mri
84826|NCT03035513|Functional MRI|functional mri
84827|NCT03035513|waves during slow sleep (CSWS)|waves during slow sleep (csws)
84828|NCT03035474|Heart Failure|heart failure
84829|NCT03035474|Quality Improvement|quality improvement
84830|NCT03035461|diagnosis annoucement|diagnosis annoucement
84831|NCT03035461|patient's feelings|patient's feelings
84832|NCT03035448|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
84833|NCT03035448|Advanced cancer|advanced cancer
84834|NCT03035448|Recurrent cancer|recurrent cancer
84835|NCT03035448|Metastatic disease|metastatic disease
84836|NCT03035448|Palliative care|palliative care
84837|NCT03035448|Videos|videos
84838|NCT03035448|Questionnaires|questionnaires
84839|NCT03035448|Surveys|surveys
84840|NCT03035435|fast-track rehabilitation|fast-track rehabilitation
84841|NCT03035435|fast-track surgery|fast-track surgery
84842|NCT03035422|Allogenic cell stem transplant, Sequential chemotherapy Haploidentical transplant|allogenic cell stem transplant, sequential chemotherapy haploidentical transplant
84843|NCT03035409|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
84844|NCT03035409|Advanced Cancer|advanced cancer
84845|NCT03035409|Metastatic or recurrent incurable solid tumors|metastatic or recurrent incurable solid tumors
84846|NCT03035409|Anamorelin|anamorelin
84847|NCT03035409|Physical activity|physical activity
84848|NCT03035409|Questionnaires|questionnaires
84849|NCT03035409|Surveys|surveys
84850|NCT03035409|Dietary Counseling|dietary counseling
84851|NCT03035409|Exercise Counseling|exercise counseling
84852|NCT03035383|Large thyroid|large thyroid
84853|NCT03035383|purse string suture|purse string suture
84854|NCT03035383|thyroidectomy|thyroidectomy
84855|NCT03035370|Pertussis|pertussis
84856|NCT03035370|Epicutaneous ImmunoTherapy (EPIT)|epicutaneous immunotherapy (epit)
84857|NCT03035370|Vaccine|vaccine
84858|NCT03035370|Viaskin PT|viaskin pt
84859|NCT03035357|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
84860|NCT03035357|Prostate cancer|prostate cancer
84861|NCT03035357|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
84862|NCT03035357|Daratumumab|daratumumab
84863|NCT03035357|Biomarker response|biomarker response
84864|NCT03035305|Seasonal malaria chemoprevention|seasonal malaria chemoprevention
84865|NCT03035305|Lipid-based nutrient supplement|lipid-based nutrient supplement
84866|NCT03035305|Children|children
84867|NCT03035305|Mali|mali
84868|NCT03035279|Advanced colorectal cancer|advanced colorectal cancer
84869|NCT03035279|Cancer|cancer
84870|NCT03035279|Metastatic colorectal cancer|metastatic colorectal cancer
84871|NCT03035279|Unresectable colorectal cancer|unresectable colorectal cancer
84872|NCT03035279|Maximum tolerated dose|maximum tolerated dose
84873|NCT03035279|Pharmacokinetics|pharmacokinetics
84874|NCT03035266|blood flow restriction|blood flow restriction
84875|NCT03035266|strength|strength
84876|NCT03035266|muscle atrophy|muscle atrophy
84877|NCT03035266|post-operative therapy|post-operative therapy
84878|NCT03035266|knee|knee
84879|NCT03035201|Memory|memory
84880|NCT03035201|Mild Cognitive Impairment|mild cognitive impairment
84881|NCT03035201|Alzheimer's Disease|alzheimer's disease
84882|NCT03035201|Cognition|cognition
84883|NCT03035188|resectable|resectable
84884|NCT03035175|Residences|residences
84885|NCT03035175|Video Laryngoscopy|video laryngoscopy
84886|NCT03035175|Intubations|intubations
84887|NCT03035175|Neonatal|neonatal
84888|NCT03035175|NICU|nicu
84889|NCT03035175|neonates|neonates
84890|NCT03035175|Medical Education|medical education
84891|NCT03035162|dual tDCS|dual tdcs
84892|NCT03035162|physical rehabilitation|physical rehabilitation
84893|NCT03035162|lower limb functions|lower limb functions
84894|NCT03035149|Obesity|obesity
84895|NCT03035149|Metabolic Syndrome|metabolic syndrome
84896|NCT03035149|Dyspnea|dyspnea
84897|NCT03035149|Pulmonary Function|pulmonary function
84898|NCT03035149|Exercise Capacity|exercise capacity
84899|NCT03035136|polyps|polyps
84900|NCT03035123|Heart Failure|heart failure
84901|NCT03035123|Therapeutic education|therapeutic education
84902|NCT03035123|Quality of life|quality of life
84903|NCT03035071|Minimal-invasive esophagectomy|minimal-invasive esophagectomy
84904|NCT03035071|Esophageal resection|esophageal resection
84905|NCT03035071|Hybrid esophagectomy|hybrid esophagectomy
84906|NCT03035058|Drug therapy|drug therapy
84907|NCT03035032|Leuprolide acetate|leuprolide acetate
84908|NCT03035032|Prostate cancer|prostate cancer
84909|NCT03035019|anxiety|anxiety
84910|NCT03035019|behavioral app|behavioral app
84911|NCT03035006|Hepatocellular carcinoma|hepatocellular carcinoma
84912|NCT03035006|Portal vein tumor thrombosis|portal vein tumor thrombosis
84913|NCT03035006|TLC388|tlc388
84914|NCT03035006|Chemoradiotherapy|chemoradiotherapy
84915|NCT03035006|Lipotecan|lipotecan
84916|NCT03034967|HCRU exacerbations|hcru exacerbations
84917|NCT03034967|SGRQ|sgrq
84918|NCT03034967|CXCR2 antagonist|cxcr2 antagonist
84919|NCT03034967|GSK1325756|gsk1325756
84920|NCT03034967|Danirixin|danirixin
84921|NCT03034967|COPD|copd
84922|NCT03034941|Obesity|obesity
84923|NCT03034941|PCOS|pcos
84924|NCT03034941|Infertility|infertility
84925|NCT03034941|Liraglutide|liraglutide
84926|NCT03034941|Metformin|metformin
84927|NCT03034941|IVF|ivf
84928|NCT03034915|Vilanterol|vilanterol
84929|NCT03034915|COPD|copd
84930|NCT03034915|HRQoL|hrqol
84931|NCT03034915|Salmeterol|salmeterol
84932|NCT03034915|Umeclidinium|umeclidinium
84933|NCT03034889|Anesthesia|anesthesia
84934|NCT03034889|Children|children
84935|NCT03034889|General Anesthesia|general anesthesia
84936|NCT03034889|Neurocognitive Outcome|neurocognitive outcome
84937|NCT03034876|"Acute Kidney Injury, diagnosis, children, shock"|"acute kidney injury, diagnosis, children, shock"
84938|NCT03034863|Family Caregivers|family caregivers
84939|NCT03034863|Spouse Caregivers|spouse caregivers
84940|NCT03034863|Veterans|veterans
84941|NCT03034863|Suicide|suicide
84942|NCT03034863|Clinical Trial|clinical trial
84943|NCT03034863|Military Families|military families
84944|NCT03034863|Military Psychology|military psychology
84945|NCT03034850|cytoreductive surgery|cytoreductive surgery
84946|NCT03034850|hyperthermic intraperitoneal peroperative chemotherapy|hyperthermic intraperitoneal peroperative chemotherapy
84947|NCT03034850|platelet function|platelet function
84948|NCT03034850|thrombin generation|thrombin generation
84949|NCT03034850|thromboelastometry|thromboelastometry
84950|NCT03034824|diode laser|diode laser
84951|NCT03034824|Er,Cr:YSGG laser|er,cr:ysgg laser
84952|NCT03034824|Aggressive Periodontitis|aggressive periodontitis
84953|NCT03034824|Clinical periodontal parameters|clinical periodontal parameters
84954|NCT03034824|Gingival crevicular fluid cytokines levels|gingival crevicular fluid cytokines levels
84955|NCT03034811|Noninflammatory degenerative joint disease|noninflammatory degenerative joint disease
84956|NCT03034811|Osteoarthritis|osteoarthritis
84957|NCT03034811|Avascular necrosis|avascular necrosis
84958|NCT03034811|Traumatic arthritis|traumatic arthritis
84959|NCT03034811|Partial knee arthroplasty|partial knee arthroplasty
84960|NCT03034811|Unicompartmental knee arthroplasty|unicompartmental knee arthroplasty
84961|NCT03034772|neovascular|neovascular
84962|NCT03034772|wet|wet
84963|NCT03034772|age-related|age-related
84964|NCT03034772|macular degeneration|macular degeneration
84965|NCT03034772|dorzolamide|dorzolamide
84966|NCT03034772|timolol|timolol
84967|NCT03034759|continuous glucose monitoring|continuous glucose monitoring
84968|NCT03034746|alzheimer's disease, physical activity, cognitive training|alzheimer's disease, physical activity, cognitive training
84969|NCT03034733|Arthroplasty|arthroplasty
84970|NCT03034733|Knee Replacement|knee replacement
84971|NCT03034733|Pain, Postoperative|pain, postoperative
84972|NCT03034733|Glucocorticoids|glucocorticoids
84973|NCT03034733|Dexamethasone|dexamethasone
84974|NCT03034720|Concussion|concussion
84975|NCT03034720|persistent post-concussive symptoms|persistent post-concussive symptoms
84976|NCT03034720|CBT|cbt
84977|NCT03034720|collaborative care|collaborative care
84978|NCT03034720|Depression|depression
84979|NCT03034720|Anxiety|anxiety
84980|NCT03034707|biotin pharmacokinetic|biotin pharmacokinetic
84981|NCT03034707|biotinylated assay|biotinylated assay
84982|NCT03034707|hormone measurement|hormone measurement
84983|NCT03034707|thyroid|thyroid
84984|NCT03034707|parathyroid|parathyroid
84985|NCT03034707|prolactin|prolactin
84986|NCT03034668|Botanical Supplement|botanical supplement
84987|NCT03034668|Performance-Enhancing Supplement|performance-enhancing supplement
84988|NCT03034655|Vestibular rehabilitation|vestibular rehabilitation
84989|NCT03034655|Falls in elderly|falls in elderly
84990|NCT03034655|Computerized dynamic posturography|computerized dynamic posturography
84991|NCT03034655|Mobile posturography|mobile posturography
84992|NCT03034642|Apoptosis|apoptosis
84993|NCT03034642|Bronchoscopy|bronchoscopy
84994|NCT03034642|Human|human
84995|NCT03034642|Mice, inbred strains|mice, inbred strains
84996|NCT03034642|Macrophages, Alveolar|macrophages, alveolar
84997|NCT03034642|MicroRNAs|micrornas
85124|NCT03033914|bleomycin|bleomycin
84998|NCT03034642|Streptococcus pneumoniae|streptococcus pneumoniae
84999|NCT03034642|Fluticasone|fluticasone
85000|NCT03034616|Primary ovarian insufficiency|primary ovarian insufficiency
85001|NCT03034616|In-vivo activation|in-vivo activation
85002|NCT03034551|Adherence|adherence
85003|NCT03034551|Financial Incentives|financial incentives
85004|NCT03034551|Remote Monitoring|remote monitoring
85005|NCT03034551|Self-Weighing|self-weighing
85006|NCT03034551|Behavioral Economics|behavioral economics
85007|NCT03034551|Telehealth|telehealth
85008|NCT03034551|mobile health (mHealth)|mobile health (mhealth)
85009|NCT03034551|Smartphone App|smartphone app
85010|NCT03034551|Wellth App|wellth app
85011|NCT03034486|Glaucoma|glaucoma
85012|NCT03034473|locally advanced rectal cancer|locally advanced rectal cancer
85013|NCT03034473|translational research|translational research
85014|NCT03034473|Biomarker|biomarker
85015|NCT03034447|Asthma|asthma
85016|NCT03034447|Obstructive Sleep Apnea|obstructive sleep apnea
85017|NCT03034447|Children|children
85018|NCT03034447|Teenagers|teenagers
85019|NCT03034408|Impulsivity|impulsivity
85020|NCT03034408|Nalmefene|nalmefene
85021|NCT03034408|Baclofen|baclofen
85022|NCT03034395|Melanoma|melanoma
85023|NCT03034395|cT2N0M0|ct2n0m0
85024|NCT03034382|morphine|morphine
85025|NCT03034382|nalbuphine|nalbuphine
85026|NCT03034382|arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
85027|NCT03034382|ultrasound guided interscalene block|ultrasound guided interscalene block
85028|NCT03034369|Integration|integration
85029|NCT03034369|Primary Care|primary care
85030|NCT03034369|Behavioral Health|behavioral health
85031|NCT03034369|Health Care Reform|health care reform
85032|NCT03034369|Medical Home|medical home
85033|NCT03034369|Accountable Care Organization|accountable care organization
85034|NCT03034356|Schizophrenia|schizophrenia
85035|NCT03034343|Mindfulness|mindfulness
85036|NCT03034343|Internet program|internet program
85037|NCT03034343|Depression|depression
85038|NCT03034343|Cost-effectiveness|cost-effectiveness
85039|NCT03034330|informal care|informal care
85040|NCT03034330|empowerment|empowerment
85041|NCT03034330|family-focused intervention|family-focused intervention
85042|NCT03034330|stroke rehabilitation|stroke rehabilitation
85043|NCT03034317|Diaphragm Pacing|diaphragm pacing
85044|NCT03034304|MASCT-I，DC，T cell|masct-i，dc，t cell
85045|NCT03034304|Advanced solid tumors|advanced solid tumors
85046|NCT03034304|Bladder Cancer|bladder cancer
85047|NCT03034304|Soft Tissue Sarcoma|soft tissue sarcoma
85048|NCT03034291|Cocoa|cocoa
85049|NCT03034291|obesity|obesity
85050|NCT03034291|HOMA-IR|homa-ir
85051|NCT03034291|BMI|bmi
85052|NCT03034291|Quality of life|quality of life
85053|NCT03034278|opioid use|opioid use
85054|NCT03034265|hypertension; exosome; angiotensin; sodium channel; kidney; aldosterone; renin; urine|hypertension; exosome; angiotensin; sodium channel; kidney; aldosterone; renin; urine
85055|NCT03034226|Hypoglycemia-Associated Autonomic Failure (HAAF)|hypoglycemia-associated autonomic failure (haaf)
85056|NCT03034213|mesh|mesh
85057|NCT03034200|Pheochromocytoma-paraganglioma|pheochromocytoma-paraganglioma
85058|NCT03034200|ONC201|onc201
85059|NCT03034187|Acute toxicity|acute toxicity
85060|NCT03034187|Late toxicity|late toxicity
85061|NCT03034187|Quality of Life since 2011(set-up SFP-prostate)|quality of life since 2011(set-up sfp-prostate)
85062|NCT03034174|tigecycline|tigecycline
85063|NCT03034174|pharmacokinetics|pharmacokinetics
85064|NCT03034148|Coronary artery disease|coronary artery disease
85065|NCT03034148|Atherothrombosis|atherothrombosis
85066|NCT03034148|Thrombin generation|thrombin generation
85067|NCT03034148|Platelet Acetyl Coenzyme A carboxylase phosphorylation|platelet acetyl coenzyme a carboxylase phosphorylation
85068|NCT03034109|Transcranial Direct Current Stimulation|transcranial direct current stimulation
85069|NCT03034109|Stroke|stroke
85070|NCT03034109|Electric Stimulation Therapy|electric stimulation therapy
85071|NCT03034109|Prefrontal Cortex|prefrontal cortex
85072|NCT03034109|Electroencephalography|electroencephalography
85073|NCT03034109|Cognition|cognition
85074|NCT03034109|Neurological Rehabilitation|neurological rehabilitation
85075|NCT03034109|Memory|memory
85076|NCT03034109|Working Memory|working memory
85077|NCT03034109|Attention|attention
85078|NCT03034109|Concentration|concentration
85079|NCT03034109|Short-Term Memory|short-term memory
85080|NCT03034109|Planning|planning
85081|NCT03034109|Executive Function|executive function
85082|NCT03034109|Cerebrovascular disease|cerebrovascular disease
85083|NCT03034083|healthy marriage|healthy marriage
85084|NCT03034083|healthy relationships|healthy relationships
85085|NCT03034083|parenting|parenting
85086|NCT03034083|healthy marriage and relationship education|healthy marriage and relationship education
85087|NCT03034070|MRI|mri
85088|NCT03034070|MRI sequences|mri sequences
85089|NCT03034070|prostate cancer|prostate cancer
85090|NCT03034070|cancer|cancer
85091|NCT03034070|staging|staging
85092|NCT03034070|bone metastasis|bone metastasis
85093|NCT03034070|node metastasis|node metastasis
85094|NCT03034031|Traumatic Brain Injury|traumatic brain injury
85095|NCT03034031|Children|children
85096|NCT03034031|Pediatric|pediatric
85097|NCT03034031|MRI|mri
85098|NCT03034031|fMRI|fmri
85099|NCT03034031|Cognition|cognition
85100|NCT03034031|DTI|dti
85101|NCT03034031|Longitudinal|longitudinal
85102|NCT03034031|Connectivity|connectivity
85103|NCT03034031|DAI|dai
85104|NCT03034031|Neuropsychology|neuropsychology
85105|NCT03034031|Rehabilitation|rehabilitation
85106|NCT03034018|insomnia|insomnia
85107|NCT03034018|hot flashes|hot flashes
85108|NCT03034018|menopause|menopause
85109|NCT03034018|suvorexant|suvorexant
85110|NCT03034018|belsomra|belsomra
85111|NCT03034005|Inhaled corticosteroids|inhaled corticosteroids
85112|NCT03034005|Airway hyper-responsiveness|airway hyper-responsiveness
85113|NCT03034005|Airway smooth muscle|airway smooth muscle
85114|NCT03034005|sodium-potassium pump|sodium-potassium pump
85115|NCT03033966|Cerebral Oximetry|cerebral oximetry
85116|NCT03033966|Cerebral Venous Thrombosis|cerebral venous thrombosis
85117|NCT03033966|Decompressive Craniectomy|decompressive craniectomy
85118|NCT03033927|Stage IV Pancreatic Cancer|stage iv pancreatic cancer
85119|NCT03033927|FOLFIRINOX|folfirinox
85120|NCT03033927|gem/nab-P chemotherapy|gem/nab-p chemotherapy
85121|NCT03033927|17-042|17-042
85122|NCT03033914|Nivolumab|nivolumab
85123|NCT03033914|adriamycin|adriamycin
85125|NCT03033914|vinblastine|vinblastine
85126|NCT03033914|dacarbazine|dacarbazine
85127|NCT03033914|16-1536|16-1536
85128|NCT03033901|Veterans|veterans
85129|NCT03033901|Comparative Effectiveness Research|comparative effectiveness research
85130|NCT03033901|Diagnosis|diagnosis
85131|NCT03033836|transgender women|transgender women
85132|NCT03033823|Alcoholism|alcoholism
85133|NCT03033823|Delirium|delirium
85134|NCT03033823|Magnesium Deficiency|magnesium deficiency
85135|NCT03033797|assitive technology|assitive technology
85136|NCT03033797|virtual reality games|virtual reality games
85137|NCT03033797|intellectual disability|intellectual disability
85138|NCT03033797|augmentative and alternative communication|augmentative and alternative communication
85139|NCT03033784|Neuroscience|neuroscience
85140|NCT03033758|comorbidities|comorbidities
85141|NCT03033732|opioid agonist treatment|opioid agonist treatment
85142|NCT03033732|pragmatic|pragmatic
85143|NCT03033732|prescription opioid use|prescription opioid use
85144|NCT03033732|patient engagement|patient engagement
85145|NCT03033719|Colorectal Surgery|colorectal surgery
85146|NCT03033719|Geriatrics|geriatrics
85147|NCT03033719|Digestive Oncology|digestive oncology
85148|NCT03033719|Colon cancer|colon cancer
85149|NCT03033719|Elderly patients|elderly patients
85150|NCT03033719|Laparoscopy|laparoscopy
85151|NCT03033719|Laparotomy|laparotomy
85152|NCT03033719|Morbidity|morbidity
85153|NCT03033667|perioperative fasting|perioperative fasting
85154|NCT03033667|free fatty acids|free fatty acids
85155|NCT03033667|coronary bypass grfting|coronary bypass grfting
85156|NCT03033589|Pain control|pain control
85157|NCT03033589|Anterior Cruciate Ligament (ACL_ Reconstruction)|anterior cruciate ligament (acl_ reconstruction)
85158|NCT03033589|Regional Anesthesia|regional anesthesia
85159|NCT03033550|HPV vaccination|hpv vaccination
85160|NCT03033550|Cervical cancer screening|cervical cancer screening
85161|NCT03033550|Primary care setting|primary care setting
85162|NCT03033550|Primary prevention of cervical cancer|primary prevention of cervical cancer
85163|NCT03033550|Secondary prevention of cervical cancer|secondary prevention of cervical cancer
85164|NCT03033550|Mobile health information|mobile health information
85165|NCT03033511|Extensive-Stage Small Cell Lung Cancer (ED SCLC)|extensive-stage small cell lung cancer (ed sclc)
85166|NCT03033511|Cancer|cancer
85167|NCT03033511|Platinum-Based Chemotherapy|platinum-based chemotherapy
85168|NCT03033511|Rovalpituzumab tesirine|rovalpituzumab tesirine
85169|NCT03033511|first-line chemotherapy|first-line chemotherapy
85170|NCT03033511|(SCLC)|(sclc)
85171|NCT03033485|Picolinamide|picolinamide
85172|NCT03033485|PET/CT|pet/ct
85173|NCT03033485|Diagnosis|diagnosis
85174|NCT03033485|Melanoma|melanoma
85175|NCT03033459|breast feeding|breast feeding
85176|NCT03033459|motivational interviewing|motivational interviewing
85177|NCT03033420|Unipolar disorder|unipolar disorder
85178|NCT03033420|Bipolar disorder|bipolar disorder
85179|NCT03033420|Randomized controlled trial|randomized controlled trial
85180|NCT03033420|Smartphone|smartphone
85181|NCT03033420|Re-admission|re-admission
85182|NCT03033420|CBT|cbt
85183|NCT03033381|Children|children
85184|NCT03033381|Inguinal hernia|inguinal hernia
85185|NCT03033381|Testis|testis
85186|NCT03033381|Doppler ultrasonography|doppler ultrasonography
85187|NCT03033368|immunological outcome|immunological outcome
85188|NCT03033368|virologic outcomes|virologic outcomes
85189|NCT03033368|HIV-1 infected adolescents|hiv-1 infected adolescents
85190|NCT03033368|EFV switch to RPV|efv switch to rpv
85191|NCT03033368|Rilpivirine pharmacokinetic|rilpivirine pharmacokinetic
85192|NCT03033368|neuropsychiatric adverse events|neuropsychiatric adverse events
85193|NCT03033355|Neurogenic Bladder, Detrusor Overactivity, Botox, fMRI, neurogenic detrusor overactivity|neurogenic bladder, detrusor overactivity, botox, fmri, neurogenic detrusor overactivity
85194|NCT03033342|Phase 1|phase 1
85195|NCT03033316|Multiple Myeloma|multiple myeloma
85196|NCT03033316|Liposomal Dexamethasone|liposomal dexamethasone
85197|NCT03033316|Targeted Drug Delivery|targeted drug delivery
85198|NCT03033303|Hu3F8|hu3f8
85199|NCT03033303|GM-CSF|gm-csf
85200|NCT03033303|Isotretinoin|isotretinoin
85201|NCT03033303|16-1643|16-1643
85202|NCT03033290|Qi-tonifying regimen|qi-tonifying regimen
85203|NCT03033290|immune-modulation|immune-modulation
85204|NCT03033290|gut microbiota|gut microbiota
85205|NCT03033251|COPD exacerbation|copd exacerbation
85206|NCT03033251|Work of breathing|work of breathing
85207|NCT03033251|Non invasive ventilation|non invasive ventilation
85208|NCT03033251|High Flow Oxygen Cannula|high flow oxygen cannula
85209|NCT03033225|Pancrease|pancrease
85210|NCT03033225|Cancer|cancer
85211|NCT03033225|Photodynamic Therapy|photodynamic therapy
85212|NCT03033225|Pancreatic|pancreatic
85213|NCT03033225|Tumor|tumor
85214|NCT03033225|unresectable|unresectable
85215|NCT03033199|Gut microbiota|gut microbiota
85216|NCT03033199|Immune thrombocytopenia|immune thrombocytopenia
85217|NCT03033186|Everolimus|everolimus
85218|NCT03033186|Long term site effects|long term site effects
85219|NCT03033186|Dried Blood Spot|dried blood spot
85220|NCT03033186|Therapeutic Drug Monitoring|therapeutic drug monitoring
85221|NCT03033160|Estrogen|estrogen
85222|NCT03033160|Hematuria|hematuria
85223|NCT03033121|growth hormone|growth hormone
85224|NCT03033121|children|children
85225|NCT03033121|metabolism|metabolism
85226|NCT03033095|TNF inhibitor|tnf inhibitor
85227|NCT03033095|Etanercept|etanercept
85228|NCT03033095|Spondyloarthritis|spondyloarthritis
85229|NCT03033095|Biomarkers analysis|biomarkers analysis
85230|NCT03033095|Personnalized medicine|personnalized medicine
85231|NCT03033056|fear-conditioning|fear-conditioning
85232|NCT03033056|behavioral avoidance|behavioral avoidance
85233|NCT03033056|anxiety disorders|anxiety disorders
85234|NCT03033056|fMRI|fmri
85235|NCT03033043|aortic|aortic
85236|NCT03033043|dissection|dissection
85237|NCT03033043|type B|type b
85238|NCT03033043|thoracic|thoracic
85239|NCT03033030|Ultrasound|ultrasound
85240|NCT03033030|Digital Breast Tomosynthesis|digital breast tomosynthesis
85241|NCT03033030|Cancer Detection rate|cancer detection rate
85242|NCT03033030|Sensitivity|sensitivity
85243|NCT03033030|Specificity|specificity
85244|NCT03033030|Breast density|breast density
85245|NCT03033017|HIV|hiv
85246|NCT03032991|Gestational diabetes|gestational diabetes
85247|NCT03032991|Neurodevelopment|neurodevelopment
85248|NCT03032991|Placenta|placenta
85249|NCT03032991|Gut microbiota|gut microbiota
85250|NCT03032991|Protectins|protectins
85252|NCT03032991|AdipoRon|adiporon
85253|NCT03032965|atrial fibrillation|atrial fibrillation
85254|NCT03032965|ablation|ablation
85255|NCT03032965|adenosine|adenosine
85256|NCT03032952|RCT|rct
85257|NCT03032952|Computerised interventions|computerised interventions
85258|NCT03032952|Mobile applications|mobile applications
85259|NCT03032952|Stress, Psychological|stress, psychological
85260|NCT03032952|Depressive symptoms|depressive symptoms
85261|NCT03032952|Anxious symptoms|anxious symptoms
85262|NCT03032952|Students|students
85263|NCT03032952|Mental health|mental health
85264|NCT03032926|Anxiety|anxiety
85265|NCT03032913|Pancreas|pancreas
85266|NCT03032913|Pancreatic|pancreatic
85267|NCT03032913|Cancer|cancer
85268|NCT03032913|Circulating tumor cell (CTC)|circulating tumor cell (ctc)
85269|NCT03032913|Adenocarcinoma|adenocarcinoma
85270|NCT03032913|Ductal|ductal
85271|NCT03032913|Exosome|exosome
85272|NCT03032900|Major lung resection|major lung resection
85273|NCT03032900|Right Ventricular Dysfunction|right ventricular dysfunction
85274|NCT03032900|2D Strain|2d strain
85275|NCT03032887|hygiene|hygiene
85276|NCT03032887|prenatal care|prenatal care
85277|NCT03032887|postnatal care|postnatal care
85278|NCT03032874|Colorectal cancer|colorectal cancer
85279|NCT03032874|Polyps|polyps
85280|NCT03032874|Colonoscopy|colonoscopy
85281|NCT03032874|Rectal bleeding|rectal bleeding
85282|NCT03032874|Nigeria|nigeria
85283|NCT03032861|Orange juice|orange juice
85284|NCT03032861|Microbiota|microbiota
85285|NCT03032861|Prebiotic|prebiotic
85286|NCT03032861|Flavanones|flavanones
85287|NCT03032861|Bioavailability|bioavailability
85288|NCT03032835|Calciphylaxis|calciphylaxis
85289|NCT03032835|Warfarin|warfarin
85290|NCT03032835|Dialysis|dialysis
85291|NCT03032822|Opioid consumption|opioid consumption
85292|NCT03032822|postdischarge|postdischarge
85293|NCT03032822|cystectomy|cystectomy
85294|NCT03032744|Pediatric|pediatric
85295|NCT03032744|School Based Health Center|school based health center
85296|NCT03032731|Physical activity|physical activity
85297|NCT03032731|Diet|diet
85298|NCT03032731|Health Behavior|health behavior
85299|NCT03032705|Restorations|restorations
85300|NCT03032705|Composite|composite
85301|NCT03032679|pain, acute, chronic, knee arthroplasty|pain, acute, chronic, knee arthroplasty
85302|NCT03032666|Thalassemia|thalassemia
85303|NCT03032666|HCV|hcv
85304|NCT03032666|Sofosbuvir|sofosbuvir
85305|NCT03032666|Ledipasvir|ledipasvir
85306|NCT03032653|ankle, fracture, rehabilitation, weightbearing, early, late|ankle, fracture, rehabilitation, weightbearing, early, late
85307|NCT03032640|Glucose|glucose
85308|NCT03032640|Sweet taste receptors|sweet taste receptors
85309|NCT03032640|Artificial sweeteners|artificial sweeteners
85310|NCT03032601|MS (Multiple Sclerosis)|ms (multiple sclerosis)
85311|NCT03032601|Acute Fulminating|acute fulminating
85312|NCT03032601|Sclerosis|sclerosis
85313|NCT03032601|FDG|fdg
85314|NCT03032601|18F Fluorodeoxyglucose|18f fluorodeoxyglucose
85315|NCT03032601|18F-FDG|18f-fdg
85316|NCT03032601|18FDG|18fdg
85317|NCT03032601|2-Fluoro-2-deoxy-D-glucose|2-fluoro-2-deoxy-d-glucose
85318|NCT03032601|2-Fluoro-2-deoxyglucose|2-fluoro-2-deoxyglucose
85319|NCT03032601|Fludeoxyglucose F 18|fludeoxyglucose f 18
85320|NCT03032601|Fluorine-18-fluorodeoxyglucose|fluorine-18-fluorodeoxyglucose
85321|NCT03032601|Fluorodeoxyglucose F 18|fluorodeoxyglucose f 18
85322|NCT03032601|PET Scan|pet scan
85323|NCT03032601|Tomography, Positron-Emission|tomography, positron-emission
85324|NCT03032601|Magnetic Resonance Imaging, Functional|magnetic resonance imaging, functional
85325|NCT03032601|fMRI|fmri
85326|NCT03032601|PET-MRI|pet-mri
85327|NCT03032601|Acetylcysteine|acetylcysteine
85328|NCT03032601|N-acetyl cysteine|n-acetyl cysteine
85329|NCT03032601|NAC|nac
85330|NCT03032601|Oral supplements|oral supplements
85331|NCT03032575|HIV|hiv
85332|NCT03032562|respiratory muscle strength|respiratory muscle strength
85333|NCT03032562|sleep-disordered breathing|sleep-disordered breathing
85334|NCT03032562|neuromuscular disease|neuromuscular disease
85335|NCT03032562|chronic-obstructive pulmonary disease|chronic-obstructive pulmonary disease
85336|NCT03032497|Brain Computer Interface|brain computer interface
85337|NCT03032497|Electroencephalogram (EEG)|electroencephalogram (eeg)
85338|NCT03032497|Chronic Pain|chronic pain
85339|NCT03032471|Subarachnoid Hemorrhage|subarachnoid hemorrhage
85340|NCT03032471|Delayed cerebral ischemia|delayed cerebral ischemia
85341|NCT03032471|Cognitive Impairment|cognitive impairment
85342|NCT03032471|Montreal Cognitive Assessment|montreal cognitive assessment
85343|NCT03032471|MoCA|moca
85344|NCT03032471|Cognitive Deterioration|cognitive deterioration
85345|NCT03032458|Shock Wave Lithotripsy|shock wave lithotripsy
85346|NCT03032458|Ketorolac|ketorolac
85347|NCT03032458|Xylocaine Gel|xylocaine gel
85348|NCT03032458|Pethidine|pethidine
85349|NCT03032445|Body Water/physiology|body water/physiology
85350|NCT03032445|Hyponatremia/etiology|hyponatremia/etiology
85351|NCT03032445|Physical Exertion/physiology|physical exertion/physiology
85352|NCT03032445|Running/physiology|running/physiology
85353|NCT03032445|Sodium/blood|sodium/blood
85354|NCT03032445|Ethanol|ethanol
85355|NCT03032380|Hospital-acquired pneumonia (HAP)|hospital-acquired pneumonia (hap)
85356|NCT03032380|S-649266|s-649266
85357|NCT03032380|linezolid|linezolid
85358|NCT03032380|meropenem|meropenem
85359|NCT03032380|Healthcare-associated pneumonia (HCAP)|healthcare-associated pneumonia (hcap)
85360|NCT03032380|nosocomial pneumonia|nosocomial pneumonia
85361|NCT03032380|Ventilator-associated pneumonia (VAP)|ventilator-associated pneumonia (vap)
85362|NCT03032380|Gram-negative pathogens|gram-negative pathogens
85363|NCT03032380|pneumonia|pneumonia
85364|NCT03032380|cefiderocol|cefiderocol
85365|NCT03032354|probiotics|probiotics
85366|NCT03032354|children|children
85367|NCT03032354|remission|remission
85368|NCT03032341|mobility assessment tool|mobility assessment tool
85369|NCT03032302|TBI|tbi
85370|NCT03032289|active transport|active transport
85371|NCT03032289|cycling|cycling
85372|NCT03032289|walking|walking
85373|NCT03032276|Safe motherhood|safe motherhood
85374|NCT03032276|Newborn survival|newborn survival
85375|NCT03032276|Community|community
85376|NCT03032276|Cluster Randomized Trial|cluster randomized trial
85377|NCT03032237|Protein intake|protein intake
85378|NCT03032237|Older adults|older adults
85379|NCT03032237|Protein-rich|protein-rich
85380|NCT03032237|Acceptance|acceptance
85381|NCT03032237|Liking|liking
85382|NCT03032237|Readymade meals|readymade meals
85383|NCT03032224|Body composition|body composition
85384|NCT03032224|sarcopenia|sarcopenia
85385|NCT03032224|Dysphagia|dysphagia
85386|NCT03032224|Surgery|surgery
85387|NCT03032224|Quality of Life|quality of life
85388|NCT03032224|Morbidity|morbidity
85389|NCT03032185|menopause|menopause
85390|NCT03032185|post-menopause|post-menopause
85391|NCT03032185|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
85392|NCT03032185|electrical stimulation therapy|electrical stimulation therapy
85393|NCT03032185|women's health|women's health
85394|NCT03032133|Total Knee Arthroplasty|total knee arthroplasty
85395|NCT03032133|Total Knee Replacement|total knee replacement
85396|NCT03032133|Outcome|outcome
85397|NCT03032133|Results|results
85398|NCT03032133|Pain|pain
85399|NCT03032107|Breast Cancer|breast cancer
85400|NCT03032094|Gingival Recession|gingival recession
85401|NCT03032055|sickle cell desease|sickle cell desease
85402|NCT03032055|vaso occlusive crisis|vaso occlusive crisis
85403|NCT03032055|acute chest syndrome|acute chest syndrome
85404|NCT03032055|Validation of predictif score of acute chest syndrome|validation of predictif score of acute chest syndrome
85405|NCT03032042|intestinal microbiome|intestinal microbiome
85406|NCT03032042|soil-transmitted helminths|soil-transmitted helminths
85407|NCT03032042|mass drug administration|mass drug administration
85408|NCT03032016|VOD|vod
85409|NCT03032016|Defibrotide|defibrotide
85410|NCT03032016|Defitelio|defitelio
85411|NCT03032016|Registry|registry
85412|NCT03032016|SOS|sos
85413|NCT03031990|Yoga|yoga
85414|NCT03031990|Oocyte cryopreservation|oocyte cryopreservation
85415|NCT03031990|In-vitro fertilization|in-vitro fertilization
85416|NCT03031951|Former athletes|former athletes
85417|NCT03031951|Body composition|body composition
85418|NCT03031951|Adaptive thermogenesis|adaptive thermogenesis
85419|NCT03031951|Physical activity|physical activity
85420|NCT03031951|Energy expenditure|energy expenditure
85421|NCT03031951|Sedentary behavior|sedentary behavior
85422|NCT03031951|Fat mass|fat mass
85423|NCT03031951|Abdominal fat mass|abdominal fat mass
85424|NCT03031951|Nutrition|nutrition
85425|NCT03031951|Behavior modification|behavior modification
85426|NCT03031938|Exposure in utero in tanezumab program|exposure in utero in tanezumab program
85427|NCT03031925|Annexin A2|annexin a2
85428|NCT03031925|biomarker|biomarker
85429|NCT03031821|Prostate Cancer|prostate cancer
85430|NCT03031821|ADT|adt
85431|NCT03031821|iADT|iadt
85432|NCT03031821|Metabolic Syndrome|metabolic syndrome
85433|NCT03031821|Androgen Deprivation Therapy|androgen deprivation therapy
85434|NCT03031821|Phase III|phase iii
85435|NCT03031821|Phase 3|phase 3
85436|NCT03031821|Randomized|randomized
85437|NCT03031821|Intermittent Androgen Deprivation Therapy|intermittent androgen deprivation therapy
85438|NCT03031795|intrauterine device|intrauterine device
85439|NCT03031782|JIA, JPsA, ERA, Secukinumab, ILAR|jia, jpsa, era, secukinumab, ilar
85440|NCT03031756|Air polishing|air polishing
85441|NCT03031743|rotavirus vaccine|rotavirus vaccine
85442|NCT03031743|human microbiome|human microbiome
85443|NCT03031743|fecal microbiome|fecal microbiome
85444|NCT03031743|vaccine immunogenicity|vaccine immunogenicity
85445|NCT03031743|Rotarix|rotarix
85446|NCT03031743|immune response, mucosal|immune response, mucosal
85447|NCT03031665|GABA|gaba
85448|NCT03031665|Depression|depression
85449|NCT03031665|Stress|stress
85450|NCT03031665|Androgens|androgens
85451|NCT03031652|pain|pain
85452|NCT03031652|axial length|axial length
85453|NCT03031652|anterior chamber depth|anterior chamber depth
85454|NCT03031652|intraocular pressure|intraocular pressure
85455|NCT03031639|endoscopic|endoscopic
85456|NCT03031639|thyroidectomy|thyroidectomy
85457|NCT03031613|intraocular pressure|intraocular pressure
85458|NCT03031613|intracerebral pressure|intracerebral pressure
85459|NCT03031587|Thermometric MRI|thermometric mri
85460|NCT03031587|Myocardium|myocardium
85461|NCT03031574|Serotonin 4 (5-HT4) receptor|serotonin 4 (5-ht4) receptor
85462|NCT03031574|Phase 1|phase 1
85463|NCT03031509|Nonunion Fracture of limb|nonunion fracture of limb
85464|NCT03031496|Cross-over|cross-over
85465|NCT03031496|Hydrochlorothiazide|hydrochlorothiazide
85466|NCT03031496|Amiloride hydrochloride|amiloride hydrochloride
85467|NCT03031496|Phase I|phase i
85468|NCT03031496|GSK3542503|gsk3542503
85469|NCT03031496|Bioequivalence|bioequivalence
85470|NCT03031496|FTIH|ftih
85471|NCT03031470|Liver Transplant|liver transplant
85472|NCT03031470|Ischemia-reperfusion injury|ischemia-reperfusion injury
85473|NCT03031470|Early allograft dysfunction|early allograft dysfunction
85474|NCT03031444|colorectal liver metastasis|colorectal liver metastasis
85475|NCT03031444|preoperative|preoperative
85476|NCT03031444|chemotherapy|chemotherapy
85477|NCT03031444|targeted therapy|targeted therapy
85478|NCT03031431|Hypothermia|hypothermia
85479|NCT03031431|Infant Warmer|infant warmer
85480|NCT03031340|Spinal fusion|spinal fusion
85481|NCT03031340|pregabalin|pregabalin
85482|NCT03031340|Spinal fusion surgeries|spinal fusion surgeries
85483|NCT03031340|two or more vertebrae|two or more vertebrae
85484|NCT03031327|Ocular Discomfort Following Refractive Surgery|ocular discomfort following refractive surgery
85485|NCT03031327|Refractive Surgery|refractive surgery
85486|NCT03031314|Joint Replacement|joint replacement
85487|NCT03031314|Knee Replacement|knee replacement
85488|NCT03031314|Wound Healing|wound healing
85489|NCT03031314|Hip Replacement|hip replacement
85490|NCT03031288|gastroesophageal reflux|gastroesophageal reflux
85491|NCT03031288|swallow|swallow
85492|NCT03031288|feeding bottle|feeding bottle
85493|NCT03031288|cardiorespiratory|cardiorespiratory
85494|NCT03031288|apnoea|apnoea
85495|NCT03031288|preterm|preterm
85496|NCT03031288|impedance-pH-metry|impedance-ph-metry
85497|NCT03031275|extracorporeal circulation|extracorporeal circulation
85498|NCT03031275|critical care outcomes|critical care outcomes
85499|NCT03031236|Early Childhood Development (ECD)|early childhood development (ecd)
85500|NCT03031236|Psychosocial stimulation|psychosocial stimulation
85501|NCT03031236|Cognition|cognition
85502|NCT03031236|Parenting|parenting
85503|NCT03031236|Malnutrition|malnutrition
85504|NCT03031236|Bangladesh|bangladesh
85505|NCT03031236|Childhood Maltreatment|childhood maltreatment
85506|NCT03031223|Spinal cord injuries|spinal cord injuries
85507|NCT03031223|low-level laser therapy|low-level laser therapy
85508|NCT03031210|Non-severe community-acquired pneumonia|non-severe community-acquired pneumonia
85509|NCT03031210|Amoxicillin treatment|amoxicillin treatment
85510|NCT03031210|Twice daily antibiotic regimen|twice daily antibiotic regimen
85511|NCT03031197|adherence|adherence
85512|NCT03031197|adolescent|adolescent
85513|NCT03031197|HIV/AIDS|hiv/aids
85514|NCT03031197|Vietnam|vietnam
85515|NCT03031184|Agitation|agitation
85516|NCT03031184|Agitated behaviours|agitated behaviours
85517|NCT03031184|Alzheimer's Disease|alzheimer's disease
85518|NCT03031171|community engagement, navigation, cancer screening|community engagement, navigation, cancer screening
85519|NCT03031132|Protein-rich breakfast|protein-rich breakfast
85520|NCT03031132|Breakfast Skipping|breakfast skipping
85521|NCT03031132|Young Adults|young adults
85522|NCT03031132|Breakfast|breakfast
85523|NCT03031132|Food form|food form
85524|NCT03031132|fMRI|fmri
85525|NCT03031132|Ghrelin|ghrelin
85526|NCT03031132|PYY|pyy
85527|NCT03031132|Sleep|sleep
85528|NCT03031119|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
85529|NCT03031106|Patient-reported outcomes, Health-related QoL, Internet-based tool|patient-reported outcomes, health-related qol, internet-based tool
85530|NCT03031093|aerosol therapy|aerosol therapy
85531|NCT03031093|pulmonary scintigraphy|pulmonary scintigraphy
85532|NCT03031093|upper airways anatomy|upper airways anatomy
85533|NCT03031093|High Flow Nasal Cannula|high flow nasal cannula
85534|NCT03031080|Collagenase, Night-splinting, Dupuytrens, Contracture|collagenase, night-splinting, dupuytrens, contracture
85535|NCT03031067|Donors and donation|donors and donation
85536|NCT03031067|Extended criteria donor|extended criteria donor
85537|NCT03031067|Organ perfusion and preservation|organ perfusion and preservation
85538|NCT03031067|Liver transplantation|liver transplantation
85539|NCT03031067|Kidney transplantation|kidney transplantation
85540|NCT03031067|Preservation injury|preservation injury
85541|NCT03031067|Ischemia reperfusion injury|ischemia reperfusion injury
85542|NCT03031054|Hydrodissection|hydrodissection
85543|NCT03031054|hyaluronic acid|hyaluronic acid
85544|NCT03031041|Hydrodissection|hydrodissection
85545|NCT03031041|short-axis|short-axis
85546|NCT03031041|long-axis|long-axis
85547|NCT03031028|refractory epilepsy,|refractory epilepsy,
85548|NCT03031028|ketogenic diet|ketogenic diet
85549|NCT03031028|classic ketogenic diet|classic ketogenic diet
85550|NCT03031028|seizure rate|seizure rate
85551|NCT03031028|efficacy|efficacy
85552|NCT03031028|epilepsy|epilepsy
85553|NCT03031015|Reduction, Fracture|reduction, fracture
85554|NCT03031002|exposure|exposure
85555|NCT03031002|spider phobia|spider phobia
85556|NCT03031002|generalization|generalization
85557|NCT03031002|extinction|extinction
85558|NCT03030976|CD19|cd19
85559|NCT03030976|CAR-T|car-t
85560|NCT03030976|SLE|sle
85561|NCT03030963|Equal ratio ventilation(ERV)|equal ratio ventilation(erv)
85562|NCT03030963|Peak inspiratory pressure(PIP)|peak inspiratory pressure(pip)
85563|NCT03030963|Blood loss|blood loss
85564|NCT03030963|Posterior lumbar interbody fusion(PLIF)|posterior lumbar interbody fusion(plif)
85565|NCT03030963|Prone position|prone position
85566|NCT03030924|suicide|suicide
85567|NCT03030885|Radiopharmaceutical (131I-MIP-1095)|radiopharmaceutical (131i-mip-1095)
85568|NCT03030885|16-1110|16-1110
85569|NCT03030846|pregnancy|pregnancy
85570|NCT03030846|pelvic floor muscles|pelvic floor muscles
85571|NCT03030846|Lumbo-pelvic pain|lumbo-pelvic pain
85572|NCT03030846|Stabilization exercises|stabilization exercises
85573|NCT03030846|abdominal muscles thickness|abdominal muscles thickness
85574|NCT03030846|Multifidus muscles thickness|multifidus muscles thickness
85575|NCT03030846|Multifidus muscles cross section area|multifidus muscles cross section area
85576|NCT03030820|cirrhosis|cirrhosis
85577|NCT03030820|Periodontitis|periodontitis
85578|NCT03030820|oral health|oral health
85579|NCT03030820|gingivitis|gingivitis
85580|NCT03030820|inflammation|inflammation
85581|NCT03030794|Gulf War Illness|gulf war illness
85582|NCT03030794|Headache|headache
85583|NCT03030794|Muscle Pain|muscle pain
85584|NCT03030794|Joint Pain|joint pain
85585|NCT03030794|TMS|tms
85586|NCT03030768|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
85587|NCT03030768|Fertility|fertility
85588|NCT03030768|mHealth|mhealth
85589|NCT03030768|Pregnancy|pregnancy
85590|NCT03030716|antinutrients|antinutrients
85591|NCT03030716|tannins|tannins
85592|NCT03030716|proanthocyanidins|proanthocyanidins
85593|NCT03030716|salivary proline-rich proteins|salivary proline-rich proteins
85594|NCT03030703|Phytic acid|phytic acid
85595|NCT03030703|Cystatin|cystatin
85596|NCT03030703|Salivary proline-rich protein|salivary proline-rich protein
85597|NCT03030703|antinutrient|antinutrient
85598|NCT03030690|Proximal Dental Caries|proximal dental caries
85599|NCT03030690|Glass Carbomer|glass carbomer
85600|NCT03030690|Hydroxyapatite Enhanced Glass Ionomer|hydroxyapatite enhanced glass ionomer
85601|NCT03030690|Primary Teeth|primary teeth
85602|NCT03030677|pecs block|pecs block
85603|NCT03030677|breast surgery|breast surgery
85604|NCT03030677|ultrasound guidence|ultrasound guidence
85605|NCT03030664|constipation|constipation
85606|NCT03030664|Lactobacillus reuteri|lactobacillus reuteri
85607|NCT03030664|probiotics|probiotics
85608|NCT03030651|Breastfeeding|breastfeeding
85609|NCT03030651|Education and support|education and support
85610|NCT03030651|Ethiopia|ethiopia
85611|NCT03030651|Timely initiation of breastfeeding|timely initiation of breastfeeding
85612|NCT03030625|Prostate Cancer|prostate cancer
85613|NCT03030625|VMAT|vmat
85614|NCT03030625|Dominant Intraprostatic Lesion|dominant intraprostatic lesion
85615|NCT03030625|Intensity modulated radiotherapy|intensity modulated radiotherapy
85616|NCT03030586|Blood cell biomarkers, peripheral circulating biomarkers|blood cell biomarkers, peripheral circulating biomarkers
85617|NCT03030573|Bile duct injury|bile duct injury
85618|NCT03030573|Bile duct defect|bile duct defect
85619|NCT03030573|Round ligament|round ligament
85620|NCT03030573|Reconstruction|reconstruction
85621|NCT03030508|biomarks|biomarks
85622|NCT03030508|colorectal cancer|colorectal cancer
85623|NCT03030508|capecitabine|capecitabine
85624|NCT03030508|gene polymorphism|gene polymorphism
85625|NCT03030495|Ischemic Heart Disease|ischemic heart disease
85626|NCT03030495|Stable angina|stable angina
85627|NCT03030495|Fractional flow reserve|fractional flow reserve
85628|NCT03030495|Index of Microcirculatory Resistance|index of microcirculatory resistance
85629|NCT03030495|Coronary Flow Reserve|coronary flow reserve
85630|NCT03030495|Intravascular Imaging|intravascular imaging
85631|NCT03030482|Anxiety|anxiety
85632|NCT03030482|intensive care|intensive care
85633|NCT03030482|mechanical ventilation|mechanical ventilation
85634|NCT03030482|touch massage|touch massage
85635|NCT03030456|whole body vibration|whole body vibration
85636|NCT03030456|Oxidative Stress|oxidative stress
85637|NCT03030456|Aged|aged
85638|NCT03030456|Biochemical profile|biochemical profile
85639|NCT03030456|muscle strength|muscle strength
85640|NCT03030456|flexibility|flexibility
85641|NCT03030443|Pain management|pain management
85642|NCT03030443|Nitrous|nitrous
85643|NCT03030417|Topoisomerase 1 Inhibitor|topoisomerase 1 inhibitor
85644|NCT03030417|Epithelial-Mesenchymal Transition|epithelial-mesenchymal transition
85645|NCT03030417|Pharmacodynamics|pharmacodynamics
85646|NCT03030417|DNA Damage|dna damage
85647|NCT03030417|Pharmacokinetics|pharmacokinetics
85648|NCT03030404|Genetics|genetics
85649|NCT03030404|Familial Background|familial background
85650|NCT03030404|Inherited Cancer Syndrome|inherited cancer syndrome
85651|NCT03030404|Germline Mutation in the CDH1 Gene|germline mutation in the cdh1 gene
85652|NCT03030404|Genetic Testing|genetic testing
85653|NCT03030391|Camp|camp
85654|NCT03030391|Radiation Absorbed Dose|radiation absorbed dose
85655|NCT03030391|Compartmental Analysis|compartmental analysis
85656|NCT03030365|Orientation, Disorientation.|orientation, disorientation.
85657|NCT03030352|Child Mental Health|child mental health
85658|NCT03030352|Parenting|parenting
85659|NCT03030352|Autonomy Support|autonomy support
85660|NCT03030352|How-to Parenting Program|how-to parenting program
85661|NCT03030352|Randomized Controlled Trial|randomized controlled trial
85662|NCT03030352|Primary Prevention|primary prevention
85663|NCT03030352|Parental Mental Health|parental mental health
85664|NCT03030352|Child Well-Being|child well-being
85665|NCT03030339|Vitamin A status|vitamin a status
85666|NCT03030339|infant|infant
85667|NCT03030339|dietary assessment|dietary assessment
85668|NCT03030339|retinol isotope dilution|retinol isotope dilution
85669|NCT03030339|breast milk intake|breast milk intake
85670|NCT03030300|type 2 diabetes|type 2 diabetes
85671|NCT03030300|remission|remission
85672|NCT03030300|short-term intensive insulin therapy|short-term intensive insulin therapy
85673|NCT03030235|diabetes|diabetes
85674|NCT03030235|heart failure|heart failure
85675|NCT03030235|dapagliflozin|dapagliflozin
85676|NCT03030235|SGLT-2 inhibitors|sglt-2 inhibitors
85677|NCT03030222|diabetes|diabetes
85678|NCT03030222|heart failure|heart failure
85679|NCT03030222|empagliflozin|empagliflozin
86079|NCT03027947|Sensation|sensation
85680|NCT03030222|SGLT-2 inhibitors|sglt-2 inhibitors
85681|NCT03030209|pancreatectomy|pancreatectomy
85682|NCT03030209|diabetes mellitus|diabetes mellitus
85683|NCT03030183|PNH|pnh
85684|NCT03030157|urothelial cancer|urothelial cancer
85685|NCT03030157|bladder cancer|bladder cancer
85686|NCT03030157|nephroureterectomy|nephroureterectomy
85687|NCT03030131|IFCT|ifct
85688|NCT03030131|neodjuvant|neodjuvant
85689|NCT03030131|immune therapy|immune therapy
85690|NCT03030131|Non small cell lung cancer|non small cell lung cancer
85691|NCT03030118|hydroxychloroquine|hydroxychloroquine
85692|NCT03030105|Cognition|cognition
85693|NCT03030105|Dementia|dementia
85694|NCT03030105|Phosphodiesterase Type 4D|phosphodiesterase type 4d
85695|NCT03030105|PDE4D|pde4d
85696|NCT03030105|Scopolamine|scopolamine
85697|NCT03030105|Donepezil|donepezil
85698|NCT03030066|DS-1001b|ds-1001b
85699|NCT03030066|IDH1 mutation|idh1 mutation
85700|NCT03030066|Developmental Phase I|developmental phase i
85701|NCT03030066|Glioma|glioma
85702|NCT03030053|Flavanols|flavanols
85703|NCT03030053|Flavonoids|flavonoids
85704|NCT03030053|Polyphenols|polyphenols
85705|NCT03030053|Cognition|cognition
85706|NCT03030053|Aging|aging
85707|NCT03030040|mindfulness-based cognitive therapy|mindfulness-based cognitive therapy
85708|NCT03030040|self-help|self-help
85709|NCT03030040|healthcare staff|healthcare staff
85710|NCT03030027|Intergeneration|intergeneration
85711|NCT03030027|Reappraisal|reappraisal
85712|NCT03030027|Caregiving|caregiving
85713|NCT03030001|mesothelin|mesothelin
85714|NCT03030001|PD-1|pd-1
85715|NCT03030001|CAR T|car t
85716|NCT03030001|solid tumor|solid tumor
85717|NCT03029988|adenocarcinoma, Colorectal Carcinoma, liver metastases|adenocarcinoma, colorectal carcinoma, liver metastases
85718|NCT03029975|beef|beef
85719|NCT03029975|protein|protein
85720|NCT03029975|resistance training|resistance training
85721|NCT03029975|strength|strength
85722|NCT03029975|performance|performance
85723|NCT03029962|Teenage Pregnancy Prevention|teenage pregnancy prevention
85724|NCT03029962|LGB Girls|lgb girls
85725|NCT03029962|Text-Messaging|text-messaging
85726|NCT03029962|Information-Motivation-Behavioral Skills(IMB)Model|information-motivation-behavioral skills(imb)model
85727|NCT03029949|chronic dizziness|chronic dizziness
85728|NCT03029949|persistent postural-perceptual dizziness|persistent postural-perceptual dizziness
85729|NCT03029949|acceptance and commitment therapy|acceptance and commitment therapy
85730|NCT03029949|behavior therapy|behavior therapy
85731|NCT03029949|vestibular rehabilitation|vestibular rehabilitation
85732|NCT03029936|obesity|obesity
85733|NCT03029936|asthma|asthma
85734|NCT03029936|diaphragm excursion|diaphragm excursion
85735|NCT03029936|pulmonary function test|pulmonary function test
85736|NCT03029923|smoking|smoking
85737|NCT03029923|depression|depression
85738|NCT03029923|Behavioral Activation|behavioral activation
85739|NCT03029910|Eccentric exercise|eccentric exercise
85740|NCT03029910|Whole body vibration|whole body vibration
85741|NCT03029910|Cryotherapy|cryotherapy
85742|NCT03029884|thalamic pain|thalamic pain
85743|NCT03029884|chronic pain|chronic pain
85744|NCT03029884|spinal cord injury|spinal cord injury
85745|NCT03029884|phantom limb|phantom limb
85746|NCT03029871|lung cancer|lung cancer
85747|NCT03029871|adenovirus|adenovirus
85748|NCT03029871|gene therapy|gene therapy
85749|NCT03029871|SBRT|sbrt
85750|NCT03029793|Esophageal Cancer|esophageal cancer
85751|NCT03029793|Prediction|prediction
85752|NCT03029793|Biomarker|biomarker
85753|NCT03029793|MRI-DWI|mri-dwi
85754|NCT03029793|PET-CT|pet-ct
85755|NCT03029767|Hypertension|hypertension
85756|NCT03029767|Anthropometry|anthropometry
85757|NCT03029767|Aerobic exercise|aerobic exercise
85758|NCT03029767|Resistance exercise|resistance exercise
85759|NCT03029728|Hereditary and acquired C1-inhibitor deficiency|hereditary and acquired c1-inhibitor deficiency
85760|NCT03029728|C1 esterase inhibitor, hereditary angioedema,|c1 esterase inhibitor, hereditary angioedema,
85761|NCT03029715|Sleeve gastrectomy|sleeve gastrectomy
85762|NCT03029715|TIVA|tiva
85763|NCT03029702|Gestational diabetes|gestational diabetes
85764|NCT03029702|Diabetes in pregnancy|diabetes in pregnancy
85765|NCT03029702|Insulin resistance|insulin resistance
85766|NCT03029702|Insulin secretion deficiency|insulin secretion deficiency
85767|NCT03029689|HIV infection|hiv infection
85768|NCT03029689|Gut microbiome|gut microbiome
85769|NCT03029689|Raltegravir|raltegravir
85770|NCT03029689|Raltegravir intensification|raltegravir intensification
85771|NCT03029689|Bacterial richness|bacterial richness
85772|NCT03029676|spinal anesthesia, TURBT, POCD, premedication|spinal anesthesia, turbt, pocd, premedication
85773|NCT03029663|bladder cancer|bladder cancer
85774|NCT03029663|postoperative complications|postoperative complications
85775|NCT03029650|Peer Review|peer review
85776|NCT03029650|Research|research
85777|NCT03029637|Resin bonded bridges|resin bonded bridges
85778|NCT03029637|Randomized controlled trial|randomized controlled trial
85779|NCT03029585|ovarian carcinoma|ovarian carcinoma
85780|NCT03029585|ovarian cancer|ovarian cancer
85781|NCT03029585|ovarian neoplasms|ovarian neoplasms
85782|NCT03029585|ovarian diseases|ovarian diseases
85783|NCT03029559|Inspiratory threshold loading|inspiratory threshold loading
85784|NCT03029520|Endodontic Postoperative Pain|endodontic postoperative pain
85785|NCT03029520|iRoot SP Sealer|iroot sp sealer
85786|NCT03029520|Randomized Clinical Trial|randomized clinical trial
85787|NCT03029520|Herofill carrier-based obturation|herofill carrier-based obturation
85788|NCT03029507|Obesity|obesity
85789|NCT03029507|Military|military
85790|NCT03029507|Acceptance and Commitment Therapy|acceptance and commitment therapy
85791|NCT03029507|Overweight|overweight
85792|NCT03029507|Weight-management|weight-management
85793|NCT03029507|Navy Personnel|navy personnel
85794|NCT03029507|Fitness|fitness
85795|NCT03029494|oxidative stress|oxidative stress
85796|NCT03029494|saliva|saliva
85797|NCT03029468|Cognitive behavioral therapy|cognitive behavioral therapy
85798|NCT03029468|Chronic pain|chronic pain
85799|NCT03029468|Sickle cell disease|sickle cell disease
85800|NCT03029468|Mobile phone app|mobile phone app
85801|NCT03029468|Mental health|mental health
85802|NCT03029468|Behavioral intervention|behavioral intervention
85803|NCT03029468|Behavioral health|behavioral health
85804|NCT03029442|Spinal Cord Injury|spinal cord injury
85805|NCT03029442|Denosumab|denosumab
85806|NCT03029442|Osteoporosis|osteoporosis
85807|NCT03029442|Dual Energy X-ray Absorptiometry|dual energy x-ray absorptiometry
85808|NCT03029429|pseudohypoparathyroidism|pseudohypoparathyroidism
85809|NCT03029429|AHO|aho
85810|NCT03029429|Albright Hereditary Osteodystrophy|albright hereditary osteodystrophy
85811|NCT03029390|Prediabetes|prediabetes
85812|NCT03029390|hyperglycemia|hyperglycemia
85813|NCT03029390|Impaired Fasting Glucose|impaired fasting glucose
85814|NCT03029390|Metformin|metformin
85815|NCT03029390|Berberine|berberine
85816|NCT03029390|glucose intolerance|glucose intolerance
85817|NCT03029377|CFS|cfs
85818|NCT03029377|Stress|stress
85819|NCT03029377|Norepinephrine Transporter (NET)|norepinephrine transporter (net)
85820|NCT03029377|Norepinephrine (NE)|norepinephrine (ne)
85821|NCT03029377|Healthy Controls|healthy controls
85822|NCT03029377|Fatigue|fatigue
85823|NCT03029364|Maximal Fat Oxidation|maximal fat oxidation
85824|NCT03029364|Exercise|exercise
85825|NCT03029364|Intra-individual variability|intra-individual variability
85826|NCT03029364|Determinants|determinants
85827|NCT03029364|Whole-body fat oxidation|whole-body fat oxidation
85828|NCT03029364|Body composition|body composition
85829|NCT03029351|albuminuria|albuminuria
85830|NCT03029351|GLP-1 Receptor Agonist|glp-1 receptor agonist
85831|NCT03029351|Type 2 Diabetes|type 2 diabetes
85832|NCT03029338|lymphoma|lymphoma
85833|NCT03029338|non-hodgkin|non-hodgkin
85834|NCT03029338|B-cell|b-cell
85835|NCT03029338|CD19 CAR T cells|cd19 car t cells
85836|NCT03029338|refractory|refractory
85837|NCT03029338|relapse|relapse
85838|NCT03029312|whole body vibration|whole body vibration
85839|NCT03029312|Muscle function|muscle function
85840|NCT03029312|Physical activity|physical activity
85841|NCT03029312|bone density|bone density
85842|NCT03029286|Breast Cancer|breast cancer
85843|NCT03029286|Breast Density|breast density
85844|NCT03029247|Anemia|anemia
85845|NCT03029247|Daprodustat|daprodustat
85846|NCT03029247|Blood pressure|blood pressure
85847|NCT03029247|ESA|esa
85848|NCT03029247|CKD|ckd
85849|NCT03029208|Daprodustat, recombinant human erythropoietin, darbepoetin, anemia, chronic kidney disease, dialysis, ESRD|daprodustat, recombinant human erythropoietin, darbepoetin, anemia, chronic kidney disease, dialysis, esrd
85850|NCT03029195|cleft lip and palate|cleft lip and palate
85851|NCT03029195|nasoalveolar molding|nasoalveolar molding
85852|NCT03029195|Egyptian infants|egyptian infants
85853|NCT03029195|quantitative analysis|quantitative analysis
85854|NCT03029182|Exercise|exercise
85855|NCT03029182|Cancer|cancer
85856|NCT03029182|Obesity|obesity
85857|NCT03029169|Supraventricular Arrhythmia|supraventricular arrhythmia
85858|NCT03029169|Septic shock|septic shock
85859|NCT03029169|Propafenone|propafenone
85860|NCT03029169|Amiodarone|amiodarone
85861|NCT03029169|Intensive Care|intensive care
85862|NCT03029156|Asthma|asthma
85863|NCT03029156|Aeroneb|aeroneb
85864|NCT03029156|Aerogen|aerogen
85865|NCT03029156|Bronchodilator|bronchodilator
85866|NCT03029143|Drug Therapy|drug therapy
85867|NCT03029130|vesicovaginal fistula|vesicovaginal fistula
85868|NCT03029130|urinary catheter|urinary catheter
85869|NCT03029130|catheter extension|catheter extension
85870|NCT03029117|rheumatic pregnancy|rheumatic pregnancy
85871|NCT03029104|Keratoconus|keratoconus
85872|NCT03029104|Forme fruste keratoconus|forme fruste keratoconus
85873|NCT03029104|Post-LASIK ectasia|post-lasik ectasia
85874|NCT03029104|Pellucid marginal degeneration|pellucid marginal degeneration
85875|NCT03029104|Forme fruste pellucid marginal degeneration|forme fruste pellucid marginal degeneration
85876|NCT03029104|Diurnal fluctuation post-radial keratotomy|diurnal fluctuation post-radial keratotomy
85877|NCT03029104|Terrien's marginal degeneration|terrien's marginal degeneration
85878|NCT03029078|XDR|xdr
85879|NCT03029078|fecal microbiota transplant|fecal microbiota transplant
85880|NCT03029078|eradicate|eradicate
85881|NCT03029078|colonization|colonization
85882|NCT03029078|CRE|cre
85883|NCT03029078|GRE|gre
85884|NCT03029078|bacteria|bacteria
85885|NCT03029065|lung Adenocarcinoma with brain (meningeal) metastasis|lung adenocarcinoma with brain (meningeal) metastasis
85886|NCT03029039|Platelet|platelet
85887|NCT03029039|severe sepsis|severe sepsis
85888|NCT03029039|inflammation|inflammation
85889|NCT03029039|S. aureus|s. aureus
85890|NCT03029039|biomarkers|biomarkers
85891|NCT03029026|Cardiac amyloidosis|cardiac amyloidosis
85892|NCT03029026|Aortic stenosis|aortic stenosis
85893|NCT03029026|DPD scintigraphy|dpd scintigraphy
85894|NCT03028987|Quadrivalent, inactivated influenza vaccine|quadrivalent, inactivated influenza vaccine
85895|NCT03028987|Quadrivalent, live, attenuated influenza vaccine|quadrivalent, live, attenuated influenza vaccine
85896|NCT03028987|Identical twin adults|identical twin adults
85897|NCT03028974|Inactivated influenza vaccine|inactivated influenza vaccine
85898|NCT03028974|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
85899|NCT03028974|Young children|young children
85900|NCT03028974|Adults|adults
85901|NCT03028922|creos xenogain|creos xenogain
85902|NCT03028909|Influenza A|influenza a
85903|NCT03028909|MEDI8852|medi8852
85904|NCT03028896|LMA Flexible|lma flexible
85905|NCT03028870|Osteoarthritis|osteoarthritis
85906|NCT03028870|Pain|pain
85907|NCT03028870|Osteoarthritis Knee|osteoarthritis knee
85908|NCT03028844|Neonate|neonate
85909|NCT03028844|preterm|preterm
85910|NCT03028844|pain|pain
85911|NCT03028844|music|music
85912|NCT03028844|EEG|eeg
85913|NCT03028844|venepuncture|venepuncture
85914|NCT03028805|Informatics|informatics
85915|NCT03028805|COPD|copd
85916|NCT03028805|quality improvement|quality improvement
85917|NCT03028792|attention training, youth, latino|attention training, youth, latino
85918|NCT03028779|Outpatient,fast-track, arthroplasty, Total knee arthroplasty (TKA), Total hip Arthroplasty (THA)|outpatient,fast-track, arthroplasty, total knee arthroplasty (tka), total hip arthroplasty (tha)
85919|NCT03028714|University|university
85920|NCT03028714|College|college
85921|NCT03028714|University students|university students
85922|NCT03028714|Health education|health education
85923|NCT03028714|Educational techonology|educational techonology
85924|NCT03028714|Internet|internet
85925|NCT03028714|Nutrition knowledge|nutrition knowledge
85926|NCT03028714|Eating behaviour|eating behaviour
85927|NCT03028714|Diet|diet
85928|NCT03028714|Physical Activity|physical activity
85929|NCT03028714|Weight gain prevention|weight gain prevention
85930|NCT03028701|Formoterol|formoterol
85931|NCT03028701|Budesonide|budesonide
85932|NCT03028701|Dry powder inhalation|dry powder inhalation
85933|NCT03028701|Discair|discair
85934|NCT03028701|COPD|copd
85935|NCT03028662|Alcohol Dependence|alcohol dependence
85936|NCT03028662|Brain Connectivity|brain connectivity
85937|NCT03028662|Inhibition|inhibition
85938|NCT03028649|β-hydroxy-β-methylbutyric acid|β-hydroxy-β-methylbutyric acid
85939|NCT03028649|Sport supplements|sport supplements
85940|NCT03028649|Training support|training support
85941|NCT03028649|Adaptation|adaptation
85942|NCT03028636|fecal incontinence|fecal incontinence
85943|NCT03028636|bowel control|bowel control
85944|NCT03028636|accidental bowel leakage|accidental bowel leakage
85945|NCT03028636|medical device|medical device
85946|NCT03028636|women's health|women's health
85947|NCT03028636|vaginal insert|vaginal insert
85948|NCT03028636|pessary|pessary
85949|NCT03028636|incontinence|incontinence
85950|NCT03028636|bowel continence|bowel continence
85951|NCT03028636|pump|pump
85952|NCT03028597|Hypertension|hypertension
85953|NCT03028597|Medication Adherence|medication adherence
85954|NCT03028597|Values Affirmation|values affirmation
85955|NCT03028597|African Americans|african americans
85956|NCT03028584|BrCa|brca
85957|NCT03028584|PrCa|prca
85958|NCT03028584|CRCa|crca
85959|NCT03028558|Electronic Cigarettes|electronic cigarettes
85960|NCT03028558|Healthy Volunteers|healthy volunteers
85961|NCT03028558|E-Cigarettes Smokers|e-cigarettes smokers
85962|NCT03028558|E-Cigarettes|e-cigarettes
85963|NCT03028545|schizophrenia|schizophrenia
85964|NCT03028545|anorexia|anorexia
85965|NCT03028545|bipolar disorders|bipolar disorders
85966|NCT03028545|personality disorders|personality disorders
85967|NCT03028532|Healthy Volunteers|healthy volunteers
85968|NCT03028532|Sports Medicine|sports medicine
85969|NCT03028532|Anti-doping|anti-doping
85970|NCT03028532|Athletes|athletes
85971|NCT03028532|Men's Health|men's health
85972|NCT03028480|Exacerbation|exacerbation
85973|NCT03028480|Mepolizumab|mepolizumab
85974|NCT03028480|NUCALA|nucala
85975|NCT03028467|GSK3196165|gsk3196165
85976|NCT03028467|Active Rheumatoid Arthritis|active rheumatoid arthritis
85977|NCT03028467|Methotrexate|methotrexate
85978|NCT03028467|Monoclonal Antibody|monoclonal antibody
85979|NCT03028467|Efficacy|efficacy
85980|NCT03028467|Electrocardiogram|electrocardiogram
85981|NCT03028467|Tolerability|tolerability
85982|NCT03028467|Pharmacokinetics|pharmacokinetics
85983|NCT03028467|Japanese Subjects|japanese subjects
85984|NCT03028441|Chikungunya|chikungunya
85985|NCT03028441|Immunogenicity|immunogenicity
85986|NCT03028441|Measles|measles
85987|NCT03028441|Vaccine|vaccine
85988|NCT03028428|Osteoarthritis|osteoarthritis
85989|NCT03028428|Stem Cell|stem cell
85990|NCT03028428|Knee|knee
85991|NCT03028428|Mesenchymal Stem Cell|mesenchymal stem cell
85992|NCT03028389|elderly patients|elderly patients
85993|NCT03028389|non-cardiac surgery|non-cardiac surgery
85994|NCT03028389|ischemic preconditioning|ischemic preconditioning
85995|NCT03028389|delirium|delirium
85996|NCT03028376|biomarker|biomarker
85997|NCT03028376|point-of-care analysis|point-of-care analysis
85998|NCT03028337|Malignant neoplasms of eye brain and other parts of central nervous system|malignant neoplasms of eye brain and other parts of central nervous system
85999|NCT03028337|Solid tumor malignancy|solid tumor malignancy
86000|NCT03028337|Radiographic evidence of spine metastasis|radiographic evidence of spine metastasis
86001|NCT03028337|Spine radiosurgery|spine radiosurgery
86002|NCT03028337|Radiation therapy|radiation therapy
86003|NCT03028337|Radiotherapy|radiotherapy
86004|NCT03028337|Questionnaires|questionnaires
86005|NCT03028337|Surveys|surveys
86006|NCT03028337|XRT|xrt
86007|NCT03028311|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
86008|NCT03028311|Metastatic liver tumors|metastatic liver tumors
86009|NCT03028311|SIR-Spheres treatment|sir-spheres treatment
86010|NCT03028311|90Y-radioembolization|90y-radioembolization
86011|NCT03028285|succinate|succinate
86012|NCT03028285|arginine|arginine
86013|NCT03028285|vasodilation|vasodilation
86014|NCT03028285|peripheral vascular disease|peripheral vascular disease
86015|NCT03028272|tympanic membrane perforation|tympanic membrane perforation
86016|NCT03028233|physical activity|physical activity
86017|NCT03028233|healthy eating|healthy eating
86018|NCT03028233|weight|weight
86019|NCT03028233|families|families
86020|NCT03028233|Community Health Worker|community health worker
86021|NCT03028233|childhood obesity|childhood obesity
86022|NCT03028233|built environment|built environment
86023|NCT03028207|EPI-Scan-II Study|epi-scan-ii study
86024|NCT03028207|COPD|copd
86025|NCT03028207|Epidemiology|epidemiology
86026|NCT03028207|Spain|spain
86027|NCT03028207|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
86028|NCT03028207|Prevalence|prevalence
86029|NCT03028207|Cross-sectional|cross-sectional
86030|NCT03028194|Pre-eclampsia|pre-eclampsia
86031|NCT03028194|Eclampsia|eclampsia
86032|NCT03028194|Postpartum uterine curettage|postpartum uterine curettage
86033|NCT03028181|smoke|smoke
86034|NCT03028181|acute pancreatitis|acute pancreatitis
86035|NCT03028181|pro/antioxidant status|pro/antioxidant status
86036|NCT03028181|pro-inflammatory factors|pro-inflammatory factors
86037|NCT03028181|lipid profile|lipid profile
86038|NCT03028181|exocrine functions of pancreas|exocrine functions of pancreas
86039|NCT03028168|Yôga|yôga
86040|NCT03028168|Breathing Techniques|breathing techniques
86041|NCT03028168|Heart Failure and Preserved Ejection Fraction|heart failure and preserved ejection fraction
86042|NCT03028129|Tuberculosis|tuberculosis
86043|NCT03028129|Primary prevention|primary prevention
86044|NCT03028129|Prisoners|prisoners
86045|NCT03028129|Controlled Clinical Trial|controlled clinical trial
86046|NCT03028129|Isoniazid|isoniazid
86047|NCT03028116|vaccine|vaccine
86048|NCT03028116|1 phase|1 phase
86049|NCT03028116|safety|safety
86050|NCT03028077|ultrafiltered red ginseng|ultrafiltered red ginseng
86051|NCT03028077|hydrolyzed ginseng|hydrolyzed ginseng
86052|NCT03028077|acute respiratory illness|acute respiratory illness
86053|NCT03028077|clinical trial|clinical trial
86054|NCT03028038|Platelet-rich plasma|platelet-rich plasma
86055|NCT03028038|Rapid maxillary expansion|rapid maxillary expansion
86056|NCT03028038|Buccal bone thickness|buccal bone thickness
86057|NCT03028038|Alveolar bone loss|alveolar bone loss
86058|NCT03028038|Alveolar bone resorption|alveolar bone resorption
86059|NCT03028025|radial artery occlusion|radial artery occlusion
86060|NCT03028025|time to hemostasis|time to hemostasis
86061|NCT03028025|radial artery|radial artery
86062|NCT03028025|transradial catheterization|transradial catheterization
86063|NCT03028025|TR band|tr band
86064|NCT03028025|Statseal|statseal
86065|NCT03028025|hemostasis band|hemostasis band
86066|NCT03028025|potassium ferrate|potassium ferrate
86067|NCT03028025|percutaneous coronary intervention|percutaneous coronary intervention
86068|NCT03028012|Trigger Point Injections|trigger point injections
86069|NCT03028012|steroid|steroid
86070|NCT03028012|nsaid|nsaid
86071|NCT03027999|Rituximab|rituximab
86072|NCT03027999|tight monitoring|tight monitoring
86073|NCT03027960|cardio-renal|cardio-renal
86074|NCT03027947|Phantom Limb Pain|phantom limb pain
86075|NCT03027947|Lower-Limb Amputation|lower-limb amputation
86076|NCT03027947|Electrodes|electrodes
86077|NCT03027947|Stimulation|stimulation
86078|NCT03027947|Pain|pain
86080|NCT03027882|Reliability|reliability
86081|NCT03027882|Validity|validity
86082|NCT03027882|Functional Testing|functional testing
86083|NCT03027856|Percutaneous intervention (PCI)|percutaneous intervention (pci)
86084|NCT03027856|Optical coherence tomography (OCT)|optical coherence tomography (oct)
86085|NCT03027856|Bifurcation lesion|bifurcation lesion
86086|NCT03027856|Bioresorbable stents (BRS)|bioresorbable stents (brs)
86087|NCT03027843|low ovarian reserve|low ovarian reserve
86088|NCT03027843|growth hormone|growth hormone
86089|NCT03027843|embryo quality|embryo quality
86090|NCT03027843|live birth|live birth
86091|NCT03027843|clinical pregnancy|clinical pregnancy
86092|NCT03027830|Provisional side-branch intervention strategy|provisional side-branch intervention strategy
86093|NCT03027830|iFR|ifr
86094|NCT03027830|Pilot study|pilot study
86095|NCT03027817|Prone positioning|prone positioning
86096|NCT03027817|Non-invasive Cardiac Output Monitoring|non-invasive cardiac output monitoring
86097|NCT03027791|Biosensors|biosensors
86098|NCT03027791|Virtual Reality|virtual reality
86099|NCT03027791|Dietary Sodium|dietary sodium
86100|NCT03027778|arterial stiffness|arterial stiffness
86101|NCT03027778|hemodialysis|hemodialysis
86102|NCT03027778|intradialytic pedalling exercise|intradialytic pedalling exercise
86103|NCT03027778|carotid-femoral pulse wave velocity|carotid-femoral pulse wave velocity
86104|NCT03027778|chronic kidney disease|chronic kidney disease
86105|NCT03027778|hemodynamics|hemodynamics
86106|NCT03027778|augmentation index|augmentation index
86107|NCT03027752|carotid endaretectomy|carotid endaretectomy
86108|NCT03027713|NAVA: neurally adjusted ventilatory assist|nava: neurally adjusted ventilatory assist
86109|NCT03027713|Diaphragm electromyographic activity|diaphragm electromyographic activity
86110|NCT03027713|Weaning|weaning
86111|NCT03027687|Smoking|smoking
86112|NCT03027687|EMA|ema
86113|NCT03027687|ERPs|erps
86114|NCT03027687|tDCS|tdcs
86115|NCT03027687|Cigarette consumption|cigarette consumption
86116|NCT03027687|Inhibitory control|inhibitory control
86117|NCT03027687|Reward processing|reward processing
86118|NCT03027674|Raynaud Phenomena|raynaud phenomena
86119|NCT03027674|System; Sclerosis|system; sclerosis
86120|NCT03027674|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
86121|NCT03027674|Ultrasound|ultrasound
86122|NCT03027674|sildenafil|sildenafil
86123|NCT03027674|Nifedipine|nifedipine
86124|NCT03027661|para-cervical block|para-cervical block
86125|NCT03027661|laparoscopic hysterectomy|laparoscopic hysterectomy
86126|NCT03027648|levonorgestrel-releasing intrauterine system|levonorgestrel-releasing intrauterine system
86127|NCT03027648|adenomyosis|adenomyosis
86128|NCT03027635|diuretic resistant ascites|diuretic resistant ascites
86129|NCT03027635|Paracentesis|paracentesis
86130|NCT03027635|PleurX|pleurx
86131|NCT03027635|Peritoneal tunnelated catheter|peritoneal tunnelated catheter
86132|NCT03027622|quality of life|quality of life
86133|NCT03027622|pericoronitis|pericoronitis
86134|NCT03027622|third molar|third molar
86135|NCT03027609|Pseudomonas aeruginosa|pseudomonas aeruginosa
86136|NCT03027609|pneumonia|pneumonia
86137|NCT03027570|Exergame|exergame
86138|NCT03027570|Cellular apps|cellular apps
86139|NCT03027570|Smartphone|smartphone
86140|NCT03027570|Overweight|overweight
86141|NCT03027570|Obesity|obesity
86142|NCT03027570|Children|children
86143|NCT03027570|Physical activity|physical activity
86144|NCT03027570|Fitness|fitness
86145|NCT03027570|Motivation|motivation
86146|NCT03027570|BMI|bmi
86147|NCT03027557|Primary Hyperparathyroidism|primary hyperparathyroidism
86148|NCT03027557|Parathyroid Adenoma|parathyroid adenoma
86149|NCT03027557|Parathyroid Hyperplasia|parathyroid hyperplasia
86150|NCT03027557|Cinacalcet|cinacalcet
86151|NCT03027557|Denosumab|denosumab
86152|NCT03027557|Drug Therapy|drug therapy
86153|NCT03027557|Bone Mineral Density|bone mineral density
86154|NCT03027557|Calcium|calcium
86155|NCT03027544|multiple brain metastases|multiple brain metastases
86156|NCT03027544|large brain metastases|large brain metastases
86157|NCT03027544|meningeal metastases|meningeal metastases
86158|NCT03027544|tomotherapy|tomotherapy
86159|NCT03027531|reproductive health, condoms, sexually transmitted diseases, contraception|reproductive health, condoms, sexually transmitted diseases, contraception
86160|NCT03027505|MUAC|muac
86161|NCT03027505|Acute malnutrition|acute malnutrition
86162|NCT03027505|RUTF|rutf
86163|NCT03027505|Children|children
86164|NCT03027505|Burkina Faso|burkina faso
86165|NCT03027492|Non-celiac Wheat Sensitivity|non-celiac wheat sensitivity
86166|NCT03027492|gynaecological disorders|gynaecological disorders
86167|NCT03027492|gluten-free diet|gluten-free diet
86168|NCT03027479|weight loss|weight loss
86169|NCT03027479|ovarian cancer|ovarian cancer
86170|NCT03027479|endometrial cancer|endometrial cancer
86171|NCT03027479|energy metabolism|energy metabolism
86172|NCT03027479|Body mass index|body mass index
86173|NCT03027479|obesity|obesity
86174|NCT03027479|muscle energy|muscle energy
86175|NCT03027466|Quitting Smoking|quitting smoking
86176|NCT03027466|Phone Application|phone application
86177|NCT03027440|Stress Response|stress response
86178|NCT03027440|Neurodevelopment|neurodevelopment
86179|NCT03027440|Biomarkers|biomarkers
86180|NCT03027440|Cohort Study|cohort study
86181|NCT03027427|Screening|screening
86182|NCT03027427|Heritable Gastric Malignancy|heritable gastric malignancy
86183|NCT03027427|Molecular Profiling|molecular profiling
86184|NCT03027427|Molecular Alterations|molecular alterations
86185|NCT03027414|Anxiety|anxiety
86186|NCT03027414|Startle|startle
86187|NCT03027414|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
86188|NCT03027414|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
86189|NCT03027414|Working Memory|working memory
86190|NCT03027401|Genetic Testing|genetic testing
86191|NCT03027401|Tumor Profiling|tumor profiling
86192|NCT03027401|Biorepository|biorepository
86193|NCT03027388|Brain Tumor|brain tumor
86194|NCT03027388|Blood Brain Barrier|blood brain barrier
86195|NCT03027388|Pharmacokinetics|pharmacokinetics
86196|NCT03027388|Pharmacodynamics|pharmacodynamics
86197|NCT03027375|chronic heart failure|chronic heart failure
86198|NCT03027375|traditional Chinese medicine|traditional chinese medicine
86199|NCT03027375|Qishen granules|qishen granules
86200|NCT03027336|dyslipidemia|dyslipidemia
86201|NCT03027336|dietary supplement|dietary supplement
86202|NCT03027323|undifferentiated hypotension|undifferentiated hypotension
86203|NCT03027323|central venous cannulation|central venous cannulation
86204|NCT03027310|Dystonic Tremor|dystonic tremor
86205|NCT03027310|Essential Tremor|essential tremor
86206|NCT03027310|Tremor|tremor
86207|NCT03027310|Voice Tremor|voice tremor
86208|NCT03027310|Parkinson's Disease|parkinson's disease
86209|NCT03027284|Neoplasm|neoplasm
86210|NCT03027258|Mobile health technology|mobile health technology
86211|NCT03027245|locally advanced or metastatic breast cancer|locally advanced or metastatic breast cancer
86212|NCT03027245|peripheral neuropathy|peripheral neuropathy
86213|NCT03027245|chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
86214|NCT03027245|eribulin|eribulin
86215|NCT03027232|infection|infection
86216|NCT03027154|diagnostic test|diagnostic test
86217|NCT03027154|children|children
86218|NCT03027154|diagnosis of tuberculosis|diagnosis of tuberculosis
86219|NCT03027141|Face Transplant|face transplant
86220|NCT03027128|Phase 1|phase 1
86221|NCT03027128|Metastatic|metastatic
86222|NCT03027128|Locally Advanced|locally advanced
86223|NCT03027128|Cancer|cancer
86224|NCT03027128|Cell Therapy|cell therapy
86225|NCT03027102|allogenic double negative T cells|allogenic double negative t cells
86226|NCT03027102|DNT cells|dnt cells
86227|NCT03027089|Aspergillus-specific IgG|aspergillus-specific igg
86228|NCT03027076|prostatitis|prostatitis
86229|NCT03027076|chronic prostatitis|chronic prostatitis
86230|NCT03027076|chronic pelvic pain syndrome|chronic pelvic pain syndrome
86231|NCT03027076|interstitial cystitis|interstitial cystitis
86232|NCT03027076|painful bladder syndrome|painful bladder syndrome
86233|NCT03027076|bladder pain syndrome|bladder pain syndrome
86234|NCT03027076|biomarkers|biomarkers
86235|NCT03027076|biological markers|biological markers
86236|NCT03027076|bacteria|bacteria
86237|NCT03027076|microbiome|microbiome
86238|NCT03027076|inflammation|inflammation
86239|NCT03027063|Speckle tracking echocardiography|speckle tracking echocardiography
86240|NCT03027050|periodontitis|periodontitis
86241|NCT03027050|Growth factors|growth factors
86242|NCT03027050|Periodontal healing|periodontal healing
86243|NCT03027024|Intraocular Lens|intraocular lens
86244|NCT03027024|trifocal|trifocal
86245|NCT03027024|cataract|cataract
86246|NCT03027024|PhysIOL|physiol
86247|NCT03026998|hereditary retinoblastoma,|hereditary retinoblastoma,
86248|NCT03026998|External beam radiation therapy (EBRT)|external beam radiation therapy (ebrt)
86249|NCT03026985|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
86250|NCT03026985|Ultrasonography|ultrasonography
86251|NCT03026985|Intensive Care Units|intensive care units
86252|NCT03026972|Safety|safety
86253|NCT03026972|Tolerance|tolerance
86254|NCT03026946|Alitretinoin|alitretinoin
86255|NCT03026946|Cyclosporine A|cyclosporine a
86256|NCT03026946|Hand eczema|hand eczema
86257|NCT03026920|Fracture|fracture
86258|NCT03026920|outcome|outcome
86259|NCT03026920|pelvic|pelvic
86260|NCT03026920|acetabular|acetabular
86261|NCT03026907|Alitretinoin|alitretinoin
86262|NCT03026907|Azathioprine|azathioprine
86263|NCT03026907|Hand eczema|hand eczema
86264|NCT03026881|PARP inhibitor|parp inhibitor
86265|NCT03026881|VEGFR inhibitor|vegfr inhibitor
86266|NCT03026881|Combination therapy|combination therapy
86267|NCT03026881|Gastric cancer|gastric cancer
86268|NCT03026868|acetabular|acetabular
86269|NCT03026868|quadrilateral surface plate|quadrilateral surface plate
86270|NCT03026855|Autologous PRP|autologous prp
86271|NCT03026855|Non-healing ulcer|non-healing ulcer
86272|NCT03026855|Point-of-care|point-of-care
86273|NCT03026829|Sound therapy|sound therapy
86274|NCT03026829|Tinnitus relief|tinnitus relief
86275|NCT03026816|epidural stimulation|epidural stimulation
86276|NCT03026816|spinal cord stimulation|spinal cord stimulation
86277|NCT03026816|autonomic dysfunction|autonomic dysfunction
86278|NCT03026790|Opioid analgesics|opioid analgesics
86279|NCT03026790|Opioid partial agonists|opioid partial agonists
86280|NCT03026790|Health care delivery|health care delivery
86281|NCT03026790|Back pain|back pain
86282|NCT03026790|Osteoarthritis|osteoarthritis
86283|NCT03026790|Veterans health|veterans health
86284|NCT03026764|cost|cost
86285|NCT03026764|total hip replacement|total hip replacement
86286|NCT03026764|outpatient Surgery|outpatient surgery
86287|NCT03026764|satisfaction|satisfaction
86288|NCT03026764|arthroplasty|arthroplasty
86289|NCT03026725|tooth sensitivity|tooth sensitivity
86290|NCT03026725|tri calcium phosphate|tri calcium phosphate
86291|NCT03026725|at-home whitening|at-home whitening
86292|NCT03026712|Robotic therapy|robotic therapy
86293|NCT03026712|tDCS|tdcs
86294|NCT03026712|non invasive electrical stimulation|non invasive electrical stimulation
86295|NCT03026712|ArmeoPower|armeopower
86296|NCT03026712|interhemispheric balance|interhemispheric balance
86297|NCT03026699|Brain|brain
86298|NCT03026699|Nervous system|nervous system
86299|NCT03026699|Neuro-oncology|neuro-oncology
86300|NCT03026699|Caregivers|caregivers
86301|NCT03026699|Cancer patient|cancer patient
86302|NCT03026699|Family caregivers|family caregivers
86303|NCT03026699|Brain tumors|brain tumors
86304|NCT03026699|Quality of life|quality of life
86305|NCT03026699|Stress|stress
86306|NCT03026699|Social support|social support
86307|NCT03026699|Feasibility|feasibility
86308|NCT03026699|Electronic Social Network Assessment Program (eSNAP)|electronic social network assessment program (esnap)
86309|NCT03026660|Moringa Oleifera|moringa oleifera
86310|NCT03026634|Sleep-Disordered Breathing|sleep-disordered breathing
86311|NCT03026634|Heart Failure|heart failure
86312|NCT03026634|Heart Transplantation|heart transplantation
86313|NCT03026569|orange juice|orange juice
86314|NCT03026569|chronic hepatitis C|chronic hepatitis c
86315|NCT03026569|biochemical markers|biochemical markers
86316|NCT03026569|oxidative stress|oxidative stress
86317|NCT03026569|nutritional status|nutritional status
86318|NCT03026569|antioxidants|antioxidants
86319|NCT03026517|Phenformin|phenformin
86320|NCT03026517|Dabrafenib|dabrafenib
86321|NCT03026517|Trametinib|trametinib
86322|NCT03026517|BRAF|braf
86323|NCT03026517|15-318|15-318
86324|NCT03026478|oral lichen planus|oral lichen planus
86325|NCT03026478|betamethasone|betamethasone
86326|NCT03026478|clobetasol|clobetasol
86327|NCT03026478|orabase|orabase
86328|NCT03026439|mild COPD|mild copd
86329|NCT03026439|early COPD|early copd
86330|NCT03026439|six-min walk test|six-min walk test
86331|NCT03026439|computed tomography|computed tomography
86332|NCT03026439|emphysema|emphysema
86333|NCT03026439|airway disease|airway disease
86334|NCT03026439|peripheral muscle mass|peripheral muscle mass
86335|NCT03026439|Saint George's Respiratory Questionnaire|saint george's respiratory questionnaire
86336|NCT03026426|Depression|depression
86337|NCT03026426|Chronic diseases|chronic diseases
86338|NCT03026426|Mobile technology|mobile technology
86339|NCT03026426|Clinical trial|clinical trial
86340|NCT03026413|atrial fibrillation|atrial fibrillation
86341|NCT03026413|pulmonary vein isolation|pulmonary vein isolation
86342|NCT03026413|Contact Force|contact force
86343|NCT03026413|antrum|antrum
86344|NCT03026387|Suicidal behavior|suicidal behavior
86345|NCT03026387|Suicide attempt|suicide attempt
86346|NCT03026387|Emergency department|emergency department
86347|NCT03026387|Psychometrics|psychometrics
86348|NCT03026387|Neuropsychological tests|neuropsychological tests
86349|NCT03026387|Suicidal ideation|suicidal ideation
86350|NCT03026374|psychosocial support|psychosocial support
86351|NCT03026374|resilience|resilience
86352|NCT03026374|metastatic breast cancer|metastatic breast cancer
86353|NCT03026374|survival|survival
86354|NCT03026374|Quality of Life|quality of life
86356|NCT03026335|Positive Youth Development|positive youth development
86357|NCT03026296|Physical Fitness|physical fitness
86358|NCT03026296|Health Status|health status
86359|NCT03026296|Exercise|exercise
86360|NCT03026296|Tobacco Use Cessation|tobacco use cessation
86361|NCT03026296|Quality of Life|quality of life
86362|NCT03026296|Healthy Diet|healthy diet
86363|NCT03026296|Health Promotion|health promotion
86364|NCT03026296|Patient Education as Topic|patient education as topic
86365|NCT03026296|Counseling|counseling
86366|NCT03026270|Physiotherapy|physiotherapy
86367|NCT03026270|Paraffin|paraffin
86368|NCT03026270|Burn|burn
86369|NCT03026270|Contracture|contracture
86370|NCT03026244|Immunity|immunity
86371|NCT03026244|Elderly|elderly
86372|NCT03026244|Inflammation|inflammation
86373|NCT03026244|Milk protein|milk protein
86374|NCT03026244|Prebiotics|prebiotics
86375|NCT03026231|Fecal microbiota transplantation|fecal microbiota transplantation
86376|NCT03026166|Cancer|cancer
86377|NCT03026166|Extensive-Stage Small Cell Lung Cancer|extensive-stage small cell lung cancer
86378|NCT03026166|Nivolumab|nivolumab
86379|NCT03026166|Ipilimumab|ipilimumab
86380|NCT03026166|Rovalpituzumab tesirine|rovalpituzumab tesirine
86381|NCT03026140|MSI tumors|msi tumors
86382|NCT03026140|MSS tumors|mss tumors
86383|NCT03026140|short-term immunotherapy|short-term immunotherapy
86384|NCT03026140|surgical resection|surgical resection
86385|NCT03026140|nivolumab|nivolumab
86386|NCT03026140|ipilimumab|ipilimumab
86387|NCT03026127|Suicide|suicide
86388|NCT03026127|Middle-aged and Older Adults|middle-aged and older adults
86389|NCT03026127|Cognitive Reappraisal|cognitive reappraisal
86390|NCT03026127|Emotion Regulation|emotion regulation
86391|NCT03026088|Chronic Heart Failure|chronic heart failure
86392|NCT03026088|Bisoprolol|bisoprolol
86393|NCT03026088|Heart rate control|heart rate control
86394|NCT03026062|Recurrent Platinum-Resistant Epithelial Ovarian Cancer|recurrent platinum-resistant epithelial ovarian cancer
86395|NCT03026062|Ovarian Cancer|ovarian cancer
86396|NCT03026062|epithelial ovarian cancer|epithelial ovarian cancer
86397|NCT03026036|Depression|depression
86398|NCT03026036|MRI|mri
86399|NCT03026036|PET|pet
86400|NCT03026036|Reward|reward
86401|NCT03026023|Heart Transplant|heart transplant
86402|NCT03026023|Cardiac Transplant|cardiac transplant
86403|NCT03026023|Hepatitis C|hepatitis c
86404|NCT03026023|Zepatier|zepatier
86405|NCT03025971|Severe Aortic Stenosis and/or severe aortic regurgitation|severe aortic stenosis and/or severe aortic regurgitation
86406|NCT03025919|Advanced glycation end-product|advanced glycation end-product
86407|NCT03025919|Glycosuria|glycosuria
86408|NCT03025893|Sunitinib|sunitinib
86409|NCT03025893|Lomustine|lomustine
86410|NCT03025893|High-dose|high-dose
86411|NCT03025893|Intermittent|intermittent
86412|NCT03025880|Advanced Breast Cancer|advanced breast cancer
86413|NCT03025880|Pembrolizumab|pembrolizumab
86414|NCT03025880|HER2-negative|her2-negative
86415|NCT03025828|Membranous nephropathy|membranous nephropathy
86416|NCT03025828|adrenocorticotropic hormone|adrenocorticotropic hormone
86417|NCT03025828|ACTH|acth
86418|NCT03025828|proteinuria|proteinuria
86419|NCT03025828|glomerulonephritis|glomerulonephritis
86420|NCT03025815|Infant, Premature|infant, premature
86421|NCT03025802|Molecular diagnosis|molecular diagnosis
86422|NCT03025802|Pathogen identification|pathogen identification
86423|NCT03025802|Sepsis|sepsis
86424|NCT03025802|Bacteremia|bacteremia
86425|NCT03025802|Rapid diagnostics|rapid diagnostics
86426|NCT03025789|T.b gambiense|t.b gambiense
86427|NCT03025789|HAT|hat
86428|NCT03025789|outpatients|outpatients
86429|NCT03025763|Craniosynostosis|craniosynostosis
86430|NCT03025763|Bone|bone
86431|NCT03025763|Birth Defect|birth defect
86432|NCT03025763|Congenital Anomaly|congenital anomaly
86433|NCT03025763|Malformation|malformation
86434|NCT03025763|Genetics|genetics
86435|NCT03025763|Genomics|genomics
86436|NCT03025763|Skull|skull
86437|NCT03025763|Human|human
86438|NCT03025763|Mouse|mouse
86439|NCT03025763|Imaging|imaging
86440|NCT03025763|Cell Biology|cell biology
86441|NCT03025763|Induced Pluripotent Stem Cells|induced pluripotent stem cells
86442|NCT03025763|System Biology|system biology
86443|NCT03025737|Hypertrophy, Left Ventricular|hypertrophy, left ventricular
86444|NCT03025737|Ventricular Remodeling|ventricular remodeling
86445|NCT03025711|Advanced HER2+ breast cancer|advanced her2+ breast cancer
86446|NCT03025711|Pertuzumab|pertuzumab
86447|NCT03025711|Trastuzumab emtansine|trastuzumab emtansine
86448|NCT03025711|Compassionate use|compassionate use
86449|NCT03025711|Early access program|early access program
86450|NCT03025711|Effectiveness|effectiveness
86451|NCT03025711|Safety|safety
86452|NCT03025698|Eltrombopag|eltrombopag
86453|NCT03025698|hATG|hatg
86454|NCT03025698|CsA|csa
86455|NCT03025698|previously untreated or relapsed severe aplastic anemia|previously untreated or relapsed severe aplastic anemia
86456|NCT03025698|recurrent aplastic anemia|recurrent aplastic anemia
86457|NCT03025698|Severe aplastic anemia|severe aplastic anemia
86458|NCT03025698|Pharmacokinetics|pharmacokinetics
86459|NCT03025698|Immunosuppressive therapy|immunosuppressive therapy
86460|NCT03025698|ETB115|etb115
86461|NCT03025685|Percutaneous Coronary Intervention|percutaneous coronary intervention
86462|NCT03025685|Coronary Artery Disease|coronary artery disease
86463|NCT03025685|Wire|wire
86464|NCT03025685|Coronary stenting|coronary stenting
86465|NCT03025659|pediatric|pediatric
86466|NCT03025659|congenital heart disease|congenital heart disease
86467|NCT03025646|Maternal depression|maternal depression
86468|NCT03025646|ASD|asd
86469|NCT03025646|Home based training program|home based training program
86470|NCT03025633|PEARL|pearl
86471|NCT03025620|Alphalinolenic acid|alphalinolenic acid
86472|NCT03025620|Lipid cardiovascular risk factors|lipid cardiovascular risk factors
86473|NCT03025620|Inflammation|inflammation
86474|NCT03025607|Prevention|prevention
86475|NCT03025607|Mobile health|mobile health
86476|NCT03025607|Autonomous motivation|autonomous motivation
86477|NCT03025594|Paralytic sellfish toxins|paralytic sellfish toxins
86478|NCT03025594|Gonyautoxin|gonyautoxin
86479|NCT03025594|Post surgery pain management|post surgery pain management
86480|NCT03025594|total knee arthroplasty|total knee arthroplasty
86481|NCT03025568|nylon|nylon
86482|NCT03025568|polyamide|polyamide
86483|NCT03025568|denture base|denture base
86484|NCT03025555|nylon|nylon
86485|NCT03025555|polyamide|polyamide
86486|NCT03025555|PEEK|peek
86487|NCT03025555|partial denture|partial denture
86488|NCT03025542|Psoriasis|psoriasis
86489|NCT03025542|Chronic Plaque Psoriasis|chronic plaque psoriasis
86490|NCT03025542|Bimekizumab|bimekizumab
86491|NCT03025490|Capnography|capnography
86492|NCT03025490|Electrophysiology|electrophysiology
86493|NCT03025477|Intraperitoneal|intraperitoneal
86494|NCT03025477|Intravenous|intravenous
86495|NCT03025477|Completeness of cytoreduction score|completeness of cytoreduction score
86496|NCT03025477|Carboplatin|carboplatin
86497|NCT03025477|Epirubicin|epirubicin
86498|NCT03025477|Paclitaxel|paclitaxel
86499|NCT03025477|Cisplatin|cisplatin
86500|NCT03025451|nutrition|nutrition
86501|NCT03025451|exercise|exercise
86502|NCT03025451|stress|stress
86503|NCT03025451|gender|gender
86504|NCT03025451|age|age
86505|NCT03025451|community support|community support
86506|NCT03025451|cardiovascular disease|cardiovascular disease
86507|NCT03025451|diabetes|diabetes
86508|NCT03025451|hypertension|hypertension
86509|NCT03025451|dyslipidemia|dyslipidemia
86510|NCT03025451|cholesterol|cholesterol
86511|NCT03025451|overweight|overweight
86512|NCT03025451|obesity|obesity
86513|NCT03025451|lifestyle|lifestyle
86514|NCT03025438|angiosarcoma|angiosarcoma
86515|NCT03025438|Cytology|cytology
86516|NCT03025438|liver|liver
86517|NCT03025438|cancer|cancer
86518|NCT03025412|Achilles Tendon|achilles tendon
86519|NCT03025412|Endoscopy|endoscopy
86520|NCT03025412|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
86521|NCT03025412|Exercise therapy|exercise therapy
86522|NCT03025399|tang wang prescription|tang wang prescription
86523|NCT03025321|Cocaine|cocaine
86524|NCT03025321|tDCS|tdcs
86525|NCT03025321|EMA|ema
86526|NCT03025321|Inhibitory control|inhibitory control
86527|NCT03025321|Reward processing|reward processing
86528|NCT03025321|Addiction|addiction
86529|NCT03025321|dlPFC|dlpfc
86530|NCT03025321|craving|craving
86531|NCT03025321|cognitive control|cognitive control
86532|NCT03025256|Melanoma and other malignant neoplasms of skin|melanoma and other malignant neoplasms of skin
86533|NCT03025256|Leptomeningeal disease|leptomeningeal disease
86534|NCT03025256|LMD|lmd
86535|NCT03025256|Nivolumab|nivolumab
86536|NCT03025256|BMS-936558|bms-936558
86537|NCT03025256|Opdivo|opdivo
86538|NCT03025243|computer aided design , dental implants , accuracy|computer aided design , dental implants , accuracy
86539|NCT03025204|Regeneration Procedures|regeneration procedures
86540|NCT03025204|Intrabony Defects|intrabony defects
86541|NCT03025204|Cronic Periodontitis|cronic periodontitis
86542|NCT03025191|incarceration|incarceration
86543|NCT03025191|HIV|hiv
86544|NCT03025152|Hou Gu Mi Xi|hou gu mi xi
86545|NCT03025152|Shen Ling Bai Zhu San|shen ling bai zhu san
86546|NCT03025152|radical gastrectomy|radical gastrectomy
86547|NCT03025152|gastric cancer|gastric cancer
86548|NCT03025152|traditional Chinese medicine|traditional chinese medicine
86549|NCT03025152|randomized controlled trial|randomized controlled trial
86550|NCT03025139|breast cancer|breast cancer
86551|NCT03025139|younger women|younger women
86552|NCT03025139|education|education
86553|NCT03025139|mindfulness meditation|mindfulness meditation
86554|NCT03025139|depression|depression
86555|NCT03025139|cancer survivor|cancer survivor
86556|NCT03025074|Liver Disease|liver disease
86557|NCT03025074|Obesity|obesity
86558|NCT03025074|Hepatitis|hepatitis
86559|NCT03025074|HIV|hiv
86560|NCT03025074|Hepatology|hepatology
86561|NCT03025061|Breath pattern|breath pattern
86562|NCT03025061|Children|children
86563|NCT03025061|Repeatability|repeatability
86564|NCT03025035|BRCA-mutation|brca-mutation
86565|NCT03025035|Immune checkpoint inhibition|immune checkpoint inhibition
86566|NCT03025035|Immunotherapy|immunotherapy
86567|NCT03025035|Advanced BRCA-mutated breast cancer|advanced brca-mutated breast cancer
86568|NCT03024957|morphine|morphine
86569|NCT03024957|dexmedetomidine|dexmedetomidine
86570|NCT03024957|immune system|immune system
86571|NCT03024944|Diabetes Mellitus|diabetes mellitus
86572|NCT03024944|Alzheimer's Disease|alzheimer's disease
86573|NCT03024944|Dementia|dementia
86574|NCT03024944|THK|thk
86575|NCT03024918|monochorionic|monochorionic
86576|NCT03024918|placental sharing|placental sharing
86577|NCT03024892|Fluorenscent image guided surgery|fluorenscent image guided surgery
86578|NCT03024892|indocyanide green|indocyanide green
86579|NCT03024892|laparoscopic cholecystectomy|laparoscopic cholecystectomy
86580|NCT03024892|common bile duct injury|common bile duct injury
86581|NCT03024879|Motilin|motilin
86582|NCT03024879|Erythromycin|erythromycin
86583|NCT03024879|Food intake|food intake
86584|NCT03024853|Best Possible Self|best possible self
86585|NCT03024853|Positive Intervention|positive intervention
86586|NCT03024853|Optimism|optimism
86587|NCT03024840|Propofol|propofol
86588|NCT03024840|Neurocognitive Disorders|neurocognitive disorders
86589|NCT03024840|Liver transplantation|liver transplantation
86590|NCT03024840|Pediatrics|pediatrics
86591|NCT03024840|Brain Injuries|brain injuries
86592|NCT03024827|Infantile Spasms|infantile spasms
86593|NCT03024827|Lennox Gastaut Syndrome|lennox gastaut syndrome
86594|NCT03024827|Doose Syndrome|doose syndrome
86595|NCT03024827|Continuous Spike Wave in Sleep|continuous spike wave in sleep
86596|NCT03024827|Landau-Kleffner Syndrome|landau-kleffner syndrome
86597|NCT03024827|Dravet Syndrome|dravet syndrome
86598|NCT03024827|Malignant Migrating Partial Seizures of Infancy (MMPSI)|malignant migrating partial seizures of infancy (mmpsi)
86599|NCT03024788|Glycosylated haemoglobin|glycosylated haemoglobin
86600|NCT03024788|advanced glycation end products|advanced glycation end products
86601|NCT03024775|Non-celiac Wheat Sensitivity|non-celiac wheat sensitivity
86602|NCT03024775|ancient wheats|ancient wheats
86603|NCT03024775|modern wheats|modern wheats
86604|NCT03024775|ATIs|atis
86605|NCT03024749|Spinal Arteriovenous Malformation|spinal arteriovenous malformation
86606|NCT03024749|Spinal Arteriovenous Fistula|spinal arteriovenous fistula
86607|NCT03024723|Obese patient|obese patient
86608|NCT03024723|nasal CPAP|nasal cpap
86609|NCT03024710|Stunting|stunting
86610|NCT03024710|complementary feeding Index|complementary feeding index
86611|NCT03024710|Bangladesh|bangladesh
86612|NCT03024697|Breast surgery|breast surgery
86613|NCT03024697|Pectoral plane block|pectoral plane block
86614|NCT03024697|PECs|pecs
86615|NCT03024697|Local anaesthesia infusion|local anaesthesia infusion
86616|NCT03024697|Analgesia|analgesia
86617|NCT03024684|Hepatocellular carcinoma|hepatocellular carcinoma
86618|NCT03024684|statin|statin
86619|NCT03024684|curative ablation|curative ablation
86620|NCT03024658|Pulmonary artery systolic pressure|pulmonary artery systolic pressure
86621|NCT03024658|Positive end expiratory pressure|positive end expiratory pressure
86622|NCT03024658|morbidly obese|morbidly obese
86623|NCT03024658|laparoscopic bariatric surgery|laparoscopic bariatric surgery
86624|NCT03024645|Postpartum Depression|postpartum depression
86625|NCT03024645|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
86626|NCT03024645|Prevention|prevention
86627|NCT03024645|Web-Based Psychological Intervention|web-based psychological intervention
86628|NCT03024593|Cyberchondria|cyberchondria
86629|NCT03024593|health-related internet use|health-related internet use
86630|NCT03024593|pathological health anxiety|pathological health anxiety
86631|NCT03024580|Megestrol Acetate|megestrol acetate
86632|NCT03024580|Steroid, Receptors|steroid, receptors
86633|NCT03024567|Calorimetry|calorimetry
86634|NCT03024567|Blood pressure|blood pressure
86635|NCT03024567|Immunophenotyping|immunophenotyping
86636|NCT03024567|Gut microbial composition|gut microbial composition
86637|NCT03024554|aortic aneurysm involving iliac arteries|aortic aneurysm involving iliac arteries
86638|NCT03024554|abdominal aortic aneurysm|abdominal aortic aneurysm
86639|NCT03024554|MFM|mfm
86640|NCT03024554|Multilayer Flow Modulator|multilayer flow modulator
86641|NCT03024554|Multilayer Stent|multilayer stent
86642|NCT03024528|Pain|pain
86643|NCT03024528|CPOT|cpot
86644|NCT03024528|ICU Delirium|icu delirium
86645|NCT03024528|Critical Care Pain Observation Tool|critical care pain observation tool
86646|NCT03024528|NRS|nrs
86647|NCT03024528|Behaviour|behaviour
86648|NCT03024528|Critical care|critical care
86649|NCT03024528|Intensive Care|intensive care
86650|NCT03024502|vulvovaginal candidiasis|vulvovaginal candidiasis
86651|NCT03024502|EPPAF mucoadhesive gel|eppaf mucoadhesive gel
86652|NCT03024502|clotrimazol|clotrimazol
86653|NCT03024489|Phase I/II|phase i/ii
86654|NCT03024476|behavioral intervention|behavioral intervention
86655|NCT03024476|prespecified medication algorithm|prespecified medication algorithm
86656|NCT03024476|bluetooth-equipped sphygmomanometer|bluetooth-equipped sphygmomanometer
86657|NCT03024463|Breast Neoplasm; Internal Lymph Node; Sentinel Lymph Node Biospy|breast neoplasm; internal lymph node; sentinel lymph node biospy
86658|NCT03024450|Gastric cancer|gastric cancer
86659|NCT03024450|HER2|her2
86660|NCT03024450|trastuzumab|trastuzumab
86661|NCT03024450|prognosis|prognosis
86662|NCT03024437|PD-L1 inhibitor|pd-l1 inhibitor
86663|NCT03024359|Obesity|obesity
86664|NCT03024359|Brown adipose tissue|brown adipose tissue
86665|NCT03024359|Monounsaturated fatty acids|monounsaturated fatty acids
86666|NCT03024359|Hypothalamic inflammation|hypothalamic inflammation
86667|NCT03024333|Dysphagia|dysphagia
86668|NCT03024333|Swallowing Sound|swallowing sound
86669|NCT03024333|Acoustic Analysis|acoustic analysis
86670|NCT03024307|Pharmaceutical Care|pharmaceutical care
86671|NCT03024307|Medication Adherence|medication adherence
86672|NCT03024307|Direct Costs|direct costs
86673|NCT03024281|Aspergillus|aspergillus
86674|NCT03024281|Antifungal susceptibility|antifungal susceptibility
86675|NCT03024281|Azole resistance|azole resistance
86676|NCT03024255|sweat gland disease|sweat gland disease
86677|NCT03024255|sweating|sweating
86678|NCT03024255|underarm|underarm
86878|NCT03022786|Dermatitis|dermatitis
86679|NCT03024229|Transplantation;perfusion machine|transplantation;perfusion machine
86680|NCT03024190|stroke|stroke
86681|NCT03024190|spasticity|spasticity
86682|NCT03024190|Kinesiotaping|kinesiotaping
86683|NCT03024190|sonography|sonography
86684|NCT03024190|exercise|exercise
86685|NCT03024177|Human rhinovirus|human rhinovirus
86686|NCT03024177|HRV|hrv
86687|NCT03024177|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
86688|NCT03024177|HSCT|hsct
86689|NCT03024177|Antiviral|antiviral
86690|NCT03024177|vapendavir|vapendavir
86691|NCT03024177|Allogeneic|allogeneic
86692|NCT03024177|Autologous|autologous
86693|NCT03024164|youth; etiology; prognosis; recurrence; biomarkers|youth; etiology; prognosis; recurrence; biomarkers
86694|NCT03024125|lean mass|lean mass
86695|NCT03024125|postmenopausal|postmenopausal
86696|NCT03024125|protein|protein
86697|NCT03024099|hippotherapy Gross Motor Function Functional performance.|hippotherapy gross motor function functional performance.
86698|NCT03024060|Actinic Keratosis|actinic keratosis
86699|NCT03024021|therapeutic hypothermia|therapeutic hypothermia
86700|NCT03024021|targeted temperature management|targeted temperature management
86701|NCT03024021|neurological outcome|neurological outcome
86702|NCT03024021|post-cardiac arrest syndrome|post-cardiac arrest syndrome
86703|NCT03024008|Critical Gap|critical gap
86704|NCT03024008|Comminuted Fracture|comminuted fracture
86705|NCT03024008|Extra-Articular|extra-articular
86706|NCT03023930|Opioid Use Disorder|opioid use disorder
86707|NCT03023917|jaundice,complication|jaundice,complication
86708|NCT03023891|glucocorticoids|glucocorticoids
86709|NCT03023891|efficacy|efficacy
86710|NCT03023891|metabolic toxicity|metabolic toxicity
86711|NCT03023865|Long gap esophageal atresia|long gap esophageal atresia
86712|NCT03023839|Delirium|delirium
86713|NCT03023839|Trauma|trauma
86714|NCT03023839|Injury|injury
86715|NCT03023839|restraints|restraints
86716|NCT03023761|Endodontic retreatments|endodontic retreatments
86717|NCT03023761|Low level laser|low level laser
86718|NCT03023761|Pain|pain
86719|NCT03023748|activated vitamin D treatment|activated vitamin d treatment
86720|NCT03023709|Quadrivalent inactivated influenza vaccine|quadrivalent inactivated influenza vaccine
86721|NCT03023709|Quadrivalent live, attenuated influenza vaccine|quadrivalent live, attenuated influenza vaccine
86722|NCT03023709|Adults with obstructive sleep apnea|adults with obstructive sleep apnea
86723|NCT03023696|C5 Palsy|c5 palsy
86724|NCT03023683|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
86725|NCT03023683|Children and young adults|children and young adults
86726|NCT03023670|Lung|lung
86727|NCT03023670|Cardiopulmonary Bypass|cardiopulmonary bypass
86728|NCT03023670|Pediatric|pediatric
86729|NCT03023670|Cardiac surgery|cardiac surgery
86730|NCT03023657|arousal|arousal
86731|NCT03023657|Consciousness Disorders|consciousness disorders
86732|NCT03023657|vegetative state|vegetative state
86733|NCT03023657|minimally conscious state|minimally conscious state
86734|NCT03023644|Congenital Heart Disease|congenital heart disease
86735|NCT03023644|Neurodevelopmental Disorders|neurodevelopmental disorders
86736|NCT03023644|Children|children
86737|NCT03023644|Executive Function|executive function
86738|NCT03023644|Working Memory|working memory
86739|NCT03023644|Cognitive interventions|cognitive interventions
86740|NCT03023644|Infant Open Heart Surgery|infant open heart surgery
86741|NCT03023631|GARDASIL 9|gardasil 9
86742|NCT03023631|Post allogeneic stem cell transplantation|post allogeneic stem cell transplantation
86743|NCT03023631|HPV infection prevention|hpv infection prevention
86744|NCT03023618|[G09.330.380]|[g09.330.380]
86745|NCT03023605|Pulmonary embolism|pulmonary embolism
86746|NCT03023605|Adherence to practice guidelines|adherence to practice guidelines
86747|NCT03023605|Age-adjusted D-dimer|age-adjusted d-dimer
86748|NCT03023605|Clinical prediction rules|clinical prediction rules
86749|NCT03023605|Elderly patients|elderly patients
86750|NCT03023592|Sjogren's Syndrome|sjogren's syndrome
86751|NCT03023592|Iguratimod|iguratimod
86752|NCT03023566|Dotarem|dotarem
86753|NCT03023566|MRI|mri
86754|NCT03023566|pediatric|pediatric
86755|NCT03023566|safety|safety
86756|NCT03023566|efficacy|efficacy
86757|NCT03023553|Trivalent, inactivated influenza vaccine|trivalent, inactivated influenza vaccine
86758|NCT03023553|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
86759|NCT03023553|Nasopharyngeal swabs|nasopharyngeal swabs
86760|NCT03023553|Young adults|young adults
86761|NCT03023540|Charcot Marie Tooth Type 1A|charcot marie tooth type 1a
86762|NCT03023540|Peripheral neuropathy|peripheral neuropathy
86763|NCT03023540|PXT3003|pxt3003
86764|NCT03023527|Refractory|refractory
86765|NCT03023527|Relapsed|relapsed
86766|NCT03023527|Nivolumab|nivolumab
86767|NCT03023514|Oocyte donation|oocyte donation
86768|NCT03023514|IVF|ivf
86769|NCT03023514|Lipoic acid|lipoic acid
86770|NCT03023514|Implantation rate|implantation rate
86771|NCT03023514|Endometrial receptivity|endometrial receptivity
86772|NCT03023488|flexible ureteroscopy|flexible ureteroscopy
86773|NCT03023488|blood flow|blood flow
86774|NCT03023436|Stomach Neoplasms|stomach neoplasms
86775|NCT03023436|Cytoreduction Surgical Procedures|cytoreduction surgical procedures
86776|NCT03023410|Revision TKA|revision tka
86777|NCT03023410|Instability|instability
86778|NCT03023410|Stiffness|stiffness
86779|NCT03023410|Aseptic Loosening|aseptic loosening
86780|NCT03023410|Polyethylene Wear|polyethylene wear
86781|NCT03023410|Malrotation|malrotation
86782|NCT03023410|Soft Tissue Imbalance|soft tissue imbalance
86783|NCT03023397|E-cig smokers|e-cig smokers
86784|NCT03023384|Acute Myeloid Leukemia|acute myeloid leukemia
86785|NCT03023384|Chemotherapy|chemotherapy
86786|NCT03023384|Autologous Stem Cell Transplantation|autologous stem cell transplantation
86787|NCT03023384|Developing country|developing country
86788|NCT03023384|Clinical network|clinical network
86789|NCT03023371|Registry; cohort study; IgG4-related disease|registry; cohort study; igg4-related disease
86790|NCT03023358|peripheral T cell lymphoma|peripheral t cell lymphoma
86791|NCT03023345|cancer|cancer
86792|NCT03023345|prostate|prostate
86793|NCT03023345|PSA|psa
86794|NCT03023345|biopsies|biopsies
86795|NCT03023345|microwave trans rectal focal treatment|microwave trans rectal focal treatment
86796|NCT03023332|Caregiver|caregiver
86797|NCT03023332|Biofeedback|biofeedback
86798|NCT03023332|Resourcefulness|resourcefulness
86799|NCT03023332|Self-Management|self-management
86800|NCT03023293|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
86801|NCT03023293|irisin|irisin
86802|NCT03023241|BPS/IC|bps/ic
86803|NCT03023241|OAB|oab
86804|NCT03023228|Diabetes mellitus|diabetes mellitus
86805|NCT03023228|Hyperglycemia|hyperglycemia
86806|NCT03023228|Inpatient|inpatient
86807|NCT03023228|self-management education|self-management education
86808|NCT03023215|Meditation|meditation
86809|NCT03023215|Breast Biopsy|breast biopsy
86810|NCT03023215|Stereotactic Breast Biopsy|stereotactic breast biopsy
86811|NCT03023215|SBB|sbb
86812|NCT03023215|Guided meditation|guided meditation
86813|NCT03023215|Focused breathing|focused breathing
86814|NCT03023215|Electroencephalogram|electroencephalogram
86815|NCT03023215|EEG|eeg
86816|NCT03023215|Heart rate|heart rate
86817|NCT03023215|HR|hr
86818|NCT03023215|Questionnaires|questionnaires
86819|NCT03023215|Surveys|surveys
86820|NCT03023189|Upper digestive bleeding|upper digestive bleeding
86821|NCT03023189|Haemorrhage|haemorrhage
86822|NCT03023189|Cirrhosis|cirrhosis
86823|NCT03023189|Antifibrinolytic|antifibrinolytic
86824|NCT03023189|Tranexamic acid|tranexamic acid
86825|NCT03023189|Emergency|emergency
86826|NCT03023176|Trivalent, inactivated influenza vaccine|trivalent, inactivated influenza vaccine
86827|NCT03023176|Child identical twins|child identical twins
86828|NCT03023176|Child fraternal twins|child fraternal twins
86829|NCT03023163|autonomic dysreflexia|autonomic dysreflexia
86830|NCT03023163|baroreceptor integrity|baroreceptor integrity
86831|NCT03023163|sympathetic integrity|sympathetic integrity
86832|NCT03023163|vagal integrity|vagal integrity
86833|NCT03023163|autonomic integrity|autonomic integrity
86834|NCT03023163|arterial stiffness|arterial stiffness
86835|NCT03023163|cognitive function|cognitive function
86836|NCT03023163|traumatic brain injury|traumatic brain injury
86837|NCT03023163|cerebral blood flow|cerebral blood flow
86838|NCT03023163|white matter hyperintensities|white matter hyperintensities
86839|NCT03023163|cerebral vascular resistance index|cerebral vascular resistance index
86840|NCT03023137|prevention|prevention
86841|NCT03023137|carbohydrate|carbohydrate
86842|NCT03023137|exercise|exercise
86843|NCT03023137|neonatal hypoglycemia|neonatal hypoglycemia
86844|NCT03023111|Cutaneous leishmaniasis|cutaneous leishmaniasis
86845|NCT03023111|miltefosine|miltefosine
86846|NCT03023111|cytokines|cytokines
86847|NCT03023111|treatment|treatment
86848|NCT03023098|Restenosis|restenosis
86849|NCT03023098|Drug-eluting balloon|drug-eluting balloon
86850|NCT03023098|Vein graft|vein graft
86851|NCT03023059|L-DOPA|l-dopa
86852|NCT03023059|GPR143|gpr143
86853|NCT03023059|PEDF|pedf
86854|NCT03023059|VEGF|vegf
86855|NCT03023033|PMTCT|pmtct
86856|NCT03023033|MNCH|mnch
86857|NCT03023020|Dual Antiplatelet Therapy|dual antiplatelet therapy
86858|NCT03022994|Non-celiac wheat sensitivity|non-celiac wheat sensitivity
86859|NCT03022994|eosinophils|eosinophils
86860|NCT03022994|lymphocytes|lymphocytes
86861|NCT03022994|duodenal biopsies|duodenal biopsies
86862|NCT03022994|rectal biopsies|rectal biopsies
86863|NCT03022825|BCG|bcg
86864|NCT03022825|bladder cancer|bladder cancer
86865|NCT03022825|immunotherapy|immunotherapy
86866|NCT03022825|interleukin-15|interleukin-15
86867|NCT03022825|intravesical|intravesical
86868|NCT03022825|non-muscle invasive|non-muscle invasive
86869|NCT03022825|NMIBC|nmibc
86870|NCT03022812|Neck pain|neck pain
86871|NCT03022812|Rehabilitation|rehabilitation
86872|NCT03022812|Exercise Therapy|exercise therapy
86873|NCT03022812|Internet|internet
86874|NCT03022799|FAF1|faf1
86875|NCT03022799|Fas (TNFRSF6)-associated factor 1|fas (tnfrsf6)-associated factor 1
86876|NCT03022799|FAF1 inhibitor|faf1 inhibitor
86877|NCT03022799|KM-819|km-819
86879|NCT03022760|Exhaustion Disorder|exhaustion disorder
86880|NCT03022682|ethnicity|ethnicity
86881|NCT03022682|inflammation|inflammation
86882|NCT03022669|mobile health|mobile health
86883|NCT03022669|veterans|veterans
86884|NCT03022669|cardiovascular disease|cardiovascular disease
86885|NCT03022669|medication adherence|medication adherence
86886|NCT03022656|Orthotic treatment, Ultrasound Imaging|orthotic treatment, ultrasound imaging
86887|NCT03022630|palliative care|palliative care
86888|NCT03022630|cirrhosis|cirrhosis
86889|NCT03022630|liver disease|liver disease
86890|NCT03022630|hepatology|hepatology
86891|NCT03022630|end of life care|end of life care
86892|NCT03022630|supportive care|supportive care
86893|NCT03022578|Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System|malignant neoplasms of eye brain and other parts of central nervous system
86894|NCT03022578|Glioblastoma|glioblastoma
86895|NCT03022578|Anaplastic Astrocytoma|anaplastic astrocytoma
86896|NCT03022578|AA|aa
86897|NCT03022578|Laser interstitial thermal therapy|laser interstitial thermal therapy
86898|NCT03022578|LITT|litt
86899|NCT03022578|Lomustine|lomustine
86900|NCT03022578|CeeNU|ceenu
86901|NCT03022578|CCNU|ccnu
86902|NCT03022565|Uveal Melanoma|uveal melanoma
86903|NCT03022552|Myocardial Infarction|myocardial infarction
86904|NCT03022552|Women|women
86905|NCT03022552|Platelets|platelets
86906|NCT03022552|Blood Collection|blood collection
86907|NCT03022552|Genomics|genomics
86908|NCT03022526|Pregnant|pregnant
86909|NCT03022526|Analgesia|analgesia
86910|NCT03022526|Labor analgesia|labor analgesia
86911|NCT03022526|Epidural|epidural
86912|NCT03022526|Combined spinal epidural|combined spinal epidural
86913|NCT03022513|Non-celiac Wheat Sensitivity|non-celiac wheat sensitivity
86914|NCT03022513|fibromyalgia|fibromyalgia
86915|NCT03022513|synovitis|synovitis
86916|NCT03022487|Sudden Cardiac Death (SCD)|sudden cardiac death (scd)
86917|NCT03022487|implantable cardioverter defibrillator|implantable cardioverter defibrillator
86918|NCT03022487|electrophysiological|electrophysiological
86919|NCT03022487|EP|ep
86920|NCT03022487|Ischaemic cardiomyopathy|ischaemic cardiomyopathy
86921|NCT03022487|Ventricular Arrhythmia|ventricular arrhythmia
86922|NCT03022487|ICD|icd
86923|NCT03022474|Childhood obesity|childhood obesity
86924|NCT03022461|Heart Failure|heart failure
86925|NCT03022461|Ventricular Dysfunction|ventricular dysfunction
86926|NCT03022461|Cardiomyopathies|cardiomyopathies
86927|NCT03022461|Heart Disease|heart disease
86928|NCT03022461|Cardiovascular Disease|cardiovascular disease
86929|NCT03022461|Heart-assist Devices|heart-assist devices
86930|NCT03022461|Thoratec Corporation|thoratec corporation
86931|NCT03022448|soft tissue sarcomas (STS)|soft tissue sarcomas (sts)
86932|NCT03022448|trabectedin|trabectedin
86933|NCT03022448|metastatic STS patients|metastatic sts patients
86934|NCT03022448|overall survival|overall survival
86935|NCT03022435|Inactivated influenza vaccine|inactivated influenza vaccine
86936|NCT03022435|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
86937|NCT03022435|Adult and elderly identical twins|adult and elderly identical twins
86938|NCT03022435|Adult fraternal twins|adult fraternal twins
86939|NCT03022422|Trivalent, inactivated influenza vaccine|trivalent, inactivated influenza vaccine
86940|NCT03022422|High-Dose trivalent, inactivated influenza vaccine|high-dose trivalent, inactivated influenza vaccine
86941|NCT03022422|Adult and elderly identical twins|adult and elderly identical twins
86942|NCT03022422|Adult fraternal twins|adult fraternal twins
86943|NCT03022409|Treatment naïve|treatment naïve
86944|NCT03022409|Head and Neck Squamous Cell Carcinoma (HNSCC)|head and neck squamous cell carcinoma (hnscc)
86945|NCT03022409|DNA Damage Repair (DDR)|dna damage repair (ddr)
86946|NCT03022396|Inactivated influenza vaccine|inactivated influenza vaccine
86947|NCT03022396|Identical twins|identical twins
86948|NCT03022396|Fraternal twins|fraternal twins
86949|NCT03022396|High-Dose influenza vaccine|high-dose influenza vaccine
86950|NCT03022396|Elderly twins|elderly twins
86951|NCT03022396|Child twins|child twins
86952|NCT03022396|Inactivated influenza vaccine, high-dose|inactivated influenza vaccine, high-dose
86953|NCT03022383|no known ocular pathology|no known ocular pathology
86954|NCT03022370|informal settlements|informal settlements
86955|NCT03022370|poverty|poverty
86956|NCT03022344|DD2 plaque study|dd2 plaque study
86957|NCT03022344|Coronary plaque|coronary plaque
86958|NCT03022344|Type-2 diabetes mellitus|type-2 diabetes mellitus
86959|NCT03022331|Idiopathic aortitis|idiopathic aortitis
86960|NCT03022331|Isolated aortitis|isolated aortitis
86961|NCT03022331|Vasculitis|vasculitis
86962|NCT03022318|GPR143|gpr143
86963|NCT03022318|PEDF|pedf
86964|NCT03022318|VEGF|vegf
86965|NCT03022318|LDOPA|ldopa
86966|NCT03022305|Hip alignment|hip alignment
86967|NCT03022305|Hip misalignment|hip misalignment
86968|NCT03022305|Shoulder function|shoulder function
86969|NCT03022305|Shoulder rotation|shoulder rotation
86970|NCT03022305|Athletic shoulder injuries|athletic shoulder injuries
86971|NCT03022305|Athletic hip alignment|athletic hip alignment
86972|NCT03022305|Hip and shoulder alignment|hip and shoulder alignment
86973|NCT03022305|Hip joint|hip joint
86974|NCT03022305|Hip joint alignment|hip joint alignment
86975|NCT03022305|Hip joint misalignment|hip joint misalignment
86976|NCT03022279|Pediatric|pediatric
86977|NCT03022279|post-operative pain prevention|post-operative pain prevention
86978|NCT03022279|Anesthesia, Infiltration|anesthesia, infiltration
86979|NCT03022279|Nerve Blockade|nerve blockade
86980|NCT03022266|Adherence|adherence
86981|NCT03022266|CleverCap® Lite BLE C035|clevercap® lite ble c035
86982|NCT03022266|Smartphone App|smartphone app
86983|NCT03022266|Telehealth|telehealth
86984|NCT03022266|Digital Health|digital health
86985|NCT03022266|Mobile Phone App|mobile phone app
86986|NCT03022266|Behavioral Economics|behavioral economics
86987|NCT03022266|Aspirin|aspirin
86988|NCT03022266|Wellth App|wellth app
86989|NCT03022253|PDA|pda
86990|NCT03022253|Platelets|platelets
86991|NCT03022227|cochlear implant ;|cochlear implant ;
86992|NCT03022214|Dietary supplementation|dietary supplementation
86993|NCT03022214|Exercise|exercise
86994|NCT03022214|Increase Resilience|increase resilience
86995|NCT03022214|Oxidative Stress|oxidative stress
86996|NCT03022214|Efficacy|efficacy
86997|NCT03022201|Motilitone|motilitone
86998|NCT03022188|pancreatic incidentaloma|pancreatic incidentaloma
86999|NCT03022188|pancreatic neuroendocrine tumor|pancreatic neuroendocrine tumor
87000|NCT03022188|EUS-guided fine-needle aspiration|eus-guided fine-needle aspiration
87001|NCT03022188|contrast-enhanced endoscopic ultrasound|contrast-enhanced endoscopic ultrasound
87002|NCT03022175|Safety|safety
87003|NCT03022175|Tolerability|tolerability
87004|NCT03022175|Pharmacokinetics|pharmacokinetics
87005|NCT03022162|Neuropathic Pain, Paclitaxel, CIPN|neuropathic pain, paclitaxel, cipn
87006|NCT03022136|epidural block|epidural block
87007|NCT03022136|dermatome|dermatome
87008|NCT03022136|human|human
87009|NCT03022136|spinal nerve|spinal nerve
87010|NCT03022136|thoracic|thoracic
87011|NCT03022071|Cognitive behavior therapy|cognitive behavior therapy
87012|NCT03022071|Psychodynamic therapy|psychodynamic therapy
87013|NCT03022071|Mediators|mediators
87014|NCT03022071|Moderators|moderators
87015|NCT03022045|Generalized Pustular Psoriasis|generalized pustular psoriasis
87016|NCT03022045|Erythrodermic Psoriasis|erythrodermic psoriasis
87017|NCT03022045|risankizumab|risankizumab
87018|NCT03022045|Japanese|japanese
87019|NCT03022032|Gynecologic cancer|gynecologic cancer
87020|NCT03022019|autologous cell suspension grafting|autologous cell suspension grafting
87021|NCT03022019|vitiligo|vitiligo
87022|NCT03022019|non-segmental|non-segmental
87023|NCT03022019|ReNovaCell|renovacell
87024|NCT03021967|incurable pathologies|incurable pathologies
87025|NCT03021967|palliative care|palliative care
87026|NCT03021954|platelet rich plasma|platelet rich plasma
87027|NCT03021954|pelvic floor disorders|pelvic floor disorders
87028|NCT03021954|primipara|primipara
87029|NCT03021941|Gaucher Disease|gaucher disease
87030|NCT03021941|Enzyme Replacement Therapy|enzyme replacement therapy
87031|NCT03021928|Stroke|stroke
87032|NCT03021928|Atrial Fibrillation|atrial fibrillation
87033|NCT03021928|Anticoagulation|anticoagulation
87034|NCT03021928|NOAC|noac
87035|NCT03021889|HIV / AIDS|hiv / aids
87036|NCT03021889|Dyslipidemia|dyslipidemia
87037|NCT03021889|Adolescents|adolescents
87038|NCT03021889|Nutritional Therapy|nutritional therapy
87039|NCT03021863|Dissemination|dissemination
87040|NCT03021863|Tone|tone
87041|NCT03021863|Survey reminders|survey reminders
87042|NCT03021863|Questionnaires|questionnaires
87043|NCT03021850|Pliability|pliability
87044|NCT03021850|Cryotherapy|cryotherapy
87045|NCT03021850|Hot temperature|hot temperature
87046|NCT03021850|Hyperthermia, induced|hyperthermia, induced
87047|NCT03021850|Randomized Controlled Trial|randomized controlled trial
87048|NCT03021850|Hamstring muscles|hamstring muscles
87049|NCT03021850|Muscle stretching exercises|muscle stretching exercises
87050|NCT03021824|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
87051|NCT03021824|ARDS|ards
87052|NCT03021824|Acute Lung Injury|acute lung injury
87053|NCT03021824|ALI|ali
87054|NCT03021824|Mechanical Ventilation|mechanical ventilation
87055|NCT03021824|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
87056|NCT03021824|Neuromuscular Blockade|neuromuscular blockade
87057|NCT03021824|Vasodilator Agents|vasodilator agents
87058|NCT03021824|Prone Position|prone position
87059|NCT03021824|ECMO|ecmo
87060|NCT03021824|Acute Respiratory Failure|acute respiratory failure
87061|NCT03021798|Sarcopenia|sarcopenia
87062|NCT03021798|Sarcopenic Obesity|sarcopenic obesity
87063|NCT03021798|observational study|observational study
87064|NCT03021798|6-minute walking distance|6-minute walking distance
87065|NCT03021798|400 meters walking test|400 meters walking test
87066|NCT03021798|Patient Reported Outcomes|patient reported outcomes
87067|NCT03021785|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
87068|NCT03021785|Anti-VEGF|anti-vegf
87069|NCT03021785|CNV|cnv
87070|NCT03021785|TK001|tk001
87071|NCT03021772|Neostigmine|neostigmine
87072|NCT03021772|Dexamethasone|dexamethasone
87073|NCT03021772|Intravenous Local Anesthesia|intravenous local anesthesia
87074|NCT03021746|African-American|african-american
87075|NCT03021720|Uterine fibroid embolization|uterine fibroid embolization
87076|NCT03021720|Uterine artery embolization|uterine artery embolization
87077|NCT03021720|Arterial access|arterial access
87078|NCT03021720|Radial access|radial access
87079|NCT03021720|Interventional radiology|interventional radiology
87080|NCT03021720|Quality of life|quality of life
87081|NCT03021720|Patient Satisfaction|patient satisfaction
87082|NCT03021720|Patient centered care|patient centered care
87083|NCT03021720|Uterine fibroid|uterine fibroid
87084|NCT03021655|Youth|youth
87085|NCT03021655|Randomized controlled trial|randomized controlled trial
87086|NCT03021655|Adventure-based training|adventure-based training
87087|NCT03021655|WhatsApp|whatsapp
87088|NCT03021642|healthy volunteer|healthy volunteer
87089|NCT03021642|Tepotinib|tepotinib
87090|NCT03021642|Mesenchymal-epithelial transition factor|mesenchymal-epithelial transition factor
87091|NCT03021642|Translocated promoter region|translocated promoter region
87092|NCT03021616|energy drink|energy drink
87093|NCT03021616|qtc interval|qtc interval
87094|NCT03021616|clotting time|clotting time
87095|NCT03021616|thorough qt study|thorough qt study
87096|NCT03021603|Hope|hope
87097|NCT03021603|psychotherapy|psychotherapy
87098|NCT03021603|palliative|palliative
87099|NCT03021603|low-intensity intervention|low-intensity intervention
87100|NCT03021590|Helicobacter pylori|helicobacter pylori
87101|NCT03021590|Helicobacter Infections|helicobacter infections
87102|NCT03021590|Proton Pump Inhibitors|proton pump inhibitors
87103|NCT03021590|sequential therapy|sequential therapy
87104|NCT03021590|Clarithromycin|clarithromycin
87105|NCT03021590|Tinidazole|tinidazole
87106|NCT03021577|orbital atherectomy system|orbital atherectomy system
87107|NCT03021577|rotational atherectomy|rotational atherectomy
87108|NCT03021577|Fractional flow reserve|fractional flow reserve
87109|NCT03021577|coronary flow reserve|coronary flow reserve
87110|NCT03021577|index of microcirculatory resistance (IMR)|index of microcirculatory resistance (imr)
87111|NCT03021551|oxygen|oxygen
87112|NCT03021551|desaturation|desaturation
87113|NCT03021551|obesity|obesity
87114|NCT03021538|Cardiopulmonary Bypass|cardiopulmonary bypass
87115|NCT03021538|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
87116|NCT03021538|Primary Graft Dysfunction|primary graft dysfunction
87117|NCT03021538|Hemorrhage|hemorrhage
87118|NCT03021538|Mechanical Ventilator|mechanical ventilator
87119|NCT03021525|Goal-directed therapy|goal-directed therapy
87120|NCT03021525|postoperative morbidity|postoperative morbidity
87121|NCT03021525|haemodynamic optimisation|haemodynamic optimisation
87122|NCT03021525|individualised medicine|individualised medicine
87123|NCT03021525|Pulse pressure variation|pulse pressure variation
87124|NCT03021525|Cardiac output|cardiac output
87125|NCT03021499|lupus nephritis|lupus nephritis
87126|NCT03021499|calcineurin inhibitors|calcineurin inhibitors
87127|NCT03021499|voclosporin|voclosporin
87128|NCT03021486|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
87129|NCT03021486|Haloperidol|haloperidol
87130|NCT03021486|Chlorpromazine|chlorpromazine
87131|NCT03021486|Chlorpromazine hydrochloride|chlorpromazine hydrochloride
87132|NCT03021486|Thorazine|thorazine
87133|NCT03021486|Symptom questionnaire|symptom questionnaire
87134|NCT03021486|Survey|survey
87135|NCT03021486|Delirium|delirium
87136|NCT03021486|Acute palliative care unit|acute palliative care unit
87137|NCT03021486|APCU|apcu
87138|NCT03021473|oxygen reserve index|oxygen reserve index
87139|NCT03021473|desaturation|desaturation
87140|NCT03021473|safety|safety
87141|NCT03021434|Water Supply/standards|water supply/standards
87142|NCT03021434|Water microbiology|water microbiology
87143|NCT03021434|India|india
87144|NCT03021434|Hand disinfection|hand disinfection
87145|NCT03021434|Escherichia coli Infections/prevention & control|escherichia coli infections/prevention & control
87146|NCT03021434|Hygiene|hygiene
87147|NCT03021434|Health behavior|health behavior
87148|NCT03021434|Drinking water|drinking water
87149|NCT03021434|Informational intervention|informational intervention
87150|NCT03021421|Total knee arthroplasty|total knee arthroplasty
87151|NCT03021421|unilateral spinal anaesthesia|unilateral spinal anaesthesia
87152|NCT03021421|psoas compartment block|psoas compartment block
87153|NCT03021421|sciatic nerve block|sciatic nerve block
87154|NCT03021421|haemodynamic effects|haemodynamic effects
87155|NCT03021343|Atrial fibrillation|atrial fibrillation
87156|NCT03021343|Colchicine|colchicine
87157|NCT03021343|Cardiac surgery|cardiac surgery
87158|NCT03021304|SB240563|sb240563
87159|NCT03021304|self-administration|self-administration
87160|NCT03021304|Mepolizumab|mepolizumab
87161|NCT03021304|safety syringe|safety syringe
87162|NCT03021304|Eosinophilic asthma|eosinophilic asthma
87163|NCT03021278|Tactile acuity|tactile acuity
87164|NCT03021278|Chronic pain|chronic pain
87165|NCT03021278|Two-point discrimination|two-point discrimination
87166|NCT03021278|Point-to-point test|point-to-point test
87167|NCT03021278|Two-point estimation|two-point estimation
87168|NCT03021278|Body image|body image
87169|NCT03021239|Ramp Test|ramp test
87170|NCT03021239|Continuous Flow -Left Ventricular Assist Device (CF-LVAD)|continuous flow -left ventricular assist device (cf-lvad)
87171|NCT03021239|LVAD Hemodynamics|lvad hemodynamics
87172|NCT03021226|Health Behavior|health behavior
87173|NCT03021174|CIPN|cipn
87174|NCT03021174|Chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
87175|NCT03021161|probiotic|probiotic
87176|NCT03021148|Non-celiac wheat sensitivity|non-celiac wheat sensitivity
87177|NCT03021148|self-reported|self-reported
87178|NCT03021122|Medication errors|medication errors
87179|NCT03021122|Resuscitation|resuscitation
87180|NCT03021122|Drugs|drugs
87181|NCT03021122|Pediatrics|pediatrics
87182|NCT03021122|Biomedical technology|biomedical technology
87183|NCT03021109|ultrasound|ultrasound
87184|NCT03021109|pediatrics|pediatrics
87185|NCT03021109|gastroenteritis|gastroenteritis
87186|NCT03021083|Lumbar multi-level fusions|lumbar multi-level fusions
87187|NCT03021083|Patient Controlled Analgesia|patient controlled analgesia
87188|NCT03021083|Fentanyl|fentanyl
87189|NCT03021083|Opioid Analgesia|opioid analgesia
87190|NCT03021070|Ante natal visit|ante natal visit
87191|NCT03021070|Facility delivery|facility delivery
87192|NCT03021070|Post natal visit|post natal visit
87193|NCT03021070|Continuum of care|continuum of care
87194|NCT03021070|Conditional cash transfer|conditional cash transfer
87195|NCT03021070|Maternal and child health|maternal and child health
87196|NCT03021070|Cluster randomized trial|cluster randomized trial
87197|NCT03021031|Parkinson's Disease|parkinson's disease
87198|NCT03021018|Epilepsy|epilepsy
87199|NCT03021018|Brivaracetam|brivaracetam
87200|NCT03021018|Epilepsy Monitoring Unit|epilepsy monitoring unit
87201|NCT03021018|Increased seizure activity|increased seizure activity
87202|NCT03020992|Axial Spondyloarthritis|axial spondyloarthritis
87203|NCT03020992|axSpA|axspa
87204|NCT03020992|Anterior Uveitis|anterior uveitis
87205|NCT03020992|Certolizumab Pegol|certolizumab pegol
87206|NCT03020992|Cimzia|cimzia
87207|NCT03020875|Acetaminophen|acetaminophen
87208|NCT03020875|Pain management|pain management
87209|NCT03020862|Dietary nitrate|dietary nitrate
87210|NCT03020862|Physical performance|physical performance
87211|NCT03020862|Blood pressure|blood pressure
87212|NCT03020862|Nitrite|nitrite
87213|NCT03020862|Exercise|exercise
87214|NCT03020849|hypofibrinogenemia|hypofibrinogenemia
87215|NCT03020849|prediction score|prediction score
87216|NCT03020849|severe trauma|severe trauma
87217|NCT03020823|SCB01A|scb01a
87218|NCT03020823|squamous cell carcinoma of head and neck|squamous cell carcinoma of head and neck
87219|NCT03020784|acute neuroinflammatory|acute neuroinflammatory
87220|NCT03020771|Crimean-congo hemorrhagic fever|crimean-congo hemorrhagic fever
87221|NCT03020771|vaccine|vaccine
87222|NCT03020771|human|human
87223|NCT03020771|phase I|phase i
87224|NCT03020745|Pharmacokinetics|pharmacokinetics
87225|NCT03020745|Safety|safety
87226|NCT03020745|Pharmacodynamics|pharmacodynamics
87227|NCT03020745|Efficacy|efficacy
87228|NCT03020745|Chronic Hepatitis B|chronic hepatitis b
87229|NCT03020745|GSK3389404|gsk3389404
87230|NCT03020732|growth factor|growth factor
87231|NCT03020732|mucogingival surgery|mucogingival surgery
87232|NCT03020732|gingival recession|gingival recession
87233|NCT03020719|Growth Parameters|growth parameters
87234|NCT03020719|Cystic Fibrosis|cystic fibrosis
87235|NCT03020706|magnesium sulphate|magnesium sulphate
87236|NCT03020706|neostigmine|neostigmine
87237|NCT03020693|electrostimulation|electrostimulation
87238|NCT03020693|exercise program|exercise program
87239|NCT03020667|Cigarette|cigarette
87240|NCT03020667|IQOS|iqos
87241|NCT03020667|Nicotine-containing product|nicotine-containing product
87242|NCT03020667|Tobacco|tobacco
87243|NCT03020641|low pressure pneumoperitoneum|low pressure pneumoperitoneum
87244|NCT03020641|standard pressure pneumoperitoneum|standard pressure pneumoperitoneum
87245|NCT03020641|laparoscopy cholecystectomy|laparoscopy cholecystectomy
87246|NCT03020628|Influenza Vaccines|influenza vaccines
87247|NCT03020628|Vaccines, Inactivated|vaccines, inactivated
87248|NCT03020628|Cell Culture-Derived|cell culture-derived
87249|NCT03020615|Sickle cell|sickle cell
87250|NCT03020615|Hydroxyurea|hydroxyurea
87251|NCT03020615|Infants|infants
87252|NCT03020589|Renal Transplant|renal transplant
87253|NCT03020589|Tacrolimus|tacrolimus
87254|NCT03020589|UNC|unc
87255|NCT03020589|Phase IV|phase iv
87256|NCT03020550|GERD|gerd
87257|NCT03020550|Galvanic Skin Response|galvanic skin response
87258|NCT03020550|Heart Rate Variability|heart rate variability
87259|NCT03020537|Trivalent inactivated influenza vaccine|trivalent inactivated influenza vaccine
87260|NCT03020537|Young children|young children
87261|NCT03020537|Young adults|young adults
87262|NCT03020511|Modern grains|modern grains
87263|NCT03020511|ancient grains|ancient grains
87264|NCT03020511|immunologic response|immunologic response
87265|NCT03020511|microbiota|microbiota
87266|NCT03020498|Inactivated influenza vaccine|inactivated influenza vaccine
87267|NCT03020498|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
87268|NCT03020498|Child identical twins and non-twins|child identical twins and non-twins
87269|NCT03020498|Young and elderly non-twin adults|young and elderly non-twin adults
87270|NCT03020472|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
87271|NCT03020472|Children|children
87272|NCT03020459|macular holes|macular holes
87273|NCT03020433|Stroke|stroke
87274|NCT03020433|rehab|rehab
87275|NCT03020433|rehabilitation|rehabilitation
87276|NCT03020433|paresis|paresis
87277|NCT03020433|paralysis|paralysis
87278|NCT03020433|stroke therapy|stroke therapy
87279|NCT03020433|CVA|cva
87280|NCT03020433|cerebrovascular accident|cerebrovascular accident
87281|NCT03020433|brain diseases|brain diseases
87282|NCT03020433|TMS|tms
87283|NCT03020433|transcranial magnetic stimulation|transcranial magnetic stimulation
87284|NCT03020433|CIMT|cimt
87285|NCT03020433|constraint induced movement therapy|constraint induced movement therapy
87286|NCT03020433|MRI|mri
87287|NCT03020407|Septic Shock|septic shock
87288|NCT03020407|Inferior vene cava diameter|inferior vene cava diameter
87289|NCT03020407|Resuscitation|resuscitation
87290|NCT03020407|Mortality|mortality
87291|NCT03020394|COPD Exacerbation|copd exacerbation
87292|NCT03020394|Noninvasive Positive Ventilation|noninvasive positive ventilation
87293|NCT03020394|Invasive Positive Ventilation|invasive positive ventilation
87294|NCT03020394|severe|severe
87295|NCT03020342|HCC|hcc
87296|NCT03020342|chimera DNA|chimera dna
87297|NCT03020342|circulating DNA|circulating dna
87298|NCT03020342|biomarker|biomarker
87299|NCT03020329|Induction Chemotherapy|induction chemotherapy
87300|NCT03020329|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
87301|NCT03020329|Chemoradiotherapy|chemoradiotherapy
87302|NCT03020290|femoropopliteal artery|femoropopliteal artery
87303|NCT03020290|interwoven nitinol stent|interwoven nitinol stent
87304|NCT03020290|self-expanding-endovascular|self-expanding-endovascular
87305|NCT03020290|TASC C and TASC D|tasc c and tasc d
87306|NCT03020290|Peripheral Arterial Disease|peripheral arterial disease
87307|NCT03020264|Type 2 Diabetes|type 2 diabetes
87308|NCT03020264|Hypoglycemia|hypoglycemia
87309|NCT03020264|Elderly|elderly
87310|NCT03020264|Insulinotherapy|insulinotherapy
87311|NCT03020251|preoperative rehabilitation program|preoperative rehabilitation program
87312|NCT03020251|chest physiotherapy|chest physiotherapy
87313|NCT03020251|lung cancer resection|lung cancer resection
87314|NCT03020212|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
87315|NCT03020212|High altitude|high altitude
87316|NCT03020212|Oxygen|oxygen
87317|NCT03020212|long-term oxygen therapy|long-term oxygen therapy
87318|NCT03020212|pulmonary hypertension|pulmonary hypertension
87319|NCT03020212|chronic hypoxemia|chronic hypoxemia
87320|NCT03020199|Psoriasis|psoriasis
87321|NCT03020134|pharmacokinetics|pharmacokinetics
87322|NCT03020134|Danoprevir/r|danoprevir/r
87323|NCT03020134|Ravidasvir|ravidasvir
87324|NCT03020095|Ravidasvir|ravidasvir
87325|NCT03020095|HCV GT1|hcv gt1
87326|NCT03020095|SVR12|svr12
87327|NCT03020095|Danoprevir/r|danoprevir/r
87328|NCT03020082|Danoprevir|danoprevir
87329|NCT03020082|non-cirrhotic|non-cirrhotic
87330|NCT03020082|Chinese HCV G1|chinese hcv g1
87331|NCT03020082|SVR12|svr12
87332|NCT03020069|Type 1 Diabetes|type 1 diabetes
87333|NCT03020069|Adolescents|adolescents
87334|NCT03020069|Glucose Monitoring|glucose monitoring
87335|NCT03020056|cataract surgery|cataract surgery
87336|NCT03020056|socioeconomic status|socioeconomic status
87337|NCT03020056|quality of life|quality of life
87338|NCT03020056|rural area|rural area
87339|NCT03020056|China|china
87340|NCT03020056|randomized controlled trial|randomized controlled trial
87341|NCT03020030|acute lymphoblastic leukemia|acute lymphoblastic leukemia
87342|NCT03020004|Danoprevir|danoprevir
87343|NCT03020004|SVR12|svr12
87344|NCT03020004|Chinese HCV G1|chinese hcv g1
87345|NCT03020004|non-cirrhotic|non-cirrhotic
87346|NCT03019991|pharmacokinetics,Danoprevir|pharmacokinetics,danoprevir
87347|NCT03019939|Acute Myeloid Leukemia|acute myeloid leukemia
87348|NCT03019939|AML|aml
87349|NCT03019939|Myelodysplastic Syndrome|myelodysplastic syndrome
87350|NCT03019939|MDS|mds
87351|NCT03019939|Neutropenia|neutropenia
87352|NCT03019939|Invasive fungal infection|invasive fungal infection
87353|NCT03019939|IFI|ifi
87354|NCT03019939|Isavuconazole|isavuconazole
87355|NCT03019939|BAL8557|bal8557
87356|NCT03019926|systemic lupus erythematosus|systemic lupus erythematosus
87357|NCT03019926|observance|observance
87358|NCT03019926|hydroxychloroquine dosage|hydroxychloroquine dosage
87359|NCT03019926|risk factors of non-observance|risk factors of non-observance
87360|NCT03019926|SLICC score|slicc score
87361|NCT03019926|SLEDAI score|sledai score
87362|NCT03019913|Skeletal muscle|skeletal muscle
87363|NCT03019861|Ayurveda|ayurveda
87364|NCT03019861|IBS|ibs
87365|NCT03019861|Complementary medicine|complementary medicine
87366|NCT03019861|nutritional counseling|nutritional counseling
87367|NCT03019848|Redox and pro-inflammatory status|redox and pro-inflammatory status
87368|NCT03019835|mivacurium|mivacurium
87369|NCT03019835|neostigmine|neostigmine
87370|NCT03019835|antagonism|antagonism
87371|NCT03019783|Endothelial function|endothelial function
87372|NCT03019770|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
87373|NCT03019770|HIV|hiv
87374|NCT03019770|Decision Aid|decision aid
87375|NCT03019770|Shared Decision Making|shared decision making
87628|NCT03018197|Medication Knowledge|medication knowledge
87376|NCT03019744|Functional Electrical Stimulation|functional electrical stimulation
87377|NCT03019744|Cerebrovascular accident|cerebrovascular accident
87378|NCT03019744|Stroke|stroke
87379|NCT03019744|Electromyography|electromyography
87380|NCT03019731|Tics|tics
87381|NCT03019731|Behavioral therapy|behavioral therapy
87382|NCT03019731|Neurologic Examination|neurologic examination
87383|NCT03019718|Inpatient rehabilitation|inpatient rehabilitation
87384|NCT03019718|Internet-based intervention|internet-based intervention
87385|NCT03019718|Aftercare|aftercare
87386|NCT03019718|Return to work|return to work
87387|NCT03019718|Psychodynamic|psychodynamic
87388|NCT03019705|Cyberchondria|cyberchondria
87389|NCT03019705|health-related internet use|health-related internet use
87390|NCT03019705|pathological health anxiety|pathological health anxiety
87391|NCT03019705|ambulatory assessment|ambulatory assessment
87392|NCT03019666|MM|mm
87393|NCT03019666|NHL|nhl
87394|NCT03019640|B-Cell Non-Hodgkin Lymphoma|b-cell non-hodgkin lymphoma
87395|NCT03019640|Relapsed follicular lymphoma|relapsed follicular lymphoma
87396|NCT03019640|Indolent B-cell histology|indolent b-cell histology
87397|NCT03019640|Natural killer cells|natural killer cells
87398|NCT03019640|NK|nk
87399|NCT03019640|Stem cell transplant|stem cell transplant
87400|NCT03019640|Rituximab|rituximab
87401|NCT03019640|Rituxan|rituxan
87402|NCT03019640|Carmustine|carmustine
87403|NCT03019640|BCNU|bcnu
87404|NCT03019640|BiCNU|bicnu
87405|NCT03019640|Etoposide|etoposide
87406|NCT03019640|VePesid|vepesid
87407|NCT03019640|Cytarabine|cytarabine
87408|NCT03019640|Ara-C|ara-c
87409|NCT03019640|Cytosar|cytosar
87410|NCT03019640|DepoCyt|depocyt
87411|NCT03019640|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
87412|NCT03019640|Melphalan|melphalan
87413|NCT03019640|Alkeran|alkeran
87414|NCT03019640|Lenalidomide|lenalidomide
87415|NCT03019640|CC-5013|cc-5013
87416|NCT03019640|Revlimid|revlimid
87417|NCT03019640|G-CSF|g-csf
87418|NCT03019640|Filgrastim|filgrastim
87419|NCT03019640|Neupogen|neupogen
87420|NCT03019601|HIV|hiv
87421|NCT03019601|PMTCT|pmtct
87422|NCT03019588|PD1|pd1
87423|NCT03019588|PD-1|pd-1
87424|NCT03019588|PDL1|pdl1
87425|NCT03019588|PD-L1|pd-l1
87426|NCT03019562|postoperative pain|postoperative pain
87427|NCT03019523|caffeine|caffeine
87428|NCT03019523|mental performance|mental performance
87429|NCT03019523|reaction time|reaction time
87430|NCT03019523|focus|focus
87431|NCT03019497|PTSD|ptsd
87432|NCT03019497|Related Problems|related problems
87433|NCT03019497|Therapy|therapy
87434|NCT03019497|Traumatic Event|traumatic event
87435|NCT03019497|Quality of Life|quality of life
87436|NCT03019497|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
87437|NCT03019497|Major depression|major depression
87438|NCT03019497|Sleep disorders|sleep disorders
87439|NCT03019497|Pain|pain
87440|NCT03019497|Stressors|stressors
87441|NCT03019497|Social support|social support
87442|NCT03019497|Substance use disorder|substance use disorder
87443|NCT03019497|Anxiety disorder|anxiety disorder
87444|NCT03019484|Self-efficacy|self-efficacy
87445|NCT03019484|Self Efficacy|self efficacy
87446|NCT03019484|Nurses's Role|nurses's role
87447|NCT03019484|Professional Role|professional role
87448|NCT03019484|Clinical Trial|clinical trial
87449|NCT03019484|Breast Feeding|breast feeding
87450|NCT03019458|prospective randomized trial|prospective randomized trial
87451|NCT03019419|sporadic ALS|sporadic als
87452|NCT03019419|perampanel|perampanel
87453|NCT03019393|non-transferrin bound iron (NTBI)|non-transferrin bound iron (ntbi)
87454|NCT03019393|Red meat|red meat
87455|NCT03019393|Non-transferrin bound iron (NTBI) in serum|non-transferrin bound iron (ntbi) in serum
87456|NCT03019367|Premature infants|premature infants
87457|NCT03019367|Umbilical cord milking|umbilical cord milking
87458|NCT03019367|Delayed cord clamping|delayed cord clamping
87459|NCT03019367|Intraventricular Hemorrhage|intraventricular hemorrhage
87460|NCT03019367|Death|death
87461|NCT03019354|high flow oxygen|high flow oxygen
87462|NCT03019354|pulmonary atelectasis|pulmonary atelectasis
87463|NCT03019354|intravenous general anesthesia|intravenous general anesthesia
87464|NCT03019341|Nausea|nausea
87465|NCT03019341|Vomiting|vomiting
87466|NCT03019341|Non-ionic contrast media|non-ionic contrast media
87467|NCT03019341|Side effect|side effect
87468|NCT03019328|peanut allergy|peanut allergy
87469|NCT03019328|food allergens|food allergens
87470|NCT03019328|atopic dermatitis|atopic dermatitis
87471|NCT03019328|eczema|eczema
87472|NCT03019328|infant food allergy testing|infant food allergy testing
87473|NCT03019328|skin prick testing|skin prick testing
87474|NCT03019328|peanut IgE|peanut ige
87475|NCT03019328|early peanut introduction|early peanut introduction
87476|NCT03019328|food allergy prevention|food allergy prevention
87477|NCT03019315|Ovarian Cancer|ovarian cancer
87478|NCT03019315|Chemotherapy|chemotherapy
87479|NCT03019315|Response Rate|response rate
87480|NCT03019315|Survival|survival
87481|NCT03019250|Colostrum|colostrum
87482|NCT03019250|Critical Care Outcomes|critical care outcomes
87483|NCT03019250|Intensive Care Unit|intensive care unit
87484|NCT03019250|Inflammation|inflammation
87485|NCT03019250|Infection|infection
87486|NCT03019250|mortality|mortality
87487|NCT03019224|Tooth whitening|tooth whitening
87488|NCT03019224|Dentifrice|dentifrice
87489|NCT03019224|Sensitivity|sensitivity
87490|NCT03019211|Physical Therapy Modalities|physical therapy modalities
87491|NCT03019211|Accidental Fall|accidental fall
87492|NCT03019211|Elderly|elderly
87493|NCT03019211|Hydrotherapy|hydrotherapy
87494|NCT03019211|Nursing Home|nursing home
87495|NCT03019198|Tranexamic Acid|tranexamic acid
87496|NCT03019198|Blood loss|blood loss
87497|NCT03019198|Tranfusion|tranfusion
87498|NCT03019185|Alport Syndrome|alport syndrome
87499|NCT03019185|Bardoxolone methyl|bardoxolone methyl
87500|NCT03019185|CDDO-ME|cddo-me
87501|NCT03019185|RTA 402|rta 402
87502|NCT03019146|Prehabilitation|prehabilitation
87503|NCT03019133|Heart rate|heart rate
87504|NCT03019133|Blood pressure variability|blood pressure variability
87505|NCT03019094|overactive bladder|overactive bladder
87506|NCT03019094|urge urinary incontinence|urge urinary incontinence
87507|NCT03019094|urgency frequency|urgency frequency
87508|NCT03019068|recruitment potential|recruitment potential
87509|NCT03019068|prediction|prediction
87510|NCT03019068|databases|databases
87511|NCT03019068|Clinical Trial Recruitment Support Systems (CTRSS)|clinical trial recruitment support systems (ctrss)
87512|NCT03019042|Hou Gu Mi Xi|hou gu mi xi
87513|NCT03019042|Shen Ling Bai Zhu San|shen ling bai zhu san
87514|NCT03019042|mild gastrointestinal disorders|mild gastrointestinal disorders
87515|NCT03019042|traditional Chinese medicine|traditional chinese medicine
87516|NCT03019042|randomized controlled trial|randomized controlled trial
87517|NCT03019029|Peripheral Nerve Amyloidosis|peripheral nerve amyloidosis
87518|NCT03019003|Head and Neck Cancer|head and neck cancer
87519|NCT03018964|Single incision|single incision
87520|NCT03018964|Solo surgery|solo surgery
87521|NCT03018951|frailty, assessement|frailty, assessement
87522|NCT03018938|mid mixture insulin analog|mid mixture insulin analog
87523|NCT03018938|basal insulin analog|basal insulin analog
87524|NCT03018912|Subjective Sleep Vital Sign (VS)|subjective sleep vital sign (vs)
87525|NCT03018912|Primary Care|primary care
87526|NCT03018912|Sleep Medicine|sleep medicine
87527|NCT03018912|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
87528|NCT03018912|Obstructive Sleep Apnea (OSA)|obstructive sleep apnea (osa)
87529|NCT03018912|Insomnia|insomnia
87530|NCT03018912|Complex Sleep Disorders|complex sleep disorders
87531|NCT03018912|Predictive Analytics|predictive analytics
87532|NCT03018912|Screening|screening
87533|NCT03018912|Therapy Outcomes|therapy outcomes
87534|NCT03018899|paravertebral block|paravertebral block
87535|NCT03018899|ultrasound|ultrasound
87536|NCT03018899|percutaneous nephrolithotomy|percutaneous nephrolithotomy
87537|NCT03018899|postoperative pain|postoperative pain
87538|NCT03018873|remote ischemic preconditioning|remote ischemic preconditioning
87539|NCT03018873|acute myocardial infarction|acute myocardial infarction
87540|NCT03018860|Active second stage|active second stage
87541|NCT03018860|Neonatal morbidity|neonatal morbidity
87542|NCT03018860|Operative delivery|operative delivery
87543|NCT03018860|Labor|labor
87544|NCT03018834|Acute Myocarditis|acute myocarditis
87545|NCT03018834|ANAKINRA|anakinra
87546|NCT03018808|Eosinophilia|eosinophilia
87547|NCT03018808|COPD prevalence|copd prevalence
87548|NCT03018808|Primary care subjects|primary care subjects
87549|NCT03018795|peri-implantitis|peri-implantitis
87550|NCT03018795|Surgical regenerative treatment|surgical regenerative treatment
87551|NCT03018795|ozone therapy|ozone therapy
87552|NCT03018730|Fabry disease|fabry disease
87553|NCT03018730|Enzyme-Replacement Therapy|enzyme-replacement therapy
87554|NCT03018730|pegunigalsidase alfa|pegunigalsidase alfa
87555|NCT03018730|PRX-102|prx-102
87556|NCT03018730|alpha galactosidase-A|alpha galactosidase-a
87557|NCT03018704|alcoholism|alcoholism
87558|NCT03018704|treatment|treatment
87559|NCT03018652|COPD|copd
87560|NCT03018652|Ig|ig
87561|NCT03018652|IPRAC|iprac
87562|NCT03018652|outpatient|outpatient
87563|NCT03018626|Non-germinal b-cell-like|non-germinal b-cell-like
87564|NCT03018626|R-ACVBP|r-acvbp
87565|NCT03018626|DA-EPOCH-R|da-epoch-r
87566|NCT03018613|Chronic Functional Constipation|chronic functional constipation
87567|NCT03018613|Intestinal Bacteria Flora Disturbance|intestinal bacteria flora disturbance
87568|NCT03018613|Fecal Microbiota Transplantation|fecal microbiota transplantation
87864|NCT03016598|oxytocin|oxytocin
87569|NCT03018600|prednisone, autoimmune disease|prednisone, autoimmune disease
87570|NCT03018509|JTE-451|jte-451
87571|NCT03018509|psoriasis|psoriasis
87572|NCT03018470|COPD|copd
87573|NCT03018470|Non invasive ventilation|non invasive ventilation
87574|NCT03018470|NIV|niv
87575|NCT03018470|Acute exacerbation COPD|acute exacerbation copd
87576|NCT03018470|AECOPD|aecopd
87577|NCT03018470|Telemonitoring|telemonitoring
87578|NCT03018457|Trabecular microarchitecture|trabecular microarchitecture
87579|NCT03018457|alveolar bone|alveolar bone
87580|NCT03018457|osseointegration|osseointegration
87581|NCT03018457|dental implant|dental implant
87582|NCT03018431|Lung ultrasonography|lung ultrasonography
87583|NCT03018431|Chest CT scan|chest ct scan
87584|NCT03018431|ventilator-associated pneumonia|ventilator-associated pneumonia
87585|NCT03018431|ventilator-associated tracheobronchitis|ventilator-associated tracheobronchitis
87586|NCT03018431|antibiotic stewardship|antibiotic stewardship
87587|NCT03018418|Anal Cancer|anal cancer
87588|NCT03018379|Obesity|obesity
87589|NCT03018379|Body composition|body composition
87590|NCT03018379|energy expenditure|energy expenditure
87591|NCT03018379|sedentarity|sedentarity
87592|NCT03018379|dietary behaviors|dietary behaviors
87593|NCT03018366|estrogen|estrogen
87594|NCT03018366|premenopause|premenopause
87595|NCT03018366|menopause|menopause
87596|NCT03018366|amenorrhea|amenorrhea
87597|NCT03018353|Hepatitis C, Chronic|hepatitis c, chronic
87598|NCT03018353|Jail|jail
87599|NCT03018353|Patient Navigation|patient navigation
87600|NCT03018353|Incarcerated Population|incarcerated population
87601|NCT03018353|HCV|hcv
87602|NCT03018353|Sofosbuvir/Velpatasvir|sofosbuvir/velpatasvir
87603|NCT03018353|Hepatitis C|hepatitis c
87604|NCT03018288|Malignant Gliomas|malignant gliomas
87605|NCT03018288|Immunotherapy|immunotherapy
87606|NCT03018275|Lyophilized Biotherapeutic, Microbiome, Probiotic|lyophilized biotherapeutic, microbiome, probiotic
87607|NCT03018275|Commensal Gram-negative Bacteria|commensal gram-negative bacteria
87608|NCT03018275|Staphylococcus Aureus|staphylococcus aureus
87609|NCT03018275|Transepidermal Water Loss|transepidermal water loss
87610|NCT03018275|Allergic Diseases|allergic diseases
87611|NCT03018262|Surround Inhibition|surround inhibition
87612|NCT03018262|Motor Control|motor control
87613|NCT03018262|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
87614|NCT03018262|TMS-Evoked Potential|tms-evoked potential
87615|NCT03018236|cocaine|cocaine
87616|NCT03018236|alcohol|alcohol
87617|NCT03018236|substance use disorders|substance use disorders
87618|NCT03018236|addiction|addiction
87619|NCT03018236|N-acetylcysteine|n-acetylcysteine
87620|NCT03018236|randomized controlled trial|randomized controlled trial
87621|NCT03018223|Acute leukemia in CR|acute leukemia in cr
87622|NCT03018223|Chronic myeloid leukemia|chronic myeloid leukemia
87623|NCT03018223|Non-Hodgkin lymphoma in high risk|non-hodgkin lymphoma in high risk
87624|NCT03018223|Graft vs. Host Disease|graft vs. host disease
87625|NCT03018223|GVHD|gvhd
87626|NCT03018223|Hematopoietic cell transplant (HCT)|hematopoietic cell transplant (hct)
87627|NCT03018197|Personal Health Record|personal health record
87629|NCT03018197|Anticoagulants|anticoagulants
87630|NCT03018197|Patient Engagement|patient engagement
87631|NCT03018184|MRI|mri
87632|NCT03018184|CCSA|ccsa
87633|NCT03018184|Contractile Cross Sectional Area|contractile cross sectional area
87634|NCT03018184|Strength|strength
87635|NCT03018171|clonidine, spinal injections|clonidine, spinal injections
87636|NCT03018132|perinatal mental health|perinatal mental health
87637|NCT03018106|Female sexual disorder|female sexual disorder
87638|NCT03018106|Aging|aging
87639|NCT03018106|Menopause|menopause
87640|NCT03018106|Obstetrics/Gynecology|obstetrics/gynecology
87641|NCT03018106|Female urogenital disorder|female urogenital disorder
87642|NCT03018093|Relapsed or refractory acute lymphoblastic leukemia|relapsed or refractory acute lymphoblastic leukemia
87643|NCT03018093|Anti-CD19 chimeric antigen receptor T-cell|anti-cd19 chimeric antigen receptor t-cell
87644|NCT03018054|moderate active ulcerative colitis|moderate active ulcerative colitis
87645|NCT03018054|Japanese|japanese
87646|NCT03018041|Kidney transplantation|kidney transplantation
87647|NCT03018041|Renal transplantation|renal transplantation
87648|NCT03018041|Omega-3 fatty acids|omega-3 fatty acids
87649|NCT03018041|Marine n-3 fatty acids|marine n-3 fatty acids
87650|NCT03018041|Fatty acids|fatty acids
87651|NCT03018041|Inflammation|inflammation
87652|NCT03018041|Interstitial fibrosis|interstitial fibrosis
87653|NCT03018041|Glomerular filtration rate|glomerular filtration rate
87654|NCT03018041|Renal function|renal function
87655|NCT03018041|Allograft function|allograft function
87656|NCT03018041|Proteinuria|proteinuria
87657|NCT03018041|Blood pressure|blood pressure
87658|NCT03018041|Heart rate variability|heart rate variability
87659|NCT03018041|Lipids|lipids
87660|NCT03018041|Blood glucose|blood glucose
87661|NCT03018041|Body mass index|body mass index
87662|NCT03018041|Fatty acid composition|fatty acid composition
87663|NCT03018041|Gas chromatography|gas chromatography
87664|NCT03018041|Interventional study|interventional study
88168|NCT03014908|Pediatrics|pediatrics
87665|NCT03018041|Allograft biopsy|allograft biopsy
87666|NCT03018041|Kidney biopsy|kidney biopsy
87667|NCT03018015|Bioequivalence|bioequivalence
87668|NCT03018015|Healthy|healthy
87669|NCT03018015|Bioavailability|bioavailability
87670|NCT03018015|Ibuprofen|ibuprofen
87671|NCT03018002|HIV, PMTCT|hiv, pmtct
87672|NCT03017989|Near Infrared Fluorescence Imaging|near infrared fluorescence imaging
87673|NCT03017989|Indocyanine green (ICG)|indocyanine green (icg)
87674|NCT03017963|acute coronary syndrome|acute coronary syndrome
87675|NCT03017963|sodium thiosulfate|sodium thiosulfate
87676|NCT03017963|maximum tolerable dose|maximum tolerable dose
87677|NCT03017963|dose-limiting toxicity|dose-limiting toxicity
87678|NCT03017911|PICC Line|picc line
87679|NCT03017911|Complications|complications
87680|NCT03017911|Thrombosis|thrombosis
87681|NCT03017911|Infection|infection
87682|NCT03017898|FiLaC|filac
87683|NCT03017898|Fistula Laser Closure|fistula laser closure
87684|NCT03017898|Laser Coagulation|laser coagulation
87685|NCT03017872|HIV, second-line|hiv, second-line
87686|NCT03017833|Solid Tumors|solid tumors
87687|NCT03017833|Advanced Cancer|advanced cancer
87688|NCT03017833|Metformin|metformin
87689|NCT03017833|Metformin ER|metformin er
87690|NCT03017833|TAK-228|tak-228
87691|NCT03017833|MLN0128|mln0128
87692|NCT03017833|TAK228|tak228
87693|NCT03017794|Radiotherapy|radiotherapy
87694|NCT03017794|Chromogranin A|chromogranin a
87695|NCT03017794|Neuroendocrine differentiation|neuroendocrine differentiation
87696|NCT03017781|Bipolar|bipolar
87697|NCT03017781|High-Risk Off-Spring|high-risk off-spring
87698|NCT03017781|Psychosocial Functioning|psychosocial functioning
87699|NCT03017768|Acute tryptophan depletion, esophageal sensitivity,|acute tryptophan depletion, esophageal sensitivity,
87700|NCT03017716|Inflammatory back pain|inflammatory back pain
87701|NCT03017716|gluten-free diet|gluten-free diet
87702|NCT03017716|celiac disease|celiac disease
87703|NCT03017716|non-celiac wheat sensitivity|non-celiac wheat sensitivity
87704|NCT03017703|Endothelial dysfunction|endothelial dysfunction
87705|NCT03017703|Insulin resistance|insulin resistance
87706|NCT03017703|Type 2 diabetes|type 2 diabetes
87707|NCT03017703|Mineralocorticoid blocker|mineralocorticoid blocker
87708|NCT03017625|COPD|copd
87709|NCT03017625|Cardiovascular Disease|cardiovascular disease
87710|NCT03017625|Platelets|platelets
87711|NCT03017625|Inflammation|inflammation
87712|NCT03017612|Presbyopia|presbyopia
87713|NCT03017573|Immunological biomarkers|immunological biomarkers
87714|NCT03017573|molecular profil|molecular profil
87715|NCT03017573|Circulating tumor DNA (ctDNA)|circulating tumor dna (ctdna)
87716|NCT03017560|Breast Cancer|breast cancer
87717|NCT03017560|Chemotherapy|chemotherapy
87718|NCT03017560|Verbal Memory|verbal memory
87719|NCT03017560|Processing Speed|processing speed
87720|NCT03017534|Patient-Therapist Interaction|patient-therapist interaction
87721|NCT03017534|Non-Specific Effects|non-specific effects
87722|NCT03017534|Manual Therapy|manual therapy
87723|NCT03017534|Neurodynamics|neurodynamics
87724|NCT03017534|Sham|sham
87725|NCT03017521|Refractory solid tumors|refractory solid tumors
87726|NCT03017521|AKT inhibitor|akt inhibitor
87727|NCT03017508|Cross-over study|cross-over study
87728|NCT03017508|Riluzole|riluzole
87729|NCT03017508|Double-blind study|double-blind study
87730|NCT03017508|Speech task|speech task
87731|NCT03017508|Social Anxiety Disorder|social anxiety disorder
87732|NCT03017495|food-drug interaction|food-drug interaction
87733|NCT03017495|drug-drug interaction|drug-drug interaction
87734|NCT03017495|pharmacokinetics|pharmacokinetics
87735|NCT03017469|Resilience|resilience
87736|NCT03017469|Workplace Stress|workplace stress
87737|NCT03017469|Occupational Fatigue|occupational fatigue
87738|NCT03017469|Compassion Fatigue|compassion fatigue
87739|NCT03017469|Peer Support|peer support
87740|NCT03017469|Self-Care|self-care
87741|NCT03017469|Employee Assistance|employee assistance
87742|NCT03017456|Survivorship|survivorship
87743|NCT03017456|Prostate Cancer|prostate cancer
87744|NCT03017456|Survivorship Care Plan|survivorship care plan
87745|NCT03017443|Weight Loss|weight loss
87746|NCT03017443|Obesity|obesity
87747|NCT03017443|Overweight|overweight
87748|NCT03017391|palliative care|palliative care
87749|NCT03017391|palliative medicine|palliative medicine
87750|NCT03017391|palliative|palliative
87751|NCT03017378|influenza vector|influenza vector
87752|NCT03017378|tuberculosis|tuberculosis
87753|NCT03017378|vaccine|vaccine
87754|NCT03017365|Motor Control|motor control
87755|NCT03017365|Balance|balance
87756|NCT03017352|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
87757|NCT03017352|Exenatide|exenatide
87758|NCT03017352|Incretins|incretins
87759|NCT03017352|GLP-1|glp-1
87760|NCT03017352|Insulin|insulin
87761|NCT03017339|Low Lever Laser Therapy|low lever laser therapy
87762|NCT03017339|Exercise Therapy|exercise therapy
87763|NCT03017339|Chronic Pain|chronic pain
87764|NCT03017287|Glucose blood measurements, glucometer, BGM, Diabetes App|glucose blood measurements, glucometer, bgm, diabetes app
88169|NCT03014895|E3112|e3112
87765|NCT03017274|Non-celiac wheat sensitivity|non-celiac wheat sensitivity
87766|NCT03017274|celiac disease|celiac disease
87767|NCT03017274|abdominal ultrasonography;|abdominal ultrasonography;
87768|NCT03017261|Osteoarthritis|osteoarthritis
87769|NCT03017261|Arthroplasty|arthroplasty
87770|NCT03017261|Robotic Surgery|robotic surgery
87771|NCT03017261|Knee|knee
87772|NCT03017248|pain|pain
87773|NCT03017248|ketamine|ketamine
87774|NCT03017248|morphine|morphine
87775|NCT03017248|analgesia|analgesia
87776|NCT03017248|emergency|emergency
87777|NCT03017144|non-technical skills (NTS)|non-technical skills (nts)
87778|NCT03017144|human factors|human factors
87779|NCT03017144|team work|team work
87780|NCT03017144|Crew Resource Management / Crisis Resource Management (CRM)|crew resource management / crisis resource management (crm)
87781|NCT03017144|technical skills (TS)|technical skills (ts)
87782|NCT03017144|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
87783|NCT03017144|Advanced cardiac life support|advanced cardiac life support
87784|NCT03017079|Semi-solidification|semi-solidification
87785|NCT03017079|caloric debt|caloric debt
87786|NCT03017079|enteral nutrition|enteral nutrition
87787|NCT03017079|critical illness|critical illness
87788|NCT03017066|Ultrasonography|ultrasonography
87789|NCT03017066|Child|child
87790|NCT03017066|Preoperative period|preoperative period
87791|NCT03017053|Neck dissection|neck dissection
87792|NCT03017053|Survival|survival
87793|NCT03017053|Early oral cancer|early oral cancer
87794|NCT03017053|Early oral cavity squamous cancer with node negative neck|early oral cavity squamous cancer with node negative neck
87795|NCT03017027|human-animal interaction|human-animal interaction
87796|NCT03017014|Crohn's Disease|crohn's disease
87797|NCT03017014|Adalimumab|adalimumab
87798|NCT03017014|Humira®|humira®
87799|NCT03016988|Mantle cell lymphoma|mantle cell lymphoma
87800|NCT03016988|Bortezomib|bortezomib
87801|NCT03016988|Fludarabine|fludarabine
87802|NCT03016988|Cytarabine|cytarabine
87803|NCT03016975|Edwards Cardioband|edwards cardioband
87804|NCT03016975|Mitral Valve|mitral valve
87805|NCT03016975|Transcatheter|transcatheter
87806|NCT03016975|Mitral repair|mitral repair
87807|NCT03016975|Functional mitral regurgitation|functional mitral regurgitation
87808|NCT03016975|Secondary mitral regurgitation|secondary mitral regurgitation
87809|NCT03016975|Annuloplasty|annuloplasty
87810|NCT03016936|Metabolic equivalents (METs)|metabolic equivalents (mets)
87811|NCT03016936|European Society of Anaesthesiology (ESA)|european society of anaesthesiology (esa)
87812|NCT03016936|Noncardiac surgery|noncardiac surgery
87813|NCT03016936|Cardiovascular Mortality|cardiovascular mortality
87814|NCT03016923|cerebral palsy|cerebral palsy
87815|NCT03016923|hemiplegia|hemiplegia
87816|NCT03016923|fes|fes
87817|NCT03016923|grasping|grasping
87818|NCT03016897|ALS|als
87819|NCT03016897|neurodegenerative|neurodegenerative
87820|NCT03016884|Herpes Zoster|herpes zoster
87821|NCT03016884|anti TNF alpha|anti tnf alpha
87822|NCT03016884|tofacitinib|tofacitinib
87823|NCT03016884|Rheumatoid Arthritis|rheumatoid arthritis
87824|NCT03016845|ciprofloxacin|ciprofloxacin
87825|NCT03016845|pharmacokinetics|pharmacokinetics
87826|NCT03016845|Intensive Care Unit|intensive care unit
87827|NCT03016845|Cystatin C|cystatin c
87828|NCT03016845|CKD-EPI|ckd-epi
87829|NCT03016845|renal function|renal function
87830|NCT03016780|Ulcerative Colitis|ulcerative colitis
87831|NCT03016780|Intestinal Bacteria Flora Disturbance|intestinal bacteria flora disturbance
87832|NCT03016780|Fecal Microbiota Transplantation|fecal microbiota transplantation
87833|NCT03016780|Intestinal Mucosal Immunity|intestinal mucosal immunity
87834|NCT03016767|oral feeding|oral feeding
87835|NCT03016767|oral stimulation|oral stimulation
87836|NCT03016767|physiotherapy intervention|physiotherapy intervention
87837|NCT03016754|sudden cardiac death|sudden cardiac death
87838|NCT03016754|SCD|scd
87839|NCT03016754|sudden cardiac arrest|sudden cardiac arrest
87840|NCT03016754|SCA|sca
87841|NCT03016754|heart failure|heart failure
87842|NCT03016754|HF|hf
87843|NCT03016741|cognitive function|cognitive function
87844|NCT03016741|hormonal therapy|hormonal therapy
87845|NCT03016741|cancer survivorship|cancer survivorship
87846|NCT03016741|dementia|dementia
87847|NCT03016741|cognitive dysfunction|cognitive dysfunction
87848|NCT03016741|mild cognitive impairment|mild cognitive impairment
87849|NCT03016728|exercise|exercise
87850|NCT03016728|physical activity|physical activity
87851|NCT03016728|pilot study|pilot study
87852|NCT03016728|randomized controlled trial|randomized controlled trial
87853|NCT03016728|cancer|cancer
87854|NCT03016728|adolescent and young adult|adolescent and young adult
87855|NCT03016728|AYA|aya
87856|NCT03016715|Epidermolysis bullosa simplex|epidermolysis bullosa simplex
87857|NCT03016676|Spinal Manipulation|spinal manipulation
87858|NCT03016676|Postural Instability|postural instability
87859|NCT03016676|Quality of Life|quality of life
87860|NCT03016650|Acetaminophen|acetaminophen
87861|NCT03016650|Ibuprofen|ibuprofen
87862|NCT03016637|endoscopic ultrasonography|endoscopic ultrasonography
87863|NCT03016637|EUS-FNA|eus-fna
87865|NCT03016598|substance-related disorders|substance-related disorders
87866|NCT03016598|Opioid Replacement Therapy|opioid replacement therapy
87867|NCT03016598|Psychophysiology|psychophysiology
87868|NCT03016598|Stress Biomarkers|stress biomarkers
87869|NCT03016572|Suicide|suicide
87870|NCT03016572|Adolescent|adolescent
87871|NCT03016572|Intervention|intervention
87872|NCT03016572|Crisis|crisis
87873|NCT03016572|Follow-Up|follow-up
87874|NCT03016559|releasing muscle, quadratus lumborum, hip angle|releasing muscle, quadratus lumborum, hip angle
87875|NCT03016546|Pregnancy|pregnancy
87876|NCT03016533|Dolutegravir|dolutegravir
87877|NCT03016533|Continued access study|continued access study
87878|NCT03016533|HIV-1|hiv-1
87879|NCT03016533|GSK1349572|gsk1349572
87880|NCT03016533|Pediatric|pediatric
87881|NCT03016507|intraocular pressure|intraocular pressure
87882|NCT03016507|phacoemulsification|phacoemulsification
87883|NCT03016507|cataract|cataract
87884|NCT03016468|Oral Treprostinil|oral treprostinil
87885|NCT03016468|Remodulin|remodulin
87886|NCT03016468|Selexipag|selexipag
87887|NCT03016468|6 Minute Walk Test|6 minute walk test
87888|NCT03016455|Kidney Transplant|kidney transplant
87889|NCT03016455|Immunology|immunology
87890|NCT03016442|Double balloon catheter|double balloon catheter
87891|NCT03016442|Dinoprostone|dinoprostone
87892|NCT03016442|Labor induction|labor induction
87893|NCT03016429|pacemaker|pacemaker
87894|NCT03016429|defibrillator|defibrillator
87895|NCT03016429|magnetic resonance imaging|magnetic resonance imaging
87896|NCT03016429|cardiac implantable electronic device|cardiac implantable electronic device
87897|NCT03016390|Cardiac Implantable Electronic Device|cardiac implantable electronic device
87898|NCT03016390|Pacemaker|pacemaker
87899|NCT03016390|Automatic Implantable Cardioverter-Defibrillator (AICD)|automatic implantable cardioverter-defibrillator (aicd)
87900|NCT03016390|Electromagnetic interference (EMI)|electromagnetic interference (emi)
87901|NCT03016390|Keyless access system|keyless access system
87902|NCT03016390|Keyless entry system|keyless entry system
87903|NCT03016377|CAR T cells|car t cells
87904|NCT03016377|CD19|cd19
87905|NCT03016377|Leukemia|leukemia
87906|NCT03016377|T Lymphocytes|t lymphocytes
87907|NCT03016377|AP1903|ap1903
87908|NCT03016377|Cytokine Release Syndrome|cytokine release syndrome
87909|NCT03016351|Hypertension|hypertension
87910|NCT03016351|Exercise|exercise
87911|NCT03016351|African Americans|african americans
87912|NCT03016351|Arterial Function|arterial function
87913|NCT03016351|Arterial Stiffness|arterial stiffness
87914|NCT03016286|Whole body vibration|whole body vibration
87915|NCT03016286|Bone myoregulation reflex|bone myoregulation reflex
87916|NCT03016286|H-reflex|h-reflex
87917|NCT03016260|Rheumatoid Arthritis|rheumatoid arthritis
87918|NCT03016260|Anti TNF|anti tnf
87919|NCT03016260|Infliximab|infliximab
87920|NCT03016260|Adalimumab|adalimumab
87921|NCT03016260|Etanercept|etanercept
87922|NCT03016260|Golimumab|golimumab
87923|NCT03016260|Certolizumab Pegol|certolizumab pegol
87924|NCT03016260|Infliximab biosimilar|infliximab biosimilar
87925|NCT03016260|Etanercept biosimilar|etanercept biosimilar
87926|NCT03016260|Methotrexate|methotrexate
87927|NCT03016247|magnetic resonance imaging, trust, reward|magnetic resonance imaging, trust, reward
87928|NCT03016234|intraocular pressure|intraocular pressure
87929|NCT03016234|trendelenburg position|trendelenburg position
87930|NCT03016234|pneumoperitoneum|pneumoperitoneum
87931|NCT03016221|local skin responses|local skin responses
87932|NCT03016221|hyperemia|hyperemia
87933|NCT03016221|thermal sensation|thermal sensation
87934|NCT03016221|topical warming ointments|topical warming ointments
87935|NCT03016221|topical cooling ointments|topical cooling ointments
87936|NCT03016221|skin perfusion|skin perfusion
87937|NCT03016221|subjective thermal sensation|subjective thermal sensation
87938|NCT03016221|muscle tissue oxygenation|muscle tissue oxygenation
87939|NCT03016221|skin temperature|skin temperature
87940|NCT03016221|skin redness|skin redness
87941|NCT03016221|erythema|erythema
87942|NCT03016143|phase II|phase ii
87943|NCT03016143|split|split
87944|NCT03016143|vaccine|vaccine
87945|NCT03016130|leukemia|leukemia
87946|NCT03016130|myelodysplastic|myelodysplastic
87947|NCT03016130|myeloid|myeloid
87948|NCT03016130|lymphoblastic|lymphoblastic
87949|NCT03016130|diet|diet
87950|NCT03016130|infection|infection
87951|NCT03016130|hematopoietic|hematopoietic
87952|NCT03016130|stem cell|stem cell
87953|NCT03016130|transplant|transplant
87954|NCT03016104|magnetic seizure therapy|magnetic seizure therapy
87955|NCT03016104|electroconvulsive therapy|electroconvulsive therapy
87956|NCT03016104|bipolar mania|bipolar mania
87957|NCT03016104|cognition|cognition
87958|NCT03016104|controlled trial|controlled trial
87959|NCT03016052|ABMT|abmt
87960|NCT03016052|social anxiety|social anxiety
87961|NCT03016052|generalized anxiety|generalized anxiety
87962|NCT03016026|ERAS,Laparoscopy,Distal Gastrectomy,Safety,Effectiveness|eras,laparoscopy,distal gastrectomy,safety,effectiveness
88770|NCT03011164|Kinematics|kinematics
87963|NCT03016000|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
87964|NCT03016000|Thalidomide|thalidomide
87965|NCT03016000|Maintenance|maintenance
87966|NCT03015987|Diode laser|diode laser
87967|NCT03015987|asymptomatic pulp|asymptomatic pulp
87968|NCT03015987|Laser activated irrigation|laser activated irrigation
87969|NCT03015987|continuous ultrasonic activation|continuous ultrasonic activation
87970|NCT03015987|post obturation pain|post obturation pain
87971|NCT03015935|Obesity, Morbid|obesity, morbid
87972|NCT03015883|Squamous Cell Carcinoma|squamous cell carcinoma
87973|NCT03015883|Alpha emitting radiation|alpha emitting radiation
87974|NCT03015870|vocal dysfunction|vocal dysfunction
87975|NCT03015870|voice|voice
87976|NCT03015870|vocal folds|vocal folds
87977|NCT03015870|vocal aging|vocal aging
87978|NCT03015844|MIBG|mibg
87979|NCT03015844|131I-MIBG|131i-mibg
87980|NCT03015844|relapsed|relapsed
87981|NCT03015844|neuroblastoma|neuroblastoma
87982|NCT03015844|pheochromocytoma|pheochromocytoma
87983|NCT03015831|Atrial fibrillation|atrial fibrillation
87984|NCT03015831|Cardiac surgery|cardiac surgery
87985|NCT03015831|Colchicine|colchicine
87986|NCT03015766|insomnia|insomnia
87987|NCT03015766|hemodialysis|hemodialysis
87988|NCT03015766|auricular acupressure|auricular acupressure
87989|NCT03015766|randomized controlled trial|randomized controlled trial
87990|NCT03015753|Migraine|migraine
87991|NCT03015753|Tai Chi|tai chi
87992|NCT03015753|Prophylaxis|prophylaxis
87993|NCT03015753|Randomized controlled trial|randomized controlled trial
87994|NCT03015740|Malignant neoplasms of urinary tract|malignant neoplasms of urinary tract
87995|NCT03015740|Other disorders of kidney and ureter|other disorders of kidney and ureter
87996|NCT03015740|Renal cell carcinoma|renal cell carcinoma
87997|NCT03015740|RCC|rcc
87998|NCT03015740|Metastatic|metastatic
87999|NCT03015740|MGCD516|mgcd516
88000|NCT03015740|Nivolumab|nivolumab
88001|NCT03015740|BMS-936558|bms-936558
88002|NCT03015740|Opdivo|opdivo
88003|NCT03015727|nasopharyngeal carcinoma|nasopharyngeal carcinoma
88004|NCT03015727|Induction chemotherapy|induction chemotherapy
88005|NCT03015727|radiotherapy|radiotherapy
88006|NCT03015727|chemoradiotherapy|chemoradiotherapy
88007|NCT03015701|Unresectable|unresectable
88008|NCT03015688|Biomarkers|biomarkers
88009|NCT03015662|Quality of Life|quality of life
88010|NCT03015662|Fatigue|fatigue
88011|NCT03015662|Anxiety|anxiety
88012|NCT03015662|Physical Therapy Modalities|physical therapy modalities
88013|NCT03015662|Pain|pain
88014|NCT03015649|breast cancer, surgical guidance system|breast cancer, surgical guidance system
88015|NCT03015636|Cognitive Behaviour Therapy|cognitive behaviour therapy
88016|NCT03015636|Psychological Intervention|psychological intervention
88017|NCT03015623|Mesenchymal stromal cells|mesenchymal stromal cells
88018|NCT03015623|MSC|msc
88019|NCT03015623|Stem cells|stem cells
88020|NCT03015623|Mesenchymal stem cells|mesenchymal stem cells
88021|NCT03015610|Personalized Medicine|personalized medicine
88022|NCT03015610|CYP2C19|cyp2c19
88023|NCT03015610|Lansoprazole|lansoprazole
88024|NCT03015610|Pharmacokinetics|pharmacokinetics
88025|NCT03015597|Smoking|smoking
88026|NCT03015597|Tobacco Smoking|tobacco smoking
88027|NCT03015597|Smoking, Tobacco|smoking, tobacco
88028|NCT03015597|Smoking Cessation|smoking cessation
88029|NCT03015597|Opiate Addiction|opiate addiction
88030|NCT03015597|Opiate Dependence|opiate dependence
88031|NCT03015597|Contingency Management|contingency management
88032|NCT03015571|heterotopic gastric mucosa|heterotopic gastric mucosa
88033|NCT03015571|cervical inlet patch|cervical inlet patch
88034|NCT03015571|narrow band imaging|narrow band imaging
88035|NCT03015571|endoscopy|endoscopy
88036|NCT03015558|Drug Resistance|drug resistance
88037|NCT03015558|Neuropathic Pain|neuropathic pain
88038|NCT03015558|opercular-insular cortex|opercular-insular cortex
88039|NCT03015558|Transcranial Direct Current Stimulation|transcranial direct current stimulation
88040|NCT03015545|Muscle Stiffness|muscle stiffness
88041|NCT03015545|Ultrasound elastography|ultrasound elastography
88042|NCT03015545|H-reflex|h-reflex
88043|NCT03015545|Whole body vibration|whole body vibration
88044|NCT03015532|knee|knee
88045|NCT03015532|knee replacement|knee replacement
88046|NCT03015532|arthroplasty|arthroplasty
88047|NCT03015532|joint replacement|joint replacement
88048|NCT03015532|knee pain|knee pain
88049|NCT03015519|GSK716155|gsk716155
88050|NCT03015519|Type 2 diabetes mellitus|type 2 diabetes mellitus
88051|NCT03015519|albiglutide|albiglutide
88052|NCT03015519|safety|safety
88053|NCT03015519|pediatric|pediatric
88054|NCT03015519|efficacy|efficacy
88055|NCT03015493|Neck pain|neck pain
88056|NCT03015493|Neurodynamics|neurodynamics
88057|NCT03015493|Spinal manipulative therapy|spinal manipulative therapy
88058|NCT03015480|Mobile Application|mobile application
88059|NCT03015480|Chronic Kidney Disease|chronic kidney disease
88060|NCT03015480|Diabetes Mellitus|diabetes mellitus
88061|NCT03015480|Albuminuria|albuminuria
88062|NCT03015480|Diet|diet
88063|NCT03015467|acute pancreatitis|acute pancreatitis
88064|NCT03015467|intestinal mucosal barrier|intestinal mucosal barrier
88065|NCT03015467|Fecal Microbiota Transplantation|fecal microbiota transplantation
88066|NCT03015454|InSight|insight
88067|NCT03015454|Dascena|dascena
88068|NCT03015441|Healthy subjects|healthy subjects
88069|NCT03015441|Probiotics|probiotics
88070|NCT03015441|Breath test|breath test
88071|NCT03015441|Dihydrogen|dihydrogen
88072|NCT03015441|Methane|methane
88073|NCT03015441|Intestinal gas production|intestinal gas production
88074|NCT03015441|Gut microbiota|gut microbiota
88075|NCT03015428|Family caregivers|family caregivers
88076|NCT03015428|training programme|training programme
88077|NCT03015428|dementia|dementia
88078|NCT03015415|elbow|elbow
88079|NCT03015415|posttraumatic stiffness|posttraumatic stiffness
88080|NCT03015415|elbow contractures|elbow contractures
88081|NCT03015415|stiff elbow|stiff elbow
88082|NCT03015415|dynamic orthoses|dynamic orthoses
88083|NCT03015415|Dynamic splint|dynamic splint
88084|NCT03015415|Rehabilitation|rehabilitation
88085|NCT03015415|Splint|splint
88086|NCT03015415|Effectiveness of bracing|effectiveness of bracing
88087|NCT03015376|epithelial ovarian cancer|epithelial ovarian cancer
88088|NCT03015376|Hereditary Breast and Ovarian Cancer Syndrome|hereditary breast and ovarian cancer syndrome
88089|NCT03015376|next-generation sequencing|next-generation sequencing
88090|NCT03015376|High-Throughput Nucleotide Sequencing|high-throughput nucleotide sequencing
88091|NCT03015363|Hypertension|hypertension
88092|NCT03015363|Telemonitoring|telemonitoring
88093|NCT03015363|Vital signs|vital signs
88094|NCT03015350|blood sevoflurane concentration|blood sevoflurane concentration
88095|NCT03015350|blood desflurane concentration|blood desflurane concentration
88096|NCT03015350|one lung ventilation|one lung ventilation
88097|NCT03015311|Blood pressure control|blood pressure control
88098|NCT03015298|gastric cancer|gastric cancer
88099|NCT03015298|Simultaneous PET/MRI|simultaneous pet/mri
88100|NCT03015298|PET/CT|pet/ct
88101|NCT03015272|minimally-verbal|minimally-verbal
88102|NCT03015272|children|children
88103|NCT03015272|intervention|intervention
88104|NCT03015272|singing|singing
88105|NCT03015272|music|music
88106|NCT03015233|Lactate|lactate
88107|NCT03015233|Acute Abdominal Pain|acute abdominal pain
88108|NCT03015233|Acute Abdomen|acute abdomen
88109|NCT03015233|Strong Ion Gap|strong ion gap
88110|NCT03015233|Renal Colic|renal colic
88111|NCT03015233|Emergency Department|emergency department
88112|NCT03015233|Emergency|emergency
88113|NCT03015233|Surgery|surgery
88114|NCT03015233|Stewart|stewart
88115|NCT03015194|LVOT (left ventricular outflow tract, obstruction)|lvot (left ventricular outflow tract, obstruction)
88116|NCT03015194|Transcatheter Mitral Valve Implantation|transcatheter mitral valve implantation
88117|NCT03015194|Transcatheter Heart Valve|transcatheter heart valve
88118|NCT03015194|Mitral Valve Regurgitation|mitral valve regurgitation
88119|NCT03015194|Mitral Valve Stenosis|mitral valve stenosis
88120|NCT03015181|Broadly Neutralizing|broadly neutralizing
88121|NCT03015181|HIV Prevention|hiv prevention
88122|NCT03015181|Anti-Drug Antibody|anti-drug antibody
88123|NCT03015181|HIV-1|hiv-1
88124|NCT03015181|Immune Response|immune response
88125|NCT03015129|Durvalumab|durvalumab
88126|NCT03015129|MEDI4736|medi4736
88127|NCT03015129|Tremelimumab|tremelimumab
88128|NCT03015129|anti-PD-L1 Antibody|anti-pd-l1 antibody
88129|NCT03015129|anti-CTLA-4 antibody|anti-ctla-4 antibody
88130|NCT03015129|16-1491|16-1491
88131|NCT03015116|photobiomodulation|photobiomodulation
88132|NCT03015116|plantar fasciitis|plantar fasciitis
88133|NCT03015090|COPD|copd
88134|NCT03015090|CYP1A2|cyp1a2
88135|NCT03015090|Theophylline|theophylline
88136|NCT03015077|Glutamine|glutamine
88137|NCT03015051|Bronchiolitis|bronchiolitis
88138|NCT03015051|High flow nasal cannula|high flow nasal cannula
88139|NCT03015051|Oxygen therapy|oxygen therapy
88140|NCT03015025|Acenocoumarol|acenocoumarol
88141|NCT03015025|Cytochrome P450|cytochrome p450
88142|NCT03015025|Pharmacogenetics|pharmacogenetics
88143|NCT03015025|Algorithm|algorithm
88144|NCT03015025|CYP2C9|cyp2c9
88145|NCT03015025|VKORC1|vkorc1
88146|NCT03015025|CYP4F2|cyp4f2
88147|NCT03015025|P450 oxidoreductase (POR)|p450 oxidoreductase (por)
88148|NCT03015012|Nutrigenomics|nutrigenomics
88149|NCT03015012|Genetics|genetics
88150|NCT03015012|Overweight|overweight
88151|NCT03015012|Obesity|obesity
88152|NCT03015012|Transplantation|transplantation
88153|NCT03015012|Nutrition|nutrition
88154|NCT03015012|Dietetics|dietetics
88156|NCT03015012|Body Composition|body composition
88157|NCT03014999|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
88158|NCT03014999|Spinal Cord Injury|spinal cord injury
88159|NCT03014999|Humans|humans
88160|NCT03014986|HCV|hcv
88161|NCT03014947|MSB11022|msb11022
88162|NCT03014947|Humira®|humira®
88163|NCT03014934|Aspergillosis|aspergillosis
88164|NCT03014934|IA|ia
88165|NCT03014908|Type 1 diabetes|type 1 diabetes
88166|NCT03014908|1H-NMR spectroscopy|1h-nmr spectroscopy
88167|NCT03014908|Metabolomics|metabolomics
88170|NCT03014895|Pharmacokinetics|pharmacokinetics
88171|NCT03014895|Japanese|japanese
88172|NCT03014869|COPD Exacerbation|copd exacerbation
88173|NCT03014869|High Flow Oxygen|high flow oxygen
88174|NCT03014869|Noninvasive Positive Ventilation|noninvasive positive ventilation
88175|NCT03014869|moderate|moderate
88176|NCT03014856|Metabolic syndrome|metabolic syndrome
88177|NCT03014856|Metabolomics|metabolomics
88178|NCT03014856|NMR spectroscopy|nmr spectroscopy
88179|NCT03014843|Esophagal sensitivity, GERD, endogenous opiods|esophagal sensitivity, gerd, endogenous opiods
88180|NCT03014791|Epidemiology|epidemiology
88181|NCT03014791|Ethnicity|ethnicity
88182|NCT03014791|Age|age
88183|NCT03014791|Weight|weight
88184|NCT03014791|Hypertensive|hypertensive
88185|NCT03014791|Cardiac Output|cardiac output
88186|NCT03014791|Peripheral Vascular Resistance|peripheral vascular resistance
88187|NCT03014791|Arterial Stiffness|arterial stiffness
88188|NCT03014791|Healthy Volunteers|healthy volunteers
88189|NCT03014791|Endothelial function|endothelial function
88190|NCT03014791|Arterial Structure|arterial structure
88191|NCT03014791|Left ventricular mass/function|left ventricular mass/function
88192|NCT03014765|endothelial dysfunction|endothelial dysfunction
88193|NCT03014765|perioperative stress|perioperative stress
88194|NCT03014765|cardiovascular complications|cardiovascular complications
88195|NCT03014765|inflammatory markers|inflammatory markers
88196|NCT03014739|Elastography|elastography
88197|NCT03014739|Musculoskeletal System|musculoskeletal system
88198|NCT03014726|reduced urine flow rate|reduced urine flow rate
88199|NCT03014726|low peak flow rate|low peak flow rate
88200|NCT03014726|urinary tract infections|urinary tract infections
88201|NCT03014713|Dexmedetomidine|dexmedetomidine
88202|NCT03014713|Dezocine|dezocine
88203|NCT03014713|Flubiprofen|flubiprofen
88204|NCT03014713|Analgesia|analgesia
88205|NCT03014713|Colorectal Surgery|colorectal surgery
88206|NCT03014687|transsphenoidal surgery|transsphenoidal surgery
88207|NCT03014674|SB-240563|sb-240563
88208|NCT03014674|subcutaneous|subcutaneous
88209|NCT03014674|lyophilized drug product|lyophilized drug product
88210|NCT03014674|Mepolizumab|mepolizumab
88211|NCT03014674|liquid drug product|liquid drug product
88212|NCT03014674|safety syringe|safety syringe
88213|NCT03014674|auto injector|auto injector
88214|NCT03014661|pollinosis, quality of life, specific immunotherapy|pollinosis, quality of life, specific immunotherapy
88215|NCT03014635|glabellar lines, frown lines|glabellar lines, frown lines
88216|NCT03014622|glabellar lines, frown lines|glabellar lines, frown lines
88217|NCT03014609|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
88218|NCT03014609|cardiovascular risk|cardiovascular risk
88219|NCT03014609|inflammation|inflammation
88220|NCT03014609|oxidative stress|oxidative stress
88221|NCT03014609|peripheral muscle function|peripheral muscle function
88222|NCT03014570|behavior,|behavior,
88223|NCT03014570|apathy|apathy
88224|NCT03014570|mood|mood
88225|NCT03014570|function|function
88226|NCT03014570|cognition|cognition
88227|NCT03014557|atrial fibrillation|atrial fibrillation
88228|NCT03014557|left atrial appendage closure|left atrial appendage closure
88229|NCT03014557|WATCHMAN|watchman
88230|NCT03014518|Adolescent|adolescent
88231|NCT03014518|Biological Markers|biological markers
88232|NCT03014518|Biomarkers|biomarkers
88233|NCT03014518|Biomarkers for suicidality|biomarkers for suicidality
88234|NCT03014518|Blood brain barrier|blood brain barrier
88235|NCT03014518|Clinical predictors|clinical predictors
88236|NCT03014518|Cytokine|cytokine
88237|NCT03014518|Feeling suicidal|feeling suicidal
88238|NCT03014518|Inflammation|inflammation
88239|NCT03014518|Inflammatory marker|inflammatory marker
88240|NCT03014518|Inpatient discharge|inpatient discharge
88241|NCT03014518|Interleukin-1 beta|interleukin-1 beta
88242|NCT03014518|IL-1ß|il-1ß
88243|NCT03014518|Interleukin-6|interleukin-6
88244|NCT03014518|IL-6|il-6
88245|NCT03014518|Kynurenic acid|kynurenic acid
88246|NCT03014518|Kynurenine pathway|kynurenine pathway
88247|NCT03014518|Neuroinflammation|neuroinflammation
88248|NCT03014518|Novel marker|novel marker
88249|NCT03014518|Peripheral blood biomarkers|peripheral blood biomarkers
88250|NCT03014518|Picolinic acid|picolinic acid
88251|NCT03014518|Plasma biomarker|plasma biomarker
88252|NCT03014518|Psychiatric inpatient|psychiatric inpatient
88253|NCT03014518|S100B|s100b
88254|NCT03014518|Serum biomarker|serum biomarker
88255|NCT03014518|Stress|stress
88256|NCT03014518|Suicide|suicide
88257|NCT03014518|Suicidal behavior|suicidal behavior
88258|NCT03014518|Suicidal risk|suicidal risk
88259|NCT03014518|Tumor necrosis factor alpha|tumor necrosis factor alpha
88260|NCT03014518|TNF-α|tnf-α
88261|NCT03014505|Cirrhosis|cirrhosis
88262|NCT03014505|Fecal Microbiota Transplantation|fecal microbiota transplantation
88263|NCT03014505|Intestinal flora|intestinal flora
88264|NCT03014505|Intestinal mucosal barrier|intestinal mucosal barrier
88265|NCT03014505|Intestinal Bacteria Flora Disturbance|intestinal bacteria flora disturbance
88266|NCT03014401|stem cell|stem cell
88267|NCT03014401|knee pain|knee pain
88268|NCT03014401|osteoarthritis|osteoarthritis
88269|NCT03014401|arthritis|arthritis
88270|NCT03014401|ADSC|adsc
88271|NCT03014401|fat stem cell|fat stem cell
88272|NCT03014349|Glaucoma|glaucoma
88273|NCT03014349|Ocular hypertension|ocular hypertension
88274|NCT03014336|co2 removal, anesthesia|co2 removal, anesthesia
88275|NCT03014323|insulin sensitivity|insulin sensitivity
88276|NCT03014323|African American|african american
88277|NCT03014323|obese|obese
88278|NCT03014310|A/H5N8|a/h5n8
88279|NCT03014310|Adjuvants|adjuvants
88280|NCT03014310|AS03|as03
88281|NCT03014310|Inactivated|inactivated
88282|NCT03014310|Influenza|influenza
88283|NCT03014310|MF59|mf59
88284|NCT03014310|Monovalent|monovalent
88285|NCT03014284|Tissue collection|tissue collection
88286|NCT03014284|colonoscopic surgical procedures|colonoscopic surgical procedures
88287|NCT03014258|Biology|biology
88288|NCT03014258|falciparum|falciparum
88289|NCT03014258|Immunity|immunity
88290|NCT03014258|Infections|infections
88291|NCT03014258|Malaria|malaria
88292|NCT03014258|Pf|pf
88293|NCT03014258|Plasmodium|plasmodium
88294|NCT03014258|Systems|systems
88295|NCT03014232|sustained low-efficiency diafiltration (SLED-f)|sustained low-efficiency diafiltration (sled-f)
88296|NCT03014232|high cut-off dialyzer|high cut-off dialyzer
88297|NCT03014232|cytokines|cytokines
88298|NCT03014180|Heart failure, CRT|heart failure, crt
88299|NCT03014167|transmission interruption|transmission interruption
88300|NCT03014167|intestinal nematodes|intestinal nematodes
88301|NCT03014167|soil-transmitted helminths|soil-transmitted helminths
88302|NCT03014167|mass drug administration|mass drug administration
88303|NCT03014167|Benin|benin
88304|NCT03014167|India|india
88305|NCT03014167|Malawi|malawi
88306|NCT03014154|video games|video games
88307|NCT03014154|asthma|asthma
88308|NCT03014154|physical exercise|physical exercise
88309|NCT03014128|musculoskeletal disorders|musculoskeletal disorders
88310|NCT03014128|upper extremity|upper extremity
88311|NCT03014128|work|work
88312|NCT03014128|surgical instruments|surgical instruments
88313|NCT03014115|arachidonic|arachidonic
88314|NCT03014115|docosahexaenoic acid|docosahexaenoic acid
88315|NCT03014115|infant formula|infant formula
88316|NCT03014089|mRNA-1325|mrna-1325
88317|NCT03014089|Zika vaccine|zika vaccine
88318|NCT03014063|sepsis|sepsis
88319|NCT03014063|septic shock|septic shock
88320|NCT03014063|vasopressin|vasopressin
88321|NCT03014063|AVP|avp
88322|NCT03014050|physical activity|physical activity
88323|NCT03014050|fitness|fitness
88324|NCT03014050|cognition|cognition
88325|NCT03014050|mood|mood
88326|NCT03014050|depression|depression
88327|NCT03014050|anxiety|anxiety
88328|NCT03014050|sleep quality|sleep quality
88329|NCT03014050|tremor|tremor
88330|NCT03014050|gait|gait
88331|NCT03014037|Orthopedics|orthopedics
88332|NCT03014024|Distal Radius Fracture|distal radius fracture
88333|NCT03014024|Low Level Laser Therapy|low level laser therapy
88334|NCT03013985|Blood glucose|blood glucose
88335|NCT03013972|ColoRectal Cancer|colorectal cancer
88336|NCT03013972|Adjuvant Chemotherapy|adjuvant chemotherapy
88337|NCT03013972|Cancer-related Fatigue|cancer-related fatigue
88338|NCT03013972|Brief fatigue inventory (BFI)|brief fatigue inventory (bfi)
88339|NCT03013972|Functional Assessment of Cancer Therapy-General 7 (FACT-G7)|functional assessment of cancer therapy-general 7 (fact-g7)
88340|NCT03013920|upper urinary tract cancer|upper urinary tract cancer
88341|NCT03013920|confocal laser endomicroscopy|confocal laser endomicroscopy
88342|NCT03013920|urothelial carcinoma|urothelial carcinoma
88343|NCT03013907|Hypertension|hypertension
88344|NCT03013907|Coping|coping
88345|NCT03013907|Relaxing|relaxing
88346|NCT03013894|bladder neoplasm|bladder neoplasm
88347|NCT03013894|urothelium carcinoma|urothelium carcinoma
88348|NCT03013894|confocal laser endomicroscopy|confocal laser endomicroscopy
88349|NCT03013881|UB-921|ub-921
88350|NCT03013881|anti-HER2 monoclonal antibody|anti-her2 monoclonal antibody
88351|NCT03013881|breast neoplasm|breast neoplasm
88352|NCT03013881|breast cancer|breast cancer
88353|NCT03013881|Herceptin|herceptin
88354|NCT03013881|Trastuzumab|trastuzumab
88355|NCT03013881|HER2|her2
88356|NCT03013855|Digital rectal exam|digital rectal exam
88357|NCT03013855|Colon cancer screening|colon cancer screening
88358|NCT03013842|pregnancy|pregnancy
88359|NCT03013842|fetal monitoring|fetal monitoring
88360|NCT03013842|fetal oximetry|fetal oximetry
88361|NCT03013842|fetal heart rate|fetal heart rate
88362|NCT03013842|pulse oximetry|pulse oximetry
88363|NCT03013842|near infrared spectroscopy|near infrared spectroscopy
88364|NCT03013829|Kidney Paired Donation|kidney paired donation
88365|NCT03013777|Familial dysautonomia|familial dysautonomia
88366|NCT03013699|diet|diet
88367|NCT03013699|nutrition|nutrition
88368|NCT03013699|survival|survival
88369|NCT03013699|recurrence|recurrence
88370|NCT03013699|cruciferous|cruciferous
88371|NCT03013699|dark leafy greens|dark leafy greens
88771|NCT03011151|pediatric|pediatric
88372|NCT03013673|leishmaniasis, visceral, neglected, HIV, co-infection, asymptomatic, Ethiopia|leishmaniasis, visceral, neglected, hiv, co-infection, asymptomatic, ethiopia
88373|NCT03013647|actinic keratosis|actinic keratosis
88374|NCT03013647|field cancerization|field cancerization
88375|NCT03013647|photodynamic therapy|photodynamic therapy
88376|NCT03013647|daylight photodynamic therapy|daylight photodynamic therapy
88377|NCT03013634|dexmedetomidine|dexmedetomidine
88378|NCT03013621|Renal Failure|renal failure
88379|NCT03013621|Renal Insufficiency|renal insufficiency
88380|NCT03013621|Acute Renal Failure|acute renal failure
88381|NCT03013621|Acute Renal Injury|acute renal injury
88382|NCT03013621|Kidney Failure|kidney failure
88383|NCT03013621|Kidney Insufficiency|kidney insufficiency
88384|NCT03013621|Acute Kidney Failure|acute kidney failure
88385|NCT03013621|Acute Kidney Injury|acute kidney injury
88386|NCT03013621|Ventricular dysfunction|ventricular dysfunction
88387|NCT03013621|Venous congestion|venous congestion
88388|NCT03013621|Renal function|renal function
88389|NCT03013621|Kidney function|kidney function
88390|NCT03013621|Venous heart failure|venous heart failure
88391|NCT03013608|Nail bed injury|nail bed injury
88392|NCT03013608|Nail bed injuries|nail bed injuries
88393|NCT03013608|Nail|nail
88394|NCT03013608|Children|children
88395|NCT03013608|Fingertip injury|fingertip injury
88396|NCT03013595|Mental health|mental health
88397|NCT03013595|Youth mental health|youth mental health
88398|NCT03013595|Adolescent|adolescent
88399|NCT03013595|Health services|health services
88400|NCT03013595|Transition|transition
88401|NCT03013595|Longitudinal cohort study|longitudinal cohort study
88402|NCT03013595|Cluster randomised controlled trial|cluster randomised controlled trial
88403|NCT03013595|Young adult|young adult
88404|NCT03013556|HBeAg positive|hbeag positive
88405|NCT03013543|POMC deficiency obesity|pomc deficiency obesity
88406|NCT03013543|LepR deficiency obesity|lepr deficiency obesity
88407|NCT03013543|Bardet-Biedl syndrome|bardet-biedl syndrome
88408|NCT03013543|Alström Syndrome|alström syndrome
88409|NCT03013530|Intensive care unit|intensive care unit
88410|NCT03013530|Triage and Therapy.|triage and therapy.
88411|NCT03013530|Advance Directives (AD).|advance directives (ad).
88412|NCT03013530|Simulation model of real situations. (hypothetical scenario)|simulation model of real situations. (hypothetical scenario)
88413|NCT03013530|Intensivist physician.|intensivist physician.
88414|NCT03013517|Allergy|allergy
88415|NCT03013517|food allergy|food allergy
88416|NCT03013517|viaskin|viaskin
88417|NCT03013517|peanut|peanut
88418|NCT03013517|epicutaneous|epicutaneous
88419|NCT03013504|randomized|randomized
88420|NCT03013504|double-blind|double-blind
88421|NCT03013504|parallel group|parallel group
88422|NCT03013504|equivalence|equivalence
88423|NCT03013504|multicentre|multicentre
88424|NCT03013504|phase III|phase iii
88425|NCT03013504|efficacy|efficacy
88426|NCT03013504|safety|safety
88427|NCT03013504|pharmacokinetics|pharmacokinetics
88428|NCT03013504|HD201|hd201
88429|NCT03013504|docetaxel|docetaxel
88430|NCT03013504|Herceptin|herceptin
88431|NCT03013504|HER2 positive|her2 positive
88432|NCT03013504|breast cancer|breast cancer
88433|NCT03013504|early breast cancer|early breast cancer
88434|NCT03013491|cancer|cancer
88435|NCT03013491|checkpoint inhibitor|checkpoint inhibitor
88436|NCT03013491|monotherapy|monotherapy
88437|NCT03013491|combination|combination
88438|NCT03013491|PD-L1|pd-l1
88439|NCT03013491|CTLA-4|ctla-4
88440|NCT03013491|solid tumor|solid tumor
88441|NCT03013491|lymphoma|lymphoma
88442|NCT03013491|BRAF|braf
88443|NCT03013491|PROCLAIM|proclaim
88444|NCT03013491|CX-072|cx-072
88445|NCT03013491|PROCLAIM-CX-072|proclaim-cx-072
88446|NCT03013374|protein accretion|protein accretion
88447|NCT03013374|body composition|body composition
88448|NCT03013361|ropivacaine, bupivacaine|ropivacaine, bupivacaine
88449|NCT03013335|Clear-cell|clear-cell
88450|NCT03013335|Nivolumab|nivolumab
88451|NCT03013335|Renal cell carcinoma|renal cell carcinoma
88452|NCT03013335|Immunotherapy|immunotherapy
88453|NCT03013309|Hybrid|hybrid
88454|NCT03013309|Implementation|implementation
88455|NCT03013309|Effectiveness|effectiveness
88456|NCT03013309|Parent training|parent training
88457|NCT03013309|Fidelity|fidelity
88458|NCT03013309|Cost-Effectiveness|cost-effectiveness
88459|NCT03013309|Primary Care|primary care
88460|NCT03013296|GIP|gip
88461|NCT03013296|GIP receptor antagonist|gip receptor antagonist
88462|NCT03013270|Rehabilitation|rehabilitation
88463|NCT03013270|Exercise|exercise
88464|NCT03013270|Training|training
88465|NCT03013257|Relapsed Graves' disease|relapsed graves' disease
88466|NCT03013257|High Intensity Focused Ultrasound|high intensity focused ultrasound
88467|NCT03013257|RAI|rai
88468|NCT03013244|prevention|prevention
88469|NCT03013244|eating disorder|eating disorder
88470|NCT03013244|men|men
88471|NCT03013244|intervention|intervention
88472|NCT03013244|muscle dysmorphia|muscle dysmorphia
88473|NCT03013244|peer-led|peer-led
88474|NCT03013231|ACL Reconstruction|acl reconstruction
88475|NCT03013231|Return to Sport|return to sport
88476|NCT03013231|Resilience|resilience
88477|NCT03013218|Neoplasms|neoplasms
88478|NCT03013218|CD47|cd47
88479|NCT03013218|SIRPα|sirpα
88480|NCT03013218|ALX148|alx148
88481|NCT03013205|adhesive capsulitis|adhesive capsulitis
88482|NCT03013153|Rectal Cancer|rectal cancer
88483|NCT03013153|Inferior Mesenteric Artery|inferior mesenteric artery
88484|NCT03013153|Ligation|ligation
88485|NCT03013153|Apical Lymph Nodes|apical lymph nodes
88486|NCT03013153|Laparoscopy|laparoscopy
88487|NCT03013153|IMA Types|ima types
88488|NCT03013140|Anesthesia, Obstetric|anesthesia, obstetric
88489|NCT03013140|fluid therapy|fluid therapy
88490|NCT03013140|cesarean section|cesarean section
88491|NCT03013140|spinal anesthesia|spinal anesthesia
88492|NCT03013127|Osteogenic Sarcoma|osteogenic sarcoma
88493|NCT03013127|Osteosarcoma|osteosarcoma
88494|NCT03013127|Sarcoma, Osteogenic|sarcoma, osteogenic
88495|NCT03013127|Pembrolizumab|pembrolizumab
88496|NCT03013127|Immunotherapy|immunotherapy
88497|NCT03013114|Bortezomib Immune thrombocytopenia|bortezomib immune thrombocytopenia
88498|NCT03013101|anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
88499|NCT03013101|advanced|advanced
88500|NCT03013101|metastatic|metastatic
88501|NCT03013101|melanoma|melanoma
88502|NCT03013088|Chronic|chronic
88503|NCT03013088|Occlusion|occlusion
88504|NCT03013088|CTO|cto
88505|NCT03013023|Behavioral and Transaction Interventions|behavioral and transaction interventions
88506|NCT03013023|Parents' Biopsychosocial Well-being|parents' biopsychosocial well-being
88507|NCT03013023|Preterm Infants|preterm infants
88508|NCT03013023|Sleep|sleep
88509|NCT03013023|Salivary cortisol|salivary cortisol
88510|NCT03013010|Randomized|randomized
88511|NCT03013010|Open Label|open label
88512|NCT03013010|Multicenter|multicenter
88513|NCT03012984|elderly|elderly
88514|NCT03012984|surgery|surgery
88515|NCT03012984|analgesia|analgesia
88516|NCT03012984|dexmedetomidine|dexmedetomidine
88517|NCT03012984|delirium|delirium
88518|NCT03012971|Elderly|elderly
88519|NCT03012971|Surgery|surgery
88520|NCT03012971|Analgesia|analgesia
88521|NCT03012971|Dexmedetomidine|dexmedetomidine
88522|NCT03012971|Long-term outcome|long-term outcome
88523|NCT03012945|Elderly|elderly
88524|NCT03012945|Cancer surgery|cancer surgery
88525|NCT03012945|Epidural anesthesia and analgesia|epidural anesthesia and analgesia
88526|NCT03012945|Long-term survival|long-term survival
88527|NCT03012945|Quality of life|quality of life
88528|NCT03012919|active decision support system|active decision support system
88529|NCT03012919|goal directed therapy|goal directed therapy
88530|NCT03012919|Lidco|lidco
88531|NCT03012919|vascular surgery|vascular surgery
88532|NCT03012919|hemodynamic optimization|hemodynamic optimization
88533|NCT03012893|ultrasonography to identify C7 spinous process|ultrasonography to identify c7 spinous process
88534|NCT03012867|criticall illness|criticall illness
88535|NCT03012867|enteral nutrition|enteral nutrition
88536|NCT03012854|Esophageal achalasia|esophageal achalasia
88537|NCT03012854|Peroral endoscopic myotomy|peroral endoscopic myotomy
88538|NCT03012854|POEM|poem
88539|NCT03012815|gabapentin|gabapentin
88540|NCT03012815|Alcohol Withdrawal Syndrome|alcohol withdrawal syndrome
88541|NCT03012815|benzodiazepine|benzodiazepine
88542|NCT03012815|symptom-triggered|symptom-triggered
88543|NCT03012724|TMS|tms
88544|NCT03012724|Deep Transcranial Magnetic Stimulation|deep transcranial magnetic stimulation
88545|NCT03012724|MDD|mdd
88546|NCT03012724|Major Depressive Disorder|major depressive disorder
88547|NCT03012659|contraceptive counseling|contraceptive counseling
88548|NCT03012659|cluster randomized trial|cluster randomized trial
88549|NCT03012659|provider counseling training|provider counseling training
88550|NCT03012646|Treprostinil|treprostinil
88551|NCT03012646|PH|ph
88552|NCT03012646|COPD|copd
88553|NCT03012646|6 Minute Walk Test|6 minute walk test
88554|NCT03012633|hyperfibrinolysis, Lysis Timer|hyperfibrinolysis, lysis timer
88555|NCT03012607|PrEP|prep
88556|NCT03012594|Small bowel motility disorder|small bowel motility disorder
88557|NCT03012594|Slow intestinal motility|slow intestinal motility
88558|NCT03012594|Small bowel bacterial overgrowth|small bowel bacterial overgrowth
88559|NCT03012555|Sickle Cell Disease|sickle cell disease
88560|NCT03012555|Vitamin D|vitamin d
88561|NCT03012529|Rifampin|rifampin
88562|NCT03012529|Double-blind|double-blind
88563|NCT03012529|Clinical Trial|clinical trial
88564|NCT03012529|Veterans|veterans
88565|NCT03012529|Diabetes|diabetes
88566|NCT03012516|Physical Therapy Specialty|physical therapy specialty
88567|NCT03012516|Exercise Test|exercise test
88568|NCT03012516|Prescriptions|prescriptions
88569|NCT03012516|Counseling|counseling
88570|NCT03012516|Primary Health Care|primary health care
88571|NCT03012516|Exercise|exercise
88572|NCT03012490|Remote monitoring|remote monitoring
88573|NCT03012477|Triple-negative metastatic breast cancer|triple-negative metastatic breast cancer
88574|NCT03012451|Stress|stress
88575|NCT03012451|Insecurity|insecurity
89161|NCT03008785|exercise|exercise
88576|NCT03012451|Mental Health|mental health
88577|NCT03012438|Near infrared fluorescence|near infrared fluorescence
88578|NCT03012438|ICG|icg
88579|NCT03012438|Parathyroid gland|parathyroid gland
88580|NCT03012425|Cognitive Behavioral Therapy|cognitive behavioral therapy
88581|NCT03012425|Acupuncture|acupuncture
88582|NCT03012425|17-001|17-001
88583|NCT03012399|Malignant Neoplasm of Breast|malignant neoplasm of breast
88584|NCT03012399|Breast Cancer|breast cancer
88585|NCT03012399|Hypnosedation|hypnosedation
88586|NCT03012399|Hypnotherapist|hypnotherapist
88587|NCT03012399|Questionnaires|questionnaires
88588|NCT03012399|Surveys|surveys
88589|NCT03012386|CD36|cd36
88590|NCT03012386|Endothelial dysfunction|endothelial dysfunction
88591|NCT03012386|African Americans|african americans
88592|NCT03012373|methadone|methadone
88593|NCT03012373|heroin|heroin
88594|NCT03012373|acupuncture|acupuncture
88595|NCT03012360|Infectiology|infectiology
88596|NCT03012360|Biology of infectious agents|biology of infectious agents
88597|NCT03012360|Hygiene|hygiene
88598|NCT03012360|Pneumology|pneumology
88599|NCT03012360|Critical Care|critical care
88600|NCT03012308|Myocardial Dysfunction|myocardial dysfunction
88601|NCT03012308|left ventricular|left ventricular
88602|NCT03012308|mitral valve doppler|mitral valve doppler
88603|NCT03012308|mitral ring doppler|mitral ring doppler
88604|NCT03012308|ultrasound signs|ultrasound signs
88605|NCT03012308|lung edema|lung edema
88606|NCT03012295|Genetic Testing|genetic testing
88607|NCT03012295|Chinese Population|chinese population
88608|NCT03012256|Cardio-Respiratory Disease Management|cardio-respiratory disease management
88609|NCT03012256|Chronic Disease Management|chronic disease management
88610|NCT03012256|Cluster-randomized Trial|cluster-randomized trial
88611|NCT03012256|Multi-component Intervention|multi-component intervention
88612|NCT03012256|DIVERT Scale|divert scale
88613|NCT03012256|Frail Elderly|frail elderly
88614|NCT03012256|Interprofessional Care|interprofessional care
88615|NCT03012256|Pragmatic Trial|pragmatic trial
88616|NCT03012256|Targeted Intervention|targeted intervention
88617|NCT03012256|Home Care|home care
88618|NCT03012204|Cerebrovascular Disease|cerebrovascular disease
88619|NCT03012204|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
88620|NCT03012178|Mitral Regurgitation|mitral regurgitation
88621|NCT03012178|Mitral valve Surgery|mitral valve surgery
88622|NCT03012178|MRI|mri
88623|NCT03012165|ADX-102|adx-102
88624|NCT03012165|Allergic Conjunctivitis|allergic conjunctivitis
88625|NCT03012152|Oncoplastic surgery|oncoplastic surgery
88626|NCT03012152|Standard conservative surgery|standard conservative surgery
88627|NCT03012152|Patient satisfaction|patient satisfaction
88628|NCT03012152|Margin Status|margin status
88629|NCT03012113|Adipose tissue|adipose tissue
88630|NCT03012113|Type 2 Diabetes|type 2 diabetes
88631|NCT03012061|Respiratory|respiratory
88632|NCT03012061|Efficacy|efficacy
88633|NCT03012061|Umeclidinium bromide|umeclidinium bromide
88634|NCT03012061|Parallel|parallel
88635|NCT03012061|Asthma|asthma
88636|NCT03012061|Dry powder inhaler|dry powder inhaler
88637|NCT03012048|water treatment|water treatment
88638|NCT03012035|psychotherapy|psychotherapy
88639|NCT03012035|exposition|exposition
88640|NCT03012035|spider fear|spider fear
88641|NCT03012035|expectation|expectation
88642|NCT03012022|Healthy Volunteers|healthy volunteers
88643|NCT03012022|Congestive Heart Failure|congestive heart failure
88644|NCT03012022|Cardiomyopathies|cardiomyopathies
88645|NCT03012022|Heart Failure|heart failure
88646|NCT03012022|Risk Factors|risk factors
88647|NCT03012009|Bowen's Disease|bowen's disease
88648|NCT03012009|Superficial Basal Cel Carcinoma|superficial basal cel carcinoma
88649|NCT03012009|Non melanoma skin cancer|non melanoma skin cancer
88650|NCT03012009|Photodynamic therapy|photodynamic therapy
88651|NCT03012009|PDT|pdt
88652|NCT03012009|CO2 laser|co2 laser
88653|NCT03012009|Laser assisted drug delivery|laser assisted drug delivery
88654|NCT03012009|Carbon dioxide laser|carbon dioxide laser
88655|NCT03012009|Laser assisted photodynamic therapy|laser assisted photodynamic therapy
88656|NCT03011983|Magnetoencephalography (MEG)|magnetoencephalography (meg)
88657|NCT03011983|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
88658|NCT03011892|Atopic dermatitis|atopic dermatitis
88659|NCT03011892|eczema|eczema
88660|NCT03011892|pruritus|pruritus
88661|NCT03011892|Janus kinase (JAK) inhibitors|janus kinase (jak) inhibitors
88662|NCT03011840|Patient education handout|patient education handout
88663|NCT03011840|Patient satisfaction|patient satisfaction
88664|NCT03011775|Pioglitazone, Insulin Resistance|pioglitazone, insulin resistance
88665|NCT03011775|Atherosclerosis, Coronary Heart Disease|atherosclerosis, coronary heart disease
88666|NCT03011749|Radium-223 therapy|radium-223 therapy
88667|NCT03011710|e-cigarette|e-cigarette
88668|NCT03011710|blood flow|blood flow
88669|NCT03011710|oral effects|oral effects
88670|NCT03011710|oral pH|oral ph
88671|NCT03011684|Fertility Preservation|fertility preservation
88672|NCT03011684|Breast Cancer|breast cancer
89162|NCT03008759|Fluoride|fluoride
88673|NCT03011671|Malignant Glioma of Brain|malignant glioma of brain
88674|NCT03011671|Acetazolamide|acetazolamide
88675|NCT03011671|Temozolomide|temozolomide
88676|NCT03011619|Depression|depression
88677|NCT03011619|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
88678|NCT03011606|prostate|prostate
88679|NCT03011606|ablation|ablation
88680|NCT03011606|focal|focal
88681|NCT03011606|cancer|cancer
88682|NCT03011580|Vitamin D|vitamin d
88683|NCT03011567|Postpartum|postpartum
88684|NCT03011541|Stem Cells|stem cells
88685|NCT03011541|Bone Marrow Derived Stem Cells|bone marrow derived stem cells
88686|NCT03011541|BMSC|bmsc
88687|NCT03011541|Mesenchymal Stem Cells|mesenchymal stem cells
88688|NCT03011541|MSC|msc
88689|NCT03011541|Eye Disease|eye disease
88690|NCT03011541|Ophthalmology|ophthalmology
88691|NCT03011541|Ophthalmic Disease|ophthalmic disease
88692|NCT03011541|Retina|retina
88693|NCT03011541|Retinal Disease|retinal disease
88694|NCT03011541|Macular Degeneration|macular degeneration
88695|NCT03011541|Age Related Macular Degeneration|age related macular degeneration
88696|NCT03011541|Myopic Macular Degeneration|myopic macular degeneration
88697|NCT03011541|Geographic Atrophy|geographic atrophy
88698|NCT03011541|Dry Macular Degeneration|dry macular degeneration
88699|NCT03011541|Wet Macular Degeneration|wet macular degeneration
88700|NCT03011541|Retinal Atrophy|retinal atrophy
88701|NCT03011541|Retinal Dystrophy|retinal dystrophy
88702|NCT03011541|Hereditary Retinal Dystrophy|hereditary retinal dystrophy
88703|NCT03011541|Malattia Leventinese|malattia leventinese
88704|NCT03011541|Retinitis Pigmentosa|retinitis pigmentosa
88705|NCT03011541|Stargardt Disease|stargardt disease
88706|NCT03011541|Cone Dystrophy|cone dystrophy
88707|NCT03011541|Rod-Cone Dystrophy|rod-cone dystrophy
88708|NCT03011541|Cone-Rod Dystrophy|cone-rod dystrophy
88709|NCT03011541|Maculopathy|maculopathy
88710|NCT03011541|Optic Nerve Disease|optic nerve disease
88711|NCT03011541|Optic Atrophy|optic atrophy
88712|NCT03011541|Optic Neuropathy|optic neuropathy
88713|NCT03011541|Ischemic Optic Neuropathy|ischemic optic neuropathy
88714|NCT03011541|Optic Nerve Damage|optic nerve damage
88715|NCT03011541|Optic Nerve Compression|optic nerve compression
88716|NCT03011541|Compressive Optic Neuropathy|compressive optic neuropathy
88717|NCT03011541|Devics Syndrome|devics syndrome
88718|NCT03011541|Ushers Syndrome|ushers syndrome
88719|NCT03011541|Neuromyelitis Optica|neuromyelitis optica
88720|NCT03011541|Dominant Optic Atrophy|dominant optic atrophy
88721|NCT03011541|Kjers Optic Atrophy|kjers optic atrophy
88722|NCT03011541|Leber Hereditary Optic Neuropathy|leber hereditary optic neuropathy
88723|NCT03011541|Blindness|blindness
88724|NCT03011541|Vision Loss|vision loss
88725|NCT03011541|Retina Atrophy|retina atrophy
88726|NCT03011437|linked color imaging|linked color imaging
88727|NCT03011437|Helicobacter Pylori|helicobacter pylori
88728|NCT03011424|Liver resection|liver resection
88729|NCT03011424|post hepatectomy liver failure|post hepatectomy liver failure
88730|NCT03011424|liver dialysis|liver dialysis
88731|NCT03011424|encephalopathy|encephalopathy
88732|NCT03011424|mortality|mortality
88733|NCT03011411|methods, qualitative research|methods, qualitative research
88734|NCT03011372|Myeloid neoplasm|myeloid neoplasm
88735|NCT03011372|fibroblast growth factor receptor inhibitor|fibroblast growth factor receptor inhibitor
88736|NCT03011372|FGFR1 rearrangement|fgfr1 rearrangement
88737|NCT03011372|8p11|8p11
88738|NCT03011372|eosinophilia|eosinophilia
88739|NCT03011372|eosinophilic syndrome|eosinophilic syndrome
88740|NCT03011372|Lymphoid neoplasm|lymphoid neoplasm
88741|NCT03011359|Colon resection|colon resection
88742|NCT03011359|Patient Controlled Analgesia|patient controlled analgesia
88743|NCT03011359|Optimizing Basal Infusion Mode|optimizing basal infusion mode
88744|NCT03011346|Aortic valve stenosis|aortic valve stenosis
88745|NCT03011346|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
88746|NCT03011346|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
88747|NCT03011346|Randomized controlled trial|randomized controlled trial
88748|NCT03011320|ovarian cancer|ovarian cancer
88749|NCT03011320|specimen collection|specimen collection
88750|NCT03011268|Tumor Necrosis Factor-alpha/antagonists & inhibitors|tumor necrosis factor-alpha/antagonists & inhibitors
88751|NCT03011268|Infliximab|infliximab
88752|NCT03011268|Adalimumab|adalimumab
88753|NCT03011268|Golimumab|golimumab
88754|NCT03011268|Recurrence|recurrence
88755|NCT03011255|Esophageal cancer|esophageal cancer
88756|NCT03011255|Peptide specific CTL|peptide specific ctl
88757|NCT03011255|Radiation|radiation
88758|NCT03011242|Psoriatic Arthritis|psoriatic arthritis
88759|NCT03011242|PDUS|pdus
88760|NCT03011203|glycogen storage disease type IIIa|glycogen storage disease type iiia
88761|NCT03011203|exercise|exercise
88762|NCT03011203|ketone esters|ketone esters
88763|NCT03011203|magnetic resonance spectroscopy|magnetic resonance spectroscopy
88764|NCT03011190|Terapia Iconica|terapia iconica
88765|NCT03011190|BPD|bpd
88766|NCT03011190|adolescence|adolescence
88767|NCT03011190|suicide|suicide
88768|NCT03011164|Running|running
88769|NCT03011164|Gait velocity|gait velocity
88772|NCT03011151|critical illness|critical illness
88773|NCT03011151|surgery|surgery
88774|NCT03011151|gastrointestinal dysfunction|gastrointestinal dysfunction
88775|NCT03011151|gastric emptying|gastric emptying
88776|NCT03011151|epithelial barrier|epithelial barrier
88777|NCT03011151|nutrition|nutrition
88778|NCT03011138|knee|knee
88779|NCT03011138|gait velocity|gait velocity
88780|NCT03011138|kinematic parameters|kinematic parameters
88781|NCT03011112|Osteoarthritis, Knee|osteoarthritis, knee
88782|NCT03011112|WOMAC|womac
88783|NCT03011112|gait|gait
88784|NCT03011112|kinematics|kinematics
88785|NCT03011086|Autoantibodies, Oral Submucous Fibrosis|autoantibodies, oral submucous fibrosis
88786|NCT03011060|neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
88787|NCT03011060|pathological complete response|pathological complete response
88788|NCT03011060|Neoadjuvant Therapy|neoadjuvant therapy
88789|NCT03011060|Capecitabine|capecitabine
88790|NCT03011060|Chemotherapy, Adjuvant|chemotherapy, adjuvant
88791|NCT03011047|endoscopic, trans-antral, subciliary|endoscopic, trans-antral, subciliary
88792|NCT03011021|Autoimmune Diabetes|autoimmune diabetes
88793|NCT03011021|Umbilical Cord Blood Regulatory T Lymphocyte|umbilical cord blood regulatory t lymphocyte
88794|NCT03011021|Liraglutide|liraglutide
88795|NCT03010995|electronic cigarette|electronic cigarette
88796|NCT03010995|endothelial function|endothelial function
88797|NCT03010969|Endothelial dysfunction|endothelial dysfunction
88798|NCT03010969|Surgery|surgery
88799|NCT03010969|Pulmonary function|pulmonary function
88800|NCT03010969|Blood glucose level|blood glucose level
88801|NCT03010969|Patient-related outcomes|patient-related outcomes
88802|NCT03010956|Arterial stiffness|arterial stiffness
88803|NCT03010956|Endothelial glycocalyx|endothelial glycocalyx
88804|NCT03010956|Coronary flow reserve|coronary flow reserve
88805|NCT03010943|virtual reality|virtual reality
88806|NCT03010943|glioma surgery|glioma surgery
88807|NCT03010943|awake craniotomy|awake craniotomy
88808|NCT03010943|brain tumor|brain tumor
88809|NCT03010943|glioma|glioma
88810|NCT03010943|neurosurgery|neurosurgery
88811|NCT03010917|Alcohol Dependence|alcohol dependence
88812|NCT03010917|Fish Oil|fish oil
88813|NCT03010891|Preterm infant|preterm infant
88814|NCT03010891|Stress|stress
88815|NCT03010891|Salivary DHEA|salivary dhea
88816|NCT03010891|Salivary cortisol|salivary cortisol
88817|NCT03010891|Actigraphy|actigraphy
88818|NCT03010878|yoga|yoga
88819|NCT03010878|chronic pain|chronic pain
88820|NCT03010878|occupational therapy|occupational therapy
88821|NCT03010878|self-management|self-management
88822|NCT03010865|HDAC inhibitors|hdac inhibitors
88823|NCT03010865|Inflammation|inflammation
88824|NCT03010852|Bariatric Surgery|bariatric surgery
88825|NCT03010852|Spirometry Monitoring|spirometry monitoring
88826|NCT03010761|addiction|addiction
88827|NCT03010761|betel-quid|betel-quid
88828|NCT03010761|drug therapy|drug therapy
88829|NCT03010761|clinical trial|clinical trial
88830|NCT03010748|corneal morphology|corneal morphology
88831|NCT03010748|Chinese population|chinese population
88832|NCT03010748|corneal curvature|corneal curvature
88833|NCT03010748|corneal thickness|corneal thickness
88834|NCT03010748|higher order aberrations|higher order aberrations
88835|NCT03010735|Kidney Failure, Chronic|kidney failure, chronic
88836|NCT03010735|Probiotics|probiotics
88837|NCT03010735|Uremic toxins|uremic toxins
88838|NCT03010735|Gastrointestinal Microbiome|gastrointestinal microbiome
88839|NCT03010709|Aneurysmal Subarachnoid Haemorrhage|aneurysmal subarachnoid haemorrhage
88840|NCT03010709|Delayed Ischaemic Neurological Deficit|delayed ischaemic neurological deficit
88841|NCT03010709|Induced Hypertension|induced hypertension
88842|NCT03010709|Partial Brain Tissue Oxygen Tension|partial brain tissue oxygen tension
88843|NCT03010709|Cerebral Microdialysis|cerebral microdialysis
88844|NCT03010696|Kidney Failure, Chronic|kidney failure, chronic
88845|NCT03010696|Uremic toxins|uremic toxins
88846|NCT03010696|Gastrointestinal Microbiome|gastrointestinal microbiome
88847|NCT03010696|Metabolomics|metabolomics
88848|NCT03010683|Arterial stiffness|arterial stiffness
88849|NCT03010683|Endothelial glycocalyx|endothelial glycocalyx
88850|NCT03010683|Coronary flow reserve|coronary flow reserve
88851|NCT03010670|Oxytocin|oxytocin
88852|NCT03010670|Gaze processing|gaze processing
88853|NCT03010670|Interpersonal motor resonance|interpersonal motor resonance
88854|NCT03010618|hall technique|hall technique
88855|NCT03010618|stainless steel crowns|stainless steel crowns
88856|NCT03010618|temporomandibular joint|temporomandibular joint
88857|NCT03010618|dental caries|dental caries
88858|NCT03010618|occlusion|occlusion
88859|NCT03010605|physical therapy post total knee replacement|physical therapy post total knee replacement
88860|NCT03010605|range of motion|range of motion
88861|NCT03010605|goniometry|goniometry
88862|NCT03010592|Lung volume reduction treatment|lung volume reduction treatment
88863|NCT03010592|Endobronchial cryotherapy|endobronchial cryotherapy
88864|NCT03010592|Microvesicles|microvesicles
88865|NCT03010579|Anemia|anemia
88866|NCT03010579|Lymphoma|lymphoma
88867|NCT03010579|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
88868|NCT03010579|Erythropoietin|erythropoietin
88869|NCT03010566|Lung volume reduction coil|lung volume reduction coil
88870|NCT03010566|Lung Microbiome|lung microbiome
88871|NCT03010527|Chronic plaque psoriasis|chronic plaque psoriasis
88872|NCT03010527|Psoriasis|psoriasis
88873|NCT03010527|Bimekizumab|bimekizumab
88874|NCT03010488|Chronotherapy|chronotherapy
88875|NCT03010488|Light Therapy|light therapy
88876|NCT03010462|Stroke|stroke
88877|NCT03010462|rTMS|rtms
88878|NCT03010462|Motor rehabilitation|motor rehabilitation
88879|NCT03010449|Lung volume reduction treatment|lung volume reduction treatment
88880|NCT03010449|Autologous blood instillation|autologous blood instillation
88881|NCT03010449|Intra-bronchial valve (IBV)|intra-bronchial valve (ibv)
88882|NCT03010449|Endobronchial valve|endobronchial valve
88883|NCT03010423|Non-obstructive coronary artery disease|non-obstructive coronary artery disease
88884|NCT03010423|Nicorandil|nicorandil
88885|NCT03010371|positive psychotherapy, online, breast cancer, survivors|positive psychotherapy, online, breast cancer, survivors
88886|NCT03010332|Cytomegalovirus|cytomegalovirus
88887|NCT03010332|Cytomegalovirus Viremia|cytomegalovirus viremia
88888|NCT03010332|Cytomegalovirus Infection|cytomegalovirus infection
88889|NCT03010332|CMV Infection|cmv infection
88890|NCT03010332|Hematopoietic Cell Transplant|hematopoietic cell transplant
88891|NCT03010332|Solid Organ Transplant|solid organ transplant
88892|NCT03010332|Human Immunodeficiency Virus|human immunodeficiency virus
88893|NCT03010332|Cytomegalovirus Disease|cytomegalovirus disease
88894|NCT03010332|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
88896|NCT03010332|CMV syndrome|cmv syndrome
88897|NCT03010332|Cytomegalovirus syndrome|cytomegalovirus syndrome
88898|NCT03010332|CMV disease|cmv disease
88899|NCT03010332|CMV viremia|cmv viremia
88900|NCT03010332|allogeneic|allogeneic
88901|NCT03010332|third-party|third-party
88902|NCT03010293|Antimicrobial therapy|antimicrobial therapy
88903|NCT03010293|Debridement|debridement
88904|NCT03010293|Osteomyelitis|osteomyelitis
88905|NCT03010293|Muscular flap|muscular flap
88906|NCT03010293|Pressure ulcer|pressure ulcer
88907|NCT03010293|Treatment failure|treatment failure
88908|NCT03010293|Vacuum-assisted closure therapy|vacuum-assisted closure therapy
88909|NCT03010267|DP-R213|dp-r213
88910|NCT03010241|Diabetes Distal Symmetric Polyneuropathy|diabetes distal symmetric polyneuropathy
88911|NCT03010241|Chinese medicine|chinese medicine
88912|NCT03010228|VLA15|vla15
88913|NCT03010228|Lyme Borreliosis|lyme borreliosis
88914|NCT03010228|Multivalent Recombinant OspA Vaccine|multivalent recombinant ospa vaccine
88915|NCT03010215|Minimally Invasive Surgery|minimally invasive surgery
88916|NCT03010215|Percutaneous distal osteotomy|percutaneous distal osteotomy
88917|NCT03010215|Distal Metatarsal Minimally-invasive Osteotomy (DMMO)|distal metatarsal minimally-invasive osteotomy (dmmo)
88918|NCT03010215|Percutaneous Tenotomy|percutaneous tenotomy
88919|NCT03010215|Forefoot|forefoot
88920|NCT03010215|Metatarsal bones|metatarsal bones
88921|NCT03010202|immune thrombocytopenia|immune thrombocytopenia
88922|NCT03010202|rituximab|rituximab
88923|NCT03010202|thrombocytopenia|thrombocytopenia
88924|NCT03010189|Cluster headache|cluster headache
88925|NCT03010189|Actigraphy|actigraphy
88926|NCT03010189|Pupillometry|pupillometry
88927|NCT03010163|pedometer|pedometer
88928|NCT03010163|walking|walking
88929|NCT03010163|taxi driver|taxi driver
88930|NCT03010163|16-1659|16-1659
88931|NCT03010150|Malignant neoplasms of lip oral cavity and pharynx|malignant neoplasms of lip oral cavity and pharynx
88932|NCT03010150|Head and Neck Cancer|head and neck cancer
88933|NCT03010150|Nasopharyngeal cancer|nasopharyngeal cancer
88934|NCT03010150|Oropharyngeal cancer|oropharyngeal cancer
88935|NCT03010150|Hypopharyngeal cancer|hypopharyngeal cancer
88936|NCT03010150|Laryngeal cancer|laryngeal cancer
88937|NCT03010150|Unknown primary cancer with cervical metastases|unknown primary cancer with cervical metastases
88938|NCT03010150|Questionnaire|questionnaire
88939|NCT03010150|Survey|survey
88940|NCT03010150|Blood draw|blood draw
88941|NCT03010150|Cytokines|cytokines
88942|NCT03010111|Latent Tuberculosis|latent tuberculosis
88943|NCT03010111|Interferons|interferons
88944|NCT03010111|Tuberculosis|tuberculosis
88945|NCT03010111|Healthcare|healthcare
88946|NCT03010098|POCD|pocd
88947|NCT03010098|narcotrend|narcotrend
88948|NCT03010098|closed-loop of target controlled infusion|closed-loop of target controlled infusion
88949|NCT03010033|pulmonary rehabilitation|pulmonary rehabilitation
88950|NCT03010033|lobectomy|lobectomy
88951|NCT03010033|smoker|smoker
88952|NCT03010020|HIV Prevention|hiv prevention
88953|NCT03010020|MSM|msm
88954|NCT03010020|Rectal Gonorrhea|rectal gonorrhea
88955|NCT03010020|Rectal Chlamydia|rectal chlamydia
88956|NCT03010020|Personalized Cognitive Counseling|personalized cognitive counseling
88957|NCT03010007|Influenza|influenza
88958|NCT03010007|High-Throughput Nucleotide Sequencing|high-throughput nucleotide sequencing
88959|NCT03010007|Viral Transmission|viral transmission
88960|NCT03009981|PSA|psa
88961|NCT03009981|Degarelix|degarelix
88962|NCT03009981|Apalutamide|apalutamide
88963|NCT03009981|Abiraterone Acetate|abiraterone acetate
88964|NCT03009981|Radical Prostatectomy|radical prostatectomy
88965|NCT03009942|nitric oxide|nitric oxide
88966|NCT03009942|arginase|arginase
88967|NCT03009942|loading|loading
88968|NCT03009890|elderly|elderly
88969|NCT03009890|intra articular|intra articular
88970|NCT03009890|RCT|rct
88971|NCT03009864|Diabetic Kidney Disease|diabetic kidney disease
88972|NCT03009864|TCM|tcm
88973|NCT03009864|RCT|rct
88974|NCT03009825|Trauma exposure|trauma exposure
88975|NCT03009825|Psychological distress|psychological distress
88976|NCT03009825|Emotion regulation|emotion regulation
88977|NCT03009825|Mindfulness|mindfulness
88978|NCT03009825|Eating pathology|eating pathology
88979|NCT03009799|adenoviral conjunctivis|adenoviral conjunctivis
88980|NCT03009799|iota-carrageenan|iota-carrageenan
88981|NCT03009773|subacute stroke|subacute stroke
88982|NCT03009773|multitasking rehabilitation|multitasking rehabilitation
88983|NCT03009773|walking|walking
88984|NCT03009747|rectal cancer|rectal cancer
88985|NCT03009747|anterior resection syndrome|anterior resection syndrome
88986|NCT03009747|sphincter-preserving surgery|sphincter-preserving surgery
88987|NCT03009708|Allograft|allograft
88988|NCT03009708|Cytomegalovirus|cytomegalovirus
88989|NCT03009708|Platelets|platelets
88990|NCT03009708|Hematopoietic stem cells|hematopoietic stem cells
88991|NCT03009708|Graft Versus Host Disease (GVH)|graft versus host disease (gvh)
88992|NCT03009708|Hemostasis|hemostasis
88993|NCT03009708|Adaptive immunity|adaptive immunity
88994|NCT03009708|Innate immunity|innate immunity
88995|NCT03009708|Post graft follow up|post graft follow up
88996|NCT03009695|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
88997|NCT03009695|Obesity|obesity
88998|NCT03009695|Food Craving|food craving
88999|NCT03009695|Appetite/Satiety Hormones|appetite/satiety hormones
89000|NCT03009695|fMRI|fmri
89001|NCT03009695|Intestinal microbiota|intestinal microbiota
89002|NCT03009695|Physical activity|physical activity
89003|NCT03009669|pleth variability index|pleth variability index
89004|NCT03009669|stroke volume variation|stroke volume variation
89005|NCT03009669|perfusion Index|perfusion index
89006|NCT03009669|intraoperative|intraoperative
89007|NCT03009669|intestinal tumor|intestinal tumor
89008|NCT03009656|Stroke|stroke
89009|NCT03009656|Emergency|emergency
89010|NCT03009656|Focal Neurological Deficits|focal neurological deficits
89011|NCT03009656|Diagnostic|diagnostic
89012|NCT03009643|Nitric Oxide|nitric oxide
89013|NCT03009643|hypoxemia|hypoxemia
89014|NCT03009643|aortic surgery|aortic surgery
89015|NCT03009630|Electromagnetic navigation bronchoscopy(ENB)|electromagnetic navigation bronchoscopy(enb)
89016|NCT03009630|Radiofrequency ablation(RFA)|radiofrequency ablation(rfa)
89017|NCT03009630|Peripheral lung cancer|peripheral lung cancer
89018|NCT03009617|adolescents|adolescents
89019|NCT03009617|web-based health education|web-based health education
89020|NCT03009617|eHealth literacy|ehealth literacy
89021|NCT03009591|Hemophilia|hemophilia
89022|NCT03009591|Elbow|elbow
89023|NCT03009591|Arthropathy|arthropathy
89024|NCT03009591|Joint pain|joint pain
89025|NCT03009591|Range of motion|range of motion
89026|NCT03009591|Myofascial techniques|myofascial techniques
89027|NCT03009591|Safety patients|safety patients
89028|NCT03009591|Quality of life|quality of life
89029|NCT03009591|Functionality|functionality
89030|NCT03009565|coronary artery disease|coronary artery disease
89031|NCT03009565|human gut microbiota|human gut microbiota
89032|NCT03009565|microbiome|microbiome
89033|NCT03009552|speckle tracking echocardiography|speckle tracking echocardiography
89034|NCT03009552|strain|strain
89035|NCT03009552|strain rate|strain rate
89036|NCT03009552|torsion|torsion
89037|NCT03009539|Prevention with Hispanic youth|prevention with hispanic youth
89038|NCT03009539|eHealth preventive intervention in primary care|ehealth preventive intervention in primary care
89039|NCT03009539|Hispanic adolescent|hispanic adolescent
89040|NCT03009539|Familias Unidas|familias unidas
89041|NCT03009539|eHealth Familias Unidas|ehealth familias unidas
89042|NCT03009539|effectiveness trial|effectiveness trial
89043|NCT03009539|sexually transmitted disease|sexually transmitted disease
89044|NCT03009539|parent-centered|parent-centered
89045|NCT03009539|Hispanic|hispanic
89046|NCT03009539|sexual risk behavior|sexual risk behavior
89047|NCT03009526|Malaria|malaria
89048|NCT03009526|Pregnancy|pregnancy
89049|NCT03009526|Malawi|malawi
89050|NCT03009526|Intermittent preventive treatment|intermittent preventive treatment
89051|NCT03009526|dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
89052|NCT03009526|sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
89053|NCT03009461|Hepatocellular carcinoma|hepatocellular carcinoma
89054|NCT03009461|Portal vein tumor thrombosis|portal vein tumor thrombosis
89055|NCT03009461|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
89056|NCT03009461|Sorafenib|sorafenib
89057|NCT03009396|Crohn's Disease,|crohn's disease,
89058|NCT03009396|moderate to severe|moderate to severe
89059|NCT03009396|remission|remission
89060|NCT03009396|Mycobacterium avium paratuberculosis|mycobacterium avium paratuberculosis
89061|NCT03009396|antibiotic|antibiotic
89062|NCT03009370|Ovarian reserve, pregnancy loss|ovarian reserve, pregnancy loss
89063|NCT03009357|wearable activity tracker|wearable activity tracker
89064|NCT03009357|thyrotoxicosis|thyrotoxicosis
89065|NCT03009344|relapsed or refractory B-cell non-Hodgkin's lymphoma|relapsed or refractory b-cell non-hodgkin's lymphoma
89066|NCT03009344|tazemetostat|tazemetostat
89067|NCT03009344|Japan|japan
89068|NCT03009331|Postoperative pulmonary dysfunction|postoperative pulmonary dysfunction
89069|NCT03009331|Postoperative pulmonary complication|postoperative pulmonary complication
89070|NCT03009331|Recruitment manouver|recruitment manouver
89071|NCT03009331|Prone position|prone position
89072|NCT03009318|Glioma|glioma
89073|NCT03009318|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
89074|NCT03009318|Methionine|methionine
89075|NCT03009318|PET/CT|pet/ct
89076|NCT03009292|solid tumor|solid tumor
89077|NCT03009292|Lenvatinib|lenvatinib
89078|NCT03009292|pharmacokinetics|pharmacokinetics
89079|NCT03009279|blood pressure|blood pressure
89080|NCT03009279|fasting plasma glucose|fasting plasma glucose
89081|NCT03009279|thyroid stimulating hormone|thyroid stimulating hormone
89082|NCT03009253|Neoadjuvant therapy|neoadjuvant therapy
89083|NCT03009253|Pancreatic Cancer|pancreatic cancer
89084|NCT03009227|colon cancer|colon cancer
89085|NCT03009227|lymph node dissection|lymph node dissection
89086|NCT03009227|D3 lymph node dissection|d3 lymph node dissection
89087|NCT03009214|solid epithelial cancer|solid epithelial cancer
89088|NCT03009214|CD44v6|cd44v6
89089|NCT03009214|c-Met|c-met
89090|NCT03009214|VEGFR-2|vegfr-2
89091|NCT03009214|RON|ron
89092|NCT03009214|receptor tyrosine kinase|receptor tyrosine kinase
89093|NCT03009188|Axenfeld-Rieger syndrom, genetic findings|axenfeld-rieger syndrom, genetic findings
89094|NCT03009136|Perennial Allergic Rhinitis|perennial allergic rhinitis
89095|NCT03009136|Herbal Medicine|herbal medicine
89096|NCT03009136|Korean Medicine|korean medicine
89097|NCT03009136|So-Cheong-Ryong-Tang|so-cheong-ryong-tang
89098|NCT03009123|cohort study|cohort study
89099|NCT03009123|prostate cancer|prostate cancer
89100|NCT03009123|population-based study|population-based study
89101|NCT03009123|benign prostatic hypertrophy|benign prostatic hypertrophy
89102|NCT03009097|Chronic periodontitis|chronic periodontitis
89103|NCT03009097|atorvastatin|atorvastatin
89104|NCT03009097|intrabony defect|intrabony defect
89105|NCT03009071|Neck Pain|neck pain
89106|NCT03009071|Disability Evaluation|disability evaluation
89107|NCT03009071|Costs and Cost Analysis|costs and cost analysis
89108|NCT03009071|Doin Exercise Therapy|doin exercise therapy
89109|NCT03009071|Acupuncture|acupuncture
89110|NCT03009058|Unresectable cancer|unresectable cancer
89111|NCT03009058|pancreatic|pancreatic
89112|NCT03009058|melanoma|melanoma
89113|NCT03009058|breast|breast
89114|NCT03009058|lung|lung
89115|NCT03009058|colorectal|colorectal
89116|NCT03009058|cholangio|cholangio
89117|NCT03009058|sarcoma|sarcoma
89118|NCT03009045|bone and joint infection|bone and joint infection
89119|NCT03009045|osteomyelitis|osteomyelitis
89120|NCT03009045|tedizolid|tedizolid
89121|NCT03009032|HIV|hiv
89122|NCT03009032|immunologic recovery|immunologic recovery
89123|NCT03009032|microbiota|microbiota
89124|NCT03009032|prebiotics|prebiotics
89125|NCT03009032|probiotics|probiotics
89126|NCT03009032|synbiotics|synbiotics
89127|NCT03009006|Calcium hydroxide intracanal medication|calcium hydroxide intracanal medication
89128|NCT03009006|Ca(OH)2 intracanal medication|ca(oh)2 intracanal medication
89129|NCT03009006|Chlorhexidene gel|chlorhexidene gel
89130|NCT03009006|CHX gel|chx gel
89131|NCT03009006|Root canal treatment|root canal treatment
89132|NCT03008967|Total Knee Arthroplasty|total knee arthroplasty
89133|NCT03008967|Total Hip Arthroplasty|total hip arthroplasty
89134|NCT03008967|Rehabilitation|rehabilitation
89135|NCT03008954|weight loss|weight loss
89136|NCT03008954|body composition|body composition
89137|NCT03008954|glycemic control|glycemic control
89138|NCT03008954|satiety|satiety
89139|NCT03008941|HIV|hiv
89140|NCT03008941|microbiota|microbiota
89141|NCT03008941|inflammation|inflammation
89142|NCT03008941|fecal microbiota restoration|fecal microbiota restoration
89143|NCT03008915|alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
89144|NCT03008915|Emphysema|emphysema
89145|NCT03008915|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
89146|NCT03008889|Repetitive Self-Injurious Behavior|repetitive self-injurious behavior
89147|NCT03008889|N-acetylcysteine (NAC)|n-acetylcysteine (nac)
89148|NCT03008876|neonate|neonate
89149|NCT03008876|acetaminophen|acetaminophen
89150|NCT03008850|Shivering|shivering
89151|NCT03008850|Intrathecal|intrathecal
89152|NCT03008850|Magnesium Sulfate|magnesium sulfate
89153|NCT03008811|Atrial Fibrillation|atrial fibrillation
89154|NCT03008811|Catheter Ablation|catheter ablation
89155|NCT03008798|Intracranial Artery|intracranial artery
89156|NCT03008798|in-stent restenosis|in-stent restenosis
89157|NCT03008798|Herbal Medicine|herbal medicine
89158|NCT03008785|isoflavone|isoflavone
89159|NCT03008785|blood pressure|blood pressure
89160|NCT03008785|climateric symptoms|climateric symptoms
89163|NCT03008759|Dental caries|dental caries
89164|NCT03008759|Dentifrice|dentifrice
89165|NCT03008720|functional electrical simulation|functional electrical simulation
89166|NCT03008707|Laparoscopic peritoneal lavage|laparoscopic peritoneal lavage
89167|NCT03008707|laparoscopic sigmoidectomy|laparoscopic sigmoidectomy
89168|NCT03008707|complicated acute diverticulitis|complicated acute diverticulitis
89169|NCT03008707|D004238|d004238
89170|NCT03008694|PET/CT|pet/ct
89171|NCT03008642|Polycythemia|polycythemia
89172|NCT03008642|CO-Rebreathing|co-rebreathing
89173|NCT03008642|red cell mass determination|red cell mass determination
89174|NCT03008642|myeloproliferative neoplasms|myeloproliferative neoplasms
89175|NCT03008603|CT-guided minimally invasive procedures|ct-guided minimally invasive procedures
89176|NCT03008603|Robot|robot
89177|NCT03008590|Pain management|pain management
89178|NCT03008590|Naltrexone|naltrexone
89179|NCT03008590|Controlled clinical trials, randomized|controlled clinical trials, randomized
89180|NCT03008512|Liver Neoplasms|liver neoplasms
89181|NCT03008512|Antineoplastic Agents|antineoplastic agents
89182|NCT03008512|Carcinoma, Hepatocellular|carcinoma, hepatocellular
89183|NCT03008512|Genexol-PM|genexol-pm
89184|NCT03008512|Neoplasms by Site|neoplasms by site
89185|NCT03008512|Sorafenib|sorafenib
89186|NCT03008512|Liver Diseases|liver diseases
89187|NCT03008512|Digestive System Neoplasms|digestive system neoplasms
89188|NCT03008499|Metastatic colorectal cancer|metastatic colorectal cancer
89189|NCT03008499|High-activity natural killer|high-activity natural killer
89190|NCT03008447|E2006|e2006
89191|NCT03008447|postural stability|postural stability
89192|NCT03008447|auditory awakening threshold|auditory awakening threshold
89193|NCT03008447|cognitive performance|cognitive performance
89194|NCT03008447|healthy participants|healthy participants
89195|NCT03008434|yoga|yoga
89196|NCT03008434|Traumatic Brain Injury|traumatic brain injury
89197|NCT03008408|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
89198|NCT03008408|Endometrial carcinoma|endometrial carcinoma
89199|NCT03008408|Advanced or Recurrent|advanced or recurrent
89200|NCT03008408|Endometrioid and mixed endometrioid tumors|endometrioid and mixed endometrioid tumors
89201|NCT03008408|Ribociclib|ribociclib
89202|NCT03008408|LEE011|lee011
89203|NCT03008408|Everolimus|everolimus
89204|NCT03008408|Afinitor|afinitor
89205|NCT03008408|Zortress|zortress
89206|NCT03008408|RAD001|rad001
89207|NCT03008408|Letrozole|letrozole
89208|NCT03008408|Femara|femara
89209|NCT03008382|Interstitial Cystitis|interstitial cystitis
89210|NCT03008382|Pelvic Pain|pelvic pain
89211|NCT03008343|Irreversible Electroporation|irreversible electroporation
89212|NCT03008343|NK Immunotherapy|nk immunotherapy
89213|NCT03008343|Recurrent Liver Carcinoma|recurrent liver carcinoma
89214|NCT03008330|Metastatic tongue cancer|metastatic tongue cancer
89215|NCT03008330|High-activity natural killer|high-activity natural killer
89216|NCT03008304|Metastatic pancreatic cancer|metastatic pancreatic cancer
89217|NCT03008304|High-activity natural killer Immunotherapy|high-activity natural killer immunotherapy
89218|NCT03008265|Fascial dehiscence|fascial dehiscence
89219|NCT03008265|Mortality|mortality
89220|NCT03008252|Non-celiac wheat sensitivity|non-celiac wheat sensitivity
89221|NCT03008252|lactose intolerance|lactose intolerance
89222|NCT03008252|cow's milk protein allergy|cow's milk protein allergy
89223|NCT03008187|AML|aml
89224|NCT03008174|tracheostomy|tracheostomy
89225|NCT03008174|quality of life|quality of life
89226|NCT03008174|speaking valve|speaking valve
89227|NCT03008174|speech|speech
89228|NCT03008174|mechanically ventilated patients|mechanically ventilated patients
89229|NCT03008161|GAIM|gaim
89230|NCT03008161|amyloid|amyloid
89231|NCT03008161|anti-aBeta|anti-abeta
89232|NCT03008161|anti-tau|anti-tau
89233|NCT03008122|Flavivirus|flavivirus
89234|NCT03008122|Inactivated|inactivated
89235|NCT03008122|Phase I|phase i
89236|NCT03008122|Vaccine|vaccine
89237|NCT03008122|ZIKA|zika
89238|NCT03008122|ZPIV|zpiv
89239|NCT03008109|EGFR-TKI|egfr-tki
89240|NCT03008109|Recombinant human endostatin|recombinant human endostatin
89241|NCT03008070|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
89242|NCT03008070|NASH|nash
89243|NCT03008070|peroxisome proliferator-activated receptor (PPAR)|peroxisome proliferator-activated receptor (ppar)
89244|NCT03008070|Liver Diseases|liver diseases
89245|NCT03008070|Fibrosis|fibrosis
89246|NCT03008070|Fatty Liver|fatty liver
89247|NCT03008070|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
89248|NCT03008070|Digestive System Diseases|digestive system diseases
89249|NCT03008070|IVA337|iva337
89250|NCT03008057|vitamin D|vitamin d
89251|NCT03008057|YKL40|ykl40
89252|NCT03008057|PAI-1|pai-1
89253|NCT03008057|RAGE|rage
89254|NCT03008057|AGEs|ages
89255|NCT03008057|glyoxalase enzyme|glyoxalase enzyme
89256|NCT03008057|TNF-alpha|tnf-alpha
89257|NCT03008057|IL-6|il-6
89258|NCT03008057|Diabetes|diabetes
89259|NCT03007992|Breast cancer|breast cancer
89260|NCT03007992|Vinorelbine|vinorelbine
89261|NCT03007992|Metronomic chemotherapy|metronomic chemotherapy
89262|NCT03007953|Palliative Care|palliative care
89263|NCT03007953|Supportive Care|supportive care
89264|NCT03007940|Implementation Strategies|implementation strategies
89265|NCT03007940|Sustainability|sustainability
89266|NCT03007940|Integrated Services|integrated services
89267|NCT03007927|pain|pain
89268|NCT03007927|hernia repair|hernia repair
89269|NCT03007927|Dexamethasone|dexamethasone
89270|NCT03007914|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
89271|NCT03007914|Medicine, Chinese Traditional|medicine, chinese traditional
89272|NCT03007914|Humans|humans
89273|NCT03007914|Treatment Outcome|treatment outcome
89274|NCT03007888|IPX203 (carbidopa-levodopa) Extended-Release capsules|ipx203 (carbidopa-levodopa) extended-release capsules
89275|NCT03007875|Metastatic lung cancer|metastatic lung cancer
89276|NCT03007875|High-activity natural killer|high-activity natural killer
89277|NCT03007836|Metastatic Nasopharyngeal Cancer|metastatic nasopharyngeal cancer
89278|NCT03007836|High-activity natural killer|high-activity natural killer
89279|NCT03007823|Metastatic Melanoma|metastatic melanoma
89280|NCT03007823|High-activity natural killer|high-activity natural killer
89281|NCT03007784|Consciousness|consciousness
89282|NCT03007784|Disorder of consciousness|disorder of consciousness
89283|NCT03007784|Minimally conscious state|minimally conscious state
89284|NCT03007784|Vegetative state|vegetative state
89285|NCT03007784|Exit-MCS|exit-mcs
89286|NCT03007784|Transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
89287|NCT03007784|CRS-R|crs-r
89288|NCT03007784|EEG|eeg
89289|NCT03007784|Cognitive ERPs|cognitive erps
89290|NCT03007758|Hernia repair|hernia repair
89291|NCT03007758|Robotic hernia repair|robotic hernia repair
89292|NCT03007758|Open hernia repair|open hernia repair
89293|NCT03007758|Incisional hernia|incisional hernia
89294|NCT03007745|Continuous positive airway pressure|continuous positive airway pressure
89295|NCT03007628|magnetic seizure therapy|magnetic seizure therapy
89296|NCT03007628|electroconvulsive therapy|electroconvulsive therapy
89297|NCT03007628|controlled trial|controlled trial
89298|NCT03007602|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
89299|NCT03007602|Aerobic exercise|aerobic exercise
89300|NCT03007602|Quality of Life|quality of life
89301|NCT03007602|Muscle Strength|muscle strength
89302|NCT03007602|Depression|depression
89303|NCT03007602|exercise capacity|exercise capacity
89304|NCT03007602|dyspnea|dyspnea
89305|NCT03007602|anxiety|anxiety
89306|NCT03007602|fatigue|fatigue
89307|NCT03007602|pulmonary functions|pulmonary functions
89308|NCT03007589|erythema|erythema
89309|NCT03007589|persistent pigment darkening|persistent pigment darkening
89310|NCT03007589|sunburn|sunburn
89311|NCT03007589|suntan|suntan
89312|NCT03007563|Diagnosis|diagnosis
89313|NCT03007563|Cell Phones|cell phones
89314|NCT03007563|Infant, Newborn|infant, newborn
89315|NCT03007550|Gastric cancer|gastric cancer
89316|NCT03007550|Laparoscopic total gastrectomy|laparoscopic total gastrectomy
89317|NCT03007550|Open total gastrectomy|open total gastrectomy
89318|NCT03007537|Erythropoietin|erythropoietin
89319|NCT03007537|Cardiac Surgery Associated-acute Kidney Injury|cardiac surgery associated-acute kidney injury
89320|NCT03007524|rosuvastatin|rosuvastatin
89321|NCT03007524|optical coherence tomography|optical coherence tomography
89322|NCT03007524|acute coronary syndrome|acute coronary syndrome
89323|NCT03007511|Percutaneous Endoscopic Gastrostomy|percutaneous endoscopic gastrostomy
89324|NCT03007511|Feeding tube|feeding tube
89325|NCT03007511|Enteral nutrition|enteral nutrition
89326|NCT03007511|Endoscopy|endoscopy
89327|NCT03007511|Gastrointestinal|gastrointestinal
89328|NCT03007472|cochlear implant, sound processor|cochlear implant, sound processor
89329|NCT03007459|Body composition|body composition
89330|NCT03007459|Bone mineral density|bone mineral density
89331|NCT03007459|Binge Eating|binge eating
89332|NCT03007459|Eating Disorder|eating disorder
89333|NCT03007459|Exercise Dependency|exercise dependency
89334|NCT03007459|Depression|depression
89335|NCT03007459|Perfectionism|perfectionism
89336|NCT03007459|Body building|body building
89337|NCT03007459|Drive for Muscularity|drive for muscularity
89338|NCT03007459|Drive for leanness|drive for leanness
89339|NCT03007446|Apatinib|apatinib
89340|NCT03007446|SOX|sox
89341|NCT03007446|Conversion Surgery|conversion surgery
89342|NCT03007446|unresectable gastric cancer|unresectable gastric cancer
89343|NCT03007433|gastric emptying|gastric emptying
89344|NCT03007433|functional dyspepsia|functional dyspepsia
89345|NCT03007433|non invasive imaging|non invasive imaging
89346|NCT03007433|MRI|mri
89347|NCT03007433|gamma scintigraphy|gamma scintigraphy
89348|NCT03007433|gastroparesis|gastroparesis
89349|NCT03007407|microsatellite stable|microsatellite stable
89350|NCT03007407|MSS|mss
89351|NCT03007407|durvalumab|durvalumab
89352|NCT03007407|tremelimumab|tremelimumab
89353|NCT03007407|mCRC|mcrc
89354|NCT03007407|NSABP|nsabp
89355|NCT03007394|Cocaine Use Disorder|cocaine use disorder
89356|NCT03007342|Amoxicillin|amoxicillin
89357|NCT03007342|clavulanic acid|clavulanic acid
89358|NCT03007342|Periapical periodontitis|periapical periodontitis
89359|NCT03007342|Post-operative pain|post-operative pain
89360|NCT03007329|SGLT2 inhibitor|sglt2 inhibitor
89361|NCT03007329|GLP1 agonist|glp1 agonist
89362|NCT03007329|type 2 Diabetes|type 2 diabetes
89363|NCT03007329|steatosis of the liver|steatosis of the liver
89364|NCT03007329|ectopic lipids|ectopic lipids
89365|NCT03007329|combined therapy|combined therapy
89366|NCT03007264|cold atmospheric plasma|cold atmospheric plasma
89367|NCT03007264|pain|pain
89368|NCT03007264|bacteria|bacteria
89369|NCT03007264|skin parameters|skin parameters
89370|NCT03007186|Blood glucose monitoring|blood glucose monitoring
89371|NCT03007186|Glucose tolerance|glucose tolerance
89372|NCT03007186|HbA1C|hba1c
89373|NCT03007186|Insulin|insulin
89374|NCT03007186|Betamethasone|betamethasone
89375|NCT03007173|umbilical pilonidal sinus|umbilical pilonidal sinus
89376|NCT03007082|endovascular treatment|endovascular treatment
89377|NCT03007082|mechanical thrombectomy|mechanical thrombectomy
89378|NCT03007082|stent retriever|stent retriever
89379|NCT03007082|human|human
89380|NCT03007056|high flow nasal cannula|high flow nasal cannula
89381|NCT03007056|nasal continuous positive airway pressure|nasal continuous positive airway pressure
89382|NCT03007056|noninvasive ventilatory support|noninvasive ventilatory support
89383|NCT03007056|newborn developmental care|newborn developmental care
89384|NCT03007056|bronchopulmonary dysplasia|bronchopulmonary dysplasia
89385|NCT03007056|weaning|weaning
89386|NCT03007056|pain|pain
89387|NCT03007056|length of stay|length of stay
89388|NCT03007030|Lung Diseases Due to External Agents|lung diseases due to external agents
89389|NCT03007030|Mesothelioma|mesothelioma
89390|NCT03007030|Unresectable malignant pleural mesothelioma|unresectable malignant pleural mesothelioma
89391|NCT03007030|MPM|mpm
89392|NCT03007030|CD30+|cd30+
89393|NCT03007030|Brentuximab vedotin|brentuximab vedotin
89394|NCT03007030|SGN-35|sgn-35
89395|NCT03007030|Adcetris|adcetris
89396|NCT03007004|Systemic aclerosis|systemic aclerosis
89397|NCT03007004|digital ulcer|digital ulcer
89398|NCT03007004|botulinum toxin|botulinum toxin
89399|NCT03006991|methotrexate, Juvenile Idiopathic Arthritis|methotrexate, juvenile idiopathic arthritis
89400|NCT03006965|hemophilia|hemophilia
89401|NCT03006965|Hemophilia A|hemophilia a
89402|NCT03006965|Factor VIII|factor viii
89403|NCT03006965|Advate|advate
89404|NCT03006965|Antithrombotic factor|antithrombotic factor
89405|NCT03006965|Pharmacokinetic dosing|pharmacokinetic dosing
89406|NCT03006965|hemarthrosis|hemarthrosis
89407|NCT03006965|myPKFiT|mypkfit
89408|NCT03006926|hepatocellular carcinoma|hepatocellular carcinoma
89409|NCT03006926|E7080|e7080
89410|NCT03006926|lenvatinib|lenvatinib
89411|NCT03006926|pembrolizumab|pembrolizumab
89412|NCT03006926|Japan|japan
89413|NCT03006913|Genetic counseling modes|genetic counseling modes
89414|NCT03006887|solid tumors|solid tumors
89415|NCT03006887|non-small cell lung cancer|non-small cell lung cancer
89416|NCT03006887|predominantly clear cell renal cell carcinoma|predominantly clear cell renal cell carcinoma
89417|NCT03006887|endometrial carcinoma|endometrial carcinoma
89418|NCT03006887|urothelial carcinoma|urothelial carcinoma
89419|NCT03006887|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
89420|NCT03006887|non-uveal melanoma|non-uveal melanoma
89421|NCT03006887|E7080|e7080
89422|NCT03006887|lenvatinib|lenvatinib
89423|NCT03006887|pembrolizumab|pembrolizumab
89424|NCT03006887|Japan|japan
89425|NCT03006848|Osteosarcoma|osteosarcoma
89426|NCT03006848|PD-L1|pd-l1
89427|NCT03006848|Immunotherapy|immunotherapy
89428|NCT03006835|Clopidogrel; Platelet Inhibition Ratio|clopidogrel; platelet inhibition ratio
89429|NCT03006822|Myofascial Trigger Points|myofascial trigger points
89430|NCT03006822|Liberation for Pression|liberation for pression
89431|NCT03006822|Therapy Soft Tissue|therapy soft tissue
89432|NCT03006809|Ulcerative colitis|ulcerative colitis
89433|NCT03006809|FMT|fmt
89434|NCT03006809|fecal transplant|fecal transplant
89435|NCT03006796|Obesity|obesity
89436|NCT03006705|ONO-4538,BMS-936558,Nivolumab,gastric,adjuvant,S-1,CapeOX|ono-4538,bms-936558,nivolumab,gastric,adjuvant,s-1,capeox
89437|NCT03006614|Breast Cancer Model|breast cancer model
89438|NCT03006614|Effects of Chemotherapy|effects of chemotherapy
89439|NCT03006614|breast cancer|breast cancer
89440|NCT03006588|FNA,EUS,retropharyngeal lymph node (RPLN),NPC|fna,eus,retropharyngeal lymph node (rpln),npc
89441|NCT03006575|Non-small cell lung cancer|non-small cell lung cancer
89442|NCT03006575|Split-course Chemoradiotherapy|split-course chemoradiotherapy
89443|NCT03006575|Locoregional recurrence|locoregional recurrence
89444|NCT03006575|Postoperative recurrence|postoperative recurrence
89445|NCT03006575|Consolidation chemotherapy|consolidation chemotherapy
89446|NCT03006549|Emergency Manual|emergency manual
89447|NCT03006549|Crisis Checklist|crisis checklist
89448|NCT03006523|donor intrauterine insemination|donor intrauterine insemination
89449|NCT03006523|insemination volume|insemination volume
89450|NCT03006523|Live Birth Rates|live birth rates
89451|NCT03006523|donor sperm|donor sperm
90058|NCT03003078|Abraxane|abraxane
89452|NCT03006510|inpatient diabetes|inpatient diabetes
89453|NCT03006510|hypoglycemia|hypoglycemia
89454|NCT03006497|neck|neck
89455|NCT03006497|motor control|motor control
89456|NCT03006497|motor learning|motor learning
89457|NCT03006484|Cardiac arrest|cardiac arrest
89458|NCT03006484|Inhospital Cardiac Arrest|inhospital cardiac arrest
89459|NCT03006484|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
89460|NCT03006471|Prediabetes|prediabetes
89461|NCT03006471|Prehypertension|prehypertension
89462|NCT03006471|Variability of blood pressure|variability of blood pressure
89463|NCT03006471|ABPM|abpm
89464|NCT03006471|Dapagliflozin|dapagliflozin
89465|NCT03006471|SGLT2|sglt2
89466|NCT03006432|OESOPHAGO-GASTRIC CARCINOMA|oesophago-gastric carcinoma
89467|NCT03006419|kidney transplantation|kidney transplantation
89468|NCT03006419|induction|induction
89469|NCT03006419|thymoglobulin|thymoglobulin
89470|NCT03006419|basiliximab|basiliximab
89471|NCT03006419|acute rejection|acute rejection
89472|NCT03006419|graft loss|graft loss
89473|NCT03006406|endometriosis|endometriosis
89474|NCT03006406|long term GnRH-a|long term gnrh-a
89475|NCT03006393|Neuroscience|neuroscience
89476|NCT03006393|Behavioral|behavioral
89477|NCT03006393|Social|social
89478|NCT03006354|high frequency oscillatory ventilation|high frequency oscillatory ventilation
89479|NCT03006354|newborn|newborn
89480|NCT03006354|noninvasive ventilation|noninvasive ventilation
89481|NCT03006354|transient tachypnea of the newborn|transient tachypnea of the newborn
89482|NCT03006328|weight gain|weight gain
89483|NCT03006328|weight loss|weight loss
89484|NCT03006315|multiple myeloma|multiple myeloma
89485|NCT03006315|garmin vivofit|garmin vivofit
89486|NCT03006302|pancreatic cancer|pancreatic cancer
89487|NCT03006302|vaccine|vaccine
89488|NCT03006302|immunotherapy|immunotherapy
89489|NCT03006302|MK-3475|mk-3475
89490|NCT03006302|PD-1|pd-1
89491|NCT03006302|IDO|ido
89492|NCT03006289|Metabolic Syndrome|metabolic syndrome
89493|NCT03006289|fasting plasma glucose|fasting plasma glucose
89494|NCT03006263|Stomach Neoplasms|stomach neoplasms
89495|NCT03006263|Totally Laparoscopic Total Gastrectomy|totally laparoscopic total gastrectomy
89496|NCT03006263|Laparoscopy Assisted Total Gastrectomy|laparoscopy assisted total gastrectomy
89497|NCT03006250|Desflurane|desflurane
89498|NCT03006250|Sevoflurane|sevoflurane
89499|NCT03006250|Respiratory Complications|respiratory complications
89500|NCT03006224|secondary smoking|secondary smoking
89501|NCT03006224|one lung ventilation|one lung ventilation
89502|NCT03006224|arterial oxygen tension|arterial oxygen tension
89503|NCT03006224|lobectomy|lobectomy
89504|NCT03006211|nitrogen protoxide|nitrogen protoxide
89505|NCT03006211|oxygen|oxygen
89506|NCT03006211|corneal endothelial|corneal endothelial
89507|NCT03006211|pediatric|pediatric
89508|NCT03006107|Irreversible pulpitis|irreversible pulpitis
89509|NCT03006107|Post endodontic pain|post endodontic pain
89510|NCT03006107|Symptomatic pulpitis pain|symptomatic pulpitis pain
89511|NCT03006107|Single visit RCT pain|single visit rct pain
89512|NCT03006107|Root canal treatment flare up|root canal treatment flare up
89513|NCT03006107|Single dose piroxicam|single dose piroxicam
89514|NCT03006107|Intraligamentary piroxicam|intraligamentary piroxicam
89515|NCT03006107|Intraligamentary mepecaine|intraligamentary mepecaine
89516|NCT03006094|questionnaire|questionnaire
89517|NCT03006094|hip|hip
89518|NCT03006094|pain|pain
89519|NCT03006081|Retinal nonperfusion|retinal nonperfusion
89520|NCT03006081|Aflibercept|aflibercept
89521|NCT03006068|Ulcerative Colitis (UC)|ulcerative colitis (uc)
89522|NCT03006068|ABT-494|abt-494
89523|NCT03006068|Open-Label Extension (OLE)|open-label extension (ole)
89524|NCT03006068|Safety|safety
89525|NCT03006068|Efficacy|efficacy
89526|NCT03006042|bupivacaine|bupivacaine
89527|NCT03006042|local anaesthetics|local anaesthetics
89528|NCT03006042|cesarean section|cesarean section
89529|NCT03006042|transversus abdominis plane block|transversus abdominis plane block
89530|NCT03006042|toxicity|toxicity
89531|NCT03006042|ultrasound guidance|ultrasound guidance
89532|NCT03006042|QTc interval|qtc interval
89533|NCT03006003|Osteoporosis|osteoporosis
89534|NCT03006003|Raloxifene|raloxifene
89535|NCT03006003|Central nervous disorders|central nervous disorders
89536|NCT03005990|Sleep disturbance|sleep disturbance
89537|NCT03005990|Body composition|body composition
89538|NCT03005990|Energy metabolism|energy metabolism
89539|NCT03005990|Exercise training|exercise training
89540|NCT03005990|Community-dwelling elderly|community-dwelling elderly
89541|NCT03005977|Urodynamics|urodynamics
89542|NCT03005977|Pyridium pad test|pyridium pad test
89543|NCT03005977|Cough stress test|cough stress test
89544|NCT03005977|Pelvic organ prolapse|pelvic organ prolapse
89545|NCT03005938|Cerebral Palsy|cerebral palsy
89546|NCT03005938|Spinal Manipulation|spinal manipulation
89547|NCT03005938|Muscle Spasticity|muscle spasticity
89548|NCT03005938|Manual Dexterity|manual dexterity
89549|NCT03005912|Speech Comprehension|speech comprehension
89550|NCT03005912|Telephony|telephony
89551|NCT03005912|VoIP|voip
89552|NCT03005886|Periodontitis|periodontitis
89553|NCT03005886|Periodontal-systemic disease|periodontal-systemic disease
89554|NCT03005886|Cardiovascular diseases|cardiovascular diseases
89555|NCT03005886|Gingival crevicular fluid|gingival crevicular fluid
89556|NCT03005886|Acute myocardial infarction|acute myocardial infarction
89557|NCT03005886|Neopterin|neopterin
89558|NCT03005886|Vascular cell adhesion molecule-1|vascular cell adhesion molecule-1
89559|NCT03005873|osteoarthritis of the knee|osteoarthritis of the knee
89560|NCT03005873|TLC599|tlc599
89561|NCT03005873|Dexamethasone|dexamethasone
89562|NCT03005873|DSP|dsp
89563|NCT03005834|Atherosclerotic cardiovascular diseases, cancers|atherosclerotic cardiovascular diseases, cancers
89564|NCT03005821|pediatric massage|pediatric massage
89565|NCT03005821|Tuina therapy|tuina therapy
89566|NCT03005821|acute diarrhea|acute diarrhea
89567|NCT03005808|appendectomy, pediatrics, nerve block, abdominal wall|appendectomy, pediatrics, nerve block, abdominal wall
89568|NCT03005795|cervical dysplasia|cervical dysplasia
89569|NCT03005795|colposcopy|colposcopy
89570|NCT03005795|anxiety|anxiety
89571|NCT03005795|music|music
89572|NCT03005795|mozart|mozart
89573|NCT03005795|randomized controlled trial|randomized controlled trial
89574|NCT03005769|persistence|persistence
89575|NCT03005769|long-acting injectable antipsychotic|long-acting injectable antipsychotic
89576|NCT03005769|adherence|adherence
89577|NCT03005743|Cervical cancer|cervical cancer
89578|NCT03005743|Brachytherapy|brachytherapy
89579|NCT03005743|Conventional planning|conventional planning
89580|NCT03005743|MR based Brachytherapy|mr based brachytherapy
89581|NCT03005717|submental|submental
89582|NCT03005717|Salmeterol Xinafoate|salmeterol xinafoate
89583|NCT03005717|LIPO-202|lipo-202
89584|NCT03005717|bulge|bulge
89585|NCT03005704|Ticagrelor|ticagrelor
89586|NCT03005704|Acetylsalicylic acid|acetylsalicylic acid
89587|NCT03005704|Platelet transfusion|platelet transfusion
89588|NCT03005704|Reversal|reversal
89589|NCT03005691|metabolite|metabolite
89590|NCT03005691|central sensitization|central sensitization
89591|NCT03005691|whiplash|whiplash
89592|NCT03005678|glucocorticoids, steroids, osteoporosis|glucocorticoids, steroids, osteoporosis
89593|NCT03005665|optic nerve sheath diameter|optic nerve sheath diameter
89594|NCT03005665|acetazolamide|acetazolamide
89595|NCT03005652|Subjective Cognitive Decline|subjective cognitive decline
89596|NCT03005652|Mental Health|mental health
89597|NCT03005652|Meditation|meditation
89598|NCT03005652|Health Education|health education
89599|NCT03005613|Pelvic organ prolapse|pelvic organ prolapse
89600|NCT03005613|Sacrospinous ligament fixation|sacrospinous ligament fixation
89601|NCT03005613|Ischial spine fascia fixation|ischial spine fascia fixation
89602|NCT03005613|Clinical outcome|clinical outcome
89603|NCT03005600|Screening, diagnosis, risk stratification, ethnic|screening, diagnosis, risk stratification, ethnic
89604|NCT03005574|Severe Mental Illness|severe mental illness
89605|NCT03005574|Cognitive Remediation|cognitive remediation
89606|NCT03005574|Employment|employment
89607|NCT03005548|Transcranial Direct Current Stimulation|transcranial direct current stimulation
89608|NCT03005548|Pain Postoperative|pain postoperative
89609|NCT03005548|Thoracotomy|thoracotomy
89610|NCT03005509|Quality improvement|quality improvement
89611|NCT03005509|Injury|injury
89612|NCT03005509|Injuries|injuries
89613|NCT03005483|GABAPENTIN POSTOPERATIVE PAIN CHILD|gabapentin postoperative pain child
89614|NCT03005470|Prehypertension|prehypertension
89615|NCT03005470|Hypertension|hypertension
89616|NCT03005470|Blood pressure|blood pressure
89617|NCT03005470|Intervention|intervention
89618|NCT03005470|Lifestyle|lifestyle
89619|NCT03005470|Blood pressure monitoring|blood pressure monitoring
89620|NCT03005470|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
89621|NCT03005470|Text Messages|text messages
89622|NCT03005470|High blood pressure|high blood pressure
89623|NCT03005444|liver cirrhosis|liver cirrhosis
89624|NCT03005444|Transjugular Intrahepatic Portosystemic Stent Shunt|transjugular intrahepatic portosystemic stent shunt
89625|NCT03005444|Anticoagulation|anticoagulation
89626|NCT03005444|Survival|survival
89627|NCT03005444|Additional decompensation|additional decompensation
89628|NCT03005431|Parenting|parenting
89629|NCT03005431|Training|training
89630|NCT03005431|Support|support
89631|NCT03005431|On-line|on-line
89632|NCT03005431|Stress|stress
89633|NCT03005405|Dental Caries|dental caries
89634|NCT03005405|Primary tooth|primary tooth
89635|NCT03005405|Ionomer Sealants|ionomer sealants
89636|NCT03005405|Glass Ionomer Restoration|glass ionomer restoration
89637|NCT03005392|Cancer|cancer
89638|NCT03005392|Physical therapy|physical therapy
89639|NCT03005392|Cardiorespiratory fitness|cardiorespiratory fitness
89640|NCT03005379|FMT|fmt
89641|NCT03005379|recurrent c. difficile|recurrent c. difficile
89642|NCT03005379|infectious disease|infectious disease
89643|NCT03005379|intestine|intestine
89644|NCT03005379|clinical trial|clinical trial
89645|NCT03005379|gastrointestinal|gastrointestinal
89646|NCT03005379|prevention|prevention
89647|NCT03005379|randomized|randomized
89648|NCT03005379|diarrhea|diarrhea
89649|NCT03005379|fecal microbiota therapy|fecal microbiota therapy
89650|NCT03005366|Atrial fibrillation|atrial fibrillation
89651|NCT03005366|vernakalant|vernakalant
89652|NCT03005366|flecainide|flecainide
89653|NCT03005366|cardioversion|cardioversion
89654|NCT03005301|electroacupuncture instrument|electroacupuncture instrument
89655|NCT03005288|type 2 diabetes|type 2 diabetes
89656|NCT03005288|obesity|obesity
89657|NCT03005288|DXA|dxa
89658|NCT03005288|MRI|mri
89659|NCT03005236|Kidney transplant|kidney transplant
89660|NCT03005236|Tacrolimus|tacrolimus
89661|NCT03005236|Envarsus|envarsus
89662|NCT03005236|Older adult|older adult
89663|NCT03005236|Elderly|elderly
89664|NCT03005158|High-sensitivity cardiac troponin I|high-sensitivity cardiac troponin i
89665|NCT03005158|Myocardial infarction|myocardial infarction
89666|NCT03005158|Acute coronary syndrome|acute coronary syndrome
89667|NCT03005158|Cluster-randomized trial|cluster-randomized trial
89668|NCT03005132|GBM; Integrative Analysis; WES|gbm; integrative analysis; wes
89669|NCT03004989|Qualitative study|qualitative study
89670|NCT03004989|Musculoskeletal Disorders|musculoskeletal disorders
89671|NCT03004989|Return to Work Programme|return to work programme
89672|NCT03004976|hematopoietic stem cells|hematopoietic stem cells
89673|NCT03004976|umbilical cord blood|umbilical cord blood
89674|NCT03004976|stroke|stroke
89675|NCT03004976|ischemic stroke|ischemic stroke
89676|NCT03004963|Peritoneal Dialysis|peritoneal dialysis
89677|NCT03004963|Volume Status|volume status
89678|NCT03004963|Body Composition Monitor|body composition monitor
89679|NCT03004911|fibromyalgia|fibromyalgia
89680|NCT03004911|mobile application|mobile application
89681|NCT03004911|self-care|self-care
89682|NCT03004911|quality of life|quality of life
89683|NCT03004872|birth experience|birth experience
89684|NCT03004872|postpartum depression|postpartum depression
89685|NCT03004872|PTSD|ptsd
89686|NCT03004872|pain during labor|pain during labor
89687|NCT03004872|pain during cesarean delivery|pain during cesarean delivery
89688|NCT03004872|non-elective induction of labor|non-elective induction of labor
89689|NCT03004872|unplanned surgery for urgent/emergent cesarean delivery|unplanned surgery for urgent/emergent cesarean delivery
89690|NCT03004872|postpartum hemorrhage|postpartum hemorrhage
89691|NCT03004859|atrial fibrillation|atrial fibrillation
89692|NCT03004859|screening|screening
89693|NCT03004859|electrocardiogram|electrocardiogram
89694|NCT03004859|community pharmacy|community pharmacy
89695|NCT03004859|Germany|germany
89696|NCT03004846|Vehicle- controlled|vehicle- controlled
89697|NCT03004846|GSK2981278|gsk2981278
89698|NCT03004846|Plaque psoriasis|plaque psoriasis
89699|NCT03004820|Minor Ischemic Stroke|minor ischemic stroke
89700|NCT03004820|Transient Ischemic Attack|transient ischemic attack
89701|NCT03004820|Remote Ischemic Conditioning|remote ischemic conditioning
89702|NCT03004807|Nutrition|nutrition
89703|NCT03004807|Aging|aging
89704|NCT03004807|Multivitamin|multivitamin
89705|NCT03004781|parenting intervention|parenting intervention
89706|NCT03004781|externalizing behavior|externalizing behavior
89707|NCT03004781|emotion coaching practices|emotion coaching practices
89708|NCT03004781|self-efficacy beliefs|self-efficacy beliefs
89709|NCT03004742|polyphenols|polyphenols
89710|NCT03004742|metabolomics|metabolomics
89711|NCT03004742|oxidative stress|oxidative stress
89712|NCT03004729|Allergy|allergy
89713|NCT03004729|Atopic Dermatitis|atopic dermatitis
89714|NCT03004729|Immunoglobulin E (IgE)|immunoglobulin e (ige)
89715|NCT03004729|CMPA|cmpa
89716|NCT03004703|Interleukin 6|interleukin 6
89717|NCT03004703|Tocilizumab|tocilizumab
89718|NCT03004703|Acute coronary syndrome|acute coronary syndrome
89719|NCT03004703|STEMI|stemi
89720|NCT03004703|Inflammation|inflammation
89721|NCT03004690|biosafety|biosafety
89722|NCT03004690|outbreaks|outbreaks
89723|NCT03004690|clinic|clinic
89724|NCT03004690|personal protective equipment|personal protective equipment
89725|NCT03004690|ergonomics|ergonomics
89726|NCT03004690|error rates|error rates
89727|NCT03004664|Latinos|latinos
89728|NCT03004664|Low Income|low income
89729|NCT03004664|Self Management|self management
89730|NCT03004664|Education|education
89731|NCT03004664|Cultural Competence|cultural competence
89732|NCT03004638|Atherosclerosis|atherosclerosis
89733|NCT03004638|Cardiovascular Disease|cardiovascular disease
89734|NCT03004638|CAD|cad
89735|NCT03004638|Atherosclerotic Cardiovascular Disease|atherosclerotic cardiovascular disease
89736|NCT03004612|prediabetes|prediabetes
89737|NCT03004599|Valvular Heart Disease|valvular heart disease
89738|NCT03004599|Critical Aortic Stenosis|critical aortic stenosis
89739|NCT03004599|Severe Aortic Stenosis|severe aortic stenosis
89740|NCT03004599|High Risk|high risk
89741|NCT03004599|Aortic Valve Replacement|aortic valve replacement
89742|NCT03004599|Cardiovascular Disease|cardiovascular disease
89743|NCT03004599|Aortic Stenosis|aortic stenosis
89744|NCT03004599|Heart Valve Therapy|heart valve therapy
89745|NCT03004599|Transcatheter|transcatheter
89746|NCT03004599|Transfemoral|transfemoral
89747|NCT03004599|TAVI|tavi
89748|NCT03004599|TAVR|tavr
89749|NCT03004599|ACURATE neo™ Aortic Bioprosthesis|acurate neo™ aortic bioprosthesis
89750|NCT03004599|ACURATE TF™ Transfemoral Delivery System|acurate tf™ transfemoral delivery system
89751|NCT03004586|Malignant Neoplasm of Respiratory and Intrathoracic Organ Carcinoma|malignant neoplasm of respiratory and intrathoracic organ carcinoma
89752|NCT03004586|Lung cancer|lung cancer
89753|NCT03004586|Ultrasound-guided transbronchial needle aspiration|ultrasound-guided transbronchial needle aspiration
89754|NCT03004586|EBUS-TBNA|ebus-tbna
89755|NCT03004586|25-gauge needle|25-gauge needle
89756|NCT03004586|22-gauge needle|22-gauge needle
89757|NCT03004573|Parkinson Disease|parkinson disease
89758|NCT03004573|emotional recognition|emotional recognition
89759|NCT03004573|Deep Brain Stimulation|deep brain stimulation
89760|NCT03004560|Bariatric|bariatric
89761|NCT03004560|standard laparoscopic surgery|standard laparoscopic surgery
89762|NCT03004560|minimally invasive|minimally invasive
89763|NCT03004560|scars|scars
89764|NCT03004560|psychology|psychology
89765|NCT03004534|Breast Cancer|breast cancer
89766|NCT03004534|Breast Carcinoma|breast carcinoma
89767|NCT03004534|Breast Tumours|breast tumours
89768|NCT03004534|Early Breast Cancer|early breast cancer
89769|NCT03004521|Lithium|lithium
89770|NCT03004521|Quetiapine|quetiapine
89771|NCT03004521|Augmentation|augmentation
89772|NCT03004508|Ginkgo Biloba Extract|ginkgo biloba extract
89773|NCT03004508|Safety|safety
89774|NCT03004508|Genomic Stability|genomic stability
89775|NCT03004508|DNA cell maintenance|dna cell maintenance
89776|NCT03004482|NICU|nicu
89777|NCT03004482|Recorded video images|recorded video images
89778|NCT03004482|physiological disorders|physiological disorders
89779|NCT03004456|Phlebotomy|phlebotomy
89780|NCT03004456|Pain|pain
89781|NCT03004456|Distress|distress
89782|NCT03004443|Psychiatry|psychiatry
89783|NCT03004430|Mantra|mantra
89784|NCT03004430|Meditation|meditation
89785|NCT03004391|Shared decision making|shared decision making
89786|NCT03004391|Follow-up|follow-up
89787|NCT03004378|obesity|obesity
89788|NCT03004378|adolescent|adolescent
89789|NCT03004378|tracking device|tracking device
89790|NCT03004378|fitbit|fitbit
89791|NCT03004326|DIV|div
89792|NCT03004326|CSS|css
89793|NCT03004326|EGPA|egpa
89794|NCT03004326|HSP|hsp
89795|NCT03004326|GPA|gpa
89796|NCT03004326|MPA|mpa
89797|NCT03004326|PAN|pan
89798|NCT03004326|Wegeners|wegeners
89799|NCT03004313|migraine|migraine
89800|NCT03004300|maxillary expansion|maxillary expansion
89801|NCT03004300|adenotonsillar hypertrophy|adenotonsillar hypertrophy
89802|NCT03004300|airway volume|airway volume
89803|NCT03004261|cytomegalovirus infection|cytomegalovirus infection
89804|NCT03004261|cytotoxic T lymphocyte|cytotoxic t lymphocyte
89805|NCT03004261|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
89806|NCT03004248|glabellar lines, frown lines|glabellar lines, frown lines
89807|NCT03004209|Erythropoietin|erythropoietin
89808|NCT03004209|Autoimmune encephalitis|autoimmune encephalitis
89809|NCT03004196|White Spot Lesion|white spot lesion
89810|NCT03004196|Probiotics|probiotics
89811|NCT03004196|Chlorhexidine|chlorhexidine
89812|NCT03004196|Streptococcus Mutans|streptococcus mutans
89813|NCT03004196|Fixed Orthodontic Treatment|fixed orthodontic treatment
89814|NCT03004170|HIV|hiv
89815|NCT03004170|Motivational Interviewing|motivational interviewing
89816|NCT03004170|Telephone|telephone
89817|NCT03004170|Telehealth|telehealth
89818|NCT03004170|Risky Sex|risky sex
89819|NCT03004170|Unprotected Sex|unprotected sex
89820|NCT03004170|Condoms|condoms
89821|NCT03004170|Older Adults|older adults
89822|NCT03004157|infant|infant
89823|NCT03004157|cardiopulmonary resuscitation|cardiopulmonary resuscitation
89824|NCT03004157|hemodynamics|hemodynamics
89825|NCT03004157|chest compressions|chest compressions
89826|NCT03004105|Malignant Neoplasm of Respiratory and Intrathoracic Organ Carcinoma|malignant neoplasm of respiratory and intrathoracic organ carcinoma
89827|NCT03004105|Advanced Lung Cancer|advanced lung cancer
89828|NCT03004105|Recurrent Nonsmall Cell Lung Cancer|recurrent nonsmall cell lung cancer
89829|NCT03004105|Selumetinib|selumetinib
89830|NCT03004105|AZD6244|azd6244
89831|NCT03004105|Durvalumab|durvalumab
89832|NCT03004105|MEDI4736|medi4736
89833|NCT03004092|bis(methylthio)gliotoxin|bis(methylthio)gliotoxin
89834|NCT03004092|lateral flow device|lateral flow device
89835|NCT03004092|JF5|jf5
89836|NCT03004092|Galactomannan|galactomannan
89837|NCT03004092|Invasive aspergillosis|invasive aspergillosis
89838|NCT03004053|Reflectance Confocal Microscopy|reflectance confocal microscopy
89839|NCT03004053|Normal Oral Tissue|normal oral tissue
89840|NCT03004053|16-1652|16-1652
89841|NCT03004027|health behaviour change|health behaviour change
89842|NCT03004027|implementation intention|implementation intention
89843|NCT03004027|if then plan|if then plan
89844|NCT03004027|skin condition|skin condition
89845|NCT03004027|visible difference|visible difference
89846|NCT03004027|self help|self help
89847|NCT03004014|sleep endoscopy|sleep endoscopy
89848|NCT03004014|sedation|sedation
89849|NCT03004001|Severe proteinuria|severe proteinuria
89850|NCT03004001|Dyslipidemia|dyslipidemia
89851|NCT03003975|Ablation|ablation
89852|NCT03003975|Cryoballoon|cryoballoon
89853|NCT03003975|Achieve|achieve
89854|NCT03003962|NSCLC|nsclc
89855|NCT03003962|PD-L1|pd-l1
89856|NCT03003962|Durvalumab|durvalumab
89857|NCT03003962|MEDI4736|medi4736
89858|NCT03003962|PFS|pfs
89859|NCT03003962|OS|os
89860|NCT03003949|perimenopause|perimenopause
89861|NCT03003949|menopause transition|menopause transition
89862|NCT03003949|estrogen|estrogen
89863|NCT03003949|stress|stress
89864|NCT03003949|mood|mood
89865|NCT03003936|Glucose tolerance|glucose tolerance
89866|NCT03003936|MTNR1B|mtnr1b
89867|NCT03003936|nutrigenomics|nutrigenomics
89868|NCT03003936|Food timing|food timing
89869|NCT03003923|Vegetable intake|vegetable intake
89870|NCT03003923|Taste exposures|taste exposures
89871|NCT03003923|Educational intervention|educational intervention
89872|NCT03003923|Preschool children|preschool children
89873|NCT03003923|Healthy eating intervention|healthy eating intervention
89874|NCT03003910|Best Possible Self|best possible self
89875|NCT03003897|Dietary Fiber|dietary fiber
89876|NCT03003897|Soluble Fiber|soluble fiber
89877|NCT03003897|Body Mass Index|body mass index
89878|NCT03003897|Body Weight|body weight
89879|NCT03003897|Blood Glucose|blood glucose
89880|NCT03003897|Insulin|insulin
89881|NCT03003871|stroke|stroke
89882|NCT03003871|randomized controled clinical trial|randomized controled clinical trial
89883|NCT03003871|oral health promotion|oral health promotion
89884|NCT03003858|gingivitis|gingivitis
89885|NCT03003858|hyaluronic acid|hyaluronic acid
89886|NCT03003858|pediatrics|pediatrics
89887|NCT03003858|medical devices|medical devices
89888|NCT03003806|Insulin pump treatment|insulin pump treatment
89889|NCT03003806|Type 1 diabetes|type 1 diabetes
89890|NCT03003806|Pump setting advisor|pump setting advisor
89891|NCT03003689|Scaling and Root Planing|scaling and root planing
89892|NCT03003689|Er:YAG|er:yag
89893|NCT03003663|Fall Prevention|fall prevention
89894|NCT03003663|Interrupted Time-Series Study|interrupted time-series study
89895|NCT03003663|Patient Safety|patient safety
89896|NCT03003663|Patient-Centered Care|patient-centered care
89897|NCT03003663|Patient Monitoring|patient monitoring
89898|NCT03003663|Health Care Technology|health care technology
89899|NCT03003663|Mobile Applications|mobile applications
89900|NCT03003663|Bedside Monitor|bedside monitor
89901|NCT03003663|Mechanical Fall|mechanical fall
89902|NCT03003650|Severe Symptomatic Aortic Valve Stenosis|severe symptomatic aortic valve stenosis
89903|NCT03003624|Incisions|incisions
89904|NCT03003624|microdissection needle|microdissection needle
89905|NCT03003598|Intraocular pressure|intraocular pressure
89906|NCT03003598|videolaryngoscope|videolaryngoscope
89907|NCT03003598|direct laryngoscope|direct laryngoscope
89908|NCT03003585|intraocular pressure|intraocular pressure
89909|NCT03003585|direct laryngoscopy|direct laryngoscopy
89910|NCT03003585|fiberoptic bronchoscopy|fiberoptic bronchoscopy
89911|NCT03003572|Sjögren's syndrome|sjögren's syndrome
89912|NCT03003572|Immunoglobulin E|immunoglobulin e
89913|NCT03003572|Anti-Ro/SSA|anti-ro/ssa
89914|NCT03003572|Autoimmune disease|autoimmune disease
89915|NCT03003572|Biomarker|biomarker
89916|NCT03003559|COPD Exacerbation|copd exacerbation
89917|NCT03003559|High Flow Oxygen|high flow oxygen
89918|NCT03003559|Nasal Cannula|nasal cannula
89919|NCT03003559|mild|mild
89920|NCT03003533|Adeno-Associated Virus (AAV)|adeno-associated virus (aav)
89921|NCT03003533|Blood Coagulation Disorders|blood coagulation disorders
89922|NCT03003533|Blood Coagulation Disorders, Inherited|blood coagulation disorders, inherited
89923|NCT03003533|Coagulation Protein Disorders|coagulation protein disorders
89924|NCT03003533|Factor VIII (FVIII)|factor viii (fviii)
89925|NCT03003533|Factor VIII (FVIII) Deficiency|factor viii (fviii) deficiency
89926|NCT03003533|Factor VIII (FVIII) Gene|factor viii (fviii) gene
89927|NCT03003533|Factor VIII (FVIII) Protein|factor viii (fviii) protein
89928|NCT03003533|Genetic Diseases, Inborn|genetic diseases, inborn
89929|NCT03003533|Genetic Diseases, X-Linked|genetic diseases, x-linked
89930|NCT03003533|Gene Therapy|gene therapy
89931|NCT03003533|Gene Transfer|gene transfer
89932|NCT03003533|Hematologic Diseases|hematologic diseases
89933|NCT03003533|Hemorrhagic Disorders|hemorrhagic disorders
89934|NCT03003533|Recombinant|recombinant
89935|NCT03003533|Vector|vector
89936|NCT03003520|Lymphoma|lymphoma
89937|NCT03003520|Diffuse-large B-Cell Lymphoma|diffuse-large b-cell lymphoma
89938|NCT03003520|Durvalumab|durvalumab
89939|NCT03003520|Anti-PD-L1 Antibody|anti-pd-l1 antibody
89940|NCT03003520|MEDI4736|medi4736
89941|NCT03003520|Immune Checkpoint|immune checkpoint
89942|NCT03003520|Rituximab|rituximab
89943|NCT03003520|Cyclophosphamide|cyclophosphamide
89944|NCT03003520|Doxorubicin|doxorubicin
89945|NCT03003520|Vincristine|vincristine
89946|NCT03003520|Prednisone/Prednisolone|prednisone/prednisolone
89947|NCT03003520|Lenalidomide|lenalidomide
89948|NCT03003507|Hyperglycemia|hyperglycemia
89949|NCT03003507|Fructose|fructose
89950|NCT03003507|Diabetes mellitus|diabetes mellitus
89951|NCT03003507|Enteral Nutrition|enteral nutrition
89952|NCT03003507|Glycemic Variability|glycemic variability
89953|NCT03003468|Anti-PD-1|anti-pd-1
89954|NCT03003468|Pembrolizumab|pembrolizumab
89955|NCT03003468|Imprime PGG|imprime pgg
89956|NCT03003468|MK-3475|mk-3475
89957|NCT03003455|Nasotracheal Intubation|nasotracheal intubation
89958|NCT03003442|Multivitamin/mineral|multivitamin/mineral
89959|NCT03003442|Exercise|exercise
89960|NCT03003442|Fatigue|fatigue
89961|NCT03003442|Stress|stress
89962|NCT03003442|Arousal|arousal
89963|NCT03003442|Energy expenditure|energy expenditure
89964|NCT03003442|Recovery biomarkers|recovery biomarkers
89965|NCT03003442|Cognition|cognition
89966|NCT03003429|Heart rate variability|heart rate variability
89967|NCT03003429|anxiety|anxiety
89968|NCT03003429|Autonomic dysfunction|autonomic dysfunction
89969|NCT03003403|mHealth|mhealth
89970|NCT03003403|Digital Health|digital health
89971|NCT03003403|Primary Care|primary care
89972|NCT03003403|Pragmatic Clinical Trial|pragmatic clinical trial
89973|NCT03003403|Behavior Change|behavior change
89974|NCT03003403|Weight Management|weight management
89975|NCT03003390|child|child
89976|NCT03003390|critical illness|critical illness
89977|NCT03003390|venous thromboembolism|venous thromboembolism
89978|NCT03003390|enoxaparin|enoxaparin
89979|NCT03003390|thrombin generation|thrombin generation
89980|NCT03003377|Sevoflurane|sevoflurane
89981|NCT03003377|Remifentanil|remifentanil
89982|NCT03003377|Laryngeal mask supreme|laryngeal mask supreme
89983|NCT03003377|laryngeal mask proseal|laryngeal mask proseal
89984|NCT03003351|Fistula|fistula
89985|NCT03003351|Cohort Study|cohort study
89986|NCT03003338|chronic HCV Genotype 1b infection|chronic hcv genotype 1b infection
89987|NCT03003338|HCV RNA|hcv rna
89988|NCT03003338|OBV/PTV/r in combination with DSV|obv/ptv/r in combination with dsv
89989|NCT03003338|neuropsychiatric manifestations|neuropsychiatric manifestations
89990|NCT03003325|low risk of thrombosis|low risk of thrombosis
89991|NCT03003325|Interferon|interferon
89992|NCT03003312|Urolithiasis|urolithiasis
89993|NCT03003312|Uyghur|uyghur
89994|NCT03003312|Prevalence|prevalence
89995|NCT03003312|Associated factors|associated factors
89996|NCT03003312|Children|children
89997|NCT03003299|Sapien 3|sapien 3
89998|NCT03003299|Partner 3|partner 3
89999|NCT03003299|cardiovascular disease|cardiovascular disease
90000|NCT03003299|heart disease|heart disease
90001|NCT03003299|aortic stenosis|aortic stenosis
90002|NCT03003299|SAVR|savr
90003|NCT03003299|TAVR|tavr
90004|NCT03003299|failing surgical valve|failing surgical valve
90005|NCT03003299|failing bioprosthetic valve|failing bioprosthetic valve
90006|NCT03003299|failing valve|failing valve
90007|NCT03003286|Contingency Behavior Management|contingency behavior management
90008|NCT03003286|Flexible|flexible
90009|NCT03003286|Unstuck|unstuck
90010|NCT03003286|Low Income|low income
90011|NCT03003286|Behavior|behavior
90012|NCT03003286|Coping|coping
90013|NCT03003286|Disparity|disparity
90014|NCT03003286|Problem Solving|problem solving
90015|NCT03003286|Self-Control|self-control
90016|NCT03003286|impulsive|impulsive
90017|NCT03003286|intervention|intervention
90018|NCT03003221|Parent training|parent training
90019|NCT03003221|Dental care|dental care
90020|NCT03003169|surgery|surgery
90021|NCT03003169|breast cancer|breast cancer
90022|NCT03003169|quality of life|quality of life
90023|NCT03003156|magnetic seizure therapy|magnetic seizure therapy
90024|NCT03003156|schizophrenia|schizophrenia
90025|NCT03003156|controlled trial|controlled trial
90026|NCT03003156|cognition|cognition
90027|NCT03003130|Hyaluronic acid|hyaluronic acid
90028|NCT03003130|Comparative study|comparative study
90029|NCT03003130|NLF|nlf
90030|NCT03003117|Infant|infant
90031|NCT03003117|Diet|diet
90032|NCT03003117|Growth|growth
90033|NCT03003117|Breastfeeding|breastfeeding
90034|NCT03003117|Complementary feeding|complementary feeding
90035|NCT03003117|Pregnancy|pregnancy
90036|NCT03003117|Body mass index|body mass index
90037|NCT03003117|Social disadvantage|social disadvantage
90038|NCT03003117|Randomized controlled trial|randomized controlled trial
90039|NCT03003117|Education|education
90040|NCT03003117|Food vouchers|food vouchers
90041|NCT03003104|Skin diseases|skin diseases
90042|NCT03003104|rosacea|rosacea
90043|NCT03003078|Pancreatic cancer|pancreatic cancer
90044|NCT03003078|Pancreas|pancreas
90045|NCT03003078|metastases|metastases
90046|NCT03003078|pancreatic tumour|pancreatic tumour
90047|NCT03003078|unresectable|unresectable
90048|NCT03003078|locally advanced|locally advanced
90049|NCT03003078|implantable|implantable
90050|NCT03003078|radiographic|radiographic
90051|NCT03003078|device|device
90052|NCT03003078|Phosphorous-32|phosphorous-32
90053|NCT03003078|OncoSil™|oncosil™
90054|NCT03003078|brachytherapy|brachytherapy
90055|NCT03003078|FOLFIRINOX|folfirinox
90056|NCT03003078|gemcitabine|gemcitabine
90057|NCT03003078|nab-paclitaxel|nab-paclitaxel
90059|NCT03003065|Inoperable cholangiocarcinoma|inoperable cholangiocarcinoma
90060|NCT03003065|Photodynamic therapy|photodynamic therapy
90061|NCT03003065|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
90062|NCT03003052|dental implants|dental implants
90063|NCT03003052|edentulous|edentulous
90064|NCT03003052|dental hygiene|dental hygiene
90065|NCT03003052|evidence-based dentistry|evidence-based dentistry
90066|NCT03003039|GB241|gb241
90067|NCT03003039|Rituximab|rituximab
90068|NCT03003039|B-cell Lymphoma|b-cell lymphoma
90069|NCT03003026|motor learning|motor learning
90070|NCT03003026|participation|participation
90071|NCT03003013|Odontogenic cysts|odontogenic cysts
90072|NCT03003013|Bone substitutes materials|bone substitutes materials
90073|NCT03003013|SYMBIOS®|symbios®
90074|NCT03003013|Platelets rich fibrin (PRF)|platelets rich fibrin (prf)
90075|NCT03003013|Bone regeneration|bone regeneration
90076|NCT03002974|Gout|gout
90077|NCT03002974|Interleukin 1 receptor antagonist|interleukin 1 receptor antagonist
90078|NCT03002974|IL-1 receptor antagonist|il-1 receptor antagonist
90079|NCT03002896|Cancer|cancer
90080|NCT03002896|Caregivers|caregivers
90081|NCT03002896|Pep-pal|pep-pal
90082|NCT03002896|Pep-Pal + Treatment as Usual|pep-pal + treatment as usual
90083|NCT03002896|Treatment as Usual|treatment as usual
90084|NCT03002857|Laryngeal Mask Airway|laryngeal mask airway
90085|NCT03002857|Urologic Surgical Procedure|urologic surgical procedure
90086|NCT03002831|CIK|cik
90087|NCT03002831|Chemotherapy|chemotherapy
90088|NCT03002831|Pancreatic Cancer|pancreatic cancer
90089|NCT03002818|Chronic Hepatitis C (HCV)|chronic hepatitis c (hcv)
90090|NCT03002818|Genotype 1|genotype 1
90091|NCT03002818|Paritaprevir|paritaprevir
90092|NCT03002818|Ritonavir|ritonavir
90093|NCT03002818|ombitasvir|ombitasvir
90094|NCT03002818|Dasabuvir|dasabuvir
90095|NCT03002818|Sustained Virological Response|sustained virological response
90096|NCT03002805|Phase I|phase i
90097|NCT03002805|CBT-1®|cbt-1®
90098|NCT03002805|Doxorubicin|doxorubicin
90099|NCT03002805|Sarcoma|sarcoma
90100|NCT03002792|anesthesia|anesthesia
90101|NCT03002792|neurodevelopment|neurodevelopment
90102|NCT03002792|dental caries|dental caries
90103|NCT03002753|OCD|ocd
90104|NCT03002753|obsessive-compulsive disorder|obsessive-compulsive disorder
90105|NCT03002753|cognitive therapy|cognitive therapy
90106|NCT03002753|metacognitive therapy|metacognitive therapy
90107|NCT03002753|cognitive restructuring|cognitive restructuring
90108|NCT03002753|detached mindfulness|detached mindfulness
90109|NCT03002753|comparison|comparison
90110|NCT03002753|Germany|germany
90111|NCT03002753|Muenster|muenster
90112|NCT03002753|Christoph-Dornier-Stiftung|christoph-dornier-stiftung
90113|NCT03002753|metacognition|metacognition
90114|NCT03002727|Colorectal cancer|colorectal cancer
90115|NCT03002727|Microsatellite|microsatellite
90116|NCT03002727|Colorectal cancer stem cells|colorectal cancer stem cells
90117|NCT03002714|Resistance Training|resistance training
90118|NCT03002714|Psychological Stress|psychological stress
90119|NCT03002714|Aging|aging
90120|NCT03002714|Hypertension|hypertension
90121|NCT03002714|Autonomic Nervous System|autonomic nervous system
90122|NCT03002701|Prevention|prevention
90123|NCT03002701|Critical care|critical care
90124|NCT03002701|Delirium|delirium
90125|NCT03002701|Nurse|nurse
90126|NCT03002701|RCT|rct
90127|NCT03002675|Adipose tissue|adipose tissue
90128|NCT03002675|Type 2 diabetes|type 2 diabetes
90129|NCT03002649|Dermatomyositis|dermatomyositis
90130|NCT03002649|Tofacitinib|tofacitinib
90131|NCT03002649|Refractory dermatomyositis|refractory dermatomyositis
90132|NCT03002636|Obesity|obesity
90133|NCT03002636|Anesthesia Complications|anesthesia complications
90134|NCT03002636|Body Mass Index (BMI)|body mass index (bmi)
90135|NCT03002623|Dual Inhibitor of HDAC and P13K Signaling|dual inhibitor of hdac and p13k signaling
90136|NCT03002623|HDAC2|hdac2
90137|NCT03002623|EGFR/RAS/RAF/MEK/ERK Signaling Pathway Inhibition|egfr/ras/raf/mek/erk signaling pathway inhibition
90138|NCT03002584|IBS, population|ibs, population
90139|NCT03002558|Hypertension|hypertension
90140|NCT03002558|Continuous Positive Airway Pressure|continuous positive airway pressure
90141|NCT03002558|Obstructive Sleep Apnea|obstructive sleep apnea
90142|NCT03002558|Cardiovascular Diseases|cardiovascular diseases
90143|NCT03002545|Magnesium|magnesium
90144|NCT03002545|Type II diabetes|type ii diabetes
90145|NCT03002545|magnesium-sensitive genes|magnesium-sensitive genes
90146|NCT03002532|Breast cancer|breast cancer
90147|NCT03002532|Brain metastasis|brain metastasis
90148|NCT03002532|Whole brain radiotherapy|whole brain radiotherapy
90149|NCT03002532|Hippocampal avoidance|hippocampal avoidance
90150|NCT03002532|Neurocognitive function|neurocognitive function
90151|NCT03002532|intracranial failure|intracranial failure
90152|NCT03002506|ceftolozane|ceftolozane
90153|NCT03002506|tazobactam|tazobactam
90154|NCT03002493|Rifampicin|rifampicin
90155|NCT03002493|Pharmacokinetics|pharmacokinetics
90156|NCT03002493|Eribulin Mesylate|eribulin mesylate
90157|NCT03002493|E7389|e7389
90859|NCT02998476|relapsed|relapsed
90158|NCT03002493|Advanced Solid Tumors|advanced solid tumors
90159|NCT03002493|Tumors|tumors
90160|NCT03002454|99mTc Pertechnetate|99mtc pertechnetate
90161|NCT03002454|Sodium Pertechnetate|sodium pertechnetate
90162|NCT03002454|Technetium|technetium
90163|NCT03002454|Molybdenum|molybdenum
90164|NCT03002454|MDP|mdp
90165|NCT03002454|neutron activation|neutron activation
90166|NCT03002402|asthma|asthma
90167|NCT03002402|insomnia|insomnia
90168|NCT03002402|cognitive-behavioral treatment|cognitive-behavioral treatment
90169|NCT03002389|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
90170|NCT03002389|COPD|copd
90171|NCT03002389|emphysema|emphysema
90172|NCT03002389|MRI|mri
90173|NCT03002389|hyper polarized gas MRI|hyper polarized gas mri
90174|NCT03002363|autism|autism
90175|NCT03002363|audiology|audiology
90176|NCT03002363|video modeling|video modeling
90177|NCT03002363|testing compliance|testing compliance
90178|NCT03002350|Circulating tumor cells (CTCs)|circulating tumor cells (ctcs)
90179|NCT03002350|Optically induced dielectrophoresis (ODEP)|optically induced dielectrophoresis (odep)
90180|NCT03002350|Cell sorting|cell sorting
90181|NCT03002350|Next-generation sequencing (NGS)|next-generation sequencing (ngs)
90182|NCT03002350|disruptive mutation|disruptive mutation
90183|NCT03002337|aromatherapy massage, yoga|aromatherapy massage, yoga
90184|NCT03002324|Vaccines|vaccines
90185|NCT03002324|Childhood Vaccination|childhood vaccination
90186|NCT03002324|Decision Making|decision making
90187|NCT03002324|Health Belief Model|health belief model
90188|NCT03002311|Bioinformatics|bioinformatics
90189|NCT03002311|Electronic pharmacology|electronic pharmacology
90190|NCT03002311|Mobile health|mobile health
90191|NCT03002311|Electronic health|electronic health
90192|NCT03002311|Adherence|adherence
90193|NCT03002311|Digital health|digital health
90194|NCT03002311|Health information technology|health information technology
90195|NCT03002311|mHealth|mhealth
90196|NCT03002311|eHealth|ehealth
90197|NCT03002259|cardiac surgery|cardiac surgery
90198|NCT03002233|TRK-820|trk-820
90199|NCT03002233|Hemodialysis|hemodialysis
90200|NCT03002233|Uremic Pruritus|uremic pruritus
90201|NCT03002194|rhytides|rhytides
90202|NCT03002194|wrinkle|wrinkle
90203|NCT03002142|Alzheimer|alzheimer
90204|NCT03002142|Hearing loss|hearing loss
90205|NCT03002142|Cognition|cognition
90206|NCT03002142|Quality of life|quality of life
90207|NCT03002142|Hearing aids|hearing aids
90208|NCT03002090|iron deficiency|iron deficiency
90209|NCT03002090|anemia|anemia
90210|NCT03002090|exercise training|exercise training
90211|NCT03002090|aerobic|aerobic
90212|NCT03002090|performance|performance
90213|NCT03002090|Chinese medicine|chinese medicine
90214|NCT03002090|BaZhen KeLi|bazhen keli
90215|NCT03002064|Esophagus squamous carcinoma|esophagus squamous carcinoma
90216|NCT03002064|First-line chemotherapy|first-line chemotherapy
90217|NCT03002064|Docetaxel|docetaxel
90218|NCT03002064|Cisplatin|cisplatin
90219|NCT03002064|5-fluorouracil|5-fluorouracil
90220|NCT03002038|neuromyelitis optica spectrum disorder|neuromyelitis optica spectrum disorder
90221|NCT03002038|azathioprine|azathioprine
90222|NCT03002038|rituximab|rituximab
90223|NCT03002038|clinical trial|clinical trial
90224|NCT03002038|annual relapse rate|annual relapse rate
90225|NCT03002038|expanded disability status scale|expanded disability status scale
90226|NCT03002012|cryptococcal antigen|cryptococcal antigen
90227|NCT03002012|preemptive treatment|preemptive treatment
90228|NCT03002012|CRAG+|crag+
90229|NCT03002012|sertraline|sertraline
90230|NCT03002012|fluconazole|fluconazole
90231|NCT03002012|randomized clinical trial|randomized clinical trial
90232|NCT03002012|HIV|hiv
90233|NCT03001999|Diabetes|diabetes
90234|NCT03001999|Positive Psychology|positive psychology
90235|NCT03001999|Physical Activity|physical activity
90236|NCT03001986|safety|safety
90237|NCT03001986|efficacy|efficacy
90238|NCT03001986|hand, foot and mouth disease (HFMD)|hand, foot and mouth disease (hfmd)
90239|NCT03001973|Lupus nephritis|lupus nephritis
90240|NCT03001973|Patient survival|patient survival
90241|NCT03001973|Renal survival|renal survival
90242|NCT03001947|IgA nephropathy|iga nephropathy
90243|NCT03001947|All-cause mortality|all-cause mortality
90244|NCT03001947|Cardiovascular mortality|cardiovascular mortality
90245|NCT03001947|A composite renal outcome|a composite renal outcome
90246|NCT03001934|Nephrotic syndrome|nephrotic syndrome
90247|NCT03001934|Treatment response|treatment response
90248|NCT03001934|Renal function|renal function
90249|NCT03001921|Hemodialysis|hemodialysis
90250|NCT03001921|Patient survival|patient survival
90251|NCT03001921|Quality of life|quality of life
90252|NCT03001921|Hemodialysis access|hemodialysis access
90253|NCT03001908|shoulder|shoulder
90254|NCT03001908|mobilization|mobilization
90255|NCT03001908|electromyography|electromyography
90256|NCT03001908|imaging ultrasound|imaging ultrasound
90257|NCT03001804|Multiple Myeloma|multiple myeloma
90258|NCT03001804|Revlimid|revlimid
90259|NCT03001804|Lenalidomide|lenalidomide
90260|NCT03001804|Non-transplantable|non-transplantable
90261|NCT03001791|CO2 laser|co2 laser
90262|NCT03001791|thermal damage zone|thermal damage zone
90263|NCT03001791|Er:YAG laser|er:yag laser
90264|NCT03001778|Physical Activity|physical activity
90265|NCT03001778|Older Adults|older adults
90266|NCT03001778|Independent Living Facilities|independent living facilities
90267|NCT03001778|Multimedia technology|multimedia technology
90268|NCT03001752|post-extraction dental implant|post-extraction dental implant
90269|NCT03001752|immediate dental implant|immediate dental implant
90270|NCT03001752|open flap|open flap
90271|NCT03001752|flapless|flapless
90272|NCT03001752|bone grafting|bone grafting
90273|NCT03001752|CT Cone Beam|ct cone beam
90274|NCT03001687|hepcidin|hepcidin
90275|NCT03001687|sepsis|sepsis
90276|NCT03001687|surgery|surgery
90277|NCT03001687|vitamin D|vitamin d
90278|NCT03001661|Propess|propess
90279|NCT03001661|Dilapan-S|dilapan-s
90280|NCT03001661|Dinoprostone|dinoprostone
90281|NCT03001661|Labour|labour
90282|NCT03001661|Induction|induction
90283|NCT03001661|Child birth|child birth
90284|NCT03001596|Neoadjuvant Chemoradiotherapy|neoadjuvant chemoradiotherapy
90285|NCT03001596|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
90286|NCT03001596|Minimally Invasive Esophagectomy|minimally invasive esophagectomy
90287|NCT03001596|Esophageal Squamous Cell Carcinoma（cT3-4aN0-1M0）|esophageal squamous cell carcinoma（ct3-4an0-1m0）
90288|NCT03001583|Mediterranean diet|mediterranean diet
90289|NCT03001583|weight loss|weight loss
90290|NCT03001583|type 2 diabetes|type 2 diabetes
90291|NCT03001583|education program|education program
90292|NCT03001583|cooking|cooking
90293|NCT03001557|Mild to Moderate Alzheimer's Disease Dementia|mild to moderate alzheimer's disease dementia
90294|NCT03001557|sleep|sleep
90295|NCT03001557|circadian rhythms|circadian rhythms
90296|NCT03001531|Complete paraplegia|complete paraplegia
90297|NCT03001466|Cataract|cataract
90298|NCT03001466|Urea-loaded NPs|urea-loaded nps
90299|NCT03001466|TEM examination|tem examination
90300|NCT03001453|Exparel|exparel
90301|NCT03001453|total hip replacement|total hip replacement
90302|NCT03001453|bupivacaine|bupivacaine
90303|NCT03001440|REMS|rems
90304|NCT03001440|Smoking cessation|smoking cessation
90305|NCT03001440|WELLBUTRIN|wellbutrin
90306|NCT03001440|ZYBAN|zyban
90307|NCT03001440|Neuropsychiatric adverse events|neuropsychiatric adverse events
90308|NCT03001388|Cystic Fibrosis Liver Disease|cystic fibrosis liver disease
90309|NCT03001388|Pancreatic insufficiency|pancreatic insufficiency
90310|NCT03001388|Cystic Fibrosis|cystic fibrosis
90311|NCT03001388|Transient Elastography|transient elastography
90312|NCT03001375|Laparoscopic colectomy.|laparoscopic colectomy.
90313|NCT03001375|Splenic flexure mobilization.|splenic flexure mobilization.
90314|NCT03001375|Anastomotic leakage.|anastomotic leakage.
90315|NCT03001349|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
90316|NCT03001349|Neuroendocrine Tumors|neuroendocrine tumors
90317|NCT03001349|NET|net
90318|NCT03001349|Malignant neoplasms of eye brain and other parts of central nervous system|malignant neoplasms of eye brain and other parts of central nervous system
90319|NCT03001349|PET/CT scan|pet/ct scan
90320|NCT03001349|68Ga-DOTATOC|68ga-dotatoc
90321|NCT03001336|Thyroid|thyroid
90322|NCT03001336|Diabetes Mellitus|diabetes mellitus
90323|NCT03001297|atherosclerosis; acute coronary syndrome; MEDI5884|atherosclerosis; acute coronary syndrome; medi5884
90324|NCT03001271|Angiotensin-(1-7)|angiotensin-(1-7)
90325|NCT03001271|Renin-angiotensin System|renin-angiotensin system
90326|NCT03001271|Autonomic Nervous System|autonomic nervous system
90327|NCT03001245|adolescents|adolescents
90328|NCT03001245|depression|depression
90329|NCT03001245|psychotherapy|psychotherapy
90330|NCT03001245|interpersonal therapy|interpersonal therapy
90331|NCT03001232|Movement-oriented Dementia Care|movement-oriented dementia care
90332|NCT03001232|QoL|qol
90333|NCT03001232|ADL|adl
90334|NCT03001232|Nursing Home|nursing home
90335|NCT03001193|Primary slow progress|primary slow progress
90336|NCT03001193|Prolonged latent phase|prolonged latent phase
90337|NCT03001193|Labor arrest|labor arrest
90338|NCT03001180|Generalized Lymphatic Anomaly|generalized lymphatic anomaly
90339|NCT03001180|Vascular Anomaly|vascular anomaly
90340|NCT03001180|Kaposiform Hemangioendothelioma|kaposiform hemangioendothelioma
90341|NCT03001180|Kaposiform Lymphangiomatosis|kaposiform lymphangiomatosis
90342|NCT03001180|Vascular Endothelial Growth Factor|vascular endothelial growth factor
90343|NCT03001180|Biomarkers|biomarkers
90344|NCT03001180|GLA|gla
90345|NCT03001180|KLA|kla
90346|NCT03001180|KHE|khe
90347|NCT03001180|GSD|gsd
90348|NCT03001167|Microbiome|microbiome
90349|NCT03001167|Antibiotics|antibiotics
90350|NCT03001167|Growth|growth
90351|NCT03001141|MultiPoint Pacing|multipoint pacing
90352|NCT03001141|Heart Failure|heart failure
90353|NCT03001141|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
90354|NCT03001141|Quadripolar pacing|quadripolar pacing
90355|NCT03001115|Adalimumab|adalimumab
90356|NCT03001115|Safety|safety
90357|NCT03001115|Hidradenitis Suppurativa|hidradenitis suppurativa
90358|NCT03001115|Korean participants|korean participants
90359|NCT03001102|Preoperative Care|preoperative care
90360|NCT03001102|Baths|baths
90361|NCT03001102|Chlorhexidine|chlorhexidine
90362|NCT03001102|Soaps|soaps
90363|NCT03001102|Povidone-Iodine|povidone-iodine
90364|NCT03001102|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
90365|NCT03001102|Surgical Wound Infection|surgical wound infection
90366|NCT03001089|Neonatology|neonatology
90367|NCT03001089|Endocrinology|endocrinology
90368|NCT03001076|hyperlididemia|hyperlididemia
90369|NCT03001076|LDL|ldl
90370|NCT03001076|cholesterol|cholesterol
90371|NCT03001076|statin intolerance|statin intolerance
90372|NCT03001037|Functional Outcome Measures|functional outcome measures
90373|NCT03001037|Wearable Sensors|wearable sensors
90374|NCT03001037|ViMove|vimove
90375|NCT03001037|Low Back Pain|low back pain
90376|NCT03001037|Range of Movement|range of movement
90377|NCT03001037|Muscle Activity|muscle activity
90378|NCT03000998|HPV|hpv
90379|NCT03000998|Cancer|cancer
90380|NCT03000985|schizophrenia|schizophrenia
90381|NCT03000985|psychoeducation program|psychoeducation program
90382|NCT03000985|family caregiver|family caregiver
90383|NCT03000985|relapse|relapse
90384|NCT03000985|medication adherence|medication adherence
90385|NCT03000985|burden|burden
90386|NCT03000972|Augmentation|augmentation
90387|NCT03000972|PET-CT|pet-ct
90388|NCT03000972|Positron Emission Tomography|positron emission tomography
90389|NCT03000972|Fluorine-18|fluorine-18
90390|NCT03000946|Pancreatectomy|pancreatectomy
90391|NCT03000946|Somatostatin analogue|somatostatin analogue
90392|NCT03000946|Octreotide|octreotide
90393|NCT03000946|Pancreatic fistula|pancreatic fistula
90394|NCT03000920|short message service (SMS)|short message service (sms)
90395|NCT03000920|screening|screening
90396|NCT03000920|cost-effectiveness|cost-effectiveness
90397|NCT03000907|prevention|prevention
90398|NCT03000907|frailty|frailty
90399|NCT03000907|obese|obese
90400|NCT03000907|elderly|elderly
90401|NCT03000907|physical exercise|physical exercise
90402|NCT03000894|cognitive-behavioral therapy for insomnia|cognitive-behavioral therapy for insomnia
90403|NCT03000894|insomnia|insomnia
90404|NCT03000894|mood disorder|mood disorder
90405|NCT03000868|Colonic Polyps|colonic polyps
90406|NCT03000868|Endoscopic Mucosal Resection|endoscopic mucosal resection
90407|NCT03000868|Colonoscopy|colonoscopy
90408|NCT03000855|Malignant biliary obstruction|malignant biliary obstruction
90409|NCT03000855|EUS - guided choledocho-duodenostomy|eus - guided choledocho-duodenostomy
90410|NCT03000855|ERCP with covered metallic stents|ercp with covered metallic stents
90411|NCT03000842|autonomic control|autonomic control
90412|NCT03000842|transcutaneous vagal nerve stimulation|transcutaneous vagal nerve stimulation
90413|NCT03000842|transauricular vagal nerve stimulation|transauricular vagal nerve stimulation
90414|NCT03000829|Code blue|code blue
90415|NCT03000829|Code team|code team
90416|NCT03000829|Crisis team leadership|crisis team leadership
90417|NCT03000829|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
90418|NCT03000829|Telemedicine|telemedicine
90419|NCT03000829|Simulation|simulation
90420|NCT03000829|Mock code|mock code
90421|NCT03000829|In-hospital cardiac arrest|in-hospital cardiac arrest
90422|NCT03000790|Anterior disc displacement|anterior disc displacement
90423|NCT03000790|TMD therapy|tmd therapy
90424|NCT03000790|internal derangement|internal derangement
90425|NCT03000790|Lingual Ring|lingual ring
90426|NCT03000777|melatonin|melatonin
90427|NCT03000777|zinc|zinc
90428|NCT03000777|Myalgic Encephalomyelitis|myalgic encephalomyelitis
90429|NCT03000777|Chronic Fatigue Syndrome|chronic fatigue syndrome
90430|NCT03000777|sleep|sleep
90431|NCT03000777|pain|pain
90432|NCT03000764|Skin biopsy|skin biopsy
90433|NCT03000764|Radiotherapy|radiotherapy
90434|NCT03000764|RNA biomarker|rna biomarker
90435|NCT03000764|HSP biomarker|hsp biomarker
90436|NCT03000764|Exon junction array|exon junction array
90437|NCT03000764|Gene expression|gene expression
90438|NCT03000764|Radiosensitivity prediction|radiosensitivity prediction
90439|NCT03000751|CT scan|ct scan
90440|NCT03000751|CT exam|ct exam
90441|NCT03000751|ionizing radiation|ionizing radiation
90442|NCT03000751|medical imaging|medical imaging
90443|NCT03000751|cat scan|cat scan
90444|NCT03000751|radiation|radiation
90445|NCT03000738|CD16- monocyte/CD16+ monocyte ratio|cd16- monocyte/cd16+ monocyte ratio
90446|NCT03000738|CytoDiff flow cytometric system|cytodiff flow cytometric system
90447|NCT03000738|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
90448|NCT03000738|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
90449|NCT03000738|prognosis|prognosis
90450|NCT03000712|adipose tissue derived mesenchymal stem cell|adipose tissue derived mesenchymal stem cell
90451|NCT03000712|osteoarthritis|osteoarthritis
90452|NCT03000712|degenerative arthritis|degenerative arthritis
90453|NCT03000712|kyung hee university hospital|kyung hee university hospital
90454|NCT03000712|biostar|biostar
90455|NCT03000712|Rbio|rbio
90456|NCT03000712|Osteoarthritis, Knee|osteoarthritis, knee
90860|NCT02998476|refractory|refractory
90457|NCT03000712|High tibial osteotomy|high tibial osteotomy
90458|NCT03000712|Joint Diseases|joint diseases
90459|NCT03000699|cognitive bias modification|cognitive bias modification
90460|NCT03000699|interpretation bias|interpretation bias
90461|NCT03000699|suicidal ideation|suicidal ideation
90462|NCT03000699|depression|depression
90463|NCT03000686|GSK2586881, Acute hypoxia, Exercise|gsk2586881, acute hypoxia, exercise
90464|NCT03000660|Amyloidosis|amyloidosis
90465|NCT03000660|AL Amyloidosis|al amyloidosis
90466|NCT03000660|Amyloid Light Chain Amylodosis|amyloid light chain amylodosis
90467|NCT03000660|ABT-199|abt-199
90468|NCT03000660|Venetoclax|venetoclax
90469|NCT03000647|Pelvic floor muscle exercise|pelvic floor muscle exercise
90470|NCT03000647|Supervision|supervision
90471|NCT03000647|Physiotherapy|physiotherapy
90472|NCT03000621|MicroRNA|microrna
90473|NCT03000621|miR-122|mir-122
90474|NCT03000621|Diagnosis|diagnosis
90475|NCT03000621|Prognosis|prognosis
90476|NCT03000595|eczema|eczema
90477|NCT03000569|Parkinson|parkinson
90478|NCT03000543|vitamin A|vitamin a
90479|NCT03000543|vitamin A isotope|vitamin a isotope
90480|NCT03000543|Inflammation|inflammation
90481|NCT03000530|Depression|depression
90482|NCT03000517|levofloxacin|levofloxacin
90483|NCT03000517|multi-drug resistant TB|multi-drug resistant tb
90484|NCT03000517|pharmacokinetics|pharmacokinetics
90485|NCT03000465|pneumoperitoneum pressure|pneumoperitoneum pressure
90486|NCT03000465|laparoscopic pressure|laparoscopic pressure
90487|NCT03000465|intra-abdominal insufflation|intra-abdominal insufflation
90488|NCT03000465|intra-abdominal pressures|intra-abdominal pressures
90489|NCT03000465|abdominal compliance|abdominal compliance
90490|NCT03000452|Multiple Myeloma|multiple myeloma
90491|NCT03000452|Daratumumab|daratumumab
90492|NCT03000452|Durvalumab|durvalumab
90493|NCT03000452|Relapsed and Refractory Multiple Myeloma|relapsed and refractory multiple myeloma
90494|NCT03000439|systemic Juvenile Idiopathic Arthritis|systemic juvenile idiopathic arthritis
90495|NCT03000439|Xeljanz|xeljanz
90496|NCT03000439|Tofacitinib|tofacitinib
90497|NCT03000439|sJIA|sjia
90498|NCT03000439|CP-690 550|cp-690 550
90499|NCT03000426|Low level laser therapy|low level laser therapy
90500|NCT03000387|Nicotine Replacement Therapy|nicotine replacement therapy
90501|NCT03000387|Smoking Cessation|smoking cessation
90502|NCT03000387|Randomized Clinical Trial|randomized clinical trial
90503|NCT03000387|Nicotine Patch|nicotine patch
90504|NCT03000387|Abstinence|abstinence
90505|NCT03000387|Placebo|placebo
90506|NCT03000387|Double blind|double blind
90507|NCT03000361|Colonoscopy|colonoscopy
90508|NCT03000361|motorized spiral endoscopy|motorized spiral endoscopy
90509|NCT03000361|adenoma detection rate|adenoma detection rate
90510|NCT03000348|Exacerbation|exacerbation
90511|NCT03000348|CF|cf
90512|NCT03000348|Lung disease|lung disease
90513|NCT03000348|Lung infection|lung infection
90514|NCT03000348|Gram negative|gram negative
90515|NCT03000348|Bacterial Infection|bacterial infection
90516|NCT03000348|pneumonia|pneumonia
90517|NCT03000348|bronchitis|bronchitis
90518|NCT03000335|microRNA|microrna
90519|NCT03000335|relapse|relapse
90520|NCT03000335|blood|blood
90521|NCT03000335|in vitro diagnostics|in vitro diagnostics
90522|NCT03000335|prediction|prediction
90523|NCT03000335|lab test|lab test
90524|NCT03000296|autologous|autologous
90525|NCT03000296|lymphoablation|lymphoablation
90526|NCT03000296|hematopoetic stem cell transplant|hematopoetic stem cell transplant
90527|NCT03000296|immune system|immune system
90528|NCT03000296|Bone marrow transplant|bone marrow transplant
90529|NCT03000283|Conivaptan|conivaptan
90530|NCT03000270|Infarct Size|infarct size
90531|NCT03000270|Impella|impella
90532|NCT03000270|Unloading|unloading
90533|NCT03000270|Left Ventricle|left ventricle
90534|NCT03000270|PPCI|ppci
90535|NCT03000270|STEMI|stemi
90536|NCT03000257|Cancer|cancer
90537|NCT03000257|Advanced Solid Tumors|advanced solid tumors
90538|NCT03000257|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
90539|NCT03000257|Triple negative breast cancer|triple negative breast cancer
90540|NCT03000257|Ovarian cancer|ovarian cancer
90541|NCT03000257|Hepatocellular carcinoma|hepatocellular carcinoma
90542|NCT03000257|Gastric cancer|gastric cancer
90543|NCT03000257|Small cell lung cancer|small cell lung cancer
90544|NCT03000257|Mesothelioma|mesothelioma
90545|NCT03000257|Cholangiocarcinoma|cholangiocarcinoma
90546|NCT03000257|Merkel cell carcinoma|merkel cell carcinoma
90547|NCT03000257|Head and neck cancer|head and neck cancer
90548|NCT03000244|Natural History|natural history
90549|NCT03000244|HCT|hct
90550|NCT03000205|Dextrose prolotherapy|dextrose prolotherapy
90551|NCT03000205|patients|patients
90552|NCT03000192|Survivorship|survivorship
90553|NCT03000192|Cancer|cancer
90554|NCT03000192|Recovery|recovery
90555|NCT03000192|Self-management|self-management
90556|NCT03000192|Cohort|cohort
90557|NCT03000179|small bowel cancer, small bowel carcinoma|small bowel cancer, small bowel carcinoma
90558|NCT03000127|testosterone|testosterone
90559|NCT03000127|multiple sclerosis|multiple sclerosis
90560|NCT03000127|fatigue|fatigue
90561|NCT03000114|Collagenase injection|collagenase injection
90562|NCT03000114|percutaneous needle aponeurotomy|percutaneous needle aponeurotomy
90563|NCT03000101|Biomarkers|biomarkers
90564|NCT03000101|Colitis|colitis
90565|NCT03000101|Colitis, Ulcerative|colitis, ulcerative
90566|NCT03000101|Colonic Diseases|colonic diseases
90567|NCT03000101|Crohn Disease|crohn disease
90568|NCT03000101|Digestive System Diseases|digestive system diseases
90569|NCT03000101|Fruit|fruit
90570|NCT03000101|Fruit and Vegetable Juices|fruit and vegetable juices
90571|NCT03000101|Gastroenteritis|gastroenteritis
90572|NCT03000101|Gastrointestinal Diseases|gastrointestinal diseases
90573|NCT03000101|Humans|humans
90574|NCT03000101|Hydrolysable Tannins|hydrolysable tannins
90575|NCT03000101|Inflammation|inflammation
90576|NCT03000101|Inflammatory Bowel Diseases|inflammatory bowel diseases
90577|NCT03000101|Intestinal Diseases|intestinal diseases
90578|NCT03000101|Punicaceae|punicaceae
90579|NCT03000075|BI 655066|bi 655066
90580|NCT03000075|ABBV-066|abbv-066
90581|NCT03000075|risankizumab|risankizumab
90582|NCT03000062|overweight, general practice|overweight, general practice
90583|NCT03000049|sepsis|sepsis
90584|NCT03000049|septic shock|septic shock
90585|NCT03000049|blood cultures|blood cultures
90586|NCT03000049|anti-infective therapy|anti-infective therapy
90587|NCT03000036|Breast cancer|breast cancer
90588|NCT03000036|Doxorubicin|doxorubicin
90589|NCT03000036|Cardiovascular Magnetic Resonance|cardiovascular magnetic resonance
90590|NCT03000036|T1 mapping|t1 mapping
90591|NCT03000023|Hepatitis C|hepatitis c
90592|NCT03000023|Patient-Reported Outcomes|patient-reported outcomes
90593|NCT03000023|DAA Treatment|daa treatment
90594|NCT03000023|Qualitative|qualitative
90595|NCT03000023|Mixed methods|mixed methods
90596|NCT03000010|Wound Vac|wound vac
90597|NCT03000010|Neuromuscular Scoliosis|neuromuscular scoliosis
90598|NCT03000010|Posterior Spinal Fusion|posterior spinal fusion
90599|NCT02999997|Physical therapy modalities|physical therapy modalities
90600|NCT02999997|Dual-task performance|dual-task performance
90601|NCT02999997|Parkinson's disease|parkinson's disease
90602|NCT02999997|Active music therapy|active music therapy
90603|NCT02999997|Physical activity|physical activity
90604|NCT02999971|circuit class therapy|circuit class therapy
90605|NCT02999971|ICF model|icf model
90606|NCT02999971|aquatic therapy|aquatic therapy
90607|NCT02999971|neuro-rehabilitation|neuro-rehabilitation
90608|NCT02999945|preterm infants|preterm infants
90609|NCT02999945|SGA infants|sga infants
90610|NCT02999945|IUGR infants|iugr infants
90611|NCT02999945|growth|growth
90612|NCT02999945|body composition|body composition
90613|NCT02999945|metabolomics|metabolomics
90614|NCT02999945|microbiome|microbiome
90615|NCT02999945|adiposity markers|adiposity markers
90616|NCT02999945|metabolic programming|metabolic programming
90617|NCT02999945|neurodevelopmental outcome|neurodevelopmental outcome
90618|NCT02999906|PAH|pah
90619|NCT02999906|Oral Treprostinil|oral treprostinil
90620|NCT02999906|dual therapy|dual therapy
90621|NCT02999906|6 Minute Walk Test|6 minute walk test
90622|NCT02999854|Haploidentical stem cell transplantation|haploidentical stem cell transplantation
90623|NCT02999854|Graft-versus-host disease|graft-versus-host disease
90624|NCT02999854|Immune reconstitution|immune reconstitution
90625|NCT02999854|Alloreactive T-cells|alloreactive t-cells
90626|NCT02999854|Photodynamic treatment|photodynamic treatment
90627|NCT02999854|Hematologic malignancy|hematologic malignancy
90628|NCT02999854|Transplant-related mortality|transplant-related mortality
90629|NCT02999854|Overall survival|overall survival
90630|NCT02999854|GRFS|grfs
90631|NCT02999854|GVHD|gvhd
90632|NCT02999841|Visceral fat|visceral fat
90633|NCT02999828|safety|safety
90634|NCT02999828|immune persistence|immune persistence
90635|NCT02999815|Tetanus|tetanus
90636|NCT02999802|Nutrient Sensing|nutrient sensing
90637|NCT02999802|Exercise|exercise
90638|NCT02999802|Elderly|elderly
90639|NCT02999789|Asthma/drug therapy|asthma/drug therapy
90640|NCT02999789|Medication Adherence/statistics & numerical data|medication adherence/statistics & numerical data
90641|NCT02999789|Reminder Systems|reminder systems
90642|NCT02999789|Communication Barriers|communication barriers
90643|NCT02999776|Plaques Psoriasis|plaques psoriasis
90644|NCT02999776|Topical|topical
90645|NCT02999776|Laser microporation|laser microporation
90646|NCT02999763|lipolysis|lipolysis
90647|NCT02999763|fat reduction|fat reduction
90648|NCT02999763|circumference reduction|circumference reduction
90649|NCT02999737|Platelet Rich Plasma|platelet rich plasma
90650|NCT02999737|PRP|prp
90651|NCT02999737|Hair loss|hair loss
90652|NCT02999737|Alopecia|alopecia
90653|NCT02999737|Hypotrichosis|hypotrichosis
90654|NCT02999737|Hair diseases|hair diseases
90655|NCT02999698|Psoriasis|psoriasis
90656|NCT02999698|Hidradenitis|hidradenitis
90657|NCT02999698|Psychological impact|psychological impact
90658|NCT02999698|Quality of life|quality of life
90659|NCT02999659|pupillometry|pupillometry
90660|NCT02999659|autonomous nerve system|autonomous nerve system
90661|NCT02999646|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
90662|NCT02999646|cancer|cancer
90663|NCT02999646|HNSCC|hnscc
90664|NCT02999646|immunotherapy|immunotherapy
90665|NCT02999646|MVX-ONCO-1|mvx-onco-1
90666|NCT02999607|Transcranial direct current stimulation|transcranial direct current stimulation
90667|NCT02999607|Positron emission tomography|positron emission tomography
90668|NCT02999529|Chemotherapy|chemotherapy
90669|NCT02999529|Oncology|oncology
90670|NCT02999503|adhd treatment|adhd treatment
90671|NCT02999503|nutrition|nutrition
90672|NCT02999477|Breast Cancer|breast cancer
90673|NCT02999464|stroke|stroke
90674|NCT02999464|qigong|qigong
90675|NCT02999464|randomized controlled trial|randomized controlled trial
90676|NCT02999464|body-mind exercise|body-mind exercise
90677|NCT02999464|balance|balance
90678|NCT02999464|quality of life|quality of life
90679|NCT02999464|wellbeing|wellbeing
90680|NCT02999412|Integrated Healthcare System|integrated healthcare system
90681|NCT02999412|Inappropriate Prescribing|inappropriate prescribing
90682|NCT02999412|Pragmatic Clinical Trial|pragmatic clinical trial
90683|NCT02999412|Crossover Design|crossover design
90684|NCT02999412|Randomised Controlled Trial|randomised controlled trial
90685|NCT02999399|Smoker|smoker
90686|NCT02999399|Former smoker|former smoker
90687|NCT02999386|stress, hyperglycemia, inflammatory markers, trauma, HbA1c|stress, hyperglycemia, inflammatory markers, trauma, hba1c
90688|NCT02999386|interleukin-6|interleukin-6
90689|NCT02999373|prevention, infection, preterm, cord blood mononuclear cells|prevention, infection, preterm, cord blood mononuclear cells
90690|NCT02999360|Aphasia|aphasia
90691|NCT02999360|Speech Therapy|speech therapy
90692|NCT02999360|Aerobic Exercise (AE)|aerobic exercise (ae)
90693|NCT02999347|Treatment Outcome|treatment outcome
90694|NCT02999347|Mid-urethral slings|mid-urethral slings
90695|NCT02999347|Gynecologic Surgery Procedures|gynecologic surgery procedures
90696|NCT02999334|Group healthcare models|group healthcare models
90697|NCT02999334|Antenatal care|antenatal care
90698|NCT02999334|Prenatal care|prenatal care
90699|NCT02999334|Perinatal health|perinatal health
90700|NCT02999334|CenteringPregnancy|centeringpregnancy
90701|NCT02999334|sub-Saharan Africa|sub-saharan africa
90702|NCT02999334|Malawi|malawi
90703|NCT02999334|Tanzania|tanzania
90704|NCT02999334|Pregnancy|pregnancy
90705|NCT02999308|haemophilia|haemophilia
90706|NCT02999308|prophylaxis|prophylaxis
90707|NCT02999308|children|children
90708|NCT02999282|TMS|tms
90709|NCT02999282|tDCS|tdcs
90710|NCT02999282|Rehabilitation|rehabilitation
90711|NCT02999269|electroconvulsive therapy|electroconvulsive therapy
90712|NCT02999269|MRI|mri
90713|NCT02999269|major depressive disorder|major depressive disorder
90714|NCT02999256|Tart Cherry Juice|tart cherry juice
90715|NCT02999256|Fat Oxidation|fat oxidation
90716|NCT02999256|Lipid Profile|lipid profile
90717|NCT02999256|Anthocyanins|anthocyanins
90718|NCT02999256|Exercise|exercise
90719|NCT02999256|Calorie Restrictive Mimetic|calorie restrictive mimetic
90720|NCT02999230|Cavities|cavities
90721|NCT02999217|iron isomaltoside|iron isomaltoside
90722|NCT02999217|plasma ferritin|plasma ferritin
90723|NCT02999217|haemoglobin|haemoglobin
90724|NCT02999217|colorectal cancer|colorectal cancer
90725|NCT02999165|Breastfeeding|breastfeeding
90726|NCT02999165|CPAP|cpap
90727|NCT02999165|Humidified High Flow Nasal Cannula Oxygen|humidified high flow nasal cannula oxygen
90728|NCT02999165|preterm neonate|preterm neonate
90729|NCT02999152|Bio-markers|bio-markers
90730|NCT02999152|Radiation|radiation
90731|NCT02999152|Appropriate therapeutic strategy|appropriate therapeutic strategy
90732|NCT02999152|Total Body Irradiation|total body irradiation
90733|NCT02999152|Partial Body Irradiation|partial body irradiation
90734|NCT02999139|Injury|injury
90735|NCT02999139|Prevention|prevention
90736|NCT02999126|Total Intravenous Anesthesia|total intravenous anesthesia
90737|NCT02999126|Titration|titration
90738|NCT02999126|Target Controlled Infusion|target controlled infusion
90739|NCT02999126|Propofol|propofol
90740|NCT02999126|Bispectral index|bispectral index
90741|NCT02999113|non-technical skills|non-technical skills
90742|NCT02999113|patient safety|patient safety
90743|NCT02999113|medical education|medical education
90744|NCT02999100|oxytocin|oxytocin
90745|NCT02999100|non-pregnant|non-pregnant
90746|NCT02999100|pregnant|pregnant
90747|NCT02999100|Postpartum Hemorrhage|postpartum hemorrhage
90748|NCT02999087|Head and Neck cancer|head and neck cancer
90749|NCT02999087|Immunotherapy|immunotherapy
90750|NCT02999074|exercise|exercise
90751|NCT02999074|resistance training|resistance training
90752|NCT02999074|aerobic training|aerobic training
90753|NCT02999074|breast cancer|breast cancer
90754|NCT02999074|neoadjuvant chemotherapy|neoadjuvant chemotherapy
90755|NCT02999074|fatigue|fatigue
90756|NCT02999074|quality of life|quality of life
90757|NCT02999074|tumor response|tumor response
91256|NCT02995824|Raltegravir|raltegravir
90758|NCT02999061|pre-term children|pre-term children
90759|NCT02999048|panax notoginseng saponins|panax notoginseng saponins
90760|NCT02999048|hypertensive intracerebral hemorrhage|hypertensive intracerebral hemorrhage
90761|NCT02999048|hematoma|hematoma
90762|NCT02999048|neurological function|neurological function
90763|NCT02999035|ocular surface sensitivity|ocular surface sensitivity
90764|NCT02999022|bone fractures|bone fractures
90765|NCT02999022|bony callus|bony callus
90766|NCT02999022|fractures, bone|fractures, bone
90767|NCT02999022|lithium|lithium
90768|NCT02999022|lithium carbonate|lithium carbonate
90769|NCT02999022|osteogenesis|osteogenesis
90770|NCT02999022|bone development|bone development
90771|NCT02999022|fracture healing|fracture healing
90772|NCT02999022|fracture repair|fracture repair
90773|NCT02998970|Cardiovascular Disease|cardiovascular disease
90774|NCT02998970|Type 2 Diabetes|type 2 diabetes
90775|NCT02998970|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
90776|NCT02998957|Acupuncture|acupuncture
90777|NCT02998957|TENS|tens
90778|NCT02998957|Physiotherapy|physiotherapy
90779|NCT02998931|Glutamin|glutamin
90780|NCT02998931|Enteral Nutrition|enteral nutrition
90781|NCT02998931|Intensive Care Unit|intensive care unit
90782|NCT02998931|Critical Care Outcomes|critical care outcomes
90783|NCT02998931|inflammatory|inflammatory
90784|NCT02998931|Immune System|immune system
90785|NCT02998918|Inflammation|inflammation
90786|NCT02998918|HDL|hdl
90787|NCT02998918|Anti-inflammatory|anti-inflammatory
90788|NCT02998918|Supplementation|supplementation
90789|NCT02998918|Curcumin|curcumin
90790|NCT02998918|polyphenol|polyphenol
90791|NCT02998918|V-cam|v-cam
90792|NCT02998918|I-cam|i-cam
90793|NCT02998918|atherosclerosis|atherosclerosis
90794|NCT02998918|cardiovascular disease|cardiovascular disease
90795|NCT02998918|atherogenesis|atherogenesis
90796|NCT02998918|antioxidant|antioxidant
90797|NCT02998918|resveratrol|resveratrol
90798|NCT02998918|quercetin|quercetin
90799|NCT02998892|Sedentary Behavior|sedentary behavior
90800|NCT02998866|Cryoballoon Pulmonary Vein Isolation|cryoballoon pulmonary vein isolation
90801|NCT02998866|Esophageal Effects|esophageal effects
90802|NCT02998853|Non culprit|non culprit
90803|NCT02998853|STEMI PCI|stemi pci
90804|NCT02998853|angio QFR|angio qfr
90805|NCT02998853|FFR|ffr
90806|NCT02998853|Staged procedure|staged procedure
90807|NCT02998840|elevated blood pressure|elevated blood pressure
90808|NCT02998814|fissure sealant|fissure sealant
90809|NCT02998814|etch and rinse|etch and rinse
90810|NCT02998814|self etch|self etch
90811|NCT02998788|heart failure|heart failure
90812|NCT02998788|risk factor|risk factor
90813|NCT02998788|cardiovascular disease|cardiovascular disease
90814|NCT02998788|lifestyle behavior|lifestyle behavior
90815|NCT02998775|in vitro protein binding|in vitro protein binding
90816|NCT02998775|hepatic impairment|hepatic impairment
90817|NCT02998775|renal impairment|renal impairment
90818|NCT02998762|major depression|major depression
90819|NCT02998762|major depressive disorder|major depressive disorder
90820|NCT02998762|biomarkers|biomarkers
90821|NCT02998762|MDD|mdd
90822|NCT02998762|long term follow up|long term follow up
90823|NCT02998736|Colon|colon
90824|NCT02998723|Basic Life Support|basic life support
90825|NCT02998723|Education, Medical|education, medical
90826|NCT02998723|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
90827|NCT02998723|Learning|learning
90828|NCT02998697|Systolic Heart Failure|systolic heart failure
90829|NCT02998697|Anemia|anemia
90830|NCT02998697|Iron Deficiency|iron deficiency
90831|NCT02998684|Autism|autism
90832|NCT02998684|Adolescent|adolescent
90833|NCT02998684|Social skills|social skills
90834|NCT02998671|Acne, inflammatory acne, efficacy, safety, PK|acne, inflammatory acne, efficacy, safety, pk
90835|NCT02998658|Laparoscopy|laparoscopy
90836|NCT02998658|Barbed sutures|barbed sutures
90837|NCT02998658|Hysterectomy|hysterectomy
90838|NCT02998645|severe acquired aplastic anemia|severe acquired aplastic anemia
90839|NCT02998645|SAA|saa
90840|NCT02998645|first line|first line
90841|NCT02998645|eltrombopag|eltrombopag
90842|NCT02998645|cyclosporine|cyclosporine
90843|NCT02998645|h-ATG|h-atg
90844|NCT02998645|severe aplastic anemia|severe aplastic anemia
90845|NCT02998645|aplastic anemia|aplastic anemia
90846|NCT02998593|Semen parameters Male infertility oligospermia Traditional Medicine|semen parameters male infertility oligospermia traditional medicine
90847|NCT02998580|late-life depression|late-life depression
90848|NCT02998580|treatment resistance|treatment resistance
90849|NCT02998515|supplemental oxygen|supplemental oxygen
90850|NCT02998515|concentrator|concentrator
90851|NCT02998515|endurance shuttle walk test|endurance shuttle walk test
90852|NCT02998502|Obsessive Compulsive Disorder (OCD)|obsessive compulsive disorder (ocd)
90853|NCT02998502|Anxiety|anxiety
90854|NCT02998502|Pediatrics|pediatrics
90855|NCT02998489|enteral nutrition|enteral nutrition
90856|NCT02998489|infant,premature|infant,premature
90857|NCT02998489|feeding method|feeding method
90858|NCT02998476|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
90861|NCT02998476|non-Hodgkin lymphoma|non-hodgkin lymphoma
90862|NCT02998476|phosphatidylinositol 3-kinase δ (PI3Kδ) inhibitor|phosphatidylinositol 3-kinase δ (pi3kδ) inhibitor
90863|NCT02998476|Bruton's tyrosine kinase (BTK)|bruton's tyrosine kinase (btk)
90864|NCT02998463|Skin-to-skin|skin-to-skin
90865|NCT02998463|Kangaroo Care|kangaroo care
90866|NCT02998463|Kangaroo Mother Care|kangaroo mother care
90867|NCT02998450|Sickle Cell Disease|sickle cell disease
90868|NCT02998450|Sickle Beta 0 Thalassemia|sickle beta 0 thalassemia
90869|NCT02998424|propofol|propofol
90870|NCT02998424|pupillary diameter|pupillary diameter
90871|NCT02998411|anti-infectives|anti-infectives
90872|NCT02998411|adults|adults
90873|NCT02998411|pharmacokinetic|pharmacokinetic
90874|NCT02998411|pharmacodynamic end-points|pharmacodynamic end-points
90875|NCT02998411|clinical cure|clinical cure
90876|NCT02998398|Biosimilar|biosimilar
90877|NCT02998385|salivary glands|salivary glands
90878|NCT02998385|sinus carcinoma|sinus carcinoma
90879|NCT02998385|radiochemotherapy concomitant|radiochemotherapy concomitant
90880|NCT02998385|cisplatin|cisplatin
90881|NCT02998385|protontherapy|protontherapy
90882|NCT02998346|Nutrition|nutrition
90883|NCT02998346|CRRT|crrt
90884|NCT02998346|CVVH|cvvh
90885|NCT02998346|citrate|citrate
90886|NCT02998346|anticoagulation|anticoagulation
90887|NCT02998346|caloric uptake|caloric uptake
90888|NCT02998333|Instability|instability
90889|NCT02998333|Ankle|ankle
90890|NCT02998333|Surgical stabilization|surgical stabilization
90891|NCT02998281|cerebral palsy|cerebral palsy
90892|NCT02998281|inspiratory muscle training|inspiratory muscle training
90893|NCT02998255|PEG|peg
90894|NCT02998255|Bowel preparation|bowel preparation
90895|NCT02998255|Colonoscopy|colonoscopy
90896|NCT02998203|organic diet|organic diet
90897|NCT02998203|health|health
90898|NCT02998203|pesticides|pesticides
90899|NCT02998203|inflammation biomarkers|inflammation biomarkers
90900|NCT02998203|oxidative stress biomarkers|oxidative stress biomarkers
90901|NCT02998177|Postoperative pain|postoperative pain
90902|NCT02998177|Rebound pain|rebound pain
90903|NCT02998177|Gut microbiome|gut microbiome
90904|NCT02998177|Gut microbiota|gut microbiota
90905|NCT02998177|Peripheral nerve block|peripheral nerve block
90906|NCT02998177|Axillary brachial plexus block|axillary brachial plexus block
90907|NCT02998138|Chronic Pain|chronic pain
90908|NCT02998138|Pain, Postoperative|pain, postoperative
90909|NCT02998112|fecal microbiota transplantation|fecal microbiota transplantation
90910|NCT02998112|Ulcerative colitis|ulcerative colitis
90911|NCT02998099|Healthy Volunteers|healthy volunteers
90912|NCT02998099|Rivipansel|rivipansel
90913|NCT02998060|Robot|robot
90914|NCT02998060|Spinal Fusion|spinal fusion
90915|NCT02998060|Spine|spine
90916|NCT02998060|Navigation|navigation
90917|NCT02998060|Freehand|freehand
90918|NCT02998008|Exercise Therapy|exercise therapy
90919|NCT02998008|Heart Function Tests|heart function tests
90920|NCT02998008|Heart/physiology|heart/physiology
90921|NCT02998008|Echocardiography|echocardiography
90922|NCT02997995|T2-T4 Breast cancer|t2-t4 breast cancer
90923|NCT02997995|Estrogen Receptor Positive Tumor|estrogen receptor positive tumor
90924|NCT02997995|PD-1|pd-1
90925|NCT02997995|Neoadjuvant|neoadjuvant
90926|NCT02997995|Immune-attractants|immune-attractants
90927|NCT02997995|lymphocytes activation|lymphocytes activation
90928|NCT02997982|Alzheimer's Disease|alzheimer's disease
90929|NCT02997982|Herpes Simplex Virus|herpes simplex virus
90931|NCT02997982|Antiviral Drugs|antiviral drugs
90932|NCT02997969|HIV|hiv
90933|NCT02997943|Obesity|obesity
90934|NCT02997943|Weight Loss|weight loss
90935|NCT02997943|Diet|diet
90936|NCT02997943|Physical Activity|physical activity
90937|NCT02997943|Mobile Health|mobile health
90938|NCT02997904|lice comb|lice comb
90939|NCT02997904|human head lice infestations|human head lice infestations
90940|NCT02997904|combing solution|combing solution
90941|NCT02997891|cognition|cognition
90942|NCT02997891|hip replacement|hip replacement
90943|NCT02997891|physical activity|physical activity
90944|NCT02997891|quality of life|quality of life
90945|NCT02997891|psychological distress|psychological distress
90946|NCT02997878|autoimmune|autoimmune
90947|NCT02997878|AiH|aih
90948|NCT02997878|PSC|psc
90949|NCT02997878|liver disease|liver disease
90950|NCT02997878|cholangitis|cholangitis
90951|NCT02997865|heart failure|heart failure
90952|NCT02997865|depressive disorder, major|depressive disorder, major
90953|NCT02997865|cognitive therapy|cognitive therapy
90954|NCT02997865|antidepressive agents|antidepressive agents
90955|NCT02997865|self-care|self-care
90956|NCT02997852|human-animal interaction|human-animal interaction
90957|NCT02997787|adenomyosis|adenomyosis
90958|NCT02997787|leiomyoma|leiomyoma
90959|NCT02997787|neutrophil to lymphocyte ratio|neutrophil to lymphocyte ratio
90960|NCT02997787|platelet to lymphocyte ratio|platelet to lymphocyte ratio
90961|NCT02997748|acute kidney injury|acute kidney injury
90962|NCT02997748|cardiac surgery|cardiac surgery
90963|NCT02997748|Remote ischemic preconditioning|remote ischemic preconditioning
90964|NCT02997748|[TIMP-2]*[IGFBP7]|[timp-2]*[igfbp7]
90965|NCT02997735|Secondhand Smoke|secondhand smoke
90966|NCT02997735|Nicotine Replacement Therapy|nicotine replacement therapy
90967|NCT02997735|Clinical Decision Support|clinical decision support
90968|NCT02997735|Tobacco quitline|tobacco quitline
90969|NCT02997722|ketamine|ketamine
90970|NCT02997722|suicide|suicide
90971|NCT02997709|Prostate Cancer|prostate cancer
90972|NCT02997709|Circulating Tumor Cells|circulating tumor cells
90973|NCT02997709|CTCs|ctcs
90974|NCT02997709|Androgen Deprivation Therapy|androgen deprivation therapy
90975|NCT02997709|ADT|adt
90976|NCT02997670|Cardiac resynchronization pacing therapy|cardiac resynchronization pacing therapy
90977|NCT02997644|patient education|patient education
90978|NCT02997644|orthopaedic surgery|orthopaedic surgery
90979|NCT02997644|post-surgical pain|post-surgical pain
90980|NCT02997644|chronic opioid use|chronic opioid use
90981|NCT02997631|Pain Management|pain management
90982|NCT02997631|Distraction Therapy|distraction therapy
90983|NCT02997631|Robot Based Distraction|robot based distraction
90984|NCT02997631|MEDi|medi
90985|NCT02997605|low disease activity|low disease activity
90986|NCT02997605|remission|remission
90987|NCT02997566|Autonomic Nervous System|autonomic nervous system
90988|NCT02997566|Sympathetic Nervous System|sympathetic nervous system
90989|NCT02997566|Heart Rate|heart rate
90990|NCT02997553|Indocyanine green (ICG)|indocyanine green (icg)
90991|NCT02997553|Sentinel lymph node biopsy|sentinel lymph node biopsy
90992|NCT02997553|Technetium99|technetium99
90993|NCT02997553|Tumors|tumors
90994|NCT02997553|Optonuclear probe|optonuclear probe
90995|NCT02997553|Surgery|surgery
90996|NCT02997540|female breast lesion|female breast lesion
90997|NCT02997540|ultrasound examination|ultrasound examination
90998|NCT02997514|Solution focused coaching|solution focused coaching
90999|NCT02997514|Self determination|self determination
91000|NCT02997488|videolaryngoscope|videolaryngoscope
91001|NCT02997475|Bulimia Nervosa|bulimia nervosa
91002|NCT02997475|Bulimia|bulimia
91003|NCT02997475|fMRI|fmri
91004|NCT02997475|Emotion Regulation|emotion regulation
91005|NCT02997475|Response Inhibition|response inhibition
91006|NCT02997462|Monocyte|monocyte
91007|NCT02997462|Oxidative Stress|oxidative stress
91008|NCT02997462|Endothelial Function|endothelial function
91009|NCT02997462|Congestive Heart Failure|congestive heart failure
91010|NCT02997449|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
91011|NCT02997449|Stereotactic ablative radiotherapy (SABR)|stereotactic ablative radiotherapy (sabr)
91012|NCT02997449|Intrathoracic nodal staging|intrathoracic nodal staging
91013|NCT02997423|Glioblastoma Multiforme|glioblastoma multiforme
91014|NCT02997423|Biomarker|biomarker
91015|NCT02997423|Cytochrome C Oxidase|cytochrome c oxidase
91016|NCT02997423|Newly diagnosed|newly diagnosed
91017|NCT02997410|Ozone|ozone
91018|NCT02997371|Traumatic brain injury|traumatic brain injury
91019|NCT02997371|Microdialysis|microdialysis
91020|NCT02997371|Interleukin-1 receptor antagonist|interleukin-1 receptor antagonist
91021|NCT02997371|Magnetic Resonance Imaging|magnetic resonance imaging
91022|NCT02997371|Positron Emission Tomography|positron emission tomography
91023|NCT02997345|PPROM|pprom
91024|NCT02997319|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
91025|NCT02997319|Insulin Resistance|insulin resistance
91026|NCT02997319|Shift Work|shift work
91027|NCT02997319|Circadian Rhythms|circadian rhythms
91028|NCT02997319|MTNR1B|mtnr1b
91029|NCT02997306|Moh's Surgery|moh's surgery
91030|NCT02997306|Erythema|erythema
91031|NCT02997306|Face|face
91032|NCT02997306|Simple Interrupted Sutures|simple interrupted sutures
91033|NCT02997306|Running Sutures|running sutures
91034|NCT02997306|Image Processing|image processing
91035|NCT02997280|acute graft-versus-host disease|acute graft-versus-host disease
91036|NCT02997280|chronic graft-versus-host disease|chronic graft-versus-host disease
91037|NCT02997280|Steroid-refractory GVHD|steroid-refractory gvhd
91038|NCT02997280|ruxolitinib|ruxolitinib
91039|NCT02997280|JAK inhibitors|jak inhibitors
91040|NCT02997254|atrial fibrillation|atrial fibrillation
91041|NCT02997254|ablation|ablation
91042|NCT02997254|abnormal heart rhythm|abnormal heart rhythm
91043|NCT02997241|Colonic Neoplasms|colonic neoplasms
91044|NCT02997241|recurrence|recurrence
91045|NCT02997215|intravenous lidocaine|intravenous lidocaine
91046|NCT02997215|postoperative pain management|postoperative pain management
91047|NCT02997202|Gilteritinib|gilteritinib
91048|NCT02997202|ASP2215|asp2215
91049|NCT02997202|Safety and Efficacy|safety and efficacy
91050|NCT02997202|Acute Myeloid Leukemia|acute myeloid leukemia
91051|NCT02997150|Idiopathic nephrotic syndrome-child-steroid dependant-IL2|idiopathic nephrotic syndrome-child-steroid dependant-il2
91052|NCT02997150|Safety|safety
91053|NCT02997150|Efficacy|efficacy
91054|NCT02997137|Chronic psychological distress|chronic psychological distress
91055|NCT02997137|Chronic exhaustion conditions|chronic exhaustion conditions
91056|NCT02997137|Perceived Stress Questionnaire 30 (PSQ30)|perceived stress questionnaire 30 (psq30)
91057|NCT02997137|Stress management|stress management
91058|NCT02997137|Dietary supplement|dietary supplement
91059|NCT02997124|Alveolar bone grafting|alveolar bone grafting
91060|NCT02997124|delirium|delirium
91061|NCT02997124|early ambulation|early ambulation
91062|NCT02997098|Hepatectomy|hepatectomy
91063|NCT02997085|Pain|pain
91064|NCT02997085|Virtual Reality|virtual reality
91065|NCT02997085|Opioid|opioid
91066|NCT02997085|Prescription pain reliever|prescription pain reliever
91067|NCT02997085|Treatment|treatment
91068|NCT02997072|electrical impedance tomography|electrical impedance tomography
91069|NCT02997072|high frequency jet ventilation|high frequency jet ventilation
91070|NCT02997072|drive pressure|drive pressure
91071|NCT02997059|Crohn disease|crohn disease
91072|NCT02997059|Candida|candida
91073|NCT02997059|ASCA|asca
91074|NCT02997046|Ferumoxytol|ferumoxytol
91075|NCT02997046|MRI|mri
91076|NCT02997046|fistula|fistula
91077|NCT02997046|graft|graft
91078|NCT02997046|kidney transplant|kidney transplant
91079|NCT02997046|angiography|angiography
91080|NCT02997046|arteriovenous|arteriovenous
91081|NCT02997033|Bone|bone
91082|NCT02997033|Sex steroids|sex steroids
91083|NCT02997033|Body composition|body composition
91084|NCT02997033|Men|men
91085|NCT02997007|tDCS|tdcs
91086|NCT02997007|Mild Cognitive Impairment|mild cognitive impairment
91087|NCT02997007|fMRI|fmri
91088|NCT02997007|Healthy ageing|healthy ageing
91089|NCT02996955|Low Back Pain|low back pain
91090|NCT02996955|Social Support|social support
91091|NCT02996955|Illness Perceptions|illness perceptions
91092|NCT02996955|Activity Advice|activity advice
91093|NCT02996942|haemophilia, joint disease, quality of life|haemophilia, joint disease, quality of life
91094|NCT02996903|Cardiac Computed Tomography (CT) Angiography (CCTA)|cardiac computed tomography (ct) angiography (ccta)
91095|NCT02996903|coronary artery disease|coronary artery disease
91096|NCT02996903|malignancy induction|malignancy induction
91097|NCT02996903|radiation dose|radiation dose
91098|NCT02996903|dose saving techniques|dose saving techniques
91099|NCT02996903|effective dose|effective dose
91100|NCT02996864|college students|college students
91101|NCT02996864|physical activity|physical activity
91102|NCT02996864|sleep behaviors|sleep behaviors
91103|NCT02996864|diet|diet
91104|NCT02996851|Fibrinolytic Agents|fibrinolytic agents
91105|NCT02996851|Adverse effects|adverse effects
91106|NCT02996851|Norway|norway
91107|NCT02996851|Registries|registries
91108|NCT02996812|Post-bariatric hypoglycemia|post-bariatric hypoglycemia
91109|NCT02996812|Non-insulinoma pancreatogenous hypoglycemia syndrome|non-insulinoma pancreatogenous hypoglycemia syndrome
91110|NCT02996812|Late dumping syndrome|late dumping syndrome
91111|NCT02996773|high-risk malignancies|high-risk malignancies
91112|NCT02996773|Lymphoma|lymphoma
91113|NCT02996773|Haploidentical|haploidentical
91114|NCT02996773|Bone Marrow Transplant (BMT)|bone marrow transplant (bmt)
91115|NCT02996773|Post-transplant|post-transplant
91116|NCT02996773|myeloablative (MAC)|myeloablative (mac)
91117|NCT02996773|reduced intensity conditioning (RIC)|reduced intensity conditioning (ric)
91118|NCT02996773|haploidentical hematopoietic cell transplantation (HHCT)|haploidentical hematopoietic cell transplantation (hhct)
91119|NCT02996773|Leukemia|leukemia
91120|NCT02996747|bone tumors|bone tumors
91121|NCT02996747|chondroma|chondroma
91122|NCT02996747|chondrosarcoma|chondrosarcoma
91123|NCT02996734|bone tumors|bone tumors
91124|NCT02996734|giant cell tumor|giant cell tumor
91125|NCT02996734|treatment|treatment
91126|NCT02996708|Telemedicine|telemedicine
91127|NCT02996708|Health economics|health economics
91128|NCT02996695|Chemoprophylaxis|chemoprophylaxis
91129|NCT02996695|Chloroquine|chloroquine
91130|NCT02996695|Cryopreserved|cryopreserved
91131|NCT02996695|Malaria|malaria
91132|NCT02996695|Plasmodium|plasmodium
91133|NCT02996695|Sporozoites|sporozoites
91134|NCT02996682|Communicable Diseases|communicable diseases
91135|NCT02996682|Hepatitis|hepatitis
91136|NCT02996682|Hepatitis C|hepatitis c
91137|NCT02996682|Virus Diseases|virus diseases
91138|NCT02996682|Liver Diseases|liver diseases
91139|NCT02996682|Digestive System Diseases|digestive system diseases
91140|NCT02996682|Hepatitis, Viral, Human|hepatitis, viral, human
91141|NCT02996682|Velpatasvir|velpatasvir
91142|NCT02996682|Flaviviridae Infections|flaviviridae infections
91143|NCT02996682|RNA Virus Infections|rna virus infections
91144|NCT02996682|Ribavirin|ribavirin
91145|NCT02996682|Sofosbuvir|sofosbuvir
91146|NCT02996682|Antiviral Agents|antiviral agents
91147|NCT02996682|Antimetabolites|antimetabolites
91148|NCT02996682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
91149|NCT02996682|Anti-Infective Agents|anti-infective agents
91150|NCT02996682|Decompensated Cirrhosis|decompensated cirrhosis
91151|NCT02996643|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
91152|NCT02996643|Brace Treatment|brace treatment
91153|NCT02996643|Ultrasound Imaging|ultrasound imaging
91154|NCT02996630|LVOTO|lvoto
91155|NCT02996630|Fallot|fallot
91156|NCT02996630|Great Arteries Transposition|great arteries transposition
91157|NCT02996617|Lymphomas Non-Hodgkin's B-Cell|lymphomas non-hodgkin's b-cell
91257|NCT02995785|Simulation|simulation
91158|NCT02996617|Lymphomas Non-Hodgkin's T-Cell|lymphomas non-hodgkin's t-cell
91159|NCT02996617|PEG-rhG-CSF|peg-rhg-csf
91160|NCT02996617|Neutropenia|neutropenia
91161|NCT02996604|acupuncture|acupuncture
91162|NCT02996604|functional dyspepsia|functional dyspepsia
91163|NCT02996604|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
91164|NCT02996591|Nerve Block|nerve block
91165|NCT02996591|General Anesthesia|general anesthesia
91166|NCT02996591|Spinal Anesthesia|spinal anesthesia
91167|NCT02996591|Pain|pain
91168|NCT02996591|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
91169|NCT02996578|Cognition|cognition
91170|NCT02996578|Cacao|cacao
91171|NCT02996578|Flavan-3-ols|flavan-3-ols
91172|NCT02996578|Blood Pressure|blood pressure
91173|NCT02996578|hemoglobin A1c protein, human|hemoglobin a1c protein, human
91174|NCT02996578|Memory|memory
91175|NCT02996565|Clinic care|clinic care
91176|NCT02996565|Team-based care|team-based care
91177|NCT02996565|Medication Therapy Management (MTM)|medication therapy management (mtm)
91178|NCT02996565|Telehealth|telehealth
91179|NCT02996565|Cluster-randomized|cluster-randomized
91180|NCT02996565|Home blood pressure monitoring|home blood pressure monitoring
91181|NCT02996565|Pharmacist|pharmacist
91182|NCT02996552|Tricuspid annulus dilation|tricuspid annulus dilation
91183|NCT02996552|mitral valve regurgitation|mitral valve regurgitation
91184|NCT02996526|vocal cord palsy dysfunction thoracic surgery complication|vocal cord palsy dysfunction thoracic surgery complication
91185|NCT02996513|Vitamin A status|vitamin a status
91186|NCT02996513|Retinol Isotope Dilution|retinol isotope dilution
91187|NCT02996513|Nigeria|nigeria
91188|NCT02996513|Preschool children|preschool children
91189|NCT02996513|Malaria|malaria
91190|NCT02996513|Inflammation|inflammation
91191|NCT02996474|Pembrolizumab|pembrolizumab
91192|NCT02996474|Decitabine|decitabine
91193|NCT02996474|AML (Acute Myelogenous Leukemia)|aml (acute myelogenous leukemia)
91194|NCT02996461|Zika Infection|zika infection
91195|NCT02996461|Immune Response|immune response
91196|NCT02996461|Flavivirus|flavivirus
91197|NCT02996461|Arthropod-Borne Virus|arthropod-borne virus
91198|NCT02996448|AD-HIES|ad-hies
91199|NCT02996448|Anti-rAls3 Antibody|anti-rals3 antibody
91200|NCT02996448|Staphylococcus Aureus|staphylococcus aureus
91201|NCT02996448|Candida Albicans|candida albicans
91202|NCT02996448|RNA Transcriptome|rna transcriptome
91203|NCT02996396|AAA, Aortoiliac Aneurysm|aaa, aortoiliac aneurysm
91204|NCT02996383|arthroplasty|arthroplasty
91205|NCT02996370|esthetic|esthetic
91206|NCT02996370|inter-implant papilla|inter-implant papilla
91207|NCT02996370|soft tissue tickness|soft tissue tickness
91208|NCT02996370|crestal bone loss|crestal bone loss
91209|NCT02996370|second stage surgery|second stage surgery
91210|NCT02996357|Incontinence-associated dermatitis|incontinence-associated dermatitis
91211|NCT02996357|Risk factor|risk factor
91212|NCT02996357|Intensive care unit|intensive care unit
91213|NCT02996357|Prevention|prevention
91214|NCT02996331|Ulcer|ulcer
91215|NCT02996331|Pressure Ulcer|pressure ulcer
91216|NCT02996331|Pathologic Processes|pathologic processes
91217|NCT02996331|Skin Ulcer|skin ulcer
91218|NCT02996331|Skin Diseases|skin diseases
91219|NCT02996292|Crowding|crowding
91220|NCT02996292|Self ligating|self ligating
91221|NCT02996292|CBCT|cbct
91222|NCT02996292|RCT|rct
91223|NCT02996279|Neonate|neonate
91224|NCT02996279|Chorioamnionitis|chorioamnionitis
91225|NCT02996279|S100A12|s100a12
91226|NCT02996266|Targeted Temperature Management|targeted temperature management
91227|NCT02996175|Behavior|behavior
91228|NCT02996175|Sleep|sleep
91229|NCT02996175|Problems|problems
91230|NCT02996175|Intervention|intervention
91231|NCT02996162|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
91232|NCT02996162|Chronic Lung Disease|chronic lung disease
91233|NCT02996162|Prematurity|prematurity
91234|NCT02996084|Imaging research|imaging research
91235|NCT02995980|breast cancer screening|breast cancer screening
91236|NCT02995980|dense breasts|dense breasts
91237|NCT02995980|dual-energy contrast-enhanced digital mammography|dual-energy contrast-enhanced digital mammography
91238|NCT02995954|Combination therapy|combination therapy
91239|NCT02995954|ACE inhibitor Calcium Antagonist|ace inhibitor calcium antagonist
91240|NCT02995941|reliability|reliability
91241|NCT02995941|validity|validity
91242|NCT02995941|classification|classification
91243|NCT02995941|irritability|irritability
91244|NCT02995941|symptom|symptom
91245|NCT02995941|intensity|intensity
91246|NCT02995941|intervention|intervention
91247|NCT02995928|Subarachnoid Hemorrhage|subarachnoid hemorrhage
91248|NCT02995928|Decompressive Craniectomy|decompressive craniectomy
91249|NCT02995928|Cerebral Aneurysm|cerebral aneurysm
91250|NCT02995837|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
91251|NCT02995837|Cerebral Blood Flow|cerebral blood flow
91252|NCT02995837|Neurocognition|neurocognition
91253|NCT02995824|Liver transplantation|liver transplantation
91254|NCT02995824|HIV infection|hiv infection
91255|NCT02995824|Antiretroviral therapy|antiretroviral therapy
91258|NCT02995733|asthma|asthma
91259|NCT02995733|African Americans|african americans
91260|NCT02995733|Hispanics|hispanics
91261|NCT02995707|Thalidomide NTDT|thalidomide ntdt
91262|NCT02995681|COPD|copd
91263|NCT02995681|Falls|falls
91264|NCT02995681|Balance training|balance training
91265|NCT02995642|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
91266|NCT02995642|Carotid Stenosis|carotid stenosis
91267|NCT02995642|Atherosclerosis|atherosclerosis
91268|NCT02995642|Angiogenesis|angiogenesis
91269|NCT02995642|Inflammation|inflammation
91270|NCT02995642|Macrophages|macrophages
91271|NCT02995642|Positron-Emission Tomography|positron-emission tomography
91272|NCT02995642|Computerized tomography|computerized tomography
91273|NCT02995642|Magnetic Resonance Imaging|magnetic resonance imaging
91274|NCT02995642|(18F)FPP(RGD)2|(18f)fpp(rgd)2
91275|NCT02995616|Robot-Assisted Gait Training|robot-assisted gait training
91276|NCT02995616|Guidance force|guidance force
91277|NCT02995616|Stroke|stroke
91278|NCT02995616|Energy Consumption|energy consumption
91279|NCT02995616|Cardiorespiratory Load|cardiorespiratory load
91280|NCT02995564|Social Skills|social skills
91281|NCT02995564|Asperger's|asperger's
91282|NCT02995564|High-functioning autism|high-functioning autism
91283|NCT02995564|Young adults|young adults
91284|NCT02995551|Menisci, Tibial|menisci, tibial
91285|NCT02995551|Knee Injuries|knee injuries
91286|NCT02995551|Arthroscopy|arthroscopy
91287|NCT02995551|Exercise|exercise
91288|NCT02995551|Young adults|young adults
91289|NCT02995551|Treatment Outcome|treatment outcome
91290|NCT02995551|Humans|humans
91291|NCT02995512|myocardial infarction|myocardial infarction
91292|NCT02995512|colchicine|colchicine
91293|NCT02995512|anti-inflammatory|anti-inflammatory
91294|NCT02995499|ASA-PS classification|asa-ps classification
91295|NCT02995499|inter-rater reliability|inter-rater reliability
91296|NCT02995499|general surgery|general surgery
91297|NCT02995473|Psoriasis|psoriasis
91298|NCT02995460|Exercise Therapy|exercise therapy
91299|NCT02995447|propofol|propofol
91300|NCT02995447|electroencephalogram|electroencephalogram
91301|NCT02995434|Virtual Reality|virtual reality
91302|NCT02995434|Cancer Survivorship|cancer survivorship
91303|NCT02995434|Pain Management|pain management
91304|NCT02995434|Cancer Pain Management|cancer pain management
91305|NCT02995434|Chronic Pain Management|chronic pain management
91306|NCT02995434|Adjunctive Pain Management|adjunctive pain management
91307|NCT02995408|resiliency training|resiliency training
91308|NCT02995408|parenting|parenting
91309|NCT02995408|Autism Spectrum Disorders|autism spectrum disorders
91310|NCT02995369|Sealants|sealants
91311|NCT02995369|Dryshield|dryshield
91312|NCT02995369|Cotton roll|cotton roll
91313|NCT02995369|Isolation|isolation
91314|NCT02995369|Efficiency|efficiency
91315|NCT02995369|Preference|preference
91316|NCT02995356|Ectopic pregnancy|ectopic pregnancy
91317|NCT02995356|Axonemal Dynein Heavy Chain 5|axonemal dynein heavy chain 5
91318|NCT02995356|Creatine Kinase|creatine kinase
91319|NCT02995356|Cervical fluid|cervical fluid
91320|NCT02995330|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
91321|NCT02995330|Bone Marrow Transplantation|bone marrow transplantation
91322|NCT02995317|Aged|aged
91323|NCT02995317|Gait|gait
91324|NCT02995317|Postural Balance|postural balance
91325|NCT02995317|Accelerometry|accelerometry
91326|NCT02995317|Physical Activity|physical activity
91327|NCT02995265|Exoskeleton|exoskeleton
91328|NCT02995265|Stroke|stroke
91329|NCT02995265|Walking|walking
91330|NCT02995265|Rehabilitation|rehabilitation
91331|NCT02995187|Apatinib|apatinib
91332|NCT02995187|Third-line and Later Therapy|third-line and later therapy
91333|NCT02995187|Small Cell Lung Cancer|small cell lung cancer
91334|NCT02995174|amblyopia|amblyopia
91335|NCT02995174|fixation stability|fixation stability
91336|NCT02995174|perceptual learning|perceptual learning
91337|NCT02995083|osteoarthritis|osteoarthritis
91338|NCT02995057|Microneedles|microneedles
91339|NCT02995057|Biocompatibility|biocompatibility
91340|NCT02995057|Allergy|allergy
91341|NCT02995057|Metal|metal
91342|NCT02995057|Nickel|nickel
91343|NCT02995057|Contact dermatitis|contact dermatitis
91344|NCT02995005|mother to child transmission|mother to child transmission
91345|NCT02995005|hepatitis B|hepatitis b
91346|NCT02995005|tenofovir|tenofovir
91347|NCT02994953|Avelumab|avelumab
91348|NCT02994953|M9241|m9241
91349|NCT02994953|NHS-IL12|nhs-il12
91350|NCT02994953|Advanced Solid Tumors|advanced solid tumors
91351|NCT02994927|ANCA-associated vasculitis|anca-associated vasculitis
91352|NCT02994927|complement|complement
91353|NCT02994927|vasculitis|vasculitis
91354|NCT02994927|C5aR|c5ar
91355|NCT02994927|avacopan|avacopan
91356|NCT02994927|CCX168|ccx168
91357|NCT02994927|MPA|mpa
91358|NCT02994927|GPA|gpa
91359|NCT02994914|Breast Cancer|breast cancer
91360|NCT02994914|Onco Geriatric Evaluation|onco geriatric evaluation
91361|NCT02994914|Radiotherapy|radiotherapy
91362|NCT02994914|Hypo fractionated radiotherapy|hypo fractionated radiotherapy
91363|NCT02994914|Normo fractionated radiotherapy|normo fractionated radiotherapy
91364|NCT02994914|Large hypo fractionated radiotherapy|large hypo fractionated radiotherapy
91365|NCT02994901|Sarcopenia|sarcopenia
91366|NCT02994901|Geriatrics|geriatrics
91367|NCT02994901|Biomarker|biomarker
91368|NCT02994836|Crohn's Disease|crohn's disease
91369|NCT02994836|Inflammatory bowel disease|inflammatory bowel disease
91370|NCT02994836|Anti-TNF discontinuation|anti-tnf discontinuation
91371|NCT02994836|Ulcerative colitis|ulcerative colitis
91372|NCT02994810|Breastfeeding|breastfeeding
91373|NCT02994810|Orientation|orientation
91374|NCT02994797|salivary glands|salivary glands
91375|NCT02994797|ultrasonography|ultrasonography
91376|NCT02994797|elastometry|elastometry
91377|NCT02994797|elastography|elastography
91378|NCT02994771|Lymphedema, Breast cancer|lymphedema, breast cancer
91379|NCT02994758|Prostate|prostate
91380|NCT02994758|bladder|bladder
91381|NCT02994758|renal|renal
91382|NCT02994758|NGS|ngs
91383|NCT02994758|DSRT|dsrt
91384|NCT02994758|drug screening|drug screening
91385|NCT02994758|sequencing|sequencing
91386|NCT02994758|personalised medicine|personalised medicine
91387|NCT02994680|Air Pollution|air pollution
91388|NCT02994680|Liquefied Petroleum Gas|liquefied petroleum gas
91389|NCT02994680|Cookstove|cookstove
91390|NCT02994680|Behavioral Intervention|behavioral intervention
91391|NCT02994680|Propane Stove|propane stove
91392|NCT02994667|Electrophysiology|electrophysiology
91393|NCT02994641|critical care|critical care
91394|NCT02994641|patient discharge|patient discharge
91395|NCT02994641|costs and cost analysis|costs and cost analysis
91396|NCT02994641|length of stay|length of stay
91397|NCT02994641|hospital mortality|hospital mortality
91398|NCT02994628|oxidative stress|oxidative stress
91399|NCT02994628|immune function|immune function
91400|NCT02994628|muscle damage|muscle damage
91401|NCT02994628|carbohydrate|carbohydrate
91402|NCT02994628|polyphenols|polyphenols
91403|NCT02994628|cycling|cycling
91404|NCT02994615|Index of Microvascular Resistance|index of microvascular resistance
91405|NCT02994615|Microvascular dysfunction|microvascular dysfunction
91406|NCT02994602|Healthy Men|healthy men
91407|NCT02994602|Male Contraception|male contraception
91408|NCT02994602|Healthy Women|healthy women
91409|NCT02994602|Transfer|transfer
91410|NCT02994602|Transference|transference
91411|NCT02994602|Gel|gel
91412|NCT02994602|Nestorone|nestorone
91413|NCT02994602|Testosterone|testosterone
91414|NCT02994550|FSH|fsh
91415|NCT02994550|LH|lh
91416|NCT02994550|IVF|ivf
91417|NCT02994511|Circulating tumour DNA|circulating tumour dna
91418|NCT02994511|ctDNA|ctdna
91419|NCT02994420|Obesity|obesity
91420|NCT02994420|Menstrual Cycle|menstrual cycle
91421|NCT02994420|Gonadal Steroid Hormones|gonadal steroid hormones
91422|NCT02994420|Satiety Response|satiety response
91423|NCT02994420|Glucagon-Like Peptide 1|glucagon-like peptide 1
91424|NCT02994420|Cholecystokinin|cholecystokinin
91425|NCT02994420|Magnetic Resonance Imaging|magnetic resonance imaging
91426|NCT02994381|Healthy Male Adults|healthy male adults
91427|NCT02994381|14C|14c
91428|NCT02994381|RPC1063|rpc1063
91429|NCT02994368|retinal degeneration|retinal degeneration
91430|NCT02994368|eye|eye
91431|NCT02994368|REP-1 gene|rep-1 gene
91432|NCT02994355|Family planning clinics|family planning clinics
91433|NCT02994355|Implementation Science|implementation science
91434|NCT02994355|Systems Analysis and Improvement Approach (SAIA)|systems analysis and improvement approach (saia)
91435|NCT02994342|vaginal dryness|vaginal dryness
91436|NCT02994342|vaginal gel|vaginal gel
91437|NCT02994342|colostrum|colostrum
91438|NCT02994342|vaginal atrophy|vaginal atrophy
91439|NCT02994329|HIV testing|hiv testing
91440|NCT02994329|Linkage to care|linkage to care
91441|NCT02994303|Fabry disease|fabry disease
91442|NCT02994303|Fabry nephropathy|fabry nephropathy
91443|NCT02994303|end-stage renal disease|end-stage renal disease
91444|NCT02994303|Anderson-Fabry disease|anderson-fabry disease
91445|NCT02994303|Fabry's disease|fabry's disease
91446|NCT02994277|"Artificial Pancreas"|"artificial pancreas"
91447|NCT02994277|"control System"|"control system"
91448|NCT02994277|"Closed loop"|"closed loop"
91449|NCT02994277|diabetes|diabetes
91450|NCT02994277|"T1DM"|"t1dm"
91451|NCT02994277|"pump"|"pump"
91452|NCT02994277|algorithm|algorithm
91453|NCT02994277|CGM|cgm
91454|NCT02994199|Active video gaming|active video gaming
91455|NCT02994199|Energy expenditure|energy expenditure
91456|NCT02994186|cognitive function|cognitive function
91457|NCT02994186|obesity|obesity
91458|NCT02994186|bariatric surgery|bariatric surgery
91459|NCT02994186|metabolic surgery|metabolic surgery
91460|NCT02994160|peripheral nerve|peripheral nerve
91461|NCT02994160|intraneural electrode|intraneural electrode
91462|NCT02994160|hand amputation|hand amputation
91463|NCT02994108|Human Papillomavirus|human papillomavirus
91464|NCT02994108|Men Who Have Sex with Men|men who have sex with men
91465|NCT02994082|Rural health|rural health
91466|NCT02994082|Veterans|veterans
91467|NCT02994082|Smokeless tobacco cessation|smokeless tobacco cessation
91468|NCT02994069|Cisplatin|cisplatin
91469|NCT02994069|Squamous Cell|squamous cell
91470|NCT02994069|Carcinoma|carcinoma
91471|NCT02994030|neuromuscular disorder|neuromuscular disorder
91472|NCT02994017|cystic fibrosis|cystic fibrosis
91473|NCT02994017|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
91474|NCT02994017|prognostic|prognostic
91475|NCT02994004|Hospital, medical decision-making, role conflict, f-MRI|hospital, medical decision-making, role conflict, f-mri
91476|NCT02993978|Pediatric radiotherapy|pediatric radiotherapy
91477|NCT02993926|Drug Therapy|drug therapy
91478|NCT02993887|Caregiver|caregiver
91479|NCT02993887|Technology Dependent Children|technology dependent children
91480|NCT02993887|Resourcefulness|resourcefulness
91481|NCT02993887|Mindfulness|mindfulness
91482|NCT02993874|Ergonemic resources|ergonemic resources
91483|NCT02993874|Walking capacity|walking capacity
91484|NCT02993874|Peripheral artery disease|peripheral artery disease
91485|NCT02993861|Epilepsy|epilepsy
91486|NCT02993861|Obese|obese
91487|NCT02993848|Scapula|scapula
91488|NCT02993848|Fracture|fracture
91489|NCT02993796|Krabbe disease|krabbe disease
91490|NCT02993796|globoid cell leukodystrophy|globoid cell leukodystrophy
91491|NCT02993796|galactosylceramide lipidosis|galactosylceramide lipidosis
91492|NCT02993796|sphingolipidosis|sphingolipidosis
91493|NCT02993783|Drug Therapy|drug therapy
91494|NCT02993757|Dengue Fever|dengue fever
91495|NCT02993757|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
91496|NCT02993757|Human Papillomavirus Disease|human papillomavirus disease
91497|NCT02993757|CYD Dengue Vaccine|cyd dengue vaccine
91498|NCT02993757|Dengvaxia®|dengvaxia®
91499|NCT02993757|Gardasil®|gardasil®
91500|NCT02993744|preterm birth|preterm birth
91501|NCT02993744|corticosteroids|corticosteroids
91502|NCT02993744|inflammatory parameters|inflammatory parameters
91503|NCT02993744|betamethasone|betamethasone
91504|NCT02993744|leukocytes|leukocytes
91505|NCT02993731|Neoplasms|neoplasms
91506|NCT02993731|Neoplasms by Site|neoplasms by site
91507|NCT02993731|Digestive System Neoplasms|digestive system neoplasms
91508|NCT02993731|Endocrine Gland Neoplasms|endocrine gland neoplasms
91509|NCT02993731|Pancreatic Neoplasms|pancreatic neoplasms
91510|NCT02993731|Adenocarcinoma|adenocarcinoma
91511|NCT02993731|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
91512|NCT02993731|Neoplasms by Histologic Type|neoplasms by histologic type
91513|NCT02993731|Digestive System Diseases|digestive system diseases
91514|NCT02993731|Pancreatic Diseases|pancreatic diseases
91515|NCT02993731|Endocrine System Diseases|endocrine system diseases
91516|NCT02993731|Albumin-Bound Paclitaxel|albumin-bound paclitaxel
91517|NCT02993731|Gemcitabine|gemcitabine
91518|NCT02993692|direct laryngoscopy|direct laryngoscopy
91519|NCT02993692|fiberopitc bronchoscopy|fiberopitc bronchoscopy
91520|NCT02993692|nasotracheal intubation|nasotracheal intubation
91521|NCT02993640|vasopressin|vasopressin
91522|NCT02993640|nitroglycerine|nitroglycerine
91523|NCT02993640|portal pressure|portal pressure
91524|NCT02993640|portal flow|portal flow
91525|NCT02993627|obesity|obesity
91526|NCT02993627|BMI|bmi
91527|NCT02993627|body weight|body weight
91528|NCT02993601|Heart Failure|heart failure
91529|NCT02993601|Edema|edema
91530|NCT02993601|Oedema|oedema
91531|NCT02993601|Decompensated Heartfailure|decompensated heartfailure
91532|NCT02993588|Melatonin|melatonin
91533|NCT02993588|IVF/ICSI|ivf/icsi
91534|NCT02993588|Poor ovarian response|poor ovarian response
91535|NCT02993575|Pharmacokinetics|pharmacokinetics
91536|NCT02993575|Flucloxacillin|flucloxacillin
91537|NCT02993575|Continuous infusion|continuous infusion
91538|NCT02993575|Intensive Care Unit|intensive care unit
91539|NCT02993562|Food intake|food intake
91540|NCT02993562|Resting Energy Expenditure|resting energy expenditure
91541|NCT02993562|Gall Bladder emptying|gall bladder emptying
91542|NCT02993562|Insulin response|insulin response
91543|NCT02993562|Body Composition|body composition
91544|NCT02993523|Acute Myeloid Leukemia|acute myeloid leukemia
91545|NCT02993523|Venetoclax|venetoclax
91546|NCT02993523|Treatment Naïve|treatment naïve
91547|NCT02993523|Azacitidine|azacitidine
91548|NCT02993510|microfracture|microfracture
91549|NCT02993510|enhanced marrow stimulation|enhanced marrow stimulation
91550|NCT02993510|articular cartilage|articular cartilage
91551|NCT02993510|Autologous Matrix-Induced Chondrogenesis|autologous matrix-induced chondrogenesis
91552|NCT02993510|Chondro-Gide®|chondro-gide®
91553|NCT02993510|knee surgery|knee surgery
91554|NCT02993510|AMIC|amic
91555|NCT02993458|dietary patterns|dietary patterns
91556|NCT02993458|blood pressure|blood pressure
91557|NCT02993458|adolescents|adolescents
91558|NCT02993458|dietary sodium|dietary sodium
91559|NCT02993393|Simulation Training [I02.903.847]|simulation training [i02.903.847]
91560|NCT02993393|Problem-Based Learning [F02.463.425.720]|problem-based learning [f02.463.425.720]
91561|NCT02993380|Olive oil|olive oil
91562|NCT02993380|Erythrocyte membrane fatty acid contents|erythrocyte membrane fatty acid contents
91563|NCT02993380|Oleic acid|oleic acid
91564|NCT02993367|Butylphthalide Soft Capsules|butylphthalide soft capsules
91565|NCT02993367|VCIND|vcind
91566|NCT02993367|fMRI|fmri
91567|NCT02993302|vitamin D|vitamin d
91568|NCT02993302|graves' disease|graves' disease
91569|NCT02993302|dendritic cells|dendritic cells
91570|NCT02993224|thalassemia|thalassemia
91571|NCT02993224|TDT|tdt
91572|NCT02993224|transfusion-dependent|transfusion-dependent
91573|NCT02993224|non-transfusion-dependent|non-transfusion-dependent
91574|NCT02993224|NTDT|ntdt
91575|NCT02993211|Bladder cancer|bladder cancer
91576|NCT02993211|Transurethral resection|transurethral resection
91577|NCT02993211|En bloc resection|en bloc resection
91578|NCT02993211|TURBT|turbt
91579|NCT02993185|pregnancy|pregnancy
91580|NCT02993185|adolescents|adolescents
91581|NCT02993185|sexually transmitted diseases|sexually transmitted diseases
91582|NCT02993185|decision making|decision making
91583|NCT02993185|prevention education|prevention education
91584|NCT02993107|AR101|ar101
91585|NCT02993107|Characterized Peanut Allergen|characterized peanut allergen
91586|NCT02993107|CPNA (Characterized Peanut Allergen)|cpna (characterized peanut allergen)
91587|NCT02993107|OIT (oral immunotherapy)|oit (oral immunotherapy)
91588|NCT02993107|Peanut Allergy|peanut allergy
91589|NCT02993107|Allergy|allergy
91590|NCT02993107|Peanut-Allergic Children|peanut-allergic children
91591|NCT02993107|Peanut-Allergic Adults|peanut-allergic adults
91592|NCT02993107|Desensitization|desensitization
91593|NCT02993107|PALISADE|palisade
91594|NCT02993094|breast cancer|breast cancer
91595|NCT02993094|advanced triple negative|advanced triple negative
91596|NCT02993094|ixazomib|ixazomib
91597|NCT02993094|carboplatin|carboplatin
91598|NCT02993094|CARIXA|carixa
91599|NCT02993094|Study Group of Medical Tumor Therapy (AGMT)|study group of medical tumor therapy (agmt)
91600|NCT02993081|YAG laser|yag laser
91601|NCT02993068|Genetic testing|genetic testing
91602|NCT02993068|Genetic educational video|genetic educational video
91603|NCT02993068|Genetic counseling|genetic counseling
91604|NCT02993068|Online genetic test results|online genetic test results
91605|NCT02993068|Telephone genetic counseling|telephone genetic counseling
91606|NCT02993068|Saliva test|saliva test
91607|NCT02993068|Questionnaires|questionnaires
91608|NCT02993068|Surveys|surveys
91609|NCT02993042|Rehabilitation|rehabilitation
91610|NCT02993042|Robot-assisted gait training|robot-assisted gait training
91611|NCT02993029|99Tc-MDP|99tc-mdp
91612|NCT02993029|osteoarthritis|osteoarthritis
91613|NCT02993029|celecoxib|celecoxib
91614|NCT02992977|Vaccine, neoantigen|vaccine, neoantigen
91615|NCT02992951|Infection|infection
91616|NCT02992951|Surgical Site Infection|surgical site infection
91617|NCT02992951|Dialkylcarbamoylchloride|dialkylcarbamoylchloride
91618|NCT02992938|Opioid hyperalgesia|opioid hyperalgesia
91619|NCT02992938|Acetazolamide|acetazolamide
91620|NCT02992938|Remifentanil|remifentanil
91621|NCT02992925|Haemophilus influenza type b|haemophilus influenza type b
91622|NCT02992925|Adsorbed Diphteria-purified Pertussis-Tetanus-Inactivate poliovirus combined vaccine|adsorbed diphteria-purified pertussis-tetanus-inactivate poliovirus combined vaccine
91623|NCT02992925|Hib|hib
91624|NCT02992925|DPT-IPV|dpt-ipv
91625|NCT02992899|stress disorders, post-traumatic|stress disorders, post-traumatic
91626|NCT02992899|posttraumatic stress disorder|posttraumatic stress disorder
91627|NCT02992899|PTSD|ptsd
91628|NCT02992899|vagal nerve|vagal nerve
91629|NCT02992886|elderly patients|elderly patients
91630|NCT02992886|rectal cancer|rectal cancer
91631|NCT02992886|preoperative chemoradiotherapy|preoperative chemoradiotherapy
91632|NCT02992886|comprehensive geriatric assessment|comprehensive geriatric assessment
91633|NCT02992860|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
91634|NCT02992860|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
91635|NCT02992860|hypomethylating agent (HMA) treatment|hypomethylating agent (hma) treatment
91636|NCT02992860|leukemic stem cell|leukemic stem cell
91637|NCT02992860|CD123|cd123
91638|NCT02992860|immunotherapy|immunotherapy
91639|NCT02992847|Multiple sclerosis|multiple sclerosis
91640|NCT02992847|Gadolinium based contrast agent|gadolinium based contrast agent
91641|NCT02992847|MRI|mri
91642|NCT02992847|Dentate nucleus|dentate nucleus
91643|NCT02992821|Hand-held|hand-held
91644|NCT02992821|Ultrasound|ultrasound
91645|NCT02992821|Diagnosis|diagnosis
91646|NCT02992821|Carotid artery stenosis|carotid artery stenosis
91647|NCT02992808|IVF|ivf
91648|NCT02992808|Ovarian stimulation|ovarian stimulation
91649|NCT02992808|Androgenic profile|androgenic profile
91650|NCT02992808|Follicular fluid|follicular fluid
91651|NCT02992808|Recombinant gonadotropins|recombinant gonadotropins
91652|NCT02992808|human menopausal gonadotropin|human menopausal gonadotropin
91653|NCT02992769|Breast Cancer|breast cancer
91654|NCT02992769|Nomogram|nomogram
91655|NCT02992769|Ultrasound|ultrasound
91656|NCT02992769|Axillary Metastases|axillary metastases
91657|NCT02992743|Sarcoma|sarcoma
91658|NCT02992743|Cell Therapy|cell therapy
91659|NCT02992743|T Cell Therapy|t cell therapy
91660|NCT02992743|NY-ESO-1|ny-eso-1
91661|NCT02992743|Immuno-oncology|immuno-oncology
91662|NCT02992743|Metastatic|metastatic
91663|NCT02992743|Previously treated|previously treated
91664|NCT02992743|T Cell Receptor|t cell receptor
91665|NCT02992730|Medication Adherence|medication adherence
91666|NCT02992665|Calcium ionophore|calcium ionophore
91667|NCT02992665|Fertilization|fertilization
91668|NCT02992665|Sperm|sperm
91669|NCT02992665|Oocyte|oocyte
91670|NCT02992665|ICSI|icsi
91671|NCT02992639|High visceral fat|high visceral fat
91672|NCT02992639|Liver enzymes|liver enzymes
91673|NCT02992639|Aminotransferase|aminotransferase
91674|NCT02992639|Mild calorie restriction|mild calorie restriction
91675|NCT02992600|non-cardiac surgery|non-cardiac surgery
91676|NCT02992600|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
91677|NCT02992574|Post-Mastectomy Radiation|post-mastectomy radiation
91678|NCT02992574|Node Negative|node negative
91679|NCT02992574|Early breast Cancer|early breast cancer
91680|NCT02992561|Aggression|aggression
91681|NCT02992561|Violence|violence
91682|NCT02992561|Post-conflict reconstruction|post-conflict reconstruction
91683|NCT02992561|Demobilization|demobilization
91684|NCT02992561|Traumatized offenders|traumatized offenders
91685|NCT02992548|chronic kidney disease|chronic kidney disease
91686|NCT02992548|pravastatin|pravastatin
91687|NCT02992548|erythrocyte membrane fatty acid|erythrocyte membrane fatty acid
91688|NCT02992483|multiple myeloma|multiple myeloma
91689|NCT02992483|lymphoma|lymphoma
91690|NCT02992483|dlbcl|dlbcl
91691|NCT02992431|patient care planning|patient care planning
91692|NCT02992431|primary health care|primary health care
91693|NCT02992431|comorbidity|comorbidity
91694|NCT02992418|Dengue Fever|dengue fever
91695|NCT02992418|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
91696|NCT02992418|CYD Dengue Vaccine|cyd dengue vaccine
91697|NCT02992418|Degavaxia®|degavaxia®
91698|NCT02992392|Tear film|tear film
91699|NCT02992392|Lipid layer|lipid layer
91700|NCT02992392|Liposic|liposic
91701|NCT02992392|Tears Naturale Forte|tears naturale forte
91702|NCT02992379|Anterior disc displacement|anterior disc displacement
91703|NCT02992379|Stabilizing splint|stabilizing splint
91704|NCT02992366|socket shield|socket shield
91705|NCT02992366|volumetric tissue alteration|volumetric tissue alteration
91706|NCT02992366|immediate implant|immediate implant
91707|NCT02992353|VATS|vats
91708|NCT02992353|NSCLC|nsclc
91709|NCT02992353|recurrence rate|recurrence rate
91710|NCT02992288|Chronic Heart Failure|chronic heart failure
91711|NCT02992288|Heart Failure with Reduced Ejection Fraction|heart failure with reduced ejection fraction
91713|NCT02992275|Muscle|muscle
91714|NCT02992275|Skeletal/physiopathology|skeletal/physiopathology
91715|NCT02992223|Aggressive B-cell non-Hodgkin Lymphoma|aggressive b-cell non-hodgkin lymphoma
91716|NCT02992223|Relapsed|relapsed
91717|NCT02992223|Refractory|refractory
91718|NCT02992223|Zevalin|zevalin
91719|NCT02992223|Y90 Ibritumomab Tiuxetan|y90 ibritumomab tiuxetan
91720|NCT02992223|Autologous stem cell transplant|autologous stem cell transplant
91721|NCT02992223|BEAM|beam
91722|NCT02992223|Recurrent|recurrent
91723|NCT02992210|CAR|car
91724|NCT02992210|chimeric antigen receptor|chimeric antigen receptor
91725|NCT02992210|adoptive T cell transfer|adoptive t cell transfer
91726|NCT02992197|Rotavirus|rotavirus
91727|NCT02992197|Oral vaccines|oral vaccines
91728|NCT02992197|Vaccine underperformance|vaccine underperformance
91729|NCT02992197|Vaccine shedding|vaccine shedding
91730|NCT02992184|HCV|hcv
91731|NCT02992184|Genedrive|genedrive
91732|NCT02992184|Point of Care|point of care
91733|NCT02992119|safety|safety
91734|NCT02992119|immunogenicity|immunogenicity
91735|NCT02992106|Maternal Obesity|maternal obesity
91736|NCT02992106|Endothelial Dysfunction|endothelial dysfunction
91737|NCT02992106|Childhood Obesity|childhood obesity
91738|NCT02992093|Polycystic ovary syndrome|polycystic ovary syndrome
91739|NCT02992093|Metabonomics|metabonomics
91740|NCT02992093|Traditional Chinese medicine syndromes|traditional chinese medicine syndromes
91741|NCT02992080|Patient with Cystic Fibrosis|patient with cystic fibrosis
91742|NCT02992080|Patient without Cystic fibrosis|patient without cystic fibrosis
91743|NCT02992067|lymph node metastasis|lymph node metastasis
91744|NCT02992067|breast cancer|breast cancer
91745|NCT02992067|CK19|ck19
91746|NCT02992067|contrast-enhanced ultrasonography|contrast-enhanced ultrasonography
91747|NCT02992028|Rotator cuff repair|rotator cuff repair
91748|NCT02992028|Vitamin C|vitamin c
91749|NCT02992028|postoperative pain|postoperative pain
91750|NCT02991989|Home-based exercise|home-based exercise
91751|NCT02991989|Exercise snacking|exercise snacking
91752|NCT02991989|Protein|protein
91753|NCT02991989|Yogurt|yogurt
91754|NCT02991976|Normobaric hyperoxia|normobaric hyperoxia
91755|NCT02991976|Cerebral oxygenation|cerebral oxygenation
91756|NCT02991976|Near-infrared spectroscopy|near-infrared spectroscopy
91757|NCT02991976|Carotid endarterectomy|carotid endarterectomy
91758|NCT02991976|TIVA|tiva
91759|NCT02991924|endobronchial ultrasound|endobronchial ultrasound
91760|NCT02991924|EBUS-TBNA|ebus-tbna
91761|NCT02991924|lung cancer|lung cancer
91762|NCT02991924|staging|staging
91763|NCT02991911|metastatic, prostate cancer|metastatic, prostate cancer
91764|NCT02991898|CML|cml
91765|NCT02991898|MDS|mds
91766|NCT02991898|CLL|cll
91767|NCT02991898|ALL|all
91768|NCT02991898|AML|aml
91769|NCT02991872|Persistence|persistence
91770|NCT02991872|Purified chicken-embryo cell rabies vaccine|purified chicken-embryo cell rabies vaccine
91771|NCT02991872|Rabies Virus Neutralizing Antibody (RVNA)|rabies virus neutralizing antibody (rvna)
91772|NCT02991872|Immunogenicity|immunogenicity
91773|NCT02991872|Post-Exposure Prophylaxis (PEP)|post-exposure prophylaxis (pep)
91774|NCT02991872|Rabipur|rabipur
91775|NCT02991859|Dose-response|dose-response
91776|NCT02991859|AMP challenge|amp challenge
91777|NCT02991859|cortisol suppression|cortisol suppression
91778|NCT02991859|dose escalation|dose escalation
91779|NCT02991859|therapeutic index|therapeutic index
91780|NCT02991846|chronic graft-versus-host disease cGVHD|chronic graft-versus-host disease cgvhd
91781|NCT02991846|Hematopoietic stem cell transplantation HSCT|hematopoietic stem cell transplantation hsct
91782|NCT02991846|NIH consensus criteria|nih consensus criteria
91783|NCT02991846|GITMO|gitmo
91784|NCT02991833|fecal incontinence|fecal incontinence
91785|NCT02991833|care product|care product
91786|NCT02991833|bowel incontinence|bowel incontinence
91787|NCT02991807|PTEN|pten
91788|NCT02991807|PTEN Gene Mutation|pten gene mutation
91789|NCT02991807|PTEN Hamartoma Tumor Syndrome|pten hamartoma tumor syndrome
91790|NCT02991807|Autism|autism
91791|NCT02991807|Intellectual Disability|intellectual disability
91792|NCT02991807|Neurocognition|neurocognition
91793|NCT02991807|Afinitor|afinitor
91794|NCT02991807|Everolimus|everolimus
91795|NCT02991807|RAD001|rad001
91796|NCT02991794|prostatectomy|prostatectomy
91797|NCT02991794|laparoscopy|laparoscopy
91798|NCT02991794|3D visualization|3d visualization
91799|NCT02991794|learning curve|learning curve
91800|NCT02991794|anastomosis|anastomosis
91801|NCT02991742|nephropathy|nephropathy
91802|NCT02991742|catheterization|catheterization
91803|NCT02991742|contrast media|contrast media
91804|NCT02991742|ioxaglate|ioxaglate
91805|NCT02991742|iodixanol|iodixanol
91806|NCT02991742|high risk|high risk
91807|NCT02991742|prevention|prevention
91808|NCT02991729|Decision aid|decision aid
91809|NCT02991703|Arterial stiffness|arterial stiffness
91810|NCT02991703|pulse wave velocity|pulse wave velocity
91811|NCT02991703|Sphygmocor|sphygmocor
91812|NCT02991703|applanation tonometry|applanation tonometry
91813|NCT02991703|pOpmètre|popmètre
91814|NCT02991703|children|children
91815|NCT02991703|EPIPAGE cohort|epipage cohort
91816|NCT02991690|Hypothermia|hypothermia
91817|NCT02991690|Cervical Spinal Cord Injury|cervical spinal cord injury
91818|NCT02991690|Trauma|trauma
91819|NCT02991677|exercise|exercise
91820|NCT02991677|neuropathy|neuropathy
91821|NCT02991664|glass ionomer cement|glass ionomer cement
91822|NCT02991664|composite resin|composite resin
91823|NCT02991651|RXR agonist IRX4204 erlotinib|rxr agonist irx4204 erlotinib
91824|NCT02991599|Hepatitis B, Vaccine|hepatitis b, vaccine
91825|NCT02991599|Immunogenicity|immunogenicity
91826|NCT02991599|methadone maintenance treatment|methadone maintenance treatment
91827|NCT02991599|Randomized Controlled Trial|randomized controlled trial
91828|NCT02991586|Emotional Instability|emotional instability
91829|NCT02991586|Family Therapy|family therapy
91830|NCT02991586|BPD|bpd
91831|NCT02991586|DBT|dbt
91832|NCT02991560|physiotherapy|physiotherapy
91833|NCT02991560|taping|taping
91834|NCT02991560|conservative treatment|conservative treatment
91835|NCT02991534|Patient Participation [N05.300.150.600.620]|patient participation [n05.300.150.600.620]
91836|NCT02991534|Health Behavior [F01.145.488]|health behavior [f01.145.488]
91837|NCT02991534|Women [M01.975]|women [m01.975]
91838|NCT02991534|Patient Satisfaction [N05.715.360.600]|patient satisfaction [n05.715.360.600]
91839|NCT02991534|Physicians, Primary Care [M01.526.485.810.800]|physicians, primary care [m01.526.485.810.800]
91840|NCT02991534|Physicians, Women [M01.526.485.810.820]|physicians, women [m01.526.485.810.820]
91841|NCT02991534|Health Educators [M01.526.485.410]|health educators [m01.526.485.410]
91842|NCT02991534|Cardiovascular Diseases [C14]|cardiovascular diseases [c14]
91843|NCT02991534|Hypertension [C14.907.489]|hypertension [c14.907.489]
91844|NCT02991534|Hyperlipidemias [C18.452.584.500.500]|hyperlipidemias [c18.452.584.500.500]
91845|NCT02991534|Dyslipidemias [C18.452.584.500]|dyslipidemias [c18.452.584.500]
91846|NCT02991534|Obesity [C18.654.726.500]|obesity [c18.654.726.500]
91847|NCT02991534|Diabetes Mellitus [C18.452.394.750]|diabetes mellitus [c18.452.394.750]
91848|NCT02991534|Tobacco Use Disorder [C25.775.912]|tobacco use disorder [c25.775.912]
91849|NCT02991534|Overweight [C23.888.144.699]|overweight [c23.888.144.699]
91850|NCT02991508|Adrecizumab|adrecizumab
91851|NCT02991508|Phase 1 clinical trial|phase 1 clinical trial
91852|NCT02991508|Adrenomedullin|adrenomedullin
91853|NCT02991508|Healthy volunteers|healthy volunteers
91854|NCT02991508|Monoclonal recombinant antibody|monoclonal recombinant antibody
91855|NCT02991495|epidemic response|epidemic response
91856|NCT02991482|MPM|mpm
91857|NCT02991456|malignant glioma|malignant glioma
91858|NCT02991456|temozolomide|temozolomide
91859|NCT02991456|temodar|temodar
91860|NCT02991456|radiation|radiation
91861|NCT02991456|emesis|emesis
91862|NCT02991456|nausea|nausea
91863|NCT02991456|vomiting|vomiting
91864|NCT02991456|chemotherapy|chemotherapy
91865|NCT02991456|Affronti|affronti
91866|NCT02991456|Peters|peters
91867|NCT02991456|00076418|00076418
91868|NCT02991430|migraine headache, episodic|migraine headache, episodic
91869|NCT02991378|preschool children|preschool children
91870|NCT02991378|emotional disorders/problems|emotional disorders/problems
91871|NCT02991378|stress related disorders/problems|stress related disorders/problems
91872|NCT02991378|early intervention|early intervention
91873|NCT02991352|Vascular Malformations|vascular malformations
91874|NCT02991352|Image Guidance|image guidance
91875|NCT02991339|Dexamethasone|dexamethasone
91876|NCT02991339|Liver Dysfunction|liver dysfunction
91877|NCT02991339|Hepatectomy|hepatectomy
91878|NCT02991339|Bilirubinaemia|bilirubinaemia
91879|NCT02991339|Jaundice|jaundice
91880|NCT02991326|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
91881|NCT02991326|Temporomandibular Disorder|temporomandibular disorder
91882|NCT02991300|focal defect|focal defect
91883|NCT02991300|focal lesion|focal lesion
91884|NCT02991300|chondral lesion|chondral lesion
91885|NCT02991300|osteochondral lesion|osteochondral lesion
91886|NCT02991274|T790M|t790m
91887|NCT02991274|EGFR (Epidermal Growth Factor Receptor) mutation|egfr (epidermal growth factor receptor) mutation
91888|NCT02991274|NSCLC|nsclc
91889|NCT02991196|Advanced colorectal cancer|advanced colorectal cancer
91890|NCT02991196|DNA mismatch repair (MMR)|dna mismatch repair (mmr)
91891|NCT02991196|MMR-proficient Subjects|mmr-proficient subjects
91892|NCT02991196|TRAIL-R2 (DR5) Antibody|trail-r2 (dr5) antibody
91893|NCT02991183|Caregivers|caregivers
91894|NCT02991183|Acceptance and Commitment Therapy|acceptance and commitment therapy
91895|NCT02991170|myocardial infarction|myocardial infarction
91896|NCT02991170|ventricular arrhythmia|ventricular arrhythmia
91897|NCT02991170|radiofrequency ablation|radiofrequency ablation
91898|NCT02991170|Coronary Artery Bypass Grafts|coronary artery bypass grafts
91899|NCT02991157|cerebral vasospasm|cerebral vasospasm
91900|NCT02991157|nimodipine|nimodipine
91901|NCT02991144|Gene Transfer|gene transfer
91902|NCT02991144|OTC Deficiency|otc deficiency
91903|NCT02991144|Urea Cycle Disorder|urea cycle disorder
91904|NCT02991131|Acute bacterial skin infection|acute bacterial skin infection
91905|NCT02991131|Acute Bacterial Skin and Skin Structure Infection (ABSSSI)|acute bacterial skin and skin structure infection (absssi)
91907|NCT02991131|Cellulitis|cellulitis
91908|NCT02991131|Erysipelas|erysipelas
91909|NCT02991131|Wound infection|wound infection
91910|NCT02991131|Methicillin resistant Staphylococcus aureus (MRSA)|methicillin resistant staphylococcus aureus (mrsa)
91911|NCT02991118|hyperlipidemia|hyperlipidemia
91912|NCT02991118|cholesterol|cholesterol
91913|NCT02991118|familial hypercholesterolemia|familial hypercholesterolemia
91914|NCT02991118|atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease
91915|NCT02991118|ASCVD|ascvd
91916|NCT02991118|HeFH|hefh
91917|NCT02991118|LDL|ldl
91918|NCT02991105|Malignancy|malignancy
91919|NCT02991105|Cancer|cancer
91920|NCT02991105|Organ Transplantation|organ transplantation
91921|NCT02991092|colon carcinoma|colon carcinoma
91922|NCT02991092|liquid treatment|liquid treatment
91923|NCT02991092|fast-track surgery|fast-track surgery
91924|NCT02991079|Food Habits|food habits
91925|NCT02991079|Health education|health education
91926|NCT02991079|Physical activity|physical activity
91927|NCT02991079|Information and Communication Technologies|information and communication technologies
91928|NCT02991066|Acute promyelocytic leukemia|acute promyelocytic leukemia
91929|NCT02991066|Coagulopathy|coagulopathy
91930|NCT02991066|Microparticles|microparticles
91931|NCT02991066|Mechanism|mechanism
91932|NCT02991053|Intra-operative anesthesia|intra-operative anesthesia
91933|NCT02991053|Pediatric patient|pediatric patient
91934|NCT02991053|Transversus Abdominis Plane Block|transversus abdominis plane block
91935|NCT02991053|ilioinguinal / iliohypogastric nerve block|ilioinguinal / iliohypogastric nerve block
91936|NCT02991027|no known ocular pathology|no known ocular pathology
91937|NCT02991014|music intervention|music intervention
91938|NCT02991014|heart rate variability|heart rate variability
91939|NCT02991014|frequency modulation|frequency modulation
91940|NCT02991014|pain perception|pain perception
91941|NCT02991014|cold pressor test (CPT)|cold pressor test (cpt)
91942|NCT02991001|Hydrodissection|hydrodissection
91943|NCT02990988|Blood donation|blood donation
91944|NCT02990988|Iron repletion|iron repletion
91945|NCT02990988|Transfusion|transfusion
91946|NCT02990975|Intra-operative anesthesia|intra-operative anesthesia
91947|NCT02990975|Pediatric patient|pediatric patient
91948|NCT02990975|Transversus Abdominis Plane Block|transversus abdominis plane block
91949|NCT02990962|perineural injection|perineural injection
91950|NCT02990962|ultrasound-guided|ultrasound-guided
91951|NCT02990962|dextrose|dextrose
91952|NCT02990962|steroid|steroid
91953|NCT02990936|Oropharynx squamous cell carcinoma|oropharynx squamous cell carcinoma
91954|NCT02990936|tumor growth|tumor growth
91955|NCT02990936|predictive markers|predictive markers
91956|NCT02990936|tumoral kinetics|tumoral kinetics
91957|NCT02990910|respiratory adverse events|respiratory adverse events
91958|NCT02990910|adenotonsillectomy|adenotonsillectomy
91959|NCT02990910|opioid analgesia|opioid analgesia
91960|NCT02990910|children|children
91961|NCT02990897|Medical informatics|medical informatics
91962|NCT02990897|Quality of care|quality of care
91963|NCT02990897|Referral|referral
91964|NCT02990884|Intra-operative anesthesia and analgesia|intra-operative anesthesia and analgesia
91965|NCT02990884|ilioinguinal / iliohyogogastric nerve block|ilioinguinal / iliohyogogastric nerve block
91966|NCT02990884|Pediatric patient|pediatric patient
91967|NCT02990819|Immunodeficiencies|immunodeficiencies
91968|NCT02990819|Immune dysregulation syndromes|immune dysregulation syndromes
91969|NCT02990793|PTSD|ptsd
91970|NCT02990793|Concussion|concussion
91971|NCT02990793|TBI|tbi
91972|NCT02990793|TMS|tms
91973|NCT02990741|atrial fibrillation|atrial fibrillation
91974|NCT02990741|automated ECG system|automated ecg system
91975|NCT02990728|Endometrial Cancer.Mirena®|endometrial cancer.mirena®
91976|NCT02990715|average risk CRC screening|average risk crc screening
91977|NCT02990715|Non compliant patients for CRC screening|non compliant patients for crc screening
91978|NCT02990715|Counterindicated patients for colonoscopy|counterindicated patients for colonoscopy
91979|NCT02990702|Infraclavicular block|infraclavicular block
91980|NCT02990702|Retroclavicular block|retroclavicular block
91981|NCT02990702|Ultrasound|ultrasound
91982|NCT02990676|Cognition|cognition
91983|NCT02990676|Computerised cognitive training|computerised cognitive training
91984|NCT02990676|Feasibility study|feasibility study
91985|NCT02990676|Huntington's disease|huntington's disease
91986|NCT02990676|Translational|translational
91987|NCT02990663|Pragmatic|pragmatic
91988|NCT02990663|Primary Care|primary care
91989|NCT02990663|Chronotherapy|chronotherapy
91990|NCT02990663|Administrative Data|administrative data
91991|NCT02990663|Stroke|stroke
91992|NCT02990663|Myocardial Infarction|myocardial infarction
91993|NCT02990663|Congestive Heart Failure|congestive heart failure
91994|NCT02990663|Glaucoma|glaucoma
91995|NCT02990663|Dementia|dementia
91996|NCT02990663|Hip Fracture|hip fracture
91997|NCT02990637|Olive leaf extract|olive leaf extract
91998|NCT02990637|Cardiovascular health|cardiovascular health
91999|NCT02990637|Cholesterol|cholesterol
92000|NCT02990624|psoriasis|psoriasis
92001|NCT02990624|photochemotherapy|photochemotherapy
92002|NCT02990624|atherosclerosis|atherosclerosis
92003|NCT02990624|metabolic syndrome|metabolic syndrome
92004|NCT02990624|cardiovascular risk|cardiovascular risk
92005|NCT02990598|Hydroxyurea|hydroxyurea
92006|NCT02990572|Amish|amish
92007|NCT02990572|Mennonite|mennonite
92008|NCT02990559|Iron repletion|iron repletion
92009|NCT02990559|Blood donation|blood donation
92010|NCT02990559|Transfusion|transfusion
92011|NCT02990507|mobility impairment|mobility impairment
92012|NCT02990507|virtual environment|virtual environment
92013|NCT02990507|exercise|exercise
92014|NCT02990507|physical activity|physical activity
92015|NCT02990468|Mucositis|mucositis
92016|NCT02990468|Xerostomia|xerostomia
92017|NCT02990455|alcohol|alcohol
92018|NCT02990455|drinking|drinking
92019|NCT02990455|smoking|smoking
92020|NCT02990455|cigarette|cigarette
92021|NCT02990455|nicotine|nicotine
92022|NCT02990442|rTMS|rtms
92023|NCT02990442|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
92024|NCT02990442|Brain Stimulation|brain stimulation
92025|NCT02990429|hypothermia|hypothermia
92026|NCT02990429|Shivering|shivering
92027|NCT02990429|Gynecologic laparoscopic surgery|gynecologic laparoscopic surgery
92029|NCT02990429|General anesthesia|general anesthesia
92030|NCT02990377|Opioid Analgesics|opioid analgesics
92031|NCT02990377|Opioid Safety|opioid safety
92032|NCT02990377|Emergency Department|emergency department
92033|NCT02990377|Motivational Enhancement|motivational enhancement
92034|NCT02990377|Interactive Voice Response|interactive voice response
92035|NCT02990377|Reinforcement Learning|reinforcement learning
92036|NCT02990377|mHealth|mhealth
92037|NCT02990364|Circumcision|circumcision
92038|NCT02990364|Analgesia|analgesia
92039|NCT02990364|Controlled Clinical Trial|controlled clinical trial
92040|NCT02990325|ABX464, HIV infection|abx464, hiv infection
92041|NCT02990299|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
92042|NCT02990299|Medication Adherence|medication adherence
92043|NCT02990299|Telemedicine|telemedicine
92044|NCT02990299|Community Health Workers|community health workers
92045|NCT02990299|Pharmacists|pharmacists
92046|NCT02990299|Mobile Health|mobile health
92047|NCT02990286|Non specific intertitial pneumonia|non specific intertitial pneumonia
92048|NCT02990286|interstitial pneumonia with autoimmune feature|interstitial pneumonia with autoimmune feature
92049|NCT02990286|connective tissue disease|connective tissue disease
92050|NCT02990286|rituximab|rituximab
92051|NCT02990286|Mycophenolate Mofetil|mycophenolate mofetil
92253|NCT02988895|Wet AMD|wet amd
92052|NCT02990286|pulmonary fibrosis|pulmonary fibrosis
92053|NCT02990247|Asthma|asthma
92054|NCT02990247|Exacerbations|exacerbations
92055|NCT02990247|Telemonitoring|telemonitoring
92056|NCT02990247|Biomarkers|biomarkers
92057|NCT02990234|Capsular Repair|capsular repair
92058|NCT02990234|FAI|fai
92059|NCT02990234|Hip|hip
92060|NCT02990221|Field Cancerization|field cancerization
92061|NCT02990208|Diaphragmatic Breathing|diaphragmatic breathing
92062|NCT02990208|Virtual Reality Exposure Therapy|virtual reality exposure therapy
92063|NCT02990182|Yellow Fever Vaccine|yellow fever vaccine
92064|NCT02990182|Immunity, Humoral|immunity, humoral
92065|NCT02990182|Immunity, Cellular|immunity, cellular
92066|NCT02990182|children|children
92067|NCT02990156|Coils|coils
92068|NCT02990091|TBI|tbi
92069|NCT02990091|DHA|dha
92070|NCT02990091|omega-3 highly unsaturated fatty acids|omega-3 highly unsaturated fatty acids
92071|NCT02990091|synaptamide|synaptamide
92072|NCT02990078|TBI|tbi
92073|NCT02990078|CVR|cvr
92074|NCT02990078|Hypercapnia|hypercapnia
92075|NCT02990078|fNIRS|fnirs
92076|NCT02990065|PROTEIN SUPPLEMENTATION|protein supplementation
92077|NCT02990065|NUTRITIONAL STATUS|nutritional status
92078|NCT02990039|physical activity|physical activity
92079|NCT02990039|sedentary time|sedentary time
92080|NCT02990039|feasibility study|feasibility study
92081|NCT02990039|accelerometer|accelerometer
92082|NCT02989987|PTSD|ptsd
92083|NCT02989987|Shame|shame
92084|NCT02989987|Narrative Exposure Therapy|narrative exposure therapy
92085|NCT02989987|Sexual and gender based violence (SGBV)|sexual and gender based violence (sgbv)
92086|NCT02989987|DR Congo|dr congo
92087|NCT02989974|Survivorship Care|survivorship care
92088|NCT02989974|Caregiving|caregiving
92089|NCT02989948|Endovascular|endovascular
92090|NCT02989935|respiratory muscle|respiratory muscle
92091|NCT02989935|bronchodilator|bronchodilator
92092|NCT02989896|Perfusion index|perfusion index
92093|NCT02989896|Peripheral nerve block success|peripheral nerve block success
92094|NCT02989896|older age|older age
92095|NCT02989883|achalasia|achalasia
92096|NCT02989883|POEM|poem
92097|NCT02989883|outcome|outcome
92098|NCT02989870|Liver Disease|liver disease
92099|NCT02989870|Child-Pugh Class A|child-pugh class a
92100|NCT02989870|Child-Pugh Class B7|child-pugh class b7
92101|NCT02989857|IDH1|idh1
92102|NCT02989831|diabetic neuropathy|diabetic neuropathy
92103|NCT02989831|foot ulcers|foot ulcers
92104|NCT02989831|random vibration|random vibration
92105|NCT02989831|vibration perception threshold|vibration perception threshold
92106|NCT02989831|mechanical noise|mechanical noise
92107|NCT02989805|Emergency Medicine|emergency medicine
92108|NCT02989805|Psychiatry|psychiatry
92109|NCT02989805|Health Promotion|health promotion
92110|NCT02989805|Public Health|public health
92111|NCT02989792|pain|pain
92112|NCT02989753|Prevention|prevention
92113|NCT02989740|Diabetes Mellitus|diabetes mellitus
92114|NCT02989740|Thincap fibroatheroma|thincap fibroatheroma
92115|NCT02989740|Optical Coherence Tomography|optical coherence tomography
92116|NCT02989740|Fractional Flow Reserve|fractional flow reserve
92117|NCT02989701|Plerixafor|plerixafor
92118|NCT02989675|pediatric|pediatric
92119|NCT02989675|critical illness|critical illness
92120|NCT02989675|Malawi|malawi
92121|NCT02989649|Drug Therapy|drug therapy
92122|NCT02989584|bladder cancer|bladder cancer
92123|NCT02989584|metastatic bladder cancer|metastatic bladder cancer
92124|NCT02989584|atezolizumab|atezolizumab
92125|NCT02989584|urothelial carcinoma|urothelial carcinoma
92126|NCT02989519|preterm labor|preterm labor
92127|NCT02989519|progesterone efficacy|progesterone efficacy
92128|NCT02989519|threatened preterm labor|threatened preterm labor
92129|NCT02989493|Alcoholism|alcoholism
92130|NCT02989493|Stress|stress
92131|NCT02989493|Norepinephrine|norepinephrine
92132|NCT02989493|Doxazosin|doxazosin
92133|NCT02989493|Anxiety|anxiety
92134|NCT02989493|Startle Potentiation|startle potentiation
92135|NCT02989493|Relapse|relapse
92136|NCT02989493|Adrenergic Antagonists|adrenergic antagonists
92137|NCT02989493|Surrogate Endpoint|surrogate endpoint
92138|NCT02989480|Cardiomyopathy|cardiomyopathy
92139|NCT02989441|Perfusion Index|perfusion index
92140|NCT02989441|Hemodynamics|hemodynamics
92141|NCT02989441|Anesthesia|anesthesia
92142|NCT02989441|Stroke Volume|stroke volume
92143|NCT02989415|Anesthesia|anesthesia
92144|NCT02989415|Mechanical Ventilation|mechanical ventilation
92145|NCT02989415|Robotic Surgery|robotic surgery
92146|NCT02989415|Postoperative Pulmonary Complications|postoperative pulmonary complications
92147|NCT02989402|Alzheimer, Rivastigmine|alzheimer, rivastigmine
92148|NCT02989363|deep brain surgery and complex back surgery|deep brain surgery and complex back surgery
92149|NCT02989337|Hyperemesis Gravidarum|hyperemesis gravidarum
92150|NCT02989337|Inflammatory adhesion molecules|inflammatory adhesion molecules
92151|NCT02989337|Dehydration|dehydration
92152|NCT02989311|Iron absorption|iron absorption
92153|NCT02989311|Iron deficiency|iron deficiency
92154|NCT02989311|Hepcidin|hepcidin
92155|NCT02989311|Stable isotopes|stable isotopes
92156|NCT02989311|Anemia|anemia
92157|NCT02989311|Infants|infants
92158|NCT02989298|Peritoneal Dialysis (PD)|peritoneal dialysis (pd)
92159|NCT02989298|Residual renal function|residual renal function
92160|NCT02989298|Peritoneum function|peritoneum function
92161|NCT02989298|Peritonitis rate|peritonitis rate
92162|NCT02989298|Technical survival|technical survival
92163|NCT02989298|Patient survival|patient survival
92165|NCT02989285|HIV-associated neurocognitive disorder (HAND)|hiv-associated neurocognitive disorder (hand)
92166|NCT02989285|Neurology|neurology
92167|NCT02989285|Latent HIV|latent hiv
92168|NCT02989285|HIV Reservoirs|hiv reservoirs
92169|NCT02989259|apatinib|apatinib
92170|NCT02989259|advanced head and neck cancer|advanced head and neck cancer
92171|NCT02989259|non-squamous|non-squamous
92172|NCT02989246|pediatrics|pediatrics
92173|NCT02989246|ventilator weaning|ventilator weaning
92174|NCT02989220|Miscarriage|miscarriage
92175|NCT02989207|Glaucoma|glaucoma
92176|NCT02989207|Trabeculectomy|trabeculectomy
92177|NCT02989207|Glaucoma drainage implant|glaucoma drainage implant
92178|NCT02989207|Africa and Africa-Caribbean|africa and africa-caribbean
92179|NCT02989168|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
92180|NCT02989168|hypoxemia|hypoxemia
92181|NCT02989168|oxygen|oxygen
92182|NCT02989142|interpregnancy|interpregnancy
92183|NCT02989142|pregnancy-induced hypertension|pregnancy-induced hypertension
92184|NCT02989142|gestational diabetes mellitus|gestational diabetes mellitus
92185|NCT02989142|caesarean section|caesarean section
92186|NCT02989142|large-for-gestational-age|large-for-gestational-age
92187|NCT02989129|Polyneuropathies and Other Disorders of the Peripheral Nervous System|polyneuropathies and other disorders of the peripheral nervous system
92188|NCT02989129|Chemotherapy Induced Neuropathic Pain|chemotherapy induced neuropathic pain
92189|NCT02989129|CINP|cinp
92190|NCT02989129|Quercetin|quercetin
92191|NCT02989129|Questionnaires|questionnaires
92192|NCT02989129|Surveys|surveys
92193|NCT02989116|Learning|learning
92194|NCT02989116|Executive functions|executive functions
92195|NCT02989116|Cognitive control|cognitive control
92196|NCT02989116|Prefrontal Cortex|prefrontal cortex
92197|NCT02989116|Typically developing children|typically developing children
92198|NCT02989116|Genotype|genotype
92199|NCT02989116|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
92200|NCT02989116|Structural Magnetic Resonance Imaging|structural magnetic resonance imaging
92201|NCT02989116|Inhibition|inhibition
92202|NCT02989116|Working Memory|working memory
92203|NCT02989116|Metacognition|metacognition
92204|NCT02989116|Mindfulness|mindfulness
92205|NCT02989116|Preterm children|preterm children
92206|NCT02989116|Developmental Psychology|developmental psychology
92207|NCT02989116|Developmental cognitive neuroscience|developmental cognitive neuroscience
92208|NCT02989116|Touch screen tablet|touch screen tablet
92209|NCT02989116|Adaptive training|adaptive training
92210|NCT02989103|Hyperthyroidism|hyperthyroidism
92211|NCT02989103|Radiation|radiation
92212|NCT02989103|Mortality|mortality
92213|NCT02989090|Patient Engagement|patient engagement
92214|NCT02989090|Defibrillators|defibrillators
92215|NCT02989090|Health Records, Personal|health records, personal
92216|NCT02989090|Patient Portal|patient portal
92217|NCT02989077|combined coronary and cerebral ischemia|combined coronary and cerebral ischemia
92218|NCT02989064|Cell Therapy|cell therapy
92219|NCT02989064|T Cell Therapy|t cell therapy
92220|NCT02989064|SPEAR T Cell|spear t cell
92221|NCT02989064|MAGE-A10|mage-a10
92222|NCT02989064|Immuno-oncology|immuno-oncology
92223|NCT02989064|Metastatic|metastatic
92224|NCT02989064|Urothelial Cancer|urothelial cancer
92225|NCT02989064|Previously Treated|previously treated
92226|NCT02989064|T Cell Receptor|t cell receptor
92227|NCT02989038|smoker|smoker
92228|NCT02989038|young adult|young adult
92229|NCT02988999|D-allulose or erythritol|d-allulose or erythritol
92230|NCT02988986|mTOR|mtor
92231|NCT02988986|Tamoxifen|tamoxifen
92232|NCT02988986|Breast Cancer|breast cancer
92233|NCT02988973|Roxadustat|roxadustat
92234|NCT02988973|Anemia|anemia
92235|NCT02988973|Non-dialysis chronic kidney disease|non-dialysis chronic kidney disease
92236|NCT02988973|ASP1517|asp1517
92237|NCT02988960|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
92238|NCT02988960|Squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
92239|NCT02988960|Advanced solid tumor|advanced solid tumor
92240|NCT02988960|Cancer|cancer
92241|NCT02988960|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
92242|NCT02988960|Cutaneous melanoma|cutaneous melanoma
92243|NCT02988947|Knee Arthroplasty|knee arthroplasty
92244|NCT02988947|Hypnosis|hypnosis
92245|NCT02988947|Pain Neuroscience Education|pain neuroscience education
92246|NCT02988947|Pain|pain
92247|NCT02988947|Catastrophizing|catastrophizing
92248|NCT02988947|Optimism|optimism
92249|NCT02988947|Distress|distress
92250|NCT02988947|Hope|hope
92251|NCT02988947|Self-Efficacy|self-efficacy
92252|NCT02988895|Brachytherapy|brachytherapy
92254|NCT02988869|COPD|copd
92255|NCT02988869|Tiotropium|tiotropium
92256|NCT02988869|Formoterol|formoterol
92257|NCT02988843|GCT|gct
92258|NCT02988830|Subcutaneous stimulation|subcutaneous stimulation
92259|NCT02988804|endoscopic endonasal transsphenoidal surgery|endoscopic endonasal transsphenoidal surgery
92260|NCT02988804|laryngeal mask|laryngeal mask
92261|NCT02988765|vulvar cancer|vulvar cancer
92262|NCT02988765|inguinal lymph node|inguinal lymph node
92263|NCT02988765|lymph node status|lymph node status
92264|NCT02988765|cytology|cytology
92265|NCT02988765|core biopsy|core biopsy
92266|NCT02988726|Neurofibroma|neurofibroma
92267|NCT02988726|Schwannoma|schwannoma
92268|NCT02988713|stimulation|stimulation
92269|NCT02988713|chronic pain|chronic pain
92270|NCT02988713|back pain|back pain
92271|NCT02988713|leg pain|leg pain
92272|NCT02988687|fatigue|fatigue
92273|NCT02988687|quality of life|quality of life
92274|NCT02988687|depression|depression
92275|NCT02988687|cognitive function|cognitive function
92276|NCT02988687|growth hormone|growth hormone
92277|NCT02988687|traumatic brain injury|traumatic brain injury
92278|NCT02988674|Adalimumab|adalimumab
92279|NCT02988674|Ankylosing spondylitis|ankylosing spondylitis
92280|NCT02988674|Psoriatic arthritis|psoriatic arthritis
92281|NCT02988674|Spondylarthritis|spondylarthritis
92282|NCT02988674|Humira®|humira®
92283|NCT02988661|Autoimmunity|autoimmunity
92284|NCT02988661|Immune System Disorders|immune system disorders
92285|NCT02988648|Metastatic Breast Cancer|metastatic breast cancer
92286|NCT02988635|Early Palliative Care|early palliative care
92287|NCT02988635|Simultaneous Care|simultaneous care
92288|NCT02988635|Chemotherapy|chemotherapy
92289|NCT02988635|Quality of Life|quality of life
92290|NCT02988596|Concussion|concussion
92291|NCT02988596|Rehabilitation|rehabilitation
92292|NCT02988583|silicone oil|silicone oil
92293|NCT02988583|emulsification|emulsification
92294|NCT02988583|retinal detachment surgery|retinal detachment surgery
92295|NCT02988557|cerebral palsy|cerebral palsy
92296|NCT02988557|gait|gait
92297|NCT02988557|slope|slope
92298|NCT02988557|electromyography|electromyography
92299|NCT02988531|PET|pet
92300|NCT02988531|MRI|mri
92301|NCT02988531|Attenuation|attenuation
92302|NCT02988531|Correction|correction
92303|NCT02988531|Cardiovascular|cardiovascular
92304|NCT02988531|coronary|coronary
92305|NCT02988531|disease|disease
92306|NCT02988518|Psychiatry|psychiatry
92307|NCT02988518|Bipolar disorder|bipolar disorder
92308|NCT02988518|Memory complaints|memory complaints
92309|NCT02988518|Global functioning|global functioning
92310|NCT02988518|Cognitive remediation|cognitive remediation
92311|NCT02988518|Working memory|working memory
92312|NCT02988466|Acute Leukemias|acute leukemias
92313|NCT02988466|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
92314|NCT02988466|Acute lymphoblastic leukemia (ALL)/lymphoma|acute lymphoblastic leukemia (all)/lymphoma
92315|NCT02988466|Biphenotypic/Undifferentiated/Prolymphocytic Leukemias|biphenotypic/undifferentiated/prolymphocytic leukemias
92316|NCT02988466|Myelodysplastic syndrome|myelodysplastic syndrome
92317|NCT02988466|Chronic myelogenous leukemia|chronic myelogenous leukemia
92318|NCT02988466|Minimal Residual Disease (MRD) positive leukemia|minimal residual disease (mrd) positive leukemia
92319|NCT02988466|Leukemia or Myelodysplastic Syndromes (MDS) in aplasia|leukemia or myelodysplastic syndromes (mds) in aplasia
92320|NCT02988466|Myeloproliferative neoplasms/myelofibrosis|myeloproliferative neoplasms/myelofibrosis
92321|NCT02988466|Relapsed large-cell lymphoma, mantle-cell lymphoma and Hodgkin lymphoma|relapsed large-cell lymphoma, mantle-cell lymphoma and hodgkin lymphoma
92322|NCT02988466|Burkitt's lymphoma|burkitt's lymphoma
92323|NCT02988466|Relapsed T-cell lymphoma|relapsed t-cell lymphoma
92324|NCT02988466|Natural Killer cell malignancies|natural killer cell malignancies
92325|NCT02988466|Relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), marginal zone B-cell lymphoma, follicular lymphoma|relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma (cll/sll), marginal zone b-cell lymphoma, follicular lymphoma
92326|NCT02988466|Lymphoplasmacytic lymphoma|lymphoplasmacytic lymphoma
92327|NCT02988466|Relapsed multiple myeloma|relapsed multiple myeloma
92328|NCT02988466|Bone marrow failure syndromes|bone marrow failure syndromes
92329|NCT02988453|mentalization-based treatment|mentalization-based treatment
92330|NCT02988453|conduct disorder|conduct disorder
92331|NCT02988453|adolescents|adolescents
92332|NCT02988440|HCC|hcc
92333|NCT02988440|Hepatocellular carcinoma|hepatocellular carcinoma
92334|NCT02988440|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
92335|NCT02988440|PDR001|pdr001
92336|NCT02988440|liver cancer|liver cancer
92337|NCT02988440|immunotherapy liver|immunotherapy liver
92338|NCT02988440|malignant hepatoma|malignant hepatoma
92339|NCT02988440|Hepatocellular cancer|hepatocellular cancer
92340|NCT02988440|advanced hepatocellular carcinoma (HCC)|advanced hepatocellular carcinoma (hcc)
92341|NCT02988440|advanced liver cancer|advanced liver cancer
92342|NCT02988440|liver cancer progression|liver cancer progression
92343|NCT02988440|sorafenib|sorafenib
92344|NCT02988440|anti-PD1|anti-pd1
92345|NCT02988440|first line|first line
92346|NCT02988414|Sepsis|sepsis
92347|NCT02988414|Infection|infection
92348|NCT02988414|Culture|culture
92349|NCT02988414|Sequencing|sequencing
92350|NCT02988414|Non-invasive|non-invasive
92351|NCT02988414|NGS|ngs
92352|NCT02988375|insomnia|insomnia
92353|NCT02988375|depression|depression
92354|NCT02988375|digital CBTI|digital cbti
92355|NCT02988375|online CBTI|online cbti
92356|NCT02988336|difficult intubation|difficult intubation
92357|NCT02988336|thyromental height|thyromental height
92358|NCT02988323|sport concussion|sport concussion
92359|NCT02988323|cervical spine|cervical spine
92360|NCT02988323|vestibular rehabilitation|vestibular rehabilitation
92361|NCT02988323|exercise|exercise
92362|NCT02988323|rehabilitation|rehabilitation
92363|NCT02988323|children|children
92364|NCT02988323|youth|youth
92365|NCT02988310|Limb Loss|limb loss
92366|NCT02988310|Gait Characteristics|gait characteristics
92367|NCT02988284|Gait variability|gait variability
92368|NCT02988271|Meditation|meditation
92369|NCT02988271|Anxiety|anxiety
92370|NCT02988271|Psychosocial distress|psychosocial distress
92371|NCT02988271|Depression|depression
92372|NCT02988271|Questionnaires|questionnaires
92373|NCT02988271|Surveys|surveys
92374|NCT02988271|Meditation Video|meditation video
92375|NCT02988271|Meditation app|meditation app
92376|NCT02988258|Ex vivo gene therapy|ex vivo gene therapy
92377|NCT02988258|T cell receptor transduction|t cell receptor transduction
92378|NCT02988258|Immunotherapy|immunotherapy
92379|NCT02988258|Allogeneic Haematopoietic Stem Cell Transplantation|allogeneic haematopoietic stem cell transplantation
92380|NCT02988258|CMV|cmv
92381|NCT02988232|Work Related Chronic Low Back Pain|work related chronic low back pain
92382|NCT02988232|Korean Medicine|korean medicine
92383|NCT02988232|Sogyeonghwalhyeol-tang|sogyeonghwalhyeol-tang
92384|NCT02988219|cardiac arrhythmia|cardiac arrhythmia
92385|NCT02988219|epidural anesthesia|epidural anesthesia
92386|NCT02988219|combined anesthesia|combined anesthesia
92387|NCT02988219|general anesthesia|general anesthesia
92388|NCT02988219|NSS|nss
92389|NCT02988219|radical nephrectomy|radical nephrectomy
92390|NCT02988219|extraperitoneal|extraperitoneal
92391|NCT02988193|clinical reasoning artificial intelligence|clinical reasoning artificial intelligence
92392|NCT02988193|poorly controlled hypertension|poorly controlled hypertension
92393|NCT02988167|Spontaneous Breathing Trial (SBT)|spontaneous breathing trial (sbt)
92394|NCT02988167|Extubation Decision Support Tool|extubation decision support tool
92395|NCT02988167|Extubation|extubation
92396|NCT02988167|Extubation Readiness|extubation readiness
92397|NCT02988154|Medical education|medical education
92398|NCT02988154|simulation|simulation
92399|NCT02988154|neurosurgical education|neurosurgical education
92400|NCT02988154|Simulation laboratory|simulation laboratory
92401|NCT02988154|Ventricular drain|ventricular drain
92402|NCT02988128|Embolization Device|embolization device
92403|NCT02988128|Flow Diverter|flow diverter
92404|NCT02988128|Intra saccular device|intra saccular device
92405|NCT02988128|Vascular Reconstruction Device|vascular reconstruction device
92406|NCT02988128|Ruptured Intracranial Aneurysm|ruptured intracranial aneurysm
92407|NCT02988128|Unruptured Intracranial Aneurysm|unruptured intracranial aneurysm
92408|NCT02988115|hyperlipidemia|hyperlipidemia
92409|NCT02988115|cholesterol|cholesterol
92410|NCT02988115|familial hypercholesterolemia|familial hypercholesterolemia
92411|NCT02988115|atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease
92412|NCT02988115|ASCVD|ascvd
92413|NCT02988115|HeFH|hefh
92414|NCT02988115|LDL|ldl
92415|NCT02988115|statin intolerence|statin intolerence
92416|NCT02988102|S100B, NSE|s100b, nse
92417|NCT02988102|moderate brain trauma|moderate brain trauma
92418|NCT02988102|mild brain trauma|mild brain trauma
92419|NCT02988089|Helicobacter Pylori Infection|helicobacter pylori infection
92420|NCT02988089|Antimicrobial susceptibility testing (AST)|antimicrobial susceptibility testing (ast)
92421|NCT02988076|database|database
92422|NCT02988076|probability|probability
92423|NCT02988076|response|response
92424|NCT02988076|depression|depression
92425|NCT02988076|medication|medication
92426|NCT02988076|quantitative|quantitative
92427|NCT02988076|electroencephalogram|electroencephalogram
92428|NCT02988063|Varithena|varithena
92429|NCT02988063|Polidocanol Endovenous Microfoam|polidocanol endovenous microfoam
92430|NCT02988050|Epilepsy Surgery|epilepsy surgery
92431|NCT02988050|Conscious sedation|conscious sedation
92432|NCT02988011|type 2 diabetes|type 2 diabetes
92433|NCT02988011|gastric by-pass surgery|gastric by-pass surgery
92434|NCT02988011|low calorie diet|low calorie diet
92435|NCT02988011|glucose metabolism|glucose metabolism
92436|NCT02987998|Pembrolizumab|pembrolizumab
92437|NCT02987998|Chemoradiation|chemoradiation
92438|NCT02987985|Opioid-sparing|opioid-sparing
92439|NCT02987985|Opioid-free|opioid-free
92440|NCT02987959|TAK-228|tak-228
92441|NCT02987959|MLN0128|mln0128
92442|NCT02987959|mTOR|mtor
92443|NCT02987933|Chronic Pain|chronic pain
92444|NCT02987933|fMRI|fmri
92445|NCT02987933|DTI|dti
92446|NCT02987894|TAVI|tavi
92447|NCT02987894|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
92448|NCT02987894|Transcatheter Aortic Valve Implant|transcatheter aortic valve implant
92449|NCT02987894|Transfemoral access|transfemoral access
92450|NCT02987894|Aortic valve regurgitation|aortic valve regurgitation
92451|NCT02987868|Somatostatin|somatostatin
92452|NCT02987868|Thyroid Hormone|thyroid hormone
92453|NCT02987868|Growth Hormone|growth hormone
92454|NCT02987842|Mild cognitive impairment|mild cognitive impairment
92455|NCT02987842|Alzhiemer's disease|alzhiemer's disease
92456|NCT02987842|Neurofeedback|neurofeedback
92457|NCT02987842|EEG|eeg
92458|NCT02987803|Patient Engagement|patient engagement
92459|NCT02987803|Public Reporting|public reporting
92460|NCT02987803|Quality Measurement|quality measurement
92461|NCT02987790|Intensive care|intensive care
92462|NCT02987790|Sepsis|sepsis
92463|NCT02987790|Biomarkers|biomarkers
92464|NCT02987790|C-reactive Protein|c-reactive protein
92465|NCT02987790|Antimicrobial|antimicrobial
92466|NCT02987790|Systemic infection|systemic infection
92467|NCT02987764|Premature|premature
92468|NCT02987764|Birth weight|birth weight
92469|NCT02987725|Adolescence|adolescence
92470|NCT02987725|Autonomic Nervous System|autonomic nervous system
92471|NCT02987725|Hypnosis|hypnosis
92472|NCT02987725|Pain|pain
92473|NCT02987725|Sickle Cell Disease|sickle cell disease
92474|NCT02987712|Thromboelastography|thromboelastography
92475|NCT02987699|Hepatocellular Carcinoma|hepatocellular carcinoma
92476|NCT02987699|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
92477|NCT02987699|optimal dose|optimal dose
92478|NCT02987686|Topical Infliximab|topical infliximab
92479|NCT02987686|Cornea|cornea
92480|NCT02987686|Keratolysis|keratolysis
92481|NCT02987673|Mini/One anastomosis gastric bypass|mini/one anastomosis gastric bypass
92482|NCT02987673|Sleeve Gastrectomy|sleeve gastrectomy
92483|NCT02987673|Gastro-esophageal sphincter function|gastro-esophageal sphincter function
92484|NCT02987634|gingivitis|gingivitis
92485|NCT02987634|dental implant|dental implant
92486|NCT02987634|mouthwash|mouthwash
92487|NCT02987595|intervention|intervention
92488|NCT02987595|lignans|lignans
92489|NCT02987595|whole-grain|whole-grain
92490|NCT02987582|mental health|mental health
92491|NCT02987582|mindfulness|mindfulness
92492|NCT02987582|shame|shame
92493|NCT02987569|Home Parenteral Nutrition|home parenteral nutrition
92494|NCT02987569|HPN|hpn
92495|NCT02987569|Total Parenteral Nutrition|total parenteral nutrition
92496|NCT02987569|TPN|tpn
92497|NCT02987569|mConnect|mconnect
92498|NCT02987569|SBS|sbs
92499|NCT02987569|short bowel disorder|short bowel disorder
92500|NCT02987569|telehealth|telehealth
92501|NCT02987569|telemedicine|telemedicine
92502|NCT02987543|metastatic castration-resistant prostate cancer (mCRPC)|metastatic castration-resistant prostate cancer (mcrpc)
92503|NCT02987543|homologous recombination repair (HRR)|homologous recombination repair (hrr)
92504|NCT02987530|primary infection|primary infection
92505|NCT02987517|running|running
92506|NCT02987517|vertical load rates|vertical load rates
92507|NCT02987517|cadence|cadence
92508|NCT02987517|footstrike|footstrike
92509|NCT02987504|Cancer|cancer
92510|NCT02987504|Solid tumor|solid tumor
92511|NCT02987504|Phase 1|phase 1
92512|NCT02987491|exercise|exercise
92513|NCT02987478|Vitamin D following intra cytoplasmic sperm injection|vitamin d following intra cytoplasmic sperm injection
92514|NCT02987452|exercise|exercise
92515|NCT02987452|resistant hypertension|resistant hypertension
92516|NCT02987452|blood pressure|blood pressure
92517|NCT02987439|COPD|copd
92518|NCT02987439|Exacerbation|exacerbation
92519|NCT02987439|Rehabilitation|rehabilitation
92520|NCT02987413|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
92521|NCT02987400|DLBCL|dlbcl
92522|NCT02987400|GA-101|ga-101
92523|NCT02987400|ABT-199|abt-199
92524|NCT02987400|relapsed DLBCL|relapsed dlbcl
92525|NCT02987400|refractory DLBCL|refractory dlbcl
92526|NCT02987400|AGMT|agmt
92527|NCT02987400|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
92528|NCT02987400|window of opportunity|window of opportunity
92529|NCT02987387|Tetralogy of Fallot|tetralogy of fallot
92530|NCT02987387|Aortic Valve Defect/Disease Resulting in Ross Procedure|aortic valve defect/disease resulting in ross procedure
92531|NCT02987387|Transcatheter pulmonary valve implantation|transcatheter pulmonary valve implantation
92532|NCT02987387|Transcatheter pulmonary valve replacement|transcatheter pulmonary valve replacement
92533|NCT02987387|Pulmonary Atresia|pulmonary atresia
92534|NCT02987387|Pulmonary Stenosis|pulmonary stenosis
92535|NCT02987374|Influenza Vaccine|influenza vaccine
92536|NCT02987348|type 2 diabetes|type 2 diabetes
92537|NCT02987309|indirect calorimetry|indirect calorimetry
92538|NCT02987309|method comparison|method comparison
92539|NCT02987296|Colorectal Cancer|colorectal cancer
92540|NCT02987296|Surgery|surgery
92541|NCT02987296|Arginine depletion|arginine depletion
92542|NCT02987296|Immune system dysfunction|immune system dysfunction
92543|NCT02987296|Arginine Supplementation|arginine supplementation
92544|NCT02987270|mass screen and treat|mass screen and treat
92545|NCT02987270|malaria|malaria
92546|NCT02987270|asymptomatic infections|asymptomatic infections
92547|NCT02987270|transmission reduction|transmission reduction
92548|NCT02987270|infectious reservoir|infectious reservoir
92549|NCT02987270|kenya|kenya
92550|NCT02987257|Therapeutics|therapeutics
92551|NCT02987257|Management|management
92552|NCT02987257|Cyclosporine|cyclosporine
92553|NCT02987257|Etanercept|etanercept
92554|NCT02987257|Supportive Care|supportive care
92555|NCT02987257|Immunopathogenesis|immunopathogenesis
92556|NCT02987257|Genetics|genetics
92557|NCT02987257|Adverse Drug Reaction|adverse drug reaction
92558|NCT02987244|Chidamide, T Cell Non-Hodgkin's Lymphoma|chidamide, t cell non-hodgkin's lymphoma
92559|NCT02987218|POCD|pocd
92560|NCT02987218|subarachnoid hemorrhage|subarachnoid hemorrhage
92561|NCT02987218|Propofol|propofol
92562|NCT02987218|Desflurane|desflurane
92563|NCT02987192|spinal anesthesia|spinal anesthesia
92564|NCT02987192|anticoagulation|anticoagulation
92565|NCT02987192|minimally invasive|minimally invasive
92566|NCT02987192|Cesarean Section|cesarean section
92567|NCT02987192|Maternal|maternal
92568|NCT02987166|immunotherapy|immunotherapy
92569|NCT02987166|pembrolizumab|pembrolizumab
92570|NCT02987166|MK-3475|mk-3475
92571|NCT02987166|High-dose conformal radiation therapy|high-dose conformal radiation therapy
92572|NCT02987166|HDCRT|hdcrt
92573|NCT02987166|advanced solid tumor|advanced solid tumor
92574|NCT02987153|Kyphoplasty|kyphoplasty
92575|NCT02987153|Spinal metastases|spinal metastases
92576|NCT02987153|IORT|iort
92577|NCT02987153|Intraoperative radiation therapy|intraoperative radiation therapy
92578|NCT02987153|Pain management|pain management
92579|NCT02987140|Parkinson's disease|parkinson's disease
92580|NCT02987140|freezing of gait|freezing of gait
92581|NCT02987140|context-dependency|context-dependency
92582|NCT02987140|transcranial magnetic stimulation|transcranial magnetic stimulation
92583|NCT02987140|visual cues|visual cues
92584|NCT02987062|Atrial Fibrillation|atrial fibrillation
92585|NCT02987062|Non-vitamin K Oral Anticoagulants|non-vitamin k oral anticoagulants
92586|NCT02987062|Vitamin K Antagonists|vitamin k antagonists
92587|NCT02987062|ROCKET-AF|rocket-af
92588|NCT02987062|RE-LY|re-ly
92589|NCT02987062|ARISTOTLE|aristotle
92590|NCT02987049|heart disease, cardiac rehabilitation|heart disease, cardiac rehabilitation
92591|NCT02987036|nebulizer technologies, lung mechanics, beta-agonistic drug|nebulizer technologies, lung mechanics, beta-agonistic drug
92592|NCT02987023|infertility, uterus, transplantation|infertility, uterus, transplantation
92593|NCT02986997|epidural anesthesia|epidural anesthesia
92594|NCT02986997|prone position|prone position
92595|NCT02986997|percutaneous nephrolithotomy|percutaneous nephrolithotomy
92596|NCT02986984|Diabetes|diabetes
92597|NCT02986984|Chronic kidney disease|chronic kidney disease
92598|NCT02986984|Progression|progression
92599|NCT02986984|Genomics|genomics
92600|NCT02986984|Transcriptomics|transcriptomics
92601|NCT02986971|Contraceptive implant|contraceptive implant
92602|NCT02986945|Depressive symptoms|depressive symptoms
92603|NCT02986945|resiliency|resiliency
92604|NCT02986945|Health Promotion|health promotion
92605|NCT02986945|minority health|minority health
92606|NCT02986945|text-messaging app|text-messaging app
92607|NCT02986945|participatory technology development|participatory technology development
92608|NCT02986932|Blood-Brain Barrier|blood-brain barrier
92609|NCT02986919|Malignant peripheral Nerve Sheath Tumors (MPNST); Neurofibromatosis sarcoma|malignant peripheral nerve sheath tumors (mpnst); neurofibromatosis sarcoma
92610|NCT02986906|ulnar neuropathy at elbow|ulnar neuropathy at elbow
92611|NCT02986906|Dextrose|dextrose
92612|NCT02986906|perineural injection|perineural injection
92613|NCT02986893|Multiple Sclerosis|multiple sclerosis
92614|NCT02986893|Diet|diet
92615|NCT02986893|Clinical Trial|clinical trial
92616|NCT02986854|Meningococcal disease|meningococcal disease
92617|NCT02986854|Booster vaccination|booster vaccination
92618|NCT02986854|Meningitis|meningitis
92619|NCT02986854|Antibody persistence|antibody persistence
92620|NCT02986828|platelet rich plasma|platelet rich plasma
92621|NCT02986828|Hydrodissection|hydrodissection
92622|NCT02986737|TAVI|tavi
92623|NCT02986737|Aortic Stenosis|aortic stenosis
92624|NCT02986737|Transcatether Aortic Valve Implantation|transcatether aortic valve implantation
92625|NCT02986724|Drug therapy|drug therapy
92626|NCT02986698|intrauterine transfusion|intrauterine transfusion
92627|NCT02986698|in utero human stem cell transplantation|in utero human stem cell transplantation
92628|NCT02986685|Refractory reflux esophagitis|refractory reflux esophagitis
92629|NCT02986685|Rabeprazole|rabeprazole
92630|NCT02986685|trimebutine maleate|trimebutine maleate
92631|NCT02986672|ADHD|adhd
92632|NCT02986672|omega 3|omega 3
92633|NCT02986672|children|children
92634|NCT02986672|nutrition|nutrition
92635|NCT02986672|MUFA|mufa
92636|NCT02986672|ADD|add
92637|NCT02986672|PUFA|pufa
92638|NCT02986672|Calanus|calanus
92639|NCT02986672|learning difficulties|learning difficulties
92640|NCT02986633|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
92844|NCT02985359|Malawi|malawi
92641|NCT02986633|Echocardiography|echocardiography
92642|NCT02986633|Biventricular Pacing|biventricular pacing
92643|NCT02986568|Ontogenetic surgery|ontogenetic surgery
92644|NCT02986568|TMMR|tmmr
92645|NCT02986568|PMMR|pmmr
92646|NCT02986568|LEER|leer
92647|NCT02986555|Stress|stress
92648|NCT02986555|Virtual Reality|virtual reality
92649|NCT02986555|Motion sickness|motion sickness
92650|NCT02986555|Visual Fatigue|visual fatigue
92651|NCT02986555|Biofeedback|biofeedback
92652|NCT02986542|newborns,femoral artery, catheterization|newborns,femoral artery, catheterization
92653|NCT02986490|Mental disorders|mental disorders
92654|NCT02986490|Antipsychotic agents|antipsychotic agents
92655|NCT02986490|Magnesium|magnesium
92656|NCT02986490|Cardiovascular risk factor|cardiovascular risk factor
92657|NCT02986490|Metabolic syndrome|metabolic syndrome
92658|NCT02986464|Virtual reality|virtual reality
92659|NCT02986464|Immersive distraction|immersive distraction
92660|NCT02986464|Virtual world|virtual world
92661|NCT02986464|Virtual environment|virtual environment
92662|NCT02986464|Procedural pain|procedural pain
92663|NCT02986464|Acute pain|acute pain
92664|NCT02986464|Pain Management|pain management
92665|NCT02986464|Children, Child|children, child
92666|NCT02986464|Kid, Kids|kid, kids
92667|NCT02986464|Pediatric, Pediatrics|pediatric, pediatrics
92668|NCT02986464|Young children|young children
92669|NCT02986464|Burns|burns
92670|NCT02986464|Burn injuries|burn injuries
92671|NCT02986464|Burn unit|burn unit
92672|NCT02986464|Hydrotherapy|hydrotherapy
92673|NCT02986464|Burn dressing|burn dressing
92674|NCT02986464|Non-pharmacological|non-pharmacological
92675|NCT02986464|Clinical Research|clinical research
92676|NCT02986464|Nursing Practice|nursing practice
92677|NCT02986438|Cocaine|cocaine
92678|NCT02986438|Addiction|addiction
92679|NCT02986438|rTMS|rtms
92680|NCT02986438|fMRI|fmri
92681|NCT02986425|Drug Utilization Review|drug utilization review
92682|NCT02986425|Older people|older people
92683|NCT02986399|fast track|fast track
92684|NCT02986386|Dental Occlusion|dental occlusion
92685|NCT02986386|Oral Health|oral health
92686|NCT02986386|Mastication|mastication
92687|NCT02986386|Dementia|dementia
92688|NCT02986386|Psychological health|psychological health
92689|NCT02986373|risankizumab|risankizumab
92690|NCT02986373|ABBV-066|abbv-066
92691|NCT02986373|BI655066|bi655066
92692|NCT02986334|chronic|chronic
92693|NCT02986334|low back|low back
92694|NCT02986334|back|back
92695|NCT02986334|pain|pain
92696|NCT02986334|brain|brain
92697|NCT02986334|MRI|mri
92698|NCT02986321|anti-inflammatory respiratory drug|anti-inflammatory respiratory drug
92699|NCT02986321|PDE4 inhibitor|pde4 inhibitor
92700|NCT02986308|Metabolomics|metabolomics
92701|NCT02986308|Intestinal Polyps|intestinal polyps
92702|NCT02986308|TCM Syndromes|tcm syndromes
92703|NCT02986308|TCM Constitution Types|tcm constitution types
92704|NCT02986295|BioMime, Ultimaster, Ischemic heart disease, DES|biomime, ultimaster, ischemic heart disease, des
92705|NCT02986282|ankle - brachial index|ankle - brachial index
92706|NCT02986269|Respiratory Function|respiratory function
92707|NCT02986269|Patient Positioning|patient positioning
92708|NCT02986269|anesthesia|anesthesia
92709|NCT02986256|telemedicine|telemedicine
92710|NCT02986230|Cancer prevention|cancer prevention
92711|NCT02986230|Clinical Decision Support|clinical decision support
92712|NCT02986230|Rural Health|rural health
92713|NCT02986230|Shared Decision Making|shared decision making
92714|NCT02986204|implant removal|implant removal
92715|NCT02986204|Nexplanon|nexplanon
92716|NCT02986204|Implanon|implanon
92717|NCT02986204|contraception|contraception
92718|NCT02986204|ENG|eng
92719|NCT02986191|gingival graft|gingival graft
92720|NCT02986191|free gingival graft|free gingival graft
92721|NCT02986191|coronally advanced flap|coronally advanced flap
92722|NCT02986191|reduced keratinized gingiva|reduced keratinized gingiva
92723|NCT02986178|Glioblastoma|glioblastoma
92724|NCT02986178|Glioma|glioma
92725|NCT02986178|PVSRIPO|pvsripo
92726|NCT02986178|Duke|duke
92727|NCT02986178|Pro00077024|pro00077024
92728|NCT02986178|Ashley|ashley
92729|NCT02986178|Brain tumor|brain tumor
92730|NCT02986178|Bigner|bigner
92731|NCT02986165|Platelet Aggregation|platelet aggregation
92732|NCT02986152|PTSD|ptsd
92733|NCT02986152|anxiety|anxiety
92734|NCT02986152|depression|depression
92735|NCT02986152|distress|distress
92736|NCT02986152|fear|fear
92737|NCT02986152|coping|coping
92738|NCT02986152|support|support
92739|NCT02986152|caregiver|caregiver
92740|NCT02986152|oncology|oncology
92741|NCT02986152|app|app
92742|NCT02986152|mobile app|mobile app
92743|NCT02986126|Depression|depression
92744|NCT02986126|Resilience|resilience
92745|NCT02986126|Minority health|minority health
92746|NCT02986126|Community-based participatory research|community-based participatory research
92845|NCT02985359|Lipid-based nutrient supplements|lipid-based nutrient supplements
92747|NCT02986126|Lesbian, gay, bisexual, transgender, and intersex (LGBTI) health|lesbian, gay, bisexual, transgender, and intersex (lgbti) health
92748|NCT02986126|Racial / ethnic health disparities|racial / ethnic health disparities
92749|NCT02986126|Patient-centered outcomes research|patient-centered outcomes research
92750|NCT02986126|Comparative-effectiveness research|comparative-effectiveness research
92751|NCT02986100|rucaparib|rucaparib
92752|NCT02986100|CO-338|co-338
92753|NCT02986100|Clovis|clovis
92754|NCT02986100|Clovis Oncology|clovis oncology
92755|NCT02986100|PARP inhibitor|parp inhibitor
92756|NCT02986100|Absorption|absorption
92757|NCT02986100|Metabolism|metabolism
92758|NCT02986100|Excretion|excretion
92759|NCT02986048|proton beam|proton beam
92760|NCT02986048|registry|registry
92761|NCT02986048|radiation|radiation
92762|NCT02986048|cancer|cancer
92763|NCT02986022|Self-efficacy|self-efficacy
92764|NCT02986022|optimism|optimism
92765|NCT02986022|altruism|altruism
92766|NCT02986022|goal setting|goal setting
92767|NCT02986009|emotion management|emotion management
92768|NCT02986009|positive and negative affect|positive and negative affect
92769|NCT02986009|satisfaction with parent-child relationship|satisfaction with parent-child relationship
92770|NCT02986009|subjective happiness|subjective happiness
92771|NCT02986009|family harmony|family harmony
92772|NCT02985996|Preventative Medicine|preventative medicine
92773|NCT02985996|Infectious Diseases|infectious diseases
92774|NCT02985996|Sexually Transmitted Diseases|sexually transmitted diseases
92775|NCT02985983|Brodalumab|brodalumab
92776|NCT02985983|KHK4827|khk4827
92777|NCT02985983|Axial Spondyloarthritis|axial spondyloarthritis
92778|NCT02985970|crush induction, RSI|crush induction, rsi
92779|NCT02985944|colorectal cancer|colorectal cancer
92780|NCT02985944|Colon polyp|colon polyp
92781|NCT02985944|Colonoscopy|colonoscopy
92782|NCT02985944|Adenoma detection rate|adenoma detection rate
92783|NCT02985905|Zinc supplementation|zinc supplementation
92784|NCT02985905|Thiol|thiol
92785|NCT02985905|Glutathione peroxidase|glutathione peroxidase
92786|NCT02985905|Sulfhydryl oxidase|sulfhydryl oxidase
92787|NCT02985892|Physical therapy|physical therapy
92788|NCT02985892|Muscle Stretching Exercises|muscle stretching exercises
92789|NCT02985892|Low Back pain|low back pain
92790|NCT02985879|PSP|psp
92791|NCT02985879|Steele-Richardson-Olszewski syndrome|steele-richardson-olszewski syndrome
92792|NCT02985879|tauopathy|tauopathy
92793|NCT02985866|Artificial Pancreas|artificial pancreas
92794|NCT02985866|Closed Loop Control|closed loop control
92795|NCT02985866|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
92796|NCT02985866|inControl Diabetes Management Platform|incontrol diabetes management platform
92797|NCT02985840|ondansetron|ondansetron
92798|NCT02985840|dexamethasone|dexamethasone
92799|NCT02985814|COPD Asthma Overlap|copd asthma overlap
92800|NCT02985775|CMV-specific T cell|cmv-specific t cell
92801|NCT02985775|haploidentical stem cell transplantation|haploidentical stem cell transplantation
92802|NCT02985775|immunologic response|immunologic response
92803|NCT02985775|acute GVHD|acute gvhd
92804|NCT02985762|bupivacaine|bupivacaine
92805|NCT02985762|exparel|exparel
92806|NCT02985762|analgesic|analgesic
92807|NCT02985762|lumbar spine|lumbar spine
92808|NCT02985749|Autism Spectrum Disorders|autism spectrum disorders
92809|NCT02985749|Pervasive Developmental Disorder|pervasive developmental disorder
92810|NCT02985749|ASD|asd
92811|NCT02985749|PDD|pdd
92812|NCT02985749|Oxytocin|oxytocin
92813|NCT02985749|Syntocinon|syntocinon
92814|NCT02985749|Social Impairment|social impairment
92815|NCT02985749|Treatment|treatment
92816|NCT02985671|Postural Low Back Pain|postural low back pain
92817|NCT02985671|Mechanical Low Back Pain|mechanical low back pain
92818|NCT02985671|Low Back Pain|low back pain
92819|NCT02985671|acetaminophen|acetaminophen
92820|NCT02985671|caffeine|caffeine
92821|NCT02985671|orphenadrine|orphenadrine
92822|NCT02985671|diclofenac sodium|diclofenac sodium
92823|NCT02985645|CGF|cgf
92824|NCT02985645|sinus augmentation|sinus augmentation
92825|NCT02985645|DIVA|diva
92826|NCT02985645|Platelet-Rich Plasma|platelet-rich plasma
92827|NCT02985554|hematologic malignancies|hematologic malignancies
92828|NCT02985554|allogeneic stem cell transplantation (allo-SCT)|allogeneic stem cell transplantation (allo-sct)
92829|NCT02985541|Birth Control|birth control
92830|NCT02985541|Heavy menstrual bleeding|heavy menstrual bleeding
92831|NCT02985515|Anosmia|anosmia
92832|NCT02985515|Olfactory Neuroplasticity|olfactory neuroplasticity
92833|NCT02985515|Intranasal Steroid Irrigation|intranasal steroid irrigation
92834|NCT02985502|Quality of Life|quality of life
92835|NCT02985502|Diabetes Mellitus|diabetes mellitus
92836|NCT02985502|Pancreatectomy|pancreatectomy
92837|NCT02985476|Electronic health records|electronic health records
92838|NCT02985476|Health records personal|health records personal
92839|NCT02985437|wound healing|wound healing
92840|NCT02985437|Bovine Lung Surfactant|bovine lung surfactant
92841|NCT02985437|SATOSU|satosu
92842|NCT02985385|Congenital Lethal Malformations|congenital lethal malformations
92843|NCT02985359|Program impact evaluation|program impact evaluation
92846|NCT02985359|Social behavior change communication|social behavior change communication
92847|NCT02985359|Childhood stunting|childhood stunting
92848|NCT02985346|Idiopathic pulmonary hemosiderosis|idiopathic pulmonary hemosiderosis
92849|NCT02985346|Bone marrow mesenchymal stem cells|bone marrow mesenchymal stem cells
92850|NCT02985333|paclitaxe,cyclophosphamide,dexamethasone, Multiple Myeloma|paclitaxe,cyclophosphamide,dexamethasone, multiple myeloma
92851|NCT02985320|Sabin strain|sabin strain
92852|NCT02985320|Inactivated poliovirus vaccine|inactivated poliovirus vaccine
92853|NCT02985320|poliomyelitis|poliomyelitis
92854|NCT02985320|safety|safety
92855|NCT02985320|immunogenicity|immunogenicity
92856|NCT02985320|infant|infant
92857|NCT02985294|Neuropathic pain|neuropathic pain
92858|NCT02985294|Quantitative Sensory Testing|quantitative sensory testing
92859|NCT02985294|Multiple Excitability Measures|multiple excitability measures
92860|NCT02985294|Threshold Tracking|threshold tracking
92861|NCT02985281|direct acting antiviral drugs, chronic hepatitis C virus infection|direct acting antiviral drugs, chronic hepatitis c virus infection
92862|NCT02985268|MitraClip|mitraclip
92863|NCT02985268|Cardiovascular resynchronization therapy|cardiovascular resynchronization therapy
92864|NCT02985268|Six minute walk test|six minute walk test
92865|NCT02985268|Mitral regurgitation|mitral regurgitation
92866|NCT02985268|CRT-D|crt-d
92867|NCT02985255|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
92868|NCT02985255|Tongue Malignancy|tongue malignancy
92869|NCT02985255|Squamous Cell Carcinoma|squamous cell carcinoma
92870|NCT02985203|lung cancer|lung cancer
92871|NCT02985203|vinorelbine|vinorelbine
92872|NCT02985203|metronomic chemotherapy|metronomic chemotherapy
92873|NCT02985190|Azacitidine|azacitidine
92874|NCT02985190|MDS|mds
92875|NCT02985190|Systemic auto-immune and inflammatory disorders|systemic auto-immune and inflammatory disorders
92876|NCT02985177|Children|children
92877|NCT02985177|Musculoskeletal injury|musculoskeletal injury
92878|NCT02985177|Emergency department|emergency department
92879|NCT02985177|Analgesia|analgesia
92880|NCT02985177|Opioids|opioids
92881|NCT02985164|Anesthesiology( H02.403.066 )|anesthesiology( h02.403.066 )
92882|NCT02985164|Radiation Protection( N06.850.810.425)|radiation protection( n06.850.810.425)
92883|NCT02985164|Cholangiopancreatography, Endoscopic Retrograde(D002760 )|cholangiopancreatography, endoscopic retrograde(d002760 )
92884|NCT02985151|Scar|scar
92885|NCT02985151|Carbon Dioxide Laser|carbon dioxide laser
92886|NCT02985151|Laser Ablation|laser ablation
92887|NCT02985125|Pancreas|pancreas
92888|NCT02985125|5-FU|5-fu
92889|NCT02985125|Gemcitabine|gemcitabine
92890|NCT02985125|LEE011|lee011
92891|NCT02985125|Everolimus|everolimus
92892|NCT02985125|Refractory|refractory
92893|NCT02985125|Chemotherapy|chemotherapy
92894|NCT02985086|term premature rupture of membranes, antibiotic prophylaxis, chorioamnionitis, endometritis, neonatal infection|term premature rupture of membranes, antibiotic prophylaxis, chorioamnionitis, endometritis, neonatal infection
92895|NCT02985060|Therapeutic hypothermia|therapeutic hypothermia
92896|NCT02985047|Brief admission|brief admission
92897|NCT02985047|admission|admission
92898|NCT02985047|deliberate self-harm|deliberate self-harm
92899|NCT02985047|self-harm|self-harm
92901|NCT02985034|RFA|rfa
92902|NCT02985034|Liver tumor|liver tumor
92903|NCT02985008|Shock, IVBP, ECMO, In hospital death|shock, ivbp, ecmo, in hospital death
92904|NCT02984995|FLT3-ITD|flt3-itd
92905|NCT02984995|Positive refractory or relapsed acute myeloid leukemia|positive refractory or relapsed acute myeloid leukemia
92906|NCT02984995|Hematology malignancy|hematology malignancy
92907|NCT02984995|Developmental Phase II|developmental phase ii
92908|NCT02984956|Hypotension|hypotension
92909|NCT02984956|Pleth variability index|pleth variability index
92910|NCT02984956|Hip Fracture|hip fracture
92911|NCT02984956|Spinal anesthesia|spinal anesthesia
92912|NCT02984943|Rheumatoid Arthritis|rheumatoid arthritis
92913|NCT02984943|Hyperbaric Oxygen|hyperbaric oxygen
92914|NCT02984917|anterior transversalis fascia repair; preperitoneal repair|anterior transversalis fascia repair; preperitoneal repair
92915|NCT02984904|Fusarium Infection|fusarium infection
92916|NCT02984904|Corneal ulcer|corneal ulcer
92917|NCT02984904|Spain|spain
92918|NCT02984904|Epidemiology|epidemiology
92919|NCT02984891|Intravascular ultrasound|intravascular ultrasound
92920|NCT02984891|Optical coherence tomography|optical coherence tomography
92921|NCT02984865|transversus plane block|transversus plane block
92922|NCT02984865|opioid|opioid
92923|NCT02984865|nalbuphine|nalbuphine
92924|NCT02984865|gastrointestinal surgery|gastrointestinal surgery
92925|NCT02984865|elderly patient|elderly patient
92926|NCT02984865|rectus sheath block|rectus sheath block
92927|NCT02984865|Peritoneal dialysis|peritoneal dialysis
92928|NCT02984839|intra-abdominal surgery|intra-abdominal surgery
92929|NCT02984839|neuromuscular blocking agent|neuromuscular blocking agent
92930|NCT02984839|post-anesthesia care unit|post-anesthesia care unit
92931|NCT02984787|Gastric Cancer|gastric cancer
92932|NCT02984787|3D|3d
92933|NCT02984787|2D|2d
92934|NCT02984774|Endometriosis|endometriosis
92935|NCT02984774|Infertility|infertility
92936|NCT02984774|Telomerase activity|telomerase activity
92937|NCT02984761|Carcinoma, Non-Small Cell Lung|carcinoma, non-small cell lung
92938|NCT02984761|Respiratory Tract Neoplasms|respiratory tract neoplasms
92939|NCT02984761|Thoracic Neoplasms|thoracic neoplasms
92940|NCT02984761|Neoplasms by Site|neoplasms by site
92941|NCT02984761|Neoplasms|neoplasms
92942|NCT02984761|Lung Diseases|lung diseases
92943|NCT02984761|Respiratory Tract Diseases|respiratory tract diseases
92944|NCT02984761|Carcinoma, Bronchogenic|carcinoma, bronchogenic
92945|NCT02984761|Bronchial Neoplasms|bronchial neoplasms
92946|NCT02984761|Radiosurgery|radiosurgery
92947|NCT02984761|Radiotherapy|radiotherapy
92948|NCT02984761|Radiotherapy, Image-Guided|radiotherapy, image-guided
92949|NCT02984761|Lung Neoplasms|lung neoplasms
92950|NCT02984748|cochlear implants|cochlear implants
92951|NCT02984748|hearing loss|hearing loss
92952|NCT02984735|chewing|chewing
92953|NCT02984735|cerebral palsy|cerebral palsy
92954|NCT02984735|chewing disorders|chewing disorders
92955|NCT02984735|gross motor function|gross motor function
92956|NCT02984722|PCOS|pcos
92957|NCT02984722|metformin|metformin
92958|NCT02984670|Cognitive therapy|cognitive therapy
92959|NCT02984670|Behavior therapy|behavior therapy
92960|NCT02984670|Moderation|moderation
92961|NCT02984670|Mediation|mediation
92962|NCT02984657|Hypoxemia|hypoxemia
92963|NCT02984657|Reverse Trendelenburg|reverse trendelenburg
92964|NCT02984592|premature ejaculation|premature ejaculation
92965|NCT02984592|intravaginal ejaculatory latency time|intravaginal ejaculatory latency time
92966|NCT02984592|premature ejaculation diagnostic tools|premature ejaculation diagnostic tools
92967|NCT02984566|Primary liver cancer|primary liver cancer
92968|NCT02984566|Secondary liver cancer|secondary liver cancer
92969|NCT02984566|Kilovoltage Intrafraction Monitoring|kilovoltage intrafraction monitoring
92970|NCT02984566|Stereotactic Ablative Body Radiation|stereotactic ablative body radiation
92971|NCT02984553|accelerometry|accelerometry
92972|NCT02984553|aerobic fitness|aerobic fitness
92973|NCT02984553|metabolic thresholds|metabolic thresholds
92974|NCT02984553|moderate to vigorous physical activity|moderate to vigorous physical activity
92975|NCT02984501|radiochemotherapy|radiochemotherapy
92976|NCT02984501|neoadjuvant therapy|neoadjuvant therapy
92977|NCT02984488|necrotic teeth|necrotic teeth
92978|NCT02984488|single visit|single visit
92979|NCT02984488|multiple visits|multiple visits
92980|NCT02984488|protaper next|protaper next
92981|NCT02984475|Beta Thalassemia|beta thalassemia
92982|NCT02984475|Metformin|metformin
92983|NCT02984475|Oxidative stress|oxidative stress
92984|NCT02984475|Iron overload|iron overload
92985|NCT02984475|Liver function|liver function
92986|NCT02984462|percutaneous|percutaneous
92987|NCT02984462|non-fixed|non-fixed
92988|NCT02984462|Akin ;|akin ;
92989|NCT02984462|osteotomy|osteotomy
92990|NCT02984449|cardiac rehabilitation|cardiac rehabilitation
92991|NCT02984449|surgical complications|surgical complications
92992|NCT02984449|quality of life|quality of life
92993|NCT02984449|preoperative|preoperative
92994|NCT02984449|cardiac surgery|cardiac surgery
92995|NCT02984423|Ovarian Cancer|ovarian cancer
92996|NCT02984423|BRCA mutations|brca mutations
92997|NCT02984410|T1-T2, N0 oropharyngeal carcinoma|t1-t2, n0 oropharyngeal carcinoma
92998|NCT02984397|pain|pain
92999|NCT02984397|ketotifen|ketotifen
93000|NCT02984397|pediatric|pediatric
93001|NCT02984397|mast cell|mast cell
93002|NCT02984384|Trauma|trauma
93003|NCT02984384|Blood clot|blood clot
93004|NCT02984384|Venous Thromboembolism|venous thromboembolism
93005|NCT02984384|Pulmonary Embolism|pulmonary embolism
93006|NCT02984384|Deep Vein Thrombosis|deep vein thrombosis
93007|NCT02984384|Thromboprophylaxis|thromboprophylaxis
93008|NCT02984384|Blood clot prevention|blood clot prevention
93009|NCT02984384|trauma patients|trauma patients
93010|NCT02984371|atrial fibrillation|atrial fibrillation
93011|NCT02984371|ganglionated plexi|ganglionated plexi
93012|NCT02984371|ischemic heart disease|ischemic heart disease
93013|NCT02984293|Atorvastatin|atorvastatin
93014|NCT02984293|LILRB5|lilrb5
93015|NCT02984293|Statin intolerance|statin intolerance
93016|NCT02984254|knee|knee
93017|NCT02984254|knee osteoarthritis|knee osteoarthritis
93018|NCT02984254|Bracing|bracing
93019|NCT02984254|patellofemoral osteoarthritis|patellofemoral osteoarthritis
93020|NCT02984189|Physical Exercise|physical exercise
93021|NCT02984189|Physical Therapy|physical therapy
93022|NCT02984189|Physical Performance|physical performance
93023|NCT02984189|Critical Power|critical power
93024|NCT02984189|Respiratory Muscle|respiratory muscle
93025|NCT02984176|Simethicone|simethicone
93026|NCT02984176|Laparoscopies|laparoscopies
93027|NCT02984176|Pain|pain
93028|NCT02984163|cancer|cancer
93029|NCT02984163|exercise|exercise
93030|NCT02984137|Lewy body disease|lewy body disease
93031|NCT02984137|REM Sleep Behavior Disorder|rem sleep behavior disorder
93032|NCT02984137|Parkinson disease|parkinson disease
93033|NCT02984137|Imaging|imaging
93034|NCT02984137|Bio-markers|bio-markers
93035|NCT02984137|Prospective cohort|prospective cohort
93036|NCT02984111|Coronary artery bypass|coronary artery bypass
93037|NCT02984111|Erythropoietin|erythropoietin
93038|NCT02984111|Inflammation|inflammation
93039|NCT02984111|IL-6|il-6
93040|NCT02984111|Reperfusion injury|reperfusion injury
93041|NCT02984111|YKL- 40|ykl- 40
93042|NCT02984098|procedural pain, 40% Dextrose, heel lance|procedural pain, 40% dextrose, heel lance
93043|NCT02984085|RDEB|rdeb
93044|NCT02984085|Stem cells|stem cells
93045|NCT02984085|Gene therapy|gene therapy
93046|NCT02984046|Acute bronchiolitis|acute bronchiolitis
93047|NCT02984046|RSV|rsv
93048|NCT02984046|CC16|cc16
93049|NCT02984046|SP-D|sp-d
93050|NCT02984046|sRAGE|srage
93051|NCT02984046|Severity|severity
93052|NCT02984046|Biomarkers|biomarkers
93053|NCT02983994|asthma, devices|asthma, devices
93054|NCT02983968|Oncology|oncology
93055|NCT02983968|Hepatology|hepatology
93056|NCT02983968|Public Health|public health
93057|NCT02983968|Liver|liver
93058|NCT02983942|ketogenic diet|ketogenic diet
93059|NCT02983942|Primary Central Nervous System Lymphoma|primary central nervous system lymphoma
93060|NCT02983942|chemotherapy|chemotherapy
93061|NCT02983916|Adhesions|adhesions
93062|NCT02983916|Adhesiolysis|adhesiolysis
93063|NCT02983916|chronic pain|chronic pain
93064|NCT02983916|post-operative complications|post-operative complications
93065|NCT02983916|anti-adhesion barrier|anti-adhesion barrier
93066|NCT02983916|cine-MRI|cine-mri
93067|NCT02983916|shared decision making|shared decision making
93068|NCT02983851|Noninvasive mechanical ventilation|noninvasive mechanical ventilation
93069|NCT02983851|Invasive mechanical ventilation|invasive mechanical ventilation
93070|NCT02983838|Amyloid|amyloid
93071|NCT02983838|BDNF|bdnf
93072|NCT02983838|major depressive disorder|major depressive disorder
93073|NCT02983838|cognitive decline|cognitive decline
93074|NCT02983825|CPAP|cpap
93075|NCT02983825|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
93076|NCT02983825|Ventilator Induced Lung Injury|ventilator induced lung injury
93077|NCT02983825|V/Q mismatch|v/q mismatch
93078|NCT02983799|BRCA, ovarian, platinum, chemotherapy|brca, ovarian, platinum, chemotherapy
93079|NCT02983760|Pulmonary embolism|pulmonary embolism
93080|NCT02983747|Platelet Rich Plasma|platelet rich plasma
93081|NCT02983747|Intervertebral Disk Injection Therapy|intervertebral disk injection therapy
93082|NCT02983747|Low Back Pain|low back pain
93083|NCT02983747|Ultrasound Guided|ultrasound guided
93084|NCT02983747|Degenerative Spinal Disease|degenerative spinal disease
93085|NCT02983734|Gulf War|gulf war
93086|NCT02983734|D-cycloserine|d-cycloserine
93087|NCT02983734|Neuroinflammation|neuroinflammation
93088|NCT02983734|Cognition|cognition
93089|NCT02983734|Memory|memory
93090|NCT02983708|Neuroregeneration|neuroregeneration
93091|NCT02983708|G-CSF|g-csf
93092|NCT02983708|Peripheral blood mononuclear cells|peripheral blood mononuclear cells
93093|NCT02983708|Cerebral palsy|cerebral palsy
93094|NCT02983682|Anesthetics, Local|anesthetics, local
93095|NCT02983682|Lidocaine|lidocaine
93096|NCT02983682|Pediatrics|pediatrics
93097|NCT02983682|Children|children
93098|NCT02983682|Adolescents|adolescents
93099|NCT02983669|Thymus Plant|thymus plant
93100|NCT02983669|Multiflotriol [Supplementary Concept]|multiflotriol [supplementary concept]
93101|NCT02983669|Zataria multiflora|zataria multiflora
93102|NCT02983669|Complementary Therapies|complementary therapies
93103|NCT02983669|Herbal Medicine|herbal medicine
93104|NCT02983669|Medicine, traditional|medicine, traditional
93105|NCT02983656|Vaccine Safety|vaccine safety
93106|NCT02983643|Skeletal Muscle Index|skeletal muscle index
93107|NCT02983643|Visceral Adipose Tissue|visceral adipose tissue
93108|NCT02983643|Metabolic Syndrome|metabolic syndrome
93109|NCT02983604|Exemestane|exemestane
93110|NCT02983604|Aromasin|aromasin
93111|NCT02983604|Fulvestrant|fulvestrant
93112|NCT02983604|Faslodex|faslodex
93113|NCT02983604|Breast Cancer,|breast cancer,
93114|NCT02983604|HER 2-|her 2-
93115|NCT02983604|Estrogen receptor positive|estrogen receptor positive
93116|NCT02983578|Pancreatic cancer|pancreatic cancer
93117|NCT02983578|Mismatch deficient colorectal cancer|mismatch deficient colorectal cancer
93118|NCT02983578|Non-small cell lung cancer|non-small cell lung cancer
93119|NCT02983578|NSCLC|nsclc
93120|NCT02983578|AZD9150|azd9150
93121|NCT02983578|MEDI4736|medi4736
93122|NCT02983578|Durvalumab|durvalumab
93123|NCT02983565|Long-term oxygen therapy|long-term oxygen therapy
93124|NCT02983565|Intelligent oxygen therapy system|intelligent oxygen therapy system
93125|NCT02983565|Auto-titrating oxygen system|auto-titrating oxygen system
93126|NCT02983552|Amblyopia|amblyopia
93127|NCT02983539|sarcomas|sarcomas
93128|NCT02983539|immunocytochemistry|immunocytochemistry
93129|NCT02983539|circulating tumor cells|circulating tumor cells
93130|NCT02983526|short stem|short stem
93131|NCT02983513|Early intervention|early intervention
93132|NCT02983513|Brain Development|brain development
93133|NCT02983513|Neurodevelopment|neurodevelopment
93134|NCT02983500|Patient Reported Outcome (PRO)|patient reported outcome (pro)
93135|NCT02983487|Bordetella Pertussis|bordetella pertussis
93136|NCT02983487|Whooping Cough|whooping cough
93137|NCT02983487|vaccine|vaccine
93138|NCT02983461|urinary incontinence|urinary incontinence
93139|NCT02983461|pelvic floor dysfunction|pelvic floor dysfunction
93140|NCT02983435|Osteopathic Treatment|osteopathic treatment
93141|NCT02983435|Postural control|postural control
93142|NCT02983435|Neuromuscular activation|neuromuscular activation
93143|NCT02983435|Physiotherapy|physiotherapy
93144|NCT02983409|computerized tomography|computerized tomography
93145|NCT02983409|Urinary Calculi|urinary calculi
93146|NCT02983409|Patient admission|patient admission
93147|NCT02983409|Pain|pain
93148|NCT02983396|RELF method|relf method
93149|NCT02983396|Medical device|medical device
93150|NCT02983396|Admission delay|admission delay
93151|NCT02983383|Varicocele|varicocele
93152|NCT02983383|TAP block|tap block
93153|NCT02983383|spinal anesthesia|spinal anesthesia
93154|NCT02983357|Shoulder Arthroplasty|shoulder arthroplasty
93155|NCT02983357|glenohumeral arthritis|glenohumeral arthritis
93156|NCT02983344|fascia iliaca compartment block|fascia iliaca compartment block
93157|NCT02983344|fentanyl|fentanyl
93158|NCT02983266|Hyperadrenergia|hyperadrenergia
93159|NCT02983266|Inflammatory stress|inflammatory stress
93160|NCT02983214|Cilostazol|cilostazol
93161|NCT02983214|Clopidogrel|clopidogrel
93162|NCT02983214|Peripheral Artery Disease|peripheral artery disease
93163|NCT02983201|Orthopedic Pain Syndromes|orthopedic pain syndromes
93164|NCT02983201|Thumbtack Intra-dermal Needle|thumbtack intra-dermal needle
93165|NCT02983201|Filiform needle|filiform needle
93166|NCT02983201|Acupuncture|acupuncture
93167|NCT02983188|Schizophrenia|schizophrenia
93168|NCT02983188|Berberine|berberine
93169|NCT02983188|Metabolic Syndrome|metabolic syndrome
93170|NCT02983188|Chinese medicine|chinese medicine
93171|NCT02983188|Herbal medicine|herbal medicine
93172|NCT02983175|ultrasonogaphy|ultrasonogaphy
93173|NCT02983175|full stomach|full stomach
93174|NCT02983175|pulmonary aspiration|pulmonary aspiration
93175|NCT02983175|anaesthesia|anaesthesia
93176|NCT02983136|Hand Hygiene|hand hygiene
93177|NCT02983136|Implementation|implementation
93178|NCT02983136|Partnership|partnership
93179|NCT02983136|Surgery|surgery
93180|NCT02983123|Acute MI|acute mi
93181|NCT02983123|Acute myocardial infarction cardiac troponin|acute myocardial infarction cardiac troponin
93182|NCT02983123|High-sensitivity cardiac troponin T|high-sensitivity cardiac troponin t
93183|NCT02983123|0/1-hour algorithm|0/1-hour algorithm
93184|NCT02983123|Outpatient clinic|outpatient clinic
93185|NCT02983123|Cardiac troponin|cardiac troponin
93186|NCT02983123|Chest pain|chest pain
93187|NCT02983110|Hormones, Transgender|hormones, transgender
93188|NCT02983097|lymphoma|lymphoma
93189|NCT02983097|relapse|relapse
93190|NCT02983097|recurrence|recurrence
93191|NCT02983097|progress|progress
93192|NCT02983097|progressive|progressive
93193|NCT02983097|b-cell lymphoma|b-cell lymphoma
93194|NCT02983097|chemotherapy|chemotherapy
93195|NCT02983097|immunotherapy|immunotherapy
93196|NCT02983097|IMiD|imid
93197|NCT02983097|Salvage chemotherapy|salvage chemotherapy
93198|NCT02983097|peripheral stem cell mobilization|peripheral stem cell mobilization
93199|NCT02983097|lenalidomide|lenalidomide
93200|NCT02983097|Rituximab|rituximab
93201|NCT02983097|CD20|cd20
93202|NCT02983097|Cytarabine|cytarabine
93203|NCT02983097|Ara-C|ara-c
93204|NCT02983097|platinum-based chemotherapy|platinum-based chemotherapy
93205|NCT02983097|Cisplatin|cisplatin
93206|NCT02983097|Carboplatin|carboplatin
93207|NCT02983097|Cisplatinum|cisplatinum
93208|NCT02983097|Carboplatinum|carboplatinum
93209|NCT02983097|Dexamethasone|dexamethasone
93210|NCT02983084|Orthodontic wires|orthodontic wires
93211|NCT02983084|Root resorption|root resorption
93212|NCT02983071|Breast Cancer|breast cancer
93213|NCT02983071|CDK 4/6 Inhibitor|cdk 4/6 inhibitor
93214|NCT02983071|HER2-Negative|her2-negative
93215|NCT02983071|HR-Positive|hr-positive
93216|NCT02983071|HR+|hr+
93217|NCT02983071|HER2-|her2-
93218|NCT02983071|HER2 -ve|her2 -ve
93219|NCT02983071|HER2 +ve|her2 +ve
93220|NCT02983032|Caregivers|caregivers
93221|NCT02983032|Insomnia|insomnia
93222|NCT02983019|influenza|influenza
93223|NCT02983019|flu|flu
93224|NCT02983019|acute respiratory viral infection|acute respiratory viral infection
93225|NCT02983019|ARVI|arvi
93226|NCT02983019|acute upper respiratory infection|acute upper respiratory infection
93227|NCT02983019|AURI|auri
93228|NCT02983006|TRAIL-DR5|trail-dr5
93229|NCT02983006|DS-8273a|ds-8273a
93230|NCT02983006|Immunoglobulin gamma-1 (IgG1)|immunoglobulin gamma-1 (igg1)
93231|NCT02983006|Cell mediated cytotoxicity (ADCC)|cell mediated cytotoxicity (adcc)
93232|NCT02983006|Complement dependent cytotoxicity (CDC)|complement dependent cytotoxicity (cdc)
93233|NCT02983006|DR5|dr5
93234|NCT02983006|Immunoglobulin G4 (IgG4)|immunoglobulin g4 (igg4)
93235|NCT02983006|Monoclonal antibody|monoclonal antibody
93236|NCT02983006|Programmed Cell Death 1 (PD-1)|programmed cell death 1 (pd-1)
93237|NCT02982993|hepatitis C virus|hepatitis c virus
93238|NCT02982993|linkage-to-care|linkage-to-care
93341|NCT02982460|Rotator cuff tendinopathy|rotator cuff tendinopathy
93239|NCT02982993|World Trade Center Health Program cohort|world trade center health program cohort
93240|NCT02982993|Baby Boomer|baby boomer
93241|NCT02982993|risk factors for hepatitis C virus infection|risk factors for hepatitis c virus infection
93242|NCT02982967|child|child
93243|NCT02982967|physical activity|physical activity
93244|NCT02982967|irisin|irisin
93245|NCT02982967|EPCs|epcs
93246|NCT02982941|Neuroblastoma|neuroblastoma
93247|NCT02982941|Rhabdomyosarcoma|rhabdomyosarcoma
93248|NCT02982941|Osteosarcoma|osteosarcoma
93249|NCT02982941|Ewing Sarcoma|ewing sarcoma
93250|NCT02982941|Wilms Tumor|wilms tumor
93251|NCT02982941|Desmoplastic Small Round Cell Tumor|desmoplastic small round cell tumor
93252|NCT02982941|pediatric|pediatric
93253|NCT02982928|Obesity|obesity
93254|NCT02982928|Bariatrics|bariatrics
93255|NCT02982928|Acetaminophen|acetaminophen
93256|NCT02982928|robot-assisted or laparoscopic bariatric surgery|robot-assisted or laparoscopic bariatric surgery
93257|NCT02982928|Pharmacokinetics|pharmacokinetics
93258|NCT02982902|Immunotherapy|immunotherapy
93259|NCT02982902|T-Cell Therapy|t-cell therapy
93260|NCT02982902|Lymphoproliferative Disorder|lymphoproliferative disorder
93261|NCT02982889|Analytical, Diagnostic,Therapeutic Technique and Equipment|analytical, diagnostic,therapeutic technique and equipment
93262|NCT02982889|Anesthesia and Analgesia|anesthesia and analgesia
93263|NCT02982876|Silicone Airway stent|silicone airway stent
93264|NCT02982876|Metallic Airway stent|metallic airway stent
93265|NCT02982850|Atrial Fibrillation|atrial fibrillation
93266|NCT02982850|Valvular Insufficiency|valvular insufficiency
93267|NCT02982850|Valvular Stenosis|valvular stenosis
93268|NCT02982824|Children|children
93270|NCT02982824|Idiopathic epilepsy|idiopathic epilepsy
93271|NCT02982824|Magnesium supplementation|magnesium supplementation
93272|NCT02982824|Seizure control|seizure control
93273|NCT02982824|Chalfont score|chalfont score
93274|NCT02982811|Activity-based|activity-based
93275|NCT02982811|Client-centred|client-centred
93276|NCT02982811|Rehabilitation|rehabilitation
93277|NCT02982811|Quality of life|quality of life
93278|NCT02982772|Nicotine Replacement|nicotine replacement
93279|NCT02982772|Smoking|smoking
93280|NCT02982772|HIV|hiv
93281|NCT02982746|Head and neck cancer|head and neck cancer
93282|NCT02982746|Person Centred Care|person centred care
93283|NCT02982746|Health related quality of life|health related quality of life
93284|NCT02982746|EORTC QLQ-C30|eortc qlq-c30
93285|NCT02982746|EORTC QLQ-C35|eortc qlq-c35
93286|NCT02982720|cholangiocarcinoma|cholangiocarcinoma
93287|NCT02982720|Pembrolizumab|pembrolizumab
93288|NCT02982720|MK-3475|mk-3475
93289|NCT02982720|Sylatron|sylatron
93290|NCT02982720|peginterferon alfa-2b|peginterferon alfa-2b
93291|NCT02982694|MSI|msi
93292|NCT02982694|colorectal|colorectal
93293|NCT02982694|chemotherapy|chemotherapy
93294|NCT02982694|Bevacizumab|bevacizumab
93295|NCT02982694|Atezolizumab|atezolizumab
93296|NCT02982681|Periodontal disease|periodontal disease
93297|NCT02982681|Platelet rich fibrin|platelet rich fibrin
93298|NCT02982668|severe stroke|severe stroke
93299|NCT02982668|Acute Stroke|acute stroke
93300|NCT02982668|Enteral Feeding|enteral feeding
93301|NCT02982668|Mortality|mortality
93302|NCT02982668|Disability|disability
93303|NCT02982668|Clinical trial|clinical trial
93304|NCT02982655|Severe Stroke|severe stroke
93305|NCT02982655|Acute Stroke|acute stroke
93306|NCT02982655|Antihypertension|antihypertension
93307|NCT02982655|mortality|mortality
93308|NCT02982655|disability|disability
93309|NCT02982655|clinical trial|clinical trial
93310|NCT02982629|Glaucoma|glaucoma
93311|NCT02982629|Eye Care|eye care
93312|NCT02982629|Community Outreach|community outreach
93313|NCT02982577|Xerostomia|xerostomia
93314|NCT02982577|Pilocarpine|pilocarpine
93315|NCT02982577|Quality of life|quality of life
93316|NCT02982564|Exercise|exercise
93317|NCT02982564|Physical Functioning|physical functioning
93318|NCT02982564|Hispanic|hispanic
93319|NCT02982538|posttraumatic stress symptoms|posttraumatic stress symptoms
93320|NCT02982538|implementation|implementation
93321|NCT02982538|dissemination|dissemination
93322|NCT02982538|PTSD|ptsd
93323|NCT02982525|Mussels|mussels
93324|NCT02982525|Dietary Intervention|dietary intervention
93325|NCT02982525|Long-term intervention|long-term intervention
93326|NCT02982525|Vitamin D status|vitamin d status
93327|NCT02982525|Selenium|selenium
93328|NCT02982525|Iodine|iodine
93329|NCT02982525|Vitamin B12|vitamin b12
93330|NCT02982525|Omega-3 index|omega-3 index
93331|NCT02982512|Potential local fields|potential local fields
93332|NCT02982512|Subthalamic neuronal activity|subthalamic neuronal activity
93333|NCT02982499|glaucoma|glaucoma
93334|NCT02982499|Leber optic neuropathy|leber optic neuropathy
93335|NCT02982499|anterior ischemic optic neuropathy|anterior ischemic optic neuropathy
93336|NCT02982486|nivolumab|nivolumab
93337|NCT02982486|ipilimumab|ipilimumab
93338|NCT02982486|immunotherapy|immunotherapy
93339|NCT02982486|PD-1 inhibitor|pd-1 inhibitor
93340|NCT02982486|sarcoma|sarcoma
93342|NCT02982460|Eccentric exercise|eccentric exercise
93343|NCT02982460|Isoinertial training|isoinertial training
93344|NCT02982447|blue laser imaging,detection,randomized trial|blue laser imaging,detection,randomized trial
93345|NCT02982434|atrial fibrillation|atrial fibrillation
93346|NCT02982434|botulinum toxin|botulinum toxin
93347|NCT02982434|ischemic heart disease|ischemic heart disease
93348|NCT02982395|Nanoxel M|nanoxel m
93349|NCT02982395|Docetaxel PM|docetaxel pm
93350|NCT02982395|Docetaxel|docetaxel
93351|NCT02982395|Mitomycin C|mitomycin c
93352|NCT02982395|BCG|bcg
93353|NCT02982395|BCG refractory|bcg refractory
93354|NCT02982395|Non muscle invasive bladder cancer|non muscle invasive bladder cancer
93355|NCT02982395|intravesical|intravesical
93356|NCT02982395|superficial bladder cancer|superficial bladder cancer
93357|NCT02982395|Urothelial carcinoma|urothelial carcinoma
93358|NCT02982395|Transitional cell carcinoma|transitional cell carcinoma
93359|NCT02982382|Low Back Pain|low back pain
93360|NCT02982382|Musculoskeletal Manipulations|musculoskeletal manipulations
93361|NCT02982382|Neurophysiology|neurophysiology
93362|NCT02982382|Education|education
93363|NCT02982317|Neuraxial anesthesia|neuraxial anesthesia
93364|NCT02982317|Obstetrics|obstetrics
93365|NCT02982317|Ultrasound|ultrasound
93366|NCT02982252|Power mobility|power mobility
93367|NCT02982252|Wheelchair skills training|wheelchair skills training
93368|NCT02982252|Older adults|older adults
93369|NCT02982226|Plantar Fasciitis|plantar fasciitis
93370|NCT02982226|Jogger's Heel|jogger's heel
93371|NCT02982226|ReNu|renu
93372|NCT02982213|Newest Vital Sign|newest vital sign
93373|NCT02982213|Anxiety|anxiety
93374|NCT02982213|Health literacy|health literacy
93375|NCT02982213|Neuraxial Analgesia|neuraxial analgesia
93376|NCT02982213|Epidural catheter placement|epidural catheter placement
93377|NCT02982213|Pregnancy|pregnancy
93378|NCT02982213|Parturients|parturients
93379|NCT02982213|Pain Catastrophizing Scale|pain catastrophizing scale
93380|NCT02982213|STAI questionnaire|stai questionnaire
93381|NCT02982213|Companion|companion
93382|NCT02982200|Embolization Device|embolization device
93383|NCT02982200|Medina|medina
93384|NCT02982200|Rupture Intracranial Aneurysm|rupture intracranial aneurysm
93385|NCT02982200|Unrupture Intracranial Aneurysm|unrupture intracranial aneurysm
93386|NCT02982187|HANDIHALER|handihaler
93387|NCT02982187|ELLIPTA|ellipta
93388|NCT02982187|TURBUHALER|turbuhaler
93389|NCT02982187|DISKUS|diskus
93390|NCT02982187|COPD|copd
93391|NCT02982187|critical error|critical error
93392|NCT02982187|inhaler preference|inhaler preference
93393|NCT02982174|no known ocular pathology|no known ocular pathology
93394|NCT02982161|Third Molar Tooth Extraction|third molar tooth extraction
93395|NCT02982148|sentinel lymph node biopsy|sentinel lymph node biopsy
93396|NCT02982148|methylene blue|methylene blue
93397|NCT02982148|intradermal injection|intradermal injection
93398|NCT02982148|subcutaneous injection|subcutaneous injection
93399|NCT02982135|hemorrhagic moyamoya disease|hemorrhagic moyamoya disease
93400|NCT02982135|bypass|bypass
93401|NCT02982135|indirect bypass|indirect bypass
93402|NCT02982083|Rheumatoid arthritis|rheumatoid arthritis
93403|NCT02982083|Raloxifene|raloxifene
93404|NCT02982083|Disease activity|disease activity
93405|NCT02982070|psychological well-being, academic success|psychological well-being, academic success
93406|NCT02982044|blood flow|blood flow
93407|NCT02982044|endothelial function|endothelial function
93408|NCT02982044|shear stress|shear stress
93409|NCT02982031|Ultrasound-guided lumbar plexus blockade|ultrasound-guided lumbar plexus blockade
93410|NCT02982031|Shamrock technique|shamrock technique
93411|NCT02982031|Paramedian transverse scan|paramedian transverse scan
93412|NCT02982031|USG LPB|usg lpb
93413|NCT02982031|USGRA|usgra
93414|NCT02982005|KHK4827 (brodalumab)|khk4827 (brodalumab)
93415|NCT02981979|Takayasu Arteritis|takayasu arteritis
93416|NCT02981979|Leflunomide|leflunomide
93417|NCT02981953|Valtech Cardio|valtech cardio
93418|NCT02981953|Cardioband|cardioband
93419|NCT02981953|Tricuspid|tricuspid
93420|NCT02981940|Brain Tumor|brain tumor
93421|NCT02981914|Classical Hodgkin Lymphoma|classical hodgkin lymphoma
93422|NCT02981914|B-cell Non-Hodgkin Lymphoma|b-cell non-hodgkin lymphoma
93423|NCT02981914|Acute Myeloid Leukemia|acute myeloid leukemia
93424|NCT02981914|Myelodysplastic Syndromes|myelodysplastic syndromes
93425|NCT02981914|pembrolizumab|pembrolizumab
93426|NCT02981875|reading eye movement|reading eye movement
93427|NCT02981862|HPV infection|hpv infection
93428|NCT02981862|Blood sample|blood sample
93429|NCT02981862|Biopsy|biopsy
93430|NCT02981836|live attenuated varicella vaccine|live attenuated varicella vaccine
93431|NCT02981836|protective effect|protective effect
93432|NCT02981836|safety|safety
93433|NCT02981836|immunogenicity|immunogenicity
93434|NCT02981836|child|child
93435|NCT02981810|TONSILLAR COBLATION|tonsillar coblation
93436|NCT02981797|symptomatic bone metastasis|symptomatic bone metastasis
93437|NCT02981797|metastatic|metastatic
93438|NCT02981797|castration resistant|castration resistant
93439|NCT02981784|chronic myeloid leukemia (CML)|chronic myeloid leukemia (cml)
93440|NCT02981784|Philadelphia-positive (Ph+)|philadelphia-positive (ph+)
93441|NCT02981784|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
93442|NCT02981732|Osteoporosis|osteoporosis
93443|NCT02981732|kidney yin deficiency syndrome|kidney yin deficiency syndrome
93444|NCT02981732|liuwei dihuang pill|liuwei dihuang pill
93445|NCT02981706|Arteriovenous Fistula (AVF)|arteriovenous fistula (avf)
93446|NCT02981706|Arteriovenous Graft (AVG)|arteriovenous graft (avg)
93447|NCT02981680|remote ischemic preconditioning; transient limb ischemia; acute kidney injury; coronary artery bypass graft surgery|remote ischemic preconditioning; transient limb ischemia; acute kidney injury; coronary artery bypass graft surgery
93448|NCT02981641|Pancreatic cancer|pancreatic cancer
93449|NCT02981641|Intraoperative radiotherapy (IORT)|intraoperative radiotherapy (iort)
93450|NCT02981641|Concurrent Chemoradiotherapy (CCRT)|concurrent chemoradiotherapy (ccrt)
93451|NCT02981602|Hepatitis|hepatitis
93452|NCT02981602|Chronic|chronic
93454|NCT02981576|Spinal Cord Injury|spinal cord injury
93455|NCT02981576|Mesenchymal Stem Cells|mesenchymal stem cells
93456|NCT02981563|engagement|engagement
93457|NCT02981563|psychiatric in-patient care|psychiatric in-patient care
93458|NCT02981563|mental health nursing|mental health nursing
93459|NCT02981563|quality interactions|quality interactions
93460|NCT02981550|Infection|infection
93461|NCT02981524|Colorectal Neoplasms|colorectal neoplasms
93462|NCT02981524|Gastrointestinal Neoplasms|gastrointestinal neoplasms
93463|NCT02981524|Digestive System Neoplasms|digestive system neoplasms
93464|NCT02981524|Neoplasms by Site|neoplasms by site
93465|NCT02981524|Neoplasms|neoplasms
93466|NCT02981524|Digestive System Diseases|digestive system diseases
93467|NCT02981524|Gastrointestinal Diseases|gastrointestinal diseases
93468|NCT02981524|Intestinal Diseases|intestinal diseases
93469|NCT02981524|Rectal Diseases|rectal diseases
93470|NCT02981524|Colonic Diseases|colonic diseases
93471|NCT02981498|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
93472|NCT02981498|Sorafenib|sorafenib
93473|NCT02981485|Fat Grafting, Breast Cancer Lymphedema|fat grafting, breast cancer lymphedema
93474|NCT02981459|bladder pain|bladder pain
93475|NCT02981459|urinary frequency|urinary frequency
93476|NCT02981459|urinary urgency|urinary urgency
93477|NCT02981459|mirabegron|mirabegron
93478|NCT02981407|Red Blood Cell Transfusion|red blood cell transfusion
93479|NCT02981407|Anemia|anemia
93480|NCT02981407|Heart Disease|heart disease
93481|NCT02981407|Cardiovascular Disease|cardiovascular disease
93482|NCT02981381|sTMS|stms
93483|NCT02981381|NeoSync|neosync
93484|NCT02981381|NEST|nest
93485|NCT02981381|synchronous|synchronous
93486|NCT02981381|non-invasive neuromodulation|non-invasive neuromodulation
93487|NCT02981381|TMS|tms
93488|NCT02981381|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
93489|NCT02981381|PTSD|ptsd
93490|NCT02981381|EEG|eeg
93491|NCT02981381|Depression|depression
93492|NCT02981368|Diagnostic|diagnostic
93493|NCT02981368|Imaging|imaging
93494|NCT02981368|2301|2301
93495|NCT02981368|PET/CT|pet/ct
93496|NCT02981368|PyL|pyl
93497|NCT02981368|PSMA|psma
93498|NCT02981368|radical prostatectomy|radical prostatectomy
93499|NCT02981368|metastatic prostate cancer|metastatic prostate cancer
93500|NCT02981368|recurrent prostate cancer|recurrent prostate cancer
93501|NCT02981355|BST-CarGel|bst-cargel
93502|NCT02981355|Microfracture|microfracture
93503|NCT02981355|Cartilage Lesion, Chondral Lesion|cartilage lesion, chondral lesion
93504|NCT02981355|Femoral condyle|femoral condyle
93505|NCT02981355|Bone Marrow Stimulation|bone marrow stimulation
93506|NCT02981355|Cartilage Repair|cartilage repair
93507|NCT02981355|Tear of Articular Cartilage of Knee, Current|tear of articular cartilage of knee, current
93508|NCT02981342|pancreatic cancer|pancreatic cancer
93509|NCT02981329|Metformin|metformin
93510|NCT02981329|Sickle Cell Anemia|sickle cell anemia
93511|NCT02981329|Sickle Cell Disease|sickle cell disease
93512|NCT02981329|Hemoglobinopathies|hemoglobinopathies
93513|NCT02981329|Hemoglobin Disorder|hemoglobin disorder
93514|NCT02981329|Blood Disease|blood disease
93515|NCT02981329|Hemoglobin Disease; Sickle-Cell, Thalassemia|hemoglobin disease; sickle-cell, thalassemia
93516|NCT02981329|Hemoglobin Disease|hemoglobin disease
93517|NCT02981277|Bronchoscopy|bronchoscopy
93518|NCT02981277|Lignocaine|lignocaine
93519|NCT02981264|Bronchoscopy|bronchoscopy
93520|NCT02981264|Lignocaine|lignocaine
93521|NCT02981264|Endobronchial Ultrasound|endobronchial ultrasound
93522|NCT02981251|Hypertension|hypertension
93523|NCT02981251|Uncontrolled blood pressure|uncontrolled blood pressure
93524|NCT02981251|Health education|health education
93525|NCT02981251|Community based|community based
93526|NCT02981199|microtransplantation|microtransplantation
93527|NCT02981199|multiple myeloma|multiple myeloma
93528|NCT02981186|Intraocular Lens|intraocular lens
93529|NCT02981186|trifocal|trifocal
93530|NCT02981186|cataract|cataract
93531|NCT02981186|PhysIOL|physiol
93532|NCT02981147|cough|cough
93533|NCT02981147|thyme|thyme
93534|NCT02981147|Cisti|cisti
93535|NCT02981147|Ivy Leaves|ivy leaves
93536|NCT02981134|bioabsorbable scaffold|bioabsorbable scaffold
93537|NCT02981134|computed tomography|computed tomography
93538|NCT02981121|Diabetes Prevention|diabetes prevention
93539|NCT02981082|Systemic Sclerosis, Scleroderma, PAH, Pulmonary Hypertension|systemic sclerosis, scleroderma, pah, pulmonary hypertension
93540|NCT02981056|Skincare regimens|skincare regimens
93541|NCT02981056|Skin moisturization|skin moisturization
93542|NCT02981056|Skin barrier|skin barrier
93543|NCT02981056|Skin development|skin development
93544|NCT02981017|Chronic sinusitis|chronic sinusitis
93545|NCT02981017|Frontal sinusitis|frontal sinusitis
93546|NCT02981017|Skull base neoplasm|skull base neoplasm
93547|NCT02981004|Aortic valve disease, patient prosthesis mismatch|aortic valve disease, patient prosthesis mismatch
93548|NCT02980965|breast cancer|breast cancer
93549|NCT02980965|neoadjuvant chemotherapy|neoadjuvant chemotherapy
93550|NCT02980965|endocrine therapy|endocrine therapy
93551|NCT02980965|concurrent|concurrent
93552|NCT02980887|Pulmonary arterial hypertension|pulmonary arterial hypertension
93553|NCT02980874|RVO|rvo
93554|NCT02980874|ME|me
93555|NCT02980874|Central Subfield Thickness|central subfield thickness
93556|NCT02980874|OCT|oct
93557|NCT02980874|Optical Coherence Tomography|optical coherence tomography
93558|NCT02980874|Cystoid Macular Edema|cystoid macular edema
93559|NCT02980874|Subretinal Fluid|subretinal fluid
93560|NCT02980874|Eylea|eylea
93561|NCT02980874|Aflibercept|aflibercept
93562|NCT02980874|Anti-VEGF|anti-vegf
93563|NCT02980874|Suprachoroidal|suprachoroidal
93564|NCT02980861|Gastric Cancer|gastric cancer
93565|NCT02980861|Splenic Hilum Lymph Nodes Dissection|splenic hilum lymph nodes dissection
93566|NCT02980861|Gastrectomy|gastrectomy
93567|NCT02980848|digital mammography|digital mammography
93568|NCT02980848|digital breast tomosynthesis|digital breast tomosynthesis
93569|NCT02980848|breast magnetic resonance imaging|breast magnetic resonance imaging
93570|NCT02980848|screening|screening
93571|NCT02980848|breast density|breast density
93572|NCT02980848|breast imaging|breast imaging
93573|NCT02980848|pre-operative magnetic resonance imaging|pre-operative magnetic resonance imaging
93574|NCT02980796|Brain|brain
93575|NCT02980796|MRI|mri
93576|NCT02980796|Exercise|exercise
93577|NCT02980796|Rehabilitation|rehabilitation
93578|NCT02980796|TMS|tms
93579|NCT02980770|Obstructive Sleep Apnea|obstructive sleep apnea
93580|NCT02980770|Obesity Hypoventilation Syndrome|obesity hypoventilation syndrome
93581|NCT02980770|Hypercapnia|hypercapnia
93582|NCT02980770|Post-Op Complication|post-op complication
93583|NCT02980770|Acid-Base Imbalance|acid-base imbalance
93584|NCT02980744|Stroke|stroke
93585|NCT02980744|Sedentary behaviour|sedentary behaviour
93586|NCT02980744|Intervention|intervention
93587|NCT02980731|Relapsed CLL|relapsed cll
93588|NCT02980731|Refractory CLL|refractory cll
93589|NCT02980731|17p deletion|17p deletion
93590|NCT02980731|TP53 gene|tp53 gene
93591|NCT02980731|B-Cell receptor inhibitor (BCRi)|b-cell receptor inhibitor (bcri)
93592|NCT02980731|European Organization of Research and Treatment of Cancer Quality of Life Core Questionnaire (EORTC QLQ-C30)|european organization of research and treatment of cancer quality of life core questionnaire (eortc qlq-c30)
93593|NCT02980731|Overall response rate (ORR)|overall response rate (orr)
93594|NCT02980731|Duration of overall response (Dor)|duration of overall response (dor)
93595|NCT02980731|Complete remission rate (CR + CRi)|complete remission rate (cr + cri)
93596|NCT02980731|Progression-free survival (PFS)|progression-free survival (pfs)
93597|NCT02980731|Overall survival (OS)|overall survival (os)
93598|NCT02980718|Olfaction training|olfaction training
93599|NCT02980718|Smell|smell
93600|NCT02980653|Phase II study|phase ii study
93601|NCT02980653|Critical body weight loss|critical body weight loss
93602|NCT02980653|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
93603|NCT02980653|Megestrol acetate|megestrol acetate
93604|NCT02980653|Head and neck cancer|head and neck cancer
93605|NCT02980640|Multiple Sclerosis|multiple sclerosis
93606|NCT02980640|Treatment|treatment
93607|NCT02980640|Quality of Life|quality of life
93608|NCT02980640|Symptoms|symptoms
93609|NCT02980627|Eating Disorders|eating disorders
93610|NCT02980627|Diabulimia|diabulimia
93611|NCT02980627|ED-T1DM|ed-t1dm
93612|NCT02980627|Type 1 Diabetes|type 1 diabetes
93613|NCT02980627|Mobile Technology|mobile technology
93614|NCT02980627|Acceptance and Commitment Therapy|acceptance and commitment therapy
93615|NCT02980614|phase-contrast MRI|phase-contrast mri
93616|NCT02980614|blood flow|blood flow
93617|NCT02980614|velocity mapping|velocity mapping
93618|NCT02980614|Quantitative MRI|quantitative mri
93619|NCT02980614|Cardiac imaging|cardiac imaging
93620|NCT02980614|Tetralogy of Fallot|tetralogy of fallot
93621|NCT02980601|Traumatic Defect|traumatic defect
93622|NCT02980601|Chronic Wounds|chronic wounds
93623|NCT02980575|COPD|copd
93624|NCT02980575|Music|music
93625|NCT02980575|Exercise|exercise
93626|NCT02980562|Bowel preparation|bowel preparation
93627|NCT02980562|Ascorbic acid|ascorbic acid
93628|NCT02980562|Bisacodyl|bisacodyl
93629|NCT02980562|Polyethylene glycol|polyethylene glycol
93630|NCT02980536|NSCLC|nsclc
93631|NCT02980536|TKI|tki
93632|NCT02980536|Mutation|mutation
93633|NCT02980536|Liquid Biopsy|liquid biopsy
93634|NCT02980497|mouthrinse|mouthrinse
93635|NCT02980497|plaque|plaque
93636|NCT02980497|gingivitis|gingivitis
93637|NCT02980497|gum bleeding|gum bleeding
93638|NCT02980484|rTMS|rtms
93639|NCT02980458|Healthy|healthy
93640|NCT02980458|Bioequivalence|bioequivalence
93641|NCT02980458|Deferiprone|deferiprone
93642|NCT02980445|Myopia|myopia
93643|NCT02980445|Outdoor time|outdoor time
93644|NCT02980445|Children|children
93645|NCT02980445|Intervention|intervention
93646|NCT02980445|Prevention|prevention
93647|NCT02980432|vestibular|vestibular
93648|NCT02980432|spatial orientation|spatial orientation
93649|NCT02980432|vision|vision
93650|NCT02980432|optokinetic|optokinetic
93651|NCT02980406|FODMAP|fodmap
93652|NCT02980406|Irritable bowel syndrome|irritable bowel syndrome
93653|NCT02980406|Gastric accommodation|gastric accommodation
93654|NCT02980406|Gastric motility|gastric motility
93655|NCT02980406|brain-gut axis|brain-gut axis
93656|NCT02980393|congenital heart disease|congenital heart disease
93657|NCT02980393|smart mobile technology|smart mobile technology
93658|NCT02980393|children|children
93659|NCT02980393|adolescents|adolescents
93660|NCT02980393|lifestyle counselling|lifestyle counselling
93661|NCT02980393|nutrition|nutrition
93662|NCT02980393|physical activity|physical activity
93663|NCT02980380|non-invasive brain computer interface|non-invasive brain computer interface
93664|NCT02980380|communication|communication
93665|NCT02980380|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
93666|NCT02980380|complete locked-in state|complete locked-in state
93667|NCT02980367|Anterior Cruciate Ligament|anterior cruciate ligament
93668|NCT02980367|ACL|acl
93669|NCT02980367|Anterior Cruciate Ligament deficiency|anterior cruciate ligament deficiency
93670|NCT02980367|ACL deficiency|acl deficiency
93671|NCT02980367|ACLD|acld
93672|NCT02980367|Anterior Cruciate Ligament reconstruction|anterior cruciate ligament reconstruction
93673|NCT02980367|ACL reconstruction|acl reconstruction
93674|NCT02980367|Anterior Cruciate Ligament physiotherapy|anterior cruciate ligament physiotherapy
93675|NCT02980367|Anterior Cruciate Ligament rehabilitation|anterior cruciate ligament rehabilitation
93676|NCT02980367|ACL physiotherapy|acl physiotherapy
93677|NCT02980367|ACL rehabilitation|acl rehabilitation
93678|NCT02980367|Anterior Cruciate Ligament management|anterior cruciate ligament management
93679|NCT02980367|ACL management|acl management
93680|NCT02980354|endothelial progenitor cells, ischaemic stroke, aging|endothelial progenitor cells, ischaemic stroke, aging
93681|NCT02980341|Oncology|oncology
93682|NCT02980341|HER3|her3
93683|NCT02980341|Antibody drug conjugate|antibody drug conjugate
93684|NCT02980341|Developmental Phase I/II|developmental phase i/ii
93685|NCT02980328|Overactive bladder|overactive bladder
93686|NCT02980328|Urinary incontinence|urinary incontinence
93687|NCT02980328|Low-level light therapy|low-level light therapy
93688|NCT02980315|nasopharyngeal carcinoma|nasopharyngeal carcinoma
93689|NCT02980315|EBV related cancers|ebv related cancers
93690|NCT02980302|Mental retardation MR|mental retardation mr
93691|NCT02980302|IQ|iq
93692|NCT02980302|Mutation|mutation
93693|NCT02980302|Gene MYT1L|gene myt1l
93694|NCT02980276|Gestational Diabetes|gestational diabetes
93695|NCT02980276|Diabetes|diabetes
93696|NCT02980276|Pregnancy|pregnancy
93697|NCT02980263|Kawasaki disease|kawasaki disease
93698|NCT02980263|Coronary artery aneurysm|coronary artery aneurysm
93699|NCT02980263|mucocutaneous lymph node syndrome|mucocutaneous lymph node syndrome
93700|NCT02980263|lymph node syndrome|lymph node syndrome
93701|NCT02980263|canakinumab|canakinumab
93702|NCT02980263|intravenous immunoglobulin naïve (IVIG-naïve)|intravenous immunoglobulin naïve (ivig-naïve)
93703|NCT02980263|intravenous immunoglobulin refractory (IVIG-refractory)|intravenous immunoglobulin refractory (ivig-refractory)
93704|NCT02980263|pediatric|pediatric
93705|NCT02980250|feeding intolerance|feeding intolerance
93706|NCT02980250|premature infant|premature infant
93707|NCT02980250|domperidone|domperidone
93708|NCT02980237|Office workers|office workers
93709|NCT02980237|Quality of life|quality of life
93710|NCT02980237|e-Learning|e-learning
93711|NCT02980237|Occupational health|occupational health
93712|NCT02980211|Alveolar Bone|alveolar bone
93713|NCT02980211|Alveolar Ridge|alveolar ridge
93714|NCT02980211|Bone Resorption|bone resorption
93715|NCT02980211|Bone Grafting|bone grafting
93716|NCT02980211|Barrier Membrane|barrier membrane
93717|NCT02980172|triage|triage
93718|NCT02980120|Eating Disorders|eating disorders
93719|NCT02980120|Anorexia Nervosa|anorexia nervosa
93720|NCT02980120|Bulimia Nervosa|bulimia nervosa
93721|NCT02980094|aging|aging
93722|NCT02980094|nutrients|nutrients
93723|NCT02980094|milk|milk
93724|NCT02980094|dietary supplementation|dietary supplementation
93725|NCT02980055|connective tissue graft|connective tissue graft
93726|NCT02980055|transplantation|transplantation
93727|NCT02980055|collagen|collagen
93728|NCT02980055|autologous|autologous
93729|NCT02980055|gingiva|gingiva
93730|NCT02980029|Resectable Tumors|resectable tumors
93731|NCT02980003|contrast media|contrast media
93732|NCT02980003|contrast-induced acute kidney injury (AKI)|contrast-induced acute kidney injury (aki)
93733|NCT02980003|contrast-induced nephropathy (CIN)|contrast-induced nephropathy (cin)
93734|NCT02979990|infertility|infertility
93735|NCT02979990|education|education
93736|NCT02979951|Observational Study|observational study
93737|NCT02979951|Non-Interventional Study|non-interventional study
93738|NCT02979951|Registries|registries
93739|NCT02979951|Prospective|prospective
93740|NCT02979951|Monitored|monitored
93741|NCT02979951|Multicentric|multicentric
93742|NCT02979951|International|international
93743|NCT02979951|Fosfomycin|fosfomycin
93744|NCT02979951|Infectofos|infectofos
93745|NCT02979951|Fomicyt|fomicyt
93746|NCT02979951|Bacterial Infections|bacterial infections
93747|NCT02979951|Gram-Negative Bacterial Infections|gram-negative bacterial infections
93748|NCT02979951|Gram-Positive Bacterial Infections|gram-positive bacterial infections
93749|NCT02979951|Bone Diseases, Infectious|bone diseases, infectious
93750|NCT02979951|Osteomyelitis|osteomyelitis
93751|NCT02979951|Central Nervous System Bacterial Infections|central nervous system bacterial infections
93752|NCT02979951|Meningitis, Bacterial|meningitis, bacterial
93753|NCT02979951|Encephalitis|encephalitis
93754|NCT02979951|Brain Abscess|brain abscess
93755|NCT02979951|Urinary Tract Infections|urinary tract infections
93756|NCT02979951|Respiratory Tract Infections|respiratory tract infections
93757|NCT02979951|Pneumonia, Bacterial|pneumonia, bacterial
93758|NCT02979951|Skin Diseases, Bacterial|skin diseases, bacterial
93759|NCT02979951|Soft Tissue Infections|soft tissue infections
93760|NCT02979951|Intraabdominal Infections|intraabdominal infections
93761|NCT02979951|Sepsis|sepsis
93762|NCT02979951|Bacteremia|bacteremia
93763|NCT02979951|Endocarditis, Bacterial|endocarditis, bacterial
93764|NCT02979951|Treatment Outcome|treatment outcome
93765|NCT02979951|Clinical Efficacy|clinical efficacy
93766|NCT02979951|Microbiological Efficacy|microbiological efficacy
93767|NCT02979951|Safety|safety
93768|NCT02979925|neuropathic pain|neuropathic pain
93769|NCT02979925|TMS|tms
93770|NCT02979925|nerve injury|nerve injury
93771|NCT02979925|transcutaneous magnetic stimulation|transcutaneous magnetic stimulation
93772|NCT02979912|Persistent corneal epithelial defect|persistent corneal epithelial defect
93773|NCT02979912|Platelet Lysate|platelet lysate
93774|NCT02979899|angiosarcoma|angiosarcoma
93775|NCT02979886|single nucleotide polymorphism,GnRH receptor, IVF|single nucleotide polymorphism,gnrh receptor, ivf
93776|NCT02979873|Rapamycin|rapamycin
93777|NCT02979873|Relapse Prevention|relapse prevention
93778|NCT02979873|Immune Tolerance|immune tolerance
93779|NCT02979847|persistent atrial fibrillation|persistent atrial fibrillation
93780|NCT02979847|catheter ablation|catheter ablation
93781|NCT02979847|hybrid|hybrid
93782|NCT02979834|fetal movement|fetal movement
93783|NCT02979834|placenta site|placenta site
93784|NCT02979834|body mass index|body mass index
93785|NCT02979834|maternal education|maternal education
93786|NCT02979821|pan-HER inhibitor|pan-her inhibitor
93787|NCT02979782|cardiac surgery|cardiac surgery
93788|NCT02979782|neurological outcome|neurological outcome
93789|NCT02979782|minimal invasive coronary artery bypass graft (Endo-CABG)|minimal invasive coronary artery bypass graft (endo-cabg)
93790|NCT02979769|Open-label extension study|open-label extension study
93791|NCT02979769|Clinical trial Phase 2|clinical trial phase 2
93792|NCT02979769|Efficacy and safety|efficacy and safety
93793|NCT02979769|Heterotopic ossification|heterotopic ossification
93794|NCT02979769|Flare-up|flare-up
93795|NCT02979769|Palovarotene|palovarotene
93796|NCT02979769|Retinoic acide receptor agonist|retinoic acide receptor agonist
93797|NCT02979769|Retinoic acide receptor gamma agonist|retinoic acide receptor gamma agonist
93798|NCT02979769|Clementia|clementia
93799|NCT02979769|Myositis Ossificans|myositis ossificans
93800|NCT02979769|Munchmeyer's Disease|munchmeyer's disease
93801|NCT02979769|FOP|fop
93802|NCT02979717|satiety|satiety
93803|NCT02979717|protein|protein
93804|NCT02979717|fiber|fiber
93805|NCT02979678|Breast cancer, quality of life|breast cancer, quality of life
93806|NCT02979639|Herpes Zoster|herpes zoster
93807|NCT02979639|Reactogenicity|reactogenicity
93808|NCT02979639|Quality of life|quality of life
93809|NCT02979639|Shingles|shingles
93810|NCT02979626|hospitalization|hospitalization
93811|NCT02979626|intensive care unit|intensive care unit
93812|NCT02979626|school absenteeism|school absenteeism
93813|NCT02979626|work absenteeism|work absenteeism
93814|NCT02979600|Oral immunotherapy|oral immunotherapy
93815|NCT02979600|Oral tolerance induction|oral tolerance induction
93816|NCT02979574|acupuncture|acupuncture
93817|NCT02979574|pain|pain
93818|NCT02979574|chronic pain|chronic pain
93819|NCT02979574|pain management|pain management
93820|NCT02979574|16-1579|16-1579
93821|NCT02979561|Dabigatran etexilate|dabigatran etexilate
93822|NCT02979561|Recurrence of DVT|recurrence of dvt
93823|NCT02979561|Pulmonary Embolism|pulmonary embolism
93824|NCT02979561|Warfarin|warfarin
93825|NCT02979548|Aprepitant|aprepitant
93826|NCT02979535|Dengue Fever|dengue fever
93827|NCT02979535|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
93828|NCT02979535|Human Papillomavirus Disease|human papillomavirus disease
93829|NCT02979535|CYD Dengue Vaccine|cyd dengue vaccine
93830|NCT02979535|Dengvaxia®|dengvaxia®
93831|NCT02979535|Cervarix®|cervarix®
93832|NCT02979522|Drug therapy, pediatric Hodgkin disease, frontline Hodgkin disease, advanced stage Hodgkin disease, pediatric lymphoma|drug therapy, pediatric hodgkin disease, frontline hodgkin disease, advanced stage hodgkin disease, pediatric lymphoma
93833|NCT02979496|immune|immune
93834|NCT02979496|citrus|citrus
93835|NCT02979470|advanced colon cancer|advanced colon cancer
93836|NCT02979470|advanced rectum cancer|advanced rectum cancer
93837|NCT02979470|circulating tumor cells|circulating tumor cells
93838|NCT02979470|immune response|immune response
93839|NCT02979470|mutations|mutations
93840|NCT02979457|telephone consultation, patient involvement|telephone consultation, patient involvement
93841|NCT02979418|Water insecurity|water insecurity
93842|NCT02979340|Cystic Fibrosis Liver Disease|cystic fibrosis liver disease
93843|NCT02979340|Pancreatic Insufficiency|pancreatic insufficiency
93844|NCT02979275|acute kidney injury|acute kidney injury
93845|NCT02979275|cardiopulmonary bypass|cardiopulmonary bypass
93846|NCT02979275|neutrophil gelatinase-associated lipocalin|neutrophil gelatinase-associated lipocalin
93847|NCT02979275|tissue hypoxia|tissue hypoxia
93848|NCT02979249|Interventional|interventional
93849|NCT02979249|open-label|open-label
93850|NCT02979249|EPP|epp
93851|NCT02979249|XLP|xlp
93852|NCT02979249|porphyria|porphyria
93853|NCT02979197|High blood pressure|high blood pressure
93854|NCT02979197|Systolic blood pressure|systolic blood pressure
93855|NCT02979197|Diastolic blood pressure|diastolic blood pressure
93856|NCT02979197|Antihypertensive|antihypertensive
93857|NCT02979184|Lymphedema, Obstructive Sleep Apnea , Intensive Decongestive Physiotherapy|lymphedema, obstructive sleep apnea , intensive decongestive physiotherapy
93858|NCT02979119|Hemophilia|hemophilia
93859|NCT02979119|Children, ,|children, ,
93860|NCT02979119|Inhibitors,|inhibitors,
93861|NCT02979119|Prophylaxis|prophylaxis
93862|NCT02979119|Long-term outcome|long-term outcome
93863|NCT02979119|Congenital|congenital
93864|NCT02979093|maternal drug addiction|maternal drug addiction
93865|NCT02979093|mother-infant attachment|mother-infant attachment
93866|NCT02979093|intranasal oxytocin|intranasal oxytocin
93867|NCT02979093|unresolved trauma|unresolved trauma
93868|NCT02979093|maternal brain responses|maternal brain responses
93869|NCT02979093|mother-infant synchrony|mother-infant synchrony
93870|NCT02979067|Apnoea time, preoxygenation, difficult airway, emergency|apnoea time, preoxygenation, difficult airway, emergency
93871|NCT02979041|neck pain|neck pain
93872|NCT02979041|Virtual reality|virtual reality
93873|NCT02979041|Range of motion|range of motion
93874|NCT02979041|physiotherapy|physiotherapy
93875|NCT02979041|Air force|air force
93876|NCT02979041|kinematics|kinematics
93877|NCT02979028|TEAS|teas
93878|NCT02979028|complication|complication
93879|NCT02978989|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
93880|NCT02978989|Solo surgery|solo surgery
93881|NCT02978989|Camera holder|camera holder
93882|NCT02978989|Cholecystitis|cholecystitis
93883|NCT02978976|RDS|rds
93884|NCT02978976|Doppler on fetal pulmonary artery|doppler on fetal pulmonary artery
93885|NCT02978963|Excessive worry|excessive worry
93886|NCT02978963|Worry|worry
93887|NCT02978963|Adolescents|adolescents
93888|NCT02978963|Intolerance of uncertainty|intolerance of uncertainty
93889|NCT02978950|duplex ultrasound|duplex ultrasound
93890|NCT02978950|trauma|trauma
93891|NCT02978950|venous thromboembolism|venous thromboembolism
93892|NCT02978950|prevention|prevention
93893|NCT02978924|spinal cord|spinal cord
93894|NCT02978924|tsDCS|tsdcs
93895|NCT02978924|3D motion capture|3d motion capture
93896|NCT02978924|EMG|emg
93897|NCT02978911|RMI|rmi
93898|NCT02978898|Follicular Lymphoma|follicular lymphoma
93899|NCT02978898|flow cytometry|flow cytometry
93900|NCT02978898|CD180|cd180
93901|NCT02978898|Toll-like receptor|toll-like receptor
93902|NCT02978898|lymphoproliferative disease|lymphoproliferative disease
93903|NCT02978885|Acute lung injury|acute lung injury
93904|NCT02978885|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
93905|NCT02978885|Whipple procedures|whipple procedures
93906|NCT02978885|pancreatico-duodenectomies|pancreatico-duodenectomies
93907|NCT02978872|Cardiac surgery|cardiac surgery
93908|NCT02978872|Quantra|quantra
93909|NCT02978872|Viscoelastic testing|viscoelastic testing
93910|NCT02978872|Coagulation|coagulation
93911|NCT02978859|MGCD516|mgcd516
93912|NCT02978859|Sarcoma|sarcoma
93913|NCT02978859|liposarcoma|liposarcoma
93914|NCT02978859|Unresectable Liposarcoma|unresectable liposarcoma
93915|NCT02978859|Metastatic Liposarcoma|metastatic liposarcoma
93916|NCT02978833|Gluteus Medius Tendinosis|gluteus medius tendinosis
93917|NCT02978820|scientific exercise approach to scoliosis|scientific exercise approach to scoliosis
93918|NCT02978820|core stabilization training|core stabilization training
93919|NCT02978820|bracing|bracing
93920|NCT02978820|adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
94024|NCT02978235|Hematologic Diseases|hematologic diseases
93921|NCT02978794|stroke, clinical pathway, medical care|stroke, clinical pathway, medical care
93922|NCT02978781|Tremor|tremor
93923|NCT02978768|dementia|dementia
93924|NCT02978768|Tai Chi|tai chi
93925|NCT02978768|mental training|mental training
93926|NCT02978768|cognitive rehabilitation|cognitive rehabilitation
93927|NCT02978742|Eating Disorders|eating disorders
93928|NCT02978742|Bulimia Nervosa|bulimia nervosa
93929|NCT02978742|Binge Eating Disorder|binge eating disorder
93930|NCT02978742|App|app
93931|NCT02978742|Smartphone|smartphone
93932|NCT02978742|Self-Help|self-help
93933|NCT02978742|Coaching|coaching
93934|NCT02978742|Recovery Record|recovery record
93935|NCT02978742|Mobile Phone|mobile phone
93936|NCT02978742|Cognitive Behavioral Therapy|cognitive behavioral therapy
93937|NCT02978729|Telemedicine|telemedicine
93938|NCT02978729|Counseling, Genetic|counseling, genetic
93939|NCT02978716|Breast Cancer|breast cancer
93940|NCT02978716|CDK 4/6 Inhibitor|cdk 4/6 inhibitor
93941|NCT02978716|Triple Negative Breast Cancer|triple negative breast cancer
93942|NCT02978716|Metastatic|metastatic
93943|NCT02978677|brain tumors|brain tumors
93944|NCT02978677|proton radiotherapy|proton radiotherapy
93945|NCT02978677|photon radiotherapy|photon radiotherapy
93946|NCT02978664|colonoscopy|colonoscopy
93947|NCT02978664|water exchange|water exchange
93948|NCT02978664|adenoma detection rate|adenoma detection rate
93949|NCT02978664|distraction|distraction
93950|NCT02978651|EDS|eds
93951|NCT02978651|OSA|osa
93952|NCT02978638|Spinal cord injury|spinal cord injury
93953|NCT02978638|Bladder capacity|bladder capacity
93954|NCT02978638|Electrical stimulation|electrical stimulation
93955|NCT02978638|Continence|continence
93956|NCT02978638|Urodynamics|urodynamics
93957|NCT02978612|Colorectal Neoplasms|colorectal neoplasms
93958|NCT02978586|PSMA|psma
93959|NCT02978586|PET/MRI|pet/mri
93960|NCT02978573|First MTP Joint|first mtp joint
93961|NCT02978573|Hallux Rigidus|hallux rigidus
93962|NCT02978573|Hallux Limitus|hallux limitus
93963|NCT02978573|Cartilage Replacement|cartilage replacement
93964|NCT02978573|Osteoarthritis|osteoarthritis
93965|NCT02978573|First MTP Joint Osteoarthritis|first mtp joint osteoarthritis
93966|NCT02978573|Big Toe Pain|big toe pain
93967|NCT02978547|Resectable pancreatic ductal adenocarcinoma|resectable pancreatic ductal adenocarcinoma
93968|NCT02978547|PDAC|pdac
93969|NCT02978547|Metformin|metformin
93970|NCT02978534|pregnant|pregnant
93971|NCT02978534|quetiapine|quetiapine
93972|NCT02978534|bipolar|bipolar
93973|NCT02978534|women|women
93974|NCT02978534|female|female
93975|NCT02978534|postpartum|postpartum
93976|NCT02978534|seroquel|seroquel
93977|NCT02978534|perinatal|perinatal
93978|NCT02978534|manic-depressive|manic-depressive
93979|NCT02978469|Habitual Physical Activity (HPA); Sedentary Behavior;|habitual physical activity (hpa); sedentary behavior;
93980|NCT02978456|IVUS guided PCI|ivus guided pci
93981|NCT02978456|QCA guided PCI|qca guided pci
93982|NCT02978443|Melanoma|melanoma
93983|NCT02978443|Mucosal|mucosal
93984|NCT02978443|Acral Lentiginous|acral lentiginous
93985|NCT02978443|Ipilimumab|ipilimumab
93986|NCT02978443|Nivolumab|nivolumab
93987|NCT02978443|Anti-tumor|anti-tumor
93988|NCT02978443|Potential Predictors|potential predictors
93989|NCT02978443|Opdivo|opdivo
93990|NCT02978443|Yervoy|yervoy
93991|NCT02978430|Fluid therapy|fluid therapy
93992|NCT02978430|Anesthesiology|anesthesiology
93993|NCT02978430|Major surgery|major surgery
93994|NCT02978430|Goal-directed fluid therapy|goal-directed fluid therapy
93995|NCT02978430|Fluid responsiveness|fluid responsiveness
93996|NCT02978430|Closed-loop system|closed-loop system
93997|NCT02978417|Medication-assisted treatment|medication-assisted treatment
93998|NCT02978417|Drug Court|drug court
93999|NCT02978417|Pilot study|pilot study
94000|NCT02978417|Opioid dependence|opioid dependence
94001|NCT02978417|Criminal justice|criminal justice
94002|NCT02978404|radiosurgery|radiosurgery
94003|NCT02978404|PD-1|pd-1
94004|NCT02978404|Nivolumab|nivolumab
94005|NCT02978326|Postpartum Care|postpartum care
94006|NCT02978287|Calcium sensing receptor|calcium sensing receptor
94007|NCT02978287|Parathyroid cell viability|parathyroid cell viability
94008|NCT02978287|Parathyroid allotransplantation|parathyroid allotransplantation
94009|NCT02978287|Transporting solution|transporting solution
94010|NCT02978235|Multiple Myeloma|multiple myeloma
94011|NCT02978235|Relapsed/Refractory|relapsed/refractory
94012|NCT02978235|Lymphoma|lymphoma
94013|NCT02978235|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
94145|NCT02977728|olfaction|olfaction
94014|NCT02978235|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
94015|NCT02978235|DLBCL|dlbcl
94016|NCT02978235|Mantle Cell Lymphoma|mantle cell lymphoma
94017|NCT02978235|MCL|mcl
94018|NCT02978235|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
94019|NCT02978235|PTCL|ptcl
94020|NCT02978235|TAS4464|tas4464
94021|NCT02978235|NEDD8|nedd8
94022|NCT02978235|NAE inhibitor|nae inhibitor
94023|NCT02978235|Neoplasms|neoplasms
94025|NCT02978235|Myeloma|myeloma
94026|NCT02978170|Bronchoscopy|bronchoscopy
94027|NCT02978170|Lung lesions|lung lesions
94028|NCT02978170|Cone Beam Computed Tomography|cone beam computed tomography
94029|NCT02978170|CBCT|cbct
94030|NCT02978170|Cone Beam CT|cone beam ct
94031|NCT02978157|Helicobacter pylori|helicobacter pylori
94032|NCT02978157|Eradication rate|eradication rate
94033|NCT02978157|Rescue treatment|rescue treatment
94034|NCT02978144|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
94035|NCT02978131|TUBERCULOSIS|tuberculosis
94036|NCT02978131|Sensitivity and Specificity|sensitivity and specificity
94037|NCT02978131|Polymerase Chain Reaction|polymerase chain reaction
94038|NCT02978131|Immunohistochemistry|immunohistochemistry
94039|NCT02978131|Histochemistry|histochemistry
94040|NCT02978131|Paraformaldehyde and paraffin embedded tissues|paraformaldehyde and paraffin embedded tissues
94041|NCT02978053|Bright light|bright light
94042|NCT02978053|Sleepiness|sleepiness
94043|NCT02978053|Sleep|sleep
94044|NCT02978053|Psychomotor vigilance|psychomotor vigilance
94045|NCT02978040|Antiplatelet therapy|antiplatelet therapy
94046|NCT02978040|Cangrelor|cangrelor
94047|NCT02978040|Tirofiban|tirofiban
94048|NCT02978040|Prasugrel|prasugrel
94049|NCT02978040|Acute Myocardial Infarction|acute myocardial infarction
94050|NCT02978040|Primary Percutaneous Coronary Intervention|primary percutaneous coronary intervention
94051|NCT02978040|Pharmacokinetic/Pharmacodynamic|pharmacokinetic/pharmacodynamic
94052|NCT02978027|motivational interviewing|motivational interviewing
94053|NCT02978027|brief alcohol intervention in primary care|brief alcohol intervention in primary care
94054|NCT02978014|Prostate|prostate
94055|NCT02978014|Radiotherapy|radiotherapy
94056|NCT02978014|Obturator|obturator
94057|NCT02978014|Toxicity|toxicity
94058|NCT02978014|Bowel|bowel
94059|NCT02978014|Urinary|urinary
94060|NCT02978014|Sexual|sexual
94061|NCT02978014|PROM|prom
94062|NCT02978014|EPIC|epic
94063|NCT02977988|Mindfulness|mindfulness
94064|NCT02977988|Women|women
94065|NCT02977988|Relapse prevention|relapse prevention
94066|NCT02977988|Clinical trial|clinical trial
94067|NCT02977988|Substance use disorder|substance use disorder
94068|NCT02977988|Ethnically diverse|ethnically diverse
94069|NCT02977988|Underserved|underserved
94070|NCT02977988|Health disparities|health disparities
94071|NCT02977988|Stress|stress
94072|NCT02977988|Addiction|addiction
94073|NCT02977988|Latina/Hispanic|latina/hispanic
94074|NCT02977988|African American|african american
94075|NCT02977988|Treatment retention|treatment retention
94076|NCT02977988|Residential treatment|residential treatment
94077|NCT02977988|Brain Imaging|brain imaging
94078|NCT02977975|Irritable bowel syndrome|irritable bowel syndrome
94079|NCT02977975|The human microbiome|the human microbiome
94080|NCT02977975|Microbiota|microbiota
94081|NCT02977975|Gut microbiota|gut microbiota
94082|NCT02977975|Probiotics|probiotics
94083|NCT02977975|Sauerkraut|sauerkraut
94084|NCT02977949|SERM|serm
94085|NCT02977949|Season|season
94086|NCT02977949|Variation|variation
94087|NCT02977949|Vitamin D|vitamin d
94088|NCT02977923|Virtual reality|virtual reality
94089|NCT02977923|Immersive distraction|immersive distraction
94090|NCT02977923|Oculus rift|oculus rift
94091|NCT02977923|Virtual world|virtual world
94092|NCT02977923|Virtual environment|virtual environment
94093|NCT02977923|Procedural pain|procedural pain
94094|NCT02977923|Procedural anxiety|procedural anxiety
94095|NCT02977923|Acute pain|acute pain
94096|NCT02977923|Pain management|pain management
94097|NCT02977923|Anxiety|anxiety
94098|NCT02977923|Children, Child|children, child
94099|NCT02977923|Kid, Kids|kid, kids
94100|NCT02977923|Pediatric, Pediatrics|pediatric, pediatrics
94101|NCT02977923|Young children|young children
94102|NCT02977923|Burns|burns
94103|NCT02977923|Burn injuries|burn injuries
94104|NCT02977923|Burn unit|burn unit
94105|NCT02977923|Physiotherapy|physiotherapy
94106|NCT02977923|Physical therapy|physical therapy
94107|NCT02977923|Burn dressing|burn dressing
94108|NCT02977923|Dressing change|dressing change
94109|NCT02977923|Non-pharmacological, nonpharmacological|non-pharmacological, nonpharmacological
94110|NCT02977923|Clinical Research|clinical research
94111|NCT02977923|Nursing Practice|nursing practice
94112|NCT02977923|Trauma|trauma
94113|NCT02977897|Diarrhea|diarrhea
94114|NCT02977897|Immunosuppression|immunosuppression
94115|NCT02977897|Post-transplantation|post-transplantation
94116|NCT02977897|Octreotide|octreotide
94117|NCT02977897|Mycophenolate Mofetil|mycophenolate mofetil
94118|NCT02977897|Fecal Calprotectin|fecal calprotectin
94119|NCT02977884|nutrition|nutrition
94120|NCT02977884|exercise|exercise
94121|NCT02977884|stress|stress
94122|NCT02977884|cardiovascular disease|cardiovascular disease
94123|NCT02977884|diabetes|diabetes
94124|NCT02977884|hypertension|hypertension
94125|NCT02977884|dyslipidemia|dyslipidemia
94126|NCT02977884|cholesterol|cholesterol
94127|NCT02977884|overweight|overweight
94128|NCT02977884|obesity|obesity
94129|NCT02977884|lifestyle|lifestyle
94130|NCT02977871|Cesarean section|cesarean section
94131|NCT02977871|operating time|operating time
94132|NCT02977871|bladder|bladder
94133|NCT02977871|urinary retention|urinary retention
94134|NCT02977845|dypsnea|dypsnea
94135|NCT02977845|fatigue|fatigue
94136|NCT02977845|anxiety|anxiety
94137|NCT02977845|Qigong|qigong
94138|NCT02977845|Lung cancer|lung cancer
94139|NCT02977832|LUTS|luts
94140|NCT02977832|Iresine celosia|iresine celosia
94141|NCT02977832|Odyliresin|odyliresin
94142|NCT02977832|medical therapy|medical therapy
94143|NCT02977780|Glioblastoma|glioblastoma
94144|NCT02977728|MTBI|mtbi
94146|NCT02977728|acute|acute
94147|NCT02977715|Democratic Republic of the Congo|democratic republic of the congo
94148|NCT02977715|IMVAMUNE|imvamune
94149|NCT02977715|Modified Vaccinia Ankara (MVA)|modified vaccinia ankara (mva)
94150|NCT02977715|Monkeypox|monkeypox
94151|NCT02977715|Orthopoxvirus|orthopoxvirus
94152|NCT02977715|Vaccine|vaccine
94153|NCT02977715|Vaccinia virus|vaccinia virus
94154|NCT02977689|Isocitrate dehydrogenase (IDH)|isocitrate dehydrogenase (idh)
94155|NCT02977689|R-2-Hydroxyglutarate (2-HG)|r-2-hydroxyglutarate (2-hg)
94156|NCT02977689|Gene encoding UDP-glucuronosyltransferase (UGT1A1)|gene encoding udp-glucuronosyltransferase (ugt1a1)
94157|NCT02977689|Glioblastoma (GBM)|glioblastoma (gbm)
94158|NCT02977689|IDH305|idh305
94159|NCT02977689|IDHR132 mutations|idhr132 mutations
94160|NCT02977689|Astrocytoma|astrocytoma
94161|NCT02977689|Oligodendroglioma|oligodendroglioma
94162|NCT02977689|Oligoastrocytoma|oligoastrocytoma
94163|NCT02977689|IDH1 R132H|idh1 r132h
94164|NCT02977689|IDH1|idh1
94165|NCT02977637|hht|hht
94166|NCT02977637|hereditary|hereditary
94167|NCT02977637|hemorrhagic|hemorrhagic
94168|NCT02977637|telangiectasia|telangiectasia
94169|NCT02977637|feraheme|feraheme
94170|NCT02977585|continous positive airway pressure|continous positive airway pressure
94171|NCT02977585|helmet|helmet
94172|NCT02977585|non invasive|non invasive
94173|NCT02977585|positive end expiratory pressure|positive end expiratory pressure
94174|NCT02977585|severe bronchiolitis|severe bronchiolitis
94175|NCT02977585|pediatric intensive care unit|pediatric intensive care unit
94176|NCT02977572|Non-invasive ventilation,|non-invasive ventilation,
94177|NCT02977572|continuous positive airway pressure|continuous positive airway pressure
94178|NCT02977572|cardiogenic pulmonary oedema,|cardiogenic pulmonary oedema,
94179|NCT02977572|acute respiratory failure|acute respiratory failure
94180|NCT02977559|Laryngeal Tube Suction Ambu AuraGain Leak Pressure|laryngeal tube suction ambu auragain leak pressure
94181|NCT02977546|Hemodynamics|hemodynamics
94182|NCT02977546|Noninvasive|noninvasive
94183|NCT02977546|Pulse contour analysis|pulse contour analysis
94184|NCT02977546|Heart failure|heart failure
94185|NCT02977546|Swan Ganz Catheterization|swan ganz catheterization
94186|NCT02977546|Pulmonary artery Catheter|pulmonary artery catheter
94187|NCT02977468|triple negative breast cancer|triple negative breast cancer
94188|NCT02977468|Pembrolizumab|pembrolizumab
94189|NCT02977468|IORT|iort
94190|NCT02977468|tumor microenvironment|tumor microenvironment
94191|NCT02977442|Mitochondrial Dynamics|mitochondrial dynamics
94192|NCT02977442|Insulin Resistance|insulin resistance
94193|NCT02977442|Exercise and Diabetes|exercise and diabetes
94194|NCT02977429|Tumor|tumor
94195|NCT02977429|Abdominal infection|abdominal infection
94196|NCT02977429|Hemodynamics|hemodynamics
94197|NCT02977429|Pcv-aCO2|pcv-aco2
94198|NCT02977429|Early Goal-directed Therapy (EGDT)|early goal-directed therapy (egdt)
94199|NCT02977416|Juvenile idiopathic arthritis|juvenile idiopathic arthritis
94200|NCT02977416|fat oxidation|fat oxidation
94201|NCT02977416|exercise|exercise
94202|NCT02977403|Binge Eating|binge eating
94203|NCT02977403|Eating Behavior|eating behavior
94204|NCT02977403|Children|children
94205|NCT02977403|Magnetoencephalography|magnetoencephalography
94206|NCT02977403|Loss of Control|loss of control
94207|NCT02977351|Periodontopathogenic microorganisms|periodontopathogenic microorganisms
94208|NCT02977351|Non-surgical periodontal treatment|non-surgical periodontal treatment
94209|NCT02977325|Physical activity level|physical activity level
94210|NCT02977325|Personal efficacy|personal efficacy
94211|NCT02977325|Knee osteoarthritis|knee osteoarthritis
94212|NCT02977325|Self-management|self-management
94213|NCT02977325|Self-care|self-care
94214|NCT02977325|Education and exercise in knee osteoarthritis|education and exercise in knee osteoarthritis
94215|NCT02977273|Meal size|meal size
94216|NCT02977260|Meal size|meal size
94217|NCT02977247|SoftVue|softvue
94218|NCT02977247|Dense Breast Tissue|dense breast tissue
94219|NCT02977247|Breast Screening|breast screening
94220|NCT02977247|Abnormal Breast|abnormal breast
94221|NCT02977247|Normal Breast|normal breast
94222|NCT02977247|Breast Imaging|breast imaging
94223|NCT02977247|Breast Biopsy|breast biopsy
94224|NCT02977247|Mammography|mammography
94225|NCT02977247|Tomosynthesis|tomosynthesis
94226|NCT02977247|Automated Breast Ultrasound|automated breast ultrasound
94227|NCT02977247|Breast Cancer|breast cancer
94228|NCT02977247|Breast Carcinoma|breast carcinoma
94229|NCT02977247|Breast Tumors|breast tumors
94230|NCT02977247|Mammary Carcinoma|mammary carcinoma
94231|NCT02977247|Malignant Breast Tumor|malignant breast tumor
94232|NCT02977247|Mammary Neoplasm|mammary neoplasm
94233|NCT02977247|Mammary Cancer|mammary cancer
94234|NCT02977247|ABUS|abus
94235|NCT02977247|AWBUS|awbus
94236|NCT02977247|Breast Tomography|breast tomography
94237|NCT02977247|ATUS|atus
94238|NCT02977247|ABTUS|abtus
94239|NCT02977247|Mammogram|mammogram
94240|NCT02977247|3D Mammogram|3d mammogram
94241|NCT02977247|3D ABUS|3d abus
94242|NCT02977247|3D Breast Ultrasound|3d breast ultrasound
94243|NCT02977247|DBT|dbt
94244|NCT02977247|FFDM|ffdm
94245|NCT02977247|Digital Mammography|digital mammography
94246|NCT02977247|Breast Ultrasound|breast ultrasound
94247|NCT02977247|Dense Breasts|dense breasts
94248|NCT02977247|Breast Density|breast density
94249|NCT02977247|Dense Parenchyma|dense parenchyma
94250|NCT02977247|Asymptomatic|asymptomatic
94251|NCT02977247|Delphinus|delphinus
94252|NCT02977247|Delphinus Medical Technologies|delphinus medical technologies
94253|NCT02977247|Diagnostic Breast Imaging|diagnostic breast imaging
94254|NCT02977221|corticotomy|corticotomy
94255|NCT02977221|piezocision|piezocision
94256|NCT02977221|piezosurgery|piezosurgery
94257|NCT02977221|acceleration of tooth movement|acceleration of tooth movement
94258|NCT02977221|crowded anterior teeth|crowded anterior teeth
94259|NCT02977208|Gabapentin|gabapentin
94260|NCT02977208|OCT2|oct2
94261|NCT02977208|OCTN1|octn1
94262|NCT02977208|Pharmacogenetics|pharmacogenetics
94263|NCT02977208|Pharmacokinetics|pharmacokinetics
94264|NCT02977208|Polymorphisms|polymorphisms
94265|NCT02977195|First in Human|first in human
94266|NCT02977195|monoclonal antibody|monoclonal antibody
94267|NCT02977195|Netrin-1|netrin-1
94268|NCT02977156|Injectable lesion|injectable lesion
94269|NCT02977156|Intra-tumoral injection|intra-tumoral injection
94270|NCT02977143|fluid responsiveness|fluid responsiveness
94271|NCT02977143|central venous pressure|central venous pressure
94272|NCT02977143|positive end-expiratory pressure|positive end-expiratory pressure
94273|NCT02977143|robot surgery|robot surgery
94274|NCT02977117|magnesium|magnesium
94275|NCT02977117|ectopic calcification|ectopic calcification
94276|NCT02977117|chronic kidney disease - mineral and bone disorder|chronic kidney disease - mineral and bone disorder
94277|NCT02977117|serum calcification propensity|serum calcification propensity
94278|NCT02977091|short stature|short stature
94279|NCT02977091|fitness|fitness
94280|NCT02977091|children|children
94281|NCT02977078|Inhaler|inhaler
94282|NCT02977065|Dyslipidemia|dyslipidemia
94283|NCT02977065|CETP Inhibitors|cetp inhibitors
94284|NCT02977065|Hyperlipidemia|hyperlipidemia
94285|NCT02977052|Melanoma|melanoma
94286|NCT02977052|Ipilimumab|ipilimumab
94287|NCT02977052|Nivolumab|nivolumab
94288|NCT02977052|Neo-adjuvant|neo-adjuvant
94289|NCT02976987|Colvir|colvir
94290|NCT02976987|high grade squamous intraepithelial lesions|high grade squamous intraepithelial lesions
94291|NCT02976987|cervix|cervix
94292|NCT02976974|chronic pain|chronic pain
94293|NCT02976974|central sensitization|central sensitization
94294|NCT02976974|function|function
94295|NCT02976974|force|force
94296|NCT02976974|ultrasonography|ultrasonography
94297|NCT02976961|Information|information
94298|NCT02976961|Empowerment|empowerment
94299|NCT02976922|RAS|ras
94300|NCT02976922|microbiome|microbiome
94301|NCT02976922|probiotics|probiotics
94302|NCT02976883|Hypoxia|hypoxia
94303|NCT02976883|HX4|hx4
94304|NCT02976883|PET CT|pet ct
94305|NCT02976883|Radiotherapy|radiotherapy
94306|NCT02976870|Hydronephrosis|hydronephrosis
94307|NCT02976870|Anterior Lumbar Interbody Fusion|anterior lumbar interbody fusion
94308|NCT02976857|refractory diffuse large B-cell lymphoma|refractory diffuse large b-cell lymphoma
94309|NCT02976857|anti-CD19 chimeric antigen receptor T-cell|anti-cd19 chimeric antigen receptor t-cell
94310|NCT02976844|optimal balloon volume|optimal balloon volume
94311|NCT02976844|positive end-expiratory pressure|positive end-expiratory pressure
94312|NCT02976831|Plaque psoriasis vulgaris|plaque psoriasis vulgaris
94313|NCT02976792|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
94314|NCT02976792|Acute Kidney Injury|acute kidney injury
94315|NCT02976792|early acute kidney injury detection|early acute kidney injury detection
94316|NCT02976792|Nephrocheck™|nephrocheck™
94317|NCT02976792|Renal Resistive Index|renal resistive index
94318|NCT02976766|Neuroprotection|neuroprotection
94319|NCT02976766|Clinical trial|clinical trial
94320|NCT02976766|Traditional Chinese medicine|traditional chinese medicine
94321|NCT02976766|Axonal loss|axonal loss
94322|NCT02976766|Jiaogulan|jiaogulan
94323|NCT02976766|Gynostemma pentaphyllum|gynostemma pentaphyllum
94324|NCT02976766|Optical coherence tomography|optical coherence tomography
94325|NCT02976753|Blood Coagulation Disorders|blood coagulation disorders
94326|NCT02976753|Hematologic Diseases|hematologic diseases
94327|NCT02976753|Coagulation Protein Disorders|coagulation protein disorders
94328|NCT02976753|Hemorrhagic Disorders|hemorrhagic disorders
94329|NCT02976753|Genetic Diseases, Inborn|genetic diseases, inborn
94330|NCT02976740|lung cancer|lung cancer
94331|NCT02976740|SBRT|sbrt
94332|NCT02976740|rhGM-CSF|rhgm-csf
94333|NCT02976740|Thymosin Alpha 1|thymosin alpha 1
94334|NCT02976727|Vitamin D|vitamin d
94335|NCT02976727|Calcipotriol|calcipotriol
94336|NCT02976727|Ablative fractional laser|ablative fractional laser
94337|NCT02976727|Actinic keratosis|actinic keratosis
94338|NCT02976727|Photodynamic therapy|photodynamic therapy
94339|NCT02976714|Cystic Fibrosis|cystic fibrosis
94340|NCT02976714|Lung disease|lung disease
94341|NCT02976714|DNA methylation|dna methylation
94342|NCT02976714|Predictive biomarkers|predictive biomarkers
94343|NCT02976701|STEMI|stemi
94344|NCT02976701|acute coronary syndrome|acute coronary syndrome
94345|NCT02976701|DLBS1033|dlbs1033
94346|NCT02976701|microvascular resistance index|microvascular resistance index
94347|NCT02976701|Left ventricular function|left ventricular function
94348|NCT02976688|Endstage renal Disease|endstage renal disease
94349|NCT02976688|Hemodialysis|hemodialysis
94350|NCT02976649|Morbid obesity|morbid obesity
94351|NCT02976649|Bariatric surgery|bariatric surgery
94352|NCT02976649|Multi-dimensional score|multi-dimensional score
94353|NCT02976636|Obesity treatment|obesity treatment
94354|NCT02976636|Parenting training|parenting training
94355|NCT02976636|Parenting style|parenting style
94356|NCT02976636|Family-based behavioral therapy|family-based behavioral therapy
94357|NCT02976623|metrics|metrics
94358|NCT02976623|feedback|feedback
94359|NCT02976623|ultrasound-guided|ultrasound-guided
94360|NCT02976623|procedural skills|procedural skills
94361|NCT02976610|hemolysis|hemolysis
94362|NCT02976597|Abdominal surgery, pain, local, transversus abdominus block.|abdominal surgery, pain, local, transversus abdominus block.
94363|NCT02976584|EEG|eeg
94364|NCT02976584|Cardiac Surgery|cardiac surgery
94365|NCT02976584|Seizure|seizure
94366|NCT02976584|Tranexamic acid|tranexamic acid
94367|NCT02976558|CAM|cam
94368|NCT02976558|allogenic Stem Cell Transplantation|allogenic stem cell transplantation
94369|NCT02976558|Graft-Versus-Host Disease|graft-versus-host disease
94370|NCT02976558|Depression|depression
94371|NCT02976558|Quality of Life|quality of life
94372|NCT02976558|Acupuncture|acupuncture
94373|NCT02976558|Traditional chinese Medicine|traditional chinese medicine
94374|NCT02976558|Integrative medicine|integrative medicine
94375|NCT02976558|Complementary and Alternative Medicine|complementary and alternative medicine
94376|NCT02976558|Music therapy TaKeTiNa|music therapy taketina
94377|NCT02976558|Clown theatrical performance|clown theatrical performance
94378|NCT02976558|Humour|humour
94379|NCT02976558|Chemotherapy side effects|chemotherapy side effects
94380|NCT02976558|Psycho neuro immune system|psycho neuro immune system
94381|NCT02976558|GvHD|gvhd
94382|NCT02976558|PNEIS|pneis
94383|NCT02976558|CMV|cmv
94384|NCT02976558|EBV|ebv
94385|NCT02976558|holistic medicine|holistic medicine
94386|NCT02976532|Electromagnetic tracking|electromagnetic tracking
94387|NCT02976532|Internal rotation gait|internal rotation gait
94388|NCT02976532|Femoral derotation osteotomy|femoral derotation osteotomy
94389|NCT02976480|Irrigation|irrigation
94390|NCT02976454|Obesity treatment|obesity treatment
94391|NCT02976454|Primary care|primary care
94392|NCT02976454|Guided Self-Help|guided self-help
94393|NCT02976428|knee soft tissue balancing|knee soft tissue balancing
94394|NCT02976428|sensor-guided|sensor-guided
94395|NCT02976428|range of motion|range of motion
94396|NCT02976415|Cardiac Surgery|cardiac surgery
94397|NCT02976415|Physiotherapy|physiotherapy
94398|NCT02976415|In-Bed Cycling|in-bed cycling
94399|NCT02976415|Mechanical Ventilation|mechanical ventilation
94400|NCT02976415|Cycle Ergometry|cycle ergometry
94401|NCT02976415|Early Mobilization|early mobilization
94402|NCT02976415|Rehabilitation|rehabilitation
94403|NCT02976415|Critical Care|critical care
94404|NCT02976415|Intensive Care Unit|intensive care unit
94405|NCT02976389|Supplemental Nutrition Assistance Program|supplemental nutrition assistance program
94406|NCT02976389|Food insecurity|food insecurity
94407|NCT02976389|fruit and vegetable|fruit and vegetable
94408|NCT02976389|healthy diet|healthy diet
94409|NCT02976376|Myocardial infarction|myocardial infarction
94410|NCT02976376|e-Health|e-health
94411|NCT02976376|mHealth|mhealth
94412|NCT02976376|mobile phones|mobile phones
94413|NCT02976376|smartphone|smartphone
94414|NCT02976376|follow-up|follow-up
94415|NCT02976363|Radiotherapy|radiotherapy
94416|NCT02976363|Respiratory muscles|respiratory muscles
94417|NCT02976363|Neoplasms|neoplasms
94418|NCT02976363|Breast|breast
94419|NCT02976350|Heart failure|heart failure
94420|NCT02976350|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
94421|NCT02976350|GH deficiency|gh deficiency
94422|NCT02976350|Testosterone deficiency|testosterone deficiency
94423|NCT02976350|Low- T3 syndrome|low- t3 syndrome
94424|NCT02976350|Multiple Hormone Deficiencies|multiple hormone deficiencies
94425|NCT02976337|Central sensitization|central sensitization
94426|NCT02976337|Endogenous opioids|endogenous opioids
94427|NCT02976337|Humans|humans
94428|NCT02976337|Latent sensitization|latent sensitization
94429|NCT02976337|Mandibular third molar extraction|mandibular third molar extraction
94430|NCT02976337|Naloxone|naloxone
94431|NCT02976337|Pain|pain
94432|NCT02976337|Pressure algometry|pressure algometry
94433|NCT02976337|Randomized controlled trial|randomized controlled trial
94434|NCT02976337|Secondary hyperalgesia|secondary hyperalgesia
94435|NCT02976337|Target controlled infusion|target controlled infusion
94436|NCT02976311|inflammatory reaction|inflammatory reaction
94437|NCT02976311|IL-6|il-6
94438|NCT02976311|TNF|tnf
94439|NCT02976311|Misgav Ladach technique|misgav ladach technique
94440|NCT02976311|Pfannenstiel-Kerr technique|pfannenstiel-kerr technique
94441|NCT02976311|cesarean delivery|cesarean delivery
94442|NCT02976311|cesarean technique|cesarean technique
94443|NCT02976298|cerebellum|cerebellum
94444|NCT02976298|supplementary motor area|supplementary motor area
94445|NCT02976285|arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
94446|NCT02976285|patch augmentation|patch augmentation
94447|NCT02976272|Bortezomib regimen|bortezomib regimen
94448|NCT02976272|patients with multiple myeloma|patients with multiple myeloma
94449|NCT02976233|Acute Respiratory Failure|acute respiratory failure
94450|NCT02976233|Non Invasive Ventilation|non invasive ventilation
94451|NCT02976233|Ultrasound|ultrasound
94452|NCT02976233|Diaphragm Thickening|diaphragm thickening
94453|NCT02976168|Cognitive functioning|cognitive functioning
94454|NCT02976168|Brain tissue oxygenation|brain tissue oxygenation
94455|NCT02976168|cerebral perfusion|cerebral perfusion
94456|NCT02976168|head down tilt|head down tilt
94457|NCT02976155|critically ill, intensive care, enteral nutrition|critically ill, intensive care, enteral nutrition
94458|NCT02976142|gastric cancer, metastatic|gastric cancer, metastatic
94459|NCT02976142|positive wash cytology|positive wash cytology
94460|NCT02976142|neoadjuvant intraperitoneal immunotherapy|neoadjuvant intraperitoneal immunotherapy
94461|NCT02976116|Fruquintinib|fruquintinib
94462|NCT02976116|NSCLC|nsclc
94463|NCT02976116|1st line|1st line
94464|NCT02976103|recovery|recovery
94465|NCT02976103|pain|pain
94466|NCT02976103|surgical drains|surgical drains
94467|NCT02976077|social cognition|social cognition
94468|NCT02976077|cognitive remediation|cognitive remediation
94469|NCT02976077|emotions|emotions
94470|NCT02976077|theory of mind|theory of mind
94471|NCT02976077|attributions|attributions
94472|NCT02976077|social perception|social perception
94473|NCT02976064|physical activity|physical activity
94474|NCT02976064|lifestyle|lifestyle
94475|NCT02976064|adaptive case management|adaptive case management
94476|NCT02976064|telemedicine|telemedicine
94477|NCT02976064|integrated care|integrated care
94478|NCT02976064|collaborative self-management|collaborative self-management
94479|NCT02976038|Primary Mitochondrial Disease|primary mitochondrial disease
94480|NCT02976038|Stealth|stealth
94481|NCT02976038|elamipretide|elamipretide
94482|NCT02976012|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
94483|NCT02976012|Aflibercept|aflibercept
94484|NCT02976012|Vitreous Hemorrhage|vitreous hemorrhage
94485|NCT02975986|Nephrolithiasis, Uric Acid|nephrolithiasis, uric acid
94486|NCT02975986|Fatty Acid|fatty acid
94487|NCT02975973|tDCS|tdcs
94488|NCT02975973|cognitive control|cognitive control
94489|NCT02975973|EEG|eeg
94490|NCT02975973|gamma oscillations|gamma oscillations
94491|NCT02975960|systemic sclerosis|systemic sclerosis
94492|NCT02975960|adipose derived stem cell|adipose derived stem cell
94493|NCT02975960|stromal vascular fraction|stromal vascular fraction
94494|NCT02975960|digital ulcer|digital ulcer
94495|NCT02975960|gangrene|gangrene
94496|NCT02975934|CRPC|crpc
94497|NCT02975934|PARP inhibitor|parp inhibitor
94498|NCT02975934|PARPi|parpi
94499|NCT02975934|BRCA|brca
94500|NCT02975934|ATM|atm
94501|NCT02975934|HRD|hrd
94502|NCT02975934|TRITON|triton
94503|NCT02975934|homologous recombination|homologous recombination
94504|NCT02975934|DNA repair|dna repair
94505|NCT02975934|DNA defect|dna defect
94506|NCT02975934|DNA anomaly|dna anomaly
94507|NCT02975934|germline|germline
94508|NCT02975934|somatic|somatic
94509|NCT02975921|Pleural Effusion|pleural effusion
94510|NCT02975921|Thoracentesis|thoracentesis
94511|NCT02975921|Pleural Cavity|pleural cavity
94512|NCT02975921|Pleurodesis|pleurodesis
94513|NCT02975921|Tunneled Pleural Catheter|tunneled pleural catheter
94514|NCT02975908|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
94515|NCT02975908|epidemiology|epidemiology
94516|NCT02975908|clinical features|clinical features
94517|NCT02975908|management|management
94518|NCT02975908|prognosis|prognosis
94519|NCT02975869|Leukemia|leukemia
94520|NCT02975869|Acute Myeloid Leukemia|acute myeloid leukemia
94521|NCT02975856|Anthocyanins|anthocyanins
94522|NCT02975856|Bioavailability|bioavailability
94523|NCT02975856|Flavonoids|flavonoids
94524|NCT02975856|Port wine|port wine
94525|NCT02975856|Red wine|red wine
94526|NCT02975817|pediatric, intraoperative, neurosurgery, inadvertent|pediatric, intraoperative, neurosurgery, inadvertent
94527|NCT02975804|cerebral palsy|cerebral palsy
94528|NCT02975804|video games|video games
94529|NCT02975804|postural control|postural control
94530|NCT02975804|balance|balance
94531|NCT02975804|children|children
94532|NCT02975791|Airway Obstruction|airway obstruction
94533|NCT02975778|80 years old|80 years old
94534|NCT02975765|corticotomy|corticotomy
94535|NCT02975765|minimally invasive|minimally invasive
94536|NCT02975765|piezosurgery|piezosurgery
94537|NCT02975765|piezocision|piezocision
94538|NCT02975765|pain|pain
94539|NCT02975765|discomfort|discomfort
94540|NCT02975739|Intratumoral|intratumoral
94541|NCT02975739|Tongue|tongue
94542|NCT02975739|Microspheres|microspheres
94543|NCT02975726|Liver Cirrhosis|liver cirrhosis
94544|NCT02975726|Refractory ascites|refractory ascites
94545|NCT02975726|PD catheter|pd catheter
94546|NCT02975713|P4,ART,IVF,FSH,LH,AMH|p4,art,ivf,fsh,lh,amh
94547|NCT02975700|PLX3397|plx3397
94548|NCT02975700|Kit-mutant Melanoma|kit-mutant melanoma
94549|NCT02975700|Unresectable or Metastatic KIT-mutated Melanoma|unresectable or metastatic kit-mutated melanoma
94550|NCT02975700|Developmental Phase I/II|developmental phase i/ii
94551|NCT02975687|Acute|acute
94552|NCT02975687|Leukemia|leukemia
94553|NCT02975687|Lymphoid|lymphoid
94554|NCT02975687|CD19|cd19
94555|NCT02975687|Refractory|refractory
94556|NCT02975635|Patients' Preferences|patients' preferences
94557|NCT02975596|educational intervention|educational intervention
94558|NCT02975583|Atherosclerosis|atherosclerosis
94559|NCT02975557|Brimonidine|brimonidine
94560|NCT02975557|Dry Eye|dry eye
94561|NCT02975557|oGVHD|ogvhd
94563|NCT02975544|social and emotional competence|social and emotional competence
94564|NCT02975544|healthy lifestyles|healthy lifestyles
94565|NCT02975544|children|children
94566|NCT02975544|educational programme|educational programme
94567|NCT02975531|Pompage|pompage
94568|NCT02975479|Hay fever|hay fever
94569|NCT02975479|Pollen allergy|pollen allergy
94570|NCT02975479|Allergic rhinitis|allergic rhinitis
94571|NCT02975440|Vilaprisan|vilaprisan
94572|NCT02975440|PK|pk
94573|NCT02975440|rifampicin|rifampicin
94574|NCT02975440|midazolam,|midazolam,
94575|NCT02975440|CYP3A4 induction|cyp3a4 induction
94576|NCT02975440|drug-drug interaction|drug-drug interaction
94577|NCT02975427|Diet|diet
94578|NCT02975427|Abdominal bioelectrical impedance analysis|abdominal bioelectrical impedance analysis
94579|NCT02975427|Anthropometry|anthropometry
94580|NCT02975427|Insulin resistance|insulin resistance
94581|NCT02975362|Acupuncture Treatment; Motor Dysfunction; Stroke Patients|acupuncture treatment; motor dysfunction; stroke patients
94582|NCT02975349|M2951|m2951
94583|NCT02975349|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
94584|NCT02975349|Bruton's Tyrosine Kinase inhibitor|bruton's tyrosine kinase inhibitor
94585|NCT02975336|Systemic Lupus Erythematosus|systemic lupus erythematosus
94586|NCT02975336|M2951|m2951
94587|NCT02975336|Placebo|placebo
94588|NCT02975336|Dose response|dose response
94589|NCT02975336|Oral Corticosteroids|oral corticosteroids
94590|NCT02975336|Safety|safety
94591|NCT02975336|Efficacy|efficacy
94592|NCT02975336|Autoimmune And Inflammatory Disorders|autoimmune and inflammatory disorders
94593|NCT02975323|hepatic venous pressure gradient|hepatic venous pressure gradient
94594|NCT02975323|liver disease|liver disease
94595|NCT02975323|US Doppler waveform|us doppler waveform
94596|NCT02975323|Cirrhosis|cirrhosis
94597|NCT02975297|smoking|smoking
94598|NCT02975297|pre-diabetes|pre-diabetes
94599|NCT02975297|overweight|overweight
94600|NCT02975297|exenatide|exenatide
94601|NCT02975297|GLP-1 agonists|glp-1 agonists
94602|NCT02975284|bronchial thermoplasty|bronchial thermoplasty
94603|NCT02975284|long term|long term
94604|NCT02975284|interventional bronchoscopy|interventional bronchoscopy
94605|NCT02975258|HIV|hiv
94606|NCT02975258|Asthma|asthma
94607|NCT02975258|Adiposity|adiposity
94608|NCT02975258|Lung disease|lung disease
94609|NCT02975258|Weight|weight
94610|NCT02975258|Fat|fat
94611|NCT02975258|Obese|obese
94612|NCT02975245|Male infertility|male infertility
94613|NCT02975245|Germ cells|germ cells
94614|NCT02975245|Chemotherapy|chemotherapy
94615|NCT02975245|Sperm|sperm
94616|NCT02975232|nutrition disparities|nutrition disparities
94617|NCT02975232|SNAP population|snap population
94618|NCT02975232|behavioral economics|behavioral economics
94619|NCT02975232|retail setting|retail setting
94620|NCT02975232|point of purchase education|point of purchase education
94621|NCT02975232|pediatric obesity|pediatric obesity
94622|NCT02975232|rural population|rural population
94623|NCT02975232|fruit and vegetable purchases|fruit and vegetable purchases
94624|NCT02975232|fruit and vegetable consumption|fruit and vegetable consumption
94625|NCT02975193|Parkinsons Disease|parkinsons disease
94626|NCT02975193|Cognition|cognition
94627|NCT02975167|Induction of labor|induction of labor
94628|NCT02975167|mechanical cervical ripening|mechanical cervical ripening
94629|NCT02975167|patient satisfaction|patient satisfaction
94630|NCT02975167|outpatient|outpatient
94631|NCT02975167|cost savings|cost savings
94632|NCT02975154|osteoarthritis|osteoarthritis
94633|NCT02975154|microcurrent|microcurrent
94634|NCT02975154|knee|knee
94635|NCT02975154|electrotherapy|electrotherapy
94636|NCT02975141|Palliative Chemotherapy|palliative chemotherapy
94637|NCT02975141|Afatinib|afatinib
94638|NCT02975141|Gemcitabine|gemcitabine
94639|NCT02975141|nab-paclitaxel|nab-paclitaxel
94640|NCT02975141|pancreatic cancer|pancreatic cancer
94641|NCT02975128|Minimal invasive|minimal invasive
94642|NCT02975128|Biopsy|biopsy
94643|NCT02975089|Frailty|frailty
94644|NCT02975089|nutrition education|nutrition education
94645|NCT02975089|designed dishware|designed dishware
94646|NCT02975089|balanced diet|balanced diet
94647|NCT02975089|multiple dietary components|multiple dietary components
94648|NCT02975076|Sanchitongshu|sanchitongshu
94649|NCT02975076|Acute Minor Stroke|acute minor stroke
94650|NCT02975076|Transient Ischemic Attack|transient ischemic attack
94651|NCT02975063|Exclusive breastfeeding|exclusive breastfeeding
94652|NCT02975024|mandibular vestibuloplasty|mandibular vestibuloplasty
94653|NCT02975024|wound healing|wound healing
94654|NCT02975024|microcirculation|microcirculation
94655|NCT02975024|Laser Speckle Contrast Imager|laser speckle contrast imager
94656|NCT02975024|Mucograft|mucograft
94657|NCT02975024|strip gingival graft|strip gingival graft
94658|NCT02975011|Magnetic Resonance Imaging|magnetic resonance imaging
94659|NCT02975011|Patient Satisfaction|patient satisfaction
94660|NCT02975011|Numeric Rating Scale|numeric rating scale
94661|NCT02974998|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
94662|NCT02974998|HIV Testing and Counseling (HTC)|hiv testing and counseling (htc)
94663|NCT02974998|Sexually Transmitted Infections (STIs)|sexually transmitted infections (stis)
94664|NCT02974998|Substance Abuse|substance abuse
94665|NCT02974998|Gender Based Violence|gender based violence
94666|NCT02974998|Gang Violence|gang violence
94667|NCT02974998|Victimization|victimization
94668|NCT02974998|Linkage to Care|linkage to care
94669|NCT02974998|Sexual Risk|sexual risk
94670|NCT02974998|Out-of-school Adolescents|out-of-school adolescents
94671|NCT02974998|Young Women|young women
94672|NCT02974985|Facelift|facelift
94673|NCT02974985|HA Filler|ha filler
94674|NCT02974985|Hyaluronic acid|hyaluronic acid
94675|NCT02974985|Facial Rejuvenation|facial rejuvenation
94676|NCT02974985|Aging Face|aging face
94677|NCT02974985|WIZDOM|wizdom
94678|NCT02974985|Midface lift|midface lift
94679|NCT02974985|Midface augmentation|midface augmentation
94680|NCT02974933|apatinib|apatinib
94681|NCT02974933|pemetrexed|pemetrexed
94682|NCT02974933|NSCLC|nsclc
94683|NCT02974907|Dry Eye Syndrome|dry eye syndrome
94684|NCT02974907|Dry Eye|dry eye
94685|NCT02974907|DES|des
94686|NCT02974868|Phase 2|phase 2
94687|NCT02974868|randomized|randomized
94688|NCT02974868|double-blind|double-blind
94689|NCT02974868|placebo|placebo
94690|NCT02974868|alopecia areata|alopecia areata
94691|NCT02974868|safety|safety
94692|NCT02974868|efficacy|efficacy
94693|NCT02974868|JAK|jak
94694|NCT02974868|janus kinase|janus kinase
94695|NCT02974868|moderate|moderate
94696|NCT02974868|severe|severe
94697|NCT02974855|hemophilia|hemophilia
94698|NCT02974829|Chronic Hepatitis B|chronic hepatitis b
94699|NCT02974816|Glooko|glooko
94700|NCT02974816|Mobile health application|mobile health application
94701|NCT02974816|Insulin treated|insulin treated
94702|NCT02974816|Type 2 Diabetes|type 2 diabetes
94703|NCT02974816|Remote patient monitoring|remote patient monitoring
94704|NCT02974816|Certified diabetes educator|certified diabetes educator
94705|NCT02974816|mHealth Advantage|mhealth advantage
94706|NCT02974816|Population health|population health
94707|NCT02974790|echocardiography|echocardiography
94708|NCT02974790|training|training
94709|NCT02974790|emergency department|emergency department
94710|NCT02974790|circulatory failure|circulatory failure
94711|NCT02974751|Aquablation|aquablation
94712|NCT02974751|AQUABEAM|aquabeam
94713|NCT02974751|BPH|bph
94714|NCT02974751|LUTS|luts
94715|NCT02974725|NSCLC|nsclc
94716|NCT02974725|KRAS|kras
94717|NCT02974725|BRAF|braf
94718|NCT02974725|LXH254|lxh254
94719|NCT02974725|LTT462|ltt462
94720|NCT02974725|Trametinib|trametinib
94721|NCT02974725|Non-small cell lung carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
94722|NCT02974725|treatment of lung cancer after first metastasis|treatment of lung cancer after first metastasis
94723|NCT02974725|lung cancer|lung cancer
94724|NCT02974725|lung adenocarcinoma|lung adenocarcinoma
94725|NCT02974725|Large-cell lung carcinoma|large-cell lung carcinoma
94726|NCT02974725|Non small cell lung carcinoma|non small cell lung carcinoma
94727|NCT02974725|Non small cell lung cancer|non small cell lung cancer
94728|NCT02974725|Large cell lung carcinoma|large cell lung carcinoma
94729|NCT02974725|Large cell lung cancer|large cell lung cancer
94730|NCT02974725|squamous cell lung carcinoma|squamous cell lung carcinoma
94731|NCT02974712|Arterial blood gases|arterial blood gases
94732|NCT02974712|MAP|map
94733|NCT02974712|HR|hr
94734|NCT02974673|Spinal Cord Injury|spinal cord injury
94735|NCT02974673|Genito sexuals disorders|genito sexuals disorders
94736|NCT02974673|Ejaculatory test|ejaculatory test
94737|NCT02974647|Ruxolitinib|ruxolitinib
94738|NCT02974647|T or NK Cell|t or nk cell
94739|NCT02974647|Relapsed|relapsed
94740|NCT02974647|Refractory|refractory
94741|NCT02974634|Ileostomy|ileostomy
94742|NCT02974608|Placental|placental
94743|NCT02974608|Fetal Loss|fetal loss
94744|NCT02974608|Observational|observational
94745|NCT02974608|Antenatal|antenatal
94746|NCT02974608|Infection|infection
94747|NCT02974608|Malaria|malaria
94748|NCT02974595|Autoinflammation|autoinflammation
94749|NCT02974595|Pediatric Syndromes|pediatric syndromes
94750|NCT02974595|Immune Dysregulation|immune dysregulation
94751|NCT02974595|IL-1 Mediated Diseases|il-1 mediated diseases
94752|NCT02974595|Interferonopathies|interferonopathies
94753|NCT02974582|Marketing|marketing
94754|NCT02974582|Smoking|smoking
94755|NCT02974582|Cigarette|cigarette
94756|NCT02974582|Young Adult|young adult
94757|NCT02974582|Socioeconomic Status|socioeconomic status
94758|NCT02974569|adolescents|adolescents
94759|NCT02974569|young adults|young adults
94760|NCT02974543|tinnitus|tinnitus
94761|NCT02974517|time-lapes|time-lapes
94762|NCT02974517|IVF/ICSI|ivf/icsi
94763|NCT02974517|pregnancy outcome|pregnancy outcome
94764|NCT02974491|hemodialysis|hemodialysis
94765|NCT02974491|diabetes mellitus|diabetes mellitus
94766|NCT02974491|apple juice|apple juice
94767|NCT02974491|potassium|potassium
94768|NCT02974478|orange juice consumption|orange juice consumption
94769|NCT02974478|glucose homeostasis|glucose homeostasis
94770|NCT02974478|antioxidative status|antioxidative status
94771|NCT02974465|Brain injuries|brain injuries
94772|NCT02974465|upper extremity|upper extremity
94773|NCT02974465|biofeedback|biofeedback
94774|NCT02974465|electromyography|electromyography
94775|NCT02974465|recovery of function|recovery of function
94776|NCT02974400|internet-based intervention|internet-based intervention
94777|NCT02974400|e-mental health|e-mental health
94778|NCT02974400|cognitive behavioural intervention|cognitive behavioural intervention
94779|NCT02974322|Crohn's Disease|crohn's disease
94780|NCT02974322|GED-0301|ged-0301
94781|NCT02974322|Mongersen|mongersen
94782|NCT02974322|Adolescent|adolescent
94783|NCT02974322|Pediatric|pediatric
94784|NCT02974322|Children|children
94785|NCT02974309|Youth|youth
94786|NCT02974309|Diabetes Management|diabetes management
94787|NCT02974309|Sleep|sleep
94788|NCT02974283|Normobaric hyperoxia|normobaric hyperoxia
94789|NCT02974283|r-tPA thrombolytic therapy|r-tpa thrombolytic therapy
94790|NCT02974257|cardiac arrest|cardiac arrest
94791|NCT02974257|thiamine|thiamine
94792|NCT02974257|oxygen consumption|oxygen consumption
94793|NCT02974257|lactate|lactate
94794|NCT02974257|shock|shock
94795|NCT02974244|Type 2 diabetes|type 2 diabetes
94796|NCT02974192|Ischemic stroke|ischemic stroke
94797|NCT02974192|Soluble CD40 Ligand|soluble cd40 ligand
94798|NCT02974192|Neopetrin|neopetrin
94799|NCT02974192|stroke risk factors|stroke risk factors
94800|NCT02974192|functional outcome|functional outcome
94801|NCT02974166|Temporomandibular Disorder|temporomandibular disorder
94802|NCT02974166|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
94803|NCT02974166|Rigid Splint|rigid splint
94804|NCT02974166|Speech Therapy|speech therapy
94805|NCT02974127|intracranial benign meningioma|intracranial benign meningioma
94806|NCT02974127|radiosurgery|radiosurgery
94807|NCT02974127|large meningioma|large meningioma
94808|NCT02974127|critical site|critical site
94809|NCT02974127|multisession radiosurgery|multisession radiosurgery
94810|NCT02974101|Spinal cord stimulation|spinal cord stimulation
94811|NCT02974101|AdaptiveStim|adaptivestim
94812|NCT02974062|Position sense|position sense
94813|NCT02974062|Lumbar stabilization exercise|lumbar stabilization exercise
94814|NCT02974049|Ivermectin|ivermectin
94815|NCT02974049|Albendazole|albendazole
94816|NCT02974049|Diethylcarbamazine|diethylcarbamazine
94817|NCT02974036|Patient education|patient education
94818|NCT02974036|Osteoarthritis|osteoarthritis
94819|NCT02974036|Primary health care|primary health care
94820|NCT02974010|d-cycloserine|d-cycloserine
94821|NCT02974010|lurasidone|lurasidone
94822|NCT02974010|ketamine|ketamine
94823|NCT02974010|randomized controlled trial|randomized controlled trial
94824|NCT02973984|Anticoagulant Treatments|anticoagulant treatments
94825|NCT02973984|Multidimensional Prognostic Index (MPI)|multidimensional prognostic index (mpi)
94826|NCT02973984|Comprehensive Geriatric Assessment (CGA)|comprehensive geriatric assessment (cga)
94827|NCT02973984|Frailty|frailty
94828|NCT02973984|Elderly|elderly
94829|NCT02973984|Atrial Fibrillation|atrial fibrillation
94830|NCT02973971|Blood cell biomarkers, peripheral circulating biomarkers|blood cell biomarkers, peripheral circulating biomarkers
94831|NCT02973958|Penis|penis
94832|NCT02973958|Pain|pain
94833|NCT02973958|Ketorolac|ketorolac
94834|NCT02973958|Circumcision|circumcision
94835|NCT02973945|Pulmonary Rehabilitation|pulmonary rehabilitation
94836|NCT02973945|High Flow Nasal Cannula|high flow nasal cannula
94837|NCT02973945|The Venturi Mask|the venturi mask
94838|NCT02973945|Exercise capacity|exercise capacity
94839|NCT02973945|Aerobic capacity|aerobic capacity
94840|NCT02973945|HFNC|hfnc
94841|NCT02973932|cognitive-behavioral psychotherapy|cognitive-behavioral psychotherapy
94842|NCT02973932|obsessive-compulsive disorder|obsessive-compulsive disorder
94843|NCT02973932|internet-based|internet-based
94844|NCT02973893|Chronic Venous Leg Ulcer|chronic venous leg ulcer
94845|NCT02973880|Steroid/antibiotic associated treatment|steroid/antibiotic associated treatment
94846|NCT02973880|Phaco-emulsification|phaco-emulsification
94847|NCT02973880|Cataract extraction|cataract extraction
94848|NCT02973867|Bone mineral density|bone mineral density
94849|NCT02973867|Myokines|myokines
94850|NCT02973867|Adipokines|adipokines
94851|NCT02973815|family meals|family meals
94852|NCT02973815|home food availability|home food availability
94853|NCT02973802|Graves Disease|graves disease
94854|NCT02973802|Phase 1|phase 1
94855|NCT02973789|Non-Small Cell Lung Cancer|non-small cell lung cancer
94856|NCT02973789|NSCLC|nsclc
94857|NCT02973789|Treatment|treatment
94858|NCT02973789|Minimal Toxicity|minimal toxicity
94859|NCT02973789|TTFields|ttfields
94860|NCT02973789|TTF|ttf
94861|NCT02973789|Tumor Treating Fields|tumor treating fields
94862|NCT02973789|Novocure|novocure
94863|NCT02973789|Docetaxel|docetaxel
94864|NCT02973789|PD-1 inhibitor|pd-1 inhibitor
94865|NCT02973789|PD-L1 inhibitor|pd-l1 inhibitor
94866|NCT02973789|Immune checkpoint inhibitor|immune checkpoint inhibitor
94867|NCT02973750|high-grade serous cancer|high-grade serous cancer
94868|NCT02973750|stage III cancer|stage iii cancer
94869|NCT02973750|stage IV cancer|stage iv cancer
94870|NCT02973724|Extubation|extubation
94871|NCT02973724|Remifentanil|remifentanil
94872|NCT02973724|Laryngomicrosurgery|laryngomicrosurgery
94873|NCT02973685|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
94874|NCT02973685|Transarterial Chemoembolization|transarterial chemoembolization
94875|NCT02973685|BCLC A/B|bclc a/b
94876|NCT02973672|Fluorescence|fluorescence
94877|NCT02973672|Surgery|surgery
94878|NCT02973672|Cancer|cancer
94879|NCT02973672|SGM-101|sgm-101
94880|NCT02973672|Near Infrared|near infrared
94881|NCT02973672|Immunophotodetection|immunophotodetection
94882|NCT02973646|chronic hepatitis b|chronic hepatitis b
94883|NCT02973646|peginterferon alfa-2b|peginterferon alfa-2b
94884|NCT02973646|interferon gene mutation|interferon gene mutation
94885|NCT02973646|interferon receptor|interferon receptor
94886|NCT02973633|Heart Failure|heart failure
94887|NCT02973633|Remodeling|remodeling
94888|NCT02973633|Myocardial Infarction|myocardial infarction
94889|NCT02973633|Left Ventricular Hypertrophy|left ventricular hypertrophy
94890|NCT02973633|Diffusion Tensor MRI|diffusion tensor mri
94891|NCT02973594|left ventricular reverse remodeling|left ventricular reverse remodeling
94892|NCT02973594|beta-1 adrenergic receptor signaling|beta-1 adrenergic receptor signaling
94893|NCT02973594|idiopathic dilated cardiomyopathy|idiopathic dilated cardiomyopathy
94894|NCT02973594|HCN4 inhibition|hcn4 inhibition
94895|NCT02973594|beta-1 adrenergic receptor blocker|beta-1 adrenergic receptor blocker
94896|NCT02973594|gene expression|gene expression
94897|NCT02973581|Surgical Pleth Index (SPI)|surgical pleth index (spi)
94898|NCT02973581|General Anaesthesia (GA),|general anaesthesia (ga),
94899|NCT02973581|Numerical Rating Scale (NRS)|numerical rating scale (nrs)
94900|NCT02973581|Adequacy of Anaesthesia (AoA)|adequacy of anaesthesia (aoa)
94901|NCT02973581|Peribulbar Block (PBB)|peribulbar block (pbb)
94902|NCT02973581|Topical Analgesia (TA)|topical analgesia (ta)
94903|NCT02973581|Oculocardiac reflex (OCR)|oculocardiac reflex (ocr)
94904|NCT02973581|Postoperative nausea nad vomiting (PONV)|postoperative nausea nad vomiting (ponv)
94905|NCT02973581|paracetamol|paracetamol
94906|NCT02973581|metamizol|metamizol
94908|NCT02973542|Ethosuximide|ethosuximide
94909|NCT02973542|Pain|pain
94910|NCT02973529|Percutaneous intervention (PCI)|percutaneous intervention (pci)
94911|NCT02973529|Optical coherence tomography (OCT)|optical coherence tomography (oct)
94912|NCT02973529|Bifurcation lesion|bifurcation lesion
94913|NCT02973529|Bioresorbable stents (BRS)|bioresorbable stents (brs)
94914|NCT02973503|Hepatitis C|hepatitis c
94915|NCT02973503|Genotype 1B|genotype 1b
94916|NCT02973503|Non Severe Fibrosis|non severe fibrosis
94917|NCT02973503|Treatment Naïve|treatment naïve
94918|NCT02973503|8 Weeks of Treatment|8 weeks of treatment
94919|NCT02973503|Elbasvir/Grazoprevir Combination|elbasvir/grazoprevir combination
94920|NCT02973490|ESD;Transanal Tube Drainage;Colorectal Tumor|esd;transanal tube drainage;colorectal tumor
94921|NCT02973438|Spinal Cord Injuries|spinal cord injuries
94922|NCT02973438|Obesity|obesity
94923|NCT02973438|Insulin Resistance|insulin resistance
94924|NCT02973438|Intermittent hypoxia|intermittent hypoxia
94925|NCT02973425|mHealth, Smoking cessation,|mhealth, smoking cessation,
94926|NCT02973399|CLL|cll
95027|NCT02972684|Cardiopulmonary Bypass|cardiopulmonary bypass
94927|NCT02973399|Leukemia, Chronic Lymphocytic|leukemia, chronic lymphocytic
94928|NCT02973399|Hsp90|hsp90
94929|NCT02973399|Ibrutinib|ibrutinib
94930|NCT02973386|Local advanced|local advanced
94931|NCT02973386|High Risk|high risk
94932|NCT02973386|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
94933|NCT02973373|MRI|mri
94934|NCT02973373|Chest|chest
94935|NCT02973373|Apnea|apnea
94936|NCT02973347|Enteral Feeding|enteral feeding
94937|NCT02973347|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
94938|NCT02973347|Mechanical Ventilation|mechanical ventilation
94939|NCT02973347|Pediatric Intensive Care Unit|pediatric intensive care unit
94940|NCT02973347|Critical Illness|critical illness
94941|NCT02973334|sweeteners|sweeteners
94942|NCT02973334|sugar|sugar
94943|NCT02973334|stress response|stress response
94944|NCT02973295|NAFLD;|nafld;
94945|NCT02973295|Fibroscan|fibroscan
94946|NCT02973295|Silymarin|silymarin
94947|NCT02973256|Meningioma grade II|meningioma grade ii
94948|NCT02973256|Meningioma grade III|meningioma grade iii
94949|NCT02973243|early warning scoring|early warning scoring
94950|NCT02973243|respiration rate|respiration rate
94951|NCT02973243|acute care teams|acute care teams
94952|NCT02973243|NEWS|news
94953|NCT02973243|CREWS|crews
94954|NCT02973230|Pregnancy, Ectopic|pregnancy, ectopic
94955|NCT02973230|Vascular Endothelial Growth Factor A|vascular endothelial growth factor a
94956|NCT02973230|Pregnancy, Tubal|pregnancy, tubal
94957|NCT02973217|Hyperthermia, Induced|hyperthermia, induced
94958|NCT02973217|Laser Coagulation|laser coagulation
94959|NCT02973217|Laser Therapy|laser therapy
94960|NCT02973204|tumor DNA|tumor dna
94961|NCT02973204|circulating tumor cells|circulating tumor cells
94962|NCT02973204|biopsy|biopsy
94963|NCT02973191|Leukemia|leukemia
94964|NCT02973191|B-Cell Acute Lymphoblastic Leukemia|b-cell acute lymphoblastic leukemia
94965|NCT02973191|JCAR015|jcar015
94966|NCT02973152|Type I Thyroplasty|type i thyroplasty
94967|NCT02973152|Reinnervation|reinnervation
94968|NCT02973113|Nivolumab|nivolumab
94969|NCT02973113|Hodgkin Lymphoma|hodgkin lymphoma
94970|NCT02973113|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
94971|NCT02973113|Lymphoproliferative Disorders|lymphoproliferative disorders
94972|NCT02973113|EBV-specific T Cells|ebv-specific t cells
94973|NCT02973074|iron deficiency|iron deficiency
94974|NCT02973074|patient blood management|patient blood management
94975|NCT02973074|anemia|anemia
94976|NCT02973048|Cesarean delivery|cesarean delivery
94977|NCT02973048|Spinal anesthesia|spinal anesthesia
94978|NCT02973048|Local anesthetics|local anesthetics
94979|NCT02973009|The Sleeve Gastrectomy (SG)|the sleeve gastrectomy (sg)
94980|NCT02973009|bariatric surgery|bariatric surgery
94981|NCT02973009|laparoscopy|laparoscopy
94982|NCT02973009|systematic closure of the epigastric|systematic closure of the epigastric
94983|NCT02972983|Staphylococcus aureus|staphylococcus aureus
94984|NCT02972983|Bacteremia|bacteremia
94985|NCT02972983|Daptomycin|daptomycin
94986|NCT02972957|intranasal|intranasal
94987|NCT02972957|flu vaccine|flu vaccine
94988|NCT02972957|Gambian children|gambian children
94989|NCT02972931|HIV infection|hiv infection
94990|NCT02972931|low HIV reservoir|low hiv reservoir
94991|NCT02972931|functional cure|functional cure
94992|NCT02972905|pharmacokinetics|pharmacokinetics
94993|NCT02972905|GSK2269557|gsk2269557
94994|NCT02972905|Dry powder Inhaler (DPI)|dry powder inhaler (dpi)
94995|NCT02972905|tolerability|tolerability
94996|NCT02972905|safety|safety
94997|NCT02972905|ELLIPTA|ellipta
94998|NCT02972879|trigger finger|trigger finger
94999|NCT02972879|Therapeutic Modalities|therapeutic modalities
95000|NCT02972879|Corticosteroid Injection|corticosteroid injection
95001|NCT02972879|non-surgical treatment|non-surgical treatment
95002|NCT02972879|physical therapy|physical therapy
95003|NCT02972840|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
95004|NCT02972840|Btk|btk
95005|NCT02972840|ACP-196|acp-196
95006|NCT02972840|Mantle Cell Lymphoma|mantle cell lymphoma
95007|NCT02972840|acalabrutinib|acalabrutinib
95008|NCT02972840|ACE-LY-308|ace-ly-308
95009|NCT02972840|Treatment naive|treatment naive
95010|NCT02972840|Lymphoma|lymphoma
95011|NCT02972840|non-Hodgkins|non-hodgkins
95012|NCT02972814|Troponin|troponin
95013|NCT02972814|Point of care test|point of care test
95014|NCT02972814|myocardial infarction|myocardial infarction
95015|NCT02972801|Spermatogonial stem cells|spermatogonial stem cells
95016|NCT02972801|Testis|testis
95017|NCT02972801|Fertility|fertility
95018|NCT02972801|Infertility|infertility
95019|NCT02972801|Oncofertility|oncofertility
95020|NCT02972762|depth of anesthesia\postoperation delirium|depth of anesthesia\postoperation delirium
95021|NCT02972736|Radiation dose|radiation dose
95022|NCT02972736|percutaneous coronary intervention|percutaneous coronary intervention
95023|NCT02972736|Coronary|coronary
95024|NCT02972736|Interventional radiology|interventional radiology
95025|NCT02972736|Electrophysiology|electrophysiology
95026|NCT02972723|Metformin Therapy in HCV|metformin therapy in hcv
95028|NCT02972684|Hemorrhage|hemorrhage
95029|NCT02972684|blood transfusion|blood transfusion
95030|NCT02972684|Point-of-care test|point-of-care test
95031|NCT02972684|health economics|health economics
95032|NCT02972671|MiStent|mistent
95033|NCT02972658|Alzheimer's Disease|alzheimer's disease
95034|NCT02972658|Dementia|dementia
95035|NCT02972658|Brain Diseases|brain diseases
95036|NCT02972658|Neurodegenerative Diseases|neurodegenerative diseases
95037|NCT02972658|Central Nervous System Diseases|central nervous system diseases
95038|NCT02972658|Nervous System Diseases|nervous system diseases
95039|NCT02972658|Mental Disorders|mental disorders
95040|NCT02972658|Delirium, Dementia, Amnestic, Cognitive Disorders|delirium, dementia, amnestic, cognitive disorders
95041|NCT02972658|Tauopathies|tauopathies
95042|NCT02972658|Memory|memory
95043|NCT02972658|Amyloid|amyloid
95044|NCT02972632|Drug Therapy|drug therapy
95045|NCT02972619|Blood Pressure|blood pressure
95046|NCT02972619|Lipids|lipids
95047|NCT02972619|Cardiovascular|cardiovascular
95048|NCT02972619|Health Services|health services
95049|NCT02972619|Hypertension|hypertension
95050|NCT02972606|HIV|hiv
95051|NCT02972606|Peripheral Neuropathy|peripheral neuropathy
95052|NCT02972606|Chronic Pain|chronic pain
95053|NCT02972606|Qualitative Research|qualitative research
95054|NCT02972567|probiotics|probiotics
95055|NCT02972567|metabolic syndrome|metabolic syndrome
95056|NCT02972567|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
95057|NCT02972528|DFU|dfu
95058|NCT02972528|Diabetic Foot Ulcer|diabetic foot ulcer
95059|NCT02972528|Diabetes|diabetes
95060|NCT02972528|Platelet Rich Plasma|platelet rich plasma
95061|NCT02972515|Smoking|smoking
95062|NCT02972515|Smoking cessation|smoking cessation
95063|NCT02972515|Multiple behaviors|multiple behaviors
95064|NCT02972515|mHealth|mhealth
95065|NCT02972515|Mobile Application|mobile application
95066|NCT02972502|Metoclopramide (Reglan)|metoclopramide (reglan)
95067|NCT02972502|Haloperidol (Haldol)|haloperidol (haldol)
95068|NCT02972476|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
95069|NCT02972463|Gastrointestinal|gastrointestinal
95070|NCT02972463|Microbiome|microbiome
95071|NCT02972463|Inflammation|inflammation
95072|NCT02972437|GAS in oral cavity|gas in oral cavity
95073|NCT02972424|pelvic fracture|pelvic fracture
95074|NCT02972424|healing|healing
95075|NCT02972424|teriparatide|teriparatide
95076|NCT02972398|treatment resistant depression|treatment resistant depression
95077|NCT02972398|N-Acetyl Cysteine|n-acetyl cysteine
95078|NCT02972398|inflammation mediators|inflammation mediators
95079|NCT02972398|oxidative stress|oxidative stress
95080|NCT02972398|brain imaging|brain imaging
95081|NCT02972385|warfarin|warfarin
95082|NCT02972385|blood clotting|blood clotting
95083|NCT02972372|esophageal cancer|esophageal cancer
95084|NCT02972372|chemoradiation|chemoradiation
95085|NCT02972372|esophagectomy|esophagectomy
95086|NCT02972359|Neridronic Acid|neridronic acid
95087|NCT02972359|Neridronate|neridronate
95088|NCT02972359|CRPS|crps
95089|NCT02972359|RSD (reflex sympathetic dystrophy)|rsd (reflex sympathetic dystrophy)
95090|NCT02972294|iron isomaltoside|iron isomaltoside
95091|NCT02972294|tranexamic acid|tranexamic acid
95092|NCT02972203|Mindfulness|mindfulness
95093|NCT02972203|primary care|primary care
95094|NCT02972203|self-control|self-control
95095|NCT02972203|self-regulation|self-regulation
95096|NCT02972203|adherence|adherence
95097|NCT02972177|Lung cancer|lung cancer
95098|NCT02972177|Transbronchial ablation|transbronchial ablation
95099|NCT02972177|Radiofrequency ablation|radiofrequency ablation
95100|NCT02972177|Microwave ablation|microwave ablation
95101|NCT02972164|Childhood obesity|childhood obesity
95102|NCT02972164|Lifestyle|lifestyle
95103|NCT02972164|Prevention|prevention
95104|NCT02972164|Intervention|intervention
95105|NCT02972164|Behavioural psychology|behavioural psychology
95106|NCT02972138|Sickle-cells Disease|sickle-cells disease
95107|NCT02972138|bisphosphonates|bisphosphonates
95108|NCT02972138|Vitamine D|vitamine d
95109|NCT02972125|Lacosamide|lacosamide
95110|NCT02972125|Bioequivalence|bioequivalence
95111|NCT02972125|Dry Syrup|dry syrup
95112|NCT02972073|Low back pain|low back pain
95113|NCT02972073|Neuromuscular control|neuromuscular control
95114|NCT02972060|Hormone Naive Prostate Cancer|hormone naive prostate cancer
95115|NCT02972047|Reflux|reflux
95116|NCT02972021|respiratory insufficiency|respiratory insufficiency
95117|NCT02972021|High-flow nasal cannula|high-flow nasal cannula
95118|NCT02972008|Aortic stenosis|aortic stenosis
95119|NCT02972008|Transaortic valve replacement|transaortic valve replacement
95120|NCT02972008|stroke|stroke
95121|NCT02972008|Epigenetic|epigenetic
95122|NCT02971969|gene therapy|gene therapy
95123|NCT02971969|Hemophilia B|hemophilia b
95124|NCT02971956|Esophageal Cancer|esophageal cancer
95125|NCT02971917|Chest radiography|chest radiography
95126|NCT02971917|Image improvements|image improvements
95127|NCT02971917|Image Reconstruction|image reconstruction
95128|NCT02971917|Preprocessing|preprocessing
95129|NCT02971917|MTF|mtf
95130|NCT02971904|newborn|newborn
95131|NCT02971904|prematurity|prematurity
95132|NCT02971904|preterm|preterm
95133|NCT02971904|human milk|human milk
95134|NCT02971904|human milk analyzer|human milk analyzer
95135|NCT02971904|neonatology|neonatology
95136|NCT02971904|neonatal intensive care unit|neonatal intensive care unit
95137|NCT02971904|low birth weight|low birth weight
95138|NCT02971865|Cognitive Behavior Therapy|cognitive behavior therapy
95139|NCT02971865|Chiropractic|chiropractic
95140|NCT02971865|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
95141|NCT02971865|Primary care shared visit|primary care shared visit
95142|NCT02971852|Hypnosis|hypnosis
95143|NCT02971852|Anesthesia|anesthesia
95144|NCT02971852|Suggestion|suggestion
95145|NCT02971852|Thermography|thermography
95146|NCT02971826|Stroke|stroke
95147|NCT02971826|thrombectomy|thrombectomy
95148|NCT02971826|REVIVETM SE|revivetm se
95149|NCT02971826|MRI|mri
95150|NCT02971826|Computed Tomography|computed tomography
95151|NCT02971813|cardiac rehabilitation|cardiac rehabilitation
95152|NCT02971813|social media|social media
95153|NCT02971813|adherence|adherence
95154|NCT02971813|motivation|motivation
95155|NCT02971800|sodium fluorescein|sodium fluorescein
95156|NCT02971800|ureteral efflux|ureteral efflux
95157|NCT02971800|laparoscopic hysterectomy|laparoscopic hysterectomy
95158|NCT02971774|stroke|stroke
95159|NCT02971774|botulinum toxin injection|botulinum toxin injection
95160|NCT02971774|daily life|daily life
95161|NCT02971748|hormone receptor-positive localized inflammatory breast cancer|hormone receptor-positive localized inflammatory breast cancer
95162|NCT02971748|Hormonal therapy|hormonal therapy
95163|NCT02971748|IBC|ibc
95164|NCT02971748|standard adjuvant hormonal therapy|standard adjuvant hormonal therapy
95165|NCT02971748|maintenance therapy|maintenance therapy
95166|NCT02971748|immune related biomarkers|immune related biomarkers
95167|NCT02971748|PD-L1 expression|pd-l1 expression
95168|NCT02971748|HR positive|hr positive
95169|NCT02971748|HR-positive localized IBC|hr-positive localized ibc
95170|NCT02971735|cognitive style|cognitive style
95171|NCT02971735|e-learning|e-learning
95172|NCT02971735|mobile technology|mobile technology
95173|NCT02971735|randomized controlled trial|randomized controlled trial
95174|NCT02971735|otolaryngology-head and neck surgery|otolaryngology-head and neck surgery
95175|NCT02971722|GLP-1 receptor agonist|glp-1 receptor agonist
95176|NCT02971657|Staphylococcus aureus phenotypic characterization|staphylococcus aureus phenotypic characterization
95177|NCT02971657|Antibiotic resistance|antibiotic resistance
95178|NCT02971657|Orthopedic device related infections|orthopedic device related infections
95179|NCT02971657|Phenotypic characterization|phenotypic characterization
95180|NCT02971631|Dumping syndrome|dumping syndrome
95181|NCT02971631|Gastrectomy|gastrectomy
95182|NCT02971631|GLP-1|glp-1
95183|NCT02971631|Insulin|insulin
95184|NCT02971618|dapagliflozin,|dapagliflozin,
95185|NCT02971618|Russia,|russia,
95186|NCT02971618|retrospective study,|retrospective study,
95187|NCT02971618|diabetes mellitus type 2|diabetes mellitus type 2
95188|NCT02971579|ERCP|ercp
95189|NCT02971579|biliary diseases|biliary diseases
95190|NCT02971579|Pancreatic diseases|pancreatic diseases
95191|NCT02971579|outcome|outcome
95192|NCT02971579|Quality|quality
95193|NCT02971579|Training|training
95194|NCT02971566|feeding intolerance|feeding intolerance
95195|NCT02971566|preterm infants|preterm infants
95196|NCT02971566|near infrared spectroscopy|near infrared spectroscopy
95197|NCT02971566|abnormal antenatal Doppler|abnormal antenatal doppler
95198|NCT02971540|Surgical Pleth Index (SPI)|surgical pleth index (spi)
95199|NCT02971540|General Anaesthesia (GA),|general anaesthesia (ga),
95200|NCT02971540|Numerical Rating Scale (NRS)|numerical rating scale (nrs)
95201|NCT02971540|Adequacy of Anaesthesia (AoA|adequacy of anaesthesia (aoa
95202|NCT02971540|Spectral Entropy (SE)|spectral entropy (se)
95203|NCT02971540|Local Anesthetic (LA)|local anesthetic (la)
95204|NCT02971488|Hepatitis C|hepatitis c
95205|NCT02971488|PWID|pwid
95206|NCT02971488|Linkage-to-care|linkage-to-care
95207|NCT02971475|Extracorporeal Shock Wave lithotripsy(ESWL)|extracorporeal shock wave lithotripsy(eswl)
95208|NCT02971475|Endoscopic Retrograde Cholangiopancreatography(ERCP)|endoscopic retrograde cholangiopancreatography(ercp)
95209|NCT02971475|chronic pancreatitis|chronic pancreatitis
95210|NCT02971475|pain relief|pain relief
95211|NCT02971462|stroke|stroke
95212|NCT02971462|Vertebrobasilar atherosclerosis|vertebrobasilar atherosclerosis
95213|NCT02971462|remote ischemic conditioning|remote ischemic conditioning
95214|NCT02971449|Village Healthcare Team|village healthcare team
95215|NCT02971449|mHealth|mhealth
95216|NCT02971449|Telemedicine|telemedicine
95217|NCT02971423|infection|infection
95218|NCT02971423|gram-negative bacterium|gram-negative bacterium
95219|NCT02971345|Hepatocellular carcinoma|hepatocellular carcinoma
95220|NCT02971345|main portal vein tumor thrombus|main portal vein tumor thrombus
95221|NCT02971345|endovascular brachytherapy|endovascular brachytherapy
95222|NCT02971345|stent|stent
95223|NCT02971345|chemoembolization|chemoembolization
95224|NCT02971306|alcoholic hepatitis|alcoholic hepatitis
95332|NCT02971059|Healthy|healthy
95225|NCT02971306|alcoholic liver disease|alcoholic liver disease
95226|NCT02971306|jaundice|jaundice
95227|NCT02971306|ascites|ascites
95228|NCT02971306|regeneration|regeneration
95229|NCT02971293|AZD8871|azd8871
95230|NCT02971293|long-acting muscarinic antagonist (LAMA)|long-acting muscarinic antagonist (lama)
95231|NCT02971293|long-acting β2-agonist (LABA)|long-acting β2-agonist (laba)
95232|NCT02971293|inhaled long-acting bronchodilator|inhaled long-acting bronchodilator
95233|NCT02971293|pharmacokinetics|pharmacokinetics
95234|NCT02971293|safety|safety
95235|NCT02971293|tolerability|tolerability
95236|NCT02971293|efficacy|efficacy
95237|NCT02971293|Phase IIa|phase iia
95238|NCT02971293|Muscarinic receptor antagonist β2 adrenoceptor agonist (MABA)|muscarinic receptor antagonist β2 adrenoceptor agonist (maba)
95239|NCT02971267|heart failure|heart failure
95240|NCT02971267|cardiomyopathy|cardiomyopathy
95241|NCT02971267|myocarditis|myocarditis
95242|NCT02971254|cognitive functions|cognitive functions
95243|NCT02971254|anaesthesia recovery|anaesthesia recovery
95244|NCT02971254|sevoflurane|sevoflurane
95245|NCT02971254|desflurane|desflurane
95246|NCT02971241|Integeneration|integeneration
95247|NCT02971241|Mobile technology|mobile technology
95248|NCT02971241|Chronic disease management|chronic disease management
95249|NCT02971241|Diabetes self-management|diabetes self-management
95250|NCT02971228|glucagon|glucagon
95251|NCT02971228|T1DM|t1dm
95252|NCT02971228|Bionic Pancreas|bionic pancreas
95253|NCT02971228|diabetes|diabetes
95254|NCT02971228|iLet|ilet
95255|NCT02971228|iPhone|iphone
95256|NCT02971228|Beta Bionics|beta bionics
95257|NCT02971228|Anti-hypoglycemia|anti-hypoglycemia
95258|NCT02971228|Glucagon Analog|glucagon analog
95259|NCT02971202|o-glcnacylation|o-glcnacylation
95260|NCT02971202|hexosamine|hexosamine
95261|NCT02971163|Syncope|syncope
95262|NCT02971163|Shared Decision-Making|shared decision-making
95263|NCT02971163|Emergency Medicine|emergency medicine
95264|NCT02971163|Decision Aid|decision aid
95265|NCT02971137|Smoking|smoking
95266|NCT02971137|Cigarette Smoking|cigarette smoking
95267|NCT02971137|Veterans|veterans
95268|NCT02971137|Tobacco Use|tobacco use
95269|NCT02971137|Pain|pain
95270|NCT02971124|Cognitive Performance|cognitive performance
95271|NCT02971124|Meaningful Play|meaningful play
95272|NCT02971124|Screening test|screening test
95273|NCT02971124|Dementia|dementia
95274|NCT02971085|low-risk prostate cancer|low-risk prostate cancer
95275|NCT02971085|active surveillance|active surveillance
95276|NCT02971085|pathologic reclassification|pathologic reclassification
95277|NCT02971072|address|address
95278|NCT02971072|atrophic|atrophic
95279|NCT02971072|base|base
95280|NCT02971072|clinical|clinical
95281|NCT02971072|cost|cost
95282|NCT02971072|data|data
95283|NCT02971072|disability|disability
95284|NCT02971072|effectiveness|effectiveness
95285|NCT02971072|attention|attention
95286|NCT02971072|biofeedback|biofeedback
95287|NCT02971072|electrical stimulation|electrical stimulation
95288|NCT02971072|electromyography|electromyography
95289|NCT02971072|exercise|exercise
95290|NCT02971072|exertion|exertion
95291|NCT02971072|health care service utilization|health care service utilization
95292|NCT02971072|improved|improved
95293|NCT02971072|injection of therapeutic agent|injection of therapeutic agent
95294|NCT02971072|innovation|innovation
95295|NCT02971072|intervention|intervention
95296|NCT02971072|knowledge|knowledge
95297|NCT02971072|local anesthetics|local anesthetics
95298|NCT02971072|measures|measures
95299|NCT02971072|modeling|modeling
95300|NCT02971072|motor|motor
95301|NCT02971072|motor control|motor control
95302|NCT02971072|muscle|muscle
95303|NCT02971072|neuroadaptation|neuroadaptation
95304|NCT02971072|neurophysiology|neurophysiology
95305|NCT02971072|novel|novel
95306|NCT02971072|outcome|outcome
95307|NCT02971072|outcome measure|outcome measure
95308|NCT02971072|pain inhibition|pain inhibition
95309|NCT02971072|patients|patients
95310|NCT02971072|pattern|pattern
95311|NCT02971072|programs|programs
95312|NCT02971072|public health relevance|public health relevance
95313|NCT02971072|rehabilitation strategy|rehabilitation strategy
95314|NCT02971072|relating to nervous system|relating to nervous system
95315|NCT02971072|reporting|reporting
95316|NCT02971072|research|research
95317|NCT02971072|rotator cuff|rotator cuff
95318|NCT02971072|shoulder|shoulder
95319|NCT02971072|staging|staging
95320|NCT02971072|strength training|strength training
95321|NCT02971072|success|success
95322|NCT02971072|systematic review|systematic review
95323|NCT02971072|techniques|techniques
95324|NCT02971072|testing|testing
95325|NCT02971072|time|time
95326|NCT02971072|training|training
95327|NCT02971072|treatment strategy|treatment strategy
95328|NCT02971072|United States|united states
95329|NCT02971072|work|work
95330|NCT02971059|Elderly|elderly
95331|NCT02971059|Phenylalanine|phenylalanine
95333|NCT02971046|healthy children|healthy children
95334|NCT02971046|protein|protein
95335|NCT02971046|glutathione|glutathione
95336|NCT02971046|protein requirement|protein requirement
95337|NCT02971033|hepatitis C virus|hepatitis c virus
95338|NCT02971033|antiviral treatment|antiviral treatment
95339|NCT02971033|viral entry inhibitor|viral entry inhibitor
95340|NCT02971033|mathematical modeling|mathematical modeling
95341|NCT02970994|Linear growth and neurodevelopment outcome|linear growth and neurodevelopment outcome
95342|NCT02970994|< 34 weeks|< 34 weeks
95343|NCT02970981|Monoclonal antibody|monoclonal antibody
95344|NCT02970981|Programmed Death-1 (PD-1)|programmed death-1 (pd-1)
95345|NCT02970981|Programmed Death-Ligand 1 (PD-L1)|programmed death-ligand 1 (pd-l1)
95346|NCT02970981|Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4)|cytotoxic t lymphocyte-associated antigen 4 (ctla-4)
95347|NCT02970981|Antigen|antigen
95348|NCT02970929|Schizophrenia|schizophrenia
95349|NCT02970916|metastatic colorectal cancer|metastatic colorectal cancer
95350|NCT02970916|FOLFIRI|folfiri
95351|NCT02970916|aflibercept|aflibercept
95352|NCT02970916|oxaliplatin|oxaliplatin
95353|NCT02970916|ACE polymorphisms|ace polymorphisms
95354|NCT02970890|Total Hip Arthroplasty (THA)|total hip arthroplasty (tha)
95355|NCT02970890|Phototherapy|phototherapy
95356|NCT02970890|Low-level laser therapy|low-level laser therapy
95357|NCT02970890|Light-emitting diodes|light-emitting diodes
95358|NCT02970877|Fecal microbiota transplant|fecal microbiota transplant
95359|NCT02970877|Intestinal microbiome|intestinal microbiome
95360|NCT02970877|Oral microbiome|oral microbiome
95361|NCT02970877|Mucosa associated microbiome|mucosa associated microbiome
95362|NCT02970877|Appetite|appetite
95363|NCT02970877|Metabolome|metabolome
95364|NCT02970877|Depression|depression
95365|NCT02970877|Anxiety|anxiety
95366|NCT02970864|Nerve regeneration|nerve regeneration
95367|NCT02970864|Peripheral nerve injury|peripheral nerve injury
95368|NCT02970864|Nerve conduits|nerve conduits
95369|NCT02970864|Sensory nerve transection|sensory nerve transection
95370|NCT02970851|Endothelin receptor antagonist (ERA)|endothelin receptor antagonist (era)
95371|NCT02970851|pulmonary artery hypertension (PAH),|pulmonary artery hypertension (pah),
95372|NCT02970851|18F-2-fluoro-2-deoxy-D-glucose (18F-FDG) Positron Emission Tomography/Computed Tomography (PET/CT)|18f-2-fluoro-2-deoxy-d-glucose (18f-fdg) positron emission tomography/computed tomography (pet/ct)
95373|NCT02970851|Rubidium-82 (82Rb) PET/CT|rubidium-82 (82rb) pet/ct
95374|NCT02970838|Formula diet|formula diet
95375|NCT02970825|exercise medicine|exercise medicine
95376|NCT02970825|youth|youth
95377|NCT02970825|adolescents|adolescents
95378|NCT02970825|students|students
95379|NCT02970721|bipolar disorder|bipolar disorder
95380|NCT02970721|adverse outcomes|adverse outcomes
95381|NCT02970721|readmission|readmission
95382|NCT02970721|polytherapy|polytherapy
95383|NCT02970695|insomnia|insomnia
95384|NCT02970695|older people|older people
95385|NCT02970695|auriculotherapy|auriculotherapy
95386|NCT02970669|Heart failure with reduced left ventricular ejection fraction (LVEF)|heart failure with reduced left ventricular ejection fraction (lvef)
95387|NCT02970669|Cardiac dysfunction|cardiac dysfunction
95388|NCT02970669|Heart muscle dysfunction|heart muscle dysfunction
95389|NCT02970669|Left ventricular (LV) dilation|left ventricular (lv) dilation
95390|NCT02970669|Left ventricular hypertrophy|left ventricular hypertrophy
95391|NCT02970669|HF|hf
95392|NCT02970669|AHF|ahf
95393|NCT02970669|CHF|chf
95394|NCT02970669|acute heart failure|acute heart failure
95395|NCT02970669|chronic heart failure|chronic heart failure
95396|NCT02970669|congestive heart failure|congestive heart failure
95397|NCT02970669|congestive cardiac failure|congestive cardiac failure
95398|NCT02970669|Heart failure|heart failure
95399|NCT02970669|HReEF|hreef
95400|NCT02970669|Physical Activity|physical activity
95401|NCT02970669|Actigraphy|actigraphy
95402|NCT02970669|Home sleep test|home sleep test
95403|NCT02970669|wake|wake
95404|NCT02970643|Olanzapine|olanzapine
95405|NCT02970643|Chemotherapy-Induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
95406|NCT02970643|Moderate risk|moderate risk
95407|NCT02970630|prophylaxis|prophylaxis
95408|NCT02970591|FODMAPS|fodmaps
95409|NCT02970591|carbohydrates|carbohydrates
95410|NCT02970591|metabolomics|metabolomics
95411|NCT02970591|microbiota|microbiota
95412|NCT02970565|Family Nurture Intervention|family nurture intervention
95413|NCT02970565|Martha G. Welch MD|martha g. welch md
95414|NCT02970565|Randomized Control Trial|randomized control trial
95415|NCT02970565|Pre-school Intervention|pre-school intervention
95416|NCT02970565|Preschool Intervention|preschool intervention
95417|NCT02970565|Multiple Family Group Intervention|multiple family group intervention
95418|NCT02970565|Emotional Connection|emotional connection
95419|NCT02970565|Co-regulation|co-regulation
95420|NCT02970552|PreTerm Birth|preterm birth
95421|NCT02970552|HIV|hiv
95422|NCT02970552|Vaginal Progesterone|vaginal progesterone
95423|NCT02970552|ART|art
95424|NCT02970526|Colorectal cancer survivors|colorectal cancer survivors
95425|NCT02970513|Escherichia coli|escherichia coli
95426|NCT02970513|Microbiota|microbiota
95427|NCT02970513|Colorectal cancer|colorectal cancer
95428|NCT02970513|Psychiatric disorders|psychiatric disorders
95429|NCT02970513|Personality traits|personality traits
95430|NCT02970500|Cognitive impairment|cognitive impairment
95431|NCT02970500|Methylphenidate|methylphenidate
95432|NCT02970500|Cancer-related cognitive impairment|cancer-related cognitive impairment
95433|NCT02970500|Mixed method|mixed method
95434|NCT02970500|Phase II study|phase ii study
95435|NCT02970500|Breast cancer|breast cancer
95436|NCT02970487|cataract|cataract
95437|NCT02970461|personal health record|personal health record
95438|NCT02970461|gamification|gamification
95439|NCT02970461|chronic patient care|chronic patient care
95440|NCT02970448|LITT|litt
95441|NCT02970448|Brain Tumor|brain tumor
95442|NCT02970448|Temozolomide|temozolomide
95443|NCT02970435|surgery|surgery
95444|NCT02970435|video discharge instructions|video discharge instructions
95445|NCT02970422|Survey|survey
95446|NCT02970422|Priorities|priorities
95447|NCT02970422|Activities|activities
95448|NCT02970422|Participation|participation
95449|NCT02970357|Evaluation|evaluation
95450|NCT02970357|Therapeutic education|therapeutic education
95451|NCT02970357|Type 1 Diabetes|type 1 diabetes
95452|NCT02970357|Children|children
95453|NCT02970344|Coping Skills Training|coping skills training
95454|NCT02970344|Diabetes Education|diabetes education
95455|NCT02970318|CLL|cll
95456|NCT02970318|BTK|btk
95457|NCT02970318|Bruton Tyrosine Kinase|bruton tyrosine kinase
95458|NCT02970318|acalabrutinib|acalabrutinib
95459|NCT02970318|ACP-196|acp-196
95460|NCT02970279|Behavioural activation|behavioural activation
95461|NCT02970279|Psychotherapy, group|psychotherapy, group
95462|NCT02970279|Depression|depression
95463|NCT02970279|Depressive disorder|depressive disorder
95464|NCT02970266|Leber Congenital Amaurosis|leber congenital amaurosis
95465|NCT02970266|Genetic Decryption|genetic decryption
95466|NCT02970266|The genotype-phenotype correlations|the genotype-phenotype correlations
95467|NCT02970266|Ethnicity families|ethnicity families
95468|NCT02970240|cardiopulmonary exercise testing|cardiopulmonary exercise testing
95469|NCT02970240|inflammation|inflammation
95470|NCT02970240|oxidative status|oxidative status
95471|NCT02970227|heart failure|heart failure
95472|NCT02970227|cardiomyopathies|cardiomyopathies
95473|NCT02970227|myocarditis|myocarditis
95474|NCT02970214|heart failure|heart failure
95475|NCT02970214|heart disease|heart disease
95476|NCT02970214|cardiovascular disease|cardiovascular disease
95477|NCT02970214|metabolic risk|metabolic risk
95478|NCT02970214|comorbidities|comorbidities
95479|NCT02970201|eHealth|ehealth
95480|NCT02970201|mHealth|mhealth
95481|NCT02970201|Hemodialysis|hemodialysis
95482|NCT02970201|Adherence|adherence
95483|NCT02970201|Electronic intervention|electronic intervention
95484|NCT02970201|ESRD|esrd
95485|NCT02970201|Nephrology|nephrology
95486|NCT02970188|time restricted feeding|time restricted feeding
95487|NCT02970188|endothelial function|endothelial function
95488|NCT02970188|arterial stiffness|arterial stiffness
95489|NCT02970188|intermittent fasting|intermittent fasting
95490|NCT02970175|Terlipressin|terlipressin
95491|NCT02970162|LEMS|lems
95492|NCT02970136|Increased Screening Uptake|increased screening uptake
95493|NCT02970136|Community Health Worker|community health worker
95494|NCT02970136|Medically Underserved|medically underserved
95495|NCT02970097|infraclavicular brachial plexus block|infraclavicular brachial plexus block
95496|NCT02970097|wrist arthroscopy|wrist arthroscopy
95497|NCT02970097|quality of recovery score|quality of recovery score
95498|NCT02970097|pain score|pain score
95499|NCT02970097|modified sleep quality assessment|modified sleep quality assessment
95500|NCT02970071|Spatio-Temporal Image Correlation|spatio-temporal image correlation
95501|NCT02970071|Complicated congenital heart disease|complicated congenital heart disease
95502|NCT02970071|Echocardiography|echocardiography
95503|NCT02970006|spinal cord stimulation|spinal cord stimulation
95504|NCT02970006|virtual reality|virtual reality
95505|NCT02970006|full body illusion|full body illusion
95506|NCT02969980|MDS|mds
95507|NCT02969980|AML progressed from MDS|aml progressed from mds
95508|NCT02969980|CMML|cmml
95509|NCT02969967|rehabilitation|rehabilitation
95510|NCT02969967|upper extremity|upper extremity
95511|NCT02969967|orthosis|orthosis
95512|NCT02969967|SaeboFlex|saeboflex
95513|NCT02969941|Parkinson Disease|parkinson disease
95514|NCT02969941|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
95515|NCT02969941|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
95516|NCT02969928|Full-mouth ultrasonic debridement|full-mouth ultrasonic debridement
95517|NCT02969928|Clarithromycin|clarithromycin
95518|NCT02969928|Amoxicillin|amoxicillin
95519|NCT02969928|Metronidazole|metronidazole
95520|NCT02969915|people who inject drugs|people who inject drugs
95521|NCT02969915|men who have sex with men|men who have sex with men
95522|NCT02969915|HIV|hiv
95523|NCT02969915|India|india
95524|NCT02969902|Procedural pain|procedural pain
95525|NCT02969902|Phlebotomy|phlebotomy
95526|NCT02969902|Distraction|distraction
95527|NCT02969902|Hand-held computer|hand-held computer
95528|NCT02969902|Children|children
95529|NCT02969889|Airtraq|airtraq
95530|NCT02969889|Intubating laryngeal mask airway|intubating laryngeal mask airway
95531|NCT02969889|BMI>35|bmi>35
95532|NCT02969863|bionic pancreas|bionic pancreas
95533|NCT02969850|vitamin D supplementation|vitamin d supplementation
95534|NCT02969850|calcium supplementation|calcium supplementation
95535|NCT02969837|Multiple Myeloma|multiple myeloma
95536|NCT02969837|Elotuzumab|elotuzumab
95537|NCT02969837|Carfilzomib (Kyprolis)|carfilzomib (kyprolis)
95538|NCT02969837|Lenalidomide (Revlimid)|lenalidomide (revlimid)
95539|NCT02969837|Dexamethasone (E-KRd)|dexamethasone (e-krd)
95540|NCT02969824|Sport Injury|sport injury
95541|NCT02969824|Concussion|concussion
95542|NCT02969824|Active Recovery|active recovery
95543|NCT02969785|Postural control|postural control
95544|NCT02969785|Physiotherapy|physiotherapy
95545|NCT02969785|Sports injuries|sports injuries
95546|NCT02969785|Low back pain|low back pain
95547|NCT02969785|training|training
95548|NCT02969759|Bioenergetics|bioenergetics
95549|NCT02969759|Protein Metabolism|protein metabolism
95550|NCT02969759|Sporadic Amyotrophic Lateral Sclerosis|sporadic amyotrophic lateral sclerosis
95551|NCT02969746|activated charcoal, direct oral anticoagulant|activated charcoal, direct oral anticoagulant
95552|NCT02969733|postoperative analgesia|postoperative analgesia
95553|NCT02969733|PainMatcher|painmatcher
95554|NCT02969707|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
95555|NCT02969707|functional MRI|functional mri
95556|NCT02969707|Fibromyalgia|fibromyalgia
95557|NCT02969707|Hypnosis|hypnosis
95558|NCT02969707|Pain Assessment|pain assessment
95559|NCT02969694|addiction|addiction
95560|NCT02969694|hypersexuality|hypersexuality
95561|NCT02969694|psychostimulants|psychostimulants
95562|NCT02969668|opioid substitution treatment|opioid substitution treatment
95563|NCT02969668|interferon-free direct acting antivirals|interferon-free direct acting antivirals
95564|NCT02969668|hepatitis c therapy|hepatitis c therapy
95565|NCT02969655|Safety|safety
95566|NCT02969655|Efficacy|efficacy
95567|NCT02969655|Daprodustat|daprodustat
95568|NCT02969655|Chronic kidney disease|chronic kidney disease
95569|NCT02969616|lumbar, fusion, DDD, Trinity Elite|lumbar, fusion, ddd, trinity elite
95570|NCT02969603|PET/MRI|pet/mri
95571|NCT02969603|muscular activity|muscular activity
95572|NCT02969603|11C-acetate|11c-acetate
95573|NCT02969590|Contraception|contraception
95574|NCT02969590|Mucus|mucus
95575|NCT02969590|Cervix|cervix
95576|NCT02969590|progestin|progestin
95577|NCT02969590|hormones|hormones
95578|NCT02969577|Androgen deprivation therapy|androgen deprivation therapy
95579|NCT02969577|ADT|adt
95580|NCT02969564|prostate cancer|prostate cancer
95581|NCT02969564|bone metastases|bone metastases
95582|NCT02969564|PET/MRI|pet/mri
95583|NCT02969525|Psoriatic Arthritis|psoriatic arthritis
95584|NCT02969525|PsA|psa
95585|NCT02969525|Bimekizumab|bimekizumab
95586|NCT02969512|Patient education|patient education
95587|NCT02969512|Advanced hip osteoarthritis|advanced hip osteoarthritis
95588|NCT02969512|Online education|online education
95589|NCT02969512|Computer-assisted instruction|computer-assisted instruction
95590|NCT02969512|e-learning|e-learning
95591|NCT02969512|Older adult|older adult
95592|NCT02969499|Electroconvulsive Therapy|electroconvulsive therapy
95593|NCT02969499|Dementia|dementia
95594|NCT02969473|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
95595|NCT02969473|concurrent chemoradiotherapy|concurrent chemoradiotherapy
95596|NCT02969473|docetaxel|docetaxel
95597|NCT02969473|cisplatin|cisplatin
95598|NCT02969473|5-fluorouracil|5-fluorouracil
95599|NCT02969447|Retained Placenta|retained placenta
95600|NCT02969447|Second trimester medical termination|second trimester medical termination
95601|NCT02969447|Third stage labor|third stage labor
95602|NCT02969447|Oxytocin|oxytocin
95603|NCT02969395|3T|3t
95604|NCT02969395|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
95605|NCT02969395|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
95606|NCT02969395|Implantable Pulse Generator (IPG)|implantable pulse generator (ipg)
95607|NCT02969395|Cardiac Resynchronization Therapy (CRT)|cardiac resynchronization therapy (crt)
95608|NCT02969395|Cardiac Implantable Electronic Device (CIED)|cardiac implantable electronic device (cied)
95609|NCT02969382|Schizophrenia|schizophrenia
95610|NCT02969369|Parkinson's Disease Psychosis|parkinson's disease psychosis
95611|NCT02969304|Tecfidera|tecfidera
95612|NCT02969304|Off-label|off-label
95613|NCT02969304|Utilization|utilization
95614|NCT02969278|vulvar cancer|vulvar cancer
95615|NCT02969278|sentinel node biopsy|sentinel node biopsy
95616|NCT02969278|inguino-femoral lymphadenectomy|inguino-femoral lymphadenectomy
95617|NCT02969278|18F FDG- PET/TC|18f fdg- pet/tc
95618|NCT02969278|guidelines|guidelines
95619|NCT02969278|preoperative imaging|preoperative imaging
95620|NCT02969265|Drug therapy|drug therapy
95621|NCT02969226|mechanical ventilation|mechanical ventilation
95622|NCT02969226|weaning|weaning
95623|NCT02969226|critically ill|critically ill
95624|NCT02969226|spontaneous breathing trial|spontaneous breathing trial
95625|NCT02969226|screening|screening
95626|NCT02969226|invasive ventilation|invasive ventilation
95627|NCT02969226|SBT technique|sbt technique
95628|NCT02969213|Electronic management of epilepsy|electronic management of epilepsy
95629|NCT02969213|biological etiology|biological etiology
95630|NCT02969213|Chinese children|chinese children
95631|NCT02969200|Fabry Disease|fabry disease
95632|NCT02969200|Nephropathy|nephropathy
95633|NCT02969200|Measured GFR|measured gfr
95634|NCT02969200|Enzyme replacement therapy|enzyme replacement therapy
95635|NCT02969161|PMTCT (Prevention of Mother-to-Child Transmission)|pmtct (prevention of mother-to-child transmission)
95636|NCT02969161|HIV (Human Immunodeficiency Virus)|hiv (human immunodeficiency virus)
95637|NCT02969161|Loss to follow-up (LTF)|loss to follow-up (ltf)
95638|NCT02969161|Option B+ (B+)|option b+ (b+)
95639|NCT02969161|ART (antiretroviral therapy)|art (antiretroviral therapy)
95640|NCT02969148|Laparoscopic|laparoscopic
95641|NCT02969148|Bursectomy|bursectomy
95642|NCT02969148|D2 lymphadenectomy|d2 lymphadenectomy
95643|NCT02969148|Gastric Cancer|gastric cancer
95644|NCT02969122|gastric cancer|gastric cancer
95645|NCT02969122|peritoneal cytology|peritoneal cytology
95646|NCT02969083|UTUC|utuc
95647|NCT02969083|Upper Tract Urothelial Carcinoma|upper tract urothelial carcinoma
95897|NCT02967068|HSP|hsp
95648|NCT02969083|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
95649|NCT02969083|Adjuvant chemotherapy|adjuvant chemotherapy
95650|NCT02969083|Radical nephroureterectomy|radical nephroureterectomy
95651|NCT02969057|Lipidemic Response|lipidemic response
95652|NCT02969031|communication|communication
95653|NCT02969018|plaque psoriasis|plaque psoriasis
95654|NCT02969005|radiopaque localizer grid|radiopaque localizer grid
95655|NCT02969005|methylene blue|methylene blue
95656|NCT02969005|reduce radiation exposure|reduce radiation exposure
95657|NCT02968979|cachexia|cachexia
95658|NCT02968979|Non-Small Cell Lung cancer|non-small cell lung cancer
95659|NCT02968979|anorexia|anorexia
95660|NCT02968979|malnutrition|malnutrition
95661|NCT02968940|Programmed cell death protein 1 (PD-1)|programmed cell death protein 1 (pd-1)
95662|NCT02968940|Programmed death-ligand 1 (PD-L1)|programmed death-ligand 1 (pd-l1)
95663|NCT02968940|Immunotherapy|immunotherapy
95664|NCT02968940|Hypofractionated Radiotherapy (HFRT)|hypofractionated radiotherapy (hfrt)
95665|NCT02968940|Isocitrate dehydrogenase (IDH)|isocitrate dehydrogenase (idh)
95666|NCT02968940|Glioma|glioma
95667|NCT02968914|Asthma|asthma
95668|NCT02968914|Chronic Obstructive pulmonary Disease|chronic obstructive pulmonary disease
95669|NCT02968914|Pharmacokinetics|pharmacokinetics
95670|NCT02968914|Healthy volunteers|healthy volunteers
95671|NCT02968875|endurance training|endurance training
95672|NCT02968875|BDNF analysis|bdnf analysis
95673|NCT02968875|cognitive function|cognitive function
95674|NCT02968875|physiological abilities|physiological abilities
95675|NCT02968849|HIV|hiv
95676|NCT02968823|Postoperative Pain|postoperative pain
95677|NCT02968823|Anesthesia|anesthesia
95678|NCT02968823|Oral Surgery|oral surgery
95679|NCT02968784|Prostate Cancer|prostate cancer
95680|NCT02968784|MRgFUS|mrgfus
95681|NCT02968784|ExAblate|exablate
95682|NCT02968784|Focused Ultrasound|focused ultrasound
95683|NCT02968771|Coronary artery disease|coronary artery disease
95684|NCT02968771|Cardiac perfusion SPECT|cardiac perfusion spect
95685|NCT02968771|Metabolomics|metabolomics
95686|NCT02968745|Rheumatoid arthritis|rheumatoid arthritis
95687|NCT02968745|human activity|human activity
95688|NCT02968745|Canadian Occupational Performance Measure|canadian occupational performance measure
95689|NCT02968706|High Flow Nasal Cannula|high flow nasal cannula
95690|NCT02968706|Colonoscopy|colonoscopy
95691|NCT02968706|Obesity|obesity
95692|NCT02968654|Blood Transfusion|blood transfusion
95693|NCT02968654|Brain Injury|brain injury
95694|NCT02968654|Outcome|outcome
95695|NCT02968654|Hemoglobin|hemoglobin
95696|NCT02968615|fiber|fiber
95697|NCT02968615|lean protein|lean protein
95698|NCT02968615|loss weight|loss weight
95699|NCT02968589|Tele-rehabilitation|tele-rehabilitation
95700|NCT02968589|Function|function
95701|NCT02968589|Quality of life|quality of life
95702|NCT02968589|Exercise|exercise
95703|NCT02968589|Occupational Therapy|occupational therapy
95704|NCT02968589|Physiotherapy|physiotherapy
95705|NCT02968589|Caregiver burden|caregiver burden
95706|NCT02968576|healthy volunteers|healthy volunteers
95707|NCT02968576|pharmacokinetics|pharmacokinetics
95708|NCT02968537|Alcohol use disorders|alcohol use disorders
95709|NCT02968537|inhibition|inhibition
95710|NCT02968537|EEG|eeg
95711|NCT02968537|cortisol|cortisol
95712|NCT02968537|Training|training
95713|NCT02968537|clinical outcome measures|clinical outcome measures
95714|NCT02968498|Blood glucose level|blood glucose level
95715|NCT02968498|Oral intake|oral intake
95716|NCT02968498|Lactulose|lactulose
95717|NCT02968498|Healthy volunteers|healthy volunteers
95718|NCT02968485|advanced solid tumor|advanced solid tumor
95919|NCT02966821|Biliary Tract Cancer|biliary tract cancer
95719|NCT02968485|Protein Kinase MEK inhibitor (MEKi)|protein kinase mek inhibitor (meki)
95720|NCT02968485|Safety|safety
95721|NCT02968485|Pharmacokinetics|pharmacokinetics
95722|NCT02968472|4s CAR-T19|4s car-t19
95723|NCT02968472|B cell leukemia|b cell leukemia
95724|NCT02968472|B-ALL|b-all
95725|NCT02968459|Mesenchymal Stem Cells|mesenchymal stem cells
95726|NCT02968459|Cesarean Section|cesarean section
95727|NCT02968459|Uterine Scar|uterine scar
95728|NCT02968446|Valchlor|valchlor
95729|NCT02968446|Vitamin D|vitamin d
95730|NCT02968446|Healthy Volunteer|healthy volunteer
95731|NCT02968433|Young Male Plasma|young male plasma
95732|NCT02968381|tobacco|tobacco
95733|NCT02968381|smoking|smoking
95734|NCT02968381|imagery|imagery
95735|NCT02968342|Hypoactive sexual desire disorder|hypoactive sexual desire disorder
95736|NCT02968212|Mycobacterium avium Complex|mycobacterium avium complex
95737|NCT02968212|Clofazimine|clofazimine
95738|NCT02968186|Mass Screening|mass screening
95739|NCT02968186|Counseling|counseling
95740|NCT02968186|Primary Health Care|primary health care
95741|NCT02968173|Bronchopulmonary dysplasia (BPD)|bronchopulmonary dysplasia (bpd)
95742|NCT02968173|RSV hospitalization|rsv hospitalization
95743|NCT02968173|Palivizumab|palivizumab
95744|NCT02968173|Immunoprophylaxis|immunoprophylaxis
95745|NCT02968173|Chronic lung disease (CLD) of prematurity|chronic lung disease (cld) of prematurity
95746|NCT02968147|atrial fibrillation|atrial fibrillation
95747|NCT02968147|catheter ablation|catheter ablation
95748|NCT02968147|general anaesthesia|general anaesthesia
95749|NCT02968082|MVD|mvd
95750|NCT02968082|Scopolamine|scopolamine
95751|NCT02968082|Microvascular Decompression|microvascular decompression
95752|NCT02968056|atrial fibrillation|atrial fibrillation
95753|NCT02968056|radiofrequency ablation|radiofrequency ablation
95754|NCT02968043|physiotherapeutic scoliosis specific exercise|physiotherapeutic scoliosis specific exercise
95755|NCT02968030|Aged|aged
95756|NCT02968030|Postural balance|postural balance
95757|NCT02968030|Muscle strength|muscle strength
95758|NCT02967991|EUS|eus
95759|NCT02967991|Biopsy|biopsy
95760|NCT02967991|Liver|liver
95761|NCT02967991|FNA|fna
95762|NCT02967991|FNB|fnb
95763|NCT02967978|risk factors|risk factors
95764|NCT02967978|Calcium isotopes|calcium isotopes
95765|NCT02967978|calcium turnover|calcium turnover
95766|NCT02967978|DXA|dxa
95767|NCT02967965|clinical confounders|clinical confounders
95768|NCT02967965|myocardial infarction size|myocardial infarction size
95769|NCT02967965|determinants of myocardial infarct injury|determinants of myocardial infarct injury
95770|NCT02967952|out-of-hospital cardiac arrest (OHCA)|out-of-hospital cardiac arrest (ohca)
95771|NCT02967952|supraglottic airway (SGA)|supraglottic airway (sga)
95898|NCT02966951|osteoarthrosis|osteoarthrosis
95772|NCT02967952|endotracheal intubation (ETI)|endotracheal intubation (eti)
95773|NCT02967952|emergency medical system (EMS)|emergency medical system (ems)
95774|NCT02967952|Supraglottic Airway Versus Endotracheal tube (SAVE)|supraglottic airway versus endotracheal tube (save)
95775|NCT02967926|common bile duct stone|common bile duct stone
95776|NCT02967926|cholangioscopy|cholangioscopy
95777|NCT02967926|SpyGlass|spyglass
95778|NCT02967926|non-fluoroscopic|non-fluoroscopic
95779|NCT02967913|Cesarean delivery|cesarean delivery
95780|NCT02967913|Obstetrical delivery|obstetrical delivery
95781|NCT02967913|PFDI-20|pfdi-20
95782|NCT02967913|UDI-6|udi-6
95783|NCT02967913|Bladder flap|bladder flap
95784|NCT02967874|Adipose -Derived Stromal Vascular Fraction Cells|adipose -derived stromal vascular fraction cells
95785|NCT02967874|Knee Osteoarthritis|knee osteoarthritis
95786|NCT02967874|Intra-articular Administration|intra-articular administration
95787|NCT02967874|Liposuction|liposuction
95788|NCT02967861|chronic periodontitis|chronic periodontitis
95789|NCT02967861|Nuclear factor-kappa B|nuclear factor-kappa b
95790|NCT02967861|Pranayama|pranayama
95791|NCT02967861|Peroxisome proliferator - activated receptor gamma|peroxisome proliferator - activated receptor gamma
95792|NCT02967861|Red complex microorganisms|red complex microorganisms
95793|NCT02967848|Radiotherapy|radiotherapy
95794|NCT02967848|Mebrofenin|mebrofenin
95795|NCT02967848|Liver|liver
95796|NCT02967848|Cancer|cancer
95797|NCT02967848|SPECT|spect
95798|NCT02967770|Metastatic|metastatic
95799|NCT02967770|Pancreas|pancreas
95800|NCT02967770|Cancer|cancer
95801|NCT02967692|PDR001|pdr001
95802|NCT02967692|dabrafenib|dabrafenib
95803|NCT02967692|trametinib|trametinib
95804|NCT02967692|melanoma|melanoma
95805|NCT02967692|immunotherapy|immunotherapy
95806|NCT02967692|PD 1 inhibitor|pd 1 inhibitor
95807|NCT02967692|anti PD1|anti pd1
95808|NCT02967692|PD-1|pd-1
95809|NCT02967692|anti-PD-1|anti-pd-1
95810|NCT02967692|combination treatment|combination treatment
95811|NCT02967692|malignant skin cancer|malignant skin cancer
95812|NCT02967692|skin cancer|skin cancer
95813|NCT02967692|BRAF V600|braf v600
95814|NCT02967692|unresectable BRAF V600 mutated melanoma|unresectable braf v600 mutated melanoma
95815|NCT02967692|metastatic BRAF V600 mutated melanoma|metastatic braf v600 mutated melanoma
95816|NCT02967679|Neuropathy|neuropathy
95817|NCT02967679|Demyelinating polyradiculoneuropathy|demyelinating polyradiculoneuropathy
95818|NCT02967640|Ketamine|ketamine
95819|NCT02967640|Analgesics|analgesics
95820|NCT02967640|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists
95821|NCT02967640|Receptors, Glutamate|receptors, glutamate
95822|NCT02967640|Shoulder|shoulder
95823|NCT02967601|shivering, cesarean section, anxiety, STAI|shivering, cesarean section, anxiety, stai
95824|NCT02967588|Medication adherence|medication adherence
95825|NCT02967588|Behavioural intervention|behavioural intervention
95826|NCT02967588|Acute coronary syndrome|acute coronary syndrome
95827|NCT02967588|Medication beliefs|medication beliefs
95828|NCT02967588|Implementation intentions|implementation intentions
95829|NCT02967575|cervical total disc replacement (cTDR)|cervical total disc replacement (ctdr)
95830|NCT02967536|cognitive function|cognitive function
95831|NCT02967536|microglia|microglia
95832|NCT02967536|neuroinflammation|neuroinflammation
95833|NCT02967523|Hepatocellular carcinoma|hepatocellular carcinoma
95834|NCT02967523|DEB-TACE|deb-tace
95835|NCT02967497|Chemotherapy|chemotherapy
95836|NCT02967497|Herbal medicine|herbal medicine
95837|NCT02967497|Lung cancer|lung cancer
95838|NCT02967484|Acupuncture|acupuncture
95839|NCT02967484|Hypertension|hypertension
95840|NCT02967484|Second prevention of Stroke|second prevention of stroke
95841|NCT02967484|Efficacy|efficacy
95842|NCT02967484|RCT|rct
95843|NCT02967484|Study protocol|study protocol
95844|NCT02967471|ARDS|ards
95845|NCT02967458|prostate cancer|prostate cancer
95846|NCT02967458|prostate ultrasound|prostate ultrasound
95847|NCT02967458|subharmonic imaging|subharmonic imaging
95848|NCT02967458|prostate biopsy|prostate biopsy
95849|NCT02967432|Staphylococcus aureus|staphylococcus aureus
95850|NCT02967432|Staphylococcal colonization|staphylococcal colonization
95851|NCT02967432|Staphylococcal infection|staphylococcal infection
95852|NCT02967432|Mupirocin|mupirocin
95853|NCT02967432|Mupirocin-resistance|mupirocin-resistance
95854|NCT02967419|Repeated Implantation Failure; TWEAK;Fn14;JAK/STAT3;Indoleamine 2,3-dioxygenase|repeated implantation failure; tweak;fn14;jak/stat3;indoleamine 2,3-dioxygenase
95855|NCT02967406|Lifestyle modification|lifestyle modification
95856|NCT02967406|Primary prevention|primary prevention
95857|NCT02967406|Community-based intervention|community-based intervention
95858|NCT02967406|Randomized control trial|randomized control trial
95859|NCT02967328|Reticulated Platelets|reticulated platelets
95860|NCT02967328|Immune Thrombocytopenia|immune thrombocytopenia
95861|NCT02967302|knee arthritis, morphine, local injection, pain|knee arthritis, morphine, local injection, pain
95862|NCT02967289|colon|colon
95863|NCT02967289|cancer|cancer
95864|NCT02967289|stage 3|stage 3
95865|NCT02967289|high-risk|high-risk
95866|NCT02967289|mFolfirinox|mfolfirinox
95867|NCT02967289|mFolfox6|mfolfox6
95868|NCT02967289|adjuvant|adjuvant
95869|NCT02967276|Metformin|metformin
95870|NCT02967276|Dexamethasone|dexamethasone
95871|NCT02967276|Multiple Myeloma|multiple myeloma
95872|NCT02967263|Acute Kidney Injury|acute kidney injury
95873|NCT02967263|Proteinosis|proteinosis
95874|NCT02967263|Epidemiology|epidemiology
95875|NCT02967263|Risk factors|risk factors
95876|NCT02967198|Fusion|fusion
95877|NCT02967198|Ablation|ablation
95878|NCT02967198|Percutaneous biopsy|percutaneous biopsy
95879|NCT02967198|Shear wave elastography|shear wave elastography
95880|NCT02967159|chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
95881|NCT02967159|asthma|asthma
95882|NCT02967107|adenoma|adenoma
95883|NCT02967107|colorectal cancer|colorectal cancer
95884|NCT02967107|polypectomy|polypectomy
95885|NCT02967107|colonoscopy|colonoscopy
95886|NCT02967081|Pulpitis|pulpitis
95887|NCT02967081|Biomarker|biomarker
95888|NCT02967081|Diagnostic|diagnostic
95889|NCT02967081|Dentinal fluid|dentinal fluid
95890|NCT02967068|CSS|css
95891|NCT02967068|EGPA|egpa
95892|NCT02967068|GCA|gca
95893|NCT02967068|GPA|gpa
95894|NCT02967068|MPA|mpa
95895|NCT02967068|PAN|pan
95896|NCT02967068|TAK|tak
95899|NCT02966951|knee|knee
95900|NCT02966951|adipose tissue|adipose tissue
95901|NCT02966951|stem cells|stem cells
95902|NCT02966951|cell therapy|cell therapy
95903|NCT02966925|Vulvovaginal dryness|vulvovaginal dryness
95904|NCT02966886|Surgical Management|surgical management
95905|NCT02966873|Post Traumatic Stress Disorder (PTSD)|post traumatic stress disorder (ptsd)
95906|NCT02966873|Addiction|addiction
95907|NCT02966873|Alcohol Use Disorder|alcohol use disorder
95908|NCT02966873|Cognitive Behavioral Therapy|cognitive behavioral therapy
95909|NCT02966873|N-acetylcysteine (NAC)|n-acetylcysteine (nac)
95910|NCT02966847|Video assisted thoracoscopy|video assisted thoracoscopy
95911|NCT02966847|Cone beam computed tomography|cone beam computed tomography
95912|NCT02966834|PBC|pbc
95913|NCT02966834|itch|itch
95914|NCT02966834|GSK2330672|gsk2330672
95915|NCT02966834|GLIMMER|glimmer
95916|NCT02966834|primary biliary cholangitis|primary biliary cholangitis
95917|NCT02966834|pruritus|pruritus
95918|NCT02966821|Sulfatinib|sulfatinib
95920|NCT02966821|Second-line|second-line
95921|NCT02966795|glecaprevir|glecaprevir
95922|NCT02966795|pibrentasvir|pibrentasvir
95923|NCT02966795|compensated cirrhosis|compensated cirrhosis
95924|NCT02966795|non-cirrhotic|non-cirrhotic
95925|NCT02966795|interferon (IFN)|interferon (ifn)
95926|NCT02966795|pegylated interferon (pegIFN)|pegylated interferon (pegifn)
95927|NCT02966795|ribavirin (RBV)|ribavirin (rbv)
95928|NCT02966795|sofosbuvir (SOF)|sofosbuvir (sof)
95929|NCT02966795|Sustained Virologic Response 12 weeks post dosing (SVR12)|sustained virologic response 12 weeks post dosing (svr12)
95930|NCT02966782|Hypomethylating Agent-Failure (HMA)|hypomethylating agent-failure (hma)
95931|NCT02966782|Higher-Risk (HR) Myelodysplastic Syndromes (MDS)|higher-risk (hr) myelodysplastic syndromes (mds)
95932|NCT02966782|Venetoclax|venetoclax
95933|NCT02966782|Azacitidine|azacitidine
95934|NCT02966782|International Prognostic Scoring System (IPSS)|international prognostic scoring system (ipss)
95935|NCT02966756|Relapsed chronic lymphocytic leukemia (CLL)|relapsed chronic lymphocytic leukemia (cll)
95936|NCT02966756|Refractory chronic lymphocytic leukemia (CLL)|refractory chronic lymphocytic leukemia (cll)
95937|NCT02966756|17p deletion|17p deletion
95938|NCT02966756|venetoclax|venetoclax
95939|NCT02966756|Leukemia|leukemia
95940|NCT02966756|Lymphoproliferative Disorders|lymphoproliferative disorders
95941|NCT02966730|follicular lymphoma|follicular lymphoma
95942|NCT02966730|Ibrutinib|ibrutinib
95943|NCT02966730|FLIPP|flipp
95944|NCT02966730|16-396|16-396
95945|NCT02966717|Rituximab|rituximab
95946|NCT02966717|Mesenchymal stem cells|mesenchymal stem cells
95947|NCT02966717|primary nephrotic syndrome|primary nephrotic syndrome
95948|NCT02966717|chronic kidney disease|chronic kidney disease
95949|NCT02966678|Glaucoma, Dychromatopsia|glaucoma, dychromatopsia
95950|NCT02966652|Male|male
95951|NCT02966652|Hypogonadism|hypogonadism
95952|NCT02966652|Primary|primary
95953|NCT02966652|Secondary|secondary
95954|NCT02966652|Androgen deficiency|androgen deficiency
95955|NCT02966626|Pragmatic, Sodium-Glucose Transporter 2 inhibitor, Malaysia|pragmatic, sodium-glucose transporter 2 inhibitor, malaysia
95956|NCT02966574|Whole body MRI|whole body mri
95957|NCT02966574|Breastcancer|breastcancer
95958|NCT02966561|Pulmonary Rehabilitation|pulmonary rehabilitation
95959|NCT02966561|Physical Activity|physical activity
95960|NCT02966561|Behaviour Change|behaviour change
95961|NCT02966561|Pedometer|pedometer
95962|NCT02966522|Thalidoide|thalidoide
95963|NCT02966483|Rectal cancer|rectal cancer
95964|NCT02966483|Laparoscopic surgery|laparoscopic surgery
95965|NCT02966483|Total mesorectal excision|total mesorectal excision
95966|NCT02966483|Transanal|transanal
95967|NCT02966483|Multicentre randomised clinical trial|multicentre randomised clinical trial
95968|NCT02966470|surgical outcomes|surgical outcomes
95969|NCT02966457|hematological infection, decolonization|hematological infection, decolonization
95970|NCT02966418|Hypoxic preconditioning|hypoxic preconditioning
95971|NCT02966418|Carotid artery stenosis|carotid artery stenosis
95972|NCT02966418|Ischemic cerebrovascular disease|ischemic cerebrovascular disease
95973|NCT02966392|Cuff pressure|cuff pressure
95974|NCT02966392|Ventilator associated pneumonia|ventilator associated pneumonia
95975|NCT02966392|Respiratory tract infections|respiratory tract infections
95976|NCT02966379|Electroacoustic stimulation|electroacoustic stimulation
95977|NCT02966353|Ruxolitinib|ruxolitinib
95978|NCT02966353|anemia|anemia
95979|NCT02966353|Primary Myelofibrosis|primary myelofibrosis
95980|NCT02966353|PMF|pmf
95981|NCT02966353|Post-Polycythemia Vera-Myelofibrosis|post-polycythemia vera-myelofibrosis
95982|NCT02966353|PPV-MF|ppv-mf
95983|NCT02966353|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
95984|NCT02966353|PET-MF|pet-mf
95985|NCT02966340|Alcoholism|alcoholism
95986|NCT02966340|Prazosin|prazosin
95987|NCT02966340|Startle Potentiation|startle potentiation
95988|NCT02966340|Norepinephrine|norepinephrine
95989|NCT02966340|Anxiety|anxiety
95990|NCT02966340|Fear|fear
95991|NCT02966340|Stress|stress
95992|NCT02966314|Angioedema|angioedema
95993|NCT02966314|Idiopathic Angioedema|idiopathic angioedema
95994|NCT02966314|IAE|iae
95995|NCT02966301|c GvHD|c gvhd
95996|NCT02966301|Arsenic Trioxyde|arsenic trioxyde
95997|NCT02966301|Hematology|hematology
95998|NCT02966275|glucagon|glucagon
95999|NCT02966275|continuous glucose monitorering (CGM)|continuous glucose monitorering (cgm)
96000|NCT02966275|artificial pancreas|artificial pancreas
96001|NCT02966275|hypoglycemia|hypoglycemia
96002|NCT02966275|post-bariatric hypoglycemia|post-bariatric hypoglycemia
96003|NCT02966275|bionic pancreas|bionic pancreas
96004|NCT02966275|bariatric surgery|bariatric surgery
96005|NCT02966249|dexmetomidine, intrathecally, intavenously,anesthesia|dexmetomidine, intrathecally, intavenously,anesthesia
96006|NCT02966236|percutaneous nephrolithotomy|percutaneous nephrolithotomy
96007|NCT02966171|Advanced Solid Malignancies|advanced solid malignancies
96008|NCT02966158|Aerobic Interval Training|aerobic interval training
96009|NCT02966158|Fitness|fitness
96010|NCT02966158|Endothelial Function|endothelial function
96011|NCT02966158|Cognition|cognition
96012|NCT02966145|CBD|cbd
96013|NCT02966145|CBS|cbs
96014|NCT02966145|CBGD|cbgd
96015|NCT02966145|PSP|psp
96016|NCT02966145|nfvPPA|nfvppa
96017|NCT02966145|oPSP|opsp
96018|NCT02966145|vPSP|vpsp
96019|NCT02966145|o/vPSP|o/vpsp
96020|NCT02966145|Corticobasal Degeneration|corticobasal degeneration
96021|NCT02966145|Corticobasal Syndrome|corticobasal syndrome
96022|NCT02966145|Cortocal-basal Ganglionic Degeneration|cortocal-basal ganglionic degeneration
96023|NCT02966145|Progressive Supranuclear Palsy|progressive supranuclear palsy
96024|NCT02966145|Nonfluent Variant Primary Progressive Aphasia|nonfluent variant primary progressive aphasia
96025|NCT02966145|Oligosymptomatic Progressive Supranuclear Palsy|oligosymptomatic progressive supranuclear palsy
96026|NCT02966145|Variant Progressive Supranuclear Palsy|variant progressive supranuclear palsy
96027|NCT02966145|Biomarker|biomarker
96028|NCT02966145|Neuroimaging|neuroimaging
96029|NCT02966145|MRI|mri
96030|NCT02966145|PET|pet
96031|NCT02966145|Tau|tau
96032|NCT02966145|Oculomotor|oculomotor
96033|NCT02966145|Retinal Imaging|retinal imaging
96034|NCT02966132|Asian American|asian american
96035|NCT02966132|Immigrant Health|immigrant health
96036|NCT02966132|Digital Health Intervention|digital health intervention
96037|NCT02966132|Federally Qualified Health Centers|federally qualified health centers
96038|NCT02966119|stroke|stroke
96039|NCT02966119|intracranial hemorrhage|intracranial hemorrhage
96040|NCT02966119|intracerebral hemorrhage|intracerebral hemorrhage
96041|NCT02966119|antithrombotic drugs|antithrombotic drugs
96042|NCT02966119|brain microbleeds|brain microbleeds
96043|NCT02966093|Differentiated thyroid cancer|differentiated thyroid cancer
96044|NCT02966093|Chinese participants|chinese participants
96045|NCT02966093|Phase 3|phase 3
96046|NCT02966093|Lenvatinib|lenvatinib
96047|NCT02966093|E7080|e7080
96048|NCT02966080|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
96049|NCT02966080|intravenous heparin|intravenous heparin
96050|NCT02966067|Microneedles|microneedles
96051|NCT02966067|Dental Anaesthesia|dental anaesthesia
96052|NCT02966041|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
96053|NCT02966041|PONV|ponv
96054|NCT02966041|CSICU|csicu
96055|NCT02966041|post-cardiac surgery|post-cardiac surgery
96056|NCT02966041|cardiac intensive care unit|cardiac intensive care unit
96057|NCT02966028|CAC|cac
96058|NCT02966028|calcium|calcium
96059|NCT02966028|ESRD|esrd
96060|NCT02966028|calcification|calcification
96061|NCT02966028|cardiovascular|cardiovascular
96062|NCT02966028|heart|heart
96063|NCT02966028|kidney|kidney
96064|NCT02966028|hemodialysis|hemodialysis
96065|NCT02966028|Agatston|agatston
96066|NCT02965989|nursery care|nursery care
96067|NCT02965989|nursery infection|nursery infection
96068|NCT02965989|online learning|online learning
96069|NCT02965950|breast cancer|breast cancer
96070|NCT02965950|TP53|tp53
96071|NCT02965950|cyclophosphamide|cyclophosphamide
96072|NCT02965937|Attentively embracing story|attentively embracing story
96073|NCT02965937|story-centred care|story-centred care
96074|NCT02965937|heart rate variability|heart rate variability
96075|NCT02965937|cognitive function|cognitive function
96076|NCT02965911|UDCA, Fenofibrate|udca, fenofibrate
96077|NCT02965898|chronic pancreatitis|chronic pancreatitis
96078|NCT02965898|vitamin d|vitamin d
96079|NCT02965898|pancreatitis|pancreatitis
96080|NCT02965898|Pancreatic stellate cell|pancreatic stellate cell
96081|NCT02965898|rct|rct
96082|NCT02965885|Phase I|phase i
96083|NCT02965885|Solid Tumors|solid tumors
96084|NCT02965885|Pharmacokinetics|pharmacokinetics
96085|NCT02965885|Pharmacodynamics|pharmacodynamics
96086|NCT02965885|MTD|mtd
96087|NCT02965885|TAS116|tas116
96088|NCT02965885|HSP90 Inhibitor|hsp90 inhibitor
96089|NCT02965885|Neoplasms|neoplasms
96090|NCT02965885|HER2 positive MBC|her2 positive mbc
96091|NCT02965885|NSCLC EGFR|nsclc egfr
96092|NCT02965885|NSCLC ALK positive|nsclc alk positive
96093|NCT02965872|Postural Balance|postural balance
96094|NCT02965859|Chronic Hepatitis B|chronic hepatitis b
96095|NCT02965846|EDE|ede
96096|NCT02965846|evaporative dry eye|evaporative dry eye
96097|NCT02965833|Contact lens induced dryness|contact lens induced dryness
96098|NCT02965820|Contact lens induced dryness|contact lens induced dryness
96099|NCT02965807|Bronchial Thermoplasty|bronchial thermoplasty
96100|NCT02965807|moderate asthma|moderate asthma
96101|NCT02965807|China|china
96102|NCT02965794|surgery|surgery
96103|NCT02965794|bowel|bowel
96104|NCT02965794|rectum|rectum
96105|NCT02965794|cancer|cancer
96106|NCT02965794|nutrition|nutrition
96107|NCT02965755|Metastatic Breast Cancer|metastatic breast cancer
96108|NCT02965755|Breast Cancer|breast cancer
96109|NCT02965755|Molecular profiling|molecular profiling
96110|NCT02965755|Personalized medicine|personalized medicine
96111|NCT02965742|DXA|dxa
96112|NCT02965742|DMS|dms
96113|NCT02965742|STRATOS|stratos
96114|NCT02965729|behavior goals|behavior goals
96115|NCT02965729|self-monitoring|self-monitoring
96116|NCT02965729|pedometer|pedometer
96117|NCT02965729|physical activity|physical activity
96118|NCT02965690|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
96119|NCT02965690|TKR|tkr
96120|NCT02965690|Knee kinematics|knee kinematics
96121|NCT02965690|Dynamic RSA|dynamic rsa
96122|NCT02965690|Fluoroscopy|fluoroscopy
96123|NCT02965690|Roentgen Fluoroscopic Stereophotogrammetric Analysis|roentgen fluoroscopic stereophotogrammetric analysis
96124|NCT02965677|drug eluting balloon|drug eluting balloon
96125|NCT02965677|Femoral Popliteal Artery|femoral popliteal artery
96126|NCT02965651|embodied conversational agent|embodied conversational agent
96127|NCT02965651|virtual patient agent|virtual patient agent
96128|NCT02965651|meditation|meditation
96129|NCT02965651|mindfulness based stress reduction|mindfulness based stress reduction
96130|NCT02965651|nutrition|nutrition
96131|NCT02965638|LHH|lhh
96132|NCT02965612|Grass Allergy|grass allergy
96133|NCT02965612|Allergic Rhinitis|allergic rhinitis
96134|NCT02965612|Allergic Asthma|allergic asthma
96135|NCT02965612|Paediatric|paediatric
96136|NCT02965599|pharmacodynamics|pharmacodynamics
96137|NCT02965599|tolerability|tolerability
96138|NCT02965599|GSK3117391|gsk3117391
96139|NCT02965599|safety|safety
96140|NCT02965599|efficacy|efficacy
96141|NCT02965599|rheumatoid arthritis|rheumatoid arthritis
96142|NCT02965599|pharmacokinetics|pharmacokinetics
96143|NCT02965547|Ischemic Preconditioning|ischemic preconditioning
96144|NCT02965547|dynamic cerebral autoregulation|dynamic cerebral autoregulation
96145|NCT02965534|night vision|night vision
96146|NCT02965534|mesopic visual acuity|mesopic visual acuity
96147|NCT02965534|aberrometry|aberrometry
96148|NCT02965534|mesopic spectacle correction|mesopic spectacle correction
96149|NCT02965534|night myopia|night myopia
96150|NCT02965508|Home-bound|home-bound
96151|NCT02965508|home-based primary care|home-based primary care
96152|NCT02965495|Osteoarthritis|osteoarthritis
96153|NCT02965482|methacholine, airway hyperresponsiveness|methacholine, airway hyperresponsiveness
96154|NCT02965417|Resistance to anti-EGFR monoclonal antibodies|resistance to anti-egfr monoclonal antibodies
96155|NCT02965417|Mutation of ECD-EGFR|mutation of ecd-egfr
96156|NCT02965404|live attenuated varicella vaccine|live attenuated varicella vaccine
96157|NCT02965404|safety|safety
96158|NCT02965404|adult|adult
96159|NCT02965404|adolescent|adolescent
96160|NCT02965404|child|child
96161|NCT02965391|Circulating Tumor DNA|circulating tumor dna
96162|NCT02965391|Half time|half time
96163|NCT02965391|Lung cancer|lung cancer
96164|NCT02965391|Surgery|surgery
96165|NCT02965391|Surveillance|surveillance
96166|NCT02965339|Vasoplegia|vasoplegia
96167|NCT02965339|endothelial dysfunction|endothelial dysfunction
96168|NCT02965339|extracorporeal circulation|extracorporeal circulation
96169|NCT02965339|cardiac surgery|cardiac surgery
96170|NCT02965300|Pulmonary lesion|pulmonary lesion
96171|NCT02965300|Volatile Organic Compositions(VOCs)|volatile organic compositions(vocs)
96172|NCT02965248|Locally advanced colorectal cancer|locally advanced colorectal cancer
96173|NCT02965248|Hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
96174|NCT02965222|blastocyst|blastocyst
96175|NCT02965222|pregnancy rate|pregnancy rate
96176|NCT02965209|endoscopy|endoscopy
96177|NCT02965209|small bowel endoscopy|small bowel endoscopy
96178|NCT02965209|motorized spiral endoscopy|motorized spiral endoscopy
96179|NCT02965209|spiral endoscopy|spiral endoscopy
96180|NCT02965144|long-term survivors, high-grade glioma|long-term survivors, high-grade glioma
96181|NCT02965079|extracorporeal CO2 removal|extracorporeal co2 removal
96182|NCT02965079|registry|registry
96183|NCT02965079|COPD and ARDS|copd and ards
96184|NCT02965079|CEDIT on behalf of APHP|cedit on behalf of aphp
96185|NCT02965040|ASP1517|asp1517
96186|NCT02965040|Normal renal function|normal renal function
96187|NCT02965040|Dialysis|dialysis
96188|NCT02965040|Roxadustat|roxadustat
96189|NCT02965040|Metabolites|metabolites
96190|NCT02965040|Pharmacokinetics|pharmacokinetics
96191|NCT02965040|Impaired renal function|impaired renal function
96192|NCT02965027|Chronic Headache|chronic headache
96193|NCT02965027|Post-Traumatic Stress Disorder|post-traumatic stress disorder
96194|NCT02965027|Iraq/Afghanistan Veteran|iraq/afghanistan veteran
96195|NCT02965014|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
96196|NCT02965014|Sexually transmitted infections (STI)|sexually transmitted infections (sti)
96197|NCT02965014|mHealth|mhealth
96198|NCT02965014|Substance abuse|substance abuse
96199|NCT02965014|Violence|violence
96200|NCT02965014|Victimization|victimization
96201|NCT02965014|Sexual Risk|sexual risk
96202|NCT02965001|Molecular Imaging|molecular imaging
96203|NCT02965001|uPAR-PET/CT|upar-pet/ct
96204|NCT02965001|Head and neck cancer|head and neck cancer
96205|NCT02965001|curative intended radiotherapy|curative intended radiotherapy
96206|NCT02964949|Nonvalvular Atrial Fibrillation|nonvalvular atrial fibrillation
96207|NCT02964949|High Creatinine Clearance|high creatinine clearance
96208|NCT02964949|Developmental Phase III|developmental phase iii
96209|NCT02964949|Anticoagulant Naïve|anticoagulant naïve
96210|NCT02964936|Anemia|anemia
96211|NCT02964936|Non-dialysis chronic kidney disease|non-dialysis chronic kidney disease
96212|NCT02964936|Roxadustat|roxadustat
96213|NCT02964936|ASP1517|asp1517
96214|NCT02964923|Genetic polymorphism|genetic polymorphism
96215|NCT02964923|Metabolic side effects of drugs|metabolic side effects of drugs
96216|NCT02964923|schizophrenia|schizophrenia
96217|NCT02964923|Second-Generation Antipsychotic|second-generation antipsychotic
96218|NCT02964923|Cannabinoid Receptor Type 1|cannabinoid receptor type 1
96219|NCT02964910|Hepatitis E|hepatitis e
96220|NCT02964897|justice involvement|justice involvement
96221|NCT02964897|Homeless|homeless
96222|NCT02964897|Vulnerable Populations|vulnerable populations
96223|NCT02964897|Linkage to care|linkage to care
96224|NCT02964897|Veterans|veterans
96225|NCT02964884|Neurofibromatosis Type 1|neurofibromatosis type 1
96226|NCT02964884|Learning Disability|learning disability
96227|NCT02964884|Reading Disability|reading disability
96228|NCT02964884|NF1|nf1
96229|NCT02964871|Long-term care facility|long-term care facility
96230|NCT02964871|Elderly|elderly
96231|NCT02964858|Radiation Dose|radiation dose
96232|NCT02964858|Optimization|optimization
96233|NCT02964858|NHL|nhl
96234|NCT02964858|DLBCL|dlbcl
96235|NCT02964858|R-CHOP|r-chop
96236|NCT02964832|Basic Cardiac Life Support, Education, Feedback|basic cardiac life support, education, feedback
96237|NCT02964793|Fetal Growth Restriction|fetal growth restriction
96238|NCT02964793|Customised Fetal Weight Reference|customised fetal weight reference
96239|NCT02964793|Estimated fetal Weight|estimated fetal weight
96240|NCT02964793|Symphysis Fundal Height|symphysis fundal height
96241|NCT02964767|HIV|hiv
96242|NCT02964767|HIV-Tb co infection|hiv-tb co infection
96243|NCT02964767|CD4 Cell|cd4 cell
96244|NCT02964741|Episodic Migraine|episodic migraine
96245|NCT02964741|Headache|headache
96246|NCT02964741|Opioid|opioid
96247|NCT02964689|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
96248|NCT02964689|KRAS mutations|kras mutations
96249|NCT02964689|Binimetinib|binimetinib
96250|NCT02964689|Pemetrexed|pemetrexed
96251|NCT02964689|Cisplatin|cisplatin
96252|NCT02964689|Phase IB trial|phase ib trial
96253|NCT02964624|Osteoarthritis|osteoarthritis
96254|NCT02964624|biomarkers|biomarkers
96255|NCT02964624|HMGB1|hmgb1
96256|NCT02964624|knee|knee
96257|NCT02964598|Adolescent|adolescent
96258|NCT02964598|Population-based|population-based
96259|NCT02964598|Social jetlag|social jetlag
96260|NCT02964598|Intervention|intervention
96261|NCT02964598|Bright light|bright light
96262|NCT02964598|Motivation|motivation
96263|NCT02964598|Circadian regulation|circadian regulation
96264|NCT02964598|Behavioral change|behavioral change
96265|NCT02964585|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
96266|NCT02964585|Endothelial Cells|endothelial cells
96267|NCT02964585|Cellular Biomarker|cellular biomarker
96268|NCT02964585|Endothelial Dysfunction|endothelial dysfunction
96269|NCT02964585|CD34+|cd34+
96270|NCT02964585|Impaired renal function|impaired renal function
96271|NCT02964546|direct oral anticoagulants|direct oral anticoagulants
96272|NCT02964546|atrial fibrillation|atrial fibrillation
96273|NCT02964546|renal function|renal function
96274|NCT02964546|ckd-epi|ckd-epi
96275|NCT02964546|plasmatic concentration|plasmatic concentration
96276|NCT02964520|trait anxiety|trait anxiety
96277|NCT02964520|A/T neurofeedback|a/t neurofeedback
96278|NCT02964520|EEG biofeedback|eeg biofeedback
96279|NCT02964520|randomized|randomized
96280|NCT02964507|GSK525762|gsk525762
96281|NCT02964507|ER+ breast cancer|er+ breast cancer
96282|NCT02964507|mTPI|mtpi
96283|NCT02964481|malignant|malignant
96284|NCT02964481|genetics|genetics
96285|NCT02964481|RYR1|ryr1
96286|NCT02964481|CAC-NA1S|cac-na1s
96287|NCT02964481|hyperthermia|hyperthermia
96288|NCT02964468|Rectal Cancer|rectal cancer
96289|NCT02964468|IMRT|imrt
96290|NCT02964468|Radiation Dose Escalation|radiation dose escalation
96291|NCT02964455|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
96292|NCT02964455|Chemoradiotherapy|chemoradiotherapy
96293|NCT02964455|Docetaxel|docetaxel
96294|NCT02964455|Nedaplatin|nedaplatin
96295|NCT02964455|Twice weekly|twice weekly
96296|NCT02964416|supratentorial craniotomy|supratentorial craniotomy
96297|NCT02964416|extubation response|extubation response
96298|NCT02964416|emergence|emergence
96299|NCT02964416|tramadol|tramadol
96300|NCT02964403|COX-2|cox-2
96301|NCT02964403|ERCP|ercp
96302|NCT02964403|Pancreatitis|pancreatitis
96303|NCT02964390|CTEPH|cteph
96304|NCT02964390|balloon pulmonary angioplasty|balloon pulmonary angioplasty
96305|NCT02964377|Pediatric|pediatric
96306|NCT02964377|muscle disease|muscle disease
96307|NCT02964377|Duchenne muscular dystrophy|duchenne muscular dystrophy
96308|NCT02964377|cardiomyopathy|cardiomyopathy
96309|NCT02964364|TAKAYASU ARTERITIS|takayasu arteritis
96310|NCT02964351|MicroRNA|microrna
96311|NCT02964351|Prostate Carcinoma|prostate carcinoma
96312|NCT02964351|PET-MR|pet-mr
96313|NCT02964325|hypoproliferative thrombocytopenia|hypoproliferative thrombocytopenia
96314|NCT02964325|hematologic malignancies|hematologic malignancies
96315|NCT02964325|thrombocytopenia|thrombocytopenia
96316|NCT02964325|platelet therapy|platelet therapy
96317|NCT02964325|apheresis|apheresis
96318|NCT02964325|pathogen reduction therapy|pathogen reduction therapy
96319|NCT02964299|Gastrointestinal endoscopy|gastrointestinal endoscopy
96320|NCT02964299|Moderate sedation|moderate sedation
96321|NCT02964299|Airway management|airway management
96322|NCT02964286|Cancer|cancer
96323|NCT02964286|Acupressure|acupressure
96324|NCT02964286|Hematopoietic Cell Growth Factors|hematopoietic cell growth factors
96325|NCT02964273|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
96326|NCT02964273|ADPKD|adpkd
96327|NCT02964273|Tolvaptan|tolvaptan
96328|NCT02964273|Renal cysts|renal cysts
96329|NCT02964273|Chronic Kidney Disease|chronic kidney disease
96330|NCT02964273|Genetic Kidney Disease|genetic kidney disease
96331|NCT02964260|Hepatocellular Carcinoma; Embolization; Ablation; simultaneously; sequentially|hepatocellular carcinoma; embolization; ablation; simultaneously; sequentially
96332|NCT02964234|Mammography Screening|mammography screening
96333|NCT02964234|Latinas|latinas
96334|NCT02964234|Breast cancer disparities|breast cancer disparities
96335|NCT02964208|Atrial Fibrillation|atrial fibrillation
96336|NCT02964208|Thromboembolism|thromboembolism
96337|NCT02964208|Stroke|stroke
96338|NCT02964208|ACP|acp
96339|NCT02964208|Left Atrial Appendage|left atrial appendage
96340|NCT02964208|Cardiac Plug|cardiac plug
96341|NCT02964182|Mental and Behavioral Disorders Due to Use of Tobacco|mental and behavioral disorders due to use of tobacco
96342|NCT02964182|Carbon monoxide Testing|carbon monoxide testing
96343|NCT02964182|CO|co
96344|NCT02964182|Questionnaires|questionnaires
96345|NCT02964182|Surveys|surveys
96346|NCT02964182|Smartphone assessments|smartphone assessments
96347|NCT02964182|Electronic assessments|electronic assessments
96348|NCT02964182|Usual brand cigarettes|usual brand cigarettes
96349|NCT02964182|UB|ub
96350|NCT02964182|Very Low Nicotine Content Cigarettes|very low nicotine content cigarettes
96351|NCT02964182|VLNCC|vlncc
96352|NCT02964182|E-cigarettes|e-cigarettes
96353|NCT02964182|ECIG|ecig
96354|NCT02964156|RA|ra
96355|NCT02964156|Insole|insole
96356|NCT02964156|Forefoot|forefoot
96357|NCT02964156|Walking Ability|walking ability
96358|NCT02964156|Pain|pain
96359|NCT02964117|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
96360|NCT02964091|Hepatitis C Virus|hepatitis c virus
96361|NCT02964091|sofosbuvir/ledipasvir|sofosbuvir/ledipasvir
96362|NCT02964091|Efficacy|efficacy
96363|NCT02964078|Kidney Disease|kidney disease
96364|NCT02964078|Metastatic|metastatic
96365|NCT02964078|Antibody|antibody
96366|NCT02964065|Influenza Vaccines|influenza vaccines
96367|NCT02964065|LAIV|laiv
96368|NCT02964039|stroke|stroke
96369|NCT02964039|rehabilitation|rehabilitation
96370|NCT02964039|gait|gait
96371|NCT02964026|pulmonary artery catheter|pulmonary artery catheter
96372|NCT02964026|Swan-Ganz catheter|swan-ganz catheter
96373|NCT02964013|Programmed Cell Death Receptor 1 (PD-1)|programmed cell death receptor 1 (pd-1)
96374|NCT02964013|Programmed Cell Death Receptor Ligand 1 (PD-L1)|programmed cell death receptor ligand 1 (pd-l1)
96375|NCT02964013|Programmed Cell Death Receptor Ligand 2 (PD-L2)|programmed cell death receptor ligand 2 (pd-l2)
96376|NCT02964013|PD-1|pd-1
96377|NCT02964013|PDL1|pdl1
96378|NCT02964013|PD-L1|pd-l1
96379|NCT02964013|PD-L2|pd-l2
96380|NCT02964000|Pain|pain
96381|NCT02964000|Low level laser therapy|low level laser therapy
96382|NCT02964000|Sham|sham
96383|NCT02964000|Chronic Pain|chronic pain
96384|NCT02964000|Opioid|opioid
96385|NCT02964000|Physical activity|physical activity
96386|NCT02964000|Quality of sleep|quality of sleep
96387|NCT02963974|cochlear implant|cochlear implant
96388|NCT02963961|Delirium|delirium
96389|NCT02963961|Cognition|cognition
96390|NCT02963961|Prehabilitation|prehabilitation
96391|NCT02963961|Neuroplasticity|neuroplasticity
96392|NCT02963909|Adjuvant|adjuvant
96393|NCT02963909|Alum|alum
96394|NCT02963909|Inactivated|inactivated
96395|NCT02963909|Purified|purified
96396|NCT02963909|Vaccine|vaccine
96397|NCT02963909|Virus|virus
96398|NCT02963909|Zika|zika
96399|NCT02963896|vestibular rehabilitation|vestibular rehabilitation
96400|NCT02963883|ScVO2|scvo2
96401|NCT02963883|Post operative red cell transfusion|post operative red cell transfusion
96402|NCT02963870|Cognitive behavioral|cognitive behavioral
96403|NCT02963870|security plan|security plan
96404|NCT02963870|suicidal Recidivism in adolescents|suicidal recidivism in adolescents
96405|NCT02963857|breast surgery|breast surgery
96406|NCT02963857|acute pain|acute pain
96407|NCT02963857|regional anesthesia|regional anesthesia
96408|NCT02963831|Oncos-102|oncos-102
96409|NCT02963831|Durvalumab|durvalumab
96410|NCT02963831|Peritoneal|peritoneal
96411|NCT02963831|Cyclophosphamide|cyclophosphamide
96412|NCT02963818|Brief intervention|brief intervention
96413|NCT02963818|Harm reduction|harm reduction
96414|NCT02963818|Young adult|young adult
96415|NCT02963818|College Student|college student
96416|NCT02963805|Children|children
96417|NCT02963805|Physical activity|physical activity
96418|NCT02963805|Physical competence|physical competence
96419|NCT02963805|Obesity|obesity
96420|NCT02963805|School|school
96421|NCT02963805|Health|health
96422|NCT02963805|Fundamental movement skills|fundamental movement skills
96423|NCT02963792|Professionalism|professionalism
96424|NCT02963792|Burnout prevention|burnout prevention
96425|NCT02963792|Resiliency|resiliency
96426|NCT02963792|Student education|student education
96427|NCT02963766|Pediatrics|pediatrics
96428|NCT02963753|Hyperemesis gravidarum|hyperemesis gravidarum
96429|NCT02963753|gestational diabetes mellitus|gestational diabetes mellitus
96430|NCT02963753|oral glucose tolerance test|oral glucose tolerance test
96431|NCT02963740|breast cancer survivor|breast cancer survivor
96432|NCT02963740|weight loss program|weight loss program
96433|NCT02963727|osteoarthrosis|osteoarthrosis
96434|NCT02963727|Knee|knee
96435|NCT02963727|Wharton Jelly|wharton jelly
96436|NCT02963714|Hepatitis B, Vaccine|hepatitis b, vaccine
96437|NCT02963714|Randomized Controlled Trial|randomized controlled trial
96438|NCT02963714|Hemodialysis|hemodialysis
96439|NCT02963714|Immunogenicity|immunogenicity
96440|NCT02963662|obesity|obesity
96441|NCT02963662|bariatric surgery|bariatric surgery
96442|NCT02963662|gut hormones|gut hormones
96443|NCT02963662|inflammatory adipokine|inflammatory adipokine
96444|NCT02963649|Drug-eluting angioplasty balloon, Drug coated angioplasty balloon, Experimental, percutaneous transluminal angioplasty (PTA)|drug-eluting angioplasty balloon, drug coated angioplasty balloon, experimental, percutaneous transluminal angioplasty (pta)
96445|NCT02963636|family medicine group|family medicine group
96446|NCT02963636|pharmacists|pharmacists
96447|NCT02963636|primary health care|primary health care
96448|NCT02963636|pharmaceutical services|pharmaceutical services
96449|NCT02963636|interprofessional relations|interprofessional relations
96450|NCT02963623|fibtem|fibtem
96451|NCT02963623|total knee replacement|total knee replacement
96452|NCT02963584|chronic total occlusion|chronic total occlusion
96453|NCT02963584|decision aid|decision aid
96454|NCT02963506|AS|as
96455|NCT02963506|Ankylosing Spondylitis|ankylosing spondylitis
96456|NCT02963506|Bimekizumab|bimekizumab
96457|NCT02963493|relapsed refractory multiple myeloma|relapsed refractory multiple myeloma
96458|NCT02963467|multiple inert gas elimination technique|multiple inert gas elimination technique
96459|NCT02963467|smoking|smoking
96460|NCT02963467|pulmonary disorder|pulmonary disorder
96461|NCT02963441|Diabetic Retinopathy|diabetic retinopathy
96462|NCT02963441|Macular Edema|macular edema
96463|NCT02963415|Subjective memory complaint|subjective memory complaint
96464|NCT02963363|Breast cancer|breast cancer
96465|NCT02963363|HER2+|her2+
96466|NCT02963363|Adapted physical activity|adapted physical activity
96467|NCT02963363|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
96468|NCT02963337|remifentanil|remifentanil
96469|NCT02963337|combined spinal-epidural analgesia|combined spinal-epidural analgesia
96470|NCT02963337|multiparous|multiparous
96471|NCT02963272|Heart failure|heart failure
96472|NCT02963272|ST2|st2
96473|NCT02963272|fibrosis|fibrosis
96474|NCT02963246|mindfulness|mindfulness
96475|NCT02963246|quality of life|quality of life
96476|NCT02963246|Bowel Disease|bowel disease
96477|NCT02963207|colorectal polyp|colorectal polyp
96478|NCT02963207|colorectal lesion|colorectal lesion
96479|NCT02963207|Modified Sano's Classification|modified sano's classification
96480|NCT02963207|NICE classification|nice classification
96481|NCT02963207|NBI|nbi
96482|NCT02963207|PIVI guidelines|pivi guidelines
96483|NCT02963207|SSA/P|ssa/p
96484|NCT02963207|sessile serrated adenoma|sessile serrated adenoma
96485|NCT02963207|sessile serrated polyp|sessile serrated polyp
96486|NCT02963194|self-processing|self-processing
96487|NCT02963194|endowment effect|endowment effect
96488|NCT02963194|neuroimage|neuroimage
96489|NCT02963181|Melatonin|melatonin
96490|NCT02963181|Yohimbine|yohimbine
96491|NCT02963181|Anti-hypertensive agents|anti-hypertensive agents
96492|NCT02963155|prostate, metastatic|prostate, metastatic
96493|NCT02963142|Intensive care|intensive care
96494|NCT02963142|Extra-corporeal membrane oxygenation (ECMO)|extra-corporeal membrane oxygenation (ecmo)
96495|NCT02963142|Severe Respiratory Infections|severe respiratory infections
96496|NCT02963142|Sequencing|sequencing
96497|NCT02963142|Metagenome|metagenome
96498|NCT02963142|Diagnosis|diagnosis
96499|NCT02963129|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
96500|NCT02963129|Epistaxis|epistaxis
96501|NCT02963116|Pharmacokinetics (PK)|pharmacokinetics (pk)
96502|NCT02963116|Bioavailability (BA)|bioavailability (ba)
96503|NCT02963116|Safety|safety
96504|NCT02963116|Tolerability|tolerability
96505|NCT02963116|Healthy Volunteers|healthy volunteers
96506|NCT02963103|Tacrolimus|tacrolimus
96507|NCT02963103|Kidney transplantation|kidney transplantation
96508|NCT02963090|SCLC|sclc
96509|NCT02963090|small cell lung cancer|small cell lung cancer
96510|NCT02963090|lung cancer|lung cancer
96511|NCT02963090|topotecan|topotecan
96512|NCT02963090|pembrolizumab|pembrolizumab
96513|NCT02963064|Immunodeficiency|immunodeficiency
96514|NCT02963064|Pediatric|pediatric
96515|NCT02963064|SCID|scid
96516|NCT02963064|Bone Marrow Transplantation|bone marrow transplantation
96517|NCT02963064|GVHD|gvhd
96518|NCT02963064|Stem Cells|stem cells
96519|NCT02963064|Chimerism|chimerism
96520|NCT02963064|Transplant|transplant
96521|NCT02963064|BMT|bmt
96522|NCT02963051|metastatic castrate-resistant prostate cancer (mCRPC)|metastatic castrate-resistant prostate cancer (mcrpc)
96523|NCT02963051|neuroendocrine prostate cancer (NEPC)|neuroendocrine prostate cancer (nepc)
96650|NCT02962089|Undernutrition|undernutrition
96524|NCT02963051|adenocarcinoma castrate-resistant prostate cancer (CRPC)|adenocarcinoma castrate-resistant prostate cancer (crpc)
96525|NCT02963051|Copper|copper
96526|NCT02963051|Disulfiram|disulfiram
96527|NCT02962999|Ketamine|ketamine
96528|NCT02962999|One lung ventilation|one lung ventilation
96529|NCT02962999|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
96530|NCT02962986|vasopressor|vasopressor
96531|NCT02962986|blood pressure|blood pressure
96532|NCT02962986|cesarean section|cesarean section
96533|NCT02962986|spinal anesthesia|spinal anesthesia
96534|NCT02962973|Advanced heart failure|advanced heart failure
96535|NCT02962973|Total artificial heart|total artificial heart
96536|NCT02962947|Melanoma|melanoma
96537|NCT02962947|Propanolol|propanolol
96538|NCT02962947|Betablockers|betablockers
96539|NCT02962908|broad|broad
96540|NCT02962908|universal|universal
96541|NCT02962908|vaccine|vaccine
96542|NCT02962908|influenza|influenza
96543|NCT02962908|peptide|peptide
96544|NCT02962908|Tcell|tcell
96545|NCT02962908|UNISEC|unisec
96546|NCT02962843|Behavior Problem|behavior problem
96547|NCT02962843|Social Competence|social competence
96548|NCT02962843|Student|student
96549|NCT02962843|Children|children
96550|NCT02962830|fetal pain|fetal pain
96551|NCT02962830|fetal analgesia|fetal analgesia
96552|NCT02962804|kidney|kidney
96553|NCT02962804|renal cell|renal cell
96554|NCT02962804|cancer|cancer
96555|NCT02962804|metastatic|metastatic
96556|NCT02962804|recurrent|recurrent
96557|NCT02962791|symptomatic heart failure|symptomatic heart failure
96558|NCT02962778|treatment-resistant|treatment-resistant
96559|NCT02962739|healthy volunteers|healthy volunteers
96560|NCT02962726|Anorexia|anorexia
96561|NCT02962726|Depression|depression
96562|NCT02962726|Microbiome|microbiome
96563|NCT02962713|Atraumatic Restorative Treatment|atraumatic restorative treatment
96564|NCT02962713|glass ionomer cement|glass ionomer cement
96565|NCT02962713|primary teeth|primary teeth
96566|NCT02962713|dental caries.|dental caries.
96567|NCT02962700|continuous haemofiltration|continuous haemofiltration
96568|NCT02962700|intermittent haemodialysis|intermittent haemodialysis
96569|NCT02962687|Veterans|veterans
96570|NCT02962687|Cognitive impairments|cognitive impairments
96571|NCT02962687|Nursing care management|nursing care management
96572|NCT02962687|Videoconferencing|videoconferencing
96573|NCT02962674|BPH|bph
96574|NCT02962661|Other forms of heart disease|other forms of heart disease
96575|NCT02962661|Left ventricular dysfunction|left ventricular dysfunction
96576|NCT02962661|LV|lv
96577|NCT02962661|Heart failure secondary to chemotherapy with anthracyclines|heart failure secondary to chemotherapy with anthracyclines
96578|NCT02962661|Human mesenchymal stem cells|human mesenchymal stem cells
96579|NCT02962661|hMSCs|hmscs
96580|NCT02962661|Mesenchymal Stromal Cells|mesenchymal stromal cells
96581|NCT02962661|MSCs|mscs
96582|NCT02962661|Intravenous infusion|intravenous infusion
96583|NCT02962661|Transendocardial injection|transendocardial injection
96584|NCT02962661|Standard of care drugs for heart failure|standard of care drugs for heart failure
96585|NCT02962648|IDA|ida
96586|NCT02962622|Neurocognition|neurocognition
96587|NCT02962622|Exercise|exercise
96588|NCT02962622|Metabolism|metabolism
96589|NCT02962622|Hispanic women|hispanic women
96590|NCT02962609|Feeding|feeding
96591|NCT02962609|preterm infant|preterm infant
96592|NCT02962609|physiological characteristics|physiological characteristics
96593|NCT02962609|position|position
96594|NCT02962609|ESL|esl
96595|NCT02962609|ESU|esu
96596|NCT02962557|ventilatory depression|ventilatory depression
96597|NCT02962544|Femtosecond|femtosecond
96598|NCT02962544|Small incision lenticule extraction|small incision lenticule extraction
96599|NCT02962544|Lenticule extraction|lenticule extraction
96600|NCT02962544|LASIK|lasik
96601|NCT02962544|Myopia|myopia
96602|NCT02962518|Pressure Device|pressure device
96603|NCT02962518|Clip|clip
96604|NCT02962518|Triamcinolone|triamcinolone
96605|NCT02962518|Fillet Technique|fillet technique
96606|NCT02962492|Dapagliflozin|dapagliflozin
96607|NCT02962492|Ketogenesis|ketogenesis
96608|NCT02962492|Type 1 Diabetes|type 1 diabetes
96609|NCT02962492|DKA|dka
96610|NCT02962492|ketones|ketones
96611|NCT02962492|exenatide/Bydureon|exenatide/bydureon
96612|NCT02962414|Everolimus|everolimus
96613|NCT02962414|Tuberous sclerosis complex|tuberous sclerosis complex
96614|NCT02962414|TSC|tsc
96615|NCT02962414|Refractory seizure|refractory seizure
96616|NCT02962414|Roll over study|roll over study
96617|NCT02962414|Long term safety|long term safety
96618|NCT02962414|PASS|pass
96619|NCT02962388|efficacy|efficacy
96620|NCT02962388|safety|safety
96621|NCT02962375|orange pomace fiber|orange pomace fiber
96622|NCT02962375|glycemic response|glycemic response
96623|NCT02962297|Vitamin E, Non Diabetic|vitamin e, non diabetic
96624|NCT02962271|Musculoskeletal Ultrasound|musculoskeletal ultrasound
96625|NCT02962271|Psoriatic Arthritis|psoriatic arthritis
96626|NCT02962271|Enthesopathy|enthesopathy
96627|NCT02962245|Ulcerative Colitis|ulcerative colitis
96628|NCT02962245|Berberine|berberine
96629|NCT02962232|drug eluting balloon|drug eluting balloon
96630|NCT02962232|arterial vasculature below the knee|arterial vasculature below the knee
96631|NCT02962219|oesophagectomy|oesophagectomy
96632|NCT02962193|ADL|adl
96633|NCT02962193|Bariatric surgery|bariatric surgery
96634|NCT02962193|Daily participation|daily participation
96635|NCT02962180|derma-rolling system, vitiligo|derma-rolling system, vitiligo
96636|NCT02962167|measles virus|measles virus
96637|NCT02962167|recurrent medulloblastoma|recurrent medulloblastoma
96638|NCT02962167|recurrent ATRT|recurrent atrt
96639|NCT02962154|Invasive Coronary Angiography|invasive coronary angiography
96640|NCT02962154|Myocardial Infarction|myocardial infarction
96641|NCT02962154|Major Depressive Disorder|major depressive disorder
96642|NCT02962154|Bipolar I Disorder|bipolar i disorder
96643|NCT02962154|Bipolar II Disorder|bipolar ii disorder
96644|NCT02962154|Mental Stress|mental stress
96645|NCT02962141|drug eluting balloon, Arteriovenous Fistulae|drug eluting balloon, arteriovenous fistulae
96646|NCT02962089|Protein-energy wasting|protein-energy wasting
96647|NCT02962089|Hemodialysis patients|hemodialysis patients
96648|NCT02962089|Microbiota|microbiota
96649|NCT02962089|Branched chain amino acids|branched chain amino acids
96651|NCT02962089|Malnutrition|malnutrition
96652|NCT02962089|Renal failure|renal failure
96653|NCT02962089|Dialysis|dialysis
96654|NCT02962089|Protein|protein
96655|NCT02962089|Appetite|appetite
96656|NCT02962089|Body composition|body composition
96657|NCT02962089|Energy expenditure|energy expenditure
96658|NCT02962063|Durvalumab|durvalumab
96659|NCT02962063|Anti-PD-L1 Antibody|anti-pd-l1 antibody
96660|NCT02962063|16-1405|16-1405
96661|NCT02962011|Cesarean, incision, suture,|cesarean, incision, suture,
96662|NCT02961998|hepatocellular carcinoma|hepatocellular carcinoma
96663|NCT02961998|sorafenib|sorafenib
96664|NCT02961998|celecoxib|celecoxib
96665|NCT02961972|vegetarianism|vegetarianism
96666|NCT02961972|Hyperhomocysteinemia|hyperhomocysteinemia
96667|NCT02961972|vegan vegetarian|vegan vegetarian
96668|NCT02961933|hypoxemia|hypoxemia
96669|NCT02961933|intubation|intubation
96670|NCT02961933|apneic oxygenation|apneic oxygenation
96671|NCT02961907|periconceptional habits|periconceptional habits
96672|NCT02961907|Pregnancy|pregnancy
96673|NCT02961907|Infertility|infertility
96674|NCT02961894|Atherectomy|atherectomy
96675|NCT02961894|Atherosclerosis|atherosclerosis
96676|NCT02961868|Renal Artery Obstruction|renal artery obstruction
96677|NCT02961868|Carotid Artery Diseases|carotid artery diseases
96678|NCT02961868|Genetic Association Studies|genetic association studies
96679|NCT02961829|Dendritic Cell vaccination using|dendritic cell vaccination using
96680|NCT02961829|antiretroviral intensification|antiretroviral intensification
96681|NCT02961829|Auranofin|auranofin
96682|NCT02961829|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
96683|NCT02961829|residual viral replication|residual viral replication
96684|NCT02961829|HIV sanctuaries|hiv sanctuaries
96685|NCT02961829|HIV latency|hiv latency
96686|NCT02961816|Lymphoma|lymphoma
96687|NCT02961816|Refractory/Relapsed Lymphoma|refractory/relapsed lymphoma
96688|NCT02961816|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
96689|NCT02961816|Hodgkin's lymphoma|hodgkin's lymphoma
96690|NCT02961816|T-cell Lymphoma|t-cell lymphoma
96691|NCT02961816|Palifermin|palifermin
96692|NCT02961816|Kepivance|kepivance
96693|NCT02961816|Panobinostat|panobinostat
96694|NCT02961816|LBH589B|lbh589b
96695|NCT02961816|Gemcitabine|gemcitabine
96696|NCT02961816|Gemcitabine Hydrochloride|gemcitabine hydrochloride
96697|NCT02961816|Gemzar|gemzar
96698|NCT02961816|Busulfan|busulfan
96699|NCT02961816|Busulfex|busulfex
96700|NCT02961816|Myleran|myleran
96701|NCT02961816|Melphalan|melphalan
96702|NCT02961816|Alkeran|alkeran
96703|NCT02961816|Rituximab|rituximab
96704|NCT02961816|Rituxan|rituxan
96705|NCT02961816|Dexamethasone|dexamethasone
96706|NCT02961816|Decadron|decadron
96707|NCT02961816|Caphosol|caphosol
96708|NCT02961816|Glutamine|glutamine
96709|NCT02961816|Enterex|enterex
96710|NCT02961816|Glutapak-10|glutapak-10
96711|NCT02961816|NutreStore|nutrestore
96712|NCT02961816|Resource|resource
96713|NCT02961816|GlutaSolve|glutasolve
96714|NCT02961816|Sympt-X G.I.|sympt-x g.i.
96715|NCT02961816|Sympt-X|sympt-x
96716|NCT02961816|Pyridoxine|pyridoxine
96717|NCT02961816|G-CSF|g-csf
96718|NCT02961816|Filgrastim|filgrastim
96719|NCT02961816|Neupogen|neupogen
96720|NCT02961816|Stem cell transplant|stem cell transplant
96721|NCT02961803|AMN|amn
96722|NCT02961803|MD1003|md1003
96723|NCT02961803|Adrenomyeloneuropathy|adrenomyeloneuropathy
96724|NCT02961803|ALD|ald
96725|NCT02961803|Adrenoleukodystrophy|adrenoleukodystrophy
96726|NCT02961803|Biotin|biotin
96727|NCT02961803|2MWT|2mwt
96728|NCT02961803|Two-minute walk test|two-minute walk test
96729|NCT02961803|TW25|tw25
96730|NCT02961803|Timed 25-Foot Walk|timed 25-foot walk
96731|NCT02961764|Critical Pathways|critical pathways
96732|NCT02961764|Health Facilities|health facilities
96733|NCT02961764|Clinical Protocols|clinical protocols
96734|NCT02961764|Patient Satisfaction|patient satisfaction
96735|NCT02961764|Absenteeism|absenteeism
96736|NCT02961764|Anti-Bacterial Agents|anti-bacterial agents
96737|NCT02961764|Quality of Life|quality of life
96738|NCT02961764|Economics, Medical|economics, medical
96739|NCT02961764|Health Resources|health resources
96740|NCT02961764|Health resource utilization|health resource utilization
96741|NCT02961764|Acute bacterial skin and skin structure infection (ABSSSI)|acute bacterial skin and skin structure infection (absssi)
96742|NCT02961751|Ciprofloxacin-susceptibility|ciprofloxacin-susceptibility
96743|NCT02961751|Gyrase A Assay|gyrase a assay
96744|NCT02961751|Neisseria gonorrhoeae|neisseria gonorrhoeae
96745|NCT02961647|Hemodynamic stress test|hemodynamic stress test
96746|NCT02961647|Surgical intervention|surgical intervention
96747|NCT02961634|onychomycosis|onychomycosis
96748|NCT02961634|nail|nail
96749|NCT02961595|Oral polio vaccine|oral polio vaccine
96750|NCT02961595|Inactivated polio vaccine|inactivated polio vaccine
96751|NCT02961595|Enterovirus|enterovirus
96752|NCT02961595|Type 1 diabetes|type 1 diabetes
96753|NCT02961595|Autoantibody|autoantibody
96754|NCT02961582|Sacral neuromodulation|sacral neuromodulation
96755|NCT02961582|Constipation|constipation
96756|NCT02961582|Slow-transit constipation|slow-transit constipation
96757|NCT02961582|Surgery|surgery
96758|NCT02961582|Colorectal surgery|colorectal surgery
96759|NCT02961582|Cost-effectiveness|cost-effectiveness
96760|NCT02961582|Quality of life|quality of life
96761|NCT02961556|AJG555|ajg555
96762|NCT02961556|Constipation|constipation
96763|NCT02961556|Phase 3|phase 3
96764|NCT02961556|Pediatric participants|pediatric participants
96765|NCT02961491|MIBG|mibg
96766|NCT02961491|Azedra|azedra
96767|NCT02961491|Rare neuroendocrine tumors|rare neuroendocrine tumors
96768|NCT02961491|Iobenguane I 131|iobenguane i 131
96769|NCT02961491|Progenics|progenics
96770|NCT02961465|Sacral neuromodulation|sacral neuromodulation
96771|NCT02961465|Constipation|constipation
96772|NCT02961465|Slow-transit constipation|slow-transit constipation
96773|NCT02961465|Surgery|surgery
96774|NCT02961465|Colorectal surgery|colorectal surgery
96775|NCT02961465|Cost-effectiveness|cost-effectiveness
96776|NCT02961465|Quality of life|quality of life
96777|NCT02961387|Tracheal stenosis, Hydrogen generator, Hydrogen-oxygen, Dyspnea.|tracheal stenosis, hydrogen generator, hydrogen-oxygen, dyspnea.
96778|NCT02961361|dexmedetomidine|dexmedetomidine
96779|NCT02961361|coracoid|coracoid
96780|NCT02961361|brachial plexus block|brachial plexus block
96781|NCT02961348|Oral anticoagulants (NOAC)|oral anticoagulants (noac)
96783|NCT02961309|marijuana|marijuana
96784|NCT02961309|tobacco cigarette|tobacco cigarette
96785|NCT02961309|smoking|smoking
96786|NCT02961296|Helicobacter Pylori|helicobacter pylori
96787|NCT02961283|BRAF Kinases|braf kinases
96788|NCT02961283|PIK3CA protein, human|pik3ca protein, human
96789|NCT02961244|Surgical Site Infection|surgical site infection
96790|NCT02961244|normothermia|normothermia
96791|NCT02961244|hypothermia|hypothermia
96792|NCT02961244|prewarming|prewarming
96793|NCT02961231|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
96794|NCT02961231|Herd immunity|herd immunity
96795|NCT02961231|Reduced dosing schedule|reduced dosing schedule
96796|NCT02961218|Sickle cell disease|sickle cell disease
96797|NCT02961218|hemoglobinopathy|hemoglobinopathy
96798|NCT02961218|pediatric|pediatric
96799|NCT02961166|IVIG|ivig
96800|NCT02961166|ARDS|ards
96801|NCT02961166|ECMO|ecmo
96802|NCT02961140|Outcome|outcome
96803|NCT02961127|tissue factor pathway inhibitor|tissue factor pathway inhibitor
96804|NCT02961114|Prostatitis, Chronic|prostatitis, chronic
96805|NCT02961114|Nocturia|nocturia
96806|NCT02961114|BPH With Urinary Obstruction|bph with urinary obstruction
96807|NCT02961101|relapsed or refractory|relapsed or refractory
96808|NCT02961101|malignancies|malignancies
96809|NCT02961101|decitabine|decitabine
96810|NCT02961101|anti-PD-1 antibody|anti-pd-1 antibody
96811|NCT02961088|Systematic review and meta-analysis|systematic review and meta-analysis
96812|NCT02961088|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
96813|NCT02961088|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
96814|NCT02961088|Clinical practice guidelines|clinical practice guidelines
96815|NCT02961088|Glycemic index|glycemic index
96816|NCT02961088|Pasta|pasta
96817|NCT02961088|Glycemic load|glycemic load
96818|NCT02961088|Body weight|body weight
96819|NCT02961088|Cardiovascular risk factors|cardiovascular risk factors
96820|NCT02961088|Cardiovascular disease|cardiovascular disease
96821|NCT02961062|ocular pain|ocular pain
96822|NCT02961062|photorefractive keratectomy (PRK)|photorefractive keratectomy (prk)
96823|NCT02961062|SAF312|saf312
96824|NCT02961062|corneal epithelial defect|corneal epithelial defect
96825|NCT02961036|Surveys and Questionnaires|surveys and questionnaires
96826|NCT02961010|school based prevention, child sexual and domestic abuse|school based prevention, child sexual and domestic abuse
96827|NCT02960997|epidermolysis bullosa simplex|epidermolysis bullosa simplex
96828|NCT02960958|Rheumatoid arthritis|rheumatoid arthritis
96829|NCT02960958|Metabolomics|metabolomics
96830|NCT02960958|urine|urine
96831|NCT02960932|Hemiplegic|hemiplegic
96832|NCT02960932|Child|child
96833|NCT02960932|Elastography|elastography
96834|NCT02960932|paralysis|paralysis
96835|NCT02960893|Ataxia|ataxia
96836|NCT02960893|SCA|sca
96837|NCT02960893|Spinocerebellar Ataxia|spinocerebellar ataxia
96838|NCT02960880|Rivaroxaban, Phenprocoumon, retrospective cohort study, Non-Valvular Atrial fibrillation, NVAF|rivaroxaban, phenprocoumon, retrospective cohort study, non-valvular atrial fibrillation, nvaf
96839|NCT02960867|paediatric|paediatric
96840|NCT02960867|kidney|kidney
96841|NCT02960815|influenza vaccine|influenza vaccine
96842|NCT02960815|Transplantation|transplantation
96843|NCT02960815|imiquimod|imiquimod
96844|NCT02960815|HIV infection|hiv infection
96845|NCT02960815|immunogenicity|immunogenicity
96846|NCT02960802|kidney transplant|kidney transplant
96847|NCT02960802|renal blood flow|renal blood flow
96848|NCT02960789|Dehydration|dehydration
96849|NCT02960789|Children|children
96850|NCT02960789|Measurement|measurement
96851|NCT02960776|Body Weight|body weight
96852|NCT02960776|Habitual sleep|habitual sleep
96853|NCT02960763|Comparative Effectiveness Research|comparative effectiveness research
96854|NCT02960763|Pragmatic Clinical Trials|pragmatic clinical trials
96855|NCT02960763|Patient-Centered Outcomes Research|patient-centered outcomes research
96856|NCT02960750|workplace|workplace
96857|NCT02960750|sedentary behavior|sedentary behavior
96858|NCT02960750|physical activity|physical activity
96859|NCT02960750|physical risk factors|physical risk factors
96860|NCT02960750|mental well-being|mental well-being
96861|NCT02960750|presenteeism|presenteeism
96862|NCT02960750|work productivity|work productivity
96863|NCT02960750|activity-related energy expenditures|activity-related energy expenditures
96864|NCT02960737|Dysphagia|dysphagia
96865|NCT02960737|Stroke|stroke
96866|NCT02960737|Intervention|intervention
96867|NCT02960737|Oral screen|oral screen
96868|NCT02960737|Incidence|incidence
96869|NCT02960724|Uroplasminogen Plasminogen Activator Receptor|uroplasminogen plasminogen activator receptor
96870|NCT02960724|Oropharyngeal cancer|oropharyngeal cancer
96871|NCT02960724|oral cancer|oral cancer
96872|NCT02960724|Positron Emission Tomography|positron emission tomography
96873|NCT02960698|cognitive impulsivity|cognitive impulsivity
96874|NCT02960698|IRM|irm
96875|NCT02960698|Tourette Syndrome|tourette syndrome
96876|NCT02960672|KL-6|kl-6
96877|NCT02960672|disease progression|disease progression
96878|NCT02960672|predict|predict
96879|NCT02960672|biomarkers|biomarkers
96880|NCT02960672|MMP-7|mmp-7
96881|NCT02960659|Metformin|metformin
96882|NCT02960659|Glucose|glucose
96883|NCT02960646|Leukemia|leukemia
96884|NCT02960646|Blood And Marrow Transplantation|blood and marrow transplantation
96885|NCT02960646|Acute lymphocytic leukemia|acute lymphocytic leukemia
96886|NCT02960646|ALL|all
96887|NCT02960646|Acute myeloid leukemia|acute myeloid leukemia
96888|NCT02960646|AML|aml
96889|NCT02960646|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
96890|NCT02960646|CLL|cll
96891|NCT02960646|Chronic myeloid leukemia|chronic myeloid leukemia
96892|NCT02960646|CML|cml
96893|NCT02960646|Hodgkin's disease|hodgkin's disease
96894|NCT02960646|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
96895|NCT02960646|NHL|nhl
96896|NCT02960646|Small lymphocytic lymphoma|small lymphocytic lymphoma
96897|NCT02960646|SLL|sll
96898|NCT02960646|Myelodysplastic syndrome (MDS|myelodysplastic syndrome (mds
96899|NCT02960646|MDS|mds
96900|NCT02960646|Aplastic anemia|aplastic anemia
96901|NCT02960646|Modified (CD45RA depleted) peripheral blood (PB) stem cell infusion|modified (cd45ra depleted) peripheral blood (pb) stem cell infusion
96902|NCT02960646|T cells|t cells
96903|NCT02960646|Haploidentical transplantation|haploidentical transplantation
96904|NCT02960646|Rituximab|rituximab
96905|NCT02960646|Rituxan|rituxan
96906|NCT02960646|Melphalan|melphalan
96907|NCT02960646|Alkeran|alkeran
96908|NCT02960646|Fludarabine|fludarabine
96909|NCT02960646|Fludarabine Phosphate|fludarabine phosphate
96910|NCT02960646|Fludara|fludara
96911|NCT02960646|Cyclophosphamide|cyclophosphamide
96912|NCT02960646|Cytoxan|cytoxan
96913|NCT02960646|Neosar|neosar
96914|NCT02960646|G-CSF|g-csf
96915|NCT02960646|Filgrastim|filgrastim
96916|NCT02960646|Neupogen|neupogen
96917|NCT02960620|Humanitarian Device Exemption|humanitarian device exemption
96918|NCT02960620|Liver Disease|liver disease
96919|NCT02960620|HDE #980006|hde #980006
96920|NCT02960594|Immunotherapy|immunotherapy
96921|NCT02960594|Human Telomerase Reverse Transcriptase (hTERT)|human telomerase reverse transcriptase (htert)
96922|NCT02960594|Breast Neoplasms|breast neoplasms
96923|NCT02960594|Lung Neoplasms|lung neoplasms
96924|NCT02960594|Pancreatic Neoplasms|pancreatic neoplasms
96925|NCT02960594|High Risk of Relapse|high risk of relapse
96926|NCT02960594|Post Definitive Surgery|post definitive surgery
96927|NCT02960594|Post Adjuvant Therapy|post adjuvant therapy
96928|NCT02960594|No Evidence of Disease|no evidence of disease
96929|NCT02960568|primaquine|primaquine
96930|NCT02960568|metabolism|metabolism
96931|NCT02960568|malaria|malaria
96932|NCT02960568|hypnozoite|hypnozoite
96933|NCT02960568|vivax|vivax
96934|NCT02960568|CYP2D6|cyp2d6
96935|NCT02960568|active duty personnel|active duty personnel
96936|NCT02960555|Myeloma|myeloma
96937|NCT02960555|Smoldering Multiple Myeloma|smoldering multiple myeloma
96938|NCT02960555|SMM|smm
96939|NCT02960555|Intermediate or high risk|intermediate or high risk
96940|NCT02960555|SAR650984|sar650984
96941|NCT02960555|Diphenhydramine|diphenhydramine
96942|NCT02960555|Benadryl|benadryl
96943|NCT02960555|Ranitidine|ranitidine
96944|NCT02960555|Ranitidine Hydrochloride|ranitidine hydrochloride
96945|NCT02960555|Zantac|zantac
96946|NCT02960555|Methylprednisolone|methylprednisolone
96947|NCT02960555|Depo-Medrol|depo-medrol
96948|NCT02960555|Medrol|medrol
96949|NCT02960555|Solu-Medrol|solu-medrol
96950|NCT02960542|lifestyle intervention|lifestyle intervention
96951|NCT02960542|weight-loss|weight-loss
96952|NCT02960503|sickle cell disease|sickle cell disease
96953|NCT02960503|pulmonary complications|pulmonary complications
96954|NCT02960503|reduced FEV1|reduced fev1
96955|NCT02960503|azithromycin|azithromycin
96956|NCT02960503|lung function|lung function
96957|NCT02960490|E6011|e6011
96958|NCT02960490|rheumatoid arthritis|rheumatoid arthritis
96959|NCT02960477|Shoulder pain|shoulder pain
96960|NCT02960477|Shoulder surgery|shoulder surgery
96961|NCT02960477|Pain neuroscience education|pain neuroscience education
96962|NCT02960477|Chronic pain|chronic pain
96963|NCT02960464|Parkinson Disease|parkinson disease
96964|NCT02960464|Depression|depression
96965|NCT02960464|Transcranial Direct Current Stimulation|transcranial direct current stimulation
96966|NCT02960464|Neuromodulation|neuromodulation
96967|NCT02960451|prodrome|prodrome
96968|NCT02960451|cognitive behavioral therapy|cognitive behavioral therapy
96969|NCT02960451|family focused therapy|family focused therapy
96970|NCT02960438|E6011|e6011
96971|NCT02960438|rheumatoid arthritis|rheumatoid arthritis
96972|NCT02960373|Dried fruit|dried fruit
96973|NCT02960373|Glycemic Index|glycemic index
96974|NCT02960373|Catalytic dose|catalytic dose
96975|NCT02960373|Glycemic response|glycemic response
96976|NCT02960373|Fructose|fructose
96977|NCT02960373|Postprandial|postprandial
96978|NCT02960373|Randomized clinical trial|randomized clinical trial
96979|NCT02960373|Carbohydrate metabolism|carbohydrate metabolism
96980|NCT02960334|Screening|screening
96981|NCT02960334|Silent Atrial Fibrillation|silent atrial fibrillation
96982|NCT02960334|Undertreated Atrial Fibrillation|undertreated atrial fibrillation
96983|NCT02960334|Actionable Atrial Fibrillation|actionable atrial fibrillation
96984|NCT02960334|MyDiagnostick|mydiagnostick
96985|NCT02960334|Opportunistic Screening|opportunistic screening
96986|NCT02960334|Preoperative Consultation|preoperative consultation
96987|NCT02960334|OAC|oac
96988|NCT02960334|VKA|vka
96989|NCT02960334|NOAC|noac
96990|NCT02960321|myocardial injury|myocardial injury
96991|NCT02960321|high-sensitivity troponin I|high-sensitivity troponin i
96992|NCT02960321|periprocedural myocardial infarction|periprocedural myocardial infarction
96993|NCT02960269|rural health|rural health
96994|NCT02960269|telehealth|telehealth
96995|NCT02960269|physiotherapy|physiotherapy
96996|NCT02960269|interprofessional|interprofessional
96997|NCT02960243|Deep Brain Stimulation|deep brain stimulation
96998|NCT02960243|Laryngeal Motor Cortex|laryngeal motor cortex
96999|NCT02960243|Essential Voice Tremor|essential voice tremor
97000|NCT02960243|Essential Tremor|essential tremor
97001|NCT02960230|peptide vaccine|peptide vaccine
97002|NCT02960230|immunotherapy|immunotherapy
97003|NCT02960230|DIPG|dipg
97004|NCT02960230|vaccine|vaccine
97005|NCT02960204|cirrhosis|cirrhosis
97006|NCT02960204|Portal Hypertension|portal hypertension
97007|NCT02960204|Non-alcoholic Steatohepatitis|non-alcoholic steatohepatitis
97008|NCT02960204|Liver cirrhosis|liver cirrhosis
97009|NCT02960152|periodontitis|periodontitis
97010|NCT02960113|cesarean section|cesarean section
97011|NCT02960113|acupressure point p6|acupressure point p6
97012|NCT02960113|scopolamine patch|scopolamine patch
97013|NCT02960100|Cancer prevention|cancer prevention
97014|NCT02960100|HPV|hpv
97015|NCT02960100|Human papillomavirus vaccine|human papillomavirus vaccine
97016|NCT02960074|Allergy, Peanut|allergy, peanut
97017|NCT02960074|Hypersensitivity Peanut|hypersensitivity peanut
97018|NCT02960074|Peanut Allergy|peanut allergy
97019|NCT02960074|Donor Feces Infusion|donor feces infusion
97020|NCT02960074|Fecal Transplant|fecal transplant
97021|NCT02960074|Fecal Transplantation|fecal transplantation
97022|NCT02960074|Intestinal Microbiota Transfer|intestinal microbiota transfer
97023|NCT02960074|Fecal Microbiota Transplantation|fecal microbiota transplantation
97024|NCT02960074|Food allergy|food allergy
97025|NCT02960061|Intraperitoneal chemotherapy|intraperitoneal chemotherapy
97026|NCT02960061|gastric cancer|gastric cancer
97027|NCT02960061|Neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
97028|NCT02960048|Anterior disc displacement|anterior disc displacement
97029|NCT02960048|TMD therapy|tmd therapy
97030|NCT02960048|internal derangement|internal derangement
97031|NCT02960048|occlusal splint|occlusal splint
97032|NCT02960048|anterior repositioning splint|anterior repositioning splint
97033|NCT02960035|Mardird sonographic enthesis index|mardird sonographic enthesis index
97034|NCT02960035|Spondyloarthropathy|spondyloarthropathy
97035|NCT02960035|Ultrasonics|ultrasonics
97036|NCT02960035|Etanercept|etanercept
97037|NCT02960022|prostate cancer|prostate cancer
97038|NCT02960022|prednisone|prednisone
97040|NCT02960022|enzalutamide|enzalutamide
97041|NCT02960022|Xtandi|xtandi
97042|NCT02960022|abiraterone acetate|abiraterone acetate
97043|NCT02959944|chronic graft versus host disease|chronic graft versus host disease
97044|NCT02959944|PCYC1140|pcyc1140
97045|NCT02959944|PCYC1140IM|pcyc1140im
97046|NCT02959944|1140|1140
97047|NCT02959944|Ibrutinib|ibrutinib
97048|NCT02959944|GVHD|gvhd
97049|NCT02959944|Steroid dependent|steroid dependent
97050|NCT02959944|refractory|refractory
97051|NCT02959944|chronic|chronic
97052|NCT02959944|PCI32765|pci32765
97053|NCT02959944|IMBRUVICA|imbruvica
97054|NCT02959944|Pharmacyclics|pharmacyclics
97055|NCT02959944|PCYC|pcyc
97056|NCT02959944|graft versus host disease|graft versus host disease
97057|NCT02959944|immunology|immunology
97058|NCT02959944|new onset graft versus host disease|new onset graft versus host disease
97059|NCT02959944|INTEGRATE|integrate
97060|NCT02959944|Corticosteroids|corticosteroids
97061|NCT02959944|prednisone|prednisone
97062|NCT02959931|Dietary Potassium|dietary potassium
97063|NCT02959892|Drug therapy|drug therapy
97064|NCT02959879|FOLFOX|folfox
97065|NCT02959879|FOLFIRINOX|folfirinox
97066|NCT02959853|Hypogonadism|hypogonadism
97067|NCT02959853|Severe obesity|severe obesity
97068|NCT02959827|Hypothyroidism,|hypothyroidism,
97069|NCT02959827|children,|children,
97070|NCT02959827|iodinated contrast agents,|iodinated contrast agents,
97071|NCT02959827|retrospective cohort,|retrospective cohort,
97072|NCT02959827|database|database
97073|NCT02959814|Fractional Flow Reserve|fractional flow reserve
97074|NCT02959814|Quantitative Coronary Analysis|quantitative coronary analysis
97075|NCT02959814|Stable coronary artery disease|stable coronary artery disease
97076|NCT02959814|Angina pectoris|angina pectoris
97077|NCT02959801|Deep Venous Thrombosis|deep venous thrombosis
97078|NCT02959801|Percutaneous Mechanical Thrombectomy|percutaneous mechanical thrombectomy
97079|NCT02959788|Heart rate variability|heart rate variability
97080|NCT02959775|Hepatitis B vaccination|hepatitis b vaccination
97081|NCT02959775|Immunogenicity|immunogenicity
97082|NCT02959775|Randomized controlled trial|randomized controlled trial
97083|NCT02959775|Drug abuse|drug abuse
97084|NCT02959762|G01 [Biological Sciences]|g01 [biological sciences]
97085|NCT02959762|G02.513 [Nutrition]|g02.513 [nutrition]
97086|NCT02959762|G06.696.259 [Child Nutrition]|g06.696.259 [child nutrition]
97087|NCT02959762|G07.553.481.398.571 [Obesity]|g07.553.481.398.571 [obesity]
97088|NCT02959762|G06 [Biochemical Phenomena, Metabolism, and Nutrition]|g06 [biochemical phenomena, metabolism, and nutrition]
97089|NCT02959762|G12.392.617 [Insulin Resistance]|g12.392.617 [insulin resistance]
97090|NCT02959762|G06.696.259.500 [Adolescent Nutrition]|g06.696.259.500 [adolescent nutrition]
97091|NCT02959762|A06 [Endocrine System]|a06 [endocrine system]
97092|NCT02959762|A07 [Cardiovascular System]|a07 [cardiovascular system]
97093|NCT02959762|C18.452.297.681 [Obesity in Diabetes]|c18.452.297.681 [obesity in diabetes]
97094|NCT02959762|C18.452.555 [Insulin Resistance]|c18.452.555 [insulin resistance]
97095|NCT02959762|C18 [Nutritional and Metabolic Diseases]|c18 [nutritional and metabolic diseases]
97096|NCT02959762|C18.452.494 [Hyperlipidemia]|c18.452.494 [hyperlipidemia]
97097|NCT02959762|C18.452.460 [Hyperglycemia]|c18.452.460 [hyperglycemia]
97098|NCT02959762|C14 [Cardiovascular Diseases]|c14 [cardiovascular diseases]
97099|NCT02959762|D11.786.875.844 [Vitamin K 2]|d11.786.875.844 [vitamin k 2]
97100|NCT02959762|D02.806.550.750 [Vitamin K 2]|d02.806.550.750 [vitamin k 2]
97101|NCT02959762|E02.293 [Diet Therapy]|e02.293 [diet therapy]
97102|NCT02959762|E02 [Therapeutics]|e02 [therapeutics]
97103|NCT02959762|F04.096.544.215.508.428 [Primary Prevention]|f04.096.544.215.508.428 [primary prevention]
97104|NCT02959762|N01.224.425.525 [Nutritional Status]|n01.224.425.525 [nutritional status]
97105|NCT02959749|Osimertinib|osimertinib
97106|NCT02959749|EGFR T790M Resistant Mutation|egfr t790m resistant mutation
97107|NCT02959749|Docetaxel|docetaxel
97108|NCT02959749|Bevacizumab|bevacizumab
97109|NCT02959749|Non Small Cell Lung|non small cell lung
97110|NCT02959736|Vegetative State (VS)|vegetative state (vs)
97111|NCT02959736|Minimally Conscious State (MCS)|minimally conscious state (mcs)
97112|NCT02959736|Brain Injuries|brain injuries
97113|NCT02959723|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
97114|NCT02959723|BMPR2|bmpr2
97115|NCT02959723|Inflammation|inflammation
97116|NCT02959710|Healthy volunteers|healthy volunteers
97117|NCT02959710|AC-1202|ac-1202
97118|NCT02959710|AC-1204|ac-1204
97119|NCT02959710|Pharmacokinetic|pharmacokinetic
97120|NCT02959710|ketone body|ketone body
97121|NCT02959697|Blepharoptosis|blepharoptosis
97122|NCT02959697|Ptosis|ptosis
97123|NCT02959697|Surgery|surgery
97124|NCT02959697|Pain Reduction|pain reduction
97125|NCT02959697|Anesthetic|anesthetic
97126|NCT02959697|Local Anesthetic|local anesthetic
97127|NCT02959697|Subconjunctival|subconjunctival
97128|NCT02959593|Primary open-angle glaucoma|primary open-angle glaucoma
97129|NCT02959593|retinal capillary blood flow|retinal capillary blood flow
97130|NCT02959593|visual stimulation|visual stimulation
97131|NCT02959580|Granulomatous|granulomatous
97132|NCT02959580|Mastitis|mastitis
97133|NCT02959580|topical steroids|topical steroids
97134|NCT02959567|cervix|cervix
97135|NCT02959567|cervical dilation|cervical dilation
97136|NCT02959567|balloon catheter|balloon catheter
97137|NCT02959554|Advanced|advanced
97138|NCT02959554|Metastatic|metastatic
97139|NCT02959554|RCC|rcc
97140|NCT02959541|Leukovorin|leukovorin
97141|NCT02959476|Postoperative pain|postoperative pain
97142|NCT02959476|Postsurgical pain|postsurgical pain
97143|NCT02959463|Malignant pleural mesothelioma|malignant pleural mesothelioma
97144|NCT02959463|MPM|mpm
97145|NCT02959463|Non-metastatic|non-metastatic
97146|NCT02959463|Pembrolizumab|pembrolizumab
97147|NCT02959463|Keytruda|keytruda
97148|NCT02959463|MK-3475|mk-3475
97149|NCT02959463|SCH-900475|sch-900475
97150|NCT02959463|Radiation therapy|radiation therapy
97151|NCT02959463|Radiation treatment|radiation treatment
97152|NCT02959463|XRT|xrt
97153|NCT02959463|Intensity modulated radiation therapy|intensity modulated radiation therapy
97154|NCT02959463|IMRT|imrt
97155|NCT02959463|Proton beam therapy|proton beam therapy
97156|NCT02959463|PBT|pbt
97157|NCT02959463|3D conformal therapy|3d conformal therapy
97158|NCT02959450|Nutritional Intervention in Oropharyngeal Dysphagia|nutritional intervention in oropharyngeal dysphagia
97159|NCT02959437|Solid tumors|solid tumors
97160|NCT02959437|NSCLC|nsclc
97161|NCT02959437|CRC|crc
97162|NCT02959359|Chronic hepatitis C|chronic hepatitis c
97163|NCT02959359|Hepatocellular Carcinoma|hepatocellular carcinoma
97164|NCT02959359|Direct-acting antiviral (DAA)|direct-acting antiviral (daa)
97165|NCT02959359|Recurrence|recurrence
97166|NCT02959346|Minimal invasive thoracoscopic surgery|minimal invasive thoracoscopic surgery
97167|NCT02959346|Pain control|pain control
97168|NCT02959346|Acupuncture|acupuncture
97169|NCT02959346|Randomized controlled trial|randomized controlled trial
97170|NCT02959307|Depression|depression
97171|NCT02959307|Major Depressive Disorder|major depressive disorder
97172|NCT02959307|Major Depressive Episode|major depressive episode
97173|NCT02959294|TBI|tbi
97174|NCT02959294|mTBI|mtbi
97175|NCT02959294|Concussion, Brain|concussion, brain
97176|NCT02959294|Loss Consciousness, Traumatic|loss consciousness, traumatic
97177|NCT02959294|Headaches|headaches
97178|NCT02959242|glaucoma, follow-up intervals, treatment efficiency|glaucoma, follow-up intervals, treatment efficiency
97179|NCT02959229|Late onset sepsis|late onset sepsis
97180|NCT02959229|Bovine Lactoferrin|bovine lactoferrin
97181|NCT02959203|Central Venous Catheter|central venous catheter
97182|NCT02959203|Ultrasound|ultrasound
97183|NCT02959203|Chest X-ray|chest x-ray
97184|NCT02959203|Pneumothorax|pneumothorax
97185|NCT02959190|prevention|prevention
97186|NCT02959190|prophylaxis|prophylaxis
97187|NCT02959190|headache|headache
97188|NCT02959177|prevention|prevention
97189|NCT02959177|prophylaxis|prophylaxis
97190|NCT02959177|headache|headache
97191|NCT02959112|pancreatitis after ERCP|pancreatitis after ercp
97192|NCT02959112|epinephrine|epinephrine
97193|NCT02959112|papilla|papilla
97194|NCT02959112|rectal indomethacin|rectal indomethacin
97195|NCT02959099|Acute coronary syndrome (ACS)|acute coronary syndrome (acs)
97196|NCT02959099|Atherosclerotic plaque morphology|atherosclerotic plaque morphology
97197|NCT02959099|Coronary Computed Tomographic Angiography (CCTA)|coronary computed tomographic angiography (ccta)
97198|NCT02959099|Gender disparities|gender disparities
97199|NCT02959086|Epidemiology|epidemiology
97200|NCT02959086|Shanghai|shanghai
97201|NCT02959086|Cancer|cancer
97202|NCT02959086|Adolescents|adolescents
97203|NCT02959086|Children|children
97204|NCT02959073|Symptom recording|symptom recording
97205|NCT02959047|MRI|mri
97206|NCT02959047|PCSK9 inhibition|pcsk9 inhibition
97207|NCT02959047|LDL cholesterol|ldl cholesterol
97208|NCT02959021|weight loss|weight loss
97209|NCT02959021|behavioral|behavioral
97210|NCT02959021|primary care|primary care
97211|NCT02959021|lifestyle|lifestyle
97212|NCT02958995|Drug Therapy|drug therapy
97213|NCT02958982|RP3128|rp3128
97214|NCT02958982|Phase 1|phase 1
97215|NCT02958982|Healthy volunteers|healthy volunteers
97216|NCT02958969|venous thromboembolism|venous thromboembolism
97217|NCT02958969|multiple myeloma|multiple myeloma
97218|NCT02958969|anticoagulation|anticoagulation
97219|NCT02958956|Drug Therapy|drug therapy
97220|NCT02958943|atrial fibrillation|atrial fibrillation
97221|NCT02958943|stroke|stroke
97222|NCT02958943|computerized decision support|computerized decision support
97223|NCT02958904|Sexuality|sexuality
97224|NCT02958904|Spinal cord injuries|spinal cord injuries
97225|NCT02958904|Erectile dysfunction|erectile dysfunction
97226|NCT02958904|depression|depression
97227|NCT02958865|Mayo score|mayo score
97228|NCT02958852|Breast Cancer|breast cancer
97229|NCT02958852|Endocrine Treatment|endocrine treatment
97230|NCT02958852|Atorvastatin|atorvastatin
97231|NCT02958852|Mechanisms of Resistance|mechanisms of resistance
97232|NCT02958852|Statins|statins
97233|NCT02958852|Fulvestrant|fulvestrant
97234|NCT02958852|Circulating Tumor Cells|circulating tumor cells
97235|NCT02958852|Statins and Endocrine Treatment|statins and endocrine treatment
97236|NCT02958852|Tumor Marker Expression|tumor marker expression
97237|NCT02958852|ER+ Metastatic Breast Cancer|er+ metastatic breast cancer
97238|NCT02958852|Circulating Tumor DNA|circulating tumor dna
97239|NCT02958852|Cholesterol|cholesterol
97240|NCT02958839|Atrial fibrillation|atrial fibrillation
97241|NCT02958839|Fibroblast Growth factor 23|fibroblast growth factor 23
97242|NCT02958800|Deprescribing|deprescribing
97243|NCT02958800|Single patient open label trial|single patient open label trial
97244|NCT02958800|Long-term care|long-term care
97245|NCT02958761|knee arthrosis|knee arthrosis
97246|NCT02958761|platelet-derived growth factors|platelet-derived growth factors
97247|NCT02958735|exercise|exercise
97248|NCT02958735|cognition|cognition
97249|NCT02958735|brain-derived neurotrophic factor|brain-derived neurotrophic factor
97250|NCT02958735|insulin-like growth factor 1|insulin-like growth factor 1
97251|NCT02958735|cortisol|cortisol
97252|NCT02958683|Optoelectronic plethysmography|optoelectronic plethysmography
97253|NCT02958683|Structure light plethysmography|structure light plethysmography
97254|NCT02958683|Respiratory Function Tests|respiratory function tests
97255|NCT02958657|Platelet function|platelet function
97256|NCT02958657|Autonomic Nervous System|autonomic nervous system
97257|NCT02958657|Multiplate® (Multiple Electrode Aggregometry - MEA)|multiplate® (multiple electrode aggregometry - mea)
97258|NCT02958657|VerifyNow®|verifynow®
97259|NCT02958644|synbiotic|synbiotic
97260|NCT02958644|obesity|obesity
97261|NCT02958644|body mass index|body mass index
97262|NCT02958644|microbiota|microbiota
97263|NCT02958605|Children|children
97264|NCT02958605|resuscitation|resuscitation
97265|NCT02958605|smartphone|smartphone
97266|NCT02958592|shear-wave elastography|shear-wave elastography
97267|NCT02958592|hepatic fibrosis|hepatic fibrosis
97268|NCT02958592|liver tumor|liver tumor
97269|NCT02958566|Pain control|pain control
97270|NCT02958566|Post-operative pain|post-operative pain
97271|NCT02958566|Narcotic|narcotic
97272|NCT02958566|Non-narcotic|non-narcotic
97273|NCT02958566|Side effect|side effect
97274|NCT02958566|Toxicity|toxicity
97275|NCT02958553|Lower Extremity Limb Loss|lower extremity limb loss
97276|NCT02958553|Prosthesis Use|prosthesis use
97277|NCT02958540|Prophylaxis|prophylaxis
97279|NCT02958527|Depression|depression
97280|NCT02958527|Depressed state|depressed state
97281|NCT02958514|IPL|ipl
97282|NCT02958514|MGD|mgd
97283|NCT02958501|Vitamin D|vitamin d
97284|NCT02958501|Inflammatory Bowel Diseases|inflammatory bowel diseases
97285|NCT02958488|34 to 36 Weeks Preterm Neonates|34 to 36 weeks preterm neonates
97286|NCT02958488|Respiratory Distress Syndrom|respiratory distress syndrom
97287|NCT02958488|High Flow Nasal Cannula|high flow nasal cannula
97288|NCT02958436|Safety|safety
97289|NCT02958436|Tolerability|tolerability
97290|NCT02958436|Pharmacokinetics|pharmacokinetics
97291|NCT02958436|REGN3500|regn3500
97292|NCT02958410|CD30|cd30
97293|NCT02958410|CAR-T|car-t
97294|NCT02958397|Myeloid Malignancies|myeloid malignancies
97295|NCT02958397|CAR-T|car-t
97296|NCT02958397|CD33|cd33
97297|NCT02958384|Myeloid Malignancies|myeloid malignancies
97298|NCT02958384|CAR-T|car-t
97299|NCT02958384|LeY|ley
97300|NCT02958371|Functional magnetic resonance imaging|functional magnetic resonance imaging
97301|NCT02958371|Taste|taste
97302|NCT02958371|Feeding behavior|feeding behavior
97303|NCT02958371|Choice behavior|choice behavior
97304|NCT02958358|pulmonary hypertension|pulmonary hypertension
97305|NCT02958358|ambrisentan|ambrisentan
97306|NCT02958358|PET imaging|pet imaging
97307|NCT02958358|CT/PET|ct/pet
97308|NCT02958332|video games|video games
97309|NCT02958306|cleft lip repair|cleft lip repair
97310|NCT02958306|cheiloplasty|cheiloplasty
97311|NCT02958306|PRP|prp
97312|NCT02958306|platelet rich plasma|platelet rich plasma
97313|NCT02958280|Exercise|exercise
97314|NCT02958280|Smartphone|smartphone
97315|NCT02958267|knee osteoarthritis|knee osteoarthritis
97912|NCT02954887|GWP42003-P|gwp42003-p
97316|NCT02958267|regenerative medicine|regenerative medicine
97317|NCT02958267|orthobiologics|orthobiologics
97318|NCT02958267|cellular therapy|cellular therapy
97319|NCT02958254|hamstring|hamstring
97320|NCT02958254|ultrasonography|ultrasonography
97321|NCT02958254|validation|validation
97322|NCT02958254|magnetic resonance imaging|magnetic resonance imaging
97323|NCT02958254|muscle thickness|muscle thickness
97324|NCT02958241|spondylolisthesis|spondylolisthesis
97325|NCT02958241|Lumbar spine|lumbar spine
97326|NCT02958241|MRI|mri
97327|NCT02958228|Positive Affect|positive affect
97328|NCT02958228|Mental Imagery|mental imagery
97329|NCT02958228|Cognitive Bias Modification|cognitive bias modification
97330|NCT02958228|Cognitive Control Training|cognitive control training
97331|NCT02958215|Orthostatic|orthostatic
97332|NCT02958215|Cesarean section|cesarean section
97333|NCT02958215|Pregnant|pregnant
97334|NCT02958215|Phenyephrine|phenyephrine
97335|NCT02958215|Hypotension|hypotension
97336|NCT02958202|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
97337|NCT02958202|DMD|dmd
97338|NCT02958202|Dystrophin|dystrophin
97339|NCT02958202|BMN 044|bmn 044
97340|NCT02958202|PRO044|pro044
97341|NCT02958202|BioMarin|biomarin
97342|NCT02958189|Twitter|twitter
97343|NCT02958189|social support|social support
97344|NCT02958189|internet intervention|internet intervention
97345|NCT02958189|sedentary lifestyle|sedentary lifestyle
97346|NCT02958189|walking|walking
97347|NCT02958189|behavior change|behavior change
97348|NCT02958163|Hepatocellular cancer|hepatocellular cancer
97349|NCT02958163|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
97350|NCT02958163|Chemoembolization, Therapeutic|chemoembolization, therapeutic
97351|NCT02958111|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
97352|NCT02958111|Adjuvant chemotherapy|adjuvant chemotherapy
97353|NCT02958111|Capecitabine|capecitabine
97354|NCT02958098|myocardial infarction|myocardial infarction
97355|NCT02958098|stroke|stroke
97356|NCT02958098|dilated cardiomyopathy|dilated cardiomyopathy
97357|NCT02958098|systolic heart failure|systolic heart failure
97358|NCT02958098|atrial fibrillation|atrial fibrillation
97359|NCT02958098|aortic dissection|aortic dissection
97360|NCT02958098|wearable devices|wearable devices
97361|NCT02958098|genomic sequencing|genomic sequencing
97362|NCT02958072|Malleoli ulcers|malleoli ulcers
97363|NCT02958072|Diabetes|diabetes
97364|NCT02958072|Healing|healing
97365|NCT02958072|Dressing|dressing
97366|NCT02958072|LeucoPatch|leucopatch
97367|NCT02958059|ERCP|ercp
97368|NCT02958059|prophylaxis|prophylaxis
97369|NCT02958059|antibiotics|antibiotics
97370|NCT02958059|infection|infection
97371|NCT02958059|cholangitis|cholangitis
97372|NCT02958020|cohort, osteoporosis, bone mineral density, Chinese|cohort, osteoporosis, bone mineral density, chinese
97373|NCT02957981|BRCA1|brca1
97374|NCT02957981|BRCA2|brca2
97375|NCT02957981|Men|men
97376|NCT02957981|Hereditary Cancer|hereditary cancer
97377|NCT02957981|Prostate Cancer|prostate cancer
97378|NCT02957981|Male Breast Cancer|male breast cancer
97379|NCT02957968|Breast Cancer|breast cancer
97380|NCT02957955|Heart failure|heart failure
97381|NCT02957942|Repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
97382|NCT02957942|Spasmodic dysphonia|spasmodic dysphonia
97383|NCT02957942|Dystonia|dystonia
97384|NCT02957877|Anticoagulation|anticoagulation
97385|NCT02957877|Anti-Xa activity|anti-xa activity
97386|NCT02957877|Low-molecular weight heparin|low-molecular weight heparin
97387|NCT02957877|Unfractionated heparin|unfractionated heparin
97388|NCT02957838|Transferrin Receptor|transferrin receptor
97389|NCT02957838|Type 2 Diabetes|type 2 diabetes
97390|NCT02957838|Stearic Acid (C18:0)|stearic acid (c18:0)
97391|NCT02957838|Mitochondrial Morphology|mitochondrial morphology
97392|NCT02957838|Crossover Study|crossover study
97393|NCT02957812|Gait|gait
97394|NCT02957812|Balance Control|balance control
97395|NCT02957812|Orthotics|orthotics
97396|NCT02957799|Pregnancy|pregnancy
97397|NCT02957799|Home Healthcare Visits|home healthcare visits
97398|NCT02957799|Community Health Workers|community health workers
97399|NCT02957799|Infants|infants
97400|NCT02957786|cytisine|cytisine
97401|NCT02957786|varenicline|varenicline
97402|NCT02957786|smoking cessation|smoking cessation
97403|NCT02957786|indigenous|indigenous
97404|NCT02957747|Women Veterans|women veterans
97405|NCT02957747|Sexual Trauma|sexual trauma
97406|NCT02957734|Vertical dimension of occlusion|vertical dimension of occlusion
97407|NCT02957734|Direct composite restorations|direct composite restorations
97408|NCT02957734|Indirect composite restorations|indirect composite restorations
97409|NCT02957734|Tooth wear|tooth wear
97410|NCT02957734|Failure|failure
97411|NCT02957734|Quality of Life|quality of life
97412|NCT02957695|frontal brain lesions|frontal brain lesions
97413|NCT02957695|neurofeedback|neurofeedback
97414|NCT02957695|cognitive functions|cognitive functions
97415|NCT02957682|Hyperlipidemias|hyperlipidemias
97416|NCT02957682|Dyslipidemias|dyslipidemias
97417|NCT02957682|Lipid Metabolism Disorders|lipid metabolism disorders
97418|NCT02957630|Estetrol (E4)|estetrol (e4)
97419|NCT02957630|Drospirenone (DRSP)|drospirenone (drsp)
97420|NCT02957630|Ethinylestradiol (EE)|ethinylestradiol (ee)
97421|NCT02957630|Levonorgestrel (LNG)|levonorgestrel (lng)
97422|NCT02957630|Oral contraceptive|oral contraceptive
97423|NCT02957630|Prevention of pregnancy|prevention of pregnancy
97424|NCT02957630|Hemostasis|hemostasis
97425|NCT02957630|Metabolism|metabolism
97426|NCT02957617|Neuropathic Pain From Lumbosacral Radiculopathy|neuropathic pain from lumbosacral radiculopathy
97427|NCT02957604|Pregnancy; Cardiovascular Diseases; High serum cholesterol|pregnancy; cardiovascular diseases; high serum cholesterol
97428|NCT02957591|Depression|depression
97429|NCT02957591|probiotic supplementation|probiotic supplementation
97430|NCT02957591|Adjuvant Therapy|adjuvant therapy
97431|NCT02957591|Gut microbiome|gut microbiome
97432|NCT02957591|Psychological functioning|psychological functioning
97433|NCT02957591|Brain imaging|brain imaging
97434|NCT02957591|Brain-Gut interactions|brain-gut interactions
97435|NCT02957591|Sleep|sleep
97436|NCT02957578|Tympanostomy Tube|tympanostomy tube
97437|NCT02957578|Ventilation Tube|ventilation tube
97438|NCT02957578|Grommet|grommet
97439|NCT02957578|Otitis Media|otitis media
97440|NCT02957578|Middle Ear Effusion|middle ear effusion
97441|NCT02957565|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
97442|NCT02957565|Questionnaires|questionnaires
97443|NCT02957565|Surveys|surveys
97444|NCT02957565|Videos|videos
97445|NCT02957565|Advanced Cancer|advanced cancer
97446|NCT02957539|motivation|motivation
97447|NCT02957539|patient incentives|patient incentives
97448|NCT02957513|Diabetes|diabetes
97449|NCT02957513|Uncontrolled|uncontrolled
97450|NCT02957513|Chronic Disease|chronic disease
97451|NCT02957513|Chronic Conditions|chronic conditions
97452|NCT02957513|Medically Underserved Areas|medically underserved areas
97453|NCT02957513|African Americans|african americans
97454|NCT02957513|Health Coaching|health coaching
97455|NCT02957513|Health Education|health education
97456|NCT02957513|Text Messaging|text messaging
97457|NCT02957513|Text Messages|text messages
97458|NCT02957513|Mobile Health|mobile health
97459|NCT02957474|Healthy Volunteers|healthy volunteers
97460|NCT02957474|Pharmacokinetics|pharmacokinetics
97461|NCT02957474|Food Effect|food effect
97462|NCT02957474|Proton Pump|proton pump
97463|NCT02957474|GED-0301|ged-0301
97464|NCT02957474|Mongersen|mongersen
97465|NCT02957422|milk|milk
97466|NCT02957422|brain aging|brain aging
97467|NCT02957422|antioxidant|antioxidant
97468|NCT02957422|glutathione|glutathione
97469|NCT02957422|dietary intervention|dietary intervention
97470|NCT02957422|brain imaging|brain imaging
97471|NCT02957409|Heart failure|heart failure
97472|NCT02957409|Heart Failure with Reduced Ejection Fraction|heart failure with reduced ejection fraction
97473|NCT02957409|HFrEF|hfref
97474|NCT02957383|Sleep, Melatonin|sleep, melatonin
97475|NCT02957383|Circadian Rhythm|circadian rhythm
97476|NCT02957383|Temperature|temperature
97477|NCT02957383|screen illumination|screen illumination
97478|NCT02957344|health communication|health communication
97479|NCT02957344|Zika virus|zika virus
97480|NCT02957344|legislation|legislation
97481|NCT02957344|vaccination|vaccination
97482|NCT02957344|Child Care|child care
97483|NCT02957305|misoprostol|misoprostol
97484|NCT02957305|miscarriage|miscarriage
97485|NCT02957279|sepsis|sepsis
97486|NCT02957279|exosomes|exosomes
97487|NCT02957279|dendritic cell|dendritic cell
97488|NCT02957266|cervical cancer|cervical cancer
97489|NCT02957266|interstitial brachytherapy|interstitial brachytherapy
97490|NCT02957266|gemcitabine|gemcitabine
97491|NCT02957266|volumetric arc therapy|volumetric arc therapy
97492|NCT02957253|Quality of care|quality of care
97493|NCT02957253|Health related quality of life|health related quality of life
97494|NCT02957253|Nurse-led clinic|nurse-led clinic
97495|NCT02957253|Health economics|health economics
97496|NCT02957240|Forearm [A01.378.800.585]|forearm [a01.378.800.585]
97497|NCT02957240|Radius [A02.835.232.087.090.700]|radius [a02.835.232.087.090.700]
97498|NCT02957240|Motor Skills [F02.808.260]|motor skills [f02.808.260]
97499|NCT02957240|Task Performance and Analysis [F02.808.600]|task performance and analysis [f02.808.600]
97500|NCT02957240|Casts, Surgical [E07.858.442.660.430.500]|casts, surgical [e07.858.442.660.430.500]
97501|NCT02957240|Splints [E07.858.690.725.430.750]|splints [e07.858.690.725.430.750]
97502|NCT02957240|motor representation techniques|motor representation techniques
97503|NCT02957240|mirror therapy|mirror therapy
97504|NCT02957240|Women [M01.975]|women [m01.975]
97505|NCT02957227|Alzheimer's disease|alzheimer's disease
97506|NCT02957227|Frontotemporal Dementia|frontotemporal dementia
97507|NCT02957227|Lewy Body Dementia|lewy body dementia
97508|NCT02957227|Diagnosis|diagnosis
97509|NCT02957188|Eicosapentaenoic acid|eicosapentaenoic acid
97510|NCT02957188|Arachidonic acid|arachidonic acid
97511|NCT02957188|Metabolism|metabolism
97512|NCT02957188|Healthy aging|healthy aging
97513|NCT02957175|Immunophenotyping|immunophenotyping
97514|NCT02957175|Perioperative Care|perioperative care
97913|NCT02954887|Cannabidiol|cannabidiol
97515|NCT02957175|Innate Immunity|innate immunity
97516|NCT02957175|Cardiac Surgical Procedures|cardiac surgical procedures
97517|NCT02957136|Respiratory Tract Infections|respiratory tract infections
97518|NCT02957136|Influenza, Human|influenza, human
97519|NCT02957136|Common Cold|common cold
97520|NCT02957136|Viral Infection|viral infection
97521|NCT02957136|Pathology, Molecular|pathology, molecular
97522|NCT02957136|Molecular Diagnostics|molecular diagnostics
97523|NCT02957136|Diagnostic Testing|diagnostic testing
97524|NCT02957136|Clinical Microbiology|clinical microbiology
97525|NCT02957136|Polymerase Chain Reaction|polymerase chain reaction
97526|NCT02957136|Antibiotic Stewardship|antibiotic stewardship
97527|NCT02957136|Antimicrobial Use|antimicrobial use
97528|NCT02957136|Emergency Department|emergency department
97529|NCT02957136|Emergency Room|emergency room
97530|NCT02957123|macrophages M2 type|macrophages m2 type
97531|NCT02957123|cytokines|cytokines
97532|NCT02957123|intranasal administration|intranasal administration
97533|NCT02957123|neuroprotection|neuroprotection
97534|NCT02957123|neuroregeneration|neuroregeneration
97535|NCT02957123|organic brain syndrome|organic brain syndrome
97536|NCT02957123|neurocognitive disorders|neurocognitive disorders
97537|NCT02957097|Gabapentin|gabapentin
97538|NCT02957097|acute pain|acute pain
97539|NCT02957084|difficult laryngoscopy|difficult laryngoscopy
97540|NCT02957084|neck circumference|neck circumference
97541|NCT02957084|sternomental distance|sternomental distance
97542|NCT02957084|thyromental distance|thyromental distance
97543|NCT02957084|hyomental distance|hyomental distance
97544|NCT02957084|thyrosternal distance|thyrosternal distance
97545|NCT02957058|Colonoscopy|colonoscopy
97546|NCT02957058|Endoscopic Mucosal Resection|endoscopic mucosal resection
97547|NCT02957058|Adenoma Recurrence|adenoma recurrence
97548|NCT02957058|EMR defect thermal ablation|emr defect thermal ablation
97549|NCT02956993|peripheral artery disease|peripheral artery disease
97550|NCT02956993|PAD|pad
97551|NCT02956993|vonapanitase|vonapanitase
97552|NCT02956993|critical limb ischemia|critical limb ischemia
97553|NCT02956993|CLI|cli
97554|NCT02956993|tibial artery|tibial artery
97555|NCT02956993|stenosis|stenosis
97556|NCT02956993|distal popliteal artery|distal popliteal artery
97557|NCT02956993|peroneal artery|peroneal artery
97558|NCT02956993|below the knee|below the knee
97559|NCT02956993|BTK|btk
97560|NCT02956993|elastase|elastase
97561|NCT02956993|chymotrypsin-like elastase 1|chymotrypsin-like elastase 1
97562|NCT02956993|CELA1|cela1
97563|NCT02956993|PRT-201|prt-201
97564|NCT02956980|type 1 interferons|type 1 interferons
97565|NCT02956980|children|children
97566|NCT02956980|gender|gender
97567|NCT02956980|pubertal status|pubertal status
97568|NCT02956980|sex difference|sex difference
97569|NCT02956967|Non-Interventional Study|non-interventional study
97570|NCT02956954|Enzyme replacement therapy|enzyme replacement therapy
97571|NCT02956941|Academic performance|academic performance
97572|NCT02956941|Behaviour change communication|behaviour change communication
97573|NCT02956941|Nutritional status|nutritional status
97574|NCT02956941|School children|school children
97575|NCT02956941|Ethiopia|ethiopia
97576|NCT02956915|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
97577|NCT02956915|SAPIEN-3 prostheses|sapien-3 prostheses
97578|NCT02956915|Length of stay|length of stay
97579|NCT02956915|Aortic stenosis|aortic stenosis
97580|NCT02956889|Carcinoma, Basal Cell|carcinoma, basal cell
97581|NCT02956889|Vismodegib|vismodegib
97582|NCT02956889|Radiotherapy|radiotherapy
97583|NCT02956837|Vaccines|vaccines
97584|NCT02956837|Respiratory Syncytial Viruses|respiratory syncytial viruses
97585|NCT02956837|Safety|safety
97586|NCT02956837|Reactogenicity|reactogenicity
97587|NCT02956837|Ranking of Formulations|ranking of formulations
97588|NCT02956837|Immunogenicity|immunogenicity
97589|NCT02956824|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
97590|NCT02956824|Sacro-iliac joints|sacro-iliac joints
97591|NCT02956824|Pelvis|pelvis
97592|NCT02956824|Erosion|erosion
97593|NCT02956824|Fat deposit|fat deposit
97594|NCT02956824|Subchondral sclerosis|subchondral sclerosis
97595|NCT02956824|Bone marrow edema|bone marrow edema
97596|NCT02956824|Axial spondyloarthritis|axial spondyloarthritis
97597|NCT02956811|Type 2 Diabetes|type 2 diabetes
97598|NCT02956811|Left Ventricular Hypertrophy|left ventricular hypertrophy
97599|NCT02956811|Dapagliflozin|dapagliflozin
97600|NCT02956785|Propess|propess
97601|NCT02956759|diabetic retinopathy|diabetic retinopathy
97602|NCT02956759|Pan-retinal photocoagulation|pan-retinal photocoagulation
97603|NCT02956759|proliferative|proliferative
97604|NCT02956759|non-proliferative|non-proliferative
97605|NCT02956733|inexpensive, fasciotomy|inexpensive, fasciotomy
97606|NCT02956707|neonates|neonates
97607|NCT02956707|cardiopulmonary bypass|cardiopulmonary bypass
97608|NCT02956707|adrenal insufficiency|adrenal insufficiency
97609|NCT02956707|congenital heart disease|congenital heart disease
97610|NCT02956694|Aged|aged
97611|NCT02956694|Cognitive impairment|cognitive impairment
97612|NCT02956694|Neurocognitive Disorders|neurocognitive disorders
97613|NCT02956694|Shared decision making|shared decision making
97614|NCT02956694|Distance learning|distance learning
97615|NCT02956694|Primary care|primary care
97616|NCT02956694|Decision support tool|decision support tool
97617|NCT02956694|Patient decision aid|patient decision aid
97618|NCT02956668|tDCS|tdcs
97619|NCT02956668|Visual field|visual field
97620|NCT02956668|Stroke|stroke
97621|NCT02956616|Enhanced Recovery|enhanced recovery
97622|NCT02956590|dyslipidemia|dyslipidemia
97623|NCT02956590|obesity|obesity
97624|NCT02956590|pitavastatin|pitavastatin
97625|NCT02956590|lipids|lipids
97626|NCT02956577|Global Longitudinal Strain (GLS)|global longitudinal strain (gls)
97627|NCT02956577|Coronary Flow Velocity Reserve (CFVR)|coronary flow velocity reserve (cfvr)
97628|NCT02956577|Cardiac dysfunction|cardiac dysfunction
97629|NCT02956577|Microcirculation|microcirculation
97630|NCT02956577|Coronary Computed Tomography Angiography (CCTA)|coronary computed tomography angiography (ccta)
97631|NCT02956577|Type 1 Diabetes|type 1 diabetes
97632|NCT02956577|Type 2 Diabetes|type 2 diabetes
97633|NCT02956551|advanced non-small cell lung cancer|advanced non-small cell lung cancer
97634|NCT02956551|cell based therapy|cell based therapy
97635|NCT02956551|safety|safety
97636|NCT02956551|clinical efficacy|clinical efficacy
97637|NCT02956486|elenbecestat|elenbecestat
97638|NCT02956486|E2609|e2609
97639|NCT02956486|Alzheimer's Disease|alzheimer's disease
97640|NCT02956486|Early Alzheimer's Disease|early alzheimer's disease
97641|NCT02956486|Prodromal Alzheimer's Disease|prodromal alzheimer's disease
97642|NCT02956486|Dementia|dementia
97643|NCT02956486|Dementia, Alzheimer's type|dementia, alzheimer's type
97644|NCT02956486|mild cognitive impairment|mild cognitive impairment
97645|NCT02956486|MissionAD1|missionad1
97646|NCT02956473|Breast Cancer|breast cancer
97647|NCT02956447|Kisspeptin|kisspeptin
97648|NCT02956447|Hyperprolactinemia|hyperprolactinemia
97649|NCT02956408|Obesity|obesity
97650|NCT02956408|Pediatrics|pediatrics
97651|NCT02956408|Vitamin D deficiency|vitamin d deficiency
97652|NCT02956395|adaptive case management approach|adaptive case management approach
97653|NCT02956395|Transitional Care|transitional care
97654|NCT02956395|multimorbidity|multimorbidity
97655|NCT02956382|Ibrutinib|ibrutinib
97656|NCT02956382|Venetoclax|venetoclax
97657|NCT02956382|Follicular|follicular
97658|NCT02956382|Refractory|refractory
97659|NCT02956382|Relapsed|relapsed
97660|NCT02956382|Lymphoma|lymphoma
97661|NCT02956343|Atrial fibrillation|atrial fibrillation
97662|NCT02956343|cardiovascular App|cardiovascular app
97663|NCT02956343|Rhythm monitoring|rhythm monitoring
97664|NCT02956343|Stroke prevention|stroke prevention
97665|NCT02956330|RVO|rvo
97666|NCT02956330|ME|me
97667|NCT02956330|Central Subfield Thickness|central subfield thickness
97668|NCT02956330|OCT|oct
97669|NCT02956330|Optical Coherence Tomography|optical coherence tomography
97670|NCT02956330|Cystoid Macular Edema|cystoid macular edema
97671|NCT02956330|Subretinal Fluid|subretinal fluid
97672|NCT02956330|Eylea|eylea
97673|NCT02956330|Aflibercept|aflibercept
97674|NCT02956330|Anti-VEGF|anti-vegf
97675|NCT02956291|glioma|glioma
97676|NCT02956291|brain tumor|brain tumor
97677|NCT02956291|brain metastasis|brain metastasis
97678|NCT02956278|allopurinol|allopurinol
97679|NCT02956252|cholecystectomy, laparoscopic|cholecystectomy, laparoscopic
97680|NCT02956252|spinal anesthesia|spinal anesthesia
97681|NCT02956252|general anesthesia|general anesthesia
97682|NCT02956252|cholecystectomy|cholecystectomy
97683|NCT02956239|cervical precancer|cervical precancer
97684|NCT02956239|screening|screening
97685|NCT02956239|treatment|treatment
97686|NCT02956239|thermo-coagulation|thermo-coagulation
97687|NCT02956239|thermal ablation|thermal ablation
97688|NCT02956239|Reducing overtreatment|reducing overtreatment
97689|NCT02956213|COPD|copd
97690|NCT02956213|air filter|air filter
97691|NCT02956213|indoor air quality|indoor air quality
97692|NCT02956213|respiratory symptoms|respiratory symptoms
97693|NCT02956213|emphysema|emphysema
97694|NCT02956213|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
97695|NCT02956213|tobacco use|tobacco use
97696|NCT02956200|Fingolimod Hydrochloride|fingolimod hydrochloride
97697|NCT02956200|Intravenous thrombolysis|intravenous thrombolysis
97698|NCT02956200|Mechanical thrombectomy|mechanical thrombectomy
97699|NCT02956200|Acute ischemic stroke|acute ischemic stroke
97700|NCT02956161|Sleep|sleep
97701|NCT02956161|Auditory stimulations|auditory stimulations
97702|NCT02956161|Slow oscillations|slow oscillations
97703|NCT02956096|tDCS|tdcs
97704|NCT02956096|Stroke|stroke
97705|NCT02956096|Autonomic Modulation|autonomic modulation
97706|NCT02956070|dental bleaching|dental bleaching
97707|NCT02956070|antiinflammatory|antiinflammatory
97708|NCT02956070|tooth sensitivity|tooth sensitivity
97709|NCT02956031|cancer prevention|cancer prevention
97710|NCT02956031|cervical screening|cervical screening
97711|NCT02956031|cervical cancer|cervical cancer
97712|NCT02956031|cervical disease|cervical disease
97914|NCT02954809|fatigue|fatigue
97713|NCT02956031|cervical neoplasm|cervical neoplasm
97714|NCT02956031|HPV testing|hpv testing
97715|NCT02956031|immunocytochemistry|immunocytochemistry
97716|NCT02956031|triage techniques|triage techniques
97717|NCT02956018|children|children
97718|NCT02955979|acute renal insufficiency|acute renal insufficiency
97719|NCT02955979|Iodinated Contrast Agents|iodinated contrast agents
97720|NCT02955979|pediatric|pediatric
97721|NCT02955966|Aspergillosis|aspergillosis
97722|NCT02955966|Haematological malignancy|haematological malignancy
97723|NCT02955966|18F-FDG PET/CT|18f-fdg pet/ct
97724|NCT02955966|Biomarkers|biomarkers
97725|NCT02955940|Solid tumors|solid tumors
97726|NCT02955940|ruxolitinib|ruxolitinib
97727|NCT02955940|regorafenib|regorafenib
97728|NCT02955940|capecitabine|capecitabine
97729|NCT02955927|Myopia control,ortho-k, atropine eye drops, children|myopia control,ortho-k, atropine eye drops, children
97730|NCT02955914|Optimism|optimism
97731|NCT02955914|Pessimism|pessimism
97732|NCT02955914|Recovery|recovery
97733|NCT02955914|Elective Cardiac surgery|elective cardiac surgery
97734|NCT02955901|Randomized controlled trial|randomized controlled trial
97735|NCT02955901|Colonoscopy|colonoscopy
97736|NCT02955901|Colon Disease|colon disease
97737|NCT02955901|Low residue diet|low residue diet
97738|NCT02955901|Colon preparation|colon preparation
97739|NCT02955875|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
97740|NCT02955875|Pharmaceutical Services|pharmaceutical services
97741|NCT02955862|Cryptococcal antigenemia|cryptococcal antigenemia
97742|NCT02955862|Cryptococcal meningitis|cryptococcal meningitis
97743|NCT02955862|HIV/AIDS|hiv/aids
97744|NCT02955849|glaucoma|glaucoma
97745|NCT02955849|rural|rural
97746|NCT02955849|China|china
97747|NCT02955849|SLT|slt
97748|NCT02955836|Patient Safety|patient safety
97749|NCT02955836|Quality indicator|quality indicator
97750|NCT02955836|Information system|information system
97751|NCT02955836|Nursing|nursing
97752|NCT02955836|Healthcare Quality|healthcare quality
97753|NCT02955836|Quality measurement|quality measurement
97754|NCT02955823|B cell Lymphoma|b cell lymphoma
97755|NCT02955823|non-Hodgkin Lymphoma|non-hodgkin lymphoma
97756|NCT02955823|Elderly patients|elderly patients
97757|NCT02955810|Newly Diagnosed|newly diagnosed
97758|NCT02955810|Treatment Naiive|treatment naiive
97759|NCT02955797|Meningitis|meningitis
97760|NCT02955797|Meningococcal Meningitis|meningococcal meningitis
97761|NCT02955797|MenACYW conjugate vaccine|menacyw conjugate vaccine
97762|NCT02955797|Nimenrix®|nimenrix®
97763|NCT02955797|Menjugate®|menjugate®
97764|NCT02955771|photodynamic therapy(PDT)|photodynamic therapy(pdt)
97765|NCT02955771|stenting|stenting
97766|NCT02955771|Hilar Cholangiocarcinoma|hilar cholangiocarcinoma
97767|NCT02955771|Deuteporfin|deuteporfin
97768|NCT02955719|Collaborative Care|collaborative care
97769|NCT02955719|Depression|depression
97770|NCT02955719|Anxiety|anxiety
97771|NCT02955719|Mild Cognitive Impairment|mild cognitive impairment
97772|NCT02955719|Integrated Care Pathway|integrated care pathway
97773|NCT02955693|Pharmacokinetics|pharmacokinetics
97774|NCT02955693|Healthy volunteers|healthy volunteers
97775|NCT02955693|Monomethylfumarate|monomethylfumarate
97776|NCT02955693|Dimethyl fumarate|dimethyl fumarate
97777|NCT02955693|Fumaderm®|fumaderm®
97778|NCT02955693|Ethyl fumarate|ethyl fumarate
97779|NCT02955680|emergence delirium|emergence delirium
97780|NCT02955680|emergence time|emergence time
97781|NCT02955680|bispectral index|bispectral index
97782|NCT02955667|invivo microscopy|invivo microscopy
97783|NCT02955667|colposcopy|colposcopy
97784|NCT02955667|cervical precancer and cancer|cervical precancer and cancer
97785|NCT02955641|Laser peripheral iridotomy|laser peripheral iridotomy
97786|NCT02955641|topical anti-inflammatory drops|topical anti-inflammatory drops
97788|NCT02955602|Primary Biliary Cholangitis (PBC)|primary biliary cholangitis (pbc)
97789|NCT02955576|Psoriasis|psoriasis
97790|NCT02955563|decision making for incapacitated patients|decision making for incapacitated patients
97791|NCT02955563|intensive care|intensive care
97792|NCT02955563|surrogate decision making|surrogate decision making
97793|NCT02955563|patient centered care|patient centered care
97794|NCT02955563|Palliative Care|palliative care
97795|NCT02955563|End of Life|end of life
97796|NCT02955563|Quality of Communication|quality of communication
97797|NCT02955563|Anxiety|anxiety
97798|NCT02955563|Depression|depression
97799|NCT02955550|Multiple Myeloma|multiple myeloma
97800|NCT02955550|Plasma Cell Myeloma|plasma cell myeloma
97801|NCT02955550|Plasma Cell Neoplasm|plasma cell neoplasm
97802|NCT02955550|Relapsed/refractory Myeloma|relapsed/refractory myeloma
97803|NCT02955550|PNK-007|pnk-007
97804|NCT02955550|Recombinant Human IL-2 (RHIL-2)|recombinant human il-2 (rhil-2)
97805|NCT02955550|Human IL-2|human il-2
97806|NCT02955550|Bone Marrow Transplant|bone marrow transplant
97807|NCT02955537|Hypertension|hypertension
97808|NCT02955537|mHealth|mhealth
97809|NCT02955485|Ankle|ankle
97810|NCT02955485|Instability|instability
97811|NCT02955485|Prediction|prediction
97812|NCT02955472|Neuralgia, Postherpetic|neuralgia, postherpetic
97813|NCT02955472|Postherpetic Neuralgia|postherpetic neuralgia
97814|NCT02955472|Diabetic Neuropathies|diabetic neuropathies
97815|NCT02955472|Diabetic Neuralgia|diabetic neuralgia
97816|NCT02955472|Diabetic Polyneuropathy|diabetic polyneuropathy
97817|NCT02955472|Diabetic Neuropathy, Painful|diabetic neuropathy, painful
97818|NCT02955472|Neuralgia|neuralgia
97819|NCT02955472|Neuropathic Pain|neuropathic pain
97820|NCT02955472|Pregabalin|pregabalin
97821|NCT02955472|Pharmacokinetics|pharmacokinetics
97822|NCT02955472|Bioequivalent|bioequivalent
97823|NCT02955459|Healthy volunteers|healthy volunteers
97824|NCT02955459|Pharmacokinetics|pharmacokinetics
97825|NCT02955446|Refractory Tumors|refractory tumors
97826|NCT02955446|Advanced Solid Tumors|advanced solid tumors
97827|NCT02955433|Rideshare|rideshare
97828|NCT02955433|Digital transportation network|digital transportation network
97829|NCT02955433|Missed appointment|missed appointment
97830|NCT02955420|Autoantibodies|autoantibodies
97831|NCT02955420|Heart Failure|heart failure
97832|NCT02955420|Fatigue Syndrome, Chronic|fatigue syndrome, chronic
97833|NCT02955420|Idiopathic Pulmonary Hypertension|idiopathic pulmonary hypertension
97834|NCT02955420|Cardiomyopathies|cardiomyopathies
97835|NCT02955394|ER+/Her2 - breast cancer|er+/her2 - breast cancer
97836|NCT02955394|Preoperative Fulvestrant|preoperative fulvestrant
97837|NCT02955394|Enzalutamide|enzalutamide
97838|NCT02955368|DP-R212|dp-r212
97839|NCT02955303|Cognitive training|cognitive training
97840|NCT02955303|Tablet computers|tablet computers
97841|NCT02955277|Cognitive training|cognitive training
97842|NCT02955277|Tablet computers|tablet computers
97843|NCT02955264|Glycosylation|glycosylation
97844|NCT02955264|Glucose Metabolic Disorder|glucose metabolic disorder
97845|NCT02955264|Galactose|galactose
97846|NCT02955251|Cancer|cancer
97847|NCT02955251|Neoplasm|neoplasm
97848|NCT02955251|Advanced solid tumor|advanced solid tumor
97849|NCT02955251|Nivolumab|nivolumab
97850|NCT02955251|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
97851|NCT02955251|Non-squamous NSCLC|non-squamous nsclc
97852|NCT02955251|Ovarian cancer|ovarian cancer
97853|NCT02955238|Intervention|intervention
97854|NCT02955238|Cardiovascular Disease|cardiovascular disease
97855|NCT02955238|CVD|cvd
97856|NCT02955238|Diabetes|diabetes
97857|NCT02955238|Latinos|latinos
97858|NCT02955238|CIMT|cimt
97859|NCT02955238|Medication Adherence|medication adherence
97860|NCT02955238|Risk Factors|risk factors
97861|NCT02955238|T2D|t2d
97862|NCT02955225|Knee loads|knee loads
97863|NCT02955225|Knee adduction moment|knee adduction moment
97864|NCT02955225|Biomechanical intervention|biomechanical intervention
97865|NCT02955225|Insole|insole
97866|NCT02955225|Shoe|shoe
97867|NCT02955212|Rheumatoid Arthritis|rheumatoid arthritis
97868|NCT02955212|Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs)|conventional synthetic disease-modifying anti-rheumatic drugs (csdmards)
97869|NCT02955212|ABT-494|abt-494
97870|NCT02955134|central blinded histological assessment|central blinded histological assessment
97871|NCT02955134|traditional Chinese medicine intervention|traditional chinese medicine intervention
97872|NCT02955134|long-term follow-up study|long-term follow-up study
97873|NCT02955134|biological specimen banks|biological specimen banks
97874|NCT02955121|Cytochrome P-450 CYP2C19|cytochrome p-450 cyp2c19
97875|NCT02955121|Pharmacogenetics|pharmacogenetics
97876|NCT02955121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
97877|NCT02955121|Percutaneous Coronary Intervention|percutaneous coronary intervention
97878|NCT02955069|Advanced or metastatic|advanced or metastatic
97879|NCT02955069|NET|net
97880|NCT02955069|pNET|pnet
97881|NCT02955069|GI NET|gi net
97882|NCT02955069|thoracic NET|thoracic net
97883|NCT02955069|GEP-NEC|gep-nec
97884|NCT02955056|Weber B|weber b
97885|NCT02955043|Hematopoietic Stem Cell Transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
97886|NCT02955043|Fatigue|fatigue
97887|NCT02955043|Insomnia|insomnia
97888|NCT02955043|Depression|depression
97889|NCT02955043|Behavioral Intervention|behavioral intervention
97890|NCT02955017|obesity|obesity
97891|NCT02955017|children|children
97892|NCT02955017|adolescents|adolescents
97893|NCT02955017|new technology|new technology
97894|NCT02955017|mobile health|mobile health
97895|NCT02955017|chronic disease|chronic disease
97896|NCT02955004|silent brain embolism|silent brain embolism
97897|NCT02955004|atrial fibrillation|atrial fibrillation
97898|NCT02955004|cardioversion|cardioversion
97899|NCT02954965|graduate student|graduate student
97900|NCT02954965|burnout|burnout
97901|NCT02954965|stress|stress
97902|NCT02954965|mood|mood
97903|NCT02954939|lupus nephritis|lupus nephritis
97904|NCT02954939|lymphocyte subsets|lymphocyte subsets
97905|NCT02954939|cytokines|cytokines
97906|NCT02954939|mycophenolate mofetil|mycophenolate mofetil
97907|NCT02954939|cyclophosphamide|cyclophosphamide
97908|NCT02954900|Breast Cancer Prevention|breast cancer prevention
97909|NCT02954900|Risk Assessment|risk assessment
97910|NCT02954900|Chemoprevention|chemoprevention
97911|NCT02954900|Decision Making|decision making
97915|NCT02954809|sleep disturbances|sleep disturbances
97916|NCT02954809|circadian activity rhythms|circadian activity rhythms
97917|NCT02954783|Prostate cancer|prostate cancer
97918|NCT02954783|Localized|localized
97919|NCT02954783|Exercise|exercise
97920|NCT02954783|Physical activity|physical activity
97921|NCT02954783|Natural killer cells|natural killer cells
97922|NCT02954783|Immune cells|immune cells
97923|NCT02954757|uterine adenomyosis|uterine adenomyosis
97924|NCT02954744|uterine fibroid|uterine fibroid
97925|NCT02954731|Cognitive Behavior Therapy|cognitive behavior therapy
97926|NCT02954731|Negative Affect|negative affect
97927|NCT02954731|Unified Protocol|unified protocol
97928|NCT02954731|Session Tracking|session tracking
97929|NCT02954731|Mechanisms of Change in Psychotherapy|mechanisms of change in psychotherapy
97930|NCT02954718|activity performance|activity performance
97931|NCT02954718|juvenile idiopathic arthritis|juvenile idiopathic arthritis
97932|NCT02954718|virtual reality|virtual reality
97933|NCT02954679|Psychoactive Substances Consumption|psychoactive substances consumption
97934|NCT02954679|Substance-related Disorder|substance-related disorder
97935|NCT02954679|Off label-use|off label-use
97936|NCT02954679|Cognitive Enhancement|cognitive enhancement
97937|NCT02954679|Students|students
97938|NCT02954679|Doping|doping
97939|NCT02954679|Stimulants|stimulants
97940|NCT02954679|Drug abuse|drug abuse
97941|NCT02954679|Methylphenidate|methylphenidate
97942|NCT02954679|Addictovigilance|addictovigilance
97943|NCT02954679|CEIP|ceip
97944|NCT02954666|cardio-neuromodulation|cardio-neuromodulation
97945|NCT02954666|cardio-neuroablation|cardio-neuroablation
97946|NCT02954666|ablation|ablation
97947|NCT02954666|ganglionated plexi|ganglionated plexi
97948|NCT02954666|anterior right ganglionated plexus|anterior right ganglionated plexus
97949|NCT02954666|syncope|syncope
97950|NCT02954653|relapsed|relapsed
97951|NCT02954653|refractory|refractory
97952|NCT02954653|acute myeloid leukemia|acute myeloid leukemia
97954|NCT02954627|Osteoarthritis|osteoarthritis
97955|NCT02954627|Obesity|obesity
97956|NCT02954627|Liraglutide 3 mg|liraglutide 3 mg
97957|NCT02954627|Liraglutide|liraglutide
97958|NCT02954627|Ultrasound|ultrasound
97959|NCT02954601|Oral Insulin|oral insulin
97960|NCT02954601|DM T2 (Diabetes Mellitus Type 2)|dm t2 (diabetes mellitus type 2)
97961|NCT02954562|anxiety|anxiety
97962|NCT02954562|fMRI|fmri
97963|NCT02954562|emotion regulation|emotion regulation
97964|NCT02954549|vitamin D deficiency, genomics, vitamin D supplementation|vitamin d deficiency, genomics, vitamin d supplementation
97965|NCT02954536|pembrolizumab|pembrolizumab
97966|NCT02954536|trastuzumab|trastuzumab
97967|NCT02954536|capecitabine|capecitabine
97968|NCT02954536|cisplatin|cisplatin
97969|NCT02954536|Stage IV|stage iv
97970|NCT02954536|HER2-positive|her2-positive
97971|NCT02954536|esophagogastric cancer|esophagogastric cancer
97972|NCT02954536|16-937|16-937
97973|NCT02954536|Oxaliplatin|oxaliplatin
97974|NCT02954536|5-Fluorouracil (5-FU)|5-fluorouracil (5-fu)
97975|NCT02954523|NSCLC|nsclc
97976|NCT02954523|Non-small cell|non-small cell
97977|NCT02954523|Lung Cancer|lung cancer
97978|NCT02954523|Dasatinib|dasatinib
97979|NCT02954523|Osimertinib|osimertinib
97980|NCT02954523|AZD9291|azd9291
97981|NCT02954523|EGFR Mutations|egfr mutations
97982|NCT02954523|Epidermal growth factor receptor (EGFR)|epidermal growth factor receptor (egfr)
97983|NCT02954445|BCMA|bcma
97984|NCT02954445|CAR-T|car-t
97985|NCT02954432|transcranial Direct Current Stimulation|transcranial direct current stimulation
97986|NCT02954432|Transcranial Ultrasound|transcranial ultrasound
97987|NCT02954432|non-invasive brain stimulation|non-invasive brain stimulation
97988|NCT02954419|IgA Nephropathy|iga nephropathy
97989|NCT02954419|Biomarker|biomarker
97990|NCT02954406|Drug Therapy|drug therapy
97991|NCT02954393|Periodontal disease|periodontal disease
97992|NCT02954393|Metronidazole|metronidazole
97993|NCT02954393|Amoxicillin|amoxicillin
97994|NCT02954393|Scaling and root planing|scaling and root planing
97995|NCT02954393|Healing phase|healing phase
97996|NCT02954354|Flu|flu
97997|NCT02954354|Baloxavir Marboxil|baloxavir marboxil
97998|NCT02954354|Oseltamivir|oseltamivir
97999|NCT02954354|Tamiflu®|tamiflu®
98000|NCT02954302|Delayed gastric emptying|delayed gastric emptying
98001|NCT02954302|pancreaticoduodenectomy|pancreaticoduodenectomy
98002|NCT02954289|modifiable risk factors|modifiable risk factors
98003|NCT02954289|lifestyle|lifestyle
98004|NCT02954289|nutrition|nutrition
98005|NCT02954289|weight control|weight control
98006|NCT02954289|dietary intervention|dietary intervention
98007|NCT02954289|health promotion|health promotion
98008|NCT02954289|patient-partner outcomes|patient-partner outcomes
98009|NCT02954289|survivorship|survivorship
98010|NCT02954289|prostate cancer outcomes|prostate cancer outcomes
98011|NCT02954276|safety|safety
98012|NCT02954263|Multiple ascending dose (MAD)|multiple ascending dose (mad)
98013|NCT02954237|Non-valvular atrial fibrillation (NVAF)|non-valvular atrial fibrillation (nvaf)
98014|NCT02954237|Anticoagulant|anticoagulant
98015|NCT02954237|Warfarin|warfarin
98016|NCT02954237|Stroke|stroke
98017|NCT02954224|sleep apnea, delirium|sleep apnea, delirium
98018|NCT02954211|rTMS|rtms
98019|NCT02954211|noninvasive brain stimulation|noninvasive brain stimulation
98020|NCT02954211|physical therapy|physical therapy
98021|NCT02954185|Shoulder Pain|shoulder pain
98022|NCT02954146|Veterans|veterans
98023|NCT02954146|Posttraumatic Stress Disorder|posttraumatic stress disorder
98024|NCT02954146|Anger|anger
98025|NCT02954146|Behavioral Health|behavioral health
98026|NCT02954146|Mobile Health Technology|mobile health technology
98027|NCT02954133|Alignment phase|alignment phase
98028|NCT02954133|Photobiomodulation|photobiomodulation
98029|NCT02954133|Orthodontic treatment|orthodontic treatment
98030|NCT02954133|Malocclusion|malocclusion
98031|NCT02954133|OrthoPulse™|orthopulse™
98032|NCT02954133|Invisalign|invisalign
98033|NCT02954120|8- hydroxy -2´- deoxyguanosine|8- hydroxy -2´- deoxyguanosine
98034|NCT02954120|Malondialdehyde|malondialdehyde
98035|NCT02954120|Total antioxidant status|total antioxidant status
98036|NCT02954120|Oxidative stres|oxidative stres
98037|NCT02954068|Oxytocin|oxytocin
98038|NCT02954055|locally advanced|locally advanced
98039|NCT02954055|metastatic|metastatic
98040|NCT02954055|breast cancer|breast cancer
98041|NCT02954055|ER-positive|er-positive
98042|NCT02954055|HER2-negative|her2-negative
98043|NCT02954055|Stage IV|stage iv
98044|NCT02954042|Incontinence|incontinence
98045|NCT02954016|Obesity|obesity
98046|NCT02954016|Weight Loss|weight loss
98047|NCT02954016|Hypertension|hypertension
98048|NCT02954016|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
98049|NCT02954016|Hyperlipidemia|hyperlipidemia
98050|NCT02954003|Obesity|obesity
98051|NCT02954003|Weight Loss|weight loss
98052|NCT02953990|Pregnancy|pregnancy
98053|NCT02953990|Self-Management|self-management
98054|NCT02953990|Yoga|yoga
98055|NCT02953951|blood transfusion|blood transfusion
98056|NCT02953951|free hemoglobin|free hemoglobin
98057|NCT02953951|nitric oxide|nitric oxide
98058|NCT02953951|endothelium-dependent vasodilatation|endothelium-dependent vasodilatation
98059|NCT02953951|peripheral artery tonometry|peripheral artery tonometry
98060|NCT02953951|cardiac surgery.|cardiac surgery.
98061|NCT02953938|Ranibizumab|ranibizumab
98062|NCT02953938|Grid&Direct short pulse laser photocoagulation|grid&direct short pulse laser photocoagulation
98063|NCT02953938|Macular edema,|macular edema,
98064|NCT02953938|Branch retinal vein occlusion (BRVO)|branch retinal vein occlusion (brvo)
98065|NCT02953938|BCVA|bcva
98066|NCT02953938|CSFT|csft
98067|NCT02953938|pro re nata|pro re nata
98068|NCT02953925|primary health care|primary health care
98069|NCT02953925|village doctor|village doctor
98070|NCT02953925|township hospital|township hospital
98071|NCT02953925|community health center|community health center
98072|NCT02953912|Rotation|rotation
98073|NCT02953912|Reciprocation|reciprocation
98074|NCT02953912|single file|single file
98075|NCT02953912|postoperative pain|postoperative pain
98076|NCT02953912|Reciproc|reciproc
98077|NCT02953912|One Shape|one shape
98078|NCT02953912|Symptomatic irreversible pulpitis|symptomatic irreversible pulpitis
98079|NCT02953899|Internet|internet
98080|NCT02953899|Contingency Management|contingency management
98081|NCT02953899|Gambling Disorder|gambling disorder
98082|NCT02953899|Rural|rural
98083|NCT02953886|Caries|caries
98084|NCT02953886|Cavity|cavity
98085|NCT02953886|Silver Diamine Fluoride (SDF)|silver diamine fluoride (sdf)
98086|NCT02953886|HOMINGS|homings
98087|NCT02953860|Advanced Breast Cancer|advanced breast cancer
98088|NCT02953860|ER+/Her2 Advanced Breast Cancer|er+/her2 advanced breast cancer
98089|NCT02953834|insulin regulation in pregnancy|insulin regulation in pregnancy
98090|NCT02953834|kisspeptin|kisspeptin
98091|NCT02953808|GSK2315698|gsk2315698
98092|NCT02953808|Dose-ascending|dose-ascending
98093|NCT02953808|Systemic amyloidosis|systemic amyloidosis
98094|NCT02953782|Colorectal Neoplasms, Hu5F9-G4, CD47, cetuximab|colorectal neoplasms, hu5f9-g4, cd47, cetuximab
98095|NCT02953756|Brain metastases|brain metastases
98096|NCT02953756|Cognition|cognition
98097|NCT02953756|Radiosurgery|radiosurgery
98098|NCT02953756|Stereotactic radiosurgery|stereotactic radiosurgery
98099|NCT02953756|Gamma Knife Radiosurgery|gamma knife radiosurgery
98100|NCT02953756|Quality of Life|quality of life
98101|NCT02953756|Fatigue|fatigue
98102|NCT02953756|Anxiety|anxiety
98103|NCT02953756|Depression|depression
98104|NCT02953743|E7080|e7080
98105|NCT02953743|Lenvatinib|lenvatinib
98106|NCT02953743|Pharmacokinetic study|pharmacokinetic study
98107|NCT02953743|Chinese participants|chinese participants
98108|NCT02953743|Unresectable Hepatocellular Carcinoma|unresectable hepatocellular carcinoma
98109|NCT02953717|Brain metastases|brain metastases
98110|NCT02953717|Cognition|cognition
98111|NCT02953717|Radiosurgery|radiosurgery
98112|NCT02953717|Gamma Knife Radiosurgery|gamma knife radiosurgery
98113|NCT02953717|Stereotactic radiosurgery|stereotactic radiosurgery
98114|NCT02953717|Whole Brain Radiation Therapy|whole brain radiation therapy
98115|NCT02953717|Quality of Life|quality of life
98116|NCT02953717|Fatigue|fatigue
98117|NCT02953717|Anxiety|anxiety
98118|NCT02953717|Depression|depression
98119|NCT02953704|Myelofibrosis|myelofibrosis
98120|NCT02953704|essential thrombocythemia|essential thrombocythemia
98121|NCT02953704|clinical characteristics|clinical characteristics
98122|NCT02953704|disease burden|disease burden
98123|NCT02953704|patient-reported outcomes|patient-reported outcomes
98124|NCT02953691|perioperative|perioperative
98125|NCT02953691|surgery|surgery
98126|NCT02953691|pain|pain
98127|NCT02953691|anxiety|anxiety
98128|NCT02953691|post operative cognitive dysfunction|post operative cognitive dysfunction
98129|NCT02953691|cognition|cognition
98130|NCT02953678|Graft-versus-host disease (GVHD)|graft-versus-host disease (gvhd)
98131|NCT02953678|acute GVHD|acute gvhd
98132|NCT02953678|steroid-refractory|steroid-refractory
98133|NCT02953678|ruxolitinib|ruxolitinib
98134|NCT02953678|Janus kinase inhibitor|janus kinase inhibitor
98135|NCT02953665|Parkinson's Disease, Liraglutide|parkinson's disease, liraglutide
98136|NCT02953665|Antidiabetic agents|antidiabetic agents
98137|NCT02953665|GLP-1 agonists|glp-1 agonists
98138|NCT02953665|Insulin resistance|insulin resistance
98139|NCT02953626|pilot RCT|pilot rct
98140|NCT02953626|waitlist-controlled RCT|waitlist-controlled rct
98141|NCT02953626|postpartum depression|postpartum depression
98142|NCT02953613|Cardiac Catheterization|cardiac catheterization
98143|NCT02953613|Cardiac intervention|cardiac intervention
98144|NCT02953613|coronary angiogram|coronary angiogram
98145|NCT02953613|coronary artery disease|coronary artery disease
98146|NCT02953613|atherosclerosis|atherosclerosis
98147|NCT02953587|Obesity|obesity
98148|NCT02953587|Bariatric Surgery|bariatric surgery
98149|NCT02953574|geriatric nursing|geriatric nursing
98150|NCT02953561|Relapsed Acute Myeloid Leukemia|relapsed acute myeloid leukemia
98151|NCT02953561|Refractory Acute Myeloid Leukemia|refractory acute myeloid leukemia
98152|NCT02953561|Acute Myeloid Leukemia|acute myeloid leukemia
98153|NCT02953561|AML|aml
98154|NCT02953561|Avelumab|avelumab
98155|NCT02953561|antiPDL1|antipdl1
98156|NCT02953561|5-azacytidine|5-azacytidine
98157|NCT02953561|Azacitidine|azacitidine
98158|NCT02953561|5-aza|5-aza
98159|NCT02953561|Vidaza|vidaza
98160|NCT02953561|5-AZC|5-azc
98161|NCT02953561|AZA-CR|aza-cr
98162|NCT02953561|Ladakamycin|ladakamycin
98163|NCT02953561|NSC-102816|nsc-102816
98164|NCT02953561|Azacytidine|azacytidine
98165|NCT02953548|GWP42003-P|gwp42003-p
98166|NCT02953548|Cannabidiol|cannabidiol
98167|NCT02953522|Polymorphism|polymorphism
98168|NCT02953522|Folate|folate
98169|NCT02953522|Oxidative stress|oxidative stress
98170|NCT02953522|Overweight and Obesity|overweight and obesity
98171|NCT02953509|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
98172|NCT02953509|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
98173|NCT02953509|indolent lymphoma|indolent lymphoma
98174|NCT02953509|Hu5F9-G4|hu5f9-g4
98175|NCT02953509|CD47|cd47
98176|NCT02953496|peripheral artery disease|peripheral artery disease
98177|NCT02953496|PAD|pad
98178|NCT02953496|vonapanitase|vonapanitase
98179|NCT02953496|claudication|claudication
98180|NCT02953496|superficial femoral artery|superficial femoral artery
98181|NCT02953496|SFA|sfa
98182|NCT02953496|popliteal artery|popliteal artery
98183|NCT02953496|stenosis|stenosis
98184|NCT02953496|elastase|elastase
98185|NCT02953496|chymotrypsin-like elastase 1|chymotrypsin-like elastase 1
98186|NCT02953496|CELA1|cela1
98187|NCT02953496|PRT-201|prt-201
98188|NCT02953483|Ex Vivo lung perfusion|ex vivo lung perfusion
98189|NCT02953470|chronic pain|chronic pain
98190|NCT02953470|community-dwelling|community-dwelling
98191|NCT02953470|older adults|older adults
98192|NCT02953470|physical activity|physical activity
98193|NCT02953470|physiotherapy|physiotherapy
98194|NCT02953470|behavioural medicine|behavioural medicine
98195|NCT02953470|biopsychosocial|biopsychosocial
98196|NCT02953470|exercise|exercise
98197|NCT02953470|independency|independency
98198|NCT02953470|everyday activities|everyday activities
98199|NCT02953470|self-efficacy|self-efficacy
98200|NCT02953470|quality of life|quality of life
98201|NCT02953470|pain-related beliefs|pain-related beliefs
98202|NCT02953470|pain-related disability|pain-related disability
98203|NCT02953431|Asthma|asthma
98204|NCT02953431|Obesity|obesity
98205|NCT02953353|Obesity|obesity
98206|NCT02953353|Feeding behavior|feeding behavior
98207|NCT02953353|Transcranial direct current stimulation|transcranial direct current stimulation
98208|NCT02953353|Weight loss|weight loss
98209|NCT02953340|Neutropenia|neutropenia
98210|NCT02953340|Breast Cancer|breast cancer
98211|NCT02953340|Long-acting Myeloid Growth Factor|long-acting myeloid growth factor
98212|NCT02953340|Early Stage Breast Cancer|early stage breast cancer
98213|NCT02953340|Docetaxel + Cyclophosphamide (TC) chemotherapy|docetaxel + cyclophosphamide (tc) chemotherapy
98214|NCT02953327|Non-Specific Effect of Vaccine|non-specific effect of vaccine
98215|NCT02953327|Middle aged|middle aged
98216|NCT02953327|Immunity, heterologous|immunity, heterologous
98317|NCT02952534|BRCA|brca
98217|NCT02953301|Cutaneous T-Cell Lymphoma (CTLC)|cutaneous t-cell lymphoma (ctlc)
98218|NCT02953301|Maintenance|maintenance
98219|NCT02953301|resminostat|resminostat
98220|NCT02953301|4SC|4sc
98221|NCT02953301|HDAC|hdac
98222|NCT02953301|Mycosis Fungoides|mycosis fungoides
98223|NCT02953301|Sézary Syndrome|sézary syndrome
98224|NCT02953262|Diabetes Mellitus|diabetes mellitus
98225|NCT02953262|Personal Health Records|personal health records
98226|NCT02953262|Patient Outcome Assessment|patient outcome assessment
98227|NCT02953262|Mental Health|mental health
98228|NCT02953184|neoadjuvant chemotherapy|neoadjuvant chemotherapy
98229|NCT02953184|Pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
98230|NCT02953184|breast cancer|breast cancer
98231|NCT02953171|Irritable Bowel Syndrome|irritable bowel syndrome
98232|NCT02953171|The human microbiome|the human microbiome
98233|NCT02953171|Microbiota|microbiota
98234|NCT02953171|Gut microbiota|gut microbiota
98235|NCT02953171|Probiotics|probiotics
98236|NCT02953171|Sauerkraut|sauerkraut
98237|NCT02953106|Asthma|asthma
98238|NCT02953106|Rhinitis|rhinitis
98239|NCT02953106|Dymista|dymista
98240|NCT02953106|allergy|allergy
98241|NCT02953093|acarbose|acarbose
98242|NCT02953093|aging|aging
98243|NCT02953054|Pain|pain
98244|NCT02953054|Bunionectomy|bunionectomy
98245|NCT02953054|Dexmedetomidine|dexmedetomidine
98246|NCT02953054|Transdermal|transdermal
98247|NCT02953054|Patch|patch
98248|NCT02953054|Postoperative|postoperative
98249|NCT02953054|DMTS|dmts
98250|NCT02953028|Continuous Positive Airway Pressure|continuous positive airway pressure
98251|NCT02953028|Mandibular Advancing Splint|mandibular advancing splint
98252|NCT02953028|Efficacy|efficacy
98253|NCT02953028|Compliance|compliance
98254|NCT02953028|Health related quality of life|health related quality of life
98255|NCT02953028|Randomized Controlled Trial|randomized controlled trial
98256|NCT02953028|Snoring|snoring
98257|NCT02953028|Mandibular Advancing Appliance|mandibular advancing appliance
98258|NCT02953028|Mandibular Advancing Device|mandibular advancing device
98259|NCT02953028|Humans|humans
98260|NCT02953028|Quality of Life|quality of life
98261|NCT02953028|Sleep Apnea, Obstructive|sleep apnea, obstructive
98262|NCT02953015|Chronic Migraine|chronic migraine
98263|NCT02953015|Manipulative treatments|manipulative treatments
98264|NCT02953015|Transcutaneous Electrical Nerve Stimulation|transcutaneous electrical nerve stimulation
98265|NCT02952989|MSI-high|msi-high
98266|NCT02952989|dMMR|dmmr
98267|NCT02952989|PD-L1|pd-l1
98268|NCT02952976|open abdomen|open abdomen
98269|NCT02952976|Damage control|damage control
98270|NCT02952976|Abdominal Compartment Syndrome|abdominal compartment syndrome
98271|NCT02952950|Intra Oral Vacuum|intra oral vacuum
98272|NCT02952950|protein content breastmilk|protein content breastmilk
98273|NCT02952937|Neuralgia, Postherpetic|neuralgia, postherpetic
98274|NCT02952937|Postherpetic Neuralgia|postherpetic neuralgia
98275|NCT02952937|Diabetic Neuropathies|diabetic neuropathies
98276|NCT02952937|Diabetic Neuralgia|diabetic neuralgia
98277|NCT02952937|Diabetic Polyneuropathy|diabetic polyneuropathy
98278|NCT02952937|Diabetic Neuropathy, Painful|diabetic neuropathy, painful
98279|NCT02952937|Neuralgia|neuralgia
98280|NCT02952937|Neuropathic Pain|neuropathic pain
98281|NCT02952937|Pregabalin|pregabalin
98282|NCT02952937|Pharmacokinetics|pharmacokinetics
98283|NCT02952937|Bioequivalent|bioequivalent
98284|NCT02952898|solar keratoses|solar keratoses
98285|NCT02952872|Computerized Brief Intervention|computerized brief intervention
98286|NCT02952833|Inactivated|inactivated
98287|NCT02952833|Phase I|phase i
98288|NCT02952833|placebo-controlled|placebo-controlled
98289|NCT02952833|Vaccine|vaccine
98290|NCT02952833|ZIKA|zika
98291|NCT02952820|insomnia|insomnia
98292|NCT02952794|endoscopic submucosal dissection (ESD)|endoscopic submucosal dissection (esd)
98293|NCT02952794|endoscopic mucosal band ligation (EMBL)|endoscopic mucosal band ligation (embl)
98294|NCT02952781|ECG Monitoring|ecg monitoring
98295|NCT02952781|Palpitations|palpitations
98296|NCT02952716|carbon monoxide poisoning|carbon monoxide poisoning
98297|NCT02952716|delayed encephalopathy|delayed encephalopathy
98298|NCT02952638|Lipids|lipids
98299|NCT02952638|lysophosphatidic acid|lysophosphatidic acid
98300|NCT02952638|Lysophospholipids|lysophospholipids
98301|NCT02952638|phosphatidylcholine|phosphatidylcholine
98302|NCT02952638|lysophosphatidylcholine|lysophosphatidylcholine
98303|NCT02952638|autotaxin|autotaxin
98304|NCT02952638|dietary|dietary
98305|NCT02952625|PET/MRI|pet/mri
98306|NCT02952599|Non-interventional Study|non-interventional study
98307|NCT02952599|Real World Evidence|real world evidence
98308|NCT02952599|Patients with Acute VTE treated with Edoxaban|patients with acute vte treated with edoxaban
98309|NCT02952599|Efficacy/Safety|efficacy/safety
98310|NCT02952560|Ultrasound|ultrasound
98311|NCT02952560|Computed Tomography|computed tomography
98312|NCT02952560|Oral cavity size|oral cavity size
98313|NCT02952560|The Mallampati classification|the mallampati classification
98314|NCT02952534|CRPC|crpc
98315|NCT02952534|PARP inhibitor|parp inhibitor
98316|NCT02952534|PARPi|parpi
98318|NCT02952534|ATM|atm
98319|NCT02952534|HRD|hrd
98320|NCT02952534|TRITON|triton
98321|NCT02952534|homologous recombination|homologous recombination
98322|NCT02952534|DNA repair|dna repair
98323|NCT02952534|DNA defect|dna defect
98324|NCT02952534|DNA anomaly|dna anomaly
98325|NCT02952534|BARD1|bard1
98326|NCT02952534|BRIP1|brip1
98327|NCT02952534|CDK12|cdk12
98328|NCT02952534|CHEK2|chek2
98329|NCT02952534|FANCA|fanca
98330|NCT02952534|NBN|nbn
98331|NCT02952534|PALB2|palb2
98332|NCT02952534|RAD51|rad51
98333|NCT02952534|RAD51B|rad51b
98334|NCT02952534|RAD51C|rad51c
98335|NCT02952534|RAD51D|rad51d
98336|NCT02952534|RAD54L|rad54l
98337|NCT02952534|germline|germline
98338|NCT02952534|somatic|somatic
98339|NCT02952495|Alcohol Consumption|alcohol consumption
98340|NCT02952495|Older Adults|older adults
98341|NCT02952482|adrenoleukodystrophy|adrenoleukodystrophy
98342|NCT02952482|C26:0-lyso-PC|c26:0-lyso-pc
98343|NCT02952469|Positron-Emission Tomography|positron-emission tomography
98344|NCT02952469|(68Ga)Glu-urea-Lys(Ahx)-HBED-CC|(68ga)glu-urea-lys(ahx)-hbed-cc
98345|NCT02952469|(68Ga)PSMA-HBED-CC|(68ga)psma-hbed-cc
98346|NCT02952469|Glu-NH-CO-NH-Lys-(Ahx)-((68)Ga(HBED-CC))|glu-nh-co-nh-lys-(ahx)-((68)ga(hbed-cc))
98347|NCT02952469|(68)Ga-PSMA|(68)ga-psma
98348|NCT02952469|68Ga-PSMA-11|68ga-psma-11
98349|NCT02952456|SUDEP|sudep
98350|NCT02952456|Epilepsy|epilepsy
98351|NCT02952456|Qualitative research|qualitative research
98352|NCT02952456|Risks associated with epilepsy|risks associated with epilepsy
98353|NCT02952456|Epilepsy-related deaths|epilepsy-related deaths
98354|NCT02952391|cognition|cognition
98355|NCT02952391|cholinergic system|cholinergic system
98356|NCT02952365|LASIK, Ingrowth, Tissue sealant|lasik, ingrowth, tissue sealant
98357|NCT02952300|irreversible pulpitis|irreversible pulpitis
98358|NCT02952300|reciprocation|reciprocation
98359|NCT02952300|rotation|rotation
98360|NCT02952300|single file|single file
98361|NCT02952300|wave one|wave one
98362|NCT02952300|neolix|neolix
98363|NCT02952209|Alveolar Ridge Preservation|alveolar ridge preservation
98364|NCT02952209|Xenograft bone graft|xenograft bone graft
98365|NCT02952209|Collagen membrane|collagen membrane
98366|NCT02952196|Amphetamine|amphetamine
98367|NCT02952196|Cannabinoids|cannabinoids
98368|NCT02952183|Autonomic nerve monitoring|autonomic nerve monitoring
98369|NCT02952183|Nerve-sparing surgery|nerve-sparing surgery
98370|NCT02952131|IBD,Crohn's,Ulcerative Bowel; Diverticulitis;IBS;UC|ibd,crohn's,ulcerative bowel; diverticulitis;ibs;uc
98371|NCT02952105|cardiac arrest|cardiac arrest
98372|NCT02952105|identify of electrocardiac rhythm|identify of electrocardiac rhythm
98373|NCT02952105|ventricuar fibrillation|ventricuar fibrillation
98374|NCT02952105|defibrillation|defibrillation
98375|NCT02952092|ASP1517|asp1517
98376|NCT02952092|Renal anemia|renal anemia
98377|NCT02952092|Hemodialysis|hemodialysis
98378|NCT02952092|Roxadustat|roxadustat
98379|NCT02952053|Myofascial Trigger Points|myofascial trigger points
98380|NCT02952053|Dry needling|dry needling
98381|NCT02952053|Myotonometry|myotonometry
98382|NCT02952040|ASP1517|asp1517
98383|NCT02952040|Pharmacokinetics|pharmacokinetics
98384|NCT02952040|Drug-drug interaction|drug-drug interaction
98385|NCT02952001|Uveitis|uveitis
98386|NCT02952001|UME|ume
98387|NCT02952001|Posterior Uveitis|posterior uveitis
98388|NCT02952001|Anterior Uveitis|anterior uveitis
98389|NCT02952001|Intermediate Uveitis|intermediate uveitis
98390|NCT02952001|Panuveitis|panuveitis
98391|NCT02952001|Non-infectious Uveitis|non-infectious uveitis
98392|NCT02952001|Triamcinolone|triamcinolone
98393|NCT02952001|Choroid|choroid
98394|NCT02952001|Choroidal Injection|choroidal injection
98395|NCT02952001|Suprachoroidal|suprachoroidal
98396|NCT02952001|Microneedle|microneedle
98397|NCT02952001|Microinjection|microinjection
98398|NCT02951949|atherosclerosis, endogenous estrogens, age|atherosclerosis, endogenous estrogens, age
98399|NCT02951897|circulating tumor cells|circulating tumor cells
98400|NCT02951897|lung adenocarcinoma|lung adenocarcinoma
98401|NCT02951897|treatment|treatment
98402|NCT02951897|early diagnosis|early diagnosis
98403|NCT02951871|Follicular lymphoma; death, rituximab, treatment related toxicity|follicular lymphoma; death, rituximab, treatment related toxicity
98404|NCT02951858|Alcohol,Smoking,and Substance Use Involvement Screening Test|alcohol,smoking,and substance use involvement screening test
98405|NCT02951858|Brief Intervention|brief intervention
98406|NCT02951858|Substance Use|substance use
98407|NCT02951858|Primary Medical and Health Care Institution|primary medical and health care institution
98408|NCT02951793|intensive care unit|intensive care unit
98409|NCT02951793|delirium|delirium
98410|NCT02951793|substance withdrawal|substance withdrawal
98411|NCT02951767|anti-PD-L1|anti-pd-l1
98412|NCT02951767|PD-L1|pd-l1
98413|NCT02951767|MPDL3280A|mpdl3280a
98414|NCT02951767|PD-1|pd-1
98415|NCT02951767|bladder cancer|bladder cancer
98416|NCT02951767|atezolizumab|atezolizumab
98417|NCT02951767|Tecentriq|tecentriq
98418|NCT02951754|ADHD|adhd
98419|NCT02951754|Adults|adults
98420|NCT02951754|treatment|treatment
98421|NCT02951754|Methylphenidate|methylphenidate
98422|NCT02951650|vagus nerve stimulation|vagus nerve stimulation
98423|NCT02951637|Adenocarcinoma, EGFR, Gefitinib, Pemetrexed, Carboplatin|adenocarcinoma, egfr, gefitinib, pemetrexed, carboplatin
98424|NCT02951624|Exercise|exercise
98425|NCT02951624|Breaking prolonged sitting|breaking prolonged sitting
98426|NCT02951624|physical activity|physical activity
98427|NCT02951572|Noninvasive Ventilation|noninvasive ventilation
98428|NCT02951572|Physical activity|physical activity
98429|NCT02951520|Patients|patients
98430|NCT02951481|Clostridium difficile.|clostridium difficile.
98431|NCT02951481|Antimicrobial Stewardship.|antimicrobial stewardship.
98432|NCT02951481|Enterocolitis, Pseudomembranous|enterocolitis, pseudomembranous
98433|NCT02951442|Arterial stiffness|arterial stiffness
98434|NCT02951442|Klotho-FGF23|klotho-fgf23
98435|NCT02951403|elbow arthroscopy|elbow arthroscopy
98436|NCT02951403|DASH|dash
98437|NCT02951403|elbow locking|elbow locking
98438|NCT02951403|elbow osteoarthritis|elbow osteoarthritis
98439|NCT02951390|Surveillance|surveillance
98440|NCT02951390|Colorectal cancer|colorectal cancer
98441|NCT02951390|Colonoscopy|colonoscopy
98442|NCT02951390|Adenoma|adenoma
98443|NCT02951390|Chromoendoscopy|chromoendoscopy
98444|NCT02951377|mechanical diagnosis therapy (MDT)|mechanical diagnosis therapy (mdt)
98445|NCT02951377|physical therapy|physical therapy
98446|NCT02951377|steroid injection|steroid injection
98447|NCT02951377|exercise|exercise
98448|NCT02951364|observational|observational
98449|NCT02951338|Physical activity|physical activity
98450|NCT02951338|Exercise|exercise
98451|NCT02951338|Behaviour change|behaviour change
98452|NCT02951338|Rehabilitation|rehabilitation
98453|NCT02951338|Self-management|self-management
98454|NCT02951338|Education|education
98455|NCT02951325|adjuvant RT|adjuvant rt
98456|NCT02951312|Emphysema|emphysema
98457|NCT02951312|Chronic bronchitis|chronic bronchitis
98458|NCT02951312|COPD|copd
98459|NCT02951312|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
98460|NCT02951286|Skeletal openbite|skeletal openbite
98461|NCT02951286|Molar intrusion|molar intrusion
98462|NCT02951286|high pull headgear|high pull headgear
98463|NCT02951273|abdominal surgery|abdominal surgery
98464|NCT02951273|blood pressure|blood pressure
98465|NCT02951273|cardiac output|cardiac output
98466|NCT02951273|cerebral blood flow|cerebral blood flow
98467|NCT02951273|cerebral oxygenation|cerebral oxygenation
98468|NCT02951273|CO2 reactivity|co2 reactivity
98469|NCT02951273|duplex ultrasound|duplex ultrasound
98470|NCT02951273|general anaesthesia|general anaesthesia
98471|NCT02951273|mesenteric traction syndrome|mesenteric traction syndrome
98472|NCT02951273|near-infrared spectroscopy|near-infrared spectroscopy
98473|NCT02951273|upper gastrointestinal cancer surgery|upper gastrointestinal cancer surgery
98474|NCT02951234|coronary artery lesions|coronary artery lesions
98475|NCT02951234|intravenous immunoglobulin|intravenous immunoglobulin
98476|NCT02951234|Kawasaki disease|kawasaki disease
98477|NCT02951234|randomized clinical trial|randomized clinical trial
98478|NCT02951234|aspirin|aspirin
98479|NCT02951130|CDH|cdh
98480|NCT02951130|PPHN|pphn
98481|NCT02951130|HRF|hrf
98482|NCT02951117|lymphoid malignancies|lymphoid malignancies
98483|NCT02951117|Next generation sequencing|next generation sequencing
98484|NCT02951117|Refractory Multiple Myeloma|refractory multiple myeloma
98485|NCT02951117|Relapsed Multiple Myeloma|relapsed multiple myeloma
98486|NCT02951052|Long-acting cabotegravir|long-acting cabotegravir
98487|NCT02951052|Virologic failure|virologic failure
98488|NCT02951052|long-acting rilpivirine|long-acting rilpivirine
98489|NCT02951052|Antiretroviral|antiretroviral
98490|NCT02951039|Non valvular Atrial Fibrillation|non valvular atrial fibrillation
98491|NCT02951039|Non-interventional Study|non-interventional study
98492|NCT02951039|Efficacy/Safety|efficacy/safety
98493|NCT02951039|Real World Evidence|real world evidence
98494|NCT02951026|knee|knee
98495|NCT02951026|osteoarthritis|osteoarthritis
98496|NCT02951026|intra-articular injection|intra-articular injection
98497|NCT02951026|SM04690|sm04690
98498|NCT02951000|thyroidectomy|thyroidectomy
98499|NCT02951000|postoperative pain|postoperative pain
98500|NCT02951000|wound healing|wound healing
98501|NCT02950987|Li-Fraumeni Syndrome (LFS)|li-fraumeni syndrome (lfs)
98502|NCT02950987|Cancer Predisposition Syndromes|cancer predisposition syndromes
98503|NCT02950987|LFS|lfs
98504|NCT02950974|sterofundin|sterofundin
98505|NCT02950974|resuscitation|resuscitation
98506|NCT02950974|normal saline|normal saline
98507|NCT02950974|chloride|chloride
98508|NCT02950974|fluid|fluid
98509|NCT02950974|SID|sid
98510|NCT02950974|pH|ph
98511|NCT02950974|osmolality|osmolality
98512|NCT02950974|urine|urine
98513|NCT02950961|Anxiety [F01.470.132]|anxiety [f01.470.132]
98514|NCT02950961|Depression [F01.145.126.350]|depression [f01.145.126.350]
98515|NCT02950961|Stress Disorders, Post-Traumatic [F03.950.750.500]|stress disorders, post-traumatic [f03.950.750.500]
98516|NCT02950961|Primary Health Care [N04.590.233.727]|primary health care [n04.590.233.727]
98517|NCT02950961|Mental Health [F02.418]|mental health [f02.418]
98518|NCT02950961|Patient Participation [N05.300.150.600.620]|patient participation [n05.300.150.600.620]
98519|NCT02950961|Patient Satisfaction [N05.300.150.600.630]|patient satisfaction [n05.300.150.600.630]
98520|NCT02950961|Patient Preference [N05.300.150.600.630.500]|patient preference [n05.300.150.600.630.500]
98521|NCT02950961|Physicians, Primary Care [M01.526.485.810.800]|physicians, primary care [m01.526.485.810.800]
98522|NCT02950961|Physicians, Women [M01.526.485.810.820]|physicians, women [m01.526.485.810.820]
98523|NCT02950961|Health Behavior [F01.145.488]|health behavior [f01.145.488]
98524|NCT02950909|Therapeutic exercise|therapeutic exercise
98525|NCT02950909|Chronic pain|chronic pain
98526|NCT02950909|Neck extensors|neck extensors
98527|NCT02950883|Cystic Fibrosis|cystic fibrosis
98528|NCT02950883|Hypertonic Saline|hypertonic saline
98529|NCT02950883|Inhaled Saline|inhaled saline
98530|NCT02950883|Digestive System Diseases|digestive system diseases
98531|NCT02950883|Genetic Diseases, Inborn|genetic diseases, inborn
98532|NCT02950883|Lung Diseases|lung diseases
98533|NCT02950883|Pancreatic Diseases|pancreatic diseases
98534|NCT02950883|Pathologic Processes|pathologic processes
98535|NCT02950883|Respiratory Tract Diseases|respiratory tract diseases
98536|NCT02950883|Computed Tomography (CT)|computed tomography (ct)
98537|NCT02950844|Atrial fibrillation|atrial fibrillation
98538|NCT02950844|Electrogram|electrogram
98539|NCT02950844|Ablation|ablation
98540|NCT02950844|Drivers|drivers
98541|NCT02950831|Chronic Pain|chronic pain
98542|NCT02950831|BurstDR|burstdr
98543|NCT02950831|spinal cord stimulation|spinal cord stimulation
98544|NCT02950831|Accelerometry|accelerometry
98545|NCT02950818|self-care|self-care
98546|NCT02950818|health education|health education
98547|NCT02950818|chronic disease|chronic disease
98548|NCT02950818|heart diseases|heart diseases
98549|NCT02950818|risk factors for heart disease|risk factors for heart disease
98550|NCT02950805|AZD5634|azd5634
98551|NCT02950805|Mucociliary Clearance|mucociliary clearance
98552|NCT02950805|Safety|safety
98553|NCT02950805|Tolerability|tolerability
98554|NCT02950805|Pharmacokinetic|pharmacokinetic
98555|NCT02950805|Cystic Fibrosis|cystic fibrosis
98556|NCT02950805|Cross-Over Study|cross-over study
98557|NCT02950792|Non-Small Cell Lung Cancer|non-small cell lung cancer
98558|NCT02950792|NSCLC|nsclc
98559|NCT02950766|Kidney Cancer|kidney cancer
98560|NCT02950753|Elevated Serum Lactate|elevated serum lactate
98561|NCT02950753|Serum lactate|serum lactate
98562|NCT02950753|Ringer's Lactate|ringer's lactate
98563|NCT02950753|Lactated Ringer's|lactated ringer's
98564|NCT02950753|Hyperlactatemia|hyperlactatemia
98565|NCT02950740|malnutrition|malnutrition
98566|NCT02950727|orthognathic surgery|orthognathic surgery
98567|NCT02950727|bicortical screws|bicortical screws
98568|NCT02950727|monocortical plates|monocortical plates
98569|NCT02950675|Burn patient|burn patient
98570|NCT02950675|Developmental Disabilities|developmental disabilities
98571|NCT02950675|Body function|body function
98572|NCT02950675|Participation|participation
98573|NCT02950675|Quality of Life|quality of life
98574|NCT02950675|longitudinal study|longitudinal study
98575|NCT02950636|Epilepsy|epilepsy
98576|NCT02950610|Electronic nose|electronic nose
98577|NCT02950610|Non invasive diagnosis of NAFLD|non invasive diagnosis of nafld
98578|NCT02950610|NAFLD|nafld
98579|NCT02950610|exhaled breath analysis|exhaled breath analysis
98580|NCT02950610|Volatile organic compounds|volatile organic compounds
98581|NCT02950545|astigmatism, contact lens, driving|astigmatism, contact lens, driving
98582|NCT02950532|Posterior ligamentous complex|posterior ligamentous complex
98583|NCT02950532|Thoracolumbar fractures|thoracolumbar fractures
98584|NCT02950532|Interspinous distance|interspinous distance
98585|NCT02950532|Local kyphosis|local kyphosis
98586|NCT02950506|Interictal|interictal
98587|NCT02950506|Cognitive|cognitive
98588|NCT02950506|Dysfunction|dysfunction
98589|NCT02950506|tDCS|tdcs
98590|NCT02950506|transcranial direct current stimulation|transcranial direct current stimulation
98591|NCT02950480|Mastectomy|mastectomy
98592|NCT02950467|HIV/AIDS|hiv/aids
98593|NCT02950467|Demoralization|demoralization
98594|NCT02950467|Psilocybin|psilocybin
98595|NCT02950467|Group therapy|group therapy
98596|NCT02950454|Progressive Multiple Sclerosis|progressive multiple sclerosis
98597|NCT02950454|Rehabilitation|rehabilitation
98598|NCT02950454|Exercise|exercise
98599|NCT02950441|Nicotinamide Riboside|nicotinamide riboside
98600|NCT02950441|Nicotinamide Adenine Dinucleotide|nicotinamide adenine dinucleotide
98601|NCT02950441|Skeletal muscle|skeletal muscle
98602|NCT02950441|Metabolism|metabolism
98603|NCT02950428|TAVI|tavi
98604|NCT02950428|Aortic Stenosis|aortic stenosis
98605|NCT02950428|transcatether Aortic Valve Implantation|transcatether aortic valve implantation
98606|NCT02950389|PMMA|pmma
98607|NCT02950389|on-line HFR|on-line hfr
98608|NCT02950389|free light chains|free light chains
98609|NCT02950389|toxins|toxins
98610|NCT02950389|removal|removal
98611|NCT02950389|hemodialysis|hemodialysis
98612|NCT02950376|synthetic drugs|synthetic drugs
98613|NCT02950376|virtual reality|virtual reality
98614|NCT02950376|addiction evaluation|addiction evaluation
98615|NCT02950376|physiological data|physiological data
98616|NCT02950376|eye movement index|eye movement index
98617|NCT02950363|Depression|depression
98618|NCT02950363|Suicide|suicide
98619|NCT02950363|Anxiety disorder|anxiety disorder
98620|NCT02950363|Burn out|burn out
98621|NCT02950363|Sleep quality|sleep quality
98622|NCT02950363|Stress|stress
98623|NCT02950350|Cervical cancer|cervical cancer
98624|NCT02950350|Precision medicine|precision medicine
98625|NCT02950350|Individualized treatment|individualized treatment
98626|NCT02950350|Surgical staging|surgical staging
98627|NCT02950337|Unbiopsied Early Stage Non Small Cell Lung Cancer|unbiopsied early stage non small cell lung cancer
98628|NCT02950324|Prehabilitation|prehabilitation
98629|NCT02950324|Oesophago-gastric|oesophago-gastric
98630|NCT02950324|Cancer|cancer
98631|NCT02950324|Neo-adjuvant|neo-adjuvant
98632|NCT02950324|Exercise|exercise
98633|NCT02950324|Cardiopulmonary exercise test|cardiopulmonary exercise test
98634|NCT02950324|Insulin resistance|insulin resistance
98635|NCT02950298|Pompe|pompe
98636|NCT02950298|Glycogen Storage Disease II|glycogen storage disease ii
98637|NCT02950298|Telemedicine|telemedicine
98638|NCT02950298|Duke University Medical Center|duke university medical center
98639|NCT02950259|Breast Cancer|breast cancer
98640|NCT02950259|Early Stage Breast Cancer|early stage breast cancer
98641|NCT02950259|Male breast cancer|male breast cancer
98642|NCT02950259|IRX-2|irx-2
98643|NCT02950259|Immunotherapy|immunotherapy
98644|NCT02950259|Triple Negative Breast Cancer|triple negative breast cancer
98645|NCT02950233|postoperative pain|postoperative pain
98646|NCT02950233|VATS|vats
98647|NCT02950233|activities of daily living|activities of daily living
98648|NCT02950233|quality of life|quality of life
98649|NCT02950194|mesh|mesh
98650|NCT02950194|rectus diastasis|rectus diastasis
98651|NCT02950194|panniculectomy|panniculectomy
98652|NCT02950194|abdominoplasty|abdominoplasty
98653|NCT02950168|Diagnostic procedures|diagnostic procedures
98654|NCT02950168|Interventional procedures|interventional procedures
98655|NCT02950168|Planned or unplanned|planned or unplanned
98656|NCT02950168|Edoxaban-treated population|edoxaban-treated population
98657|NCT02950142|order sets|order sets
98658|NCT02950142|decision support|decision support
98659|NCT02950142|laboratory test|laboratory test
98660|NCT02950142|primary care|primary care
98661|NCT02950129|pelvic girdle dysfunction|pelvic girdle dysfunction
98662|NCT02950103|solid tumor|solid tumor
98663|NCT02950103|phase II|phase ii
98664|NCT02950103|phosphoethanolamine|phosphoethanolamine
98665|NCT02950090|Knee symptoms|knee symptoms
98666|NCT02950090|physical activity|physical activity
98667|NCT02950090|Fitbit|fitbit
98668|NCT02950090|Accelerometer|accelerometer
98669|NCT02950090|remote coaching|remote coaching
98670|NCT02950064|BRCA|brca
98671|NCT02950064|BRCA1|brca1
98672|NCT02950064|BRCA2|brca2
98673|NCT02950064|Pancreatic cancer|pancreatic cancer
98674|NCT02950064|Ovarian cancer|ovarian cancer
98675|NCT02950064|Castrate resistant prostate cancer|castrate resistant prostate cancer
98676|NCT02950064|Triple negative breast cancer|triple negative breast cancer
98677|NCT02950064|Breast cancer|breast cancer
98678|NCT02950064|DNA repair mutation-positive solid tumors|dna repair mutation-positive solid tumors
98679|NCT02950051|CLL|cll
98680|NCT02950038|Lung Cancer, Nonsmall Cell|lung cancer, nonsmall cell
98681|NCT02950038|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
98682|NCT02950038|NSCLC|nsclc
98683|NCT02950038|Stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
98684|NCT02950038|Recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
98685|NCT02950038|Ibrutinib|ibrutinib
98686|NCT02950038|PCI-32765|pci-32765
98687|NCT02950038|Imbruvica|imbruvica
98688|NCT02950038|Nivolumab|nivolumab
98689|NCT02950038|BMS-936558|bms-936558
98690|NCT02950038|Opdivo|opdivo
98691|NCT02950012|Healthy|healthy
98692|NCT02950012|Bloating|bloating
98693|NCT02950012|Abdominal Discomfort|abdominal discomfort
98694|NCT02950012|Gas|gas
98695|NCT02950012|Probiotic|probiotic
98696|NCT02950012|Bacillus Subtillis|bacillus subtillis
98697|NCT02949999|Calcineurin inhibitor|calcineurin inhibitor
98698|NCT02949999|Voclosporin|voclosporin
98699|NCT02949973|lupus nephritis|lupus nephritis
98700|NCT02949973|calcineurin inhibitors|calcineurin inhibitors
98701|NCT02949973|voclosporin|voclosporin
98702|NCT02949960|Eczema|eczema
98703|NCT02949960|Dermatitis|dermatitis
98704|NCT02949960|Skin Diseases|skin diseases
98705|NCT02949960|Skin Diseases, Genetic|skin diseases, genetic
98706|NCT02949960|Dermatitis, Atopic|dermatitis, atopic
98707|NCT02949960|Skin Diseases, Eczematous|skin diseases, eczematous
98708|NCT02949960|Hypersensitivity|hypersensitivity
98709|NCT02949960|Immune System Diseases|immune system diseases
98710|NCT02949947|Malignant Neoplasms of Mesothelial and Soft Tissue|malignant neoplasms of mesothelial and soft tissue
98711|NCT02949947|Gastrointestinal Stromal Tumor|gastrointestinal stromal tumor
98712|NCT02949947|GIST|gist
98915|NCT02948608|spondylitis|spondylitis
98713|NCT02949947|Iron-deficiency anemia|iron-deficiency anemia
98714|NCT02949947|Ferric Carboxymaltose|ferric carboxymaltose
98715|NCT02949947|Injectafer|injectafer
98716|NCT02949947|Iron supplement|iron supplement
98717|NCT02949947|Health Questionnaire|health questionnaire
98718|NCT02949947|Survey|survey
98719|NCT02949908|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
98720|NCT02949908|Rebif|rebif
98721|NCT02949908|Treatment Satisfaction Questionnaire for Medication Version II|treatment satisfaction questionnaire for medication version ii
98722|NCT02949908|Multiple Sclerosis International Quality of Life Questionnaire|multiple sclerosis international quality of life questionnaire
98723|NCT02949882|Diarrhea|diarrhea
98724|NCT02949882|Constipation|constipation
98725|NCT02949882|Elderly|elderly
98726|NCT02949882|Nursing Homes|nursing homes
98727|NCT02949882|Probiotics|probiotics
98728|NCT02949882|Bowel Habits|bowel habits
98729|NCT02949830|RNAi therapeutic|rnai therapeutic
98730|NCT02949830|Porphyria|porphyria
98731|NCT02949830|AIP|aip
98732|NCT02949830|Heme/Haem Arginate|heme/haem arginate
98733|NCT02949791|cisplatin|cisplatin
98734|NCT02949791|HIPEC|hipec
98735|NCT02949791|Intra abdominal pressure|intra abdominal pressure
98736|NCT02949791|tissue drug concentration|tissue drug concentration
98737|NCT02949713|HIV|hiv
98738|NCT02949713|infant feeding|infant feeding
98739|NCT02949713|mHealth|mhealth
98740|NCT02949713|behavioural intervention|behavioural intervention
98741|NCT02949700|metformin|metformin
98742|NCT02949700|head and neck cancer|head and neck cancer
98743|NCT02949687|ileal interposition|ileal interposition
98744|NCT02949687|metabolic surgery|metabolic surgery
98745|NCT02949687|diabetes|diabetes
98746|NCT02949687|intra abdominal selective denervation|intra abdominal selective denervation
98747|NCT02949648|Electronic cigarette|electronic cigarette
98748|NCT02949635|Aged|aged
98749|NCT02949635|Patient readmission|patient readmission
98750|NCT02949635|Geriatric Assessment|geriatric assessment
98751|NCT02949635|Mortality|mortality
98752|NCT02949622|Metabolic syndrome|metabolic syndrome
98753|NCT02949622|Mediterranean diet|mediterranean diet
98754|NCT02949622|Stress|stress
98755|NCT02949622|quality of life|quality of life
98756|NCT02949622|psychological factors|psychological factors
98757|NCT02949609|stroke|stroke
98758|NCT02949609|mirror therapy|mirror therapy
98759|NCT02949609|neurorehabilitation|neurorehabilitation
98760|NCT02949596|quality of sexual life|quality of sexual life
98761|NCT02949596|intensity-modulated radiotherapy|intensity-modulated radiotherapy
98762|NCT02949596|concurrent chemoradiotherapy|concurrent chemoradiotherapy
98763|NCT02949583|DENTAL PLAQUE|dental plaque
98764|NCT02949583|MEDICINAL PLANTS|medicinal plants
98765|NCT02949583|GINGIVITIS|gingivitis
98766|NCT02949505|Prehabilitation|prehabilitation
98767|NCT02949505|liver transplant|liver transplant
98768|NCT02949505|functional capacity|functional capacity
98769|NCT02949505|exercise|exercise
98770|NCT02949492|Liver|liver
98771|NCT02949492|Transplant|transplant
98772|NCT02949492|Immunosuppression|immunosuppression
98773|NCT02949479|sex offenses|sex offenses
98774|NCT02949466|knee osteoarthritis|knee osteoarthritis
98775|NCT02949466|triamcinolone|triamcinolone
98776|NCT02949466|therapeutic effects|therapeutic effects
98777|NCT02949453|suicide|suicide
98778|NCT02949453|prevention|prevention
98779|NCT02949440|Laparoscopic right Hemicolectomy|laparoscopic right hemicolectomy
98780|NCT02949440|Caudal-to-cranial Approach|caudal-to-cranial approach
98781|NCT02949427|Microbiome|microbiome
98782|NCT02949427|Mycobiome|mycobiome
98783|NCT02949427|Virome|virome
98784|NCT02949427|Pediatric leukemia|pediatric leukemia
98785|NCT02949427|Pediatric bone marrow transplantation|pediatric bone marrow transplantation
98786|NCT02949414|Malacia|malacia
98787|NCT02949414|Stenosis|stenosis
98788|NCT02949414|Trachea|trachea
98789|NCT02949414|Transplant|transplant
98790|NCT02949349|Systemic Lupus Erythematosus|systemic lupus erythematosus
98791|NCT02949349|Lupus Nephritis|lupus nephritis
98792|NCT02949349|Mycophenolate Mofetil|mycophenolate mofetil
98793|NCT02949349|Azathioprine|azathioprine
98794|NCT02949349|Maintenance Therapy|maintenance therapy
98795|NCT02949349|Prednisolone|prednisolone
98796|NCT02949349|Serum albumin|serum albumin
98797|NCT02949349|Serum creatinine|serum creatinine
98798|NCT02949349|Spot urine protein/creatinine ratio|spot urine protein/creatinine ratio
98799|NCT02949323|children|children
98800|NCT02949323|renal stone|renal stone
98801|NCT02949323|metabolic evaluation|metabolic evaluation
98802|NCT02949323|Mutational analysis|mutational analysis
98803|NCT02949297|abdominal|abdominal
98804|NCT02949297|aortic|aortic
98805|NCT02949297|aneurysm|aneurysm
98806|NCT02949271|epidural analgesia|epidural analgesia
98807|NCT02949258|gastric cancer|gastric cancer
98808|NCT02949258|Borrmann type 4|borrmann type 4
98809|NCT02949258|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
98810|NCT02949258|Intra-arterial administration|intra-arterial administration
98811|NCT02949245|Spine|spine
98812|NCT02949245|Surgery|surgery
98813|NCT02949245|Prospective Studies|prospective studies
98814|NCT02949245|Deformity|deformity
98815|NCT02949245|Neurologic deficit|neurologic deficit
98816|NCT02949180|Atrial fibrillation|atrial fibrillation
98817|NCT02949180|Rhythm monitoring|rhythm monitoring
98818|NCT02949180|Cardiovascular App|cardiovascular app
98819|NCT02949180|m-health|m-health
98820|NCT02949167|Nurse-led follow-up after breast cancer|nurse-led follow-up after breast cancer
98821|NCT02949115|Red beetroot|red beetroot
98822|NCT02949115|Dietary Nitrate|dietary nitrate
98823|NCT02949115|Polyphenols|polyphenols
98824|NCT02949115|Endothelial Function|endothelial function
98825|NCT02949115|High-Fat Meal|high-fat meal
98826|NCT02949115|Overweight|overweight
98827|NCT02949115|Obesity|obesity
98828|NCT02949115|Aging|aging
98829|NCT02949115|Cardiometabolic|cardiometabolic
98830|NCT02949089|safety|safety
98831|NCT02949089|tolerability|tolerability
98832|NCT02949089|rising multiple doses|rising multiple doses
98833|NCT02949089|ACH04|ach04
98834|NCT02949089|adult|adult
98835|NCT02949089|male|male
98836|NCT02949063|school lunch|school lunch
98837|NCT02949063|occupational therapy|occupational therapy
98838|NCT02949024|Diabetes mellitus|diabetes mellitus
98839|NCT02949024|Diabetic retinopathy|diabetic retinopathy
98840|NCT02949024|Microneedle|microneedle
98841|NCT02949024|Microinjection|microinjection
98842|NCT02949024|Triamcinolone|triamcinolone
98843|NCT02949024|Choroid|choroid
98844|NCT02949024|Choroid Injection|choroid injection
98845|NCT02949024|Aflibercept|aflibercept
98846|NCT02949024|Suprachoroidal|suprachoroidal
98847|NCT02949011|Tamiflu®|tamiflu®
98848|NCT02949011|Influenza|influenza
98849|NCT02949011|Oseltamivir|oseltamivir
98850|NCT02949011|Flu|flu
98851|NCT02949011|S-033188|s-033188
98852|NCT02948985|Metastatic colorectal cancer|metastatic colorectal cancer
98853|NCT02948985|Cetuximab|cetuximab
98854|NCT02948985|CTCs|ctcs
98855|NCT02948985|ct DNA|ct dna
98856|NCT02948972|deep infiltrating endometriosis|deep infiltrating endometriosis
98857|NCT02948972|endometriosis surgery|endometriosis surgery
98858|NCT02948972|In vitro fertilization|in vitro fertilization
98859|NCT02948946|lung cancer|lung cancer
98860|NCT02948946|pancreatic cancer|pancreatic cancer
98861|NCT02948933|Dengue Fever|dengue fever
98862|NCT02948933|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
98863|NCT02948933|Dengvaxia®|dengvaxia®
98864|NCT02948920|ephedrine|ephedrine
98865|NCT02948920|core temperature|core temperature
98866|NCT02948920|tympanic temperature|tympanic temperature
98867|NCT02948920|heat loss|heat loss
98868|NCT02948920|spinal anesthesia|spinal anesthesia
98869|NCT02948920|neuraxial|neuraxial
98870|NCT02948920|hypothermia|hypothermia
98871|NCT02948920|shivering|shivering
98872|NCT02948881|Osteoporosis|osteoporosis
98873|NCT02948881|bisphosphonates|bisphosphonates
98874|NCT02948881|bone|bone
98875|NCT02948868|Methamphetamine|methamphetamine
98876|NCT02948868|MRI|mri
98877|NCT02948868|South Africa|south africa
98878|NCT02948868|Contingency Management|contingency management
98879|NCT02948855|Long non-coding RNA（LncRNA）|long non-coding rna（lncrna）
98880|NCT02948855|Thymoma|thymoma
98881|NCT02948855|Autoimmune disease|autoimmune disease
98882|NCT02948855|Notch2 Signaling pathway|notch2 signaling pathway
98883|NCT02948855|Regulatory B cell（Breg）|regulatory b cell（breg）
98884|NCT02948829|Drug therapy|drug therapy
98885|NCT02948803|intervention|intervention
98886|NCT02948803|mHealth|mhealth
98887|NCT02948803|physical activity|physical activity
98888|NCT02948803|active transport|active transport
98889|NCT02948803|smartphone|smartphone
98890|NCT02948803|application|application
98891|NCT02948764|breast cancer|breast cancer
98892|NCT02948764|vacuum-assisted biopsy|vacuum-assisted biopsy
98893|NCT02948764|pathological complete response|pathological complete response
98894|NCT02948712|distress|distress
98895|NCT02948712|survivorship|survivorship
98896|NCT02948712|transition period|transition period
98897|NCT02948699|nasopharyngeal carcinoma|nasopharyngeal carcinoma
98898|NCT02948699|intensity-modulated radiotherapy|intensity-modulated radiotherapy
98899|NCT02948699|nutrition support|nutrition support
98900|NCT02948699|nutrition assessment|nutrition assessment
98901|NCT02948686|dentin bonding agents|dentin bonding agents
98902|NCT02948686|tooth sensitivity|tooth sensitivity
98903|NCT02948686|composite resin restoration|composite resin restoration
98904|NCT02948673|type 2 diabetes|type 2 diabetes
98905|NCT02948673|mitochondrial reactive oxygen species production|mitochondrial reactive oxygen species production
98906|NCT02948673|oxidative stress|oxidative stress
98907|NCT02948673|antioxidant treatment|antioxidant treatment
98908|NCT02948673|glutathione supplementation|glutathione supplementation
98909|NCT02948621|Endoscopic sleeve gastroplasty|endoscopic sleeve gastroplasty
98910|NCT02948621|Excess weight loss|excess weight loss
98911|NCT02948621|Quality of life|quality of life
98912|NCT02948608|spondyloarthropathy|spondyloarthropathy
98913|NCT02948608|ankylosing spondylitis|ankylosing spondylitis
98914|NCT02948608|spinal diseases|spinal diseases
98916|NCT02948608|spondylarthritis|spondylarthritis
98917|NCT02948608|psoriasis|psoriasis
98918|NCT02948608|uveitis|uveitis
98919|NCT02948608|joint diseases|joint diseases
98920|NCT02948582|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
98921|NCT02948582|COPD|copd
98922|NCT02948582|Emphysema|emphysema
98923|NCT02948582|Chronic bronchitis|chronic bronchitis
98924|NCT02948569|Obesity|obesity
98925|NCT02948569|Hyperlipidemia|hyperlipidemia
98926|NCT02948569|Impaired fasting glucose|impaired fasting glucose
98927|NCT02948569|Insulin resistance|insulin resistance
98928|NCT02948569|Hypertension|hypertension
98929|NCT02948504|Unruptured Intracranial Aneurysm|unruptured intracranial aneurysm
98930|NCT02948504|Small aneurysms|small aneurysms
98931|NCT02948504|Risk of rupture|risk of rupture
98932|NCT02948504|Natural history|natural history
98933|NCT02948504|Endovascular Coiling|endovascular coiling
98934|NCT02948504|Surgical clipping|surgical clipping
98935|NCT02948491|Complementary Therapies|complementary therapies
98936|NCT02948491|Neonate Intensive Care Units (NICU)|neonate intensive care units (nicu)
98937|NCT02948491|Child Development|child development
98938|NCT02948491|Infants Premature|infants premature
98939|NCT02948478|precariousness|precariousness
98940|NCT02948478|care pathways|care pathways
98941|NCT02948465|Neutrophil Extracellular Traps|neutrophil extracellular traps
98942|NCT02948452|anorexia nervosa|anorexia nervosa
98943|NCT02948452|anxiety|anxiety
98944|NCT02948452|reward|reward
98945|NCT02948452|recurrence|recurrence
98946|NCT02948452|magnetic resonance imaging|magnetic resonance imaging
98947|NCT02948439|pregnancy|pregnancy
98948|NCT02948439|cardiovascular|cardiovascular
98949|NCT02948439|nervous system|nervous system
98950|NCT02948439|exercise|exercise
98951|NCT02948426|Immunotherapy|immunotherapy
98952|NCT02948426|Adoptive Cell Therapy|adoptive cell therapy
98953|NCT02948426|Carcinomatosis|carcinomatosis
98954|NCT02948426|CA125|ca125
98955|NCT02948413|Traumatic Stress|traumatic stress
98956|NCT02948413|Oncology|oncology
98957|NCT02948413|Lymphoma|lymphoma
98958|NCT02948413|Leukemia|leukemia
98959|NCT02948413|Mesothelioma|mesothelioma
98960|NCT02948335|Microbial communities|microbial communities
98961|NCT02948335|Hospital environment|hospital environment
98962|NCT02948335|Disinfection|disinfection
98963|NCT02948335|Adenosine triphosphate measures|adenosine triphosphate measures
98964|NCT02948335|Bioburden|bioburden
98965|NCT02948322|Acromegaly,|acromegaly,
98966|NCT02948322|water retention|water retention
98967|NCT02948322|myocardial fibrosis|myocardial fibrosis
98968|NCT02948322|left ventricular hypertrophy|left ventricular hypertrophy
98969|NCT02948322|left ventricular dysfunction|left ventricular dysfunction
98970|NCT02948309|Primary diagnosis|primary diagnosis
98971|NCT02948309|Relapse|relapse
98972|NCT02948257|Vessel closure|vessel closure
98973|NCT02948257|Antegrade access|antegrade access
98974|NCT02948257|Femoral arteriotomy|femoral arteriotomy
98975|NCT02948257|Peripheral endovascular interventions|peripheral endovascular interventions
98976|NCT02948244|fshd|fshd
98977|NCT02948244|creatine monohydrate|creatine monohydrate
98978|NCT02948244|children|children
98979|NCT02948244|pediatrics|pediatrics
98980|NCT02948244|Facio-Scapulo-Humeral Dystrophy|facio-scapulo-humeral dystrophy
98981|NCT02948205|Infertility, TU-LESS, 3D laparoscopy|infertility, tu-less, 3d laparoscopy
98982|NCT02948192|Preterm Delivery|preterm delivery
98983|NCT02948192|Preterm Birth|preterm birth
98984|NCT02948192|Vaginal Microbiome|vaginal microbiome
98985|NCT02948192|Microbiome|microbiome
98986|NCT02948192|Gut Microbiome|gut microbiome
98987|NCT02948192|African American|african american
98988|NCT02948192|Metabolomics|metabolomics
98989|NCT02948192|Pregnancy|pregnancy
98990|NCT02948166|remote endarterectomy|remote endarterectomy
98991|NCT02948166|Angioplasty with stenting of the superficial femoral artery|angioplasty with stenting of the superficial femoral artery
98992|NCT02948140|Subdiaphragmatic infarction|subdiaphragmatic infarction
98993|NCT02948101|Malignant Neoplasm of Female Genital Organs|malignant neoplasm of female genital organs
98994|NCT02948101|Epithelial ovarian cancer|epithelial ovarian cancer
98995|NCT02948101|Fallopian tube cancer|fallopian tube cancer
98996|NCT02948101|Primary peritoneal cancer|primary peritoneal cancer
98997|NCT02948101|PD 0360324|pd 0360324
98998|NCT02948101|Cyclophosphamide|cyclophosphamide
98999|NCT02948101|Cytoxan|cytoxan
99000|NCT02948101|Neosar|neosar
99001|NCT02948101|Pharmacokinetic testing|pharmacokinetic testing
99002|NCT02948101|PK|pk
99003|NCT02948101|Pharmacodynamic testing|pharmacodynamic testing
99004|NCT02948101|PD|pd
99005|NCT02948088|Tenosynovial Giant Cell Tumors|tenosynovial giant cell tumors
99006|NCT02948088|Disease registry|disease registry
99007|NCT02948088|Routine clinical practice|routine clinical practice
99008|NCT02948088|Real World Evidence|real world evidence
99009|NCT02948062|ALD|ald
99010|NCT02948062|Newborn Screening|newborn screening
99011|NCT02948049|Accelerometer|accelerometer
99012|NCT02948049|Spinal Cord Stimulator|spinal cord stimulator
99013|NCT02948049|Peripheral Nerve Stimulator|peripheral nerve stimulator
99014|NCT02948049|Physical Function|physical function
99015|NCT02947997|Healthy Volunteers|healthy volunteers
99016|NCT02947984|sphenoid region|sphenoid region
99017|NCT02947984|parasellar area|parasellar area
99018|NCT02947984|photon radiation therapy|photon radiation therapy
99019|NCT02947984|proton radiation therapy|proton radiation therapy
99020|NCT02947958|teleconsultation|teleconsultation
99021|NCT02947958|urology|urology
99022|NCT02947958|primary care|primary care
99023|NCT02947958|tertiary care|tertiary care
99024|NCT02947932|acute pancreatitis|acute pancreatitis
99025|NCT02947932|post-ERCP|post-ercp
99026|NCT02947932|endoscopy|endoscopy
99027|NCT02947919|Perioperative Period|perioperative period
99028|NCT02947919|Music|music
99029|NCT02947906|Gait|gait
99030|NCT02947906|Loading|loading
99031|NCT02947906|Multiple Sclerosis|multiple sclerosis
99032|NCT02947906|Plantar Pressure|plantar pressure
99033|NCT02947893|Nilotinib in Alzheimer's disease|nilotinib in alzheimer's disease
99034|NCT02947880|autism, Bumetanide|autism, bumetanide
99035|NCT02947854|Vaccine|vaccine
99036|NCT02947854|Photochemical Internalisation|photochemical internalisation
99037|NCT02947854|Immune Response|immune response
99038|NCT02947854|Peptide vaccine|peptide vaccine
99039|NCT02947854|Anti cancer vaccine|anti cancer vaccine
99040|NCT02947828|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
99041|NCT02947828|Polyneuropathies, Diabetic|polyneuropathies, diabetic
99042|NCT02947750|Hypertension|hypertension
99043|NCT02947750|Kidney Disorder|kidney disorder
99044|NCT02947750|Nephrology|nephrology
99045|NCT02947750|Physiology|physiology
99046|NCT02947737|Skin graft|skin graft
99047|NCT02947724|chocolate cyst|chocolate cyst
99048|NCT02947724|laparoscopy|laparoscopy
99049|NCT02947724|surgicel|surgicel
99050|NCT02947711|E2027|e2027
99051|NCT02947711|Healthy participants|healthy participants
99052|NCT02947711|Pharmacokinetics|pharmacokinetics
99053|NCT02947698|acute kidney injury|acute kidney injury
99054|NCT02947698|weekend admission|weekend admission
99055|NCT02947698|mortality|mortality
99056|NCT02947685|breast cancer|breast cancer
99057|NCT02947685|malignant tumor of the breast|malignant tumor of the breast
99058|NCT02947685|HER2+|her2+
99059|NCT02947685|HR+|hr+
99060|NCT02947685|metastatic breast cancer|metastatic breast cancer
99061|NCT02947659|Body mass index|body mass index
99062|NCT02947659|Academic stress|academic stress
99063|NCT02947659|Musculoskeletal disorders|musculoskeletal disorders
99064|NCT02947607|Human gut microbiome|human gut microbiome
99065|NCT02947607|Colorectal cancer|colorectal cancer
99066|NCT02947607|Colorectal adenoma|colorectal adenoma
99067|NCT02947607|Gut bacteria|gut bacteria
99068|NCT02947607|Metagenomics|metagenomics
99069|NCT02947607|Metatranscriptomics|metatranscriptomics
99070|NCT02947581|subarachnoid neurocysticercosis|subarachnoid neurocysticercosis
99071|NCT02947581|albendazole|albendazole
99072|NCT02947581|praziquantel|praziquantel
99073|NCT02947568|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
99074|NCT02947568|Chronic Kidney Disease|chronic kidney disease
99075|NCT02947568|Diabetes Mellitus|diabetes mellitus
99076|NCT02947568|Cross-sectional|cross-sectional
99077|NCT02947555|diabetes mellitus|diabetes mellitus
99078|NCT02947555|atherosclerosis|atherosclerosis
99079|NCT02947555|AGE|age
99080|NCT02947555|lens autofluorescence|lens autofluorescence
99081|NCT02947529|Hemiarthroplasty|hemiarthroplasty
99082|NCT02947529|Intramedullary nail|intramedullary nail
99083|NCT02947529|Tranexamic acid|tranexamic acid
99084|NCT02947529|Transfusion|transfusion
99085|NCT02947516|Endoscopic Ultrasound-Guided Fine Needle Aspiration|endoscopic ultrasound-guided fine needle aspiration
99086|NCT02947516|liver|liver
99087|NCT02947516|biopsy|biopsy
99088|NCT02947516|pain|pain
99089|NCT02947503|Gestational Diabetes|gestational diabetes
99090|NCT02947503|Insulin Resistance|insulin resistance
99091|NCT02947503|Metformin|metformin
99092|NCT02947503|Hyperinsulinaemia|hyperinsulinaemia
99093|NCT02947503|Prevention of Complications|prevention of complications
99094|NCT02947503|Long Term Study|long term study
99095|NCT02947503|Mother and Child|mother and child
99096|NCT02947503|Health Benefits|health benefits
99097|NCT02947490|Blood pressure monitoring|blood pressure monitoring
99098|NCT02947490|self BP monitoring|self bp monitoring
99099|NCT02947490|self BP management|self bp management
99100|NCT02947438|Renal anemia|renal anemia
99101|NCT02947438|Haemodialysis|haemodialysis
99102|NCT02947438|Maintenance phase|maintenance phase
99103|NCT02947412|sleeve gastrectomy|sleeve gastrectomy
99104|NCT02947412|long-term follow-up|long-term follow-up
99105|NCT02947412|gastroesophageal reflux disease after sleeve|gastroesophageal reflux disease after sleeve
99106|NCT02947412|revisional surgery|revisional surgery
99107|NCT02947399|Thyroid|thyroid
99108|NCT02947399|I-124|i-124
99109|NCT02947399|Thyroid hormone Withdrawal|thyroid hormone withdrawal
99110|NCT02947373|brain tumor|brain tumor
99111|NCT02947373|children|children
99112|NCT02947321|Radiofrequency ablation|radiofrequency ablation
99113|NCT02947308|Anxiety|anxiety
99114|NCT02947308|Depression|depression
99115|NCT02947243|Virtual reality|virtual reality
99116|NCT02947243|Immersive distraction|immersive distraction
99117|NCT02947243|Oculus rift|oculus rift
99118|NCT02947243|Virtual world|virtual world
99119|NCT02947243|Virtual environment|virtual environment
99120|NCT02947243|Procedural pain|procedural pain
99121|NCT02947243|Procedural anxiety|procedural anxiety
99122|NCT02947243|Acute pain|acute pain
99123|NCT02947243|Pain management|pain management
99124|NCT02947243|Anxiety|anxiety
99125|NCT02947243|Children, Child|children, child
99126|NCT02947243|Kid, Kids|kid, kids
99127|NCT02947243|Pediatric, Pediatrics|pediatric, pediatrics
99128|NCT02947243|Young children|young children
99129|NCT02947243|Burns|burns
99130|NCT02947243|Burn injuries|burn injuries
99131|NCT02947243|Burn unit|burn unit
99132|NCT02947243|Physiotherapy|physiotherapy
99133|NCT02947243|Physical therapy|physical therapy
99134|NCT02947243|Burn dressing|burn dressing
99135|NCT02947243|Dressing change|dressing change
99136|NCT02947243|Non-pharmacological, nonpharmacological|non-pharmacological, nonpharmacological
99137|NCT02947243|Clinical Research|clinical research
99138|NCT02947243|Nursing Practice|nursing practice
99139|NCT02947230|Mobility|mobility
99140|NCT02947230|Aging|aging
99141|NCT02947230|Knowledge Translation|knowledge translation
99142|NCT02947230|Physical Activity|physical activity
99143|NCT02947217|Immunology|immunology
99144|NCT02947217|Pregnancy|pregnancy
99145|NCT02947217|Implantation Rate|implantation rate
99146|NCT02947217|Fertilization in Vitro|fertilization in vitro
99147|NCT02947204|Bronchiolitis|bronchiolitis
99148|NCT02947204|Length of Hospital Stay|length of hospital stay
99149|NCT02947204|Clinical Trial|clinical trial
99150|NCT02947204|Oxygen Saturation Monitoring|oxygen saturation monitoring
99151|NCT02947152|HKT288|hkt288
99152|NCT02947152|CDH6|cdh6
99153|NCT02947152|ADC|adc
99154|NCT02947152|maytansine|maytansine
99155|NCT02947152|epithelial ovarian cancer|epithelial ovarian cancer
99156|NCT02947152|renal cell carcinoma|renal cell carcinoma
99157|NCT02947152|RCC|rcc
99158|NCT02947126|cystic fibrosis|cystic fibrosis
99159|NCT02947126|mucociliary clearance|mucociliary clearance
99160|NCT02947126|CFTR|cftr
99161|NCT02947113|cancer|cancer
99162|NCT02947100|Sickle Cell Disease|sickle cell disease
99163|NCT02947100|omega-3 fatty acids|omega-3 fatty acids
99164|NCT02947100|Docosahexaenoic Acid (DHA)|docosahexaenoic acid (dha)
99165|NCT02947100|Eicosapentaenoic Acid (EPA)|eicosapentaenoic acid (epa)
99166|NCT02947087|Islet autotransplantation|islet autotransplantation
99167|NCT02947087|Alpha1 anti trypsin|alpha1 anti trypsin
99168|NCT02947074|Yoga|yoga
99169|NCT02947074|Meditation|meditation
99170|NCT02947074|Glutathione|glutathione
99171|NCT02947074|Catecholamine|catecholamine
99172|NCT02947074|polysomnography|polysomnography
99173|NCT02947061|Advanced Breast Cancer,first treatment, S1, Capecitabine|advanced breast cancer,first treatment, s1, capecitabine
99174|NCT02947035|thyroid cancer|thyroid cancer
99175|NCT02947035|thyroid nodule|thyroid nodule
99176|NCT02947035|thyroidectomy|thyroidectomy
99177|NCT02947035|personalized medicine|personalized medicine
99178|NCT02947022|gadolinium|gadolinium
99179|NCT02947022|deposition|deposition
99180|NCT02947022|GBCA|gbca
99181|NCT02947022|Extremity Pain|extremity pain
99182|NCT02947022|Skin Pain|skin pain
99183|NCT02947022|Chest Wall Pain|chest wall pain
99184|NCT02946944|Pulmonary Embolism|pulmonary embolism
99185|NCT02946944|sildenafil|sildenafil
99186|NCT02946944|oral anticoagulation therapy|oral anticoagulation therapy
99187|NCT02946918|levothyroxine|levothyroxine
99188|NCT02946853|Atrial Fibrillation|atrial fibrillation
99189|NCT02946853|CRT|crt
99190|NCT02946853|AV Junction Ablation|av junction ablation
99191|NCT02946853|LVESV|lvesv
99192|NCT02946827|FODMAPs diet|fodmaps diet
99193|NCT02946827|micro-macro nutrients intake|micro-macro nutrients intake
99194|NCT02946827|IBS (Irritable Bowel Syndrome)|ibs (irritable bowel syndrome)
99195|NCT02946814|essential oils|essential oils
99196|NCT02946814|microscope, colfocal|microscope, colfocal
99197|NCT02946814|dental plaque|dental plaque
99198|NCT02946801|Biofilms|biofilms
99199|NCT02946801|essential oils|essential oils
99200|NCT02946801|alcohol|alcohol
99201|NCT02946801|microscopy, confocal|microscopy, confocal
99202|NCT02946801|mouthwashes|mouthwashes
99203|NCT02946775|septicemia|septicemia
99204|NCT02946775|bacteremia|bacteremia
99205|NCT02946775|pneumonia|pneumonia
99206|NCT02946775|meningitis|meningitis
99207|NCT02946762|HIV|hiv
99208|NCT02946762|TB|tb
99209|NCT02946762|Antiretroviral Treatment|antiretroviral treatment
99210|NCT02946762|Anti-tuberculosis Treatment|anti-tuberculosis treatment
99211|NCT02946762|HIV Counselling and Testing|hiv counselling and testing
99212|NCT02946762|Treatment as Prevention|treatment as prevention
99213|NCT02946749|Scar pregnancy|scar pregnancy
99214|NCT02946749|Placenta planting abnormal disease|placenta planting abnormal disease
99215|NCT02946749|Early diagnosis|early diagnosis
99216|NCT02946749|Individualized treatment|individualized treatment
99217|NCT02946736|Sleep|sleep
99218|NCT02946736|Physical Health|physical health
99219|NCT02946736|Psychological Health|psychological health
99220|NCT02946736|Well-Being|well-being
99221|NCT02946736|Employee|employee
99222|NCT02946736|Actigraphy|actigraphy
99223|NCT02946710|Alzheimer disease|alzheimer disease
99224|NCT02946710|Alzheimer's disease, biomarkers|alzheimer's disease, biomarkers
99225|NCT02946710|p75NTR-ECD|p75ntr-ecd
99226|NCT02946697|Chinese|chinese
99227|NCT02946697|cancer survivors|cancer survivors
99228|NCT02946697|Quality of Life|quality of life
99229|NCT02946697|Social Support|social support
99230|NCT02946658|COPD, Emphysema|copd, emphysema
99231|NCT02946619|Chinese breast cancer survivors|chinese breast cancer survivors
99232|NCT02946619|expressive writing|expressive writing
99233|NCT02946554|Acute-On-Chronic Liver Failure|acute-on-chronic liver failure
99234|NCT02946554|ACLF|aclf
99235|NCT02946541|DA-1229|da-1229
99236|NCT02946541|evogliptin|evogliptin
99237|NCT02946541|DPP-IV inhibitor|dpp-iv inhibitor
99238|NCT02946541|Suganon|suganon
99239|NCT02946541|DPP-4 inhibitor|dpp-4 inhibitor
99240|NCT02946515|Pediatrics|pediatrics
99241|NCT02946489|cannabis|cannabis
99242|NCT02946489|mindfulness based relapse prevention|mindfulness based relapse prevention
99243|NCT02946489|motivational enhancement therapy|motivational enhancement therapy
99244|NCT02946437|severe SAH|severe sah
99245|NCT02946437|prevention of vasospasm and/ or brain oedema|prevention of vasospasm and/ or brain oedema
99246|NCT02946437|Sevoflurane|sevoflurane
99247|NCT02946437|Postconditioning|postconditioning
99248|NCT02946411|Hyperglycemia|hyperglycemia
99249|NCT02946385|meningococcal disease|meningococcal disease
99250|NCT02946385|meningitis|meningitis
99251|NCT02946385|booster|booster
99252|NCT02946385|antibody persistence|antibody persistence
99253|NCT02946372|retina surgery|retina surgery
99254|NCT02946372|macula|macula
99255|NCT02946372|macular hole|macular hole
99256|NCT02946372|internal limiting membrane (ILM)|internal limiting membrane (ilm)
99257|NCT02946372|vitrectomy|vitrectomy
99258|NCT02946372|autologous transplantation|autologous transplantation
99259|NCT02946346|Human papillomaviruses|human papillomaviruses
99260|NCT02946346|Clearance|clearance
99261|NCT02946346|Kinetics|kinetics
99262|NCT02946346|Ecology|ecology
99263|NCT02946346|Bacterial vaginosis|bacterial vaginosis
99264|NCT02946346|Immune response|immune response
99265|NCT02946346|Microbiota|microbiota
99266|NCT02946333|Multiple Myeloma|multiple myeloma
99267|NCT02946333|autologous stem cell transplant (ASCT)|autologous stem cell transplant (asct)
99268|NCT02946333|QoLMMBuS|qolmmbus
99269|NCT02946333|healthcare costs|healthcare costs
99270|NCT02946320|PCI, bioabsorbable scaffold|pci, bioabsorbable scaffold
99271|NCT02946281|self-management|self-management
99272|NCT02946281|health behavior|health behavior
99273|NCT02946281|cardiac disease|cardiac disease
99274|NCT02946281|habits|habits
99275|NCT02946281|lifestyle|lifestyle
99276|NCT02946255|Psychosis|psychosis
99277|NCT02946255|Psychosis NOS|psychosis nos
99278|NCT02946255|Schizophrenia|schizophrenia
99279|NCT02946255|Hospital discharge|hospital discharge
99280|NCT02946255|Inpatient psychiatry|inpatient psychiatry
99281|NCT02946190|Acellular pertussis vaccines Genetically-detoxified pertussis toxin Adolescents|acellular pertussis vaccines genetically-detoxified pertussis toxin adolescents
99282|NCT02946177|Immunology|immunology
99283|NCT02946177|Pregnancy|pregnancy
99284|NCT02946177|Implantation Rate|implantation rate
99285|NCT02946177|Fertilization in Vitro|fertilization in vitro
99286|NCT02946177|Oocyte donor egg recipient|oocyte donor egg recipient
99287|NCT02946151|Epilepsy|epilepsy
99288|NCT02946151|Seizure monitoring|seizure monitoring
99289|NCT02946151|Electroencephalography|electroencephalography
99290|NCT02946138|Hepatocellular Carcinoma|hepatocellular carcinoma
99291|NCT02946138|carbon-ion radiotherapy|carbon-ion radiotherapy
99292|NCT02946138|GM-CSF|gm-csf
99293|NCT02946138|immunotherapy|immunotherapy
99294|NCT02946086|motor skill learning, visuo-spatial attention|motor skill learning, visuo-spatial attention
99295|NCT02946047|HIV|hiv
99296|NCT02946047|ART|art
99297|NCT02946047|Antiretroviral|antiretroviral
99298|NCT02946047|Therapy|therapy
99299|NCT02946047|Reservoir|reservoir
99300|NCT02946047|Cure|cure
99301|NCT02946034|CKD|ckd
99302|NCT02946034|HCV|hcv
99303|NCT02946021|Lymphedema|lymphedema
99304|NCT02946021|Cancer|cancer
99305|NCT02946021|Head Cancer|head cancer
99306|NCT02946021|Neck Cancer|neck cancer
99307|NCT02945982|Portal Hypertension|portal hypertension
99308|NCT02945982|Fuzheng Huayu|fuzheng huayu
99309|NCT02945982|Hepatitis B|hepatitis b
99310|NCT02945969|dietary sodium|dietary sodium
99311|NCT02945969|albuminuria|albuminuria
99312|NCT02945969|chronic kidney disease|chronic kidney disease
99313|NCT02945956|Portal Hypertension|portal hypertension
99314|NCT02945956|Fuzheng Huayu|fuzheng huayu
99315|NCT02945956|Hepatitis B|hepatitis b
99316|NCT02945930|Enbucrilate|enbucrilate
99317|NCT02945930|Esophageal and Gastric Varices|esophageal and gastric varices
99318|NCT02945930|Endoscopy|endoscopy
99319|NCT02945930|Safety|safety
99320|NCT02945930|Efficacy|efficacy
99321|NCT02945891|mass screening|mass screening
99322|NCT02945891|coverage|coverage
99323|NCT02945891|self-sampling|self-sampling
99324|NCT02945891|clinical validity|clinical validity
99325|NCT02945878|radiotherapy, oral mucositis,oral mucosa protection|radiotherapy, oral mucositis,oral mucosa protection
99326|NCT02945839|Migraine|migraine
99327|NCT02945839|emergency department|emergency department
99328|NCT02945826|urokinase plasminogen activator receptor|urokinase plasminogen activator receptor
99329|NCT02945826|positron emission tomography|positron emission tomography
99330|NCT02945826|glioblastoma multiforme|glioblastoma multiforme
99331|NCT02945813|Prostate Cancer|prostate cancer
99332|NCT02945813|Prostate Cancer after Prostatectomy|prostate cancer after prostatectomy
99333|NCT02945813|Phase II Trial|phase ii trial
99334|NCT02945813|Salvage Radiotherapy|salvage radiotherapy
99335|NCT02945813|Metformin|metformin
99336|NCT02945800|relapsed|relapsed
99337|NCT02945800|refractory|refractory
99338|NCT02945800|soft tissue|soft tissue
99339|NCT02945800|bones and joints|bones and joints
99340|NCT02945800|non-rhabdomyosarcoma soft tissue sarcoma|non-rhabdomyosarcoma soft tissue sarcoma
99341|NCT02945800|pediatric|pediatric
99342|NCT02945787|Spanish speaking|spanish speaking
99343|NCT02945787|self-help|self-help
99344|NCT02945787|tobacco abstinence|tobacco abstinence
99345|NCT02945787|public health|public health
99346|NCT02945787|Forever Free|forever free
99347|NCT02945787|Stop Smoking for Good|stop smoking for good
99348|NCT02945774|PET|pet
99349|NCT02945774|MRI|mri
99350|NCT02945774|Inflammation|inflammation
99351|NCT02945774|Microglia|microglia
99352|NCT02945774|FEPPA|feppa
99353|NCT02945748|pediatric|pediatric
99354|NCT02945748|cardiac output|cardiac output
99355|NCT02945748|fluid responsiveness|fluid responsiveness
99356|NCT02945748|critically ill|critically ill
99357|NCT02945748|hemodynamic monitoring|hemodynamic monitoring
99358|NCT02945735|depression|depression
99359|NCT02945735|cognitive bias modification|cognitive bias modification
99360|NCT02945735|MDD|mdd
99361|NCT02945735|major depressive disorder|major depressive disorder
99362|NCT02945735|attention bias modification treatment|attention bias modification treatment
99363|NCT02945722|Hemodialysis|hemodialysis
99364|NCT02945722|S. Aureus|s. aureus
99365|NCT02945722|Decolonization|decolonization
99366|NCT02945722|Persistent carriage|persistent carriage
99367|NCT02945709|PTSD|ptsd
99368|NCT02945709|attention training|attention training
99369|NCT02945709|cognitive bias modification|cognitive bias modification
99370|NCT02945696|nerve block|nerve block
99371|NCT02945696|laparoscopy|laparoscopy
99372|NCT02945696|anesthesia|anesthesia
99373|NCT02945683|atopic dermatitis, probiotics, vitamin D3, L. reuteri|atopic dermatitis, probiotics, vitamin d3, l. reuteri
99374|NCT02945644|obstructive sleep apnea|obstructive sleep apnea
99375|NCT02945644|trazodone|trazodone
99376|NCT02945644|positive airway pressure|positive airway pressure
99377|NCT02945644|adherence|adherence
99378|NCT02945631|HPV|hpv
99379|NCT02945631|Induction Chemotherapy|induction chemotherapy
99380|NCT02945631|De-Intensified Chemoradiotherapy|de-intensified chemoradiotherapy
99381|NCT02945631|Oropharynx Cancer|oropharynx cancer
99382|NCT02945618|cryotherapy|cryotherapy
99383|NCT02945618|physical therapy|physical therapy
99384|NCT02945592|Hemispatial Neglect|hemispatial neglect
99385|NCT02945592|cueing|cueing
99386|NCT02945592|egocentric-allocentric|egocentric-allocentric
99387|NCT02945592|early rehabilitation|early rehabilitation
99388|NCT02945592|parietal tDCS|parietal tdcs
99389|NCT02945579|Breast Cancer|breast cancer
99390|NCT02945579|Surveillance|surveillance
99391|NCT02945579|Breast biopsy|breast biopsy
99392|NCT02945579|Questionnaires|questionnaires
99393|NCT02945579|Surveys|surveys
99394|NCT02945540|Gestational diabetes|gestational diabetes
99395|NCT02945540|Patient education|patient education
99396|NCT02945540|Patient Satisfaction|patient satisfaction
99397|NCT02945514|Healthy|healthy
99398|NCT02945514|Diet|diet
99399|NCT02945514|Microbiome|microbiome
99400|NCT02945514|Personalized|personalized
99401|NCT02945514|Custom|custom
99402|NCT02945475|functional magnetic resonance imaging|functional magnetic resonance imaging
99403|NCT02945475|eating behavior|eating behavior
99404|NCT02945475|sugar|sugar
99405|NCT02945475|fructose|fructose
99406|NCT02945449|Wharton jelly mesenchymal stem cells|wharton jelly mesenchymal stem cells
99407|NCT02945449|Erectile Dysfunction|erectile dysfunction
99408|NCT02945449|Diabetes|diabetes
99409|NCT02945397|Return to work|return to work
99410|NCT02945397|Work rehabilitation|work rehabilitation
99411|NCT02945397|Sick-leave|sick-leave
99412|NCT02945384|family well-being|family well-being
99413|NCT02945332|exercise|exercise
99414|NCT02945332|activity|activity
99415|NCT02945332|behavior|behavior
99416|NCT02945306|Sleep Disordered Breathing|sleep disordered breathing
99417|NCT02945306|Adenotonsillectomy|adenotonsillectomy
99418|NCT02945306|Child|child
99419|NCT02945293|Pain|pain
99420|NCT02945293|Elderly|elderly
99421|NCT02945293|Aged|aged
99422|NCT02945293|Opioid|opioid
99423|NCT02945293|Cognition|cognition
99424|NCT02945293|Side-effects|side-effects
99425|NCT02945293|Alcohol|alcohol
99426|NCT02945293|Alcohol Use Disorder (AUD)|alcohol use disorder (aud)
99427|NCT02945293|Older|older
99428|NCT02945280|apixaban|apixaban
99429|NCT02945280|factor Xa inhibitors|factor xa inhibitors
99430|NCT02945280|antithrombotic agent|antithrombotic agent
99431|NCT02945280|deep vein thrombosis|deep vein thrombosis
99432|NCT02945280|upper extremity|upper extremity
99433|NCT02945267|Pancreatic Cancer|pancreatic cancer
99434|NCT02945267|Unresectable|unresectable
99435|NCT02945267|Maintenance Treatment|maintenance treatment
99436|NCT02945254|sleep onset latency|sleep onset latency
99437|NCT02945254|sleep quality|sleep quality
99438|NCT02945254|insomnia|insomnia
99439|NCT02945228|Genotype 2|genotype 2
99440|NCT02945228|Paritaprevir|paritaprevir
99441|NCT02945228|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
99442|NCT02945228|Ritonavir|ritonavir
99443|NCT02945228|Ombitasvir|ombitasvir
99444|NCT02945189|Pregnancy|pregnancy
99445|NCT02945176|Boston Keratoprosthesis|boston keratoprosthesis
99446|NCT02945150|hemodialysis|hemodialysis
99447|NCT02945150|peritoneal dialysis|peritoneal dialysis
99448|NCT02945150|renal failure|renal failure
99449|NCT02945150|kidney transplant|kidney transplant
99450|NCT02945085|older adults|older adults
99451|NCT02945085|family caregivers|family caregivers
99452|NCT02945085|Medicare Advantage beneficiaries|medicare advantage beneficiaries
99453|NCT02945072|Child Behavior|child behavior
99454|NCT02945072|Problem Behavior|problem behavior
99455|NCT02945072|postoperative behaviour problems|postoperative behaviour problems
99456|NCT02945059|Liver regeneration|liver regeneration
99457|NCT02945059|portal vein embolization|portal vein embolization
99458|NCT02945059|gelatin powder|gelatin powder
99459|NCT02945059|liver surgery|liver surgery
99460|NCT02945059|hepatectomy|hepatectomy
99461|NCT02945033|Pi3k mutation|pi3k mutation
99462|NCT02945033|Aspirin|aspirin
99463|NCT02944968|Interventional|interventional
99464|NCT02944968|Radiofrequency Ablation|radiofrequency ablation
99465|NCT02944968|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
99466|NCT02944929|Spastic hemiparesis|spastic hemiparesis
99467|NCT02944929|Stroke|stroke
99468|NCT02944929|Self-rehabilitation|self-rehabilitation
99469|NCT02944929|Botulinum Toxin Injections|botulinum toxin injections
99470|NCT02944903|audit|audit
99471|NCT02944903|Lung cancer|lung cancer
99472|NCT02944903|screening practice|screening practice
99473|NCT02944903|Egypt|egypt
99474|NCT02944851|Blood donors|blood donors
99475|NCT02944851|blood donation|blood donation
99476|NCT02944851|traumatic blood loss|traumatic blood loss
99477|NCT02944851|Trauma|trauma
99478|NCT02944838|older adults|older adults
99479|NCT02944838|physical activity|physical activity
99480|NCT02944838|built environment|built environment
99481|NCT02944825|Urolithiasis|urolithiasis
99482|NCT02944825|UTI|uti
99483|NCT02944786|Chronic pain|chronic pain
99484|NCT02944786|Adolescents|adolescents
99485|NCT02944786|School nurse|school nurse
99486|NCT02944773|newborn|newborn
99487|NCT02944773|facilitated tucking|facilitated tucking
99488|NCT02944773|position|position
99489|NCT02944773|weight|weight
99490|NCT02944773|stress|stress
99491|NCT02944747|Gestational age, Preterm birth, LMP, Bangladesh|gestational age, preterm birth, lmp, bangladesh
99492|NCT02944734|Candesartan|candesartan
99493|NCT02944734|Amlodipine|amlodipine
99494|NCT02944734|Hypertension|hypertension
99495|NCT02944734|Vascular Diseases|vascular diseases
99496|NCT02944734|Cardiovascular Diseases|cardiovascular diseases
99497|NCT02944734|Antihypertensive Agents|antihypertensive agents
99498|NCT02944734|Vasodilator Agents|vasodilator agents
99499|NCT02944734|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
99500|NCT02944734|Angiotensin Receptor Antagonists|angiotensin receptor antagonists
99501|NCT02944734|Calcium Channel Blockers|calcium channel blockers
99502|NCT02944721|Neuropathic Pain|neuropathic pain
99503|NCT02944708|maintenance chemotherapy|maintenance chemotherapy
99504|NCT02944695|audit|audit
99505|NCT02944695|infection control|infection control
99506|NCT02944695|bronchoscopy unit|bronchoscopy unit
99507|NCT02944695|Egypt|egypt
99508|NCT02944682|Obstetrics|obstetrics
99509|NCT02944682|Pregnancy Outcomes|pregnancy outcomes
99510|NCT02944682|Pediatrics|pediatrics
99511|NCT02944682|Atherosclerosis|atherosclerosis
99512|NCT02944682|Cancer|cancer
99513|NCT02944682|Cardiovascular Disease|cardiovascular disease
99514|NCT02944682|Public Health|public health
99515|NCT02944682|Environmental Air Pollutants|environmental air pollutants
99516|NCT02944656|Perioperative pain|perioperative pain
99517|NCT02944656|Outpatient surgery|outpatient surgery
99518|NCT02944656|Obstetrics/gynecology|obstetrics/gynecology
99519|NCT02944656|Pain management|pain management
99520|NCT02944630|quality of life|quality of life
99521|NCT02944630|psychotherapy|psychotherapy
99522|NCT02944630|psoriasis|psoriasis
99523|NCT02944630|treatments|treatments
99524|NCT02944578|Cancer|cancer
99525|NCT02944578|HIV|hiv
99526|NCT02944578|Oncology|oncology
99527|NCT02944578|Infectious Diseases|infectious diseases
99528|NCT02944578|HPV|hpv
99529|NCT02944578|Preventive Medicine|preventive medicine
99530|NCT02944539|Mitochondrial DNA copy number|mitochondrial dna copy number
99531|NCT02944539|Gastric cancer|gastric cancer
99532|NCT02944526|suprascapular nerve|suprascapular nerve
99533|NCT02944500|Brain|brain
99534|NCT02944500|Liraglutide|liraglutide
99535|NCT02944500|MRI|mri
99536|NCT02944487|safety|safety
99537|NCT02944487|pharmacokinetics|pharmacokinetics
99538|NCT02944474|Pharmacokinetics|pharmacokinetics
99539|NCT02944474|Safety|safety
99540|NCT02944448|Osteoarthritis|osteoarthritis
99541|NCT02944448|Hip|hip
99542|NCT02944448|Knee|knee
99543|NCT02944448|CR485|cr485
99544|NCT02944448|Analgesic|analgesic
99545|NCT02944448|Kappa opioid|kappa opioid
99546|NCT02944435|Glutaminase Inhibitor|glutaminase inhibitor
99547|NCT02944435|Glutaminase|glutaminase
99548|NCT02944435|CB-839|cb-839
99549|NCT02944396|metastatic|metastatic
99550|NCT02944396|non-small cell lung cancer|non-small cell lung cancer
99551|NCT02944396|Eastern Cooperative Oncology Group (ECOG)|eastern cooperative oncology group (ecog)
99552|NCT02944396|veliparib|veliparib
99553|NCT02944396|nivolumab|nivolumab
99554|NCT02944396|Platinum Doublet Chemotherapy|platinum doublet chemotherapy
99555|NCT02944396|carboplatin|carboplatin
99556|NCT02944396|paclitaxel|paclitaxel
99557|NCT02944396|pemetrexed|pemetrexed
99558|NCT02944396|Response Evaluation Criteria In Solid Tumors (RECIST)|response evaluation criteria in solid tumors (recist)
99559|NCT02944396|Common Terminology Criteria for Adverse Events (CTCAE)|common terminology criteria for adverse events (ctcae)
99560|NCT02944396|Poly (ADP) ribose polymerase (PARP)|poly (adp) ribose polymerase (parp)
99561|NCT02944396|Immuno Oncology|immuno oncology
99562|NCT02944383|Hypertriglycerides|hypertriglycerides
99563|NCT02944344|breast cancer|breast cancer
99564|NCT02944344|stage 4|stage 4
99565|NCT02944344|metastatic|metastatic
99566|NCT02944344|hospice|hospice
99567|NCT02944344|palliative care|palliative care
99568|NCT02944344|end of life|end of life
99569|NCT02944344|advance directive|advance directive
99570|NCT02944344|oncology|oncology
99571|NCT02944344|caregiver|caregiver
99572|NCT02944344|provider|provider
99573|NCT02944344|coping|coping
99574|NCT02944344|support|support
99575|NCT02944344|online|online
99576|NCT02944331|Steam ablation|steam ablation
99577|NCT02944331|Endothermal ablation|endothermal ablation
99578|NCT02944331|Varicose vein treatment|varicose vein treatment
99579|NCT02944331|Venous insufficiency|venous insufficiency
99580|NCT02944331|Saphenous vein reflux|saphenous vein reflux
99581|NCT02944331|Recurrent varicosity|recurrent varicosity
99582|NCT02944318|Physical Activity|physical activity
99583|NCT02944318|Healthy Lifestyle|healthy lifestyle
99584|NCT02944318|Academic performance|academic performance
99585|NCT02944292|Intra-abdominal pressure|intra-abdominal pressure
99586|NCT02944292|Intra-abdominal hypertension|intra-abdominal hypertension
99587|NCT02944266|post general anaesthesia induced|post general anaesthesia induced
99588|NCT02944253|Diet, Reducing|diet, reducing
99589|NCT02944253|Hunger|hunger
99590|NCT02944253|Appetite Regulation|appetite regulation
99591|NCT02944253|Ketogenic Diet|ketogenic diet
99592|NCT02944253|Caloric Restriction|caloric restriction
99593|NCT02944253|Weight Loss|weight loss
99594|NCT02944253|Ketosis|ketosis
99595|NCT02944214|Hyperuricemia|hyperuricemia
99596|NCT02944214|Renal Function|renal function
99597|NCT02944214|Chronic kidney disease|chronic kidney disease
99598|NCT02944214|Febuxostat|febuxostat
99599|NCT02944214|Benzbromarone|benzbromarone
99600|NCT02944201|carvedilol|carvedilol
99601|NCT02944201|biomarkers|biomarkers
99602|NCT02944201|autonomic nerves|autonomic nerves
99603|NCT02944188|enhanced recovery after surgery|enhanced recovery after surgery
99604|NCT02944188|right hemicolectomy|right hemicolectomy
99605|NCT02944162|AML|aml
99606|NCT02944162|CD33|cd33
99607|NCT02944162|CAR-NK|car-nk
99608|NCT02944136|cancer|cancer
99609|NCT02944136|stepped collaborative care intervention|stepped collaborative care intervention
99610|NCT02944136|depression|depression
99611|NCT02944136|quality of life|quality of life
99612|NCT02944136|stress|stress
99613|NCT02944136|dyadic function|dyadic function
99614|NCT02944136|spousal or intimate caregiver|spousal or intimate caregiver
99615|NCT02944123|Half dose|half dose
99616|NCT02944123|Newer oral P2Y12 receptor inhibitors|newer oral p2y12 receptor inhibitors
99617|NCT02944123|Acute coronary syndrome|acute coronary syndrome
99618|NCT02944097|Bioavailability|bioavailability
99619|NCT02944097|Pharmacokinetics|pharmacokinetics
99620|NCT02944097|trans-resveratrol|trans-resveratrol
99621|NCT02944097|trans-epsilon-viniferin|trans-epsilon-viniferin
99622|NCT02944097|Vineatrol 30|vineatrol 30
99623|NCT02944084|Bioavailability|bioavailability
99624|NCT02944084|Pharmacokinetics|pharmacokinetics
99625|NCT02944084|Rice bran extract|rice bran extract
99626|NCT02944084|Vitamin E|vitamin e
99627|NCT02944084|Gamma-oryzanol|gamma-oryzanol
99628|NCT02944084|Ferulic acid|ferulic acid
99629|NCT02944071|femoropopliteal artery lesions|femoropopliteal artery lesions
99630|NCT02944071|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
99631|NCT02944071|Peripheral Artery Disease|peripheral artery disease
99632|NCT02944071|Drug-coated Balloon|drug-coated balloon
99633|NCT02944058|Multiloc|multiloc
99634|NCT02944058|Philos|philos
99635|NCT02944058|Locking plate|locking plate
99636|NCT02944058|Straight nail|straight nail
99637|NCT02944058|Randomized controlled trial|randomized controlled trial
99638|NCT02944058|3 and 4 part fractures|3 and 4 part fractures
99639|NCT02944019|Nonvalvular Atrial Fibrillation|nonvalvular atrial fibrillation
99640|NCT02944019|Post Authorisation Safety Study|post authorisation safety study
99641|NCT02944019|Safety|safety
99642|NCT02944019|Real World Evidence|real world evidence
99643|NCT02944006|MRI|mri
99644|NCT02943993|Post-Authorisation Safety Study|post-authorisation safety study
99645|NCT02943993|Real World Evidence|real world evidence
99646|NCT02943993|Edoxaban|edoxaban
99647|NCT02943993|Efficacy/Safety|efficacy/safety
99648|NCT02943980|Intraoperative nerve monitoring, airway management|intraoperative nerve monitoring, airway management
99649|NCT02943967|Refractive Surgical Procedures|refractive surgical procedures
99650|NCT02943967|Photorefractive Keratectomy|photorefractive keratectomy
99651|NCT02943967|Aberrometry|aberrometry
99652|NCT02943954|Fractional Flow Reserve|fractional flow reserve
99653|NCT02943915|Spinal Cord|spinal cord
99654|NCT02943915|Injury|injury
99655|NCT02943915|Exoskeleton|exoskeleton
99656|NCT02943915|Ekso|ekso
99657|NCT02943915|Rehabilitation|rehabilitation
99658|NCT02943902|immunogenicity|immunogenicity
99659|NCT02943889|Mesenchymal stem cells|mesenchymal stem cells
99660|NCT02943889|Liver cirrhosis|liver cirrhosis
99661|NCT02943889|Stem cell therapy|stem cell therapy
99662|NCT02943876|risk prediction|risk prediction
99663|NCT02943876|risk score|risk score
99664|NCT02943876|accuracy of risk perception|accuracy of risk perception
99665|NCT02943876|self-help|self-help
99666|NCT02943876|psychological distress|psychological distress
99667|NCT02943850|stem cells|stem cells
99668|NCT02943850|growth factor|growth factor
99669|NCT02943850|ALS|als
99670|NCT02943824|brachytherapy|brachytherapy
99671|NCT02943824|machine learning|machine learning
99672|NCT02943824|treatment planning|treatment planning
99673|NCT02943824|Low-Dose-Rate brachytherapy|low-dose-rate brachytherapy
99674|NCT02943811|endometrial cancer|endometrial cancer
99675|NCT02943811|survival|survival
99676|NCT02943811|uterine manipulator|uterine manipulator
99677|NCT02943798|Pulmonary Large Cell Neuroendocrine Carcinoma,chemotherapy|pulmonary large cell neuroendocrine carcinoma,chemotherapy
99678|NCT02943785|Transcatheter Aortic Valve Implantation -- TAVI|transcatheter aortic valve implantation -- tavi
99679|NCT02943785|Anticoagulation|anticoagulation
99680|NCT02943785|Atrial Fibrillation|atrial fibrillation
99681|NCT02943785|ENVISAGE-TAVI-AF|envisage-tavi-af
99682|NCT02943746|Standard Protein Diet|standard protein diet
99683|NCT02943746|High Protein Diet|high protein diet
99684|NCT02943746|Growth|growth
99685|NCT02943746|Body Composition|body composition
99686|NCT02943746|Extremely Low Birth Weight|extremely low birth weight
99687|NCT02943746|Human Milk Derived Fortifier|human milk derived fortifier
99688|NCT02943746|Protein|protein
99689|NCT02943746|Targeted Fortification|targeted fortification
99690|NCT02943746|Human Milk Diet|human milk diet
99691|NCT02943746|Prematurity|prematurity
99692|NCT02943733|Pancreatic neuroendocrine tumors (pNETs)|pancreatic neuroendocrine tumors (pnets)
99693|NCT02943733|Pancreatic neuroendocrine tumors|pancreatic neuroendocrine tumors
99694|NCT02943733|pNETs|pnets
99695|NCT02943733|NETs|nets
99696|NCT02943707|liver diseases|liver diseases
99697|NCT02943707|Bone Marrow Cell Transplantation|bone marrow cell transplantation
99698|NCT02943694|TaTME|tatme
99699|NCT02943694|Complications|complications
99700|NCT02943694|Instrument|instrument
99702|NCT02943642|CTCL|ctcl
99703|NCT02943642|Cutaneous T Cell Lymphoma|cutaneous t cell lymphoma
99704|NCT02943616|Absorb GT1 BVS|absorb gt1 bvs
99705|NCT02943616|BVS|bvs
99706|NCT02943616|Bioabsorbable|bioabsorbable
99707|NCT02943616|Myocardial ischemia|myocardial ischemia
99708|NCT02943616|Stent thrombosis|stent thrombosis
99709|NCT02943616|Stents|stents
99710|NCT02943603|mFOLFOX6|mfolfox6
99711|NCT02943603|pembrolizumab|pembrolizumab
99712|NCT02943590|Cancer Treatment Related to Heart Failure|cancer treatment related to heart failure
99713|NCT02943551|Pediatrics|pediatrics
99714|NCT02943551|Respiratory disease|respiratory disease
99715|NCT02943551|antibiotic use|antibiotic use
99716|NCT02943538|Crohn's Disease|crohn's disease
99717|NCT02943538|Colitis, Ulcerative|colitis, ulcerative
99718|NCT02943538|Telemedicine|telemedicine
99719|NCT02943525|vaginal packing|vaginal packing
99720|NCT02943525|pelvic organ prolapse|pelvic organ prolapse
99721|NCT02943525|pain and satisfaction|pain and satisfaction
99722|NCT02943486|Mesenchymal stromal cells|mesenchymal stromal cells
99723|NCT02943486|Fitostimoline|fitostimoline
99724|NCT02943486|MSC derivatives|msc derivatives
99725|NCT02943486|Diabetes|diabetes
99726|NCT02943473|Smoldering multiple myeloma|smoldering multiple myeloma
99727|NCT02943473|myeloma|myeloma
99728|NCT02943473|smoldering|smoldering
99729|NCT02943473|ibrutinib|ibrutinib
99730|NCT02943408|Veterans|veterans
99731|NCT02943408|mental health|mental health
99732|NCT02943408|Patient-Centered Care|patient-centered care
99733|NCT02943382|MGD|mgd
99734|NCT02943382|Autologous Serum|autologous serum
99735|NCT02943382|Meibomian gland dysfunction|meibomian gland dysfunction
99736|NCT02943382|Dry eye disease|dry eye disease
99737|NCT02943382|FAB|fab
99738|NCT02943382|Fingerprick autologous blood|fingerprick autologous blood
99739|NCT02943369|cangrelor|cangrelor
99740|NCT02943369|ticagrelor|ticagrelor
99741|NCT02943369|P2Y12 receptor antagonist|p2y12 receptor antagonist
99742|NCT02943369|acute myocardial infarction|acute myocardial infarction
99743|NCT02943330|Depression|depression
99744|NCT02943330|Cytokines|cytokines
99745|NCT02943330|Hemodialysis|hemodialysis
99746|NCT02943330|Interferon treatment|interferon treatment
99747|NCT02943330|Hepatitis C|hepatitis c
99748|NCT02943304|Pregnancy|pregnancy
99749|NCT02943304|Fetal Development|fetal development
99750|NCT02943304|Child Development|child development
99751|NCT02943304|Developmental Disabilities|developmental disabilities
99752|NCT02943304|Zika Virus Infection|zika virus infection
99753|NCT02943291|Exercise therapy|exercise therapy
99754|NCT02943291|Adipose tissue|adipose tissue
99755|NCT02943291|Mitochondria|mitochondria
99756|NCT02943291|Oxidative Phosphorylation|oxidative phosphorylation
99757|NCT02943265|Care Coordination|care coordination
99758|NCT02943252|apatinib|apatinib
99759|NCT02943252|S1|s1
99760|NCT02943252|advanced head and neck cancer|advanced head and neck cancer
99761|NCT02943252|non-squamous|non-squamous
99762|NCT02943213|Chlorpromazine|chlorpromazine
99763|NCT02943213|Hydrochloride|hydrochloride
99764|NCT02943213|Chlorpromazine Hydrochloride|chlorpromazine hydrochloride
99765|NCT02943213|Bioavailability|bioavailability
99766|NCT02943213|Variability|variability
99767|NCT02943213|Variable|variable
99768|NCT02943213|Absorption|absorption
99769|NCT02943213|USL Pharma|usl pharma
99770|NCT02943213|USL|usl
99771|NCT02943213|Healthy|healthy
99772|NCT02943213|South Africa|south africa
99773|NCT02943213|Cycle|cycle
99774|NCT02943213|Anti-Psychotic|anti-psychotic
99775|NCT02943161|Obesity|obesity
99776|NCT02943161|L-citrulline|l-citrulline
99777|NCT02943109|patient portal|patient portal
99778|NCT02943109|Health Information Technology|health information technology
99779|NCT02943109|Electronic Health Records|electronic health records
99780|NCT02943109|Inpatient Care|inpatient care
99781|NCT02943109|Outpatient Care|outpatient care
99782|NCT02943109|Patient Engagement|patient engagement
99783|NCT02943070|Rezum|rezum
99784|NCT02943070|Water Vapor Ablation|water vapor ablation
99785|NCT02943031|bile duct tumor|bile duct tumor
99786|NCT02943031|individualized precise treatment programs|individualized precise treatment programs
99787|NCT02943018|ultrasound anovaginal distance, observer variation|ultrasound anovaginal distance, observer variation
99788|NCT02942979|Facilitation|facilitation
99789|NCT02942979|Implementation|implementation
99790|NCT02942979|Homelessness|homelessness
99791|NCT02942979|Substance Use Disorder|substance use disorder
99792|NCT02942979|Mental Illness|mental illness
99793|NCT02942979|Co-Occurring Disorders|co-occurring disorders
99794|NCT02942979|Veterans|veterans
99795|NCT02942979|Primary Care|primary care
99796|NCT02942966|Angioplasty|angioplasty
99797|NCT02942966|Below the Knee|below the knee
99798|NCT02942966|PAD|pad
99799|NCT02942966|Critical Limb Ischemia|critical limb ischemia
99800|NCT02942966|Lesion|lesion
99801|NCT02942966|Claudication|claudication
99802|NCT02942953|Pacemaker, Artificial|pacemaker, artificial
99803|NCT02942953|Diaphragmatic pacing|diaphragmatic pacing
99804|NCT02942927|Polypharmacy|polypharmacy
99805|NCT02942927|Multimorbidity|multimorbidity
99806|NCT02942927|Randomized Control Trial|randomized control trial
99807|NCT02942927|Drug Discontinuation|drug discontinuation
99808|NCT02942927|Patient Preference|patient preference
99809|NCT02942927|eHealth|ehealth
99810|NCT02942901|PET-CT|pet-ct
99811|NCT02942901|pulmonary metstasectomy|pulmonary metstasectomy
99812|NCT02942888|Mild Cognitive Impairment|mild cognitive impairment
99813|NCT02942888|MCI|mci
99814|NCT02942888|NAD|nad
99815|NCT02942888|nicotinamide riboside|nicotinamide riboside
99816|NCT02942888|aging|aging
99817|NCT02942875|upper limb|upper limb
99818|NCT02942875|mirror therapy|mirror therapy
99819|NCT02942875|rehabilitation|rehabilitation
99820|NCT02942875|subacute|subacute
99821|NCT02942849|Bemfola|bemfola
99822|NCT02942849|r-hFSH|r-hfsh
99823|NCT02942849|Oocytes|oocytes
99824|NCT02942849|Pregnancy|pregnancy
99825|NCT02942849|OHSS|ohss
99826|NCT02942836|Respiration Rate Detection|respiration rate detection
99827|NCT02942823|obesity|obesity
99828|NCT02942823|child|child
99829|NCT02942823|primary prevention|primary prevention
99830|NCT02942823|serious game|serious game
99831|NCT02942823|nutrition|nutrition
99832|NCT02942823|physical activity|physical activity
99833|NCT02942823|psychosocial|psychosocial
99834|NCT02942823|stress|stress
99835|NCT02942823|knowledge|knowledge
99836|NCT02942823|diet|diet
99837|NCT02942823|energy density|energy density
99838|NCT02942823|beverages|beverages
99839|NCT02942823|food pyramide|food pyramide
99840|NCT02942732|Vitamin D|vitamin d
99841|NCT02942732|Glucose|glucose
99842|NCT02942732|HbA1C|hba1c
99843|NCT02942732|Insulin resistance|insulin resistance
99844|NCT02942732|Blood lipids|blood lipids
99845|NCT02942693|Apatinib|apatinib
99846|NCT02942693|Particle therapy|particle therapy
99847|NCT02942680|coronary artery bypass grafting|coronary artery bypass grafting
99848|NCT02942641|Urethral catheter|urethral catheter
99849|NCT02942641|clean intermittent catheterization|clean intermittent catheterization
99850|NCT02942641|UTI|uti
99851|NCT02942641|pain|pain
99852|NCT02942641|quality of life|quality of life
99853|NCT02942641|hematuria|hematuria
99854|NCT02942641|cloudy urine|cloudy urine
99855|NCT02942589|Portion Size|portion size
99856|NCT02942563|Local Advanced Rectal Cancer|local advanced rectal cancer
99857|NCT02942563|Total Neoadjuvant Therapy|total neoadjuvant therapy
99858|NCT02942563|FOLFOXIRI|folfoxiri
99859|NCT02942498|behavior, cognitive|behavior, cognitive
99860|NCT02942472|clinical pregnancy rate after embryo transfer|clinical pregnancy rate after embryo transfer
99861|NCT02942459|music therapy|music therapy
99862|NCT02942459|double-blinded|double-blinded
99863|NCT02942459|Randomized Controlled study (RCT)|randomized controlled study (rct)
99864|NCT02942459|Schizophrenia, negative symptoms|schizophrenia, negative symptoms
99865|NCT02942407|Renal dialysis|renal dialysis
99866|NCT02942329|humanized anti-PD-1 monoclonal antibody|humanized anti-pd-1 monoclonal antibody
99867|NCT02942329|apatinib|apatinib
99868|NCT02942329|Gastric Neoplasms|gastric neoplasms
99869|NCT02942329|Gastric Cancer|gastric cancer
99870|NCT02942329|Cancer of Stomach|cancer of stomach
99871|NCT02942329|Hepatocellular Carcinoma|hepatocellular carcinoma
99872|NCT02942329|Liver Cancer, Adult|liver cancer, adult
99873|NCT02942329|Liver Cell Carcinoma|liver cell carcinoma
99874|NCT02942316|Heart Rate|heart rate
99875|NCT02942316|Reflex, Pupillary|reflex, pupillary
99876|NCT02942316|Monitoring, Intraoperative|monitoring, intraoperative
99877|NCT02942303|Botulinum Toxin, Rejuvenation, Brow lift, Eyebrow.|botulinum toxin, rejuvenation, brow lift, eyebrow.
99878|NCT02942290|Higher-Risk (HR) Myelodysplastic Syndromes (MDS)|higher-risk (hr) myelodysplastic syndromes (mds)
99879|NCT02942290|Pharmacokinetic|pharmacokinetic
99880|NCT02942290|Venetoclax|venetoclax
99881|NCT02942290|Azacitidine|azacitidine
99882|NCT02942290|Acute Myelogenous Leukemia|acute myelogenous leukemia
99883|NCT02942290|Myelodysplastic Syndromes (MDS)|myelodysplastic syndromes (mds)
99884|NCT02942290|Treatment-Naïve Higher-Risk|treatment-naïve higher-risk
99885|NCT02942277|Malaria|malaria
99886|NCT02942277|Reactogenicity|reactogenicity
99887|NCT02942277|Antibody|antibody
99888|NCT02942277|Direct Skin Feed|direct skin feed
99889|NCT02942277|Mosquito|mosquito
99890|NCT02942264|Brain Tumor|brain tumor
99891|NCT02942264|Glioblastoma|glioblastoma
99892|NCT02942264|Relapse|relapse
99893|NCT02942264|Randomized|randomized
99894|NCT02942264|temodar|temodar
99895|NCT02942251|MDD|mdd
99896|NCT02942251|big data analytics|big data analytics
99897|NCT02942238|CME|cme
99898|NCT02942238|Right hemi Colon cancer|right hemi colon cancer
99899|NCT02942238|D3|d3
99900|NCT02942238|laparoscopy|laparoscopy
99901|NCT02942225|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
99902|NCT02942225|metabolomics|metabolomics
99903|NCT02942225|neuropsychological deficits|neuropsychological deficits
99904|NCT02942225|pathway analysis|pathway analysis
99905|NCT02942212|Smoking Cessation|smoking cessation
99906|NCT02942212|Nicotine patch|nicotine patch
99907|NCT02942212|Nicoderm Committed Quitters|nicoderm committed quitters
99908|NCT02942212|CQ|cq
99909|NCT02942212|Nicoderm CQ|nicoderm cq
99910|NCT02942212|Questionnaires|questionnaires
99911|NCT02942212|Surveys|surveys
99912|NCT02942212|Interviews|interviews
99913|NCT02942212|Breath tests|breath tests
99914|NCT02942173|CD45RA-depletion|cd45ra-depletion
99915|NCT02942173|TCR-alpha/beta depletion|tcr-alpha/beta depletion
99916|NCT02942173|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
99917|NCT02942121|surgery education|surgery education
99918|NCT02942121|radical cystectomy|radical cystectomy
99919|NCT02942121|cystectomy|cystectomy
99920|NCT02942121|muscle-invasive bladder cancer|muscle-invasive bladder cancer
99921|NCT02942108|piezolectric surgery|piezolectric surgery
99922|NCT02942108|conventional surgery|conventional surgery
99923|NCT02942108|lower third molars|lower third molars
99924|NCT02942095|Advanced Solid Tumors|advanced solid tumors
99925|NCT02942095|Metastatic cancer|metastatic cancer
99926|NCT02942095|Ixazomib|ixazomib
99927|NCT02942095|MLN9708|mln9708
99928|NCT02942095|Erlotinib|erlotinib
99929|NCT02942095|Erlotinib hydrochloride|erlotinib hydrochloride
99930|NCT02942095|OSI-774|osi-774
99931|NCT02942095|CP358774|cp358774
99932|NCT02942095|Tarceva|tarceva
99933|NCT02942043|Malignant pleural effusion|malignant pleural effusion
99934|NCT02942043|Bevacizumab|bevacizumab
99935|NCT02941991|Stargardt's Macular Dystrophy|stargardt's macular dystrophy
99936|NCT02941991|Retinal Diseases|retinal diseases
99937|NCT02941991|Macular Degeneration|macular degeneration
99938|NCT02941991|fundus flavimaculatus|fundus flavimaculatus
99939|NCT02941991|hESC-RPE|hesc-rpe
99940|NCT02941991|ASP7316|asp7316
99941|NCT02941991|juvenile macular dystrophy|juvenile macular dystrophy
99942|NCT02941991|SMD|smd
99943|NCT02941939|high intensity interval training|high intensity interval training
99944|NCT02941939|hyperbaric oxygen|hyperbaric oxygen
99945|NCT02941926|HR-positive HER2-negative|hr-positive her2-negative
99946|NCT02941926|advanced breast cancer|advanced breast cancer
99947|NCT02941926|LEE011|lee011
99948|NCT02941926|ribociclib|ribociclib
99949|NCT02941926|letrozole|letrozole
99950|NCT02941926|goserelin|goserelin
99951|NCT02941926|CDK|cdk
99952|NCT02941926|CDK4|cdk4
99953|NCT02941926|CDK6|cdk6
99954|NCT02941926|CDK4/6|cdk4/6
99955|NCT02941926|Phase IIIb|phase iiib
99956|NCT02941926|ER-positive|er-positive
99957|NCT02941926|PR-positive|pr-positive
99958|NCT02941926|premenopausal|premenopausal
99959|NCT02941926|postmenopausal|postmenopausal
99960|NCT02941926|men with advanced breast cancer|men with advanced breast cancer
99961|NCT02941900|Genetic Testing|genetic testing
99962|NCT02941900|16-1243|16-1243
99963|NCT02941887|Social behavior|social behavior
99964|NCT02941887|Gingivitis|gingivitis
99965|NCT02941887|Periodontitis|periodontitis
99966|NCT02941887|Down's Syndrome|down's syndrome
99967|NCT02941874|IRAP|irap
99968|NCT02941874|Insulin Regulated Amino Peptidase|insulin regulated amino peptidase
99969|NCT02941874|Diagnostic biomarker|diagnostic biomarker
99970|NCT02941874|Type 2 diabetes|type 2 diabetes
99971|NCT02941861|Hepatocellular carcinoma|hepatocellular carcinoma
99972|NCT02941861|Cholangiocarcinoma|cholangiocarcinoma
99973|NCT02941861|Recurrence|recurrence
99974|NCT02941835|pre-operative radiotherapy|pre-operative radiotherapy
99975|NCT02941783|Kovaltry|kovaltry
99976|NCT02941783|hemophilia A|hemophilia a
99977|NCT02941783|Japan|japan
99978|NCT02941783|Post-marketing surveillance|post-marketing surveillance
99979|NCT02941770|Adolescents|adolescents
99980|NCT02941770|Overweight|overweight
99981|NCT02941770|Obesity|obesity
99982|NCT02941770|Weight Loss|weight loss
99983|NCT02941770|Physical activity consultation|physical activity consultation
99984|NCT02941770|Cardiorespiratory fitness|cardiorespiratory fitness
99985|NCT02941770|Endothelial structure|endothelial structure
99986|NCT02941770|Endothelial function|endothelial function
99987|NCT02941757|Mediterranean Diet|mediterranean diet
99988|NCT02941757|Firefighters|firefighters
99989|NCT02941757|workplace|workplace
99990|NCT02941757|Intervention|intervention
99991|NCT02941757|obesity|obesity
99992|NCT02941757|Randomized Control Trial|randomized control trial
99993|NCT02941744|nivolumab|nivolumab
99994|NCT02941744|ipilimumab|ipilimumab
99995|NCT02941744|low fixed dose|low fixed dose
99996|NCT02941744|adjuvant therapy|adjuvant therapy
99997|NCT02941744|Melanoma|melanoma
99998|NCT02941718|Smoking|smoking
99999|NCT02941718|Smoking cessation|smoking cessation
100000|NCT02941718|Nicotine|nicotine
100001|NCT02941705|stem cell research|stem cell research
100002|NCT02941640|Laparoscopic appendectomy|laparoscopic appendectomy
100003|NCT02941640|Endoloop|endoloop
100004|NCT02941640|Stapler|stapler
100005|NCT02941640|Hem-o-lok clip|hem-o-lok clip
100006|NCT02941640|DS clip|ds clip
100007|NCT02941601|Thoracic Neoplasms|thoracic neoplasms
100008|NCT02941601|Lung Diseases|lung diseases
100009|NCT02941601|Lung Cancer|lung cancer
100010|NCT02941601|Respiratory Tract Diseases|respiratory tract diseases
100011|NCT02941601|Respiratory Tract Neoplasms|respiratory tract neoplasms
100012|NCT02941601|Antineoplastic Agents|antineoplastic agents
100013|NCT02941601|Monoclonal Antibodies|monoclonal antibodies
100014|NCT02941562|rectal cancer, radiotherapy|rectal cancer, radiotherapy
100015|NCT02941536|Circulating Tumor Cells|circulating tumor cells
100016|NCT02941536|Stereotactic Radiosurgery|stereotactic radiosurgery
100017|NCT02941497|Stress, Psychological|stress, psychological
100018|NCT02941497|Obesity|obesity
100019|NCT02941497|Physical Activity|physical activity
100020|NCT02941497|Fruit|fruit
100021|NCT02941497|Vegetables|vegetables
100022|NCT02941497|Social Marketing|social marketing
100023|NCT02941497|Peer Influence|peer influence
100024|NCT02941497|Community-Based Participatory Research|community-based participatory research
100025|NCT02941471|Constipation|constipation
100026|NCT02941471|Neuromodulation|neuromodulation
100027|NCT02941471|Interferential|interferential
100028|NCT02941471|Transabdominal|transabdominal
100029|NCT02941445|DPP4-inhibitors|dpp4-inhibitors
100030|NCT02941419|Platelet lysate|platelet lysate
100031|NCT02941419|Critical limb ischemia|critical limb ischemia
100032|NCT02941419|Peripheral arterial disease|peripheral arterial disease
100033|NCT02941406|Retina|retina
100034|NCT02941406|Perimetry|perimetry
100035|NCT02941393|internal tocodynamometry, external tocodynamometry, cesarean section, labor, newborn, vacuum extraction, dystocia|internal tocodynamometry, external tocodynamometry, cesarean section, labor, newborn, vacuum extraction, dystocia
100036|NCT02941380|coronary artery bypass grafting|coronary artery bypass grafting
100037|NCT02941380|cardiopulmonary bypass|cardiopulmonary bypass
100038|NCT02941380|Cerebral oxidative stress|cerebral oxidative stress
100039|NCT02941380|Cerebral inflammatory stress|cerebral inflammatory stress
100040|NCT02941380|Cerebral hemodynamics|cerebral hemodynamics
100041|NCT02941380|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
100042|NCT02941341|Bemfola|bemfola
100043|NCT02941341|r-hFSH|r-hfsh
100044|NCT02941341|ART|art
100045|NCT02941341|Oocytes|oocytes
100046|NCT02941341|OHSS|ohss
100047|NCT02941341|Pregnancy|pregnancy
100048|NCT02941328|SMA, SMN1, Kugelberg-Welander|sma, smn1, kugelberg-welander
100049|NCT02941315|Cardiomyopathy|cardiomyopathy
100050|NCT02941315|Heart Failure|heart failure
100051|NCT02941315|Cardiac Magnetic Resonance|cardiac magnetic resonance
100052|NCT02941302|gliomas|gliomas
100053|NCT02941302|biological boundary|biological boundary
100054|NCT02941302|imaging border|imaging border
100055|NCT02941302|operation|operation
100056|NCT02941263|AMD|amd
100057|NCT02941263|Georgraphic Atrophy|georgraphic atrophy
100058|NCT02941263|Macular Degeneration|macular degeneration
100059|NCT02941237|Pulse oximetry|pulse oximetry
100060|NCT02941237|Children|children
100061|NCT02941211|cervix|cervix
100062|NCT02941211|cervical dilation|cervical dilation
100063|NCT02941211|balloon catheter|balloon catheter
100064|NCT02941172|Brown adipose tissue|brown adipose tissue
100065|NCT02941172|Cannabinoid receptor|cannabinoid receptor
100066|NCT02941172|PET imaging|pet imaging
100067|NCT02941172|Metabolism|metabolism
100068|NCT02941120|Cartilage defect|cartilage defect
100069|NCT02941120|Knee|knee
100070|NCT02941120|ACT (Autologous chondrocyte implantation)|act (autologous chondrocyte implantation)
100071|NCT02941120|NOVOCART® Inject|novocart® inject
100072|NCT02941107|Aboriginal|aboriginal
100073|NCT02941107|Rotavirus|rotavirus
100074|NCT02941107|Vaccine|vaccine
100075|NCT02941107|Diarrhoea|diarrhoea
100076|NCT02941081|iron supplement|iron supplement
100077|NCT02941068|severe sepsis|severe sepsis
100078|NCT02941068|intra-abdominal perforation|intra-abdominal perforation
100079|NCT02941068|surgical intensive care unit|surgical intensive care unit
100080|NCT02941068|fungal infection|fungal infection
100081|NCT02941068|prophylactic anti-fungal treatment|prophylactic anti-fungal treatment
100082|NCT02941055|Diet|diet
100083|NCT02941055|Inflammation|inflammation
100084|NCT02941055|Metabolomics|metabolomics
100085|NCT02941029|Radiation|radiation
100086|NCT02941029|Chemotherapy|chemotherapy
100087|NCT02941003|Early stage lung adenocarcinoma|early stage lung adenocarcinoma
100088|NCT02941003|Intraoperative frozen section|intraoperative frozen section
100089|NCT02941003|Diagnostic criteria|diagnostic criteria
100090|NCT02940977|Circulating tumor cell|circulating tumor cell
100091|NCT02940977|Epithelial to mesenchymal transition|epithelial to mesenchymal transition
100092|NCT02940977|Prostate specific antigen (PSA)|prostate specific antigen (psa)
100093|NCT02940977|Partin table|partin table
100094|NCT02940925|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
100095|NCT02940925|induction chemotherapy|induction chemotherapy
100096|NCT02940912|Parkinson disease|parkinson disease
100097|NCT02940912|Insomnia|insomnia
100098|NCT02940912|Sleep disorders|sleep disorders
100099|NCT02940912|Polysomnography|polysomnography
100100|NCT02940912|Apomorphine|apomorphine
100101|NCT02940912|Multiple sleep latency test|multiple sleep latency test
100102|NCT02940912|Parkinson Disease Sleep Scale 2 (PDSS-2)|parkinson disease sleep scale 2 (pdss-2)
100103|NCT02940873|severe hypoglycemia|severe hypoglycemia
100104|NCT02940873|impaired awareness of hypoglycemia|impaired awareness of hypoglycemia
100105|NCT02940873|type 1 diabetes mellitus|type 1 diabetes mellitus
100106|NCT02940873|cognitive behavioral therapy|cognitive behavioral therapy
100107|NCT02940873|structured education|structured education
100108|NCT02940847|ultrasound-guided technique|ultrasound-guided technique
100109|NCT02940847|blind technique|blind technique
100110|NCT02940847|medial brachial cutaneous nerve block|medial brachial cutaneous nerve block
100111|NCT02940847|intercostobrachial nerve block|intercostobrachial nerve block
100112|NCT02940821|Tooth Whitening|tooth whitening
100113|NCT02940808|Caffeine|caffeine
100114|NCT02940808|EEG|eeg
100115|NCT02940808|Theta/beta ratio|theta/beta ratio
100116|NCT02940808|Eye-blink rates|eye-blink rates
100117|NCT02940808|Cognitive control|cognitive control
100118|NCT02940808|Emotional Stroop|emotional stroop
100119|NCT02940808|Global/local congruency|global/local congruency
100120|NCT02940808|N-Back|n-back
100121|NCT02940808|Prefrontal Cortex|prefrontal cortex
100122|NCT02940795|breast feeding|breast feeding
100123|NCT02940795|fructose|fructose
100124|NCT02940769|depression|depression
100125|NCT02940769|insomnia|insomnia
100126|NCT02940769|light|light
100127|NCT02940769|cortisol|cortisol
100128|NCT02940769|melatonin|melatonin
100129|NCT02940756|Malaria, efficacy, safety, ACT, DR Congo|malaria, efficacy, safety, act, dr congo
100130|NCT02940743|Hemodialysis|hemodialysis
100131|NCT02940704|Reciproc|reciproc
100132|NCT02940704|One Shape|one shape
100133|NCT02940704|reciprocation|reciprocation
100134|NCT02940704|continuous rotation|continuous rotation
100135|NCT02940704|irreversible pulpitis|irreversible pulpitis
100136|NCT02940704|postoperative pain|postoperative pain
100137|NCT02940678|Trauma|trauma
100138|NCT02940678|Clinical prediction models|clinical prediction models
100139|NCT02940678|Transferability studies|transferability studies
100140|NCT02940678|Sweden|sweden
100141|NCT02940652|Laryngeal mask,MRI|laryngeal mask,mri
100142|NCT02940626|Pneumonia|pneumonia
100143|NCT02940626|S. aureus|s. aureus
100144|NCT02940626|Mechanically ventilated|mechanically ventilated
100145|NCT02940613|Rapid response|rapid response
100146|NCT02940613|Eating Disorders|eating disorders
100147|NCT02940613|Cognitive Behavior Therapy|cognitive behavior therapy
100148|NCT02940613|Bulimia Nervosa|bulimia nervosa
100149|NCT02940613|Binge Eating Disorder|binge eating disorder
100150|NCT02940613|Purging Disorder|purging disorder
100151|NCT02940600|normothermic perfusion|normothermic perfusion
100152|NCT02940600|old donors|old donors
100153|NCT02940600|extended criteria grafts|extended criteria grafts
100154|NCT02940600|reconditioning|reconditioning
100155|NCT02940587|Non Healing Wound|non healing wound
100156|NCT02940574|Oxytocin|oxytocin
100157|NCT02940574|Autism Spectrum Disorders|autism spectrum disorders
100158|NCT02940548|non-dipper hypertension|non-dipper hypertension
100159|NCT02940548|young|young
100160|NCT02940548|middle-aged|middle-aged
100161|NCT02940548|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
100162|NCT02940548|arterial stiffness|arterial stiffness
100163|NCT02940548|nifedipine gastrointestinal therapeutic system (GITS)|nifedipine gastrointestinal therapeutic system (gits)
100164|NCT02940496|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
100165|NCT02940496|Advanced liver cancer|advanced liver cancer
100166|NCT02940496|Advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
100167|NCT02940496|Pembrolizumab|pembrolizumab
100168|NCT02940496|Keytruda|keytruda
100169|NCT02940496|MK-3475|mk-3475
100170|NCT02940496|SCH-900475|sch-900475
100171|NCT02940496|Biomarkers|biomarkers
100172|NCT02940483|Ependymoma|ependymoma
100173|NCT02940457|tDCS|tdcs
100174|NCT02940457|MCI|mci
100175|NCT02940457|Working Memory|working memory
100176|NCT02940457|fNIRS|fnirs
100177|NCT02940418|Diabetes Mellitus|diabetes mellitus
100178|NCT02940418|Type 1|type 1
100179|NCT02940418|Adipose derived mesenchymal stem cells|adipose derived mesenchymal stem cells
100180|NCT02940405|Ketorolac Premedication|ketorolac premedication
100181|NCT02940405|Anesthetic Efficiency|anesthetic efficiency
100182|NCT02940405|Post-Endodontic Pain|post-endodontic pain
100183|NCT02940405|Post-operative pain|post-operative pain
100184|NCT02940405|Irreversible Pulpitis|irreversible pulpitis
100185|NCT02940405|Oral premedication|oral premedication
100186|NCT02940392|Rezum|rezum
100187|NCT02940340|infective endocarditis|infective endocarditis
100188|NCT02940340|systemic microcirculation|systemic microcirculation
100189|NCT02940327|ECMO|ecmo
100190|NCT02940327|PPHN|pphn
100191|NCT02940327|Pulmonary Hypertension of the Newborn|pulmonary hypertension of the newborn
100192|NCT02940327|Markers of inflammation|markers of inflammation
100193|NCT02940327|Mi-Ecmo|mi-ecmo
100194|NCT02940249|Polyphenol|polyphenol
100195|NCT02940249|Apple|apple
100196|NCT02940249|Fruit|fruit
100197|NCT02940249|Hyperglycaemia|hyperglycaemia
100198|NCT02940249|Metabolic|metabolic
100199|NCT02940223|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
100200|NCT02940223|Cancer-related fatigue|cancer-related fatigue
100201|NCT02940223|Fish oil|fish oil
100202|NCT02940223|Icosapent ethyl|icosapent ethyl
100203|NCT02940223|Quality of life questionnaire|quality of life questionnaire
100204|NCT02940223|Symptom questionnaire|symptom questionnaire
100205|NCT02940223|Walk test|walk test
100206|NCT02940223|Chair/stand test|chair/stand test
100207|NCT02940223|Placebo|placebo
100208|NCT02940223|Resistance exercises|resistance exercises
100209|NCT02940223|Walking program|walking program
100210|NCT02940223|Resistance training|resistance training
100211|NCT02940223|Stretching exercises|stretching exercises
100212|NCT02940223|Advanced cancer|advanced cancer
100213|NCT02940197|overweight|overweight
100214|NCT02940197|Caloric Restriction|caloric restriction
100215|NCT02940184|Physiology|physiology
100216|NCT02940171|burns|burns
100217|NCT02940171|critically ill|critically ill
100218|NCT02940171|surgery outcome|surgery outcome
100219|NCT02940171|mortality|mortality
100220|NCT02940158|lentils|lentils
100221|NCT02940158|diabetes|diabetes
100222|NCT02940158|glycemia|glycemia
100223|NCT02940158|insulin|insulin
100224|NCT02940158|glucose|glucose
100225|NCT02940145|inflammatory biomarkers|inflammatory biomarkers
100714|NCT02936713|probiotics|probiotics
100226|NCT02940145|Interleukines|interleukines
100227|NCT02940145|resistance training|resistance training
100228|NCT02940145|phase angle|phase angle
100229|NCT02940145|oxidative stress|oxidative stress
100230|NCT02940106|oocyte cryopreservation|oocyte cryopreservation
100231|NCT02940106|closed vitrification|closed vitrification
100232|NCT02940106|open vitrification|open vitrification
100233|NCT02940067|prehabilitation|prehabilitation
100234|NCT02940067|pancreatectomy|pancreatectomy
100235|NCT02940067|nutrition|nutrition
100236|NCT02940067|exercise|exercise
100237|NCT02940054|Early diagnosis|early diagnosis
100238|NCT02940041|Diagnosis|diagnosis
100239|NCT02940041|Sonography|sonography
100240|NCT02940041|Magnetic Ressonance|magnetic ressonance
100241|NCT02940015|Quality Control|quality control
100242|NCT02940015|Urine|urine
100243|NCT02940015|Tissue|tissue
100244|NCT02940015|Normal|normal
100245|NCT02940002|Plaque form psoriasis vulgaris|plaque form psoriasis vulgaris
100246|NCT02939989|Chronic Hepatitis C (HCV)|chronic hepatitis c (hcv)
100247|NCT02939989|HCV Genotype 1 (HCV GT1)|hcv genotype 1 (hcv gt1)
100248|NCT02939989|HCV Genotype 2 (HCV GT2)|hcv genotype 2 (hcv gt2)
100249|NCT02939989|HCV Genotype 3 (HCV GT3)|hcv genotype 3 (hcv gt3)
100250|NCT02939989|HCV Genotype 4 (HCV GT4)|hcv genotype 4 (hcv gt4)
100251|NCT02939989|HCV Genotype 5 (HCV GT5)|hcv genotype 5 (hcv gt5)
100252|NCT02939989|HCV Genotype 6 (HCV GT6)|hcv genotype 6 (hcv gt6)
100253|NCT02939989|Compensated Cirrhosis|compensated cirrhosis
100254|NCT02939989|Non-cirrhotics|non-cirrhotics
100255|NCT02939989|Virologic failure|virologic failure
100256|NCT02939976|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
100257|NCT02939963|weaning|weaning
100258|NCT02939963|mechanical ventilation|mechanical ventilation
100259|NCT02939963|work of breathing|work of breathing
100260|NCT02939963|automatic tube compensation|automatic tube compensation
100261|NCT02939963|pressure support ventilation|pressure support ventilation
100262|NCT02939911|Residual neuromuscular blockade|residual neuromuscular blockade
100263|NCT02939872|DAPT|dapt
100264|NCT02939872|BVS|bvs
100265|NCT02939872|Bioresorbable Vascular Scaffold|bioresorbable vascular scaffold
100266|NCT02939872|Dual Antiplatelet Therapy|dual antiplatelet therapy
100267|NCT02939859|Multiple Sclerosis|multiple sclerosis
100268|NCT02939859|Demyelinating Diseases|demyelinating diseases
100269|NCT02939859|Nervous System Diseases|nervous system diseases
100270|NCT02939859|Autoimmune Disorders|autoimmune disorders
100271|NCT02939846|Safety|safety
100272|NCT02939846|Solid tumor|solid tumor
100273|NCT02939846|Trametinib|trametinib
100274|NCT02939846|Pharmacokinetics|pharmacokinetics
100275|NCT02939820|RNAi therapeutic|rnai therapeutic
100276|NCT02939820|FAP|fap
100277|NCT02939820|Familial Amyloid Polyneuropathies|familial amyloid polyneuropathies
100278|NCT02939820|TTR|ttr
100279|NCT02939820|Transthyretin|transthyretin
100280|NCT02939820|Amyloidosis|amyloidosis
100281|NCT02939807|Yeliva™|yeliva™
100282|NCT02939807|hepatocellular carcinoma|hepatocellular carcinoma
100283|NCT02939807|ABC294640|abc294640
100284|NCT02939807|hepatic neoplasms|hepatic neoplasms
100285|NCT02939807|liver neoplasms|liver neoplasms
100286|NCT02939807|hepatic cancer|hepatic cancer
100287|NCT02939794|cardiac surgery|cardiac surgery
100288|NCT02939794|hemoglobin|hemoglobin
100289|NCT02939794|iron|iron
100290|NCT02939755|Collaborative care intervention|collaborative care intervention
100291|NCT02939755|Cancer|cancer
100292|NCT02939755|Depression|depression
100293|NCT02939755|Palliative care|palliative care
100294|NCT02939755|Quality of life|quality of life
100295|NCT02939755|Fatigue|fatigue
100296|NCT02939755|Pain|pain
100297|NCT02939742|preterm premature rupture of membranes|preterm premature rupture of membranes
100298|NCT02939742|complications of prematurity|complications of prematurity
100299|NCT02939742|neonatal morbidity|neonatal morbidity
100300|NCT02939742|respiratory distress syndrome|respiratory distress syndrome
100301|NCT02939742|antenatal corticosteroids|antenatal corticosteroids
100302|NCT02939742|betamethasone|betamethasone
100303|NCT02939729|prehabilitation|prehabilitation
100304|NCT02939729|physiotherapy|physiotherapy
100305|NCT02939729|cardiac|cardiac
100306|NCT02939729|thoracic|thoracic
100307|NCT02939729|preoperative|preoperative
100308|NCT02939716|small bowel|small bowel
100309|NCT02939716|bloating|bloating
100310|NCT02939716|flow|flow
100311|NCT02939703|Adipose tissue|adipose tissue
100312|NCT02939703|calorimetry|calorimetry
100313|NCT02939703|energy expenditure|energy expenditure
100314|NCT02939703|microbiome|microbiome
100315|NCT02939690|Catheter|catheter
100316|NCT02939690|Umbilical vein|umbilical vein
100317|NCT02939690|Neonate|neonate
100318|NCT02939664|banded gastric bypass|banded gastric bypass
100319|NCT02939664|weight loss|weight loss
100320|NCT02939651|Metastatic|metastatic
100321|NCT02939651|High grade|high grade
100322|NCT02939638|Plant-based diet|plant-based diet
100323|NCT02939638|Obesity|obesity
100324|NCT02939638|Insulin sensitivity|insulin sensitivity
100325|NCT02939638|Intracellular lipid|intracellular lipid
100326|NCT02939638|Postprandial metabolism|postprandial metabolism
100327|NCT02939638|Vegan diet|vegan diet
100328|NCT02939638|Beta-cell function|beta-cell function
100329|NCT02939612|Stress management|stress management
100330|NCT02939612|App|app
100331|NCT02939599|Pulmonary hypertension (PH),|pulmonary hypertension (ph),
100332|NCT02939599|Increase blood pressure in the pulmonary artery|increase blood pressure in the pulmonary artery
100333|NCT02939599|Increased blood pressure in the pulmonary vein|increased blood pressure in the pulmonary vein
100334|NCT02939599|Increased blood pressure in the lung vasculature|increased blood pressure in the lung vasculature
100335|NCT02939599|Shortness of breath|shortness of breath
100336|NCT02939599|Dizziness|dizziness
100337|NCT02939599|Fainting|fainting
100338|NCT02939599|Leg swelling|leg swelling
100339|NCT02939599|Cough|cough
100340|NCT02939599|Angina pector|angina pector
100341|NCT02939586|Sleep, Sleep apnoea, Haemodialysis, Haemodiafiltration, end stage kidney disease|sleep, sleep apnoea, haemodialysis, haemodiafiltration, end stage kidney disease
100342|NCT02939560|Autism Spectrum Disorder|autism spectrum disorder
100343|NCT02939560|Autism|autism
100344|NCT02939560|Depressive|depressive
100345|NCT02939560|Depression|depression
100346|NCT02939547|intravenous|intravenous
100347|NCT02939547|cyclodextrin|cyclodextrin
100348|NCT02939547|compassionate|compassionate
100349|NCT02939547|Trappsol|trappsol
100350|NCT02939534|Parkinson's disease|parkinson's disease
100351|NCT02939534|autoimmunity|autoimmunity
100352|NCT02939521|Pincer Nail|pincer nail
100353|NCT02939521|Surgery|surgery
100354|NCT02939508|Acute lower gastrointestinal dysfunction|acute lower gastrointestinal dysfunction
100355|NCT02939508|Colon-originated lesions|colon-originated lesions
100356|NCT02939508|Critical patient|critical patient
100357|NCT02939508|Colonoscopic decompression|colonoscopic decompression
100358|NCT02939508|Anticholinergic drugs|anticholinergic drugs
100359|NCT02939495|Premature Ejaculation|premature ejaculation
100360|NCT02939495|Erectile Dysfunction|erectile dysfunction
100361|NCT02939495|DAP-SPEED|dap-speed
100362|NCT02939495|Dapoxetine|dapoxetine
100363|NCT02939495|Sildenafil|sildenafil
100364|NCT02939469|Sympathetic Nerve Activity|sympathetic nerve activity
100365|NCT02939469|Skin Sympathetic Nerve Activity|skin sympathetic nerve activity
100366|NCT02939456|prostate|prostate
100367|NCT02939456|cancer|cancer
100368|NCT02939456|MRI|mri
100369|NCT02939417|Laminate veneers|laminate veneers
100370|NCT02939417|Grape seed extract|grape seed extract
100371|NCT02939417|Emax|emax
100372|NCT02939417|collagen cross-linking agent|collagen cross-linking agent
100373|NCT02939404|Energy Intake|energy intake
100374|NCT02939404|Energy Expenditure|energy expenditure
100375|NCT02939404|Eating Behavior|eating behavior
100376|NCT02939404|Cold Exposure|cold exposure
100377|NCT02939378|ketogenic diet|ketogenic diet
100378|NCT02939378|recurrent glioblastoma|recurrent glioblastoma
100379|NCT02939378|chemotherapy|chemotherapy
100380|NCT02939352|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
100381|NCT02939352|Magnetic Resonance Imaging|magnetic resonance imaging
100382|NCT02939352|MRI, Functional|mri, functional
100383|NCT02939339|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
100384|NCT02939313|alcohol|alcohol
100385|NCT02939313|addiction|addiction
100386|NCT02939313|cTBS|ctbs
100387|NCT02939300|Melanoma|melanoma
100388|NCT02939300|Leptomeningeal Metastases|leptomeningeal metastases
100389|NCT02939287|autologous|autologous
100390|NCT02939287|myeloma|myeloma
100391|NCT02939287|transplant|transplant
100392|NCT02939209|Rotator cuff repair|rotator cuff repair
100393|NCT02939209|Interscalene block|interscalene block
100394|NCT02939209|Hydromorphone|hydromorphone
100395|NCT02939209|Pain|pain
100396|NCT02939209|Rebound pain|rebound pain
100397|NCT02939183|Multiple Myeloma|multiple myeloma
100398|NCT02939157|Diagnostic Ultrasound|diagnostic ultrasound
100399|NCT02939157|Primary Care|primary care
100400|NCT02939131|Cognitive Behavioral Therapy|cognitive behavioral therapy
100401|NCT02939131|Medication Management|medication management
100402|NCT02939092|Gingival Bleeding on probing|gingival bleeding on probing
100403|NCT02939079|Multiple Sclerosis|multiple sclerosis
100404|NCT02939079|Fingolimod|fingolimod
100405|NCT02939079|Fish Oil|fish oil
100406|NCT02939053|Bioimpedance spectroscopy|bioimpedance spectroscopy
100407|NCT02939040|positive activities intervention|positive activities intervention
100408|NCT02939040|peri-operative|peri-operative
100409|NCT02939014|Drug therapy|drug therapy
100410|NCT02938988|Periodontal Diseases|periodontal diseases
100411|NCT02938988|Down Syndrome|down syndrome
100412|NCT02938975|malaria|malaria
100413|NCT02938975|personal protection|personal protection
100414|NCT02938975|permethrin treated clothing|permethrin treated clothing
100415|NCT02938975|insect repellents|insect repellents
100416|NCT02938975|army personnel|army personnel
100417|NCT02938975|cluster randomised trial|cluster randomised trial
100418|NCT02938949|Myocardial Infarction|myocardial infarction
100419|NCT02938949|Low Density Lipoprotein Cholesterol|low density lipoprotein cholesterol
100420|NCT02938949|proprotein convertase subtilisin kexin 9, human|proprotein convertase subtilisin kexin 9, human
100421|NCT02938949|alirocumab|alirocumab
100422|NCT02938910|Primary hyperaldosteronism|primary hyperaldosteronism
100423|NCT02938910|Secondary hyperaldosteronism|secondary hyperaldosteronism
100424|NCT02938910|Cardiac fibrosis|cardiac fibrosis
100425|NCT02938910|magnetic resonance imaging|magnetic resonance imaging
100426|NCT02938897|Telehealth|telehealth
100427|NCT02938897|Weight loss|weight loss
100428|NCT02938897|Diet quality|diet quality
100429|NCT02938897|Behavioral counseling|behavioral counseling
100430|NCT02938871|synbiotic|synbiotic
100431|NCT02938871|infections|infections
100432|NCT02938871|probiotics|probiotics
100433|NCT02938871|liver transplantation|liver transplantation
100434|NCT02938832|cardiovascular disease, diet, diabetes|cardiovascular disease, diet, diabetes
100435|NCT02938819|upper limbs|upper limbs
100436|NCT02938819|physiotherapy|physiotherapy
100437|NCT02938793|cancer, malignancy|cancer, malignancy
100438|NCT02938780|Behavioral economics|behavioral economics
100439|NCT02938780|Breast cancer survivors|breast cancer survivors
100440|NCT02938780|nutrition|nutrition
100441|NCT02938780|physical activity|physical activity
100442|NCT02938767|peritoneal dialysis|peritoneal dialysis
100443|NCT02938767|carotid intima-media thickness|carotid intima-media thickness
100444|NCT02938767|coronary flow reserve|coronary flow reserve
100445|NCT02938767|cardiovascular mortality|cardiovascular mortality
100446|NCT02938754|Hemiparesis|hemiparesis
100447|NCT02938754|Functional independence|functional independence
100448|NCT02938754|Virtual Rehabilitation|virtual rehabilitation
100449|NCT02938741|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
100450|NCT02938741|lymphoblastic lymphoma|lymphoblastic lymphoma
100451|NCT02938741|stem-cell transplant|stem-cell transplant
100452|NCT02938741|T-cell lymphoma|t-cell lymphoma
100453|NCT02938741|ATG|atg
100454|NCT02938728|AntiPD1|antipd1
100455|NCT02938702|Active surveillance|active surveillance
100456|NCT02938650|nitrolipid|nitrolipid
100457|NCT02938650|microbiome|microbiome
100458|NCT02938650|inflammation|inflammation
100459|NCT02938650|cytokine|cytokine
100460|NCT02938598|maternal depression|maternal depression
100461|NCT02938598|pediatric-based maternal depression screening|pediatric-based maternal depression screening
100462|NCT02938598|maternal health services|maternal health services
100463|NCT02938546|Non-small-cell lung cancer|non-small-cell lung cancer
100464|NCT02938546|18F-FDG PET/CT|18f-fdg pet/ct
100465|NCT02938546|treatment response assessment|treatment response assessment
100466|NCT02938520|Antiretroviral agent|antiretroviral agent
100467|NCT02938520|Maintenance|maintenance
100468|NCT02938520|rilpivirine|rilpivirine
100469|NCT02938520|dolutegravir|dolutegravir
100470|NCT02938520|TMC278|tmc278
100471|NCT02938520|Triumeq|triumeq
100472|NCT02938520|non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
100473|NCT02938520|once monthly, every 4 weeks, once daily|once monthly, every 4 weeks, once daily
100474|NCT02938520|GSK1265744|gsk1265744
100475|NCT02938520|CAB|cab
100476|NCT02938520|Tivicay|tivicay
100477|NCT02938520|Long-Acting Intramuscular rilpivirine|long-acting intramuscular rilpivirine
100478|NCT02938520|lamivudine|lamivudine
100479|NCT02938520|integrase inhibitor|integrase inhibitor
100480|NCT02938520|Long-Acting Intramuscular Cabotegravir|long-acting intramuscular cabotegravir
100481|NCT02938520|ART naïve|art naïve
100482|NCT02938520|cabotegravir|cabotegravir
100483|NCT02938520|abacavir|abacavir
100484|NCT02938507|Overactive bladder, Incontinence|overactive bladder, incontinence
100485|NCT02938481|colon cancer, lymph node, extent of bowel resection|colon cancer, lymph node, extent of bowel resection
100486|NCT02938455|Hyperalgesia|hyperalgesia
100487|NCT02938455|Opioids|opioids
100488|NCT02938455|Postoperative pain|postoperative pain
100489|NCT02938455|DNA methylation|dna methylation
100490|NCT02938429|congenital|congenital
100491|NCT02938390|Nipple Sparing Mastectomy|nipple sparing mastectomy
100492|NCT02938390|Ultrasound|ultrasound
100493|NCT02938351|Collaborative care intervention|collaborative care intervention
100494|NCT02938351|kidney transplant|kidney transplant
100495|NCT02938325|Electroencephalogram|electroencephalogram
100496|NCT02938325|awareness|awareness
100497|NCT02938286|Fractional laser|fractional laser
100498|NCT02938286|Topical anesthesia|topical anesthesia
100499|NCT02938286|Drug delivery|drug delivery
100500|NCT02938286|CO2 laser|co2 laser
100501|NCT02938286|Er:YAG laser|er:yag laser
100502|NCT02938247|Malnutrition|malnutrition
100503|NCT02938247|Geriatric subjects|geriatric subjects
100504|NCT02938247|Nursing home|nursing home
100505|NCT02938234|Malnutrition|malnutrition
100506|NCT02938234|Geriatric subjects|geriatric subjects
100507|NCT02938234|Nursing home|nursing home
100508|NCT02938221|TeleStroke|telestroke
100509|NCT02938221|HINTS|hints
100510|NCT02938221|Diagnosis|diagnosis
100511|NCT02938221|Telemedicine|telemedicine
100512|NCT02938221|Acute Vestibular Syndrome|acute vestibular syndrome
100513|NCT02938169|low back pain|low back pain
100514|NCT02938169|surface EMG|surface emg
100515|NCT02938169|exercise|exercise
100516|NCT02938156|Hemophilia|hemophilia
100517|NCT02938143|Jumpers knee|jumpers knee
100518|NCT02938143|Patellar Tendinopathy|patellar tendinopathy
100519|NCT02938143|Jumping Athletes|jumping athletes
100520|NCT02938143|UTE MRI|ute mri
100521|NCT02938143|Exercise Therapy|exercise therapy
100522|NCT02938143|NBA|nba
100523|NCT02938117|obesity|obesity
100524|NCT02938117|eccentric exercise|eccentric exercise
100525|NCT02938117|body composition|body composition
100526|NCT02938117|training program|training program
100527|NCT02938091|Hispanics|hispanics
100528|NCT02938091|Single nucleotide polymorphism|single nucleotide polymorphism
100529|NCT02938091|Hepatic lipase|hepatic lipase
100530|NCT02938052|Heart Failure|heart failure
100531|NCT02938052|Positive Psychology|positive psychology
100532|NCT02938052|Adherence to Health Behaviors|adherence to health behaviors
100533|NCT02938039|laryngeal airways|laryngeal airways
100534|NCT02938039|infants|infants
100535|NCT02938039|neonates|neonates
100536|NCT02938039|children|children
100537|NCT02938039|anesthetized|anesthetized
100538|NCT02938000|aerobic training|aerobic training
100539|NCT02938000|stroke|stroke
100540|NCT02938000|exercise|exercise
100541|NCT02938000|stroke recovery|stroke recovery
100542|NCT02937974|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
100543|NCT02937974|Xuebijing|xuebijing
100544|NCT02937948|Locally advanced|locally advanced
100545|NCT02937922|Exercise|exercise
100546|NCT02937922|Endothelium|endothelium
100547|NCT02937922|Hypertension|hypertension
100548|NCT02937922|Endothelial progenitor cell|endothelial progenitor cell
100549|NCT02937922|Endothelial microparticle|endothelial microparticle
100550|NCT02937909|woundcare community nursing competence|woundcare community nursing competence
100551|NCT02937883|Daily Activities|daily activities
100552|NCT02937818|Platinum Refractory Extensive-Stage Carcinoma, Small Cell Lung|platinum refractory extensive-stage carcinoma, small cell lung
100553|NCT02937818|Platinum Refractory Extensive-Stage Oat Cell Carcinoma of Lung|platinum refractory extensive-stage oat cell carcinoma of lung
100554|NCT02937818|Platinum Refractory Extensive-Stage Oat Cell Lung Cancer|platinum refractory extensive-stage oat cell lung cancer
100555|NCT02937818|Platinum Refractory Extensive-Stage Small Cell Cancer Of The Lung|platinum refractory extensive-stage small cell cancer of the lung
100556|NCT02937818|Platinum Refractory Extensive-Stage Small Cell Lung Cancer|platinum refractory extensive-stage small cell lung cancer
100557|NCT02937740|Hypogonadism|hypogonadism
100558|NCT02937714|Teachers|teachers
100559|NCT02937714|mental health literacy|mental health literacy
100560|NCT02937714|school mental health promotion|school mental health promotion
100561|NCT02937688|Parkinson's disease|parkinson's disease
100562|NCT02937688|Deep Brain Stimulation|deep brain stimulation
100563|NCT02937675|small molecule inhibitor of protein translation|small molecule inhibitor of protein translation
100564|NCT02937675|immunomodulator|immunomodulator
100565|NCT02937675|phase 1 dose escalation|phase 1 dose escalation
100566|NCT02937649|Obesity|obesity
100567|NCT02937649|Bariatric surgery|bariatric surgery
100568|NCT02937649|Sleeve gastrectomy|sleeve gastrectomy
100569|NCT02937649|Staple-line Leak|staple-line leak
100570|NCT02937649|Bougie|bougie
100571|NCT02937649|Calibration|calibration
100572|NCT02937597|proficiency based progression|proficiency based progression
100573|NCT02937597|feedback|feedback
100574|NCT02937597|computer based assessment|computer based assessment
100575|NCT02937597|non technical skills|non technical skills
100576|NCT02937597|deteriorating patient|deteriorating patient
100577|NCT02937597|ISBAR|isbar
100578|NCT02937571|Carfilzomib|carfilzomib
100579|NCT02937571|Lenalidomide|lenalidomide
100580|NCT02937571|Dexamethasone|dexamethasone
100581|NCT02937571|15-326|15-326
100582|NCT02937558|hypoglycemia|hypoglycemia
100583|NCT02937532|Fear of falling|fear of falling
100584|NCT02937532|Fear avoidance behavior|fear avoidance behavior
100585|NCT02937532|cognitive behavioral therapy|cognitive behavioral therapy
100586|NCT02937532|Rehabilitation|rehabilitation
100587|NCT02937519|Chronomodulated Chemotherapy|chronomodulated chemotherapy
100588|NCT02937519|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
100589|NCT02937519|Advanced Nasopharyngeal Cancer|advanced nasopharyngeal cancer
100590|NCT02937506|propofol|propofol
100591|NCT02937506|colonoscopy|colonoscopy
100592|NCT02937506|patient satisfaction|patient satisfaction
100593|NCT02937480|stroke|stroke
100594|NCT02937480|physical activity|physical activity
100595|NCT02937480|task performance|task performance
100596|NCT02937480|clinical protocol|clinical protocol
100597|NCT02937467|SWE|swe
100598|NCT02937467|diagnosis|diagnosis
100599|NCT02937454|Acute Heart Failure|acute heart failure
100600|NCT02937454|Iron Deficiency|iron deficiency
100601|NCT02937441|C10.228.140.187|c10.228.140.187
100602|NCT02937428|vaccination|vaccination
100603|NCT02937428|pain|pain
100604|NCT02937428|fear|fear
100605|NCT02937428|psychological intervention|psychological intervention
100606|NCT02937415|carbon monoxide|carbon monoxide
100607|NCT02937415|oxidative stress|oxidative stress
100608|NCT02937415|waterpipe smoking|waterpipe smoking
100609|NCT02937415|cigarette smoking|cigarette smoking
100610|NCT02937415|pulmonary function test|pulmonary function test
100611|NCT02937350|chronic kidney disease|chronic kidney disease
100612|NCT02937350|vitamin d catabolism|vitamin d catabolism
100613|NCT02937311|Taping, stroke|taping, stroke
100614|NCT02937311|rehabilitation|rehabilitation
100615|NCT02937311|shoulder pain|shoulder pain
100616|NCT02937311|electrical stimulation|electrical stimulation
100617|NCT02937298|Diet Induced Thermogenesis|diet induced thermogenesis
100618|NCT02937298|Obesity|obesity
100619|NCT02937298|Energy balance|energy balance
100620|NCT02937298|Energy expenditure|energy expenditure
100621|NCT02937298|berries|berries
100622|NCT02937298|Sea Buckthorn|sea buckthorn
100623|NCT02937298|Wild garlic|wild garlic
100624|NCT02937272|TGF Beta|tgf beta
100625|NCT02937233|Zika|zika
100626|NCT02937233|Vaccine|vaccine
100627|NCT02937233|ZPIV|zpiv
100628|NCT02937207|Bronchial Asthma|bronchial asthma
100629|NCT02937207|Traditional Chinese Medicine|traditional chinese medicine
100630|NCT02937194|Early childhood caries (ECC)|early childhood caries (ecc)
100631|NCT02937194|Oral health promotion|oral health promotion
100632|NCT02937194|Randomized controlled trial|randomized controlled trial
100633|NCT02937142|Behavior Therapy|behavior therapy
100634|NCT02937142|Cognitive Therapy|cognitive therapy
100635|NCT02937142|Adolescents|adolescents
100636|NCT02937142|Psychotherapy, Group|psychotherapy, group
100637|NCT02937129|Infrared tympanic thermometer|infrared tympanic thermometer
100638|NCT02937129|Axillary thermometer|axillary thermometer
100639|NCT02937129|Mercury glass thermometer|mercury glass thermometer
100640|NCT02937129|Adult emergency department|adult emergency department
100641|NCT02937103|Leukemia|leukemia
100642|NCT02937103|Myeloid|myeloid
100643|NCT02937103|CD123|cd123
100644|NCT02937103|CAR-T|car-t
100645|NCT02937090|Polycystic Ovary Syndrome|polycystic ovary syndrome
100646|NCT02937090|Intestinal Microbiota|intestinal microbiota
100647|NCT02937077|etiology|etiology
100648|NCT02937038|Urine Biomarkers|urine biomarkers
100649|NCT02937038|Child Nutrition|child nutrition
100650|NCT02937038|Hydration|hydration
100651|NCT02937038|Parent Nutrition Habits|parent nutrition habits
100652|NCT02937025|Nonvalvular atrial fibrillation|nonvalvular atrial fibrillation
100653|NCT02937025|Stroke|stroke
100654|NCT02937025|Left Atrial Appendage Closure|left atrial appendage closure
100655|NCT02937025|Intervention|intervention
100656|NCT02937012|Primary Biliary Cirrhosis|primary biliary cirrhosis
100657|NCT02937012|Primary Biliary Cholangitis|primary biliary cholangitis
100658|NCT02937012|Bezafibrate|bezafibrate
100659|NCT02937012|Ursodeoxycholic acid|ursodeoxycholic acid
100660|NCT02936973|simple obesity|simple obesity
100661|NCT02936973|catgut implantation|catgut implantation
100662|NCT02936934|Adverse Drug Reaction|adverse drug reaction
100663|NCT02936934|Morphine|morphine
100664|NCT02936934|Oxycodone|oxycodone
100665|NCT02936934|Abdominal hysterectomy|abdominal hysterectomy
100666|NCT02936921|Toxoplasma gondii|toxoplasma gondii
100667|NCT02936921|Toxoplasmosis|toxoplasmosis
100668|NCT02936921|congenital|congenital
100669|NCT02936921|prenatal|prenatal
100670|NCT02936921|screening|screening
100671|NCT02936921|treatment|treatment
100672|NCT02936921|diagnosis|diagnosis
100673|NCT02936908|Neuromuscular Diseases|neuromuscular diseases
100674|NCT02936908|Muscular dystrophy|muscular dystrophy
100675|NCT02936908|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
100676|NCT02936908|Acute respiratory failure|acute respiratory failure
100677|NCT02936908|respiratory care|respiratory care
100678|NCT02936908|mechanical ventilation|mechanical ventilation
100679|NCT02936908|weaning|weaning
100680|NCT02936908|Intensive Care Unit|intensive care unit
100681|NCT02936908|Critical Care|critical care
100682|NCT02936908|Survival|survival
100683|NCT02936882|ultrasonography|ultrasonography
100684|NCT02936882|aspiration|aspiration
100685|NCT02936882|emergency|emergency
100686|NCT02936882|children|children
100687|NCT02936882|antrum|antrum
100688|NCT02936843|Pain|pain
100689|NCT02936843|Inflammation|inflammation
100690|NCT02936843|Diabetes Mellitus|diabetes mellitus
100691|NCT02936843|Adult|adult
100692|NCT02936843|Neuropathy|neuropathy
100693|NCT02936817|HRCT|hrct
100694|NCT02936817|High Resolution Computed Tomography scans|high resolution computed tomography scans
100695|NCT02936817|Functional Respiratory Imaging|functional respiratory imaging
100696|NCT02936817|CT scan|ct scan
100697|NCT02936817|Computed Tomography|computed tomography
100698|NCT02936817|COPD|copd
100699|NCT02936817|sputum producing COPD patients|sputum producing copd patients
100700|NCT02936817|Aerobika® device|aerobika® device
100701|NCT02936804|early stage lung cancer|early stage lung cancer
100702|NCT02936804|LDCT screening|ldct screening
100703|NCT02936804|lung resection|lung resection
100704|NCT02936804|electromagnetic navigation bronchoscopy|electromagnetic navigation bronchoscopy
100705|NCT02936804|peripheral biomarker|peripheral biomarker
100706|NCT02936791|autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
100707|NCT02936791|ADPKD|adpkd
100708|NCT02936791|PKD biomarkers|pkd biomarkers
100709|NCT02936791|Kidney Institute|kidney institute
100710|NCT02936791|University of Kansas Medical Center|university of kansas medical center
100711|NCT02936778|Short-term medical and psychosocial functioning|short-term medical and psychosocial functioning
100712|NCT02936713|flatulence|flatulence
100713|NCT02936713|gas|gas
100715|NCT02936713|fermented milk|fermented milk
100716|NCT02936713|diet|diet
100717|NCT02936713|functional gastrointestinal disorders|functional gastrointestinal disorders
100718|NCT02936700|Psychiatry|psychiatry
100719|NCT02936700|Suicide|suicide
100720|NCT02936700|Randomized controlled trial|randomized controlled trial
100721|NCT02936700|ACT|act
100722|NCT02936700|fMRI|fmri
100723|NCT02936687|blood flow|blood flow
100724|NCT02936687|magnetic resonance imaging|magnetic resonance imaging
100725|NCT02936687|insulin|insulin
100726|NCT02936687|vasodilation|vasodilation
100727|NCT02936661|postpartum hemorrhage， cesarean section， tranexamic acid|postpartum hemorrhage， cesarean section， tranexamic acid
100728|NCT02936648|Hepatitis C|hepatitis c
100729|NCT02936635|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
100730|NCT02936635|ALS|als
100731|NCT02936635|tirasemtiv|tirasemtiv
100732|NCT02936609|healthcare access|healthcare access
100733|NCT02936609|healthcare utilization|healthcare utilization
100734|NCT02936609|preventive services|preventive services
100735|NCT02936609|cancer survivors|cancer survivors
100736|NCT02936531|evoked response potential|evoked response potential
100737|NCT02936531|ERP|erp
100738|NCT02936531|Brain Network Activation|brain network activation
100739|NCT02936531|BNA|bna
100740|NCT02936531|Biomarker|biomarker
100741|NCT02936518|ankyloglossia|ankyloglossia
100742|NCT02936518|breastfeeding|breastfeeding
100743|NCT02936518|lip tie|lip tie
100744|NCT02936505|chronic lung allograft dysfunction|chronic lung allograft dysfunction
100745|NCT02936505|cyclosporin|cyclosporin
100746|NCT02936505|tacrolimus|tacrolimus
100747|NCT02936505|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
100748|NCT02936505|Restrictive Allograft Syndrome|restrictive allograft syndrome
100749|NCT02936505|CLAD|clad
100750|NCT02936492|Phase I|phase i
100751|NCT02936492|Healthy volunteers|healthy volunteers
100752|NCT02936466|Psychiatry|psychiatry
100753|NCT02936466|Randomized controlled trial|randomized controlled trial
100754|NCT02936466|Bipolar disorder|bipolar disorder
100755|NCT02936466|Serious game|serious game
100756|NCT02936466|Compliance|compliance
100757|NCT02936466|Psychoeducation|psychoeducation
100758|NCT02936453|Spinal Cord Injury|spinal cord injury
100759|NCT02936453|Epidural Electrical Stimulation|epidural electrical stimulation
100760|NCT02936453|Robot-assisted|robot-assisted
100761|NCT02936440|acute kidney injury|acute kidney injury
100762|NCT02936440|intensive care unit|intensive care unit
100763|NCT02936440|bioelectrical impedance analysis|bioelectrical impedance analysis
100764|NCT02936414|Berberine|berberine
100765|NCT02936414|Cytokine|cytokine
100766|NCT02936414|CRP|crp
100767|NCT02936414|Metabolism|metabolism
100768|NCT02936414|Schizophrenia|schizophrenia
100769|NCT02936388|uveal melanoma|uveal melanoma
100770|NCT02936388|liver metastasis|liver metastasis
100771|NCT02936388|chemoembolisation|chemoembolisation
100772|NCT02936388|radioembolisation|radioembolisation
100773|NCT02936375|lupus|lupus
100774|NCT02936375|nephritis|nephritis
100775|NCT02936375|iguratimod|iguratimod
100776|NCT02936362|Bread|bread
100777|NCT02936362|Microbiome|microbiome
100778|NCT02936362|Blood tests|blood tests
100779|NCT02936362|Sourdough bread|sourdough bread
100780|NCT02936362|Dietary intervention|dietary intervention
100781|NCT02936349|Hereditary Hemorrhagic Telangiectasia (HHT)|hereditary hemorrhagic telangiectasia (hht)
100782|NCT02936349|Pulmonary Arteriovenous Malformation (PAVM)|pulmonary arteriovenous malformation (pavm)
100783|NCT02936349|Transthoracic Contrast Echocardiogram (TTCE)|transthoracic contrast echocardiogram (ttce)
100784|NCT02936323|SCLC small cell lung cancer|sclc small cell lung cancer
100785|NCT02936323|pancreatic neuroendocrine NET|pancreatic neuroendocrine net
100786|NCT02936323|GI neuroendocrine NET|gi neuroendocrine net
100787|NCT02936310|stress|stress
100788|NCT02936310|mindfulness|mindfulness
100789|NCT02936310|Mindful Living With Stress Intervention|mindful living with stress intervention
100790|NCT02936310|nurse|nurse
100791|NCT02936310|HIV/AIDS|hiv/aids
100792|NCT02936271|Radiofrequency Ablation|radiofrequency ablation
100793|NCT02936271|Sclerotherapy|sclerotherapy
100794|NCT02936271|Vasculera|vasculera
100795|NCT02936219|complementary feeding|complementary feeding
100796|NCT02936219|breast milk|breast milk
100797|NCT02936219|formula feeding|formula feeding
100798|NCT02936219|combined feeding|combined feeding
100799|NCT02936219|preterm infants|preterm infants
100800|NCT02936219|body composition|body composition
100801|NCT02936206|proliferation Index|proliferation index
100802|NCT02936206|Tamoxifen|tamoxifen
100803|NCT02936206|Fulvestrant|fulvestrant
100804|NCT02936206|cyclinD1|cyclind1
100805|NCT02936206|Breast cancer|breast cancer
100806|NCT02936180|Rheumatoid arthritis|rheumatoid arthritis
100807|NCT02936180|Flu vaccine|flu vaccine
100808|NCT02936180|Influenza|influenza
100809|NCT02936167|Ringer Lactate|ringer lactate
100810|NCT02936167|Plasmalyte|plasmalyte
100811|NCT02936167|Perioperative Period|perioperative period
100812|NCT02936141|homeless, mental disorders, attendance|homeless, mental disorders, attendance
100813|NCT02936102|Phase I|phase i
100814|NCT02936102|FAZ053|faz053
100815|NCT02936102|PDR001|pdr001
100816|NCT02936102|Checkpoint inhibitor|checkpoint inhibitor
100817|NCT02936102|PD-L1|pd-l1
100818|NCT02936102|PD-1|pd-1
100819|NCT02936063|Head and neck surgery|head and neck surgery
100820|NCT02936063|Scar cosmesis|scar cosmesis
100821|NCT02936063|Surgical staples|surgical staples
100822|NCT02936063|Sutures|sutures
100823|NCT02936063|Patient satisfaction|patient satisfaction
100824|NCT02936050|Echocardiography|echocardiography
100825|NCT02936050|Telemedicine|telemedicine
100826|NCT02936050|Nurses|nurses
100827|NCT02936050|Decision support|decision support
100828|NCT02936050|eHealth|ehealth
100829|NCT02936037|progressive multiple sclerosis|progressive multiple sclerosis
100830|NCT02936037|MS|ms
100831|NCT02936037|EDSS|edss
100832|NCT02936037|TW25|tw25
100833|NCT02936037|multiple sclerosis|multiple sclerosis
100834|NCT02935998|schizophrenia|schizophrenia
100835|NCT02935998|agitation|agitation
100836|NCT02935998|ziprasidone|ziprasidone
100837|NCT02935985|spontaneous intracerebral hemorrhage|spontaneous intracerebral hemorrhage
100838|NCT02935985|point-of-care bio-markers|point-of-care bio-markers
100839|NCT02935985|multicenter|multicenter
100840|NCT02935985|Emergency Department|emergency department
100841|NCT02935985|Romania|romania
100842|NCT02935972|prostate biopsy, analgesia, anesthesia, pain, prostate cancer|prostate biopsy, analgesia, anesthesia, pain, prostate cancer
100843|NCT02935946|pharyngeal swallow, NICU, intervention, thickening|pharyngeal swallow, nicu, intervention, thickening
100844|NCT02935920|PRO, follow up|pro, follow up
100845|NCT02935894|oxygenated lipids|oxygenated lipids
100846|NCT02935894|metabolic profiling|metabolic profiling
100847|NCT02935894|sphingoid bases|sphingoid bases
100848|NCT02935894|ceramides|ceramides
100849|NCT02935894|endocannabinoids|endocannabinoids
100850|NCT02935894|non-invasive sampling|non-invasive sampling
100851|NCT02935868|Saliva|saliva
100852|NCT02935855|Diabetic patients|diabetic patients
100853|NCT02935855|nondiabetic patients|nondiabetic patients
100854|NCT02935842|Parkinson's Disease|parkinson's disease
100855|NCT02935842|Word Retrieval|word retrieval
100856|NCT02935842|Apraxia Symptoms|apraxia symptoms
100857|NCT02935842|Dysarthria|dysarthria
100858|NCT02935829|energy intake|energy intake
100859|NCT02935829|blood glucose|blood glucose
100860|NCT02935829|carob flour|carob flour
100861|NCT02935790|unresectable|unresectable
100862|NCT02935790|melanoma|melanoma
100863|NCT02935777|Pomegranate extract|pomegranate extract
100864|NCT02935777|cognitive function|cognitive function
100865|NCT02935777|cognition|cognition
100866|NCT02935777|polyphenols|polyphenols
100867|NCT02935777|memory|memory
100868|NCT02935738|prednisolone|prednisolone
100869|NCT02935738|anti-sperm antibodies|anti-sperm antibodies
100870|NCT02935738|sperm penetration assay|sperm penetration assay
100871|NCT02935712|Safety|safety
100872|NCT02935712|Tolerability|tolerability
100873|NCT02935712|AZD8601|azd8601
100874|NCT02935712|Type II Diabetes|type ii diabetes
100875|NCT02935582|Topical|topical
100876|NCT02935582|Real-world|real-world
100877|NCT02935582|Local standard of care|local standard of care
100878|NCT02935582|Non-interventional|non-interventional
100879|NCT02935582|Calcipotriol|calcipotriol
100880|NCT02935569|Alopecia|alopecia
100881|NCT02935569|Radiotherapy|radiotherapy
100882|NCT02935556|Post Partum Pre-eclampsia|post partum pre-eclampsia
100883|NCT02935517|Color vision deficiency|color vision deficiency
100884|NCT02935517|Color vision defects|color vision defects
100885|NCT02935517|Vision disorders|vision disorders
100886|NCT02935517|Sensation disorders|sensation disorders
100887|NCT02935517|Neurologic manifestations|neurologic manifestations
100888|NCT02935517|Nervous system diseases|nervous system diseases
100889|NCT02935517|Eye diseases|eye diseases
100890|NCT02935517|Signs and symptoms|signs and symptoms
100891|NCT02935504|Depression|depression
100892|NCT02935504|Pregnancy|pregnancy
100893|NCT02935504|Postpartum|postpartum
100894|NCT02935491|TAVI|tavi
100895|NCT02935491|Aortic stenosis|aortic stenosis
100896|NCT02935491|aortic stiffness|aortic stiffness
100897|NCT02935491|calcifications|calcifications
100898|NCT02935491|CT-scan|ct-scan
100899|NCT02935491|Vascular impedance|vascular impedance
100900|NCT02935478|bariatric surgery|bariatric surgery
100901|NCT02935478|minimally invasive|minimally invasive
100902|NCT02935478|Embolization|embolization
100903|NCT02935478|ghrelin|ghrelin
100904|NCT02935478|gastric artery embolization|gastric artery embolization
100905|NCT02935452|Self-management|self-management
100906|NCT02935452|Supportive self-management|supportive self-management
100907|NCT02935452|Normalisation process theory|normalisation process theory
100908|NCT02935452|Social networks|social networks
100909|NCT02935439|Mobile Phone|mobile phone
100910|NCT02935439|Self-efficacy|self-efficacy
100911|NCT02935439|Quality of Life|quality of life
100912|NCT02935439|Knowledge|knowledge
100913|NCT02935439|Feasibility|feasibility
100914|NCT02935426|cyanoacrylate|cyanoacrylate
100915|NCT02935426|sutures|sutures
100916|NCT02935400|porphyria|porphyria
100917|NCT02935400|biomarkers|biomarkers
101429|NCT02932202|Obesity|obesity
100918|NCT02935387|Very early rheumatoid arthritis|very early rheumatoid arthritis
100919|NCT02935374|children|children
100920|NCT02935374|intestinal microbiome|intestinal microbiome
100921|NCT02935374|microbiota|microbiota
100922|NCT02935374|antimicrobial course|antimicrobial course
100923|NCT02935374|amoxicillin|amoxicillin
100924|NCT02935374|amoxicillin-clavulanate|amoxicillin-clavulanate
100925|NCT02935374|macrolide|macrolide
100926|NCT02935322|Prevention|prevention
100927|NCT02935309|rectum|rectum
100928|NCT02935309|transrectal|transrectal
100929|NCT02935309|carcinoma|carcinoma
100931|NCT02935270|Neglect|neglect
100932|NCT02935270|Rehabilitation|rehabilitation
100933|NCT02935244|Epidemiology|epidemiology
100934|NCT02935231|minimal cessation advice|minimal cessation advice
100935|NCT02935231|proactive|proactive
100936|NCT02935231|nicotine replacement therapy|nicotine replacement therapy
100937|NCT02935231|smoking hotspots|smoking hotspots
100938|NCT02935192|seasonal influenza|seasonal influenza
100939|NCT02935192|vaccine|vaccine
100940|NCT02935153|CD22|cd22
100941|NCT02935153|CAR-T|car-t
100942|NCT02935153|Leukemia|leukemia
100943|NCT02935153|Lymphoma|lymphoma
100944|NCT02935127|absorbable sutures|absorbable sutures
100945|NCT02935114|Tooth Bleaching|tooth bleaching
100946|NCT02935114|Tooth Bleaching Agents|tooth bleaching agents
100947|NCT02935114|Tooth Whitening|tooth whitening
100948|NCT02935114|Hydrogen Peroxide|hydrogen peroxide
100949|NCT02935114|Carbamide Peroxide|carbamide peroxide
100950|NCT02935101|glucocorticoids|glucocorticoids
100951|NCT02935101|craving|craving
100952|NCT02935101|Heroin|heroin
100953|NCT02935101|Cocaine|cocaine
100954|NCT02935101|dependency|dependency
100955|NCT02935088|FFR|ffr
100956|NCT02935088|Percutaneous coronary intervention|percutaneous coronary intervention
100957|NCT02935062|Speech|speech
100958|NCT02935062|Speech Therapy|speech therapy
100959|NCT02935062|Speech Sound Disorders|speech sound disorders
100960|NCT02935062|Phonological Disorders|phonological disorders
100961|NCT02935062|Auditory Perception|auditory perception
100962|NCT02935010|Helicobacter pylori|helicobacter pylori
100963|NCT02935010|Bismuth quadruple therapy|bismuth quadruple therapy
100964|NCT02935010|Tailored therapy|tailored therapy
100965|NCT02935010|Empiric therapy|empiric therapy
100966|NCT02935010|clarithromycin susceptibility|clarithromycin susceptibility
100967|NCT02934997|sepsis|sepsis
100968|NCT02934997|septic shock|septic shock
100969|NCT02934997|cholesterol|cholesterol
100970|NCT02934997|high density lipoprotein|high density lipoprotein
100971|NCT02934984|Pancreatic Cancer|pancreatic cancer
100972|NCT02934984|recurrence|recurrence
100973|NCT02934984|DNA|dna
100974|NCT02934958|Colon Cancer Screening|colon cancer screening
100975|NCT02934945|Budesonide/formoterol|budesonide/formoterol
100976|NCT02934945|Typical asthma|typical asthma
100977|NCT02934945|Cough variant asthma|cough variant asthma
100978|NCT02934919|Nalmefene|nalmefene
100979|NCT02934919|Impulse control disorders|impulse control disorders
100980|NCT02934919|Parkinson's disease|parkinson's disease
100981|NCT02934919|Tolerance|tolerance
100982|NCT02934919|Efficacy|efficacy
100983|NCT02934906|Neonatal Alloimmune Thrombocytopenia|neonatal alloimmune thrombocytopenia
100984|NCT02934906|pregnancy|pregnancy
100985|NCT02934906|human platelet allogantigen|human platelet allogantigen
100986|NCT02934906|asian|asian
100987|NCT02934906|Chinese|chinese
100988|NCT02934880|adapted physical activity, cognitive functions|adapted physical activity, cognitive functions
100989|NCT02934854|GAMT deficiency|gamt deficiency
100990|NCT02934854|GAMT and AGAT deficiencies|gamt and agat deficiencies
100991|NCT02934854|Creatine Transporter Deficiency|creatine transporter deficiency
100992|NCT02934854|Brain Creatine Transporter Deficiency|brain creatine transporter deficiency
100993|NCT02934815|psychological intervention|psychological intervention
100994|NCT02934815|breast cancer|breast cancer
100995|NCT02934815|supportive-expressive group therapy|supportive-expressive group therapy
100996|NCT02934815|emotion regulation|emotion regulation
100997|NCT02934815|social support|social support
100998|NCT02934815|attachment|attachment
100999|NCT02934815|quality of life|quality of life
101000|NCT02934789|submucosal fibroids|submucosal fibroids
101001|NCT02934789|heavy menstrual bleeding|heavy menstrual bleeding
101002|NCT02934789|quality of life|quality of life
101003|NCT02934776|DTI|dti
101004|NCT02934776|prostate cancer|prostate cancer
101005|NCT02934776|MRI|mri
101006|NCT02934750|pursed lip breathing|pursed lip breathing
101007|NCT02934750|interstitial lund disease|interstitial lund disease
101008|NCT02934750|exercise physiology|exercise physiology
101009|NCT02934737|Obesity|obesity
101010|NCT02934737|Diabetes Mellitus|diabetes mellitus
101011|NCT02934724|HPV vaccines|hpv vaccines
101012|NCT02934724|HPV-6|hpv-6
101013|NCT02934724|HPV-11|hpv-11
101014|NCT02934724|HPV-16|hpv-16
101015|NCT02934724|HPV-18|hpv-18
101016|NCT02934724|Gardasil|gardasil
101017|NCT02934711|Multimorbidity|multimorbidity
101018|NCT02934711|Exercise coordinated groups (GECO)|exercise coordinated groups (geco)
101019|NCT02934711|Caregivers|caregivers
101020|NCT02934685|Prostatic Neoplasms|prostatic neoplasms
101021|NCT02934685|radiotherapy|radiotherapy
101022|NCT02934646|Robotics|robotics
101023|NCT02934646|Upper Extremity|upper extremity
101024|NCT02934633|injury|injury
101025|NCT02934633|child|child
101026|NCT02934633|cars|cars
101027|NCT02934633|pedestrians|pedestrians
101028|NCT02934633|child safety|child safety
101029|NCT02934633|interactive|interactive
101030|NCT02934633|computer|computer
101031|NCT02934633|prevention|prevention
101032|NCT02934633|internet|internet
101033|NCT02934633|CD-ROM|cd-rom
101034|NCT02934620|pregnancy|pregnancy
101035|NCT02934620|condom|condom
101036|NCT02934620|HIV|hiv
101037|NCT02934620|sexually transmitted infections|sexually transmitted infections
101038|NCT02934607|Asthma|asthma
101039|NCT02934607|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
101040|NCT02934607|Spacer device|spacer device
101041|NCT02934607|Symbicort|symbicort
101042|NCT02934607|Pressurized metered-dose inhaler|pressurized metered-dose inhaler
101043|NCT02934607|Relative bioavailability|relative bioavailability
101044|NCT02934607|Crossover|crossover
101045|NCT02934607|AstraZeneca|astrazeneca
101046|NCT02934607|Safety|safety
101047|NCT02934607|Activated charcoal|activated charcoal
101048|NCT02934607|AeroChamber Plus Flow-Vu spacer device|aerochamber plus flow-vu spacer device
101049|NCT02934568|Ribociclib|ribociclib
101050|NCT02934568|LEE011|lee011
101051|NCT02934542|Laparoscope holder|laparoscope holder
101052|NCT02934542|Colon resection|colon resection
101053|NCT02934542|Right hemicolectomy|right hemicolectomy
101054|NCT02934542|Left hemicolectomy|left hemicolectomy
101055|NCT02934542|Sigmoid resection|sigmoid resection
101056|NCT02934542|Anti-reflux|anti-reflux
101057|NCT02934542|Hiatal hernia|hiatal hernia
101058|NCT02934516|Obstructed labor|obstructed labor
101059|NCT02934516|C section. push method|c section. push method
101060|NCT02934516|reverse breech|reverse breech
101061|NCT02934503|Chemotherapy|chemotherapy
101062|NCT02934503|PD-L1|pd-l1
101063|NCT02934503|Thoracic radiotherapy|thoracic radiotherapy
101064|NCT02934503|PD-1|pd-1
101065|NCT02934503|MK-3475|mk-3475
101066|NCT02934477|Myelofibrosis|myelofibrosis
101067|NCT02934477|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
101068|NCT02934477|Medicare|medicare
101069|NCT02934438|nitric oxide|nitric oxide
101070|NCT02934438|Neo40 supplement,|neo40 supplement,
101071|NCT02934438|exercise tolerance|exercise tolerance
101072|NCT02934425|Pork|pork
101073|NCT02934425|Refined carbohydrates|refined carbohydrates
101074|NCT02934425|Satiety|satiety
101075|NCT02934425|Glucose|glucose
101076|NCT02934425|Insulin|insulin
101077|NCT02934425|Breakfast|breakfast
101078|NCT02934425|Lipoprotein lipids|lipoprotein lipids
101079|NCT02934399|dynamic hormone diagnostics|dynamic hormone diagnostics
101080|NCT02934399|adrenal insufficiency|adrenal insufficiency
101081|NCT02934399|congenital adrenal hyperplasia|congenital adrenal hyperplasia
101082|NCT02934399|primary hyperaldosteronism|primary hyperaldosteronism
101083|NCT02934399|cushing syndrome|cushing syndrome
101084|NCT02934399|growth hormone deficiency|growth hormone deficiency
101085|NCT02934399|acromegaly|acromegaly
101086|NCT02934360|Lung Cancer|lung cancer
101087|NCT02934360|Breast Cancer|breast cancer
101088|NCT02934360|cell free DNA|cell free dna
101089|NCT02934360|biomarker|biomarker
101090|NCT02934347|Intubation, Back-up position; Glottis, View|intubation, back-up position; glottis, view
101091|NCT02934334|major depression|major depression
101092|NCT02934334|major depressive episode|major depressive episode
101093|NCT02934334|biomarkers|biomarkers
101094|NCT02934334|relapse|relapse
101095|NCT02934334|near term relapse|near term relapse
101096|NCT02934334|m-health|m-health
101097|NCT02934321|Erythritol|erythritol
101098|NCT02934321|Satiety Response|satiety response
101099|NCT02934321|Ghrelin|ghrelin
101100|NCT02934295|Rubeola|rubeola
101101|NCT02934269|Healthy subjects|healthy subjects
101102|NCT02934269|Safety|safety
101103|NCT02934269|CC-90006|cc-90006
101104|NCT02934269|Phase 1|phase 1
101105|NCT02934269|Tolerability|tolerability
101106|NCT02934256|Neurofibromatosis Type 2|neurofibromatosis type 2
101107|NCT02934256|Vestibular Schwannoma|vestibular schwannoma
101108|NCT02934256|Other NF2-related tumors|other nf2-related tumors
101109|NCT02934243|Laryngeal Masks|laryngeal masks
101110|NCT02934243|Ventilation|ventilation
101111|NCT02934243|Risk factors|risk factors
101112|NCT02934204|PCNSL|pcnsl
101113|NCT02934204|DLBCL|dlbcl
101114|NCT02934204|methotrexate|methotrexate
101115|NCT02934204|temozolomide|temozolomide
101116|NCT02934191|Tonsillectomy|tonsillectomy
101117|NCT02934191|Post-operative complications|post-operative complications
101118|NCT02934191|Post-operative pain|post-operative pain
101119|NCT02934178|shigellosis|shigellosis
101120|NCT02934178|Enterobacteriaceae Infections|enterobacteriaceae infections
101121|NCT02934178|Gram-Negative Bacterial Infections|gram-negative bacterial infections
101122|NCT02934178|Bacterial Infections|bacterial infections
101123|NCT02934178|Gastroenteritis|gastroenteritis
101124|NCT02934178|Gastrointestinal Diseases|gastrointestinal diseases
101125|NCT02934178|Digestive System Diseases|digestive system diseases
101126|NCT02934178|Intestinal Diseases|intestinal diseases
101127|NCT02934165|child safety|child safety
101128|NCT02934165|injury|injury
101129|NCT02934165|computer|computer
101130|NCT02934165|prevention|prevention
101131|NCT02934165|internet|internet
101132|NCT02934152|Gastroesophageal reflux disease|gastroesophageal reflux disease
101133|NCT02934152|Helicobacter pylori|helicobacter pylori
101134|NCT02934139|N91115|n91115
101135|NCT02934139|Cavosonstat|cavosonstat
101136|NCT02934139|Healthy Volunteer|healthy volunteer
101137|NCT02934113|weight loss|weight loss
101138|NCT02934113|text messaging|text messaging
101139|NCT02934113|workplace|workplace
101140|NCT02934113|participatory approach|participatory approach
101141|NCT02934113|health care workers|health care workers
101142|NCT02934100|Calcaneal spur|calcaneal spur
101143|NCT02934100|Heel spur|heel spur
101144|NCT02934100|ESWT|eswt
101145|NCT02934100|Extracorporeal shock wave therapy|extracorporeal shock wave therapy
101146|NCT02934100|ultrasound therapy|ultrasound therapy
101147|NCT02934100|electric field diathermy|electric field diathermy
101148|NCT02934100|skanlab 25 bodywave|skanlab 25 bodywave
101149|NCT02934100|sham laser therapy|sham laser therapy
101150|NCT02934087|snare technique|snare technique
101151|NCT02934087|cannulation of contralateral gate|cannulation of contralateral gate
101152|NCT02934087|endovascular|endovascular
101153|NCT02934087|aneurysm|aneurysm
101154|NCT02934087|AAA|aaa
101155|NCT02934087|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
101156|NCT02934074|Limb Loss|limb loss
101157|NCT02934074|Gait Variability|gait variability
101158|NCT02934074|Phantom Sensation|phantom sensation
101159|NCT02934074|Phantom Pain|phantom pain
101160|NCT02934074|Peripheral Sensation|peripheral sensation
101161|NCT02934061|Acute low back pain|acute low back pain
101162|NCT02934022|Maraviroc|maraviroc
101163|NCT02934022|HAART regimen|haart regimen
101164|NCT02934022|Immunologic response|immunologic response
101165|NCT02933996|immunosuppression|immunosuppression
101166|NCT02933996|cardiac sugery|cardiac sugery
101167|NCT02933996|Transcutaneous electrical acupoint stimulation|transcutaneous electrical acupoint stimulation
101168|NCT02933996|postoperative|postoperative
101169|NCT02933957|Vascular Evaluation|vascular evaluation
101170|NCT02933957|influencing factor|influencing factor
101171|NCT02933957|She Minority population|she minority population
101172|NCT02933944|locally recurrent|locally recurrent
101173|NCT02933918|Probiotics|probiotics
101174|NCT02933918|Nasal Irrigation|nasal irrigation
101175|NCT02933918|Healthy Volunteers|healthy volunteers
101176|NCT02933801|metastatic castration resistant prostate cancer (mCRPC)|metastatic castration resistant prostate cancer (mcrpc)
101177|NCT02933801|Prostate Cancer|prostate cancer
101178|NCT02933801|phase II trial|phase ii trial
101179|NCT02933801|ODM-201|odm-201
101180|NCT02933801|maintenance therapy|maintenance therapy
101181|NCT02933788|cardiovascular disease|cardiovascular disease
101182|NCT02933788|atherosclerosis|atherosclerosis
101183|NCT02933723|influenza vaccine|influenza vaccine
101184|NCT02933723|nursing home|nursing home
101185|NCT02933723|influenza|influenza
101186|NCT02933723|vaccination|vaccination
101187|NCT02933723|immunity|immunity
101188|NCT02933723|cell-mediated immunity|cell-mediated immunity
101189|NCT02933723|humoral immunity|humoral immunity
101190|NCT02933710|Japanese encephalitis|japanese encephalitis
101191|NCT02933710|IMOJEV®|imojev®
101192|NCT02933710|Japanese encephalitis chimeric virus vaccine|japanese encephalitis chimeric virus vaccine
101193|NCT02933697|Atrial Fibrillation|atrial fibrillation
101194|NCT02933697|Kidney disease|kidney disease
101195|NCT02933697|Anticoagulation|anticoagulation
101196|NCT02933671|suprainguinal fascia iliaca (SIFI)|suprainguinal fascia iliaca (sifi)
101197|NCT02933671|nerve block|nerve block
101198|NCT02933645|Insulin|insulin
101199|NCT02933645|Intranasal|intranasal
101200|NCT02933645|Glucose/metabolism|glucose/metabolism
101201|NCT02933645|Glucose homeostasis|glucose homeostasis
101202|NCT02933632|Osteoarthritis|osteoarthritis
101203|NCT02933632|Physiotherapy|physiotherapy
101204|NCT02933632|Rehabilitation|rehabilitation
101205|NCT02933632|Clinical Trials|clinical trials
101206|NCT02933632|Accelerated rehabilitation|accelerated rehabilitation
101207|NCT02933632|Hip Replacement Arthroplasty|hip replacement arthroplasty
101208|NCT02933554|bariatric surgery|bariatric surgery
101209|NCT02933554|minimally invasive|minimally invasive
101210|NCT02933554|Embolization|embolization
101211|NCT02933554|NASH|nash
101212|NCT02933554|ghrelin|ghrelin
101213|NCT02933554|gastric artery embolization|gastric artery embolization
101214|NCT02933515|yoga|yoga
101215|NCT02933515|occupational therapy|occupational therapy
101216|NCT02933515|stroke|stroke
101217|NCT02933463|children with high caries risk|children with high caries risk
101218|NCT02933437|Brugada syndrome|brugada syndrome
101219|NCT02933437|SCN5A|scn5a
101220|NCT02933437|SCN10A|scn10a
101221|NCT02933437|Ajmaline|ajmaline
101222|NCT02933411|Bleeding Disorders|bleeding disorders
101223|NCT02933411|Heavy Menstrual Bleeding|heavy menstrual bleeding
101224|NCT02933359|cranial vault|cranial vault
101225|NCT02933359|calvarial trauma|calvarial trauma
101226|NCT02933359|calvarial reconstruction|calvarial reconstruction
101227|NCT02933320|Indolent B-cell Lymphoma|indolent b-cell lymphoma
101228|NCT02933320|Chronic Lymphocytic Leukaemia|chronic lymphocytic leukaemia
101229|NCT02933320|Waldenström Macroglobulinaemia|waldenström macroglobulinaemia
101230|NCT02933320|BI-1206|bi-1206
101231|NCT02933320|CD32b|cd32b
101232|NCT02933294|uniportal|uniportal
101233|NCT02933294|lung cancer|lung cancer
101234|NCT02933294|VATS|vats
101235|NCT02933268|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
101236|NCT02933268|Polycystic Kidney Disease|polycystic kidney disease
101237|NCT02933268|ADPKD|adpkd
101238|NCT02933268|Water|water
101239|NCT02933268|Vasopressin|vasopressin
101240|NCT02933268|Dietary|dietary
101241|NCT02933255|Safety|safety
101242|NCT02933255|Neoadjuvant|neoadjuvant
101243|NCT02933255|Prostatectomy|prostatectomy
101244|NCT02933255|Immunotherapy|immunotherapy
101245|NCT02933255|Vaccine|vaccine
101246|NCT02933242|Cancer|cancer
101247|NCT02933216|Cesarean Scar Diverticula|cesarean scar diverticula
101248|NCT02933177|Dementia|dementia
101249|NCT02933177|Alzheimer disease|alzheimer disease
101250|NCT02933177|Behavioral and Psychological Symptoms of Dementia|behavioral and psychological symptoms of dementia
101251|NCT02933177|non-drug intervention|non-drug intervention
101252|NCT02933138|Lipoprotein Lipase|lipoprotein lipase
101253|NCT02933138|Hypertriglyceridemia|hypertriglyceridemia
101254|NCT02933138|Triglycerides|triglycerides
101255|NCT02933138|Lipolysis|lipolysis
101256|NCT02933138|Multifactorial Chylomicronemia|multifactorial chylomicronemia
101257|NCT02933125|substance abuse|substance abuse
101258|NCT02933125|group psychotherapy|group psychotherapy
101259|NCT02933125|family therapy|family therapy
101260|NCT02933125|longitudinal study|longitudinal study
101261|NCT02933125|child and adolescent|child and adolescent
101262|NCT02933112|Oral appliance therapy|oral appliance therapy
101263|NCT02933086|Pregnant|pregnant
101264|NCT02933086|Low Back Pain|low back pain
101265|NCT02933086|Postural Control|postural control
101266|NCT02933060|intravenous fluid|intravenous fluid
101267|NCT02933060|headache|headache
101268|NCT02933047|Hysterectomy|hysterectomy
101269|NCT02933047|Patient satisfaction|patient satisfaction
101270|NCT02933047|Rehabilitation|rehabilitation
101271|NCT02933047|Laparoscopy|laparoscopy
101272|NCT02933047|Return to work|return to work
101273|NCT02933047|Exercise|exercise
101274|NCT02933034|ISCHEMIC OR CORONARY HEART DISEASE|ischemic or coronary heart disease
101275|NCT02933034|MYOCARDIAL INFARCTION|myocardial infarction
101276|NCT02933034|MAGNETIC RESONANCE IMAGING|magnetic resonance imaging
101277|NCT02933034|DELAYED GADOLINIUM ENHANCEMENT MRI|delayed gadolinium enhancement mri
101278|NCT02933034|MANGANESE-ENHANCED MRI|manganese-enhanced mri
101279|NCT02933034|INFARCT VOLUME/SIZE|infarct volume/size
101280|NCT02933034|ALL CAUSE MORTALITY|all cause mortality
101281|NCT02933034|VENTRICULAR ARRHYTHMIAS|ventricular arrhythmias
101282|NCT02933021|MGUS|mgus
101283|NCT02933008|ACL|acl
101284|NCT02933008|biofeedback|biofeedback
101285|NCT02933008|injury prevention|injury prevention
101286|NCT02933008|virtual reality|virtual reality
101287|NCT02932995|Optical Coherence Tomography|optical coherence tomography
101288|NCT02932995|Drug-Eluting Stent|drug-eluting stent
101289|NCT02932982|primary care|primary care
101290|NCT02932982|chest pain|chest pain
101291|NCT02932982|dyspnea|dyspnea
101292|NCT02932956|GPC3-Positive Solid Tumors|gpc3-positive solid tumors
101293|NCT02932956|GPC3-CAR T cells|gpc3-car t cells
101294|NCT02932956|GPC3|gpc3
101295|NCT02932956|Glypican|glypican
101296|NCT02932930|QLB|qlb
101297|NCT02932930|Abdominoplasty|abdominoplasty
101298|NCT02932930|Quadratus lumborum block|quadratus lumborum block
101299|NCT02932904|Drug therapy|drug therapy
101300|NCT02932865|azoospermia|azoospermia
101301|NCT02932865|male fertility|male fertility
101302|NCT02932865|MD-TESE|md-tese
101303|NCT02932865|miRNA|mirna
101304|NCT02932865|piRNA|pirna
101305|NCT02932865|male infertility|male infertility
101306|NCT02932852|stem cell|stem cell
101307|NCT02932852|mesenchymal|mesenchymal
101308|NCT02932852|ADASc|adasc
101309|NCT02932852|transplantation|transplantation
101310|NCT02932852|cornea|cornea
101311|NCT02932852|corneal defects|corneal defects
101312|NCT02932852|keratoconus|keratoconus
101313|NCT02932852|scaffold|scaffold
101314|NCT02932852|lamina|lamina
101315|NCT02932839|Epilepsy surgery|epilepsy surgery
101316|NCT02932839|Micro-electrode arrays|micro-electrode arrays
101317|NCT02932839|Single-neuron recordings|single-neuron recordings
101318|NCT02932839|Electrocorticography|electrocorticography
101319|NCT02932826|Autoimmune Diabetes|autoimmune diabetes
101320|NCT02932826|Umbilical Cord Blood Cell|umbilical cord blood cell
101321|NCT02932826|Regulatory T Lymphocyte|regulatory t lymphocyte
101322|NCT02932826|Cell Therapy|cell therapy
101323|NCT02932800|Catheters|catheters
101324|NCT02932800|Vascular Access Devices|vascular access devices
101325|NCT02932800|Suture Techniques|suture techniques
101326|NCT02932800|microbiota|microbiota
101327|NCT02932800|Blood Circulation|blood circulation
101328|NCT02932774|SAR|sar
101329|NCT02932774|seasonal allergic rhinitis|seasonal allergic rhinitis
101330|NCT02932774|hay fever|hay fever
101331|NCT02932774|seasonal allergic rhinoconjunctivitis|seasonal allergic rhinoconjunctivitis
101332|NCT02932761|cesarean scar diverticula|cesarean scar diverticula
101333|NCT02932761|vaginal repair|vaginal repair
101334|NCT02932761|GnRHa|gnrha
101335|NCT02932722|Propofol|propofol
101336|NCT02932722|Sevoflurane|sevoflurane
101337|NCT02932722|Preconditioning|preconditioning
101338|NCT02932709|Emergency|emergency
101339|NCT02932709|follow-up|follow-up
101340|NCT02932709|nurse|nurse
101341|NCT02932709|phone|phone
101342|NCT02932709|suicide attempts|suicide attempts
101343|NCT02932683|Resuscitation|resuscitation
101344|NCT02932683|Neonatal|neonatal
101345|NCT02932683|Education|education
101346|NCT02932644|Rheumatoid Arthritis|rheumatoid arthritis
101347|NCT02932644|Cardiovascular event|cardiovascular event
101348|NCT02932644|Cardiovascular mortality|cardiovascular mortality
101349|NCT02932644|Vitamin D|vitamin d
101350|NCT02932631|hemiparesis|hemiparesis
101351|NCT02932631|STROKE|stroke
101352|NCT02932631|neural plasticity|neural plasticity
101353|NCT02932631|PHYSICAL THERAPY|physical therapy
101354|NCT02932605|Schizophrenia|schizophrenia
101355|NCT02932605|Cannabidiol|cannabidiol
101356|NCT02932605|Positron Emission Tomography (PET)|positron emission tomography (pet)
101357|NCT02932605|Microglia|microglia
101358|NCT02932566|Heart failure|heart failure
101359|NCT02932566|Heart failure with preserved ejection fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
101360|NCT02932566|Myocardial fibrosis|myocardial fibrosis
101361|NCT02932566|Extracellular volume fraction (ECV)|extracellular volume fraction (ecv)
101362|NCT02932566|Interstitial fibrosis|interstitial fibrosis
101363|NCT02932553|bioresorbable vascular scaffold|bioresorbable vascular scaffold
101364|NCT02932553|variant angina|variant angina
101365|NCT02932553|moderate coronary artery disease|moderate coronary artery disease
101366|NCT02932553|vasospastic angina|vasospastic angina
101367|NCT02932527|cannabis|cannabis
101368|NCT02932501|Bisphosphonate|bisphosphonate
101369|NCT02932501|Jaw|jaw
101370|NCT02932501|Osteonecrosis|osteonecrosis
101371|NCT02932501|Antiresorptive drugs|antiresorptive drugs
101372|NCT02932501|Denosumab|denosumab
101373|NCT02932488|PET-MR|pet-mr
101374|NCT02932488|5-HT1B receptor|5-ht1b receptor
101375|NCT02932488|Sumatriptan|sumatriptan
101376|NCT02932488|phMRI|phmri
101377|NCT02932488|[11C]AZ10419369|[11c]az10419369
101378|NCT02932436|empagliflozin|empagliflozin
101379|NCT02932436|diastolic function|diastolic function
101380|NCT02932436|poorly controlled type 2 diabetes mellitus|poorly controlled type 2 diabetes mellitus
101381|NCT02932423|Sugar-sweetened beverage|sugar-sweetened beverage
101382|NCT02932423|Overweight|overweight
101383|NCT02932423|Obese|obese
101384|NCT02932423|Sugar|sugar
101385|NCT02932423|Water|water
101386|NCT02932397|Ambulatory surgery|ambulatory surgery
101387|NCT02932397|Perioperative outcomes|perioperative outcomes
101388|NCT02932397|General anesthesia under desflurane|general anesthesia under desflurane
101389|NCT02932397|Prevention of coughing|prevention of coughing
101390|NCT02932397|Propofol|propofol
101391|NCT02932384|HIV|hiv
101392|NCT02932384|Black/African American|black/african american
101393|NCT02932384|Men|men
101394|NCT02932384|Gay/bisexual|gay/bisexual
101395|NCT02932384|Los Angeles|los angeles
101396|NCT02932371|Cardiac output|cardiac output
101397|NCT02932358|Intensive care units|intensive care units
101398|NCT02932358|Delirium|delirium
101399|NCT02932358|Cross infection|cross infection
101400|NCT02932358|Mortality|mortality
101401|NCT02932358|Length of stay|length of stay
101402|NCT02932358|Burnout, Professional|burnout, professional
101403|NCT02932358|Depression|depression
101404|NCT02932358|Anxiety|anxiety
101405|NCT02932345|EGFR mutation; non-small-cell lung cancer;|egfr mutation; non-small-cell lung cancer;
101406|NCT02932332|shortness of breath|shortness of breath
101407|NCT02932332|oxygen|oxygen
101408|NCT02932332|breathing therapies|breathing therapies
101409|NCT02932319|induction of labour|induction of labour
101410|NCT02932319|nulliparous|nulliparous
101411|NCT02932319|prolonged pregnancy|prolonged pregnancy
101412|NCT02932319|foley catheter|foley catheter
101413|NCT02932319|vaginal birth|vaginal birth
101414|NCT02932280|Recurrent|recurrent
101415|NCT02932280|Refractory Disease|refractory disease
101416|NCT02932280|Neratinib|neratinib
101417|NCT02932280|16-878|16-878
101418|NCT02932267|Acne|acne
101419|NCT02932267|Dark skin|dark skin
101420|NCT02932254|Physiological Effects of Drugs|physiological effects of drugs
101421|NCT02932254|Rocuronium|rocuronium
101422|NCT02932254|Sugammadex sodium|sugammadex sodium
101423|NCT02932254|Magnesium|magnesium
101424|NCT02932254|Neuromuscular block, antagonism|neuromuscular block, antagonism
101425|NCT02932215|mobile health device|mobile health device
101426|NCT02932215|substance abuse treatment|substance abuse treatment
101427|NCT02932215|quality of life|quality of life
101428|NCT02932215|lorcaserin|lorcaserin
101430|NCT02932202|Pregnancy|pregnancy
101431|NCT02932202|Weight Gain|weight gain
101432|NCT02932189|Mechanical Ventilator Weaning|mechanical ventilator weaning
101433|NCT02932189|Respiratory Muscle Training|respiratory muscle training
101434|NCT02932189|Mortality Rate|mortality rate
101435|NCT02932176|Arteries|arteries
101436|NCT02932163|Chronic low back pain|chronic low back pain
101437|NCT02932163|disability|disability
101438|NCT02932163|endurance|endurance
101439|NCT02932150|CHB|chb
101440|NCT02932150|HBV|hbv
101441|NCT02932137|SLE,IL-2|sle,il-2
101442|NCT02932124|German Resuscitation Registry|german resuscitation registry
101443|NCT02932124|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
101444|NCT02932124|cardiopulmonary resuscitation|cardiopulmonary resuscitation
101445|NCT02932124|mechanical chest compression devices|mechanical chest compression devices
101446|NCT02932111|IBS|ibs
101447|NCT02932111|Osteopathic manipulative treatment|osteopathic manipulative treatment
101448|NCT02932111|pain|pain
101449|NCT02932085|Transcranial magnetic stimulation|transcranial magnetic stimulation
101450|NCT02932085|Magnetic resonance imaging|magnetic resonance imaging
101451|NCT02932085|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
101452|NCT02932059|Metamemory|metamemory
101453|NCT02932059|Schizophrenia|schizophrenia
101454|NCT02932059|Aging|aging
101455|NCT02932059|Learning|learning
101456|NCT02932059|Judgement of learning|judgement of learning
101457|NCT02932059|Sentence construction strategy|sentence construction strategy
101458|NCT02932046|eating disorders|eating disorders
101459|NCT02932046|anorexia nervosa|anorexia nervosa
101460|NCT02932046|appetite|appetite
101461|NCT02932020|disc herniation|disc herniation
101462|NCT02932020|spinal stenosis|spinal stenosis
101463|NCT02932007|persistent|persistent
101464|NCT02932007|longstanding persistent|longstanding persistent
101465|NCT02931994|dental floss|dental floss
101466|NCT02931994|gingival embrasure|gingival embrasure
101467|NCT02931994|oral hygiene|oral hygiene
101468|NCT02931981|DKK4|dkk4
101469|NCT02931981|Gastrointestinal Stromal Tumor|gastrointestinal stromal tumor
101470|NCT02931981|Biomarker|biomarker
101471|NCT02931968|Monolithic Zirconia|monolithic zirconia
101472|NCT02931968|Implant supported prosthesis|implant supported prosthesis
101473|NCT02931968|Fixed partial denture|fixed partial denture
101474|NCT02931955|allergy|allergy
101475|NCT02931955|insect venom|insect venom
101476|NCT02931955|pollen|pollen
101477|NCT02931955|systems biology|systems biology
101478|NCT02931942|AA|aa
101479|NCT02931916|smart-phone|smart-phone
101480|NCT02931916|assessment|assessment
101481|NCT02931916|chronic ankle instability|chronic ankle instability
101482|NCT02931903|implant supported restorations|implant supported restorations
101483|NCT02931903|IPS Emax (lithium disilicate glass-ceramic)|ips emax (lithium disilicate glass-ceramic)
101484|NCT02931903|Vita Enamic (hybrid dental ceramic)|vita enamic (hybrid dental ceramic)
101485|NCT02931903|implant survival|implant survival
101486|NCT02931903|peri-implant tissue response|peri-implant tissue response
101487|NCT02931890|gastric cancer|gastric cancer
101488|NCT02931890|radiotherapy|radiotherapy
101489|NCT02931890|chemoradiotherapy|chemoradiotherapy
101490|NCT02931877|Sevoflurane|sevoflurane
101491|NCT02931877|Propofol|propofol
101492|NCT02931877|Cardiac valvular surgery|cardiac valvular surgery
101493|NCT02931877|Cardiopulmonary bypass|cardiopulmonary bypass
101494|NCT02931877|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
101495|NCT02931825|high risk|high risk
101496|NCT02931825|surveillance|surveillance
101497|NCT02931825|screening|screening
101498|NCT02931825|colonoscopy|colonoscopy
101499|NCT02931812|cirrhosis|cirrhosis
101500|NCT02931812|reward system|reward system
101501|NCT02931812|taste sensitivity|taste sensitivity
101502|NCT02931812|chronic renal failure|chronic renal failure
101503|NCT02931799|Colitis, Ulcerative|colitis, ulcerative
101504|NCT02931799|Crohn Disease|crohn disease
101505|NCT02931799|Inflammatory Bowel Diseases|inflammatory bowel diseases
101506|NCT02931799|Gastroenterology|gastroenterology
101507|NCT02931799|Quality Improvement|quality improvement
101508|NCT02931799|Post-Discharge|post-discharge
101509|NCT02931786|core body temperature|core body temperature
101510|NCT02931786|magnetic resonance imaging|magnetic resonance imaging
101511|NCT02931786|propofol|propofol
101512|NCT02931786|ketofol|ketofol
101513|NCT02931773|Diabetes Autonomic Cardiovascular|diabetes autonomic cardiovascular
101514|NCT02931747|Bacopa Monnieri|bacopa monnieri
101515|NCT02931747|Working memory|working memory
101516|NCT02931747|Cognitive processing|cognitive processing
101517|NCT02931747|Student|student
101518|NCT02931721|Azospermia|azospermia
101519|NCT02931721|Micro Dissection Testicular Sperm Extraction|micro dissection testicular sperm extraction
101520|NCT02931721|Male infertility|male infertility
101521|NCT02931721|Testis|testis
101522|NCT02931721|MRI|mri
101523|NCT02931708|Heart Failure|heart failure
101524|NCT02931708|Diaphragm|diaphragm
101525|NCT02931708|Electrical Stimulation|electrical stimulation
101526|NCT02931695|post partum|post partum
101527|NCT02931682|Creatine transporter|creatine transporter
101825|NCT02930005|Bipolar|bipolar
101528|NCT02931682|developmental delay|developmental delay
101529|NCT02931682|intellectual disability|intellectual disability
101530|NCT02931682|X-linked|x-linked
101531|NCT02931682|language|language
101532|NCT02931682|seizure|seizure
101533|NCT02931682|observational|observational
101534|NCT02931682|brain spectroscopy|brain spectroscopy
101535|NCT02931656|Gestational Diabetes|gestational diabetes
101536|NCT02931643|Spices|spices
101537|NCT02931643|Functional food|functional food
101538|NCT02931643|Cardiometabolic risk|cardiometabolic risk
101539|NCT02931643|Metabolic syndrome|metabolic syndrome
101540|NCT02931643|Inflammation|inflammation
101541|NCT02931643|Peripheral blood mononuclear cell|peripheral blood mononuclear cell
101542|NCT02931643|Acute|acute
101543|NCT02931643|miRNA|mirna
101544|NCT02931630|Whey protein|whey protein
101545|NCT02931630|Dietary fibers|dietary fibers
101546|NCT02931630|Wheat bran|wheat bran
101547|NCT02931630|Arabinoxylan|arabinoxylan
101548|NCT02931630|Postprandial lipaemia|postprandial lipaemia
101549|NCT02931630|Body composition|body composition
101550|NCT02931630|Blood pressure|blood pressure
101551|NCT02931630|Metabolic rate|metabolic rate
101552|NCT02931630|Insulin sensitivity|insulin sensitivity
101553|NCT02931630|Metabolic syndrome|metabolic syndrome
101554|NCT02931604|sinus wash|sinus wash
101555|NCT02931604|sinus lavage|sinus lavage
101556|NCT02931604|Sinusitis|sinusitis
101557|NCT02931591|Small for gestational age|small for gestational age
101558|NCT02931591|insulin sensitivity|insulin sensitivity
101559|NCT02931591|IGF-1 response|igf-1 response
101560|NCT02931591|growth hormone treatment|growth hormone treatment
101561|NCT02931578|glycemic index|glycemic index
101562|NCT02931552|Breast cancer|breast cancer
101563|NCT02931552|Latinas|latinas
101564|NCT02931552|Peer support counselor|peer support counselor
101565|NCT02931552|Spanish speaking|spanish speaking
101566|NCT02931552|Community based|community based
101567|NCT02931552|Rural|rural
101568|NCT02931526|Tigecycline|tigecycline
101569|NCT02931526|Continuous Renal Replacement Therapy|continuous renal replacement therapy
101570|NCT02931526|Pharmacokinetics|pharmacokinetics
101571|NCT02931500|machine learning|machine learning
101572|NCT02931500|cohort study|cohort study
101573|NCT02931474|Growth Hormone|growth hormone
101574|NCT02931474|Traumatic Brain Injury|traumatic brain injury
101575|NCT02931474|Insomnia|insomnia
101576|NCT02931474|Polysomnography|polysomnography
101577|NCT02931474|NREM Sleep|nrem sleep
101578|NCT02931461|endobronchial transbronchial needle aspiration lung cancer procore|endobronchial transbronchial needle aspiration lung cancer procore
101579|NCT02931448|Device assessment|device assessment
101580|NCT02931435|Genicular Radiofrequency Ablation|genicular radiofrequency ablation
101581|NCT02931435|Knee Arthroplasty, Total|knee arthroplasty, total
101582|NCT02931422|HIV|hiv
101583|NCT02931422|financial incentive|financial incentive
101584|NCT02931422|pediatric HIV testing|pediatric hiv testing
101585|NCT02931409|Positive end-expiratory pressure|positive end-expiratory pressure
101586|NCT02931409|Static pulmonary compliance|static pulmonary compliance
101587|NCT02931409|Lung Protective Ventilation|lung protective ventilation
101588|NCT02931409|Radical cystectomy and urinary diversion|radical cystectomy and urinary diversion
101589|NCT02931409|Postoperative pulmonary complications|postoperative pulmonary complications
101590|NCT02931409|Procalcitonin|procalcitonin
101591|NCT02931383|Liraglutide|liraglutide
101592|NCT02931383|Liraglutide 3 mg|liraglutide 3 mg
101593|NCT02931383|Osteoarthritis|osteoarthritis
101594|NCT02931383|Obesity|obesity
101595|NCT02931383|Ultrasound|ultrasound
101596|NCT02931370|Osteoarthritis|osteoarthritis
101597|NCT02931370|Obesity|obesity
101598|NCT02931370|Ultrasound|ultrasound
101599|NCT02931370|Liraglutide|liraglutide
101600|NCT02931370|Liraglutide 3mg|liraglutide 3mg
101601|NCT02931357|Treatment of teething in infants|treatment of teething in infants
101602|NCT02931344|Osteoarthrtis|osteoarthrtis
101603|NCT02931344|Obesity|obesity
101604|NCT02931344|Liraglutide 3 mg|liraglutide 3 mg
101605|NCT02931344|Liraglutide|liraglutide
101606|NCT02931344|Biomarkers|biomarkers
101607|NCT02931318|Organ donation|organ donation
101608|NCT02931318|brain death|brain death
101609|NCT02931318|public opinion|public opinion
101610|NCT02931305|Epimedium prenylflavonoids|epimedium prenylflavonoids
101611|NCT02931305|Osteoporosis|osteoporosis
101612|NCT02931305|Cardiovascular diseases|cardiovascular diseases
101613|NCT02931305|Phase 1|phase 1
101614|NCT02931305|safety|safety
101615|NCT02931305|tolerability|tolerability
101616|NCT02931292|sleeve gastrectomy|sleeve gastrectomy
101617|NCT02931292|laparoscopy|laparoscopy
101618|NCT02931292|bariatric surgery|bariatric surgery
101619|NCT02931292|obesity surgery|obesity surgery
101620|NCT02931292|metabolic surgery|metabolic surgery
101621|NCT02931214|Healthy Subjects|healthy subjects
101622|NCT02931214|Pharmacokinetics|pharmacokinetics
101623|NCT02931214|Pharmacodynamics|pharmacodynamics
101624|NCT02931201|Positron-Emission Tomography|positron-emission tomography
101625|NCT02931201|Prognosis|prognosis
101626|NCT02931188|Vascular Diseases|vascular diseases
101627|NCT02931188|Lipids|lipids
101628|NCT02931188|Cholesteryl Ester Transfer Protein (CETP) Inhibition|cholesteryl ester transfer protein (cetp) inhibition
101629|NCT02931188|Anacetrapib|anacetrapib
101630|NCT02931188|Cardiovascular Disease|cardiovascular disease
101631|NCT02931188|Cholesterol|cholesterol
101632|NCT02931175|ACTH gel|acth gel
101633|NCT02931175|Non-Infectious Uveitis|non-infectious uveitis
101634|NCT02931175|ACTHAR|acthar
101635|NCT02931175|Posterior Uveitis|posterior uveitis
101636|NCT02931175|Intermediate Uveitis|intermediate uveitis
101637|NCT02931175|Pan Uveitis|pan uveitis
101638|NCT02931175|Uveitis|uveitis
101639|NCT02931149|platelet-rich plasma|platelet-rich plasma
101640|NCT02931149|endoscopic mucosal resection|endoscopic mucosal resection
101641|NCT02931149|endoscopic submucosal dissection|endoscopic submucosal dissection
101642|NCT02931110|Diffuse large B-cell lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
101643|NCT02931110|follicular lymphoma (FL)|follicular lymphoma (fl)
101644|NCT02931110|mantle cell lymphoma (MCL)|mantle cell lymphoma (mcl)
101645|NCT02931110|Hodgkin lymphoma (HL)|hodgkin lymphoma (hl)
101646|NCT02931110|Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)|chronic lymphocytic leukemia/small lymphocytic lymphoma (cll/sll)
101647|NCT02931110|Multiple myeloma (MM)|multiple myeloma (mm)
101648|NCT02931097|Parkinson's disease|parkinson's disease
101649|NCT02931097|Deep brain stimulation|deep brain stimulation
101650|NCT02931097|Mesencephalic locomotor region|mesencephalic locomotor region
101651|NCT02931058|Knee-extension exercise|knee-extension exercise
101652|NCT02931058|Quadriceps exercise|quadriceps exercise
101653|NCT02931058|Knee osteoarthritis|knee osteoarthritis
101654|NCT02931058|Exercise adherence|exercise adherence
101655|NCT02931058|Dose-response relationship|dose-response relationship
101656|NCT02931058|Prehabilitation|prehabilitation
101657|NCT02931045|extracellular vesicles|extracellular vesicles
101658|NCT02931045|inflammation|inflammation
101659|NCT02931045|thrombosis|thrombosis
101660|NCT02931045|antiplatelet drugs|antiplatelet drugs
101661|NCT02931032|nano receptor|nano receptor
101662|NCT02931032|oral microbiology|oral microbiology
101663|NCT02931032|dental caries|dental caries
101664|NCT02931032|periodontal disease|periodontal disease
101665|NCT02931019|fiberoptic|fiberoptic
101666|NCT02931019|intubation|intubation
101667|NCT02931019|posture|posture
101668|NCT02930954|NSCLC, EGFR, Bim, mutation abundance|nsclc, egfr, bim, mutation abundance
101669|NCT02930941|tranexamic acid|tranexamic acid
101670|NCT02930941|epistaxis|epistaxis
101671|NCT02930941|emergency medicine|emergency medicine
101672|NCT02930941|intranasal|intranasal
101673|NCT02930941|TXA|txa
101674|NCT02930928|Anaesthesia|anaesthesia
101675|NCT02930928|Anthropometry|anthropometry
101676|NCT02930928|Body weight and measures|body weight and measures
101677|NCT02930928|Development|development
101678|NCT02930928|Emergency treatment|emergency treatment
101679|NCT02930928|Patient safety|patient safety
101680|NCT02930915|Head and Neck Cancer|head and neck cancer
101681|NCT02930915|Radiotherapy|radiotherapy
101682|NCT02930902|Pancreatic Cancer|pancreatic cancer
101683|NCT02930902|Pembrolizumab|pembrolizumab
101684|NCT02930902|MK3475|mk3475
101685|NCT02930902|Paricalcitol|paricalcitol
101686|NCT02930902|Zemplar|zemplar
101687|NCT02930902|Gemcitabine|gemcitabine
101688|NCT02930902|Hydrochloride Gemzar|hydrochloride gemzar
101689|NCT02930902|Nab-paclitaxel|nab-paclitaxel
101690|NCT02930902|Paclitaxel|paclitaxel
101691|NCT02930902|Abraxane|abraxane
101692|NCT02930902|ABI-007|abi-007
101693|NCT02930902|Resectable Pancreatic Cancer|resectable pancreatic cancer
101694|NCT02930889|Therapeutic Embolization|therapeutic embolization
101695|NCT02930889|Prostatic Artery Embolization|prostatic artery embolization
101696|NCT02930876|sarcopenia|sarcopenia
101697|NCT02930876|cancer|cancer
101698|NCT02930876|chemotherapy|chemotherapy
101699|NCT02930876|palliative care|palliative care
101700|NCT02930876|resistance training|resistance training
101701|NCT02930733|Postoperative Analgesia|postoperative analgesia
101702|NCT02930733|Ultrasound guided serratus plane block|ultrasound guided serratus plane block
101703|NCT02930720|TAUS|taus
101704|NCT02930720|breathing protocols and cough|breathing protocols and cough
101705|NCT02930720|pelvic floor displacement|pelvic floor displacement
101706|NCT02930720|women|women
101707|NCT02930720|SUI|sui
101708|NCT02930707|magnesium sulfate|magnesium sulfate
101709|NCT02930707|postoperative pain|postoperative pain
101710|NCT02930707|TAP block|tap block
101711|NCT02930707|total abdominal hysterectomy|total abdominal hysterectomy
101712|NCT02930655|Fabry disease|fabry disease
101713|NCT02930655|lucerastat|lucerastat
101714|NCT02930642|Mindfulness|mindfulness
101715|NCT02930642|Obesity|obesity
101716|NCT02930642|Food insecurity|food insecurity
101717|NCT02930642|Delay discounting|delay discounting
101718|NCT02930629|Recovery Period, Anesthesia|recovery period, anesthesia
101719|NCT02930629|Neuromuscular Monitoring|neuromuscular monitoring
101720|NCT02930603|Developmental Disabilities|developmental disabilities
101721|NCT02930603|Body function and body structure|body function and body structure
101722|NCT02930603|Participation|participation
101723|NCT02930603|Life activities|life activities
101724|NCT02930603|Quality of Life|quality of life
101725|NCT02930577|treatment adherence|treatment adherence
101726|NCT02930577|outpatient treatment|outpatient treatment
101727|NCT02930577|drug dependence|drug dependence
101728|NCT02930525|apnea|apnea
101729|NCT02930525|children|children
101730|NCT02930525|hypercarbia|hypercarbia
101731|NCT02930525|procedural sedation|procedural sedation
101732|NCT02930525|HFNC|hfnc
101733|NCT02930512|Bone mineral density|bone mineral density
101734|NCT02930512|Osteoporosis|osteoporosis
101735|NCT02930512|Parkinson's disease|parkinson's disease
101736|NCT02930512|Bone turnover markers|bone turnover markers
101737|NCT02930486|Syndesmosis|syndesmosis
101738|NCT02930486|Injury|injury
101739|NCT02930486|Ankle|ankle
101740|NCT02930486|Fracture|fracture
101741|NCT02930486|Weber C|weber c
101742|NCT02930473|Psychotherapy|psychotherapy
101743|NCT02930473|Nursing|nursing
101744|NCT02930473|Nursing Care|nursing care
101745|NCT02930473|Nursing Model|nursing model
101746|NCT02930473|Randomised Controlled Trial|randomised controlled trial
101747|NCT02930434|Vitamin D|vitamin d
101748|NCT02930434|cholecalciferol|cholecalciferol
101749|NCT02930434|Antarctica|antarctica
101750|NCT02930434|Chile|chile
101751|NCT02930434|cathelicidin|cathelicidin
101752|NCT02930434|bone metabolism|bone metabolism
101753|NCT02930434|cardiovascular risk|cardiovascular risk
101754|NCT02930421|mild COPD|mild copd
101755|NCT02930421|Exercise training|exercise training
101756|NCT02930421|Six minute walking distance|six minute walking distance
101757|NCT02930421|Quality of life|quality of life
101758|NCT02930421|Saint George Respiratory Questionnaire (SGRQ)|saint george respiratory questionnaire (sgrq)
101759|NCT02930395|Concussion|concussion
101760|NCT02930395|Professional rugby players|professional rugby players
101761|NCT02930395|S100B|s100b
101762|NCT02930330|Exercise|exercise
101763|NCT02930330|Interval training|interval training
101764|NCT02930330|Blood platelets|blood platelets
101765|NCT02930330|Platelet function tests|platelet function tests
101766|NCT02930330|Physical fitness|physical fitness
101767|NCT02930330|Rehabilitation|rehabilitation
101768|NCT02930304|tennis elbow|tennis elbow
101769|NCT02930304|pain|pain
101770|NCT02930304|shock wave|shock wave
101771|NCT02930304|kinesio taping|kinesio taping
101772|NCT02930252|Self-expandable metal stent|self-expandable metal stent
101773|NCT02930252|strictures|strictures
101774|NCT02930252|biliary|biliary
101775|NCT02930239|ACL-reconstruction|acl-reconstruction
101776|NCT02930239|Gait rehabilitation|gait rehabilitation
101777|NCT02930239|Anti Gravity treadmill|anti gravity treadmill
101778|NCT02930239|ACL-rehabilitation|acl-rehabilitation
101779|NCT02930213|unresponsive wakefulness syndrome|unresponsive wakefulness syndrome
101780|NCT02930213|minimally conscious state|minimally conscious state
101781|NCT02930213|circadian rhythms|circadian rhythms
101782|NCT02930213|free-running period|free-running period
101783|NCT02930200|Smoking Cessation|smoking cessation
101784|NCT02930200|Smartphone Based Smoking Cessation|smartphone based smoking cessation
101785|NCT02930187|Rheumatoid arthritis, remission, ultrasound|rheumatoid arthritis, remission, ultrasound
101786|NCT02930161|Nonalcoholic Fatty Liver Disease|nonalcoholic fatty liver disease
101787|NCT02930161|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
101788|NCT02930161|Methionine|methionine
101789|NCT02930161|Succinic acid|succinic acid
101790|NCT02930148|mHealth|mhealth
101791|NCT02930148|adolescents|adolescents
101792|NCT02930148|quasi-experimental study|quasi-experimental study
101793|NCT02930148|apps|apps
101794|NCT02930148|lifestyles|lifestyles
101795|NCT02930148|lifestyles knowledge|lifestyles knowledge
101796|NCT02930148|dietary behaviour|dietary behaviour
101797|NCT02930148|physical activity|physical activity
101798|NCT02930148|sleeping behaviour|sleeping behaviour
101799|NCT02930135|Indirect Pulp Capping, Young Permanent Molars|indirect pulp capping, young permanent molars
101800|NCT02930070|sepsis|sepsis
101801|NCT02930070|qSOFA|qsofa
101802|NCT02930070|SOFA|sofa
101803|NCT02930070|diagnostic accuracy|diagnostic accuracy
101804|NCT02930057|lumbar dorsal root ganglion|lumbar dorsal root ganglion
101805|NCT02930057|transforaminal epidural steroid injection|transforaminal epidural steroid injection
101806|NCT02930057|chronic lumbosacral radicular pain|chronic lumbosacral radicular pain
101807|NCT02930057|pulsed radiofrequency treatment|pulsed radiofrequency treatment
101808|NCT02930057|betamethasone|betamethasone
101809|NCT02930057|dorsal root ganglion|dorsal root ganglion
101810|NCT02930044|Emergency department|emergency department
101811|NCT02930044|Insulin|insulin
101812|NCT02930044|Adult|adult
101813|NCT02930031|muscle injury|muscle injury
101814|NCT02930031|exercise|exercise
101815|NCT02930031|redox status|redox status
101816|NCT02930031|immune cells|immune cells
101817|NCT02930018|Acute Ischemic Stroke|acute ischemic stroke
101818|NCT02930018|Endovascular Thrombectomy|endovascular thrombectomy
101819|NCT02930018|Neuroprotection|neuroprotection
101820|NCT02930018|Tat-NR2B9c|tat-nr2b9c
101821|NCT02930018|NA-1|na-1
101822|NCT02930005|Psychotic|psychotic
101823|NCT02930005|Schizophrenia|schizophrenia
101824|NCT02930005|Schizoaffective|schizoaffective
101826|NCT02929979|PTSD|ptsd
101827|NCT02929979|Alcohol Use Disorder|alcohol use disorder
101828|NCT02929979|Cognitive Training|cognitive training
101829|NCT02929979|Veterans|veterans
101830|NCT02929953|premature birth|premature birth
101831|NCT02929953|risk factor|risk factor
101832|NCT02929953|type 1 diabetes mellitus|type 1 diabetes mellitus
101833|NCT02929953|seasonality|seasonality
101834|NCT02929953|prevalence|prevalence
101835|NCT02929953|enteral feeding|enteral feeding
101836|NCT02929953|immunomodulating medications|immunomodulating medications
101837|NCT02929953|early onset|early onset
101838|NCT02929927|PDT|pdt
101839|NCT02929914|Carious dentin|carious dentin
101840|NCT02929914|Photodynamic Therapy|photodynamic therapy
101841|NCT02929888|ST-segment elevacion myocardial infarction, platelets|st-segment elevacion myocardial infarction, platelets
101842|NCT02929836|Ablation Linear Lesions|ablation linear lesions
101843|NCT02929797|pancreatic cancer|pancreatic cancer
101844|NCT02929784|Hemiplegic Shoulder Pain|hemiplegic shoulder pain
101845|NCT02929784|transcranial Direct Current Stimulation|transcranial direct current stimulation
101846|NCT02929784|Stroke|stroke
101847|NCT02929771|Virtual Reality|virtual reality
101848|NCT02929771|Subcutaneous Port Sampling|subcutaneous port sampling
101849|NCT02929771|Pain|pain
101850|NCT02929771|Children|children
101851|NCT02929745|immunology, genetics|immunology, genetics
101852|NCT02929667|Fluoxetine|fluoxetine
101853|NCT02929641|Optical Enhancement technology|optical enhancement technology
101854|NCT02929641|coloractal polyp prediction|coloractal polyp prediction
101855|NCT02929602|prescribing|prescribing
101856|NCT02929602|effectiveness|effectiveness
101857|NCT02929602|dental|dental
101858|NCT02929602|opioid|opioid
101859|NCT02929602|analgesic|analgesic
101860|NCT02929576|metastatic|metastatic
101861|NCT02929576|triple negative|triple negative
101862|NCT02929550|Cardiovascular disease|cardiovascular disease
101863|NCT02929550|Costs|costs
101864|NCT02929550|Guidelines|guidelines
101865|NCT02929550|Lipids|lipids
101866|NCT02929550|Myocardial infarction|myocardial infarction
101867|NCT02929537|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
101868|NCT02929537|registration research|registration research
101869|NCT02929537|Medicine, Chinese Traditional|medicine, chinese traditional
101870|NCT02929524|Ketamine|ketamine
101871|NCT02929524|Intranasal administration|intranasal administration
101872|NCT02929524|Pediatric nursing|pediatric nursing
101873|NCT02929498|GSK2879552|gsk2879552
101874|NCT02929498|Revised International Prognostic Scoring System (IPSS-R)|revised international prognostic scoring system (ipss-r)
101875|NCT02929498|azacitidine|azacitidine
101876|NCT02929498|hypomethylating agents|hypomethylating agents
101877|NCT02929498|myelodysplastic syndrome|myelodysplastic syndrome
101878|NCT02929472|Physical Activity|physical activity
101879|NCT02929472|Physical Fitness|physical fitness
101880|NCT02929472|Intervention|intervention
101881|NCT02929472|Children and Adolescents|children and adolescents
101882|NCT02929459|Gut Microbiota|gut microbiota
101883|NCT02929459|Riboflavin|riboflavin
101884|NCT02929459|Vitamin B2|vitamin b2
101885|NCT02929459|oGTT|ogtt
101886|NCT02929459|Faecalibacterium prausnitzii|faecalibacterium prausnitzii
101887|NCT02929446|mobilisation|mobilisation
101888|NCT02929446|physiotherapy|physiotherapy
101889|NCT02929433|disability|disability
101890|NCT02929433|pain|pain
101891|NCT02929433|Rotator Cuff Tear|rotator cuff tear
101892|NCT02929433|rehabilitation|rehabilitation
101893|NCT02929433|range of motion (ROM)|range of motion (rom)
101894|NCT02929420|Multicenter|multicenter
101895|NCT02929420|randomized|randomized
101896|NCT02929420|open|open
101897|NCT02929420|parallel controlled|parallel controlled
101898|NCT02929394|Histologically proven locally advanced or metastatic high grade STS (excluding histologies insensitive to chemotherapy such as ASPS, PECOMA subtypes)|histologically proven locally advanced or metastatic high grade sts (excluding histologies insensitive to chemotherapy such as asps, pecoma subtypes)
101899|NCT02929381|Narrow Band Imaging|narrow band imaging
101900|NCT02929381|Colorectal Cancer Screening|colorectal cancer screening
101901|NCT02929381|Colonoscopy|colonoscopy
101902|NCT02929381|Responsive Insertion Technology|responsive insertion technology
101903|NCT02929381|Near Focus|near focus
101904|NCT02929368|PICC-Line|picc-line
101905|NCT02929355|Carotid atherosclerosis|carotid atherosclerosis
101906|NCT02929355|duplex ultrasonography|duplex ultrasonography
101907|NCT02929355|diabetes|diabetes
101908|NCT02929355|vascular events|vascular events
101909|NCT02929277|farm children|farm children
101910|NCT02929277|non-farm children|non-farm children
101911|NCT02929264|Healthy volunteer|healthy volunteer
101912|NCT02929264|Experimental hyperalgesia|experimental hyperalgesia
101913|NCT02929264|fMRI|fmri
101914|NCT02929225|bacterial translocation;micro-inflammation;hemodialysis|bacterial translocation;micro-inflammation;hemodialysis
101915|NCT02929212|Gastric Bypass|gastric bypass
101916|NCT02929212|Meal Texture|meal texture
101917|NCT02929212|Meal Number|meal number
101918|NCT02929212|GLP-1|glp-1
101919|NCT02929212|Glucose|glucose
101920|NCT02929134|Lymphedema|lymphedema
101921|NCT02929134|Lymphatic Filariasis|lymphatic filariasis
101922|NCT02929134|Filariasis|filariasis
101923|NCT02929134|Doxycycline|doxycycline
101924|NCT02929121|Lymphedema|lymphedema
101925|NCT02929121|Lymphatic Filariasis|lymphatic filariasis
101926|NCT02929121|Filariasis|filariasis
101927|NCT02929121|Doxycycline|doxycycline
101928|NCT02929108|hospice|hospice
101929|NCT02929108|caregiver|caregiver
101930|NCT02929082|magnetic resonance force|magnetic resonance force
101931|NCT02929069|Minority Stress|minority stress
101932|NCT02929017|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
101933|NCT02929017|Fibrosis|fibrosis
101934|NCT02929017|IPF|ipf
101935|NCT02929017|Caregivers|caregivers
101936|NCT02929017|Pulmonary|pulmonary
101937|NCT02929017|Palliative|palliative
101938|NCT02929017|end of life|end of life
101939|NCT02929017|Idiopathic|idiopathic
101940|NCT02929004|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
101941|NCT02929004|Local vibration training|local vibration training
101942|NCT02929004|Ligamentoplasty|ligamentoplasty
101943|NCT02929004|Anterior cruciate ligament|anterior cruciate ligament
101944|NCT02929004|Corticospinal excitability|corticospinal excitability
101945|NCT02929004|Elastography|elastography
101946|NCT02929004|Knee extensor muscles|knee extensor muscles
101947|NCT02929004|Readaptation|readaptation
101948|NCT02928991|Acquired aplastic anemia|acquired aplastic anemia
101949|NCT02928991|Inherited bone marrow failure|inherited bone marrow failure
101950|NCT02928978|Premalignant Breast Disease|premalignant breast disease
101951|NCT02928978|ALH|alh
101952|NCT02928978|ADH|adh
101953|NCT02928978|DCIS|dcis
101954|NCT02928978|LCIS|lcis
101955|NCT02928978|Breast Cancer Prevention|breast cancer prevention
101956|NCT02928978|Ruxolitinib|ruxolitinib
101957|NCT02928965|psychosis|psychosis
101958|NCT02928965|schizophrenia|schizophrenia
101959|NCT02928965|negative symptoms|negative symptoms
101960|NCT02928965|minocycline|minocycline
101961|NCT02928952|Mindfulness|mindfulness
101962|NCT02928939|multimorbidity|multimorbidity
101963|NCT02928939|multiple chronic conditions|multiple chronic conditions
101964|NCT02928939|drug-drug interactions|drug-drug interactions
101965|NCT02928939|drug-disease interactions|drug-disease interactions
101966|NCT02928939|polypharmacy|polypharmacy
101967|NCT02928939|Oral anticoagulants|oral anticoagulants
101968|NCT02928939|Steroids|steroids
101969|NCT02928913|sedentary|sedentary
101970|NCT02928913|non-sedentary|non-sedentary
101971|NCT02928913|populations|populations
101972|NCT02928900|Adolescents|adolescents
101973|NCT02928900|Clinical training|clinical training
101974|NCT02928900|HIV care and treatment|hiv care and treatment
101975|NCT02928900|Africa|africa
101976|NCT02928861|Positron-Emission Tomography|positron-emission tomography
101977|NCT02928861|Prognosis|prognosis
101978|NCT02928835|Total knee arthroplasty|total knee arthroplasty
101979|NCT02928835|Knee flexion|knee flexion
101980|NCT02928835|Dynamic orthosis|dynamic orthosis
101981|NCT02928822|stroke|stroke
101982|NCT02928822|broca's aphasia|broca's aphasia
101983|NCT02928822|priming|priming
101984|NCT02928822|Intensive language-action therapy|intensive language-action therapy
101985|NCT02928822|Rehabilitation gaming system|rehabilitation gaming system
101986|NCT02928809|temporomandibular joint|temporomandibular joint
101987|NCT02928809|temporomandibular disorder|temporomandibular disorder
101988|NCT02928809|muscle fatigue|muscle fatigue
101989|NCT02928809|low-level laser therapy|low-level laser therapy
101990|NCT02928796|Attentional capacity|attentional capacity
101991|NCT02928796|Working memory|working memory
101992|NCT02928796|Simulation-based training|simulation-based training
101993|NCT02928796|Eye-tracking|eye-tracking
101994|NCT02928796|Visual attention|visual attention
101995|NCT02928796|Psychophysiological measurement|psychophysiological measurement
101996|NCT02928796|Surgical simulation|surgical simulation
101997|NCT02928796|Computer-based simulation|computer-based simulation
101998|NCT02928783|Home-based cardiac rehabilitation|home-based cardiac rehabilitation
101999|NCT02928783|Quality of Medical Care|quality of medical care
102000|NCT02928783|Heart Failure|heart failure
102001|NCT02928757|Care coordination|care coordination
102002|NCT02928757|Complex care kids Ontario|complex care kids ontario
102003|NCT02928757|Technology-dependent|technology-dependent
102004|NCT02928757|Quality of life|quality of life
102005|NCT02928744|Resistance|resistance
102006|NCT02928744|Forced oscillations|forced oscillations
102007|NCT02928744|Dyspnea|dyspnea
102008|NCT02928731|Cancer|cancer
102009|NCT02928731|Quality of life|quality of life
102010|NCT02928731|Child|child
102011|NCT02928718|Post-ERCP pancreatitis|post-ercp pancreatitis
102012|NCT02928718|Genetic variation|genetic variation
102013|NCT02928705|analgesia|analgesia
102014|NCT02928705|prehospital|prehospital
102015|NCT02928705|telemedicine|telemedicine
102016|NCT02928705|ambulance|ambulance
102017|NCT02928705|opioids|opioids
102018|NCT02928705|teleconsultation|teleconsultation
102019|NCT02928705|tele-emergency medical services|tele-emergency medical services
102020|NCT02928705|adverse events|adverse events
102021|NCT02928705|prehospital emergency medical service physician|prehospital emergency medical service physician
102022|NCT02928692|Minocycline|minocycline
102023|NCT02928692|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
102024|NCT02928692|Postoperative delirium|postoperative delirium
102025|NCT02928679|Magnetic resonance imaging|magnetic resonance imaging
102026|NCT02928679|Dynamic contrast enhanced MRI|dynamic contrast enhanced mri
102027|NCT02928679|Liraglutide 3 mg|liraglutide 3 mg
102028|NCT02928679|Liraglutide|liraglutide
102029|NCT02928679|Obesity|obesity
102030|NCT02928679|Osteoarthritis|osteoarthritis
102031|NCT02928666|decision-support|decision-support
102032|NCT02928666|ontology|ontology
102033|NCT02928666|computer-interpretable guidelines|computer-interpretable guidelines
102034|NCT02928666|comorbidities|comorbidities
102035|NCT02928653|energy intake|energy intake
102036|NCT02928653|energy expenditure|energy expenditure
102037|NCT02928653|appetite|appetite
102038|NCT02928614|Osteoarthritis|osteoarthritis
102039|NCT02928614|Obesity|obesity
102040|NCT02928614|Liraglutide 3 mg|liraglutide 3 mg
102041|NCT02928614|Liraglutide|liraglutide
102042|NCT02928614|Biomarkers|biomarkers
102043|NCT02928575|Glioblastoma|glioblastoma
102044|NCT02928575|Sunitinib|sunitinib
102045|NCT02928575|Temozolomide|temozolomide
102046|NCT02928575|Radiation Therapy,|radiation therapy,
102047|NCT02928575|MGMT|mgmt
102048|NCT02928575|Biomarkers|biomarkers
102049|NCT02928549|interviews|interviews
102050|NCT02928549|16-1378|16-1378
102051|NCT02928523|Autologous Fecal Microbiota Transplantation|autologous fecal microbiota transplantation
102052|NCT02928497|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
102053|NCT02928497|Left atrial appendage|left atrial appendage
102054|NCT02928484|Functional dyspepsia|functional dyspepsia
102055|NCT02928484|Abdominal pain|abdominal pain
102056|NCT02928484|Flatulence|flatulence
102057|NCT02928484|Probiotics|probiotics
102058|NCT02928484|Bifidobacterium|bifidobacterium
102059|NCT02928484|Lactobacillus|lactobacillus
102060|NCT02928471|Liraglutide|liraglutide
102061|NCT02928471|Liraglutide 3 mg|liraglutide 3 mg
102062|NCT02928471|Osteoarthritis|osteoarthritis
102063|NCT02928471|Obesity|obesity
102064|NCT02928471|Magnetic resonance imaging|magnetic resonance imaging
102065|NCT02928471|Computed tomography|computed tomography
102066|NCT02928471|Dynamic contrast enhanced MRI|dynamic contrast enhanced mri
102067|NCT02928445|Dementia with Lewy bodies|dementia with lewy bodies
102068|NCT02928445|dementia|dementia
102069|NCT02928445|RVT-101|rvt-101
102070|NCT02928445|intepirdine|intepirdine
102071|NCT02928445|Lewy bodies|lewy bodies
102072|NCT02928432|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
102073|NCT02928432|Abiraterone acetate|abiraterone acetate
102074|NCT02928432|Steroids Switch|steroids switch
102075|NCT02928393|Stroke|stroke
102076|NCT02928393|Motor impairment|motor impairment
102077|NCT02928393|Stroke recovery|stroke recovery
102078|NCT02928393|Middle cerebral artery stroke|middle cerebral artery stroke
102079|NCT02928393|Fugl Meyer|fugl meyer
102080|NCT02928393|Fugl-Meyer Motor Scale (FMMS)|fugl-meyer motor scale (fmms)
102081|NCT02928354|Asthma|asthma
102082|NCT02928354|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
102083|NCT02928354|Healthy volunteers|healthy volunteers
102084|NCT02928354|Pharmacokinetics (PK)|pharmacokinetics (pk)
102085|NCT02928354|Bioavailability|bioavailability
102086|NCT02928354|AZD7594|azd7594
102087|NCT02928354|Safety|safety
102088|NCT02928354|Tolerability|tolerability
102089|NCT02928328|craniofacial pain|craniofacial pain
102090|NCT02928328|masticatory muscle|masticatory muscle
102091|NCT02928328|burning mouth syndrome|burning mouth syndrome
102092|NCT02928328|temporomandibular disorders|temporomandibular disorders
102093|NCT02928276|Rheumakit|rheumakit
102094|NCT02928276|Rheumatoid Arthritis|rheumatoid arthritis
102095|NCT02928276|anti-TNF|anti-tnf
102096|NCT02928237|tDCS|tdcs
102097|NCT02928237|cancer liver|cancer liver
102098|NCT02928237|chronic abdominal pain|chronic abdominal pain
102100|NCT02928237|VDS|vds
102101|NCT02928237|HAM-D|ham-d
102102|NCT02928237|BPI|bpi
102103|NCT02928237|analgesia|analgesia
102104|NCT02928224|Colorectal cancer|colorectal cancer
102105|NCT02928224|BRAF|braf
102106|NCT02928224|BRAFV600E|brafv600e
102107|NCT02928198|Tomography, Optical Coherence|tomography, optical coherence
102108|NCT02928198|Percutaneous Coronary Intervention|percutaneous coronary intervention
102109|NCT02928198|Cardiac Catheterization|cardiac catheterization
102110|NCT02928198|Coronary Biovascular Scaffold|coronary biovascular scaffold
102111|NCT02928185|training manuals|training manuals
102112|NCT02928185|patients and caregivers|patients and caregivers
102113|NCT02928185|16-1334|16-1334
102114|NCT02928172|q-CON|q-con
102115|NCT02928172|q-NOX|q-nox
102116|NCT02928172|BIS|bis
102117|NCT02928172|Electroencephalograms (EEG)|electroencephalograms (eeg)
102118|NCT02928172|Laryngeal Mask Airway (LMA)|laryngeal mask airway (lma)
102119|NCT02928172|Sedation|sedation
102120|NCT02928172|General Anesthesia|general anesthesia
102121|NCT02928159|Low Pulse Amplitude Seizure Therapy|low pulse amplitude seizure therapy
102122|NCT02928159|Electroconvulsive Therapy|electroconvulsive therapy
102715|NCT02924402|DLBCL|dlbcl
102123|NCT02928159|Low Pulse Amplitude Electroconvulsive Therapy|low pulse amplitude electroconvulsive therapy
102124|NCT02928159|Low Pulse Amplitude ECT|low pulse amplitude ect
102125|NCT02928159|LAP|lap
102126|NCT02928159|LAP-ST|lap-st
102127|NCT02928159|ECT|ect
102128|NCT02928159|Mood disorders|mood disorders
102129|NCT02928159|Psychotic disorders|psychotic disorders
102130|NCT02928146|TAPP|tapp
102131|NCT02928146|TEP|tep
102132|NCT02928146|Lichtenstein|lichtenstein
102133|NCT02928146|syntethic mesh|syntethic mesh
102134|NCT02928146|hernioplasty|hernioplasty
102135|NCT02928133|Non-vitamin K antagonist oral anticoagulant (NOAC)|non-vitamin k antagonist oral anticoagulant (noac)
102136|NCT02928133|Congenital heart disease|congenital heart disease
102137|NCT02928133|Atrial fibrillation|atrial fibrillation
102138|NCT02928133|Atrial tachyarrhythmia|atrial tachyarrhythmia
102139|NCT02928133|Thromboembolism|thromboembolism
102140|NCT02928094|refractory angina|refractory angina
102141|NCT02928094|myocardial ischemia|myocardial ischemia
102142|NCT02928094|angiogenesis|angiogenesis
102143|NCT02928068|telehealth|telehealth
102144|NCT02928055|Stroke|stroke
102145|NCT02928055|Shoulder Pain|shoulder pain
102146|NCT02928055|Electrical stimulation|electrical stimulation
102147|NCT02928055|Neuromuscular stimulation|neuromuscular stimulation
102148|NCT02928055|Intramuscular stimulation|intramuscular stimulation
102149|NCT02928029|Radium-223 dichloride|radium-223 dichloride
102150|NCT02928029|bortezomib|bortezomib
102151|NCT02928029|dexamethasone|dexamethasone
102152|NCT02928029|early relapsed multiple myeloma|early relapsed multiple myeloma
102153|NCT02928029|combination therapy multiple myeloma|combination therapy multiple myeloma
102154|NCT02928016|carbohydrate counting method|carbohydrate counting method
102155|NCT02928016|protein|protein
102156|NCT02928016|fat|fat
102157|NCT02928016|glucose|glucose
102158|NCT02928016|type 1 diabetes|type 1 diabetes
102159|NCT02928003|Lung surgery|lung surgery
102160|NCT02927977|dry needling|dry needling
102161|NCT02927977|exercise|exercise
102162|NCT02927977|manual therapy|manual therapy
102163|NCT02927951|Diabetes Mellitus|diabetes mellitus
102164|NCT02927951|Peripheral Neuropathy|peripheral neuropathy
102165|NCT02927951|Diabetic Pain|diabetic pain
102166|NCT02927899|Tomato-Soy-Arugula|tomato-soy-arugula
102167|NCT02927873|Safety|safety
102168|NCT02927873|Respiratory syncytial virus (RSV)|respiratory syncytial virus (rsv)
102169|NCT02927873|Immunogenicity|immunogenicity
102170|NCT02927873|Reactogenicity|reactogenicity
102171|NCT02927873|Infants|infants
102172|NCT02927873|Vaccine|vaccine
102173|NCT02927860|sleep|sleep
102174|NCT02927860|exercise|exercise
102175|NCT02927860|activity|activity
102176|NCT02927821|Adult Day Care Centers|adult day care centers
102177|NCT02927821|Caregivers|caregivers
102178|NCT02927808|Motivational Interviewing|motivational interviewing
102179|NCT02927808|LDL-C|ldl-c
102180|NCT02927808|LDL target|ldl target
102181|NCT02927808|Medication adherence|medication adherence
102182|NCT02927782|Cerebrospinal Fluid Leak|cerebrospinal fluid leak
102183|NCT02927782|Lumbar|lumbar
102184|NCT02927756|Non-Hodgkin Lymphoma Transformed Recurrent|non-hodgkin lymphoma transformed recurrent
102185|NCT02927756|Discordant Lymphomas|discordant lymphomas
102186|NCT02927756|Composite Lymphomas|composite lymphomas
102187|NCT02927756|Follicular Lymphoma|follicular lymphoma
102188|NCT02927756|Aggressive Lymphoma|aggressive lymphoma
102189|NCT02927730|Retained placenta, surgical hysteroscopy, residua|retained placenta, surgical hysteroscopy, residua
102190|NCT02927717|Grade 3b Follicular Lymphoma|grade 3b follicular lymphoma
102191|NCT02927717|2016 WHO Criteria|2016 who criteria
102192|NCT02927717|Front-line treatment|front-line treatment
102193|NCT02927717|Rituximab|rituximab
102194|NCT02927704|Aggressive Periodontitis|aggressive periodontitis
102195|NCT02927704|monocyte chemoattractant protein-1|monocyte chemoattractant protein-1
102196|NCT02927704|gingival crevicular fluid|gingival crevicular fluid
102197|NCT02927704|enzyme-linked immunosorbent assay|enzyme-linked immunosorbent assay
102198|NCT02927691|Rehabilitation|rehabilitation
102199|NCT02927691|Parkinson's disease|parkinson's disease
102200|NCT02927691|Swallowing|swallowing
102201|NCT02927691|Cough|cough
102202|NCT02927691|Dysphagia|dysphagia
102203|NCT02927691|Dystussia|dystussia
102204|NCT02927678|Diabetic foot|diabetic foot
102205|NCT02927678|Osteomyelitis|osteomyelitis
102206|NCT02927678|Antibiotic treatment|antibiotic treatment
102207|NCT02927678|White Blood Cell SPECT/CT|white blood cell spect/ct
102208|NCT02927665|Weight Loss|weight loss
102209|NCT02927613|Home mechanical ventilation|home mechanical ventilation
102210|NCT02927613|Mortality|mortality
102211|NCT02927613|Complications|complications
102212|NCT02927613|Developing country|developing country
102213|NCT02927600|Glycemic response|glycemic response
102214|NCT02927600|Glycemic index|glycemic index
102215|NCT02927600|Meal intervention|meal intervention
102216|NCT02927600|Chinese population|chinese population
102217|NCT02927587|TCI|tci
102218|NCT02927587|fiberoptic bronchoscopy|fiberoptic bronchoscopy
102219|NCT02927587|sedation|sedation
102220|NCT02927574|drug-coated balloon angioplasty|drug-coated balloon angioplasty
102221|NCT02927574|angioplasty|angioplasty
102222|NCT02927574|plain old balloon angioplasty|plain old balloon angioplasty
102223|NCT02927574|peripheral arterial disease|peripheral arterial disease
102224|NCT02927574|intermittent claudication|intermittent claudication
102225|NCT02927574|systematic review|systematic review
102226|NCT02927574|meta-analysis|meta-analysis
102227|NCT02927574|Paclitaxel|paclitaxel
102228|NCT02927522|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
102229|NCT02927522|Donepezil|donepezil
102230|NCT02927522|Hip replacement|hip replacement
102231|NCT02927522|Knee replacement|knee replacement
102232|NCT02927496|Lymphedema|lymphedema
102233|NCT02927496|Lymphatic Filariasis|lymphatic filariasis
102234|NCT02927496|Filariasis|filariasis
102235|NCT02927496|Doxycycline|doxycycline
102236|NCT02927483|Venous Insufficiency|venous insufficiency
102237|NCT02927470|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
102238|NCT02927457|Cutaneous Lupus Erythematosus-CLE|cutaneous lupus erythematosus-cle
102239|NCT02927457|Spleen Tyrosine Kinase-SYK|spleen tyrosine kinase-syk
102240|NCT02927457|Photoprovocation-PV|photoprovocation-pv
102241|NCT02927457|GSK2646264|gsk2646264
102242|NCT02927431|Anti-inflammatory|anti-inflammatory
102243|NCT02927431|Danirixin|danirixin
102244|NCT02927431|Influenza|influenza
102245|NCT02927431|Hospitalized patients|hospitalized patients
102246|NCT02927405|gabapentin|gabapentin
102247|NCT02927405|TAP block|tap block
102248|NCT02927366|Pulmonary hypertension (PH),|pulmonary hypertension (ph),
102249|NCT02927366|Increase blood pressure in the pulmonary artery|increase blood pressure in the pulmonary artery
102250|NCT02927366|Increased blood pressure in the pulmonary vein|increased blood pressure in the pulmonary vein
102251|NCT02927366|Increased blood pressure in the lung vasculature|increased blood pressure in the lung vasculature
102252|NCT02927366|Shortness of breath|shortness of breath
102253|NCT02927366|Dizziness|dizziness
102254|NCT02927366|Fainting|fainting
102255|NCT02927366|Leg swelling|leg swelling
102256|NCT02927366|Cough|cough
102257|NCT02927366|Angina pector|angina pector
102258|NCT02927353|Bioequivalence, Biosimilarity, Pharmacokinetics, adalimumab|bioequivalence, biosimilarity, pharmacokinetics, adalimumab
102259|NCT02927340|Lung Cancer|lung cancer
102260|NCT02927288|PTSD, mTBI|ptsd, mtbi
102261|NCT02927262|Acute myeloid leukemia|acute myeloid leukemia
102262|NCT02927262|First Complete Remission|first complete remission
102263|NCT02927262|gilteritinib|gilteritinib
102264|NCT02927262|FLT3/ITD|flt3/itd
102265|NCT02927262|AML|aml
102266|NCT02927262|ASP2215|asp2215
102267|NCT02927236|Non-Invasive Brain Stimulation|non-invasive brain stimulation
102268|NCT02927236|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
102269|NCT02927210|Healthy Men|healthy men
102270|NCT02927210|Male Contraception|male contraception
102271|NCT02927210|Androgen|androgen
102272|NCT02927210|Dimethandrolone|dimethandrolone
102273|NCT02927171|Skilled Nursing Facility|skilled nursing facility
102274|NCT02927171|Post-Acute Care|post-acute care
102275|NCT02927171|Older Adults|older adults
102276|NCT02927171|Physical Function|physical function
102277|NCT02927171|Rehabilitation|rehabilitation
102278|NCT02927132|Drinking, Alcohol|drinking, alcohol
102279|NCT02927119|thyroglobulin|thyroglobulin
102280|NCT02927119|iodine|iodine
102281|NCT02927119|pregnancy|pregnancy
102282|NCT02927106|leukemia|leukemia
102283|NCT02927106|myeloid|myeloid
102284|NCT02927106|genomics|genomics
102285|NCT02927080|FSHD|fshd
102286|NCT02927041|hemodynamic transesophageal echocardiography|hemodynamic transesophageal echocardiography
102287|NCT02927028|energy availability|energy availability
102288|NCT02927028|walnuts|walnuts
102289|NCT02926989|Isotonic|isotonic
102290|NCT02926989|Hypotonic|hypotonic
102291|NCT02926989|Intravenous fluids|intravenous fluids
102292|NCT02926976|Schizophrenia|schizophrenia
102293|NCT02926963|Chronic Granulomatous Disease, Nox2, p22phox, iPS cells|chronic granulomatous disease, nox2, p22phox, ips cells
102294|NCT02926911|Ductal Carcinoma|ductal carcinoma
102295|NCT02926898|seizure|seizure
102296|NCT02926898|tonic clonic|tonic clonic
102297|NCT02926898|epilepsy|epilepsy
102298|NCT02926898|myoclonic|myoclonic
102299|NCT02926898|encephalopathy|encephalopathy
102300|NCT02926885|liver|liver
102301|NCT02926885|laparoscopy|laparoscopy
102302|NCT02926885|Bariatric Surgery|bariatric surgery
102303|NCT02926885|Esophagogastric Junction|esophagogastric junction
102304|NCT02926885|obesity|obesity
102305|NCT02926872|Screening|screening
102306|NCT02926872|Hepatic Injury|hepatic injury
102307|NCT02926872|Pediatric Patients|pediatric patients
102308|NCT02926846|Peritoneal dialysis|peritoneal dialysis
102309|NCT02926846|Lavage|lavage
102310|NCT02926820|Huntington disease|huntington disease
102438|NCT02926287|ambulatory surgery|ambulatory surgery
102311|NCT02926820|cognitive rehabilitation|cognitive rehabilitation
102312|NCT02926820|cognitive dysfunction|cognitive dysfunction
102313|NCT02926807|Atopic Dermatitis|atopic dermatitis
102314|NCT02926807|Vascular Inflammation|vascular inflammation
102315|NCT02926807|Coronary Atherosclerosis|coronary atherosclerosis
102316|NCT02926807|Ascending aorta|ascending aorta
102317|NCT02926807|Pet scan|pet scan
102318|NCT02926768|Cancer|cancer
102319|NCT02926768|Non Small Cell Lung Cancer|non small cell lung cancer
102320|NCT02926768|EGFR sensitivity mutation|egfr sensitivity mutation
102321|NCT02926768|T790M|t790m
102322|NCT02926768|NSCLC|nsclc
102323|NCT02926768|epidermal growth factor receptor|epidermal growth factor receptor
102324|NCT02926768|EGFR|egfr
102325|NCT02926768|EGFR inhibitor|egfr inhibitor
102326|NCT02926768|Solid Tumors|solid tumors
102327|NCT02926755|Intra Venous Ultrasound (IVUS)|intra venous ultrasound (ivus)
102328|NCT02926755|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
102329|NCT02926755|Optical Coherence Tomography (OCT)|optical coherence tomography (oct)
102330|NCT02926755|Acute Myocardial Infarction|acute myocardial infarction
102331|NCT02926755|Coronary Artery Disease (CAD)|coronary artery disease (cad)
102332|NCT02926755|Angiography|angiography
102333|NCT02926742|Thrombolysis|thrombolysis
102334|NCT02926742|Ultrasound Thrombolysis|ultrasound thrombolysis
102335|NCT02926742|Pulmonary Embolism|pulmonary embolism
102336|NCT02926742|Saddle PE|saddle pe
102337|NCT02926742|Submassive PE|submassive pe
102338|NCT02926742|Massive PE|massive pe
102339|NCT02926742|Bilateral PE|bilateral pe
102340|NCT02926729|Breast Cancer|breast cancer
102341|NCT02926716|Stomach neoplasm|stomach neoplasm
102342|NCT02926716|Endoscopy|endoscopy
102343|NCT02926716|Narrow band imaging|narrow band imaging
102344|NCT02926703|seizure|seizure
102345|NCT02926703|lactate|lactate
102346|NCT02926703|creatine kinase|creatine kinase
102347|NCT02926677|PTSD|ptsd
102348|NCT02926677|Child Trauma|child trauma
102349|NCT02926677|Cue-Centered Treatment|cue-centered treatment
102350|NCT02926677|Trauma-Focused Cognitive-Behavioral Therapy|trauma-focused cognitive-behavioral therapy
102351|NCT02926677|fNIRs|fnirs
102352|NCT02926677|CCT|cct
102353|NCT02926677|TF-CBT|tf-cbt
102354|NCT02926677|Posttraumatic stress|posttraumatic stress
102355|NCT02926677|NIRX|nirx
102356|NCT02926625|Unspecific fever|unspecific fever
102357|NCT02926625|Ethiopia|ethiopia
102358|NCT02926625|iCCM|iccm
102359|NCT02926625|CHW|chw
102360|NCT02926625|HEW|hew
102361|NCT02926599|High Fidelity Simulation|high fidelity simulation
102362|NCT02926586|RUNX1-RUNX1T1|runx1-runx1t1
102363|NCT02926586|CBFβ-MYH11|cbfβ-myh11
102364|NCT02926586|fludarabine|fludarabine
102365|NCT02926586|cytarabine|cytarabine
102366|NCT02926573|oral cavity|oral cavity
102367|NCT02926573|oropharynx|oropharynx
102368|NCT02926573|hypopharynx and larynx|hypopharynx and larynx
102369|NCT02926560|Chronic inflammatory rheumatism|chronic inflammatory rheumatism
102370|NCT02926547|proteomics|proteomics
102371|NCT02926534|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
102372|NCT02926534|smoking|smoking
102373|NCT02926534|prevalence|prevalence
102374|NCT02926534|cross-sectional study|cross-sectional study
102375|NCT02926534|Kazakhstan|kazakhstan
102376|NCT02926521|nerve block catheter|nerve block catheter
102377|NCT02926521|catheter fixation|catheter fixation
102378|NCT02926521|catheter dressing|catheter dressing
102379|NCT02926508|Reading|reading
102380|NCT02926508|Learning|learning
102381|NCT02926508|Cognition|cognition
102382|NCT02926482|Evidence-based practice implementation|evidence-based practice implementation
102383|NCT02926482|Buprenorphine|buprenorphine
102384|NCT02926482|Addiction treatment|addiction treatment
102385|NCT02926482|Extended-release naltrexone|extended-release naltrexone
102386|NCT02926482|Opioid use disorder|opioid use disorder
102387|NCT02926469|Virtual Reality|virtual reality
102388|NCT02926469|Analgesia|analgesia
102389|NCT02926469|Immersive Virtual Reality|immersive virtual reality
102390|NCT02926469|VR|vr
102391|NCT02926469|Labor|labor
102392|NCT02926469|Pain|pain
102393|NCT02926443|Shoulder|shoulder
102394|NCT02926443|Motor control|motor control
102395|NCT02926443|Proprioception|proprioception
102396|NCT02926443|Usual physiotherapy care|usual physiotherapy care
102397|NCT02926443|Supervised exercise program|supervised exercise program
102398|NCT02926404|Sagittal alignment|sagittal alignment
102399|NCT02926404|Surgical planning|surgical planning
102400|NCT02926404|Patient-specific|patient-specific
102401|NCT02926404|Adult Spinal Deformity|adult spinal deformity
102402|NCT02926352|LLLT|lllt
102403|NCT02926352|LLLS|llls
102404|NCT02926352|Low-Level Laser Stimulation|low-level laser stimulation
102405|NCT02926352|Low-Level Laser Therapy|low-level laser therapy
102406|NCT02926352|Low-Level Light Therapy|low-level light therapy
102407|NCT02926352|Transcranial infrared light stimulation|transcranial infrared light stimulation
102408|NCT02926352|Near-infrared light|near-infrared light
102409|NCT02926352|Photobiomodulation|photobiomodulation
102410|NCT02926352|Fear Extinction|fear extinction
102411|NCT02926352|Exposure Therapy|exposure therapy
102412|NCT02926352|Claustrophobia|claustrophobia
102413|NCT02926352|Fear of enclosed spaces|fear of enclosed spaces
102414|NCT02926352|Fear of contamination|fear of contamination
102415|NCT02926352|Fear of public speaking|fear of public speaking
102416|NCT02926352|Anxiety sensitivity|anxiety sensitivity
102417|NCT02926352|Cytochrome oxidase|cytochrome oxidase
102418|NCT02926352|Memory consolidation|memory consolidation
102419|NCT02926352|Cognitive enhancer|cognitive enhancer
102420|NCT02926326|Healthy Male volunteers|healthy male volunteers
102421|NCT02926313|RCT|rct
102422|NCT02926313|Specialized seating|specialized seating
102423|NCT02926313|Pressure ulcers|pressure ulcers
102424|NCT02926300|crohn's disease|crohn's disease
102425|NCT02926300|stem cell therapy|stem cell therapy
102426|NCT02926300|inflammatory bowel disease|inflammatory bowel disease
102427|NCT02926300|hUCB-MSC|hucb-msc
102428|NCT02926300|UCB-MSC|ucb-msc
102429|NCT02926300|Umbilical cord Blood|umbilical cord blood
102430|NCT02926300|Rheumatoid Arthritis|rheumatoid arthritis
102431|NCT02926300|RA|ra
102432|NCT02926300|Stem cell|stem cell
102433|NCT02926300|Cell therapy|cell therapy
102434|NCT02926300|Furestem|furestem
102435|NCT02926300|Mesenchymal stem cell|mesenchymal stem cell
102436|NCT02926300|MSC|msc
102437|NCT02926287|prolapse surgery|prolapse surgery
102439|NCT02926274|whole blood|whole blood
102440|NCT02926274|trauma|trauma
102441|NCT02926274|transfusion|transfusion
102442|NCT02926274|coagulopathy|coagulopathy
102443|NCT02926248|Arthrofibrosis|arthrofibrosis
102444|NCT02926235|Total Knee Arthroplasty|total knee arthroplasty
102445|NCT02926209|colonoscopy|colonoscopy
102446|NCT02926209|adenoma|adenoma
102447|NCT02926209|polyp|polyp
102448|NCT02926209|crc screening|crc screening
102449|NCT02926196|ER-Negative|er-negative
102450|NCT02926196|PR-Negative|pr-negative
102451|NCT02926196|HER2-Negative|her2-negative
102452|NCT02926144|Intratracheal intubation|intratracheal intubation
102453|NCT02926144|videolaryngoscope|videolaryngoscope
102454|NCT02926144|McGrath MAC|mcgrath mac
102455|NCT02926131|stick test|stick test
102456|NCT02926118|Glucose|glucose
102457|NCT02926118|Continuous glucose monitor|continuous glucose monitor
102458|NCT02926118|Glycemic load|glycemic load
102459|NCT02926118|Dietary intervention|dietary intervention
102460|NCT02926066|Aromatic L-amino acid decarboxylase (AADC)|aromatic l-amino acid decarboxylase (aadc)
102461|NCT02926014|Dysphagia|dysphagia
102462|NCT02926014|Lingual Tonsil Hypertrophy|lingual tonsil hypertrophy
102463|NCT02926014|Lingual Tonsil Enlargement|lingual tonsil enlargement
102464|NCT02926001|Taxes|taxes
102465|NCT02926001|Beverages/economics|beverages/economics
102466|NCT02926001|Carbonated Beverages/economics|carbonated beverages/economics
102467|NCT02926001|Diet, Food and Nutrition/economics|diet, food and nutrition/economics
102468|NCT02926001|Economics|economics
102469|NCT02926001|Energy Intake|energy intake
102470|NCT02926001|Risk Factors|risk factors
102471|NCT02925988|Critically ill|critically ill
102472|NCT02925988|High risk neonates|high risk neonates
102473|NCT02925949|Treatment|treatment
102474|NCT02925949|Adherence|adherence
102475|NCT02925949|Intervention|intervention
102476|NCT02925949|MSM Couples|msm couples
102477|NCT02925936|Radiography|radiography
102478|NCT02925936|Radiation|radiation
102479|NCT02925936|Diagnostic imaging|diagnostic imaging
102480|NCT02925871|stroke|stroke
102481|NCT02925871|rehabilitation|rehabilitation
102482|NCT02925871|interdisciplinary health team|interdisciplinary health team
102483|NCT02925871|patient-centered care|patient-centered care
102484|NCT02925871|care transition|care transition
102485|NCT02925858|Ketamine|ketamine
102486|NCT02925858|Cardiac surgery|cardiac surgery
102487|NCT02925858|Pain|pain
102488|NCT02925832|Deep topical fornix nerve block Anesthesia|deep topical fornix nerve block anesthesia
102489|NCT02925832|Ropivacaine|ropivacaine
102490|NCT02925832|Bupivacaine|bupivacaine
102491|NCT02925832|Anaesthesia|anaesthesia
102492|NCT02925832|Eye surgery blocks|eye surgery blocks
102493|NCT02925832|Phacoemulsification|phacoemulsification
102494|NCT02925819|Mitral regurgitation|mitral regurgitation
102495|NCT02925819|Mitral stenosis|mitral stenosis
102496|NCT02925819|Mitral valve repair deterioration|mitral valve repair deterioration
102497|NCT02925819|Bioprosthesis degeneration|bioprosthesis degeneration
102498|NCT02925780|Enamel defects|enamel defects
102499|NCT02925780|Fluorosis|fluorosis
102500|NCT02925741|bed linens|bed linens
102501|NCT02925728|Finger-Food|finger-food
102502|NCT02925702|Castration Resistant Prostate Cancer|castration resistant prostate cancer
102503|NCT02925702|Radium-223|radium-223
102504|NCT02925702|Biomarkers|biomarkers
102505|NCT02925663|executive functioning|executive functioning
102506|NCT02925650|Alzheimer's Disease|alzheimer's disease
102507|NCT02925650|SILK™|silk™
102508|NCT02925650|Pharmacodynamics|pharmacodynamics
102509|NCT02925650|Safety|safety
102510|NCT02925650|Pharmacokinetics|pharmacokinetics
102511|NCT02925624|ablation index|ablation index
102512|NCT02925624|pulmonary vein isolation|pulmonary vein isolation
102513|NCT02925624|implantable loop recorder|implantable loop recorder
102514|NCT02925611|Postoperative delirium|postoperative delirium
102515|NCT02925611|spine surgery|spine surgery
102516|NCT02925611|isoflurane|isoflurane
102517|NCT02925611|desflurane|desflurane
102518|NCT02925598|Laringeal masks|laringeal masks
102519|NCT02925598|Cholecystectomy, Laparascopic|cholecystectomy, laparascopic
102520|NCT02925598|Intubation, intratracheal|intubation, intratracheal
102521|NCT02925572|pediatric obesity|pediatric obesity
102522|NCT02925572|eccentric exercise|eccentric exercise
102523|NCT02925572|body composition|body composition
102524|NCT02925572|training program|training program
102525|NCT02925559|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
102526|NCT02925559|Glycemic Variability|glycemic variability
102527|NCT02925559|Dapagliflozin|dapagliflozin
102528|NCT02925559|Gliclazide MR|gliclazide mr
102529|NCT02925559|Continuous Glucose Monitoring|continuous glucose monitoring
102530|NCT02925559|Mean Amplitude of Glycemic Excursions|mean amplitude of glycemic excursions
102531|NCT02925559|MAGE|mage
102532|NCT02925546|Healthy|healthy
102533|NCT02925546|Pharmacokinetics|pharmacokinetics
102534|NCT02925546|Phase I|phase i
102535|NCT02925546|GSK2798745|gsk2798745
102536|NCT02925546|Tablet|tablet
102537|NCT02925533|Bladder Cancer|bladder cancer
102538|NCT02925533|Urothelial Cancer|urothelial cancer
102539|NCT02925520|Cholestasis|cholestasis
102540|NCT02925494|Uterine Fibroids|uterine fibroids
102541|NCT02925494|Elagolix|elagolix
102542|NCT02925494|Heavy Menstrual Bleeding|heavy menstrual bleeding
102543|NCT02925494|Elagolix Sodium|elagolix sodium
102544|NCT02925494|Elagolix plus Norethindrone Acetate|elagolix plus norethindrone acetate
102545|NCT02925481|Yoga|yoga
102546|NCT02925481|PTSD|ptsd
102547|NCT02925481|mental health|mental health
102548|NCT02925481|stillbirth|stillbirth
102549|NCT02925468|orthodontics|orthodontics
102550|NCT02925455|Hemiplegia|hemiplegia
102551|NCT02925455|Functional Electrical Stimulation|functional electrical stimulation
102552|NCT02925455|Video Games|video games
102553|NCT02925455|Occupational Therapy|occupational therapy
102554|NCT02925442|Unilateral Knee Arthroplasty|unilateral knee arthroplasty
102555|NCT02925442|Radiofrequency Ablation|radiofrequency ablation
102556|NCT02925442|Genicular|genicular
102557|NCT02925442|RFA|rfa
102558|NCT02925442|C-RFA|c-rfa
102559|NCT02925442|t-RFA|t-rfa
102560|NCT02925442|total knee replacement|total knee replacement
102561|NCT02925364|magnetic resonance imaging|magnetic resonance imaging
102562|NCT02925364|central pain processing|central pain processing
102563|NCT02925364|anatomical MRI|anatomical mri
102564|NCT02925364|fMRI|fmri
102565|NCT02925325|Major depressive disorder|major depressive disorder
102566|NCT02925325|Music therapy|music therapy
102567|NCT02925325|Residual symptoms|residual symptoms
102568|NCT02925286|gambling prevention|gambling prevention
102569|NCT02925286|workplace policy|workplace policy
102570|NCT02925273|dementia|dementia
102571|NCT02925234|Molecular tumor profile|molecular tumor profile
102572|NCT02925234|Multidisciplinary tumor board|multidisciplinary tumor board
102573|NCT02925234|Antitumor drugs|antitumor drugs
102574|NCT02925234|Molecular Targeted Therapy|molecular targeted therapy
102575|NCT02925234|Drug Repositioning|drug repositioning
102576|NCT02925234|Off-Label Use|off-label use
102577|NCT02925234|Sequence Analysis, DNA|sequence analysis, dna
102578|NCT02925221|Kidney Disease|kidney disease
102579|NCT02925221|ADPKD-Related Outcome|adpkd-related outcome
102580|NCT02925221|Quality of Life|quality of life
102581|NCT02925195|Vitamin D|vitamin d
102582|NCT02925195|cardiovascular disease|cardiovascular disease
102583|NCT02925195|MESA|mesa
102584|NCT02925195|genetics|genetics
102585|NCT02925195|pharmacogenetics|pharmacogenetics
102586|NCT02925195|blood pressure|blood pressure
102587|NCT02925195|biomarkers|biomarkers
102588|NCT02925169|Subglottis, cricoid, airway shape, CT imaging|subglottis, cricoid, airway shape, ct imaging
102589|NCT02925156|Activity Energy Expenditure|activity energy expenditure
102590|NCT02925156|Doubly Labeled Water|doubly labeled water
102591|NCT02925156|Physical Activity|physical activity
102592|NCT02925156|Obesity|obesity
102593|NCT02925156|Diabetes|diabetes
102594|NCT02925156|Cardiovascular Disease|cardiovascular disease
102595|NCT02925156|Adiponectin|adiponectin
102596|NCT02925156|Leptin|leptin
102597|NCT02925156|Ghrelin|ghrelin
102598|NCT02925143|Residual nerve blockade|residual nerve blockade
102599|NCT02925143|Neuromuscular monitoring|neuromuscular monitoring
102600|NCT02925143|Residual curarization|residual curarization
102601|NCT02925143|Neuromuscular blocking agents|neuromuscular blocking agents
102602|NCT02925143|E-learning|e-learning
102603|NCT02925143|Web based learning|web based learning
102604|NCT02925117|ABT-494|abt-494
102605|NCT02925117|Atopic Dermatitis|atopic dermatitis
102606|NCT02925104|cMET, INC280, food,|cmet, inc280, food,
102607|NCT02925065|Parkinson's|parkinson's
102608|NCT02925065|Non-traditional guitar instruction|non-traditional guitar instruction
102609|NCT02925065|Guitar therapy|guitar therapy
102610|NCT02925065|Upper extremity motor function|upper extremity motor function
102611|NCT02925065|Hand dexterity|hand dexterity
102612|NCT02925039|Rehabilitation|rehabilitation
102613|NCT02925039|Geriatric|geriatric
102614|NCT02925013|Omega 3|omega 3
102615|NCT02925013|Lipids|lipids
102616|NCT02925013|Pregnancy|pregnancy
102617|NCT02925000|Advanced Malignancy|advanced malignancy
102618|NCT02925000|lymphoma|lymphoma
102619|NCT02925000|TLC178|tlc178
102620|NCT02924948|Endoscopic ultrasonography|endoscopic ultrasonography
102621|NCT02924922|renal cell carcinoma|renal cell carcinoma
102622|NCT02924922|laparoscopic partial nephrectomy|laparoscopic partial nephrectomy
102623|NCT02924922|robot-assisted partial nephrectomy|robot-assisted partial nephrectomy
102624|NCT02924922|nephron sparing surgery|nephron sparing surgery
102625|NCT02924922|warm ischemia time|warm ischemia time
102626|NCT02924922|renal function loss|renal function loss
102627|NCT02924870|health education|health education
102628|NCT02924792|Intraosseous access|intraosseous access
102629|NCT02924740|stress urinary incontinence|stress urinary incontinence
102630|NCT02924740|quality of life|quality of life
102631|NCT02924740|pelvic floor muscle training|pelvic floor muscle training
102632|NCT02924740|pelvic floor muscle exercises|pelvic floor muscle exercises
102633|NCT02924740|vaginal tampon training|vaginal tampon training
102634|NCT02924727|Spontaneous AMI|spontaneous ami
102635|NCT02924727|HF hospitalization|hf hospitalization
102636|NCT02924727|outpatient HF|outpatient hf
102637|NCT02924727|LV systolic dysfunction|lv systolic dysfunction
102638|NCT02924727|pulmonary congestion|pulmonary congestion
102639|NCT02924727|STEMI|stemi
102640|NCT02924727|NSTEMI|nstemi
102641|NCT02924727|randomized clinical trial|randomized clinical trial
102642|NCT02924727|LCZ696|lcz696
102643|NCT02924727|ramipril|ramipril
102644|NCT02924714|GIST|gist
102645|NCT02924701|prognosis|prognosis
102646|NCT02924688|umeclidinium bromide|umeclidinium bromide
102647|NCT02924688|fluticasone furoate|fluticasone furoate
102648|NCT02924688|vilanterol|vilanterol
102649|NCT02924688|fixed dose combination|fixed dose combination
102650|NCT02924688|lung function|lung function
102651|NCT02924688|albuterol/salbutamol|albuterol/salbutamol
102652|NCT02924688|asthma|asthma
102653|NCT02924688|closed triple therapy|closed triple therapy
102654|NCT02924675|neuropathic pain, ent cancer, pregabalin|neuropathic pain, ent cancer, pregabalin
102655|NCT02924649|Brain injury|brain injury
102656|NCT02924649|Early mobilisation|early mobilisation
102657|NCT02924649|Consciousness|consciousness
102658|NCT02924649|Cerebral blood flow|cerebral blood flow
102659|NCT02924649|Blood pressure|blood pressure
102660|NCT02924636|C-section|c-section
102661|NCT02924636|Instrumental delivery|instrumental delivery
102662|NCT02924636|Pregnancy complications|pregnancy complications
102663|NCT02924636|Macrosomia|macrosomia
102664|NCT02924636|Neonatal complications|neonatal complications
102665|NCT02924584|hormonal receptor positive, human epidermal growth factor receptor 2 negative, breast cancer, aromatse inhibitor, overall survival, prevalence|hormonal receptor positive, human epidermal growth factor receptor 2 negative, breast cancer, aromatse inhibitor, overall survival, prevalence
102666|NCT02924558|Egg|egg
102667|NCT02924558|Protein|protein
102668|NCT02924558|Unsaturated fatty acids|unsaturated fatty acids
102669|NCT02924558|Triglycerides|triglycerides
102670|NCT02924558|Insulin sensitivity|insulin sensitivity
102671|NCT02924558|Lipid triad|lipid triad
102672|NCT02924506|cervical arthroplasty|cervical arthroplasty
102673|NCT02924493|Endometriosis|endometriosis
102674|NCT02924493|IBS|ibs
102675|NCT02924493|Irritable bowel syndrome|irritable bowel syndrome
102676|NCT02924493|low FODMAP diet|low fodmap diet
102677|NCT02924493|FODMAPs|fodmaps
102678|NCT02924493|visceral syndrome|visceral syndrome
102679|NCT02924493|fermentable carbohydrates|fermentable carbohydrates
102680|NCT02924493|visceral hypersensitivity|visceral hypersensitivity
102681|NCT02924493|cross organ effect|cross organ effect
102682|NCT02924480|invasive bladder cancer|invasive bladder cancer
102683|NCT02924480|cystectomy|cystectomy
102684|NCT02924480|high grade bladder cancer|high grade bladder cancer
102685|NCT02924467|reminder systems|reminder systems
102686|NCT02924467|Influenza vaccines|influenza vaccines
102687|NCT02924454|metoprolol|metoprolol
102688|NCT02924454|lipid emulsion|lipid emulsion
102689|NCT02924454|pharmacodynamics|pharmacodynamics
102690|NCT02924454|pharmacokinetics|pharmacokinetics
102691|NCT02924441|Mammogram|mammogram
102692|NCT02924441|Pain Management|pain management
102693|NCT02924441|Lidocaine|lidocaine
102695|NCT02924402|NHL|nhl
102696|NCT02924402|B-cell Prolymphocytic Leukemia|b-cell prolymphocytic leukemia
102697|NCT02924402|Transformed Lymphoma|transformed lymphoma
102698|NCT02924402|Burkitt's Lymphoma|burkitt's lymphoma
102699|NCT02924402|Mantle Cell Lymphoma|mantle cell lymphoma
102700|NCT02924402|Hairy Cell Leukemia|hairy cell leukemia
102701|NCT02924402|Splenic Marginal Zone Lymphoma|splenic marginal zone lymphoma
102702|NCT02924402|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
102703|NCT02924402|Variant Hairy Cell Leukemia|variant hairy cell leukemia
102704|NCT02924402|Splenic B-cell Lymphoma/Leukemia|splenic b-cell lymphoma/leukemia
102705|NCT02924402|Lymphoplasmacytic Lymphoma|lymphoplasmacytic lymphoma
102706|NCT02924402|Extranodal Marginal Zone Lymphoma (MALT)|extranodal marginal zone lymphoma (malt)
102707|NCT02924402|MALT Lymphoma|malt lymphoma
102708|NCT02924402|Nodal Marginal Zone Lymphoma|nodal marginal zone lymphoma
102709|NCT02924402|Follicular Lymphoma|follicular lymphoma
102710|NCT02924402|In Situ Follicular Neoplasia|in situ follicular neoplasia
102711|NCT02924402|Duodenal-type Follicular Lymphoma|duodenal-type follicular lymphoma
102712|NCT02924402|Large B-cell Lymphoma with IRF4 rearrangement|large b-cell lymphoma with irf4 rearrangement
102713|NCT02924402|Primary Cutaneous Follicle Center Lymphoma|primary cutaneous follicle center lymphoma
102714|NCT02924402|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
102716|NCT02924402|T-cell/Histiocyte-Rich Large B-cell Lymphoma|t-cell/histiocyte-rich large b-cell lymphoma
102717|NCT02924402|Primary Cutaneous DLBCL, leg type|primary cutaneous dlbcl, leg type
102718|NCT02924402|EBV-positive DLBCL, NOS|ebv-positive dlbcl, nos
102719|NCT02924402|EBV-positive Mucocutaneous Ulcer|ebv-positive mucocutaneous ulcer
102720|NCT02924402|DLBCL Associated with Chronic Inflammation|dlbcl associated with chronic inflammation
102721|NCT02924402|Lymphomatoid Granulomatosis|lymphomatoid granulomatosis
102722|NCT02924402|Primary Mediastinal (Thymic) Large B-cell Lymphoma|primary mediastinal (thymic) large b-cell lymphoma
102723|NCT02924402|Intravascular Large B-cell Lymphoma|intravascular large b-cell lymphoma
102724|NCT02924402|ALK+ Large B-cell Lymphoma|alk+ large b-cell lymphoma
102725|NCT02924402|Plasmablastic Lymphoma|plasmablastic lymphoma
102726|NCT02924402|Primary Effusion Lymphoma|primary effusion lymphoma
102727|NCT02924402|HHV8+ DLBCL|hhv8+ dlbcl
102728|NCT02924402|Burkitt-like Lymphoma with 11q Aberration|burkitt-like lymphoma with 11q aberration
102729|NCT02924402|High-grade B-cell Lymphoma|high-grade b-cell lymphoma
102730|NCT02924402|B-cell Lymphoma, unclassifiable|b-cell lymphoma, unclassifiable
102731|NCT02924402|Post-transplant Lymphoproliferative Disorder|post-transplant lymphoproliferative disorder
102732|NCT02924402|PTLD|ptld
102733|NCT02924402|CLL|cll
102734|NCT02924402|SLL|sll
102735|NCT02924402|High-grade Lymphoma|high-grade lymphoma
102736|NCT02924402|Richter's Transformation|richter's transformation
102737|NCT02924376|Cholangiocarcinoma|cholangiocarcinoma
102738|NCT02924376|fibroblast growth factor (FGF)|fibroblast growth factor (fgf)
102739|NCT02924376|fibroblast growth factor receptor (FGFR)|fibroblast growth factor receptor (fgfr)
102740|NCT02924376|FGF/FGFR alterations|fgf/fgfr alterations
102741|NCT02924363|Cardiac Magnetic Resonance|cardiac magnetic resonance
102742|NCT02924363|Mitra Clip|mitra clip
102743|NCT02924363|Mitral Valve|mitral valve
102744|NCT02924337|QT/QTC interval|qt/qtc interval
102745|NCT02924337|Hypoglycemic Agents|hypoglycemic agents
102746|NCT02924337|Imeglimin|imeglimin
102747|NCT02924337|Healthy Volunteers|healthy volunteers
102748|NCT02924324|local Injection|local injection
102749|NCT02924324|pain Medication|pain medication
102750|NCT02924324|propofol|propofol
102751|NCT02924324|ropivacaine|ropivacaine
102752|NCT02924324|16-1417|16-1417
102753|NCT02924311|Diabetic Macular Edema|diabetic macular edema
102754|NCT02924272|Drug Therapy|drug therapy
102755|NCT02924259|muscle soreness|muscle soreness
102756|NCT02924259|pain|pain
102757|NCT02924259|myofascial release|myofascial release
102758|NCT02924246|immunity|immunity
102759|NCT02924246|vaccination|vaccination
102760|NCT02924246|milk|milk
102761|NCT02924233|Squamous|squamous
102762|NCT02924233|Non-Small Cell Lung Cancer|non-small cell lung cancer
102763|NCT02924233|NSCLC|nsclc
102764|NCT02924207|diabetes mellitus|diabetes mellitus
102765|NCT02924181|pulmonary vein isolation|pulmonary vein isolation
102766|NCT02924181|contact force sensing catheter|contact force sensing catheter
102767|NCT02924142|Kennedy classification for edentulous ridge|kennedy classification for edentulous ridge
102768|NCT02924129|Chronic Pain|chronic pain
102769|NCT02924129|Back Pain|back pain
102770|NCT02924129|Leg Pain|leg pain
102771|NCT02924129|Pain|pain
102772|NCT02924129|Neurologic Manifestations|neurologic manifestations
102773|NCT02924129|Nervous System Diseases|nervous system diseases
102774|NCT02924129|Signs and Symptoms|signs and symptoms
102775|NCT02924129|SCS|scs
102776|NCT02924129|Closed Loop|closed loop
102777|NCT02924116|insomnia|insomnia
102778|NCT02924116|sleep|sleep
102779|NCT02924116|Bioboosti|bioboosti
102780|NCT02924116|Biomobie|biomobie
102781|NCT02924116|device|device
102782|NCT02924103|acute rhinosinusitis|acute rhinosinusitis
102783|NCT02924103|staphylococcus aureus|staphylococcus aureus
102784|NCT02924103|nasal vestibule|nasal vestibule
102785|NCT02924103|contamination|contamination
102786|NCT02924090|Major depressive disorder|major depressive disorder
102787|NCT02924090|Etomidate|etomidate
102788|NCT02924090|Ketamine|ketamine
102789|NCT02924090|Hyperventilation|hyperventilation
102790|NCT02924090|Electroconvulsive therapy|electroconvulsive therapy
102791|NCT02924090|Depression|depression
102792|NCT02924090|Anesthesia|anesthesia
102793|NCT02924090|Nervous System Diseases|nervous system diseases
102794|NCT02924090|Mental Disorders|mental disorders
102795|NCT02924090|Electroencephalography|electroencephalography
102796|NCT02924090|Cerebral Metabolism|cerebral metabolism
102797|NCT02924038|low-grade glioma|low-grade glioma
102798|NCT02924038|glioma|glioma
102799|NCT02924038|immunotherapy|immunotherapy
102800|NCT02924038|vaccine|vaccine
102801|NCT02924038|WHO grade II|who grade ii
102802|NCT02924012|post exercise hypotension|post exercise hypotension
102803|NCT02924012|exercise|exercise
102804|NCT02924012|video games|video games
102805|NCT02923999|HIV|hiv
102806|NCT02923999|MAB|mab
102807|NCT02923999|PLANT|plant
102808|NCT02923986|Liposomal Grb-2 treatment of Ph+ CML|liposomal grb-2 treatment of ph+ cml
102809|NCT02923986|Liposomal Grb-2 with Das for Ph+ CML|liposomal grb-2 with das for ph+ cml
102810|NCT02923947|Pharmacokinetics,|pharmacokinetics,
102811|NCT02923947|Renal impairment,|renal impairment,
102812|NCT02923947|Safety assessments,|safety assessments,
102813|NCT02923947|Solid tumours,|solid tumours,
102814|NCT02923947|EGFRm+|egfrm+
102815|NCT02923947|EGFRm+/T790M+ inhibitor|egfrm+/t790m+ inhibitor
102816|NCT02923908|Palatability|palatability
102817|NCT02923908|Pediatrics|pediatrics
102818|NCT02923908|Facial Recognition|facial recognition
102819|NCT02923908|Taste|taste
102820|NCT02923908|Facial Expressions|facial expressions
102821|NCT02923882|Low-birth-weight|low-birth-weight
102822|NCT02923882|Model kitchen|model kitchen
102823|NCT02923882|Improved cookstove|improved cookstove
102824|NCT02923869|Levobupivacaine|levobupivacaine
102825|NCT02923869|Bupivacaine|bupivacaine
102826|NCT02923869|Nerve Block|nerve block
102827|NCT02923869|Cleft Palate|cleft palate
102828|NCT02923856|Helicobacter pylori|helicobacter pylori
102829|NCT02923856|Antibiotic resistance|antibiotic resistance
102830|NCT02923856|Sequencing|sequencing
102831|NCT02923843|frailty|frailty
102832|NCT02923843|comprehensive geriatric assessment|comprehensive geriatric assessment
102833|NCT02923817|spinal cord injury|spinal cord injury
102834|NCT02923817|autologous transplants|autologous transplants
102835|NCT02923817|bone marrow derived mononuclear cells|bone marrow derived mononuclear cells
102836|NCT02923804|steatosis|steatosis
102837|NCT02923804|NAFL|nafl
102838|NCT02923804|NAFLD|nafld
102839|NCT02923804|Polyunsaturated fatty acids|polyunsaturated fatty acids
102840|NCT02923804|omega-3|omega-3
102841|NCT02923804|EPA|epa
102842|NCT02923804|DHA|dha
102843|NCT02923804|fish oil|fish oil
102844|NCT02923739|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
102845|NCT02923739|Ovarian Cancer|ovarian cancer
102846|NCT02923739|Fallopian Tube Cancer|fallopian tube cancer
102847|NCT02923739|Primary Peritoneal Cancer|primary peritoneal cancer
102848|NCT02923739|relapsed/refractory|relapsed/refractory
102849|NCT02923739|Platinum-resistant disease|platinum-resistant disease
102850|NCT02923739|Paclitaxel|paclitaxel
102851|NCT02923739|Taxol|taxol
102852|NCT02923739|Bevacizumab|bevacizumab
102853|NCT02923739|Avastin|avastin
102854|NCT02923739|rhuMAb-VEGF|rhumab-vegf
102855|NCT02923739|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
102856|NCT02923739|Emactuzumab|emactuzumab
102857|NCT02923739|RO5509554|ro5509554
102858|NCT02923726|Antitachycardia Pacing Therapy|antitachycardia pacing therapy
102859|NCT02923726|Shock Therapy|shock therapy
102860|NCT02923726|Primary Prevention|primary prevention
102861|NCT02923700|platelet rich plasma|platelet rich plasma
102862|NCT02923700|intra-articular injection|intra-articular injection
102863|NCT02923700|leukocytes|leukocytes
102864|NCT02923687|Ketorolac|ketorolac
102865|NCT02923687|Root canal treatment|root canal treatment
102866|NCT02923687|Pain|pain
102867|NCT02923687|Premedication|premedication
102868|NCT02923661|single implant|single implant
102869|NCT02923635|Oncoplastic breast surgery|oncoplastic breast surgery
102870|NCT02923635|Standard Wide Local Excision|standard wide local excision
102871|NCT02923596|Keloid|keloid
102872|NCT02923570|proton-beam radiation therapy (PBRT)|proton-beam radiation therapy (pbrt)
102873|NCT02923570|intensity-modulated radiation therapy (IMRT)|intensity-modulated radiation therapy (imrt)
102874|NCT02923570|16-1416|16-1416
102875|NCT02923544|Uterine Manipulator|uterine manipulator
102876|NCT02923544|Yukio's Uterine Manipulating Instrument (YUMI)|yukio's uterine manipulating instrument (yumi)
102877|NCT02923544|16-1397|16-1397
102878|NCT02923518|Heart Screening|heart screening
102879|NCT02923518|Master Athletes|master athletes
102880|NCT02923518|Cardiovascular Disease|cardiovascular disease
102881|NCT02923479|Rehabilitation|rehabilitation
102882|NCT02923479|Robotics|robotics
102883|NCT02923466|refractory solid tumor|refractory solid tumor
102884|NCT02923427|laryngeal mask Supreme|laryngeal mask supreme
102885|NCT02923427|i-gel|i-gel
102886|NCT02923427|laparoscopic gynecological surgery|laparoscopic gynecological surgery
102887|NCT02923414|Cardioversion|cardioversion
102888|NCT02923401|Exercise|exercise
102889|NCT02923401|Biomarkers|biomarkers
102890|NCT02923401|Breast cancer high risk|breast cancer high risk
102891|NCT02923401|Treadmill|treadmill
102892|NCT02923401|Stationary bicycle|stationary bicycle
102893|NCT02923401|Questionnaires|questionnaires
102894|NCT02923401|Surveys|surveys
102895|NCT02923401|Motivational sessions|motivational sessions
102896|NCT02923401|Phone calls|phone calls
102897|NCT02923401|Printed materials|printed materials
102898|NCT02923362|GERD|gerd
102899|NCT02923362|Reflux|reflux
102900|NCT02923362|Acid Reflux|acid reflux
102901|NCT02923362|Heartburn|heartburn
102902|NCT02923362|Regurgitation|regurgitation
102903|NCT02923362|Laryngopharyngeal Reflux|laryngopharyngeal reflux
102904|NCT02923362|Hiatal Hernia|hiatal hernia
102905|NCT02923362|LPR|lpr
102906|NCT02923362|LINX|linx
102907|NCT02923362|Magnetic Sphincter Augmentation|magnetic sphincter augmentation
102908|NCT02923362|Antireflux Surgery|antireflux surgery
102909|NCT02923362|Nissen|nissen
102910|NCT02923349|Solid tumor|solid tumor
102911|NCT02923349|adenocarcinoma of the endometrium|adenocarcinoma of the endometrium
102912|NCT02923349|ovarian cancer|ovarian cancer
102913|NCT02923349|renal cell carcinoma|renal cell carcinoma
102914|NCT02923349|melanoma|melanoma
102915|NCT02923349|non-small cell lung cancer|non-small cell lung cancer
102916|NCT02923349|OX40|ox40
102917|NCT02923349|immunoglobulin G monoclonal antibody|immunoglobulin g monoclonal antibody
102918|NCT02923336|liver cirrhosis|liver cirrhosis
102919|NCT02923336|variceal bleeding|variceal bleeding
102920|NCT02923336|non selective beta blockers|non selective beta blockers
102921|NCT02923323|Neurocognitive Function|neurocognitive function
102922|NCT02923323|MRI|mri
102923|NCT02923323|Diffusion Tensor Imaging (DTI)|diffusion tensor imaging (dti)
102924|NCT02923323|Sleep|sleep
102925|NCT02923297|parkinson|parkinson
102926|NCT02923297|alpha-synuclein|alpha-synuclein
102927|NCT02923297|GALIG|galig
102928|NCT02923297|quantitative PCR (polymerase chain reaction)|quantitative pcr (polymerase chain reaction)
102929|NCT02923271|Driving|driving
102930|NCT02923271|Teens|teens
102931|NCT02923271|Texting|texting
102932|NCT02923271|Cellphone|cellphone
102933|NCT02923271|DriveID|driveid
102934|NCT02923271|Motor vehicle accident|motor vehicle accident
102935|NCT02923258|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
102936|NCT02923258|concurrent chemotherapy|concurrent chemotherapy
102937|NCT02923258|High-Risk|high-risk
102938|NCT02923232|Contact lens; Accommodation; Visual performance|contact lens; accommodation; visual performance
102939|NCT02923219|Facial Rejuvenation|facial rejuvenation
102940|NCT02923219|Adipose-Derived Stem Cells|adipose-derived stem cells
102941|NCT02923206|apheresis|apheresis
102942|NCT02923206|pregnancy|pregnancy
102943|NCT02923206|pre-eclampsia|pre-eclampsia
102945|NCT02923206|sFlt-1|sflt-1
102946|NCT02923206|Pre-term|pre-term
102947|NCT02923167|CP|cp
102948|NCT02923167|Cerebral Palsy|cerebral palsy
102949|NCT02923167|Robotic|robotic
102950|NCT02923167|Hand|hand
102951|NCT02923167|Rehabilitation|rehabilitation
102952|NCT02923154|NASH|nash
102953|NCT02923141|substance use|substance use
102954|NCT02923141|trauma|trauma
102955|NCT02923141|HIV|hiv
102956|NCT02923141|viral load|viral load
102957|NCT02923141|women|women
102958|NCT02923115|Venous thromboembolism|venous thromboembolism
102959|NCT02923115|VTE|vte
102960|NCT02923115|Pulmonary embolism|pulmonary embolism
102961|NCT02923115|PE|pe
102962|NCT02923115|Acute Submassive Pulmonary Embolism|acute submassive pulmonary embolism
102963|NCT02923102|Recovery|recovery
102964|NCT02923102|Muscle soreness|muscle soreness
102965|NCT02923102|Lemon Verbena|lemon verbena
102966|NCT02923089|Diabetes|diabetes
102967|NCT02923089|Lentils|lentils
102968|NCT02923089|Pulses|pulses
102969|NCT02923089|Postprandial glycemia|postprandial glycemia
102970|NCT02923076|Allogeneic Hematopoietic Cell Transplantation|allogeneic hematopoietic cell transplantation
102971|NCT02923063|Chronic Kidney Disease|chronic kidney disease
102972|NCT02923063|Mitochondrial Metabolism|mitochondrial metabolism
102973|NCT02923063|Physical Performance|physical performance
102974|NCT02923063|Exercise Intolerance|exercise intolerance
102975|NCT02923063|Muscle Fatigue|muscle fatigue
102976|NCT02922998|CD64 antigens|cd64 antigens
102977|NCT02922998|Biomarkers|biomarkers
102978|NCT02922998|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
102979|NCT02922998|Interleukin-4|interleukin-4
102980|NCT02922998|Interferon-gamma|interferon-gamma
102981|NCT02922998|C-reactive protein|c-reactive protein
102982|NCT02922998|lipopolysaccharide-binding protein|lipopolysaccharide-binding protein
102983|NCT02922998|procalcitonin|procalcitonin
102984|NCT02922998|Cytokines|cytokines
102985|NCT02922998|Patients|patients
102986|NCT02922998|Human|human
102987|NCT02922998|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
102988|NCT02922998|Sepsis|sepsis
102989|NCT02922998|Infection|infection
102990|NCT02922998|Antibiotics|antibiotics
102991|NCT02922998|Intensive Care Units|intensive care units
102992|NCT02922998|Point-of-Care Systems|point-of-care systems
102993|NCT02922998|Bedside Testing|bedside testing
102994|NCT02922985|Cesarean delivery|cesarean delivery
102995|NCT02922985|Multimodal pain management|multimodal pain management
102996|NCT02922972|Keloid scar|keloid scar
102997|NCT02922972|Wound healing|wound healing
102998|NCT02922972|Platelet-Rich Plasma|platelet-rich plasma
102999|NCT02922972|RegenLab|regenlab
103000|NCT02922959|Opioid Substitution Treatment|opioid substitution treatment
103001|NCT02922959|Telephone intervention|telephone intervention
103002|NCT02922959|secondary prevention|secondary prevention
103003|NCT02922959|naloxone|naloxone
103004|NCT02922946|entinostat|entinostat
103005|NCT02922946|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
103006|NCT02922946|HDAC|hdac
103007|NCT02922933|entinostat|entinostat
103008|NCT02922933|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
103009|NCT02922933|HDAC|hdac
103010|NCT02922868|Cystoscopy|cystoscopy
103011|NCT02922868|EndoSheath|endosheath
103012|NCT02922868|Infection Control|infection control
103013|NCT02922868|Bacteriuria|bacteriuria
103014|NCT02922842|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
103015|NCT02922829|Food Insecurity|food insecurity
103016|NCT02922829|Nutrition|nutrition
103017|NCT02922816|Carbapenem-resistant Enterobacteriaceae (CRE)|carbapenem-resistant enterobacteriaceae (cre)
103018|NCT02922816|Vancomycin-resistant Enterococcus (VRE)|vancomycin-resistant enterococcus (vre)
103019|NCT02922816|Multidrug Resistant Organism (MDRO)|multidrug resistant organism (mdro)
103020|NCT02922816|Fecal Microbiota Transplant (FMT)|fecal microbiota transplant (fmt)
103021|NCT02922816|Renal Transplant|renal transplant
103022|NCT02922816|Colonization|colonization
103023|NCT02922816|Infection|infection
103024|NCT02922816|Antibiotic Resistance|antibiotic resistance
103025|NCT02922816|Resistome|resistome
103026|NCT02922816|Multidrug Resistant (MDR) Pseudomonas|multidrug resistant (mdr) pseudomonas
103027|NCT02922790|smoker|smoker
103028|NCT02922790|smoking|smoking
103029|NCT02922790|cigarette|cigarette
103030|NCT02922790|cessation|cessation
103031|NCT02922790|DNA|dna
103032|NCT02922790|DNA damage|dna damage
103033|NCT02922790|blood draw|blood draw
103034|NCT02922790|feedback|feedback
103035|NCT02922790|cellular|cellular
103036|NCT02922790|tobacco|tobacco
103037|NCT02922790|tobacco smoke|tobacco smoke
103038|NCT02922764|Solid malignancy|solid malignancy
103039|NCT02922764|Lymphoma|lymphoma
103040|NCT02922764|Solid tumor|solid tumor
103041|NCT02922764|Melanoma|melanoma
103042|NCT02922764|Non-small cell lung cancer|non-small cell lung cancer
103043|NCT02922764|Epithelial ovarian carcinoma|epithelial ovarian carcinoma
103044|NCT02922764|Triple Breast cancer|triple breast cancer
103045|NCT02922764|NSCLC|nsclc
103046|NCT02922764|EOC|eoc
103047|NCT02922764|TNBC|tnbc
103048|NCT02922764|LXR|lxr
103049|NCT02922764|ApoE|apoe
103050|NCT02922764|mBC|mbc
103051|NCT02922764|Small cell lung cancer|small cell lung cancer
103052|NCT02922764|Renal cell cancer|renal cell cancer
103053|NCT02922764|Bladder cancer|bladder cancer
103054|NCT02922764|SCLC|sclc
103055|NCT02922764|RCC|rcc
103056|NCT02922764|BLC|blc
103057|NCT02922751|transient elastography|transient elastography
103058|NCT02922751|pediatric liver disease|pediatric liver disease
103059|NCT02922751|biliary atresia|biliary atresia
103060|NCT02922751|Alagille Syndrome|alagille syndrome
103061|NCT02922751|Alpha1 Anti-Trypsin Deficiency|alpha1 anti-trypsin deficiency
103062|NCT02922751|liver fibrosis|liver fibrosis
103063|NCT02922751|cholestasis|cholestasis
103064|NCT02922738|Clinical Knowledge Systems, Decision support, Dermatology|clinical knowledge systems, decision support, dermatology
103065|NCT02922738|Technology Assessment|technology assessment
103066|NCT02922673|human endotoxemia|human endotoxemia
103067|NCT02922673|LPS|lps
103068|NCT02922673|acetylsalicylic acid|acetylsalicylic acid
103069|NCT02922673|placebo|placebo
103070|NCT02922673|endotoxin tolerance|endotoxin tolerance
103071|NCT02922660|Ambulatory surgery|ambulatory surgery
103072|NCT02922660|Ophthalmic|ophthalmic
103073|NCT02922660|Inhalation anesthesia|inhalation anesthesia
103074|NCT02922660|Desflurane|desflurane
103075|NCT02922660|Total intravenous anesthesia|total intravenous anesthesia
103076|NCT02922634|postoperative health outcomes|postoperative health outcomes
103077|NCT02922634|older surgical patients|older surgical patients
103078|NCT02922608|Education, Medical|education, medical
103079|NCT02922543|Multiple Myeloma|multiple myeloma
103080|NCT02922543|Teratogenicity|teratogenicity
103081|NCT02922543|Thrombocytopenia and haemorrhage|thrombocytopenia and haemorrhage
103082|NCT02922543|Neutropenia and infection|neutropenia and infection
103083|NCT02922543|Venous thromboembolism|venous thromboembolism
103084|NCT02922543|Allergic reactions|allergic reactions
103085|NCT02922543|Diarrhoea or constipation|diarrhoea or constipation
103086|NCT02922543|Peripheral neuropathy|peripheral neuropathy
103087|NCT02922543|Cardiac failure|cardiac failure
103088|NCT02922543|Arrhythmia|arrhythmia
103089|NCT02922543|Renal failure|renal failure
103090|NCT02922543|Myocardial infarction|myocardial infarction
103091|NCT02922543|Interstitial lung disease|interstitial lung disease
103092|NCT02922543|Tumour lysis syndrome|tumour lysis syndrome
103093|NCT02922517|biomarkers|biomarkers
103094|NCT02922517|echocardiography|echocardiography
103095|NCT02922517|MRI imaging|mri imaging
103096|NCT02922517|nuclear medicine|nuclear medicine
103097|NCT02922504|First trimester abortion|first trimester abortion
103098|NCT02922504|Surgical abortion|surgical abortion
103099|NCT02922504|Music intervention|music intervention
103100|NCT02922504|Local anesthesia|local anesthesia
103101|NCT02922504|Pain|pain
103102|NCT02922439|chronic disease|chronic disease
103103|NCT02922439|multimorbidity|multimorbidity
103104|NCT02922439|chronic disease self-management|chronic disease self-management
103105|NCT02922439|tailored information|tailored information
103106|NCT02922439|mobile applications|mobile applications
103107|NCT02922426|ALKS 3831|alks 3831
103108|NCT02922426|Samidorphan|samidorphan
103109|NCT02922426|Olanzapine|olanzapine
103110|NCT02922413|Porphyria|porphyria
103111|NCT02922413|Heme|heme
103112|NCT02922400|Autism|autism
103113|NCT02922400|Traumatic Brain Injury|traumatic brain injury
103114|NCT02922400|Schizophrenia|schizophrenia
103892|NCT02918032|CGI-58 gene|cgi-58 gene
103115|NCT02922400|Virtual-Reality Social Cognition Training|virtual-reality social cognition training
103116|NCT02922387|varenicline|varenicline
103117|NCT02922387|COPD|copd
103118|NCT02922387|asthma|asthma
103119|NCT02922387|pneumonia|pneumonia
103120|NCT02922387|smoking cessation|smoking cessation
103121|NCT02922374|acute severe colitis|acute severe colitis
103122|NCT02922374|corticosteroids|corticosteroids
103123|NCT02922374|UCEIS|uceis
103124|NCT02922374|fecal calprotectin|fecal calprotectin
103125|NCT02922348|premature ovarian failure|premature ovarian failure
103126|NCT02922348|hormone replacement|hormone replacement
103127|NCT02922335|Antisocial Behavior|antisocial behavior
103128|NCT02922335|Mental Illness|mental illness
103129|NCT02922335|Emerging Adulthood|emerging adulthood
103130|NCT02922335|Criminal Behavior|criminal behavior
103131|NCT02922335|Serious Mental Illness|serious mental illness
103132|NCT02922322|Mat Pilates|mat pilates
103133|NCT02922322|Chronic Nonspecific low back pain|chronic nonspecific low back pain
103134|NCT02922322|Quality of life|quality of life
103135|NCT02922322|Disability|disability
103136|NCT02922322|transverse abdominal muscle|transverse abdominal muscle
103137|NCT02922283|T cell response|t cell response
103138|NCT02922283|Interleukin 2|interleukin 2
103139|NCT02922283|PET scan|pet scan
103140|NCT02922283|Ipilimumab|ipilimumab
103141|NCT02922283|Pembrolizumab|pembrolizumab
103142|NCT02922283|Nivolumab|nivolumab
103143|NCT02922270|peritoneal dialysis: outcome|peritoneal dialysis: outcome
103144|NCT02922270|peritoneal dialysis: complications|peritoneal dialysis: complications
103145|NCT02922270|peritoneal dialysis: technique|peritoneal dialysis: technique
103146|NCT02922270|peritoneal dialysis: peritonitis|peritoneal dialysis: peritonitis
103147|NCT02922244|herbal products|herbal products
103148|NCT02922244|reduction of radiation-induced dermatitis|reduction of radiation-induced dermatitis
103149|NCT02922244|breast cancer|breast cancer
103150|NCT02922244|radiotherapy|radiotherapy
103151|NCT02922218|Castration Resistant Prostate Cancer|castration resistant prostate cancer
103152|NCT02922218|Enzalutamide|enzalutamide
103153|NCT02922218|Biomarkers|biomarkers
103154|NCT02922192|Anti-inflammatory|anti-inflammatory
103155|NCT02922192|Biologics|biologics
103156|NCT02922192|Biologic and Biosimilars Collective Intelligence Consortium|biologic and biosimilars collective intelligence consortium
103157|NCT02922192|BBCIC|bbcic
103158|NCT02922179|Insulin|insulin
103159|NCT02922179|Diabetes|diabetes
103160|NCT02922179|Biologic and Biosimilars Collective Intelligence Consortium|biologic and biosimilars collective intelligence consortium
103161|NCT02922179|BBCIC|bbcic
103162|NCT02922179|Descriptive analysis|descriptive analysis
103163|NCT02922153|CryoAnalgesia|cryoanalgesia
103164|NCT02922153|Thoracotomy|thoracotomy
103165|NCT02922153|FEV1|fev1
103166|NCT02922153|VAS|vas
103167|NCT02922140|pharmaceutical care service, clinical pharmacist|pharmaceutical care service, clinical pharmacist
103168|NCT02922140|Cardiac rehabilitation unit|cardiac rehabilitation unit
103169|NCT02922140|Acute coronary syndrome|acute coronary syndrome
103170|NCT02922140|patient education and counselling|patient education and counselling
103171|NCT02922127|Ulipristal Acetate (UPA)|ulipristal acetate (upa)
103172|NCT02922127|Breast Cancer|breast cancer
103173|NCT02922127|Combined Oral Contraceptive (COC)|combined oral contraceptive (coc)
103174|NCT02922114|Ultrasonography|ultrasonography
103175|NCT02922114|Clinical assesment|clinical assesment
103176|NCT02922114|joint abnormalities|joint abnormalities
103177|NCT02922088|Vein Graft Failure|vein graft failure
103178|NCT02922088|Coronary Artery Bypass Graft Surgery|coronary artery bypass graft surgery
103179|NCT02922088|Vascular Grafts|vascular grafts
103180|NCT02922088|Saphenous Vein Grafts|saphenous vein grafts
103181|NCT02922088|Vein Graft Disease|vein graft disease
103182|NCT02922088|Vein Graft Treatment|vein graft treatment
103183|NCT02922088|Vein Graft Handling|vein graft handling
103184|NCT02922075|gingival recession|gingival recession
103185|NCT02922075|immediate implant and provisional placement|immediate implant and provisional placement
103186|NCT02922075|bone graft|bone graft
103187|NCT02922075|connective tissue graft|connective tissue graft
103188|NCT02922075|collagen matrix|collagen matrix
103189|NCT02922062|lipids|lipids
103190|NCT02922062|saturated fat|saturated fat
103191|NCT02922062|palm oil|palm oil
103192|NCT02922049|Probe Based Confocal Laser Endomicroscopy (pCLE)|probe based confocal laser endomicroscopy (pcle)
103193|NCT02922049|Barrett's esophagus|barrett's esophagus
103194|NCT02922049|BORN|born
103195|NCT02922049|Intestinal metaplasia|intestinal metaplasia
103196|NCT02921997|A/H5N1|a/h5n1
103197|NCT02921997|A/H7N9|a/h7n9
103198|NCT02921997|ASO3 Adjuvant|aso3 adjuvant
103199|NCT02921997|influenza|influenza
103200|NCT02921997|monovalent|monovalent
103201|NCT02921997|pH1N1|ph1n1
103202|NCT02921997|vaccines|vaccines
103203|NCT02921984|Salivary Gland Tumors|salivary gland tumors
103204|NCT02921984|Head and Neck Cancer|head and neck cancer
103205|NCT02921984|concurrent chemotherapy|concurrent chemotherapy
103206|NCT02921984|genetic testing|genetic testing
103207|NCT02921958|Parents of children with disabilities|parents of children with disabilities
103208|NCT02921932|Physiotherapy|physiotherapy
104089|NCT02916888|Eczema|eczema
103209|NCT02921932|Inspiratory Muscle Training|inspiratory muscle training
103210|NCT02921932|Perioperative Medicine|perioperative medicine
103211|NCT02921932|Postoperative outcomes|postoperative outcomes
103212|NCT02921932|Preoperative nutrition|preoperative nutrition
103213|NCT02921932|Elderly, frail|elderly, frail
103214|NCT02921906|Insulin|insulin
103215|NCT02921906|Glucose|glucose
103216|NCT02921906|Incretin|incretin
103217|NCT02921906|GLP-1|glp-1
103218|NCT02921906|Food|food
103219|NCT02921867|ultrasound|ultrasound
103220|NCT02921867|radiology|radiology
103221|NCT02921867|simulation|simulation
103222|NCT02921867|abdominal ultrasound|abdominal ultrasound
103223|NCT02921867|medical education|medical education
103224|NCT02921841|Adolescents|adolescents
103225|NCT02921841|HIV prevention|hiv prevention
103226|NCT02921841|computerized intervention|computerized intervention
103227|NCT02921841|mental health treatment|mental health treatment
103228|NCT02921828|Pomalyst|pomalyst
103229|NCT02921828|Teratogenicity|teratogenicity
103230|NCT02921828|bone marrow suppression|bone marrow suppression
103231|NCT02921828|thromboembolism|thromboembolism
103232|NCT02921828|peripheral neuropathy|peripheral neuropathy
103233|NCT02921828|infection|infection
103234|NCT02921828|tumour lysis syndrome|tumour lysis syndrome
103235|NCT02921828|somnolence|somnolence
103236|NCT02921828|depressed level of consciousness|depressed level of consciousness
103237|NCT02921828|confusion|confusion
103238|NCT02921828|fatigue|fatigue
103239|NCT02921828|dizziness|dizziness
103240|NCT02921828|acute renal failure|acute renal failure
103241|NCT02921828|heart failure|heart failure
103242|NCT02921828|arrhythmia|arrhythmia
103243|NCT02921828|interstitial pneumonia|interstitial pneumonia
103244|NCT02921828|hypersensitivity|hypersensitivity
103245|NCT02921828|hepatic function disorder|hepatic function disorder
103246|NCT02921828|jaundice|jaundice
103247|NCT02921815|Leukemia|leukemia
103248|NCT02921815|Acute Myeloid Leukemia|acute myeloid leukemia
103249|NCT02921815|Revlimid|revlimid
103250|NCT02921802|Teratogenicity|teratogenicity
103251|NCT02921802|Thrombocytopenia and haemorrhage|thrombocytopenia and haemorrhage
103252|NCT02921802|Neutropenia and infection|neutropenia and infection
103253|NCT02921802|Venous thromboembolism|venous thromboembolism
103254|NCT02921802|Allergic reactions|allergic reactions
103255|NCT02921802|Diarrhoea or constipation|diarrhoea or constipation
103256|NCT02921802|Peripheral neuropathy|peripheral neuropathy
103257|NCT02921802|Cardiac failure|cardiac failure
103258|NCT02921802|Arrhythmia|arrhythmia
103259|NCT02921802|Renal failure|renal failure
103260|NCT02921802|Myocardial infarction|myocardial infarction
103261|NCT02921802|Interstitial lung disease|interstitial lung disease
103262|NCT02921802|Tumour lysis syndrome|tumour lysis syndrome
103263|NCT02921802|Transformation from myelodysplastic syndrome to acute myeloid leukemia|transformation from myelodysplastic syndrome to acute myeloid leukemia
103264|NCT02921789|Bleselumab|bleselumab
103265|NCT02921789|ASKP1240|askp1240
103266|NCT02921789|Efficacy and Safety|efficacy and safety
103267|NCT02921776|Vidatalk|vidatalk
103268|NCT02921776|App|app
103269|NCT02921776|Augmentative and Alternative Communication|augmentative and alternative communication
103270|NCT02921776|iPad|ipad
103271|NCT02921776|Android|android
103272|NCT02921776|Mechanical ventilation|mechanical ventilation
103273|NCT02921776|Patient Communication|patient communication
103274|NCT02921776|Critical Illness|critical illness
103275|NCT02921750|wound reduction wound healing, venous ulcers|wound reduction wound healing, venous ulcers
103276|NCT02921737|metastatic|metastatic
103277|NCT02921737|pancreatic|pancreatic
103278|NCT02921737|adenocarcinoma|adenocarcinoma
103279|NCT02921724|cancer|cancer
103280|NCT02921724|oral drug|oral drug
103281|NCT02921724|sunitinib|sunitinib
103282|NCT02921724|capecitabine|capecitabine
103283|NCT02921724|mobile app|mobile app
103284|NCT02921659|nicotinamide riboside|nicotinamide riboside
103285|NCT02921659|aging|aging
103286|NCT02921659|arterial stiffness|arterial stiffness
103287|NCT02921659|endothelial dysfunction|endothelial dysfunction
103288|NCT02921646|energetic expenditure|energetic expenditure
103289|NCT02921633|Immunization|immunization
103290|NCT02921633|Behavioural insights|behavioural insights
103291|NCT02921633|Children|children
103292|NCT02921620|Gastrointestinal symptoms|gastrointestinal symptoms
103293|NCT02921620|Diarrhea|diarrhea
103294|NCT02921620|Abdominal pain|abdominal pain
103295|NCT02921581|Dose painting|dose painting
103296|NCT02921581|18F-FDG|18f-fdg
103297|NCT02921581|Positron emission tomography|positron emission tomography
103298|NCT02921581|Radiotherapy|radiotherapy
103299|NCT02921555|RCT (randomized controlled trial)|rct (randomized controlled trial)
103300|NCT02921529|Postoperative recovery|postoperative recovery
103301|NCT02921529|colon surgery|colon surgery
103302|NCT02921516|Adolescence|adolescence
103303|NCT02921516|Adherence|adherence
103304|NCT02921438|Cardiovascular Diseases|cardiovascular diseases
103305|NCT02921438|Heart Diseases|heart diseases
103306|NCT02921438|Myocardial Ischemia|myocardial ischemia
103307|NCT02921438|NSTE ACS|nste acs
103308|NCT02921438|NSTEMI|nstemi
103309|NCT02921438|Unstable Angina Pectoris|unstable angina pectoris
103310|NCT02921438|Coronary Artery Disease|coronary artery disease
103311|NCT02921425|lifestyle|lifestyle
103312|NCT02921425|patient health record|patient health record
103313|NCT02921425|Veterans|veterans
103314|NCT02921425|prediabetes|prediabetes
103315|NCT02921373|perfluorocarbon imaging|perfluorocarbon imaging
103316|NCT02921373|peripheral blood mononuclear cells|peripheral blood mononuclear cells
103317|NCT02921373|cancer immunotherapy|cancer immunotherapy
103318|NCT02921373|prostate cancer|prostate cancer
103319|NCT02921373|MRI|mri
103320|NCT02921360|thrombolytic therapy|thrombolytic therapy
103321|NCT02921360|tissue plasminogen activator|tissue plasminogen activator
103322|NCT02921360|aspirin|aspirin
103323|NCT02921321|MRI|mri
103324|NCT02921321|Muscular Dystrophy|muscular dystrophy
103325|NCT02921321|Cardiac|cardiac
103326|NCT02921321|Late gadolinium enhancement|late gadolinium enhancement
103327|NCT02921308|Prematurity|prematurity
103328|NCT02921308|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
103329|NCT02921308|MRI|mri
103330|NCT02921308|PFT|pft
103331|NCT02921308|Emphysema|emphysema
103332|NCT02921282|genes|genes
103333|NCT02921282|cues|cues
103334|NCT02921282|reward|reward
103335|NCT02921282|smoking|smoking
103336|NCT02921230|atherosclerosis|atherosclerosis
103337|NCT02921230|Superficial Femoral Artery (SFA)|superficial femoral artery (sfa)
103338|NCT02921230|Proximal Popliteal Artery (PPA)|proximal popliteal artery (ppa)
103339|NCT02921230|stenting|stenting
103340|NCT02921230|paclitaxel|paclitaxel
103341|NCT02921217|Cardiovascular diseases|cardiovascular diseases
103342|NCT02921217|abdominal visceral fat|abdominal visceral fat
103343|NCT02921217|subcutaneous body fat|subcutaneous body fat
103344|NCT02921217|body weight|body weight
103345|NCT02921217|waist circumference|waist circumference
103346|NCT02921217|lipid profile|lipid profile
103347|NCT02921217|insulin resistance|insulin resistance
103348|NCT02921217|glucose metabolism|glucose metabolism
103349|NCT02921217|blood pressure|blood pressure
103350|NCT02921217|inflammation|inflammation
103351|NCT02921217|adiponectin|adiponectin
103352|NCT02921217|leptin|leptin
103353|NCT02921217|metabolomics|metabolomics
103354|NCT02921217|cardiovascular risk factor|cardiovascular risk factor
103355|NCT02921204|Vitamin D|vitamin d
103356|NCT02921204|Calcium|calcium
103357|NCT02921204|Phytic Acid|phytic acid
103358|NCT02921204|body weight|body weight
103359|NCT02921191|recombinant human granulocyte colony-stimulating factors|recombinant human granulocyte colony-stimulating factors
103360|NCT02921191|G-CSFs|g-csfs
103361|NCT02921191|biosimilar|biosimilar
103362|NCT02921191|biologics|biologics
103363|NCT02921191|High Neutropenia Risk Chemotherapy|high neutropenia risk chemotherapy
103364|NCT02921191|Biologic and Biosimilars Collective Intelligence Consortium|biologic and biosimilars collective intelligence consortium
103365|NCT02921191|bbcic|bbcic
103366|NCT02921165|tooth extraction|tooth extraction
103367|NCT02921165|tooth socket healing|tooth socket healing
103368|NCT02921165|hypertension|hypertension
103369|NCT02921165|rinses|rinses
103370|NCT02921139|Hepatocellular Carcinoma|hepatocellular carcinoma
103371|NCT02921139|Transcatheter Arterial Chemoembolization (TACE)|transcatheter arterial chemoembolization (tace)
103372|NCT02921139|Stereotactic ablative radiotherapy (SABR)|stereotactic ablative radiotherapy (sabr)
103373|NCT02921113|suPAR|supar
103374|NCT02921113|Acute Kidney Injury|acute kidney injury
103375|NCT02921113|On-Pump Cardiac Surgery|on-pump cardiac surgery
103376|NCT02921113|Biomarker|biomarker
103377|NCT02921048|Eicosapentaenoic Acid|eicosapentaenoic acid
103378|NCT02921048|Docosahexaenoic Acid|docosahexaenoic acid
103379|NCT02921048|Ambient Air Pollution|ambient air pollution
103380|NCT02921035|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
103381|NCT02921035|Interferon beta-1a|interferon beta-1a
103382|NCT02921035|Rebif®|rebif®
103383|NCT02921035|Morisky Medication Adherence Scale|morisky medication adherence scale
103384|NCT02921022|Gemcitabine|gemcitabine
103385|NCT02921022|Nab-paclitaxel|nab-paclitaxel
103386|NCT02921022|PEGPH20|pegph20
103387|NCT02921022|Rivaroxaban|rivaroxaban
103388|NCT02921022|thromboembolic event (TE)|thromboembolic event (te)
103389|NCT02921022|16-1066|16-1066
103390|NCT02920996|NSCLC|nsclc
103391|NCT02920996|MET|met
103392|NCT02920996|Non-small cell lung cancer|non-small cell lung cancer
103393|NCT02920996|MET mutation|met mutation
103394|NCT02920996|NTRK rearrangement|ntrk rearrangement
103395|NCT02920996|NTRK|ntrk
103396|NCT02920996|targeted therapy|targeted therapy
103397|NCT02920996|MET exon 14|met exon 14
103398|NCT02920996|NTRK1|ntrk1
103399|NCT02920996|NTRK2|ntrk2
103400|NCT02920996|NTRK3|ntrk3
103401|NCT02920996|merestinib|merestinib
103402|NCT02920996|LY2801653|ly2801653
103403|NCT02920918|Systolic Heart Failure|systolic heart failure
103404|NCT02920918|Canagliflozin|canagliflozin
103405|NCT02920918|Sitagliptin Phosphate|sitagliptin phosphate
103406|NCT02920918|Type 2 Diabetes|type 2 diabetes
103407|NCT02920918|SGLT2 inhibitor|sglt2 inhibitor
103408|NCT02920918|DPPIV inhibitor|dppiv inhibitor
103409|NCT02920866|Functional strength integration|functional strength integration
103410|NCT02920866|Rehabilitation|rehabilitation
103411|NCT02920866|Hip arthroplasty|hip arthroplasty
103412|NCT02920866|Physical function|physical function
103413|NCT02920866|Muscle performance|muscle performance
103414|NCT02920866|Movement compensations|movement compensations
103415|NCT02920853|chronic pain|chronic pain
103416|NCT02920827|HIV Infections|hiv infections
103417|NCT02920827|HIV seronegativity|hiv seronegativity
103418|NCT02920801|saxagliptin|saxagliptin
103419|NCT02920801|endothelial progenitor cell|endothelial progenitor cell
103420|NCT02920801|flow-mediated dilation|flow-mediated dilation
103421|NCT02920788|Rehabilitation|rehabilitation
103422|NCT02920788|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
103423|NCT02920749|anaesthesia|anaesthesia
103424|NCT02920749|costs|costs
103425|NCT02920749|recovery profiles|recovery profiles
103426|NCT02920723|Sleep Apnea Syndromes|sleep apnea syndromes
103427|NCT02920723|Sleep Apnea, Obstructives|sleep apnea, obstructives
103428|NCT02920723|Training|training
103429|NCT02920684|Early rehabilitation|early rehabilitation
103430|NCT02920684|Mechanical ventilation|mechanical ventilation
103431|NCT02920684|Physiotherapy|physiotherapy
103432|NCT02920658|NAVS Naphthalan|navs naphthalan
103433|NCT02920658|Betamethasone dipropionate|betamethasone dipropionate
103434|NCT02920658|Topical treatment|topical treatment
103435|NCT02920645|ICH|ich
103436|NCT02920645|AVM|avm
103805|NCT02918422|Diet Intervention|diet intervention
103437|NCT02920645|intracerebral hemorrhage|intracerebral hemorrhage
103438|NCT02920645|arterio-venous malformation|arterio-venous malformation
103439|NCT02920645|AVICH|avich
103440|NCT02920632|Parkinson|parkinson
103441|NCT02920632|Cognitive training|cognitive training
103442|NCT02920632|Cognitive rehabilitation|cognitive rehabilitation
103443|NCT02920632|Brain networks|brain networks
103444|NCT02920619|ultrasound|ultrasound
103445|NCT02920619|muscle|muscle
103446|NCT02920606|pulpotomy|pulpotomy
103447|NCT02920606|pulpitis|pulpitis
103448|NCT02920606|mature tooth|mature tooth
103449|NCT02920606|tricalcium silicate|tricalcium silicate
103450|NCT02920593|Vitamin D; hypertensive disorders of pregnancy|vitamin d; hypertensive disorders of pregnancy
103451|NCT02920580|Subarachnoid hemorrhage|subarachnoid hemorrhage
103452|NCT02920580|Spontaneous intracerebral hemorrhage|spontaneous intracerebral hemorrhage
103453|NCT02920580|Global cerebral anoxia/cardiac arrest|global cerebral anoxia/cardiac arrest
103454|NCT02920580|Meningitis/Encephalitis/Cerebral abscess|meningitis/encephalitis/cerebral abscess
103455|NCT02920580|Seizure|seizure
103456|NCT02920580|Traumatic Brain Injury (TBI)|traumatic brain injury (tbi)
103457|NCT02920580|Ischemic Stroke|ischemic stroke
103458|NCT02920580|Brain tumor|brain tumor
103459|NCT02920554|gallbladder cancer|gallbladder cancer
103460|NCT02920554|bisegmentectomy|bisegmentectomy
103461|NCT02920515|epidemiology|epidemiology
103462|NCT02920515|treatment|treatment
103463|NCT02920515|molecular pathological mechanism|molecular pathological mechanism
103464|NCT02920515|environmental disrupting chemicals|environmental disrupting chemicals
103465|NCT02920489|severity of labor pain|severity of labor pain
103466|NCT02920489|individualized administration|individualized administration
103467|NCT02920489|neuraxial labor analgesia|neuraxial labor analgesia
103468|NCT02920476|lung|lung
103469|NCT02920476|metastatic|metastatic
103470|NCT02920476|carcinoma|carcinoma
103471|NCT02920463|Anti-Infective agents|anti-infective agents
103472|NCT02920463|Antimicrobial stewardship|antimicrobial stewardship
103473|NCT02920463|Empirical antibiotic therapy|empirical antibiotic therapy
103474|NCT02920463|De-escalation|de-escalation
103475|NCT02920463|Critical care|critical care
103476|NCT02920450|lung|lung
103477|NCT02920450|carcinoma|carcinoma
103478|NCT02920437|dietary salt|dietary salt
103479|NCT02920437|24 hour urinary sodium excretion|24 hour urinary sodium excretion
103480|NCT02920437|blood pressure|blood pressure
103481|NCT02920437|hypertension|hypertension
103482|NCT02920346|Neonatal Systemic lupus erythematosus|neonatal systemic lupus erythematosus
103483|NCT02920346|Sjogren's syndrome|sjogren's syndrome
103484|NCT02920346|Fetal Atrioventricular Block|fetal atrioventricular block
103485|NCT02920346|Fetal Heart Block|fetal heart block
103486|NCT02920333|stroke|stroke
103487|NCT02920333|transcraniel direct current stimulation|transcraniel direct current stimulation
103488|NCT02920333|repetitive transcraniel magnetic stimulation|repetitive transcraniel magnetic stimulation
103489|NCT02920333|rehabilitation|rehabilitation
103490|NCT02920333|lower extremities|lower extremities
103491|NCT02920307|laparoscopic inguinal hernia repair|laparoscopic inguinal hernia repair
103492|NCT02920307|total extraperitoneoscopic hernia repair|total extraperitoneoscopic hernia repair
103493|NCT02920307|transabdominal preperitoneal hernia repair|transabdominal preperitoneal hernia repair
103494|NCT02920307|inguinal hernia|inguinal hernia
103495|NCT02920307|laparoscopy|laparoscopy
103496|NCT02920307|hernia repair|hernia repair
103497|NCT02920307|herniorraphy|herniorraphy
103498|NCT02920307|laparoscopic surgery|laparoscopic surgery
103499|NCT02920294|probiotics, microbiota, ileostoma|probiotics, microbiota, ileostoma
103500|NCT02920268|dance-intervention|dance-intervention
103501|NCT02920268|yoga|yoga
103502|NCT02920268|adolescents|adolescents
103503|NCT02920268|recurrent abdominal pain|recurrent abdominal pain
103504|NCT02920242|Travelers|travelers
103505|NCT02920242|diarrhea|diarrhea
103506|NCT02920242|rifaximin|rifaximin
103507|NCT02920242|equivalence|equivalence
103508|NCT02920229|68Ga-PSMA|68ga-psma
103509|NCT02920229|HBED-PET/CT|hbed-pet/ct
103510|NCT02920229|biochemical relapse|biochemical relapse
103511|NCT02920229|prostate cancer|prostate cancer
103512|NCT02920229|radically treated|radically treated
103513|NCT02920216|Head and Neck Neoplasms|head and neck neoplasms
103514|NCT02920216|Recurrence|recurrence
103515|NCT02920216|Indocyanine Green|indocyanine green
103516|NCT02920216|Salvage surgery|salvage surgery
103517|NCT02920203|Sudden unexpected death|sudden unexpected death
103518|NCT02920203|young subjects|young subjects
103519|NCT02920203|molecular genetic autopsy|molecular genetic autopsy
103520|NCT02920203|sequencing|sequencing
103521|NCT02920138|Obesity|obesity
103522|NCT02920138|intraabdominal pressure|intraabdominal pressure
103523|NCT02920138|cerebral oxymeter|cerebral oxymeter
103524|NCT02920138|sleeve gastrectomy|sleeve gastrectomy
103525|NCT02920138|laparoscopy|laparoscopy
103526|NCT02920125|Vascular disease|vascular disease
103527|NCT02920112|Obesity|obesity
103528|NCT02920112|Bariatric Surgery|bariatric surgery
103529|NCT02920112|Bariatrics|bariatrics
103530|NCT02920112|Cognitive Therapy|cognitive therapy
103531|NCT02920112|Binge eating|binge eating
103532|NCT02920099|Nutrition literacy|nutrition literacy
103533|NCT02920073|Microbiota|microbiota
103534|NCT02920073|anorexia nervosa|anorexia nervosa
103535|NCT02920073|under nutrition|under nutrition
103536|NCT02920073|inpatients|inpatients
103537|NCT02920073|enteral nutrition|enteral nutrition
103538|NCT02920060|RSE|rse
103539|NCT02920047|Fimasartan|fimasartan
103540|NCT02920008|AML, acute myeloid leukemia, guadecitabine, SGI-110, Phase 3|aml, acute myeloid leukemia, guadecitabine, sgi-110, phase 3
103541|NCT02919982|Anticoagulant|anticoagulant
103542|NCT02919982|Nonvalvular atrial fibrillation|nonvalvular atrial fibrillation
103543|NCT02919982|Registries|registries
103544|NCT02919969|Anal Cancer|anal cancer
103545|NCT02919956|Single Ventricle|single ventricle
103546|NCT02919956|Fontan|fontan
103547|NCT02919904|prostate cancer|prostate cancer
103548|NCT02919904|sleep|sleep
103549|NCT02919904|androgen deprivation therapy|androgen deprivation therapy
103550|NCT02919891|intra-epidermal nerve fibre density|intra-epidermal nerve fibre density
103551|NCT02919891|IENFD|ienfd
103552|NCT02919891|Chronic Pain|chronic pain
103553|NCT02919891|Post-mastectomy|post-mastectomy
103554|NCT02919891|Post-mastectomy pain syndrome|post-mastectomy pain syndrome
103555|NCT02919891|PMPS|pmps
103556|NCT02919891|Chronic Post-Surgical Pain|chronic post-surgical pain
103557|NCT02919891|CPSP|cpsp
103558|NCT02919891|Mastectomy|mastectomy
103806|NCT02918422|Metabolic Syndrome|metabolic syndrome
103559|NCT02919813|mindfulness group therapy|mindfulness group therapy
103560|NCT02919813|vulvodynia|vulvodynia
103561|NCT02919813|vulvar pain|vulvar pain
103562|NCT02919787|Neoadjuvant treatment|neoadjuvant treatment
103563|NCT02919761|persistant disease activity|persistant disease activity
103564|NCT02919748|dementia|dementia
103565|NCT02919748|cognitive decline|cognitive decline
103566|NCT02919748|choral singing|choral singing
103567|NCT02919748|health education program|health education program
103568|NCT02919748|randomized controlled trial|randomized controlled trial
103569|NCT02919735|Alopecia|alopecia
103570|NCT02919735|Hair|hair
103571|NCT02919735|Chemotherapy|chemotherapy
103572|NCT02919735|Cancer|cancer
103573|NCT02919722|Music therapy|music therapy
103574|NCT02919722|sensorimotor cortex|sensorimotor cortex
103575|NCT02919722|brain injury|brain injury
103576|NCT02919696|CDK4/6 Inhibitor|cdk4/6 inhibitor
103577|NCT02919683|Head and Neck Cancer|head and neck cancer
103578|NCT02919670|Stem Cell Transplant|stem cell transplant
103579|NCT02919644|vaccination|vaccination
103580|NCT02919644|autologous dendritic cells|autologous dendritic cells
103581|NCT02919644|autologous tumour homogenate|autologous tumour homogenate
103582|NCT02919644|curative resection|curative resection
103583|NCT02919644|stage IV colorectal cancer|stage iv colorectal cancer
103584|NCT02919618|Ventricular Tachycardia|ventricular tachycardia
103585|NCT02919618|Ablation|ablation
103586|NCT02919618|Noninvasive|noninvasive
103587|NCT02919605|Cutaneous Leishmaniasis|cutaneous leishmaniasis
103588|NCT02919605|pentamidine isothionate|pentamidine isothionate
103589|NCT02919605|treatment|treatment
103590|NCT02919553|endoscopic ultrasound|endoscopic ultrasound
103591|NCT02919553|wet-suction technique|wet-suction technique
103592|NCT02919553|capillary technique|capillary technique
103593|NCT02919553|fine needle aspiration|fine needle aspiration
103594|NCT02919553|fine needle biopsy|fine needle biopsy
103595|NCT02919514|fall prevention|fall prevention
103596|NCT02919514|Aging|aging
103597|NCT02919514|surfaces|surfaces
103598|NCT02919475|JTE-051|jte-051
103599|NCT02919475|Active Rheumatoid Arthritis|active rheumatoid arthritis
103600|NCT02919475|Efficacy|efficacy
103601|NCT02919475|Safety|safety
103602|NCT02919475|Tolerability|tolerability
104191|NCT02916056|ADAS-cog|adas-cog
103603|NCT02919475|Rheumatoid Arthritis|rheumatoid arthritis
103604|NCT02919462|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
103605|NCT02919462|advanced stage IIIB|advanced stage iiib
103606|NCT02919462|high Thymidylate Synthase expression|high thymidylate synthase expression
103607|NCT02919462|Treatment|treatment
103608|NCT02919462|Chemotherapy Naïve Patients|chemotherapy naïve patients
103609|NCT02919462|stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer|stage iiib-iv non-squamous non-small cell lung cancer
103610|NCT02919462|Cisplatin and Pemetrexed|cisplatin and pemetrexed
103611|NCT02919462|Cisplatin and Oral Vinorelbine|cisplatin and oral vinorelbine
103612|NCT02919449|Lung Cancer Measles Nivolumab Opdivo|lung cancer measles nivolumab opdivo
103613|NCT02919384|Embryonic development|embryonic development
103614|NCT02919384|blastocyst stage|blastocyst stage
103615|NCT02919345|Dapagliflozin|dapagliflozin
103616|NCT02919345|Glibenclamide|glibenclamide
103617|NCT02919345|Endothelial Function|endothelial function
103618|NCT02919345|Vascular Endothelial Cells|vascular endothelial cells
103619|NCT02919345|Flow Mediated Dilation|flow mediated dilation
103620|NCT02919267|One lung ventilation|one lung ventilation
103621|NCT02919267|Lung collapse|lung collapse
103622|NCT02919267|Bronchial blocker|bronchial blocker
103623|NCT02919267|Double lumen tube|double lumen tube
103624|NCT02919267|video assisted thoracoscopic surgery|video assisted thoracoscopic surgery
103625|NCT02919267|VATS|vats
103626|NCT02919267|DLT|dlt
103627|NCT02919267|Thoracic surgery|thoracic surgery
103628|NCT02919267|Video-assisted|video-assisted
103629|NCT02919241|dental anxiety|dental anxiety
103630|NCT02919241|cognitive therapy|cognitive therapy
103631|NCT02919228|cerebral oxygen metabolism|cerebral oxygen metabolism
103632|NCT02919228|functional near-infrared spectroscopy|functional near-infrared spectroscopy
103633|NCT02919228|partial pressure of carbon dioxide|partial pressure of carbon dioxide
103634|NCT02919228|heart rate variability|heart rate variability
103635|NCT02919228|blood pressure|blood pressure
103636|NCT02919228|affect|affect
103637|NCT02919228|mood|mood
103638|NCT02919228|respiration|respiration
103639|NCT02919228|systematic randomized cross-over study|systematic randomized cross-over study
103640|NCT02919228|systemic physiology|systemic physiology
103641|NCT02919228|electro-dermal activity|electro-dermal activity
103642|NCT02919228|pulse-respiratory quotient|pulse-respiratory quotient
103643|NCT02919189|cerebral oxygen metabolism|cerebral oxygen metabolism
103644|NCT02919189|functional near-infrared spectroscopy|functional near-infrared spectroscopy
103645|NCT02919189|partial pressure of carbon dioxide|partial pressure of carbon dioxide
103646|NCT02919189|heart rate variability|heart rate variability
103647|NCT02919189|blood pressure|blood pressure
103648|NCT02919189|affect|affect
103649|NCT02919189|mood|mood
103650|NCT02919189|respiration|respiration
103651|NCT02919189|systematic randomized cross-over study|systematic randomized cross-over study
103652|NCT02919189|systemic physiology|systemic physiology
103653|NCT02919189|electro-dermal activity|electro-dermal activity
103654|NCT02919189|pulse-respiratory quotient|pulse-respiratory quotient
103655|NCT02919163|cerebral oxygen metabolism|cerebral oxygen metabolism
103656|NCT02919163|functional near-infrared spectroscopy|functional near-infrared spectroscopy
103657|NCT02919163|partial pressure of carbon dioxide|partial pressure of carbon dioxide
103658|NCT02919163|heart rate variability|heart rate variability
103659|NCT02919163|blood pressure|blood pressure
103660|NCT02919163|affect|affect
103661|NCT02919163|mood|mood
103662|NCT02919163|respiration|respiration
103663|NCT02919163|systematic randomized cross-over study|systematic randomized cross-over study
103664|NCT02919163|systemic physiology|systemic physiology
103665|NCT02919163|electro-dermal activity|electro-dermal activity
103666|NCT02919163|pulse-respiratory quotient|pulse-respiratory quotient
103667|NCT02919150|Myofascial Trigger Points|myofascial trigger points
103668|NCT02919150|Myotonometry|myotonometry
103669|NCT02919150|Isokinetic Dynamometry|isokinetic dynamometry
103670|NCT02919150|Assessment|assessment
103671|NCT02919150|Reliability|reliability
103672|NCT02919137|cerebral oxygen metabolism|cerebral oxygen metabolism
103673|NCT02919137|functional near-infrared spectroscopy|functional near-infrared spectroscopy
103674|NCT02919137|partial pressure of carbon dioxide|partial pressure of carbon dioxide
103675|NCT02919137|heart rate variability|heart rate variability
103676|NCT02919137|blood pressure|blood pressure
103677|NCT02919137|affect|affect
103678|NCT02919137|mood|mood
103679|NCT02919137|respiration|respiration
103680|NCT02919137|systematic randomized cross-over study|systematic randomized cross-over study
103681|NCT02919137|systemic physiology|systemic physiology
103682|NCT02919137|electro-dermal activity|electro-dermal activity
103683|NCT02919137|pulse-respiratory quotient|pulse-respiratory quotient
103684|NCT02919124|Coronary artery bypass grafting|coronary artery bypass grafting
103685|NCT02919124|Anastomosis|anastomosis
103686|NCT02919124|Ultrasonography|ultrasonography
103687|NCT02919059|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
103688|NCT02919059|DM|dm
103689|NCT02919046|neuroblastoma|neuroblastoma
103690|NCT02919046|CAR-T|car-t
103691|NCT02919033|randomized controlled trial|randomized controlled trial
103692|NCT02919033|telemedicine|telemedicine
103693|NCT02919033|hypertension|hypertension
103694|NCT02919033|primary care|primary care
103695|NCT02919033|medication adherence|medication adherence
103696|NCT02919020|Proprioceptive Neuromuscular Facilitation (PNF )|proprioceptive neuromuscular facilitation (pnf )
103697|NCT02919020|resistance exercise|resistance exercise
103698|NCT02918968|enzalutamide|enzalutamide
103699|NCT02918968|Xtandi|xtandi
103700|NCT02918968|Prostate Cancer|prostate cancer
103701|NCT02918955|head and neck cancer|head and neck cancer
103702|NCT02918955|radiotherapy|radiotherapy
103703|NCT02918955|chemotherapy|chemotherapy
103704|NCT02918955|neck dissection|neck dissection
103705|NCT02918955|surgery|surgery
103706|NCT02918955|quality of life|quality of life
103707|NCT02918955|toxicity|toxicity
103708|NCT02918955|oropharyngeal cancer|oropharyngeal cancer
103709|NCT02918955|laryngeal cancer|laryngeal cancer
103710|NCT02918955|hypopharyngeal cancer|hypopharyngeal cancer
103711|NCT02918929|First-in-human|first-in-human
103712|NCT02918929|Single Ascending Dose|single ascending dose
103713|NCT02918929|Multiple Ascending Dose|multiple ascending dose
103714|NCT02918890|Pediatric|pediatric
103715|NCT02918890|HABIT|habit
103716|NCT02918890|CIMT|cimt
103717|NCT02918890|Cerebral Palsy|cerebral palsy
103718|NCT02918890|Hemiplegia|hemiplegia
103719|NCT02918890|Children|children
103720|NCT02918890|Therapy|therapy
103721|NCT02918877|Volatile Anesthetics|volatile anesthetics
103722|NCT02918877|Intravenous Anesthetics|intravenous anesthetics
103723|NCT02918877|Inflammatory Lung Injury|inflammatory lung injury
103724|NCT02918877|Postoperative Pulmonary Complications|postoperative pulmonary complications
103725|NCT02918877|Cardiac Surgery|cardiac surgery
103726|NCT02918877|Cardiopulmonary Bypass|cardiopulmonary bypass
103727|NCT02918864|Autism Spectrum Disorder|autism spectrum disorder
103728|NCT02918864|Oxytocin|oxytocin
103729|NCT02918864|Social Skills|social skills
103730|NCT02918864|Social cognitive skills|social cognitive skills
103731|NCT02918864|Cognitive Behavioral Intervention|cognitive behavioral intervention
103732|NCT02918864|Combination treatment|combination treatment
103733|NCT02918864|Syntocinon|syntocinon
103734|NCT02918864|NETT (Nonverbal communication, Emotion recognition, Theory of mind Training)|nett (nonverbal communication, emotion recognition, theory of mind training)
103735|NCT02918864|emotion recognition|emotion recognition
103736|NCT02918864|theory of mind|theory of mind
103737|NCT02918838|HIV|hiv
103738|NCT02918838|Antiretroviral (ARV)|antiretroviral (arv)
103739|NCT02918838|co-trimoxazole|co-trimoxazole
103740|NCT02918838|SMS|sms
103741|NCT02918838|Lottery incentive|lottery incentive
103742|NCT02918838|mobile health|mobile health
103743|NCT02918838|Uganda|uganda
103744|NCT02918838|Youth|youth
103745|NCT02918825|schizophrenia|schizophrenia
103746|NCT02918825|clinical trial|clinical trial
103747|NCT02918825|olanzapine|olanzapine
103748|NCT02918825|paliperidone|paliperidone
103749|NCT02918812|Hysterosalpingography|hysterosalpingography
103750|NCT02918812|Pain relief|pain relief
103751|NCT02918812|Infertility|infertility
103752|NCT02918812|Intracervical block|intracervical block
103753|NCT02918812|Diclofenac|diclofenac
103754|NCT02918786|oxygen therapy|oxygen therapy
103755|NCT02918786|continuous positive airway pressure|continuous positive airway pressure
103756|NCT02918786|extubation|extubation
103757|NCT02918773|Pediatrics|pediatrics
103758|NCT02918773|Emergency Medicine|emergency medicine
103759|NCT02918773|Ear infection|ear infection
103760|NCT02918760|Gabapentin, chronic pelvic pain.|gabapentin, chronic pelvic pain.
103761|NCT02918734|Anterior Cruciate Ligament|anterior cruciate ligament
103762|NCT02918734|Bone-Patellar Tendon-Bone Grafting|bone-patellar tendon-bone grafting
103763|NCT02918721|Hyaluronic Acid, Nasolabial Fold, Lidocaine|hyaluronic acid, nasolabial fold, lidocaine
103764|NCT02918708|vaccination|vaccination
103765|NCT02918708|immunisation|immunisation
103766|NCT02918708|pneumococcal|pneumococcal
103767|NCT02918708|conjugate|conjugate
103768|NCT02918695|Geriatric assessment|geriatric assessment
103769|NCT02918695|Fit and frail elderly|fit and frail elderly
103770|NCT02918695|Geriatric oncology|geriatric oncology
103771|NCT02918656|Cochrane|cochrane
103772|NCT02918656|Abstract|abstract
103773|NCT02918656|Infographics|infographics
103774|NCT02918656|Understanding|understanding
103775|NCT02918643|Elderly|elderly
103776|NCT02918643|Potentially Inappropriate Medications|potentially inappropriate medications
103777|NCT02918630|E-cigarettes|e-cigarettes
103778|NCT02918630|Schizophrenia|schizophrenia
103779|NCT02918617|dentin hypersensitivity|dentin hypersensitivity
103780|NCT02918617|nanohydroxyapatite|nanohydroxyapatite
103781|NCT02918617|calcium sodium phosphosilicate|calcium sodium phosphosilicate
103782|NCT02918617|toothpaste|toothpaste
103783|NCT02918617|tooth cream|tooth cream
103784|NCT02918604|peripheral vein access|peripheral vein access
103785|NCT02918604|infrared|infrared
103786|NCT02918604|pediatric|pediatric
103787|NCT02918578|Physical Inactivity|physical inactivity
103788|NCT02918578|Behavior Change|behavior change
103789|NCT02918526|Laryngeal masks|laryngeal masks
103790|NCT02918513|Wellness|wellness
103791|NCT02918513|Mental Wellness|mental wellness
103792|NCT02918513|Well-Being|well-being
103793|NCT02918500|Coronary Artery Bypass Surgery (CABG)|coronary artery bypass surgery (cabg)
103794|NCT02918500|Nicotine Replacement Therapy (NRT)|nicotine replacement therapy (nrt)
103795|NCT02918474|Contralateral prophylactic breast cancer|contralateral prophylactic breast cancer
103796|NCT02918474|CPM|cpm
103797|NCT02918474|Breast cancer surgery|breast cancer surgery
103798|NCT02918474|Breast Cancer|breast cancer
103799|NCT02918474|Questionnaire|questionnaire
103800|NCT02918474|Survey|survey
103801|NCT02918474|Decision tool|decision tool
103802|NCT02918474|Contralateral Prophylactic Mastectomy|contralateral prophylactic mastectomy
103803|NCT02918435|WE CARE|we care
103804|NCT02918435|Pediatric practices|pediatric practices
103807|NCT02918422|Feeding Study|feeding study
103808|NCT02918422|Prediabetes|prediabetes
103809|NCT02918396|Atrial Fibrillation|atrial fibrillation
103810|NCT02918396|Atrial Fibrosis|atrial fibrosis
103811|NCT02918396|Late Gadolinium Enhancement Magnetic Resonance Imaging|late gadolinium enhancement magnetic resonance imaging
103812|NCT02918396|Computational Modeling|computational modeling
103813|NCT02918396|Rotor Anchor Sites|rotor anchor sites
103814|NCT02918370|Alcohol Use Disorder|alcohol use disorder
103815|NCT02918370|Bipolar Disorder|bipolar disorder
103816|NCT02918370|Mood|mood
103817|NCT02918370|Alcohol Craving|alcohol craving
103818|NCT02918370|Aripiprazole|aripiprazole
103819|NCT02918344|calcium phosphate paste|calcium phosphate paste
103820|NCT02918305|denervation|denervation
103821|NCT02918305|resistant hypertension|resistant hypertension
103822|NCT02918292|Unrelated Cord Blood (UCB)|unrelated cord blood (ucb)
103823|NCT02918292|Haploidentical Bone Marrow|haploidentical bone marrow
103824|NCT02918292|Hematopoietic Stem Cell Transplant (HSCT)|hematopoietic stem cell transplant (hsct)
103825|NCT02918292|Severe Aplastic Anemia (SAA)|severe aplastic anemia (saa)
103826|NCT02918292|Antithymocyte Globulin (ATG)|antithymocyte globulin (atg)
103827|NCT02918266|Drug Therapy|drug therapy
103828|NCT02918253|High dose-rate brachytherapy|high dose-rate brachytherapy
103829|NCT02918227|Ejaculation|ejaculation
103830|NCT02918227|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
103831|NCT02918227|Prostate|prostate
103832|NCT02918214|Septic Shock|septic shock
103833|NCT02918214|echocardiography|echocardiography
103834|NCT02918214|diastolic dysfunction|diastolic dysfunction
103835|NCT02918214|Transthoracic|transthoracic
103836|NCT02918214|Transesophageal|transesophageal
103837|NCT02918214|hyperkinesia|hyperkinesia
103838|NCT02918214|prognosis|prognosis
103839|NCT02918201|Administration, topical|administration, topical
103840|NCT02918201|Tranexamic Acid|tranexamic acid
103841|NCT02918201|Postoperative Care|postoperative care
103842|NCT02918201|Bandages|bandages
103843|NCT02918201|Occlusive Dressings|occlusive dressings
103844|NCT02918175|mHealth|mhealth
103845|NCT02918162|pembrolizumab|pembrolizumab
103846|NCT02918162|adenocarcinoma|adenocarcinoma
103847|NCT02918162|gastric cancer|gastric cancer
103848|NCT02918162|Locoregional gastric adenocarcinoma|locoregional gastric adenocarcinoma
103849|NCT02918162|Locoregional GE junction adenocarcinoma|locoregional ge junction adenocarcinoma
103850|NCT02918149|Ultrasonography|ultrasonography
103851|NCT02918149|Infant|infant
103852|NCT02918149|Newborn|newborn
103853|NCT02918149|Lumbar puncture|lumbar puncture
103854|NCT02918149|Spinal puncture|spinal puncture
103855|NCT02918149|Cerebrospinal fluid|cerebrospinal fluid
103856|NCT02918123|Psoriasis|psoriasis
103857|NCT02918123|Plaque psoriasis|plaque psoriasis
103858|NCT02918123|Stem cell|stem cell
103859|NCT02918123|Cell therapy|cell therapy
103860|NCT02918123|Furestem|furestem
103861|NCT02918123|Mesenchymal stem cell|mesenchymal stem cell
103862|NCT02918123|MSC|msc
103863|NCT02918123|Umbilical cord blood|umbilical cord blood
103864|NCT02918123|hUCB-MSC|hucb-msc
103865|NCT02918123|UCB-MSC|ucb-msc
103866|NCT02918097|Cost effectiveness|cost effectiveness
103867|NCT02918097|Bipolar disorder|bipolar disorder
103868|NCT02918097|Depressive episodes|depressive episodes
103869|NCT02918097|Quality of Life|quality of life
103870|NCT02918084|sequential administration chemiotherapy|sequential administration chemiotherapy
103871|NCT02918084|early breast cancer|early breast cancer
103872|NCT02918084|breast cancer|breast cancer
103873|NCT02918084|aromatase inhibitor|aromatase inhibitor
103874|NCT02918084|adjuvant|adjuvant
103875|NCT02918084|post menopausal|post menopausal
103876|NCT02918071|Asthma,|asthma,
103877|NCT02918071|Bronchial Diseases,|bronchial diseases,
103878|NCT02918071|Respiratory Tract Diseases,|respiratory tract diseases,
103879|NCT02918071|Lung Diseases,|lung diseases,
103880|NCT02918071|Obstructive Lung Diseases,|obstructive lung diseases,
103881|NCT02918071|Benralizumab|benralizumab
103882|NCT02918058|Frailty|frailty
103883|NCT02918058|Deprescription|deprescription
103884|NCT02918045|Tooth Extraction|tooth extraction
103885|NCT02918045|Surgical Hemostasis|surgical hemostasis
103886|NCT02918045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
103887|NCT02918045|Chitosan|chitosan
103888|NCT02918032|Jordans anomaly|jordans anomaly
103889|NCT02918032|neutral lipid storage disease|neutral lipid storage disease
103890|NCT02918032|triglyceride deposit cardiovasculopathy|triglyceride deposit cardiovasculopathy
103891|NCT02918032|ATGL gene|atgl gene
103893|NCT02918032|primary triglyceride deposit cardiomyovasculopathy (TGCV)|primary triglyceride deposit cardiomyovasculopathy (tgcv)
103894|NCT02918032|neutral lipid storage disease with myopathy (NLSD-M)|neutral lipid storage disease with myopathy (nlsd-m)
103895|NCT02917993|non-small cell lung cancer|non-small cell lung cancer
103896|NCT02917993|locally advanced|locally advanced
103897|NCT02917993|metastatic|metastatic
103898|NCT02917993|epidermal growth factor receptor (EGFR) inhibition|epidermal growth factor receptor (egfr) inhibition
103899|NCT02917993|Janus kinase inhibition|janus kinase inhibition
103900|NCT02917980|structural Heart Diseases|structural heart diseases
103901|NCT02917980|surgical treatment|surgical treatment
103902|NCT02917980|interventional treatment|interventional treatment
103903|NCT02917980|hybrid treatment|hybrid treatment
103904|NCT02917954|eHealth/mHealth solutions|ehealth/mhealth solutions
103905|NCT02917954|complex care needs|complex care needs
103906|NCT02917954|seniors|seniors
103907|NCT02917954|patient-centred care|patient-centred care
103908|NCT02917954|goal-oriented care|goal-oriented care
103909|NCT02917954|primary health care|primary health care
103910|NCT02917954|implementation|implementation
103911|NCT02917954|pragmatic trial|pragmatic trial
103912|NCT02917954|health outcomes|health outcomes
103913|NCT02917954|cost-effectiveness analysis|cost-effectiveness analysis
103914|NCT02917928|carnosine, type 2 diabetes, cardiovascular factors|carnosine, type 2 diabetes, cardiovascular factors
103915|NCT02917915|COPD|copd
103916|NCT02917915|Emphysema|emphysema
103917|NCT02917915|Chronic Bronchitis|chronic bronchitis
103918|NCT02917915|Pulmonary rehabilitation|pulmonary rehabilitation
103919|NCT02917915|Lung Diseases, Obstructive|lung diseases, obstructive
103920|NCT02917902|student-run free clinic|student-run free clinic
103921|NCT02917902|food supply|food supply
103922|NCT02917902|food insecure|food insecure
103923|NCT02917902|medically uninsured|medically uninsured
103924|NCT02917902|medically underserved|medically underserved
103925|NCT02917889|Caffeine|caffeine
103926|NCT02917889|Autonomic Nervous System|autonomic nervous system
103927|NCT02917889|Recovery|recovery
103928|NCT02917889|Aerobic exercise|aerobic exercise
103929|NCT02917876|Obstructive Sleep Apnea|obstructive sleep apnea
103930|NCT02917876|Pregnancy|pregnancy
103931|NCT02917876|Obesity|obesity
103932|NCT02917876|Fluid shifts|fluid shifts
103933|NCT02917876|Body composition|body composition
103934|NCT02917876|Sleep|sleep
103935|NCT02917863|Hypothyroidism|hypothyroidism
103936|NCT02917863|Microbiota|microbiota
103937|NCT02917863|Thyroid hormone|thyroid hormone
103938|NCT02917863|L-Thyroxine|l-thyroxine
103939|NCT02917863|Celiac disease|celiac disease
103940|NCT02917850|stroke|stroke
103941|NCT02917850|gait|gait
103942|NCT02917850|hip flexors|hip flexors
103943|NCT02917850|paresis|paresis
103944|NCT02917850|hemiplegia|hemiplegia
103945|NCT02917798|Genetic Testing|genetic testing
103946|NCT02917798|16-919|16-919
103947|NCT02917772|tailored immuno therapy|tailored immuno therapy
103948|NCT02917772|Nivolumab|nivolumab
103949|NCT02917772|Ipilimumab|ipilimumab
103950|NCT02917772|boost|boost
103951|NCT02917759|liver cancer|liver cancer
103952|NCT02917759|biliary tract cancer|biliary tract cancer
103953|NCT02917759|cholangiocarcinoma|cholangiocarcinoma
103954|NCT02917759|hepatocellular carcinoma|hepatocellular carcinoma
103955|NCT02917759|liver tumor|liver tumor
103956|NCT02917759|biliary tumor|biliary tumor
103957|NCT02917759|hepatoma|hepatoma
103958|NCT02917759|liver mass|liver mass
103959|NCT02917746|Cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
103960|NCT02917746|Imiquimod|imiquimod
103961|NCT02917746|Treatment|treatment
103962|NCT02917746|Predictive biomarkers|predictive biomarkers
103963|NCT02917720|TKI discontinuation|tki discontinuation
103964|NCT02917707|CRC|crc
103965|NCT02917707|liver metastasis|liver metastasis
103966|NCT02917681|ALS|als
103967|NCT02917681|mesenchymal stem cells|mesenchymal stem cells
103968|NCT02917681|intrathecal|intrathecal
103969|NCT02917668|Obesity|obesity
103970|NCT02917668|Hyperoxia|hyperoxia
103971|NCT02917668|Hypercapnia|hypercapnia
103972|NCT02917668|Postoperative complications|postoperative complications
103973|NCT02917668|Cardiac surgical procedures|cardiac surgical procedures
103974|NCT02917655|Education|education
103975|NCT02917655|Quality of Life|quality of life
103976|NCT02917655|Osteoarthritis|osteoarthritis
103977|NCT02917655|Metabolic Syndrome|metabolic syndrome
103978|NCT02917642|bacterial infection|bacterial infection
103979|NCT02917642|endotoxin|endotoxin
103980|NCT02917642|passive ultrasonic irrigation|passive ultrasonic irrigation
103981|NCT02917642|root canal treatment|root canal treatment
103982|NCT02917590|Spinal cord injury|spinal cord injury
103983|NCT02917590|dual-task obstacle crossing|dual-task obstacle crossing
103984|NCT02917564|Choroidal effusions|choroidal effusions
103985|NCT02917564|Trabeculectomy|trabeculectomy
103986|NCT02917551|Bacteremia, duration, non-critically ill, non-ICU|bacteremia, duration, non-critically ill, non-icu
103987|NCT02917525|Calcium metabolism|calcium metabolism
103988|NCT02917525|Matrix Gla Protein|matrix gla protein
103989|NCT02917525|Vitamin K2|vitamin k2
103990|NCT02917486|ExtraCorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
103991|NCT02917486|patient in intensive care|patient in intensive care
103992|NCT02917486|pharmacokinetic modeling|pharmacokinetic modeling
103993|NCT02917473|Medical skin examination|medical skin examination
103994|NCT02917473|Skin Self Examination|skin self examination
103995|NCT02917473|Sun protection|sun protection
103996|NCT02917460|Rady|rady
103997|NCT02917460|Pediatric|pediatric
103998|NCT02917460|Genomic|genomic
103999|NCT02917460|Precision medicine|precision medicine
104000|NCT02917460|Biorepository|biorepository
104001|NCT02917447|PTSD|ptsd
104002|NCT02917447|Women Veterans|women veterans
104003|NCT02917447|Online intervention|online intervention
104004|NCT02917434|Obesity|obesity
104005|NCT02917434|Psoriatic arthritis|psoriatic arthritis
104006|NCT02917434|Psoriasis|psoriasis
104007|NCT02917434|Metabolic syndrome|metabolic syndrome
104008|NCT02917434|Cardiovascular disease|cardiovascular disease
104009|NCT02917395|hypertrophic cardiomyopathy, disopyramide,|hypertrophic cardiomyopathy, disopyramide,
104010|NCT02917369|LCLC; Integrative Analysis; Metastasis|lclc; integrative analysis; metastasis
104011|NCT02917356|Healing touch|healing touch
104012|NCT02917356|Faith Healing|faith healing
104013|NCT02917356|Pain|pain
104014|NCT02917356|Joint stiffness|joint stiffness
104015|NCT02917356|Functional status|functional status
104016|NCT02917356|Mental health|mental health
104017|NCT02917356|Osteoarthritis|osteoarthritis
104018|NCT02917304|Quadrivalent Influenza Vaccines|quadrivalent influenza vaccines
104019|NCT02917291|Trauma Spinal Cord|trauma spinal cord
104020|NCT02917291|Thoracic Acute Spinal Cord Injury|thoracic acute spinal cord injury
104021|NCT02917291|Neurosurgery|neurosurgery
104022|NCT02917291|Cell Therapy|cell therapy
104023|NCT02917291|ATMP|atmp
104024|NCT02917291|HC016 adipose mesenchymal stem cell|hc016 adipose mesenchymal stem cell
104025|NCT02917291|SPINE|spine
104026|NCT02917213|acute myocardial infarction|acute myocardial infarction
104027|NCT02917213|cardiac embolism|cardiac embolism
104028|NCT02917213|intracardiac fluid dynamics|intracardiac fluid dynamics
104029|NCT02917213|silent brain infarct|silent brain infarct
104030|NCT02917213|intracardiac blood stasis|intracardiac blood stasis
104031|NCT02917174|asthma|asthma
104032|NCT02917174|m-health|m-health
104033|NCT02917174|asthma control|asthma control
104034|NCT02917174|self-management|self-management
104035|NCT02917161|Prostate|prostate
104036|NCT02917161|Prostatic Neoplams|prostatic neoplams
104037|NCT02917161|Therapeutic Embolization|therapeutic embolization
104038|NCT02917161|Prostatectomy|prostatectomy
104039|NCT02917122|Parkinson disease|parkinson disease
104040|NCT02917122|transcranial direct current stimulation|transcranial direct current stimulation
104041|NCT02917122|depression|depression
104042|NCT02917122|dopamine transporter|dopamine transporter
104043|NCT02917122|single photon emission computerized tomography|single photon emission computerized tomography
104044|NCT02917083|chimeric antigen receptors|chimeric antigen receptors
104045|NCT02917083|immunotherapy|immunotherapy
104046|NCT02917083|CAR T-cells|car t-cells
104047|NCT02917083|lymphoma|lymphoma
104048|NCT02917083|Cyclophosphamide|cyclophosphamide
104049|NCT02917083|fludarabine|fludarabine
104050|NCT02917070|Consanguinity-associated kidney diseases|consanguinity-associated kidney diseases
104051|NCT02917070|Turkey population|turkey population
104052|NCT02917031|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
104053|NCT02917031|Heart Failure|heart failure
104054|NCT02917031|Saxagliptin|saxagliptin
104055|NCT02917031|Sitagliptin|sitagliptin
104056|NCT02917018|Dexmedetomidine|dexmedetomidine
104057|NCT02917018|Stress response|stress response
104058|NCT02917018|Emergence agitation|emergence agitation
104059|NCT02917005|breast cancer|breast cancer
104060|NCT02917005|hormone receptor positive, HER2 negative|hormone receptor positive, her2 negative
104061|NCT02917005|palbociclib|palbociclib
104062|NCT02917005|premenopausal|premenopausal
104063|NCT02916992|spontaneous pneumothorax|spontaneous pneumothorax
104064|NCT02916992|familial pneumothorax|familial pneumothorax
104065|NCT02916992|Birt-Hogg-Dube syndrome|birt-hogg-dube syndrome
104066|NCT02916992|prevalence|prevalence
104067|NCT02916992|FLCN mutation|flcn mutation
104068|NCT02916992|Lung cysts|lung cysts
104069|NCT02916992|BHD|bhd
104070|NCT02916992|inherited disease|inherited disease
104071|NCT02916992|genetic disease|genetic disease
104072|NCT02916992|primary pneumothorax|primary pneumothorax
104073|NCT02916992|CAT scan|cat scan
104074|NCT02916992|CT scan|ct scan
104075|NCT02916940|sprains of the proximal interphalangeal joints of the long fingers|sprains of the proximal interphalangeal joints of the long fingers
104076|NCT02916940|Diprophos|diprophos
104077|NCT02916927|ketamine|ketamine
104078|NCT02916927|emergency department|emergency department
104079|NCT02916914|preterm|preterm
104080|NCT02916914|feeding|feeding
104081|NCT02916914|oral transition|oral transition
104082|NCT02916901|Dyslipidemia|dyslipidemia
104083|NCT02916901|CKD-519|ckd-519
104084|NCT02916901|CETP inhibitor|cetp inhibitor
104085|NCT02916901|ABPM|abpm
104086|NCT02916888|Atopic dermatitis|atopic dermatitis
104087|NCT02916888|Topical corticosteroid|topical corticosteroid
104088|NCT02916888|Pediatric|pediatric
104090|NCT02916888|Quality of life|quality of life
104091|NCT02916875|Shared decision Making|shared decision making
104092|NCT02916875|Follow-up|follow-up
104093|NCT02916862|fiber|fiber
104094|NCT02916862|calcium absorption|calcium absorption
104095|NCT02916862|bone mass|bone mass
104096|NCT02916862|adolescents|adolescents
104097|NCT02916849|Accidental Falls|accidental falls
104098|NCT02916849|Prevention & Control|prevention & control
104099|NCT02916849|Exercise|exercise
104100|NCT02916849|Exercise therapy/methods*|exercise therapy/methods*
104101|NCT02916849|Aged|aged
104102|NCT02916849|Aged 80 and over|aged 80 and over
104103|NCT02916849|Smartphone|smartphone
104104|NCT02916849|Computers|computers
104105|NCT02916849|Computers handheld|computers handheld
104106|NCT02916849|Motivation|motivation
104107|NCT02916849|Postural balance|postural balance
104108|NCT02916849|Health behaviour|health behaviour
104109|NCT02916849|mHealth|mhealth
104110|NCT02916849|eHealth|ehealth
104111|NCT02916810|transcranial magnetic stimulation|transcranial magnetic stimulation
104112|NCT02916810|schizophrenia|schizophrenia
104113|NCT02916810|MRI|mri
104114|NCT02916797|Feedback|feedback
104115|NCT02916797|Physical Therapy|physical therapy
104116|NCT02916784|Sit-to-stand|sit-to-stand
104117|NCT02916784|Walking devices|walking devices
104118|NCT02916771|Smoldering Multiple Myeloma|smoldering multiple myeloma
104119|NCT02916758|older adults|older adults
104120|NCT02916758|community mobility|community mobility
104121|NCT02916758|wellness|wellness
104122|NCT02916758|isolation|isolation
104123|NCT02916745|Non-small cell lung cancer|non-small cell lung cancer
104124|NCT02916745|NSCLC|nsclc
104125|NCT02916745|lung cancer|lung cancer
104126|NCT02916745|lung carcinoma|lung carcinoma
104127|NCT02916745|lung metastasis|lung metastasis
104128|NCT02916732|asymptomatics|asymptomatics
104129|NCT02916732|microcephaly|microcephaly
104130|NCT02916732|abnormalities|abnormalities
104131|NCT02916719|neo-adjuvant radiotherapy|neo-adjuvant radiotherapy
104132|NCT02916719|breast cancer|breast cancer
104133|NCT02916719|MRI|mri
104134|NCT02916693|Mirabegron|mirabegron
104135|NCT02916693|Overactive Bladder|overactive bladder
104136|NCT02916693|Erectile Dysfunction|erectile dysfunction
104137|NCT02916693|Beta 3 agonist|beta 3 agonist
104138|NCT02916680|Pancreatic islet transplantation|pancreatic islet transplantation
104139|NCT02916641|Fuzhenghuayu|fuzhenghuayu
104140|NCT02916628|smoking cessation|smoking cessation
104141|NCT02916628|group counseling|group counseling
104142|NCT02916628|acupressure|acupressure
104143|NCT02916628|serotonin|serotonin
104144|NCT02916628|depressive symptoms|depressive symptoms
104145|NCT02916628|resilience|resilience
104146|NCT02916537|prostate cancer|prostate cancer
104147|NCT02916537|prostate specific membrane antigen|prostate specific membrane antigen
104148|NCT02916537|prostate neoplasms|prostate neoplasms
104149|NCT02916537|metastatic prostate cancer|metastatic prostate cancer
104150|NCT02916537|prostatic hyperplasia|prostatic hyperplasia
104151|NCT02916524|Aphasia|aphasia
104152|NCT02916524|Bilingualism|bilingualism
104153|NCT02916524|Language therapy|language therapy
104154|NCT02916524|Rehabilitation of speech and language disorders|rehabilitation of speech and language disorders
104155|NCT02916524|Speech-language pathology|speech-language pathology
104156|NCT02916498|chronic neuropathic pain in the low back and legs|chronic neuropathic pain in the low back and legs
104157|NCT02916498|subperception spinal cord stimulation|subperception spinal cord stimulation
104158|NCT02916485|bioresorbable scaffold|bioresorbable scaffold
104159|NCT02916485|vascular restoration therapy|vascular restoration therapy
104160|NCT02916472|AYA|aya
104161|NCT02916472|exercise|exercise
104162|NCT02916472|cancer|cancer
104163|NCT02916472|cybercycling|cybercycling
104164|NCT02916407|Anesthesia|anesthesia
104165|NCT02916407|Agitation|agitation
104166|NCT02916407|Extubation|extubation
104167|NCT02916316|Lymphoma|lymphoma
104168|NCT02916316|Large B-Cell|large b-cell
104169|NCT02916316|Cardiotoxicity|cardiotoxicity
104170|NCT02916303|Schizophrenia|schizophrenia
104171|NCT02916303|Psychosis|psychosis
104172|NCT02916303|Effectiveness|effectiveness
104173|NCT02916290|Fuzhenghuayu|fuzhenghuayu
104174|NCT02916264|scalp block, surgical peth index|scalp block, surgical peth index
104175|NCT02916160|Chronic Heart failure|chronic heart failure
104176|NCT02916160|Sleep Apnea Syndrome|sleep apnea syndrome
104177|NCT02916160|Continuous Positive Airways Pressure|continuous positive airways pressure
104178|NCT02916160|SACUBITRIL - VALSARTAN|sacubitril - valsartan
104179|NCT02916108|Concussion|concussion
104552|NCT02914210|TKA|tka
104180|NCT02916108|Mild traumatic brain injury|mild traumatic brain injury
104182|NCT02916082|Cervical length|cervical length
104183|NCT02916082|Prolonged pregnancy|prolonged pregnancy
104184|NCT02916082|Vaginal birth|vaginal birth
104185|NCT02916069|Spectroscopy|spectroscopy
104186|NCT02916069|Transcranial Doppler|transcranial doppler
104187|NCT02916069|Bispectral index|bispectral index
104188|NCT02916069|Cardiac surgery|cardiac surgery
104189|NCT02916056|Alzheimer's disease|alzheimer's disease
104190|NCT02916056|RAGE|rage
104192|NCT02916056|CDR-sb|cdr-sb
104193|NCT02916043|acute kidney injury|acute kidney injury
104194|NCT02916043|cardiovascular surgery|cardiovascular surgery
104195|NCT02916043|mortality|mortality
104196|NCT02916030|Vitamin D|vitamin d
104197|NCT02916030|Stroke|stroke
104198|NCT02916030|Parathormone|parathormone
104199|NCT02916017|Humira|humira
104200|NCT02916017|Adalimumab|adalimumab
104201|NCT02916017|Non-infectious Intermediate-, Posterior-, or Pan-uveitis|non-infectious intermediate-, posterior-, or pan-uveitis
104202|NCT02916004|Analgesia|analgesia
104203|NCT02916004|Pain measurement|pain measurement
104204|NCT02916004|Nociception|nociception
104205|NCT02916004|Electromyography|electromyography
104206|NCT02916004|Electrical stimulation|electrical stimulation
104207|NCT02916004|Pupillometry|pupillometry
104208|NCT02916004|Critical care|critical care
104209|NCT02916004|Sedation|sedation
104210|NCT02915991|Coronary catheterization|coronary catheterization
104211|NCT02915991|Instantaneous wave free ratio (iFR)|instantaneous wave free ratio (ifr)
104212|NCT02915991|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
104213|NCT02915991|automated co-registration|automated co-registration
104214|NCT02915939|Family caregiving|family caregiving
104215|NCT02915939|Institutionalization|institutionalization
104216|NCT02915939|Residential long-term care|residential long-term care
104217|NCT02915939|Placement|placement
104218|NCT02915939|Psychosocial support|psychosocial support
104219|NCT02915939|Dementia|dementia
104220|NCT02915939|Caregivers|caregivers
104221|NCT02915939|Nursing homes|nursing homes
104222|NCT02915939|Assisted Living Facilities|assisted living facilities
104223|NCT02915939|Long-Term Care|long-term care
104224|NCT02915939|Intervention Study|intervention study
104225|NCT02915939|Psychosocial Support Systems|psychosocial support systems
104226|NCT02915939|Social Support|social support
104227|NCT02915939|Coping|coping
104228|NCT02915900|In vitro fertilization|in vitro fertilization
104229|NCT02915887|neck pain|neck pain
104230|NCT02915887|chronic|chronic
104231|NCT02915887|taping|taping
104232|NCT02915887|kinematics|kinematics
104233|NCT02915887|motion analysis|motion analysis
104234|NCT02915887|physiotherapy|physiotherapy
104235|NCT02915861|immune responses|immune responses
104236|NCT02915861|vaccines|vaccines
104237|NCT02915848|deep brain stimulation|deep brain stimulation
104238|NCT02915848|local field potential|local field potential
104239|NCT02915848|kinematic analysis|kinematic analysis
104240|NCT02915835|Scleroderma|scleroderma
104241|NCT02915835|Digital Ulcer|digital ulcer
104242|NCT02915809|Influenza Vaccines|influenza vaccines
104243|NCT02915796|Endothelial progenitor cell|endothelial progenitor cell
104244|NCT02915796|Percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
104245|NCT02915783|unresectable advanced|unresectable advanced
104246|NCT02915783|metastatic|metastatic
104247|NCT02915770|Moderate dilatation of common bile duct|moderate dilatation of common bile duct
104248|NCT02915757|Depression|depression
104249|NCT02915757|EDOR test|edor test
104250|NCT02915757|Electrodermal hyporeactivity|electrodermal hyporeactivity
104251|NCT02915744|Breast Cancer Brain Metastases (BCBM)|breast cancer brain metastases (bcbm)
104252|NCT02915744|Carcinoma|carcinoma
104253|NCT02915731|Vitamin A stores|vitamin a stores
104254|NCT02915731|Stable isotope dilution|stable isotope dilution
104255|NCT02915731|Multiple vitamin A interventions|multiple vitamin a interventions
104256|NCT02915718|dilated cardiomyopathy|dilated cardiomyopathy
104257|NCT02915718|immunoadsorption|immunoadsorption
104258|NCT02915692|Foley|foley
104259|NCT02915692|CAUTI|cauti
104260|NCT02915692|ERASE CAUTI|erase cauti
104261|NCT02915679|Suicidal behavior|suicidal behavior
104262|NCT02915679|psychological and social pain|psychological and social pain
104263|NCT02915679|physical pain|physical pain
104264|NCT02915679|pain perception|pain perception
104265|NCT02915666|Melanoma, skin|melanoma, skin
104266|NCT02915627|Antishock Garment|antishock garment
104267|NCT02915614|alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
104268|NCT02915614|pulmonary rehabilitation|pulmonary rehabilitation
104269|NCT02915614|exercise training|exercise training
104270|NCT02915614|skeletal muscle biopsy|skeletal muscle biopsy
104271|NCT02915562|rehabilitation|rehabilitation
104272|NCT02915562|exercise|exercise
104273|NCT02915562|outcome measurement|outcome measurement
104274|NCT02915549|premature infant|premature infant
104275|NCT02915549|early progressive feeding|early progressive feeding
104276|NCT02915536|iodine excess|iodine excess
104277|NCT02915536|thyroid disease|thyroid disease
104278|NCT02915536|children|children
104279|NCT02915536|tolerable upper intake level|tolerable upper intake level
104280|NCT02915523|Ovarian Cancer|ovarian cancer
104281|NCT02915523|Histone Deacetylase Inhibitors|histone deacetylase inhibitors
104282|NCT02915523|Entinostat|entinostat
104283|NCT02915523|Solid tumor|solid tumor
104284|NCT02915523|Avelumab|avelumab
104285|NCT02915523|SNDX-275|sndx-275
104286|NCT02915523|Ovarian Neoplasms|ovarian neoplasms
104287|NCT02915523|Ovarian Diseases|ovarian diseases
104288|NCT02915523|Fallopian Tube Cancer|fallopian tube cancer
104289|NCT02915523|Peritoneal Cancer|peritoneal cancer
104290|NCT02915497|Prolonged Exposure Therapy|prolonged exposure therapy
104291|NCT02915484|Transcranial Direct Current Stimulation|transcranial direct current stimulation
104292|NCT02915484|Apathy|apathy
104293|NCT02915484|Stroke|stroke
104294|NCT02915484|Empathy|empathy
104295|NCT02915484|Electric Stimulation Therapy|electric stimulation therapy
104296|NCT02915484|Depression|depression
104297|NCT02915484|Anhedonia|anhedonia
104298|NCT02915484|Prefrontal Cortex|prefrontal cortex
104299|NCT02915484|Electroencephalography|electroencephalography
104300|NCT02915484|Cognition|cognition
104301|NCT02915484|Emotions|emotions
104302|NCT02915484|Neurological Rehabilitation|neurological rehabilitation
104303|NCT02915484|Brain Diseases|brain diseases
104304|NCT02915484|Cerebrovascular Disorders|cerebrovascular disorders
104305|NCT02915471|Adolescent|adolescent
104306|NCT02915471|Online Peer Support|online peer support
104307|NCT02915471|Managing Cancer|managing cancer
104308|NCT02915471|Mentor|mentor
104309|NCT02915458|Weaning|weaning
104310|NCT02915458|Mechanical ventilation|mechanical ventilation
104311|NCT02915458|synchrosqueezing transform|synchrosqueezing transform
104312|NCT02915445|EpCAM CAR-T, solid tumors, cancer immunotherapy|epcam car-t, solid tumors, cancer immunotherapy
104313|NCT02915432|Anti PD-1|anti pd-1
104314|NCT02915432|JS001|js001
104315|NCT02915432|Gastric Adenocarcinoma|gastric adenocarcinoma
104316|NCT02915432|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
104317|NCT02915432|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
104318|NCT02915432|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
104319|NCT02915432|Simon's Two Stage|simon's two stage
104320|NCT02915432|ORR|orr
104321|NCT02915393|Chronic Gastritis|chronic gastritis
104322|NCT02915393|Qi Deficiency Constitution|qi deficiency constitution
104323|NCT02915393|Next Generation Sequencing|next generation sequencing
104324|NCT02915393|Proteomics|proteomics
104325|NCT02915393|Metabonomics|metabonomics
104326|NCT02915367|HIV/AIDS|hiv/aids
104327|NCT02915367|adherence|adherence
104328|NCT02915367|women|women
104329|NCT02915367|real time monitoring|real time monitoring
104330|NCT02915367|risk|risk
104331|NCT02915367|SMS|sms
104332|NCT02915367|mHealth|mhealth
104333|NCT02915315|blood pressure|blood pressure
104334|NCT02915315|Hypertrophy|hypertrophy
104335|NCT02915315|Left Ventricular|left ventricular
104336|NCT02915315|arterial Stiffness|arterial stiffness
104337|NCT02915315|Proteinuria|proteinuria
104338|NCT02915315|baPWV|bapwv
104339|NCT02915315|ambulatory Blood Pressure|ambulatory blood pressure
104340|NCT02915302|Influenza|influenza
104341|NCT02915302|Influenza virus vaccine|influenza virus vaccine
104342|NCT02915302|Fluzone® Quadrivalent Influenza Vaccine (No Preservative)|fluzone® quadrivalent influenza vaccine (no preservative)
104343|NCT02915289|Caesarean section|caesarean section
104344|NCT02915289|Chlorhexidine gluconate|chlorhexidine gluconate
104345|NCT02915276|Blastocyst|blastocyst
104346|NCT02915276|Human|human
104347|NCT02915276|DNA|dna
104348|NCT02915276|Blastocentesis|blastocentesis
104349|NCT02915263|Diabetes Complications|diabetes complications
104350|NCT02915263|Diabetes Mellitus|diabetes mellitus
104351|NCT02915263|Diabetic Neuropathies|diabetic neuropathies
104352|NCT02915263|IGIV-C|igiv-c
104353|NCT02915263|Immune Globulin Injection (Human), 10% Caprylate/Chromatography|immune globulin injection (human), 10% caprylate/chromatography
104354|NCT02915263|Gamunex-C|gamunex-c
104355|NCT02915237|Veterans|veterans
104356|NCT02915237|Gulf War Illness|gulf war illness
104357|NCT02915237|Gulf War Veterans's Illness|gulf war veterans's illness
104358|NCT02915237|Gulf War Veterans' Medically Unexplained Illnesses|gulf war veterans' medically unexplained illnesses
104359|NCT02915211|Epilepsy|epilepsy
104360|NCT02915211|Glut|glut
104361|NCT02915211|Ketogenic|ketogenic
104362|NCT02915211|Glucose|glucose
104363|NCT02915198|Metformin|metformin
104364|NCT02915198|Atherosclerosis|atherosclerosis
104365|NCT02915198|Prediabetic State|prediabetic state
104366|NCT02915198|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
104367|NCT02915198|Coronary Artery Disease|coronary artery disease
104368|NCT02915198|Peripheral Arterial Disease|peripheral arterial disease
104369|NCT02915198|Cerebrovascular Disorders|cerebrovascular disorders
104370|NCT02915185|exercise|exercise
104371|NCT02915185|rehabilitation|rehabilitation
104372|NCT02915185|recovery of function|recovery of function
104373|NCT02915185|transcranial magnetic stimulation|transcranial magnetic stimulation
104374|NCT02915185|transcranial direct-current stimulation|transcranial direct-current stimulation
104375|NCT02915172|Advanced Cancer|advanced cancer
104376|NCT02915172|Malignant neoplasm of breast|malignant neoplasm of breast
104377|NCT02915172|Malignant neoplasms of bone and articular cartilage|malignant neoplasms of bone and articular cartilage
104378|NCT02915172|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
104379|NCT02915172|Malignant neoplasms of eye brain and other parts of central nervous system|malignant neoplasms of eye brain and other parts of central nervous system
104380|NCT02915172|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
104381|NCT02915172|Malignant neoplasms of ill-defined secondary and unspecified sites|malignant neoplasms of ill-defined secondary and unspecified sites
104585|NCT02914093|Hypercapnia|hypercapnia
104382|NCT02915172|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
104383|NCT02915172|Malignant neoplasms of lip oral cavity and pharynx|malignant neoplasms of lip oral cavity and pharynx
104384|NCT02915172|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
104385|NCT02915172|Malignant neoplasms of mesothelial and soft tissue|malignant neoplasms of mesothelial and soft tissue
104386|NCT02915172|Malignant neoplasms of respiratory and intrathoracic organs|malignant neoplasms of respiratory and intrathoracic organs
104387|NCT02915172|Malignant neoplasms of thyroid and other endocrine glands|malignant neoplasms of thyroid and other endocrine glands
104388|NCT02915172|Malignant neoplasms of urinary tract|malignant neoplasms of urinary tract
104389|NCT02915172|Lenvatinib|lenvatinib
104390|NCT02915172|E7080|e7080
104391|NCT02915172|Lenvima|lenvima
104392|NCT02915172|Capecitabine|capecitabine
104393|NCT02915172|Xeloda|xeloda
104394|NCT02915146|eczema|eczema
104395|NCT02915146|phototherapy|phototherapy
104396|NCT02915146|uva1|uva1
104397|NCT02915146|uvb|uvb
104398|NCT02915146|adults|adults
104399|NCT02915146|children|children
104400|NCT02915133|high myopia|high myopia
104401|NCT02915133|myopia foveoschisis|myopia foveoschisis
104402|NCT02915133|macular buckling|macular buckling
104403|NCT02915120|Knee pain|knee pain
104404|NCT02915120|osteoarthritis|osteoarthritis
104405|NCT02915120|genicular nerve|genicular nerve
104406|NCT02915120|ultrasonography|ultrasonography
104407|NCT02915120|pulsed radiofrequency|pulsed radiofrequency
104408|NCT02915107|drug eluting stents|drug eluting stents
104409|NCT02915107|coronary vascular healing|coronary vascular healing
104410|NCT02915068|patient-provider communication|patient-provider communication
104411|NCT02915068|Electronic Health Records|electronic health records
104412|NCT02915068|Provider education|provider education
104413|NCT02915055|Analgesic efficacy|analgesic efficacy
104414|NCT02915055|knee arthroplasty|knee arthroplasty
104415|NCT02915055|Opioid consumption|opioid consumption
104416|NCT02915055|Pain Medicine|pain medicine
104417|NCT02915055|Narcotics|narcotics
104418|NCT02915055|Multimodal Analgesia|multimodal analgesia
104419|NCT02915042|Pain|pain
104420|NCT02915042|dexmedetomidine|dexmedetomidine
104421|NCT02915042|postoperative|postoperative
104422|NCT02915029|Native American|native american
104423|NCT02915029|Community Health Representative|community health representative
104424|NCT02915029|Home base|home base
104425|NCT02915029|Diabetes|diabetes
104426|NCT02915029|Point of care testing|point of care testing
104427|NCT02915029|Patient Activation Measure|patient activation measure
104428|NCT02915029|Patient preferences|patient preferences
104429|NCT02915003|health care navigation|health care navigation
104430|NCT02915003|health literacy|health literacy
104431|NCT02915003|Affordable Care Act|affordable care act
104432|NCT02914977|Relapsed|relapsed
104433|NCT02914977|Refractory|refractory
104434|NCT02914964|Fatigue|fatigue
104435|NCT02914964|Quality of Life|quality of life
104436|NCT02914964|Diet|diet
104437|NCT02914951|Autism|autism
104438|NCT02914951|Irritability|irritability
104439|NCT02914951|Disruptive Behavior|disruptive behavior
104440|NCT02914951|Aggression|aggression
104441|NCT02914951|Behavior Therapy|behavior therapy
104442|NCT02914951|Cognitive Behavioral Therapy|cognitive behavioral therapy
104443|NCT02914951|Intellectual Disability|intellectual disability
104444|NCT02914951|Cognitive Impairment|cognitive impairment
104445|NCT02914925|CIT|cit
104446|NCT02914925|ArmeoSpring|armeospring
104447|NCT02914925|TMS|tms
104448|NCT02914899|Chinese Taxi Drivers|chinese taxi drivers
104449|NCT02914899|16-949|16-949
104450|NCT02914886|Diabetes|diabetes
104451|NCT02914886|Lipoatrophy|lipoatrophy
104452|NCT02914886|children|children
104453|NCT02914886|adolescents|adolescents
104454|NCT02914886|adults|adults
104455|NCT02914886|insulin therapy|insulin therapy
104456|NCT02914873|prostate cancer|prostate cancer
104457|NCT02914873|active surveillance|active surveillance
104458|NCT02914873|standardised treatment triggers|standardised treatment triggers
104459|NCT02914873|MRI|mri
104460|NCT02914873|randomized|randomized
104461|NCT02914821|consumption|consumption
104462|NCT02914821|decision making|decision making
104463|NCT02914821|policy|policy
104464|NCT02914821|sweetened beverages|sweetened beverages
104465|NCT02914821|taxes|taxes
104466|NCT02914821|Diet, Food, and Nutrition|diet, food, and nutrition
104467|NCT02914769|Depression|depression
104468|NCT02914769|Ayahuasca|ayahuasca
104469|NCT02914769|Psychedelics|psychedelics
104470|NCT02914743|Oral health|oral health
104471|NCT02914743|Diabetes|diabetes
104472|NCT02914743|Interprofessionalism|interprofessionalism
104473|NCT02914743|Periodontal disease|periodontal disease
104474|NCT02914730|diabetes|diabetes
104475|NCT02914730|insulin|insulin
104476|NCT02914730|medication adherence|medication adherence
104477|NCT02914717|golimumab|golimumab
104478|NCT02914691|Type 2 diabetes|type 2 diabetes
104479|NCT02914691|Diabetic Nephropathy|diabetic nephropathy
104480|NCT02914691|Proteomics|proteomics
104481|NCT02914691|Albuminuria|albuminuria
104482|NCT02914691|SGLT2 inhibitor|sglt2 inhibitor
104483|NCT02914678|Emergency Medical Services|emergency medical services
104484|NCT02914678|Analgesics|analgesics
104485|NCT02914665|Heart failure|heart failure
104486|NCT02914665|diuresis|diuresis
104487|NCT02914665|dropsy|dropsy
104488|NCT02914665|congestion|congestion
104489|NCT02914665|elamipretide|elamipretide
104490|NCT02914665|MTP-131|mtp-131
104491|NCT02914665|Bendavia™|bendavia™
104492|NCT02914652|Congenital Heart Disease|congenital heart disease
104493|NCT02914652|Ventricular Septal Defect|ventricular septal defect
104494|NCT02914652|Beta-2-agonists|beta-2-agonists
104495|NCT02914652|Surgery|surgery
104496|NCT02914652|Follow-up|follow-up
104497|NCT02914626|Glaucoma, Neovascular|glaucoma, neovascular
104498|NCT02914626|Ranibizumab|ranibizumab
104499|NCT02914626|Intraocular pressure|intraocular pressure
104500|NCT02914626|anti-VEGF|anti-vegf
104501|NCT02914626|intravitreal injection|intravitreal injection
104502|NCT02914483|Myocardial Infarction|myocardial infarction
104503|NCT02914483|Women|women
104504|NCT02914483|Stress Management|stress management
104505|NCT02914470|advanced|advanced
104506|NCT02914431|Personalized Titanium Plate|personalized titanium plate
104507|NCT02914431|Orthognathic Surgery|orthognathic surgery
104508|NCT02914431|Maxilla Repositioning|maxilla repositioning
104509|NCT02914431|Accuracy|accuracy
104510|NCT02914431|Computer-aided Design and Manufacturing|computer-aided design and manufacturing
104511|NCT02914418|transcranial magnetic stimulation|transcranial magnetic stimulation
104512|NCT02914418|Spinal Cord Injuries|spinal cord injuries
104513|NCT02914418|Muscle Spasticity|muscle spasticity
104514|NCT02914418|Pain|pain
104515|NCT02914418|Spinal Cord|spinal cord
104516|NCT02914418|Spinal Cord Diseases|spinal cord diseases
104517|NCT02914405|131-I-mIBG therapy|131-i-mibg therapy
104518|NCT02914405|ch14.18/CHO|ch14.18/cho
104519|NCT02914405|Nivolumab|nivolumab
104520|NCT02914392|case control study|case control study
104521|NCT02914392|Environmental Factors|environmental factors
104522|NCT02914392|Fetal Congenital Heart Disease|fetal congenital heart disease
104523|NCT02914366|Ambroxol|ambroxol
104524|NCT02914366|Dementia|dementia
104525|NCT02914366|Parkinson's disease|parkinson's disease
104526|NCT02914366|Disease modifying treatment|disease modifying treatment
104527|NCT02914366|Pharmacological Chaperone|pharmacological chaperone
104528|NCT02914366|GBA1|gba1
104529|NCT02914353|Factor X!a|factor x!a
104530|NCT02914353|anticoagulant|anticoagulant
104531|NCT02914353|thromboembolism|thromboembolism
104532|NCT02914353|venous thromboembolism|venous thromboembolism
104533|NCT02914353|embolism and thrombosis|embolism and thrombosis
104534|NCT02914353|enzyme inhibitors|enzyme inhibitors
104535|NCT02914353|hematologic agent|hematologic agent
104536|NCT02914327|CLL|cll
104537|NCT02914327|Leukemia, Chronic Lymphocytic|leukemia, chronic lymphocytic
104538|NCT02914327|Hsp90|hsp90
104539|NCT02914327|BTK|btk
104540|NCT02914327|Ibrutinib|ibrutinib
104541|NCT02914314|epilepsy|epilepsy
104542|NCT02914314|refractory partial seizures|refractory partial seizures
104543|NCT02914249|Orange juice|orange juice
104544|NCT02914249|Low-calorie diet|low-calorie diet
104545|NCT02914249|Body composition|body composition
104546|NCT02914249|Weight-loss|weight-loss
104547|NCT02914249|Metabolic biomarkers|metabolic biomarkers
104548|NCT02914249|Obese|obese
104549|NCT02914236|Nasal valve|nasal valve
104550|NCT02914236|Nasal airway obstruction|nasal airway obstruction
104551|NCT02914210|TKR|tkr
104553|NCT02914210|Knee|knee
104554|NCT02914210|Surgery|surgery
104555|NCT02914210|Replacement|replacement
104556|NCT02914210|Rehabilitation|rehabilitation
104557|NCT02914210|Virtual|virtual
104558|NCT02914210|Physical Therapy|physical therapy
104559|NCT02914210|Telerehabilitation|telerehabilitation
104560|NCT02914197|Decision|decision
104561|NCT02914197|Mammography|mammography
104562|NCT02914197|Informed Choice|informed choice
104563|NCT02914197|Full Information|full information
104564|NCT02914197|Decision Aid|decision aid
104565|NCT02914197|Self-efficacy|self-efficacy
104566|NCT02914197|Shared decision making|shared decision making
104567|NCT02914197|Over-detection|over-detection
104568|NCT02914197|Over-diagnosis|over-diagnosis
104569|NCT02914184|Safety|safety
104570|NCT02914184|Healthy infants|healthy infants
104571|NCT02914184|Immunogenicity|immunogenicity
104572|NCT02914184|Human Rotavirus (HRV)|human rotavirus (hrv)
104573|NCT02914171|Myopathic right ventricle|myopathic right ventricle
104574|NCT02914158|breast cancer|breast cancer
104575|NCT02914158|ovarian function suppression (OFS)|ovarian function suppression (ofs)
104576|NCT02914158|aromatase inhibitors（AIs）|aromatase inhibitors（ais）
104577|NCT02914158|tamoxifen（TAM）|tamoxifen（tam）
104578|NCT02914119|Residual nerve blockade|residual nerve blockade
104579|NCT02914119|Neuromuscular monitoring|neuromuscular monitoring
104580|NCT02914119|Residual curarization|residual curarization
104581|NCT02914119|Neuromuscular blocking agents|neuromuscular blocking agents
104582|NCT02914106|Neuroactive steroids|neuroactive steroids
104583|NCT02914106|Acute Ischemic Stroke|acute ischemic stroke
104584|NCT02914106|Patients|patients
104586|NCT02914093|Physiotherapy|physiotherapy
104587|NCT02914093|Inspiratory Muscle Training|inspiratory muscle training
104588|NCT02914067|Pediatric brain tumors|pediatric brain tumors
104589|NCT02914067|Cognitive deficits|cognitive deficits
104590|NCT02914067|Resting state functional connectivity|resting state functional connectivity
104591|NCT02914067|NIH toolbox|nih toolbox
104592|NCT02914054|ITP|itp
104593|NCT02914041|Kyphosis|kyphosis
104594|NCT02914041|Kyphosis wall distance|kyphosis wall distance
104595|NCT02914041|elderly|elderly
104596|NCT02914028|TAP block|tap block
104597|NCT02914028|subacute pain|subacute pain
104598|NCT02914028|inguinal herniography|inguinal herniography
104599|NCT02913937|ultrasonic irrigation|ultrasonic irrigation
104600|NCT02913937|pain|pain
104601|NCT02913937|healing|healing
104602|NCT02913937|apical periodontitis|apical periodontitis
104603|NCT02913924|Marijuana|marijuana
104604|NCT02913924|Treatment|treatment
104605|NCT02913911|feedback|feedback
104606|NCT02913898|learning|learning
104607|NCT02913872|Spirometry|spirometry
104608|NCT02913872|Exhaled Nitric Oxide|exhaled nitric oxide
104609|NCT02913872|Primary Care|primary care
104610|NCT02913859|prostate cancer|prostate cancer
104611|NCT02913859|hormone-sensitive|hormone-sensitive
104612|NCT02913859|metastasis|metastasis
104613|NCT02913846|denutrition|denutrition
104614|NCT02913846|hospital length of stay|hospital length of stay
104615|NCT02913846|patient's autonomy|patient's autonomy
104616|NCT02913833|Pain|pain
104617|NCT02913833|Hospital length of stay|hospital length of stay
104618|NCT02913833|Revalidation unit|revalidation unit
104619|NCT02913781|Polar body removal|polar body removal
104620|NCT02913781|ICSI|icsi
104621|NCT02913781|Fertilization failure|fertilization failure
104622|NCT02913742|Intraoperative Neurophysiological Monitoring|intraoperative neurophysiological monitoring
104623|NCT02913729|breast cancer|breast cancer
104624|NCT02913703|Ghrelin|ghrelin
104625|NCT02913690|Hemodialysis|hemodialysis
104626|NCT02913690|Tocotrienol|tocotrienol
104627|NCT02913690|Vitamin E|vitamin e
104628|NCT02913677|feeding intolerance|feeding intolerance
104629|NCT02913677|minimal enteral nutrition|minimal enteral nutrition
104630|NCT02913677|very low birth weight|very low birth weight
104631|NCT02913677|preterm infant|preterm infant
104632|NCT02913664|Dementia|dementia
104633|NCT02913664|Alzheimer's Disease|alzheimer's disease
104634|NCT02913664|Cognitive Function|cognitive function
104635|NCT02913664|Blood Pressure|blood pressure
104636|NCT02913664|Cholesterol|cholesterol
104637|NCT02913664|Physical Activity|physical activity
104638|NCT02913664|Exercise|exercise
104639|NCT02913664|Magnetic Resonance Imaging|magnetic resonance imaging
104640|NCT02913651|Idiopathic hypersomnia|idiopathic hypersomnia
104641|NCT02913651|heart rate variability|heart rate variability
104642|NCT02913651|parasympathetic activity|parasympathetic activity
104643|NCT02913651|autonomic arousal response|autonomic arousal response
104644|NCT02913625|Brachial plexus|brachial plexus
104645|NCT02913625|Regional anesthesia|regional anesthesia
104646|NCT02913625|Infraclavicular|infraclavicular
104647|NCT02913625|Retroclavicular|retroclavicular
104648|NCT02913625|Parasagittal|parasagittal
104649|NCT02913625|Upper limb surgery|upper limb surgery
104650|NCT02913625|Ultrasound guided block|ultrasound guided block
104651|NCT02913625|Coracoid|coracoid
104652|NCT02913612|Hemangioma|hemangioma
104653|NCT02913612|Infantile Hemangioma|infantile hemangioma
104654|NCT02913612|Pharmacokinetics|pharmacokinetics
104655|NCT02913508|Drug therapy|drug therapy
104656|NCT02913495|Progesterone|progesterone
104657|NCT02913495|Prevention of preterm birth|prevention of preterm birth
104658|NCT02913469|Morphine，Ticagrelor，STEMI，PCI|morphine，ticagrelor，stemi，pci
104659|NCT02913417|uveal melanoma|uveal melanoma
104660|NCT02913417|liver metastases|liver metastases
104661|NCT02913391|noninvasive ventilation|noninvasive ventilation
104662|NCT02913391|myocardial revascularization|myocardial revascularization
104663|NCT02913391|pulmonary atelectasis|pulmonary atelectasis
104664|NCT02913391|hypoxia|hypoxia
104665|NCT02913391|positive end-expiratory pressure|positive end-expiratory pressure
104666|NCT02913391|coronary artery bypass grafting|coronary artery bypass grafting
104667|NCT02913391|extracorporeal circulation|extracorporeal circulation
104668|NCT02913365|Haemoptysis|haemoptysis
104669|NCT02913365|Hemoptysis|hemoptysis
104670|NCT02913365|Airway bleeding|airway bleeding
104671|NCT02913365|Pulmonary hemorrhage|pulmonary hemorrhage
104672|NCT02913339|screening|screening
104673|NCT02913339|telemedicine|telemedicine
104674|NCT02913339|risk assessment|risk assessment
104675|NCT02913339|prevention|prevention
104676|NCT02913300|Lignocaine|lignocaine
104677|NCT02913261|GvHD (Graft versus Host Disease)|gvhd (graft versus host disease)
104678|NCT02913261|INC424|inc424
104679|NCT02913261|ruxolitinib|ruxolitinib
104680|NCT02913261|best available therapy (BAT)|best available therapy (bat)
104681|NCT02913261|corticosteroid-refractory acute graft vs. host disease|corticosteroid-refractory acute graft vs. host disease
104682|NCT02913261|allogeneic stem cell transplantation|allogeneic stem cell transplantation
104785|NCT02912442|autoantibodies|autoantibodies
104683|NCT02913261|steroid refractory acute graft vs. host disease|steroid refractory acute graft vs. host disease
104684|NCT02913261|Janus Kinase (JAK) inhibitor|janus kinase (jak) inhibitor
104685|NCT02913248|periodontitis|periodontitis
104686|NCT02913248|saliva|saliva
104687|NCT02913248|bacteria|bacteria
104688|NCT02913235|biofilm|biofilm
104689|NCT02913235|saliva|saliva
104690|NCT02913235|bacteria|bacteria
104691|NCT02913235|oral hygiene|oral hygiene
104692|NCT02913222|femoroacetabular impingement|femoroacetabular impingement
104693|NCT02913222|labral tear|labral tear
104694|NCT02913222|rehabilitation|rehabilitation
104695|NCT02913183|acute stroke|acute stroke
104696|NCT02913183|young health plasma|young health plasma
104697|NCT02913183|efficacy|efficacy
104698|NCT02913183|safety|safety
104699|NCT02913105|Non-alcoholic Steatohepatitis|non-alcoholic steatohepatitis
104700|NCT02913105|NASH|nash
104701|NCT02913105|Fatty liver disease|fatty liver disease
104702|NCT02913014|Antiarrhythmic Agents|antiarrhythmic agents
104703|NCT02913014|Catheter Ablation, electric|catheter ablation, electric
104704|NCT02913014|Cardiac Arrhythmias|cardiac arrhythmias
104705|NCT02913014|Anti-Arrhythmia Drugs|anti-arrhythmia drugs
104706|NCT02913001|Diet|diet
104707|NCT02913001|glycemic index|glycemic index
104708|NCT02913001|glycemic load|glycemic load
104709|NCT02913001|Acne Vulgaris|acne vulgaris
104710|NCT02912988|Subfertility|subfertility
104711|NCT02912988|In-vitro fertilization|in-vitro fertilization
104712|NCT02912988|Letrozole|letrozole
104713|NCT02912949|Bispecific Antibody IgG1, HER2, HER3|bispecific antibody igg1, her2, her3
104714|NCT02912949|First-in-human|first-in-human
104715|NCT02912949|MCLA-128|mcla-128
104716|NCT02912949|Antibodies, Bispecific|antibodies, bispecific
104717|NCT02912949|Immunologic Factors|immunologic factors
104718|NCT02912949|Cytokines|cytokines
104719|NCT02912936|medium chain triglyceride|medium chain triglyceride
104720|NCT02912936|MCT|mct
104721|NCT02912936|coconut oil|coconut oil
104722|NCT02912936|MRI|mri
104723|NCT02912936|PET|pet
104724|NCT02912936|ketones|ketones
104725|NCT02912923|Stroke|stroke
104726|NCT02912923|Rehabilitation Robotics|rehabilitation robotics
104727|NCT02912923|Bimanual|bimanual
104728|NCT02912923|Compensatory Movements|compensatory movements
104729|NCT02912923|Hemiplegia|hemiplegia
104730|NCT02912923|Kinematics|kinematics
104731|NCT02912923|Reaching|reaching
104732|NCT02912923|Trunk|trunk
104733|NCT02912897|EBV-CTL|ebv-ctl
104734|NCT02912897|Multiple sclerosis|multiple sclerosis
104735|NCT02912897|cellular therapy|cellular therapy
104736|NCT02912897|clinically isolated syndrome|clinically isolated syndrome
104737|NCT02912871|subthalamotomy|subthalamotomy
104738|NCT02912871|motor features|motor features
104739|NCT02912871|deep brain stimulation|deep brain stimulation
104740|NCT02912832|Diagnosis|diagnosis
104741|NCT02912806|Knee Arthroplasty|knee arthroplasty
104742|NCT02912806|Total knee replacement|total knee replacement
104743|NCT02912806|Knee osteoarthritis|knee osteoarthritis
104744|NCT02912806|Patient-Outcomes Measurement Program|patient-outcomes measurement program
104745|NCT02912806|Surgical Registries|surgical registries
104746|NCT02912806|Shared Decision Making|shared decision making
104747|NCT02912806|Patient Reported Outcomes|patient reported outcomes
104748|NCT02912806|Patient Experience|patient experience
104749|NCT02912806|Cohort Studies|cohort studies
104750|NCT02912767|lower-extremity lymphedema|lower-extremity lymphedema
104751|NCT02912767|16-1001|16-1001
104752|NCT02912702|Pegaspargase|pegaspargase
104753|NCT02912702|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
104754|NCT02912702|Epstein Barr virus|epstein barr virus
104755|NCT02912702|initial treatment|initial treatment
104756|NCT02912689|COPD|copd
104757|NCT02912689|Non-invasive ventilation|non-invasive ventilation
104758|NCT02912689|NAVA|nava
104759|NCT02912676|Cancer|cancer
104760|NCT02912676|Thioguanine|thioguanine
104761|NCT02912676|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
104762|NCT02912676|6 Mercaptopurine|6 mercaptopurine
104763|NCT02912676|Maintenance Therapy of Leukemia|maintenance therapy of leukemia
104764|NCT02912676|Denmark|denmark
104765|NCT02912676|Lymphoblastic Lymphoma|lymphoblastic lymphoma
104766|NCT02912650|ibuprofen|ibuprofen
104767|NCT02912650|acetaminophen|acetaminophen
104768|NCT02912650|pain|pain
104769|NCT02912650|molar extraction|molar extraction
104770|NCT02912624|Physical Examination|physical examination
104771|NCT02912624|Diagnostic Imaging|diagnostic imaging
104772|NCT02912624|Ultrasonography|ultrasonography
104773|NCT02912624|Hemodynamics|hemodynamics
104774|NCT02912624|Patient Outcome Assessment|patient outcome assessment
104775|NCT02912624|Mortality|mortality
104776|NCT02912585|colostrum|colostrum
104777|NCT02912572|Endometrial Cancer|endometrial cancer
104778|NCT02912546|Stroke, Acute|stroke, acute
104779|NCT02912455|Post-Bariatric Surgery|post-bariatric surgery
104780|NCT02912455|hemoglobin A1c protein, human|hemoglobin a1c protein, human
104781|NCT02912442|thyroid|thyroid
104782|NCT02912442|infertility|infertility
104783|NCT02912442|autoimmunity|autoimmunity
104784|NCT02912442|pregnancy loss|pregnancy loss
104786|NCT02912364|Eslicarbazepine|eslicarbazepine
104787|NCT02912364|Carbamazepine|carbamazepine
104788|NCT02912364|cognition|cognition
104789|NCT02912351|Total Knee Arthroplasty|total knee arthroplasty
104790|NCT02912351|Total Knee Replacement|total knee replacement
104791|NCT02912351|Revision Knee Arthroplasty|revision knee arthroplasty
104792|NCT02912338|Sarcopenic obesity|sarcopenic obesity
104793|NCT02912338|Body composition|body composition
104794|NCT02912338|Physical function|physical function
104795|NCT02912338|quality of life|quality of life
104796|NCT02912338|long term care|long term care
104797|NCT02912312|Malignant neoplasm of breast|malignant neoplasm of breast
104798|NCT02912312|Lymphedema|lymphedema
104799|NCT02912312|Standard regional nodal irradiation|standard regional nodal irradiation
104800|NCT02912312|RNI|rni
104801|NCT02912312|Shortened regional nodal irradiation|shortened regional nodal irradiation
104802|NCT02912312|Radiation therapy|radiation therapy
104803|NCT02912312|XRT|xrt
104804|NCT02912312|Arm swelling|arm swelling
104805|NCT02912312|Questionnaires|questionnaires
104806|NCT02912312|Surveys|surveys
104807|NCT02912273|Geriatric assessment|geriatric assessment
104808|NCT02912247|tumor necrosis factor-a blocker|tumor necrosis factor-a blocker
104809|NCT02912247|pharmacokinetics|pharmacokinetics
104810|NCT02912247|safety|safety
104811|NCT02912169|Alzheimer's Disease|alzheimer's disease
104812|NCT02912169|Alzheimer's|alzheimer's
104813|NCT02912169|Stem cell|stem cell
104814|NCT02912169|Adipose-derived stem cells|adipose-derived stem cells
104815|NCT02912169|ASC|asc
104816|NCT02912169|ADSC|adsc
104817|NCT02912156|Pharmacokinetic|pharmacokinetic
104818|NCT02912130|Exercise|exercise
104819|NCT02912130|Nutrition|nutrition
104820|NCT02912130|Sarcopenia|sarcopenia
104821|NCT02912130|Healthy Ageing|healthy ageing
104822|NCT02912130|Elderly|elderly
104823|NCT02912130|Muscular Hypertrophy|muscular hypertrophy
104824|NCT02912104|primary ovarian insufficiency|primary ovarian insufficiency
104825|NCT02912104|premature ovarian failure|premature ovarian failure
104826|NCT02912104|Infertility|infertility
104827|NCT02912104|human amniotic epithelial cells transplantation|human amniotic epithelial cells transplantation
104828|NCT02912052|Perioperative Chemotherapy|perioperative chemotherapy
104829|NCT02912052|Postoperative Chemotherapy|postoperative chemotherapy
104830|NCT02912052|Colon Cancer|colon cancer
104831|NCT02912052|Resectable Liver Metastasis|resectable liver metastasis
104832|NCT02912000|Dental Health Services|dental health services
104833|NCT02912000|Sugar-Sweetened Beverages|sugar-sweetened beverages
104834|NCT02912000|Tobacco control|tobacco control
104835|NCT02912000|Pediatrics|pediatrics
104836|NCT02912000|Parents|parents
104837|NCT02911974|fine needle biopsy|fine needle biopsy
104838|NCT02911974|EUS|eus
104839|NCT02911974|solid pancreatic mass|solid pancreatic mass
104840|NCT02911896|physical function|physical function
104841|NCT02911896|critical care|critical care
104842|NCT02911857|Canakinumab,|canakinumab,
104843|NCT02911857|interleukin-1|interleukin-1
104844|NCT02911857|Periodic Fevers Syndrome|periodic fevers syndrome
104845|NCT02911857|TRAPS|traps
104846|NCT02911857|HIDS|hids
104847|NCT02911857|crFMF|crfmf
104848|NCT02911857|auto-inflammatory diseases|auto-inflammatory diseases
104849|NCT02911857|extension study|extension study
104850|NCT02911805|Exercise|exercise
104851|NCT02911805|Retinal Degeneration|retinal degeneration
104852|NCT02911805|Neuropharmacology|neuropharmacology
104853|NCT02911805|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
104854|NCT02911805|Biometry|biometry
104855|NCT02911805|Immunochemistry|immunochemistry
104856|NCT02911805|Molecular Biology|molecular biology
104857|NCT02911805|Neurosciences|neurosciences
104858|NCT02911805|Ophthalmology|ophthalmology
104859|NCT02911792|hyperfiltering|hyperfiltering
104860|NCT02911792|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
104861|NCT02911766|Periodontal Index|periodontal index
104862|NCT02911727|Cesarean section|cesarean section
104863|NCT02911727|Postnatal Care|postnatal care
104864|NCT02911714|Kidney Transplantation|kidney transplantation
104865|NCT02911714|Delayed Graft Function|delayed graft function
104866|NCT02911714|Acute Allograft Rejection|acute allograft rejection
104867|NCT02911714|Acute Kidney Injury|acute kidney injury
104868|NCT02911597|Ketamine|ketamine
104869|NCT02911597|Naltrexone|naltrexone
104870|NCT02911597|Treatment-Resistant|treatment-resistant
104871|NCT02911597|TRD|trd
104872|NCT02911545|Atrial fibrillation|atrial fibrillation
104873|NCT02911545|Anticoagulation|anticoagulation
104874|NCT02911545|Cardioversion|cardioversion
104875|NCT02911532|pterygium|pterygium
104876|NCT02911532|tissue engineering|tissue engineering
104877|NCT02911532|atretoblepharia|atretoblepharia
104878|NCT02911519|Schizophrenia|schizophrenia
104879|NCT02911519|Patient Education|patient education
104880|NCT02911493|sedentary time|sedentary time
104881|NCT02911493|number of steps/day|number of steps/day
104882|NCT02911493|mobility|mobility
104883|NCT02911493|disability|disability
104884|NCT02911428|Ebola|ebola
104885|NCT02911428|Ebola Virus Vaccines|ebola virus vaccines
104886|NCT02911428|Haemorrhagic Fever|haemorrhagic fever
104887|NCT02911428|Ebola Infection|ebola infection
104888|NCT02911428|GP protein, Ebola virus|gp protein, ebola virus
104889|NCT02911415|Ebola|ebola
104890|NCT02911415|Ebola Virus Vaccines|ebola virus vaccines
104891|NCT02911415|Haemorrhagic Fever|haemorrhagic fever
104892|NCT02911415|Ebola Infection|ebola infection
104893|NCT02911415|GP protein, Ebola virus|gp protein, ebola virus
104894|NCT02911311|conbercept|conbercept
104895|NCT02911311|anti-VEGF agent|anti-vegf agent
104896|NCT02911311|panretinal photocoagulation|panretinal photocoagulation
104897|NCT02911285|Alcohol|alcohol
104898|NCT02911285|PTSD|ptsd
104899|NCT02911285|Trauma|trauma
104900|NCT02911285|Veteran|veteran
104901|NCT02911285|Substance|substance
104902|NCT02911285|Drug|drug
104903|NCT02911285|Post Traumatic Stress Disorder|post traumatic stress disorder
104904|NCT02911285|Military|military
104905|NCT02911272|Partograph|partograph
104906|NCT02911272|Best action line|best action line
104907|NCT02911272|Prolonged labour prevention|prolonged labour prevention
104908|NCT02911207|chronic ill patients|chronic ill patients
104909|NCT02911207|Emotion management skill|emotion management skill
104910|NCT02911207|Quality of Life|quality of life
104911|NCT02911181|BIVA measurement|biva measurement
104912|NCT02911181|SNAQ score|snaq score
104913|NCT02911168|NERVE BLOCK|nerve block
104914|NCT02911168|ANESTHESIA RECOVERY PERIOD|anesthesia recovery period
104915|NCT02911168|PAIN MANAGEMENT|pain management
104916|NCT02911155|Cohort Study|cohort study
104917|NCT02911155|Radiation|radiation
104918|NCT02911155|Occupation|occupation
104919|NCT02911142|Treatment Naive|treatment naive
104920|NCT02911142|Immune Modulatory|immune modulatory
104921|NCT02911142|Chemotherapy|chemotherapy
104922|NCT02911142|AIDS-Related Lymphoma|aids-related lymphoma
104923|NCT02911142|PEL|pel
104924|NCT02911129|Chronic Stroke|chronic stroke
104925|NCT02911129|Neglect|neglect
104926|NCT02911129|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
104927|NCT02911129|Visual and Motor Integration|visual and motor integration
104928|NCT02911129|Visual Fields|visual fields
104929|NCT02911116|Panuveitis|panuveitis
104930|NCT02911116|Intermediate Uveitis|intermediate uveitis
104931|NCT02911116|Uveitis|uveitis
104932|NCT02911103|Electrophysiology|electrophysiology
104933|NCT02911103|Neurosurgery|neurosurgery
104934|NCT02911103|Dystonia|dystonia
104935|NCT02911103|Deep Brain Stimulation|deep brain stimulation
104936|NCT02911090|Endometriosis|endometriosis
104937|NCT02911090|Chronic pelvic pain|chronic pelvic pain
104938|NCT02911090|Dyspareunia|dyspareunia
104939|NCT02911077|Bacteria|bacteria
104940|NCT02911064|Questionnaires|questionnaires
104941|NCT02911064|Surveys|surveys
104942|NCT02911064|Benign neoplasms|benign neoplasms
104943|NCT02911064|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
104944|NCT02911064|Inpatient rehabilitation therapy|inpatient rehabilitation therapy
104945|NCT02911038|Complete denture|complete denture
104946|NCT02911038|PMMA|pmma
104947|NCT02911038|Stereolithography|stereolithography
104948|NCT02911025|epilepsy|epilepsy
104949|NCT02911025|sleep|sleep
104950|NCT02911025|antiepileptic drugs|antiepileptic drugs
104951|NCT02910986|Mammography|mammography
104952|NCT02910986|Breast Density|breast density
104953|NCT02910986|Hispanic|hispanic
104954|NCT02910973|Inflammation, Vagus Nerve Stimulation|inflammation, vagus nerve stimulation
104955|NCT02910960|fine needle biopsy|fine needle biopsy
104956|NCT02910960|EUS|eus
104957|NCT02910960|solid pancreatic mass|solid pancreatic mass
104958|NCT02910934|Indoor Residual Spray|indoor residual spray
104959|NCT02910934|IRS|irs
104960|NCT02910934|Insecticide Treated Net|insecticide treated net
104961|NCT02910934|LLIN|llin
104962|NCT02910934|ITN|itn
104963|NCT02910921|Migraine|migraine
104964|NCT02910921|Prediction|prediction
104965|NCT02910921|Forecast|forecast
104966|NCT02910921|App|app
104967|NCT02910921|Fitbit|fitbit
104968|NCT02910921|Individual|individual
104969|NCT02910921|Algorithm|algorithm
104970|NCT02910921|Machine Learning|machine learning
104971|NCT02910921|Mayo Clinic|mayo clinic
104972|NCT02910921|Allergan|allergan
104973|NCT02910921|Second Opinion|second opinion
104974|NCT02910908|Elderly|elderly
104975|NCT02910908|ESRD prognosis|esrd prognosis
104976|NCT02910908|help decision making dialysis therapeutic project|help decision making dialysis therapeutic project
104977|NCT02910882|Pancreas Cancer|pancreas cancer
104978|NCT02910882|Unresectable|unresectable
104979|NCT02910882|Chemoradiation|chemoradiation
104980|NCT02910882|PEGPH20|pegph20
104981|NCT02910843|rectal cancer|rectal cancer
104982|NCT02910843|Neoadjuvant treatment|neoadjuvant treatment
104983|NCT02910843|Regorafenib|regorafenib
104984|NCT02910843|Capecitabine|capecitabine
104985|NCT02910843|locally advanced rectal cancer|locally advanced rectal cancer
104986|NCT02910843|Phase Ib trial|phase ib trial
104987|NCT02910804|GBM|gbm
104988|NCT02910804|GRPR|grpr
104989|NCT02910804|IRDye800|irdye800
104990|NCT02910804|NIRF|nirf
104991|NCT02910804|surgery|surgery
104992|NCT02910726|indocyanine green fluorescent dye|indocyanine green fluorescent dye
104993|NCT02910726|Technetium lymphoscintigraphy|technetium lymphoscintigraphy
104994|NCT02910726|sentinel lymph node biopsy|sentinel lymph node biopsy
104995|NCT02910726|16-1003|16-1003
104996|NCT02910700|Melanoma|melanoma
104997|NCT02910700|Metastatic Melanoma|metastatic melanoma
104998|NCT02910700|BRAF- mutated metastatic melanoma|braf- mutated metastatic melanoma
104999|NCT02910700|BRAF-wild type metastatic melanoma|braf-wild type metastatic melanoma
105000|NCT02910700|Nivolumab|nivolumab
105001|NCT02910700|BMS-936558|bms-936558
105002|NCT02910700|Opdivo|opdivo
105003|NCT02910700|Dabrafenib|dabrafenib
105004|NCT02910700|Tafinlar|tafinlar
105005|NCT02910700|GSK2118436|gsk2118436
105006|NCT02910700|Trametinib|trametinib
105007|NCT02910700|GSK1120212|gsk1120212
105008|NCT02910687|Non ST Elevation Myocardial Infarction (NSTEMI)|non st elevation myocardial infarction (nstemi)
105009|NCT02910687|Elderly|elderly
105010|NCT02910687|Frailty|frailty
105011|NCT02910687|Prognostic value|prognostic value
105012|NCT02910661|Kidney Transplantation|kidney transplantation
105013|NCT02910648|healthy|healthy
105014|NCT02910648|BMI|bmi
105015|NCT02910648|weight loss|weight loss
105016|NCT02910648|sleep|sleep
105017|NCT02910648|healthy sleeper|healthy sleeper
105018|NCT02910648|overweight|overweight
105019|NCT02910648|obese|obese
105020|NCT02910635|Thorough QTc, Therapeutic dose, supra therapeutic dose|thorough qtc, therapeutic dose, supra therapeutic dose
105021|NCT02910622|breast|breast
105022|NCT02910622|ovarian|ovarian
105023|NCT02910622|cancer|cancer
105024|NCT02910609|preterm|preterm
105025|NCT02910609|patent ductus arterioles|patent ductus arterioles
105026|NCT02910609|treatment|treatment
105027|NCT02910557|CTCAE - Common Terminology Criteria for Adverse Events|ctcae - common terminology criteria for adverse events
105028|NCT02910557|eCRF - electronic case report form|ecrf - electronic case report form
105029|NCT02910557|ECOG - Eastern Cooperative Oncology Group|ecog - eastern cooperative oncology group
105030|NCT02910557|EDC - electronic data capture|edc - electronic data capture
105031|NCT02910557|GM-CSF - human granulocyte macrophage colony-stimulating factor|gm-csf - human granulocyte macrophage colony-stimulating factor
105032|NCT02910557|HCP - health care provider|hcp - health care provider
105033|NCT02910557|HSV-1 - herpes simplex virus type 1|hsv-1 - herpes simplex virus type 1
105034|NCT02910557|ICF - informed consent form|icf - informed consent form
105035|NCT02910557|ICP - infected cell protein|icp - infected cell protein
105036|NCT02910557|IEC - Independent Ethics Committee|iec - independent ethics committee
105037|NCT02910557|IRB - Institutional Review Board|irb - institutional review board
105038|NCT02910557|MedDRA - Medical Dictionary for Regulatory Activities|meddra - medical dictionary for regulatory activities
105039|NCT02910557|PFU - plaque-forming unit|pfu - plaque-forming unit
105040|NCT02910557|qPCR - quantitative polymerase chain reaction|qpcr - quantitative polymerase chain reaction
105041|NCT02910557|SmPC - Summary of Product Characteristics|smpc - summary of product characteristics
105042|NCT02910557|USPI - United States Prescribing Information|uspi - united states prescribing information
105043|NCT02910531|Cystinuria|cystinuria
105044|NCT02910531|Kidney stone|kidney stone
105045|NCT02910531|Alpha lipoic acid|alpha lipoic acid
105046|NCT02910479|Body Temperature|body temperature
105047|NCT02910479|Thermometers|thermometers
105048|NCT02910453|Pulmonary lobectomy|pulmonary lobectomy
105049|NCT02910453|Video-Assisted Thoracic Surgery|video-assisted thoracic surgery
105050|NCT02910453|Opto-electronic plethysmography|opto-electronic plethysmography
105051|NCT02910453|Posterolateral thoracotomy|posterolateral thoracotomy
105052|NCT02910427|stroke|stroke
105053|NCT02910427|potassium and magnesium-enriched salt|potassium and magnesium-enriched salt
105054|NCT02910427|neurological performance|neurological performance
105055|NCT02910388|conization|conization
105056|NCT02910388|LLETZ|lletz
105057|NCT02910388|loop excision|loop excision
105058|NCT02910388|randomized controlled trial|randomized controlled trial
105059|NCT02910388|colposcopy|colposcopy
105060|NCT02910388|direct colposcopic vision|direct colposcopic vision
105061|NCT02910388|intraoperative colposcopy|intraoperative colposcopy
105062|NCT02910375|golimumab|golimumab
105063|NCT02910375|drug monitoring|drug monitoring
105064|NCT02910375|home based care|home based care
105065|NCT02910349|valvular hear disease|valvular hear disease
105066|NCT02910349|echocardiography|echocardiography
105067|NCT02910349|magnetic resonance|magnetic resonance
105068|NCT02910349|global longitudinal strain|global longitudinal strain
105069|NCT02910349|T1 relaxation time|t1 relaxation time
105070|NCT02910310|Uterine Balloon Tamponade|uterine balloon tamponade
105071|NCT02910297|cannabidiol|cannabidiol
105072|NCT02910297|Dravet Syndrome|dravet syndrome
105073|NCT02910297|Lennox Gastaut Syndrome|lennox gastaut syndrome
105074|NCT02910284|HSV|hsv
105075|NCT02910284|Herpes|herpes
105076|NCT02910284|Genital Herpes|genital herpes
105077|NCT02910258|myelofibrosis|myelofibrosis
105078|NCT02910258|pegylated interferon|pegylated interferon
105079|NCT02910245|Therapeutic Drug Monitoring|therapeutic drug monitoring
105080|NCT02910245|Mercaptopurine (6-MP)|mercaptopurine (6-mp)
105081|NCT02910245|Thiopurine|thiopurine
105082|NCT02910245|Efficacy|efficacy
105083|NCT02910232|Rice starch|rice starch
105084|NCT02910232|Porous composite|porous composite
105085|NCT02910232|Biomaterial|biomaterial
105086|NCT02910232|Bone regeneration|bone regeneration
105087|NCT02910232|Clinical trial|clinical trial
105088|NCT02910232|Hydroxyapatite|hydroxyapatite
105089|NCT02910219|HER2|her2
105090|NCT02910219|pertuzumab|pertuzumab
105091|NCT02910219|trastuzumab|trastuzumab
105092|NCT02910219|docetaxel|docetaxel
105093|NCT02910219|paclitaxel|paclitaxel
105094|NCT02910219|carboplatin|carboplatin
105095|NCT02910219|crofelemer|crofelemer
105096|NCT02910219|chemotherapy induced diarrhea|chemotherapy induced diarrhea
105097|NCT02910206|etomidate|etomidate
105098|NCT02910206|propofol|propofol
105099|NCT02910193|alcoholism|alcoholism
105100|NCT02910193|genetics|genetics
105101|NCT02910193|functional MRI|functional mri
105102|NCT02910193|structural MRI|structural mri
105103|NCT02910193|first-degree relatives|first-degree relatives
105104|NCT02910180|Tissue Repository|tissue repository
105105|NCT02910180|Cerebrovascular Diseases|cerebrovascular diseases
105106|NCT02910180|Stroke|stroke
105107|NCT02910180|Aneurysm|aneurysm
105108|NCT02910180|Arteriovenous malformation|arteriovenous malformation
105109|NCT02910180|Fistula|fistula
105110|NCT02910180|Intracranial Stenosis|intracranial stenosis
105111|NCT02910180|Treatment|treatment
105112|NCT02910180|Registry|registry
105113|NCT02910180|Outcomes|outcomes
105114|NCT02910141|Type 2 diabetes|type 2 diabetes
105115|NCT02910141|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
105116|NCT02910141|Meta-analysis|meta-analysis
105117|NCT02910141|Insulin pump therapy|insulin pump therapy
105118|NCT02910141|Multiple daily insulin injections|multiple daily insulin injections
105119|NCT02910102|RVT-101|rvt-101
105120|NCT02910102|intepirdine|intepirdine
105121|NCT02910102|Alzheimer's disease|alzheimer's disease
105122|NCT02910102|Dementia with Lewy bodies|dementia with lewy bodies
105123|NCT02910102|Lewy body dementia|lewy body dementia
105124|NCT02910102|Parkinson's Disease Dementia|parkinson's disease dementia
105125|NCT02910089|Diabetes Mellitus Type 2|diabetes mellitus type 2
105126|NCT02910063|Relapsed/Refractory Aggressive B-Cell Non Hodgkin Lymphoma|relapsed/refractory aggressive b-cell non hodgkin lymphoma
105127|NCT02910063|Blinatumomab|blinatumomab
105128|NCT02910063|Leukemia|leukemia
105129|NCT02910063|Standard of Care|standard of care
105130|NCT02910063|SOC|soc
105131|NCT02910063|Cancer|cancer
105132|NCT02910063|Chemotherapy|chemotherapy
105133|NCT02910050|androgen receptor|androgen receptor
105134|NCT02910050|bicalutamide|bicalutamide
105135|NCT02910050|aromatase inhibitors|aromatase inhibitors
105136|NCT02910050|advanced breast cancer|advanced breast cancer
105137|NCT02910050|letrozole|letrozole
105138|NCT02910050|anastrozole|anastrozole
105139|NCT02910050|exemestane|exemestane
105140|NCT02910037|metagenomic next-generation sequencing|metagenomic next-generation sequencing
105141|NCT02910037|microbiological diagnosis|microbiological diagnosis
105142|NCT02910037|bacterial infections|bacterial infections
105143|NCT02910037|viral infections|viral infections
105144|NCT02910037|fungal infections|fungal infections
105145|NCT02910037|parasitic infections|parasitic infections
105146|NCT02909998|Biomarkers|biomarkers
105147|NCT02909998|Genetic|genetic
105148|NCT02909998|Chronic arthritis|chronic arthritis
105149|NCT02909998|Treatment|treatment
105150|NCT02909985|Infrared|infrared
105151|NCT02909985|Dark Adaptation|dark adaptation
105152|NCT02909985|Vision|vision
105153|NCT02909985|Scotopic Threshold Response|scotopic threshold response
105154|NCT02909985|Transient Receptor Potential (TRP) Channels|transient receptor potential (trp) channels
105155|NCT02909985|Human|human
105156|NCT02909959|sulforaphane|sulforaphane
105157|NCT02909959|glucoraphanin|glucoraphanin
105158|NCT02909959|physiologic effects of drugs|physiologic effects of drugs
105159|NCT02909946|multidrug-resistant organisms|multidrug-resistant organisms
105160|NCT02909946|nursing home|nursing home
105161|NCT02909946|post-acute care|post-acute care
105162|NCT02909946|long-term care|long-term care
105163|NCT02909946|infection control|infection control
105164|NCT02909920|Telerehabilitation|telerehabilitation
105165|NCT02909920|Physiotherapy|physiotherapy
105166|NCT02909920|Surgery|surgery
105167|NCT02909920|Telemedicine|telemedicine
105168|NCT02909894|Sedentary behaviour|sedentary behaviour
105169|NCT02909894|Postprandial glycaemic response|postprandial glycaemic response
105170|NCT02909881|polysaccharide|polysaccharide
105171|NCT02909881|oxidation|oxidation
105172|NCT02909881|endurance exercise|endurance exercise
105173|NCT02909855|children|children
105174|NCT02909855|psychological predictors|psychological predictors
105175|NCT02909855|side-effects|side-effects
105176|NCT02909855|vaccination|vaccination
105177|NCT02909842|influenza|influenza
105178|NCT02909842|vaccine|vaccine
105179|NCT02909842|probiotic|probiotic
105180|NCT02909842|immune response|immune response
105181|NCT02909829|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
105182|NCT02909829|Artificial Pancreas|artificial pancreas
105183|NCT02909829|Closed-Loop Delivery|closed-loop delivery
105184|NCT02909829|Insulin|insulin
105185|NCT02909829|Adolescent|adolescent
105186|NCT02909829|Missed Bolus|missed bolus
105187|NCT02909803|glucose|glucose
105188|NCT02909803|glycemic index|glycemic index
105189|NCT02909803|lentil|lentil
105190|NCT02909803|polyphenols|polyphenols
105191|NCT02909803|metabolites|metabolites
105192|NCT02909803|bioavailability|bioavailability
105193|NCT02909777|Lymphoma|lymphoma
105194|NCT02909777|Neuroblastoma|neuroblastoma
105195|NCT02909777|Brain Tumor|brain tumor
105196|NCT02909777|Solid Tumor|solid tumor
105197|NCT02909764|Salty taste|salty taste
105198|NCT02909764|Psychophysics|psychophysics
105199|NCT02909764|Genetics|genetics
105200|NCT02909764|Diet|diet
105201|NCT02909764|Age|age
105202|NCT02909725|Physical activity|physical activity
105203|NCT02909725|Sedentary time|sedentary time
105204|NCT02909725|Pregnancy|pregnancy
105205|NCT02909725|Pregnant women|pregnant women
105206|NCT02909725|Weight gain|weight gain
105207|NCT02909712|sub-Saharan|sub-saharan
105208|NCT02909712|dihydroartemisinin|dihydroartemisinin
105209|NCT02909712|piperaquine|piperaquine
105210|NCT02909712|sulphadoxine-pyrimethamine|sulphadoxine-pyrimethamine
105211|NCT02909712|antimalarials|antimalarials
105212|NCT02909686|Gulf War Syndrome|gulf war syndrome
105213|NCT02909686|Chronic Multisymptom Illnesses|chronic multisymptom illnesses
105214|NCT02909686|Medically Unexplained Illnesses|medically unexplained illnesses
105215|NCT02909673|adolescent behavior|adolescent behavior
105216|NCT02909673|intimate partner violence|intimate partner violence
105217|NCT02909673|youth risk behavior|youth risk behavior
105218|NCT02909673|violence prevention|violence prevention
105219|NCT02909673|teen dating violence|teen dating violence
105220|NCT02909621|OsteoArthritis; FLEXOFYTOL®; Curcuma; biomarkers|osteoarthritis; flexofytol®; curcuma; biomarkers
105221|NCT02909556|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
105222|NCT02909556|TAVI|tavi
105223|NCT02909556|Transcatheter Aortic Valve Implant|transcatheter aortic valve implant
105224|NCT02909556|Transfemoral access|transfemoral access
105225|NCT02909530|Endoscopic ultrasound-guided fine needle biopsy|endoscopic ultrasound-guided fine needle biopsy
105226|NCT02909530|Olympus EZ Shot 3Plus|olympus ez shot 3plus
105227|NCT02909530|Olympus EZ Shot 2|olympus ez shot 2
105228|NCT02909452|entinostat|entinostat
105229|NCT02909452|pembrolizumab|pembrolizumab
105230|NCT02909452|solid tumor|solid tumor
105231|NCT02909452|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
105232|NCT02909426|Screening|screening
105233|NCT02909426|Digital mammography|digital mammography
105234|NCT02909426|Ultrasonography|ultrasonography
105235|NCT02909426|Sensitivity|sensitivity
105236|NCT02909426|Specificity|specificity
105237|NCT02909413|desflurane|desflurane
105238|NCT02909413|sevoflurane|sevoflurane
105239|NCT02909400|mitochondrial|mitochondrial
105240|NCT02909400|oxidative phosphorylation (oxphos)|oxidative phosphorylation (oxphos)
105241|NCT02909400|MELAS|melas
105242|NCT02909400|MIDD|midd
105243|NCT02909400|KH176|kh176
105244|NCT02909400|Proof of Concept|proof of concept
105245|NCT02909387|Epilepsy|epilepsy
105246|NCT02909387|Seizure Disorder|seizure disorder
105247|NCT02909374|Implementation|implementation
105248|NCT02909374|fall prevention|fall prevention
105249|NCT02909374|balance training|balance training
105250|NCT02909348|Neoplasms|neoplasms
105251|NCT02909348|Melanoma|melanoma
105252|NCT02909348|Immunotherapy|immunotherapy
105253|NCT02909348|Biomarkers|biomarkers
105254|NCT02909309|Propofol|propofol
105255|NCT02909309|Deep Sedation|deep sedation
105256|NCT02909309|Anoxia|anoxia
105257|NCT02909309|Hypercapnia|hypercapnia
105258|NCT02909231|Patient Outcome Assessment|patient outcome assessment
105259|NCT02909218|HIV/AIDS, Swaziland|hiv/aids, swaziland
105260|NCT02909205|child|child
105261|NCT02909205|gastrostomy|gastrostomy
105262|NCT02909205|supportive care|supportive care
105263|NCT02909205|educational program|educational program
105264|NCT02909192|Parkinson's Disease|parkinson's disease
105265|NCT02909192|Excessive Daytime Sleepiness|excessive daytime sleepiness
105266|NCT02909192|Circadian Rhythms|circadian rhythms
105267|NCT02909192|Light Therapy|light therapy
105268|NCT02909179|Community Health Workers, mHealth, mobile phones, ANC, PNC, essential newborn care|community health workers, mhealth, mobile phones, anc, pnc, essential newborn care
105269|NCT02909153|Triferic|triferic
105270|NCT02909153|ferric pyrophosphate citrate|ferric pyrophosphate citrate
105271|NCT02909153|peritoneal dialysis|peritoneal dialysis
105272|NCT02909153|anemia|anemia
105273|NCT02909153|chronic kidney disease|chronic kidney disease
105274|NCT02909153|FPC|fpc
105275|NCT02909127|deglutition|deglutition
105276|NCT02909127|deglutition disorders|deglutition disorders
105277|NCT02909127|pediatric dysphagia|pediatric dysphagia
105278|NCT02909127|swallowing|swallowing
105279|NCT02909114|stereotactic boday radiotherapy, oligometastases|stereotactic boday radiotherapy, oligometastases
105280|NCT02909101|Working memory|working memory
105281|NCT02909101|cognitive training|cognitive training
105282|NCT02909101|HIV|hiv
105283|NCT02909101|substance abuse|substance abuse
105284|NCT02909088|stuttering|stuttering
105285|NCT02909088|childhood onset fluency disorder|childhood onset fluency disorder
105286|NCT02909088|ecopipam|ecopipam
105287|NCT02909075|PET/CT|pet/ct
105288|NCT02909075|MRI|mri
105289|NCT02909075|Assess Thymic Function|assess thymic function
105290|NCT02909075|16-1244|16-1244
105291|NCT02909062|Electronic Activity Monitoring (EAM)|electronic activity monitoring (eam)
105292|NCT02909062|16-493|16-493
105293|NCT02909049|Prostate Biopsy|prostate biopsy
105294|NCT02909049|Local Anesthesia|local anesthesia
105295|NCT02909049|Pain|pain
105296|NCT02909049|Biopsy of prostate|biopsy of prostate
105297|NCT02909036|Melphalan|melphalan
105298|NCT02909036|Autologous Hematopoietic Progenitor Cell Transplant|autologous hematopoietic progenitor cell transplant
105299|NCT02909036|High Dose Therapy|high dose therapy
105300|NCT02909036|16-875|16-875
105301|NCT02909023|Hepatitis B Virus|hepatitis b virus
105302|NCT02909023|Elispot test|elispot test
105303|NCT02909023|T cellular immune response|t cellular immune response
105304|NCT02908984|unilateral headache|unilateral headache
105305|NCT02908984|cervical pain|cervical pain
105306|NCT02908984|neck pain|neck pain
105307|NCT02908984|voxel based morphometry|voxel based morphometry
105308|NCT02908984|diffusion tensor imaging|diffusion tensor imaging
105309|NCT02908984|structural brain changes|structural brain changes
105310|NCT02908984|rehabilitation|rehabilitation
105311|NCT02908971|soy based formula|soy based formula
105312|NCT02908971|overweight|overweight
105313|NCT02908971|adrenarche,|adrenarche,
105314|NCT02908971|gonadarache|gonadarache
105315|NCT02908945|Ketamine|ketamine
105316|NCT02908945|Anesthesia|anesthesia
105317|NCT02908945|EEG|eeg
105318|NCT02908945|NeuroSENSE|neurosense
105319|NCT02908945|Pain|pain
105320|NCT02908919|Colonoscopy|colonoscopy
105321|NCT02908919|Picosulfate sodium|picosulfate sodium
105322|NCT02908919|Polyethylene glycol|polyethylene glycol
105323|NCT02908919|Magnesium citrate|magnesium citrate
105324|NCT02908919|Ascorbic acid|ascorbic acid
105325|NCT02908919|SPMC (solution picosulfate + magnesium citrate)|spmc (solution picosulfate + magnesium citrate)
105326|NCT02908919|PEGA (Polyethylene glycol + ascorbic acid)|pega (polyethylene glycol + ascorbic acid)
105327|NCT02908880|MANTA, arterial closure device, large bore closure device|manta, arterial closure device, large bore closure device
105328|NCT02908867|Sexuality|sexuality
105329|NCT02908867|Spinal cord injuries|spinal cord injuries
105330|NCT02908867|Complementary Therapies|complementary therapies
105331|NCT02908867|Medicinal plants|medicinal plants
105332|NCT02908854|Spices|spices
105333|NCT02908854|Herbs|herbs
105334|NCT02908854|Vegetables|vegetables
105335|NCT02908854|National School Lunch Program|national school lunch program
105336|NCT02908854|High school|high school
105337|NCT02908828|Biological Products/therapeutic use|biological products/therapeutic use
105338|NCT02908828|Copepoda|copepoda
105339|NCT02908828|Dietary Supplements|dietary supplements
105340|NCT02908828|Fish Oils|fish oils
105341|NCT02908828|Fatty Acids, Omega-3|fatty acids, omega-3
105342|NCT02908828|Oxygen Consumption|oxygen consumption
105343|NCT02908828|Calanus|calanus
105344|NCT02908828|Maximal oxygen uptake|maximal oxygen uptake
105345|NCT02908828|Zooplankton|zooplankton
105346|NCT02908789|Photochemotherapy|photochemotherapy
105347|NCT02908763|Chronic Hepatitis B|chronic hepatitis b
105348|NCT02908763|Peginterferon Alpha|peginterferon alpha
105349|NCT02908750|oncology|oncology
105350|NCT02908750|cancer|cancer
105351|NCT02908750|non small cell lung cancer|non small cell lung cancer
105352|NCT02908750|anticancer drug|anticancer drug
105353|NCT02908750|lung neoplasms|lung neoplasms
105354|NCT02908750|pharmacokinetics|pharmacokinetics
105355|NCT02908750|AZD9291|azd9291
105356|NCT02908750|osimertinib|osimertinib
105357|NCT02908750|fexofenadine|fexofenadine
105358|NCT02908750|TAGRISSO™|tagrisso™
105359|NCT02908750|EGFR genes|egfr genes
105360|NCT02908724|Familial cardiomyopathies|familial cardiomyopathies
105361|NCT02908724|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
105362|NCT02908724|Left ventricular hypertrophy|left ventricular hypertrophy
105363|NCT02908659|intensive care unit|intensive care unit
105364|NCT02908659|patient's monitoring|patient's monitoring
105365|NCT02908659|respiratory rate|respiratory rate
105366|NCT02908633|open angle glaucoma|open angle glaucoma
105367|NCT02908633|canaloplasty|canaloplasty
105368|NCT02908633|migs|migs
105369|NCT02908633|abic|abic
105370|NCT02908594|Nursing|nursing
105371|NCT02908594|ESRD|esrd
105372|NCT02908594|hemodialysis|hemodialysis
105373|NCT02908594|intradialytic exercise|intradialytic exercise
105374|NCT02908594|depression|depression
105375|NCT02908594|fatigue|fatigue
105376|NCT02908594|Quality Of Life|quality of life
105377|NCT02908594|self-efficacy|self-efficacy
105378|NCT02908594|resilience|resilience
105379|NCT02908568|mandibular stretching, trigeminocardiac reflex|mandibular stretching, trigeminocardiac reflex
105380|NCT02908555|type 1 diabetes|type 1 diabetes
105381|NCT02908555|adolescents|adolescents
105382|NCT02908555|sleep|sleep
105383|NCT02908490|Arthritis, Rheumatoid|arthritis, rheumatoid
105384|NCT02908490|Atherosclerosis|atherosclerosis
105385|NCT02908464|Cardiac Surgery|cardiac surgery
105386|NCT02908464|Delirium|delirium
105780|NCT02906046|SCA 3|sca 3
105387|NCT02908464|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
105388|NCT02908451|Cancer|cancer
105389|NCT02908451|Antibody Drug Conjugate|antibody drug conjugate
105390|NCT02908451|AbGn-107|abgn-107
105391|NCT02908451|Adenocarcinoma|adenocarcinoma
105392|NCT02908451|Gastric|gastric
105393|NCT02908451|Colorectal|colorectal
105394|NCT02908451|Pancreatic|pancreatic
105395|NCT02908412|Nerve Block|nerve block
105396|NCT02908412|Spectrophotometry|spectrophotometry
105397|NCT02908412|Bupivacaine|bupivacaine
105398|NCT02908412|Spinal Surgery|spinal surgery
105399|NCT02908412|Blood Loss, Surgical|blood loss, surgical
105400|NCT02908386|Head and neck tumors|head and neck tumors
105401|NCT02908386|Proton|proton
105402|NCT02908386|Photon|photon
105403|NCT02908386|replanning timing|replanning timing
105404|NCT02908373|risk management|risk management
105405|NCT02908373|nursing home|nursing home
105406|NCT02908373|elderly|elderly
105407|NCT02908373|care|care
105408|NCT02908360|Double positive lymphocyte T F prausnitzii|double positive lymphocyte t f prausnitzii
105409|NCT02908347|Plaque psoriasis|plaque psoriasis
105410|NCT02908347|chronic|chronic
105411|NCT02908347|moderate|moderate
105412|NCT02908347|severe|severe
105413|NCT02908347|Plaque|plaque
105414|NCT02908308|Induced hypothermia|induced hypothermia
105415|NCT02908308|Mild induced hypothermia|mild induced hypothermia
105416|NCT02908308|Therapeutic hypothermia|therapeutic hypothermia
105417|NCT02908308|Cardiac arrest|cardiac arrest
105418|NCT02908308|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
105419|NCT02908308|Mortality|mortality
105420|NCT02908308|Neurological function|neurological function
105421|NCT02908308|Randomised clinical trial|randomised clinical trial
105422|NCT02908282|tear film|tear film
105423|NCT02908282|omega-3 fatty acids|omega-3 fatty acids
105424|NCT02908282|eye drops|eye drops
105425|NCT02908269|Influenza|influenza
105426|NCT02908269|Fluzone® Quadrivalent, Influenza Vaccine (2016-2017 formulation)|fluzone® quadrivalent, influenza vaccine (2016-2017 formulation)
105427|NCT02908269|Fluzone® High-Dose, Influenza Vaccine (2016-2017 formulation)|fluzone® high-dose, influenza vaccine (2016-2017 formulation)
105428|NCT02908256|PVI|pvi
105429|NCT02908256|delta PP|delta pp
105430|NCT02908256|vascular filling|vascular filling
105431|NCT02908243|Hemophilia|hemophilia
105432|NCT02908243|Primary prophylaxis|primary prophylaxis
105433|NCT02908243|Pettersson Score|pettersson score
105434|NCT02908243|Joint function study|joint function study
105435|NCT02908243|Comorbidity|comorbidity
105436|NCT02908217|Polymyalgia Rheumatica|polymyalgia rheumatica
105437|NCT02908217|Tocilizumab|tocilizumab
105438|NCT02908217|Glucocorticoid|glucocorticoid
105439|NCT02908204|superficial esophageal squamous cell carcinoma|superficial esophageal squamous cell carcinoma
105440|NCT02908204|efficacy|efficacy
105441|NCT02908204|survival|survival
105442|NCT02908178|ductal carcinoma in situ (DCIS)|ductal carcinoma in situ (dcis)
105443|NCT02908178|sentinel lymph node biopsy (SLNB)|sentinel lymph node biopsy (slnb)
105444|NCT02908087|Diabetes Type 1|diabetes type 1
105445|NCT02908087|Diabetes, Insulin-Dependent|diabetes, insulin-dependent
105446|NCT02908087|Liraglutide|liraglutide
105447|NCT02908087|GLP-1 Analogue|glp-1 analogue
105448|NCT02908087|Early diagnosis|early diagnosis
105449|NCT02908074|Hypogonadotropic|hypogonadotropic
105450|NCT02908074|hypogonadism|hypogonadism
105451|NCT02908074|testosterone|testosterone
105452|NCT02908061|Mesh Placement|mesh placement
105453|NCT02908061|Radical Cystectomy|radical cystectomy
105454|NCT02908061|16-1285|16-1285
105455|NCT02908048|liver cancer|liver cancer
105456|NCT02908048|cholangiocarcinoma (CCA)|cholangiocarcinoma (cca)
105457|NCT02908048|cirrhosis|cirrhosis
105458|NCT02908048|hepatitis|hepatitis
105459|NCT02908048|bile duct cancer|bile duct cancer
105460|NCT02908048|hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
105461|NCT02908048|hepatobiliary carcinoma|hepatobiliary carcinoma
105462|NCT02908048|hepatoma|hepatoma
105463|NCT02908048|liver mass|liver mass
105464|NCT02907983|Menopause|menopause
105465|NCT02907983|Post-menopausal|post-menopausal
105466|NCT02907970|Cervical cancer|cervical cancer
105467|NCT02907970|Screening|screening
105468|NCT02907970|Barriers|barriers
105469|NCT02907931|hemodynamics|hemodynamics
105470|NCT02907931|ultrasonography|ultrasonography
105471|NCT02907879|Subarachnoid Hemorrhage|subarachnoid hemorrhage
105472|NCT02907879|Ultrasound perfusion imaging|ultrasound perfusion imaging
105473|NCT02907879|cerebral hypoperfusion|cerebral hypoperfusion
105474|NCT02907879|vasospasm|vasospasm
105475|NCT02907879|DIND|dind
105476|NCT02907879|infarction|infarction
105477|NCT02907827|complete remission|complete remission
105478|NCT02907827|cfDNA|cfdna
105479|NCT02907827|DW-MRI|dw-mri
105480|NCT02907827|surveillance|surveillance
105481|NCT02907814|Uveitis|uveitis
105482|NCT02907814|Optical Coherence Tomography|optical coherence tomography
105483|NCT02907801|congenital muscular torticollis|congenital muscular torticollis
105484|NCT02907801|infants|infants
105485|NCT02907801|perception-action approach|perception-action approach
105486|NCT02907788|Cystic fibrosis|cystic fibrosis
105487|NCT02907788|Neutrophils|neutrophils
105489|NCT02907788|Inflammation|inflammation
105490|NCT02907788|Lung disease|lung disease
105491|NCT02907788|PRAGMA|pragma
105492|NCT02907762|Endovascular|endovascular
105493|NCT02907762|EVAR|evar
105494|NCT02907762|Neck Angulation|neck angulation
105495|NCT02907710|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
105496|NCT02907710|endostar|endostar
105497|NCT02907710|chemoradiotherapy|chemoradiotherapy
105498|NCT02907697|HIV/AIDS|hiv/aids
105499|NCT02907697|adherence|adherence
105500|NCT02907697|substance use|substance use
105501|NCT02907697|HIV care continuum|hiv care continuum
105502|NCT02907684|Cardiovascular disease|cardiovascular disease
105503|NCT02907684|Non alcoholic fatty liver|non alcoholic fatty liver
105504|NCT02907684|Diabetes|diabetes
105505|NCT02907684|Almonds|almonds
105506|NCT02907684|Endothelium-dependent vasodilation|endothelium-dependent vasodilation
105507|NCT02907684|Fecal short chain fatty acids (SCFAs)|fecal short chain fatty acids (scfas)
105508|NCT02907684|Snacking|snacking
105509|NCT02907671|carpal tunnel injection|carpal tunnel injection
105510|NCT02907671|corticosteroid|corticosteroid
105511|NCT02907671|ultrasound-guided|ultrasound-guided
105512|NCT02907671|musculoskeletal ultrasound|musculoskeletal ultrasound
105513|NCT02907658|Internet Use Disorder|internet use disorder
105514|NCT02907658|Internet Gaming Disorder|internet gaming disorder
105515|NCT02907658|Cognitive-Behavioral Intervention|cognitive-behavioral intervention
105516|NCT02907658|Indicated Prevention|indicated prevention
105517|NCT02907658|Adolescents|adolescents
105518|NCT02907658|Internet Addiction|internet addiction
105519|NCT02907632|Metoclopramide|metoclopramide
105520|NCT02907632|Pro kinetic|pro kinetic
105521|NCT02907632|Gastroesophageal Reflux|gastroesophageal reflux
105522|NCT02907632|Premature Infant|premature infant
105523|NCT02907632|Low Birth Weight|low birth weight
105524|NCT02907632|Kangaroo Mother Care Method|kangaroo mother care method
105525|NCT02907619|Duchenne muscular dystrophy, myostatin, open-label|duchenne muscular dystrophy, myostatin, open-label
105526|NCT02907606|Non-small-cell Lung Cancer|non-small-cell lung cancer
105527|NCT02907606|circulating tumor DNA|circulating tumor dna
105528|NCT02907606|urine|urine
105529|NCT02907593|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
105530|NCT02907593|Pulmonary|pulmonary
105531|NCT02907593|Surfactant|surfactant
105532|NCT02907593|Steroids|steroids
105533|NCT02907593|Extremely low gestational age|extremely low gestational age
105534|NCT02907580|influenza|influenza
105535|NCT02907580|vaccination|vaccination
105536|NCT02907554|Preconditioning|preconditioning
105537|NCT02907554|Tissue and organ procurement|tissue and organ procurement
105538|NCT02907554|Cyclosporine A|cyclosporine a
105539|NCT02907554|Kidney transplantation|kidney transplantation
105540|NCT02907554|Delayed graft function|delayed graft function
105541|NCT02907541|eLearning|elearning
105542|NCT02907541|Quality Improvement Methods|quality improvement methods
105543|NCT02907541|Knowledge Transfer|knowledge transfer
105544|NCT02907541|Impact of learning|impact of learning
105545|NCT02907515|single implant retained mandibular overdenture|single implant retained mandibular overdenture
105546|NCT02907489|post operative pain|post operative pain
105547|NCT02907489|triple antibiotic paste|triple antibiotic paste
105548|NCT02907489|intracanal medication|intracanal medication
105549|NCT02907476|Vagal-gamma amino-butyric acid (GABA)|vagal-gamma amino-butyric acid (gaba)
105550|NCT02907476|Yoga|yoga
105551|NCT02907476|Walking|walking
105552|NCT02907463|Aortic Valve Replacement|aortic valve replacement
105553|NCT02907463|Aortic Stenosis|aortic stenosis
105554|NCT02907463|EDWARDS INTUITY Elite|edwards intuity elite
105555|NCT02907463|Rapid deployment valves|rapid deployment valves
105556|NCT02907437|Minocycline|minocycline
105557|NCT02907437|Negative symptoms|negative symptoms
105558|NCT02907437|Cognitive symptoms|cognitive symptoms
105559|NCT02907437|Inflammation|inflammation
105560|NCT02907411|Quadrivas|quadrivas
105561|NCT02907411|Veins|veins
105562|NCT02907411|Lipedema|lipedema
105563|NCT02907411|Lymphedema|lymphedema
105564|NCT02907398|Neurostimulation|neurostimulation
105565|NCT02907398|Hypoglossal nerve|hypoglossal nerve
105566|NCT02907398|Tongue|tongue
105567|NCT02907398|Upper airway stimulation|upper airway stimulation
105568|NCT02907398|Surgery|surgery
105569|NCT02907385|Rectal Cancer|rectal cancer
105570|NCT02907385|Low Anterior Resection|low anterior resection
105571|NCT02907385|LifeSeal|lifeseal
105572|NCT02907385|Surgical Sealant|surgical sealant
105573|NCT02907372|cognitive dysfunctions|cognitive dysfunctions
105574|NCT02907372|cognitive complaints|cognitive complaints
105575|NCT02907372|metastatic prostate cancer|metastatic prostate cancer
105576|NCT02907372|new generations of hormone-therapy|new generations of hormone-therapy
105577|NCT02907333|Condom use|condom use
105578|NCT02907333|Human Papillomavirus|human papillomavirus
105579|NCT02907333|Conization|conization
105580|NCT02907307|LactiSal|lactisal
105581|NCT02907307|Vaginal therapy|vaginal therapy
105582|NCT02907294|PDE10 inhibitor|pde10 inhibitor
105583|NCT02907294|phosphodiesterase 10 inhibitor|phosphodiesterase 10 inhibitor
105584|NCT02907294|Huntington's disease|huntington's disease
105781|NCT02906046|Ataxic Gait|ataxic gait
105585|NCT02907294|psychiatric disorders|psychiatric disorders
105586|NCT02907281|Multiple sclerosis,|multiple sclerosis,
105588|NCT02907281|Optical coherence tomography|optical coherence tomography
105589|NCT02907281|OCT,|oct,
105590|NCT02907281|RRMS|rrms
105591|NCT02907268|botulinum toxin type A, intradermal|botulinum toxin type a, intradermal
105592|NCT02907255|Pulse oximetry|pulse oximetry
105593|NCT02907255|vital signs monitoring|vital signs monitoring
105594|NCT02907255|wireless notification of clinicians|wireless notification of clinicians
105595|NCT02907255|respiratory monitoring system|respiratory monitoring system
105596|NCT02907242|stillbirth|stillbirth
105597|NCT02907242|cerebroplacental ratio|cerebroplacental ratio
105598|NCT02907242|fetal growth restriction|fetal growth restriction
105599|NCT02907216|Healthy Japanese infants|healthy japanese infants
105600|NCT02907216|Safety|safety
105601|NCT02907216|Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus (DPT-IPV) vaccine|diphtheria, tetanus, pertussis and inactivated poliovirus (dpt-ipv) vaccine
105602|NCT02907216|Vaccination|vaccination
105603|NCT02907216|Oral HRV liquid vaccine|oral hrv liquid vaccine
105604|NCT02907216|Immunogenicity|immunogenicity
105605|NCT02907190|pulses|pulses
105606|NCT02907190|beans|beans
105607|NCT02907190|blood glucose|blood glucose
105608|NCT02907190|insulin|insulin
105609|NCT02907112|meat intake|meat intake
105610|NCT02907112|meat analogues|meat analogues
105611|NCT02907112|LDL Cholesterol|ldl cholesterol
105612|NCT02907112|HDL Cholesterol|hdl cholesterol
105613|NCT02907099|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
105614|NCT02907099|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
105615|NCT02907099|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
105616|NCT02907099|BL-8040|bl-8040
105617|NCT02907099|Pembrolizumab|pembrolizumab
105618|NCT02907099|Keytruda|keytruda
105619|NCT02907099|MK-3475|mk-3475
105620|NCT02907099|SCH-900475|sch-900475
105621|NCT02907099|Phone call|phone call
105622|NCT02907060|prolonged pregnancy|prolonged pregnancy
105623|NCT02907060|mechanical cervical ripening|mechanical cervical ripening
105624|NCT02906995|pharmacokinetics|pharmacokinetics
105625|NCT02906995|nicotine absorption|nicotine absorption
105626|NCT02906982|Periodontal diseases|periodontal diseases
105627|NCT02906982|Periodontitis|periodontitis
105628|NCT02906982|Gingivitis|gingivitis
105629|NCT02906982|Teeth Whitening|teeth whitening
105630|NCT02906982|Dental Plaque Index|dental plaque index
105631|NCT02906982|Periodontal Index|periodontal index
105632|NCT02906982|Teeth Whitening Agents|teeth whitening agents
105633|NCT02906982|Tooth Discoloration|tooth discoloration
105634|NCT02906982|Mean Probing Depth|mean probing depth
105635|NCT02906982|Pocket Depth|pocket depth
105636|NCT02906943|Molecular Profiling|molecular profiling
105637|NCT02906943|Advanced Cancer|advanced cancer
105638|NCT02906943|Advanced Solid Tumors|advanced solid tumors
105639|NCT02906943|Phase I Clinical Trial Candidates|phase i clinical trial candidates
105640|NCT02906943|Next Generation Sequencing|next generation sequencing
105641|NCT02906878|Intensive Care|intensive care
105642|NCT02906878|Haematology|haematology
105643|NCT02906878|Platelets prophylactic transfusion|platelets prophylactic transfusion
105644|NCT02906839|cardiovascular risk|cardiovascular risk
105645|NCT02906839|risk of atrial fibrillation recurrence|risk of atrial fibrillation recurrence
105646|NCT02906839|sleep apnea syndrome|sleep apnea syndrome
105647|NCT02906839|atrial fibrillation|atrial fibrillation
105648|NCT02906826|Airway clearance technique|airway clearance technique
105649|NCT02906826|Positive expiratory pressure technique|positive expiratory pressure technique
105650|NCT02906826|Adherence|adherence
105651|NCT02906813|Drug Therapy|drug therapy
105652|NCT02906800|cisplatin|cisplatin
105653|NCT02906800|head and neck cancer|head and neck cancer
105654|NCT02906800|digoxin|digoxin
105655|NCT02906787|Smoking Cessation|smoking cessation
105656|NCT02906787|Weight Loss|weight loss
105657|NCT02906761|asthma, aspirin|asthma, aspirin
105658|NCT02906748|parathyroid autografting|parathyroid autografting
105659|NCT02906748|thyroidectomy|thyroidectomy
105660|NCT02906748|survival rate|survival rate
105661|NCT02906748|hypoparathyroidism|hypoparathyroidism
105662|NCT02906722|Nebulized colistin|nebulized colistin
105663|NCT02906722|Intravenous colistin|intravenous colistin
105664|NCT02906722|ventilator-associated pneumonia|ventilator-associated pneumonia
105665|NCT02906722|multidrug resistance|multidrug resistance
105666|NCT02906722|Gram-negative bacteria|gram-negative bacteria
105667|NCT02906696|Chronic myelogenous leukemia|chronic myelogenous leukemia
105668|NCT02906696|CML|cml
105669|NCT02906696|Chronic phase post frontline TKI failure|chronic phase post frontline tki failure
105670|NCT02906696|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
105671|NCT02906696|TKI|tki
105672|NCT02906696|Bosutinib|bosutinib
105673|NCT02906696|SKI-606|ski-606
105674|NCT02906696|Phone calls|phone calls
105675|NCT02906696|Questionnaires|questionnaires
105676|NCT02906696|Surveys|surveys
105677|NCT02906683|Urinary Incontinence|urinary incontinence
105678|NCT02906683|Urinary Incontinence, Stress|urinary incontinence, stress
105679|NCT02906683|Lower Urinary Tract Symptoms|lower urinary tract symptoms
105680|NCT02906670|Epithelial malignancies|epithelial malignancies
105681|NCT02906657|Medication Reconciliation|medication reconciliation
105682|NCT02906657|Adverse Drug Event|adverse drug event
105683|NCT02906657|Elderly|elderly
105684|NCT02906657|patient pharmaceutical record|patient pharmaceutical record
105685|NCT02906644|Nicotine addiction|nicotine addiction
105686|NCT02906644|Cigarette smoking|cigarette smoking
105687|NCT02906644|Smoking cessation|smoking cessation
105688|NCT02906644|lorcaserin|lorcaserin
105689|NCT02906644|Belviq|belviq
105690|NCT02906644|Nicotine patches|nicotine patches
105691|NCT02906631|encephalitis,|encephalitis,
105692|NCT02906631|neurologic outcomes of all-cause encephalitis in intensive care unit|neurologic outcomes of all-cause encephalitis in intensive care unit
105693|NCT02906631|outcome, intensive care unit|outcome, intensive care unit
105694|NCT02906553|Nitric Oxide|nitric oxide
105695|NCT02906553|Cognition|cognition
105696|NCT02906527|Cardiology|cardiology
105697|NCT02906527|Oral anticoagulants|oral anticoagulants
105698|NCT02906527|Risk and Benefit analysis|risk and benefit analysis
105699|NCT02906527|Health insurance databases|health insurance databases
105700|NCT02906527|Safety|safety
105701|NCT02906527|Elderly|elderly
105702|NCT02906514|Hydroxyethyl Starch|hydroxyethyl starch
105703|NCT02906514|Cardiac surgery|cardiac surgery
105704|NCT02906514|Priming of cardiopulmonary bypass|priming of cardiopulmonary bypass
105705|NCT02906501|Risperidone|risperidone
105706|NCT02906501|ADHD|adhd
105708|NCT02906501|IGT|igt
105709|NCT02906501|CNP|cnp
105710|NCT02906501|Executive functions|executive functions
105711|NCT02906488|Quality of life|quality of life
105712|NCT02906475|Dermatitis, atopic|dermatitis, atopic
105713|NCT02906475|prevention and control|prevention and control
105714|NCT02906475|Infant|infant
105715|NCT02906475|Skin care|skin care
105716|NCT02906475|randomized controlled trial|randomized controlled trial
105717|NCT02906462|Leonetti French law|leonetti french law
105718|NCT02906462|Palliative care|palliative care
105719|NCT02906449|concussion, mild head injury, mindfulness|concussion, mild head injury, mindfulness
105720|NCT02906436|Lung transplantation|lung transplantation
105721|NCT02906436|ExVivo reconditionning|exvivo reconditionning
105722|NCT02906423|Quality of Life|quality of life
105723|NCT02906423|Patient-Centered Care|patient-centered care
105724|NCT02906423|Patient Outcome Assessment|patient outcome assessment
105725|NCT02906384|hippocampus avoidance|hippocampus avoidance
105726|NCT02906384|volumetric modulated arc therapy|volumetric modulated arc therapy
105727|NCT02906384|functional MRI|functional mri
105728|NCT02906384|hopkins Verbal Learning Test|hopkins verbal learning test
105729|NCT02906384|prophylactic cranial irradiation|prophylactic cranial irradiation
105730|NCT02906345|Septic shock|septic shock
105731|NCT02906345|Fresh frozen plasma|fresh frozen plasma
105732|NCT02906306|Older adults|older adults
105733|NCT02906306|Occupational Therapy|occupational therapy
105734|NCT02906306|Self-Efficacy|self-efficacy
105735|NCT02906306|Psychological Well-being|psychological well-being
105736|NCT02906280|EBUS-TBNA|ebus-tbna
105737|NCT02906241|African Americans|african americans
105738|NCT02906241|prostate cancer|prostate cancer
105739|NCT02906241|Minority|minority
105740|NCT02906241|Racial /Ethnic disparity|racial /ethnic disparity
105741|NCT02906241|Cancer care|cancer care
105742|NCT02906241|patient-physician communication|patient-physician communication
105743|NCT02906241|cancer clinical trial accrual|cancer clinical trial accrual
105744|NCT02906228|non-ionizing radiation|non-ionizing radiation
105745|NCT02906215|mHealth|mhealth
105746|NCT02906215|implementation|implementation
105747|NCT02906163|EGFR mutation positive|egfr mutation positive
105748|NCT02906163|Thymosin Alpha 1|thymosin alpha 1
105749|NCT02906163|Tyrosine Kinase inhibitor|tyrosine kinase inhibitor
105750|NCT02906163|Thymalfasin|thymalfasin
105751|NCT02906163|Non Small Cell Lung Cancer|non small cell lung cancer
105752|NCT02906150|EGFR Wild Type|egfr wild type
105753|NCT02906150|Thymosin Alpha 1|thymosin alpha 1
105754|NCT02906150|Non-Small Cell Lung Cancer|non-small cell lung cancer
105755|NCT02906150|Thymalfasin|thymalfasin
105756|NCT02906124|hypercholesterolaemia|hypercholesterolaemia
105757|NCT02906124|Lipid lowering therapies|lipid lowering therapies
105758|NCT02906124|Pregnancy|pregnancy
105759|NCT02906111|Estriol|estriol
105760|NCT02906111|Prolapse|prolapse
105761|NCT02906111|Quality of life|quality of life
105762|NCT02906111|Vaginal health|vaginal health
105763|NCT02906111|Vaginal surgery|vaginal surgery
105764|NCT02906098|Gingivitis|gingivitis
105765|NCT02906098|Adolescents|adolescents
105766|NCT02906098|Oral hygiene|oral hygiene
105767|NCT02906098|Oral health behavior|oral health behavior
105768|NCT02906098|Periodontal infection control|periodontal infection control
105769|NCT02906085|[C10.228.140.546.399.750.250]|[c10.228.140.546.399.750.250]
105770|NCT02906072|Obesity|obesity
105771|NCT02906072|Body fat|body fat
105772|NCT02906072|Plant-based diet|plant-based diet
105773|NCT02906072|Plant-based meal replacement|plant-based meal replacement
105774|NCT02906059|RAS|ras
105775|NCT02906059|KRAS|kras
105776|NCT02906059|NRAS|nras
105777|NCT02906059|BRAF|braf
105778|NCT02906059|Mutated|mutated
105779|NCT02906059|Wee1 inhibitor|wee1 inhibitor
105782|NCT02906033|Surgical Procedures, Operative|surgical procedures, operative
105783|NCT02906033|Operating Rooms|operating rooms
105784|NCT02906033|Quality of Life|quality of life
105785|NCT02906033|Surgery-related anxiety|surgery-related anxiety
105786|NCT02905994|Leukemia|leukemia
105787|NCT02905981|IRIDA|irida
105788|NCT02905981|Triferic|triferic
105789|NCT02905981|soluble ferric pyrophosphate|soluble ferric pyrophosphate
105790|NCT02905981|Shohl's solution|shohl's solution
105791|NCT02905968|Anastomotic leak|anastomotic leak
105792|NCT02905968|Low rectal cancer|low rectal cancer
105793|NCT02905929|sedentary behavior|sedentary behavior
105794|NCT02905929|standing|standing
105795|NCT02905929|sitting|sitting
105796|NCT02905929|inclinometer|inclinometer
105797|NCT02905864|Liraglutide|liraglutide
105798|NCT02905864|Liraglutide 3 mg|liraglutide 3 mg
105799|NCT02905864|Osteoarthritis|osteoarthritis
105800|NCT02905864|Obesity|obesity
105801|NCT02905799|Osteoarthritis|osteoarthritis
105802|NCT02905799|Knee|knee
105803|NCT02905799|Resveratrol|resveratrol
105804|NCT02905799|Oral Treatment|oral treatment
105805|NCT02905799|Pain|pain
105806|NCT02905799|Trial|trial
105807|NCT02905786|General Practice|general practice
105808|NCT02905786|Nurse practitioner|nurse practitioner
105809|NCT02905786|Natriuretic peptides|natriuretic peptides
105810|NCT02905786|Clinical audit|clinical audit
105811|NCT02905773|Intensity|intensity
105812|NCT02905760|Acute Myocardial Infarction|acute myocardial infarction
105813|NCT02905760|Right ventricular infarction|right ventricular infarction
105814|NCT02905760|Diuretic|diuretic
105815|NCT02905760|Fluid Expansion|fluid expansion
105816|NCT02905747|Exercise Therapy|exercise therapy
105817|NCT02905747|Musculoskeletal Pain|musculoskeletal pain
105818|NCT02905747|Knee osteoarthritis|knee osteoarthritis
105819|NCT02905747|Physical Therapy Modalities|physical therapy modalities
105820|NCT02905734|Nicotine replacement therapy|nicotine replacement therapy
105821|NCT02905734|Tobacco|tobacco
105822|NCT02905708|normothermia|normothermia
105823|NCT02905708|hypothermia|hypothermia
105824|NCT02905695|Post-partum Perineal pain|post-partum perineal pain
105825|NCT02905695|Episiotomy|episiotomy
105826|NCT02905695|First-degree tear|first-degree tear
105827|NCT02905669|distensibility|distensibility
105828|NCT02905669|impedance planimetry|impedance planimetry
105829|NCT02905669|esophagus|esophagus
105830|NCT02905669|esophago-gastric junction|esophago-gastric junction
105831|NCT02905669|pylorus|pylorus
105832|NCT02905656|quitline|quitline
105833|NCT02905656|nicotine replacement therapy|nicotine replacement therapy
105834|NCT02905656|tobacco intervention|tobacco intervention
105835|NCT02905656|smokers not ready to quit|smokers not ready to quit
105836|NCT02905643|Pseudoprogression|pseudoprogression
105837|NCT02905643|Brain Cancer|brain cancer
105838|NCT02905630|coronary flow reserve|coronary flow reserve
105839|NCT02905630|angina|angina
105840|NCT02905630|exercise training|exercise training
105841|NCT02905617|Breast Augmentation|breast augmentation
105842|NCT02905617|Breast Revision-Augmentation|breast revision-augmentation
105843|NCT02905604|rTMS|rtms
105844|NCT02905604|negative symptoms|negative symptoms
105845|NCT02905604|intermittent theta burst|intermittent theta burst
105846|NCT02905604|iTBS|itbs
105847|NCT02905604|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
105848|NCT02905604|dorsomedial prefrontal cortex|dorsomedial prefrontal cortex
105849|NCT02905604|dmPFC|dmpfc
105850|NCT02905604|NIRS|nirs
105851|NCT02905591|pharmacological ascorbate|pharmacological ascorbate
105852|NCT02905591|ascorbic acid|ascorbic acid
105853|NCT02905591|radiation|radiation
105854|NCT02905591|chemotherapy|chemotherapy
105855|NCT02905591|carboplatin|carboplatin
105856|NCT02905591|paclitaxel|paclitaxel
105857|NCT02905578|Ascorbate|ascorbate
105858|NCT02905578|Vitamin C|vitamin c
105859|NCT02905578|Pharmacological ascorbate|pharmacological ascorbate
105860|NCT02905578|Pharmacologic ascorbate|pharmacologic ascorbate
105861|NCT02905578|Ascorbic Acid|ascorbic acid
105862|NCT02905578|gemcitabine|gemcitabine
105863|NCT02905578|nab-paclitaxel|nab-paclitaxel
105864|NCT02905565|Multicenter|multicenter
105865|NCT02905565|Randomized|randomized
105866|NCT02905565|Double-Blind|double-blind
105867|NCT02905565|Placebo-Controlled|placebo-controlled
105868|NCT02905565|Add-On to Standard-of-Care|add-on to standard-of-care
105869|NCT02905565|Safety|safety
105870|NCT02905565|Efficacy|efficacy
105871|NCT02905552|Myelodysplastic syndrome (myelodysplasia)|myelodysplastic syndrome (myelodysplasia)
105872|NCT02905552|Infection|infection
105873|NCT02905552|Risk Factors|risk factors
105874|NCT02905539|Iron|iron
105875|NCT02905539|anemia|anemia
105876|NCT02905539|phosphorus|phosphorus
105877|NCT02905539|FGF-23|fgf-23
105878|NCT02905526|Reproductive health|reproductive health
105879|NCT02905513|Reproductive health|reproductive health
105880|NCT02905500|Disability-Adjusted Life Years|disability-adjusted life years
105881|NCT02905500|Epidemiology|epidemiology
105882|NCT02905500|Public Health|public health
105985|NCT02904902|japanese participants|japanese participants
105883|NCT02905487|Gestational Diabetes Mellitus|gestational diabetes mellitus
105884|NCT02905487|Obesity|obesity
105885|NCT02905487|Adipocytokin|adipocytokin
105886|NCT02905474|chronic kidney disease, mobile applications, mHealth, medication reconciliation, self-management|chronic kidney disease, mobile applications, mhealth, medication reconciliation, self-management
105887|NCT02905461|Reproductive health|reproductive health
105888|NCT02905448|Obesity|obesity
105889|NCT02905448|Body composition|body composition
105890|NCT02905448|Atherosclerosis|atherosclerosis
105891|NCT02905448|Insulin resistance|insulin resistance
105892|NCT02905448|Hyperuricemia|hyperuricemia
105893|NCT02905435|burns|burns
105894|NCT02905435|autografts|autografts
105895|NCT02905435|humans|humans
105896|NCT02905435|biodegradable polyurethane|biodegradable polyurethane
105897|NCT02905435|dermal matrix|dermal matrix
105898|NCT02905435|synthetic|synthetic
105899|NCT02905422|physical activity|physical activity
105900|NCT02905422|sleep|sleep
105901|NCT02905422|nutrition|nutrition
105902|NCT02905422|Soldier|soldier
105903|NCT02905422|prevention|prevention
105904|NCT02905422|remote monitoring|remote monitoring
105905|NCT02905422|mobile technology|mobile technology
105906|NCT02905396|small fiber neuropathy|small fiber neuropathy
105907|NCT02905396|spinal cord stimulation|spinal cord stimulation
105908|NCT02905396|treatment|treatment
105909|NCT02905396|pain|pain
105910|NCT02905370|Home Health|home health
105911|NCT02905370|Rehabilitation|rehabilitation
105912|NCT02905370|High Intensity|high intensity
105913|NCT02905370|Hospital Associated Deconditioning|hospital associated deconditioning
105914|NCT02905370|Functional Mobility|functional mobility
105915|NCT02905370|Physical Function|physical function
105916|NCT02905357|Myocardial Infarction|myocardial infarction
105917|NCT02905357|Women|women
105918|NCT02905357|Imaging|imaging
105919|NCT02905305|cochlear implants|cochlear implants
105920|NCT02905305|Dexamethasone|dexamethasone
105921|NCT02905305|combined device|combined device
105922|NCT02905279|spider phobia|spider phobia
105923|NCT02905279|animal phobia|animal phobia
105924|NCT02905279|exposure therapy|exposure therapy
105925|NCT02905279|biofeedback|biofeedback
105926|NCT02905279|relaxation training|relaxation training
105927|NCT02905240|Autologous Protein Solution|autologous protein solution
105928|NCT02905240|APS|aps
105929|NCT02905240|intra-articular injection|intra-articular injection
105930|NCT02905240|osteoarthritis|osteoarthritis
105931|NCT02905227|Adult smokers|adult smokers
105932|NCT02905227|Asthma|asthma
105933|NCT02905227|Healthy volunteers|healthy volunteers
105934|NCT02905188|hepatocellular carcinoma|hepatocellular carcinoma
105935|NCT02905188|GPC3-CAR T cells|gpc3-car t cells
105936|NCT02905188|GPC3-positive hepatocellular carcinoma|gpc3-positive hepatocellular carcinoma
105937|NCT02905175|rheumatoid arthritis|rheumatoid arthritis
105938|NCT02905175|Porphyromonas gingivalis|porphyromonas gingivalis
105939|NCT02905149|Oncological|oncological
105940|NCT02905149|Surgery|surgery
105941|NCT02905149|Breast|breast
105942|NCT02905149|Reconstruction|reconstruction
105943|NCT02905136|autoantibodies|autoantibodies
105944|NCT02905136|neuronal synaptic receptors|neuronal synaptic receptors
105945|NCT02905136|autoimmune encephalitis|autoimmune encephalitis
105946|NCT02905110|Malignant Neoplasms, Brain|malignant neoplasms, brain
105947|NCT02905097|Knee arthroplasty, Total|knee arthroplasty, total
105948|NCT02905097|Knee replacement, Total|knee replacement, total
105949|NCT02905097|Survival rate|survival rate
105950|NCT02905097|Osseointegration|osseointegration
105951|NCT02905097|Gait|gait
105952|NCT02905071|mental health|mental health
105953|NCT02905071|well-being at work|well-being at work
105954|NCT02905071|screening|screening
105955|NCT02905071|psychosocial risk|psychosocial risk
105956|NCT02905071|psychometrics|psychometrics
105957|NCT02905071|questionnaire|questionnaire
105958|NCT02905071|job stress|job stress
105959|NCT02905032|Afib|afib
105960|NCT02905032|Atrial fib|atrial fib
105961|NCT02905032|Shared|shared
105962|NCT02905032|Decision|decision
105963|NCT02905032|Making|making
105964|NCT02905032|Aid|aid
105965|NCT02905032|AF|af
105966|NCT02905006|Psoriasis|psoriasis
105967|NCT02905006|Chronic Plaque Psoriasis|chronic plaque psoriasis
105968|NCT02905006|Bimekizumab|bimekizumab
105969|NCT02904980|Quiet eye training|quiet eye training
105970|NCT02904980|Visual Attention|visual attention
105971|NCT02904954|Lung neoplasms|lung neoplasms
105972|NCT02904954|Bronchial Neoplasms|bronchial neoplasms
105973|NCT02904954|Carcinoma, bronchogenic|carcinoma, bronchogenic
105974|NCT02904954|Neoplasms|neoplasms
105975|NCT02904954|Neoplasms by site|neoplasms by site
105976|NCT02904954|Respiratory Tract Diseases|respiratory tract diseases
105977|NCT02904954|Respiratory Tract Neoplasms|respiratory tract neoplasms
105978|NCT02904954|Thoracic Neoplasms|thoracic neoplasms
105979|NCT02904941|Children|children
105980|NCT02904941|Skin Transplantation|skin transplantation
105981|NCT02904941|Amniotic Membrane|amniotic membrane
105982|NCT02904902|efficacy|efficacy
105983|NCT02904902|safety|safety
105984|NCT02904902|adalimumab|adalimumab
105986|NCT02904850|Non-small cell lung cancer|non-small cell lung cancer
105987|NCT02904850|locally advanced or metastatic|locally advanced or metastatic
105988|NCT02904850|erlotinib monotherapy|erlotinib monotherapy
105989|NCT02904837|Randomized clinical trial|randomized clinical trial
105990|NCT02904837|Parkinson's disease|parkinson's disease
105991|NCT02904837|Mental practice|mental practice
105992|NCT02904837|Gait|gait
105993|NCT02904824|adipose tissue|adipose tissue
105994|NCT02904824|adult stem cells|adult stem cells
105995|NCT02904824|vocal cord paralysis|vocal cord paralysis
105996|NCT02904811|Chlamydia trachomatis|chlamydia trachomatis
105997|NCT02904811|Pelvic inflammatory disease|pelvic inflammatory disease
105998|NCT02904798|sunscreen|sunscreen
105999|NCT02904798|photoprotection|photoprotection
106000|NCT02904798|visible light|visible light
106001|NCT02904746|follow-up|follow-up
106002|NCT02904746|mental health appointment|mental health appointment
106003|NCT02904720|Vitamin D; Pregnancy|vitamin d; pregnancy
106004|NCT02904707|Skin Graft|skin graft
106005|NCT02904668|chronic pain|chronic pain
106006|NCT02904642|SMS reminder|sms reminder
106007|NCT02904642|incentive|incentive
106008|NCT02904642|mobile phone|mobile phone
106009|NCT02904642|Immunization|immunization
106010|NCT02904590|IBD|ibd
106011|NCT02904590|Infection|infection
106012|NCT02904577|Indolent B-Cell Lymphomas|indolent b-cell lymphomas
106013|NCT02904577|prospective collection|prospective collection
106014|NCT02904564|drug delivery|drug delivery
106015|NCT02904564|Idiopathic Guttate Hypomelanosis|idiopathic guttate hypomelanosis
106016|NCT02904551|prospective study|prospective study
106017|NCT02904551|free gingival graft|free gingival graft
106018|NCT02904551|keratinized gingiva|keratinized gingiva
106019|NCT02904551|dental implant|dental implant
106020|NCT02904538|Dexamethasone|dexamethasone
106021|NCT02904538|Regional anesthesia|regional anesthesia
106022|NCT02904538|Front foot surgery|front foot surgery
106023|NCT02904538|Metacarpal osteotomy|metacarpal osteotomy
106024|NCT02904525|newly diagnosed|newly diagnosed
106025|NCT02904525|MRI|mri
106026|NCT02904499|Atrial Fibrillation|atrial fibrillation
106027|NCT02904499|Anticoagulants|anticoagulants
106028|NCT02904499|Pharmacoepidemiology|pharmacoepidemiology
106029|NCT02904447|hemicap|hemicap
106030|NCT02904447|hallux rigidus|hallux rigidus
106031|NCT02904434|voriconazole|voriconazole
106032|NCT02904434|absorption|absorption
106033|NCT02904434|pharmacokinetic|pharmacokinetic
106034|NCT02904434|grapefruit juice|grapefruit juice
106035|NCT02904434|bioavailability|bioavailability
106036|NCT02904434|intestinal first-pass metabolism|intestinal first-pass metabolism
106037|NCT02904434|pharmacokinetics|pharmacokinetics
106038|NCT02904434|intestinal|intestinal
106039|NCT02904421|scoliosis|scoliosis
106040|NCT02904421|spinal deformity|spinal deformity
106041|NCT02904421|vitamin D|vitamin d
106042|NCT02904421|bone health|bone health
106043|NCT02904408|quality of life|quality of life
106044|NCT02904408|psychotherapy|psychotherapy
106045|NCT02904408|hidradenitis|hidradenitis
106046|NCT02904408|treatments|treatments
106047|NCT02904356|OCD|ocd
106048|NCT02904356|TMS|tms
106049|NCT02904356|Neuromodulation|neuromodulation
106050|NCT02904356|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
106051|NCT02904356|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
106052|NCT02904356|Imaging|imaging
106053|NCT02904343|hemodialysis machine|hemodialysis machine
106054|NCT02904343|quality|quality
106055|NCT02904343|safety|safety
106056|NCT02904343|domestic|domestic
106057|NCT02904304|Flu|flu
106058|NCT02904304|Treatment|treatment
106059|NCT02904291|Bariatric surgery|bariatric surgery
106060|NCT02904291|Gastrointestinal tract|gastrointestinal tract
106061|NCT02904291|Biological availability|biological availability
106062|NCT02904291|Pharmacokinetics|pharmacokinetics
106063|NCT02904291|Amlodipine|amlodipine
106064|NCT02904278|Mobile Application Intervention|mobile application intervention
106065|NCT02904278|Teen Pocket PATH® [TPP]|teen pocket path® [tpp]
106066|NCT02904278|Adherence|adherence
106067|NCT02904278|Medical Management|medical management
106068|NCT02904265|continuous spike wave in sleep|continuous spike wave in sleep
106069|NCT02904265|Landau-Kleffner syndrome|landau-kleffner syndrome
106070|NCT02904265|acetazolamide|acetazolamide
106071|NCT02904265|diazepam|diazepam
106072|NCT02904252|Transient elastography|transient elastography
106073|NCT02904252|Fibrotest|fibrotest
106074|NCT02904239|Multidetector Computed Tomography|multidetector computed tomography
106075|NCT02904239|Incidental cardiac findings|incidental cardiac findings
106076|NCT02904239|Thoracic high-pitch Computed Tomography|thoracic high-pitch computed tomography
106077|NCT02904239|Management guidelines|management guidelines
106078|NCT02904226|ICOS|icos
106079|NCT02904226|ICOS agonist monoclonal antibody|icos agonist monoclonal antibody
106080|NCT02904226|JTX-2011|jtx-2011
106081|NCT02904226|Anti-PD-1|anti-pd-1
106082|NCT02904226|Nivolumab|nivolumab
106083|NCT02904226|ICONIC|iconic
106084|NCT02904226|Immunotherapy|immunotherapy
106085|NCT02904226|Immuno-oncology|immuno-oncology
106086|NCT02904226|Cancer|cancer
106087|NCT02904226|Solid Tumor|solid tumor
106088|NCT02904226|Dose Escalation|dose escalation
106089|NCT02904226|Dose Expansion|dose expansion
106090|NCT02904213|vaccine|vaccine
106091|NCT02904213|ComBe Five|combe five
106092|NCT02904213|Vietnam|vietnam
106093|NCT02904213|pentavalent|pentavalent
106094|NCT02904135|Circulating Tumor Cells|circulating tumor cells
106095|NCT02904070|Threat of|threat of
106096|NCT02904044|School|school
106097|NCT02904044|Sport|sport
106098|NCT02904044|Injuries|injuries
106099|NCT02904005|Suicide|suicide
106100|NCT02904005|Prediction|prediction
106101|NCT02904005|Prospective study|prospective study
106102|NCT02904005|Suicide attempt|suicide attempt
106103|NCT02904005|Risk management|risk management
106104|NCT02903992|Frail Elderly|frail elderly
106105|NCT02903992|sarcopenia|sarcopenia
106106|NCT02903966|Tolerability|tolerability
106107|NCT02903966|GSK2982772|gsk2982772
106108|NCT02903966|Safety|safety
106109|NCT02903966|Pharmacokinetics|pharmacokinetics
106110|NCT02903966|RIP1 kinase inhibitor|rip1 kinase inhibitor
106111|NCT02903966|Ulcerative colitis|ulcerative colitis
106112|NCT02903966|Pharmacodynamics|pharmacodynamics
106113|NCT02903914|Immuno-Oncology|immuno-oncology
106114|NCT02903914|Checkpoint Inhibitors|checkpoint inhibitors
106115|NCT02903914|Tumor Metabolism|tumor metabolism
106116|NCT02903914|Programmed cell death protein-1 (PD-1) inhibitor|programmed cell death protein-1 (pd-1) inhibitor
106117|NCT02903914|Programmed death ligand 1 (PD-L1) inhibitor|programmed death ligand 1 (pd-l1) inhibitor
106118|NCT02903914|Solid Tumors|solid tumors
106119|NCT02903914|RCC|rcc
106120|NCT02903914|MEL|mel
106121|NCT02903914|NSCLC|nsclc
106122|NCT02903914|Arginase|arginase
106123|NCT02903914|Arginase Inhibitor|arginase inhibitor
106124|NCT02903914|INCB001158 (CB-1158)|incb001158 (cb-1158)
106125|NCT02903914|SCCHN|scchn
106126|NCT02903914|GEJ|gej
106127|NCT02903914|Immune Therapy|immune therapy
106128|NCT02903901|Delirium|delirium
106129|NCT02903862|Caregivers|caregivers
106130|NCT02903862|Case Management|case management
106131|NCT02903862|Alzheimer's Disease|alzheimer's disease
106132|NCT02903862|Cognition|cognition
106133|NCT02903862|Caregiver Burden|caregiver burden
106134|NCT02903862|Depression|depression
106135|NCT02903823|spinal cord injury|spinal cord injury
106136|NCT02903823|cerebral palsy|cerebral palsy
106137|NCT02903823|stroke|stroke
106138|NCT02903797|Endometrial hyperplasia|endometrial hyperplasia
106139|NCT02903797|Irisin|irisin
106140|NCT02903797|fibronectin type III domain containing 5|fibronectin type iii domain containing 5
106141|NCT02903797|FNDC5 (fibronectin type III domain containing )|fndc5 (fibronectin type iii domain containing )
106142|NCT02903771|Cantrixil|cantrixil
106143|NCT02903771|Intraperitoneal|intraperitoneal
106144|NCT02903719|Phrenic|phrenic
106145|NCT02903719|Nerve block|nerve block
106146|NCT02903719|Postoperative shoulder pain|postoperative shoulder pain
106147|NCT02903719|Liver resection|liver resection
106148|NCT02903706|gold miners|gold miners
106149|NCT02903706|plasmodium carriers|plasmodium carriers
106150|NCT02903706|artemisinine resistance|artemisinine resistance
106151|NCT02903680|Relapse Prevention|relapse prevention
106152|NCT02903680|Children|children
106153|NCT02903667|bone grafting|bone grafting
106154|NCT02903667|implantology|implantology
106155|NCT02903667|oral surgery|oral surgery
106156|NCT02903628|myopia|myopia
106157|NCT02903615|glucose|glucose
106158|NCT02903615|inflammation|inflammation
106159|NCT02903602|sharing histories|sharing histories
106160|NCT02903602|autobiographical memory|autobiographical memory
106161|NCT02903602|health behavior|health behavior
106162|NCT02903602|narrative communication|narrative communication
106163|NCT02903602|community health workers|community health workers
106164|NCT02903602|global health|global health
106165|NCT02903602|maternal and child health|maternal and child health
106166|NCT02903602|stunting|stunting
106167|NCT02903537|Multiple Sclerosis|multiple sclerosis
106168|NCT02903537|Dendritic Cells|dendritic cells
106169|NCT02903537|Immune Tolerance|immune tolerance
106170|NCT02903537|Myelin Proteins|myelin proteins
106171|NCT02903537|Tolerogenic dendritic cells|tolerogenic dendritic cells
106172|NCT02903511|Metformin|metformin
106173|NCT02903511|total kidney volume|total kidney volume
106174|NCT02903511|glomerular filtration rate|glomerular filtration rate
106175|NCT02903498|disease control survival|disease control survival
106176|NCT02903472|SCI|sci
106177|NCT02903472|microbiome|microbiome
106178|NCT02903472|metabolome|metabolome
106179|NCT02903472|GI|gi
106180|NCT02903472|UTI|uti
106181|NCT02903472|DNA|dna
106182|NCT02903472|genomics|genomics
106183|NCT02903472|infections|infections
106184|NCT02903472|tetraplegic|tetraplegic
106185|NCT02903472|paraplegic|paraplegic
106186|NCT02903459|Central Fat|central fat
106187|NCT02903459|Subcutaneous Fat|subcutaneous fat
106188|NCT02903459|Lumbar Lordosis Degree|lumbar lordosis degree
106189|NCT02903459|Cellulite|cellulite
106190|NCT02903433|Avocado|avocado
106191|NCT02903433|Cardiovascular disease|cardiovascular disease
106192|NCT02903407|Ventilators, Mechanical|ventilators, mechanical
106193|NCT02903407|Intensive Care Units|intensive care units
106194|NCT02903407|Deep Sedation|deep sedation
106195|NCT02903381|Smoldering Multiple Myeloma|smoldering multiple myeloma
106196|NCT02903368|Prostate Cancer|prostate cancer
106197|NCT02903342|Fever|fever
106198|NCT02903342|Febrile illness|febrile illness
106199|NCT02903342|Children|children
106200|NCT02903316|Fluid responsiveness|fluid responsiveness
106201|NCT02903316|Perioperative|perioperative
106202|NCT02903316|Extra systoles|extra systoles
106203|NCT02903316|Coronary artery bypass|coronary artery bypass
106204|NCT02903316|Systolic arterial pressure|systolic arterial pressure
106205|NCT02903264|Gestational Diabetes Mellitus|gestational diabetes mellitus
106206|NCT02903264|Obesity|obesity
106207|NCT02903264|Periodontal Disease|periodontal disease
106208|NCT02903251|Oxytocin|oxytocin
106209|NCT02903251|Administration, Intranasal|administration, intranasal
106210|NCT02903251|Ethanol|ethanol
106211|NCT02903238|placebo|placebo
106212|NCT02903238|pain|pain
106213|NCT02903238|osteoarthritis|osteoarthritis
106214|NCT02903225|Heart rate variability|heart rate variability
106215|NCT02903225|Systolic heart failure|systolic heart failure
106216|NCT02903225|Physical exercise|physical exercise
106217|NCT02903225|Parasympathetic indexes|parasympathetic indexes
106218|NCT02903212|Apoptotic cells|apoptotic cells
106219|NCT02903199|Whey Protein|whey protein
106220|NCT02903199|Postprandial Glycaemia|postprandial glycaemia
106221|NCT02903199|Appetite Response|appetite response
106222|NCT02903186|infants|infants
106223|NCT02903186|minorities|minorities
106224|NCT02903186|overfeeding|overfeeding
106225|NCT02903186|WIC program|wic program
106226|NCT02903186|feeding practices|feeding practices
106227|NCT02903186|breastfeeding|breastfeeding
106228|NCT02903173|respiratory depression|respiratory depression
106229|NCT02903173|postpartum|postpartum
106230|NCT02903173|neuraxial morphine|neuraxial morphine
106231|NCT02903173|cesarean delivery|cesarean delivery
106232|NCT02903160|Castration resistant|castration resistant
106233|NCT02903160|Prostate cancer|prostate cancer
106234|NCT02903160|Metastatic|metastatic
106235|NCT02903160|First-line|first-line
106236|NCT02903160|Treatment naive|treatment naive
106237|NCT02903160|Rapidly cycling|rapidly cycling
106238|NCT02903160|Non-cross resistant|non-cross resistant
106239|NCT02903147|IVDR; driving behavior patterns; Meta-Cognitive Intervention|ivdr; driving behavior patterns; meta-cognitive intervention
106240|NCT02903121|Unscheduled bleeding|unscheduled bleeding
106241|NCT02903121|Long acting contraception|long acting contraception
106242|NCT02903095|Single ascending dose|single ascending dose
106243|NCT02903082|Myeloid-Derivated suppressive cell|myeloid-derivated suppressive cell
106244|NCT02903082|Sepsis|sepsis
106245|NCT02903082|Inflammatory Response Syndrome, Systemic|inflammatory response syndrome, systemic
106246|NCT02903069|newly diagnosed|newly diagnosed
106247|NCT02903069|malignant glioma|malignant glioma
106248|NCT02903069|WHO Grade 4|who grade 4
106249|NCT02903069|WHO Grade IV|who grade iv
106250|NCT02903069|marizomib|marizomib
106251|NCT02903069|MRZ|mrz
106252|NCT02903069|TMZ|tmz
106253|NCT02903069|RT|rt
106254|NCT02903069|brain cancer|brain cancer
106255|NCT02903069|proteasome inhibitor|proteasome inhibitor
106256|NCT02903069|radiation|radiation
106257|NCT02903069|temozolomide|temozolomide
106258|NCT02903069|temodar|temodar
106259|NCT02903069|chemotherapy|chemotherapy
106260|NCT02903069|concurrent|concurrent
106261|NCT02903069|adjuvant|adjuvant
106262|NCT02903069|Optune|optune
106263|NCT02903069|Novocure|novocure
106264|NCT02903069|NovoTTF|novottf
106265|NCT02903056|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
106266|NCT02903056|Diffusion Spectrum Imaging|diffusion spectrum imaging
106267|NCT02903056|Susceptibility weighted imaging|susceptibility weighted imaging
106268|NCT02903056|Magnetic Resonance Imaging|magnetic resonance imaging
106269|NCT02903043|MicroRNAs|micrornas
106270|NCT02903043|Angiogenesis|angiogenesis
106271|NCT02903043|Skeletal muscle|skeletal muscle
106272|NCT02903043|COPD|copd
106273|NCT02903030|Gastrointestinal Microbiome|gastrointestinal microbiome
106274|NCT02902991|liquid biopsy, breast cancer,circulating tumor biomarker|liquid biopsy, breast cancer,circulating tumor biomarker
106275|NCT02902978|E6130|e6130
106276|NCT02902978|Japanese healthy adult male participants|japanese healthy adult male participants
106277|NCT02902978|Phase 1|phase 1
106278|NCT02902978|Pharmacokinetics|pharmacokinetics
106279|NCT02902965|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
106280|NCT02902965|Bortezomib|bortezomib
106281|NCT02902965|Dexamethasone|dexamethasone
106282|NCT02902965|Ibrutinib|ibrutinib
106283|NCT02902939|Immune Suppression, Inflammatory Response, Cardiac Surgery|immune suppression, inflammatory response, cardiac surgery
106284|NCT02902913|platelet reactivity|platelet reactivity
106285|NCT02902913|phenolic|phenolic
106286|NCT02902913|extra virgin olive oil|extra virgin olive oil
106287|NCT02902913|cyclooxygenase|cyclooxygenase
106288|NCT02902913|oleocanthal|oleocanthal
106289|NCT02902913|oxylipin|oxylipin
106290|NCT02902900|Multiple Myeloma|multiple myeloma
106291|NCT02902900|Pomalidomide|pomalidomide
106292|NCT02902900|Efficacy|efficacy
106293|NCT02902835|Buprenorphine treatment|buprenorphine treatment
106294|NCT02902835|Incarceration|incarceration
106295|NCT02902835|Linkage Intervention|linkage intervention
106296|NCT02902835|Opioid use disorder|opioid use disorder
106297|NCT02902822|melanoma|melanoma
106298|NCT02902822|non-melanoma skin cancer|non-melanoma skin cancer
106299|NCT02902822|mole|mole
106300|NCT02902822|app|app
106301|NCT02902822|cliccailneo|cliccailneo
106302|NCT02902809|open-label study|open-label study
106303|NCT02902809|tralokinumab|tralokinumab
106304|NCT02902809|subcutaneous|subcutaneous
106305|NCT02902809|inadequately controlled asthma|inadequately controlled asthma
106306|NCT02902809|asthma|asthma
106307|NCT02902809|medium to high-dose of inhaled corticosteroid|medium to high-dose of inhaled corticosteroid
106308|NCT02902809|long-acting β2-agonist|long-acting β2-agonist
106309|NCT02902770|Pain|pain
106310|NCT02902770|Lidocaine|lidocaine
106311|NCT02902770|Ketorolac|ketorolac
106312|NCT02902757|FDG|fdg
106313|NCT02902757|PET/CT very early response (48 hrs)|pet/ct very early response (48 hrs)
106314|NCT02902705|White adipose tissue|white adipose tissue
106315|NCT02902705|chronic kidney disease|chronic kidney disease
106316|NCT02902705|uremia|uremia
106317|NCT02902705|adipocytes|adipocytes
106318|NCT02902692|brief|brief
106319|NCT02902692|mindfulness|mindfulness
106320|NCT02902666|Bioequivalence|bioequivalence
106321|NCT02902666|Paracetamol 1000 mg/codeine 30 mg|paracetamol 1000 mg/codeine 30 mg
106322|NCT02902666|Co-efferalgan 500 mg/30 mg|co-efferalgan 500 mg/30 mg
106323|NCT02902653|misoprostol|misoprostol
106324|NCT02902653|dinoprostonal|dinoprostonal
106325|NCT02902653|induction|induction
106326|NCT02902614|embryo biopsy|embryo biopsy
106327|NCT02902614|preimplantation genetic testing|preimplantation genetic testing
106328|NCT02902614|animal pole|animal pole
106329|NCT02902614|vegetal pole|vegetal pole
106330|NCT02902614|day 3 embryo biopsy|day 3 embryo biopsy
106331|NCT02902614|embryo implantation|embryo implantation
106332|NCT02902614|Blastomeres|blastomeres
106333|NCT02902588|Blood-Brain Barrier|blood-brain barrier
106334|NCT02902588|Magnetic Resonance Imaging|magnetic resonance imaging
106335|NCT02902588|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
106336|NCT02902588|Indocyanine green|indocyanine green
106337|NCT02902575|Stomach Neoplasms|stomach neoplasms
106338|NCT02902575|Laparoscopy|laparoscopy
106339|NCT02902575|Advanced Gastric Cancer|advanced gastric cancer
106340|NCT02902575|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
106341|NCT02902549|Optical Coherence Tomography|optical coherence tomography
106342|NCT02902549|Fluorescence Imaging|fluorescence imaging
106343|NCT02902549|Sidestream Darkfield Microscopy|sidestream darkfield microscopy
106344|NCT02902549|Laser Speckle Contrast Imaging|laser speckle contrast imaging
106345|NCT02902536|Myasthenia Gravis|myasthenia gravis
106346|NCT02902510|yoga|yoga
106347|NCT02902510|function|function
106348|NCT02902510|Parkinson's disease|parkinson's disease
106349|NCT02902510|gait|gait
106350|NCT02902510|balance|balance
106351|NCT02902458|implantable cardioverter defibrillator|implantable cardioverter defibrillator
106352|NCT02902458|primary prevention|primary prevention
106353|NCT02902458|psychological follow-up|psychological follow-up
106354|NCT02902458|anxiety|anxiety
106355|NCT02902458|depression|depression
106356|NCT02902458|quality of life|quality of life
106357|NCT02902445|Vaccine|vaccine
106358|NCT02902445|Polymorphism|polymorphism
106359|NCT02902432|endostar|endostar
106360|NCT02902432|cisplatin|cisplatin
106361|NCT02902393|Fibrinolysis|fibrinolysis
106362|NCT02902393|tPA|tpa
106363|NCT02902367|mobility|mobility
106364|NCT02902367|exercise|exercise
106365|NCT02902367|walking capacity|walking capacity
106366|NCT02902367|fat mass|fat mass
106367|NCT02902367|muscles|muscles
106368|NCT02902341|Nutrition Therapy|nutrition therapy
106369|NCT02902315|Muscle soreness|muscle soreness
106370|NCT02902315|Free radicals|free radicals
106371|NCT02902315|Ascorbic acid|ascorbic acid
106372|NCT02902315|Alpha-Tocopherol|alpha-tocopherol
106373|NCT02902315|Cryotherapy|cryotherapy
106374|NCT02902315|Exercise tolerance|exercise tolerance
106375|NCT02902315|Resistance training|resistance training
106376|NCT02902302|Bioequivalence|bioequivalence
106377|NCT02902302|Ibuprofen 400 mg/5 ml|ibuprofen 400 mg/5 ml
106378|NCT02902302|Moment 400 mg coated tablet|moment 400 mg coated tablet
106379|NCT02902302|Oral Suspension|oral suspension
106380|NCT02902289|Bioequivalence|bioequivalence
106381|NCT02902289|Ibuprofen 200 mg/5 ml|ibuprofen 200 mg/5 ml
106382|NCT02902289|Moment 200 mg coated tablet|moment 200 mg coated tablet
106383|NCT02902289|Oral Suspension|oral suspension
106384|NCT02902276|plasma citrulline|plasma citrulline
106385|NCT02902276|lipopolysaccharide|lipopolysaccharide
106386|NCT02902276|critically ill|critically ill
106387|NCT02902276|Hospitalization in an Intensive Care Unit|hospitalization in an intensive care unit
106388|NCT02902263|Telemedecine|telemedecine
106389|NCT02902263|Thrombolysis|thrombolysis
106390|NCT02902250|Vertebroplasty|vertebroplasty
106391|NCT02902250|Core decompression|core decompression
106392|NCT02902250|Osteoporosis|osteoporosis
106393|NCT02902211|ankle foot orthosis|ankle foot orthosis
106394|NCT02902211|biomechanics|biomechanics
106395|NCT02902211|mobility|mobility
106396|NCT02902185|Chidamide|chidamide
106397|NCT02902185|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
106398|NCT02902185|HIV-1 Reservoir|hiv-1 reservoir
106399|NCT02902185|Chronic HIV infections|chronic hiv infections
106400|NCT02902185|HIV Eradication|hiv eradication
106401|NCT02902185|Antiretroviral Therapy|antiretroviral therapy
106402|NCT02902159|Stress|stress
106403|NCT02902159|Low Mood|low mood
106404|NCT02902159|Mental Health|mental health
106405|NCT02902159|Peer Support|peer support
106406|NCT02902159|Online|online
106407|NCT02902133|cerebrospinal fluid leak|cerebrospinal fluid leak
106408|NCT02902107|Low Dose Rate Brachytherapy|low dose rate brachytherapy
106409|NCT02902107|CivaSheet|civasheet
106410|NCT02902107|16-605|16-605
106411|NCT02902042|Unresectable or metastatic BRAF V600 mutant melanoma|unresectable or metastatic braf v600 mutant melanoma
106412|NCT02902042|Encorafenib, binimetinib, pembrolizumab|encorafenib, binimetinib, pembrolizumab
106413|NCT02902029|unresectable stage IIIB, IIIC, IV melanoma|unresectable stage iiib, iiic, iv melanoma
106414|NCT02902016|PPARgamma|ppargamma
106415|NCT02902016|Lactose intolerance|lactose intolerance
106416|NCT02902016|Lactase|lactase
106417|NCT02901990|mumps|mumps
106418|NCT02901990|immunity|immunity
106419|NCT02901990|cohort study|cohort study
106420|NCT02901990|children|children
106421|NCT02901990|vaccine|vaccine
106422|NCT02901977|Hypertension|hypertension
106423|NCT02901977|Blood pressure|blood pressure
106424|NCT02901977|Hemostasis|hemostasis
106425|NCT02901977|Endothelial function|endothelial function
106426|NCT02901951|adult subjects|adult subjects
106427|NCT02901951|Hepatitis B antibody|hepatitis b antibody
106428|NCT02901951|Hepatitis B|hepatitis b
106429|NCT02901951|HBV|hbv
106430|NCT02901925|ABY-029|aby-029
106431|NCT02901925|Affibody|affibody
106432|NCT02901925|Molecular Fluorescence-Guided Surgery|molecular fluorescence-guided surgery
106433|NCT02901925|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
106434|NCT02901912|physical activity|physical activity
106435|NCT02901912|sedentarism|sedentarism
106436|NCT02901912|fecal enzymatic activity|fecal enzymatic activity
106437|NCT02901886|Rheumatoid Arthritis|rheumatoid arthritis
106438|NCT02901886|Smoking Cessation|smoking cessation
106439|NCT02901886|Disease Activity|disease activity
106440|NCT02901886|Clinical Prevention|clinical prevention
106441|NCT02901808|NOMI|nomi
106442|NCT02901808|Angiography|angiography
106443|NCT02901808|Digital Subtraction Angiography (DSA)|digital subtraction angiography (dsa)
106444|NCT02901782|Knee|knee
106445|NCT02901782|Titanium Plate|titanium plate
106446|NCT02901730|laser peripheral iridoplasty|laser peripheral iridoplasty
106447|NCT02901730|treatment|treatment
106448|NCT02901678|skelatal open bite, posterior intrusion|skelatal open bite, posterior intrusion
106449|NCT02901626|Short cervix|short cervix
106450|NCT02901626|Preterm delivery|preterm delivery
106451|NCT02901626|Singletons|singletons
106452|NCT02901626|Pregnancy|pregnancy
106453|NCT02901626|Pessary|pessary
106454|NCT02901600|DMBT1 expression|dmbt1 expression
106455|NCT02901600|Colorectal cancer|colorectal cancer
106456|NCT02901548|BCG refractory CIS|bcg refractory cis
106457|NCT02901548|Urothelial CIS of bladder|urothelial cis of bladder
106458|NCT02901548|Carcinoma in situ (CIS)|carcinoma in situ (cis)
106459|NCT02901548|Bacillus Calmette-Guérin (BCG)|bacillus calmette-guérin (bcg)
106460|NCT02901548|Medi4736|medi4736
106461|NCT02901548|Durvalumab|durvalumab
106462|NCT02901548|CIS of the bladder|cis of the bladder
106463|NCT02901548|Bladder cancer|bladder cancer
106464|NCT02901548|BCG Vaccine|bcg vaccine
106465|NCT02901548|Bladder diseases|bladder diseases
106466|NCT02901548|Urothelial diseases|urothelial diseases
106467|NCT02901535|telemedicine|telemedicine
106468|NCT02901535|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
106469|NCT02901535|Primary Health care|primary health care
106470|NCT02901535|spirometry|spirometry
106471|NCT02901522|telemedicine|telemedicine
106472|NCT02901522|asthma control test|asthma control test
106473|NCT02901522|Primary Health care|primary health care
106474|NCT02901522|spirometry|spirometry
106475|NCT02901509|Chikungunya|chikungunya
106476|NCT02901509|Quality of Life|quality of life
106477|NCT02901483|Head and Neck|head and neck
106478|NCT02901457|Body Image|body image
106479|NCT02901418|chronic hepatitis B|chronic hepatitis b
106480|NCT02901418|mother to child transmission|mother to child transmission
106481|NCT02901418|interruption|interruption
106482|NCT02901418|hepatitis B immunoglobulin|hepatitis b immunoglobulin
106483|NCT02901418|pregnancy|pregnancy
106484|NCT02901418|HBsAg|hbsag
106485|NCT02901418|newborns|newborns
106486|NCT02901405|sarcoma|sarcoma
106487|NCT02901405|infection|infection
106488|NCT02901405|negative pressure|negative pressure
106489|NCT02901392|Male Urethral Slings|male urethral slings
106490|NCT02901392|Artificial Urinary Sphincter|artificial urinary sphincter
106491|NCT02901392|Prostatectomy|prostatectomy
106492|NCT02901392|Radiotherapy|radiotherapy
106493|NCT02901379|atorvastatin|atorvastatin
106494|NCT02901379|myocardial edema|myocardial edema
106495|NCT02901379|Follistatin-like 1|follistatin-like 1
106496|NCT02901379|FSTL1|fstl1
106497|NCT02901379|atorvastatin 80mg|atorvastatin 80mg
106498|NCT02901379|coronary artery bypass surgery|coronary artery bypass surgery
106499|NCT02901366|Mass balance|mass balance
106500|NCT02901340|Borderline idiopathic isolated oligohydramnios|borderline idiopathic isolated oligohydramnios
106501|NCT02901340|Fetal renal artery doppler indices|fetal renal artery doppler indices
106502|NCT02901340|neonatal outcomes|neonatal outcomes
106503|NCT02901340|Maternal hydration|maternal hydration
106504|NCT02901327|Lumbar Stabilisation Exercise|lumbar stabilisation exercise
106505|NCT02901327|Treadmill Walk|treadmill walk
106506|NCT02901327|Multifidus Muscle Activation|multifidus muscle activation
106507|NCT02901327|Pain Intensity|pain intensity
106508|NCT02901327|Functional Disability|functional disability
106509|NCT02901288|pulmonary tuberculosis|pulmonary tuberculosis
106510|NCT02901288|shortened regimen|shortened regimen
106511|NCT02901288|clinical trial|clinical trial
106512|NCT02901275|Clinical Trial, Phase II|clinical trial, phase ii
106513|NCT02901275|Analgesia|analgesia
106514|NCT02901262|continuous EEG|continuous eeg
106515|NCT02901249|Cost effectiveness|cost effectiveness
106516|NCT02901249|Unipolar Depression|unipolar depression
106517|NCT02901249|Major Depression Disorder|major depression disorder
106518|NCT02901249|Quality of life disorder|quality of life disorder
106519|NCT02901236|trabeculectomy|trabeculectomy
106520|NCT02901236|glaucoma|glaucoma
106521|NCT02901236|filtration surgery|filtration surgery
106522|NCT02901236|wound healing|wound healing
106523|NCT02901236|angiogenesis|angiogenesis
106524|NCT02901236|mitomycin|mitomycin
106525|NCT02901236|vascular endothelial growth factor inhibition|vascular endothelial growth factor inhibition
106526|NCT02901223|Oncoplastic breast surgery|oncoplastic breast surgery
106527|NCT02901223|oncological safety|oncological safety
106528|NCT02901223|patient satisfaction|patient satisfaction
106529|NCT02901210|Recta prolapse|recta prolapse
106530|NCT02901210|Intraoperative bleeding|intraoperative bleeding
106531|NCT02901210|mucosal cauterization|mucosal cauterization
106532|NCT02901197|capnography|capnography
106533|NCT02901171|Smoking cessation|smoking cessation
106534|NCT02901171|Acceptance and Commitment Therapy|acceptance and commitment therapy
106535|NCT02901171|Smartphone|smartphone
106536|NCT02901158|esophageal pressure|esophageal pressure
106537|NCT02901158|chest wall elastance|chest wall elastance
106538|NCT02901158|lung elastance|lung elastance
106539|NCT02901158|transpulmonary pressure|transpulmonary pressure
106540|NCT02901145|immunotherapy,solid tumor,pediatric|immunotherapy,solid tumor,pediatric
106541|NCT02901106|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
106542|NCT02901106|Dimethyl fumarate|dimethyl fumarate
106543|NCT02901093|Stapes surgery|stapes surgery
106544|NCT02901093|Sensorineural complications|sensorineural complications
106545|NCT02901093|Inner ear|inner ear
106546|NCT02901093|Imaging|imaging
106547|NCT02901093|Cone Beam CT|cone beam ct
106548|NCT02901067|Fibrinolysis|fibrinolysis
106549|NCT02901015|schizophrenia|schizophrenia
106550|NCT02901002|Complex Regional Pain Syndromes|complex regional pain syndromes
106551|NCT02901002|Pain|pain
106552|NCT02901002|Spontaneous sensations|spontaneous sensations
106553|NCT02901002|interoception|interoception
106554|NCT02900989|Psychiatry|psychiatry
106555|NCT02900989|Pediatrics|pediatrics
106556|NCT02900989|Suicide|suicide
106557|NCT02900976|Organ Transplantation|organ transplantation
106558|NCT02900963|Nutrition|nutrition
106559|NCT02900963|Head and Neck Cancer|head and neck cancer
106560|NCT02900950|cancer|cancer
106561|NCT02900950|resection margin|resection margin
106562|NCT02900950|pathology|pathology
106563|NCT02900950|pancreas|pancreas
106564|NCT02900937|Stents|stents
106565|NCT02900937|Angioplasty|angioplasty
106566|NCT02900937|Coronary Vessels|coronary vessels
106567|NCT02900937|Coronary Artery Disease|coronary artery disease
106568|NCT02900937|Angina Pectoris|angina pectoris
106569|NCT02900937|Myocardial Ischemia|myocardial ischemia
106570|NCT02900937|Myocardial Infarction|myocardial infarction
106571|NCT02900937|Myocardial Revascularization|myocardial revascularization
106572|NCT02900924|PAD|pad
106573|NCT02900924|PVD|pvd
106574|NCT02900924|SFA stent|sfa stent
106575|NCT02900911|head and neck cancer|head and neck cancer
106576|NCT02900911|dysphagia|dysphagia
106577|NCT02900911|rehabilitation|rehabilitation
106578|NCT02900911|radiation therapy|radiation therapy
106579|NCT02900820|Anti-Bacterial Agents|anti-bacterial agents
106580|NCT02900820|Primary Health Care|primary health care
106581|NCT02900820|Drug Resistance, Microbial|drug resistance, microbial
106582|NCT02900820|Respiratory Tract Infections|respiratory tract infections
106583|NCT02900781|Arthroplasty|arthroplasty
106584|NCT02900781|Physical Therapy|physical therapy
106585|NCT02900768|Bone Marrow Transplantation|bone marrow transplantation
106586|NCT02900768|Exercise|exercise
106587|NCT02900768|Rehabilitation|rehabilitation
106588|NCT02900768|Cancer|cancer
106589|NCT02900755|Electroencephalography|electroencephalography
106590|NCT02900755|Perampanel|perampanel
106591|NCT02900742|lung cancer|lung cancer
106592|NCT02900742|traditional Chinese medicine|traditional chinese medicine
106593|NCT02900742|maintenance therapy|maintenance therapy
106594|NCT02900742|chemotherapy|chemotherapy
106595|NCT02900677|Pancreatic Cancer|pancreatic cancer
106596|NCT02900677|Fatigue|fatigue
106597|NCT02900677|Nutrition|nutrition
106598|NCT02900677|Quality of Life|quality of life
106599|NCT02900664|CRC|crc
106600|NCT02900664|TNBC|tnbc
106601|NCT02900664|NSCLC (adenocarcinoma)|nsclc (adenocarcinoma)
106602|NCT02900664|Immunomodulation|immunomodulation
106603|NCT02900664|Biomarkers|biomarkers
106604|NCT02900664|Bayesian logistic regression model|bayesian logistic regression model
106605|NCT02900664|PDR001|pdr001
106606|NCT02900664|Immunotherapy|immunotherapy
106607|NCT02900651|MAK683, DLBCL, EED - Embryonic ectoderm development, EZH2 - Enhancer of zeste homolog 2|mak683, dlbcl, eed - embryonic ectoderm development, ezh2 - enhancer of zeste homolog 2
106608|NCT02900638|mentoring|mentoring
106609|NCT02900638|children|children
106610|NCT02900638|cardiovascular health|cardiovascular health
106611|NCT02900612|dyslipidemias,|dyslipidemias,
106612|NCT02900612|aging|aging
106613|NCT02900612|water aerobics training|water aerobics training
106614|NCT02900612|resistance aquatic training|resistance aquatic training
106615|NCT02900612|lipid profile|lipid profile
106616|NCT02900599|HIV|hiv
106617|NCT02900599|Behavior|behavior
106618|NCT02900547|Systolic Heart Failure|systolic heart failure
106619|NCT02900547|medical algorithm decision support system|medical algorithm decision support system
106620|NCT02900534|grief|grief
106621|NCT02900534|depression|depression
106622|NCT02900534|bereavement|bereavement
106623|NCT02900534|divorce|divorce
106624|NCT02900534|online self-help|online self-help
106625|NCT02900495|Nocturnal Enuresis|nocturnal enuresis
106626|NCT02900495|Bedwetting|bedwetting
106627|NCT02900495|TENS|tens
106628|NCT02900469|RANK|rank
106629|NCT02900469|RANKL|rankl
106630|NCT02900456|Intra-aortic Balloon Pumps|intra-aortic balloon pumps
106631|NCT02900456|Registry|registry
106632|NCT02900417|type 2 diabetes|type 2 diabetes
106633|NCT02900417|gut microbiota|gut microbiota
106634|NCT02900417|sitagliptin|sitagliptin
106635|NCT02900378|physical activity|physical activity
106636|NCT02900378|actigraphy|actigraphy
106637|NCT02900378|sleep|sleep
106638|NCT02900378|sacubitril/valsartan|sacubitril/valsartan
106639|NCT02900378|enalapril|enalapril
106640|NCT02900378|heart failure|heart failure
106641|NCT02900378|reduced ejection fraction|reduced ejection fraction
106642|NCT02900378|randomized controlled trial|randomized controlled trial
106643|NCT02900378|accelerometry|accelerometry
106644|NCT02900365|trauma|trauma
106645|NCT02900365|cataract|cataract
106646|NCT02900365|lensectomy|lensectomy
106647|NCT02900365|time|time
106648|NCT02900365|early|early
106649|NCT02900365|late|late
106650|NCT02900352|Alcohol Use Disorder|alcohol use disorder
106651|NCT02900352|Alcoholism|alcoholism
106652|NCT02900352|Alcohol Dependence|alcohol dependence
106653|NCT02900352|Zonisamide|zonisamide
106654|NCT02900352|Alcohol Intoxication|alcohol intoxication
106655|NCT02900352|Drinking Behaviors|drinking behaviors
106656|NCT02900352|Anticonvulsants|anticonvulsants
106657|NCT02900339|MRI|mri
106658|NCT02900339|Sequence optimization|sequence optimization
106659|NCT02900339|Healthy volunteers|healthy volunteers
106660|NCT02900326|Exercise capacity|exercise capacity
106661|NCT02900326|Mindfulness|mindfulness
106662|NCT02900326|Quality of life|quality of life
106663|NCT02900313|acute kidney injury|acute kidney injury
106664|NCT02900313|cardiac surgery|cardiac surgery
106665|NCT02900313|cardiac surgery associated acute kidney injury|cardiac surgery associated acute kidney injury
106666|NCT02900313|renal replacement therapy|renal replacement therapy
106667|NCT02900313|renal recovery|renal recovery
106668|NCT02900313|serum hyperphosphatemia|serum hyperphosphatemia
106669|NCT02900287|Survival|survival
106670|NCT02900287|Cancer|cancer
106671|NCT02900248|Biomarkers|biomarkers
106672|NCT02900248|High-Throughput Nucleotide Sequencing|high-throughput nucleotide sequencing
106673|NCT02900248|Neoplasms|neoplasms
106674|NCT02900248|Myelodysplastic Syndromes|myelodysplastic syndromes
106675|NCT02900235|Healthy|healthy
106676|NCT02900209|Influenza|influenza
106677|NCT02900209|Exacerbations|exacerbations
106678|NCT02900196|Probiotics|probiotics
106679|NCT02900196|Antibiotic Associated Diarrhea|antibiotic associated diarrhea
106680|NCT02900196|Gastro-Intestinal disorders|gastro-intestinal disorders
106681|NCT02900196|Helicobacter pylori|helicobacter pylori
106682|NCT02900170|Rivaroxaban, Acute Kidney Injury|rivaroxaban, acute kidney injury
106683|NCT02900157|Advanced Solid Tumor|advanced solid tumor
106684|NCT02900157|Immunotherapy|immunotherapy
106685|NCT02900157|MEDI9090|medi9090
106686|NCT02900157|MEDI4736|medi4736
106687|NCT02900157|Durvalumab|durvalumab
106688|NCT02900118|Bone metastasis|bone metastasis
106689|NCT02900118|PET-CT|pet-ct
106690|NCT02900118|whole-body MRI|whole-body mri
106691|NCT02900092|postmenopausal|postmenopausal
106692|NCT02900092|women|women
106693|NCT02900092|depression|depression
106694|NCT02900079|malaria|malaria
106695|NCT02900079|rapid diagnostic test|rapid diagnostic test
106696|NCT02900079|travel|travel
106697|NCT02900079|fever|fever
106698|NCT02900079|self care|self care
106699|NCT02900066|fever|fever
106700|NCT02900066|traveler|traveler
106701|NCT02900066|arbovirus|arbovirus
106702|NCT02900066|rickettsia|rickettsia
106703|NCT02900066|malaria|malaria
106704|NCT02900066|filter paper|filter paper
106705|NCT02900066|diagnosis|diagnosis
106706|NCT02900001|myocardial infarction|myocardial infarction
106707|NCT02900001|invasive strategy|invasive strategy
106708|NCT02900001|elderly|elderly
106709|NCT02900001|deferred|deferred
106710|NCT02899988|IL-23|il-23
106711|NCT02899988|dermatology|dermatology
106712|NCT02899975|Validation|validation
106713|NCT02899975|Information and Fitness Software|information and fitness software
106714|NCT02899975|Elderly|elderly
106715|NCT02899975|WeTakeCare|wetakecare
106716|NCT02899949|dapagliflozin|dapagliflozin
106717|NCT02899949|type 2 diabetes|type 2 diabetes
106718|NCT02899949|real-world data|real-world data
106719|NCT02899936|Mass drug administration|mass drug administration
106720|NCT02899936|Safety Data|safety data
106721|NCT02899897|echocardiography|echocardiography
106722|NCT02899884|Drug Therapy|drug therapy
106723|NCT02899871|joint pain|joint pain
106724|NCT02899858|Thoracic spinal cord injury|thoracic spinal cord injury
106725|NCT02899858|Paralysis|paralysis
106726|NCT02899858|ASIA A|asia a
106727|NCT02899858|Device|device
106728|NCT02899832|children|children
106729|NCT02899832|spasms|spasms
106730|NCT02899819|pesticides|pesticides
106731|NCT02899819|exposure|exposure
106732|NCT02899819|in utero|in utero
106733|NCT02899806|Video Information|video information
106734|NCT02899806|Satisfaction|satisfaction
106735|NCT02899806|Anxiety|anxiety
106736|NCT02899806|Epidural Analgesia|epidural analgesia
106737|NCT02899806|Comprehension|comprehension
106738|NCT02899806|delivery|delivery
106739|NCT02899767|transfusion dependency|transfusion dependency
106740|NCT02899767|transfusion intensity|transfusion intensity
106741|NCT02899767|prognosis|prognosis
106742|NCT02899767|chemotherapy|chemotherapy
106743|NCT02899754|lung cancer|lung cancer
106744|NCT02899754|decision support|decision support
106745|NCT02899754|implementation|implementation
106746|NCT02899741|Medically intractable epilepsy, Omega-3|medically intractable epilepsy, omega-3
106747|NCT02899689|Labor|labor
106748|NCT02899689|Foley|foley
106749|NCT02899689|Dilapan|dilapan
106750|NCT02899689|Cervical Dilators|cervical dilators
106751|NCT02899689|Induction|induction
106752|NCT02899650|Delayed Onset Muscle Soreness|delayed onset muscle soreness
106753|NCT02899650|Eccentric exercise|eccentric exercise
106754|NCT02899650|Masters athlete|masters athlete
106755|NCT02899637|Incomplete Spinal Cord Injury|incomplete spinal cord injury
106756|NCT02899637|Rehabilitation|rehabilitation
106757|NCT02899637|Non-invasive brain stimulation|non-invasive brain stimulation
106758|NCT02899637|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
106759|NCT02899611|Epilepsy|epilepsy
106760|NCT02899585|Palliative care|palliative care
106761|NCT02899546|Peripherally Inserted Central Catheter|peripherally inserted central catheter
106762|NCT02899546|Infections|infections
106763|NCT02899546|Radiology|radiology
106764|NCT02899533|PAH|pah
106765|NCT02899533|Pulmonary hypertension|pulmonary hypertension
106766|NCT02899507|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
106767|NCT02899507|Prophylactic antibiotics|prophylactic antibiotics
106768|NCT02899468|TBI|tbi
106769|NCT02899468|Virtual Reality|virtual reality
106770|NCT02899455|Hypertension|hypertension
106771|NCT02899455|Hyperlipidemia|hyperlipidemia
106772|NCT02899442|cardiovascular risk|cardiovascular risk
106773|NCT02899442|Occupational Health|occupational health
106774|NCT02899442|night work|night work
106775|NCT02899442|Public Health|public health
106776|NCT02899442|Preventive Health Services|preventive health services
106777|NCT02899416|cardiovascular risk|cardiovascular risk
106778|NCT02899416|young adulthood|young adulthood
106779|NCT02899403|Cognitive Tasks|cognitive tasks
106780|NCT02899403|Mild Cognitive Impairment|mild cognitive impairment
106781|NCT02899403|Neurophysiological Correlates|neurophysiological correlates
106782|NCT02899403|Healthy Volunteers|healthy volunteers
106783|NCT02899377|PET/CT|pet/ct
106784|NCT02899377|Primary Sjögren's Syndrome|primary sjögren's syndrome
106785|NCT02899377|Magnetic resonance imaging|magnetic resonance imaging
106786|NCT02899377|11^C-MET|11^c-met
106787|NCT02899377|18^F-FDG|18^f-fdg
106788|NCT02899364|Sodium thiosulfate|sodium thiosulfate
106789|NCT02899364|STEMI|stemi
106790|NCT02899364|Infarct size|infarct size
106791|NCT02899364|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
106792|NCT02899364|Hydrogen sulfide|hydrogen sulfide
106793|NCT02899286|Acute myeloid leukemia|acute myeloid leukemia
106794|NCT02899286|AML|aml
106795|NCT02899286|pegylated recombinant human arginase|pegylated recombinant human arginase
106796|NCT02899286|PEG-BCT-100|peg-bct-100
106797|NCT02899273|Early Childhood Caries|early childhood caries
106798|NCT02899273|eye-tracking|eye-tracking
106799|NCT02899273|children|children
106800|NCT02899273|dentistry|dentistry
106801|NCT02899273|face perception|face perception
106802|NCT02899247|composite resin|composite resin
106803|NCT02899247|surface sealant|surface sealant
106804|NCT02899234|Nicotine|nicotine
106805|NCT02899234|Electronic Cigarette|electronic cigarette
106806|NCT02899195|Unresectable Mesothelioma|unresectable mesothelioma
106807|NCT02899195|Durvalumab|durvalumab
106808|NCT02899195|Anti-Programmed Death-Ligand 1 Antibody|anti-programmed death-ligand 1 antibody
106809|NCT02899169|Acute promyelocytic leukemia|acute promyelocytic leukemia
106810|NCT02899169|Realgar-Indigo Naturalis Formula|realgar-indigo naturalis formula
106811|NCT02899169|All-trans Retinoic Acid|all-trans retinoic acid
106812|NCT02899091|Alzheimer's disease|alzheimer's disease
106813|NCT02899091|Mesenchymal Stem cells|mesenchymal stem cells
106814|NCT02899052|Multiple Myeloma|multiple myeloma
106815|NCT02899052|Refractory myeloma|refractory myeloma
106816|NCT02899052|Relapsed myeloma|relapsed myeloma
106817|NCT02899026|Glucocorticosteroids|glucocorticosteroids
106818|NCT02899026|Sirukumab|sirukumab
106819|NCT02899026|Prednisone|prednisone
106820|NCT02899026|Polymyalgia Rheumatica|polymyalgia rheumatica
106821|NCT02899013|Perianal Lesions|perianal lesions
106822|NCT02898987|HIV|hiv
106823|NCT02898987|Hepatitis C|hepatitis c
106824|NCT02898987|Comorbidities|comorbidities
106825|NCT02898987|AIDS|aids
106826|NCT02898948|procalcitonin|procalcitonin
106827|NCT02898948|bacterial infection|bacterial infection
106828|NCT02898909|femtosecond laser-assisted cataract surgery|femtosecond laser-assisted cataract surgery
106829|NCT02898909|nuclear lens fragmentation|nuclear lens fragmentation
106830|NCT02898844|dieting|dieting
106831|NCT02898844|dyads|dyads
106832|NCT02898844|psychological well-being|psychological well-being
106833|NCT02898844|weight loss|weight loss
106834|NCT02898844|cortisol|cortisol
106835|NCT02898792|sensitivity, opioid|sensitivity, opioid
106836|NCT02898753|GSD-II|gsd-ii
106837|NCT02898753|Pompe Disease|pompe disease
106838|NCT02898753|Glycogen Storage Diseases|glycogen storage diseases
106839|NCT02898753|GAA|gaa
106840|NCT02898740|Parkinson's disease|parkinson's disease
106841|NCT02898740|exercise therapy|exercise therapy
106842|NCT02898740|quality of life|quality of life
106843|NCT02898701|Motor Learning|motor learning
106844|NCT02898701|Dose of Motor Practice|dose of motor practice
106845|NCT02898701|Postural Control|postural control
106846|NCT02898701|Serial Reaction Time Task|serial reaction time task
106847|NCT02898701|Retention|retention
106848|NCT02898701|Transfer|transfer
106849|NCT02898701|Overpractice|overpractice
106850|NCT02898701|Overtraining|overtraining
106851|NCT02898701|Overlearning|overlearning
106852|NCT02898688|Influenza vaccine|influenza vaccine
106853|NCT02898688|Pertussis vaccine|pertussis vaccine
106854|NCT02898688|Perinatal vaccination|perinatal vaccination
106855|NCT02898688|Infant vaccination|infant vaccination
106856|NCT02898662|inhaled|inhaled
106857|NCT02898662|TLR9 agonist|tlr9 agonist
106858|NCT02898662|withdrawal design|withdrawal design
106859|NCT02898662|loss of control|loss of control
106860|NCT02898532|Children, ADHD, target shooting sport|children, adhd, target shooting sport
106861|NCT02898506|Diabetes Type 1|diabetes type 1
106862|NCT02898506|Diabetes, Insulin-Dependent|diabetes, insulin-dependent
106863|NCT02898506|Liraglutide|liraglutide
106864|NCT02898506|Preclinical Type 1 Diabetes|preclinical type 1 diabetes
106865|NCT02898506|GLP-1 Analogue|glp-1 analogue
106866|NCT02898506|Dysglycemia|dysglycemia
106867|NCT02898506|Prevention|prevention
106868|NCT02898493|Validation of questionnaire|validation of questionnaire
106869|NCT02898493|Quality of life|quality of life
106870|NCT02898441|lung cancer screening|lung cancer screening
106871|NCT02898441|low-dose CT|low-dose ct
106872|NCT02898441|high-risk population|high-risk population
106873|NCT02898415|HCC|hcc
106874|NCT02898415|Liver Transplantation|liver transplantation
106875|NCT02898415|AFP|afp
106876|NCT02898415|Mortality|mortality
106877|NCT02898415|Competing risk|competing risk
106878|NCT02898415|Selection criteria|selection criteria
106879|NCT02898415|Recurrence|recurrence
106880|NCT02898376|spa care|spa care
106881|NCT02898376|randomised controlled trial|randomised controlled trial
106882|NCT02898376|pentoxifylline/tocopherol combination|pentoxifylline/tocopherol combination
106883|NCT02898376|late sequelae|late sequelae
106884|NCT02898376|radiotherapy|radiotherapy
106885|NCT02898363|Care of disabled population|care of disabled population
106886|NCT02898363|Mental retardation|mental retardation
106887|NCT02898363|Cancer screening|cancer screening
106888|NCT02898363|Cancer prevention|cancer prevention
106889|NCT02898324|Bullying|bullying
106890|NCT02898324|KiVa program|kiva program
106891|NCT02898324|Primary school students|primary school students
106892|NCT02898311|CAD-CAM|cad-cam
106893|NCT02898311|composite dental resin|composite dental resin
106894|NCT02898311|Immediate dental implant loading|immediate dental implant loading
106895|NCT02898259|Lenalidomide|lenalidomide
106896|NCT02898259|Ixazomib|ixazomib
106897|NCT02898259|Rituximab|rituximab
106898|NCT02898246|heart failure|heart failure
106899|NCT02898246|fear of physical activity|fear of physical activity
106900|NCT02898246|motor activity|motor activity
106901|NCT02898233|depression|depression
106902|NCT02898233|internet-based|internet-based
106903|NCT02898233|treatment|treatment
106904|NCT02898233|low-level light therapy|low-level light therapy
106905|NCT02898233|LLLT|lllt
106906|NCT02898233|deprexis|deprexis
106907|NCT02898194|Surrogate Decision-making|surrogate decision-making
106908|NCT02898194|Health Care|health care
106909|NCT02898194|Medical Decisions|medical decisions
106910|NCT02898194|End of Life Care|end of life care
106911|NCT02898168|stroke|stroke
106912|NCT02898168|Rehabilitation|rehabilitation
106913|NCT02898168|WalkAide (WA)|walkaide (wa)
106914|NCT02898168|Functional Electrical Stimulation (FES)|functional electrical stimulation (fes)
106915|NCT02898155|Avoidable hospitalizations|avoidable hospitalizations
106916|NCT02898155|primary care|primary care
106917|NCT02898155|geographicvariation|geographicvariation
106918|NCT02898142|Postprandial test|postprandial test
106919|NCT02898142|Metabolic syndrime|metabolic syndrime
106920|NCT02898142|HTG|htg
106921|NCT02898129|chronic respiratory diseases|chronic respiratory diseases
106922|NCT02898129|housing|housing
106923|NCT02898129|lung function test|lung function test
106924|NCT02898116|ALK-rearranged|alk-rearranged
106925|NCT02898116|ALK-positive|alk-positive
106926|NCT02898116|ALK Inhibitor|alk inhibitor
106927|NCT02898116|Ensartinib|ensartinib
106928|NCT02898116|X-396|x-396
106929|NCT02898116|anti-PD-L1|anti-pd-l1
106930|NCT02898116|Durvalumab|durvalumab
106931|NCT02898116|MEDI4736|medi4736
106932|NCT02898116|ALK|alk
106933|NCT02898090|Quality indicators|quality indicators
106934|NCT02898090|Appropriateness|appropriateness
106935|NCT02898090|Oral anticoagulant prescriptions|oral anticoagulant prescriptions
106936|NCT02898090|Development and validation|development and validation
106937|NCT02898090|Hospital information system|hospital information system
106938|NCT02898090|Information Storage and Retrieval|information storage and retrieval
106939|NCT02898090|Natural Language Processing|natural language processing
106940|NCT02898077|Second line|second line
106941|NCT02898077|Angiogenesis|angiogenesis
106942|NCT02898077|Vascular endothelial growth factor receptor 2|vascular endothelial growth factor receptor 2
106943|NCT02898051|heparin low-molecular-weight;pharmacokinetics|heparin low-molecular-weight;pharmacokinetics
106944|NCT02898012|Glioblastoma Multiforme|glioblastoma multiforme
106945|NCT02898012|temozolomide|temozolomide
106946|NCT02898012|bevacizumab|bevacizumab
106947|NCT02897973|Spinal loads|spinal loads
106948|NCT02897973|Trunk muscle force|trunk muscle force
106949|NCT02897973|Computational modeling|computational modeling
106950|NCT02897973|Unilateral lower limb amputation|unilateral lower limb amputation
106951|NCT02897960|wheezing|wheezing
106952|NCT02897960|bronchiolitis|bronchiolitis
106953|NCT02897960|respiratory sound algorithm|respiratory sound algorithm
106954|NCT02897947|Lumbosacral Region|lumbosacral region
106956|NCT02897947|Registries|registries
106957|NCT02897895|Lung transplantation in end-stage lung diseases|lung transplantation in end-stage lung diseases
106958|NCT02897843|Electroconvulsive Therapy|electroconvulsive therapy
106959|NCT02897843|Transcranial Direct Current Stimulation|transcranial direct current stimulation
106960|NCT02897843|cognition|cognition
106961|NCT02897817|Methotrexate|methotrexate
106962|NCT02897817|Treatment adherence|treatment adherence
106963|NCT02897804|multiphase optimization strategy|multiphase optimization strategy
106964|NCT02897804|college students|college students
106965|NCT02897778|entinostat|entinostat
106966|NCT02897778|solid tumor|solid tumor
106967|NCT02897778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors
106968|NCT02897765|Checkpoint Inhibitor|checkpoint inhibitor
106969|NCT02897765|Immunotherapy|immunotherapy
106970|NCT02897765|Personal Vaccine|personal vaccine
106971|NCT02897765|Neoantigen|neoantigen
106972|NCT02897765|Poly-ICLC|poly-iclc
106973|NCT02897765|Peptide|peptide
106974|NCT02897752|stroke|stroke
106975|NCT02897752|Rehabilitation|rehabilitation
106976|NCT02897752|WalkAide (WA)|walkaide (wa)
106977|NCT02897752|Functional Electrical Stimulation (FES)|functional electrical stimulation (fes)
106978|NCT02897713|mechanical ventilation|mechanical ventilation
106979|NCT02897713|enteral nutrition|enteral nutrition
106980|NCT02897713|feeding intolerance|feeding intolerance
106981|NCT02897700|Chemotherapy|chemotherapy
106982|NCT02897700|Safety|safety
106983|NCT02897700|Tolerability|tolerability
106984|NCT02897700|Efficacy|efficacy
106985|NCT02897687|Autism Spectrum Disorder|autism spectrum disorder
106986|NCT02897687|Social Skills|social skills
106987|NCT02897687|Social Media|social media
106988|NCT02897661|fecal microbiota transplantation|fecal microbiota transplantation
106989|NCT02897661|enteral nutrition|enteral nutrition
106990|NCT02897622|Eating disorders|eating disorders
106991|NCT02897622|severe and enduring|severe and enduring
106992|NCT02897622|quality of life|quality of life
106993|NCT02897622|case management|case management
106994|NCT02897609|Beta-lactamine|beta-lactamine
106995|NCT02897609|β-lactamine|β-lactamine
106996|NCT02897570|ghrelin|ghrelin
106997|NCT02897570|breakfast meal|breakfast meal
106998|NCT02897570|P-300|p-300
106999|NCT02897531|Ileocolic, stapled, laparoscopy, right hemicolectomy|ileocolic, stapled, laparoscopy, right hemicolectomy
107000|NCT02897518|Videolaryngoscopes|videolaryngoscopes
107001|NCT02897518|Intubation|intubation
107002|NCT02897505|post traumatic stress disorder (PTSD)|post traumatic stress disorder (ptsd)
107003|NCT02897466|ventilator-associated pneumonia|ventilator-associated pneumonia
107004|NCT02897466|Multidrug-resistant bacteria|multidrug-resistant bacteria
107005|NCT02897440|Femoral Neck Fracture|femoral neck fracture
107006|NCT02897440|Hip Arthroplasty|hip arthroplasty
107007|NCT02897440|Repairing of soft tissue|repairing of soft tissue
107008|NCT02897427|Oropharyngeal cancer|oropharyngeal cancer
107009|NCT02897427|Anal cancer|anal cancer
107010|NCT02897427|Penile cancer|penile cancer
107011|NCT02897427|Human papillomavirus|human papillomavirus
107012|NCT02897427|HPV|hpv
107013|NCT02897427|HPV 16 E antigens|hpv 16 e antigens
107014|NCT02897427|Oropharyngeal cancer screening|oropharyngeal cancer screening
107015|NCT02897427|Dysplasia|dysplasia
107016|NCT02897427|Ultrasound scans of throat and the lymph nodes in neck|ultrasound scans of throat and the lymph nodes in neck
107017|NCT02897427|Anal cancer screening|anal cancer screening
107018|NCT02897427|Anal pap test|anal pap test
107019|NCT02897427|High-resolution anoscopy|high-resolution anoscopy
107020|NCT02897427|HRA|hra
107021|NCT02897427|Penile cancer screening|penile cancer screening
107022|NCT02897401|urinary N'Nitrosonornicotine|urinary n'nitrosonornicotine
107023|NCT02897401|nicotine|nicotine
107024|NCT02897401|electronic cigarette|electronic cigarette
107025|NCT02897401|nicotine remplacement treatment|nicotine remplacement treatment
107026|NCT02897362|ADHD|adhd
107027|NCT02897362|Sleep|sleep
107028|NCT02897362|Adolescents|adolescents
107029|NCT02897362|Neurocognition|neurocognition
107030|NCT02897362|Polysomnography|polysomnography
107031|NCT02897310|critically ill patients|critically ill patients
107032|NCT02897310|acute kidney injury|acute kidney injury
107033|NCT02897310|renal replacement therapy|renal replacement therapy
107034|NCT02897310|long term outcome|long term outcome
107035|NCT02897284|Mindfulness-based|mindfulness-based
107036|NCT02897284|Self-care|self-care
107037|NCT02897284|Health workers|health workers
107038|NCT02897284|Epigenetics|epigenetics
107039|NCT02897271|Eosinophilic Gastrointestinal Disorders|eosinophilic gastrointestinal disorders
107040|NCT02897258|Dialysis|dialysis
107041|NCT02897258|Thrombosis|thrombosis
107042|NCT02897258|Haemorrhage|haemorrhage
107043|NCT02897245|Myelogenous|myelogenous
107044|NCT02897245|Chronic|chronic
107045|NCT02897245|BCR-ABL Positive|bcr-abl positive
107046|NCT02897232|Human Papillomavirus Vaccine|human papillomavirus vaccine
107047|NCT02897232|HPV|hpv
107048|NCT02897232|Patient Acceptance|patient acceptance
107049|NCT02897232|Physician Comfort|physician comfort
107050|NCT02897232|Male Vaccination|male vaccination
107051|NCT02897232|HPV Associated Cancers|hpv associated cancers
107052|NCT02897219|SGLT2 inhibitor|sglt2 inhibitor
107053|NCT02897219|ASP1941|asp1941
107054|NCT02897219|type 1 diabetes mellitus|type 1 diabetes mellitus
107055|NCT02897206|Acute pancreatitis|acute pancreatitis
107056|NCT02897206|Antibiotic prophylaxis|antibiotic prophylaxis
107057|NCT02897206|Imipenem-cilastatin|imipenem-cilastatin
107058|NCT02897206|Infected pancreatic necrosis|infected pancreatic necrosis
107059|NCT02897206|Infection|infection
107060|NCT02897206|Organ failure|organ failure
107061|NCT02897180|tuberculosis|tuberculosis
107062|NCT02897180|latent tuberculosis infection|latent tuberculosis infection
107063|NCT02897180|Food supplement|food supplement
107064|NCT02897180|Mycobacterium manresensis|mycobacterium manresensis
107065|NCT02897180|Nyaditum resae|nyaditum resae
107066|NCT02897180|Efficacy trial|efficacy trial
107067|NCT02897167|Psychosis|psychosis
107068|NCT02897167|Antipsychotic Agents|antipsychotic agents
107069|NCT02897167|Immunology|immunology
107070|NCT02897167|Schizophrenia Spectrum and Other Psychotic Disorders|schizophrenia spectrum and other psychotic disorders
107072|NCT02897141|Health Management App|health management app
107073|NCT02897141|HIV symptoms|hiv symptoms
107074|NCT02897128|Sarcoma|sarcoma
107075|NCT02897128|Radiation|radiation
107076|NCT02897128|Wound healing|wound healing
107077|NCT02897115|Axial Spondyloarthritis|axial spondyloarthritis
107078|NCT02897115|Humira|humira
107079|NCT02897089|universal adhesive|universal adhesive
107080|NCT02897089|fissure sealants|fissure sealants
107081|NCT02897089|retention|retention
107082|NCT02897063|midodrine|midodrine
107083|NCT02897063|droxidopa|droxidopa
107084|NCT02897063|splanchnic circulation|splanchnic circulation
107085|NCT02897037|Bivalirudin|bivalirudin
107086|NCT02897037|Acute myocardial infarction|acute myocardial infarction
107087|NCT02897037|percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
107088|NCT02897024|Cerebral Palsy|cerebral palsy
107089|NCT02897024|Motor Impairments|motor impairments
107090|NCT02896985|Patient Reported Outcome 2 (PRO 2)|patient reported outcome 2 (pro 2)
107091|NCT02896985|C-Reactive Protein (CRP)|c-reactive protein (crp)
107092|NCT02896985|Adalimumab|adalimumab
107093|NCT02896985|Harvey Bradshaw Index (HBI)|harvey bradshaw index (hbi)
107094|NCT02896985|Therapeutic Drug Monitoring (TDM)|therapeutic drug monitoring (tdm)
107095|NCT02896985|Anti-Adalimumab Antibody (AAA)|anti-adalimumab antibody (aaa)
107096|NCT02896972|vitrectomy|vitrectomy
107097|NCT02896972|macular hole retinal detachment|macular hole retinal detachment
107098|NCT02896972|high myopia|high myopia
107099|NCT02896920|Hidradenitis Suppurativa (HS)|hidradenitis suppurativa (hs)
107100|NCT02896920|Humira®|humira®
107101|NCT02896920|Canada|canada
107102|NCT02896816|Parkinson's|parkinson's
107103|NCT02896803|Pancreatic Cancer|pancreatic cancer
107104|NCT02896803|Chemotherapy|chemotherapy
107105|NCT02896790|Cancer|cancer
107106|NCT02896790|Oral Therapy|oral therapy
107107|NCT02896790|Compliance|compliance
107108|NCT02896790|Anthropology|anthropology
107109|NCT02896790|Psychology|psychology
107110|NCT02896777|pH|ph
107111|NCT02896777|IVF|ivf
107112|NCT02896777|live birth rate|live birth rate
107113|NCT02896751|CPAP|cpap
107114|NCT02896751|Noninvasive Ventilation Mask|noninvasive ventilation mask
107115|NCT02896725|Venous leg ulcer|venous leg ulcer
107116|NCT02896725|Acellular skin substitutes|acellular skin substitutes
107117|NCT02896725|Keratin dressings|keratin dressings
107118|NCT02896699|Pre-exposure prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
107119|NCT02896699|diffusion of innovation|diffusion of innovation
107120|NCT02896699|men who have sex with men|men who have sex with men
107121|NCT02896699|LGBT|lgbt
107122|NCT02896699|African American|african american
107123|NCT02896699|Black|black
107124|NCT02896699|HIV|hiv
107125|NCT02896699|network analysis|network analysis
107126|NCT02896699|network intervention|network intervention
107127|NCT02896686|Ileostomy closure|ileostomy closure
107128|NCT02896686|Polypropylene Mesh|polypropylene mesh
107129|NCT02896686|Incisional hernia|incisional hernia
107130|NCT02896673|positive expiratory pressure (PEP)|positive expiratory pressure (pep)
107131|NCT02896673|Acute Respiratory Distress Syndrome (ARDS)|acute respiratory distress syndrome (ards)
107132|NCT02896673|electrical impedance tomography (EIT)|electrical impedance tomography (eit)
107133|NCT02896673|tidal volume (TV)|tidal volume (tv)
107134|NCT02896673|transpulmonary pressure (TPP)|transpulmonary pressure (tpp)
107135|NCT02896621|Sleep Apnea|sleep apnea
107136|NCT02896621|Hypertension|hypertension
107137|NCT02896621|Chlortalidone|chlortalidone
107138|NCT02896621|Diastolic function|diastolic function
107139|NCT02896569|resurfacing|resurfacing
107140|NCT02896569|ablation|ablation
107141|NCT02896556|image analysis|image analysis
107142|NCT02896543|dendritic cells|dendritic cells
107143|NCT02896543|P-selectin|p-selectin
107144|NCT02896504|Chemobrain|chemobrain
107145|NCT02896504|Chemotherapy|chemotherapy
107146|NCT02896504|Hormonal Therapy|hormonal therapy
107147|NCT02896504|Neuroimaging|neuroimaging
107148|NCT02896465|Children|children
107149|NCT02896465|Diarrhea|diarrhea
107150|NCT02896465|Human milk oligosaccharides|human milk oligosaccharides
107151|NCT02896439|Traumatic|traumatic
107152|NCT02896439|Acetabular|acetabular
107153|NCT02896426|Parent training|parent training
107154|NCT02896426|Preschoolers|preschoolers
107155|NCT02896426|Behavior problems|behavior problems
107156|NCT02896426|Oppositional Defiant Disorder|oppositional defiant disorder
107157|NCT02896426|ODD|odd
107158|NCT02896426|Conduct Disorder|conduct disorder
107159|NCT02896426|CD|cd
107160|NCT02896426|Children|children
107161|NCT02896426|Parenting|parenting
107162|NCT02896426|Collaborative Problem Solving|collaborative problem solving
107163|NCT02896426|CPS|cps
107164|NCT02896426|Disruptive behavior|disruptive behavior
107165|NCT02896348|Hemiparesis|hemiparesis
107166|NCT02896348|Stroke|stroke
107167|NCT02896348|Rehabilitation|rehabilitation
107168|NCT02896348|Home-based|home-based
107169|NCT02896335|Recurrent Brain metastases|recurrent brain metastases
107170|NCT02896283|wound healing|wound healing
107171|NCT02896283|low-level laser therapy|low-level laser therapy
107172|NCT02896283|gingival recession|gingival recession
107173|NCT02896270|idiopathic podocytopathies|idiopathic podocytopathies
107174|NCT02896270|Neprology|neprology
107175|NCT02896257|Quality Improvement|quality improvement
107176|NCT02896257|Quality Enhancement Research Initiatives|quality enhancement research initiatives
107177|NCT02896257|QuERI|queri
107178|NCT02896257|Interventional|interventional
107179|NCT02896257|Multicenter|multicenter
107180|NCT02896257|Inhaled corticosteroids|inhaled corticosteroids
107181|NCT02896257|Pneumonia|pneumonia
107182|NCT02896257|Safety|safety
107183|NCT02896257|De-implementation|de-implementation
107184|NCT02896257|Respiratory Tract Diseases|respiratory tract diseases
107185|NCT02896257|Lung Diseases|lung diseases
107186|NCT02896257|Lung Diseases, Obstructive|lung diseases, obstructive
107187|NCT02896257|Pulmonary Diseases, Chronic Obstructive COPD|pulmonary diseases, chronic obstructive copd
107188|NCT02896244|Clostridium difficile|clostridium difficile
107189|NCT02896244|Clostridium difficile infection|clostridium difficile infection
107190|NCT02896244|antibiotics|antibiotics
107191|NCT02896244|antibiotics associated diarrhea|antibiotics associated diarrhea
107192|NCT02896244|microbiome|microbiome
107193|NCT02896244|microbiota|microbiota
107194|NCT02896218|Vancomycin|vancomycin
107195|NCT02896218|Critically Ill|critically ill
107196|NCT02896218|Pharmacist|pharmacist
107197|NCT02896218|Population Pharmacokinetic|population pharmacokinetic
107198|NCT02896218|Bayesian Methods|bayesian methods
107199|NCT02896192|POMC deficiency obesity|pomc deficiency obesity
107200|NCT02896192|PCSK1 deficiency obesity|pcsk1 deficiency obesity
107201|NCT02896179|Multiple sclerosis|multiple sclerosis
107202|NCT02896179|Gait rehabilitation|gait rehabilitation
107203|NCT02896179|Quality of life|quality of life
107204|NCT02896179|Virtual reality|virtual reality
107205|NCT02896179|Cognitive deficit|cognitive deficit
107206|NCT02896179|Robot assisted gait training|robot assisted gait training
107207|NCT02896166|nsclc and stage I and microwave ablation|nsclc and stage i and microwave ablation
107208|NCT02896140|Type 2 diabetes|type 2 diabetes
107209|NCT02896140|Obesity|obesity
107210|NCT02896140|Nutrition|nutrition
107211|NCT02896140|Dairy|dairy
107212|NCT02896127|Ankylosing Spondyloarthritis|ankylosing spondyloarthritis
107213|NCT02896127|Axial spondyloarthritis|axial spondyloarthritis
107214|NCT02896101|Mild to moderate|mild to moderate
107215|NCT02896075|delayed onset muscle soreness|delayed onset muscle soreness
107216|NCT02896075|laughter|laughter
107217|NCT02896049|neoplasms|neoplasms
107218|NCT02896049|hyperthermia|hyperthermia
107219|NCT02896036|Laparoscopic Entry|laparoscopic entry
107220|NCT02896036|Veress Needle|veress needle
107221|NCT02896036|Intraperitoneal insufflation|intraperitoneal insufflation
107222|NCT02896036|Time|time
107223|NCT02896036|Complications|complications
107224|NCT02896023|predictors|predictors
107225|NCT02896023|ovarian reserve|ovarian reserve
107226|NCT02896023|infertile women|infertile women
107227|NCT02896010|Mobile Health|mobile health
107228|NCT02895997|mental fatigue|mental fatigue
107229|NCT02895997|critical care|critical care
107230|NCT02895984|Social network analysis|social network analysis
107231|NCT02895984|Brief Motivational Interviewing|brief motivational interviewing
107232|NCT02895984|College Students|college students
107233|NCT02895971|Venous Thromboembolism|venous thromboembolism
107234|NCT02895971|professional Practices|professional practices
107235|NCT02895906|22q11.2 DS|22q11.2 ds
107236|NCT02895880|Communication Tool|communication tool
107237|NCT02895880|Cancer Survivors|cancer survivors
107238|NCT02895880|Increase Statin|increase statin
107239|NCT02895880|16-1128|16-1128
107240|NCT02895854|Low risk prostate cancer|low risk prostate cancer
107241|NCT02895854|Intermediate risk prostate cancer|intermediate risk prostate cancer
107242|NCT02895854|Low dose-rate brachytherapy|low dose-rate brachytherapy
107243|NCT02895854|Hypofractionated|hypofractionated
107244|NCT02895854|Robotic external beam radiation|robotic external beam radiation
107245|NCT02895854|Quality of life|quality of life
107246|NCT02895841|oncology|oncology
107247|NCT02895841|bone marrow transplant|bone marrow transplant
107248|NCT02895841|sickle cell disease|sickle cell disease
107249|NCT02895802|down syndrome|down syndrome
107250|NCT02895789|spinal muscular atrophy|spinal muscular atrophy
107251|NCT02895789|oxidative capacity|oxidative capacity
107252|NCT02895789|exercise tolerance|exercise tolerance
107253|NCT02895789|mitochondrial myopathy|mitochondrial myopathy
107255|NCT02895789|six minute walk test|six minute walk test
107256|NCT02895789|neuromuscular disease|neuromuscular disease
107257|NCT02895789|ambulation|ambulation
107258|NCT02895789|exercise|exercise
107259|NCT02895789|mitochondria|mitochondria
107260|NCT02895789|cycle ergometry|cycle ergometry
107261|NCT02895789|near infrared spectroscopy|near infrared spectroscopy
107262|NCT02895763|QUALITY OF LIFE|quality of life
107263|NCT02895763|NEUROMUSCULAR DISEASES|neuromuscular diseases
107264|NCT02895750|diabetes type 2|diabetes type 2
107265|NCT02895750|Metformin|metformin
107266|NCT02895750|chronic kidney disease|chronic kidney disease
107267|NCT02895750|CKD|ckd
107268|NCT02895737|aortic stenosis, transcatheter aortic valve replacement, stroke, ischemic infarction, cerebral embolic protection device|aortic stenosis, transcatheter aortic valve replacement, stroke, ischemic infarction, cerebral embolic protection device
107269|NCT02895724|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
107270|NCT02895724|secondary lymphedema|secondary lymphedema
107271|NCT02895698|Cupping|cupping
107272|NCT02895698|Dry cupping|dry cupping
107273|NCT02895698|Myofascial trigger points|myofascial trigger points
107274|NCT02895685|Simulation|simulation
107275|NCT02895685|Self-regulated training|self-regulated training
107276|NCT02895685|Education|education
107277|NCT02895685|Open surgery|open surgery
107278|NCT02895685|Dyad training|dyad training
107279|NCT02895659|fluid management|fluid management
107280|NCT02895659|critical illness|critical illness
107281|NCT02895659|hemodynamics|hemodynamics
107282|NCT02895659|buffered infusates|buffered infusates
107283|NCT02895633|MR imaging|mr imaging
107284|NCT02895633|Diffusion weighted imaging|diffusion weighted imaging
107285|NCT02895633|MR proton spectroscopy|mr proton spectroscopy
107286|NCT02895633|CT perfusion|ct perfusion
107287|NCT02895633|Contrast enhanced ultrasound|contrast enhanced ultrasound
107288|NCT02895568|Antimalarial drug|antimalarial drug
107289|NCT02895568|Resistance|resistance
107290|NCT02895568|Republic of Chard|republic of chard
107291|NCT02895555|ODI|odi
107292|NCT02895503|Stage IA Non-Small Cell Lung Carcinoma|stage ia non-small cell lung carcinoma
107293|NCT02895503|Stage IB Non-Small Cell Lung Carcinoma|stage ib non-small cell lung carcinoma
107294|NCT02895503|Stage IIA Non-Small Cell Lung Carcinoma|stage iia non-small cell lung carcinoma
107295|NCT02895503|Stage IIB Non-Small Cell Lung Carcinoma|stage iib non-small cell lung carcinoma
107296|NCT02895503|Stage IIIA Non-Small Cell Lung Cancer|stage iiia non-small cell lung cancer
107297|NCT02895503|Stage IIIB Non-Small Cell Lung Cancer|stage iiib non-small cell lung cancer
107298|NCT02895503|Stage IV Non-Small Cell Lung Cancer|stage iv non-small cell lung cancer
107299|NCT02895451|Exercise-based cardiac rehabilitation|exercise-based cardiac rehabilitation
107300|NCT02895451|Physical capacity|physical capacity
107301|NCT02895451|Adherence|adherence
107302|NCT02895451|Behavioral medicine|behavioral medicine
107303|NCT02895438|Gluten-Sensitive|gluten-sensitive
107304|NCT02895438|Diet, Gluten-Free|diet, gluten-free
107305|NCT02895438|Irritable Bowel Syndrome|irritable bowel syndrome
107306|NCT02895438|non Coeliac Gluten sensitivity|non coeliac gluten sensitivity
107307|NCT02895438|children|children
107308|NCT02895425|Renal Transplant|renal transplant
107309|NCT02895386|Hypertension|hypertension
107310|NCT02895386|High Blood Pressure|high blood pressure
107311|NCT02895386|Systolic Blood Pressure|systolic blood pressure
107312|NCT02895386|Uncontrolled Hypertension|uncontrolled hypertension
107313|NCT02895386|Essential Hypertension|essential hypertension
107314|NCT02895386|Resistant Hypertension|resistant hypertension
107315|NCT02895386|Vascular Disease|vascular disease
107316|NCT02895373|platelet inhibition|platelet inhibition
107317|NCT02895373|alprostadil|alprostadil
107318|NCT02895373|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
107319|NCT02895373|bleeding|bleeding
107320|NCT02895373|thromboembolic|thromboembolic
107321|NCT02895334|CHD|chd
107322|NCT02895334|Congenital Heart Disease|congenital heart disease
107323|NCT02895321|nano-hydroxyapatite|nano-hydroxyapatite
107324|NCT02895321|potassium nitrate|potassium nitrate
107325|NCT02895308|compliance|compliance
107326|NCT02895295|Medicare Part D|medicare part d
107327|NCT02895295|decision support|decision support
107328|NCT02895295|prescription drugs|prescription drugs
107329|NCT02895295|expert recommendation|expert recommendation
107330|NCT02895295|health insurance choice|health insurance choice
107331|NCT02895282|Obesity|obesity
107332|NCT02895282|Chronobiology|chronobiology
107333|NCT02895282|Circadian|circadian
107334|NCT02895269|Complementary Alternative Providers|complementary alternative providers
107335|NCT02895269|Collaborative Shared Care|collaborative shared care
107336|NCT02895269|Primary Health Care Providers|primary health care providers
107337|NCT02895269|Psychosis|psychosis
107338|NCT02895230|Androgen-deprivation therapy|androgen-deprivation therapy
107339|NCT02895230|Prostate cancer|prostate cancer
107340|NCT02895230|Nationwide population-based cohort|nationwide population-based cohort
107341|NCT02895230|Myocardial infarction|myocardial infarction
107342|NCT02895230|Ischemic stroke|ischemic stroke
107343|NCT02895217|Energy expenditure|energy expenditure
107344|NCT02895217|Food intake|food intake
107345|NCT02895217|Women|women
107346|NCT02895217|aquacycling|aquacycling
107347|NCT02895204|Fermented Maillard reacted whey protein|fermented maillard reacted whey protein
107348|NCT02895204|Natural killer cell activity|natural killer cell activity
107349|NCT02895204|Immune function|immune function
107350|NCT02895204|Pre-albumin|pre-albumin
107351|NCT02895204|Interleukin-12|interleukin-12
107352|NCT02895178|Breast cancer|breast cancer
107353|NCT02895178|Survivors|survivors
107354|NCT02895178|Exercise|exercise
107355|NCT02895165|breast neoplasms|breast neoplasms
107356|NCT02895165|fertility preservation|fertility preservation
107357|NCT02895165|pregnancy|pregnancy
107358|NCT02895152|COPD|copd
107359|NCT02895152|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
107360|NCT02895152|Pulmonary Rehabilitation|pulmonary rehabilitation
107361|NCT02895152|Activity Monitors|activity monitors
107362|NCT02895152|Fitbit|fitbit
107363|NCT02895152|Fitness Tracker|fitness tracker
107364|NCT02895139|Additive Manufacture|additive manufacture
107365|NCT02895139|Orthotic Insole|orthotic insole
107366|NCT02895126|vulnerable family|vulnerable family
107367|NCT02895113|Aspirin|aspirin
107368|NCT02895113|Diabetes|diabetes
107369|NCT02895113|Renal function|renal function
107370|NCT02895113|Thromboxane|thromboxane
107371|NCT02895100|ulcerative colitis|ulcerative colitis
107372|NCT02895100|inflammatory bowel disease|inflammatory bowel disease
107373|NCT02895100|PROPEL|propel
107374|NCT02895100|Propel Study|propel study
107375|NCT02895087|diurnal variation|diurnal variation
107376|NCT02895087|stress|stress
107377|NCT02895074|femtosecond laser-assisted cataract surgery (FLACS)|femtosecond laser-assisted cataract surgery (flacs)
107378|NCT02895074|subfoveal choroidal thickness (SFCT)|subfoveal choroidal thickness (sfct)
107379|NCT02895074|conventional phacoemulsification surgery (CPS)|conventional phacoemulsification surgery (cps)
107380|NCT02895009|Coronary Disease|coronary disease
107381|NCT02895009|Radial artery occlusion|radial artery occlusion
107482|NCT02894372|Oral spray|oral spray
107382|NCT02895009|transradial coronary intervention|transradial coronary intervention
107383|NCT02894996|pediatric|pediatric
107384|NCT02894996|anesthesia|anesthesia
107385|NCT02894996|fluid responsiveness|fluid responsiveness
107386|NCT02894996|hemodynamic|hemodynamic
107387|NCT02894983|wrist fracture|wrist fracture
107388|NCT02894983|colles fracture|colles fracture
107389|NCT02894983|non-operative|non-operative
107390|NCT02894983|rehabilitation|rehabilitation
107391|NCT02894944|Pancreatic cancer|pancreatic cancer
107392|NCT02894944|Adenovirus|adenovirus
107393|NCT02894944|Gene therapy|gene therapy
107394|NCT02894931|macrophage atherogenicity|macrophage atherogenicity
107395|NCT02894931|dietary interventions|dietary interventions
107396|NCT02894931|sugars|sugars
107397|NCT02894931|amino acids|amino acids
107398|NCT02894931|artificial sweeteners|artificial sweeteners
107399|NCT02894931|atherosclerosis|atherosclerosis
107400|NCT02894892|Electron Microscopy|electron microscopy
107401|NCT02894892|Helicobacter pylori|helicobacter pylori
107402|NCT02894892|Bismuth|bismuth
107403|NCT02894879|Postoperative pulmonary complications|postoperative pulmonary complications
107404|NCT02894866|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
107405|NCT02894866|hyperbaric oxygen therapy|hyperbaric oxygen therapy
107406|NCT02894840|GPO Tri Fluvac Vaccine|gpo tri fluvac vaccine
107407|NCT02894840|Tri Fluvac Vaccine|tri fluvac vaccine
107408|NCT02894814|Self administration|self administration
107409|NCT02894814|Medication|medication
107410|NCT02894814|Inpatient|inpatient
107411|NCT02894814|Self-care|self-care
107412|NCT02894814|Self-management|self-management
107413|NCT02894814|Medical patients|medical patients
107414|NCT02894749|hybrid rooms|hybrid rooms
107415|NCT02894749|cone-beam computed tomography|cone-beam computed tomography
107416|NCT02894723|Hypertension,|hypertension,
107417|NCT02894723|Nitric Oxide|nitric oxide
107418|NCT02894723|L-Arginine|l-arginine
107419|NCT02894723|Arterial Stiffness|arterial stiffness
107420|NCT02894723|Ambulatory blood pressure measurement|ambulatory blood pressure measurement
107421|NCT02894710|postoperative pain|postoperative pain
107422|NCT02894710|intravenous lidocaine|intravenous lidocaine
107423|NCT02894710|chronic post-surgical pain|chronic post-surgical pain
107424|NCT02894710|remifentanil|remifentanil
107425|NCT02894710|patient controlled analgesia|patient controlled analgesia
107426|NCT02894710|morphine consumption|morphine consumption
107427|NCT02894710|ENT surgery|ent surgery
107428|NCT02894632|MRI|mri
107429|NCT02894632|Motion|motion
107430|NCT02894632|Respiratory movement|respiratory movement
107431|NCT02894632|Artifacts correction|artifacts correction
107432|NCT02894619|urinary incontinence|urinary incontinence
107433|NCT02894619|anal incontinence|anal incontinence
107434|NCT02894619|sexuality|sexuality
107435|NCT02894619|quality of life|quality of life
107436|NCT02894606|Kidney Transplant|kidney transplant
107437|NCT02894606|Immunology|immunology
107438|NCT02894593|Antiplaque agents|antiplaque agents
107439|NCT02894593|chemical plaque control|chemical plaque control
107440|NCT02894593|oral hygiene|oral hygiene
107441|NCT02894593|essential oils|essential oils
107442|NCT02894593|alcohol|alcohol
107443|NCT02894593|mouthwash|mouthwash
107444|NCT02894541|Dyslipidemia|dyslipidemia
107445|NCT02894541|CKD-519|ckd-519
107446|NCT02894541|CETP inhibitor|cetp inhibitor
107447|NCT02894541|Food Drug Interaction|food drug interaction
107448|NCT02894528|Alveolar ridge|alveolar ridge
107449|NCT02894528|guided bone regeneration|guided bone regeneration
107450|NCT02894528|bone grafts|bone grafts
107451|NCT02894502|Self-care|self-care
107452|NCT02894502|Motivational interviewing|motivational interviewing
107453|NCT02894502|Heart failure|heart failure
107454|NCT02894502|Caregivers|caregivers
107455|NCT02894476|satisfaction with care|satisfaction with care
107456|NCT02894476|outpatient care|outpatient care
107457|NCT02894476|self-reported health status|self-reported health status
107458|NCT02894476|alcohol dependence|alcohol dependence
107459|NCT02894476|opioid dependence|opioid dependence
107460|NCT02894463|dental care|dental care
107461|NCT02894463|emeno|emeno
107462|NCT02894463|abuse|abuse
107463|NCT02894450|Atrial fibrillation|atrial fibrillation
107464|NCT02894450|oral anticoagulant|oral anticoagulant
107465|NCT02894450|bioassay|bioassay
107466|NCT02894450|elderly subject|elderly subject
107467|NCT02894437|prevention|prevention
107468|NCT02894437|organization|organization
107469|NCT02894437|pressure ulcers|pressure ulcers
107470|NCT02894424|Inner limiting membrane|inner limiting membrane
107471|NCT02894424|Microperimetry|microperimetry
107472|NCT02894424|surgical's dye|surgical's dye
107473|NCT02894411|MRI|mri
107474|NCT02894411|Excyclotorsion|excyclotorsion
107475|NCT02894398|HR+|hr+
107476|NCT02894398|HER2-|her2-
107477|NCT02894398|Locally advanced (inoperable or metastatic) Breast Cancer|locally advanced (inoperable or metastatic) breast cancer
107478|NCT02894398|Palbociclib|palbociclib
107479|NCT02894398|Aromatase inhibitor or fulvestrant|aromatase inhibitor or fulvestrant
107480|NCT02894398|Pre-/perimenopausal receiving LHRH agonist / ovarian ablation|pre-/perimenopausal receiving lhrh agonist / ovarian ablation
107481|NCT02894398|Postmenopausal|postmenopausal
107483|NCT02894372|Topical sprays|topical sprays
107484|NCT02894372|Faringomoss|faringomoss
107485|NCT02894372|Local phytotherapy|local phytotherapy
107486|NCT02894359|Cervical spine|cervical spine
107487|NCT02894359|Musculoskeletal imagery|musculoskeletal imagery
107488|NCT02894359|computer modelling of cervical spine|computer modelling of cervical spine
107489|NCT02894359|ConeBeam.|conebeam.
107490|NCT02894346|Motivation|motivation
107491|NCT02894346|Teachers|teachers
107492|NCT02894346|Physical activity|physical activity
107493|NCT02894346|School|school
107494|NCT02894333|Parkinson's disease|parkinson's disease
107495|NCT02894333|Action-effect prediction|action-effect prediction
107496|NCT02894333|Sensory attenuation|sensory attenuation
107497|NCT02894333|Voluntary action|voluntary action
107498|NCT02894320|Parkinson's disease|parkinson's disease
107499|NCT02894320|Voluntary action|voluntary action
107500|NCT02894320|Action-effect preactivation|action-effect preactivation
107501|NCT02894320|Action-effect prediction|action-effect prediction
107502|NCT02894307|Mechanical prosthesis|mechanical prosthesis
107503|NCT02894307|Rivaroxaban|rivaroxaban
107504|NCT02894294|malaria|malaria
107505|NCT02894294|chemoprevention|chemoprevention
107506|NCT02894294|season|season
107507|NCT02894294|anemia|anemia
107508|NCT02894294|impact|impact
107509|NCT02894294|coverage|coverage
107510|NCT02894294|children|children
107511|NCT02894281|Pupillary light reflex|pupillary light reflex
107512|NCT02894281|Multiple sclerosis|multiple sclerosis
107513|NCT02894190|Non Invasive Ventilation (NIV)|non invasive ventilation (niv)
107514|NCT02894190|Adherence|adherence
107515|NCT02894190|Beliefs|beliefs
107516|NCT02894190|Development|development
107517|NCT02894190|Validation|validation
107518|NCT02894177|E02.880.820.950|e02.880.820.950
107519|NCT02894164|Cystatin C|cystatin c
107520|NCT02894164|Creatinine|creatinine
107521|NCT02894164|Glomerular Filtration Rate|glomerular filtration rate
107522|NCT02894125|Chronic Low Back Pain|chronic low back pain
107523|NCT02894125|Old subject|old subject
107524|NCT02894125|SPA Therapy|spa therapy
107525|NCT02894125|Pain|pain
107526|NCT02894125|Function|function
107527|NCT02894125|Expectations|expectations
107528|NCT02894125|Fears|fears
107529|NCT02894112|endothelial dependent vasodilation|endothelial dependent vasodilation
107530|NCT02894112|blood flow|blood flow
107531|NCT02894112|blood glucose|blood glucose
107532|NCT02894112|triglycerides|triglycerides
107533|NCT02894112|non-fat milk|non-fat milk
107534|NCT02894112|dairy|dairy
107535|NCT02894099|Aged|aged
107536|NCT02894099|Sedentary Behaviour|sedentary behaviour
107537|NCT02894099|Blood Glucose|blood glucose
107538|NCT02894099|Insulin|insulin
107539|NCT02894099|Inflammatory markers|inflammatory markers
107540|NCT02894086|acute appendicitis|acute appendicitis
107541|NCT02894086|ambulatory appendicectomy|ambulatory appendicectomy
107542|NCT02894073|obese patients|obese patients
107543|NCT02894073|peripheral venous catheter|peripheral venous catheter
107544|NCT02894060|Cardiovascular events|cardiovascular events
107545|NCT02894047|calcium-sensitive receptor|calcium-sensitive receptor
107546|NCT02894034|optic nerve sheath|optic nerve sheath
107547|NCT02894034|meningeal hemorrhage|meningeal hemorrhage
107548|NCT02894034|early phase|early phase
107549|NCT02894034|prognostic|prognostic
107550|NCT02894021|padding|padding
107551|NCT02894021|lymphoceles|lymphoceles
107552|NCT02894021|prevention|prevention
107553|NCT02893995|PAH|pah
107554|NCT02893995|Subcutaneous Treprostinil|subcutaneous treprostinil
107555|NCT02893995|Remodulin|remodulin
107556|NCT02893995|6 Minute Walk Test|6 minute walk test
107557|NCT02893969|Physical Activity|physical activity
107558|NCT02893969|Rest|rest
107559|NCT02893956|Echocardiography|echocardiography
107560|NCT02893956|postural support|postural support
107561|NCT02893956|preterm neonate|preterm neonate
107562|NCT02893904|Propofol|propofol
107563|NCT02893904|Sevoflurane|sevoflurane
107564|NCT02893904|Bispectral Index|bispectral index
107565|NCT02893904|Children|children
107566|NCT02893904|Electroencephalographic signs|electroencephalographic signs
107567|NCT02893891|Obesity|obesity
107568|NCT02893891|Bariatric medicine|bariatric medicine
107569|NCT02893891|Sleeve gastric resection|sleeve gastric resection
107570|NCT02893891|Gastric plication|gastric plication
107571|NCT02893891|Intragastric ballon|intragastric ballon
107572|NCT02893891|Body composition|body composition
107573|NCT02893891|Adipokines|adipokines
107574|NCT02893891|Ghrelin|ghrelin
107575|NCT02893891|Bone mineral density|bone mineral density
107576|NCT02893891|Quality of life|quality of life
107577|NCT02893878|Seasonal influenza vaccines|seasonal influenza vaccines
107578|NCT02893878|Passive Enhanced Safety surveillance|passive enhanced safety surveillance
107579|NCT02893878|England|england
107580|NCT02893878|Pilot study|pilot study
107581|NCT02893865|Apnea syndrome|apnea syndrome
107582|NCT02893865|Coronary artery disease|coronary artery disease
107583|NCT02893865|Oxidative stress|oxidative stress
107584|NCT02893865|Continuous positive airway pressure|continuous positive airway pressure
107585|NCT02893865|Endothelial dysfunction|endothelial dysfunction
107586|NCT02893839|Allergy|allergy
107587|NCT02893839|cross-reactivity|cross-reactivity
107588|NCT02893839|oral allergy syndrome|oral allergy syndrome
107589|NCT02893839|potato|potato
107590|NCT02893839|sensitization|sensitization
107591|NCT02893826|Aneurysm|aneurysm
107592|NCT02893826|Ruptured|ruptured
107593|NCT02893826|nimodipine|nimodipine
107594|NCT02893826|subarachnoid hemorrhage|subarachnoid hemorrhage
107595|NCT02893800|assistive technology|assistive technology
107596|NCT02893800|dementia care|dementia care
107597|NCT02893800|tracking technology|tracking technology
107598|NCT02893800|locating systems|locating systems
107599|NCT02893800|user experience|user experience
107600|NCT02893787|Speckle Tracking|speckle tracking
107601|NCT02893787|Anthracyclines|anthracyclines
107602|NCT02893787|Chilhood cancers|chilhood cancers
107603|NCT02893787|Myocardial function|myocardial function
107604|NCT02893787|Echocardiography|echocardiography
107605|NCT02893761|breast cancer|breast cancer
107606|NCT02893761|survival|survival
107607|NCT02893761|prognosis factors|prognosis factors
107608|NCT02893748|colon|colon
107609|NCT02893748|polyps|polyps
107610|NCT02893748|cancer|cancer
107611|NCT02893748|screening|screening
107612|NCT02893735|Clinical Trial|clinical trial
107613|NCT02893735|Composite resin|composite resin
107614|NCT02893722|ivf ,atosiban,repeated implantation failure,RCT|ivf ,atosiban,repeated implantation failure,rct
107615|NCT02893683|Paris Visual Learning Test|paris visual learning test
107616|NCT02893683|visual memory|visual memory
107617|NCT02893683|criterion validity|criterion validity
107618|NCT02893657|MELD score|meld score
107619|NCT02893657|hemodynamics|hemodynamics
107620|NCT02893657|liver abnormalities|liver abnormalities
107621|NCT02893566|overweight|overweight
107622|NCT02893566|body mass index|body mass index
107623|NCT02893566|university students|university students
107624|NCT02893566|physical activity|physical activity
107625|NCT02893566|sedentary behavior|sedentary behavior
107626|NCT02893566|body composition|body composition
107627|NCT02893566|Mi Band|mi band
107628|NCT02893514|Drug Use|drug use
107629|NCT02893488|dolutegravir|dolutegravir
107630|NCT02893488|abacavir|abacavir
107631|NCT02893488|relative bioavailability|relative bioavailability
107632|NCT02893488|palatability|palatability
107633|NCT02893488|GSK2619619|gsk2619619
107634|NCT02893488|palatability questionnaire|palatability questionnaire
107635|NCT02893488|lamivudine|lamivudine
107636|NCT02893488|pediatric|pediatric
107637|NCT02893488|calcium|calcium
107638|NCT02893488|dispersible tablet|dispersible tablet
107639|NCT02893462|data warehousing|data warehousing
107640|NCT02893462|data aggregation|data aggregation
107641|NCT02893462|data mining|data mining
107642|NCT02893449|Parkinson|parkinson
107643|NCT02893449|SAS-SR|sas-sr
107644|NCT02893449|Social adaptation|social adaptation
107645|NCT02893449|Patients suffering from Parkinson's disease|patients suffering from parkinson's disease
107646|NCT02893423|Ropivacaine|ropivacaine
107647|NCT02893423|C-Section Analgesia|c-section analgesia
107648|NCT02893423|Tap Block|tap block
107649|NCT02893358|Allisartan Isoproxil|allisartan isoproxil
107650|NCT02893358|left ventricular hypertrophy|left ventricular hypertrophy
107651|NCT02893358|large arterial stiffness|large arterial stiffness
107652|NCT02893358|microalbuminuria|microalbuminuria
107653|NCT02893345|Self Care (Rehabilitation)|self care (rehabilitation)
107654|NCT02893345|Community Participation|community participation
107655|NCT02893345|Patient-Centered Outcomes Research|patient-centered outcomes research
107656|NCT02893345|Informatics, Clinical|informatics, clinical
107657|NCT02893319|Infant Feeding|infant feeding
107658|NCT02893319|Infant Growth|infant growth
107659|NCT02893306|Type1 Diabetes Mellitus|type1 diabetes mellitus
107660|NCT02893306|Multipotent stromal cell|multipotent stromal cell
107661|NCT02893306|Mesenchymal stem cell|mesenchymal stem cell
107662|NCT02893306|Insulin|insulin
107663|NCT02893306|Pancreatic reserve|pancreatic reserve
107664|NCT02893306|Disease progression|disease progression
107665|NCT02893267|Stroke|stroke
107666|NCT02893267|Shoulder Pain|shoulder pain
107667|NCT02893267|Electrical stimulation|electrical stimulation
107668|NCT02893267|Neuromuscular stimulation|neuromuscular stimulation
107669|NCT02893267|Intramuscular stimulation|intramuscular stimulation
107670|NCT02893267|Physical Therapy|physical therapy
107671|NCT02893254|ankylosing spondylitis, tumor necrosis factor-α inhibitors|ankylosing spondylitis, tumor necrosis factor-α inhibitors
107672|NCT02893228|forced expiratory volume in 1 second|forced expiratory volume in 1 second
107673|NCT02893228|forced vital capacity|forced vital capacity
107674|NCT02893228|peak expiratory flow rate|peak expiratory flow rate
107675|NCT02893228|interscalene block|interscalene block
107676|NCT02893228|diaphragmatic paresis|diaphragmatic paresis
107677|NCT02893202|PTSD|ptsd
107678|NCT02893202|Equine assisted activities|equine assisted activities
107679|NCT02893202|quality of life|quality of life
107680|NCT02893189|CD19+|cd19+
107681|NCT02893189|allogeneic transplant|allogeneic transplant
107682|NCT02893189|relapse|relapse
107683|NCT02893176|Lung Transplant|lung transplant
107684|NCT02893176|Macitentan|macitentan
107685|NCT02893176|CLAD|clad
107686|NCT02893176|BOS|bos
107687|NCT02893176|bronchiolitis obliterans|bronchiolitis obliterans
107688|NCT02893176|chronic lung allograft dysfunction|chronic lung allograft dysfunction
107689|NCT02893176|Organ Rejection|organ rejection
107690|NCT02893163|Metabolic Syndrome|metabolic syndrome
107691|NCT02893163|Cancer Risk|cancer risk
107692|NCT02893163|Lifestyle Interventions|lifestyle interventions
107693|NCT02893163|Primary Care|primary care
107694|NCT02893163|Behavioural Change|behavioural change
107695|NCT02893150|Mindful Eating|mindful eating
107696|NCT02893150|Overweight|overweight
107697|NCT02893150|Primary Care|primary care
107698|NCT02893150|Randomized Clinical Trial|randomized clinical trial
107699|NCT02893137|Tumour treating fields|tumour treating fields
107701|NCT02893137|Craniectomy|craniectomy
107702|NCT02893137|TTFields|ttfields
107703|NCT02893124|chronic hepatitis B|chronic hepatitis b
107704|NCT02893111|neuromyelitis optica spectrum disorders|neuromyelitis optica spectrum disorders
107705|NCT02893111|Bortezomib|bortezomib
107706|NCT02893111|Velcade|velcade
107707|NCT02893111|Proteasome inhibitor|proteasome inhibitor
107708|NCT02893072|Diabetes, Gestational|diabetes, gestational
107709|NCT02893072|Nutrition Therapy|nutrition therapy
107710|NCT02893046|care pathway|care pathway
107711|NCT02893046|hospital- private network|hospital- private network
107712|NCT02893046|early consultation|early consultation
107713|NCT02893033|Dysphagia|dysphagia
107714|NCT02893033|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
107715|NCT02893033|Stroke|stroke
107716|NCT02893020|Emotional experience and burnout in physicians|emotional experience and burnout in physicians
107717|NCT02892994|therapeutic ultrasound|therapeutic ultrasound
107718|NCT02892968|Regional Anesthesia Ultrasound guided|regional anesthesia ultrasound guided
107719|NCT02892968|Emergency Department|emergency department
107720|NCT02892968|Knowledge to Practice Intervention|knowledge to practice intervention
107721|NCT02892955|Heart Failure|heart failure
107722|NCT02892955|LVAS|lvas
107723|NCT02892955|Ventricular Dysfunction|ventricular dysfunction
107724|NCT02892955|Cardiomyopathy|cardiomyopathy
107725|NCT02892955|Heart Disease|heart disease
107726|NCT02892955|Cardiovascular Disease|cardiovascular disease
107727|NCT02892955|Heart-assist devices|heart-assist devices
107728|NCT02892955|Thoratec Corporation|thoratec corporation
107729|NCT02892942|Controlled ovarian hyperstimulation|controlled ovarian hyperstimulation
107730|NCT02892942|Estradiol|estradiol
107731|NCT02892942|Embryo implantation|embryo implantation
107732|NCT02892942|Endometrial receptivity|endometrial receptivity
107733|NCT02892942|Fertility preservation|fertility preservation
107734|NCT02892929|Motivational Interviewing|motivational interviewing
107735|NCT02892929|Hypertension|hypertension
107736|NCT02892929|Nursing|nursing
107737|NCT02892929|Randomized Controlled Trial|randomized controlled trial
107738|NCT02892929|Life Style|life style
107739|NCT02892916|Delirium|delirium
107740|NCT02892916|Ketamine|ketamine
107741|NCT02892916|Elective orthopaedic surgery|elective orthopaedic surgery
107742|NCT02892903|Fractional flow reserve (FFR)|fractional flow reserve (ffr)
107743|NCT02892903|Pressure wire (PW)|pressure wire (pw)
107744|NCT02892903|Coronary angiography|coronary angiography
107745|NCT02892877|Complete Hydatidiform mole|complete hydatidiform mole
107746|NCT02892877|Partial Hydatidiform mole|partial hydatidiform mole
107747|NCT02892877|Invasive mole|invasive mole
107748|NCT02892877|Choriocarcinoma|choriocarcinoma
107749|NCT02892877|Post-molar neoplasia|post-molar neoplasia
107750|NCT02892877|Placental Site Trophoblastic Tumor (PSTT)|placental site trophoblastic tumor (pstt)
107751|NCT02892877|Epithelioid Trophoblastic Tumor (ETT)|epithelioid trophoblastic tumor (ett)
107752|NCT02892877|hCG follow-up|hcg follow-up
107753|NCT02892864|Bell's Palsy|bell's palsy
107754|NCT02892864|Peripheral facial palsy|peripheral facial palsy
107755|NCT02892851|STN-DBS|stn-dbs
107756|NCT02892851|Craving|craving
107757|NCT02892851|Cocaine addiction|cocaine addiction
107758|NCT02892838|mobile bearing knee prosthesis|mobile bearing knee prosthesis
107759|NCT02892825|Music|music
107760|NCT02892825|cataract surgery|cataract surgery
107761|NCT02892825|topical anaesthesia|topical anaesthesia
107762|NCT02892825|anxiety|anxiety
107763|NCT02892825|hypertension|hypertension
107764|NCT02892786|circulating tumor cell|circulating tumor cell
107765|NCT02892786|CellSearch™ method|cellsearch™ method
107766|NCT02892786|RT-PCR|rt-pcr
107767|NCT02892773|electrical impedance tomography|electrical impedance tomography
107768|NCT02892773|incentive spirometry|incentive spirometry
107769|NCT02892773|EzPAP|ezpap
107770|NCT02892773|lung volume|lung volume
107771|NCT02892773|atelectasis|atelectasis
107772|NCT02892773|positive airway pressure|positive airway pressure
107773|NCT02892773|pulmonary complication|pulmonary complication
107774|NCT02892773|abdominal surgery|abdominal surgery
107775|NCT02892773|end-expiratory lung volume|end-expiratory lung volume
107776|NCT02892747|Chronic Heart Failure (CHF)|chronic heart failure (chf)
107777|NCT02892747|Dietetics education|dietetics education
107778|NCT02892747|Malnutrition|malnutrition
107779|NCT02892721|CT Colonography|ct colonography
107780|NCT02892721|Virtual colonoscopy|virtual colonoscopy
107781|NCT02892721|Colorectal cancer|colorectal cancer
107782|NCT02892721|Colon cancer|colon cancer
107783|NCT02892721|Training|training
107784|NCT02892708|supratentorial gliomas|supratentorial gliomas
107785|NCT02892708|surgery|surgery
107786|NCT02892708|magnetic resonance spectroscopy|magnetic resonance spectroscopy
107787|NCT02892708|elderly|elderly
107788|NCT02892630|Immune Thrombocytopenia|immune thrombocytopenia
107789|NCT02892630|Pregnancy|pregnancy
107790|NCT02892617|Modic 1|modic 1
107791|NCT02892617|low back pain|low back pain
107792|NCT02892604|Type 1 diabetes|type 1 diabetes
107793|NCT02892604|artificial pancreas|artificial pancreas
107794|NCT02892604|closed-loop insulin infusion|closed-loop insulin infusion
107795|NCT02892565|systemic lupus erythematosus|systemic lupus erythematosus
107796|NCT02892565|antiphospholipid syndrome|antiphospholipid syndrome
107797|NCT02892565|antiphospholipid antibodies|antiphospholipid antibodies
107798|NCT02892513|Colorectal Surgery|colorectal surgery
107799|NCT02892513|transcutaneous electric nerve stimulation|transcutaneous electric nerve stimulation
107800|NCT02892487|Quality of life|quality of life
107801|NCT02892487|Radiotherapy|radiotherapy
107802|NCT02892487|Dysphagia|dysphagia
107803|NCT02892487|Oral cavity|oral cavity
107804|NCT02892487|Oropharynx|oropharynx
107805|NCT02892487|Hypopharynx|hypopharynx
107806|NCT02892487|Larynx|larynx
107807|NCT02892487|Swallowing rehabilitation|swallowing rehabilitation
107808|NCT02892487|Toxicity|toxicity
107809|NCT02892474|Coronary Arteriosclerosis|coronary arteriosclerosis
107810|NCT02892474|Hybrid Coronary Revascularization|hybrid coronary revascularization
107811|NCT02892474|Coronary Artery Bypass Grafting|coronary artery bypass grafting
107812|NCT02892461|Anemia, Iron-Deficiency|anemia, iron-deficiency
107813|NCT02892461|Cesarean Section|cesarean section
107814|NCT02892461|Umbilical Cord Milking|umbilical cord milking
107815|NCT02892461|Randomized Controlled Trial|randomized controlled trial
107816|NCT02892409|Drug Therapy|drug therapy
107817|NCT02892344|Phase III, blinded, QMF149, Mometasone furoate (MF), mild asthma, Adolescent, adult|phase iii, blinded, qmf149, mometasone furoate (mf), mild asthma, adolescent, adult
107818|NCT02892331|exercise|exercise
107819|NCT02892331|insulin resistance|insulin resistance
107820|NCT02892331|mitochondrial function|mitochondrial function
107821|NCT02892331|arterial stiffness|arterial stiffness
107822|NCT02892331|exercise intensity|exercise intensity
107823|NCT02892331|fitness|fitness
107824|NCT02892305|Pancreaticoduodenectomy|pancreaticoduodenectomy
107825|NCT02892305|Hepatectomy|hepatectomy
107826|NCT02892305|Liver ablation|liver ablation
107827|NCT02892279|Microneurography|microneurography
107828|NCT02892279|Air pollution|air pollution
107829|NCT02892266|Transplant recipients|transplant recipients
107830|NCT02892266|Adolescents|adolescents
107831|NCT02892266|Post-Traumatic Stress Symptoms (PTSS)|post-traumatic stress symptoms (ptss)
107832|NCT02892266|Transplant Recipient and Family Impact(s)|transplant recipient and family impact(s)
107833|NCT02892253|postoperative hypocalcemia|postoperative hypocalcemia
107834|NCT02892253|near infrared imaging|near infrared imaging
107835|NCT02892253|parathyroid autofluorescence|parathyroid autofluorescence
107836|NCT02892227|bedside echography|bedside echography
107837|NCT02892162|atrial fibrillation|atrial fibrillation
107838|NCT02892162|catheter ablation|catheter ablation
107839|NCT02892149|AKB-6548|akb-6548
107840|NCT02892149|Chronic kidney disease|chronic kidney disease
107841|NCT02892149|anemia|anemia
107842|NCT02892149|CKD|ckd
107843|NCT02892149|chronic renal insufficiency|chronic renal insufficiency
107844|NCT02892149|renal impairment|renal impairment
107845|NCT02892149|erythropoietin|erythropoietin
107846|NCT02892149|kidney|kidney
107847|NCT02892149|renal|renal
107848|NCT02892149|oral anemia treatment|oral anemia treatment
107849|NCT02892149|hemoglobin|hemoglobin
107850|NCT02892149|hypoxia-inducible factor|hypoxia-inducible factor
107851|NCT02892149|HIF|hif
107852|NCT02892149|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
107853|NCT02892149|HIF-PHI|hif-phi
107854|NCT02892149|efficacy|efficacy
107855|NCT02892149|safety|safety
107856|NCT02892149|Phase 3|phase 3
107857|NCT02892149|cardiovascular|cardiovascular
107858|NCT02892149|DD-CKD|dd-ckd
107859|NCT02892123|HER2|her2
107860|NCT02892123|bispecific antibody|bispecific antibody
107861|NCT02892123|biparatopic antibody|biparatopic antibody
107862|NCT02892123|breast cancer|breast cancer
107863|NCT02892123|gastric cancer|gastric cancer
107864|NCT02892123|gastroesophageal cancer|gastroesophageal cancer
107865|NCT02892123|ovarian cancer|ovarian cancer
107866|NCT02892123|non-small cell lung cancer|non-small cell lung cancer
107867|NCT02892110|Marijuana use|marijuana use
107868|NCT02892110|Varenicline/Chantix|varenicline/chantix
107869|NCT02892110|Motivational enhancement therapy|motivational enhancement therapy
107870|NCT02892097|tDCS|tdcs
107871|NCT02892097|neglect|neglect
107872|NCT02892097|paresis|paresis
107873|NCT02892097|transcranial direct current stimulation|transcranial direct current stimulation
107874|NCT02892097|rehabilitation|rehabilitation
107875|NCT02892084|Chronic Stroke ( > 6 months)|chronic stroke ( > 6 months)
107876|NCT02892084|non-invasive brain stimulation|non-invasive brain stimulation
107877|NCT02892084|rehabilitation|rehabilitation
107878|NCT02892084|walking|walking
107879|NCT02892084|kinetics|kinetics
107880|NCT02892045|neuromuscular block|neuromuscular block
107881|NCT02892045|monitoring|monitoring
107882|NCT02892019|indacaterol acetate, asthma, GINA 2015, pediatrics|indacaterol acetate, asthma, gina 2015, pediatrics
107883|NCT02891993|Cancer Care|cancer care
107884|NCT02891980|Ad26|ad26
107885|NCT02891980|Ebola|ebola
107886|NCT02891980|immunogenicity response|immunogenicity response
107887|NCT02891980|MVA-Multi Filo|mva-multi filo
107888|NCT02891980|Omics|omics
107889|NCT02891980|Zaire|zaire
107890|NCT02891954|Glucosuria|glucosuria
107891|NCT02891954|SGLT2 inhibitors|sglt2 inhibitors
107892|NCT02891954|Canagliflozin|canagliflozin
107893|NCT02891954|FGF23|fgf23
107894|NCT02891954|Parathyroid hormone|parathyroid hormone
107895|NCT02891954|1,25-Dihydroxyvitamin D|1,25-dihydroxyvitamin d
107896|NCT02891954|Glucagon|glucagon
107897|NCT02891954|Ketone bodies|ketone bodies
107898|NCT02891954|Uric acid|uric acid
107899|NCT02891954|Pharmacogenomics|pharmacogenomics
107900|NCT02891928|Type 2 diabetes|type 2 diabetes
107901|NCT02891928|Diabetic neuropathy|diabetic neuropathy
107902|NCT02891928|Disorders of equilibrium|disorders of equilibrium
107903|NCT02891928|"Rocker sole shoes"|"rocker sole shoes"
107904|NCT02891928|Walking|walking
107905|NCT02891915|Antimicrobial|antimicrobial
107906|NCT02891915|Beta-Lactam|beta-lactam
107907|NCT02891915|Pneumonia|pneumonia
107908|NCT02891915|Short Course|short course
107909|NCT02891915|Standard Course|standard course
107910|NCT02891915|Therapy|therapy
107911|NCT02891876|direct pulp capping, biodentine|direct pulp capping, biodentine
107912|NCT02891863|Implantable Cardioverter-Defibrillator|implantable cardioverter-defibrillator
107913|NCT02891837|L-citrulline|l-citrulline
107914|NCT02891837|pediatric|pediatric
107915|NCT02891837|Lung Injury|lung injury
107916|NCT02891837|Bypass|bypass
107917|NCT02891837|Heart Defects|heart defects
107918|NCT02891837|Clinical Sequelae|clinical sequelae
107919|NCT02891824|PD-L1|pd-l1
107920|NCT02891824|Atezolizumab|atezolizumab
107921|NCT02891824|Randomized, double blinded|randomized, double blinded
107922|NCT02891824|first or second late relapse|first or second late relapse
107923|NCT02891824|progressive non-mucinous epithelial ovarian cancer, primary peritoneal adenocarcinoma and / or fallopian-tube adenocarcinoma|progressive non-mucinous epithelial ovarian cancer, primary peritoneal adenocarcinoma and / or fallopian-tube adenocarcinoma
107924|NCT02891824|progression-free survival|progression-free survival
107925|NCT02891811|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
107926|NCT02891811|carfilzomib|carfilzomib
107927|NCT02891811|thalidomide|thalidomide
107928|NCT02891811|lenalidomide|lenalidomide
107929|NCT02891811|dexamethasone|dexamethasone
107930|NCT02891811|transplant ineligible|transplant ineligible
107931|NCT02891811|induction therapy|induction therapy
107932|NCT02891811|maintenance|maintenance
107933|NCT02891811|Study Group of Medical Tumour Therapy (AGMT)|study group of medical tumour therapy (agmt)
107934|NCT02891798|analgesia,|analgesia,
107935|NCT02891798|buprenorphine|buprenorphine
107936|NCT02891798|clonidine|clonidine
107937|NCT02891798|dexamethasone|dexamethasone
107938|NCT02891798|bupivacaine|bupivacaine
107939|NCT02891798|nerve block|nerve block
107940|NCT02891733|Expression of the Neurotensin|expression of the neurotensin
107941|NCT02891733|Neurotensin|neurotensin
107942|NCT02891668|Basal Metabolic rate|basal metabolic rate
107943|NCT02891668|Quality of life|quality of life
107944|NCT02891668|Resting energy expenditure|resting energy expenditure
107945|NCT02891668|Insulin resistance|insulin resistance
107946|NCT02891668|Cognitive Function|cognitive function
107947|NCT02891668|Body Composition|body composition
107948|NCT02891642|malignancy|malignancy
107949|NCT02891642|Pleural Effusion|pleural effusion
107950|NCT02891642|Pleural Neoplasms|pleural neoplasms
107951|NCT02891642|Ascites|ascites
107952|NCT02891616|Melanoma|melanoma
107953|NCT02891616|18F-FLT|18f-flt
107954|NCT02891616|18F-FDG|18f-fdg
107955|NCT02891616|PET/CT|pet/ct
107956|NCT02891616|PET/MR|pet/mr
107957|NCT02891577|intra abdominal hypertension|intra abdominal hypertension
107958|NCT02891577|shock|shock
107959|NCT02891577|critically ill|critically ill
107960|NCT02891564|therapeutic video games, mobile interventions|therapeutic video games, mobile interventions
107961|NCT02891551|Leukemia|leukemia
107962|NCT02891551|Chronic|chronic
107963|NCT02891551|Acute|acute
107964|NCT02891551|Observational|observational
107965|NCT02891551|Non-interventional|non-interventional
107966|NCT02891551|OCEAN|ocean
107967|NCT02891551|Netherlands|netherlands
107968|NCT02891551|azacitidine|azacitidine
107969|NCT02891538|EGCG|egcg
107970|NCT02891538|Green Tea|green tea
107971|NCT02891538|Colon Cancer|colon cancer
107972|NCT02891512|Magnetic Fields|magnetic fields
107973|NCT02891512|Pain|pain
107974|NCT02891512|Paresthesia|paresthesia
107975|NCT02891512|Visual Analogue Scale|visual analogue scale
107976|NCT02891499|Miniscrews|miniscrews
107977|NCT02891499|Mini-implants|mini-implants
107978|NCT02891499|Temporal anchorage devices|temporal anchorage devices
107979|NCT02891499|Bone screws|bone screws
107980|NCT02891499|Stability|stability
107981|NCT02891499|Displacement|displacement
107982|NCT02891499|Low-level laser therapy|low-level laser therapy
107983|NCT02891499|Cone-beam computed tomography|cone-beam computed tomography
107984|NCT02891499|Resonance frequency analysis|resonance frequency analysis
107985|NCT02891499|Orthodontic|orthodontic
107986|NCT02891499|Orthodontic miniscrew implant|orthodontic miniscrew implant
107987|NCT02891486|spinal surgery, surgical site infection|spinal surgery, surgical site infection
107988|NCT02891473|Posture|posture
107989|NCT02891473|Pain|pain
107990|NCT02891473|Muscle stretching|muscle stretching
107991|NCT02891473|Mézières method|mézières method
107992|NCT02891473|Camptocormia|camptocormia
107993|NCT02891473|Trunk control|trunk control
107994|NCT02891460|Mitomycin C|mitomycin c
107995|NCT02891460|MMC|mmc
107996|NCT02891460|NMIBC|nmibc
107997|NCT02891460|Non Muscle Invasive Bladder Cancer|non muscle invasive bladder cancer
107998|NCT02891460|Hydrogel Reverse thermal gelation|hydrogel reverse thermal gelation
107999|NCT02891460|Drug retention|drug retention
108000|NCT02891460|Urinary Bladder Neoplasms|urinary bladder neoplasms
108001|NCT02891460|Urologic Neoplasms|urologic neoplasms
108002|NCT02891460|Urinary Bladder Diseases|urinary bladder diseases
108003|NCT02891460|Urologic Diseases|urologic diseases
108004|NCT02891434|Duchenne muscular dystrophy|duchenne muscular dystrophy
108005|NCT02891434|motor learning|motor learning
108006|NCT02891434|motor abilities|motor abilities
108007|NCT02891395|allogeneic stem cell transplantation|allogeneic stem cell transplantation
108008|NCT02891395|imatinib Mesylate|imatinib mesylate
108009|NCT02891395|Nilotinib|nilotinib
108010|NCT02891382|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
108011|NCT02891382|Weight Loss|weight loss
108012|NCT02891382|Financial Incentives|financial incentives
108013|NCT02891382|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
108014|NCT02891356|Adiponectin|adiponectin
108015|NCT02891356|Bone remodelling markers|bone remodelling markers
108016|NCT02891343|Cognitive Function|cognitive function
108017|NCT02891343|Hypoxia|hypoxia
108018|NCT02891343|Neurophysiological Function|neurophysiological function
108019|NCT02891343|Effect of Alzheimer Disease symptomatic drugs|effect of alzheimer disease symptomatic drugs
108020|NCT02891343|Healthy Subjects|healthy subjects
108021|NCT02891330|Roux-en-Y Gastric ByPass|roux-en-y gastric bypass
108022|NCT02891304|esophagogastroduodenoscopy|esophagogastroduodenoscopy
108023|NCT02891291|optical coherence tomography|optical coherence tomography
108024|NCT02891278|Leukemia|leukemia
108025|NCT02891278|Sertraline|sertraline
108026|NCT02891278|Cytosine Arabinoside|cytosine arabinoside
108027|NCT02891278|Relapsed AML|relapsed aml
108028|NCT02891278|Refractory AML|refractory aml
108029|NCT02891239|laser treatment|laser treatment
108030|NCT02891226|inflammatory bowel disease|inflammatory bowel disease
108031|NCT02891226|IL-23|il-23
108032|NCT02891226|biologic|biologic
108033|NCT02891187|Postoperative Care|postoperative care
108034|NCT02891187|Telephone follow-up|telephone follow-up
108035|NCT02891187|Healthcare Value|healthcare value
108036|NCT02891174|ibuprofen|ibuprofen
108037|NCT02891174|acetaminophen|acetaminophen
108038|NCT02891174|blood pressure|blood pressure
108039|NCT02891174|post-partum|post-partum
108040|NCT02891174|pain control|pain control
108041|NCT02891174|pre-eclampsia|pre-eclampsia
108042|NCT02891174|gestational hypertension|gestational hypertension
108043|NCT02891161|durvalumab|durvalumab
108044|NCT02891161|MEDI4736|medi4736
108045|NCT02891161|anti-PD-L1|anti-pd-l1
108046|NCT02891135|"WHO 'Treat all Antiretroviral Guidelines"|"who 'treat all antiretroviral guidelines"
108047|NCT02891135|Simplified Algorithm for Treatment Eligibility (SLATE)|simplified algorithm for treatment eligibility (slate)
108048|NCT02891096|respiratory complications|respiratory complications
108049|NCT02891096|respiratory muscle strength|respiratory muscle strength
108050|NCT02891096|discriminator|discriminator
108051|NCT02891083|adjuvant chemotherapy|adjuvant chemotherapy
108052|NCT02891083|adjuvant radiotherapy|adjuvant radiotherapy
108053|NCT02891083|lymph node metastasis|lymph node metastasis
108054|NCT02891083|surgery|surgery
108055|NCT02891083|squamous cell carcinoma|squamous cell carcinoma
108056|NCT02891070|Cranial Surgery|cranial surgery
108057|NCT02891070|Cerebrospinal Fluid Leak|cerebrospinal fluid leak
108058|NCT02891070|Tisseel|tisseel
108059|NCT02891031|Rhus|rhus
108060|NCT02891031|Medicine, Traditional|medicine, traditional
108061|NCT02891031|Herbal medicine|herbal medicine
108062|NCT02891031|Uric acid|uric acid
108063|NCT02890966|SHR4640 pharmacokinetics pharmacodynamics|shr4640 pharmacokinetics pharmacodynamics
108064|NCT02890927|Geriatric Nursing|geriatric nursing
108065|NCT02890927|Geriatric co-management|geriatric co-management
108066|NCT02890927|Geriatric team|geriatric team
108067|NCT02890901|Escherichia coli|escherichia coli
108068|NCT02890901|Bloodstream infections|bloodstream infections
108069|NCT02890901|Severity|severity
108070|NCT02890901|Score|score
108071|NCT02890901|Host factors|host factors
108072|NCT02890901|Microbiology|microbiology
108073|NCT02890888|small vessel disease of the brain|small vessel disease of the brain
108074|NCT02890888|hyperbaric oxygen|hyperbaric oxygen
108075|NCT02890888|functional connectivity MRI|functional connectivity mri
108076|NCT02890875|ethanol lock|ethanol lock
108077|NCT02890875|parenteral nutrition|parenteral nutrition
108078|NCT02890862|Kinematics|kinematics
108079|NCT02890862|Activity of Daily living|activity of daily living
108080|NCT02890862|3D motion analysis|3d motion analysis
108081|NCT02890836|Blood pressure|blood pressure
108082|NCT02890836|Hypertension|hypertension
108083|NCT02890836|White coat hypertension|white coat hypertension
108084|NCT02890836|Preeclampsia|preeclampsia
108085|NCT02890836|Anti-hypertensiva|anti-hypertensiva
108086|NCT02890823|Antiepileptic Drugs|antiepileptic drugs
108087|NCT02890823|Vitamin D Deficiency|vitamin d deficiency
108088|NCT02890823|Asian|asian
108089|NCT02890810|Acupuncture|acupuncture
108090|NCT02890810|Back Pain|back pain
108091|NCT02890810|Chronic Pain|chronic pain
108092|NCT02890797|bronchiolitis|bronchiolitis
108093|NCT02890797|parenchymal condensation|parenchymal condensation
108094|NCT02890797|chest X-ray|chest x-ray
108095|NCT02890797|chest ultrasound|chest ultrasound
108096|NCT02890771|Turmeric|turmeric
108097|NCT02890771|Chronic periodontitis|chronic periodontitis
108098|NCT02890758|Natural Killer Cell|natural killer cell
108099|NCT02890758|ALT-803|alt-803
108100|NCT02890745|Empagliflozin|empagliflozin
108101|NCT02890745|Oxidative stress|oxidative stress
108102|NCT02890745|Oxidative nucleic acid modifications|oxidative nucleic acid modifications
108103|NCT02890745|8-oxo-7,8-dihydro-2'-deoxyguanosine|8-oxo-7,8-dihydro-2'-deoxyguanosine
108104|NCT02890745|8-oxo-7,8-dihydroguanosine|8-oxo-7,8-dihydroguanosine
108105|NCT02890706|Pulmonary embolism (PE)|pulmonary embolism (pe)
108106|NCT02890706|Dual-Energy CT (DECT)|dual-energy ct (dect)
108107|NCT02890706|Subtraction imaging|subtraction imaging
108108|NCT02890693|gestational diabetes mellitus|gestational diabetes mellitus
108109|NCT02890693|randomized controlled trial|randomized controlled trial
108110|NCT02890693|lifestyle intervention|lifestyle intervention
108111|NCT02890693|cardiovascular|cardiovascular
108112|NCT02890693|metabolic|metabolic
108113|NCT02890693|mental health|mental health
108114|NCT02890693|depression|depression
108115|NCT02890693|physical activity|physical activity
108116|NCT02890693|dietary intervention|dietary intervention
108117|NCT02890680|platelet-rich fibrin|platelet-rich fibrin
108118|NCT02890680|third molar|third molar
108119|NCT02890680|bone regeneration|bone regeneration
108120|NCT02890667|Cancer|cancer
108121|NCT02890667|incidence|incidence
108122|NCT02890667|health insurance data|health insurance data
108123|NCT02890667|algorithms|algorithms
108124|NCT02890654|Teenagers|teenagers
108125|NCT02890654|Multidisciplinary approach|multidisciplinary approach
108126|NCT02890654|Pain|pain
108127|NCT02890654|Surgery|surgery
108128|NCT02890628|Thai-Myanmar border|thai-myanmar border
108129|NCT02890615|Survivors|survivors
108130|NCT02890615|Self Care|self care
108131|NCT02890589|Acute coronary syndrome|acute coronary syndrome
108132|NCT02890589|ST (Software Test) -elevation|st (software test) -elevation
108133|NCT02890576|cochlear implant|cochlear implant
108134|NCT02890576|telemedicine|telemedicine
108135|NCT02890576|new organization of patient monitoring|new organization of patient monitoring
108136|NCT02890563|Varicose veins|varicose veins
108137|NCT02890563|Compression stockings|compression stockings
108138|NCT02890563|Sclerotherapy|sclerotherapy
108139|NCT02890563|Radiofrequency ablation|radiofrequency ablation
108140|NCT02890550|Ciliopathy|ciliopathy
108141|NCT02890550|Retinitis pigmentosa|retinitis pigmentosa
108142|NCT02890550|ALMS1 gene|alms1 gene
108143|NCT02890537|Osteonecrosis|osteonecrosis
108144|NCT02890537|Femoral Head|femoral head
108145|NCT02890537|Hip|hip
108146|NCT02890537|Orthopedics|orthopedics
108147|NCT02890537|Bone|bone
108148|NCT02890537|Musculoskeletal Disorders|musculoskeletal disorders
108149|NCT02890524|aphthous stomatitis|aphthous stomatitis
108150|NCT02890524|night guard|night guard
108151|NCT02890524|inflammatory cytokine|inflammatory cytokine
108152|NCT02890459|HIV|hiv
108153|NCT02890459|incentives|incentives
108154|NCT02890459|behavioral economics|behavioral economics
108155|NCT02890446|attentional focus|attentional focus
108156|NCT02890446|upper extremity|upper extremity
108157|NCT02890446|hemiparesis|hemiparesis
108158|NCT02890446|stroke|stroke
108159|NCT02890394|Neck Pain|neck pain
108160|NCT02890394|Suboccipital inhibition|suboccipital inhibition
108161|NCT02890394|Physical Therapy|physical therapy
108162|NCT02890368|CD47|cd47
108163|NCT02890368|SIRPa|sirpa
108164|NCT02890368|Immunotherapy|immunotherapy
108165|NCT02890368|Checkpoint inhibitor|checkpoint inhibitor
108166|NCT02890342|Propionic Acidemia|propionic acidemia
108167|NCT02890342|Inborn Error of Metabolism|inborn error of metabolism
108168|NCT02890342|Genetics|genetics
108169|NCT02890342|Pccb|pccb
108170|NCT02890342|Pcca|pcca
108171|NCT02890290|Frail Elderly|frail elderly
108172|NCT02890290|Diet, Food, and Nutrition|diet, food, and nutrition
108173|NCT02890290|physical function|physical function
108174|NCT02890290|marine protein hydrolysates|marine protein hydrolysates
108175|NCT02890290|protein intake|protein intake
108176|NCT02890290|seafood intake|seafood intake
108177|NCT02890290|ageing|ageing
108178|NCT02890290|old|old
108179|NCT02890290|nutrition|nutrition
108180|NCT02890290|frail|frail
108181|NCT02890264|End stage renal disease|end stage renal disease
108182|NCT02890264|Dialysis|dialysis
108183|NCT02890251|Infant|infant
108184|NCT02890251|Premature|premature
108185|NCT02890251|Diseases|diseases
108186|NCT02890238|Sildenafil Citrate|sildenafil citrate
108187|NCT02890238|Induction of Ovulation|induction of ovulation
108188|NCT02890238|Pregnancy Rate|pregnancy rate
108189|NCT02890225|stones|stones
108190|NCT02890225|external physical vibration lithecbole|external physical vibration lithecbole
108191|NCT02890212|Major depression, selenium, placebo, sertraline|major depression, selenium, placebo, sertraline
108192|NCT02890186|narcotrend|narcotrend
108193|NCT02890186|propofol|propofol
108194|NCT02890186|remifentanil|remifentanil
108195|NCT02890186|closed-loop of target controlled infusion|closed-loop of target controlled infusion
108196|NCT02890173|Essential hypertension|essential hypertension
108197|NCT02890173|Mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
108198|NCT02890173|Esaxerenone|esaxerenone
108199|NCT02890173|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
108200|NCT02890160|Bioresorbable Vascular Scaffold|bioresorbable vascular scaffold
108201|NCT02890147|SADs|sads
108202|NCT02890147|Healthy Volunteers|healthy volunteers
108203|NCT02890147|Molecular profiles|molecular profiles
108204|NCT02890147|Omics Techniques|omics techniques
108205|NCT02890134|SADs|sads
108206|NCT02890134|Molecular Reclassification|molecular reclassification
108207|NCT02890121|SADs|sads
108208|NCT02890121|Molecular Reclassification|molecular reclassification
108209|NCT02890108|High-Intensity Sweeteners|high-intensity sweeteners
108210|NCT02890108|Non-Nutritive Sweeteners|non-nutritive sweeteners
108211|NCT02890108|Artificial sweeteners|artificial sweeteners
108212|NCT02890108|Glucose intolerance|glucose intolerance
108213|NCT02890082|Breast cancer|breast cancer
108214|NCT02890082|fertility|fertility
108215|NCT02890082|chemotherapy|chemotherapy
108216|NCT02890069|PDR001|pdr001
108217|NCT02890069|CRC|crc
108218|NCT02890069|TNBC|tnbc
108219|NCT02890069|NSCLC|nsclc
108220|NCT02890069|Immunomodulation|immunomodulation
108221|NCT02890069|Biomarkers|biomarkers
108222|NCT02890069|Bayesian logistic regression model|bayesian logistic regression model
108223|NCT02890056|sugar-sweetened beverage consumption|sugar-sweetened beverage consumption
108224|NCT02890056|water consumption|water consumption
108225|NCT02890056|dietary behaviors|dietary behaviors
108226|NCT02890056|youth|youth
108227|NCT02890043|spine|spine
108228|NCT02890043|robot-assisted surgery|robot-assisted surgery
108229|NCT02890043|pedicle screw|pedicle screw
108230|NCT02890030|Cisplatin-based therapy|cisplatin-based therapy
108231|NCT02890030|Ototoxicity|ototoxicity
108232|NCT02890030|Neurotoxicity|neurotoxicity
108233|NCT02890017|outpatient surgery|outpatient surgery
108234|NCT02890017|urology medico-economic|urology medico-economic
108235|NCT02890017|hotel|hotel
108236|NCT02890004|Subarachnoid Hemorrhage|subarachnoid hemorrhage
108237|NCT02890004|Neurointensive care|neurointensive care
108238|NCT02890004|Observational registry|observational registry
108239|NCT02889991|Myofascial pain.|myofascial pain.
108240|NCT02889991|Myofascial trigger point.|myofascial trigger point.
108241|NCT02889991|Infraspinatus muscle.|infraspinatus muscle.
108242|NCT02889991|Deep dry needling.|deep dry needling.
108243|NCT02889991|Local twitch response.|local twitch response.
108244|NCT02889991|Fascial mechanotransduction.|fascial mechanotransduction.
108245|NCT02889991|Needle grasp.|needle grasp.
108246|NCT02889991|Myofascial fibrosis.|myofascial fibrosis.
108247|NCT02889991|Elastography.|elastography.
108248|NCT02889978|Cancer Screening|cancer screening
108249|NCT02889978|High-Throughput Nucleotide Sequencing|high-throughput nucleotide sequencing
108250|NCT02889978|Deep Sequencing|deep sequencing
108251|NCT02889978|Circulating cell-free tumor DNA|circulating cell-free tumor dna
108252|NCT02889965|Multiple sclerosis|multiple sclerosis
108253|NCT02889965|Pharmacoepidemiology|pharmacoepidemiology
108254|NCT02889965|Disease modifying drugs|disease modifying drugs
108255|NCT02889965|Neuro-myelitis optica|neuro-myelitis optica
108256|NCT02889952|postoperative hypocalcemia|postoperative hypocalcemia
108257|NCT02889952|near infrared imaging|near infrared imaging
108258|NCT02889952|parathyroid autofluorescence|parathyroid autofluorescence
108259|NCT02889939|rehabilitation|rehabilitation
108260|NCT02889939|recovery of function|recovery of function
108261|NCT02889939|environment|environment
108262|NCT02889900|ovarian cancer|ovarian cancer
108263|NCT02889887|Preterm|preterm
108264|NCT02889887|Sensory Processing|sensory processing
108265|NCT02889887|Motor Development|motor development
108266|NCT02889874|Radiation therapy|radiation therapy
108267|NCT02889874|omission|omission
108268|NCT02889874|non-inferiority|non-inferiority
108269|NCT02889874|breast cancer|breast cancer
108270|NCT02889861|Uveal melanoma|uveal melanoma
108271|NCT02889861|Cutaneous melanoma|cutaneous melanoma
108272|NCT02889835|Class II|class ii
108273|NCT02889835|molar and premolar|molar and premolar
108274|NCT02889835|resin composite|resin composite
108275|NCT02889835|adult|adult
108276|NCT02889835|restoration|restoration
108277|NCT02889809|Growth Velocity|growth velocity
108278|NCT02889809|Prepubertal|prepubertal
108279|NCT02889809|Asthma|asthma
108280|NCT02889809|Paediatric|paediatric
108281|NCT02889783|urodynamics|urodynamics
108282|NCT02889783|urethral sensation|urethral sensation
108283|NCT02889783|urethral pain|urethral pain
108284|NCT02889757|tuberculosis|tuberculosis
108285|NCT02889757|acetylcysteine|acetylcysteine
108286|NCT02889757|hepatotoxicity|hepatotoxicity
108287|NCT02889744|Temperature|temperature
108288|NCT02889744|Hypothermia|hypothermia
108289|NCT02889744|Brain|brain
108290|NCT02889744|Oxygen|oxygen
108291|NCT02889744|Prognosis|prognosis
108292|NCT02889731|Suicide|suicide
108293|NCT02889731|Heights|heights
108294|NCT02889731|Suicide hot spots|suicide hot spots
108295|NCT02889731|Bridges|bridges
108296|NCT02889705|Ultrasonography|ultrasonography
108297|NCT02889705|echotexture|echotexture
108298|NCT02889705|K value|k value
108299|NCT02889705|SCM muscles|scm muscles
108300|NCT02889705|CMT infants|cmt infants
108301|NCT02889692|lung cancer|lung cancer
108302|NCT02889692|traditional Chinese medicine|traditional chinese medicine
108303|NCT02889692|maintenance therapy|maintenance therapy
108304|NCT02889692|targeted therapy|targeted therapy
108305|NCT02889679|Colonoscopy|colonoscopy
108306|NCT02889679|Polypectomy|polypectomy
108307|NCT02889666|relapsed|relapsed
108308|NCT02889666|non-small cell lung cancer|non-small cell lung cancer
108309|NCT02889666|cisplatin|cisplatin
108310|NCT02889666|carboplatin|carboplatin
108311|NCT02889666|oxaliplatin|oxaliplatin
108312|NCT02889666|docetaxel|docetaxel
108313|NCT02889666|gemcitabine|gemcitabine
108314|NCT02889640|Educational Achievement|educational achievement
108315|NCT02889640|Individualized Tutoring|individualized tutoring
108316|NCT02889640|Mathematics|mathematics
108317|NCT02889640|Academic Mismatch|academic mismatch
108318|NCT02889640|Achievement Gap|achievement gap
108319|NCT02889627|Fecal Microbiota Transplantation|fecal microbiota transplantation
108320|NCT02889627|Gut microbiota|gut microbiota
108321|NCT02889627|Brain-gut axis|brain-gut axis
108322|NCT02889627|Epilepsy|epilepsy
108323|NCT02889588|Refractive Surgery|refractive surgery
108324|NCT02889588|higher order aberrations|higher order aberrations
108325|NCT02889562|apixaban|apixaban
108326|NCT02889562|anticoagulant|anticoagulant
108327|NCT02889562|CABG|cabg
108328|NCT02889562|thrombosis|thrombosis
108329|NCT02889562|fibrillation|fibrillation
108330|NCT02889536|parastomal hernia|parastomal hernia
108331|NCT02889536|ostomy|ostomy
108332|NCT02889536|qualitative|qualitative
108333|NCT02889536|phenomenological-hermeneutic research|phenomenological-hermeneutic research
108334|NCT02889536|symptoms|symptoms
108335|NCT02889536|parastomal bulging|parastomal bulging
108336|NCT02889523|Front line therapy|front line therapy
108337|NCT02889523|Age-adjusted International Prognostic Index (aa-IPI) >1|age-adjusted international prognostic index (aa-ipi) >1
108338|NCT02889523|60 to 80 years|60 to 80 years
108339|NCT02889510|diabetes|diabetes
108340|NCT02889510|liraglutide|liraglutide
108341|NCT02889510|lung function|lung function
108342|NCT02889497|vaccine|vaccine
108343|NCT02889497|safety|safety
108344|NCT02889497|immunogenicity|immunogenicity
108345|NCT02889458|Chinese|chinese
108346|NCT02889458|Breast Cancer|breast cancer
108347|NCT02889458|Women|women
108348|NCT02889419|Multiple Sclerosis|multiple sclerosis
108349|NCT02889419|Disability|disability
108350|NCT02889419|Underwear|underwear
108351|NCT02889419|Urinary catheter|urinary catheter
108352|NCT02889419|Self-catheterisation|self-catheterisation
108353|NCT02889380|Infertility|infertility
108354|NCT02889380|Cetrotide|cetrotide
108355|NCT02889380|Assisted reproductive technology (ART)|assisted reproductive technology (art)
108356|NCT02889341|Docosahexanoic Acid,|docosahexanoic acid,
108357|NCT02889341|DNA fragmentation|dna fragmentation
108358|NCT02889341|male fertility|male fertility
108359|NCT02889341|Sperm parameters improvements|sperm parameters improvements
108360|NCT02889315|PAH|pah
108361|NCT02889315|treprostinil|treprostinil
108362|NCT02889315|LenusPro|lenuspro
108363|NCT02889315|implantable device|implantable device
108364|NCT02889315|quality of life|quality of life
108365|NCT02889289|traumatic brain injury|traumatic brain injury
108366|NCT02889289|virtual reality|virtual reality
108367|NCT02889289|Xbox kinect|xbox kinect
108368|NCT02889289|balance|balance
108369|NCT02889250|geriatric|geriatric
108370|NCT02889250|depression|depression
108371|NCT02889250|deep brain stimulation|deep brain stimulation
108372|NCT02889250|subcallosal cingulate|subcallosal cingulate
108373|NCT02889237|Fracture healing|fracture healing
108374|NCT02889237|Calcium supplementation|calcium supplementation
108375|NCT02889237|Vitamin D supplementation|vitamin d supplementation
108376|NCT02889237|HR-pQCT|hr-pqct
108377|NCT02889224|Obesity|obesity
108378|NCT02889224|Cortisol|cortisol
108379|NCT02889224|Hydrocortisone|hydrocortisone
108380|NCT02889224|Endocannabinoïds|endocannabinoïds
108381|NCT02889198|web-based tool|web-based tool
108382|NCT02889198|child, preschool|child, preschool
108383|NCT02889198|nutrition|nutrition
108384|NCT02889198|implementation|implementation
108385|NCT02889198|child care|child care
108386|NCT02889185|Optical Coherence Tomography|optical coherence tomography
108387|NCT02889185|Retinal camera|retinal camera
108388|NCT02889159|photoaging|photoaging
108389|NCT02889146|Intensive Care Units|intensive care units
108390|NCT02889146|Physical Therapy Specialty|physical therapy specialty
108391|NCT02889146|Critical illness|critical illness
108392|NCT02889146|Muscle weakness|muscle weakness
108393|NCT02889146|Bed rest|bed rest
108394|NCT02889133|Iron deficiency|iron deficiency
108395|NCT02889133|Transfusion|transfusion
108396|NCT02889133|Blood donation|blood donation
108397|NCT02889120|Drug advice by phone|drug advice by phone
108398|NCT02889120|Teleprescription|teleprescription
108399|NCT02889120|Medical call centre|medical call centre
108400|NCT02889120|Out of hours call|out of hours call
108401|NCT02889081|birth cohort|birth cohort
108402|NCT02889081|prenatal|prenatal
108403|NCT02889081|skin barrier|skin barrier
108404|NCT02889081|atopic dermatitis|atopic dermatitis
108405|NCT02889081|key nutritional factors|key nutritional factors
108406|NCT02889016|PANS|pans
108407|NCT02889016|PANDAS|pandas
108408|NCT02888951|Diabetes|diabetes
108409|NCT02888951|Diabetes Mellitus|diabetes mellitus
108410|NCT02888951|Gastric Ultrasound|gastric ultrasound
108411|NCT02888951|Preoperative fasting|preoperative fasting
108412|NCT02888951|Empty Stomach|empty stomach
108413|NCT02888951|Gastric Diabetes|gastric diabetes
108414|NCT02888912|glass ionomer cement|glass ionomer cement
108415|NCT02888912|composite resin|composite resin
108416|NCT02888886|systemic inflammation|systemic inflammation
108417|NCT02888873|composite resin|composite resin
108418|NCT02888873|Clinical trial|clinical trial
108419|NCT02888873|FDI (World Dental Federation) criteria|fdi (world dental federation) criteria
108420|NCT02888860|genetic susceptibility|genetic susceptibility
108421|NCT02888860|candida infection|candida infection
108422|NCT02888860|colonization|colonization
108423|NCT02888847|post bleaching teeth sensitivity|post bleaching teeth sensitivity
108424|NCT02888834|elderly|elderly
108425|NCT02888834|adverse drug reactions|adverse drug reactions
108426|NCT02888834|hospitalized subjects|hospitalized subjects
108427|NCT02888834|community-dwelling|community-dwelling
108428|NCT02888808|gastroesophageal reflux disease|gastroesophageal reflux disease
108429|NCT02888808|women|women
108430|NCT02888808|Nigeria|nigeria
108431|NCT02888808|obesity|obesity
108432|NCT02888795|hypertonic dextrose prolotherapy|hypertonic dextrose prolotherapy
108433|NCT02888795|osteoarthritis|osteoarthritis
108434|NCT02888769|Coronary artery disease|coronary artery disease
108435|NCT02888769|Text messages|text messages
108436|NCT02888769|Blood pressure|blood pressure
108437|NCT02888769|Lifestyle|lifestyle
108438|NCT02888769|Risk factors|risk factors
108439|NCT02888756|Immunotherapy|immunotherapy
108440|NCT02888756|mRNA|mrna
108441|NCT02888756|Lentivirus infection|lentivirus infection
108442|NCT02888756|Virus disease|virus disease
108443|NCT02888756|Sexually transmitted disease|sexually transmitted disease
108444|NCT02888756|Immunodeficiency syndrome|immunodeficiency syndrome
108445|NCT02888730|cystic fibrosis|cystic fibrosis
108446|NCT02888730|chronic rhinosinusitis|chronic rhinosinusitis
108447|NCT02888730|Lung Diseases|lung diseases
108448|NCT02888730|tobramycin|tobramycin
108449|NCT02888730|nebulized sonic aerosol therapy|nebulized sonic aerosol therapy
108450|NCT02888704|Atopic dermatitis|atopic dermatitis
108451|NCT02888704|Mesenchymal stem cells|mesenchymal stem cells
108452|NCT02888678|ASPIRES|aspires
108453|NCT02888652|Coronary Heart Disease|coronary heart disease
108454|NCT02888652|PCI|pci
108455|NCT02888652|Anti-Platelet Agents|anti-platelet agents
108456|NCT02888613|mini-lumbotomy|mini-lumbotomy
108457|NCT02888613|mini-laparotomy|mini-laparotomy
108458|NCT02888613|retroperitoneal approach|retroperitoneal approach
108459|NCT02888613|transperitoneal approach|transperitoneal approach
108460|NCT02888613|abdominal aortic surgery|abdominal aortic surgery
108461|NCT02888535|primary immunodeficiency|primary immunodeficiency
108462|NCT02888535|secondary immunodeficiency|secondary immunodeficiency
108463|NCT02888535|intensive care unit|intensive care unit
108464|NCT02888535|infection|infection
108465|NCT02888535|adult|adult
108466|NCT02888509|depression|depression
108467|NCT02888509|anxiety disorder|anxiety disorder
108468|NCT02888509|bipolar disorder|bipolar disorder
108469|NCT02888509|Magnetic Resonance Imaging|magnetic resonance imaging
108470|NCT02888483|physical activity|physical activity
108471|NCT02888483|energy expenditure|energy expenditure
108472|NCT02888457|nasopharyngeal carriage|nasopharyngeal carriage
108473|NCT02888457|Streptococcus pneumoniae|streptococcus pneumoniae
108474|NCT02888457|acute otitis media|acute otitis media
108475|NCT02888457|day-care centers|day-care centers
108476|NCT02888431|pH|ph
108477|NCT02888431|base deficit|base deficit
108478|NCT02888431|lactate values|lactate values
108479|NCT02888431|venous blood samples|venous blood samples
108480|NCT02888431|arterial blood samples|arterial blood samples
108481|NCT02888418|vaccine|vaccine
108482|NCT02888418|safety|safety
108483|NCT02888418|immunogenicity|immunogenicity
108484|NCT02888405|Body Composition|body composition
108485|NCT02888366|breast cancer|breast cancer
108486|NCT02888366|breath test|breath test
108487|NCT02888366|Menssana|menssana
108488|NCT02888366|Ancillary|ancillary
108489|NCT02888366|Mammography|mammography
108490|NCT02888366|Rapid Point-of-care|rapid point-of-care
108491|NCT02888366|Inflatable Bag|inflatable bag
108492|NCT02888353|Magnetic Resonance Imaging and Pacemakers ICD|magnetic resonance imaging and pacemakers icd
108493|NCT02888340|Acupuncture|acupuncture
108494|NCT02888340|Emergency Department|emergency department
108495|NCT02888340|Pain|pain
108496|NCT02888314|mHealth|mhealth
108497|NCT02888314|Pokemon Go|pokemon go
108498|NCT02888288|adolescent|adolescent
108499|NCT02888288|adolescence|adolescence
108500|NCT02888288|HIV/AIDS|hiv/aids
108501|NCT02888288|mental health|mental health
108502|NCT02888288|cognitive behavioral therapy|cognitive behavioral therapy
108503|NCT02888262|Bipolar disorder|bipolar disorder
108504|NCT02888262|Blood|blood
108505|NCT02888262|Smartphone|smartphone
108506|NCT02888262|Brain imaging|brain imaging
108507|NCT02888262|Cognition|cognition
108508|NCT02888262|Neuropsychology|neuropsychology
108509|NCT02888249|Tobacco withdrawal|tobacco withdrawal
108510|NCT02888249|Autonomic Agents|autonomic agents
108511|NCT02888236|Psoriasis|psoriasis
108512|NCT02888080|pulmonary sarcoidosis|pulmonary sarcoidosis
108513|NCT02888080|sarcoidosis|sarcoidosis
108514|NCT02888080|canakinumab|canakinumab
108515|NCT02888080|autoimmune diseases|autoimmune diseases
108516|NCT02888080|granulomas|granulomas
108517|NCT02888080|inflammation|inflammation
108518|NCT02888080|lung function testing|lung function testing
108519|NCT02888080|immunosuppressive agents|immunosuppressive agents
108520|NCT02888080|interleukin|interleukin
108521|NCT02888080|interleukin-1Beta|interleukin-1beta
108522|NCT02888080|[F-18]FDG-PET/CT|[f-18]fdg-pet/ct
108523|NCT02888080|respiratory|respiratory
108524|NCT02888080|pulmonary|pulmonary
108525|NCT02888080|steroids|steroids
108526|NCT02888080|corticosteroids|corticosteroids
108527|NCT02888080|lung diseases|lung diseases
108528|NCT02888067|Neuromuscular Blockade|neuromuscular blockade
108529|NCT02888041|Cervical ripening|cervical ripening
108530|NCT02888041|Pregnancy|pregnancy
108531|NCT02888041|Vaginal Administration|vaginal administration
108532|NCT02888028|Remote ICD follow-up|remote icd follow-up
108533|NCT02888028|HRQoL|hrqol
108534|NCT02888028|Health related Quality of Life|health related quality of life
108535|NCT02888028|Depression|depression
108536|NCT02888028|anxiety|anxiety
108537|NCT02888028|device acceptance|device acceptance
108538|NCT02888028|telemedicine|telemedicine
108539|NCT02888028|telemonitoring|telemonitoring
108540|NCT02887989|Virtual Reality|virtual reality
108541|NCT02887989|Non-Opioid Pain Management|non-opioid pain management
108542|NCT02887976|Prostate Cancer|prostate cancer
108543|NCT02887976|Castrate Resistant Prostate Cancer (CRPC)|castrate resistant prostate cancer (crpc)
108544|NCT02887976|metastatic|metastatic
108545|NCT02887976|castrate resistant|castrate resistant
108546|NCT02887963|Iron Deficiency|iron deficiency
108547|NCT02887963|Iron Deficiency Anemia|iron deficiency anemia
108548|NCT02887963|Pregnant Women|pregnant women
108549|NCT02887963|Gestation|gestation
108550|NCT02887963|China|china
108551|NCT02887963|Epidemiology|epidemiology
108552|NCT02887872|stroke|stroke
108553|NCT02887872|upper extremity function|upper extremity function
108554|NCT02887872|rehabilitation|rehabilitation
108555|NCT02887820|ECMO|ecmo
108556|NCT02887820|TEG|teg
108557|NCT02887807|Cardiac arrest|cardiac arrest
108558|NCT02887807|Shockable|shockable
108559|NCT02887807|Cyclosporine|cyclosporine
108560|NCT02887794|pitch discrimination|pitch discrimination
108561|NCT02887794|auditory processing disorders|auditory processing disorders
108562|NCT02887794|auditory perception|auditory perception
108563|NCT02887794|auditory-verbal hallucinations|auditory-verbal hallucinations
108564|NCT02887794|theory of mind|theory of mind
108565|NCT02887729|Polycystic disease|polycystic disease
108566|NCT02887703|ataxia|ataxia
108567|NCT02887703|balance training|balance training
108568|NCT02887703|vibrotactile biofeedback|vibrotactile biofeedback
108569|NCT02887703|sensory augmentation|sensory augmentation
108570|NCT02887703|cerebellar ataxia|cerebellar ataxia
108571|NCT02887690|MPL|mpl
108572|NCT02887690|prosthetic limb|prosthetic limb
108573|NCT02887690|upper extremity|upper extremity
108574|NCT02887690|prosthesis|prosthesis
108575|NCT02887677|Dapagliflozin|dapagliflozin
108576|NCT02887677|Arterial Stiffness|arterial stiffness
108577|NCT02887677|Aortic Pressure|aortic pressure
108578|NCT02887651|cerebrale metastases|cerebrale metastases
108579|NCT02887651|radiotherapy|radiotherapy
108580|NCT02887651|surgery|surgery
108581|NCT02887651|complete surgical resection|complete surgical resection
108582|NCT02887651|resection|resection
108583|NCT02887651|cavity boost radiation therapy|cavity boost radiation therapy
108584|NCT02887651|observation|observation
108585|NCT02887586|Auricular Needling|auricular needling
108586|NCT02887586|Mechanism Study|mechanism study
108587|NCT02887586|Anorexia|anorexia
108588|NCT02887586|Cancer|cancer
108589|NCT02887573|Bowel preparation|bowel preparation
108590|NCT02887573|Colorectal polyps|colorectal polyps
108591|NCT02887573|Colon capsule endoscopy|colon capsule endoscopy
108592|NCT02887560|Right ventricle|right ventricle
108593|NCT02887560|Pulmonary transplantation|pulmonary transplantation
108594|NCT02887560|Strain|strain
108595|NCT02887560|isovolumic acceleration (IVA)|isovolumic acceleration (iva)
108596|NCT02887495|scleroderma|scleroderma
108597|NCT02887495|biorepository|biorepository
108598|NCT02887482|DNA|dna
108599|NCT02887482|Vaccine|vaccine
108600|NCT02887469|Hyponatremia|hyponatremia
108601|NCT02887469|Hypertonic saline|hypertonic saline
108602|NCT02887469|Treatment|treatment
108603|NCT02887469|Osmotic demyelination syndrome|osmotic demyelination syndrome
108604|NCT02887430|foot reflexology|foot reflexology
108605|NCT02887430|pain intensity|pain intensity
108606|NCT02887430|health-related quality of life|health-related quality of life
108607|NCT02887417|platelet activation|platelet activation
108608|NCT02887391|hemodialysis|hemodialysis
108609|NCT02887391|nutritional status|nutritional status
108610|NCT02887378|bronchial biopsy|bronchial biopsy
108611|NCT02887365|colon cancer|colon cancer
108612|NCT02887365|MSI-L|msi-l
108613|NCT02887365|MSS|mss
108614|NCT02887365|Tegafur-Uracil|tegafur-uracil
108615|NCT02887365|Low-Level Microsatellite-Instability|low-level microsatellite-instability
108616|NCT02887339|Informed Consent|informed consent
108617|NCT02887339|Research donation request|research donation request
108618|NCT02887339|Effective Communication|effective communication
108619|NCT02887313|Rectal cancer|rectal cancer
108620|NCT02887313|Neoadjuvant chemoradiation therapy|neoadjuvant chemoradiation therapy
108621|NCT02887300|Quality of Health Care|quality of health care
108622|NCT02887300|Psychological Stress|psychological stress
108623|NCT02887300|Burnout|burnout
108624|NCT02887300|Health Care Professional|health care professional
108625|NCT02887300|Mantra Meditation|mantra meditation
108626|NCT02887300|Health Care Economics|health care economics
108627|NCT02887274|Systemic Inflammatory Response Syndrome (SIRS)|systemic inflammatory response syndrome (sirs)
108628|NCT02887274|Sepsis|sepsis
108629|NCT02887274|Severe Sepsis|severe sepsis
108630|NCT02887274|Septic shock|septic shock
108631|NCT02887274|Multiple organ failure|multiple organ failure
108632|NCT02887261|Power Port|power port
108633|NCT02887248|nab-paclitaxel|nab-paclitaxel
108634|NCT02887248|gemcitabine|gemcitabine
108635|NCT02887222|Epidural|epidural
108636|NCT02887222|Labor analgesia|labor analgesia
108637|NCT02887222|Programmed intermittent epidural bolus|programmed intermittent epidural bolus
108638|NCT02887196|Breast Cancer|breast cancer
108639|NCT02887183|Heart failure|heart failure
108640|NCT02887183|Reduced left ventricular ejection fraction|reduced left ventricular ejection fraction
108641|NCT02887183|HFrEF|hfref
108642|NCT02887183|NT-proBNP|nt-probnp
108643|NCT02887183|Cardiac remodeling|cardiac remodeling
108644|NCT02887170|Adolescent|adolescent
108645|NCT02887170|Lost to contact|lost to contact
108646|NCT02887170|Recurrence|recurrence
108647|NCT02887170|Long-term outcome|long-term outcome
108648|NCT02887131|Subtalar arthritis|subtalar arthritis
108649|NCT02887131|Subtalar instability|subtalar instability
108650|NCT02887118|Erythrocytes|erythrocytes
108651|NCT02887118|Sickle Cell Disease|sickle cell disease
108652|NCT02887092|health determinants|health determinants
108653|NCT02887092|epidemiology|epidemiology
108654|NCT02887092|maintaining autonomy|maintaining autonomy
108655|NCT02887092|psychology|psychology
108656|NCT02887092|osteoarthritis|osteoarthritis
108657|NCT02887092|perceived health|perceived health
108658|NCT02887053|MRI|mri
108659|NCT02887053|Healthy subjects|healthy subjects
108660|NCT02887040|Diffuse, intrinsic brain stem glioma|diffuse, intrinsic brain stem glioma
108661|NCT02887040|Antineoplaston therapy|antineoplaston therapy
108662|NCT02887040|Radiation|radiation
108663|NCT02887014|bowel preparation|bowel preparation
108664|NCT02887014|colonoscopy|colonoscopy
108665|NCT02887014|inpatients|inpatients
108666|NCT02887014|cathartics|cathartics
108667|NCT02887001|cost study|cost study
108668|NCT02887001|clinical pharmacist|clinical pharmacist
108669|NCT02886988|Botulinum toxin type A, scar|botulinum toxin type a, scar
108670|NCT02886975|Renal Insufficiency, Chronic|renal insufficiency, chronic
108671|NCT02886975|Diet, Protein-Restricted|diet, protein-restricted
108672|NCT02886936|transtibial amputees|transtibial amputees
108673|NCT02886910|Chorioamnionitis|chorioamnionitis
108674|NCT02886910|Early onset neonatal sepsis|early onset neonatal sepsis
108675|NCT02886910|Antibiotics|antibiotics
108676|NCT02886910|Clinical observation|clinical observation
108677|NCT02886897|Refractory solid tumors|refractory solid tumors
108678|NCT02886897|Dendritic and Cytokine-induced killer cell|dendritic and cytokine-induced killer cell
108679|NCT02886897|Anti-PD-1 antibody|anti-pd-1 antibody
108781|NCT02886130|Athletes|athletes
108680|NCT02886897|Combination immunotherapy|combination immunotherapy
108681|NCT02886884|Diabetes|diabetes
108682|NCT02886884|Endothelial dysfunction|endothelial dysfunction
108683|NCT02886884|Stem cells|stem cells
108684|NCT02886858|Depression|depression
108685|NCT02886858|Moods disorders|moods disorders
108686|NCT02886858|electroconvulsive therapy|electroconvulsive therapy
108687|NCT02886845|SNP,Breast Neoplasms|snp,breast neoplasms
108688|NCT02886832|Prostate Health|prostate health
108689|NCT02886819|Whole body vibration|whole body vibration
108690|NCT02886819|Tonic vibration reflex|tonic vibration reflex
108691|NCT02886819|Bone myoregulation reflex|bone myoregulation reflex
108692|NCT02886806|closed loop|closed loop
108693|NCT02886806|remifentanil|remifentanil
108694|NCT02886806|propofol|propofol
108695|NCT02886767|skin to skin contact|skin to skin contact
108696|NCT02886754|Clinical Communication|clinical communication
108697|NCT02886754|ISBAR|isbar
108698|NCT02886754|Simulation|simulation
108699|NCT02886754|Performance|performance
108700|NCT02886754|Non technical skills|non technical skills
108701|NCT02886754|Proficiency|proficiency
108702|NCT02886741|campaign|campaign
108703|NCT02886741|surgical site infection|surgical site infection
108704|NCT02886741|orthopedic surgery|orthopedic surgery
108705|NCT02886741|quality improvement|quality improvement
108706|NCT02886741|infection control|infection control
108707|NCT02886650|Paediatrics|paediatrics
108708|NCT02886650|epilepsy surgery|epilepsy surgery
108709|NCT02886650|genetic mutation|genetic mutation
108710|NCT02886650|focal seizures|focal seizures
108711|NCT02886637|A baumannii infection|a baumannii infection
108712|NCT02886637|Immunosuppression|immunosuppression
108713|NCT02886637|prognosis|prognosis
108714|NCT02886637|immune function|immune function
108715|NCT02886585|Brain Metastases|brain metastases
108716|NCT02886559|demethylating agent|demethylating agent
108717|NCT02886559|chidamide|chidamide
108718|NCT02886533|Major haemorrhage|major haemorrhage
108719|NCT02886533|Oral anticoagulation|oral anticoagulation
108720|NCT02886533|Antiplatelet drugs|antiplatelet drugs
108721|NCT02886533|Gastrointestinal bleeding|gastrointestinal bleeding
108722|NCT02886533|Intracranial haemorrhage|intracranial haemorrhage
108723|NCT02886520|Urinary incontinence|urinary incontinence
108724|NCT02886520|Materials|materials
108725|NCT02886520|Surgery|surgery
108726|NCT02886520|Transobturator tape|transobturator tape
108727|NCT02886520|Polyvinylidene fluoride|polyvinylidene fluoride
108728|NCT02886520|Polypropylene|polypropylene
108729|NCT02886481|thyroidectomy|thyroidectomy
108730|NCT02886481|Electrophysiologic|electrophysiologic
108731|NCT02886481|vocal cord movement|vocal cord movement
108732|NCT02886429|dexmedetomidine|dexmedetomidine
108733|NCT02886429|bupivacaine|bupivacaine
108734|NCT02886429|Ultrasound guided paravertebral block|ultrasound guided paravertebral block
108735|NCT02886429|pain|pain
108736|NCT02886429|post-thoracotomy|post-thoracotomy
108737|NCT02886416|HIV infection|hiv infection
108738|NCT02886390|remote ischemic conditioning|remote ischemic conditioning
108739|NCT02886390|r-tPA thrombolytic therapy|r-tpa thrombolytic therapy
108740|NCT02886351|Moderate Sedation|moderate sedation
108741|NCT02886351|Pediatric Dentistry|pediatric dentistry
108742|NCT02886351|Anxiety|anxiety
108743|NCT02886325|Receipt of Preventive Cancer Screening|receipt of preventive cancer screening
108744|NCT02886299|Fibrates|fibrates
108745|NCT02886299|Statins|statins
108746|NCT02886299|Hemodialysis|hemodialysis
108747|NCT02886299|Dyslipidemia|dyslipidemia
108748|NCT02886299|Improved Oxidative Stress|improved oxidative stress
108749|NCT02886299|Egypt|egypt
108750|NCT02886273|Sudden Cardiac Arrest|sudden cardiac arrest
108751|NCT02886273|Out-of-hospital|out-of-hospital
108752|NCT02886273|Ventricular fibrillation|ventricular fibrillation
108753|NCT02886273|Classification|classification
108754|NCT02886273|Mechanisms|mechanisms
108755|NCT02886273|Biomarkers|biomarkers
108756|NCT02886234|HIV|hiv
108757|NCT02886234|Mindfulness|mindfulness
108758|NCT02886234|Adherence behaviors|adherence behaviors
108759|NCT02886234|Stress|stress
108760|NCT02886234|Depression|depression
108761|NCT02886221|Hallux Valgus|hallux valgus
108762|NCT02886221|Reverdin-Isham Osteotomy|reverdin-isham osteotomy
108763|NCT02886221|Minimally Invasive Surgery|minimally invasive surgery
108764|NCT02886221|Percutaneous Distal Osteotomy|percutaneous distal osteotomy
108765|NCT02886221|First Ray|first ray
108766|NCT02886221|Forefoot|forefoot
108767|NCT02886182|chronic hepatitis B|chronic hepatitis b
108768|NCT02886182|pregnancy|pregnancy
108769|NCT02886182|Cellular immune response|cellular immune response
108770|NCT02886182|Clinical implications|clinical implications
108771|NCT02886169|Sacha Inchi|sacha inchi
108772|NCT02886169|High-fat meal|high-fat meal
108773|NCT02886169|Postprandial inflammatory responses|postprandial inflammatory responses
108774|NCT02886156|OSA|osa
108775|NCT02886156|CPAP|cpap
108776|NCT02886156|cognitive function|cognitive function
108777|NCT02886156|gut microbiota|gut microbiota
108778|NCT02886156|metabolomics|metabolomics
108779|NCT02886130|Alpha-GPC|alpha-gpc
108780|NCT02886130|Volleyball|volleyball
108782|NCT02886130|Executive functions|executive functions
108783|NCT02886130|Vertical jump|vertical jump
108784|NCT02886130|Peak power|peak power
108785|NCT02886104|synchronous|synchronous
108786|NCT02886104|metachronous|metachronous
108787|NCT02886104|colorectal liver metastasis|colorectal liver metastasis
108788|NCT02886104|resection|resection
108789|NCT02886104|ablation|ablation
108790|NCT02886091|Keloids|keloids
108791|NCT02886091|Shaving|shaving
108792|NCT02886091|Ears|ears
108793|NCT02886091|Cryosurgery|cryosurgery
108794|NCT02886091|Hypertrophic scars|hypertrophic scars
108795|NCT02886065|Myeloma|myeloma
108796|NCT02886052|Cognitive behavior therapy|cognitive behavior therapy
108797|NCT02886052|Internet treatment|internet treatment
108798|NCT02886052|Self-help treatment|self-help treatment
108799|NCT02886052|Insomnia|insomnia
108800|NCT02886052|ICBT|icbt
108801|NCT02886052|CBT-i|cbt-i
108802|NCT02886052|Bereavement|bereavement
108803|NCT02886039|Cardiorespiratory arrest|cardiorespiratory arrest
108804|NCT02886039|Neurologic outcome|neurologic outcome
108805|NCT02886039|Electroencephalogram|electroencephalogram
108806|NCT02886039|Somatosensory evoked potential|somatosensory evoked potential
108807|NCT02886039|Synek classification|synek classification
108808|NCT02886039|Cerebral performance category|cerebral performance category
108809|NCT02886039|Hypothermia|hypothermia
108810|NCT02886026|Laser|laser
108811|NCT02886026|Bladder cancer|bladder cancer
108812|NCT02886026|Treatment|treatment
108813|NCT02886026|Outpatient|outpatient
108814|NCT02886026|TUR-BT|tur-bt
108815|NCT02886013|prevalence|prevalence
108816|NCT02885974|Celecoxib|celecoxib
108817|NCT02885974|Bladder Cancer|bladder cancer
108818|NCT02885909|type 2 diabetes|type 2 diabetes
108819|NCT02885909|inpatient|inpatient
108820|NCT02885909|glucose control|glucose control
108821|NCT02885909|continue glucose monitor|continue glucose monitor
108822|NCT02885896|Call center|call center
108823|NCT02885896|nurses|nurses
108824|NCT02885896|pediatrics|pediatrics
108825|NCT02885896|standardized messages|standardized messages
108826|NCT02885896|family counseling|family counseling
108827|NCT02885870|biomarker|biomarker
108828|NCT02885870|spinal cord disease|spinal cord disease
108829|NCT02885870|resonance imaging|resonance imaging
108830|NCT02885870|electrophysiology|electrophysiology
108831|NCT02885831|Abduction splint|abduction splint
108832|NCT02885831|Pubo-femoral distance|pubo-femoral distance
108833|NCT02885792|Schizophrenia|schizophrenia
108834|NCT02885792|Cardiovascular disease|cardiovascular disease
108835|NCT02885792|Premature mortality|premature mortality
108836|NCT02885792|Arteriosclerosis|arteriosclerosis
108837|NCT02885792|Risk factor|risk factor
108838|NCT02885792|Intervention|intervention
108839|NCT02885792|Treatment|treatment
108840|NCT02885792|Somatic morbidity|somatic morbidity
108841|NCT02885766|CML|cml
108842|NCT02885766|Myeloid leukaemia chronic|myeloid leukaemia chronic
108843|NCT02885766|CML progression|cml progression
108844|NCT02885766|Chronic phase chronic myeloid leukemia|chronic phase chronic myeloid leukemia
108845|NCT02885766|PF-114|pf-114
108846|NCT02885766|Cytogenetic response CCyR|cytogenetic response ccyr
108847|NCT02885766|Major molecular response MMR|major molecular response mmr
108848|NCT02885766|Complete molecular response CMR|complete molecular response cmr
108849|NCT02885766|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
108850|NCT02885766|2-nd generation Bcr-Abl inhibitors resistant|2-nd generation bcr-abl inhibitors resistant
108851|NCT02885753|colorectal|colorectal
108852|NCT02885753|cancer|cancer
108853|NCT02885753|metastasis|metastasis
108854|NCT02885753|hepatic|hepatic
108855|NCT02885701|postoperative dressing|postoperative dressing
108856|NCT02885701|postoperative splint|postoperative splint
108857|NCT02885701|mini-open carpal tunnel release|mini-open carpal tunnel release
108858|NCT02885688|Septic Shock|septic shock
108859|NCT02885688|Sepsis|sepsis
108860|NCT02885688|Standard of care|standard of care
108861|NCT02885688|Liquid nutrition|liquid nutrition
108862|NCT02885688|Metabolic support|metabolic support
108863|NCT02885688|Enteral nutrition|enteral nutrition
108864|NCT02885688|Insulin Drip|insulin drip
108865|NCT02885688|Glucose Drip|glucose drip
108866|NCT02885662|Primary aldosteronism|primary aldosteronism
108867|NCT02885662|Hypertension|hypertension
108868|NCT02885662|mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
108869|NCT02885662|Developmental Phase III|developmental phase iii
108870|NCT02885636|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
108871|NCT02885636|Pulmonary Hypertension|pulmonary hypertension
108872|NCT02885597|Juanbi Pill|juanbi pill
108873|NCT02885597|Methotrexate|methotrexate
108874|NCT02885597|Active|active
108875|NCT02885597|Rheumatoid Arthritis|rheumatoid arthritis
108876|NCT02885584|Mechanical ventilation|mechanical ventilation
108877|NCT02885558|Receptors, Calcium Channel Blocker|receptors, calcium channel blocker
108878|NCT02885532|alcohol|alcohol
108879|NCT02885519|Vocational Rehabilitation|vocational rehabilitation
108880|NCT02885519|Common Mental Disorders|common mental disorders
109186|NCT02883517|digital PCR|digital pcr
108881|NCT02885519|Return to Work|return to work
108882|NCT02885519|Mental Health Services|mental health services
108883|NCT02885519|Psychological Stress|psychological stress
108884|NCT02885519|Adjustment Disorder|adjustment disorder
108885|NCT02885519|Burnout|burnout
108886|NCT02885519|Integration|integration
108887|NCT02885519|Cognitive Behavior Therapy|cognitive behavior therapy
108888|NCT02885493|Parkinson march|parkinson march
108889|NCT02885467|Total Knee Arthroplasty|total knee arthroplasty
108890|NCT02885441|Inflammation|inflammation
108891|NCT02885389|Infantile spasms|infantile spasms
108892|NCT02885389|West syndrome|west syndrome
108893|NCT02885389|variant|variant
108894|NCT02885389|mutation|mutation
108895|NCT02885389|CNV|cnv
108896|NCT02885389|sequencing|sequencing
108897|NCT02885376|Mucositis|mucositis
108898|NCT02885337|Frail Elderly|frail elderly
108899|NCT02885337|Arthroplasty|arthroplasty
108900|NCT02885337|Frailty|frailty
108901|NCT02885324|High Grade Glioma|high grade glioma
108902|NCT02885324|Cabozantinib|cabozantinib
108903|NCT02885324|GBM|gbm
108904|NCT02885324|Children|children
108905|NCT02885324|AA|aa
108906|NCT02885311|Drinking|drinking
108907|NCT02885311|Excessive drinking|excessive drinking
108908|NCT02885311|Alcohol use disorders|alcohol use disorders
108909|NCT02885311|Primary Care|primary care
108910|NCT02885285|Parkinson's disease|parkinson's disease
108911|NCT02885285|fatigue|fatigue
108912|NCT02885285|anxiety|anxiety
108913|NCT02885285|depression|depression
108914|NCT02885285|exercise|exercise
108915|NCT02885272|Malignant neoplasms of eye brain and other parts of central nervous system|malignant neoplasms of eye brain and other parts of central nervous system
108916|NCT02885272|Glioblastoma|glioblastoma
108917|NCT02885272|FDG PET|fdg pet
108918|NCT02885272|CT|ct
108919|NCT02885272|MRI|mri
108920|NCT02885246|Panama|panama
108921|NCT02885246|Influenza B|influenza b
108922|NCT02885246|Influenza A|influenza a
108923|NCT02885246|Strain circulation|strain circulation
108924|NCT02885246|Database|database
108925|NCT02885233|Fall Prevention|fall prevention
108926|NCT02885233|Multiple Sclerosis|multiple sclerosis
108927|NCT02885233|Web-based education|web-based education
108928|NCT02885233|Self-efficacy|self-efficacy
108929|NCT02885207|Limbic encephalitis|limbic encephalitis
108930|NCT02885207|anti-neuronal antibodies|anti-neuronal antibodies
108931|NCT02885194|Parkinson Disease|parkinson disease
108932|NCT02885194|Pain|pain
108933|NCT02885194|Deep Brain Stimulation|deep brain stimulation
108934|NCT02885194|Laser-Evoked Potentials|laser-evoked potentials
108935|NCT02885168|vasoreactivity|vasoreactivity
108936|NCT02885168|recombinant activated protein C|recombinant activated protein c
108937|NCT02885116|NHF|nhf
108938|NCT02885116|pulmonary hypertension|pulmonary hypertension
108939|NCT02885103|NHF|nhf
108940|NCT02885103|nasal highflow|nasal highflow
108941|NCT02885038|Platelet Transfusion|platelet transfusion
108942|NCT02885025|hypersensitivity|hypersensitivity
108943|NCT02885025|antioxidants|antioxidants
108944|NCT02884999|trauma|trauma
108945|NCT02884999|bleeding|bleeding
108946|NCT02884999|coagulopathy|coagulopathy
108947|NCT02884999|guidelines compliance|guidelines compliance
108948|NCT02884999|recommendation|recommendation
108949|NCT02884999|transfusion|transfusion
108950|NCT02884986|Etoricoxib|etoricoxib
108951|NCT02884986|Spinal anaesthesia|spinal anaesthesia
108952|NCT02884986|Postoperative pain|postoperative pain
108953|NCT02884973|congenital heart|congenital heart
108955|NCT02884960|Uterine Fibroids|uterine fibroids
108956|NCT02884960|Embolization|embolization
108957|NCT02884947|Brain Neoplasms|brain neoplasms
108958|NCT02884947|Magnetic Resonance Imaging|magnetic resonance imaging
108959|NCT02884947|Neurosurgery|neurosurgery
108960|NCT02884934|venous thromboembolism|venous thromboembolism
108961|NCT02884934|recurrent venous thromboembolism|recurrent venous thromboembolism
108962|NCT02884934|anticoagulant-related bleeding|anticoagulant-related bleeding
108963|NCT02884921|Postoperative pain|postoperative pain
108964|NCT02884921|Dental treatment|dental treatment
108965|NCT02884921|Paracetamol|paracetamol
108966|NCT02884895|Intubating Laryngeal Tube Suction|intubating laryngeal tube suction
108967|NCT02884895|Blind intubation|blind intubation
108968|NCT02884882|Stroke Basal Ganglia|stroke basal ganglia
108969|NCT02884882|Emotional change|emotional change
108970|NCT02884869|Blind intubation,|blind intubation,
108971|NCT02884869|Laryngeal Mask Airway|laryngeal mask airway
108972|NCT02884856|color|color
108973|NCT02884856|dentistry|dentistry
108974|NCT02884856|gender|gender
108975|NCT02884843|Laryngeal Tube|laryngeal tube
108976|NCT02884843|blind intubation|blind intubation
108977|NCT02884843|fiberoptic|fiberoptic
108978|NCT02884804|Postpartum Hemorrhage|postpartum hemorrhage
108979|NCT02884804|Immature platelet|immature platelet
108980|NCT02884791|FGF21|fgf21
108981|NCT02884791|Fibroblast growth factor|fibroblast growth factor
108982|NCT02884791|fructose|fructose
108983|NCT02884778|pain|pain
108984|NCT02884778|monitoring|monitoring
108985|NCT02884778|anesthesia|anesthesia
108986|NCT02884765|mandibular condyle|mandibular condyle
108987|NCT02884765|subcondylar|subcondylar
108988|NCT02884765|mandible|mandible
108989|NCT02884765|fracture|fracture
108990|NCT02884700|Legionella|legionella
108991|NCT02884700|Legionnaires' disease|legionnaires' disease
108992|NCT02884700|Diagnosis|diagnosis
108993|NCT02884700|Prognosis|prognosis
108994|NCT02884674|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
108995|NCT02884674|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
108996|NCT02884648|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
108997|NCT02884648|Ovarian Cancer|ovarian cancer
108998|NCT02884648|Fallopian tube cancer|fallopian tube cancer
108999|NCT02884648|Primary peritoneal cancer|primary peritoneal cancer
109000|NCT02884648|Bevacizumab|bevacizumab
109001|NCT02884648|Avastin|avastin
109002|NCT02884648|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
109003|NCT02884648|rhuMab-VEGF|rhumab-vegf
109004|NCT02884635|Methotrexate|methotrexate
109005|NCT02884635|ASP1707|asp1707
109006|NCT02884635|Rheumatoid arthritis|rheumatoid arthritis
109007|NCT02884622|Lung disease|lung disease
109008|NCT02884622|Epigenetics|epigenetics
109009|NCT02884622|DNA methylation|dna methylation
109010|NCT02884622|Modifier genes|modifier genes
109011|NCT02884596|Inferior alveolar nerve block|inferior alveolar nerve block
109012|NCT02884596|irreversible pulpitis|irreversible pulpitis
109013|NCT02884596|selective serotonin reuptake inhibitor antidepressants|selective serotonin reuptake inhibitor antidepressants
109014|NCT02884583|Food allergy|food allergy
109015|NCT02884583|asthma|asthma
109016|NCT02884583|Predictive factor|predictive factor
109017|NCT02884583|Exacerbation|exacerbation
109018|NCT02884583|Prevalence|prevalence
109019|NCT02884570|Tracheotomy|tracheotomy
109020|NCT02884570|Anxiety|anxiety
109021|NCT02884570|Depression|depression
109022|NCT02884570|Back Home|back home
109023|NCT02884518|dopamine receptor occupancy|dopamine receptor occupancy
109024|NCT02884518|antipsychotics|antipsychotics
109025|NCT02884518|positron emission tomography|positron emission tomography
109026|NCT02884492|inflammation|inflammation
109027|NCT02884492|aging|aging
109028|NCT02884492|mild cognitive impairment|mild cognitive impairment
109029|NCT02884453|gastrooesophageal carcinoma|gastrooesophageal carcinoma
109030|NCT02884427|Direct current|direct current
109031|NCT02884427|Dynamometry|dynamometry
109032|NCT02884427|Hand strength|hand strength
109033|NCT02884427|Electrotherapy|electrotherapy
109034|NCT02884427|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
109035|NCT02884414|Knee Pathology|knee pathology
109036|NCT02884375|Elderly|elderly
109037|NCT02884375|Cancer|cancer
109038|NCT02884375|Geriatric assessment|geriatric assessment
109039|NCT02884375|Treatment|treatment
109040|NCT02884375|Epidemiology|epidemiology
109041|NCT02884362|melanoma clinical biological database|melanoma clinical biological database
109042|NCT02884349|Computer aided orthopaedic surgery|computer aided orthopaedic surgery
109043|NCT02884349|Implant orientation|implant orientation
109044|NCT02884349|Range of motion|range of motion
109045|NCT02884310|Remifentanil|remifentanil
109046|NCT02884310|Heart Rate Variability|heart rate variability
109047|NCT02884310|Pupil dilation|pupil dilation
109048|NCT02884310|SPI|spi
109049|NCT02884284|breast cancer|breast cancer
109050|NCT02884284|database|database
109051|NCT02884271|CPR|cpr
109052|NCT02884271|cardiac arrest|cardiac arrest
109053|NCT02884271|operating room|operating room
109054|NCT02884258|Assisted Reproductive Technology|assisted reproductive technology
109055|NCT02884258|Obesity|obesity
109056|NCT02884258|Bariatric Surgery|bariatric surgery
109057|NCT02884258|Infertility|infertility
109058|NCT02884258|Fertility Preservation|fertility preservation
109059|NCT02884245|Fertility|fertility
109060|NCT02884245|Reproductive processes|reproductive processes
109061|NCT02884245|In vitro fertilization|in vitro fertilization
109062|NCT02884245|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
109063|NCT02884245|Estrogens|estrogens
109064|NCT02884245|Follicule Stimulating Hormon|follicule stimulating hormon
109065|NCT02884219|Early treatment|early treatment
109066|NCT02884219|Expectative treatment|expectative treatment
109067|NCT02884219|Patent ductus arteriosus|patent ductus arteriosus
109068|NCT02884219|Preterm|preterm
109069|NCT02884206|heart failure|heart failure
109070|NCT02884206|cognition|cognition
109071|NCT02884206|positron emission tomography|positron emission tomography
109072|NCT02884206|magnetic resonance imaging|magnetic resonance imaging
109073|NCT02884206|LCZ696|lcz696
109074|NCT02884206|valsartan|valsartan
109075|NCT02884206|Chronic heart failure|chronic heart failure
109077|NCT02884193|Cooling|cooling
109078|NCT02884193|Cryotherapy|cryotherapy
109079|NCT02884193|isometric Force|isometric force
109080|NCT02884193|Palmar Grip|palmar grip
109081|NCT02884193|Dynamometry|dynamometry
109082|NCT02884180|Dexamethasone|dexamethasone
109083|NCT02884180|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
109084|NCT02884180|Revision|revision
109085|NCT02884154|Endoscopic ultrasonography|endoscopic ultrasonography
109086|NCT02884154|Biopsy|biopsy
109087|NCT02884154|Gastrointestinal tract|gastrointestinal tract
109088|NCT02884154|Subepithelial tumor|subepithelial tumor
109089|NCT02884141|Renal Artery Obstruction|renal artery obstruction
109090|NCT02884141|Carotid Artery Diseases|carotid artery diseases
109091|NCT02884141|Genetic Association Studies|genetic association studies
109092|NCT02884102|genetic sequencing|genetic sequencing
109093|NCT02884102|relapsed|relapsed
109094|NCT02884076|Hemorrhoids|hemorrhoids
109095|NCT02884076|Sodergren score|sodergren score
109096|NCT02884076|Validation|validation
109097|NCT02884063|PGS|pgs
109098|NCT02884063|PGD|pgd
109099|NCT02884063|free embryo DNA|free embryo dna
109100|NCT02884063|NGS|ngs
109101|NCT02884037|NAFLD|nafld
109102|NCT02884037|Rifaximin|rifaximin
109103|NCT02884037|Endotoxin and Homeostatic Model Assessment|endotoxin and homeostatic model assessment
109104|NCT02884024|obesity|obesity
109105|NCT02884024|inflammation|inflammation
109106|NCT02884024|cancer risk|cancer risk
109107|NCT02884011|Chronic antihypertensives|chronic antihypertensives
109108|NCT02884011|Septic shock|septic shock
109109|NCT02884011|Vasopressor|vasopressor
109110|NCT02884011|Vasopressor dosing|vasopressor dosing
109111|NCT02883998|home-based physical therapy|home-based physical therapy
109112|NCT02883998|outpatient physical therapy|outpatient physical therapy
109113|NCT02883998|unicompartmental knee arthroplasty|unicompartmental knee arthroplasty
109114|NCT02883998|PT (Physical Therapy)|pt (physical therapy)
109115|NCT02883998|osteoarthritis|osteoarthritis
109116|NCT02883972|Immunization|immunization
109117|NCT02883972|Behavioural insights|behavioural insights
109118|NCT02883972|Children|children
109119|NCT02883959|critically ill|critically ill
109120|NCT02883959|mechanical ventilation|mechanical ventilation
109121|NCT02883959|pain|pain
109122|NCT02883959|nursing|nursing
109123|NCT02883959|music|music
109124|NCT02883842|Coronary artery disease|coronary artery disease
109125|NCT02883842|Diabetes|diabetes
109126|NCT02883842|Text messages|text messages
109127|NCT02883777|Kidney Transplantation|kidney transplantation
109128|NCT02883777|Low Glycemic Index|low glycemic index
109129|NCT02883777|High Protein|high protein
109130|NCT02883764|eicosapentaenoic acid|eicosapentaenoic acid
109131|NCT02883764|EPA|epa
109132|NCT02883764|docosahexaenoic acid|docosahexaenoic acid
109133|NCT02883764|DHA|dha
109134|NCT02883764|omega-3 index|omega-3 index
109135|NCT02883751|diabetes mellitus|diabetes mellitus
109136|NCT02883751|amputation stumps|amputation stumps
109137|NCT02883751|diabetic foot|diabetic foot
109138|NCT02883751|phototherapy|phototherapy
109139|NCT02883751|clinical trial|clinical trial
109140|NCT02883725|Esophageal atresia|esophageal atresia
109141|NCT02883712|epilepsy|epilepsy
109142|NCT02883712|pharmacoresistant|pharmacoresistant
109143|NCT02883712|antiepileptic drug|antiepileptic drug
109144|NCT02883712|pharmacokinetic|pharmacokinetic
109145|NCT02883712|pharmacodynamic|pharmacodynamic
109146|NCT02883712|pharmacogenetic|pharmacogenetic
109147|NCT02883699|Breast cancer|breast cancer
109148|NCT02883699|Prostate cancer|prostate cancer
109149|NCT02883699|Exercise prescription|exercise prescription
109150|NCT02883699|High intensity interval training|high intensity interval training
109151|NCT02883699|Daily undulating periodization training|daily undulating periodization training
109152|NCT02883699|Aerobic training|aerobic training
109153|NCT02883699|Resistance training|resistance training
109154|NCT02883699|Physical fitness|physical fitness
109155|NCT02883699|Exercise|exercise
109156|NCT02883686|depression|depression
109157|NCT02883686|pregnancy|pregnancy
109158|NCT02883686|behavioral activation|behavioral activation
109159|NCT02883686|peer delivery|peer delivery
109160|NCT02883686|effectiveness|effectiveness
109161|NCT02883673|Postpartum Hemorrhage|postpartum hemorrhage
109162|NCT02883660|genetics|genetics
109163|NCT02883660|Antidepressants|antidepressants
109164|NCT02883647|chronic hepatitis b, nucleos(t)ide analog|chronic hepatitis b, nucleos(t)ide analog
109165|NCT02883634|Back pain|back pain
109166|NCT02883634|spinal manipulation|spinal manipulation
109167|NCT02883621|upper endoscopy|upper endoscopy
109168|NCT02883621|cap assisted endoscopy|cap assisted endoscopy
109169|NCT02883621|esophagus|esophagus
109170|NCT02883608|Papilla|papilla
109171|NCT02883608|major duodenal papilla|major duodenal papilla
109172|NCT02883608|ampulla of vater|ampulla of vater
109173|NCT02883595|thymosin alpha 1; sepsis; monocyte; pharmacokinetics|thymosin alpha 1; sepsis; monocyte; pharmacokinetics
109174|NCT02883582|asthma ,hydrogen|asthma ,hydrogen
109175|NCT02883569|Low back pain|low back pain
109176|NCT02883569|Intervertebral Disc Degeneration|intervertebral disc degeneration
109177|NCT02883569|Spinal stenosis|spinal stenosis
109178|NCT02883569|Comparative Effectiveness Research|comparative effectiveness research
109179|NCT02883569|Cost-Benefit Analysis|cost-benefit analysis
109180|NCT02883556|Carcinoma|carcinoma
109181|NCT02883556|Squamous Cell|squamous cell
109182|NCT02883556|Skin|skin
109183|NCT02883556|pembrolizumab|pembrolizumab
109184|NCT02883556|Programmed Cell Death 1 Ligand 1|programmed cell death 1 ligand 1
109185|NCT02883517|cell-free circulating DNA;|cell-free circulating dna;
109187|NCT02883517|liquid biopsy|liquid biopsy
109188|NCT02883504|E/e' ratio|e/e' ratio
109189|NCT02883504|Doppler echocardiography, filling pressure|doppler echocardiography, filling pressure
109190|NCT02883504|Left Ventricular end-Diastolic Pressure|left ventricular end-diastolic pressure
109191|NCT02883465|diaphragmatic dysfunction|diaphragmatic dysfunction
109192|NCT02883465|mechanical ventilation weaning|mechanical ventilation weaning
109193|NCT02883465|failure extubation rate|failure extubation rate
109194|NCT02883439|MP29-02|mp29-02
109195|NCT02883426|H3N2v Influenza Viruses|h3n2v influenza viruses
109196|NCT02883413|Adolescents|adolescents
109197|NCT02883413|Cognitive Flexibility|cognitive flexibility
109198|NCT02883413|Behavioral Flexibility|behavioral flexibility
109199|NCT02883387|DIEP flap|diep flap
109200|NCT02883387|Deep inferior epigastric artery perforator flap|deep inferior epigastric artery perforator flap
109201|NCT02883374|cephalic and cervical adenocystic Carcinoma|cephalic and cervical adenocystic carcinoma
109202|NCT02883374|Chidamide|chidamide
109203|NCT02883309|Hemodialysis|hemodialysis
109204|NCT02883309|Skeletal muscle|skeletal muscle
109205|NCT02883309|Exercise|exercise
109206|NCT02883309|Rehabilitation|rehabilitation
109207|NCT02883309|Disability Evaluation|disability evaluation
109208|NCT02883257|Major Depression|major depression
109209|NCT02883257|Major Depressive Disorder|major depressive disorder
109210|NCT02883257|Persistent Depressive Disorder|persistent depressive disorder
109211|NCT02883257|Cognitive Behavioral Therapy|cognitive behavioral therapy
109212|NCT02883257|Biomarkers|biomarkers
109213|NCT02883218|immunosuppression|immunosuppression
109214|NCT02883218|community-acquired sepsis|community-acquired sepsis
109215|NCT02883218|mortality|mortality
109216|NCT02883192|Cesarean section|cesarean section
109217|NCT02883192|spinal anesthesia|spinal anesthesia
109218|NCT02883192|hypotension|hypotension
109219|NCT02883192|ondansetron|ondansetron
109220|NCT02883153|Zirconium-89|zirconium-89
109222|NCT02883153|imaging|imaging
109223|NCT02883153|girentuximab|girentuximab
109224|NCT02883140|Sialography|sialography
109225|NCT02883140|Cone-beam CT|cone-beam ct
109226|NCT02883140|MRI sialography|mri sialography
109227|NCT02883140|non tumor salivary symptoms|non tumor salivary symptoms
109228|NCT02883127|Motivational Interviewing|motivational interviewing
109229|NCT02883127|Diet|diet
109230|NCT02883127|Carbohydrates|carbohydrates
109231|NCT02883127|Psychosocial factors|psychosocial factors
109232|NCT02883114|PF-06648671|pf-06648671
109233|NCT02883114|GSM|gsm
109234|NCT02883114|CYP3A|cyp3a
109235|NCT02883114|drug interaction|drug interaction
109236|NCT02883088|Optical coherence tomograhpy|optical coherence tomograhpy
109237|NCT02883088|registry|registry
109238|NCT02883088|Coronary artery disease|coronary artery disease
109239|NCT02883036|tigecycline|tigecycline
109240|NCT02883036|treatment|treatment
109241|NCT02883036|mitochondrial biogenesis|mitochondrial biogenesis
109242|NCT02883036|metabolic characteristics|metabolic characteristics
109243|NCT02883023|Bleomycin|bleomycin
109244|NCT02883023|Electroporation|electroporation
109245|NCT02883010|Surgical incision|surgical incision
109246|NCT02883010|surgical complication|surgical complication
109247|NCT02883010|NPWT|npwt
109248|NCT02883010|negative pressure|negative pressure
109249|NCT02883010|colorectal surgery|colorectal surgery
109250|NCT02883010|dehisced|dehisced
109251|NCT02882971|chronic pain|chronic pain
109252|NCT02882971|rating scale|rating scale
109253|NCT02882958|Radiology|radiology
109254|NCT02882932|peritonitis|peritonitis
109255|NCT02882932|solutions|solutions
109256|NCT02882932|normal saline|normal saline
109257|NCT02882932|infection|infection
109258|NCT02882932|peritoneal lavage|peritoneal lavage
109259|NCT02882906|Stroke|stroke
109260|NCT02882906|Pain|pain
109261|NCT02882906|Shoulder|shoulder
109262|NCT02882867|Prospective|prospective
109263|NCT02882867|Epidemiology|epidemiology
109264|NCT02882867|Track and Field|track and field
109265|NCT02882841|AIEC (Adherent and Invasive Escherichia Coli)|aiec (adherent and invasive escherichia coli)
109266|NCT02882841|Mucosal Healing|mucosal healing
109267|NCT02882841|Non-invasive biomarkers|non-invasive biomarkers
109268|NCT02882815|IrisFIT PFO|irisfit pfo
109269|NCT02882802|anger|anger
109270|NCT02882802|aggression|aggression
109271|NCT02882763|Early intervention|early intervention
109272|NCT02882763|ECCE|ecce
109273|NCT02882763|Intervention study|intervention study
109274|NCT02882763|Child development|child development
109275|NCT02882763|At-risk families|at-risk families
109276|NCT02882763|Psychosocial stress|psychosocial stress
109277|NCT02882763|Prevention|prevention
109278|NCT02882763|Educational opportunities|educational opportunities
109279|NCT02882763|Randomized controlled trial|randomized controlled trial
109280|NCT02882763|Evaluation|evaluation
109281|NCT02882763|Parenting|parenting
109282|NCT02882763|Parent-child interaction|parent-child interaction
109283|NCT02882750|Lung Cancer|lung cancer
109284|NCT02882750|Quality of Life|quality of life
109285|NCT02882750|VATS|vats
109286|NCT02882750|SABR|sabr
109287|NCT02882698|Down syndrome|down syndrome
109288|NCT02882698|motor skills|motor skills
109289|NCT02882698|physiotherapy|physiotherapy
109290|NCT02882698|mobile telephone|mobile telephone
109291|NCT02882698|exposure to virtual reality therapy|exposure to virtual reality therapy
109292|NCT02882685|Roux-en-Y gastric bypass|roux-en-y gastric bypass
109293|NCT02882685|Mini-gastric bypass|mini-gastric bypass
109294|NCT02882685|Single anastomosis gastric bypass|single anastomosis gastric bypass
109295|NCT02882659|Clinical Trial, Phase I|clinical trial, phase i
109296|NCT02882646|stroke|stroke
109297|NCT02882646|cerebral palsy|cerebral palsy
109298|NCT02882646|rehabilitation|rehabilitation
109299|NCT02882646|robotics|robotics
109300|NCT02882646|therapy|therapy
109301|NCT02882646|bilateral|bilateral
109302|NCT02882633|lumbar plexus block|lumbar plexus block
109303|NCT02882633|fascia iliac block|fascia iliac block
109304|NCT02882633|quality of recovery score|quality of recovery score
109305|NCT02882633|pain score|pain score
109306|NCT02882620|Colorectal neoplasm|colorectal neoplasm
109307|NCT02882620|Screening|screening
109308|NCT02882620|Patient navigation|patient navigation
109309|NCT02882620|Randomized controlled trial|randomized controlled trial
109310|NCT02882620|Cost-benefit analysis|cost-benefit analysis
109311|NCT02882620|Health behavior|health behavior
109312|NCT02882620|Health equity|health equity
109313|NCT02882620|American Indians|american indians
109314|NCT02882620|Community-based participatory research|community-based participatory research
109315|NCT02882620|Fecal occult blood test|fecal occult blood test
109316|NCT02882607|HIV|hiv
109317|NCT02882607|Prevention|prevention
109318|NCT02882607|unintended pregnancy|unintended pregnancy
109319|NCT02882607|Malawi|malawi
109320|NCT02882607|adolescent women|adolescent women
109321|NCT02882607|community|community
109322|NCT02882607|rural|rural
109323|NCT02882581|Metformin|metformin
109324|NCT02882581|Pharmacokinetics|pharmacokinetics
109325|NCT02882581|Organic cation transporter|organic cation transporter
109326|NCT02882581|Multidrug and toxin extrusion|multidrug and toxin extrusion
109327|NCT02882581|Pharmacogenetics|pharmacogenetics
109328|NCT02882581|positron emission tomography|positron emission tomography
109329|NCT02882542|cerebral oxygen metabolism|cerebral oxygen metabolism
109330|NCT02882542|functional near-infrared spectroscopy|functional near-infrared spectroscopy
109331|NCT02882542|partial pressure of carbon dioxide|partial pressure of carbon dioxide
109332|NCT02882542|heart rate variability|heart rate variability
109333|NCT02882542|blood pressure|blood pressure
109334|NCT02882542|affect|affect
109335|NCT02882542|mood|mood
109336|NCT02882542|respiration|respiration
109337|NCT02882542|systematic randomized cross-over study|systematic randomized cross-over study
109338|NCT02882542|systemic physiology|systemic physiology
109339|NCT02882542|electro-dermal activity|electro-dermal activity
109340|NCT02882542|pulse-respiratory quotient|pulse-respiratory quotient
109341|NCT02882529|cerebral oxygen metabolism|cerebral oxygen metabolism
109342|NCT02882529|functional near-infrared spectroscopy|functional near-infrared spectroscopy
109343|NCT02882529|partial pressure of carbon dioxide|partial pressure of carbon dioxide
109344|NCT02882529|heart rate variability|heart rate variability
109345|NCT02882529|blood pressure|blood pressure
109346|NCT02882529|affect|affect
109347|NCT02882529|mood|mood
109348|NCT02882529|respiration|respiration
109349|NCT02882529|systematic randomized cross-over study|systematic randomized cross-over study
109350|NCT02882529|systemic physiology|systemic physiology
109351|NCT02882529|electro-dermal activity|electro-dermal activity
109352|NCT02882529|pulse-respiratory quotient|pulse-respiratory quotient
109353|NCT02882516|cerebral oxygen metabolism|cerebral oxygen metabolism
109354|NCT02882516|functional near-infrared spectroscopy|functional near-infrared spectroscopy
109355|NCT02882516|partial pressure of carbon dioxide|partial pressure of carbon dioxide
109356|NCT02882516|heart rate variability|heart rate variability
109357|NCT02882516|blood pressure|blood pressure
109358|NCT02882516|affect|affect
109359|NCT02882516|mood|mood
109360|NCT02882516|respiration|respiration
109361|NCT02882516|systematic randomized cross-over study|systematic randomized cross-over study
109362|NCT02882516|systemic physiology|systemic physiology
109363|NCT02882516|electro-dermal activity|electro-dermal activity
109364|NCT02882516|pulse-respiratory quotient|pulse-respiratory quotient
109365|NCT02882503|Endoscopic ultrasound|endoscopic ultrasound
109366|NCT02882503|Radiofrequency ablation|radiofrequency ablation
109367|NCT02882503|Pancreas|pancreas
109368|NCT02882490|Tourette syndrome|tourette syndrome
109369|NCT02882464|gingival recession|gingival recession
109370|NCT02882464|mucogingival surgery|mucogingival surgery
109371|NCT02882451|bile duct|bile duct
109372|NCT02882451|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
109373|NCT02882451|pinaverium bromide|pinaverium bromide
109374|NCT02882425|selexipag|selexipag
109375|NCT02882425|bioavailability|bioavailability
109376|NCT02882412|effectiveness|effectiveness
109377|NCT02882412|buprenorphine/naloxone|buprenorphine/naloxone
109378|NCT02882412|iatrogenic opioid dependence|iatrogenic opioid dependence
109379|NCT02882399|athletes|athletes
109380|NCT02882373|Hypertensive diseases|hypertensive diseases
109381|NCT02882373|Renal failure|renal failure
109382|NCT02882373|High blood pressure|high blood pressure
109383|NCT02882373|Proteinuria|proteinuria
109384|NCT02882373|L-Arginine|l-arginine
109385|NCT02882373|Placebo|placebo
109386|NCT02882373|Phone call|phone call
109387|NCT02882334|Focal Dystonia|focal dystonia
109388|NCT02882334|Writer's cramp|writer's cramp
109389|NCT02882321|Malignant Tumor of Lymphoid Hemopoietic and Related Tissue|malignant tumor of lymphoid hemopoietic and related tissue
109390|NCT02882321|Acute myeloid leukemia|acute myeloid leukemia
109392|NCT02882321|Relapsed/Refractory|relapsed/refractory
109393|NCT02882321|IACS-010759|iacs-010759
109394|NCT02882321|Phone Call follow up|phone call follow up
109395|NCT02882282|Diseases of oral cavity salivary glands and jaws|diseases of oral cavity salivary glands and jaws
109396|NCT02882282|High risk oral intra-epithelial neoplasias|high risk oral intra-epithelial neoplasias
109397|NCT02882282|IEN|ien
109398|NCT02882282|Oral pre-malignant lesion(s)|oral pre-malignant lesion(s)
109399|NCT02882282|History of invasive oral cancer|history of invasive oral cancer
109400|NCT02882282|Pembrolizumab|pembrolizumab
109401|NCT02882282|Keytruda|keytruda
109402|NCT02882282|MK-3475|mk-3475
109403|NCT02882282|SCH-900475|sch-900475
109404|NCT02882282|Observation only|observation only
109405|NCT02882269|locally advanced colon cancer|locally advanced colon cancer
109406|NCT02882269|neoadjuvant chemotherapy|neoadjuvant chemotherapy
109407|NCT02882256|laceration|laceration
109408|NCT02882256|urinary tract infection|urinary tract infection
109409|NCT02882256|minor head injury|minor head injury
109410|NCT02882256|concussion|concussion
109411|NCT02882217|Double-blind|double-blind
109412|NCT02882217|Randomized|randomized
109413|NCT02882217|Dose-escalating|dose-escalating
109414|NCT02882217|Placebo-controlled|placebo-controlled
109415|NCT02882217|Phase I|phase i
109416|NCT02882217|Healthy volunteers|healthy volunteers
109417|NCT02882217|Bronchial asthma|bronchial asthma
109418|NCT02882217|Histamine glutarimide|histamine glutarimide
109419|NCT02882217|EURRUS|eurrus
109420|NCT02882191|contraception|contraception
109421|NCT02882178|Prostate cancer|prostate cancer
109422|NCT02882178|cabazitaxel|cabazitaxel
109423|NCT02882178|consensus|consensus
109424|NCT02882178|conformity|conformity
109425|NCT02882178|prescription|prescription
109426|NCT02882178|conditions of use|conditions of use
109427|NCT02882165|COPD|copd
109428|NCT02882165|Early Intervention|early intervention
109429|NCT02882165|Risk|risk
109430|NCT02882165|Stratification|stratification
109431|NCT02882152|Analgesia|analgesia
109432|NCT02882152|Nerve Block|nerve block
109433|NCT02882152|Pain, Postoperative|pain, postoperative
109434|NCT02882139|Electrical storm|electrical storm
109435|NCT02882126|PAH|pah
109436|NCT02882126|Subcutaneous Treprostinil|subcutaneous treprostinil
109437|NCT02882126|Remodulin|remodulin
109438|NCT02882126|6 Minute Walk Test|6 minute walk test
109439|NCT02882100|influenza|influenza
109440|NCT02882100|vaccine|vaccine
109441|NCT02882100|vaccination|vaccination
109442|NCT02882100|nursing home|nursing home
109443|NCT02882100|cluster randomized trial|cluster randomized trial
109444|NCT02882100|respiratory-related hospitalization|respiratory-related hospitalization
109445|NCT02882061|neck pain|neck pain
109446|NCT02882061|physical examination|physical examination
109447|NCT02882061|thoracic manipulation|thoracic manipulation
109448|NCT02882048|Opioid addiction|opioid addiction
109449|NCT02882048|Opioid weaning|opioid weaning
109451|NCT02882035|patient comfort|patient comfort
109452|NCT02882022|Eustachian tube dysfunction|eustachian tube dysfunction
109453|NCT02882022|Audiometry|audiometry
109454|NCT02881996|appendicitis|appendicitis
109455|NCT02881996|pain|pain
109456|NCT02881996|perforation|perforation
109457|NCT02881983|alcohol use disorder|alcohol use disorder
109458|NCT02881983|emotion processing|emotion processing
109459|NCT02881983|abstinence|abstinence
109460|NCT02881983|sympathetic system|sympathetic system
109461|NCT02881983|parasympathetic system|parasympathetic system
109462|NCT02881957|critical illness|critical illness
109463|NCT02881957|craniocerebral trauma|craniocerebral trauma
109464|NCT02881957|intracranial aneurysm|intracranial aneurysm
109465|NCT02881957|spinal cord injuries|spinal cord injuries
109466|NCT02881957|seizures|seizures
109467|NCT02881957|meningitis|meningitis
109468|NCT02881957|stroke|stroke
109469|NCT02881957|vitamin d deficiency|vitamin d deficiency
109470|NCT02881957|cholecalciferol|cholecalciferol
109471|NCT02881957|intracranial hemorrhages|intracranial hemorrhages
109472|NCT02881944|Gulf War Illness|gulf war illness
109473|NCT02881944|Diet|diet
109474|NCT02881944|IBS|ibs
109475|NCT02881944|FODMAP|fodmap
109476|NCT02881931|Huntington's disease|huntington's disease
109477|NCT02881931|functional rating scale|functional rating scale
109478|NCT02881931|cognitive pre-testing|cognitive pre-testing
109479|NCT02881931|patient reported outcome (PRO)|patient reported outcome (pro)
109480|NCT02881931|HDGEC participant at Pre-Manifest stage|hdgec participant at pre-manifest stage
109481|NCT02881931|HDGEC participant at Early-Manifest stage|hdgec participant at early-manifest stage
109482|NCT02881931|Corresponding HDGEC participant companion|corresponding hdgec participant companion
109483|NCT02881892|CAPD|capd
109484|NCT02881892|Peritoneal solute transport rate|peritoneal solute transport rate
109485|NCT02881892|Dialysis adequacy|dialysis adequacy
109486|NCT02881866|Air hunger|air hunger
109487|NCT02881866|Work/effort|work/effort
109488|NCT02881866|Aerosolized|aerosolized
109489|NCT02881866|Hypercapnia|hypercapnia
109490|NCT02881866|Resistive load|resistive load
109491|NCT02881866|Nebulised|nebulised
109492|NCT02881853|healthy|healthy
109493|NCT02881853|atopic|atopic
109494|NCT02881827|Saliva|saliva
109495|NCT02881827|Low-level laser therapy|low-level laser therapy
109496|NCT02881827|Masseter muscle|masseter muscle
109497|NCT02881827|Salivary glands|salivary glands
109498|NCT02881814|Lung ultrasound|lung ultrasound
109499|NCT02881814|Chest physiotherapy|chest physiotherapy
109500|NCT02881814|Decision-making process|decision-making process
109501|NCT02881814|Diagnostic|diagnostic
109502|NCT02881801|accelerometry|accelerometry
109503|NCT02881775|TMS|tms
109504|NCT02881775|rTMS|rtms
109505|NCT02881775|corticospinal|corticospinal
109506|NCT02881775|quadriceps|quadriceps
109507|NCT02881762|hepatitis C virus (HCV)|hepatitis c virus (hcv)
109508|NCT02881762|Maraviroc|maraviroc
109509|NCT02881762|Human immunodeficiency virus (HCV)|human immunodeficiency virus (hcv)
109510|NCT02881671|genetic|genetic
109511|NCT02881671|congenital atrioventricular block|congenital atrioventricular block
109512|NCT02881671|progressive Cardiac Conduction Disease|progressive cardiac conduction disease
109513|NCT02881658|Plant sterols|plant sterols
109514|NCT02881658|Low-Density Lipoprotein Cholesterol|low-density lipoprotein cholesterol
109515|NCT02881658|Phytosterols|phytosterols
109516|NCT02881658|Soya Beverage|soya beverage
109517|NCT02881645|Intensive care units|intensive care units
109518|NCT02881645|Nursing Care|nursing care
109519|NCT02881645|Critical incidents|critical incidents
109520|NCT02881645|Best practices|best practices
109521|NCT02881619|Tooth bleaching|tooth bleaching
109522|NCT02881593|Operating in Minimally Invasive|operating in minimally invasive
109523|NCT02881567|Multiple Sclerosis|multiple sclerosis
109524|NCT02881567|Daclizumab|daclizumab
109525|NCT02881567|Tysabri-Switch|tysabri-switch
109526|NCT02881528|Type 1 Diabetes|type 1 diabetes
109527|NCT02881528|Juvenile Diabetes|juvenile diabetes
109528|NCT02881502|granulocyte activation|granulocyte activation
109529|NCT02881502|HDAC2|hdac2
109530|NCT02881502|severe asthma|severe asthma
109531|NCT02881437|Primary Immunodeficiency|primary immunodeficiency
109532|NCT02881437|SubCutaneous Immunoglobulins|subcutaneous immunoglobulins
109533|NCT02881424|Familiarity|familiarity
109534|NCT02881424|Recollection|recollection
109535|NCT02881424|Face Recognition|face recognition
109536|NCT02881424|Alcohol dependence|alcohol dependence
109537|NCT02881424|Social cognition|social cognition
109538|NCT02881411|self-soft tissue therapy|self-soft tissue therapy
109539|NCT02881411|trigger points|trigger points
109540|NCT02881411|feasibility study|feasibility study
109541|NCT02881398|Mobile Health|mobile health
109542|NCT02881398|Telemedicine|telemedicine
109543|NCT02881398|Pocket-Echocardiography|pocket-echocardiography
109544|NCT02881385|Synchrony|synchrony
109545|NCT02881385|Pressure Support Ventilation|pressure support ventilation
109546|NCT02881372|oral food desensitization|oral food desensitization
109547|NCT02881372|food elimination|food elimination
109548|NCT02881372|food reintroduction|food reintroduction
109549|NCT02881346|Psoriasis vulgaris|psoriasis vulgaris
109550|NCT02881346|Plaque|plaque
109551|NCT02881346|Topical|topical
109552|NCT02881346|Calcipotriol|calcipotriol
109553|NCT02881346|Foam|foam
109554|NCT02881346|Spray|spray
109555|NCT02881307|Rheumatoid Arthritis (RA)|rheumatoid arthritis (ra)
109556|NCT02881307|Musculoskeletal Ultrasound (MSUS)|musculoskeletal ultrasound (msus)
109557|NCT02881255|implantable cardioverter defibrillator|implantable cardioverter defibrillator
109558|NCT02881255|subcutaneous ICD|subcutaneous icd
109559|NCT02881255|transvenous ICD|transvenous icd
109560|NCT02881255|inherited arrhythmia syndrome|inherited arrhythmia syndrome
109561|NCT02881203|breast cancer|breast cancer
109562|NCT02881203|radiation|radiation
109563|NCT02881203|DIBH|dibh
109564|NCT02881203|cardiac toxicity|cardiac toxicity
109565|NCT02881177|oxytocin|oxytocin
109566|NCT02881177|tolerability|tolerability
109567|NCT02881177|HIV|hiv
109568|NCT02881177|men who have sex with men (MSM)|men who have sex with men (msm)
109569|NCT02881177|addiction|addiction
109570|NCT02881164|Glycemia|glycemia
109571|NCT02881164|Satiety|satiety
109572|NCT02881164|Insulin|insulin
109573|NCT02881164|Breakfast|breakfast
109574|NCT02881164|Low glycemic index|low glycemic index
109575|NCT02881164|High glycemic index|high glycemic index
109576|NCT02881151|Deep brain stimulation|deep brain stimulation
109577|NCT02881151|DBS|dbs
109578|NCT02881151|Central thalamus|central thalamus
109579|NCT02881151|TBI|tbi
109580|NCT02881151|Traumatic brain injury|traumatic brain injury
109581|NCT02881086|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
109582|NCT02881086|Lymphoblastic lymphoma|lymphoblastic lymphoma
109583|NCT02881086|Nelarabine|nelarabine
109584|NCT02881086|BCR-ABL|bcr-abl
109585|NCT02881086|MRD|mrd
109586|NCT02881086|PEG-Asparaginase|peg-asparaginase
109587|NCT02881086|Rituximab|rituximab
109588|NCT02881073|Placental Growth Factor|placental growth factor
109589|NCT02881073|Maternal Morbidity|maternal morbidity
109590|NCT02881073|Neonatal Morbidity|neonatal morbidity
109591|NCT02881073|Pre-eclampsia|pre-eclampsia
109592|NCT02881073|Heath Economics|heath economics
109593|NCT02881060|Glucagon|glucagon
109594|NCT02881060|Ethanol|ethanol
109595|NCT02881034|Anemia|anemia
109596|NCT02881034|Antiviral Agents|antiviral agents
109597|NCT02881034|Glomerular Filtration Rate|glomerular filtration rate
109598|NCT02881034|Hepatitis C|hepatitis c
109599|NCT02881034|Ribavirin|ribavirin
109600|NCT02881034|Telaprevir|telaprevir
109601|NCT02881021|elastic tape|elastic tape
109602|NCT02881021|kinesiology taping|kinesiology taping
109603|NCT02881021|physiotherapy|physiotherapy
109604|NCT02881021|rotator cuff|rotator cuff
109605|NCT02881021|shoulder pain|shoulder pain
109606|NCT02881021|tendon injuries|tendon injuries
109607|NCT02880995|dopamine receptor occupancy|dopamine receptor occupancy
109608|NCT02880995|antipsychotics|antipsychotics
109609|NCT02880995|positron emission tomography|positron emission tomography
109610|NCT02880956|Early Alzheimer's Disease (AD)|early alzheimer's disease (ad)
109611|NCT02880956|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
109612|NCT02880956|Mild Alzheimer's Disease (AD)|mild alzheimer's disease (ad)
109613|NCT02880956|Tau|tau
109614|NCT02880956|Early dementia|early dementia
109615|NCT02880956|Tauopathies|tauopathies
109616|NCT02880956|AD|ad
109617|NCT02880956|Neurodegenerative diseases|neurodegenerative diseases
109618|NCT02880956|Memory loss|memory loss
109619|NCT02880956|Nervous system diseases|nervous system diseases
109620|NCT02880930|vitamin D|vitamin d
109621|NCT02880917|Attention|attention
109622|NCT02880917|Memory (short and long-term)|memory (short and long-term)
109623|NCT02880917|Conflict monitoring tasks|conflict monitoring tasks
109624|NCT02880917|Verbal fluency|verbal fluency
109625|NCT02880878|Subcortical Intracerebral Hemorrhage|subcortical intracerebral hemorrhage
109626|NCT02880878|Intracerebral Hemorrhage|intracerebral hemorrhage
109627|NCT02880878|Intracranial Hemorrhages|intracranial hemorrhages
109628|NCT02880878|ICH|ich
109629|NCT02880878|Hemorrhage|hemorrhage
109630|NCT02880878|Cerebrovascular Disorders|cerebrovascular disorders
109631|NCT02880878|Brain Diseases|brain diseases
109632|NCT02880878|Central Nervous System Diseases|central nervous system diseases
109633|NCT02880878|Nervous System Diseases|nervous system diseases
109634|NCT02880878|Vascular Diseases|vascular diseases
109635|NCT02880878|Cardiovascular Diseases|cardiovascular diseases
109636|NCT02880878|Pathologic Processes|pathologic processes
109637|NCT02880878|MIPS|mips
109638|NCT02880878|Minimally Invasive Parafascicular Surgery|minimally invasive parafascicular surgery
109639|NCT02880878|Neurosurgery|neurosurgery
109640|NCT02880878|Medical Economic|medical economic
109641|NCT02880878|Hospital Economics|hospital economics
109642|NCT02880865|vaccine|vaccine
109643|NCT02880852|Systemic Lupus Erythematosus|systemic lupus erythematosus
109644|NCT02880852|Belimumab|belimumab
109645|NCT02880852|Pharmacodynamics|pharmacodynamics
109646|NCT02880852|safety tolerability|safety tolerability
109647|NCT02880852|Pharmacokinetics|pharmacokinetics
109648|NCT02880852|Chinese subjects|chinese subjects
109649|NCT02880800|Analgesia, Patient-Controlled|analgesia, patient-controlled
109650|NCT02880800|Analgesics, Opioid|analgesics, opioid
109651|NCT02880800|Drug-Related Side Effects and Adverse Reactions|drug-related side effects and adverse reactions
109652|NCT02880774|Temporomandibular Joint Disorders|temporomandibular joint disorders
109653|NCT02880774|Mandibular Movement|mandibular movement
109654|NCT02880774|Músculoesqueléticas Manipulations|músculoesqueléticas manipulations
109655|NCT02880774|Modalities of Physiotherapy.|modalities of physiotherapy.
109656|NCT02880761|hemodialysis|hemodialysis
109657|NCT02880761|chronic renal failure|chronic renal failure
109658|NCT02880761|arteriovenous fistulae|arteriovenous fistulae
109659|NCT02880748|Water exchange colonoscopy|water exchange colonoscopy
109660|NCT02880748|Adenoma miss rate|adenoma miss rate
109661|NCT02880748|Polyps|polyps
109662|NCT02880735|Myotonic Dystrophy|myotonic dystrophy
109663|NCT02880735|Noninvasive Ventilation|noninvasive ventilation
109664|NCT02880735|Respiratory Failure|respiratory failure
109665|NCT02880722|Irritable Bowel Syndrome (IBS)|irritable bowel syndrome (ibs)
109666|NCT02880722|Experience Sampling Method (ESM)|experience sampling method (esm)
109667|NCT02880722|Ecological Momentary Assessment (EMA)|ecological momentary assessment (ema)
109668|NCT02880722|Abdominal pain|abdominal pain
109669|NCT02880696|Time Perception|time perception
109670|NCT02880696|Tactile Perception|tactile perception
109671|NCT02880696|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
109672|NCT02880683|Electrical Stimulation Therapy|electrical stimulation therapy
109673|NCT02880683|Parasympathetic Nervous System|parasympathetic nervous system
109674|NCT02880683|Sympathetic Fibers|sympathetic fibers
109675|NCT02880683|Post Ganglionic|post ganglionic
109676|NCT02880683|Congestive Heart Failure|congestive heart failure
109677|NCT02880683|Heart Failure|heart failure
109678|NCT02880670|Rheumatoid|rheumatoid
109679|NCT02880657|superoxide dismutase|superoxide dismutase
109680|NCT02880657|melon concentrate|melon concentrate
109681|NCT02880657|oxidative stress|oxidative stress
109682|NCT02880657|physical training|physical training
109683|NCT02880644|Central retinal vein occlusion|central retinal vein occlusion
109684|NCT02880644|OCT-A|oct-a
109685|NCT02880644|CRVO|crvo
109686|NCT02880618|Heart Failure|heart failure
109687|NCT02880618|Reduced ejection fraction|reduced ejection fraction
109688|NCT02880540|Adolescent|adolescent
109689|NCT02880540|Bariatric|bariatric
109690|NCT02880540|Obesity|obesity
109691|NCT02880540|Pain|pain
109692|NCT02880540|Opiate-sparing|opiate-sparing
109693|NCT02880475|Moderate to severe chronic non-malignant pain|moderate to severe chronic non-malignant pain
109694|NCT02880462|schizophrenia|schizophrenia
109695|NCT02880462|sulforaphane|sulforaphane
109696|NCT02880423|salpingectomy|salpingectomy
109697|NCT02880423|cesarean section|cesarean section
109698|NCT02880423|tubal ligation|tubal ligation
109699|NCT02880423|morbidity|morbidity
109700|NCT02880410|Glioblastoma|glioblastoma
109701|NCT02880410|NeuroBlate|neuroblate
109702|NCT02880410|LITT|litt
109703|NCT02880410|Quality of Life|quality of life
109704|NCT02880397|Anti-inflammatory agents, antimicrobials, Periodontitis|anti-inflammatory agents, antimicrobials, periodontitis
109705|NCT02880371|Advanced Solid Tumors|advanced solid tumors
109706|NCT02880371|Pembrolizumab|pembrolizumab
109707|NCT02880371|ARRY-382|arry-382
109708|NCT02880371|CSF-1R|csf-1r
109709|NCT02880371|CSF1R|csf1r
109710|NCT02880371|cfms|cfms
109711|NCT02880332|Chronic pain|chronic pain
109712|NCT02880332|Endogenous Pain Processing|endogenous pain processing
109713|NCT02880332|Central sensitization|central sensitization
109714|NCT02880332|Pain neuroscience education|pain neuroscience education
109715|NCT02880319|Bone Cancer|bone cancer
109716|NCT02880293|transplant conditioning|transplant conditioning
109717|NCT02880293|KIR/HLA based haploidentical donor selection|kir/hla based haploidentical donor selection
109718|NCT02880293|allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
109719|NCT02880254|body mass index change|body mass index change
109720|NCT02880254|weight loss|weight loss
109721|NCT02880254|patient compliance|patient compliance
109722|NCT02880202|Massage Therapy|massage therapy
109723|NCT02880202|Hospice|hospice
109724|NCT02880202|Integrative Medicine|integrative medicine
109725|NCT02880202|Palliative Care|palliative care
109726|NCT02880202|Caregivers|caregivers
109727|NCT02880189|Obesity NOS|obesity nos
109728|NCT02880189|NASH|nash
109729|NCT02880189|NASH with Fibrosis|nash with fibrosis
109730|NCT02880189|Intragastric Balloon|intragastric balloon
109731|NCT02880189|ORBERA|orbera
109732|NCT02880189|ORBERA Intragastric Balloon|orbera intragastric balloon
109733|NCT02880176|Behavioral Economics|behavioral economics
109734|NCT02880176|Financial Incentives|financial incentives
109735|NCT02880176|Bladder Cancer|bladder cancer
109736|NCT02880176|Ambulation|ambulation
109737|NCT02880176|Surgical Co-Morbidity|surgical co-morbidity
109738|NCT02880176|Fitbit|fitbit
109739|NCT02880176|Mobile Health|mobile health
109740|NCT02880176|Radical Cystectomy|radical cystectomy
109741|NCT02880150|elite climbers|elite climbers
109742|NCT02880150|near infrared spectroscopy|near infrared spectroscopy
109743|NCT02880124|Isotope Labeling, Stable|isotope labeling, stable
109744|NCT02880124|Exercise, Physical|exercise, physical
109745|NCT02880124|Calorimetry, Indirect|calorimetry, indirect
109746|NCT02880124|Athletic Performance|athletic performance
109747|NCT02880124|Sugar Maple|sugar maple
109748|NCT02880111|Malignant Brain Tumor|malignant brain tumor
109749|NCT02880111|patient sputum|patient sputum
109750|NCT02880098|Neonatology|neonatology
109751|NCT02880098|Troponin T|troponin t
109752|NCT02880098|Standards|standards
109753|NCT02880059|Sleep Apnea, Aneurysm, Subarachnoid Hemorrhage, Blood Pressure.|sleep apnea, aneurysm, subarachnoid hemorrhage, blood pressure.
109754|NCT02880046|immune response|immune response
109755|NCT02880046|T lymphocyte|t lymphocyte
109756|NCT02880046|PD-1/PDL-1 pathway|pd-1/pdl-1 pathway
109757|NCT02880033|Parkinson's disease|parkinson's disease
109758|NCT02880033|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
109759|NCT02880033|Peripheral blood mononuclear cells|peripheral blood mononuclear cells
109760|NCT02880033|ex vivo model for oxidative stress|ex vivo model for oxidative stress
109761|NCT02880033|iron metabolism and chelation|iron metabolism and chelation
109762|NCT02880007|Pulsed dose-rate brachytherapy|pulsed dose-rate brachytherapy
109763|NCT02880007|3D dosimetry|3d dosimetry
109764|NCT02880007|Prospective Studies|prospective studies
109765|NCT02880007|Radiotherapy Dosage|radiotherapy dosage
109766|NCT02880007|Uterine Cervical Neoplasms/radiotherapy|uterine cervical neoplasms/radiotherapy
109767|NCT02880007|Brachytherapy/methods|brachytherapy/methods
109768|NCT02879968|serum squamous cell carcinoma antigen|serum squamous cell carcinoma antigen
109769|NCT02879968|tumor volume|tumor volume
109770|NCT02879968|Head and Neck Cancer|head and neck cancer
109771|NCT02879955|Glucagon-Like Peptide 1|glucagon-like peptide 1
109772|NCT02879955|Carbohydrates|carbohydrates
109773|NCT02879955|Gastric bypass|gastric bypass
109774|NCT02879955|Bariatric Surgery|bariatric surgery
109775|NCT02879955|Overweight|overweight
109776|NCT02879942|Placental volume|placental volume
109777|NCT02879942|First-trimester screening|first-trimester screening
109778|NCT02879942|Ultrasound|ultrasound
109779|NCT02879942|Preeclampsia|preeclampsia
109780|NCT02879942|Intrauterine growth restriction|intrauterine growth restriction
109781|NCT02879942|Biochemical markers|biochemical markers
109782|NCT02879942|Uterine artery doppler|uterine artery doppler
109783|NCT02879929|chronic nasal dysfunction|chronic nasal dysfunction
109784|NCT02879929|Quality of life|quality of life
109785|NCT02879929|measurement|measurement
109786|NCT02879929|self-reporting questionnaire|self-reporting questionnaire
109787|NCT02879929|development|development
109788|NCT02879929|validation|validation
109789|NCT02879903|Porphyromonas gingivalis|porphyromonas gingivalis
109790|NCT02879903|Periodontal treatment|periodontal treatment
109791|NCT02879903|Smokers|smokers
109792|NCT02879877|First in human|first in human
109793|NCT02879877|subjects|subjects
109794|NCT02879864|fatigue|fatigue
109795|NCT02879864|tiredness|tiredness
109796|NCT02879864|luxo therapy|luxo therapy
109797|NCT02879864|therapy by light|therapy by light
109798|NCT02879851|ultrasound|ultrasound
109799|NCT02879851|Koelis system|koelis system
109800|NCT02879851|MRI|mri
109801|NCT02879851|gold grain|gold grain
109802|NCT02879825|Ventricular Premature Complexes|ventricular premature complexes
109803|NCT02879812|Transplantation Surgery|transplantation surgery
109804|NCT02879812|Nephrology|nephrology
109805|NCT02879812|Organ and Tissue Transplantation|organ and tissue transplantation
109806|NCT02879799|Family-centered care|family-centered care
109807|NCT02879799|Family-integrated care|family-integrated care
109808|NCT02879799|Neonatal intensive care unit|neonatal intensive care unit
109809|NCT02879799|Premature|premature
109810|NCT02879799|Infant|infant
109811|NCT02879773|Respiratory Function Tests|respiratory function tests
109812|NCT02879773|Computed tomography|computed tomography
109813|NCT02879773|Thoracic surgical procedures|thoracic surgical procedures
109814|NCT02879773|Diagnosis|diagnosis
109815|NCT02879760|Lung|lung
109816|NCT02879760|Cancer|cancer
109817|NCT02879760|Chemotherapy|chemotherapy
109818|NCT02879760|Oncolytic virus|oncolytic virus
109819|NCT02879760|Immunotherapy|immunotherapy
109820|NCT02879760|Pembrolizumab|pembrolizumab
109821|NCT02879760|Keytruda|keytruda
109822|NCT02879747|treatment|treatment
109823|NCT02879747|growth hormone|growth hormone
109824|NCT02879747|childhood|childhood
109825|NCT02879747|short stature|short stature
109826|NCT02879734|peritoneal dialysis|peritoneal dialysis
109827|NCT02879734|laparoscopy|laparoscopy
109828|NCT02879734|omentum|omentum
109829|NCT02879721|Gastrointestinal|gastrointestinal
109830|NCT02879708|Social Accountability|social accountability
109831|NCT02879708|Healthcare Quality|healthcare quality
109832|NCT02879708|Health System Strengthening|health system strengthening
109833|NCT02879708|Child Health|child health
109834|NCT02879708|Childhood pneumonia|childhood pneumonia
109835|NCT02879708|Childhood diarrhea|childhood diarrhea
109836|NCT02879682|glioma|glioma
109837|NCT02879682|brain metastases|brain metastases
109838|NCT02879682|nTMS|ntms
109839|NCT02879630|pharmacokinetics|pharmacokinetics
109840|NCT02879630|acyclovir|acyclovir
109841|NCT02879604|cognitive remediation, cost-effectiveness analysis|cognitive remediation, cost-effectiveness analysis
109842|NCT02879552|Upper blepharoplasty|upper blepharoplasty
109843|NCT02879552|brassiere sutures|brassiere sutures
109844|NCT02879552|tarsal platform show|tarsal platform show
109845|NCT02879552|eyeshadow space|eyeshadow space
109846|NCT02879552|brow fat span|brow fat span
109847|NCT02879539|cochlear implants, power consumption,|cochlear implants, power consumption,
109848|NCT02879526|Relapse/Refratory Peripheral T Cell Lymphoma|relapse/refratory peripheral t cell lymphoma
109849|NCT02879526|Chidamide|chidamide
109850|NCT02879526|Cyclophosphamide、Prednisone、Thalidomide(CPT)|cyclophosphamide、prednisone、thalidomide(cpt)
109851|NCT02879500|Systematic review and meta-analysis|systematic review and meta-analysis
109852|NCT02879500|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
109853|NCT02879500|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
109854|NCT02879500|Clinical practice guidelines|clinical practice guidelines
109855|NCT02879500|Randomized controlled trials|randomized controlled trials
109856|NCT02879500|Prospective cohort studies|prospective cohort studies
109857|NCT02879500|Body weight|body weight
109858|NCT02879500|Body mass index|body mass index
109859|NCT02879500|Adiposity|adiposity
109860|NCT02879500|Overweight|overweight
109861|NCT02879500|Obesity|obesity
109862|NCT02879461|SURGERY|surgery
109863|NCT02879461|REHABILITATION|rehabilitation
109864|NCT02879448|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
109865|NCT02879448|Left Atrial Appendage|left atrial appendage
109866|NCT02879409|HbA1c variability|hba1c variability
109867|NCT02879409|Diabetes Mellitus Type 2|diabetes mellitus type 2
109868|NCT02879409|Diabetes microvascular complications|diabetes microvascular complications
109869|NCT02879409|Diabetes macrovascular complications|diabetes macrovascular complications
109870|NCT02879396|Older adults|older adults
109871|NCT02879396|Avoidable admissions|avoidable admissions
109872|NCT02879396|Assisted living home|assisted living home
109873|NCT02879396|Emergency service calls|emergency service calls
109874|NCT02879396|Heading Assisted Living Facilities|heading assisted living facilities
109875|NCT02879383|Type 2 Diabetes|type 2 diabetes
109876|NCT02879370|Anastomotic Leak|anastomotic leak
109877|NCT02879370|Rectal cancer|rectal cancer
109878|NCT02879370|Double stapling technique|double stapling technique
109879|NCT02879357|Care management|care management
109880|NCT02879357|end of life|end of life
109881|NCT02879357|advanced care planning|advanced care planning
109882|NCT02879357|palliative care|palliative care
109883|NCT02879331|pulmonary emphysema|pulmonary emphysema
109884|NCT02879331|coils|coils
109885|NCT02879331|cycloergometry|cycloergometry
109886|NCT02879331|lung volume reduction|lung volume reduction
109887|NCT02879305|erythropoiesis stimulating agents|erythropoiesis stimulating agents
109888|NCT02879305|GSK1278863|gsk1278863
109889|NCT02879305|daprodustat|daprodustat
109890|NCT02879305|anemia|anemia
109891|NCT02879305|chronic kidney disease|chronic kidney disease
109892|NCT02879305|hemoglobin|hemoglobin
109893|NCT02879305|recombinant human erythropoietin|recombinant human erythropoietin
109894|NCT02879292|Pyloric stenosis spinal anesthesia postoperative pain|pyloric stenosis spinal anesthesia postoperative pain
109895|NCT02879279|Stroke|stroke
109896|NCT02879279|Upper limb|upper limb
109897|NCT02879279|Robotic rehabilitation|robotic rehabilitation
109898|NCT02879266|Dengue Vaccine|dengue vaccine
109899|NCT02879188|degenerative joint disease|degenerative joint disease
109900|NCT02879188|total knee arthroplasty|total knee arthroplasty
109901|NCT02879188|physical therapy|physical therapy
109902|NCT02879188|arthroplasty, replacement, knee|arthroplasty, replacement, knee
109903|NCT02879149|Ankle Fusions|ankle fusions
109904|NCT02879149|AUGMENT® Bone Graft|augment® bone graft
109905|NCT02879149|Autologous Bone Graft|autologous bone graft
109906|NCT02879149|arthritis|arthritis
109907|NCT02879149|ankle pain|ankle pain
109908|NCT02879149|foot pain|foot pain
109909|NCT02879149|hindfoot fracture|hindfoot fracture
109910|NCT02879149|ankle fracture|ankle fracture
109911|NCT02879136|Gait|gait
109912|NCT02879136|Balance|balance
109913|NCT02879136|PD|pd
109914|NCT02879110|Sulforaphane|sulforaphane
109915|NCT02879110|clinic trial|clinic trial
109916|NCT02879110|Autism Spectrum Disorder|autism spectrum disorder
109917|NCT02879110|Efficacy|efficacy
109918|NCT02879110|Safety|safety
109919|NCT02879110|Mechanism|mechanism
109920|NCT02879032|Treadmill Scores|treadmill scores
109921|NCT02879032|Coronary Angiogram|coronary angiogram
109922|NCT02879032|Coronary Artery Disease|coronary artery disease
109923|NCT02879006|Chinese herbal therapy|chinese herbal therapy
109924|NCT02879006|Oral immunotherapy|oral immunotherapy
109925|NCT02879006|Food allergy|food allergy
109926|NCT02879006|Omalizumab|omalizumab
109927|NCT02878928|Pharmacogenetic testing|pharmacogenetic testing
109928|NCT02878928|PGx|pgx
109929|NCT02878928|Depression|depression
109930|NCT02878928|Neuropsychiatric diseases|neuropsychiatric diseases
109931|NCT02878928|IDgenetix|idgenetix
109932|NCT02878928|AltheaDx|altheadx
109933|NCT02878902|emergency|emergency
109934|NCT02878902|coordination|coordination
109935|NCT02878902|dialysis|dialysis
109936|NCT02878824|Neurophysiology|neurophysiology
109937|NCT02878824|Autonomic|autonomic
109938|NCT02878824|Sensory|sensory
109939|NCT02878824|Child|child
109940|NCT02878824|Ethnicity|ethnicity
109941|NCT02878824|Environment|environment
109942|NCT02878811|heart failure|heart failure
109943|NCT02878811|prospective|prospective
109944|NCT02878811|cohort|cohort
109945|NCT02878785|AML|aml
109946|NCT02878746|Mirror therapy|mirror therapy
109947|NCT02878746|Proprioception|proprioception
109948|NCT02878746|Rehabilitation|rehabilitation
109949|NCT02878746|Stroke|stroke
109950|NCT02878746|Hemiplegia|hemiplegia
109951|NCT02878720|ischemic stroke|ischemic stroke
109952|NCT02878720|hemorrhagic chronic|hemorrhagic chronic
109953|NCT02878720|non-invasive vagus nerve stimulation|non-invasive vagus nerve stimulation
109954|NCT02878720|robot-assisted rehabilitation|robot-assisted rehabilitation
109955|NCT02878681|Diabetic Macular Edema.|diabetic macular edema.
109956|NCT02878668|procalcitonin|procalcitonin
109957|NCT02878668|post-operative|post-operative
109958|NCT02878668|complication|complication
109959|NCT02878668|CRP|crp
109960|NCT02878655|N0 clinical and radiological|n0 clinical and radiological
109961|NCT02878655|dissection IIb sector|dissection iib sector
109962|NCT02878564|Schistosomiasis mansoni|schistosomiasis mansoni
109963|NCT02878564|HIV susceptibility|hiv susceptibility
109964|NCT02878564|Genital immunology|genital immunology
109965|NCT02878564|Mucosal immunology|mucosal immunology
109966|NCT02878564|HIV entry assay|hiv entry assay
109967|NCT02878564|Adult women|adult women
109968|NCT02878512|Segmental Epidural|segmental epidural
109969|NCT02878512|Regional Anesthesia for PCNL|regional anesthesia for pcnl
109970|NCT02878499|autism|autism
109971|NCT02878499|autism spectrum disorder|autism spectrum disorder
109972|NCT02878499|ASD|asd
109973|NCT02878499|sleep|sleep
109974|NCT02878499|Circadian|circadian
109975|NCT02878499|Biological rhythms|biological rhythms
109976|NCT02878499|melatonin|melatonin
109977|NCT02878499|Cognition|cognition
109978|NCT02878499|Behavior|behavior
109979|NCT02878499|Longitudinal|longitudinal
109980|NCT02878499|Longitudinal accelerated design|longitudinal accelerated design
109981|NCT02878486|Physical activity|physical activity
109982|NCT02878486|Alzheimer's disease|alzheimer's disease
109983|NCT02878486|cognitive impairment|cognitive impairment
109984|NCT02878486|sedentary behavior|sedentary behavior
109985|NCT02878486|insulin sensitivity|insulin sensitivity
109986|NCT02878447|Haemoptysis|haemoptysis
109987|NCT02878447|Radiotherapy|radiotherapy
109988|NCT02878447|Tuberculosis|tuberculosis
109989|NCT02878447|Aspergilloma|aspergilloma
109990|NCT02878447|Bronchiectasis|bronchiectasis
109991|NCT02878434|Cancer|cancer
109992|NCT02878434|Fertility|fertility
109993|NCT02878434|Pregnancy|pregnancy
109994|NCT02878434|Chemotherapy|chemotherapy
109995|NCT02878434|Radiotherapy|radiotherapy
109996|NCT02878434|Long term|long term
109997|NCT02878434|Follow up|follow up
109998|NCT02878395|genomics|genomics
109999|NCT02878395|epigenomics|epigenomics
110000|NCT02878395|recurrence|recurrence
110001|NCT02878382|PDT|pdt
110002|NCT02878382|skin cancer|skin cancer
110003|NCT02878382|calcipotriol|calcipotriol
110004|NCT02878369|fluid replacement|fluid replacement
110005|NCT02878356|Motivational Interviewing, Clinical supervision, Education|motivational interviewing, clinical supervision, education
110006|NCT02878330|Respiratory Syncytial Virus, RSV|respiratory syncytial virus, rsv
110007|NCT02878330|Preterm Infants|preterm infants
110008|NCT02878330|Lower Respiratory Tract Infection|lower respiratory tract infection
110009|NCT02878317|Glycosylation End Products, Advanced|glycosylation end products, advanced
110010|NCT02878317|Skin autofluorescence|skin autofluorescence
110011|NCT02878317|Renal Dialysis|renal dialysis
110012|NCT02878304|Prognosis|prognosis
110013|NCT02878304|Hand function|hand function
110014|NCT02878304|Rehabilitation|rehabilitation
110015|NCT02878304|Spasticity|spasticity
110016|NCT02878304|MRI|mri
110017|NCT02878278|Chidamide|chidamide
110018|NCT02878278|Administration method|administration method
110019|NCT02878265|malaria|malaria
110020|NCT02878265|vitamin A|vitamin a
110021|NCT02878265|Zinc|zinc
110022|NCT02878265|Multivitamin|multivitamin
110023|NCT02878252|COPD, Asthma, ACOS|copd, asthma, acos
110024|NCT02878239|knee osteoarthritis|knee osteoarthritis
110025|NCT02878239|gait|gait
110026|NCT02878239|Kellgren-Lawrence Scores|kellgren-lawrence scores
110027|NCT02878161|rheumatoid arthritis|rheumatoid arthritis
110028|NCT02878161|tumor necrosis factor α inhibitor|tumor necrosis factor α inhibitor
110029|NCT02878161|predictive|predictive
110030|NCT02878161|iTRAQ|itraq
110031|NCT02878161|signal pathway|signal pathway
110032|NCT02878148|Nephrolithiasis|nephrolithiasis
110033|NCT02878148|Ureteral stone|ureteral stone
110034|NCT02878148|Acute renal colic|acute renal colic
110035|NCT02878148|Ultrasonography|ultrasonography
110036|NCT02878148|Computed tomography|computed tomography
110037|NCT02878148|Diagnosis|diagnosis
110038|NCT02878122|ovarian cancer|ovarian cancer
110039|NCT02878122|chemo resistance|chemo resistance
110040|NCT02878122|predictive factors|predictive factors
110041|NCT02878122|cohort study|cohort study
110042|NCT02878122|bio bank|bio bank
110043|NCT02878109|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
110044|NCT02878109|Transarterial chemoembolization (TACE)|transarterial chemoembolization (tace)
110045|NCT02878096|nocturnal polyuria|nocturnal polyuria
110046|NCT02878083|vedolizumab,|vedolizumab,
110047|NCT02878083|confocal endomicroscopy|confocal endomicroscopy
110048|NCT02878083|biomarker|biomarker
110049|NCT02878083|ULCERATIVE COLITIS|ulcerative colitis
110050|NCT02878070|Spinal Cord Injuries|spinal cord injuries
110051|NCT02878070|Telemedicine|telemedicine
110052|NCT02878070|Health Behaviors|health behaviors
110053|NCT02878057|Apatinib|apatinib
110054|NCT02878057|HER-2 Negative|her-2 negative
110055|NCT02878057|Chest wall Metastasis|chest wall metastasis
110056|NCT02878057|Multicenter Phase II Study|multicenter phase ii study
110057|NCT02878057|Breast cancer|breast cancer
110058|NCT02878044|Shared Decision Making, Decision Aid|shared decision making, decision aid
110059|NCT02878031|Integrated Community Case Management|integrated community case management
110060|NCT02878031|Community Health Worker|community health worker
110061|NCT02878031|Nigeria|nigeria
110062|NCT02878018|Cohort Study|cohort study
110063|NCT02878018|Children|children
110064|NCT02878018|Henoch-Schonlein Purpura Nephritis|henoch-schonlein purpura nephritis
110065|NCT02878018|Traditional Chinese Medicine|traditional chinese medicine
110066|NCT02878005|Intubating Laryngeal Tube|intubating laryngeal tube
110067|NCT02878005|blind intubation|blind intubation
110068|NCT02878005|fiberoptic|fiberoptic
110069|NCT02877992|Infertility|infertility
110070|NCT02877992|Tachykinin|tachykinin
110071|NCT02877992|Kisspeptin|kisspeptin
110072|NCT02877940|ProSeal LMA|proseal lma
110073|NCT02877940|LTS-D|lts-d
110074|NCT02877940|i-gel|i-gel
110379|NCT02876172|dyad|dyad
110075|NCT02877914|heart failure, retrospective|heart failure, retrospective
110076|NCT02877888|cost effectiveness|cost effectiveness
110077|NCT02877888|fluoride varnish|fluoride varnish
110078|NCT02877888|dental caries|dental caries
110079|NCT02877875|anxiety|anxiety
110080|NCT02877875|depression|depression
110081|NCT02877875|trauma|trauma
110082|NCT02877875|behavior problems|behavior problems
110083|NCT02877875|evidence-based treatments|evidence-based treatments
110084|NCT02877875|manualized treatments|manualized treatments
110085|NCT02877875|cognitive-behavioral therapy|cognitive-behavioral therapy
110086|NCT02877875|youth|youth
110087|NCT02877875|mental health|mental health
110088|NCT02877849|fMRI|fmri
110089|NCT02877849|brain networks|brain networks
110090|NCT02877849|biomarker|biomarker
110091|NCT02877849|relapse|relapse
110092|NCT02877849|alcohol|alcohol
110093|NCT02877836|Dystonia|dystonia
110094|NCT02877836|fMRI|fmri
110096|NCT02877836|DBS|dbs
110097|NCT02877823|Pediatric Antipsychotic Treatment|pediatric antipsychotic treatment
110098|NCT02877823|Pediatric healthy lifestyle intervention|pediatric healthy lifestyle intervention
110099|NCT02877823|Parent peer support|parent peer support
110100|NCT02877784|screening|screening
110101|NCT02877784|OPMD|opmd
110102|NCT02877784|dysphagia|dysphagia
110103|NCT02877784|dysarthria|dysarthria
110104|NCT02877758|cutaneous aging|cutaneous aging
110105|NCT02877758|skin rejuvenation|skin rejuvenation
110106|NCT02877758|wrinkles|wrinkles
110107|NCT02877732|Concussion|concussion
110108|NCT02877732|Athletes|athletes
110109|NCT02877732|Eye-tracking|eye-tracking
110110|NCT02877732|Vision|vision
110111|NCT02877706|Registry|registry
110112|NCT02877693|ICD|icd
110113|NCT02877693|Thoracic MRI Scan|thoracic mri scan
110114|NCT02877693|tachycardia|tachycardia
110115|NCT02877680|Strengths-based|strengths-based
110116|NCT02877680|Mobile Health (mHealth)|mobile health (mhealth)
110117|NCT02877680|Adolescence|adolescence
110118|NCT02877680|Resilience|resilience
110119|NCT02877680|Family|family
110120|NCT02877667|tattoo|tattoo
110121|NCT02877667|laser|laser
110122|NCT02877654|Plasmatic zonulin|plasmatic zonulin
110123|NCT02877654|Irritable Bowel Syndrome|irritable bowel syndrome
110124|NCT02877654|Intestinal permeability|intestinal permeability
110125|NCT02877641|Current Smoker|current smoker
110126|NCT02877641|Former Smoker|former smoker
110127|NCT02877628|pharmacokinetic|pharmacokinetic
110128|NCT02877628|pharmacodynamic|pharmacodynamic
110129|NCT02877628|tacrolimus|tacrolimus
110130|NCT02877628|CYP3A5|cyp3a5
110131|NCT02877628|liver transplantation|liver transplantation
110132|NCT02877563|peripheral artery disease|peripheral artery disease
110133|NCT02877563|contrast enhanced ultrasound|contrast enhanced ultrasound
110134|NCT02877550|untreated Follicular lymphoma|untreated follicular lymphoma
110135|NCT02877550|non-Hodgkin lymphoma|non-hodgkin lymphoma
110136|NCT02877550|Obinutuzumab|obinutuzumab
110137|NCT02877550|Gazyva|gazyva
110138|NCT02877550|Gazyvaro|gazyvaro
110139|NCT02877550|Venetoclax|venetoclax
110140|NCT02877550|Venclexta|venclexta
110141|NCT02877446|Left ventricular assist device (LVAD)|left ventricular assist device (lvad)
110142|NCT02877446|Terminal heart failure|terminal heart failure
110143|NCT02877446|Ventricular assist device (VAD)|ventricular assist device (vad)
110144|NCT02877433|Small diameter implant|small diameter implant
110145|NCT02877433|Cross-arch prostheses|cross-arch prostheses
110146|NCT02877420|Endoscopy|endoscopy
110147|NCT02877420|Simulation Training|simulation training
110148|NCT02877420|Non-technical Skills|non-technical skills
110149|NCT02877381|Tranexamic Acid|tranexamic acid
110150|NCT02877381|Blood Transfusion|blood transfusion
110151|NCT02877342|Injury|injury
110152|NCT02877342|Injuries|injuries
110153|NCT02877342|Triage|triage
110154|NCT02877329|psychological effects|psychological effects
110155|NCT02877303|Leukemia|leukemia
110156|NCT02877303|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
110157|NCT02877303|ALL|all
110158|NCT02877303|Newly diagnosed B-Cell Lineage Acute lymphoblastic leukemia|newly diagnosed b-cell lineage acute lymphoblastic leukemia
110159|NCT02877303|Blinatumomab|blinatumomab
110160|NCT02877303|Blincyto|blincyto
110161|NCT02877303|G-CSF|g-csf
110162|NCT02877303|Filgrastim|filgrastim
110163|NCT02877303|Neupogen|neupogen
110164|NCT02877303|Pegfilgrastim|pegfilgrastim
110165|NCT02877303|Neulasta|neulasta
110166|NCT02877303|PEG-G-CSF|peg-g-csf
110167|NCT02877303|Cyclophosphamide|cyclophosphamide
110168|NCT02877303|Cytoxan|cytoxan
110169|NCT02877303|Neosar|neosar
110170|NCT02877303|Revimmune|revimmune
110171|NCT02877303|Clafen|clafen
110172|NCT02877303|Mesna|mesna
110173|NCT02877303|Mesnex|mesnex
110174|NCT02877303|Dexamethasone|dexamethasone
110175|NCT02877303|Decadron|decadron
110176|NCT02877303|Ofatumumab|ofatumumab
110177|NCT02877303|Arzerra|arzerra
110178|NCT02877303|Methotrexate|methotrexate
110179|NCT02877303|MTX|mtx
110180|NCT02877303|Doxorubicin|doxorubicin
110181|NCT02877303|Doxorubicin Hydrochloride|doxorubicin hydrochloride
110182|NCT02877303|Adriamycin PFS|adriamycin pfs
110183|NCT02877303|Adriamycin RDF|adriamycin rdf
110184|NCT02877303|Adriamycin|adriamycin
110185|NCT02877303|Rubex|rubex
110186|NCT02877303|Vincristine|vincristine
110187|NCT02877303|Oncovin|oncovin
110188|NCT02877303|Vincasar PFS|vincasar pfs
110189|NCT02877303|Vincristine Sulfate|vincristine sulfate
110190|NCT02877303|LCR|lcr
110191|NCT02877303|VCR|vcr
110192|NCT02877303|Cytarabine|cytarabine
110193|NCT02877303|ARA-C|ara-c
110194|NCT02877303|Cytosar|cytosar
110195|NCT02877303|DepoCyt|depocyt
110196|NCT02877303|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
110197|NCT02877303|Arabino Sylcytosine|arabino sylcytosine
110198|NCT02877303|Cytosine Arabinoside|cytosine arabinoside
110199|NCT02877303|Rituximab|rituximab
110200|NCT02877303|Rituxan|rituxan
110201|NCT02877303|Leucovorin|leucovorin
110202|NCT02877303|Citrovorum|citrovorum
110203|NCT02877303|Wellcovorin|wellcovorin
110204|NCT02877303|6-Mercaptopurine|6-mercaptopurine
110205|NCT02877303|Mercaptopurine|mercaptopurine
110206|NCT02877303|Purinethol|purinethol
110207|NCT02877303|6-MP|6-mp
110208|NCT02877303|Prednisone|prednisone
110209|NCT02877303|Deltasone|deltasone
110210|NCT02877303|Orasone|orasone
110211|NCT02877303|Prednicen-M|prednicen-m
110212|NCT02877290|COPD|copd
110213|NCT02877290|NIRS|nirs
110214|NCT02877290|NIV|niv
110215|NCT02877290|Exercise|exercise
110216|NCT02877264|Vapendavir|vapendavir
110217|NCT02877264|Bioavailability|bioavailability
110218|NCT02877264|Biological Availability|biological availability
110219|NCT02877264|Volunteers|volunteers
110220|NCT02877251|Venous Thromboembolism|venous thromboembolism
110221|NCT02877251|Venous Thrombosis|venous thrombosis
110222|NCT02877251|Pulmonary Thromboembolism|pulmonary thromboembolism
110223|NCT02877251|National Registry|national registry
110224|NCT02877251|Mexico|mexico
110225|NCT02877251|Major Adverse Cardiovascular Events|major adverse cardiovascular events
110226|NCT02877238|remote ischemic preconditioning|remote ischemic preconditioning
110227|NCT02877238|sevoflurane|sevoflurane
110228|NCT02877238|total intravenous anesthetic|total intravenous anesthetic
110229|NCT02877212|ITP|itp
110230|NCT02877212|Eltrombopag|eltrombopag
110231|NCT02877212|Steroid refractory|steroid refractory
110232|NCT02877212|Fc Receptor|fc receptor
110233|NCT02877199|Hepatitis C|hepatitis c
110234|NCT02877199|anti-E1E2 antibodies|anti-e1e2 antibodies
110235|NCT02877199|cirrhosis|cirrhosis
110236|NCT02877199|triple therapy|triple therapy
110237|NCT02877173|Arteriosclerosis Obliterans|arteriosclerosis obliterans
110238|NCT02877173|Atherosclerotic Occlusive Disease of the Lower Extremities|atherosclerotic occlusive disease of the lower extremities
110239|NCT02877173|Intermittent Claudication|intermittent claudication
110240|NCT02877121|interstitial lung disease|interstitial lung disease
110241|NCT02877121|Respiratory Muscle Function|respiratory muscle function
110242|NCT02877121|Neural Respiratory Drive|neural respiratory drive
110243|NCT02877056|Colorectal adenocarcinoma|colorectal adenocarcinoma
110244|NCT02877056|Neoadjuvant therapy|neoadjuvant therapy
110245|NCT02877056|Endoscopy|endoscopy
110246|NCT02877056|Endoscopic biopsy|endoscopic biopsy
110247|NCT02877056|Biomarkers|biomarkers
110248|NCT02877056|Genes|genes
110249|NCT02876991|choline positron emission tomography|choline positron emission tomography
110250|NCT02876991|occult recurrence|occult recurrence
110251|NCT02876991|prostatic adenocarcinoma|prostatic adenocarcinoma
110252|NCT02876991|sodium fluoride positron emission tomography|sodium fluoride positron emission tomography
110253|NCT02876952|Cardio-respiratory fitness|cardio-respiratory fitness
110254|NCT02876952|high intensity exercise training|high intensity exercise training
110255|NCT02876939|Hereditary Sensory Neuropathy|hereditary sensory neuropathy
110256|NCT02876939|Autonomic Neuropathy|autonomic neuropathy
110257|NCT02876939|Familial Dysautonomia|familial dysautonomia
110258|NCT02876939|proprioception|proprioception
110259|NCT02876939|motor control|motor control
110260|NCT02876939|sensory nervous system.|sensory nervous system.
110261|NCT02876939|HSAN III|hsan iii
110262|NCT02876939|IKBKAP gene mutation|ikbkap gene mutation
110263|NCT02876926|HIV testing|hiv testing
110264|NCT02876926|Self-testing|self-testing
110265|NCT02876926|Counseling|counseling
110266|NCT02876926|Referral|referral
110267|NCT02876874|Rheumatoid Arthritis|rheumatoid arthritis
110268|NCT02876874|lymph nodes morphology|lymph nodes morphology
110269|NCT02876874|drainage of lymphatic vessels|drainage of lymphatic vessels
110270|NCT02876861|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
110271|NCT02876861|upper tract urothelial carcinoma|upper tract urothelial carcinoma
110272|NCT02876848|Administrative Claims, Healthcare|administrative claims, healthcare
110273|NCT02876848|Aromatase Inhibitors|aromatase inhibitors
110274|NCT02876848|Breast Neoplasms|breast neoplasms
110275|NCT02876848|Health Services for the Aged|health services for the aged
110276|NCT02876848|Medical Informatics Applications|medical informatics applications
110277|NCT02876848|Medication Adherence|medication adherence
110278|NCT02876848|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
110377|NCT02876172|psychotherapy|psychotherapy
110279|NCT02876848|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators
110280|NCT02876848|Telemedicine|telemedicine
110281|NCT02876835|hemoglobin|hemoglobin
110282|NCT02876835|anemia|anemia
110283|NCT02876835|non-dialysis|non-dialysis
110284|NCT02876835|GSK1278863|gsk1278863
110285|NCT02876835|erythropoiesis stimulating agents|erythropoiesis stimulating agents
110286|NCT02876835|daprodustat|daprodustat
110287|NCT02876835|chronic kidney disease|chronic kidney disease
110288|NCT02876809|centenarians|centenarians
110289|NCT02876809|geriatric|geriatric
110290|NCT02876809|telomere length|telomere length
110291|NCT02876809|progerin|progerin
110292|NCT02876809|metagenome|metagenome
110293|NCT02876809|metabolome|metabolome
110294|NCT02876796|fractional de novo lipogenesis|fractional de novo lipogenesis
110295|NCT02876796|DNL|dnl
110296|NCT02876796|pharmacodynamic|pharmacodynamic
110297|NCT02876796|pharmacokinetic|pharmacokinetic
110298|NCT02876705|Patterns|patterns
110299|NCT02876705|Pain|pain
110300|NCT02876705|Cycling|cycling
110301|NCT02876705|Running|running
110302|NCT02876705|Exhaustion|exhaustion
110303|NCT02876679|Hematopoietic Stem Cell|hematopoietic stem cell
110304|NCT02876679|Transplantation|transplantation
110305|NCT02876679|Graft vs Host Disease|graft vs host disease
110306|NCT02876679|Cyclophosphamide|cyclophosphamide
110307|NCT02876679|Anti-Thymocyte Globulin|anti-thymocyte globulin
110308|NCT02876679|GVHD prophylaxis|gvhd prophylaxis
110309|NCT02876666|Spinal Cord Injuries|spinal cord injuries
110310|NCT02876666|Health Behavior|health behavior
110311|NCT02876653|Obstructive sleep apnea|obstructive sleep apnea
110312|NCT02876653|Aging|aging
110313|NCT02876653|Telomere length|telomere length
110314|NCT02876614|radionuclide cisternography|radionuclide cisternography
110315|NCT02876614|CSF leak|csf leak
110316|NCT02876614|imaging|imaging
110317|NCT02876601|Coagulation|coagulation
110318|NCT02876601|Inflammation|inflammation
110319|NCT02876601|Defibrotide|defibrotide
110320|NCT02876601|Fibrinolysis|fibrinolysis
110321|NCT02876588|Wrong-Patient Errors|wrong-patient errors
110322|NCT02876588|Retract-and-Reorder Tool|retract-and-reorder tool
110323|NCT02876562|Gingival Recession Coverage|gingival recession coverage
110324|NCT02876549|G6PD|g6pd
110325|NCT02876549|Primaquine|primaquine
110326|NCT02876510|Ovarian Cancer|ovarian cancer
110327|NCT02876510|Esophageal Cancer|esophageal cancer
110328|NCT02876510|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
110329|NCT02876510|Squamous non-small cell lung cancer|squamous non-small cell lung cancer
110330|NCT02876510|Gastric Cancer|gastric cancer
110331|NCT02876458|Coronary angiogram|coronary angiogram
110332|NCT02876458|Survival rate|survival rate
110333|NCT02876458|Neurological sequel|neurological sequel
110334|NCT02876445|Huntington's disease|huntington's disease
110335|NCT02876445|Caregiver|caregiver
110336|NCT02876445|ZARIT burden scale|zarit burden scale
110337|NCT02876419|nucleic acid polymer REP 2139 HBsAg hepatitis B hepatitis D|nucleic acid polymer rep 2139 hbsag hepatitis b hepatitis d
110338|NCT02876367|Epidemiology|epidemiology
110339|NCT02876354|Hemodialysis|hemodialysis
110340|NCT02876354|Vitamin k2|vitamin k2
110341|NCT02876354|Vascular calcifications|vascular calcifications
110342|NCT02876341|Chronic antihypertensives|chronic antihypertensives
110343|NCT02876341|New onset atrial fibrillation|new onset atrial fibrillation
110344|NCT02876341|Septic shock|septic shock
110345|NCT02876328|Ebola Vaccine|ebola vaccine
110346|NCT02876315|innate immunity|innate immunity
110347|NCT02876315|elderly adults|elderly adults
110348|NCT02876315|multivitamin supplement|multivitamin supplement
110349|NCT02876315|vitamin D|vitamin d
110350|NCT02876315|vitamin C|vitamin c
110351|NCT02876315|zinc|zinc
110352|NCT02876302|Inflammatory Breast Cancer|inflammatory breast cancer
110353|NCT02876302|Breast Cancer|breast cancer
110354|NCT02876302|Triple Negative Breast Cancer|triple negative breast cancer
110355|NCT02876263|aortic diseases|aortic diseases
110356|NCT02876263|aortic aneurysm|aortic aneurysm
110357|NCT02876263|electroencephalography|electroencephalography
110358|NCT02876263|Near-Infrared spectroscopy|near-infrared spectroscopy
110359|NCT02876263|Transcranial Doppler ultrasonography|transcranial doppler ultrasonography
110360|NCT02876263|Cardiopulmonary arrest|cardiopulmonary arrest
110361|NCT02876263|Hypothermia, Induced|hypothermia, induced
110362|NCT02876250|Lung transplantation|lung transplantation
110363|NCT02876250|Cyclosporine|cyclosporine
110364|NCT02876250|Postconditioning|postconditioning
110365|NCT02876211|Renal disease|renal disease
110366|NCT02876211|Erythropoiesis|erythropoiesis
110367|NCT02876211|Erythropoietin stimulating agent|erythropoietin stimulating agent
110368|NCT02876211|Iron|iron
110369|NCT02876211|Klotho|klotho
110370|NCT02876211|Selective vitamin D receptor activation|selective vitamin d receptor activation
110371|NCT02876198|Retinal neovascularization|retinal neovascularization
110372|NCT02876198|Anti-VEGF|anti-vegf
110373|NCT02876198|Retinal Nerve Fiber Layer (RNFL)|retinal nerve fiber layer (rnfl)
110374|NCT02876185|Glaucoma surveillance|glaucoma surveillance
110375|NCT02876185|Orthoptist|orthoptist
110376|NCT02876172|PTSD|ptsd
110378|NCT02876172|MDMA|mdma
110380|NCT02876172|cognitive behavioral therapy|cognitive behavioral therapy
110381|NCT02876159|Vaccination|vaccination
110382|NCT02876146|Albendazole|albendazole
110383|NCT02876146|Benzimidazole|benzimidazole
110384|NCT02876146|Echinococcus multilocularis|echinococcus multilocularis
110385|NCT02876146|Alveolar echinococcosis|alveolar echinococcosis
110386|NCT02876146|Liver Diseases|liver diseases
110387|NCT02876107|Malignant neoplasm of breast|malignant neoplasm of breast
110388|NCT02876107|Breast cancer|breast cancer
110389|NCT02876107|Newly diagnosed primary triple-negative inflammatory breast cancer|newly diagnosed primary triple-negative inflammatory breast cancer
110390|NCT02876107|Inflammatory breast cancer|inflammatory breast cancer
110392|NCT02876107|TN-IBC|tn-ibc
110393|NCT02876107|Breast biopsy|breast biopsy
110394|NCT02876107|Mammogram|mammogram
110395|NCT02876107|Ultrasound|ultrasound
110396|NCT02876107|Paclitaxel|paclitaxel
110397|NCT02876107|Taxol|taxol
110398|NCT02876107|Carboplatin|carboplatin
110399|NCT02876107|Paraplatin|paraplatin
110400|NCT02876107|Panitumumab|panitumumab
110401|NCT02876107|Vectibix|vectibix
110402|NCT02876107|Doxorubicin|doxorubicin
110403|NCT02876107|Doxorubicin Hydrochloride|doxorubicin hydrochloride
110404|NCT02876107|Adriamycin PFS|adriamycin pfs
110405|NCT02876107|Adriamycin RDF|adriamycin rdf
110406|NCT02876107|Adriamycin|adriamycin
110407|NCT02876107|Rubex|rubex
110408|NCT02876107|Cyclophosphamide|cyclophosphamide
110409|NCT02876107|Cytoxan|cytoxan
110410|NCT02876107|Neosar|neosar
110411|NCT02876055|Nerve Block/methods|nerve block/methods
110412|NCT02876055|Pain, Postoperative/prevention & control|pain, postoperative/prevention & control
110413|NCT02876055|Anesthetics, Local/administration & dosage|anesthetics, local/administration & dosage
110414|NCT02876055|Brachial Plexus/ultrasonography|brachial plexus/ultrasonography
110415|NCT02876055|Shoulder Pain/prevention & control|shoulder pain/prevention & control
110416|NCT02876042|Heart Failure|heart failure
110417|NCT02876042|Preserved Ejection Fraction|preserved ejection fraction
110418|NCT02875938|left middle cerebral artery|left middle cerebral artery
110419|NCT02875938|cerebrovascular accident (CVA)|cerebrovascular accident (cva)
110420|NCT02875938|stroke|stroke
110421|NCT02875925|blood coagulation|blood coagulation
110422|NCT02875912|Family|family
110423|NCT02875912|Care Rituals|care rituals
110424|NCT02875912|End of Life|end of life
110425|NCT02875912|Discordance of care|discordance of care
110426|NCT02875860|CDH|cdh
110427|NCT02875860|Congenital Diaphragmatic Hernia|congenital diaphragmatic hernia
110428|NCT02875860|Fetal Tracheal Occlusion|fetal tracheal occlusion
110429|NCT02875860|FETO|feto
110430|NCT02875860|plug-unplug|plug-unplug
110431|NCT02875860|GoldBal2|goldbal2
110432|NCT02875860|Balloon|balloon
110433|NCT02875860|Goldvalve Balloon|goldvalve balloon
110434|NCT02875860|TOTAL|total
110435|NCT02875795|linguistic|linguistic
110436|NCT02875795|quality of life|quality of life
110437|NCT02875782|Smoking Cessation|smoking cessation
110438|NCT02875769|cetylpyridinium chloride|cetylpyridinium chloride
110439|NCT02875769|chlorhexidine|chlorhexidine
110440|NCT02875769|oral aerosol|oral aerosol
110441|NCT02875769|oral splatter|oral splatter
110442|NCT02875769|mouthwash|mouthwash
110443|NCT02875769|microbiology|microbiology
110444|NCT02875704|DR|dr
110445|NCT02875704|AMD|amd
110446|NCT02875691|disease activity|disease activity
110447|NCT02875652|circulation tumor DNA|circulation tumor dna
110448|NCT02875652|choroidal melanoma|choroidal melanoma
110449|NCT02875639|Ischemic Heart Failure|ischemic heart failure
110450|NCT02875639|coronary artery disease|coronary artery disease
110451|NCT02875639|qi deficiency and blood stasis|qi deficiency and blood stasis
110452|NCT02875613|Nasopharyngeal|nasopharyngeal
110453|NCT02875613|PD-L1|pd-l1
110454|NCT02875613|monoclonal antibody|monoclonal antibody
110455|NCT02875613|Epstein-barr virus|epstein-barr virus
110456|NCT02875600|chronic gastro-intestinal ischemia|chronic gastro-intestinal ischemia
110457|NCT02875600|oxygen deficiency of the gastro-intestinal tract|oxygen deficiency of the gastro-intestinal tract
110458|NCT02875587|OHSS|ohss
110459|NCT02875587|Infertility|infertility
110460|NCT02875587|Cabergoline|cabergoline
110461|NCT02875587|Calcium gluconate|calcium gluconate
110462|NCT02875587|IVF-ET|ivf-et
110463|NCT02875574|Isoniazid|isoniazid
110464|NCT02875574|Drug Resistance|drug resistance
110465|NCT02875535|Evidence-based|evidence-based
110466|NCT02875535|lesbian, gay, bisexual, transgender, intersex, and queer|lesbian, gay, bisexual, transgender, intersex, and queer
110467|NCT02875535|adolescent|adolescent
110468|NCT02875535|Suicide prevention|suicide prevention
110469|NCT02875535|Implementation study|implementation study
110470|NCT02875522|COPD|copd
110471|NCT02875522|Exercise Training|exercise training
110472|NCT02875522|Flow-Mediated Dilation|flow-mediated dilation
110473|NCT02875522|Arterial Stiffness|arterial stiffness
110474|NCT02875522|Echocardiography|echocardiography
110475|NCT02875522|Cerebrovascular Physiology|cerebrovascular physiology
110476|NCT02875470|non-surgical periodontal debridement|non-surgical periodontal debridement
110477|NCT02875470|root planing/instrumentation|root planing/instrumentation
110478|NCT02875470|cytokine(s)|cytokine(s)
110479|NCT02875470|dental plaque|dental plaque
110480|NCT02875470|microscopy, electron, scanning|microscopy, electron, scanning
110481|NCT02875457|small cell lung cancer; apatinib; etoposide; cisplatin|small cell lung cancer; apatinib; etoposide; cisplatin
110482|NCT02875405|postoperative|postoperative
110483|NCT02875405|pericardiotomy|pericardiotomy
110484|NCT02875405|prevention|prevention
110485|NCT02875405|cardiac surgery|cardiac surgery
110486|NCT02875405|left|left
110487|NCT02875405|posterior|posterior
110488|NCT02875379|Noninvasive Ventilation|noninvasive ventilation
110489|NCT02875379|Mechanical Ventilation|mechanical ventilation
110490|NCT02875353|Post-Polypectomy|post-polypectomy
110491|NCT02875353|Colon bleeding|colon bleeding
110492|NCT02875353|Stigmata of recent hemorrhage|stigmata of recent hemorrhage
110493|NCT02875327|SEER|seer
110494|NCT02875327|Medicaid|medicaid
110495|NCT02875327|Cancer|cancer
110496|NCT02875327|Health Services Research|health services research
110497|NCT02875327|Epidemiology|epidemiology
110498|NCT02875301|Exercise|exercise
110499|NCT02875301|Brain Health|brain health
110500|NCT02875301|Dose Response|dose response
110501|NCT02875301|Cognition|cognition
110502|NCT02875262|intracranial aneurysm|intracranial aneurysm
110503|NCT02875262|subarachnoid hemorrhage|subarachnoid hemorrhage
110504|NCT02875262|stroke|stroke
110505|NCT02875262|chelator|chelator
110506|NCT02875249|post-antibiotic diarrhea|post-antibiotic diarrhea
110507|NCT02875249|intestinal microbiome|intestinal microbiome
110508|NCT02875223|Safety|safety
110509|NCT02875223|CC-90011|cc-90011
110510|NCT02875223|Relapsed and/or Refractory Solid Tumors|relapsed and/or refractory solid tumors
110511|NCT02875223|Non-Hodgkin's Lymphomas|non-hodgkin's lymphomas
110512|NCT02875210|Anterior Cruciate Ligament|anterior cruciate ligament
110513|NCT02875210|A02.835.583.512.100|a02.835.583.512.100
110514|NCT02875197|Kinetics|kinetics
110515|NCT02875197|Biomechanics|biomechanics
110516|NCT02875197|Amputation|amputation
110517|NCT02875197|Prosthesis|prosthesis
110518|NCT02875197|Transtibial|transtibial
110519|NCT02875184|Psoriatic Arthritis|psoriatic arthritis
110520|NCT02875184|Apremilast|apremilast
110521|NCT02875184|CC-10004|cc-10004
110522|NCT02875171|Anthracyclines; Cardiotoxicity; 2-D Echocardiography|anthracyclines; cardiotoxicity; 2-d echocardiography
110523|NCT02875145|Corneal Transplantation|corneal transplantation
110524|NCT02875145|Graft Survival|graft survival
110525|NCT02875106|Sinus rhythm|sinus rhythm
110526|NCT02875041|rehabilitation|rehabilitation
110527|NCT02875041|balance|balance
110528|NCT02875028|Coagulations|coagulations
110529|NCT02875028|Platelets|platelets
110530|NCT02875028|Inflammation|inflammation
110531|NCT02875028|endotoxemia|endotoxemia
110532|NCT02875028|vorapaxar|vorapaxar
110533|NCT02875015|Anesthetics|anesthetics
110534|NCT02875015|Anesthetic Effects|anesthetic effects
110535|NCT02875015|Mid-urethral sling|mid-urethral sling
110536|NCT02874976|sedentary lifestyle|sedentary lifestyle
110537|NCT02874963|Diabetes|diabetes
110538|NCT02874963|Oral Hygiene|oral hygiene
110539|NCT02874963|Periodontal Surgery|periodontal surgery
110540|NCT02874963|Periodontal Medicine|periodontal medicine
110541|NCT02874950|Exercise|exercise
110542|NCT02874937|Syncope|syncope
110543|NCT02874937|Vasovagal|vasovagal
110544|NCT02874937|Atomoxetine|atomoxetine
110545|NCT02874924|Geriatrics|geriatrics
110546|NCT02874911|Exergaming|exergaming
110547|NCT02874911|Neurodegenerative diseases|neurodegenerative diseases
110548|NCT02874911|Rare disease|rare disease
110549|NCT02874911|Motor exercises|motor exercises
110550|NCT02874911|Training|training
110551|NCT02874911|Spinocerebellar ataxia|spinocerebellar ataxia
110552|NCT02874885|Locally-advanced rectal cancer|locally-advanced rectal cancer
110553|NCT02874885|LARC|larc
110554|NCT02874885|Colorectal cancer|colorectal cancer
110555|NCT02874885|CRC|crc
110556|NCT02874885|Rectosigmoid cancer|rectosigmoid cancer
110557|NCT02874885|No known diagnosis of colorectal cancer|no known diagnosis of colorectal cancer
110558|NCT02874885|Blood draws|blood draws
110559|NCT02874885|Blood samples|blood samples
110560|NCT02874885|Circulating tumor cells (CTC)|circulating tumor cells (ctc)
110561|NCT02874885|CTC|ctc
110562|NCT02874872|Nursing homes|nursing homes
110563|NCT02874872|Antibiotic Stewardship|antibiotic stewardship
110564|NCT02874872|Antibiotic Resistance|antibiotic resistance
110565|NCT02874859|DIABETIC RETINOPATHY|diabetic retinopathy
110566|NCT02874859|Intravitreal aflibercept|intravitreal aflibercept
110567|NCT02874833|Depression|depression
110568|NCT02874833|Unipolar depression|unipolar depression
110569|NCT02874833|Bipolar affective disorder|bipolar affective disorder
110570|NCT02874833|Exercise|exercise
110571|NCT02874833|Internet-based intervention|internet-based intervention
110572|NCT02874820|Imidazoline Receptor 2|imidazoline receptor 2
110573|NCT02874820|(4,5-dihydro-1H-imidazol-2-yl)-1-methyl-1H-indole|(4,5-dihydro-1h-imidazol-2-yl)-1-methyl-1h-indole
110574|NCT02874820|BU99008|bu99008
110575|NCT02874820|[11C]-BU99008|[11c]-bu99008
110576|NCT02874820|Radionuclide Imaging|radionuclide imaging
110577|NCT02874820|Molecular Imaging|molecular imaging
110578|NCT02874807|Hyponatremia|hyponatremia
110579|NCT02874807|SGLT2 inhibitor|sglt2 inhibitor
110580|NCT02874794|Heart Failure|heart failure
110581|NCT02874794|Reduced Ejection Fraction|reduced ejection fraction
110582|NCT02874794|Central Aortic Stiffness|central aortic stiffness
110583|NCT02874794|Vascular|vascular
110584|NCT02874794|Echocardiogram|echocardiogram
110585|NCT02874755|Quality of Care|quality of care
110586|NCT02874755|Standardized Patients|standardized patients
110587|NCT02874729|Biomarkers, Tumor|biomarkers, tumor
110588|NCT02874729|Biological Assay|biological assay
110589|NCT02874716|Quality of Care|quality of care
110590|NCT02874716|Standardized Patients|standardized patients
110591|NCT02874677|Multiple sclerosis|multiple sclerosis
110592|NCT02874677|Ventilatory threshold|ventilatory threshold
110593|NCT02874677|Effort Reeducation|effort reeducation
110594|NCT02874651|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
110595|NCT02874651|EB Virus|eb virus
110596|NCT02874651|DNA|dna
110597|NCT02874651|vascular endothecial growth factor receptor inhibitor|vascular endothecial growth factor receptor inhibitor
110598|NCT02874651|Apatinib|apatinib
110599|NCT02874612|Young Adults|young adults
110600|NCT02874612|Psychosocial Functioning|psychosocial functioning
110601|NCT02874573|Inflammation|inflammation
110602|NCT02874573|Schizophrenia|schizophrenia
110603|NCT02874560|CNS|cns
110604|NCT02874560|Antipsychotic|antipsychotic
110605|NCT02874560|Functional remission|functional remission
110606|NCT02874560|Observational study|observational study
110607|NCT02874560|FROGS|frogs
110608|NCT02874560|PSP|psp
110609|NCT02874560|Functioning|functioning
110610|NCT02874560|Schizophrenia|schizophrenia
110611|NCT02874508|leukocyte subpopulations|leukocyte subpopulations
110612|NCT02874508|perioperative myocardial infarction|perioperative myocardial infarction
110613|NCT02874508|non-cardiac surgery|non-cardiac surgery
110614|NCT02874508|perioperative cardiovascular risk|perioperative cardiovascular risk
110615|NCT02874495|Crohn's disease|crohn's disease
110616|NCT02874495|Rectal Distension|rectal distension
110617|NCT02874495|Remission|remission
110618|NCT02874495|Anticipation|anticipation
110619|NCT02874495|Painful|painful
110620|NCT02874482|Schizophrenia|schizophrenia
110621|NCT02874482|Change blindness|change blindness
110622|NCT02874482|Eye tracking|eye tracking
110623|NCT02874482|Implicit response|implicit response
110624|NCT02874469|sudden death|sudden death
110625|NCT02874469|post-traumatic stress disorder|post-traumatic stress disorder
110626|NCT02874469|psychological distress|psychological distress
110627|NCT02874469|diary|diary
110628|NCT02874469|resuscitation|resuscitation
110629|NCT02874456|Zyca virus|zyca virus
110630|NCT02874352|intensive care|intensive care
110631|NCT02874352|tracheostomy|tracheostomy
110632|NCT02874339|Acute cardiogenic pulmonary|acute cardiogenic pulmonary
110633|NCT02874339|Respiratory failure|respiratory failure
110634|NCT02874339|Hypercapnia|hypercapnia
110635|NCT02874339|High flow nasal oxygen|high flow nasal oxygen
110636|NCT02874339|Non invasive ventilation|non invasive ventilation
110637|NCT02874339|Emergency department|emergency department
110638|NCT02874326|Sandostatin LAR|sandostatin lar
110639|NCT02874326|Somatostatin|somatostatin
110640|NCT02874326|Octreotide|octreotide
110641|NCT02874313|CPAP|cpap
110642|NCT02874313|Sleep apnea|sleep apnea
110643|NCT02874313|Diabetes|diabetes
110644|NCT02874313|Diabetic retinopathy|diabetic retinopathy
110645|NCT02874287|Coronary Artery Disease|coronary artery disease
110646|NCT02874287|Hydroxychloroquine|hydroxychloroquine
110647|NCT02874274|Corticobasal syndrome|corticobasal syndrome
110648|NCT02874274|Dementia with Lewy Bodies|dementia with lewy bodies
110649|NCT02874274|Home Visit Program (HVP)|home visit program (hvp)
110650|NCT02874274|Multidimensional Caregiver Strain Index|multidimensional caregiver strain index
110651|NCT02874274|Parkinson's Disease Dementia|parkinson's disease dementia
110652|NCT02874274|Progressive Supranuclear Palsy|progressive supranuclear palsy
110653|NCT02874222|aromatase inhibitors|aromatase inhibitors
110654|NCT02874183|Heart Failure|heart failure
110655|NCT02874183|HF|hf
110656|NCT02874183|CHF|chf
110657|NCT02874183|RCT|rct
110658|NCT02874183|Self-efficacy|self-efficacy
110659|NCT02874183|Pharmacy|pharmacy
110660|NCT02874183|Pharmacist|pharmacist
110661|NCT02874183|Transition of Care|transition of care
110662|NCT02874183|Readmission|readmission
110663|NCT02874131|Posttraumatic Stress Disorder|posttraumatic stress disorder
110664|NCT02874131|Major Depressive Disorder|major depressive disorder
110665|NCT02874131|Behavioral Activation|behavioral activation
110666|NCT02874131|Cognitive Processing Therapy|cognitive processing therapy
110667|NCT02874131|Comorbidity|comorbidity
110668|NCT02874131|Military|military
110669|NCT02874105|Medical treatment|medical treatment
110670|NCT02874105|physiotherapy|physiotherapy
110671|NCT02874092|Methotrexate (MTX)|methotrexate (mtx)
110672|NCT02874092|Ticagrelor|ticagrelor
110673|NCT02874066|Hepatitis C virus|hepatitis c virus
110674|NCT02874066|Hemodialysis|hemodialysis
110675|NCT02874066|Direct acting antiviral agents|direct acting antiviral agents
110676|NCT02874053|Risk Perceptions|risk perceptions
110677|NCT02874053|Medical Tradeoffs|medical tradeoffs
110678|NCT02874053|Regulatory Focus|regulatory focus
110679|NCT02874053|Integral Affect|integral affect
110680|NCT02874027|gut microbiota|gut microbiota
110681|NCT02874027|depression|depression
110682|NCT02874027|gut-brain axis|gut-brain axis
110683|NCT02874027|circadian rhythm|circadian rhythm
110684|NCT02874027|Traumatic Brain Injury|traumatic brain injury
110685|NCT02874001|psychology|psychology
110686|NCT02874001|caregiver support time|caregiver support time
110687|NCT02873975|Advanced Cancers|advanced cancers
110688|NCT02873975|Solid tumors|solid tumors
110689|NCT02873975|MYC amplification|myc amplification
110690|NCT02873975|CCNE1 amplification|ccne1 amplification
110691|NCT02873975|Rb loss|rb loss
110692|NCT02873975|FBXW7 mutation|fbxw7 mutation
110693|NCT02873975|BRCA1 mutation|brca1 mutation
110694|NCT02873975|BRCA2 mutation|brca2 mutation
110695|NCT02873975|PALB2 mutation|palb2 mutation
110696|NCT02873975|RAD51C mutation|rad51c mutation
110697|NCT02873975|RAD51D mutation|rad51d mutation
110698|NCT02873975|ATR mutation|atr mutation
110699|NCT02873975|ATM mutation|atm mutation
110700|NCT02873975|CHK2 mutation|chk2 mutation
110701|NCT02873975|Fanconi anemia|fanconi anemia
110702|NCT02873962|Relapsed Ovarian Cancer|relapsed ovarian cancer
110703|NCT02873949|immunology factors|immunology factors
110704|NCT02873949|TREM|trem
110705|NCT02873949|stress|stress
110706|NCT02873923|clinical trial|clinical trial
110707|NCT02873923|surrogate endpoints|surrogate endpoints
110708|NCT02873923|meta analysis|meta analysis
110709|NCT02873897|elderly|elderly
110710|NCT02873858|elderly|elderly
110711|NCT02873780|Pulmonary rehabilitation|pulmonary rehabilitation
110712|NCT02873780|COPD|copd
110713|NCT02873780|Evaluation|evaluation
110714|NCT02873780|oxygen desaturation|oxygen desaturation
110715|NCT02873780|exercise capacity|exercise capacity
110716|NCT02873767|First in human|first in human
110717|NCT02873767|Healthy volunteers|healthy volunteers
110718|NCT02873741|Sexually Transmitted Diseases (STDs)|sexually transmitted diseases (stds)
110719|NCT02873741|Cancer|cancer
110720|NCT02873741|AIDS|aids
110721|NCT02873728|chronic ulcer|chronic ulcer
110722|NCT02873728|diabetic ulcer|diabetic ulcer
110723|NCT02873728|venous ulcer|venous ulcer
110724|NCT02873728|remote ischemic conditioning|remote ischemic conditioning
110725|NCT02873715|Childhood weight control|childhood weight control
110726|NCT02873702|Drug therapy|drug therapy
110727|NCT02873689|Drug therapy|drug therapy
110728|NCT02873676|prevalence; lifestyle modification; clinical outcomes|prevalence; lifestyle modification; clinical outcomes
110729|NCT02873650|Hepatic impairment|hepatic impairment
110730|NCT02873650|Healthy volunteers|healthy volunteers
110731|NCT02873650|Clinical pharmacology study|clinical pharmacology study
110732|NCT02873650|DRB436|drb436
110733|NCT02873650|dabrafenib|dabrafenib
110734|NCT02873650|normal hepatic function|normal hepatic function
110735|NCT02873650|impaired hepatic function|impaired hepatic function
110736|NCT02873637|total knee replacement|total knee replacement
110737|NCT02873637|anesthesia|anesthesia
110738|NCT02873637|catheter|catheter
110739|NCT02873624|Acute Kidney Injury , Laparoscopic Cholecystectomy|acute kidney injury , laparoscopic cholecystectomy
110740|NCT02873598|Induction Chemotherapy|induction chemotherapy
110741|NCT02873598|Stereotactic Body Radiotherapy (SBRT)|stereotactic body radiotherapy (sbrt)
110742|NCT02873598|Dose Escalation|dose escalation
110743|NCT02873598|Locally Advanced Pancreatic Cancer (LAPC)|locally advanced pancreatic cancer (lapc)
110744|NCT02873598|Maximum Tolerated Dose (MTD)|maximum tolerated dose (mtd)
110745|NCT02873572|Online poker|online poker
110746|NCT02873572|Casino|casino
110747|NCT02873572|Massively Multiplayer Online Role-Playing Game (MMORPG)|massively multiplayer online role-playing game (mmorpg)
110748|NCT02873572|Iowa Gambling Task (IGT)|iowa gambling task (igt)
110749|NCT02873572|High Resolution Electroencephalography (HR-EEG)|high resolution electroencephalography (hr-eeg)
110750|NCT02873559|older|older
110751|NCT02873559|frail|frail
110752|NCT02873559|men|men
110753|NCT02873559|progressive muscle training|progressive muscle training
110754|NCT02873559|muscle training|muscle training
110755|NCT02873559|exercise|exercise
110756|NCT02873559|testosterone|testosterone
110757|NCT02873520|Precision Cell Immunotherapy|precision cell immunotherapy
110758|NCT02873520|Chemotherapy|chemotherapy
110759|NCT02873520|Advanced Gastric Cancer|advanced gastric cancer
110760|NCT02873507|transplantation, liver|transplantation, liver
110761|NCT02873494|Hemodynamic monitoring|hemodynamic monitoring
110762|NCT02873494|cardiac output|cardiac output
110763|NCT02873494|Transthoracic echocardiography|transthoracic echocardiography
110764|NCT02873494|Impedance cardiography|impedance cardiography
110765|NCT02873494|Child|child
110766|NCT02873494|Physioflow|physioflow
110767|NCT02873494|pediatric intensive care unit|pediatric intensive care unit
110768|NCT02873442|Precision Cell Immunotherapy|precision cell immunotherapy
110769|NCT02873442|Transcatheter Arterial Chemoembolization|transcatheter arterial chemoembolization
110770|NCT02873442|Advanced Liver Cancer|advanced liver cancer
110771|NCT02873416|Precision Cell Immunotherapy|precision cell immunotherapy
110772|NCT02873416|Chemotherapy|chemotherapy
110773|NCT02873416|Advanced Lung Cancer|advanced lung cancer
110774|NCT02873390|PD-1 Antibody|pd-1 antibody
110775|NCT02873390|CAR-T Cells|car-t cells
110776|NCT02873390|EGFR family|egfr family
110777|NCT02873390|Advanced Malignancies|advanced malignancies
110778|NCT02873377|Hispanics|hispanics
110779|NCT02873377|Construction workers|construction workers
110780|NCT02873377|Tobacco Quitline|tobacco quitline
110781|NCT02873377|Nicotine replacement therapy|nicotine replacement therapy
110782|NCT02873351|L-DOPA|l-dopa
110783|NCT02873351|GPR143|gpr143
110784|NCT02873351|PEDF|pedf
110785|NCT02873351|VEGF|vegf
110786|NCT02873325|ADV|adv
110787|NCT02873325|CMV|cmv
110788|NCT02873325|HSCT|hsct
110789|NCT02873299|PTSD, Post Traumatic Stress Disorder|ptsd, post traumatic stress disorder
110790|NCT02873286|RSV Vaccines|rsv vaccines
110791|NCT02873286|Respiratory Syncytial Virus Vaccines|respiratory syncytial virus vaccines
110792|NCT02873260|Dengue Vaccine|dengue vaccine
110793|NCT02873234|Telemedicine|telemedicine
110794|NCT02873234|Chinese Medicine syndrome differentiation|chinese medicine syndrome differentiation
110795|NCT02873234|Long-term study|long-term study
110796|NCT02873234|Relapse rate|relapse rate
110797|NCT02873234|Suicide rate|suicide rate
110798|NCT02873234|Antidepressants|antidepressants
110799|NCT02873208|Alkermes|alkermes
110800|NCT02873208|ALKS 3831|alks 3831
110801|NCT02873208|Samidorphan|samidorphan
110802|NCT02873208|Schizophrenia|schizophrenia
110803|NCT02873208|Safety|safety
110804|NCT02873182|Intraoperative monitoring|intraoperative monitoring
110805|NCT02873182|Intraoperative neuromonitoring|intraoperative neuromonitoring
110806|NCT02873182|Autonomic nervous system|autonomic nervous system
110807|NCT02873182|Spine surgery|spine surgery
110808|NCT02873182|Pelvic surgery|pelvic surgery
110809|NCT02873182|Sexual function|sexual function
110810|NCT02873182|Bowel function|bowel function
110811|NCT02873182|Bladder function|bladder function
110812|NCT02873169|Left ventricular assist device|left ventricular assist device
110813|NCT02873169|Ventricular Arrhythmias|ventricular arrhythmias
110814|NCT02873169|Implantable Cardioverter-defibrillator|implantable cardioverter-defibrillator
110815|NCT02873156|E2027|e2027
110816|NCT02873156|Healthy participants|healthy participants
110817|NCT02873156|Pharmacokinetics|pharmacokinetics
110818|NCT02873156|Pharmacodynamics|pharmacodynamics
110819|NCT02873117|Benign prostate hyperplasia|benign prostate hyperplasia
110820|NCT02873117|5 alpha reductase inhibitor|5 alpha reductase inhibitor
110821|NCT02873117|prostate cancer|prostate cancer
110822|NCT02873117|Symptomatic|symptomatic
110823|NCT02873117|treated|treated
110824|NCT02873013|prostate cancer|prostate cancer
110825|NCT02873013|observational study|observational study
110826|NCT02873000|incentive spirometry|incentive spirometry
110827|NCT02873000|outcome|outcome
110828|NCT02873000|length of stay,|length of stay,
110829|NCT02873000|hospital complication|hospital complication
110830|NCT02873000|general internal medicine|general internal medicine
110831|NCT02873000|hospital medicine|hospital medicine
110832|NCT02873000|non-critically-ill|non-critically-ill
110833|NCT02872974|Cardiovascular diseases|cardiovascular diseases
110834|NCT02872974|Gestational diabetes mellitus|gestational diabetes mellitus
110835|NCT02872974|Pediatrics|pediatrics
110836|NCT02872974|Fetal programming|fetal programming
110837|NCT02872974|Cohort study|cohort study
110838|NCT02872948|Non invasive prenatal testing|non invasive prenatal testing
110839|NCT02872948|Down Syndrome|down syndrome
110840|NCT02872948|Digital PCR|digital pcr
110841|NCT02872922|Endothelial function|endothelial function
110842|NCT02872922|Ultrasonic Therapy|ultrasonic therapy
110843|NCT02872922|Vascular endothelium|vascular endothelium
110844|NCT02872922|Nitric oxide|nitric oxide
110845|NCT02872922|Ultrasound|ultrasound
110846|NCT02872883|Prelabour rupture of membranes|prelabour rupture of membranes
110847|NCT02872883|term pregnancy|term pregnancy
110848|NCT02872883|management|management
110849|NCT02872883|vaginal examination|vaginal examination
110850|NCT02872883|induction of labour|induction of labour
110851|NCT02872883|expectant management|expectant management
110852|NCT02872870|language disorders|language disorders
110853|NCT02872870|developmental disorders of oral and written language|developmental disorders of oral and written language
110854|NCT02872831|Fine needle aspiration|fine needle aspiration
110855|NCT02872818|Apoptotic signal pathway|apoptotic signal pathway
110856|NCT02872818|Survivin|survivin
110857|NCT02872818|Bcl-2|bcl-2
110858|NCT02872818|Bax|bax
110859|NCT02872818|c-Myc|c-myc
110860|NCT02872818|Caspase-9|caspase-9
110861|NCT02872818|endometrial hyperplasia|endometrial hyperplasia
110862|NCT02872818|endometrium cancer|endometrium cancer
110863|NCT02872792|cycloergometer|cycloergometer
110864|NCT02872753|Autologous Conditioned Plasma|autologous conditioned plasma
110865|NCT02872753|meniscectomy|meniscectomy
110866|NCT02872753|randomized controlled trial|randomized controlled trial
110867|NCT02872753|intra-op injection|intra-op injection
110868|NCT02872714|Urothelial carcinoma|urothelial carcinoma
110869|NCT02872714|fibroblast growth factor (FGF)|fibroblast growth factor (fgf)
110870|NCT02872714|fibroblast growth factor receptor (FGFR)|fibroblast growth factor receptor (fgfr)
111274|NCT02870140|PCI|pci
110871|NCT02872714|FGF/FGFR alterations|fgf/fgfr alterations
110872|NCT02872675|Asthma|asthma
110873|NCT02872675|Exercise-Induced Asthma|exercise-induced asthma
110874|NCT02872675|Gut Bacteria|gut bacteria
110875|NCT02872675|Bimuno® Galactooligosaccharide|bimuno® galactooligosaccharide
110876|NCT02872675|Pulmonary Function|pulmonary function
110877|NCT02872675|Prebiotics|prebiotics
110878|NCT02872675|Exercise-Induced Bronchoconstriction|exercise-induced bronchoconstriction
110879|NCT02872675|Gut Microbiota|gut microbiota
110880|NCT02872675|Nutritional Intervention|nutritional intervention
110881|NCT02872675|Eucapnic Voluntary Hyperpnoea|eucapnic voluntary hyperpnoea
110882|NCT02872675|Systemic Inflammation|systemic inflammation
110883|NCT02872675|Systemic Immune Function|systemic immune function
110884|NCT02872675|Regulatory T Cells|regulatory t cells
110885|NCT02872675|TH1 Cells|th1 cells
110886|NCT02872675|TH2 Cells|th2 cells
110887|NCT02872675|Short-Chain Fatty Acids|short-chain fatty acids
110888|NCT02872675|Acetate|acetate
110889|NCT02872675|Propionate|propionate
110890|NCT02872675|Butyrate|butyrate
110891|NCT02872675|Metabolomics|metabolomics
110892|NCT02872675|Airway Inflammation|airway inflammation
110893|NCT02872675|Intestinal Permeability|intestinal permeability
110894|NCT02872610|suicidal thoughts|suicidal thoughts
110895|NCT02872610|suicidal ideation|suicidal ideation
110896|NCT02872610|Internet intervention|internet intervention
110897|NCT02872610|self-help|self-help
110898|NCT02872571|islet of Langerhans|islet of langerhans
110899|NCT02872571|transplantation|transplantation
110900|NCT02872571|muscle|muscle
110901|NCT02872506|Quality of life|quality of life
110902|NCT02872506|Crohn's disease|crohn's disease
110903|NCT02872506|Ileocecal resection|ileocecal resection
110904|NCT02872506|Anti TNF|anti tnf
110905|NCT02872493|obesity|obesity
110906|NCT02872493|bariatric surgery|bariatric surgery
110907|NCT02872493|bowel length|bowel length
110908|NCT02872480|Concussion|concussion
110909|NCT02872480|Exercise|exercise
110910|NCT02872467|Cocaine|cocaine
110911|NCT02872467|Mothers|mothers
110912|NCT02872467|Pregnant women|pregnant women
110913|NCT02872467|Postpartum women|postpartum women
110914|NCT02872467|Oxytocin|oxytocin
110915|NCT02872467|Substance use disorders|substance use disorders
110916|NCT02872467|Substance abuse|substance abuse
110917|NCT02872467|Prenatal substance use|prenatal substance use
110918|NCT02872467|stress|stress
110919|NCT02872454|Major Depression|major depression
110920|NCT02872454|Text Messaging|text messaging
110921|NCT02872454|Guided Self-Help|guided self-help
110922|NCT02872402|gestational diabetes|gestational diabetes
110923|NCT02872402|dietary modification|dietary modification
110924|NCT02872402|weight loss|weight loss
110925|NCT02872402|physical activity|physical activity
110926|NCT02872402|breastfeeding|breastfeeding
110927|NCT02872376|Anemia|anemia
110928|NCT02872376|Crohn's disease|crohn's disease
110929|NCT02872376|Ulcerative colitis|ulcerative colitis
110930|NCT02872363|breast screening|breast screening
110931|NCT02872363|breast cancer|breast cancer
110932|NCT02872363|mammogram|mammogram
110933|NCT02872363|uptake|uptake
110934|NCT02872363|reminder|reminder
110935|NCT02872363|text message|text message
110936|NCT02872363|SMS|sms
110937|NCT02872311|Vaccine|vaccine
110938|NCT02872311|Influenza|influenza
110939|NCT02872311|High Dose|high dose
110940|NCT02872311|Adjuvanted|adjuvanted
110941|NCT02872298|Severe|severe
110942|NCT02872298|Refractory|refractory
110943|NCT02872259|metastatic melanoma|metastatic melanoma
110944|NCT02872259|advanced Non-resectable melanoma|advanced non-resectable melanoma
110945|NCT02872181|Maternal Position|maternal position
110946|NCT02872181|Tilt|tilt
110947|NCT02872181|Left Uterine Displacement|left uterine displacement
110948|NCT02872181|Cesarean Delivery|cesarean delivery
110949|NCT02872181|Cesarean Section|cesarean section
110950|NCT02872155|contrast-induced nephropathy|contrast-induced nephropathy
110951|NCT02872155|renal insufficiency|renal insufficiency
110952|NCT02872155|computed tomography|computed tomography
110953|NCT02872129|Fibromyalgia|fibromyalgia
110954|NCT02872129|chronic widespread pain|chronic widespread pain
110955|NCT02872129|follow-up|follow-up
110956|NCT02872129|pain|pain
110957|NCT02872129|fatigue|fatigue
110958|NCT02872129|symptoms|symptoms
110959|NCT02872129|workability|workability
110960|NCT02872129|physical function|physical function
110961|NCT02872090|COPD|copd
110962|NCT02872090|bronchodilatators|bronchodilatators
110963|NCT02872090|autonomic nervous system|autonomic nervous system
110964|NCT02872090|cardiovascular system|cardiovascular system
110965|NCT02872077|AA for NAS|aa for nas
110966|NCT02872064|Early breast cancer|early breast cancer
110967|NCT02872064|Photodynamic therapy|photodynamic therapy
110969|NCT02872064|Visudyne|visudyne
110970|NCT02872064|Verteporfin|verteporfin
110971|NCT02872051|Vocational Rehabilitation|vocational rehabilitation
110972|NCT02872051|Anxiety|anxiety
110973|NCT02872051|Depression|depression
110974|NCT02872051|Common Mental Disorders|common mental disorders
110975|NCT02872051|Cognitive Behavior Therapy|cognitive behavior therapy
110976|NCT02872051|Return to Work|return to work
110977|NCT02872051|Mental Health Services|mental health services
110978|NCT02872051|Integration|integration
110979|NCT02871999|Acupuncture Therapy|acupuncture therapy
110980|NCT02871999|Pain degree after surgery|pain degree after surgery
110981|NCT02871973|parenting|parenting
110982|NCT02871973|child development|child development
110983|NCT02871973|language|language
110984|NCT02871947|severe asthma|severe asthma
110985|NCT02871934|Pharmacogenetics|pharmacogenetics
110986|NCT02871934|SLCO1B1 protein, human|slco1b1 protein, human
110987|NCT02871934|OATP1B1 protein, human|oatp1b1 protein, human
110988|NCT02871934|Simvastatin|simvastatin
110989|NCT02871934|Cardiovascular disease|cardiovascular disease
110990|NCT02871934|Cholesterol|cholesterol
110991|NCT02871934|Statin-related myotoxicity|statin-related myotoxicity
110992|NCT02871934|Veterans|veterans
110993|NCT02871934|Point-of-care|point-of-care
110994|NCT02871921|Behavioral prevention|behavioral prevention
110995|NCT02871921|social interaction|social interaction
110996|NCT02871921|dementia|dementia
110997|NCT02871921|MRI|mri
110998|NCT02871895|sepsis|sepsis
110999|NCT02871895|severe sepsis|severe sepsis
111000|NCT02871895|septic shock|septic shock
111001|NCT02871895|multiple organ failure|multiple organ failure
111002|NCT02871869|Cinobufacini Tablets|cinobufacini tablets
111003|NCT02871869|CHOP protocol|chop protocol
111004|NCT02871856|Screening|screening
111005|NCT02871856|Computed tomography|computed tomography
111006|NCT02871856|Lung cancer|lung cancer
111007|NCT02871830|Physical activity|physical activity
111008|NCT02871830|Walking|walking
111009|NCT02871830|Intervention|intervention
111010|NCT02871830|Adolescent girls|adolescent girls
111011|NCT02871830|Randomised trial|randomised trial
111012|NCT02871817|Near Corrected Visual Acuity|near corrected visual acuity
111013|NCT02871817|Early Treatment Diabetes Retinopathy Study|early treatment diabetes retinopathy study
111014|NCT02871817|Amsler Grid|amsler grid
111015|NCT02871817|Home Monitoring|home monitoring
111016|NCT02871791|Her2-negative metastatic breast cancer|her2-negative metastatic breast cancer
111017|NCT02871791|Hormone receptor (HR)-positive breast cancer|hormone receptor (hr)-positive breast cancer
111018|NCT02871765|Patient education|patient education
111019|NCT02871765|Knowledge|knowledge
111020|NCT02871765|Life distress|life distress
111021|NCT02871765|Quality of life|quality of life
111022|NCT02871752|prostate cancer|prostate cancer
111023|NCT02871752|active surveillance|active surveillance
111024|NCT02871752|MBSR|mbsr
111025|NCT02871752|couples|couples
111026|NCT02871752|health promotion|health promotion
111027|NCT02871752|quality of life|quality of life
111028|NCT02871752|mindfulness|mindfulness
111029|NCT02871739|Communication skills training|communication skills training
111030|NCT02871739|Shared Decision Making|shared decision making
111031|NCT02871739|Decision making|decision making
111032|NCT02871739|Decision Aids|decision aids
111033|NCT02871739|lung cancer screening|lung cancer screening
111034|NCT02871726|Prostate Cancer Detection|prostate cancer detection
111035|NCT02871726|Prostate Biopsy|prostate biopsy
111036|NCT02871726|Prostate Cancer|prostate cancer
111037|NCT02871726|Transrectal Ultrasound|transrectal ultrasound
111038|NCT02871713|quadratus lumborum block|quadratus lumborum block
111039|NCT02871700|stroke|stroke
111040|NCT02871700|translational rehabilitation|translational rehabilitation
111041|NCT02871700|mirror neuron system|mirror neuron system
111042|NCT02871700|action observation|action observation
111043|NCT02871700|mirror therapy|mirror therapy
111044|NCT02871700|MEG|meg
111045|NCT02871674|Behavioural interventions|behavioural interventions
111046|NCT02871674|Sleep difficulties|sleep difficulties
111047|NCT02871674|Children|children
111048|NCT02871674|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
111049|NCT02871674|Randomised controlled trial|randomised controlled trial
111050|NCT02871674|Saudi Arabia|saudi arabia
111051|NCT02871674|Behavioural Insomnia|behavioural insomnia
111052|NCT02871661|vulvodynia|vulvodynia
111053|NCT02871661|pelvic floor muscles|pelvic floor muscles
111054|NCT02871661|kinesiotherapy|kinesiotherapy
111055|NCT02871661|electrical therapy|electrical therapy
111056|NCT02871661|physical therapy|physical therapy
111057|NCT02871661|amitriptyline|amitriptyline
111058|NCT02871661|female sexual dysfunction.|female sexual dysfunction.
111059|NCT02871648|Healthy|healthy
111060|NCT02871609|Biofilm|biofilm
111061|NCT02871609|Morbidity|morbidity
111062|NCT02871609|Ureteral Catheterization|ureteral catheterization
111063|NCT02871570|Hepatic Impairment|hepatic impairment
111064|NCT02871570|Rivipansel|rivipansel
111065|NCT02871544|BNP|bnp
111066|NCT02871544|NGAL|ngal
111067|NCT02871544|Sepsis|sepsis
111068|NCT02871544|Mortality|mortality
111069|NCT02871531|retinal detachment|retinal detachment
111070|NCT02871531|pneumatic retinopexy|pneumatic retinopexy
111071|NCT02871531|vitrectomy|vitrectomy
111072|NCT02871479|Atopic Dermatitis|atopic dermatitis
111073|NCT02871479|Eczema|eczema
111074|NCT02871453|Ischemic Stroke|ischemic stroke
111075|NCT02871453|Motor Dysfunction|motor dysfunction
111076|NCT02871453|Scalp Acupuncture|scalp acupuncture
111077|NCT02871427|Lewy body dementia|lewy body dementia
111078|NCT02871427|Dementia with Lewy bodies|dementia with lewy bodies
111079|NCT02871427|Parkinson's disease dementia|parkinson's disease dementia
111080|NCT02871427|Visual hallucinations|visual hallucinations
111081|NCT02871427|REM sleep behavior disorder|rem sleep behavior disorder
111082|NCT02871401|IPF|ipf
111083|NCT02871401|Herpesvirus|herpesvirus
111084|NCT02871401|Valganciclovir|valganciclovir
111085|NCT02871388|Physical activity|physical activity
111086|NCT02871388|Diet|diet
111087|NCT02871388|Nutrition|nutrition
111088|NCT02871388|Breast cancer prevention|breast cancer prevention
111089|NCT02871388|Mammography screening|mammography screening
111090|NCT02871375|myopia|myopia
111091|NCT02871375|presbyopia|presbyopia
111092|NCT02871349|Autism|autism
111093|NCT02871349|ASD|asd
111094|NCT02871336|Cata collection|cata collection
111095|NCT02871336|Pancreatic cancer surgery|pancreatic cancer surgery
111096|NCT02871323|Myelofibrosis Transformation in Essential Thrombocythemia|myelofibrosis transformation in essential thrombocythemia
111097|NCT02871297|adolescent|adolescent
111098|NCT02871297|children|children
111099|NCT02871284|cancer|cancer
111100|NCT02871284|anticancer treatment|anticancer treatment
111101|NCT02871284|exercise|exercise
111102|NCT02871284|physical activity|physical activity
111103|NCT02871284|sensorimotor training|sensorimotor training
111104|NCT02871284|chemotherapy-induced polyneuropathy|chemotherapy-induced polyneuropathy
111105|NCT02871245|Acupuncture Therapy|acupuncture therapy
111106|NCT02871245|Laparoscopic Surgery|laparoscopic surgery
111107|NCT02871245|Gastrointestinal Tract Recovery of Function|gastrointestinal tract recovery of function
111108|NCT02871219|Follicular lymphoma|follicular lymphoma
111109|NCT02871219|Obinutuzumab|obinutuzumab
111110|NCT02871219|GA101|ga101
111111|NCT02871219|Gazyva|gazyva
111112|NCT02871219|Lenalidomide|lenalidomide
111113|NCT02871219|CC-5013|cc-5013
111114|NCT02871219|Revlimid|revlimid
111115|NCT02871193|paravertebral block|paravertebral block
111116|NCT02871193|patient controlled analgesia|patient controlled analgesia
111117|NCT02871193|ropivacaine|ropivacaine
111118|NCT02871193|dexamethasone|dexamethasone
111119|NCT02871180|Hypoglycemia|hypoglycemia
111120|NCT02871180|Type 1 diabetes|type 1 diabetes
111121|NCT02871167|oocyte/embryo cryopreservation|oocyte/embryo cryopreservation
111122|NCT02871128|Hemoglobin|hemoglobin
111123|NCT02871128|serum iron|serum iron
111124|NCT02871128|serum ferritin|serum ferritin
111125|NCT02871128|Hematocrit|hematocrit
111126|NCT02871128|antioxidant|antioxidant
111127|NCT02871115|Cancer Care|cancer care
111128|NCT02871102|mechanical ventilation|mechanical ventilation
111129|NCT02871102|respiratory mechanics|respiratory mechanics
111130|NCT02871102|acute respiratory distress syndrome|acute respiratory distress syndrome
111131|NCT02871102|positive end-expiratory pressure|positive end-expiratory pressure
111132|NCT02871102|tidal volume|tidal volume
111133|NCT02871089|Type 1 Diabetes|type 1 diabetes
111134|NCT02871089|Closed-loop glucose control|closed-loop glucose control
111135|NCT02871089|Artificial Pancreas|artificial pancreas
111136|NCT02871089|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
111137|NCT02871089|Multiple daily injection therapy|multiple daily injection therapy
111138|NCT02871089|New onset type 1 diabetes|new onset type 1 diabetes
111139|NCT02871089|Residual C-Peptide secretion|residual c-peptide secretion
111140|NCT02871089|Beta-cell function preservation|beta-cell function preservation
111141|NCT02871089|Continuous glucose monitoring|continuous glucose monitoring
111142|NCT02871050|Biobank|biobank
111143|NCT02871050|biorepository|biorepository
111144|NCT02871050|Castlebank|castlebank
111145|NCT02871050|Castleman Disease|castleman disease
111146|NCT02871050|CD|cd
111147|NCT02871050|MCD|mcd
111148|NCT02871050|iMCD|imcd
111149|NCT02871050|Castleman|castleman
111150|NCT02871050|Castleman's Disease|castleman's disease
111151|NCT02871050|multicentric Castleman's disease|multicentric castleman's disease
111152|NCT02871050|multicentric Castleman disease|multicentric castleman disease
111153|NCT02871050|Angiofollicular Lymph Hyperplasia|angiofollicular lymph hyperplasia
111154|NCT02871024|Polymyxin B|polymyxin b
111155|NCT02871024|Pneumonia|pneumonia
111156|NCT02871024|Sepsis|sepsis
111157|NCT02871024|Urinary tract infection|urinary tract infection
111158|NCT02871011|Tinea Bronchodilator Agents|tinea bronchodilator agents
111159|NCT02871011|Tinea Pedis|tinea pedis
111160|NCT02871011|Nitric Oxide|nitric oxide
111161|NCT02871011|Dermatomycoses|dermatomycoses
111162|NCT02871011|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors
111163|NCT02871011|Infectious|infectious
111164|NCT02871011|Infection|infection
111165|NCT02871011|Mycoses|mycoses
111166|NCT02871011|Skin Diseases|skin diseases
111167|NCT02871011|Foot Dermatoses|foot dermatoses
111168|NCT02871011|Foot Diseases|foot diseases
111169|NCT02871011|Pruritus|pruritus
111170|NCT02871011|Skin Manifestations Signs and Symptoms|skin manifestations signs and symptoms
111171|NCT02870946|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
111172|NCT02870946|Cardiogenic Shock|cardiogenic shock
111173|NCT02870946|Renal Replacement Therapy|renal replacement therapy
111174|NCT02870933|CD 133+|cd 133+
111175|NCT02870933|Transepicardial with Transseptal Implantation|transepicardial with transseptal implantation
111176|NCT02870933|CABG|cabg
111177|NCT02870907|primary enucleation|primary enucleation
111178|NCT02870907|retinoblastoma|retinoblastoma
111179|NCT02870868|slow breathing|slow breathing
111180|NCT02870868|yoga|yoga
111181|NCT02870868|mind-body practicers|mind-body practicers
111182|NCT02870842|ultrasonography|ultrasonography
111183|NCT02870842|child|child
111184|NCT02870842|perioperative period|perioperative period
111185|NCT02870842|general anesthesia|general anesthesia
111186|NCT02870842|lung|lung
111187|NCT02870777|MRD|mrd
111188|NCT02870777|Acute myeloid leukemia|acute myeloid leukemia
111189|NCT02870764|Danshenduofensuanyan|danshenduofensuanyan
111190|NCT02870764|Lp-PLA2|lp-pla2
111191|NCT02870764|coronary artery disease|coronary artery disease
111192|NCT02870764|Salvia miltiorrhiza|salvia miltiorrhiza
111193|NCT02870751|ETEC|etec
111194|NCT02870751|human challenge study|human challenge study
111195|NCT02870751|heat stable toxin|heat stable toxin
111196|NCT02870751|tourist diarrhea|tourist diarrhea
111197|NCT02870751|diarrhea|diarrhea
111198|NCT02870751|enterotoxigenic|enterotoxigenic
111199|NCT02870725|chronic headaches, migraines, depression|chronic headaches, migraines, depression
111200|NCT02870712|perineal tear of first degree|perineal tear of first degree
111201|NCT02870712|suture|suture
111202|NCT02870699|chemotherapy neoadjuvant|chemotherapy neoadjuvant
111203|NCT02870686|ERCP|ercp
111204|NCT02870686|EUS guided ERCP without fluoroscopy|eus guided ercp without fluoroscopy
111205|NCT02870673|acupuncture|acupuncture
111206|NCT02870673|electrical stimulation|electrical stimulation
111207|NCT02870673|carpal tunnel syndrome|carpal tunnel syndrome
111208|NCT02870608|Elastography|elastography
111209|NCT02870556|cervical epidural, laryngectomy, pharyngocutaneous fistula|cervical epidural, laryngectomy, pharyngocutaneous fistula
111210|NCT02870543|Bruxism|bruxism
111211|NCT02870543|Sleep bruxism|sleep bruxism
111212|NCT02870543|Sleep related bruxism|sleep related bruxism
111213|NCT02870543|Homeopathy|homeopathy
111214|NCT02870504|laser peripheral iridoplasty|laser peripheral iridoplasty
111215|NCT02870504|treatment|treatment
111216|NCT02870491|Child Diarrhea|child diarrhea
111217|NCT02870491|Cluster Randomized Controlled Trial|cluster randomized controlled trial
111218|NCT02870491|Oral Rehydration|oral rehydration
111219|NCT02870491|ORS|ors
111220|NCT02870491|Zinc|zinc
111221|NCT02870491|Brac|brac
111222|NCT02870491|Community Health Workers|community health workers
111223|NCT02870491|Uganda|uganda
111224|NCT02870465|outpatient versus operating room|outpatient versus operating room
111225|NCT02870465|k wire infection|k wire infection
111226|NCT02870465|closed reduction internal fixation|closed reduction internal fixation
111227|NCT02870452|Haemophilia|haemophilia
111228|NCT02870452|RCT|rct
111229|NCT02870452|Pain|pain
111230|NCT02870452|Hemarthrosis|hemarthrosis
111231|NCT02870452|Hypnosis|hypnosis
111232|NCT02870452|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
111233|NCT02870452|Quality of Life|quality of life
111234|NCT02870452|Distress|distress
111235|NCT02870452|Cytokines|cytokines
111236|NCT02870426|Olfactory ensheathing cells|olfactory ensheathing cells
111237|NCT02870413|telehealth|telehealth
111238|NCT02870387|chronic illness|chronic illness
111239|NCT02870387|children|children
111240|NCT02870387|children with medical complexity|children with medical complexity
111241|NCT02870387|medical home|medical home
111242|NCT02870387|inpatient consultation|inpatient consultation
111243|NCT02870335|low back|low back
111244|NCT02870335|manual therapy|manual therapy
111245|NCT02870335|stretching|stretching
111246|NCT02870322|overweight|overweight
111247|NCT02870322|obesity|obesity
111248|NCT02870322|lifestyle prescription|lifestyle prescription
111249|NCT02870322|prevention|prevention
111250|NCT02870322|physical activity|physical activity
111251|NCT02870322|healthy eating|healthy eating
111252|NCT02870283|Cost effectiveness|cost effectiveness
111253|NCT02870283|Bipolar disorder|bipolar disorder
111254|NCT02870283|Mixed episodes|mixed episodes
111255|NCT02870283|Quality of life|quality of life
111256|NCT02870270|saliva|saliva
111257|NCT02870270|microflora|microflora
111258|NCT02870270|diet|diet
111259|NCT02870270|quality of life|quality of life
111260|NCT02870270|oral cancer|oral cancer
111261|NCT02870244|Melanoma|melanoma
111262|NCT02870244|Gene Therapy|gene therapy
111263|NCT02870244|Adoptive T-Cell Transfer|adoptive t-cell transfer
111264|NCT02870244|IL-2|il-2
111265|NCT02870192|Rectal Prolapse|rectal prolapse
111266|NCT02870179|Pulse Oximetry|pulse oximetry
111267|NCT02870179|Temperature|temperature
111268|NCT02870179|Respiratory Rate|respiratory rate
111269|NCT02870179|Respiratory Gases|respiratory gases
111270|NCT02870179|This study determines the measurement accuracy of the physiological parameters|this study determines the measurement accuracy of the physiological parameters
111271|NCT02870140|CAD|cad
111272|NCT02870140|ACS|acs
111273|NCT02870140|All comers|all comers
111275|NCT02870114|Haemophilia|haemophilia
111276|NCT02870114|Quality of Life|quality of life
111277|NCT02870114|Distress|distress
111278|NCT02870114|Hemarthrosis|hemarthrosis
111279|NCT02870114|Pain|pain
111280|NCT02870101|Nucleic acid amplification tests|nucleic acid amplification tests
111281|NCT02870101|Neisseria gonorrhoeae infection|neisseria gonorrhoeae infection
111282|NCT02870101|Chlamydia trachomatis infection|chlamydia trachomatis infection
111283|NCT02870101|Sexually transmitted diseases|sexually transmitted diseases
111284|NCT02870101|Pharynx|pharynx
111285|NCT02870101|Rectum|rectum
111286|NCT02870101|Gram-Negative Bacterial Infections|gram-negative bacterial infections
111287|NCT02870101|Bacterial Infections|bacterial infections
111288|NCT02870101|Genital Diseases, Male|genital diseases, male
111289|NCT02870101|Genital Diseases, Female|genital diseases, female
111290|NCT02870062|Chlorhexidine baths|chlorhexidine baths
111291|NCT02870062|Critical patient|critical patient
111292|NCT02870062|Healthcare associated infections|healthcare associated infections
111293|NCT02870062|Critical care environment|critical care environment
111294|NCT02870062|Patient colonization|patient colonization
111295|NCT02870049|early detection|early detection
111296|NCT02869971|Prostatic artery embolization|prostatic artery embolization
111297|NCT02869971|Combined Therapy|combined therapy
111298|NCT02869971|IPSS|ipss
111299|NCT02869958|Asthma|asthma
111300|NCT02869958|Exacerbation|exacerbation
111301|NCT02869958|Treatment|treatment
111302|NCT02869958|Internet|internet
111303|NCT02869958|Emergency care|emergency care
111304|NCT02869945|de novo untreated Parkinson Disease|de novo untreated parkinson disease
111305|NCT02869945|genetic|genetic
111306|NCT02869945|COMT Polymorphism|comt polymorphism
111307|NCT02869945|gene|gene
111308|NCT02869945|brain MRI|brain mri
111309|NCT02869945|brain MPET|brain mpet
111310|NCT02869841|laparotomy|laparotomy
111311|NCT02869841|pain|pain
111312|NCT02869841|rectus sheath block|rectus sheath block
111313|NCT02869815|Methylene blue|methylene blue
111314|NCT02869815|Indocyanine green|indocyanine green
111315|NCT02869815|Neoadjuvant Therapy|neoadjuvant therapy
111316|NCT02869815|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
111317|NCT02869815|Breast Neoplasms|breast neoplasms
111318|NCT02869802|Cancer|cancer
111319|NCT02869802|Pancreatic Cancer|pancreatic cancer
111320|NCT02869802|Advanced Pancreatic Ductal Adenocarcinoma|advanced pancreatic ductal adenocarcinoma
111321|NCT02869802|PDAC|pdac
111322|NCT02869802|Genomic Analysis|genomic analysis
111323|NCT02869802|Molecular subtyping|molecular subtyping
111324|NCT02869763|Ethanol|ethanol
111325|NCT02869763|Steroid profile|steroid profile
111326|NCT02869763|Pharmacokinetics|pharmacokinetics
111327|NCT02869737|Point of Care Device; post traumatic coagulopathy|point of care device; post traumatic coagulopathy
111576|NCT02868008|multimodal imaging|multimodal imaging
111328|NCT02869724|IMV : voluntary drug intoxications|imv : voluntary drug intoxications
111329|NCT02869724|Drug|drug
111330|NCT02869724|Divided prescription|divided prescription
111331|NCT02869672|safety|safety
111332|NCT02869672|immunogenicity|immunogenicity
111333|NCT02869672|vaccine|vaccine
111334|NCT02869659|obesity|obesity
111335|NCT02869659|pre-diabetes|pre-diabetes
111336|NCT02869659|overweight|overweight
111337|NCT02869659|lifestyle change|lifestyle change
111338|NCT02869659|glucose|glucose
111339|NCT02869646|PTSD|ptsd
111340|NCT02869646|acupuncture|acupuncture
111341|NCT02869646|integrative medicine|integrative medicine
111342|NCT02869464|Aneurysm|aneurysm
111343|NCT02869464|Intracranial Aneurysm|intracranial aneurysm
111344|NCT02869464|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
111345|NCT02869438|Asthma, Bronchial Diseases, Respiratory Tract Diseases, Lung Diseases, Obstructive Lung Diseases|asthma, bronchial diseases, respiratory tract diseases, lung diseases, obstructive lung diseases
111346|NCT02869399|head and neck cancer, nutritional intervention|head and neck cancer, nutritional intervention
111347|NCT02869386|stroke|stroke
111348|NCT02869386|prehospital|prehospital
111349|NCT02869386|telemedicine|telemedicine
111350|NCT02869386|thrombolysis|thrombolysis
111351|NCT02869386|thrombectomy|thrombectomy
111352|NCT02869386|endovascular treatment|endovascular treatment
111353|NCT02869386|functional outcome|functional outcome
111354|NCT02869347|recombinant C1 esterase inhibitor|recombinant c1 esterase inhibitor
111355|NCT02869347|acute kidney injury|acute kidney injury
111356|NCT02869347|coronary angiography|coronary angiography
111357|NCT02869347|contrast media|contrast media
111358|NCT02869347|Conestat alfa|conestat alfa
111359|NCT02869347|inflammation|inflammation
111360|NCT02869308|Cardiomyopathy|cardiomyopathy
111361|NCT02869308|Chemotherapy|chemotherapy
111362|NCT02869308|Left ventricular ejection fraction|left ventricular ejection fraction
111363|NCT02869295|Metastatic Solid Tumors|metastatic solid tumors
111364|NCT02869295|Locally Advanced Solid Tumors|locally advanced solid tumors
111365|NCT02869256|chronic myeloid leukemia|chronic myeloid leukemia
111366|NCT02869256|practices evaluation|practices evaluation
111367|NCT02869243|A malignant growing astrocytoma of central nervous system|a malignant growing astrocytoma of central nervous system
111368|NCT02869230|Breast cancer|breast cancer
111369|NCT02869230|Non palpable breast lesions|non palpable breast lesions
111370|NCT02869230|radioguided occult lesion localization|radioguided occult lesion localization
111371|NCT02869217|NY-ESO-1 expressing solid tumors in HLA-A2 positive patients|ny-eso-1 expressing solid tumors in hla-a2 positive patients
111372|NCT02869165|Postmenopausal|postmenopausal
111373|NCT02869152|sentinel lymph node|sentinel lymph node
111374|NCT02869152|lymphatic mapping|lymphatic mapping
111375|NCT02869152|rectal tumor|rectal tumor
111376|NCT02869152|rectal cancer|rectal cancer
111377|NCT02869152|early stage|early stage
111378|NCT02869139|Thirst|thirst
111379|NCT02869139|Ice|ice
111380|NCT02869139|Menthol|menthol
111381|NCT02869139|Perioperative Nursing.|perioperative nursing.
111382|NCT02869139|Recovery Room|recovery room
111383|NCT02869126|99mTc-Sestamibi|99mtc-sestamibi
111384|NCT02869126|thallium-201|thallium-201
111385|NCT02869126|semiconductor camera|semiconductor camera
111386|NCT02869100|magnetic resonance imaging|magnetic resonance imaging
111387|NCT02869100|sodium fluoride positron emission tomography|sodium fluoride positron emission tomography
111388|NCT02869074|von Willebrand disease (VWD)|von willebrand disease (vwd)
111389|NCT02869074|von Willebrand factor (VWF)|von willebrand factor (vwf)
111390|NCT02869074|von Willebrand factor gene|von willebrand factor gene
111391|NCT02869074|next generation sequencing|next generation sequencing
111392|NCT02869074|diagnosis|diagnosis
111393|NCT02869074|VWD Spanish Cohort|vwd spanish cohort
111394|NCT02869061|Bladder neck obstruction|bladder neck obstruction
111395|NCT02869061|Bladder outlet obstruction|bladder outlet obstruction
111396|NCT02869061|Benign prostatic hyperplasia|benign prostatic hyperplasia
111397|NCT02869061|Urinary bladder neck obstruction|urinary bladder neck obstruction
111398|NCT02869061|Bladder neck contracture|bladder neck contracture
111399|NCT02869061|Bladder neck stricture|bladder neck stricture
111400|NCT02869061|Bladder neck stenosis|bladder neck stenosis
111401|NCT02869061|Transurethral resection of the prostate|transurethral resection of the prostate
111402|NCT02869061|Prostatectomy|prostatectomy
111403|NCT02869061|Stromal vascular fraction (SVF)|stromal vascular fraction (svf)
111404|NCT02869061|Adipose-derived regenerative cells (ADRC)|adipose-derived regenerative cells (adrc)
111405|NCT02869061|Adipose tissue|adipose tissue
111406|NCT02869061|Stem cells|stem cells
111407|NCT02869048|Biological Specimen Banks|biological specimen banks
111408|NCT02869048|Innate Immunity|innate immunity
111409|NCT02869048|Clinical Study|clinical study
111410|NCT02869048|Complement system proteins|complement system proteins
111411|NCT02869048|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
111412|NCT02869048|Neurodegenerative disease|neurodegenerative disease
111413|NCT02869048|Motor neuron disease|motor neuron disease
111414|NCT02869035|PET|pet
111415|NCT02869035|Serotonin|serotonin
111416|NCT02869035|5-HT4R|5-ht4r
111417|NCT02869035|MRI|mri
111418|NCT02869035|fMRI|fmri
111419|NCT02869035|EEG|eeg
111420|NCT02869035|Cortisol awakening response|cortisol awakening response
111421|NCT02869035|Oxidative stress|oxidative stress
111422|NCT02869035|Mental health|mental health
111423|NCT02869035|Prediction of treatment response|prediction of treatment response
111424|NCT02869035|Inflammation|inflammation
111425|NCT02869035|5-HTTLPR|5-httlpr
111426|NCT02869035|Brain imaging|brain imaging
111427|NCT02869035|Early life stress|early life stress
111428|NCT02869035|Selective Serotonin Reuptake Inhibitor|selective serotonin reuptake inhibitor
111429|NCT02869035|Escitalopram|escitalopram
111430|NCT02869035|Psychometrics|psychometrics
111431|NCT02869035|Moderate depression|moderate depression
111432|NCT02869035|Severe depression|severe depression
111433|NCT02869035|ERP|erp
111434|NCT02869035|rsfMRI|rsfmri
111435|NCT02869035|11C-SB207145|11c-sb207145
111436|NCT02869035|Sexual function|sexual function
111437|NCT02869035|MDD|mdd
111438|NCT02869035|Affective cognition|affective cognition
111439|NCT02869035|Cold cognition|cold cognition
111440|NCT02869035|Social cognition|social cognition
111441|NCT02869035|Anxiety|anxiety
111442|NCT02869009|stroke|stroke
111443|NCT02869009|clopidogrel|clopidogrel
111444|NCT02869009|antiplatelets|antiplatelets
111445|NCT02868957|CAD|cad
111446|NCT02868957|Digital imaging|digital imaging
111447|NCT02868957|Prosthetic Dentistry|prosthetic dentistry
111448|NCT02868931|self-management|self-management
111449|NCT02868931|empowerment|empowerment
111450|NCT02868931|treatment and education program|treatment and education program
111451|NCT02868931|insulin pump|insulin pump
111452|NCT02868931|diabetes education|diabetes education
111453|NCT02868866|physical activity|physical activity
111454|NCT02868866|nutrition|nutrition
111455|NCT02868866|fruits and vegetables|fruits and vegetables
111456|NCT02868866|faith-based|faith-based
111457|NCT02868866|churches|churches
111458|NCT02868853|diet|diet
111459|NCT02868853|weight loss|weight loss
111460|NCT02868853|tracking|tracking
111461|NCT02868853|mobile|mobile
111462|NCT02868853|calories|calories
111463|NCT02868840|stroke|stroke
111464|NCT02868840|Tai ji|tai ji
111465|NCT02868840|postural balance|postural balance
111466|NCT02868840|cognition|cognition
111666|NCT02867488|vitamin A|vitamin a
111467|NCT02868827|cholecalciferol and critical illness|cholecalciferol and critical illness
111468|NCT02868827|Mortality and cholecalciferol supplementation|mortality and cholecalciferol supplementation
111469|NCT02868801|Pregabalin|pregabalin
111470|NCT02868788|inflammation|inflammation
111471|NCT02868788|insulin resistance|insulin resistance
111472|NCT02868788|type 2 diabetes|type 2 diabetes
111473|NCT02868788|obesity|obesity
111474|NCT02868762|neck pain, voice disorder|neck pain, voice disorder
111475|NCT02868749|Hyaluronic Acid|hyaluronic acid
111476|NCT02868749|histology|histology
111477|NCT02868749|ultrasound|ultrasound
111478|NCT02868749|subcutaneous|subcutaneous
111479|NCT02868749|adipose tissue|adipose tissue
111480|NCT02868723|cerebrovascular disease|cerebrovascular disease
111481|NCT02868723|patient management|patient management
111482|NCT02868723|stroke management|stroke management
111483|NCT02868723|prognosis|prognosis
111484|NCT02868723|3D Carotid Doppler Imaging|3d carotid doppler imaging
111485|NCT02868723|Randomization|randomization
111486|NCT02868710|primary prevention|primary prevention
111487|NCT02868671|mild TBI|mild tbi
111488|NCT02868671|Post-traumatic Stress Disorders|post-traumatic stress disorders
111489|NCT02868671|Acupuncture|acupuncture
111490|NCT02868658|Influenza|influenza
111491|NCT02868658|health care workers|health care workers
111492|NCT02868658|nosocomial|nosocomial
111493|NCT02868658|asymptomatic|asymptomatic
111494|NCT02868658|France|france
111495|NCT02868632|Unresectable|unresectable
111496|NCT02868632|Locally Advanced|locally advanced
111497|NCT02868632|Non-Metastatic|non-metastatic
111498|NCT02868619|fMRI|fmri
111499|NCT02868619|Deep brain stimulation|deep brain stimulation
111500|NCT02868619|Food|food
111501|NCT02868619|Eating|eating
111502|NCT02868619|Reward|reward
111503|NCT02868580|ALS|als
111504|NCT02868580|Antiretroviral Therapy, Triumeq|antiretroviral therapy, triumeq
111505|NCT02868541|microorganisms|microorganisms
111506|NCT02868541|pilgrim|pilgrim
111507|NCT02868541|hajj|hajj
111508|NCT02868528|advanced age women|advanced age women
111509|NCT02868528|blastocyst culture|blastocyst culture
111510|NCT02868528|PGS|pgs
111511|NCT02868528|live birth rate|live birth rate
111512|NCT02868502|Glaucoma|glaucoma
111513|NCT02868502|Open Angle Glaucoma|open angle glaucoma
111514|NCT02868502|Intra Ocular Pressure|intra ocular pressure
111515|NCT02868502|Ocular Hypotensive Drops|ocular hypotensive drops
111516|NCT02868502|Trabeculectomy|trabeculectomy
111517|NCT02868502|Cyclophotocoagulation|cyclophotocoagulation
111518|NCT02868502|Glaucoma Drainage Device|glaucoma drainage device
111519|NCT02868489|Microbiota|microbiota
111520|NCT02868463|oxygen tension|oxygen tension
111521|NCT02868463|Female Urinary Microbiome|female urinary microbiome
111522|NCT02868463|Urinary Tract Symptoms|urinary tract symptoms
111523|NCT02868463|Urine Oxygen Level|urine oxygen level
111524|NCT02868398|Ulcerative Colitis|ulcerative colitis
111525|NCT02868398|Golimumab|golimumab
111526|NCT02868398|Deep and prolonged remission|deep and prolonged remission
111527|NCT02868385|Schistosomiasis|schistosomiasis
111528|NCT02868385|Schistosoma mansoni|schistosoma mansoni
111529|NCT02868385|Bilharzia|bilharzia
111530|NCT02868372|Cesarean section|cesarean section
111531|NCT02868372|Betadine|betadine
111532|NCT02868372|Wound infection|wound infection
111533|NCT02868320|SMS|sms
111534|NCT02868320|text messaging|text messaging
111535|NCT02868320|diabetes self management|diabetes self management
111536|NCT02868320|glycemic control|glycemic control
111537|NCT02868320|mHealth|mhealth
111538|NCT02868320|mobile health|mobile health
111539|NCT02868320|diabetes education|diabetes education
111540|NCT02868281|Cluster Randomization|cluster randomization
111541|NCT02868281|Peak Expiratory Flow|peak expiratory flow
111542|NCT02868281|Forced Expiratory Volume|forced expiratory volume
111543|NCT02868281|Standardized Asthma Quality of Life Questionnaire|standardized asthma quality of life questionnaire
111544|NCT02868281|Asthma Control Test|asthma control test
111545|NCT02868268|Neuroblastoma|neuroblastoma
111546|NCT02868255|Biobank analyses|biobank analyses
111547|NCT02868255|Effect evaluation of the drug|effect evaluation of the drug
111548|NCT02868255|patient-derived cells|patient-derived cells
111549|NCT02868255|SIRPα/CD47 expression|sirpα/cd47 expression
111550|NCT02868242|HCV genotype 1 or 4 (GT-1 or GT-4)|hcv genotype 1 or 4 (gt-1 or gt-4)
111551|NCT02868242|Direct Acting Antiviral|direct acting antiviral
111552|NCT02868242|Combination Therapy|combination therapy
111553|NCT02868242|Hepatitis C, Chronic|hepatitis c, chronic
111554|NCT02868242|Liver Diseases|liver diseases
111555|NCT02868242|Virus Diseases|virus diseases
111556|NCT02868177|Prevention|prevention
111557|NCT02868151|Oral mucositis, chemo radiotherapy, vitamin c,|oral mucositis, chemo radiotherapy, vitamin c,
111558|NCT02868138|Sickle cell disease|sickle cell disease
111559|NCT02868138|Hydroxyurea|hydroxyurea
111560|NCT02868138|Compliance|compliance
111561|NCT02868125|pertrochanteric|pertrochanteric
111562|NCT02868125|radiography|radiography
111563|NCT02868112|Cancer Care|cancer care
111564|NCT02868112|Palliative Care|palliative care
111565|NCT02868112|Geriatrics|geriatrics
111566|NCT02868112|Quality of Life|quality of life
111567|NCT02868086|Age-related macular degeneration|age-related macular degeneration
111568|NCT02868086|Optical coherence tomography angiography|optical coherence tomography angiography
111569|NCT02868047|chronic pancreatitis|chronic pancreatitis
111570|NCT02868047|endoscopic ultrasound|endoscopic ultrasound
111571|NCT02868034|Low Back Pain|low back pain
111572|NCT02868034|Spinal Manipulation|spinal manipulation
111573|NCT02868034|Exercise|exercise
111574|NCT02868021|Elderly|elderly
111575|NCT02868021|Exercise|exercise
111577|NCT02868008|surgical risk|surgical risk
111578|NCT02868008|arteriovenous malformations|arteriovenous malformations
111579|NCT02867982|platform switching|platform switching
111580|NCT02867982|crestal bone remodeling|crestal bone remodeling
111581|NCT02867982|soft tissue thickness|soft tissue thickness
111582|NCT02867982|dental implant|dental implant
111583|NCT02867969|Spinocerebellar ataxia|spinocerebellar ataxia
111584|NCT02867969|Exergaming|exergaming
111585|NCT02867969|Neurodegenerative diseases|neurodegenerative diseases
111586|NCT02867969|Rare disease|rare disease
111587|NCT02867969|Motor exercises|motor exercises
111588|NCT02867969|Premanifest stage|premanifest stage
111589|NCT02867969|Training|training
111590|NCT02867956|Ovarian cancer|ovarian cancer
111591|NCT02867956|Apatinib|apatinib
111592|NCT02867956|Etoposide|etoposide
111593|NCT02867956|Chemotherapy|chemotherapy
111594|NCT02867943|sepsis, shock,Lactate,volume controlled ventilation|sepsis, shock,lactate,volume controlled ventilation
111595|NCT02867930|Echocardiography|echocardiography
111596|NCT02867930|Transesophageal|transesophageal
111597|NCT02867930|Dexmedetomidine|dexmedetomidine
111598|NCT02867930|Ketamine|ketamine
111599|NCT02867930|Propofol|propofol
111600|NCT02867917|Fibers|fibers
111601|NCT02867917|Constipation|constipation
111602|NCT02867891|FLT3-ITD|flt3-itd
111603|NCT02867891|AML|aml
111604|NCT02867891|allo-HSCT|allo-hsct
111605|NCT02867839|Gastric cancer|gastric cancer
111606|NCT02867839|Adjuvant chemotherapy|adjuvant chemotherapy
111607|NCT02867839|S1|s1
111608|NCT02867839|Oxaliplatin|oxaliplatin
111609|NCT02867826|Endoscopy|endoscopy
111610|NCT02867826|Ampulla of Vater|ampulla of vater
111611|NCT02867826|Duodenoscopy|duodenoscopy
111612|NCT02867813|High Cholesterol|high cholesterol
111613|NCT02867813|Treatment for high cholesterol|treatment for high cholesterol
111614|NCT02867813|Lowering cholesterol|lowering cholesterol
111615|NCT02867813|Lowering high cholesterol|lowering high cholesterol
111616|NCT02867813|Hypercholesterolemia|hypercholesterolemia
111617|NCT02867800|Sickle Cell Disease|sickle cell disease
111618|NCT02867800|Graft Versus Host Disease|graft versus host disease
111619|NCT02867800|Abatacept|abatacept
111620|NCT02867800|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
111621|NCT02867787|Shoulder Joint|shoulder joint
111622|NCT02867787|A02.835.583.748|a02.835.583.748
111623|NCT02867774|chronic pelvic pain|chronic pelvic pain
111624|NCT02867774|central pain amplification|central pain amplification
111625|NCT02867774|exercise|exercise
111626|NCT02867774|physical activity|physical activity
111627|NCT02867761|COPD|copd
111628|NCT02867761|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
111629|NCT02867761|Pulmonary Function Tests|pulmonary function tests
111630|NCT02867761|Current Smoker|current smoker
111631|NCT02867761|Former Smoker|former smoker
111632|NCT02867761|Chronic Obstructive Airway Disease|chronic obstructive airway disease
111633|NCT02867761|Respiratory Symptoms|respiratory symptoms
111634|NCT02867748|tvt abbrevo , Serasis|tvt abbrevo , serasis
111635|NCT02867735|Macular Edema|macular edema
111636|NCT02867735|Diabetic Macular Edema (DME)|diabetic macular edema (dme)
111637|NCT02867735|Neovascular age-related Macular Degeneration(AMD)|neovascular age-related macular degeneration(amd)
111638|NCT02867735|Retinal Vein Occlusions(RVO)|retinal vein occlusions(rvo)
111639|NCT02867696|Bariatric Surgery|bariatric surgery
111640|NCT02867696|Physical Activity|physical activity
111641|NCT02867696|Weight Management|weight management
111642|NCT02867696|Weight Loss|weight loss
111643|NCT02867683|vibrotactile feedback|vibrotactile feedback
111644|NCT02867683|vestibular rehabilitation|vestibular rehabilitation
111645|NCT02867683|balance|balance
111646|NCT02867670|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
111647|NCT02867644|conversational hypnosis|conversational hypnosis
111648|NCT02867644|imaging|imaging
111649|NCT02867644|care|care
111650|NCT02867644|breast neoplasia|breast neoplasia
111651|NCT02867644|anxiety|anxiety
111652|NCT02867644|pain|pain
111653|NCT02867631|Intervention study|intervention study
111654|NCT02867631|Maternal obesity|maternal obesity
111655|NCT02867631|Nutrition|nutrition
111656|NCT02867631|Maternal child health|maternal child health
111657|NCT02867514|tobacco|tobacco
111658|NCT02867514|craving|craving
111659|NCT02867514|tDCS|tdcs
111660|NCT02867514|attentional tasks|attentional tasks
111661|NCT02867501|venous distension|venous distension
111662|NCT02867501|venous reflux|venous reflux
111663|NCT02867488|carotenoids|carotenoids
111664|NCT02867488|phylloquinone|phylloquinone
111665|NCT02867488|tocopherols|tocopherols
111667|NCT02867384|Graft vs. Host Disease|graft vs. host disease
111668|NCT02867358|acute uncomplicated influenza|acute uncomplicated influenza
111669|NCT02867319|safety|safety
111670|NCT02867319|vaccine|vaccine
111671|NCT02867306|methotrexate (MTX)|methotrexate (mtx)
111672|NCT02867306|Pharmacokinetics|pharmacokinetics
111673|NCT02867306|ASP1707|asp1707
111674|NCT02867306|Rheumatoid Arthritis (RA)|rheumatoid arthritis (ra)
111675|NCT02867280|Sorafenib|sorafenib
111676|NCT02867280|Microvascular invasion|microvascular invasion
111677|NCT02867280|adjuvant therapy|adjuvant therapy
111678|NCT02867280|hepatocellular carcinoma|hepatocellular carcinoma
111679|NCT02867267|thymosin alpha 1; thymalfasin; sepsis; immunodepression|thymosin alpha 1; thymalfasin; sepsis; immunodepression
111680|NCT02867254|candida|candida
111681|NCT02867254|endodontic lesion|endodontic lesion
111682|NCT02867254|diabetes|diabetes
111683|NCT02867202|intrauterine balloon|intrauterine balloon
111684|NCT02867202|intrauterine contraceptive device|intrauterine contraceptive device
111685|NCT02867202|Asherman Syndrome|asherman syndrome
111686|NCT02867189|anterior chamber flare|anterior chamber flare
111687|NCT02867189|cataract|cataract
111688|NCT02867189|intraocular pressure|intraocular pressure
111689|NCT02867189|micro-instrument|micro-instrument
111690|NCT02867189|photograph-based atlas|photograph-based atlas
111691|NCT02867189|visual|visual
111692|NCT02867189|training nurse|training nurse
111693|NCT02867111|sperm selection|sperm selection
111694|NCT02867111|ICSI|icsi
111695|NCT02867111|Assisted Reproductive Techniques|assisted reproductive techniques
111696|NCT02867098|healthy|healthy
111697|NCT02867098|volunteer|volunteer
111698|NCT02867085|MDS|mds
111699|NCT02867085|Myelodysplastic Syndromes|myelodysplastic syndromes
111700|NCT02867033|desmoid tumour|desmoid tumour
111701|NCT02867020|apalutamide|apalutamide
111702|NCT02867020|abiraterone|abiraterone
111703|NCT02867020|prostate cancer|prostate cancer
111704|NCT02867007|KW-0761|kw-0761
111705|NCT02867007|KHK2455|khk2455
111706|NCT02867007|Metastatic Solid Tumors|metastatic solid tumors
111707|NCT02867007|Locally Advanced Solid Tumors|locally advanced solid tumors
111708|NCT02867007|Mogamulizumab|mogamulizumab
111709|NCT02867007|Oncology|oncology
111710|NCT02867007|Anti-Tumor|anti-tumor
111711|NCT02866994|Women|women
111712|NCT02866981|Brain Metastases|brain metastases
111713|NCT02866955|aromatase inhibitors|aromatase inhibitors
111714|NCT02866955|Metastases|metastases
111715|NCT02866929|orthodontics|orthodontics
111716|NCT02866929|periodontics|periodontics
111717|NCT02866929|piezosurgery|piezosurgery
111718|NCT02866929|accelerated orthodontics|accelerated orthodontics
111719|NCT02866929|Surgically Accelerated Orthodontic Treatment|surgically accelerated orthodontic treatment
111720|NCT02866903|Peritoneal carcinosis|peritoneal carcinosis
111721|NCT02866903|intraperitoneal (IP) OXAliplatin|intraperitoneal (ip) oxaliplatin
111722|NCT02866903|Phase I/II dose escalation trial|phase i/ii dose escalation trial
111723|NCT02866903|FOLFIRI Bevacizumab chemotherapy|folfiri bevacizumab chemotherapy
111724|NCT02866890|Laryngeal Tube Suction|laryngeal tube suction
111725|NCT02866890|seal pressure|seal pressure
111726|NCT02866890|mechanical ventilation|mechanical ventilation
111727|NCT02866877|augmented renal clearance|augmented renal clearance
111728|NCT02866864|Allergen|allergen
111729|NCT02866864|Veterinary|veterinary
111730|NCT02866864|Allergy|allergy
111731|NCT02866864|Animals|animals
111732|NCT02866838|Tranexamic acid|tranexamic acid
111733|NCT02866838|NOAC|noac
111734|NCT02866838|Direct Oral Anticoagulant (DOAC)|direct oral anticoagulant (doac)
111735|NCT02866838|Direct oral anticoagulants|direct oral anticoagulants
111736|NCT02866838|Non-Vitamin K antagonist oral anticoagulants|non-vitamin k antagonist oral anticoagulants
111737|NCT02866825|Inflammation|inflammation
111738|NCT02866825|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
111739|NCT02866825|Pathologic Processes|pathologic processes
111740|NCT02866825|Organ Dysfunction|organ dysfunction
111741|NCT02866799|Multimorbidity|multimorbidity
111742|NCT02866799|Primary Health Care|primary health care
111743|NCT02866799|Polypharmacy|polypharmacy
111744|NCT02866799|Comorbidity|comorbidity
111745|NCT02866799|Medication Adherence|medication adherence
111746|NCT02866799|Medication Appropriateness Index|medication appropriateness index
111747|NCT02866799|Patient-Centered Care|patient-centered care
111748|NCT02866773|Family|family
111749|NCT02866773|well-being|well-being
111750|NCT02866773|Physical activity|physical activity
111751|NCT02866773|Diet|diet
111752|NCT02866760|Smoking Cessation|smoking cessation
111753|NCT02866734|Diabetic Retinopathy|diabetic retinopathy
111754|NCT02866734|Screening|screening
111755|NCT02866734|Fee for screening|fee for screening
111756|NCT02866734|Private practice|private practice
111757|NCT02866721|Human Mesenchymal Stem Cells|human mesenchymal stem cells
111758|NCT02866695|Actinic Keratosis|actinic keratosis
111759|NCT02866695|lung transplant|lung transplant
111760|NCT02866695|kidney transplant|kidney transplant
111761|NCT02866643|contraceptive implant|contraceptive implant
111762|NCT02866643|postpartum contraception|postpartum contraception
112064|NCT02865109|NURTURE|nurture
111763|NCT02866643|breastfeeding and contraception|breastfeeding and contraception
111764|NCT02866630|Sevoflurane|sevoflurane
111765|NCT02866630|Desflurane|desflurane
111766|NCT02866630|Coronary Sinus|coronary sinus
111767|NCT02866630|Oxygenator Exhaust|oxygenator exhaust
111768|NCT02866630|Lactate|lactate
111769|NCT02866630|Cardiopulmonary bypass|cardiopulmonary bypass
111770|NCT02866617|Quality of Life|quality of life
111771|NCT02866617|Vacuum formed thermoplastic retainer|vacuum formed thermoplastic retainer
111772|NCT02866617|Orthodontic study model|orthodontic study model
111773|NCT02866617|3D reconstructed study model|3d reconstructed study model
111774|NCT02866604|Traumatic brain injury|traumatic brain injury
111775|NCT02866604|isotonic balanced fluid|isotonic balanced fluid
111776|NCT02866591|mammography|mammography
111777|NCT02866591|pain|pain
111778|NCT02866591|quality of life|quality of life
111779|NCT02866591|screening|screening
111780|NCT02866591|image quality|image quality
111781|NCT02866591|radiology|radiology
111782|NCT02866526|adolescents|adolescents
111783|NCT02866526|young adults|young adults
111784|NCT02866448|Cardiovascular disease|cardiovascular disease
111785|NCT02866448|Flavonoid|flavonoid
111786|NCT02866448|Isoquercetin|isoquercetin
111787|NCT02866448|Aspirin|aspirin
111788|NCT02866448|Platelet function|platelet function
111789|NCT02866448|Vascular function|vascular function
111790|NCT02866448|Blood pressure|blood pressure
111791|NCT02866435|MRI|mri
111792|NCT02866422|OCD|ocd
111793|NCT02866409|dexmedetomidine|dexmedetomidine
111794|NCT02866409|nerve block|nerve block
111795|NCT02866409|anesthesia infiltration|anesthesia infiltration
111796|NCT02866396|chronic pain|chronic pain
111797|NCT02866396|oxycodone|oxycodone
111798|NCT02866396|pregabalin|pregabalin
111799|NCT02866396|lumbar spine surgery|lumbar spine surgery
111800|NCT02866396|multimodal analgesia|multimodal analgesia
111801|NCT02866344|Microwave ablation|microwave ablation
111802|NCT02866344|Ablation techniques|ablation techniques
111803|NCT02866344|Operative surgical procedures|operative surgical procedures
111804|NCT02866344|Hepatic resection|hepatic resection
111805|NCT02866344|Surgery|surgery
111806|NCT02866344|Outcomes assessment|outcomes assessment
111807|NCT02866305|primary spontaneous pneumothorax|primary spontaneous pneumothorax
111808|NCT02866305|epidemiology|epidemiology
111809|NCT02866305|genetics|genetics
111810|NCT02866305|risk factors|risk factors
111811|NCT02866292|Pelvic Floor|pelvic floor
111812|NCT02866292|Pregnancy|pregnancy
111813|NCT02866292|Physical Therapy Specialty|physical therapy specialty
111814|NCT02866253|Dehydroepiandrosterone（DHEA）|dehydroepiandrosterone（dhea）
111815|NCT02866253|DOR（Diminished Ovarian Reserve)|dor（diminished ovarian reserve)
111816|NCT02866253|IVF(In vitro fertilization)|ivf(in vitro fertilization)
111817|NCT02866253|BMP-15(Bone Morphogenetic Protein 15)|bmp-15(bone morphogenetic protein 15)
111818|NCT02866227|Bacterial|bacterial
111819|NCT02866227|Candidiasis|candidiasis
111820|NCT02866227|Gel|gel
111821|NCT02866227|Insert|insert
111822|NCT02866227|TOL-463|tol-463
111823|NCT02866227|Vaginal|vaginal
111824|NCT02866227|Vaginitis|vaginitis
111825|NCT02866227|Vaginoses|vaginoses
111826|NCT02866227|Vulvovaginal|vulvovaginal
111827|NCT02866201|Turista|turista
111828|NCT02866175|percutaneous intervention|percutaneous intervention
111829|NCT02866175|vitamin K antagonist|vitamin k antagonist
111830|NCT02866149|Cancer|cancer
111831|NCT02866149|circulating tumor biomarkers|circulating tumor biomarkers
111832|NCT02866149|circulating tumor DNA|circulating tumor dna
111833|NCT02866149|Circulating tumor Cell (CTC)|circulating tumor cell (ctc)
111834|NCT02866097|integrated community case management|integrated community case management
111835|NCT02866097|Mobile Health (mHealth)|mobile health (mhealth)
111836|NCT02866097|rapid diagnostic test|rapid diagnostic test
111837|NCT02866097|artemether-lumefantrine|artemether-lumefantrine
111838|NCT02866097|amoxicillin|amoxicillin
111839|NCT02866097|zinc|zinc
111840|NCT02866097|oral rehydration solution (ORS)|oral rehydration solution (ors)
111841|NCT02866097|District Health Information System 2 (DHIS2)|district health information system 2 (dhis2)
111842|NCT02866097|iCCM-DHIS2|iccm-dhis2
111843|NCT02866097|ZCAHRD|zcahrd
111844|NCT02866084|vestibular migraines|vestibular migraines
111845|NCT02866084|dizziness|dizziness
111846|NCT02866084|migraine headache|migraine headache
111847|NCT02866045|Subepithelial lesions|subepithelial lesions
111848|NCT02866045|Endoscopic Ultrasound-Guided Fine Needle Aspiration|endoscopic ultrasound-guided fine needle aspiration
111849|NCT02866006|HPV|hpv
111850|NCT02866006|Type 16, 18|type 16, 18
111851|NCT02866006|E6E7|e6e7
111852|NCT02866006|Immune therapeutic vaccine|immune therapeutic vaccine
111853|NCT02865993|cesarean section|cesarean section
111854|NCT02865993|cesarean section complications|cesarean section complications
111855|NCT02865993|betadine irrigation|betadine irrigation
111856|NCT02865980|inflammation, infection|inflammation, infection
111857|NCT02865967|Decision Support Techniques|decision support techniques
111858|NCT02865967|Delayed Diagnosis|delayed diagnosis
111859|NCT02865967|Natural Language Processing|natural language processing
111860|NCT02865967|Geographic Information Systems|geographic information systems
111861|NCT02865941|Target Fortification|target fortification
111862|NCT02865941|Breast milk analysis|breast milk analysis
111863|NCT02865941|Nutrition|nutrition
111864|NCT02865941|Macronutrient intake|macronutrient intake
111865|NCT02865941|Protein accretion|protein accretion
111866|NCT02865915|Acne|acne
111867|NCT02865915|Hirsutism|hirsutism
111868|NCT02865915|Menstrual Irregularity|menstrual irregularity
111869|NCT02865915|Alopecia|alopecia
111870|NCT02865902|Low level laser therapy|low level laser therapy
111871|NCT02865902|wound healing|wound healing
111872|NCT02865902|periodontology|periodontology
111873|NCT02865889|laparoscopic surgery|laparoscopic surgery
111874|NCT02865889|Uterine Neoplasms|uterine neoplasms
111875|NCT02865876|Infectious keratitis|infectious keratitis
111876|NCT02865876|Cross-linking|cross-linking
111877|NCT02865863|Multivitamin|multivitamin
111878|NCT02865863|Eurycomalongifoliawater extract|eurycomalongifoliawater extract
111879|NCT02865863|Quality of Life|quality of life
111880|NCT02865863|Mood|mood
111881|NCT02865850|vadadustat|vadadustat
111882|NCT02865850|AKB-6548|akb-6548
111883|NCT02865850|anemia|anemia
111884|NCT02865850|chronic kidney disease|chronic kidney disease
111885|NCT02865850|CKD|ckd
111886|NCT02865850|chronic renal insufficiency|chronic renal insufficiency
111887|NCT02865850|renal impairment|renal impairment
111888|NCT02865850|erythropoietin|erythropoietin
111889|NCT02865850|kidney|kidney
111890|NCT02865850|renal|renal
111891|NCT02865850|oral anemia treatment|oral anemia treatment
111892|NCT02865850|hemoglobin|hemoglobin
111893|NCT02865850|hypoxia-inducible factor|hypoxia-inducible factor
111894|NCT02865850|HIF|hif
111895|NCT02865850|efficacy|efficacy
111896|NCT02865850|safety|safety
111897|NCT02865850|phase 3|phase 3
111898|NCT02865850|cardiovascular|cardiovascular
111899|NCT02865837|Brachytherapy|brachytherapy
111900|NCT02865837|Organs at Risk|organs at risk
111901|NCT02865837|Bladder volume|bladder volume
111902|NCT02865837|Cervical cancer|cervical cancer
111903|NCT02865824|Colonoscopy|colonoscopy
111904|NCT02865811|Ovarian Cancer|ovarian cancer
111905|NCT02865798|Heart Valve Diseases|heart valve diseases
111906|NCT02865798|Cardiovascular Diseases|cardiovascular diseases
111907|NCT02865798|Heart Disease|heart disease
111908|NCT02865798|Valvular Heart Diseases|valvular heart diseases
111909|NCT02865785|recurrent implantation failure|recurrent implantation failure
111910|NCT02865785|intralipid|intralipid
111911|NCT02865785|uterine natural killer cells|uterine natural killer cells
111912|NCT02865746|Steroids|steroids
111913|NCT02865746|Pain measurement|pain measurement
111914|NCT02865733|Remodulin®|remodulin®
111915|NCT02865733|pulmonary vascular resistance|pulmonary vascular resistance
111916|NCT02865733|univentricular physiology|univentricular physiology
111917|NCT02865707|ulcerative colitis|ulcerative colitis
111918|NCT02865707|prebiotics|prebiotics
111919|NCT02865707|b-fructans|b-fructans
111920|NCT02865707|inulin|inulin
111921|NCT02865707|oligofructose|oligofructose
111922|NCT02865707|intestinal microbiota|intestinal microbiota
111923|NCT02865681|Infertility|infertility
111924|NCT02865681|Gonadotropins|gonadotropins
111925|NCT02865681|Menopur|menopur
111926|NCT02865681|Ovarian stimulation|ovarian stimulation
111927|NCT02865642|Stroke|stroke
111928|NCT02865642|Serotonin|serotonin
111929|NCT02865642|Hand Paresis|hand paresis
111930|NCT02865616|CDI|cdi
111931|NCT02865616|recurrent infection|recurrent infection
111932|NCT02865616|MET-2|met-2
111933|NCT02865616|C. difficile|c. difficile
111934|NCT02865590|Maxillary Sinus/surgery|maxillary sinus/surgery
111935|NCT02865590|Bone Substitutes|bone substitutes
111936|NCT02865590|Radiography, Panoramic|radiography, panoramic
111937|NCT02865564|Probiotics|probiotics
111938|NCT02865564|Anti-Bacterial Agents|anti-bacterial agents
111939|NCT02865564|Infant, Newborn|infant, newborn
111940|NCT02865564|Gastrointestinal Microbiome|gastrointestinal microbiome
111941|NCT02865564|Colic|colic
111942|NCT02865564|Gastrointestinal Diseases|gastrointestinal diseases
111943|NCT02865564|Body Composition|body composition
111944|NCT02865564|Bone Density|bone density
111945|NCT02865564|Randomized Controlled Trial|randomized controlled trial
111946|NCT02865564|Lactobacillus reuteri|lactobacillus reuteri
111947|NCT02865564|Pediatrics|pediatrics
111948|NCT02865564|Feces|feces
111949|NCT02865564|ultrasonography|ultrasonography
111950|NCT02865564|High-Throughput Nucleotide Sequencing|high-throughput nucleotide sequencing
111951|NCT02865564|Electric Impedance|electric impedance
111952|NCT02865564|Surveys and Questionnaires|surveys and questionnaires
111953|NCT02865538|Hot flashes|hot flashes
111954|NCT02865538|Post-menopausal|post-menopausal
111955|NCT02865525|Surveys and Questionnaires|surveys and questionnaires
111956|NCT02865525|Patient Education as Topic|patient education as topic
111957|NCT02865525|Medication Adherence|medication adherence
111958|NCT02865525|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
111959|NCT02865525|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
111960|NCT02865525|Heart failure|heart failure
111961|NCT02865512|thoracic epidural injection|thoracic epidural injection
111962|NCT02865512|patient position|patient position
111963|NCT02865486|Gastric emptying|gastric emptying
111965|NCT02865486|lipid emulsions|lipid emulsions
111966|NCT02865486|breath test|breath test
111967|NCT02865486|GI peptide hormones|gi peptide hormones
111968|NCT02865473|Schlemm's canal lumen area|schlemm's canal lumen area
111969|NCT02865473|PEX|pex
111970|NCT02865460|Chronic Pain|chronic pain
111971|NCT02865460|Cognitive Disorders|cognitive disorders
111972|NCT02865460|Inflammation|inflammation
111973|NCT02865460|Neurologic manifestations|neurologic manifestations
111974|NCT02865460|Dementia|dementia
111975|NCT02865460|Mental Disorders|mental disorders
111976|NCT02865460|Ubiquinol/ubiquinone|ubiquinol/ubiquinone
111977|NCT02865460|Pathologic Processes|pathologic processes
111978|NCT02865460|Nervous System Diseases|nervous system diseases
111979|NCT02865460|Hormones, Hormone Substitutes, and Hormone Antagon|hormones, hormone substitutes, and hormone antagon
111980|NCT02865460|Anti-Inflammatory Agents|anti-inflammatory agents
111981|NCT02865460|Pharmacologic Actions|pharmacologic actions
111982|NCT02865460|Therapeutic Uses|therapeutic uses
111983|NCT02865460|Physiological Effects of Drugs|physiological effects of drugs
111984|NCT02865460|Gulf war illness|gulf war illness
111985|NCT02865460|Chronic fatigue|chronic fatigue
111986|NCT02865447|dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
111987|NCT02865447|DEXA|dexa
111988|NCT02865447|DXA|dxa
111989|NCT02865447|total hip arthroplasty|total hip arthroplasty
111990|NCT02865447|PROFEMUR|profemur
111991|NCT02865447|PRESERVE|preserve
111992|NCT02865447|bone mineral density|bone mineral density
111993|NCT02865447|BMD|bmd
111994|NCT02865447|osteoarthritis|osteoarthritis
111995|NCT02865447|THA|tha
111996|NCT02865447|musculoskeletal disease|musculoskeletal disease
111997|NCT02865408|Amino acids|amino acids
111998|NCT02865408|critically-ill|critically-ill
111999|NCT02865408|catabolic|catabolic
112000|NCT02865408|nutrition|nutrition
112001|NCT02865408|anabolic|anabolic
112002|NCT02865395|Belladonna and Opium Suppositories|belladonna and opium suppositories
112003|NCT02865382|Adenoma detection rate|adenoma detection rate
112004|NCT02865382|Optical Enhancement Technonogy|optical enhancement technonogy
112005|NCT02865382|Colonoscopy|colonoscopy
112006|NCT02865369|chronic hepatitis C|chronic hepatitis c
112007|NCT02865369|Daclatasvir|daclatasvir
112008|NCT02865369|Asunaprevir|asunaprevir
112009|NCT02865369|fibrosis|fibrosis
112010|NCT02865369|transient elastography|transient elastography
112011|NCT02865356|atopic dermatitis|atopic dermatitis
112012|NCT02865356|eczema|eczema
112013|NCT02865356|children|children
112014|NCT02865356|skin|skin
112015|NCT02865356|topical|topical
112016|NCT02865356|cyclosporine|cyclosporine
112017|NCT02865343|Functional Electrical Stimulation (FES)-Rowing|functional electrical stimulation (fes)-rowing
112018|NCT02865330|Intermediate Risk Prostate Cancer|intermediate risk prostate cancer
112019|NCT02865330|Low Risk Prostate Cancer|low risk prostate cancer
112020|NCT02865330|Active Surveillance|active surveillance
112021|NCT02865304|metastatic breast cancer|metastatic breast cancer
112022|NCT02865304|HER-2-negative|her-2-negative
112023|NCT02865304|endostar|endostar
112024|NCT02865252|manual therapy|manual therapy
112025|NCT02865252|mobilization with movement|mobilization with movement
112026|NCT02865239|Imaging, Three-Dimensional|imaging, three-dimensional
112027|NCT02865239|Magnetic Resonance Imaging/methods*|magnetic resonance imaging/methods*
112028|NCT02865239|Breast Neoplasms/diagnosis*|breast neoplasms/diagnosis*
112029|NCT02865239|Prone Position|prone position
112030|NCT02865239|Prospective Studies|prospective studies
112031|NCT02865226|thoracic surgery|thoracic surgery
112032|NCT02865226|thoracotomy|thoracotomy
112033|NCT02865213|Open bite|open bite
112034|NCT02865213|Molar intrusion|molar intrusion
112035|NCT02865213|Temporary anchorage devices|temporary anchorage devices
112036|NCT02865200|Nutrition|nutrition
112037|NCT02865200|Public Health|public health
112038|NCT02865187|Vitamin D|vitamin d
112039|NCT02865187|polycystic ovary syndrome|polycystic ovary syndrome
112040|NCT02865187|polycystic ovarian syndrome|polycystic ovarian syndrome
112041|NCT02865187|PCOS|pcos
112042|NCT02865187|sexual dysfunction|sexual dysfunction
112043|NCT02865187|female sexual dysfunction|female sexual dysfunction
112044|NCT02865187|low libido|low libido
112045|NCT02865174|Thrombin-gelatin matrix|thrombin-gelatin matrix
112046|NCT02865174|Floseal|floseal
112047|NCT02865174|Tranexamic Acid|tranexamic acid
112048|NCT02865174|Total Knee Arthroplasty|total knee arthroplasty
112049|NCT02865135|HPV Related Head and Neck|hpv related head and neck
112050|NCT02865135|Cervical|cervical
112051|NCT02865135|Anal Cancer|anal cancer
112052|NCT02865109|Spinal Muscular Atrophy|spinal muscular atrophy
112053|NCT02865109|SMA|sma
112054|NCT02865109|SMN|smn
112055|NCT02865109|SMNRx|smnrx
112056|NCT02865109|ISIS-SMNRx|isis-smnrx
112057|NCT02865109|ISIS-SMN Rx|isis-smn rx
112058|NCT02865109|ISIS 396443|isis 396443
112059|NCT02865109|ISIS-396443|isis-396443
112060|NCT02865109|ENDEAR|endear
112061|NCT02865109|IONIS-SMNRx|ionis-smnrx
112062|NCT02865109|IONIS-SMN Rx|ionis-smn rx
112063|NCT02865109|EMBRACE|embrace
112065|NCT02865109|IONIS|ionis
112066|NCT02865109|BIOGEN|biogen
112067|NCT02865109|SHINE|shine
112068|NCT02865109|Nusinersen|nusinersen
112069|NCT02865070|premature|premature
112070|NCT02865070|wireless vitals|wireless vitals
112071|NCT02865070|vitals monitor|vitals monitor
112072|NCT02865044|Fatty Acids|fatty acids
112073|NCT02865044|Fish Oil|fish oil
112074|NCT02865044|Marine Copepod|marine copepod
112075|NCT02865044|Fatty Acid Absorption|fatty acid absorption
112076|NCT02865018|Neuromyelitis Optica|neuromyelitis optica
112077|NCT02865018|Cetirizine|cetirizine
112078|NCT02864992|lung|lung
112079|NCT02864992|neoplasm|neoplasm
112080|NCT02864992|cancer|cancer
112081|NCT02864992|tumor|tumor
112082|NCT02864992|adenocarcinoma|adenocarcinoma
112083|NCT02864992|MET exon 14|met exon 14
112084|NCT02864992|METex14|metex14
112085|NCT02864992|pulmonary|pulmonary
112086|NCT02864992|stage III|stage iii
112087|NCT02864992|stage IV|stage iv
112088|NCT02864992|c-Met|c-met
112089|NCT02864992|cMET|cmet
112090|NCT02864992|NSCLC|nsclc
112091|NCT02864992|advanced non-small cell lung cancer|advanced non-small cell lung cancer
112092|NCT02864966|Safety study|safety study
112093|NCT02864966|new product|new product
112094|NCT02864966|normal healthy skin.|normal healthy skin.
112095|NCT02864953|Stroke|stroke
112096|NCT02864953|Infarction|infarction
112097|NCT02864953|Cerebrovascular Disorders|cerebrovascular disorders
112098|NCT02864953|Brain Diseases|brain diseases
112099|NCT02864953|Brain Edema Ischemia|brain edema ischemia
112100|NCT02864953|Pathological Processes Necrosis|pathological processes necrosis
112101|NCT02864953|Central Nervous System Diseases|central nervous system diseases
112102|NCT02864953|Vascular Diseases|vascular diseases
112103|NCT02864953|Cardiovascular Diseases|cardiovascular diseases
112104|NCT02864953|Glyburide|glyburide
112105|NCT02864953|Hypoglycemic Agents|hypoglycemic agents
112106|NCT02864953|Physiological Effects of Drugs|physiological effects of drugs
112107|NCT02864940|Memory|memory
112108|NCT02864940|aneurysm|aneurysm
112109|NCT02864940|deficits|deficits
112110|NCT02864940|trouble|trouble
112111|NCT02864940|forgetful|forgetful
112112|NCT02864940|ruptured|ruptured
112113|NCT02864940|subarachnoid|subarachnoid
112114|NCT02864940|hemorrhage|hemorrhage
112115|NCT02864927|Meningitis|meningitis
112116|NCT02864927|Meningococcal Meningitis|meningococcal meningitis
112117|NCT02864927|Meningococcal Infections|meningococcal infections
112118|NCT02864927|Menactra®|menactra®
112119|NCT02864927|Meningococcal Vaccine|meningococcal vaccine
112120|NCT02864888|Diffuse, intrinsic brain stem glioma|diffuse, intrinsic brain stem glioma
112121|NCT02864888|QT/QTc interval|qt/qtc interval
112122|NCT02864888|Radiation|radiation
112123|NCT02864888|Antineoplaston therapy|antineoplaston therapy
112124|NCT02864875|Fibrinogen|fibrinogen
112125|NCT02864875|Tromboelastography|tromboelastography
112126|NCT02864849|Rectal cancer|rectal cancer
112127|NCT02864849|neoadjuvant|neoadjuvant
112128|NCT02864849|radiotherapy|radiotherapy
112129|NCT02864849|chemotherapy|chemotherapy
112130|NCT02864849|toxicity|toxicity
112131|NCT02864836|Copper|copper
112132|NCT02864836|isotopic distribution|isotopic distribution
112133|NCT02864836|cancer|cancer
112134|NCT02864823|Scleromalacia perforans|scleromalacia perforans
112135|NCT02864823|Necrotizing Scleritis|necrotizing scleritis
112136|NCT02864823|Perichondrium|perichondrium
112137|NCT02864797|Health related quality of life|health related quality of life
112138|NCT02864797|patient reported outcomes|patient reported outcomes
112139|NCT02864797|cohort|cohort
112140|NCT02864797|e-health|e-health
112141|NCT02864771|Ventricular Arrhythmias|ventricular arrhythmias
112142|NCT02864771|ICD|icd
112143|NCT02864771|Biological markers|biological markers
112144|NCT02864745|early rehabilitation|early rehabilitation
112145|NCT02864745|critically ill|critically ill
112146|NCT02864745|muscle weakness|muscle weakness
112147|NCT02864745|neuromuscular stimulation|neuromuscular stimulation
112148|NCT02864745|functional electrical stimulation-assisted cycle ergometry|functional electrical stimulation-assisted cycle ergometry
112149|NCT02864745|ICUAW|icuaw
112150|NCT02864732|Low back pain|low back pain
112151|NCT02864732|stabilization exercises|stabilization exercises
112152|NCT02864732|neuromuscular electrical stimulation|neuromuscular electrical stimulation
112153|NCT02864719|Heart arrest|heart arrest
112154|NCT02864719|Cardiac arrest|cardiac arrest
112155|NCT02864719|Fatigue|fatigue
112156|NCT02864693|Microprocessor Controlled Ankle|microprocessor controlled ankle
112157|NCT02864693|Transtibial Amputee|transtibial amputee
112158|NCT02864693|Pacifica LP|pacifica lp
112159|NCT02864693|Kinnex|kinnex
112160|NCT02864680|cannabis|cannabis
112161|NCT02864680|magnocellular pathway|magnocellular pathway
112162|NCT02864654|Critical lower limb ischemia|critical lower limb ischemia
112163|NCT02864654|Atherosclerosis obliterans|atherosclerosis obliterans
112164|NCT02864654|Diabetic angiopathies|diabetic angiopathies
112165|NCT02864654|Thromboangiitis obliterans|thromboangiitis obliterans
112166|NCT02864654|Ischemic ulcers|ischemic ulcers
112660|NCT02861573|PD-L1|pd-l1
112167|NCT02864654|Peripheral arterial disease|peripheral arterial disease
112168|NCT02864654|Indirect revascularisation|indirect revascularisation
112169|NCT02864654|Intramuscular injection|intramuscular injection
112170|NCT02864654|Ankle-brachial index|ankle-brachial index
112171|NCT02864654|Transcutaneous oxygen tension|transcutaneous oxygen tension
112172|NCT02864654|Stromal vascular fraction (SVF)|stromal vascular fraction (svf)
112173|NCT02864654|Adipose-derived regenerative cells (ADRC)|adipose-derived regenerative cells (adrc)
112174|NCT02864654|Adipose tissue|adipose tissue
112175|NCT02864654|Stem cells|stem cells
112176|NCT02864641|chronic kidney disease|chronic kidney disease
112177|NCT02864641|adolescents|adolescents
112178|NCT02864641|renal disease|renal disease
112179|NCT02864641|CKD|ckd
112180|NCT02864628|RSV Vaccines|rsv vaccines
112181|NCT02864628|Respiratory Syncytial Virus Vaccines|respiratory syncytial virus vaccines
112182|NCT02864615|renal cell carcinoma|renal cell carcinoma
112183|NCT02864615|metastasis|metastasis
112184|NCT02864615|stereotactic body radiation therapy|stereotactic body radiation therapy
112185|NCT02864615|targted therapy|targted therapy
112186|NCT02864615|immune checkpoint inhibitors|immune checkpoint inhibitors
112187|NCT02864602|Regional anesthesia|regional anesthesia
112188|NCT02864602|Adjuvant|adjuvant
112189|NCT02864602|Dexamethasone|dexamethasone
112190|NCT02864589|Tourette, Tic, Tics|tourette, tic, tics
112191|NCT02864550|Men who have sex with men|men who have sex with men
112192|NCT02864550|Human immunodeficiency virus|human immunodeficiency virus
112193|NCT02864550|Doxycycline|doxycycline
112194|NCT02864550|Tetracycline|tetracycline
112195|NCT02864537|warfarin|warfarin
112196|NCT02864537|self-management|self-management
112197|NCT02864537|Conventional management|conventional management
112198|NCT02864537|Training|training
112199|NCT02864537|TTR|ttr
112200|NCT02864537|Complications|complications
112201|NCT02864537|Quality of life|quality of life
112202|NCT02864524|Physical Therapy Modalities|physical therapy modalities
112203|NCT02864524|Exercises|exercises
112204|NCT02864524|Musculoskeletal Manipulations|musculoskeletal manipulations
112205|NCT02864485|Live donor liver transplantation|live donor liver transplantation
112206|NCT02864459|Ultrasonography|ultrasonography
112207|NCT02864459|Weaning|weaning
112208|NCT02864433|cholera|cholera
112209|NCT02864433|oral cholera vaccine|oral cholera vaccine
112210|NCT02864433|diarrhea|diarrhea
112211|NCT02864420|home hospital|home hospital
112212|NCT02864420|acute care home|acute care home
112213|NCT02864420|care redesign|care redesign
112214|NCT02864420|delivery innovation|delivery innovation
112215|NCT02864420|heart failure|heart failure
112216|NCT02864420|pneumonia|pneumonia
112217|NCT02864420|cellulitis|cellulitis
112218|NCT02864420|urinary tract infections|urinary tract infections
112219|NCT02864342|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
112220|NCT02864342|COPD|copd
112221|NCT02864342|Respiratory|respiratory
112222|NCT02864342|adherence|adherence
112223|NCT02864342|medication reminders|medication reminders
112224|NCT02864329|Male Infertility|male infertility
112225|NCT02864329|micro RNAs|micro rnas
112226|NCT02864329|small interfering RNAs|small interfering rnas
112227|NCT02864329|miRNA|mirna
112228|NCT02864329|siRNA|sirna
112229|NCT02864316|radiation-induced solid tumors|radiation-induced solid tumors
112230|NCT02864316|Nivolumab|nivolumab
112231|NCT02864316|Phase 2 study|phase 2 study
112232|NCT02864303|Alzheimer's disease|alzheimer's disease
112233|NCT02864303|Mild Cognitive Impairment|mild cognitive impairment
112234|NCT02864303|Saliva|saliva
112235|NCT02864303|Amyloid peptides|amyloid peptides
112236|NCT02864303|Diagnosis|diagnosis
112237|NCT02864290|Pharmacokinetics of AGS62P1|pharmacokinetics of ags62p1
112238|NCT02864290|AGS62P1|ags62p1
112240|NCT02864290|Acute Myeloid Leukemia|acute myeloid leukemia
112241|NCT02864277|Gynecology|gynecology
112242|NCT02864277|Cancer|cancer
112243|NCT02864277|General Surgery|general surgery
112244|NCT02864277|Recovery Quality|recovery quality
112245|NCT02864277|Length of hospital stay|length of hospital stay
112246|NCT02864238|electronic milestone pathway|electronic milestone pathway
112247|NCT02864238|cardiac valve surgery|cardiac valve surgery
112248|NCT02864186|Pain|pain
112249|NCT02864186|Quality of life|quality of life
112250|NCT02864186|wound healing|wound healing
112251|NCT02864173|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
112252|NCT02864173|Postoperative cognitive decline|postoperative cognitive decline
112253|NCT02864173|Postoperative delirium|postoperative delirium
112254|NCT02864173|Cognitive outcome|cognitive outcome
112255|NCT02864173|Neuropsychology|neuropsychology
112256|NCT02864173|Genetics|genetics
112257|NCT02864160|Language Concordance|language concordance
112258|NCT02864160|Diabetes Self-Management|diabetes self-management
112259|NCT02864160|Health Coaching|health coaching
112260|NCT02864160|Latinos|latinos
112261|NCT02864134|Optic neuritis|optic neuritis
112262|NCT02864134|ganglion cell layer|ganglion cell layer
112263|NCT02864121|High-risk human papillomavirus|high-risk human papillomavirus
112264|NCT02864121|Integration of HR-HPV DNA|integration of hr-hpv dna
112265|NCT02864121|biomarker of severity|biomarker of severity
112266|NCT02864121|biomarker of evolution|biomarker of evolution
112267|NCT02864095|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
112268|NCT02864095|Epinephrine|epinephrine
112269|NCT02864095|Tranexamic acid|tranexamic acid
112270|NCT02864082|X-linked, lamellar|x-linked, lamellar
112271|NCT02864043|Barrett's Esophagus|barrett's esophagus
112272|NCT02864043|Barrett's|barrett's
112273|NCT02864043|OCT|oct
112274|NCT02864043|VLE|vle
112275|NCT02864030|Eribulin mesylate|eribulin mesylate
112276|NCT02864030|Halaven|halaven
112277|NCT02864030|Polymorphisms|polymorphisms
112278|NCT02864030|Tolerability|tolerability
112279|NCT02864004|Parkinson disease|parkinson disease
112280|NCT02864004|Quality of Life|quality of life
112281|NCT02864004|Apomorphine infusion|apomorphine infusion
112282|NCT02863978|Sepsis|sepsis
112283|NCT02863978|Neonates|neonates
112284|NCT02863978|Cardio-respiratory maturation|cardio-respiratory maturation
112285|NCT02863978|Neurobehavioral maturation|neurobehavioral maturation
112286|NCT02863926|BKA|bka
112287|NCT02863926|amputation|amputation
112288|NCT02863926|MarrowStim|marrowstim
112289|NCT02863926|below knee amputation|below knee amputation
112290|NCT02863926|wound complication|wound complication
112291|NCT02863926|vascular disease|vascular disease
112292|NCT02863926|critical limb ischemia|critical limb ischemia
112293|NCT02863926|peripheral artery disease|peripheral artery disease
112294|NCT02863926|AKA|aka
112295|NCT02863926|stem cells|stem cells
112296|NCT02863926|bone marrow|bone marrow
112297|NCT02863887|Weight Loss|weight loss
112298|NCT02863887|African American|african american
112299|NCT02863887|Community Based|community based
112300|NCT02863887|Mobile technology|mobile technology
112301|NCT02863887|Translational science|translational science
112302|NCT02863874|Perineal tear|perineal tear
112303|NCT02863874|Labor|labor
112304|NCT02863874|Triclosan|triclosan
112305|NCT02863861|Sedation|sedation
112306|NCT02863861|Pediatric Patients|pediatric patients
112307|NCT02863822|Functional Dyspepsia|functional dyspepsia
112308|NCT02863822|Low FODMAP|low fodmap
112309|NCT02863822|Dietary Modification|dietary modification
112310|NCT02863809|Keratolysis|keratolysis
112311|NCT02863809|Corneal Melting|corneal melting
112312|NCT02863809|Boston KPro|boston kpro
112313|NCT02863809|Keratoprosthesis|keratoprosthesis
112314|NCT02863770|endosonography|endosonography
112315|NCT02863744|mmp-8|mmp-8
112316|NCT02863744|early stages of wound healing|early stages of wound healing
112317|NCT02863744|wound healing marker|wound healing marker
112318|NCT02863731|postural changes|postural changes
112319|NCT02863731|alternating postures|alternating postures
112320|NCT02863731|Cognitive performance|cognitive performance
112321|NCT02863731|Height-adjustable desk|height-adjustable desk
112322|NCT02863731|Worksite|worksite
112323|NCT02863718|CLL|cll
112324|NCT02863692|CLL|cll
112325|NCT02863692|B-PLL|b-pll
112326|NCT02863692|T-PLL|t-pll
112327|NCT02863692|SLL|sll
112328|NCT02863692|T-NK-LGL|t-nk-lgl
112329|NCT02863692|HCL|hcl
112330|NCT02863692|Richter´s Transformation|richter´s transformation
112331|NCT02863679|tetracaine hydrochloride gel|tetracaine hydrochloride gel
112332|NCT02863679|analgesia|analgesia
112333|NCT02863679|intrauterine balloon|intrauterine balloon
112334|NCT02863679|hysteroscope operation|hysteroscope operation
112335|NCT02863666|Cariopulmonary, cardiac arrest|cariopulmonary, cardiac arrest
112336|NCT02863653|social participation|social participation
112337|NCT02863653|International Classification of Functioning|international classification of functioning
112338|NCT02863640|Senile macular degeneration|senile macular degeneration
112339|NCT02863640|Parkinson's disease|parkinson's disease
112340|NCT02863627|Emergencies|emergencies
112341|NCT02863627|newborn|newborn
112342|NCT02863627|care|care
112343|NCT02863601|Buprenorphine|buprenorphine
112344|NCT02863601|Opiate Substitution Treatment|opiate substitution treatment
112345|NCT02863575|third molar extraction|third molar extraction
112346|NCT02863575|ibuprofen|ibuprofen
112347|NCT02863575|ibuprofen/caffeine|ibuprofen/caffeine
112348|NCT02863575|post-surgical dental pain|post-surgical dental pain
112349|NCT02863536|Recurrence of Bacterial Vaginosis|recurrence of bacterial vaginosis
112350|NCT02863510|Carbon dioxide angiography|carbon dioxide angiography
112351|NCT02863510|Renal sympathetic denervation|renal sympathetic denervation
112352|NCT02863510|Uncontrolled hypertension|uncontrolled hypertension
112353|NCT02863510|Chronic kidney disease|chronic kidney disease
112354|NCT02863471|Pancreas|pancreas
112355|NCT02863471|Adenocarcinoma|adenocarcinoma
112356|NCT02863471|Hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
112357|NCT02863471|HIPEC|hipec
112358|NCT02863471|Pancreatic surgery|pancreatic surgery
112359|NCT02863471|Gemcitabine|gemcitabine
112360|NCT02863458|MDS|mds
112361|NCT02863458|AML|aml
112362|NCT02863458|hypomethylating agents (HMA)|hypomethylating agents (hma)
112363|NCT02863458|Surveillance Epidemiology and End Results (SEER)|surveillance epidemiology and end results (seer)
112364|NCT02863445|Obesity|obesity
112365|NCT02863445|Body weight|body weight
112366|NCT02863445|Emergency contraception|emergency contraception
112367|NCT02863445|Levonogestrel|levonogestrel
112368|NCT02863445|Ulipristal acetate|ulipristal acetate
112369|NCT02863406|Dust rate|dust rate
112370|NCT02863406|Microscopic analysis|microscopic analysis
112371|NCT02863380|Individualized Medicine|individualized medicine
112372|NCT02863380|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
112373|NCT02863380|Transcranial Direct Current Stimulation Monocentric|transcranial direct current stimulation monocentric
112374|NCT02863380|Compariative Cross-Over 3 Arms Study Randomized, Single-Blind Method|compariative cross-over 3 arms study randomized, single-blind method
112375|NCT02863380|Functional Neuroimaging|functional neuroimaging
112376|NCT02863302|Acute Myeloid Leukemia, Reflexology|acute myeloid leukemia, reflexology
112377|NCT02863263|foam dressing|foam dressing
112378|NCT02863263|MedifoamⓇ|medifoamⓡ
112379|NCT02863263|BetafoamⓇ|betafoamⓡ
112380|NCT02863263|povidone iodine|povidone iodine
112381|NCT02863237|brain injury|brain injury
112382|NCT02863237|mechanical ventilation|mechanical ventilation
112383|NCT02863237|weaning|weaning
112384|NCT02863198|unexplained infertility|unexplained infertility
112385|NCT02863198|endometrial injury|endometrial injury
112386|NCT02863198|pregnancy|pregnancy
112387|NCT02863185|chronic kidney disease|chronic kidney disease
112388|NCT02863185|pitavastatin|pitavastatin
112389|NCT02863185|erythrocyte membrane fatty acid|erythrocyte membrane fatty acid
112390|NCT02863172|Hereditary colorectal cancer syndrome|hereditary colorectal cancer syndrome
112391|NCT02863172|Questionnaires|questionnaires
112392|NCT02863172|Surveys|surveys
112393|NCT02863172|Blood sample|blood sample
112394|NCT02863172|Saliva sample|saliva sample
112395|NCT02863146|locally advanced breast cancer|locally advanced breast cancer
112396|NCT02863146|alopecia|alopecia
112397|NCT02863146|eribulin|eribulin
112398|NCT02863120|Bupivacaine|bupivacaine
112399|NCT02863120|Osteoarthritis|osteoarthritis
112400|NCT02863120|Arthritis|arthritis
112401|NCT02863120|Joint Diseases|joint diseases
112402|NCT02863120|Ropivacaine|ropivacaine
112403|NCT02863120|Anesthetics, Local|anesthetics, local
112404|NCT02863120|Anesthetics|anesthetics
112405|NCT02863107|Colon Cancer|colon cancer
112406|NCT02863107|Rectal Cancer|rectal cancer
112407|NCT02863107|Questionnaires|questionnaires
112408|NCT02863107|Surveys|surveys
112409|NCT02863107|Blood draw|blood draw
112410|NCT02863094|schizophrenia|schizophrenia
112411|NCT02863094|auditory hallucinations|auditory hallucinations
112412|NCT02863094|functional magnetic resonance imaging|functional magnetic resonance imaging
112413|NCT02863094|transcranial magnetic stimulation|transcranial magnetic stimulation
112414|NCT02863068|Sickle cell disease|sickle cell disease
112415|NCT02863068|sodium nitrite|sodium nitrite
112416|NCT02863068|wound healing|wound healing
112417|NCT02863068|Ulcer|ulcer
112418|NCT02863055|MPM|mpm
112419|NCT02863055|Unresectable|unresectable
112420|NCT02863055|Phase II|phase ii
112421|NCT02863055|Randomized|randomized
112422|NCT02863055|Maintenance|maintenance
112423|NCT02863029|Intestinal stem cells|intestinal stem cells
112424|NCT02863016|dialysis|dialysis
112425|NCT02863016|hemodiafiltration|hemodiafiltration
112426|NCT02862990|Breast cancer|breast cancer
112427|NCT02862990|Fertility|fertility
112428|NCT02862964|back pain|back pain
112429|NCT02862951|pregnancy|pregnancy
112430|NCT02862925|fetal monitoring|fetal monitoring
112431|NCT02862925|cesarean delivery|cesarean delivery
112432|NCT02862925|obstetrics|obstetrics
112433|NCT02862925|midwifery|midwifery
112434|NCT02862925|developing countries|developing countries
112435|NCT02862912|Chloroprocaine|chloroprocaine
112436|NCT02862912|cervical cerclage|cervical cerclage
112437|NCT02862912|spinal anesthesia|spinal anesthesia
112438|NCT02862912|Bupivacaine|bupivacaine
112439|NCT02862873|Spinal anaesthesia|spinal anaesthesia
112440|NCT02862821|biomarkers of psychiatric disorder|biomarkers of psychiatric disorder
112441|NCT02862821|gambling addiction|gambling addiction
112442|NCT02862821|high resolution-ElectroEncephaloGraphy (HR-EEG)|high resolution-electroencephalography (hr-eeg)
112443|NCT02862808|Whole exome sequencing|whole exome sequencing
112444|NCT02862808|Molecular diagnostic|molecular diagnostic
112445|NCT02862808|Genetic counselling|genetic counselling
112446|NCT02862795|colonoscopy|colonoscopy
112447|NCT02862730|diabetes|diabetes
112448|NCT02862730|closed-loop|closed-loop
112449|NCT02862730|dual hormone|dual hormone
112450|NCT02862730|exercise|exercise
112451|NCT02862717|Cost effectiveness|cost effectiveness
112452|NCT02862717|cost utility|cost utility
112453|NCT02862717|ESRD|esrd
112454|NCT02862717|hemodialysis|hemodialysis
112455|NCT02862717|ICER|icer
112456|NCT02862717|Markov model|markov model
112457|NCT02862717|peritoneal dialysis|peritoneal dialysis
112458|NCT02862691|toothache|toothache
112459|NCT02862626|Diabetic children|diabetic children
112460|NCT02862626|Mothers|mothers
112461|NCT02862613|Precision Cells|precision cells
112462|NCT02862613|Transcatheter Arterial Chemoembolization|transcatheter arterial chemoembolization
112463|NCT02862613|Advanced Liver Cancer|advanced liver cancer
112464|NCT02862600|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
112465|NCT02862600|heart failure|heart failure
112466|NCT02862600|cardiopulmonary exercise testing|cardiopulmonary exercise testing
112467|NCT02862600|6 minute walk test|6 minute walk test
112468|NCT02862600|perhexiline|perhexiline
112469|NCT02862600|carnitine palmitoyltransferase|carnitine palmitoyltransferase
112470|NCT02862600|mixed ion channel effects|mixed ion channel effects
112471|NCT02862600|late sodium current inhibitor|late sodium current inhibitor
112472|NCT02862600|calcium channel inhibition|calcium channel inhibition
112473|NCT02862587|Precision Cells|precision cells
112474|NCT02862587|Chemotherapy|chemotherapy
112475|NCT02862587|Advanced Lung Cancer|advanced lung cancer
112476|NCT02862574|Rheumatoid Arthritis|rheumatoid arthritis
112477|NCT02862574|Tumor Necrosis Factor Inhibitor|tumor necrosis factor inhibitor
112478|NCT02862574|TNF-IR|tnf-ir
112479|NCT02862574|Methotrexate|methotrexate
112480|NCT02862561|Precision Cell Immunotherapy|precision cell immunotherapy
112481|NCT02862561|Chemotherapy|chemotherapy
112482|NCT02862561|Advanced Malignancies|advanced malignancies
112483|NCT02862522|uric acid|uric acid
112484|NCT02862522|microvascular dysfunction|microvascular dysfunction
112485|NCT02862522|inflammation|inflammation
112486|NCT02862509|Post-frontal sinus operation chronic rhinosinusitis patients|post-frontal sinus operation chronic rhinosinusitis patients
112487|NCT02862509|Budesonide nasal instillation|budesonide nasal instillation
112488|NCT02862509|Vertex to floor position|vertex to floor position
112489|NCT02862496|Hyperemesis Gravidarum|hyperemesis gravidarum
112490|NCT02862496|Bone Health|bone health
112491|NCT02862496|Urine N-telopeptide|urine n-telopeptide
112492|NCT02862496|Serum calcium|serum calcium
112493|NCT02862496|Serum parathormone|serum parathormone
112494|NCT02862496|Serum vit D|serum vit d
112495|NCT02862470|Lovastatin|lovastatin
112496|NCT02862470|Vildagliptin|vildagliptin
112497|NCT02862470|Exosome|exosome
112498|NCT02862470|Anaplastic thyroid cancer|anaplastic thyroid cancer
112499|NCT02862470|Proteomics|proteomics
112500|NCT02862470|Urine|urine
112501|NCT02862470|Biological marker|biological marker
112502|NCT02862457|Advanced Solid Tumors|advanced solid tumors
112503|NCT02862457|PD-1|pd-1
112504|NCT02862457|PD1|pd1
112505|NCT02862457|Programmed Cell Death-1|programmed cell death-1
112506|NCT02862457|Programmed Cell Death 1|programmed cell death 1
112507|NCT02862457|Programmed Cell Death-Ligand 1 (PD-L1)|programmed cell death-ligand 1 (pd-l1)
112508|NCT02862457|Programmed Cell Death-Ligand 2 (PD-L2)|programmed cell death-ligand 2 (pd-l2)
112509|NCT02862457|PDL1|pdl1
112510|NCT02862457|PDL2|pdl2
112511|NCT02862418|MRI|mri
112512|NCT02862418|UTE MRI|ute mri
112513|NCT02862418|Pulmonary|pulmonary
112514|NCT02862405|Vision loss|vision loss
112515|NCT02862405|Object recognition|object recognition
112516|NCT02862405|Space recognition|space recognition
112517|NCT02862392|Scoliosis|scoliosis
112518|NCT02862392|Adolescent|adolescent
112519|NCT02862392|Idiopathic scoliosis|idiopathic scoliosis
112520|NCT02862392|Predictive factors|predictive factors
112521|NCT02862366|myeloproliferative neoplasms|myeloproliferative neoplasms
112522|NCT02862366|Circulating Procoagulants Microparticles|circulating procoagulants microparticles
112523|NCT02862353|Validation new test|validation new test
112524|NCT02862327|anaesthetic techniques|anaesthetic techniques
112525|NCT02862327|regional anesthesia|regional anesthesia
112526|NCT02862327|brachial plexus block|brachial plexus block
112527|NCT02862327|Local Anesthetic|local anesthetic
112528|NCT02862327|ropivacaine|ropivacaine
112529|NCT02862327|analgesia|analgesia
112530|NCT02862327|steroid|steroid
112531|NCT02862327|dexamethasone|dexamethasone
112532|NCT02862327|placebo|placebo
112533|NCT02862327|adjuvant|adjuvant
112534|NCT02862327|ultrasound guided|ultrasound guided
112535|NCT02862314|Procalcitonin|procalcitonin
112536|NCT02862301|Histone Deacetylases|histone deacetylases
112537|NCT02862301|Histone Acetyltransferases|histone acetyltransferases
112538|NCT02862223|Coagulation|coagulation
112539|NCT02862223|Circulatory Function|circulatory function
112540|NCT02862223|Blood Pressure|blood pressure
112541|NCT02862223|Inflammatory response|inflammatory response
112542|NCT02862223|Blood Glucose|blood glucose
112543|NCT02862223|Healthy vascular function|healthy vascular function
112544|NCT02862210|Lithium|lithium
112545|NCT02862210|Lithium Carbonate|lithium carbonate
112546|NCT02862145|Biosy accessible melanoma|biosy accessible melanoma
112547|NCT02862132|VDZ: Vedolizumab|vdz: vedolizumab
112548|NCT02862132|UC: Ulcerative colitis|uc: ulcerative colitis
112549|NCT02862132|CD: Crohn's disease|cd: crohn's disease
112550|NCT02862132|TDM: Therapeutic drug monitoring|tdm: therapeutic drug monitoring
112551|NCT02862119|percutaneous coronary intervention|percutaneous coronary intervention
112552|NCT02862119|fractional flow reserve|fractional flow reserve
112553|NCT02862119|all cause mortality|all cause mortality
112554|NCT02862119|myocardial infarction|myocardial infarction
112555|NCT02862119|registry-based randomized clinical trial|registry-based randomized clinical trial
112556|NCT02862106|Chronic Hepatitis B|chronic hepatitis b
112557|NCT02862106|HBeAg positive|hbeag positive
112558|NCT02862106|Therapeutic HBV Vaccine|therapeutic hbv vaccine
112559|NCT02862106|HBV-specific Cytotoxic T Lymphocyte|hbv-specific cytotoxic t lymphocyte
112560|NCT02862067|SGLT2|sglt2
112561|NCT02862067|type 2 diabetes mellitus|type 2 diabetes mellitus
112562|NCT02862067|systolic heart failure|systolic heart failure
112563|NCT02862067|heart failure with reduced ejection fraction|heart failure with reduced ejection fraction
112564|NCT02862054|haemophagocytic lymphohistiocytosis|haemophagocytic lymphohistiocytosis
112565|NCT02862054|splenectomy|splenectomy
112566|NCT02862054|unknown etiology|unknown etiology
112567|NCT02862028|PD-1 antibody|pd-1 antibody
112568|NCT02862028|CAR-T cells|car-t cells
112569|NCT02862028|EGFR family|egfr family
112570|NCT02862028|advanced solid tumor|advanced solid tumor
112571|NCT02862002|opioid therapy|opioid therapy
112572|NCT02862002|medical oncology.|medical oncology.
112573|NCT02861989|osteoporosis|osteoporosis
112574|NCT02861989|prevention|prevention
112575|NCT02861989|care management|care management
112576|NCT02861989|focus groups|focus groups
112577|NCT02861963|Femoral Allogenic Vein Valve Conduit|femoral allogenic vein valve conduit
112706|NCT02861417|Neosar|neosar
112578|NCT02861963|Rehabilitation of native pulmonary arteries|rehabilitation of native pulmonary arteries
112579|NCT02861950|hypospadias|hypospadias
112580|NCT02861950|caudal|caudal
112581|NCT02861950|urethrocutaneous fistula|urethrocutaneous fistula
112582|NCT02861950|penile nerve block|penile nerve block
112583|NCT02861911|Muscle function|muscle function
112584|NCT02861911|Oxidative stress|oxidative stress
112585|NCT02861911|Quality of life|quality of life
112586|NCT02861911|Physical activities|physical activities
112587|NCT02861898|EGFR|egfr
112588|NCT02861898|Epidermal Growth Factor Receptor|epidermal growth factor receptor
112589|NCT02861898|EGFRvIII|egfrviii
112590|NCT02861885|Colonoscopy|colonoscopy
112591|NCT02861885|sessile serrated lesions|sessile serrated lesions
112592|NCT02861885|chromoendoscopy|chromoendoscopy
112593|NCT02861885|narrow band imaging|narrow band imaging
112594|NCT02861885|Indigo Carmin®|indigo carmin®
112595|NCT02861885|Pit pattern|pit pattern
112596|NCT02861885|Kudo classification|kudo classification
112597|NCT02861885|NICE classification|nice classification
112598|NCT02861885|neoplasms by histologic type|neoplasms by histologic type
112599|NCT02861872|Ovarian|ovarian
112600|NCT02861872|Ovarian cancer|ovarian cancer
112601|NCT02861872|Chemotherapy|chemotherapy
112602|NCT02861872|Intraperitoneal chemotherapy|intraperitoneal chemotherapy
112603|NCT02861872|pharmacokinetics|pharmacokinetics
112604|NCT02861859|Breast cancer|breast cancer
112605|NCT02861859|Breast Carcinoma|breast carcinoma
112606|NCT02861859|Breast Tumors|breast tumors
112607|NCT02861859|Chemotherapy|chemotherapy
112608|NCT02861859|Antiemetic effects|antiemetic effects
112609|NCT02861859|Antiemetic drugs|antiemetic drugs
112610|NCT02861859|Drug Therapy|drug therapy
112611|NCT02861846|epilepsy|epilepsy
112612|NCT02861846|Alzheimer|alzheimer
112613|NCT02861846|biomarkers|biomarkers
112614|NCT02861846|predictive value|predictive value
112615|NCT02861820|fMRI|fmri
112616|NCT02861820|brain networks|brain networks
112617|NCT02861820|biomarker|biomarker
112618|NCT02861820|relapse|relapse
112619|NCT02861820|stimulants|stimulants
112620|NCT02861794|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
112621|NCT02861794|Total Knee Replacement (TKR)|total knee replacement (tkr)
112622|NCT02861794|Kinematics|kinematics
112623|NCT02861794|RSA|rsa
112624|NCT02861794|Knee arthroplasty|knee arthroplasty
112625|NCT02861794|Implant stability|implant stability
112626|NCT02861781|Bariatric surgery|bariatric surgery
112627|NCT02861755|Depression|depression
112628|NCT02861755|Depressive Disorder|depressive disorder
112629|NCT02861755|Psychological Stress|psychological stress
112630|NCT02861755|Behavioral Symptoms|behavioral symptoms
112631|NCT02861755|Mental Disorders|mental disorders
112632|NCT02861755|Mood Disorders|mood disorders
112633|NCT02861729|Partial coverage restoration|partial coverage restoration
112634|NCT02861729|Crown|crown
112635|NCT02861729|Posterior teeth|posterior teeth
112636|NCT02861729|All ceramic|all ceramic
112637|NCT02861729|Zirconia reinforced lithium silicate|zirconia reinforced lithium silicate
112638|NCT02861729|Lithium disilicate|lithium disilicate
112639|NCT02861729|CAD/CAM|cad/cam
112640|NCT02861690|Esophageal Cancer|esophageal cancer
112641|NCT02861690|nedaplatin|nedaplatin
112642|NCT02861690|Liposomal Paclitaxel|liposomal paclitaxel
112643|NCT02861638|Total hip replacement|total hip replacement
112644|NCT02861638|Action observation treatment|action observation treatment
112645|NCT02861638|Rehabilitation|rehabilitation
112646|NCT02861638|Arthroplasty|arthroplasty
112647|NCT02861612|peripheral nerves|peripheral nerves
112648|NCT02861612|quadriplegia|quadriplegia
112649|NCT02861612|nerve transfer|nerve transfer
112650|NCT02861612|surgical procedures, operative|surgical procedures, operative
112651|NCT02861612|hand|hand
112652|NCT02861612|upper extremity|upper extremity
112653|NCT02861612|quality of life|quality of life
112654|NCT02861586|Chikungunya, infectious disease|chikungunya, infectious disease
112655|NCT02861573|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
112656|NCT02861573|mCRPC|mcrpc
112657|NCT02861573|PD1|pd1
112658|NCT02861573|PD-1|pd-1
112659|NCT02861573|PDL1|pdl1
112661|NCT02861508|Ultrasonography|ultrasonography
112662|NCT02861495|upper extremity fracture|upper extremity fracture
112663|NCT02861482|PPH, Bakri Ballon|pph, bakri ballon
112664|NCT02861469|qualitative study, end of life, ethics, palliative care|qualitative study, end of life, ethics, palliative care
112665|NCT02861456|Adolescent|adolescent
112666|NCT02861456|Low Back Pain|low back pain
112667|NCT02861456|Athlete|athlete
112668|NCT02861430|colon cancer|colon cancer
112669|NCT02861430|sentinel node|sentinel node
112670|NCT02861417|Other diseases of blood and blood-forming organs|other diseases of blood and blood-forming organs
112671|NCT02861417|Acute myeloid leukemia|acute myeloid leukemia
112672|NCT02861417|AML|aml
112673|NCT02861417|Acute lymphocytic leukemia|acute lymphocytic leukemia
112674|NCT02861417|ALL|all
112675|NCT02861417|Chronic myeloid leukemia|chronic myeloid leukemia
112676|NCT02861417|CML|cml
112677|NCT02861417|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
112678|NCT02861417|CLL|cll
112679|NCT02861417|Myelodysplastic syndrome|myelodysplastic syndrome
112680|NCT02861417|MDS|mds
112681|NCT02861417|Myeloproliferative syndrome|myeloproliferative syndrome
112682|NCT02861417|Non-Hodgkins lymphoma|non-hodgkins lymphoma
112683|NCT02861417|NHL|nhl
112684|NCT02861417|Hodgkins lymphoma|hodgkins lymphoma
112685|NCT02861417|HL|hl
112686|NCT02861417|Multiple myeloma|multiple myeloma
112687|NCT02861417|MM|mm
112688|NCT02861417|Stem cell infusion|stem cell infusion
112689|NCT02861417|Stem cell transplant|stem cell transplant
112690|NCT02861417|Haploidentical donor|haploidentical donor
112691|NCT02861417|Matched donor|matched donor
112692|NCT02861417|Thiotepa|thiotepa
112693|NCT02861417|Mycophenolate Mofetil|mycophenolate mofetil
112694|NCT02861417|MMF|mmf
112695|NCT02861417|CellCept|cellcept
112696|NCT02861417|Busulfan|busulfan
112697|NCT02861417|Busulfex|busulfex
112698|NCT02861417|Myleran|myleran
112699|NCT02861417|Fludarabine|fludarabine
112700|NCT02861417|Fludarabine phosphate|fludarabine phosphate
112701|NCT02861417|Fludara|fludara
112702|NCT02861417|Mesna|mesna
112703|NCT02861417|Mesnex|mesnex
112704|NCT02861417|Cyclophosphamide|cyclophosphamide
112705|NCT02861417|Cytoxan|cytoxan
112707|NCT02861417|Tacrolimus|tacrolimus
112708|NCT02861417|Prograf|prograf
112709|NCT02861417|G-CSF|g-csf
112710|NCT02861417|Filgrastim|filgrastim
112711|NCT02861417|Neupogen|neupogen
112712|NCT02861404|HPV|hpv
112713|NCT02861378|anaesthesia, dental|anaesthesia, dental
112714|NCT02861378|lidocaine|lidocaine
112715|NCT02861352|Zinc|zinc
112716|NCT02861352|DNA Integrity|dna integrity
112717|NCT02861352|Gene Expression|gene expression
112718|NCT02861352|diet zinc|diet zinc
112719|NCT02861352|nutrition requirements|nutrition requirements
112720|NCT02861326|chronic periodontitis, dental scaling, periodontal pockets|chronic periodontitis, dental scaling, periodontal pockets
112721|NCT02861300|CB-839|cb-839
112722|NCT02861300|PIK3CA|pik3ca
112723|NCT02861300|capecitabine|capecitabine
112724|NCT02861248|Burn Scar|burn scar
112725|NCT02861248|Micro-plasma Radiofrequency Therapy|micro-plasma radiofrequency therapy
112726|NCT02861183|sodium hyaluronate|sodium hyaluronate
112727|NCT02861183|OVT|ovt
112728|NCT02861183|hyaluronic acid|hyaluronic acid
112729|NCT02861170|Mindfulness|mindfulness
112730|NCT02861170|Chronic Pain|chronic pain
112731|NCT02861170|Chronic Hip Pain|chronic hip pain
112732|NCT02861170|Total Hip Arthroplasty|total hip arthroplasty
112733|NCT02861170|Disability|disability
112734|NCT02861170|Quality of Life|quality of life
112735|NCT02861157|Type 1 Diabetes|type 1 diabetes
112736|NCT02861157|Adolescents|adolescents
112737|NCT02861157|T1D|t1d
112738|NCT02861131|Sugammadex|sugammadex
112739|NCT02861131|Neuromuscular Blockade|neuromuscular blockade
112740|NCT02861118|Drug Therapy|drug therapy
112741|NCT02861092|Serious adverse event|serious adverse event
112742|NCT02861092|bone and joint infection|bone and joint infection
112743|NCT02861092|obesity|obesity
112744|NCT02861092|dose adjustment|dose adjustment
112745|NCT02861066|Mindfulness-based Intervention|mindfulness-based intervention
112746|NCT02861066|Wellbeing|wellbeing
112747|NCT02861066|Treatment|treatment
112748|NCT02861027|Osteoarthritis|osteoarthritis
112749|NCT02861027|Total hip arthroplasty|total hip arthroplasty
112750|NCT02861027|Physiotherapy|physiotherapy
112751|NCT02861027|Functional Electrical Stimulation|functional electrical stimulation
112752|NCT02861001|tracheotomy|tracheotomy
112753|NCT02861001|bronchoscopy|bronchoscopy
112754|NCT02861001|critical care|critical care
112755|NCT02860975|Prolonged Hypoxia|prolonged hypoxia
112756|NCT02860975|Safety|safety
112757|NCT02860975|Mitochondrial function|mitochondrial function
112758|NCT02860949|Local anesthetic infiltration|local anesthetic infiltration
112759|NCT02860949|Posterior capsular infiltration|posterior capsular infiltration
112760|NCT02860949|Multimodal anesthesia|multimodal anesthesia
112761|NCT02860949|Knee arthroplasty|knee arthroplasty
112762|NCT02860949|Pain control|pain control
112763|NCT02860949|Osteoarthritis, Knee|osteoarthritis, knee
112764|NCT02860923|glucagon-like peptide-1|glucagon-like peptide-1
112765|NCT02860923|exenatide|exenatide
112766|NCT02860923|placebo|placebo
112767|NCT02860923|multicenter trial|multicenter trial
112768|NCT02860910|hot flashes|hot flashes
112769|NCT02860910|postmenopause|postmenopause
112770|NCT02860910|perimenopause|perimenopause
112771|NCT02860832|Cyberbullying|cyberbullying
112772|NCT02860832|Traditional bullying|traditional bullying
112773|NCT02860832|Depression|depression
112774|NCT02860819|Multiple relapsed/refractory testicular germ cell tumors|multiple relapsed/refractory testicular germ cell tumors
112775|NCT02860819|PARP inhibition|parp inhibition
112776|NCT02860819|Chemotherapy|chemotherapy
112777|NCT02860819|Gemcitabine|gemcitabine
112778|NCT02860819|Carboplatin|carboplatin
112779|NCT02860793|PTK7|ptk7
112780|NCT02860793|Acute Myeloid Leukemia|acute myeloid leukemia
112781|NCT02860767|Prosthesis-Related Infections|prosthesis-related infections
112782|NCT02860767|Antibiotic dosing|antibiotic dosing
112783|NCT02860767|Reimplantation|reimplantation
112784|NCT02860767|Knee-prothesis|knee-prothesis
112785|NCT02860767|Hip-prothesis|hip-prothesis
112786|NCT02860741|Sub-Clinical Depression|sub-clinical depression
112787|NCT02860728|COPD|copd
112788|NCT02860728|Resistance Training|resistance training
112789|NCT02860728|Exercise Training|exercise training
112790|NCT02860728|Dyspnea|dyspnea
112791|NCT02860715|Safety|safety
112792|NCT02860715|Pharmacodynamics|pharmacodynamics
112793|NCT02860715|Dose-Limiting Toxicity (DLT)|dose-limiting toxicity (dlt)
112794|NCT02860715|Immunogenicity|immunogenicity
112795|NCT02860715|Pharmacokinetics|pharmacokinetics
112796|NCT02860702|Single Ventricle|single ventricle
112797|NCT02860702|Congenital Heart Defect|congenital heart defect
112798|NCT02860689|Sexuality|sexuality
112799|NCT02860689|Spinal cord injuries|spinal cord injuries
112800|NCT02860689|Penile erection|penile erection
112801|NCT02860689|erectile dysfunction|erectile dysfunction
112802|NCT02860689|Psychological Sexual Dysfunctions|psychological sexual dysfunctions
112803|NCT02860676|CLL|cll
112804|NCT02860676|cancer|cancer
112805|NCT02860676|UC-961|uc-961
112806|NCT02860676|cirmtuzumab|cirmtuzumab
112807|NCT02860637|Sexuality|sexuality
112808|NCT02860637|Spinal cord injuries|spinal cord injuries
112809|NCT02860637|Penile erection|penile erection
112810|NCT02860637|erectile dysfunction|erectile dysfunction
112811|NCT02860624|GERD|gerd
112812|NCT02860611|Type 1 diabetes|type 1 diabetes
112813|NCT02860611|Type 2 diabetes|type 2 diabetes
112814|NCT02860611|T helper 1 cytokines|t helper 1 cytokines
112815|NCT02860598|ESAs|esas
112816|NCT02860598|erythropoietin|erythropoietin
112817|NCT02860598|AML|aml
112818|NCT02860598|HSCT|hsct
112819|NCT02860585|Metastatic breast cancer|metastatic breast cancer
112820|NCT02860585|high-dose chemotherapy|high-dose chemotherapy
112821|NCT02860585|autologous haematopoietic progenitor cell transplantation|autologous haematopoietic progenitor cell transplantation
112822|NCT02860572|fluid therapy|fluid therapy
112823|NCT02860572|oliguria|oliguria
112824|NCT02860572|endothelial injury|endothelial injury
112825|NCT02860559|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
112826|NCT02860559|Severe Combined Immunodeficiency|severe combined immunodeficiency
112827|NCT02860546|Refractory|refractory
112828|NCT02860546|Metastatic|metastatic
112829|NCT02860546|Colorectal cancer|colorectal cancer
112830|NCT02860546|TAS-102|tas-102
112831|NCT02860546|Nivolumab|nivolumab
112832|NCT02860546|Microsatellite Stable|microsatellite stable
112833|NCT02860546|Programmed cell death protein1 (PD 1)|programmed cell death protein1 (pd 1)
112834|NCT02860533|Blood pressure|blood pressure
112835|NCT02860533|smartphone App|smartphone app
112836|NCT02860533|Hypertension|hypertension
112837|NCT02860533|Stress testing|stress testing
112838|NCT02860533|Prevention|prevention
112839|NCT02860533|Cardiovascular risk factors|cardiovascular risk factors
112840|NCT02860520|Retinitis pigmentosa:|retinitis pigmentosa:
112841|NCT02860494|Tuberous sclerosis complex (TSC)|tuberous sclerosis complex (tsc)
112842|NCT02860494|topical everolimus|topical everolimus
112843|NCT02860494|seamless design|seamless design
112844|NCT02860494|dose-escalation study|dose-escalation study
112845|NCT02860494|m-TOR inhibitor|m-tor inhibitor
112846|NCT02860455|CO poisoning|co poisoning
112847|NCT02860455|CO-oximetry|co-oximetry
112848|NCT02860455|Pulse oximetry|pulse oximetry
112849|NCT02860455|Carbon monoxide saturation (SpCO)|carbon monoxide saturation (spco)
112850|NCT02860455|Emergency Department|emergency department
112851|NCT02860455|Sensitivity|sensitivity
112852|NCT02860455|Specificity|specificity
112853|NCT02860442|Alcohol misuse|alcohol misuse
112854|NCT02860442|Smartphone app|smartphone app
112855|NCT02860442|Screening, Brief Intervention, Referral to Treatment (SBIRT)|screening, brief intervention, referral to treatment (sbirt)
112856|NCT02860416|Neurology|neurology
112857|NCT02860403|Cervical spinal cord injury|cervical spinal cord injury
112858|NCT02860403|Motor imagery|motor imagery
112859|NCT02860403|Magnetoencephalography|magnetoencephalography
112860|NCT02860377|emergence agitation|emergence agitation
112861|NCT02860377|emergence time|emergence time
112862|NCT02860377|pediatric|pediatric
112863|NCT02860351|subclavian vein|subclavian vein
113058|NCT02858960|Oxygen|oxygen
112864|NCT02860338|Psuedobulbar affect, PBA|psuedobulbar affect, pba
112865|NCT02860299|patients|patients
112866|NCT02860273|Pulmonary Rehabilitation|pulmonary rehabilitation
112867|NCT02860273|COPD|copd
112868|NCT02860273|High Flow Nasal Cannula|high flow nasal cannula
112869|NCT02860273|HFNC|hfnc
112870|NCT02860273|Aerobic capacity|aerobic capacity
112871|NCT02860260|BDNF|bdnf
112872|NCT02860247|antibiotic|antibiotic
112873|NCT02860247|MALDI-TOF MS|maldi-tof ms
112874|NCT02860247|susceptibility testing|susceptibility testing
112875|NCT02860234|Rectal cancer|rectal cancer
112876|NCT02860234|neoadjuvant|neoadjuvant
112877|NCT02860234|radiotherapy|radiotherapy
112878|NCT02860234|chemotherapy|chemotherapy
112879|NCT02860234|organ preservation|organ preservation
112880|NCT02860221|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
112881|NCT02860221|Epinephrine|epinephrine
112882|NCT02860221|Tranexamic acid|tranexamic acid
112883|NCT02860208|Peri-Implantitis|peri-implantitis
112884|NCT02860208|Surgical therapy|surgical therapy
112885|NCT02860208|Follow-up|follow-up
112886|NCT02860208|Supportive peri-implant therapy|supportive peri-implant therapy
112887|NCT02860130|Regional Citrate Anticoagulation (RCA)|regional citrate anticoagulation (rca)
112888|NCT02860130|Continuous Renal Replacement Therapy (CRRT)|continuous renal replacement therapy (crrt)
112889|NCT02860130|Acute Kidney Injury|acute kidney injury
112890|NCT02860117|ketamine|ketamine
112891|NCT02860117|continuous infusion|continuous infusion
112892|NCT02860117|severe burned patients|severe burned patients
112893|NCT02860104|microwave ablation|microwave ablation
112894|NCT02860104|breast|breast
112895|NCT02860104|multicenter|multicenter
112896|NCT02860091|ropivacaine infusion|ropivacaine infusion
112897|NCT02860091|regional anesthesia|regional anesthesia
112898|NCT02860091|paravertebral block|paravertebral block
112899|NCT02860078|pain|pain
112900|NCT02860078|epidural|epidural
112901|NCT02860078|ultrasound|ultrasound
112902|NCT02860013|Telemedicine|telemedicine
112903|NCT02860013|Effectiveness|effectiveness
112904|NCT02860013|Cost-effectiveness|cost-effectiveness
112905|NCT02859987|US|us
112906|NCT02859987|Nursing Services|nursing services
112907|NCT02859974|Paradoxical vocal fold motion disorder (PVFMD)|paradoxical vocal fold motion disorder (pvfmd)
112908|NCT02859974|vocal cord dysfunction (VCD)|vocal cord dysfunction (vcd)
112909|NCT02859974|Respiratory retraining|respiratory retraining
112910|NCT02859974|Respiratory disorders|respiratory disorders
112911|NCT02859948|AML|aml
112912|NCT02859935|HIV|hiv
112913|NCT02859935|drug abuse|drug abuse
112914|NCT02859935|MSM|msm
112915|NCT02859935|Risk behavior|risk behavior
112916|NCT02859935|Sexually transmitted diseases|sexually transmitted diseases
112917|NCT02859935|Sexually transmitted infections|sexually transmitted infections
112918|NCT02859922|Laryngeal Tube Supreme Spontaneous Ventilation|laryngeal tube supreme spontaneous ventilation
112919|NCT02859857|Glioblastoma Multiforme|glioblastoma multiforme
112920|NCT02859857|Solid Tumors|solid tumors
112921|NCT02859857|Ependymoma|ependymoma
112922|NCT02859727|APDS; PASLI; PI3Kdelta; p110delta-activating mutation causing senescent T cells, lymphadenopathy and immunodeficiency; Activated PI3Kdelta Syndrome;|apds; pasli; pi3kdelta; p110delta-activating mutation causing senescent t cells, lymphadenopathy and immunodeficiency; activated pi3kdelta syndrome;
112923|NCT02859662|abdominal compartment syndrome|abdominal compartment syndrome
112924|NCT02859662|abdominal aortic aneurysm|abdominal aortic aneurysm
112925|NCT02859662|ruptured aneurysm|ruptured aneurysm
112926|NCT02859649|working memory|working memory
112927|NCT02859649|short term memory|short term memory
112928|NCT02859649|gesture|gesture
112929|NCT02859584|Acute hepatitis|acute hepatitis
112930|NCT02859584|acute liver failure|acute liver failure
112931|NCT02859584|adrenal dysfunction|adrenal dysfunction
112932|NCT02859584|salivary cortisol|salivary cortisol
112933|NCT02859584|serum free cortisol|serum free cortisol
112934|NCT02859545|chronic pain|chronic pain
112935|NCT02859545|pain|pain
112936|NCT02859545|validation|validation
112937|NCT02859545|couples|couples
112938|NCT02859545|romantic relationships|romantic relationships
112939|NCT02859545|emotional validation|emotional validation
112940|NCT02859532|blood coagulation|blood coagulation
112941|NCT02859532|Endogenous Thrombin Potential|endogenous thrombin potential
112942|NCT02859532|rotational thromboelastometry|rotational thromboelastometry
112943|NCT02859480|Rosuvastatin Calcium|rosuvastatin calcium
112944|NCT02859480|Percutaneous Coronary Intervention|percutaneous coronary intervention
112945|NCT02859480|Drug-Eluting Stents|drug-eluting stents
112946|NCT02859480|Patient Outcome Assessment|patient outcome assessment
112947|NCT02859480|Biomarkers|biomarkers
112948|NCT02859480|Hyperlipidemias|hyperlipidemias
112949|NCT02859480|Dyslipidemias|dyslipidemias
112950|NCT02859480|Atherosclerosis|atherosclerosis
112951|NCT02859480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
112952|NCT02859480|Anticholesteremic Agents|anticholesteremic agents
112953|NCT02859480|Hypolipidemic Agents|hypolipidemic agents
112954|NCT02859480|Lipid Regulating Agents|lipid regulating agents
112955|NCT02859467|Physical Therapy Modalities|physical therapy modalities
112956|NCT02859467|Exercise|exercise
113163|NCT02858362|Utrophin|utrophin
112957|NCT02859467|Electrical Stimulation Therapy|electrical stimulation therapy
112958|NCT02859467|Bandages|bandages
112959|NCT02859454|PD-L1 Expression|pd-l1 expression
112960|NCT02859454|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
112961|NCT02859454|Juvenile-onset Disease|juvenile-onset disease
112962|NCT02859454|Papillomatous Lesions|papillomatous lesions
112963|NCT02859454|Monoclonal Antibody|monoclonal antibody
112964|NCT02859441|Intravitreal Injection|intravitreal injection
112965|NCT02859441|Retinal Capillary Hemangioma|retinal capillary hemangioma
112966|NCT02859428|Hereditary Spastic Paraplegia|hereditary spastic paraplegia
112967|NCT02859415|Metastatic Colorectal Cancer|metastatic colorectal cancer
112968|NCT02859415|Metastatic Renal Cell Cancer|metastatic renal cell cancer
112970|NCT02859415|ABCB4 Liver Toxicity|abcb4 liver toxicity
112971|NCT02859415|ABCB11 Heptatoxicity|abcb11 heptatoxicity
112972|NCT02859402|T-cell Non-Hodgkin Lymphoma|t-cell non-hodgkin lymphoma
112973|NCT02859402|NK/T-cell Non-Hodgkin Lymphoma|nk/t-cell non-hodgkin lymphoma
112974|NCT02859402|Relapsed, refractory|relapsed, refractory
112975|NCT02859402|Conditioning|conditioning
112976|NCT02859402|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
112977|NCT02859389|Leukemia|leukemia
112978|NCT02859389|Down Syndrome|down syndrome
112979|NCT02859389|Neurocognitive|neurocognitive
112980|NCT02859389|Survivorship|survivorship
112981|NCT02859389|Attention|attention
112982|NCT02859389|Executive function|executive function
112983|NCT02859389|Late effects|late effects
112984|NCT02859376|Preterm infants|preterm infants
112985|NCT02859376|Pain|pain
112986|NCT02859376|Sucrose|sucrose
112987|NCT02859350|Plasmodium falciparum|plasmodium falciparum
112988|NCT02859350|PfSPZ Vaccine|pfspz vaccine
112989|NCT02859350|PfSPZ Challenge (NF54)|pfspz challenge (nf54)
112990|NCT02859350|CHMI|chmi
112991|NCT02859350|Chloroquine|chloroquine
112992|NCT02859350|Chemoprophylaxis|chemoprophylaxis
112993|NCT02859350|PfSPZ-CVac|pfspz-cvac
112994|NCT02859337|obesity|obesity
112995|NCT02859337|body weight|body weight
112996|NCT02859337|BMI|bmi
112997|NCT02859337|emergency contraception|emergency contraception
112998|NCT02859337|levonorgestrel|levonorgestrel
112999|NCT02859337|ulipristal acetate|ulipristal acetate
113000|NCT02859324|CC-122|cc-122
113001|NCT02859324|Nivolumab|nivolumab
113002|NCT02859324|Hepatocellular Carcinoma|hepatocellular carcinoma
113003|NCT02859324|Phase 1/2|phase 1/2
113004|NCT02859324|Safety|safety
113005|NCT02859311|Recovery|recovery
113006|NCT02859298|Premature Delivery|premature delivery
113007|NCT02859298|Polarimetric Imaging|polarimetric imaging
113008|NCT02859298|Polarimetric colposcope|polarimetric colposcope
113009|NCT02859298|Diagnostic tool|diagnostic tool
113010|NCT02859285|Arousal|arousal
113011|NCT02859285|Orgasm|orgasm
113012|NCT02859285|Clitoral|clitoral
113013|NCT02859285|Estradiol|estradiol
113014|NCT02859285|Post Menopausal|post menopausal
113015|NCT02859272|Suspension, benign hysterectomy, post operative prolapse|suspension, benign hysterectomy, post operative prolapse
113016|NCT02859233|Spinal Puncture|spinal puncture
113017|NCT02859233|Dural puncture|dural puncture
113018|NCT02859233|Nursing|nursing
113019|NCT02859220|hemodialysis|hemodialysis
113020|NCT02859220|PTH|pth
113021|NCT02859207|Early Alzheimer's disease|early alzheimer's disease
113022|NCT02859207|E2609|e2609
113023|NCT02859207|Mild and Moderate Hepatic Impairment|mild and moderate hepatic impairment
113024|NCT02859181|Increased Metabolic Requirement|increased metabolic requirement
113025|NCT02859168|Neck|neck
113026|NCT02859168|Shoulder|shoulder
113027|NCT02859168|Manual Therapies|manual therapies
113028|NCT02859142|Varenicline|varenicline
113029|NCT02859129|Epanova|epanova
113030|NCT02859129|omega-3 carboxylic acids|omega-3 carboxylic acids
113031|NCT02859129|Vascepa|vascepa
113032|NCT02859129|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester
113033|NCT02859129|Crestor|crestor
113034|NCT02859129|rosuvastatin|rosuvastatin
113035|NCT02859116|Metabolic diseases|metabolic diseases
113036|NCT02859077|NSCLC|nsclc
113037|NCT02859077|BIM|bim
113038|NCT02859077|EGFR mutation|egfr mutation
113039|NCT02859064|radioembolization|radioembolization
113040|NCT02859064|somatostatin analogs|somatostatin analogs
113041|NCT02859064|carcinoid|carcinoid
113042|NCT02859064|neuroendocrine|neuroendocrine
113043|NCT02859064|liver-directed therapy|liver-directed therapy
113044|NCT02859051|Cognitive Behavioral Support provided by Robot|cognitive behavioral support provided by robot
113045|NCT02859025|Alveolar cleft|alveolar cleft
113046|NCT02859025|Osteoplasty|osteoplasty
113047|NCT02859025|Tissue engineering|tissue engineering
113048|NCT02859025|Stem cells|stem cells
113049|NCT02859025|Regenerative medicine|regenerative medicine
113050|NCT02859025|Bone|bone
113051|NCT02859025|Lateral ramus|lateral ramus
113052|NCT02858999|primary plasma cell leukaemia|primary plasma cell leukaemia
113053|NCT02858999|treatment|treatment
113054|NCT02858960|High Flow Nasal Cannula|high flow nasal cannula
113055|NCT02858960|COPD|copd
113056|NCT02858960|Pulmonary rehabilitation|pulmonary rehabilitation
113057|NCT02858960|HFNC|hfnc
113059|NCT02858947|composite resin|composite resin
113060|NCT02858947|bulk-fill|bulk-fill
113061|NCT02858947|teeth endodontically-treated|teeth endodontically-treated
113062|NCT02858934|Short preoperative tomotherapy|short preoperative tomotherapy
113063|NCT02858934|Radiotherapy|radiotherapy
113064|NCT02858921|Neoadjuvant Therapy|neoadjuvant therapy
113065|NCT02858921|Pembrolizumab|pembrolizumab
113066|NCT02858921|Dabrafenib|dabrafenib
113067|NCT02858921|Trametinib|trametinib
113068|NCT02858921|Pathological response|pathological response
113069|NCT02858921|RECIST|recist
113070|NCT02858921|Immune response|immune response
113071|NCT02858921|BRAF|braf
113072|NCT02858921|Randomised|randomised
113073|NCT02858921|Stage IIIB/C|stage iiib/c
113074|NCT02858921|Biomarkers, Tumour|biomarkers, tumour
113075|NCT02858921|Biomarkers, Drug response|biomarkers, drug response
113076|NCT02858921|Metabolic Response|metabolic response
113077|NCT02858895|High grade glioma|high grade glioma
113078|NCT02858895|malignant glioma|malignant glioma
113079|NCT02858895|recurrent glioblastoma|recurrent glioblastoma
113080|NCT02858895|recurrent GBM|recurrent gbm
113081|NCT02858895|recurrent GB|recurrent gb
113082|NCT02858895|glioblastoma (GB)|glioblastoma (gb)
113083|NCT02858895|glioblastoma multiforme (GBM)|glioblastoma multiforme (gbm)
113084|NCT02858895|progressive glioblastoma|progressive glioblastoma
113085|NCT02858895|Brain tumor|brain tumor
113086|NCT02858895|Brain cancer|brain cancer
113087|NCT02858895|immunotherapy|immunotherapy
113088|NCT02858895|targeted|targeted
113089|NCT02858895|IL4R|il4r
113090|NCT02858843|genetics|genetics
113092|NCT02858830|adipose tissue|adipose tissue
113093|NCT02858830|diabetes|diabetes
113094|NCT02858830|dyslipidemia|dyslipidemia
113095|NCT02858830|metabolic|metabolic
113096|NCT02858830|hyperinsulinemia|hyperinsulinemia
113097|NCT02858804|mantle cell lymphoma|mantle cell lymphoma
113098|NCT02858804|EDOCH|edoch
113099|NCT02858804|DHAP|dhap
113100|NCT02858804|maintenance therapy|maintenance therapy
113101|NCT02858778|Palliative Care|palliative care
113102|NCT02858778|Emergency Department|emergency department
113103|NCT02858752|Attention|attention
113104|NCT02858752|Short-term memory|short-term memory
113105|NCT02858752|Aural Memory|aural memory
113106|NCT02858752|Visual Memory|visual memory
113107|NCT02858752|Child|child
113108|NCT02858752|EEG|eeg
113109|NCT02858726|Hemodialysis|hemodialysis
113110|NCT02858726|CR845|cr845
113111|NCT02858726|Kappa opioid|kappa opioid
113112|NCT02858726|Anti-itch|anti-itch
113113|NCT02858713|psoriasis|psoriasis
113114|NCT02858700|neonatal bacterial infection|neonatal bacterial infection
113115|NCT02858700|procalcitonin|procalcitonin
113116|NCT02858635|Suicidal behaviour|suicidal behaviour
113117|NCT02858635|Impulsivity|impulsivity
113118|NCT02858635|Genetics|genetics
113119|NCT02858635|Serotonin|serotonin
113120|NCT02858622|pediatric|pediatric
113121|NCT02858622|renal transplant|renal transplant
113122|NCT02858622|pain|pain
113123|NCT02858622|dual TAB|dual tab
113124|NCT02858583|Chest Compression|chest compression
113125|NCT02858583|Newborn|newborn
113126|NCT02858583|Infant|infant
113127|NCT02858583|Sustained Inflation|sustained inflation
113128|NCT02858570|Meningococcal Vaccines|meningococcal vaccines
113129|NCT02858570|Immunogenicity, Reactogenicity and Safety of Vaccine|immunogenicity, reactogenicity and safety of vaccine
113130|NCT02858544|Mild traumatic brain injury|mild traumatic brain injury
113131|NCT02858518|anticoagulant|anticoagulant
113132|NCT02858492|efficacy|efficacy
113133|NCT02858492|safety|safety
113134|NCT02858492|pharmacokinetics|pharmacokinetics
113135|NCT02858492|pharmacodynamics|pharmacodynamics
113136|NCT02858492|Rheumatoid Arthritis|rheumatoid arthritis
113137|NCT02858492|autoimmune|autoimmune
113138|NCT02858453|Interstitial cystitis|interstitial cystitis
113139|NCT02858453|Bladder pain syndrome|bladder pain syndrome
113140|NCT02858453|Painful bladder syndrome|painful bladder syndrome
113141|NCT02858453|Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)|interstitial cystitis/bladder pain syndrome (ic/bps)
113142|NCT02858453|AQX-1125|aqx-1125
113143|NCT02858453|SHIP1|ship1
113144|NCT02858453|Chronic interstitial cystitis|chronic interstitial cystitis
113145|NCT02858440|Primary dose|primary dose
113146|NCT02858440|Reactogenicity|reactogenicity
113147|NCT02858440|Immunogenicity|immunogenicity
113148|NCT02858440|Booster dose|booster dose
113149|NCT02858440|Combined vaccine|combined vaccine
113150|NCT02858440|Russian Infants|russian infants
113151|NCT02858440|Infanrix®-IPV/Hib|infanrix®-ipv/hib
113152|NCT02858427|cognitive inhibition|cognitive inhibition
113153|NCT02858427|elderly|elderly
113154|NCT02858427|suicide attempt|suicide attempt
113155|NCT02858427|depression|depression
113156|NCT02858388|Otitis Media with Effusion|otitis media with effusion
113157|NCT02858388|Exudative otitis media|exudative otitis media
113158|NCT02858375|quality of life|quality of life
113159|NCT02858375|botulinum toxin|botulinum toxin
113160|NCT02858375|provoked vulvodynia|provoked vulvodynia
113161|NCT02858362|DMD|dmd
113162|NCT02858362|Muscular Dystrophy|muscular dystrophy
113164|NCT02858362|Duchenne|duchenne
113165|NCT02858362|PhaseOut DMD|phaseout dmd
113166|NCT02858336|Luteinizing Hormone (LH)|luteinizing hormone (lh)
113167|NCT02858336|Functional Hypothalamic Amenorrhea (HA)|functional hypothalamic amenorrhea (ha)
113168|NCT02858336|Energy Deficiency|energy deficiency
113169|NCT02858336|Gonadotropin-Releasing Hormone|gonadotropin-releasing hormone
113170|NCT02858336|Leptin|leptin
113171|NCT02858323|Alloimmunization|alloimmunization
113172|NCT02858323|Refractoriness|refractoriness
113173|NCT02858323|Corrected Count Increment|corrected count increment
113174|NCT02858323|HLA-Compatible|hla-compatible
113175|NCT02858310|Vulvar High Grade Squamous Intraepithelial Lesion|vulvar high grade squamous intraepithelial lesion
113176|NCT02858310|Vulvar Intraepithelial Neoplasia|vulvar intraepithelial neoplasia
113177|NCT02858310|Vaccine|vaccine
113178|NCT02858310|Immunotherapy|immunotherapy
113179|NCT02858310|Human Papillomavirus|human papillomavirus
113180|NCT02858297|Oral lichen planus|oral lichen planus
113181|NCT02858297|Glucosamine|glucosamine
113182|NCT02858297|IL-8|il-8
113183|NCT02858258|MCL|mcl
113184|NCT02858245|MitraClip|mitraclip
113185|NCT02858245|Structural Heart Failure|structural heart failure
113186|NCT02858245|Degenerative Mitral Regurgitation (DMR)|degenerative mitral regurgitation (dmr)
113187|NCT02858245|Actigraphy|actigraphy
113188|NCT02858232|MASCT-I|masct-i
113189|NCT02858232|Solid Tumors|solid tumors
113190|NCT02858219|Botulinum toxin|botulinum toxin
113191|NCT02858219|Pain improvement|pain improvement
113192|NCT02858206|Locally advanced esophageal cancer|locally advanced esophageal cancer
113193|NCT02858206|Radiotherapy and nimotuzumab|radiotherapy and nimotuzumab
113194|NCT02858206|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
113195|NCT02858154|OSA|osa
113196|NCT02858154|obstructive sleep apnea|obstructive sleep apnea
113197|NCT02858154|infants|infants
113198|NCT02858154|high flow nasal cannula|high flow nasal cannula
113199|NCT02858154|HFNC|hfnc
113200|NCT02858141|oncogeriatric evaluation|oncogeriatric evaluation
113201|NCT02858141|pancreatic cancer|pancreatic cancer
113202|NCT02858141|Database|database
113203|NCT02858102|Schizophrenia|schizophrenia
113204|NCT02858102|Psychosis|psychosis
113205|NCT02858102|Obesity|obesity
113206|NCT02858102|Neurocognition|neurocognition
113207|NCT02858102|Depression|depression
113208|NCT02858102|Bipolar disorder|bipolar disorder
113209|NCT02858102|Metabolomics|metabolomics
113210|NCT02858102|Biomarkers|biomarkers
113211|NCT02858102|Hypertension|hypertension
113212|NCT02858102|Dyslipidemia|dyslipidemia
113213|NCT02858102|Hyperglycemia|hyperglycemia
113214|NCT02858102|Hypertriglyceridemia|hypertriglyceridemia
113215|NCT02858076|Anti-VEGF|anti-vegf
113216|NCT02858076|Vitrectomy|vitrectomy
113217|NCT02858063|Breast cancer|breast cancer
113218|NCT02858063|Quality Of Life|quality of life
113219|NCT02858063|Women|women
113220|NCT02858063|Partner|partner
113221|NCT02858011|behavior change communication|behavior change communication
113222|NCT02858011|cash transfer|cash transfer
113223|NCT02858011|household welfare|household welfare
113224|NCT02858011|child nutrition status|child nutrition status
113225|NCT02857985|Myocardial Infarction|myocardial infarction
113227|NCT02857985|rotational angiography|rotational angiography
113228|NCT02857972|Menstruation, Female Barrier, Sanitary pads|menstruation, female barrier, sanitary pads
113229|NCT02857933|cerebral palsy|cerebral palsy
113230|NCT02857933|motor impairments|motor impairments
113231|NCT02857920|Vascular Endothelial Growth Factor (VEGF) antibody|vascular endothelial growth factor (vegf) antibody
113232|NCT02857920|solid tumor|solid tumor
113233|NCT02857920|NK Immunotherapy|nk immunotherapy
113234|NCT02857907|Kidney transplantation|kidney transplantation
113235|NCT02857907|Immunosuppressive treatment|immunosuppressive treatment
113236|NCT02857894|Polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
113237|NCT02857881|keratoconus|keratoconus
113238|NCT02857881|photokeratectomy|photokeratectomy
113239|NCT02857881|de-epithelization|de-epithelization
113240|NCT02857868|Hepatic Impairment|hepatic impairment
113241|NCT02857868|ABL001|abl001
113242|NCT02857868|Child-Pugh|child-pugh
113243|NCT02857868|healthy subjects with normal hepatic function|healthy subjects with normal hepatic function
113244|NCT02857855|liver transplantation|liver transplantation
113245|NCT02857855|postoperative infection|postoperative infection
113246|NCT02857855|biliary complications|biliary complications
113247|NCT02857855|patient survival|patient survival
113248|NCT02857855|graft survival|graft survival
113249|NCT02857855|supplemental oxygen|supplemental oxygen
113250|NCT02857829|Cognition|cognition
113251|NCT02857829|working memory|working memory
113252|NCT02857829|nootropic|nootropic
113253|NCT02857829|reaction time|reaction time
113254|NCT02857829|healthy individuals|healthy individuals
113255|NCT02857829|cognitive enhancement|cognitive enhancement
113256|NCT02857803|Virtual Reality|virtual reality
113257|NCT02857803|Cognitive Rehabilitation|cognitive rehabilitation
113258|NCT02857803|Motor Rehabilitation|motor rehabilitation
113259|NCT02857803|Ecological validity|ecological validity
113260|NCT02857803|Personalisation|personalisation
113261|NCT02857790|Rotablation|rotablation
113262|NCT02857790|High speed rotational atherectomy|high speed rotational atherectomy
113263|NCT02857790|Type IV myocardial infarction|type iv myocardial infarction
113264|NCT02857790|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
113265|NCT02857790|CMR|cmr
113266|NCT02857790|Percutaneous Coronary Intervention|percutaneous coronary intervention
113267|NCT02857751|depression|depression
113268|NCT02857751|PTSD|ptsd
113269|NCT02857751|anxiety|anxiety
113270|NCT02857751|surf therapy|surf therapy
113271|NCT02857699|Quality of life|quality of life
113272|NCT02857699|Phase I trials|phase i trials
113273|NCT02857673|Children with Special Health Care Needs|children with special health care needs
113274|NCT02857673|Violence Prevention|violence prevention
113275|NCT02857660|Sarcopenia|sarcopenia
113276|NCT02857660|Obesity|obesity
113277|NCT02857660|Whole-Body Electromyostimulation|whole-body electromyostimulation
113278|NCT02857660|Protein Supplementation|protein supplementation
113279|NCT02857660|community dwelling men|community dwelling men
113280|NCT02857647|Bariatric surgery|bariatric surgery
113281|NCT02857647|Anxiety|anxiety
113282|NCT02857647|Nutrition knowledge|nutrition knowledge
113283|NCT02857647|Weight loss expectations|weight loss expectations
113284|NCT02857634|Urinary Bladder cancer|urinary bladder cancer
113285|NCT02857634|diagnosis|diagnosis
113286|NCT02857634|Cellvizio Dual Band|cellvizio dual band
113287|NCT02857582|Antibiotic-induced diarrhea|antibiotic-induced diarrhea
113288|NCT02857582|Clostridium-difficile toxin|clostridium-difficile toxin
113289|NCT02857582|Pseudomembranous colitis|pseudomembranous colitis
113290|NCT02857504|double lumen tube|double lumen tube
113291|NCT02857504|hook|hook
113292|NCT02857439|Trauma of the shoulder|trauma of the shoulder
113293|NCT02857413|Xerostomia|xerostomia
113294|NCT02857413|Radiotherapy|radiotherapy
113295|NCT02857348|decision making|decision making
113296|NCT02857348|heuristics|heuristics
113297|NCT02857283|Air pollution|air pollution
113298|NCT02857283|Air pollutant exposure|air pollutant exposure
113299|NCT02857283|Ozone|ozone
113300|NCT02857270|MAPK|mapk
113301|NCT02857270|RAS|ras
113302|NCT02857270|BRAF|braf
113303|NCT02857257|IBS|ibs
113304|NCT02857257|Microbiota|microbiota
113305|NCT02857244|Freezing of Gait|freezing of gait
113306|NCT02857231|Bioimpedance spectroscopy|bioimpedance spectroscopy
113307|NCT02857205|Hirschsprung Associated EnteroColitis (HAEC)|hirschsprung associated enterocolitis (haec)
113308|NCT02857179|bariatric surgery|bariatric surgery
113309|NCT02857179|follow-up|follow-up
113310|NCT02857179|weight loss|weight loss
113311|NCT02857179|complications|complications
113312|NCT02857179|comorbidities evolution|comorbidities evolution
113313|NCT02857166|JS001|js001
113314|NCT02857166|solid tumors|solid tumors
113315|NCT02857153|MAP|map
113316|NCT02857153|Blood loss|blood loss
113317|NCT02857153|Postoperative delirium|postoperative delirium
113318|NCT02857153|Elderly patients|elderly patients
113319|NCT02857153|Noncardiothoracic surgery|noncardiothoracic surgery
113320|NCT02857127|Low income population|low income population
113321|NCT02857127|Motor Activity|motor activity
113322|NCT02857127|Primary Health Care|primary health care
113323|NCT02857088|depression|depression
113324|NCT02857088|emotional reactivity|emotional reactivity
113325|NCT02857036|rhythm|rhythm
113326|NCT02857036|depression|depression
113327|NCT02857036|antidepressant treatment|antidepressant treatment
113328|NCT02857023|Neurocognitive|neurocognitive
113329|NCT02857023|Working memory|working memory
113330|NCT02857023|Cogmed|cogmed
113331|NCT02857023|Cognitive training|cognitive training
113332|NCT02856984|Pregnancy|pregnancy
113333|NCT02856984|Infant|infant
113334|NCT02856971|Hinge Knee Prosthesis|hinge knee prosthesis
113335|NCT02856971|TKA infection|tka infection
113336|NCT02856971|rotating hinge prosthesis|rotating hinge prosthesis
113337|NCT02856971|hinge knee arthroplasty|hinge knee arthroplasty
113338|NCT02856945|fracture|fracture
113339|NCT02856945|children|children
113340|NCT02856945|knee|knee
113341|NCT02856945|clinical criteria|clinical criteria
113342|NCT02856945|decision making|decision making
113343|NCT02856906|Orofacial Pain|orofacial pain
113344|NCT02856906|Electromyography|electromyography
113345|NCT02856906|dental occlusion|dental occlusion
113346|NCT02856893|AZD9291|azd9291
113347|NCT02856893|Osimertinib|osimertinib
113348|NCT02856893|Gefitinib|gefitinib
113349|NCT02856893|NSCLC|nsclc
113350|NCT02856893|liquid biopsy|liquid biopsy
113351|NCT02856893|ctDNA|ctdna
113352|NCT02856841|epithelial ovarian cancer|epithelial ovarian cancer
113353|NCT02856841|optimum cytoreduction|optimum cytoreduction
113354|NCT02856815|Immuncell-LC|immuncell-lc
113355|NCT02856815|Transarterial Chemoembolization|transarterial chemoembolization
113356|NCT02856789|Fibrin structure|fibrin structure
113357|NCT02856789|Thromboelastography|thromboelastography
113358|NCT02856789|Fibrin formation|fibrin formation
113359|NCT02856789|Fibrinolysis|fibrinolysis
113360|NCT02856789|TEG 5000|teg 5000
113361|NCT02856789|TEG 6S|teg 6s
113362|NCT02856789|Coagulo-lytic balance|coagulo-lytic balance
113363|NCT02856789|Normal range|normal range
113364|NCT02856776|Vitamin D|vitamin d
113365|NCT02856776|Metabolomics|metabolomics
113366|NCT02856776|Microbiota|microbiota
113367|NCT02856776|Gene Expression|gene expression
113368|NCT02856711|Group Prenatal Visits,CenteringPregnancy|group prenatal visits,centeringpregnancy
113369|NCT02856698|Acute heart failure|acute heart failure
113370|NCT02856698|morphine|morphine
113371|NCT02856698|midazolam|midazolam
113372|NCT02856698|in-hospital mortality|in-hospital mortality
113373|NCT02856672|Laryngeal Tube Supreme Laryngeal Mask Airway Leak Pressure|laryngeal tube supreme laryngeal mask airway leak pressure
113374|NCT02856620|cardiac mechanics|cardiac mechanics
113375|NCT02856620|circulating biomarkers|circulating biomarkers
113376|NCT02856620|frailty|frailty
113377|NCT02856542|Psoriasis vulgaris, scalp, topical, applicator, device|psoriasis vulgaris, scalp, topical, applicator, device
113378|NCT02856503|DCIS|dcis
113379|NCT02856503|IBC|ibc
113380|NCT02856503|Breast Cancer|breast cancer
113381|NCT02856503|Invasive Breast Carcinoma|invasive breast carcinoma
113382|NCT02856503|High Grade Ductal Carcinoma in-situ|high grade ductal carcinoma in-situ
113383|NCT02856412|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
113384|NCT02856412|Exercise|exercise
113385|NCT02856412|Mindfulness|mindfulness
113386|NCT02856399|methadone|methadone
113387|NCT02856399|cancer pain|cancer pain
113388|NCT02856399|long term effect|long term effect
113389|NCT02856373|Denervation|denervation
113390|NCT02856373|Renal Artery|renal artery
113391|NCT02856360|Football|football
113392|NCT02856360|Cleats|cleats
113393|NCT02856360|Stiffness|stiffness
113394|NCT02856347|Medullary Thyroid Cancer|medullary thyroid cancer
113395|NCT02856347|PET F-DOPA|pet f-dopa
113396|NCT02856347|18-FDOPA|18-fdopa
113397|NCT02856334|chronic pelvic pain|chronic pelvic pain
113398|NCT02856334|vulvodynia|vulvodynia
113399|NCT02856334|pelvic pain|pelvic pain
113400|NCT02856334|psychosocial factors|psychosocial factors
113401|NCT02856334|central sensitization|central sensitization
113402|NCT02856295|postpartum venous thromboembolism|postpartum venous thromboembolism
113403|NCT02856295|prophylactic dose of low molecular weight heparin|prophylactic dose of low molecular weight heparin
113404|NCT02856295|anti 10a|anti 10a
113405|NCT02856269|Zinc|zinc
113406|NCT02856256|Energy drink|energy drink
113407|NCT02856256|Choroid|choroid
113408|NCT02856230|Critical limb ischemia|critical limb ischemia
113409|NCT02856230|bellow-the-knee angioplasty|bellow-the-knee angioplasty
113410|NCT02856230|drug-eluting balloon|drug-eluting balloon
113411|NCT02856165|infant|infant
113412|NCT02856165|oxygen therapy|oxygen therapy
113413|NCT02856165|High flow nasal canula oxygen therapy|high flow nasal canula oxygen therapy
113414|NCT02856165|Bronchiolitis|bronchiolitis
113415|NCT02856152|Healthy Volunteer|healthy volunteer
113416|NCT02856139|ultra-widefield fluorescein angiography|ultra-widefield fluorescein angiography
113417|NCT02856139|peripheral retina|peripheral retina
113418|NCT02856139|normal eyes|normal eyes
113419|NCT02856126|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
113420|NCT02856126|Transarterial Chemoembolization|transarterial chemoembolization
113421|NCT02856113|Drug therapy|drug therapy
113422|NCT02856087|acute pain|acute pain
113423|NCT02856087|postoperative|postoperative
113424|NCT02856087|surgery|surgery
113425|NCT02856048|GnRH agonist|gnrh agonist
113426|NCT02856048|Ovarian reserve|ovarian reserve
113427|NCT02856048|Fertility Preservation|fertility preservation
113428|NCT02856048|Alkylating Agents|alkylating agents
113429|NCT02856035|chronic stroke|chronic stroke
113430|NCT02856035|functional MRI|functional mri
113431|NCT02856035|functional NIRS|functional nirs
113432|NCT02856035|motor learning|motor learning
113433|NCT02856035|FES|fes
113434|NCT02856035|upper extremity|upper extremity
113435|NCT02856035|neural feedback|neural feedback
113436|NCT02856035|arm/hand functional training|arm/hand functional training
113437|NCT02856022|electrical ilioinguinal nerve stimulation|electrical ilioinguinal nerve stimulation
113438|NCT02856022|bladder pain syndrome|bladder pain syndrome
113439|NCT02856022|intravesical irrigation|intravesical irrigation
113440|NCT02855996|fatherhood|fatherhood
113441|NCT02855996|father involvement|father involvement
113442|NCT02855996|economic stability|economic stability
113443|NCT02855996|co-parenting|co-parenting
113444|NCT02855996|healthy relationships|healthy relationships
113445|NCT02855996|father-child engagement|father-child engagement
113446|NCT02855957|Alpha-Hemoglobin Stabilizing Protein|alpha-hemoglobin stabilizing protein
113447|NCT02855957|alpha-Hb pool|alpha-hb pool
113448|NCT02855957|thalassemias|thalassemias
113449|NCT02855957|diagnostic method|diagnostic method
113450|NCT02855957|biomarker|biomarker
113451|NCT02855944|ovarian cancer|ovarian cancer
113452|NCT02855944|fallopian tube cancer|fallopian tube cancer
113453|NCT02855944|primary peritoneal cancer|primary peritoneal cancer
113454|NCT02855944|peritoneal cancer|peritoneal cancer
113455|NCT02855944|platinum sensitive|platinum sensitive
113456|NCT02855944|relapsed disease|relapsed disease
113457|NCT02855944|PARP Inhibitor|parp inhibitor
113458|NCT02855944|PARP|parp
113459|NCT02855944|rucaparib|rucaparib
113460|NCT02855944|ruca|ruca
113461|NCT02855944|homologous recombination|homologous recombination
113462|NCT02855944|homologous recombination deficiency|homologous recombination deficiency
113463|NCT02855944|genomic scarring|genomic scarring
113464|NCT02855944|loss of heterozygosity|loss of heterozygosity
113465|NCT02855944|CO-338|co-338
113466|NCT02855944|PF-01367338|pf-01367338
113467|NCT02855944|PF 01367338|pf 01367338
113468|NCT02855944|CO-338-043|co-338-043
113469|NCT02855944|platinum sensitive ovarian cancer|platinum sensitive ovarian cancer
113470|NCT02855944|platinum sensitive fallopian tube cancer|platinum sensitive fallopian tube cancer
113471|NCT02855944|platinum sensitive primary peritoneal cancer|platinum sensitive primary peritoneal cancer
113472|NCT02855944|platinum sensitive peritoneal cancer|platinum sensitive peritoneal cancer
113473|NCT02855944|gynecological cancer|gynecological cancer
113474|NCT02855944|Clovis|clovis
113475|NCT02855944|Clovis oncology|clovis oncology
113476|NCT02855944|ARIEL2|ariel2
113477|NCT02855944|ARIEL 2|ariel 2
113478|NCT02855944|ARIEL-2|ariel-2
113479|NCT02855944|ARIEL-3|ariel-3
113480|NCT02855944|ARIEL 3|ariel 3
113481|NCT02855944|ARIEL3|ariel3
113482|NCT02855944|ARIEL4|ariel4
113483|NCT02855944|ARIEL-4|ariel-4
113484|NCT02855944|ARIEL 4|ariel 4
113485|NCT02855944|A4|a4
113486|NCT02855944|advanced OC|advanced oc
113487|NCT02855944|platinum resistant ovarian cancer|platinum resistant ovarian cancer
113488|NCT02855944|platinum resistant primary ovarian cancer|platinum resistant primary ovarian cancer
113489|NCT02855944|Rubraca|rubraca
113490|NCT02855944|High grade serous|high grade serous
113491|NCT02855944|Partially platinum sensitive|partially platinum sensitive
113492|NCT02855918|Psychiatry|psychiatry
113493|NCT02855918|Depressive disorder|depressive disorder
113494|NCT02855918|Suicidal behavior|suicidal behavior
113495|NCT02855918|Genetics|genetics
113496|NCT02855905|Exercise|exercise
113497|NCT02855905|Cold Temperature|cold temperature
113498|NCT02855892|GV1001|gv1001
113499|NCT02855892|BPH|bph
113500|NCT02855892|Benign prostatic hyperplasia|benign prostatic hyperplasia
113501|NCT02855788|gastric cancer|gastric cancer
113502|NCT02855788|gastroesophageal cancer|gastroesophageal cancer
113503|NCT02855788|metastatic|metastatic
113504|NCT02855788|advanced|advanced
113505|NCT02855736|Suicidal inpatients|suicidal inpatients
113506|NCT02855736|Positive Psychology|positive psychology
113507|NCT02855736|Gratitude|gratitude
113508|NCT02855736|Psychological pain|psychological pain
113509|NCT02855723|Squamous carcinoma of oral cavity and oropharynx|squamous carcinoma of oral cavity and oropharynx
113510|NCT02855723|Sentinel lymph node|sentinel lymph node
113511|NCT02855723|Lymph node dissection|lymph node dissection
113512|NCT02855723|Equivalence|equivalence
113513|NCT02855671|microcirculation|microcirculation
113514|NCT02855671|thermal|thermal
113515|NCT02855671|temperature|temperature
113516|NCT02855658|Sjögren's syndrome|sjögren's syndrome
113517|NCT02855658|Gan-Lu-Yin|gan-lu-yin
113518|NCT02855658|Sang-Ju-Yin|sang-ju-yin
113519|NCT02855658|Xuefu-Zhuyu-Decoction|xuefu-zhuyu-decoction
113520|NCT02855658|Oxidative stress|oxidative stress
113521|NCT02855658|Immune regulation|immune regulation
113522|NCT02855658|Gene modulation|gene modulation
113523|NCT02855658|SS-1|ss-1
113524|NCT02855645|Trichosanthes root|trichosanthes root
113525|NCT02855645|Traditional Chinese Medicine|traditional chinese medicine
113526|NCT02855645|Clinical trial|clinical trial
113527|NCT02855632|G-CSF|g-csf
113528|NCT02855632|adhesion reformation|adhesion reformation
113529|NCT02855632|Asherman syndrome|asherman syndrome
113530|NCT02855619|inspiratory muscles training programs|inspiratory muscles training programs
113531|NCT02855619|Ventilator-induced diaphragmatic dysfunction|ventilator-induced diaphragmatic dysfunction
113532|NCT02855619|Weaning|weaning
113533|NCT02855619|Intensive care unit|intensive care unit
113534|NCT02855606|Oral PrEP|oral prep
113535|NCT02855606|TGW|tgw
113536|NCT02855606|Thai MSM|thai msm
113537|NCT02855593|acupuncture|acupuncture
113538|NCT02855580|Pharmacogenomic|pharmacogenomic
113539|NCT02855580|child|child
113540|NCT02855580|psychiatry|psychiatry
113541|NCT02855580|Obsessive Compulsive Disorder|obsessive compulsive disorder
113542|NCT02855580|Depression|depression
113543|NCT02855580|Anxiety|anxiety
113544|NCT02855580|CYP2D6|cyp2d6
113545|NCT02855580|CYP2C19|cyp2c19
113546|NCT02855580|Selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
113547|NCT02855580|SSRI|ssri
113548|NCT02855567|surgery|surgery
113549|NCT02855567|acupuncture|acupuncture
113550|NCT02855567|gynecology|gynecology
113551|NCT02855567|pain|pain
113552|NCT02855567|narcotics|narcotics
113553|NCT02855554|myocardial tissue characterization|myocardial tissue characterization
113554|NCT02855541|Blood Glucose|blood glucose
113555|NCT02855541|Physical Fitness|physical fitness
113556|NCT02855541|Body Composition|body composition
113557|NCT02855541|Lipids|lipids
113558|NCT02855528|Tin Filter|tin filter
113559|NCT02855528|Coronary Artery Calcium Scoring|coronary artery calcium scoring
113560|NCT02855528|Radiation dose reduction|radiation dose reduction
113561|NCT02855515|drug-induced sleep endoscopy|drug-induced sleep endoscopy
113562|NCT02855515|obstructive sleep apnoea|obstructive sleep apnoea
113563|NCT02855515|VOTE classification|vote classification
113564|NCT02855515|AHI|ahi
113565|NCT02855515|BMI|bmi
113566|NCT02855489|Condom Use|condom use
113567|NCT02855489|HIV/STD|hiv/std
113568|NCT02855489|Intervention|intervention
113569|NCT02855489|Theory of Planned Behavior|theory of planned behavior
113570|NCT02855489|Dismantling Study Design|dismantling study design
113571|NCT02855463|Giant virus|giant virus
113572|NCT02855463|Amoeba|amoeba
113573|NCT02855424|stroke|stroke
113574|NCT02855424|exercise capacity|exercise capacity
113575|NCT02855385|Rectal bleeding, , ,|rectal bleeding, , ,
113576|NCT02855385|Attitude|attitude
113577|NCT02855385|Health seeking behaviour|health seeking behaviour
113578|NCT02855385|Nigeria|nigeria
113579|NCT02855385|Screening|screening
113580|NCT02855385|high risk patients|high risk patients
113581|NCT02855359|Antibodies, Monoclonal|antibodies, monoclonal
113582|NCT02855359|SGN-19A|sgn-19a
113583|NCT02855359|Denintuzumab Mafodotin|denintuzumab mafodotin
113584|NCT02855359|DLBCL|dlbcl
113585|NCT02855359|Antibody-Drug Conjugate|antibody-drug conjugate
113586|NCT02855359|Antigens, CD19|antigens, cd19
113587|NCT02855359|Hematologic Diseases|hematologic diseases
113588|NCT02855359|Immune System Diseases|immune system diseases
113589|NCT02855359|Immunoproliferative Disorders|immunoproliferative disorders
113590|NCT02855359|Immunotherapy|immunotherapy
113591|NCT02855359|Lymphatic Diseases|lymphatic diseases
113592|NCT02855359|Lymphoma|lymphoma
113593|NCT02855359|Lymphoma, B-Cell|lymphoma, b-cell
113594|NCT02855359|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
113595|NCT02855359|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
113596|NCT02855359|Monomethyl auristatin F|monomethyl auristatin f
113597|NCT02855359|Neoplasms|neoplasms
113598|NCT02855359|Neoplasms by Histologic Type|neoplasms by histologic type
113599|NCT02855359|Transformed Lymphoma / DLBCL|transformed lymphoma / dlbcl
113600|NCT02855359|Cyclophosphamide|cyclophosphamide
113601|NCT02855359|Doxorubicin|doxorubicin
113602|NCT02855359|Liposomal doxorubicin|liposomal doxorubicin
113603|NCT02855359|Prednisone|prednisone
113604|NCT02855359|Rituximab|rituximab
113605|NCT02855359|Vincristine|vincristine
113606|NCT02855359|Alkylating Agents|alkylating agents
113607|NCT02855359|Anti-Inflammatory Agents|anti-inflammatory agents
113608|NCT02855359|Antibiotic, Antineoplastic|antibiotic, antineoplastic
113609|NCT02855359|Antimitotic Agents|antimitotic agents
113610|NCT02855359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
113611|NCT02855359|Antineoplastic Agents|antineoplastic agents
113612|NCT02855359|Phytogenic Antirheumatic Agents|phytogenic antirheumatic agents
113613|NCT02855359|Glucocorticoids|glucocorticoids
113614|NCT02855359|Drug Therapy|drug therapy
113615|NCT02855359|Follicular Lymphoma Grade 3b|follicular lymphoma grade 3b
113616|NCT02855359|immunosuppressive agents|immunosuppressive agents
113617|NCT02855333|Merendino procedure|merendino procedure
113618|NCT02855333|Feasibility, Safety and QoL of the Merendino procedure|feasibility, safety and qol of the merendino procedure
113619|NCT02855320|Biologics safety|biologics safety
113620|NCT02855320|Rheumatoid arthritis|rheumatoid arthritis
113621|NCT02855320|Spondyloarthritis|spondyloarthritis
113622|NCT02855320|patient education|patient education
113623|NCT02855320|self-management|self-management
113624|NCT02855307|Closed-loop system|closed-loop system
113625|NCT02855307|Artificial pancreas|artificial pancreas
113626|NCT02855307|Exercise|exercise
113627|NCT02855307|Hypoglycemia|hypoglycemia
113628|NCT02855307|Insulin|insulin
113629|NCT02855307|Type 1 diabetes|type 1 diabetes
113630|NCT02855294|oral contraceptive pills|oral contraceptive pills
113631|NCT02855294|Joint stability|joint stability
113632|NCT02855268|Kidney disease|kidney disease
113633|NCT02855268|Nephritis|nephritis
113634|NCT02855268|Hereditary nephritis|hereditary nephritis
113635|NCT02855268|Hereditary kidney disease|hereditary kidney disease
113636|NCT02855229|Translational|translational
113637|NCT02855229|Electrophysiology|electrophysiology
113638|NCT02855216|Physiotherapy|physiotherapy
113639|NCT02855216|Range of motion|range of motion
113640|NCT02855216|Inhibition sub-occipital techniques|inhibition sub-occipital techniques
113641|NCT02855190|Ga68-citrate|ga68-citrate
113643|NCT02855190|PET/MR and PET/CT|pet/mr and pet/ct
113644|NCT02855190|Periprosthetic joint infection|periprosthetic joint infection
113645|NCT02855177|Hyperlipidemia|hyperlipidemia
113646|NCT02855164|LJN452|ljn452
113647|NCT02855164|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
113648|NCT02855164|NASH|nash
113649|NCT02855164|phase 2|phase 2
113650|NCT02855164|adaptive design|adaptive design
113651|NCT02855164|randomized|randomized
113652|NCT02855151|EUS|eus
113653|NCT02855138|isotretinoin|isotretinoin
113654|NCT02855138|PCOS|pcos
113655|NCT02855138|acne vulgaris|acne vulgaris
113656|NCT02855125|NSCLC|nsclc
113657|NCT02855125|phase 2 study|phase 2 study
113658|NCT02855125|TAS-114|tas-114
113659|NCT02855125|S-1|s-1
113660|NCT02855073|adipose-derived mesenchymal progenitor cells|adipose-derived mesenchymal progenitor cells
113661|NCT02855073|Artz|artz
113662|NCT02855034|child and infant|child and infant
113663|NCT02855034|Blood samples|blood samples
113664|NCT02855021|Dementia|dementia
113665|NCT02855021|Cerebral metabolism|cerebral metabolism
113666|NCT02855021|PET scan|pet scan
113667|NCT02855008|Social Problem-Solving|social problem-solving
113668|NCT02855008|Intellectual Disability|intellectual disability
113669|NCT02855008|Problem Behaviors|problem behaviors
113670|NCT02855008|Community based intervention|community based intervention
113671|NCT02855008|Prevention|prevention
113672|NCT02854956|phenotype|phenotype
113673|NCT02854956|X-linked mental retardation|x-linked mental retardation
113674|NCT02854956|neuronal networks|neuronal networks
113675|NCT02854956|cognitive processes|cognitive processes
113676|NCT02854930|Clinical death|clinical death
113677|NCT02854930|state of consciousness|state of consciousness
113678|NCT02854904|Immunomodulatory|immunomodulatory
113679|NCT02854904|dexmedetomidine|dexmedetomidine
113680|NCT02854904|anesthesia|anesthesia
113681|NCT02854904|alpha-2 agonist|alpha-2 agonist
113682|NCT02854904|arthrodesis|arthrodesis
113683|NCT02854904|spinal fusion|spinal fusion
113684|NCT02854904|Immune effect|immune effect
113685|NCT02854904|double randomized clinical trials|double randomized clinical trials
113686|NCT02854891|Effects|effects
113687|NCT02854891|Heat|heat
113688|NCT02854891|Light|light
113689|NCT02854826|Frail Older Adults, Interprofessional Team|frail older adults, interprofessional team
113690|NCT02854813|overactive bladder|overactive bladder
113691|NCT02854813|coronary artery disease|coronary artery disease
113692|NCT02854813|gensini score|gensini score
113693|NCT02854800|varenicline|varenicline
113694|NCT02854800|buprenorphine|buprenorphine
113695|NCT02854787|Spinal anesthesia|spinal anesthesia
113696|NCT02854787|cesarean|cesarean
113697|NCT02854787|blood pressure|blood pressure
113698|NCT02854787|Norepinephrine|norepinephrine
113699|NCT02854787|Phenylephrine|phenylephrine
113700|NCT02854735|Head and Neck Neoplasms|head and neck neoplasms
113701|NCT02854735|Total body composition|total body composition
113702|NCT02854735|Dual-Energy X-Ray Absorptiometry|dual-energy x-ray absorptiometry
113703|NCT02854735|Malnutrition|malnutrition
113704|NCT02854735|Muscle quantification|muscle quantification
113705|NCT02854722|deferasirox|deferasirox
113706|NCT02854722|iron accumulation|iron accumulation
113707|NCT02854696|Islet cell Transplantation|islet cell transplantation
113708|NCT02854696|cost-effectiveness analysis|cost-effectiveness analysis
113709|NCT02854696|Cost-utility analysis|cost-utility analysis
113710|NCT02854696|Type 1 Diabetes|type 1 diabetes
113711|NCT02854683|Chronic Fatigue Syndrome (CFS)|chronic fatigue syndrome (cfs)
113712|NCT02854683|Myalgic Encephalomyelitis (ME)|myalgic encephalomyelitis (me)
113713|NCT02854683|Postural Tachycardia Syndrome (POTS)|postural tachycardia syndrome (pots)
113714|NCT02854683|Neurally Mediated Syncope (NMS)|neurally mediated syncope (nms)
113715|NCT02854683|Systemic Exertion Intolerance Disease (SEID)|systemic exertion intolerance disease (seid)
113716|NCT02854683|Orthostatic Intolerance (OI)|orthostatic intolerance (oi)
113717|NCT02854683|Oral Rehydration Solution (ORS)|oral rehydration solution (ors)
113718|NCT02854683|Lower Body Negative Pressure (LBNP)|lower body negative pressure (lbnp)
113719|NCT02854670|capsaicin|capsaicin
113720|NCT02854670|pain improvement|pain improvement
113721|NCT02854670|provoked vulvodynia|provoked vulvodynia
113722|NCT02854657|melanoma|melanoma
113723|NCT02854657|skin self-examination|skin self-examination
113724|NCT02854631|Cirrhosis|cirrhosis
113725|NCT02854631|Prednisone|prednisone
113726|NCT02854631|Jaundice|jaundice
113727|NCT02854605|Non-alcoholic fatty liver disease (NAFLD)|non-alcoholic fatty liver disease (nafld)
113728|NCT02854605|Fibrosis|fibrosis
113729|NCT02854605|GS-9674|gs-9674
113730|NCT02854592|rtPA|rtpa
113731|NCT02854592|urokinase|urokinase
113732|NCT02854579|Hypoxic-Ischemic Encephalopathy|hypoxic-ischemic encephalopathy
113733|NCT02854579|progenitor cell|progenitor cell
113734|NCT02854579|paracrine factor|paracrine factor
113735|NCT02854579|adipose mesenchymal stem cell|adipose mesenchymal stem cell
113736|NCT02854579|neonate|neonate
113737|NCT02854566|periprosthetic fracture of the femur|periprosthetic fracture of the femur
113738|NCT02854566|hip prosthesis|hip prosthesis
113739|NCT02854540|hyperhidrosis|hyperhidrosis
113740|NCT02854540|palmar|palmar
113741|NCT02854540|sweating|sweating
113742|NCT02854540|iontophoresis|iontophoresis
113743|NCT02854540|sweat gland diseases|sweat gland diseases
113744|NCT02854540|skin diseases|skin diseases
113745|NCT02854514|endometrial -cytokines|endometrial -cytokines
113746|NCT02854501|Homocysteine|homocysteine
113747|NCT02854501|Preeclampsia|preeclampsia
113748|NCT02854501|poor placentation|poor placentation
113749|NCT02854475|skin parameters|skin parameters
113750|NCT02854475|cholesterol|cholesterol
113751|NCT02854475|Raman spectroscopy|raman spectroscopy
113752|NCT02854462|Language Development|language development
113753|NCT02854462|Shared Picture Book reading|shared picture book reading
113754|NCT02854462|Preschoolers|preschoolers
113755|NCT02854462|Inference making|inference making
113756|NCT02854449|Immune Marker|immune marker
113757|NCT02854449|Immunologic Marker|immunologic marker
113758|NCT02854449|Radiotherapy|radiotherapy
113759|NCT02854449|Dose Hypofractionation|dose hypofractionation
113760|NCT02854436|Prostate cancer|prostate cancer
113761|NCT02854436|CRPC|crpc
113762|NCT02854436|Metastatic castrate-resistant prostate cancer|metastatic castrate-resistant prostate cancer
113763|NCT02854436|Prostate neoplasm|prostate neoplasm
113764|NCT02854436|Galahad|galahad
113765|NCT02854436|Niraparib|niraparib
113766|NCT02854436|DNA anomalies|dna anomalies
113767|NCT02854436|DNA defect|dna defect
113768|NCT02854436|PARP inhibitor|parp inhibitor
113769|NCT02854436|PARPi|parpi
113770|NCT02854410|dietary sodium nitrate|dietary sodium nitrate
113771|NCT02854410|radiotherapy|radiotherapy
113772|NCT02854410|nasopharyngeal carcinoma|nasopharyngeal carcinoma
113773|NCT02854384|Epilepsy|epilepsy
113774|NCT02854384|Mobile phone|mobile phone
113775|NCT02854371|gadoxetic acid|gadoxetic acid
113776|NCT02854371|T1 map|t1 map
113777|NCT02854371|MRI|mri
113778|NCT02854345|CZT camera|czt camera
113779|NCT02854345|pinhole|pinhole
113780|NCT02854332|Pain|pain
113781|NCT02854332|Analgesic|analgesic
113782|NCT02854332|Stimulation|stimulation
113783|NCT02854332|Motor Cortex|motor cortex
113784|NCT02854306|Bariatric surgery|bariatric surgery
113785|NCT02854306|Mindfulness|mindfulness
113786|NCT02854306|Obese|obese
113787|NCT02854293|palliative care|palliative care
113788|NCT02854293|cancer|cancer
113789|NCT02854293|quality of life|quality of life
113790|NCT02854280|Hypoxia|hypoxia
113791|NCT02854280|Brain|brain
113792|NCT02854280|Effort|effort
113793|NCT02854267|organ procurement|organ procurement
113794|NCT02854267|brain death|brain death
113795|NCT02854267|organ donation|organ donation
113796|NCT02854267|next of kins|next of kins
113797|NCT02854254|phlebitis|phlebitis
113798|NCT02854254|catheter|catheter
113799|NCT02854254|congestive heart failure|congestive heart failure
113800|NCT02854254|dobutamine|dobutamine
113801|NCT02854241|MRI|mri
113802|NCT02854241|HCC|hcc
113803|NCT02854241|surveillance|surveillance
113804|NCT02854228|Pituitary tumor|pituitary tumor
113805|NCT02854228|pituitary carcinoma|pituitary carcinoma
113806|NCT02854228|acromegaly|acromegaly
113807|NCT02854228|cushing|cushing
113808|NCT02854228|prolactinoma|prolactinoma
113809|NCT02854163|Secukinumab|secukinumab
113810|NCT02854163|Neutrophils|neutrophils
113811|NCT02854163|Vitamin D|vitamin d
113812|NCT02854124|Melanoma|melanoma
113813|NCT02854124|Dissemination|dissemination
113814|NCT02854124|Initiating stem cells|initiating stem cells
113815|NCT02854098|BHJS, constipation|bhjs, constipation
113816|NCT02854085|Prevention of Cognitive Decline|prevention of cognitive decline
113817|NCT02854085|Art Therapy|art therapy
113818|NCT02854085|Music Reminiscence Activity|music reminiscence activity
113819|NCT02854085|Elderly|elderly
113820|NCT02854072|GV1001|gv1001
113821|NCT02854059|Asymptomatic antibody-mediated TTP|asymptomatic antibody-mediated ttp
113822|NCT02854046|calcific uremic arteriolopathy|calcific uremic arteriolopathy
113823|NCT02854046|case-control study|case-control study
113824|NCT02854046|cohort study|cohort study
113825|NCT02854033|amyloid|amyloid
113826|NCT02854033|plaques|plaques
113827|NCT02854033|neuroimaging|neuroimaging
113828|NCT02854033|biomarkers|biomarkers
113829|NCT02854033|cognition disorder|cognition disorder
113830|NCT02854033|early detection|early detection
113831|NCT02854033|pre-dementia|pre-dementia
113832|NCT02854033|dementia|dementia
113833|NCT02854033|Alzheimer's disease|alzheimer's disease
113834|NCT02854033|tau|tau
113835|NCT02854020|Aircraft|aircraft
113836|NCT02854020|Emergency|emergency
113837|NCT02854020|First aid|first aid
113838|NCT02854020|Cabin crew|cabin crew
113839|NCT02854020|Burn|burn
113840|NCT02854020|Cardiac arrest|cardiac arrest
113841|NCT02854007|Coronary artery disease|coronary artery disease
113842|NCT02854007|Angioplasty|angioplasty
113843|NCT02854007|Bioresorbable coronary device|bioresorbable coronary device
113844|NCT02854007|QALY (Quality-Adjusted Life Years)|qaly (quality-adjusted life years)
113845|NCT02853994|DCB|dcb
113846|NCT02853994|DEB|deb
113847|NCT02853994|Sirolimus|sirolimus
113848|NCT02853994|PCI|pci
113849|NCT02853994|ISR|isr
113850|NCT02853994|SVD|svd
113851|NCT02853994|Restenosis|restenosis
113852|NCT02853994|Bifurcation|bifurcation
113853|NCT02853994|CAD|cad
113854|NCT02853994|Coronary artery|coronary artery
113855|NCT02853968|Unlock the Cell|unlock the cell
113856|NCT02853968|Castleman's Disease|castleman's disease
113857|NCT02853968|CD|cd
113858|NCT02853968|Castleman Disease|castleman disease
113859|NCT02853968|MCD|mcd
113860|NCT02853968|iMCD|imcd
113861|NCT02853968|Angiofollicular Lymph Hyperplasia|angiofollicular lymph hyperplasia
113862|NCT02853968|multicentric Castleman's disease|multicentric castleman's disease
113863|NCT02853968|multicentric Castleman disease|multicentric castleman disease
113864|NCT02853968|idiopathic multicentric Castleman disease|idiopathic multicentric castleman disease
113865|NCT02853929|Pertussis|pertussis
113866|NCT02853929|Immunogenicity|immunogenicity
113867|NCT02853929|Poliomyelitis|poliomyelitis
113868|NCT02853929|Tetanus|tetanus
113869|NCT02853929|Hepatitis B|hepatitis b
113870|NCT02853929|Diptheria|diptheria
113871|NCT02853903|solid tumor|solid tumor
113872|NCT02853903|NK immunotherapy|nk immunotherapy
113873|NCT02853890|Birth|birth
113874|NCT02853890|obstetric analgesia|obstetric analgesia
113875|NCT02853890|obstetric anesthesia|obstetric anesthesia
113876|NCT02853864|Gender|gender
113877|NCT02853864|Propofol|propofol
113878|NCT02853864|Dexmedetomidine|dexmedetomidine
113879|NCT02853864|Interaction|interaction
113880|NCT02853851|Stress factors,|stress factors,
113881|NCT02853851|intensive care units,|intensive care units,
113882|NCT02853851|scale,|scale,
113883|NCT02853851|quality of care|quality of care
113884|NCT02853838|acute viral bronchiolitis|acute viral bronchiolitis
113885|NCT02853838|respiratory syncytial virus|respiratory syncytial virus
113886|NCT02853838|chest physiotherapy|chest physiotherapy
113887|NCT02853812|tinnitus|tinnitus
113888|NCT02853812|residual inhibition|residual inhibition
113889|NCT02853786|cochlear implant|cochlear implant
113890|NCT02853786|language environment|language environment
113891|NCT02853786|speech therapy assessment|speech therapy assessment
113892|NCT02853786|LENA technology|lena technology
113893|NCT02853773|sweeteners|sweeteners
113894|NCT02853773|sugar|sugar
113895|NCT02853773|EEG|eeg
113896|NCT02853773|food viewing|food viewing
113897|NCT02853773|food intake|food intake
113898|NCT02853747|arterial stiffness|arterial stiffness
113899|NCT02853747|retinal vessels|retinal vessels
113900|NCT02853747|physical activity|physical activity
113901|NCT02853747|children|children
113902|NCT02853708|E. coli|e. coli
113903|NCT02853708|extended-spectrum beta-lactamase|extended-spectrum beta-lactamase
113904|NCT02853708|molecular epidemiology|molecular epidemiology
113905|NCT02853708|risk factors|risk factors
113906|NCT02853695|Hysteroscopy|hysteroscopy
113907|NCT02853695|Diffusion|diffusion
113908|NCT02853695|Implementation|implementation
113909|NCT02853695|Diagnostic hysteroscopy|diagnostic hysteroscopy
113910|NCT02853695|Operative hysteroscopy|operative hysteroscopy
113911|NCT02853682|glycocalyx|glycocalyx
113912|NCT02853682|capillary leak syndrome|capillary leak syndrome
113913|NCT02853656|preterm birth|preterm birth
113914|NCT02853656|gestation|gestation
113915|NCT02853617|S. pneumoniae|s. pneumoniae
113916|NCT02853617|N. meningitidis|n. meningitidis
113917|NCT02853617|H. influenza|h. influenza
113918|NCT02853617|B. pertussis|b. pertussis
113919|NCT02853617|C. tetani|c. tetani
113920|NCT02853617|MRSA|mrsa
113921|NCT02853591|laparoscopy|laparoscopy
113922|NCT02853591|hysterectomy|hysterectomy
113923|NCT02853500|Liver Cancer|liver cancer
113924|NCT02853487|Cluster headache|cluster headache
113925|NCT02853487|actigraphy|actigraphy
113926|NCT02853487|circadian rhythm|circadian rhythm
113927|NCT02853461|biofilm|biofilm
113928|NCT02853461|periprosthetic joint infection|periprosthetic joint infection
113929|NCT02853461|hip|hip
113930|NCT02853461|endoprothesis|endoprothesis
113931|NCT02853461|ceramic|ceramic
113932|NCT02853461|bearing components|bearing components
113933|NCT02853461|sonication|sonication
113934|NCT02853461|low grade infection|low grade infection
113935|NCT02853461|joint aspiration|joint aspiration
113936|NCT02853448|Plasma|plasma
113937|NCT02853448|Serum|serum
113938|NCT02853448|Effective Blood Draws|effective blood draws
113939|NCT02853435|Cross-over|cross-over
113940|NCT02853435|Gepotidacin|gepotidacin
113941|NCT02853435|Pharmacokinetics|pharmacokinetics
113942|NCT02853435|Relative Bioavailability|relative bioavailability
113943|NCT02853435|non-compartmental PK analysis|non-compartmental pk analysis
113944|NCT02853435|High shear wet granulation|high shear wet granulation
113945|NCT02853396|internalised stigma|internalised stigma
113946|NCT02853396|self stigma|self stigma
113947|NCT02853396|inpatients|inpatients
113948|NCT02853396|CBT|cbt
113949|NCT02853396|Cognitive therapy|cognitive therapy
113950|NCT02853383|Chronic Obstructive Pulmonary Diseases, COPD|chronic obstructive pulmonary diseases, copd
113951|NCT02853357|Thoracic manipulation|thoracic manipulation
113952|NCT02853357|Low back pain|low back pain
113953|NCT02853357|Core strengthening|core strengthening
113954|NCT02853357|Thoracic spine thrust manipulation|thoracic spine thrust manipulation
113955|NCT02853344|PD1|pd1
113956|NCT02853344|PD-1|pd-1
113957|NCT02853344|PDL1|pdl1
113958|NCT02853344|PD-L1|pd-l1
113959|NCT02853331|PD1|pd1
113960|NCT02853331|PD-1|pd-1
113961|NCT02853331|PDL1|pdl1
113962|NCT02853331|PD-L1|pd-l1
113963|NCT02853331|VEGFR TKI|vegfr tki
113964|NCT02853305|PD1|pd1
113965|NCT02853305|PD-1|pd-1
113966|NCT02853305|PDL1|pdl1
113967|NCT02853305|PD-L1|pd-l1
113968|NCT02853266|Kawasaki disease|kawasaki disease
113969|NCT02853266|non-cruzi-related antibody (NCRA)|non-cruzi-related antibody (ncra)
113970|NCT02853253|Preterm neonates|preterm neonates
113971|NCT02853240|Cerebral palsy|cerebral palsy
113972|NCT02853240|children|children
113973|NCT02853240|muscle spasticity|muscle spasticity
113974|NCT02853240|botulinum toxin injection|botulinum toxin injection
113975|NCT02853227|Telemark score, reliability|telemark score, reliability
113976|NCT02853214|Dysglobulinemia|dysglobulinemia
113977|NCT02853214|Multiple Myeloma|multiple myeloma
113978|NCT02853214|MGUS|mgus
113979|NCT02853214|Waldenström|waldenström
113980|NCT02853214|genetic factors|genetic factors
113981|NCT02853214|Sequencing|sequencing
113982|NCT02853201|Extubation|extubation
113983|NCT02853201|Intercostal Muscles|intercostal muscles
113984|NCT02853201|Diaphragm|diaphragm
113985|NCT02853201|Sternocleidomastoid Muscle|sternocleidomastoid muscle
113986|NCT02853162|Stereotactic body radiotherapy|stereotactic body radiotherapy
113987|NCT02853162|MRI|mri
113988|NCT02853162|Renal cell carcinoma|renal cell carcinoma
113989|NCT02853149|Spinal Cord Injury|spinal cord injury
113990|NCT02853149|disability|disability
113991|NCT02853149|obesity|obesity
113992|NCT02853149|cardiometabolic|cardiometabolic
113993|NCT02853149|Caregiver|caregiver
113994|NCT02853110|MRI, stereotactic body radiotherapy, hypofractionation|mri, stereotactic body radiotherapy, hypofractionation
113995|NCT02853084|Auto-inflammatory diseases|auto-inflammatory diseases
113996|NCT02853084|IL-1 inhibitors|il-1 inhibitors
113997|NCT02853084|HL2351|hl2351
113998|NCT02853084|Cryopyrin‑Associated Periodic Syndromes (CAPS)|cryopyrin‑associated periodic syndromes (caps)
113999|NCT02853084|Neonatal Onset Multisystem Inflammatory Disease (NOMID)|neonatal onset multisystem inflammatory disease (nomid)
114000|NCT02853084|Muckle-Wells Syndrome (MWS)|muckle-wells syndrome (mws)
114001|NCT02853084|Familial Cold Autoinflammatory Syndrome (FCAS)|familial cold autoinflammatory syndrome (fcas)
114002|NCT02853058|stillbirth|stillbirth
114003|NCT02853058|hemorrhage|hemorrhage
114004|NCT02853019|Emotion|emotion
114005|NCT02853019|motivation|motivation
114006|NCT02853019|cognition|cognition
114007|NCT02853019|schizophrenia|schizophrenia
114008|NCT02853006|Cancer lung|cancer lung
114009|NCT02853006|Fluids|fluids
114010|NCT02853006|LungCancerTest|lungcancertest
114011|NCT02853006|radiological anomalies|radiological anomalies
114012|NCT02853006|non-cancerous|non-cancerous
114013|NCT02853006|carriers|carriers
114014|NCT02853006|Patient reference|patient reference
114015|NCT02852993|Erythrocyte Transfusion|erythrocyte transfusion
114016|NCT02852993|Survival|survival
114017|NCT02852967|Skin Diseases|skin diseases
114018|NCT02852967|Auto-Immune Diseases|auto-immune diseases
114019|NCT02852967|Plaque|plaque
114020|NCT02852967|Dermatology|dermatology
114021|NCT02852954|Progesterone Induced Blocking Factor|progesterone induced blocking factor
114022|NCT02852954|Endometrial Cancer|endometrial cancer
114023|NCT02852941|Impedance|impedance
114024|NCT02852941|Kidney Transplantation|kidney transplantation
114025|NCT02852928|ILD; chILD|ild; child
114026|NCT02852915|Colonic Neoplasms|colonic neoplasms
114027|NCT02852915|Laparoscopic Surgery|laparoscopic surgery
114028|NCT02852915|T4|t4
114029|NCT02852902|Bloodstream infections caused by MDR Enterobacteriaceae|bloodstream infections caused by mdr enterobacteriaceae
114030|NCT02852902|Extended-spectrum β-lactamase-producers|extended-spectrum β-lactamase-producers
114031|NCT02852902|Carbapenemase-producing organisms|carbapenemase-producing organisms
114032|NCT02852902|Solid Organ Transplantation|solid organ transplantation
114033|NCT02852902|Multidrug-resistant Enterobacteriaceae|multidrug-resistant enterobacteriaceae
114034|NCT02852902|Anti-Infective Agents|anti-infective agents
114035|NCT02852889|internal jugular vein distensibility,haemodynamics|internal jugular vein distensibility,haemodynamics
114036|NCT02852876|Safety of ASP2151|safety of asp2151
114037|NCT02852876|Phase 1|phase 1
114038|NCT02852876|Pharmacokinetics|pharmacokinetics
114039|NCT02852876|Healthy male subjects|healthy male subjects
114040|NCT02852876|Tolerability|tolerability
114041|NCT02852876|Food effect of ASP2151|food effect of asp2151
114042|NCT02852811|Climacteric|climacteric
114043|NCT02852811|Education|education
114044|NCT02852811|Mental health|mental health
114045|NCT02852811|Menopause|menopause
114046|NCT02852772|Cognitive impairment|cognitive impairment
114047|NCT02852772|HIV|hiv
114048|NCT02852772|Microalbuminuria|microalbuminuria
114049|NCT02852772|Chronic kidney disease|chronic kidney disease
114050|NCT02852720|Pharmacokinetics|pharmacokinetics
114051|NCT02852720|levobupivacaine|levobupivacaine
114052|NCT02852720|Pregnancy|pregnancy
114053|NCT02852720|Cesarean section|cesarean section
114054|NCT02852720|Electrocardiography|electrocardiography
114055|NCT02852668|elderly|elderly
114056|NCT02852668|strength training|strength training
114057|NCT02852668|power training|power training
114058|NCT02852668|functional capacity|functional capacity
114059|NCT02852668|gait biomechanics|gait biomechanics
114060|NCT02852655|Brain Tumor|brain tumor
114061|NCT02852642|power training|power training
114062|NCT02852642|plyometric training|plyometric training
114063|NCT02852642|functional capacity|functional capacity
114064|NCT02852629|decision-support sheet|decision-support sheet
114065|NCT02852616|Course|course
114066|NCT02852616|Posttraumatic Stress Disorder|posttraumatic stress disorder
114067|NCT02852616|Narrative Exposure Therapy|narrative exposure therapy
114068|NCT02852603|dissection|dissection
114069|NCT02852603|aneurysm|aneurysm
114070|NCT02852603|thoracic aorta|thoracic aorta
114071|NCT02852590|Observational|observational
114072|NCT02852590|Pediatric|pediatric
114073|NCT02852590|Off-Label Use|off-label use
114074|NCT02852590|Unlicensed drug use|unlicensed drug use
114075|NCT02852590|Adverse Drug Reaction|adverse drug reaction
114076|NCT02852590|Hospitalized Children|hospitalized children
114077|NCT02852590|Pediatric inpatients|pediatric inpatients
114078|NCT02852577|panic disorder|panic disorder
114079|NCT02852577|agoraphobia|agoraphobia
114080|NCT02852577|clonazepam|clonazepam
114081|NCT02852577|paroxetine|paroxetine
114082|NCT02852564|Non-Muscle|non-muscle
114083|NCT02852564|Invasive|invasive
114084|NCT02852564|Bladder|bladder
114085|NCT02852564|Cancer|cancer
114086|NCT02852564|Muscle|muscle
114087|NCT02852564|Surgery|surgery
114088|NCT02852564|Transurethral|transurethral
114089|NCT02852564|Resection|resection
114090|NCT02852564|Tumor|tumor
114091|NCT02852564|Ethacrynic|ethacrynic
114092|NCT02852564|Acid|acid
114093|NCT02852564|Mitomycin|mitomycin
114094|NCT02852564|Urine|urine
114095|NCT02852564|NMIBC|nmibc
114096|NCT02852512|Laparoscopic Sacrocolpopexy|laparoscopic sacrocolpopexy
114097|NCT02852512|Robotic Assisted Sacrocolpopexy|robotic assisted sacrocolpopexy
114098|NCT02852512|Pelvic Organ Prolapse|pelvic organ prolapse
114099|NCT02852499|environmental epidemiology|environmental epidemiology
114100|NCT02852499|cohort|cohort
114101|NCT02852499|atmospheric pollutant|atmospheric pollutant
114102|NCT02852499|chemical pollutant|chemical pollutant
114103|NCT02852499|growth, neuro-development, respiratory health|growth, neuro-development, respiratory health
114104|NCT02852499|big data|big data
114105|NCT02852499|biological samples (RNA, DNA, urines ...)|biological samples (rna, dna, urines ...)
114106|NCT02852499|e-dohad and exposome|e-dohad and exposome
114107|NCT02852486|BCR-ABL Positive|bcr-abl positive
114108|NCT02852486|Leukemia, Chronic Myeloid|leukemia, chronic myeloid
114109|NCT02852486|Imatinib|imatinib
114110|NCT02852486|Pioglitazone|pioglitazone
114111|NCT02852473|Continuous Positive Airway Pressure|continuous positive airway pressure
114112|NCT02852473|Radiotherapy|radiotherapy
114113|NCT02852473|Proton Therapy|proton therapy
114114|NCT02852382|scalp block|scalp block
114115|NCT02852382|local infiltration|local infiltration
114116|NCT02852330|Voltage tomography|voltage tomography
114117|NCT02852304|liver|liver
114118|NCT02852304|transplant|transplant
114119|NCT02852304|Lysosomal Acid Lipase|lysosomal acid lipase
114120|NCT02852278|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
114121|NCT02852278|ALS|als
114122|NCT02852278|motor neuron diseases|motor neuron diseases
114123|NCT02852278|Progressive Muscular Atrophy|progressive muscular atrophy
114124|NCT02852278|Primary Lateral Sclerosis|primary lateral sclerosis
114125|NCT02852278|Hereditary Spastic Paraplegia|hereditary spastic paraplegia
114126|NCT02852265|oral contraceptive|oral contraceptive
114127|NCT02852265|contraceptive implant|contraceptive implant
114128|NCT02852265|contraception|contraception
114129|NCT02852265|adherence|adherence
114130|NCT02852265|adverse event|adverse event
114131|NCT02852239|Renal impairment|renal impairment
114132|NCT02852239|Healthy volunteers|healthy volunteers
114133|NCT02852239|Clinical pharmacology study|clinical pharmacology study
114134|NCT02852239|DRB436|drb436
114135|NCT02852239|dabrafenib|dabrafenib
114136|NCT02852239|normal renal function|normal renal function
114137|NCT02852239|impaired renal function|impaired renal function
114138|NCT02852213|AADC|aadc
114139|NCT02852213|gene therapy|gene therapy
114140|NCT02852187|Intervertebral Disc Degeneration|intervertebral disc degeneration
114141|NCT02852187|Lumbar Spinal Disease|lumbar spinal disease
114142|NCT02852148|Wound|wound
114143|NCT02852148|Pressure Ulcer|pressure ulcer
114144|NCT02852148|Diabetic Foot Ulcer|diabetic foot ulcer
114145|NCT02852148|Venous Leg Ulcer|venous leg ulcer
114146|NCT02852148|Burn|burn
114147|NCT02852148|Quality of Life|quality of life
114148|NCT02852135|Laryngeal Mask Airway|laryngeal mask airway
114149|NCT02852135|lateral position|lateral position
114150|NCT02852135|laparoscopic surgery|laparoscopic surgery
114151|NCT02852122|prostate cancer|prostate cancer
114152|NCT02852122|C11 Choline PET/MR|c11 choline pet/mr
114153|NCT02852122|staging|staging
114154|NCT02852122|biochemical failure|biochemical failure
114155|NCT02852096|gastric cancer|gastric cancer
114156|NCT02852096|Her2/neu|her2/neu
114157|NCT02852096|dual paraffin blocks|dual paraffin blocks
114158|NCT02852096|trastuzumab|trastuzumab
114159|NCT02852070|bronchoalveolar lavage|bronchoalveolar lavage
114160|NCT02852070|lower respiratory tract infections|lower respiratory tract infections
114161|NCT02851979|premature newborns|premature newborns
114162|NCT02851979|apneas prevention|apneas prevention
114163|NCT02851979|olfactory stimulation|olfactory stimulation
114164|NCT02851979|latin square design|latin square design
114165|NCT02851966|Non-obstructive Azoospermia|non-obstructive azoospermia
114166|NCT02851966|Sperm Retrieval|sperm retrieval
114167|NCT02851966|Infertility, Male|infertility, male
114168|NCT02851966|Semen|semen
114169|NCT02851966|Biomarkers|biomarkers
114170|NCT02851966|Proteomics|proteomics
114171|NCT02851966|Enzyme-Linked Immunosorbent Assay|enzyme-linked immunosorbent assay
114172|NCT02851953|cervix, cervical dilation, balloon catheter|cervix, cervical dilation, balloon catheter
114173|NCT02851940|Pain|pain
114174|NCT02851940|Bleeding|bleeding
114175|NCT02851940|Hemorrhoids|hemorrhoids
114176|NCT02851940|Band Ligation|band ligation
114177|NCT02851940|hypertonic saline sclerotherapy|hypertonic saline sclerotherapy
114178|NCT02851836|attachment|attachment
114179|NCT02851836|adolescent|adolescent
114180|NCT02851836|picture|picture
114181|NCT02851823|Er-YAG lasers|er-yag lasers
114182|NCT02851823|Nd-YAG lasers|nd-yag lasers
114183|NCT02851823|chronic periodontitis|chronic periodontitis
114184|NCT02851823|nonsurgical periodontal debridement|nonsurgical periodontal debridement
114185|NCT02851810|attachment|attachment
114186|NCT02851810|oculomotor marker|oculomotor marker
114187|NCT02851810|emotion regulation|emotion regulation
114188|NCT02851784|hepatocellular carcinoma|hepatocellular carcinoma
114189|NCT02851784|ablation|ablation
114190|NCT02851784|immunotherapy|immunotherapy
114191|NCT02851784|cytokine induced kill cell|cytokine induced kill cell
114192|NCT02851732|Quality Improvement|quality improvement
114193|NCT02851732|Cluster Analysis|cluster analysis
114194|NCT02851719|Urinary Incontinence, Stress|urinary incontinence, stress
114195|NCT02851719|Pelvic Floor|pelvic floor
114196|NCT02851719|Exercise|exercise
114197|NCT02851719|Patient Compliance|patient compliance
114198|NCT02851706|Brain Tumor|brain tumor
114199|NCT02851706|Glioma|glioma
114200|NCT02851706|Astrocytoma|astrocytoma
114201|NCT02851706|Brain Cancer|brain cancer
114202|NCT02851706|Spine Cander|spine cander
114203|NCT02851615|Anemia, Sickle Cell|anemia, sickle cell
114204|NCT02851615|Self Care|self care
114205|NCT02851615|Adolescent|adolescent
114206|NCT02851615|Young Adult|young adult
114207|NCT02851615|Disease Management|disease management
114208|NCT02851615|Behavioral Activation|behavioral activation
114209|NCT02851615|Peer Communication|peer communication
114210|NCT02851576|Adenovirus|adenovirus
114211|NCT02851550|liver|liver
114212|NCT02851550|transplant|transplant
114213|NCT02851550|Lysosomal Acid Lipase|lysosomal acid lipase
114214|NCT02851472|TRAGI (transfusion related acute gut injury)|tragi (transfusion related acute gut injury)
114215|NCT02851472|inhaled nitric oxide (iNO)|inhaled nitric oxide (ino)
114216|NCT02851472|prematurity|prematurity
114217|NCT02851472|PRBC transfusion|prbc transfusion
114218|NCT02851472|NEC (necrotizing enterocolitis)|nec (necrotizing enterocolitis)
114219|NCT02851472|NIRS (near infrared spectroscopy)|nirs (near infrared spectroscopy)
114220|NCT02851472|ELGAN (extremely low gestational age neonate)|elgan (extremely low gestational age neonate)
114221|NCT02851459|Vaccines|vaccines
114222|NCT02851407|stem cell transplant|stem cell transplant
114223|NCT02851407|hematopoietic stem cell transplant (HSCT)|hematopoietic stem cell transplant (hsct)
114224|NCT02851407|veno-occlusive disease (VOD)|veno-occlusive disease (vod)
114225|NCT02851407|sinosoidial obstruction syndrome (SOS)|sinosoidial obstruction syndrome (sos)
114226|NCT02851368|Indocyanine Green|indocyanine green
114227|NCT02851368|Fluorescence Imaging|fluorescence imaging
114228|NCT02851342|Cognition|cognition
114230|NCT02851329|stage IV EGFR-mutant|stage iv egfr-mutant
114231|NCT02851329|EGFR TKIs|egfr tkis
114232|NCT02851329|progression-free survival|progression-free survival
114233|NCT02851329|prognosis|prognosis
114234|NCT02851329|computed tomography|computed tomography
114235|NCT02851290|Hypospadias|hypospadias
114236|NCT02851290|Caudal block|caudal block
114237|NCT02851290|Dorsal penile nerve block|dorsal penile nerve block
114238|NCT02851290|Anesthesia|anesthesia
114239|NCT02851290|Urethrocutaneous fistula|urethrocutaneous fistula
114240|NCT02851290|Urethral stricture|urethral stricture
114241|NCT02851290|Meatal stenosis|meatal stenosis
114242|NCT02851290|Glanular dehiscence|glanular dehiscence
114243|NCT02851277|Peanut Allergy|peanut allergy
114244|NCT02851277|ASP0892|asp0892
114245|NCT02851264|Early Esophageal Squamous Neoplasia|early esophageal squamous neoplasia
114246|NCT02851264|optical enhancement technology|optical enhancement technology
114247|NCT02851264|virtual chromoendoscopy|virtual chromoendoscopy
114248|NCT02851251|eye disease|eye disease
114249|NCT02851251|neonatal eye disease|neonatal eye disease
114250|NCT02851251|newborn|newborn
114251|NCT02851251|screening|screening
114252|NCT02851251|multicenter|multicenter
114253|NCT02851134|genetic|genetic
114254|NCT02851121|Neurophysiological|neurophysiological
114255|NCT02851121|Perception-action|perception-action
114256|NCT02851121|Link|link
114257|NCT02851108|falciparum malaria|falciparum malaria
114258|NCT02851108|sub saharan|sub saharan
114259|NCT02851108|africa|africa
114260|NCT02851108|elimination disorder|elimination disorder
114261|NCT02851082|Training Program|training program
114262|NCT02851082|Endurance|endurance
114263|NCT02851082|Von Willebrand factor|von willebrand factor
114264|NCT02851069|Chronic Hepatitis C|chronic hepatitis c
114265|NCT02851069|Paritaprevir/r - Ombitasvir, ± Dasabuvir|paritaprevir/r - ombitasvir, ± dasabuvir
114266|NCT02851069|Sustained Virological Response|sustained virological response
114267|NCT02851069|Observational Study|observational study
114364|NCT02850341|Walking|walking
114268|NCT02851069|Chronic Hepatitis C genotype 1|chronic hepatitis c genotype 1
114269|NCT02851056|Myeloma|myeloma
114270|NCT02851056|Vaccine|vaccine
114271|NCT02851056|Dendritic cell|dendritic cell
114272|NCT02851056|autologous hematopoietic cell transplant|autologous hematopoietic cell transplant
114273|NCT02851056|HCT|hct
114274|NCT02851030|Child, Preschool|child, preschool
114275|NCT02851030|Child Care|child care
114276|NCT02850991|Esophageal cancer, radiation, chemotherapy|esophageal cancer, radiation, chemotherapy
114277|NCT02850939|Breast cancer|breast cancer
114278|NCT02850939|Endocrine hormonal therapy|endocrine hormonal therapy
114279|NCT02850939|mHealth|mhealth
114280|NCT02850926|Concussion|concussion
114281|NCT02850926|Soccer|soccer
114282|NCT02850926|Adolescent|adolescent
114283|NCT02850874|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
114284|NCT02850874|perioperative systemic chemotherapy|perioperative systemic chemotherapy
114285|NCT02850874|peritoneal disease|peritoneal disease
114286|NCT02850848|Pharmacokinetic|pharmacokinetic
114287|NCT02850835|Decision Aid|decision aid
114288|NCT02850835|Pelvic Organ Prolapse (POP)|pelvic organ prolapse (pop)
114289|NCT02850822|chemotherapy|chemotherapy
114290|NCT02850809|radiofrequency ablation|radiofrequency ablation
114291|NCT02850809|complications|complications
114292|NCT02850796|Mindfulness|mindfulness
114293|NCT02850796|self-compassion|self-compassion
114294|NCT02850796|Acceptance and Commitment Therapy|acceptance and commitment therapy
114295|NCT02850796|weight self-stigma|weight self-stigma
114296|NCT02850796|quality-of-life|quality-of-life
114297|NCT02850783|colon cancer|colon cancer
114298|NCT02850757|Modified William's airway|modified william's airway
114299|NCT02850757|fiberoptic bronchoscope|fiberoptic bronchoscope
114300|NCT02850757|U shape Guedls airway|u shape guedls airway
114301|NCT02850757|oral airways|oral airways
114302|NCT02850757|efficacy and safety|efficacy and safety
114303|NCT02850705|Neuromyelitis Optica|neuromyelitis optica
114304|NCT02850705|Myelitis|myelitis
114305|NCT02850705|Optic Neuritis|optic neuritis
114306|NCT02850705|autoantibody|autoantibody
114307|NCT02850705|demyelination|demyelination
114308|NCT02850679|Atrial Fibrillation|atrial fibrillation
114309|NCT02850679|Cardioversion|cardioversion
114310|NCT02850666|social skills|social skills
114311|NCT02850666|child|child
114312|NCT02850666|theory of mind|theory of mind
114313|NCT02850666|drama|drama
114314|NCT02850666|occupational therapy|occupational therapy
114315|NCT02850666|Speech-language pathology|speech-language pathology
114316|NCT02850653|Acute Endophthalmitis.|acute endophthalmitis.
114317|NCT02850653|PCR|pcr
114318|NCT02850653|Ocular sampling|ocular sampling
114319|NCT02850627|acute coronary syndrome|acute coronary syndrome
114320|NCT02850627|Tongguan capsule|tongguan capsule
114321|NCT02850627|miRNAs|mirnas
114322|NCT02850601|Oral lichen planus|oral lichen planus
114323|NCT02850601|Dexamethasone solution|dexamethasone solution
114324|NCT02850562|body composition,|body composition,
114325|NCT02850562|Dual-Energy X-Ray Absorptiometry|dual-energy x-ray absorptiometry
114326|NCT02850562|sarcopenia|sarcopenia
114327|NCT02850562|peripheral quantitative computed tomography|peripheral quantitative computed tomography
114328|NCT02850562|muscle density|muscle density
114329|NCT02850562|elderly|elderly
114330|NCT02850549|neck pain|neck pain
114331|NCT02850549|cervical|cervical
114332|NCT02850549|classification|classification
114333|NCT02850549|outcomes|outcomes
114334|NCT02850549|physical therapy|physical therapy
114335|NCT02850536|Colorectal Cancer|colorectal cancer
114336|NCT02850536|Liver Metastases|liver metastases
114337|NCT02850536|Breast Cancer|breast cancer
114338|NCT02850536|Gastric Cancer|gastric cancer
114339|NCT02850536|Pancreas Cancer|pancreas cancer
114340|NCT02850536|Carcinoembryonic antigen|carcinoembryonic antigen
114341|NCT02850536|CAR-T|car-t
114342|NCT02850536|Immunotherapy|immunotherapy
114343|NCT02850510|Harsh discipline|harsh discipline
114344|NCT02850510|parental competence|parental competence
114345|NCT02850510|positive parenting|positive parenting
114346|NCT02850497|optical coherence tomography|optical coherence tomography
114347|NCT02850497|malapposition|malapposition
114348|NCT02850497|endothelization|endothelization
114349|NCT02850471|Postoperative pulmonary complications|postoperative pulmonary complications
114350|NCT02850471|Transcutaneous electric acupoint stimulation|transcutaneous electric acupoint stimulation
114351|NCT02850471|pulmonary protection|pulmonary protection
114352|NCT02850432|Magnetic resonance imaging|magnetic resonance imaging
114353|NCT02850432|Extracellular volume matrix fraction|extracellular volume matrix fraction
114354|NCT02850432|Peripheral artery disease|peripheral artery disease
114355|NCT02850432|Blood-oxygen level dependent|blood-oxygen level dependent
114356|NCT02850432|Cardiac function|cardiac function
114357|NCT02850393|suppression mnemonic|suppression mnemonic
114358|NCT02850393|emotional response|emotional response
114359|NCT02850393|inhibitory control of failures|inhibitory control of failures
114360|NCT02850393|neurological alterations|neurological alterations
114361|NCT02850341|Physical Activity|physical activity
114362|NCT02850341|Mental Health|mental health
114363|NCT02850341|Health Behavior|health behavior
114365|NCT02850341|Physical Exercise|physical exercise
114366|NCT02850341|Mental disorder|mental disorder
114367|NCT02850315|optimal coherence tomography|optimal coherence tomography
114368|NCT02850315|myocardial reperfusion|myocardial reperfusion
114369|NCT02850276|HIV disease|hiv disease
114370|NCT02850276|gastrointestinal problems|gastrointestinal problems
114371|NCT02850263|Diabetic Retinopathy|diabetic retinopathy
114372|NCT02850263|Diabetic Macular Oedema|diabetic macular oedema
114373|NCT02850263|Diabetic Macular Edema|diabetic macular edema
114374|NCT02850263|Aflibercept|aflibercept
114375|NCT02850250|Observational|observational
114376|NCT02850250|pharmacokinetic|pharmacokinetic
114377|NCT02850250|cardiac|cardiac
114378|NCT02850250|Cefuroxime|cefuroxime
114379|NCT02850250|Paediatric|paediatric
114380|NCT02850237|cerebral saturation|cerebral saturation
114381|NCT02850237|capnography|capnography
114382|NCT02850237|pre-hospital|pre-hospital
114383|NCT02850198|ischemic stroke|ischemic stroke
114384|NCT02850185|COPD|copd
114385|NCT02850185|hydrogen|hydrogen
114386|NCT02850172|nutrition|nutrition
114387|NCT02850172|exercise|exercise
114388|NCT02850172|inspiratory muscle training|inspiratory muscle training
114390|NCT02850146|cognition|cognition
114391|NCT02850146|longitudinal|longitudinal
114392|NCT02850146|cognitive decline|cognitive decline
114393|NCT02850146|observational|observational
114394|NCT02850146|imaging|imaging
114395|NCT02850120|surgical mesh|surgical mesh
114396|NCT02850120|observational study|observational study
114397|NCT02850120|intraoperative complications|intraoperative complications
114398|NCT02850120|postoperative complications|postoperative complications
114399|NCT02850107|Atherectomy, Drug-Coated Balloon|atherectomy, drug-coated balloon
114400|NCT02850094|Physical activity|physical activity
114401|NCT02850094|Exercise|exercise
114402|NCT02850094|Financial Incentives|financial incentives
114403|NCT02850081|Carotid endarterectomy|carotid endarterectomy
114404|NCT02850081|CEA|cea
114405|NCT02850081|stroke|stroke
114406|NCT02850081|asymptomatic stenosis|asymptomatic stenosis
114407|NCT02850055|physiotherapy, Temporomandibular Joint Disorder, tinnitus.|physiotherapy, temporomandibular joint disorder, tinnitus.
114408|NCT02850042|motor recovery|motor recovery
114409|NCT02850042|human|human
114410|NCT02850042|occupation-based practice|occupation-based practice
114411|NCT02850042|motor training|motor training
114412|NCT02850042|transcranial magnetic stimulation|transcranial magnetic stimulation
114413|NCT02850029|antimicrobial|antimicrobial
114414|NCT02850029|intensive care units|intensive care units
114415|NCT02850016|Romidepsin|romidepsin
114416|NCT02850016|3BNC117|3bnc117
114417|NCT02850016|Broadly neutralizing antibody|broadly neutralizing antibody
114418|NCT02849977|POMC|pomc
114419|NCT02849977|PCSK1|pcsk1
114420|NCT02849977|Pro-opiomelanocortin|pro-opiomelanocortin
114421|NCT02849964|Incidence|incidence
114422|NCT02849964|Renal Replacement Therapy|renal replacement therapy
114423|NCT02849964|Socioeconomic Factors|socioeconomic factors
114424|NCT02849964|Clinical Practice Pattern|clinical practice pattern
114425|NCT02849951|Colitis|colitis
114426|NCT02849951|Colitis, Ulcerative|colitis, ulcerative
114427|NCT02849951|Ulcer|ulcer
114428|NCT02849951|Colonic Diseases|colonic diseases
114429|NCT02849951|Digestive System Diseases|digestive system diseases
114430|NCT02849951|Gastroenteritis|gastroenteritis
114431|NCT02849951|Gastrointestinal Diseases|gastrointestinal diseases
114432|NCT02849951|Inflammatory Bowel Diseases|inflammatory bowel diseases
114433|NCT02849951|Intestinal Diseases|intestinal diseases
114434|NCT02849951|Pathologic Processes|pathologic processes
114435|NCT02849951|Mesalamine|mesalamine
114436|NCT02849938|children with medical complexity|children with medical complexity
114437|NCT02849938|Telemedicine|telemedicine
114438|NCT02849938|Tracheostomy|tracheostomy
114439|NCT02849925|Pit and Fissure Sealants|pit and fissure sealants
114440|NCT02849925|Caries|caries
114441|NCT02849925|Glass ionomer|glass ionomer
114442|NCT02849925|Resin|resin
114443|NCT02849886|GvHD|gvhd
114444|NCT02849886|Suicide gene|suicide gene
114445|NCT02849886|Dimerizer drug AP1903|dimerizer drug ap1903
114446|NCT02849886|Hematological stem cell transplantation|hematological stem cell transplantation
114447|NCT02849834|Neuropathic Pain|neuropathic pain
114448|NCT02849834|Stimulation of the Motor Cortex (SCM)|stimulation of the motor cortex (scm)
114449|NCT02849834|Pharmacoresistant|pharmacoresistant
114450|NCT02849834|rTMS|rtms
114451|NCT02849808|Corneal Transplantation|corneal transplantation
114452|NCT02849795|Obesity, Abdominal|obesity, abdominal
114453|NCT02849795|Adipokines|adipokines
114454|NCT02849795|Risk of cardiovascular diseases|risk of cardiovascular diseases
114455|NCT02849782|Gait analysis|gait analysis
114456|NCT02849782|Fampridine|fampridine
114457|NCT02849782|Fatigue|fatigue
114458|NCT02849782|Daily activity|daily activity
114459|NCT02849782|Cognition|cognition
114460|NCT02849756|Intensive care|intensive care
114461|NCT02849756|elderly|elderly
114462|NCT02849756|autonomy|autonomy
114463|NCT02849756|Future|future
114464|NCT02849756|older patients|older patients
114465|NCT02849756|intensive care unit|intensive care unit
114466|NCT02849743|oxytocin|oxytocin
114467|NCT02849743|hypothalamic obesity|hypothalamic obesity
114468|NCT02849743|craniopharyngioma|craniopharyngioma
114469|NCT02849743|metabolism|metabolism
114471|NCT02849730|Patient controlled analgesia|patient controlled analgesia
114472|NCT02849730|Epidural patient controlled analgesia|epidural patient controlled analgesia
114473|NCT02849730|Elderly patient|elderly patient
114474|NCT02849730|Side effect|side effect
114475|NCT02849730|Postoperative pain|postoperative pain
114476|NCT02849704|Chronic Pancreatitis|chronic pancreatitis
114477|NCT02849704|Pancreatic Function|pancreatic function
114478|NCT02849704|Reduced Exocrine Pancreatic Function|reduced exocrine pancreatic function
114479|NCT02849704|Pancreatic Insufficiency|pancreatic insufficiency
114480|NCT02849678|Postoperative Pain|postoperative pain
114481|NCT02849678|Bowel Surgery|bowel surgery
114482|NCT02849678|Regional Anesthesia|regional anesthesia
114483|NCT02849665|Kangaroo-Mother Care Method; child development|kangaroo-mother care method; child development
114484|NCT02849652|Smoking cessation|smoking cessation
114485|NCT02849652|Nicotine dependence|nicotine dependence
114486|NCT02849652|Organizational change|organizational change
114487|NCT02849652|Mental Healthcare|mental healthcare
114488|NCT02849626|Partial-Onset Seizures|partial-onset seizures
114489|NCT02849626|Primary Generalized Tonic-Clonic Seizures|primary generalized tonic-clonic seizures
114490|NCT02849626|Adjunctive Therapy|adjunctive therapy
114491|NCT02849626|Epilepsy|epilepsy
114492|NCT02849613|cell therapy|cell therapy
114493|NCT02849613|stem cell|stem cell
114494|NCT02849613|transplantation|transplantation
114495|NCT02849613|graft|graft
114496|NCT02849613|recovery|recovery
114497|NCT02849613|repair|repair
114498|NCT02849613|stroke|stroke
114499|NCT02849613|mesenchymal stem cell|mesenchymal stem cell
114500|NCT02849613|regenerative|regenerative
114501|NCT02849600|Vital pulp therapy,Young permanent tooth,Treatment outcome|vital pulp therapy,young permanent tooth,treatment outcome
114502|NCT02849587|Driving Under the Influence|driving under the influence
114503|NCT02849587|Memory Impairment|memory impairment
114504|NCT02849587|Reaction Time|reaction time
114505|NCT02849587|Time Perception|time perception
114506|NCT02849561|Pupillary light reflex|pupillary light reflex
114507|NCT02849561|Cardio respiratory arrest|cardio respiratory arrest
114508|NCT02849535|Oral chemotherapy|oral chemotherapy
114509|NCT02849535|Relative dose intensity|relative dose intensity
114510|NCT02849535|Health related program|health related program
114511|NCT02849535|Secured drug intake|secured drug intake
114512|NCT02849522|Lower Urinary Tract Symptoms caused by Benign Prostatic Enlargement (LUTS BPE)|lower urinary tract symptoms caused by benign prostatic enlargement (luts bpe)
114513|NCT02849522|Prostate Artery Embolisation (PAE)|prostate artery embolisation (pae)
114514|NCT02849522|Transurethral Resection of the Prostate (TURP)|transurethral resection of the prostate (turp)
114515|NCT02849522|Open prostatectomy|open prostatectomy
114516|NCT02849522|Laser enucleation or ablation of the prostate (Green Light, KTP, HoLEP)|laser enucleation or ablation of the prostate (green light, ktp, holep)
114517|NCT02849522|IPSS Score|ipss score
114518|NCT02849522|IIEF Score|iief score
114519|NCT02849522|Complications|complications
114520|NCT02849522|Quality of Life|quality of life
114521|NCT02849483|PONV|ponv
114522|NCT02849483|digestive signs and symptoms|digestive signs and symptoms
114523|NCT02849483|vomiting|vomiting
114524|NCT02849483|antiemetics|antiemetics
114525|NCT02849483|nausea|nausea
114526|NCT02849483|ramosetron|ramosetron
114527|NCT02849470|Adipose Stem/Stromal Cells|adipose stem/stromal cells
114528|NCT02849470|PRP|prp
114529|NCT02849470|SVF|svf
114530|NCT02849470|Cell Therapy|cell therapy
114531|NCT02849470|Alopecia|alopecia
114532|NCT02849470|GF|gf
114533|NCT02849444|renal function|renal function
114534|NCT02849444|Relapsed Multiple myeloma|relapsed multiple myeloma
114535|NCT02849444|anti-MM therapy|anti-mm therapy
114536|NCT02849431|mindfulness|mindfulness
114537|NCT02849418|Botulinum toxin type A|botulinum toxin type a
114538|NCT02849418|Urinary Incontinence|urinary incontinence
114539|NCT02849418|Neurogenic Detrusor Overactivity|neurogenic detrusor overactivity
114540|NCT02849392|Pistachio|pistachio
114541|NCT02849392|Body composition|body composition
114542|NCT02849392|Erythrocyte membrane incorporation of fatty acids|erythrocyte membrane incorporation of fatty acids
114543|NCT02849392|Dietary quality/micronutrient quality|dietary quality/micronutrient quality
114544|NCT02849392|Blood lipids|blood lipids
114545|NCT02849392|Inflammatory markers|inflammatory markers
114546|NCT02849392|Bone density|bone density
114547|NCT02849392|Bone turnover markers|bone turnover markers
114548|NCT02849392|Satiety|satiety
114549|NCT02849379|tongue cancer|tongue cancer
114550|NCT02849379|cryosurgery|cryosurgery
114551|NCT02849379|NK immunotherapy|nk immunotherapy
114552|NCT02849366|Sarcoma|sarcoma
114553|NCT02849366|Cryosurgery|cryosurgery
114554|NCT02849366|NK Immunotherapy|nk immunotherapy
114555|NCT02849353|Ovarian Cancer|ovarian cancer
114556|NCT02849353|cryosurgery|cryosurgery
114557|NCT02849353|NK immunotherapy|nk immunotherapy
114558|NCT02849340|Cervical Cancer|cervical cancer
114559|NCT02849340|cryosurgery|cryosurgery
114560|NCT02849340|NK immunotherapy|nk immunotherapy
114561|NCT02849327|Pharyngeal cancer|pharyngeal cancer
114562|NCT02849327|Cryosurgery|cryosurgery
114563|NCT02849327|NK immunotherapy|nk immunotherapy
114564|NCT02849314|laryngeal cancer|laryngeal cancer
114565|NCT02849314|cryosurgery|cryosurgery
114566|NCT02849314|NK immunotherapy|nk immunotherapy
114567|NCT02849249|allergy|allergy
114568|NCT02849249|Immunotherapy|immunotherapy
114569|NCT02849249|SCIT|scit
114570|NCT02849236|PECS block,|pecs block,
114571|NCT02849236|pectoral block,|pectoral block,
114572|NCT02849236|breast augmentation|breast augmentation
114573|NCT02849223|Mild Traumatic Brain Injury|mild traumatic brain injury
114574|NCT02849223|Transcranial Direct Current Stimulation|transcranial direct current stimulation
114575|NCT02849223|Working Memory|working memory
114576|NCT02849197|pilonidal sinus|pilonidal sinus
114577|NCT02849197|complication|complication
114578|NCT02849197|recurrence|recurrence
114579|NCT02849171|18F-fluorocholine (18F-FCH) PET|18f-fluorocholine (18f-fch) pet
114580|NCT02849171|16-676|16-676
114581|NCT02849171|High-grade Gliomas|high-grade gliomas
114582|NCT02849158|Rectoscopy|rectoscopy
114583|NCT02849158|Proctectomy|proctectomy
114584|NCT02849158|Fibroblasts|fibroblasts
114585|NCT02849145|Circulating tumor DNA|circulating tumor dna
114586|NCT02849119|Robot; Laparoscopic|robot; laparoscopic
114587|NCT02849119|Partial nephrectomy|partial nephrectomy
114588|NCT02849119|Transperitoneal|transperitoneal
114589|NCT02849119|Retroperitoneal|retroperitoneal
114590|NCT02849119|Laparoscopic Surgery|laparoscopic surgery
114591|NCT02849119|Surgical Procedures, Robotic|surgical procedures, robotic
114592|NCT02849119|Nephrectomy|nephrectomy
114593|NCT02849106|3D culture|3d culture
114594|NCT02849106|chemogram|chemogram
114595|NCT02849106|FOLFOX|folfox
114596|NCT02849106|FOLFIRI|folfiri
114597|NCT02849093|Optical coherence tomography|optical coherence tomography
114598|NCT02849093|imaging of ocular structures|imaging of ocular structures
114599|NCT02849067|ischaemic heart disease|ischaemic heart disease
114600|NCT02849067|comedy session|comedy session
114601|NCT02849067|laughter therapy|laughter therapy
114602|NCT02849041|Circulating Tumor Cells|circulating tumor cells
114603|NCT02849041|Lung|lung
114604|NCT02849028|gut microbiota|gut microbiota
114605|NCT02849028|sleep disorder|sleep disorder
114606|NCT02849028|gut-brain axis|gut-brain axis
114607|NCT02849028|circadian rhythm|circadian rhythm
114608|NCT02849028|Traumatic Brain Injury|traumatic brain injury
114609|NCT02849015|liver tumor|liver tumor
114610|NCT02849015|cryosurgery|cryosurgery
114611|NCT02849015|NK immunotherapy|nk immunotherapy
114612|NCT02849002|Concussion|concussion
114613|NCT02848989|Breast Cancer Surgery Pain|breast cancer surgery pain
114614|NCT02848989|Breast Cancer|breast cancer
114615|NCT02848950|Metformin|metformin
114616|NCT02848950|fecundability|fecundability
114617|NCT02848950|uterine doppler|uterine doppler
114618|NCT02848937|calcium balance|calcium balance
114619|NCT02848937|dialysis|dialysis
114620|NCT02848937|concentrate with citrate|concentrate with citrate
114621|NCT02848924|prevalence|prevalence
114622|NCT02848924|surgery|surgery
114623|NCT02848924|Treatments|treatments
114624|NCT02848911|acute lymphoblastic leukemia|acute lymphoblastic leukemia
114625|NCT02848898|Focal Vibrations|focal vibrations
114626|NCT02848898|Neurorehabilitation|neurorehabilitation
114627|NCT02848898|Spasticity|spasticity
114628|NCT02848898|Multiple Sclerosis|multiple sclerosis
114629|NCT02848885|Magnetic resonance imaging|magnetic resonance imaging
114630|NCT02848885|Anosognosia|anosognosia
114631|NCT02848885|Electrical stimulation of the brain|electrical stimulation of the brain
114632|NCT02848872|Tumor-infiltrating lymphocytes (TILs)|tumor-infiltrating lymphocytes (tils)
114633|NCT02848859|cognitive behavioral therapy for insomnia|cognitive behavioral therapy for insomnia
114634|NCT02848859|randomized controlled trial|randomized controlled trial
114635|NCT02848846|Amputees|amputees
114636|NCT02848820|Appendicitis|appendicitis
114637|NCT02848820|Appendectomy|appendectomy
114638|NCT02848820|Antibiotics|antibiotics
114639|NCT02848781|Sudden Cardiac Death|sudden cardiac death
114640|NCT02848781|ICD Therapy|icd therapy
114641|NCT02848781|VT Ablation|vt ablation
114642|NCT02848690|Sodium restriction|sodium restriction
114643|NCT02848690|Dietary sodium restriction questionnaire (DSRQ)|dietary sodium restriction questionnaire (dsrq)
114644|NCT02848690|Low-sodium diet|low-sodium diet
114645|NCT02848690|Adherence|adherence
114646|NCT02848690|Educational intervention|educational intervention
114647|NCT02848677|advanced glycation end-products|advanced glycation end-products
114648|NCT02848677|Cardiovascular disease|cardiovascular disease
114649|NCT02848677|Low Sodium Diet|low sodium diet
114650|NCT02848677|vascular inflammation|vascular inflammation
114651|NCT02848638|PET, Yttrium-90|pet, yttrium-90
114652|NCT02848625|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
114653|NCT02848625|Yoga|yoga
114654|NCT02848625|Quality of life|quality of life
114655|NCT02848612|anticoagulation|anticoagulation
114656|NCT02848612|aneurysmal subarachnoid haemorrhage|aneurysmal subarachnoid haemorrhage
114657|NCT02848612|interventional neuroradiology|interventional neuroradiology
114658|NCT02848612|coil embolization|coil embolization
114761|NCT02847962|Vitamin A|vitamin a
114659|NCT02848599|postoperative analgesia|postoperative analgesia
114660|NCT02848599|postoperative cognitive disfunction|postoperative cognitive disfunction
114662|NCT02848586|ECIGS|ecigs
114663|NCT02848586|e-cigarettes|e-cigarettes
114664|NCT02848586|lung inflammation|lung inflammation
114665|NCT02848560|Cystic Fibrosis|cystic fibrosis
114666|NCT02848560|orkambi|orkambi
114667|NCT02848560|129Xe MRI|129xe mri
114668|NCT02848560|hyperpolarized xenon|hyperpolarized xenon
114669|NCT02848560|LCI|lci
114670|NCT02848560|CFTR modulator therapy|cftr modulator therapy
114671|NCT02848534|fever|fever
114672|NCT02848534|hyperthermia|hyperthermia
114673|NCT02848534|inflammatory syndrome|inflammatory syndrome
114674|NCT02848521|ADPKD|adpkd
114675|NCT02848521|CKD|ckd
114676|NCT02848521|Rapid progressor|rapid progressor
114677|NCT02848521|quality of life|quality of life
114678|NCT02848521|DCE|dce
114679|NCT02848508|Metformin|metformin
114680|NCT02848508|moderate renal failure|moderate renal failure
114681|NCT02848508|severe renal failure|severe renal failure
114682|NCT02848508|chronic kidney disease|chronic kidney disease
114683|NCT02848508|hyperlactatemia|hyperlactatemia
114684|NCT02848508|lactic acidosis|lactic acidosis
114685|NCT02848495|Aneurysm|aneurysm
114686|NCT02848495|Biocollection|biocollection
114687|NCT02848495|Familial Form|familial form
114688|NCT02848482|Photodynamic therapy|photodynamic therapy
114689|NCT02848456|Manipulation, Spinal|manipulation, spinal
114690|NCT02848456|H-Reflex|h-reflex
114691|NCT02848456|Muscle Contraction|muscle contraction
114692|NCT02848456|Muscle Strength Dynamometer|muscle strength dynamometer
114693|NCT02848443|metastatic|metastatic
114694|NCT02848443|colorectal|colorectal
114695|NCT02848443|cancer|cancer
114696|NCT02848443|oxaliplatin|oxaliplatin
114697|NCT02848443|dose-escalation|dose-escalation
114698|NCT02848443|Lonsurf|lonsurf
114699|NCT02848443|nivolumab|nivolumab
114700|NCT02848443|bevacizumab|bevacizumab
114701|NCT02848430|Humulus lupulus|humulus lupulus
114702|NCT02848404|Mild cognitive impairment|mild cognitive impairment
114703|NCT02848404|Cognitive rehabilitation|cognitive rehabilitation
114704|NCT02848404|Cognitive therapy|cognitive therapy
114705|NCT02848404|Alzheimer's disease|alzheimer's disease
114706|NCT02848404|Memory enhancement|memory enhancement
114707|NCT02848404|Categorical language fluency|categorical language fluency
114708|NCT02848378|Advanced Oxidation Protein Products|advanced oxidation protein products
114709|NCT02848378|Gingival crevicular fluid|gingival crevicular fluid
114710|NCT02848378|Monocyte chemoattractant protein-1|monocyte chemoattractant protein-1
114711|NCT02848378|Periodontal Disease|periodontal disease
114712|NCT02848365|Measurement|measurement
114713|NCT02848248|Acute Myeloid Leukemia|acute myeloid leukemia
114714|NCT02848248|Antibody-Drug Conjugate|antibody-drug conjugate
114715|NCT02848248|CD123 Antigen|cd123 antigen
114716|NCT02848248|Drug Therapy|drug therapy
114717|NCT02848248|AML|aml
114718|NCT02848248|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
114719|NCT02848235|Prevention of Mother to Child Transmission|prevention of mother to child transmission
114720|NCT02848235|Antenatal Care for HIV positive women|antenatal care for hiv positive women
114721|NCT02848235|Kenya|kenya
114722|NCT02848222|contact lens discomfort|contact lens discomfort
114723|NCT02848222|dry eye disease|dry eye disease
114724|NCT02848222|meibomian gland dysfunction|meibomian gland dysfunction
114725|NCT02848222|Bruder mask|bruder mask
114726|NCT02848209|Peeling|peeling
114727|NCT02848209|Histological skin changes|histological skin changes
114728|NCT02848209|Trichloroacetic acid peel|trichloroacetic acid peel
114729|NCT02848209|phenol/croton oil peel|phenol/croton oil peel
114730|NCT02848170|essential hypertension|essential hypertension
114731|NCT02848170|mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
114732|NCT02848170|Developmental Phase III|developmental phase iii
114733|NCT02848157|dexmedetomidine|dexmedetomidine
114734|NCT02848157|pudendal block|pudendal block
114735|NCT02848157|hypospadias|hypospadias
114736|NCT02848144|Immunoparalysis|immunoparalysis
114737|NCT02848144|immune response|immune response
114738|NCT02848144|sepsis|sepsis
114739|NCT02848144|toxic shock syndrome|toxic shock syndrome
114740|NCT02848118|Hypoventilation|hypoventilation
114741|NCT02848118|capnography|capnography
114742|NCT02848118|bronchoscopy|bronchoscopy
114743|NCT02848105|aGVHD|agvhd
114744|NCT02848105|valproic acid|valproic acid
114745|NCT02848092|Visual Attention|visual attention
114746|NCT02848092|Automobile Driving|automobile driving
114747|NCT02848001|CC-90009|cc-90009
114748|NCT02848001|Hematologic Cancers|hematologic cancers
114749|NCT02848001|Leukemia|leukemia
114750|NCT02848001|Acute Myeloid Leukemia|acute myeloid leukemia
114751|NCT02847988|muscle strength|muscle strength
114752|NCT02847988|muscle function|muscle function
114753|NCT02847988|functional status|functional status
114754|NCT02847975|Becker|becker
114755|NCT02847975|dystrophy|dystrophy
114756|NCT02847975|sympatholysis|sympatholysis
114757|NCT02847962|Fortified-blended foods|fortified-blended foods
114758|NCT02847962|Extrusion|extrusion
114759|NCT02847962|Sorghum|sorghum
114760|NCT02847962|Cowpea|cowpea
114762|NCT02847962|Iron|iron
114763|NCT02847962|Protein|protein
114764|NCT02847962|Food Aid|food aid
114765|NCT02847962|Anemia, Iron-Deficiency|anemia, iron-deficiency
114766|NCT02847962|Deficiency, Vitamin A|deficiency, vitamin a
114767|NCT02847962|Growth Velocity|growth velocity
114768|NCT02847962|Stunting|stunting
114769|NCT02847962|Wasting|wasting
114770|NCT02847962|Protein-Energy Malnutrition|protein-energy malnutrition
114771|NCT02847962|Complementary Feeding|complementary feeding
114772|NCT02847962|Corn|corn
114773|NCT02847962|Soy|soy
114774|NCT02847962|Fortified Foods|fortified foods
114775|NCT02847962|Food assistance|food assistance
114776|NCT02847936|triclosan|triclosan
114777|NCT02847936|sutures|sutures
114778|NCT02847936|infection|infection
114779|NCT02847923|Mobile Devices|mobile devices
114780|NCT02847923|Augmentative and Alternative Communication|augmentative and alternative communication
114781|NCT02847923|Cerebral Palsy|cerebral palsy
114782|NCT02847910|tissue suction tube|tissue suction tube
114783|NCT02847910|disposable instrument|disposable instrument
114784|NCT02847910|induced abortion|induced abortion
114785|NCT02847884|IBD|ibd
114786|NCT02847884|Crohn's disease|crohn's disease
114787|NCT02847884|Remicade|remicade
114788|NCT02847884|Infliximab|infliximab
114789|NCT02847884|Level|level
114790|NCT02847884|Drug Level|drug level
114791|NCT02847884|Children|children
114792|NCT02847871|mobility|mobility
114793|NCT02847871|exercise|exercise
114794|NCT02847871|nutrition|nutrition
114795|NCT02847871|primary care|primary care
114796|NCT02847871|prevention|prevention
114797|NCT02847871|care pathway|care pathway
114798|NCT02847871|elderly patient|elderly patient
114799|NCT02847858|unsafe sex|unsafe sex
114800|NCT02847858|unprotected sex|unprotected sex
114801|NCT02847858|adolescents|adolescents
114802|NCT02847858|Latinas|latinas
114803|NCT02847858|Hispanic|hispanic
114804|NCT02847858|mobile health applications|mobile health applications
114805|NCT02847858|unintended pregnancy|unintended pregnancy
114806|NCT02847858|teen pregnancy prevention|teen pregnancy prevention
114807|NCT02847858|school-based health centers|school-based health centers
114808|NCT02847845|chronic fatigue syndrome|chronic fatigue syndrome
114809|NCT02847845|idiopathic chronic fatigue|idiopathic chronic fatigue
114810|NCT02847845|red ginseng|red ginseng
114811|NCT02847845|cortisol|cortisol
114812|NCT02847845|anti-oxidant|anti-oxidant
114813|NCT02847832|Adnexal Diseases|adnexal diseases
114814|NCT02847832|Ovary|ovary
114815|NCT02847832|Ovarian Neoplasms|ovarian neoplasms
114816|NCT02847832|Ovarian Cysts|ovarian cysts
114817|NCT02847832|Ovarian Diseases|ovarian diseases
114818|NCT02847832|Ultrasonography|ultrasonography
114819|NCT02847832|Ultrasonography, Doppler|ultrasonography, doppler
114820|NCT02847832|Diagnosis|diagnosis
114821|NCT02847832|Early Diagnosis|early diagnosis
114822|NCT02847832|Early Detection of Cancer|early detection of cancer
114823|NCT02847832|Genital Neoplasms, Female|genital neoplasms, female
114824|NCT02847832|Genital Diseases, Female|genital diseases, female
114825|NCT02847832|Urogenital Neoplasms|urogenital neoplasms
114826|NCT02847832|Cysts|cysts
114827|NCT02847832|Endocrine System Diseases|endocrine system diseases
114828|NCT02847832|Gonadal Disorders|gonadal disorders
114829|NCT02847832|Neoplasms|neoplasms
114830|NCT02847832|Endocrine Gland Neoplasms|endocrine gland neoplasms
114831|NCT02847832|International Ovarian Tumor Analysis|international ovarian tumor analysis
114832|NCT02847832|Simple Rules|simple rules
114833|NCT02847832|Preoperative evaluation|preoperative evaluation
114834|NCT02847832|Prediction Models|prediction models
114835|NCT02847832|Logistic Regression Models|logistic regression models
114836|NCT02847832|Mathematical Models|mathematical models
114837|NCT02847832|Adnexal Masses|adnexal masses
114838|NCT02847832|Ovarian Tumors|ovarian tumors
114839|NCT02847832|Risk of Malignancy|risk of malignancy
114840|NCT02847793|Attentional Bias Modification (ABM)|attentional bias modification (abm)
114841|NCT02847793|Cognitive Bias Modification (CBM)|cognitive bias modification (cbm)
114842|NCT02847793|Depression|depression
114843|NCT02847793|Dysphoria|dysphoria
114844|NCT02847793|Gaze patterns|gaze patterns
114845|NCT02847793|Eye-tracking|eye-tracking
114846|NCT02847767|Liver Perfusion|liver perfusion
114847|NCT02847767|Hepatocellular Carcinoma|hepatocellular carcinoma
114848|NCT02847767|Dynamic Contrast-Enhanced Computed Tomography|dynamic contrast-enhanced computed tomography
114849|NCT02847754|bony metastases|bony metastases
114850|NCT02847754|physical exercise|physical exercise
114851|NCT02847741|Depression|depression
114852|NCT02847741|Cholesterol|cholesterol
114853|NCT02847741|Suicidal behavior|suicidal behavior
114854|NCT02847741|Predictive factor|predictive factor
114855|NCT02847715|PRO|pro
114856|NCT02847715|PROM|prom
114857|NCT02847715|Adverse event|adverse event
114858|NCT02847715|QTool|qtool
114859|NCT02847715|Aftercare|aftercare
114860|NCT02847702|Osteoarthritis|osteoarthritis
114861|NCT02847702|Pain|pain
114862|NCT02847702|Osteoarthritis, knee|osteoarthritis, knee
114863|NCT02847689|Premature Birth|premature birth
114864|NCT02847689|Obstetric Labor, Premature|obstetric labor, premature
114865|NCT02847689|Obstetric Labor Complications|obstetric labor complications
114866|NCT02847689|Pregnancy Complications|pregnancy complications
114867|NCT02847676|Peritoneal adhesions|peritoneal adhesions
114868|NCT02847676|Stem cells|stem cells
114869|NCT02847676|MSC|msc
114870|NCT02847663|Cold|cold
114871|NCT02847663|recovery|recovery
114872|NCT02847650|Early Parkinson Disease|early parkinson disease
114873|NCT02847650|Phase 2|phase 2
114874|NCT02847637|Hemophilia A|hemophilia a
114875|NCT02847637|Emicizumab|emicizumab
114876|NCT02847611|Dynamometer mechanic|dynamometer mechanic
114877|NCT02847611|Strength of prehension|strength of prehension
114878|NCT02847611|Comparison|comparison
114879|NCT02847611|Device|device
114880|NCT02847611|Diagnosis|diagnosis
114881|NCT02847611|Healthy Volunteers|healthy volunteers
114882|NCT02847598|CLE, SLE, Cutaneous Lupus Erythematosus, Systemic Lupus Erythematosus, Lupus|cle, sle, cutaneous lupus erythematosus, systemic lupus erythematosus, lupus
114883|NCT02847585|water-soluble ubiquinol supplementation|water-soluble ubiquinol supplementation
114884|NCT02847585|pediatric cardiomyopathy|pediatric cardiomyopathy
114885|NCT02847585|antioxidant|antioxidant
114886|NCT02847585|inflammation|inflammation
114887|NCT02847585|complementary therapy|complementary therapy
114888|NCT02847533|resistant depression|resistant depression
114889|NCT02847533|inflammation|inflammation
114890|NCT02847520|Disorders related to gaming and gambling; poker|disorders related to gaming and gambling; poker
114891|NCT02847507|HIV|hiv
114892|NCT02847507|Hepatitis E|hepatitis e
114893|NCT02847481|Fecal Microbiota Transplantation|fecal microbiota transplantation
114894|NCT02847455|Ilaprazole|ilaprazole
114895|NCT02847455|Proton pump inhibitor|proton pump inhibitor
114896|NCT02847455|Duodenal ulcer|duodenal ulcer
114897|NCT02847455|Acid suppression|acid suppression
114898|NCT02847455|Randomized trial|randomized trial
114899|NCT02847442|Ongentys|ongentys
114900|NCT02847403|dysglycemia|dysglycemia
114901|NCT02847403|MCI|mci
114902|NCT02847403|exenatide LAR|exenatide lar
114903|NCT02847403|GLP-1|glp-1
114904|NCT02847390|diabetes mellitus|diabetes mellitus
114905|NCT02847390|physician education|physician education
114906|NCT02847390|nursing education|nursing education
114907|NCT02847390|hyperglycemia|hyperglycemia
114908|NCT02847390|hypoglycemia|hypoglycemia
114909|NCT02847390|inpatient|inpatient
114910|NCT02847390|hospital|hospital
114911|NCT02847390|glycemic control|glycemic control
114912|NCT02847364|chewing gum|chewing gum
114913|NCT02847364|prevention|prevention
114914|NCT02847351|arabinoxylan, HOMA index, glycemic control, obesity.|arabinoxylan, homa index, glycemic control, obesity.
114915|NCT02847338|Hypertension|hypertension
114916|NCT02847312|Oat|oat
114917|NCT02847312|Phenolic acid|phenolic acid
114918|NCT02847312|Avenanthramide|avenanthramide
114919|NCT02847312|FMD|fmd
114920|NCT02847312|LDI|ldi
114921|NCT02847312|Gut microbiota|gut microbiota
114922|NCT02847312|Blood Pressure|blood pressure
114923|NCT02847312|Renin Angiotensin|renin angiotensin
114924|NCT02847312|Nitric Oxide|nitric oxide
114925|NCT02847299|cough help|cough help
114926|NCT02847299|mechanical insufflation|mechanical insufflation
114927|NCT02847299|mechanical ventilation|mechanical ventilation
114928|NCT02847299|neuromuscular diseases|neuromuscular diseases
114929|NCT02847299|peak cough flow|peak cough flow
114930|NCT02847273|NIRS|nirs
114931|NCT02847273|Regional oxygen saturation|regional oxygen saturation
114932|NCT02847273|cardiac surgery with bypass|cardiac surgery with bypass
114933|NCT02847247|healthy|healthy
114934|NCT02847234|Cervical necrotizing fasciitis|cervical necrotizing fasciitis
114935|NCT02847234|mediastinitis|mediastinitis
114936|NCT02847221|cough peak flow|cough peak flow
114937|NCT02847221|scheduled weaning trial|scheduled weaning trial
114938|NCT02847221|scheduled extubation|scheduled extubation
114939|NCT02847221|prognosis|prognosis
114940|NCT02847208|cystic fibrosis|cystic fibrosis
114941|NCT02847208|contraception|contraception
114942|NCT02847208|gynaecological follow-up|gynaecological follow-up
114943|NCT02847208|screening|screening
114944|NCT02847208|Pap smear|pap smear
114945|NCT02847208|counselling|counselling
114946|NCT02847195|pediatric intensive care|pediatric intensive care
114947|NCT02847195|pain assessment|pain assessment
114948|NCT02847195|tracheal aspiration|tracheal aspiration
114949|NCT02847195|sedation|sedation
114950|NCT02847195|pupillometer|pupillometer
114951|NCT02847156|cystic fibrosis|cystic fibrosis
114952|NCT02847156|viruses|viruses
114953|NCT02847156|respiratory viral infection|respiratory viral infection
114954|NCT02847156|children|children
114955|NCT02847143|Attachement|attachement
114956|NCT02847143|Oxytocin|oxytocin
114957|NCT02847143|fMRI|fmri
114958|NCT02847117|Natural Mastiha, Bioavailability|natural mastiha, bioavailability
114959|NCT02847091|Ipragliflozin|ipragliflozin
114960|NCT02847091|SGLT2 inhibitor|sglt2 inhibitor
114961|NCT02847091|Type 2 diabetes mellitus|type 2 diabetes mellitus
114962|NCT02847091|ASP1941|asp1941
114963|NCT02847078|Coronary Disease|coronary disease
115273|NCT02845362|Assessment|assessment
114964|NCT02847078|percutaneous coronary intervention|percutaneous coronary intervention
114965|NCT02847078|secondary prevention|secondary prevention
114966|NCT02847078|smart phone app|smart phone app
114967|NCT02847026|inactivated poliovirus vaccine|inactivated poliovirus vaccine
114968|NCT02847026|fractional inactivated poliovirus vaccine|fractional inactivated poliovirus vaccine
114969|NCT02847026|Rotavirus|rotavirus
114970|NCT02847026|Rotarix|rotarix
114971|NCT02847026|RotaTeq|rotateq
114972|NCT02847026|fIPV|fipv
114973|NCT02847026|IPV|ipv
114974|NCT02847013|Postcesarean Section|postcesarean section
114975|NCT02847013|Postoperative|postoperative
114976|NCT02847000|Decitabine|decitabine
114977|NCT02847000|Tetrahydrouridine|tetrahydrouridine
114978|NCT02847000|Epigenetic Therapy|epigenetic therapy
114979|NCT02846987|Abemaciclib i|abemaciclib i
114980|NCT02846987|LY2835219|ly2835219
114981|NCT02846987|16-376|16-376
114982|NCT02846974|Pulse Oximetry|pulse oximetry
114983|NCT02846974|Free and Open Source|free and open source
114984|NCT02846961|inflammatory bowel disease|inflammatory bowel disease
114985|NCT02846961|biosimilar|biosimilar
114986|NCT02846961|anti-drug antibody|anti-drug antibody
114987|NCT02846961|trough drug concentration|trough drug concentration
114988|NCT02846948|sepsis|sepsis
114989|NCT02846948|echocardiography|echocardiography
114990|NCT02846948|urgent|urgent
114991|NCT02846948|abdominal surgery|abdominal surgery
114992|NCT02846935|p16/CDKN2A|p16/cdkn2a
114993|NCT02846935|TP53|tp53
114994|NCT02846935|THU|thu
114995|NCT02846935|Decitabine|decitabine
114996|NCT02846935|Tetrahydrouridine|tetrahydrouridine
114997|NCT02846935|DEC|dec
114998|NCT02846883|aneurysms|aneurysms
114999|NCT02846857|Closed-loop system|closed-loop system
115000|NCT02846857|Artificial pancreas|artificial pancreas
115001|NCT02846857|Type 1 diabetes|type 1 diabetes
115002|NCT02846857|Hypoglycemia|hypoglycemia
115003|NCT02846857|Insulin|insulin
115004|NCT02846857|Glucagon|glucagon
115005|NCT02846831|Type 1 diabetes|type 1 diabetes
115006|NCT02846831|Artificial pancreas|artificial pancreas
115007|NCT02846831|Closed-loop system|closed-loop system
115008|NCT02846831|Hypoglycemia|hypoglycemia
115009|NCT02846831|Insulin|insulin
115010|NCT02846818|Microdialysis|microdialysis
115011|NCT02846818|Cardiac surgery|cardiac surgery
115012|NCT02846818|Lactate to pyruvate ratio|lactate to pyruvate ratio
115013|NCT02846818|Cardiopulmonary bypass|cardiopulmonary bypass
115014|NCT02846818|Neurological complications|neurological complications
115015|NCT02846779|Insulin persistence|insulin persistence
115016|NCT02846779|Telepharmacy|telepharmacy
115017|NCT02846766|advanced cancer|advanced cancer
115018|NCT02846766|FGF|fgf
115019|NCT02846766|FGFR|fgfr
115020|NCT02846766|Fibroblast Growth Factor Receptor|fibroblast growth factor receptor
115021|NCT02846740|cranial electric stimulation|cranial electric stimulation
115022|NCT02846740|suicide|suicide
115023|NCT02846740|psychiatric inpatients|psychiatric inpatients
115024|NCT02846727|Hypoperfusion|hypoperfusion
115025|NCT02846727|Sepsis|sepsis
115026|NCT02846714|Education|education
115027|NCT02846714|Prevention and Control|prevention and control
115028|NCT02846714|Behavioral Research|behavioral research
115029|NCT02846701|Neuropathic pain|neuropathic pain
115030|NCT02846701|Antidepressant|antidepressant
115031|NCT02846701|Duloxetine|duloxetine
115032|NCT02846701|Liquid Chromatography|liquid chromatography
115033|NCT02846701|Mass Spectrometry|mass spectrometry
115034|NCT02846675|SVF|svf
115035|NCT02846675|Stromal Vascular Fraction|stromal vascular fraction
115036|NCT02846675|osteoarthritis(OA)|osteoarthritis(oa)
115037|NCT02846675|knee|knee
115038|NCT02846675|adipose|adipose
115039|NCT02846662|depression|depression
115040|NCT02846662|mobile technology|mobile technology
115041|NCT02846662|community trial|community trial
115042|NCT02846623|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
115043|NCT02846623|CLL|cll
115044|NCT02846623|Relapsed, Refractory|relapsed, refractory
115045|NCT02846623|High-risk Untreated|high-risk untreated
115046|NCT02846623|High-risk molecular features|high-risk molecular features
115047|NCT02846623|Genetic mutation|genetic mutation
115048|NCT02846623|17p/TP53 deletion|17p/tp53 deletion
115049|NCT02846623|Obinutuzumab|obinutuzumab
115050|NCT02846623|GA101|ga101
115051|NCT02846623|Gazyva|gazyva
115052|NCT02846623|Atezolizumab|atezolizumab
115053|NCT02846623|MPDL3280A|mpdl3280a
115054|NCT02846623|Tencentriq|tencentriq
115055|NCT02846623|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
115056|NCT02846623|SLL|sll
115057|NCT02846610|anesthesia|anesthesia
115058|NCT02846610|continuous regional anesthesia|continuous regional anesthesia
115059|NCT02846610|complications|complications
115060|NCT02846610|epidural analgesia|epidural analgesia
115061|NCT02846610|antibiotics|antibiotics
115062|NCT02846597|Respiratory distress syndrome|respiratory distress syndrome
115063|NCT02846597|Sustained lung inflation|sustained lung inflation
115064|NCT02846597|Delivery room|delivery room
115065|NCT02846584|CAR T|car t
115066|NCT02846584|HSCT|hsct
115067|NCT02846571|Islet Transplantation|islet transplantation
115068|NCT02846571|Type 1 Diabetes|type 1 diabetes
115069|NCT02846571|Immune Tolerance Induction|immune tolerance induction
115070|NCT02846571|Diabetes Complications|diabetes complications
115071|NCT02846571|Intraocular Transplantation|intraocular transplantation
115072|NCT02846571|Eye Anterior Chamber|eye anterior chamber
115073|NCT02846571|Kidney Transplantation|kidney transplantation
115074|NCT02846571|Immunosuppression|immunosuppression
115075|NCT02846571|Type 2 Diabetes|type 2 diabetes
115076|NCT02846558|calorie restriction|calorie restriction
115077|NCT02846558|weight loss|weight loss
115078|NCT02846532|Thromboembolism|thromboembolism
115079|NCT02846532|Fontan Procedure|fontan procedure
115080|NCT02846532|Children|children
115081|NCT02846493|Ovarian hyperstimulation syndrome|ovarian hyperstimulation syndrome
115082|NCT02846493|Dexamethasone|dexamethasone
115083|NCT02846467|Informed consent|informed consent
115084|NCT02846467|Patient Education|patient education
115085|NCT02846467|Mobile applications|mobile applications
115086|NCT02846441|posthepatectomy liver failure|posthepatectomy liver failure
115087|NCT02846441|ALPPS|alpps
115088|NCT02846441|hepatobiliary scintigraphy|hepatobiliary scintigraphy
115089|NCT02846441|SPECT|spect
115090|NCT02846441|mebrofenin|mebrofenin
115091|NCT02846415|Dementia|dementia
115092|NCT02846415|Play and Playthings|play and playthings
115093|NCT02846415|Cognition|cognition
115094|NCT02846415|Memory|memory
115095|NCT02846402|HIV testing|hiv testing
115096|NCT02846402|Female sex workers|female sex workers
115097|NCT02846402|HIV self-testing|hiv self-testing
115098|NCT02846389|Radiation therapy for Breast Cancer|radiation therapy for breast cancer
115099|NCT02846363|stroke|stroke
115100|NCT02846363|public awareness campaign|public awareness campaign
115101|NCT02846363|call to EMS|call to ems
115102|NCT02846337|cardio-renal syndrome|cardio-renal syndrome
115103|NCT02846337|hemodialysis|hemodialysis
115104|NCT02846337|peritoneal dialysis|peritoneal dialysis
115105|NCT02846337|hemofiltration|hemofiltration
115106|NCT02846337|composite endpoint|composite endpoint
115107|NCT02846311|test|test
115108|NCT02846311|winter|winter
115109|NCT02846311|season|season
115110|NCT02846298|Drug Monitoring|drug monitoring
115111|NCT02846298|ICU|icu
115112|NCT02846298|Pharmacokinetic|pharmacokinetic
115113|NCT02846298|Pharmacodynamic|pharmacodynamic
115114|NCT02846298|antibiotic|antibiotic
115115|NCT02846298|Glycopeptides|glycopeptides
115116|NCT02846298|β-lactam-aminoglycoside|β-lactam-aminoglycoside
115117|NCT02846285|Bleeding|bleeding
115118|NCT02846259|intracranial aneurysm|intracranial aneurysm
115119|NCT02846259|cerebral ischemia|cerebral ischemia
115120|NCT02846259|aspirin|aspirin
115121|NCT02846246|aged care|aged care
115122|NCT02846246|health|health
115123|NCT02846246|home care services|home care services
115124|NCT02846246|person-centred care|person-centred care
115125|NCT02846220|Medication Adherence|medication adherence
115126|NCT02846220|Middle Aged 45-64|middle aged 45-64
115127|NCT02846220|Aged 65-79|aged 65-79
115128|NCT02846220|Aged, 80 and over|aged, 80 and over
115129|NCT02846207|cerebral infarction|cerebral infarction
115130|NCT02846207|syndrome of qi deficiency and blood stasis|syndrome of qi deficiency and blood stasis
115131|NCT02846207|Buyanghuanwu decoction|buyanghuanwu decoction
115132|NCT02846207|clinical effects and mechanisms|clinical effects and mechanisms
115133|NCT02846194|Fibromyalgia|fibromyalgia
115134|NCT02846194|Guided Imagery|guided imagery
115135|NCT02846194|chronic pain|chronic pain
115136|NCT02846155|preparation|preparation
115137|NCT02846155|capsule endoscopy|capsule endoscopy
115138|NCT02846129|multiple gestation|multiple gestation
115139|NCT02846129|complications|complications
115140|NCT02846129|cesarean delivery|cesarean delivery
115141|NCT02846116|all ceramic crown|all ceramic crown
115142|NCT02846116|Lithium disilicate|lithium disilicate
115143|NCT02846116|e-max|e-max
115144|NCT02846116|vita suprinity|vita suprinity
115145|NCT02846077|sleep|sleep
115146|NCT02846077|social networks|social networks
115147|NCT02846077|undergraduates|undergraduates
115148|NCT02846077|mood|mood
115149|NCT02846077|circadian rhythms|circadian rhythms
115150|NCT02846051|varicose vein|varicose vein
115151|NCT02846051|physical activity|physical activity
115152|NCT02846038|Pediatric cancer|pediatric cancer
115153|NCT02846038|Childhood cancer|childhood cancer
115154|NCT02846038|High-risk disease|high-risk disease
115155|NCT02846038|Prognosis|prognosis
115156|NCT02846038|Communication|communication
115157|NCT02846038|Bad news|bad news
115158|NCT02846038|Pediatric oncologist|pediatric oncologist
115159|NCT02846038|Parent|parent
115160|NCT02846038|Relapse|relapse
115161|NCT02846038|Progression|progression
115162|NCT02845999|natural killer cells|natural killer cells
115163|NCT02845999|adoptive transfer|adoptive transfer
115164|NCT02845999|allogenic immunotherapy|allogenic immunotherapy
115165|NCT02845999|gastrointestinal cancer EGFR+|gastrointestinal cancer egfr+
115166|NCT02845986|Stomach Neoplasms|stomach neoplasms
115167|NCT02845986|Laparoscopy|laparoscopy
115168|NCT02845986|Spleen-Preserving|spleen-preserving
115169|NCT02845986|No.10 Lymph Node Dissection|no.10 lymph node dissection
115170|NCT02845973|gut microbiota|gut microbiota
115171|NCT02845921|Propofol|propofol
115172|NCT02845921|Hypotension|hypotension
115173|NCT02845921|Induction of anaesthesia|induction of anaesthesia
115174|NCT02845921|Leg elevation|leg elevation
115175|NCT02845921|Leg wrapping|leg wrapping
115176|NCT02845895|Screening for nutritional disorder|screening for nutritional disorder
115177|NCT02845895|Comparison of two organizations|comparison of two organizations
115178|NCT02845895|Indicator IPAQSS|indicator ipaqss
115179|NCT02845856|recurrent lung cancer|recurrent lung cancer
115180|NCT02845856|EGFR mutation|egfr mutation
115181|NCT02845856|Cetuximab|cetuximab
115182|NCT02845856|NK immunotherapy|nk immunotherapy
115183|NCT02845843|Middle East Respiratory Syndrome Coronavirus|middle east respiratory syndrome coronavirus
115184|NCT02845843|MERS-CoV|mers-cov
115185|NCT02845843|Clinical trial|clinical trial
115186|NCT02845843|Lopinavir|lopinavir
115187|NCT02845843|Ritonavir|ritonavir
115188|NCT02845843|Interferon beta|interferon beta
115189|NCT02845830|dementia|dementia
115190|NCT02845830|elderly|elderly
115191|NCT02845830|quality of life|quality of life
115192|NCT02845830|assessment|assessment
115193|NCT02845830|factor|factor
115194|NCT02845830|trajectory|trajectory
115195|NCT02845830|change|change
115196|NCT02845830|early stage|early stage
115197|NCT02845804|coronary artery disease|coronary artery disease
115198|NCT02845804|percutaneous coronary intervention|percutaneous coronary intervention
115199|NCT02845804|everolimus-eluting stents|everolimus-eluting stents
115200|NCT02845778|melatonin|melatonin
115201|NCT02845778|pharmacokinetics|pharmacokinetics
115202|NCT02845765|Erectile Dysfunction|erectile dysfunction
115203|NCT02845765|ED|ed
115204|NCT02845765|Fundus Oculi|fundus oculi
115205|NCT02845765|Retinal Vascularization|retinal vascularization
115206|NCT02845765|International Index of Erectile Function Questionnaire|international index of erectile function questionnaire
115207|NCT02845765|IIEF|iief
115208|NCT02845765|Dynamic Vessel Analyzer|dynamic vessel analyzer
115209|NCT02845765|DVA|dva
115210|NCT02845765|Phosphodiesterase type 5 Inhibitor|phosphodiesterase type 5 inhibitor
115211|NCT02845765|PDE5Is|pde5is
115212|NCT02845739|kidney transplantation|kidney transplantation
115213|NCT02845739|human papillomavirus|human papillomavirus
115214|NCT02845687|nicotine addiction|nicotine addiction
115215|NCT02845687|cigarette smoking|cigarette smoking
115216|NCT02845661|Narcotrend index|narcotrend index
115217|NCT02845661|OAA/S scale|oaa/s scale
115218|NCT02845661|Dexmedetomidine|dexmedetomidine
115219|NCT02845661|Sedation|sedation
115220|NCT02845648|anticholinergics|anticholinergics
115221|NCT02845648|awakener|awakener
115222|NCT02845622|Hazelnut|hazelnut
115223|NCT02845622|Cocoa|cocoa
115224|NCT02845622|Flavonoid|flavonoid
115225|NCT02845622|Lipids|lipids
115226|NCT02845622|Vascular Reactivity|vascular reactivity
115227|NCT02845609|Congenital macrothrombocytopenia|congenital macrothrombocytopenia
115228|NCT02845609|Sialic acid|sialic acid
115229|NCT02845609|Bleeding|bleeding
115230|NCT02845583|Nursing|nursing
115231|NCT02845583|Diagnosis Related Group|diagnosis related group
115232|NCT02845583|Activity based costing|activity based costing
115233|NCT02845557|Youth|youth
115234|NCT02845557|Type 2 Diabetes|type 2 diabetes
115235|NCT02845557|glucose homeostasis|glucose homeostasis
115236|NCT02845557|incretin effect|incretin effect
115237|NCT02845544|Postural Balance|postural balance
115238|NCT02845531|Variant angina|variant angina
115239|NCT02845531|Aborted sudden cardiac death|aborted sudden cardiac death
115240|NCT02845531|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
115241|NCT02845531|Optimal Medical Therapy|optimal medical therapy
115242|NCT02845531|ICD|icd
115243|NCT02845505|intravascular ultrasonography|intravascular ultrasonography
115244|NCT02845505|Computed Tomography|computed tomography
115245|NCT02845492|Exercise|exercise
115246|NCT02845492|Qigong|qigong
115247|NCT02845492|Mind-Body|mind-body
115248|NCT02845492|Fatigue|fatigue
115249|NCT02845492|Cancer|cancer
115250|NCT02845492|EEG|eeg
115251|NCT02845492|HRV|hrv
115252|NCT02845466|Venous Leg Ulcer|venous leg ulcer
115253|NCT02845466|Diabetic Foot Ulcer|diabetic foot ulcer
115254|NCT02845466|Wound Healing|wound healing
115255|NCT02845466|Growth Factor|growth factor
115256|NCT02845466|Protease Inhibitor|protease inhibitor
115257|NCT02845453|youth|youth
115258|NCT02845453|adolescent|adolescent
115259|NCT02845453|young adult|young adult
115260|NCT02845453|substance use disorder|substance use disorder
115261|NCT02845453|bipolar disorder|bipolar disorder
115262|NCT02845453|quetiapine|quetiapine
115263|NCT02845440|Pragmatic Trial|pragmatic trial
115264|NCT02845440|Community Health Workers|community health workers
115265|NCT02845440|Academic Detailing|academic detailing
115266|NCT02845427|Closed Suction Drain|closed suction drain
115267|NCT02845427|Wound Hematoma|wound hematoma
115268|NCT02845388|IVF|ivf
115269|NCT02845362|Neuromuscular|neuromuscular
115270|NCT02845362|dysphagia|dysphagia
115271|NCT02845362|Swallowing disorders|swallowing disorders
115272|NCT02845362|Questionnaire|questionnaire
115274|NCT02845284|adolescent|adolescent
115275|NCT02845284|reproductive health|reproductive health
115276|NCT02845245|Comminuted intra-articular distal tibia fractures|comminuted intra-articular distal tibia fractures
115277|NCT02845245|3D printing|3d printing
115278|NCT02845245|pre-operative planning|pre-operative planning
115279|NCT02845232|Acute myeloid leukemia|acute myeloid leukemia
115280|NCT02845232|Therapy|therapy
115281|NCT02845232|Blood transfusion|blood transfusion
115282|NCT02845232|Cost-effectiveness|cost-effectiveness
115283|NCT02845232|Prognosis|prognosis
115284|NCT02845206|Total Knee Replacement|total knee replacement
115285|NCT02845206|Patient Specific Instrumentation|patient specific instrumentation
115286|NCT02845180|lipectomy|lipectomy
115287|NCT02845180|panniculectomy|panniculectomy
115288|NCT02845154|Ischemia reperfusion|ischemia reperfusion
115289|NCT02845154|post-reperfusion syndrome|post-reperfusion syndrome
115290|NCT02845154|living donor liver transplantation|living donor liver transplantation
115291|NCT02845154|patient outcome|patient outcome
115292|NCT02845141|ACL|acl
115293|NCT02845141|Revision surgery|revision surgery
115294|NCT02845141|tunnel enlargement|tunnel enlargement
115295|NCT02845141|bone substitute material|bone substitute material
115296|NCT02845141|bone graft|bone graft
115297|NCT02845115|Middle Ear Implant|middle ear implant
115298|NCT02845115|laser velocimetry|laser velocimetry
115299|NCT02845102|Chronic Illness|chronic illness
115300|NCT02845102|Chronic Pain|chronic pain
115301|NCT02845102|Depression|depression
115302|NCT02845102|Comorbid Depression|comorbid depression
115303|NCT02845102|Cognitive Behavioral Therapy|cognitive behavioral therapy
115304|NCT02845102|Relational Agent Technology|relational agent technology
115305|NCT02845102|CBT|cbt
115306|NCT02845102|Virtual Counselor|virtual counselor
115307|NCT02845076|Noninvasive ventilation|noninvasive ventilation
115308|NCT02845076|Respiratory insufficiency|respiratory insufficiency
115309|NCT02845076|Hypercapnia|hypercapnia
115310|NCT02845076|ventilator weaning|ventilator weaning
115311|NCT02845063|muscle plasticity|muscle plasticity
115312|NCT02845063|exercise|exercise
115313|NCT02845063|rehabilitation|rehabilitation
115314|NCT02845063|perfusion|perfusion
115315|NCT02845063|ACE|ace
115316|NCT02845063|genotype|genotype
115317|NCT02845063|hypertension|hypertension
115318|NCT02845063|molecular biology|molecular biology
115319|NCT02845050|neo-adjuvant|neo-adjuvant
115320|NCT02845050|vinflunine|vinflunine
115321|NCT02845050|cisplatin|cisplatin
115322|NCT02845050|radical cystectomy|radical cystectomy
115323|NCT02845050|muscle-invasive bladder cancer|muscle-invasive bladder cancer
115324|NCT02845050|JaNEO|janeo
115325|NCT02845011|Cardio first angle|cardio first angle
115326|NCT02845011|CPR|cpr
115327|NCT02845011|Cardiopulmonary Arrest|cardiopulmonary arrest
115328|NCT02845011|Clinical trial|clinical trial
115329|NCT02844998|intravaginal ejaculatory latency time|intravaginal ejaculatory latency time
115330|NCT02844998|international physical activity questionnaire|international physical activity questionnaire
115331|NCT02844998|premature ejaculation diagnostic tool|premature ejaculation diagnostic tool
115332|NCT02844985|Sexual Addiction|sexual addiction
115333|NCT02844985|Genomics|genomics
115334|NCT02844985|Personality|personality
115335|NCT02844985|Polymorphism|polymorphism
115336|NCT02844972|arrest or limitation of active treatment|arrest or limitation of active treatment
115337|NCT02844972|emergency treatment|emergency treatment
115338|NCT02844959|Atrial Fibrillation|atrial fibrillation
115339|NCT02844959|Biomarkers|biomarkers
115340|NCT02844959|Inflammatory Response|inflammatory response
115341|NCT02844959|C-reactive protein|c-reactive protein
115342|NCT02844959|FGF2|fgf2
115343|NCT02844959|MMP8|mmp8
115344|NCT02844959|troponin I|troponin i
115345|NCT02844959|body temperature|body temperature
115346|NCT02844946|Acceptance and Commitment Therapy|acceptance and commitment therapy
115347|NCT02844946|mild Traumatic Brain Injury|mild traumatic brain injury
115348|NCT02844946|Veterans|veterans
115349|NCT02844946|Post Traumatic Stress Disorder|post traumatic stress disorder
115350|NCT02844907|Incretins|incretins
115351|NCT02844907|GLP-1|glp-1
115352|NCT02844907|Exendin-9|exendin-9
115353|NCT02844907|Insulin Resistance|insulin resistance
115354|NCT02844894|intubation, ischemia modified albumine, dexmedetomidine, esmolol|intubation, ischemia modified albumine, dexmedetomidine, esmolol
115355|NCT02844868|stroke|stroke
115356|NCT02844868|hemiplegia|hemiplegia
115357|NCT02844868|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
115358|NCT02844868|rehabilitation|rehabilitation
115359|NCT02844868|lower extremity|lower extremity
115360|NCT02844868|gait training|gait training
115361|NCT02844855|Alzheimer|alzheimer
115362|NCT02844855|Parkinson|parkinson
115363|NCT02844855|Action memory|action memory
115364|NCT02844842|mild or moderate|mild or moderate
115365|NCT02844829|Prostate Cancer|prostate cancer
115366|NCT02844829|Magnetic Resonance Imaging|magnetic resonance imaging
115367|NCT02844777|topical ointment|topical ointment
115368|NCT02844777|skin|skin
115369|NCT02844777|hexokinase|hexokinase
115370|NCT02844777|precancerous conditions|precancerous conditions
115676|NCT02843100|Microbiome|microbiome
115371|NCT02844777|carcinoma, squamous cell|carcinoma, squamous cell
115372|NCT02844712|Drug hypersensitivity|drug hypersensitivity
115373|NCT02844712|Betalactam|betalactam
115374|NCT02844712|Drug provocation test|drug provocation test
115375|NCT02844699|prostate cancer|prostate cancer
115376|NCT02844699|adenovirus|adenovirus
115377|NCT02844699|TLR5|tlr5
115378|NCT02844699|immunotherapy|immunotherapy
115379|NCT02844699|Ad5|ad5
115380|NCT02844686|Myocardial perfusion imaging|myocardial perfusion imaging
115381|NCT02844686|Single-Photon Emission Computer-Assisted Tomography|single-photon emission computer-assisted tomography
115382|NCT02844673|Sickle cell disease|sickle cell disease
115383|NCT02844673|Hydroxyurea|hydroxyurea
115384|NCT02844673|Adherence|adherence
115385|NCT02844673|randomized trial|randomized trial
115386|NCT02844673|medication possession ratio|medication possession ratio
115387|NCT02844660|Diabetes Mellitus|diabetes mellitus
115388|NCT02844660|Foot Diseases|foot diseases
115389|NCT02844660|Foot Ulcer|foot ulcer
115390|NCT02844634|pre-exposure prophylaxis|pre-exposure prophylaxis
115391|NCT02844634|men who have sex with men|men who have sex with men
115392|NCT02844634|HIV prevention|hiv prevention
115393|NCT02844634|sexually transmitted infection|sexually transmitted infection
115394|NCT02844634|syphilis|syphilis
115395|NCT02844608|Health-related quality of life|health-related quality of life
115396|NCT02844608|Oncology clinical practice|oncology clinical practice
115397|NCT02844608|Electronic collection|electronic collection
115398|NCT02844595|Smoking, psychological treatment, depression|smoking, psychological treatment, depression
115399|NCT02844569|Dental Implants|dental implants
115400|NCT02844569|Bone Grafting|bone grafting
115401|NCT02844556|SMILE surgery|smile surgery
115402|NCT02844556|FS-LASIK surgery|fs-lasik surgery
115403|NCT02844556|multicenter|multicenter
115404|NCT02844543|concussion, eye-tracking, athletes, vision|concussion, eye-tracking, athletes, vision
115405|NCT02844530|adults|adults
115406|NCT02844517|Artificial Pancreas|artificial pancreas
115407|NCT02844517|Closed Loop Control|closed loop control
115408|NCT02844517|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
115409|NCT02844504|Fatigue|fatigue
115410|NCT02844504|Breast cancer|breast cancer
115411|NCT02844504|Force|force
115412|NCT02844504|Motor imagery|motor imagery
115413|NCT02844504|Cancer Treatment|cancer treatment
115414|NCT02844478|Caregiving|caregiving
115415|NCT02844478|Family caregiving|family caregiving
115416|NCT02844478|Stress|stress
115417|NCT02844478|dementia caregiving|dementia caregiving
115418|NCT02844478|Hispanics|hispanics
115419|NCT02844478|Spanish|spanish
115420|NCT02844478|Telomere|telomere
115421|NCT02844465|epilepsy|epilepsy
115422|NCT02844465|laser ablation|laser ablation
115423|NCT02844465|Visualase|visualase
115424|NCT02844465|laser interstitial thermal therapy|laser interstitial thermal therapy
115425|NCT02844452|Atopic Dermatitis|atopic dermatitis
115426|NCT02844452|acupuncture|acupuncture
115427|NCT02844452|visit frequency|visit frequency
115428|NCT02844452|adult patient with AD|adult patient with ad
115429|NCT02844426|synbiotic|synbiotic
115430|NCT02844426|soluble dietary fiber|soluble dietary fiber
115431|NCT02844426|slow transit constipation|slow transit constipation
115432|NCT02844426|microbiota|microbiota
115433|NCT02844387|cancer|cancer
115434|NCT02844387|brain|brain
115435|NCT02844387|arginine|arginine
115436|NCT02844387|radiation|radiation
115437|NCT02844374|Epilepsy|epilepsy
115438|NCT02844374|Surgery candidate|surgery candidate
115439|NCT02844374|EEG's Signal|eeg's signal
115440|NCT02844361|high-risk|high-risk
115441|NCT02844361|ASCT|asct
115442|NCT02844348|Pain|pain
115443|NCT02844348|Hypnosis|hypnosis
115444|NCT02844348|Chronic Dialysis|chronic dialysis
115445|NCT02844348|Arterial Disease|arterial disease
115446|NCT02844335|Breast Cancer|breast cancer
115447|NCT02844335|Cryosurgery|cryosurgery
115448|NCT02844335|NK Immunotherapy|nk immunotherapy
115449|NCT02844296|short-bout exercise|short-bout exercise
115450|NCT02844296|craving|craving
115451|NCT02844296|handgrip|handgrip
115452|NCT02844296|smoking cessation|smoking cessation
115453|NCT02844296|RCT|rct
115454|NCT02844283|HGF,myocardial infarction|hgf,myocardial infarction
115455|NCT02844257|Acute myeloid leukaemia|acute myeloid leukaemia
115456|NCT02844257|Transfusion dependency|transfusion dependency
115457|NCT02844257|Transfusion intensity|transfusion intensity
115458|NCT02844257|Prognosis|prognosis
115459|NCT02844257|Chemotherapy|chemotherapy
115460|NCT02844244|family well-being|family well-being
115461|NCT02844244|positive psychology|positive psychology
115462|NCT02844218|Acute myeloid leukemia|acute myeloid leukemia
115463|NCT02844218|Chemotherapy|chemotherapy
115464|NCT02844218|Low-intensity therapy|low-intensity therapy
115465|NCT02844218|Older patients|older patients
115466|NCT02844218|Prognosis|prognosis
115467|NCT02844218|Supportive care|supportive care
115468|NCT02844205|nursing care|nursing care
115469|NCT02844205|observational scale|observational scale
115470|NCT02844205|neonate|neonate
115471|NCT02844205|premature infant|premature infant
115775|NCT02842372|GvHD|gvhd
115472|NCT02844205|developmental care|developmental care
115473|NCT02844192|Vancomycin|vancomycin
115474|NCT02844192|under dosage|under dosage
115475|NCT02844192|intensive care unit|intensive care unit
115476|NCT02844192|pharmacokinetics|pharmacokinetics
115477|NCT02844153|Metformin|metformin
115478|NCT02844153|type 2 diabetes|type 2 diabetes
115479|NCT02844153|chronic kidney disease|chronic kidney disease
115480|NCT02844153|antidiabetic medications|antidiabetic medications
115481|NCT02844153|lactic acidosis|lactic acidosis
115482|NCT02844114|Ganoderma Lucidum Spore|ganoderma lucidum spore
115483|NCT02844114|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
115484|NCT02844114|Chemotherapy|chemotherapy
115485|NCT02844114|Gemcitabine|gemcitabine
115486|NCT02844114|Cisplatin|cisplatin
115487|NCT02844088|meningococcus C|meningococcus c
115488|NCT02844075|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
115489|NCT02844075|pembrolizumab|pembrolizumab
115490|NCT02844075|PD-1|pd-1
115491|NCT02844075|neoadjuvant|neoadjuvant
115492|NCT02844075|chemoradiation|chemoradiation
115493|NCT02844049|Deep Brain Stimulation|deep brain stimulation
115494|NCT02844049|Quality of Life|quality of life
115495|NCT02844036|Distal Lesions|distal lesions
115496|NCT02844036|Post-embolic HTP|post-embolic htp
115497|NCT02844036|Angioplasty|angioplasty
115498|NCT02844023|Arteritis|arteritis
115499|NCT02844023|Biomarker|biomarker
115500|NCT02844023|Horton disease|horton disease
115501|NCT02843997|Bipolar disorder|bipolar disorder
115502|NCT02843997|Endophenotype|endophenotype
115503|NCT02843997|Family|family
115504|NCT02843997|Autosomal dominant expression|autosomal dominant expression
115505|NCT02843997|Sequencing|sequencing
115506|NCT02843997|Heritability|heritability
115507|NCT02843984|Amniocentesis|amniocentesis
115508|NCT02843971|Water Drinking Test|water drinking test
115509|NCT02843971|Intraocular Pressure|intraocular pressure
115510|NCT02843971|Sensimed Triggerfish|sensimed triggerfish
115511|NCT02843958|Medical device|medical device
115512|NCT02843958|Hemoptic|hemoptic
115513|NCT02843958|Vitamin K antagonist|vitamin k antagonist
115514|NCT02843958|Diagnostic in vitro|diagnostic in vitro
115515|NCT02843945|brachytherapy|brachytherapy
115516|NCT02843945|CivaSheet|civasheet
115517|NCT02843945|CivaTech|civatech
115518|NCT02843945|whipple|whipple
115519|NCT02843945|radiation|radiation
115520|NCT02843945|borderline resectable|borderline resectable
115521|NCT02843945|locally advanced|locally advanced
115522|NCT02843945|Pd-103|pd-103
115523|NCT02843945|intraoperative radiation|intraoperative radiation
115524|NCT02843932|Somatoform|somatoform
115525|NCT02843932|Psychogenic|psychogenic
115526|NCT02843919|Electrocardiography|electrocardiography
115527|NCT02843919|Electroencephalography|electroencephalography
115528|NCT02843919|Neural Correlates|neural correlates
115529|NCT02843919|Mental Workload|mental workload
115530|NCT02843906|alzheimer disease|alzheimer disease
115531|NCT02843906|bipolar disorders|bipolar disorders
115532|NCT02843906|mild cognitive impairement|mild cognitive impairement
115533|NCT02843893|Pupillary|pupillary
115534|NCT02843893|Reflexes|reflexes
115535|NCT02843893|Analgesia|analgesia
115536|NCT02843893|Sedation|sedation
115537|NCT02843880|CMV reactivation|cmv reactivation
115538|NCT02843880|CMV disease|cmv disease
115539|NCT02843880|Predictive factors|predictive factors
115540|NCT02843880|Critically ill patients|critically ill patients
115541|NCT02843880|Septic shock|septic shock
115542|NCT02843867|Transplantation|transplantation
115543|NCT02843867|Immunology|immunology
115544|NCT02843867|Atherosclerosis|atherosclerosis
115545|NCT02843828|Exoskeleton Device|exoskeleton device
115546|NCT02843828|elderly|elderly
115547|NCT02843828|stroke|stroke
115548|NCT02843828|gait rehabilitation|gait rehabilitation
115549|NCT02843815|Non-small cell lung cancer|non-small cell lung cancer
115550|NCT02843815|Cryosurgery|cryosurgery
115551|NCT02843815|NK Immunotherapy|nk immunotherapy
115552|NCT02843802|Metastatic liver cancer|metastatic liver cancer
115553|NCT02843802|Cryosurgery|cryosurgery
115554|NCT02843802|NK Immunotherapy|nk immunotherapy
115555|NCT02843789|Adipokines|adipokines
115556|NCT02843789|Tocilizumab|tocilizumab
115557|NCT02843776|Palliative Care|palliative care
115558|NCT02843776|Euthanasia|euthanasia
115559|NCT02843776|Epidemiologic Studies|epidemiologic studies
115560|NCT02843750|Rehabilitation|rehabilitation
115561|NCT02843750|Inspiratory Muscle Training|inspiratory muscle training
115562|NCT02843724|Uncontrolled Type 2 Diabetes|uncontrolled type 2 diabetes
115563|NCT02843724|HbA1c >7.0%|hba1c >7.0%
115564|NCT02843711|Lungcarta Panel|lungcarta panel
115565|NCT02843711|lung adenocarcinoma|lung adenocarcinoma
115566|NCT02843672|metatarsalgia|metatarsalgia
115567|NCT02843672|surgery|surgery
115568|NCT02843672|weil|weil
115569|NCT02843672|MIS|mis
115570|NCT02843672|percutaneous|percutaneous
115571|NCT02843672|DMMO|dmmo
115572|NCT02843646|gait training|gait training
115573|NCT02843646|stepping|stepping
115574|NCT02843633|Acute Coronary Syndrome|acute coronary syndrome
115575|NCT02843633|Percutaneous Coronary Intervention|percutaneous coronary intervention
115576|NCT02843633|Drug Coated Stent|drug coated stent
115577|NCT02843633|Drug Eluting Stent|drug eluting stent
115578|NCT02843620|Native Collagen|native collagen
115579|NCT02843620|Joint|joint
115580|NCT02843620|Joint Discomfort|joint discomfort
115581|NCT02843607|Kidney Cancer|kidney cancer
115582|NCT02843607|Cryosurgery|cryosurgery
115583|NCT02843607|NK Immunotherapy|nk immunotherapy
115584|NCT02843581|Esophageal Cancer|esophageal cancer
115585|NCT02843581|NK immunotherapy|nk immunotherapy
115586|NCT02843581|Safety|safety
115587|NCT02843581|Efficacy|efficacy
115588|NCT02843555|Leukodystrophy|leukodystrophy
115589|NCT02843555|Myelin Gene|myelin gene
115590|NCT02843555|Myelin Protein|myelin protein
115591|NCT02843555|Sural Nerve Biopsy|sural nerve biopsy
115592|NCT02843555|Undiagnosed Disease|undiagnosed disease
115593|NCT02843555|Schwann Cell|schwann cell
115594|NCT02843555|White Matter Pathology|white matter pathology
115595|NCT02843555|Motor Delay|motor delay
115596|NCT02843555|Cognitive Regression|cognitive regression
115597|NCT02843555|Motor Deterioration|motor deterioration
115598|NCT02843555|Unknown Disease|unknown disease
115599|NCT02843542|Positron emission tomography-magnetic resonance imaging (PET-MR)|positron emission tomography-magnetic resonance imaging (pet-mr)
115600|NCT02843542|Hyperthyroidism|hyperthyroidism
115601|NCT02843542|Positron emission tomography-computed tomography (PET-CT)|positron emission tomography-computed tomography (pet-ct)
115602|NCT02843529|biomarkers|biomarkers
115603|NCT02843529|CSF|csf
115604|NCT02843529|EEG|eeg
115605|NCT02843529|MRI|mri
115606|NCT02843529|Digital biomarkers|digital biomarkers
115607|NCT02843490|neovascular age-related macular edema|neovascular age-related macular edema
115608|NCT02843490|biomarker|biomarker
115609|NCT02843490|ranibizumab|ranibizumab
115610|NCT02843490|lucentis|lucentis
115611|NCT02843438|Toxoplasmosis|toxoplasmosis
115612|NCT02843438|Uveitis|uveitis
115613|NCT02843438|Chorioretinitis|chorioretinitis
115614|NCT02843438|Infection|infection
115615|NCT02843425|Cancer Prevention|cancer prevention
115616|NCT02843425|Precancerous colorectal polyps|precancerous colorectal polyps
115617|NCT02843425|Canned beans|canned beans
115618|NCT02843425|Questionnaires|questionnaires
115619|NCT02843425|Surveys|surveys
115620|NCT02843425|Stool samples|stool samples
115621|NCT02843412|Gastric cancer|gastric cancer
115622|NCT02843412|Her2/neu|her2/neu
115623|NCT02843412|Dual paraffin blocks|dual paraffin blocks
115624|NCT02843412|Trastuzumab|trastuzumab
115625|NCT02843412|Clinical Prospective Multicenter Cohort Study|clinical prospective multicenter cohort study
115626|NCT02843399|Diabetes Mellitus Type 2|diabetes mellitus type 2
115627|NCT02843386|Uveal melanoma|uveal melanoma
115628|NCT02843386|High risk of metastasis|high risk of metastasis
115629|NCT02843386|Genomic high risk signature|genomic high risk signature
115630|NCT02843386|Adjuvant chemotherapy|adjuvant chemotherapy
115631|NCT02843360|public health|public health
115632|NCT02843347|Biorepository|biorepository
115633|NCT02843347|Genetics|genetics
115634|NCT02843334|Fabry disease|fabry disease
115635|NCT02843334|End Stage Renal Disease|end stage renal disease
115636|NCT02843334|chronic dialysis|chronic dialysis
115637|NCT02843334|alpha galactosidase A|alpha galactosidase a
115638|NCT02843334|Lyso-GB3|lyso-gb3
115639|NCT02843334|GLA mutation|gla mutation
115640|NCT02843334|Prevalence|prevalence
115641|NCT02843321|infection|infection
115642|NCT02843308|hoarding disorder|hoarding disorder
115643|NCT02843308|hoarding|hoarding
115644|NCT02843308|clutter|clutter
115645|NCT02843295|renal transplantation|renal transplantation
115646|NCT02843295|immunology|immunology
115647|NCT02843295|rejection|rejection
115648|NCT02843269|RCT|rct
115649|NCT02843269|Multi-component intervention|multi-component intervention
115650|NCT02843269|Health personnel|health personnel
115651|NCT02843269|Physical exercise training|physical exercise training
115652|NCT02843230|Brain Tumor|brain tumor
115653|NCT02843204|solid tumor|solid tumor
115654|NCT02843204|anti-PD-L1|anti-pd-l1
115655|NCT02843204|NK immunotherapy|nk immunotherapy
115656|NCT02843191|Rectal Cancer|rectal cancer
115657|NCT02843191|Consolidation Chemotherapy|consolidation chemotherapy
115658|NCT02843178|nutrition|nutrition
115659|NCT02843178|food security|food security
115660|NCT02843178|behavioral economics|behavioral economics
115661|NCT02843165|stereotactic body radiation therapy|stereotactic body radiation therapy
115662|NCT02843165|checkpoint blockade immunotherapy|checkpoint blockade immunotherapy
115663|NCT02843139|Circulating microRNA|circulating microrna
115664|NCT02843139|Childhood obesity|childhood obesity
115665|NCT02843139|Adulthood diabetes|adulthood diabetes
115666|NCT02843126|recurrent breast cancer|recurrent breast cancer
115667|NCT02843126|Her-2 positive|her-2 positive
115668|NCT02843126|Trastuzumab|trastuzumab
115669|NCT02843126|NK immunotherapy|nk immunotherapy
115670|NCT02843113|single father|single father
115671|NCT02843113|parenting behavior|parenting behavior
115672|NCT02843100|Crohn's Disease|crohn's disease
115673|NCT02843100|Pediatric|pediatric
115674|NCT02843100|Exclusive Enteral Nutrition|exclusive enteral nutrition
115675|NCT02843100|Diet|diet
115677|NCT02843087|Breastfeeding|breastfeeding
115678|NCT02843087|Microbiome|microbiome
115679|NCT02843087|BEACH|beach
115680|NCT02843087|Human milk|human milk
115681|NCT02843087|Pediatric Obesity|pediatric obesity
115682|NCT02843074|B-cell tumors|b-cell tumors
115683|NCT02843074|autologous stem cell transplantation|autologous stem cell transplantation
115684|NCT02843074|blood cancers|blood cancers
115685|NCT02843061|B lymphoma|b lymphoma
115686|NCT02843061|Rituximab|rituximab
115687|NCT02843061|NK immunotherapy|nk immunotherapy
115688|NCT02843048|Osteoporosis|osteoporosis
115689|NCT02843048|Bariatric Surgery|bariatric surgery
115690|NCT02843048|Physical exercise|physical exercise
115691|NCT02843048|Obesity|obesity
115692|NCT02843022|postpartum|postpartum
115693|NCT02843022|nursing|nursing
115694|NCT02843022|follow-up|follow-up
115695|NCT02842983|Esmolol|esmolol
115696|NCT02842983|Hypotension|hypotension
115697|NCT02842983|Shock, Septic|shock, septic
115698|NCT02842983|Sepsis|sepsis
115699|NCT02842983|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
115700|NCT02842983|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists
115701|NCT02842983|Adrenergic Antagonists|adrenergic antagonists
115702|NCT02842983|Pharmacologic Actions|pharmacologic actions
115703|NCT02842983|Physiological Effects of Drugs|physiological effects of drugs
115704|NCT02842931|DLBCL, R-DA-EPOCH-21, R-mNHL-BFM-90, auto-SCT|dlbcl, r-da-epoch-21, r-mnhl-bfm-90, auto-sct
115705|NCT02842918|Thoracic Spine Manipulation|thoracic spine manipulation
115706|NCT02842918|Neurodynamics|neurodynamics
115707|NCT02842918|Sham|sham
115708|NCT02842866|Meningitis|meningitis
115709|NCT02842866|Meningococcal Meningitis|meningococcal meningitis
115710|NCT02842866|Meningococcal Infections|meningococcal infections
115711|NCT02842866|MenACYW conjugate vaccine|menacyw conjugate vaccine
115712|NCT02842866|Menomune® - A/C/Y/W-135|menomune® - a/c/y/w-135
115713|NCT02842853|Meningitis|meningitis
115714|NCT02842853|Meningococcal Meningitis|meningococcal meningitis
115715|NCT02842853|Meningococcal Infections|meningococcal infections
115716|NCT02842853|MenACYW conjugate vaccine|menacyw conjugate vaccine
115717|NCT02842853|Licensed MCV4 vaccine|licensed mcv4 vaccine
115718|NCT02842827|LSD1|lsd1
115719|NCT02842814|Systemic Lupus Erythematosus|systemic lupus erythematosus
115720|NCT02842814|Stable|stable
115721|NCT02842814|Relapse Risk|relapse risk
115722|NCT02842814|Glucocorticoid Withdrawal|glucocorticoid withdrawal
115723|NCT02842788|prone position|prone position
115724|NCT02842788|acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
115725|NCT02842788|mechanical ventilation|mechanical ventilation
115726|NCT02842788|ICU|icu
115727|NCT02842788|prevalence|prevalence
115728|NCT02842775|rehabilitation|rehabilitation
115729|NCT02842762|Echocardiography, Three-dimensional|echocardiography, three-dimensional
115730|NCT02842762|Cardiac Surgical Procedures|cardiac surgical procedures
115731|NCT02842762|Cardiac Pacing, Artificial|cardiac pacing, artificial
115732|NCT02842762|Anesthesia|anesthesia
115733|NCT02842736|heavy menstrual bleeding|heavy menstrual bleeding
115734|NCT02842736|endometrial ablation|endometrial ablation
115735|NCT02842723|craniopharyngioma|craniopharyngioma
115736|NCT02842723|protontherapy|protontherapy
115737|NCT02842697|clinically significant portal hypertension|clinically significant portal hypertension
115738|NCT02842697|hepatic venous pressure gradient|hepatic venous pressure gradient
115739|NCT02842697|computed tomographic angiography|computed tomographic angiography
115740|NCT02842671|autism|autism
115741|NCT02842671|ambassador|ambassador
115742|NCT02842658|Chemotherapy|chemotherapy
115743|NCT02842658|Exercise|exercise
115744|NCT02842645|Foetal Exposure During Pregnancy|foetal exposure during pregnancy
115745|NCT02842645|Health|health
115746|NCT02842645|Growth|growth
115747|NCT02842580|colorectal|colorectal
115748|NCT02842580|cancer|cancer
115749|NCT02842580|metastasis|metastasis
115750|NCT02842554|PDN|pdn
115751|NCT02842554|Painful Diabetic Neuropathy|painful diabetic neuropathy
115752|NCT02842554|Diabetes|diabetes
115753|NCT02842502|Skin Substitutes|skin substitutes
115754|NCT02842489|colonoscopy insertion|colonoscopy insertion
115755|NCT02842489|tilt-down position|tilt-down position
115756|NCT02842476|pulse oximetry|pulse oximetry
115757|NCT02842437|dexmedetomidine|dexmedetomidine
115758|NCT02842437|sepsis|sepsis
115759|NCT02842437|respiration|respiration
115760|NCT02842424|Ramipril|ramipril
115761|NCT02842424|Angiotensin-converting enzyme|angiotensin-converting enzyme
115762|NCT02842424|Claudication|claudication
115763|NCT02842424|Myopathy|myopathy
115764|NCT02842424|Peripheral Arterial Disease|peripheral arterial disease
115765|NCT02842411|bowel preparation|bowel preparation
115766|NCT02842411|chronic constipation|chronic constipation
115767|NCT02842411|risk factor|risk factor
115768|NCT02842398|gait|gait
115769|NCT02842398|balance|balance
115770|NCT02842398|street-crossing|street-crossing
115771|NCT02842385|soft tissue thickness|soft tissue thickness
115772|NCT02842385|dental implant|dental implant
115773|NCT02842385|crestal bone loss|crestal bone loss
115774|NCT02842372|Acute Graft Versus Host Disease in Skin|acute graft versus host disease in skin
115776|NCT02842372|Ectoin|ectoin
115777|NCT02842372|Dermatitis|dermatitis
115778|NCT02842372|Inflammation of the skin|inflammation of the skin
115779|NCT02842372|Topical therapy skin GvHD|topical therapy skin gvhd
115780|NCT02842346|Ultrasound; umbilical Doppler; resistance index; fetal growth|ultrasound; umbilical doppler; resistance index; fetal growth
115781|NCT02842307|Acupuncture|acupuncture
115782|NCT02842307|Expertise-based randomized controlled trial|expertise-based randomized controlled trial
115783|NCT02842307|Nausea|nausea
115784|NCT02842307|Vomiting|vomiting
115785|NCT02842307|Cancer|cancer
115786|NCT02842294|bevacizumab|bevacizumab
115787|NCT02842294|health related quality of life|health related quality of life
115788|NCT02842255|Sleep apnea|sleep apnea
115789|NCT02842255|Oximeter|oximeter
115790|NCT02842255|Calibration|calibration
115791|NCT02842255|Oxygen partial pressure|oxygen partial pressure
115792|NCT02842229|Myelodysplastic Syndromes|myelodysplastic syndromes
115793|NCT02842229|Leukemia Myeloid Acute|leukemia myeloid acute
115794|NCT02842229|Multiple Myeloma|multiple myeloma
115795|NCT02842229|Leukemia, Lymphocytic, Chronic|leukemia, lymphocytic, chronic
115796|NCT02842229|Elderly Patients|elderly patients
115797|NCT02842229|Haematological malignancy|haematological malignancy
115798|NCT02842229|Elderly|elderly
115799|NCT02842229|Health Status|health status
115800|NCT02842229|Scale validation|scale validation
115801|NCT02842229|Retrospective|retrospective
115802|NCT02842216|Pharmaceutical preparations|pharmaceutical preparations
115803|NCT02842216|Dietary supplements|dietary supplements
115804|NCT02842203|colorectal cancer|colorectal cancer
115805|NCT02842190|Neonatal|neonatal
115806|NCT02842190|NIPPV|nippv
115807|NCT02842190|BIPAP|bipap
115808|NCT02842190|Extubation failure|extubation failure
115809|NCT02842151|IOL|iol
115810|NCT02842125|Colorectal|colorectal
115811|NCT02842125|solid tumors|solid tumors
115812|NCT02842125|hepatocellular|hepatocellular
115813|NCT02842125|Ad-P53|ad-p53
115814|NCT02842125|metastatic|metastatic
115815|NCT02842125|capecitabine|capecitabine
115816|NCT02842112|Acute myeloid leukemia|acute myeloid leukemia
115817|NCT02842112|prognosis|prognosis
115818|NCT02842112|stem cell harvest|stem cell harvest
115819|NCT02842112|autologous transplant|autologous transplant
115820|NCT02842112|leukemia stem cell|leukemia stem cell
115821|NCT02842060|Prevention & Control|prevention & control
115822|NCT02842060|Young Adult|young adult
115823|NCT02842060|Internet|internet
115824|NCT02842047|caregiver|caregiver
115825|NCT02842047|end of life|end of life
115826|NCT02842034|schizophrenia|schizophrenia
115827|NCT02842034|rTMS|rtms
115828|NCT02842008|Exercise Therapy|exercise therapy
115829|NCT02842008|Shoulder pain|shoulder pain
115830|NCT02842008|Shoulder injuries|shoulder injuries
115831|NCT02842008|Shoulder function|shoulder function
115832|NCT02842008|Prevention|prevention
115833|NCT02842008|Wheelchair users|wheelchair users
115834|NCT02841995|cGVHD|cgvhd
115835|NCT02841995|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
115836|NCT02841995|Immune System Diseases|immune system diseases
115837|NCT02841995|Steroid refractory chronic graft vs host disease (cGVHD)|steroid refractory chronic graft vs host disease (cgvhd)
115838|NCT02841995|Bone Marrow Transplantation|bone marrow transplantation
115839|NCT02841995|Anti-Inflammatory Agents|anti-inflammatory agents
115840|NCT02841995|Glucocorticoids|glucocorticoids
115841|NCT02841995|Corticosteroids|corticosteroids
115842|NCT02841969|Ulcer|ulcer
115843|NCT02841969|Electrolysed|electrolysed
115844|NCT02841969|Water|water
115845|NCT02841943|Fluid responsiveness|fluid responsiveness
115846|NCT02841943|Near-infrared spectroscopy|near-infrared spectroscopy
115847|NCT02841943|Thoracic surgery|thoracic surgery
115848|NCT02841943|Hypovolemia|hypovolemia
115849|NCT02841943|veno-arterial carbon dioxide gradient|veno-arterial carbon dioxide gradient
115850|NCT02841943|arterio-venous oxygen gradient|arterio-venous oxygen gradient
115851|NCT02841943|hypercarbia|hypercarbia
115852|NCT02841943|Carotid artery|carotid artery
115853|NCT02841943|ultrasonography|ultrasonography
115854|NCT02841943|Doppler|doppler
115855|NCT02841930|Healthcare Access|healthcare access
115856|NCT02841930|Undocumented Immigrants|undocumented immigrants
115857|NCT02841930|Primary Prevention|primary prevention
115858|NCT02841800|radiofrequency ablation|radiofrequency ablation
115859|NCT02841800|malignant biliary stenosis|malignant biliary stenosis
115860|NCT02841787|Depression|depression
115861|NCT02841787|Web-based intervention|web-based intervention
115862|NCT02841787|Aging|aging
115863|NCT02841787|Geriatrics|geriatrics
115864|NCT02841787|Social network|social network
115865|NCT02841787|Older adults|older adults
115866|NCT02841748|Pembrolizumab|pembrolizumab
115867|NCT02841748|HNSCC|hnscc
115868|NCT02841735|brief intervention|brief intervention
115869|NCT02841735|web-based interventions|web-based interventions
115870|NCT02841735|harm reduction|harm reduction
115871|NCT02841735|young adult|young adult
115872|NCT02841735|college student|college student
115873|NCT02841709|insomnia|insomnia
115874|NCT02841709|elderly|elderly
115875|NCT02841709|Polysomnography|polysomnography
115876|NCT02841696|Heart failure|heart failure
115877|NCT02841696|Systolic dysfunction|systolic dysfunction
115878|NCT02841696|GLS|gls
115879|NCT02841696|Arterial stiffness|arterial stiffness
115880|NCT02841696|Left ventricular hypertrophy|left ventricular hypertrophy
115881|NCT02841657|3 Dimensional Laparoscopy|3 dimensional laparoscopy
115882|NCT02841657|Visual work load|visual work load
115883|NCT02841657|Nasa Task Load Index|nasa task load index
115884|NCT02841657|Simulator Sickness Questionnaire|simulator sickness questionnaire
115885|NCT02841553|Endoplasmic Reticulum Stress|endoplasmic reticulum stress
115886|NCT02841540|Myelodysplastic Syndromes|myelodysplastic syndromes
115887|NCT02841540|Acute Myeloid Leukemia|acute myeloid leukemia
115888|NCT02841540|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
115889|NCT02841540|H3B-8800|h3b-8800
115890|NCT02841501|Gene Expression Profiling|gene expression profiling
115891|NCT02841501|Genome-Wide Association Study|genome-wide association study
115892|NCT02841501|Polymorphism, Single Nucleotide|polymorphism, single nucleotide
115893|NCT02841501|Drug Resistance, Fungal|drug resistance, fungal
115894|NCT02841475|Atrial Fibrillation , Comorbidities|atrial fibrillation , comorbidities
115895|NCT02841462|thermal ablation|thermal ablation
115896|NCT02841462|recurrent Bursitis|recurrent bursitis
115897|NCT02841462|chronic Bursitis|chronic bursitis
115898|NCT02841462|olecranon|olecranon
115899|NCT02841462|intra-bursal perfusion|intra-bursal perfusion
115900|NCT02841449|Hydration|hydration
115901|NCT02841449|Glycemic control|glycemic control
115902|NCT02841449|Appetite|appetite
115903|NCT02841449|Endocrinology|endocrinology
115904|NCT02841436|irreversible electroporation|irreversible electroporation
115905|NCT02841436|pancreatic cancer|pancreatic cancer
115906|NCT02841423|physical status I-III;|physical status i-iii;
115907|NCT02841423|age > 55 yr)|age > 55 yr)
115908|NCT02841423|undergoing surgery (duration, > 1 h)|undergoing surgery (duration, > 1 h)
115909|NCT02841410|Food|food
115910|NCT02841410|Emotion|emotion
115911|NCT02841410|Health|health
115912|NCT02841410|Nutrition|nutrition
115913|NCT02841410|Heuristic|heuristic
115914|NCT02841410|Reasoning|reasoning
115915|NCT02841410|Magnetic Resonance Imaging|magnetic resonance imaging
115916|NCT02841384|patellofemoral pain syndrome|patellofemoral pain syndrome
115917|NCT02841384|postural balance|postural balance
115918|NCT02841384|knee|knee
115919|NCT02841384|physiotherapy|physiotherapy
115920|NCT02841371|estimated glomerular filtration rate|estimated glomerular filtration rate
115921|NCT02841371|serum creatinine|serum creatinine
115922|NCT02841371|serum cystatin C|serum cystatin c
115923|NCT02841371|chronic kidney disease|chronic kidney disease
115924|NCT02841358|Niemann-Pick Disease, Type C|niemann-pick disease, type c
115925|NCT02841358|Psychiatric|psychiatric
115926|NCT02841358|Psychotic disorders|psychotic disorders
115927|NCT02841345|emotional processing|emotional processing
115928|NCT02841345|action|action
115929|NCT02841332|Recurrent Glioblastoma|recurrent glioblastoma
115930|NCT02841332|Positron emission tomography|positron emission tomography
115931|NCT02841332|Fluoro misonidazole|fluoro misonidazole
115932|NCT02841332|MRI multimodal|mri multimodal
115933|NCT02841319|Virtual reality|virtual reality
115934|NCT02841319|Hemiplegic|hemiplegic
115935|NCT02841319|Cerebral Palsy|cerebral palsy
115936|NCT02841319|upper extremity|upper extremity
115937|NCT02841319|hand function|hand function
115938|NCT02841293|Anorectal cancer|anorectal cancer
115939|NCT02841293|perineal morbidity|perineal morbidity
115940|NCT02841293|cost-utility analysis|cost-utility analysis
115941|NCT02841293|biological meshes|biological meshes
115942|NCT02841241|esmolol|esmolol
115943|NCT02841241|adrenergic storm|adrenergic storm
115944|NCT02841241|septic shock|septic shock
115945|NCT02841228|SIB-IMRT|sib-imrt
115946|NCT02841228|NSCLC|nsclc
115947|NCT02841228|Radiochemothearpy|radiochemothearpy
115948|NCT02841215|Gale|gale
115949|NCT02841215|Severe forms of scabies|severe forms of scabies
115950|NCT02841215|Oral parasitic drug|oral parasitic drug
115951|NCT02841215|Ivermectin|ivermectin
115952|NCT02841202|optical coherence tomography|optical coherence tomography
115953|NCT02841202|oral contraceptive pills|oral contraceptive pills
115954|NCT02841163|Magnetic Resonance Imaging|magnetic resonance imaging
115955|NCT02841163|Patient Satisfaction|patient satisfaction
115956|NCT02841163|Numeric Rating Scale|numeric rating scale
115957|NCT02841124|Decision making|decision making
115958|NCT02841098|Carotid stenosis,stroke,endarterectomy,medical therapy|carotid stenosis,stroke,endarterectomy,medical therapy
115959|NCT02841085|Genetic|genetic
115960|NCT02841085|Thrombophilia|thrombophilia
115961|NCT02841059|quality of life|quality of life
115962|NCT02841059|urinary incontinence|urinary incontinence
115963|NCT02841059|POP|pop
115964|NCT02841046|stroke volume variation|stroke volume variation
115965|NCT02841046|cardiac index|cardiac index
115966|NCT02841046|non-severe patients|non-severe patients
115967|NCT02841046|gastrointestinal surgery|gastrointestinal surgery
115968|NCT02841033|Daratumumab|daratumumab
115969|NCT02840994|CV301, NSCLC, Pembrolizumab, Nivolumab|cv301, nsclc, pembrolizumab, nivolumab
115970|NCT02840955|Atopic dermatitis|atopic dermatitis
115971|NCT02840955|Staphylococcus aureus|staphylococcus aureus
115972|NCT02840955|Microbiome|microbiome
115973|NCT02840955|Staphefekt|staphefekt
115974|NCT02840942|intravenous line|intravenous line
115975|NCT02840942|robot|robot
115976|NCT02840916|Laser acupuncture|laser acupuncture
115977|NCT02840916|Postpartum weight retention|postpartum weight retention
115978|NCT02840916|Obesity|obesity
115979|NCT02840903|CTA|cta
115980|NCT02840903|Computed Tomographic Angiography|computed tomographic angiography
115981|NCT02840877|tuberculosis culture|tuberculosis culture
115982|NCT02840877|alcohol use|alcohol use
115983|NCT02840851|Magnetic Resonance Imaging|magnetic resonance imaging
115984|NCT02840851|Transcranial Doppler Ultrasound|transcranial doppler ultrasound
115985|NCT02840851|Hypercapnia|hypercapnia
115986|NCT02840799|Heart Failure|heart failure
115987|NCT02840799|Exercise Intolerance|exercise intolerance
115988|NCT02840799|Ejection Fraction|ejection fraction
115989|NCT02840786|stents|stents
115990|NCT02840786|atherectomy|atherectomy
115991|NCT02840786|femoral artery|femoral artery
115992|NCT02840786|popliteal artery|popliteal artery
115993|NCT02840773|RANKL|rankl
115994|NCT02840773|OPG|opg
115995|NCT02840773|Peri-implant crevicular fluid|peri-implant crevicular fluid
115996|NCT02840760|tardive dyskinesia.|tardive dyskinesia.
115997|NCT02840760|rTMS|rtms
115998|NCT02840747|Lymphomatoid Papulosis|lymphomatoid papulosis
115999|NCT02840747|Sézary Syndrome|sézary syndrome
116000|NCT02840747|T-Cell Lymphoma|t-cell lymphoma
116001|NCT02840734|Kinesio taping|kinesio taping
116002|NCT02840734|Obese adults|obese adults
116003|NCT02840734|Muscular function|muscular function
116004|NCT02840734|Fatigue|fatigue
116005|NCT02840682|resource limited setting|resource limited setting
116006|NCT02840682|Thailand-Myanmar border|thailand-myanmar border
116007|NCT02840669|Cardiomyopathy|cardiomyopathy
116008|NCT02840643|hemispherectomy|hemispherectomy
116009|NCT02840643|brain|brain
116010|NCT02840643|hand function|hand function
116011|NCT02840630|n3 LC-PUFA|n3 lc-pufa
116012|NCT02840630|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
116013|NCT02840630|South Asian|south asian
116014|NCT02840630|HbA1c|hba1c
116015|NCT02840630|Omega 3 status|omega 3 status
116016|NCT02840617|ICG|icg
116017|NCT02840617|prostate cancer|prostate cancer
116018|NCT02840591|Citicoline, Ramelteon, Rozerem|citicoline, ramelteon, rozerem
116019|NCT02840539|Mantle cell lymphoma|mantle cell lymphoma
116020|NCT02840539|Bortezomib|bortezomib
116021|NCT02840539|Cytarabine|cytarabine
116022|NCT02840526|PVB|pvb
116023|NCT02840526|PCA|pca
116024|NCT02840526|nephrectomy|nephrectomy
116025|NCT02840526|postoperative pain|postoperative pain
116026|NCT02840513|Smartphone app|smartphone app
116027|NCT02840513|CO self-monitoring|co self-monitoring
116028|NCT02840500|Breakthrough Cancer Pain|breakthrough cancer pain
116029|NCT02840500|Quality of life|quality of life
116030|NCT02840500|Palliative Care Units|palliative care units
116031|NCT02840487|Zika Infection|zika infection
116032|NCT02840487|Flavivirus|flavivirus
116033|NCT02840487|Vaccine-Mediated Protection|vaccine-mediated protection
116034|NCT02840487|Immune Response|immune response
116035|NCT02840487|Arthropod-Borne Virus|arthropod-borne virus
116036|NCT02840474|HIV Viral Load|hiv viral load
116037|NCT02840474|Antiviral|antiviral
116038|NCT02840474|CD4 Count|cd4 count
116039|NCT02840474|HIV-1 Infection|hiv-1 infection
116040|NCT02840448|Williams Syndrome|williams syndrome
116041|NCT02840448|Blood Flow|blood flow
116042|NCT02840448|Brain|brain
116043|NCT02840448|Arterial Stiffness|arterial stiffness
116044|NCT02840435|Nicotine addiction|nicotine addiction
116045|NCT02840435|Cigarette smoking|cigarette smoking
116046|NCT02840422|Hyaluronic acid|hyaluronic acid
116047|NCT02840422|Knee osteoarthritis|knee osteoarthritis
116048|NCT02840422|Quality of life|quality of life
116049|NCT02840396|language|language
116050|NCT02840396|DLPFC|dlpfc
116051|NCT02840396|rTMS|rtms
116052|NCT02840396|Executive Functions|executive functions
116053|NCT02840370|transcranial direct current stimulation|transcranial direct current stimulation
116054|NCT02840370|aphasia|aphasia
116055|NCT02840370|language production|language production
116056|NCT02840370|prefrontal cortex|prefrontal cortex
116057|NCT02840357|Chronic inflammation|chronic inflammation
116058|NCT02840357|Adults|adults
116059|NCT02840357|overweight|overweight
116060|NCT02840357|obese|obese
116061|NCT02840344|Couple Functioning|couple functioning
116062|NCT02840344|Stress Reduction|stress reduction
116063|NCT02840331|Gastric carcinoma|gastric carcinoma
116064|NCT02840331|Peritoneal carcinomatosis|peritoneal carcinomatosis
116065|NCT02840331|Photodynamic diagnosis|photodynamic diagnosis
116066|NCT02840331|Photodynamic therapy|photodynamic therapy
116067|NCT02840331|St. John's Wort|st. john's wort
116068|NCT02840331|Peritoneal metastasis|peritoneal metastasis
116069|NCT02840318|Terminal care|terminal care
116070|NCT02840318|Residential facilities|residential facilities
116071|NCT02840318|Integrated health care systems|integrated health care systems
116072|NCT02840318|Interdisciplinary health team|interdisciplinary health team
116073|NCT02840318|Palliative care|palliative care
116074|NCT02840305|Natural scenes|natural scenes
116075|NCT02840305|Brain bases|brain bases
116076|NCT02840305|Visual perception|visual perception
116077|NCT02840305|MRI|mri
116078|NCT02840292|Late Preterms|late preterms
116079|NCT02840292|Neurobehavioral Assessment of Preterm Infants (NAPI)|neurobehavioral assessment of preterm infants (napi)
116080|NCT02840279|cognition|cognition
116081|NCT02840279|dementia|dementia
116082|NCT02840279|phosphodiesterase type 4D|phosphodiesterase type 4d
116083|NCT02840279|PDE4D|pde4d
116084|NCT02840227|Cancer|cancer
116085|NCT02840227|General anesthesia|general anesthesia
116086|NCT02840227|Epidural anesthesia|epidural anesthesia
116087|NCT02840201|biomarkers|biomarkers
116088|NCT02840188|goalkeeper's fracture|goalkeeper's fracture
116089|NCT02840175|Treatment tapering|treatment tapering
116090|NCT02840175|Oligoarticular|oligoarticular
116091|NCT02840175|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
116092|NCT02840175|Inactive disease|inactive disease
116093|NCT02840175|Biologic therapy|biologic therapy
116094|NCT02840162|prostate cancer|prostate cancer
116095|NCT02840162|NSAIDs|nsaids
116096|NCT02840162|chemoprevention|chemoprevention
116097|NCT02840162|celecoxib|celecoxib
116098|NCT02840162|COX-2 inhibitors|cox-2 inhibitors
116099|NCT02840149|68Ga-DOTA-TATE, PET/CT|68ga-dota-tate, pet/ct
116100|NCT02840136|Respiratory infection|respiratory infection
116101|NCT02840136|Antibiotic therapy|antibiotic therapy
116102|NCT02840136|LC-MS/MS|lc-ms/ms
116103|NCT02840136|Sputum antibiotic concentrations|sputum antibiotic concentrations
116104|NCT02840097|Brain injuries|brain injuries
116105|NCT02840097|Wounds and injuries|wounds and injuries
116106|NCT02840097|Hemorrhage|hemorrhage
116107|NCT02840097|Tranexamic acid|tranexamic acid
116108|NCT02840097|Child|child
116109|NCT02840084|breast implant capsular contracture|breast implant capsular contracture
116110|NCT02840045|electroencephalography (EEG)|electroencephalography (eeg)
116111|NCT02840019|Fetal MRI|fetal mri
116112|NCT02840019|Pregnancy|pregnancy
116113|NCT02840019|Pregnant Women|pregnant women
116114|NCT02840019|MRI Coil|mri coil
116115|NCT02840019|MRI Sequence Development/Testing|mri sequence development/testing
116116|NCT02840019|Abnormal Fetuses|abnormal fetuses
116117|NCT02840019|Typically Developing Fetuses|typically developing fetuses
116118|NCT02840019|Fetal MRI Technology Development|fetal mri technology development
116119|NCT02840006|Vasoconstrictor Agents|vasoconstrictor agents
116120|NCT02840006|Vasodilator Agents|vasodilator agents
116121|NCT02839993|tDCS effects|tdcs effects
116122|NCT02839993|associative learning|associative learning
116123|NCT02839980|oropharyngeal colonization|oropharyngeal colonization
116124|NCT02839915|Language Impairment|language impairment
116125|NCT02839850|Arthroplasty|arthroplasty
116126|NCT02839850|replacement|replacement
116127|NCT02839850|Knee|knee
116128|NCT02839850|function|function
116129|NCT02839850|radiographic|radiographic
116130|NCT02839850|survivorship|survivorship
116131|NCT02839837|Depression|depression
116132|NCT02839837|Depressive Disorder|depressive disorder
116133|NCT02839837|Exercise|exercise
116134|NCT02839837|Neuroplasticity|neuroplasticity
116135|NCT02839837|Non-invasive brain stimulation|non-invasive brain stimulation
116136|NCT02839837|Healthy Control|healthy control
116137|NCT02839824|bowel cleansing|bowel cleansing
116138|NCT02839824|bowel preparation|bowel preparation
116139|NCT02839811|Betalactams|betalactams
116140|NCT02839811|In vitro diagnosis|in vitro diagnosis
116141|NCT02839798|sTMS|stms
116142|NCT02839798|NEST|nest
116143|NCT02839798|NeoSync|neosync
116144|NCT02839798|synchronous|synchronous
116145|NCT02839798|non-invasive neuromodulation|non-invasive neuromodulation
116146|NCT02839798|TMS|tms
116147|NCT02839798|transcranial magnetic stimulation|transcranial magnetic stimulation
116148|NCT02839798|EEG|eeg
116149|NCT02839798|bipolar|bipolar
116150|NCT02839798|depression|depression
116151|NCT02839785|Cerebral palsy|cerebral palsy
116152|NCT02839785|Physiotherapy|physiotherapy
116153|NCT02839785|Children|children
116154|NCT02839785|Ibuprofen|ibuprofen
116155|NCT02839785|Pain|pain
116156|NCT02839785|Anxiety|anxiety
116157|NCT02839772|podoconiosis|podoconiosis
116158|NCT02839772|glycerine|glycerine
116159|NCT02839772|RCT|rct
116160|NCT02839772|SBF|sbf
116161|NCT02839772|TEWL|tewl
116162|NCT02839772|SC hydration|sc hydration
116163|NCT02839759|Hearing loss|hearing loss
116164|NCT02839759|Presbycusis|presbycusis
116165|NCT02839759|Aging|aging
116166|NCT02839759|Teleaudiology|teleaudiology
116167|NCT02839733|Brain Imaging|brain imaging
116168|NCT02839733|Adult|adult
116169|NCT02839733|DNA Testing|dna testing
116170|NCT02839733|Children|children
116171|NCT02839694|Lung Resection|lung resection
116172|NCT02839694|Surgery|surgery
116173|NCT02839694|Bilateral Lung Metastases|bilateral lung metastases
116174|NCT02839681|Lung Adenocarcinoma|lung adenocarcinoma
116175|NCT02839681|Immunotoxin|immunotoxin
116176|NCT02839681|Immunotherapy|immunotherapy
116177|NCT02839668|breast cancer|breast cancer
116178|NCT02839668|angiogenesis|angiogenesis
116179|NCT02839668|VEGF|vegf
116180|NCT02839603|Visceral leishmaniasis|visceral leishmaniasis
116181|NCT02839603|HIV co-infection|hiv co-infection
116182|NCT02839603|Asymptomatic|asymptomatic
116183|NCT02839590|Glaucoma|glaucoma
116184|NCT02839590|Ocular hypertension|ocular hypertension
116185|NCT02839590|Aqueous dynamics|aqueous dynamics
116186|NCT02839564|chronic abdominal pain|chronic abdominal pain
116187|NCT02839564|laparoscopic adhesiolysis|laparoscopic adhesiolysis
116188|NCT02839564|placebo|placebo
116189|NCT02839551|Betalactams|betalactams
116190|NCT02839551|Drug hypersensitivity|drug hypersensitivity
116191|NCT02839551|Drug provocation test|drug provocation test
116192|NCT02839551|Reactive dose|reactive dose
116193|NCT02839538|infiltration|infiltration
116194|NCT02839538|hemorrhoidectomy|hemorrhoidectomy
116195|NCT02839538|postoperative pain|postoperative pain
116196|NCT02839525|Eccentric exercise|eccentric exercise
116197|NCT02839525|Dietary supplement|dietary supplement
116198|NCT02839525|Muscle damage|muscle damage
116199|NCT02839499|seniors|seniors
116200|NCT02839499|mixed food|mixed food
116201|NCT02839499|normal texture food|normal texture food
116202|NCT02839486|antibiotic prophylaxis|antibiotic prophylaxis
116203|NCT02839486|pharmacokinetics|pharmacokinetics
116204|NCT02839486|cardiopulmonary bypass|cardiopulmonary bypass
116205|NCT02839447|semen|semen
116206|NCT02839447|sperm|sperm
116207|NCT02839447|oxidative stress|oxidative stress
116208|NCT02839447|reactive oxygen species|reactive oxygen species
116209|NCT02839447|idiopathic male infertility|idiopathic male infertility
116210|NCT02839408|periodontitis|periodontitis
116211|NCT02839408|azithromycin|azithromycin
116212|NCT02839408|probiotic|probiotic
116213|NCT02839395|screen illumination|screen illumination
116214|NCT02839395|melatonin|melatonin
116215|NCT02839395|body temperature|body temperature
116216|NCT02839395|cognitive functioning|cognitive functioning
116217|NCT02839395|light pollution|light pollution
116218|NCT02839369|walking performance|walking performance
116219|NCT02839369|Cerebral Palsy, Typically Developed|cerebral palsy, typically developed
116220|NCT02839330|Influenza|influenza
116221|NCT02839330|Vaccine|vaccine
116222|NCT02839330|Flu|flu
116223|NCT02839330|Avian|avian
116224|NCT02839330|Pandemic|pandemic
116225|NCT02839330|H5N1|h5n1
116226|NCT02839330|MF59|mf59
116227|NCT02839317|Dysbiosis|dysbiosis
116228|NCT02839317|Crohn's disease|crohn's disease
116229|NCT02839317|Age|age
116230|NCT02839278|Immunomodulation|immunomodulation
116231|NCT02839226|ulcers|ulcers
116232|NCT02839226|wounds|wounds
116233|NCT02839226|diabetes|diabetes
116234|NCT02839226|venous ulcers|venous ulcers
116235|NCT02839226|arterial ulcers|arterial ulcers
116236|NCT02839226|granulation tissue|granulation tissue
116237|NCT02839226|protein kinase c|protein kinase c
116238|NCT02839200|Insomnia|insomnia
116239|NCT02839200|Polysomnography|polysomnography
116240|NCT02839174|low carbohydrate diet|low carbohydrate diet
116241|NCT02839161|Hookworm|hookworm
116242|NCT02839161|Vaccine|vaccine
116243|NCT02839161|Na-GST-1|na-gst-1
116244|NCT02839161|Na-APR-1|na-apr-1
116245|NCT02839161|Necator americanus|necator americanus
116246|NCT02839148|Appetite, Stunting, Satiety, Children|appetite, stunting, satiety, children
116247|NCT02839122|Dutasteride|dutasteride
116248|NCT02839122|Tadalafil|tadalafil
116249|NCT02839070|Sleep|sleep
116250|NCT02839070|Learning|learning
116251|NCT02839070|Circadian Rhythms|circadian rhythms
116252|NCT02839057|Axis fractures|axis fractures
116253|NCT02839057|Elderly|elderly
116254|NCT02839057|Mortality|mortality
116255|NCT02839057|Surgical treatment|surgical treatment
116256|NCT02839031|diabetes mellitus|diabetes mellitus
116257|NCT02839031|glycaemia|glycaemia
116258|NCT02839031|cognitive-behavioral treatment|cognitive-behavioral treatment
116259|NCT02839031|coping|coping
116260|NCT02839031|parents|parents
116261|NCT02839031|children|children
116262|NCT02839005|Wound Closure Thechnical|wound closure thechnical
116263|NCT02839005|Wound Healing|wound healing
116264|NCT02838992|Cyclophosphamide|cyclophosphamide
116265|NCT02838992|Umbilical Cord Blood|umbilical cord blood
116267|NCT02838979|Glutamine|glutamine
116268|NCT02838979|Chronic Kidney Disease|chronic kidney disease
116269|NCT02838966|immunomodulation|immunomodulation
116270|NCT02838966|immunonutrition|immunonutrition
116271|NCT02838953|Ultrasonography|ultrasonography
116272|NCT02838953|Respiratory Function Tests|respiratory function tests
116273|NCT02838953|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
116274|NCT02838953|Rehabilitation|rehabilitation
116275|NCT02838927|Hypoparathyroidism|hypoparathyroidism
116276|NCT02838927|Epidemiology|epidemiology
116277|NCT02838927|Medication Therapy Management|medication therapy management
116278|NCT02838914|Right atrium|right atrium
116279|NCT02838914|Echocardiography|echocardiography
116280|NCT02838914|Remodeling|remodeling
116281|NCT02838888|Adenoma|adenoma
116282|NCT02838888|computer|computer
116283|NCT02838888|automatic|automatic
116284|NCT02838888|polyp|polyp
116285|NCT02838888|detection|detection
116286|NCT02838862|Neuroendocrine Tumors|neuroendocrine tumors
116287|NCT02838862|MALDI-MS|maldi-ms
116288|NCT02838862|Proteomics|proteomics
116289|NCT02838862|Biomarkers, Tumor|biomarkers, tumor
116290|NCT02838862|Precision Medicine|precision medicine
116291|NCT02838836|Cancer|cancer
116292|NCT02838836|Circulating tumor cells (CTCs)|circulating tumor cells (ctcs)
116293|NCT02838836|Disseminated tumor cells (DTCs)|disseminated tumor cells (dtcs)
116294|NCT02838836|Circulating tumor DNA (ctDNA)|circulating tumor dna (ctdna)
116295|NCT02838823|anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
116296|NCT02838823|triple negative breast cancer|triple negative breast cancer
116297|NCT02838823|safety|safety
116298|NCT02838810|peginterferon alfa|peginterferon alfa
116299|NCT02838810|Chronic Hepatitis B|chronic hepatitis b
116300|NCT02838797|Parkinson's disease|parkinson's disease
116301|NCT02838797|Gastroparesis|gastroparesis
116302|NCT02838797|Constipation|constipation
116303|NCT02838797|Prokinetic|prokinetic
116304|NCT02838797|5-HT4-receptor partial agonist|5-ht4-receptor partial agonist
116305|NCT02838771|Swallowing Disorder|swallowing disorder
116306|NCT02838771|Dysphagia|dysphagia
116307|NCT02838758|Morton's neuroma|morton's neuroma
116308|NCT02838758|Intermetatarsal neuroma|intermetatarsal neuroma
116309|NCT02838758|forefoot pain|forefoot pain
116310|NCT02838758|ultrasound guided cryoablation|ultrasound guided cryoablation
116311|NCT02838758|ultrasound guided perineural lidocaine injection|ultrasound guided perineural lidocaine injection
116312|NCT02838706|postoperative anemia|postoperative anemia
116313|NCT02838706|perfusion index|perfusion index
116314|NCT02838680|aortic stenosis|aortic stenosis
116315|NCT02838680|transcatheter aortic valve replacement (TAVR)|transcatheter aortic valve replacement (tavr)
116316|NCT02838654|cervical epidural space|cervical epidural space
116317|NCT02838654|wave form analysis|wave form analysis
116318|NCT02838615|spinal stenosis|spinal stenosis
116319|NCT02838615|epidural steroid injection|epidural steroid injection
116320|NCT02838602|carbon ions therapy|carbon ions therapy
116321|NCT02838602|radiotherapy|radiotherapy
116322|NCT02838602|radioresistant tumors|radioresistant tumors
116323|NCT02838602|cancer|cancer
116324|NCT02838602|randomized trial|randomized trial
116325|NCT02838589|Cerebrovascular Stroke|cerebrovascular stroke
116326|NCT02838589|Ischemic Stroke|ischemic stroke
116327|NCT02838589|Glucagon like peptide - 1|glucagon like peptide - 1
116328|NCT02838563|Dementia|dementia
116329|NCT02838563|Alzheimer|alzheimer
116330|NCT02838563|Well-Being|well-being
116331|NCT02838550|Physical Activity|physical activity
116332|NCT02838550|Motivational Online Intervention|motivational online intervention
116333|NCT02838550|Pedometers|pedometers
116334|NCT02838537|Triptan|triptan
116335|NCT02838537|Drug utilization|drug utilization
116336|NCT02838537|Elderly|elderly
116337|NCT02838537|Drug abuse|drug abuse
116338|NCT02838537|Cardiovascular disease|cardiovascular disease
116339|NCT02838524|Spontaneous Breathing Trial|spontaneous breathing trial
116340|NCT02838524|Inspiratory Effort|inspiratory effort
116341|NCT02838524|Mechanical Ventilation|mechanical ventilation
116342|NCT02838524|Respiratory muscle load-capacity balance|respiratory muscle load-capacity balance
116343|NCT02838498|ERCP|ercp
116344|NCT02838498|EMS|ems
116345|NCT02838498|Cannulation|cannulation
116346|NCT02838498|Successful rate|successful rate
116347|NCT02838498|Trainee|trainee
116348|NCT02838407|Chronic lower respiratory tract infection|chronic lower respiratory tract infection
116349|NCT02838407|Bonchoalveolar lavage|bonchoalveolar lavage
116350|NCT02838407|Nasopharyngeal swabs|nasopharyngeal swabs
116351|NCT02838290|Burnout|burnout
116352|NCT02838290|Psychiatric morbidity|psychiatric morbidity
116353|NCT02838290|Anxiety|anxiety
116354|NCT02838290|Grief|grief
116355|NCT02838290|Alcohol and drug use|alcohol and drug use
116356|NCT02838277|lymphatic vessels|lymphatic vessels
116357|NCT02838277|leaky vessels|leaky vessels
116358|NCT02838277|hypertrophic adipocyte|hypertrophic adipocyte
116359|NCT02838212|adverse drug reaction|adverse drug reaction
116360|NCT02838212|hospital mortality|hospital mortality
116361|NCT02838212|incidence|incidence
116362|NCT02838199|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
116363|NCT02838199|TAVR|tavr
116364|NCT02838199|TAVI|tavi
116365|NCT02838199|SAVR|savr
116366|NCT02838186|colonoscopy|colonoscopy
116367|NCT02838186|right colon retroflexion|right colon retroflexion
116368|NCT02838186|adenoma detection rate|adenoma detection rate
116369|NCT02838186|feasibility|feasibility
116370|NCT02838186|surveillance interval|surveillance interval
116371|NCT02838160|educational strategies|educational strategies
116372|NCT02838160|KAP|kap
116373|NCT02838160|psychological and clinical outcomes|psychological and clinical outcomes
116374|NCT02838160|intensive care unit|intensive care unit
116375|NCT02838160|follow-up study|follow-up study
116376|NCT02838160|RCT|rct
116377|NCT02838134|Laparoscopic donor nephrectomy|laparoscopic donor nephrectomy
116378|NCT02838134|Early quality of recovery|early quality of recovery
116379|NCT02838121|bisphosphonate|bisphosphonate
116380|NCT02838121|Total hip replacement|total hip replacement
116381|NCT02838121|functional outcomes|functional outcomes
116382|NCT02838121|bone mineral density|bone mineral density
116383|NCT02838095|nap|nap
116384|NCT02838095|sleep restriction|sleep restriction
116385|NCT02838095|recovery sleep|recovery sleep
116386|NCT02838095|cognitive performance|cognitive performance
116387|NCT02838095|subjective sleepiness|subjective sleepiness
116388|NCT02838095|mood|mood
116389|NCT02838095|neurobehavioural functions|neurobehavioural functions
116390|NCT02838082|traumatic brain injury|traumatic brain injury
116391|NCT02838082|sleep-wake cycle disturbance|sleep-wake cycle disturbance
116392|NCT02838082|circadian disruption|circadian disruption
116393|NCT02838056|anesthesia, epidural|anesthesia, epidural
116394|NCT02838056|skin temperature|skin temperature
116395|NCT02838030|Preeclampsia|preeclampsia
116396|NCT02838030|L-arginine|l-arginine
116397|NCT02838004|Refractive lens exchange (RLE) or cataract surgery|refractive lens exchange (rle) or cataract surgery
116398|NCT02837991|Kidney Cancer|kidney cancer
116399|NCT02837991|Celldex|celldex
116400|NCT02837991|Dose Escalation|dose escalation
116401|NCT02837991|Ovarian Cancer|ovarian cancer
116402|NCT02837991|Ovarian Carcinoma|ovarian carcinoma
116403|NCT02837991|Kidney Diseases|kidney diseases
116404|NCT02837978|Arthritis, Rheumatoid|arthritis, rheumatoid
116405|NCT02837978|Tacrolimus|tacrolimus
116406|NCT02837978|Treatment outcome|treatment outcome
116407|NCT02837978|Safety|safety
116408|NCT02837952|Ibuprofen, acetaminophen, pain, molar extraction|ibuprofen, acetaminophen, pain, molar extraction
116409|NCT02837913|Perioperative Warming|perioperative warming
116410|NCT02837887|Cancer|cancer
116411|NCT02837887|Depression|depression
116412|NCT02837874|Gastric cancer|gastric cancer
116413|NCT02837874|gastrojejunostomy|gastrojejunostomy
116414|NCT02837874|isoperistaltic|isoperistaltic
116415|NCT02837874|antiperistaltic|antiperistaltic
116416|NCT02837861|Metabolic Support|metabolic support
116417|NCT02837861|Nutritional Support|nutritional support
116418|NCT02837861|Neuro-endocrine Event|neuro-endocrine event
116419|NCT02837861|Enteral feedings|enteral feedings
116420|NCT02837861|Parenteral feeding|parenteral feeding
116421|NCT02837848|Rotator Cuff Tendinopathy|rotator cuff tendinopathy
116422|NCT02837848|Exercises|exercises
116423|NCT02837848|Coactivation|coactivation
116424|NCT02837848|Strengthening|strengthening
116425|NCT02837822|Spinal Cord Stimulation|spinal cord stimulation
116426|NCT02837822|Quantitative Sensory Testing|quantitative sensory testing
116427|NCT02837809|low-dose computed tomography|low-dose computed tomography
116428|NCT02837809|lung|lung
116429|NCT02837809|randomized controlled trial|randomized controlled trial
116430|NCT02837809|neoplasms|neoplasms
116431|NCT02837809|screening|screening
116432|NCT02837809|smoking|smoking
116433|NCT02837770|pain|pain
116434|NCT02837770|intravitreal injection|intravitreal injection
116435|NCT02837770|anti-VEGF|anti-vegf
116436|NCT02837770|diclofenac eye drops|diclofenac eye drops
116437|NCT02837770|oral diclofenac|oral diclofenac
116438|NCT02837770|Short Form of McGill Pain Questionnaire|short form of mcgill pain questionnaire
116439|NCT02837653|cardiovascular Risk|cardiovascular risk
116440|NCT02837640|Retinitis Pigmentosa|retinitis pigmentosa
116441|NCT02837640|Levodopa|levodopa
116442|NCT02837627|gastroesophageal reflux|gastroesophageal reflux
116443|NCT02837627|tube enteral feeding|tube enteral feeding
116444|NCT02837627|preterm infants|preterm infants
116445|NCT02837601|Laparoscopic surgical procedures|laparoscopic surgical procedures
116446|NCT02837601|Shoulder Pain|shoulder pain
116447|NCT02837601|Abdominal Pain|abdominal pain
116448|NCT02837601|Pediatrics|pediatrics
116449|NCT02837588|chronic pelvic pain|chronic pelvic pain
116450|NCT02837588|trigger points|trigger points
116451|NCT02837588|hiperthermy|hiperthermy
116452|NCT02837575|HSV-2|hsv-2
116453|NCT02837575|Genital Herpes|genital herpes
116454|NCT02837575|Herpes|herpes
116455|NCT02837575|Herpes Simplex Virus, Type 2|herpes simplex virus, type 2
116456|NCT02837562|Radiation exposure|radiation exposure
116457|NCT02837562|Cardiac catheterization|cardiac catheterization
116458|NCT02837523|Lysosomal Storage Diseases|lysosomal storage diseases
116459|NCT02837497|pediatric|pediatric
116460|NCT02837497|heart arrest|heart arrest
116461|NCT02837471|Pedometer usability|pedometer usability
116462|NCT02837471|Usability and feasibility|usability and feasibility
116463|NCT02837471|web application|web application
116464|NCT02837458|Electric current|electric current
116465|NCT02837458|Nerve block|nerve block
116466|NCT02837458|somatosensory evaluation|somatosensory evaluation
116467|NCT02837432|Depression|depression
116468|NCT02837432|Cortisol|cortisol
116469|NCT02837432|Sadness|sadness
116470|NCT02837432|Genetics|genetics
116471|NCT02837432|Stress|stress
116472|NCT02837419|extracorporeal life support|extracorporeal life support
116473|NCT02837419|health related quality of life|health related quality of life
116474|NCT02837380|Long-acting muscarinic antagonist|long-acting muscarinic antagonist
116475|NCT02837380|Long-acting beta2 agonist|long-acting beta2 agonist
116476|NCT02837380|Dry powder inhaler|dry powder inhaler
116477|NCT02837380|Inhaled corticosteroid|inhaled corticosteroid
116478|NCT02837367|nutrigenetics|nutrigenetics
116479|NCT02837367|medical foods|medical foods
116480|NCT02837367|obesity|obesity
116481|NCT02837367|children|children
116482|NCT02837367|adults|adults
116483|NCT02837354|Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy|cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy
116484|NCT02837341|medical device|medical device
116485|NCT02837328|Magnesium Supplementation|magnesium supplementation
116486|NCT02837328|Magnesium|magnesium
116487|NCT02837328|Dietary Supplement|dietary supplement
116488|NCT02837328|Arrhythmia|arrhythmia
116489|NCT02837302|Liver cirrhosis|liver cirrhosis
116490|NCT02837302|Branched chain amino acid|branched chain amino acid
116491|NCT02837302|End-Stage Liver Disease score|end-stage liver disease score
116492|NCT02837289|patellofemoral pain syndrome|patellofemoral pain syndrome
116493|NCT02837289|therapy taping|therapy taping
116494|NCT02837289|knee|knee
116495|NCT02837289|physical therapy|physical therapy
116496|NCT02837289|runners|runners
116497|NCT02837276|Intermittent Hypoxemia|intermittent hypoxemia
116498|NCT02837276|Acute Kidney Injury|acute kidney injury
116499|NCT02837276|Preterm infant|preterm infant
116500|NCT02837250|HIV|hiv
116501|NCT02837250|Substance Use|substance use
116502|NCT02837224|retained surgical sponge|retained surgical sponge
116503|NCT02837224|adverse event|adverse event
116504|NCT02837185|Cervical dystonia|cervical dystonia
116505|NCT02837185|Transcranial magnetic stimulation|transcranial magnetic stimulation
116506|NCT02837185|Electromyography|electromyography
116507|NCT02837185|TMS|tms
116508|NCT02837185|EMG|emg
116509|NCT02837159|colorectal cancer|colorectal cancer
116510|NCT02837159|Health Life Style Habits|health life style habits
116511|NCT02837159|Health|health
116512|NCT02837146|RA|ra
116513|NCT02837120|retrospective study|retrospective study
116514|NCT02837120|acute myocardial infarction|acute myocardial infarction
116515|NCT02837120|acute aortic dissection|acute aortic dissection
116516|NCT02837120|pulmonary embolism|pulmonary embolism
116517|NCT02837120|unstable angina|unstable angina
116518|NCT02837068|Hemiplegia|hemiplegia
116519|NCT02837068|shoulder pain|shoulder pain
116520|NCT02837068|wheelchair|wheelchair
116521|NCT02837068|stroke|stroke
116522|NCT02837068|rehabilitation|rehabilitation
116523|NCT02837055|intubation, intratracheal|intubation, intratracheal
116524|NCT02837055|critical care|critical care
116525|NCT02837042|penile cancer|penile cancer
116526|NCT02837042|Pembrolizumab|pembrolizumab
116527|NCT02837042|penile squamous cell carcinoma|penile squamous cell carcinoma
116528|NCT02837042|squamous cell cancer|squamous cell cancer
116529|NCT02837016|Self-Control|self-control
116530|NCT02837016|Biofeedback|biofeedback
116531|NCT02837016|Respiration|respiration
116532|NCT02837003|Drug-Eluting Stent|drug-eluting stent
116533|NCT02836977|tegafur-uracil|tegafur-uracil
116534|NCT02836925|hepatitis C|hepatitis c
116535|NCT02836925|NHL|nhl
116536|NCT02836925|Indolent B-cell lymphoma|indolent b-cell lymphoma
116537|NCT02836912|Rehabilitation|rehabilitation
116538|NCT02836899|acute kidney injury; nitric oxide; cardiopulmonary bypass; endothelial dysfunction; cardiac surgery|acute kidney injury; nitric oxide; cardiopulmonary bypass; endothelial dysfunction; cardiac surgery
116539|NCT02836834|immunotherapy|immunotherapy
116540|NCT02836834|check point inhibitor|check point inhibitor
116541|NCT02836834|PD-1 antibody|pd-1 antibody
116542|NCT02836834|solid tumor|solid tumor
116543|NCT02836834|lymphoma|lymphoma
116544|NCT02836834|phase 1 trial|phase 1 trial
116545|NCT02836808|Multidisciplinary interventions|multidisciplinary interventions
116546|NCT02836808|Long term control|long term control
116547|NCT02836808|Empowerment|empowerment
116548|NCT02836795|anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
116549|NCT02836795|advanced solid tumors|advanced solid tumors
116550|NCT02836795|safety|safety
116551|NCT02836782|HIV/HCV|hiv/hcv
116552|NCT02836782|Antiretroviral therapy|antiretroviral therapy
116553|NCT02836782|HIV-DNA|hiv-dna
116554|NCT02836782|Direct acting antiviral|direct acting antiviral
116555|NCT02836769|Rehabilitation|rehabilitation
116556|NCT02836769|Head and neck cancer|head and neck cancer
116557|NCT02836769|Quality of life|quality of life
116558|NCT02836769|self-efficacy|self-efficacy
116559|NCT02836743|REM sleep behavior disorder|rem sleep behavior disorder
116560|NCT02836743|Melatonin|melatonin
116561|NCT02836717|sacral nerve modulation|sacral nerve modulation
116562|NCT02836717|quality of life|quality of life
116563|NCT02836717|stimulator maintenance|stimulator maintenance
116564|NCT02836717|SNM|snm
116565|NCT02836691|Autonomic nervous system|autonomic nervous system
116566|NCT02836691|Uncontrolled severe asthma|uncontrolled severe asthma
116567|NCT02836691|Paucigranulocitic asthma phenotype|paucigranulocitic asthma phenotype
116568|NCT02836691|Stress|stress
116569|NCT02836665|Emergency Room|emergency room
116570|NCT02836665|Manchester Triage System|manchester triage system
116571|NCT02836665|Telemedicine|telemedicine
116572|NCT02836665|Patients|patients
116573|NCT02836652|HeartMate II (HMII)|heartmate ii (hmii)
116574|NCT02836652|Left Ventricular Assist Device (LVAD)|left ventricular assist device (lvad)
116575|NCT02836600|notch inhibitor|notch inhibitor
116576|NCT02836548|advanced melanoma|advanced melanoma
116674|NCT02836093|Exercise|exercise
116577|NCT02836548|BRAF V600 mutation|braf v600 mutation
116578|NCT02836548|vorinostat|vorinostat
116579|NCT02836548|HDAC inhibitor|hdac inhibitor
116580|NCT02836535|complications|complications
116581|NCT02836535|surgery|surgery
116582|NCT02836522|Health-Related Symptom Index|health-related symptom index
116583|NCT02836522|ANCHOR( ANal Cancer HSIL (high grade squamous intraepithelial lesions) Outcomes Research study)|anchor( anal cancer hsil (high grade squamous intraepithelial lesions) outcomes research study)
116584|NCT02836509|Low Back Pain|low back pain
116585|NCT02836509|Ibuprofen|ibuprofen
116586|NCT02836509|Paracetamol|paracetamol
116587|NCT02836509|Emergency Medicine|emergency medicine
116588|NCT02836496|Safety|safety
116589|NCT02836496|Mepolizumab|mepolizumab
116590|NCT02836496|Hypereosinophilic syndrome|hypereosinophilic syndrome
116591|NCT02836496|HES flare|hes flare
116592|NCT02836496|Efficacy|efficacy
116593|NCT02836470|Post-operative Ileus|post-operative ileus
116594|NCT02836470|Post-Operative Abdominal Adhesions|post-operative abdominal adhesions
116595|NCT02836470|Return of Gastrointestinal Function|return of gastrointestinal function
116596|NCT02836470|Anastomosis|anastomosis
116597|NCT02836470|Enterotomy|enterotomy
116598|NCT02836470|Enterostomy|enterostomy
116599|NCT02836470|Colorectal Surgery|colorectal surgery
116600|NCT02836470|Intestines Surgery|intestines surgery
116601|NCT02836431|Pediatric|pediatric
116602|NCT02836431|Sedation|sedation
116603|NCT02836431|Dexmedetomidine|dexmedetomidine
116604|NCT02836418|FSHD|fshd
116605|NCT02836418|LGMD|lgmd
116606|NCT02836405|Autism|autism
116607|NCT02836405|ASD|asd
116608|NCT02836405|Autistic Disorder|autistic disorder
116609|NCT02836405|Pervasive Development Disorders|pervasive development disorders
116610|NCT02836405|Pervasive Child Development Disorders|pervasive child development disorders
116611|NCT02836405|Asperger's Syndrome|asperger's syndrome
116612|NCT02836405|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
116614|NCT02836405|Autism Spectrum Disorder|autism spectrum disorder
116615|NCT02836379|Breakthrough Cancer Pain|breakthrough cancer pain
116616|NCT02836379|Quality of life|quality of life
116617|NCT02836379|Radiotherapy|radiotherapy
116618|NCT02836366|Proximal humerus|proximal humerus
116619|NCT02836366|Fracture|fracture
116620|NCT02836366|Nailing|nailing
116621|NCT02836340|neuroprotection|neuroprotection
116622|NCT02836327|MRI|mri
116623|NCT02836327|Multiple Sclerosis|multiple sclerosis
116624|NCT02836327|Neuromyelitis Optica Spectrum Disorders|neuromyelitis optica spectrum disorders
116625|NCT02836327|Multimodel|multimodel
116626|NCT02836314|Anorganic bovine bone mineral;|anorganic bovine bone mineral;
116627|NCT02836314|Graft|graft
116628|NCT02836314|Intrabony periodontal defect|intrabony periodontal defect
116629|NCT02836314|platelet rich fibrin|platelet rich fibrin
116630|NCT02836288|Ketamine|ketamine
116631|NCT02836288|Treatment of Depression|treatment of depression
116632|NCT02836275|Adnexal Diseases|adnexal diseases
116633|NCT02836275|Ovary|ovary
116634|NCT02836275|Ovarian Neoplasms|ovarian neoplasms
116635|NCT02836275|Ovarian Cysts|ovarian cysts
116636|NCT02836275|Ovarian Diseases|ovarian diseases
116637|NCT02836275|Ultrasonography|ultrasonography
116638|NCT02836275|Ultrasonography, Doppler|ultrasonography, doppler
116639|NCT02836275|Magnetic Resonance Imaging|magnetic resonance imaging
116640|NCT02836275|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
116641|NCT02836275|Diagnosis|diagnosis
116642|NCT02836275|Early Diagnosis|early diagnosis
116643|NCT02836275|Early Detection of Cancer|early detection of cancer
116644|NCT02836275|Genital Neoplasms, Female|genital neoplasms, female
116645|NCT02836275|Genital Diseases, Female|genital diseases, female
116646|NCT02836275|Urogenital Neoplasms|urogenital neoplasms
116647|NCT02836275|Cysts|cysts
116648|NCT02836275|Endocrine System Diseases|endocrine system diseases
116649|NCT02836275|Gonadal Disorders|gonadal disorders
116650|NCT02836275|Neoplasms|neoplasms
116651|NCT02836275|Endocrine Gland Neoplasms|endocrine gland neoplasms
116652|NCT02836275|International Ovarian Tumor Analysis|international ovarian tumor analysis
116653|NCT02836275|Simple Rules|simple rules
116654|NCT02836275|Preoperative Evaluation|preoperative evaluation
116655|NCT02836275|Perfusion -and Diffusion-weighted Imaging|perfusion -and diffusion-weighted imaging
116656|NCT02836275|Adnexal Masses|adnexal masses
116657|NCT02836275|Ovarian Tumors|ovarian tumors
116658|NCT02836249|Hepatitis|hepatitis
116659|NCT02836249|Tenofovir|tenofovir
116660|NCT02836249|Viread|viread
116661|NCT02836236|Hepatitis|hepatitis
116662|NCT02836236|Tenofovir|tenofovir
116663|NCT02836236|Viread|viread
116664|NCT02836210|27-gauge Pars plana vitrectomy|27-gauge pars plana vitrectomy
116665|NCT02836197|Uncertainty;hope;cancer;communication skills training;physicians|uncertainty;hope;cancer;communication skills training;physicians
116666|NCT02836184|Hemodialysis,Hyperphosphatemia,Nicotinic Acids|hemodialysis,hyperphosphatemia,nicotinic acids
116667|NCT02836119|Gut Microbiota|gut microbiota
116668|NCT02836119|Gut Microbiome|gut microbiome
116669|NCT02836119|Sleep|sleep
116670|NCT02836119|Infancy|infancy
116671|NCT02836119|Development|development
116672|NCT02836106|Healthy Volunteers|healthy volunteers
116673|NCT02836106|Obese Volunteers|obese volunteers
116675|NCT02836093|Radiation Treatment|radiation treatment
116676|NCT02836093|16-941|16-941
116677|NCT02836080|Mental Health|mental health
116678|NCT02836080|Randomized|randomized
116679|NCT02836080|Pragmatic|pragmatic
116680|NCT02836080|Integrated Collaborative Care|integrated collaborative care
116681|NCT02836080|Addiction|addiction
116682|NCT02836080|Youth|youth
116683|NCT02836054|biomarkers|biomarkers
116684|NCT02836054|CSF|csf
116685|NCT02836054|MRI|mri
116686|NCT02836054|Alzheimer's disease|alzheimer's disease
116687|NCT02836054|bipolar disorder|bipolar disorder
116688|NCT02836054|cognitive functions|cognitive functions
116689|NCT02836041|assess sleep|assess sleep
116690|NCT02836041|Sleep Deprivation|sleep deprivation
116691|NCT02836041|16-866|16-866
116692|NCT02836015|Shared Medical Visits|shared medical visits
116693|NCT02836015|Spanish-speaking|spanish-speaking
116694|NCT02835989|Community Paramedicine|community paramedicine
116695|NCT02835989|Paramedic|paramedic
116696|NCT02835989|Emergency Medical Services|emergency medical services
116697|NCT02835989|High Frequency Callers|high frequency callers
116698|NCT02835989|Lift Assists|lift assists
116699|NCT02835963|acute heart failure|acute heart failure
116700|NCT02835963|dyspnea|dyspnea
116701|NCT02835963|predictive value|predictive value
116702|NCT02835924|regorafenib|regorafenib
116703|NCT02835924|metastatic colorectal cancer|metastatic colorectal cancer
116704|NCT02835872|fiber|fiber
116705|NCT02835872|cholesterol|cholesterol
116706|NCT02835859|Obesity, sweet taste receptors|obesity, sweet taste receptors
116707|NCT02835846|Overactive Bladder Syndrome|overactive bladder syndrome
116708|NCT02835846|Female Urinary Microbiome|female urinary microbiome
116709|NCT02835846|Urinary Urgency|urinary urgency
116710|NCT02835846|Estrogen|estrogen
116711|NCT02835846|Nocturia|nocturia
116712|NCT02835846|Incontinence|incontinence
116713|NCT02835833|advanced solid tumors|advanced solid tumors
116714|NCT02835833|Nintedanib|nintedanib
116715|NCT02835833|Bevacizumab|bevacizumab
116716|NCT02835833|dose escalation|dose escalation
116717|NCT02835820|HIV|hiv
116718|NCT02835820|Neurocognitive|neurocognitive
116719|NCT02835820|Ketogenic Diet|ketogenic diet
116720|NCT02835807|skin cancer|skin cancer
116721|NCT02835794|Myelodysplastic Syndromes|myelodysplastic syndromes
116722|NCT02835781|Breast Implants|breast implants
116723|NCT02835781|Acellular Dermal Matrix|acellular dermal matrix
116724|NCT02835729|AML|aml
116725|NCT02835716|Phosphodiesterase type 4 inhibitor|phosphodiesterase type 4 inhibitor
116726|NCT02835716|ustekinumab|ustekinumab
116727|NCT02835716|secukinumab|secukinumab
116728|NCT02835716|P40 subunit|p40 subunit
116729|NCT02835716|Interleukin IL-12|interleukin il-12
116730|NCT02835716|Interleukin IL-23|interleukin il-23
116731|NCT02835716|Apoprotein e4|apoprotein e4
116732|NCT02835716|Interleukin IL-17A|interleukin il-17a
116733|NCT02835703|Congenital heart disease|congenital heart disease
116734|NCT02835703|Coarctation of aorta|coarctation of aorta
116735|NCT02835703|Aortic arch hypoplasia|aortic arch hypoplasia
116736|NCT02835703|Cerebral selective antegrade perfusion|cerebral selective antegrade perfusion
116737|NCT02835703|Double arterial cannulation|double arterial cannulation
116738|NCT02835690|PD1|pd1
116739|NCT02835690|PD-1|pd-1
116740|NCT02835690|PDL1|pdl1
116741|NCT02835690|PD-L1|pd-l1
116742|NCT02835677|Caregivers|caregivers
116743|NCT02835677|Activities of Daily Living|activities of daily living
116744|NCT02835664|Nicotinamide Riboside|nicotinamide riboside
116745|NCT02835664|Obesity|obesity
116746|NCT02835664|Metabolic health|metabolic health
116747|NCT02835664|Insulin resistance|insulin resistance
116748|NCT02835664|Mitochondrial function|mitochondrial function
116749|NCT02835664|Brown adipose tissue|brown adipose tissue
116750|NCT02835664|Energy expenditure|energy expenditure
116751|NCT02835664|Ectopic lipid accumulation|ectopic lipid accumulation
116752|NCT02835664|Cardiovascular risk|cardiovascular risk
116753|NCT02835664|Acetylcarnitine|acetylcarnitine
116754|NCT02835651|Palmitic acid|palmitic acid
116755|NCT02835651|Stearic acid|stearic acid
116756|NCT02835651|HDL-metabolism|hdl-metabolism
116757|NCT02835651|Human intervention study|human intervention study
116758|NCT02835625|Diagnostic Imaging|diagnostic imaging
116759|NCT02835625|Mammography|mammography
116760|NCT02835625|Randomized Controlled Trial|randomized controlled trial
116761|NCT02835625|Tomosynthesis|tomosynthesis
116762|NCT02835625|Early performance measures|early performance measures
116763|NCT02835625|Recall|recall
116764|NCT02835625|Radiation dose|radiation dose
116765|NCT02835625|Cancer detection|cancer detection
116766|NCT02835625|Sensitivity|sensitivity
116767|NCT02835625|Specificity|specificity
116768|NCT02835625|Cost|cost
116769|NCT02835625|Economy|economy
116770|NCT02835586|paclitaxel|paclitaxel
116771|NCT02835586|critical ischemia|critical ischemia
116772|NCT02835586|restenosis|restenosis
116773|NCT02835586|femoropopliteal artery lesions TASC C and D|femoropopliteal artery lesions tasc c and d
116774|NCT02835547|cardiovascular event|cardiovascular event
116775|NCT02835547|risk factors|risk factors
116776|NCT02835547|inflammatory diseases and acquired dysimmune|inflammatory diseases and acquired dysimmune
116777|NCT02835534|acute ST elevation myocardial infarction|acute st elevation myocardial infarction
116778|NCT02835456|CAUTI|cauti
116779|NCT02835456|Biofilm|biofilm
116780|NCT02835456|Urinary tract infections|urinary tract infections
116781|NCT02835456|micropattern|micropattern
116782|NCT02835456|Catheter|catheter
116783|NCT02835443|Ischemic Stroke|ischemic stroke
116784|NCT02835443|Deep Brain Stimulation|deep brain stimulation
116785|NCT02835443|DBS|dbs
116786|NCT02835443|Physical Therapy|physical therapy
116787|NCT02835443|Rehab|rehab
116788|NCT02835443|Brain Stimulation|brain stimulation
116789|NCT02835430|Coronally advanced flap|coronally advanced flap
116790|NCT02835430|Gingival recession|gingival recession
116791|NCT02835430|Bone, demineralized|bone, demineralized
116792|NCT02835430|Bone, freeze-dried|bone, freeze-dried
116793|NCT02835430|platelet-rich fibrin|platelet-rich fibrin
116794|NCT02835430|root coverage procedures|root coverage procedures
116795|NCT02835417|fetal heart rate variability|fetal heart rate variability
116796|NCT02835417|entropy|entropy
116797|NCT02835417|multifractal analysis|multifractal analysis
116798|NCT02835417|scattering transform|scattering transform
116799|NCT02835417|sparse vector machine|sparse vector machine
116800|NCT02835417|acidosis|acidosis
116801|NCT02835378|bilateral upper limb amputation|bilateral upper limb amputation
116802|NCT02835378|prosthetic fitting|prosthetic fitting
116803|NCT02835378|epidemiology|epidemiology
116804|NCT02835378|clinical practices|clinical practices
116805|NCT02835378|totally non-functional hand|totally non-functional hand
116806|NCT02835365|baclofen|baclofen
116807|NCT02835365|alcohol|alcohol
116808|NCT02835365|withdrawal|withdrawal
116809|NCT02835352|anxiety|anxiety
116810|NCT02835326|Older Adults|older adults
116811|NCT02835326|Weight Loss|weight loss
116812|NCT02835326|Exercise|exercise
116813|NCT02835326|Knee pain|knee pain
116814|NCT02835300|Asthma|asthma
116815|NCT02835300|Adolescents|adolescents
116816|NCT02835300|e-Health|e-health
116817|NCT02835300|Intervention|intervention
116818|NCT02835274|parkinson disease|parkinson disease
116819|NCT02835274|deep brain stimulation|deep brain stimulation
116820|NCT02835274|directional stimulation|directional stimulation
116821|NCT02835261|Obesity|obesity
116822|NCT02835261|Metabolic Disorders|metabolic disorders
116823|NCT02835209|spontaneous breathing test|spontaneous breathing test
116824|NCT02835209|premature infant|premature infant
116825|NCT02835209|work of breathing|work of breathing
116826|NCT02835170|Immunoglobulin G|immunoglobulin g
116827|NCT02835170|Treatment|treatment
116828|NCT02835157|Normal saline|normal saline
116829|NCT02835157|Balanced saline|balanced saline
116830|NCT02835157|Septic shock|septic shock
116831|NCT02835157|Children|children
116832|NCT02835157|Hyperchloremia|hyperchloremia
116833|NCT02835157|Acute kidney injury|acute kidney injury
116834|NCT02835131|hyperinsulinemia|hyperinsulinemia
116835|NCT02835131|hypoglycemia|hypoglycemia
116836|NCT02835131|somatostatin|somatostatin
116837|NCT02835131|pasireotide|pasireotide
116838|NCT02835131|congenital|congenital
116839|NCT02835079|Duchenne Tamoxifen|duchenne tamoxifen
116840|NCT02835066|Stage I|stage i
116841|NCT02835066|Stage II|stage ii
116842|NCT02835066|Stage IIIA|stage iiia
116843|NCT02835066|Stage IIIB|stage iiib
116844|NCT02835066|Stage IV|stage iv
116845|NCT02835066|Non-Small Cell|non-small cell
116846|NCT02835040|Corticosteroid|corticosteroid
116847|NCT02835040|Antibiotic|antibiotic
116848|NCT02835040|Early mobilization|early mobilization
116849|NCT02835040|Malnutrition|malnutrition
116850|NCT02835027|Acute limb ischaemia(ALI)|acute limb ischaemia(ali)
116851|NCT02835027|Acute ischaemia of the lower extremity|acute ischaemia of the lower extremity
116852|NCT02835027|Thrombosis|thrombosis
116853|NCT02835027|Emboli|emboli
116854|NCT02835027|Endovascular surgery|endovascular surgery
116855|NCT02835027|Surgery|surgery
116856|NCT02835027|Amputation free survival|amputation free survival
116857|NCT02835027|Long time survival|long time survival
116858|NCT02835027|Demographics|demographics
116859|NCT02835014|Diabetes Mellitus Type I|diabetes mellitus type i
116860|NCT02835014|Adolescents|adolescents
116861|NCT02835014|Mental Health|mental health
116862|NCT02835014|Self efficacy|self efficacy
116863|NCT02835014|parenting styles|parenting styles
116864|NCT02834988|Endometrial Cancer|endometrial cancer
116865|NCT02834988|Sentinel Lymph Node Dissection|sentinel lymph node dissection
116866|NCT02834988|SLND|slnd
116867|NCT02834975|Fallopian Tube Carcinoma|fallopian tube carcinoma
116868|NCT02834975|Peritoneal Carcinoma|peritoneal carcinoma
116869|NCT02834975|Epithelial Ovarian Cancer|epithelial ovarian cancer
116870|NCT02834962|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
116871|NCT02834897|EOS imagery|eos imagery
116872|NCT02834884|rare cancer|rare cancer
116873|NCT02834884|biomarker|biomarker
116874|NCT02834884|molecular screening|molecular screening
116875|NCT02834884|cancer|cancer
116876|NCT02834884|biobanking|biobanking
116877|NCT02834858|Umbilical Cord Mesenchymal Stem Cells|umbilical cord mesenchymal stem cells
116878|NCT02834819|bronchiolitis|bronchiolitis
116879|NCT02834819|hypoxia|hypoxia
116880|NCT02834819|hypertonic saline|hypertonic saline
116881|NCT02834793|Lennox-Gastaut Syndrome (LGS)|lennox-gastaut syndrome (lgs)
116882|NCT02834793|Inadequately controlled seizures|inadequately controlled seizures
116883|NCT02834780|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
116884|NCT02834780|H3B-6527|h3b-6527
116885|NCT02834754|post-operative|post-operative
116886|NCT02834715|Diabetes|diabetes
116887|NCT02834715|Stevia|stevia
116888|NCT02834715|insulin secretion|insulin secretion
116889|NCT02834715|insulin sensitivity|insulin sensitivity
116890|NCT02834715|Sweetener|sweetener
116891|NCT02834702|sinew acupuncture|sinew acupuncture
116892|NCT02834702|neck pain|neck pain
116893|NCT02834702|chronic pain|chronic pain
116894|NCT02834676|DiscoGel(R)|discogel(r)
116895|NCT02834676|gelified ethanol|gelified ethanol
116896|NCT02834676|percutaneous treatment|percutaneous treatment
116897|NCT02834676|Oswestry Disability Index (ODI)|oswestry disability index (odi)
116898|NCT02834676|Visual analog Scale (VAS)|visual analog scale (vas)
116899|NCT02834676|Neuropathic Pain Questionnaire (DN-4)|neuropathic pain questionnaire (dn-4)
116900|NCT02834676|cervical|cervical
116901|NCT02834637|HPV|hpv
116902|NCT02834637|cervical cancer|cervical cancer
116903|NCT02834637|vaccines|vaccines
116904|NCT02834637|HPV vaccine|hpv vaccine
116905|NCT02834637|dose reduction|dose reduction
116906|NCT02834637|Human papilloma virus vaccine schedules|human papilloma virus vaccine schedules
116907|NCT02834624|surfactant|surfactant
116908|NCT02834624|respiratory distress syndrome|respiratory distress syndrome
116909|NCT02834624|inflammation|inflammation
116910|NCT02834624|c-reactive protein|c-reactive protein
116911|NCT02834624|lipid peroxidation|lipid peroxidation
116912|NCT02834546|Hepatocellular Carcinoma|hepatocellular carcinoma
116913|NCT02834546|Sorafenib|sorafenib
116914|NCT02834546|Toxicity|toxicity
116915|NCT02834546|Plasmatic concentration|plasmatic concentration
116916|NCT02834533|Lokomat;|lokomat;
116917|NCT02834533|robotic rehabilitation.|robotic rehabilitation.
116918|NCT02834533|Multiple Sclerosis;|multiple sclerosis;
116919|NCT02834533|Virtual reality|virtual reality
116920|NCT02834494|locally advanced breast cancer|locally advanced breast cancer
116921|NCT02834494|neoadjuvant chemotherapy|neoadjuvant chemotherapy
116922|NCT02834481|Pain Care|pain care
116923|NCT02834481|Pediatric and Neonatal Intensive Care Units|pediatric and neonatal intensive care units
116924|NCT02834468|Dexamethasone|dexamethasone
116925|NCT02834468|Rituximab|rituximab
116926|NCT02834468|Cyclosporin|cyclosporin
116927|NCT02834468|Intravenous Immunoglobulin|intravenous immunoglobulin
116928|NCT02834455|Thoracoscopy|thoracoscopy
116929|NCT02834403|breast cancer|breast cancer
116930|NCT02834403|nitric oxide synthase|nitric oxide synthase
116931|NCT02834403|docetaxel|docetaxel
116932|NCT02834403|L-NMMA|l-nmma
116933|NCT02834390|AML|aml
116934|NCT02834390|phase 1|phase 1
116935|NCT02834390|hematology|hematology
116936|NCT02834390|malignancy|malignancy
116937|NCT02834390|newly diagnosed|newly diagnosed
116938|NCT02834377|Cardiac Output|cardiac output
116939|NCT02834377|Hemodynamics|hemodynamics
116940|NCT02834377|Perioperative Care|perioperative care
116941|NCT02834338|activity tracking|activity tracking
116942|NCT02834338|postoperative recovery|postoperative recovery
116943|NCT02834338|ERAS|eras
116944|NCT02834338|fast-track surgery|fast-track surgery
116945|NCT02834325|high flow nasal cannula|high flow nasal cannula
116946|NCT02834325|success|success
116947|NCT02834325|failure|failure
116948|NCT02834325|ROX index|rox index
116949|NCT02834312|Estetrol|estetrol
116950|NCT02834312|Vasomotor symptoms|vasomotor symptoms
116951|NCT02834312|Menopause|menopause
116952|NCT02834260|absorbable implant|absorbable implant
116953|NCT02834260|subconjunctival|subconjunctival
116954|NCT02834260|immune rejection|immune rejection
116955|NCT02834260|safety profile|safety profile
116956|NCT02834260|dexamethasone|dexamethasone
116957|NCT02834234|mesothelioma|mesothelioma
116958|NCT02834234|peritoneum|peritoneum
116959|NCT02834234|genomic|genomic
116960|NCT02834234|CGH arrays|cgh arrays
116961|NCT02834221|Femoral vein puncture|femoral vein puncture
116962|NCT02834195|Cerebral palsy|cerebral palsy
116963|NCT02834195|reliability|reliability
116964|NCT02834195|upper limb and hand patterns|upper limb and hand patterns
116965|NCT02834195|classification|classification
116966|NCT02834169|Rare peritoneal surface malignancies|rare peritoneal surface malignancies
116967|NCT02834169|pseudomyxoma peritonei|pseudomyxoma peritonei
116968|NCT02834169|peritoneal mesothelioma|peritoneal mesothelioma
116969|NCT02834169|desmoplastic small round cell tumor|desmoplastic small round cell tumor
116970|NCT02834169|psammocarcinoma|psammocarcinoma
116971|NCT02834169|primary peritoneal serous carcinoma|primary peritoneal serous carcinoma
116972|NCT02834169|diffuse peritoneal leiomyomatosis|diffuse peritoneal leiomyomatosis
116973|NCT02834169|appendiceal mucinous neoplasms|appendiceal mucinous neoplasms
116974|NCT02834169|registry|registry
116975|NCT02834169|population-based database|population-based database
116976|NCT02834143|vascular|vascular
116977|NCT02834143|Limb Ischemia|limb ischemia
116978|NCT02834117|Ovulation Induction|ovulation induction
116979|NCT02834117|quality of life|quality of life
116980|NCT02834117|Reproductive Physiological Processes|reproductive physiological processes
116981|NCT02834117|fertility|fertility
116982|NCT02834078|HbA1c|hba1c
116983|NCT02834078|Pre Diabetes|pre diabetes
116984|NCT02834078|Berberine|berberine
116985|NCT02834065|Postoperative Cognitive Decline|postoperative cognitive decline
116986|NCT02834065|Deep Hypothermic Circulatory Arrest|deep hypothermic circulatory arrest
116987|NCT02834065|Cardiovascular Surgical Procedures|cardiovascular surgical procedures
116988|NCT02834065|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
116989|NCT02834065|Small Ubiquitin-Related Modifier Proteins|small ubiquitin-related modifier proteins
116990|NCT02834052|Immunotherapy|immunotherapy
116991|NCT02834052|Anti-programmed death 1 (PD-1) inhibitor|anti-programmed death 1 (pd-1) inhibitor
116992|NCT02834052|Immunostimulant|immunostimulant
116993|NCT02834052|monoclonal antibody|monoclonal antibody
116994|NCT02834052|TLR3 agonist|tlr3 agonist
116995|NCT02834052|Immunologic factors|immunologic factors
116996|NCT02834039|Tidal volume|tidal volume
116997|NCT02834039|renal transplant|renal transplant
116998|NCT02834039|donor|donor
116999|NCT02834039|nephrectomy|nephrectomy
117000|NCT02834039|ventilation|ventilation
117001|NCT02834039|Living renal transplant donor patient|living renal transplant donor patient
117002|NCT02834026|Muscle Strength|muscle strength
117003|NCT02834026|Muscle Strength Dynamometer|muscle strength dynamometer
117004|NCT02834026|Chronic Renal Disease|chronic renal disease
117005|NCT02834026|Exercise|exercise
117006|NCT02834026|Physical therapy modalities|physical therapy modalities
117007|NCT02833987|Direct oral anticoagulants|direct oral anticoagulants
117008|NCT02833987|Safety|safety
117009|NCT02833987|Major bleed|major bleed
117010|NCT02833987|Adverse events|adverse events
117011|NCT02833974|GSK2245035|gsk2245035
117012|NCT02833974|TLR7 agonist|tlr7 agonist
117013|NCT02833974|allergic asthma|allergic asthma
117014|NCT02833974|FEV1|fev1
117015|NCT02833948|Heart Valve Disease|heart valve disease
117016|NCT02833948|Randomized Controlled Trial|randomized controlled trial
117017|NCT02833948|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
117018|NCT02833948|TAVR|tavr
117019|NCT02833948|Valve Thrombosis|valve thrombosis
117020|NCT02833935|spinal cord injury|spinal cord injury
117021|NCT02833935|physical activity|physical activity
117022|NCT02833935|self-determination theory|self-determination theory
117023|NCT02833935|life satisfaction|life satisfaction
117024|NCT02833883|Enzalutamide|enzalutamide
117025|NCT02833883|CC-115|cc-115
117026|NCT02833883|16-074|16-074
117027|NCT02833857|Secondary Hyperparathyroidism, chronic kidney disease, hemodialysis|secondary hyperparathyroidism, chronic kidney disease, hemodialysis
117028|NCT02833844|Hyperlipidemia|hyperlipidemia
117029|NCT02833844|Dyslipidemia|dyslipidemia
117030|NCT02833844|Proprotein convertase subtilisin/kexin type 9 (PCSK9)|proprotein convertase subtilisin/kexin type 9 (pcsk9)
117031|NCT02833844|Inhibition|inhibition
117032|NCT02833844|HIV infection|hiv infection
117033|NCT02833844|Cluster of differentiation|cluster of differentiation
117034|NCT02833844|Viral load|viral load
117035|NCT02833805|immunosuppression|immunosuppression
117036|NCT02833805|nonmyeloablative|nonmyeloablative
117037|NCT02833805|non-myeloablative|non-myeloablative
117038|NCT02833805|allogeneic|allogeneic
117039|NCT02833805|tacrolimus|tacrolimus
117040|NCT02833805|bone marrow|bone marrow
117041|NCT02833805|bone marrow transplant|bone marrow transplant
117042|NCT02833805|cyclophosphamide|cyclophosphamide
117043|NCT02833805|thymoglobulin|thymoglobulin
117044|NCT02833805|ATG|atg
117045|NCT02833805|fludarabine|fludarabine
117046|NCT02833766|Breast Cancer|breast cancer
117047|NCT02833766|advanced triple Negative, EGFR positive breast cancer|advanced triple negative, egfr positive breast cancer
117048|NCT02833766|doxorubicin|doxorubicin
117049|NCT02833766|triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
117050|NCT02833740|Mid-Upper Arm Circumference (MUAC)|mid-upper arm circumference (muac)
117051|NCT02833740|Mother MUAC|mother muac
117052|NCT02833740|Community screening for acute malnutrition|community screening for acute malnutrition
117053|NCT02833727|asthma; smoking; Eosinophils; health care costs|asthma; smoking; eosinophils; health care costs
117054|NCT02833675|angioedema|angioedema
117055|NCT02833675|C1Inhibitor|c1inhibitor
117056|NCT02833675|bradykinin|bradykinin
117057|NCT02833675|Histamin|histamin
117058|NCT02833662|Hypoxia|hypoxia
117059|NCT02833662|Perioperative outcomes|perioperative outcomes
117060|NCT02833649|Keratoconus|keratoconus
117061|NCT02833649|Crosslinking|crosslinking
117062|NCT02833649|Toric ICL|toric icl
117063|NCT02833623|Helicobacter Pylori eradication rate|helicobacter pylori eradication rate
117064|NCT02833623|Efficacy of Short-message-based Re-education (SMRE)|efficacy of short-message-based re-education (smre)
117065|NCT02833610|Multiple Myeloma|multiple myeloma
117066|NCT02833597|peripheral artery disease|peripheral artery disease
117067|NCT02833597|transcutaneous oxygen pressure|transcutaneous oxygen pressure
117068|NCT02833597|claudication|claudication
117069|NCT02833597|rowing ergometer|rowing ergometer
117070|NCT02833584|Paracetamol|paracetamol
117071|NCT02833558|Endoscopy, Gastrointestinal|endoscopy, gastrointestinal
117072|NCT02833558|Endoscopic Submucosal Dissection|endoscopic submucosal dissection
117073|NCT02833558|Bleeding|bleeding
117074|NCT02833519|pregnant women|pregnant women
117075|NCT02833519|exercise|exercise
117076|NCT02833519|depression|depression
117077|NCT02833519|anxiety|anxiety
117078|NCT02833493|Magnetic Resonance Imaging|magnetic resonance imaging
117079|NCT02833493|Iron overload|iron overload
117080|NCT02833493|Iron chelation therapy|iron chelation therapy
117081|NCT02833493|Follow-up|follow-up
117082|NCT02833467|Circulating Tumor DNA|circulating tumor dna
117083|NCT02833467|Heterogeneous|heterogeneous
117084|NCT02833467|Multiple primary lung cancer|multiple primary lung cancer
117085|NCT02833454|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
117086|NCT02833454|Direct Insertion of Anterior Cruciate Ligament|direct insertion of anterior cruciate ligament
117087|NCT02833415|Visceral|visceral
117088|NCT02833415|Obesity|obesity
117089|NCT02833415|Adipose|adipose
117090|NCT02833415|Diabetes|diabetes
117091|NCT02833402|Sacral Neuromodulation|sacral neuromodulation
117092|NCT02833402|Urinary leakage|urinary leakage
117093|NCT02833402|Urinary incontinence|urinary incontinence
117094|NCT02833402|Urinary microbiome|urinary microbiome
117095|NCT02833376|microbiota|microbiota
117096|NCT02833376|ethanol|ethanol
117097|NCT02833376|chlorhexidine|chlorhexidine
117098|NCT02833363|gastric microbiota|gastric microbiota
117099|NCT02833363|Helicobacter pylori|helicobacter pylori
117100|NCT02833363|Non-atrophic Gasrititis|non-atrophic gasrititis
117101|NCT02833363|Atrophic gastritis|atrophic gastritis
117102|NCT02833363|Intestinal metaplasia|intestinal metaplasia
117103|NCT02833363|intraepithelial neoplasia|intraepithelial neoplasia
117104|NCT02833363|Gastric cancer|gastric cancer
117105|NCT02833337|Bone|bone
117106|NCT02833337|Maxilla|maxilla
117107|NCT02833337|Cone-Beam Computed Tomography|cone-beam computed tomography
117108|NCT02833337|Regeneration|regeneration
117109|NCT02833324|Postoperative Period|postoperative period
117110|NCT02833324|Colorectal Surgery|colorectal surgery
117111|NCT02833324|Surgery|surgery
117112|NCT02833311|Neuromusculoskeletal condition|neuromusculoskeletal condition
117113|NCT02833298|Sustained Virological Response|sustained virological response
117114|NCT02833298|SVR|svr
117115|NCT02833298|patient navigation|patient navigation
117116|NCT02833298|screening|screening
117117|NCT02833298|HCC|hcc
117118|NCT02833298|HCV|hcv
117119|NCT02833272|benzodiazepines|benzodiazepines
117120|NCT02833272|Z-drugs|z-drugs
117121|NCT02833259|Pneumonia|pneumonia
117122|NCT02833259|Patient readmission|patient readmission
117123|NCT02833259|Community-acquired infections|community-acquired infections
117124|NCT02833259|Observational study|observational study
117125|NCT02833259|Quality of health care|quality of health care
117126|NCT02833259|Models, Statistical|models, statistical
117127|NCT02833246|texting|texting
117128|NCT02833246|Adherence to Oral Anticancer Medications|adherence to oral anticancer medications
117129|NCT02833246|16-810|16-810
117130|NCT02833233|Early stage|early stage
117131|NCT02833233|Resectable|resectable
117132|NCT02833233|Ipilimumab|ipilimumab
117133|NCT02833233|Nivolumab|nivolumab
117134|NCT02833233|Cryoablation|cryoablation
117135|NCT02833233|16-495|16-495
117136|NCT02833220|blood pressure|blood pressure
117137|NCT02833207|blood flow|blood flow
117138|NCT02833207|vasodilation|vasodilation
117139|NCT02833207|Doppler Ultrasound|doppler ultrasound
117140|NCT02833207|endothelium dependent dilation|endothelium dependent dilation
117141|NCT02833168|Neuromuscular disorders|neuromuscular disorders
117142|NCT02833168|Sleep disordered breathing|sleep disordered breathing
117143|NCT02833168|Dyspnea|dyspnea
117144|NCT02833155|entinostat|entinostat
117145|NCT02833155|breast cancer|breast cancer
117146|NCT02833142|Healthy Volunteer|healthy volunteer
117147|NCT02833142|opicinumab|opicinumab
117148|NCT02833116|radiculalgia|radiculalgia
117149|NCT02833116|chronic pain|chronic pain
117150|NCT02833116|quality of life|quality of life
117151|NCT02833103|Pinaverium Bromide|pinaverium bromide
117152|NCT02833103|cholecystectomy|cholecystectomy
117153|NCT02833103|Sphincter of Oddi Dysfunction|sphincter of oddi dysfunction
117154|NCT02833012|Healthy volunteers|healthy volunteers
117155|NCT02833012|Caprylic triglyceride oil|caprylic triglyceride oil
117156|NCT02833012|AC-1202|ac-1202
117157|NCT02833012|AC-1204|ac-1204
117158|NCT02833012|Pharmacokinetic|pharmacokinetic
117159|NCT02833012|ketone body|ketone body
117160|NCT02833012|Axona|axona
117161|NCT02832999|Diabetes|diabetes
117162|NCT02832999|GLP-1|glp-1
117163|NCT02832999|Insulin secretion|insulin secretion
117164|NCT02832999|insulin sensitivity|insulin sensitivity
117165|NCT02832999|Africa|africa
117166|NCT02832999|Liraglutide|liraglutide
117167|NCT02832999|Vildaglipin|vildaglipin
117168|NCT02832986|Frailty consultation|frailty consultation
117169|NCT02832973|Hypertension Resistant to Conventional Therapy|hypertension resistant to conventional therapy
117170|NCT02832973|Natriuretic Agents|natriuretic agents
117171|NCT02832973|Renin-Angiotensin System|renin-angiotensin system
117172|NCT02832973|Bisoprolol|bisoprolol
117173|NCT02832960|Thyroid Dysfunction|thyroid dysfunction
117174|NCT02832960|Atherosclerosis|atherosclerosis
117175|NCT02832960|Heart Failure|heart failure
117176|NCT02832960|Cardiovascular imaging|cardiovascular imaging
117177|NCT02832960|Randomized Controlled Trial|randomized controlled trial
117178|NCT02832934|Thyroid Dysfunction|thyroid dysfunction
117179|NCT02832934|Atherosclerosis|atherosclerosis
117180|NCT02832934|Heart Failure|heart failure
117181|NCT02832934|Cardiovascular Imaging|cardiovascular imaging
117182|NCT02832934|Randomized Controlled Trial|randomized controlled trial
117183|NCT02832921|Alzheimer's disease|alzheimer's disease
117184|NCT02832921|virtual reality|virtual reality
117185|NCT02832921|cognitive training|cognitive training
117186|NCT02832895|Adults|adults
117187|NCT02832895|Frontal bone window|frontal bone window
117188|NCT02832895|Transcranial doppler|transcranial doppler
117189|NCT02832882|HCC|hcc
117190|NCT02832882|RFA|rfa
117191|NCT02832869|Polyp detection rate|polyp detection rate
117192|NCT02832869|Adenoma detection rate|adenoma detection rate
117193|NCT02832869|Boston Bowel Preparation Scale|boston bowel preparation scale
117194|NCT02832830|bony metastases|bony metastases
117195|NCT02832830|palliative radiotherapy|palliative radiotherapy
117196|NCT02832817|Oxygen therapy|oxygen therapy
117197|NCT02832817|Pulse oximeter|pulse oximeter
117198|NCT02832817|Hypoxia|hypoxia
117199|NCT02832817|Hypoxemia|hypoxemia
117200|NCT02832817|Arterial blood gas|arterial blood gas
117201|NCT02832791|ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION|anterior cruciate ligament reconstruction
117202|NCT02832791|QUADRICEPS TENDON|quadriceps tendon
117203|NCT02832791|HAMSTRING TENDON|hamstring tendon
117204|NCT02832765|Palliative radiotherapy|palliative radiotherapy
117205|NCT02832765|Bone metastases|bone metastases
117206|NCT02832739|Technology acceptance|technology acceptance
117207|NCT02832739|Usability|usability
117208|NCT02832739|eHealth|ehealth
117209|NCT02832739|self-management support in chronic illness|self-management support in chronic illness
117210|NCT02832739|prevention|prevention
117211|NCT02832739|Special Orthopaedic Co-Morbidity after hip/knee replacement|special orthopaedic co-morbidity after hip/knee replacement
117212|NCT02832726|absorption of Vitamin B12|absorption of vitamin b12
117213|NCT02832713|Knee osteoarthritis|knee osteoarthritis
117214|NCT02832713|Intra-articular botulinum toxin|intra-articular botulinum toxin
117215|NCT02832713|Hyaluronic acid|hyaluronic acid
117216|NCT02832713|Pain|pain
117217|NCT02832713|Function|function
117218|NCT02832700|glycopeptides|glycopeptides
117219|NCT02832700|dietary proteins|dietary proteins
117220|NCT02832700|whey protein|whey protein
117221|NCT02832700|caseinomacropeptide|caseinomacropeptide
117222|NCT02832700|antiinflammatories|antiinflammatories
117223|NCT02832700|human microbiome|human microbiome
117224|NCT02832661|renal allograft|renal allograft
117225|NCT02832661|graft injuries|graft injuries
117226|NCT02832661|biopsy|biopsy
117227|NCT02832661|biomarkers|biomarkers
117228|NCT02832661|omics approach|omics approach
117229|NCT02832635|brain metastasis|brain metastasis
117230|NCT02832635|whole-brain radiotherapy|whole-brain radiotherapy
117231|NCT02832635|TMZ|tmz
117232|NCT02832635|avoidance of hippocampus|avoidance of hippocampus
117233|NCT02832622|MultiPoint Pacing|multipoint pacing
117234|NCT02832622|Heart Failure|heart failure
117235|NCT02832622|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
117236|NCT02832622|SJM Quadripolar Biventricular Pacing|sjm quadripolar biventricular pacing
117237|NCT02832609|closing volume|closing volume
117238|NCT02832609|expiratory flow limitation|expiratory flow limitation
117239|NCT02832609|obesity|obesity
117240|NCT02832609|orthopnea|orthopnea
117241|NCT02832596|Anesthesia|anesthesia
117242|NCT02832596|Blood pressure|blood pressure
117243|NCT02832596|Plasma Volume|plasma volume
117244|NCT02832596|Vasopressor agents|vasopressor agents
117245|NCT02832596|Coronary artery bypass|coronary artery bypass
117246|NCT02832596|Glycocalyx|glycocalyx
117247|NCT02832596|ANP|anp
117248|NCT02832596|Coagulation|coagulation
117249|NCT02832583|PRP, hyaluronic acid, mesotherapy, skin wrinkle, skin rejuvenation|prp, hyaluronic acid, mesotherapy, skin wrinkle, skin rejuvenation
117250|NCT02832557|Autism|autism
117251|NCT02832557|Asperger's Syndrome|asperger's syndrome
117252|NCT02832557|microRNA|microrna
117253|NCT02832557|epigenetic|epigenetic
117254|NCT02832557|biomarker|biomarker
117255|NCT02832544|atrial fibrillation|atrial fibrillation
117256|NCT02832544|stroke|stroke
117257|NCT02832531|atrial fibrillation|atrial fibrillation
117258|NCT02832531|stroke|stroke
117259|NCT02832492|disorders of consciousness|disorders of consciousness
117260|NCT02832492|unresponsive wakefulness syndrome|unresponsive wakefulness syndrome
117261|NCT02832492|pupil near response|pupil near response
117262|NCT02832492|prognosis of consciousness recovery|prognosis of consciousness recovery
117263|NCT02832453|High intensity physical exercise|high intensity physical exercise
117264|NCT02832453|Primary health care|primary health care
117265|NCT02832453|Behaviour change interventions|behaviour change interventions
117266|NCT02832427|Coronary artery bypass grafting|coronary artery bypass grafting
117267|NCT02832427|Heart valve surgery|heart valve surgery
117574|NCT02830438|ultrasound|ultrasound
117268|NCT02832427|Postoperative morbidity|postoperative morbidity
117269|NCT02832427|Operative mortality|operative mortality
117270|NCT02832401|event-related potentials|event-related potentials
117271|NCT02832401|EEG|eeg
117272|NCT02832401|caffeine|caffeine
117273|NCT02832401|psychosis|psychosis
117274|NCT02832401|schizophrenia|schizophrenia
117275|NCT02832336|Caffeine|caffeine
117276|NCT02832336|Caffeine citrate|caffeine citrate
117277|NCT02832336|Neurological disorder|neurological disorder
117278|NCT02832336|Excessive daytime sleepiness|excessive daytime sleepiness
117279|NCT02832336|Orexin|orexin
117280|NCT02832336|adenosine antagonist|adenosine antagonist
117281|NCT02832323|hemodialysis|hemodialysis
117282|NCT02832323|EPO|epo
117283|NCT02832323|MIRCERA|mircera
117284|NCT02832310|valsalva|valsalva
117285|NCT02832258|Enterobacteria|enterobacteria
117286|NCT02832258|Children|children
117287|NCT02832258|Febrile urinary tract infection|febrile urinary tract infection
117288|NCT02832258|Cystitis|cystitis
117289|NCT02832258|Extended-spectrum beta-lactamase-producing Enterobacteriaceae|extended-spectrum beta-lactamase-producing enterobacteriaceae
117290|NCT02832232|Physiotherapy|physiotherapy
117291|NCT02832232|Manual Therapy|manual therapy
117292|NCT02832232|Neck Pain|neck pain
117293|NCT02832219|Overweight|overweight
117294|NCT02832219|Molecular hydrogen|molecular hydrogen
117295|NCT02832219|Insulin|insulin
117296|NCT02832206|Atrial fibrillation|atrial fibrillation
117297|NCT02832206|Hybrid ablation|hybrid ablation
117298|NCT02832180|Rheumatoid|rheumatoid
117299|NCT02832141|Skin blood flow|skin blood flow
117300|NCT02832141|Skin redness|skin redness
117301|NCT02832141|Sympathetic nervous system|sympathetic nervous system
117302|NCT02832141|Regional Blood Flow|regional blood flow
117303|NCT02832128|Cochlear Implant|cochlear implant
117304|NCT02832115|Radial Artery Spasm|radial artery spasm
117305|NCT02832115|Cardiac Catheterization|cardiac catheterization
117306|NCT02832115|Vascular Access Site Complications|vascular access site complications
117307|NCT02832115|Vasodilator|vasodilator
117308|NCT02832115|Nitroglycerine|nitroglycerine
117309|NCT02832115|Lidocaine|lidocaine
117310|NCT02832102|prognostic modelling|prognostic modelling
117311|NCT02832102|radiomics|radiomics
117312|NCT02832102|clinical decision support system|clinical decision support system
117313|NCT02832102|big data analysis|big data analysis
117314|NCT02832102|multiscale prognostic signatures|multiscale prognostic signatures
117315|NCT02832102|patient-clinician co-decision tools|patient-clinician co-decision tools
117316|NCT02832089|atrial fibrillation|atrial fibrillation
117317|NCT02832089|rate reduction|rate reduction
117318|NCT02832050|play|play
117319|NCT02832050|therapy|therapy
117320|NCT02832024|stents|stents
117321|NCT02832024|atherectomy|atherectomy
117322|NCT02832024|femoral artery|femoral artery
117323|NCT02832024|popliteal artery|popliteal artery
117324|NCT02832024|In-stent Restenosis|in-stent restenosis
117325|NCT02831985|Child|child
117326|NCT02831985|Middle ear ventilation|middle ear ventilation
117327|NCT02831985|Follow-up studies|follow-up studies
117328|NCT02831985|General practitioners|general practitioners
117329|NCT02831972|Healthy Volunteers|healthy volunteers
117330|NCT02831959|Non-Small Cell Lung Cancer|non-small cell lung cancer
117331|NCT02831959|NSCLC|nsclc
117332|NCT02831959|Brain metastases|brain metastases
117333|NCT02831959|Treatment|treatment
117334|NCT02831959|Minimal toxicity|minimal toxicity
117335|NCT02831959|TTFields|ttfields
117336|NCT02831959|TTF|ttf
117337|NCT02831959|Tumor Treating Fields|tumor treating fields
117338|NCT02831959|Novocure|novocure
117339|NCT02831959|SRS|srs
117340|NCT02831959|Stereotactic radiosurgery|stereotactic radiosurgery
117341|NCT02831946|skin closure|skin closure
117342|NCT02831946|intracuticular suture|intracuticular suture
117343|NCT02831946|glue (dermabond)|glue (dermabond)
117344|NCT02831933|lung cancer|lung cancer
117345|NCT02831933|metastatic|metastatic
117346|NCT02831933|gene therapy|gene therapy
117347|NCT02831933|immunotherapy|immunotherapy
117348|NCT02831933|melanoma|melanoma
117349|NCT02831933|uveal|uveal
117350|NCT02831920|Prostate Cancer|prostate cancer
117351|NCT02831920|MRI|mri
117352|NCT02831920|CEUS|ceus
117353|NCT02831920|Contrast Ultrasound|contrast ultrasound
117354|NCT02831920|Fusion|fusion
117355|NCT02831920|targeted biopsy|targeted biopsy
117356|NCT02831907|Ultrasonography|ultrasonography
117357|NCT02831907|Portal vein Doppler|portal vein doppler
117358|NCT02831907|Renal Doppler|renal doppler
117359|NCT02831907|Cardio-Intestinal syndrome|cardio-intestinal syndrome
117360|NCT02831907|Delirium|delirium
117361|NCT02831907|Renal congestion|renal congestion
117362|NCT02831907|Intra-renal hemodynamics|intra-renal hemodynamics
117363|NCT02831894|insomnia|insomnia
117364|NCT02831894|sedative hypnotics|sedative hypnotics
117365|NCT02831894|hypnotic tapering|hypnotic tapering
117366|NCT02831855|Rheumatoid Arthritis|rheumatoid arthritis
117367|NCT02831855|Tofacitinib|tofacitinib
117368|NCT02831855|CP-690,550|cp-690,550
117369|NCT02831855|Xeljanz|xeljanz
117370|NCT02831855|methotrexate withdrawal|methotrexate withdrawal
117371|NCT02831855|withdrawal study|withdrawal study
117372|NCT02831829|cardiac rehabilitation|cardiac rehabilitation
117373|NCT02831829|coronary artery disease|coronary artery disease
117374|NCT02831777|non-invasive blood pressure|non-invasive blood pressure
117375|NCT02831764|tolerability|tolerability
117376|NCT02831764|HIV 1|hiv 1
117377|NCT02831764|efficacy|efficacy
117378|NCT02831764|treatment naïve|treatment naïve
117379|NCT02831764|two-drug regimen|two-drug regimen
117380|NCT02831764|safety|safety
117381|NCT02831764|non inferiority|non inferiority
117382|NCT02831751|Influenza|influenza
117383|NCT02831751|Human|human
117384|NCT02831751|RNA Virus Infections|rna virus infections
117385|NCT02831751|Immulogic|immulogic
117386|NCT02831751|Immunogenic Factors|immunogenic factors
117387|NCT02831751|Physiological Effects of Drug|physiological effects of drug
117388|NCT02831751|Virus Diseases|virus diseases
117389|NCT02831751|Orthomyxoviridae Infections|orthomyxoviridae infections
117390|NCT02831751|Infection|infection
117391|NCT02831738|Fiber|fiber
117392|NCT02831738|Polydextrose|polydextrose
117393|NCT02831738|Glycemic Index|glycemic index
117394|NCT02831712|NTBI|ntbi
117395|NCT02831712|Iron status|iron status
117396|NCT02831712|Iron supplement|iron supplement
117397|NCT02831699|Zika|zika
117398|NCT02831699|Guillain Barré|guillain barré
117399|NCT02831686|Selinexor (KPT-330)|selinexor (kpt-330)
117400|NCT02831686|Ixazomib|ixazomib
117401|NCT02831686|dexamethasone|dexamethasone
117402|NCT02831686|15-310|15-310
117403|NCT02831673|safety|safety
117404|NCT02831673|treatment naïve|treatment naïve
117405|NCT02831673|HIV 1|hiv 1
117406|NCT02831673|dolutegravir plus lamivudine|dolutegravir plus lamivudine
117407|NCT02831673|non inferiority|non inferiority
117408|NCT02831673|tolerability|tolerability
117409|NCT02831673|dolutegravir plus tenofovir/emtricitabine|dolutegravir plus tenofovir/emtricitabine
117410|NCT02831673|efficacy|efficacy
117411|NCT02831634|Breast cancer|breast cancer
117412|NCT02831634|cutaneous melanoma|cutaneous melanoma
117413|NCT02831621|overweight|overweight
117414|NCT02831621|ectopic fat|ectopic fat
117415|NCT02831621|exercise|exercise
117416|NCT02831621|diet|diet
117417|NCT02831582|Breast Cancer|breast cancer
117418|NCT02831582|Postmenopausal|postmenopausal
117419|NCT02831582|Stage IA|stage ia
117420|NCT02831582|Stage IB|stage ib
117421|NCT02831582|Stage IIA|stage iia
117422|NCT02831582|Stage IIB|stage iib
117423|NCT02831582|Stage IIIA|stage iiia
117424|NCT02831582|Stage IIIB|stage iiib
117425|NCT02831582|Stage IIIC|stage iiic
117426|NCT02831556|Ultrasound|ultrasound
117427|NCT02831556|Abdomen|abdomen
117428|NCT02831556|Pelvis|pelvis
117429|NCT02831556|3D|3d
117430|NCT02831504|Myotonic Dystrophy type 1|myotonic dystrophy type 1
117431|NCT02831504|DM1|dm1
117432|NCT02831504|Muscular Dystrophy|muscular dystrophy
117433|NCT02831504|Neuromuscular Diseases|neuromuscular diseases
117434|NCT02831491|metastatic|metastatic
117435|NCT02831465|Dynamic hyperinflation|dynamic hyperinflation
117436|NCT02831465|Maximal Voluntary Ventilation|maximal voluntary ventilation
117437|NCT02831465|Inspiratory capacity|inspiratory capacity
117438|NCT02831465|healthy subjects|healthy subjects
117439|NCT02831452|pelvic floor muscles|pelvic floor muscles
117440|NCT02831452|evaluation|evaluation
117441|NCT02831452|dynamometer|dynamometer
117442|NCT02831452|perineometer|perineometer
117443|NCT02831439|Choosing Wisely|choosing wisely
117444|NCT02831439|Breast cancer|breast cancer
117445|NCT02831439|Controlled trial|controlled trial
117446|NCT02831439|High-value health care|high-value health care
117447|NCT02831439|Health services research|health services research
117448|NCT02831348|Asthma|asthma
117449|NCT02831348|Allergic rhinitis|allergic rhinitis
117450|NCT02831348|Rhinitis|rhinitis
117451|NCT02831348|Pneumonia|pneumonia
117452|NCT02831348|Cystic fibrosis|cystic fibrosis
117453|NCT02831322|Transradial|transradial
117454|NCT02831322|ﬂow-mediated vasodilation|ﬂow-mediated vasodilation
117455|NCT02831309|physical activity|physical activity
117456|NCT02831296|SMA|sma
117457|NCT02831296|Werdnig-Hoffmann disease|werdnig-hoffmann disease
117458|NCT02831296|Kugelberg-Welander disease|kugelberg-welander disease
117459|NCT02831283|inflammation|inflammation
117460|NCT02831283|aging|aging
117461|NCT02831283|mild cognitive impairment|mild cognitive impairment
117462|NCT02831270|cardiac surgery|cardiac surgery
117463|NCT02831270|acute normovolemic hemodilution|acute normovolemic hemodilution
117464|NCT02831257|Neurofibromatosis 2|neurofibromatosis 2
117465|NCT02831218|bioresorbable vascular scaffold|bioresorbable vascular scaffold
117466|NCT02831218|coronary artery disease|coronary artery disease
117467|NCT02831205|bioresorbable vascular scaffold|bioresorbable vascular scaffold
117468|NCT02831205|coronary artery disease|coronary artery disease
117469|NCT02831166|Vascular closure devices|vascular closure devices
117470|NCT02831166|Transradial approach|transradial approach
117471|NCT02831166|Transfemoral approach|transfemoral approach
117472|NCT02831140|Fast track|fast track
117473|NCT02831140|rehabilitation|rehabilitation
117779|NCT02829671|Depression|depression
117474|NCT02831140|post operative complications|post operative complications
117475|NCT02831127|short message service; adherence; stent exchange; ERCP|short message service; adherence; stent exchange; ercp
117476|NCT02831101|BIS|bis
117477|NCT02831101|Elderly|elderly
117478|NCT02831101|Propofol|propofol
117479|NCT02831101|Sufentanil|sufentanil
117480|NCT02831101|Loss of consciousness|loss of consciousness
117481|NCT02831088|Neu2000KWL|neu2000kwl
117482|NCT02831088|Neuroprotection|neuroprotection
117483|NCT02831088|endovascular therapy|endovascular therapy
117484|NCT02831088|glutamate|glutamate
117485|NCT02831088|free radical|free radical
117486|NCT02831075|Adipose-derived Stem Cells|adipose-derived stem cells
117487|NCT02831062|nutrition|nutrition
117488|NCT02831062|progression|progression
117489|NCT02831049|Reconsolidation|reconsolidation
117490|NCT02831010|prematurity|prematurity
117491|NCT02830971|standardized learning curve|standardized learning curve
117492|NCT02830971|Nurse|nurse
117493|NCT02830971|intensive care unit|intensive care unit
117494|NCT02830971|Mastery|mastery
117495|NCT02830971|Training|training
117496|NCT02830971|Developing|developing
117497|NCT02830971|Skills|skills
117498|NCT02830919|Osteoarthritis of knee|osteoarthritis of knee
117499|NCT02830919|Glucosamine sulfate|glucosamine sulfate
117500|NCT02830919|Chondroitin sulfate|chondroitin sulfate
117501|NCT02830906|Total Knee Arthroplasty|total knee arthroplasty
117502|NCT02830906|Intrathecal Morphine|intrathecal morphine
117503|NCT02830906|Ramosetron|ramosetron
117504|NCT02830906|Ondansetron|ondansetron
117505|NCT02830906|postoperative nausea and vomiting|postoperative nausea and vomiting
117506|NCT02830880|Imaging|imaging
117507|NCT02830880|Nuclear medicine|nuclear medicine
117508|NCT02830880|Oncology|oncology
117509|NCT02830880|Radiology|radiology
117510|NCT02830880|Urogenital disorders|urogenital disorders
117511|NCT02830867|glutathione|glutathione
117512|NCT02830867|glutathione synthetase deficiency|glutathione synthetase deficiency
117513|NCT02830867|autosomal inheritance|autosomal inheritance
117514|NCT02830867|recessive|recessive
117515|NCT02830841|RIPC|ripc
117516|NCT02830841|hepatic ischemic and reperfusion injury|hepatic ischemic and reperfusion injury
117517|NCT02830841|pediatric living donor liver transplantation|pediatric living donor liver transplantation
117518|NCT02830815|Broadband click stimulus testing|broadband click stimulus testing
117519|NCT02830815|General Anesthesia|general anesthesia
117520|NCT02830815|Sevoflurane|sevoflurane
117521|NCT02830815|Propofol|propofol
117522|NCT02830815|Amplitude latency|amplitude latency
117523|NCT02830815|Wave V|wave v
117524|NCT02830776|dermatochalasis|dermatochalasis
117525|NCT02830776|bimatoprost|bimatoprost
117526|NCT02830776|blepharoplasty|blepharoplasty
117527|NCT02830763|neutral lipid storage disease|neutral lipid storage disease
117528|NCT02830763|CNT-02|cnt-02
117529|NCT02830763|primary triglyceride deposit cardiomyovasculopathy (TGCV)|primary triglyceride deposit cardiomyovasculopathy (tgcv)
117530|NCT02830763|neutral lipid storage disease with myopathy (NLSD-M)|neutral lipid storage disease with myopathy (nlsd-m)
117531|NCT02830737|Small Hepatocellular Carcinoma|small hepatocellular carcinoma
117532|NCT02830737|No-touch RFA|no-touch rfa
117533|NCT02830737|Traditional RFA|traditional rfa
117534|NCT02830737|Recurrence rate|recurrence rate
117535|NCT02830724|Metastatic Solid Cancers|metastatic solid cancers
117536|NCT02830724|Renal Cell Cancer|renal cell cancer
117537|NCT02830724|Cell Therapy|cell therapy
117538|NCT02830724|CAR T Cells|car t cells
117539|NCT02830711|happiness|happiness
117540|NCT02830711|anger|anger
117541|NCT02830711|sadness|sadness
117542|NCT02830711|anticipation|anticipation
117543|NCT02830698|Nervous System|nervous system
117544|NCT02830698|Hypnosis|hypnosis
117545|NCT02830698|Electrocardiography, Ambulatory|electrocardiography, ambulatory
117546|NCT02830685|pre-pectoral breast reconstruction|pre-pectoral breast reconstruction
117547|NCT02830685|subcutaneous breast reconstruction|subcutaneous breast reconstruction
117548|NCT02830633|laparoscopy|laparoscopy
117549|NCT02830633|rectal cancer|rectal cancer
117550|NCT02830633|pelvic autonomic nerve|pelvic autonomic nerve
117551|NCT02830568|Kidney transplantation|kidney transplantation
117552|NCT02830568|Surgical procedures|surgical procedures
117553|NCT02830568|Kidney living donors|kidney living donors
117554|NCT02830568|Quality of life|quality of life
117555|NCT02830542|Clostridium difficile|clostridium difficile
117556|NCT02830542|C Diff|c diff
117557|NCT02830542|CDI|cdi
117558|NCT02830529|Mindfulness|mindfulness
117559|NCT02830529|African American|african american
117560|NCT02830529|fMRI|fmri
117561|NCT02830477|Previously treated patients|previously treated patients
117562|NCT02830451|Registry|registry
117563|NCT02830451|Spine|spine
117564|NCT02830451|Surgery|surgery
117565|NCT02830451|Medical Oncology|medical oncology
117566|NCT02830451|Radiation Oncology|radiation oncology
117567|NCT02830451|Neoplasms|neoplasms
117568|NCT02830451|Metastasis|metastasis
117569|NCT02830451|Chemotherapy|chemotherapy
117570|NCT02830451|Radiation Therapy|radiation therapy
117571|NCT02830451|Tumor Markers|tumor markers
117572|NCT02830438|kidney disease|kidney disease
117573|NCT02830438|fibrosis|fibrosis
117575|NCT02830438|elastography|elastography
117576|NCT02830425|Multimorbidity|multimorbidity
117577|NCT02830425|Polypharmacy|polypharmacy
117578|NCT02830425|Appropriateness|appropriateness
117579|NCT02830425|STOPP|stopp
117580|NCT02830425|START|start
117581|NCT02830399|treatment-resistant-depression|treatment-resistant-depression
117582|NCT02830399|rTMS|rtms
117583|NCT02830399|ECT|ect
117584|NCT02830399|Augmentation strategy|augmentation strategy
117585|NCT02830373|LVIS stents|lvis stents
117586|NCT02830373|Intracranial aneurysm|intracranial aneurysm
117587|NCT02830373|Unruptured aneurysm|unruptured aneurysm
117588|NCT02830373|Wide-necked aneurysm|wide-necked aneurysm
117589|NCT02830360|Antiarrhythmic drug therapy|antiarrhythmic drug therapy
117590|NCT02830360|VT Catheter ablation|vt catheter ablation
117591|NCT02830360|ICD Therapy|icd therapy
117592|NCT02830360|Ischemic Heart Disease|ischemic heart disease
117593|NCT02830347|antibiotic resistance|antibiotic resistance
117594|NCT02830347|oral microbiome|oral microbiome
117595|NCT02830334|Suicide|suicide
117596|NCT02830334|Youth Suicide|youth suicide
117597|NCT02830308|Hormones|hormones
117598|NCT02830308|Endocrine|endocrine
117599|NCT02830308|Hypercortisolism|hypercortisolism
117600|NCT02830308|Bone|bone
117601|NCT02830308|Hypothalamic-Pituitary Dysfunction|hypothalamic-pituitary dysfunction
117602|NCT02830295|body awareness therapy|body awareness therapy
117603|NCT02830295|physical therapy|physical therapy
117604|NCT02830295|movement therapy|movement therapy
117605|NCT02830269|Neuro-ICU|neuro-icu
117606|NCT02830269|Third ventricle|third ventricle
117607|NCT02830269|Computer Tomography|computer tomography
117608|NCT02830269|Transcranial Doppler ultrasonography|transcranial doppler ultrasonography
117609|NCT02830256|Intensive care unit|intensive care unit
117610|NCT02830256|Neuro-ICU|neuro-icu
117611|NCT02830256|Pain|pain
117612|NCT02830256|Intubation|intubation
117613|NCT02830256|critical care|critical care
117614|NCT02830256|patients|patients
117615|NCT02830217|STEMI|stemi
117616|NCT02830217|primary PCI|primary pci
117617|NCT02830217|sST2|sst2
117618|NCT02830217|prognosis|prognosis
117619|NCT02830204|mitral valve regurgitation|mitral valve regurgitation
117620|NCT02830204|mitral valve stenosis|mitral valve stenosis
117621|NCT02830191|Cyclosporine, Dried blood spot|cyclosporine, dried blood spot
117622|NCT02830152|Stroke|stroke
117623|NCT02830152|intracerebral hemorrhage|intracerebral hemorrhage
117624|NCT02830152|left atrial appendage occlusion|left atrial appendage occlusion
117625|NCT02830152|atrial fibrillation|atrial fibrillation
117626|NCT02830152|oral anticoagulation|oral anticoagulation
117627|NCT02830152|preventive therapy|preventive therapy
117628|NCT02830126|Outcomes|outcomes
117629|NCT02830126|Information technology|information technology
117630|NCT02830113|periodontitis|periodontitis
117631|NCT02830113|diabetes|diabetes
117632|NCT02830113|prevention|prevention
117633|NCT02830113|impaired glucose tolerance|impaired glucose tolerance
117634|NCT02830113|insulin resistance|insulin resistance
117635|NCT02830100|Intern speech|intern speech
117636|NCT02830100|Speech and visual imaging|speech and visual imaging
117637|NCT02830100|Mind and oral drift|mind and oral drift
117638|NCT02830100|Cognitive performance|cognitive performance
117639|NCT02830100|Magnetic Resonance Imaging|magnetic resonance imaging
117640|NCT02830087|randomized controlled trial|randomized controlled trial
117641|NCT02830087|tourniquet|tourniquet
117642|NCT02830087|tourniquet cuff pressure|tourniquet cuff pressure
117643|NCT02830087|total knee arthroplasty|total knee arthroplasty
117644|NCT02830087|total knee replacement|total knee replacement
117645|NCT02830087|pain, postoperative|pain, postoperative
117646|NCT02830087|range of motion, articular|range of motion, articular
117647|NCT02830087|blood loss, surgical|blood loss, surgical
117648|NCT02830087|muscle strength, quadriceps|muscle strength, quadriceps
117649|NCT02830087|walking|walking
117650|NCT02830087|manipulation, orthopedic/therapeutic use|manipulation, orthopedic/therapeutic use
117651|NCT02830087|wound healing/surgery|wound healing/surgery
117652|NCT02830074|Sleep Apnea Syndromes|sleep apnea syndromes
117653|NCT02830074|Spinal Cord Injuries|spinal cord injuries
117654|NCT02830074|Sleep|sleep
117655|NCT02830074|Quality of life|quality of life
117656|NCT02830061|Cancer|cancer
117657|NCT02830061|Teenage|teenage
117658|NCT02830061|Young Adult|young adult
117659|NCT02830061|Fertility|fertility
117660|NCT02830061|Cryopreservation|cryopreservation
117661|NCT02830061|Experience|experience
117662|NCT02830048|diabetes|diabetes
117663|NCT02830048|glibenclamide|glibenclamide
117664|NCT02830048|glucagon|glucagon
117665|NCT02830035|ultrasound guided|ultrasound guided
117666|NCT02830035|spinal anesthesia|spinal anesthesia
117667|NCT02830035|neuraxial block|neuraxial block
117668|NCT02830035|paramedian|paramedian
117669|NCT02830022|autism spectrum disorder|autism spectrum disorder
117670|NCT02829996|glaucoma|glaucoma
117671|NCT02829996|primary open-angle glaucoma|primary open-angle glaucoma
117672|NCT02829996|ocular hypertension|ocular hypertension
117673|NCT02829996|adenosine agonist|adenosine agonist
117674|NCT02829996|eye drop|eye drop
117675|NCT02829996|trabodenoson|trabodenoson
117676|NCT02829996|trabecular meshwork|trabecular meshwork
117677|NCT02829983|clarithromycin|clarithromycin
117678|NCT02829983|periodontal debridement|periodontal debridement
117679|NCT02829983|aggressive periodontitis|aggressive periodontitis
117680|NCT02829970|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
117681|NCT02829970|Alcohol-Related Disorders|alcohol-related disorders
117682|NCT02829970|Substance-Related Disorders|substance-related disorders
117683|NCT02829970|Motivational Interviewing|motivational interviewing
117684|NCT02829970|Behavior Therapy|behavior therapy
117685|NCT02829944|Cesarean section|cesarean section
117686|NCT02829931|recurrent glioma|recurrent glioma
117687|NCT02829931|high grade glioma|high grade glioma
117688|NCT02829931|head and neck disease|head and neck disease
117689|NCT02829931|grade III glioma|grade iii glioma
117690|NCT02829931|grade IV glioma|grade iv glioma
117691|NCT02829931|radiation therapy|radiation therapy
117692|NCT02829918|advanced biliary tract cancer|advanced biliary tract cancer
117693|NCT02829918|refractory biliary tract cancer|refractory biliary tract cancer
117694|NCT02829918|digestive diseases|digestive diseases
117695|NCT02829918|immunotherapy|immunotherapy
117696|NCT02829905|mass screening|mass screening
117697|NCT02829905|patient satisfaction|patient satisfaction
117698|NCT02829905|radiography|radiography
117699|NCT02829905|mammography|mammography
117700|NCT02829879|Dentin Sensitivity|dentin sensitivity
117701|NCT02829879|Arginin|arginin
117702|NCT02829879|Potassium Nitrate|potassium nitrate
117703|NCT02829879|Dentifrice|dentifrice
117704|NCT02829879|RCT|rct
117705|NCT02829853|SARCOIDOSIS|sarcoidosis
117706|NCT02829853|GRANULOMA DISEASES|granuloma diseases
117707|NCT02829853|GENETICS|genetics
117708|NCT02829853|PREDISPOSITION|predisposition
117709|NCT02829853|EXOME (WES-NGS)|exome (wes-ngs)
117710|NCT02829840|Leukemia|leukemia
117711|NCT02829840|FLT3-Mutated Acute Myeloid Leukemia|flt3-mutated acute myeloid leukemia
117712|NCT02829840|FLT3-Mutated High-Risk Myelodysplastic Syndrome|flt3-mutated high-risk myelodysplastic syndrome
117713|NCT02829840|Acute Myeloid Leukemia|acute myeloid leukemia
117714|NCT02829840|AML|aml
117715|NCT02829840|Myelodysplastic Syndrome|myelodysplastic syndrome
117716|NCT02829840|MDS|mds
117717|NCT02829840|Ponatinib|ponatinib
117718|NCT02829840|Iclusig|iclusig
117719|NCT02829840|AP24534|ap24534
117720|NCT02829840|5-azacytidine|5-azacytidine
117721|NCT02829840|Azacitidine|azacitidine
117722|NCT02829840|5-aza|5-aza
117723|NCT02829840|Vidaza|vidaza
117724|NCT02829840|5-AZC|5-azc
117725|NCT02829840|AZA-CR|aza-cr
117726|NCT02829840|Ladakamycin|ladakamycin
117727|NCT02829840|NSC-102816|nsc-102816
117728|NCT02829840|Azacytidine|azacytidine
117729|NCT02829827|Radiprodil|radiprodil
117730|NCT02829827|Infantile spasms|infantile spasms
117731|NCT02829827|IS|is
117732|NCT02829827|Infantile|infantile
117733|NCT02829827|Spasms|spasms
117734|NCT02829827|Epilepsy|epilepsy
117735|NCT02829827|Paediatrics|paediatrics
117736|NCT02829827|Drug-resistant|drug-resistant
117737|NCT02829827|West Syndrome|west syndrome
117738|NCT02829827|Hypsarrhythmia|hypsarrhythmia
117739|NCT02829814|Pain|pain
117740|NCT02829814|Sleep|sleep
117741|NCT02829814|Fibromyalgia|fibromyalgia
117742|NCT02829814|FM|fm
117743|NCT02829801|animal assisted therapy|animal assisted therapy
117744|NCT02829801|well-being|well-being
117745|NCT02829801|Alzheimer's Disease|alzheimer's disease
117746|NCT02829788|Digestive peritoneal carcinomatosis|digestive peritoneal carcinomatosis
117747|NCT02829788|laparoscopy|laparoscopy
117748|NCT02829788|laparotomy|laparotomy
117749|NCT02829788|peritoneal cancer index (PCI)|peritoneal cancer index (pci)
117750|NCT02829788|staging|staging
117751|NCT02829762|isolated|isolated
117752|NCT02829762|at risk of isolation|at risk of isolation
117753|NCT02829762|patients|patients
117754|NCT02829749|Heart Valve Diseases|heart valve diseases
117755|NCT02829749|Heart failure|heart failure
117756|NCT02829749|Heart diseases|heart diseases
117757|NCT02829749|Mitral valve insufficiency|mitral valve insufficiency
117758|NCT02829736|lung neoplasm|lung neoplasm
117759|NCT02829736|lung metastasis|lung metastasis
117760|NCT02829736|enhanced recovery after surgery|enhanced recovery after surgery
117761|NCT02829736|fast-track surgery|fast-track surgery
117762|NCT02829736|intraoperative chest tube removal|intraoperative chest tube removal
117763|NCT02829736|pain|pain
117764|NCT02829736|lung function|lung function
117765|NCT02829736|reasons for admission|reasons for admission
117766|NCT02829723|Phase I/II|phase i/ii
117767|NCT02829723|BLZ945|blz945
117768|NCT02829723|PDR001|pdr001
117769|NCT02829723|CSF-1R|csf-1r
117770|NCT02829723|PD-1|pd-1
117771|NCT02829710|Analgesia|analgesia
117772|NCT02829710|intensive care units|intensive care units
117773|NCT02829710|clinical protocol|clinical protocol
117774|NCT02829710|deep sedation|deep sedation
117775|NCT02829710|nursing assessment|nursing assessment
117776|NCT02829697|Regional anaesthesia|regional anaesthesia
117777|NCT02829671|Loneliness|loneliness
117778|NCT02829671|Suicidal behavior|suicidal behavior
117780|NCT02829645|eating disoders|eating disoders
117781|NCT02829645|neuropsychology|neuropsychology
117782|NCT02829645|pronostic|pronostic
117783|NCT02829632|mobile technology|mobile technology
117784|NCT02829632|feedback message|feedback message
117785|NCT02829632|self-monitoring|self-monitoring
117786|NCT02829619|Obesity|obesity
117787|NCT02829619|Nutrigenetics|nutrigenetics
117788|NCT02829619|Food Timing|food timing
117789|NCT02829619|Weight loss|weight loss
117790|NCT02829606|Age-related Macular Degeneration|age-related macular degeneration
117791|NCT02829606|Central Scotoma|central scotoma
117792|NCT02829606|Head Mounted Display|head mounted display
117793|NCT02829580|endothelial function|endothelial function
117794|NCT02829580|flow-mediated dilation|flow-mediated dilation
117795|NCT02829580|vascular elastic properties|vascular elastic properties
117796|NCT02829554|Emotion|emotion
117797|NCT02829554|Judgment|judgment
117798|NCT02829554|Decision Making|decision making
117799|NCT02829541|Single Ascending Dose (SAD), Healthy Volunteers|single ascending dose (sad), healthy volunteers
117800|NCT02829502|Cerebrovascular disease|cerebrovascular disease
117801|NCT02829502|Glucagon like peptide 1|glucagon like peptide 1
117802|NCT02829489|nutrition|nutrition
117803|NCT02829489|foregut tumors|foregut tumors
117804|NCT02829489|patient related outcomes|patient related outcomes
117805|NCT02829489|audit|audit
117806|NCT02829476|Adolescent idiopathic Scoliosis|adolescent idiopathic scoliosis
117807|NCT02829476|Ghrelin|ghrelin
117808|NCT02829450|peritoneal ultrafiltration|peritoneal ultrafiltration
117809|NCT02829450|congestive heart failure|congestive heart failure
117810|NCT02829450|chronic kidney disease|chronic kidney disease
117811|NCT02829398|cerebral ischemia|cerebral ischemia
117812|NCT02829385|Apatinib|apatinib
117813|NCT02829385|XELOX Regimen|xelox regimen
117814|NCT02829385|metastatic colorectal cancer|metastatic colorectal cancer
117815|NCT02829346|Tranexamic acid|tranexamic acid
117816|NCT02829346|Peri-articular injection|peri-articular injection
117817|NCT02829346|Total knee arthroplasty|total knee arthroplasty
117818|NCT02829346|Blood loss|blood loss
117819|NCT02829346|Osteoarthritis, Knee|osteoarthritis, knee
117820|NCT02829333|analgesia|analgesia
117821|NCT02829333|anesthesia|anesthesia
117822|NCT02829333|leiomyomas|leiomyomas
117823|NCT02829333|tumor|tumor
117824|NCT02829333|vascular endothelial growth factor|vascular endothelial growth factor
117825|NCT02829333|anesthesia technique on tumor|anesthesia technique on tumor
117826|NCT02829320|efficacy|efficacy
117827|NCT02829320|hemodialysis (HD)|hemodialysis (hd)
117828|NCT02829320|hemoglobin (Hgb)|hemoglobin (hgb)
117829|NCT02829320|erythropoiesis-stimulating agents (ESAs)|erythropoiesis-stimulating agents (esas)
117830|NCT02829320|GSK1278863|gsk1278863
117831|NCT02829307|89Zirconium|89zirconium
117832|NCT02829307|Open label|open label
117833|NCT02829307|Pharmacokinetics|pharmacokinetics
117834|NCT02829307|Radioactive|radioactive
117835|NCT02829307|Clearance|clearance
117836|NCT02829307|Biodistribution|biodistribution
117837|NCT02829281|knee osteoarthritis|knee osteoarthritis
117838|NCT02829281|Intra-articular injection|intra-articular injection
117839|NCT02829281|Botulinum Toxin Type A|botulinum toxin type a
117840|NCT02829281|Corticosteroid|corticosteroid
117841|NCT02829268|Wolfram syndrome|wolfram syndrome
117842|NCT02829268|Diabetes Mellitus|diabetes mellitus
117843|NCT02829268|Optic Nerve Atrophy|optic nerve atrophy
117844|NCT02829268|Ataxia|ataxia
117845|NCT02829268|Endoplasmic Reticulum Stress|endoplasmic reticulum stress
117846|NCT02829255|High altitude|high altitude
117847|NCT02829255|Cerebral autoregulation|cerebral autoregulation
117848|NCT02829255|Transfer function analysis|transfer function analysis
117849|NCT02829242|Near Infrared Spectroscopy|near infrared spectroscopy
117850|NCT02829242|Somatic Saturation|somatic saturation
117851|NCT02829242|Well Leg Compartment Syndrome|well leg compartment syndrome
117852|NCT02829242|Robotic Assisted Laparoscopic Surgery|robotic assisted laparoscopic surgery
117853|NCT02829242|Trendelenburg Position|trendelenburg position
117854|NCT02829216|myelosuppression|myelosuppression
117855|NCT02829216|mesenchymal stromal cells|mesenchymal stromal cells
117856|NCT02829203|Frailty|frailty
117857|NCT02829203|Surgery|surgery
117858|NCT02829190|External carotid artery|external carotid artery
117859|NCT02829190|Facial artery|facial artery
117860|NCT02829190|Lingual artery|lingual artery
117861|NCT02829190|Superior thyroid artery|superior thyroid artery
117862|NCT02829190|Internal maxillary artery|internal maxillary artery
117863|NCT02829190|Phase-contrast MRI|phase-contrast mri
117864|NCT02829190|Rate of flow|rate of flow
117865|NCT02829190|Superficial temporal artery|superficial temporal artery
117866|NCT02829177|Type 1 diabetes|type 1 diabetes
117867|NCT02829177|Diabetic nephropathy|diabetic nephropathy
117868|NCT02829177|Albuminuria|albuminuria
117869|NCT02829177|Allopurinol|allopurinol
117870|NCT02829164|Tonsillectomy|tonsillectomy
117871|NCT02829164|primary IgA nephropathy|primary iga nephropathy
117872|NCT02829164|primary nephropathy|primary nephropathy
117873|NCT02829164|IgA|iga
117874|NCT02829164|Berger's disease|berger's disease
117875|NCT02829164|Purpura rheumatoid|purpura rheumatoid
117876|NCT02829164|kidney failure|kidney failure
117877|NCT02829151|Peripheral artery disease|peripheral artery disease
117878|NCT02829151|Critical limb ischemia|critical limb ischemia
117879|NCT02829151|Angioplasty|angioplasty
117880|NCT02829151|Antiplatelet therapy|antiplatelet therapy
117881|NCT02829125|Early rehabilitation|early rehabilitation
117882|NCT02829125|abdominal surgery|abdominal surgery
117883|NCT02829125|ERAS|eras
117884|NCT02829112|Shulman|shulman
117885|NCT02829112|fasciitis|fasciitis
117886|NCT02829112|Shulman fasciitis|shulman fasciitis
117887|NCT02829112|eosinophilic fasciitis|eosinophilic fasciitis
117888|NCT02829112|inflammatory disease|inflammatory disease
117889|NCT02829112|prevalence|prevalence
117890|NCT02829073|Tinnitus|tinnitus
117891|NCT02829073|Double-blind|double-blind
117892|NCT02829073|Neuromonic Tinnitus Treatment Program|neuromonic tinnitus treatment program
117893|NCT02829073|Oasis™|oasis™
117894|NCT02829060|nephrolithiasis|nephrolithiasis
117895|NCT02829060|percutaneous nephrolithiasis|percutaneous nephrolithiasis
117896|NCT02829060|urinary tract infection (UTI)|urinary tract infection (uti)
117897|NCT02829060|Sepsis|sepsis
117898|NCT02829034|pulmonary hypertension|pulmonary hypertension
117899|NCT02829034|right ventricular function|right ventricular function
117900|NCT02829034|ranolazine|ranolazine
117901|NCT02829021|Sensitivity|sensitivity
117902|NCT02829021|Specificity|specificity
117903|NCT02829021|Breast cancer|breast cancer
117904|NCT02829021|Mammography|mammography
117905|NCT02829021|Thermography|thermography
117906|NCT02829021|Infrared|infrared
117907|NCT02829021|Dynamic|dynamic
117908|NCT02829021|Diagnostic accuracy|diagnostic accuracy
117909|NCT02829021|Diagnostic odds ratio|diagnostic odds ratio
117910|NCT02829008|HER2 negative breast cancer|her2 negative breast cancer
117911|NCT02829008|low-dose bevacizumab|low-dose bevacizumab
117912|NCT02829008|pemetrexed|pemetrexed
117913|NCT02828995|Diabetes Mellitus|diabetes mellitus
117914|NCT02828995|Stigma|stigma
117915|NCT02828995|Social Determinants of Health|social determinants of health
117916|NCT02828982|powered ankle prosthesis|powered ankle prosthesis
117917|NCT02828982|activity monitoring|activity monitoring
117918|NCT02828982|muscle fatigue|muscle fatigue
117919|NCT02828982|below knee amputation|below knee amputation
117920|NCT02828969|Trajectory|trajectory
117921|NCT02828969|Emergency room|emergency room
117922|NCT02828969|Conduct disorder|conduct disorder
117923|NCT02828969|Care management|care management
117924|NCT02828956|eating disorders|eating disorders
117925|NCT02828956|ANSOCQ|ansocq
117926|NCT02828956|anorexia nervosa|anorexia nervosa
117927|NCT02828878|Apoptosis|apoptosis
117928|NCT02828878|FAS Ligand|fas ligand
117929|NCT02828878|Bone marrow transplantation|bone marrow transplantation
117930|NCT02828878|GvHD|gvhd
117931|NCT02828878|Stem cells|stem cells
117932|NCT02828865|Hepatocellular Carcinoma|hepatocellular carcinoma
117933|NCT02828865|irreversible electroporation|irreversible electroporation
117934|NCT02828865|liver cancer|liver cancer
117935|NCT02828852|pregnancy|pregnancy
117936|NCT02828852|platelets|platelets
117937|NCT02828839|Transperineal|transperineal
117938|NCT02828839|Transrectal|transrectal
117939|NCT02828839|Needle Guide|needle guide
117940|NCT02828839|Biopsy|biopsy
117941|NCT02828761|chest pain|chest pain
117942|NCT02828761|calcium score|calcium score
117943|NCT02828761|coronary calcium score|coronary calcium score
117944|NCT02828761|coronary calcium scoring|coronary calcium scoring
117945|NCT02828761|calcium scoring|calcium scoring
117946|NCT02828761|cacs|cacs
117947|NCT02828761|ccs|ccs
117948|NCT02828748|cannabinoids|cannabinoids
117949|NCT02828748|inflammatory bowel disease|inflammatory bowel disease
117950|NCT02828722|Circadian rhythm|circadian rhythm
117951|NCT02828722|Critical Illness|critical illness
117952|NCT02828722|Mechanical ventilation|mechanical ventilation
117953|NCT02828722|Environmental modulation|environmental modulation
117954|NCT02828696|CAD-CAM composites|cad-cam composites
117955|NCT02828696|Worn dentition|worn dentition
117956|NCT02828696|minimally invasive treatment|minimally invasive treatment
117957|NCT02828683|DES|des
117958|NCT02828683|PCI|pci
117959|NCT02828683|STEMI|stemi
117960|NCT02828683|Interventional Cardiology|interventional cardiology
117961|NCT02828657|ORBERA|orbera
117962|NCT02828644|ADHD|adhd
117963|NCT02828592|SAA|saa
117964|NCT02828579|obesity|obesity
117965|NCT02828579|bariatric surgery|bariatric surgery
117966|NCT02828579|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
117967|NCT02828553|Wearable device|wearable device
117968|NCT02828553|Fitbit|fitbit
117969|NCT02828553|Inpatient|inpatient
117970|NCT02828540|HT047|ht047
117971|NCT02828540|Pueraria lobata|pueraria lobata
117972|NCT02828540|Scutellaria baicalensis|scutellaria baicalensis
117973|NCT02828501|Pain Threshold|pain threshold
117974|NCT02828436|Hypertension|hypertension
117975|NCT02828436|High Blood Pressure|high blood pressure
117976|NCT02828423|periodontal regeneration|periodontal regeneration
117977|NCT02828410|serum bovine immunoglobulin protein isolate|serum bovine immunoglobulin protein isolate
117978|NCT02828410|IPAA|ipaa
117979|NCT02828410|quality of life|quality of life
117980|NCT02828384|fodmap diet|fodmap diet
117981|NCT02828332|Autism Spectrum Disorders|autism spectrum disorders
117982|NCT02828332|Cohort|cohort
117983|NCT02828306|stroke|stroke
117984|NCT02828306|head trauma|head trauma
117985|NCT02828306|Patient Specific Implant|patient specific implant
117986|NCT02828306|skull defect|skull defect
117987|NCT02828267|Tanzania|tanzania
117988|NCT02828267|Alcohol Use|alcohol use
117989|NCT02828267|Brief Intervention|brief intervention
117990|NCT02828228|obesity|obesity
117991|NCT02828228|weight loss|weight loss
117992|NCT02828228|vitamin D deficiency|vitamin d deficiency
117993|NCT02828228|body composition|body composition
117994|NCT02828202|Melanoma|melanoma
117995|NCT02828202|Skin|skin
117996|NCT02828202|Biobank|biobank
117997|NCT02828189|Physical Therapy Modalities|physical therapy modalities
117998|NCT02828189|Breast Cancer Treatment|breast cancer treatment
117999|NCT02828189|Exercise Therapy|exercise therapy
118000|NCT02828189|Dyspnea|dyspnea
118001|NCT02828176|cardiometry|cardiometry
118002|NCT02828176|uterine displacement|uterine displacement
118003|NCT02828111|Gorlin Syndrome|gorlin syndrome
118004|NCT02828111|Basal Cell Nevus Syndrome BCNS|basal cell nevus syndrome bcns
118005|NCT02828111|nevoid basal cell carcinoma syndrome|nevoid basal cell carcinoma syndrome
118006|NCT02828111|Basal cell carcinoma|basal cell carcinoma
118007|NCT02828111|Hedgehog inhibitor|hedgehog inhibitor
118008|NCT02828111|Surgically Eligible Basal Cell Carcinomas|surgically eligible basal cell carcinomas
118009|NCT02828098|aggressive solid tumors|aggressive solid tumors
118010|NCT02828059|Caesarean section|caesarean section
118011|NCT02828007|EIT|eit
118012|NCT02828007|NIV|niv
118013|NCT02827968|PDL-1|pdl-1
118014|NCT02827942|pylori|pylori
118015|NCT02827903|Metformin|metformin
118016|NCT02827903|Rosuvastatin|rosuvastatin
118017|NCT02827903|type 2 diabetes|type 2 diabetes
118018|NCT02827903|dyslipidemia|dyslipidemia
118019|NCT02827864|Mirror therapy|mirror therapy
118020|NCT02827864|transcranial direct current stimulation|transcranial direct current stimulation
118021|NCT02827864|stroke|stroke
118022|NCT02827864|neurorehabilitation|neurorehabilitation
118023|NCT02827851|Damage of articular cartilage|damage of articular cartilage
118024|NCT02827851|Cartilage degeneration|cartilage degeneration
118025|NCT02827851|Intraarticular injection|intraarticular injection
118026|NCT02827851|SVF|svf
118027|NCT02827851|Stromal vascular fraction|stromal vascular fraction
118028|NCT02827851|Adipose-derived regenerative cells (ADRC)|adipose-derived regenerative cells (adrc)
118029|NCT02827851|Adipose tissue|adipose tissue
118030|NCT02827851|Stem cells|stem cells
118031|NCT02827825|Neurosurgical|neurosurgical
118032|NCT02827825|Intensive Care|intensive care
118033|NCT02827799|heart failure|heart failure
118034|NCT02827799|insomnia|insomnia
118035|NCT02827799|sleep disorders|sleep disorders
118036|NCT02827799|actigraphy|actigraphy
118037|NCT02827799|cardiomyopathy|cardiomyopathy
118038|NCT02827799|depression|depression
118039|NCT02827799|sleepiness|sleepiness
118040|NCT02827799|anxiety|anxiety
118041|NCT02827799|fatigue|fatigue
118042|NCT02827786|hepatic tumours|hepatic tumours
118043|NCT02827773|Literacy|literacy
118044|NCT02827747|Keratoconus progression|keratoconus progression
118045|NCT02827747|Vitamins and keratoconus|vitamins and keratoconus
118046|NCT02827747|Vitamin supplementation|vitamin supplementation
118047|NCT02827682|IoC|ioc
118048|NCT02827682|monitor|monitor
118049|NCT02827682|elderly|elderly
118050|NCT02827682|postoperative effectiveness|postoperative effectiveness
118051|NCT02827656|Fertilization in vitro|fertilization in vitro
118052|NCT02827656|Luteal Phase|luteal phase
118053|NCT02827656|ovarian hyperstimulation syndrome|ovarian hyperstimulation syndrome
118054|NCT02827617|Ibrutinib|ibrutinib
118055|NCT02827617|TP53|tp53
118056|NCT02827617|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
118057|NCT02827604|Caesarean section|caesarean section
118058|NCT02827604|lower uterine segment|lower uterine segment
118059|NCT02827604|sonography|sonography
118060|NCT02827591|repeat cesarean section|repeat cesarean section
118061|NCT02827591|lower uterine segment|lower uterine segment
118062|NCT02827591|quantitative sonography|quantitative sonography
118063|NCT02827565|colorectal cancer|colorectal cancer
118064|NCT02827565|Kras mutation|kras mutation
118065|NCT02827565|Nras mutation|nras mutation
118066|NCT02827565|Braf mutation|braf mutation
118067|NCT02827552|pediatric oncology|pediatric oncology
118068|NCT02827552|radiotherapy|radiotherapy
118069|NCT02827552|radiosensitivity|radiosensitivity
118070|NCT02827513|Centanafadine|centanafadine
118071|NCT02827513|Adult attention-deficit hyperactivity disorder|adult attention-deficit hyperactivity disorder
118072|NCT02827513|Healthy participants|healthy participants
118073|NCT02827448|Left Ventricular Assist Device|left ventricular assist device
118074|NCT02827448|Heart Transplantation|heart transplantation
118075|NCT02827448|Perioperative|perioperative
118076|NCT02827448|Acute Kidney Injury|acute kidney injury
118077|NCT02827448|Renal|renal
118078|NCT02827448|Kidney|kidney
118079|NCT02827448|Total Artificial Heart|total artificial heart
118080|NCT02827422|therapeutic hypothermia|therapeutic hypothermia
118081|NCT02827409|Delayed cord clamping|delayed cord clamping
118082|NCT02827396|Disability|disability
118083|NCT02827396|children|children
118084|NCT02827396|parents|parents
118085|NCT02827396|depression|depression
118086|NCT02827396|knowledge|knowledge
118087|NCT02827396|psychosocial intervention|psychosocial intervention
118088|NCT02827344|PD-1/PD-L1|pd-1/pd-l1
118089|NCT02827344|Immune checkpoints|immune checkpoints
118090|NCT02827344|Immunotherapy|immunotherapy
118091|NCT02827344|lung cancer|lung cancer
118092|NCT02827344|circulating tumor cells|circulating tumor cells
118093|NCT02827344|immunocytochemistry|immunocytochemistry
118094|NCT02827344|ISET|iset
118095|NCT02827344|MDSC|mdsc
118096|NCT02827344|Stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
118097|NCT02827331|Benzodiazepines|benzodiazepines
118098|NCT02827331|Fracture|fracture
118099|NCT02827318|Blood glucose|blood glucose
118100|NCT02827305|antiplaque|antiplaque
118101|NCT02827305|antigingivitis|antigingivitis
118102|NCT02827292|music|music
118103|NCT02827292|inflammation|inflammation
118104|NCT02827279|Autism Spectrum Disorder|autism spectrum disorder
118105|NCT02827279|Emotion|emotion
118106|NCT02827253|brain|brain
118107|NCT02827253|haemodialysis|haemodialysis
118108|NCT02827253|intradialytic hypotension|intradialytic hypotension
118109|NCT02827240|Female sex workers|female sex workers
118110|NCT02827240|HIV testing|hiv testing
118111|NCT02827240|HIV self-test|hiv self-test
118112|NCT02827227|HIV-infected patients|hiv-infected patients
118113|NCT02827227|cART|cart
118114|NCT02827227|immune restoration|immune restoration
118115|NCT02827227|markers|markers
118116|NCT02827214|Thoracolumbar spine|thoracolumbar spine
118117|NCT02827214|Burst fractures|burst fractures
118118|NCT02827214|Conservative treatment|conservative treatment
118119|NCT02827214|Surgical treatment|surgical treatment
118120|NCT02827214|Thoracic or lumbar vertebrae|thoracic or lumbar vertebrae
118121|NCT02827201|pancreatic cancer|pancreatic cancer
118122|NCT02827162|Dengue Fever|dengue fever
118123|NCT02827162|Dengue Haemorrhagic Fever|dengue haemorrhagic fever
118124|NCT02827162|Tetravalent Dengue Vaccine|tetravalent dengue vaccine
118125|NCT02827149|HSCT|hsct
118126|NCT02827149|high resolution HLA typing|high resolution hla typing
118127|NCT02827149|unrelated donor|unrelated donor
118128|NCT02827084|electromyography|electromyography
118129|NCT02827084|torque|torque
118130|NCT02827084|quadriceps muscle|quadriceps muscle
118131|NCT02827058|Delivery, obstetric|delivery, obstetric
118132|NCT02827058|Analgesia, Epidural|analgesia, epidural
118133|NCT02827058|Injections, Epidural|injections, epidural
118134|NCT02827058|Needles|needles
118135|NCT02827058|Cesarean Section|cesarean section
118136|NCT02827032|Hypertension|hypertension
118137|NCT02827006|Bone graft|bone graft
118138|NCT02827006|Calcium phosphate bone cement|calcium phosphate bone cement
118139|NCT02827006|RCT|rct
118140|NCT02827006|Xray|xray
118141|NCT02827006|CT|ct
118142|NCT02826993|PillCAM2|pillcam2
118143|NCT02826967|Hydro-San Plus colonic irrigation system|hydro-san plus colonic irrigation system
118144|NCT02826967|Screening colonoscopy|screening colonoscopy
118145|NCT02826954|Paranasal Sinus Diseases|paranasal sinus diseases
118146|NCT02826954|Nasal Obstruction|nasal obstruction
118147|NCT02826941|hypothermia treatment|hypothermia treatment
118148|NCT02826915|newborn|newborn
118149|NCT02826915|infant|infant
118150|NCT02826915|child|child
118151|NCT02826915|EEG|eeg
118152|NCT02826915|NIRS|nirs
118153|NCT02826902|Total intravenous anesthesia|total intravenous anesthesia
118154|NCT02826902|desflurane|desflurane
118155|NCT02826902|QoR-40|qor-40
118156|NCT02826902|cosmetic lower limb lengthening|cosmetic lower limb lengthening
118157|NCT02826889|Fluid responsiveness|fluid responsiveness
118158|NCT02826889|corrected flow time|corrected flow time
118159|NCT02826889|pleth variability index|pleth variability index
118160|NCT02826889|prone position|prone position
118161|NCT02826876|Laparoscopic surgery|laparoscopic surgery
118162|NCT02826863|seizure|seizure
118163|NCT02826863|tonic-atonic|tonic-atonic
118164|NCT02826863|epilepsy|epilepsy
118165|NCT02826863|myoclonic|myoclonic
118166|NCT02826863|encephalopathy|encephalopathy
118167|NCT02826850|Osteoarthritis, Knee|osteoarthritis, knee
118168|NCT02826850|Pulsed Radiofrequency Treatment|pulsed radiofrequency treatment
118169|NCT02826850|Ultrasonography, Interventional|ultrasonography, interventional
118170|NCT02826837|Advanced Colorectal Cancer|advanced colorectal cancer
118171|NCT02826824|corpus callosum agenesis|corpus callosum agenesis
118172|NCT02826824|agenesis|agenesis
118173|NCT02826824|corpus callosum|corpus callosum
118174|NCT02826811|Graft dysfunction|graft dysfunction
118175|NCT02826811|Graft loss|graft loss
118176|NCT02826811|kidney|kidney
118177|NCT02826811|Transplantation|transplantation
118178|NCT02826811|BKV|bkv
118179|NCT02826811|Anti-BKV|anti-bkv
118180|NCT02826811|Nephropathy|nephropathy
118181|NCT02826811|Immunosuppression|immunosuppression
118182|NCT02826811|Prognostic markers|prognostic markers
118183|NCT02826798|VBI-1501A|vbi-1501a
118184|NCT02826798|VBI-1501|vbi-1501
118185|NCT02826798|prophylactic vaccine|prophylactic vaccine
118186|NCT02826798|virus diseases|virus diseases
118187|NCT02826798|cytomegalovirus|cytomegalovirus
118188|NCT02826798|CMV|cmv
118189|NCT02826798|cytomegalovirus infections|cytomegalovirus infections
118190|NCT02826798|cytomegalovirus vaccines|cytomegalovirus vaccines
118191|NCT02826798|Herpesviridae Infections|herpesviridae infections
118192|NCT02826798|Phase 1|phase 1
118193|NCT02826798|Human Herpesvirus 5|human herpesvirus 5
118194|NCT02826798|HHV5|hhv5
118195|NCT02826798|Vaccines, virus-like particle|vaccines, virus-like particle
118196|NCT02826798|VLP|vlp
118197|NCT02826798|enveloped virus-like particle|enveloped virus-like particle
118198|NCT02826798|eVLP|evlp
118199|NCT02826759|sphingolipid|sphingolipid
118200|NCT02826759|diabetes mellitus|diabetes mellitus
118201|NCT02826759|biomarker|biomarker
118202|NCT02826759|obesity|obesity
118203|NCT02826759|insulin resistance|insulin resistance
118204|NCT02826733|preterm infants|preterm infants
118205|NCT02826733|term infants|term infants
118206|NCT02826733|hemispheric dominance|hemispheric dominance
118207|NCT02826720|HDL cholesterol|hdl cholesterol
118208|NCT02826720|Hyperlipidemia|hyperlipidemia
118209|NCT02826720|LDL cholesterol|ldl cholesterol
118210|NCT02826720|Periodontal disease|periodontal disease
118211|NCT02826720|Triglyceride|triglyceride
118212|NCT02826655|WF-OCT|wf-oct
118213|NCT02826655|OCT|oct
118214|NCT02826655|diabetic retinopathy|diabetic retinopathy
118215|NCT02826655|diabetic macular edema|diabetic macular edema
118216|NCT02826642|newly diagnosed acute myeloid leukemia|newly diagnosed acute myeloid leukemia
118217|NCT02826642|AML|aml
118218|NCT02826642|myeloid dysplastic syndrome|myeloid dysplastic syndrome
118219|NCT02826642|MDS|mds
118220|NCT02826642|IDH305|idh305
118221|NCT02826642|standard of care in IDH1 mutant acute myeloid leukemia|standard of care in idh1 mutant acute myeloid leukemia
118222|NCT02826629|Sensorimotor Integration|sensorimotor integration
118223|NCT02826629|Schizophrenia|schizophrenia
118224|NCT02826629|TMS|tms
118225|NCT02826629|Oculomotor|oculomotor
118226|NCT02826629|Motor Control|motor control
118227|NCT02826616|Trimetazidine|trimetazidine
118228|NCT02826616|ST-segment elevation myocardial|st-segment elevation myocardial
118229|NCT02826616|Reperfusion injury|reperfusion injury
118230|NCT02826616|Percutaneous coronary intervention|percutaneous coronary intervention
118231|NCT02826603|Plaque psoriasis,|plaque psoriasis,
118232|NCT02826603|secukinumab,|secukinumab,
118233|NCT02826603|ustekinumab|ustekinumab
118234|NCT02826564|radiotherapy|radiotherapy
118235|NCT02826564|immunotherapy|immunotherapy
118236|NCT02826512|BRCA1-like|brca1-like
118237|NCT02826512|HER2 negative|her2 negative
118238|NCT02826499|Pediguard|pediguard
118239|NCT02826499|Pedicular screws|pedicular screws
118240|NCT02826499|Fluoroscopy|fluoroscopy
118241|NCT02826473|Dementia|dementia
118242|NCT02826473|Dementia screening|dementia screening
118243|NCT02826473|General Hospital|general hospital
118244|NCT02826473|Inpatients|inpatients
118245|NCT02826460|Transplant|transplant
118246|NCT02826460|Adherence|adherence
118247|NCT02826434|Breast Cancer|breast cancer
118248|NCT02826434|vaccine|vaccine
118249|NCT02826434|immunotherapy|immunotherapy
118250|NCT02826434|PD-L1 Inhibitor|pd-l1 inhibitor
118251|NCT02826434|triple negative breast cancer|triple negative breast cancer
118252|NCT02826421|Intraocular lens|intraocular lens
118253|NCT02826395|Prostate cancer|prostate cancer
118254|NCT02826395|diagnostic|diagnostic
118255|NCT02826395|imaging|imaging
118256|NCT02826395|PET/CT|pet/ct
118257|NCT02826395|Acetate carbon-11|acetate carbon-11
118258|NCT02826369|Algorithms|algorithms
118259|NCT02826369|Image Processing, Computer-Assisted/methods*|image processing, computer-assisted/methods*
118260|NCT02826369|Magnetic Resonance Imaging/methods*|magnetic resonance imaging/methods*
118261|NCT02826369|Data Compression|data compression
118262|NCT02826369|Breast Neoplasms|breast neoplasms
118263|NCT02826356|Angioedema|angioedema
118264|NCT02826356|Emergency treatment|emergency treatment
118265|NCT02826356|Treatment availability|treatment availability
118266|NCT02826356|Health Equity|health equity
118267|NCT02826343|COPD|copd
118268|NCT02826330|Crohn's Disease|crohn's disease
118269|NCT02826330|Healthy relatives|healthy relatives
118270|NCT02826330|Dysbiosis|dysbiosis
118271|NCT02826330|Biomarkers|biomarkers
118272|NCT02826304|Vaginal Hysterectomy|vaginal hysterectomy
118273|NCT02826304|Laparoscopic assisted vaginal hysterectomy|laparoscopic assisted vaginal hysterectomy
118274|NCT02826304|Large uteri|large uteri
118275|NCT02826291|OSNA|osna
118276|NCT02826291|sentinel|sentinel
118277|NCT02826291|lymph|lymph
118278|NCT02826291|node|node
118279|NCT02826291|endometrial|endometrial
118280|NCT02826291|cancer|cancer
118281|NCT02826278|Newborn genitalia|newborn genitalia
118282|NCT02826278|reference charts|reference charts
118283|NCT02826252|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
118284|NCT02826213|Renal infusion|renal infusion
118579|NCT02824523|AERD|aerd
118285|NCT02826213|Renal infusion device|renal infusion device
118286|NCT02826200|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
118287|NCT02826200|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
118288|NCT02826200|Prosthetic Cardiac Valve Thrombosis|prosthetic cardiac valve thrombosis
118289|NCT02826200|Cerebrovascular Accident|cerebrovascular accident
118290|NCT02826200|Prosthetic Valve Malfunction|prosthetic valve malfunction
118291|NCT02826200|Four-dimensional volume rendered cardiac CT|four-dimensional volume rendered cardiac ct
118292|NCT02826200|Transesophageal echocardiography|transesophageal echocardiography
118293|NCT02826200|Transthoracic echocardiography|transthoracic echocardiography
118294|NCT02826200|Brain MRI|brain mri
118295|NCT02826187|Acetabular implant|acetabular implant
118296|NCT02826161|Neoplasms|neoplasms
118297|NCT02826161|Neoplasms by Site|neoplasms by site
118298|NCT02826161|Lung Neoplasms|lung neoplasms
118299|NCT02826161|Thoracic Neoplasms|thoracic neoplasms
118300|NCT02826161|Respiratory Tract Neoplasms|respiratory tract neoplasms
118301|NCT02826161|Bronchial Neoplasms|bronchial neoplasms
118302|NCT02826096|Psychiatry|psychiatry
118303|NCT02826096|psychological|psychological
118304|NCT02826096|psychotherapy|psychotherapy
118305|NCT02826096|randomize|randomize
118306|NCT02826096|Biofeedback|biofeedback
118307|NCT02826070|Chronic Hepatitis B|chronic hepatitis b
118308|NCT02826031|Sodium Hyaluronate|sodium hyaluronate
118309|NCT02826031|mild to moderate knee osteoarthritis|mild to moderate knee osteoarthritis
118310|NCT02826018|RNAi therapeutic|rnai therapeutic
118311|NCT02826018|Hepatitis B|hepatitis b
118312|NCT02826018|Chronic Hepatitis B|chronic hepatitis b
118313|NCT02826018|Hepatitis B, Chronic|hepatitis b, chronic
118314|NCT02826018|Hepatitis B Infection|hepatitis b infection
118315|NCT02826018|HBV|hbv
118316|NCT02825927|Dysphagia|dysphagia
118317|NCT02825927|Oral screen|oral screen
118318|NCT02825927|Intervention|intervention
118319|NCT02825927|Oral Health|oral health
118320|NCT02825927|Food Intake|food intake
118321|NCT02825927|Quality of life|quality of life
118322|NCT02825927|Elderly|elderly
118323|NCT02825927|Short-term care facilities|short-term care facilities
118324|NCT02825914|glycopeptides|glycopeptides
118325|NCT02825914|human microbiome|human microbiome
118326|NCT02825914|caseinomacropeptide|caseinomacropeptide
118327|NCT02825914|whey protein|whey protein
118328|NCT02825914|dietary proteins|dietary proteins
118329|NCT02825849|endometrium|endometrium
118330|NCT02825849|thin uterine lining|thin uterine lining
118331|NCT02825849|uterine scarring|uterine scarring
118332|NCT02825836|M7583|m7583
118333|NCT02825836|Bruton's Tyrosine Kinase Inhibitor|bruton's tyrosine kinase inhibitor
118334|NCT02825836|Lymphoma|lymphoma
118335|NCT02825836|Open|open
118336|NCT02825836|Phase I|phase i
118337|NCT02825810|breast cancer|breast cancer
118338|NCT02825810|long-term survival|long-term survival
118339|NCT02825810|motor control|motor control
118340|NCT02825810|cervical pain|cervical pain
118341|NCT02825797|Broadly neutralizing antibody|broadly neutralizing antibody
118342|NCT02825797|3BNC117|3bnc117
118343|NCT02825797|10-1074|10-1074
118344|NCT02825784|potassium chronic kidney disease CKD children|potassium chronic kidney disease ckd children
118345|NCT02825758|Micronutrients|micronutrients
118346|NCT02825758|restricted|restricted
118347|NCT02825758|ketogenic|ketogenic
118348|NCT02825758|diet|diet
118349|NCT02825758|acceptability|acceptability
118350|NCT02825732|Alzheimer's disease or related disorder|alzheimer's disease or related disorder
118351|NCT02825732|Comorbidity|comorbidity
118352|NCT02825732|Charlson comorbidity index|charlson comorbidity index
118353|NCT02825732|Caregiver burden|caregiver burden
118354|NCT02825732|Cohort|cohort
118355|NCT02825732|Dementia|dementia
118356|NCT02825732|Behavioral disorders|behavioral disorders
118357|NCT02825732|Functional dependency|functional dependency
118358|NCT02825719|Fibroid|fibroid
118359|NCT02825719|Ulipristal|ulipristal
118360|NCT02825719|Selective progesterone receptor modulator|selective progesterone receptor modulator
118361|NCT02825719|Chinese|chinese
118362|NCT02825706|Hemophilia|hemophilia
118363|NCT02825706|Educational Physiotherapy|educational physiotherapy
118364|NCT02825706|Pain|pain
118365|NCT02825706|Quality of life|quality of life
118366|NCT02825706|Illness Behaviour|illness behaviour
118367|NCT02825706|Elbow|elbow
118368|NCT02825680|Weight Loss|weight loss
118369|NCT02825680|Body Weight Maintenance|body weight maintenance
118370|NCT02825680|Quality Improvement|quality improvement
118371|NCT02825667|Haemophilia|haemophilia
118372|NCT02825667|Ankle|ankle
118373|NCT02825667|Arthropathy|arthropathy
118374|NCT02825667|Pain|pain
118375|NCT02825667|Range of motion|range of motion
118376|NCT02825667|Myofascial techniques|myofascial techniques
118377|NCT02825654|Pulmonary|pulmonary
118378|NCT02825654|Lung|lung
118379|NCT02825654|Military and environmental exposures|military and environmental exposures
118380|NCT02825654|Epidemiologic|epidemiologic
118381|NCT02825654|Observational|observational
118382|NCT02825654|Interview or questionnaire|interview or questionnaire
118383|NCT02825654|Deployment related|deployment related
118384|NCT02825654|Enduring Freedom|enduring freedom
118385|NCT02825654|Iraqi Freedom|iraqi freedom
118386|NCT02825615|radial artery cannulation|radial artery cannulation
118387|NCT02825615|ultrasound guided|ultrasound guided
118388|NCT02825615|first success rate|first success rate
118389|NCT02825615|systolic blood pressure|systolic blood pressure
118390|NCT02825615|shock|shock
118391|NCT02825602|Vietnam veteran|vietnam veteran
118392|NCT02825602|aging|aging
118393|NCT02825602|health|health
118394|NCT02825602|War Injury|war injury
118395|NCT02825602|Conventional Warfare|conventional warfare
118396|NCT02825602|Toxic Effect|toxic effect
118397|NCT02825602|Chemical|chemical
118398|NCT02825589|BIA|bia
118399|NCT02825589|chronic hemodialysis|chronic hemodialysis
118400|NCT02825589|sleep quality|sleep quality
118401|NCT02825550|Hepatoma|hepatoma
118402|NCT02825550|Transcatheter Arterial chemo-embolization|transcatheter arterial chemo-embolization
118403|NCT02825550|microsphere|microsphere
118404|NCT02825511|basal cell carcinoma, histological diagnosis, prognostic impact|basal cell carcinoma, histological diagnosis, prognostic impact
118405|NCT02825472|Congenital Heart Disease|congenital heart disease
118406|NCT02825472|Sport|sport
118407|NCT02825472|Exercise training|exercise training
118408|NCT02825459|abstinence|abstinence
118409|NCT02825459|abuse liability|abuse liability
118410|NCT02825459|electronic cigarette|electronic cigarette
118411|NCT02825459|e-cigarette|e-cigarette
118412|NCT02825459|electronic nicotine delivery device|electronic nicotine delivery device
118413|NCT02825459|harm reduction|harm reduction
118414|NCT02825459|nicotine|nicotine
118415|NCT02825459|nicotine dependence|nicotine dependence
118416|NCT02825459|smoking|smoking
118417|NCT02825459|smoking cessation|smoking cessation
118418|NCT02825459|tobacco|tobacco
118419|NCT02825459|vape|vape
118420|NCT02825459|vaping|vaping
118421|NCT02825459|withdrawal|withdrawal
118422|NCT02825446|radio frequency denervation|radio frequency denervation
118423|NCT02825446|tibial arteries|tibial arteries
118424|NCT02825446|atherosclerosis of the peripheral arteries|atherosclerosis of the peripheral arteries
118425|NCT02825381|Arthroplasty|arthroplasty
118426|NCT02825381|Hip|hip
118427|NCT02825355|robotic surgery procedure|robotic surgery procedure
118428|NCT02825355|indocyanine green|indocyanine green
118429|NCT02825355|sentinel lymph node mapping|sentinel lymph node mapping
118430|NCT02825342|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
118431|NCT02825342|Proton Pump Inhibitor (PPI)|proton pump inhibitor (ppi)
118432|NCT02825316|Crohn's disease|crohn's disease
118433|NCT02825316|inflammatory bowel diseases|inflammatory bowel diseases
118434|NCT02825316|Mediterranean diet|mediterranean diet
118435|NCT02825316|microbiome|microbiome
118436|NCT02825303|postural changes|postural changes
118437|NCT02825303|Height adjustable desk|height adjustable desk
118438|NCT02825303|Prolonged sitting|prolonged sitting
118439|NCT02825303|Cognitive performance|cognitive performance
118440|NCT02825290|Frozen-thawed embryo transfer (FET)|frozen-thawed embryo transfer (fet)
118441|NCT02825290|Luteal support|luteal support
118442|NCT02825290|Progesterone|progesterone
118443|NCT02825290|Natural cycle|natural cycle
118444|NCT02825290|Cryopreservation|cryopreservation
118445|NCT02825290|IVF|ivf
118446|NCT02825290|hCG|hcg
118447|NCT02825290|GnRH-Agonist|gnrh-agonist
118448|NCT02825290|Pregnancy rate|pregnancy rate
118449|NCT02825277|3D Power Doppler|3d power doppler
118450|NCT02825277|uteroplacental vascularization|uteroplacental vascularization
118451|NCT02825277|preeclampsia|preeclampsia
118452|NCT02825277|intra-uterine growth restriction|intra-uterine growth restriction
118453|NCT02825277|placental morphology|placental morphology
118454|NCT02825264|Glaucoma Drainage Device|glaucoma drainage device
118455|NCT02825264|STARflo|starflo
118456|NCT02825238|exercise|exercise
118457|NCT02825238|osteoarthritis|osteoarthritis
118458|NCT02825238|knee|knee
118459|NCT02825238|patellofemoral pain|patellofemoral pain
118460|NCT02825225|Prostatic Neoplasms|prostatic neoplasms
118461|NCT02825225|Biopsy|biopsy
118462|NCT02825225|Anesthesia|anesthesia
118463|NCT02825225|Detection|detection
118464|NCT02825212|Hepatitis C|hepatitis c
118465|NCT02825212|Cryoglobulinemia|cryoglobulinemia
118466|NCT02825160|Iloprost|iloprost
118467|NCT02825160|Ventavis|ventavis
118468|NCT02825160|Prostacycline analogue|prostacycline analogue
118469|NCT02825160|Pulmonary arterial hypertension|pulmonary arterial hypertension
118470|NCT02825160|Japan|japan
118471|NCT02825160|Post-marketing surveillance|post-marketing surveillance
118472|NCT02825147|pegaspargase,methotrexate|pegaspargase,methotrexate
118473|NCT02825134|heart valve disease|heart valve disease
118474|NCT02825134|valvular bioprosthesis|valvular bioprosthesis
118475|NCT02825134|aortic valve replacement|aortic valve replacement
118476|NCT02825134|Randomized clinical trial|randomized clinical trial
118477|NCT02825108|human chorionic gonadotropin (hCG), implantation rate intrauterine hCG clinical pregnancy rate frozen embryo transfer cycles|human chorionic gonadotropin (hcg), implantation rate intrauterine hcg clinical pregnancy rate frozen embryo transfer cycles
118478|NCT02825095|malignant pleural effusion,talc pleurodesis,quality of life|malignant pleural effusion,talc pleurodesis,quality of life
118479|NCT02825082|Emergency general surgery|emergency general surgery
118480|NCT02825082|Geriatric|geriatric
118481|NCT02825082|Outcomes|outcomes
118482|NCT02825082|Frailty|frailty
118483|NCT02825043|COPD|copd
118484|NCT02825004|Burnout|burnout
118485|NCT02825004|Health Care Workers|health care workers
118486|NCT02825004|Coping Skills|coping skills
118487|NCT02825004|Clinical Trial|clinical trial
118488|NCT02824952|Tagrisso|tagrisso
118489|NCT02824952|AZD9291|azd9291
118490|NCT02824952|EGFRm|egfrm
118491|NCT02824952|NSCLC|nsclc
118492|NCT02824900|Vibration Stimuli|vibration stimuli
118493|NCT02824900|Contraversive Pusher Syndrome|contraversive pusher syndrome
118494|NCT02824887|Electroacupuncture|electroacupuncture
118495|NCT02824887|Deep needling|deep needling
118496|NCT02824887|Lumbar disc herniation five points|lumbar disc herniation five points
118497|NCT02824887|Long term effect|long term effect
118498|NCT02824887|Prospective cohort study|prospective cohort study
118499|NCT02824848|congenital muscular torticollis|congenital muscular torticollis
118500|NCT02824848|infants|infants
118501|NCT02824848|passive stretching|passive stretching
118502|NCT02824848|perception-action approach|perception-action approach
118503|NCT02824822|Sudden Unexpected Death in Epilepsy|sudden unexpected death in epilepsy
118504|NCT02824822|SUDEP|sudep
118505|NCT02824822|Sudden Cardiac Arrest|sudden cardiac arrest
118506|NCT02824822|Sudden Cardiac Death|sudden cardiac death
118507|NCT02824822|Sleep|sleep
118508|NCT02824822|Ion channel disease|ion channel disease
118509|NCT02824822|Long QT syndrome|long qt syndrome
118510|NCT02824822|Brugada|brugada
118511|NCT02824822|Catecholaminergic Polymorphic Ventricular Tachycardia|catecholaminergic polymorphic ventricular tachycardia
118512|NCT02824809|hypogonadism|hypogonadism
118513|NCT02824809|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
118514|NCT02824809|Severity of Illness Index|severity of illness index
118515|NCT02824809|Testosterone|testosterone
118516|NCT02824796|ADHD|adhd
118517|NCT02824783|colorectal surgery|colorectal surgery
118518|NCT02824783|enhanced recovery|enhanced recovery
118519|NCT02824757|interstitial lung disease|interstitial lung disease
118520|NCT02824757|glucocorticcoid|glucocorticcoid
118521|NCT02824757|glucose|glucose
118522|NCT02824757|continuous glucose monitor|continuous glucose monitor
118523|NCT02824744|Bronchiolitis|bronchiolitis
118524|NCT02824744|High flow nasal canula|high flow nasal canula
118525|NCT02824731|brain tumors|brain tumors
118526|NCT02824731|proton radiotherapy|proton radiotherapy
118527|NCT02824731|photon radiotherapy|photon radiotherapy
118528|NCT02824718|Hypoparathyroidism|hypoparathyroidism
118529|NCT02824718|PTH(1-34)|pth(1-34)
118530|NCT02824718|Thiazides|thiazides
118531|NCT02824718|Hypercalciuria|hypercalciuria
118532|NCT02824718|Calcium sensing receptor|calcium sensing receptor
118533|NCT02824705|Heart|heart
118534|NCT02824705|multiple organ dysfunction syndrome|multiple organ dysfunction syndrome
118535|NCT02824705|pediatric critical care|pediatric critical care
118536|NCT02824705|congenital heart disease|congenital heart disease
118537|NCT02824679|Normal labour|normal labour
118538|NCT02824679|Augmentation of labour|augmentation of labour
118539|NCT02824679|Hyoscine butylbromide|hyoscine butylbromide
118540|NCT02824653|acute GVHD|acute gvhd
118541|NCT02824653|chronic GVHD|chronic gvhd
118542|NCT02824653|steroid-refractory|steroid-refractory
118543|NCT02824653|Mesenchymal Stem Cells|mesenchymal stem cells
118544|NCT02824640|Addiction|addiction
118545|NCT02824640|Adherence|adherence
118546|NCT02824640|Adverse Effects|adverse effects
118547|NCT02824640|Direct Acting Antiviral Agent|direct acting antiviral agent
118548|NCT02824640|Chronic Hepatitis C|chronic hepatitis c
118549|NCT02824640|Resistance Development|resistance development
118550|NCT02824640|Methadone Clinic|methadone clinic
118551|NCT02824640|Primary Care|primary care
118552|NCT02824640|Directly Observed Therapy|directly observed therapy
118553|NCT02824640|Randomized Controlled Trial|randomized controlled trial
118554|NCT02824640|Resistance|resistance
118555|NCT02824640|Reinfection|reinfection
118556|NCT02824640|Treatment Outcome|treatment outcome
118557|NCT02824640|Patient Navigation|patient navigation
118558|NCT02824640|Multi-Site|multi-site
118559|NCT02824640|Liver Disease|liver disease
118560|NCT02824640|Intervention|intervention
118561|NCT02824640|Sustained Viral Response|sustained viral response
118562|NCT02824588|Pain|pain
118563|NCT02824588|Working memory|working memory
118564|NCT02824575|breast cancer|breast cancer
118565|NCT02824575|chemotherapy|chemotherapy
118566|NCT02824575|metastasis|metastasis
118567|NCT02824575|tumor micro-environment|tumor micro-environment
118568|NCT02824549|Flash glucose monitoring|flash glucose monitoring
118569|NCT02824549|skin reactions|skin reactions
118570|NCT02824549|usability|usability
118571|NCT02824549|accuracy|accuracy
118572|NCT02824536|3BNC117|3bnc117
118573|NCT02824536|10-1074|10-1074
118574|NCT02824536|Broadly neutralizing antibody|broadly neutralizing antibody
118575|NCT02824536|HIV Prevention|hiv prevention
118576|NCT02824523|asthma|asthma
118577|NCT02824523|nasal polyps|nasal polyps
118578|NCT02824523|aspirin sensitivity|aspirin sensitivity
118580|NCT02824484|Guided written disclosure protocol|guided written disclosure protocol
118581|NCT02824484|Emotional disclosure|emotional disclosure
118582|NCT02824484|Meaning|meaning
118583|NCT02824484|Post-Traumatic Growth|post-traumatic growth
118584|NCT02824484|Cancer|cancer
118585|NCT02824471|Sickle Cell Disease|sickle cell disease
118586|NCT02824471|Biofluidic Chip Technology|biofluidic chip technology
118587|NCT02824458|EGFR tyrosine kinase inhibitors|egfr tyrosine kinase inhibitors
118588|NCT02824458|VEGFR inhibitor|vegfr inhibitor
118589|NCT02824458|NSCLC|nsclc
118590|NCT02824406|Sickle Cell Anemia|sickle cell anemia
118591|NCT02824406|Cerebrovascular Reserve|cerebrovascular reserve
118592|NCT02824406|Perfusion|perfusion
118593|NCT02824406|Vasculopathy|vasculopathy
118594|NCT02824406|Magnetic Resonance Imaging|magnetic resonance imaging
118595|NCT02824393|Mesenchymal stem cell|mesenchymal stem cell
118596|NCT02824393|Chronic autoimmune urticaria|chronic autoimmune urticaria
118597|NCT02824367|Parkinson|parkinson
118598|NCT02824367|Perfectionism|perfectionism
118599|NCT02824341|Parkinson 's disease|parkinson 's disease
118600|NCT02824341|REM sleep behavior disorder|rem sleep behavior disorder
118601|NCT02824341|Reward system|reward system
118602|NCT02824341|Functional MRI|functional mri
118603|NCT02824289|skin cancer|skin cancer
118604|NCT02824289|prevention|prevention
118605|NCT02824289|worksite|worksite
118606|NCT02824289|policy|policy
118607|NCT02824263|obstructive sleep apnea|obstructive sleep apnea
118608|NCT02824263|CPAP|cpap
118609|NCT02824263|metabolism|metabolism
118610|NCT02824250|Migraine|migraine
118611|NCT02824250|Mindfulness|mindfulness
118612|NCT02824250|MBSR|mbsr
118613|NCT02824224|levonorgestrel|levonorgestrel
118614|NCT02824224|breakthrough bleeding|breakthrough bleeding
118615|NCT02824198|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
118616|NCT02824198|Dengue Virus|dengue virus
118617|NCT02824198|CYD Dengue Vaccine|cyd dengue vaccine
118618|NCT02824185|FCH-PET/MRI|fch-pet/mri
118619|NCT02824185|primary HCC|primary hcc
118620|NCT02824185|curative treatment|curative treatment
118621|NCT02824185|resection|resection
118622|NCT02824185|thermo-ablation|thermo-ablation
118623|NCT02824185|transplantation|transplantation
118624|NCT02824172|Cast immobilization|cast immobilization
118625|NCT02824172|Complete rest|complete rest
118626|NCT02824172|Osgood Schlatter|osgood schlatter
118627|NCT02824159|ibrutinib|ibrutinib
118628|NCT02824159|idelalisib|idelalisib
118629|NCT02824159|side effect|side effect
118630|NCT02824159|pharmacokinetic|pharmacokinetic
118631|NCT02824159|plasma balance mean concentration|plasma balance mean concentration
118632|NCT02824146|atelectasis|atelectasis
118633|NCT02824146|children|children
118634|NCT02824146|lung ultrasound|lung ultrasound
118635|NCT02824146|lung recruitment|lung recruitment
118636|NCT02824133|Glioma grade III|glioma grade iii
118637|NCT02824133|Glioma grade IV|glioma grade iv
118638|NCT02824133|Glioma recurrent|glioma recurrent
118639|NCT02824133|IDHwt|idhwt
118640|NCT02824133|FGFR-TACC fusion|fgfr-tacc fusion
118641|NCT02824120|ischemic heart disease|ischemic heart disease
118642|NCT02824120|laugh therapy|laugh therapy
118643|NCT02824094|Expanded Access Protocol|expanded access protocol
118644|NCT02824094|crizotinib|crizotinib
118645|NCT02824094|Xalkori|xalkori
118646|NCT02824094|ROS1|ros1
118647|NCT02824094|Japanese|japanese
118648|NCT02824094|A8081064|a8081064
118649|NCT02824081|Psychiatry|psychiatry
118650|NCT02824081|Depressive disorder|depressive disorder
118651|NCT02824081|Suicide|suicide
118652|NCT02824081|Inflammation|inflammation
118653|NCT02824042|Phase 1|phase 1
118654|NCT02824042|Solid tumors|solid tumors
118655|NCT02824042|Mesothelin|mesothelin
118656|NCT02824042|Itraconazole|itraconazole
118657|NCT02824042|PK DDI|pk ddi
118658|NCT02824042|ECG thorough QTC|ecg thorough qtc
118659|NCT02823977|ketamine|ketamine
118660|NCT02823977|dexmedetomidine|dexmedetomidine
118661|NCT02823977|alcohol|alcohol
118662|NCT02823964|exocrine pancreatic insufficiency|exocrine pancreatic insufficiency
118663|NCT02823964|cystic fibrosis|cystic fibrosis
118664|NCT02823964|pancreatic enzyme replacement therapy|pancreatic enzyme replacement therapy
118665|NCT02823912|Capsaicin|capsaicin
118666|NCT02823912|Dyslipidemia|dyslipidemia
118667|NCT02823912|Inflammatory cytokines|inflammatory cytokines
118668|NCT02823899|cholera vaccine|cholera vaccine
118669|NCT02823899|hikojima serotype|hikojima serotype
118670|NCT02823899|randomized trial|randomized trial
118671|NCT02823899|immunogenicity|immunogenicity
118672|NCT02823886|myocardial infarction|myocardial infarction
118673|NCT02823886|MRI|mri
118674|NCT02823886|inflammatory biomarkers|inflammatory biomarkers
118675|NCT02823873|Hypertension|hypertension
118676|NCT02823873|Pregnant|pregnant
118677|NCT02823873|Preeclampsia|preeclampsia
118678|NCT02823873|Gestational Hypertension|gestational hypertension
118679|NCT02823873|Blood Pressure|blood pressure
118680|NCT02823873|Pregnant Women|pregnant women
118681|NCT02823873|Postpartum Women|postpartum women
118682|NCT02823860|Peritoneal carcinomatosis|peritoneal carcinomatosis
118683|NCT02823860|Biobanking|biobanking
118684|NCT02823860|Biospecimen research|biospecimen research
118685|NCT02823860|Prospective clinical database|prospective clinical database
118686|NCT02823860|Tissue banking|tissue banking
118687|NCT02823860|Quality of Life|quality of life
118688|NCT02823860|various histological subtypes|various histological subtypes
118689|NCT02823847|Malignant neoplasms of mesothelial and soft tissue|malignant neoplasms of mesothelial and soft tissue
118690|NCT02823847|Human immunodeficiency virus|human immunodeficiency virus
118691|NCT02823847|HIV|hiv
118692|NCT02823847|Carbon monoxide test|carbon monoxide test
118693|NCT02823847|Self-help materials|self-help materials
118694|NCT02823847|Visual Oral Screening Examination|visual oral screening examination
118695|NCT02823847|Direct Fluorescent Oral Visualization Examination|direct fluorescent oral visualization examination
118696|NCT02823847|Oral Biopsy|oral biopsy
118697|NCT02823834|osteoarthritis|osteoarthritis
118698|NCT02823834|avascular necrosis|avascular necrosis
118699|NCT02823834|ankylosis|ankylosis
118700|NCT02823834|protrusio acetabuli|protrusio acetabuli
118701|NCT02823834|painful hip dysplasia|painful hip dysplasia
118702|NCT02823834|rheumatoid arthritis|rheumatoid arthritis
118703|NCT02823834|correction of functional deformity|correction of functional deformity
118704|NCT02823821|End-Stage Kidney Disease|end-stage kidney disease
118705|NCT02823821|Hemodialysis|hemodialysis
118706|NCT02823821|Dialysate|dialysate
118707|NCT02823821|Sodium|sodium
118708|NCT02823821|Cluster-randomisation|cluster-randomisation
118709|NCT02823795|Patient participation|patient participation
118710|NCT02823795|Empowerment|empowerment
118711|NCT02823795|Medication management|medication management
118712|NCT02823795|Symptom management|symptom management
118713|NCT02823795|Self determination theory|self determination theory
118714|NCT02823795|Motivational Interviewing|motivational interviewing
118715|NCT02823782|Laminar HP|laminar hp
118716|NCT02823782|Complex HP|complex hp
118717|NCT02823769|clinical study|clinical study
118718|NCT02823769|dental fillings|dental fillings
118719|NCT02823743|recurrent pregnancy loss, Habitual abortion|recurrent pregnancy loss, habitual abortion
118720|NCT02823704|Sepsis|sepsis
118721|NCT02823704|Chest pain|chest pain
118722|NCT02823704|Abdominal pain|abdominal pain
118723|NCT02823704|Electrolyte disturbances|electrolyte disturbances
118724|NCT02823704|Stroke|stroke
118725|NCT02823704|Triage|triage
118726|NCT02823704|Risk for death|risk for death
118727|NCT02823691|NETs|nets
118728|NCT02823665|gastric bypass surgery|gastric bypass surgery
118729|NCT02823665|Hypoglycemia|hypoglycemia
118730|NCT02823665|sleeve gastrectomy|sleeve gastrectomy
118731|NCT02823665|glucose tolerance|glucose tolerance
118732|NCT02823613|ENaC|enac
118733|NCT02823613|Exosomes|exosomes
118734|NCT02823613|Urinary biomarker|urinary biomarker
118735|NCT02823613|Salt regulation|salt regulation
118736|NCT02823600|retinal screening|retinal screening
118737|NCT02823600|outpatient dialysis|outpatient dialysis
118738|NCT02823587|Bronchiectasis|bronchiectasis
118739|NCT02823587|Mucociliary clearance|mucociliary clearance
118740|NCT02823587|Exercise|exercise
118741|NCT02823587|Inflammation|inflammation
118742|NCT02823535|military|military
118743|NCT02823535|veteran|veteran
118744|NCT02823535|military spouse|military spouse
118745|NCT02823444|Magnetic Resonance Imaging|magnetic resonance imaging
118746|NCT02823444|Magnetic Resonance Angiography|magnetic resonance angiography
118747|NCT02823431|voiding efficiency|voiding efficiency
118748|NCT02823431|detrusor underactivity|detrusor underactivity
118749|NCT02823431|urodynamics|urodynamics
118750|NCT02823418|primipara|primipara
118751|NCT02823418|childbirth|childbirth
118752|NCT02823418|neuraxial labor analgesia|neuraxial labor analgesia
118753|NCT02823418|postpartum depression|postpartum depression
118754|NCT02823405|Advance malignancy|advance malignancy
118755|NCT02823392|unexpected difficult bag mask ventilation|unexpected difficult bag mask ventilation
118756|NCT02823392|difficult intubation|difficult intubation
118757|NCT02823392|predictors|predictors
118758|NCT02823392|pediatric anesthesia|pediatric anesthesia
118759|NCT02823379|physical activity|physical activity
118760|NCT02823379|overweight|overweight
118761|NCT02823379|obese|obese
118762|NCT02823379|exercise|exercise
118763|NCT02823379|women|women
118764|NCT02823379|African American|african american
118765|NCT02823379|Smartphone|smartphone
118766|NCT02823379|cardiovascular disease risk|cardiovascular disease risk
118767|NCT02823366|PBC|pbc
118768|NCT02823366|UDCA|udca
118769|NCT02823366|Fenofibrate|fenofibrate
118770|NCT02823353|PBC|pbc
118771|NCT02823353|UDCA|udca
118772|NCT02823353|Fenofibrate|fenofibrate
118773|NCT02823288|intimate partner violence|intimate partner violence
118774|NCT02823288|masculinity|masculinity
118775|NCT02823288|community mobilization|community mobilization
118776|NCT02823288|social intervention|social intervention
118777|NCT02823288|rape|rape
118778|NCT02823262|Breast Cancer|breast cancer
118779|NCT02823262|Estrogen Receptor Positive Breast Cancer|estrogen receptor positive breast cancer
118780|NCT02823262|Node-negative Breast Cancer|node-negative breast cancer
118879|NCT02822560|Endovascular Aortic Repair (EVAR)|endovascular aortic repair (evar)
118781|NCT02823262|Human Epidermal Growth Factor 2 Negative Carcinoma of Breast|human epidermal growth factor 2 negative carcinoma of breast
118782|NCT02823236|Keloid|keloid
118783|NCT02823236|Scar|scar
118784|NCT02823223|Endobronchial Valve|endobronchial valve
118785|NCT02823197|determinants|determinants
118786|NCT02823197|active transport|active transport
118787|NCT02823197|intervention|intervention
118788|NCT02823197|adolescents|adolescents
118789|NCT02823184|Myeloproliferative neoplasms|myeloproliferative neoplasms
118790|NCT02823184|Endoplasmic reticulum stress|endoplasmic reticulum stress
118791|NCT02823171|Bioequivalence Study|bioequivalence study
118792|NCT02823171|Healthy subjects|healthy subjects
118793|NCT02823158|Parkinson Disease|parkinson disease
118794|NCT02823158|Morbus Parkinson|morbus parkinson
118795|NCT02823158|Basal Ganglia|basal ganglia
118796|NCT02823158|Pallidal Stimulation|pallidal stimulation
118797|NCT02823145|seizure|seizure
118798|NCT02823145|tonic clonic|tonic clonic
118799|NCT02823145|epilepsy|epilepsy
118800|NCT02823145|myoclonic|myoclonic
118801|NCT02823145|encephalopathy|encephalopathy
118802|NCT02823119|Mini-hysteroscopy|mini-hysteroscopy
118803|NCT02823119|Office hysteroscopy|office hysteroscopy
118804|NCT02823119|Pain|pain
118805|NCT02823093|vascular calcification|vascular calcification
118806|NCT02823093|aortic calcification|aortic calcification
118807|NCT02823093|vitamin K antagonist|vitamin k antagonist
118808|NCT02823093|fluindione|fluindione
118809|NCT02823093|warfarin|warfarin
118810|NCT02823093|matrix gla protein|matrix gla protein
118811|NCT02823067|Pemphigoid|pemphigoid
118812|NCT02823067|Bullous pemphigoid|bullous pemphigoid
118813|NCT02823067|Pruritus|pruritus
118814|NCT02823067|Senile pruritus|senile pruritus
118815|NCT02823067|Neuropsychiatric symptoms|neuropsychiatric symptoms
118816|NCT02823054|elective surgery|elective surgery
118817|NCT02823054|CABG|cabg
118818|NCT02823054|One-lung ventilation|one-lung ventilation
118819|NCT02823054|EZ Blockers|ez blockers
118820|NCT02823054|pleural effusion|pleural effusion
118821|NCT02823041|cognitive training|cognitive training
118822|NCT02823041|aerobic exercise|aerobic exercise
118823|NCT02823041|neurotrophic factors|neurotrophic factors
118824|NCT02823041|randomized controlled trial|randomized controlled trial
118825|NCT02823041|functional outcome|functional outcome
118826|NCT02823028|Smoking|smoking
118827|NCT02823028|Social Media|social media
118828|NCT02823028|Twitter|twitter
118829|NCT02823028|Behavior Change|behavior change
118830|NCT02823028|Social Support|social support
118831|NCT02822989|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
118832|NCT02822989|Musculoskeletal Pain|musculoskeletal pain
118833|NCT02822989|Inflammation|inflammation
118834|NCT02822963|Transurethral resection of the prostate|transurethral resection of the prostate
118835|NCT02822963|Anticoagulants|anticoagulants
118836|NCT02822963|Platelet aggregation inhibitors|platelet aggregation inhibitors
118837|NCT02822911|elderly|elderly
118838|NCT02822911|chronic alcoholism|chronic alcoholism
118839|NCT02822911|Carbohydrate Deficient Transferrin|carbohydrate deficient transferrin
118840|NCT02822911|Biological Detection / Diagnosis|biological detection / diagnosis
118841|NCT02822898|Maintenance|maintenance
118842|NCT02822898|Intravenous solutions|intravenous solutions
118843|NCT02822898|Intravenous fluids|intravenous fluids
118844|NCT02822898|Tonicity|tonicity
118845|NCT02822898|Potassium|potassium
118846|NCT02822898|Sodium|sodium
118847|NCT02822898|Fluid retention|fluid retention
118848|NCT02822872|infertility|infertility
118849|NCT02822872|stress|stress
118850|NCT02822872|scalp hair|scalp hair
118851|NCT02822872|cortisol|cortisol
118852|NCT02822846|Lung ultrasound|lung ultrasound
118853|NCT02822846|Sliding lung|sliding lung
118854|NCT02822846|Probe position|probe position
118855|NCT02822755|Exercise|exercise
118856|NCT02822755|Adherence|adherence
118857|NCT02822755|Physical Therapy|physical therapy
118858|NCT02822703|smoking cessation|smoking cessation
118859|NCT02822703|tobacco use disorder|tobacco use disorder
118860|NCT02822703|delay discounting|delay discounting
118861|NCT02822703|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
118862|NCT02822703|relapse prevention|relapse prevention
118863|NCT02822690|palliative care|palliative care
118864|NCT02822690|Quality of dying|quality of dying
118865|NCT02822664|Brain, pedophilia, neuroimaging|brain, pedophilia, neuroimaging
118866|NCT02822638|Myocardial infarction|myocardial infarction
118867|NCT02822638|biomarkers|biomarkers
118868|NCT02822638|STEMI|stemi
118869|NCT02822625|Capsaicin|capsaicin
118870|NCT02822625|QUTENZA®|qutenza®
118871|NCT02822625|Hypnosis|hypnosis
118872|NCT02822625|Peripheral Neuropathic|peripheral neuropathic
118873|NCT02822612|optical coherence tomography|optical coherence tomography
118874|NCT02822612|optical imaging|optical imaging
118875|NCT02822612|retinal imaging|retinal imaging
118876|NCT02822599|CBP, congenital heart defects, cardiopulmonary bypass|cbp, congenital heart defects, cardiopulmonary bypass
118877|NCT02822586|CD30-positive|cd30-positive
118878|NCT02822586|Stage IB to Stage IVA|stage ib to stage iva
119473|NCT02818790|Prevention|prevention
118880|NCT02822560|percutaneous EVAR (pEVAR)|percutaneous evar (pevar)
118881|NCT02822560|cost analysis|cost analysis
118882|NCT02822560|procedure time|procedure time
118883|NCT02822521|Rheumatoid Arthritis|rheumatoid arthritis
118884|NCT02822521|Mobile Health|mobile health
118885|NCT02822521|Pain|pain
118886|NCT02822521|Arthritis|arthritis
118887|NCT02822495|Lymphoproliferative Disorders|lymphoproliferative disorders
118888|NCT02822495|Epstein-Barr Virus|epstein-barr virus
118889|NCT02822495|Epstein-Barr Viremia|epstein-barr viremia
118890|NCT02822495|Post Transplant Lymphoproliferative Disorder|post transplant lymphoproliferative disorder
118891|NCT02822495|EBV-PTLD|ebv-ptld
118892|NCT02822495|Solid Organ Transplant|solid organ transplant
118893|NCT02822495|Hematopoietic Cell Transplant|hematopoietic cell transplant
118894|NCT02822495|primary immunodeficiency|primary immunodeficiency
118895|NCT02822495|acquired immunodeficiency|acquired immunodeficiency
118896|NCT02822495|Epstein-Barr Virus Lymphoma|epstein-barr virus lymphoma
118897|NCT02822495|HIV/AIDS lymphoma|hiv/aids lymphoma
118898|NCT02822495|Rheumatoid arthritis AND lymphoma|rheumatoid arthritis and lymphoma
118899|NCT02822495|Allogeneic, off-the-shelf T-cell immunotherapy|allogeneic, off-the-shelf t-cell immunotherapy
118900|NCT02822495|TNF-alpha inhibitors AND lymphoma|tnf-alpha inhibitors and lymphoma
118901|NCT02822495|Inflammatory bowel disease AND lymphoma|inflammatory bowel disease and lymphoma
118902|NCT02822469|TMD Infrared Thermography Physical Therapy Modalities|tmd infrared thermography physical therapy modalities
118903|NCT02822456|dysphagia|dysphagia
118904|NCT02822456|intermittent tube|intermittent tube
118905|NCT02822456|individual 3D printed guiding tube|individual 3d printed guiding tube
118906|NCT02822430|Pain|pain
118907|NCT02822430|Psychiatric disorders|psychiatric disorders
118908|NCT02822417|Recover time|recover time
118909|NCT02822404|kidney toxicity|kidney toxicity
118910|NCT02822378|Postmenopausal Osteoporosis|postmenopausal osteoporosis
118911|NCT02822378|Human|human
118912|NCT02822378|Female|female
118913|NCT02822378|Non-pharmacologic therapy|non-pharmacologic therapy
118914|NCT02822326|Leukemia|leukemia
118915|NCT02822326|CART CD19|cart cd19
118916|NCT02822326|Chemotherapy Resistant|chemotherapy resistant
118917|NCT02822326|Chemotherapy Refractory|chemotherapy refractory
118918|NCT02822326|CD19 +|cd19 +
118919|NCT02822326|Lymphoma|lymphoma
118920|NCT02822235|Drug Therapy|drug therapy
118921|NCT02822222|essential hypertension|essential hypertension
118922|NCT02822222|hypertension|hypertension
118923|NCT02822222|high blood pressure|high blood pressure
118924|NCT02822222|cardiovascular diseases|cardiovascular diseases
118925|NCT02822222|RMJH-111b|rmjh-111b
118926|NCT02822222|magnesium|magnesium
118927|NCT02822222|magnesium citrate|magnesium citrate
118928|NCT02822222|calcium channel blockers|calcium channel blockers
118929|NCT02822222|vasodilators|vasodilators
118930|NCT02822222|antihypertensive agents|antihypertensive agents
118931|NCT02822209|coordinating nurse of thoracic oncology|coordinating nurse of thoracic oncology
118932|NCT02822209|quality of care in thoracic oncology|quality of care in thoracic oncology
118933|NCT02822209|lung cancer quality of life|lung cancer quality of life
118934|NCT02822144|ischemic stroke|ischemic stroke
118935|NCT02822144|thrombectomy|thrombectomy
118936|NCT02822144|anesthesia|anesthesia
118937|NCT02822144|sedation|sedation
118938|NCT02822118|IBS-D; Chang'an I Recipe; Placebo|ibs-d; chang'an i recipe; placebo
118939|NCT02822066|Effectivity|effectivity
118940|NCT02822066|safety|safety
118941|NCT02822066|irreversible electroporation|irreversible electroporation
118942|NCT02822066|liver|liver
118943|NCT02822066|pancreas|pancreas
118944|NCT02822053|Ultrasonography-guided Laser Ablation|ultrasonography-guided laser ablation
118945|NCT02822040|Root Resorption|root resorption
118946|NCT02822040|Panoramic Radiograph|panoramic radiograph
118947|NCT02822001|Sugammadex|sugammadex
118948|NCT02821975|Depression|depression
118949|NCT02821975|Cognitive function|cognitive function
118950|NCT02821975|Work|work
118951|NCT02821962|Sedentary behaviour|sedentary behaviour
118952|NCT02821949|Non Small Cells Lung Cancer|non small cells lung cancer
118953|NCT02821949|Procalcitonin|procalcitonin
118954|NCT02821936|positron emission tomography|positron emission tomography
118955|NCT02821936|parametric imaging|parametric imaging
118956|NCT02821936|lung cancer|lung cancer
118957|NCT02821884|Stroke|stroke
118958|NCT02821884|Transcranial direct current stimulation|transcranial direct current stimulation
118959|NCT02821884|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
118960|NCT02821884|upper extremity motor recovery|upper extremity motor recovery
118961|NCT02821832|Tuberculosis|tuberculosis
118962|NCT02821832|PET/CT Scanning|pet/ct scanning
118963|NCT02821832|Immunological Markers|immunological markers
118964|NCT02821832|4-Month Treatment Completion|4-month treatment completion
118965|NCT02821819|ovarian stimulation|ovarian stimulation
118966|NCT02821819|random|random
118967|NCT02821819|egg donation|egg donation
118968|NCT02821819|antagonist|antagonist
118969|NCT02821819|gnrh agonist trigger|gnrh agonist trigger
118970|NCT02821806|Normal Volunteer|normal volunteer
118971|NCT02821806|Donation|donation
118972|NCT02821806|Adoptive T Cell Therapy|adoptive t cell therapy
118973|NCT02821806|Peripheral Blood Mononuclear Cells|peripheral blood mononuclear cells
118974|NCT02821780|Biospecimen Procurement|biospecimen procurement
118975|NCT02821780|Laboratory Research Specimens|laboratory research specimens
118976|NCT02821767|Pathogenesis|pathogenesis
118977|NCT02821767|Ocular Disorders|ocular disorders
118978|NCT02821767|Eye|eye
118979|NCT02821767|Eye Diseases|eye diseases
118980|NCT02821754|PDL1-Mediated Adaptive Resistance|pdl1-mediated adaptive resistance
118981|NCT02821754|Monoclonal Antibody|monoclonal antibody
118982|NCT02821754|CTLA-4|ctla-4
118983|NCT02821754|Ablative Therapy|ablative therapy
118984|NCT02821754|Combination of Tremelimumab and Durvalumab|combination of tremelimumab and durvalumab
118985|NCT02821741|Sensory Stimulation|sensory stimulation
118986|NCT02821728|Prostate|prostate
118987|NCT02821728|Sulphate|sulphate
118988|NCT02821728|ATP|atp
118989|NCT02821728|PTEN|pten
118990|NCT02821702|placenta accreta|placenta accreta
118991|NCT02821702|cesarean section|cesarean section
118992|NCT02821702|artery embolization|artery embolization
118993|NCT02821689|Dermatopolymyositis|dermatopolymyositis
118994|NCT02821689|Interstitial lung disease|interstitial lung disease
118995|NCT02821689|Pirfenidone|pirfenidone
118996|NCT02821637|teens|teens
118997|NCT02821637|effort rehabilitation|effort rehabilitation
118998|NCT02821637|quality of life|quality of life
118999|NCT02821637|wellbeing|wellbeing
119000|NCT02821637|physical skills assessment|physical skills assessment
119001|NCT02821611|Student Stress|student stress
119002|NCT02821611|Meditation|meditation
119003|NCT02821611|Sleep Quality|sleep quality
119004|NCT02821611|Blood Pressure|blood pressure
119005|NCT02821559|Colorectal cancer|colorectal cancer
119006|NCT02821559|raltitrexed|raltitrexed
119007|NCT02821559|oxaliplatin|oxaliplatin
119008|NCT02821559|bevacizumab|bevacizumab
119009|NCT02821559|biweekly|biweekly
119010|NCT02821559|triweekly|triweekly
119011|NCT02821520|Polypoidal Choroidal Vasculopathy|polypoidal choroidal vasculopathy
119012|NCT02821520|Photodynamic Therapy|photodynamic therapy
119013|NCT02821520|Conbercept|conbercept
119014|NCT02821520|Efficacy|efficacy
119015|NCT02821520|Safety|safety
119016|NCT02821520|vascular endothelial growth factor|vascular endothelial growth factor
119017|NCT02821494|HPV|hpv
119018|NCT02821494|Vaccination|vaccination
119019|NCT02821494|Immunotherapy|immunotherapy
119020|NCT02821481|Neuromuscular|neuromuscular
119021|NCT02821481|Supplementation|supplementation
119022|NCT02821481|Elderly|elderly
119023|NCT02821455|Isoflurane|isoflurane
119024|NCT02821455|Sevoflurane|sevoflurane
119025|NCT02821455|Bispectral Index|bispectral index
119026|NCT02821455|Pulmonary Surgical Procedures|pulmonary surgical procedures
119027|NCT02821442|Electroacupuncture|electroacupuncture
119028|NCT02821442|Neuropathic Pain|neuropathic pain
119029|NCT02821442|Chemotherapy Induced Peripheral Neuropathy|chemotherapy induced peripheral neuropathy
119030|NCT02821429|Respiratory weaning|respiratory weaning
119031|NCT02821429|Pulmonary ventilation|pulmonary ventilation
119032|NCT02821416|asthma|asthma
119033|NCT02821390|intravitreal injection|intravitreal injection
119034|NCT02821390|pain|pain
119035|NCT02821390|non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
119036|NCT02821390|anti-VEGF|anti-vegf
119037|NCT02821390|nepafenac|nepafenac
119038|NCT02821377|cirrhosis|cirrhosis
119039|NCT02821377|ascites|ascites
119040|NCT02821377|immunology|immunology
119041|NCT02821377|inflammation|inflammation
119042|NCT02821377|nutrition|nutrition
119043|NCT02821351|Afib|afib
119044|NCT02821338|Bioequivalence|bioequivalence
119045|NCT02821338|Lamotrigine Extended Release|lamotrigine extended release
119046|NCT02821338|Generic|generic
119047|NCT02821338|Pharmacokinetic|pharmacokinetic
119048|NCT02821299|Laryngeal transplantation|laryngeal transplantation
119049|NCT02821299|Laryngeal function|laryngeal function
119050|NCT02821299|Swallowing|swallowing
119051|NCT02821299|Voice production|voice production
119052|NCT02821299|Respiration|respiration
119053|NCT02821299|Quality of life|quality of life
119054|NCT02821247|Treatment Naïve Patients|treatment naïve patients
119055|NCT02821234|Insomnia|insomnia
119056|NCT02821234|Hyperarousal|hyperarousal
119057|NCT02821208|Psychogenic nonepileptic seizure, quality of life|psychogenic nonepileptic seizure, quality of life
119058|NCT02821169|sinus surgery|sinus surgery
119059|NCT02821169|sphenopalatin ganglion|sphenopalatin ganglion
119060|NCT02821169|ropivacaine|ropivacaine
119061|NCT02821169|local anesthesia|local anesthesia
119062|NCT02821143|Telemedicine|telemedicine
119063|NCT02821143|Nursing Home|nursing home
119064|NCT02821143|Hospitalization|hospitalization
119065|NCT02821130|Dyspnea|dyspnea
119066|NCT02821130|Exercise|exercise
119067|NCT02821130|Cystic Fibrosis|cystic fibrosis
119068|NCT02821117|Diabetes Mellitus, Paediatric|diabetes mellitus, paediatric
119069|NCT02821117|Sensing Technology|sensing technology
119070|NCT02821104|Complement|complement
119071|NCT02821104|endothelial function|endothelial function
119072|NCT02821104|insulin sensitivity|insulin sensitivity
119073|NCT02821104|adolescents|adolescents
119074|NCT02821104|inflammation|inflammation
119075|NCT02821078|phase-contrast MRI|phase-contrast mri
119076|NCT02821078|blood flow|blood flow
119077|NCT02821078|velocity mapping|velocity mapping
119078|NCT02821078|abdominal imaging|abdominal imaging
119079|NCT02821078|Quantitative MRI|quantitative mri
119080|NCT02821039|Idiopathic Pulmonary Fibrosis, Usual Interstitial Pneumonia|idiopathic pulmonary fibrosis, usual interstitial pneumonia
119081|NCT02821000|PD1|pd1
119082|NCT02821000|PD-1|pd-1
119083|NCT02821000|PDL1|pdl1
119084|NCT02821000|PD-L1|pd-l1
119085|NCT02820987|Septic shock, Beta Lactams, Extended infusion, PK/PD|septic shock, beta lactams, extended infusion, pk/pd
119086|NCT02820961|Breast Neoplasms|breast neoplasms
119087|NCT02820961|Breast Diseases|breast diseases
119088|NCT02820961|Exemestane|exemestane
119089|NCT02820961|Protein Kinase Inhibitors|protein kinase inhibitors
119090|NCT02820961|Aromatase Inhibitors|aromatase inhibitors
119091|NCT02820961|entinostat|entinostat
119092|NCT02820961|Cancer of the Breast|cancer of the breast
119093|NCT02820961|Metastatic Breast Cancer|metastatic breast cancer
119094|NCT02820961|Hormone Receptor Positive Breast Cancer|hormone receptor positive breast cancer
119095|NCT02820961|Estrogen Receptor|estrogen receptor
119096|NCT02820961|ER+ Breast Cancer|er+ breast cancer
119097|NCT02820961|Breast Tumor|breast tumor
119098|NCT02820935|Cytochrome P450|cytochrome p450
119099|NCT02820935|Pharmacokinetics|pharmacokinetics
119100|NCT02820935|CC-220|cc-220
119101|NCT02820935|Healthy Subjects|healthy subjects
119102|NCT02820922|Emergency orthopedic surgery|emergency orthopedic surgery
119103|NCT02820922|anesthesia|anesthesia
119104|NCT02820922|general anesthesia|general anesthesia
119105|NCT02820922|regional anesthesia|regional anesthesia
119106|NCT02820909|ultrasound guidance|ultrasound guidance
119107|NCT02820909|emergency wards|emergency wards
119108|NCT02820909|arterial and venous catheters|arterial and venous catheters
119109|NCT02820909|femoral|femoral
119110|NCT02820909|complications|complications
119111|NCT02820870|Cardiovascular Disease|cardiovascular disease
119112|NCT02820870|Quality Improvement|quality improvement
119113|NCT02820870|Decision Support Tool|decision support tool
119114|NCT02820870|Performance Measurement|performance measurement
119115|NCT02820870|Primary Prevention|primary prevention
119116|NCT02820857|Gastroentero-pancreatic neuroendocrine carcinomas|gastroentero-pancreatic neuroendocrine carcinomas
119117|NCT02820857|Second-line treatment|second-line treatment
119118|NCT02820857|Bevacizumab|bevacizumab
119119|NCT02820857|Folfiri|folfiri
119120|NCT02820844|Overactive bladder|overactive bladder
119121|NCT02820844|Botulinum toxin type A|botulinum toxin type a
119122|NCT02820844|Urinary incontinence|urinary incontinence
119123|NCT02820831|Frail Elderly|frail elderly
119124|NCT02820831|Peripheral Vascular Surgery|peripheral vascular surgery
119125|NCT02820831|Risk Assessment|risk assessment
119126|NCT02820831|Functional status|functional status
119127|NCT02820818|thoracic magnetic resonance imaging|thoracic magnetic resonance imaging
119128|NCT02820818|pulmonary function test|pulmonary function test
119129|NCT02820805|children|children
119130|NCT02820805|dietary carbohydrates|dietary carbohydrates
119131|NCT02820805|solanum tuberosum|solanum tuberosum
119132|NCT02820805|cognition|cognition
119133|NCT02820805|memory|memory
119134|NCT02820805|emotions|emotions
119135|NCT02820805|blood glucose|blood glucose
119136|NCT02820779|Willis|willis
119137|NCT02820779|Intracranial aneurysms|intracranial aneurysms
119138|NCT02820766|Posterior Stabilized Knee|posterior stabilized knee
119139|NCT02820766|Total Knee Arthroscopy|total knee arthroscopy
119140|NCT02820766|Journey II BCS|journey ii bcs
119141|NCT02820753|Universal Medication Schedule|universal medication schedule
119142|NCT02820753|Health Literacy|health literacy
119143|NCT02820753|Medication adherence|medication adherence
119144|NCT02820740|Epilepsy|epilepsy
119145|NCT02820740|Medial Temporal Lobe Epilepsy|medial temporal lobe epilepsy
119146|NCT02820740|Seizure|seizure
119147|NCT02820740|NeuroBlate|neuroblate
119148|NCT02820740|LITT|litt
119149|NCT02820740|Quality of Life|quality of life
119150|NCT02820701|Osteopathic Manipulation|osteopathic manipulation
119151|NCT02820701|Somatic Dysfunction|somatic dysfunction
119152|NCT02820701|Musculoskeletal Ultrasound|musculoskeletal ultrasound
119153|NCT02820688|Local Anesthtetics|local anesthtetics
119154|NCT02820688|Nerve Block|nerve block
119155|NCT02820688|Bupivacaine|bupivacaine
119156|NCT02820688|Prilocaine|prilocaine
119157|NCT02820675|quality improvement|quality improvement
119158|NCT02820675|routine data|routine data
119159|NCT02820675|risk adjustment|risk adjustment
119160|NCT02820675|sepsis, severe sepsis, septic shock|sepsis, severe sepsis, septic shock
119161|NCT02820675|quality of coding|quality of coding
119162|NCT02820649|Exercise training|exercise training
119163|NCT02820649|Endothelial function|endothelial function
119164|NCT02820623|implementation|implementation
119165|NCT02820623|fidelity|fidelity
119166|NCT02820623|cognitive behavioral therapy|cognitive behavioral therapy
119167|NCT02820558|Neuropeptide|neuropeptide
119168|NCT02820558|Therapy|therapy
119169|NCT02820558|Onset|onset
119170|NCT02820545|patient safety culture|patient safety culture
119171|NCT02820545|hospital|hospital
119172|NCT02820545|patient perception|patient perception
119173|NCT02820545|healthcare professional perception|healthcare professional perception
119174|NCT02820545|sociological|sociological
119175|NCT02820545|qualitative|qualitative
119176|NCT02820545|questionnaire construct|questionnaire construct
119177|NCT02820545|psychometrics|psychometrics
119178|NCT02820519|Neuropathic pain|neuropathic pain
119179|NCT02820519|Loxapine|loxapine
119180|NCT02820519|Antipsychotics|antipsychotics
119181|NCT02820519|Co-Analgesics|co-analgesics
119182|NCT02820519|Tolerability|tolerability
119183|NCT02820519|Analgesic efficacy|analgesic efficacy
119184|NCT02820506|robotic surgery procedures|robotic surgery procedures
119185|NCT02820506|indocyanine green|indocyanine green
119186|NCT02820506|sentinel lymph node mapping|sentinel lymph node mapping
119187|NCT02820480|stroke|stroke
119188|NCT02820480|rehabilitation|rehabilitation
119189|NCT02820480|robotics|robotics
119190|NCT02820480|cerebral palsy|cerebral palsy
119191|NCT02820480|therapy|therapy
119192|NCT02820467|Indocyanine|indocyanine
119193|NCT02820467|Angiography|angiography
119194|NCT02820467|Ischemia|ischemia
119195|NCT02820454|AGuIX|aguix
119196|NCT02820454|polysiloxane gadolinium-chelates based nanoparticles|polysiloxane gadolinium-chelates based nanoparticles
119197|NCT02820415|aneuploidy|aneuploidy
119198|NCT02820415|next generation sequencing|next generation sequencing
119199|NCT02820415|oocyte vitrification|oocyte vitrification
119200|NCT02820415|preimplantation genetic diagnosis|preimplantation genetic diagnosis
119201|NCT02820415|preimplantation genetic screening|preimplantation genetic screening
119202|NCT02820402|Pregnancy|pregnancy
119203|NCT02820402|Obesity|obesity
119204|NCT02820402|Diet|diet
119205|NCT02820402|Maternal/child health|maternal/child health
119206|NCT02820402|Asthma/allergy|asthma/allergy
119207|NCT02820402|Air pollution|air pollution
119208|NCT02820402|Epigenetics|epigenetics
119209|NCT02820402|Cognition/behavior|cognition/behavior
119210|NCT02820376|4D computed tomography|4d computed tomography
119211|NCT02820376|Kidney function tests|kidney function tests
119212|NCT02820376|Living Donors|living donors
119213|NCT02820363|wound|wound
119214|NCT02820363|open fracture|open fracture
119215|NCT02820363|fracture|fracture
119216|NCT02820363|tibial|tibial
119217|NCT02820350|Acute Renal Failure|acute renal failure
119218|NCT02820350|Acute kidney injury|acute kidney injury
119219|NCT02820350|Continuous Renal Replacement Therapy|continuous renal replacement therapy
119220|NCT02820350|Selective cytopheretic device|selective cytopheretic device
119221|NCT02820350|Pediatric|pediatric
119222|NCT02820311|Thorough QT (TQT)|thorough qt (tqt)
119223|NCT02820311|cardiac safety|cardiac safety
119224|NCT02820272|Cold water|cold water
119225|NCT02820272|Negative pressure wound therapy|negative pressure wound therapy
119226|NCT02820272|pain|pain
119227|NCT02820246|nutrition assessment|nutrition assessment
119228|NCT02820246|nutrition therapy|nutrition therapy
119229|NCT02820246|nutrition surveys|nutrition surveys
119230|NCT02820246|patient outcome assessment|patient outcome assessment
119231|NCT02820246|outcome and process assessment|outcome and process assessment
119232|NCT02820246|benchmarking|benchmarking
119233|NCT02820246|risk assessment|risk assessment
119234|NCT02820246|scoring system|scoring system
119235|NCT02820220|Knowledge|knowledge
119236|NCT02820220|Programs|programs
119237|NCT02820220|Patients|patients
119238|NCT02820220|Students|students
119239|NCT02820220|Nurses|nurses
119240|NCT02820207|Carotid Artery Plaque|carotid artery plaque
119241|NCT02820207|Contrast Enhanced Ultrasound|contrast enhanced ultrasound
119242|NCT02820207|Plague Histopathology|plague histopathology
119243|NCT02820181|tracheostomy ties|tracheostomy ties
119244|NCT02820168|Designing|designing
119245|NCT02820168|Patient-Oriented|patient-oriented
119246|NCT02820168|Prescriptions|prescriptions
119247|NCT02820155|Alzheimer's disease,cognitive function|alzheimer's disease,cognitive function
119248|NCT02820142|biomarker|biomarker
119249|NCT02820142|Renal Function|renal function
119250|NCT02820129|polypharmacy|polypharmacy
119251|NCT02820129|wallet card|wallet card
119252|NCT02820129|medication|medication
119253|NCT02820129|self-efficacy|self-efficacy
119254|NCT02820129|patient enablement|patient enablement
119255|NCT02820103|Patient delay|patient delay
119256|NCT02820103|Behaviour change|behaviour change
119257|NCT02820103|Intervention Modelling Experiment|intervention modelling experiment
119258|NCT02820090|Inflammatory Factor|inflammatory factor
119259|NCT02820090|Mechanical Ventilation|mechanical ventilation
119260|NCT02820077|Endoscopy, Gastrointestinal|endoscopy, gastrointestinal
119261|NCT02820051|bronchoscopy|bronchoscopy
119262|NCT02820051|conscious sedation|conscious sedation
119263|NCT02820051|midazolam|midazolam
119264|NCT02820051|patient comfort|patient comfort
119265|NCT02820051|propofol|propofol
119266|NCT02820012|Scoliosis|scoliosis
119267|NCT02820012|ST2R|st2r
119268|NCT02819986|occupational functioning|occupational functioning
119269|NCT02819986|Worries|worries
119270|NCT02819986|Pain|pain
119271|NCT02819986|Disability|disability
119474|NCT02818790|Diet|diet
119272|NCT02819973|Patient Education|patient education
119273|NCT02819973|ICD|icd
119274|NCT02819973|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
119275|NCT02819973|Video|video
119276|NCT02819973|Decision|decision
119277|NCT02819973|Decision making|decision making
119278|NCT02819960|probiotics|probiotics
119279|NCT02819960|irinotecan|irinotecan
119280|NCT02819960|diarrhea|diarrhea
119281|NCT02819960|Lactobacillus rhamnosus|lactobacillus rhamnosus
119282|NCT02819960|Bifidobacterium animalis|bifidobacterium animalis
119283|NCT02819960|prevention|prevention
119284|NCT02819960|chemotherapy|chemotherapy
119285|NCT02819947|systemic sclerosis|systemic sclerosis
119286|NCT02819947|cohort|cohort
119287|NCT02819947|Korean|korean
119288|NCT02819921|Hot Flashes|hot flashes
119289|NCT02819921|Breast Neoplasms|breast neoplasms
119290|NCT02819921|Tamoxifen|tamoxifen
119291|NCT02819921|Desvenlafaxine Succinate|desvenlafaxine succinate
119292|NCT02819895|Phone Appointment Reminder|phone appointment reminder
119293|NCT02819895|Immunization Rates|immunization rates
119294|NCT02819895|mHealth|mhealth
119295|NCT02819882|Unresectable|unresectable
119296|NCT02819882|locally|locally
119297|NCT02819882|advanced|advanced
119298|NCT02819882|metastatic disease|metastatic disease
119299|NCT02819843|T-VEC (Talimogene Laherparepvec)|t-vec (talimogene laherparepvec)
119300|NCT02819843|Radiotherapy|radiotherapy
119301|NCT02819843|16-224|16-224
119302|NCT02819830|Aerobic exercise|aerobic exercise
119303|NCT02819830|Strength training|strength training
119304|NCT02819830|Inflammation|inflammation
119305|NCT02819830|cardiovascular disease|cardiovascular disease
119306|NCT02819817|Aloe Vera, wound, healing|aloe vera, wound, healing
119307|NCT02819791|Cardiovascular|cardiovascular
119308|NCT02819791|therapeutic education|therapeutic education
119309|NCT02819778|Diagnosis|diagnosis
119310|NCT02819778|Craniocerebral Trauma|craniocerebral trauma
119311|NCT02819778|Pediatrics|pediatrics
119312|NCT02819778|S100B|s100b
119313|NCT02819778|mild traumatic brain injury|mild traumatic brain injury
119314|NCT02819752|squamous cell carcinoma|squamous cell carcinoma
119315|NCT02819752|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
119316|NCT02819726|an inadquate response to anti -TNF therapy|an inadquate response to anti -tnf therapy
119317|NCT02819713|Prostate Biopsy|prostate biopsy
119318|NCT02819713|NRS-score|nrs-score
119319|NCT02819713|instillagel|instillagel
119320|NCT02819713|ultrasound conductive gel|ultrasound conductive gel
119321|NCT02819700|behavioural disorders|behavioural disorders
119322|NCT02819687|Phase I|phase i
119323|NCT02819687|Healthy|healthy
119324|NCT02819687|Pharmacokinetics|pharmacokinetics
119325|NCT02819687|Pharmacodynamics|pharmacodynamics
119326|NCT02819674|hypertension|hypertension
119327|NCT02819674|early onset|early onset
119328|NCT02819674|target organ damage|target organ damage
119329|NCT02819661|Elective Caesarean Section|elective caesarean section
119330|NCT02819661|obese women|obese women
119331|NCT02819661|BMI≥30|bmi≥30
119332|NCT02819661|spinal anesthesia combined with intrathecal morphine|spinal anesthesia combined with intrathecal morphine
119333|NCT02819648|symptomatic|symptomatic
119334|NCT02819648|irreversible|irreversible
119335|NCT02819635|ABT-494|abt-494
119336|NCT02819635|Moderately to Severely Active UC|moderately to severely active uc
119337|NCT02819570|early-onset neonatal sepsis|early-onset neonatal sepsis
119338|NCT02819570|Prophylactic antibiotics|prophylactic antibiotics
119339|NCT02819570|Pregnancy|pregnancy
119340|NCT02819570|PPROM|pprom
119341|NCT02819570|EOS|eos
119342|NCT02819544|Digestive System|digestive system
119343|NCT02819531|Coronary Atherectomy|coronary atherectomy
119344|NCT02819531|percutaneous coronary intervention|percutaneous coronary intervention
119345|NCT02819518|PD1|pd1
119346|NCT02819518|PD-1|pd-1
119347|NCT02819518|PDL1|pdl1
119348|NCT02819518|PD-L1|pd-l1
119349|NCT02819505|beta-alanine|beta-alanine
119350|NCT02819505|carnosine|carnosine
119351|NCT02819505|neuromuscular|neuromuscular
119352|NCT02819505|stimulation|stimulation
119353|NCT02819505|skeletal muscle|skeletal muscle
119354|NCT02819492|Adenoma|adenoma
119355|NCT02819492|Colonoscopy|colonoscopy
119356|NCT02819492|Withdrawal|withdrawal
119357|NCT02819492|Proximal|proximal
119358|NCT02819492|Observation Time|observation time
119359|NCT02819479|Radiation necrosis|radiation necrosis
119360|NCT02819479|Radiation adverse event|radiation adverse event
119361|NCT02819479|Intra-arterial chemotherapy|intra-arterial chemotherapy
119362|NCT02819479|Bevacizumab|bevacizumab
119363|NCT02819479|Blood brain barrier disruption|blood brain barrier disruption
119364|NCT02819479|Blood brain barrier breakdown|blood brain barrier breakdown
119365|NCT02819466|intragastric volume|intragastric volume
119366|NCT02819466|stomach|stomach
119367|NCT02819466|fasting|fasting
119368|NCT02819453|Corticosteroid|corticosteroid
119369|NCT02819427|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
119370|NCT02819427|Electroencephalography|electroencephalography
119371|NCT02819427|children|children
119471|NCT02818790|Motivational Interviewing|motivational interviewing
119372|NCT02819388|randomized control trial; contraception; inequalities|randomized control trial; contraception; inequalities
119373|NCT02819375|propofol|propofol
119374|NCT02819375|ketamine|ketamine
119375|NCT02819375|remifentanil|remifentanil
119376|NCT02819349|Relapse Prevention|relapse prevention
119377|NCT02819349|People with Schizophrenia|people with schizophrenia
119378|NCT02819349|Text-Messaging|text-messaging
119379|NCT02819349|Assertive Community Treatment (ACT)|assertive community treatment (act)
119380|NCT02819336|urinary incontinence|urinary incontinence
119381|NCT02819336|electroacupuncture|electroacupuncture
119382|NCT02819336|stroke|stroke
119383|NCT02819336|complications|complications
119384|NCT02819336|randomized controlled trial|randomized controlled trial
119385|NCT02819336|pilot projects|pilot projects
119386|NCT02819284|Ocular Discomfort|ocular discomfort
119387|NCT02819284|Pain|pain
119388|NCT02819284|Corticosteroid|corticosteroid
119389|NCT02819284|Hyperemia|hyperemia
119390|NCT02819284|Dry Eye|dry eye
119391|NCT02819219|Dietary Supplements|dietary supplements
119392|NCT02819219|Exercise|exercise
119393|NCT02819193|Breastfeeding|breastfeeding
119394|NCT02819193|mother's milk|mother's milk
119395|NCT02819193|breast milk|breast milk
119396|NCT02819193|raw milk|raw milk
119397|NCT02819193|neonate|neonate
119398|NCT02819193|Neonatal intensive care unit (NICU)|neonatal intensive care unit (nicu)
119399|NCT02819180|Influenza|influenza
119400|NCT02819167|ischemic stroke|ischemic stroke
119401|NCT02819167|brain reserve|brain reserve
119402|NCT02819167|cognitive reserve|cognitive reserve
119403|NCT02819167|cognitive prognosis|cognitive prognosis
119404|NCT02819115|Influenza|influenza
119405|NCT02819089|anterior cervical spine surgery|anterior cervical spine surgery
119406|NCT02819089|ACDF|acdf
119407|NCT02819089|Dexmedetomidine|dexmedetomidine
119408|NCT02819089|Anesthesia|anesthesia
119409|NCT02819089|Agitation|agitation
119410|NCT02819089|Riker sedation agitation scores|riker sedation agitation scores
119411|NCT02819050|CPAP|cpap
119412|NCT02819050|Extremely Low Birth Weight Infant (ELBW)|extremely low birth weight infant (elbw)
119413|NCT02819050|Non-invasive respiratory support|non-invasive respiratory support
119414|NCT02819050|Premature infants|premature infants
119415|NCT02819050|Non invasive ventilation weaning|non invasive ventilation weaning
119416|NCT02819037|Gastric bypass|gastric bypass
119417|NCT02819037|Intestinal Bacterial Overgrowth Syndrome|intestinal bacterial overgrowth syndrome
119418|NCT02819037|Gas chromatography|gas chromatography
119419|NCT02819011|Ankle Foot Orthoses|ankle foot orthoses
119420|NCT02819011|falls|falls
119421|NCT02819011|Fall Prevention|fall prevention
119422|NCT02819011|Frailty|frailty
119423|NCT02819011|Concern for falls|concern for falls
119424|NCT02819011|Footwear|footwear
119425|NCT02819011|Mobility|mobility
119426|NCT02818998|Diabetic macular edema|diabetic macular edema
119427|NCT02818998|DME|dme
119428|NCT02818959|Aortic Valve Disease|aortic valve disease
119429|NCT02818959|Aortic Valve Replacement|aortic valve replacement
119430|NCT02818959|Transcatheter|transcatheter
119431|NCT02818959|Transfemoral|transfemoral
119432|NCT02818959|Aortic Stenosis|aortic stenosis
119433|NCT02818946|MRI|mri
119434|NCT02818946|Spontaneous Nipple Discharge|spontaneous nipple discharge
119435|NCT02818946|Breast Cancer|breast cancer
119436|NCT02818933|24-hour diet recall|24-hour diet recall
119437|NCT02818933|Adolescents|adolescents
119438|NCT02818933|Web-based diet recall|web-based diet recall
119439|NCT02818920|Pembrolizumab|pembrolizumab
119440|NCT02818920|Neoadjuvant|neoadjuvant
119441|NCT02818920|Tumor Infiltrating Lymphocytes (TILs)|tumor infiltrating lymphocytes (tils)
119442|NCT02818894|THA, Hip Replacement, Spinal Anesthesia|tha, hip replacement, spinal anesthesia
119443|NCT02818894|Total hip arthroplasty|total hip arthroplasty
119444|NCT02818894|anterior total hip replacement|anterior total hip replacement
119445|NCT02818881|aerobic|aerobic
119446|NCT02818881|muscle activity|muscle activity
119447|NCT02818881|energy expenditure|energy expenditure
119448|NCT02818855|Root coverage|root coverage
119449|NCT02818855|Gingival recession|gingival recession
119450|NCT02818855|Plastic surgery|plastic surgery
119451|NCT02818855|Connective tissue graft|connective tissue graft
119452|NCT02818855|Mucograft|mucograft
119453|NCT02818842|Database|database
119454|NCT02818842|Birth defects|birth defects
119455|NCT02818842|Neonatal pathologies|neonatal pathologies
119456|NCT02818829|Adenocarcinoma|adenocarcinoma
119457|NCT02818829|Endoscopic ultrasonography|endoscopic ultrasonography
119458|NCT02818829|Fine-needle aspiration|fine-needle aspiration
119459|NCT02818829|Biomarkers|biomarkers
119460|NCT02818829|Epidemiology|epidemiology
119461|NCT02818829|DNA tumors|dna tumors
119462|NCT02818816|Brimonidine tartrate|brimonidine tartrate
119463|NCT02818816|Intraocular pressure|intraocular pressure
119464|NCT02818816|Prostate Cancer|prostate cancer
119465|NCT02818816|Prostatectomy|prostatectomy
119466|NCT02818803|propolis|propolis
119467|NCT02818803|therapeutic|therapeutic
119468|NCT02818803|miconazole|miconazole
119469|NCT02818803|denture stomatitis|denture stomatitis
119470|NCT02818790|mHealth|mhealth
119472|NCT02818790|Obesity|obesity
119475|NCT02818790|Physical Activity|physical activity
119476|NCT02818790|Health Preventive System|health preventive system
119477|NCT02818777|Parkinson's Disease|parkinson's disease
119478|NCT02818777|Tremor|tremor
119479|NCT02818777|tolerability|tolerability
119480|NCT02818777|safety|safety
119481|NCT02818777|cognition|cognition
119482|NCT02818777|anxiety|anxiety
119483|NCT02818777|psychosis|psychosis
119484|NCT02818777|mood|mood
119485|NCT02818777|dyskinesia|dyskinesia
119486|NCT02818777|cannabidiol|cannabidiol
119487|NCT02818777|cannabis|cannabis
119488|NCT02818777|efficacy|efficacy
119489|NCT02818777|sleep|sleep
119490|NCT02818777|motor symptoms|motor symptoms
119491|NCT02818777|non-motor symptoms|non-motor symptoms
119492|NCT02818777|quality of life|quality of life
119493|NCT02818777|marijuana|marijuana
119494|NCT02818764|serum biomarkers|serum biomarkers
119495|NCT02818764|cerebral blood flow|cerebral blood flow
119496|NCT02818764|modified Blessed Dementia Rating scale|modified blessed dementia rating scale
119497|NCT02818764|Confusion Assessment Method|confusion assessment method
119498|NCT02818764|Delirium Rating Scale-98|delirium rating scale-98
119499|NCT02818751|Anxiety|anxiety
119500|NCT02818751|Adolescents with Anxiety|adolescents with anxiety
119501|NCT02818738|Idiopathic nephrotic syndrome|idiopathic nephrotic syndrome
119502|NCT02818738|Steroid sensitive nephrotic syndrome|steroid sensitive nephrotic syndrome
119503|NCT02818738|Levamisole|levamisole
119504|NCT02818738|Prednisone|prednisone
119505|NCT02818738|Children|children
119506|NCT02818686|Ulcerative Colitis, Active Moderate and Severe|ulcerative colitis, active moderate and severe
119507|NCT02818673|diagnostic performances|diagnostic performances
119508|NCT02818673|ascites|ascites
119509|NCT02818647|tonsillectomy|tonsillectomy
119510|NCT02818647|electrocautery|electrocautery
119511|NCT02818647|postoperative pain|postoperative pain
119512|NCT02818647|visual analogue scale|visual analogue scale
119513|NCT02818608|Cerebrovascular Accident|cerebrovascular accident
119514|NCT02818608|Cerebrovascular Stroke|cerebrovascular stroke
119515|NCT02818608|Cerebral Stroke|cerebral stroke
119516|NCT02818595|voice recognition|voice recognition
119517|NCT02818582|Liberia|liberia
119518|NCT02818582|EBV|ebv
119519|NCT02818582|Semen|semen
119520|NCT02818504|obesity|obesity
119521|NCT02818504|dysglycemia|dysglycemia
119522|NCT02818504|hypercholesterolemia|hypercholesterolemia
119523|NCT02818504|lifestyle|lifestyle
119524|NCT02818504|smoking|smoking
119525|NCT02818504|physical activity|physical activity
119526|NCT02818439|Old person|old person
119527|NCT02818426|cancer immunotherapy|cancer immunotherapy
119528|NCT02818426|CD4 T lymphocyte helper|cd4 t lymphocyte helper
119529|NCT02818426|telomerase|telomerase
119530|NCT02818413|Stool microbiome|stool microbiome
119531|NCT02818413|Stool metabolome|stool metabolome
119532|NCT02818413|Single nucleotide polymorphisms|single nucleotide polymorphisms
119533|NCT02818400|maxillofacial surgery|maxillofacial surgery
119534|NCT02818400|face graft|face graft
119535|NCT02818400|composite tissue|composite tissue
119536|NCT02818400|stem cell infusion|stem cell infusion
119537|NCT02818400|allotransplantation|allotransplantation
119538|NCT02818400|microsurgery|microsurgery
119539|NCT02818387|propofol|propofol
119540|NCT02818387|midazolam|midazolam
119541|NCT02818387|remifentanil|remifentanil
119542|NCT02818387|combination|combination
119543|NCT02818387|synergic|synergic
119544|NCT02818387|pharmacodynamics|pharmacodynamics
119545|NCT02818387|Loss of consciousness|loss of consciousness
119546|NCT02818361|Rheumatoid Arthritis|rheumatoid arthritis
119547|NCT02818361|Tripterygium wilfordii Hook F|tripterygium wilfordii hook f
119548|NCT02818361|double-blinded|double-blinded
119549|NCT02818361|randomized controlled trial|randomized controlled trial
119550|NCT02818361|Tripterygium|tripterygium
119551|NCT02818361|Administration|administration
119552|NCT02818361|Topical|topical
119553|NCT02818348|HIV infection|hiv infection
119554|NCT02818348|Darunavir/cobicistat|darunavir/cobicistat
119555|NCT02818348|Etravirine, drug-drug interactions|etravirine, drug-drug interactions
119556|NCT02818348|Population PK analysis|population pk analysis
119557|NCT02818296|Intolerance of uncertainty|intolerance of uncertainty
119558|NCT02818296|Anxiety|anxiety
119559|NCT02818283|Human Immunodeficiency Virus|human immunodeficiency virus
119560|NCT02818283|hypercholesterolemia|hypercholesterolemia
119561|NCT02818283|pretzels|pretzels
119562|NCT02818283|nutritional study|nutritional study
119563|NCT02818283|dietary soy|dietary soy
119564|NCT02818283|antiretroviral therapy|antiretroviral therapy
119565|NCT02818244|commercial heart monitors|commercial heart monitors
119566|NCT02818244|accuracy|accuracy
119567|NCT02818244|EKG|ekg
119568|NCT02818244|varying degrees of exertion|varying degrees of exertion
119569|NCT02818166|magnetic resonance|magnetic resonance
119570|NCT02818166|right mini-thoracotomy|right mini-thoracotomy
119571|NCT02818153|Allergic rhinitis|allergic rhinitis
119572|NCT02818140|Postoperative pain|postoperative pain
119573|NCT02818140|Transmuscular quadratus lumborum block|transmuscular quadratus lumborum block
119574|NCT02818140|Block|block
119575|NCT02818140|Ropivacaine|ropivacaine
119576|NCT02818140|TQL|tql
119577|NCT02818140|percutaneous nephrolithotomy|percutaneous nephrolithotomy
119578|NCT02818140|PNL|pnl
119579|NCT02818140|Ultrasound-guided|ultrasound-guided
119580|NCT02818114|PTSD|ptsd
119581|NCT02818114|Prolonged Exposure|prolonged exposure
119582|NCT02818114|Peer Support|peer support
119583|NCT02818075|Peer support|peer support
119584|NCT02818075|Postpartum Depression|postpartum depression
119585|NCT02818075|Adolescent Pregnancy|adolescent pregnancy
119586|NCT02818062|Endophthalmitis|endophthalmitis
119587|NCT02818062|Cytokines|cytokines
119588|NCT02818062|Chemokines|chemokines
119589|NCT02818062|Inflammation|inflammation
119590|NCT02818062|Regulation|regulation
119591|NCT02818049|Bronchioalveolar Lavage|bronchioalveolar lavage
119592|NCT02818010|physical activity|physical activity
119593|NCT02818010|chronic kidney disease|chronic kidney disease
119594|NCT02818010|nephrology|nephrology
119595|NCT02818010|stage 3|stage 3
119596|NCT02818010|stage 4|stage 4
119597|NCT02818010|stage 5|stage 5
119598|NCT02817997|patient registry|patient registry
119599|NCT02817997|ACCELERATE study|accelerate study
119600|NCT02817997|CD|cd
119601|NCT02817997|MCD|mcd
119602|NCT02817997|iMCD|imcd
119603|NCT02817997|Castleman|castleman
119604|NCT02817997|Castleman's Disease|castleman's disease
119605|NCT02817997|Angiofollicular Lymph Hyperplasia|angiofollicular lymph hyperplasia
119606|NCT02817997|multicentric Castleman's disease|multicentric castleman's disease
119607|NCT02817997|multicentric Castleman disease|multicentric castleman disease
119608|NCT02817984|Abdominoplasty|abdominoplasty
119609|NCT02817971|feedback|feedback
119610|NCT02817971|pneumonia|pneumonia
119611|NCT02817971|quality of care|quality of care
119612|NCT02817958|inguinal lymph nodes|inguinal lymph nodes
119613|NCT02817958|penile cancer|penile cancer
119614|NCT02817958|squamous|squamous
119615|NCT02817958|TIP chemotherapy|tip chemotherapy
119616|NCT02817945|TATE-RGD|tate-rgd
119617|NCT02817945|SSTR2|sstr2
119618|NCT02817945|integrin αvβ3|integrin αvβ3
119619|NCT02817919|Pharmacovigilance|pharmacovigilance
119620|NCT02817919|Africa|africa
119621|NCT02817893|∆POP: variation of the plethysmographic waveform of pulse oximetry|∆pop: variation of the plethysmographic waveform of pulse oximetry
119622|NCT02817893|∆PP: pulse pressure variation|∆pp: pulse pressure variation
119623|NCT02817893|pulse oximetry plethysmographic|pulse oximetry plethysmographic
119624|NCT02817893|abdominal surgery|abdominal surgery
119625|NCT02817880|rTMS, tDCS, tsDCS, pain, algoneurodystrophy , neurostimulation|rtms, tdcs, tsdcs, pain, algoneurodystrophy , neurostimulation
119626|NCT02817841|Estetrol|estetrol
119627|NCT02817841|Drospirenone|drospirenone
119628|NCT02817841|Prevention of pregnancy|prevention of pregnancy
119629|NCT02817841|Oral contraception|oral contraception
119630|NCT02817828|Estetrol|estetrol
119631|NCT02817815|Atrial fibrillation, blood platelet|atrial fibrillation, blood platelet
119632|NCT02817802|Registry|registry
119633|NCT02817802|Magmaris|magmaris
119634|NCT02817802|Coronary Artery Disease|coronary artery disease
119635|NCT02817802|PCI|pci
119636|NCT02817789|TAVI|tavi
119637|NCT02817789|Antiplatelet agent|antiplatelet agent
119638|NCT02817789|Ticagrelor|ticagrelor
119639|NCT02817789|Cerebrovascular events|cerebrovascular events
119640|NCT02817776|Interventional|interventional
119641|NCT02817776|Radiofrequency Ablation|radiofrequency ablation
119642|NCT02817776|Persistent Atrial Fibrillation|persistent atrial fibrillation
119643|NCT02817750|volunteers|volunteers
119644|NCT02817750|Pharmacokinetics|pharmacokinetics
119645|NCT02817724|Breast Neoplasms|breast neoplasms
119646|NCT02817724|survivor|survivor
119647|NCT02817724|occupational therapy|occupational therapy
119648|NCT02817724|mobile applications|mobile applications
119649|NCT02817724|Quality of Life|quality of life
119650|NCT02817711|infection|infection
119651|NCT02817711|bone and joint infection|bone and joint infection
119652|NCT02817711|relapse|relapse
119653|NCT02817711|adverse event|adverse event
119654|NCT02817698|smoking|smoking
119655|NCT02817698|cannabis|cannabis
119656|NCT02817698|cocaine|cocaine
119657|NCT02817685|surveillance|surveillance
119658|NCT02817685|hepatocellular carcinoma|hepatocellular carcinoma
119659|NCT02817685|ultrasound|ultrasound
119660|NCT02817685|cirrhosis|cirrhosis
119661|NCT02817685|chronic hepatitis B|chronic hepatitis b
119662|NCT02817672|Human|human
119663|NCT02817672|Mental Disorders|mental disorders
119664|NCT02817672|intervention|intervention
119665|NCT02817672|digital health|digital health
119666|NCT02817659|Glucagon|glucagon
119667|NCT02817646|Intensive Care Unit|intensive care unit
119668|NCT02817646|Critical Illness|critical illness
119669|NCT02817646|Body composition|body composition
119670|NCT02817646|Protein nutrition|protein nutrition
119671|NCT02817633|Anitibodies|anitibodies
119672|NCT02817633|TSR-022|tsr-022
119673|NCT02817633|Advanced solid tumors|advanced solid tumors
119674|NCT02817633|Metastatic solid tumors|metastatic solid tumors
119675|NCT02817633|Immunotherapy|immunotherapy
119676|NCT02817633|PD-1|pd-1
119677|NCT02817633|Anti-PD-1|anti-pd-1
119678|NCT02817633|colorectal cancer|colorectal cancer
119679|NCT02817633|non-small cell lung cancer|non-small cell lung cancer
119680|NCT02817633|Melanoma|melanoma
119681|NCT02817607|Sensation|sensation
119682|NCT02817594|Chronic Hepatitis C|chronic hepatitis c
119683|NCT02817594|Paritaprevir/r - Ombitasvir, ± Dasabuvir|paritaprevir/r - ombitasvir, ± dasabuvir
119684|NCT02817594|Sustained Virological Response|sustained virological response
119685|NCT02817594|Observational Study|observational study
119686|NCT02817594|Chronic Hepatitis C genotype 1|chronic hepatitis c genotype 1
119687|NCT02817594|Chronic Hepatitis C genotype 4|chronic hepatitis c genotype 4
119688|NCT02817581|National Early Warning Score (NEWS)|national early warning score (news)
119689|NCT02817581|Lactate|lactate
119690|NCT02817581|Emergency Department|emergency department
119691|NCT02817568|Aggressive Periodontitis|aggressive periodontitis
119692|NCT02817568|C-C chemokine receptor 2|c-c chemokine receptor 2
119693|NCT02817568|Gene expression|gene expression
119694|NCT02817568|monocyte chemoattractant protein-1,|monocyte chemoattractant protein-1,
119695|NCT02817568|restriction fragment length polymorphism|restriction fragment length polymorphism
119696|NCT02817555|Anemia|anemia
119697|NCT02817555|Hemodialysis|hemodialysis
119698|NCT02817555|Erythropoiesis Stimulating Agent|erythropoiesis stimulating agent
119699|NCT02817555|Cost|cost
119700|NCT02817516|Drug Therapy|drug therapy
119701|NCT02817503|hypertension|hypertension
119702|NCT02817503|BP titration|bp titration
119703|NCT02817503|intensive blood pressure control|intensive blood pressure control
119704|NCT02817503|primary prevention|primary prevention
119705|NCT02817503|China|china
119706|NCT02817503|H-type Hypertension|h-type hypertension
119707|NCT02817490|hypermobility|hypermobility
119708|NCT02817490|Ehlers-Danlos Syndrome|ehlers-danlos syndrome
119709|NCT02817490|patient education program|patient education program
119710|NCT02817477|Intranasal Ketamine, Analgesia, Trauma, Morphine, Mass Casualty|intranasal ketamine, analgesia, trauma, morphine, mass casualty
119711|NCT02817451|Diphtheria|diphtheria
119712|NCT02817451|Tetanus|tetanus
119713|NCT02817451|Pertussis|pertussis
119714|NCT02817451|Hepatitis B|hepatitis b
119715|NCT02817451|DTaP IPV HB PRP-T Combined Vaccine|dtap ipv hb prp-t combined vaccine
119716|NCT02817451|Human Immunodeficiency Virus|human immunodeficiency virus
119717|NCT02817425|S-1|s-1
119718|NCT02817425|Adjuvant Chemotherapy|adjuvant chemotherapy
119719|NCT02817425|TEGAFOX|tegafox
119720|NCT02817412|binge eating|binge eating
119721|NCT02817412|obesity|obesity
119722|NCT02817412|overeating|overeating
119723|NCT02817399|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
119724|NCT02817399|Functional Electrical stimulation|functional electrical stimulation
119725|NCT02817399|Gait analysis|gait analysis
119726|NCT02817399|Physical therapy|physical therapy
119727|NCT02817386|postoperative delirium|postoperative delirium
119728|NCT02817386|microRNA|microrna
119729|NCT02817373|IVF|ivf
119730|NCT02817373|embryo transfer|embryo transfer
119731|NCT02817373|ultrasound|ultrasound
119732|NCT02817373|implantation|implantation
119733|NCT02817334|Near-infrared fluorescence|near-infrared fluorescence
119734|NCT02817334|Indocyanine green, ICG|indocyanine green, icg
119735|NCT02817334|breast cancer|breast cancer
119736|NCT02817308|Antigen, CA-19-9|antigen, ca-19-9
119737|NCT02817308|Salivas|salivas
119738|NCT02817308|body fluids|body fluids
119739|NCT02817269|Shoulder pain|shoulder pain
119740|NCT02817269|Trigger points|trigger points
119741|NCT02817269|Referred pain|referred pain
119742|NCT02817269|Visual analogue scale|visual analogue scale
119743|NCT02817191|age-related cataract|age-related cataract
119744|NCT02817191|Holy-Comod|holy-comod
119745|NCT02817191|Tears Naturale Forte|tears naturale forte
119746|NCT02817191|phacoemulsification|phacoemulsification
119747|NCT02817191|inflammatory mediators|inflammatory mediators
119748|NCT02817165|Probiotics, diarrhea, antibiotic, children, hospital|probiotics, diarrhea, antibiotic, children, hospital
119749|NCT02817152|periodontal treatment|periodontal treatment
119750|NCT02817152|low-level light therapy|low-level light therapy
119751|NCT02817126|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
119752|NCT02817126|Robotic Surgical Procedures|robotic surgical procedures
119753|NCT02817126|Laparoscopic Surgical Procedures|laparoscopic surgical procedures
119754|NCT02817126|Rectal Cancer|rectal cancer
119755|NCT02817126|Intraoperative Complications|intraoperative complications
119756|NCT02817126|Postoperative Complications|postoperative complications
119757|NCT02817126|Recovery of Function|recovery of function
119758|NCT02817126|Recurrence|recurrence
119759|NCT02817126|Disease Progression|disease progression
119760|NCT02817126|Survival|survival
119761|NCT02817087|Stroke|stroke
119762|NCT02817061|no keywords for disease type and/or category|no keywords for disease type and/or category
119763|NCT02817035|interstitial lung disease|interstitial lung disease
119764|NCT02817035|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
119765|NCT02817035|mechanical ventilation|mechanical ventilation
119766|NCT02817035|expiratory delay|expiratory delay
119767|NCT02817035|neural inspiratory time|neural inspiratory time
119768|NCT02817022|Developmentally Supportive Care|developmentally supportive care
119769|NCT02817009|Behavioral Health Intervention|behavioral health intervention
119770|NCT02817009|Randomized Control Trial|randomized control trial
119771|NCT02817009|Family Intervention|family intervention
119772|NCT02817009|Nutrition|nutrition
119773|NCT02817009|Weight Management|weight management
119774|NCT02817009|Multidisciplinary Program|multidisciplinary program
119775|NCT02816944|Endoscopic ultrasonography|endoscopic ultrasonography
119776|NCT02816944|Laser ablation|laser ablation
119777|NCT02816931|Treatment|treatment
119778|NCT02816931|Drug Monitoring|drug monitoring
119779|NCT02816931|Minimum Inhibitory Concentration|minimum inhibitory concentration
119780|NCT02816931|Dried Blood Spot Method|dried blood spot method
119781|NCT02816931|Pharmacokinetics|pharmacokinetics
119782|NCT02816931|Pharmacodynamics|pharmacodynamics
119783|NCT02816905|intraocular pressure|intraocular pressure
119784|NCT02816905|topical steroids|topical steroids
119785|NCT02816905|strabismus|strabismus
119786|NCT02816892|aortic dissection|aortic dissection
119787|NCT02816892|biomarkers|biomarkers
119788|NCT02816892|diagnosis|diagnosis
119789|NCT02816866|childhood cancer|childhood cancer
119790|NCT02816866|survivorship care|survivorship care
119791|NCT02816866|health services|health services
119792|NCT02816866|barriers|barriers
119793|NCT02816840|prostate cancer|prostate cancer
119794|NCT02816840|radiotherapy|radiotherapy
119795|NCT02816840|PET-CT/MRI|pet-ct/mri
119796|NCT02816814|Menopause|menopause
119797|NCT02816814|Diet|diet
119798|NCT02816814|Lipidomic profile|lipidomic profile
119799|NCT02816814|Vasomotor symptoms|vasomotor symptoms
119800|NCT02816814|Omega-3 fatty acids|omega-3 fatty acids
119801|NCT02816788|PTSD|ptsd
119802|NCT02816788|Equine Assisted Therapy|equine assisted therapy
119803|NCT02816775|hemodynamics|hemodynamics
119804|NCT02816775|QT interval|qt interval
119805|NCT02816762|CPAP|cpap
119806|NCT02816762|Sleep apnea|sleep apnea
119807|NCT02816762|Diabetes|diabetes
119808|NCT02816762|Nephropathy|nephropathy
119809|NCT02816762|Albuminuria|albuminuria
119810|NCT02816749|Diabetic Foot|diabetic foot
119811|NCT02816749|Wound Healing|wound healing
119812|NCT02816749|Larva|larva
119813|NCT02816749|Occlusive Dressings|occlusive dressings
119814|NCT02816736|Heart Failure|heart failure
119815|NCT02816736|Heart Diseases|heart diseases
119816|NCT02816736|Cardiovascular Diseases|cardiovascular diseases
119817|NCT02816736|Valsartan|valsartan
119818|NCT02816736|Entresto|entresto
119819|NCT02816723|mindfulness|mindfulness
119820|NCT02816723|aging|aging
119821|NCT02816723|Veterans|veterans
119822|NCT02816697|Smoking Habits|smoking habits
119823|NCT02816684|phobic disorders|phobic disorders
119824|NCT02816684|anxiety disorders|anxiety disorders
119825|NCT02816645|Parkinson's Disease|parkinson's disease
119826|NCT02816645|Biomarker|biomarker
119827|NCT02816645|Iron|iron
119828|NCT02816645|R2*|r2*
119829|NCT02816645|MRI|mri
119830|NCT02816645|Patients|patients
119831|NCT02816645|UK Parkinson's Disease Society Brain Bank|uk parkinson's disease society brain bank
119832|NCT02816632|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
119833|NCT02816632|Galvanic Vestibular Stimulation|galvanic vestibular stimulation
119834|NCT02816632|Feedback Processing|feedback processing
119835|NCT02816632|Reward, Social, Vestibular System|reward, social, vestibular system
119836|NCT02816632|Cingulate Cortex|cingulate cortex
119837|NCT02816632|Decision-making|decision-making
119838|NCT02816619|Parkinson's disease|parkinson's disease
119839|NCT02816619|Physical activity|physical activity
119840|NCT02816619|Physical exercise|physical exercise
119841|NCT02816606|ACL reconstruction|acl reconstruction
119842|NCT02816593|carbamide peroxide|carbamide peroxide
119843|NCT02816593|Hydrogen peroxide|hydrogen peroxide
119844|NCT02816593|Quality of life|quality of life
119845|NCT02816554|Japanese Encephalitis|japanese encephalitis
119846|NCT02816554|JECEVAX|jecevax
119847|NCT02816554|Vietnam|vietnam
119848|NCT02816528|Antibiotics|antibiotics
119849|NCT02816528|Primary care|primary care
119850|NCT02816528|Stewardship|stewardship
119851|NCT02816528|General practitioners|general practitioners
119852|NCT02816515|Non interventional study|non interventional study
119853|NCT02816515|Ectoin|ectoin
119854|NCT02816515|Mouth wash|mouth wash
119855|NCT02816515|Mucositis|mucositis
119856|NCT02816515|Chemotherapy|chemotherapy
119857|NCT02816515|Radiotherapy|radiotherapy
119858|NCT02816502|childhood|childhood
119859|NCT02816502|adversity|adversity
119860|NCT02816450|Water|water
119861|NCT02816450|Children|children
119862|NCT02816450|Cognition|cognition
119863|NCT02816450|Hydration|hydration
119864|NCT02816424|Screening and Brief Intervention|screening and brief intervention
119865|NCT02816424|Motivational Interviewing|motivational interviewing
119866|NCT02816424|Teen Pregnancy Prevention|teen pregnancy prevention
119867|NCT02816385|PV-loops (pressure-volume loops)|pv-loops (pressure-volume loops)
119868|NCT02816385|Myocardial contractility|myocardial contractility
119869|NCT02816385|Cardioplegia|cardioplegia
119870|NCT02816385|Induced|induced
119871|NCT02816359|Position patient|position patient
119872|NCT02816359|Esophageal pressure|esophageal pressure
119873|NCT02816346|shigella|shigella
119874|NCT02816320|hospital mortality|hospital mortality
119875|NCT02816320|standardized mortality ratios|standardized mortality ratios
119876|NCT02816320|patient safety|patient safety
119877|NCT02816320|healthcare quality|healthcare quality
119878|NCT02816320|hospital performance|hospital performance
119879|NCT02816320|administrative data|administrative data
119880|NCT02816281|Surgical case cancellation|surgical case cancellation
119881|NCT02816281|Pre-operative assessment clinic|pre-operative assessment clinic
119882|NCT02816242|Concept Map|concept map
119883|NCT02816242|critical thinking|critical thinking
119884|NCT02816242|medical student teaching|medical student teaching
119885|NCT02816229|Haemoptysis|haemoptysis
119886|NCT02816229|Aspergillus|aspergillus
119887|NCT02816229|Endobronchial valve|endobronchial valve
119888|NCT02816229|Interventional pulmonology|interventional pulmonology
119889|NCT02816229|Tuberculosis|tuberculosis
119890|NCT02816138|Geriatrics|geriatrics
119891|NCT02816138|Depression|depression
119892|NCT02816138|Elderly|elderly
119893|NCT02816138|Cognition|cognition
119894|NCT02816138|Memory|memory
119895|NCT02816125|breast cancer|breast cancer
119896|NCT02816125|fatty acids|fatty acids
119897|NCT02816125|omega-3|omega-3
119898|NCT02816060|pain measurement|pain measurement
119899|NCT02816047|wearable cardioverter defibrillator|wearable cardioverter defibrillator
119900|NCT02816047|LifeVest|lifevest
119901|NCT02816047|sudden death|sudden death
119902|NCT02816047|defibrillator|defibrillator
119903|NCT02816034|Learning|learning
119904|NCT02816034|Cerebellum|cerebellum
119905|NCT02816021|Melanoma and other malignant neoplasms of skin|melanoma and other malignant neoplasms of skin
119906|NCT02816021|Metastatic melanoma|metastatic melanoma
119907|NCT02816021|Advanced melanoma|advanced melanoma
119908|NCT02816021|Azacitidine|azacitidine
119909|NCT02816021|5-azacytidine|5-azacytidine
119910|NCT02816021|5-aza|5-aza
119911|NCT02816021|Vidaza|vidaza
119912|NCT02816021|5-AZC|5-azc
119913|NCT02816021|Ladakamycin|ladakamycin
119914|NCT02816021|NSC-102816|nsc-102816
119915|NCT02816021|Azacytidine|azacytidine
119916|NCT02816021|Pembrolizumab|pembrolizumab
119917|NCT02816021|Keytruda|keytruda
119918|NCT02816021|MK-3475|mk-3475
119919|NCT02816021|SCH-900475|sch-900475
119920|NCT02816008|cognitive rehabilitation|cognitive rehabilitation
119921|NCT02816008|memory|memory
119922|NCT02816008|attention|attention
119923|NCT02816008|spatial neglect|spatial neglect
119924|NCT02816008|executive dysfunctioning|executive dysfunctioning
119925|NCT02815995|Malignant neoplasms of bone and articular cartilage|malignant neoplasms of bone and articular cartilage
119926|NCT02815995|Multiple sarcoma subtypes|multiple sarcoma subtypes
119927|NCT02815995|Advanced and/or metastatic sarcoma|advanced and/or metastatic sarcoma
119928|NCT02815995|Adipocytic tumors|adipocytic tumors
119929|NCT02815995|Vascular tumors|vascular tumors
119930|NCT02815995|Leiomyosarcoma|leiomyosarcoma
119931|NCT02815995|Angiosarcoma|angiosarcoma
119932|NCT02815995|Epithelioid hemangioendothelioma|epithelioid hemangioendothelioma
119933|NCT02815995|Undifferentiated pleomorphic sarcoma|undifferentiated pleomorphic sarcoma
119934|NCT02815995|Synovial sarcoma|synovial sarcoma
119935|NCT02815995|Osteosarcoma|osteosarcoma
119936|NCT02815995|Other sarcoma histologies|other sarcoma histologies
119937|NCT02815995|Durvalumab|durvalumab
119938|NCT02815995|Tremelimumab|tremelimumab
119939|NCT02815969|neuroendocrine tumors|neuroendocrine tumors
119940|NCT02815969|indol profile|indol profile
119941|NCT02815969|catecholamines|catecholamines
119942|NCT02815969|LC-MS/MS|lc-ms/ms
119943|NCT02815956|percutaneous tibial nerve stimulation|percutaneous tibial nerve stimulation
119944|NCT02815956|randomized|randomized
119945|NCT02815956|controlled study|controlled study
119946|NCT02815930|High cost user (HCU)|high cost user (hcu)
119947|NCT02815930|Healthcare utilization|healthcare utilization
119948|NCT02815930|Healthcare expenditures|healthcare expenditures
119949|NCT02815930|Medication use|medication use
119950|NCT02815930|Medication expenditures|medication expenditures
119951|NCT02815930|Multimorbidity|multimorbidity
119952|NCT02815930|Observational study|observational study
119953|NCT02815904|Neonates|neonates
119954|NCT02815904|physical therapy|physical therapy
119955|NCT02815904|neonatal intensive care units|neonatal intensive care units
119956|NCT02815904|yakson touch|yakson touch
119957|NCT02815904|kinesthetic stimulation|kinesthetic stimulation
119958|NCT02815865|Primiparous|primiparous
119959|NCT02815865|Foley catheter|foley catheter
119960|NCT02815865|Dinoprostone|dinoprostone
119961|NCT02815865|Induction|induction
119962|NCT02815852|breast cancer in women under 40 years old|breast cancer in women under 40 years old
119963|NCT02815852|biopsy|biopsy
119964|NCT02815852|ultrasonography|ultrasonography
119965|NCT02815852|Magnetic Resonance Imaging|magnetic resonance imaging
119966|NCT02815839|urate transporter 1|urate transporter 1
119967|NCT02815839|SHR4640|shr4640
119968|NCT02815839|single ascending dose|single ascending dose
119969|NCT02815839|pharmacokinetics|pharmacokinetics
119970|NCT02815839|pharmacodynamics|pharmacodynamics
119971|NCT02815813|Serious Mental Illness|serious mental illness
119972|NCT02815813|Young Adults|young adults
119973|NCT02815813|Obesity|obesity
119974|NCT02815813|Cardiometabolic Risk|cardiometabolic risk
119975|NCT02815813|Physical Activity|physical activity
119976|NCT02815813|Weight Loss|weight loss
119977|NCT02815813|Fitness|fitness
119978|NCT02815813|Peer Support|peer support
119979|NCT02815813|Smartphone|smartphone
119980|NCT02815813|Mobile Technology|mobile technology
119981|NCT02815813|mHealth|mhealth
119982|NCT02815813|Social Media|social media
119983|NCT02815813|Facebook|facebook
119984|NCT02815813|Lifestyle Intervention|lifestyle intervention
119985|NCT02815800|Treatment|treatment
119986|NCT02815800|Motor signs|motor signs
119987|NCT02815800|Non motor signs|non motor signs
119988|NCT02815800|Fluctuations|fluctuations
119989|NCT02815800|Open labelled|open labelled
119990|NCT02815787|SP2086|sp2086
119991|NCT02815787|Glyburide|glyburide
119992|NCT02815787|drug-drug interaction|drug-drug interaction
119993|NCT02815774|SP2086|sp2086
119994|NCT02815774|Renal Insufficiency|renal insufficiency
119995|NCT02815774|Pharmacokinetic|pharmacokinetic
119996|NCT02815748|SP2086|sp2086
119997|NCT02815748|Metabolite identification|metabolite identification
119998|NCT02815748|Material balance|material balance
119999|NCT02815722|SP2086|sp2086
120000|NCT02815722|Simvastatin|simvastatin
120001|NCT02815722|drug-drug interaction|drug-drug interaction
120002|NCT02815696|MRI T2 weighted|mri t2 weighted
120003|NCT02815696|intervertebral disc|intervertebral disc
120004|NCT02815696|glycosaminoglycans|glycosaminoglycans
120005|NCT02815683|Bronchoscopy|bronchoscopy
120006|NCT02815683|Emphysema|emphysema
120007|NCT02815657|SP2086|sp2086
120008|NCT02815657|Valsartan|valsartan
120009|NCT02815657|Drug-drug Interaction|drug-drug interaction
120010|NCT02815631|fractional flow reserve|fractional flow reserve
120011|NCT02815631|cardiogoniometry|cardiogoniometry
120012|NCT02815618|Time-resolved spectroscopy|time-resolved spectroscopy
120013|NCT02815618|Diffuse correlation spectroscopy|diffuse correlation spectroscopy
120014|NCT02815618|Neonatology|neonatology
120015|NCT02815579|HIV|hiv
120016|NCT02815579|Food insecurity|food insecurity
120017|NCT02815579|Microcredit loan|microcredit loan
120018|NCT02815579|Agriculture|agriculture
120019|NCT02815579|Livelihoods|livelihoods
120020|NCT02815566|kidney, antiretroviral agent, tenofovir, osteoporosis, women|kidney, antiretroviral agent, tenofovir, osteoporosis, women
120021|NCT02815527|enteral nutrition|enteral nutrition
120022|NCT02815527|intensive care unit|intensive care unit
120023|NCT02815527|whey|whey
120024|NCT02815527|protein|protein
120025|NCT02815527|muscle mass|muscle mass
120026|NCT02815527|leucin|leucin
120027|NCT02815527|energy expenditure|energy expenditure
120028|NCT02815514|aortic valve stenosis|aortic valve stenosis
120029|NCT02815514|aortic valve insufficiency|aortic valve insufficiency
120030|NCT02815514|transapical aortic valve implantation|transapical aortic valve implantation
120031|NCT02815514|aortic valve replacement|aortic valve replacement
120032|NCT02815514|percutaneous aortic valve replacement|percutaneous aortic valve replacement
120033|NCT02815514|aortic valve valvuloplasty|aortic valve valvuloplasty
120034|NCT02815501|Thyroid dysfunction|thyroid dysfunction
120035|NCT02815501|obstetric complications|obstetric complications
120036|NCT02815462|Frequent hospital admissions|frequent hospital admissions
120037|NCT02815462|Risk stratification|risk stratification
120038|NCT02815462|Readmissions|readmissions
120039|NCT02815449|Iron fortification|iron fortification
120040|NCT02815449|Bioavailability|bioavailability
120041|NCT02815449|Nigeria|nigeria
120042|NCT02815449|Women|women
120043|NCT02815449|Bouillon cubes|bouillon cubes
120044|NCT02815410|Glioblastoma Multiforme|glioblastoma multiforme
120045|NCT02815410|Levetiracetam|levetiracetam
120046|NCT02815410|Temozolomide|temozolomide
120047|NCT02815410|Survival outcome|survival outcome
120048|NCT02815397|Double Hit DLBCL|double hit dlbcl
120049|NCT02815319|Dexamethasone|dexamethasone
120050|NCT02815319|Chemotherapy|chemotherapy
120051|NCT02815306|Congenital idiopathic clubfoot|congenital idiopathic clubfoot
120052|NCT02815306|Pirani score|pirani score
120053|NCT02815306|infant|infant
120054|NCT02815306|polyaxial brace|polyaxial brace
120055|NCT02815293|EDE|ede
120056|NCT02815293|evaporative dry eye|evaporative dry eye
120057|NCT02815280|acne|acne
120058|NCT02815267|acne|acne
120059|NCT02815254|Physiotherapy|physiotherapy
120060|NCT02815254|hip fracture|hip fracture
120061|NCT02815254|rehabilitation|rehabilitation
120062|NCT02815254|high dose exercise|high dose exercise
120063|NCT02815254|low dose exercise|low dose exercise
120064|NCT02815215|congenital clubfoot|congenital clubfoot
120065|NCT02815189|pain|pain
120066|NCT02815176|Plasminogen activator inhibitor-1|plasminogen activator inhibitor-1
120067|NCT02815176|Wide angle fluorescein angiography|wide angle fluorescein angiography
120068|NCT02815176|Choroid|choroid
120069|NCT02815137|Digital PCR|digital pcr
120070|NCT02815137|classical|classical
120071|NCT02815137|Hodgkin Lymphoma|hodgkin lymphoma
120072|NCT02815137|mutation|mutation
120073|NCT02815085|heart failure|heart failure
120074|NCT02815085|mHealth|mhealth
120075|NCT02815072|Fontan palliation|fontan palliation
120076|NCT02815072|Marfan's syndrome|marfan's syndrome
120077|NCT02815046|urgency urinary incontinence|urgency urinary incontinence
120078|NCT02815046|stress urinary incontinence|stress urinary incontinence
120079|NCT02815046|Botulinum toxin A|botulinum toxin a
120080|NCT02815046|Bulkamid|bulkamid
120081|NCT02815033|Hormono-Sensitive prostate cancer|hormono-sensitive prostate cancer
120082|NCT02815033|Enzalutamide|enzalutamide
120083|NCT02815033|Imaging|imaging
120084|NCT02815033|PET/CT|pet/ct
120085|NCT02815033|Whole body MRI|whole body mri
120086|NCT02815033|Circulating tumour cells|circulating tumour cells
120087|NCT02815033|Cell-free tumour DNA|cell-free tumour dna
120088|NCT02815020|Primary care|primary care
120089|NCT02815020|Self-management support|self-management support
120090|NCT02815020|Care coordination|care coordination
120091|NCT02815020|Practice-based research network|practice-based research network
120092|NCT02814994|Mechanical Ventilation|mechanical ventilation
120093|NCT02814994|ARDS|ards
120094|NCT02814994|Ventilator Strategy|ventilator strategy
120095|NCT02814994|Outcome|outcome
120096|NCT02814981|hydroxyzine|hydroxyzine
120097|NCT02814981|Long QT|long qt
120098|NCT02814968|Castration-resistant prostate cancer|castration-resistant prostate cancer
120099|NCT02814968|Enzalutamide|enzalutamide
120100|NCT02814968|Imaging|imaging
120101|NCT02814968|PET/CT|pet/ct
120102|NCT02814968|Whole body MRI|whole body mri
120103|NCT02814968|Circulating tumour cells|circulating tumour cells
120104|NCT02814968|Cell-free tumour DNA|cell-free tumour dna
120105|NCT02814955|atrial fibrillation|atrial fibrillation
120106|NCT02814955|pulmonary veins|pulmonary veins
120107|NCT02814955|oral anticoagulant|oral anticoagulant
120108|NCT02814955|electrophysiology|electrophysiology
120109|NCT02814955|anticoagulant drugs|anticoagulant drugs
120110|NCT02814929|ROP|rop
120111|NCT02814929|Risk factors|risk factors
120112|NCT02814929|Incidence|incidence
120113|NCT02814929|Turkey|turkey
120114|NCT02814916|Acute Bacterial Skin and Skin Structure Infection (ABSSSI)|acute bacterial skin and skin structure infection (absssi)
120115|NCT02814903|aldosterone|aldosterone
120116|NCT02814903|cardiac surgery|cardiac surgery
120117|NCT02814903|atrial fibrillation|atrial fibrillation
120118|NCT02814903|galectin-3|galectin-3
120119|NCT02814903|mitochondria|mitochondria
120120|NCT02814903|ngal|ngal
120121|NCT02814903|acute kidney failure|acute kidney failure
120122|NCT02814903|epicardial fat|epicardial fat
120123|NCT02814903|right atrial sample|right atrial sample
120124|NCT02814890|Thoracic paravertebral block|thoracic paravertebral block
120125|NCT02814890|Dexmedetomidine|dexmedetomidine
120126|NCT02814890|Video-assisted Pneumonectomy|video-assisted pneumonectomy
120127|NCT02814890|Ropivacaine|ropivacaine
120128|NCT02814890|Pain, Postoperative|pain, postoperative
120129|NCT02814877|Antibiotic stewardship|antibiotic stewardship
120130|NCT02814877|cost-effectiveness evaluation|cost-effectiveness evaluation
120131|NCT02814877|Antibiotic use|antibiotic use
120132|NCT02814864|Hematology|hematology
120133|NCT02814864|Mesenchymal Stromal Cell|mesenchymal stromal cell
120134|NCT02814864|radiotherapy|radiotherapy
120135|NCT02814864|gastro-intestinal complications|gastro-intestinal complications
120136|NCT02814864|lower digestive tract cancers|lower digestive tract cancers
120138|NCT02814864|bleeding|bleeding
120139|NCT02814864|diarrhea|diarrhea
120140|NCT02814864|pelvic radiation disease|pelvic radiation disease
120141|NCT02814851|Left atrium appendage (LAA) occlusion|left atrium appendage (laa) occlusion
120142|NCT02814851|Transesophageal echocardiography|transesophageal echocardiography
120143|NCT02814851|Cardiac output hemodynamic measurement|cardiac output hemodynamic measurement
120144|NCT02814851|Leycom Pressure/Volume Combination Catheter|leycom pressure/volume combination catheter
120145|NCT02814838|Diabetes mellitus Type 1|diabetes mellitus type 1
120146|NCT02814838|Beta cells function|beta cells function
120147|NCT02814825|ViviGen|vivigen
120148|NCT02814825|ACDF|acdf
120149|NCT02814825|Cervical|cervical
120150|NCT02814760|acute ischemic stroke|acute ischemic stroke
120151|NCT02814760|stepped-wedge|stepped-wedge
120152|NCT02814760|interactive training|interactive training
120153|NCT02814760|implementation|implementation
120154|NCT02814760|emergency department|emergency department
120155|NCT02814734|Intra-Abdominal Hypertension|intra-abdominal hypertension
120156|NCT02814734|Abdominal Compartment Syndrome|abdominal compartment syndrome
120157|NCT02814734|Round Belly Sign|round belly sign
120158|NCT02814734|Radiology|radiology
120159|NCT02814734|CT findings|ct findings
120160|NCT02814734|Intensive Care|intensive care
120161|NCT02814708|Sepsis|sepsis
120162|NCT02814708|Vaccination|vaccination
120163|NCT02814695|Male infertility|male infertility
120164|NCT02814695|oxidative stress|oxidative stress
120165|NCT02814695|antioxidants|antioxidants
120166|NCT02814695|probiotics|probiotics
120167|NCT02814695|Vitamin E|vitamin e
120168|NCT02814695|Baker's Yeast|baker's yeast
120169|NCT02814682|palliative care|palliative care
120170|NCT02814682|quality|quality
120171|NCT02814682|indicator|indicator
120172|NCT02814682|multi-dimensional|multi-dimensional
120173|NCT02814656|muscarinic receptor antagonist and β2 adrenoceptor agonist [MABA]|muscarinic receptor antagonist and β2 adrenoceptor agonist [maba]
120174|NCT02814656|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
120175|NCT02814656|Asthma (in combination with an inhaled corticosteroid [ICS]|asthma (in combination with an inhaled corticosteroid [ics]
120176|NCT02814656|alpha-lactose monohydrate|alpha-lactose monohydrate
120177|NCT02814656|dry powder inhaler|dry powder inhaler
120178|NCT02814656|long-acting β2-agonist (LABA)|long-acting β2-agonist (laba)
120179|NCT02814656|long-acting muscarinic antagonist (LAMA)|long-acting muscarinic antagonist (lama)
120180|NCT02814656|fixed-dose combination (FDC)|fixed-dose combination (fdc)
120181|NCT02814643|Male and female adolescent patients|male and female adolescent patients
120182|NCT02814643|severe asthma|severe asthma
120183|NCT02814604|Front-of-Pack Labelling|front-of-pack labelling
120184|NCT02814604|Star rating system|star rating system
120185|NCT02814604|Traffic light rating system|traffic light rating system
120186|NCT02814604|Consumer Behavior|consumer behavior
120187|NCT02814604|Health Literacy|health literacy
120188|NCT02814604|Mobile Apps|mobile apps
120189|NCT02814604|Nutrition Labeling|nutrition labeling
120190|NCT02814604|Healthy food choices|healthy food choices
120191|NCT02814578|OCT|oct
120192|NCT02814578|IVUS|ivus
120193|NCT02814578|BVS|bvs
120194|NCT02814565|Drug therapy|drug therapy
120195|NCT02814526|exercise|exercise
120196|NCT02814513|Children|children
120197|NCT02814513|Adolescents|adolescents
120198|NCT02814487|DAM|dam
120199|NCT02814487|multiple sclerosis|multiple sclerosis
120200|NCT02814487|MSFC|msfc
120201|NCT02814487|application|application
120202|NCT02814487|smartphone|smartphone
120203|NCT02814474|PET/CT|pet/ct
120204|NCT02814474|Heart failure|heart failure
120205|NCT02814474|hydroxybutyrate|hydroxybutyrate
120206|NCT02814435|Retina|retina
120207|NCT02814435|Retinal Degeneration|retinal degeneration
120208|NCT02814435|Quality of Life Measures|quality of life measures
120209|NCT02814422|Triglyceride-rich lipoprotein|triglyceride-rich lipoprotein
120210|NCT02814422|dementia|dementia
120211|NCT02814422|Alzheimer's disease|alzheimer's disease
120212|NCT02814422|mild cognition impairment|mild cognition impairment
120213|NCT02814422|amyloid-beta|amyloid-beta
120214|NCT02814396|Ventricular|ventricular
120215|NCT02814396|CVD|cvd
120216|NCT02814396|Ventricular arrhythmias|ventricular arrhythmias
120217|NCT02814383|Prematurity|prematurity
120218|NCT02814383|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
120219|NCT02814383|Cerebral Perfusion|cerebral perfusion
120220|NCT02814383|Cerebral Autoregulation|cerebral autoregulation
120221|NCT02814357|Blood glucose, serum insulin|blood glucose, serum insulin
120222|NCT02814344|labour|labour
120223|NCT02814331|Video-EEG|video-eeg
120224|NCT02814331|near-infrared spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
120225|NCT02814318|Vancomycin|vancomycin
120226|NCT02814318|Penicillin|penicillin
120227|NCT02814318|Clindamycin|clindamycin
120228|NCT02814318|Group B streptococcal infection|group b streptococcal infection
120229|NCT02814318|Rectovaginal GBS colonization|rectovaginal gbs colonization
120230|NCT02814318|Vaginal GBS colonization|vaginal gbs colonization
120231|NCT02814318|Intrapartum|intrapartum
120232|NCT02814318|Prophylaxis|prophylaxis
120233|NCT02814227|obstructive sleep apnea screening device|obstructive sleep apnea screening device
120234|NCT02814201|Motor slowing|motor slowing
120235|NCT02814201|Computerized mental chronometry paradigm|computerized mental chronometry paradigm
120236|NCT02814188|Exercise|exercise
120237|NCT02814175|Psoriatic Arthritis|psoriatic arthritis
120238|NCT02814162|Subarachnoid Hemorrhage, Aneurysmal|subarachnoid hemorrhage, aneurysmal
120239|NCT02814162|Predictive|predictive
120240|NCT02814162|Adiponectin|adiponectin
120241|NCT02814149|delayed implant|delayed implant
120242|NCT02814149|esthetics|esthetics
120243|NCT02814149|immediate implant|immediate implant
120244|NCT02814149|bone augmentation|bone augmentation
120245|NCT02814123|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
120246|NCT02814123|Pramlintide|pramlintide
120247|NCT02814123|Artificial Pancreas|artificial pancreas
120248|NCT02814123|Closed-Loop System|closed-loop system
120249|NCT02814123|Insulin|insulin
120250|NCT02814110|Granulocyte colony-stimulating factor|granulocyte colony-stimulating factor
120251|NCT02814110|muscular dystrophy|muscular dystrophy
120252|NCT02814110|muscle strength|muscle strength
120253|NCT02814110|children|children
120254|NCT02814110|adolescents|adolescents
120255|NCT02814097|Heart Failure|heart failure
120256|NCT02814097|HFpEF|hfpef
120257|NCT02814097|elamipretide|elamipretide
120258|NCT02814097|MTP-131|mtp-131
120259|NCT02814097|Bendavia™|bendavia™
120260|NCT02814071|Early Feeding|early feeding
120261|NCT02814071|Acute Pancreatitis|acute pancreatitis
120262|NCT02814071|Pediatric|pediatric
120263|NCT02814058|pharmacokinetics|pharmacokinetics
120264|NCT02814058|Healthy Volunteers|healthy volunteers
120265|NCT02814045|biomarkers, sleep fragmentation, intermittent hypoxia|biomarkers, sleep fragmentation, intermittent hypoxia
120266|NCT02814032|proteomic|proteomic
120267|NCT02814032|cervical lymph node metastasis|cervical lymph node metastasis
120268|NCT02814019|respiratory function in DMD|respiratory function in dmd
120269|NCT02814006|marital relationship|marital relationship
120270|NCT02813993|infertility|infertility
120271|NCT02813993|fertility awareness|fertility awareness
120272|NCT02813993|preconceptional care|preconceptional care
120273|NCT02813993|health interventions|health interventions
120274|NCT02813993|couples|couples
120275|NCT02813980|SUDEP|sudep
120276|NCT02813980|Sudden cardiac death|sudden cardiac death
120277|NCT02813980|Sudden unexpected death in epilepsy|sudden unexpected death in epilepsy
120278|NCT02813980|Sleep|sleep
120279|NCT02813980|Polysomnography|polysomnography
120280|NCT02813980|Autonomic|autonomic
120281|NCT02813980|Cardiovascular|cardiovascular
120282|NCT02813941|Randomized controlled trial|randomized controlled trial
120283|NCT02813941|Systematic review|systematic review
120284|NCT02813941|Summary of finding tables|summary of finding tables
120285|NCT02813941|GRADE|grade
120286|NCT02813941|AHRQ|ahrq
120287|NCT02813928|ColoRectal Cancer|colorectal cancer
120288|NCT02813928|Cancerology|cancerology
120289|NCT02813928|Translational Research|translational research
120290|NCT02813928|ccfDNA|ccfdna
120291|NCT02813915|cardiac monitoring, Cheetah Medical, passive leg raises|cardiac monitoring, cheetah medical, passive leg raises
120292|NCT02813889|infant|infant
120293|NCT02813889|baby|baby
120294|NCT02813889|developmental delay|developmental delay
120295|NCT02813889|robotics|robotics
120296|NCT02813889|cerebral palsy|cerebral palsy
120297|NCT02813850|sickle cell disease|sickle cell disease
120298|NCT02813850|oxygen therapy|oxygen therapy
120299|NCT02813850|pregnancy|pregnancy
120300|NCT02813850|pregnancy in sickle cell disease|pregnancy in sickle cell disease
120301|NCT02813837|relapsed|relapsed
120302|NCT02813837|refractory|refractory
120303|NCT02813837|CD19+|cd19+
120304|NCT02813837|leukemia|leukemia
120305|NCT02813837|lymphoma|lymphoma
120306|NCT02813811|Temperature-controlled Laminar Airflow|temperature-controlled laminar airflow
120307|NCT02813811|Exacerbation frequency|exacerbation frequency
120308|NCT02813798|Renal Insufficiency|renal insufficiency
120309|NCT02813772|infants|infants
120310|NCT02813772|colic|colic
120311|NCT02813759|GLYCEMIA|glycemia
120312|NCT02813759|SATIETY|satiety
120313|NCT02813759|C PEPTIDE|c peptide
120314|NCT02813759|PRELOAD|preload
120315|NCT02813759|INSULIN|insulin
120316|NCT02813746|Obesity|obesity
120317|NCT02813746|Tobacco|tobacco
120318|NCT02813746|Epigenetic|epigenetic
120319|NCT02813746|Transcriptomic|transcriptomic
120320|NCT02813746|microRNAs|micrornas
120321|NCT02813746|miRNAs|mirnas
120322|NCT02813733|thyroid surgery|thyroid surgery
120323|NCT02813733|surgical outcomes|surgical outcomes
120324|NCT02813733|patient safety|patient safety
120325|NCT02813733|healthcare quality|healthcare quality
120326|NCT02813733|surgeons performance|surgeons performance
120327|NCT02813720|Erosions|erosions
120328|NCT02813720|Onycholysis|onycholysis
120329|NCT02813720|HR-pQCT|hr-pqct
120330|NCT02813720|Psoriatic arthritis|psoriatic arthritis
120331|NCT02813707|Vitamins|vitamins
120332|NCT02813707|Mineral|mineral
120333|NCT02813707|Surgery|surgery
120334|NCT02813694|Pneumonia|pneumonia
120335|NCT02813694|CABP|cabp
120336|NCT02813694|CAP|cap
120337|NCT02813694|Community acquired bacterial pneumonia|community acquired bacterial pneumonia
120338|NCT02813681|Acute Pain|acute pain
120339|NCT02813681|ultrasonography|ultrasonography
120340|NCT02813668|Nutrition|nutrition
120341|NCT02813668|Occupational Health|occupational health
120342|NCT02813655|tetracosactide|tetracosactide
120343|NCT02813655|Synacthène®|synacthène®
120344|NCT02813655|cosyntropin|cosyntropin
120345|NCT02813655|post-dural syndrom|post-dural syndrom
120346|NCT02813655|post-dural puncture headache|post-dural puncture headache
120347|NCT02813642|chronic kidney disease starting dialysis|chronic kidney disease starting dialysis
120348|NCT02813642|cardiovascular risk|cardiovascular risk
120349|NCT02813642|bone mineral metabolism markers|bone mineral metabolism markers
120350|NCT02813629|transcranial Direct Current Stimulation|transcranial direct current stimulation
120351|NCT02813629|Peripheral Electrical Stimulation|peripheral electrical stimulation
120352|NCT02813629|Sickle Cell Disease|sickle cell disease
120353|NCT02813629|Transcutaneous Electrical Nerve Stimulation|transcutaneous electrical nerve stimulation
120354|NCT02813629|quantitative Electroencephalography|quantitative electroencephalography
120355|NCT02813603|EBUS-TBNA|ebus-tbna
120356|NCT02813603|staging|staging
120357|NCT02813603|lymph node metastases|lymph node metastases
120358|NCT02813577|Legs|legs
120359|NCT02813577|Drug Coated Angioplasty Balloon|drug coated angioplasty balloon
120360|NCT02813577|Experimental|experimental
120361|NCT02813577|Standard Angioplasty Balloon|standard angioplasty balloon
120362|NCT02813564|Autism|autism
120363|NCT02813564|Cognitive Training|cognitive training
120364|NCT02813564|Brain|brain
120365|NCT02813564|fMRI|fmri
120366|NCT02813551|Preeclampsia, puerperium|preeclampsia, puerperium
120367|NCT02813538|Thrombelastography|thrombelastography
120368|NCT02813538|Antithrombin proteins|antithrombin proteins
120369|NCT02813538|Liver surgery|liver surgery
120370|NCT02813538|Liver function tests|liver function tests
120371|NCT02813525|Aortic Isthmus|aortic isthmus
120372|NCT02813525|Isthmic Systolic Index|isthmic systolic index
120373|NCT02813525|feasibility|feasibility
120374|NCT02813525|reproducibility|reproducibility
120375|NCT02813525|mortality|mortality
120376|NCT02813525|delivery|delivery
120377|NCT02813499|Acute Coronary Syndrome|acute coronary syndrome
120378|NCT02813473|SYNTAX Score II|syntax score ii
120379|NCT02813473|Multi Slice Computed Tomography|multi slice computed tomography
120380|NCT02813473|MSCT|msct
120381|NCT02813473|Heart Team|heart team
120382|NCT02813473|Fractional Flow Reserve Computed Tomography|fractional flow reserve computed tomography
120384|NCT02813473|FFR MSCT|ffr msct
120385|NCT02813473|PCI|pci
120386|NCT02813473|CABG|cabg
120387|NCT02813473|Percutaneous Coronary Intervention|percutaneous coronary intervention
120388|NCT02813473|Coronary Artery Bypass Graft|coronary artery bypass graft
120389|NCT02813434|Cerebral amyloid imaging|cerebral amyloid imaging
120390|NCT02813434|Florbetapir|florbetapir
120391|NCT02813434|18F-AV-45|18f-av-45
120392|NCT02813434|poststroke|poststroke
120393|NCT02813421|CGM|cgm
120394|NCT02813382|bupivacaine|bupivacaine
120395|NCT02813382|prilocaine|prilocaine
120396|NCT02813382|2-chloroprocaine|2-chloroprocaine
120397|NCT02813330|Women|women
120398|NCT02813330|severe|severe
120399|NCT02813330|low back ache|low back ache
120400|NCT02813330|labor|labor
120401|NCT02813317|Surgery|surgery
120402|NCT02813317|Breast cancer|breast cancer
120403|NCT02813317|Quality of life|quality of life
120404|NCT02813317|Care pathway|care pathway
120405|NCT02813317|Economic evaluation|economic evaluation
120406|NCT02813304|Acute|acute
120407|NCT02813304|rotator cuff tendinopathy|rotator cuff tendinopathy
120408|NCT02813304|exercise|exercise
120409|NCT02813304|loading|loading
120410|NCT02813304|ice|ice
120411|NCT02813304|cryotherapy|cryotherapy
120412|NCT02813304|randomised control trial|randomised control trial
120413|NCT02813291|Motor imagery|motor imagery
120414|NCT02813291|transcranial direct current stimulation|transcranial direct current stimulation
120415|NCT02813291|motor learning|motor learning
120416|NCT02813291|aging|aging
120417|NCT02813265|Ocular Discomfort|ocular discomfort
120418|NCT02813265|Pain|pain
120419|NCT02813265|Corticosteroid|corticosteroid
120420|NCT02813265|Hyperemia|hyperemia
120421|NCT02813265|Dry Eye|dry eye
120422|NCT02813252|long-term follow-up|long-term follow-up
120423|NCT02813252|chimeric antigen receptor (CAR) T cells|chimeric antigen receptor (car) t cells
120424|NCT02813252|JCAR015|jcar015
120425|NCT02813239|IVF|ivf
120426|NCT02813239|Dual trigger|dual trigger
120427|NCT02813239|GnRH agonist|gnrh agonist
120428|NCT02813239|hCG|hcg
120429|NCT02813239|mature oocytes|mature oocytes
120430|NCT02813226|castration-resistant|castration-resistant
120431|NCT02813226|molecular imaging|molecular imaging
120432|NCT02813226|abiraterone acetate|abiraterone acetate
120433|NCT02813226|enzalutamide|enzalutamide
120434|NCT02813226|metabolic response|metabolic response
120435|NCT02813213|skin transplantation|skin transplantation
120436|NCT02813213|grafting skin|grafting skin
120437|NCT02813200|COPD, inhaler device, handling|copd, inhaler device, handling
120438|NCT02813187|venous leg ulcer|venous leg ulcer
120439|NCT02813187|venous|venous
120440|NCT02813187|QCDR|qcdr
120441|NCT02813187|quality measure|quality measure
120442|NCT02813187|wound|wound
120443|NCT02813187|Outcome|outcome
120444|NCT02813187|Lymphedema|lymphedema
120445|NCT02813161|diabetic foot ulcer|diabetic foot ulcer
120446|NCT02813161|diabetes|diabetes
120447|NCT02813161|arterial disease|arterial disease
120448|NCT02813161|neuropathy|neuropathy
120449|NCT02813161|amputation|amputation
120450|NCT02813161|QCDR|qcdr
120451|NCT02813161|quality measure|quality measure
120452|NCT02813161|wound|wound
120453|NCT02813096|HCC|hcc
120454|NCT02813096|PVTT|pvtt
120455|NCT02813096|Folofox4|folofox4
120456|NCT02813096|Early Recurrence|early recurrence
120457|NCT02813044|anesthesia|anesthesia
120458|NCT02813044|intravenous|intravenous
120459|NCT02813044|neurosurgery|neurosurgery
120460|NCT02813044|pituitary neoplasm|pituitary neoplasm
120461|NCT02813044|postoperative period|postoperative period
120462|NCT02813031|functional meat products|functional meat products
120463|NCT02813031|hypocaloric fats|hypocaloric fats
120464|NCT02813031|diglyceride|diglyceride
120465|NCT02813031|obesity|obesity
120466|NCT02813018|child|child
120467|NCT02813018|analgesia|analgesia
120468|NCT02813018|epidural|epidural
120469|NCT02813018|pain|pain
120470|NCT02813018|postoperative|postoperative
120471|NCT02813018|orthopedics|orthopedics
120472|NCT02813005|High frequency jet ventilation|high frequency jet ventilation
120473|NCT02812966|peripheral arterial disease|peripheral arterial disease
120474|NCT02812966|drug coated balloon|drug coated balloon
120475|NCT02812927|Glycemic lability index|glycemic lability index
120476|NCT02812927|Continuous glucose monitoring system|continuous glucose monitoring system
120477|NCT02812927|intensive care|intensive care
120478|NCT02812927|Insulin|insulin
120479|NCT02812888|Hyperthyroidism|hyperthyroidism
120480|NCT02812888|Betatrophin|betatrophin
120481|NCT02812836|anorectal manometry|anorectal manometry
120482|NCT02812836|children|children
120483|NCT02812836|constipation|constipation
120484|NCT02812823|manometry|manometry
120485|NCT02812823|children|children
120486|NCT02812823|constipation|constipation
120487|NCT02812823|functional disorders|functional disorders
120488|NCT02812797|Adipokines|adipokines
120489|NCT02812797|Chronic Heart Failure|chronic heart failure
120490|NCT02812797|Prognosis|prognosis
120491|NCT02812784|Nephrocheck™|nephrocheck™
120492|NCT02812784|acute kidney injury|acute kidney injury
120493|NCT02812758|sedation depth|sedation depth
120494|NCT02812758|indices of preload dependence|indices of preload dependence
120495|NCT02812745|anaesthesia|anaesthesia
120496|NCT02812732|HPV vaccination|hpv vaccination
120497|NCT02812732|provider education|provider education
120498|NCT02812667|Metastatic|metastatic
120499|NCT02812667|NSCLC|nsclc
120500|NCT02812667|nivolumab|nivolumab
120501|NCT02812667|plinabulin|plinabulin
120502|NCT02812667|BPI-2358|bpi-2358
120503|NCT02812667|opdivo|opdivo
120504|NCT02812667|Non-Small Cell Lung Cancer|non-small cell lung cancer
120505|NCT02812667|cancer|cancer
120506|NCT02812654|Sarcoma|sarcoma
120507|NCT02812654|soft tissue sarcoma|soft tissue sarcoma
120508|NCT02812654|neoadjuvant chemotherapy|neoadjuvant chemotherapy
120509|NCT02812654|neoadjuvant radiotherapy|neoadjuvant radiotherapy
120510|NCT02812654|hypofractionated radiotherapy|hypofractionated radiotherapy
120511|NCT02812641|Concurrent chemoradiation|concurrent chemoradiation
120512|NCT02812641|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
120513|NCT02812641|Vascular endothelial growth factor|vascular endothelial growth factor
120514|NCT02812628|laparoscopic surgery|laparoscopic surgery
120515|NCT02812628|abdominoperineal resection|abdominoperineal resection
120516|NCT02812628|rectal cancer|rectal cancer
120517|NCT02812628|individualized surgery|individualized surgery
120518|NCT02812628|levator muscle|levator muscle
120519|NCT02812615|Environmental Enteric Dysfunction|environmental enteric dysfunction
120520|NCT02812602|Total Knee Replacement|total knee replacement
120521|NCT02812602|Stitch|stitch
120522|NCT02812602|Removal|removal
120523|NCT02812602|Pain|pain
120524|NCT02812589|MRI|mri
120525|NCT02812576|Group B streptococcus|group b streptococcus
120526|NCT02812576|Infants|infants
120527|NCT02812576|China|china
120528|NCT02812550|full-spectrum endoscopy|full-spectrum endoscopy
120529|NCT02812550|polyp detection rate|polyp detection rate
120530|NCT02812550|colorectal cancer|colorectal cancer
120531|NCT02812550|colorectal screening|colorectal screening
120532|NCT02812550|adenoma detection rate|adenoma detection rate
120533|NCT02812550|endoscopic innovations|endoscopic innovations
120534|NCT02812537|Trajectories|trajectories
120535|NCT02812537|emergency room|emergency room
120536|NCT02812537|conduct disorder|conduct disorder
120537|NCT02812537|care management|care management
120538|NCT02812524|Immunotherapy|immunotherapy
120539|NCT02812524|Yervoy|yervoy
120540|NCT02812524|Head and neck cancer|head and neck cancer
120541|NCT02812524|Pre-operative|pre-operative
120542|NCT02812498|teleconsultation|teleconsultation
120543|NCT02812498|insulin therapy|insulin therapy
120544|NCT02812498|HbA1c|hba1c
120545|NCT02812459|Electrical Stimulation Therapy|electrical stimulation therapy
120546|NCT02812459|Kinesio taping|kinesio taping
120547|NCT02812459|Exercise|exercise
120548|NCT02812446|biofilm|biofilm
120549|NCT02812446|staphylokinase|staphylokinase
120550|NCT02812446|Staphylococcus aureus|staphylococcus aureus
120551|NCT02812446|microarrays|microarrays
120552|NCT02812446|bone binding sialoprotein|bone binding sialoprotein
120553|NCT02812446|bone and joint infection|bone and joint infection
120554|NCT02812446|blood group|blood group
120555|NCT02812433|birth asphyxia|birth asphyxia
120556|NCT02812433|brain|brain
120557|NCT02812433|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
120558|NCT02812433|neonate|neonate
120559|NCT02812433|neuroprotection|neuroprotection
120560|NCT02812433|neurorestoration|neurorestoration
120561|NCT02812433|newborn|newborn
120562|NCT02812433|sildenafil|sildenafil
120563|NCT02812420|Malignant neoplasms of urinary tract|malignant neoplasms of urinary tract
120564|NCT02812420|Urothelial Carcinoma|urothelial carcinoma
120565|NCT02812420|Muscle-invasive, high-risk bladder cancer|muscle-invasive, high-risk bladder cancer
120566|NCT02812420|Ineligible for neoadjuvant cisplatin-containing chemotherapies|ineligible for neoadjuvant cisplatin-containing chemotherapies
120567|NCT02812420|Bladder cancer|bladder cancer
120568|NCT02812420|Cystectomy|cystectomy
120569|NCT02812420|Bladder cancer surgery|bladder cancer surgery
120570|NCT02812420|Durvalumab|durvalumab
120571|NCT02812420|MEDI4736|medi4736
120572|NCT02812420|Tremelimumab|tremelimumab
120573|NCT02812420|Phone calls|phone calls
120574|NCT02812394|Parkinson's disease|parkinson's disease
120575|NCT02812394|Episodic motor fluctuations (OFF periods)|episodic motor fluctuations (off periods)
120576|NCT02812381|Trigger Points, movement|trigger points, movement
120577|NCT02812355|off-pump|off-pump
120578|NCT02812355|coronary artery bypass|coronary artery bypass
120579|NCT02812355|heparinization|heparinization
120580|NCT02812342|Alopecia|alopecia
120581|NCT02812316|Myopia|myopia
120582|NCT02812316|Scleral lens|scleral lens
120583|NCT02812316|Astigmatism|astigmatism
120584|NCT02812316|Presbyopia|presbyopia
120585|NCT02812290|antibody mediated rejection, T cell mediated rejection|antibody mediated rejection, t cell mediated rejection
120586|NCT02812277|anastrozole|anastrozole
120587|NCT02812277|letrozole|letrozole
120588|NCT02812277|postmenopausal patients|postmenopausal patients
120589|NCT02812238|Inflammasome|inflammasome
120590|NCT02812238|Sirt3|sirt3
120591|NCT02812238|Nicotinamide Riboside|nicotinamide riboside
120592|NCT02812238|Fasting|fasting
120593|NCT02812212|ureteropelvic junction obstruction|ureteropelvic junction obstruction
120594|NCT02812212|cortical transit time|cortical transit time
120595|NCT02812186|Neuromuscular blockade|neuromuscular blockade
120596|NCT02812173|urinary drainage|urinary drainage
120597|NCT02812173|urethral catheter|urethral catheter
120598|NCT02812173|suprapubic tube|suprapubic tube
120599|NCT02812173|pain|pain
120600|NCT02812173|discomfort|discomfort
120601|NCT02812173|radical prostatectomy|radical prostatectomy
120602|NCT02812173|robotic surgery|robotic surgery
120603|NCT02812173|urinary infection|urinary infection
120604|NCT02812147|L-dihydoxyphenylserine|l-dihydoxyphenylserine
120605|NCT02812147|L-DOPS|l-dops
120606|NCT02812147|Northera|northera
120607|NCT02812134|phosphorus supplementation|phosphorus supplementation
120608|NCT02812134|FGF23|fgf23
120609|NCT02812134|anorexic|anorexic
120610|NCT02812134|adolescents|adolescents
120611|NCT02812134|undernutrition|undernutrition
120612|NCT02812108|intracranial aneurysm|intracranial aneurysm
120613|NCT02812108|endovascular treatment|endovascular treatment
120614|NCT02812108|recanalization|recanalization
120615|NCT02812108|outcome|outcome
120616|NCT02812108|hemodynamics|hemodynamics
120617|NCT02812108|computational fluid dynamic|computational fluid dynamic
120618|NCT02812108|stent|stent
120619|NCT02812108|flow diversion|flow diversion
120620|NCT02812082|Web-based|web-based
120621|NCT02812082|patient education application|patient education application
120622|NCT02812082|16-769|16-769
120623|NCT02812056|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
120624|NCT02812056|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
120625|NCT02812056|Malignant neoplasms of lip oral cavity and pharynx|malignant neoplasms of lip oral cavity and pharynx
120626|NCT02812056|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
120627|NCT02812056|Human papilloma virus associated malignancies|human papilloma virus associated malignancies
120628|NCT02812056|HPV|hpv
120629|NCT02812056|Alisertib|alisertib
120630|NCT02812056|MLN8237|mln8237
120631|NCT02812056|TAK-228|tak-228
120632|NCT02812056|MLN0128|mln0128
120633|NCT02812043|onychomycosis|onychomycosis
120634|NCT02812043|amorolfine|amorolfine
120635|NCT02812043|long-pulsed Nd:YAG|long-pulsed nd:yag
120636|NCT02812043|fungal infection|fungal infection
120637|NCT02812030|Observational Study|observational study
120638|NCT02812030|aflibercept|aflibercept
120639|NCT02812030|Diabetic Retinopathy|diabetic retinopathy
120640|NCT02812030|Visual Acuity|visual acuity
120641|NCT02812017|educational intervention|educational intervention
120642|NCT02812017|language development|language development
120643|NCT02812017|postpartum|postpartum
120644|NCT02812017|parental attachment|parental attachment
120645|NCT02812017|achievement gap|achievement gap
120646|NCT02812017|language gap|language gap
120647|NCT02812017|school readiness|school readiness
120648|NCT02812004|Vitreous Floaters|vitreous floaters
120649|NCT02812004|Mouches Voulantes|mouches voulantes
120650|NCT02811991|paracetamol|paracetamol
120651|NCT02811991|post-operative analgesia|post-operative analgesia
120652|NCT02811965|heel|heel
120653|NCT02811965|pressure ulcer|pressure ulcer
120654|NCT02811965|pressure mapping|pressure mapping
120655|NCT02811952|bladder cancer|bladder cancer
120656|NCT02811939|Cannabis|cannabis
120657|NCT02811939|Marijuana|marijuana
120658|NCT02811939|THC|thc
120659|NCT02811939|Dronabinol|dronabinol
120660|NCT02811939|Pregnenolone|pregnenolone
120661|NCT02811939|PREG|preg
120662|NCT02811939|Psychotic Disorders|psychotic disorders
120663|NCT02811926|parastomal bulging|parastomal bulging
120664|NCT02811926|peristomal bulging|peristomal bulging
120665|NCT02811926|ileostomy|ileostomy
120666|NCT02811926|colostomy|colostomy
120667|NCT02811926|enterostomy|enterostomy
120668|NCT02811926|incidence|incidence
120669|NCT02811926|risk factor|risk factor
120670|NCT02811913|sensory impairment|sensory impairment
120671|NCT02811913|sensory deficit|sensory deficit
120672|NCT02811913|upper limb|upper limb
120673|NCT02811913|transcranial magnetic stimulation|transcranial magnetic stimulation
120674|NCT02811913|brain stimulation|brain stimulation
120675|NCT02811913|rehabilitation|rehabilitation
120676|NCT02811900|obesity surgery|obesity surgery
120677|NCT02811900|Roux en Y gastric bypass|roux en y gastric bypass
120678|NCT02811900|sleeve gastrectomy|sleeve gastrectomy
120679|NCT02811900|excess weight loss|excess weight loss
120680|NCT02811900|quality of life|quality of life
120681|NCT02811874|diabetes education|diabetes education
120682|NCT02811874|community health workers|community health workers
120683|NCT02811874|diabetes control|diabetes control
120684|NCT02811861|Renal Cell Carcinoma (RCC)|renal cell carcinoma (rcc)
120685|NCT02811861|Lenvatinib|lenvatinib
120686|NCT02811861|First-line RCC|first-line rcc
120687|NCT02811861|Treatment-naive RCC|treatment-naive rcc
120688|NCT02811861|Everolimus|everolimus
120689|NCT02811861|Pembrolizumab|pembrolizumab
120690|NCT02811861|Sunitinib|sunitinib
120691|NCT02811861|Phase 3 RCC|phase 3 rcc
120692|NCT02811861|Phase 3 first-line RCC|phase 3 first-line rcc
120693|NCT02811861|Phase 3 treatment-naive RCC|phase 3 treatment-naive rcc
120694|NCT02811822|GMI-1271|gmi-1271
120695|NCT02811822|bortezomib|bortezomib
120696|NCT02811822|carfilzomib|carfilzomib
120697|NCT02811822|multiple myeloma|multiple myeloma
120698|NCT02811809|Prostate cancer|prostate cancer
120699|NCT02811809|Apalutamide|apalutamide
120700|NCT02811809|IHT|iht
120701|NCT02811809|BCR|bcr
120702|NCT02811809|Biochemical recurrence|biochemical recurrence
120703|NCT02811809|intermittent hormone therapy|intermittent hormone therapy
120704|NCT02811796|drug eluting stents|drug eluting stents
120705|NCT02811796|flow fractional reserve|flow fractional reserve
120706|NCT02811796|prognosis|prognosis
120707|NCT02811796|angio-based FFR|angio-based ffr
120708|NCT02811783|Pruritus|pruritus
120709|NCT02811783|Mycosis Fungoides|mycosis fungoides
120710|NCT02811783|CTCL|ctcl
120711|NCT02811783|naloxone|naloxone
120712|NCT02811783|opiate antagonist|opiate antagonist
120713|NCT02811783|Sézary Syndrome|sézary syndrome
120714|NCT02811718|Stress Management|stress management
120715|NCT02811718|Resiliency|resiliency
120716|NCT02811718|Skype|skype
120717|NCT02811692|Database|database
120718|NCT02811692|Diabetic Macular Edema (DME)|diabetic macular edema (dme)
120719|NCT02811692|Wet Age-related Macular Degeneration (wAMD)|wet age-related macular degeneration (wamd)
120720|NCT02811692|Retinal Diseases|retinal diseases
120721|NCT02811692|Optic Nerve Diseases|optic nerve diseases
120722|NCT02811692|Corneal Diseases|corneal diseases
120723|NCT02811692|Vision Disorders|vision disorders
120724|NCT02811679|Lymphoma|lymphoma
120725|NCT02811653|Motor slowing|motor slowing
120726|NCT02811640|Intra-Abdominal Pressure|intra-abdominal pressure
120727|NCT02811640|Stryker Pressure Monitor|stryker pressure monitor
120728|NCT02811627|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
120729|NCT02811627|Memantine|memantine
120730|NCT02811627|Treatment prediction biomarker|treatment prediction biomarker
120731|NCT02811614|intracerebral hemorrhage,hypertensive|intracerebral hemorrhage,hypertensive
120732|NCT02811614|minimally invasive surgery|minimally invasive surgery
120733|NCT02811614|neuroendoscopic surgery|neuroendoscopic surgery
120734|NCT02811614|stereotactic aspiration|stereotactic aspiration
120735|NCT02811601|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
120736|NCT02811575|Coloscopy|coloscopy
120737|NCT02811549|Cochlear Implant|cochlear implant
120738|NCT02811549|HiRes™ 90K Advantage Implant|hires™ 90k advantage implant
120739|NCT02811549|HiFocus™ Mid-Scala electrode|hifocus™ mid-scala electrode
120740|NCT02811549|HiFocus™ 1J electrode|hifocus™ 1j electrode
120741|NCT02811549|HiFocus Helix™ electrode|hifocus helix™ electrode
120742|NCT02811549|Cochlear Implantation|cochlear implantation
120743|NCT02811549|Listening Benefits|listening benefits
120744|NCT02811549|Adults|adults
120745|NCT02811549|Cochlear Implant Benefit|cochlear implant benefit
120746|NCT02811549|Electrical Stimulation|electrical stimulation
120747|NCT02811549|HiRes™ Ultra Implant with HiFocus™ Mid‐Scala electrode|hires™ ultra implant with hifocus™ mid‐scala electrode
120748|NCT02811484|Obesity|obesity
120749|NCT02811458|Panic Disorder|panic disorder
120750|NCT02811458|Agoraphobia|agoraphobia
120751|NCT02811458|Social Anxiety Disorder|social anxiety disorder
120752|NCT02811458|Generalized Anxiety Disorder|generalized anxiety disorder
120753|NCT02811458|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
120754|NCT02811445|microbiome, metabolome, aging, lean mass, physical function|microbiome, metabolome, aging, lean mass, physical function
120755|NCT02811432|Kangaroo mother care|kangaroo mother care
120756|NCT02811432|Neonates|neonates
120757|NCT02811432|Low birth weight|low birth weight
120758|NCT02811432|Unstable|unstable
120759|NCT02811393|Bariatric surgery, sarcopenia|bariatric surgery, sarcopenia
120761|NCT02811380|Healthcare associated infections (HAI)|healthcare associated infections (hai)
120762|NCT02811380|CLABSI|clabsi
120763|NCT02811380|Noble metal alloy coating|noble metal alloy coating
120764|NCT02811380|CVC related thrombosis|cvc related thrombosis
120765|NCT02811341|Scopolamine butylbromide PCLE|scopolamine butylbromide pcle
120766|NCT02811276|High-protein diet|high-protein diet
120767|NCT02811276|Energy metabolism|energy metabolism
120768|NCT02811276|Substrate oxidation|substrate oxidation
120769|NCT02811250|Renal cancer|renal cancer
120770|NCT02811250|Stereotactic radiotherapy|stereotactic radiotherapy
120771|NCT02811185|PET|pet
120772|NCT02811185|CT|ct
120773|NCT02811185|PET/CT|pet/ct
121377|NCT02807571|Hand|hand
120774|NCT02811172|Biological multi-paradigm model|biological multi-paradigm model
120775|NCT02811172|Biomarkers|biomarkers
120776|NCT02811172|Triglycerides|triglycerides
120777|NCT02811172|Cholesterol|cholesterol
120778|NCT02811172|Prolactin|prolactin
120779|NCT02811172|Glucose|glucose
120780|NCT02811146|Heart Failure|heart failure
120781|NCT02811146|Noninvasive Ventilation|noninvasive ventilation
120782|NCT02811146|Positive- Pressure Respiration|positive- pressure respiration
120783|NCT02811133|inositol|inositol
120784|NCT02811120|meningococcal|meningococcal
120785|NCT02811120|conjugate|conjugate
120786|NCT02811120|vaccine|vaccine
120787|NCT02811120|quadrivalent|quadrivalent
120788|NCT02811120|meningococcal quadrivalent conjugate vaccine|meningococcal quadrivalent conjugate vaccine
120789|NCT02811107|anxiety|anxiety
120790|NCT02811107|pain|pain
120791|NCT02811107|preoperative area|preoperative area
120792|NCT02811107|premedication|premedication
120793|NCT02811068|HPV|hpv
120794|NCT02811068|vaccine|vaccine
120795|NCT02811068|Human Papillomavirus Virus Vaccine|human papillomavirus virus vaccine
120796|NCT02811029|neurological|neurological
120797|NCT02811029|difficulties|difficulties
120798|NCT02811016|High Altitude|high altitude
120799|NCT02811016|budesonide|budesonide
120800|NCT02811016|hypoxia|hypoxia
120801|NCT02811003|Insertional Achilles|insertional achilles
120802|NCT02810990|bosutinib|bosutinib
120803|NCT02810990|chronic myeloid leukemia|chronic myeloid leukemia
120804|NCT02810977|gastric volume|gastric volume
120805|NCT02810977|gastric content|gastric content
120806|NCT02810977|ultrasound|ultrasound
120807|NCT02810977|perioperative fasting|perioperative fasting
120808|NCT02810964|Schizophrenia|schizophrenia
120809|NCT02810964|Schizoaffective Disorder|schizoaffective disorder
120810|NCT02810964|Sulforaphane|sulforaphane
120811|NCT02810964|Sulforaphane supplement|sulforaphane supplement
120812|NCT02810951|RDEB|rdeb
120813|NCT02810938|Ablation|ablation
120814|NCT02810938|Mifi technology|mifi technology
120815|NCT02810938|maximum voltage-guided ablation|maximum voltage-guided ablation
120816|NCT02810899|child|child
120817|NCT02810899|craniotomy|craniotomy
120818|NCT02810899|intelligence tests|intelligence tests
120819|NCT02810899|dexmedetomidine|dexmedetomidine
120820|NCT02810899|Disruption|disruption
120821|NCT02810899|Dehiscence|dehiscence
120822|NCT02810899|Mild Cognitive Disorder|mild cognitive disorder
120823|NCT02810886|Prostate Cancer|prostate cancer
120824|NCT02810860|laparoscopic cholecystectomy|laparoscopic cholecystectomy
120825|NCT02810847|Amblyopia|amblyopia
120826|NCT02810847|strabismus|strabismus
120827|NCT02810847|virtual reality|virtual reality
120828|NCT02810847|computer games|computer games
120829|NCT02810834|Executive Function|executive function
120830|NCT02810834|Academic Performance|academic performance
120831|NCT02810821|Gonadal hormones|gonadal hormones
120832|NCT02810821|Gonadotropins|gonadotropins
120833|NCT02810821|Cardiovascular diseases|cardiovascular diseases
120834|NCT02810821|Lipids|lipids
120835|NCT02810821|Obesity|obesity
120836|NCT02810821|Atherosclerosis|atherosclerosis
120837|NCT02810821|Glucose metabolism disorders|glucose metabolism disorders
120838|NCT02810821|Metabolic syndrome|metabolic syndrome
120839|NCT02810821|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
120840|NCT02810808|Neovascular Age-related Macular Degeneration|neovascular age-related macular degeneration
120841|NCT02810808|Ranibizumab|ranibizumab
120842|NCT02810808|Pro Re Nata|pro re nata
120843|NCT02810795|Coronary|coronary
120844|NCT02810795|Artery|artery
120845|NCT02810795|Computed tomography|computed tomography
120846|NCT02810795|FFR|ffr
120847|NCT02810795|CT myocardial perfusion|ct myocardial perfusion
120848|NCT02810795|Dynamic|dynamic
120849|NCT02810782|opiate dependence|opiate dependence
120850|NCT02810782|withdrawal|withdrawal
120851|NCT02810782|newborn|newborn
120852|NCT02810730|pancreas|pancreas
120853|NCT02810730|adenocarcinoma|adenocarcinoma
120854|NCT02810704|Anticoagulant|anticoagulant
120855|NCT02810704|Venous Thromboembolism|venous thromboembolism
120856|NCT02810704|Pulmonary Embolism|pulmonary embolism
120857|NCT02810704|Total Knee Arthroplasty|total knee arthroplasty
120858|NCT02810704|Total Hip Arthroplasty|total hip arthroplasty
120859|NCT02810691|Diabetes|diabetes
120860|NCT02810691|Fiber|fiber
120861|NCT02810691|Supplementation|supplementation
120862|NCT02810691|Soluble fiber|soluble fiber
120863|NCT02810691|Post-prandial blood glucose|post-prandial blood glucose
120864|NCT02810691|Nutrition|nutrition
120865|NCT02810678|Tuberculosis|tuberculosis
120866|NCT02810665|Repeatability|repeatability
120867|NCT02810665|Concordance|concordance
120868|NCT02810665|Agreement|agreement
120869|NCT02810665|ETDRS visual acuity chart|etdrs visual acuity chart
120870|NCT02810665|numeric|numeric
120871|NCT02810665|Landolt C|landolt c
120872|NCT02810665|Roman alphabet|roman alphabet
120873|NCT02810652|Cancer Surgery Care|cancer surgery care
120874|NCT02810639|pain|pain
120875|NCT02810587|Endophthalmitis|endophthalmitis
120876|NCT02810587|Intravitreous injection|intravitreous injection
120983|NCT02810028|Becker's muscular dystrophy|becker's muscular dystrophy
120877|NCT02810587|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
120878|NCT02810587|topical antibiotics|topical antibiotics
120879|NCT02810561|Troponin|troponin
120880|NCT02810535|Local IgE|local ige
120881|NCT02810535|Non-allergic rhinitis|non-allergic rhinitis
120882|NCT02810535|Allergic rhinitis to house dust mite|allergic rhinitis to house dust mite
120883|NCT02810509|Wafarin|wafarin
120884|NCT02810509|Cardioembolic (CE) stroke|cardioembolic (ce) stroke
120885|NCT02810509|ischemic stroke|ischemic stroke
120886|NCT02810483|Prader-Willi|prader-willi
120887|NCT02810483|SPW|spw
120888|NCT02810483|impulsivity|impulsivity
120889|NCT02810483|eating disorders|eating disorders
120890|NCT02810483|topiramate|topiramate
120891|NCT02810457|Cancer|cancer
120892|NCT02810457|Bevacizumab|bevacizumab
120893|NCT02810457|Carboplatin|carboplatin
120894|NCT02810457|Paclitaxel|paclitaxel
120895|NCT02810418|Immunotoxin|immunotoxin
120896|NCT02810418|Mesothelin|mesothelin
120897|NCT02810418|Antibody-based Therapeutics|antibody-based therapeutics
120898|NCT02810418|Advanced Cancer|advanced cancer
120899|NCT02810405|Sample|sample
120900|NCT02810405|Storage|storage
120901|NCT02810405|Molecular Profiling|molecular profiling
120902|NCT02810405|Biopsy|biopsy
120903|NCT02810405|Repository|repository
120904|NCT02810379|informed consent|informed consent
120905|NCT02810379|ERCP|ercp
120906|NCT02810379|video|video
120907|NCT02810366|Verbal Autopsy|verbal autopsy
120908|NCT02810366|Physician-coded verbal autopsy|physician-coded verbal autopsy
120909|NCT02810366|Computer-coded verbal autopsy|computer-coded verbal autopsy
120910|NCT02810366|InterVA|interva
120911|NCT02810366|Naive Bayes Classifier (NBC)|naive bayes classifier (nbc)
120912|NCT02810366|Tariff|tariff
120913|NCT02810366|InSilicoVA|insilicova
120914|NCT02810366|Randomised Control Trial|randomised control trial
120915|NCT02810366|SmartVA|smartva
120916|NCT02810366|King-Lu|king-lu
120917|NCT02810327|Alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
120918|NCT02810327|AATD|aatd
120919|NCT02810327|Alpha-1|alpha-1
120920|NCT02810327|SERPINA1|serpina1
120921|NCT02810327|MZ|mz
120922|NCT02810327|Carrier|carrier
120923|NCT02810327|Heterozygote|heterozygote
120924|NCT02810327|Smoking|smoking
120925|NCT02810327|COPD|copd
120926|NCT02810327|Emphysema|emphysema
120927|NCT02810327|Sequencing|sequencing
120928|NCT02810301|gluten|gluten
120929|NCT02810301|non-celiac|non-celiac
120930|NCT02810301|gluten sensitivity|gluten sensitivity
120931|NCT02810288|Airway anatomy|airway anatomy
120932|NCT02810288|difficult intubation|difficult intubation
120933|NCT02810288|congenital syndromes|congenital syndromes
120934|NCT02810262|Lung cancer|lung cancer
120935|NCT02810262|Bone metastases|bone metastases
120936|NCT02810262|EGFR|egfr
120937|NCT02810262|KRAS|kras
120938|NCT02810262|Bone biomarkers|bone biomarkers
120939|NCT02810262|Metabolic parameters|metabolic parameters
120940|NCT02810249|African American YMSM|african american ymsm
120941|NCT02810249|PrEP|prep
120942|NCT02810249|HIV Pre-Exposure Prophylaxis|hiv pre-exposure prophylaxis
120943|NCT02810249|Common Sense Model|common sense model
120944|NCT02810249|Healthcare|healthcare
120945|NCT02810249|HIV Prevention|hiv prevention
120946|NCT02810236|Focal breast pain|focal breast pain
120947|NCT02810236|Directed Ultrasound|directed ultrasound
120948|NCT02810236|Reassurance|reassurance
120949|NCT02810236|Anxiety|anxiety
120950|NCT02810210|Zika|zika
120951|NCT02810210|microcephaly|microcephaly
120952|NCT02810210|congenital abnormalities|congenital abnormalities
120953|NCT02810210|new-born|new-born
120954|NCT02810210|infant|infant
120955|NCT02810184|bone augmentation|bone augmentation
120956|NCT02810184|long-term bone volume changes|long-term bone volume changes
120957|NCT02810184|immediate provisional implant|immediate provisional implant
120958|NCT02810171|anxiety|anxiety
120959|NCT02810171|social anxiety disorder|social anxiety disorder
120960|NCT02810171|generalized anxiety disorder|generalized anxiety disorder
120961|NCT02810171|phobias|phobias
120962|NCT02810171|fears|fears
120963|NCT02810171|worry|worry
120964|NCT02810145|traumatic brain injury|traumatic brain injury
120965|NCT02810145|cerebral desaturation|cerebral desaturation
120966|NCT02810145|intensive care|intensive care
120967|NCT02810145|hemodynamics|hemodynamics
120968|NCT02810145|Loss|loss
120969|NCT02810145|Consciousness|consciousness
120970|NCT02810106|Spect|spect
120971|NCT02810106|Stress Test|stress test
120972|NCT02810106|Myocardial Perfusion CT|myocardial perfusion ct
120973|NCT02810106|CT angiography|ct angiography
120974|NCT02810093|Breast cancer|breast cancer
120975|NCT02810093|Text mining|text mining
120976|NCT02810093|Big Data|big data
120977|NCT02810093|Machine Learning|machine learning
120978|NCT02810054|regeneration|regeneration
120979|NCT02810054|intrabony defects|intrabony defects
120980|NCT02810054|enamel matrix derivative|enamel matrix derivative
120981|NCT02810054|MIST|mist
120982|NCT02810028|Limb girdle muscular dystrophy|limb girdle muscular dystrophy
121375|NCT02807584|adhesive|adhesive
120984|NCT02810028|Facioscapulohumeral muscular dystrophy|facioscapulohumeral muscular dystrophy
120985|NCT02810028|Inclusion-body myositis|inclusion-body myositis
120986|NCT02810028|Acceptance and Commitment Therapy|acceptance and commitment therapy
120987|NCT02810028|ACT|act
120988|NCT02809950|postoperative nausea and vomiting, oral carbohydrate beverage|postoperative nausea and vomiting, oral carbohydrate beverage
120989|NCT02809937|aged|aged
120990|NCT02809937|surgical procedures, operative|surgical procedures, operative
120991|NCT02809937|delirium|delirium
120992|NCT02809937|dexmedetomidine|dexmedetomidine
120993|NCT02809937|long-term outcome|long-term outcome
120994|NCT02809924|endotracheal intubation|endotracheal intubation
120995|NCT02809924|teaching|teaching
120996|NCT02809924|just-in-time|just-in-time
120997|NCT02809898|Biomarkers, Neoplasms|biomarkers, neoplasms
120998|NCT02809885|Hepatitis E|hepatitis e
120999|NCT02809885|Pediatric|pediatric
121000|NCT02809885|Transplantation|transplantation
121001|NCT02809885|Prevalence|prevalence
121002|NCT02809820|ACS|acs
121003|NCT02809820|Beta Blockers|beta blockers
121004|NCT02809820|platelet aggregation|platelet aggregation
121005|NCT02809820|light transmission aggregometry|light transmission aggregometry
121006|NCT02809820|Beta-Adrenergic Blockers|beta-adrenergic blockers
121007|NCT02809807|Work of Breathing; Hypoxemia; Respiratory Acidosis; Respiratory effort; COPD|work of breathing; hypoxemia; respiratory acidosis; respiratory effort; copd
121008|NCT02809781|ankylosing spondylitis|ankylosing spondylitis
121009|NCT02809781|mesenchymal stem cell|mesenchymal stem cell
121010|NCT02809781|etanercept|etanercept
121011|NCT02809768|Healthy participants|healthy participants
121012|NCT02809768|Pharmacokinetic Drug-Drug Interaction|pharmacokinetic drug-drug interaction
121013|NCT02809768|Avatrombopag|avatrombopag
121014|NCT02809755|Obesity|obesity
121015|NCT02809755|laparoscopic gastric banding|laparoscopic gastric banding
121016|NCT02809755|band revision|band revision
121017|NCT02809755|laparoscopic gastric banding sleeve gastrectomy|laparoscopic gastric banding sleeve gastrectomy
121018|NCT02809742|Pregnant|pregnant
121019|NCT02809742|Labor|labor
121020|NCT02809742|Epidural|epidural
121021|NCT02809742|Analgesia|analgesia
121022|NCT02809742|Intermittent|intermittent
121023|NCT02809651|Infrascanner|infrascanner
121024|NCT02809651|Intracranial hemorrhage|intracranial hemorrhage
121025|NCT02809625|Dynamic contrast -enhanced MRI|dynamic contrast -enhanced mri
121026|NCT02809625|brucella spondylitis|brucella spondylitis
121027|NCT02809599|vertigo|vertigo
121028|NCT02809599|dizziness|dizziness
121029|NCT02809586|Alcohol|alcohol
121030|NCT02809586|Teens|teens
121031|NCT02809586|Young Adults|young adults
121032|NCT02809586|Social Media|social media
121033|NCT02809573|peripheral T-cell lymphoma|peripheral t-cell lymphoma
121034|NCT02809573|PTCL|ptcl
121035|NCT02809573|chidamide|chidamide
121036|NCT02809573|CHOP|chop
121037|NCT02809573|phase Ib|phase ib
121038|NCT02809560|Lymphocytes Th2|lymphocytes th2
121039|NCT02809560|Cav1 channels|cav1 channels
121040|NCT02809534|Anlotinib|anlotinib
121041|NCT02809534|AL3818|al3818
121042|NCT02809508|Omega-3|omega-3
121043|NCT02809508|Child nutrition|child nutrition
121044|NCT02809508|Dietary recommendations|dietary recommendations
121045|NCT02809508|Cardiovascular risk markers|cardiovascular risk markers
121046|NCT02809508|Cognitive function|cognitive function
121047|NCT02809508|Mental health|mental health
121048|NCT02809482|Volunteers|volunteers
121049|NCT02809443|Zika|zika
121050|NCT02809443|Vaccine|vaccine
121051|NCT02809443|DNA|dna
121052|NCT02809391|Postural Balance|postural balance
121053|NCT02809391|Gait|gait
121054|NCT02809391|Foot Orthotic|foot orthotic
121055|NCT02809391|Proprioception|proprioception
121056|NCT02809391|Somatosensory|somatosensory
121057|NCT02809365|insulin treated|insulin treated
121058|NCT02809339|Chemotherapy|chemotherapy
121059|NCT02809339|ovarian cancer|ovarian cancer
121060|NCT02809339|Patient reported outcome|patient reported outcome
121061|NCT02809339|Quality of Care|quality of care
121062|NCT02809326|efficiency|efficiency
121063|NCT02809326|exposure therapy|exposure therapy
121064|NCT02809326|PTSD|ptsd
121065|NCT02809326|combat|combat
121066|NCT02809326|veterans|veterans
121067|NCT02809313|gingivitis|gingivitis
121068|NCT02809313|probiotic|probiotic
121069|NCT02809313|non- surgical treatment|non- surgical treatment
121070|NCT02809274|iron deficiency|iron deficiency
121071|NCT02809274|polycythemia vera|polycythemia vera
121072|NCT02809261|Carpal Tunnel Syndrome|carpal tunnel syndrome
121073|NCT02809261|Perineural injection|perineural injection
121074|NCT02809261|Dextrose|dextrose
121075|NCT02809248|LTX Study|ltx study
121076|NCT02809235|asthma|asthma
121077|NCT02809235|smooth muscle|smooth muscle
121078|NCT02809235|lauric acid|lauric acid
121079|NCT02809235|dietary supplement|dietary supplement
121080|NCT02809222|Myelodysplastic syndrome|myelodysplastic syndrome
121081|NCT02809222|Ascorbic acid|ascorbic acid
121082|NCT02809222|Oxidative stress|oxidative stress
121083|NCT02809222|Preleukemia|preleukemia
121084|NCT02809196|Food Habits|food habits
121085|NCT02809196|Adolescents|adolescents
121086|NCT02809196|Digital Communication|digital communication
121087|NCT02809183|metabolic acidosis|metabolic acidosis
121088|NCT02809183|serum bicarbonate|serum bicarbonate
121089|NCT02809183|kidney disease|kidney disease
121090|NCT02809131|CIED infection|cied infection
121091|NCT02809118|Deafness|deafness
121092|NCT02809118|Hearing Loss|hearing loss
121093|NCT02809118|Hearing Loss, Sensorineural|hearing loss, sensorineural
121094|NCT02809118|Ear Diseases|ear diseases
121095|NCT02809118|Hearing Disorders|hearing disorders
121096|NCT02809118|Nervous System Diseases|nervous system diseases
121097|NCT02809118|Neurologic Manifestations|neurologic manifestations
121098|NCT02809118|Otorhinolaryngologic Diseases|otorhinolaryngologic diseases
121099|NCT02809118|Sensation Disorders|sensation disorders
121100|NCT02809118|Signs and Symptoms|signs and symptoms
121101|NCT02809118|Hearing and Speech Impairment|hearing and speech impairment
121102|NCT02809118|Hearing Loss, Unilateral|hearing loss, unilateral
121103|NCT02809105|Chronic constipation|chronic constipation
121104|NCT02809105|Linaclotide|linaclotide
121105|NCT02809105|ASP0456|asp0456
121106|NCT02809092|Acute Myeloid Leukemia, Natural Killer Cells|acute myeloid leukemia, natural killer cells
121107|NCT02809066|premenstrual syndrome|premenstrual syndrome
121108|NCT02809066|calcium|calcium
121109|NCT02809066|quality of life|quality of life
121110|NCT02809053|low tumor burden follicular lymphoma (LTBFL)|low tumor burden follicular lymphoma (ltbfl)
121111|NCT02809014|Fluoride|fluoride
121112|NCT02809014|Dental caries|dental caries
121113|NCT02809014|Dentifrice|dentifrice
121114|NCT02809001|Fat grafting|fat grafting
121115|NCT02809001|Expansion-related complications|expansion-related complications
121116|NCT02808988|Bisphosphonate|bisphosphonate
121117|NCT02808988|osteoporosis|osteoporosis
121118|NCT02808988|RANKL|rankl
121119|NCT02808988|OPG|opg
121120|NCT02808988|periodontitis|periodontitis
121121|NCT02808975|Hidradenitis Suppurativa|hidradenitis suppurativa
121122|NCT02808975|axilla|axilla
121123|NCT02808975|inguinal region|inguinal region
121124|NCT02808975|Hurley Stage I, II, or III|hurley stage i, ii, or iii
121125|NCT02808975|adalimumab|adalimumab
121126|NCT02808975|secondary intention|secondary intention
121127|NCT02808975|abcess and inflammatory nodule (AN) count|abcess and inflammatory nodule (an) count
121128|NCT02808949|Prevention|prevention
121129|NCT02808949|Lactating Women|lactating women
121130|NCT02808949|Healthy|healthy
121131|NCT02808936|remote ischemic conditioning|remote ischemic conditioning
121132|NCT02808936|orthopedic surgery|orthopedic surgery
121133|NCT02808936|ischemic heart disease|ischemic heart disease
121134|NCT02808910|behavior|behavior
121135|NCT02808910|food intake|food intake
121136|NCT02808910|salt|salt
121137|NCT02808910|vegetables|vegetables
121138|NCT02808910|portion size|portion size
121139|NCT02808910|weight loss|weight loss
121140|NCT02808910|habits|habits
121141|NCT02808897|Chest tubes|chest tubes
121142|NCT02808897|Atrial fibrillation|atrial fibrillation
121143|NCT02808897|Thoracic surgery|thoracic surgery
121144|NCT02808897|Critical care|critical care
121145|NCT02808858|MDS|mds
121146|NCT02808858|Myelodisplastic Syndrome|myelodisplastic syndrome
121147|NCT02808845|coronary angiography|coronary angiography
121148|NCT02808845|contrast-induced acute kidney injury|contrast-induced acute kidney injury
121149|NCT02808845|microalbuminuria|microalbuminuria
121150|NCT02808832|Human papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
121151|NCT02808832|Cervical cancer screening|cervical cancer screening
121152|NCT02808832|Provider intervention|provider intervention
121153|NCT02808819|Asthma|asthma
121154|NCT02808819|Bronchial Diseases|bronchial diseases
121155|NCT02808819|Respiratory Tract Diseases|respiratory tract diseases
121156|NCT02808819|Lung Diseases|lung diseases
121157|NCT02808819|Obstructive Lung Diseases|obstructive lung diseases
121158|NCT02808806|stroke|stroke
121159|NCT02808806|cerebral infarction|cerebral infarction
121160|NCT02808806|brain infarction|brain infarction
121161|NCT02808806|ischemic stroke|ischemic stroke
121162|NCT02808806|treatment|treatment
121163|NCT02808806|intravenous thrombolysis|intravenous thrombolysis
121164|NCT02808806|intraarterial thrombectomy|intraarterial thrombectomy
121165|NCT02808806|delay|delay
121166|NCT02808806|total system delay|total system delay
121167|NCT02808806|pre-hospital delay|pre-hospital delay
121168|NCT02808806|in-hospital delay|in-hospital delay
121169|NCT02808806|feedback|feedback
121170|NCT02808806|real-time feedback|real-time feedback
121171|NCT02808806|visual feedback|visual feedback
121172|NCT02808793|ISM|ism
121173|NCT02808793|Mastocytosis|mastocytosis
121174|NCT02808793|Indolent Mastocytosis|indolent mastocytosis
121175|NCT02808780|Ulcerative Colitis|ulcerative colitis
121176|NCT02808780|Simponi (Golimumab)|simponi (golimumab)
121177|NCT02808780|Thiopurines|thiopurines
121178|NCT02808780|Lymphoma|lymphoma
121179|NCT02808780|Malignancies|malignancies
121180|NCT02808767|Acute myocardial infarction|acute myocardial infarction
121181|NCT02808767|Primary coronary intervention|primary coronary intervention
121182|NCT02808767|Antiplatelet therapy|antiplatelet therapy
121183|NCT02808728|Total Knee Arthroplasty|total knee arthroplasty
121184|NCT02808728|Total Knee Replacement|total knee replacement
121185|NCT02808728|Exparel|exparel
121186|NCT02808728|Liposomal Bupivacaine|liposomal bupivacaine
121187|NCT02808728|Ropivacaine|ropivacaine
121188|NCT02808728|Postoperative Pain Management|postoperative pain management
121189|NCT02808702|Attention|attention
121190|NCT02808702|Cognitive behavioral therapy|cognitive behavioral therapy
121191|NCT02808702|Neuroimaging|neuroimaging
121192|NCT02808689|Moderate|moderate
121193|NCT02808689|Severe|severe
121194|NCT02808676|Cognitive training|cognitive training
121195|NCT02808676|Vitamin D|vitamin d
121196|NCT02808676|Exercise|exercise
121197|NCT02808637|Pain management|pain management
121198|NCT02808637|vaccination|vaccination
121199|NCT02808637|manual pressure|manual pressure
121200|NCT02808637|needle aspiration|needle aspiration
121201|NCT02808624|Oxaliplatin, peripheral neuropathy, L-CARNOSINE|oxaliplatin, peripheral neuropathy, l-carnosine
121202|NCT02808598|Clinical Trials|clinical trials
121203|NCT02808598|Education|education
121204|NCT02808598|Hispanic Americans|hispanic americans
121205|NCT02808598|African Americans|african americans
121206|NCT02808598|Health Disparities|health disparities
121207|NCT02808598|Patient Participation|patient participation
121208|NCT02808598|Refusal to Participate|refusal to participate
121209|NCT02808572|chronic kidney disease|chronic kidney disease
121210|NCT02808572|vascular calcifications|vascular calcifications
121211|NCT02808572|cardiovascular risk|cardiovascular risk
121212|NCT02808546|Gallbladder stone|gallbladder stone
121213|NCT02808546|Risk factor|risk factor
121214|NCT02808546|Case-control study|case-control study
121215|NCT02808546|Obesity|obesity
121216|NCT02808546|Hypertension|hypertension
121217|NCT02808546|Alcohol consumption|alcohol consumption
121218|NCT02808520|Social participation|social participation
121219|NCT02808520|Children and adolescents with cancer|children and adolescents with cancer
121220|NCT02808520|Quality of life with hodgkin-lymphoma|quality of life with hodgkin-lymphoma
121221|NCT02808520|Social inequalities and cancer|social inequalities and cancer
121222|NCT02808494|Preeclampsia|preeclampsia
121223|NCT02808494|Fetal Growth Restriction|fetal growth restriction
121224|NCT02808481|systemic sclerosis|systemic sclerosis
121225|NCT02808481|cardiac disease|cardiac disease
121226|NCT02808481|Heart transplantation|heart transplantation
121227|NCT02808481|primitive cardiac damage|primitive cardiac damage
121228|NCT02808468|Sexual assault|sexual assault
121229|NCT02808468|Posttraumatic Stress Disorder|posttraumatic stress disorder
121230|NCT02808468|Alcohol use|alcohol use
121231|NCT02808468|Cognitive therapy|cognitive therapy
121232|NCT02808429|Atacicept|atacicept
121233|NCT02808429|IgA Nephropathy|iga nephropathy
121234|NCT02808429|Berger´s disease|berger´s disease
121235|NCT02808429|Glomerulonephritis|glomerulonephritis
121236|NCT02808429|Proteinuria|proteinuria
121237|NCT02808416|Solid tumors|solid tumors
121238|NCT02808416|Brain metastases|brain metastases
121239|NCT02808416|DC vaccine|dc vaccine
121240|NCT02808416|Personalized vaccine|personalized vaccine
121241|NCT02808416|Tumor antigens|tumor antigens
121242|NCT02808416|PBMCs|pbmcs
121243|NCT02808364|Recurrent glioblastoma|recurrent glioblastoma
121244|NCT02808364|DC vaccine|dc vaccine
121245|NCT02808364|tumor antigen|tumor antigen
121246|NCT02808364|personalized vaccine|personalized vaccine
121247|NCT02808299|statin|statin
121248|NCT02808299|hepatitis B virus|hepatitis b virus
121249|NCT02808273|Bemiparine|bemiparine
121250|NCT02808273|Antithrombotic microsurgery protocol|antithrombotic microsurgery protocol
121251|NCT02808273|Comparative study|comparative study
121252|NCT02808273|Anticoagulant microsurgery protocol|anticoagulant microsurgery protocol
121253|NCT02808260|sub-clinical atrial fibrillation|sub-clinical atrial fibrillation
121254|NCT02808260|biomarkers|biomarkers
121255|NCT02808260|implanted pacemaker or defibrillator|implanted pacemaker or defibrillator
121256|NCT02808247|advanced metastatic soft tissue sarcoma|advanced metastatic soft tissue sarcoma
121257|NCT02808221|Heart failure|heart failure
121258|NCT02808221|heart disease|heart disease
121259|NCT02808221|left ventricular|left ventricular
121260|NCT02808195|Cerebral Palsy|cerebral palsy
121261|NCT02808195|Neurological Rehabilitation|neurological rehabilitation
121262|NCT02808195|Upper Extremity|upper extremity
121263|NCT02808156|Cerebral Palsy,|cerebral palsy,
121264|NCT02808156|Upper limb neurorehabilitation|upper limb neurorehabilitation
121265|NCT02808156|Upper Extremity|upper extremity
121266|NCT02808156|Neurological Rehabilitation|neurological rehabilitation
121267|NCT02808130|hyperlipidemia, periodontal disease, oxidative stress,|hyperlipidemia, periodontal disease, oxidative stress,
121268|NCT02808117|microfinance institution|microfinance institution
121270|NCT02808078|Instrumented treadmill|instrumented treadmill
121271|NCT02808078|Augmented reality|augmented reality
121272|NCT02808078|Neurorehabilitation|neurorehabilitation
121273|NCT02808078|Gait disorders|gait disorders
121274|NCT02808065|Kidney transplant|kidney transplant
121275|NCT02808065|Kidney transplantation|kidney transplantation
121276|NCT02808065|Renal transplant|renal transplant
121277|NCT02808065|Renal transplantation|renal transplantation
121278|NCT02808052|Bacterial infections|bacterial infections
121376|NCT02807584|dressing|dressing
121279|NCT02808026|severe hypertension|severe hypertension
121280|NCT02808026|grade III hypertension|grade iii hypertension
121281|NCT02808026|mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
121282|NCT02807987|Mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
121283|NCT02807987|Moderate renal impairment|moderate renal impairment
121284|NCT02807987|Hypertension|hypertension
121285|NCT02807974|Hypertension with Type 2 Diabetes and Albuminuria|hypertension with type 2 diabetes and albuminuria
121286|NCT02807974|Diabetic nephropathy|diabetic nephropathy
121287|NCT02807974|Diabetic renal disease|diabetic renal disease
121288|NCT02807974|Albuminuria|albuminuria
121289|NCT02807974|Mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
121290|NCT02807961|Translational read through|translational read through
121291|NCT02807948|MRI Scan, pacemakers, ICD, CRT|mri scan, pacemakers, icd, crt
121292|NCT02807922|Palliative Care|palliative care
121293|NCT02807922|zopiclone|zopiclone
121294|NCT02807896|biomarker|biomarker
121295|NCT02807896|pancreatic cancer|pancreatic cancer
121296|NCT02807896|bile duct cancer|bile duct cancer
121297|NCT02807896|miRNA|mirna
121298|NCT02807883|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
121299|NCT02807883|ALL|all
121300|NCT02807883|B-lineage Acute Lymphoblastic Leukemia|b-lineage acute lymphoblastic leukemia
121301|NCT02807883|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
121302|NCT02807883|Blinatumomab|blinatumomab
121303|NCT02807883|Blincyto|blincyto
121304|NCT02807883|Post allogeneic stem cell transplant|post allogeneic stem cell transplant
121305|NCT02807870|Parental training|parental training
121306|NCT02807870|Preschool age|preschool age
121307|NCT02807870|Attention Deficit/Hyperactivity Disorder (ADHD)|attention deficit/hyperactivity disorder (adhd)
121308|NCT02807857|low-interventional observational study,|low-interventional observational study,
121309|NCT02807857|CHF,|chf,
121310|NCT02807857|heart failure,|heart failure,
121311|NCT02807857|primary care,|primary care,
121312|NCT02807857|ESC guidelines,|esc guidelines,
121313|NCT02807857|Europe,|europe,
121314|NCT02807857|NT-proBNP,|nt-probnp,
121315|NCT02807857|reduced ventricular ejection fraction (EF),|reduced ventricular ejection fraction (ef),
121316|NCT02807844|Triple negative breast cancer|triple negative breast cancer
121317|NCT02807844|Pancreatic carcinoma|pancreatic carcinoma
121318|NCT02807844|Melanoma|melanoma
121319|NCT02807844|Endometrial Carcinoma|endometrial carcinoma
121320|NCT02807844|Immuno oncology|immuno oncology
121321|NCT02807844|Monoclonal antibody|monoclonal antibody
121322|NCT02807844|PDR001|pdr001
121323|NCT02807844|MCS110|mcs110
121324|NCT02807831|Executive Function|executive function
121325|NCT02807831|Language|language
121326|NCT02807831|Preschool child|preschool child
121327|NCT02807831|Development|development
121328|NCT02807818|Child development|child development
121329|NCT02807818|Infant|infant
121330|NCT02807818|Mother-Child Relations|mother-child relations
121331|NCT02807805|castration resistant prostate cancer|castration resistant prostate cancer
121332|NCT02807792|Perianal surgery|perianal surgery
121333|NCT02807779|angioplasty|angioplasty
121334|NCT02807779|peripheral artery disease|peripheral artery disease
121335|NCT02807779|peripheral vascular disease|peripheral vascular disease
121336|NCT02807779|atherosclerosis|atherosclerosis
121337|NCT02807779|balloon angioplasty|balloon angioplasty
121338|NCT02807779|dexamethasone|dexamethasone
121339|NCT02807779|drug coated balloon|drug coated balloon
121340|NCT02807779|paclitaxel|paclitaxel
121341|NCT02807779|walking|walking
121342|NCT02807779|claudication|claudication
121343|NCT02807766|autism|autism
121344|NCT02807766|Brain Plasticity|brain plasticity
121345|NCT02807766|Behavioral Intervention|behavioral intervention
121346|NCT02807766|Magnetic Resonance Imaging|magnetic resonance imaging
121347|NCT02807753|Hemophilia|hemophilia
121348|NCT02807753|Arthropathy|arthropathy
121349|NCT02807753|Pediatric|pediatric
121350|NCT02807740|Virtual Reality|virtual reality
121351|NCT02807740|Rehabilitation|rehabilitation
121352|NCT02807740|Cardiocirculatory system|cardiocirculatory system
121353|NCT02807740|Parkinson Disease|parkinson disease
121354|NCT02807688|health promotion|health promotion
121355|NCT02807688|lifestyles|lifestyles
121356|NCT02807688|physical comorbidity|physical comorbidity
121357|NCT02807688|risk factors|risk factors
121358|NCT02807688|behavioural change|behavioural change
121359|NCT02807662|posttraumatic stress disorder|posttraumatic stress disorder
121360|NCT02807662|prenatal care|prenatal care
121361|NCT02807636|Urothelial carcinoma|urothelial carcinoma
121362|NCT02807636|Bladder cancer|bladder cancer
121363|NCT02807636|Anti-PD-L1|anti-pd-l1
121364|NCT02807636|Transitional carcinoma|transitional carcinoma
121365|NCT02807636|Tecentriq|tecentriq
121366|NCT02807636|Atezolizumab|atezolizumab
121367|NCT02807636|IMvigor130|imvigor130
121368|NCT02807610|Etomidate lipuro|etomidate lipuro
121369|NCT02807610|Induction characteristics|induction characteristics
121370|NCT02807584|Wound|wound
121371|NCT02807584|burns|burns
121372|NCT02807584|acute|acute
121373|NCT02807584|chronic|chronic
121374|NCT02807584|foam|foam
121378|NCT02807558|AML|aml
121379|NCT02807558|MDS|mds
121380|NCT02807545|Scoliosis-Specific Exercises|scoliosis-specific exercises
121381|NCT02807545|Schroth|schroth
121382|NCT02807519|Oral health|oral health
121383|NCT02807519|Saliva|saliva
121384|NCT02807519|Biomarker|biomarker
121385|NCT02807519|Cytokines|cytokines
121386|NCT02807519|Cancer|cancer
121387|NCT02807519|children|children
121388|NCT02807506|elders|elders
121389|NCT02807506|robotics|robotics
121390|NCT02807506|low income population|low income population
121391|NCT02807506|activities of daily living|activities of daily living
121392|NCT02807506|instrumental activities of daily living|instrumental activities of daily living
121393|NCT02807506|social robotics|social robotics
121394|NCT02807506|stroke|stroke
121395|NCT02807506|aged|aged
121396|NCT02807506|Retirement|retirement
121397|NCT02807506|Housing for elderly|housing for elderly
121398|NCT02807506|Homes for the aged|homes for the aged
121399|NCT02807493|Pregnancy|pregnancy
121400|NCT02807493|Labor and Delivery|labor and delivery
121401|NCT02807493|Occlusal Support Device|occlusal support device
121402|NCT02807467|reduction|reduction
121403|NCT02807467|delirium|delirium
121404|NCT02807467|duration|duration
121405|NCT02807467|severity|severity
121406|NCT02807454|Phase 2|phase 2
121407|NCT02807454|Open-Label|open-label
121408|NCT02807454|Durvalumab|durvalumab
121409|NCT02807454|Daratumumab|daratumumab
121410|NCT02807454|Multiple Myeloma|multiple myeloma
121411|NCT02807454|Relapsed and Refractory (RRMM)|relapsed and refractory (rrmm)
121412|NCT02807454|FUSION MM-003|fusion mm-003
121413|NCT02807454|PD-L1|pd-l1
121414|NCT02807441|Bleeding|bleeding
121415|NCT02807441|Aspirin|aspirin
121416|NCT02807441|Spine|spine
121417|NCT02807441|Surgery|surgery
121418|NCT02807428|post-surgical pain|post-surgical pain
121419|NCT02807428|total knee arthroplasty|total knee arthroplasty
121420|NCT02807428|total knee replacement|total knee replacement
121421|NCT02807415|cystic fibrosis|cystic fibrosis
121422|NCT02807415|CFTR|cftr
121423|NCT02807415|CFTR modulation|cftr modulation
121424|NCT02807415|sweat test|sweat test
121425|NCT02807415|intestinal current measurement, ICM|intestinal current measurement, icm
121426|NCT02807415|nasal transepithelial potential difference measurement, NPD|nasal transepithelial potential difference measurement, npd
121427|NCT02807402|Ombitasvir|ombitasvir
121428|NCT02807402|Dasabuvir|dasabuvir
121429|NCT02807402|Paritaprevir|paritaprevir
121430|NCT02807402|HCV|hcv
121431|NCT02807402|Chronic Hepatitis C|chronic hepatitis c
121432|NCT02807363|endometriosis|endometriosis
121433|NCT02807363|gonadotropin-releasing hormone agonist|gonadotropin-releasing hormone agonist
121434|NCT02807363|healthy volunteers|healthy volunteers
121435|NCT02807363|leuprolide oral tablet|leuprolide oral tablet
121436|NCT02807350|Intermittent Exotropia|intermittent exotropia
121437|NCT02807350|IXT|ixt
121438|NCT02807350|overminus|overminus
121439|NCT02807337|Oral mucositis|oral mucositis
121440|NCT02807311|Malnutrition|malnutrition
121441|NCT02807311|Undernutrition|undernutrition
121442|NCT02807311|lung transplantation|lung transplantation
121443|NCT02807311|artificial nutrition|artificial nutrition
121444|NCT02807311|nutritional supplements|nutritional supplements
121445|NCT02807311|enteral nutrition|enteral nutrition
121446|NCT02807298|Intarligamentary|intarligamentary
121447|NCT02807298|Articaine|articaine
121448|NCT02807298|Lidocaine|lidocaine
121449|NCT02807246|Probiotic|probiotic
121450|NCT02807246|Neonatal Hyperbilirubinemia|neonatal hyperbilirubinemia
121451|NCT02807220|Imuneks|imuneks
121452|NCT02807207|To Study pharmacokinetics and Cardiac safety pacritinib study|to study pharmacokinetics and cardiac safety pacritinib study
121453|NCT02807155|Transitional Care|transitional care
121454|NCT02807155|Young Adult|young adult
121455|NCT02807155|Guided Imagery|guided imagery
121456|NCT02807116|Drug-Interaction Study|drug-interaction study
121457|NCT02807103|Rituximab|rituximab
121458|NCT02807103|remission induction|remission induction
121459|NCT02807103|eosinophilic granulomatosis with polyangiitis|eosinophilic granulomatosis with polyangiitis
121460|NCT02807090|Low Back Pain|low back pain
121461|NCT02807090|Exercise|exercise
121462|NCT02807090|Dance Therapy|dance therapy
121463|NCT02807090|Physical Therapy|physical therapy
121464|NCT02807077|Healthy subjects|healthy subjects
121465|NCT02807038|Respiratory Function Tests|respiratory function tests
121466|NCT02807038|Air pollution|air pollution
121467|NCT02807038|Pregnancy|pregnancy
121468|NCT02807038|Spirometry|spirometry
121469|NCT02807012|Home care services|home care services
121470|NCT02807012|Nursing|nursing
121471|NCT02807012|Clinical trial|clinical trial
121472|NCT02807012|Geriatric nursing|geriatric nursing
121473|NCT02807012|Family caregiver|family caregiver
121474|NCT02807012|Aged|aged
121475|NCT02806999|Heart disease|heart disease
121476|NCT02806999|Postoperative period|postoperative period
121477|NCT02806999|Hyperglycemia|hyperglycemia
121478|NCT02806999|Berberine|berberine
121479|NCT02806999|Insulin|insulin
121480|NCT02806999|Clinical trials as topic|clinical trials as topic
121481|NCT02806947|Acute GVHD|acute gvhd
121482|NCT02806947|Standard-Risk|standard-risk
121483|NCT02806947|Sirolimus|sirolimus
121484|NCT02806947|Refined Minnesota Risk Criteria|refined minnesota risk criteria
121485|NCT02806947|Ann Arbor|ann arbor
121486|NCT02806947|Biomarker|biomarker
121487|NCT02806947|Steroid-Free|steroid-free
121488|NCT02806921|Scleral Contact Lens|scleral contact lens
121489|NCT02806921|Tear Proteases|tear proteases
121490|NCT02806921|Tear Cytokines|tear cytokines
121491|NCT02806908|Driving|driving
121492|NCT02806895|Driving|driving
121493|NCT02806856|Middle Cerebral Artery Stroke|middle cerebral artery stroke
121494|NCT02806856|tDCS|tdcs
121495|NCT02806856|Acute|acute
121496|NCT02806843|stroke|stroke
121497|NCT02806843|hemiplegia|hemiplegia
121498|NCT02806843|healthy|healthy
121499|NCT02806843|robotics|robotics
121500|NCT02806843|rehabilitation|rehabilitation
121501|NCT02806843|therapy|therapy
121502|NCT02806830|Intravitreal injection|intravitreal injection
121503|NCT02806830|AMD|amd
121504|NCT02806830|Diabetic Retinopathy|diabetic retinopathy
121505|NCT02806830|Retinal Artery Occlusion|retinal artery occlusion
121506|NCT02806830|Myopia, Degenerative|myopia, degenerative
121507|NCT02806830|eye drops|eye drops
121508|NCT02806804|vaccine|vaccine
121509|NCT02806804|safety|safety
121510|NCT02806804|immunogenicity|immunogenicity
121511|NCT02806791|Patients|patients
121512|NCT02806778|cardiac arrest|cardiac arrest
121513|NCT02806778|jugular venous oximetry|jugular venous oximetry
121514|NCT02806778|hypoxic brain injury|hypoxic brain injury
121515|NCT02806765|Dynamic Stability|dynamic stability
121516|NCT02806765|Postural Stability|postural stability
121517|NCT02806765|Gait Speed|gait speed
121518|NCT02806765|Hand Grip Strength|hand grip strength
121519|NCT02806765|Timed Get-up and Go|timed get-up and go
121520|NCT02806765|Older Adults|older adults
121521|NCT02806752|Polypoidal Choroidal Vasculopathy|polypoidal choroidal vasculopathy
121522|NCT02806739|Soy protein|soy protein
121523|NCT02806739|isoflavones|isoflavones
121524|NCT02806739|gestational diabetes|gestational diabetes
121525|NCT02806700|Diabetes|diabetes
121526|NCT02806700|Social Media|social media
121527|NCT02806687|Locally advanced pancreatic adenocarcinoma|locally advanced pancreatic adenocarcinoma
121528|NCT02806687|gene therapy|gene therapy
121529|NCT02806687|gemcitabine|gemcitabine
121530|NCT02806687|chemosensitization|chemosensitization
121531|NCT02806674|Helicobacter pylori|helicobacter pylori
121532|NCT02806674|Antibiotic resistance|antibiotic resistance
121533|NCT02806674|Sequencing|sequencing
121534|NCT02806661|Robotic surgery|robotic surgery
121535|NCT02806661|Vagus nerve preserving|vagus nerve preserving
121536|NCT02806635|Relationship Distress|relationship distress
121537|NCT02806635|Relationship Satisfaction|relationship satisfaction
121538|NCT02806635|Marriage|marriage
121539|NCT02806635|Web-based|web-based
121540|NCT02806635|Internet|internet
121541|NCT02806622|Sports|sports
121542|NCT02806622|University|university
121543|NCT02806622|Lower Extremity|lower extremity
121544|NCT02806622|Hip Joint|hip joint
121545|NCT02806609|football|football
121546|NCT02806609|cryotherapy|cryotherapy
121547|NCT02806609|balance|balance
121548|NCT02806609|electromyography|electromyography
121549|NCT02806557|Neoplasms|neoplasms
121550|NCT02806557|Neutropenia|neutropenia
121551|NCT02806557|drug therapy|drug therapy
121552|NCT02806557|Hematologic tests|hematologic tests
121553|NCT02806557|Point-of-care Systems|point-of-care systems
121554|NCT02806557|Febrile neutropenia|febrile neutropenia
121555|NCT02806544|Breast neoplasms|breast neoplasms
121556|NCT02806544|Breast cancer|breast cancer
121557|NCT02806544|Locally advanced breast cancer|locally advanced breast cancer
121558|NCT02806544|Neoadjuvant endocrine therapy|neoadjuvant endocrine therapy
121559|NCT02806544|Tamoxifen|tamoxifen
121560|NCT02806544|Low and middle income country|low and middle income country
121561|NCT02806531|vaccine|vaccine
121562|NCT02806531|safety|safety
121563|NCT02806518|DIEP|diep
121564|NCT02806518|Computed Tomography|computed tomography
121565|NCT02806518|Doppler|doppler
121566|NCT02806518|Thermography|thermography
121567|NCT02806440|Low dose naltrexone|low dose naltrexone
121568|NCT02806440|Pain|pain
121569|NCT02806375|Myelofibrosis|myelofibrosis
121570|NCT02806375|Ruxolitinib|ruxolitinib
121571|NCT02806375|Cyclophosphamide|cyclophosphamide
121572|NCT02806375|Immunosuppressive Agents|immunosuppressive agents
121573|NCT02806375|Immune System Diseases|immune system diseases
121574|NCT02806375|Busulfan|busulfan
121575|NCT02806375|Fludarabine|fludarabine
121576|NCT02806375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
121577|NCT02806375|Myeloablative Agonists|myeloablative agonists
121578|NCT02806375|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
121579|NCT02806375|Allogeneic|allogeneic
121580|NCT02806362|Non-cirrhotic|non-cirrhotic
121581|NCT02806362|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
121582|NCT02806362|moderate fibrosis|moderate fibrosis
121583|NCT02806362|Chronic Hepatitis C Virus ( HCV)|chronic hepatitis c virus ( hcv)
121690|NCT02805660|Mocetinostat|mocetinostat
121584|NCT02806362|Chronic Hepatitis C Genotype 1b|chronic hepatitis c genotype 1b
121585|NCT02806349|American ginseng|american ginseng
121586|NCT02806349|Konjac glucomannan fiber|konjac glucomannan fiber
121587|NCT02806336|exercise training|exercise training
121588|NCT02806336|assistive device|assistive device
121589|NCT02806336|weight loss|weight loss
121590|NCT02806336|function|function
121591|NCT02806336|mobility|mobility
121592|NCT02806310|Aortic Valve|aortic valve
121593|NCT02806310|Bicuspid|bicuspid
121594|NCT02806297|cholecystectomy|cholecystectomy
121595|NCT02806284|vaccination|vaccination
121596|NCT02806284|Streptococcus pneumoniae|streptococcus pneumoniae
121597|NCT02806271|Worry Postponement|worry postponement
121598|NCT02806271|Stimulus Control|stimulus control
121599|NCT02806245|Congenital Heart Disease (CHD)|congenital heart disease (chd)
121600|NCT02806245|Cardiopulmonary Bypass (CPB)|cardiopulmonary bypass (cpb)
121601|NCT02806245|Cardiac Index|cardiac index
121602|NCT02806245|Hemodynamics|hemodynamics
121603|NCT02806245|Pediatrics|pediatrics
121604|NCT02806232|Praziquantel ODT formulation|praziquantel odt formulation
121605|NCT02806232|Biltricide|biltricide
121606|NCT02806219|Bioequivalence|bioequivalence
121607|NCT02806219|Certolizumab pegol|certolizumab pegol
121608|NCT02806219|Human Volunteers|human volunteers
121609|NCT02806193|cardiovascular|cardiovascular
121610|NCT02806193|cardiac|cardiac
121611|NCT02806193|MRI|mri
121612|NCT02806193|CMR|cmr
121613|NCT02806193|CT|ct
121614|NCT02806193|ECG|ecg
121615|NCT02806193|magnetic resonance|magnetic resonance
121616|NCT02806193|imaging|imaging
121617|NCT02806154|Cancer|cancer
121618|NCT02806154|Chemotherapy toxicity|chemotherapy toxicity
121619|NCT02806154|Elderly patients|elderly patients
121620|NCT02806154|DEXA|dexa
121621|NCT02806154|muscle mass|muscle mass
121622|NCT02806141|Aerosolized colistin|aerosolized colistin
121623|NCT02806141|Intravenous colistin|intravenous colistin
121624|NCT02806128|cerebral infarction|cerebral infarction
121625|NCT02806128|kallikrein|kallikrein
121626|NCT02806128|KLK|klk
121627|NCT02806089|chronic kidney disease|chronic kidney disease
121628|NCT02806089|malnutrition inflammation atherogenesis syndrome|malnutrition inflammation atherogenesis syndrome
121629|NCT02806089|muscle strength|muscle strength
121630|NCT02806089|muscle mass|muscle mass
121631|NCT02806089|lean body mass|lean body mass
121632|NCT02806089|physical activity|physical activity
121633|NCT02806076|HCC|hcc
121634|NCT02806076|RFA|rfa
121635|NCT02806063|Prosthesis|prosthesis
121636|NCT02806063|joint infection|joint infection
121637|NCT02806063|perioperative samples|perioperative samples
121638|NCT02806050|FES PET|fes pet
121639|NCT02806050|Palbociclib|palbociclib
121640|NCT02805985|Degenerative Disc Disease|degenerative disc disease
121641|NCT02805985|Spondylolisthesis|spondylolisthesis
121642|NCT02805985|Retrolisthesis|retrolisthesis
121643|NCT02805972|Obesity|obesity
121644|NCT02805972|Binge eating|binge eating
121645|NCT02805868|Severe|severe
121646|NCT02805868|Anemia|anemia
121647|NCT02805868|Aplastic|aplastic
121648|NCT02805868|Post-Polycythemic|post-polycythemic
121649|NCT02805868|Transformation|transformation
121650|NCT02805868|Thrombocythemia|thrombocythemia
121651|NCT02805868|Essential|essential
121652|NCT02805842|non adherence|non adherence
121653|NCT02805842|Tacrolimus|tacrolimus
121654|NCT02805842|Advagraf|advagraf
121655|NCT02805829|NK cells|nk cells
121656|NCT02805829|Trastuzumab|trastuzumab
121657|NCT02805816|Celiac disease|celiac disease
121658|NCT02805816|Tissue transglutaminase|tissue transglutaminase
121659|NCT02805816|Histology|histology
121660|NCT02805790|Primary Mitochondrial Disease|primary mitochondrial disease
121661|NCT02805790|Mitochondrial Myopathy|mitochondrial myopathy
121662|NCT02805790|Elamipretide|elamipretide
121663|NCT02805790|MTP-131|mtp-131
121664|NCT02805790|Bendavia™|bendavia™
121665|NCT02805751|Achilles|achilles
121666|NCT02805751|Tendon|tendon
121667|NCT02805751|Loading|loading
121668|NCT02805751|Rehabilitation|rehabilitation
121669|NCT02805738|Chronic Hepatitis B|chronic hepatitis b
121670|NCT02805738|tenofovir|tenofovir
121671|NCT02805738|CKD-390|ckd-390
121672|NCT02805725|Advanced solid tumor|advanced solid tumor
121673|NCT02805725|Advanced pretreated soft tissue sarcomas|advanced pretreated soft tissue sarcomas
121674|NCT02805725|Phase I/II trial|phase i/ii trial
121675|NCT02805725|Dose escalation|dose escalation
121676|NCT02805725|PK study|pk study
121677|NCT02805712|Heart Failure|heart failure
121678|NCT02805712|Palliative Care|palliative care
121679|NCT02805699|Clinical Efficacy|clinical efficacy
121680|NCT02805699|Baofeikang Granules|baofeikang granules
121681|NCT02805699|Combined Pulmonary Fibrosis and Emphysema|combined pulmonary fibrosis and emphysema
121682|NCT02805686|Toxicity, Drug|toxicity, drug
121683|NCT02805673|Osteopathy|osteopathy
121684|NCT02805673|Support|support
121685|NCT02805673|Treatment|treatment
121686|NCT02805673|Pain|pain
121687|NCT02805673|Quality of Life|quality of life
121688|NCT02805660|MGCD0103|mgcd0103
121689|NCT02805660|MEDI4736|medi4736
121691|NCT02805660|Durvalumab|durvalumab
121692|NCT02805660|HDAC Inhibitor|hdac inhibitor
121693|NCT02805660|PD-L1 Inhibitor|pd-l1 inhibitor
121694|NCT02805660|Phase 1|phase 1
121695|NCT02805660|Phase 2|phase 2
121696|NCT02805660|Metastatic Solid Tumor|metastatic solid tumor
121697|NCT02805660|Non-small cell lung cancer|non-small cell lung cancer
121698|NCT02805660|immunotherapy|immunotherapy
121699|NCT02805660|checkpoint inhibitor|checkpoint inhibitor
121700|NCT02805647|25-Hydroxy-vitamin D, children, bone fractures, vitamin D receptor polymorphism|25-hydroxy-vitamin d, children, bone fractures, vitamin d receptor polymorphism
121701|NCT02805634|nine holes peg|nine holes peg
121702|NCT02805634|triple stimulation|triple stimulation
121703|NCT02805634|multiple sclerosis|multiple sclerosis
121704|NCT02805582|Peripheral Nerve Block|peripheral nerve block
121705|NCT02805569|videolaryngoscope|videolaryngoscope
121706|NCT02805569|intubation stylet|intubation stylet
121707|NCT02805569|articulating stylet|articulating stylet
121708|NCT02805569|difficult airway|difficult airway
121709|NCT02805530|oligometastatic disease, radical treatment|oligometastatic disease, radical treatment
121710|NCT02805517|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
121711|NCT02805517|Transplant Donors|transplant donors
121712|NCT02805504|Bupivacaine|bupivacaine
121713|NCT02805504|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
121714|NCT02805491|Hypospadias|hypospadias
121715|NCT02805491|newborns|newborns
121716|NCT02805491|pesticide|pesticide
121717|NCT02805491|Picardie|picardie
121718|NCT02805465|Heart Failure|heart failure
121719|NCT02805465|Atrial Fibrillation|atrial fibrillation
121721|NCT02805465|BiVP|bivp
121722|NCT02805465|HBP|hbp
121723|NCT02805387|labor dystocia|labor dystocia
121724|NCT02805374|Pharmacokinetics|pharmacokinetics
121725|NCT02805374|ASP1517|asp1517
121726|NCT02805374|Food effect|food effect
121727|NCT02805348|Kiklin|kiklin
121728|NCT02805348|Bixalomer|bixalomer
121729|NCT02805348|Chronic Kidney Disease|chronic kidney disease
121730|NCT02805335|Central Venous Catheter|central venous catheter
121731|NCT02805335|Catheter Bloodstream Related Infection|catheter bloodstream related infection
121732|NCT02805335|Economic evaluation|economic evaluation
121733|NCT02805309|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
121734|NCT02805309|Exercise|exercise
121735|NCT02805309|Frailty|frailty
121736|NCT02805309|Functional Outcomes|functional outcomes
121737|NCT02805309|Cognitive Behavioral Intervention|cognitive behavioral intervention
121738|NCT02805283|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
121739|NCT02805270|adverse drug events, preventable, potential, counselling, medication reconciliation|adverse drug events, preventable, potential, counselling, medication reconciliation
121740|NCT02805244|JTZ-951|jtz-951
121741|NCT02805244|Pharmacokinetics|pharmacokinetics
121742|NCT02805244|14C-JTZ-951|14c-jtz-951
121743|NCT02805244|Mass balance|mass balance
121744|NCT02805244|Time course|time course
121745|NCT02805205|PEG-rhG-CSF neutropenia|peg-rhg-csf neutropenia
121746|NCT02805192|Emergency Department|emergency department
121747|NCT02805192|Estimation of age and weight|estimation of age and weight
121748|NCT02805192|Size measurement|size measurement
121749|NCT02805166|PEG-rhG-CSF|peg-rhg-csf
121750|NCT02805153|PEG-rhG-CSF|peg-rhg-csf
121751|NCT02805140|mother|mother
121752|NCT02805140|social support|social support
121753|NCT02805140|mobile app|mobile app
121754|NCT02805140|videoconference|videoconference
121755|NCT02805140|sedentary|sedentary
121756|NCT02805140|physical activity|physical activity
121757|NCT02805127|Asthma|asthma
121758|NCT02805127|COPD|copd
121759|NCT02805127|Capnography|capnography
121760|NCT02805114|Asthma|asthma
121761|NCT02805114|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
121762|NCT02805114|Capnography|capnography
121763|NCT02805062|Trapped Lung|trapped lung
121764|NCT02805036|alveolar recruitment|alveolar recruitment
121765|NCT02805036|stroke volume/physiology|stroke volume/physiology
121766|NCT02805036|cardiac output/physiology|cardiac output/physiology
121767|NCT02804997|non-invasive ventilation|non-invasive ventilation
121768|NCT02804997|cardiac surgery|cardiac surgery
121769|NCT02804984|idiopathic cytopenia of undetermined significance (ICUS)|idiopathic cytopenia of undetermined significance (icus)
121770|NCT02804984|molecular defects|molecular defects
121771|NCT02804958|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
121772|NCT02804958|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
121773|NCT02804958|Clinical outcomes|clinical outcomes
121774|NCT02804945|Blood And Marrow Transplantation|blood and marrow transplantation
121775|NCT02804945|Adult Respiratory Distress Syndrome|adult respiratory distress syndrome
121776|NCT02804945|ARDS|ards
121777|NCT02804945|Allogeneic human mesenchymal stem cells|allogeneic human mesenchymal stem cells
121778|NCT02804945|hMSCs|hmscs
121779|NCT02804945|Placebo|placebo
121780|NCT02804945|Plasma-Lyte A solution|plasma-lyte a solution
121781|NCT02804945|Standard of Care|standard of care
121782|NCT02804945|Recent onset pulmonary toxicity|recent onset pulmonary toxicity
121783|NCT02804893|Lung cancer, video-assisted thoracoscopic surgery, robotic-assisted thoracoscopic surgery|lung cancer, video-assisted thoracoscopic surgery, robotic-assisted thoracoscopic surgery
121784|NCT02804880|Smoking cessation|smoking cessation
121785|NCT02804880|Quit to Win|quit to win
121786|NCT02804880|Brief intervention|brief intervention
121787|NCT02804880|Personalized active referral|personalized active referral
121788|NCT02804880|Instant messaging|instant messaging
121789|NCT02804880|SMS|sms
121790|NCT02804880|Smoking Cessation Intervention|smoking cessation intervention
121791|NCT02804841|Vitamin D supplementation|vitamin d supplementation
121792|NCT02804841|Cognitive function|cognitive function
121793|NCT02804841|Physical function|physical function
121794|NCT02804841|Successful ageing|successful ageing
121795|NCT02804841|Prevention|prevention
121796|NCT02804841|Cholecalciferol|cholecalciferol
121797|NCT02804841|Dementia|dementia
121798|NCT02804841|Muscle mass|muscle mass
121799|NCT02804815|Aspirin|aspirin
121800|NCT02804815|prostate|prostate
121801|NCT02804815|colorectal|colorectal
121802|NCT02804815|breast|breast
121803|NCT02804815|gastro-oesophageal|gastro-oesophageal
121804|NCT02804815|recurrence|recurrence
121805|NCT02804789|Prevention|prevention
121806|NCT02804763|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
121807|NCT02804763|Dapirolizumab Pegol (DZP)|dapirolizumab pegol (dzp)
121808|NCT02804750|Cushing's Syndrome|cushing's syndrome
121809|NCT02804750|Cushing's Disease|cushing's disease
121810|NCT02804750|Cushings|cushings
121811|NCT02804750|Hypercortisolemia|hypercortisolemia
121812|NCT02804750|Cushingoid|cushingoid
121813|NCT02804750|Type 2 Diabetes|type 2 diabetes
121814|NCT02804750|Impaired Glucose Intolerance|impaired glucose intolerance
121815|NCT02804750|Hypertension|hypertension
121816|NCT02804750|Adrenal Corticotrophic Hormone (ACTH)|adrenal corticotrophic hormone (acth)
121817|NCT02804750|Adrenocortical Carcinoma|adrenocortical carcinoma
121818|NCT02804750|Primary Pigmented Nodular Adrenal Disease (PPNAD)|primary pigmented nodular adrenal disease (ppnad)
121819|NCT02804750|Moon Facies|moon facies
121820|NCT02804750|Dorsocervical Fat Pad|dorsocervical fat pad
121821|NCT02804750|Adrenal Adenoma|adrenal adenoma
121822|NCT02804750|Adrenal Carcinoma|adrenal carcinoma
121823|NCT02804750|Adrenal Autonomy|adrenal autonomy
121824|NCT02804750|Cortisol|cortisol
121825|NCT02804724|HIV|hiv
121826|NCT02804724|Human immunodeficiency virus|human immunodeficiency virus
121827|NCT02804724|Late diagnosis|late diagnosis
121828|NCT02804672|Cardiovascular health|cardiovascular health
121829|NCT02804672|Diet|diet
121830|NCT02804672|Functional limitations|functional limitations
121831|NCT02804672|Frailty|frailty
121832|NCT02804672|Older adults|older adults
121833|NCT02804659|micro-RNA|micro-rna
121834|NCT02804646|Recombinant human endostatin(Endostar)|recombinant human endostatin(endostar)
121835|NCT02804646|Durative transfusion|durative transfusion
121836|NCT02804646|adenocarcinoma of lung|adenocarcinoma of lung
121837|NCT02804633|IV acetaminophen|iv acetaminophen
121838|NCT02804633|Colorectal Surgery|colorectal surgery
121839|NCT02804633|Enhance Recovery|enhance recovery
121840|NCT02804633|Opioid Consumption|opioid consumption
121841|NCT02804633|Pain Management|pain management
121842|NCT02804607|burn|burn
121843|NCT02804607|child|child
121844|NCT02804607|graft|graft
121845|NCT02804607|development|development
121846|NCT02804607|complications|complications
121847|NCT02804607|autonomy|autonomy
121848|NCT02804568|Schizophrenia|schizophrenia
121849|NCT02804568|Alkermes|alkermes
121850|NCT02804568|ALK 3831|alk 3831
121851|NCT02804568|Samidorphan|samidorphan
121852|NCT02804555|reactive oxygen species|reactive oxygen species
121853|NCT02804555|elective cesarean section|elective cesarean section
121854|NCT02804555|oxygen therapy|oxygen therapy
121855|NCT02804555|newborn|newborn
121856|NCT02804542|fascia iliaca blocks|fascia iliaca blocks
121857|NCT02804529|Laparoscopic entry|laparoscopic entry
121858|NCT02804529|Meng's point|meng's point
121859|NCT02804529|Veress needle|veress needle
121860|NCT02804477|adherence|adherence
121861|NCT02804477|opioid|opioid
121862|NCT02804477|MMAS 8, morisky medication adherence scale|mmas 8, morisky medication adherence scale
121863|NCT02804477|validation|validation
121864|NCT02804425|Medical Education|medical education
121865|NCT02804425|Simulation|simulation
121866|NCT02804425|Anesthesia crisis management|anesthesia crisis management
121867|NCT02804425|Learning outcomes|learning outcomes
121868|NCT02804412|communication disorders|communication disorders
121869|NCT02804412|language and speech disorder rehabilitation|language and speech disorder rehabilitation
121870|NCT02804412|stroke|stroke
121871|NCT02804399|rifampin|rifampin
121872|NCT02804399|pharmacokinetics|pharmacokinetics
121873|NCT02804399|PF-06463922|pf-06463922
121874|NCT02804399|drug interaction|drug interaction
121875|NCT02804386|HCV|hcv
121876|NCT02804386|safety|safety
121877|NCT02804386|efficacy|efficacy
121878|NCT02804386|EVR|evr
121879|NCT02804386|SVR|svr
121880|NCT02804373|oxytocin|oxytocin
121881|NCT02804373|adults|adults
121882|NCT02804347|Olfactory Dysfunction|olfactory dysfunction
121883|NCT02804347|Electroconvulsive Therapy|electroconvulsive therapy
121884|NCT02804347|Theta Burst Stimulation|theta burst stimulation
122183|NCT02802423|TNBC|tnbc
121885|NCT02804321|catheter ablation|catheter ablation
121886|NCT02804321|galectin 3|galectin 3
121887|NCT02804321|ngal|ngal
121888|NCT02804321|aldosterone|aldosterone
121889|NCT02804321|atrial fibrillation|atrial fibrillation
121890|NCT02804308|Combined Training|combined training
121891|NCT02804308|Breast Cancer|breast cancer
121892|NCT02804308|Body Composition|body composition
121893|NCT02804308|Postmenopausal Women|postmenopausal women
121894|NCT02804308|Aromatase Inhibitors|aromatase inhibitors
121895|NCT02804308|Quality of life|quality of life
121896|NCT02804295|Prescription Drug|prescription drug
121897|NCT02804295|Misuse|misuse
121898|NCT02804269|Healthy Volunteer|healthy volunteer
121899|NCT02804269|Dilated cardiomyopathy|dilated cardiomyopathy
121900|NCT02804269|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
121901|NCT02804269|ischemic heart disease|ischemic heart disease
121902|NCT02804269|Cardiovascular Magnetic Resonance Imaging|cardiovascular magnetic resonance imaging
121903|NCT02804243|nasal high flow therapy|nasal high flow therapy
121904|NCT02804243|rehabilitation|rehabilitation
121905|NCT02804243|exercise endurance|exercise endurance
121906|NCT02804178|ATR-101|atr-101
121907|NCT02804178|classic congenital adrenal hyperplasia|classic congenital adrenal hyperplasia
121908|NCT02804178|21-hydroxylase deficiency|21-hydroxylase deficiency
121909|NCT02804178|CAH|cah
121910|NCT02804165|Type 1 diabetes|type 1 diabetes
121911|NCT02804165|Enterovirus|enterovirus
121912|NCT02804165|Genetics|genetics
121913|NCT02804165|Gene-Virus interaction|gene-virus interaction
121914|NCT02804152|pregnancy|pregnancy
121915|NCT02804152|pain|pain
121916|NCT02804152|prescription opioid|prescription opioid
121917|NCT02804139|Cesarean Section|cesarean section
121918|NCT02804139|Postpartum issues|postpartum issues
121919|NCT02804126|acute pain|acute pain
121920|NCT02804126|transversus abdominis plane block|transversus abdominis plane block
121921|NCT02804126|quadratus lumborum block|quadratus lumborum block
121922|NCT02804126|neuropathic pain|neuropathic pain
121923|NCT02804100|Circulating Tumor DNA|circulating tumor dna
121924|NCT02804100|Lung cancer|lung cancer
121925|NCT02804100|Plasma DNA|plasma dna
121926|NCT02804061|nutrition|nutrition
121927|NCT02804061|exercise|exercise
121928|NCT02804061|behavior change|behavior change
121929|NCT02804061|adherence|adherence
121930|NCT02804048|Dyspareunia|dyspareunia
121931|NCT02804048|Pelvic floor muscles|pelvic floor muscles
121932|NCT02804048|Women|women
121933|NCT02804022|Respiratory Depression|respiratory depression
121934|NCT02804009|anxiety|anxiety
121935|NCT02804009|coronary angiography|coronary angiography
121936|NCT02803957|Degenerative|degenerative
121937|NCT02803957|Mitral Regurgitation|mitral regurgitation
121938|NCT02803944|azithromycin|azithromycin
121939|NCT02803944|cystic fibrosis|cystic fibrosis
121940|NCT02803944|pulmonary function|pulmonary function
121941|NCT02803931|Cardiogoniometry|cardiogoniometry
121942|NCT02803931|Electrocardiography|electrocardiography
121943|NCT02803879|cardiac resynchronisation therapy|cardiac resynchronisation therapy
121944|NCT02803879|cardiogoniometry|cardiogoniometry
121945|NCT02803866|Parenting Self-efficacy|parenting self-efficacy
121946|NCT02803866|Parent training program|parent training program
121947|NCT02803866|Perceived self-efficacy tool|perceived self-efficacy tool
121948|NCT02803853|Native American|native american
121949|NCT02803853|Obesity|obesity
121950|NCT02803853|Multi level|multi level
121951|NCT02803853|Policy|policy
121952|NCT02803853|Schools|schools
121953|NCT02803853|Worksite|worksite
121954|NCT02803853|Social Media|social media
121955|NCT02803853|Food Store|food store
121956|NCT02803840|Large B-Cell|large b-cell
121957|NCT02803840|Diffuse|diffuse
121958|NCT02803827|diarrhoea|diarrhoea
121959|NCT02803827|gastroenteritis|gastroenteritis
121960|NCT02803827|rapid diagnostics|rapid diagnostics
121961|NCT02803827|probiotics|probiotics
121962|NCT02803814|Pancreatoduodenectomy|pancreatoduodenectomy
121963|NCT02803814|Pancreatic tumors|pancreatic tumors
121964|NCT02803814|Periampullary tumors|periampullary tumors
121965|NCT02803801|Parents' ability to guide their child|parents' ability to guide their child
121966|NCT02803801|Parent perception of competence|parent perception of competence
121967|NCT02803801|Parent understanding of their child's unique learning style|parent understanding of their child's unique learning style
121968|NCT02803788|ramosetron, ondansetron, dexamethasone,|ramosetron, ondansetron, dexamethasone,
121969|NCT02803762|ADME|adme
121970|NCT02803762|Pacritinib|pacritinib
121971|NCT02803671|preterm neonates|preterm neonates
121972|NCT02803671|EEG-NIRS|eeg-nirs
121973|NCT02803658|smoking|smoking
121974|NCT02803645|healthy subjects|healthy subjects
121975|NCT02803645|cardiovascular risk factors|cardiovascular risk factors
121976|NCT02803645|markers of arterial inflammation|markers of arterial inflammation
121977|NCT02803645|markers of oxidative stress|markers of oxidative stress
121978|NCT02803632|young|young
121979|NCT02803632|disruptive mood dysregulation disorder|disruptive mood dysregulation disorder
121980|NCT02803632|actigraphic profile|actigraphic profile
121981|NCT02803619|Non-small cell lung cancer|non-small cell lung cancer
121982|NCT02803619|leptomeningeal metastasis|leptomeningeal metastasis
121983|NCT02803619|EGFR sensitive mutations|egfr sensitive mutations
121984|NCT02803606|hypothermia|hypothermia
121985|NCT02803606|routine care|routine care
121986|NCT02803606|preterm neonates|preterm neonates
121987|NCT02803593|a technology-based intervention|a technology-based intervention
121988|NCT02803593|Asian American|asian american
121989|NCT02803593|survivorship|survivorship
121990|NCT02803541|chronic kidney disease|chronic kidney disease
121991|NCT02803541|exercise|exercise
121992|NCT02803541|pediatrics|pediatrics
121993|NCT02803541|summer camp|summer camp
121994|NCT02803515|intra peritonal chemo hyperthermia|intra peritonal chemo hyperthermia
121995|NCT02803515|peritoneal carcinomatosis|peritoneal carcinomatosis
121996|NCT02803515|ovarian cancer|ovarian cancer
121997|NCT02803502|thrombin generation test|thrombin generation test
121998|NCT02803502|factor VIII|factor viii
121999|NCT02803502|hemophilia|hemophilia
122000|NCT02803489|chronic heart failure|chronic heart failure
122001|NCT02803489|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
122002|NCT02803489|diabetes|diabetes
122003|NCT02803476|PCO|pco
122004|NCT02803476|Vitamin D|vitamin d
122005|NCT02803476|Insulin resistance|insulin resistance
122006|NCT02803463|peritoneal closure|peritoneal closure
122007|NCT02803463|appendectomy|appendectomy
122008|NCT02803463|postoperative pain|postoperative pain
122009|NCT02803463|life quality|life quality
122010|NCT02803450|Effects of; Anesthesia|effects of; anesthesia
122011|NCT02803450|spinal and epidural|spinal and epidural
122012|NCT02803437|Castration-resistant prostate cancer|castration-resistant prostate cancer
122013|NCT02803424|robot-assisted laparoscopic radical prostatectomy|robot-assisted laparoscopic radical prostatectomy
122014|NCT02803424|Autoflow|autoflow
122015|NCT02803424|trendelenburg position|trendelenburg position
122016|NCT02803424|pneumoperitoneum|pneumoperitoneum
122017|NCT02803411|Coronary Heart Disease|coronary heart disease
122271|NCT02801955|gastric adenocarcinoma|gastric adenocarcinoma
122018|NCT02803411|Coronary Computed Tomography Angiography (CCTA)|coronary computed tomography angiography (ccta)
122019|NCT02803411|Coronary Atherosclerotic Plaque|coronary atherosclerotic plaque
122020|NCT02803411|coronary atherosclerosis|coronary atherosclerosis
122021|NCT02803398|Compression bandages|compression bandages
122022|NCT02803385|Patient Controlled Epidural Analgesia|patient controlled epidural analgesia
122023|NCT02803385|Continous Epidural Infusion Analgesia|continous epidural infusion analgesia
122024|NCT02803372|partial nephrectomy|partial nephrectomy
122025|NCT02803372|acute kidney injury|acute kidney injury
122026|NCT02803372|LiDCOrapid|lidcorapid
122027|NCT02803372|circulatory management|circulatory management
122028|NCT02803359|Laryngeal evoked brainstem response (LEBR)|laryngeal evoked brainstem response (lebr)
122029|NCT02803359|laryngopharyngeal sensory discrimination testing (LPSDT)|laryngopharyngeal sensory discrimination testing (lpsdt)
122030|NCT02803359|brainstem activity|brainstem activity
122031|NCT02803346|sepsis|sepsis
122032|NCT02803346|septic shock|septic shock
122033|NCT02803346|immunosuppression|immunosuppression
122034|NCT02803346|HLA-DR|hla-dr
122035|NCT02803346|lymphopenia|lymphopenia
122036|NCT02803333|NSCLC|nsclc
122037|NCT02803333|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
122038|NCT02803333|Lung Diseases|lung diseases
122039|NCT02803333|Thoracic Neoplasms|thoracic neoplasms
122040|NCT02803320|Sunscreen active|sunscreen active
122041|NCT02803307|osteoarthritis of the knee|osteoarthritis of the knee
122042|NCT02803307|TLC599|tlc599
122043|NCT02803307|Dexamethasone|dexamethasone
122044|NCT02803307|DSP|dsp
122045|NCT02803255|Injuries|injuries
122046|NCT02803255|Spinal Cord|spinal cord
122047|NCT02803242|copd|copd
122048|NCT02803242|emphysema|emphysema
122049|NCT02803242|bronchitis|bronchitis
122050|NCT02803242|bronchiectasis|bronchiectasis
122051|NCT02803203|Osimertinib|osimertinib
122052|NCT02803203|bevacizumab|bevacizumab
122053|NCT02803203|metastatic|metastatic
122054|NCT02803203|16-033|16-033
122055|NCT02803190|Spine curve|spine curve
122056|NCT02803190|Posture|posture
122057|NCT02803190|Fracture|fracture
122058|NCT02803190|sarcopenia|sarcopenia
122059|NCT02803190|Exercise|exercise
122060|NCT02803177|large bone defect|large bone defect
122061|NCT02803177|bone marrow-derived mononuclear cells|bone marrow-derived mononuclear cells
122062|NCT02803151|Stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
122063|NCT02803151|Lymph node metastasis|lymph node metastasis
122064|NCT02803151|T cell immunity|t cell immunity
122065|NCT02803151|cell-free DNA|cell-free dna
122066|NCT02803138|Chronic Hepatitis C|chronic hepatitis c
122067|NCT02803138|Paritaprevir/r - Ombitasvir, ± Dasabuvir|paritaprevir/r - ombitasvir, ± dasabuvir
122068|NCT02803138|Sustained Virological Response|sustained virological response
122069|NCT02803138|Observational Study|observational study
122070|NCT02803138|Chronic Hepatitis C genotype 1|chronic hepatitis c genotype 1
122071|NCT02803138|Chronic Hepatitis C genotype 4|chronic hepatitis c genotype 4
122072|NCT02803125|PTSD|ptsd
122073|NCT02803125|Aging|aging
122074|NCT02803125|Veteran|veteran
122075|NCT02803125|Intervention|intervention
122076|NCT02803086|Prostate cancer|prostate cancer
122077|NCT02803086|Radiotherapy|radiotherapy
122078|NCT02803086|Hematopoietic stem cells|hematopoietic stem cells
122079|NCT02803086|Radiotoxicity|radiotoxicity
122080|NCT02802982|Thrombocytopenia|thrombocytopenia
122081|NCT02802982|Neonates|neonates
122082|NCT02802956|Life participation|life participation
122083|NCT02802943|CLL, Peptid Vaccination|cll, peptid vaccination
122084|NCT02802917|Eye stinging potential|eye stinging potential
122085|NCT02802904|Healthy subjects|healthy subjects
122086|NCT02802891|Asthma|asthma
122087|NCT02802891|Allergy|allergy
122088|NCT02802891|Diagnosis|diagnosis
122089|NCT02802891|Endocrine disruptors|endocrine disruptors
122090|NCT02802891|Children|children
122091|NCT02802839|Virtual Reality|virtual reality
122092|NCT02802839|venipuncture|venipuncture
122093|NCT02802826|Exercise|exercise
122094|NCT02802826|Chemotherapy|chemotherapy
122095|NCT02802826|Physical Activity|physical activity
122096|NCT02802826|Breast Cancer|breast cancer
122097|NCT02802813|Single-blinded controlled trial|single-blinded controlled trial
122098|NCT02802813|Primaquine|primaquine
122099|NCT02802787|Quality of life|quality of life
122100|NCT02802787|Occupation|occupation
122101|NCT02802787|Pain|pain
122102|NCT02802787|Fatigue|fatigue
122103|NCT02802774|Post-operative treatment|post-operative treatment
122104|NCT02802748|Early Breast Cancer|early breast cancer
122105|NCT02802748|Hormone Receptor-positive|hormone receptor-positive
122106|NCT02802748|Window-of-opportunity|window-of-opportunity
122107|NCT02802748|PAM50|pam50
122108|NCT02802748|Luminal A|luminal a
122109|NCT02802748|Luminal B|luminal b
122110|NCT02802748|proliferation signature|proliferation signature
122111|NCT02802748|metronomic vinorelbine|metronomic vinorelbine
122112|NCT02802748|letrozole|letrozole
122113|NCT02802735|Pharmacokinetics|pharmacokinetics
122114|NCT02802735|Apremilast|apremilast
122115|NCT02802735|Healthy Adult Male|healthy adult male
122116|NCT02802735|Korean Subjects|korean subjects
122117|NCT02802722|convalescence|convalescence
122118|NCT02802722|inflammation|inflammation
122119|NCT02802722|resolution|resolution
122120|NCT02802722|vitamin D|vitamin d
122121|NCT02802709|knee|knee
122122|NCT02802696|Transfusion|transfusion
122123|NCT02802696|Transfusion Medicine|transfusion medicine
122124|NCT02802696|Diuretic|diuretic
122125|NCT02802683|Hypotension|hypotension
122126|NCT02802683|cesarean section|cesarean section
122127|NCT02802657|Age-related Macular Degeneration|age-related macular degeneration
122128|NCT02802657|Conbercept|conbercept
122129|NCT02802657|Treat-and-Extend Regimen|treat-and-extend regimen
122130|NCT02802657|Pro Re Nata|pro re nata
122131|NCT02802631|Bacterial infections|bacterial infections
122132|NCT02802618|Validity|validity
122133|NCT02802618|Reliability|reliability
122134|NCT02802618|Rehabilitation|rehabilitation
122135|NCT02802618|Translation|translation
122136|NCT02802618|Education|education
122137|NCT02802579|obesity|obesity
122138|NCT02802579|dual source CT|dual source ct
122139|NCT02802579|coronary CT angiography|coronary ct angiography
122140|NCT02802579|prognosis|prognosis
122141|NCT02802579|bariatric surgery|bariatric surgery
122142|NCT02802579|gastric bypass surgery|gastric bypass surgery
122143|NCT02802579|coronary arterial disease|coronary arterial disease
122144|NCT02802579|major adverse coronary event|major adverse coronary event
122145|NCT02802566|Maternal Obesity|maternal obesity
122146|NCT02802566|Inflammation|inflammation
122147|NCT02802553|SmartGoggles|smartgoggles
122148|NCT02802553|sentinel lymph nodes|sentinel lymph nodes
122149|NCT02802553|indocyanine green|indocyanine green
122150|NCT02802553|Cardio-Green|cardio-green
122151|NCT02802553|Spy Elite|spy elite
122152|NCT02802540|nabilone|nabilone
122153|NCT02802540|anorexia|anorexia
122154|NCT02802540|Non-Small Cell Lung Cancer|non-small cell lung cancer
122155|NCT02802514|Gastrointestinal|gastrointestinal
122156|NCT02802514|Glucagon like peptide|glucagon like peptide
122157|NCT02802514|Nausea|nausea
122158|NCT02802514|Magnetic resonance imaging|magnetic resonance imaging
122159|NCT02802501|Safety|safety
122160|NCT02802501|Artemisinin Combination Therapy|artemisinin combination therapy
122161|NCT02802501|Efficacy|efficacy
122162|NCT02802501|Tafenoquine|tafenoquine
122163|NCT02802501|Superiority|superiority
122164|NCT02802501|Primaquine|primaquine
122165|NCT02802501|Radical cure|radical cure
122166|NCT02802501|Vivax|vivax
122168|NCT02802501|Plasmodium vivax malaria|plasmodium vivax malaria
122169|NCT02802501|Dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
122170|NCT02802488|D-dimers|d-dimers
122171|NCT02802488|Atrial fibrillation|atrial fibrillation
122172|NCT02802475|antibodies|antibodies
122173|NCT02802475|auto-immune encephalitis|auto-immune encephalitis
122174|NCT02802475|epilepsy|epilepsy
122175|NCT02802475|limbic encephalitis|limbic encephalitis
122176|NCT02802462|endothelial progenitor cell|endothelial progenitor cell
122177|NCT02802462|hemodynamic|hemodynamic
122178|NCT02802462|Exercise|exercise
122179|NCT02802462|HIIT|hiit
122180|NCT02802449|Vitamin D|vitamin d
122181|NCT02802449|Hypovitaminosis D|hypovitaminosis d
122182|NCT02802449|HTN|htn
122184|NCT02802423|Breast cancer|breast cancer
122185|NCT02802423|Triple negative|triple negative
122186|NCT02802397|Early ovarian reserve decreased|early ovarian reserve decreased
122187|NCT02802384|Paget's Disease of Bone|paget's disease of bone
122188|NCT02802384|Healthy controls|healthy controls
122189|NCT02802371|caregiver burden|caregiver burden
122190|NCT02802371|Alzheimer disease and related disorders|alzheimer disease and related disorders
122191|NCT02802371|elderly|elderly
122192|NCT02802371|pharmaceutical care|pharmaceutical care
122193|NCT02802371|optimization of drug prescribing|optimization of drug prescribing
122194|NCT02802371|psychosocial intervention|psychosocial intervention
122195|NCT02802358|Falls|falls
122196|NCT02802358|Functionality|functionality
122197|NCT02802332|neonatal|neonatal
122198|NCT02802332|preterm|preterm
122199|NCT02802332|Nepal|nepal
122200|NCT02802332|family-initiated identification|family-initiated identification
122201|NCT02802332|basic newborn care|basic newborn care
122202|NCT02802306|Angioplasty|angioplasty
122203|NCT02802306|Peripheral Artery Disease|peripheral artery disease
122204|NCT02802306|PAD|pad
122205|NCT02802306|Lesion|lesion
122206|NCT02802306|Claudication|claudication
122207|NCT02802293|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
122208|NCT02802293|Major Depressive Disorder|major depressive disorder
122209|NCT02802280|endothelial dysfunction|endothelial dysfunction
122210|NCT02802254|physical activity|physical activity
122211|NCT02802254|patient feedback|patient feedback
122212|NCT02802254|risk perception|risk perception
122213|NCT02802254|pedometer|pedometer
122214|NCT02802215|Diabetes Mellitus|diabetes mellitus
122215|NCT02802215|Pregnancy|pregnancy
122216|NCT02802202|Palpation|palpation
122217|NCT02802202|Chronic Pain|chronic pain
122218|NCT02802202|Muscle|muscle
122219|NCT02802189|Chronic Mechanical Neck Pain|chronic mechanical neck pain
122220|NCT02802189|exercise|exercise
122221|NCT02802189|Integrated Neuromuscular Inhibition Technique|integrated neuromuscular inhibition technique
122222|NCT02802163|untreated multiple myeloma|untreated multiple myeloma
122223|NCT02802163|newly diagnosed myeloma|newly diagnosed myeloma
122224|NCT02802163|transplant eligible|transplant eligible
122225|NCT02802150|Zanthoxylum schinifolium seed Oil|zanthoxylum schinifolium seed oil
122226|NCT02802150|soy bean oil|soy bean oil
122227|NCT02802150|omega-3 fatty acid|omega-3 fatty acid
122228|NCT02802150|dry eye disease|dry eye disease
122229|NCT02802137|tafluprost|tafluprost
122230|NCT02802137|dorzolamide|dorzolamide
122231|NCT02802137|timolol|timolol
122232|NCT02802137|FC|fc
122233|NCT02802124|hepatocellular carcinoma|hepatocellular carcinoma
122234|NCT02802124|carbon-ion radiotherapy|carbon-ion radiotherapy
122235|NCT02802124|toxicity|toxicity
122236|NCT02802124|efficacy|efficacy
122237|NCT02802111|Beta Agonists|beta agonists
122238|NCT02802111|Asthma|asthma
122239|NCT02802111|Albuterol|albuterol
122240|NCT02802111|Levalbuterol|levalbuterol
122241|NCT02802098|Metastatic breast cancer|metastatic breast cancer
122242|NCT02802098|bevacizumab maintenance|bevacizumab maintenance
122243|NCT02802098|Durvalumab|durvalumab
122244|NCT02802085|Total Knee Arthroplasty|total knee arthroplasty
122245|NCT02802085|Total Knee Replacement|total knee replacement
122246|NCT02802085|TKA|tka
122247|NCT02802085|TKR|tkr
122248|NCT02802085|Stiffness of Knee|stiffness of knee
122249|NCT02802085|Deformity|deformity
122250|NCT02802085|Knee Joint|knee joint
122251|NCT02802085|Instability|instability
122252|NCT02802085|Post-traumatic|post-traumatic
122253|NCT02802085|Arthrosis|arthrosis
122254|NCT02802046|FFRCT|ffrct
122255|NCT02802046|Angina pectoris grade|angina pectoris grade
122256|NCT02802046|Fractional flow reserve|fractional flow reserve
122257|NCT02802046|CCTA|ccta
122258|NCT02802033|Registry|registry
122259|NCT02802033|Spine|spine
122260|NCT02802033|Osteobiologics|osteobiologics
122261|NCT02802033|Spinal Fusion|spinal fusion
122262|NCT02801994|Patient-ventilator interaction|patient-ventilator interaction
122263|NCT02801994|Inspiratory muscles|inspiratory muscles
122264|NCT02801994|Electromyogram|electromyogram
122265|NCT02801994|Mechanical ventilation|mechanical ventilation
122266|NCT02801994|Proportional Assist Ventilation|proportional assist ventilation
122267|NCT02801981|tolerability|tolerability
122268|NCT02801981|healthy volunteers|healthy volunteers
122269|NCT02801981|Cholestasis|cholestasis
122270|NCT02801981|safety|safety
122272|NCT02801955|tumor markers|tumor markers
122273|NCT02801955|peritoneal cytology|peritoneal cytology
122274|NCT02801942|Biomarker|biomarker
122275|NCT02801942|Immune Profile|immune profile
122276|NCT02801942|Biopsy|biopsy
122277|NCT02801942|Leukocyte subsets|leukocyte subsets
122278|NCT02801942|Inguinal lymph nodes|inguinal lymph nodes
122279|NCT02801942|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
122280|NCT02801916|Humans|humans
122281|NCT02801916|Glycemic response|glycemic response
122282|NCT02801916|Oat beta-glucan|oat beta-glucan
122283|NCT02801877|Depression|depression
122284|NCT02801877|Anxiety|anxiety
122285|NCT02801877|Behavior Therapy|behavior therapy
122286|NCT02801877|Technology Assisted|technology assisted
122287|NCT02801877|Mobile Phone|mobile phone
122288|NCT02801877|Cellular Phone|cellular phone
122289|NCT02801877|Smartphone|smartphone
122290|NCT02801877|App|app
122291|NCT02801877|Coach|coach
122292|NCT02801864|tDCS|tdcs
122293|NCT02801864|transcranial direct current stimulation|transcranial direct current stimulation
122294|NCT02801864|intensive speech therapy|intensive speech therapy
122295|NCT02801864|chronic|chronic
122296|NCT02801864|post stroke|post stroke
122297|NCT02801864|aphasia|aphasia
122298|NCT02801864|production|production
122299|NCT02801864|language|language
122300|NCT02801851|Delirium|delirium
122301|NCT02801838|Inspiratory muscles|inspiratory muscles
122302|NCT02801838|Patient-ventilator interaction|patient-ventilator interaction
122303|NCT02801838|Electromyogram|electromyogram
122304|NCT02801838|Mechanical ventilation|mechanical ventilation
122305|NCT02801825|axillay artery|axillay artery
122306|NCT02801825|cannulation|cannulation
122307|NCT02801825|femoral artery|femoral artery
122308|NCT02801812|Nailfold Capillaroscopy|nailfold capillaroscopy
122309|NCT02801799|Anaesthesia|anaesthesia
122310|NCT02801799|Analgesia|analgesia
122311|NCT02801799|Nerve blocks|nerve blocks
122312|NCT02801799|Peripheral nerve blocks|peripheral nerve blocks
122313|NCT02801799|Regional anaesthesia|regional anaesthesia
122314|NCT02801799|therapeutic techniques|therapeutic techniques
122315|NCT02801799|ropivacaine|ropivacaine
122316|NCT02801799|nerve block duration|nerve block duration
122317|NCT02801799|lower limb|lower limb
122318|NCT02801799|Postoperative pain|postoperative pain
122319|NCT02801786|Mammography|mammography
122320|NCT02801786|Premedication|premedication
122321|NCT02801786|Pain|pain
122322|NCT02801786|Discomfort|discomfort
122323|NCT02801786|Breast|breast
122324|NCT02801773|gingivitis|gingivitis
122325|NCT02801773|probiotic|probiotic
122326|NCT02801773|non- surgical treatment|non- surgical treatment
122327|NCT02801760|HIV|hiv
122328|NCT02801760|Self-Consent|self-consent
122329|NCT02801760|PrEP|prep
122330|NCT02801760|Autonomous Research Consent|autonomous research consent
122331|NCT02801760|Participation-associated Outcomes|participation-associated outcomes
122332|NCT02801747|HIV care continuum|hiv care continuum
122333|NCT02801747|antiretroviral therapy|antiretroviral therapy
122334|NCT02801747|engagement in HIV care|engagement in hiv care
122335|NCT02801747|Multiphase Optimization Strategy (MOST)|multiphase optimization strategy (most)
122336|NCT02801708|Embolic stroke of undetermined source|embolic stroke of undetermined source
122337|NCT02801708|Atrial fibrillation|atrial fibrillation
122338|NCT02801695|pre-eclampsia|pre-eclampsia
122339|NCT02801695|citrulline|citrulline
122340|NCT02801695|pregnancy|pregnancy
122341|NCT02801669|anticoagulants|anticoagulants
122342|NCT02801669|DU-176b|du-176b
122343|NCT02801669|edoxaban|edoxaban
122344|NCT02801669|factor Xa|factor xa
122345|NCT02801669|oral|oral
122346|NCT02801669|prevention|prevention
122347|NCT02801669|atrial fibrillation|atrial fibrillation
122348|NCT02801643|PET|pet
122349|NCT02801643|dopamine|dopamine
122350|NCT02801643|fMRI|fmri
122351|NCT02801643|reward|reward
122352|NCT02801617|Latanoprost|latanoprost
122353|NCT02801617|Glaucoma|glaucoma
122354|NCT02801617|Ocular hypertension|ocular hypertension
122355|NCT02801617|Crossover study|crossover study
122356|NCT02801578|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
122357|NCT02801578|CLL|cll
122358|NCT02801578|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
122359|NCT02801578|Ibrutinib|ibrutinib
122360|NCT02801578|PCI-32765|pci-32765
122361|NCT02801578|Imbruvica|imbruvica
122362|NCT02801578|Pharmacodynamics|pharmacodynamics
122363|NCT02801552|regenerative endodontic treatment|regenerative endodontic treatment
122364|NCT02801552|platelet-rich fibrin|platelet-rich fibrin
122365|NCT02801552|Immature permanent tooth|immature permanent tooth
122366|NCT02801552|apical periodontitis|apical periodontitis
122367|NCT02801513|mindfulness|mindfulness
122368|NCT02801513|EEG|eeg
122369|NCT02801513|error-related negativity|error-related negativity
122370|NCT02801513|late positive potential|late positive potential
122371|NCT02801513|long-range temporal correlations|long-range temporal correlations
122372|NCT02801500|bilioenteric anastomosis|bilioenteric anastomosis
122373|NCT02801487|Carbon Ion Therapy|carbon ion therapy
122374|NCT02801487|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
122375|NCT02801435|EGFR inhibitor|egfr inhibitor
122376|NCT02801435|topical agent|topical agent
122377|NCT02801435|psoriasis|psoriasis
122378|NCT02801435|phase 1|phase 1
122379|NCT02801422|cannabis|cannabis
122380|NCT02801422|fMRI|fmri
122381|NCT02801422|addiction|addiction
122382|NCT02801422|relapse|relapse
122383|NCT02801409|Lung Cancer|lung cancer
122384|NCT02801409|Surgical Resection|surgical resection
122385|NCT02801409|Epidural Anesthesia and Analgesia|epidural anesthesia and analgesia
122386|NCT02801409|Long-Term Outcome|long-term outcome
122387|NCT02801357|substance withdrawal syndrome|substance withdrawal syndrome
122388|NCT02801357|opiate addiction|opiate addiction
122592|NCT02800005|laparotomy|laparotomy
122389|NCT02801357|opiate dependence|opiate dependence
122390|NCT02801357|opioid withdrawal syndrome|opioid withdrawal syndrome
122391|NCT02801357|buprenorphine|buprenorphine
122392|NCT02801344|exercise|exercise
122393|NCT02801344|performance|performance
122394|NCT02801344|recovery|recovery
122395|NCT02801344|muscle|muscle
122396|NCT02801344|protein|protein
122397|NCT02801331|Stochastic Resonance|stochastic resonance
122398|NCT02801331|Fetus/Newborn Infant|fetus/newborn infant
122399|NCT02801331|Drug Withdrawal|drug withdrawal
122400|NCT02801331|Substance Abuse|substance abuse
122401|NCT02801318|Patient|patient
122402|NCT02801305|Scleroderma|scleroderma
122403|NCT02801305|Diltiazem|diltiazem
122404|NCT02801305|Nitroglycerin|nitroglycerin
122405|NCT02801305|Topical|topical
122406|NCT02801279|Cerebral Palsy|cerebral palsy
122407|NCT02801279|Occupational Therapy|occupational therapy
122408|NCT02801279|Upper Limb Motor Training|upper limb motor training
122409|NCT02801266|Contraception|contraception
122410|NCT02801266|Reproductive and Sexual Health|reproductive and sexual health
122411|NCT02801266|Counseling|counseling
122412|NCT02801266|Contraceptive Counseling|contraceptive counseling
122413|NCT02801240|Inflammatory Bowel Disease|inflammatory bowel disease
122414|NCT02801227|premature rupture of membrane|premature rupture of membrane
122415|NCT02801227|primipara|primipara
122416|NCT02801227|term|term
122417|NCT02801227|bishop|bishop
122418|NCT02801214|cannabis|cannabis
122419|NCT02801214|fMRI|fmri
122420|NCT02801214|emotion|emotion
122421|NCT02801201|sedation|sedation
122422|NCT02801201|spinal anesthesia|spinal anesthesia
122423|NCT02801162|arterial blood gas|arterial blood gas
122424|NCT02801123|Complimentary Cancer Therapies|complimentary cancer therapies
122425|NCT02801123|Psychosocial Oncology|psychosocial oncology
122426|NCT02801123|Behavioural Medicine|behavioural medicine
122427|NCT02801123|Mindfulness Based Cancer Recovery|mindfulness based cancer recovery
122428|NCT02801123|Tai Chi|tai chi
122429|NCT02801123|Qigong|qigong
122430|NCT02801123|Mindfulness-Based Stress Reduction|mindfulness-based stress reduction
122431|NCT02801123|Yoga|yoga
122432|NCT02801123|Preference-based trial|preference-based trial
122433|NCT02801084|Reduced|reduced
122434|NCT02801084|Environmental|environmental
122435|NCT02801084|Stimulation|stimulation
122436|NCT02801071|Post-Polio Syndrome|post-polio syndrome
122438|NCT02801058|Osteopathic manipulative treatment|osteopathic manipulative treatment
122439|NCT02801058|Abdominal Diaphragm mobility|abdominal diaphragm mobility
122440|NCT02801058|Thoracic Ultrasounds|thoracic ultrasounds
122441|NCT02800980|lymphocele|lymphocele
122442|NCT02800980|sclerotherapy|sclerotherapy
122443|NCT02800980|drainage|drainage
122444|NCT02800980|percutaneous|percutaneous
122445|NCT02800967|platelet activation|platelet activation
122446|NCT02800967|platelet aggregation|platelet aggregation
122447|NCT02800967|Aronia|aronia
122448|NCT02800967|flow cytometry|flow cytometry
122449|NCT02800967|polyphenols|polyphenols
122450|NCT02800967|cardiovascular disease risk|cardiovascular disease risk
122451|NCT02800954|Multiple Myeloma|multiple myeloma
122452|NCT02800954|bone lesions|bone lesions
122453|NCT02800954|Macrophage-Colony Stimulating Factor|macrophage-colony stimulating factor
122454|NCT02800941|Pulmonary Arterial hypertension|pulmonary arterial hypertension
122455|NCT02800941|Oral anticoagulants|oral anticoagulants
122456|NCT02800941|Major bleedings|major bleedings
122457|NCT02800915|Spinal Cord Injury|spinal cord injury
122458|NCT02800915|Pressure Ulcer|pressure ulcer
122459|NCT02800915|Health Related Quality of Life|health related quality of life
122460|NCT02800915|Telemedicine|telemedicine
122461|NCT02800915|Service Innovation|service innovation
122462|NCT02800915|Rehabilitation|rehabilitation
122463|NCT02800915|Interdisciplinary collaboration|interdisciplinary collaboration
122464|NCT02800915|User- participation|user- participation
122465|NCT02800915|Activity and participation|activity and participation
122466|NCT02800915|Health economics|health economics
122467|NCT02800889|relapsed|relapsed
122468|NCT02800889|refractory|refractory
122469|NCT02800889|solid tumors|solid tumors
122470|NCT02800850|Dementia|dementia
122471|NCT02800850|Depression|depression
122472|NCT02800850|Agitation|agitation
122473|NCT02800850|Bright Light|bright light
122474|NCT02800837|left main|left main
122475|NCT02800837|stent|stent
122476|NCT02800837|self-expandable|self-expandable
122477|NCT02800837|DES|des
122478|NCT02800837|Stentys|stentys
122479|NCT02800811|FR104|fr104
122480|NCT02800811|CD28|cd28
122481|NCT02800811|immunomodulation|immunomodulation
122482|NCT02800811|T regulatory cell|t regulatory cell
122483|NCT02800811|Pegylated monovalent anti-CD28 Fab antibody|pegylated monovalent anti-cd28 fab antibody
122484|NCT02800798|Obstructive sleep apnea|obstructive sleep apnea
122485|NCT02800798|Preeclampsia|preeclampsia
122486|NCT02800798|Pregnancy|pregnancy
122487|NCT02800798|Stopbang|stopbang
122488|NCT02800772|pancreatic duct|pancreatic duct
122489|NCT02800772|ERCP|ercp
122490|NCT02800772|acetic acid|acetic acid
122491|NCT02800746|Prognathic surgery|prognathic surgery
122492|NCT02800746|intravenous iron|intravenous iron
122493|NCT02800720|Fibromyalgia Syndromey|fibromyalgia syndromey
122494|NCT02800681|Asperger Syndrome|asperger syndrome
122495|NCT02800681|Autism Spectrum Disorder|autism spectrum disorder
122496|NCT02800681|Schizotypal disorder|schizotypal disorder
122497|NCT02800681|Schizophrenia Spectrum Disorder|schizophrenia spectrum disorder
122498|NCT02800681|Psychopathology|psychopathology
122499|NCT02800681|Examination of Anomalous Self Disorder|examination of anomalous self disorder
122500|NCT02800681|Autism Diagnostic Observation Schedule|autism diagnostic observation schedule
122501|NCT02800681|Phenomenology|phenomenology
122502|NCT02800681|Differential diagnosis|differential diagnosis
122503|NCT02800681|Young Adult|young adult
122504|NCT02800668|Duodenal Jejunal Bypass Liner|duodenal jejunal bypass liner
122505|NCT02800668|obesity|obesity
122506|NCT02800668|weight loss therapy|weight loss therapy
122507|NCT02800655|ARV treatment Naive|arv treatment naive
122508|NCT02800655|Medication Adherence|medication adherence
122509|NCT02800655|Digital Health Feedback System|digital health feedback system
122510|NCT02800655|Proteus Digital Health|proteus digital health
122511|NCT02800642|Bayer|bayer
122512|NCT02800642|Aflibercept|aflibercept
122513|NCT02800642|Eylea|eylea
122514|NCT02800642|Intravitreal|intravitreal
122515|NCT02800616|Academic Achievement|academic achievement
122516|NCT02800616|Accelerometry|accelerometry
122517|NCT02800616|Children|children
122518|NCT02800616|Primary school Intervention|primary school intervention
122519|NCT02800616|Nutrition|nutrition
122520|NCT02800616|Obesity|obesity
122521|NCT02800616|Physical Activity|physical activity
122522|NCT02800616|Prevention|prevention
122523|NCT02800616|School Health|school health
122524|NCT02800603|preschool mental health|preschool mental health
122525|NCT02800603|emotional and behaviour problems|emotional and behaviour problems
122526|NCT02800590|Adult participants|adult participants
122527|NCT02800590|Sedation|sedation
122528|NCT02800590|elective|elective
122529|NCT02800525|Benign pigmented lesions|benign pigmented lesions
122530|NCT02800525|Picosecond laser|picosecond laser
122531|NCT02800525|Q-switched laser|q-switched laser
122532|NCT02800512|pelvic organ prolapse|pelvic organ prolapse
122533|NCT02800512|cystocele|cystocele
122534|NCT02800512|rectocele|rectocele
122535|NCT02800512|enterocele|enterocele
122536|NCT02800473|Bladder cancer|bladder cancer
122537|NCT02800473|Hexvix|hexvix
122538|NCT02800473|Bimodal Endoscopic Imager|bimodal endoscopic imager
122539|NCT02800473|Cystoscopy|cystoscopy
122540|NCT02800460|Subthalamic nucleus|subthalamic nucleus
122541|NCT02800460|Basal ganglia|basal ganglia
122542|NCT02800460|Parkinson disease|parkinson disease
122543|NCT02800460|Magnetic Resonance Imaging|magnetic resonance imaging
122544|NCT02800460|Susceptibility-Weighted Imaging|susceptibility-weighted imaging
122545|NCT02800434|allograft|allograft
122546|NCT02800434|hands|hands
122547|NCT02800434|immunosuppression|immunosuppression
122548|NCT02800434|fMRI|fmri
122549|NCT02800395|Alzheimer|alzheimer
122550|NCT02800395|oxydative stress|oxydative stress
122551|NCT02800395|nutrition|nutrition
122552|NCT02800395|biomarkers|biomarkers
122553|NCT02800382|paraoxonase|paraoxonase
122554|NCT02800382|lung diseases|lung diseases
122555|NCT02800369|Human papillomavirus|human papillomavirus
122556|NCT02800369|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
122557|NCT02800369|zinc finger nuclease|zinc finger nuclease
122558|NCT02800356|Age-Related Macular Degeneration|age-related macular degeneration
122559|NCT02800356|Geographic Atrophy|geographic atrophy
122560|NCT02800356|Reticular pseudodrusen|reticular pseudodrusen
122561|NCT02800356|Lasers|lasers
122562|NCT02800356|PASCAL 577|pascal 577
122563|NCT02800304|malnutrition|malnutrition
122564|NCT02800304|food intake|food intake
122565|NCT02800304|frailty|frailty
122566|NCT02800291|food intake|food intake
122567|NCT02800265|healthy volunteer|healthy volunteer
122568|NCT02800265|healthy|healthy
122569|NCT02800265|cancer prevention|cancer prevention
122570|NCT02800265|prevention|prevention
122571|NCT02800252|fatty acids|fatty acids
122572|NCT02800252|aspirin|aspirin
122573|NCT02800252|diabetes mellitus|diabetes mellitus
122574|NCT02800252|chronic periodontitis|chronic periodontitis
122575|NCT02800252|periodontal debridement|periodontal debridement
122576|NCT02800200|platelet rich plasma|platelet rich plasma
122577|NCT02800200|extracorporeal shock wave|extracorporeal shock wave
122578|NCT02800122|acute dyspnea|acute dyspnea
122579|NCT02800122|emergency|emergency
122580|NCT02800122|acute heart failure|acute heart failure
122581|NCT02800109|Fetal growth|fetal growth
122582|NCT02800109|Newborn growth|newborn growth
122583|NCT02800070|autologous stem cell transplant|autologous stem cell transplant
122584|NCT02800070|gene therapy|gene therapy
122585|NCT02800070|Fabry disease|fabry disease
122586|NCT02800070|lentivirus|lentivirus
122587|NCT02800070|haematopoietic stem cell transplant|haematopoietic stem cell transplant
122588|NCT02800018|hypothermia therapy|hypothermia therapy
122589|NCT02800018|perinatal asphyxia|perinatal asphyxia
122590|NCT02800005|gastric cancer|gastric cancer
122591|NCT02800005|gastrectomy|gastrectomy
122593|NCT02800005|surgical outcome|surgical outcome
122594|NCT02800005|survival|survival
122595|NCT02800005|abdominal fat area|abdominal fat area
122596|NCT02800005|Body Mass Index|body mass index
122597|NCT02799953|diabetes mellitus and hypertension|diabetes mellitus and hypertension
122598|NCT02799953|consumer health information technology|consumer health information technology
122599|NCT02799953|self-monitoring|self-monitoring
122600|NCT02799953|randomized controlled trial|randomized controlled trial
122601|NCT02799927|Indirect Pulp Treatment|indirect pulp treatment
122602|NCT02799927|Primary Teeth|primary teeth
122603|NCT02799927|Biodentine|biodentine
122604|NCT02799927|Calcium Hydroxide|calcium hydroxide
122605|NCT02799927|Split-Mouth design|split-mouth design
122606|NCT02799901|advanced melanoma|advanced melanoma
122607|NCT02799901|high dose radiotherapy|high dose radiotherapy
122608|NCT02799901|Nivolumab|nivolumab
122609|NCT02799888|Graft-versus-host Disease|graft-versus-host disease
122610|NCT02799888|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
122611|NCT02799888|Acute Leukemia|acute leukemia
122612|NCT02799888|Myelodysplastic syndrome|myelodysplastic syndrome
122613|NCT02799888|Lymphoma|lymphoma
122614|NCT02799875|respiratory distress syndrome|respiratory distress syndrome
122615|NCT02799875|permissive hypercapnia|permissive hypercapnia
122616|NCT02799875|ventilator strategy|ventilator strategy
122617|NCT02799862|metastatic|metastatic
122618|NCT02799862|locally advanced|locally advanced
122619|NCT02799862|unresectable|unresectable
122620|NCT02799862|NSCLC|nsclc
122621|NCT02799849|narcolepsy|narcolepsy
122622|NCT02799849|metabolism|metabolism
122623|NCT02799823|aortic stenosis|aortic stenosis
122624|NCT02799823|transcatheter aortic valve replacement|transcatheter aortic valve replacement
122625|NCT02799810|lung transplantation|lung transplantation
122626|NCT02799810|psychosocial functioning|psychosocial functioning
122627|NCT02799810|longitudinal|longitudinal
122628|NCT02799810|TERS|ters
122629|NCT02799810|adherence|adherence
122630|NCT02799810|Quality of life|quality of life
122631|NCT02799797|adductor canal block|adductor canal block
122632|NCT02799784|tiotropium|tiotropium
122633|NCT02799784|COPD|copd
122634|NCT02799784|olodaterol|olodaterol
122635|NCT02799784|Umeclidinium bromide|umeclidinium bromide
122636|NCT02799784|efficacy|efficacy
122637|NCT02799784|vilanterol|vilanterol
122638|NCT02799771|Pulmonary arterial hypertension|pulmonary arterial hypertension
122639|NCT02799771|Interstitial lung disease at HRCT|interstitial lung disease at hrct
122640|NCT02799745|Therapeutic Cancer Progression|therapeutic cancer progression
122641|NCT02799745|Pathological Cancer Progression|pathological cancer progression
122642|NCT02799745|Enzalutamide|enzalutamide
122643|NCT02799745|Prostate Cancer|prostate cancer
122644|NCT02799745|Active surveillance|active surveillance
122645|NCT02799732|Feasibility Study|feasibility study
122646|NCT02799732|HPV vaccine|hpv vaccine
122647|NCT02799732|1Dose Trial|1dose trial
122648|NCT02799719|Fat mass|fat mass
122649|NCT02799719|hemodialysis patients|hemodialysis patients
122650|NCT02799719|inflammation|inflammation
122651|NCT02799719|adipocytokines|adipocytokines
122652|NCT02799719|bioimpedance spectroscopy|bioimpedance spectroscopy
122653|NCT02799706|Prostate cancer|prostate cancer
122654|NCT02799706|GnRH antagonist|gnrh antagonist
122655|NCT02799706|GnRH agonist|gnrh agonist
122656|NCT02799706|radiation therapy|radiation therapy
122657|NCT02799706|very high risk localized prostate cancer|very high risk localized prostate cancer
122658|NCT02799706|locally advanced prostate cancer|locally advanced prostate cancer
122659|NCT02799693|Catheter Ablation|catheter ablation
122660|NCT02799693|Ventricular Tachycardia|ventricular tachycardia
122661|NCT02799693|Intramural Needle Catheter|intramural needle catheter
122662|NCT02799680|CART|cart
122663|NCT02799680|AML|aml
122664|NCT02799667|negative pressure wound therapy|negative pressure wound therapy
122665|NCT02799667|cesarean delivery|cesarean delivery
122666|NCT02799654|Total Hip Arthroplasty|total hip arthroplasty
122667|NCT02799641|Contraception|contraception
122668|NCT02799641|IUD|iud
122669|NCT02799641|levonorgestrel releasing intrauterine device|levonorgestrel releasing intrauterine device
122670|NCT02799641|lidocaine|lidocaine
122671|NCT02799641|valium|valium
122672|NCT02799641|diazepam|diazepam
122673|NCT02799641|pain|pain
122674|NCT02799641|VAS|vas
122675|NCT02799641|visual analog scale|visual analog scale
122676|NCT02799628|Trust|trust
122677|NCT02799628|Low Back Pain|low back pain
122678|NCT02799628|Treatment Outcome|treatment outcome
122679|NCT02799602|Metastatic hormone sensitive prostate cancer|metastatic hormone sensitive prostate cancer
122680|NCT02799576|Ultrasound|ultrasound
122681|NCT02799576|Regional blockade|regional blockade
122682|NCT02799576|Infraclavicular brachial plexus|infraclavicular brachial plexus
122683|NCT02799550|CART|cart
122684|NCT02799550|ALL|all
122685|NCT02799550|elderly|elderly
122686|NCT02799550|Relapsed|relapsed
122687|NCT02799550|Refractory|refractory
122688|NCT02799550|CD19+|cd19+
122689|NCT02799511|biological markers|biological markers
122690|NCT02799498|etanercept|etanercept
122691|NCT02799498|healthy subject|healthy subject
122692|NCT02799498|open-label|open-label
122693|NCT02799498|randomized|randomized
122694|NCT02799498|PK|pk
122695|NCT02799498|auto-injection|auto-injection
122696|NCT02799498|pharmacokinetic|pharmacokinetic
122697|NCT02799472|GSK3196165|gsk3196165
122698|NCT02799472|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
122699|NCT02799472|disease-modifying antirheumatic drugs (DMARDs)|disease-modifying antirheumatic drugs (dmards)
122700|NCT02799472|granulocyte-macrophage colony stimulating factor (GM-CSF)|granulocyte-macrophage colony stimulating factor (gm-csf)
122701|NCT02799472|Rheumatoid Arthritis|rheumatoid arthritis
122702|NCT02799472|Methotrexate|methotrexate
122703|NCT02799459|Hypnoanesthesia|hypnoanesthesia
122704|NCT02799459|Hypnosis|hypnosis
122705|NCT02799459|conization|conization
122706|NCT02799446|sinusitis, rhinitis, rhinosinusitis, chronic|sinusitis, rhinitis, rhinosinusitis, chronic
122707|NCT02799433|Water|water
122708|NCT02799433|Physical activity|physical activity
122709|NCT02799433|Child care|child care
122710|NCT02799433|Weight change|weight change
122711|NCT02799420|confocal laser endomicroscopy|confocal laser endomicroscopy
122712|NCT02799420|undifferentiated gastric cancer|undifferentiated gastric cancer
122713|NCT02799420|target biopsy|target biopsy
122714|NCT02799381|carbidopa|carbidopa
122715|NCT02799381|levodopa|levodopa
122716|NCT02799381|efficacy|efficacy
122717|NCT02799381|levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
122718|NCT02799381|Advanced Parkinson's Disease|advanced parkinson's disease
122719|NCT02799303|screening|screening
122720|NCT02799303|biopsy|biopsy
122721|NCT02799303|magnetic resonance imaging|magnetic resonance imaging
122722|NCT02799303|prostate specific antigen|prostate specific antigen
122723|NCT02799264|fasted|fasted
122724|NCT02799264|healthy volunteers|healthy volunteers
122725|NCT02799264|cabotegravir|cabotegravir
122726|NCT02799264|high fat|high fat
122727|NCT02799264|pharmacokinetics|pharmacokinetics
122728|NCT02799264|randomized|randomized
122729|NCT02799264|Phase I|phase i
122730|NCT02799264|two way crossover|two way crossover
122731|NCT02799251|lymphopenia|lymphopenia
122732|NCT02799251|postoperative infection|postoperative infection
122733|NCT02799251|thoracic cancer surgery|thoracic cancer surgery
122734|NCT02799251|digestive cancer surgery|digestive cancer surgery
122735|NCT02799238|glioblastoma, GBM, immunotherapy, autologous lymphoid effector cells specific against tumour cells, ALECSAT, Stupp regimen, TMZ, radiotherapy/TMZ|glioblastoma, gbm, immunotherapy, autologous lymphoid effector cells specific against tumour cells, alecsat, stupp regimen, tmz, radiotherapy/tmz
122736|NCT02799225|carbapenems|carbapenems
122737|NCT02799212|Hepatocellular carcinoma|hepatocellular carcinoma
122738|NCT02799212|Hepatectomy|hepatectomy
122739|NCT02799212|Ascites|ascites
122740|NCT02799212|Somatostatin|somatostatin
122741|NCT02799186|Spontaneous Coronary Artery Dissection|spontaneous coronary artery dissection
122742|NCT02799186|haematoma|haematoma
122743|NCT02799186|Fibromuscular Dysplasia|fibromuscular dysplasia
122744|NCT02799186|genetic analysis|genetic analysis
122745|NCT02799186|Acute Coronary Syndrome|acute coronary syndrome
122746|NCT02799173|cardiovascular calcification|cardiovascular calcification
122747|NCT02799173|RANK: Receptor Activator of Nuclear Factor kappa B|rank: receptor activator of nuclear factor kappa b
122748|NCT02799173|RANKL: Receptor Activator of Nuclear Factor kappa B Ligand|rankl: receptor activator of nuclear factor kappa b ligand
122749|NCT02799173|OPG: Osteoprotegerin|opg: osteoprotegerin
122750|NCT02799173|SLE: Systemic lupus erythematosus|sle: systemic lupus erythematosus
122751|NCT02799147|Allogeneic Transplantation|allogeneic transplantation
122752|NCT02799147|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
122753|NCT02799147|Leukemia, Acute Lymphoblastic|leukemia, acute lymphoblastic
122754|NCT02799147|Acute Myeloid Leukemia|acute myeloid leukemia
122755|NCT02799147|Mixed-Lineage Acute Leukemias|mixed-lineage acute leukemias
122756|NCT02799147|Immune System Diseases|immune system diseases
122757|NCT02799147|Immunosuppressive Agents|immunosuppressive agents
122758|NCT02799147|Myeloablative Agonists|myeloablative agonists
122759|NCT02799147|Busulfan|busulfan
122760|NCT02799147|Fludarabine|fludarabine
122761|NCT02799147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
122762|NCT02799147|Bendamustine Hydrochloride|bendamustine hydrochloride
122763|NCT02799134|Cortisol Awakening Response suppression|cortisol awakening response suppression
122764|NCT02799134|Dexamethasone Suppression Test|dexamethasone suppression test
122765|NCT02799134|high-order cognition|high-order cognition
122766|NCT02799134|social cognition|social cognition
122767|NCT02799108|children|children
122768|NCT02799108|language|language
122769|NCT02799108|NIRS|nirs
122770|NCT02799095|Immunotherapy|immunotherapy
122771|NCT02799095|IL-2|il-2
122772|NCT02799095|Interleukin-2|interleukin-2
122773|NCT02799095|Solid tumors|solid tumors
122774|NCT02799056|Airway Extubation|airway extubation
122775|NCT02799056|Ultrasonography|ultrasonography
122776|NCT02799056|Ventilator Weaning|ventilator weaning
122777|NCT02799043|FIRMap, Rotor, FIRM-guided procedure|firmap, rotor, firm-guided procedure
122778|NCT02799017|Aphasia|aphasia
122779|NCT02799017|Reading|reading
122780|NCT02799017|Writing|writing
122781|NCT02799017|Naming|naming
122782|NCT02799017|Language|language
122783|NCT02799017|Chronic post stroke|chronic post stroke
122784|NCT02799017|Phonology|phonology
122785|NCT02799017|Semantic Feature Analysis|semantic feature analysis
122786|NCT02799017|Recovery|recovery
122787|NCT02798991|REarranged during Transfection Growth Factor Receptor Tyrosine Kinase Inhibitor|rearranged during transfection growth factor receptor tyrosine kinase inhibitor
122788|NCT02798978|pharmacokinetics|pharmacokinetics
122789|NCT02798978|TLR4 agonist|tlr4 agonist
122790|NCT02798978|cancer|cancer
122791|NCT02798978|tolerability|tolerability
122792|NCT02798978|GSK1795091|gsk1795091
122793|NCT02798978|pharmacodynamics|pharmacodynamics
122794|NCT02798978|safety|safety
122795|NCT02798965|parvovirus genome|parvovirus genome
122796|NCT02798952|Hepatitis B antibodies|hepatitis b antibodies
122797|NCT02798952|Safety|safety
122798|NCT02798952|Challenge dose|challenge dose
122799|NCT02798952|Persistence|persistence
122800|NCT02798952|Engerix B Kinder|engerix b kinder
122801|NCT02798952|Infanrix hexa|infanrix hexa
122802|NCT02798952|Immunogenicity|immunogenicity
122803|NCT02798952|Adolescents|adolescents
122804|NCT02798939|spontaneous bacterial peritonitis|spontaneous bacterial peritonitis
122805|NCT02798939|lactoferrin|lactoferrin
122806|NCT02798939|procalcitonin|procalcitonin
122807|NCT02798939|Aution® urine dipsticks|aution® urine dipsticks
122808|NCT02798926|hypothermia|hypothermia
122809|NCT02798926|central venous catheter placement|central venous catheter placement
122810|NCT02798926|Polyethylene bag|polyethylene bag
122811|NCT02798913|dual antiplatelet therapy|dual antiplatelet therapy
122812|NCT02798913|peripheral transluminal angioplasty|peripheral transluminal angioplasty
122813|NCT02798900|Task-specific exercise|task-specific exercise
122814|NCT02798900|Ultrasonic Waves|ultrasonic waves
122815|NCT02798900|Biomechanics|biomechanics
122816|NCT02798900|Gait|gait
122817|NCT02798900|Rehabilitation|rehabilitation
122818|NCT02798900|Exercise therapy|exercise therapy
122819|NCT02798887|Regeneration|regeneration
122820|NCT02798887|Bone regeneration|bone regeneration
122821|NCT02798887|Grafting, Bone|grafting, bone
122822|NCT02798887|Allograft|allograft
122823|NCT02798887|Xenograft|xenograft
122824|NCT02798874|Ticagrelor|ticagrelor
122825|NCT02798874|No-reflow|no-reflow
122826|NCT02798874|Acute ST-segment elevation myocardial|acute st-segment elevation myocardial
122827|NCT02798874|Reperfusion injury|reperfusion injury
122828|NCT02798874|Percutaneous coronary intervention|percutaneous coronary intervention
122829|NCT02798796|breast cancer|breast cancer
122830|NCT02798796|conservative surgery|conservative surgery
122831|NCT02798796|MRI|mri
122832|NCT02798783|Vestibular Aqueduct|vestibular aqueduct
122833|NCT02798783|SLC26A4|slc26a4
122834|NCT02798783|FOXI1|foxi1
122835|NCT02798783|Temporal Bone|temporal bone
122836|NCT02798731|Heart transplant|heart transplant
122837|NCT02798731|Microvascular dysfunction|microvascular dysfunction
122838|NCT02798731|Cardiac allograft vasculopathy|cardiac allograft vasculopathy
122839|NCT02798731|Fractional flow reserve|fractional flow reserve
122840|NCT02798731|Coronary flow reserve|coronary flow reserve
122841|NCT02798731|Index of microvascular resistance|index of microvascular resistance
122842|NCT02798705|Cardiac amyloidosis|cardiac amyloidosis
122843|NCT02798705|Fractional flow reserve|fractional flow reserve
122844|NCT02798705|Microvascular dysfunction|microvascular dysfunction
122845|NCT02798705|Coronary flow reserve|coronary flow reserve
122846|NCT02798705|Index of microcirculatory resistance|index of microcirculatory resistance
122847|NCT02798692|Prevention|prevention
122848|NCT02798666|Physical fitness|physical fitness
122849|NCT02798666|Respiratory exchange ratio|respiratory exchange ratio
122850|NCT02798666|Insulin sensitivity|insulin sensitivity
122851|NCT02798666|High intensity interval training|high intensity interval training
122852|NCT02798666|Continuous exercise training|continuous exercise training
122853|NCT02798601|Cerebral edema|cerebral edema
122854|NCT02798601|Hypernatremia|hypernatremia
122855|NCT02798601|Extended Glasgow Outcome Scale|extended glasgow outcome scale
122856|NCT02798601|Intracranial pressure|intracranial pressure
122857|NCT02798601|Mannitol|mannitol
122858|NCT02798601|Hypertonic saline|hypertonic saline
122859|NCT02798601|Mortality|mortality
122860|NCT02798588|coma|coma
122861|NCT02798588|prognosis|prognosis
122862|NCT02798588|comparative study|comparative study
122863|NCT02798588|functional imaging|functional imaging
122864|NCT02798588|PET-MRI|pet-mri
122865|NCT02798588|electrophysiology|electrophysiology
122866|NCT02798575|COPD|copd
122867|NCT02798575|invasive ventilation|invasive ventilation
122868|NCT02798575|exacerbation|exacerbation
122869|NCT02798575|home care|home care
122870|NCT02798575|mechanical ventilation|mechanical ventilation
122871|NCT02798575|unsuccessful weaning|unsuccessful weaning
122872|NCT02798575|ventilatory parameters|ventilatory parameters
122873|NCT02798562|low dose CT|low dose ct
122874|NCT02798562|contrast-enhanced|contrast-enhanced
122875|NCT02798562|breast cancer screening|breast cancer screening
122876|NCT02798562|computer tomography|computer tomography
122877|NCT02798549|HBV|hbv
122878|NCT02798549|liver|liver
122879|NCT02798536|Immunotoxin|immunotoxin
122880|NCT02798536|Mesothelin|mesothelin
122881|NCT02798536|Targeted Therapy|targeted therapy
122882|NCT02798523|Methylprednisolone|methylprednisolone
122883|NCT02798523|Immunologic|immunologic
122884|NCT02798523|Infusion|infusion
122885|NCT02798523|Topical|topical
122886|NCT02798523|Intravenous|intravenous
122887|NCT02798510|Gallbladder Carcinoma|gallbladder carcinoma
122888|NCT02798510|Extrahepatic Cholangiocarcinoma|extrahepatic cholangiocarcinoma
122889|NCT02798510|Chemoradiotherapy|chemoradiotherapy
122890|NCT02798497|PVL|pvl
122891|NCT02798497|Pneumonias|pneumonias
122892|NCT02798497|Staphylococcus aureus|staphylococcus aureus
122893|NCT02798484|Diffusion Weighted Magnetic Resonance Imaging|diffusion weighted magnetic resonance imaging
122894|NCT02798484|Breast cancer|breast cancer
122895|NCT02798484|Neo-adjuvant therapy|neo-adjuvant therapy
122896|NCT02798471|Pediatric|pediatric
122897|NCT02798471|Venous thrombolism|venous thrombolism
122898|NCT02798471|Pulmonary embolism|pulmonary embolism
122899|NCT02798458|Fabry's Disease|fabry's disease
122901|NCT02798445|venous ulcer|venous ulcer
122902|NCT02798445|vein|vein
122903|NCT02798445|juxta cures|juxta cures
122904|NCT02798445|foam|foam
122905|NCT02798445|laser|laser
122906|NCT02798432|Total Knee Arthroplasty|total knee arthroplasty
122907|NCT02798432|Hybrid|hybrid
122908|NCT02798432|Cemented|cemented
122909|NCT02798432|Fixation|fixation
122910|NCT02798406|brain|brain
122911|NCT02798406|Central Nervous System (CNS) diseases|central nervous system (cns) diseases
122912|NCT02798406|Central Nervous System (CNS) neoplasms|central nervous system (cns) neoplasms
122913|NCT02798406|CNS|cns
122914|NCT02798406|conditionally replicative adenovirus|conditionally replicative adenovirus
122915|NCT02798406|DNX-2401|dnx-2401
122916|NCT02798406|pembrolizumab|pembrolizumab
122917|NCT02798406|KEYTRUDA|keytruda
122918|NCT02798406|MK-3475|mk-3475
122919|NCT02798406|SCH 900475|sch 900475
122920|NCT02798406|lambrolizumab|lambrolizumab
122921|NCT02798406|neoplasm, germ cell and embryonal|neoplasm, germ cell and embryonal
122922|NCT02798406|neoplasm, granular and epithelial|neoplasm, granular and epithelial
122923|NCT02798406|Alcyone|alcyone
122924|NCT02798406|Alcyone Lifesciences|alcyone lifesciences
122925|NCT02798406|AMC|amc
122926|NCT02798406|cannula|cannula
122927|NCT02798406|MEMS cannula|mems cannula
122928|NCT02798406|DNX-2401 + pembrolizumab|dnx-2401 + pembrolizumab
122929|NCT02798406|Delta-24|delta-24
122930|NCT02798406|Delta-24-RGD|delta-24-rgd
122931|NCT02798406|Checkpoint inhibitor|checkpoint inhibitor
122932|NCT02798406|anti-PD1/PD-L1|anti-pd1/pd-l1
122933|NCT02798406|immunotherapy|immunotherapy
122934|NCT02798406|monoclonal antibody|monoclonal antibody
122935|NCT02798406|KEYNOTE-192|keynote-192
122936|NCT02798367|insomnia|insomnia
122937|NCT02798367|cognitive behavioral therapy for insomnia|cognitive behavioral therapy for insomnia
122938|NCT02798367|melatonin|melatonin
122939|NCT02798354|Depression|depression
122940|NCT02798354|Blood Pressure|blood pressure
122941|NCT02798354|Anemias, Iron-Deficiency|anemias, iron-deficiency
122942|NCT02798354|Streptococcal Infections|streptococcal infections
122943|NCT02798354|Sexually Transmitted Diseases|sexually transmitted diseases
122944|NCT02798354|Lead Poisoning, Nervous System, Childhood|lead poisoning, nervous system, childhood
122945|NCT02798354|Thyrotropin|thyrotropin
122946|NCT02798315|Paritaprevir/r - Ombitasvir, ± Dasabuvir|paritaprevir/r - ombitasvir, ± dasabuvir
122947|NCT02798315|Sustained Virological Response|sustained virological response
122948|NCT02798315|Chronic Hepatitis C genotype 4|chronic hepatitis c genotype 4
122949|NCT02798315|Observational Study|observational study
122950|NCT02798315|Chronic Hepatitis C genotype 1|chronic hepatitis c genotype 1
122951|NCT02798315|Chronic Hepatitis C|chronic hepatitis c
122952|NCT02798276|Myocardial infarction|myocardial infarction
122953|NCT02798276|Cardiac regeneration|cardiac regeneration
122954|NCT02798276|Cardiac surgery|cardiac surgery
122955|NCT02798250|Type 1 diabetes|type 1 diabetes
122956|NCT02798250|Artificial pancreas|artificial pancreas
122957|NCT02798250|Closed-loop system|closed-loop system
122958|NCT02798250|Postprandial glucose control|postprandial glucose control
122959|NCT02798250|Hypoglycemia|hypoglycemia
122960|NCT02798250|Insulin|insulin
122961|NCT02798250|Glucagon|glucagon
122962|NCT02798237|exercise|exercise
122963|NCT02798237|walking|walking
122964|NCT02798237|health|health
122965|NCT02798224|Colorectal Cancer Screening|colorectal cancer screening
122966|NCT02798224|CRC Screening|crc screening
122967|NCT02798224|Rectum|rectum
122968|NCT02798224|Colon|colon
122969|NCT02798224|Screening|screening
122970|NCT02798224|Populations at Risk|populations at risk
122971|NCT02798224|CRC|crc
122972|NCT02798224|colorectal cancer (CRC)|colorectal cancer (crc)
122973|NCT02798211|PsA, ACR, CASPAR|psa, acr, caspar
122974|NCT02798159|Sexual Dysfunction|sexual dysfunction
122975|NCT02798159|Physiological Sexual Dysfunctions|physiological sexual dysfunctions
122976|NCT02798159|Psychological Sexual and Gender Disorders|psychological sexual and gender disorders
122977|NCT02798159|Sildenafil|sildenafil
122978|NCT02798146|in-vitro fertilization|in-vitro fertilization
122979|NCT02798146|luteal phase|luteal phase
123078|NCT02797860|Rocuronium|rocuronium
122980|NCT02798081|augmentative and alternative communication|augmentative and alternative communication
122981|NCT02798081|social inclusion|social inclusion
122982|NCT02798081|serious games|serious games
122983|NCT02798081|Information and communication technologies|information and communication technologies
122984|NCT02798068|Steroids|steroids
122985|NCT02798068|Cardiac surgery|cardiac surgery
122986|NCT02798068|Endothelial dysfunction|endothelial dysfunction
122987|NCT02798068|Glycocalyx|glycocalyx
122988|NCT02798068|Flow mediated vasodilation|flow mediated vasodilation
122989|NCT02798029|Brain Metastases|brain metastases
122990|NCT02798029|Parenchymal Brain Metastases|parenchymal brain metastases
122991|NCT02798029|Oligometastatic brain metastases|oligometastatic brain metastases
122992|NCT02798029|Frameless Fractionated Stereotactic Radiation Therapy|frameless fractionated stereotactic radiation therapy
122993|NCT02798029|FFSRT|ffsrt
122994|NCT02798003|Cachexia|cachexia
122995|NCT02798003|Food reward|food reward
122996|NCT02797990|[G08.686.785.760.769.500]|[g08.686.785.760.769.500]
122997|NCT02797990|[G08.686.785.760.769]|[g08.686.785.760.769]
122998|NCT02797990|[N02.360]|[n02.360]
122999|NCT02797990|[C25.775.650]|[c25.775.650]
123000|NCT02797990|[C25.775.793]|[c25.775.793]
123001|NCT02797990|[C25.775.635]|[c25.775.635]
123002|NCT02797990|[C25.775.675]|[c25.775.675]
123003|NCT02797990|[C25.775.300]|[c25.775.300]
123004|NCT02797990|[C25.775.467]|[c25.775.467]
123005|NCT02797990|[C25.775.225]|[c25.775.225]
123006|NCT02797990|[C25.775.100]|[c25.775.100]
123007|NCT02797990|[C25.775]|[c25.775]
123008|NCT02797977|Replication Stress|replication stress
123009|NCT02797977|Advanced solid tumors|advanced solid tumors
123010|NCT02797977|CCNE1|ccne1
123011|NCT02797977|TP53|tp53
123012|NCT02797977|BRCA1|brca1
123013|NCT02797977|BRCA2|brca2
123014|NCT02797977|MYC|myc
123015|NCT02797977|RAD50|rad50
123016|NCT02797977|Fanconi anemia|fanconi anemia
123017|NCT02797977|Cell Cycle|cell cycle
123018|NCT02797977|Urothelial carcinoma|urothelial carcinoma
123019|NCT02797977|Small cell lung cancer|small cell lung cancer
123020|NCT02797977|Soft tissue sarcoma|soft tissue sarcoma
123021|NCT02797977|Cervical/anogenital cancer|cervical/anogenital cancer
123022|NCT02797977|Phase 1|phase 1
123023|NCT02797977|Phase 2|phase 2
123024|NCT02797977|Dose escalation|dose escalation
123025|NCT02797977|Chk1 inhibitor|chk1 inhibitor
123026|NCT02797977|Checkpoint Kinase 1|checkpoint kinase 1
123027|NCT02797977|Synthetic lethality|synthetic lethality
123028|NCT02797977|Next-Generation Sequencing|next-generation sequencing
123029|NCT02797977|Genetic biomarkers|genetic biomarkers
123030|NCT02797964|Replication stress|replication stress
123031|NCT02797964|Advanced solid tumors|advanced solid tumors
123032|NCT02797964|CCNE1|ccne1
123033|NCT02797964|TP53|tp53
123034|NCT02797964|BRCA1|brca1
123035|NCT02797964|BRCA2|brca2
123036|NCT02797964|MYC|myc
123037|NCT02797964|RAD50|rad50
123038|NCT02797964|Fanconi anemia|fanconi anemia
123039|NCT02797964|Cell cycle|cell cycle
123040|NCT02797964|Metastatic Colorectal Cancer|metastatic colorectal cancer
123041|NCT02797964|Platinum-Resistant or Intolerant High Grade Serious Ovarian Cancer|platinum-resistant or intolerant high grade serious ovarian cancer
123042|NCT02797964|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
123043|NCT02797964|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
123044|NCT02797964|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
123045|NCT02797964|Squamous Cell Carcinoma of the Anus|squamous cell carcinoma of the anus
123046|NCT02797964|Phase 1|phase 1
123047|NCT02797964|Phase 2|phase 2
123048|NCT02797964|Dose escalation|dose escalation
123049|NCT02797964|Chk1 inhibitor|chk1 inhibitor
123050|NCT02797964|Checkpoint kinase 1|checkpoint kinase 1
123051|NCT02797964|Synthetic lethality|synthetic lethality
123052|NCT02797964|Next-Generation Sequencing|next-generation sequencing
123053|NCT02797964|Genetic biomarkers|genetic biomarkers
123054|NCT02797951|cluster headache|cluster headache
123055|NCT02797951|headache|headache
123056|NCT02797951|brain diseases|brain diseases
123057|NCT02797951|central nervous system diseases|central nervous system diseases
123058|NCT02797951|headache disorders|headache disorders
123059|NCT02797951|headache disorders, primary|headache disorders, primary
123060|NCT02797951|nervous system diseases|nervous system diseases
123061|NCT02797951|neurologic manifestations|neurologic manifestations
123062|NCT02797951|pain|pain
123063|NCT02797951|trigeminal autonomic cephalalgias|trigeminal autonomic cephalalgias
123064|NCT02797925|Achilles tendon|achilles tendon
123065|NCT02797925|Patella tendon|patella tendon
123066|NCT02797925|Inflammation|inflammation
123067|NCT02797925|Edema|edema
123068|NCT02797925|Clinical|clinical
123069|NCT02797925|Structural|structural
123070|NCT02797912|pulmonary function|pulmonary function
123071|NCT02797912|respiratory muscle function|respiratory muscle function
123072|NCT02797912|body composition|body composition
123073|NCT02797912|exercise tolerance|exercise tolerance
123074|NCT02797886|Hemiplegia|hemiplegia
123075|NCT02797886|Drop foot|drop foot
123076|NCT02797886|Foot drop|foot drop
123077|NCT02797860|Transabdominal cervicoisthmic cerclage|transabdominal cervicoisthmic cerclage
123079|NCT02797860|Pregnant Women|pregnant women
123080|NCT02797847|TTR-mediated Amyloidosis|ttr-mediated amyloidosis
123081|NCT02797847|Amyloidosis, Hereditary|amyloidosis, hereditary
123082|NCT02797847|Amyloid Neuropathies, Familial|amyloid neuropathies, familial
123083|NCT02797847|Familial Amyloid Polyneuropathies|familial amyloid polyneuropathies
123084|NCT02797847|Amyloid Neuropathies|amyloid neuropathies
123085|NCT02797847|Amyloidosis, Hereditary, Transthyretin-Related|amyloidosis, hereditary, transthyretin-related
123086|NCT02797847|Familial Amyloidosis|familial amyloidosis
123087|NCT02797847|RNAi therapeutic|rnai therapeutic
123088|NCT02797834|Extracellular vesicles|extracellular vesicles
123089|NCT02797834|Endometrial fluid|endometrial fluid
123090|NCT02797834|Menstrual cycle|menstrual cycle
123091|NCT02797834|Exosomes|exosomes
123092|NCT02797834|Microvesicles|microvesicles
123093|NCT02797834|Apoptotic bodies|apoptotic bodies
123094|NCT02797821|HPP|hpp
123095|NCT02797821|asfotase alfa|asfotase alfa
123096|NCT02797808|OCD|ocd
123097|NCT02797743|Healthy Volunteers|healthy volunteers
123098|NCT02797730|Art Therapy|art therapy
123099|NCT02797730|Caregiver's|caregiver's
123100|NCT02797691|Cognitive Behavior Therapy|cognitive behavior therapy
123101|NCT02797691|Depression|depression
123102|NCT02797691|Anxiety|anxiety
123103|NCT02797691|Pashto|pashto
123104|NCT02797691|Pakistani|pakistani
123105|NCT02797691|Afghan|afghan
123106|NCT02797652|Breast cancer|breast cancer
123107|NCT02797652|ctDNA|ctdna
123108|NCT02797652|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
123109|NCT02797652|Adjuvant chemotherapy|adjuvant chemotherapy
123110|NCT02797639|Intellectual Disability|intellectual disability
123111|NCT02797639|Collaborative Consultation|collaborative consultation
123112|NCT02797639|Participation|participation
123113|NCT02797600|Appalachia|appalachia
123114|NCT02797587|Alcohol Use|alcohol use
123115|NCT02797587|Tobacco Use|tobacco use
123116|NCT02797587|Smoking|smoking
123117|NCT02797587|Inflammation|inflammation
123118|NCT02797587|Coronary Heart Disease|coronary heart disease
123119|NCT02797587|Russia|russia
123120|NCT02797587|Varenicline|varenicline
123121|NCT02797587|Cytisine|cytisine
123122|NCT02797587|Nicotine Replacement Therapy|nicotine replacement therapy
123123|NCT02797587|Partial Agonist Therapy|partial agonist therapy
123124|NCT02797587|HIV|hiv
123125|NCT02797587|Reynolds risk score|reynolds risk score
123126|NCT02797587|VACS index|vacs index
123127|NCT02797561|Fractional flow reserve|fractional flow reserve
123128|NCT02797561|Tandem|tandem
123129|NCT02797561|Percutaneous Coronary Intervention|percutaneous coronary intervention
123130|NCT02797548|drug-eluting stent|drug-eluting stent
123131|NCT02797548|antiplatelet therapy|antiplatelet therapy
123132|NCT02797548|noncardiac surgery|noncardiac surgery
123133|NCT02797509|Intensive Care Unit|intensive care unit
123134|NCT02797496|Parkinson's disease|parkinson's disease
123135|NCT02797496|Mild to moderate stage|mild to moderate stage
123136|NCT02797496|Asymmetric Motor Strengthening|asymmetric motor strengthening
123137|NCT02797496|Rehabilitation|rehabilitation
123138|NCT02797457|Bilateral amputation of the forearms|bilateral amputation of the forearms
123139|NCT02797457|Bilateral allograft|bilateral allograft
123140|NCT02797457|Prosthetic forehands|prosthetic forehands
123141|NCT02797457|Medical economic evaluation|medical economic evaluation
123142|NCT02797418|Attentional disorders, intellectual deficiency|attentional disorders, intellectual deficiency
123143|NCT02797405|radiation therapy|radiation therapy
123144|NCT02797405|radiosensitivity|radiosensitivity
123145|NCT02797405|in vitro diagnostic medical devices|in vitro diagnostic medical devices
123146|NCT02797405|Adverse Event post radiotherapy|adverse event post radiotherapy
123147|NCT02797392|Tailored lifestyle intervention|tailored lifestyle intervention
123148|NCT02797392|Selective prevention|selective prevention
123149|NCT02797392|Primary care|primary care
123150|NCT02797392|Web based health risk assessment|web based health risk assessment
123151|NCT02797392|Patient-centered health information system|patient-centered health information system
123152|NCT02797392|Lifestyle intervention|lifestyle intervention
123153|NCT02797392|preventive treatment|preventive treatment
123154|NCT02797379|Psychoeducation|psychoeducation
123155|NCT02797379|Self-help|self-help
123156|NCT02797327|Molecular signature|molecular signature
123157|NCT02797327|Thailand-Myanmar border|thailand-myanmar border
123158|NCT02797314|Type 2 diabetes|type 2 diabetes
123159|NCT02797314|Bone quality|bone quality
123160|NCT02797314|Bone biopsies|bone biopsies
123161|NCT02797314|Vertebral fractures|vertebral fractures
123162|NCT02797314|Osteodensitometry|osteodensitometry
123163|NCT02797314|Trabecular Bone Score|trabecular bone score
123164|NCT02797301|early reading skills|early reading skills
123165|NCT02797249|preeclampsia|preeclampsia
123166|NCT02797249|low dose aspirin|low dose aspirin
123167|NCT02797249|prevention|prevention
123168|NCT02797236|Phase I|phase i
123169|NCT02797236|conjugate vaccine|conjugate vaccine
123170|NCT02797236|Shigella flexneri 2a|shigella flexneri 2a
123171|NCT02797236|safety|safety
123172|NCT02797236|Immunogenicity|immunogenicity
123173|NCT02797236|Healthy adults|healthy adults
123174|NCT02797223|alopecia|alopecia
123175|NCT02797223|chemotherapy|chemotherapy
123176|NCT02797223|breast cancer|breast cancer
123177|NCT02797158|TAVI|tavi
123178|NCT02797158|Aortic stenosis|aortic stenosis
123179|NCT02797158|Coronary artery disease|coronary artery disease
123180|NCT02797158|Coronary angiography|coronary angiography
123181|NCT02797158|Percutaneous Coronary Intervention|percutaneous coronary intervention
123182|NCT02797158|Myocardial ischemia|myocardial ischemia
123183|NCT02797158|SPECT|spect
123184|NCT02797158|Coronary revascularization|coronary revascularization
123185|NCT02797145|Digoxin|digoxin
123187|NCT02797119|Tranexamic acid|tranexamic acid
123188|NCT02797119|Fibrinolysis|fibrinolysis
123189|NCT02797119|Cesarean section|cesarean section
123190|NCT02797119|Pharmacokinetics|pharmacokinetics
123191|NCT02797119|D dimers|d dimers
123192|NCT02797119|Fibrinogen|fibrinogen
123193|NCT02797119|Plasmin|plasmin
123194|NCT02797119|Transfusion|transfusion
123195|NCT02797106|Drooling|drooling
123196|NCT02797106|Cerebral palsy|cerebral palsy
123197|NCT02797106|Botulinium toxin|botulinium toxin
123198|NCT02797106|Practice survey of health professionals|practice survey of health professionals
123199|NCT02797106|Children|children
123200|NCT02797093|anti-retroviral therapy|anti-retroviral therapy
123201|NCT02797080|ACTIMMUNE|actimmune
123202|NCT02797080|interferon y-1b|interferon y-1b
123203|NCT02797067|Extracorporeal Shock Wave lithotripsy(ESWL)|extracorporeal shock wave lithotripsy(eswl)
123204|NCT02797067|Prophylaxis|prophylaxis
123205|NCT02797067|Indomethacin|indomethacin
123206|NCT02797067|Chronic pancreatitis|chronic pancreatitis
123207|NCT02797054|HPV vaccination|hpv vaccination
123208|NCT02797054|Vaccination decision-making|vaccination decision-making
123209|NCT02797054|Tailored health messaging|tailored health messaging
123210|NCT02797054|Barriers to vaccination|barriers to vaccination
123211|NCT02797054|Attitudes|attitudes
123212|NCT02797041|Multiple myeloma|multiple myeloma
123213|NCT02797041|Bortezomib|bortezomib
123214|NCT02797041|Relapsed multiple myeloma|relapsed multiple myeloma
123215|NCT02797041|Rechallenge|rechallenge
123216|NCT02797028|Hyperuricemia|hyperuricemia
123217|NCT02797028|endothelial function|endothelial function
123218|NCT02797028|anthocyanidins|anthocyanidins
123219|NCT02797015|MS|ms
123220|NCT02797015|RMS|rms
123221|NCT02797015|Multiple Sclerosis|multiple sclerosis
123222|NCT02797015|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
123223|NCT02796976|arterial stiffness|arterial stiffness
123224|NCT02796976|retinal vessels|retinal vessels
123225|NCT02796976|physical activity|physical activity
123226|NCT02796976|ageing|ageing
123227|NCT02796963|HIV|hiv
123228|NCT02796963|MSM|msm
123229|NCT02796963|test uptake|test uptake
123230|NCT02796963|crowdsourcing|crowdsourcing
123231|NCT02796950|Acipimox|acipimox
123232|NCT02796950|GLP-1|glp-1
123233|NCT02796950|Insulin secretion|insulin secretion
123234|NCT02796937|Pulmonary Emphysema|pulmonary emphysema
123235|NCT02796937|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
123236|NCT02796937|AATD|aatd
123237|NCT02796937|Alpha-1 PI Deficiency|alpha-1 pi deficiency
123238|NCT02796937|Alpha-1 Proteinase Inhibitor|alpha-1 proteinase inhibitor
123239|NCT02796924|Psychogenic Non-Epileptic Seizure|psychogenic non-epileptic seizure
123240|NCT02796924|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
123241|NCT02796924|Brain Stimulation|brain stimulation
123242|NCT02796898|Prostate Cancer|prostate cancer
123243|NCT02796898|PSA|psa
123244|NCT02796898|Androgen Deprivation Therapy (ADT)|androgen deprivation therapy (adt)
123245|NCT02796859|Inflammation|inflammation
123246|NCT02796859|Psychosis|psychosis
123247|NCT02796859|Schizophrenia|schizophrenia
123248|NCT02796846|CPAP (continuous positive airway pressure)|cpap (continuous positive airway pressure)
123249|NCT02796846|OSA (Obstructive sleep apnea)|osa (obstructive sleep apnea)
123250|NCT02796833|Home parenteral nutrition|home parenteral nutrition
123251|NCT02796833|Liver injury|liver injury
123252|NCT02796833|Intravenous Lipid Emulsions|intravenous lipid emulsions
123253|NCT02796833|Catheter-related infections|catheter-related infections
123254|NCT02796833|Safety|safety
123255|NCT02796820|Huaier Granule|huaier granule
123256|NCT02796820|After radical surgery|after radical surgery
123257|NCT02796820|Prevention of Recurrence and Metastasis|prevention of recurrence and metastasis
123258|NCT02796820|Efficacy and safety|efficacy and safety
123259|NCT02796794|Enteral nutrition|enteral nutrition
123260|NCT02796794|Genistein|genistein
123261|NCT02796794|Cytokine|cytokine
123262|NCT02796755|Central Nervous System (CNS) Glutamate|central nervous system (cns) glutamate
123263|NCT02796755|Breast Cancer Treatment|breast cancer treatment
123264|NCT02796755|Fatigue|fatigue
123265|NCT02796755|Cognitive Dysfunction|cognitive dysfunction
123266|NCT02796755|Behavioral|behavioral
123267|NCT02796755|Psychometrics|psychometrics
123268|NCT02796755|Imaging Technology|imaging technology
123269|NCT02796755|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
123270|NCT02796742|SSTIs|sstis
123271|NCT02796742|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
123272|NCT02796742|Methicillin susceptible Staphylococcus aureus (MSSA)|methicillin susceptible staphylococcus aureus (mssa)
123375|NCT02796300|bioflo|bioflo
123273|NCT02796742|the toxin Panton-Valentine Leukocidin (PVL)|the toxin panton-valentine leukocidin (pvl)
123274|NCT02796742|Emergency Departments|emergency departments
123275|NCT02796716|Wounded warriors|wounded warriors
123276|NCT02796716|Battlefield infection|battlefield infection
123277|NCT02796716|ESBL|esbl
123278|NCT02796716|MRSA|mrsa
123279|NCT02796716|KPC|kpc
123280|NCT02796690|nasal carriage|nasal carriage
123281|NCT02796690|Staphylococcus aureus|staphylococcus aureus
123282|NCT02796690|good hygiene practices|good hygiene practices
123283|NCT02796677|Safety|safety
123284|NCT02796677|Efficacy|efficacy
123285|NCT02796677|Aclidinium bromide|aclidinium bromide
123286|NCT02796677|Formoterol fumarate|formoterol fumarate
123287|NCT02796677|Tiotropium|tiotropium
123288|NCT02796677|Bronchodilation|bronchodilation
123289|NCT02796677|COPD|copd
123290|NCT02796664|Ginseng|ginseng
123291|NCT02796664|Stroke|stroke
123292|NCT02796664|Quantitative MR flow analysis|quantitative mr flow analysis
123293|NCT02796651|Perforomist|perforomist
123294|NCT02796651|Pressair|pressair
123295|NCT02796651|COPD|copd
123296|NCT02796651|Cigarette smoking|cigarette smoking
123297|NCT02796651|Formoterol fumarate|formoterol fumarate
123298|NCT02796651|long-acting β2-adrenergic agonists (LABA)|long-acting β2-adrenergic agonists (laba)
123299|NCT02796651|long-acting muscarinic antagonists (LAMA)|long-acting muscarinic antagonists (lama)
123300|NCT02796638|Acute Heart Failure|acute heart failure
123301|NCT02796638|Positive-Pressure Ventilation|positive-pressure ventilation
123302|NCT02796638|Adaptive Servo-Ventilation|adaptive servo-ventilation
123303|NCT02796625|EEG|eeg
123304|NCT02796625|healthy subjects|healthy subjects
123305|NCT02796612|anxiety|anxiety
123306|NCT02796612|breast cancer, suspected|breast cancer, suspected
123307|NCT02796612|breast biopsy|breast biopsy
123308|NCT02796612|empathy|empathy
123309|NCT02796612|standardized and structured information|standardized and structured information
123310|NCT02796612|anxiety reduction|anxiety reduction
123311|NCT02796586|Refugee Health|refugee health
123312|NCT02796586|Resettled Refugee|resettled refugee
123313|NCT02796586|Family Planning|family planning
123314|NCT02796586|Contraception|contraception
123315|NCT02796586|Group Counseling|group counseling
123316|NCT02796586|Group contraceptive counseling|group contraceptive counseling
123317|NCT02796573|blended care|blended care
123318|NCT02796573|CBT|cbt
123319|NCT02796573|B-CBT|b-cbt
123320|NCT02796573|depression|depression
123321|NCT02796560|Drugs, Generic|drugs, generic
123322|NCT02796560|Generic Equivalency|generic equivalency
123323|NCT02796547|Episiotomy|episiotomy
123324|NCT02796547|Levobupivacaine|levobupivacaine
123325|NCT02796534|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
123326|NCT02796521|malnutrition|malnutrition
123327|NCT02796521|aging|aging
123328|NCT02796521|diet therapy|diet therapy
123329|NCT02796508|Healthy aging|healthy aging
123330|NCT02796508|Cognitive training|cognitive training
123331|NCT02796508|Video-games|video-games
123332|NCT02796508|Attention|attention
123333|NCT02796508|Working memory|working memory
123334|NCT02796508|Wellbeing|wellbeing
123335|NCT02796495|Neuroplasticity|neuroplasticity
123336|NCT02796495|Sensory Feedback|sensory feedback
123337|NCT02796495|Nerve stimulation|nerve stimulation
123338|NCT02796495|Robotic Hand|robotic hand
123339|NCT02796456|apelin|apelin
123340|NCT02796456|colostrum|colostrum
123341|NCT02796456|plasma|plasma
123342|NCT02796456|glycemic markers|glycemic markers
123343|NCT02796456|lipidic markers|lipidic markers
123344|NCT02796456|pregnancy|pregnancy
123345|NCT02796456|postpartum|postpartum
123346|NCT02796443|acute cholecystitis|acute cholecystitis
123347|NCT02796443|early versus delayed surgery|early versus delayed surgery
123348|NCT02796430|Indirect calorimetry|indirect calorimetry
123349|NCT02796430|critical care|critical care
123350|NCT02796430|mechanical ventilation|mechanical ventilation
123351|NCT02796430|energy expenditure|energy expenditure
123352|NCT02796430|ICALIC study|icalic study
123353|NCT02796404|home monitoring|home monitoring
123354|NCT02796404|cardiac monitoring|cardiac monitoring
123355|NCT02796391|nicotine|nicotine
123356|NCT02796391|cigarettes|cigarettes
123357|NCT02796391|very low nicotine content (VLNC)|very low nicotine content (vlnc)
123358|NCT02796391|smoking cessation|smoking cessation
123359|NCT02796378|physical activity|physical activity
123360|NCT02796378|statin therapy|statin therapy
123361|NCT02796378|diabetes mellitus|diabetes mellitus
123362|NCT02796378|cardiovascular disease|cardiovascular disease
123363|NCT02796378|Q10-supplementation|q10-supplementation
123364|NCT02796365|Exercise|exercise
123365|NCT02796365|Cancer|cancer
123366|NCT02796365|Cardiotoxicity|cardiotoxicity
123367|NCT02796365|Cardiomyopathy|cardiomyopathy
123368|NCT02796365|Cardiac Rehabilitation|cardiac rehabilitation
123369|NCT02796339|Inflammatory Bowel Diseases|inflammatory bowel diseases
123370|NCT02796339|natural Mastiha|natural mastiha
123371|NCT02796339|supplement|supplement
123372|NCT02796326|tracheal stenosis|tracheal stenosis
123373|NCT02796326|tracheal dilatation|tracheal dilatation
123374|NCT02796326|ventilation|ventilation
123376|NCT02796300|Duramax catheter|duramax catheter
123377|NCT02796300|dialysis|dialysis
123378|NCT02796287|Amnesia|amnesia
123379|NCT02796287|transient global amnesia|transient global amnesia
123380|NCT02796261|Anaplastic Astrocytoma|anaplastic astrocytoma
123381|NCT02796261|Grade 3 Glioma|grade 3 glioma
123382|NCT02796261|Glioma|glioma
123383|NCT02796261|Eflornithine|eflornithine
123384|NCT02796261|Brain Cancer|brain cancer
123385|NCT02796261|Brain Tumor|brain tumor
123386|NCT02796261|Neuro-oncology|neuro-oncology
123387|NCT02796261|Progressive Anaplastic Astrocytoma|progressive anaplastic astrocytoma
123388|NCT02796261|Recurrent Anaplastic Astrocytoma|recurrent anaplastic astrocytoma
123389|NCT02796261|Progressive Glioma|progressive glioma
123390|NCT02796261|Recurrent Glioma|recurrent glioma
123391|NCT02796261|Malignant Glioma|malignant glioma
123392|NCT02796261|Progressive Brain Tumor|progressive brain tumor
123393|NCT02796261|Recurrent Brain Tumor|recurrent brain tumor
123394|NCT02796248|type 1 diabetes|type 1 diabetes
123395|NCT02796248|glucose control|glucose control
123396|NCT02796248|stigma|stigma
123397|NCT02796248|youth|youth
123398|NCT02796222|Hemophilia|hemophilia
123399|NCT02796222|Recombinant factor VIII|recombinant factor viii
123400|NCT02796222|Recombinant factor VIII Fc|recombinant factor viii fc
123401|NCT02796222|Recombinant factor IX|recombinant factor ix
123402|NCT02796222|Patient-reported outcomes|patient-reported outcomes
123403|NCT02796222|Recombinant factor IX Fc|recombinant factor ix fc
123404|NCT02796209|atomoxetine|atomoxetine
123405|NCT02796209|autonomic failure|autonomic failure
123406|NCT02796196|Hematopoietic|hematopoietic
123407|NCT02796196|Recipient|recipient
123408|NCT02796170|SGLT-2 inhibitor|sglt-2 inhibitor
123409|NCT02796170|urinary angiotensinogen|urinary angiotensinogen
123410|NCT02796157|bioresorbable vascular scaffold, drug eluting stent, coronary artery disease|bioresorbable vascular scaffold, drug eluting stent, coronary artery disease
123411|NCT02796144|schizophrenia|schizophrenia
123412|NCT02796144|schizoaffective disorder|schizoaffective disorder
123413|NCT02796144|overweight|overweight
123414|NCT02796144|obesity|obesity
123415|NCT02796144|weight loss|weight loss
123416|NCT02796144|metformin|metformin
123417|NCT02796144|lorcaserin|lorcaserin
123418|NCT02796131|Phase I|phase i
123419|NCT02796131|Healthy|healthy
123420|NCT02796131|Pharmacodynamics|pharmacodynamics
123421|NCT02796118|Pharmacokinetics|pharmacokinetics
123422|NCT02796118|Healthy non-elderly and elderly subjects|healthy non-elderly and elderly subjects
123423|NCT02796118|ASP2151|asp2151
123424|NCT02796118|Safety|safety
123425|NCT02796092|Pelvic Congestion Syndrome|pelvic congestion syndrome
123426|NCT02796092|Pelvic Venous Insufficiency|pelvic venous insufficiency
123427|NCT02796092|Chronic pelvic pain|chronic pelvic pain
123428|NCT02796066|Acne, topical, SCD-1 inhibitor, moderate, severe|acne, topical, scd-1 inhibitor, moderate, severe
123429|NCT02796040|Parkinson's disease|parkinson's disease
123430|NCT02796040|Impulse control disorders|impulse control disorders
123431|NCT02796040|Diffusion tensor imaging|diffusion tensor imaging
123432|NCT02796040|MRI|mri
123433|NCT02796040|Mesocorticolimbic pathway|mesocorticolimbic pathway
123434|NCT02796027|Health Services Research|health services research
123435|NCT02795988|Secondary|secondary
123436|NCT02795962|Endovascular Procedures|endovascular procedures
123437|NCT02795962|Emergency Medical Services|emergency medical services
123438|NCT02795949|Enterobacteriaceae|enterobacteriaceae
123439|NCT02795949|Bacteremia|bacteremia
123440|NCT02795949|Escalation|escalation
123441|NCT02795949|Bacterial resistance|bacterial resistance
123442|NCT02795949|Bloodstream infection|bloodstream infection
123443|NCT02795949|Recurrence|recurrence
123444|NCT02795936|rehabilitation|rehabilitation
123445|NCT02795936|exercise|exercise
123446|NCT02795897|genetics|genetics
123447|NCT02795897|genomics|genomics
123448|NCT02795897|amyotrophic lateral sclerosis (ALS)|amyotrophic lateral sclerosis (als)
123449|NCT02795897|primary lateral sclerosis (PLS)|primary lateral sclerosis (pls)
123450|NCT02795897|progressive muscular atrophy (PMA)|progressive muscular atrophy (pma)
123451|NCT02795897|motor neuron disease|motor neuron disease
123452|NCT02795884|Lung cancer|lung cancer
123453|NCT02795884|NSCLC|nsclc
123454|NCT02795884|adjuvant treatment|adjuvant treatment
123455|NCT02795871|Congenital Adrenal Hyperplasia|congenital adrenal hyperplasia
123456|NCT02795871|Prenatal treatment|prenatal treatment
123457|NCT02795871|Dexamethasone|dexamethasone
123458|NCT02795871|Neuropsychological assessment|neuropsychological assessment
123459|NCT02795871|Cognitive development|cognitive development
123460|NCT02795858|Carcinoid Tumors|carcinoid tumors
123461|NCT02795806|Address|address
123462|NCT02795793|appendicitis|appendicitis
123463|NCT02795793|non-operative management|non-operative management
123464|NCT02795793|children|children
123465|NCT02795793|pediatric|pediatric
123466|NCT02795754|GSK2838232|gsk2838232
123467|NCT02795754|HIV|hiv
123468|NCT02795754|repeated dose escalation|repeated dose escalation
123469|NCT02795754|immediate release tablet|immediate release tablet
123470|NCT02795754|single dose escalation|single dose escalation
123471|NCT02795715|tDCS|tdcs
123472|NCT02795702|tDCS|tdcs
123473|NCT02795676|Glomerular filtration rate|glomerular filtration rate
123474|NCT02795676|Proteinuria|proteinuria
123475|NCT02795676|PRX-102|prx-102
123476|NCT02795676|pegunigalsidase alfa|pegunigalsidase alfa
123477|NCT02795676|Fabry Disease|fabry disease
123478|NCT02795663|Near-InfraRed Spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
123479|NCT02795663|Deep brain stimulation of SubThalamic Nucleus (DBS)|deep brain stimulation of subthalamic nucleus (dbs)
123480|NCT02795650|Metastatic|metastatic
123481|NCT02795650|Pancreas|pancreas
123482|NCT02795637|Attention deficit hyperactivity disorder (ADHD),|attention deficit hyperactivity disorder (adhd),
123483|NCT02795637|Binge-Eating Disorder (BED)|binge-eating disorder (bed)
123484|NCT02795611|Family-centered|family-centered
123485|NCT02795611|Autism spectrum disorder|autism spectrum disorder
123486|NCT02795611|Occupational therapy|occupational therapy
123487|NCT02795611|Participation|participation
123488|NCT02795611|Play|play
123489|NCT02795585|Fractional Flow Reserve|fractional flow reserve
123490|NCT02795585|Coronary Artery Disease|coronary artery disease
123491|NCT02795572|Breast Neoplasms|breast neoplasms
123492|NCT02795572|Peripheral Neuropathies|peripheral neuropathies
123493|NCT02795559|Nutrition|nutrition
123494|NCT02795559|Humans|humans
123495|NCT02795559|Obesity|obesity
123496|NCT02795559|Blood glucose|blood glucose
123497|NCT02795559|Dietary fiber|dietary fiber
123498|NCT02795559|Appetite|appetite
123499|NCT02795559|Short chain fatty acids|short chain fatty acids
123500|NCT02795546|periodontal regeneration|periodontal regeneration
123501|NCT02795533|Cognitive function|cognitive function
123502|NCT02795533|Quality of Life|quality of life
123503|NCT02795507|cross education|cross education
123504|NCT02795507|visual feedback|visual feedback
123505|NCT02795468|Peripheral|peripheral
123506|NCT02795468|Arterial|arterial
123507|NCT02795468|Catheterization|catheterization
123508|NCT02795455|Eating Disorders|eating disorders
123509|NCT02795455|Food Avoidance|food avoidance
123510|NCT02795455|Reward Learning|reward learning
123511|NCT02795455|Reward System|reward system
123512|NCT02795455|Family-based treatment|family-based treatment
123513|NCT02795455|interoceptive exposure|interoceptive exposure
123514|NCT02795455|insula-amygdala-ventral striatum subcircuits|insula-amygdala-ventral striatum subcircuits
123515|NCT02795429|Phase Ib/II|phase ib/ii
123516|NCT02795429|INC280|inc280
123517|NCT02795429|PDR001|pdr001
123518|NCT02795429|checkpoint inhibitor|checkpoint inhibitor
123519|NCT02795429|PD-1|pd-1
123520|NCT02795416|Moderate to severe plaque psoriasis, PASI, secukinumab, monoclonal antibody, Turkish population|moderate to severe plaque psoriasis, pasi, secukinumab, monoclonal antibody, turkish population
123521|NCT02795403|HCV, liver|hcv, liver
123522|NCT02795390|Chinese herbal medicine formula|chinese herbal medicine formula
123523|NCT02795390|MaZiRenWan|mazirenwan
123524|NCT02795390|Randomized controlled trial|randomized controlled trial
123525|NCT02795390|Constipation|constipation
123526|NCT02795390|Palliative care in cancer|palliative care in cancer
123527|NCT02795377|arterial hypertension|arterial hypertension
123528|NCT02795377|microparticle|microparticle
123529|NCT02795377|endothelial function|endothelial function
123530|NCT02795364|High Grade Glioma|high grade glioma
123531|NCT02795364|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
123532|NCT02795364|Surgical resection|surgical resection
123533|NCT02795364|Prognosis|prognosis
123534|NCT02795325|Primary Hyperoxaluria Type 1|primary hyperoxaluria type 1
123535|NCT02795325|PH1|ph1
123536|NCT02795325|Calcium Oxalate Stones|calcium oxalate stones
123537|NCT02795325|Kidney Stones|kidney stones
123538|NCT02795325|Liver Enzyme Deficiency|liver enzyme deficiency
123539|NCT02795325|Genetic Diseases|genetic diseases
123540|NCT02795325|Inborn Kidney Diseases|inborn kidney diseases
123541|NCT02795325|Metabolic Diseases|metabolic diseases
123542|NCT02795325|Inborn Errors|inborn errors
123543|NCT02795325|Urological Diseases|urological diseases
123544|NCT02795325|Carbohydrate Metabolism|carbohydrate metabolism
123545|NCT02795325|Hyperoxaluria|hyperoxaluria
123546|NCT02795325|AGT|agt
123547|NCT02795325|RNAi|rnai
123548|NCT02795325|siRNA|sirna
123549|NCT02795325|DCR-PH1|dcr-ph1
123550|NCT02795312|Cigarette Smoking|cigarette smoking
123551|NCT02795286|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
123552|NCT02795286|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
123553|NCT02795286|Chronic Hemodialysis|chronic hemodialysis
123554|NCT02795286|In-center HD|in-center hd
123555|NCT02795286|Sodium|sodium
123556|NCT02795286|Isotonic Dialysis|isotonic dialysis
123557|NCT02795273|Rhinitis|rhinitis
123558|NCT02795273|Conjunctivitis|conjunctivitis
123559|NCT02795273|Grass|grass
123560|NCT02795273|Allergy|allergy
123561|NCT02795260|ESAT6|esat6
123562|NCT02795260|CFP10|cfp10
123563|NCT02795260|skin test|skin test
123564|NCT02795260|diagnostic test|diagnostic test
123565|NCT02795195|re-irradiation|re-irradiation
123566|NCT02795195|carbon ion therapy|carbon ion therapy
123567|NCT02795182|Relapsed|relapsed
123568|NCT02795182|Refractory|refractory
123569|NCT02795156|regorafenib|regorafenib
123570|NCT02795156|afatinib|afatinib
123571|NCT02795156|targeted therapy|targeted therapy
123572|NCT02795156|cabozantinib|cabozantinib
123573|NCT02795143|TEN|ten
123574|NCT02795104|RISE|rise
123575|NCT02795091|clean supplies|clean supplies
123576|NCT02795091|ICU floor|icu floor
123577|NCT02795091|bacteria colony|bacteria colony
123578|NCT02795091|catheter associated with infection|catheter associated with infection
123579|NCT02795078|Atherosclerotic Intracranial Arterial Stenosis|atherosclerotic intracranial arterial stenosis
123580|NCT02795078|Intracranial Aneurysms|intracranial aneurysms
123581|NCT02795052|Neurologic Disease|neurologic disease
123582|NCT02795052|Cerebral Vascular Accident|cerebral vascular accident
123583|NCT02795052|Stroke|stroke
123584|NCT02795052|Traumatic Brain Injury|traumatic brain injury
123585|NCT02795052|Multiple Sclerosis|multiple sclerosis
123586|NCT02795052|Parkinsons Disease|parkinsons disease
123587|NCT02795052|Neuropathy|neuropathy
123588|NCT02795052|Neurodegeneration|neurodegeneration
123589|NCT02795052|Diabetic Neuropathy|diabetic neuropathy
123590|NCT02795052|Cerebral Ischemia|cerebral ischemia
123591|NCT02795026|dry needling|dry needling
123592|NCT02795026|vulvodynia|vulvodynia
123593|NCT02795026|pelvic pain chronic|pelvic pain chronic
123594|NCT02795013|Genetic studies|genetic studies
123595|NCT02795013|Pediatric|pediatric
123596|NCT02795000|Primary Ovarian Insufficiency|primary ovarian insufficiency
123597|NCT02795000|nomogram|nomogram
123598|NCT02794987|Bile duct|bile duct
123599|NCT02794987|indeterminate stricture|indeterminate stricture
123600|NCT02794987|cholangioscopy|cholangioscopy
123601|NCT02794987|Spyglass|spyglass
123602|NCT02794948|primary ovarian insufficiency|primary ovarian insufficiency
123603|NCT02794948|TCM intervention|tcm intervention
123604|NCT02794935|inspiratory muscle training|inspiratory muscle training
123605|NCT02794935|heart failure|heart failure
123606|NCT02794935|obstructive sleep apnea|obstructive sleep apnea
123607|NCT02794922|Vitamin B|vitamin b
123608|NCT02794922|Temporomandibular joint disorder|temporomandibular joint disorder
123609|NCT02794922|trpv1|trpv1
123610|NCT02794909|Point-of-care ultrasound|point-of-care ultrasound
123611|NCT02794909|ED|ed
123612|NCT02794909|Low and middle-income country|low and middle-income country
123613|NCT02794909|Echocardiography|echocardiography
123614|NCT02794909|Lung ultrasound|lung ultrasound
123615|NCT02794909|Resuscitation|resuscitation
123616|NCT02794857|ALS|als
123617|NCT02794857|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
123618|NCT02794857|Motor Neuron Disease|motor neuron disease
123619|NCT02794857|Central Nervous System Diseases|central nervous system diseases
123620|NCT02794857|Nervous System Diseases|nervous system diseases
123621|NCT02794857|Neurodegenerative Diseases|neurodegenerative diseases
123622|NCT02794857|Neuromuscular Diseases|neuromuscular diseases
123623|NCT02794857|Inflammation|inflammation
123624|NCT02794857|C-Reactive Protein|c-reactive protein
123625|NCT02794831|NSAIDs|nsaids
123626|NCT02794831|Bacterial Infections|bacterial infections
123627|NCT02794831|Severity|severity
123628|NCT02794831|Self Medication|self medication
123629|NCT02794818|Prevention|prevention
123630|NCT02794818|Nutrition|nutrition
123631|NCT02794792|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
123632|NCT02794792|ASP1941|asp1941
123633|NCT02794792|Ipragliflozin|ipragliflozin
123634|NCT02794779|cesarean section|cesarean section
123635|NCT02794779|labor|labor
123636|NCT02794779|oxytocin|oxytocin
123637|NCT02794753|Trichotillomania|trichotillomania
123638|NCT02794753|Hair-pulling Disorder|hair-pulling disorder
123639|NCT02794753|Cognitive Training|cognitive training
123640|NCT02794753|Neuroplasticity|neuroplasticity
123641|NCT02794753|Working Memory|working memory
123642|NCT02794740|Osteoarthritis|osteoarthritis
123643|NCT02794714|Laparoscopic Gynecologic Surgeries|laparoscopic gynecologic surgeries
123644|NCT02794688|Non-lactating|non-lactating
123645|NCT02794688|idiopathic granulomatous mastitis|idiopathic granulomatous mastitis
123646|NCT02794688|periductal mastitis|periductal mastitis
123647|NCT02794688|ductal lavage|ductal lavage
123648|NCT02794675|resectable|resectable
123649|NCT02794675|Cesium 131|cesium 131
123650|NCT02794675|brachytherapy|brachytherapy
123651|NCT02794662|Oxygen Delivery System, Nasal Cannula|oxygen delivery system, nasal cannula
123652|NCT02794662|Oxygen Delivery System, Incubator|oxygen delivery system, incubator
123653|NCT02794623|cochlear implants|cochlear implants
123654|NCT02794623|hearing loss|hearing loss
123655|NCT02794610|Tacrolimus|tacrolimus
123656|NCT02794610|Ocular penetration|ocular penetration
123657|NCT02794610|Topical|topical
123658|NCT02794597|Unplanned Pregnancy, LARC|unplanned pregnancy, larc
123659|NCT02794558|Breast Cancer, MRgFus, Focused Ultrasound|breast cancer, mrgfus, focused ultrasound
123660|NCT02794519|Asthma Control Questionnaire|asthma control questionnaire
123661|NCT02794519|interleukin-6|interleukin-6
123662|NCT02794519|Sirukumab|sirukumab
123663|NCT02794519|severe, poorly controlled asthma|severe, poorly controlled asthma
123664|NCT02794519|asthma|asthma
123665|NCT02794519|ACQ|acq
123666|NCT02794506|Diabetes mellitus|diabetes mellitus
123667|NCT02794506|Chronic periodontitis|chronic periodontitis
123668|NCT02794506|Propolis|propolis
123669|NCT02794480|ELLIPTA|ellipta
123670|NCT02794480|metered dose inhaler|metered dose inhaler
123671|NCT02794480|Dry powder inhaler|dry powder inhaler
123672|NCT02794467|Heavy menstrual bleeding|heavy menstrual bleeding
123673|NCT02794467|Adenomyosis|adenomyosis
123674|NCT02794467|Safety|safety
123675|NCT02794467|Epelsiban|epelsiban
123676|NCT02794467|Tolerability|tolerability
123677|NCT02794467|Proof of concept|proof of concept
123678|NCT02794428|Gastric adenocarcinoma|gastric adenocarcinoma
123679|NCT02794428|Gastric intestinal metaplasia|gastric intestinal metaplasia
123680|NCT02794428|Atrophic gastritis|atrophic gastritis
123681|NCT02794428|Gastric premalignant lesion|gastric premalignant lesion
123682|NCT02794415|HIV|hiv
123683|NCT02794415|disability|disability
123684|NCT02794415|rehabilitation|rehabilitation
123685|NCT02794415|exercise|exercise
123686|NCT02794389|Acetylcysteine|acetylcysteine
123687|NCT02794376|IBS|ibs
123688|NCT02794350|RBANS-H|rbans-h
123689|NCT02794350|Cochlear implantation|cochlear implantation
123690|NCT02794350|Cognition|cognition
123691|NCT02794350|Older adults|older adults
123692|NCT02794350|RBANS|rbans
123693|NCT02794285|Lupus Erythematosus, Systemic Autoimmune Diseases, Connective Tissue Diseases,Immune System Diseases|lupus erythematosus, systemic autoimmune diseases, connective tissue diseases,immune system diseases
123694|NCT02794272|GABA concentration|gaba concentration
123695|NCT02794272|tDCS|tdcs
123696|NCT02794259|GABA concentration|gaba concentration
123697|NCT02794259|tDCS|tdcs
123698|NCT02794233|Deep Brain Stimulation|deep brain stimulation
123699|NCT02794233|Electric Impedance|electric impedance
123700|NCT02794233|Parkinson disease|parkinson disease
123701|NCT02794220|E-cigarette|e-cigarette
123702|NCT02794220|healthy volunteer study|healthy volunteer study
123703|NCT02794220|Pharmacokinetics|pharmacokinetics
123704|NCT02794220|Nicorette|nicorette
123705|NCT02794207|Pediatric|pediatric
123706|NCT02794207|Cancer|cancer
123707|NCT02794207|AML|aml
123708|NCT02794207|Qualitative Interview|qualitative interview
123709|NCT02794194|Chronic Ankle Instability|chronic ankle instability
123710|NCT02794194|Whole Body Vibration|whole body vibration
123711|NCT02794194|Proprioception|proprioception
123712|NCT02794181|Transfusion-Transmitted Infections|transfusion-transmitted infections
123713|NCT02794181|Dengue Virus|dengue virus
123714|NCT02794181|Chikungunya Virus|chikungunya virus
123715|NCT02794181|Natural History|natural history
123716|NCT02794181|Blood Transfusion|blood transfusion
123717|NCT02794142|hemodialysis|hemodialysis
123718|NCT02794142|muscle dysfunction|muscle dysfunction
123719|NCT02794142|mitochondria|mitochondria
123720|NCT02794142|oxidative stress|oxidative stress
123721|NCT02794142|inflammation|inflammation
123722|NCT02794142|renal transplantation|renal transplantation
123723|NCT02794103|Virtual reality|virtual reality
123724|NCT02794103|Immersive distraction|immersive distraction
123725|NCT02794103|Virtual world|virtual world
123726|NCT02794103|Virtual environment|virtual environment
123727|NCT02794103|Procedural pain|procedural pain
123728|NCT02794103|Procedural anxiety|procedural anxiety
123729|NCT02794103|Acute pain|acute pain
123730|NCT02794103|Pain management|pain management
123731|NCT02794103|Anxiety|anxiety
123732|NCT02794103|Children, Child|children, child
123733|NCT02794103|Kid, Kids|kid, kids
123734|NCT02794103|Pediatric, Pediatrics|pediatric, pediatrics
123735|NCT02794103|Young children|young children
123736|NCT02794103|Burns|burns
123737|NCT02794103|Burn injuries|burn injuries
123738|NCT02794103|Burn unit|burn unit
123739|NCT02794103|Hydrotherapy|hydrotherapy
123740|NCT02794103|Burn dressing|burn dressing
123741|NCT02794103|Non-pharmacological|non-pharmacological
123742|NCT02794103|Clinical Research|clinical research
123743|NCT02794103|Nursing Practice|nursing practice
123744|NCT02794090|Behavioral treatment|behavioral treatment
123745|NCT02794090|Telephone coaching|telephone coaching
123746|NCT02794090|Outpatient clinic|outpatient clinic
123747|NCT02794077|Nasopharyngeal undifferentiated carcinoma|nasopharyngeal undifferentiated carcinoma
123748|NCT02793947|Peri-incisional injection|peri-incisional injection
123749|NCT02793947|Multimodal analgesia|multimodal analgesia
123750|NCT02793947|Femur fracture|femur fracture
123751|NCT02793934|Rehabilitation|rehabilitation
123752|NCT02793934|ICF|icf
123753|NCT02793934|Pilot project|pilot project
123754|NCT02793934|Stroke|stroke
123755|NCT02793934|Acute myocardial infarction|acute myocardial infarction
123756|NCT02793934|Total hip replacement|total hip replacement
123757|NCT02793921|Alteration|alteration
123758|NCT02793921|Cognitive Function|cognitive function
123759|NCT02793921|Exercise|exercise
123760|NCT02793908|Endometriosis|endometriosis
123761|NCT02793908|Subcutaneous progesterone|subcutaneous progesterone
123762|NCT02793908|luteal phase|luteal phase
123763|NCT02793895|Atrial fibrillation/flutter|atrial fibrillation/flutter
123764|NCT02793895|Postoperative atrial arrhythmia|postoperative atrial arrhythmia
123765|NCT02793895|Cardiac surgery|cardiac surgery
123766|NCT02793895|Stroke prevention|stroke prevention
123767|NCT02793895|Oral anticoagulation|oral anticoagulation
123768|NCT02793895|Cardiac rhythm monitoring|cardiac rhythm monitoring
124968|NCT02786992|Misoprostol|misoprostol
123769|NCT02793869|congenital cataract;anterior segment characteristics|congenital cataract;anterior segment characteristics
123770|NCT02793856|lung cancer|lung cancer
123771|NCT02793856|immune checkpoint|immune checkpoint
123772|NCT02793856|PD-1|pd-1
123773|NCT02793856|CRISPER|crisper
123774|NCT02793856|autologous cell infusion|autologous cell infusion
123775|NCT02793830|medication adherence|medication adherence
123776|NCT02793830|mHealth|mhealth
123777|NCT02793830|China|china
123778|NCT02793830|heart disease|heart disease
123779|NCT02793817|postsurgical|postsurgical
123780|NCT02793817|postoperative|postoperative
123781|NCT02793817|ocular|ocular
123782|NCT02793817|cataract|cataract
123783|NCT02793817|inflammation|inflammation
123784|NCT02793817|pain|pain
123785|NCT02793817|corticosteroid|corticosteroid
123786|NCT02793804|HIV self-testing|hiv self-testing
123787|NCT02793804|HIV|hiv
123788|NCT02793804|Zambia|zambia
123789|NCT02793791|high grade dysplastic nodule (HGDN)|high grade dysplastic nodule (hgdn)
123790|NCT02793791|low grade dysplastic nodule (LGDN)|low grade dysplastic nodule (lgdn)
123791|NCT02793778|Crohn's Disease|crohn's disease
123792|NCT02793778|Digestive System Diseases|digestive system diseases
123793|NCT02793778|Gastrointestinal Diseases|gastrointestinal diseases
123794|NCT02793778|Intestinal Diseases|intestinal diseases
123795|NCT02793778|mucosal healing|mucosal healing
123796|NCT02793778|inflammatory bowel disease|inflammatory bowel disease
123797|NCT02793778|Medical Food|medical food
123798|NCT02793778|Nutritional intervention|nutritional intervention
123799|NCT02793765|Advanced Prostate Cancer|advanced prostate cancer
123800|NCT02793765|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
123801|NCT02793765|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
123802|NCT02793765|Metastatic disease|metastatic disease
123803|NCT02793765|CRPC|crpc
123804|NCT02793752|IVF|ivf
123805|NCT02793752|In vitro fertilization|in vitro fertilization
123806|NCT02793752|Cumulus Cells|cumulus cells
123807|NCT02793752|Oocyte|oocyte
123808|NCT02793752|Embryo|embryo
123809|NCT02793752|Fertility|fertility
123810|NCT02793739|Safety|safety
123811|NCT02793739|Efficacy|efficacy
123812|NCT02793739|Longevity|longevity
123813|NCT02793726|Hip Prosthesis|hip prosthesis
123814|NCT02793713|EBUS|ebus
123815|NCT02793713|Prediction|prediction
123816|NCT02793713|malignancy|malignancy
123817|NCT02793713|lymph nodes|lymph nodes
123818|NCT02793713|lung cancer|lung cancer
123819|NCT02793713|Diagnostic Techniques, Respiratory System|diagnostic techniques, respiratory system
123820|NCT02793700|Betamethasone|betamethasone
123821|NCT02793674|effort of breathing|effort of breathing
123822|NCT02793674|high flow nasal cannula|high flow nasal cannula
123823|NCT02793674|respiratory distress|respiratory distress
123824|NCT02793648|Depression|depression
123825|NCT02793648|Elderly|elderly
123826|NCT02793635|Paraplegia|paraplegia
123827|NCT02793635|Gait|gait
123828|NCT02793635|Exoskeleton|exoskeleton
123829|NCT02793622|Chemoprevention|chemoprevention
123830|NCT02793622|Malaria|malaria
123831|NCT02793622|Sulfadoxine-Pyrimethamine|sulfadoxine-pyrimethamine
123832|NCT02793622|Dihydroartemisinin-Piperaquine|dihydroartemisinin-piperaquine
123833|NCT02793609|induction of labor|induction of labor
123834|NCT02793609|double balloon catheter|double balloon catheter
123835|NCT02793609|mechanical ripening|mechanical ripening
123836|NCT02793505|metformin|metformin
123837|NCT02793505|pregnancy outcomes|pregnancy outcomes
123838|NCT02793505|birth defects|birth defects
123839|NCT02793505|spontaneous abortion|spontaneous abortion
123840|NCT02793505|pharmacoepidemiology|pharmacoepidemiology
123841|NCT02793466|Durvalumab|durvalumab
123842|NCT02793466|solid tumors|solid tumors
123843|NCT02793466|Immunotherapy|immunotherapy
123844|NCT02793466|Check Point Inhibitor|check point inhibitor
123845|NCT02793466|pediatrics|pediatrics
123846|NCT02793466|children|children
123847|NCT02793401|High Intensity Laser|high intensity laser
123848|NCT02793401|Ultrasound|ultrasound
123849|NCT02793401|Chronic Shoulder Pain|chronic shoulder pain
123850|NCT02793375|Montelukast|montelukast
123851|NCT02793375|Tonsillectomy|tonsillectomy
123852|NCT02793349|angioplasty|angioplasty
123853|NCT02793349|stents|stents
123854|NCT02793349|polymers|polymers
123855|NCT02793349|absorbable implants|absorbable implants
123856|NCT02793271|Depression|depression
123857|NCT02793271|Primary Health Care|primary health care
123858|NCT02793271|Social Stigma|social stigma
123859|NCT02793271|Stereotyping|stereotyping
123860|NCT02793271|Health Care Quality|health care quality
123861|NCT02793271|Access|access
123862|NCT02793271|Evaluation|evaluation
123863|NCT02793258|tDCS|tdcs
123864|NCT02793258|neuromodulation|neuromodulation
123865|NCT02793258|depression|depression
123866|NCT02793258|cognition|cognition
123867|NCT02793232|Safety|safety
123868|NCT02793232|Tolerability|tolerability
123869|NCT02793232|Pharmacokinetics|pharmacokinetics
123870|NCT02793232|Alzheimer's disease|alzheimer's disease
123871|NCT02793219|Advanced Prostate Cancer|advanced prostate cancer
124074|NCT02792127|Cognitive Behaviour Therapy|cognitive behaviour therapy
123872|NCT02793219|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
123873|NCT02793219|CRPC|crpc
123874|NCT02793219|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
123875|NCT02793219|Metastatic disease|metastatic disease
123876|NCT02793206|Drusen|drusen
123877|NCT02793206|SD-OCT|sd-oct
123878|NCT02793167|acute kidney injury|acute kidney injury
123879|NCT02793167|medication alert systems|medication alert systems
123880|NCT02793154|gastric emptying|gastric emptying
123881|NCT02793154|albiglutide|albiglutide
123882|NCT02793154|GMA|gma
123883|NCT02793154|exenatide|exenatide
123884|NCT02793154|type 2 diabetes mellitus|type 2 diabetes mellitus
123885|NCT02793141|Pneumonia|pneumonia
123886|NCT02793141|Intensive Care Unit|intensive care unit
123887|NCT02793141|Nosocomial pneumonia|nosocomial pneumonia
123888|NCT02793141|Hospital-acquired pneumonia|hospital-acquired pneumonia
123889|NCT02793141|Ventilator-associated pneumonia|ventilator-associated pneumonia
123890|NCT02793141|ICU|icu
123891|NCT02793141|HAP|hap
123892|NCT02793141|VAP|vap
123893|NCT02793141|Critical Care|critical care
123894|NCT02793128|TC-3|tc-3
123895|NCT02793128|Mitogel|mitogel
123896|NCT02793128|UTUC|utuc
123897|NCT02793128|Ureteral|ureteral
123898|NCT02793128|Upper Tract|upper tract
123899|NCT02793128|Carcinoma|carcinoma
123900|NCT02793128|Kidney|kidney
123901|NCT02793128|Renal|renal
123902|NCT02793128|Gel|gel
123903|NCT02793128|Local|local
123904|NCT02793128|Mitomycin C|mitomycin c
123905|NCT02793128|Prolonged Release|prolonged release
123906|NCT02793128|Slow Release|slow release
123907|NCT02793128|Kidney Sparing|kidney sparing
123908|NCT02793128|T1|t1
123909|NCT02793128|T0|t0
123910|NCT02793128|Low Grade|low grade
123911|NCT02793128|Transitional Cell Carcinoma of Renal Pelvis|transitional cell carcinoma of renal pelvis
123912|NCT02793128|TCC|tcc
123913|NCT02793102|mental anorexia|mental anorexia
123914|NCT02793102|sensory workshops|sensory workshops
123915|NCT02793102|BMI|bmi
123916|NCT02793076|Posture|posture
123917|NCT02793076|Body image|body image
123918|NCT02793076|Dancing|dancing
123919|NCT02793076|Group|group
123920|NCT02793076|Survivors|survivors
123921|NCT02793063|Brittle Bone|brittle bone
123922|NCT02793063|Osteogenesis Imperfecta|osteogenesis imperfecta
123923|NCT02793063|BBD|bbd
123924|NCT02793063|OI|oi
123925|NCT02793063|Congenital Abnormalities|congenital abnormalities
123926|NCT02793063|Congenital Bone Disorder|congenital bone disorder
123927|NCT02793063|Lobstein Syndrome|lobstein syndrome
123928|NCT02793050|Trabectedin|trabectedin
123929|NCT02793050|Soft Tissue Sarcoma|soft tissue sarcoma
123930|NCT02793050|Observational|observational
123931|NCT02793037|zirconia|zirconia
123932|NCT02793037|resin bonded bridge|resin bonded bridge
123933|NCT02793024|food shopping intervention|food shopping intervention
123934|NCT02792972|Analgesic|analgesic
123935|NCT02792972|Medicinal plants|medicinal plants
123936|NCT02792972|Skin|skin
123937|NCT02792972|Antimicrobial agents|antimicrobial agents
123938|NCT02792972|Pain Measurement|pain measurement
123939|NCT02792907|Foot Surgery|foot surgery
123940|NCT02792907|Compliance|compliance
123941|NCT02792907|Compressive Stockings|compressive stockings
123942|NCT02792894|cluster randomized trial|cluster randomized trial
123943|NCT02792894|developmental delays|developmental delays
123944|NCT02792894|neurodevelopmental disorders|neurodevelopmental disorders
123945|NCT02792894|autism|autism
123946|NCT02792894|intellectual disability|intellectual disability
123947|NCT02792894|low resource settings|low resource settings
123948|NCT02792894|family volunteers|family volunteers
123949|NCT02792881|Stomach Neoplasms|stomach neoplasms
123950|NCT02792881|Laparoscopy|laparoscopy
123951|NCT02792881|Remnant gastric cancer|remnant gastric cancer
123952|NCT02792855|Snifﬁng Position|snifﬁng position
123953|NCT02792855|Simple Head Extension|simple head extension
123954|NCT02792829|Bioavailability of Lenvatinib suspension|bioavailability of lenvatinib suspension
123955|NCT02792829|Palatability of Lenvatinib suspension|palatability of lenvatinib suspension
123956|NCT02792829|Lenvatinib|lenvatinib
123957|NCT02792829|Lenvima|lenvima
123958|NCT02792829|E7080|e7080
123959|NCT02792829|Capsule formulation|capsule formulation
123960|NCT02792829|Healthy volunteers|healthy volunteers
123961|NCT02792803|POAG|poag
123962|NCT02792803|Primary open angle glaucoma|primary open angle glaucoma
123963|NCT02792803|Ocular Hypertension|ocular hypertension
123964|NCT02792803|Xalatan|xalatan
123965|NCT02792803|Latanoprost|latanoprost
123966|NCT02792803|Ocular Hyperemia|ocular hyperemia
123967|NCT02792803|IOP|iop
123968|NCT02792803|Intraocular Pressure|intraocular pressure
123969|NCT02792803|Allergan|allergan
123970|NCT02792803|prostaglandin|prostaglandin
123971|NCT02792790|Amyloidosis|amyloidosis
123972|NCT02792790|Carpal tunnel syndrome|carpal tunnel syndrome
123973|NCT02792777|Concept Mapping|concept mapping
123974|NCT02792777|VOICe|voice
123975|NCT02792777|Interviews|interviews
123976|NCT02792777|Patient-Centered Research|patient-centered research
123977|NCT02792764|port|port
123978|NCT02792764|peripheral intravenous lines|peripheral intravenous lines
123979|NCT02792764|oncology|oncology
123980|NCT02792751|Depth of anesthesia|depth of anesthesia
123981|NCT02792751|BIS|bis
123982|NCT02792751|ERCP|ercp
123983|NCT02792751|Positive Regulation|positive regulation
123984|NCT02792712|Acute myocardial infarction|acute myocardial infarction
123985|NCT02792712|Antiplatelet agents|antiplatelet agents
123986|NCT02792712|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
123987|NCT02792686|Healthy Volunteers|healthy volunteers
123988|NCT02792673|Embryo transfer media|embryo transfer media
123989|NCT02792673|improvement of embryo transfer technique|improvement of embryo transfer technique
123990|NCT02792673|improvement of implantation|improvement of implantation
123991|NCT02792673|"Hyaluronan-enriched media Embryo Glue®"|"hyaluronan-enriched media embryo glue®"
123992|NCT02792673|"30% Protein-supplemented Culture Medium Global Total®"|"30% protein-supplemented culture medium global total®"
123993|NCT02792673|Autologous Follicular Fluid as embryo transfer medium|autologous follicular fluid as embryo transfer medium
123994|NCT02792634|Bariatric surgery|bariatric surgery
123995|NCT02792634|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
123996|NCT02792634|Obesity|obesity
123997|NCT02792608|Mindfulness-based Therapy|mindfulness-based therapy
123998|NCT02792608|Brain Tumour Survivors|brain tumour survivors
123999|NCT02792608|Depressive Symptoms|depressive symptoms
124000|NCT02792608|Quality of Life|quality of life
124001|NCT02792608|Perceived Stress|perceived stress
124002|NCT02792608|Wellbeing|wellbeing
124003|NCT02792608|Treatment|treatment
124004|NCT02792582|Brain tumor|brain tumor
124005|NCT02792582|Pediatrics|pediatrics
124006|NCT02792582|Radiation therapy|radiation therapy
124007|NCT02792582|Proton therapy|proton therapy
124008|NCT02792582|Surgery|surgery
124009|NCT02792569|IVA|iva
124010|NCT02792569|Hippo Pathway|hippo pathway
124011|NCT02792569|Follicle activation|follicle activation
124012|NCT02792569|Low Responder|low responder
124013|NCT02792569|POI|poi
124014|NCT02792569|Poor Ovarian Reserve|poor ovarian reserve
124015|NCT02792569|Poor Ovarian Response|poor ovarian response
124016|NCT02792569|Salvador/Warts/Hippo pathway|salvador/warts/hippo pathway
124017|NCT02792556|drug abortion|drug abortion
124018|NCT02792556|urine pregnancy test|urine pregnancy test
124019|NCT02792556|negative predictive value|negative predictive value
124020|NCT02792556|check Top test|check top test
124021|NCT02792556|transvaginal ultrasound|transvaginal ultrasound
124022|NCT02792543|nutrition|nutrition
124023|NCT02792543|double enterostomy|double enterostomy
124024|NCT02792543|chyme reinfusion|chyme reinfusion
124025|NCT02792543|randomized controlled trial|randomized controlled trial
124026|NCT02792439|Fitness|fitness
124027|NCT02792439|Health kit|health kit
124028|NCT02792439|Researchkit|researchkit
124029|NCT02792439|Walking|walking
124030|NCT02792426|Smoking Cessation|smoking cessation
124031|NCT02792426|Nicotine Dependence|nicotine dependence
124032|NCT02792426|Tobacco Dependence|tobacco dependence
124033|NCT02792413|osteoporosis|osteoporosis
124034|NCT02792413|chronic kidney disease|chronic kidney disease
124035|NCT02792413|anti-RANK ligand antibody|anti-rank ligand antibody
124036|NCT02792413|bone mineral density|bone mineral density
124037|NCT02792413|vascular calcifications|vascular calcifications
124038|NCT02792387|cardio-renal syndrome|cardio-renal syndrome
124039|NCT02792387|right heart dysfunction|right heart dysfunction
124040|NCT02792387|central venous pressure|central venous pressure
124041|NCT02792387|eGFR|egfr
124042|NCT02792387|low-flow theory|low-flow theory
124043|NCT02792374|Dental patients|dental patients
124044|NCT02792374|Psychological Profile|psychological profile
124045|NCT02792361|Post-Operative Pterional Craniotomy|post-operative pterional craniotomy
124046|NCT02792361|Suction Drain|suction drain
124047|NCT02792361|Benefits|benefits
124048|NCT02792348|congenital urine flow impairment|congenital urine flow impairment
124049|NCT02792348|urinary metabolomics profile|urinary metabolomics profile
124050|NCT02792348|Nuclear Magnetic Resonance|nuclear magnetic resonance
124051|NCT02792322|Cancer|cancer
124052|NCT02792322|Oropharynx|oropharynx
124053|NCT02792270|Surgery|surgery
124054|NCT02792231|Relapsing multiple sclerosis|relapsing multiple sclerosis
124055|NCT02792231|Ofatumumab|ofatumumab
124056|NCT02792218|Relapsing multiple sclerosis|relapsing multiple sclerosis
124057|NCT02792218|Ofatumumab|ofatumumab
124058|NCT02792205|Willebrand factor deficiency|willebrand factor deficiency
124059|NCT02792205|hematology|hematology
124060|NCT02792205|Willebrand:Collagen-binding|willebrand:collagen-binding
124061|NCT02792166|Morbid obesity|morbid obesity
124062|NCT02792166|Metabolic syndrome|metabolic syndrome
124063|NCT02792166|Metabolic surgery|metabolic surgery
124064|NCT02792166|Bariatric surgery|bariatric surgery
124065|NCT02792166|SADI|sadi
124066|NCT02792166|BPD-DS|bpd-ds
124067|NCT02792153|estrogen|estrogen
124068|NCT02792153|anxiety|anxiety
124069|NCT02792153|amenorrhea|amenorrhea
124070|NCT02792153|eating disorders|eating disorders
124071|NCT02792140|Psychology|psychology
124072|NCT02792140|Dreams|dreams
124073|NCT02792127|Social Anxiety|social anxiety
124383|NCT02790346|hemiparesis|hemiparesis
124075|NCT02792127|Online Program|online program
124076|NCT02792114|T-Cell|t-cell
124077|NCT02792114|Chimeric antigen receptor (CAR)|chimeric antigen receptor (car)
124078|NCT02792114|CAR T cells|car t cells
124079|NCT02792114|Triple-negative breast cancer|triple-negative breast cancer
124080|NCT02792114|Immunotherapy T-cell therapy|immunotherapy t-cell therapy
124081|NCT02792114|16-040|16-040
124082|NCT02792114|immunotherapy|immunotherapy
124083|NCT02792114|CAR|car
124084|NCT02792088|HBV|hbv
124085|NCT02792075|Coronary Stenosis|coronary stenosis
124086|NCT02792075|Intracoronary Imaging|intracoronary imaging
124087|NCT02792075|VH-IVUS|vh-ivus
124088|NCT02792075|OCT|oct
124089|NCT02792075|NIRS|nirs
124090|NCT02792075|gray scale IVUS|gray scale ivus
124091|NCT02792062|Drug therapy|drug therapy
124092|NCT02792023|Colorectal cancer|colorectal cancer
124093|NCT02792023|Immunochemical occult blood test|immunochemical occult blood test
124094|NCT02792010|T1rho MRI|t1rho mri
124095|NCT02792010|hip|hip
124096|NCT02792010|cartilage|cartilage
124097|NCT02792010|Healthy participants|healthy participants
124098|NCT02791997|Audition|audition
124099|NCT02791997|Stroke|stroke
124100|NCT02791997|Migraine|migraine
124101|NCT02791997|Attention|attention
124102|NCT02791997|Short-term memory,|short-term memory,
124103|NCT02791997|Emotions|emotions
124104|NCT02791997|EEG|eeg
124105|NCT02791997|MEG|meg
124106|NCT02791984|Suprasternal|suprasternal
124107|NCT02791984|echography|echography
124108|NCT02791984|fluid responsiveness|fluid responsiveness
124109|NCT02791971|Contraception|contraception
124110|NCT02791971|Birth control|birth control
124111|NCT02791971|Social communication|social communication
124112|NCT02791971|Adolescent|adolescent
124113|NCT02791971|Social network|social network
124114|NCT02791971|Health education|health education
124115|NCT02791971|Reproductive health|reproductive health
124116|NCT02791945|TBI|tbi
124117|NCT02791945|hazardous and harmful alcohol use|hazardous and harmful alcohol use
124118|NCT02791945|Veterans|veterans
124119|NCT02791945|co-occurring disorders|co-occurring disorders
124120|NCT02791945|pharmacotherapy|pharmacotherapy
124121|NCT02791932|Pregnancy|pregnancy
124122|NCT02791932|Postpartum period|postpartum period
124123|NCT02791932|Depression|depression
124124|NCT02791906|Chronic Kidney Diseases|chronic kidney diseases
124125|NCT02791906|Chronic Kidney Insufficiency|chronic kidney insufficiency
124126|NCT02791906|Chronic Renal Diseases|chronic renal diseases
124127|NCT02791906|Chronic Renal Insufficiency|chronic renal insufficiency
124128|NCT02791906|Kidney Insufficiency, Chronic|kidney insufficiency, chronic
124129|NCT02791906|Cardiac Failure|cardiac failure
124130|NCT02791906|Congestive Heart Failure|congestive heart failure
124131|NCT02791906|Heart Decompensation|heart decompensation
124132|NCT02791906|Heart Failure, Congestive|heart failure, congestive
124133|NCT02791906|Myocardial Failure|myocardial failure
124134|NCT02791880|acute kidney injury|acute kidney injury
124135|NCT02791880|transcatheter aortic valve replacement|transcatheter aortic valve replacement
124136|NCT02791880|genomics|genomics
124137|NCT02791880|biomarker|biomarker
124138|NCT02791841|Reading|reading
124139|NCT02791841|Developmental Dyslexia,|developmental dyslexia,
124140|NCT02791841|Music|music
124141|NCT02791841|Rhythm|rhythm
124142|NCT02791841|Action Video Games|action video games
124143|NCT02791841|Hemisphere-Specific Stimulation|hemisphere-specific stimulation
124144|NCT02791815|selexipag|selexipag
124145|NCT02791815|pharmacokinetics|pharmacokinetics
124146|NCT02791815|midazolam|midazolam
124147|NCT02791802|Lipoprotein(a)|lipoprotein(a)
124148|NCT02791802|lipoprotein/lipid apheresis|lipoprotein/lipid apheresis
124149|NCT02791802|CV disease|cv disease
124150|NCT02791789|Autism Spectrum Disorder|autism spectrum disorder
124151|NCT02791789|SEMATIC|sematic
124152|NCT02791789|software|software
124153|NCT02791776|scoliosis|scoliosis
124154|NCT02791763|Renal Anemia|renal anemia
124155|NCT02791763|Japanese|japanese
124156|NCT02791763|chronic kidney disease|chronic kidney disease
124157|NCT02791763|Peritoneal dialysis|peritoneal dialysis
124158|NCT02791763|GSK1278863|gsk1278863
124159|NCT02791763|Non-dialysis|non-dialysis
124160|NCT02791750|hormone replacement therapy|hormone replacement therapy
124161|NCT02791750|breast cancer|breast cancer
124162|NCT02791750|follow up|follow up
124163|NCT02791737|Hematologic Malignancy|hematologic malignancy
124164|NCT02791737|Exercise|exercise
124165|NCT02791737|Decreased Physical Activity|decreased physical activity
124166|NCT02791711|Bronchiolitis|bronchiolitis
124167|NCT02791711|Continuous Positive Airway Pressure|continuous positive airway pressure
124168|NCT02791711|HFNC|hfnc
124169|NCT02791698|cortisol|cortisol
124170|NCT02791698|hair|hair
124171|NCT02791698|urinary|urinary
124172|NCT02791685|Cardiac Rehabilitation|cardiac rehabilitation
124173|NCT02791672|Perioperative Care|perioperative care
124174|NCT02791672|Breast Reconstruction|breast reconstruction
124175|NCT02791659|radiation exposure|radiation exposure
124176|NCT02791659|ERCP|ercp
124177|NCT02791659|prone|prone
124966|NCT02787005|PDL1|pdl1
124178|NCT02791659|left lateral decubitus|left lateral decubitus
124179|NCT02791607|Circulating tumor cells|circulating tumor cells
124180|NCT02791607|Head and neck cancer|head and neck cancer
124181|NCT02791607|Survival Prognosis|survival prognosis
124182|NCT02791607|P16Ink4A|p16ink4a
124183|NCT02791607|HPV|hpv
124184|NCT02791555|pradaxa|pradaxa
124185|NCT02791555|warfarin|warfarin
124186|NCT02791542|Asthma|asthma
124187|NCT02791516|Osteoporosis.|osteoporosis.
124188|NCT02791516|Osteoporosis-Postmenopausal.|osteoporosis-postmenopausal.
124189|NCT02791516|Bone Diseases-Metabolic.|bone diseases-metabolic.
124190|NCT02791516|Bone Diseases.|bone diseases.
124191|NCT02791516|Musculoskeletal Diseases.|musculoskeletal diseases.
124192|NCT02791503|Irreversible electroporation (IRE|irreversible electroporation (ire
124193|NCT02791503|Stereotactic ablative radiotherapy (SABR|stereotactic ablative radiotherapy (sabr
124194|NCT02791503|Efficacy|efficacy
124195|NCT02791503|Tumor ablation|tumor ablation
124196|NCT02791503|Chemotherapy|chemotherapy
124197|NCT02791503|Locally advanced pancreatic cancer (LAPC)|locally advanced pancreatic cancer (lapc)
124198|NCT02791477|Attune|attune
124199|NCT02791464|Meditation|meditation
124200|NCT02791464|TM|tm
124201|NCT02791464|PTSD|ptsd
124202|NCT02791464|Trauma|trauma
124203|NCT02791464|Female Prisoners|female prisoners
124204|NCT02791451|COPD|copd
124205|NCT02791451|telemonitoring|telemonitoring
124206|NCT02791451|exacerbation|exacerbation
124207|NCT02791425|Brain-Computer Interface|brain-computer interface
124208|NCT02791425|Intratracheal intubation|intratracheal intubation
124209|NCT02791425|Mechanical ventilation|mechanical ventilation
124210|NCT02791425|Nonverbal communication|nonverbal communication
124211|NCT02791425|Critical illness|critical illness
124212|NCT02791425|Electroencephalography|electroencephalography
124213|NCT02791425|Visual Evoked Potential|visual evoked potential
124214|NCT02791412|left main|left main
124215|NCT02791412|unprotected|unprotected
124216|NCT02791412|percutaneous coronary intervention|percutaneous coronary intervention
124217|NCT02791412|coronary-artery bypass graft|coronary-artery bypass graft
124218|NCT02791399|opioid safety|opioid safety
124219|NCT02791399|opioid misuse|opioid misuse
124220|NCT02791399|opioid abuse|opioid abuse
124221|NCT02791399|patient-centered|patient-centered
124222|NCT02791399|opioid|opioid
124223|NCT02791399|opiate|opiate
124224|NCT02791399|chronic pain|chronic pain
124225|NCT02791399|primary care|primary care
124226|NCT02791399|Veteran|veteran
124227|NCT02791399|clinical care|clinical care
124228|NCT02791360|Brain|brain
124229|NCT02791360|Radiotherapy|radiotherapy
124230|NCT02791360|MRI|mri
124231|NCT02791360|Sequelae|sequelae
124232|NCT02791334|PDL1|pdl1
124233|NCT02791334|PD-L1|pd-l1
124234|NCT02791295|Type 2 diabetes|type 2 diabetes
124235|NCT02791295|lifestyle intervention|lifestyle intervention
124236|NCT02791295|insulin pump treatment|insulin pump treatment
124237|NCT02791295|body weight|body weight
124238|NCT02791295|body composition|body composition
124239|NCT02791282|Chronic Thromboembolic Pulmonary Hypertension (CTEPH)|chronic thromboembolic pulmonary hypertension (cteph)
124240|NCT02791282|MRI|mri
124241|NCT02791282|SPECT|spect
124242|NCT02791230|amyloidosis|amyloidosis
124243|NCT02791230|amyloid|amyloid
124244|NCT02791230|transthyretin|transthyretin
124245|NCT02791230|TTR|ttr
124246|NCT02791191|BACE inhibitor|bace inhibitor
124247|NCT02791100|height|height
124248|NCT02791100|weight|weight
124249|NCT02791100|diet|diet
124250|NCT02791100|complementary foods|complementary foods
124251|NCT02791100|protein|protein
124252|NCT02791100|calcium|calcium
124253|NCT02791009|HF|hf
124254|NCT02791009|HFrEF|hfref
124255|NCT02791009|HFpEF|hfpef
124256|NCT02791009|MRI|mri
124257|NCT02791009|biomarker|biomarker
124258|NCT02790996|sepsis|sepsis
124259|NCT02790996|neonate|neonate
124260|NCT02790996|vancomycin|vancomycin
124261|NCT02790983|Registry|registry
124262|NCT02790983|Spine|spine
124263|NCT02790983|Surgery|surgery
124264|NCT02790983|Medical Oncology|medical oncology
124265|NCT02790983|Radiation Oncology|radiation oncology
124266|NCT02790983|Neoplasms|neoplasms
124267|NCT02790944|Germline|germline
124268|NCT02790944|Pancreatic|pancreatic
124269|NCT02790944|Genetic Testing|genetic testing
124270|NCT02790931|diabetic foot|diabetic foot
124271|NCT02790931|therapeutic exercises|therapeutic exercises
124272|NCT02790931|foot|foot
124273|NCT02790931|preventive care|preventive care
124274|NCT02790931|rehabilitation|rehabilitation
124275|NCT02790931|Diabetic Neuropathy|diabetic neuropathy
124276|NCT02790918|Pulmonary Hypertension|pulmonary hypertension
124277|NCT02790918|MRI|mri
124278|NCT02790905|pregnant and post-partum women|pregnant and post-partum women
124279|NCT02790905|Validation questionnaires|validation questionnaires
124280|NCT02790905|Thai-Myanmar border|thai-myanmar border
124281|NCT02790892|type 1 diabetes|type 1 diabetes
124282|NCT02790892|type 2 diabetes|type 2 diabetes
124283|NCT02790892|children|children
124284|NCT02790892|adolescents|adolescents
124285|NCT02790892|young adults|young adults
124286|NCT02790892|youth|youth
124287|NCT02790892|transition|transition
124288|NCT02790892|art therapy|art therapy
124289|NCT02790892|behavioral therapy|behavioral therapy
124290|NCT02790879|Transitional care|transitional care
124291|NCT02790879|teenagers|teenagers
124292|NCT02790879|cystic fibrosis|cystic fibrosis
124293|NCT02790879|pulmonary function|pulmonary function
124294|NCT02790879|nutritional function|nutritional function
124295|NCT02790879|Patients who experiment a transition pediatric - adult care|patients who experiment a transition pediatric - adult care
124296|NCT02790866|Decision Aid|decision aid
124297|NCT02790866|Informed Decision Making|informed decision making
124298|NCT02790866|Shared Decision making|shared decision making
124299|NCT02790866|Screening|screening
124300|NCT02790853|Cancer of Head and Neck|cancer of head and neck
124301|NCT02790853|Oral Potentially Malignant Disorders|oral potentially malignant disorders
124302|NCT02790853|OPMD|opmd
124303|NCT02790853|Multimodal Imaging|multimodal imaging
124304|NCT02790853|Suspicious oral mucosal lesion|suspicious oral mucosal lesion
124305|NCT02790853|Pathologic diagnosis of dysplasia|pathologic diagnosis of dysplasia
124306|NCT02790853|History of resected oral cancer|history of resected oral cancer
124307|NCT02790853|White Light Examination|white light examination
124308|NCT02790853|WL|wl
124309|NCT02790853|Wide-field auto-fluorescence imaging device PS2.1/PS3|wide-field auto-fluorescence imaging device ps2.1/ps3
124310|NCT02790853|Proflavine Hemisulfate|proflavine hemisulfate
124311|NCT02790853|High-Resolution Optical System|high-resolution optical system
124312|NCT02790853|HRME|hrme
124313|NCT02790853|Brush Biopsy|brush biopsy
124314|NCT02790853|Tissue Biopsy|tissue biopsy
124315|NCT02790840|Volunteers|volunteers
124316|NCT02790801|chronic heart failure|chronic heart failure
124317|NCT02790801|atrial fibrillation|atrial fibrillation
124318|NCT02790801|anticoagulant|anticoagulant
124319|NCT02790762|stem cells|stem cells
124320|NCT02790762|Mesenchymal Stem Cells|mesenchymal stem cells
124321|NCT02790762|Umbilical Cord-Mesenchymal Stem Cells|umbilical cord-mesenchymal stem cells
124322|NCT02790762|Pneumoconiosis|pneumoconiosis
124323|NCT02790749|Developmental hip dysplasia|developmental hip dysplasia
124324|NCT02790749|Intra-articular pathology|intra-articular pathology
124325|NCT02790749|Adult hip dysplasia|adult hip dysplasia
124326|NCT02790749|Labral tear, hip|labral tear, hip
124327|NCT02790749|Chondromalacia, hip|chondromalacia, hip
124328|NCT02790736|propranolol|propranolol
124329|NCT02790736|public speaking anxiety|public speaking anxiety
124330|NCT02790710|propanolol|propanolol
124331|NCT02790710|obsessive-compulsive disorder|obsessive-compulsive disorder
124332|NCT02790697|Indirect calorimetry|indirect calorimetry
124333|NCT02790697|ICALIC Study|icalic study
124334|NCT02790697|Energy expenditure|energy expenditure
124335|NCT02790697|VO2|vo2
124336|NCT02790697|VCO2|vco2
124337|NCT02790697|Respiratory quotient|respiratory quotient
124338|NCT02790658|Grumixama|grumixama
124339|NCT02790658|Urolithins|urolithins
124340|NCT02790658|Anthocyanins|anthocyanins
124341|NCT02790658|Metabolomic Approach|metabolomic approach
124342|NCT02790658|Ellagitannins|ellagitannins
124343|NCT02790658|Subjects|subjects
124344|NCT02790645|Type 1 diabetes|type 1 diabetes
124345|NCT02790645|Health technologies|health technologies
124346|NCT02790645|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
124347|NCT02790645|Telemedicine|telemedicine
124348|NCT02790645|Glycemic variability|glycemic variability
124349|NCT02790645|Inflammatory markers,|inflammatory markers,
124350|NCT02790645|Oxidative stress|oxidative stress
124351|NCT02790645|Depression|depression
124352|NCT02790645|Quality of life|quality of life
124353|NCT02790645|Cost-effectiveness|cost-effectiveness
124354|NCT02790632|Aneurysm, Ruptured|aneurysm, ruptured
124355|NCT02790632|Nimodipine|nimodipine
124356|NCT02790632|Subarachnoid Hemorrhage|subarachnoid hemorrhage
124357|NCT02790567|diagnostic performance|diagnostic performance
124358|NCT02790567|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
124359|NCT02790567|rapid immunological diagnostic method|rapid immunological diagnostic method
124360|NCT02790567|immunoassay|immunoassay
124361|NCT02790567|pretest scoring systems|pretest scoring systems
124362|NCT02790567|4Ts score|4ts score
124363|NCT02790567|HEP score|hep score
124364|NCT02790541|aging|aging
124365|NCT02790541|HBOT|hbot
124366|NCT02790541|reverse|reverse
124367|NCT02790541|angiogenesis|angiogenesis
124368|NCT02790541|elderly|elderly
124369|NCT02790541|mitochohndria|mitochohndria
124370|NCT02790528|statin|statin
124371|NCT02790528|vasospastic angina|vasospastic angina
124372|NCT02790476|Safe|safe
124373|NCT02790476|Prescribing|prescribing
124374|NCT02790476|Opioids|opioids
124375|NCT02790463|Allopurinol|allopurinol
124376|NCT02790398|Transdiagnostic treatment protocol|transdiagnostic treatment protocol
124377|NCT02790398|Transdiagnostic treatment protocol + PA component|transdiagnostic treatment protocol + pa component
124378|NCT02790372|Nursing homes|nursing homes
124379|NCT02790372|Norway|norway
124380|NCT02790359|Carbon dioxide|carbon dioxide
124381|NCT02790359|Air|air
124382|NCT02790359|Colonoscopy|colonoscopy
124384|NCT02790346|deformity of the foot and ankle|deformity of the foot and ankle
124385|NCT02790320|Eribulin mesylate|eribulin mesylate
124386|NCT02790320|Halaven|halaven
124387|NCT02790320|Breast cancer|breast cancer
124388|NCT02790307|multiple sclerosis|multiple sclerosis
124389|NCT02790307|overactive bladder|overactive bladder
124390|NCT02790307|urinary incontinence|urinary incontinence
124391|NCT02790307|tibial nerve stimulation|tibial nerve stimulation
124392|NCT02790294|magnetic resonance imaging|magnetic resonance imaging
124393|NCT02790268|Cionni Ring|cionni ring
124394|NCT02790268|Ultrasound Biomicroscopy|ultrasound biomicroscopy
124395|NCT02790242|Mechanical Circulatory Support Device (MCSD)|mechanical circulatory support device (mcsd)
124396|NCT02790242|ventricular Assist Device (VAD)|ventricular assist device (vad)
124397|NCT02790229|rehabilitation, anti-gravity treadmill|rehabilitation, anti-gravity treadmill
124398|NCT02790216|Image guided brachytherapy|image guided brachytherapy
124399|NCT02790151|working memory, recollection training, transfer|working memory, recollection training, transfer
124400|NCT02790138|Drug Therapy|drug therapy
124401|NCT02790112|Body Mass Index|body mass index
124402|NCT02790112|Body Composition|body composition
124403|NCT02790112|Glucose Metabolism Disorders|glucose metabolism disorders
124404|NCT02790112|Bone Development|bone development
124405|NCT02790112|Gonadal Disorders|gonadal disorders
124406|NCT02790112|Fertility|fertility
124407|NCT02790112|Overweight|overweight
124408|NCT02790112|Obesity|obesity
124409|NCT02790112|Menarche|menarche
124410|NCT02790099|Pain|pain
124411|NCT02790099|Postoperative pain control|postoperative pain control
124412|NCT02790099|Rectus sheath block|rectus sheath block
124413|NCT02790099|Intrathecal morphine|intrathecal morphine
124414|NCT02790099|Caesarean section|caesarean section
124415|NCT02790086|hypothermia|hypothermia
124416|NCT02790086|prevalence|prevalence
124417|NCT02790086|perioperative|perioperative
124418|NCT02790086|anemia|anemia
124419|NCT02790086|myocardial injury|myocardial injury
124420|NCT02790086|troponin T|troponin t
124421|NCT02790086|noncardiac surgery|noncardiac surgery
124422|NCT02790073|Calciphylaxis|calciphylaxis
124423|NCT02790073|Calcific Uremic Arteriolopathy|calcific uremic arteriolopathy
124424|NCT02790073|Dialysis|dialysis
124425|NCT02790073|End Stage Renal Disease|end stage renal disease
124426|NCT02790073|Rare disease (ORPHA280062)|rare disease (orpha280062)
124427|NCT02790073|Calcification|calcification
124428|NCT02790073|Calcium Metabolism Disorders|calcium metabolism disorders
124429|NCT02790073|Calcinosis|calcinosis
124430|NCT02790073|Metabolic Diseases|metabolic diseases
124431|NCT02790060|diabetes|diabetes
124432|NCT02790047|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
124433|NCT02790047|Exercise Therapy|exercise therapy
124434|NCT02790047|Positive Expiratory Pressure|positive expiratory pressure
124435|NCT02790047|Physical Fitness|physical fitness
124436|NCT02790047|Quality of Life|quality of life
124437|NCT02790008|echocardiography|echocardiography
124438|NCT02790008|magnetic resonance imaging|magnetic resonance imaging
124439|NCT02790008|cardiopulmonary exercise test|cardiopulmonary exercise test
124440|NCT02789995|Intensive Care Unit - Acquired Weakness (ICU-AW)|intensive care unit - acquired weakness (icu-aw)
124441|NCT02789982|PTSD|ptsd
124442|NCT02789982|Trauma related disorders|trauma related disorders
124443|NCT02789982|Reconsolidation blockade|reconsolidation blockade
124444|NCT02789982|Paris attacks|paris attacks
124445|NCT02789956|Internal connection|internal connection
124446|NCT02789956|Cobalt/Chrome|cobalt/chrome
124447|NCT02789956|Cad-cam Framework|cad-cam framework
124448|NCT02789956|marginal bone level|marginal bone level
124449|NCT02789943|IHD Normal EF|ihd normal ef
124450|NCT02789930|Weight estimation|weight estimation
124451|NCT02789930|Patient safety|patient safety
124452|NCT02789917|ACS|acs
124453|NCT02789917|Triple-Therapy|triple-therapy
124454|NCT02789917|AF|af
124455|NCT02789917|oral anticoagulation (OAC)|oral anticoagulation (oac)
124456|NCT02789917|non-vitamin-K oral anticoagulant (NOAC)|non-vitamin-k oral anticoagulant (noac)
124457|NCT02789878|Neoadjuvant therapy|neoadjuvant therapy
124458|NCT02789878|High-risk Prostate Cancer|high-risk prostate cancer
124459|NCT02789865|Acute appendicitis|acute appendicitis
124460|NCT02789865|Endoscopic retrograde appendicitis therapy|endoscopic retrograde appendicitis therapy
124461|NCT02789865|Endoscopic retrograde appendicography|endoscopic retrograde appendicography
124462|NCT02789865|Endoscopic therapy|endoscopic therapy
124463|NCT02789865|Appendectomy|appendectomy
124464|NCT02789865|Antibiotic Therapy|antibiotic therapy
124465|NCT02789787|Cleft Lip|cleft lip
124466|NCT02789787|Palate|palate
124467|NCT02789787|Class III|class iii
124468|NCT02789787|Malocclusion|malocclusion
124469|NCT02789787|Protraction|protraction
124470|NCT02789761|Flow-mediated dilatation (FMD)|flow-mediated dilatation (fmd)
124471|NCT02789761|Vascular function|vascular function
124472|NCT02789761|cognitive function|cognitive function
124473|NCT02789735|Pregnancy|pregnancy
124474|NCT02789735|laser therapy|laser therapy
124475|NCT02789735|persistent pain|persistent pain
124476|NCT02789735|pelvic pain|pelvic pain
124477|NCT02789722|Mate|mate
124478|NCT02789722|Vascular protection|vascular protection
124479|NCT02789722|Endothelial function|endothelial function
124480|NCT02789722|Ilex paraguariensis|ilex paraguariensis
124481|NCT02789657|neoadjuvant breast cancer|neoadjuvant breast cancer
124482|NCT02789657|stage I-III breast cancer|stage i-iii breast cancer
124483|NCT02789657|HER 2 positive breast cancer|her 2 positive breast cancer
124484|NCT02789644|Ursodeoxycholic acid|ursodeoxycholic acid
124485|NCT02789644|Metabolomics/biomarker|metabolomics/biomarker
124486|NCT02789644|Pharmacokinetics|pharmacokinetics
124487|NCT02789605|Aphthous Stomatitis [C07.465.864.750]|aphthous stomatitis [c07.465.864.750]
124488|NCT02789592|REM Sleep Behavior Disorder|rem sleep behavior disorder
124489|NCT02789592|Parkinson Disease|parkinson disease
124490|NCT02789592|Randomized Controlled Trial|randomized controlled trial
124491|NCT02789592|Clinical Trial|clinical trial
124492|NCT02789592|Melatonin|melatonin
124493|NCT02789592|Clonazepam|clonazepam
124494|NCT02789579|prophylactic|prophylactic
124495|NCT02789579|Urinary Tract Infections|urinary tract infections
124496|NCT02789579|Minimally invasive upper tract lithotomy|minimally invasive upper tract lithotomy
124497|NCT02789566|Primaquine|primaquine
124498|NCT02789566|Pharmacokinetic|pharmacokinetic
124499|NCT02789553|Glucose digestion|glucose digestion
124500|NCT02789553|Bypass surgery|bypass surgery
124501|NCT02789553|C13-glucose tracer|c13-glucose tracer
124502|NCT02789553|Insulin secretion|insulin secretion
124503|NCT02789540|COPD symptoms|copd symptoms
124504|NCT02789527|healthy volunteers|healthy volunteers
124505|NCT02789514|esophagogastroduodenoscopy|esophagogastroduodenoscopy
124506|NCT02789514|paediatric|paediatric
124507|NCT02789501|Catheter|catheter
124508|NCT02789501|Dysfunctions|dysfunctions
124509|NCT02789501|Blood Stream Infections|blood stream infections
124510|NCT02789501|Haemodialysis|haemodialysis
124511|NCT02789501|Taurolidine|taurolidine
124512|NCT02789501|Tunneled|tunneled
124513|NCT02789436|halitosis|halitosis
124514|NCT02789436|chronic periodontitis|chronic periodontitis
124515|NCT02789436|probiotic|probiotic
124516|NCT02789410|Cesarean delivery|cesarean delivery
124517|NCT02789410|Analgesia|analgesia
124518|NCT02789410|Intrathecal opioids|intrathecal opioids
124519|NCT02789397|Granulomatous and lymphocytic interstitial lung disease|granulomatous and lymphocytic interstitial lung disease
124520|NCT02789397|common variable immunodeficiency|common variable immunodeficiency
124521|NCT02789397|Rituximab|rituximab
124522|NCT02789397|Azathioprine|azathioprine
124523|NCT02789397|primary immunodeficiency|primary immunodeficiency
124524|NCT02789397|GLIILD|gliild
124525|NCT02789397|CVID|cvid
124526|NCT02789384|soft-tissue sarcomas|soft-tissue sarcomas
124527|NCT02789384|CINSARC|cinsarc
124528|NCT02789384|biomarker|biomarker
124529|NCT02789384|efficacy|efficacy
124530|NCT02789384|pronostic|pronostic
124531|NCT02789371|EUS-FNA|eus-fna
124532|NCT02789371|modified wet suction technique|modified wet suction technique
124533|NCT02789371|dry suction technique|dry suction technique
124534|NCT02789358|cryotherapy|cryotherapy
124535|NCT02789345|T790M|t790m
124536|NCT02789345|epidermal growth factor receptor (EGFR)|epidermal growth factor receptor (egfr)
124537|NCT02789332|carboplatin|carboplatin
124538|NCT02789332|olaparib|olaparib
124539|NCT02789332|pCR|pcr
124540|NCT02789332|neoadjuvant|neoadjuvant
124541|NCT02789332|triple-negative|triple-negative
124542|NCT02789332|hormonreceptor-positive|hormonreceptor-positive
124543|NCT02789332|BRCA1/2|brca1/2
124544|NCT02789332|HRD, homologous recominant deficient|hrd, homologous recominant deficient
124545|NCT02789332|breast cancer|breast cancer
124546|NCT02789332|genetic testing (somatic and germline mutations)|genetic testing (somatic and germline mutations)
124547|NCT02789319|Blood Glucose Monitoring System|blood glucose monitoring system
124548|NCT02789319|BGMS|bgms
124549|NCT02789319|Diabetes|diabetes
124550|NCT02789319|Patient Use|patient use
124551|NCT02789306|Preventive therapy|preventive therapy
124552|NCT02789306|Dental implants|dental implants
124553|NCT02789293|Glaucoma|glaucoma
124554|NCT02789293|Ultrasound|ultrasound
124555|NCT02789293|Ciliary body|ciliary body
124556|NCT02789267|Head and Neck Cancer|head and neck cancer
124557|NCT02789267|Quality of Life|quality of life
124558|NCT02789267|Dietary support|dietary support
124559|NCT02789254|acute myeloid leukemia|acute myeloid leukemia
124560|NCT02789254|Fms-like receptor tyrosine kinase (FLT3)|fms-like receptor tyrosine kinase (flt3)
124561|NCT02789254|stem cell transplantation|stem cell transplantation
124562|NCT02789254|complete remission|complete remission
124563|NCT02789254|CD135|cd135
124564|NCT02789254|antibodies|antibodies
124565|NCT02789254|Leukemia|leukemia
124566|NCT02789254|AML|aml
124567|NCT02789254|Fc-optimized|fc-optimized
124568|NCT02789241|Endotoxin|endotoxin
124569|NCT02789241|healthy|healthy
124570|NCT02789241|volunteers|volunteers
124571|NCT02789241|males|males
124572|NCT02789241|females|females
124573|NCT02789215|Child care food costs|child care food costs
124574|NCT02789215|Meal participation rates|meal participation rates
124575|NCT02789215|Child and Adult Care Food Program|child and adult care food program
124576|NCT02789202|dental caries|dental caries
124577|NCT02789202|deciduous tooth|deciduous tooth
124578|NCT02789176|Phenobarbital|phenobarbital
124579|NCT02789176|EEG|eeg
124580|NCT02789176|family impact|family impact
124581|NCT02789176|neurodevelopment|neurodevelopment
124582|NCT02789163|breast|breast
124583|NCT02789163|ultrasound|ultrasound
124584|NCT02789163|diagnostic exam|diagnostic exam
124585|NCT02789163|automated volume breast scanner|automated volume breast scanner
124586|NCT02789137|metastatic renal cell carcinoma|metastatic renal cell carcinoma
124587|NCT02789124|fluid responsiveness|fluid responsiveness
124588|NCT02789124|carotid artery flow time|carotid artery flow time
124589|NCT02789124|passive leg raise|passive leg raise
124590|NCT02789098|ST Elevation Myocardial Infarction|st elevation myocardial infarction
124591|NCT02789098|Ventricular remodeling|ventricular remodeling
124592|NCT02789098|Biomarkers|biomarkers
124593|NCT02789098|Coronary endothelial function|coronary endothelial function
124594|NCT02789098|Positron Emission Tomography|positron emission tomography
124595|NCT02789085|TENS|tens
124596|NCT02789085|ULF-TENS|ulf-tens
124597|NCT02789085|ANS|ans
124598|NCT02789085|Dentistry|dentistry
124599|NCT02789085|TMD|tmd
124600|NCT02789059|Becker muscular dystrophy|becker muscular dystrophy
124601|NCT02789059|Facioscapulohumeral dystrophy|facioscapulohumeral dystrophy
124602|NCT02789059|congenital myopathy|congenital myopathy
124603|NCT02789059|motor neurone diseases|motor neurone diseases
124604|NCT02789046|adult|adult
124605|NCT02789046|vascular access|vascular access
124606|NCT02789046|preoperative period|preoperative period
124607|NCT02789046|peripheral venous catheterization|peripheral venous catheterization
124608|NCT02789033|diabetic foot ulcers|diabetic foot ulcers
124609|NCT02789033|chitosan|chitosan
124610|NCT02789033|isosorbide dinitrate spray|isosorbide dinitrate spray
124611|NCT02789020|Rasagiline|rasagiline
124612|NCT02788981|triple-negative breast cancer|triple-negative breast cancer
124613|NCT02788981|advanced breast cancer|advanced breast cancer
124614|NCT02788981|nab-paclitaxel|nab-paclitaxel
124615|NCT02788981|mifepristone|mifepristone
124616|NCT02788981|glucocorticoid receptor-positive breast cancer|glucocorticoid receptor-positive breast cancer
124617|NCT02788968|Psychology and Cognitive Neuroscience of development|psychology and cognitive neuroscience of development
124618|NCT02788968|Adolescent and young adult healthy volunteers|adolescent and young adult healthy volunteers
124619|NCT02788968|Anatomical and functionally Magnetic Resonance Imaging (MRI)|anatomical and functionally magnetic resonance imaging (mri)
124620|NCT02788968|Conflict detection|conflict detection
124621|NCT02788968|Reasoning|reasoning
124622|NCT02788955|Protein|protein
124623|NCT02788955|Diet intervention|diet intervention
124624|NCT02788955|Muscle|muscle
124625|NCT02788955|Colorectal cancer|colorectal cancer
124626|NCT02788942|Port|port
124627|NCT02788942|Infection|infection
124628|NCT02788942|cholecystectomy|cholecystectomy
124629|NCT02788929|Percutaneous Transluminal Coronary Intervention|percutaneous transluminal coronary intervention
124630|NCT02788929|Cardiac Rehabilitation|cardiac rehabilitation
124631|NCT02788929|Fitbit Charge HR|fitbit charge hr
124632|NCT02788916|Drug Therapy|drug therapy
124633|NCT02788903|Obesity Counseling|obesity counseling
124634|NCT02788864|Forest ranger|forest ranger
124635|NCT02788864|P.falciparum|p.falciparum
124636|NCT02788864|P.vivax|p.vivax
124637|NCT02788864|Dihydroartemisinine-piperaquine (DP)|dihydroartemisinine-piperaquine (dp)
124638|NCT02788864|Primaquine|primaquine
124639|NCT02788851|Stimulant Medication|stimulant medication
124640|NCT02788851|Exercise|exercise
124641|NCT02788851|Functional Outcome|functional outcome
124642|NCT02788851|Effectiveness|effectiveness
124643|NCT02788851|Symptoms|symptoms
124644|NCT02788838|Magnetic Resonance Imaging|magnetic resonance imaging
124645|NCT02788838|Energy Intake|energy intake
124646|NCT02788838|Commercials|commercials
124647|NCT02788838|Children|children
124648|NCT02788799|ST Elevation|st elevation
124649|NCT02788799|LCX Artery|lcx artery
124650|NCT02788786|chlorhexidine|chlorhexidine
124651|NCT02788786|cetylpyridinium chloride|cetylpyridinium chloride
124652|NCT02788786|gingival crevicular fluid|gingival crevicular fluid
124653|NCT02788734|carpal tunnel syndrome|carpal tunnel syndrome
124654|NCT02788734|CTS|cts
124655|NCT02788734|inherited peripheral neuropathy|inherited peripheral neuropathy
124656|NCT02788734|Charcot-Marie-Tooth disease|charcot-marie-tooth disease
124657|NCT02788734|Hereditary Neuropathy|hereditary neuropathy
124658|NCT02788734|Pressure Palsies|pressure palsies
124659|NCT02788734|CMT|cmt
124660|NCT02788734|HNPP|hnpp
124661|NCT02788708|paclitaxel|paclitaxel
124662|NCT02788708|lenvatinib|lenvatinib
124663|NCT02788695|Visual Nonspecific|visual nonspecific
124664|NCT02788682|VDBP|vdbp
124665|NCT02788682|single nucleotide polymorphisms (SNPs)|single nucleotide polymorphisms (snps)
124666|NCT02788682|interferon based therapy|interferon based therapy
124667|NCT02788682|Egypt|egypt
124668|NCT02788656|heart failure|heart failure
124669|NCT02788656|neprilysin|neprilysin
124670|NCT02788656|implantable hemodynamic monitor|implantable hemodynamic monitor
124671|NCT02788656|angiotensin-receptor blocker|angiotensin-receptor blocker
124672|NCT02788656|angiotensin-converting enzyme inhibitor|angiotensin-converting enzyme inhibitor
124673|NCT02788604|psychosocial screening, quality of life|psychosocial screening, quality of life
124674|NCT02788552|Neurological|neurological
124675|NCT02788552|Diet and Nutrition|diet and nutrition
124676|NCT02788552|Mental Health|mental health
124677|NCT02788539|Chronic Pain|chronic pain
124678|NCT02788539|mhealth|mhealth
124679|NCT02788539|Integrative Medicine|integrative medicine
124680|NCT02788539|MBSR|mbsr
124681|NCT02788539|Mindfulness Based Stress Reduction|mindfulness based stress reduction
124682|NCT02788539|Web based|web based
124683|NCT02788539|Internet Based|internet based
124684|NCT02788526|Carcinoma,Hepatocellular|carcinoma,hepatocellular
124685|NCT02788526|Chemoembolization|chemoembolization
124686|NCT02788526|Adjuvant therapy|adjuvant therapy
124687|NCT02788526|Hepatocellular|hepatocellular
124688|NCT02788526|Microvessels invasion|microvessels invasion
124689|NCT02788500|Epidemiology|epidemiology
124690|NCT02788500|Sports medicine|sports medicine
124691|NCT02788500|Research protocol|research protocol
124692|NCT02788500|Athletic injuries|athletic injuries
124693|NCT02788500|Sports for persons with disabilities|sports for persons with disabilities
124694|NCT02788448|Percutaneous vascular closure device|percutaneous vascular closure device
124695|NCT02788448|Large hole closure device|large hole closure device
124696|NCT02788396|STEMI|stemi
124697|NCT02788396|PPCI|ppci
124698|NCT02788396|post-dilatation|post-dilatation
124699|NCT02788396|coronary microcirculation|coronary microcirculation
124700|NCT02788370|Positive expiratory pressure|positive expiratory pressure
124701|NCT02788370|Cardiopulmonary responses|cardiopulmonary responses
124702|NCT02788370|Exercise|exercise
124703|NCT02788370|Older people|older people
124704|NCT02788357|motor training|motor training
124705|NCT02788357|motor recovery|motor recovery
124706|NCT02788357|human|human
124707|NCT02788357|neuroplasticity|neuroplasticity
124708|NCT02788357|transcranial magnetic stimulation|transcranial magnetic stimulation
124709|NCT02788344|Observational study|observational study
124710|NCT02788344|Myocardial revascularization|myocardial revascularization
124711|NCT02788344|Thrombolytic therapy|thrombolytic therapy
124712|NCT02788344|Hospital mortality|hospital mortality
124713|NCT02788344|Hemorrhage|hemorrhage
124714|NCT02788344|Quality of health care|quality of health care
124715|NCT02788344|Angioplasty|angioplasty
124716|NCT02788318|Epilepsy|epilepsy
124717|NCT02788318|SUDEP|sudep
124718|NCT02788318|Serotonin|serotonin
124719|NCT02788292|acetylcysteine|acetylcysteine
124720|NCT02788292|three-dimensional reconstruction|three-dimensional reconstruction
124721|NCT02788292|autologous fat grafting|autologous fat grafting
124722|NCT02788279|Locally advanced or Metastatic colorectal adenocarcinoma|locally advanced or metastatic colorectal adenocarcinoma
124723|NCT02788266|Cervical lesion|cervical lesion
124724|NCT02788266|gingival recession|gingival recession
124725|NCT02788266|restorative materials|restorative materials
124726|NCT02788253|Mallampati|mallampati
124727|NCT02788253|Intubation difficult|intubation difficult
124728|NCT02788253|Mask ventilation difficult|mask ventilation difficult
124729|NCT02788227|Ebola Vaccine|ebola vaccine
124730|NCT02788214|Gastric Cancer|gastric cancer
124731|NCT02788214|Bacterial Risk Factors|bacterial risk factors
124732|NCT02788214|DNA Methylation|dna methylation
124733|NCT02788214|DNA Sequencing|dna sequencing
124734|NCT02788214|Biobank|biobank
124735|NCT02788201|COXEN|coxen
124736|NCT02788201|Bladder Cancer|bladder cancer
124737|NCT02788201|Molecular Profiles|molecular profiles
124738|NCT02788201|Algorithm|algorithm
124739|NCT02788201|Biomarkers|biomarkers
124740|NCT02788188|First in Human|first in human
124741|NCT02788188|Middle East Respiratory Syndrome (MERS)|middle east respiratory syndrome (mers)
124742|NCT02788188|Tc Bovine-Derived|tc bovine-derived
124743|NCT02788188|Transchromosomic Cattle|transchromosomic cattle
124744|NCT02788175|HIV Immune Therapy|hiv immune therapy
124745|NCT02788175|Monoclonal Antibody|monoclonal antibody
124746|NCT02788175|Integrin|integrin
124747|NCT02788149|Ultrasonography|ultrasonography
124748|NCT02788149|Submental|submental
124749|NCT02788149|Lateral Parapharyngeal wall|lateral parapharyngeal wall
124750|NCT02788149|Tongue base thickness|tongue base thickness
124751|NCT02788149|Polysomnography|polysomnography
124752|NCT02788123|De-Nol|de-nol
124753|NCT02788123|NSAID-induced gastropathy|nsaid-induced gastropathy
124754|NCT02788123|Pantoprazole|pantoprazole
124755|NCT02788123|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate
124756|NCT02788123|Russia|russia
124757|NCT02788097|blastocysts|blastocysts
124758|NCT02788097|progesterone|progesterone
124759|NCT02788097|implantation|implantation
124760|NCT02788097|artificial frozen embryo transfer|artificial frozen embryo transfer
124761|NCT02788084|Next Generation Sequencing|next generation sequencing
124762|NCT02788084|Cell free DNA|cell free dna
124763|NCT02788071|Irritable Bowel Syndrome|irritable bowel syndrome
124764|NCT02788071|Fecal Microbiota Transplantation|fecal microbiota transplantation
124765|NCT02788071|Microbiota|microbiota
124766|NCT02788058|Hypofractionated Radiotherapy|hypofractionated radiotherapy
124767|NCT02788058|EGFR Positive|egfr positive
124768|NCT02788058|Lung Adenocarcinoma|lung adenocarcinoma
124769|NCT02788058|Limited Metastases|limited metastases
124770|NCT02788019|Adductor canal block, nerve block|adductor canal block, nerve block
124771|NCT02787941|acute coronary syndrome|acute coronary syndrome
124772|NCT02787941|medication adherence|medication adherence
124773|NCT02787941|pharmacist-led interventions|pharmacist-led interventions
124774|NCT02787941|Vietnam|vietnam
124775|NCT02787915|dendritic cells|dendritic cells
124776|NCT02787915|cytotoxic T lymphocyte|cytotoxic t lymphocyte
124777|NCT02787915|DC vaccine|dc vaccine
124778|NCT02787863|Pneumococcal vaccine|pneumococcal vaccine
124779|NCT02787863|Polioxidonium|polioxidonium
124780|NCT02787837|Castration Resistant Prostate Cancer|castration resistant prostate cancer
124781|NCT02787837|Abiraterone Acetate|abiraterone acetate
124782|NCT02787837|Biomarkers|biomarkers
124783|NCT02787824|iron deficiency|iron deficiency
124784|NCT02787824|hemodialysis|hemodialysis
124786|NCT02787811|Pregnancy rate|pregnancy rate
124787|NCT02787811|predictors|predictors
124788|NCT02787798|Nervous System|nervous system
124789|NCT02787798|Cardiac disease|cardiac disease
124790|NCT02787785|Subcutaneous|subcutaneous
124791|NCT02787785|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
124792|NCT02787785|MADIT|madit
124793|NCT02787785|Diabetes|diabetes
124794|NCT02787785|Myocardial Infarction|myocardial infarction
124795|NCT02787759|stroke|stroke
124796|NCT02787759|walking|walking
124797|NCT02787759|balance|balance
124798|NCT02787759|exercise|exercise
124799|NCT02787746|AD|ad
124800|NCT02787746|Donepezil|donepezil
124801|NCT02787746|Safety|safety
124802|NCT02787733|performance|performance
124803|NCT02787733|recovery|recovery
124804|NCT02787720|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
124805|NCT02787720|Pulmonary Rehabilitation|pulmonary rehabilitation
124806|NCT02787720|Rehabilitation Plan|rehabilitation plan
124807|NCT02787720|Rehabilitation Techniques|rehabilitation techniques
124808|NCT02787720|Survivor|survivor
124809|NCT02787720|Randomized Controlled Trial|randomized controlled trial
124810|NCT02787707|Breast cancer|breast cancer
124811|NCT02787707|Traditional medicine|traditional medicine
124812|NCT02787707|Chemotherapy Induced Nausea and Vomiting|chemotherapy induced nausea and vomiting
124813|NCT02787707|Bunium Persicum|bunium persicum
124814|NCT02787707|Rhus Coriaria|rhus coriaria
124815|NCT02787694|stroke|stroke
124816|NCT02787694|walking|walking
124817|NCT02787694|balance|balance
124818|NCT02787694|exercise|exercise
124819|NCT02787668|childhood obesity|childhood obesity
124820|NCT02787668|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
124821|NCT02787668|insulin resistance|insulin resistance
124822|NCT02787668|carbohydrate-restriction|carbohydrate-restriction
124823|NCT02787655|Aging|aging
124824|NCT02787642|Advanced soft-tissue sarcoma|advanced soft-tissue sarcoma
124825|NCT02787642|Unresectable Soft-tissue Sarcoma|unresectable soft-tissue sarcoma
124826|NCT02787629|D007440|d007440
124827|NCT02787590|Neurology|neurology
124828|NCT02787577|Sleep Duration|sleep duration
124829|NCT02787577|Sleep Quality|sleep quality
124830|NCT02787577|Body Composition|body composition
124831|NCT02787577|Energy Intake|energy intake
124832|NCT02787577|Energy Expenditure|energy expenditure
124833|NCT02787577|Energy Balance|energy balance
124834|NCT02787577|Cardiovascular Risk|cardiovascular risk
124835|NCT02787564|fruit, vegetables|fruit, vegetables
124836|NCT02787538|Rheumatoid Arthritis|rheumatoid arthritis
124837|NCT02787538|Decision Aids|decision aids
124838|NCT02787538|Biologics|biologics
124839|NCT02787512|ERCP|ercp
124840|NCT02787512|stent|stent
124841|NCT02787512|preoperative biliary drainage|preoperative biliary drainage
124842|NCT02787499|Drug resistance|drug resistance
124843|NCT02787499|Standard of care|standard of care
124844|NCT02787499|sub-saharan africa|sub-saharan africa
124845|NCT02787499|antiretroviral therapy|antiretroviral therapy
124846|NCT02787499|diagnostics|diagnostics
124847|NCT02787499|implementation|implementation
124848|NCT02787486|Down syndrome|down syndrome
124849|NCT02787486|Edwards syndrome|edwards syndrome
124850|NCT02787486|Patau syndrome|patau syndrome
124851|NCT02787486|Klinefelter syndrome|klinefelter syndrome
124852|NCT02787486|DiGeorge syndrome|digeorge syndrome
124853|NCT02787486|Chromosome Deletion|chromosome deletion
124854|NCT02787486|Aneuploidy|aneuploidy
124855|NCT02787473|Squamous cell lung cancer|squamous cell lung cancer
124856|NCT02787473|Pemetrexed|pemetrexed
124857|NCT02787473|Radiosensitivity|radiosensitivity
124858|NCT02787460|Parenting|parenting
124859|NCT02787460|Family Relations|family relations
124860|NCT02787460|Marriage|marriage
124861|NCT02787460|Relationships|relationships
124862|NCT02787447|Hypofractionated Radiotherapy|hypofractionated radiotherapy
124863|NCT02787447|Thymosin Alpha 1|thymosin alpha 1
124864|NCT02787447|Lung Adenocarcinoma|lung adenocarcinoma
124865|NCT02787447|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors
124866|NCT02787434|African american men|african american men
124867|NCT02787434|prostate cancer screening|prostate cancer screening
124868|NCT02787434|web-based decision aid|web-based decision aid
124967|NCT02787005|PD-L1|pd-l1
124869|NCT02787434|informed decision making|informed decision making
124870|NCT02787434|shared decision-making|shared decision-making
124871|NCT02787421|Reconstructive Surgery|reconstructive surgery
124872|NCT02787421|Rhinoplasty|rhinoplasty
124873|NCT02787382|cytomegalovirus|cytomegalovirus
124874|NCT02787382|TORCH|torch
124875|NCT02787382|prenatal diagnosis|prenatal diagnosis
124876|NCT02787382|congenital infections|congenital infections
124877|NCT02787382|fetal abnormalities|fetal abnormalities
124878|NCT02787382|echocardiography|echocardiography
124879|NCT02787382|myocardial deformation|myocardial deformation
124880|NCT02787369|Refractory Leukemia|refractory leukemia
124881|NCT02787369|Leukemia|leukemia
124882|NCT02787356|Skin Diseases, Erythema|skin diseases, erythema
124883|NCT02787330|pediatric cancer|pediatric cancer
124884|NCT02787330|psychosocial|psychosocial
124885|NCT02787330|siblings|siblings
124886|NCT02787317|bivalirudin|bivalirudin
124887|NCT02787317|myocardial injure|myocardial injure
124888|NCT02787304|NAFLD activity score|nafld activity score
124889|NCT02787304|ASBTi|asbti
124890|NCT02787304|MRI PDFF|mri pdff
124891|NCT02787304|NAS|nas
124892|NCT02787304|NAFLD|nafld
124893|NCT02787304|liver disease|liver disease
124894|NCT02787304|ASBT|asbt
124895|NCT02787304|MRI proton density fat fraction|mri proton density fat fraction
124896|NCT02787304|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
124897|NCT02787304|apical sodium dependent bile acid transporter inhibitor|apical sodium dependent bile acid transporter inhibitor
124898|NCT02787304|fatty liver|fatty liver
124899|NCT02787304|NASH|nash
124900|NCT02787278|rtPA|rtpa
124901|NCT02787278|Intracranial hemorrhage|intracranial hemorrhage
124902|NCT02787265|High density spinal cord stimulation|high density spinal cord stimulation
124903|NCT02787265|Virtual expert registry|virtual expert registry
124904|NCT02787226|liposomal bupivacaine|liposomal bupivacaine
124905|NCT02787226|analgesia for total shoulder arthroplasty|analgesia for total shoulder arthroplasty
124906|NCT02787226|peripheral nerve blocks for total shoulder arthroplasty|peripheral nerve blocks for total shoulder arthroplasty
124907|NCT02787213|proteomics|proteomics
124908|NCT02787213|pregnancy|pregnancy
124909|NCT02787213|biomarkers|biomarkers
124910|NCT02787213|preterm birth|preterm birth
124911|NCT02787200|electroencephalogram (EEG),Human brain,Brain-Computer Interface|electroencephalogram (eeg),human brain,brain-computer interface
124912|NCT02787187|Standard lymphadenectomy|standard lymphadenectomy
124913|NCT02787187|extended lymphadenectomy|extended lymphadenectomy
124914|NCT02787187|pancreaticoduodenectomy|pancreaticoduodenectomy
124915|NCT02787174|Asthma|asthma
124916|NCT02787174|Medication adherence|medication adherence
124917|NCT02787174|Intervention study|intervention study
124918|NCT02787161|Chronic Kidney Disease|chronic kidney disease
124919|NCT02787161|Hemodialysis|hemodialysis
124920|NCT02787161|Hemodiafiltration|hemodiafiltration
124921|NCT02787161|Renal Replacement Therapy|renal replacement therapy
124922|NCT02787161|Physical Activity|physical activity
124923|NCT02787161|Accelerometer|accelerometer
124924|NCT02787148|cognitive behavioral therapy|cognitive behavioral therapy
124925|NCT02787148|psychotherapy|psychotherapy
124926|NCT02787148|cardiovascular health|cardiovascular health
124927|NCT02787148|psychoneuroimmunology|psychoneuroimmunology
124928|NCT02787135|Delusions|delusions
124929|NCT02787135|Schizophrenia|schizophrenia
124930|NCT02787135|Cognitive Behavior Therapy|cognitive behavior therapy
124931|NCT02787135|Emotion|emotion
124932|NCT02787135|Emotion regulation|emotion regulation
124933|NCT02787135|self-esteem|self-esteem
124934|NCT02787135|sleep quality|sleep quality
124935|NCT02787135|Efficacy of change|efficacy of change
124936|NCT02787122|Schizophrenia|schizophrenia
124937|NCT02787122|psychotic disorders|psychotic disorders
124938|NCT02787122|Cognitive Behavior Therapy|cognitive behavior therapy
124939|NCT02787122|emotion regulation|emotion regulation
124940|NCT02787122|self-esteem|self-esteem
124941|NCT02787122|randomized-controlled trial|randomized-controlled trial
124942|NCT02787109|Safety|safety
124943|NCT02787109|Immunogenicity|immunogenicity
124944|NCT02787109|Phase I|phase i
124945|NCT02787096|dynamic knee laxity measurement|dynamic knee laxity measurement
124946|NCT02787096|laxi-MRI|laxi-mri
124947|NCT02787096|partial anterior cruciate ligament tear|partial anterior cruciate ligament tear
124948|NCT02787083|Interstitial Cystitis|interstitial cystitis
124949|NCT02787044|influenza vaccine|influenza vaccine
124950|NCT02787044|cardiopulmonary hospitalization|cardiopulmonary hospitalization
124951|NCT02787044|heart failure|heart failure
124952|NCT02787044|myocardial infarction|myocardial infarction
124953|NCT02787044|clinical trial|clinical trial
124954|NCT02787031|hip fracture|hip fracture
124955|NCT02787031|geriatric|geriatric
124956|NCT02787031|epidemiology|epidemiology
124957|NCT02787031|practice variation|practice variation
124958|NCT02787031|anesthesia|anesthesia
124959|NCT02787018|Brachial plexus block|brachial plexus block
124960|NCT02787018|Ropivacaine|ropivacaine
124961|NCT02787018|Dexmedetomidine|dexmedetomidine
124962|NCT02787018|Dexamethasone|dexamethasone
124963|NCT02787018|Adjuvants, anesthesia|adjuvants, anesthesia
124964|NCT02787005|PD1|pd1
124965|NCT02787005|PD-1|pd-1
124969|NCT02786992|Oxytocin|oxytocin
124970|NCT02786992|Carbetocin|carbetocin
124971|NCT02786992|Prevention|prevention
124972|NCT02786992|Post-partum hemorrhage|post-partum hemorrhage
124973|NCT02786979|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
124974|NCT02786979|Arteriosclerosis|arteriosclerosis
124975|NCT02786979|beraprost|beraprost
124976|NCT02786979|Aspirin|aspirin
124977|NCT02786966|Cervical spine injuries|cervical spine injuries
124978|NCT02786966|Canadian C-spine Rule|canadian c-spine rule
124979|NCT02786966|Emergency Medical Services|emergency medical services
124980|NCT02786966|Paramedic|paramedic
124981|NCT02786966|Cervical spine fracture|cervical spine fracture
124982|NCT02786953|Sleep|sleep
124983|NCT02786953|Adherence|adherence
124984|NCT02786953|Diabetes Management|diabetes management
124985|NCT02786953|Adolescent|adolescent
124986|NCT02786940|remote|remote
124987|NCT02786940|cardiac monitoring|cardiac monitoring
124988|NCT02786940|mortality|mortality
124989|NCT02786927|HANDIHALER|handihaler
124990|NCT02786927|Dry Powder Inhaler|dry powder inhaler
124991|NCT02786927|COPD|copd
124992|NCT02786927|ELLIPTA|ellipta
124993|NCT02786927|Inhaler preference attributes|inhaler preference attributes
124994|NCT02786875|lifestyle|lifestyle
124995|NCT02786875|low glycemic index diet|low glycemic index diet
124996|NCT02786875|exercise|exercise
124997|NCT02786875|vitamin D|vitamin d
124998|NCT02786875|breast cancer|breast cancer
124999|NCT02786875|Mediterranean diet|mediterranean diet
125000|NCT02786862|mechanical ventilation|mechanical ventilation
125001|NCT02786862|independent ventilation|independent ventilation
125002|NCT02786862|ventilation/perfusion mismatch|ventilation/perfusion mismatch
125003|NCT02786862|thoracic anesthesia|thoracic anesthesia
125004|NCT02786849|Electric Stimulation|electric stimulation
125005|NCT02786849|Electric Stimulation Therapy|electric stimulation therapy
125006|NCT02786836|acute liver failure|acute liver failure
125007|NCT02786836|methacetin|methacetin
125008|NCT02786836|breath test|breath test
125009|NCT02786836|severe acute liver injury|severe acute liver injury
125010|NCT02786836|hepatic encephalopathy|hepatic encephalopathy
125011|NCT02786836|ALFSG Registry|alfsg registry
125012|NCT02786836|acetaminophen toxicity|acetaminophen toxicity
125013|NCT02786797|breast cancer|breast cancer
125014|NCT02786797|mindfulness-based stress reduction|mindfulness-based stress reduction
125015|NCT02786797|cognitive impairment|cognitive impairment
125016|NCT02786771|Stress Management|stress management
125017|NCT02786771|Mindfulness|mindfulness
125018|NCT02786771|Meditation|meditation
125019|NCT02786771|Stress Resilience|stress resilience
125020|NCT02786732|Psoriasis|psoriasis
125021|NCT02786719|Sargramostim|sargramostim
125022|NCT02786719|Cyclophosphamide|cyclophosphamide
125023|NCT02786719|Topotecan|topotecan
125024|NCT02786719|Cisplatin|cisplatin
125025|NCT02786719|Dexrazoxane|dexrazoxane
125026|NCT02786719|Doxorubicin|doxorubicin
125027|NCT02786719|Etoposide|etoposide
125028|NCT02786719|Filgrastim|filgrastim
125029|NCT02786719|Vincristine|vincristine
125030|NCT02786719|Mesna|mesna
125031|NCT02786706|Traumatic Brain Injury|traumatic brain injury
125032|NCT02786706|Intracranial Pressure|intracranial pressure
125033|NCT02786706|Ultrasonography|ultrasonography
125034|NCT02786706|Computer-Assisted Image Analysis|computer-assisted image analysis
125035|NCT02786706|Intracranial Hypertension|intracranial hypertension
125036|NCT02786706|Acute brain injuries|acute brain injuries
125037|NCT02786693|TEP-scan|tep-scan
125038|NCT02786654|Acute myocardial infarction|acute myocardial infarction
125039|NCT02786654|mortality|mortality
125040|NCT02786654|evidence-based care|evidence-based care
125041|NCT02786654|Myocardial Ischaemia National Audit Project|myocardial ischaemia national audit project
125042|NCT02786654|β blockers|β blockers
125043|NCT02786641|nasopharyngeal carcinoma|nasopharyngeal carcinoma
125044|NCT02786641|induction chemotherapy|induction chemotherapy
125045|NCT02786641|concurrent chemotherapy|concurrent chemotherapy
125046|NCT02786641|docetaxel|docetaxel
125047|NCT02786641|cisplatin|cisplatin
125048|NCT02786641|xeloda|xeloda
125049|NCT02786641|nomogram|nomogram
125050|NCT02786615|men who have sex with men (MSM)|men who have sex with men (msm)
125051|NCT02786589|Lung cancer Immunotherapy|lung cancer immunotherapy
125052|NCT02786589|Plasmodium vivax|plasmodium vivax
125053|NCT02786589|Immunotherapy|immunotherapy
125054|NCT02786576|Moderate to Severe Hidradenitis Suppurativa|moderate to severe hidradenitis suppurativa
125055|NCT02786576|Adalimumab|adalimumab
125056|NCT02786563|power doppler (PD)|power doppler (pd)
125057|NCT02786563|ultrasonographic (US)|ultrasonographic (us)
125058|NCT02786563|rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
125059|NCT02786563|disease activity scale (DAS)|disease activity scale (das)
125060|NCT02786563|C-reactive protein (CRP)|c-reactive protein (crp)
125061|NCT02786550|Lower blepharoplasty, Botulinum toxin, Scar|lower blepharoplasty, botulinum toxin, scar
125062|NCT02786537|Hepatitis C|hepatitis c
125063|NCT02786524|Palliative Care|palliative care
125064|NCT02786524|Triage|triage
125065|NCT02786524|Symptom Evaluation|symptom evaluation
125066|NCT02786524|Chemotherapy|chemotherapy
125067|NCT02786524|Patient Distress|patient distress
125068|NCT02786498|Tibial Shaft|tibial shaft
125069|NCT02786498|Tibia|tibia
125070|NCT02786498|Femoral Shaft|femoral shaft
125071|NCT02786498|Femur|femur
125072|NCT02786498|Vitamin D|vitamin d
125073|NCT02786498|Fracture Healing|fracture healing
125074|NCT02786485|BPX-501|bpx-501
125075|NCT02786485|Rimiducid|rimiducid
125076|NCT02786485|AP1903|ap1903
125077|NCT02786485|Hematological malignancies|hematological malignancies
125078|NCT02786485|Hematologic diseases|hematologic diseases
125079|NCT02786485|Leukemias and Myelodysplastic Syndromes|leukemias and myelodysplastic syndromes
125080|NCT02786485|Lymphomas|lymphomas
125081|NCT02786485|Multiple myeloma|multiple myeloma
125082|NCT02786472|Bystander behaviors|bystander behaviors
125083|NCT02786472|Incoming students|incoming students
125084|NCT02786472|CampusSave|campussave
125085|NCT02786472|Prevention|prevention
125086|NCT02786472|Sexual Assault|sexual assault
125087|NCT02786472|Incapacitation|incapacitation
125088|NCT02786459|Prostate|prostate
125089|NCT02786459|Local Recurrence|local recurrence
125090|NCT02786459|Radical Prostatectomy|radical prostatectomy
125091|NCT02786446|Lidocaine gel|lidocaine gel
125092|NCT02786446|Extracorporeal shockwave lithotripsy|extracorporeal shockwave lithotripsy
125093|NCT02786446|Naproxen sodium|naproxen sodium
125094|NCT02786446|Pain score|pain score
125095|NCT02786420|pregnancy|pregnancy
125096|NCT02786420|magnetic resonance imaging|magnetic resonance imaging
125097|NCT02786420|environmental air pollutants|environmental air pollutants
125098|NCT02786407|overactive bladder|overactive bladder
125099|NCT02786407|Botulinum Toxin Type A for Injection|botulinum toxin type a for injection
125100|NCT02786368|Food Production|food production
125101|NCT02786368|Inadequacy|inadequacy
125102|NCT02786368|Dietary zinc|dietary zinc
125103|NCT02786368|Iron|iron
125104|NCT02786368|vitamin A|vitamin a
125105|NCT02786342|Hepatocellular Carcinoma|hepatocellular carcinoma
125106|NCT02786342|Sorafenib|sorafenib
125107|NCT02786342|HCC|hcc
125108|NCT02786342|Angiogenesis|angiogenesis
125109|NCT02786342|Polymorphisms|polymorphisms
125110|NCT02786329|colorectal cancer|colorectal cancer
125111|NCT02786329|TIVA|tiva
125112|NCT02786329|sevoflurane|sevoflurane
125113|NCT02786329|lidocaine|lidocaine
125114|NCT02786264|transcatheter aortic valve replacement|transcatheter aortic valve replacement
125115|NCT02786264|anesthesia|anesthesia
125116|NCT02786264|conscious sedation|conscious sedation
125117|NCT02786264|managed anesthesia care|managed anesthesia care
125118|NCT02786199|Hepatocellular Carcinoma(HCC)|hepatocellular carcinoma(hcc)
125119|NCT02786199|Ultrasound|ultrasound
125120|NCT02786199|Backscatter|backscatter
125121|NCT02786199|Differentiation grade|differentiation grade
125122|NCT02786199|Survival|survival
125123|NCT02786186|Psoriasis|psoriasis
125124|NCT02786186|Plaque Psoriasis|plaque psoriasis
125125|NCT02786186|Chronic Plaque Psoriasis|chronic plaque psoriasis
125126|NCT02786186|Cosentyx|cosentyx
125127|NCT02786186|Secukinumab|secukinumab
125128|NCT02786186|Moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
125129|NCT02786186|PURE registry|pure registry
125130|NCT02786186|Registry|registry
125131|NCT02786173|PRIME|prime
125132|NCT02786173|PAD|pad
125133|NCT02786173|PVD|pvd
125134|NCT02786173|Observational|observational
125135|NCT02786173|CLI|cli
125136|NCT02786173|PRIME Registry|prime registry
125137|NCT02786147|Breast Cancer|breast cancer
125138|NCT02786147|Ovarian Cancer|ovarian cancer
125139|NCT02786147|B-RST|b-rst
125140|NCT02786121|hip replacement,|hip replacement,
125141|NCT02786121|rehabilitation,|rehabilitation,
125142|NCT02786121|early ambulation,|early ambulation,
125143|NCT02786108|left gastric artery|left gastric artery
125144|NCT02786108|embolization|embolization
125145|NCT02786108|obesity|obesity
125146|NCT02786095|Atrial fibrillation|atrial fibrillation
125147|NCT02786095|anti arrhythmic drug|anti arrhythmic drug
125148|NCT02786095|NOAC|noac
125149|NCT02786095|warfarin|warfarin
125150|NCT02786095|coumadin|coumadin
125151|NCT02786056|Respiratory Function Tests|respiratory function tests
125152|NCT02786056|Lung|lung
125153|NCT02785965|electroacupuncture|electroacupuncture
125154|NCT02785965|lifestyle modification|lifestyle modification
125156|NCT02785965|exercise|exercise
125157|NCT02785965|Dai Meridian|dai meridian
125158|NCT02785926|pesticide exposure|pesticide exposure
125159|NCT02785926|respiratory control|respiratory control
125160|NCT02785926|sleep|sleep
125161|NCT02785900|Antibodies, monoclonal|antibodies, monoclonal
125162|NCT02785900|Antibody drug conjugate|antibody drug conjugate
125163|NCT02785900|Antigens, cluster of differentiation 33 (CD33)|antigens, cluster of differentiation 33 (cd33)
125164|NCT02785900|Drug therapy|drug therapy
125165|NCT02785900|Immunotherapy|immunotherapy
125166|NCT02785887|Breast cancer|breast cancer
125167|NCT02785887|lung cancer|lung cancer
125168|NCT02785887|Gastrointestinal Cancer|gastrointestinal cancer
125169|NCT02785887|Ovarian cancer|ovarian cancer
125170|NCT02785887|Prostate cancer|prostate cancer
125171|NCT02785887|bladder cancer|bladder cancer
125276|NCT02785237|OCT|oct
125172|NCT02785861|hormonal therapy|hormonal therapy
125173|NCT02785861|walking|walking
125174|NCT02785861|fatigue|fatigue
125175|NCT02785822|Reproductive Techniques, Assisted|reproductive techniques, assisted
125176|NCT02785809|Oral contraceptives|oral contraceptives
125177|NCT02785809|long-term use|long-term use
125178|NCT02785809|AMH|amh
125179|NCT02785809|Ovarian reserve parameters|ovarian reserve parameters
125180|NCT02785783|EndoRings™|endorings™
125181|NCT02785757|adenocarcinoma|adenocarcinoma
125182|NCT02785757|venous thromboembolism|venous thromboembolism
125183|NCT02785757|thrombin generation assay|thrombin generation assay
125184|NCT02785731|pelvic mass|pelvic mass
125185|NCT02785731|ovarian cancer|ovarian cancer
125186|NCT02785731|gynecological cancer|gynecological cancer
125187|NCT02785731|risk prediction|risk prediction
125188|NCT02785718|Contact system|contact system
125189|NCT02785718|Factor XI deficiency|factor xi deficiency
125190|NCT02785718|Factor XII deficiency|factor xii deficiency
125191|NCT02785718|Global haemostasis assays|global haemostasis assays
125192|NCT02785705|immunization|immunization
125193|NCT02785705|vaccine schedule|vaccine schedule
125194|NCT02785705|poliomyelitis|poliomyelitis
125195|NCT02785705|polio|polio
125196|NCT02785705|oral polio vaccine|oral polio vaccine
125197|NCT02785705|inactivated polio vaccine|inactivated polio vaccine
125198|NCT02785692|soft tissue sarcoma|soft tissue sarcoma
125199|NCT02785692|IMRT and sarcoma|imrt and sarcoma
125200|NCT02785692|preoperative highly conformal radiation therapy|preoperative highly conformal radiation therapy
125201|NCT02785692|soft tissue sarcoma and wound healing|soft tissue sarcoma and wound healing
125202|NCT02785692|postoperative complications|postoperative complications
125203|NCT02785692|treatment tolerance of soft tissue IMRT|treatment tolerance of soft tissue imrt
125204|NCT02785679|Allergy|allergy
125205|NCT02785679|Cow's milk|cow's milk
125206|NCT02785679|breast feeding|breast feeding
125207|NCT02785679|Cow's milk formula|cow's milk formula
125208|NCT02785679|prevention|prevention
125209|NCT02785666|Men who have sex with men|men who have sex with men
125210|NCT02785666|Elimination|elimination
125211|NCT02785653|sevoflurane|sevoflurane
125212|NCT02785653|rocuronium|rocuronium
125213|NCT02785653|intubation|intubation
125214|NCT02785627|Bone health|bone health
125215|NCT02785627|Bone microarchitecture|bone microarchitecture
125216|NCT02785627|Androgen deprivation therapy (ADT)|androgen deprivation therapy (adt)
125217|NCT02785588|MRI Scanner|mri scanner
125218|NCT02785588|NICU|nicu
125219|NCT02785562|PDL1 expression : Protein Death Ligand 1 expression .|pdl1 expression : protein death ligand 1 expression .
125220|NCT02785549|Acute diverticulitis|acute diverticulitis
125221|NCT02785549|Antibiotic|antibiotic
125222|NCT02785549|Outpatient treatment|outpatient treatment
125223|NCT02785536|minority health|minority health
125224|NCT02785536|social class|social class
125225|NCT02785536|healthcare disparities|healthcare disparities
125226|NCT02785536|tobacco use disorder|tobacco use disorder
125227|NCT02785497|Electrical stimulation|electrical stimulation
125228|NCT02785497|wound healing|wound healing
125229|NCT02785497|Polarity current|polarity current
125230|NCT02785497|Burn|burn
125231|NCT02785497|Chronic ulcer|chronic ulcer
125232|NCT02785484|Cigarette smoking|cigarette smoking
125233|NCT02785484|Smoking|smoking
125234|NCT02785484|Tobacco use|tobacco use
125235|NCT02785471|Suicide prevention|suicide prevention
125236|NCT02785471|men's mental health|men's mental health
125237|NCT02785471|depression|depression
125238|NCT02785471|suicide ideation and behaviors|suicide ideation and behaviors
125239|NCT02785419|Rehabilitation|rehabilitation
125240|NCT02785419|Upper Extremity|upper extremity
125241|NCT02785419|Physical Therapy|physical therapy
125242|NCT02785406|cocaine|cocaine
125243|NCT02785406|sleep|sleep
125244|NCT02785406|anxiety|anxiety
125245|NCT02785406|craving|craving
125246|NCT02785406|addiction|addiction
125247|NCT02785406|orexin|orexin
125248|NCT02785406|cue reactivity|cue reactivity
125249|NCT02785406|suvorexant|suvorexant
125250|NCT02785406|Belsomra|belsomra
125251|NCT02785393|Methamphetamine|methamphetamine
125252|NCT02785393|Dependence|dependence
125253|NCT02785341|adapted physical activity|adapted physical activity
125254|NCT02785328|Memory|memory
125255|NCT02785328|sleep|sleep
125256|NCT02785328|narcolepsy|narcolepsy
125257|NCT02785328|apnea|apnea
125258|NCT02785328|epilepsy|epilepsy
125259|NCT02785302|Pediatric|pediatric
125260|NCT02785302|HIV|hiv
125261|NCT02785302|Transition|transition
125262|NCT02785302|Adult Care|adult care
125263|NCT02785263|Anal cancer|anal cancer
125264|NCT02785263|Shared decision making|shared decision making
125265|NCT02785250|vaccine|vaccine
125266|NCT02785250|immunotherapy|immunotherapy
125267|NCT02785250|IDO1 inhibitor|ido1 inhibitor
125268|NCT02785250|ovarian|ovarian
125269|NCT02785250|fallopian tube|fallopian tube
125270|NCT02785250|peritoneal|peritoneal
125271|NCT02785250|cancer|cancer
125272|NCT02785250|recurrent|recurrent
125273|NCT02785250|tumor|tumor
125274|NCT02785250|measurable|measurable
125275|NCT02785237|Drug-eluting stent|drug-eluting stent
125277|NCT02785237|Re-endothelialization|re-endothelialization
125278|NCT02785146|Huaier Granule|huaier granule
125279|NCT02785146|After radical surgery|after radical surgery
125280|NCT02785146|Prevention of recurrence and metastasis|prevention of recurrence and metastasis
125281|NCT02785146|Efficacy and safety|efficacy and safety
125282|NCT02785120|Phase 2|phase 2
125283|NCT02785120|Efficacy|efficacy
125284|NCT02785120|Safety|safety
125285|NCT02785120|Ischemic Stroke|ischemic stroke
125286|NCT02785107|Exercise|exercise
125287|NCT02785107|Habit|habit
125288|NCT02785107|MVPA|mvpa
125289|NCT02785107|M-PAC|m-pac
125290|NCT02785107|Automaticity|automaticity
125291|NCT02785107|Physical Activity|physical activity
125292|NCT02785094|Caesarean Section Rate|caesarean section rate
125293|NCT02785094|Primigravida|primigravida
125294|NCT02785081|Thoracic epidural|thoracic epidural
125295|NCT02785081|Magnetic Resonance Imaging|magnetic resonance imaging
125296|NCT02785081|Children|children
125297|NCT02785068|Phase I|phase i
125298|NCT02785068|Cancer|cancer
125299|NCT02785068|EGFR|egfr
125300|NCT02785068|Metastatic Colorectal Cancer|metastatic colorectal cancer
125301|NCT02785068|Oncology|oncology
125302|NCT02785068|RAS/RAF Wild-Type|ras/raf wild-type
125303|NCT02785068|Nal-IRI|nal-iri
125304|NCT02785068|EGFR Inhibitor|egfr inhibitor
125305|NCT02785068|Oligoclonal Antibody|oligoclonal antibody
125306|NCT02785068|Nanoliposome|nanoliposome
125307|NCT02785068|Nanoliposomal Irinotecan|nanoliposomal irinotecan
125308|NCT02785016|Stress Urinary Incontinence|stress urinary incontinence
125309|NCT02785016|Suburethral Sling|suburethral sling
125310|NCT02785003|Colorectal Surgery|colorectal surgery
125311|NCT02785003|Acute Pain|acute pain
125312|NCT02785003|Pain|pain
125313|NCT02785003|post-operative pain|post-operative pain
125314|NCT02785003|ketamine|ketamine
125315|NCT02784938|Employment|employment
125316|NCT02784938|Mental Illness|mental illness
125317|NCT02784938|Photovoice|photovoice
125318|NCT02784912|Biomarkers|biomarkers
125319|NCT02784912|Ventricular Dysfunction|ventricular dysfunction
125320|NCT02784912|Ventricular Tachycardia|ventricular tachycardia
125321|NCT02784912|Electrical Storm|electrical storm
125322|NCT02784912|ST2|st2
125323|NCT02784912|Galectin-3|galectin-3
125324|NCT02784912|NT-proBNP|nt-probnp
125325|NCT02784912|Iron Deficiency|iron deficiency
125326|NCT02784912|hs-CRP|hs-crp
125327|NCT02784912|hs-TnT|hs-tnt
125328|NCT02784886|Placenta accreta|placenta accreta
125329|NCT02784886|previous caesarean|previous caesarean
125330|NCT02784886|placenta praevia|placenta praevia
125331|NCT02784886|Cell-free fetal DNA|cell-free fetal dna
125332|NCT02784886|Biological markers|biological markers
125333|NCT02784873|High intensity interval training|high intensity interval training
125334|NCT02784873|Coronary heart disease|coronary heart disease
125335|NCT02784873|Exercise training|exercise training
125336|NCT02784873|Cardiac rehabilitation|cardiac rehabilitation
125337|NCT02784873|Interval training|interval training
125338|NCT02784860|colonoscopy|colonoscopy
125339|NCT02784860|lidocaine|lidocaine
125340|NCT02784860|propofol|propofol
125341|NCT02784860|sedation|sedation
125342|NCT02784834|CLL|cll
125343|NCT02784834|cancer|cancer
125344|NCT02784834|DMF|dmf
125345|NCT02784834|SLL|sll
125346|NCT02784834|dimethylfumarate|dimethylfumarate
125347|NCT02784834|relapsed|relapsed
125348|NCT02784834|refractory|refractory
125349|NCT02784795|Notch Inhibitor|notch inhibitor
125350|NCT02784782|Spinal|spinal
125351|NCT02784782|Vertebral|vertebral
125352|NCT02784782|Burstfracture|burstfracture
125353|NCT02784782|Orthesis|orthesis
125354|NCT02784782|Brace|brace
125355|NCT02784782|Thoracolumbar|thoracolumbar
125356|NCT02784756|Quantiferon-CMV|quantiferon-cmv
125357|NCT02784756|solid organ transplant|solid organ transplant
125358|NCT02784756|CMV Disease|cmv disease
125359|NCT02784743|Wuchereria bancrofti|wuchereria bancrofti
125360|NCT02784743|Anopheles|anopheles
125361|NCT02784743|Albendazole|albendazole
125362|NCT02784743|Ivermectin|ivermectin
125363|NCT02784743|MDA|mda
125364|NCT02784730|breast cancer|breast cancer
125365|NCT02784730|chemotherapy|chemotherapy
125366|NCT02784730|peripherally inserted central catheter|peripherally inserted central catheter
125367|NCT02784730|implantable device|implantable device
125368|NCT02784730|randomized controlled trial|randomized controlled trial
125369|NCT02784730|iterative placement|iterative placement
125370|NCT02784730|Catheterization, Central Venous|catheterization, central venous
125371|NCT02784717|rivaroxaban,|rivaroxaban,
125372|NCT02784717|non-interventional,|non-interventional,
125373|NCT02784717|atrial fibrillation,|atrial fibrillation,
125374|NCT02784717|stroke prevention,|stroke prevention,
125375|NCT02784665|CSC|csc
125376|NCT02784665|Micropulse Laser|micropulse laser
125377|NCT02784665|Traditional Laser|traditional laser
125378|NCT02784639|KRAS/BRAF mutational status|kras/braf mutational status
125379|NCT02784626|Dexmedetomidine|dexmedetomidine
125380|NCT02784626|Propofol|propofol
125381|NCT02784626|Pain, Postoperative|pain, postoperative
125382|NCT02784600|Partial-thickness|partial-thickness
125383|NCT02784600|Full-thickness|full-thickness
125384|NCT02784587|stellate ganglion block|stellate ganglion block
125385|NCT02784587|cardiac surgery|cardiac surgery
125386|NCT02784574|Rehabilitation|rehabilitation
125387|NCT02784574|Aftercare|aftercare
125388|NCT02784561|allogeneic peripheral blood stem cell transplantation|allogeneic peripheral blood stem cell transplantation
125389|NCT02784561|conditioning regimen|conditioning regimen
125390|NCT02784561|acute leukemia|acute leukemia
125391|NCT02784561|relapsed/refractory|relapsed/refractory
125392|NCT02784509|Physical Activity|physical activity
125393|NCT02784509|Sedentary Behavior|sedentary behavior
125394|NCT02784509|Cardiometabolic Risk Factors|cardiometabolic risk factors
125395|NCT02784509|Childhood and Adolescence|childhood and adolescence
125396|NCT02784496|Myelofibrosis|myelofibrosis
125397|NCT02784496|Primary Myelofibrosis|primary myelofibrosis
125398|NCT02784496|PMF|pmf
125399|NCT02784496|Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis|post polycythemia vera/essential thrombocythemia myelofibrosis
125400|NCT02784496|Post-PV/ET MF|post-pv/et mf
125401|NCT02784496|Ruxolitinib|ruxolitinib
125402|NCT02784496|Jakafi|jakafi
125403|NCT02784496|INCB018424|incb018424
125404|NCT02784496|INC424|inc424
125405|NCT02784496|Questionnaires|questionnaires
125406|NCT02784496|Surveys|surveys
125407|NCT02784444|NASH|nash
125408|NCT02784405|percutaneous coronary intervention|percutaneous coronary intervention
125409|NCT02784405|stent implantation|stent implantation
125410|NCT02784379|Mastalgia|mastalgia
125411|NCT02784379|electromyography|electromyography
125412|NCT02784379|Pectoral|pectoral
125413|NCT02784366|Cancer immunotherapy|cancer immunotherapy
125414|NCT02784366|Ipilimumab|ipilimumab
125415|NCT02784353|Rehabilitation|rehabilitation
125416|NCT02784353|Quality of life|quality of life
125417|NCT02784353|Surgery|surgery
125418|NCT02784353|Hepatic neoplasms|hepatic neoplasms
125419|NCT02784353|Biliary tract neoplasms|biliary tract neoplasms
125420|NCT02784353|Pancreatic neoplasms|pancreatic neoplasms
125421|NCT02784340|Postoperative pain|postoperative pain
125422|NCT02784340|dexamethasone|dexamethasone
125423|NCT02784340|cesarean section|cesarean section
125424|NCT02784314|Clinically localized prostate cancer|clinically localized prostate cancer
125425|NCT02784314|Robotic-assisted prostatectomy|robotic-assisted prostatectomy
125426|NCT02784314|Laparoscopic prostatectomy|laparoscopic prostatectomy
125427|NCT02784314|Erectile function ;|erectile function ;
125428|NCT02784314|Cost efficacy study|cost efficacy study
125429|NCT02784288|head and neck neoplasms|head and neck neoplasms
125430|NCT02784288|HPV|hpv
125431|NCT02784288|human papilloma virus|human papilloma virus
125432|NCT02784288|de-escalation|de-escalation
125433|NCT02784288|low-risk|low-risk
125434|NCT02784288|oropharyngeal cancer|oropharyngeal cancer
125435|NCT02784262|Botulinum Toxin Type A|botulinum toxin type a
125436|NCT02784262|Block|block
125437|NCT02784262|Sphenopalatine Ganglion|sphenopalatine ganglion
125438|NCT02784249|Glaucoma|glaucoma
125439|NCT02784249|glaucoma surgery|glaucoma surgery
125440|NCT02784249|ab interno|ab interno
125441|NCT02784223|F18-choline|f18-choline
125442|NCT02784223|Surgery|surgery
125443|NCT02784223|Indeterminate|indeterminate
125444|NCT02784223|Thyroid node|thyroid node
125445|NCT02784210|Multiple Sclerosis|multiple sclerosis
125446|NCT02784210|Corticosteroids|corticosteroids
125447|NCT02784184|Hypothalamic-pituitary-gonadal axis|hypothalamic-pituitary-gonadal axis
125448|NCT02784158|Non-small cell lung cancer|non-small cell lung cancer
125449|NCT02784158|Non-small cell lung carcinoma|non-small cell lung carcinoma
125450|NCT02784158|Epithelial lung cancer|epithelial lung cancer
125451|NCT02784158|Squamous cell carcinoma|squamous cell carcinoma
125452|NCT02784158|Large cell carcinoma|large cell carcinoma
125453|NCT02784158|Adenocarcinoma|adenocarcinoma
125454|NCT02784158|Anaplastic lymphoma kinase (ALK)|anaplastic lymphoma kinase (alk)
125455|NCT02784158|Carcinoma|carcinoma
125456|NCT02784158|Advanced Cancers|advanced cancers
125457|NCT02784158|Brigatinib|brigatinib
125458|NCT02784158|AP26113|ap26113
125459|NCT02784119|temporary porto-caval shunt|temporary porto-caval shunt
125460|NCT02784119|liver graft|liver graft
125461|NCT02784119|extended criteria donor|extended criteria donor
125462|NCT02784106|Rheumatoid Arthritis|rheumatoid arthritis
125463|NCT02784106|M2951|m2951
125464|NCT02784106|Bruton's Tyrosine Kinase (BTK)|bruton's tyrosine kinase (btk)
125465|NCT02784093|Chronic Constipation|chronic constipation
125466|NCT02784093|Fecal impaction|fecal impaction
125467|NCT02784093|Gastrografin|gastrografin
125468|NCT02784093|Randomized Controlled Trial|randomized controlled trial
125469|NCT02784080|Liver Transplantation|liver transplantation
125470|NCT02784080|HLA alloantibodies|hla alloantibodies
125471|NCT02784080|donor specific antibodies|donor specific antibodies
125472|NCT02784080|Mortality|mortality
125473|NCT02784080|Re-transplantation|re-transplantation
125474|NCT02784080|Rejection|rejection
125475|NCT02784080|Acute rejection|acute rejection
125476|NCT02784080|Chronic rejection|chronic rejection
125477|NCT02784080|Biliary complications|biliary complications
125478|NCT02784080|Biliary stricture|biliary stricture
125479|NCT02784080|Arterial thrombosis|arterial thrombosis
125480|NCT02784080|Arterial stenosis|arterial stenosis
125481|NCT02784080|Portal vein thrombosis|portal vein thrombosis
125482|NCT02784080|Fibrosis|fibrosis
125483|NCT02784080|Single antigen bead|single antigen bead
125484|NCT02784080|Cross-match|cross-match
125485|NCT02784041|knee arthroplasty|knee arthroplasty
125486|NCT02784041|adductor canal block|adductor canal block
125487|NCT02784041|periarticular infiltration|periarticular infiltration
125488|NCT02784028|Peritoneal Carcinomatosis|peritoneal carcinomatosis
125489|NCT02784028|SGM-101|sgm-101
125490|NCT02783989|Endothelial function|endothelial function
125491|NCT02783989|Inflammation|inflammation
125492|NCT02783989|Genes related to vascular risk|genes related to vascular risk
125493|NCT02783963|Coronary Artery Disease|coronary artery disease
125494|NCT02783963|Coronary Thrombosis|coronary thrombosis
125495|NCT02783963|Coronary Stenosis|coronary stenosis
125496|NCT02783963|Tomography, Optical Coherence|tomography, optical coherence
125497|NCT02783963|Magnetic Resonance Imaging|magnetic resonance imaging
125498|NCT02783950|Genomics|genomics
125499|NCT02783950|Adjuvant Treatment|adjuvant treatment
125500|NCT02783937|Premature|premature
125501|NCT02783937|Ovarian|ovarian
125502|NCT02783937|Failure|failure
125503|NCT02783937|Filgrastim|filgrastim
125504|NCT02783924|vitamin D|vitamin d
125505|NCT02783924|genomics|genomics
125506|NCT02783924|proteomics|proteomics
125507|NCT02783924|metabolomics|metabolomics
125508|NCT02783924|adipose tissue|adipose tissue
125509|NCT02783911|Clinical and Radiograph|clinical and radiograph
125510|NCT02783898|pre syncope, palpitations|pre syncope, palpitations
125511|NCT02783859|Children|children
125512|NCT02783859|Anti-Bacterial Agents|anti-bacterial agents
125513|NCT02783859|Indigenous Population|indigenous population
125514|NCT02783859|Hospitals|hospitals
125515|NCT02783846|Propofol|propofol
125516|NCT02783846|Dexmedetomidine|dexmedetomidine
125517|NCT02783846|Dose|dose
125518|NCT02783846|Bispectral index monitor|bispectral index monitor
125519|NCT02783833|malaria, induced blood stage model challenge|malaria, induced blood stage model challenge
125520|NCT02783820|malaria, single ascending dose,|malaria, single ascending dose,
125521|NCT02783794|BP-C1|bp-c1
125522|NCT02783794|CDBPA|cdbpa
125523|NCT02783794|Cis-coordinated complexes of platinum(II) with polymer of benzene polycarboxylic acids derived from lignin|cis-coordinated complexes of platinum(ii) with polymer of benzene polycarboxylic acids derived from lignin
125524|NCT02783794|Benzene polycarboxylic acids complex with cis-diammineplatinum(II)|benzene polycarboxylic acids complex with cis-diammineplatinum(ii)
125525|NCT02783794|Metastatic Breast Cancer|metastatic breast cancer
125526|NCT02783794|Platinum analogue|platinum analogue
125527|NCT02783794|Metronomic chemotherapy|metronomic chemotherapy
125528|NCT02783794|Breast cancer|breast cancer
125529|NCT02783794|Cisplatin|cisplatin
125530|NCT02783781|Cardiac surgery (extracorporeal circulation; beating heart)|cardiac surgery (extracorporeal circulation; beating heart)
125531|NCT02783781|Biological data|biological data
125532|NCT02783781|Preoperative biological variables|preoperative biological variables
125533|NCT02783781|EuroSCORE II|euroscore ii
125534|NCT02783781|Risk prediction|risk prediction
125535|NCT02783768|E-cigarettes|e-cigarettes
125536|NCT02783768|COPD|copd
125537|NCT02783755|pain|pain
125538|NCT02783755|coping|coping
125539|NCT02783755|mhealth|mhealth
125540|NCT02783755|Breast cancer|breast cancer
125541|NCT02783742|provider-patient communication|provider-patient communication
125542|NCT02783742|coaching|coaching
125543|NCT02783742|feedback|feedback
125544|NCT02783742|burnout|burnout
125545|NCT02783729|E2006|e2006
125546|NCT02783729|Lemborexant|lemborexant
125547|NCT02783729|zolpidem tartrate|zolpidem tartrate
125548|NCT02783729|Ambien CR|ambien cr
125549|NCT02783729|Insomnia|insomnia
125550|NCT02783703|Insulin resistance|insulin resistance
125551|NCT02783664|Breast Cancer|breast cancer
125552|NCT02783664|BRCA1|brca1
125553|NCT02783664|BRCA2|brca2
125554|NCT02783664|stress|stress
125555|NCT02783664|gene testing|gene testing
125556|NCT02783664|genetic screening|genetic screening
125557|NCT02783664|psychological support|psychological support
125558|NCT02783664|State-Trait Anxiety Inventory|state-trait anxiety inventory
125559|NCT02783664|Cancer Worry Scale|cancer worry scale
125560|NCT02783664|Health Anxiety Inventory|health anxiety inventory
125561|NCT02783664|gene mutations|gene mutations
125562|NCT02783625|Duvelisib|duvelisib
125563|NCT02783625|Romidepsin|romidepsin
125564|NCT02783625|Bortezomib|bortezomib
125565|NCT02783625|16-042|16-042
125566|NCT02783573|dementia|dementia
125567|NCT02783573|brain diseases|brain diseases
125568|NCT02783573|neurodegenerative diseases|neurodegenerative diseases
125569|NCT02783573|central nervous system diseases|central nervous system diseases
125570|NCT02783573|nervous system diseases|nervous system diseases
125571|NCT02783573|mental disorders|mental disorders
125572|NCT02783573|delirium, dementia, amnestic, cognitive|delirium, dementia, amnestic, cognitive
125573|NCT02783573|tauopathies|tauopathies
125574|NCT02783573|memory|memory
125575|NCT02783573|amyloid|amyloid
125576|NCT02783560|Sleep|sleep
125577|NCT02783560|Electrodermal Activity|electrodermal activity
125578|NCT02783560|Mealtimes|mealtimes
125579|NCT02783534|Acupuncture|acupuncture
125580|NCT02783534|Primary Dysmenorrhea|primary dysmenorrhea
125581|NCT02783534|Randomized Controlled Trial|randomized controlled trial
125582|NCT02783534|Placebo Effect|placebo effect
125583|NCT02783521|Hispanic men|hispanic men
125584|NCT02783521|Weight loss|weight loss
125585|NCT02783521|Diet|diet
125586|NCT02783521|Physical activity|physical activity
125587|NCT02783521|Intervention|intervention
125588|NCT02783508|Labor analgesia|labor analgesia
125589|NCT02783508|Nitrous Oxide|nitrous oxide
125590|NCT02783508|Meperidine|meperidine
125591|NCT02783508|Multiparous|multiparous
125592|NCT02783508|Visual analogue scale|visual analogue scale
125593|NCT02783495|glioma|glioma
125594|NCT02783495|neurocognitive|neurocognitive
125595|NCT02783495|quality of life|quality of life
125596|NCT02783456|renal hemodynamic|renal hemodynamic
125597|NCT02783456|central hemodynamic|central hemodynamic
125598|NCT02783456|pilot study|pilot study
125599|NCT02783456|flight noise|flight noise
125600|NCT02783456|healthy participant|healthy participant
125601|NCT02783456|renal plasma flow|renal plasma flow
125602|NCT02783456|filtration fraction|filtration fraction
125603|NCT02783456|renal vascular resistance|renal vascular resistance
125604|NCT02783456|calculated intra glomerular pressure|calculated intra glomerular pressure
125605|NCT02783443|Anesthesia, glycocalyx, perfused boundary region|anesthesia, glycocalyx, perfused boundary region
125606|NCT02783430|Ketamine|ketamine
125607|NCT02783430|Palliative care|palliative care
125608|NCT02783430|Supportive care|supportive care
125609|NCT02783430|Early palliative care|early palliative care
125610|NCT02783430|Fast acting antidepressant|fast acting antidepressant
125611|NCT02783430|End of life care|end of life care
125612|NCT02783430|Cancer|cancer
125613|NCT02783430|psychological distress|psychological distress
125614|NCT02783430|antidepressant|antidepressant
125615|NCT02783430|serotonin norepinephrine reuptake inhibitors|serotonin norepinephrine reuptake inhibitors
125616|NCT02783417|Visceral fat|visceral fat
125617|NCT02783404|bacteraemia|bacteraemia
125618|NCT02783404|endocarditis|endocarditis
125619|NCT02783404|antibiotic prophylaxis|antibiotic prophylaxis
125620|NCT02783404|dentistry|dentistry
125621|NCT02783378|impedance metry|impedance metry
125622|NCT02783378|gaviscon|gaviscon
125623|NCT02783339|Next Generation Neuroform Stent System|next generation neuroform stent system
125624|NCT02783339|Intracranial|intracranial
125625|NCT02783339|Stent system|stent system
125626|NCT02783339|Saccular aneurysm|saccular aneurysm
125627|NCT02783339|Stent assisted coiling|stent assisted coiling
125628|NCT02783326|Chronic Disease Obstructive Pulmonary|chronic disease obstructive pulmonary
125629|NCT02783326|Rehabilitation|rehabilitation
125630|NCT02783326|Physical Therapy|physical therapy
125631|NCT02783313|pathogen inactivation|pathogen inactivation
125632|NCT02783313|platelets|platelets
125633|NCT02783300|GSK3326595|gsk3326595
125634|NCT02783300|glioblastoma multiforme (GBM)|glioblastoma multiforme (gbm)
125635|NCT02783300|Solid tumor|solid tumor
125636|NCT02783300|Non-Hodgkin's lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
125637|NCT02783300|breast cancer|breast cancer
125638|NCT02783300|bladder cancer|bladder cancer
125639|NCT02783300|dose escalation|dose escalation
125640|NCT02783287|Exercise adherence|exercise adherence
125641|NCT02783287|Medication adherence|medication adherence
125642|NCT02783287|Mobile health|mobile health
125643|NCT02783287|Cardiac rehabilitation|cardiac rehabilitation
125644|NCT02783261|radioembolization|radioembolization
125645|NCT02783261|hypertrophy|hypertrophy
125646|NCT02783261|Y90|y90
125647|NCT02783248|Percutaneous mitral commissurotomy|percutaneous mitral commissurotomy
125648|NCT02783248|Mitral Stenosis|mitral stenosis
125649|NCT02783235|VIA|via
125650|NCT02783235|Cervical Cancer|cervical cancer
125651|NCT02783235|Training|training
125652|NCT02783222|breast cancer|breast cancer
125653|NCT02783222|elderly patients|elderly patients
125654|NCT02783170|Tdap vaccine|tdap vaccine
125655|NCT02783170|Flu vaccine|flu vaccine
125656|NCT02783170|vaccines in pregnancy|vaccines in pregnancy
125657|NCT02783170|immunizations in pregnancy|immunizations in pregnancy
125658|NCT02783170|Whooping Cough|whooping cough
125659|NCT02783170|Pertussis|pertussis
125660|NCT02783170|Influenza|influenza
125661|NCT02783157|Autonomic|autonomic
125662|NCT02783157|Vagal nerve stimulation|vagal nerve stimulation
125663|NCT02783157|Postoperative atrial fibrillation|postoperative atrial fibrillation
125664|NCT02783144|Analgesia|analgesia
125665|NCT02783144|Dexamethasone|dexamethasone
125666|NCT02783144|Levobupivacaine|levobupivacaine
125667|NCT02783144|Ultrasound-guided|ultrasound-guided
125668|NCT02783144|Tranversus Abdominis|tranversus abdominis
125669|NCT02783131|inventions|inventions
125670|NCT02783131|Simulation Training|simulation training
125671|NCT02783131|Postpartum Haemorrhage|postpartum haemorrhage
125672|NCT02783131|Non Technical Skills|non technical skills
125673|NCT02783131|teamwork|teamwork
125674|NCT02783131|Crew Resource Management, Healthcare|crew resource management, healthcare
125675|NCT02783118|Depression|depression
125676|NCT02783118|Prevention|prevention
125678|NCT02783118|Smartphone app|smartphone app
125679|NCT02783105|Music therapy|music therapy
125680|NCT02783105|Paroxysmal sympathetic hyperactivity|paroxysmal sympathetic hyperactivity
125681|NCT02783105|Traumatic brain injury|traumatic brain injury
125682|NCT02783079|Breast Cancer|breast cancer
125683|NCT02783079|Prostate Cancer|prostate cancer
125684|NCT02783079|Colon Cancer|colon cancer
125685|NCT02783079|Lung Cancer|lung cancer
125686|NCT02783079|Gynecologic Cancer|gynecologic cancer
125687|NCT02783014|overactive bladder|overactive bladder
125688|NCT02782988|Olfaction|olfaction
125689|NCT02782988|CMV|cmv
125690|NCT02782962|nystagmus|nystagmus
125691|NCT02782962|vertigo|vertigo
125692|NCT02782962|unsteadiness|unsteadiness
125693|NCT02782962|emergency duplex ultrasonography|emergency duplex ultrasonography
125694|NCT02782936|Work of Breathing; Hypoxemia; Respiratory Acidosis; Respiratory effort|work of breathing; hypoxemia; respiratory acidosis; respiratory effort
125695|NCT02782923|Cervical Spine Surgery|cervical spine surgery
125696|NCT02782923|Simulation|simulation
125697|NCT02782897|intravenous immunoglobulin|intravenous immunoglobulin
125698|NCT02782897|intracerebral hemorrhage|intracerebral hemorrhage
125699|NCT02782897|perihematomal edema|perihematomal edema
125700|NCT02782884|post-operative pain|post-operative pain
125701|NCT02782871|Transfer|transfer
125702|NCT02782871|Intra-hospital|intra-hospital
125703|NCT02782871|Ventilator|ventilator
125704|NCT02782871|Manual ventilation|manual ventilation
125705|NCT02782871|Head and neck surgery|head and neck surgery
125706|NCT02782858|Multiple Sclerosis|multiple sclerosis
125707|NCT02782858|Multiple Sclerosis Relapsing-Remitting|multiple sclerosis relapsing-remitting
125708|NCT02782858|GNbAC1|gnbac1
125709|NCT02782858|MRI|mri
125710|NCT02782858|Monoclonal antibody|monoclonal antibody
125711|NCT02782858|Multiple Sclerosis associated retrovirus MSRV|multiple sclerosis associated retrovirus msrv
125712|NCT02782858|MS|ms
125713|NCT02782858|RRMS|rrms
125714|NCT02782858|HERV-W|herv-w
125715|NCT02782832|Neuromuscular|neuromuscular
125716|NCT02782832|Blockade|blockade
125717|NCT02782832|Surgery|surgery
125718|NCT02782819|Shock resuscitation|shock resuscitation
125719|NCT02782819|colloid|colloid
125720|NCT02782819|crystalloid|crystalloid
125721|NCT02782793|Endoscopic|endoscopic
125722|NCT02782793|Mucosal|mucosal
125723|NCT02782793|Resection|resection
125724|NCT02782780|insomnia|insomnia
125725|NCT02782780|insomnia disorder|insomnia disorder
125726|NCT02782780|Gulf War Illness|gulf war illness
125727|NCT02782780|Chronic Multisymptom Illness|chronic multisymptom illness
125728|NCT02782728|intimate partner violence|intimate partner violence
125729|NCT02782728|reproductive coercion|reproductive coercion
125730|NCT02782728|women's health|women's health
125731|NCT02782728|relationship abuse|relationship abuse
125732|NCT02782702|Botulism Toxin|botulism toxin
125733|NCT02782663|Crohn's Disease|crohn's disease
125734|NCT02782663|Efficacy|efficacy
125735|NCT02782663|Safety|safety
125736|NCT02782663|Tolerability|tolerability
125737|NCT02782663|ABT-494|abt-494
125738|NCT02782650|Limits|limits
125739|NCT02782650|Prenatal Counseling|prenatal counseling
125740|NCT02782650|Decision-making|decision-making
125741|NCT02782650|Foetal Complications|foetal complications
125742|NCT02782650|Counseling|counseling
125743|NCT02782650|Viability|viability
125744|NCT02782637|limits of viability|limits of viability
125745|NCT02782637|Prenatal Counseling|prenatal counseling
125746|NCT02782637|Decision-making|decision-making
125747|NCT02782637|Viability|viability
125748|NCT02782637|Counseling|counseling
125749|NCT02782611|Happiness|happiness
125750|NCT02782611|Subjective Well-Being|subjective well-being
125751|NCT02782611|Psychological Flourishing|psychological flourishing
125752|NCT02782611|Well-Being|well-being
125753|NCT02782611|Health|health
125754|NCT02782611|Behavioral Change|behavioral change
125755|NCT02782611|Life Satisfaction|life satisfaction
125756|NCT02782611|Affect|affect
125757|NCT02782611|Emotion|emotion
125758|NCT02782611|Goals|goals
125759|NCT02782611|Meaning in Life|meaning in life
125760|NCT02782598|Negative|negative
125761|NCT02782598|Atrioventricular|atrioventricular
125762|NCT02782598|Hysteresis|hysteresis
125763|NCT02782598|Cardiac Resynchronization|cardiac resynchronization
125764|NCT02782598|MultiPoint|multipoint
125765|NCT02782585|neck pain|neck pain
125766|NCT02782585|Manual therapy|manual therapy
125767|NCT02782585|psychological interaction|psychological interaction
125768|NCT02782572|Exercise|exercise
125769|NCT02782572|Cardiac Rehabilitation|cardiac rehabilitation
125770|NCT02782572|Non-invasive ventilation|non-invasive ventilation
125771|NCT02782520|Cardiopulmonary bypass|cardiopulmonary bypass
125772|NCT02782520|Swan Ganz|swan ganz
125773|NCT02782520|Fluid expansion|fluid expansion
125774|NCT02782520|hypertonic saline solution|hypertonic saline solution
125775|NCT02782507|pilot study|pilot study
125776|NCT02782507|CBT trial|cbt trial
125777|NCT02782494|Latent tuberculosis infection, dialysis|latent tuberculosis infection, dialysis
125778|NCT02782468|Drug Therapy|drug therapy
125779|NCT02782442|cognitive training|cognitive training
125780|NCT02782429|ketamine|ketamine
125781|NCT02782429|Cardiac Surgery|cardiac surgery
125782|NCT02782429|Neurocognitive Disorders|neurocognitive disorders
125783|NCT02782416|Renal|renal
125784|NCT02782416|Latent|latent
125785|NCT02782416|Tuberculosis|tuberculosis
125786|NCT02782403|Leukemia|leukemia
125787|NCT02782403|Chronic Myeloid Leukemia|chronic myeloid leukemia
125788|NCT02782403|CML|cml
125789|NCT02782403|Chronic Myeloid Leukemia, Chronic Phase|chronic myeloid leukemia, chronic phase
125790|NCT02782403|CML-CP|cml-cp
125791|NCT02782403|Chronic Myeloid Leukemia in Accelerated Phase|chronic myeloid leukemia in accelerated phase
125792|NCT02782403|CML-AP|cml-ap
125793|NCT02782403|Chronic Myeloid Leukemia in Blast Phase|chronic myeloid leukemia in blast phase
125794|NCT02782403|CML-BP|cml-bp
125795|NCT02782403|Axitinib|axitinib
125796|NCT02782403|AG-013736|ag-013736
125797|NCT02782403|Inlyta|inlyta
125798|NCT02782403|Bosutinib|bosutinib
125799|NCT02782403|SKI-606|ski-606
125800|NCT02782390|Stainless dental crown|stainless dental crown
125801|NCT02782390|Composite Resin|composite resin
125802|NCT02782390|Primary teeth|primary teeth
125803|NCT02782377|Faecal Incontinence|faecal incontinence
125804|NCT02782377|Obstructive Defaecation|obstructive defaecation
125805|NCT02782377|Rectal Prolapse|rectal prolapse
125806|NCT02782364|Faecal Incontinence|faecal incontinence
125807|NCT02782338|warfarin|warfarin
125808|NCT02782338|Voltaren eye drops|voltaren eye drops
125809|NCT02782338|INR|inr
125810|NCT02782312|Bronchiectasis|bronchiectasis
125811|NCT02782312|ICS+LABA|ics+laba
125812|NCT02782299|Decision aid|decision aid
125813|NCT02782299|Shared decision making|shared decision making
125814|NCT02782299|Older adult patients|older adult patients
125815|NCT02782299|Distal radius fracture|distal radius fracture
125816|NCT02782286|ketorolac|ketorolac
125817|NCT02782286|pain relieve|pain relieve
125818|NCT02782286|morphine|morphine
125819|NCT02782273|ketorolac|ketorolac
125820|NCT02782273|pain relieve|pain relieve
125821|NCT02782273|morphine|morphine
125822|NCT02782221|lipolysis|lipolysis
125823|NCT02782221|ATGL|atgl
125824|NCT02782182|Pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
125825|NCT02782182|FOLFIRINOX|folfirinox
125826|NCT02782182|resectable pancreatic cancer|resectable pancreatic cancer
125827|NCT02782156|Process Evaluation|process evaluation
125828|NCT02782156|alcohol withdrawal syndrome|alcohol withdrawal syndrome
125829|NCT02782143|delirium detection|delirium detection
125830|NCT02782130|HIV|hiv
125831|NCT02782130|YMSM|ymsm
125832|NCT02782130|Trans women|trans women
125833|NCT02782130|ART Adherence|art adherence
125834|NCT02782130|Intervention|intervention
125835|NCT02782104|Depressive Disorder, Treatment-Resistant|depressive disorder, treatment-resistant
125836|NCT02782104|Esketamine|esketamine
125837|NCT02782104|JNJ-54135419|jnj-54135419
125838|NCT02782091|MET|met
125839|NCT02782091|Prognosis|prognosis
125840|NCT02782091|Cognition|cognition
125841|NCT02782091|Ecological|ecological
125842|NCT02782091|Executive function|executive function
125843|NCT02782078|osteoarticular infection|osteoarticular infection
125844|NCT02782078|rifampicin|rifampicin
125845|NCT02782078|clindamycin|clindamycin
125846|NCT02782078|enzymatic induction|enzymatic induction
125847|NCT02782078|antibiotherapy resistance|antibiotherapy resistance
125848|NCT02782065|validation|validation
125849|NCT02782065|pediatrics|pediatrics
125850|NCT02782065|asthma severity|asthma severity
125851|NCT02782052|pulmonary arterial hypertension|pulmonary arterial hypertension
125852|NCT02782052|spirometry|spirometry
125853|NCT02782052|dynamic lung hyperinflation|dynamic lung hyperinflation
125854|NCT02782052|bronchodilator|bronchodilator
125855|NCT02782052|dyspnoea|dyspnoea
125856|NCT02782052|Idiopathic|idiopathic
125857|NCT02782052|heritable|heritable
125858|NCT02782052|PAH|pah
125859|NCT02782026|pulmonary hypertension|pulmonary hypertension
125860|NCT02782026|early detection|early detection
125861|NCT02782013|community acquired pneumonia|community acquired pneumonia
125862|NCT02782013|CAP|cap
125863|NCT02782013|disease progression|disease progression
125864|NCT02782000|dementia|dementia
125865|NCT02782000|early recognition|early recognition
125866|NCT02782000|general practitioner|general practitioner
125867|NCT02782000|training|training
125868|NCT02781935|unresectable colorectal liver metastasis|unresectable colorectal liver metastasis
125869|NCT02781935|diffusion weighted MRI|diffusion weighted mri
125870|NCT02781935|disappearing liver metastasis|disappearing liver metastasis
125871|NCT02781922|cardiac stem/progenitor cells|cardiac stem/progenitor cells
125872|NCT02781922|autologous cell therapy|autologous cell therapy
125873|NCT02781922|functional single ventricle|functional single ventricle
125874|NCT02781922|congenital heart disease|congenital heart disease
125875|NCT02781909|NSAIDS|nsaids
125876|NCT02781909|tuberculosis treatment|tuberculosis treatment
125877|NCT02781909|anti-inflammatories|anti-inflammatories
125878|NCT02781909|Host-directed therapies|host-directed therapies
125879|NCT02781909|TB|tb
125880|NCT02781896|TAVI|tavi
125881|NCT02781896|aortic valve bioprothesis|aortic valve bioprothesis
125882|NCT02781896|TAVI simplification|tavi simplification
125883|NCT02781896|aortic stenosis|aortic stenosis
125884|NCT02781896|rapid left ventricular pacing|rapid left ventricular pacing
125885|NCT02781896|TAVR|tavr
125886|NCT02781883|Liposomal Grb-2 treatment of AML|liposomal grb-2 treatment of aml
125887|NCT02781883|Liposomal Grb-2 with LDAC for AML|liposomal grb-2 with ldac for aml
125888|NCT02781857|Exhaled Breath|exhaled breath
125889|NCT02781857|Mass Spectrometry|mass spectrometry
125890|NCT02781857|Fingerprinting|fingerprinting
125891|NCT02781818|hidradenitis|hidradenitis
125892|NCT02781818|intralesional|intralesional
125893|NCT02781818|triamcinolone|triamcinolone
125894|NCT02781779|Cardiac Implantable Electronic Device|cardiac implantable electronic device
125895|NCT02781779|Implant|implant
125896|NCT02781766|Haemophilia A|haemophilia a
125897|NCT02781766|prophylaxis|prophylaxis
125898|NCT02781766|thrombin generation assay|thrombin generation assay
125899|NCT02781766|factor VIII|factor viii
125900|NCT02781766|prophylactic therapy|prophylactic therapy
125901|NCT02781740|Continous Positive Airway Pressure|continous positive airway pressure
125902|NCT02781740|CPAP|cpap
125903|NCT02781740|Sham CPAP|sham cpap
125904|NCT02781740|CPAP withdrawal|cpap withdrawal
125905|NCT02781740|suboptimal CPAP|suboptimal cpap
125906|NCT02781727|Human Growth Hormone|human growth hormone
125907|NCT02781727|hGH|hgh
125908|NCT02781727|GHD|ghd
125909|NCT02781727|rHGH|rhgh
125910|NCT02781727|Pediatric Growth Hormone Deficiency|pediatric growth hormone deficiency
125911|NCT02781727|Long Acting Growth Hormone|long acting growth hormone
125912|NCT02781727|Somatropin|somatropin
125913|NCT02781727|Prodrug|prodrug
125914|NCT02781727|Growth Failure|growth failure
125915|NCT02781727|Growth Hormone Replacement Therapy|growth hormone replacement therapy
125916|NCT02781727|Sustained Release|sustained release
125917|NCT02781727|Sustained Release Growth Hormone|sustained release growth hormone
125918|NCT02781727|Growth Hormone Deficiency|growth hormone deficiency
125919|NCT02781714|contraception|contraception
125920|NCT02781714|postpartum period|postpartum period
125921|NCT02781714|mobile health|mobile health
125922|NCT02781714|mHealth|mhealth
125923|NCT02781714|Kenya|kenya
125924|NCT02781714|couples|couples
125925|NCT02781675|Diet|diet
125926|NCT02781675|Mediterranean|mediterranean
125927|NCT02781675|Cholesterol|cholesterol
125928|NCT02781675|Inflammation|inflammation
125929|NCT02781662|Safety|safety
125930|NCT02781662|Hospitalization|hospitalization
125931|NCT02781662|Older Persons|older persons
125932|NCT02781662|High-Risk|high-risk
125933|NCT02781649|Renal|renal
125934|NCT02781649|Transplants|transplants
125935|NCT02781649|Hepatitis C|hepatitis c
125936|NCT02781649|HCV-negative|hcv-negative
125937|NCT02781649|Infected|infected
125938|NCT02781649|Donors|donors
125939|NCT02781636|Efficacy|efficacy
125940|NCT02781636|Implantable|implantable
125941|NCT02781636|Wireless|wireless
125942|NCT02781636|Neuromodulation|neuromodulation
125943|NCT02781636|Device|device
125944|NCT02781636|Tibial|tibial
125945|NCT02781623|Quadriceps|quadriceps
125946|NCT02781623|Tibial Plateau|tibial plateau
125947|NCT02781623|Fracture|fracture
125948|NCT02781610|Cystic fibrosis|cystic fibrosis
125949|NCT02781610|Pulmonary exacerbation|pulmonary exacerbation
125950|NCT02781610|Antibiotic|antibiotic
125951|NCT02781610|Treatment duration|treatment duration
125952|NCT02781610|Lung infection|lung infection
125953|NCT02781610|Cystic Fibrosis Foundation|cystic fibrosis foundation
125954|NCT02781610|Cystic Fibrosis Foundation National Patient Registry|cystic fibrosis foundation national patient registry
125955|NCT02781597|Hemoptysis|hemoptysis
125956|NCT02781597|Tranexamic acid|tranexamic acid
125957|NCT02781597|VAS score|vas score
125958|NCT02781545|Child Development|child development
125959|NCT02781545|Psychomotor Performance|psychomotor performance
125960|NCT02781545|Newborns|newborns
125961|NCT02781545|Surgery|surgery
125962|NCT02781493|Prucalopride|prucalopride
125963|NCT02781493|Polyethylene Glycol|polyethylene glycol
125964|NCT02781493|bowel preparation|bowel preparation
125965|NCT02781467|Acute Myeloid|acute myeloid
125966|NCT02781467|Leukemia|leukemia
125967|NCT02781467|PNK-007|pnk-007
125968|NCT02781467|Human IL-2|human il-2
125969|NCT02781467|RHIL-2|rhil-2
125970|NCT02781467|Fludarabine|fludarabine
125971|NCT02781467|Cyclophosphamide|cyclophosphamide
125972|NCT02781454|SALS|sals
125973|NCT02781454|Mexiletine|mexiletine
125974|NCT02781454|TMS|tms
125975|NCT02781454|NCS|ncs
125976|NCT02781402|Overweight BMI Individuals|overweight bmi individuals
125977|NCT02781402|Normal BMI Individuals|normal bmi individuals
125978|NCT02781402|Recovery Heart Rate|recovery heart rate
125979|NCT02781389|Basal cell carcinoma (BCC)|basal cell carcinoma (bcc)
125980|NCT02781389|advanced BCC (aBCC)|advanced bcc (abcc)
125981|NCT02781376|Primary Care|primary care
125982|NCT02781376|Computer Decision Support System|computer decision support system
125983|NCT02781376|Guidelines|guidelines
125984|NCT02781376|Snoring|snoring
125985|NCT02781363|thoracic ultrasound|thoracic ultrasound
125986|NCT02781363|children|children
125987|NCT02781363|efficacy|efficacy
125988|NCT02781363|emergency service|emergency service
125989|NCT02781350|high fat diet|high fat diet
125990|NCT02781350|insulinogenesis|insulinogenesis
125991|NCT02781350|Fiber|fiber
125992|NCT02781350|inflammation|inflammation
125993|NCT02781324|Ultrasonic Bone Scalpel|ultrasonic bone scalpel
125994|NCT02781324|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
125995|NCT02781324|Posterior Spinal Fusion|posterior spinal fusion
125996|NCT02781324|Estimated Blood Loss|estimated blood loss
125997|NCT02781272|pelvic mass|pelvic mass
125998|NCT02781272|ovarian cancer|ovarian cancer
125999|NCT02781272|gynecological cancer|gynecological cancer
126000|NCT02781272|risk prediction|risk prediction
126001|NCT02781259|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
126002|NCT02781259|Fluorescence|fluorescence
126003|NCT02781259|Breast Neoplasms|breast neoplasms
126004|NCT02781259|Indocyanine Green|indocyanine green
126005|NCT02781220|MCI|mci
126006|NCT02781220|Dementia|dementia
126007|NCT02781220|amyloid PET|amyloid pet
126008|NCT02781220|physician diagnosis|physician diagnosis
126009|NCT02781220|Alzheimer's disease|alzheimer's disease
126010|NCT02781220|AD|ad
126011|NCT02781220|PET imaging|pet imaging
126012|NCT02781220|Appropriate Use Criteria|appropriate use criteria
126013|NCT02781220|patient-reported outcomes|patient-reported outcomes
126014|NCT02781220|patient adherence|patient adherence
126015|NCT02781207|syncope|syncope
126016|NCT02781207|point-of-care ultrasound|point-of-care ultrasound
126017|NCT02781181|Stenting|stenting
126018|NCT02781181|Protection device|protection device
126019|NCT02781181|EPD usage|epd usage
126020|NCT02781168|Premature newborn|premature newborn
126021|NCT02781168|Cortisol|cortisol
126022|NCT02781168|Stress|stress
126023|NCT02781155|Health related quality of life|health related quality of life
126024|NCT02781155|Moxibustion|moxibustion
126025|NCT02781155|Cancer|cancer
126026|NCT02781155|Chemotherapy|chemotherapy
126027|NCT02781155|Neutropenia|neutropenia
126028|NCT02781155|Anaemia|anaemia
126029|NCT02781155|Thrombocytopenia|thrombocytopenia
126030|NCT02781155|Self management|self management
126031|NCT02781155|Wellbeing|wellbeing
126032|NCT02781129|Memory|memory
126033|NCT02781129|Responsive Neurostimulator System|responsive neurostimulator system
126034|NCT02781090|HIV|hiv
126035|NCT02781090|Tobacco|tobacco
126036|NCT02781090|Cigarette|cigarette
126037|NCT02781090|Smoking|smoking
126038|NCT02781090|Social Network|social network
126039|NCT02781090|Internet|internet
126040|NCT02781090|Cessation|cessation
126041|NCT02781077|Stroke|stroke
126042|NCT02781077|walking competency|walking competency
126043|NCT02781077|Task-oriented exercise program|task-oriented exercise program
126044|NCT02781077|Exercise intensity|exercise intensity
126045|NCT02781012|Pancreatic Disease|pancreatic disease
126046|NCT02781012|Pancreas|pancreas
126047|NCT02781012|Borderline Resectable|borderline resectable
126048|NCT02781012|Pancreatic Cancer|pancreatic cancer
126049|NCT02781012|Pancreatitis|pancreatitis
126050|NCT02781012|Family history of pancreatic cancer|family history of pancreatic cancer
126051|NCT02781012|Healthy|healthy
126052|NCT02781012|Healthy at risk|healthy at risk
126053|NCT02780999|Osteoarthritis|osteoarthritis
126054|NCT02780999|hand|hand
126055|NCT02780999|orthotic|orthotic
126056|NCT02780999|rehabilitation|rehabilitation
126057|NCT02780986|female entertainment worker|female entertainment worker
126058|NCT02780986|heterosexual men|heterosexual men
126059|NCT02780986|entertainment establishment|entertainment establishment
126060|NCT02780986|condom use|condom use
126061|NCT02780986|sexually transmitted infection|sexually transmitted infection
126062|NCT02780986|Singapore|singapore
126063|NCT02780947|Ventricular tachycardia|ventricular tachycardia
126064|NCT02780947|Ablation|ablation
126065|NCT02780947|Myocardial Infarction|myocardial infarction
126066|NCT02780947|Heart Failure|heart failure
126067|NCT02780934|Pressure Dressing|pressure dressing
126068|NCT02780934|Post-operative Care|post-operative care
126069|NCT02780934|Simple Adhesive Dressing|simple adhesive dressing
126070|NCT02780934|Mohs|mohs
126071|NCT02780921|Prehabilitation|prehabilitation
126072|NCT02780921|Oesophageal cancer|oesophageal cancer
126073|NCT02780921|Gastric cancer|gastric cancer
126074|NCT02780921|Fitness|fitness
126075|NCT02780921|Preconditionning|preconditionning
126076|NCT02780921|two parallel arms|two parallel arms
126077|NCT02780895|Parkinson Disease|parkinson disease
126078|NCT02780895|stereotactic surgery|stereotactic surgery
126079|NCT02780895|human allogeneic fetal derived stem cells|human allogeneic fetal derived stem cells
126080|NCT02780882|Pasireotide|pasireotide
126081|NCT02780882|Ectopic ACTH|ectopic acth
126082|NCT02780882|SOM230|som230
126083|NCT02780882|ectopic ACTH-dependent Cushing's syndrome|ectopic acth-dependent cushing's syndrome
126084|NCT02780856|Caries Activity Demineralisation|caries activity demineralisation
126085|NCT02780856|Demineralisation|demineralisation
126086|NCT02780843|Stroke|stroke
126087|NCT02780843|Tomography, X-Ray Computed|tomography, x-ray computed
126088|NCT02780843|Magnetic Resonance Imaging|magnetic resonance imaging
126089|NCT02780843|Thrombolytic Therapy|thrombolytic therapy
126090|NCT02780830|Lymphoma|lymphoma
126091|NCT02780830|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
126092|NCT02780830|non-GCB Diffuse Large B-Cell Lymphoma|non-gcb diffuse large b-cell lymphoma
126093|NCT02780830|Relapsed or Refractory non-GCB Diffuse Large B-Cell Lymphoma|relapsed or refractory non-gcb diffuse large b-cell lymphoma
126094|NCT02780830|Vistusertib|vistusertib
126095|NCT02780830|AZD2014|azd2014
126096|NCT02780830|Ibrutinib|ibrutinib
126097|NCT02780830|Imbruvica|imbruvica
126098|NCT02780791|Infertility|infertility
126099|NCT02780791|Ovarian Failure, Premature|ovarian failure, premature
126100|NCT02780791|Ovarian Follicle|ovarian follicle
126101|NCT02780791|Ovary|ovary
126102|NCT02780791|Tissue Transplantation|tissue transplantation
126103|NCT02780791|Cryopreservation|cryopreservation
126104|NCT02780791|Pelvis|pelvis
126105|NCT02780791|Chemotherapy|chemotherapy
126106|NCT02780791|Pregnancy Rate|pregnancy rate
126107|NCT02780791|Folliculogenesis|folliculogenesis
126108|NCT02780791|Endometrium|endometrium
126109|NCT02780791|Estrogens|estrogens
126110|NCT02780791|Progestins|progestins
126111|NCT02780791|Follicle Stimulating Hormone|follicle stimulating hormone
126112|NCT02780791|Estradiol|estradiol
126113|NCT02780791|Progesterone|progesterone
126114|NCT02780791|Hormones|hormones
126115|NCT02780791|Maturation of Follicles|maturation of follicles
126116|NCT02780791|Pregnant Women|pregnant women
126117|NCT02780791|Premature Menopause|premature menopause
126118|NCT02780791|Ovarian Insufficiency|ovarian insufficiency
126119|NCT02780791|Ovarian Insufficiency, Premature|ovarian insufficiency, premature
126120|NCT02780791|Cytotoxic therapy|cytotoxic therapy
126121|NCT02780791|Fertility Protection|fertility protection
126122|NCT02780791|Reproductive Medicine|reproductive medicine
126123|NCT02780791|Reproductive Techniques|reproductive techniques
126124|NCT02780791|Reproductive Technology|reproductive technology
126125|NCT02780791|Cryotherapy|cryotherapy
126126|NCT02780791|Pregnancy|pregnancy
126127|NCT02780739|Psychological Tests|psychological tests
126128|NCT02780739|Neuropsychological Tests|neuropsychological tests
126129|NCT02780739|Transcranial Direct Current Stimulation|transcranial direct current stimulation
126130|NCT02780739|Exercise|exercise
126131|NCT02780739|Circuit-Based Exercise|circuit-based exercise
126132|NCT02780739|Video Games|video games
126133|NCT02780739|Magnetic Resonance Imaging|magnetic resonance imaging
126134|NCT02780739|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
126135|NCT02780739|Cognition|cognition
126136|NCT02780739|Executive Function|executive function
126137|NCT02780739|Learning|learning
126138|NCT02780739|Problem Solving|problem solving
126139|NCT02780739|Transfer (Psychology)|transfer (psychology)
126140|NCT02780739|Decision Making|decision making
126141|NCT02780739|Brain|brain
126142|NCT02780739|Gray Matter|gray matter
126143|NCT02780739|White Matter|white matter
126144|NCT02780726|Peritoneal dialysis|peritoneal dialysis
126145|NCT02780726|Roxadustat|roxadustat
126146|NCT02780726|Renal anemia|renal anemia
126147|NCT02780726|ASP1517|asp1517
126148|NCT02780713|Breast cancer|breast cancer
126149|NCT02780713|Healthy volunteers|healthy volunteers
126150|NCT02780713|Pharmacokinetics|pharmacokinetics
126151|NCT02780713|AZD9496|azd9496
126152|NCT02780713|Safety|safety
126153|NCT02780713|Tolerability|tolerability
126154|NCT02780674|Polymyositis, dermatomyositis, Sjogren's syndrome, SLE, SSc|polymyositis, dermatomyositis, sjogren's syndrome, sle, ssc
126155|NCT02780648|stereotactic radiotherapy|stereotactic radiotherapy
126156|NCT02780648|pancreatic adenocarcinoma|pancreatic adenocarcinoma
126157|NCT02780635|family, caregiving, ptsd, couples|family, caregiving, ptsd, couples
126158|NCT02780609|autologous hematopoietic cell transplantation (HCT)|autologous hematopoietic cell transplantation (hct)
126159|NCT02780609|high-dose melphalan|high-dose melphalan
126160|NCT02780609|selinexor|selinexor
126161|NCT02780596|Infant|infant
126162|NCT02780596|Toddler|toddler
126163|NCT02780596|Primary Care|primary care
126164|NCT02780570|SVPE|svpe
126165|NCT02780570|intravenous immunoglobulin|intravenous immunoglobulin
126166|NCT02780570|plasmapheresis|plasmapheresis
126167|NCT02780557|Vocabulary|vocabulary
126168|NCT02780557|Book reading|book reading
126169|NCT02780557|Infancy|infancy
126170|NCT02780557|Parenting|parenting
126171|NCT02780544|Infant, premature|infant, premature
126172|NCT02780544|Pain|pain
126173|NCT02780544|Stress, physiological|stress, physiological
126174|NCT02780544|Stress, psychological|stress, psychological
126175|NCT02780544|skin-to-skin contact|skin-to-skin contact
126176|NCT02780518|oxygen|oxygen
126177|NCT02780518|carbon dioxide|carbon dioxide
126178|NCT02780492|Duchenne muscular dystrophy|duchenne muscular dystrophy
126179|NCT02780492|Natural history|natural history
126180|NCT02780492|Outcome measures|outcome measures
126181|NCT02780492|North Star Ambulatory Assessment (NSAA)|north star ambulatory assessment (nsaa)
126182|NCT02780492|6 minute walk distance (6MWD)|6 minute walk distance (6mwd)
126183|NCT02780492|Myoset|myoset
126184|NCT02780492|Exon skipping|exon skipping
126185|NCT02780479|Prednisone|prednisone
126186|NCT02780479|Dexamethasone|dexamethasone
126187|NCT02780479|Asthma exacerbation|asthma exacerbation
126188|NCT02780479|Hospitalized|hospitalized
126189|NCT02780466|Septic shock|septic shock
126190|NCT02780466|Endotracheal intubation|endotracheal intubation
126191|NCT02780466|Outcome|outcome
126192|NCT02780440|Post Stroke Recovery|post stroke recovery
126193|NCT02780440|Mirror Therapy|mirror therapy
126194|NCT02780440|Unimanual mirror therapy|unimanual mirror therapy
126195|NCT02780440|Bimanual mirror therapy|bimanual mirror therapy
126196|NCT02780440|Stroke|stroke
126197|NCT02780427|Dose-Response Relationship, Drug|dose-response relationship, drug
126198|NCT02780414|Hypertension|hypertension
126199|NCT02780414|Proteinuria|proteinuria
126200|NCT02780414|Thrombocytopenia|thrombocytopenia
126201|NCT02780414|Renal Insufficiency|renal insufficiency
126202|NCT02780414|Impaired Liver Function|impaired liver function
126203|NCT02780414|Pulmonary Edema|pulmonary edema
126204|NCT02780401|Stage I|stage i
126205|NCT02780401|Stage II|stage ii
126206|NCT02780401|Stage III|stage iii
126207|NCT02780388|MEDI4920, CD40L, RA, rheumatoid arthritis|medi4920, cd40l, ra, rheumatoid arthritis
126208|NCT02780375|Transcriptional Responses|transcriptional responses
126209|NCT02780375|Radiation|radiation
126210|NCT02780323|Celecoxib|celecoxib
126211|NCT02780323|CELBESTA|celbesta
126212|NCT02780310|Lenvatinib|lenvatinib
126213|NCT02780310|15-327|15-327
126214|NCT02780297|primary hyperoxaluria|primary hyperoxaluria
126215|NCT02780297|Dent Disease|dent disease
126216|NCT02780297|enteric hyperoxaluria|enteric hyperoxaluria
126217|NCT02780297|cystinuria|cystinuria
126218|NCT02780297|Lowe Syndrome|lowe syndrome
126219|NCT02780297|Adenine phosphoribosyltransferase deficiency|adenine phosphoribosyltransferase deficiency
126221|NCT02780297|APRTd|aprtd
126222|NCT02780297|APRT|aprt
126223|NCT02780297|hyperoxaluria|hyperoxaluria
126224|NCT02780297|oxalate|oxalate
126225|NCT02780297|oxalosis|oxalosis
126226|NCT02780297|PH type 1|ph type 1
126227|NCT02780297|PH type 2|ph type 2
126228|NCT02780297|PH type 3|ph type 3
126229|NCT02780297|Dents|dents
126230|NCT02780297|Dent|dent
126231|NCT02780297|Dent 1|dent 1
126232|NCT02780297|Dent 2|dent 2
126233|NCT02780297|APRT deficiency|aprt deficiency
126234|NCT02780284|Gut Microbiota|gut microbiota
126235|NCT02780284|Butyrate|butyrate
126236|NCT02780284|Physical activity|physical activity
126237|NCT02780271|Breast Cancer|breast cancer
126238|NCT02780271|Cancer survivor|cancer survivor
126239|NCT02780271|e-communication|e-communication
126240|NCT02780271|diet and physical activity|diet and physical activity
126241|NCT02780271|fruits/vegetables daily servings|fruits/vegetables daily servings
126242|NCT02780271|energy density|energy density
126243|NCT02780245|Caesarean Section|caesarean section
126244|NCT02780245|Tranexamic Acid|tranexamic acid
126245|NCT02780245|Postpartum Hemorrhage|postpartum hemorrhage
126246|NCT02780245|Ecbolics|ecbolics
126247|NCT02780232|Depression|depression
126248|NCT02780232|Adolescence|adolescence
126249|NCT02780232|Prevention|prevention
126250|NCT02780232|Early intervention|early intervention
126251|NCT02780232|E-Mental Health|e-mental health
126252|NCT02780180|Aminopeptidase A inhibitor|aminopeptidase a inhibitor
126253|NCT02780180|Heart Failure|heart failure
126254|NCT02780180|Up-titration|up-titration
126255|NCT02780180|Dose-Response Relationship, Drug|dose-response relationship, drug
126256|NCT02780180|Pharmacokinetics|pharmacokinetics
126257|NCT02780180|Patient Safety|patient safety
126258|NCT02780180|Treatment Efficacy|treatment efficacy
126259|NCT02780167|Phase 2|phase 2
126260|NCT02780167|randomized|randomized
126261|NCT02780167|double-blind|double-blind
126262|NCT02780167|placebo|placebo
126263|NCT02780167|atopic dermatitis|atopic dermatitis
126264|NCT02780167|safety|safety
126265|NCT02780167|efficacy|efficacy
126266|NCT02780167|JAK|jak
126267|NCT02780167|janus kinase|janus kinase
126268|NCT02780167|moderate|moderate
126269|NCT02780167|severe|severe
126270|NCT02780154|7G8 clone|7g8 clone
126271|NCT02780154|NF54 strain|nf54 strain
126272|NCT02780154|Non-immune|non-immune
126273|NCT02780154|PCR|pcr
126274|NCT02780154|PfSPZ Challenge|pfspz challenge
126275|NCT02780154|Plasmodium falciparum|plasmodium falciparum
126276|NCT02780154|qPCR|qpcr
126277|NCT02780154|Sporozoites|sporozoites
126278|NCT02780141|Renal anemia|renal anemia
126279|NCT02780141|Roxadustat|roxadustat
126280|NCT02780141|ASP1517|asp1517
126281|NCT02780141|Hemodialysis|hemodialysis
126282|NCT02780128|neuroblastoma|neuroblastoma
126283|NCT02780128|cancer|cancer
126284|NCT02780128|genetic profiling|genetic profiling
126285|NCT02780128|ceritinib|ceritinib
126286|NCT02780128|ribociclib|ribociclib
126287|NCT02780128|trametinib|trametinib
126288|NCT02780128|HDM201|hdm201
126289|NCT02780102|ADHD|adhd
126290|NCT02780102|Cognitive-motor rehabilitation|cognitive-motor rehabilitation
126291|NCT02780102|Active Control Group|active control group
126292|NCT02780102|Stimulant Medication|stimulant medication
126293|NCT02780089|Metastatic|metastatic
126294|NCT02780089|Unresectable|unresectable
126295|NCT02780063|Dilation|dilation
126296|NCT02780063|Intraocular|intraocular
126297|NCT02780063|Ophthalmology|ophthalmology
126298|NCT02780050|cardiopulmonary resuscitation|cardiopulmonary resuscitation
126299|NCT02780050|manikins|manikins
126300|NCT02780050|physical fitness|physical fitness
126301|NCT02780024|Neo-Adjuvant Metformin|neo-adjuvant metformin
126302|NCT02780024|Neo-Adjuvant Temozolomide|neo-adjuvant temozolomide
126303|NCT02780024|Temozolomide and accelerated hypofractionation|temozolomide and accelerated hypofractionation
126304|NCT02780024|Metformin and accelerated hypofractionation|metformin and accelerated hypofractionation
126305|NCT02780024|Adjuvant Temozolomide|adjuvant temozolomide
126306|NCT02780024|Adjuvant Metformin|adjuvant metformin
126307|NCT02780011|CD30+|cd30+
126308|NCT02780011|Relapsed|relapsed
126309|NCT02780011|Refractory|refractory
126310|NCT02780011|ALCL|alcl
126311|NCT02779985|Lycium Barbarum|lycium barbarum
126312|NCT02779985|Energy expenditure|energy expenditure
126313|NCT02779985|Postprandial metabolism|postprandial metabolism
126314|NCT02779972|Cardiac Physiology|cardiac physiology
126315|NCT02779972|Physiology|physiology
126316|NCT02779933|Hospital-acquired Pneumonia|hospital-acquired pneumonia
126317|NCT02779933|Epidemiology|epidemiology
126318|NCT02779933|Risk Factors|risk factors
126319|NCT02779920|refractory gastroparesis|refractory gastroparesis
126320|NCT02779920|per oral pyloromyotomy|per oral pyloromyotomy
126321|NCT02779907|Paediatric|paediatric
126322|NCT02779907|Malawi|malawi
126323|NCT02779894|Sleep Apnea|sleep apnea
126324|NCT02779894|Communication Based Technology|communication based technology
126325|NCT02779894|ICT|ict
126326|NCT02779868|body composition|body composition
126327|NCT02779868|functional capacity|functional capacity
126328|NCT02779868|quality of life|quality of life
126329|NCT02779855|triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
126330|NCT02779855|estrogen receptor|estrogen receptor
126331|NCT02779855|progesterone receptor|progesterone receptor
126332|NCT02779855|invasive ductal carcinoma|invasive ductal carcinoma
126333|NCT02779855|breast cancer tumors|breast cancer tumors
126334|NCT02779790|Systematic Review and Meta-Analysis|systematic review and meta-analysis
126335|NCT02779790|Evidence-Based Medicine|evidence-based medicine
126336|NCT02779790|Evidence-Based Nutrition|evidence-based nutrition
126337|NCT02779790|Clinical Practice Guidelines|clinical practice guidelines
126338|NCT02779790|Liquid Meal Replacements|liquid meal replacements
126339|NCT02779790|Body Weight|body weight
126340|NCT02779790|Systolic Blood Pressure|systolic blood pressure
126341|NCT02779790|Diastolic Blood Pressure|diastolic blood pressure
126342|NCT02779790|Fasting Blood Glucose|fasting blood glucose
126343|NCT02779790|Fasting Blood Insulin|fasting blood insulin
126344|NCT02779790|HbA1c|hba1c
126345|NCT02779790|Total Cholesterol|total cholesterol
126346|NCT02779790|Triglycerides|triglycerides
126347|NCT02779790|LDL-C|ldl-c
126348|NCT02779790|HDL-C|hdl-c
126349|NCT02779790|Controlled Feeding Trials|controlled feeding trials
126350|NCT02779764|Hemodialysis|hemodialysis
126351|NCT02779764|ASP1517|asp1517
126352|NCT02779764|Roxadustat|roxadustat
126353|NCT02779764|Renal anemia|renal anemia
126354|NCT02779725|Symptom Management|symptom management
126355|NCT02779712|Remote ischaemic conditioning|remote ischaemic conditioning
126356|NCT02779686|Macular Degeneration|macular degeneration
126357|NCT02779686|Genetic testing|genetic testing
126358|NCT02779686|Age-Related Macular degeneration|age-related macular degeneration
126359|NCT02779686|Age-Related Maculopathies|age-related maculopathies
126360|NCT02779660|Atrial Fibrillation|atrial fibrillation
126361|NCT02779647|Overweight, obesity, play, physical activity, accelerometry.|overweight, obesity, play, physical activity, accelerometry.
126362|NCT02779608|malignant ascites|malignant ascites
126363|NCT02779582|Progesterone|progesterone
126364|NCT02779582|Menstrual Flow|menstrual flow
126365|NCT02779556|Health Literacy|health literacy
126366|NCT02779556|Diabetes|diabetes
126367|NCT02779543|In lab sleep studies|in lab sleep studies
126368|NCT02779517|upper extremity|upper extremity
126369|NCT02779517|stroke|stroke
126370|NCT02779517|rehabilitation|rehabilitation
126371|NCT02779517|robotics|robotics
126372|NCT02779517|telepresence|telepresence
126373|NCT02779517|elderly|elderly
126374|NCT02779517|aged|aged
126375|NCT02779517|Housing for the elderly|housing for the elderly
126376|NCT02779517|retirement|retirement
126377|NCT02779517|homes for the aged|homes for the aged
126378|NCT02779491|fruit and vegetables|fruit and vegetables
126379|NCT02779491|food intake|food intake
126380|NCT02779491|knowledge|knowledge
126381|NCT02779478|chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
126382|NCT02779478|cavitary|cavitary
126383|NCT02779478|nodular bronchiectatic disease|nodular bronchiectatic disease
126384|NCT02779478|NTM|ntm
126385|NCT02779465|vitamin D treatment|vitamin d treatment
126386|NCT02779465|chronic hepatitis B|chronic hepatitis b
126387|NCT02779452|neurodevelopment|neurodevelopment
126388|NCT02779452|electroencephalography|electroencephalography
126389|NCT02779452|gestational diabetes mellitus|gestational diabetes mellitus
126497|NCT02778763|Breast cancer|breast cancer
126390|NCT02779452|omega 3 polyunsaturated fatty acids|omega 3 polyunsaturated fatty acids
126391|NCT02779426|Atopic dermatitis|atopic dermatitis
126392|NCT02779426|Text Messages|text messages
126393|NCT02779426|Health literacy|health literacy
126394|NCT02779400|INR|inr
126395|NCT02779400|coagulation|coagulation
126396|NCT02779400|vitamin K antagonist|vitamin k antagonist
126397|NCT02779387|GnRH-a|gnrh-a
126398|NCT02779387|endometriosis|endometriosis
126399|NCT02779387|efficiency|efficiency
126400|NCT02779374|ovarian insufficiency Bone Marrow|ovarian insufficiency bone marrow
126401|NCT02779361|green tea|green tea
126402|NCT02779361|steroid profile|steroid profile
126403|NCT02779348|Nebicapone|nebicapone
126404|NCT02779348|Warfarin|warfarin
126405|NCT02779335|tube-fed|tube-fed
126406|NCT02779335|Formula Tolerance|formula tolerance
126407|NCT02779335|Pediatric Patients|pediatric patients
126408|NCT02779322|gastric bypass|gastric bypass
126409|NCT02779322|hospital charges|hospital charges
126410|NCT02779322|mini gastric bypass|mini gastric bypass
126411|NCT02779309|Frail Older Adults|frail older adults
126412|NCT02779309|Mortality|mortality
126413|NCT02779309|Home Care|home care
126414|NCT02779309|Survival Analysis|survival analysis
126415|NCT02779309|Clinical Prediction Rule|clinical prediction rule
126416|NCT02779296|Cyanoacrylates|cyanoacrylates
126417|NCT02779296|Mammaplasty|mammaplasty
126418|NCT02779296|Mastectomy|mastectomy
126419|NCT02779257|hypoglycemia|hypoglycemia
126420|NCT02779244|Orthopedic|orthopedic
126421|NCT02779244|Post-operative|post-operative
126422|NCT02779244|Weight bearing|weight bearing
126423|NCT02779244|Range of motion|range of motion
126424|NCT02779218|Hemiplegia|hemiplegia
126425|NCT02779205|Cell therapy|cell therapy
126426|NCT02779205|Stromal Cells|stromal cells
126427|NCT02779205|Stem cells|stem cells
126428|NCT02779205|Adipose tissue|adipose tissue
126429|NCT02779205|Children|children
126430|NCT02779166|hip arthroscopy|hip arthroscopy
126431|NCT02779153|SLE|sle
126432|NCT02779153|H.P. Acthar Gel|h.p. acthar gel
126433|NCT02779140|BoNT|bont
126434|NCT02779140|botulinum|botulinum
126435|NCT02779140|Botulism|botulism
126436|NCT02779140|Clostridium|clostridium
126437|NCT02779140|Neurotoxin|neurotoxin
126438|NCT02779140|NTM-1632|ntm-1632
126439|NCT02779127|Smoking|smoking
126440|NCT02779127|Endothelium|endothelium
126441|NCT02779127|Passive smoking|passive smoking
126442|NCT02779114|Rheumatoid Arthritis|rheumatoid arthritis
126443|NCT02779114|Remission|remission
126444|NCT02779114|Dose reduction|dose reduction
126445|NCT02779101|Central nervous system lymphoma|central nervous system lymphoma
126446|NCT02779101|Pembrolizumab|pembrolizumab
126447|NCT02779075|Sleeve Gastrectomy|sleeve gastrectomy
126448|NCT02779075|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
126449|NCT02779036|Stroke|stroke
126450|NCT02779036|task-oriented home exercise|task-oriented home exercise
126451|NCT02779036|walking competency|walking competency
126452|NCT02779036|Usual Physiotherapy care|usual physiotherapy care
126453|NCT02778997|Shunt|shunt
126454|NCT02778997|CSF|csf
126455|NCT02778997|Dysfunction|dysfunction
126456|NCT02778997|Complication|complication
126457|NCT02778984|Anesthesia|anesthesia
126458|NCT02778984|facial mask|facial mask
126459|NCT02778971|MCI|mci
126460|NCT02778971|Dementia|dementia
126461|NCT02778971|amyloid PET|amyloid pet
126462|NCT02778971|physician diagnosis|physician diagnosis
126463|NCT02778971|Alzheimer's disease|alzheimer's disease
126464|NCT02778971|AD|ad
126465|NCT02778971|PET imaging|pet imaging
126466|NCT02778971|Appropriate Use Criteria|appropriate use criteria
126467|NCT02778971|patient-reported outcomes|patient-reported outcomes
126468|NCT02778958|bariatric surgery|bariatric surgery
126469|NCT02778958|morbid obesity|morbid obesity
126470|NCT02778958|nonopioid analgesics|nonopioid analgesics
126471|NCT02778945|spinal surgery|spinal surgery
126472|NCT02778945|sugammadex|sugammadex
126473|NCT02778945|deep neuromuscular block|deep neuromuscular block
126474|NCT02778945|shear wave elastography|shear wave elastography
126475|NCT02778945|neuromuscular monitoring|neuromuscular monitoring
126476|NCT02778919|Endometriosis|endometriosis
126477|NCT02778906|Abatacept|abatacept
126478|NCT02778893|Conmana|conmana
126479|NCT02778893|Thalidomide|thalidomide
126480|NCT02778893|NSCLC|nsclc
126481|NCT02778893|EGFR mutation|egfr mutation
126482|NCT02778854|NSCLC|nsclc
126483|NCT02778854|liquid biopsy|liquid biopsy
126484|NCT02778854|driver mutation|driver mutation
126485|NCT02778828|linezolide|linezolide
126486|NCT02778828|tuberculosis|tuberculosis
126487|NCT02778828|MDR-TB|mdr-tb
126488|NCT02778802|Pulmonary Hypertension|pulmonary hypertension
126489|NCT02778802|Emphysema|emphysema
126490|NCT02778802|COPD|copd
126491|NCT02778776|Metformin|metformin
126492|NCT02778776|Agave Inulin|agave inulin
126493|NCT02778776|METS|mets
126494|NCT02778776|Inflammation parameters|inflammation parameters
126495|NCT02778776|Urodynamic parameters|urodynamic parameters
126496|NCT02778776|Prostate hyperplasia|prostate hyperplasia
126498|NCT02778763|TLR2|tlr2
126499|NCT02778763|Neutropenia|neutropenia
126500|NCT02778750|Cystic Fibrosis (CF)|cystic fibrosis (cf)
126501|NCT02778737|ACT, CBT, Randomized controlled trial, Chronic Pain|act, cbt, randomized controlled trial, chronic pain
126502|NCT02778711|anti-IL-17|anti-il-17
126503|NCT02778711|secukinumab|secukinumab
126504|NCT02778672|bacterial pneumonia|bacterial pneumonia
126505|NCT02778672|children|children
126506|NCT02778672|diagnosing pneumonia|diagnosing pneumonia
126507|NCT02778672|thermal imaging|thermal imaging
126508|NCT02778633|Volume responsiveness mean systemic filling pressure|volume responsiveness mean systemic filling pressure
126509|NCT02778620|Volume responsiveness mean systemic filling pressure|volume responsiveness mean systemic filling pressure
126510|NCT02778607|Atypical Parkinsonism Syndrome (APS)|atypical parkinsonism syndrome (aps)
126511|NCT02778581|Cognitive Impairment, Alzheimer's Disease, Vegetal Oil|cognitive impairment, alzheimer's disease, vegetal oil
126512|NCT02778542|Automated Hovering|automated hovering
126513|NCT02778542|Remote Monitoring|remote monitoring
126514|NCT02778542|Bidirectional Text Messaging|bidirectional text messaging
126515|NCT02778529|stroke|stroke
126516|NCT02778529|amputees|amputees
126517|NCT02778529|spinal cord injuries|spinal cord injuries
126518|NCT02778529|cerebral palsy|cerebral palsy
126519|NCT02778529|robotics|robotics
126520|NCT02778529|rehabilitation|rehabilitation
126521|NCT02778503|Tooth, Deciduous|tooth, deciduous
126522|NCT02778503|Dentition, Permanent|dentition, permanent
126523|NCT02778503|Dental Atraumatic Restorative Treatment|dental atraumatic restorative treatment
126524|NCT02778503|Glass Ionomer Cements|glass ionomer cements
126525|NCT02778503|Dental Caries|dental caries
126526|NCT02778490|sleeve gastrectomy, bariatric surgery|sleeve gastrectomy, bariatric surgery
126527|NCT02778464|Inflammatory Bowel Disease|inflammatory bowel disease
126528|NCT02778464|Pregnancy|pregnancy
126529|NCT02778464|Stool markers|stool markers
126530|NCT02778464|Calprotectin|calprotectin
126531|NCT02778464|Faecal S100A12 (f-SA12)|faecal s100a12 (f-sa12)
126532|NCT02778464|Faecal calprotectin (f-Cp)|faecal calprotectin (f-cp)
126533|NCT02778425|partial splenic embolization|partial splenic embolization
126534|NCT02778412|Thyroid cancer|thyroid cancer
126535|NCT02778412|Thyroid nodules|thyroid nodules
126536|NCT02778412|Thyroid neoplasia|thyroid neoplasia
126537|NCT02778412|Thyroiditis|thyroiditis
126538|NCT02778399|Pelvic Pain|pelvic pain
126539|NCT02778399|Endometriosis|endometriosis
126540|NCT02778399|Dysmenorrhea|dysmenorrhea
126541|NCT02778399|Dyspareunia|dyspareunia
126542|NCT02778360|Attention deficit|attention deficit
126543|NCT02778360|Neurofeedback|neurofeedback
126544|NCT02778360|ADHD|adhd
126545|NCT02778360|Methylphenidate|methylphenidate
126546|NCT02778347|Palliative care|palliative care
126547|NCT02778347|Need assessment|need assessment
126548|NCT02778347|Tools|tools
126549|NCT02778347|Validity|validity
126550|NCT02778347|Quality of care|quality of care
126551|NCT02778308|Gallbladder cancer, adjuvant chemotherapy, gemcitabine|gallbladder cancer, adjuvant chemotherapy, gemcitabine
126552|NCT02778269|ECG|ecg
126553|NCT02778269|CGM|cgm
126554|NCT02778269|Hypoglycaemia|hypoglycaemia
126555|NCT02778269|Sudden Cardiac Death|sudden cardiac death
126556|NCT02778256|depression, bipolar disorder|depression, bipolar disorder
126557|NCT02778230|fiber|fiber
126558|NCT02778230|gastrointestinal|gastrointestinal
126559|NCT02778230|microbiota|microbiota
126560|NCT02778191|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
126561|NCT02778191|cisplatin|cisplatin
126562|NCT02778191|carboplatin|carboplatin
126563|NCT02778191|5-fluorouracil|5-fluorouracil
126564|NCT02778087|motor recovery|motor recovery
126565|NCT02778087|mirror therapy|mirror therapy
126566|NCT02778087|upper extremity|upper extremity
126567|NCT02778074|Internet Cognitive Behavioural Therapy|internet cognitive behavioural therapy
126568|NCT02778061|Intra Uterine Ball|intra uterine ball
126569|NCT02778061|IUD|iud
126570|NCT02778061|copper|copper
126571|NCT02778061|contraception|contraception
126572|NCT02778022|Child behavior disorders|child behavior disorders
126573|NCT02778022|Parent child relationship|parent child relationship
126574|NCT02778022|Primary care|primary care
126575|NCT02778009|Medical student|medical student
126576|NCT02778009|Activity Monitor|activity monitor
126577|NCT02778009|Medical school|medical school
126578|NCT02778009|Fitness|fitness
126579|NCT02777996|screening|screening
126580|NCT02777983|patient education|patient education
126581|NCT02777983|low back pain|low back pain
126582|NCT02777983|technology|technology
126583|NCT02777970|Acute pain|acute pain
126584|NCT02777970|Acute moderate to severe pain|acute moderate to severe pain
126585|NCT02777970|Postoperative pain|postoperative pain
126586|NCT02777970|Dexketoprofen Tramadol|dexketoprofen tramadol
126587|NCT02777970|Dexketoprofen trometamol|dexketoprofen trometamol
126588|NCT02777970|Tramadol hydrochloride|tramadol hydrochloride
126589|NCT02777970|Multimodal analgesia|multimodal analgesia
126590|NCT02777970|Third molar extraction|third molar extraction
126591|NCT02777970|Fixed drug combination|fixed drug combination
126592|NCT02777970|Paracetamol|paracetamol
126593|NCT02777970|Analgesics|analgesics
126594|NCT02777957|Echocardiography|echocardiography
126595|NCT02777957|Lung Transplantation|lung transplantation
126596|NCT02777944|motivation|motivation
126597|NCT02777944|attendance|attendance
126598|NCT02777918|food intake|food intake
126599|NCT02777905|late life|late life
126600|NCT02777905|mindfulness meditation|mindfulness meditation
126601|NCT02777879|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
126602|NCT02777853|tea|tea
126603|NCT02777853|cardiovascular|cardiovascular
126604|NCT02777853|vascular|vascular
126605|NCT02777853|metabolism|metabolism
126606|NCT02777853|microcirculation|microcirculation
126607|NCT02777853|physical inactivity|physical inactivity
126608|NCT02777853|polyphenols|polyphenols
126609|NCT02777853|conduit artery|conduit artery
126610|NCT02777853|endothelial function|endothelial function
126611|NCT02777853|cerebrovascular|cerebrovascular
126612|NCT02777853|insulin sensitivity|insulin sensitivity
126613|NCT02777827|Abediterol|abediterol
126614|NCT02777827|Dry powder inhaler|dry powder inhaler
126615|NCT02777827|Pressured metered-dose inhaler|pressured metered-dose inhaler
126616|NCT02777827|Pharmacokinetic|pharmacokinetic
126617|NCT02777827|Pharmacodynamic|pharmacodynamic
126618|NCT02777827|Safety|safety
126619|NCT02777814|colorectal cancer|colorectal cancer
126620|NCT02777814|Entecavir|entecavir
126621|NCT02777814|Hepatitis B Carrier|hepatitis b carrier
126622|NCT02777801|gastric cancer|gastric cancer
126623|NCT02777801|hepatitis B carrier|hepatitis b carrier
126624|NCT02777801|entecavir|entecavir
126625|NCT02777788|Chinese Traditional Medicine|chinese traditional medicine
126626|NCT02777775|NF1|nf1
126627|NCT02777775|CNF|cnf
126628|NCT02777775|PNF|pnf
126629|NCT02777775|Skin Tumors|skin tumors
126630|NCT02777736|Lymphoma, B cell|lymphoma, b cell
126631|NCT02777736|Central nervous system relapse|central nervous system relapse
126632|NCT02777736|Methotrexate|methotrexate
126633|NCT02777736|Intrathecal chemotherapy|intrathecal chemotherapy
126634|NCT02777723|Dry Eye Syndrome|dry eye syndrome
126635|NCT02777723|Sodium Hyaluronate|sodium hyaluronate
126636|NCT02777723|CKD-350|ckd-350
126637|NCT02777697|cancer treatment protocols|cancer treatment protocols
126638|NCT02777697|chronic cancer pain|chronic cancer pain
126639|NCT02777697|cognitive function|cognitive function
126640|NCT02777697|quality of life|quality of life
126641|NCT02777697|anxiety|anxiety
126642|NCT02777697|depression|depression
126643|NCT02777684|Physical activity|physical activity
126644|NCT02777684|Knee osteoarthritis|knee osteoarthritis
126645|NCT02777684|Non pharmacological treatment|non pharmacological treatment
126646|NCT02777684|Qualitative study|qualitative study
126647|NCT02777658|Epidermal Growth Factor Receptor (EGFR), non-small cell lung cancer (NSCLC), EGFR T790M, EGFR Mutation-Positive Locally Advanced or Advanced NSCLC|epidermal growth factor receptor (egfr), non-small cell lung cancer (nsclc), egfr t790m, egfr mutation-positive locally advanced or advanced nsclc
126648|NCT02777619|Pharmacodynamic|pharmacodynamic
126649|NCT02777619|Dexmedetomidine|dexmedetomidine
126650|NCT02777619|Propofol|propofol
126651|NCT02777619|Target-controlled Infusion Intravenous Anesthesia|target-controlled infusion intravenous anesthesia
126652|NCT02777606|Severe Sepsis|severe sepsis
126653|NCT02777606|Sini Decoction|sini decoction
126654|NCT02777606|Immune Function|immune function
126655|NCT02777606|Mortality|mortality
126656|NCT02777580|Thrombolytic Therapy|thrombolytic therapy
126657|NCT02777580|Primary PCI|primary pci
126658|NCT02777554|Healthy Subjects|healthy subjects
126659|NCT02777554|Apremilast|apremilast
126660|NCT02777554|Pharmacokinetic|pharmacokinetic
126661|NCT02777541|early enteral nutrition|early enteral nutrition
126662|NCT02777541|children|children
126663|NCT02777541|percutaneous endoscopic gastrostomy|percutaneous endoscopic gastrostomy
126664|NCT02777515|electronic cigarette|electronic cigarette
126665|NCT02777489|obesity|obesity
126666|NCT02777489|perindopril|perindopril
126667|NCT02777489|carboxypeptidase D|carboxypeptidase d
126668|NCT02777489|genotyping|genotyping
126669|NCT02777489|theranostic|theranostic
126670|NCT02777450|low back pain|low back pain
126671|NCT02777450|physical examination|physical examination
126672|NCT02777450|local anesthesia|local anesthesia
126673|NCT02777437|Colonic Neoplasms|colonic neoplasms
126674|NCT02777437|Laparoscopic Surgery|laparoscopic surgery
126675|NCT02777437|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
126676|NCT02777437|T4|t4
126677|NCT02777411|Vaccines|vaccines
126678|NCT02777411|Hand, Foot and Mouth Disease|hand, foot and mouth disease
126679|NCT02777411|EV71 enteroviruses vaccine|ev71 enteroviruses vaccine
126680|NCT02777398|Intra-spinal Canal|intra-spinal canal
126681|NCT02777398|Tumor|tumor
126682|NCT02777398|Minimal Invasive Surgery|minimal invasive surgery
126683|NCT02777398|Clinical Trial|clinical trial
126684|NCT02777398|Quadrant Channel|quadrant channel
126685|NCT02777385|Head and Neck|head and neck
126686|NCT02777385|Locally Advanced|locally advanced
126687|NCT02777385|Squamous Cell Carcinoma|squamous cell carcinoma
126688|NCT02777385|SCCHN|scchn
126689|NCT02777385|Untreated|untreated
126690|NCT02777385|High Risk|high risk
126691|NCT02777385|Intermediate Risk|intermediate risk
126692|NCT02777385|Radiation Therapy|radiation therapy
126693|NCT02777385|Cisplatin|cisplatin
126694|NCT02777372|Zoloft|zoloft
126695|NCT02777372|PMS|pms
126696|NCT02777372|Menses|menses
126697|NCT02777359|patent foramen ovale|patent foramen ovale
126698|NCT02777359|migraine|migraine
126699|NCT02777359|treatment|treatment
126700|NCT02777346|WOUNDS, PENETRATING|wounds, penetrating
126701|NCT02777346|CHILD, PRESCHOOL|child, preschool
126702|NCT02777346|CHILD|child
126703|NCT02777346|INFANT|infant
126704|NCT02777346|ADOLESCENT|adolescent
126705|NCT02777346|SUTURES|sutures
126706|NCT02777346|POLYGLACTIN 910|polyglactin 910
126707|NCT02777346|POLYPROPYLENES|polypropylenes
126708|NCT02777333|Simulation|simulation
126709|NCT02777333|Arthroscopy|arthroscopy
126710|NCT02777333|Motion analysis|motion analysis
126711|NCT02777320|Sciatica|sciatica
126712|NCT02777320|Ibuprofen|ibuprofen
126713|NCT02777320|Paracetamol|paracetamol
126714|NCT02777320|Emergency Medicine|emergency medicine
126715|NCT02777307|Laparoscopic|laparoscopic
126716|NCT02777307|Cholecistectomy|cholecistectomy
126717|NCT02777307|Collection|collection
126718|NCT02777307|Bleeding|bleeding
126719|NCT02777307|reoperation|reoperation
126720|NCT02777281|Shoulder Pain|shoulder pain
126721|NCT02777281|Wheelchair|wheelchair
126722|NCT02777281|Spinal Cord injury|spinal cord injury
126723|NCT02777242|Hypogonadism|hypogonadism
126724|NCT02777242|Testosterone enanthate|testosterone enanthate
126725|NCT02777216|RDN|rdn
126726|NCT02777203|morcellation|morcellation
126727|NCT02777203|myomectomy|myomectomy
126728|NCT02777203|hysterectomy|hysterectomy
126729|NCT02777190|misoprostol|misoprostol
126730|NCT02777190|cytotec|cytotec
126731|NCT02777190|cervical ripening|cervical ripening
126732|NCT02777190|labor, induced|labor, induced
126733|NCT02777190|active labor|active labor
126734|NCT02777138|Adipose tissue|adipose tissue
126735|NCT02777138|Inflammation|inflammation
126736|NCT02777138|Age Comparison|age comparison
126737|NCT02777138|Macrophages|macrophages
126738|NCT02777138|T-lymphocytes|t-lymphocytes
126739|NCT02777138|Adipose Progenitors|adipose progenitors
126740|NCT02777125|pediatrics|pediatrics
126741|NCT02777125|metered dose inhalers|metered dose inhalers
126742|NCT02777125|breath actuated nebulizers|breath actuated nebulizers
126743|NCT02777112|high-risk|high-risk
126744|NCT02777112|early prevention|early prevention
126745|NCT02777112|productivity|productivity
126746|NCT02777112|return on investment|return on investment
126747|NCT02777112|workplace|workplace
126748|NCT02777112|e-mental health program|e-mental health program
126749|NCT02777112|job coach|job coach
126750|NCT02777099|remote ischemic postconditioning|remote ischemic postconditioning
126751|NCT02777099|autonomic function|autonomic function
126752|NCT02777099|heart rate variability|heart rate variability
126753|NCT02777099|acute ischemic stroke|acute ischemic stroke
126754|NCT02777099|prognosis|prognosis
126755|NCT02777086|HIV|hiv
126756|NCT02777086|Risk Behaviors|risk behaviors
126757|NCT02777086|Decision-making|decision-making
126758|NCT02777073|Diabetic ketoacidosis|diabetic ketoacidosis
126759|NCT02777073|Insulin|insulin
126760|NCT02777073|Type 1 Diabetes|type 1 diabetes
126761|NCT02777073|glucose (sugar) control|glucose (sugar) control
126762|NCT02777073|SGLT-2 inhibitors|sglt-2 inhibitors
126763|NCT02777060|virtual reality|virtual reality
126764|NCT02777060|sensor-based balance training|sensor-based balance training
126765|NCT02777060|gait|gait
126766|NCT02777060|balance|balance
126767|NCT02777047|Thromboembolism|thromboembolism
126768|NCT02777047|Medication Safety|medication safety
126769|NCT02777047|Hospital-community collaboration|hospital-community collaboration
126770|NCT02777047|Pilot RCT|pilot rct
126771|NCT02777047|Telehealth|telehealth
126772|NCT02777034|Laparoscopy|laparoscopy
126773|NCT02777034|Enhanced Recovery|enhanced recovery
126774|NCT02777034|Fast-track|fast-track
126775|NCT02777021|Pediatric|pediatric
126776|NCT02777021|Acute Myeloid Leukemia|acute myeloid leukemia
126777|NCT02777021|Quality of Life|quality of life
126778|NCT02777021|Neutropenia Management|neutropenia management
126779|NCT02777021|Patient Centered Outcomes|patient centered outcomes
126780|NCT02777021|Chemotherapy|chemotherapy
126781|NCT02776982|Gastroesophageal reflux disease|gastroesophageal reflux disease
126782|NCT02776982|GERD|gerd
126783|NCT02776982|Barrett's Esophagus|barrett's esophagus
126784|NCT02776982|Esophageal adenocarcinoma|esophageal adenocarcinoma
126785|NCT02776969|Papillary Carcinoma|papillary carcinoma
126786|NCT02776969|Gene Hunting|gene hunting
126787|NCT02776969|Familial|familial
126788|NCT02776956|atrial fibrillation;left atrial function|atrial fibrillation;left atrial function
126789|NCT02776930|Injury Prediction|injury prediction
126790|NCT02776930|Return to Work|return to work
126791|NCT02776930|Injury Prevention|injury prevention
126792|NCT02776917|metastatic breast cancer|metastatic breast cancer
126793|NCT02776917|locally advanced, unresectable breast cancer|locally advanced, unresectable breast cancer
126794|NCT02776917|HER2/NEU negative|her2/neu negative
126795|NCT02776904|Concussion|concussion
126796|NCT02776904|Football player|football player
126797|NCT02776904|Movement assessment|movement assessment
126798|NCT02776904|Soccer player|soccer player
126799|NCT02776891|lymphoma|lymphoma
126800|NCT02776891|gallium citrate|gallium citrate
126801|NCT02776891|PET|pet
127048|NCT02775552|Ethiopia|ethiopia
126802|NCT02776865|suprascapular nerve block|suprascapular nerve block
126803|NCT02776813|CD20+|cd20+
126804|NCT02776813|B-cell|b-cell
126805|NCT02776813|ACTR087|actr087
126806|NCT02776813|Relapsed|relapsed
126807|NCT02776813|Refractory|refractory
126808|NCT02776800|Wound|wound
126809|NCT02776800|Surgical Wound|surgical wound
126810|NCT02776800|Trauma Wound|trauma wound
126811|NCT02776800|Home Health Care|home health care
126812|NCT02776800|Home Health Nurse|home health nurse
126813|NCT02776800|Pressure Ulcer|pressure ulcer
126814|NCT02776800|Diabetic Foot Ulcer|diabetic foot ulcer
126815|NCT02776800|Venous Leg Ulcer|venous leg ulcer
126816|NCT02776800|Arterial Ulcer|arterial ulcer
126817|NCT02776800|Wound Dehiscence|wound dehiscence
126818|NCT02776800|Open Wound|open wound
126819|NCT02776774|spine|spine
126820|NCT02776748|Tenofovir disoproxil|tenofovir disoproxil
126821|NCT02776748|Pre-exposure prophylaxis|pre-exposure prophylaxis
126822|NCT02776748|Breastfeeding|breastfeeding
126823|NCT02776748|Emtricitabine|emtricitabine
126824|NCT02776748|Tenofovir|tenofovir
126825|NCT02776748|Post-partum|post-partum
126826|NCT02776748|HIV prevention|hiv prevention
126827|NCT02776748|Women|women
126828|NCT02776748|Pharmacokinetics|pharmacokinetics
126829|NCT02776722|Systematic Review and Meta-analysis|systematic review and meta-analysis
126830|NCT02776722|randomized controlled trial|randomized controlled trial
126831|NCT02776722|Evidence-Based Medicine|evidence-based medicine
126832|NCT02776722|carbohydrate metabolism|carbohydrate metabolism
126833|NCT02776722|postprandial|postprandial
126834|NCT02776722|glycemic response|glycemic response
126835|NCT02776722|glycemic control|glycemic control
126836|NCT02776722|insulin sensitivity|insulin sensitivity
126837|NCT02776722|beta-cell function|beta-cell function
126838|NCT02776722|sugars|sugars
126839|NCT02776722|fructose|fructose
126840|NCT02776722|allulose|allulose
126841|NCT02776722|tagatose|tagatose
126842|NCT02776722|sorbose|sorbose
126843|NCT02776696|Closed Loop|closed loop
126844|NCT02776696|Artificial Pancreas|artificial pancreas
126845|NCT02776644|renal cell carcinoma|renal cell carcinoma
126846|NCT02776644|sunitinib, pazopanib|sunitinib, pazopanib
126847|NCT02776644|temsirolimus|temsirolimus
126848|NCT02776644|sorafenib|sorafenib
126849|NCT02776644|everolimus|everolimus
126850|NCT02776644|interferon alpha|interferon alpha
126851|NCT02776644|interleukin 2|interleukin 2
126852|NCT02776592|Healthy Children|healthy children
126853|NCT02776579|Resistance Training; Muscle Strength|resistance training; muscle strength
126854|NCT02776566|Anticoagulation|anticoagulation
126855|NCT02776566|Anticoagulation Management|anticoagulation management
126856|NCT02776566|Self-Testing|self-testing
126857|NCT02776566|Self-Management|self-management
126858|NCT02776566|Warfarin|warfarin
126859|NCT02776566|Thromboembolism|thromboembolism
126860|NCT02776566|Blood Coagulation Disorders|blood coagulation disorders
126861|NCT02776566|Health Disparities|health disparities
126862|NCT02776566|Minorities|minorities
126863|NCT02776566|African American|african american
126864|NCT02776566|Hispanic|hispanic
126865|NCT02776566|Cardiovascular Disease|cardiovascular disease
126866|NCT02776566|Models of Anticoagulation Care|models of anticoagulation care
126867|NCT02776566|Tele-Health|tele-health
126868|NCT02776566|Home Self-Testing|home self-testing
126869|NCT02776527|Gastric cancer|gastric cancer
126870|NCT02776527|D2 Lymphadenectomy|d2 lymphadenectomy
126871|NCT02776527|postoprative adjuvant chemotherapy|postoprative adjuvant chemotherapy
126872|NCT02776527|Apatinib|apatinib
126873|NCT02776527|disease free survival|disease free survival
126874|NCT02776488|brain trauma, metabolic therapy|brain trauma, metabolic therapy
126875|NCT02776462|Eye Tracking|eye tracking
126876|NCT02776462|Concussion|concussion
126877|NCT02776462|Outcome Measures|outcome measures
126878|NCT02776410|sustainable healthy eating|sustainable healthy eating
126879|NCT02776410|consumer behaviour|consumer behaviour
126880|NCT02776410|consumer attitudes|consumer attitudes
126881|NCT02776384|Heart Failure|heart failure
126882|NCT02776384|Biomarkers|biomarkers
126883|NCT02776384|Echocardiography|echocardiography
126884|NCT02776384|Cardiopulmonary Function Tests|cardiopulmonary function tests
126885|NCT02776371|Helicobacter pylori|helicobacter pylori
126886|NCT02776371|Sequential therapy|sequential therapy
126887|NCT02776371|Modified non-clarithromycin triple therapy|modified non-clarithromycin triple therapy
126888|NCT02776345|calcific tendonitis|calcific tendonitis
126889|NCT02776345|rotator cuff calcific tendonitis|rotator cuff calcific tendonitis
126890|NCT02776332|breastfeeding|breastfeeding
126891|NCT02776332|premature infants|premature infants
126892|NCT02776332|manual expression|manual expression
126893|NCT02776319|Non-invasive brain stimulation|non-invasive brain stimulation
126894|NCT02776319|tobacco use disorder|tobacco use disorder
126895|NCT02776319|craving|craving
126896|NCT02776280|water|water
126897|NCT02776280|salt|salt
126898|NCT02776280|oral fluids|oral fluids
126899|NCT02776280|plaque|plaque
126900|NCT02776280|dental caries|dental caries
126901|NCT02776254|anti-retroviral therapy|anti-retroviral therapy
126902|NCT02776254|differentiated care|differentiated care
126903|NCT02776241|ADPKD|adpkd
126904|NCT02776241|total kidney volume|total kidney volume
126905|NCT02776241|kidney disease|kidney disease
126906|NCT02776189|Anaesthesia|anaesthesia
126907|NCT02776189|MRI|mri
126908|NCT02776189|Brain|brain
126909|NCT02776176|enhanced recovery after surgery|enhanced recovery after surgery
126910|NCT02776176|hirschsprung disease|hirschsprung disease
126911|NCT02776163|Salivary Gland Tumors|salivary gland tumors
126912|NCT02776163|Head-an-Neck cancer|head-an-neck cancer
126913|NCT02776163|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
126914|NCT02776163|High-Risk|high-risk
126915|NCT02776163|Cisplatin|cisplatin
126916|NCT02776163|Docetaxel|docetaxel
126917|NCT02776150|probe melting curve|probe melting curve
126918|NCT02776150|Drug resistance|drug resistance
126919|NCT02776150|Tuberculosis, Pulmonary|tuberculosis, pulmonary
126920|NCT02776137|Docetaxel|docetaxel
126921|NCT02776137|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
126922|NCT02776137|High-Risk|high-risk
126923|NCT02776137|Squamous Cell Carcinoma|squamous cell carcinoma
126924|NCT02776137|Head-and-Neck Cancer|head-and-neck cancer
126925|NCT02776124|Nutritional status|nutritional status
126926|NCT02776124|nasopharyngeal carcinoma|nasopharyngeal carcinoma
126927|NCT02776124|Nutritional Counseling|nutritional counseling
126928|NCT02776124|concurrent chemoradiotherapy|concurrent chemoradiotherapy
126929|NCT02776124|oral nutritional supplements|oral nutritional supplements
126930|NCT02776111|Kidney Transplant|kidney transplant
126931|NCT02776098|Cystic Fibrosis|cystic fibrosis
126932|NCT02776098|Glucose Intolerance|glucose intolerance
126933|NCT02776098|Muscle Accrual|muscle accrual
126934|NCT02776098|Cystic Fibrosis-related Diabetes|cystic fibrosis-related diabetes
126935|NCT02776098|Healthy Controls|healthy controls
126936|NCT02776098|Healthy Participants|healthy participants
126937|NCT02776085|optic nerve sheath diameter|optic nerve sheath diameter
126938|NCT02776085|ultrasound|ultrasound
126939|NCT02776085|shunt failure|shunt failure
126940|NCT02776072|Tecfidera, DMF, dimethyl fumarate, Fingolimod, Glatiramer acetate, Teriflunomide, Gilenya, Copaxone, Aubagio|tecfidera, dmf, dimethyl fumarate, fingolimod, glatiramer acetate, teriflunomide, gilenya, copaxone, aubagio
126941|NCT02776059|survival|survival
126942|NCT02776059|pegfilgrastim|pegfilgrastim
126943|NCT02776059|cirrhosis, alcoholic|cirrhosis, alcoholic
126944|NCT02776046|Oxygen, surgical site infection, postoperative complication, recruitment maneuvers, open lung strategy|oxygen, surgical site infection, postoperative complication, recruitment maneuvers, open lung strategy
126945|NCT02776033|tolerability|tolerability
126946|NCT02776033|safety|safety
126947|NCT02776033|GSK2982772|gsk2982772
126948|NCT02776033|RIP1 kinase inhibitor|rip1 kinase inhibitor
126949|NCT02776033|psoriasis|psoriasis
126950|NCT02776007|Continuous Glucose Monitoring System|continuous glucose monitoring system
126951|NCT02775955|Pharmacokinetics|pharmacokinetics
126952|NCT02775929|Tenofovir disoproxil|tenofovir disoproxil
126953|NCT02775929|Emtricitabine|emtricitabine
126954|NCT02775929|Pre-exposure Prophylaxis|pre-exposure prophylaxis
126955|NCT02775929|Antiretroviral Therapy|antiretroviral therapy
126956|NCT02775929|HIV Prevention|hiv prevention
126957|NCT02775929|FTC TDF|ftc tdf
126958|NCT02775929|PrEP|prep
126959|NCT02775929|HIV Infected Partners|hiv infected partners
126960|NCT02775929|HIV Uninfected Partners|hiv uninfected partners
126961|NCT02775903|MEDI4736|medi4736
126962|NCT02775903|Durvalumab|durvalumab
126963|NCT02775903|Myelodysplastic Syndromes|myelodysplastic syndromes
126964|NCT02775903|Acute Myeloid Leukemia|acute myeloid leukemia
126965|NCT02775903|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
126966|NCT02775903|Azacitidine|azacitidine
126967|NCT02775903|Safety|safety
126968|NCT02775903|Efficacy|efficacy
126969|NCT02775903|PD-L1|pd-l1
126970|NCT02775877|PCOS|pcos
126971|NCT02775877|letrozole|letrozole
126972|NCT02775877|clomiphene|clomiphene
126973|NCT02775786|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
126974|NCT02775786|Pancreatic Cancer|pancreatic cancer
126975|NCT02775773|TXA|txa
126976|NCT02775773|PPH|pph
126977|NCT02775760|brain|brain
126978|NCT02775760|brain mapping|brain mapping
126979|NCT02775760|cognition|cognition
126980|NCT02775760|exercise|exercise
126981|NCT02775760|physical activity|physical activity
126982|NCT02775760|hippocampus|hippocampus
126983|NCT02775760|entorhinal cortex|entorhinal cortex
126984|NCT02775760|spatial navigation|spatial navigation
126985|NCT02775760|learning|learning
126986|NCT02775760|memory|memory
126987|NCT02775760|magnetic resonance imaging|magnetic resonance imaging
126988|NCT02775760|functional neuroimaging|functional neuroimaging
126989|NCT02775760|physical endurance|physical endurance
126990|NCT02775760|physical fitness|physical fitness
126991|NCT02775760|resistance training|resistance training
126992|NCT02775760|walking|walking
127089|NCT02775448|Climacteric|climacteric
126993|NCT02775760|muscle stretching exercises|muscle stretching exercises
126994|NCT02775760|exercise test|exercise test
126995|NCT02775760|neuropsychological tests|neuropsychological tests
126996|NCT02775760|executive function|executive function
126997|NCT02775760|attention|attention
126998|NCT02775760|body composition|body composition
126999|NCT02775734|Polycystic Ovary Syndrome|polycystic ovary syndrome
127000|NCT02775734|N-acetyl-cysteine|n-acetyl-cysteine
127001|NCT02775734|Clomiphene citrate|clomiphene citrate
127002|NCT02775734|Clomiphene citrate resistant|clomiphene citrate resistant
127003|NCT02775734|Laparoscopic ovarian drilling|laparoscopic ovarian drilling
127004|NCT02775734|therapy|therapy
127005|NCT02775721|Nursing Education|nursing education
127006|NCT02775721|Weight Loss|weight loss
127007|NCT02775721|Gastrostomy Tube Care|gastrostomy tube care
127008|NCT02775695|pancreatic cancer|pancreatic cancer
127009|NCT02775695|Resectable Pancreatic Cancer|resectable pancreatic cancer
127010|NCT02775695|Doxycycline|doxycycline
127011|NCT02775695|Metakaryote cells|metakaryote cells
127012|NCT02775695|Eukaryotic cells|eukaryotic cells
127013|NCT02775695|Cancer Stem Cells|cancer stem cells
127014|NCT02775695|Targeted Cancer Stem Cell Therapy|targeted cancer stem cell therapy
127015|NCT02775695|Multi-metakaryocide therapy|multi-metakaryocide therapy
127016|NCT02775695|Doxycycline Hyclate|doxycycline hyclate
127017|NCT02775695|Tetracycline|tetracycline
127018|NCT02775682|epilepsy, dynamic cerebral autoregulation|epilepsy, dynamic cerebral autoregulation
127019|NCT02775669|noninvasive ICP monitoring|noninvasive icp monitoring
127020|NCT02775656|Cimzia®|cimzia®
127021|NCT02775656|CZP|czp
127022|NCT02775656|Pregnancy Follow up study|pregnancy follow up study
127023|NCT02775656|Autoimmune diseases|autoimmune diseases
127024|NCT02775656|Pregnancy outcomes|pregnancy outcomes
127025|NCT02775656|major congenital malformations|major congenital malformations
127026|NCT02775656|birth outcomes|birth outcomes
127027|NCT02775656|malformation|malformation
127028|NCT02775656|birth defect|birth defect
127029|NCT02775643|Melanoma|melanoma
127030|NCT02775643|Spitzoid Melanoma|spitzoid melanoma
127031|NCT02775643|Congenital Melanoma|congenital melanoma
127032|NCT02775643|Melanoma Arising in Giant Nevi|melanoma arising in giant nevi
127033|NCT02775643|Melanocytic lesions with indeterminate biological behavior|melanocytic lesions with indeterminate biological behavior
127034|NCT02775643|Pigment synthesizing melanomas|pigment synthesizing melanomas
127035|NCT02775604|fall risks at home|fall risks at home
127036|NCT02775604|video technology|video technology
127037|NCT02775604|home assessment|home assessment
127038|NCT02775578|heart failure|heart failure
127039|NCT02775578|coronary artery disease|coronary artery disease
127040|NCT02775578|biomarkers|biomarkers
127041|NCT02775578|Percutaneous Coronary Intervention, PCI|percutaneous coronary intervention, pci
127042|NCT02775578|Coronary Artery Bypass Grafting, CABG|coronary artery bypass grafting, cabg
127043|NCT02775552|Child Nutrition|child nutrition
127044|NCT02775552|Breastfeeding|breastfeeding
127045|NCT02775552|Complementary Feeding|complementary feeding
127046|NCT02775552|Infant and Young Child Feeding|infant and young child feeding
127047|NCT02775552|Social and Behavior Change Communication|social and behavior change communication
127049|NCT02775539|Pulmonary hypertension|pulmonary hypertension
127050|NCT02775539|Mirabegron|mirabegron
127051|NCT02775539|Heart failure|heart failure
127052|NCT02775539|B3 adrenergic|b3 adrenergic
127053|NCT02775526|Mixed urinary incontinence|mixed urinary incontinence
127054|NCT02775526|Transobturator tape (TOT)|transobturator tape (tot)
127055|NCT02775526|Tension-Free Vaginal Tape (TVT)|tension-free vaginal tape (tvt)
127056|NCT02775526|Burch colposuspension|burch colposuspension
127057|NCT02775526|Urinary incontinence|urinary incontinence
127058|NCT02775500|pregnancy|pregnancy
127059|NCT02775500|apremilast|apremilast
127060|NCT02775500|Otezla|otezla
127061|NCT02775500|autoimmune disease|autoimmune disease
127062|NCT02775500|psoriatic arthritis|psoriatic arthritis
127063|NCT02775500|psoriasis|psoriasis
127064|NCT02775500|TNF|tnf
127065|NCT02775500|tumor necrosis factor|tumor necrosis factor
127066|NCT02775500|birth outcome|birth outcome
127067|NCT02775500|birth defect|birth defect
127068|NCT02775487|COPD|copd
127069|NCT02775487|Air quality|air quality
127070|NCT02775474|Methadone|methadone
127071|NCT02775474|Pain, Postoperative|pain, postoperative
127072|NCT02775474|Chronic Pain|chronic pain
127073|NCT02775474|Bariatric Surgery|bariatric surgery
127074|NCT02775461|Pancreas Cancer|pancreas cancer
127075|NCT02775461|Chronic Pancreatitis|chronic pancreatitis
127076|NCT02775461|Pancreatic Cyst|pancreatic cyst
127077|NCT02775461|BRCA1|brca1
127078|NCT02775461|BRCA2|brca2
127079|NCT02775461|Lynch Syndrome|lynch syndrome
127080|NCT02775461|Peutz-Jeghers syndrome|peutz-jeghers syndrome
127081|NCT02775461|ATM mutation|atm mutation
127082|NCT02775461|FAMMM Syndrome|fammm syndrome
127083|NCT02775461|Pancreatitis|pancreatitis
127084|NCT02775461|Family History of Pancreas Cancer|family history of pancreas cancer
127085|NCT02775461|Family History of Cancer|family history of cancer
127086|NCT02775448|Homeopathy|homeopathy
127087|NCT02775448|Carduus marianus|carduus marianus
127088|NCT02775448|Dyslipidemia|dyslipidemia
127090|NCT02775448|Obesity|obesity
127091|NCT02775448|Triglycerides|triglycerides
127092|NCT02775448|Cholesterol|cholesterol
127093|NCT02775448|Insulin resistance|insulin resistance
127094|NCT02775448|LDL-cholesterol|ldl-cholesterol
127095|NCT02775448|HDL-cholesterol|hdl-cholesterol
127096|NCT02775435|PD1|pd1
127097|NCT02775435|PD-1|pd-1
127098|NCT02775435|PDL1|pdl1
127099|NCT02775435|PD-L1|pd-l1
127100|NCT02775383|National MDS Study|national mds study
127101|NCT02775383|MDS|mds
127102|NCT02775383|Idiopathic|idiopathic
127103|NCT02775383|cytopenia|cytopenia
127104|NCT02775383|cytopenias|cytopenias
127105|NCT02775383|ICUS|icus
127106|NCT02775383|MDS/MPN|mds/mpn
127107|NCT02775383|Myeloproliferative Neoplasm|myeloproliferative neoplasm
127108|NCT02775383|Biorepository|biorepository
127109|NCT02775344|Laparoscopy|laparoscopy
127110|NCT02775344|ovarian cystectomy|ovarian cystectomy
127111|NCT02775344|three dimension laparoscopy|three dimension laparoscopy
127112|NCT02775331|shift scheduling|shift scheduling
127113|NCT02775331|work-life interaction|work-life interaction
127114|NCT02775331|working time control|working time control
127115|NCT02775331|public sector|public sector
127116|NCT02775318|Stellate Ganglion|stellate ganglion
127117|NCT02775318|Digital Subtraction Angiography|digital subtraction angiography
127118|NCT02775318|Transcranial Doppler Ultrasonography|transcranial doppler ultrasonography
127119|NCT02775279|acute coronary syndrome, telomere length, predictive factor|acute coronary syndrome, telomere length, predictive factor
127120|NCT02775253|Brown adipose tissue|brown adipose tissue
127121|NCT02775253|Subcutaneous white adipose tissue|subcutaneous white adipose tissue
127122|NCT02775253|White adipose tissue|white adipose tissue
127123|NCT02775240|Maribavir|maribavir
127124|NCT02775214|Storz C-MAC|storz c-mac
127125|NCT02775214|direct laryngoscopy|direct laryngoscopy
127126|NCT02775214|pyloromyotomy|pyloromyotomy
127127|NCT02775214|rapid sequence|rapid sequence
127128|NCT02775201|plantaris|plantaris
127129|NCT02775201|Tendinopathy|tendinopathy
127130|NCT02775201|Achilles|achilles
127131|NCT02775201|Release|release
127132|NCT02775175|Ramadan|ramadan
127133|NCT02775175|Fasting|fasting
127134|NCT02775175|Nutrition|nutrition
127135|NCT02775175|Quality of Life|quality of life
127136|NCT02775136|brain injuries|brain injuries
127137|NCT02775136|neurological monitoring|neurological monitoring
127138|NCT02775084|n-3|n-3
127139|NCT02775084|Polyunsaturated|polyunsaturated
127140|NCT02775084|Fatty acids|fatty acids
127141|NCT02775084|Antigens|antigens
127142|NCT02775084|Cognition|cognition
127143|NCT02775084|CD4|cd4
127144|NCT02775045|EoE|eoe
127145|NCT02775032|advance care planning|advance care planning
127146|NCT02775032|general practice|general practice
127147|NCT02775032|family practice|family practice
127148|NCT02775032|palliative care|palliative care
127149|NCT02775032|end-of-life care|end-of-life care
127150|NCT02774967|root coverage|root coverage
127151|NCT02774967|gingival recession|gingival recession
127152|NCT02774967|periodontal surgery|periodontal surgery
127153|NCT02774954|Change the cycle|change the cycle
127154|NCT02774954|social learning theory|social learning theory
127155|NCT02774954|people who inject drugs|people who inject drugs
127156|NCT02774954|injection drug use|injection drug use
127157|NCT02774954|Information, Motivation, Behavior Skills Model|information, motivation, behavior skills model
127158|NCT02774954|Longitudinal cohort study|longitudinal cohort study
127159|NCT02774928|Pulmonary Hypertension|pulmonary hypertension
127160|NCT02774928|COPD|copd
127161|NCT02774928|ILD|ild
127162|NCT02774928|OSA|osa
127163|NCT02774902|Drug Therapy|drug therapy
127164|NCT02774889|Falls Prevention|falls prevention
127165|NCT02774889|Stepping On|stepping on
127166|NCT02774889|Health Promotion|health promotion
127167|NCT02774889|Implementation|implementation
127168|NCT02774889|Health Maintenance|health maintenance
127169|NCT02774876|Closed-loop system|closed-loop system
127170|NCT02774876|Artificial pancreas|artificial pancreas
127171|NCT02774876|Glucose control|glucose control
127172|NCT02774876|Meal|meal
127173|NCT02774850|Pediatric|pediatric
127174|NCT02774850|Neutropenia Management|neutropenia management
127175|NCT02774850|Acute Myeloid Leukemia|acute myeloid leukemia
127176|NCT02774850|Chart Abstraction|chart abstraction
127177|NCT02774850|Chemotherapy|chemotherapy
127178|NCT02774837|nucleoside analogues|nucleoside analogues
127179|NCT02774837|tenofovir|tenofovir
127180|NCT02774837|telbivudine|telbivudine
127181|NCT02774837|quantitative HBsAg|quantitative hbsag
127182|NCT02774837|combination therapy|combination therapy
127183|NCT02774798|Rectal Prolapse|rectal prolapse
127184|NCT02774798|Rectal Intussuception|rectal intussuception
127185|NCT02774759|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
127186|NCT02774759|Endometrial cancer survivors|endometrial cancer survivors
127187|NCT02774759|Obese|obese
127188|NCT02774759|Weight loss intervention|weight loss intervention
127189|NCT02774759|Resistance training|resistance training
127190|NCT02774759|Aerobic exercise|aerobic exercise
127191|NCT02774759|Questionnaires|questionnaires
127192|NCT02774759|Surveys|surveys
127193|NCT02774759|Accelerometer|accelerometer
127194|NCT02774759|Fitness Test|fitness test
127195|NCT02774759|Telephone Coaching|telephone coaching
127196|NCT02774759|Video Chat Sessions|video chat sessions
127197|NCT02774707|Dry eye|dry eye
127198|NCT02774694|nociceptive flexion reflex|nociceptive flexion reflex
127199|NCT02774694|interventional pain management|interventional pain management
127200|NCT02774668|gender|gender
127201|NCT02774668|arterial stiffness|arterial stiffness
127202|NCT02774668|blood pressure|blood pressure
127203|NCT02774668|weight loss|weight loss
127204|NCT02774668|uric acid|uric acid
127205|NCT02774655|healthy volunteers|healthy volunteers
127206|NCT02774655|patient compliance|patient compliance
127207|NCT02774655|exercise|exercise
127208|NCT02774655|motivation|motivation
127209|NCT02774642|PTSD|ptsd
127210|NCT02774642|insomnia|insomnia
127211|NCT02774642|CBT-I|cbt-i
127212|NCT02774642|Prolonged Exposure|prolonged exposure
127213|NCT02774642|Veteran|veteran
127214|NCT02774629|food allergy|food allergy
127215|NCT02774629|skin prick test|skin prick test
127216|NCT02774629|atopy patch test|atopy patch test
127217|NCT02774590|Acne vulgaris|acne vulgaris
127218|NCT02774590|Rosacea|rosacea
127219|NCT02774577|Oxygen Consumption|oxygen consumption
127220|NCT02774577|Aged|aged
127221|NCT02774577|Whole Body Vibration|whole body vibration
127222|NCT02774551|Body composition|body composition
127223|NCT02774551|Muscle strength|muscle strength
127224|NCT02774551|Health related quality of life|health related quality of life
127225|NCT02774538|Cervical HPV infection|cervical hpv infection
127226|NCT02774538|Oral HPV infection|oral hpv infection
127227|NCT02774538|Sexually transmitted infection|sexually transmitted infection
127228|NCT02774525|child welfare system|child welfare system
127229|NCT02774525|parental substance use problem|parental substance use problem
127230|NCT02774525|child maltreatment|child maltreatment
127231|NCT02774525|parenting|parenting
127232|NCT02774473|Metastatic|metastatic
127233|NCT02774473|Rb+|rb+
127234|NCT02774473|Breast Cancer|breast cancer
127235|NCT02774408|backup ventilation|backup ventilation
127236|NCT02774408|preterm infants|preterm infants
127237|NCT02774408|functional residual capacity|functional residual capacity
127238|NCT02774408|chronic lung disease|chronic lung disease
127239|NCT02774382|Recurrence|recurrence
127240|NCT02774382|Infection|infection
127241|NCT02774369|cancer|cancer
127242|NCT02774369|insomnia|insomnia
127243|NCT02774369|sleep|sleep
127244|NCT02774369|physical exercise|physical exercise
127245|NCT02774369|aerobic|aerobic
127246|NCT02774369|cognitive-behavioral therapy|cognitive-behavioral therapy
127247|NCT02774369|self-help|self-help
127248|NCT02774369|RCT|rct
127249|NCT02774356|Brainstem|brainstem
127250|NCT02774356|Encoding|encoding
127251|NCT02774356|Pitch|pitch
127252|NCT02774304|elastance|elastance
127253|NCT02774304|fluid responsiveness|fluid responsiveness
127254|NCT02774265|Fracture|fracture
127255|NCT02774265|Prophylaxis|prophylaxis
127256|NCT02774226|Flow-Mediated Dilation|flow-mediated dilation
127257|NCT02774226|Kuvan|kuvan
127258|NCT02774226|Antioxidant|antioxidant
127259|NCT02774226|FEV1|fev1
127260|NCT02774187|Hepatocellular Carcinoma|hepatocellular carcinoma
127261|NCT02774187|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
127262|NCT02774187|Sorafenib|sorafenib
127263|NCT02774174|Proximal Humerus|proximal humerus
127264|NCT02774109|low back pain|low back pain
127265|NCT02774109|fish oil|fish oil
127266|NCT02774109|omega 3|omega 3
127267|NCT02774096|Aortic dissection|aortic dissection
127268|NCT02774096|Cerebral and Spinal Protection|cerebral and spinal protection
127269|NCT02774096|Post-conditioning|post-conditioning
127270|NCT02774083|older people|older people
127271|NCT02774083|cognitive training|cognitive training
127272|NCT02774070|AAJ RA MRI synovitis|aaj ra mri synovitis
127273|NCT02774057|Captafer®|captafer®
127274|NCT02774057|Iron Sulfate|iron sulfate
127275|NCT02774057|Iron deficiency anemia|iron deficiency anemia
127276|NCT02774057|inflammatory bowel disease|inflammatory bowel disease
127277|NCT02774044|preterm neonates, surfactant|preterm neonates, surfactant
127278|NCT02774031|Anesthesia, Inhalation|anesthesia, inhalation
127279|NCT02774031|Laparoscopy|laparoscopy
127280|NCT02774031|Prostatectomy|prostatectomy
127281|NCT02774031|Cystectomy|cystectomy
127282|NCT02774031|Gynecologic Surgical Procedures|gynecologic surgical procedures
127283|NCT02774018|Mindfulness|mindfulness
127284|NCT02774018|Elderly|elderly
127285|NCT02774018|Psychopathology|psychopathology
127286|NCT02773992|Solitary Pulmonary Nodule|solitary pulmonary nodule
127287|NCT02773992|Itos|itos
127288|NCT02773992|lung cancer|lung cancer
127289|NCT02773979|challenge|challenge
127290|NCT02773979|malaria|malaria
127291|NCT02773979|P. falciparum|p. falciparum
127292|NCT02773979|PfSPZ|pfspz
127293|NCT02773979|sporozoites|sporozoites
127294|NCT02773979|vaccine|vaccine
127295|NCT02773953|CPAP|cpap
127296|NCT02773953|Telemonitoring|telemonitoring
127297|NCT02773927|Agave inulin|agave inulin
127298|NCT02773927|Adiponectin|adiponectin
127299|NCT02773927|Metabolic syndrome|metabolic syndrome
127300|NCT02773927|Metformin|metformin
127301|NCT02773927|Insulin resistance|insulin resistance
127302|NCT02773914|Activity of Daily Living (ADL)|activity of daily living (adl)
127303|NCT02773914|Comprehensive Geriatric Assessment|comprehensive geriatric assessment
127304|NCT02773914|Elderly|elderly
127305|NCT02773914|Frailty|frailty
127306|NCT02773914|Randomized controlled study|randomized controlled study
127307|NCT02773901|intracranial pressure|intracranial pressure
127308|NCT02773901|noninvasive monitoring|noninvasive monitoring
127309|NCT02773901|lumbar puncture|lumbar puncture
127310|NCT02773888|intracranial pressure|intracranial pressure
127311|NCT02773888|noninvasive monitoring|noninvasive monitoring
127312|NCT02773875|artificial pancreas|artificial pancreas
127313|NCT02773862|brain injuries|brain injuries
127314|NCT02773862|noninvasive monitoring|noninvasive monitoring
127315|NCT02773862|intracranial pressure|intracranial pressure
127316|NCT02773849|IFN|ifn
127317|NCT02773849|BCG-unresponsive|bcg-unresponsive
127318|NCT02773849|Non-Muscle Invasive Bladder Cancer|non-muscle invasive bladder cancer
127319|NCT02773836|tobacco use|tobacco use
127320|NCT02773836|e-cigarettes|e-cigarettes
127321|NCT02773836|public policy|public policy
127322|NCT02773836|ITC|itc
127323|NCT02773823|obesity|obesity
127324|NCT02773823|children|children
127325|NCT02773823|cardiovascular health|cardiovascular health
127326|NCT02773823|intervention study|intervention study
127327|NCT02773797|Sedation|sedation
127328|NCT02773797|Dexmedetomidine|dexmedetomidine
127329|NCT02773771|Muscle Atrophy|muscle atrophy
127330|NCT02773771|Critical Illness|critical illness
127331|NCT02773771|Ultrasound|ultrasound
127332|NCT02773771|beta-hydroxy-beta-methylbutyrate|beta-hydroxy-beta-methylbutyrate
127333|NCT02773771|ICU|icu
127334|NCT02773680|respiration|respiration
127335|NCT02773680|monitoring, physiologic|monitoring, physiologic
127336|NCT02773680|diagnostic techniques, respiratory system|diagnostic techniques, respiratory system
127337|NCT02773654|shoulder|shoulder
127338|NCT02773654|motion|motion
127339|NCT02773654|measurement|measurement
127340|NCT02773654|healthy shoulder|healthy shoulder
127341|NCT02773654|shoulder motion|shoulder motion
127342|NCT02773602|Analgesia|analgesia
127343|NCT02773602|caudal analgesia|caudal analgesia
127344|NCT02773602|ropivacaine|ropivacaine
127345|NCT02773602|clonidine|clonidine
127346|NCT02773602|dexamethasone|dexamethasone
127347|NCT02773550|Multiple Myeloma|multiple myeloma
127348|NCT02773524|Metastatic|metastatic
127349|NCT02773524|Locally recurrent|locally recurrent
127350|NCT02773524|Oesophago-gastric junction|oesophago-gastric junction
127351|NCT02773524|Stomach|stomach
127352|NCT02773524|Adenocarcinoma|adenocarcinoma
127353|NCT02773524|Undifferentiated Carcinoma|undifferentiated carcinoma
127354|NCT02773472|colorectal|colorectal
127355|NCT02773472|electroacupuncture|electroacupuncture
127356|NCT02773472|laparoscopic surgery|laparoscopic surgery
127357|NCT02773446|ETEC|etec
127358|NCT02773446|Escherichia coli|escherichia coli
127359|NCT02773446|enteritis|enteritis
127360|NCT02773446|Challenge|challenge
127361|NCT02773446|CS6|cs6
127362|NCT02773446|Enterotoxigenic|enterotoxigenic
127363|NCT02773407|Undifferentiated febrile illness|undifferentiated febrile illness
127364|NCT02773407|Azithromycin|azithromycin
127365|NCT02773407|Cotrimoxazole|cotrimoxazole
127366|NCT02773407|Efficacy|efficacy
127367|NCT02773407|Enteric fever|enteric fever
127368|NCT02773407|Fever clearance time|fever clearance time
127369|NCT02773394|Hepatitis C Virus|hepatitis c virus
127370|NCT02773394|Observational|observational
127371|NCT02773394|Brazil|brazil
127372|NCT02773342|Invasive Pulmonal Aspergillosis|invasive pulmonal aspergillosis
127373|NCT02773342|Neutropenic Patients|neutropenic patients
127374|NCT02773342|Haematological Malignancies|haematological malignancies
127375|NCT02773342|Chest Computed Tomography|chest computed tomography
127376|NCT02773329|chemotherapy induced peripheral neuropathy|chemotherapy induced peripheral neuropathy
127377|NCT02773329|Cancer|cancer
127378|NCT02773329|game-based exercise|game-based exercise
127379|NCT02773329|exercise|exercise
127380|NCT02773329|wearable sensors|wearable sensors
127381|NCT02773329|balance|balance
127382|NCT02773329|falls|falls
127383|NCT02773329|virtual reality|virtual reality
127384|NCT02773303|Neurofeedback|neurofeedback
127385|NCT02773303|balance, postural|balance, postural
127386|NCT02773303|postural equilibrium|postural equilibrium
127387|NCT02773303|EEG|eeg
127388|NCT02773290|Aplastic Anemia|aplastic anemia
127389|NCT02773251|Postoperative adhesion|postoperative adhesion
127390|NCT02773251|Laparoscopy|laparoscopy
127391|NCT02773251|Adhesion barrier|adhesion barrier
127392|NCT02773225|non severe Aplastic Anemia,|non severe aplastic anemia,
127393|NCT02773186|postoperative|postoperative
127394|NCT02773186|behavioral changes|behavioral changes
127395|NCT02773173|Colorectal Laparoscopic Surgery|colorectal laparoscopic surgery
127396|NCT02773134|Post-operative Bracing|post-operative bracing
127397|NCT02773134|Rigid Lumbosacral Orthosis|rigid lumbosacral orthosis
127398|NCT02773134|Posterior Spine Fusion|posterior spine fusion
127399|NCT02773134|Quality of Life|quality of life
127400|NCT02773134|Lumbar Degenerative Conditions|lumbar degenerative conditions
127401|NCT02773121|Cognition|cognition
127402|NCT02773121|Learning|learning
127403|NCT02773121|Memory|memory
127404|NCT02773121|Executive Function|executive function
127405|NCT02773121|Attention|attention
127406|NCT02773121|Neuropsychological Tests|neuropsychological tests
127407|NCT02773121|Physical Activity|physical activity
127408|NCT02773121|Physical Fitness|physical fitness
127409|NCT02773121|Exercise|exercise
127410|NCT02773121|Resistance Training|resistance training
127411|NCT02773121|Walking|walking
127412|NCT02773121|Muscle Stretching Exercises|muscle stretching exercises
127413|NCT02773121|Exercise Test|exercise test
127414|NCT02773121|Balance|balance
127415|NCT02773121|Flexibility|flexibility
127416|NCT02773121|Body Composition|body composition
127417|NCT02773095|Novartis Access|novartis access
127418|NCT02773095|noncommunicable disease burden|noncommunicable disease burden
127419|NCT02773095|medicine availability and price|medicine availability and price
127420|NCT02773095|Kenya|kenya
127421|NCT02773082|Treatment-Resistant|treatment-resistant
127422|NCT02773082|Anxiety|anxiety
127423|NCT02773056|transfemoral|transfemoral
127424|NCT02773056|amputation|amputation
127425|NCT02773056|perspiration|perspiration
127426|NCT02773056|socket|socket
127427|NCT02773056|socket comfort|socket comfort
127428|NCT02773030|Multiple Myeloma|multiple myeloma
127429|NCT02773030|Relapsed|relapsed
127430|NCT02773030|Refractory|refractory
127431|NCT02773030|Pharmacokinetics|pharmacokinetics
127432|NCT02773030|Safety|safety
127433|NCT02773030|Efficacy|efficacy
127434|NCT02773030|CC-220|cc-220
127435|NCT02773030|Relapsed and refractory multiple myeloma|relapsed and refractory multiple myeloma
127436|NCT02773017|sedation|sedation
127437|NCT02773017|age|age
127438|NCT02773017|dexmedetomidine|dexmedetomidine
127439|NCT02773004|Genomic test|genomic test
127440|NCT02773004|Chemotherapy decision|chemotherapy decision
127441|NCT02772978|decision making|decision making
127442|NCT02772978|impulsivity|impulsivity
127443|NCT02772926|Benfotiamine|benfotiamine
127444|NCT02772926|Advanced glycation end products|advanced glycation end products
127445|NCT02772926|Soluble receptor for AGEs|soluble receptor for ages
127446|NCT02772926|Endogenous secretory receptor for AGEs|endogenous secretory receptor for ages
127447|NCT02772900|Aging|aging
127448|NCT02772900|Beetroot|beetroot
127449|NCT02772900|Dietary Nitrate|dietary nitrate
127450|NCT02772900|Functional Food|functional food
127451|NCT02772900|Vascular Function|vascular function
127452|NCT02772887|pregnancy|pregnancy
127453|NCT02772887|type 2 diabetes|type 2 diabetes
127454|NCT02772887|asymmetric dimethylarginine|asymmetric dimethylarginine
127455|NCT02772887|L-arginine|l-arginine
127456|NCT02772887|L-citrulline|l-citrulline
127457|NCT02772887|placental growth factor (PlGF)|placental growth factor (plgf)
127458|NCT02772887|blood pressure|blood pressure
127459|NCT02772874|fecal incontinence|fecal incontinence
127460|NCT02772874|severity|severity
127461|NCT02772874|ultrasound|ultrasound
127462|NCT02772874|anorectal manometry|anorectal manometry
127463|NCT02772874|classification|classification
127464|NCT02772835|nCPAP|ncpap
127465|NCT02772835|nHFOV|nhfov
127466|NCT02772835|Preterm|preterm
127467|NCT02772835|RDS|rds
127468|NCT02772835|CO2 Elimination|co2 elimination
127469|NCT02772809|stroke|stroke
127470|NCT02772809|hemiplegia|hemiplegia
127471|NCT02772809|rehabilitation|rehabilitation
127472|NCT02772809|robotics|robotics
127473|NCT02772809|neuroplasticity|neuroplasticity
127474|NCT02772796|Pharmacokinetics|pharmacokinetics
127475|NCT02772796|Healthy Volunteer Study|healthy volunteer study
127476|NCT02772783|brain|brain
127477|NCT02772783|fMRI|fmri
127478|NCT02772783|carbohydrate|carbohydrate
127479|NCT02772783|insulin clamp|insulin clamp
127480|NCT02772783|intake regulation|intake regulation
127481|NCT02772783|overweight|overweight
127482|NCT02772783|glycemic index|glycemic index
127483|NCT02772757|hearing loss|hearing loss
127484|NCT02772757|hearing aids|hearing aids
127485|NCT02772757|outcome assessment|outcome assessment
127486|NCT02772744|Hepatitis C virus genotype 4|hepatitis c virus genotype 4
127487|NCT02772744|Antiviral|antiviral
127488|NCT02772744|Virologic Response|virologic response
127489|NCT02772731|mastectomy|mastectomy
127490|NCT02772718|Hypoglycemia|hypoglycemia
127491|NCT02772705|Standardized Uptake Value|standardized uptake value
127492|NCT02772705|Diagnosis|diagnosis
127493|NCT02772679|Diabetes|diabetes
127494|NCT02772679|Treg|treg
127495|NCT02772679|Proluekin|proluekin
127496|NCT02772666|Relative afferent pupillary defect (RAPD)|relative afferent pupillary defect (rapd)
127497|NCT02772666|Multiple sclerosis|multiple sclerosis
127498|NCT02772666|Glaucoma|glaucoma
127499|NCT02772653|Microcirculation|microcirculation
127500|NCT02772653|Videomicroscopy|videomicroscopy
127501|NCT02772653|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
127502|NCT02772653|B-Type Natriuretic Peptide|b-type natriuretic peptide
128009|NCT02769494|Oral ulcer|oral ulcer
127503|NCT02772653|Thromboelastometry|thromboelastometry
127504|NCT02772653|Trauma|trauma
127505|NCT02772653|Resuscitation|resuscitation
127506|NCT02772653|Hypovolemic shock|hypovolemic shock
127507|NCT02772640|Hypercholesterolemia|hypercholesterolemia
127508|NCT02772640|Rosuvastatin|rosuvastatin
127509|NCT02772640|Statin|statin
127510|NCT02772640|Ezetimibe|ezetimibe
127511|NCT02772640|Compliance|compliance
127512|NCT02772640|Cholesterol|cholesterol
127513|NCT02772640|Secondary prevention|secondary prevention
127514|NCT02772640|Coronary artery disease|coronary artery disease
127515|NCT02772640|Cholesterol absorption inhibitor|cholesterol absorption inhibitor
127516|NCT02772627|Parkinson's disease, Nebicapone|parkinson's disease, nebicapone
127517|NCT02772614|Nebicapone, Parkinson's disease|nebicapone, parkinson's disease
127518|NCT02772601|ABBV-066|abbv-066
127519|NCT02772601|BI 655066|bi 655066
127520|NCT02772601|risankizumab|risankizumab
127521|NCT02772588|ARN-509|arn-509
127522|NCT02772588|Abiraterone|abiraterone
127523|NCT02772588|Leuprolide|leuprolide
127524|NCT02772588|Intensity-Modulated and Image-Guided Radiation Therapy|intensity-modulated and image-guided radiation therapy
127525|NCT02772588|15-334|15-334
127526|NCT02772588|apalutamide,|apalutamide,
127527|NCT02772588|JNJ-56021927|jnj-56021927
127528|NCT02772575|MOLECULAR PREDICTORS|molecular predictors
127529|NCT02772575|Hepatic trans-arterial embolization (TAE)|hepatic trans-arterial embolization (tae)
127530|NCT02772575|16-385|16-385
127531|NCT02772562|prostate cancer|prostate cancer
127532|NCT02772549|Diagnosis|diagnosis
127533|NCT02772536|Chronic Tinnitus Tinted Light Change in Perception|chronic tinnitus tinted light change in perception
127534|NCT02772523|Primary Prevention|primary prevention
127535|NCT02772510|Stroke|stroke
127536|NCT02772510|Rehabilitation|rehabilitation
127537|NCT02772510|Hand|hand
127538|NCT02772510|Game|game
127539|NCT02772510|Functional electrical stimulation|functional electrical stimulation
127540|NCT02772510|Virtual reality|virtual reality
127541|NCT02772497|DME|dme
127542|NCT02772497|Anti VEGF|anti vegf
127543|NCT02772497|VEGF trap|vegf trap
127544|NCT02772497|Diabetes|diabetes
127545|NCT02772497|Diabetic retinopathy|diabetic retinopathy
127546|NCT02772497|ZALTRAP|zaltrap
127547|NCT02772497|Ziv aflibercept|ziv aflibercept
127548|NCT02772484|noninvasive monitoring|noninvasive monitoring
127549|NCT02772471|intracranial pressure|intracranial pressure
127550|NCT02772471|noninvasive monitoring|noninvasive monitoring
127551|NCT02772458|Crohn's Disease|crohn's disease
127552|NCT02772458|gut brain axis|gut brain axis
127553|NCT02772458|reduced appetite|reduced appetite
127554|NCT02772445|Empowerment|empowerment
127555|NCT02772445|Caregiver|caregiver
127556|NCT02772432|resiliency training|resiliency training
127557|NCT02772432|parenting|parenting
127558|NCT02772432|special learning disability|special learning disability
127559|NCT02772406|ulcerative colitis|ulcerative colitis
127560|NCT02772406|colonoscopy|colonoscopy
127561|NCT02772406|Dysplasia|dysplasia
127562|NCT02772406|Diagnosis|diagnosis
127563|NCT02772367|cardiotoxicity|cardiotoxicity
127564|NCT02772367|16-025|16-025
127565|NCT02772354|Pediatric population, ablation|pediatric population, ablation
127566|NCT02772341|Asthma|asthma
127567|NCT02772341|Halotherapy|halotherapy
127568|NCT02772341|Airway hyper-reactivity|airway hyper-reactivity
127569|NCT02772341|Metacholine|metacholine
127570|NCT02772328|Testing|testing
127571|NCT02772328|Access|access
127572|NCT02772315|genomics|genomics
127573|NCT02772315|proteomics|proteomics
127574|NCT02772315|metabolomics|metabolomics
127575|NCT02772315|endocrine hypertension|endocrine hypertension
127576|NCT02772315|primary aldosteronism|primary aldosteronism
127577|NCT02772315|Cushing syndrom|cushing syndrom
127578|NCT02772315|pheochromocytoma|pheochromocytoma
127579|NCT02772289|Mesenchyme Stem Cells|mesenchyme stem cells
127580|NCT02772289|Cesarean Section|cesarean section
127581|NCT02772289|Scars|scars
127582|NCT02772276|Glomerular Filtration Rate|glomerular filtration rate
127583|NCT02772263|Paramedicine|paramedicine
127584|NCT02772263|Community Paramedic|community paramedic
127585|NCT02772263|Elderly|elderly
127586|NCT02772250|bowel preparation|bowel preparation
127587|NCT02772250|polyethylene glycol|polyethylene glycol
127588|NCT02772250|face-to-face re-education|face-to-face re-education
127589|NCT02772250|telephone re-education|telephone re-education
127590|NCT02772250|Boston Bowel Preparation Scale|boston bowel preparation scale
127591|NCT02772237|concussion|concussion
127592|NCT02772237|sports-related concussion|sports-related concussion
127593|NCT02772237|mTBI|mtbi
127594|NCT02772237|Riboflavin|riboflavin
127595|NCT02772237|Vitamin B2|vitamin b2
127596|NCT02772159|COPD|copd
127597|NCT02772159|ADME|adme
127598|NCT02772159|Healthy Normal Males|healthy normal males
127599|NCT02772159|Phase 1|phase 1
127600|NCT02772120|Infertility|infertility
127601|NCT02772120|In vitro fertilization|in vitro fertilization
127602|NCT02772120|Embryo transfer|embryo transfer
127603|NCT02772120|Blastocyst|blastocyst
127604|NCT02772120|Progesterone|progesterone
127605|NCT02772120|Crinone|crinone
127606|NCT02772107|Small Cell Lung Carcinoma|small cell lung carcinoma
127607|NCT02772094|glioblastoma multiforme|glioblastoma multiforme
127608|NCT02772094|glioblastoma|glioblastoma
127609|NCT02772094|newly diagnosed glioblastoma|newly diagnosed glioblastoma
127610|NCT02772094|immunotherapy|immunotherapy
127611|NCT02772094|dendritic cells|dendritic cells
127612|NCT02772094|grade IV astrocytoma|grade iv astrocytoma
127613|NCT02772094|oncology|oncology
127614|NCT02772094|neurology|neurology
127615|NCT02772094|glioma|glioma
127616|NCT02772094|brain tumor|brain tumor
127617|NCT02772094|ADCTA-G|adcta-g
127618|NCT02772055|Moxa smoke|moxa smoke
127619|NCT02772055|Moxibustion|moxibustion
127620|NCT02772055|Knee osteoarthritis|knee osteoarthritis
127621|NCT02772042|Manual Therapy|manual therapy
127622|NCT02772042|Physiotherapy|physiotherapy
127623|NCT02772042|Manipulation|manipulation
127624|NCT02771990|Back Pain|back pain
127625|NCT02771964|outcome assessment|outcome assessment
127626|NCT02771964|postoperative period|postoperative period
127627|NCT02771951|Childhood|childhood
127628|NCT02771951|Obesity|obesity
127629|NCT02771938|radiotherapy, breast cancer, DIEP flap|radiotherapy, breast cancer, diep flap
127630|NCT02771925|Gabapentin|gabapentin
127631|NCT02771925|Alcohol Dependence|alcohol dependence
127632|NCT02771899|Imaging, Three-Dimensional|imaging, three-dimensional
127633|NCT02771899|Spine|spine
127634|NCT02771899|Scoliosis|scoliosis
127635|NCT02771886|mindfulness|mindfulness
127636|NCT02771886|urges|urges
127637|NCT02771886|adolescents|adolescents
127638|NCT02771886|risk behaviors|risk behaviors
127639|NCT02771886|therapy intervention|therapy intervention
127640|NCT02771860|denosumab|denosumab
127641|NCT02771860|RANKL-blockade|rankl-blockade
127642|NCT02771834|Postural balance|postural balance
127643|NCT02771834|Osteoporosis|osteoporosis
127644|NCT02771834|Postmenopause|postmenopause
127645|NCT02771834|Vitamin D|vitamin d
127646|NCT02771834|Kyfhosis|kyfhosis
127647|NCT02771834|Muscle strength|muscle strength
127648|NCT02771808|CABG|cabg
127649|NCT02771795|HER2|her2
127650|NCT02771795|Trastuzumab|trastuzumab
127651|NCT02771795|Biosimilar|biosimilar
127652|NCT02771795|Cancer|cancer
127653|NCT02771795|Breast|breast
127654|NCT02771795|Positive|positive
127655|NCT02771782|BCG|bcg
127656|NCT02771782|TDaP-IPV|tdap-ipv
127657|NCT02771782|DPT Vaccine|dpt vaccine
127658|NCT02771769|cell-free DNA|cell-free dna
127659|NCT02771769|copy number instability|copy number instability
127660|NCT02771769|liquid biopsy|liquid biopsy
127661|NCT02771769|cancer|cancer
127662|NCT02771756|Breast cancer|breast cancer
127663|NCT02771756|Lung cancer|lung cancer
127664|NCT02771756|Nutritional support|nutritional support
127665|NCT02771756|Safety|safety
127666|NCT02771756|Effectiveness|effectiveness
127667|NCT02771743|Neuroblastoma|neuroblastoma
127668|NCT02771743|High risk|high risk
127669|NCT02771743|Tandem high dose chemotherapy|tandem high dose chemotherapy
127670|NCT02771691|Adolescent|adolescent
127671|NCT02771652|Multiple Sclerosis|multiple sclerosis
127672|NCT02771652|Quality of Life|quality of life
127673|NCT02771652|exercise|exercise
127674|NCT02771652|internet|internet
127675|NCT02771639|Hip arthroplasty|hip arthroplasty
127676|NCT02771639|periprosthetic joint infection|periprosthetic joint infection
127677|NCT02771639|outcome|outcome
127678|NCT02771626|RCC|rcc
127679|NCT02771626|MEL|mel
127680|NCT02771626|NSCLC|nsclc
127681|NCT02771626|Immuno-Oncology|immuno-oncology
127682|NCT02771626|Tumor Metabolism|tumor metabolism
127683|NCT02771626|Glutaminase|glutaminase
127684|NCT02771626|Glutaminase Inhibitor|glutaminase inhibitor
127685|NCT02771613|Morbidity Mortality Review|morbidity mortality review
127686|NCT02771613|medical simulation|medical simulation
127687|NCT02771613|in situ simulation|in situ simulation
127688|NCT02771613|multi professional simulation|multi professional simulation
127689|NCT02771613|hospital adverse event|hospital adverse event
127690|NCT02771600|Procedural pain|procedural pain
127691|NCT02771600|Procedural anxiety|procedural anxiety
127692|NCT02771600|Pediatrics|pediatrics
127693|NCT02771600|Needle-related procedures|needle-related procedures
127694|NCT02771587|alcohol|alcohol
127695|NCT02771587|energy drink|energy drink
127696|NCT02771587|coagulability|coagulability
127697|NCT02771587|caffeine|caffeine
127698|NCT02771587|taurine|taurine
127699|NCT02771587|driving performance|driving performance
127700|NCT02771574|Bariatric surgery complications|bariatric surgery complications
127701|NCT02771574|Glucose Metabolism Disorders|glucose metabolism disorders
127702|NCT02771574|Exendin (9-39)|exendin (9-39)
127703|NCT02771574|GLP-1|glp-1
127704|NCT02771561|Patent Foramen Ovale|patent foramen ovale
127705|NCT02771561|Obstructive Sleep Apnea|obstructive sleep apnea
127706|NCT02771561|Apnea-Hypopnea Index|apnea-hypopnea index
127707|NCT02771561|Oxygen Desaturation Index|oxygen desaturation index
127708|NCT02771561|Epworth Sleepiness Scale|epworth sleepiness scale
127709|NCT02771561|Quality of life|quality of life
127710|NCT02771561|Continuous Positive Airway Pressure|continuous positive airway pressure
127711|NCT02771561|Obstructive Sleep Apnea-Hypopnea Syndrome|obstructive sleep apnea-hypopnea syndrome
127712|NCT02771561|Gore™ septal occluder device|gore™ septal occluder device
127713|NCT02771548|Knee injuries|knee injuries
127714|NCT02771548|Rehabilitation|rehabilitation
127715|NCT02771548|Return to sport|return to sport
127716|NCT02771548|Biomechanics|biomechanics
127717|NCT02771522|Caries, Acitivity, Demineralsiation|caries, acitivity, demineralsiation
127719|NCT02771509|Cardiac Surgery|cardiac surgery
127720|NCT02771509|Acute Kidney Injury|acute kidney injury
127721|NCT02771470|Gut microflora|gut microflora
127722|NCT02771470|Lung cancer|lung cancer
127723|NCT02771470|Chemotherapy|chemotherapy
127724|NCT02771470|Immunity|immunity
127725|NCT02771470|Nutrition|nutrition
127726|NCT02771457|Influximab|influximab
127727|NCT02771457|IFX|ifx
127728|NCT02771457|Remicade|remicade
127729|NCT02771418|Carotid endarterectomy|carotid endarterectomy
127730|NCT02771418|postoperative cognitive dysfunction|postoperative cognitive dysfunction
127731|NCT02771405|HCV-HCC-DAAs|hcv-hcc-daas
127732|NCT02771366|neuroinflammation|neuroinflammation
127733|NCT02771366|cognitive function|cognitive function
127734|NCT02771366|aging adults|aging adults
127735|NCT02771314|NSCLC|nsclc
127736|NCT02771314|AZD9291|azd9291
127737|NCT02771314|>= 2nd line|>= 2nd line
127738|NCT02771314|liquid biopsy|liquid biopsy
127739|NCT02771314|EGFR TKIs|egfr tkis
127740|NCT02771314|EGFR mutant|egfr mutant
127741|NCT02771301|IDH1R132H Dendritic cell glioma|idh1r132h dendritic cell glioma
127742|NCT02771288|Kawasaki disease|kawasaki disease
127743|NCT02771288|optical coherence tomography|optical coherence tomography
127744|NCT02771288|multislice computed tomography|multislice computed tomography
127745|NCT02771249|Latent Tuberculosis Infection (LTBI)|latent tuberculosis infection (ltbi)
127746|NCT02771249|Antiretrovirals (ARVs)|antiretrovirals (arvs)
127747|NCT02771249|HIV|hiv
127748|NCT02771249|UGT1A1|ugt1a1
127749|NCT02771249|Drug-Drug Interaction (DDI)|drug-drug interaction (ddi)
127750|NCT02771236|Inherited Eye Disease|inherited eye disease
127751|NCT02771210|Active psoriatic arthritis|active psoriatic arthritis
127752|NCT02771210|Axial spondyloarthritides|axial spondyloarthritides
127753|NCT02771210|Subcutaneous|subcutaneous
127754|NCT02771210|Secukinumab in prefilled syringe|secukinumab in prefilled syringe
127755|NCT02771210|Enthesitis|enthesitis
127756|NCT02771210|Achilles tendon|achilles tendon
127757|NCT02771197|AML|aml
127758|NCT02771171|Pediatric Airway, Three-dimensional Imaging, CT Scan|pediatric airway, three-dimensional imaging, ct scan
127759|NCT02771158|critical care|critical care
127760|NCT02771158|shock, septic|shock, septic
127761|NCT02771158|sepsis|sepsis
127762|NCT02771158|hypotension|hypotension
127763|NCT02771158|midodrine|midodrine
127764|NCT02771093|Type 2, Diabetes, Diabetes Mellitus|type 2, diabetes, diabetes mellitus
127765|NCT02771041|Hip prothesis|hip prothesis
127766|NCT02771002|critically ill patients|critically ill patients
127767|NCT02771002|septic shock|septic shock
127768|NCT02771002|peripheral perfusion index|peripheral perfusion index
127769|NCT02771002|capillary refill time|capillary refill time
127770|NCT02771002|mottling score|mottling score
127771|NCT02771002|microcirculation|microcirculation
127772|NCT02770989|Cardiac Ablation|cardiac ablation
127773|NCT02770989|Safety|safety
127774|NCT02770989|Performance|performance
127775|NCT02770989|Laser|laser
127776|NCT02770963|discogenic|discogenic
127777|NCT02770963|Acupuncture Therapy|acupuncture therapy
127778|NCT02770963|randomized controlled trial|randomized controlled trial
127779|NCT02770950|Knee Osteoarthritis|knee osteoarthritis
127780|NCT02770937|laparoscopy, simulator|laparoscopy, simulator
127781|NCT02770924|cataract|cataract
127782|NCT02770924|phacoemulsification|phacoemulsification
127783|NCT02770924|AT LISA TRI TORIC|at lisa tri toric
127784|NCT02770924|IOL|iol
127785|NCT02770911|Rectal Carcinoma|rectal carcinoma
127786|NCT02770911|Laparoscopy|laparoscopy
127787|NCT02770911|Anastomotic Leak|anastomotic leak
127788|NCT02770911|Double-stapling technique|double-stapling technique
127789|NCT02770898|probation|probation
127790|NCT02770898|evidence-based|evidence-based
127791|NCT02770898|well-being|well-being
127792|NCT02770898|physical exercise|physical exercise
127793|NCT02770898|family well-being|family well-being
127794|NCT02770872|serum amyloid a|serum amyloid a
127795|NCT02770872|lipoprotein|lipoprotein
127796|NCT02770872|insulin resistance|insulin resistance
127797|NCT02770872|dyslipidemia|dyslipidemia
127798|NCT02770859|Achalasia|achalasia
127799|NCT02770833|Proteins (seafood and meat)|proteins (seafood and meat)
127800|NCT02770833|GI|gi
127801|NCT02770833|Energy expenditure|energy expenditure
127802|NCT02770833|Energy balance|energy balance
127803|NCT02770833|Thermogenesis (DIT)|thermogenesis (dit)
127804|NCT02770833|Appetite regulating hormones|appetite regulating hormones
127805|NCT02770833|Appetite sensations|appetite sensations
127806|NCT02770833|Glucose allostatis|glucose allostatis
127807|NCT02770833|Amino acid metabolism|amino acid metabolism
127808|NCT02770833|Satiety|satiety
127809|NCT02770833|Food preferences|food preferences
127810|NCT02770807|Ataxia Teleangiectasia|ataxia teleangiectasia
127811|NCT02770807|AT|at
127812|NCT02770807|EryDex system|erydex system
127813|NCT02770807|Dexamethasone|dexamethasone
127814|NCT02770807|Dexamethasone sodium phosphate|dexamethasone sodium phosphate
127815|NCT02770781|survivors|survivors
127816|NCT02770781|physical fitness|physical fitness
127817|NCT02770768|HSDD (Hypoactive Sexual Desire Disorder)|hsdd (hypoactive sexual desire disorder)
127818|NCT02770768|EEG (Electroencephalogram)|eeg (electroencephalogram)
127819|NCT02770742|patient satisfaction|patient satisfaction
127820|NCT02770742|unsedated colonoscopy|unsedated colonoscopy
127821|NCT02770742|intestinal diseases|intestinal diseases
127822|NCT02770729|intracameral moxifloxacin|intracameral moxifloxacin
127823|NCT02770729|endophthalmitis|endophthalmitis
127824|NCT02770729|Vigamox|vigamox
127825|NCT02770729|endothelial cell density|endothelial cell density
127826|NCT02770677|Yoga|yoga
127827|NCT02770677|COPD|copd
127828|NCT02770677|rehabilitation|rehabilitation
127829|NCT02770651|optical coherence tomography|optical coherence tomography
127830|NCT02770651|everolimus-eluting stent|everolimus-eluting stent
127831|NCT02770651|zotarolimus-eluting stent|zotarolimus-eluting stent
127832|NCT02770638|Healthy|healthy
127833|NCT02770638|Sport|sport
127834|NCT02770638|Athlete|athlete
127835|NCT02770638|Male|male
127836|NCT02770638|University|university
127837|NCT02770638|Adults|adults
127838|NCT02770638|Rugby Football Union|rugby football union
127839|NCT02770638|Professional|professional
127840|NCT02770638|Competitive sport|competitive sport
127841|NCT02770638|Scoop Stretcher|scoop stretcher
127842|NCT02770638|Ferno Scoop Stretcher|ferno scoop stretcher
127843|NCT02770638|Long back spinal board|long back spinal board
127844|NCT02770638|Emergency Medical Services|emergency medical services
127845|NCT02770638|Long backboard|long backboard
127846|NCT02770638|Patient Extrication|patient extrication
127847|NCT02770638|Triple Immobilisation|triple immobilisation
127848|NCT02770638|Pre hospital Medicine|pre hospital medicine
127849|NCT02770638|Rigid Cervical Collar|rigid cervical collar
127850|NCT02770638|Pressure Testing|pressure testing
127851|NCT02770638|Tissue Pressure Testing|tissue pressure testing
127852|NCT02770638|Visual Analogue Scale|visual analogue scale
127853|NCT02770638|Pressure Sores|pressure sores
127854|NCT02770638|Pressure area damage|pressure area damage
127855|NCT02770638|Tissue Viability|tissue viability
127856|NCT02770638|Tissue Interface Pressure|tissue interface pressure
127857|NCT02770638|Comfort|comfort
127858|NCT02770638|Pain|pain
127859|NCT02770625|Type I Gaucher|type i gaucher
127860|NCT02770625|ISU302|isu302
127861|NCT02770625|Imiglucerase|imiglucerase
127862|NCT02770599|IBD|ibd
127863|NCT02770599|HRQoL|hrqol
127864|NCT02770599|QoC|qoc
127865|NCT02770599|Adherence|adherence
127866|NCT02770599|IBD nurse|ibd nurse
127867|NCT02770599|MDT|mdt
127868|NCT02770573|nano-hydroxyapatite|nano-hydroxyapatite
127869|NCT02770508|antiretroviral naive|antiretroviral naive
127870|NCT02770508|dual therapy|dual therapy
127871|NCT02770482|dementia|dementia
127872|NCT02770482|biomarkers|biomarkers
127873|NCT02770482|cerebrospinal fluid|cerebrospinal fluid
127874|NCT02770469|Breast Cancer|breast cancer
127875|NCT02770469|Korean Americans|korean americans
127876|NCT02770469|Survivorship|survivorship
127877|NCT02770469|Quality of Life|quality of life
127878|NCT02770469|Coping Skills|coping skills
127879|NCT02770469|Perceived Stress|perceived stress
127880|NCT02770456|fish oil, preterm birth, pregnancy, China, prevention|fish oil, preterm birth, pregnancy, china, prevention
127881|NCT02770443|Recovered LVEF|recovered lvef
127882|NCT02770443|DCM|dcm
127883|NCT02770391|HSD3B1 Genotype|hsd3b1 genotype
127884|NCT02770391|Steroid Metabolism|steroid metabolism
127885|NCT02770391|High-risk Prostate Cancer|high-risk prostate cancer
127886|NCT02770391|ARN-509|arn-509
127887|NCT02770378|Temozolomide|temozolomide
127888|NCT02770378|Recurrent Glioblastoma|recurrent glioblastoma
127889|NCT02770352|retrospective chart review|retrospective chart review
127890|NCT02770352|prospective chart review|prospective chart review
127891|NCT02770352|fistula formation and repair|fistula formation and repair
127892|NCT02770352|database|database
127893|NCT02770352|demographics of women with fistulas|demographics of women with fistulas
127894|NCT02770352|internationally accepted risks factors for fistula formation|internationally accepted risks factors for fistula formation
127895|NCT02770339|Pharmacogenomics|pharmacogenomics
127896|NCT02770339|Psychiatric crisis|psychiatric crisis
127897|NCT02770339|Drug overdose|drug overdose
127898|NCT02770339|Psychotropic medications|psychotropic medications
127899|NCT02770326|Safety of Stool Transplant|safety of stool transplant
127900|NCT02770326|Fecal Microbiota Transplantation (FMT)|fecal microbiota transplantation (fmt)
127901|NCT02770326|15-337|15-337
127902|NCT02770300|automatic|automatic
127903|NCT02770300|personalized|personalized
127904|NCT02770300|robotic therapy|robotic therapy
127905|NCT02770261|DP-R208|dp-r208
127906|NCT02770222|Pharmacokinetics|pharmacokinetics
127907|NCT02770196|Community-Supported Agriculture|community-supported agriculture
127908|NCT02770196|Local Food System|local food system
127909|NCT02770196|Vegetable|vegetable
127910|NCT02770196|Fruit|fruit
127911|NCT02770196|Childhood Obesity|childhood obesity
127912|NCT02770183|Myocardial stunning|myocardial stunning
127913|NCT02770183|Echocardiography, Transesophageal|echocardiography, transesophageal
127914|NCT02770183|Extracorporeal Circulation|extracorporeal circulation
127915|NCT02770144|Child Quality of Life|child quality of life
127916|NCT02770144|Financial Coaching|financial coaching
127917|NCT02770144|Socioeconomic Status|socioeconomic status
127918|NCT02770144|Social Determinants of Health|social determinants of health
127919|NCT02770131|hypercholesterolaemia|hypercholesterolaemia
127920|NCT02770131|lipid-lowering therapies|lipid-lowering therapies
127921|NCT02770118|sleep restriction|sleep restriction
127922|NCT02770118|obesity|obesity
127923|NCT02770118|brown adipose tissue|brown adipose tissue
127924|NCT02770105|L-theanine|l-theanine
127925|NCT02770105|caffeine|caffeine
127926|NCT02770105|selective attention|selective attention
127927|NCT02770105|fMRI|fmri
127928|NCT02770105|RVRT|rvrt
127929|NCT02770079|Insulin sensitivity|insulin sensitivity
127930|NCT02770053|Foraminal enlargement|foraminal enlargement
127931|NCT02770053|Root canal treatment|root canal treatment
127932|NCT02770040|Acute Severe Ulcerative Colitis|acute severe ulcerative colitis
127933|NCT02770040|Steroid Refractory Ulcerative Colitis|steroid refractory ulcerative colitis
127934|NCT02770027|Colon Surgery|colon surgery
127935|NCT02770027|blood viscosity|blood viscosity
127936|NCT02770014|Non-Small Cell Lung Cancer|non-small cell lung cancer
127937|NCT02770014|Epidermal Growth Factor Receptor|epidermal growth factor receptor
127938|NCT02770001|Admixture|admixture
127939|NCT02770001|African American|african american
127940|NCT02770001|African American Genetics|african american genetics
127941|NCT02769988|Adolescents|adolescents
127942|NCT02769988|Health Information Literacy|health information literacy
127943|NCT02769988|Health Education|health education
127944|NCT02769975|Endocrinology|endocrinology
127945|NCT02769975|Obesity|obesity
127946|NCT02769975|Pediatric|pediatric
127947|NCT02769975|Growth Disorder|growth disorder
127948|NCT02769975|Pubertal Development|pubertal development
127949|NCT02769962|PARP Inhibitor|parp inhibitor
127950|NCT02769962|Topoisomerase I (Top1)|topoisomerase i (top1)
127951|NCT02769962|Camptothecins|camptothecins
127952|NCT02769962|Nanoparticle Drug Conjugate|nanoparticle drug conjugate
127953|NCT02769949|Genetics|genetics
127954|NCT02769949|Metabolic|metabolic
127955|NCT02769949|Dysmorphic Syndromes|dysmorphic syndromes
127956|NCT02769949|Developmental Delay|developmental delay
127957|NCT02769949|Genetic Counseling|genetic counseling
127958|NCT02769936|Receptors|receptors
127959|NCT02769936|N-Methyl-D-Aspartate|n-methyl-d-aspartate
127960|NCT02769923|WestPharma ID-adapter|westpharma id-adapter
127961|NCT02769923|Star ID syringe|star id syringe
127962|NCT02769923|BCG needle syringe|bcg needle syringe
127963|NCT02769923|fractional dose IPV|fractional dose ipv
127964|NCT02769923|fIPV|fipv
127965|NCT02769923|polio|polio
127966|NCT02769923|Polio Endgame|polio endgame
127967|NCT02769923|IPV|ipv
127968|NCT02769884|artificial pancreas|artificial pancreas
127969|NCT02769832|Abraxane|abraxane
127970|NCT02769832|Albumin-bound Paclitaxel|albumin-bound paclitaxel
127971|NCT02769832|SCLC|sclc
127972|NCT02769832|Gemzar|gemzar
127973|NCT02769819|Flexible fiberscope|flexible fiberscope
127974|NCT02769754|LIVER|liver
127975|NCT02769754|RESECTION|resection
127976|NCT02769754|SURGERY|surgery
127977|NCT02769741|Cashew|cashew
127978|NCT02769741|Lipoprotein|lipoprotein
127979|NCT02769715|Removable partial dentures|removable partial dentures
127980|NCT02769715|partial edentulism|partial edentulism
127981|NCT02769702|Uveitis|uveitis
127982|NCT02769689|Multiple sclerosis|multiple sclerosis
127983|NCT02769689|Natalizumab|natalizumab
127984|NCT02769689|Fingolimod|fingolimod
127985|NCT02769689|Methylprednisolone|methylprednisolone
127986|NCT02769650|Coronary stenosis|coronary stenosis
127987|NCT02769650|Drug-eluting stent|drug-eluting stent
127988|NCT02769650|Coronary angioplasty with stenting|coronary angioplasty with stenting
127989|NCT02769650|Ischemic Heart Disease|ischemic heart disease
127990|NCT02769650|Chronic total occlusion|chronic total occlusion
127991|NCT02769650|Right coronary artery|right coronary artery
127992|NCT02769650|Stress-MRI|stress-mri
127993|NCT02769637|upper gastrointestinal tract|upper gastrointestinal tract
127994|NCT02769637|lung microbiota and inflammation|lung microbiota and inflammation
127995|NCT02769624|Congenital heart disease|congenital heart disease
127996|NCT02769598|Pain|pain
127997|NCT02769598|Nociception|nociception
127998|NCT02769598|Pediatric intensive care|pediatric intensive care
127999|NCT02769598|Pain assessment scale|pain assessment scale
128000|NCT02769598|ANI index|ani index
128001|NCT02769585|Obesity|obesity
128002|NCT02769585|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
128003|NCT02769585|weight reduction|weight reduction
128004|NCT02769572|Knee osteoarthritis|knee osteoarthritis
128005|NCT02769572|moxibustion|moxibustion
128006|NCT02769572|diclofenac sodium gel|diclofenac sodium gel
128007|NCT02769520|squamous cell carcinoma head and neck|squamous cell carcinoma head and neck
128008|NCT02769520|pembrolizumab|pembrolizumab
128010|NCT02769494|Crohn's disease|crohn's disease
128011|NCT02769468|Temperature-Probe Placement-preterm infant-case room|temperature-probe placement-preterm infant-case room
128012|NCT02769455|Food Labelling|food labelling
128013|NCT02769442|Intravenous|intravenous
128014|NCT02769442|Catheter|catheter
128015|NCT02769442|Puncture|puncture
128016|NCT02769442|Peripheral Catheterization|peripheral catheterization
128017|NCT02769442|First Stick Success|first stick success
128018|NCT02769442|Contamination|contamination
128019|NCT02769442|Terumo|terumo
128020|NCT02769442|SurFlash|surflash
128021|NCT02769416|spinal cord injury|spinal cord injury
128022|NCT02769416|traumatic brain injury|traumatic brain injury
128023|NCT02769403|Job Satisfaction|job satisfaction
128024|NCT02769403|Job Performance|job performance
128025|NCT02769403|Primary Care|primary care
128026|NCT02769390|Analgesia|analgesia
128027|NCT02769390|Bupivacaine|bupivacaine
128028|NCT02769390|Clonidine|clonidine
128029|NCT02769377|diabetes, glucometer, mobile-phone|diabetes, glucometer, mobile-phone
128030|NCT02769364|Advanced or Metastatic Breast Cancer|advanced or metastatic breast cancer
128031|NCT02769364|Eribulin|eribulin
128032|NCT02769351|volume overload|volume overload
128033|NCT02769351|heart failure|heart failure
128034|NCT02769351|cardiac decompensation|cardiac decompensation
128035|NCT02769351|ultrafiltration|ultrafiltration
128036|NCT02769338|Implementation|implementation
128037|NCT02769338|Quality Improvement|quality improvement
128038|NCT02769338|Stroke|stroke
128039|NCT02769338|Transient Ischemic Attack|transient ischemic attack
128040|NCT02769338|TIA|tia
128041|NCT02769338|System Redesign|system redesign
128042|NCT02769338|QI Intervention|qi intervention
128043|NCT02769325|atropine|atropine
128044|NCT02769325|pain, postoperative|pain, postoperative
128045|NCT02769312|Quality of Life|quality of life
128046|NCT02769312|Post-Traumatic Stress Disorder|post-traumatic stress disorder
128047|NCT02769312|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
128048|NCT02769312|Feasibility studies|feasibility studies
128049|NCT02769260|pyrosequencing|pyrosequencing
128050|NCT02769260|16S DNA gene|16s dna gene
128051|NCT02769260|Confocal Laser Scanning Microscope|confocal laser scanning microscope
128052|NCT02769260|bacterial viability|bacterial viability
128053|NCT02769260|bacterial diversity|bacterial diversity
128054|NCT02769247|naproxen|naproxen
128055|NCT02769247|lidocaine|lidocaine
128056|NCT02769247|intrauterine device|intrauterine device
128057|NCT02769247|IUD|iud
128058|NCT02769247|pain|pain
128059|NCT02769234|EEG|eeg
128060|NCT02769234|ERP|erp
128061|NCT02769234|Event-related Potentials|event-related potentials
128062|NCT02769234|Alzheimer's|alzheimer's
128063|NCT02769234|P300|p300
128064|NCT02769208|Air Pollution|air pollution
128065|NCT02769208|Air Filtration|air filtration
128066|NCT02769208|Exposure Assessment|exposure assessment
128067|NCT02769208|HEPA Filter|hepa filter
128068|NCT02769208|Electrostatic Precipitator|electrostatic precipitator
128193|NCT02768389|Modified Atkins Diet|modified atkins diet
128069|NCT02769208|Cardiovascular Disease Biomarkers|cardiovascular disease biomarkers
128070|NCT02769208|Respiratory Disease Biomarkers|respiratory disease biomarkers
128071|NCT02769182|Older adults|older adults
128072|NCT02769182|falls|falls
128073|NCT02769182|cognition|cognition
128074|NCT02769182|smart phone|smart phone
128075|NCT02769169|Ranibizumab, regression of the polyps|ranibizumab, regression of the polyps
128076|NCT02769143|Postmenopausal|postmenopausal
128077|NCT02769143|Bone Density|bone density
128078|NCT02769143|Exercise|exercise
128079|NCT02769104|aromatase inhibitors|aromatase inhibitors
128080|NCT02769104|chemotherapy|chemotherapy
128081|NCT02769104|neoadjuvant|neoadjuvant
128082|NCT02769104|postmenopausal|postmenopausal
128083|NCT02769104|breast cancer|breast cancer
128084|NCT02769078|Anticoagulation|anticoagulation
128085|NCT02769065|Drug Therapy|drug therapy
128086|NCT02769052|endometriosis|endometriosis
128087|NCT02769052|dyspareunia|dyspareunia
128088|NCT02769052|physical therapy|physical therapy
128089|NCT02769052|sexuality|sexuality
128090|NCT02769052|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
128091|NCT02769013|Schistosoma haematobium plasmodium falciparum transmission|schistosoma haematobium plasmodium falciparum transmission
128092|NCT02768987|exercise|exercise
128093|NCT02768987|physical activity|physical activity
128094|NCT02768987|behavior modification|behavior modification
128095|NCT02768987|coping skills|coping skills
128096|NCT02768987|self management|self management
128097|NCT02768987|glycemic control|glycemic control
128098|NCT02768987|overweight|overweight
128099|NCT02768987|obesity|obesity
128100|NCT02768987|body composition|body composition
128101|NCT02768987|adherence|adherence
128102|NCT02768961|sofosbuvir|sofosbuvir
128103|NCT02768961|ledipasvir|ledipasvir
128104|NCT02768961|ribavirin|ribavirin
128105|NCT02768961|prisoner|prisoner
128106|NCT02768961|hepatitis c|hepatitis c
128107|NCT02768961|prevalence|prevalence
128108|NCT02768961|hepatitis b|hepatitis b
128109|NCT02768922|Telemedicine|telemedicine
128110|NCT02768922|Telerehabilitation|telerehabilitation
128111|NCT02768922|Speech and language therapy|speech and language therapy
128112|NCT02768883|Childhood asthma|childhood asthma
128113|NCT02768883|Latino|latino
128114|NCT02768844|Stochastic Resonance|stochastic resonance
128115|NCT02768844|Fetus/Newborn Infant|fetus/newborn infant
128116|NCT02768844|Drug Withdrawal|drug withdrawal
128117|NCT02768844|Substance Abuse|substance abuse
128118|NCT02768818|Maternal Obesity Complicating Pregnancy|maternal obesity complicating pregnancy
128119|NCT02768805|Influenza|influenza
128120|NCT02768805|Human|human
128121|NCT02768805|RNA Virus Infections|rna virus infections
128122|NCT02768805|Immunologic|immunologic
128123|NCT02768805|Immunogenic Factors|immunogenic factors
128124|NCT02768805|Physiological Effects of Drug|physiological effects of drug
128125|NCT02768805|Virus Diseases|virus diseases
128126|NCT02768805|Orthomyxoviridae Infections|orthomyxoviridae infections
128127|NCT02768805|Infection|infection
128128|NCT02768779|hair|hair
128129|NCT02768766|MEK inhibitor|mek inhibitor
128130|NCT02768766|Selumetinib|selumetinib
128131|NCT02768766|hyd-sulfate AZD6244|hyd-sulfate azd6244
128132|NCT02768766|Uveal melanoma|uveal melanoma
128133|NCT02768766|Melanoma|melanoma
128134|NCT02768753|Robotic thyroidectomy|robotic thyroidectomy
128135|NCT02768753|Robotic central neck dissection|robotic central neck dissection
128136|NCT02768753|Axillary bilateral-breast approach|axillary bilateral-breast approach
128137|NCT02768753|Bilateral axillo-breast approach|bilateral axillo-breast approach
128138|NCT02768727|neurocognitive function|neurocognitive function
128139|NCT02768727|neural inertia|neural inertia
128140|NCT02768727|xenon gas|xenon gas
128141|NCT02768714|Breast Cancer High risk Stage II or Stage III / IV|breast cancer high risk stage ii or stage iii / iv
128142|NCT02768701|Pembrolizumab|pembrolizumab
128143|NCT02768701|cyclophosphamide|cyclophosphamide
128144|NCT02768688|Human Brain|human brain
128145|NCT02768688|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
128146|NCT02768688|Dexmedetomidine|dexmedetomidine
128147|NCT02768688|Cerebral blood flow|cerebral blood flow
128148|NCT02768675|Kyphotic|kyphotic
128149|NCT02768675|Corrective Surgery|corrective surgery
128150|NCT02768675|Spinal fractures|spinal fractures
128151|NCT02768636|Omega-3, ANS, HRV, SDNN|omega-3, ans, hrv, sdnn
128152|NCT02768610|dexmedetomidine|dexmedetomidine
128153|NCT02768584|severe mental illness|severe mental illness
128154|NCT02768584|nursing|nursing
128155|NCT02768584|therapeutic alliance|therapeutic alliance
128156|NCT02768584|psychiatric diseases|psychiatric diseases
128157|NCT02768571|cerebrolysin, stroke, motor function|cerebrolysin, stroke, motor function
128158|NCT02768558|Lung Cancer|lung cancer
128159|NCT02768558|NSCLC|nsclc
128160|NCT02768558|Nivolumab|nivolumab
128161|NCT02768545|Hepatitis C|hepatitis c
128162|NCT02768545|Ezetimibe|ezetimibe
128163|NCT02768545|Cholesterol|cholesterol
128164|NCT02768545|Enterohepatic Circulation|enterohepatic circulation
128165|NCT02768545|Bile|bile
128166|NCT02768545|Feces|feces
128167|NCT02768532|Crohn's disease|crohn's disease
128168|NCT02768532|Vedolizumab|vedolizumab
128169|NCT02768532|TNF (Tumor Necrosis Factor)|tnf (tumor necrosis factor)
128170|NCT02768532|Clinical response|clinical response
128171|NCT02768532|Clinical remission|clinical remission
128172|NCT02768519|Participants|participants
128173|NCT02768506|obesity, malabsorption, gastric bypass, SADI-S|obesity, malabsorption, gastric bypass, sadi-s
128174|NCT02768480|Diabetes|diabetes
128175|NCT02768480|phone calls|phone calls
128176|NCT02768480|glycemic control|glycemic control
128177|NCT02768467|Alloderm graft|alloderm graft
128178|NCT02768467|Allograft|allograft
128179|NCT02768467|Buccal Mucosa|buccal mucosa
128180|NCT02768454|broad-spectrum antimicrobial|broad-spectrum antimicrobial
128181|NCT02768454|antibiotics pharmacist|antibiotics pharmacist
128182|NCT02768428|Knowledge [K01.468]|knowledge [k01.468]
128183|NCT02768428|Video-Audio Media [V01.255.500]|video-audio media [v01.255.500]
128184|NCT02768428|Handbooks [V02.520]|handbooks [v02.520]
128185|NCT02768402|Mitral Valve Regurgitation|mitral valve regurgitation
128186|NCT02768402|Primary MR|primary mr
128187|NCT02768402|Secondary MR|secondary mr
128188|NCT02768402|MR|mr
128189|NCT02768402|Heart Failure|heart failure
128190|NCT02768402|Structural Heart|structural heart
128191|NCT02768402|Secondary Mitral Valve Regurgitation|secondary mitral valve regurgitation
128192|NCT02768402|Primary Mitral Valve Regurgitation|primary mitral valve regurgitation
128194|NCT02768389|MAD|mad
128195|NCT02768389|Brain Tumor|brain tumor
128196|NCT02768389|Glioblastoma|glioblastoma
128197|NCT02768363|Immunotherapy|immunotherapy
128198|NCT02768363|Tumor vaccine|tumor vaccine
128199|NCT02768363|Immuno-oncology|immuno-oncology
128200|NCT02768363|Cytotoxicity|cytotoxicity
128201|NCT02768363|Prostate cancer|prostate cancer
128202|NCT02768363|Active Surveillance|active surveillance
128203|NCT02768350|lung collapse|lung collapse
128204|NCT02768350|ventilator hyper inflation|ventilator hyper inflation
128205|NCT02768350|hemodynamic responses|hemodynamic responses
128206|NCT02768350|ventilatory responses|ventilatory responses
128207|NCT02768350|trauma patients|trauma patients
128208|NCT02768337|brain metastasis|brain metastasis
129002|NCT02763254|DLBCL|dlbcl
128209|NCT02768337|operable brain metastasis|operable brain metastasis
128210|NCT02768324|sepsis|sepsis
128211|NCT02768324|Gastrointestinal Microbiome|gastrointestinal microbiome
128212|NCT02768324|Gut microbiota|gut microbiota
128213|NCT02768324|Gut Flora|gut flora
128214|NCT02768324|Intestinal Flora|intestinal flora
128215|NCT02768311|Instrumentation Post-operative pain Root canal preparation|instrumentation post-operative pain root canal preparation
128216|NCT02768298|Heart failure|heart failure
128217|NCT02768298|systolic heart failure|systolic heart failure
128218|NCT02768298|heart failure with reduced ejection fraction|heart failure with reduced ejection fraction
128219|NCT02768298|exercise capacity|exercise capacity
128220|NCT02768285|apical patency|apical patency
128221|NCT02768285|root canal treatment|root canal treatment
128222|NCT02768233|Medication-overuse Headache|medication-overuse headache
128223|NCT02768233|Educational Programme|educational programme
128224|NCT02768233|Personality Profiles|personality profiles
128225|NCT02768181|nutrition-specific behaviour change communication|nutrition-specific behaviour change communication
128226|NCT02768181|dietary supplements|dietary supplements
128227|NCT02768168|Dezocine|dezocine
128228|NCT02768168|Dexamethasone 21-phosphate|dexamethasone 21-phosphate
128229|NCT02768168|Pain|pain
128230|NCT02768168|Pruritus|pruritus
128231|NCT02768155|OA, Osteoarthritis, Knee|oa, osteoarthritis, knee
128232|NCT02768116|Active Transfer of Plaque|active transfer of plaque
128233|NCT02768103|upper extremity|upper extremity
128234|NCT02768103|spinal cord injury|spinal cord injury
128235|NCT02768103|surgical reconstruction|surgical reconstruction
128236|NCT02768103|MRI, functional|mri, functional
128237|NCT02768103|rehabilitation|rehabilitation
128238|NCT02768077|melatonin|melatonin
128239|NCT02768077|sleep disturbances|sleep disturbances
128240|NCT02768025|smoking cessation|smoking cessation
128241|NCT02768025|tobacco control|tobacco control
128242|NCT02768025|acupuncture|acupuncture
128243|NCT02768025|Korean Medicine|korean medicine
128244|NCT02768025|Traditional & Complementary Medicine|traditional & complementary medicine
128245|NCT02767999|Acute ischemic stroke|acute ischemic stroke
128246|NCT02767986|Hispanic|hispanic
128247|NCT02767986|Health Belief Model|health belief model
128248|NCT02767986|Cultural Consensus Theory|cultural consensus theory
128249|NCT02767986|Cancer Genetics|cancer genetics
128250|NCT02767986|Qualitative|qualitative
128251|NCT02767960|Tenascin-C|tenascin-c
128252|NCT02767908|Tobacco|tobacco
128253|NCT02767908|Smoking Cessation|smoking cessation
128254|NCT02767869|Metabolic syndrome|metabolic syndrome
128255|NCT02767869|central obesity|central obesity
128256|NCT02767869|Banaba|banaba
128257|NCT02767869|insulin secretion|insulin secretion
128258|NCT02767869|insulin sensitivity|insulin sensitivity
128259|NCT02767804|ALK-positive NSCLC|alk-positive nsclc
128260|NCT02767778|Acute ischemic stroke|acute ischemic stroke
128261|NCT02767778|Neuroprotection|neuroprotection
128262|NCT02767778|Extremely low frequency magnetic fields|extremely low frequency magnetic fields
128263|NCT02767752|Resectable pancreatic cancer|resectable pancreatic cancer
128264|NCT02767752|Adjuvant|adjuvant
128265|NCT02767713|Cognition Disorders|cognition disorders
128266|NCT02767713|Cardiac Surgical Procedures|cardiac surgical procedures
128267|NCT02767713|dexamethasone|dexamethasone
128268|NCT02767687|Postoperative Care|postoperative care
128269|NCT02767687|Postoperative Period|postoperative period
128270|NCT02767687|Heart Surgery|heart surgery
128271|NCT02767674|R-Gemox|r-gemox
128272|NCT02767674|R-miniCHOP|r-minichop
128273|NCT02767674|elderly patients with diffuse large B cell lymphoma|elderly patients with diffuse large b cell lymphoma
128274|NCT02767661|metronomic capecitabine|metronomic capecitabine
128275|NCT02767661|aromatase inhibitor|aromatase inhibitor
128276|NCT02767661|first line treatment|first line treatment
128277|NCT02767661|metastatic breast cancer|metastatic breast cancer
128278|NCT02767648|cholestasis|cholestasis
128279|NCT02767648|neonatal|neonatal
128280|NCT02767648|infant|infant
128281|NCT02767596|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
128282|NCT02767596|treatment|treatment
128283|NCT02767596|GLP-1|glp-1
128284|NCT02767583|Neuropathology|neuropathology
128285|NCT02767570|Osteoarthritis, Knee|osteoarthritis, knee
128286|NCT02767570|Arthritis|arthritis
128287|NCT02767570|Joint Diseases|joint diseases
128288|NCT02767570|Musculoskeletal Diseases|musculoskeletal diseases
128289|NCT02767570|Rheumatic Diseases|rheumatic diseases
128290|NCT02767544|laparoscopic hysterectomy|laparoscopic hysterectomy
128291|NCT02767544|postoperative pain|postoperative pain
128292|NCT02767544|local analgesia|local analgesia
128293|NCT02767544|vaginal wound|vaginal wound
128294|NCT02767479|eradication rates|eradication rates
128295|NCT02767479|rabeprazole|rabeprazole
128296|NCT02767479|esomeprazole|esomeprazole
128297|NCT02767453|Shoulder arthroplasty|shoulder arthroplasty
128298|NCT02767453|Closed suction drainage|closed suction drainage
128299|NCT02767453|Glenohumeral|glenohumeral
128300|NCT02767453|Drainage tube|drainage tube
128301|NCT02767427|Infection Control|infection control
128302|NCT02767427|Preoperative Care|preoperative care
128303|NCT02767427|Chlorhexidine|chlorhexidine
128304|NCT02767427|Pre-Surgical Wash|pre-surgical wash
128305|NCT02767427|Spine Surgery|spine surgery
128306|NCT02767427|Surgical site infections|surgical site infections
128307|NCT02767427|Cutaneous bacterial load on skin|cutaneous bacterial load on skin
128308|NCT02767401|PET-CT|pet-ct
128309|NCT02767401|Cardiac magnetic resonance (CMR) imaging|cardiac magnetic resonance (cmr) imaging
128310|NCT02767401|Major adverse cardiac events (MACEs)|major adverse cardiac events (maces)
128311|NCT02767401|coronary artery disease|coronary artery disease
128312|NCT02767375|Hepatocellular Carcinoma|hepatocellular carcinoma
128313|NCT02767375|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
128314|NCT02767362|atorvastatin|atorvastatin
128315|NCT02767362|endometrium|endometrium
128316|NCT02767362|endometrial cancer|endometrial cancer
128317|NCT02767310|Bioequivalence|bioequivalence
128318|NCT02767310|two rosuvastatin-containing products|two rosuvastatin-containing products
128319|NCT02767284|Contrast Sensitivity|contrast sensitivity
128320|NCT02767284|Diagnostic Techniques, Ophthalmological|diagnostic techniques, ophthalmological
128321|NCT02767258|Dry eye|dry eye
128322|NCT02767258|Diseases of the eye and adnexa|diseases of the eye and adnexa
128323|NCT02767245|Thiamine|thiamine
128324|NCT02767245|Congestive heart failure|congestive heart failure
128325|NCT02767245|Atrial fibrillation|atrial fibrillation
128326|NCT02767245|Graves' disease|graves' disease
128327|NCT02767232|PHLO|phlo
128328|NCT02767232|deep vein thrombosis|deep vein thrombosis
128329|NCT02767232|deep venous thrombosis|deep venous thrombosis
128330|NCT02767232|blood clot|blood clot
128331|NCT02767232|catheter-directed thrombolysis|catheter-directed thrombolysis
128332|NCT02767232|thrombolysis|thrombolysis
128333|NCT02767232|post-thrombotic syndrome|post-thrombotic syndrome
128334|NCT02767232|PTS|pts
128335|NCT02767232|recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
128336|NCT02767232|rt-PA|rt-pa
128337|NCT02767232|Activase|activase
128338|NCT02767232|Alteplase|alteplase
128339|NCT02767219|Ophthalmology|ophthalmology
128340|NCT02767206|Transnasal endoscopy|transnasal endoscopy
128341|NCT02767206|ultrathin endoscopes|ultrathin endoscopes
128342|NCT02767206|esophageal varices|esophageal varices
128343|NCT02767206|gastric varices|gastric varices
128344|NCT02767167|Cow's milk|cow's milk
128345|NCT02767167|Iodine|iodine
128346|NCT02767167|Selenium|selenium
128347|NCT02767167|Women|women
128348|NCT02767167|Child-bearing age|child-bearing age
128349|NCT02767154|extracorporeal circulation|extracorporeal circulation
128350|NCT02767141|Hunger|hunger
128351|NCT02767141|food insecurity|food insecurity
128352|NCT02767141|behaviors|behaviors
128353|NCT02767128|pharmacokinetics|pharmacokinetics
128354|NCT02767128|healthy adult volunteer|healthy adult volunteer
128355|NCT02767102|Mediterranean diet|mediterranean diet
128356|NCT02767102|indoleamine|indoleamine
128357|NCT02767102|nutraceuticals|nutraceuticals
128358|NCT02767102|nutrition|nutrition
128359|NCT02767102|oxidative stress|oxidative stress
128360|NCT02767089|Glucocorticoids, Biomarkers, Dissociated Agonist of the Glucocorticoid Receptor|glucocorticoids, biomarkers, dissociated agonist of the glucocorticoid receptor
128361|NCT02767076|paramedian spinal anesthesia|paramedian spinal anesthesia
128362|NCT02767076|real time|real time
128363|NCT02767076|ultrasound|ultrasound
128364|NCT02767076|knee surgeries|knee surgeries
128365|NCT02767076|conventional|conventional
128366|NCT02767050|DENTAL CARIES|dental caries
128367|NCT02767050|TOBACCO USERS|tobacco users
128368|NCT02767050|SMOKERS|smokers
128369|NCT02767050|SMOKELESS TOBACCO CHEWERS|smokeless tobacco chewers
128370|NCT02767011|surgical site infection|surgical site infection
128371|NCT02766985|FSHD|fshd
128372|NCT02766985|muscular dystrophy|muscular dystrophy
128373|NCT02766972|Intracranial Aneurysm|intracranial aneurysm
128374|NCT02766972|Surgical Clipping|surgical clipping
128375|NCT02766972|Rapid Ventricular Pacing|rapid ventricular pacing
128376|NCT02766959|chronic rhinosinusitis|chronic rhinosinusitis
128377|NCT02766959|airway physiology|airway physiology
128378|NCT02766959|taste receptors|taste receptors
128379|NCT02766959|tas2r|tas2r
128380|NCT02766959|epithelial biology|epithelial biology
128381|NCT02766959|upper respiratory disease|upper respiratory disease
128382|NCT02766946|Mechanical Ventilation|mechanical ventilation
128383|NCT02766933|tenofovir|tenofovir
128384|NCT02766933|hepatocellular carcinoma|hepatocellular carcinoma
128385|NCT02766933|cirrhosis|cirrhosis
128386|NCT02766881|Ductal Carcinoma in Situ|ductal carcinoma in situ
128387|NCT02766881|DSC|dsc
128388|NCT02766881|Breast Conserving Surgery|breast conserving surgery
128389|NCT02766855|cysteamine|cysteamine
128390|NCT02766855|nephropathic cystinosis|nephropathic cystinosis
128391|NCT02766855|cystine crystals|cystine crystals
128392|NCT02766842|SharkCore|sharkcore
128393|NCT02766842|ProCore|procore
128394|NCT02766829|spinal|spinal
128395|NCT02766829|anesthesia|anesthesia
128396|NCT02766829|sitting|sitting
128397|NCT02766829|cross leg|cross leg
128398|NCT02766829|spinal-bone contact|spinal-bone contact
128399|NCT02766738|residential aged care|residential aged care
128400|NCT02766738|mobility|mobility
128401|NCT02766738|social participation|social participation
128402|NCT02766738|functional capability|functional capability
128403|NCT02766712|catheter ablation|catheter ablation
128404|NCT02766712|atrial fibrillation|atrial fibrillation
128405|NCT02766699|Astrocytoma, Grade IV|astrocytoma, grade iv
128406|NCT02766699|Doxorubicin|doxorubicin
128407|NCT02766699|Glioblastoma|glioblastoma
128408|NCT02766699|Neoplasms|neoplasms
128409|NCT02766699|Neoplasms by Site|neoplasms by site
128410|NCT02766699|Antineoplastic Agents|antineoplastic agents
128411|NCT02766699|Drug Delivery Systems|drug delivery systems
128412|NCT02766699|Molecular Targeted Therapy|molecular targeted therapy
128413|NCT02766699|Nanoparticles|nanoparticles
128414|NCT02766699|Disease Progression|disease progression
128415|NCT02766699|Recurrence|recurrence
128416|NCT02766699|Brain Neoplasms|brain neoplasms
128417|NCT02766699|Immunotherapy|immunotherapy
128418|NCT02766699|Receptor, Epidermal Growth Factor|receptor, epidermal growth factor
128419|NCT02766699|Antibodies, Bispecific|antibodies, bispecific
128420|NCT02766686|Prostate cancer|prostate cancer
128421|NCT02766686|proton radiotherapy|proton radiotherapy
128422|NCT02766686|photon radiotherapy|photon radiotherapy
128423|NCT02766660|Thyroid ophthalmopathy|thyroid ophthalmopathy
128424|NCT02766660|optical coherence tomography|optical coherence tomography
128425|NCT02766647|Filgrastim|filgrastim
128426|NCT02766634|filgrastim|filgrastim
128427|NCT02766621|First in human, Phase 1, Healthy volunteers|first in human, phase 1, healthy volunteers
128428|NCT02766608|COPD|copd
128429|NCT02766582|Ovarian|ovarian
128430|NCT02766582|platinum|platinum
128431|NCT02766582|pembrolizumab|pembrolizumab
128432|NCT02766582|taxane|taxane
128433|NCT02766569|IRFACODE II, ASD closure, ASD device, erosion, arrhythmia|irfacode ii, asd closure, asd device, erosion, arrhythmia
128434|NCT02766543|prostate cancer|prostate cancer
128435|NCT02766543|high intensity transurethral ultrasound ablation|high intensity transurethral ultrasound ablation
128436|NCT02766543|MRI-guided|mri-guided
128437|NCT02766543|minimally invasive|minimally invasive
128438|NCT02766543|real-time temperature feedback control|real-time temperature feedback control
128439|NCT02766491|Stretching|stretching
128440|NCT02766465|Sickle Cell Disease|sickle cell disease
128441|NCT02766465|Young Adults|young adults
128442|NCT02766465|Phase II Trial|phase ii trial
128443|NCT02766465|Hematopoietic Cell Transplantation (HCT)|hematopoietic cell transplantation (hct)
128444|NCT02766465|Human Leukocyte Antigen (HLA)|human leukocyte antigen (hla)
128445|NCT02766400|Stroke|stroke
128446|NCT02766400|Rehabilitation|rehabilitation
128447|NCT02766400|Cognition|cognition
128448|NCT02766400|Disability|disability
128449|NCT02766400|Intervention|intervention
128450|NCT02766374|Asthma|asthma
128451|NCT02766374|Biofeedback|biofeedback
128452|NCT02766374|Heart rate variability biofeedback|heart rate variability biofeedback
128453|NCT02766374|Inhaled corticosteroids|inhaled corticosteroids
128454|NCT02766361|Bipolar disorder|bipolar disorder
128455|NCT02766361|Psychotherapy|psychotherapy
128456|NCT02766361|Cognitive rehabilitation|cognitive rehabilitation
128457|NCT02766348|DC-CTL, NSCLC|dc-ctl, nsclc
128458|NCT02766322|Alcohol metabolism|alcohol metabolism
128459|NCT02766322|Bariatric surgery|bariatric surgery
128460|NCT02766322|Effects of alcohol on driving|effects of alcohol on driving
128461|NCT02766309|Self-assessment of health, Sf12-v2|self-assessment of health, sf12-v2
128462|NCT02766296|PTSD|ptsd
128463|NCT02766296|trauma|trauma
128464|NCT02766296|working memory|working memory
128465|NCT02766296|working memory training|working memory training
128466|NCT02766283|Children|children
128467|NCT02766283|Iodinated contrast agents|iodinated contrast agents
128468|NCT02766270|Grade II/III Glioma|grade ii/iii glioma
128469|NCT02766270|IDH|idh
128470|NCT02766270|TERT|tert
128471|NCT02766270|Chemoradiotherapy|chemoradiotherapy
128472|NCT02766270|Temozolomide|temozolomide
128473|NCT02766218|toddler obesity|toddler obesity
128474|NCT02766218|responsive feeding|responsive feeding
128475|NCT02766218|behavioral weight control|behavioral weight control
128476|NCT02766218|pregnancy weight gain|pregnancy weight gain
128477|NCT02766218|early life risk factors|early life risk factors
128478|NCT02766205|Embolic Stroke of Undetermined Source|embolic stroke of undetermined source
128479|NCT02766205|Atrial fibrillation|atrial fibrillation
128480|NCT02766205|prognostic score|prognostic score
128481|NCT02766192|ketamine|ketamine
128482|NCT02766192|mindfulness based cognitive therapy|mindfulness based cognitive therapy
128483|NCT02766192|PTSD|ptsd
128484|NCT02766192|trauma memory|trauma memory
128485|NCT02766192|memory extinction|memory extinction
128486|NCT02766192|memory re-consolidation|memory re-consolidation
128487|NCT02766192|metabolomics|metabolomics
128488|NCT02766192|TIMBER (Trauma Intervention using Mindfulness Based Extinction and Re-consolidation of trauma memories)|timber (trauma intervention using mindfulness based extinction and re-consolidation of trauma memories)
128489|NCT02766127|radiotherapy|radiotherapy
128490|NCT02766114|CTS|cts
128491|NCT02766114|Carpal tunnel syndrome|carpal tunnel syndrome
128492|NCT02766114|Carpal tunnel release|carpal tunnel release
128493|NCT02766114|Mini incision of carpal tunnel release|mini incision of carpal tunnel release
128494|NCT02766114|Cosmetic surgery of carpal tunnel syndrome|cosmetic surgery of carpal tunnel syndrome
128495|NCT02766114|endoscopic carpal tunnel surgery|endoscopic carpal tunnel surgery
128496|NCT02766114|Carpal Tunnel Release Through Mini Transverse Approach|carpal tunnel release through mini transverse approach
128497|NCT02766114|Dr. Sayed Issa's Approach|dr. sayed issa's approach
128498|NCT02766114|CTRMTA|ctrmta
128499|NCT02766114|OCTR|octr
128500|NCT02766114|ECTR|ectr
128501|NCT02766114|Open Carpal Tunnel Release|open carpal tunnel release
128502|NCT02766114|Endoscopic Carpal Tunnel Release|endoscopic carpal tunnel release
128503|NCT02766114|Syria|syria
128504|NCT02766114|Cosmetic|cosmetic
128505|NCT02766114|Safety|safety
128506|NCT02766114|Rehabilitation,|rehabilitation,
128507|NCT02766114|Complications|complications
128508|NCT02766114|Surgery|surgery
128509|NCT02766114|Satisfaction|satisfaction
128510|NCT02766088|Dengue|dengue
128511|NCT02766088|Household|household
128512|NCT02766088|Southeast Asia|southeast asia
128513|NCT02766088|Latin America|latin america
128514|NCT02766088|Surveillance|surveillance
128515|NCT02766075|Transcatheter Aortic Valve Disease|transcatheter aortic valve disease
128516|NCT02766075|Supervised TAVR Exercise Program|supervised tavr exercise program
128517|NCT02766062|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
128518|NCT02766062|metabolic syndrome|metabolic syndrome
128519|NCT02766062|propofol|propofol
128520|NCT02766062|sevoflurane|sevoflurane
128521|NCT02766049|HIV|hiv
128522|NCT02766049|immunotherapy|immunotherapy
128523|NCT02766049|clinical trial|clinical trial
128524|NCT02766049|dendritic cell|dendritic cell
128525|NCT02766036|Proteinuria|proteinuria
128526|NCT02766036|Propolis|propolis
128527|NCT02766036|Chronic Kidney Disease|chronic kidney disease
128528|NCT02766023|CTV-05|ctv-05
128529|NCT02766023|LACTIN-V|lactin-v
128530|NCT02766023|Lactobacillus|lactobacillus
128531|NCT02766023|MetroGel®|metrogel®
128532|NCT02766023|Vaginitis|vaginitis
128533|NCT02765997|AML|aml
128534|NCT02765997|ALL|all
128535|NCT02765997|MDS|mds
128536|NCT02765984|implantation site|implantation site
128537|NCT02765984|placental site|placental site
128538|NCT02765984|Doppler|doppler
128539|NCT02765971|chewing gums|chewing gums
128540|NCT02765971|laxatives|laxatives
128541|NCT02765971|bowel function|bowel function
128542|NCT02765945|Exercise|exercise
128543|NCT02765945|Osteoporosis|osteoporosis
128544|NCT02765945|Cytokines|cytokines
128545|NCT02765932|Hip|hip
128546|NCT02765932|Knee|knee
128547|NCT02765932|replacement|replacement
128548|NCT02765932|surgery|surgery
128549|NCT02765919|Carcinoma cervix|carcinoma cervix
128550|NCT02765919|RCT(randomised controlled trial)|rct(randomised controlled trial)
128551|NCT02765919|9 Gray|9 gray
128552|NCT02765919|Brachytherapy|brachytherapy
128553|NCT02765906|video|video
128554|NCT02765906|educational tool|educational tool
128555|NCT02765906|preeclampsia|preeclampsia
128556|NCT02765906|hypertension|hypertension
128557|NCT02765906|pregnancy|pregnancy
128558|NCT02765906|patient education|patient education
128559|NCT02765906|graphic card|graphic card
128560|NCT02765906|eclampsia|eclampsia
128561|NCT02765906|HELLP|hellp
128562|NCT02765906|anxiety|anxiety
128563|NCT02765906|anxiety assessment|anxiety assessment
128564|NCT02765906|STAI 6|stai 6
128565|NCT02765841|HoFH|hofh
128566|NCT02765815|TKA|tka
128567|NCT02765815|Knee replacement|knee replacement
128568|NCT02765815|Arthritis|arthritis
128569|NCT02765815|Knee|knee
128570|NCT02765776|Anti-HIV Drugs|anti-hiv drugs
128571|NCT02765776|Raltegravir Potassium|raltegravir potassium
128572|NCT02765776|Aged|aged
128573|NCT02765776|Retrospective Study|retrospective study
128574|NCT02765776|Medical Records|medical records
128575|NCT02765750|Emergence agitation|emergence agitation
128576|NCT02765711|ticagrelor|ticagrelor
128577|NCT02765711|acute coronary syndrome|acute coronary syndrome
128578|NCT02765698|Magnetic Resonance Imaging|magnetic resonance imaging
128579|NCT02765672|Combat Veterans|combat veterans
128580|NCT02765672|Automobile Driving|automobile driving
128581|NCT02765672|Fitness to Drive|fitness to drive
128582|NCT02765659|HIV|hiv
128583|NCT02765659|Prevention|prevention
128584|NCT02765659|Implementation|implementation
128585|NCT02765659|Community based participatory research|community based participatory research
128586|NCT02765620|Positron-Emission Tomography|positron-emission tomography
128587|NCT02765620|Response Criteria|response criteria
128588|NCT02765620|solid tumor|solid tumor
128589|NCT02765607|Blood circulation|blood circulation
128590|NCT02765607|Cardiac surgical procedures|cardiac surgical procedures
128591|NCT02765607|Homeostasis|homeostasis
128592|NCT02765594|Glomerulonephritis, IGA|glomerulonephritis, iga
128593|NCT02765594|Kidney Diseases|kidney diseases
128594|NCT02765594|Autoimmune Diseases|autoimmune diseases
128595|NCT02765594|Glomerulonephritis|glomerulonephritis
128596|NCT02765594|Nephritis|nephritis
128597|NCT02765594|Immune System Diseases|immune system diseases
128598|NCT02765594|Urologic Diseases|urologic diseases
128599|NCT02765594|Hydroxychloroquine|hydroxychloroquine
128600|NCT02765594|Anti-Infective Agents|anti-infective agents
128601|NCT02765594|Antimalarials|antimalarials
128602|NCT02765594|Antiparasitic Agents|antiparasitic agents
128603|NCT02765594|Antiprotozoal Agents|antiprotozoal agents
128604|NCT02765594|Antirheumatic Agents|antirheumatic agents
128605|NCT02765594|Enzyme Inhibitors|enzyme inhibitors
128606|NCT02765594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
128607|NCT02765594|Pharmacologic Actions|pharmacologic actions
128608|NCT02765594|Therapeutic Uses|therapeutic uses
128609|NCT02765594|interleukin-6|interleukin-6
128610|NCT02765594|interferon-alpha|interferon-alpha
128611|NCT02765594|tumor necrosis factor-alpha|tumor necrosis factor-alpha
128612|NCT02765581|Acupuncture|acupuncture
128613|NCT02765581|Migraine|migraine
128614|NCT02765581|Randomized Controlled Trial|randomized controlled trial
128615|NCT02765581|Placebo Effect|placebo effect
128616|NCT02765568|Coronary Artery Disease|coronary artery disease
128617|NCT02765568|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
128618|NCT02765542|Depression|depression
128619|NCT02765542|mHealth|mhealth
128620|NCT02765542|Interactive Voice Response|interactive voice response
128621|NCT02765542|Bolivia|bolivia
128622|NCT02765542|Mental health|mental health
128623|NCT02765529|Environmental Pollution|environmental pollution
128624|NCT02765529|Fine particles|fine particles
128625|NCT02765529|Biomarkers|biomarkers
128626|NCT02765529|Elderly|elderly
128627|NCT02765490|Hepatitis C, Chronic|hepatitis c, chronic
128628|NCT02765490|AL-335|al-335
128629|NCT02765490|Odalasvir|odalasvir
128630|NCT02765490|Simeprevir|simeprevir
128631|NCT02765490|ODV|odv
128632|NCT02765490|SMV|smv
128633|NCT02765490|ACH-3102|ach-3102
128634|NCT02765490|ACH-0143102|ach-0143102
128635|NCT02765490|TMC435|tmc435
128636|NCT02765477|Acute myocardial infarction|acute myocardial infarction
128637|NCT02765477|ST Elevation Myocardial Infarction|st elevation myocardial infarction
128638|NCT02765477|Acute Coronary Occlusion|acute coronary occlusion
128639|NCT02765477|Electrocardiogram|electrocardiogram
128640|NCT02765477|Ventricular Paced Rhythm|ventricular paced rhythm
128641|NCT02765477|Modified Sgarbossa Criteria|modified sgarbossa criteria
128642|NCT02765451|non-academic|non-academic
128643|NCT02765451|health institution|health institution
128644|NCT02765451|development|development
128645|NCT02765451|clinical research|clinical research
128646|NCT02765451|cancer|cancer
128647|NCT02765451|private hospital|private hospital
128648|NCT02765451|public hospital|public hospital
128649|NCT02765451|northwestern france|northwestern france
128650|NCT02765451|france|france
128651|NCT02765451|hospitals|hospitals
128652|NCT02765412|decision support|decision support
128653|NCT02765412|patient preferences|patient preferences
128654|NCT02765412|risk adjustment|risk adjustment
128655|NCT02765386|Cochlear implants|cochlear implants
128656|NCT02765386|Hybrid fittings|hybrid fittings
128657|NCT02765386|Cross-over frequency|cross-over frequency
128658|NCT02765373|aromatase inhibitors|aromatase inhibitors
128659|NCT02765373|lipid levels|lipid levels
128660|NCT02765360|EIT|eit
128661|NCT02765360|NIV|niv
128662|NCT02765308|Uveitis|uveitis
128663|NCT02765308|Glaucoma|glaucoma
128664|NCT02765308|Aqueous humor dynamics|aqueous humor dynamics
128665|NCT02765295|Hydrogen|hydrogen
128666|NCT02765295|Inhalation|inhalation
128667|NCT02765295|bronchiectasis|bronchiectasis
128668|NCT02765282|Deep brain stimulation (DBS)|deep brain stimulation (dbs)
128669|NCT02765282|Kinesia|kinesia
128670|NCT02765269|cancer pain|cancer pain
128671|NCT02765269|mobile applications|mobile applications
128672|NCT02765243|neuroblastoma|neuroblastoma
128673|NCT02765243|GD2|gd2
128674|NCT02765243|Chimeric antigen receptor|chimeric antigen receptor
128675|NCT02765243|Immunotherapy|immunotherapy
128676|NCT02765243|Cyclophosphamide|cyclophosphamide
128677|NCT02765243|Fludarabine|fludarabine
128678|NCT02765217|Antibiotic associated diarrhea|antibiotic associated diarrhea
128679|NCT02765217|Children|children
128680|NCT02765217|Prevention|prevention
128681|NCT02765217|Lactobacillus reuteri DSM 17938|lactobacillus reuteri dsm 17938
128682|NCT02765217|Probiotic|probiotic
128683|NCT02765191|Magnetic Resonance Imaging|magnetic resonance imaging
128684|NCT02765191|Norepinephrine|norepinephrine
128685|NCT02765191|Fluid Therapy|fluid therapy
128686|NCT02765191|Renal Circulation|renal circulation
128687|NCT02765165|Phase 1|phase 1
128688|NCT02765165|Phase 2|phase 2
128689|NCT02765165|Glioblastoma Multiforme|glioblastoma multiforme
128690|NCT02765165|Glioblastoma|glioblastoma
128691|NCT02765165|GBM|gbm
128692|NCT02765165|Brain Tumor|brain tumor
128693|NCT02765165|Brain Cancer|brain cancer
128694|NCT02765165|Tumor|tumor
128695|NCT02765165|Solid Tumor|solid tumor
128696|NCT02765165|Tumour|tumour
128697|NCT02765165|Lomustine|lomustine
128698|NCT02765165|CCNU|ccnu
128699|NCT02765165|CXCR4|cxcr4
128700|NCT02765165|Phase 1 Clinical Trial|phase 1 clinical trial
128701|NCT02765165|Phase 2 Clinical Trial|phase 2 clinical trial
128702|NCT02765152|exercise|exercise
128703|NCT02765152|rhythmic movement|rhythmic movement
128704|NCT02765152|discrete movement|discrete movement
128705|NCT02765100|Bipolar Disorder|bipolar disorder
128706|NCT02765100|Obesity|obesity
128707|NCT02765100|Depression|depression
128708|NCT02765074|subcutaneous tocilizumab|subcutaneous tocilizumab
128709|NCT02765074|High Resolution peripheral QCT (HR-pQCT)|high resolution peripheral qct (hr-pqct)
128710|NCT02765074|bone erosion|bone erosion
128711|NCT02765074|bone microarchitecture|bone microarchitecture
128712|NCT02765074|rheumatoid arthritis|rheumatoid arthritis
128713|NCT02765048|Adolescent girls|adolescent girls
128714|NCT02765048|Child welfare|child welfare
128715|NCT02765048|Trauma treatment|trauma treatment
128716|NCT02765048|PTSD|ptsd
128717|NCT02765048|Depression|depression
128718|NCT02765048|Social problem-solving|social problem-solving
128719|NCT02765009|Fluid overload|fluid overload
128720|NCT02765009|Multiple organ failure|multiple organ failure
128721|NCT02765009|Diuretics|diuretics
128722|NCT02765009|Fluid restriction|fluid restriction
128723|NCT02765009|Body weight|body weight
128724|NCT02764983|Combat Veterans|combat veterans
128725|NCT02764983|Automobile Driving|automobile driving
128726|NCT02764983|Fitness to Drive|fitness to drive
128727|NCT02764905|Diabetes|diabetes
128728|NCT02764905|Cognitive-physical rehabilitation|cognitive-physical rehabilitation
128729|NCT02764905|Self care management|self care management
128730|NCT02764879|Omega 3 fatty acids|omega 3 fatty acids
128731|NCT02764879|Root planning|root planning
128732|NCT02764879|chronic periodontitis|chronic periodontitis
128733|NCT02764866|Lung cancer|lung cancer
128734|NCT02764866|Sleep apnea|sleep apnea
128735|NCT02764866|Sleep disordered breathing|sleep disordered breathing
128736|NCT02764853|HIV|hiv
128737|NCT02764853|Black|black
128738|NCT02764853|African American|african american
128739|NCT02764853|Women|women
128740|NCT02764853|Cognitive Behavioral Therapy|cognitive behavioral therapy
128741|NCT02764853|Racism|racism
128742|NCT02764853|Stigma|stigma
128743|NCT02764853|Discrimination|discrimination
128744|NCT02764853|Gender related stressors|gender related stressors
128745|NCT02764853|Resilience|resilience
128746|NCT02764853|Behavioral Medicine|behavioral medicine
128747|NCT02764827|skin prick test|skin prick test
128748|NCT02764827|grass and weed pollens|grass and weed pollens
128749|NCT02764788|Auriculotherapy|auriculotherapy
128750|NCT02764762|Drug Therapy|drug therapy
128751|NCT02764749|vascular function|vascular function
128752|NCT02764749|endothelial function|endothelial function
128753|NCT02764749|polyphenols|polyphenols
128754|NCT02764697|Glaucoma associated with uveitis|glaucoma associated with uveitis
128755|NCT02764671|recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
128756|NCT02764671|safety|safety
128757|NCT02764671|immunogenicity|immunogenicity
128758|NCT02764645|Cardiopulmonary Bypass|cardiopulmonary bypass
128759|NCT02764619|Upstream therapy, spironolactone|upstream therapy, spironolactone
128760|NCT02764619|Atrial remodelling|atrial remodelling
128761|NCT02764619|Modified look-locker inversion recover (MOLLI) sequences|modified look-locker inversion recover (molli) sequences
128762|NCT02764619|T1 mapping|t1 mapping
128763|NCT02764619|Diffuse myocardial fibrosis|diffuse myocardial fibrosis
128764|NCT02764606|Lung Cancer|lung cancer
128765|NCT02764606|Biomarkers|biomarkers
128766|NCT02764606|Bone|bone
128767|NCT02764606|Metastases|metastases
128768|NCT02764593|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
128769|NCT02764593|HNSCC|hnscc
128770|NCT02764593|Nivolumab|nivolumab
128771|NCT02764554|Post-Marketing Surveillance|post-marketing surveillance
128772|NCT02764554|Lenvima|lenvima
128773|NCT02764554|Lenvatinib|lenvatinib
128774|NCT02764554|E7080|e7080
128775|NCT02764554|Differentiated thyroid carcinoma|differentiated thyroid carcinoma
128776|NCT02764554|Refractory to radioactive iodine|refractory to radioactive iodine
128777|NCT02764554|Progressive|progressive
128778|NCT02764554|locally recurrent|locally recurrent
128779|NCT02764554|metastatic|metastatic
128780|NCT02764541|Breast Cancer|breast cancer
128781|NCT02764541|Invasive Lobular Carcinoma|invasive lobular carcinoma
128782|NCT02764528|Hygiene|hygiene
128783|NCT02764515|Kunxian Capsule|kunxian capsule
128784|NCT02764515|efficacy|efficacy
128785|NCT02764515|rheumatoid arthritis|rheumatoid arthritis
128786|NCT02764515|Methotrexate|methotrexate
128787|NCT02764502|Epidural Identification pressure gauge|epidural identification pressure gauge
128788|NCT02764476|psychogenic|psychogenic
128789|NCT02764476|non-epileptic seizures|non-epileptic seizures
128790|NCT02764476|functional neurological symptom disorder|functional neurological symptom disorder
128791|NCT02764476|PNES|pnes
128792|NCT02764476|PMD|pmd
128793|NCT02764476|virtual reality|virtual reality
128794|NCT02764476|3D augmented reality|3d augmented reality
128795|NCT02764476|mirror therapy|mirror therapy
128796|NCT02764463|Fiber Reinforced Composites|fiber reinforced composites
128797|NCT02764463|Resin cements|resin cements
128798|NCT02764463|Survival|survival
128799|NCT02764450|composite|composite
128800|NCT02764450|restoration|restoration
128801|NCT02764450|polymerization|polymerization
128802|NCT02764424|Newborn|newborn
128803|NCT02764424|Heart Rate Variability (HRV)|heart rate variability (hrv)
128804|NCT02764424|Analgesic Nociception Index (ANI)|analgesic nociception index (ani)
128805|NCT02764424|Autonomous Nervous System (ANS)|autonomous nervous system (ans)
128806|NCT02764411|Capillary malformations|capillary malformations
128807|NCT02764411|Onrealtea|onrealtea
128808|NCT02764411|port-wine stain|port-wine stain
128809|NCT02764411|treatment|treatment
128810|NCT02764411|topical|topical
128811|NCT02764372|Arm rehabilitation|arm rehabilitation
128812|NCT02764372|Serious games|serious games
128813|NCT02764372|stroke|stroke
128814|NCT02764372|Multiple sclerosis|multiple sclerosis
128815|NCT02764346|Arthritis|arthritis
128816|NCT02764346|Self-management|self-management
128817|NCT02764346|Pain|pain
128818|NCT02764333|TPIV200/huFR-1|tpiv200/hufr-1
128819|NCT02764333|Anti-PD-L1|anti-pd-l1
128820|NCT02764333|vaccine|vaccine
128821|NCT02764333|16-011|16-011
128822|NCT02764294|anxiety|anxiety
128823|NCT02764294|pain|pain
128824|NCT02764294|satisfaction|satisfaction
128825|NCT02764294|cystoscopy|cystoscopy
128826|NCT02764294|music|music
128827|NCT02764294|video|video
128828|NCT02764294|stress ball|stress ball
128829|NCT02764294|nursing|nursing
128830|NCT02764268|Gastric Cancer|gastric cancer
128831|NCT02764268|Pharmacokinetics|pharmacokinetics
128832|NCT02764268|Dose titration|dose titration
128833|NCT02764242|insect sting allergy|insect sting allergy
128834|NCT02764242|recombinant venom allergen|recombinant venom allergen
128835|NCT02764203|Dark Chocolate|dark chocolate
128836|NCT02764203|Blood Pressure|blood pressure
128837|NCT02764203|Wearable Devices|wearable devices
128838|NCT02764203|Digital Health|digital health
128839|NCT02764164|TDCS|tdcs
128840|NCT02764151|GBM|gbm
128841|NCT02764151|malignant glioma|malignant glioma
128842|NCT02764151|glioma|glioma
128843|NCT02764151|anaplastic glioma|anaplastic glioma
128844|NCT02764151|astrocytoma|astrocytoma
128845|NCT02764151|IDO|ido
128846|NCT02764151|IDO1|ido1
128847|NCT02764151|PF-06840003|pf-06840003
128848|NCT02764138|poverty|poverty
128849|NCT02764138|discrimination|discrimination
128850|NCT02764125|Parkinson's Disease|parkinson's disease
128851|NCT02764125|Wearing-off|wearing-off
128852|NCT02764112|warfarin|warfarin
128853|NCT02764073|Heart failure|heart failure
128854|NCT02764073|Bioimpedance|bioimpedance
128855|NCT02764073|Lung ultrasonography|lung ultrasonography
128856|NCT02764060|Periodontitis|periodontitis
128857|NCT02764060|Tongue coating|tongue coating
128858|NCT02764060|Tongue cleaning|tongue cleaning
128859|NCT02764060|Bacterial load|bacterial load
128860|NCT02764047|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
128861|NCT02764047|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
128862|NCT02764047|NAFLD|nafld
128863|NCT02764047|NASH|nash
128864|NCT02764034|Low level Laser|low level laser
128865|NCT02764034|Tissue culture|tissue culture
128866|NCT02764034|Endometrial receptivity|endometrial receptivity
128867|NCT02764021|HbA1c|hba1c
128868|NCT02764021|Diabetes-Releated Complications|diabetes-releated complications
128869|NCT02764021|Diet, Low Carbohydrate|diet, low carbohydrate
128870|NCT02764021|Carbohydrate-Restricted Diet|carbohydrate-restricted diet
128871|NCT02764021|Diabetes Mellitus|diabetes mellitus
128872|NCT02764021|Metabolic Disorder|metabolic disorder
128873|NCT02764021|Glucose Metabolism Disorders|glucose metabolism disorders
128874|NCT02764021|Endocrine System Diseases|endocrine system diseases
128875|NCT02764008|Postoperative Analgesia|postoperative analgesia
128876|NCT02764008|Peritubal infiltration|peritubal infiltration
128877|NCT02764008|Ultrasound guided low thoracic paravertebral block|ultrasound guided low thoracic paravertebral block
128878|NCT02764008|Percutaneous Nephrolithotomy pain|percutaneous nephrolithotomy pain
128879|NCT02763995|HIV|hiv
128880|NCT02763995|pharmaceutical care|pharmaceutical care
128881|NCT02763995|older patients|older patients
128882|NCT02763995|cardiovascular risk|cardiovascular risk
128883|NCT02763995|pharmacotherapy follow up|pharmacotherapy follow up
128884|NCT02763982|left ventricular ejection fraction|left ventricular ejection fraction
128885|NCT02763982|peak oxygen uptake|peak oxygen uptake
128886|NCT02763982|respiratory muscles|respiratory muscles
128887|NCT02763982|quality of life|quality of life
128888|NCT02763956|Gelstix, Hydrogel|gelstix, hydrogel
128889|NCT02763930|Cardiovascular disease|cardiovascular disease
128890|NCT02763930|Blood pressure|blood pressure
128891|NCT02763930|Hypertension|hypertension
128892|NCT02763930|Dairy products|dairy products
128893|NCT02763930|Milk|milk
128894|NCT02763930|Cheese|cheese
128895|NCT02763891|Balance|balance
128896|NCT02763891|Mobility|mobility
128897|NCT02763891|Trunk control|trunk control
128898|NCT02763878|Uncut Roux-en-Y|uncut roux-en-y
128899|NCT02763878|Billroth II anastomosis|billroth ii anastomosis
128900|NCT02763878|Distal gastric cancer|distal gastric cancer
128901|NCT02763878|Nutrition status|nutrition status
128902|NCT02763878|Postoperative complications|postoperative complications
128903|NCT02763852|Parkinson's Disease|parkinson's disease
128904|NCT02763852|Nebicapone|nebicapone
128905|NCT02763839|Parkinson's disease|parkinson's disease
128906|NCT02763839|Nebicapone|nebicapone
128907|NCT02763826|Transcranial Direct Current Stimulation|transcranial direct current stimulation
128908|NCT02763826|tDCS|tdcs
128909|NCT02763800|Parkinson's disease|parkinson's disease
128910|NCT02763800|Nebicapone|nebicapone
128911|NCT02763774|coronary artery bypass|coronary artery bypass
128912|NCT02763774|sistemic inflammatory response syndrome|sistemic inflammatory response syndrome
128913|NCT02763774|left ventricular dysfunction|left ventricular dysfunction
128914|NCT02763774|postoperative complications|postoperative complications
128915|NCT02763774|physical fitness|physical fitness
128916|NCT02763735|Pulmonary arterial hypertension|pulmonary arterial hypertension
128917|NCT02763735|Right ventricle|right ventricle
128918|NCT02763735|Right ventricular function|right ventricular function
128919|NCT02763735|Metabolism|metabolism
128920|NCT02763735|Non-invasive imaging|non-invasive imaging
128921|NCT02763735|Healthy Subjects|healthy subjects
128922|NCT02763722|atopic dermatitis|atopic dermatitis
128923|NCT02763722|allergic contact dermatitis|allergic contact dermatitis
128924|NCT02763722|cosmetics|cosmetics
128925|NCT02763722|transepidermal water loos|transepidermal water loos
128926|NCT02763696|Metagenomics|metagenomics
128927|NCT02763696|Vaginal microflora|vaginal microflora
128928|NCT02763696|High-throughput sequencing|high-throughput sequencing
128929|NCT02763683|Parkinsons Disease|parkinsons disease
128930|NCT02763683|PET Imaging|pet imaging
128931|NCT02763683|PIB|pib
128932|NCT02763683|VAT|vat
128933|NCT02763683|Dementia|dementia
128934|NCT02763670|Heart failure|heart failure
128935|NCT02763670|patient education as topic|patient education as topic
128936|NCT02763670|patient care management|patient care management
128937|NCT02763657|fMRI|fmri
128938|NCT02763657|reasoning|reasoning
128939|NCT02763657|development|development
128940|NCT02763644|transplant associated microangiopathy|transplant associated microangiopathy
128941|NCT02763618|Neurofeedback|neurofeedback
128942|NCT02763618|theta/beta ratio|theta/beta ratio
128943|NCT02763618|multiple baseline|multiple baseline
128944|NCT02763605|Acanthamoeba Keratitis|acanthamoeba keratitis
128945|NCT02763605|in vivo confocal microscopic|in vivo confocal microscopic
128946|NCT02763592|Localized Neuropathic pain|localized neuropathic pain
128947|NCT02763592|5% lidocaine medicated plaster|5% lidocaine medicated plaster
128948|NCT02763592|Knee surgery|knee surgery
128949|NCT02763566|Hormone Receptor-Positive|hormone receptor-positive
128950|NCT02763566|HER2-Negative|her2-negative
128951|NCT02763566|CDK4|cdk4
128952|NCT02763566|CDK6|cdk6
128953|NCT02763553|Ketone Bodies|ketone bodies
128954|NCT02763553|Enteral Nutrition|enteral nutrition
128955|NCT02763553|Ketogenic Diet|ketogenic diet
128956|NCT02763540|ILD|ild
128957|NCT02763540|Pathology|pathology
128958|NCT02763540|diagnosis|diagnosis
128959|NCT02763540|lung biopsy|lung biopsy
128960|NCT02763527|smoking cessation|smoking cessation
128961|NCT02763501|bariatric surgery|bariatric surgery
128962|NCT02763501|gastric bypass|gastric bypass
128963|NCT02763501|intestinal obstruction|intestinal obstruction
128964|NCT02763501|postoperative complication|postoperative complication
128965|NCT02763501|methods|methods
128966|NCT02763501|laparoscopy|laparoscopy
128967|NCT02763488|blood flow restriction training|blood flow restriction training
128968|NCT02763488|occlusion training|occlusion training
128969|NCT02763488|total knee arthroplasty|total knee arthroplasty
128970|NCT02763488|post-operative rehabilitation|post-operative rehabilitation
128971|NCT02763475|Killer Cells, Natural|killer cells, natural
128972|NCT02763475|Consolidation treatment|consolidation treatment
128973|NCT02763475|cytologic remission|cytologic remission
128974|NCT02763475|Haploidentical NK Cells|haploidentical nk cells
128975|NCT02763475|allogeneic|allogeneic
128976|NCT02763475|IL-2 Expanded NK Cells|il-2 expanded nk cells
128977|NCT02763462|Acute Febrile Illness|acute febrile illness
128978|NCT02763436|term infant, neonatal transition, cord clamping, NIRS, arterial oxygen saturation, regional cerebral oxygen saturation, cerebral blood volume|term infant, neonatal transition, cord clamping, nirs, arterial oxygen saturation, regional cerebral oxygen saturation, cerebral blood volume
128979|NCT02763423|umbilical cord stem cell|umbilical cord stem cell
128980|NCT02763423|diabetic ketoacidosis|diabetic ketoacidosis
128981|NCT02763371|high GI lunch|high gi lunch
128982|NCT02763371|low GI lunch|low gi lunch
128983|NCT02763358|obesity|obesity
128984|NCT02763358|weight loss|weight loss
128985|NCT02763332|Fibromyalgia|fibromyalgia
128986|NCT02763332|Efficacy|efficacy
128987|NCT02763332|Taping|taping
128988|NCT02763319|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
128989|NCT02763319|bendamustine|bendamustine
128990|NCT02763319|rituximab|rituximab
128991|NCT02763319|combination therapy|combination therapy
128992|NCT02763319|CD19 monoclonal antibody|cd19 monoclonal antibody
128993|NCT02763319|transplant ineligible|transplant ineligible
128994|NCT02763293|pain|pain
128995|NCT02763293|effectiveness|effectiveness
128996|NCT02763293|manual therapy|manual therapy
128997|NCT02763267|Insulin sensitivity|insulin sensitivity
128998|NCT02763267|Insulin secretion|insulin secretion
128999|NCT02763267|Pregnancy|pregnancy
129000|NCT02763267|Placental proteins|placental proteins
129001|NCT02763254|Epstein-Barr Virus|epstein-barr virus
129003|NCT02763254|PTLD|ptld
129004|NCT02763254|EBV|ebv
129005|NCT02763254|CIVIC|civic
129006|NCT02763254|HL|hl
129007|NCT02763254|T cell|t cell
129008|NCT02763241|rhinitis|rhinitis
129009|NCT02763228|Physical Activity|physical activity
129010|NCT02763228|Breast Cancer|breast cancer
129011|NCT02763228|minority|minority
129012|NCT02763228|African American|african american
129013|NCT02763202|transition of care|transition of care
129014|NCT02763202|pragmatic clinical trial|pragmatic clinical trial
129015|NCT02763202|telemedicine|telemedicine
129016|NCT02763202|emergency medical technician|emergency medical technician
129017|NCT02763189|Mentoring|mentoring
129018|NCT02763189|Endotracheal Tube Exchange|endotracheal tube exchange
129019|NCT02763189|Training|training
129020|NCT02763176|hCG testing, multi-level pregnancy test|hcg testing, multi-level pregnancy test
129021|NCT02763150|Gestational Diabetes Prevention|gestational diabetes prevention
129022|NCT02763124|Pseudophakic|pseudophakic
129023|NCT02763111|ankylosing spondylitis|ankylosing spondylitis
129024|NCT02763111|interleukin 17|interleukin 17
129025|NCT02763111|monoclonal antibody|monoclonal antibody
129026|NCT02763098|cardiovascular responses|cardiovascular responses
129027|NCT02763098|analgesics opioid|analgesics opioid
129028|NCT02763098|remifentanil|remifentanil
129029|NCT02763046|Ankylosing Spondylitis|ankylosing spondylitis
129030|NCT02763046|NSAID|nsaid
129031|NCT02763046|ASAS|asas
129032|NCT02763046|Secukinumab|secukinumab
129033|NCT02763046|Subcutaneous|subcutaneous
129034|NCT02763020|high glycemic index, polyphenols, blood glucose, satiety|high glycemic index, polyphenols, blood glucose, satiety
129035|NCT02762994|interleukin 17|interleukin 17
129036|NCT02762994|monoclonal antibody|monoclonal antibody
129037|NCT02762994|psoriasis|psoriasis
129038|NCT02762981|CORT125134|cort125134
129039|NCT02762981|nabpaclitaxel|nabpaclitaxel
129040|NCT02762981|Triple-Negative Breast Cancer|triple-negative breast cancer
129041|NCT02762981|Ovarian Epithelial Cancer|ovarian epithelial cancer
129042|NCT02762981|GR Antagonist|gr antagonist
129043|NCT02762981|Glucocorticoid Receptor Antagonist|glucocorticoid receptor antagonist
129044|NCT02762981|Pancreatic Cancer|pancreatic cancer
129045|NCT02762981|Solid Tumors|solid tumors
129046|NCT02762955|adalimumab|adalimumab
129047|NCT02762955|biosimilar|biosimilar
129048|NCT02762955|BCD-057|bcd-057
129049|NCT02762955|psoriasis|psoriasis
129050|NCT02762955|tumor necrosis factor|tumor necrosis factor
129051|NCT02762955|monoclonal antibody|monoclonal antibody
129052|NCT02762942|cervical ripening|cervical ripening
129053|NCT02762942|misoprostol|misoprostol
129054|NCT02762942|supracervical balloon|supracervical balloon
129055|NCT02762942|Foley catheter|foley catheter
129056|NCT02762929|Analgesia|analgesia
129057|NCT02762929|Bunionectomy|bunionectomy
129058|NCT02762903|Shoulder arthroplasty|shoulder arthroplasty
129059|NCT02762903|Lesser Tuberosity Osteotomy|lesser tuberosity osteotomy
129060|NCT02762903|Subscapularis tenotomy|subscapularis tenotomy
129061|NCT02762864|aspirin|aspirin
129062|NCT02762864|ticagrelor|ticagrelor
129063|NCT02762864|clopidogrel|clopidogrel
129064|NCT02762851|Influenza|influenza
129065|NCT02762851|Vaccine|vaccine
129066|NCT02762851|Heart failure|heart failure
129067|NCT02762851|Vascular|vascular
129068|NCT02762799|neutrophil count|neutrophil count
129069|NCT02762799|filgrastim|filgrastim
129070|NCT02762799|granulocyte colony-stimulating factor|granulocyte colony-stimulating factor
129071|NCT02762747|Hernia, Inguinal|hernia, inguinal
129072|NCT02762747|Extraperitoneal Hernioplasty|extraperitoneal hernioplasty
129073|NCT02762747|Drain|drain
129074|NCT02762747|Mesh Repair|mesh repair
129075|NCT02762747|Laparoscopic|laparoscopic
129076|NCT02762734|adolescent|adolescent
129077|NCT02762734|suicide|suicide
129078|NCT02762721|FGFR2 fusion|fgfr2 fusion
129079|NCT02762721|iCCA|icca
129080|NCT02762721|mixed HCC-CCA|mixed hcc-cca
129081|NCT02762721|Intrahepatic Cholangiocarcinoma|intrahepatic cholangiocarcinoma
129082|NCT02762721|Mixed Hepatocellular Cholangiocarcinoma|mixed hepatocellular cholangiocarcinoma
129083|NCT02762721|Cholangiocarcinoma|cholangiocarcinoma
129084|NCT02762721|ArQule|arqule
129085|NCT02762708|Bariatric Surgery|bariatric surgery
129086|NCT02762708|Weight loss|weight loss
129087|NCT02762695|Hypertension|hypertension
129088|NCT02762695|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
129089|NCT02762695|Case Management|case management
129090|NCT02762669|Uterine contraction|uterine contraction
129091|NCT02762669|Oxytocin desensitization|oxytocin desensitization
129092|NCT02762643|DP-R213|dp-r213
129093|NCT02762617|Healthy Volunteers|healthy volunteers
129094|NCT02762617|Women's Health|women's health
129095|NCT02762552|Stroke|stroke
129096|NCT02762552|Etiology|etiology
129097|NCT02762552|Recurrence|recurrence
129098|NCT02762552|Transcranial holter|transcranial holter
129099|NCT02762552|Microembolic signals|microembolic signals
129100|NCT02762526|lipectomy|lipectomy
129101|NCT02762526|abdominoplasty|abdominoplasty
129102|NCT02762526|plethysmography optoelectronics|plethysmography optoelectronics
129103|NCT02762526|diaphragmatic mobility|diaphragmatic mobility
129104|NCT02762526|lung function|lung function
129105|NCT02762526|respiratory muscles|respiratory muscles
129106|NCT02762474|nab-paclitaxel|nab-paclitaxel
129107|NCT02762474|IMRT|imrt
129108|NCT02762474|esophageal cancer|esophageal cancer
129109|NCT02762461|Fertilization in Vitro|fertilization in vitro
129110|NCT02762461|Sperm Injections, Intracytoplasmic|sperm injections, intracytoplasmic
129111|NCT02762461|Endometriosis|endometriosis
129112|NCT02762422|endothelial function|endothelial function
129113|NCT02762422|iron stores|iron stores
129114|NCT02762422|red blood cell|red blood cell
129115|NCT02762422|blood donation|blood donation
129116|NCT02762409|critical care|critical care
129117|NCT02762409|reduction of depression syndrome|reduction of depression syndrome
129118|NCT02762409|anxiety|anxiety
129119|NCT02762409|quality of life|quality of life
129120|NCT02762409|post traumatic stress|post traumatic stress
129121|NCT02762409|discomforts|discomforts
129122|NCT02762396|Young ischemic stroke|young ischemic stroke
129123|NCT02762396|Risk factors|risk factors
129124|NCT02762396|Causes|causes
129125|NCT02762396|Consequences|consequences
129126|NCT02762370|osteoarthritis|osteoarthritis
129127|NCT02762370|knee|knee
129128|NCT02762370|pain|pain
129129|NCT02762370|diabetes|diabetes
129130|NCT02762370|intra-articular|intra-articular
129131|NCT02762370|injection|injection
129132|NCT02762370|corticosteroid|corticosteroid
129133|NCT02762357|Novosyn Quick|novosyn quick
129134|NCT02762357|Episiotomy|episiotomy
129135|NCT02762331|Vitamin C|vitamin c
129136|NCT02762331|Coronary Artery Bypass Grafting|coronary artery bypass grafting
129137|NCT02762331|Atrial Fibrillation|atrial fibrillation
129138|NCT02762331|Cardiac Valve Repair|cardiac valve repair
129139|NCT02762305|fall risk|fall risk
129140|NCT02762305|RSVP bone builders|rsvp bone builders
129141|NCT02762305|Group Exercise|group exercise
129142|NCT02762305|Older adults|older adults
129143|NCT02762305|Balance confidence|balance confidence
129144|NCT02762305|life satisfaction|life satisfaction
129145|NCT02762305|balance|balance
129146|NCT02762292|Mechanical ventilation|mechanical ventilation
129147|NCT02762292|Children|children
129148|NCT02762292|Work of breathing|work of breathing
129149|NCT02762279|Mechanical ventilation|mechanical ventilation
129150|NCT02762279|Children|children
129151|NCT02762279|Esophageal Pressure|esophageal pressure
129152|NCT02762279|Pleural Pressure|pleural pressure
129153|NCT02762240|Accreditation|accreditation
129154|NCT02762240|Certification|certification
129155|NCT02762240|General Practice|general practice
129156|NCT02762240|Family Medicine|family medicine
129157|NCT02762240|Randomized Controlled Trial|randomized controlled trial
129158|NCT02762227|CEUS|ceus
129159|NCT02762227|CT|ct
129160|NCT02762227|gallbladder cholesterol polyps|gallbladder cholesterol polyps
129161|NCT02762227|adenoma|adenoma
129162|NCT02762227|gallbladder cancer|gallbladder cancer
129163|NCT02762214|Uterin manipulator|uterin manipulator
129164|NCT02762214|Endometrial Cancer|endometrial cancer
129165|NCT02762214|Laparoscopy|laparoscopy
129166|NCT02762214|Robotic|robotic
129167|NCT02762188|wet ARMD|wet armd
129168|NCT02762188|VEGF|vegf
129169|NCT02762188|intra vitreal injections|intra vitreal injections
129170|NCT02762175|maxillomandibular advancement|maxillomandibular advancement
129171|NCT02762175|obstructive sleep apnea|obstructive sleep apnea
129172|NCT02762175|apnea-hypopnea index|apnea-hypopnea index
129173|NCT02762175|quality of life|quality of life
129174|NCT02762162|antiplatelet|antiplatelet
129175|NCT02762162|stent thrombosis|stent thrombosis
129176|NCT02762149|Tsui Test|tsui test
129177|NCT02762149|Labour|labour
129178|NCT02762149|Epidural catheter|epidural catheter
129179|NCT02762097|polyps|polyps
129180|NCT02762097|saline sonography|saline sonography
129181|NCT02762097|infertility|infertility
129182|NCT02762084|Gorlin Syndrome|gorlin syndrome
129183|NCT02762084|Basal Cell|basal cell
129184|NCT02762084|Nevus Syndrome|nevus syndrome
129185|NCT02762084|BCNS|bcns
129186|NCT02762084|nevoid basal cell carcinoma syndrome|nevoid basal cell carcinoma syndrome
129187|NCT02762084|Basal cell carcinoma|basal cell carcinoma
129188|NCT02762084|Hedgehog|hedgehog
129189|NCT02762084|Surgically Eligible Basal Cell Carcinomas|surgically eligible basal cell carcinomas
129190|NCT02762058|Acquired Brain Injury|acquired brain injury
129191|NCT02762058|Stroke Rehabilitation|stroke rehabilitation
129192|NCT02762045|Therapeutic Vaccine HIV Adenovirus type 5 vector|therapeutic vaccine hiv adenovirus type 5 vector
129193|NCT02762032|Skin Biopsy|skin biopsy
129194|NCT02762032|PrimaVie|primavie
129195|NCT02762032|Herbal Supplement|herbal supplement
129196|NCT02762019|Stomatitis|stomatitis
129197|NCT02762019|Laser|laser
129198|NCT02762019|Children|children
129199|NCT02762019|Chemotherapy|chemotherapy
129200|NCT02762019|Treatment|treatment
129201|NCT02762006|durvalumab|durvalumab
129202|NCT02762006|tremelimumab|tremelimumab
129203|NCT02762006|Phase Ib|phase ib
129204|NCT02762006|Locally Advanced|locally advanced
129205|NCT02761980|ibuprofen; acetaminophen; induced fever; fever|ibuprofen; acetaminophen; induced fever; fever
129206|NCT02761967|Physical activity|physical activity
129207|NCT02761967|Pregnancy|pregnancy
129208|NCT02761967|Childbirth|childbirth
129209|NCT02761967|Postpartum period|postpartum period
129210|NCT02761967|Exercise|exercise
129211|NCT02761954|regional anesthesia|regional anesthesia
129212|NCT02761954|caudal block|caudal block
129213|NCT02761928|Facet Joint|facet joint
129214|NCT02761928|Sacroiliac Joint|sacroiliac joint
129215|NCT02761928|Myofascial Trigger Point Pain|myofascial trigger point pain
129216|NCT02761928|Injectables|injectables
129217|NCT02761915|Neuroblastoma|neuroblastoma
129218|NCT02761915|Immunotherapy|immunotherapy
129219|NCT02761915|1RG-CART|1rg-cart
129220|NCT02761915|Cyclophosphamide|cyclophosphamide
129221|NCT02761915|Fludarabine|fludarabine
129222|NCT02761915|CAR T-cells|car t-cells
129223|NCT02761915|Anti-GD2|anti-gd2
129224|NCT02761915|GD2|gd2
129225|NCT02761915|CAR|car
129226|NCT02761915|Chimeric Antigen Receptor|chimeric antigen receptor
129227|NCT02761902|Children|children
129228|NCT02761902|Polysomnography|polysomnography
129229|NCT02761902|sleep|sleep
129230|NCT02761902|obstructive sleep apnea;|obstructive sleep apnea;
129231|NCT02761902|Chinese|chinese
129232|NCT02761863|Mesothelioma|mesothelioma
129233|NCT02761863|CD 74|cd 74
129234|NCT02761863|VEGF|vegf
129235|NCT02761824|Quality of Life|quality of life
129236|NCT02761824|Occupation|occupation
129237|NCT02761772|Preimplantation Factor|preimplantation factor
129238|NCT02761746|HIV|hiv
129239|NCT02761746|Adherence|adherence
129240|NCT02761746|Health Outcomes|health outcomes
129241|NCT02761733|Shared Decision Making|shared decision making
129242|NCT02761733|Case Management|case management
129243|NCT02761733|Decision Aid|decision aid
129244|NCT02761694|AKT1|akt1
129245|NCT02761694|AKT2|akt2
129246|NCT02761694|AKT3|akt3
129247|NCT02761694|PI3K|pi3k
129248|NCT02761694|PTEN-null|pten-null
129249|NCT02761694|solid tumors|solid tumors
129250|NCT02761694|cancer|cancer
129251|NCT02761694|ARQ 751|arq 751
129252|NCT02761694|ArQule|arqule
129253|NCT02761694|PTEN|pten
129254|NCT02761681|Acceptance and Commitment Therapy|acceptance and commitment therapy
129255|NCT02761681|Mindfulness|mindfulness
129256|NCT02761681|Guided self-help|guided self-help
129257|NCT02761681|College students|college students
129258|NCT02761681|Focused Interviews|focused interviews
129259|NCT02761681|RCT Control Condition|rct control condition
129260|NCT02761681|RCT ACT-CL Condition|rct act-cl condition
129261|NCT02761668|Pathological tooth migration|pathological tooth migration
129262|NCT02761668|periodontal regenerative surgery|periodontal regenerative surgery
129263|NCT02761668|vertical infrabony defects|vertical infrabony defects
129264|NCT02761668|xenogeneic bone graft|xenogeneic bone graft
129265|NCT02761668|orthodontic therapy|orthodontic therapy
129266|NCT02761655|Dementia|dementia
129267|NCT02761655|Medication Adherence|medication adherence
129268|NCT02761655|Perspective Memory|perspective memory
129269|NCT02761590|intermuscular fat|intermuscular fat
129270|NCT02761590|circuit training|circuit training
129271|NCT02761590|adipokines|adipokines
129272|NCT02761590|inflammation|inflammation
129273|NCT02761590|computed tomography scan|computed tomography scan
129274|NCT02761577|Acetylcysteine|acetylcysteine
129275|NCT02761577|Sodium Bicarbonate|sodium bicarbonate
129276|NCT02761577|Lipocalins|lipocalins
129277|NCT02761577|Creatinine|creatinine
129278|NCT02761577|Blood Urea Nitrogen|blood urea nitrogen
129279|NCT02761564|Cardiac surgery|cardiac surgery
129280|NCT02761564|Blood transfusion|blood transfusion
129281|NCT02761564|ScvO2|scvo2
129282|NCT02761538|obesity|obesity
129283|NCT02761538|Overweight|overweight
129284|NCT02761538|ICTs|icts
129285|NCT02761538|Cost-effectiveness|cost-effectiveness
129286|NCT02761525|silver nanoparticles antimicrobial activity|silver nanoparticles antimicrobial activity
129287|NCT02761486|aspirin|aspirin
129288|NCT02761486|gut microbiome|gut microbiome
129289|NCT02761486|inflammation|inflammation
129290|NCT02761486|placebo|placebo
129291|NCT02761486|circulating biomarker|circulating biomarker
129292|NCT02761447|Motor control Laterality|motor control laterality
129293|NCT02761447|Pain Perception|pain perception
129294|NCT02761447|Lower Extremity|lower extremity
129295|NCT02761447|Complementary Therapies|complementary therapies
129296|NCT02761447|Physical Therapy Modalities|physical therapy modalities
129297|NCT02761434|copeptin|copeptin
129298|NCT02761434|vasopressin|vasopressin
129299|NCT02761434|dehydration|dehydration
129300|NCT02761434|insulin resistance|insulin resistance
129301|NCT02761434|Diabetes|diabetes
129302|NCT02761434|Glucose regulation|glucose regulation
129303|NCT02761421|IOPD|iopd
129304|NCT02761408|Head and neck cancer|head and neck cancer
129305|NCT02761408|Asian|asian
129306|NCT02761408|ALDH2|aldh2
129307|NCT02761369|food addiction|food addiction
129308|NCT02761369|obesity|obesity
129309|NCT02761369|deep TMS|deep tms
129310|NCT02761369|PAS|pas
129311|NCT02761369|Food Stroop|food stroop
129312|NCT02761369|brain laterality|brain laterality
129313|NCT02761369|EEG|eeg
129314|NCT02761369|INP|inp
129315|NCT02761343|cardiac arrhythmia|cardiac arrhythmia
129316|NCT02761343|cardiac ablation|cardiac ablation
129317|NCT02761343|congenital cardiac disease|congenital cardiac disease
129318|NCT02761343|cardiac ablation lesions under Magnetic Resonance imaging|cardiac ablation lesions under magnetic resonance imaging
129319|NCT02761330|Anesthesia|anesthesia
129320|NCT02761330|Electroconvulsive therapy|electroconvulsive therapy
129321|NCT02761330|Delirium|delirium
129322|NCT02761330|Electroencephalography|electroencephalography
129323|NCT02761330|Seizures|seizures
129324|NCT02761330|Depression|depression
129325|NCT02761330|Ketamine|ketamine
129326|NCT02761330|Etomidate|etomidate
129327|NCT02761330|Physiological Effects of Drugs|physiological effects of drugs
129328|NCT02761330|Pharmacologic Actions|pharmacologic actions
129329|NCT02761330|Confusion|confusion
129330|NCT02761330|Mental Disorders|mental disorders
129331|NCT02761330|Neurobehavioral Manifestations|neurobehavioral manifestations
129332|NCT02761330|Signs and Symptoms|signs and symptoms
129333|NCT02761330|Neurologic Manifestations|neurologic manifestations
129334|NCT02761330|Cognitive Disorders|cognitive disorders
129335|NCT02761317|bowel preparation|bowel preparation
129336|NCT02761317|bisacodyl|bisacodyl
129337|NCT02761317|polyethyleneglycol|polyethyleneglycol
129338|NCT02761317|colorectal surgery|colorectal surgery
129339|NCT02761291|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
129340|NCT02761291|EB virus|eb virus
129341|NCT02761291|metastasis|metastasis
129342|NCT02761291|recurrence|recurrence
129343|NCT02761291|cytolytic viral activation therapy|cytolytic viral activation therapy
129344|NCT02761291|gemcitabine|gemcitabine
129345|NCT02761291|valproic acid|valproic acid
129346|NCT02761291|ganciclovir|ganciclovir
129347|NCT02761291|valganciclovir|valganciclovir
129348|NCT02761265|Degenerative Adult Scoliosis|degenerative adult scoliosis
129349|NCT02761265|Gait Analysis|gait analysis
129350|NCT02761265|Balance Analysis|balance analysis
129351|NCT02761265|Biomechanics|biomechanics
129352|NCT02761265|Neuromuscular Control|neuromuscular control
129353|NCT02761265|Thoracolumbar Deformity|thoracolumbar deformity
129354|NCT02761252|Bilastine|bilastine
129355|NCT02761252|Montelukast|montelukast
129356|NCT02761252|total symptom score|total symptom score
129357|NCT02761252|AQLQ|aqlq
129358|NCT02761239|cricopharyngeal muscle|cricopharyngeal muscle
129359|NCT02761239|innervation by EBSLN|innervation by ebsln
129360|NCT02761239|A prospective case-controlled study|a prospective case-controlled study
129361|NCT02761226|platform switching|platform switching
129362|NCT02761226|dental implant|dental implant
129363|NCT02761226|crestal bone level|crestal bone level
129364|NCT02761226|implant stability|implant stability
129365|NCT02761226|postoperative complication|postoperative complication
129366|NCT02761187|Drug Therapy|drug therapy
129367|NCT02761174|Vascular lesions|vascular lesions
129368|NCT02761174|inflammation|inflammation
129370|NCT02761161|PTSD|ptsd
129371|NCT02761161|Sleep|sleep
129372|NCT02761161|Refugee|refugee
129373|NCT02761161|IRT|irt
129374|NCT02761161|Mianserin|mianserin
129375|NCT02761148|white matter hyperintensity|white matter hyperintensity
129376|NCT02761148|brain network|brain network
129377|NCT02761148|MRI|mri
129378|NCT02761148|cognition|cognition
129379|NCT02761148|emotion|emotion
129380|NCT02761135|Biopsy technique|biopsy technique
129381|NCT02761135|Transrectal ultrasonography probe|transrectal ultrasonography probe
129382|NCT02761135|Side-fire|side-fire
129383|NCT02761135|Prostate cancer|prostate cancer
129384|NCT02761135|End-fire|end-fire
129385|NCT02761083|Eye surgery|eye surgery
129386|NCT02761083|Suture material|suture material
129387|NCT02761083|Novosyn Quick|novosyn quick
129388|NCT02761083|Vicryl Rapid|vicryl rapid
129389|NCT02761070|glioblastoma|glioblastoma
129390|NCT02761070|recurrent|recurrent
129391|NCT02761070|dose-dense temozolomide|dose-dense temozolomide
129392|NCT02761070|bevacizumab|bevacizumab
129393|NCT02761031|Heart rate variability|heart rate variability
129394|NCT02761031|Electrocardiography|electrocardiography
129395|NCT02761031|Observational study|observational study
129396|NCT02761031|Non-interventional study|non-interventional study
129397|NCT02761031|Risk assessment|risk assessment
129398|NCT02761031|Perioperative|perioperative
129399|NCT02761005|Eradication therapy|eradication therapy
129400|NCT02761005|Mutation of 23S rRNA of H. pylori|mutation of 23s rrna of h. pylori
129401|NCT02761005|Personalized therapy|personalized therapy
129402|NCT02760979|knee arthroplasty|knee arthroplasty
129403|NCT02760953|Bladder Cancer|bladder cancer
129404|NCT02760953|Cryoablation|cryoablation
129405|NCT02760940|Inflammatory bowel diseases|inflammatory bowel diseases
129406|NCT02760940|Anemia|anemia
129407|NCT02760940|Crohn's disease|crohn's disease
129408|NCT02760940|Ulcerative colitis|ulcerative colitis
129409|NCT02760940|Oral iron|oral iron
129410|NCT02760940|Quality of life|quality of life
129411|NCT02760914|adipose tissue|adipose tissue
129412|NCT02760914|inflammatory mediators|inflammatory mediators
129413|NCT02760914|gene expression|gene expression
129801|NCT02758665|CLL|cll
129414|NCT02760875|Achilles Tendon Rupture|achilles tendon rupture
129415|NCT02760875|Conservative treatment|conservative treatment
129416|NCT02760875|early weight bearing|early weight bearing
129417|NCT02760875|Achilles Tendon Length|achilles tendon length
129418|NCT02760875|Ultrasound|ultrasound
129419|NCT02760875|Foot Pressure Mapping|foot pressure mapping
129420|NCT02760875|ATRA|atra
129421|NCT02760875|Heel Raise Work|heel raise work
129422|NCT02760849|Hereditary Breast and Ovarian Cancer Syndrome|hereditary breast and ovarian cancer syndrome
129423|NCT02760849|HBOC|hboc
129424|NCT02760849|Deleterious mutation in ovarian cancer genes|deleterious mutation in ovarian cancer genes
129425|NCT02760849|Changes in female sexual function|changes in female sexual function
129426|NCT02760849|Salpingectomy with delayed oophorectomy|salpingectomy with delayed oophorectomy
129427|NCT02760849|ISDO|isdo
129428|NCT02760849|Risk-reducing salpingo-oophorectomy (RRSO)|risk-reducing salpingo-oophorectomy (rrso)
129429|NCT02760849|RRSO|rrso
129430|NCT02760849|Questionnaires|questionnaires
129431|NCT02760849|Surveys|surveys
129432|NCT02760836|Crohn's disease|crohn's disease
129433|NCT02760836|disease outcomes|disease outcomes
129434|NCT02760784|Achilles Tendon Rupture|achilles tendon rupture
129435|NCT02760784|Conservative treatment|conservative treatment
129436|NCT02760784|early weight bearing|early weight bearing
129437|NCT02760784|Dynamic|dynamic
129438|NCT02760784|ATRS|atrs
129439|NCT02760784|ATRA|atra
129440|NCT02760784|Heel Raise Work|heel raise work
129441|NCT02760771|THV (trans-catheter heart valve)|thv (trans-catheter heart valve)
129442|NCT02760771|severe aortic stenosis|severe aortic stenosis
129443|NCT02760771|pre-dilation|pre-dilation
129444|NCT02760771|rapid pacing|rapid pacing
129445|NCT02760771|BAV (balloon artery valvuloplasty|bav (balloon artery valvuloplasty
129446|NCT02760758|non-nucleoside inhibitor|non-nucleoside inhibitor
129447|NCT02760758|NNI|nni
129448|NCT02760758|HCV|hcv
129449|NCT02760758|DAA|daa
129450|NCT02760745|fever|fever
129451|NCT02760745|shivering|shivering
129452|NCT02760745|chills|chills
129453|NCT02760745|rigors|rigors
129454|NCT02760745|severe bacterial infection|severe bacterial infection
129455|NCT02760719|3% hypertonic solution|3% hypertonic solution
129456|NCT02760719|duration of hospitalisation|duration of hospitalisation
129457|NCT02760693|bipolar disorder, naturalistic cohort study,|bipolar disorder, naturalistic cohort study,
129458|NCT02760693|defined catchment area,long term treatment|defined catchment area,long term treatment
129459|NCT02760680|Chronic Heart Failure|chronic heart failure
129460|NCT02760680|Sleep-Disordered Breathing|sleep-disordered breathing
129461|NCT02760680|Peripheral Arterial Tone|peripheral arterial tone
129462|NCT02760667|Oropharyngeal cancer|oropharyngeal cancer
129463|NCT02760667|Laryngeal cancer|laryngeal cancer
129464|NCT02760641|obesity|obesity
129465|NCT02760641|low carbohydrate diet|low carbohydrate diet
129466|NCT02760641|metabolism|metabolism
129467|NCT02760641|body composition|body composition
129468|NCT02760641|visceral fat|visceral fat
129469|NCT02760641|older adults|older adults
129470|NCT02760641|insulin sensitivity|insulin sensitivity
129471|NCT02760615|Drug therapy|drug therapy
129472|NCT02760602|anti-amyloid|anti-amyloid
129473|NCT02760602|monoclonal antibody|monoclonal antibody
129474|NCT02760589|ACL tear|acl tear
129475|NCT02760589|ACL lesion|acl lesion
129476|NCT02760589|ACL reconstruction|acl reconstruction
129477|NCT02760589|InternalBrace|internalbrace
129478|NCT02760589|functional performance test|functional performance test
129479|NCT02760589|anterior cruciate ligament|anterior cruciate ligament
129480|NCT02760537|Liver Neoplasms|liver neoplasms
129481|NCT02760537|Hepatitis B|hepatitis b
129482|NCT02760537|Hepatitis B vaccination|hepatitis b vaccination
129483|NCT02760537|Asian Americans|asian americans
129484|NCT02760537|Lay health workers|lay health workers
129485|NCT02760537|Community health workers|community health workers
129486|NCT02760511|Randomized Controlled Trial|randomized controlled trial
129487|NCT02760511|Anthocyanin|anthocyanin
129488|NCT02760511|Antioxidants|antioxidants
129489|NCT02760485|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
129490|NCT02760485|Relapsed Diffuse large B-cell lymphoma|relapsed diffuse large b-cell lymphoma
129491|NCT02760485|Refractory Diffuse large B-cell lymphoma|refractory diffuse large b-cell lymphoma
129492|NCT02760485|activated B cell|activated b cell
129493|NCT02760485|germinal center B-cell|germinal center b-cell
129494|NCT02760485|non-Hodgkin lymphoma|non-hodgkin lymphoma
129495|NCT02760485|JAK1 inhibitor|jak1 inhibitor
129496|NCT02760485|Bruton's tyrosine kinase (BTK) inhibitor|bruton's tyrosine kinase (btk) inhibitor
129497|NCT02760472|Retinopathy of Prematurity|retinopathy of prematurity
129498|NCT02760472|Preterm|preterm
129499|NCT02760472|Fatty acids|fatty acids
129500|NCT02760433|moderate Rheumatoid Arthritis|moderate rheumatoid arthritis
129501|NCT02760433|severe Rheumatoid Arthritis|severe rheumatoid arthritis
129502|NCT02760433|Olokizumab|olokizumab
129503|NCT02760407|moderate Rheumatoid Arthritis|moderate rheumatoid arthritis
129504|NCT02760407|severe Rheumatoid Arthritis|severe rheumatoid arthritis
129505|NCT02760407|subcutaneous|subcutaneous
129506|NCT02760407|Olokizumab|olokizumab
129507|NCT02760394|chronic ischemic heart disease|chronic ischemic heart disease
129508|NCT02760394|coronary bypass|coronary bypass
129509|NCT02760394|refractory stable angina|refractory stable angina
129510|NCT02760394|HBOT|hbot
129511|NCT02760394|reperfusion|reperfusion
129512|NCT02760394|neoangiogenesis|neoangiogenesis
129513|NCT02760394|microvascular|microvascular
129514|NCT02760394|myocardial perfusion|myocardial perfusion
129515|NCT02760368|moderate Rheumatoid Arthritis|moderate rheumatoid arthritis
129516|NCT02760368|severe Rheumatoid Arthritis|severe rheumatoid arthritis
129517|NCT02760368|subcutaneous|subcutaneous
129518|NCT02760368|Olokizumab|olokizumab
129519|NCT02760342|Pharmacokinetics|pharmacokinetics
129520|NCT02760342|Metformin|metformin
129521|NCT02760342|Drug-drug interaction|drug-drug interaction
129522|NCT02760342|ASP015K|asp015k
129523|NCT02760329|asthma|asthma
129524|NCT02760329|COPD|copd
129525|NCT02760329|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
129526|NCT02760329|lung disease|lung disease
129527|NCT02760329|chronic airways disease|chronic airways disease
129528|NCT02760329|obstructive lung disease|obstructive lung disease
129529|NCT02760316|Healthy Volunteers|healthy volunteers
129530|NCT02760316|Obese|obese
129531|NCT02760316|Insulin Resistant Subjects|insulin resistant subjects
129532|NCT02760316|Rheumatoid Arthritis|rheumatoid arthritis
129533|NCT02760303|insulin dependent diabetes mellitus|insulin dependent diabetes mellitus
129534|NCT02760303|adolescents and young adults|adolescents and young adults
129535|NCT02760303|stress reduction|stress reduction
129536|NCT02760303|metabolic control|metabolic control
129537|NCT02760290|Forced Expiratory Volume in 1 second|forced expiratory volume in 1 second
129538|NCT02760290|Forced expiratory vital capacity|forced expiratory vital capacity
129539|NCT02760290|Peak expiratory flow|peak expiratory flow
129540|NCT02760277|Duchenne muscular dystrophy|duchenne muscular dystrophy
129541|NCT02760277|vamorolone|vamorolone
129542|NCT02760264|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
129543|NCT02760264|vamorolone|vamorolone
129544|NCT02760251|immunomodulation|immunomodulation
129545|NCT02760238|myeloproliferative neoplasm|myeloproliferative neoplasm
129546|NCT02760238|myelodysplastic syndrome|myelodysplastic syndrome
129547|NCT02760238|registry|registry
129548|NCT02760238|leukemia|leukemia
129549|NCT02760238|Bone Marrow Diseases|bone marrow diseases
129550|NCT02760238|Hematologic Diseases|hematologic diseases
129551|NCT02760238|Neoplasms|neoplasms
129552|NCT02760225|Pembrolizumab|pembrolizumab
129553|NCT02760225|PET imaging|pet imaging
129554|NCT02760225|Melanoma|melanoma
129555|NCT02760225|Non-small cell lung cancer|non-small cell lung cancer
129556|NCT02760212|Shockwave therapy|shockwave therapy
129557|NCT02760212|fMRI|fmri
129558|NCT02760212|blood biomarkers|blood biomarkers
129559|NCT02760173|verticality perception|verticality perception
129560|NCT02760147|Pressure Support Ventilation|pressure support ventilation
129561|NCT02760134|Super-Mini Percutaneous Nephrolithotomy(SMP)|super-mini percutaneous nephrolithotomy(smp)
129562|NCT02760134|Renal Pelvic Pressure|renal pelvic pressure
129563|NCT02760121|Acetazolamide|acetazolamide
129564|NCT02760121|Methazolamide|methazolamide
129565|NCT02760121|Control of breathing|control of breathing
129566|NCT02760121|Hypoxic pulmonary vasoconstriction|hypoxic pulmonary vasoconstriction
129567|NCT02760108|Early onset Parkinson's disease|early onset parkinson's disease
129568|NCT02760108|Familial Parkinson's disease|familial parkinson's disease
129569|NCT02760108|Parkinson's disease|parkinson's disease
129570|NCT02760108|Genetics|genetics
129571|NCT02760095|environmental enteric dysfunction|environmental enteric dysfunction
129572|NCT02760095|environmental enteropathy|environmental enteropathy
129573|NCT02760095|zinc|zinc
129574|NCT02760095|vitamin A|vitamin a
129575|NCT02760095|Bangladesh|bangladesh
129576|NCT02760082|Multiple Sclerosis|multiple sclerosis
129577|NCT02760082|Qualitative study|qualitative study
129578|NCT02760082|Motivation|motivation
129579|NCT02760056|Thyroid hormone|thyroid hormone
129580|NCT02760056|Remyelination|remyelination
129581|NCT02760004|Depression|depression
129582|NCT02759991|Hepatitis E virus|hepatitis e virus
129583|NCT02759991|Viral Hepatitis Vaccines|viral hepatitis vaccines
129584|NCT02759978|Imaging|imaging
129585|NCT02759978|Computed Tomography|computed tomography
129586|NCT02759978|Magnetic Resonance Imaging|magnetic resonance imaging
129587|NCT02759978|Positron Emission Tomography|positron emission tomography
129588|NCT02759978|Leukocyte Scintigraphy|leukocyte scintigraphy
129589|NCT02759978|Microbiological diagnostics|microbiological diagnostics
129590|NCT02759978|Sonication|sonication
129591|NCT02759978|Drug Monitoring|drug monitoring
129592|NCT02759978|Cardiac Surgery|cardiac surgery
129593|NCT02759952|retinitis pigmentosa|retinitis pigmentosa
129594|NCT02759952|PDE6A|pde6a
129595|NCT02759952|gene therapy trial|gene therapy trial
129596|NCT02759939|Shared Decision-Making|shared decision-making
129597|NCT02759939|Patient-Provider Communication|patient-provider communication
129598|NCT02759926|Healthy volunteers|healthy volunteers
129599|NCT02759926|Obesity|obesity
129600|NCT02759926|Bitter|bitter
129601|NCT02759913|neuromuscular diseases|neuromuscular diseases
129602|NCT02759848|COPD, tuberculosis, mortality|copd, tuberculosis, mortality
129603|NCT02759835|EGFR Tyrosine Kinase Inhibitors|egfr tyrosine kinase inhibitors
129604|NCT02759835|T790M Mutation|t790m mutation
129605|NCT02759835|Local Ablative Therapies|local ablative therapies
129606|NCT02759835|Oligoprogressive Disease|oligoprogressive disease
129607|NCT02759835|Acquired Resistance|acquired resistance
129608|NCT02759822|Haploidentical Hematopoietic Stem Cell Transplantation|haploidentical hematopoietic stem cell transplantation
129609|NCT02759822|Partially Matched Hematopoietic Stem Cell Transplantation|partially matched hematopoietic stem cell transplantation
129610|NCT02759822|Post-transplant Cyclophosphamide|post-transplant cyclophosphamide
129611|NCT02759822|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
129612|NCT02759783|Radiotherapy|radiotherapy
129613|NCT02759783|oligometastases|oligometastases
129614|NCT02759783|SBRT|sbrt
129615|NCT02759757|Kinesio Taping|kinesio taping
129616|NCT02759757|Low back Pain|low back pain
129617|NCT02759757|Electromyographic|electromyographic
129618|NCT02759757|EMG|emg
129619|NCT02759744|Thermal Ablation|thermal ablation
129620|NCT02759744|Localized Prostate Cancer|localized prostate cancer
129621|NCT02759744|Medtronic-Visualase|medtronic-visualase
129622|NCT02759744|Thermal Damage|thermal damage
129623|NCT02759744|PSA Levels|psa levels
129624|NCT02759731|Murine Models|murine models
129625|NCT02759731|Rheumatoid Arthritis|rheumatoid arthritis
129626|NCT02759731|Corticosteroids|corticosteroids
129627|NCT02759731|Systemic Therapy|systemic therapy
129628|NCT02759731|Inflammatory Cytokines|inflammatory cytokines
129629|NCT02759718|pancreatic neuroendocrine tumor|pancreatic neuroendocrine tumor
129630|NCT02759718|chromogranin A|chromogranin a
129631|NCT02759705|fertility|fertility
129632|NCT02759705|sexuality|sexuality
129633|NCT02759705|male|male
129634|NCT02759705|exstrophy-epispadias complex|exstrophy-epispadias complex
129635|NCT02759705|bladder exstrophy|bladder exstrophy
129636|NCT02759705|epispadias|epispadias
129637|NCT02759666|PARP|parp
129638|NCT02759666|advanced solid tumor|advanced solid tumor
129639|NCT02759640|c-Met kinase inhibitor|c-met kinase inhibitor
129640|NCT02759640|Advanced solid tumors|advanced solid tumors
129641|NCT02759627|Rehabilitation|rehabilitation
129642|NCT02759627|Gait|gait
129643|NCT02759627|Ambulation|ambulation
129644|NCT02759627|Exercise Therapy|exercise therapy
129645|NCT02759627|Physical Exertion|physical exertion
129646|NCT02759627|Motor Skills|motor skills
129647|NCT02759601|HDAC Inhibitor|hdac inhibitor
129648|NCT02759601|Tefinostat|tefinostat
129649|NCT02759601|Inflammation|inflammation
129650|NCT02759601|Hepatocellular Carcinoma|hepatocellular carcinoma
129651|NCT02759601|Cancer associated Inflammation in Hepatocellular Carcinoma|cancer associated inflammation in hepatocellular carcinoma
129652|NCT02759588|GL-ONC1|gl-onc1
129653|NCT02759588|oncolytic virus|oncolytic virus
129654|NCT02759588|virotherapy|virotherapy
129655|NCT02759588|Viral therapy|viral therapy
129656|NCT02759588|immunotherapy|immunotherapy
129657|NCT02759588|immune therapy|immune therapy
129658|NCT02759588|vaccinia|vaccinia
129659|NCT02759588|vaccinia virus|vaccinia virus
129660|NCT02759588|Genelux|genelux
129661|NCT02759588|ovarian cancer|ovarian cancer
129662|NCT02759588|platinum resistant|platinum resistant
129663|NCT02759588|platinum refractory|platinum refractory
129664|NCT02759588|peritoneal carcinomatosis|peritoneal carcinomatosis
129665|NCT02759588|fallopian cancer|fallopian cancer
129666|NCT02759588|cancer|cancer
129667|NCT02759588|abdominal cancer|abdominal cancer
129668|NCT02759588|imaging|imaging
129669|NCT02759588|carcinoma|carcinoma
129670|NCT02759588|DNA virus|dna virus
129671|NCT02759588|neoplasms|neoplasms
129672|NCT02759588|neoplasms by histological type|neoplasms by histological type
129673|NCT02759588|neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
129674|NCT02759588|Poxviridae infections|poxviridae infections
129675|NCT02759588|Virus diseases|virus diseases
129676|NCT02759588|recurrent ovarian cancer|recurrent ovarian cancer
129677|NCT02759588|intermediate platinum-sensitive|intermediate platinum-sensitive
129678|NCT02759549|Radiation Therapy|radiation therapy
129679|NCT02759523|Magnetic Resonance Imaging|magnetic resonance imaging
129680|NCT02759523|Portion Size|portion size
129681|NCT02759523|Energy Intake|energy intake
129682|NCT02759510|cardiac output|cardiac output
129683|NCT02759510|norepinephrin|norepinephrin
129684|NCT02759510|cesarean section|cesarean section
129685|NCT02759484|CHWs|chws
129686|NCT02759484|Health Education|health education
129687|NCT02759484|Disease Self Management|disease self management
129688|NCT02759445|alcohol induced cardiomyopathy|alcohol induced cardiomyopathy
129689|NCT02759445|myocardial deformation imaging|myocardial deformation imaging
129690|NCT02759432|high-intensity interval training|high-intensity interval training
129691|NCT02759432|adolescents|adolescents
129692|NCT02759432|physical fitness|physical fitness
129693|NCT02759432|quality of life|quality of life
129694|NCT02759432|school-based intervention|school-based intervention
129695|NCT02759367|Nutrition|nutrition
129696|NCT02759367|Potassium|potassium
129697|NCT02759354|Immune response|immune response
129698|NCT02759328|Stroke|stroke
129699|NCT02759328|Rehabilitation|rehabilitation
129700|NCT02759328|Serious games|serious games
129701|NCT02759328|Virtual reality|virtual reality
129702|NCT02759328|Xbox Kinect™|xbox kinect™
129703|NCT02759302|MRI|mri
129704|NCT02759302|LGMD|lgmd
129705|NCT02759302|POMT2|pomt2
129706|NCT02759289|Arsenic|arsenic
129707|NCT02759276|Nailfold Videocapillaroscopy|nailfold videocapillaroscopy
129708|NCT02759276|Venous Occlusion Plethysmography|venous occlusion plethysmography
129709|NCT02759276|Endothelial Function|endothelial function
129710|NCT02759276|Microcirculation|microcirculation
129711|NCT02759276|Inflammatory Biomarkers|inflammatory biomarkers
129712|NCT02759185|PTSD|ptsd
129713|NCT02759185|marijuana|marijuana
129714|NCT02759185|cannabis|cannabis
129715|NCT02759185|sleep|sleep
129716|NCT02759185|THC|thc
129717|NCT02759185|CBD|cbd
129718|NCT02759172|Suicide prevention|suicide prevention
129719|NCT02759172|Jail|jail
129720|NCT02759120|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
129721|NCT02759120|IPF|ipf
129722|NCT02759120|pulmonary fibrosis|pulmonary fibrosis
129723|NCT02759120|antimicrobial therapy|antimicrobial therapy
129724|NCT02759120|doxycycline|doxycycline
129725|NCT02759120|co-trimoxazole|co-trimoxazole
129726|NCT02759094|GERD|gerd
129727|NCT02759094|Implantable medical device|implantable medical device
129728|NCT02759094|RefluxStop|refluxstop
129729|NCT02759094|Reflux|reflux
129730|NCT02759094|Gastroesophageal Reflux|gastroesophageal reflux
129731|NCT02759094|Laparoscopy|laparoscopy
129732|NCT02759094|pH-Monitoring|ph-monitoring
129733|NCT02759094|PPI proton pump inhibitors|ppi proton pump inhibitors
129734|NCT02759068|vegetative state|vegetative state
129735|NCT02759068|minimally conscious state|minimally conscious state
129736|NCT02759068|music|music
129737|NCT02759068|preference|preference
129738|NCT02758990|Food|food
129739|NCT02758990|Nutrigenomics|nutrigenomics
129740|NCT02758990|Precision Medicine|precision medicine
129741|NCT02758990|Pharmacogenetics|pharmacogenetics
129742|NCT02758990|Lifestyle|lifestyle
129743|NCT02758977|Colorectal liver metastases|colorectal liver metastases
129744|NCT02758977|Liver Surgery|liver surgery
129745|NCT02758977|ALPPS|alpps
129746|NCT02758977|Two Stage Hepatectomy|two stage hepatectomy
129747|NCT02758977|Surgical Oncology|surgical oncology
129748|NCT02758977|Hepatectomy|hepatectomy
129749|NCT02758964|TAVR|tavr
129750|NCT02758964|TAVI|tavi
129751|NCT02758964|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
129752|NCT02758964|Intracranial Embolism|intracranial embolism
129753|NCT02758951|Induction Chemotherapy|induction chemotherapy
129754|NCT02758951|Chemotherapy, Adjuvant|chemotherapy, adjuvant
129755|NCT02758951|Molecular Targeted Therapy|molecular targeted therapy
129756|NCT02758951|Colorectal Surgery|colorectal surgery
129757|NCT02758951|Cytoreductive Surgery|cytoreductive surgery
129758|NCT02758951|Hyperthermic Intraperitoneal Chemotherapy|hyperthermic intraperitoneal chemotherapy
129759|NCT02758951|Peritoneum|peritoneum
129760|NCT02758951|Peritoneal Lavage|peritoneal lavage
129761|NCT02758951|Peritoneal Cavity|peritoneal cavity
129762|NCT02758951|Ascitic Fluid|ascitic fluid
129763|NCT02758951|Chemotherapy, Cancer, Regional Perfusion|chemotherapy, cancer, regional perfusion
129764|NCT02758951|Antineoplastic Combined Chemotherapy Protocols|antineoplastic combined chemotherapy protocols
129765|NCT02758951|Drug Therapy, Combination|drug therapy, combination
129766|NCT02758951|Drug Therapy|drug therapy
129767|NCT02758951|Morbidity|morbidity
129768|NCT02758951|Mortality|mortality
129769|NCT02758951|Hospital Mortality|hospital mortality
129770|NCT02758951|Chemically-Induced Disorders|chemically-induced disorders
129771|NCT02758951|Drug-Related Side Effects and Adverse Reactions|drug-related side effects and adverse reactions
129772|NCT02758951|Laparotomy|laparotomy
129773|NCT02758899|Anterior cervical discectomy|anterior cervical discectomy
129774|NCT02758899|Anterior cervical fusion|anterior cervical fusion
129775|NCT02758860|Colonoscopy|colonoscopy
129776|NCT02758860|Diverticular disease of the colon|diverticular disease of the colon
129777|NCT02758860|Classification|classification
129778|NCT02758847|critical lower limb ischemia with tissue loss|critical lower limb ischemia with tissue loss
129779|NCT02758834|Preterm Infants|preterm infants
129780|NCT02758834|Phytosterols|phytosterols
129781|NCT02758834|Parenteral Nutrition|parenteral nutrition
129782|NCT02758821|C-reactive protein|c-reactive protein
129783|NCT02758821|antibiotic|antibiotic
129784|NCT02758795|protein|protein
129785|NCT02758795|inflammation|inflammation
129786|NCT02758795|anti-inflammatory agents|anti-inflammatory agents
129787|NCT02758743|smoking|smoking
129788|NCT02758743|tobacco|tobacco
129789|NCT02758743|smoking cessation|smoking cessation
129790|NCT02758730|GBA mutation|gba mutation
129791|NCT02758704|Intubation|intubation
129792|NCT02758704|Neonatal|neonatal
129793|NCT02758704|Teaching|teaching
129794|NCT02758704|Stress|stress
129795|NCT02758704|Simulation|simulation
129796|NCT02758691|memory|memory
129797|NCT02758691|insulin|insulin
129798|NCT02758678|P-selectin|p-selectin
129799|NCT02758678|Lung Cancer|lung cancer
129800|NCT02758678|Raman Spectroscopy|raman spectroscopy
129802|NCT02758665|chronic lymphocytic leukemia|chronic lymphocytic leukemia
129803|NCT02758665|ibrutinib|ibrutinib
129804|NCT02758665|venetoclax|venetoclax
129805|NCT02758665|obinutuzumab|obinutuzumab
129806|NCT02758665|TP53 Deletion|tp53 deletion
129807|NCT02758652|chemoresistance|chemoresistance
129808|NCT02758652|miRNA|mirna
129809|NCT02758652|microRNA|microrna
129810|NCT02758639|parental cancer|parental cancer
129811|NCT02758639|children psychosocial adjustment|children psychosocial adjustment
129812|NCT02758639|psychosocial intervention|psychosocial intervention
129813|NCT02758574|acute pulmonary embolism|acute pulmonary embolism
129814|NCT02758574|submassive pulmonary embolism|submassive pulmonary embolism
129815|NCT02758574|thrombolysis|thrombolysis
129816|NCT02758574|catheter directed thrombolysis|catheter directed thrombolysis
129817|NCT02758574|ultrasound assisted thrombolysis|ultrasound assisted thrombolysis
129818|NCT02758561|decisional aid|decisional aid
129819|NCT02758561|workshops|workshops
129820|NCT02758561|urinary incontinence|urinary incontinence
129821|NCT02758561|pelvic organ prolapse|pelvic organ prolapse
129822|NCT02758561|pelvic floor dysfunction|pelvic floor dysfunction
129823|NCT02758561|decisional conflict|decisional conflict
129824|NCT02758548|Total IgE measurement|total ige measurement
129825|NCT02758548|Novel Point-of-care test device|novel point-of-care test device
129826|NCT02758548|atopic conditions|atopic conditions
129827|NCT02758548|in vitro diagnostic test|in vitro diagnostic test
129828|NCT02758522|Diabetes Mellitus|diabetes mellitus
129829|NCT02758522|Hospital Hyperglycemia|hospital hyperglycemia
129830|NCT02758496|Autism, chart review, transcranial magnetic stimulation (TMS)|autism, chart review, transcranial magnetic stimulation (tms)
129831|NCT02758470|Muscle Fatigue|muscle fatigue
129832|NCT02758470|Acetazolamide|acetazolamide
129833|NCT02758470|Methazolamide|methazolamide
129834|NCT02758457|cad/cam|cad/cam
129835|NCT02758457|dental porcelain|dental porcelain
129836|NCT02758457|zirconia|zirconia
129837|NCT02758457|press on metal|press on metal
129838|NCT02758444|environmental enteric dysfunction|environmental enteric dysfunction
129839|NCT02758444|environmental enteropathy|environmental enteropathy
129840|NCT02758444|zinc absorption|zinc absorption
129841|NCT02758444|Bangladesh|bangladesh
129842|NCT02758444|toddlers|toddlers
129843|NCT02758444|zinc isotope|zinc isotope
129844|NCT02758431|testosterone|testosterone
129845|NCT02758418|Adjustment disorders online|adjustment disorders online
129846|NCT02758418|Psychological Treatments|psychological treatments
129847|NCT02758418|Information and Communication Technologies|information and communication technologies
129848|NCT02758418|Internet|internet
129849|NCT02758405|Epidural|epidural
129850|NCT02758405|Labor analgesia|labor analgesia
129851|NCT02758405|Programmed intermittent epidural bolus|programmed intermittent epidural bolus
129852|NCT02758392|Healthy|healthy
129853|NCT02758392|JNJ-61178104|jnj-61178104
129854|NCT02758392|Placebo|placebo
129855|NCT02758392|Safety|safety
129856|NCT02758379|coronary artery disease|coronary artery disease
129857|NCT02758379|calcified lesions|calcified lesions
129858|NCT02758379|lithotripsy|lithotripsy
129859|NCT02758366|glioblastoma multiforme|glioblastoma multiforme
129860|NCT02758366|high grade glioma|high grade glioma
129861|NCT02758366|diffuse intrinsic pontine glioma|diffuse intrinsic pontine glioma
129862|NCT02758366|DIPG|dipg
129863|NCT02758366|doxorubicin|doxorubicin
129864|NCT02758366|temozolomide|temozolomide
129865|NCT02758366|malignant glioma|malignant glioma
129866|NCT02758366|Brainstem Glioma|brainstem glioma
129867|NCT02758366|diffuse spinal glioma|diffuse spinal glioma
129868|NCT02758366|bilateral thalamic glioma|bilateral thalamic glioma
129869|NCT02758366|Anaplastic Astrocytoma|anaplastic astrocytoma
129870|NCT02758366|Gliomatosis Cerebri|gliomatosis cerebri
129871|NCT02758366|Midline Diffuse Glioma|midline diffuse glioma
129872|NCT02758353|Malaria in Pregnancy|malaria in pregnancy
129873|NCT02758353|Nigeria|nigeria
129874|NCT02758353|Sulfadoxine-Pyrimethamine|sulfadoxine-pyrimethamine
129875|NCT02758353|Scale up|scale up
129876|NCT02758353|Primary Health Care|primary health care
129877|NCT02758340|induction of labor|induction of labor
129878|NCT02758340|misoprostol|misoprostol
129879|NCT02758340|foley's balloon catheter|foley's balloon catheter
129880|NCT02758327|Tear Osmolarity|tear osmolarity
129881|NCT02758327|Keratitis Sicca|keratitis sicca
129882|NCT02758327|Ocular Surface Disease|ocular surface disease
129883|NCT02758327|TheraTears|theratears
129884|NCT02758314|PD-1|pd-1
129885|NCT02758314|PD-L1|pd-l1
129886|NCT02758314|NSCLC|nsclc
129887|NCT02758288|Kidney transplant|kidney transplant
129888|NCT02758288|BK Viremia|bk viremia
129889|NCT02758288|BK Nephropathy|bk nephropathy
129890|NCT02758275|Medication adherence|medication adherence
129891|NCT02758275|Patient compliance|patient compliance
129892|NCT02758275|Diabetes mellitus, Type 2|diabetes mellitus, type 2
129893|NCT02758275|Hypertension|hypertension
129894|NCT02758275|Nursing|nursing
129895|NCT02758275|Nursing process|nursing process
129896|NCT02758275|Teaching|teaching
129897|NCT02758275|Randomized controlled trial|randomized controlled trial
129898|NCT02758210|Bradycardia|bradycardia
129899|NCT02758210|Atrial Tachyarrhythmia|atrial tachyarrhythmia
129900|NCT02758210|Smart Phone|smart phone
129901|NCT02758210|Tablet|tablet
129902|NCT02758197|Mindfulness|mindfulness
129903|NCT02758197|Chronic Pain|chronic pain
129904|NCT02758197|Quality of Life|quality of life
129905|NCT02758197|Immune Function|immune function
129906|NCT02758197|Cancer survivors|cancer survivors
129907|NCT02758197|Disability|disability
129908|NCT02758132|Castrate-resistant prostate cancer with bone metastases|castrate-resistant prostate cancer with bone metastases
129909|NCT02758106|chest wall oscillation|chest wall oscillation
129910|NCT02758106|acute respiratory failure|acute respiratory failure
129911|NCT02758106|airway secretion|airway secretion
129912|NCT02758080|Personalized medicine|personalized medicine
129913|NCT02758080|Next generation sequencing|next generation sequencing
129914|NCT02758041|Acne|acne
129915|NCT02758028|Youth|youth
129916|NCT02758028|Adventure-based training|adventure-based training
129917|NCT02758028|WhatsApp messages|whatsapp messages
129918|NCT02758015|betaine|betaine
129919|NCT02758015|betaine hydrochloride|betaine hydrochloride
129920|NCT02758015|healthy volunteer|healthy volunteer
129921|NCT02758015|gastric pH|gastric ph
129922|NCT02758002|atrial fibrillation ablation|atrial fibrillation ablation
129923|NCT02758002|ablation|ablation
129924|NCT02758002|atrial fibrillation rotors|atrial fibrillation rotors
129925|NCT02757989|Low risk MDS|low risk mds
129926|NCT02757989|Transplantation|transplantation
129927|NCT02757963|Screening tool|screening tool
129928|NCT02757963|International Prostate Symptom Score|international prostate symptom score
129929|NCT02757963|Lower urinary tract symptoms|lower urinary tract symptoms
129930|NCT02757963|BPO|bpo
129931|NCT02757963|BPE|bpe
129932|NCT02757963|Benign prostatic enlargement|benign prostatic enlargement
129933|NCT02757963|Benign prostatic obstruction|benign prostatic obstruction
129934|NCT02757963|LUTS|luts
129935|NCT02757963|Benign prostatic hyperplasia|benign prostatic hyperplasia
129936|NCT02757963|IPSS|ipss
129937|NCT02757963|BPH|bph
129938|NCT02757950|exposed and unexposed cohorts|exposed and unexposed cohorts
129939|NCT02757950|post-marketing, maternal immunization|post-marketing, maternal immunization
129940|NCT02757950|neonate related Adverse Events|neonate related adverse events
129941|NCT02757950|Congenital anomaly|congenital anomaly
129942|NCT02757950|RefortrixTM|refortrixtm
129943|NCT02757950|Pregnancy related Adverse Events|pregnancy related adverse events
129944|NCT02757937|Medication Adherence|medication adherence
129945|NCT02757937|Self-efficacy|self-efficacy
129946|NCT02757937|Behavior|behavior
129947|NCT02757937|Diabetes|diabetes
129948|NCT02757937|Diabetes Mellitus|diabetes mellitus
129949|NCT02757911|XCGD|xcgd
129950|NCT02757898|Red Blood Cell (RBC) transfusion|red blood cell (rbc) transfusion
129951|NCT02757898|Biotin labeled red blood cells|biotin labeled red blood cells
129952|NCT02757885|bone marrow transplant|bone marrow transplant
129953|NCT02757872|Hypertension|hypertension
129954|NCT02757872|Kidney Diseases|kidney diseases
129955|NCT02757872|Vitamin D|vitamin d
129956|NCT02757872|Omega 3 fatty acids|omega 3 fatty acids
129957|NCT02757846|Radiomics|radiomics
129958|NCT02757846|prognosis|prognosis
129959|NCT02757846|medical images|medical images
129960|NCT02757846|Hepatocellular carcinoma|hepatocellular carcinoma
129961|NCT02757820|anesthesia; airway; laryngeal mask airway; I-gel; Air-Q|anesthesia; airway; laryngeal mask airway; i-gel; air-q
129962|NCT02757807|Erectile Dysfunction|erectile dysfunction
129963|NCT02757781|Patient empowerment|patient empowerment
129964|NCT02757781|Patient involvement|patient involvement
129965|NCT02757781|Patient participation|patient participation
129966|NCT02757781|Healthcare professional attitudes|healthcare professional attitudes
129967|NCT02757781|Chronic diseases|chronic diseases
129968|NCT02757768|Myrbetriq|myrbetriq
129969|NCT02757768|Lower Urinary Tract Symptoms|lower urinary tract symptoms
129970|NCT02757768|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
129971|NCT02757768|Overactive Bladder|overactive bladder
129972|NCT02757768|Betmiga|betmiga
129973|NCT02757768|Mirabegron|mirabegron
129974|NCT02757768|Tamsulosin Hydrochloride|tamsulosin hydrochloride
129975|NCT02757742|sudden cardiac death|sudden cardiac death
129976|NCT02757742|ventricular arrhythmias|ventricular arrhythmias
129977|NCT02757742|cardiopathy|cardiopathy
129978|NCT02757742|late gadolinium enhancement|late gadolinium enhancement
129979|NCT02757716|addiction remission|addiction remission
129980|NCT02757716|addiction transfer|addiction transfer
129981|NCT02757703|somatostatin|somatostatin
129982|NCT02757703|variceal bleeding|variceal bleeding
129983|NCT02757703|terlipressin|terlipressin
129984|NCT02757664|achilles|achilles
129985|NCT02757664|tendinopathy|tendinopathy
129986|NCT02757664|Physical Therapy Modalities|physical therapy modalities
129987|NCT02757664|High-Energy Shock Waves|high-energy shock waves
129988|NCT02757612|laser diode, pain|laser diode, pain
129989|NCT02757586|chronic lymphocytic leukemia|chronic lymphocytic leukemia
129990|NCT02757586|XPO1|xpo1
129991|NCT02757586|in vitro|in vitro
129992|NCT02757586|in vivo|in vivo
129993|NCT02757560|saturated fat|saturated fat
130101|NCT02757079|DSM-5|dsm-5
129994|NCT02757560|acute insulin resistance|acute insulin resistance
129995|NCT02757560|insulin suppression test|insulin suppression test
129996|NCT02757560|dietary fatty acids|dietary fatty acids
129997|NCT02757521|Bipolar Depressive Disorder|bipolar depressive disorder
129998|NCT02757521|Treatment- Resistant Bipolar Disorder|treatment- resistant bipolar disorder
129999|NCT02757521|Nitrous Oxide|nitrous oxide
130000|NCT02757495|sevoflurane emergence agitation|sevoflurane emergence agitation
130001|NCT02757495|caudal dexmedetomidine|caudal dexmedetomidine
130002|NCT02757482|Patient training|patient training
130003|NCT02757482|Warfarin|warfarin
130004|NCT02757482|International Normalized Ratio|international normalized ratio
130005|NCT02757482|Nursing|nursing
130006|NCT02757456|exercise|exercise
130007|NCT02757456|hemodialysis|hemodialysis
130008|NCT02757456|pulse wave velocity|pulse wave velocity
130009|NCT02757456|micro RNAs|micro rnas
130010|NCT02757443|Phosphocreatine|phosphocreatine
130011|NCT02757443|Creatine Phosphate|creatine phosphate
130012|NCT02757443|Neoton|neoton
130013|NCT02757443|Phosphate, Creatine|phosphate, creatine
130014|NCT02757443|Phosphorylcreatine|phosphorylcreatine
130015|NCT02757404|botulinum toxin|botulinum toxin
130016|NCT02757404|spasticity|spasticity
130017|NCT02757404|injection technique|injection technique
130018|NCT02757404|neuronox|neuronox
130019|NCT02757404|meditoxin|meditoxin
130020|NCT02757391|Advanced gastrointestinal malignancies|advanced gastrointestinal malignancies
130021|NCT02757391|Metastatic gastrointestinal tumor|metastatic gastrointestinal tumor
130022|NCT02757391|Adoptive T cell infusion|adoptive t cell infusion
130023|NCT02757391|Cyclophosphamide|cyclophosphamide
130024|NCT02757391|Cytoxan|cytoxan
130025|NCT02757391|Neosar|neosar
130026|NCT02757391|IL-2|il-2
130027|NCT02757391|Aldesleukin|aldesleukin
130028|NCT02757391|Interleukin-2|interleukin-2
130029|NCT02757391|Proleukin|proleukin
130030|NCT02757391|Pembrolizumab|pembrolizumab
130031|NCT02757391|Keytruda|keytruda
130032|NCT02757391|MK-3475|mk-3475
130033|NCT02757391|SCH-900475|sch-900475
130034|NCT02757391|Phone calls|phone calls
130035|NCT02757378|Pain|pain
130036|NCT02757378|Brain|brain
130037|NCT02757378|Plasticity|plasticity
130038|NCT02757378|Education|education
130039|NCT02757378|Manual Therapy|manual therapy
130040|NCT02757378|Straight Leg Raise|straight leg raise
130041|NCT02757378|Remapping|remapping
130042|NCT02757365|aspirin|aspirin
130043|NCT02757352|ankylosing|ankylosing
130044|NCT02757352|nonradiographic spondyloarthritis|nonradiographic spondyloarthritis
130045|NCT02757339|neurobiology|neurobiology
130046|NCT02757339|PTSD|ptsd
130047|NCT02757339|DID|did
130048|NCT02757326|sphingosine kinase 2 inhibitor|sphingosine kinase 2 inhibitor
130049|NCT02757326|sphingosine kinase 2|sphingosine kinase 2
130050|NCT02757326|SK2 inhibitor|sk2 inhibitor
130051|NCT02757326|SK2|sk2
130052|NCT02757313|marijuana|marijuana
130053|NCT02757313|driving|driving
130054|NCT02757313|THC|thc
130055|NCT02757313|cannabis|cannabis
130056|NCT02757313|intoxication|intoxication
130057|NCT02757313|MRI|mri
130058|NCT02757287|Ovarian stimulation|ovarian stimulation
130059|NCT02757287|LH inhibition|lh inhibition
130060|NCT02757274|Urologic Surgical Procedure|urologic surgical procedure
130061|NCT02757274|Male|male
130062|NCT02757261|Bruxism|bruxism
130063|NCT02757261|Child|child
130064|NCT02757261|Occlusal splint|occlusal splint
130065|NCT02757261|Bite force|bite force
130066|NCT02757261|Acunpuncture|acunpuncture
130067|NCT02757261|Laser|laser
130068|NCT02757261|Muscle actvity|muscle actvity
130069|NCT02757261|Salivary Cortisol|salivary cortisol
130070|NCT02757235|chronic subdural hematoma|chronic subdural hematoma
130071|NCT02757235|irrigation|irrigation
130072|NCT02757235|recurrence|recurrence
130073|NCT02757235|burr hole evacuation|burr hole evacuation
130074|NCT02757235|temperature|temperature
130075|NCT02757209|ASTHMA|asthma
130076|NCT02757209|COPD|copd
130077|NCT02757209|budesonide|budesonide
130078|NCT02757209|formoterol|formoterol
130079|NCT02757209|Salmeterol|salmeterol
130080|NCT02757209|Fluticasone|fluticasone
130081|NCT02757209|Spiromax|spiromax
130082|NCT02757209|DPI|dpi
130083|NCT02757209|Diskus|diskus
130084|NCT02757196|Immune Thrombocytopenia|immune thrombocytopenia
130085|NCT02757196|Rituximab|rituximab
130086|NCT02757196|methylprednisolone|methylprednisolone
130087|NCT02757157|Hydrotherapy|hydrotherapy
130088|NCT02757157|Walking|walking
130089|NCT02757131|Mobility|mobility
130090|NCT02757131|Elderly|elderly
130091|NCT02757131|Hospitalized patient|hospitalized patient
130092|NCT02757118|Cardiac Surgery, blood viscosity|cardiac surgery, blood viscosity
130093|NCT02757092|Pulmonary rehabilitation|pulmonary rehabilitation
130094|NCT02757092|lung cancer|lung cancer
130095|NCT02757092|Thoracoscopy|thoracoscopy
130096|NCT02757079|Melatonin|melatonin
130097|NCT02757079|NPC-15|npc-15
130098|NCT02757079|Sleep disorders|sleep disorders
130099|NCT02757079|Neurodevelopmental disorder|neurodevelopmental disorder
130100|NCT02757079|Sleep latency|sleep latency
130102|NCT02757066|Melatonin|melatonin
130103|NCT02757066|NPC-15|npc-15
130104|NCT02757066|Sleep disorders|sleep disorders
130105|NCT02757066|Autism spectrum disorders|autism spectrum disorders
130106|NCT02757066|DSM-5|dsm-5
130107|NCT02757053|Brain Concussion|brain concussion
130108|NCT02757053|Brain Injuries|brain injuries
130109|NCT02757053|Diffuse Axonal Injury|diffuse axonal injury
130110|NCT02757053|Football|football
130111|NCT02757053|Head Protective Devices|head protective devices
130112|NCT02757053|Magnetic Resonance Imaging|magnetic resonance imaging
130113|NCT02757053|Helmet|helmet
130114|NCT02757053|Third party add-on|third party add-on
130115|NCT02757040|chronic lymphocytic leukemia|chronic lymphocytic leukemia
130116|NCT02757040|ibrutinib|ibrutinib
130117|NCT02757040|arsenic trioxide|arsenic trioxide
130118|NCT02757040|phosphatidylinositol 3-kinase|phosphatidylinositol 3-kinase
130119|NCT02757027|CABG surgery|cabg surgery
130120|NCT02757027|blood viscosity|blood viscosity
130121|NCT02757001|Retrievable Inferior Vena Cava Filters|retrievable inferior vena cava filters
130122|NCT02757001|Pulmonary Embolism|pulmonary embolism
130123|NCT02756923|Male Infertility|male infertility
130124|NCT02756923|Spermatogonial stem cell|spermatogonial stem cell
130125|NCT02756910|open abdominal surgery|open abdominal surgery
130126|NCT02756910|anesthesia, general|anesthesia, general
130127|NCT02756897|Leukemia|leukemia
130128|NCT02756897|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
130129|NCT02756897|CLL|cll
130130|NCT02756897|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
130131|NCT02756897|SLL|sll
130132|NCT02756897|Refractory and/or relapsed|refractory and/or relapsed
130133|NCT02756897|Ibrutinib|ibrutinib
130134|NCT02756897|PCI-32765|pci-32765
130135|NCT02756897|Imbruvica|imbruvica
130136|NCT02756897|Venetoclax|venetoclax
130137|NCT02756897|ABT-199|abt-199
130138|NCT02756897|GDC-0199|gdc-0199
130139|NCT02756845|Non CNS Tumor|non cns tumor
130140|NCT02756832|Drug Therapy|drug therapy
130141|NCT02756819|Drug Therapy|drug therapy
130142|NCT02756806|Tattoo removal, Picosecond Laser, Q-switched Laser|tattoo removal, picosecond laser, q-switched laser
130143|NCT02756780|Remission|remission
130144|NCT02756780|Carer|carer
130145|NCT02756780|Psychological|psychological
130146|NCT02756780|Bereaved|bereaved
130147|NCT02756780|Cancer|cancer
130148|NCT02756780|Breast|breast
130149|NCT02756780|Prostate|prostate
130150|NCT02756780|Colorectal|colorectal
130151|NCT02756780|Music|music
130152|NCT02756741|Cirrhosis|cirrhosis
130153|NCT02756741|hepatitis B virus|hepatitis b virus
130154|NCT02756741|Alcohol|alcohol
130155|NCT02756741|varices|varices
130156|NCT02756702|TKA|tka
130157|NCT02756702|TKR|tkr
130158|NCT02756702|All-Poly|all-poly
130159|NCT02756702|posterior stabilized|posterior stabilized
130160|NCT02756689|Mechanical cervical ripening|mechanical cervical ripening
130161|NCT02756689|Transcervical catheter|transcervical catheter
130162|NCT02756689|Foley catheter for labor induction|foley catheter for labor induction
130163|NCT02756689|Cervical ripening|cervical ripening
130164|NCT02756689|Induction of labor|induction of labor
130165|NCT02756676|Parkinson Disease|parkinson disease
130166|NCT02756676|Quality of Life|quality of life
130167|NCT02756676|Rehabilitation|rehabilitation
130168|NCT02756663|multiple myeloma|multiple myeloma
130169|NCT02756663|MM|mm
130170|NCT02756663|relapsed|relapsed
130171|NCT02756663|relapsed and refractory|relapsed and refractory
130172|NCT02756663|panobinostat|panobinostat
130173|NCT02756663|LBH589|lbh589
130174|NCT02756663|histone deacetylase inhibitor|histone deacetylase inhibitor
130175|NCT02756663|carfilzomib|carfilzomib
130176|NCT02756663|proteasome inhibitor|proteasome inhibitor
130177|NCT02756650|Behcet Disease|behcet disease
130178|NCT02756650|Inflammation|inflammation
130179|NCT02756650|Immune system|immune system
130180|NCT02756650|Arthritis|arthritis
130181|NCT02756611|Oncology|oncology
130182|NCT02756611|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
130183|NCT02756611|17p Deletion|17p deletion
130184|NCT02756611|TP53 Mutation|tp53 mutation
130185|NCT02756611|Relapsed|relapsed
130186|NCT02756611|Refractory|refractory
130187|NCT02756611|B-Cell receptor inhibitor|b-cell receptor inhibitor
130188|NCT02756598|sufentanil|sufentanil
130189|NCT02756598|propofol|propofol
130190|NCT02756598|personality/stress test|personality/stress test
130191|NCT02756598|fast-track|fast-track
130192|NCT02756585|computed tomography|computed tomography
130193|NCT02756585|perfusion imaging|perfusion imaging
130194|NCT02756585|brain death|brain death
130195|NCT02756585|traumatic brain injury|traumatic brain injury
130196|NCT02756559|sepsis|sepsis
130197|NCT02756559|microRNAs|micrornas
130198|NCT02756520|chronic kidney disease, pre-dialytic|chronic kidney disease, pre-dialytic
130199|NCT02756520|Ketosteril, keto-acids|ketosteril, keto-acids
130200|NCT02756520|diet, protein-restricted|diet, protein-restricted
130201|NCT02756520|renal function|renal function
130202|NCT02756507|anxiety symptoms|anxiety symptoms
130203|NCT02756507|depression symptoms|depression symptoms
130507|NCT02754544|fMRI|fmri
130204|NCT02756507|internalizing symptoms|internalizing symptoms
130205|NCT02756468|pancreatic cancer|pancreatic cancer
130206|NCT02756468|procalcitonin|procalcitonin
130207|NCT02756455|gastric cancer|gastric cancer
130208|NCT02756455|procalcitonin|procalcitonin
130209|NCT02756429|atrial fibrillation|atrial fibrillation
130210|NCT02756429|stroke|stroke
130211|NCT02756429|thromboembolism|thromboembolism
130212|NCT02756429|inflammation|inflammation
130213|NCT02756416|Reversible Cerebral Vasoconstriction Syndrome (RCVS)|reversible cerebral vasoconstriction syndrome (rcvs)
130214|NCT02756416|Arterial spin labeling (ASL) MRI|arterial spin labeling (asl) mri
130215|NCT02756390|Insomnia cancer Survivor|insomnia cancer survivor
130216|NCT02756364|Drug Therapy|drug therapy
130217|NCT02756325|Azoospermia, IVF, MRI|azoospermia, ivf, mri
130218|NCT02756299|Sleep Apnea|sleep apnea
130219|NCT02756299|Positive Airway Pressure|positive airway pressure
130220|NCT02756299|Patient Education|patient education
130221|NCT02756286|Electroencephalography|electroencephalography
130222|NCT02756286|Attention|attention
130223|NCT02756273|ileostomy|ileostomy
130224|NCT02756273|morbidity|morbidity
130225|NCT02756273|colorectal surgery|colorectal surgery
130226|NCT02756247|Buparlisib|buparlisib
130227|NCT02756247|BKM120|bkm120
130228|NCT02756247|Ibrutinib|ibrutinib
130229|NCT02756247|16-009|16-009
130230|NCT02756221|symptoms|symptoms
130231|NCT02756208|vaccine|vaccine
130232|NCT02756208|healthy volunteer|healthy volunteer
130233|NCT02756195|Patient safety|patient safety
130234|NCT02756195|adverse events|adverse events
130235|NCT02756195|pediatric surgery|pediatric surgery
130236|NCT02756195|quality improvement|quality improvement
130237|NCT02756195|health systems|health systems
130238|NCT02756195|observational study|observational study
130239|NCT02756195|non-routine event|non-routine event
130240|NCT02756195|National Surgical Improvement Program|national surgical improvement program
130241|NCT02756169|Obesity|obesity
130242|NCT02756169|Breastfeeding|breastfeeding
130243|NCT02756169|Grow up|grow up
130244|NCT02756169|Milk composition|milk composition
130245|NCT02756169|Mexico|mexico
130246|NCT02756156|interscalene|interscalene
130247|NCT02756156|infraclavicular|infraclavicular
130248|NCT02756156|humerus surgery|humerus surgery
130249|NCT02756143|fetal heart|fetal heart
130250|NCT02756143|cesarean section|cesarean section
130251|NCT02756143|exercise|exercise
130252|NCT02756143|pregnancy|pregnancy
130253|NCT02756091|Intracranial Artery Dissection|intracranial artery dissection
130254|NCT02756091|IAD|iad
130255|NCT02756091|Stroke|stroke
130256|NCT02756091|Observational Study|observational study
130257|NCT02756065|Bipolar|bipolar
130258|NCT02756065|schizophrenia|schizophrenia
130259|NCT02756065|schizoaffective|schizoaffective
130260|NCT02756026|Breast milk|breast milk
130261|NCT02756026|mineral|mineral
130262|NCT02756026|vitamin|vitamin
130263|NCT02756013|chemotherapy dosing|chemotherapy dosing
130264|NCT02756013|Body surface area|body surface area
130265|NCT02756013|BSA|bsa
130266|NCT02756013|paclitaxel|paclitaxel
130267|NCT02756013|carboplatin|carboplatin
130268|NCT02756013|dose dense|dose dense
130269|NCT02756000|myocardial infarction|myocardial infarction
130270|NCT02756000|percutaneous coronary intervention|percutaneous coronary intervention
130271|NCT02756000|multivessel coronary artery disease|multivessel coronary artery disease
130272|NCT02756000|dobutamine stress echocardiography|dobutamine stress echocardiography
130273|NCT02755961|End-stage renal disease|end-stage renal disease
130274|NCT02755961|Phosphate binders|phosphate binders
130275|NCT02755961|Hyperphosphatemia|hyperphosphatemia
130276|NCT02755961|Dietary education|dietary education
130277|NCT02755922|Mesenchymal Stem Cells|mesenchymal stem cells
130278|NCT02755922|Treatment|treatment
130279|NCT02755909|Cardiac surgery, anxiety, education|cardiac surgery, anxiety, education
130280|NCT02755883|Physical activity|physical activity
130281|NCT02755883|non-small lung cancer|non-small lung cancer
130282|NCT02755883|positive affect|positive affect
130283|NCT02755857|Prophylaxis|prophylaxis
130284|NCT02755857|Bioavailability|bioavailability
130285|NCT02755857|Pharmacokinetics|pharmacokinetics
130286|NCT02755844|endometrial carcinomas|endometrial carcinomas
130287|NCT02755844|metronomic cyclophosphamide|metronomic cyclophosphamide
130288|NCT02755844|metformin|metformin
130289|NCT02755844|olaparib|olaparib
130290|NCT02755844|dose-escalation study|dose-escalation study
130291|NCT02755818|high density lipoprotein (HDL)|high density lipoprotein (hdl)
130292|NCT02755818|lipid|lipid
130293|NCT02755818|insulin resistance|insulin resistance
130294|NCT02755818|glomerular filtration rate (GFR)|glomerular filtration rate (gfr)
130295|NCT02755818|obesity|obesity
130296|NCT02755805|Stroke|stroke
130297|NCT02755805|Rehabilitation|rehabilitation
130298|NCT02755805|Cognition|cognition
130299|NCT02755805|Intervention|intervention
130300|NCT02755805|Strategy training|strategy training
130301|NCT02755792|Mild Cognitive Impairment|mild cognitive impairment
130302|NCT02755792|Cognitive training|cognitive training
130303|NCT02755792|Calligraphy|calligraphy
130304|NCT02755792|Emotional calmness|emotional calmness
130606|NCT02753790|Hippocampus|hippocampus
130305|NCT02755792|Working memory|working memory
130306|NCT02755753|Rebamipide|rebamipide
130307|NCT02755740|female|female
130308|NCT02755688|atrial fibrillation|atrial fibrillation
130309|NCT02755688|catheter ablation|catheter ablation
130310|NCT02755688|thoracoscopic surgical ablation|thoracoscopic surgical ablation
130311|NCT02755688|long standing persistent atrial fibrillation|long standing persistent atrial fibrillation
130312|NCT02755662|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
130313|NCT02755662|mandibular repositioning device|mandibular repositioning device
130314|NCT02755636|Health Behavior Change|health behavior change
130315|NCT02755636|Primary Health Care|primary health care
130316|NCT02755636|Patient Participation|patient participation
130317|NCT02755636|Provider-Patient Communication|provider-patient communication
130318|NCT02755636|Cluster-Randomized Trial|cluster-randomized trial
130319|NCT02755636|Mobile Health|mobile health
130320|NCT02755610|Peritoneal Dialysis|peritoneal dialysis
130321|NCT02755610|Checklist|checklist
130322|NCT02755597|relapsed/refractory multiple myeloma|relapsed/refractory multiple myeloma
130323|NCT02755597|relapsed multiple myeloma|relapsed multiple myeloma
130324|NCT02755597|refractory multiple myeloma|refractory multiple myeloma
130325|NCT02755597|multiple myeloma|multiple myeloma
130326|NCT02755584|Aging|aging
130327|NCT02755584|Senescent Cells|senescent cells
130328|NCT02755532|Pharmacokinetics|pharmacokinetics
130329|NCT02755532|Bupivacaine|bupivacaine
130330|NCT02755532|Axillary brachial plexus block|axillary brachial plexus block
130331|NCT02755519|primary aldosteronism|primary aldosteronism
130332|NCT02755519|confirmatory test|confirmatory test
130333|NCT02755519|hypertension|hypertension
130334|NCT02755506|Ultrasound elastography|ultrasound elastography
130335|NCT02755506|Thoracic lesions|thoracic lesions
130336|NCT02755506|EBUS-TBNA|ebus-tbna
130337|NCT02755480|bone marrow transplant|bone marrow transplant
130338|NCT02755480|infection|infection
130339|NCT02755480|computed tomography|computed tomography
130340|NCT02755480|radiation dose|radiation dose
130341|NCT02755441|Diagnosis|diagnosis
130342|NCT02755441|Prognosis|prognosis
130343|NCT02755441|Biomarker|biomarker
130344|NCT02755415|Rehabilitation|rehabilitation
130345|NCT02755415|Robotic|robotic
130346|NCT02755415|Gait|gait
130347|NCT02755415|Quality of Life|quality of life
130348|NCT02755389|Tracheal intubation|tracheal intubation
130349|NCT02755389|High flow nasal oxygen|high flow nasal oxygen
130350|NCT02755389|Airway management|airway management
130351|NCT02755389|Apneic oxygenation|apneic oxygenation
130352|NCT02755363|COPD|copd
130353|NCT02755363|residual volume|residual volume
130354|NCT02755363|osteopathy|osteopathy
130355|NCT02755363|hyperinflation|hyperinflation
130356|NCT02755350|PrEP|prep
130357|NCT02755350|HIV Prevention|hiv prevention
130358|NCT02755350|combination prevention|combination prevention
130359|NCT02755350|demonstration project|demonstration project
130360|NCT02755337|adenocarcinoma|adenocarcinoma
130361|NCT02755337|non-adenocarcinoma|non-adenocarcinoma
130362|NCT02755298|Treatment Outcome|treatment outcome
130363|NCT02755298|Acetazolamide|acetazolamide
130364|NCT02755272|Triple Negative Breast Cancer|triple negative breast cancer
130365|NCT02755259|Acetazolamide|acetazolamide
130366|NCT02755259|Hemodynamics|hemodynamics
130367|NCT02755246|subjective cognitive decline|subjective cognitive decline
130368|NCT02755246|dementia|dementia
130369|NCT02755246|lifestyle|lifestyle
130370|NCT02755246|polyamine|polyamine
130371|NCT02755246|memory|memory
130372|NCT02755246|elderly|elderly
130373|NCT02755246|prevention|prevention
130374|NCT02755246|treatment|treatment
130375|NCT02755246|dietary supplement|dietary supplement
130376|NCT02755246|Polyamine-enriched diet|polyamine-enriched diet
130377|NCT02755194|pharmacokinetics|pharmacokinetics
130378|NCT02755194|Drug-in-milk|drug-in-milk
130379|NCT02755194|breastfeeding|breastfeeding
130380|NCT02755194|drug safety|drug safety
130381|NCT02755194|population pharmacokinetics|population pharmacokinetics
130382|NCT02755155|acute circulatory failure requiring norepinephrine|acute circulatory failure requiring norepinephrine
130383|NCT02755155|SIRS|sirs
130384|NCT02755155|Albumin, therapeutic|albumin, therapeutic
130385|NCT02755116|Nausea|nausea
130386|NCT02755116|Vomiting|vomiting
130387|NCT02755103|Mindfulness|mindfulness
130388|NCT02755103|Comorbid PTSD and SUD|comorbid ptsd and sud
130389|NCT02755103|Meditation|meditation
130390|NCT02755090|nitrous|nitrous
130391|NCT02755090|pain|pain
130392|NCT02755077|Anesthesia induction|anesthesia induction
130393|NCT02755077|Airway|airway
130394|NCT02755077|Mask ventilation|mask ventilation
130395|NCT02755038|postmenopausal women|postmenopausal women
130396|NCT02755038|scalp hair|scalp hair
130397|NCT02755038|estrogen|estrogen
130398|NCT02755038|progesterone|progesterone
130399|NCT02755025|Sepsis|sepsis
130400|NCT02755025|SOFA score|sofa score
130401|NCT02755025|Automated calculation|automated calculation
130402|NCT02755012|Maternal Health|maternal health
130403|NCT02755012|Guatemala|guatemala
130404|NCT02755012|Indigenous Population|indigenous population
130405|NCT02755012|Stunting|stunting
130406|NCT02755012|Food Insecurity|food insecurity
130407|NCT02755012|Poverty|poverty
130408|NCT02755012|Social Support|social support
130409|NCT02755012|Maternal Autonomy|maternal autonomy
130410|NCT02755012|Paternal Support|paternal support
130411|NCT02755012|Cortisol Rhythm|cortisol rhythm
130412|NCT02754986|heart rate variability|heart rate variability
130413|NCT02754960|Gastrointestinal bleeding|gastrointestinal bleeding
130414|NCT02754960|Vascular malformation|vascular malformation
130415|NCT02754960|Angiodysplasia|angiodysplasia
130416|NCT02754960|Thalidomide|thalidomide
130417|NCT02754947|Assessment and Consultation Team (ACT)|assessment and consultation team (act)
130418|NCT02754947|Rapid Response Team (RRT)|rapid response team (rrt)
130419|NCT02754947|Perioperative complications|perioperative complications
130420|NCT02754947|Respiratory insufficiency|respiratory insufficiency
130421|NCT02754947|ASA status|asa status
130422|NCT02754934|chronic|chronic
130423|NCT02754895|acute coronary syndrome|acute coronary syndrome
130424|NCT02754895|health behavior|health behavior
130425|NCT02754895|factorial design|factorial design
130426|NCT02754895|positive psychology|positive psychology
130427|NCT02754882|NSCLC|nsclc
130428|NCT02754882|bevacizumab|bevacizumab
130429|NCT02754882|avastin|avastin
130430|NCT02754856|Colorectal Cancer|colorectal cancer
130431|NCT02754856|Liver Metastases|liver metastases
130432|NCT02754856|Resectable liver metastases|resectable liver metastases
130433|NCT02754856|Tremelimumab|tremelimumab
130434|NCT02754856|Fluorouracil|fluorouracil
130435|NCT02754856|5-Fluorouracil|5-fluorouracil
130436|NCT02754856|5-FU|5-fu
130437|NCT02754856|Adrucil|adrucil
130438|NCT02754856|Efudex|efudex
130439|NCT02754856|Leucovorin|leucovorin
130440|NCT02754856|Citrovorum|citrovorum
130441|NCT02754856|Wellcovorin|wellcovorin
130442|NCT02754856|Oxaliplatin|oxaliplatin
130443|NCT02754856|Eloxatin|eloxatin
130444|NCT02754856|Bevacizumab|bevacizumab
130445|NCT02754856|Avastin|avastin
130446|NCT02754856|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
130447|NCT02754856|MEDI4736|medi4736
130448|NCT02754856|Durvalumab|durvalumab
130449|NCT02754778|arterial stiffness|arterial stiffness
130450|NCT02754778|preeclampsia|preeclampsia
130451|NCT02754778|HELLP-syndrome|hellp-syndrome
130452|NCT02754778|pulse wave velocity|pulse wave velocity
130453|NCT02754778|advanced glycation endproducts|advanced glycation endproducts
130454|NCT02754778|skin autofluorescence|skin autofluorescence
130455|NCT02754778|conditional workout|conditional workout
130456|NCT02754778|postpartum|postpartum
130457|NCT02754778|cardiovascular risk|cardiovascular risk
130458|NCT02754778|pregnancy|pregnancy
130459|NCT02754778|vicorder|vicorder
130460|NCT02754778|age reader|age reader
130461|NCT02754752|Malignant neoplasm of breast|malignant neoplasm of breast
130462|NCT02754752|Electro-acupuncture|electro-acupuncture
130463|NCT02754752|Questionnaires|questionnaires
130465|NCT02754752|Standard of care|standard of care
130466|NCT02754752|Chronic Pain|chronic pain
130467|NCT02754739|Pravastatin|pravastatin
130468|NCT02754739|Insulin Resistance|insulin resistance
130469|NCT02754700|Anterior Cruciate Ligament|anterior cruciate ligament
130470|NCT02754687|male contraception|male contraception
130471|NCT02754687|healthy men|healthy men
130472|NCT02754687|androgen|androgen
130473|NCT02754687|Nortestosterone|nortestosterone
130474|NCT02754687|Dodecylcarbonate|dodecylcarbonate
130475|NCT02754687|11-Beta|11-beta
130476|NCT02754687|11β|11β
130477|NCT02754687|contraception|contraception
130478|NCT02754661|Polyps; Capsule endoscopy; CT Colonography; Colonoscopy; Average risk patients for colorectal cancer screening|polyps; capsule endoscopy; ct colonography; colonoscopy; average risk patients for colorectal cancer screening
130479|NCT02754635|Abnormal first or second trimester biochemical markers|abnormal first or second trimester biochemical markers
130480|NCT02754635|maternal and perinatal morbidity/mortality|maternal and perinatal morbidity/mortality
130481|NCT02754622|Rehabilitation|rehabilitation
130482|NCT02754609|Celiac Disease|celiac disease
130483|NCT02754609|Necator americanus|necator americanus
130484|NCT02754609|Helminths|helminths
130485|NCT02754609|Autoimmunity|autoimmunity
130486|NCT02754609|Clinical Trials, Phase I|clinical trials, phase i
130487|NCT02754609|Randomized Controlled Trial|randomized controlled trial
130488|NCT02754583|trachoma|trachoma
130489|NCT02754583|soil transmitted helminths|soil transmitted helminths
130490|NCT02754583|sanitation|sanitation
130491|NCT02754583|face washing|face washing
130492|NCT02754583|antibiotics|antibiotics
130493|NCT02754570|Open-angle glaucoma|open-angle glaucoma
130494|NCT02754570|Ocular hypertension|ocular hypertension
130495|NCT02754570|Latanoprost|latanoprost
130496|NCT02754570|Pilocarpine|pilocarpine
130497|NCT02754544|Brain tumor|brain tumor
130498|NCT02754544|Metastatic brain tumor|metastatic brain tumor
130499|NCT02754544|Neurosurgery|neurosurgery
130500|NCT02754544|Electrocorticogram|electrocorticogram
130501|NCT02754544|ECoG|ecog
130502|NCT02754544|Transcranial magnetic stimulation|transcranial magnetic stimulation
130503|NCT02754544|TMS|tms
130504|NCT02754544|Direct electrical stimulation|direct electrical stimulation
130505|NCT02754544|DES|des
130506|NCT02754544|Functional MRI|functional mri
130508|NCT02754544|PMT High-Resolution Grids|pmt high-resolution grids
130509|NCT02754544|CorTec High-Resolution Hybrid Grids|cortec high-resolution hybrid grids
130510|NCT02754544|Digital glove|digital glove
130511|NCT02754544|Neurological exam|neurological exam
130512|NCT02754544|Ad-Tech Grids|ad-tech grids
130513|NCT02754544|Grip Sensor|grip sensor
130514|NCT02754531|Cole formula|cole formula
130515|NCT02754531|Pediatric patients|pediatric patients
130516|NCT02754531|intubation|intubation
130517|NCT02754531|Ultrasonography|ultrasonography
130518|NCT02754531|Endotracheal tube|endotracheal tube
130519|NCT02754531|uncuffed|uncuffed
130520|NCT02754531|pediatric|pediatric
130521|NCT02754505|Keywords: intensive care, muscle wasting, discharge, neuromuscular weakness, mobilization|keywords: intensive care, muscle wasting, discharge, neuromuscular weakness, mobilization
130522|NCT02754453|Weight Regain|weight regain
130523|NCT02754453|Group Treatment|group treatment
130524|NCT02754453|Weight Loss|weight loss
130525|NCT02754427|Surveillance|surveillance
130526|NCT02754427|Physiotherapy|physiotherapy
130527|NCT02754427|Arm morbidity|arm morbidity
130528|NCT02754414|platelets|platelets
130529|NCT02754414|transfusion|transfusion
130530|NCT02754414|cold storage|cold storage
130531|NCT02754414|apheresis|apheresis
130532|NCT02754401|public health|public health
130533|NCT02754401|periodontitis|periodontitis
130534|NCT02754401|self-reported questionnaire|self-reported questionnaire
130535|NCT02754388|LDCT, screening, health behavior, psychological factors|ldct, screening, health behavior, psychological factors
130536|NCT02754375|biological markers|biological markers
130537|NCT02754375|rTMS|rtms
130538|NCT02754362|Poly-ICLC and bevacizumab|poly-iclc and bevacizumab
130539|NCT02754362|humanized monoclonal antibody|humanized monoclonal antibody
130540|NCT02754349|pulse wave velocity|pulse wave velocity
130541|NCT02754349|augmentation index|augmentation index
130542|NCT02754349|central pulse pressure|central pulse pressure
130543|NCT02754310|Education, medical|education, medical
130544|NCT02754310|Simulation Training|simulation training
130545|NCT02754297|Neuroendocrine tumors|neuroendocrine tumors
130546|NCT02754297|Personalized|personalized
130547|NCT02754297|Peptide receptor radionuclide therapy|peptide receptor radionuclide therapy
130548|NCT02754297|PRRT|prrt
130549|NCT02754297|177Lu-DOTATATE|177lu-dotatate
130550|NCT02754297|177Lu-octreotate|177lu-octreotate
130551|NCT02754245|multicenter study|multicenter study
130552|NCT02754245|emergency department|emergency department
130553|NCT02754245|overcrowding status|overcrowding status
130554|NCT02754245|estimation tool|estimation tool
130555|NCT02754245|validation|validation
130556|NCT02754232|Physical training|physical training
130557|NCT02754232|Telemedicine|telemedicine
130558|NCT02754232|Daily activities|daily activities
130559|NCT02754232|Cross sectoral|cross sectoral
130560|NCT02754219|Diabetes Mellitus, Type II|diabetes mellitus, type ii
130561|NCT02754193|Venous-Arterial ExtraCorporeal Membrane Oxygenation|venous-arterial extracorporeal membrane oxygenation
130562|NCT02754180|adjuvant|adjuvant
130563|NCT02754180|pancreatic cancer|pancreatic cancer
130564|NCT02754180|R1 resection|r1 resection
130565|NCT02754180|positive lymph nodes|positive lymph nodes
130566|NCT02754167|Hepcidin|hepcidin
130567|NCT02754167|hemoglobin|hemoglobin
130568|NCT02754167|iron|iron
130569|NCT02754167|anemia of chronic disease|anemia of chronic disease
130570|NCT02754089|Body weight changes|body weight changes
130571|NCT02754089|Medicine, Traditional|medicine, traditional
130572|NCT02754089|Herbal medicine|herbal medicine
130573|NCT02754089|Rhus|rhus
130574|NCT02754089|Waist Circumference|waist circumference
130575|NCT02754089|Waist-Hip Ratio|waist-hip ratio
130576|NCT02754089|Body mass index|body mass index
130577|NCT02754076|Sanfilippo Syndrome Type B|sanfilippo syndrome type b
130578|NCT02754024|Stemless shoulder prosthesis|stemless shoulder prosthesis
130579|NCT02754011|HER2 negative|her2 negative
130580|NCT02754011|Locally advanced or metastatic|locally advanced or metastatic
130581|NCT02753998|Stenosis of arteriovenous fistula|stenosis of arteriovenous fistula
130582|NCT02753998|Angioplasty|angioplasty
130583|NCT02753998|Paclitaxel-Coated Balloon Angioplasty|paclitaxel-coated balloon angioplasty
130584|NCT02753920|voiding trial|voiding trial
130585|NCT02753920|prolapse|prolapse
130586|NCT02753894|Dose-finding|dose-finding
130587|NCT02753894|Hemodialysis|hemodialysis
130588|NCT02753894|ASP1585|asp1585
130589|NCT02753894|Chronic kidney disease|chronic kidney disease
130590|NCT02753868|Intradialytic exercise|intradialytic exercise
130591|NCT02753868|Cardiac and arterial function|cardiac and arterial function
130592|NCT02753842|Sexually Transmitted Infections|sexually transmitted infections
130593|NCT02753842|Condoms|condoms
130594|NCT02753842|Contraceptive Devices|contraceptive devices
130595|NCT02753842|HIV|hiv
130596|NCT02753816|Tranexamic Acid|tranexamic acid
130597|NCT02753816|Burn|burn
130598|NCT02753816|Surgery|surgery
130599|NCT02753816|Tangential|tangential
130600|NCT02753816|Excision|excision
130601|NCT02753790|Brain|brain
130602|NCT02753790|Metastasis|metastasis
130603|NCT02753790|IMRT|imrt
130604|NCT02753790|Radiation|radiation
130605|NCT02753790|Cancer|cancer
130607|NCT02753790|Intensity modulated radiotherapy|intensity modulated radiotherapy
130608|NCT02753790|Quality of life|quality of life
130609|NCT02753790|QOL|qol
130610|NCT02753712|Small airway disease|small airway disease
130611|NCT02753712|asthma|asthma
130612|NCT02753699|Chronic hepatitis C|chronic hepatitis c
130613|NCT02753686|HR+ HER2|hr+ her2
130614|NCT02753686|postmenopausal|postmenopausal
130615|NCT02753686|advanced breast cancer|advanced breast cancer
130616|NCT02753686|non steroidal aromatase inhibitor (NSAI) exposure|non steroidal aromatase inhibitor (nsai) exposure
130617|NCT02753686|metastatic|metastatic
130618|NCT02753686|endocrine therapy|endocrine therapy
130619|NCT02753686|targeted therapy|targeted therapy
130620|NCT02753686|prospective|prospective
130621|NCT02753686|observational|observational
130622|NCT02753686|registry|registry
130623|NCT02753686|real world setting|real world setting
130624|NCT02753686|non-interventional|non-interventional
130625|NCT02753686|Canadian|canadian
130626|NCT02753673|Breast Conserving Therapy|breast conserving therapy
130627|NCT02753673|Reported Outcomes Instrument|reported outcomes instrument
130628|NCT02753673|16-325|16-325
130629|NCT02753660|spinal, anesthesia, pendant, spinal-bone contact, puncture|spinal, anesthesia, pendant, spinal-bone contact, puncture
130630|NCT02753608|exhaled breath condensate|exhaled breath condensate
130631|NCT02753608|volatile organic compounds|volatile organic compounds
130632|NCT02753595|PEGylated Recombinant Human Hyaluronidase|pegylated recombinant human hyaluronidase
130633|NCT02753595|Eribulin Mesylate|eribulin mesylate
130634|NCT02753595|E7389|e7389
130635|NCT02753595|PEGPH20|pegph20
130636|NCT02753595|Human Epidermal Growth Factor Receptor 2-Negative|human epidermal growth factor receptor 2-negative
130637|NCT02753595|High-Hyaluronan|high-hyaluronan
130638|NCT02753582|Elderly, pre-frail, SOD|elderly, pre-frail, sod
130639|NCT02753569|Magnetic Resonance Imaging|magnetic resonance imaging
130640|NCT02753569|PET/CT|pet/ct
130641|NCT02753569|non-small cell lung cancer|non-small cell lung cancer
130642|NCT02753556|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
130643|NCT02753556|COPD|copd
130644|NCT02753556|ScreenFlow|screenflow
130645|NCT02753556|Screening|screening
130646|NCT02753556|Lung Disease|lung disease
130647|NCT02753556|Mobile Health|mobile health
130648|NCT02753556|Peak Flow Meter|peak flow meter
130649|NCT02753556|Usability|usability
130650|NCT02753517|hepatobiliary scintigraphy|hepatobiliary scintigraphy
130651|NCT02753517|extended hepatectomy|extended hepatectomy
130652|NCT02753517|volumetry|volumetry
130653|NCT02753504|Dyslipidemia|dyslipidemia
130654|NCT02753491|short interview, diabetes, lifestyle changes, primary care|short interview, diabetes, lifestyle changes, primary care
130655|NCT02753478|hypothermia|hypothermia
130656|NCT02753465|Rectal Neoplasms|rectal neoplasms
130657|NCT02753465|anastomosis|anastomosis
130658|NCT02753465|OS|os
130659|NCT02753465|DFS|dfs
130660|NCT02753465|LCA|lca
130661|NCT02753465|laparoscopic surgery|laparoscopic surgery
130662|NCT02753452|youth|youth
130663|NCT02753452|disability|disability
130664|NCT02753452|transition|transition
130665|NCT02753452|life skills|life skills
130666|NCT02753452|adolescence|adolescence
130667|NCT02753413|Vaccine|vaccine
130668|NCT02753413|Safety|safety
130669|NCT02753413|Reactogenicity|reactogenicity
130670|NCT02753413|Respiratory syncytial virus (RSV)|respiratory syncytial virus (rsv)
130671|NCT02753387|mouthwash|mouthwash
130672|NCT02753387|head and neck cancer|head and neck cancer
130673|NCT02753387|chlorhexidine|chlorhexidine
130674|NCT02753387|pathogens germs|pathogens germs
130675|NCT02753374|cystic fibrosis, Chinese, children|cystic fibrosis, chinese, children
130676|NCT02753361|Ultrasound|ultrasound
130677|NCT02753361|regional blockade|regional blockade
130678|NCT02753361|lipoma|lipoma
130679|NCT02753335|CRPS, graded motor imagery, desensitization, fMRI, DMN|crps, graded motor imagery, desensitization, fmri, dmn
130680|NCT02753322|Dual task training|dual task training
130681|NCT02753322|Dual task interference|dual task interference
130682|NCT02753322|Sub-acute stroke|sub-acute stroke
130683|NCT02753322|Physiotherapy training|physiotherapy training
130684|NCT02753322|Community ambulation|community ambulation
130685|NCT02753322|Balance|balance
130686|NCT02753309|BCG|bcg
130687|NCT02753309|Rapamycin|rapamycin
130688|NCT02753296|Cancer|cancer
130689|NCT02753296|Fertility Preservation|fertility preservation
130690|NCT02753296|Patient Decision Aid|patient decision aid
130691|NCT02753283|Bone loss|bone loss
130692|NCT02753283|Frail Geriatric Patients|frail geriatric patients
130693|NCT02753283|Nursing Home Patients|nursing home patients
130694|NCT02753283|Long-term Care Patients|long-term care patients
130695|NCT02753283|Osteoporosis|osteoporosis
130696|NCT02753283|Osteoporotic Fractures|osteoporotic fractures
130697|NCT02753257|stroke|stroke
130698|NCT02753257|stroke mimic|stroke mimic
130699|NCT02753244|Cognitive VideoGames|cognitive videogames
130700|NCT02753179|Bilateral vestibular hypofunction|bilateral vestibular hypofunction
130701|NCT02753179|Video Head Impulse Test|video head impulse test
130702|NCT02753179|Covert-saccades|covert-saccades
130703|NCT02753179|Quality of life|quality of life
130801|NCT02752685|MK-3475|mk-3475
130704|NCT02753179|Dynamic visual acuity|dynamic visual acuity
130705|NCT02753166|PTSD (Post Traumatic Stress Disorder)|ptsd (post traumatic stress disorder)
130706|NCT02753166|Emergency Department|emergency department
130707|NCT02753127|Colorectal Neoplasms|colorectal neoplasms
130708|NCT02753127|Colonic Diseases|colonic diseases
130709|NCT02753127|Digestive System Diseases|digestive system diseases
130710|NCT02753127|Digestive System Neoplasms|digestive system neoplasms
130711|NCT02753127|Gastrointestinal Diseases|gastrointestinal diseases
130712|NCT02753127|Gastrointestinal Neoplasms|gastrointestinal neoplasms
130713|NCT02753127|Intestinal Diseases|intestinal diseases
130714|NCT02753127|Intestinal Neoplasms|intestinal neoplasms
130715|NCT02753127|Neoplasms|neoplasms
130716|NCT02753127|Neoplasms by Histologic Type|neoplasms by histologic type
130717|NCT02753127|Neoplasms by Site|neoplasms by site
130718|NCT02753127|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
130719|NCT02753127|Rectal Diseases|rectal diseases
130720|NCT02753114|Ketamine|ketamine
130721|NCT02753114|Intranasal|intranasal
130722|NCT02753114|Emergency Medical Services|emergency medical services
130723|NCT02753114|Pain|pain
130724|NCT02753114|Analgesia|analgesia
130725|NCT02753101|Positron Emission Tomography|positron emission tomography
130726|NCT02753101|Magnetic Resonance Imaging|magnetic resonance imaging
130727|NCT02753101|PET/MRI|pet/mri
130728|NCT02753101|sigma-1 receptor|sigma-1 receptor
130729|NCT02753101|radiopharmaceutical|radiopharmaceutical
130730|NCT02753101|complex regional pain syndrome|complex regional pain syndrome
130731|NCT02753101|sciatica|sciatica
130732|NCT02753101|chronic pain|chronic pain
130733|NCT02753088|Equivalence|equivalence
130734|NCT02753088|BCD-063|bcd-063
130735|NCT02753088|Copaxone-Teva|copaxone-teva
130736|NCT02753049|HIV|hiv
130737|NCT02753049|AIDS|aids
130738|NCT02753049|Adolescent|adolescent
130739|NCT02753049|Adherence|adherence
130740|NCT02753049|Retention|retention
130741|NCT02753049|mHealth|mhealth
130742|NCT02753036|cognition|cognition
130743|NCT02753036|chemotherapy|chemotherapy
130744|NCT02753036|polyneuropathy|polyneuropathy
130745|NCT02753036|paclitaxel|paclitaxel
130746|NCT02753036|cancer|cancer
130747|NCT02753036|chemobrain|chemobrain
130748|NCT02752984|Peripherally inserted central venous catheter|peripherally inserted central venous catheter
130749|NCT02752932|Head and neck cancer|head and neck cancer
130750|NCT02752932|Patient derived Xenograft|patient derived xenograft
130751|NCT02752932|Chemotherapy|chemotherapy
130752|NCT02752932|Metastases|metastases
130753|NCT02752906|Meningitis|meningitis
130754|NCT02752906|Meningococcal Meningitis|meningococcal meningitis
130755|NCT02752906|Meningococcal Infections|meningococcal infections
130756|NCT02752906|MenACYW conjugate vaccine|menacyw conjugate vaccine
130757|NCT02752906|Licensed Meningococcal Conjugate Vaccine (MCV4)|licensed meningococcal conjugate vaccine (mcv4)
130758|NCT02752893|estrogen|estrogen
130759|NCT02752893|estrogen receptor|estrogen receptor
130760|NCT02752893|ER+|er+
130761|NCT02752893|HER2|her2
130762|NCT02752893|HER2-|her2-
130763|NCT02752893|HER2-negative|her2-negative
130764|NCT02752893|xenograft|xenograft
130765|NCT02752893|co-clinical|co-clinical
130766|NCT02752893|mice|mice
130767|NCT02752893|patient-derived xenograft|patient-derived xenograft
130768|NCT02752893|patient-derived|patient-derived
130769|NCT02752893|breast cancer|breast cancer
130770|NCT02752893|precision medicine|precision medicine
130771|NCT02752893|personalized medicine|personalized medicine
130772|NCT02752867|traditional Chinese medicine granules|traditional chinese medicine granules
130773|NCT02752867|Cognitive Impairment|cognitive impairment
130774|NCT02752867|Acute cerebral infraction|acute cerebral infraction
130775|NCT02752867|treatment|treatment
130776|NCT02752854|pain scores|pain scores
130777|NCT02752854|pressure algometer|pressure algometer
130778|NCT02752854|healthy volunteer adults|healthy volunteer adults
130779|NCT02752802|Contrast Media|contrast media
130780|NCT02752802|Angiography|angiography
130781|NCT02752789|alloantibodies|alloantibodies
130782|NCT02752789|donor specific antibodies (DSA)-preformed, de novo|donor specific antibodies (dsa)-preformed, de novo
130783|NCT02752789|self-antigens|self-antigens
130784|NCT02752789|chronic allograft function|chronic allograft function
130785|NCT02752776|Moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
130786|NCT02752763|Dry eye|dry eye
130787|NCT02752763|isotretinoin, AS|isotretinoin, as
130788|NCT02752763|Autologous serum|autologous serum
130789|NCT02752724|major depressive disorder|major depressive disorder
130790|NCT02752724|electroconvulsive therapy|electroconvulsive therapy
130791|NCT02752724|metabolomics|metabolomics
130792|NCT02752724|treatment resistant depression|treatment resistant depression
130793|NCT02752724|anesthesiology|anesthesiology
130794|NCT02752724|ketamine|ketamine
130795|NCT02752724|prospective randomized clinical trial|prospective randomized clinical trial
130796|NCT02752711|Minor head trauma|minor head trauma
130797|NCT02752711|Children|children
130798|NCT02752711|Clinical decision rule|clinical decision rule
130799|NCT02752685|Nab-Paclitaxel|nab-paclitaxel
130800|NCT02752685|Abraxane|abraxane
130802|NCT02752672|dithranol|dithranol
130803|NCT02752672|therapeutic mechanisms|therapeutic mechanisms
130804|NCT02752659|Monitoring|monitoring
130805|NCT02752646|cataract|cataract
130806|NCT02752633|Xanthine dehydrogenase inhibitor treatment, pharmacotherapy|xanthine dehydrogenase inhibitor treatment, pharmacotherapy
130807|NCT02752620|osteopathic manipulative treatment|osteopathic manipulative treatment
130808|NCT02752620|Chronic nonspecific low back pain|chronic nonspecific low back pain
130809|NCT02752620|low back pain|low back pain
130810|NCT02752594|probiotic|probiotic
130811|NCT02752594|mutans streptococci|mutans streptococci
130812|NCT02752594|bacillus coagulans|bacillus coagulans
130813|NCT02752594|caries|caries
130814|NCT02752581|suction drain|suction drain
130815|NCT02752581|knee arthroscopy|knee arthroscopy
130816|NCT02752581|knee pain|knee pain
130817|NCT02752555|Oligoasthenoteratozoospermia|oligoasthenoteratozoospermia
130818|NCT02752555|Male factor managment|male factor managment
130819|NCT02752555|Intacytoplasmic sperm injection|intacytoplasmic sperm injection
130820|NCT02752529|Liver Transplantation|liver transplantation
130821|NCT02752529|Individualized Therapy|individualized therapy
130822|NCT02752529|Polymorphism|polymorphism
130823|NCT02752477|Opioid-sparing|opioid-sparing
130824|NCT02752464|Weight Loss|weight loss
130825|NCT02752464|Health Status Disparities|health status disparities
130826|NCT02752438|high frequency oscillatory ventilation|high frequency oscillatory ventilation
130827|NCT02752438|rescue|rescue
130828|NCT02752438|newborn|newborn
130829|NCT02752425|Speech disorders|speech disorders
130830|NCT02752425|Speech therapy|speech therapy
130831|NCT02752425|Visual feedback|visual feedback
130832|NCT02752425|Buccopharyngeal surgery|buccopharyngeal surgery
130833|NCT02752425|Central nervous system damage|central nervous system damage
130834|NCT02752373|GTC Seizures|gtc seizures
130835|NCT02752360|intestinal reconstruction|intestinal reconstruction
130836|NCT02752360|end to end anastomosis|end to end anastomosis
130837|NCT02752321|patient discharge|patient discharge
130838|NCT02752321|patient engagement|patient engagement
130839|NCT02752321|patient satisfaction|patient satisfaction
130840|NCT02752321|continuity of patient care|continuity of patient care
130841|NCT02752321|hospital discharge|hospital discharge
130842|NCT02752321|health technology|health technology
130843|NCT02752321|eDischarge|edischarge
130844|NCT02752321|multimedia|multimedia
130845|NCT02752321|mobile applications|mobile applications
130846|NCT02752321|software applications|software applications
130847|NCT02752321|portable electronic applications|portable electronic applications
130848|NCT02752282|Family Planning|family planning
130849|NCT02752282|LNG-IUS|lng-ius
130850|NCT02752282|Health Education|health education
130851|NCT02752256|tissue plasminogen activator|tissue plasminogen activator
130852|NCT02752243|acute leukemia|acute leukemia
130853|NCT02752243|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
130854|NCT02752243|Stem Cell Transplantation|stem cell transplantation
130855|NCT02752230|Post operative pain|post operative pain
130856|NCT02752230|Bariatric Surgery|bariatric surgery
130857|NCT02752204|Relapsed|relapsed
130858|NCT02752204|Refractory|refractory
130859|NCT02752204|Lymphoma|lymphoma
130860|NCT02752191|ferumoxytol|ferumoxytol
130861|NCT02752178|Depression|depression
130862|NCT02752178|Major depressive disorder|major depressive disorder
130863|NCT02752178|MDD|mdd
130864|NCT02752152|Counseling|counseling
130865|NCT02752139|Sleep Disorders|sleep disorders
130866|NCT02752139|Cerebral Hemodynamics|cerebral hemodynamics
130867|NCT02752139|Dynamic Cerebral Auto-Regulation|dynamic cerebral auto-regulation
130868|NCT02752139|Stroke|stroke
130869|NCT02752126|Esophageal sparing|esophageal sparing
130870|NCT02752126|Conventional radiotherapy|conventional radiotherapy
130871|NCT02752126|Palliative radiation|palliative radiation
130872|NCT02752126|Central lung tumors|central lung tumors
130873|NCT02752113|diabetes mellitus type 2|diabetes mellitus type 2
130874|NCT02752113|Metformin|metformin
130875|NCT02752113|Micro- and macrocirculation|micro- and macrocirculation
130876|NCT02752113|HbA1c >= 7%|hba1c >= 7%
130877|NCT02752100|Lower Extremity Arterial Occlusive Disease|lower extremity arterial occlusive disease
130878|NCT02752100|Interventional Therapy|interventional therapy
130879|NCT02752074|Melanoma|melanoma
130880|NCT02752074|Metastatic Melanoma|metastatic melanoma
130881|NCT02752035|AML|aml
130882|NCT02752035|ASP2215|asp2215
130883|NCT02752035|Newly Diagnosed AML|newly diagnosed aml
130884|NCT02752035|gilteritinib|gilteritinib
130885|NCT02752035|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
130886|NCT02752035|FLT3|flt3
130887|NCT02752022|e-cigarettes|e-cigarettes
130888|NCT02752022|nitrosamines|nitrosamines
130889|NCT02752022|smoking cessation|smoking cessation
130890|NCT02752009|Breast Cancer|breast cancer
130891|NCT02752009|Armpit lymph nodes Cancer|armpit lymph nodes cancer
130892|NCT02751996|Chronic Hepatitis|chronic hepatitis
130893|NCT02751996|HBV|hbv
130894|NCT02751996|Double blind|double blind
130895|NCT02751983|Suicide|suicide
130896|NCT02751983|Psychiatric Rehabilitation|psychiatric rehabilitation
130897|NCT02751983|Acceptance and Commitment Therapy|acceptance and commitment therapy
130898|NCT02751983|Brief Psychotherapy|brief psychotherapy
130899|NCT02751983|Inpatients|inpatients
130900|NCT02751970|Dental adhesive|dental adhesive
130901|NCT02751970|adhesive systems|adhesive systems
130902|NCT02751970|Dental Restoration Failure|dental restoration failure
130903|NCT02751944|exercise-induced|exercise-induced
130904|NCT02751944|joint pain|joint pain
130905|NCT02751944|joint stiffness|joint stiffness
130906|NCT02751944|post-menopausal|post-menopausal
130907|NCT02751944|women|women
130908|NCT02751944|cartilage turnover|cartilage turnover
130909|NCT02751944|CTX-II|ctx-ii
130910|NCT02751931|Pediatrics|pediatrics
130911|NCT02751931|Urodynamics|urodynamics
130912|NCT02751931|Mirabegron|mirabegron
130913|NCT02751931|Phase 3|phase 3
130914|NCT02751931|Neurogenic Detrusor Overactivity|neurogenic detrusor overactivity
130915|NCT02751918|Mesothelin-expressing platinum-resistant cancer|mesothelin-expressing platinum-resistant cancer
130916|NCT02751814|Childcare Center Regulations|childcare center regulations
130917|NCT02751814|Physical Activity|physical activity
130918|NCT02751814|Sedentary Behavior|sedentary behavior
130919|NCT02751814|Screen-time Behavior|screen-time behavior
130920|NCT02751788|childcare center regulations|childcare center regulations
130921|NCT02751788|physical activity|physical activity
130922|NCT02751788|sedentary behavior|sedentary behavior
130923|NCT02751788|screen-time behavior|screen-time behavior
130924|NCT02751775|Childcare center regulations|childcare center regulations
130925|NCT02751775|Physical Activity|physical activity
130926|NCT02751775|Sedentary Behavior|sedentary behavior
130927|NCT02751775|Screen-Time Behavior|screen-time behavior
130928|NCT02751775|Focus groups|focus groups
130929|NCT02751723|cancer disease|cancer disease
130930|NCT02751723|palliative care|palliative care
130931|NCT02751723|palliative therapy|palliative therapy
130932|NCT02751723|cancer|cancer
130933|NCT02751723|patient´s needs|patient´s needs
130934|NCT02751723|patient care|patient care
130935|NCT02751723|disease burden|disease burden
130936|NCT02751684|Rapid Sequence Induction|rapid sequence induction
130937|NCT02751684|European|european
130938|NCT02751684|Evaluation|evaluation
130939|NCT02751684|EUROpE RSI|europe rsi
130940|NCT02751684|Standards|standards
130941|NCT02751684|RSI|rsi
130942|NCT02751645|Pediatric|pediatric
130943|NCT02751645|Cardiac|cardiac
130944|NCT02751645|Surgery|surgery
130945|NCT02751632|Ultra High Risk of Psychosis|ultra high risk of psychosis
130946|NCT02751632|Prodrome|prodrome
130947|NCT02751619|Pre-emptive analgesia|pre-emptive analgesia
130948|NCT02751619|Post-thoracotomy pain|post-thoracotomy pain
130949|NCT02751619|Lidocaine patch|lidocaine patch
130950|NCT02751606|Ferumoxtran|ferumoxtran
130951|NCT02751606|MRI Scans|mri scans
130952|NCT02751593|pregnancy|pregnancy
130953|NCT02751593|Immune Thrombocytopenia|immune thrombocytopenia
130954|NCT02751593|dexamethasone|dexamethasone
130955|NCT02751528|Breast Cancer|breast cancer
130956|NCT02751528|Breast Cancer male|breast cancer male
130957|NCT02751528|Breast Neoplasms|breast neoplasms
130958|NCT02751528|Breast Neoplasms male|breast neoplasms male
130959|NCT02751528|Vaccine|vaccine
130960|NCT02751528|HER2|her2
130961|NCT02751528|Metastatic|metastatic
130962|NCT02751528|Locally Advanced|locally advanced
130963|NCT02751528|Unresectable|unresectable
130964|NCT02751528|Solid Tumor|solid tumor
130965|NCT02751528|Phase 1|phase 1
130966|NCT02751528|Cancer Vaccine|cancer vaccine
130967|NCT02751502|Children|children
130968|NCT02751502|Pediatrics|pediatrics
130969|NCT02751502|Arm|arm
130970|NCT02751502|Upper limb|upper limb
130971|NCT02751502|bimanual training|bimanual training
130972|NCT02751502|physical training|physical training
130973|NCT02751437|preterm|preterm
130974|NCT02751437|arginine|arginine
130975|NCT02751437|immune function|immune function
130976|NCT02751437|nutrition|nutrition
130977|NCT02751424|Multidrug-resistant|multidrug-resistant
130978|NCT02751424|Gram negative bacterial infection|gram negative bacterial infection
130979|NCT02751424|Safety|safety
130980|NCT02751424|Pharmacokinetic|pharmacokinetic
130981|NCT02751333|Esophageal stricture|esophageal stricture
130982|NCT02751333|Esophageal leak|esophageal leak
130983|NCT02751333|Esophageal perforation|esophageal perforation
130984|NCT02751333|Esophageal fistula|esophageal fistula
130985|NCT02751333|Endostitch|endostitch
130986|NCT02751333|Esophageal stent|esophageal stent
130987|NCT02751307|metformin|metformin
130988|NCT02751307|clozapine|clozapine
130989|NCT02751307|schizophrenia|schizophrenia
130990|NCT02751307|metabolic traits|metabolic traits
130991|NCT02751294|Healthy Volunteer|healthy volunteer
130992|NCT02751294|Malaria|malaria
130993|NCT02751294|Pharmacokinetics|pharmacokinetics
130994|NCT02751294|Tafenoquine|tafenoquine
130995|NCT02751281|pneumatic|pneumatic
130996|NCT02751281|ultra-sonic|ultra-sonic
130997|NCT02751281|percutaneous nephrolithotomy|percutaneous nephrolithotomy
130998|NCT02751268|infraorbital nerve block|infraorbital nerve block
130999|NCT02751268|infratrochlear nerve block|infratrochlear nerve block
131000|NCT02751268|septorhinoplasty|septorhinoplasty
131001|NCT02751268|general anesthesia|general anesthesia
131002|NCT02751268|postoperative analgesia|postoperative analgesia
131003|NCT02751242|Diuretic Resistance|diuretic resistance
131004|NCT02751242|Emergency Medicine|emergency medicine
131005|NCT02751229|Mental illness|mental illness
131006|NCT02751229|adolescents|adolescents
131007|NCT02751229|intervention|intervention
131008|NCT02751229|stigma|stigma
131009|NCT02751229|disclosure|disclosure
131010|NCT02751229|secrecy|secrecy
131011|NCT02751216|high frequency / high density spinal cord stimulation|high frequency / high density spinal cord stimulation
131012|NCT02751216|EEG|eeg
131013|NCT02751216|conditioned pain modulation|conditioned pain modulation
131014|NCT02751177|KRAS gene mutation|kras gene mutation
131015|NCT02751177|NRAS gene mutation|nras gene mutation
131016|NCT02751177|BRAF gene mutation|braf gene mutation
131017|NCT02751138|Immune phenotype|immune phenotype
131018|NCT02751138|Cytokines|cytokines
131019|NCT02751138|Genetic aberration|genetic aberration
131020|NCT02751138|Overall survival|overall survival
131021|NCT02751138|Progression free survival|progression free survival
131022|NCT02751125|Mesenchymal stem cells|mesenchymal stem cells
131023|NCT02751125|bone augmentation|bone augmentation
131024|NCT02751125|bone regeneration|bone regeneration
131025|NCT02751086|minimally invasive surgery|minimally invasive surgery
131026|NCT02751086|gastrectomy|gastrectomy
131027|NCT02751086|robotic surgery|robotic surgery
131028|NCT02751086|laparoscopic surgery|laparoscopic surgery
131029|NCT02751086|laparoscopy|laparoscopy
131030|NCT02751086|robot-assisted|robot-assisted
131031|NCT02751086|robotic|robotic
131032|NCT02751086|robotic gastrectomy|robotic gastrectomy
131033|NCT02751086|laparoscopic gastrectomy|laparoscopic gastrectomy
131034|NCT02751086|minimally invasive gastrectomy|minimally invasive gastrectomy
131035|NCT02751073|Microbiota|microbiota
131036|NCT02751073|Proteome|proteome
131037|NCT02751034|Wrinkle Severity Rating Scale|wrinkle severity rating scale
131038|NCT02751034|Global Aesthetic Improvement Scale|global aesthetic improvement scale
131039|NCT02751034|Hyaluronic acid filler|hyaluronic acid filler
131040|NCT02751034|filler|filler
131041|NCT02751034|Nasolabial Fold|nasolabial fold
131042|NCT02750995|myelodysplastic syndrome|myelodysplastic syndrome
131043|NCT02750995|acute myeloid leukemia|acute myeloid leukemia
131044|NCT02750995|azacitidine|azacitidine
131045|NCT02750995|peptide vaccine|peptide vaccine
131046|NCT02750995|cancer testis antigen|cancer testis antigen
131047|NCT02750995|cancer vaccine|cancer vaccine
131048|NCT02750995|immunotherapy|immunotherapy
131049|NCT02750995|combination therapy|combination therapy
131050|NCT02750995|NY-ESO-1|ny-eso-1
131051|NCT02750995|PRAME|prame
131052|NCT02750995|MAGE-A3|mage-a3
131053|NCT02750995|WT-1|wt-1
131054|NCT02750995|vaccine|vaccine
131055|NCT02750969|tinnitus|tinnitus
131056|NCT02750969|lidocain patch|lidocain patch
131057|NCT02750956|endocan protein|endocan protein
131058|NCT02750956|VEGF A|vegf a
131059|NCT02750956|TNF-alpha|tnf-alpha
131060|NCT02750956|after treatment|after treatment
131061|NCT02750930|Extension|extension
131062|NCT02750930|Long-term Safety|long-term safety
131063|NCT02750930|Pharmacodynamics|pharmacodynamics
131064|NCT02750930|Albiglutide|albiglutide
131065|NCT02750930|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
131066|NCT02750917|postoperative pain|postoperative pain
131067|NCT02750917|lornoxicam|lornoxicam
131068|NCT02750917|etoricoxib|etoricoxib
131069|NCT02750917|total knee arthroplasty|total knee arthroplasty
131070|NCT02750904|Smoking Cessation|smoking cessation
131071|NCT02750904|Acceptance & Commitment Therapy|acceptance & commitment therapy
131072|NCT02750904|Cognitive Behavioral Therapy|cognitive behavioral therapy
131073|NCT02750904|Bipolar Disorder|bipolar disorder
131074|NCT02750891|high grade glioma|high grade glioma
131075|NCT02750891|HGG|hgg
131076|NCT02750891|DIPG|dipg
131077|NCT02750878|Urinary Incontinence, Stress [C13.351.968.934.814.500]|urinary incontinence, stress [c13.351.968.934.814.500]
131078|NCT02750865|biomedical technology|biomedical technology
131079|NCT02750865|palliative care|palliative care
131080|NCT02750800|Rheumatoid arthritis|rheumatoid arthritis
131081|NCT02750800|Ankylosing spondylitis|ankylosing spondylitis
131082|NCT02750800|Psoriatic arthritis|psoriatic arthritis
131083|NCT02750800|Psoriasis|psoriasis
131084|NCT02750800|Crohn's disease|crohn's disease
131085|NCT02750800|Ulcerative colitis|ulcerative colitis
131086|NCT02750800|Patient support program|patient support program
131087|NCT02750800|Quality of life|quality of life
131088|NCT02750800|Patient related outcomes|patient related outcomes
131089|NCT02750800|Observational study|observational study
131090|NCT02750722|Exercise|exercise
131091|NCT02750722|Lung diffusion capacity|lung diffusion capacity
131092|NCT02750722|Sputum viscoelasticity|sputum viscoelasticity
131093|NCT02750722|Lung disease|lung disease
131094|NCT02750709|HT-1|ht-1
131095|NCT02750709|Tyrosinemia|tyrosinemia
131096|NCT02750709|Nitisinone|nitisinone
131097|NCT02750709|Bioequivalence|bioequivalence
131098|NCT02750709|Healthy Volunteer|healthy volunteer
131099|NCT02750709|Orfadin|orfadin
131100|NCT02750696|Acetaminophen|acetaminophen
131101|NCT02750696|Analgesia|analgesia
131102|NCT02750696|Codeine|codeine
131103|NCT02750696|Drug Combinations|drug combinations
131104|NCT02750696|Endodontics|endodontics
131105|NCT02750696|Periapical abscess|periapical abscess
131106|NCT02750696|Randomized Controlled Trial|randomized controlled trial
131107|NCT02750696|Tramadol|tramadol
131108|NCT02750696|Visual analog scale|visual analog scale
131109|NCT02750683|inotropic effect, norepinephrine, septic shock,|inotropic effect, norepinephrine, septic shock,
131110|NCT02750670|Lymphoma|lymphoma
131111|NCT02750670|Non-Hodgkin's|non-hodgkin's
131112|NCT02750670|CD20+|cd20+
131113|NCT02750670|Obinutuzumab|obinutuzumab
131114|NCT02750670|GDP Chemotherapy|gdp chemotherapy
131115|NCT02750670|Refractory and aggressive non-Hodgkin lymphoma|refractory and aggressive non-hodgkin lymphoma
131116|NCT02750631|depression|depression
131117|NCT02750631|melatonin|melatonin
131118|NCT02750631|light therapy|light therapy
131119|NCT02750631|Wake Therapy|wake therapy
131120|NCT02750631|chronobiology|chronobiology
131121|NCT02750592|Ankylosing Spondylitis|ankylosing spondylitis
131122|NCT02750540|Tenofovir enema|tenofovir enema
131123|NCT02750423|Cardiology|cardiology
131124|NCT02750423|Surgery|surgery
131126|NCT02750397|Kidney Transplant|kidney transplant
131127|NCT02750397|Liver Transplant|liver transplant
131128|NCT02750397|Transplant|transplant
131129|NCT02750371|Cavernous sinus meningioma|cavernous sinus meningioma
131130|NCT02750371|Pituitary adenoma|pituitary adenoma
131131|NCT02750371|Hippocampus|hippocampus
131132|NCT02750371|Irradiation|irradiation
131133|NCT02750371|Autobiographical memory|autobiographical memory
131134|NCT02750358|Enzalutamide|enzalutamide
131135|NCT02750358|15-307|15-307
131136|NCT02750345|HT-1|ht-1
131137|NCT02750345|Tyrosinemia|tyrosinemia
131138|NCT02750345|Nitisinone|nitisinone
131139|NCT02750345|Bioavailability|bioavailability
131140|NCT02750345|Healthy Volunteer|healthy volunteer
131141|NCT02750345|Food-Effect|food-effect
131142|NCT02750332|HT-1|ht-1
131143|NCT02750332|Tyrosinemia|tyrosinemia
131144|NCT02750332|Nitisinone|nitisinone
131145|NCT02750332|Bioavailability|bioavailability
131146|NCT02750332|Healthy Volunteer|healthy volunteer
131147|NCT02750332|Food-Effect|food-effect
131148|NCT02750319|Amiodarone|amiodarone
131149|NCT02750319|N-Acetylcysteine|n-acetylcysteine
131150|NCT02750319|16-307|16-307
131151|NCT02750293|vitamin D|vitamin d
131152|NCT02750293|blood pressure|blood pressure
131153|NCT02750293|serum lipids|serum lipids
131154|NCT02750293|glucose metabolism|glucose metabolism
131155|NCT02750293|muscle function|muscle function
131156|NCT02750293|arterial stiffness|arterial stiffness
131157|NCT02750293|depression|depression
131158|NCT02750293|psoriasis|psoriasis
131159|NCT02750293|sleep|sleep
131160|NCT02750293|bone density|bone density
131161|NCT02750267|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
131162|NCT02750267|Artificial Pancreas Project (APP)|artificial pancreas project (app)
131163|NCT02750267|Diabetes Assistant (DiAs)|diabetes assistant (dias)
131164|NCT02750267|Closed-Loop Control (CLC)|closed-loop control (clc)
131165|NCT02750267|Continuous Glucose Monitor|continuous glucose monitor
131166|NCT02750267|Pediatric|pediatric
131167|NCT02750267|Insulin Pump|insulin pump
131168|NCT02750241|active video game|active video game
131169|NCT02750241|mHealth|mhealth
131170|NCT02750241|cancer survivor|cancer survivor
131171|NCT02750241|women's health|women's health
131172|NCT02750241|breast cancer|breast cancer
131173|NCT02750241|physical activity|physical activity
131174|NCT02750241|support group|support group
131175|NCT02750241|survivorship|survivorship
131176|NCT02750215|MET exon 14 skipping|met exon 14 skipping
131177|NCT02750215|Stage IV non-small cell lung cancer NSCLC|stage iv non-small cell lung cancer nsclc
131178|NCT02750202|Genital warts|genital warts
131179|NCT02750202|HPV types|hpv types
131180|NCT02750202|HPV vaccine|hpv vaccine
131181|NCT02750202|Cervical cytology|cervical cytology
131182|NCT02750202|Therapeutic vaccine|therapeutic vaccine
131183|NCT02750202|Quadrivalent HPV vaccine|quadrivalent hpv vaccine
131184|NCT02750176|Rehabilitation|rehabilitation
131185|NCT02750176|Closed chain exercises|closed chain exercises
131186|NCT02750137|Tetracaine|tetracaine
131187|NCT02750124|participation|participation
131188|NCT02750124|self sampling|self sampling
131189|NCT02750124|Screening|screening
131190|NCT02750098|Diabetes Mellitus, Cataract, Aqueous humor|diabetes mellitus, cataract, aqueous humor
131191|NCT02750085|Hemophilia A|hemophilia a
131192|NCT02750085|pharmacokinetics|pharmacokinetics
131193|NCT02750085|myPKFiT|mypkfit
131194|NCT02750020|Telephone survey|telephone survey
131195|NCT02749955|HIV prevention|hiv prevention
131196|NCT02749955|Pre exposure prophylaxis|pre exposure prophylaxis
131197|NCT02749955|Men who have sex with men|men who have sex with men
131198|NCT02749955|Partner services|partner services
131199|NCT02749955|Linkage to care|linkage to care
131200|NCT02749955|Seronegative|seronegative
131201|NCT02749955|Sexually transmitted diseases|sexually transmitted diseases
131202|NCT02749942|Diabetes|diabetes
131203|NCT02749942|Remote Ischemic Conditioning|remote ischemic conditioning
131204|NCT02749942|Neuropathy|neuropathy
131205|NCT02749942|Angiopathy|angiopathy
131206|NCT02749929|Distal radius fracture, Low Level Laser Therapy|distal radius fracture, low level laser therapy
131207|NCT02749916|SWI|swi
131208|NCT02749916|MP-RAGE|mp-rage
131209|NCT02749916|DANTE T1-SPACE|dante t1-space
131210|NCT02749877|Pediatric Cancer|pediatric cancer
131211|NCT02749877|Training|training
131212|NCT02749877|Working Memory|working memory
131213|NCT02749877|Physical Activity|physical activity
131214|NCT02749877|Brain Tumor|brain tumor
131215|NCT02749877|Physical Exercise|physical exercise
131216|NCT02749864|Hepatitis|hepatitis
131217|NCT02749864|Prevalence|prevalence
131218|NCT02749864|Epidemiology|epidemiology
131219|NCT02749864|Infectious diseases|infectious diseases
131220|NCT02749851|pregnancy|pregnancy
131221|NCT02749851|growth restriction|growth restriction
131222|NCT02749838|Cancer|cancer
131223|NCT02749838|Genomic testing|genomic testing
131224|NCT02749838|Genetic testing|genetic testing
131225|NCT02749838|Molecular screening|molecular screening
131226|NCT02749838|Molecular Profiling|molecular profiling
131227|NCT02749838|Biomarker|biomarker
131228|NCT02749838|Biopsy|biopsy
131229|NCT02749838|Tumor sampling|tumor sampling
131230|NCT02749838|Registry|registry
131231|NCT02749825|Prostate|prostate
131232|NCT02749825|Cancer|cancer
131233|NCT02749825|Trelstar|trelstar
131234|NCT02749760|Ulnar collateral ligament|ulnar collateral ligament
131235|NCT02749760|elbow injuries|elbow injuries
131236|NCT02749760|dynamic elbow stabilizers|dynamic elbow stabilizers
131237|NCT02749760|Tommy John's procedure|tommy john's procedure
131238|NCT02749760|elbow injuries in pitchers|elbow injuries in pitchers
131239|NCT02749747|Menopause|menopause
131240|NCT02749747|nonhormonal treatment|nonhormonal treatment
131241|NCT02749747|sulpiride|sulpiride
131242|NCT02749734|Human embryo stem cell derived retinal pigment epitheliums|human embryo stem cell derived retinal pigment epitheliums
131243|NCT02749734|Subretinal transplantation|subretinal transplantation
131244|NCT02749734|Wet Age related Macular degeneration|wet age related macular degeneration
131245|NCT02749734|Stargardt's macular dystrophy|stargardt's macular dystrophy
131246|NCT02749721|depression|depression
131247|NCT02749721|brain network activation|brain network activation
131248|NCT02749721|vortioxetine|vortioxetine
131249|NCT02749708|IRX5183|irx5183
131250|NCT02749708|relapsed/refractory AML|relapsed/refractory aml
131251|NCT02749708|high-risk MDS|high-risk mds
131252|NCT02749695|menopause, climacteric syndrome, insomnia, placental extract|menopause, climacteric syndrome, insomnia, placental extract
131253|NCT02749682|Nyhus classification|nyhus classification
131254|NCT02749682|constipation severity scale|constipation severity scale
131255|NCT02749682|groin hernia|groin hernia
131256|NCT02749669|Inappropriate hospitalization|inappropriate hospitalization
131257|NCT02749669|elderly|elderly
131258|NCT02749669|mild or moderate cognitive impairment|mild or moderate cognitive impairment
131259|NCT02749669|qualitative research|qualitative research
131260|NCT02749669|economic evaluation|economic evaluation
131261|NCT02749656|Scalp psoriasis|scalp psoriasis
131262|NCT02749656|0.25% Desoximetasone cream|0.25% desoximetasone cream
131263|NCT02749591|stroke rehabilitation|stroke rehabilitation
131264|NCT02749591|spasticity|spasticity
131265|NCT02749591|Botulinum toxin type A injection|botulinum toxin type a injection
131266|NCT02749591|robot-assisted therapy|robot-assisted therapy
131267|NCT02749591|mirror therapy|mirror therapy
131268|NCT02749591|randomized controlled trial|randomized controlled trial
131269|NCT02749565|asthma|asthma
131270|NCT02749565|fibrocyte|fibrocyte
131271|NCT02749565|airway remodeling|airway remodeling
131272|NCT02749565|OSA|osa
131273|NCT02749565|hypoxia|hypoxia
131274|NCT02749539|Mastectomy|mastectomy
131275|NCT02749539|Shoulder Pain|shoulder pain
131276|NCT02749539|ROM|rom
131277|NCT02749539|Kinesio Tape|kinesio tape
131278|NCT02749526|Recombinant human endostatin，Endo|recombinant human endostatin，endo
131279|NCT02749500|Motor control|motor control
131280|NCT02749487|Critical Care|critical care
131281|NCT02749487|Neutrophils|neutrophils
131282|NCT02749487|Lymphocytes|lymphocytes
131283|NCT02749461|preterm infants|preterm infants
131284|NCT02749461|pain|pain
131285|NCT02749461|assessment|assessment
131286|NCT02749461|contextual factors|contextual factors
131287|NCT02749461|diagnostic accuracy|diagnostic accuracy
131288|NCT02749435|Digital disease management tool|digital disease management tool
131289|NCT02749435|Type 2 diabetes mellitus/ T2DM|type 2 diabetes mellitus/ t2dm
131290|NCT02749435|HbA1c|hba1c
131291|NCT02749435|Standard care|standard care
131292|NCT02749435|PRO questionnaires|pro questionnaires
131293|NCT02749435|Smart phone/ personal computer with internet access|smart phone/ personal computer with internet access
131294|NCT02749422|cognitive dysfunction|cognitive dysfunction
131295|NCT02749422|memory loss|memory loss
131296|NCT02749422|non-invasive transcranial magnetic stimulation (TMS)|non-invasive transcranial magnetic stimulation (tms)
131297|NCT02749422|rTMS|rtms
131298|NCT02749422|Magstim Rapid2|magstim rapid2
131299|NCT02749357|gait|gait
131300|NCT02749357|robotic orthosis|robotic orthosis
131301|NCT02749344|Frozen Embryo Transfer, Progesterone, Endometrium|frozen embryo transfer, progesterone, endometrium
131302|NCT02749318|Behavior Modification|behavior modification
131303|NCT02749318|Genetic Testing|genetic testing
131304|NCT02749318|Risk Management|risk management
131305|NCT02749318|Oral Health Care|oral health care
131306|NCT02749292|rituximab|rituximab
131307|NCT02749292|maintenance|maintenance
131308|NCT02749292|remission|remission
131309|NCT02749266|chiropractic, cognition|chiropractic, cognition
131310|NCT02749253|Post Traumatic Stress Disorder (PTSD)|post traumatic stress disorder (ptsd)
131311|NCT02749253|Sudarshan Kriya Yoga (SKY)|sudarshan kriya yoga (sky)
131312|NCT02749227|Clinically non-functioning pituitary adenomas (CNFAs)|clinically non-functioning pituitary adenomas (cnfas)
131313|NCT02749227|silent corticotroph adenomas|silent corticotroph adenomas
131314|NCT02749201|Obesity|obesity
131315|NCT02749201|sleeve gastrectomy|sleeve gastrectomy
131316|NCT02749188|Urine Specimen Collection/methods|urine specimen collection/methods
131317|NCT02749188|Infant|infant
131318|NCT02749188|Newborn|newborn
131319|NCT02749188|Feasibility Studies|feasibility studies
131320|NCT02749188|Bladder stimulation|bladder stimulation
131321|NCT02749175|cricoid pressure|cricoid pressure
131322|NCT02749149|Cardiac|cardiac
131323|NCT02749149|Surgery|surgery
131324|NCT02749149|Frailty|frailty
131325|NCT02749149|Frail|frail
131326|NCT02749149|Patients|patients
131327|NCT02749149|Recovery|recovery
131328|NCT02749149|Morbidity|morbidity
131329|NCT02749149|Outcomes|outcomes
131330|NCT02749149|Mortality|mortality
131331|NCT02749149|Heart|heart
131332|NCT02749149|Perioperative|perioperative
131333|NCT02749149|Disability|disability
131334|NCT02749149|WHODAS|whodas
131335|NCT02749136|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
131336|NCT02749136|Borderline resectable|borderline resectable
131337|NCT02749136|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
131338|NCT02749136|FOLFIRINOX|folfirinox
131339|NCT02749110|Mass screening|mass screening
131340|NCT02749110|Family medicine|family medicine
131341|NCT02749110|Human Papillomavirus DNA tests|human papillomavirus dna tests
131342|NCT02749110|Papanicolaou test|papanicolaou test
131343|NCT02749110|Early detection of cancer/methods*|early detection of cancer/methods*
131344|NCT02749110|Specimen Handling/methods*|specimen handling/methods*
131345|NCT02749110|Patient compliance|patient compliance
131346|NCT02749110|Adult|adult
131347|NCT02749110|Female|female
131348|NCT02749110|Humans|humans
131349|NCT02749110|Randomized controlled trial|randomized controlled trial
131350|NCT02749084|chronic graft versus host disease|chronic graft versus host disease
131351|NCT02749084|T regulatory cell|t regulatory cell
131352|NCT02749058|capsulectomy|capsulectomy
131353|NCT02749058|capsulotomy|capsulotomy
131354|NCT02749019|BBN-RGD|bbn-rgd
131355|NCT02749019|GRPR|grpr
131356|NCT02749019|integrin αvβ3|integrin αvβ3
131357|NCT02749006|Bipolar-I disorder|bipolar-i disorder
131358|NCT02749006|Depression|depression
131359|NCT02749006|intermittent Theta-Burst Stimulation (rTMS)|intermittent theta-burst stimulation (rtms)
131360|NCT02749006|neuromodulatory technique|neuromodulatory technique
131361|NCT02748967|Healthy|healthy
131362|NCT02748967|ExPEC4V|expec4v
131363|NCT02748967|JNJ-63871860|jnj-63871860
131364|NCT02748967|Safety|safety
131365|NCT02748941|unstable/stable atherosclerotic plaque|unstable/stable atherosclerotic plaque
131366|NCT02748941|HITS|hits
131367|NCT02748941|GSM|gsm
131368|NCT02748941|CEUS|ceus
131369|NCT02748941|HR MRI|hr mri
131370|NCT02748941|mi-RNA|mi-rna
131371|NCT02748915|Cochlear Implant|cochlear implant
131372|NCT02748915|ECAP|ecap
131373|NCT02748915|EABR|eabr
131374|NCT02748915|perceptual levels|perceptual levels
131375|NCT02748915|hearing performances|hearing performances
131376|NCT02748902|Verruca vulgaris|verruca vulgaris
131377|NCT02748902|Common warts|common warts
131378|NCT02748902|Verruca|verruca
131379|NCT02748902|Warts|warts
131380|NCT02748902|Papilloma virus|papilloma virus
131381|NCT02748902|ingenol mebutate 0.05% gel|ingenol mebutate 0.05% gel
131382|NCT02748902|hands|hands
131383|NCT02748889|SCLC|sclc
131384|NCT02748889|Small Cell|small cell
131385|NCT02748889|Lung Cancer|lung cancer
131386|NCT02748889|MPDL3280A|mpdl3280a
131387|NCT02748889|atezolizumab|atezolizumab
131388|NCT02748863|psoriasis|psoriasis
131389|NCT02748863|secukinumab|secukinumab
131390|NCT02748863|pre-filled syringes|pre-filled syringes
131391|NCT02748850|apheresis patients|apheresis patients
131392|NCT02748824|Age- Related Macular Degeneration; Diabetic Retinopathy; Glaucoma; Cataract|age- related macular degeneration; diabetic retinopathy; glaucoma; cataract
131393|NCT02748811|elderly|elderly
131394|NCT02748811|intervention study|intervention study
131395|NCT02748811|geriatrics|geriatrics
131396|NCT02748811|chemotherapy|chemotherapy
131397|NCT02748772|Anti-angiogenesis Drugs|anti-angiogenesis drugs
131398|NCT02748772|Advanced Colorectal Cancer|advanced colorectal cancer
131399|NCT02748772|Endostar|endostar
131400|NCT02748772|Thalidomide|thalidomide
131401|NCT02748772|Vascular Endothelial Growth Factor A|vascular endothelial growth factor a
131402|NCT02748759|Continous Passive Motion|continous passive motion
131403|NCT02748759|Manual Physical Therapy|manual physical therapy
131404|NCT02748759|Range of Motion, Articular|range of motion, articular
131405|NCT02748759|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
131406|NCT02748759|Rehabilitation|rehabilitation
131407|NCT02748759|Kaltenborn Manual Therapy|kaltenborn manual therapy
131408|NCT02748746|Lymphedema|lymphedema
131409|NCT02748746|Electric Impedance|electric impedance
131410|NCT02748746|Breast Cancer|breast cancer
131411|NCT02748733|Adapted APD|adapted apd
131412|NCT02748733|Dialytic Sodium Removal|dialytic sodium removal
131413|NCT02748733|Ultrafiltration|ultrafiltration
131414|NCT02748733|Clearance rate|clearance rate
131415|NCT02748733|Intraperitoneal pressure|intraperitoneal pressure
131416|NCT02748720|Premature|premature
131417|NCT02748720|Respiratory Function Monitor|respiratory function monitor
131418|NCT02748694|Drug Therapy|drug therapy
131419|NCT02748681|obstructive sleep apnea|obstructive sleep apnea
131420|NCT02748681|CPAP|cpap
131421|NCT02748681|stroke|stroke
131422|NCT02748681|telemedicine|telemedicine
131423|NCT02748681|neurorehabilitation|neurorehabilitation
131424|NCT02748681|systolic blood pressure|systolic blood pressure
131425|NCT02748629|inguinal hernia|inguinal hernia
131426|NCT02748629|mesh|mesh
131427|NCT02748629|lichtenstein|lichtenstein
131428|NCT02748629|hernia repair|hernia repair
131429|NCT02748629|selfgripping mesh|selfgripping mesh
131430|NCT02748616|Colitis|colitis
131431|NCT02748616|Bile|bile
131432|NCT02748577|Migraines|migraines
131433|NCT02748577|Pain responses|pain responses
131434|NCT02748551|Gastric cancer|gastric cancer
131435|NCT02748551|locally advanced gastric cancer|locally advanced gastric cancer
131436|NCT02748551|laparoscopic surgery|laparoscopic surgery
131437|NCT02748551|laparoscopic procedure|laparoscopic procedure
131438|NCT02748551|comparison laparoscopic with open procedure|comparison laparoscopic with open procedure
131439|NCT02748551|multicenter trials|multicenter trials
131440|NCT02748486|schizophrenia|schizophrenia
131441|NCT02748486|randomized controlled trial|randomized controlled trial
131442|NCT02748486|metacognitive training|metacognitive training
131443|NCT02748486|single sessions|single sessions
131444|NCT02748473|Pilates exercises|pilates exercises
131445|NCT02748473|pelvic floor muscle contraction|pelvic floor muscle contraction
131446|NCT02748434|iPro2 Continuous Blood Glucose Recorder|ipro2 continuous blood glucose recorder
131447|NCT02748434|Subclinical|subclinical
131448|NCT02748421|retina surgery|retina surgery
131449|NCT02748421|image guided surgery|image guided surgery
131450|NCT02748421|optical coherence tomography assisted|optical coherence tomography assisted
131451|NCT02748369|TCA cycle flux|tca cycle flux
131452|NCT02748369|in vivo measurements|in vivo measurements
131453|NCT02748369|Stable isotopes|stable isotopes
131454|NCT02748369|Arteriovenous balance|arteriovenous balance
131455|NCT02748369|Metabolome|metabolome
131456|NCT02748369|Proteome|proteome
131457|NCT02748369|Exosomes|exosomes
131458|NCT02748356|Spina Bifida|spina bifida
131459|NCT02748356|Spinal Cord Injury|spinal cord injury
131460|NCT02748317|Spina Bifida|spina bifida
131461|NCT02748317|Spinal Cord Injury|spinal cord injury
131462|NCT02748317|Lower Urinary Tract Symptoms|lower urinary tract symptoms
131463|NCT02748317|Probiotics|probiotics
131464|NCT02748317|Intermittent Catheterization|intermittent catheterization
131465|NCT02748291|Sedentary|sedentary
131466|NCT02748291|Knee osteoarthritis|knee osteoarthritis
131467|NCT02748291|Knee pain|knee pain
131468|NCT02748291|Gonarthritis|gonarthritis
131469|NCT02748291|Arthritis|arthritis
131470|NCT02748291|Walking|walking
131471|NCT02748291|Pedometer|pedometer
131472|NCT02748291|Physical Activity|physical activity
131473|NCT02748291|Activities of Daily Function|activities of daily function
131474|NCT02748291|Department of Health Physical Activity Guidelines|department of health physical activity guidelines
131475|NCT02748291|Improve pain|improve pain
131476|NCT02748291|Decrease pain|decrease pain
131477|NCT02748291|Improve function|improve function
131478|NCT02748291|Increase function|increase function
131479|NCT02748291|Activity Monitoring|activity monitoring
131480|NCT02748291|Monitoring, Ambulatory/instrumentation|monitoring, ambulatory/instrumentation
131481|NCT02748278|subfertility|subfertility
131482|NCT02748278|In-vitro fertilization|in-vitro fertilization
131483|NCT02748239|diabetes self-management education|diabetes self-management education
131484|NCT02748239|insulin therapy|insulin therapy
131485|NCT02748174|Migraine|migraine
131486|NCT02748174|Curelator|curelator
131487|NCT02748161|Hepatocellular carcinoma|hepatocellular carcinoma
131488|NCT02748161|DEB-TACE|deb-tace
131489|NCT02748161|QED|qed
131490|NCT02748148|Medication Therapy Management|medication therapy management
131491|NCT02748148|Pharmacogenomics|pharmacogenomics
131492|NCT02748122|Adolescents|adolescents
131493|NCT02748122|Insulin|insulin
131494|NCT02748122|T2DM|t2dm
131495|NCT02748109|Physical Therapy|physical therapy
131496|NCT02748109|Balance Disorder|balance disorder
131497|NCT02748109|Concussion|concussion
131498|NCT02748109|Mild Traumatic Brain Injury|mild traumatic brain injury
131499|NCT02748096|Unicompartmental Knee Replacement|unicompartmental knee replacement
131695|NCT02746835|fall risk|fall risk
131500|NCT02748096|Patient Specific Instrumentation|patient specific instrumentation
131501|NCT02748083|tDCS|tdcs
131502|NCT02748083|schizophrenia|schizophrenia
131503|NCT02748083|cognition|cognition
131504|NCT02748083|fMRI|fmri
131505|NCT02748031|Congenital cataracts|congenital cataracts
131506|NCT02748031|Opacity location|opacity location
131507|NCT02748031|Opacity shape|opacity shape
131508|NCT02748031|Classification|classification
131509|NCT02748031|Clinical applicability|clinical applicability
131510|NCT02748005|Fenugreek seed extract|fenugreek seed extract
131511|NCT02748005|testosterone|testosterone
131512|NCT02748005|protodioscin|protodioscin
131513|NCT02748005|hypogonadism|hypogonadism
131514|NCT02747979|hemodialysis|hemodialysis
131515|NCT02747979|hyperparathyroidism|hyperparathyroidism
131516|NCT02747979|refractory pruritus|refractory pruritus
131517|NCT02747979|ostalgia|ostalgia
131518|NCT02747979|insomnia|insomnia
131519|NCT02747979|CVD incidence|cvd incidence
131520|NCT02747979|life quality|life quality
131521|NCT02747966|access flow|access flow
131522|NCT02747966|access recirculation|access recirculation
131523|NCT02747966|cardiac output|cardiac output
131524|NCT02747966|cardiac index|cardiac index
131525|NCT02747966|hemodialysis|hemodialysis
131526|NCT02747927|Drug therapy|drug therapy
131527|NCT02747901|KINESIOTAPING|kinesiotaping
131528|NCT02747901|COLD THERAPY|cold therapy
131529|NCT02747901|FUNCTIONAL PERFORMANCE|functional performance
131530|NCT02747888|Thyroid|thyroid
131531|NCT02747875|pediatric|pediatric
131532|NCT02747875|cardiac bypass surgery|cardiac bypass surgery
131533|NCT02747875|methadone|methadone
131534|NCT02747875|fentanyl|fentanyl
131535|NCT02747875|morphine|morphine
131536|NCT02747862|Attenuated Familial Adenomatous Polyposis|attenuated familial adenomatous polyposis
131537|NCT02747862|AFAP|afap
131538|NCT02747862|Deleterious Familial Adenomatous Polyposis|deleterious familial adenomatous polyposis
131539|NCT02747862|FAP|fap
131540|NCT02747862|Chart review|chart review
131541|NCT02747797|Advanced Cancer|advanced cancer
131542|NCT02747797|Lucitanib (E3810)|lucitanib (e3810)
131543|NCT02747797|Fibroblast Growth Factor Receptor|fibroblast growth factor receptor
131544|NCT02747797|FGFR|fgfr
131545|NCT02747797|Vascular Endothelial Growth Factor Receptor|vascular endothelial growth factor receptor
131546|NCT02747797|VEGFR|vegfr
131547|NCT02747797|Platelet Derived Growth Factor Receptor|platelet derived growth factor receptor
131548|NCT02747797|PDGFR|pdgfr
131549|NCT02747797|metastatic malignancy|metastatic malignancy
131550|NCT02747784|cognitive dysfunction|cognitive dysfunction
131551|NCT02747784|cognitive training|cognitive training
131552|NCT02747771|effectiveness|effectiveness
131553|NCT02747771|trichotillomania|trichotillomania
131554|NCT02747771|hair pulling|hair pulling
131555|NCT02747771|habit reversal training|habit reversal training
131556|NCT02747771|acceptance and commitment therapy|acceptance and commitment therapy
131557|NCT02747771|cognitive behavioral therapy|cognitive behavioral therapy
131558|NCT02747758|neuropathic pain|neuropathic pain
131559|NCT02747758|neuralgia|neuralgia
131560|NCT02747758|tDCS|tdcs
131561|NCT02747758|transcranial direct current stimulation|transcranial direct current stimulation
131562|NCT02747745|Caregivers|caregivers
131563|NCT02747745|Case Management|case management
131564|NCT02747745|Community Dwelling|community dwelling
131565|NCT02747706|peer mentor|peer mentor
131566|NCT02747706|health coach|health coach
131567|NCT02747706|parent support|parent support
131568|NCT02747706|parent mentor|parent mentor
131569|NCT02747680|type 1 diabetes|type 1 diabetes
131570|NCT02747680|hypoglycemia unawareness|hypoglycemia unawareness
131571|NCT02747680|healthy control|healthy control
131572|NCT02747667|iol dislocation|iol dislocation
131573|NCT02747667|iol complication|iol complication
131574|NCT02747667|intraocular lens|intraocular lens
131575|NCT02747667|Implant or Graft|implant or graft
131576|NCT02747667|Eye|eye
131577|NCT02747654|NAT2 genotype guided dosing|nat2 genotype guided dosing
131578|NCT02747628|Transdermal nicotine|transdermal nicotine
131579|NCT02747628|Transdermal melatonin|transdermal melatonin
131580|NCT02747628|Postoperative pain|postoperative pain
131581|NCT02747628|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
131582|NCT02747615|Preoperative autologous blood donation, allogeneic blood transfusion, parenteral iron, tranexamic acid, revision total hip arthroplasty, hemoglobin, hematocrit|preoperative autologous blood donation, allogeneic blood transfusion, parenteral iron, tranexamic acid, revision total hip arthroplasty, hemoglobin, hematocrit
131583|NCT02747602|Healthy volunteers|healthy volunteers
131584|NCT02747602|Caprylic triglyceride oil|caprylic triglyceride oil
131585|NCT02747602|AC-1204|ac-1204
131586|NCT02747602|Pharmacokinetic|pharmacokinetic
131587|NCT02747602|Ketone body|ketone body
131588|NCT02747576|Childhood Cancer Survivor|childhood cancer survivor
131589|NCT02747576|Social-cognition|social-cognition
131590|NCT02747576|Healthy Volunteers|healthy volunteers
131591|NCT02747563|prostate cancer|prostate cancer
131593|NCT02747563|digital rectal examination|digital rectal examination
131594|NCT02747472|GIP|gip
131595|NCT02747472|GIP receptor antagonist|gip receptor antagonist
131798|NCT02745925|Hepcidin|hepcidin
131596|NCT02747446|fructose, triglyceride, oral glucose tolerance|fructose, triglyceride, oral glucose tolerance
131597|NCT02747433|robot-assisted therapy|robot-assisted therapy
131598|NCT02747433|task-oriented training|task-oriented training
131599|NCT02747433|motor learning|motor learning
131600|NCT02747420|Posterior Tibial Nerve Stimulation, Bladder|posterior tibial nerve stimulation, bladder
131601|NCT02747368|Wet age-related macular degeneration|wet age-related macular degeneration
131602|NCT02747368|Age-related macular degeneration|age-related macular degeneration
131603|NCT02747368|Ocusweep|ocusweep
131604|NCT02747368|Driving health|driving health
131605|NCT02747368|Visual field|visual field
131606|NCT02747368|Contrast sensitivity|contrast sensitivity
131607|NCT02747342|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
131608|NCT02747342|Monotherapy|monotherapy
131609|NCT02747329|BuMA Supreme|buma supreme
131610|NCT02747329|Xience V/Prime|xience v/prime
131611|NCT02747329|OCT|oct
131612|NCT02747329|neointima formation|neointima formation
131613|NCT02747316|Iron bioavailability|iron bioavailability
131614|NCT02747316|Hepcidin|hepcidin
131615|NCT02747316|Iron absorption|iron absorption
131616|NCT02747303|brain metastases|brain metastases
131617|NCT02747303|Stereotactic Radiosurgery|stereotactic radiosurgery
131618|NCT02747290|BBN-RGD|bbn-rgd
131619|NCT02747290|PET|pet
131620|NCT02747290|integrin αvβ3|integrin αvβ3
131621|NCT02747290|GRPR|grpr
131622|NCT02747264|eRAPID|erapid
131623|NCT02747264|PRO|pro
131624|NCT02747264|PROM|prom
131625|NCT02747264|Adverse event|adverse event
131626|NCT02747264|QTool|qtool
131627|NCT02747264|CTCAE|ctcae
131628|NCT02747251|"Shoulder Impingement Syndrome[Mesh]"|"shoulder impingement syndrome[mesh]"
131629|NCT02747251|"Rehabilitation[Mesh]"|"rehabilitation[mesh]"
131630|NCT02747251|"Exercise[Mesh]"|"exercise[mesh]"
131631|NCT02747251|"Rotator Cuff[Mesh]"|"rotator cuff[mesh]"
131632|NCT02747238|Pregnancy|pregnancy
131633|NCT02747238|Epidural|epidural
131634|NCT02747238|Labor|labor
131635|NCT02747225|electrical properties|electrical properties
131636|NCT02747225|malignant tissues|malignant tissues
131637|NCT02747225|in vivo|in vivo
131638|NCT02747212|electrical properties|electrical properties
131639|NCT02747212|malignant tissues|malignant tissues
131640|NCT02747212|ex vivo|ex vivo
131641|NCT02747199|SYNERGY|synergy
131642|NCT02747199|Neointimal formation|neointimal formation
131643|NCT02747199|OCT|oct
131644|NCT02747199|coronary angioscopy|coronary angioscopy
131645|NCT02747199|coronary artery disease|coronary artery disease
131646|NCT02747186|lidocaine, jaw|lidocaine, jaw
131647|NCT02747173|metastatic, bone metastases|metastatic, bone metastases
131648|NCT02747160|Cancer|cancer
131649|NCT02747160|Anxiety|anxiety
131650|NCT02747160|Cognitive behavior therapy|cognitive behavior therapy
131651|NCT02747160|Elderly|elderly
131652|NCT02747160|Caregivers|caregivers
131653|NCT02747121|External inspections|external inspections
131654|NCT02747108|Veterans|veterans
131655|NCT02747108|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
131656|NCT02747108|Prediabetes|prediabetes
131657|NCT02747108|Decision-making|decision-making
131658|NCT02747108|Motivation|motivation
131659|NCT02747108|Health Promotion|health promotion
131660|NCT02747108|Prevention and Control|prevention and control
131661|NCT02747095|CT|ct
131662|NCT02747095|Spectral Images|spectral images
131663|NCT02747082|endodontic retreatment|endodontic retreatment
131664|NCT02747082|sodium hypochlorite|sodium hypochlorite
131665|NCT02747082|chlorhexidine|chlorhexidine
131666|NCT02747082|calcium hydroxide|calcium hydroxide
131667|NCT02747082|Retreatment|retreatment
131668|NCT02747069|Heart rate|heart rate
131669|NCT02747069|Electronic Stethoscope|electronic stethoscope
131670|NCT02747069|Electrocardiogram|electrocardiogram
131671|NCT02747069|Resuscitation|resuscitation
131672|NCT02747030|Central retinal vein occlusion|central retinal vein occlusion
131673|NCT02747030|Retinal endovascular surgery|retinal endovascular surgery
131674|NCT02747030|Retinal vein cannulation|retinal vein cannulation
131675|NCT02747030|Ocriplasmin|ocriplasmin
131676|NCT02747017|transplant|transplant
131677|NCT02746965|magnetic seizure therapy|magnetic seizure therapy
131678|NCT02746965|randomized controlled trials|randomized controlled trials
131679|NCT02746965|schizophrenia|schizophrenia
131680|NCT02746965|cognition|cognition
131681|NCT02746939|program evaluation|program evaluation
131682|NCT02746939|health literacy|health literacy
131683|NCT02746939|fitness|fitness
131684|NCT02746939|nutrition|nutrition
131685|NCT02746939|education|education
131686|NCT02746913|Pelvic, Urodynamic, Vaginal Wall|pelvic, urodynamic, vaginal wall
131687|NCT02746874|Total Knee Replacement, Replacement of the knee joint,|total knee replacement, replacement of the knee joint,
131688|NCT02746861|peer mentor|peer mentor
131689|NCT02746861|peer supporter|peer supporter
131690|NCT02746861|peer coach|peer coach
131691|NCT02746861|peer-to-peer mentoring|peer-to-peer mentoring
131692|NCT02746848|cornea epithelium healing Amniotic Membrane Eye Drop|cornea epithelium healing amniotic membrane eye drop
131693|NCT02746835|physical condition|physical condition
131694|NCT02746835|self-efficacy|self-efficacy
131696|NCT02746835|exercise program|exercise program
131697|NCT02746822|acute myocardial infarction,|acute myocardial infarction,
131698|NCT02746822|thrombus aspiration|thrombus aspiration
131699|NCT02746679|Asherman syndrome|asherman syndrome
131700|NCT02746679|Mindfulness|mindfulness
131701|NCT02746679|Anxiety|anxiety
131702|NCT02746679|Depression|depression
131703|NCT02746679|Quality of Life|quality of life
131704|NCT02746653|Fascia Closure Device, hernia,|fascia closure device, hernia,
131705|NCT02746614|adaptive behavior|adaptive behavior
131706|NCT02746614|motor proficiency|motor proficiency
131707|NCT02746614|psychomotor therapy|psychomotor therapy
131708|NCT02746614|intellectual disability|intellectual disability
131709|NCT02746588|miscarriage|miscarriage
131710|NCT02746588|uterine abnormalities|uterine abnormalities
131711|NCT02746588|Chronic infection|chronic infection
131712|NCT02746562|Assisted reproduction|assisted reproduction
131713|NCT02746562|In vitro fertilisation|in vitro fertilisation
131714|NCT02746562|Frozen embryo transfer (FER)|frozen embryo transfer (fer)
131715|NCT02746536|COPD|copd
131716|NCT02746536|Inspiratory capacity|inspiratory capacity
131717|NCT02746536|Exercise|exercise
131718|NCT02746523|NHL|nhl
131719|NCT02746523|Concussion|concussion
131720|NCT02746523|Biomarkers|biomarkers
131721|NCT02746497|Menopause|menopause
131722|NCT02746497|Hot flushes|hot flushes
131723|NCT02746497|Acupuncture|acupuncture
131724|NCT02746497|Randomized controlled trial|randomized controlled trial
131725|NCT02746458|Blood Flow Restriction|blood flow restriction
131726|NCT02746458|Muscle Weakness|muscle weakness
131727|NCT02746458|Physical therapy techniques|physical therapy techniques
131728|NCT02746458|closed femoral fracture injuries|closed femoral fracture injuries
131729|NCT02746445|Autism|autism
131730|NCT02746445|ASD|asd
131731|NCT02746445|Autism Spectrum Disorder|autism spectrum disorder
131732|NCT02746432|CRC-Insulin|crc-insulin
131733|NCT02746354|Chronic Pain|chronic pain
131734|NCT02746354|Analgesics, Opioid|analgesics, opioid
131735|NCT02746354|Primary Health Care|primary health care
131736|NCT02746276|malnutrition|malnutrition
131737|NCT02746276|antibiotics|antibiotics
131738|NCT02746276|antimicrobial resistance|antimicrobial resistance
131739|NCT02746276|pharmacokinetics|pharmacokinetics
131740|NCT02746263|Elective total knee arthroplasty|elective total knee arthroplasty
131741|NCT02746237|Serotonin|serotonin
131742|NCT02746237|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
131743|NCT02746237|Pharmacokinetics|pharmacokinetics
131744|NCT02746237|Phase 1|phase 1
131745|NCT02746237|Healthy Volunteers|healthy volunteers
131746|NCT02746224|Colorectal cancer|colorectal cancer
131747|NCT02746224|Colorectal surgery|colorectal surgery
131748|NCT02746211|immunology|immunology
131749|NCT02746211|pathogenicity|pathogenicity
131750|NCT02746198|Probiotics, Antibiotics, AAD, Helicobacter p.|probiotics, antibiotics, aad, helicobacter p.
131751|NCT02746185|cancer|cancer
131752|NCT02746185|venous thromboembolism|venous thromboembolism
131753|NCT02746185|low-molecular weight heparin|low-molecular weight heparin
131754|NCT02746185|rivaroxaban|rivaroxaban
131755|NCT02746172|cochlear implants|cochlear implants
131756|NCT02746172|Mapping|mapping
131757|NCT02746172|in-situ audiometry|in-situ audiometry
131758|NCT02746107|shared decision making|shared decision making
131759|NCT02746107|oral anticoagulant|oral anticoagulant
131760|NCT02746107|atrial fibrillation|atrial fibrillation
131761|NCT02746107|stroke|stroke
131762|NCT02746107|decision to treat|decision to treat
131763|NCT02746081|BAY1436032|bay1436032
131764|NCT02746081|Solid tumors|solid tumors
131765|NCT02746081|IDH1|idh1
131766|NCT02746081|Cancer|cancer
131767|NCT02746081|Safety|safety
131768|NCT02746081|Tolerability|tolerability
131769|NCT02746081|Pharmacokinetics|pharmacokinetics
131770|NCT02746081|Pharmacodynamics|pharmacodynamics
131771|NCT02746081|Efficacy|efficacy
131772|NCT02746081|Food-effect|food-effect
131773|NCT02746068|Bone Marrow Lesions|bone marrow lesions
131774|NCT02746068|AXS02|axs02
131775|NCT02746068|Axsome|axsome
131776|NCT02746068|Knee OA|knee oa
131777|NCT02746068|Osteoarthritis|osteoarthritis
131778|NCT02746042|chronic rhinosinusitis|chronic rhinosinusitis
131779|NCT02746042|Sinupret extract|sinupret extract
131780|NCT02746042|herbal medicinal product|herbal medicinal product
131781|NCT02746003|drinking water|drinking water
131782|NCT02746003|salinity|salinity
131783|NCT02745990|erythropoietin|erythropoietin
131784|NCT02745990|preterm|preterm
131785|NCT02745990|brain injury|brain injury
131786|NCT02745990|cerebral palsy|cerebral palsy
131787|NCT02745990|PVL|pvl
131788|NCT02745951|cardiopulmonary bypass|cardiopulmonary bypass
131789|NCT02745951|cardioplegia|cardioplegia
131790|NCT02745951|cardioprotection|cardioprotection
131791|NCT02745951|coronary artery bypass graft surgery|coronary artery bypass graft surgery
131792|NCT02745951|heliox|heliox
131793|NCT02745938|Exercise test|exercise test
131794|NCT02745938|GDF-15|gdf-15
131795|NCT02745938|Growth and Differentiation Factor 15|growth and differentiation factor 15
131796|NCT02745925|Iron bioavailability|iron bioavailability
131797|NCT02745925|Inflammation|inflammation
131799|NCT02745925|Iron absorption|iron absorption
131800|NCT02745912|Drug Therapy|drug therapy
131801|NCT02745899|asthma|asthma
131802|NCT02745899|cow milk|cow milk
131803|NCT02745899|pulmonary function testing|pulmonary function testing
131804|NCT02745899|children|children
131805|NCT02745899|mucus|mucus
131806|NCT02745860|selexipag|selexipag
131807|NCT02745860|pharmacokinetics|pharmacokinetics
131808|NCT02745821|coronary flow reserve|coronary flow reserve
131809|NCT02745821|fractional flow reserve|fractional flow reserve
131810|NCT02745821|diabetes mellitus|diabetes mellitus
131811|NCT02745821|coronary artery disease|coronary artery disease
131812|NCT02745821|percutaneous coronary intervention|percutaneous coronary intervention
131813|NCT02745821|coronary physiology|coronary physiology
131814|NCT02745821|index of microcirculatory resistance|index of microcirculatory resistance
131815|NCT02745795|Motivational interview|motivational interview
131816|NCT02745795|adolescents|adolescents
131817|NCT02745795|obesity|obesity
131818|NCT02745795|overweight|overweight
131819|NCT02745795|physical activity|physical activity
131820|NCT02745795|diet|diet
131821|NCT02745782|Pulpitis|pulpitis
131822|NCT02745782|Syncope|syncope
131823|NCT02745782|Trigeminal Cardio-Reflex|trigeminal cardio-reflex
131824|NCT02745756|Children|children
131825|NCT02745756|Cancer|cancer
131826|NCT02745756|High-risk neuroblastoma|high-risk neuroblastoma
131827|NCT02745743|Phase 1|phase 1
131828|NCT02745743|Dose escalation|dose escalation
131829|NCT02745743|Dose expansion|dose expansion
131830|NCT02745743|Positive transcription elongation factor b inhibitor|positive transcription elongation factor b inhibitor
131831|NCT02745743|Cyclin-dependent kinase 9 inhibitor|cyclin-dependent kinase 9 inhibitor
131832|NCT02745717|Severe aplastic anemia|severe aplastic anemia
131833|NCT02745717|immunosuppressive therapy|immunosuppressive therapy
131834|NCT02745717|cord blood transfusion|cord blood transfusion
131835|NCT02745704|chronic hepatitis B|chronic hepatitis b
131836|NCT02745704|peginterferon alfa|peginterferon alfa
131837|NCT02745691|quality of life|quality of life
131838|NCT02745691|psychometric validation|psychometric validation
131839|NCT02745691|international field study|international field study
131840|NCT02745691|patient-reported outcome (PRO)|patient-reported outcome (pro)
131841|NCT02745678|Enema|enema
131842|NCT02745678|Ulcerative Colitis|ulcerative colitis
131843|NCT02745652|median nerve|median nerve
131844|NCT02745652|wrist joint|wrist joint
131845|NCT02745652|carpal tunnel|carpal tunnel
131846|NCT02745639|rectal cancer|rectal cancer
131847|NCT02745639|radiotherapy|radiotherapy
131848|NCT02745639|chemotherapy|chemotherapy
131849|NCT02745639|VMAT|vmat
131850|NCT02745639|toxicity|toxicity
131851|NCT02745600|RFA|rfa
131852|NCT02745600|Liver|liver
131853|NCT02745600|Ablation Techniques|ablation techniques
131854|NCT02745600|Treatment Simulation|treatment simulation
131855|NCT02745600|Computer assisted therapy|computer assisted therapy
131856|NCT02745574|should and upper abdominal pain, post-laparoscopy|should and upper abdominal pain, post-laparoscopy
131857|NCT02745561|Endostatin|endostatin
131858|NCT02745561|Oxaliplatin|oxaliplatin
131859|NCT02745561|Esophageal Cancer|esophageal cancer
131860|NCT02745561|chemoradiotherapy|chemoradiotherapy
131861|NCT02745548|Lung Cancer|lung cancer
131862|NCT02745548|NSCLC (Non Small Cell Lung Cancer)|nsclc (non small cell lung cancer)
131863|NCT02745548|SABR (Stereotactic ablative radiotherapy)|sabr (stereotactic ablative radiotherapy)
131864|NCT02745535|Hepatitis C relapse|hepatitis c relapse
131865|NCT02745522|Placebo analgesia|placebo analgesia
131866|NCT02745522|Working memory|working memory
131867|NCT02745509|Extensive Intraoperative Peritoneal Lavage|extensive intraoperative peritoneal lavage
131868|NCT02745509|EIPL|eipl
131869|NCT02745509|Gastric Cancer|gastric cancer
131870|NCT02745496|Image-guided biopsy|image-guided biopsy
131871|NCT02745496|Tumour detection|tumour detection
131872|NCT02745496|Diagnostic|diagnostic
131873|NCT02745496|Biomarkers|biomarkers
131874|NCT02745483|RFA|rfa
131875|NCT02745470|lean/obese diabetes mellitus|lean/obese diabetes mellitus
131876|NCT02745470|functional MRI|functional mri
131877|NCT02745470|GLP-1|glp-1
131878|NCT02745470|appetite|appetite
131879|NCT02745470|activation of brain|activation of brain
131880|NCT02745470|connectivity|connectivity
131881|NCT02745444|Living kidney transplantation|living kidney transplantation
131882|NCT02745444|Chronic kidney disease|chronic kidney disease
131883|NCT02745444|Acute kidney injury|acute kidney injury
131884|NCT02745431|Likeability|likeability
131885|NCT02745431|Being liked|being liked
131886|NCT02745405|Weight Stigma|weight stigma
131887|NCT02745405|Cortisol Reactivity|cortisol reactivity
131888|NCT02745405|Eating Behavior|eating behavior
131889|NCT02745392|migraine|migraine
131890|NCT02745392|migraine headache|migraine headache
131891|NCT02745392|acute migraine|acute migraine
131892|NCT02745392|acute migraine headache|acute migraine headache
131893|NCT02745353|Cancer|cancer
131894|NCT02745353|Constipation|constipation
131895|NCT02745353|Opioid|opioid
131896|NCT02745327|oral vaccination|oral vaccination
131897|NCT02745327|nutrition|nutrition
132291|NCT02743416|Screening|screening
131898|NCT02745314|Aortic Stenosis, Frailty, Elderly, moertality|aortic stenosis, frailty, elderly, moertality
131899|NCT02745275|Peer Education|peer education
131900|NCT02745275|Health Coaches|health coaches
131901|NCT02745275|Community Dwelling Seniors|community dwelling seniors
131902|NCT02745275|Health Literacy|health literacy
131903|NCT02745275|Health Education|health education
131904|NCT02745275|Healthy Ageing|healthy ageing
131905|NCT02745236|Atrial Fibrillation|atrial fibrillation
131906|NCT02745236|Health Related Quality of Life|health related quality of life
131907|NCT02745236|Nurse Practitioner|nurse practitioner
131908|NCT02745236|Sustainable Models of Healthcare|sustainable models of healthcare
131909|NCT02745236|Patient Satisfaction|patient satisfaction
131910|NCT02745171|Parkinson's disease|parkinson's disease
131911|NCT02745171|Quality of life|quality of life
131912|NCT02745171|Functional mobility|functional mobility
131913|NCT02745171|Follow up|follow up
131914|NCT02745158|Fibrodysplasia ossificans progressiva|fibrodysplasia ossificans progressiva
131915|NCT02745158|FOP|fop
131916|NCT02745158|International FOP Association|international fop association
131917|NCT02745158|Patient Advocacy Group|patient advocacy group
131918|NCT02745158|Patient Registry|patient registry
131919|NCT02745158|Natural History|natural history
131920|NCT02745158|Patient-Reported Outcomes|patient-reported outcomes
131921|NCT02745158|Observational Database|observational database
131922|NCT02745158|Bone Morphogenetic Protein|bone morphogenetic protein
131923|NCT02745158|BMP|bmp
131924|NCT02745158|Bone Growth|bone growth
131925|NCT02745158|Joint|joint
131926|NCT02745158|Mobility|mobility
131927|NCT02745158|Flare-Up|flare-up
131928|NCT02745158|Heterotopic Ossification|heterotopic ossification
131929|NCT02745158|Ectopic Bone|ectopic bone
131930|NCT02745158|Osteochondroma|osteochondroma
131931|NCT02745158|Hallux Valgus|hallux valgus
131932|NCT02745158|ALK2|alk2
131933|NCT02745158|ACVR1|acvr1
131934|NCT02745158|Activin A|activin a
131935|NCT02745158|IFOPA|ifopa
131936|NCT02745158|Activin A Receptor Type I|activin a receptor type i
131937|NCT02745158|Activin Receptor-like Kinase-2|activin receptor-like kinase-2
131938|NCT02745145|Double-Blind Method|double-blind method
131939|NCT02745145|Interstitial Lung Diseases|interstitial lung diseases
131940|NCT02745145|Systemic Scleroderma|systemic scleroderma
131941|NCT02745145|Abituzumab|abituzumab
131942|NCT02745145|Mycophenolate|mycophenolate
131943|NCT02745145|Efficacy, Safety|efficacy, safety
131944|NCT02745132|Chronic, Cognition Disorders|chronic, cognition disorders
131945|NCT02745132|Neurocognition Disorders|neurocognition disorders
131946|NCT02745132|Cognitive Impairments|cognitive impairments
131947|NCT02745132|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
131948|NCT02745132|MRI functional|mri functional
131949|NCT02745132|Verbal fluency|verbal fluency
131950|NCT02745106|Chronic thromboembolic pulmonary hypertension, Navigation system, Ablation|chronic thromboembolic pulmonary hypertension, navigation system, ablation
131951|NCT02745093|Abortion induced|abortion induced
131952|NCT02745093|Patient Acceptance of Healthcare|patient acceptance of healthcare
131953|NCT02745093|safety|safety
131954|NCT02745093|effectiveness|effectiveness
131955|NCT02745093|misoprostol|misoprostol
131956|NCT02745093|mifepristone|mifepristone
131957|NCT02745080|Psoriatic Arthritis|psoriatic arthritis
131958|NCT02745080|secukinumab|secukinumab
131959|NCT02745080|adalimumab|adalimumab
131960|NCT02745080|monoclonal antibody|monoclonal antibody
131962|NCT02745054|oral anticoagulants|oral anticoagulants
131963|NCT02745054|bleeding|bleeding
131964|NCT02745054|anticoagulation reversal|anticoagulation reversal
131965|NCT02745041|Fibrinogen|fibrinogen
131966|NCT02745041|Cryoprecipitate|cryoprecipitate
131967|NCT02745028|delayed gastric emptying|delayed gastric emptying
131968|NCT02745028|children|children
131969|NCT02745028|monosodium glutamate|monosodium glutamate
131970|NCT02745015|periodontitis|periodontitis
131971|NCT02745015|diabetes|diabetes
131972|NCT02745015|HbA1c|hba1c
131973|NCT02745015|inflammation|inflammation
131974|NCT02745002|Bronchoscopy|bronchoscopy
131975|NCT02745002|Bronchoscopes|bronchoscopes
131976|NCT02744989|Schizophrenia|schizophrenia
131977|NCT02744989|Transcranial direct-current stimulation (tDCS)|transcranial direct-current stimulation (tdcs)
131978|NCT02744989|Sham|sham
131979|NCT02744989|Positive and Negative Syndrome Scale (PANSS)|positive and negative syndrome scale (panss)
131980|NCT02744989|Functional Magnetic Resonance Imaging (fRMI)|functional magnetic resonance imaging (frmi)
131981|NCT02744989|Brain-Derived-Neurotrophic Factor (BDNF)|brain-derived-neurotrophic factor (bdnf)
131982|NCT02744976|Coronary artery disease|coronary artery disease
131983|NCT02744976|Atherosclerosis|atherosclerosis
131984|NCT02744976|Prediabetes|prediabetes
131985|NCT02744976|Intravascular ultrasound|intravascular ultrasound
131986|NCT02744976|Insulin resistance|insulin resistance
131987|NCT02744976|Percutaneous coronary intervention|percutaneous coronary intervention
131988|NCT02744976|Metformin|metformin
131989|NCT02744950|pulley|pulley
131990|NCT02744950|scalp defects|scalp defects
131991|NCT02744911|speech problems|speech problems
131992|NCT02744898|uterus|uterus
131993|NCT02744898|gynecological|gynecological
131994|NCT02744898|corpus uteri|corpus uteri
131995|NCT02744872|lung transplantation|lung transplantation
131996|NCT02744872|chronic renal insufficiency|chronic renal insufficiency
131997|NCT02744859|Decision Making|decision making
131998|NCT02744859|Consumption|consumption
131999|NCT02744859|Economics|economics
132000|NCT02744846|antibiotics|antibiotics
132001|NCT02744846|children|children
132002|NCT02744846|pediatric|pediatric
132003|NCT02744846|body mass index|body mass index
132004|NCT02744846|Observational Study|observational study
132005|NCT02744846|Comparative Effectiveness Research|comparative effectiveness research
132006|NCT02744846|Obesity|obesity
132007|NCT02744846|Growth Trajectory|growth trajectory
132008|NCT02744846|Cohort Study|cohort study
132009|NCT02744846|Electronic Medical Record|electronic medical record
132010|NCT02744846|Qualitative Research|qualitative research
132011|NCT02744833|DVT|dvt
132012|NCT02744807|intrauterine adhesions|intrauterine adhesions
132013|NCT02744807|Chronic endometritis|chronic endometritis
132014|NCT02744807|infections|infections
132015|NCT02744807|Hysteroscopy|hysteroscopy
132016|NCT02744781|Muscular Atrophy|muscular atrophy
132017|NCT02744781|Asymmetry|asymmetry
132018|NCT02744781|Athletes|athletes
132019|NCT02744768|Acute Lymphoblastic Leukemia, adult, dasatinib, blinatumomab|acute lymphoblastic leukemia, adult, dasatinib, blinatumomab
132020|NCT02744716|intrauterine balloon|intrauterine balloon
132021|NCT02744716|uterine endometrial repair|uterine endometrial repair
132022|NCT02744716|intrauterine adhesion|intrauterine adhesion
132023|NCT02744716|aspirin|aspirin
132024|NCT02744690|Eye Disease|eye disease
132025|NCT02744690|Intraocular Pressure|intraocular pressure
132026|NCT02744690|Visual Acuity|visual acuity
132027|NCT02744690|Trabeculectomy|trabeculectomy
132028|NCT02744677|Tetralogy of Fallot|tetralogy of fallot
132029|NCT02744677|Aortic Valve Defect/Disease Resulting in Ross Procedure|aortic valve defect/disease resulting in ross procedure
132030|NCT02744677|Pulmonary Atresia|pulmonary atresia
132031|NCT02744677|Pulmonary Stenosis|pulmonary stenosis
132032|NCT02744677|Truncus Arteriosus|truncus arteriosus
132033|NCT02744677|Transposition of the Great Arteries|transposition of the great arteries
132034|NCT02744677|Transcatheter pulmonary valve implantation|transcatheter pulmonary valve implantation
132035|NCT02744677|Transcatheter pulmonary valve replacement|transcatheter pulmonary valve replacement
132036|NCT02744677|TPV|tpv
132037|NCT02744677|TPVR|tpvr
132038|NCT02744677|TPVI|tpvi
132039|NCT02744664|Lung Neoplasms|lung neoplasms
132040|NCT02744664|EGFR mutation|egfr mutation
132041|NCT02744664|Cryotherapy|cryotherapy
132042|NCT02744664|Icotinib|icotinib
132043|NCT02744638|bacterial vaginosis|bacterial vaginosis
132044|NCT02744638|probiotics|probiotics
132045|NCT02744638|Amsel Score|amsel score
132046|NCT02744638|Nugent Score|nugent score
132047|NCT02744599|Feasibility trial|feasibility trial
132048|NCT02744586|Sexually transmitted infections|sexually transmitted infections
132049|NCT02744586|Neglected tropical diseases|neglected tropical diseases
132050|NCT02744586|Non-communicable diseases|non-communicable diseases
132051|NCT02744534|Prostate Cancer|prostate cancer
132052|NCT02744534|Imaging Technology|imaging technology
132053|NCT02744534|Oncology|oncology
132054|NCT02744534|Prostate Biopsy|prostate biopsy
132055|NCT02744508|palonosetron, dexamethasone, PONV (postoperative nausea and vomiting)|palonosetron, dexamethasone, ponv (postoperative nausea and vomiting)
132056|NCT02744495|cardiac surgery|cardiac surgery
132057|NCT02744495|corticoids|corticoids
132058|NCT02744495|droperidol|droperidol
132059|NCT02744495|antiemetics|antiemetics
132060|NCT02744495|Postoperative Vomiting|postoperative vomiting
132061|NCT02744495|Postoperative Nausea|postoperative nausea
132062|NCT02744495|Postoperative Emesis|postoperative emesis
132063|NCT02744495|prophylaxis|prophylaxis
132064|NCT02744469|Tuberculosis|tuberculosis
132065|NCT02744469|population structure|population structure
132066|NCT02744469|implications|implications
132067|NCT02744469|lineages|lineages
132068|NCT02744469|spoligotyping|spoligotyping
132069|NCT02744469|sputum|sputum
132070|NCT02744469|resistance|resistance
132071|NCT02744469|culture|culture
132072|NCT02744469|diagnostics|diagnostics
132073|NCT02744469|outcome|outcome
132074|NCT02744469|new/retreatment patient|new/retreatment patient
132075|NCT02744456|Hydrochlorothiazide tablet|hydrochlorothiazide tablet
132076|NCT02744456|Norvasc|norvasc
132077|NCT02744456|Cozaar|cozaar
132078|NCT02744456|amlodipine besylate tablets|amlodipine besylate tablets
132079|NCT02744456|losartan potassium tablets|losartan potassium tablets
132080|NCT02744456|Hypertension|hypertension
132081|NCT02744456|High Blood Pressure|high blood pressure
132082|NCT02744430|Medical expulsive therapy|medical expulsive therapy
132083|NCT02744430|ureteral stone|ureteral stone
132084|NCT02744430|stent pain|stent pain
132085|NCT02744417|smoking cessation|smoking cessation
132086|NCT02744417|tobacco|tobacco
132087|NCT02744417|periodontal|periodontal
132088|NCT02744417|subgingival microorganisms|subgingival microorganisms
132089|NCT02744352|infraclavicular brachial plexus block|infraclavicular brachial plexus block
132090|NCT02744352|quality of recovery score|quality of recovery score
132091|NCT02744352|pain score|pain score
132092|NCT02744352|disability assessment of shoulder and hand questionnaire|disability assessment of shoulder and hand questionnaire
132093|NCT02744339|PH-HFpEF|ph-hfpef
132094|NCT02744300|Gestational diabetes mellitus (GDM) in most recent pregnancy|gestational diabetes mellitus (gdm) in most recent pregnancy
132095|NCT02744287|Non Resectable Pancreatic Cancer|non resectable pancreatic cancer
132096|NCT02744287|BPX-601|bpx-601
132097|NCT02744287|AP1903|ap1903
132098|NCT02744287|CAR T|car t
132099|NCT02744287|PSCA-CAR|psca-car
132100|NCT02744274|acupuncture|acupuncture
132101|NCT02744274|chemotherapy|chemotherapy
132102|NCT02744274|peripheral neuropathy|peripheral neuropathy
132103|NCT02744274|randomized clinical trial|randomized clinical trial
132104|NCT02744274|numbness|numbness
132105|NCT02744261|HIV|hiv
132106|NCT02744261|STI|sti
132107|NCT02744261|Primary Prevention|primary prevention
132108|NCT02744261|Topical Microbicides|topical microbicides
132109|NCT02744261|User Experience|user experience
132110|NCT02744261|Drug Delivery Systems|drug delivery systems
132111|NCT02744248|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
132112|NCT02744196|rheumatoid arthritis|rheumatoid arthritis
132113|NCT02744196|rheumatism|rheumatism
132114|NCT02744196|Acellbia|acellbia
132115|NCT02744196|methotrexate|methotrexate
132116|NCT02744196|biologic therapy|biologic therapy
132117|NCT02744196|monoclonal antibody|monoclonal antibody
132118|NCT02744196|rituximab|rituximab
132119|NCT02744183|Exercise|exercise
132120|NCT02744183|Fasted|fasted
132121|NCT02744183|Glucose|glucose
132122|NCT02744183|Energy Balance|energy balance
132123|NCT02744170|COPD|copd
132124|NCT02744170|Incremental Shuttle Walk Test|incremental shuttle walk test
132125|NCT02744170|Endurance Shuttle Walk Test|endurance shuttle walk test
132126|NCT02744170|oxygen therapy|oxygen therapy
132127|NCT02744131|PCOS|pcos
132128|NCT02744131|Metformin|metformin
132129|NCT02744131|OCP|ocp
132130|NCT02744131|metabolic parameters|metabolic parameters
132131|NCT02744118|Media Use|media use
132132|NCT02744092|Rivaroxaban (Xarelto)|rivaroxaban (xarelto)
132133|NCT02744092|Apixaban (Eliquis)|apixaban (eliquis)
132134|NCT02744092|Edoxaban (Savaysa)|edoxaban (savaysa)
132135|NCT02744092|Dabigatran (Pradaxa)|dabigatran (pradaxa)
132136|NCT02744092|Warfarin (Coumadin)|warfarin (coumadin)
132137|NCT02744092|Low molecular weight heparin (LMWH)|low molecular weight heparin (lmwh)
132138|NCT02744079|diet|diet
132139|NCT02744079|dietary intervention|dietary intervention
132140|NCT02744079|carbohydrate restriction|carbohydrate restriction
132141|NCT02744079|low carbohydrate|low carbohydrate
132142|NCT02744079|fat restriction|fat restriction
132143|NCT02744079|low fat|low fat
132144|NCT02744079|cancer|cancer
132145|NCT02744079|breast cancer|breast cancer
132146|NCT02744079|pre-surgical window|pre-surgical window
132147|NCT02744079|biomarker|biomarker
132148|NCT02744053|Breast Cancer|breast cancer
132149|NCT02744053|Malignant neoplasm of breast|malignant neoplasm of breast
132150|NCT02744053|Triple Negative Breast Cancer|triple negative breast cancer
132151|NCT02744053|TNBC|tnbc
132152|NCT02744053|Tc99m Sestamibi Molecular Breast Imaging|tc99m sestamibi molecular breast imaging
132153|NCT02744053|MBI|mbi
132154|NCT02744053|Dynamic Contrast Enhanced Molecular Resonance Imaging|dynamic contrast enhanced molecular resonance imaging
132155|NCT02744053|DCE-MRI|dce-mri
132156|NCT02744040|HIV reservoir|hiv reservoir
132157|NCT02744040|alcohol|alcohol
132158|NCT02744040|ART|art
132159|NCT02744027|Generalized Lymphatic Anomaly|generalized lymphatic anomaly
132160|NCT02744027|Kaposiform Lymphangiomatosis|kaposiform lymphangiomatosis
132161|NCT02744027|Dynamic Contrast Enhanced Magnetic Resonance Lymphangiogram|dynamic contrast enhanced magnetic resonance lymphangiogram
132162|NCT02744027|Magnetic Resonance Imaging|magnetic resonance imaging
132163|NCT02743988|cerebral oxygenation|cerebral oxygenation
132164|NCT02743988|NIRS|nirs
132165|NCT02743988|near-infrared spectroscopy|near-infrared spectroscopy
132166|NCT02743988|bradycardia|bradycardia
132167|NCT02743988|hypoxemia|hypoxemia
132168|NCT02743988|cerebral perfusion|cerebral perfusion
132169|NCT02743988|cardiac output|cardiac output
132170|NCT02743988|apnea|apnea
132171|NCT02743988|desaturation|desaturation
132172|NCT02743988|oxygen saturation target range|oxygen saturation target range
132173|NCT02743949|Drug therapy|drug therapy
132174|NCT02743910|preoperative|preoperative
132175|NCT02743910|neoadjuvant|neoadjuvant
132176|NCT02743910|plasma tumor DNA|plasma tumor dna
132177|NCT02743910|ptDNA|ptdna
132178|NCT02743897|end-stage renal disease|end-stage renal disease
132179|NCT02743871|FIH, Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, Atopic Dermatitis, Chronic Rhinosinusitis, Nasal Polyps|fih, pharmacokinetics, pharmacodynamics, safety, tolerability, atopic dermatitis, chronic rhinosinusitis, nasal polyps
132180|NCT02743858|Lymphedema|lymphedema
132181|NCT02743858|Surveillance Program|surveillance program
132182|NCT02743858|Axillary Lymph Node Dissection|axillary lymph node dissection
132183|NCT02743858|16-220|16-220
132184|NCT02743845|Rare|rare
132185|NCT02743845|Undiagnosed|undiagnosed
132186|NCT02743845|Orphan Disease|orphan disease
132187|NCT02743845|Genomic Sequencing|genomic sequencing
132188|NCT02743832|Surgery, Oral|surgery, oral
132189|NCT02743832|Tumor budding|tumor budding
132190|NCT02743819|Melanoma|melanoma
132191|NCT02743819|Pembrolizumab|pembrolizumab
132192|NCT02743819|Ipilimumab|ipilimumab
132193|NCT02743806|Drug Therapy|drug therapy
132194|NCT02743793|single organ liver or kidney allograft|single organ liver or kidney allograft
132195|NCT02743793|operationally tolerant allograft recipients|operationally tolerant allograft recipients
132196|NCT02743793|longitudinal follow-up|longitudinal follow-up
132197|NCT02743780|Ocular Hypertension|ocular hypertension
132198|NCT02743780|Open-Angle Glaucoma|open-angle glaucoma
132199|NCT02743780|POAG|poag
132200|NCT02743780|Glaucoma|glaucoma
132201|NCT02743767|Airway management|airway management
132202|NCT02743767|General anaesthesia|general anaesthesia
132203|NCT02743767|Critical incidents|critical incidents
132204|NCT02743767|Complications|complications
132205|NCT02743741|Somatostatin Receptor Positive Neuroendocrine Tumors|somatostatin receptor positive neuroendocrine tumors
132206|NCT02743728|perinatal stroke|perinatal stroke
132207|NCT02743728|transcranial magnetic stimulation|transcranial magnetic stimulation
132208|NCT02743728|magnetic resonance imaging|magnetic resonance imaging
132209|NCT02743728|diffusion tensor imaging|diffusion tensor imaging
132210|NCT02743728|non-invasive brain stimulation|non-invasive brain stimulation
132211|NCT02743728|infant|infant
132212|NCT02743715|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
132213|NCT02743715|Transcranial direct current stimulation|transcranial direct current stimulation
132214|NCT02743715|Neuromodulation|neuromodulation
132215|NCT02743702|Effectiveness|effectiveness
132216|NCT02743702|Physical therapy modalities|physical therapy modalities
132217|NCT02743702|neuromuscular diseases|neuromuscular diseases
132218|NCT02743689|Postoperative|postoperative
132219|NCT02743689|Cardiac surgery|cardiac surgery
132220|NCT02743676|Avian Influenza|avian influenza
132221|NCT02743663|pediatric|pediatric
132222|NCT02743663|lung ventilation inhomogeneity|lung ventilation inhomogeneity
132223|NCT02743663|preschool|preschool
132224|NCT02743663|asthma|asthma
132225|NCT02743663|wheeze|wheeze
132226|NCT02743650|Low Serum Bicarbonate Level|low serum bicarbonate level
132227|NCT02743650|Sodium Bicarbonate|sodium bicarbonate
132228|NCT02743637|Cancer|cancer
132229|NCT02743637|Oncology|oncology
132230|NCT02743637|Solid Tumors|solid tumors
132231|NCT02743637|Phase 1|phase 1
132232|NCT02743637|SDX-7320|sdx-7320
132233|NCT02743637|SynDevRx|syndevrx
132234|NCT02743637|MetAP2|metap2
132235|NCT02743637|Breast|breast
132236|NCT02743637|Post menopausal|post menopausal
132237|NCT02743637|Colorectal|colorectal
132238|NCT02743637|Pancreatic|pancreatic
132239|NCT02743637|Ovarian|ovarian
132240|NCT02743637|Endometrial|endometrial
132241|NCT02743637|Esophageal|esophageal
132242|NCT02743637|Lung|lung
132243|NCT02743637|Renal|renal
132244|NCT02743637|Prostate|prostate
132245|NCT02743637|Liver|liver
132246|NCT02743611|BPX-701|bpx-701
132247|NCT02743611|AP1903|ap1903
132248|NCT02743611|Rimiducid|rimiducid
132249|NCT02743611|AML|aml
132250|NCT02743611|MDS|mds
132251|NCT02743611|Primary Refractory AML|primary refractory aml
132252|NCT02743611|Relapsed AML|relapsed aml
132253|NCT02743611|Refractory Myeloid Neoplasms|refractory myeloid neoplasms
132254|NCT02743598|HIV infection|hiv infection
132255|NCT02743598|Diabetes Mellitus type 2|diabetes mellitus type 2
132256|NCT02743598|Obesity|obesity
132257|NCT02743598|Neurocognitive function|neurocognitive function
132258|NCT02743572|premature infant|premature infant
132259|NCT02743572|anemia|anemia
132260|NCT02743572|iron-fortification|iron-fortification
132261|NCT02743572|parenteral nutrition|parenteral nutrition
132262|NCT02743572|randomized controlled trial|randomized controlled trial
132263|NCT02743546|B-Cell, Malignancy|b-cell, malignancy
132264|NCT02743546|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
132265|NCT02743546|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
132266|NCT02743546|Lymphoma, Follicular|lymphoma, follicular
132267|NCT02743546|Lymphocytic, Chronic, B-Cell|lymphocytic, chronic, b-cell
132268|NCT02743546|JNJ-64052781|jnj-64052781
132269|NCT02743546|Ibrutinib|ibrutinib
132270|NCT02743533|cardiovascular diseases, prognosis|cardiovascular diseases, prognosis
132271|NCT02743520|sleep apnea|sleep apnea
132272|NCT02743481|Pesticide|pesticide
132273|NCT02743481|Agriculture|agriculture
132274|NCT02743481|Cancer|cancer
132275|NCT02743481|Childhood|childhood
132276|NCT02743481|Leukemia|leukemia
132277|NCT02743468|Bronchoscopy|bronchoscopy
132278|NCT02743468|Pollutants|pollutants
132279|NCT02743468|Human Pulmonary Cells|human pulmonary cells
132280|NCT02743468|Cytochrome P450|cytochrome p450
132281|NCT02743468|Soluble Epoxide Hydrolase|soluble epoxide hydrolase
132282|NCT02743455|Fever|fever
132283|NCT02743455|Immunogenicity|immunogenicity
132284|NCT02743455|MVA-BN|mva-bn
132285|NCT02743455|Reactogenicity|reactogenicity
132286|NCT02743455|Vaccine|vaccine
132287|NCT02743455|Yellow|yellow
132288|NCT02743429|ch14.18/CHO|ch14.18/cho
132289|NCT02743429|neuroblastoma|neuroblastoma
132290|NCT02743429|long term infusion|long term infusion
132292|NCT02743416|Stroke prevention|stroke prevention
132293|NCT02743416|Cost effectiveness|cost effectiveness
132294|NCT02743390|blood pressure|blood pressure
132295|NCT02743390|inflammation|inflammation
132296|NCT02743390|tumor Necrosis Factor-alpha|tumor necrosis factor-alpha
132297|NCT02743377|GsI+/-|gsi+/-
132298|NCT02743377|Camp|camp
132299|NCT02743377|GNAS|gnas
132300|NCT02743351|Cell Transplants|cell transplants
132301|NCT02743351|Hematopoietic Cell Transplant|hematopoietic cell transplant
132302|NCT02743351|HSCT|hsct
132303|NCT02743351|Hematologic Malignancies|hematologic malignancies
132304|NCT02743351|Hematologic Malignancy|hematologic malignancy
132305|NCT02743351|Acute Myeloid Leukemia|acute myeloid leukemia
132306|NCT02743351|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
132307|NCT02743351|ALL|all
132308|NCT02743351|AML|aml
132309|NCT02743351|Myelodysplastic Syndrome|myelodysplastic syndrome
132310|NCT02743351|MDS|mds
132311|NCT02743351|Allogeneic|allogeneic
132312|NCT02743351|CML|cml
132313|NCT02743351|Stem Cell Transplant|stem cell transplant
132314|NCT02743351|Transplant|transplant
132315|NCT02743338|Sleep Restriction|sleep restriction
132316|NCT02743338|Sleep Compression|sleep compression
132317|NCT02743338|Cognitive Behavioral Therapy|cognitive behavioral therapy
132318|NCT02743312|Balance-Based Torso-Weighting|balance-based torso-weighting
132319|NCT02743312|Physical Activity|physical activity
132320|NCT02743312|Neurorehabilitation|neurorehabilitation
132321|NCT02743286|sedentary behavior|sedentary behavior
132322|NCT02743286|sitting|sitting
132323|NCT02743286|feasibility|feasibility
132324|NCT02743286|endothelial function|endothelial function
132325|NCT02743286|metabolism|metabolism
132326|NCT02743260|phenotype|phenotype
132327|NCT02743260|transporter|transporter
132328|NCT02743260|cocktail|cocktail
132329|NCT02743247|Healthy volunteer|healthy volunteer
132330|NCT02743221|metastatic|metastatic
132331|NCT02743221|colorectal|colorectal
132332|NCT02743221|cancer|cancer
132333|NCT02743221|untreated|untreated
132334|NCT02743221|first-line|first-line
132335|NCT02743221|S95005|s95005
132336|NCT02743221|bevacizumab|bevacizumab
132337|NCT02743221|capecitabine|capecitabine
132338|NCT02743208|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
132339|NCT02743208|Surgical Procedures, Operative|surgical procedures, operative
132340|NCT02743208|Hip Prosthesis|hip prosthesis
132341|NCT02743169|Geographic Information Systems|geographic information systems
132342|NCT02743169|Spatial Analysis|spatial analysis
132343|NCT02743169|Emergency Medical Services|emergency medical services
132344|NCT02743156|IVUS|ivus
132345|NCT02743156|Acute Renal Failure|acute renal failure
132346|NCT02743156|Angioplasty|angioplasty
132347|NCT02743156|stent|stent
132348|NCT02743156|contrast|contrast
132349|NCT02743156|percutaneous coronary intervention|percutaneous coronary intervention
132350|NCT02743156|intravascular ultrasound|intravascular ultrasound
132351|NCT02743143|Exercise therapy|exercise therapy
132352|NCT02743143|Cardiovascular disease|cardiovascular disease
132353|NCT02743143|Risk|risk
132354|NCT02743130|Berries|berries
132355|NCT02743130|Blackcurrant (Ribes nigrum)|blackcurrant (ribes nigrum)
132356|NCT02743130|Lingonberry (Vaccinium vitis-idaea)|lingonberry (vaccinium vitis-idaea)
132357|NCT02743130|Sucrose|sucrose
132358|NCT02743130|Inverted sugar|inverted sugar
132359|NCT02743130|Postprandial glucose response|postprandial glucose response
132360|NCT02743130|Postprandial insulin response|postprandial insulin response
132361|NCT02743117|Trivalent|trivalent
132362|NCT02743117|Influenza|influenza
132363|NCT02743117|FluMist Quadrivalent|flumist quadrivalent
132364|NCT02743117|Vaccine|vaccine
132365|NCT02743117|Prevention|prevention
132366|NCT02743117|Healthy|healthy
132367|NCT02743117|Monovalent|monovalent
132368|NCT02743091|heart failure|heart failure
132369|NCT02743091|survival|survival
132370|NCT02743091|end-stage kidney disease|end-stage kidney disease
132371|NCT02743078|Glioblastoma|glioblastoma
132372|NCT02743078|Glioma|glioma
132373|NCT02743078|Gliosarcoma|gliosarcoma
132374|NCT02743078|Optune|optune
132375|NCT02743078|TTFields|ttfields
132376|NCT02743065|HepaSphere|hepasphere
132377|NCT02743039|Low income|low income
132378|NCT02743039|Education|education
132379|NCT02743039|Poverty|poverty
132380|NCT02743039|Children|children
132381|NCT02743039|Parents|parents
132382|NCT02743039|Head Start|head start
132383|NCT02743000|fMRI|fmri
132384|NCT02743000|emotion conflict task|emotion conflict task
132385|NCT02743000|monetary incentive delay|monetary incentive delay
132386|NCT02742974|Trauma|trauma
132387|NCT02742974|Minimally Invasive Hemodynamic Monitoring|minimally invasive hemodynamic monitoring
132388|NCT02742974|Perioperative|perioperative
132389|NCT02742974|Complications|complications
132390|NCT02742974|Hemodynamics|hemodynamics
132391|NCT02742974|Operative procedures|operative procedures
132392|NCT02742961|orthopedics|orthopedics
132393|NCT02742961|anesthesiology|anesthesiology
132394|NCT02742961|nerve block|nerve block
132395|NCT02742961|length of stay|length of stay
132396|NCT02742961|Patient readmission|patient readmission
132397|NCT02742948|elective caesarean section|elective caesarean section
132398|NCT02742948|antibiotics|antibiotics
132399|NCT02742948|endometritis|endometritis
132400|NCT02742922|self harm|self harm
132401|NCT02742922|culturally adapted therapy|culturally adapted therapy
132402|NCT02742922|problem solving therapy|problem solving therapy
132403|NCT02742922|low and middle income countries|low and middle income countries
132404|NCT02742896|Erectile dysfunction|erectile dysfunction
132405|NCT02742896|cognitive function|cognitive function
132406|NCT02742870|Diffusion MRI|diffusion mri
132407|NCT02742870|ADC histograms|adc histograms
132408|NCT02742870|Adnexal tumor|adnexal tumor
132409|NCT02742844|phase I/IIa|phase i/iia
132410|NCT02742844|mesenchymal stem cells|mesenchymal stem cells
132411|NCT02742844|ABCB5+|abcb5+
132412|NCT02742844|APZ2|apz2
132413|NCT02742844|chronic venous ulcer|chronic venous ulcer
132414|NCT02742844|varicose ulcer|varicose ulcer
132415|NCT02742844|skin ulcer|skin ulcer
132416|NCT02742844|advanced therapy medicinal product|advanced therapy medicinal product
132417|NCT02742844|APZ2-II-01|apz2-ii-01
132418|NCT02742844|autologous use|autologous use
132419|NCT02742844|somatic cell therapy|somatic cell therapy
132420|NCT02742818|forced-air warming|forced-air warming
132421|NCT02742818|hypothermia|hypothermia
132422|NCT02742818|endovascular surgery|endovascular surgery
132423|NCT02742818|blanket|blanket
132424|NCT02742805|hives|hives
132425|NCT02742792|sleep apnea|sleep apnea
132426|NCT02742792|elderly|elderly
132427|NCT02742792|exercise|exercise
132428|NCT02742766|Dose escalation study|dose escalation study
132429|NCT02742766|Safety|safety
132430|NCT02742766|Pharmacodynamics|pharmacodynamics
132431|NCT02742766|Pharmacokinetics|pharmacokinetics
132432|NCT02742766|GSK3008356|gsk3008356
132433|NCT02742766|Tolerability|tolerability
132434|NCT02742753|Otitis|otitis
132435|NCT02742753|Vaccine|vaccine
132436|NCT02742753|Sweden|sweden
132437|NCT02742753|Database|database
132438|NCT02742675|prostate cancer|prostate cancer
132439|NCT02742675|androgen deprivation therapy|androgen deprivation therapy
132440|NCT02742675|local treatment|local treatment
132441|NCT02742662|Obesity|obesity
132442|NCT02742662|Overweight|overweight
132443|NCT02742662|Prediabetes|prediabetes
132444|NCT02742662|Smartphone application|smartphone application
132445|NCT02742662|Technology|technology
132446|NCT02742662|Weight Loss|weight loss
132447|NCT02742662|Lifestyle Intervention|lifestyle intervention
132448|NCT02742623|Cancer|cancer
132449|NCT02742623|Deep Venous Thrombosis|deep venous thrombosis
132450|NCT02742623|Pulmonary Embolism|pulmonary embolism
132451|NCT02742584|cough stress test|cough stress test
132452|NCT02742584|urodynamics|urodynamics
132453|NCT02742584|pad test|pad test
132454|NCT02742571|Biological evaluation of denutrition|biological evaluation of denutrition
132455|NCT02742571|Denutrition|denutrition
132456|NCT02742571|PINI score|pini score
132457|NCT02742558|cholera vaccine|cholera vaccine
132458|NCT02742558|randomized trial|randomized trial
132459|NCT02742558|immunogenicity|immunogenicity
132460|NCT02742506|Brain-damaged|brain-damaged
132461|NCT02742506|Disorders of consciousness|disorders of consciousness
132462|NCT02742506|Post-coma|post-coma
132463|NCT02742506|consciousness|consciousness
132464|NCT02742506|coma|coma
132465|NCT02742506|vegetative state|vegetative state
132466|NCT02742506|minimally conscious state|minimally conscious state
132467|NCT02742506|music|music
132468|NCT02742506|P300|p300
132469|NCT02742493|relapse|relapse
132470|NCT02742493|irregularity|irregularity
132471|NCT02742493|recession|recession
132472|NCT02742493|retention|retention
132473|NCT02742480|stroke|stroke
132474|NCT02742480|oral anticoagulants|oral anticoagulants
132475|NCT02742480|cardioembolic|cardioembolic
132476|NCT02742454|Umbilical Cord Clamping|umbilical cord clamping
132477|NCT02742454|Intraventricular Hemorrhage|intraventricular hemorrhage
132478|NCT02742454|Extremely Preterm Infants|extremely preterm infants
132479|NCT02742337|Epigenetic|epigenetic
132480|NCT02742324|efficacy|efficacy
132481|NCT02742324|safety|safety
132482|NCT02742298|Neuromuscular Ultrasound|neuromuscular ultrasound
132483|NCT02742298|Electrical Impedance Myography|electrical impedance myography
132484|NCT02742285|antimalarials|antimalarials
132485|NCT02742285|blood samples|blood samples
132486|NCT02742285|drug concentrations|drug concentrations
132487|NCT02742285|pharmacokinetics|pharmacokinetics
132488|NCT02742285|lumefantrine|lumefantrine
132489|NCT02742285|healthy volunteers|healthy volunteers
132490|NCT02742233|Diabetes|diabetes
132491|NCT02742233|Wound Healing|wound healing
132492|NCT02742233|Dipeptidyl Peptidase 4 Inhibition|dipeptidyl peptidase 4 inhibition
132493|NCT02742220|intermittent claudication|intermittent claudication
132494|NCT02742220|exercise|exercise
132495|NCT02742220|blood pressure|blood pressure
132496|NCT02742220|cardiovascular system|cardiovascular system
132497|NCT02742194|ginger obesity|ginger obesity
132498|NCT02742194|ginger inflammation|ginger inflammation
132499|NCT02742194|treatment of obesity|treatment of obesity
132500|NCT02742155|Family Research|family research
132501|NCT02742116|Expanded carrier screening|expanded carrier screening
132502|NCT02742090|CLL|cll
132503|NCT02742025|Coronary Angiography|coronary angiography
132504|NCT02742012|electroencephalogram|electroencephalogram
132505|NCT02742012|hemodynamic monitoring|hemodynamic monitoring
132506|NCT02742012|respiratory monitoring|respiratory monitoring
132507|NCT02741986|risk assessment|risk assessment
132508|NCT02741986|sepsis|sepsis
132509|NCT02741986|acute kidney injury (AKI)|acute kidney injury (aki)
132510|NCT02741973|Yoga|yoga
132511|NCT02741973|Stress|stress
132512|NCT02741973|Adolescents|adolescents
132513|NCT02741973|School|school
132514|NCT02741973|Children|children
132515|NCT02741960|metformin|metformin
132516|NCT02741960|systemic lupus erythematosus|systemic lupus erythematosus
132517|NCT02741947|Parkinson|parkinson
132518|NCT02741947|Therapeutic Equivalence|therapeutic equivalence
132519|NCT02741947|Levodopa|levodopa
132520|NCT02741895|Biosensing Techniques|biosensing techniques
132521|NCT02741895|Patient Readmission|patient readmission
132522|NCT02741882|Microcephaly|microcephaly
132523|NCT02741882|zika Virus|zika virus
132524|NCT02741882|Case-control study|case-control study
132525|NCT02741869|Staphylococcus aureus; nare carriage|staphylococcus aureus; nare carriage
132526|NCT02741804|Memory|memory
132527|NCT02741791|AXS-05|axs-05
132528|NCT02741791|Major Depressive Disorder|major depressive disorder
132529|NCT02741791|Treatment Resistant Depression|treatment resistant depression
132530|NCT02741791|TRD|trd
132531|NCT02741791|MDD|mdd
132532|NCT02741791|Axsome|axsome
132533|NCT02741791|NMDA receptor|nmda receptor
132534|NCT02741791|Refractory depression|refractory depression
132535|NCT02741791|Resistant depression|resistant depression
132536|NCT02741791|Depression|depression
132537|NCT02741778|Esophagogastric Junction|esophagogastric junction
132538|NCT02741778|Adenocarcinoma|adenocarcinoma
132539|NCT02741778|Cardia|cardia
132540|NCT02741765|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
132541|NCT02741765|Exercise|exercise
132542|NCT02741765|Brain Plasticity|brain plasticity
132543|NCT02741752|histomorphometry|histomorphometry
132544|NCT02741739|Drug concentration|drug concentration
132545|NCT02741739|REGN1033|regn1033
132546|NCT02741739|blood|blood
132547|NCT02741700|Adherence|adherence
132548|NCT02741700|Disparities|disparities
132549|NCT02741700|Patient Outcomes|patient outcomes
132550|NCT02741687|stress hyperglycemia|stress hyperglycemia
132551|NCT02741687|blood glucose|blood glucose
132552|NCT02741674|Observational Study|observational study
132553|NCT02741674|Comparative Effectiveness Research|comparative effectiveness research
132554|NCT02741648|Red Blood Cell Transfusion|red blood cell transfusion
132555|NCT02741648|Digestive tract problems|digestive tract problems
132556|NCT02741648|Extremely Low Birth Weight|extremely low birth weight
132557|NCT02741622|Exercise therapy|exercise therapy
132558|NCT02741609|Borrelia|borrelia
132559|NCT02741609|spirochetes|spirochetes
132560|NCT02741609|culture|culture
132561|NCT02741609|immunostaining|immunostaining
132562|NCT02741596|DX-2930(SHP643)|dx-2930(shp643)
132563|NCT02741596|Dyax|dyax
132564|NCT02741596|Hereditary Angioedema|hereditary angioedema
132565|NCT02741557|Fixed-dose Combination (FDC)|fixed-dose combination (fdc)
132566|NCT02741557|Bioequivalence|bioequivalence
132567|NCT02741557|Dolutegravir|dolutegravir
132568|NCT02741557|Rilpivirine|rilpivirine
132569|NCT02741544|Second primary cancers|second primary cancers
132570|NCT02741544|Cataracts|cataracts
132571|NCT02741544|Newly-diagnosed multiple myeloma|newly-diagnosed multiple myeloma
132572|NCT02741544|Revlimid capsules|revlimid capsules
132573|NCT02741518|obesity|obesity
132574|NCT02741518|FMT|fmt
132575|NCT02741505|cerebrospinal fluid (CSF)|cerebrospinal fluid (csf)
132576|NCT02741505|sleep|sleep
132577|NCT02741505|Obstructive Sleep Apnea (OSA)|obstructive sleep apnea (osa)
132578|NCT02741505|Sleep Disordered Breathing (SDB)|sleep disordered breathing (sdb)
132579|NCT02741505|Period Limb Movement during Sleep (PLMS)|period limb movement during sleep (plms)
132580|NCT02741479|dancers|dancers
132581|NCT02741440|Spinocerebellar Ataxia|spinocerebellar ataxia
132582|NCT02741427|Tooth discoloration|tooth discoloration
132583|NCT02741427|Toothpaste|toothpaste
132584|NCT02741427|Tooth bleaching|tooth bleaching
132585|NCT02741427|Clinical trial|clinical trial
132586|NCT02741414|Helicobacter pylori|helicobacter pylori
132587|NCT02741414|Antibiotic resistance|antibiotic resistance
132588|NCT02741414|Sequencing|sequencing
132589|NCT02741414|Mechanism|mechanism
132590|NCT02741401|Complementary therapies|complementary therapies
132591|NCT02741401|Massage|massage
132592|NCT02741401|Gastrointestinal cancer|gastrointestinal cancer
132593|NCT02741388|selinexor|selinexor
132594|NCT02741388|lymphoma|lymphoma
132595|NCT02741388|inhibitor of nuclear export|inhibitor of nuclear export
132596|NCT02741362|Type III hypersensitivity autoimmune disease|type iii hypersensitivity autoimmune disease
132597|NCT02741349|Atrial fibrillation|atrial fibrillation
132598|NCT02741349|Risk score|risk score
132599|NCT02741323|HIV-infected with end-stage kidney disease|hiv-infected with end-stage kidney disease
132600|NCT02741297|Spinal Cord Stimulation|spinal cord stimulation
132601|NCT02741297|Chronic Pain|chronic pain
132602|NCT02741232|analgesics, opioids|analgesics, opioids
132603|NCT02741232|pectoral block|pectoral block
132604|NCT02741206|psycho-education|psycho-education
132605|NCT02741206|maternal depression|maternal depression
132606|NCT02741206|Reach Out Stay Strong Essentials|reach out stay strong essentials
132607|NCT02741193|Transcranial magnet stimulation (nTMS)|transcranial magnet stimulation (ntms)
132608|NCT02741193|Brainsight Neuronavigation|brainsight neuronavigation
132609|NCT02741193|Electromyography|electromyography
132610|NCT02741193|EMG|emg
132611|NCT02741167|peritoneal surface malignancies|peritoneal surface malignancies
132612|NCT02741167|cytoreductive surgery|cytoreductive surgery
132613|NCT02741167|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
132614|NCT02741154|aromataze inhibitor, poor responder ,induction|aromataze inhibitor, poor responder ,induction
132615|NCT02741128|Dengue Fever|dengue fever
132616|NCT02741128|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
132617|NCT02741128|Human Immunodeficiency Virus|human immunodeficiency virus
132618|NCT02741128|CYD Dengue Vaccine|cyd dengue vaccine
132619|NCT02741115|Fontan|fontan
132620|NCT02741115|Maximal Oxygen Consumption|maximal oxygen consumption
132621|NCT02741115|Vascular Function|vascular function
132622|NCT02741115|EndoPAT|endopat
132623|NCT02741115|Myocardial Performance|myocardial performance
132624|NCT02741102|Infertility|infertility
132625|NCT02741102|AUFI|aufi
132626|NCT02741089|Analgosedation|analgosedation
132627|NCT02741089|Internal Quality Assurance|internal quality assurance
132628|NCT02741063|oxytocin|oxytocin
132629|NCT02741063|attentional bias|attentional bias
132630|NCT02741063|Autism|autism
132631|NCT02741011|Cone-Beam Computed Tomography|cone-beam computed tomography
132632|NCT02741011|Mentally Handicapped|mentally handicapped
132633|NCT02740998|Microbiome|microbiome
132634|NCT02740998|Progestin|progestin
132635|NCT02740998|Long-acting contraception|long-acting contraception
132636|NCT02740985|AZD4635|azd4635
132637|NCT02740985|durvalumab|durvalumab
132638|NCT02740985|non-small cell lung cancer|non-small cell lung cancer
132639|NCT02740985|advanced solid malignancies|advanced solid malignancies
132640|NCT02740985|prostate cancer|prostate cancer
132641|NCT02740985|colorectal cancer|colorectal cancer
132642|NCT02740933|Brain Tumor Surgery|brain tumor surgery
132643|NCT02740868|Magnetic Resonance Imaging,cystic fibrosis,asthma,healthy|magnetic resonance imaging,cystic fibrosis,asthma,healthy
132644|NCT02740855|sclerotherapy|sclerotherapy
132645|NCT02740855|ethanol|ethanol
132646|NCT02740855|pulmonal hypertension|pulmonal hypertension
132647|NCT02740790|Human papillomavirus|human papillomavirus
132648|NCT02740790|vaccine|vaccine
132649|NCT02740790|cervical infection|cervical infection
132650|NCT02740790|cervical cancer|cervical cancer
132651|NCT02740764|Functional autonomy level|functional autonomy level
132652|NCT02740764|Lawton Instrumental Activities of Daily Living|lawton instrumental activities of daily living
132653|NCT02740764|Cognitive disorders|cognitive disorders
132654|NCT02740764|Potentially inappropriate medication|potentially inappropriate medication
132655|NCT02740764|elderly|elderly
132656|NCT02740764|Optimization of drug prescribing|optimization of drug prescribing
132657|NCT02740738|Knee Arthroplasty|knee arthroplasty
132658|NCT02740738|Hip Arthroplasty|hip arthroplasty
132659|NCT02740725|Amblyopia|amblyopia
132660|NCT02740725|Interaction Binocular Treatment (I-BiTTM)|interaction binocular treatment (i-bittm)
132661|NCT02740725|Patch Therapy|patch therapy
132662|NCT02740712|rucaparib|rucaparib
132663|NCT02740712|CO-338|co-338
132664|NCT02740712|Clovis|clovis
132665|NCT02740712|Clovis Oncology|clovis oncology
132666|NCT02740712|PARP Inhibitor|parp inhibitor
132667|NCT02740712|Drug-Drug Interaction|drug-drug interaction
132668|NCT02740699|Cholesterol|cholesterol
132669|NCT02740699|Heart Disease|heart disease
132670|NCT02740699|CT Scan|ct scan
132671|NCT02740699|Crestor|crestor
132672|NCT02740699|Lipitor|lipitor
132673|NCT02740686|COPD|copd
132674|NCT02740686|Exercise|exercise
132675|NCT02740686|Immunity|immunity
132676|NCT02740686|Inflammation|inflammation
132677|NCT02740686|Biomarkers|biomarkers
132678|NCT02740660|Albuterol|albuterol
132679|NCT02740660|Caffeine|caffeine
132680|NCT02740660|Lean Body Mass|lean body mass
132681|NCT02740660|Fat Mass|fat mass
132682|NCT02740634|PCA|pca
132683|NCT02740634|LPA|lpa
132684|NCT02740595|nicotine|nicotine
132685|NCT02740595|endothelial function|endothelial function
132686|NCT02740595|oxidative stress|oxidative stress
132687|NCT02740569|scleroderma|scleroderma
132688|NCT02740569|sleep apnea|sleep apnea
132689|NCT02740569|pulmonary disease|pulmonary disease
132690|NCT02740556|Hepatitis C|hepatitis c
132691|NCT02740556|Adherence|adherence
132692|NCT02740556|Adheretech|adheretech
132693|NCT02740556|HepCure|hepcure
132694|NCT02740556|Telehealth|telehealth
132695|NCT02740556|Health apps|health apps
132696|NCT02740543|World Trade Center|world trade center
132697|NCT02740543|WTC|wtc
132698|NCT02740543|Induced Sputum|induced sputum
132699|NCT02740543|Exhaled Breath Condensate|exhaled breath condensate
132700|NCT02740504|Respiration rate|respiration rate
132701|NCT02740465|ACE|ace
132702|NCT02740465|Anxiety|anxiety
132703|NCT02740465|COPD|copd
132704|NCT02740452|Rupture|rupture
132705|NCT02740452|Anterior Cruciate Ligament (ACL)|anterior cruciate ligament (acl)
132706|NCT02740452|Laxity knee|laxity knee
132707|NCT02740452|Instability knee|instability knee
132708|NCT02740400|Endobronchial ultrasonography|endobronchial ultrasonography
132709|NCT02740400|guided sheath|guided sheath
132710|NCT02740400|diagnosis|diagnosis
132711|NCT02740400|accuracy|accuracy
132712|NCT02740400|complication|complication
132713|NCT02740374|ROTEM|rotem
132714|NCT02740374|Thromboelastometry|thromboelastometry
132715|NCT02740374|spine surgery|spine surgery
132716|NCT02740374|allogenic blood transfusion|allogenic blood transfusion
132717|NCT02740374|blood loss|blood loss
132718|NCT02740374|red blood cell transfusion|red blood cell transfusion
132719|NCT02740335|anticoagulant reversal|anticoagulant reversal
132720|NCT02740335|urgent surgery|urgent surgery
132721|NCT02740335|invasive procedures|invasive procedures
132722|NCT02740335|vitamin K|vitamin k
132723|NCT02740335|prothrombin complex concentrate|prothrombin complex concentrate
132724|NCT02740335|four-factor prothrombin complex concentrate (4F-PCC)|four-factor prothrombin complex concentrate (4f-pcc)
132725|NCT02740322|Hum Test, Weber test, audiogram|hum test, weber test, audiogram
132726|NCT02740309|inflammatory bowel disease|inflammatory bowel disease
132727|NCT02740309|childhood chronic disease|childhood chronic disease
132728|NCT02740309|adolescent depression|adolescent depression
132729|NCT02740309|adolescent anxiety|adolescent anxiety
132730|NCT02740309|integrated brief behavioral therapy|integrated brief behavioral therapy
132731|NCT02740309|adolescent psychosocial risks|adolescent psychosocial risks
132732|NCT02740309|adolescent chronic disease|adolescent chronic disease
132733|NCT02740309|childhood depression|childhood depression
132734|NCT02740309|childhood anxiety|childhood anxiety
132735|NCT02740309|childhood psychosocial risks|childhood psychosocial risks
132736|NCT02740283|Gestational Diabetes Mellitus|gestational diabetes mellitus
132737|NCT02740283|Oral Glucose Tolerance Test|oral glucose tolerance test
132738|NCT02740270|advanced solid tumors|advanced solid tumors
132739|NCT02740270|lymphomas|lymphomas
132740|NCT02740270|GWN323|gwn323
132741|NCT02740270|PDR001|pdr001
132742|NCT02740270|advanced malignancies|advanced malignancies
132743|NCT02740270|anti-GITR|anti-gitr
132744|NCT02740270|anti-PD-1|anti-pd-1
132745|NCT02740270|adults|adults
132746|NCT02740231|viscosupplement|viscosupplement
132747|NCT02740231|osteoarthritis|osteoarthritis
132748|NCT02740231|knee|knee
132749|NCT02740231|intra-articular injection|intra-articular injection
132750|NCT02740231|arthritis|arthritis
132751|NCT02740231|degenerative|degenerative
132752|NCT02740218|Psoriasis|psoriasis
132753|NCT02740218|Apremilast|apremilast
132754|NCT02740218|APPRECIATE|appreciate
132755|NCT02740218|Dermatology|dermatology
132756|NCT02740218|Retrospective|retrospective
132757|NCT02740218|Observational|observational
132758|NCT02740205|Patients with Enteral Feeding|patients with enteral feeding
132759|NCT02740179|Eplerenone|eplerenone
132760|NCT02740179|Cardiovascular Disease|cardiovascular disease
132761|NCT02740179|Mineralocorticoid Receptor Antagonist|mineralocorticoid receptor antagonist
132762|NCT02740179|Coronary Vasculature|coronary vasculature
132763|NCT02740179|Myocardial Inflammation|myocardial inflammation
132764|NCT02740179|Myocardial Fibrosis|myocardial fibrosis
132765|NCT02740179|Atherosclerosis|atherosclerosis
132766|NCT02740179|Aldosterone|aldosterone
132767|NCT02740166|Esophageal Varices; propranolol; banding ligation|esophageal varices; propranolol; banding ligation
132768|NCT02740140|chronic coinfection|chronic coinfection
132769|NCT02740127|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
132770|NCT02740127|Adult Penile Prosthesis Surgery|adult penile prosthesis surgery
132771|NCT02740127|Caudal nerve block|caudal nerve block
132772|NCT02740127|CNB|cnb
132773|NCT02740127|General anesthesia|general anesthesia
132774|NCT02740127|GA|ga
132775|NCT02740127|Ropivacaine|ropivacaine
132776|NCT02740127|Naropin|naropin
132777|NCT02740127|Epinephrine|epinephrine
132778|NCT02740127|Decadron|decadron
132779|NCT02740127|Dexamethasone|dexamethasone
132780|NCT02740127|Clonidine|clonidine
132781|NCT02740127|Propofol|propofol
132782|NCT02740127|Diprivan|diprivan
132783|NCT02740114|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
132784|NCT02740114|Open gynecologic surgery|open gynecologic surgery
132785|NCT02740114|Local wound infiltration|local wound infiltration
132786|NCT02740114|Gynecologic cancer|gynecologic cancer
132787|NCT02740114|Bupivacaine|bupivacaine
132788|NCT02740114|Liposomal Bupivacaine|liposomal bupivacaine
132789|NCT02740114|Oxycodone|oxycodone
132790|NCT02740114|ETH-Oxydose [DSC]|eth-oxydose [dsc]
132791|NCT02740114|OxyContin|oxycontin
132792|NCT02740114|OxyIR|oxyir
132793|NCT02740114|Roxicodone|roxicodone
132794|NCT02740114|Questionnaires|questionnaires
132795|NCT02740114|Surveys|surveys
132796|NCT02740114|MD Anderson Symptom Inventory|md anderson symptom inventory
132797|NCT02740114|MDASI|mdasi
132798|NCT02740114|Pill diary|pill diary
132799|NCT02740114|Medication log|medication log
132800|NCT02740101|oxytocin|oxytocin
132801|NCT02740101|social reward|social reward
132802|NCT02740101|social punishment|social punishment
132803|NCT02740075|Mechanical versus hand ventilation|mechanical versus hand ventilation
132804|NCT02740075|Transport ventilation|transport ventilation
132805|NCT02740049|Epithelial Cells|epithelial cells
132806|NCT02740010|MIOL|miol
132807|NCT02740010|extended depth of focus|extended depth of focus
132808|NCT02740010|cataract|cataract
132809|NCT02740010|visual acuity|visual acuity
132810|NCT02740010|halos|halos
132811|NCT02739984|diabetes|diabetes
132812|NCT02739984|type 2 diabetes|type 2 diabetes
132813|NCT02739984|high blood cholesterol|high blood cholesterol
132814|NCT02739984|hypercholesterolemia|hypercholesterolemia
132815|NCT02739984|mixed dyslipidemia|mixed dyslipidemia
132816|NCT02739984|high cholesterol|high cholesterol
132817|NCT02739984|statin intolerant|statin intolerant
132818|NCT02739945|Ulnar Nerve Compression, Cubital Tunnel|ulnar nerve compression, cubital tunnel
132819|NCT02739932|Attenuated Psychotic Symptoms|attenuated psychotic symptoms
132820|NCT02739919|Kidney stones|kidney stones
132821|NCT02739919|Renal Calculi|renal calculi
132822|NCT02739880|Vaginal discomfort|vaginal discomfort
132823|NCT02739880|Vaginal dryness|vaginal dryness
132824|NCT02739867|occult cancer|occult cancer
132825|NCT02739867|venous thromboembolism|venous thromboembolism
132826|NCT02739867|tumor-educated platelets|tumor-educated platelets
132827|NCT02739867|platelet RNA profiling|platelet rna profiling
132828|NCT02739867|early diagnosis|early diagnosis
132829|NCT02739867|screening|screening
132830|NCT02739854|trauma|trauma
132831|NCT02739854|atelectasis|atelectasis
132832|NCT02739841|hemodynamic response|hemodynamic response
132833|NCT02739828|Quality of life|quality of life
132834|NCT02739815|Caesarean Section|caesarean section
132835|NCT02739815|Tranexamic Acid|tranexamic acid
132836|NCT02739815|Postpartum Hemorrhage|postpartum hemorrhage
132837|NCT02739815|Ecbolics|ecbolics
132838|NCT02739789|tDCS rejection affect mood fMRI|tdcs rejection affect mood fmri
132839|NCT02739763|PfSPZ|pfspz
132840|NCT02739763|Semi-immune adults|semi-immune adults
132841|NCT02739763|Kenya|kenya
132842|NCT02739763|challenge|challenge
132843|NCT02739763|CHMI|chmi
132844|NCT02739763|malaria|malaria
132845|NCT02739737|Bias|bias
132846|NCT02739737|Orthopedics|orthopedics
132847|NCT02739737|Peer Review|peer review
132848|NCT02739698|ovarian cancer|ovarian cancer
132849|NCT02739659|prostate carcinoma|prostate carcinoma
132850|NCT02739659|carbon-ion radiotherapy|carbon-ion radiotherapy
132851|NCT02739659|efficacy|efficacy
132852|NCT02739659|toxicity|toxicity
132853|NCT02739633|Chemotherapy|chemotherapy
132854|NCT02739633|Gemcitabine|gemcitabine
132855|NCT02739633|Recurrent and metastatic adenocarcinoma of the pancreas|recurrent and metastatic adenocarcinoma of the pancreas
132856|NCT02739633|Genexol-PM|genexol-pm
132857|NCT02739633|Paclitaxel|paclitaxel
132858|NCT02739607|emotional disorders|emotional disorders
132859|NCT02739607|internet-delivered intervention|internet-delivered intervention
132860|NCT02739607|anxiety|anxiety
132861|NCT02739607|depression|depression
132862|NCT02739607|transdiagnostic|transdiagnostic
132863|NCT02739568|EDS|eds
132864|NCT02739568|OSA|osa
132865|NCT02739555|Osteoid osteoma|osteoid osteoma
132866|NCT02739555|Bisphophonates|bisphophonates
132867|NCT02739542|Radiologically Isolated Syndrome (RIS)|radiologically isolated syndrome (ris)
132868|NCT02739490|physiotherapeutic techniques|physiotherapeutic techniques
132869|NCT02739490|pelvis|pelvis
132870|NCT02739490|Muscle strength|muscle strength
132871|NCT02739477|Favipiravir|favipiravir
132872|NCT02739477|Tolerance|tolerance
132873|NCT02739477|Survivor|survivor
132874|NCT02739477|Ebola Virus|ebola virus
132875|NCT02739477|Genital reservoir|genital reservoir
132876|NCT02739477|Guinea|guinea
132877|NCT02739464|Burn|burn
132878|NCT02739464|Exercise|exercise
132879|NCT02739464|Ergometer|ergometer
132880|NCT02739464|MP-10|mp-10
132881|NCT02739451|immunocompromized patients|immunocompromized patients
132882|NCT02739451|critically ill patients|critically ill patients
132883|NCT02739438|Pulmonary inflammation|pulmonary inflammation
132884|NCT02739438|Endothelial dysfunction|endothelial dysfunction
132885|NCT02739438|Electronic Cigarettes|electronic cigarettes
132886|NCT02739425|Sentinel lymph node biopsy (SLNB)|sentinel lymph node biopsy (slnb)
132887|NCT02739425|Superparamagnetic iron oxide (SPIO) tracer|superparamagnetic iron oxide (spio) tracer
132888|NCT02739399|phenylephrine|phenylephrine
132889|NCT02739399|alpha mimetics|alpha mimetics
132890|NCT02739399|pulse pressure variation|pulse pressure variation
132891|NCT02739399|venous return|venous return
132892|NCT02739347|tDCS|tdcs
132893|NCT02739347|cognitive control|cognitive control
132894|NCT02739347|working memory|working memory
132895|NCT02739347|EEG|eeg
132896|NCT02739347|gamma oscillations|gamma oscillations
132897|NCT02739321|Autism|autism
132898|NCT02739321|ASD|asd
132899|NCT02739321|Sleep|sleep
132900|NCT02739321|Mattress|mattress
132901|NCT02739308|proprioception|proprioception
132902|NCT02739308|ankle sprain|ankle sprain
132903|NCT02739308|fencing|fencing
132904|NCT02739269|ovarian response|ovarian response
132905|NCT02739269|anti-Mullerian hormone|anti-mullerian hormone
132906|NCT02739269|antral follicle count|antral follicle count
132907|NCT02739256|voiding trial|voiding trial
132908|NCT02739256|pelvic organ prolapse|pelvic organ prolapse
132909|NCT02739256|post-operative catheterization|post-operative catheterization
132910|NCT02739204|Celecoxib|celecoxib
132911|NCT02739204|Relapse-free OSCC patient|relapse-free oscc patient
132912|NCT02739204|Recurrence|recurrence
132913|NCT02739204|Survival|survival
132914|NCT02739204|Prognosis|prognosis
132915|NCT02739191|NPWT|npwt
132916|NCT02739165|Acute exacerbations|acute exacerbations
132917|NCT02739165|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
132918|NCT02739165|Recombinant human soluble thrombomodulin|recombinant human soluble thrombomodulin
132919|NCT02739165|ART-123|art-123
132920|NCT02739152|Sepsis|sepsis
132921|NCT02739152|Severe sepsis|severe sepsis
132922|NCT02739152|Infections|infections
132923|NCT02739152|Worsening|worsening
132924|NCT02739126|Diagnosis|diagnosis
132925|NCT02739113|OMECs|omecs
132926|NCT02739113|Cornea|cornea
132927|NCT02739113|Amniotic membrane|amniotic membrane
132928|NCT02739113|Collagenase|collagenase
132929|NCT02739100|pharmacokinetics|pharmacokinetics
132930|NCT02739100|bioequivalence|bioequivalence
132931|NCT02739087|radiation free cardiac catheterization|radiation free cardiac catheterization
132932|NCT02739061|pathogenesis|pathogenesis
132933|NCT02739061|cognitive behavioral group therapy|cognitive behavioral group therapy
132934|NCT02738996|Diabetes|diabetes
132935|NCT02738996|Sedentary Lifestyle|sedentary lifestyle
132936|NCT02738983|Non-small cell lung cancer|non-small cell lung cancer
132937|NCT02738983|epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI)|epidermal growth factor receptor tyrosine kinase inhibitor (egfr-tki)
132938|NCT02738983|Radiotherapy|radiotherapy
132939|NCT02738983|wild type|wild type
132940|NCT02738931|dolutegravir|dolutegravir
132941|NCT02738931|lamivudine|lamivudine
132942|NCT02738931|Bioavailability|bioavailability
132943|NCT02738931|fixed dose combinations|fixed dose combinations
132944|NCT02738918|Renal Transplant|renal transplant
132945|NCT02738918|Anti HLA antibodies|anti hla antibodies
132946|NCT02738918|Humoral rejection|humoral rejection
132947|NCT02738892|Pregnancy|pregnancy
132948|NCT02738892|Stillbirth|stillbirth
132949|NCT02738892|Preterm birth|preterm birth
132950|NCT02738866|breast cancer|breast cancer
132951|NCT02738866|Metastatic Breast Cancer|metastatic breast cancer
132952|NCT02738866|palbociclib|palbociclib
132953|NCT02738866|fulvestrant|fulvestrant
132954|NCT02738814|emergence agitation|emergence agitation
132955|NCT02738814|emergence delirium|emergence delirium
132956|NCT02738814|PAED scale|paed scale
132957|NCT02738814|The Modified Aldrete Scoring System|the modified aldrete scoring system
132958|NCT02738814|treatment|treatment
132959|NCT02738814|pediatric|pediatric
132960|NCT02738814|sevoflurane|sevoflurane
132961|NCT02738801|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
132962|NCT02738801|GLPG1690|glpg1690
132963|NCT02738801|Autotaxin|autotaxin
132964|NCT02738788|airway|airway
132965|NCT02738788|airway changes|airway changes
132966|NCT02738788|MMS|mms
132967|NCT02738788|prone position|prone position
132968|NCT02738788|Trendelenburg position|trendelenburg position
132969|NCT02738775|multiple sclerosis|multiple sclerosis
132970|NCT02738762|intensive care|intensive care
132971|NCT02738762|glutamine|glutamine
132972|NCT02738762|length of stay|length of stay
132973|NCT02738749|sudden cardiac death, sodium channel splicing variant|sudden cardiac death, sodium channel splicing variant
132974|NCT02738723|Limited-stage small cell lung cancer|limited-stage small cell lung cancer
132975|NCT02738723|Stereotactic body radiation therapy|stereotactic body radiation therapy
132976|NCT02738723|Intensity modulated radiation therapy|intensity modulated radiation therapy
132977|NCT02738723|Radiation|radiation
132978|NCT02738723|Chemotherapy|chemotherapy
132979|NCT02738697|Carcinoma,Hepatocellular|carcinoma,hepatocellular
132980|NCT02738697|Adjuvant chemotherapy|adjuvant chemotherapy
132981|NCT02738697|Microvessels invasion|microvessels invasion
132982|NCT02738697|Survival|survival
132983|NCT02738697|Recurrence|recurrence
132984|NCT02738684|lung cancer|lung cancer
132985|NCT02738684|adenocarcinoma|adenocarcinoma
132986|NCT02738684|EGFR|egfr
132987|NCT02738684|plasma free nucleic acids|plasma free nucleic acids
132988|NCT02738671|functional MRI|functional mri
132989|NCT02738671|olfactory function|olfactory function
132990|NCT02738671|bariatric surgery|bariatric surgery
132991|NCT02738658|Coronary microcirculatory dysfunction|coronary microcirculatory dysfunction
132992|NCT02738658|Coronary endothelium dysfunction|coronary endothelium dysfunction
132993|NCT02738619|allergic rhinitis|allergic rhinitis
132994|NCT02738619|immunotherapy|immunotherapy
132995|NCT02738619|vitamin D|vitamin d
132996|NCT02738606|Colorectal Cancer|colorectal cancer
132997|NCT02738606|Other diseases of intestines|other diseases of intestines
133302|NCT02736630|turkey|turkey
132998|NCT02738606|Liver and Unresectable Pulmonary Metastases|liver and unresectable pulmonary metastases
132999|NCT02738606|Resectable liver metastases|resectable liver metastases
133000|NCT02738606|Liver resection|liver resection
133001|NCT02738606|Chemotherapy|chemotherapy
133002|NCT02738554|HBV|hbv
133003|NCT02738554|treatment cessation|treatment cessation
133004|NCT02738554|HBsAg|hbsag
133005|NCT02738554|HBcrAg|hbcrag
133006|NCT02738554|nucleoside analogue|nucleoside analogue
133007|NCT02738554|entecavir|entecavir
133008|NCT02738554|tenofovir|tenofovir
133009|NCT02738502|HIV|hiv
133010|NCT02738502|prevention of mother-to-child transmission|prevention of mother-to-child transmission
133011|NCT02738502|Ritonavir boosted darunavir monotherapy|ritonavir boosted darunavir monotherapy
133012|NCT02738489|PD-1/PD-L1 advanced Melanoma immunotherapy|pd-1/pd-l1 advanced melanoma immunotherapy
133013|NCT02738463|ferritin LBW|ferritin lbw
133014|NCT02738450|cognitive decline|cognitive decline
133015|NCT02738437|osteogenesis|osteogenesis
133016|NCT02738437|Positron-Emission Tomography|positron-emission tomography
133017|NCT02738437|Radiostereometric analysis|radiostereometric analysis
133018|NCT02738424|Low Back Pain|low back pain
133019|NCT02738424|MRI|mri
133020|NCT02738372|Chronic Pain|chronic pain
133021|NCT02738372|Biopsychosocial Factors|biopsychosocial factors
133022|NCT02738372|Shoulder pain|shoulder pain
133023|NCT02738372|Prognosis|prognosis
133024|NCT02738372|Central Nervous System Sensitization|central nervous system sensitization
133025|NCT02738359|colon cancer|colon cancer
133026|NCT02738359|rectum cancer|rectum cancer
133027|NCT02738359|colonoscopy|colonoscopy
133028|NCT02738359|fecal immunological test|fecal immunological test
133029|NCT02738359|colon capsule|colon capsule
133030|NCT02738346|Small Cell Lung Cancer|small cell lung cancer
133031|NCT02738346|Topotecan|topotecan
133032|NCT02738346|Etoposide|etoposide
133033|NCT02738307|High Altitude|high altitude
133034|NCT02738307|Attention|attention
133035|NCT02738307|Cognitive Function|cognitive function
133036|NCT02738307|Acclimatization|acclimatization
133037|NCT02738307|Sleep|sleep
133038|NCT02738255|Obstructive sleep apnea|obstructive sleep apnea
133039|NCT02738255|Mouth breathing|mouth breathing
133040|NCT02738255|Apnea-Hypopnea Index (AHI)|apnea-hypopnea index (ahi)
133041|NCT02738242|Functional Electrical Stimulation|functional electrical stimulation
133042|NCT02738242|Upper motor neuron injury or disease|upper motor neuron injury or disease
133043|NCT02738242|Drop foot|drop foot
133044|NCT02738242|Thigh muscle weakness|thigh muscle weakness
133045|NCT02738203|Pain Management|pain management
133046|NCT02738203|IUD insertion|iud insertion
133047|NCT02738190|albumin|albumin
133048|NCT02738190|fresh frozen plasma|fresh frozen plasma
133049|NCT02738190|extracorporeal circulation|extracorporeal circulation
133050|NCT02738190|cardiovascular surgery|cardiovascular surgery
133051|NCT02738190|pediatric population|pediatric population
133052|NCT02738177|misopristol|misopristol
133053|NCT02738177|effox|effox
133054|NCT02738177|cervical ripening|cervical ripening
133055|NCT02738138|HCV Genotype 3|hcv genotype 3
133056|NCT02738138|Non-cirrhotic|non-cirrhotic
133057|NCT02738138|HCV Genotype 1|hcv genotype 1
133058|NCT02738138|HCV Genotype 6|hcv genotype 6
133059|NCT02738138|Human Immunodeficiency Virus (HIV) Infection|human immunodeficiency virus (hiv) infection
133060|NCT02738138|HCV Genotype 5|hcv genotype 5
133061|NCT02738138|HCV Treatment Naive|hcv treatment naive
133062|NCT02738138|HCV Genotype 4|hcv genotype 4
133063|NCT02738138|HCV Treatment Experienced|hcv treatment experienced
133064|NCT02738138|HCV Genotype 2|hcv genotype 2
133065|NCT02738138|Hepatitis C Virus (HCV) Infection|hepatitis c virus (hcv) infection
133066|NCT02738138|Compensated Cirrhosis|compensated cirrhosis
133067|NCT02738125|Adalimumab|adalimumab
133068|NCT02738125|Ulcerative Colitis|ulcerative colitis
133069|NCT02738125|SOTHIS|sothis
133070|NCT02738125|Effectiveness|effectiveness
133071|NCT02738086|Amputation|amputation
133072|NCT02738086|Physical Activity|physical activity
133073|NCT02738086|Rehabilitation|rehabilitation
133074|NCT02738034|Hypertension|hypertension
133075|NCT02738034|Cognition|cognition
133076|NCT02738034|Computerized Training|computerized training
133077|NCT02738034|Cogmed|cogmed
133078|NCT02738021|Psychosocial|psychosocial
133079|NCT02738021|Psychotherapy|psychotherapy
133080|NCT02738021|Maternal|maternal
133081|NCT02737995|Iron deficiency|iron deficiency
133082|NCT02737982|coronary heart disease|coronary heart disease
133083|NCT02737982|gender|gender
133084|NCT02737982|platelet|platelet
133085|NCT02737982|microvascular dysfunction|microvascular dysfunction
133086|NCT02737982|sexual hormones|sexual hormones
133087|NCT02737982|cardiac magnetic resonance|cardiac magnetic resonance
133088|NCT02737982|percutaneous coronary interventions|percutaneous coronary interventions
133089|NCT02737969|Transesophageal Echocardiography/angiography (TEE/Angio)|transesophageal echocardiography/angiography (tee/angio)
133090|NCT02737943|Skin graft|skin graft
133091|NCT02737943|Burn|burn
133092|NCT02737943|MEBO|mebo
133093|NCT02737943|Wound dressing|wound dressing
133094|NCT02737943|Wound care|wound care
133095|NCT02737943|Raw Area|raw area
133096|NCT02737930|Acute ischemic stroke|acute ischemic stroke
133097|NCT02737930|Homonymous hemianopia|homonymous hemianopia
133098|NCT02737930|Homonymous quadrantanopia|homonymous quadrantanopia
133099|NCT02737930|Visual field loss|visual field loss
133100|NCT02737930|Post-stroke recovery|post-stroke recovery
133101|NCT02737930|Fluoxetine|fluoxetine
133102|NCT02737930|Selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
133103|NCT02737904|Muscle spasticity|muscle spasticity
133104|NCT02737865|Focal nodular hyperplasia|focal nodular hyperplasia
133105|NCT02737865|Ultrasonography|ultrasonography
133106|NCT02737865|Superb-Microvascular imaging|superb-microvascular imaging
133107|NCT02737865|Contrast-enhanced ultrasonography|contrast-enhanced ultrasonography
133108|NCT02737813|isobaric marcaine|isobaric marcaine
133109|NCT02737813|hyperbaric marcaine|hyperbaric marcaine
133110|NCT02737787|Second or Greater Remission|second or greater remission
133111|NCT02737787|WT1 Analog Peptide Vaccine|wt1 analog peptide vaccine
133112|NCT02737787|Montanide|montanide
133113|NCT02737787|GM-CSF|gm-csf
133114|NCT02737787|Nivolumab|nivolumab
133115|NCT02737787|15-247|15-247
133116|NCT02737774|Icotinib|icotinib
133117|NCT02737774|chemotherapy|chemotherapy
133118|NCT02737774|EGFR|egfr
133119|NCT02737761|Heart Failure|heart failure
133120|NCT02737761|Positive Psychology|positive psychology
133121|NCT02737761|Adherence to Health Behaviors|adherence to health behaviors
133122|NCT02737748|Donor Site Wounds|donor site wounds
133123|NCT02737696|prescription opioid|prescription opioid
133124|NCT02737696|prevention|prevention
133125|NCT02737696|computer-based|computer-based
133126|NCT02737696|adolescent|adolescent
133127|NCT02737683|Disease|disease
133128|NCT02737683|anxiety|anxiety
133129|NCT02737683|depression|depression
133130|NCT02737683|combine|combine
133131|NCT02737683|negative emotional states|negative emotional states
133132|NCT02737683|functional dyspepsia|functional dyspepsia
133133|NCT02737657|Canagliflozin|canagliflozin
133134|NCT02737657|Metformin|metformin
133135|NCT02737657|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
133136|NCT02737657|INVOKANA|invokana
133137|NCT02737657|Sulfonylurea|sulfonylurea
133138|NCT02737644|Congenital Heart Disease|congenital heart disease
133139|NCT02737644|Key Nutritional Factors|key nutritional factors
133140|NCT02737644|conception|conception
133141|NCT02737644|pregnant|pregnant
133142|NCT02737605|Esketamine|esketamine
133143|NCT02737605|Healthy|healthy
133144|NCT02737605|Pharmacokinetics|pharmacokinetics
133145|NCT02737605|Electrocardiogram|electrocardiogram
133146|NCT02737605|Repolarization|repolarization
133147|NCT02737579|cardiac catheterization|cardiac catheterization
133148|NCT02737579|cardiac MRI|cardiac mri
133149|NCT02737566|Smoking Cessation|smoking cessation
133150|NCT02737566|Financial Incentives|financial incentives
133151|NCT02737566|Contingency Management|contingency management
133152|NCT02737566|Vulnerable Populations|vulnerable populations
133153|NCT02737566|Medically Uninsured|medically uninsured
133154|NCT02737566|Medicaid|medicaid
133155|NCT02737527|ultrasound|ultrasound
133156|NCT02737527|lumbar sympathetic block|lumbar sympathetic block
133157|NCT02737514|adenoma detection rate|adenoma detection rate
133158|NCT02737514|colonoscopy|colonoscopy
133159|NCT02737514|water exchange|water exchange
133160|NCT02737501|Non-small cell lung cancer|non-small cell lung cancer
133161|NCT02737501|Non-small cell lung carcinoma|non-small cell lung carcinoma
133162|NCT02737501|Epithelial lung cancer|epithelial lung cancer
133163|NCT02737501|Squamous cell carcinoma|squamous cell carcinoma
133164|NCT02737501|Large cell carcinoma|large cell carcinoma
133165|NCT02737501|Adenocarcinoma|adenocarcinoma
133166|NCT02737501|Carcinoma|carcinoma
133167|NCT02737501|Anaplastic Lymphoma Kinase (ALK)|anaplastic lymphoma kinase (alk)
133168|NCT02737501|Advanced Cancers|advanced cancers
133169|NCT02737501|Brigatinib|brigatinib
133170|NCT02737501|AP26113|ap26113
133171|NCT02737488|Therapy|therapy
133172|NCT02737488|Trauma Systems Therapy|trauma systems therapy
133173|NCT02737410|Resilience|resilience
133174|NCT02737410|Coping|coping
133175|NCT02737410|Psychosomatic|psychosomatic
133176|NCT02737410|Hypnosis|hypnosis
133177|NCT02737410|Construct Validation|construct validation
133178|NCT02737384|Combined immunodeficiencies|combined immunodeficiencies
133179|NCT02737384|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
133180|NCT02737384|CD45RA|cd45ra
133181|NCT02737384|primitive immunodeficiencies|primitive immunodeficiencies
133182|NCT02737384|pediatric transplantation|pediatric transplantation
133183|NCT02737384|CD45RA depletion|cd45ra depletion
133184|NCT02737358|nicotine|nicotine
133185|NCT02737358|tobacco|tobacco
133186|NCT02737358|smoking|smoking
133187|NCT02737358|cessation|cessation
133188|NCT02737358|N-acetylcysteine|n-acetylcysteine
133189|NCT02737358|NAC|nac
133190|NCT02737358|pharmacotherapy|pharmacotherapy
133191|NCT02737358|relapse|relapse
133192|NCT02737358|tobacco use disorder|tobacco use disorder
133193|NCT02737345|fibrinolysis|fibrinolysis
133194|NCT02737345|liver transplant|liver transplant
133195|NCT02737345|thromboelastometry|thromboelastometry
133196|NCT02737319|Contrast,nephropathy, angioplasty, stable coronary|contrast,nephropathy, angioplasty, stable coronary
133197|NCT02737306|Allogeneic Stem-Cell Transplantation|allogeneic stem-cell transplantation
133198|NCT02737280|infant|infant
133199|NCT02737280|high flow nasal cannulae|high flow nasal cannulae
133200|NCT02737280|oxygen therapy|oxygen therapy
133201|NCT02737280|bronchiolitis|bronchiolitis
133202|NCT02737267|Genetics|genetics
133203|NCT02737267|Polymorphism|polymorphism
133204|NCT02737267|Epigenetics|epigenetics
133205|NCT02737267|Metagenomics|metagenomics
133206|NCT02737267|Metabolomics|metabolomics
133207|NCT02737267|Metabolic syndrome conditions|metabolic syndrome conditions
133208|NCT02737267|Precision nutrition|precision nutrition
133209|NCT02737254|Attachment|attachment
133210|NCT02737254|Oxytocin|oxytocin
133211|NCT02737254|Cognitive bias modification|cognitive bias modification
133212|NCT02737254|Middle childhood|middle childhood
133213|NCT02737241|Prostate|prostate
133214|NCT02737241|Laser|laser
133215|NCT02737241|Enucleation|enucleation
133216|NCT02737202|LAM|lam
133217|NCT02737189|Basilar Artery Occlusion|basilar artery occlusion
133218|NCT02737189|Ischemic Stroke|ischemic stroke
133219|NCT02737189|Mechanical Embolectomy|mechanical embolectomy
133220|NCT02737176|Smoking Cessation|smoking cessation
133221|NCT02737176|Mouth Diseases|mouth diseases
133222|NCT02737176|Periodontal Diseases|periodontal diseases
133223|NCT02737176|Leukoplakia|leukoplakia
133224|NCT02737176|Keratosis|keratosis
133225|NCT02737176|Implant|implant
133226|NCT02737176|Lichen Planus|lichen planus
133227|NCT02737163|Programmable shunts|programmable shunts
133228|NCT02737163|Strata valve|strata valve
133229|NCT02737124|Acetaminophen|acetaminophen
133230|NCT02737124|Surgery|surgery
133231|NCT02737124|Meniscectomy|meniscectomy
133232|NCT02737098|PTSD|ptsd
133233|NCT02737098|virtual care|virtual care
133234|NCT02737098|implementation|implementation
133235|NCT02737098|telepsychiatry|telepsychiatry
133236|NCT02737098|telepsychology|telepsychology
133237|NCT02737085|CD19-targeted CAR-T Cell|cd19-targeted car-t cell
133238|NCT02737085|CD20-targeted CAR-T Cell|cd20-targeted car-t cell
133239|NCT02737085|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
133240|NCT02737072|immuno-oncology|immuno-oncology
133241|NCT02737046|Adult T-cell Leukemia-Lymphoma|adult t-cell leukemia-lymphoma
133242|NCT02737046|ATLL|atll
133243|NCT02737033|ADHD|adhd
133244|NCT02737033|Adults|adults
133245|NCT02737033|Treatment|treatment
133246|NCT02737033|Rhodiola|rhodiola
133247|NCT02737020|ADHD|adhd
133248|NCT02737020|Adults|adults
133249|NCT02737020|Treatment|treatment
133250|NCT02737020|Rhodiola rosea|rhodiola rosea
133251|NCT02737007|Malaria|malaria
133252|NCT02737007|Microdose|microdose
133253|NCT02737007|GSK3191607|gsk3191607
133254|NCT02736994|edentulous|edentulous
133255|NCT02736994|patients|patients
133256|NCT02736994|with full|with full
133257|NCT02736981|Obesity|obesity
133258|NCT02736981|Weight Loss|weight loss
133259|NCT02736981|Young Adults|young adults
133260|NCT02736968|Amebic|amebic
133261|NCT02736968|Auranofin|auranofin
133262|NCT02736968|GI Protozoa|gi protozoa
133263|NCT02736968|Giardiasis|giardiasis
133264|NCT02736968|Reprofiled|reprofiled
133265|NCT02736890|Botulinum Toxin A|botulinum toxin a
133266|NCT02736890|Neuropathic pain|neuropathic pain
133267|NCT02736890|Spinal cord injury|spinal cord injury
133268|NCT02736890|Pain management|pain management
133269|NCT02736890|Rehabilitation|rehabilitation
133270|NCT02736877|keratoconus|keratoconus
133271|NCT02736877|bullous keratopathy|bullous keratopathy
133272|NCT02736877|corneal dystrophy|corneal dystrophy
133273|NCT02736851|disability|disability
133274|NCT02736851|home|home
133275|NCT02736851|stretching exercises|stretching exercises
133276|NCT02736838|Pressure|pressure
133277|NCT02736838|Pressure Ulcer|pressure ulcer
133278|NCT02736838|Skin perfusion|skin perfusion
133279|NCT02736838|Skin oxygenation|skin oxygenation
133280|NCT02736812|Randomized controlled trial|randomized controlled trial
133281|NCT02736812|Lyophilized Plasma|lyophilized plasma
133282|NCT02736812|Advanced Trauma Life Support Care|advanced trauma life support care
133283|NCT02736786|proton|proton
133284|NCT02736773|Guided Bone|guided bone
133285|NCT02736773|Pre-implant referred|pre-implant referred
133286|NCT02736773|Regeneration|regeneration
133287|NCT02736747|Stroke|stroke
133288|NCT02736747|Muscle Spasticity|muscle spasticity
133289|NCT02736747|Cryotherapy|cryotherapy
133290|NCT02736747|Gait|gait
133291|NCT02736747|Muscle Weakness|muscle weakness
133292|NCT02736747|Proprioception|proprioception
133293|NCT02736708|Primary sclerosing cholangitis|primary sclerosing cholangitis
133294|NCT02736695|PPA|ppa
133295|NCT02736669|weight loss|weight loss
133296|NCT02736669|body weight|body weight
133297|NCT02736669|behavioral|behavioral
133298|NCT02736643|LDCT, screening|ldct, screening
133299|NCT02736630|general anaesthesia|general anaesthesia
133300|NCT02736630|elective surgery|elective surgery
133301|NCT02736630|national epidemiology|national epidemiology
133303|NCT02736565|metastatic|metastatic
133304|NCT02736565|askin tumor|askin tumor
133305|NCT02736565|neuroectodermal tumor|neuroectodermal tumor
133306|NCT02736565|pNET|pnet
133307|NCT02736565|sarcoma|sarcoma
133308|NCT02736565|soft tissue|soft tissue
133309|NCT02736552|Gastric cancer|gastric cancer
133310|NCT02736552|Adjuvant chemotherapy|adjuvant chemotherapy
133311|NCT02736552|S-1|s-1
133312|NCT02736552|D2 resection|d2 resection
133313|NCT02736526|moderate intermittent exotropia|moderate intermittent exotropia
133314|NCT02736526|surgical treatment|surgical treatment
133315|NCT02736526|observation|observation
133316|NCT02736513|Tagrisso|tagrisso
133317|NCT02736513|AZD9291|azd9291
133318|NCT02736513|EGFRm|egfrm
133319|NCT02736513|brain metastases|brain metastases
133320|NCT02736513|NSCLC|nsclc
133321|NCT02736500|neuroendocrine tumors|neuroendocrine tumors
133322|NCT02736500|gastro entero pancreatic neuroendocrine tumors|gastro entero pancreatic neuroendocrine tumors
133323|NCT02736500|Radioisotope therapy|radioisotope therapy
133324|NCT02736500|177Lu-DOTATATE|177lu-dotatate
133325|NCT02736500|METRONOMIC CAPECITABINE|metronomic capecitabine
133326|NCT02736487|Air Pollution|air pollution
133327|NCT02736487|Exposure Assessment|exposure assessment
133328|NCT02736487|Filtration|filtration
133329|NCT02736487|Cardiovascular Outcomes|cardiovascular outcomes
133330|NCT02736487|Respiratory Outcomes|respiratory outcomes
133331|NCT02736487|Short-term Intervention|short-term intervention
133332|NCT02736461|Orbital fractures|orbital fractures
133333|NCT02736461|Strabismus|strabismus
133334|NCT02736461|Predicting factors|predicting factors
133335|NCT02736461|orbital floor fractures|orbital floor fractures
133336|NCT02736448|GEP-NET tumors|gep-net tumors
133337|NCT02736448|Lu-PRRT|lu-prrt
133338|NCT02736448|177Lutethium - Peptide Receptor Radionuclide Therapy|177lutethium - peptide receptor radionuclide therapy
133339|NCT02736448|gastro-entero-pancreatic neuroendocrine tumors|gastro-entero-pancreatic neuroendocrine tumors
133340|NCT02736448|18-FDG Positron Emission Tomography (PET) positive|18-fdg positron emission tomography (pet) positive
133341|NCT02736448|low dose of capecitabine|low dose of capecitabine
133597|NCT02734615|endocrine therapy|endocrine therapy
133342|NCT02736435|Magnetic Resonance Guided High Intensity Focused Ultrasound|magnetic resonance guided high intensity focused ultrasound
133343|NCT02736435|MR-HIFU|mr-hifu
133344|NCT02736435|Fibroids|fibroids
133345|NCT02736435|Leuprolide Acetate|leuprolide acetate
133346|NCT02736357|Lymphoma|lymphoma
133347|NCT02736357|Cohort|cohort
133348|NCT02736357|non-Hodgkin|non-hodgkin
133349|NCT02736344|coronary luminal diameter|coronary luminal diameter
133350|NCT02736344|lesions|lesions
133351|NCT02736344|vessels|vessels
133352|NCT02736331|Cognitive performance|cognitive performance
133353|NCT02736331|Metabolic control|metabolic control
133354|NCT02736331|Pharmacokinetic profile|pharmacokinetic profile
133355|NCT02736331|Anthocyanins|anthocyanins
133356|NCT02736305|ovarian|ovarian
133357|NCT02736305|regorafenib|regorafenib
133358|NCT02736305|platinum resistant|platinum resistant
133359|NCT02736305|clear cell|clear cell
133360|NCT02736305|endometrioid|endometrioid
133361|NCT02736266|Muscle-invasive|muscle-invasive
133362|NCT02736266|Urothelial bladder carcinoma|urothelial bladder carcinoma
133363|NCT02736266|Neoadjuvant therapy|neoadjuvant therapy
133364|NCT02736266|Radical cystectomy|radical cystectomy
133365|NCT02736253|foot amputation|foot amputation
133366|NCT02736253|Osteomyelitis|osteomyelitis
133367|NCT02736253|Diabetic Foot|diabetic foot
133368|NCT02736227|liver transplantation|liver transplantation
133369|NCT02736227|immunosuppression|immunosuppression
133370|NCT02736227|everolimus|everolimus
133371|NCT02736227|tacrolimus|tacrolimus
133372|NCT02736227|kidney function|kidney function
133373|NCT02736227|liver function|liver function
133374|NCT02736227|biomarkers|biomarkers
133375|NCT02736188|GNE Myopathy|gne myopathy
133376|NCT02736188|GNEM|gnem
133377|NCT02736188|Nonaka|nonaka
133378|NCT02736188|Hereditary Inclusion Body Myopathy|hereditary inclusion body myopathy
133379|NCT02736188|HIBM|hibm
133380|NCT02736188|DMRV|dmrv
133381|NCT02736188|QSM|qsm
133382|NCT02736162|Perampanel|perampanel
133383|NCT02736162|E2007|e2007
133384|NCT02736162|Phase 4|phase 4
133385|NCT02736162|Fycompa|fycompa
133386|NCT02736136|maternal parenting self-efficacy|maternal parenting self-efficacy
133387|NCT02736136|parental stress|parental stress
133388|NCT02736136|maternal sensitivity|maternal sensitivity
133389|NCT02736136|mother-infant bond|mother-infant bond
133390|NCT02736110|Osteoarthritis, knee|osteoarthritis, knee
133391|NCT02736084|optimism|optimism
133392|NCT02736084|positive affect|positive affect
133393|NCT02736084|adherence|adherence
133394|NCT02736084|health behavior|health behavior
133395|NCT02736084|diabetes|diabetes
133396|NCT02736006|Alveolo-capillar membrane|alveolo-capillar membrane
133397|NCT02736006|decompression illness|decompression illness
133398|NCT02736006|diving|diving
133399|NCT02736006|occupational|occupational
133400|NCT02735993|Celution|celution
133401|NCT02735993|ADRC|adrc
133402|NCT02735993|Heart Failure|heart failure
133403|NCT02735993|Device|device
133404|NCT02735980|SCLC|sclc
133405|NCT02735980|LY2606368|ly2606368
133406|NCT02735980|CHK1|chk1
133407|NCT02735915|Immunogenicity|immunogenicity
133408|NCT02735915|Safety|safety
133409|NCT02735915|Long term follow-up|long term follow-up
133410|NCT02735915|Adults|adults
133411|NCT02735915|Herpes zoster|herpes zoster
133412|NCT02735902|antivitamins K|antivitamins k
133413|NCT02735876|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
133414|NCT02735876|Btk|btk
133415|NCT02735876|ACP-196|acp-196
133416|NCT02735876|Mantle Cell Lymphoma|mantle cell lymphoma
133417|NCT02735876|MCL|mcl
133418|NCT02735811|Implantable defibrillator|implantable defibrillator
133419|NCT02735811|Cardiomyopathies|cardiomyopathies
133420|NCT02735720|thoracic endovascular aortic repair|thoracic endovascular aortic repair
133421|NCT02735720|endograft|endograft
133422|NCT02735720|cardiac remodelling|cardiac remodelling
133423|NCT02735720|thoracic aortic aneurysm|thoracic aortic aneurysm
133424|NCT02735720|penetrating aortic ulcer|penetrating aortic ulcer
133425|NCT02735720|MRI|mri
133426|NCT02735694|Sleep apnea|sleep apnea
133427|NCT02735694|Hypoglossal Nerve|hypoglossal nerve
133428|NCT02735694|N-methyl-D-aspartate receptors|n-methyl-d-aspartate receptors
133429|NCT02735694|Cycloserine|cycloserine
133430|NCT02735694|Short-term potentiation|short-term potentiation
133431|NCT02735668|Shoulder Pain|shoulder pain
133432|NCT02735668|Pattern Motor|pattern motor
133433|NCT02735668|Physical Therapy Modalities|physical therapy modalities
133434|NCT02735668|Breast Cancer Treatment|breast cancer treatment
133435|NCT02735655|endoscopy|endoscopy
133436|NCT02735655|Education|education
133437|NCT02735655|capsule endoscopy|capsule endoscopy
133438|NCT02735655|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
133439|NCT02735655|esophagogastroduodenoscopy|esophagogastroduodenoscopy
133440|NCT02735655|colonoscopy|colonoscopy
133441|NCT02735655|Double-Balloon Enteroscopy|double-balloon enteroscopy
133442|NCT02735655|Global status|global status
133443|NCT02735655|unmet need|unmet need
133444|NCT02735616|heart rate variability|heart rate variability
133445|NCT02735616|stroke|stroke
133446|NCT02735577|Alcohol|alcohol
133447|NCT02735577|Craving|craving
133448|NCT02735577|Functional MRI|functional mri
133449|NCT02735577|Cognitive control|cognitive control
133450|NCT02735577|Risky decision-making|risky decision-making
133451|NCT02735577|Disulfiram|disulfiram
133452|NCT02735564|Weight Loss|weight loss
133453|NCT02735564|Magnetic Resonance Imaging|magnetic resonance imaging
133454|NCT02735564|gut microbiota|gut microbiota
133455|NCT02735551|LARC|larc
133456|NCT02735551|IUD|iud
133457|NCT02735551|Contraceptive Implant|contraceptive implant
133458|NCT02735551|Contraception|contraception
133459|NCT02735551|Community college|community college
133460|NCT02735525|telemedicine|telemedicine
133461|NCT02735525|smartphone|smartphone
133462|NCT02735499|onabotulinum toxin A|onabotulinum toxin a
133463|NCT02735499|Urinary bladder|urinary bladder
133464|NCT02735499|EMDA|emda
133465|NCT02735499|iontophoresis|iontophoresis
133466|NCT02735499|electrophoresis|electrophoresis
133467|NCT02735499|Urinary incontinence|urinary incontinence
133468|NCT02735486|Ginger|ginger
133469|NCT02735486|blood pressure|blood pressure
133470|NCT02735486|flow mediated dilatation|flow mediated dilatation
133471|NCT02735434|Health anxiety|health anxiety
133472|NCT02735434|illness anxiety disorder|illness anxiety disorder
133473|NCT02735434|ACT|act
133474|NCT02735434|internet|internet
133475|NCT02735421|acne|acne
133476|NCT02735421|scars|scars
133477|NCT02735395|Periodontal Diseases|periodontal diseases
133478|NCT02735395|Metronidazole|metronidazole
133479|NCT02735395|Amoxicillin|amoxicillin
133480|NCT02735395|Chronic periodontitis|chronic periodontitis
133481|NCT02735395|Root Planing|root planing
133482|NCT02735382|Translational Medical Research|translational medical research
133483|NCT02735382|Clinical Practice Guidelines|clinical practice guidelines
133484|NCT02735382|Electronic Health Records|electronic health records
133485|NCT02735382|Smoking|smoking
133486|NCT02735382|Tobacco|tobacco
133487|NCT02735382|Quitline|quitline
133488|NCT02735330|CCP|ccp
133489|NCT02735317|Nasopharyngeal carcinoma (NPC)|nasopharyngeal carcinoma (npc)
133490|NCT02735317|radiotherapy|radiotherapy
133491|NCT02735317|oral mucositis (OM)|oral mucositis (om)
133492|NCT02735291|Leukemia CAR-T|leukemia car-t
133493|NCT02735265|Rehabilitation|rehabilitation
133494|NCT02735265|Virtual reality|virtual reality
133495|NCT02735252|Castration Resistant|castration resistant
133496|NCT02735252|Metastatic|metastatic
133497|NCT02735239|Oesophageal Cancer|oesophageal cancer
133498|NCT02735239|Oesophageal adenocarcinoma|oesophageal adenocarcinoma
133499|NCT02735239|Oesophageal squamous cell carcinoma|oesophageal squamous cell carcinoma
133500|NCT02735239|Immunotherapy|immunotherapy
133501|NCT02735239|Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4)|cytotoxic t-lymphocyte-associated protein 4 (ctla-4)
133502|NCT02735239|Programmed cell death protein 1 (PD-1)|programmed cell death protein 1 (pd-1)
133503|NCT02735239|Programmed death ligand 1 (PD-L1)|programmed death ligand 1 (pd-l1)
133504|NCT02735226|stroke|stroke
133505|NCT02735226|Shanghai Healthcare|shanghai healthcare
133506|NCT02735226|Healthcare Quality, Access, and Evaluation|healthcare quality, access, and evaluation
133507|NCT02735213|Central Serous Choroidopathy|central serous choroidopathy
133508|NCT02735213|Micropulse Laser Treatment|micropulse laser treatment
133509|NCT02735213|Traditional laser Treatment|traditional laser treatment
133510|NCT02735213|optical coherence tomography|optical coherence tomography
133511|NCT02735174|Telehealth|telehealth
133512|NCT02735174|Sensor cap|sensor cap
133513|NCT02735174|School based care|school based care
133514|NCT02735174|Community health|community health
133515|NCT02735174|AsthmaTreatSmart Application|asthmatreatsmart application
133516|NCT02735161|Sarcoidosis|sarcoidosis
133517|NCT02735161|Fatigue|fatigue
133518|NCT02735161|Exercise|exercise
133519|NCT02735148|Postural balance|postural balance
133520|NCT02735148|Accidental falls|accidental falls
133521|NCT02735148|Rehabilitation|rehabilitation
133522|NCT02735148|Cerebrovascular Accident|cerebrovascular accident
133523|NCT02735148|Walking|walking
133524|NCT02735148|Mobility limitation|mobility limitation
133525|NCT02735135|bedridden|bedridden
133526|NCT02735109|VIN|vin
133527|NCT02735096|Bilateral Vestibular Hypofunction|bilateral vestibular hypofunction
133528|NCT02735096|Unilateral Vestibular Hypofunction|unilateral vestibular hypofunction
133529|NCT02735096|Imbalance|imbalance
133530|NCT02735070|Common cold treatment|common cold treatment
133531|NCT02735057|oesophagus cancer|oesophagus cancer
133532|NCT02735031|Glucagon-Like Peptide 1|glucagon-like peptide 1
133533|NCT02735031|Impaired hypoglycemic awareness|impaired hypoglycemic awareness
133534|NCT02734992|Migraines|migraines
133535|NCT02734992|Tension-type Headache|tension-type headache
133536|NCT02734992|Acceptance|acceptance
133537|NCT02734979|lymphedema|lymphedema
133538|NCT02734979|edema|edema
133539|NCT02734966|Drug-Induced|drug-induced
133540|NCT02734966|Acute Liver Injury|acute liver injury
133541|NCT02734953|Inhaled nitric oxide|inhaled nitric oxide
133542|NCT02734953|Exercise|exercise
133543|NCT02734953|6 minute walk test|6 minute walk test
133544|NCT02734953|CardioMems|cardiomems
133545|NCT02734927|schizophrenia|schizophrenia
133546|NCT02734927|motivation|motivation
133547|NCT02734927|executive control|executive control
133548|NCT02734901|polyphenols|polyphenols
133549|NCT02734901|vascular function|vascular function
133550|NCT02734901|endothelial function|endothelial function
133551|NCT02734901|raspberry|raspberry
133552|NCT02734888|arterial inflammation|arterial inflammation
133553|NCT02734888|electronic cigarettes|electronic cigarettes
133554|NCT02734888|PET scan|pet scan
133555|NCT02734875|anticoagulants|anticoagulants
133556|NCT02734875|NOACs|noacs
133557|NCT02734875|warfarin|warfarin
133558|NCT02734875|randomized designed delay|randomized designed delay
133559|NCT02734875|intervention|intervention
133560|NCT02734875|machine learning algorithm|machine learning algorithm
133561|NCT02734875|primary care|primary care
133562|NCT02734862|mycoses|mycoses
133563|NCT02734810|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
133564|NCT02734810|Cystic Fibrosis|cystic fibrosis
133565|NCT02734810|Liprotamase|liprotamase
133566|NCT02734810|Pancreatic Enzyme Replacement Therapy (PERT)|pancreatic enzyme replacement therapy (pert)
133567|NCT02734771|DLBCL|dlbcl
133568|NCT02734745|diabetes type 1|diabetes type 1
133569|NCT02734745|flash glucose monitoring|flash glucose monitoring
133570|NCT02734732|Prostate|prostate
133571|NCT02734732|Biopsy|biopsy
133572|NCT02734732|Infection|infection
133573|NCT02734732|Prophylaxis|prophylaxis
133574|NCT02734732|Antibiotic|antibiotic
133575|NCT02734693|Attention-Deficit Hyperactivity Disorder (ADHD)|attention-deficit hyperactivity disorder (adhd)
133576|NCT02734680|Pancreatic cancer|pancreatic cancer
133577|NCT02734680|Intraoperative radiotherapy(IORT)|intraoperative radiotherapy(iort)
133578|NCT02734680|Postoperative radiochemotherapy|postoperative radiochemotherapy
133579|NCT02734654|oxidative stress|oxidative stress
133580|NCT02734654|lung lobectomy|lung lobectomy
133581|NCT02734615|LSZ102|lsz102
133582|NCT02734615|LEE011|lee011
133583|NCT02734615|ribociclib|ribociclib
133584|NCT02734615|Kisqali|kisqali
133585|NCT02734615|BYL719|byl719
133586|NCT02734615|alpelisib|alpelisib
133587|NCT02734615|ER+ breast cancer|er+ breast cancer
133588|NCT02734615|advanced ER+ breast cancer|advanced er+ breast cancer
133589|NCT02734615|metastatic ER+ breast cancer|metastatic er+ breast cancer
133590|NCT02734615|SERD|serd
133591|NCT02734615|SERM|serm
133592|NCT02734615|fulvestrant|fulvestrant
133593|NCT02734615|tamoxifen|tamoxifen
133594|NCT02734615|aromatase inhibitor|aromatase inhibitor
133595|NCT02734615|ESR1|esr1
133596|NCT02734615|estrogen receptor|estrogen receptor
133598|NCT02734602|depression|depression
133599|NCT02734602|post-traumatic stress disorder|post-traumatic stress disorder
133600|NCT02734602|sv2a|sv2a
133601|NCT02734602|ketamine|ketamine
133602|NCT02734602|PET|pet
133603|NCT02734589|Ulcerative Colitis|ulcerative colitis
133604|NCT02734589|Nutrition|nutrition
133605|NCT02734589|microbiome|microbiome
133606|NCT02734576|Venous Sinus Stenting|venous sinus stenting
133607|NCT02734576|Dural Sinus Stenting|dural sinus stenting
133608|NCT02734550|Sepsis|sepsis
133609|NCT02734550|Invasive Candida Infection|invasive candida infection
133610|NCT02734550|Biomarker|biomarker
133611|NCT02734550|(1,3)-β-D-glucan|(1,3)-β-d-glucan
133612|NCT02734550|Antifungal therapy|antifungal therapy
133613|NCT02734550|Intensive care medicine|intensive care medicine
133614|NCT02734550|Critically ill|critically ill
133615|NCT02734524|Natural killer cells|natural killer cells
133616|NCT02734524|NSCLC|nsclc
133617|NCT02734524|NCT|nct
133618|NCT02734524|Combined therapy|combined therapy
133619|NCT02734485|Progressive supranuclear palsy|progressive supranuclear palsy
133620|NCT02734485|Deep transcranial magnetic stimulation|deep transcranial magnetic stimulation
133621|NCT02734472|blood pressure|blood pressure
133622|NCT02734472|Hypertrophy, Left Ventricular|hypertrophy, left ventricular
133623|NCT02734472|Vascular Stiffness|vascular stiffness
133624|NCT02734472|Proteinuria|proteinuria
133625|NCT02734472|Carotid Artery Diseases|carotid artery diseases
133626|NCT02734446|Bronchial Inflammation|bronchial inflammation
133627|NCT02734446|Asthma|asthma
133628|NCT02734446|Childhood Asthma Control Test (C-ACT)|childhood asthma control test (c-act)
133629|NCT02734446|Asthma Exacerbations|asthma exacerbations
133630|NCT02734433|Advanced solid tumors|advanced solid tumors
133631|NCT02734433|Asian subjects|asian subjects
133632|NCT02734433|Developmental Phase I|developmental phase i
133633|NCT02734420|Dental caries|dental caries
133634|NCT02734420|PDT|pdt
133635|NCT02734420|LLLT|lllt
133636|NCT02734420|pediatric dentistry|pediatric dentistry
133637|NCT02734394|exercise|exercise
133638|NCT02734394|body composition|body composition
133639|NCT02734394|metabolism|metabolism
133640|NCT02734394|nutrition|nutrition
133641|NCT02734381|elderly patients|elderly patients
133642|NCT02734381|prevalence|prevalence
133643|NCT02734381|emergency department use|emergency department use
133644|NCT02734381|main presenting disease|main presenting disease
133645|NCT02734355|atrial fibrillation|atrial fibrillation
133646|NCT02734355|catheter ablation|catheter ablation
133647|NCT02734355|left atrium|left atrium
133648|NCT02734355|mechanical function|mechanical function
133649|NCT02734355|contractility|contractility
133650|NCT02734329|Nephron sparing surgery|nephron sparing surgery
133651|NCT02734329|Zero ischemia|zero ischemia
133652|NCT02734329|Warm ischemia|warm ischemia
133653|NCT02734329|Laparoscopic|laparoscopic
133654|NCT02734329|Radiofrequency ablation|radiofrequency ablation
133655|NCT02734329|Microwave ablation|microwave ablation
133656|NCT02734303|Dietary Radioactivity|dietary radioactivity
133657|NCT02734303|Dietary Assessment|dietary assessment
133658|NCT02734303|Retrospective Recall|retrospective recall
133659|NCT02734303|Focus Group|focus group
133660|NCT02734290|metastatic|metastatic
133661|NCT02734290|Human epidermal growth factor receptor 2 (Her2) negative breast cancer|human epidermal growth factor receptor 2 (her2) negative breast cancer
133662|NCT02734290|Estrogen Receptor (ER) negative breast cancer|estrogen receptor (er) negative breast cancer
133663|NCT02734290|Progesterone Receptor (PR) negative breast cancer|progesterone receptor (pr) negative breast cancer
133664|NCT02734290|Immunotherapy|immunotherapy
133665|NCT02734290|Breast Cancer|breast cancer
133666|NCT02734277|Insulin|insulin
133667|NCT02734277|Glucose Intolerance|glucose intolerance
133668|NCT02734277|Prior ITN027AI Study Participants-NCT00129259|prior itn027ai study participants-nct00129259
133669|NCT02734277|Prior ITN045AI Study Participants-NCT00965458|prior itn045ai study participants-nct00965458
133670|NCT02734251|Healthy mood|healthy mood
133671|NCT02734251|Stress management|stress management
133672|NCT02734251|Relora|relora
133673|NCT02734251|Healthy subjects|healthy subjects
133674|NCT02734225|total knee replacement|total knee replacement
133675|NCT02734225|total knee arthroplasty|total knee arthroplasty
133676|NCT02734225|rehabilitation|rehabilitation
133677|NCT02734225|physical therapy|physical therapy
133678|NCT02734225|balance|balance
133679|NCT02734212|Stigmatization|stigmatization
133680|NCT02734199|Birth Control|birth control
133681|NCT02734199|Contraception|contraception
133682|NCT02734199|IUD|iud
133683|NCT02734186|Filariasis|filariasis
133684|NCT02734186|Schistosoma Mansoni|schistosoma mansoni
133685|NCT02734186|Coinfection|coinfection
133686|NCT02734160|immunotherapy|immunotherapy
133687|NCT02734160|check point inhibitors|check point inhibitors
133688|NCT02734160|transforming growth factor (TGF)-beta R1 kinase inhibitor|transforming growth factor (tgf)-beta r1 kinase inhibitor
133689|NCT02734134|Periprosthetic joint infection|periprosthetic joint infection
133690|NCT02734121|breast cancer|breast cancer
133691|NCT02734121|breast reconstruction|breast reconstruction
133692|NCT02734121|shared decision making|shared decision making
133693|NCT02734121|decision support intervention|decision support intervention
133694|NCT02734108|Sever anorexia nervosa|sever anorexia nervosa
133695|NCT02734082|stroke|stroke
133696|NCT02734082|ischemia|ischemia
133697|NCT02734082|Berne|berne
133698|NCT02734069|carboplatin|carboplatin
133699|NCT02734043|bundled payment|bundled payment
133700|NCT02734030|Anterior Knee Pain Syndrome|anterior knee pain syndrome
133701|NCT02734030|Quadriceps Femoris|quadriceps femoris
133702|NCT02734030|Muscle Inhibition|muscle inhibition
133703|NCT02734030|Interpolated Twitch Technique|interpolated twitch technique
133704|NCT02734030|Muscle Architecture|muscle architecture
133705|NCT02734030|Single Leg Squat|single leg squat
133706|NCT02734030|Women Knee Pain|women knee pain
133707|NCT02734004|MEDIOLA|mediola
133708|NCT02734004|Olaparib|olaparib
133709|NCT02734004|MEDI4736|medi4736
133710|NCT02734004|Bevacizumab|bevacizumab
133711|NCT02734004|Ovarian cancer|ovarian cancer
133712|NCT02734004|Breast cancer|breast cancer
133713|NCT02734004|Small Cell Lung Cancer|small cell lung cancer
133714|NCT02734004|Gastric Cancer|gastric cancer
133715|NCT02734004|Phase I/II, Adults|phase i/ii, adults
133716|NCT02734004|PDL-1|pdl-1
133717|NCT02733978|Ozone oxygen|ozone oxygen
133718|NCT02733978|ulcer healing|ulcer healing
133719|NCT02733965|clinical pharmacy consultations|clinical pharmacy consultations
133720|NCT02733965|oral anti-cancer therapy|oral anti-cancer therapy
133721|NCT02733965|serious adverse events|serious adverse events
133722|NCT02733965|medication reconciliation|medication reconciliation
133723|NCT02733939|technology|technology
133724|NCT02733939|informal care|informal care
133725|NCT02733939|caregiver burden|caregiver burden
133726|NCT02733913|atrial fibrillation|atrial fibrillation
133727|NCT02733913|pulmonary vein isolation|pulmonary vein isolation
133728|NCT02733913|heart rate turbulence|heart rate turbulence
133729|NCT02733913|baroreflex sensitivity|baroreflex sensitivity
133730|NCT02733900|aseptic osteonecrosis|aseptic osteonecrosis
133731|NCT02733900|femoral head|femoral head
133732|NCT02733900|micro scanner|micro scanner
133733|NCT02733900|Raman spectrometry|raman spectrometry
133734|NCT02733900|MRI|mri
133735|NCT02733861|dental implant|dental implant
133736|NCT02733861|stability|stability
133737|NCT02733861|implant stability quotient|implant stability quotient
133738|NCT02733848|Roux-en-Y gastric bypass|roux-en-y gastric bypass
133739|NCT02733848|Hypoglycemia|hypoglycemia
133740|NCT02733848|Creon|creon
133741|NCT02733822|opiate|opiate
133742|NCT02733822|heroin|heroin
133743|NCT02733822|opioid|opioid
133744|NCT02733822|overdose|overdose
133745|NCT02733822|naloxone|naloxone
133746|NCT02733809|Hepatocellular Carcinoma|hepatocellular carcinoma
133747|NCT02733809|Sorafenib|sorafenib
133748|NCT02733796|zika virus|zika virus
133749|NCT02733796|semen analysis|semen analysis
133750|NCT02733796|sexual transmission|sexual transmission
133751|NCT02733757|Clonidine|clonidine
133752|NCT02733757|Sub-Tenon's and Peribulbar block|sub-tenon's and peribulbar block
133753|NCT02733757|IOP|iop
133754|NCT02733757|OPP|opp
133755|NCT02733757|OPA|opa
133756|NCT02733744|Stem cell transplant|stem cell transplant
133757|NCT02733744|fecal microbiota transplantation|fecal microbiota transplantation
133758|NCT02733718|Necrotizing enterocolitis|necrotizing enterocolitis
133759|NCT02733718|Transfusion|transfusion
133760|NCT02733718|Mesenteric Oxygenisation|mesenteric oxygenisation
133761|NCT02733705|Pain|pain
133762|NCT02733705|TRUS biopsy|trus biopsy
133763|NCT02733692|HIV|hiv
133764|NCT02733692|STDs|stds
133765|NCT02733692|web-based app|web-based app
133766|NCT02733692|women|women
133767|NCT02733666|Absorbable screw|absorbable screw
133768|NCT02733666|Internal fixation|internal fixation
133769|NCT02733666|Children|children
133770|NCT02733653|Superficial Femoral Artery|superficial femoral artery
133771|NCT02733653|Proximal Popliteal Artery|proximal popliteal artery
133772|NCT02733653|Endovascular therapy|endovascular therapy
133773|NCT02733653|Atherectomy|atherectomy
133774|NCT02733601|breast cancer epidemiology algeria registry|breast cancer epidemiology algeria registry
133775|NCT02733588|hypoglycemia|hypoglycemia
133776|NCT02733588|glucagon|glucagon
133777|NCT02733588|glucose metabolism disorders|glucose metabolism disorders
133778|NCT02733588|hormones|hormones
133779|NCT02733588|gastrointestinal agents|gastrointestinal agents
133780|NCT02733588|bariatric surgery|bariatric surgery
133781|NCT02733588|incretins|incretins
133782|NCT02733536|endotracheal intubation|endotracheal intubation
133783|NCT02733536|trauma|trauma
133784|NCT02733536|paramedic|paramedic
133785|NCT02733510|kidney transplantation|kidney transplantation
133786|NCT02733510|subclinical rejection|subclinical rejection
133787|NCT02733510|steroid pulse therapy|steroid pulse therapy
133788|NCT02733497|sympathectomy, sympathicotomy, heart rate variability,|sympathectomy, sympathicotomy, heart rate variability,
133789|NCT02733484|Obesity,Probiotics,Treatment|obesity,probiotics,treatment
133790|NCT02733471|Lidocaine|lidocaine
133791|NCT02733471|Endoscopy|endoscopy
133792|NCT02733471|Tolerance|tolerance
133793|NCT02733393|Thoracotomy|thoracotomy
133794|NCT02733393|Postoperative|postoperative
133795|NCT02733393|Lidocaine|lidocaine
133796|NCT02733393|Sphenopalatine Ganglion Block|sphenopalatine ganglion block
133797|NCT02733380|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
133798|NCT02733380|Relapsed and refractory|relapsed and refractory
133799|NCT02733380|Histone deacetylase inhibitor|histone deacetylase inhibitor
133800|NCT02733380|Chidamide|chidamide
133801|NCT02733341|Adenosine Diphosphate|adenosine diphosphate
133802|NCT02733341|Cardiovascular Magnetic Resonance (CMR)|cardiovascular magnetic resonance (cmr)
133803|NCT02733341|Index of microvascular resistance (IMR)|index of microvascular resistance (imr)
133804|NCT02733341|Vasodilator stimulated phosphoprotein phosphorylation (VASP)|vasodilator stimulated phosphoprotein phosphorylation (vasp)
133805|NCT02733341|Pharmacodynamic|pharmacodynamic
133806|NCT02733341|Antiplatelet|antiplatelet
133807|NCT02733341|Myocardial Infarction (MI)|myocardial infarction (mi)
133808|NCT02733341|Cangrelor|cangrelor
133809|NCT02733341|Ticagrelor|ticagrelor
133810|NCT02733341|Coronary artery bypass graft (CABG)|coronary artery bypass graft (cabg)
133811|NCT02733341|Primary percutaneous coronary intervention (PPCI)|primary percutaneous coronary intervention (ppci)
133812|NCT02733328|Cardio-pulmonary bypass (CPB)|cardio-pulmonary bypass (cpb)
133813|NCT02733328|renal replacement therapy (RRT)|renal replacement therapy (rrt)
133814|NCT02733328|enzyme-linked immunosorbent assay (ELISA)|enzyme-linked immunosorbent assay (elisa)
133815|NCT02733263|gut microbiota|gut microbiota
133816|NCT02733263|fiber|fiber
133817|NCT02733263|diet quality|diet quality
133818|NCT02733263|immunity|immunity
133819|NCT02733250|NSCLC|nsclc
133820|NCT02733250|Pembrolizumab|pembrolizumab
133821|NCT02733250|Nab-paclitaxel|nab-paclitaxel
133822|NCT02733237|oxytocin|oxytocin
133823|NCT02733237|infidelity|infidelity
133824|NCT02733224|lenalidomide adherence MEMS|lenalidomide adherence mems
133825|NCT02733211|Closed Loop|closed loop
133826|NCT02733185|chelation|chelation
133827|NCT02733172|Vulvodynia|vulvodynia
133828|NCT02733172|Endophenotypes|endophenotypes
133829|NCT02733172|functional MRI|functional mri
133830|NCT02733159|Performance Status 2|performance status 2
133831|NCT02733159|Pembrolizumab|pembrolizumab
133832|NCT02733159|MK-3475|mk-3475
133833|NCT02733133|Testosterone|testosterone
133834|NCT02733133|AndroGel|androgel
133835|NCT02733133|Transference|transference
133836|NCT02733133|Women|women
133837|NCT02733133|Children|children
133838|NCT02733107|Non-small Cell Lung Cancer|non-small cell lung cancer
133839|NCT02733107|Apatinib|apatinib
133840|NCT02733107|Etoposide|etoposide
133841|NCT02733081|Long Acting Reversible Contraception|long acting reversible contraception
133842|NCT02733081|Intrauterine Device (IUD)|intrauterine device (iud)
133843|NCT02733081|Intrauterine Device (IUD) Insertion|intrauterine device (iud) insertion
133844|NCT02733081|Family Planning|family planning
133845|NCT02733081|International Family Planning|international family planning
133846|NCT02733055|Postural Equilibrium|postural equilibrium
133847|NCT02733055|Musculoskeletal Equilibrium|musculoskeletal equilibrium
133848|NCT02733055|Eye Movements|eye movements
133849|NCT02733055|Saccades|saccades
133850|NCT02733055|Pursuit, Smooth|pursuit, smooth
133851|NCT02733042|Lymphoma|lymphoma
133852|NCT02733042|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
133853|NCT02733042|Durvalumab|durvalumab
133854|NCT02733042|Anti-PD-L1 Antibody|anti-pd-l1 antibody
133855|NCT02733042|MEDI4736|medi4736
133856|NCT02733042|Immune Checkpoint|immune checkpoint
133857|NCT02733042|Lymphatic Disease|lymphatic disease
133858|NCT02733042|B-Cell Malignancies|b-cell malignancies
133859|NCT02733042|Abscopal Effect|abscopal effect
133860|NCT02733042|Lenalidomide|lenalidomide
133861|NCT02733042|Bendamustine|bendamustine
133862|NCT02733042|Rituximab|rituximab
133863|NCT02733042|Ibrutinib|ibrutinib
133864|NCT02733042|Lymphoma, B-Cell|lymphoma, b-cell
133865|NCT02733042|Lymphoma, Non Hodgkin,|lymphoma, non hodgkin,
133866|NCT02733042|Hodgkin Disease|hodgkin disease
133867|NCT02733042|Leukemia, Lymphocytic, Chronic, B-Cell,|leukemia, lymphocytic, chronic, b-cell,
133868|NCT02733042|Lymphoma, Follicular|lymphoma, follicular
133869|NCT02733042|Lymphoma, Diffuse Large B-Cell|lymphoma, diffuse large b-cell
133870|NCT02733042|Lymphoma, Mantle Cell|lymphoma, mantle cell
133871|NCT02733042|Lymphoma, Small Lymphocytic|lymphoma, small lymphocytic
133872|NCT02733042|Immune System Diseases|immune system diseases
133873|NCT02733042|Immunoproliferative Disorders|immunoproliferative disorders
133874|NCT02733042|Lymphoproliferative Disorders|lymphoproliferative disorders
133875|NCT02733003|Implementation Science|implementation science
133876|NCT02733003|HIV|hiv
133877|NCT02733003|Sexual Risk|sexual risk
133878|NCT02733003|Sexually Transmitted Diseases|sexually transmitted diseases
133879|NCT02733003|Substance Abuse|substance abuse
133880|NCT02733003|Violence and Victimization|violence and victimization
133881|NCT02733003|Linkage to care|linkage to care
133882|NCT02733003|Gender-based Violence|gender-based violence
133883|NCT02733003|Antiretroviral Therapy (ART)|antiretroviral therapy (art)
133884|NCT02732990|Training|training
133885|NCT02732990|One-legged exercise|one-legged exercise
133886|NCT02732990|Peripheral blood flow|peripheral blood flow
133887|NCT02732990|Cardiac function|cardiac function
133888|NCT02732990|Muscle metaboreflex|muscle metaboreflex
133889|NCT02732964|satisfaction|satisfaction
133890|NCT02732938|CCR2i, nab-paclitaxel, Abraxane, gemcitabine, pancreas|ccr2i, nab-paclitaxel, abraxane, gemcitabine, pancreas
133891|NCT02732925|Vertebral Compression Fracture|vertebral compression fracture
133892|NCT02732925|Balloon Kyphoplasty|balloon kyphoplasty
133893|NCT02732925|Conservative treatment|conservative treatment
133894|NCT02732925|Sham procedure|sham procedure
133895|NCT02732925|VCFs|vcfs
133896|NCT02732925|Multiple Myeloma|multiple myeloma
133897|NCT02732912|falls|falls
133898|NCT02732912|sleep|sleep
133899|NCT02732899|AMD|amd
133900|NCT02732886|foam dressing|foam dressing
133901|NCT02732860|personalized patient-derived xenografts (pPDX)|personalized patient-derived xenografts (ppdx)
133902|NCT02732860|molecular profiling|molecular profiling
133903|NCT02732860|epigenetic analysis|epigenetic analysis
133904|NCT02732860|drug sensitivity testing|drug sensitivity testing
133905|NCT02732860|triple negative|triple negative
133906|NCT02732860|metastatic|metastatic
133907|NCT02732860|serous|serous
133908|NCT02732847|Respiratory infections|respiratory infections
133909|NCT02732847|Primary care|primary care
133910|NCT02732847|Antibiotics|antibiotics
133911|NCT02732847|Delayed prescriptions|delayed prescriptions
133912|NCT02732834|Clinician-Patient Communication|clinician-patient communication
133913|NCT02732834|16-001|16-001
133914|NCT02732821|Gastroparesis|gastroparesis
133915|NCT02732821|G-POEM|g-poem
133916|NCT02732821|Gastric Per Oral Endoscopic Myotomy|gastric per oral endoscopic myotomy
133917|NCT02732808|Double stimulations|double stimulations
133918|NCT02732808|luteal-phase ovarian stimulation|luteal-phase ovarian stimulation
133919|NCT02732808|poor ovarian response|poor ovarian response
133920|NCT02732782|Achilles tendon|achilles tendon
133921|NCT02732782|isometric muscle training|isometric muscle training
133922|NCT02732782|competitive sports|competitive sports
133923|NCT02732782|strength training|strength training
133924|NCT02732782|eccentric exercise|eccentric exercise
133925|NCT02732782|isometric exercise|isometric exercise
133926|NCT02732782|chronic condition|chronic condition
133927|NCT02732782|regeneration|regeneration
133928|NCT02732782|tendon|tendon
133929|NCT02732782|tendon properties|tendon properties
133930|NCT02732782|tendinopathy|tendinopathy
133931|NCT02732782|tendinosis|tendinosis
133932|NCT02732782|intervention|intervention
133933|NCT02732782|training load|training load
133934|NCT02732782|high performance sports|high performance sports
133935|NCT02732756|ADHD|adhd
133936|NCT02732756|Sleep|sleep
133937|NCT02732756|Attention|attention
133938|NCT02732756|Adolescence|adolescence
133939|NCT02732743|childhod constipation|childhod constipation
133940|NCT02732730|ART (Antir-retroviral therapy)|art (antir-retroviral therapy)
133941|NCT02732730|PrEP (Pre-Exposure Prophylaxis)|prep (pre-exposure prophylaxis)
133942|NCT02732730|DAIDS (Division of AIDS)|daids (division of aids)
133943|NCT02732730|HPTN (HIV Prevention Trials Network)|hptn (hiv prevention trials network)
133944|NCT02732704|Aortic Valve Disease|aortic valve disease
133945|NCT02732704|Aortic Regurgitation|aortic regurgitation
133946|NCT02732691|Aortic Valve Disease|aortic valve disease
133947|NCT02732691|Aortic Valve Stenosis|aortic valve stenosis
133948|NCT02732613|Laryngeal Mask Airway|laryngeal mask airway
133949|NCT02732613|Body weight|body weight
133950|NCT02732613|Complication|complication
133951|NCT02732600|Veterans|veterans
133952|NCT02732600|Veterans Health|veterans health
133953|NCT02732600|Patient Compliance|patient compliance
133954|NCT02732600|Primary Health Care|primary health care
133955|NCT02732600|Health Care Providers|health care providers
133956|NCT02732600|Health Promotion|health promotion
133957|NCT02732522|misoprostol|misoprostol
133958|NCT02732522|induction of labor|induction of labor
133959|NCT02732522|sublingual|sublingual
133960|NCT02732496|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
133961|NCT02732496|Tourette Syndrome|tourette syndrome
133962|NCT02732496|Working Memory Training|working memory training
133963|NCT02732483|gastric cancer|gastric cancer
133964|NCT02732483|bleeding|bleeding
133965|NCT02732483|gastrointestinal hemorrhage|gastrointestinal hemorrhage
133966|NCT02732470|Systemic Lupus Erythematous|systemic lupus erythematous
133967|NCT02732470|Qi Gong|qi gong
133968|NCT02732470|Quality of life|quality of life
133969|NCT02732457|HIV|hiv
133970|NCT02732457|Persistence|persistence
133971|NCT02732457|Reservoirs|reservoirs
133972|NCT02732457|Stem Cell Transplant|stem cell transplant
133973|NCT02732457|Functional Cure|functional cure
133974|NCT02732444|Erythrocytes Membranes Stability|erythrocytes membranes stability
133975|NCT02732444|Oxidative Stress|oxidative stress
133976|NCT02732444|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
133977|NCT02732444|Advanced Pulmonary Disease (APD)|advanced pulmonary disease (apd)
133978|NCT02732444|Long-Term Home Oxygen Therapy (LTOT)|long-term home oxygen therapy (ltot)
133979|NCT02732418|CI-contraceptive injection|ci-contraceptive injection
133980|NCT02732418|DMPA-Depot medroxyprogesterone acetate|dmpa-depot medroxyprogesterone acetate
133981|NCT02732418|MPA-Medroxyprogesterone Acetate|mpa-medroxyprogesterone acetate
133982|NCT02732418|subQ-subcutaneous|subq-subcutaneous
133983|NCT02732379|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
133984|NCT02732379|Aromatherapy|aromatherapy
133985|NCT02732379|Quality of Health Care|quality of health care
133986|NCT02732366|aged [MeSH term]|aged [mesh term]
133987|NCT02732366|exercise [MeSH term]|exercise [mesh term]
133988|NCT02732340|triple-branched stent graft|triple-branched stent graft
133989|NCT02732340|the occluded rate of false lumen|the occluded rate of false lumen
133990|NCT02732275|Relapsed non-hodgkin lymphoma.|relapsed non-hodgkin lymphoma.
133991|NCT02732275|phase 1|phase 1
133992|NCT02732275|oncology|oncology
133993|NCT02732262|acute pain|acute pain
133994|NCT02732262|postoperative|postoperative
133995|NCT02732262|surgery|surgery
133996|NCT02732249|Helicobacter pylori|helicobacter pylori
133997|NCT02732249|Clarithromycin|clarithromycin
133998|NCT02732249|Amoxicillin|amoxicillin
133999|NCT02732249|Metronidazole|metronidazole
134000|NCT02732249|Eradication|eradication
134001|NCT02732236|marginal zone lymphoma|marginal zone lymphoma
134002|NCT02732236|Cohort|cohort
134003|NCT02732236|Rituximab|rituximab
134004|NCT02732236|HBV|hbv
134005|NCT02732223|Atherosclerosis|atherosclerosis
134006|NCT02732223|omega 3|omega 3
134007|NCT02732223|plant sterols|plant sterols
134008|NCT02732223|polyphenols|polyphenols
134009|NCT02732184|AML|aml
134010|NCT02732184|MDS|mds
134011|NCT02732158|Novel laboratory methods|novel laboratory methods
134012|NCT02732145|Three-Vulvar-Rings|three-vulvar-rings
134013|NCT02732145|Three-Rings-Vulvoscopy|three-rings-vulvoscopy
134014|NCT02732145|N-S-P scheme|n-s-p scheme
134015|NCT02732145|Vulvoscopy Index|vulvoscopy index
134016|NCT02732145|Vulvar Dermatosis|vulvar dermatosis
134017|NCT02732145|Vulvar Lichen Sclerosus|vulvar lichen sclerosus
134018|NCT02732145|Lichen Planus|lichen planus
134019|NCT02732145|Lichen Simplex Chronicus|lichen simplex chronicus
134020|NCT02732145|Vulvodynia|vulvodynia
134021|NCT02732145|Provoked Vestibulodynia|provoked vestibulodynia
134022|NCT02732145|Vulvar Vestibulitis|vulvar vestibulitis
134023|NCT02732145|Vulvar Diseases|vulvar diseases
134024|NCT02732119|HR-positive|hr-positive
134025|NCT02732119|HER2-negative|her2-negative
134026|NCT02732119|Advanced breast cancer|advanced breast cancer
134027|NCT02732119|LEE011|lee011
134028|NCT02732119|ribociclib|ribociclib
134029|NCT02732119|everolimus|everolimus
134030|NCT02732119|Afinitor|afinitor
134031|NCT02732119|exemestane|exemestane
134032|NCT02732119|Aromasin|aromasin
134033|NCT02732119|CDK|cdk
134034|NCT02732119|CDK4|cdk4
134035|NCT02732119|CDK6|cdk6
134036|NCT02732119|CDK4/6|cdk4/6
134037|NCT02732119|CDK4/6 inhibitor|cdk4/6 inhibitor
134038|NCT02732119|Phase III|phase iii
134039|NCT02732119|ER-positive|er-positive
134040|NCT02732119|PR-positive|pr-positive
134041|NCT02732119|Postmenopausal|postmenopausal
134042|NCT02732106|ADRCs, cell characterization|adrcs, cell characterization
134043|NCT02732080|primary percutaneous coronary intervention|primary percutaneous coronary intervention
134044|NCT02732080|microvascular obstruction|microvascular obstruction
134045|NCT02732080|myocardial edema|myocardial edema
134046|NCT02732080|microvascular resistance|microvascular resistance
134047|NCT02732080|acute myocardial infarction|acute myocardial infarction
134048|NCT02732067|Anesthesia|anesthesia
134049|NCT02732054|HBV vaccination, immunity|hbv vaccination, immunity
134050|NCT02732015|Sarcoma|sarcoma
134051|NCT02732015|Locally advanced|locally advanced
134052|NCT02732015|High risk for relapse|high risk for relapse
134053|NCT02732015|Metastatic|metastatic
134054|NCT02732015|Questionnaires|questionnaires
134055|NCT02732015|Surveys|surveys
134056|NCT02732015|Rolapitant|rolapitant
134057|NCT02732015|Fosaprepitant|fosaprepitant
134058|NCT02732015|Dexamethasone|dexamethasone
134059|NCT02732015|Decadron|decadron
134060|NCT02732015|Ondansetron|ondansetron
134061|NCT02732015|Zofran|zofran
134062|NCT02732015|Doxorubicin|doxorubicin
134063|NCT02732015|Adriamycin PFS|adriamycin pfs
134064|NCT02732015|Adriamycin RDF|adriamycin rdf
134065|NCT02732015|Rubex|rubex
134066|NCT02732015|Mesna|mesna
134067|NCT02732015|Mesnex|mesnex
134068|NCT02732015|Ifosfamide|ifosfamide
134069|NCT02732015|Ifex|ifex
134070|NCT02732015|Vincristine|vincristine
134071|NCT02732015|Nausea|nausea
134072|NCT02732015|Vomiting|vomiting
134073|NCT02732002|shoulder|shoulder
134074|NCT02732002|rotator cuff- injury|rotator cuff- injury
134075|NCT02732002|management|management
134076|NCT02732002|rehabilitation model|rehabilitation model
134077|NCT02731976|Gluten-Free diet|gluten-free diet
134078|NCT02731976|Healthy individuals|healthy individuals
134079|NCT02731963|Outcomes|outcomes
134080|NCT02731963|Bowel preparation|bowel preparation
134081|NCT02731950|Sternotomy , cardiac surgery , pain|sternotomy , cardiac surgery , pain
134082|NCT02731924|Appendicitis|appendicitis
134083|NCT02731924|Ultrasound|ultrasound
134084|NCT02731924|Emergency Department|emergency department
134085|NCT02731872|COPD|copd
134086|NCT02731872|oxygen treatment|oxygen treatment
134087|NCT02731872|quality of life|quality of life
134088|NCT02731846|Efficacy|efficacy
134089|NCT02731846|Triple therapy|triple therapy
134090|NCT02731846|Parallel|parallel
134091|NCT02731846|Respiratory|respiratory
134092|NCT02731820|potassium citrate|potassium citrate
134093|NCT02731807|TA-65|ta-65
134094|NCT02731807|Telemorase|telemorase
134095|NCT02731807|Dietary Supplement|dietary supplement
134096|NCT02731794|cardiopulmonary bypass|cardiopulmonary bypass
134097|NCT02731794|coronary artery bypass grafting|coronary artery bypass grafting
134098|NCT02731794|inflammatory response|inflammatory response
134099|NCT02731794|cardiac dysfunction|cardiac dysfunction
134100|NCT02731781|OUTCOME|outcome
134101|NCT02731781|PROGNOSIS|prognosis
134102|NCT02731781|PEDIATRIC HEAd injury|pediatric head injury
134103|NCT02731781|CT SCAN|ct scan
134104|NCT02731755|Oats|oats
134105|NCT02731755|Phenolic acid|phenolic acid
134106|NCT02731755|FMD|fmd
134107|NCT02731755|LDI|ldi
134108|NCT02731755|Renin angiotensin|renin angiotensin
134109|NCT02731755|Nitric oxide|nitric oxide
134110|NCT02731729|Ipilimumab|ipilimumab
134111|NCT02731729|Nivolumab|nivolumab
134112|NCT02731729|Stage III-IV Melanoma|stage iii-iv melanoma
134113|NCT02731729|Progressed or Relapsed on PD-1 Inhibitor Therapy|progressed or relapsed on pd-1 inhibitor therapy
134114|NCT02731729|16-043|16-043
134115|NCT02731703|overdenture|overdenture
134116|NCT02731703|overlay|overlay
134117|NCT02731703|implant supported|implant supported
134118|NCT02731703|denture|denture
134119|NCT02731703|dental prosthesis|dental prosthesis
134120|NCT02731703|maxillary|maxillary
134121|NCT02731690|GNE Myopathy|gne myopathy
134122|NCT02731690|Nonaka|nonaka
134123|NCT02731690|GNEM|gnem
134124|NCT02731690|Hereditary Inclusion Body Myopathy|hereditary inclusion body myopathy
134125|NCT02731690|HIBM|hibm
134126|NCT02731690|DMRV|dmrv
134127|NCT02731690|QSM|qsm
134128|NCT02731664|Irritable bowel syndrome|irritable bowel syndrome
134129|NCT02731664|Functional dyspepsia|functional dyspepsia
134130|NCT02731664|Gastric emptying|gastric emptying
134131|NCT02731664|Gastrointestinal peptide hormones|gastrointestinal peptide hormones
134132|NCT02731638|cornea|cornea
134133|NCT02731638|ulcer|ulcer
134134|NCT02731638|fungal|fungal
134135|NCT02731638|keratitis|keratitis
134136|NCT02731625|Kettlebell training|kettlebell training
134137|NCT02731625|High-intensity interval training|high-intensity interval training
134138|NCT02731612|Bipolar Disorder|bipolar disorder
134139|NCT02731612|Cognition|cognition
134140|NCT02731612|Euthymic|euthymic
134141|NCT02731612|Lurasidone|lurasidone
134142|NCT02731599|Parkinson Disease|parkinson disease
134143|NCT02731599|treadmill|treadmill
134144|NCT02731599|Rehabilitation|rehabilitation
134145|NCT02731586|Dental Implants|dental implants
134146|NCT02731586|Allogenic mesenchymal stem cells|allogenic mesenchymal stem cells
134147|NCT02731586|osseointegration|osseointegration
134148|NCT02731586|primary stability|primary stability
134149|NCT02731586|resonance frequency analysis|resonance frequency analysis
134150|NCT02731586|RFA|rfa
134151|NCT02731586|implants and stem cells|implants and stem cells
134152|NCT02731586|use of stem cells|use of stem cells
134153|NCT02731586|stem cells|stem cells
134154|NCT02731573|Mediastenitis|mediastenitis
134155|NCT02731560|Pakistan, Rituximab|pakistan, rituximab
134156|NCT02731560|RA|ra
134157|NCT02731521|MRS Biomarkers|mrs biomarkers
134158|NCT02731508|Transcranial Direct Current Stimulation|transcranial direct current stimulation
134159|NCT02731508|Neuroplasticity|neuroplasticity
134160|NCT02731482|Bronchiectasis|bronchiectasis
134161|NCT02731482|Rehabilitation|rehabilitation
134162|NCT02731482|Quality of Life|quality of life
134163|NCT02731482|Physiotherapy Specialty|physiotherapy specialty
134164|NCT02731456|high altitude|high altitude
134165|NCT02731456|cognition|cognition
134166|NCT02731456|sleep|sleep
134167|NCT02731443|dreaming|dreaming
134168|NCT02731443|epilepsy|epilepsy
134169|NCT02731443|neurosurgery|neurosurgery
134170|NCT02731443|temporal lobectomy|temporal lobectomy
134171|NCT02731378|erythropoietin|erythropoietin
134172|NCT02731378|iron supplementation|iron supplementation
134173|NCT02731378|inadequately responsive|inadequately responsive
134174|NCT02731378|chemotherapy-induced anaemia|chemotherapy-induced anaemia
134175|NCT02731365|Parkinson's Disease|parkinson's disease
134176|NCT02731300|Transcranial direct current stimulation|transcranial direct current stimulation
134177|NCT02731300|Cathodal stimulation|cathodal stimulation
134178|NCT02731300|Childhood Pharmacoresistant epilepsy|childhood pharmacoresistant epilepsy
134179|NCT02731300|Lennox-Gastaut syndrome|lennox-gastaut syndrome
134180|NCT02731235|Stroke|stroke
134181|NCT02731235|stroke, acute|stroke, acute
134182|NCT02731235|Cerebral small vessel disease|cerebral small vessel disease
134183|NCT02731222|CEAP classification|ceap classification
134184|NCT02731222|CVD: Chronic Venous Disease|cvd: chronic venous disease
134185|NCT02731222|Onychodystrophy|onychodystrophy
134186|NCT02731222|Body Mass Index|body mass index
134187|NCT02731196|exercise|exercise
134188|NCT02731196|lumbar microdiscectomy|lumbar microdiscectomy
134189|NCT02731183|Fecal Microbiota Transplantation|fecal microbiota transplantation
134190|NCT02731183|Chronic intestinal pseudo obstruction|chronic intestinal pseudo obstruction
134191|NCT02731183|Efficacy and safety|efficacy and safety
134192|NCT02731170|Parkinson Disease|parkinson disease
134193|NCT02731170|Advanced Stages|advanced stages
134194|NCT02731170|Rehabilitation|rehabilitation
134195|NCT02731144|Loss of Physical Function|loss of physical function
134196|NCT02731118|glaucoma|glaucoma
134197|NCT02731118|intraocular pressure lowering treatment|intraocular pressure lowering treatment
134198|NCT02731118|antisectory factor (AF)|antisectory factor (af)
134199|NCT02731118|Salovum|salovum
134200|NCT02731105|acne|acne
134201|NCT02731105|vulgaris|vulgaris
134202|NCT02731105|Clindamycin|clindamycin
134203|NCT02731105|Tretinoin|tretinoin
134204|NCT02731105|Adapalen|adapalen
134205|NCT02731105|Benzoylperoxid|benzoylperoxid
134206|NCT02731105|Epiduo|epiduo
134207|NCT02731105|Acnatac|acnatac
134208|NCT02731092|lactoferrin|lactoferrin
134209|NCT02731092|very low birth weight infants|very low birth weight infants
134210|NCT02731092|preterm infants|preterm infants
134211|NCT02731079|Sleeve gastrectomy stapler Covidien Ethicon bleeding leak|sleeve gastrectomy stapler covidien ethicon bleeding leak
134212|NCT02731053|Depression|depression
134213|NCT02731053|Prevention|prevention
134214|NCT02731053|Adolescents|adolescents
134215|NCT02731053|School|school
134216|NCT02731053|Effectiveness|effectiveness
134217|NCT02731014|Dry Needling|dry needling
134218|NCT02730975|pharmacokinetics|pharmacokinetics
134219|NCT02730975|food-effect|food-effect
134220|NCT02730975|fat diet|fat diet
134221|NCT02730975|abiraterone acetate|abiraterone acetate
134222|NCT02730949|D-Chiro-Inositol, type 1 diabetes|d-chiro-inositol, type 1 diabetes
134223|NCT02730923|Clinical Trials, Randomized|clinical trials, randomized
134224|NCT02730923|Clinical Trial, Phase I|clinical trial, phase i
134225|NCT02730923|Clinical Trial, Phase II|clinical trial, phase ii
134226|NCT02730923|Multicenter Trials|multicenter trials
134227|NCT02730923|Aromatase Inhibitors|aromatase inhibitors
134228|NCT02730923|mTOR kinase inhibitor|mtor kinase inhibitor
134229|NCT02730910|Bioavailability|bioavailability
134230|NCT02730910|adults|adults
134231|NCT02730897|Surgery|surgery
134232|NCT02730897|Thoracotomy|thoracotomy
134233|NCT02730897|VATS|vats
134234|NCT02730884|Leukemia|leukemia
134235|NCT02730884|Myelofibrosis|myelofibrosis
134236|NCT02730884|MF|mf
134237|NCT02730884|Anemia|anemia
134238|NCT02730884|Splenomegaly|splenomegaly
134239|NCT02730884|Post-polycythemia vera MF|post-polycythemia vera mf
134240|NCT02730884|post-PV|post-pv
134241|NCT02730884|post-essential thrombocythemia MF|post-essential thrombocythemia mf
134242|NCT02730884|post-ET|post-et
134243|NCT02730884|Rigosertib|rigosertib
134244|NCT02730884|ON 01910.Na|on 01910.na
134245|NCT02730884|Questionnaire|questionnaire
134246|NCT02730884|Survey|survey
134247|NCT02730858|Metastatic Breast Cancer|metastatic breast cancer
134248|NCT02730858|Palliative Care|palliative care
134249|NCT02730858|Breast Cancer|breast cancer
134250|NCT02730858|End of life|end of life
134251|NCT02730858|Health service research|health service research
134252|NCT02730845|Elective|elective
134253|NCT02730845|local anesthesia|local anesthesia
134254|NCT02730845|knee arthroscopy|knee arthroscopy
134255|NCT02730845|Dexmedetomidine|dexmedetomidine
134256|NCT02730793|Cystic Fibrosis|cystic fibrosis
134257|NCT02730793|P. aeruginosa (PA)|p. aeruginosa (pa)
134258|NCT02730754|Mood Disorders|mood disorders
134259|NCT02730754|Illness Perception|illness perception
134260|NCT02730754|Primary Care|primary care
134261|NCT02730754|Medication Adherence|medication adherence
134262|NCT02730741|diarrhoea|diarrhoea
134263|NCT02730741|metfomin|metfomin
134264|NCT02730741|type 2 diabetes|type 2 diabetes
134265|NCT02730741|microbiota|microbiota
134266|NCT02730728|adductor canal block|adductor canal block
134267|NCT02730728|tinetti score|tinetti score
134268|NCT02730728|time to up and go test|time to up and go test
134269|NCT02730728|Ambulation distance|ambulation distance
134270|NCT02730728|pain score|pain score
134271|NCT02730728|quality of recovery score|quality of recovery score
134272|NCT02730689|DP-R207|dp-r207
134273|NCT02730689|Rosuvastatin|rosuvastatin
134274|NCT02730689|Ezetimibe|ezetimibe
134275|NCT02730676|electronic cigarettes|electronic cigarettes
134276|NCT02730676|e-cigarette|e-cigarette
134277|NCT02730676|combustible cigarette|combustible cigarette
134278|NCT02730676|cigarette|cigarette
134279|NCT02730676|menthol|menthol
134280|NCT02730676|cig-alike|cig-alike
134281|NCT02730676|subjective measures|subjective measures
134282|NCT02730676|pharmacokinetics|pharmacokinetics
134283|NCT02730676|craving|craving
134284|NCT02730663|Endoscopic ultrasound guided transluminal drainage|endoscopic ultrasound guided transluminal drainage
134285|NCT02730650|FACE-Q|face-q
134286|NCT02730650|Platelet Rich Therapy|platelet rich therapy
134287|NCT02730650|PRT|prt
134288|NCT02730624|piperacillin/tazobactam|piperacillin/tazobactam
134289|NCT02730624|critically ill|critically ill
134290|NCT02730624|severe sepsis|severe sepsis
134291|NCT02730624|septic shock|septic shock
134292|NCT02730611|Vertical sleeve gastrectomy|vertical sleeve gastrectomy
134293|NCT02730611|Metabolic syndrome|metabolic syndrome
134294|NCT02730611|Disorder of Bile Acid and Cholesterol Metabolism|disorder of bile acid and cholesterol metabolism
134295|NCT02730611|Cholangiocarcinoma|cholangiocarcinoma
134296|NCT02730611|Hepatocellular carcinoma|hepatocellular carcinoma
134297|NCT02730585|C-reactive protein|c-reactive protein
134298|NCT02730572|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
134299|NCT02730572|Methylphenidate|methylphenidate
134300|NCT02730559|Motivational Interviewing|motivational interviewing
134301|NCT02730533|endoscopic submucosal dissection|endoscopic submucosal dissection
134302|NCT02730533|proton pump inhibitor|proton pump inhibitor
134303|NCT02730533|bleeding|bleeding
134304|NCT02730520|respiratory disease|respiratory disease
134305|NCT02730520|allergen sensitization|allergen sensitization
134306|NCT02730520|aging|aging
134307|NCT02730520|skin tests|skin tests
134308|NCT02730520|air allergens|air allergens
134309|NCT02730494|mycosis|mycosis
134310|NCT02730494|Candidiasis|candidiasis
134311|NCT02730494|Lcr35®|lcr35®
134312|NCT02730494|Lcr Regenerans®|lcr regenerans®
134313|NCT02730455|Stroke|stroke
134314|NCT02730351|Fluticasone furoate|fluticasone furoate
134315|NCT02730351|activity monitoring|activity monitoring
134316|NCT02730351|Vilanterol|vilanterol
134317|NCT02730351|Cross-over|cross-over
134318|NCT02730351|exercise-induced bronchoconstriction|exercise-induced bronchoconstriction
134319|NCT02730351|exercise challenge|exercise challenge
134320|NCT02730351|double-dummy|double-dummy
134321|NCT02730351|asthma|asthma
134322|NCT02730351|spirometry|spirometry
134323|NCT02730351|fluticasone propionate|fluticasone propionate
134324|NCT02730338|Castrate-Resistant|castrate-resistant
134325|NCT02730325|CDI|cdi
134326|NCT02730325|C. diff|c. diff
134327|NCT02730325|Ulcerative Colitis|ulcerative colitis
134328|NCT02730325|UC|uc
134329|NCT02730325|IBD|ibd
134330|NCT02730325|Inflammatory Bowel Disease|inflammatory bowel disease
134331|NCT02730312|AML|aml
134332|NCT02730312|B-ALL|b-all
134333|NCT02730312|BPDCN|bpdcn
134334|NCT02730312|CML|cml
134335|NCT02730312|Blast Crisis|blast crisis
134336|NCT02730286|human activity|human activity
134337|NCT02730286|International Classification of Functioning|international classification of functioning
134338|NCT02730260|Directive coaching|directive coaching
134339|NCT02730260|Nondirective coaching|nondirective coaching
134340|NCT02730260|smoking cessation quitline|smoking cessation quitline
134341|NCT02730260|social support|social support
134342|NCT02730247|ramucirumab|ramucirumab
134343|NCT02730247|docetaxel|docetaxel
134344|NCT02730221|Administrative workload|administrative workload
134345|NCT02730221|Patient data management system|patient data management system
134346|NCT02730221|Intensive Care Unit|intensive care unit
134347|NCT02730221|Work sampling method|work sampling method
134348|NCT02730221|Nursing Activity Score|nursing activity score
134349|NCT02730182|postural control|postural control
134350|NCT02730182|high altitude|high altitude
134351|NCT02730169|Hypogonadotropic|hypogonadotropic
134352|NCT02730169|hypogonadism|hypogonadism
134353|NCT02730169|testosterone|testosterone
134354|NCT02730143|Altitude|altitude
134355|NCT02730143|Nocturnal breathing pattern|nocturnal breathing pattern
134356|NCT02730130|Pembrolizumab|pembrolizumab
134357|NCT02730130|Radiotherapy|radiotherapy
134358|NCT02730130|16-032|16-032
134359|NCT02730117|Acute kidney injury|acute kidney injury
134360|NCT02730117|Furosemide stress test|furosemide stress test
134361|NCT02730117|critical care|critical care
134362|NCT02730078|Mood Disorders|mood disorders
134363|NCT02730078|Self Care|self care
134364|NCT02730078|Primary Care|primary care
134365|NCT02730065|Cerebral small vessel disease|cerebral small vessel disease
134366|NCT02730065|Lifestyle modification|lifestyle modification
134367|NCT02730065|Physical activity|physical activity
134368|NCT02730065|Primary prevention|primary prevention
134369|NCT02730065|Aerobic dance|aerobic dance
134370|NCT02730065|Cognition|cognition
134371|NCT02730065|Depression|depression
134372|NCT02730065|Activities of daily living|activities of daily living
134373|NCT02730065|Cerebral autoregulation|cerebral autoregulation
134374|NCT02730052|Blood pressure control|blood pressure control
134375|NCT02730052|Hypertension|hypertension
134376|NCT02730052|Office blood pressure|office blood pressure
134377|NCT02730052|Self-measured blood pressure,|self-measured blood pressure,
134378|NCT02730052|Telemonitoring|telemonitoring
134379|NCT02730039|Cancer Care Providers|cancer care providers
134380|NCT02730039|Psychotherapy|psychotherapy
134381|NCT02730039|15-321|15-321
134382|NCT02730026|Ketofrofen|ketofrofen
134383|NCT02730026|Omeprazole|omeprazole
134384|NCT02730026|Lower Third Molar|lower third molar
134385|NCT02730026|Oral Surgery|oral surgery
134386|NCT02730013|Older adults|older adults
134387|NCT02730013|Square stepping exercise|square stepping exercise
134388|NCT02730013|Mind-motor exercise|mind-motor exercise
134389|NCT02730013|Long-term care|long-term care
134390|NCT02730013|Global cognitive functioning|global cognitive functioning
134391|NCT02730000|Dental Atraumatic Restorative Treatment|dental atraumatic restorative treatment
134392|NCT02730000|Primary Teeth|primary teeth
134393|NCT02730000|Clinical Efficacy|clinical efficacy
134394|NCT02730000|Cost Analysis|cost analysis
134395|NCT02730000|Glass Ionomer Cement|glass ionomer cement
134396|NCT02729987|online|online
134397|NCT02729987|internet|internet
134398|NCT02729987|CBT|cbt
134399|NCT02729987|Stress|stress
134400|NCT02729987|Work|work
134401|NCT02729987|Internet based treatment|internet based treatment
134402|NCT02729974|thromboelastography|thromboelastography
134403|NCT02729935|Parecoxib|parecoxib
134404|NCT02729935|Bladder Discomfort|bladder discomfort
134405|NCT02729909|Drug therapy|drug therapy
134406|NCT02729870|Ketones|ketones
134407|NCT02729870|Gastroenteritis|gastroenteritis
134408|NCT02729844|Incidence|incidence
134409|NCT02729844|Risk factors|risk factors
134410|NCT02729844|Outcome|outcome
134411|NCT02729831|decision making|decision making
134412|NCT02729831|decision aids|decision aids
134413|NCT02729831|decision quality instruments|decision quality instruments
134414|NCT02729831|osteoarthritis|osteoarthritis
134415|NCT02729831|shared decision making|shared decision making
134416|NCT02729818|Retina|retina
134417|NCT02729818|Microperimetry|microperimetry
134418|NCT02729818|Visual Fields|visual fields
134419|NCT02729805|ketamine|ketamine
134420|NCT02729805|chronic pain|chronic pain
134421|NCT02729805|mastectomy|mastectomy
134422|NCT02729805|acute pain|acute pain
134423|NCT02729792|depression|depression
134424|NCT02729792|treatment resistance|treatment resistance
134425|NCT02729792|biomarkers|biomarkers
134426|NCT02729792|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
134427|NCT02729766|Hyponatremia|hyponatremia
134428|NCT02729766|SGLT2 inhibitor|sglt2 inhibitor
134429|NCT02729740|Penumbra Smart coils|penumbra smart coils
134430|NCT02729740|PC 400|pc 400
134431|NCT02729740|AV malformations|av malformations
134432|NCT02729740|AV fistulae|av fistulae
134433|NCT02729688|Venous insufficiency|venous insufficiency
134434|NCT02729688|Compression|compression
134435|NCT02729688|Bandaging|bandaging
134436|NCT02729675|fruit & vegetable, market, education, worksite, food access|fruit & vegetable, market, education, worksite, food access
134437|NCT02729597|neuromuscular disorders|neuromuscular disorders
134438|NCT02729597|MRI|mri
134439|NCT02729597|white matter|white matter
134440|NCT02729597|brain|brain
134441|NCT02729597|myotonic dystrophy|myotonic dystrophy
134442|NCT02729558|brain metastases|brain metastases
134443|NCT02729558|radiotherapy|radiotherapy
134444|NCT02729558|resection|resection
134445|NCT02729545|acupuncture, POCS|acupuncture, pocs
134446|NCT02729532|Extra-pulmonary tuberculosis|extra-pulmonary tuberculosis
134447|NCT02729532|multiple drug resistant tuberculosis|multiple drug resistant tuberculosis
134448|NCT02729532|mycobacterium tuberculosis|mycobacterium tuberculosis
134449|NCT02729532|human immunodeficiency virus|human immunodeficiency virus
134450|NCT02729506|hepatocellular carcinoma|hepatocellular carcinoma
134451|NCT02729506|transarterial radioembolization|transarterial radioembolization
134452|NCT02729506|chemoembolization chemoembolization|chemoembolization chemoembolization
134453|NCT02729506|clinical trial|clinical trial
134454|NCT02729493|Liver Cancer CAR-T|liver cancer car-t
134455|NCT02729467|Healthy|healthy
134456|NCT02729467|JNJ-53718678|jnj-53718678
134457|NCT02729467|Itraconazole|itraconazole
134458|NCT02729467|Rifampicin|rifampicin
134459|NCT02729467|Pharmacokinetics|pharmacokinetics
134460|NCT02729428|Aging|aging
134461|NCT02729428|White Matter Hyperintensity Volume|white matter hyperintensity volume
134462|NCT02729428|Default Mode Network Connectivity|default mode network connectivity
134463|NCT02729428|Cognitive Function|cognitive function
134464|NCT02729428|Cardiorespiratory Fitness|cardiorespiratory fitness
134465|NCT02729428|Magnetic Resonance Imaging|magnetic resonance imaging
134466|NCT02729415|Hair Diseases|hair diseases
134467|NCT02729415|Alopecia|alopecia
134468|NCT02729402|Adults|adults
134469|NCT02729389|Social Status|social status
134470|NCT02729389|Hispanics|hispanics
134471|NCT02729389|Energy Balance|energy balance
134472|NCT02729389|Stress|stress
134473|NCT02729376|Healthy Volunteers|healthy volunteers
134474|NCT02729337|technology|technology
134475|NCT02729337|adolescent|adolescent
134476|NCT02729337|developing country|developing country
134477|NCT02729337|hiv prevention|hiv prevention
134478|NCT02729337|mHealth|mhealth
134479|NCT02729324|nasopharyngeal carcinoma (NPC)|nasopharyngeal carcinoma (npc)
134480|NCT02729324|radiation dermatitis|radiation dermatitis
134481|NCT02729324|intensity modulated radiation therapy (IMRT)|intensity modulated radiation therapy (imrt)
134482|NCT02729311|exercise|exercise
134483|NCT02729311|function|function
134484|NCT02729311|quality of life|quality of life
134485|NCT02729311|caregiver|caregiver
134486|NCT02729298|Tolero|tolero
134487|NCT02729298|Phase 1a / 1b|phase 1a / 1b
134488|NCT02729298|First in human|first in human
134489|NCT02729298|Solid Tumors with immunotherapy progression|solid tumors with immunotherapy progression
134490|NCT02729298|AXL inhibitor|axl inhibitor
134491|NCT02729298|Advanced Malignancy|advanced malignancy
134492|NCT02729298|Cancer|cancer
134493|NCT02729298|EGFR+ NSCLC with progression on ≤2 lines of oral TKIs|egfr+ nsclc with progression on ≤2 lines of oral tkis
134494|NCT02729298|BRAF-Mutated CRC|braf-mutated crc
134495|NCT02729298|KRAS-Mutated CRC|kras-mutated crc
134496|NCT02729298|NRAS-Mutated CRC|nras-mutated crc
134497|NCT02729298|Persistent/Recurrent Ovarian Cancer|persistent/recurrent ovarian cancer
134498|NCT02729298|BRAF-Mutated Melanoma with immunotherapy progression|braf-mutated melanoma with immunotherapy progression
134499|NCT02729259|VRD|vrd
134500|NCT02729233|mucosal barrier function|mucosal barrier function
134501|NCT02729220|Aging|aging
134502|NCT02729220|Oxidative stress|oxidative stress
134503|NCT02729220|Proteases|proteases
134504|NCT02729220|Bronchoscopy|bronchoscopy
134505|NCT02729207|NSAID Patch|nsaid patch
134506|NCT02729168|Rabies|rabies
134507|NCT02729168|Vaccine|vaccine
134508|NCT02729168|Safety|safety
134509|NCT02729168|INDIRAB|indirab
134510|NCT02729168|Vietnam|vietnam
134511|NCT02729155|Ischemic Preconditioning|ischemic preconditioning
134512|NCT02729155|Postconditioning|postconditioning
134513|NCT02729155|Angioplasty|angioplasty
134514|NCT02729155|Angiography|angiography
134515|NCT02729155|Contrast-Induced Nephropathy|contrast-induced nephropathy
134516|NCT02729142|HRpQCT|hrpqct
134517|NCT02729142|transplant|transplant
134518|NCT02729142|bone microarchitecture|bone microarchitecture
134519|NCT02729129|Diesel exhaust|diesel exhaust
134520|NCT02729129|Air pollution|air pollution
134521|NCT02729129|Intervention|intervention
134522|NCT02729129|Plethysmography|plethysmography
134523|NCT02729116|Extended-Spectrum ß-lactamase-producing Escherichia coli|extended-spectrum ß-lactamase-producing escherichia coli
134524|NCT02729116|Extended-Spectrum ß-lactamase-producing Klebsiella pneumoniae|extended-spectrum ß-lactamase-producing klebsiella pneumoniae
134525|NCT02729116|Kidney Transplantation|kidney transplantation
134526|NCT02729116|Urinary Tract Infections|urinary tract infections
134527|NCT02729090|Peripheral Arterial Disease, exercise|peripheral arterial disease, exercise
134528|NCT02729064|Intranasal Insulin|intranasal insulin
134529|NCT02729064|Insulin concentration|insulin concentration
134530|NCT02729064|Blood glucose|blood glucose
134531|NCT02729064|Cerebro Spinal Fluid insulin|cerebro spinal fluid insulin
134532|NCT02729064|Intraoperative blood glucose|intraoperative blood glucose
134533|NCT02729064|Cardiac Surgery|cardiac surgery
134534|NCT02729064|Thoracic Surgery|thoracic surgery
134535|NCT02729051|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
134536|NCT02729051|fluticasone furoate/umeclidinium bromide/vilanterol (FF/UMEC/VI)|fluticasone furoate/umeclidinium bromide/vilanterol (ff/umec/vi)
134537|NCT02729051|Umeclidinium bromide (UMEC)|umeclidinium bromide (umec)
134538|NCT02729051|Closed triple therapy|closed triple therapy
134539|NCT02729051|Placebo|placebo
134540|NCT02729051|Open triple therapy|open triple therapy
134541|NCT02729051|fluticasone furoate/vilanterol (FF/VI)|fluticasone furoate/vilanterol (ff/vi)
134542|NCT02729038|Normal Renal Function|normal renal function
134543|NCT02729038|end stage renal disease (ESRD)|end stage renal disease (esrd)
134544|NCT02729038|Pharmacokinetics|pharmacokinetics
134545|NCT02729038|Gepotidacin|gepotidacin
134546|NCT02729038|Renal Impairment|renal impairment
134547|NCT02729025|Hyperlipidemia|hyperlipidemia
134548|NCT02729025|Dyslipidemia|dyslipidemia
134549|NCT02729025|Proprotein convertase subtilisin/kexin type 9 (PCSK9) Inhibition|proprotein convertase subtilisin/kexin type 9 (pcsk9) inhibition
134550|NCT02729025|Arterial Wall Inflamation|arterial wall inflamation
134551|NCT02729025|Elevated lipoprotein a|elevated lipoprotein a
134552|NCT02729012|Children|children
134553|NCT02728999|Trendelenburg position|trendelenburg position
134554|NCT02728999|Robotic assisted gynecologic procedures|robotic assisted gynecologic procedures
134555|NCT02728999|benign gynecologic conditions|benign gynecologic conditions
134556|NCT02728986|Costs and Cost Analysis|costs and cost analysis
134557|NCT02728986|Humans|humans
134558|NCT02728986|Health Care Costs|health care costs
134559|NCT02728986|varicose ulcer|varicose ulcer
134560|NCT02728986|Compression Bandages|compression bandages
134561|NCT02728973|colorectal resection|colorectal resection
134562|NCT02728973|enhanced recovery after surgery|enhanced recovery after surgery
134563|NCT02728973|Postoperative Complications|postoperative complications
134564|NCT02728973|length of hospital stay|length of hospital stay
134565|NCT02728947|Parkinson's Disease|parkinson's disease
134566|NCT02728934|Rheumatoid Arthritis|rheumatoid arthritis
134567|NCT02728934|Golimumab|golimumab
134568|NCT02728934|Infliximab|infliximab
134569|NCT02728895|Drug Therapy|drug therapy
134570|NCT02728882|Lymphoma CAR-T|lymphoma car-t
134571|NCT02728843|Parkinson's disease|parkinson's disease
134572|NCT02728843|Deferiprone|deferiprone
134573|NCT02728830|gynecologic cancers|gynecologic cancers
134574|NCT02728830|mullerian cancers|mullerian cancers
134575|NCT02728830|tumoral immunoprofile|tumoral immunoprofile
134576|NCT02728817|Vascular access|vascular access
134577|NCT02728817|Hemodialysis|hemodialysis
134578|NCT02728817|Arteriovenous fistula|arteriovenous fistula
134579|NCT02728817|Stenosis|stenosis
134580|NCT02728817|Failure|failure
134581|NCT02728752|DM|dm
134582|NCT02728726|Postoperative respiratory depression|postoperative respiratory depression
134583|NCT02728726|Neuromuscular Agents|neuromuscular agents
134584|NCT02728713|Cranial manipulation|cranial manipulation
134585|NCT02728713|Visual function|visual function
134586|NCT02728687|peripheral neuropathy|peripheral neuropathy
134587|NCT02728687|Diabetes|diabetes
134588|NCT02728687|Pain|pain
134589|NCT02728674|COPD|copd
134590|NCT02728674|Breathlessness|breathlessness
134591|NCT02728674|Symptom|symptom
134592|NCT02728674|Opioids|opioids
134593|NCT02728674|Gender bias|gender bias
134594|NCT02728648|Pain Management|pain management
134595|NCT02728648|Pharmacokinetics|pharmacokinetics
134596|NCT02728648|Pharmacodynamics|pharmacodynamics
134597|NCT02728635|Adipose tissue, epigenetic, abdominal gluteal fat|adipose tissue, epigenetic, abdominal gluteal fat
134598|NCT02728622|ovarian cancer|ovarian cancer
134599|NCT02728622|platinum-resistant|platinum-resistant
134600|NCT02728622|endocrine treatment|endocrine treatment
134601|NCT02728622|chemotherapy|chemotherapy
134602|NCT02728622|tamoxifen|tamoxifen
134603|NCT02728583|Plant sterols|plant sterols
134604|NCT02728583|Fish oil|fish oil
134605|NCT02728583|Blood lipids|blood lipids
134606|NCT02728570|flavonoids|flavonoids
134607|NCT02728570|insulin resistance|insulin resistance
134608|NCT02728570|plasma lipids|plasma lipids
134609|NCT02728570|intestinal microbiome|intestinal microbiome
134610|NCT02728570|intestinal inflammation|intestinal inflammation
134611|NCT02728570|subclinical inflammation|subclinical inflammation
134612|NCT02728557|Therapeutic alliance|therapeutic alliance
134613|NCT02728557|Psychotherapy|psychotherapy
134614|NCT02728557|Psychodynamic psychotherapy|psychodynamic psychotherapy
134615|NCT02728557|supportive-expressive treatment|supportive-expressive treatment
134616|NCT02728557|Process research|process research
134617|NCT02728557|Attachment theory|attachment theory
134618|NCT02728557|Attachment orientation|attachment orientation
134619|NCT02728557|Mechanism of change in psychotherapy|mechanism of change in psychotherapy
134620|NCT02728466|flavanols|flavanols
134621|NCT02728466|cocoa procyanidins|cocoa procyanidins
134622|NCT02728466|vascular function|vascular function
134623|NCT02728466|endothelial function|endothelial function
134624|NCT02728427|Suprapubic Catheterization|suprapubic catheterization
134625|NCT02728427|Transurethral Catheterization|transurethral catheterization
134626|NCT02728427|Rectal Cancer|rectal cancer
134627|NCT02728427|Laparoscopic Surgery|laparoscopic surgery
134628|NCT02728414|Diabetes Mellitus, Type 2, Probiotics, Treatment|diabetes mellitus, type 2, probiotics, treatment
134629|NCT02728401|inflammation|inflammation
134630|NCT02728401|sepsis|sepsis
134631|NCT02728401|pediatric|pediatric
134632|NCT02728401|transcripts|transcripts
134633|NCT02728401|serum proteins|serum proteins
134634|NCT02728401|cardiopulmonary bypass|cardiopulmonary bypass
134635|NCT02728388|NF1|nf1
134636|NCT02728388|Neurofibroma|neurofibroma
134637|NCT02728388|Neurofibromatosis Type 1|neurofibromatosis type 1
134638|NCT02728362|tibial shaft fractures|tibial shaft fractures
134639|NCT02728284|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
134640|NCT02728219|Recurrent Hepatocellular Carcinoma|recurrent hepatocellular carcinoma
134641|NCT02728219|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
134642|NCT02728219|AFP conversion|afp conversion
134643|NCT02728193|treatments|treatments
134644|NCT02728193|hepatocellular carcinoma|hepatocellular carcinoma
134645|NCT02728180|Acute Ischemic Stroke|acute ischemic stroke
134646|NCT02728180|Xingnaojing injection|xingnaojing injection
134647|NCT02728180|Randomized Controlled Trial|randomized controlled trial
134648|NCT02728180|Traditional Chinese Medicine|traditional chinese medicine
134649|NCT02728167|Hepatectomy|hepatectomy
134650|NCT02728167|Liver metastasis|liver metastasis
134651|NCT02728167|High-Intensity Focused Ultrasound|high-intensity focused ultrasound
134652|NCT02728167|Liver metastases (LM) requiring surgery|liver metastases (lm) requiring surgery
134653|NCT02728154|pre-clinical diastolic dysfunction (pre-HFpEF)|pre-clinical diastolic dysfunction (pre-hfpef)
134654|NCT02728128|Milrinone|milrinone
134655|NCT02728115|Huntington's Disease|huntington's disease
134656|NCT02728115|Stem Cell|stem cell
134657|NCT02728115|Dental Pulp Stem Cells|dental pulp stem cells
134658|NCT02728102|Multiple Myeloma|multiple myeloma
134659|NCT02728102|Lenalidomide|lenalidomide
134660|NCT02728102|Maintenance Therapy|maintenance therapy
134661|NCT02728102|Hematologic Disorders|hematologic disorders
134662|NCT02728102|Vaccine|vaccine
134663|NCT02728102|GM-CSF|gm-csf
134664|NCT02728102|Transplant|transplant
134665|NCT02728102|Anti-Myeloma Agents|anti-myeloma agents
134666|NCT02728076|Breast Cancer|breast cancer
134667|NCT02728076|Accelerated Partial Breast Irradiation|accelerated partial breast irradiation
134668|NCT02728037|Myofascial Trigger Points|myofascial trigger points
134669|NCT02728037|Myofascial Pain|myofascial pain
134670|NCT02728037|Intramuscular Anesthetic Injection|intramuscular anesthetic injection
134671|NCT02727998|PTSD|ptsd
134672|NCT02727972|depression|depression
134673|NCT02727972|bipolar|bipolar
134674|NCT02727972|post-traumatic stress disorder|post-traumatic stress disorder
134675|NCT02727972|mood disorders|mood disorders
134676|NCT02727972|PET|pet
134677|NCT02727972|mGluRr|mglurr
134678|NCT02727972|glutamate system|glutamate system
134679|NCT02727972|MRI|mri
134680|NCT02727959|UC|uc
134681|NCT02727959|CD|cd
134682|NCT02727959|IBD|ibd
134683|NCT02727894|Screening|screening
134684|NCT02727894|pTNM|ptnm
134685|NCT02727894|Metastasis|metastasis
134686|NCT02727894|Chemotherapy|chemotherapy
134687|NCT02727894|Resection Margins|resection margins
134688|NCT02727881|AMD, CNV, choroidal neovascularization, retinal eye disease|amd, cnv, choroidal neovascularization, retinal eye disease
134689|NCT02727855|Cholera|cholera
134690|NCT02727855|Vaccine|vaccine
134691|NCT02727855|Strategy|strategy
134692|NCT02727842|cochlear implant|cochlear implant
134693|NCT02727842|Sound Processor|sound processor
134694|NCT02727803|Acute Myelogenous Leukemia|acute myelogenous leukemia
134695|NCT02727803|AML|aml
134696|NCT02727803|Myelodysplastic syndrome|myelodysplastic syndrome
134697|NCT02727803|MDS|mds
134698|NCT02727803|Multiple myeloma|multiple myeloma
134699|NCT02727803|MM|mm
134700|NCT02727803|Umbilical cord blood transplant|umbilical cord blood transplant
134701|NCT02727803|UCB|ucb
134702|NCT02727803|Natural killer cells|natural killer cells
134703|NCT02727803|NK|nk
134704|NCT02727803|Busulfan|busulfan
134705|NCT02727803|Busulfex|busulfex
134706|NCT02727803|Myleran|myleran
134707|NCT02727803|Fludarabine|fludarabine
134708|NCT02727803|Fludarabine Phosphate|fludarabine phosphate
134709|NCT02727803|Fludara|fludara
134710|NCT02727803|Clofarabine|clofarabine
134711|NCT02727803|Clofarex|clofarex
134712|NCT02727803|Clolar|clolar
134713|NCT02727803|Rabbit ATB|rabbit atb
134714|NCT02727803|ATG (Rabbit)|atg (rabbit)
134715|NCT02727803|Rabbit Antithymocyte Globulin|rabbit antithymocyte globulin
134716|NCT02727803|Rabbit Antilymphocyte Globulin|rabbit antilymphocyte globulin
134717|NCT02727803|rATG Thymoglobulin|ratg thymoglobulin
134718|NCT02727803|Total Body Irradiation|total body irradiation
134719|NCT02727803|TBI|tbi
134720|NCT02727803|Radiation therapy|radiation therapy
134721|NCT02727803|XRT|xrt
134722|NCT02727803|Rituximab|rituximab
134723|NCT02727803|Rituxan|rituxan
134724|NCT02727803|Cyclophosphamide|cyclophosphamide
134725|NCT02727803|Cytoxan|cytoxan
134726|NCT02727803|Neosar|neosar
134727|NCT02727803|Melphalan|melphalan
134728|NCT02727803|Alkeran|alkeran
134729|NCT02727777|Lymphoma|lymphoma
134730|NCT02727777|Relapsed Lymphoma|relapsed lymphoma
134731|NCT02727777|MLN0128|mln0128
134732|NCT02727777|Blood sugar|blood sugar
134733|NCT02727777|Glucometer|glucometer
134734|NCT02727777|TK228|tk228
134735|NCT02727764|Arthritis|arthritis
134736|NCT02727764|Gene therapy|gene therapy
134737|NCT02727764|Phase Ib|phase ib
134738|NCT02727764|Intra-articular|intra-articular
134739|NCT02727738|Hyperthyroidism|hyperthyroidism
134740|NCT02727738|Methimazole|methimazole
134741|NCT02727738|Selenium|selenium
134742|NCT02727712|coronary artery bypass graft|coronary artery bypass graft
134743|NCT02727712|thoracic paravertebral block|thoracic paravertebral block
134744|NCT02727699|Mild Dementia|mild dementia
134745|NCT02727699|Actinogen|actinogen
134746|NCT02727699|Alzheimer's Disease|alzheimer's disease
134747|NCT02727699|Xanamem|xanamem
134748|NCT02727699|Cortisol|cortisol
134749|NCT02727699|UE2343|ue2343
134750|NCT02727699|XanADu|xanadu
134751|NCT02727686|transsphenoidal pituitary surgery|transsphenoidal pituitary surgery
134752|NCT02727673|cancer stem cells|cancer stem cells
134753|NCT02727660|COPD|copd
134754|NCT02727647|Moderate hemophilia A|moderate hemophilia a
134755|NCT02727647|Severe hemophilia A|severe hemophilia a
134756|NCT02727647|Intermediate dose prophylaxis|intermediate dose prophylaxis
134757|NCT02727647|Low dose prophylaxis|low dose prophylaxis
134758|NCT02727634|Hemodynamics|hemodynamics
134759|NCT02727634|Echocardiography, Doppler, Pulsed|echocardiography, doppler, pulsed
134760|NCT02727621|Dexmedetomidine|dexmedetomidine
134761|NCT02727621|Cardiac|cardiac
134762|NCT02727621|Coronary Artery Bypass Grapht|coronary artery bypass grapht
134763|NCT02727621|Sedation|sedation
134764|NCT02727621|Propofol|propofol
134765|NCT02727621|Intravenous Anesthetics|intravenous anesthetics
134766|NCT02727582|MDR|mdr
134767|NCT02727556|skin conductance response|skin conductance response
134768|NCT02727556|facial muscle activity|facial muscle activity
134769|NCT02727556|heart rate variability|heart rate variability
134770|NCT02727556|eyetracking|eyetracking
134771|NCT02727543|Hypertension|hypertension
134772|NCT02727543|mHealth|mhealth
134773|NCT02727543|Medication Non-adherence|medication non-adherence
134774|NCT02727530|Infant Colic|infant colic
134775|NCT02727530|Manual Therapy|manual therapy
134776|NCT02727530|Effectiveness|effectiveness
134777|NCT02727517|Resuscitation|resuscitation
134778|NCT02727517|Cord clamping|cord clamping
134779|NCT02727504|Aortic valve stenosis|aortic valve stenosis
134780|NCT02727504|low flow|low flow
134781|NCT02727504|dobutamine stress echocardiography|dobutamine stress echocardiography
134782|NCT02727491|opioid analgesics,|opioid analgesics,
134783|NCT02727491|opioid consumption|opioid consumption
134784|NCT02727491|adverse effects|adverse effects
134785|NCT02727491|postoperative pain|postoperative pain
134786|NCT02727491|tonsillectomy|tonsillectomy
134787|NCT02727478|Balance|balance
134788|NCT02727478|Rehabilitation|rehabilitation
134789|NCT02727478|Exercise|exercise
134790|NCT02727478|basal ganglia|basal ganglia
134791|NCT02727478|Gait|gait
134792|NCT02727478|Training|training
134793|NCT02727478|physical activity|physical activity
134794|NCT02727439|microvascular function|microvascular function
134795|NCT02727439|laser Doppler flowmetry|laser doppler flowmetry
134796|NCT02727439|exercise|exercise
134797|NCT02727426|microvascular function|microvascular function
134798|NCT02727426|laser Doppler flowmetry|laser doppler flowmetry
134799|NCT02727426|high salt diet|high salt diet
134800|NCT02727374|Fear to Fall|fear to fall
134801|NCT02727374|Geriatric|geriatric
134802|NCT02727374|Rehabilitation|rehabilitation
134803|NCT02727374|Psychology|psychology
134804|NCT02727361|Dystonia|dystonia
134805|NCT02727361|Binding potential|binding potential
134806|NCT02727361|FEOBV|feobv
134807|NCT02727348|femoral sciatic block spinal diabetic foot haemodynamic pain|femoral sciatic block spinal diabetic foot haemodynamic pain
134808|NCT02727335|Non-squamous non-small cell lung cancer|non-squamous non-small cell lung cancer
134809|NCT02727335|crizotinib|crizotinib
134810|NCT02727309|Apatinib|apatinib
134811|NCT02727309|Second-line Treatment|second-line treatment
134812|NCT02727309|Hepatocellular Cancer|hepatocellular cancer
134813|NCT02727309|TACE|tace
134814|NCT02727283|Healthy volunteer|healthy volunteer
134815|NCT02727283|Safety|safety
134816|NCT02727283|Pharmacokinetics|pharmacokinetics
134817|NCT02727283|Dose escalation|dose escalation
134818|NCT02727283|GSK3179106|gsk3179106
134819|NCT02727283|Rearranged during Transfection|rearranged during transfection
134820|NCT02727283|Irritable Bowel Syndrome|irritable bowel syndrome
134821|NCT02727283|Adults|adults
134822|NCT02727270|Movement disorders|movement disorders
134823|NCT02727270|Metabolic Stress|metabolic stress
134824|NCT02727257|Parkinson's disease|parkinson's disease
134825|NCT02727257|rehabilitation|rehabilitation
134826|NCT02727257|attention|attention
134827|NCT02727257|executive functions|executive functions
134828|NCT02727244|Pain Catastrophizing Scale|pain catastrophizing scale
134829|NCT02727231|closed loop glucose control|closed loop glucose control
134830|NCT02727231|hypoglycemia|hypoglycemia
134831|NCT02727231|type 1 diabetes|type 1 diabetes
134832|NCT02727231|HbA1C<7.5%|hba1c<7.5%
134833|NCT02727166|intestinal gas|intestinal gas
134834|NCT02727166|functional gut symptoms|functional gut symptoms
134835|NCT02727166|intestinal sensitivity|intestinal sensitivity
134836|NCT02727166|intestinal motility|intestinal motility
134837|NCT02727153|Colonic cancer|colonic cancer
134838|NCT02727153|E.R.A.S. programs|e.r.a.s. programs
134839|NCT02727153|Safety|safety
134840|NCT02727114|skin thickness|skin thickness
134841|NCT02727114|high-frequency ultrasound|high-frequency ultrasound
134842|NCT02727101|Focal epilepsy, Perampanel|focal epilepsy, perampanel
134843|NCT02727088|Dental Pulp Disease|dental pulp disease
134844|NCT02727088|Endodontics|endodontics
134845|NCT02727088|Pulp Capping|pulp capping
134846|NCT02727088|Pulpotomy|pulpotomy
134847|NCT02727088|Pulpectomy|pulpectomy
134848|NCT02727075|Occult Gastrointestinal Bleeding|occult gastrointestinal bleeding
134849|NCT02727075|Iron Deficiency Anemia|iron deficiency anemia
134850|NCT02727075|Aged 75 Years and Older|aged 75 years and older
134851|NCT02727062|pain|pain
134852|NCT02727062|radiation|radiation
134853|NCT02727062|head and neck cancer|head and neck cancer
134854|NCT02727062|smartphone pain app|smartphone pain app
134855|NCT02727062|OM Pain App|om pain app
134856|NCT02727023|Healthy|healthy
134857|NCT02727010|Motor disability|motor disability
134858|NCT02727010|Motor impairment|motor impairment
134859|NCT02727010|Pregnancy|pregnancy
134860|NCT02727010|Parenthood|parenthood
134861|NCT02727010|Child psychology|child psychology
134862|NCT02726997|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
134863|NCT02726997|Ovarian Cancer|ovarian cancer
134864|NCT02726997|Primary Peritoneal Carcinoma|primary peritoneal carcinoma
134865|NCT02726997|Fallopian Tube Cancer|fallopian tube cancer
134866|NCT02726997|High-grade epithelial non-mucinous ovarian cancer|high-grade epithelial non-mucinous ovarian cancer
134867|NCT02726997|Laparoscopy surgery|laparoscopy surgery
134868|NCT02726997|Durvalumab|durvalumab
134869|NCT02726997|MEDI4736|medi4736
134870|NCT02726997|Carboplatin|carboplatin
134871|NCT02726997|Paraplatin|paraplatin
134872|NCT02726997|Paclitaxel|paclitaxel
134873|NCT02726997|Taxol|taxol
134874|NCT02726984|stroke|stroke
134875|NCT02726984|carotid plaque|carotid plaque
134876|NCT02726984|18F-sodium fluoride PET/MR|18f-sodium fluoride pet/mr
134877|NCT02726971|Intrauterine Adhesion|intrauterine adhesion
134878|NCT02726971|Oestrogen Artificial Periodic Therapy|oestrogen artificial periodic therapy
134879|NCT02726958|aortic valve replacement|aortic valve replacement
134880|NCT02726958|percutaneous valve|percutaneous valve
134881|NCT02726958|blood glucose variability|blood glucose variability
134882|NCT02726958|TAVI|tavi
134883|NCT02726932|Peritonitis|peritonitis
134884|NCT02726932|Inflammatory Markers|inflammatory markers
134885|NCT02726932|Patient Outcome Assessment|patient outcome assessment
134886|NCT02726932|Classification|classification
134887|NCT02726932|Multiple Organ Failure|multiple organ failure
134888|NCT02726932|Intraabdominal Infections|intraabdominal infections
134889|NCT02726919|focal epilepsy|focal epilepsy
134890|NCT02726919|clobazam|clobazam
134891|NCT02726906|Alzheimer's disease|alzheimer's disease
134892|NCT02726906|Mild Cognitive Impairment|mild cognitive impairment
134893|NCT02726906|Brain Imaging|brain imaging
134894|NCT02726867|refractory status epilepticus|refractory status epilepticus
134895|NCT02726867|levetiracetam|levetiracetam
134896|NCT02726867|lacosamide|lacosamide
134897|NCT02726867|ketamine|ketamine
134898|NCT02726841|Thoracic aorta|thoracic aorta
134899|NCT02726841|Abdominal aorta|abdominal aorta
134900|NCT02726841|Stents|stents
134901|NCT02726789|nucleic acid polymer REP 2139 HBsAg hepatitis B|nucleic acid polymer rep 2139 hbsag hepatitis b
134902|NCT02726763|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
134903|NCT02726763|Cognitive Training|cognitive training
134904|NCT02726763|16-034|16-034
134905|NCT02726750|Monoclonal gammopathy of unknown significance|monoclonal gammopathy of unknown significance
134906|NCT02726750|MGUS|mgus
134907|NCT02726750|Smoldering multiple myeloma|smoldering multiple myeloma
134908|NCT02726750|SMM|smm
134909|NCT02726750|Asymptomatic monoclonal gammopathies|asymptomatic monoclonal gammopathies
134910|NCT02726750|Biomarker testing|biomarker testing
134911|NCT02726750|Blood collection|blood collection
134912|NCT02726750|Blood draw|blood draw
134913|NCT02726737|inferior alveolar nerve block|inferior alveolar nerve block
134914|NCT02726737|irreversible pulpitis|irreversible pulpitis
134915|NCT02726737|local anesthesia|local anesthesia
134916|NCT02726737|sodium bicarbonate|sodium bicarbonate
134917|NCT02726724|Stress-Resident performance-Observers|stress-resident performance-observers
134918|NCT02726685|respiratory training|respiratory training
134919|NCT02726685|functional performance|functional performance
134920|NCT02726672|inspiratory muscles|inspiratory muscles
134921|NCT02726672|multiple sclerosis|multiple sclerosis
134922|NCT02726672|rehabilitation|rehabilitation
134923|NCT02726646|Local Drug Delivery|local drug delivery
134924|NCT02726646|Antibiotics|antibiotics
134925|NCT02726646|Doxycycline|doxycycline
134926|NCT02726646|Smokers|smokers
134927|NCT02726646|Chronic Periodontitis|chronic periodontitis
134928|NCT02726620|Decision support|decision support
134929|NCT02726620|Decision Support Systems, Clinical|decision support systems, clinical
134930|NCT02726620|Decision Support Techniques|decision support techniques
134931|NCT02726620|Hypotension|hypotension
134932|NCT02726620|Intraoperative Hypotension|intraoperative hypotension
134933|NCT02726620|Acute Kidney Injury|acute kidney injury
134934|NCT02726620|Postoperative Myocardial Injury|postoperative myocardial injury
134935|NCT02726620|Postoperative Mortality|postoperative mortality
134936|NCT02726620|Blood Pressure|blood pressure
134937|NCT02726607|Prevention of mother-to-child transmission (PMTCT)|prevention of mother-to-child transmission (pmtct)
134938|NCT02726607|Kenya|kenya
134939|NCT02726607|HITSystem 2.0|hitsystem 2.0
134940|NCT02726607|retention through PMTCT cascade of care|retention through pmtct cascade of care
134941|NCT02726607|Early Infant Diagnosis|early infant diagnosis
134942|NCT02726607|eHealth system-level intervention|ehealth system-level intervention
134943|NCT02726594|Magnetic Resonance Imaging, Patient Satisfaction|magnetic resonance imaging, patient satisfaction
134944|NCT02726568|EGFR-TKI|egfr-tki
134945|NCT02726568|NSCLC|nsclc
134946|NCT02726568|Icotinib|icotinib
134947|NCT02726555|Red yeast rice|red yeast rice
134948|NCT02726555|Atorvastatin|atorvastatin
134949|NCT02726555|Mild cardiovascular disease|mild cardiovascular disease
134950|NCT02726542|obesity|obesity
134951|NCT02726542|adolescence|adolescence
134952|NCT02726542|fatty liver|fatty liver
134953|NCT02726542|growth hormone|growth hormone
134954|NCT02726516|Performance|performance
134955|NCT02726503|anaplastic thyroid cancer, lenvatinib|anaplastic thyroid cancer, lenvatinib
134956|NCT02726490|gestational diabetes, pregnancy, diabetes|gestational diabetes, pregnancy, diabetes
134957|NCT02726464|Platelet-rich Plasma|platelet-rich plasma
134958|NCT02726464|Cell-Derived Microparticles|cell-derived microparticles
134959|NCT02726464|Pain Management|pain management
134960|NCT02726464|Blood Platelets|blood platelets
134961|NCT02726464|Therapeutics|therapeutics
134962|NCT02726464|Inflammation|inflammation
134963|NCT02726464|ThromboLUX|thrombolux
134964|NCT02726464|Dynamic Light Scattering|dynamic light scattering
134965|NCT02726399|Ramucirumab|ramucirumab
134966|NCT02726399|Trastuzumab|trastuzumab
134967|NCT02726399|Capecitabine|capecitabine
134968|NCT02726399|Cisplatin|cisplatin
134969|NCT02726399|HER2-Positive|her2-positive
134970|NCT02726399|15-301|15-301
134971|NCT02726360|Communication|communication
134972|NCT02726360|15-316|15-316
134973|NCT02726360|Physician|physician
134974|NCT02726360|Use|use
134975|NCT02726360|Non-English|non-english
134976|NCT02726360|Language Skills|language skills
134977|NCT02726334|Metastatic|metastatic
134978|NCT02726308|Dexamethasone|dexamethasone
134979|NCT02726308|Super-hydration|super-hydration
134980|NCT02726308|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
134981|NCT02726308|Nausea|nausea
134982|NCT02726308|Vomiting|vomiting
134983|NCT02726308|Postoperative|postoperative
134984|NCT02726269|Helicobacter Pylory infections|helicobacter pylory infections
134985|NCT02726269|Levofloxacin|levofloxacin
134986|NCT02726269|Antibiotic resistance|antibiotic resistance
134987|NCT02726269|Clarithromycin|clarithromycin
134988|NCT02726269|Mutations|mutations
134989|NCT02726269|Fluorescence|fluorescence
134990|NCT02726269|Hybridization|hybridization
134991|NCT02726256|Diabetes|diabetes
134992|NCT02726256|DM complication|dm complication
134993|NCT02726243|Inflammatory bowel disease|inflammatory bowel disease
134994|NCT02726243|Crohn's Disease|crohn's disease
134995|NCT02726243|Ulcerative Colitis|ulcerative colitis
134996|NCT02726243|colorectal cancer|colorectal cancer
134997|NCT02726243|primary sclerosing cholangitis|primary sclerosing cholangitis
134998|NCT02726217|CareSmarts|caresmarts
134999|NCT02726217|SMS-based mobile|sms-based mobile
135000|NCT02726178|Apnea|apnea
135001|NCT02726178|bradycardia|bradycardia
135002|NCT02726178|immunization|immunization
135003|NCT02726178|inflammation|inflammation
135004|NCT02726178|preterms|preterms
135005|NCT02726152|Diagnostic laparoscopy|diagnostic laparoscopy
135006|NCT02726152|Acute appendicitis|acute appendicitis
135007|NCT02726152|Appendiceal stump|appendiceal stump
135008|NCT02726139|Factor VIII|factor viii
135009|NCT02726139|inhibitor|inhibitor
135010|NCT02726139|assay|assay
135011|NCT02726126|Transdermal fentanyl|transdermal fentanyl
135012|NCT02726126|Transdermal melatonin|transdermal melatonin
135013|NCT02726126|Postoperative pain|postoperative pain
135014|NCT02726126|lumber laminectomy|lumber laminectomy
135015|NCT02726126|Relief|relief
135016|NCT02726113|prostate cancer|prostate cancer
135017|NCT02726113|vitamin D|vitamin d
135018|NCT02726100|Telemedicine|telemedicine
135019|NCT02726100|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
135020|NCT02726100|Decision Support Systems, Clinical|decision support systems, clinical
135021|NCT02726100|Family Health Promoter|family health promoter
135022|NCT02726100|Primary Health Care|primary health care
135023|NCT02726087|Ministernotomy|ministernotomy
135024|NCT02726087|aortic valve stenosis|aortic valve stenosis
135025|NCT02726087|quality of life|quality of life
135026|NCT02726087|satisfaction|satisfaction
135027|NCT02726087|cardiac surgery|cardiac surgery
135028|NCT02726074|epilepsy|epilepsy
135029|NCT02726074|partial-onset seizures|partial-onset seizures
135030|NCT02726074|secondarily generalized seizures|secondarily generalized seizures
135031|NCT02726035|Self-injurious behavior|self-injurious behavior
135032|NCT02726035|Self mutilation|self mutilation
135033|NCT02726035|naltrexone|naltrexone
135034|NCT02725996|Hepatocellular Carcinoma|hepatocellular carcinoma
135035|NCT02725996|Natural Killer cells|natural killer cells
135036|NCT02725983|Gingivitis|gingivitis
135037|NCT02725983|Oral Hygiene|oral hygiene
135038|NCT02725983|Intra oral camera|intra oral camera
135039|NCT02725983|Self regulation|self regulation
135040|NCT02725983|bleeding|bleeding
135041|NCT02725970|HEALTH|health
135042|NCT02725970|barriers|barriers
135043|NCT02725970|facilitators|facilitators
135045|NCT02725970|BMI|bmi
135046|NCT02725970|Public Schools|public schools
135047|NCT02725957|Bioblast|bioblast
135048|NCT02725944|Cryptogenic stroke|cryptogenic stroke
135049|NCT02725944|Occult paroxysmal atrial fibrillation|occult paroxysmal atrial fibrillation
135050|NCT02725931|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
135051|NCT02725931|COPD|copd
135052|NCT02725931|Pulmonary rehabilitation|pulmonary rehabilitation
135053|NCT02725931|Physical activity|physical activity
135054|NCT02725931|Exercise|exercise
135055|NCT02725918|NSCLC|nsclc
135056|NCT02725918|EGFR-TKI failure|egfr-tki failure
135057|NCT02725918|chemotherapy|chemotherapy
135058|NCT02725905|Weight Management Counseling|weight management counseling
135059|NCT02725905|Medical School Education|medical school education
135060|NCT02725892|lung cancer epidemiology algeria registry|lung cancer epidemiology algeria registry
135061|NCT02725866|Observational Study|observational study
135062|NCT02725866|Sustained Virological Response|sustained virological response
135063|NCT02725866|Chronic Hepatitis C genotype 1|chronic hepatitis c genotype 1
135064|NCT02725866|Chronic Hepatitis C|chronic hepatitis c
135065|NCT02725866|Paritaprevir/r - Ombitasvir, ± Dasabuvir,|paritaprevir/r - ombitasvir, ± dasabuvir,
135066|NCT02725866|Chronic Hepatitis C genotype 4|chronic hepatitis c genotype 4
135067|NCT02725853|Transcranial Direct Current Stimulation|transcranial direct current stimulation
135068|NCT02725853|Arm Training|arm training
135069|NCT02725853|Virtual Reality Exposure Therapy|virtual reality exposure therapy
135070|NCT02725840|pulmonary vasculature|pulmonary vasculature
135071|NCT02725840|radiation late effects|radiation late effects
135072|NCT02725840|proton therapy|proton therapy
135073|NCT02725814|Sucrose|sucrose
135074|NCT02725814|Effectiveness|effectiveness
135075|NCT02725814|Healthcare Delivery|healthcare delivery
135076|NCT02725814|Neonates|neonates
135077|NCT02725814|Nursing|nursing
135078|NCT02725775|Orange Juice, Polyphenol, Cognition|orange juice, polyphenol, cognition
135079|NCT02725762|Dry AMD|dry amd
135080|NCT02725762|Vision Loss|vision loss
135081|NCT02725762|AMD|amd
135082|NCT02725749|shoulder|shoulder
135083|NCT02725749|low level laser therapy|low level laser therapy
135084|NCT02725749|exercises|exercises
135085|NCT02725710|uterine aspiration|uterine aspiration
135086|NCT02725658|Neoadjuvant Therapy|neoadjuvant therapy
135087|NCT02725658|Diffuse Optical Spectroscopic Imaging|diffuse optical spectroscopic imaging
135088|NCT02725658|DOSI|dosi
135089|NCT02725658|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
135090|NCT02725645|Surface electromyography|surface electromyography
135091|NCT02725645|children|children
135092|NCT02725645|backpack|backpack
135093|NCT02725632|Sodium channel|sodium channel
135094|NCT02725632|splicing variant|splicing variant
135095|NCT02725632|sleep apnea syndrome|sleep apnea syndrome
135096|NCT02725606|Neutropenia|neutropenia
135097|NCT02725606|Breast Cancer|breast cancer
135098|NCT02725606|GW003|gw003
135099|NCT02725593|Diabetes Mellitus|diabetes mellitus
135100|NCT02725593|Dapagliflozin|dapagliflozin
135101|NCT02725593|Placebo|placebo
135102|NCT02725593|Insulin resistance|insulin resistance
135103|NCT02725593|Metabolic Diseases|metabolic diseases
135104|NCT02725580|Neuronal ceroid lipofuscinosis|neuronal ceroid lipofuscinosis
135105|NCT02725580|NCL|ncl
135106|NCT02725580|Gene Transfer|gene transfer
135107|NCT02725580|Gray Foundation|gray foundation
135108|NCT02725541|HER2 equivocal|her2 equivocal
135109|NCT02725541|Trastuzumab emtansine|trastuzumab emtansine
135110|NCT02725541|Breast cancer|breast cancer
135111|NCT02725502|T1DM|t1dm
135112|NCT02725502|Linagliptin|linagliptin
135113|NCT02725502|mix meal test|mix meal test
135114|NCT02725489|Vigil|vigil
135115|NCT02725489|durvalumab|durvalumab
135116|NCT02725489|MEDI4736|medi4736
135117|NCT02725489|PD-L1|pd-l1
135118|NCT02725489|anti PD-L1|anti pd-l1
135119|NCT02725489|immunotherapy|immunotherapy
135120|NCT02725489|PD-L1 inhibitor|pd-l1 inhibitor
135121|NCT02725489|breast cancer|breast cancer
135122|NCT02725489|ovarian cancer|ovarian cancer
135123|NCT02725489|fallopian tube cancer|fallopian tube cancer
135124|NCT02725489|primary peritoneal cancer|primary peritoneal cancer
135125|NCT02725489|uterine cancer|uterine cancer
135126|NCT02725489|cervical cancer|cervical cancer
135127|NCT02725489|endometrial cancer|endometrial cancer
135128|NCT02725463|vestibular|vestibular
135129|NCT02725463|implant|implant
135130|NCT02725463|prosthesis|prosthesis
135131|NCT02725463|labyrinth|labyrinth
135132|NCT02725463|ototoxicity|ototoxicity
135133|NCT02725463|gentamicin|gentamicin
135134|NCT02725463|oscillopsia|oscillopsia
135135|NCT02725463|disequilibrium|disequilibrium
135136|NCT02725463|dizziness|dizziness
135137|NCT02725463|vestibulopathy|vestibulopathy
135138|NCT02725463|inner ear|inner ear
135139|NCT02725450|Motor Imagery|motor imagery
135140|NCT02725450|Fine motor skills|fine motor skills
135141|NCT02725450|Disabled|disabled
135142|NCT02725411|Chronic low back pain|chronic low back pain
135143|NCT02725411|Chronic pain|chronic pain
135144|NCT02725398|Buscopan|buscopan
135145|NCT02725398|probe-based confocal laser endomicroscopy|probe-based confocal laser endomicroscopy
135146|NCT02725398|Imaging Quality|imaging quality
135147|NCT02725385|No Evidence of Disease|no evidence of disease
135148|NCT02725372|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
135149|NCT02725372|PAH|pah
135150|NCT02725372|Inhaled Nitric Oxide|inhaled nitric oxide
135151|NCT02725372|iNO|ino
135152|NCT02725372|long term oxygen therapy|long term oxygen therapy
135153|NCT02725372|oxygen therapy|oxygen therapy
135154|NCT02725359|Thyroidectomy pain|thyroidectomy pain
135155|NCT02725359|Tizanidine|tizanidine
135156|NCT02725359|Postoperative analgesia|postoperative analgesia
135157|NCT02725359|Ultrasound guided Superficial cervical plexus block|ultrasound guided superficial cervical plexus block
135158|NCT02725346|Surgical Planning Solution|surgical planning solution
135159|NCT02725346|Acromioplasty|acromioplasty
135160|NCT02725346|Shoulder Surgery|shoulder surgery
135161|NCT02725346|Critical Shoulder Angle|critical shoulder angle
135162|NCT02725333|Glenohumeral stabilization|glenohumeral stabilization
135163|NCT02725333|Computer tomography|computer tomography
135164|NCT02725333|Subtle or minor instability|subtle or minor instability
135165|NCT02725333|Unstable painful shoulder|unstable painful shoulder
135166|NCT02725333|Apprehension|apprehension
135167|NCT02725333|Dislocation|dislocation
135168|NCT02725333|Subluxation|subluxation
135169|NCT02725333|Kinematics modeling|kinematics modeling
135170|NCT02725333|Biomechanics|biomechanics
135171|NCT02725333|Motion capture|motion capture
135172|NCT02725333|3D simulation|3d simulation
135173|NCT02725320|rotator cuff|rotator cuff
135174|NCT02725320|shoulder reconstruction|shoulder reconstruction
135175|NCT02725294|exacerbation|exacerbation
135176|NCT02725294|access to care|access to care
135177|NCT02725294|telemedicine|telemedicine
135178|NCT02725268|Drug Therapy|drug therapy
135179|NCT02725229|Postoperative pain|postoperative pain
135180|NCT02725229|Parasternal block|parasternal block
135181|NCT02725229|Sternotomy|sternotomy
135182|NCT02725229|TENS|tens
135183|NCT02725203|Cardiovascular risk management|cardiovascular risk management
135184|NCT02725203|behaviour change techniques|behaviour change techniques
135185|NCT02725203|self-management|self-management
135186|NCT02725203|physical activity|physical activity
135187|NCT02725203|nurse-led|nurse-led
135188|NCT02725203|behaviour change wheel|behaviour change wheel
135189|NCT02725203|primary care|primary care
135190|NCT02725203|clustered RCT|clustered rct
135591|NCT02723136|Smartphone|smartphone
135191|NCT02725177|Ocular Sarcoidosis|ocular sarcoidosis
135192|NCT02725164|oxygen|oxygen
135193|NCT02725164|nitrous oxide|nitrous oxide
135194|NCT02725164|sevoflurane|sevoflurane
135195|NCT02725164|carbon dioxide|carbon dioxide
135196|NCT02725164|endotracheal tube|endotracheal tube
135197|NCT02725164|respiration|respiration
135198|NCT02725151|inferior vena cava ultrasound|inferior vena cava ultrasound
135199|NCT02725151|acute|acute
135200|NCT02725151|heart failure|heart failure
135201|NCT02725151|management|management
135202|NCT02725151|decompensation|decompensation
135203|NCT02725138|Helicobacter pylori|helicobacter pylori
135204|NCT02725138|probiotic|probiotic
135205|NCT02725138|bacterial density|bacterial density
135206|NCT02725125|Stomach Cancer CAR-T|stomach cancer car-t
135207|NCT02725099|STEMI|stemi
135208|NCT02725060|POTS|pots
135209|NCT02725060|Orthostatic Intolerance|orthostatic intolerance
135210|NCT02725060|Orthostatic Tachycardia|orthostatic tachycardia
135211|NCT02725047|Osteoarthritis, Knee|osteoarthritis, knee
135212|NCT02725047|Cryotherapy|cryotherapy
135213|NCT02725047|Thermotherapy|thermotherapy
135214|NCT02725047|Hypothermia|hypothermia
135215|NCT02725047|Knee|knee
135216|NCT02725047|Physiotherapy|physiotherapy
135217|NCT02725021|tobacco prevention|tobacco prevention
135218|NCT02725008|Asthma|asthma
135219|NCT02725008|Pediatric|pediatric
135220|NCT02725008|Emergency Department|emergency department
135221|NCT02725008|Dexamethasone|dexamethasone
135222|NCT02725008|Steroid|steroid
135223|NCT02724982|Self esteem|self esteem
135224|NCT02724982|Body mass index|body mass index
135225|NCT02724969|text messaging|text messaging
135226|NCT02724969|short message service|short message service
135227|NCT02724956|supraglottic airway device (SGAD) insertion|supraglottic airway device (sgad) insertion
135228|NCT02724956|SGAD|sgad
135229|NCT02724956|ventilation and intubation|ventilation and intubation
135230|NCT02724956|gastric drainage channel|gastric drainage channel
135231|NCT02724956|fiberoptic assessment|fiberoptic assessment
135232|NCT02724943|child obesity|child obesity
135233|NCT02724943|primary prevention|primary prevention
135234|NCT02724943|primary care|primary care
135235|NCT02724943|weight management|weight management
135236|NCT02724943|child overweight|child overweight
135238|NCT02724930|low back pain, chronic pain, cognitive behavior therapy|low back pain, chronic pain, cognitive behavior therapy
135239|NCT02724904|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
135240|NCT02724904|CNS Non-Hodgkin lymphoma|cns non-hodgkin lymphoma
135241|NCT02724891|Pelvic Floor Dysfunction|pelvic floor dysfunction
135242|NCT02724878|Kidney Cancer|kidney cancer
135243|NCT02724865|Oral Appliance Therapy|oral appliance therapy
135244|NCT02724852|MMR|mmr
135245|NCT02724852|vaccination|vaccination
135246|NCT02724852|HIV|hiv
135247|NCT02724852|Serologic response|serologic response
135248|NCT02724826|Expectations|expectations
135249|NCT02724826|Outcomes|outcomes
135250|NCT02724826|Qigong|qigong
135251|NCT02724826|Exercise therapy|exercise therapy
135252|NCT02724826|Disability|disability
135253|NCT02724826|Neck movements,|neck movements,
135254|NCT02724800|Insomnia|insomnia
135255|NCT02724800|Veterans|veterans
135256|NCT02724800|Cognitive Behavioral Therapy for Insomnia|cognitive behavioral therapy for insomnia
135257|NCT02724800|Brief Behavioral Treatment for Insomnia|brief behavioral treatment for insomnia
135258|NCT02724800|Comparative Effectiveness Research|comparative effectiveness research
135259|NCT02724787|Post-traumatic stress disorder|post-traumatic stress disorder
135260|NCT02724787|Veterans|veterans
135261|NCT02724787|Aggression|aggression
135262|NCT02724787|Emotion regulation|emotion regulation
135263|NCT02724774|infants|infants
135264|NCT02724774|mental health|mental health
135265|NCT02724774|postpartum period|postpartum period
135266|NCT02724748|Aggression|aggression
135267|NCT02724748|Mental Health|mental health
135268|NCT02724748|Education, Continuing|education, continuing
135269|NCT02724735|Depression|depression
135270|NCT02724735|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
135271|NCT02724735|Major Depressive Disorder|major depressive disorder
135272|NCT02724735|Neurogenesis|neurogenesis
135273|NCT02724735|Synaptogenesis|synaptogenesis
135274|NCT02724735|NSI-189|nsi-189
135275|NCT02724735|Neuralstem|neuralstem
135276|NCT02724722|melamine|melamine
135277|NCT02724722|phthalate|phthalate
135278|NCT02724709|Automatic Data Processing|automatic data processing
135279|NCT02724709|Three-Dimensional Echocardiography|three-dimensional echocardiography
135280|NCT02724709|Aortic Valve|aortic valve
135281|NCT02724683|ascites|ascites
135282|NCT02724683|drainage|drainage
135283|NCT02724683|catheter|catheter
135284|NCT02724683|symptoms|symptoms
135285|NCT02724683|management|management
135286|NCT02724683|quality of life|quality of life
135287|NCT02724683|malignant|malignant
135288|NCT02724683|cancer|cancer
135289|NCT02724657|Child|child
135290|NCT02724657|Breathing exercises|breathing exercises
135291|NCT02724631|Clogged enteral access devices|clogged enteral access devices
135292|NCT02724631|Occluded enteral access device|occluded enteral access device
135293|NCT02724631|Enteral nutrition|enteral nutrition
135294|NCT02724631|Enteral access device|enteral access device
135295|NCT02724631|Tube Feeding|tube feeding
135296|NCT02724631|Gastric Feeding Tubes|gastric feeding tubes
135297|NCT02724618|Curcumin|curcumin
135298|NCT02724618|Protection, Radiation|protection, radiation
135299|NCT02724618|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
135300|NCT02724618|Radiation Therapy|radiation therapy
135301|NCT02724618|Prostate Cancer|prostate cancer
135302|NCT02724605|RBCS,|rbcs,
135303|NCT02724605|Transfusion,|transfusion,
135304|NCT02724605|Pediatric|pediatric
135305|NCT02724605|Changes|changes
135306|NCT02724566|Type 2 diabetic volunteers|type 2 diabetic volunteers
135307|NCT02724527|Cystic Fibrosis|cystic fibrosis
135308|NCT02724527|N91115|n91115
135309|NCT02724527|Cavosonstat|cavosonstat
135310|NCT02724488|Advanced cancer|advanced cancer
135311|NCT02724488|Advanced solid tumors|advanced solid tumors
135312|NCT02724488|Phase I clinical trial candidates|phase i clinical trial candidates
135313|NCT02724488|Phase II clinical trial candidates|phase ii clinical trial candidates
135314|NCT02724488|Phase III clinical trial candidates|phase iii clinical trial candidates
135315|NCT02724488|Head and Neck|head and neck
135316|NCT02724488|Melanoma|melanoma
135317|NCT02724488|Upper Aerodigestive cancer|upper aerodigestive cancer
135318|NCT02724488|Oral Cavity|oral cavity
135319|NCT02724488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors
135320|NCT02724488|ICIs|icis
135321|NCT02724488|ctDNA|ctdna
135322|NCT02724488|Whole Exome Sequencing|whole exome sequencing
135323|NCT02724488|Molecular Profiling|molecular profiling
135324|NCT02724475|Laser Ablation|laser ablation
135325|NCT02724475|Portal Vein Tumor|portal vein tumor
135326|NCT02724475|Thrombus|thrombus
135327|NCT02724462|smoking cessation|smoking cessation
135328|NCT02724462|app for quitting smoking|app for quitting smoking
135329|NCT02724449|IAD|iad
135330|NCT02724449|Fecal incontinence|fecal incontinence
135331|NCT02724436|Yittrium-90|yittrium-90
135332|NCT02724436|Hepatocellular Carcinoma|hepatocellular carcinoma
135333|NCT02724423|epilepsy|epilepsy
135334|NCT02724423|seizure|seizure
135335|NCT02724410|appendectomy|appendectomy
135336|NCT02724397|Colon cancer|colon cancer
135337|NCT02724397|Diagnosis|diagnosis
135338|NCT02724397|Adenoma|adenoma
135339|NCT02724397|Serrated lesions|serrated lesions
135340|NCT02724358|Carcinoma|carcinoma
135341|NCT02724358|Hepatocellular|hepatocellular
135342|NCT02724358|Notch1|notch1
135343|NCT02724345|Cell keratin 18|cell keratin 18
135344|NCT02724332|Aspartate beta hydroxylase|aspartate beta hydroxylase
135345|NCT02724332|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
135346|NCT02724319|percutaneous coronary intervention|percutaneous coronary intervention
135347|NCT02724319|clopidogrel|clopidogrel
135348|NCT02724319|loss-of-function allele|loss-of-function allele
135349|NCT02724267|131I-chTNT-1/B treatment|131i-chtnt-1/b treatment
135350|NCT02724254|Genital warts|genital warts
135351|NCT02724254|HPV types|hpv types
135352|NCT02724254|Sexually Transmitted Disease|sexually transmitted disease
135353|NCT02724254|Papillomavirus Infections|papillomavirus infections
135354|NCT02724254|Viral Disease|viral disease
135355|NCT02724254|Anogenital warts|anogenital warts
135356|NCT02724254|AGW|agw
135357|NCT02724254|HPV6|hpv6
135358|NCT02724254|HPV11|hpv11
135359|NCT02724254|Human papillomavirus infection|human papillomavirus infection
135360|NCT02724254|HPV|hpv
135361|NCT02724254|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
135362|NCT02724254|Aviragen Therapeutics|aviragen therapeutics
135363|NCT02724254|Aviragen|aviragen
135364|NCT02724241|nicotine|nicotine
135365|NCT02724241|autonomic tone|autonomic tone
135366|NCT02724241|oxidative stress|oxidative stress
135367|NCT02724228|Achondroplasia|achondroplasia
135368|NCT02724228|Dwarfism|dwarfism
135369|NCT02724228|Bone Diseases, Developmental|bone diseases, developmental
135370|NCT02724228|Bone Diseases|bone diseases
135371|NCT02724215|Subarachnoid hemorrhage|subarachnoid hemorrhage
135372|NCT02724215|Sleep Apnea|sleep apnea
135373|NCT02724202|Curcumin|curcumin
135374|NCT02724202|5FU|5fu
135375|NCT02724202|5-fluorouracil|5-fluorouracil
135376|NCT02724202|Adracil|adracil
135377|NCT02724202|5FU Resistant|5fu resistant
135378|NCT02724202|Metastatic Colon Cancer|metastatic colon cancer
135379|NCT02724202|Colon Cancer|colon cancer
135380|NCT02724189|electronic pre-assessment|electronic pre-assessment
135381|NCT02724189|preoperative assessment|preoperative assessment
135382|NCT02724163|Acute Myeloid Leukaemia|acute myeloid leukaemia
135383|NCT02724163|Children|children
135384|NCT02724163|Gemtuzumab ozogamicin|gemtuzumab ozogamicin
135385|NCT02724163|Liposomal daunorubicin|liposomal daunorubicin
135386|NCT02724163|Mitoxantrone|mitoxantrone
135387|NCT02724163|Randomised controlled trial|randomised controlled trial
135388|NCT02724163|Risk stratification|risk stratification
135389|NCT02724163|Minimal residual disease|minimal residual disease
135390|NCT02724163|Stem cell transplant|stem cell transplant
135391|NCT02724150|Gastroduodenal Ulcer|gastroduodenal ulcer
135392|NCT02724150|Marginal Ulcer|marginal ulcer
135393|NCT02724150|Peptic Ulcer Hemorrhage|peptic ulcer hemorrhage
135394|NCT02724150|Peptic Ulcer|peptic ulcer
135395|NCT02724137|Total Knee Replacement|total knee replacement
135396|NCT02724137|Physical Therapy|physical therapy
135397|NCT02724137|Fitbit®|fitbit®
135398|NCT02724124|exercise muscle stretching|exercise muscle stretching
135399|NCT02724124|electromyography|electromyography
135400|NCT02724111|Neuromuscular blockade|neuromuscular blockade
135401|NCT02724111|Surgical rating scale|surgical rating scale
135402|NCT02724111|Rocuronium|rocuronium
135403|NCT02724111|Sugammadex|sugammadex
135404|NCT02724111|Spinal surgery|spinal surgery
135405|NCT02724111|General anesthesia|general anesthesia
135406|NCT02724098|Palliative Therapy|palliative therapy
135407|NCT02724072|Thoracic Surgery|thoracic surgery
135408|NCT02724072|Aortic Arch|aortic arch
135409|NCT02724072|Frozen Elephant Trunk|frozen elephant trunk
135410|NCT02724072|Performance Goal|performance goal
135411|NCT02724046|Neisseria meningitidis|neisseria meningitidis
135412|NCT02724046|Ciprofloxacin|ciprofloxacin
135413|NCT02724046|Chemoprevention|chemoprevention
135414|NCT02724033|post operative nausea vomiting|post operative nausea vomiting
135415|NCT02724033|Inner ear surgery|inner ear surgery
135416|NCT02724020|Drug therapy|drug therapy
135417|NCT02724007|Trauma|trauma
135418|NCT02724007|India|india
135419|NCT02724007|ICISS|iciss
135420|NCT02723994|B-cell acute lymphoblastic leukemia (ALL)|b-cell acute lymphoblastic leukemia (all)
135421|NCT02723994|pediatric|pediatric
135422|NCT02723994|multi-agent chemotherapy|multi-agent chemotherapy
135423|NCT02723994|JAK inhibitor|jak inhibitor
135424|NCT02723981|Stent , COMBO Stent, anticoagulation|stent , combo stent, anticoagulation
135425|NCT02723955|ICOS receptor agonist antibody|icos receptor agonist antibody
135426|NCT02723955|Pembrolizumab|pembrolizumab
135427|NCT02723955|KEYNOTE-478|keynote-478
135428|NCT02723955|GSK3359609|gsk3359609
135429|NCT02723955|Cohort expansion|cohort expansion
135430|NCT02723955|Dose escalation|dose escalation
135431|NCT02723942|glypican-3(GPC3)|glypican-3(gpc3)
135432|NCT02723942|chimeric antigen receptor-modified T cell(CAR-T)|chimeric antigen receptor-modified t cell(car-t)
135433|NCT02723942|hepatocellular carcinoma(HCC)|hepatocellular carcinoma(hcc)
135434|NCT02723929|transcranial direct current stimulation|transcranial direct current stimulation
135435|NCT02723929|transcranial ultrasound|transcranial ultrasound
135436|NCT02723929|non-invasive brain stimulation|non-invasive brain stimulation
135437|NCT02723916|Parents|parents
135438|NCT02723916|Child|child
135439|NCT02723916|Preschool|preschool
135440|NCT02723916|eHealth|ehealth
135441|NCT02723903|somatization symptom score|somatization symptom score
135442|NCT02723903|SSS checklist|sss checklist
135443|NCT02723903|coronary angiography|coronary angiography
135444|NCT02723903|Patient Health Questionnaire|patient health questionnaire
135445|NCT02723903|Generalized Anxiety Disorder 7-items|generalized anxiety disorder 7-items
135446|NCT02723877|TNBC|tnbc
135447|NCT02723864|Pharmacodynamic|pharmacodynamic
135448|NCT02723864|DNA Damage Repair|dna damage repair
135449|NCT02723864|BRCA Null|brca null
135450|NCT02723864|Apoptosis|apoptosis
135451|NCT02723864|Combination Therapy|combination therapy
135452|NCT02723838|Bladder|bladder
135453|NCT02723838|Cancer|cancer
135454|NCT02723838|REOLYSIN®|reolysin®
135455|NCT02723838|Gemcitabine|gemcitabine
135456|NCT02723838|Cisplatin|cisplatin
135457|NCT02723838|Reovirus|reovirus
135458|NCT02723838|Oncolytic virus|oncolytic virus
135459|NCT02723825|Distal tibia|distal tibia
135460|NCT02723825|fractures|fractures
135461|NCT02723825|epiphyses|epiphyses
135462|NCT02723825|children|children
135463|NCT02723812|Influenza|influenza
135464|NCT02723812|GCFLU|gcflu
135465|NCT02723812|vaccine|vaccine
135466|NCT02723812|Vietnam|vietnam
135467|NCT02723799|Hope|hope
135468|NCT02723786|Delayed Graft Function|delayed graft function
135469|NCT02723786|Renal Transplantation|renal transplantation
135470|NCT02723786|Prevention|prevention
135471|NCT02723786|GSK1070806|gsk1070806
135472|NCT02723773|Efficacy|efficacy
135473|NCT02723773|Immunogenicity|immunogenicity
135474|NCT02723773|Safety|safety
135475|NCT02723773|Adults|adults
135476|NCT02723773|Herpes zoster|herpes zoster
135477|NCT02723747|myocardial ischemia|myocardial ischemia
135478|NCT02723747|magnetic resonance imaging|magnetic resonance imaging
135479|NCT02723747|perfusion|perfusion
135480|NCT02723747|software|software
135481|NCT02723734|Decipher®|decipher®
135482|NCT02723734|African-American men|african-american men
135483|NCT02723734|prostate|prostate
135484|NCT02723734|low risk PCa|low risk pca
135485|NCT02723734|intermediate risk PCa|intermediate risk pca
135486|NCT02723734|genomic classifier (GC)|genomic classifier (gc)
135487|NCT02723721|Lentigo maligna|lentigo maligna
135488|NCT02723695|Cochlear implant|cochlear implant
135489|NCT02723695|Perception|perception
135490|NCT02723695|Posture|posture
135491|NCT02723695|Quality of life|quality of life
135492|NCT02723669|Relative Bioavailability|relative bioavailability
135493|NCT02723656|smoking|smoking
135494|NCT02723656|cancer|cancer
135495|NCT02723656|cancer registry|cancer registry
135496|NCT02723656|smoking cessation|smoking cessation
135497|NCT02723643|Hypertension|hypertension
135498|NCT02723643|Essential hypertension|essential hypertension
135499|NCT02723643|Blood pressure|blood pressure
135500|NCT02723643|Cardiovascular diseases|cardiovascular diseases
135501|NCT02723630|Bioequivalence|bioequivalence
135502|NCT02723630|Lenvatinib|lenvatinib
135503|NCT02723630|Healthy Volunteers|healthy volunteers
135504|NCT02723630|Lenvima|lenvima
135505|NCT02723630|E7080|e7080
135506|NCT02723591|FK506|fk506
135507|NCT02723591|Kidney Transplantation|kidney transplantation
135508|NCT02723591|Tacrolimus|tacrolimus
135509|NCT02723591|Astagraf XL|astagraf xl
135510|NCT02723552|preeclampsia|preeclampsia
135511|NCT02723552|young adult hypertension|young adult hypertension
135512|NCT02723552|preterm birth|preterm birth
135513|NCT02723526|Metastatic Hormone-Sensitive Prostate Cancer；circulating tumor cells；Prognosis；Liquid biopsy|metastatic hormone-sensitive prostate cancer；circulating tumor cells；prognosis；liquid biopsy
135514|NCT02723513|Proton MRI|proton mri
135515|NCT02723513|Noble Gas MRI|noble gas mri
135516|NCT02723513|Pulmonary Function|pulmonary function
135517|NCT02723500|Magnetic Resonance Imaging|magnetic resonance imaging
135518|NCT02723500|Pulmonary Function|pulmonary function
135519|NCT02723487|TAP block|tap block
135520|NCT02723487|pediatric|pediatric
135521|NCT02723487|Laparoscopic|laparoscopic
135522|NCT02723487|postoperative pain|postoperative pain
135523|NCT02723474|Magnetic Resonance Imaging|magnetic resonance imaging
135524|NCT02723474|Pulmonary Function|pulmonary function
135525|NCT02723396|Parkinson's disease|parkinson's disease
135526|NCT02723396|Sleep Benefit|sleep benefit
135527|NCT02723383|alcoholism|alcoholism
135528|NCT02723383|intensive care|intensive care
135529|NCT02723383|Baclofen|baclofen
135530|NCT02723383|restlessness|restlessness
135531|NCT02723383|Delirium tremens|delirium tremens
135532|NCT02723383|Alcohol withdrawal syndrome|alcohol withdrawal syndrome
135533|NCT02723370|Quality of Healthcare|quality of healthcare
135534|NCT02723370|Colorectal neoplasms|colorectal neoplasms
135535|NCT02723370|Health Literacy|health literacy
135536|NCT02723370|Teach-Back Communication|teach-back communication
135537|NCT02723370|Evidence Based Practice|evidence based practice
135538|NCT02723370|Colonoscopy|colonoscopy
135539|NCT02723357|Financial Coaching|financial coaching
135540|NCT02723357|Mental Health|mental health
135541|NCT02723357|Social Determinants|social determinants
135542|NCT02723357|Medical-Financial Partnership|medical-financial partnership
135543|NCT02723357|Toxic Stress|toxic stress
135544|NCT02723344|PTSD|ptsd
135545|NCT02723344|Mild TBI|mild tbi
135546|NCT02723344|Probiotic|probiotic
135547|NCT02723344|Inflammation|inflammation
135548|NCT02723331|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
135549|NCT02723331|Perioperative Therapy|perioperative therapy
135550|NCT02723331|Resectable Pancreas Ductal Adenocarcinoma|resectable pancreas ductal adenocarcinoma
135551|NCT02723331|Borderline Resectable Pancreas Ductal Adenocarcinoma|borderline resectable pancreas ductal adenocarcinoma
135552|NCT02723331|Nab-paclitaxel|nab-paclitaxel
135553|NCT02723331|Abraxane|abraxane
135554|NCT02723331|Gemcitabine|gemcitabine
135555|NCT02723331|Neoadjuvant Therapy|neoadjuvant therapy
135556|NCT02723331|Adjuvant Therapy|adjuvant therapy
135557|NCT02723318|Cognition|cognition
135558|NCT02723318|Financial Coaching|financial coaching
135559|NCT02723318|Social Determinants of Health|social determinants of health
135560|NCT02723318|Socioeconomic Status|socioeconomic status
135561|NCT02723305|Klinefelter syndrome|klinefelter syndrome
135562|NCT02723305|XXY|xxy
135563|NCT02723305|Sex chromosome aneuploidy|sex chromosome aneuploidy
135564|NCT02723305|sex chromosome variation|sex chromosome variation
135565|NCT02723305|hypogonadism|hypogonadism
135566|NCT02723305|cardiometabolic|cardiometabolic
135567|NCT02723305|body composition|body composition
135568|NCT02723305|exercise capacity|exercise capacity
135569|NCT02723279|Urgency-frequency Syndrome|urgency-frequency syndrome
135570|NCT02723279|Electrical Pudendal Nerve Stimulation|electrical pudendal nerve stimulation
135571|NCT02723279|Tolterodine Tartrate|tolterodine tartrate
135572|NCT02723266|American Indian, Alaska Native Adolescents|american indian, alaska native adolescents
135573|NCT02723266|Preconception Counseling|preconception counseling
135574|NCT02723266|Reproductive Health|reproductive health
135575|NCT02723266|Gestational Diabetes Mellitus|gestational diabetes mellitus
135576|NCT02723253|rectal cancer|rectal cancer
135577|NCT02723253|radiotherapy|radiotherapy
135578|NCT02723253|chemotherapy|chemotherapy
135579|NCT02723253|Raltitrexed|raltitrexed
135580|NCT02723253|Oxaliplatin|oxaliplatin
135581|NCT02723240|NUC-3373|nuc-3373
135582|NCT02723240|Dose escalation|dose escalation
135583|NCT02723240|Nucleotide Analogue|nucleotide analogue
135584|NCT02723227|Parenting Stress|parenting stress
135585|NCT02723227|Stress|stress
135586|NCT02723227|Social Determinants|social determinants
135587|NCT02723227|Socioeconomic status|socioeconomic status
135588|NCT02723227|Financial Coaching|financial coaching
135589|NCT02723175|Fibromyalgia|fibromyalgia
135590|NCT02723175|Pain|pain
135592|NCT02723136|Internship|internship
135593|NCT02723136|Internal Medicine|internal medicine
135594|NCT02723123|CPAP|cpap
135595|NCT02723123|NIPPV|nippv
135596|NCT02723123|Extubation failure|extubation failure
135597|NCT02723123|Cardiorespiratory behaviour|cardiorespiratory behaviour
135598|NCT02723123|NIV-NAVA|niv-nava
135599|NCT02723110|Type 2 Diabetes Risk|type 2 diabetes risk
135600|NCT02723084|Hepatitis C Virus|hepatitis c virus
135601|NCT02723084|Non-cirrhotic|non-cirrhotic
135602|NCT02723084|Hepatitis C Genotype 2|hepatitis c genotype 2
135603|NCT02723084|Chronic Hepatitis C Virus|chronic hepatitis c virus
135604|NCT02723058|Depression|depression
135605|NCT02723058|Homelessness|homelessness
135606|NCT02723058|Primary care|primary care
135607|NCT02723006|Drug Therapy|drug therapy
135608|NCT02722954|malignancy|malignancy
135609|NCT02722954|metastatic|metastatic
135610|NCT02722954|Demcizumab|demcizumab
135611|NCT02722954|Pembrolizumab|pembrolizumab
135612|NCT02722954|Phase 1b|phase 1b
135613|NCT02722941|autologous hematopoietic cell transplant (HCT)|autologous hematopoietic cell transplant (hct)
135614|NCT02722941|autologous|autologous
135615|NCT02722928|Postoperative pneumocephalus|postoperative pneumocephalus
135616|NCT02722928|Fraction of inspired oxygen|fraction of inspired oxygen
135617|NCT02722928|Intracranial surgery|intracranial surgery
135618|NCT02722915|fMRI|fmri
135619|NCT02722915|neurofeedback|neurofeedback
135620|NCT02722915|hallucination|hallucination
135621|NCT02722915|schizophrenia|schizophrenia
135622|NCT02722902|Metabolic flexibility|metabolic flexibility
135623|NCT02722902|Insulin sensitivity|insulin sensitivity
135624|NCT02722889|Ascending aorta|ascending aorta
135625|NCT02722889|Elongation of the aorta|elongation of the aorta
135626|NCT02722889|Type A dissection|type a dissection
135627|NCT02722889|Aortic rupture|aortic rupture
135628|NCT02722889|Aortic length|aortic length
135629|NCT02722876|Rehabilitation|rehabilitation
135630|NCT02722876|Cross-education|cross-education
135631|NCT02722850|breast cancer|breast cancer
135632|NCT02722850|cancer survivorship|cancer survivorship
135633|NCT02722850|dietary intake|dietary intake
135634|NCT02722850|physical activity|physical activity
135635|NCT02722850|quality of life|quality of life
135636|NCT02722824|motor symptoms|motor symptoms
135637|NCT02722811|Etanercept|etanercept
135638|NCT02722811|Osteoarthritis Of Knee|osteoarthritis of knee
135639|NCT02722811|TNF-α|tnf-α
135640|NCT02722811|IL-1α|il-1α
135641|NCT02722811|Subcutaneous Injection|subcutaneous injection
135642|NCT02722785|Exercise training|exercise training
135643|NCT02722785|Surgical complications|surgical complications
135644|NCT02722785|Cancer prognosis|cancer prognosis
135645|NCT02722785|Muscle function|muscle function
135646|NCT02722785|Body composition|body composition
135647|NCT02722785|Pulmonary function|pulmonary function
135648|NCT02722785|Quality of life|quality of life
135649|NCT02722772|Intra-Articular Injection|intra-articular injection
135650|NCT02722772|Etanercept|etanercept
135651|NCT02722772|TNF-α|tnf-α
135652|NCT02722772|IL-1|il-1
135653|NCT02722772|Osteoarthritis of Knee|osteoarthritis of knee
135654|NCT02722746|Epidural Analgesia|epidural analgesia
135655|NCT02722733|Hodgkin's lymphoma|hodgkin's lymphoma
135656|NCT02722733|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
135657|NCT02722733|mobilization|mobilization
135658|NCT02722733|G-CSF|g-csf
135659|NCT02722733|filgrastim|filgrastim
135660|NCT02722733|cytosine arabinoside|cytosine arabinoside
135661|NCT02722733|autologous stem cell transplantation|autologous stem cell transplantation
135662|NCT02722720|Carotid atherosclerosis|carotid atherosclerosis
135663|NCT02722720|Carotid stenosis|carotid stenosis
135664|NCT02722720|Ischemic attack|ischemic attack
135665|NCT02722720|Stroke|stroke
135666|NCT02722720|Carotid stenting|carotid stenting
135667|NCT02722720|Transradial approach|transradial approach
135668|NCT02722720|Transfemoral approach|transfemoral approach
135669|NCT02722720|Bleeding|bleeding
135670|NCT02722720|Thromboembolism|thromboembolism
135671|NCT02722720|Embolism|embolism
135672|NCT02722720|Neurocognitive disorders|neurocognitive disorders
135673|NCT02722668|AML|aml
135674|NCT02722668|ALL|all
135675|NCT02722668|CML|cml
135676|NCT02722668|CLL|cll
135677|NCT02722668|SLL|sll
135678|NCT02722655|Pediatrics|pediatrics
135679|NCT02722629|COPD|copd
135680|NCT02722629|Respiratory Aspiration|respiratory aspiration
135681|NCT02722629|COPD acute exacerbation|copd acute exacerbation
135682|NCT02722616|Ultrasound|ultrasound
135683|NCT02722590|Epilepsy|epilepsy
135684|NCT02722590|Partial-onset seizures|partial-onset seizures
135685|NCT02722590|secondarily generalized seizures|secondarily generalized seizures
135686|NCT02722551|Mitral|mitral
135687|NCT02722551|Regurgitation|regurgitation
135688|NCT02722551|Insufficiency|insufficiency
135689|NCT02722551|Degenerative|degenerative
135690|NCT02722551|Functional|functional
135691|NCT02722551|Primary|primary
135692|NCT02722551|Secondary|secondary
135693|NCT02722551|Organic|organic
135694|NCT02722551|Transcatheter|transcatheter
135695|NCT02722551|TMVR|tmvr
135696|NCT02722551|TMVI|tmvi
135697|NCT02722551|Heart valve|heart valve
135698|NCT02722551|Mitral valve|mitral valve
135699|NCT02722551|Transapical|transapical
135700|NCT02722551|Transfemoral|transfemoral
135701|NCT02722551|Transeptal|transeptal
135702|NCT02722551|Severe|severe
135703|NCT02722525|ADT|adt
135704|NCT02722525|Prostate cancer|prostate cancer
135705|NCT02722499|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
135706|NCT02722499|Diabetes Mellitus, Adult-Onset|diabetes mellitus, adult-onset
135707|NCT02722499|Diabetes Mellitus, Non-Insulin-Dependent|diabetes mellitus, non-insulin-dependent
135708|NCT02722499|Diabetes Mellitus, Noninsulin Dependent|diabetes mellitus, noninsulin dependent
135709|NCT02722499|Diabetes Mellitus, Type II|diabetes mellitus, type ii
135710|NCT02722499|African American|african american
135711|NCT02722499|Blacks|blacks
135712|NCT02722499|non-Hispanic Blacks|non-hispanic blacks
135713|NCT02722499|Randomized Control Trial|randomized control trial
135714|NCT02722499|Controlled Clinical Trial|controlled clinical trial
135715|NCT02722499|Behavioral Research|behavioral research
135716|NCT02722499|Behavioral Medicine|behavioral medicine
135717|NCT02722421|efavirenz|efavirenz
135718|NCT02722421|levonorgestrel|levonorgestrel
135719|NCT02722421|contraceptive implant|contraceptive implant
135720|NCT02722408|LDL-C|ldl-c
135721|NCT02722408|Lipid Regulator|lipid regulator
135722|NCT02722382|Chronic Kidney Disease|chronic kidney disease
135723|NCT02722291|presbyopia|presbyopia
135724|NCT02722265|Essential hypertension|essential hypertension
135725|NCT02722265|Long-term treatment|long-term treatment
135726|NCT02722265|Mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
135727|NCT02722252|In Vitro Fertilization with ICSI|in vitro fertilization with icsi
135728|NCT02722239|Xigduo;|xigduo;
135729|NCT02722239|bioequivalence;|bioequivalence;
135730|NCT02722239|crossover;|crossover;
135731|NCT02722239|Russia|russia
135855|NCT02721459|BRAF V600 K mutation|braf v600 k mutation
135732|NCT02722226|High fidelity simulation|high fidelity simulation
135733|NCT02722226|Sedation|sedation
135734|NCT02722226|Medical education|medical education
135735|NCT02722200|fMRI obesity|fmri obesity
135736|NCT02722148|Eosinophilic Esophagitis|eosinophilic esophagitis
135737|NCT02722148|Diet Elimination Therapy|diet elimination therapy
135738|NCT02722122|Cystic Fibrosis|cystic fibrosis
135740|NCT02722122|AIR DNase™|air dnase™
135741|NCT02722122|Digestive System Diseases|digestive system diseases
135742|NCT02722122|Genetic Diseases, Inborn|genetic diseases, inborn
135743|NCT02722122|Infant, New born, Diseases|infant, new born, diseases
135744|NCT02722122|Lung diseases|lung diseases
135745|NCT02722122|Pancreatic Diseases|pancreatic diseases
135746|NCT02722122|Respiratory Tract Diseases|respiratory tract diseases
135747|NCT02722096|arteriovenous fistula|arteriovenous fistula
135748|NCT02722096|regional anesthesia|regional anesthesia
135749|NCT02722096|local anesthesia|local anesthesia
135750|NCT02722096|early complication|early complication
135751|NCT02722031|intensive care|intensive care
135752|NCT02722031|prevalence|prevalence
135753|NCT02722031|hypoxemia|hypoxemia
135754|NCT02722031|ARDS|ards
135755|NCT02722005|Health related quality of life|health related quality of life
135756|NCT02722005|Financial Coaching|financial coaching
135757|NCT02722005|Medical Financial Partnership|medical financial partnership
135758|NCT02722005|Social Determinants of Health|social determinants of health
135759|NCT02722005|Socioeconomic status|socioeconomic status
135760|NCT02721966|Assessment of spondyloarthritis international society (ASAS)|assessment of spondyloarthritis international society (asas)
135761|NCT02721966|ASAS|asas
135762|NCT02721966|axial|axial
135763|NCT02721966|Psoriatic Arthritis (PsA)|psoriatic arthritis (psa)
135764|NCT02721966|PsA|psa
135765|NCT02721966|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
135766|NCT02721966|MRI|mri
135767|NCT02721927|refugees|refugees
135768|NCT02721927|Syrian|syrian
135769|NCT02721927|cost|cost
135770|NCT02721927|visit|visit
135771|NCT02721914|low-back pain|low-back pain
135772|NCT02721914|massage therapy|massage therapy
135773|NCT02721914|Gymnastics|gymnastics
135774|NCT02721914|disability|disability
135775|NCT02721901|Gastrointestinal Disorders|gastrointestinal disorders
135776|NCT02721901|Nutrition|nutrition
135777|NCT02721901|Behavioral|behavioral
135778|NCT02721862|gallstones|gallstones
135779|NCT02721862|cholelithiasis|cholelithiasis
135780|NCT02721862|sleeve gastrectomy|sleeve gastrectomy
135781|NCT02721797|hypermobility|hypermobility
135782|NCT02721797|collagen|collagen
135783|NCT02721797|joint|joint
135784|NCT02721797|hyperflexation|hyperflexation
135785|NCT02721784|MRI|mri
135786|NCT02721784|Radiotherapy|radiotherapy
135787|NCT02721758|Motivational Interviewing|motivational interviewing
135788|NCT02721758|Health Behavior|health behavior
135789|NCT02721758|Cardiac Rehabilitation|cardiac rehabilitation
135790|NCT02721732|Advanced Cancers|advanced cancers
135791|NCT02721732|Rare tumors|rare tumors
135792|NCT02721732|Squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
135793|NCT02721732|Anaplastic thyroid cancer|anaplastic thyroid cancer
135893|NCT02721173|Adapalene|adapalene
135794|NCT02721732|Adrenocortical carcinoma|adrenocortical carcinoma
135795|NCT02721732|Medullary renal cell carcinoma|medullary renal cell carcinoma
135796|NCT02721732|Carcinoma of unknown primary|carcinoma of unknown primary
135797|NCT02721732|Penile carcinoma|penile carcinoma
135798|NCT02721732|Thymoma|thymoma
135799|NCT02721732|Testicular carcinoma|testicular carcinoma
135800|NCT02721732|Paraganglioma-pheochromocytoma|paraganglioma-pheochromocytoma
135801|NCT02721732|Pembrolizumab|pembrolizumab
135802|NCT02721732|Keytruda|keytruda
135803|NCT02721732|MK-3475|mk-3475
135804|NCT02721732|SCH-900475|sch-900475
135805|NCT02721719|Ulcerative Colitis|ulcerative colitis
135806|NCT02721719|UC|uc
135807|NCT02721719|Vedolizumab|vedolizumab
135808|NCT02721719|Entyvio|entyvio
135809|NCT02721719|Inflammatory Bowl Disease|inflammatory bowl disease
135810|NCT02721719|IBD|ibd
135811|NCT02721719|T-Lymphocytes, Regulatory|t-lymphocytes, regulatory
135812|NCT02721706|Nutrition assessment|nutrition assessment
135813|NCT02721706|inpatients|inpatients
135814|NCT02721706|cost-benefit analysis|cost-benefit analysis
135815|NCT02721706|quality of life|quality of life
135816|NCT02721706|body composition|body composition
135817|NCT02721706|mass screening|mass screening
135818|NCT02721693|Troponin|troponin
135819|NCT02721693|Exercise|exercise
135820|NCT02721667|Blood pressure|blood pressure
135821|NCT02721667|Telemonitoring|telemonitoring
135822|NCT02721667|Case management|case management
135823|NCT02721667|Seniors|seniors
135824|NCT02721654|Plasma-Lyte|plasma-lyte
135825|NCT02721654|Sodium chloride|sodium chloride
135826|NCT02721654|Saline|saline
135827|NCT02721654|Fluid resuscitation|fluid resuscitation
135828|NCT02721654|Intravenous fluid therapy|intravenous fluid therapy
135829|NCT02721654|Critically ill|critically ill
135830|NCT02721654|Critical care|critical care
135831|NCT02721628|Keratoconus|keratoconus
135832|NCT02721615|intra spinal pressure|intra spinal pressure
135833|NCT02721615|spinal cord perfusion pressure|spinal cord perfusion pressure
135834|NCT02721615|microdialysis|microdialysis
135835|NCT02721615|duroplasty|duroplasty
135836|NCT02721537|Brain Nicotinamide Adenine Dinucleotide (NAD+)|brain nicotinamide adenine dinucleotide (nad+)
135837|NCT02721537|Adenosine Triphosphate (ATP) Depletion|adenosine triphosphate (atp) depletion
135838|NCT02721537|Polyadenosine Diphosphate-Ribosepolymerase (PARP) Activation|polyadenosine diphosphate-ribosepolymerase (parp) activation
135839|NCT02721524|Ring Annuloplasty|ring annuloplasty
135840|NCT02721524|Suture Annuloplasty|suture annuloplasty
135841|NCT02721524|Functional Tricuspid Regurgitation|functional tricuspid regurgitation
135842|NCT02721498|Respiratory Physiotherapy|respiratory physiotherapy
135843|NCT02721498|Airway clearance techniques|airway clearance techniques
135844|NCT02721498|Outcome measures|outcome measures
135845|NCT02721485|Ringer's Lactate|ringer's lactate
135846|NCT02721485|Normal Saline|normal saline
135847|NCT02721485|resuscitation fluids|resuscitation fluids
135848|NCT02721485|hypovolemia|hypovolemia
135849|NCT02721459|unresectable melanoma|unresectable melanoma
135850|NCT02721459|stage III melanoma|stage iii melanoma
135851|NCT02721459|stage IV melanoma|stage iv melanoma
135852|NCT02721459|AJCC melanoma staging|ajcc melanoma staging
135853|NCT02721459|American Joint Committee on Cancer (AJCC)|american joint committee on cancer (ajcc)
135854|NCT02721459|BRAF V600 E mutation|braf v600 e mutation
135856|NCT02721394|Challenging Behaviour|challenging behaviour
135857|NCT02721394|Functional Communication Training|functional communication training
135858|NCT02721394|Positive Behavioural Support|positive behavioural support
135859|NCT02721394|Family carer training|family carer training
135860|NCT02721381|Autism Spectrum Disorder|autism spectrum disorder
135861|NCT02721381|Parent training|parent training
135862|NCT02721381|Telehealth|telehealth
135864|NCT02721355|Chronic gastritis|chronic gastritis
135865|NCT02721355|Gastric ulcer|gastric ulcer
135866|NCT02721355|Helicobacter pylori|helicobacter pylori
135867|NCT02721355|IgY|igy
135868|NCT02721342|Chronic proteinuric nephropathies|chronic proteinuric nephropathies
135869|NCT02721329|Obstructive Sleep Apnea|obstructive sleep apnea
135870|NCT02721329|OSA|osa
135871|NCT02721329|Insomnia|insomnia
135872|NCT02721329|CPAP|cpap
135873|NCT02721329|SensAwake|sensawake
135874|NCT02721290|Knee surgery|knee surgery
135875|NCT02721277|Parenteral nutrition, Total|parenteral nutrition, total
135876|NCT02721277|Infant, newborn|infant, newborn
135877|NCT02721277|Cholestasis|cholestasis
135878|NCT02721277|Enterocolitis, Necrotizing|enterocolitis, necrotizing
135879|NCT02721251|exercise|exercise
135880|NCT02721251|weight loss|weight loss
135881|NCT02721251|sleep apnea|sleep apnea
135882|NCT02721212|Robotic|robotic
135883|NCT02721212|Stroke|stroke
135884|NCT02721212|Upper Limb Rehabilitation|upper limb rehabilitation
135885|NCT02721186|Malaria|malaria
135886|NCT02721186|Plasmodium|plasmodium
135887|NCT02721186|Mass drug administration|mass drug administration
135888|NCT02721186|Malaria elimination|malaria elimination
135889|NCT02721186|Zanzibar|zanzibar
135890|NCT02721186|Dihydroartemisinin-Piperaquine|dihydroartemisinin-piperaquine
135891|NCT02721186|Single low dose Primaquine|single low dose primaquine
135892|NCT02721173|Tazarotene|tazarotene
135894|NCT02721173|Clindamycin|clindamycin
135895|NCT02721160|performance-based financing|performance-based financing
135896|NCT02721160|malnutrition|malnutrition
135897|NCT02721160|impact evaluation|impact evaluation
135898|NCT02721108|Mindfulness|mindfulness
135899|NCT02721108|Headspace|headspace
135900|NCT02721108|Psychological approaches|psychological approaches
135901|NCT02721108|Progressive muscle relaxation|progressive muscle relaxation
135902|NCT02721082|tobacco treatment|tobacco treatment
135903|NCT02721069|Seizures|seizures
135904|NCT02721069|Epilepsy|epilepsy
135905|NCT02721043|Personalized vaccine|personalized vaccine
135906|NCT02721043|Poly-ICLC|poly-iclc
135907|NCT02721043|Immunotherapy|immunotherapy
135908|NCT02721043|Cancer|cancer
135909|NCT02721030|Heartfailure|heartfailure
135910|NCT02721030|1-year mortality|1-year mortality
135911|NCT02721030|heartfailure quality of life|heartfailure quality of life
135912|NCT02721030|sub-Saharan Africa|sub-saharan africa
135913|NCT02721017|Nuss|nuss
135914|NCT02721017|Nuss Procedure|nuss procedure
135915|NCT02721017|pectus excavatum|pectus excavatum
135916|NCT02721017|cryoanalgesia|cryoanalgesia
135917|NCT02721004|Rheumatoid arthritis|rheumatoid arthritis
135918|NCT02721004|RoActemra|roactemra
135919|NCT02721004|Tocilizumab|tocilizumab
135920|NCT02720965|Pain Acute|pain acute
135921|NCT02720965|Orthopedic Surgery|orthopedic surgery
135922|NCT02720965|Satisfaction Nerve Blocks|satisfaction nerve blocks
135923|NCT02720913|Time|time
135924|NCT02720913|COR-KNOT|cor-knot
135925|NCT02720913|Standard|standard
135926|NCT02720913|Cost|cost
135927|NCT02720887|pregnant women|pregnant women
135928|NCT02720887|nanoparticles|nanoparticles
135929|NCT02720887|amniotic fluid|amniotic fluid
135930|NCT02720861|RNF213 rs112735431 Gene|rnf213 rs112735431 gene
135931|NCT02720861|Acute Non-embolic ischemic stroke|acute non-embolic ischemic stroke
135932|NCT02720848|double-balloon enteroscopy|double-balloon enteroscopy
135933|NCT02720809|micronutrients|micronutrients
135934|NCT02720809|blood pressure|blood pressure
135935|NCT02720809|allergy|allergy
135936|NCT02720809|lung function|lung function
135937|NCT02720796|PDX|pdx
135938|NCT02720796|TumorGraft|tumorgraft
135939|NCT02720796|Patient derived xenograft|patient derived xenograft
135940|NCT02720796|sarcoma|sarcoma
135941|NCT02720783|Pharmacokinetics|pharmacokinetics
135942|NCT02720783|Econazole nitrate 150mg|econazole nitrate 150mg
135943|NCT02720783|Benzydamine HCl 6mg|benzydamine hcl 6mg
135944|NCT02720783|Vaginal pessary|vaginal pessary
135945|NCT02720783|Tolerability|tolerability
135946|NCT02720770|growth hormone|growth hormone
135947|NCT02720718|Gastric Bypass Status for Obesity Complicating Pregnancy, Childbirth and the Puerperium|gastric bypass status for obesity complicating pregnancy, childbirth and the puerperium
135948|NCT02720718|Laparoscopy|laparoscopy
135949|NCT02720718|Suture Techniques|suture techniques
135950|NCT02720718|Sutures|sutures
135951|NCT02720705|sevoflurane emergence agitation|sevoflurane emergence agitation
135952|NCT02720692|Pain|pain
135953|NCT02720692|Analgesia|analgesia
135954|NCT02720692|N1539|n1539
135955|NCT02720692|Phase 3|phase 3
135956|NCT02720679|Genetics|genetics
135957|NCT02720679|Whole genome sequencing|whole genome sequencing
135958|NCT02720679|Pediatrics and hematology|pediatrics and hematology
135959|NCT02720627|acne|acne
135960|NCT02720627|cortexolone|cortexolone
135961|NCT02720627|anti-androgen|anti-androgen
135962|NCT02720614|accelerated hypofractionated radiotherapy|accelerated hypofractionated radiotherapy
135963|NCT02720614|three-dimensional conformal radiation therapy|three-dimensional conformal radiation therapy
135964|NCT02720614|concurrent radiochemotherapy|concurrent radiochemotherapy
135965|NCT02720601|irinotecan|irinotecan
135966|NCT02720601|capecitabine|capecitabine
135967|NCT02720601|gemcitabine|gemcitabine
135968|NCT02720601|biliary tract cancer|biliary tract cancer
135969|NCT02720601|gallbladder cancer|gallbladder cancer
135970|NCT02720601|second-line|second-line
135971|NCT02720575|Vitamin D|vitamin d
135972|NCT02720575|Bioavailability|bioavailability
135973|NCT02720575|Fortified Bread|fortified bread
135974|NCT02720536|Anemia.|anemia.
135975|NCT02720536|Myelodysplastic Syndrome|myelodysplastic syndrome
135976|NCT02720536|Thalassemia|thalassemia
135977|NCT02720536|Film coated tablet|film coated tablet
135978|NCT02720523|rheumatoid arthritis|rheumatoid arthritis
135979|NCT02720523|ABT-494|abt-494
135980|NCT02720523|Japanese|japanese
135981|NCT02720523|Antirheumatic agents|antirheumatic agents
135982|NCT02720510|multiple myeloma|multiple myeloma
135983|NCT02720510|farydak|farydak
135984|NCT02720510|panobinostat|panobinostat
135985|NCT02720510|LBH589|lbh589
135986|NCT02720510|ASCT|asct
135987|NCT02720510|transplant|transplant
135988|NCT02720471|local analgesia|local analgesia
135989|NCT02720471|total hip replacement|total hip replacement
135990|NCT02720471|local infiltrations|local infiltrations
135991|NCT02720458|Hypnotics withdrawal in insomniac patients|hypnotics withdrawal in insomniac patients
135992|NCT02720458|Cognitive-Behavioural Therapy (CBT)|cognitive-behavioural therapy (cbt)
135993|NCT02720458|Internet-delivered self-help program|internet-delivered self-help program
135994|NCT02720458|Sleep restriction|sleep restriction
135995|NCT02720458|Stimulus control|stimulus control
135996|NCT02720458|Half-life benzodiazepine|half-life benzodiazepine
135997|NCT02720458|Z-drug|z-drug
135998|NCT02720445|Alzheimer's Disease|alzheimer's disease
135999|NCT02720445|Nicotine|nicotine
136000|NCT02720445|Transdermal Patch|transdermal patch
136001|NCT02720432|early intervention, infant|early intervention, infant
136002|NCT02720419|drug eluting stent|drug eluting stent
136003|NCT02720419|percutaneous coronary intervention|percutaneous coronary intervention
136004|NCT02720419|real world|real world
136005|NCT02720380|Asthma|asthma
136006|NCT02720380|Physical Therapy Specialty|physical therapy specialty
136007|NCT02720380|Breathing Exercises|breathing exercises
136008|NCT02720380|Child|child
136009|NCT02720380|Clinical Trail|clinical trail
136010|NCT02720302|Overweight|overweight
136011|NCT02720302|Children|children
136012|NCT02720302|Treatment|treatment
136013|NCT02720302|Prevention|prevention
136014|NCT02720302|Lifestyle intervention|lifestyle intervention
136015|NCT02720289|injury prevention|injury prevention
136016|NCT02720276|stroke|stroke
136017|NCT02720276|exercise|exercise
136018|NCT02720276|walking|walking
136019|NCT02720276|mobility|mobility
136020|NCT02720263|Schizophrenia|schizophrenia
136021|NCT02720263|ASP4345|asp4345
136022|NCT02720250|omega-3 fatty acids, microcirculation, laser Doppler flowmetry, lipid profile|omega-3 fatty acids, microcirculation, laser doppler flowmetry, lipid profile
136023|NCT02720237|Alcohol use|alcohol use
136025|NCT02720237|Viral Load|viral load
136026|NCT02720237|ART|art
136027|NCT02720211|headache|headache
136028|NCT02720211|photophobia|photophobia
136029|NCT02720211|migraine|migraine
136030|NCT02720211|light sensitivity|light sensitivity
136031|NCT02720211|tints|tints
136032|NCT02720211|thin films|thin films
136033|NCT02720146|Dry eye|dry eye
136034|NCT02720133|ramadan fasting|ramadan fasting
136035|NCT02720133|variation of biochemical parameters|variation of biochemical parameters
136036|NCT02720133|variation of hematological parameters|variation of hematological parameters
136037|NCT02720133|verify now assay|verify now assay
136038|NCT02720107|fingolimod,|fingolimod,
136039|NCT02720107|Biomarker,|biomarker,
136040|NCT02720107|Multiple sclerosis,|multiple sclerosis,
136041|NCT02720107|Relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
136042|NCT02720094|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
136043|NCT02720094|PrEP|prep
136044|NCT02720068|PD1|pd1
136045|NCT02720068|PD-1|pd-1
136046|NCT02720068|PDL1|pdl1
136047|NCT02720068|PD-L1|pd-l1
136048|NCT02720055|Distal Radius Fracture|distal radius fracture
136049|NCT02720055|Outcomes|outcomes
136050|NCT02720055|Psychological Intervention|psychological intervention
136051|NCT02720029|aspiration|aspiration
136052|NCT02720029|reflux|reflux
136053|NCT02720016|Post Traumatic Stress Disorder|post traumatic stress disorder
136054|NCT02720016|Marital Therapy|marital therapy
136055|NCT02720016|Veterans|veterans
136056|NCT02720016|Telemedicine|telemedicine
136057|NCT02720016|Couples|couples
136058|NCT02720003|Atherosclerosis|atherosclerosis
136059|NCT02720003|Superficial Femoral Artery|superficial femoral artery
136060|NCT02720003|Proximal Popliteal Artery|proximal popliteal artery
136061|NCT02719990|VRS-317|vrs-317
136062|NCT02719990|Long Acting Growth Hormone|long acting growth hormone
136063|NCT02719990|Versartis|versartis
136064|NCT02719990|somavaratan|somavaratan
136065|NCT02719990|Growth Hormone Deficiency|growth hormone deficiency
136066|NCT02719990|Adult Growth Hormone Deficiency|adult growth hormone deficiency
136067|NCT02719990|AGHD|aghd
136068|NCT02719990|Growth Hormone Replacement|growth hormone replacement
136069|NCT02719990|Growth Hormone Replacement Therapy|growth hormone replacement therapy
136070|NCT02719990|XTEN|xten
136071|NCT02719964|Cognitive Training|cognitive training
136072|NCT02719964|Traumatic Brain Injury|traumatic brain injury
136073|NCT02719964|Video Games|video games
136074|NCT02719951|autism|autism
136075|NCT02719951|fragile X syndrome (FXS)|fragile x syndrome (fxs)
136076|NCT02719951|PET (Positron Emission Tomography)|pet (positron emission tomography)
136077|NCT02719951|glutamate|glutamate
136078|NCT02719925|magnesium deficiency|magnesium deficiency
136079|NCT02719925|stress psycological|stress psycological
136080|NCT02719925|sleep duration and quality|sleep duration and quality
136081|NCT02719925|mineral water rich in magnesium|mineral water rich in magnesium
136082|NCT02719899|NLRP3 Inflammasome|nlrp3 inflammasome
136083|NCT02719899|Sirtuin 3|sirtuin 3
136084|NCT02719899|T-Cell Polarity|t-cell polarity
136085|NCT02719899|Caloric Restriction|caloric restriction
136086|NCT02719873|obesity , pregnancy , maternal and fetal outcome|obesity , pregnancy , maternal and fetal outcome
136087|NCT02719847|Lung cancer|lung cancer
136088|NCT02719847|Non-Small Cell Lung|non-small cell lung
136089|NCT02719847|NSCLC|nsclc
136090|NCT02719847|Suspected non small cell lung cancer|suspected non small cell lung cancer
136091|NCT02719847|Endobronchial ultrasound-guided transbronchial needle aspiration|endobronchial ultrasound-guided transbronchial needle aspiration
136092|NCT02719847|EBUS-TBNA|ebus-tbna
136193|NCT02719093|FSH therapy|fsh therapy
136093|NCT02719821|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
136094|NCT02719821|Fatigue|fatigue
136095|NCT02719821|Insomnia|insomnia
136096|NCT02719821|Depression|depression
136097|NCT02719821|Behavioral Intervention|behavioral intervention
136098|NCT02719808|Vertical infection transmission|vertical infection transmission
136099|NCT02719808|Tenofovir|tenofovir
136100|NCT02719795|Breast Neoplasms|breast neoplasms
136101|NCT02719795|Nerve block|nerve block
136102|NCT02719795|Anesthesia|anesthesia
136103|NCT02719769|Positive Blood Culture|positive blood culture
136104|NCT02719743|children|children
136105|NCT02719743|H5N1|h5n1
136106|NCT02719743|observer-blind|observer-blind
136107|NCT02719743|Influenza|influenza
136108|NCT02719743|dose-ranging|dose-ranging
136109|NCT02719717|VATS lobectomy|vats lobectomy
136110|NCT02719717|vascular sealing|vascular sealing
136111|NCT02719717|energy|energy
136112|NCT02719717|pulmonary artery|pulmonary artery
136113|NCT02719691|MLN0128|mln0128
136114|NCT02719691|Dual TORC1/2 Inhibitor|dual torc1/2 inhibitor
136115|NCT02719691|MLN8237|mln8237
136116|NCT02719691|Aurora A inhibitor|aurora a inhibitor
136117|NCT02719691|Alisertib|alisertib
136118|NCT02719691|Triple-Negative Breast Cancer|triple-negative breast cancer
136119|NCT02719652|intracranial atherosclerotic disease（ICAD）|intracranial atherosclerotic disease（icad）
136120|NCT02719652|vulnerable plaque|vulnerable plaque
136121|NCT02719652|high-resolution magnetic resonance imaging （HR-MRI）|high-resolution magnetic resonance imaging （hr-mri）
136122|NCT02719626|senior|senior
136123|NCT02719626|nutrition|nutrition
136124|NCT02719626|home delivered meals|home delivered meals
136125|NCT02719626|food safety|food safety
136126|NCT02719626|emergency prep|emergency prep
136127|NCT02719600|Virtual Reality|virtual reality
136128|NCT02719587|saliva|saliva
136129|NCT02719587|omega-3|omega-3
136130|NCT02719574|AML|aml
136131|NCT02719574|MDS|mds
136132|NCT02719574|IDH1|idh1
136133|NCT02719574|IDH|idh
136134|NCT02719535|corneal reshaping therapy|corneal reshaping therapy
136135|NCT02719535|corneal biomechanics|corneal biomechanics
136136|NCT02719483|Children|children
136137|NCT02719483|Spasticity|spasticity
136138|NCT02719483|Extracorporeal shock wave therapy|extracorporeal shock wave therapy
136139|NCT02719483|Cerebral palsy|cerebral palsy
136140|NCT02719483|Gross motor function|gross motor function
136141|NCT02719470|Cognition Impairment|cognition impairment
136142|NCT02719470|Rehabilitation|rehabilitation
136143|NCT02719470|Parkinson's Disease|parkinson's disease
136144|NCT02719457|Exercise testing|exercise testing
136145|NCT02719457|COPD|copd
136146|NCT02719457|Upper and Lower limb exercise|upper and lower limb exercise
136147|NCT02719418|Thromboembolism|thromboembolism
136148|NCT02719418|Venous Thrombosis|venous thrombosis
136149|NCT02719418|Embolism and Thrombosis|embolism and thrombosis
136150|NCT02719418|Chronic Renal Diseases|chronic renal diseases
136151|NCT02719418|Kidney Failure, Chronic|kidney failure, chronic
136152|NCT02719418|Renal Failure, Chronic|renal failure, chronic
136153|NCT02719418|Venous Thromboembolism|venous thromboembolism
136154|NCT02719418|Tinzaparin|tinzaparin
136155|NCT02719418|Innohep|innohep
136156|NCT02719418|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight
136157|NCT02719405|milk|milk
136158|NCT02719405|allergy|allergy
136159|NCT02719405|tolerance|tolerance
136160|NCT02719327|Alzheimer's disease|alzheimer's disease
136161|NCT02719327|Cerebrospinal fluid|cerebrospinal fluid
136162|NCT02719327|brain blood flow|brain blood flow
136163|NCT02719327|cognition|cognition
136164|NCT02719327|icosapent ethyl|icosapent ethyl
136165|NCT02719327|Vascepa|vascepa
136166|NCT02719327|omega-3 fatty acids|omega-3 fatty acids
136167|NCT02719327|eicosapentaenoic acid|eicosapentaenoic acid
136168|NCT02719262|Melamine|melamine
136169|NCT02719262|Renal damage|renal damage
136170|NCT02719262|Workplace intervention|workplace intervention
136171|NCT02719249|ESRD|esrd
136172|NCT02719249|Fabry disease|fabry disease
136173|NCT02719236|Coxarthrosis|coxarthrosis
136174|NCT02719236|Hip arthroplasty|hip arthroplasty
136175|NCT02719236|Direct Anterior Approach|direct anterior approach
136176|NCT02719236|Direct Lateral Approach|direct lateral approach
136177|NCT02719223|Intradialytic hypotension|intradialytic hypotension
136178|NCT02719223|hemodynamic parameters|hemodynamic parameters
136179|NCT02719223|Hemodiafiltration|hemodiafiltration
136180|NCT02719223|NICAS device (non-invasive cardiac system)|nicas device (non-invasive cardiac system)
136181|NCT02719158|Acute otitis media with tympanostomy tubes|acute otitis media with tympanostomy tubes
136182|NCT02719158|OTIPRIO|otiprio
136183|NCT02719145|micro RNA|micro rna
136184|NCT02719145|asthma|asthma
136185|NCT02719145|COPD|copd
136186|NCT02719132|Diabetes Mellitus type 2, dapagliflozin, quality of life|diabetes mellitus type 2, dapagliflozin, quality of life
136187|NCT02719106|real world data|real world data
136188|NCT02719106|percutaneous coronary intervention|percutaneous coronary intervention
136189|NCT02719106|drug eluting stent|drug eluting stent
136190|NCT02719093|Infertility Male|infertility male
136191|NCT02719093|Receptors FSH|receptors fsh
136192|NCT02719093|Varicocele|varicocele
136194|NCT02719080|anaesthetists, surgeons, stress, burnout|anaesthetists, surgeons, stress, burnout
136195|NCT02719067|neuropsychological function|neuropsychological function
136196|NCT02719067|neuroimage|neuroimage
136197|NCT02719067|developmental changes|developmental changes
136198|NCT02719054|Depression|depression
136199|NCT02719054|Child Development|child development
136200|NCT02719054|Stimulation|stimulation
136201|NCT02719054|CBT|cbt
136202|NCT02719054|Bangladesh|bangladesh
136203|NCT02719015|Melanoma|melanoma
136204|NCT02719015|Refractory Metastatic Melanoma|refractory metastatic melanoma
136205|NCT02719015|rAd.CD40L|rad.cd40l
136206|NCT02719015|ISF35|isf35
136207|NCT02719015|Intratumoral|intratumoral
136208|NCT02719015|IT|it
136209|NCT02719015|Pembrolizumab|pembrolizumab
136210|NCT02719015|Keytruda|keytruda
136211|NCT02719015|MK-3475|mk-3475
136212|NCT02719015|SCH-900475|sch-900475
136213|NCT02719015|MM|mm
136214|NCT02718989|H-reflex|h-reflex
136215|NCT02718989|TENS|tens
136216|NCT02718989|Tone|tone
136217|NCT02718976|Hip surgery anesthesia|hip surgery anesthesia
136218|NCT02718976|Perioperative analgesia|perioperative analgesia
136219|NCT02718950|Brown Adipose Tissue|brown adipose tissue
136220|NCT02718950|Hypothalamic Activation|hypothalamic activation
136221|NCT02718950|Non-shivering Thermogenesis|non-shivering thermogenesis
136222|NCT02718950|Basal Metabolic Rate|basal metabolic rate
136223|NCT02718950|Liraglutide|liraglutide
136224|NCT02718950|Victoza|victoza
136225|NCT02718950|Body Composition|body composition
136226|NCT02718950|Body weight|body weight
136227|NCT02718950|Adipose Tissue Biopsy|adipose tissue biopsy
136228|NCT02718937|Viral diseases|viral diseases
136229|NCT02718937|Antiviral|antiviral
136230|NCT02718937|Paramyxoviridae infections|paramyxoviridae infections
136231|NCT02718937|RSV|rsv
136232|NCT02718937|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
136233|NCT02718937|Aviragen Therapeutics|aviragen therapeutics
136234|NCT02718937|Aviragen|aviragen
136235|NCT02718924|Thromboelastometry|thromboelastometry
136236|NCT02718924|pregnancy|pregnancy
136237|NCT02718924|obesity|obesity
136238|NCT02718898|genital|genital
136239|NCT02718885|inulin-type fructans|inulin-type fructans
136240|NCT02718885|hemodialysis|hemodialysis
136241|NCT02718885|gut microbiome|gut microbiome
136242|NCT02718885|mineral and bone disorder|mineral and bone disorder
136243|NCT02718859|advanced pancreatic cancer|advanced pancreatic cancer
136244|NCT02718859|nature killer cell|nature killer cell
136245|NCT02718859|irreversible electroporation|irreversible electroporation
136246|NCT02718833|Multiple Myeloma|multiple myeloma
136247|NCT02718833|Relapse|relapse
136248|NCT02718807|Patient Care|patient care
136249|NCT02718807|Education|education
136250|NCT02718794|Simulation Training [I02.903.847]|simulation training [i02.903.847]
136251|NCT02718794|Problem-Based Learning [F02.463.425.720]|problem-based learning [f02.463.425.720]
136252|NCT02718794|Airway Management [E02.041]|airway management [e02.041]
136253|NCT02718755|Hematologic malignancy|hematologic malignancy
136254|NCT02718755|Relapsed and refractory hematologic malignancies|relapsed and refractory hematologic malignancies
136255|NCT02718755|Acute myeloid leukemia|acute myeloid leukemia
136257|NCT02718755|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
136258|NCT02718755|ALL|all
136259|NCT02718755|Burkitt's leukemia/lymphoma|burkitt's leukemia/lymphoma
136260|NCT02718755|Prolymphocytic leukemia|prolymphocytic leukemia
136261|NCT02718755|Biphenotypic acute leukemia|biphenotypic acute leukemia
136262|NCT02718755|Blast-phase of chronic myeloid leukemia|blast-phase of chronic myeloid leukemia
136263|NCT02718755|CML|cml
136264|NCT02718755|B-cell lymphoma|b-cell lymphoma
136265|NCT02718755|Richter's transformation of chronic lymphocytic leukemia|richter's transformation of chronic lymphocytic leukemia
136266|NCT02718755|CLL|cll
136267|NCT02718755|Fludarabine|fludarabine
136268|NCT02718755|Fludarabine phosphate|fludarabine phosphate
136269|NCT02718755|Fludara|fludara
136270|NCT02718755|Cytarabine|cytarabine
136271|NCT02718755|Ara-C|ara-c
136272|NCT02718755|Cytosar|cytosar
136273|NCT02718755|DepoCyt|depocyt
136274|NCT02718755|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
136275|NCT02718729|Anastomotic leakage|anastomotic leakage
136276|NCT02718729|Rectal cancer|rectal cancer
136277|NCT02718729|Laparoscopic|laparoscopic
136278|NCT02718729|Rectal resection|rectal resection
136279|NCT02718716|ITP|itp
136280|NCT02718690|H-Reflex|h-reflex
136281|NCT02718690|Current Density|current density
136282|NCT02718690|TENS|tens
136283|NCT02718651|ALK rearrangement|alk rearrangement
136284|NCT02718651|Circulating tumor DNA|circulating tumor dna
136285|NCT02718651|Plasma DNA|plasma dna
136286|NCT02718651|Non-small cell lung cancer|non-small cell lung cancer
136287|NCT02718651|Tyrosine kinase inhibitors|tyrosine kinase inhibitors
136288|NCT02718625|Pressure Ulcers|pressure ulcers
136289|NCT02718625|Bed sores|bed sores
136290|NCT02718625|Long-term care|long-term care
136291|NCT02718625|Nursing home|nursing home
136292|NCT02718612|Uraemic Sarcopenia|uraemic sarcopenia
136293|NCT02718612|Sarcopenic Obesity|sarcopenic obesity
136294|NCT02718586|Myokines|myokines
136599|NCT02716831|Bulimia|bulimia
136295|NCT02718586|Protein Energy Wasting|protein energy wasting
136296|NCT02718586|Hemodialysis|hemodialysis
136297|NCT02718573|Hepatitis C|hepatitis c
136298|NCT02718573|Interferon-free|interferon-free
136299|NCT02718573|DDA's|dda's
136300|NCT02718547|Diabetes mellitus|diabetes mellitus
136301|NCT02718547|Diabetic macular edema|diabetic macular edema
136302|NCT02718547|Intra ocular pressure|intra ocular pressure
136303|NCT02718547|Ocular perfusion pressure|ocular perfusion pressure
136304|NCT02718547|Retinal perfusion|retinal perfusion
136305|NCT02718521|contrast-induced nephropathy|contrast-induced nephropathy
136306|NCT02718521|hydration therapy combined with intravenous infusion of isosorbide|hydration therapy combined with intravenous infusion of isosorbide
136307|NCT02718521|percutaneous coronary intervention|percutaneous coronary intervention
136308|NCT02718469|Ebola|ebola
136309|NCT02718469|VSV|vsv
136310|NCT02718469|Vesicular Stomatitis Virus|vesicular stomatitis virus
136311|NCT02718469|Vaccine|vaccine
136312|NCT02718469|Zaire|zaire
136313|NCT02718417|untreated epithelial ovarian|untreated epithelial ovarian
136314|NCT02718417|fallopian tube|fallopian tube
136315|NCT02718417|primary peritoneal cancer|primary peritoneal cancer
136316|NCT02718404|MR-HIFU|mr-hifu
136317|NCT02718404|bone metastases|bone metastases
136318|NCT02718404|pain treatment|pain treatment
136319|NCT02718391|Intradermal Autologous Dendritic Cell Vaccine|intradermal autologous dendritic cell vaccine
136320|NCT02718391|Malignant Melanoma|malignant melanoma
136321|NCT02718391|Adjuvant|adjuvant
136322|NCT02718391|vaccin|vaccin
136323|NCT02718391|therapy|therapy
136324|NCT02718391|randomized trial|randomized trial
136325|NCT02718391|observation|observation
136326|NCT02718378|safety|safety
136327|NCT02718378|pharmacokinetics|pharmacokinetics
136328|NCT02718378|pharmacodynamics|pharmacodynamics
136329|NCT02718378|randomized|randomized
136330|NCT02718365|Lung Neoplasms|lung neoplasms
136331|NCT02718365|Surgery|surgery
136332|NCT02718365|VATS|vats
136333|NCT02718365|GGO|ggo
136334|NCT02718365|GGN|ggn
136335|NCT02718365|Segmentectomy|segmentectomy
136336|NCT02718365|Wedge Resection|wedge resection
136337|NCT02718365|Prognosis|prognosis
136338|NCT02718313|intraventricular conduction delay|intraventricular conduction delay
136339|NCT02718300|Primary myelofibrosis (PMF)|primary myelofibrosis (pmf)
136340|NCT02718300|post-polycythemia vera myelofibrosis (PPV-MF)|post-polycythemia vera myelofibrosis (ppv-mf)
136341|NCT02718300|post-essential thrombocythemia myelofibrosis (PET-MF)|post-essential thrombocythemia myelofibrosis (pet-mf)
136342|NCT02718300|myeloproliferative neoplasms (MPNs)|myeloproliferative neoplasms (mpns)
136343|NCT02718300|phosphoinositide 3-kinase (PI3K) inhibitor|phosphoinositide 3-kinase (pi3k) inhibitor
136344|NCT02718300|Janus kinase (JAK) inhibitor|janus kinase (jak) inhibitor
136345|NCT02718287|language development|language development
136346|NCT02718287|socio-emotional development|socio-emotional development
136347|NCT02718287|cognitive development|cognitive development
136348|NCT02718287|motor skills|motor skills
136349|NCT02718274|HIV self-testing|hiv self-testing
136350|NCT02718274|Malawi|malawi
136351|NCT02718274|HIV|hiv
136352|NCT02718248|self-harm|self-harm
136353|NCT02718248|problem-solving therapy|problem-solving therapy
136354|NCT02718248|emergency department|emergency department
136355|NCT02718248|e-therapy|e-therapy
136356|NCT02718248|suicide prevention|suicide prevention
136357|NCT02718222|Post-partum intrauterine device (PPIUD)|post-partum intrauterine device (ppiud)
136358|NCT02718157|Polymerase Chain Reaction (PCR)|polymerase chain reaction (pcr)
136359|NCT02718157|GBS|gbs
136360|NCT02718157|Streptococcus agalactiae|streptococcus agalactiae
136361|NCT02718157|Antepartum women|antepartum women
136362|NCT02718144|dose-escalation|dose-escalation
136363|NCT02718144|safety|safety
136364|NCT02718144|dose-limiting toxicity|dose-limiting toxicity
136365|NCT02718131|Tibial Pseudarthrosis|tibial pseudarthrosis
136366|NCT02718105|KIR HLA-C|kir hla-c
136367|NCT02718105|ART|art
136368|NCT02718066|HBI-8000|hbi-8000
136369|NCT02718066|Nivolumab|nivolumab
136370|NCT02718066|Melanoma|melanoma
136371|NCT02718066|Renal Cell Carcinoma|renal cell carcinoma
136372|NCT02718066|Non-Small Cell Lung Cancer|non-small cell lung cancer
136373|NCT02718027|Hereditary Nephritis|hereditary nephritis
136374|NCT02718027|Nephritis, Familial|nephritis, familial
136375|NCT02718027|Hereditary Familial Congenital Hemorrhagic Nephritis|hereditary familial congenital hemorrhagic nephritis
136376|NCT02718014|Non Surgical Therapy|non surgical therapy
136377|NCT02718001|Mitral|mitral
136378|NCT02718001|Regurgitation|regurgitation
136379|NCT02718001|Insufficiency|insufficiency
136380|NCT02718001|Degenerative|degenerative
136381|NCT02718001|Functional|functional
136382|NCT02718001|Primary|primary
136383|NCT02718001|Secondary|secondary
136384|NCT02718001|Organic|organic
136385|NCT02718001|Transcatheter|transcatheter
136386|NCT02718001|TMVR|tmvr
136387|NCT02718001|TMVI|tmvi
136388|NCT02718001|Heart Valve|heart valve
136389|NCT02718001|Mitral Valve|mitral valve
136390|NCT02718001|Transseptal|transseptal
136391|NCT02718001|Trans-Septal|trans-septal
136392|NCT02718001|Transeptal|transeptal
136393|NCT02718001|Severe|severe
136394|NCT02717988|rheumatoid arthritis|rheumatoid arthritis
136395|NCT02717988|healthy volunteers|healthy volunteers
136396|NCT02717988|moderately to severely active|moderately to severely active
136397|NCT02717975|Urinary retention|urinary retention
136398|NCT02717975|trial removal of catheter|trial removal of catheter
136399|NCT02717975|valve|valve
136400|NCT02717962|Glioma|glioma
136401|NCT02717962|Glioblastoma|glioblastoma
136402|NCT02717962|Glioblastoma multiforme|glioblastoma multiforme
136403|NCT02717962|GBM|gbm
136404|NCT02717962|brain tumor|brain tumor
136405|NCT02717962|brain cancer|brain cancer
136406|NCT02717962|recurrent brain tumor|recurrent brain tumor
136407|NCT02717962|recurrent brain cancer|recurrent brain cancer
136408|NCT02717962|refractory brain tumor|refractory brain tumor
136409|NCT02717962|refractory brain cancer|refractory brain cancer
136410|NCT02717962|recurrent GBM|recurrent gbm
136411|NCT02717962|refractory GBM|refractory gbm
136412|NCT02717962|recurrent glioma|recurrent glioma
136413|NCT02717962|refractory glioma|refractory glioma
136414|NCT02717962|recurrent glioblastoma|recurrent glioblastoma
136415|NCT02717962|refractory glioblastoma|refractory glioblastoma
136416|NCT02717962|recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
136417|NCT02717962|refractory glioblastoma multiforme|refractory glioblastoma multiforme
136418|NCT02717962|failed bevacizumab|failed bevacizumab
136419|NCT02717962|temodar failure|temodar failure
136420|NCT02717962|temozolomide failure|temozolomide failure
136421|NCT02717949|hepatitis C|hepatitis c
136422|NCT02717949|low-grade lymphoma|low-grade lymphoma
136423|NCT02717936|squamous cell carcinoma|squamous cell carcinoma
136424|NCT02717936|dermatosurgery|dermatosurgery
136425|NCT02717936|immunohistochemistry|immunohistochemistry
136426|NCT02717923|metastatic colorectal cancer|metastatic colorectal cancer
136427|NCT02717923|maintenance treatment|maintenance treatment
136428|NCT02717923|cetuximab|cetuximab
136429|NCT02717910|Games|games
136430|NCT02717910|Adolescent|adolescent
136431|NCT02717910|Health education|health education
136432|NCT02717910|Smoking|smoking
136433|NCT02717910|Health literacy|health literacy
136434|NCT02717884|AML|aml
136435|NCT02717884|MDS|mds
136436|NCT02717884|relapsed|relapsed
136437|NCT02717884|trans-retinoic acid ATRA|trans-retinoic acid atra
136438|NCT02717884|epigenetic treatment|epigenetic treatment
136439|NCT02717884|non-M3 AML blasts|non-m3 aml blasts
136440|NCT02717884|tranylcypromine TCP|tranylcypromine tcp
136441|NCT02717884|LSD1|lsd1
136442|NCT02717884|refractory|refractory
136443|NCT02717871|Collagen cross-linking, PACK-CXL, infectious keratitis, CXL.|collagen cross-linking, pack-cxl, infectious keratitis, cxl.
136444|NCT02717845|varus malignment|varus malignment
136445|NCT02717845|osteoarthritis|osteoarthritis
136446|NCT02717845|knee|knee
136447|NCT02717819|Sarcopenia|sarcopenia
136448|NCT02717819|Muscular atrophy|muscular atrophy
136449|NCT02717819|Frailty|frailty
136450|NCT02717819|Acute illness|acute illness
136451|NCT02717819|Ageing|ageing
136452|NCT02717819|Protein supplementation|protein supplementation
136453|NCT02717819|Whey protein|whey protein
136454|NCT02717819|Resistance training|resistance training
136455|NCT02717819|Strength training|strength training
136456|NCT02717767|pneumonia|pneumonia
136457|NCT02717767|diagnosis|diagnosis
136458|NCT02717767|prognosis|prognosis
136459|NCT02717767|tracheal aspirate|tracheal aspirate
136460|NCT02717767|bronchoalveolar lavage|bronchoalveolar lavage
136461|NCT02717663|Reinforcement|reinforcement
136462|NCT02717663|Walking|walking
136463|NCT02717663|Exercise|exercise
136464|NCT02717663|Built Environment|built environment
136465|NCT02717663|Adaptive|adaptive
136466|NCT02717663|Financial incentive|financial incentive
136467|NCT02717663|Walkability|walkability
136468|NCT02717650|Exercise Testing|exercise testing
136469|NCT02717650|Maximal Exercise Testing|maximal exercise testing
136470|NCT02717650|Maximal Exercise Capacity|maximal exercise capacity
136471|NCT02717650|Peak Exercise Capacity|peak exercise capacity
136472|NCT02717650|Adults|adults
136473|NCT02717650|Step Tests|step tests
136474|NCT02717637|oxycodone, caesarean, spinal anesthesia|oxycodone, caesarean, spinal anesthesia
136475|NCT02717624|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
136476|NCT02717624|Btk|btk
136477|NCT02717624|ACP-196|acp-196
136478|NCT02717624|Mantle Cell Lymphoma|mantle cell lymphoma
136479|NCT02717624|MCL|mcl
136480|NCT02717624|acalabrutinib|acalabrutinib
136481|NCT02717624|ACE-LY-106|ace-ly-106
136482|NCT02717611|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
136483|NCT02717611|Ibrutinib Intolerant|ibrutinib intolerant
136484|NCT02717598|cold snare polypectomy|cold snare polypectomy
136485|NCT02717598|hot snare polypectomy|hot snare polypectomy
136486|NCT02717585|Continuous Positive Airway Pressure therapy|continuous positive airway pressure therapy
136487|NCT02717585|Chronic Pain|chronic pain
136488|NCT02717585|Sleep Disturbance|sleep disturbance
136489|NCT02717559|Anterior cruciate ligament / injuries|anterior cruciate ligament / injuries
136490|NCT02717559|Anterior cruciate ligament / surgery|anterior cruciate ligament / surgery
136491|NCT02717559|knee injuries / surgery|knee injuries / surgery
136492|NCT02717559|outcomes research|outcomes research
136493|NCT02717559|prospective studies|prospective studies
136494|NCT02717559|osteoarthritis|osteoarthritis
136495|NCT02717546|Distal Tibia Fracture Screw|distal tibia fracture screw
136496|NCT02717520|glass hybrid|glass hybrid
136497|NCT02717520|composite|composite
136498|NCT02717494|PPV-23|ppv-23
136499|NCT02717494|PCV-10|pcv-10
136501|NCT02717494|Immunization|immunization
136502|NCT02717494|Pregnancy|pregnancy
136503|NCT02717455|Diffuse Intrinsic Pontine Glioma|diffuse intrinsic pontine glioma
136504|NCT02717442|Meniere's Disease|meniere's disease
136505|NCT02717442|Vertigo|vertigo
136506|NCT02717416|upper gastrointestinal bleeding|upper gastrointestinal bleeding
136507|NCT02717416|endoscopic hemostasis|endoscopic hemostasis
136508|NCT02717416|hemostatic powder|hemostatic powder
136509|NCT02717403|Chronic Disease Management|chronic disease management
136510|NCT02717403|Rheumatoid Arthritis|rheumatoid arthritis
136511|NCT02717403|Facebook|facebook
136512|NCT02717403|Social networking|social networking
136513|NCT02717403|Internet|internet
136514|NCT02717403|Questionnaires|questionnaires
136515|NCT02717403|Surveys|surveys
136516|NCT02717403|Phone interview|phone interview
136517|NCT02717390|Reading|reading
136518|NCT02717390|Early Childhood development|early childhood development
136519|NCT02717390|Talking|talking
136520|NCT02717390|Playing|playing
136521|NCT02717390|Praising|praising
136522|NCT02717390|Safety|safety
136523|NCT02717390|Injury prevention|injury prevention
136524|NCT02717377|Micro bouts|micro bouts
136525|NCT02717377|Physical Activity|physical activity
136526|NCT02717338|blood donor|blood donor
136527|NCT02717338|retention|retention
136528|NCT02717338|motivation|motivation
136529|NCT02717338|self-determination theory|self-determination theory
136530|NCT02717247|tRNS|trns
136531|NCT02717247|Food addiction,|food addiction,
136532|NCT02717247|Obesity|obesity
136533|NCT02717247|Craving|craving
136534|NCT02717247|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
136535|NCT02717182|self management program|self management program
136536|NCT02717182|patient education|patient education
136537|NCT02717182|self care program|self care program
136538|NCT02717169|health promotion|health promotion
136539|NCT02717169|health action process|health action process
136540|NCT02717169|activity tracker|activity tracker
136541|NCT02717169|sleep regulation|sleep regulation
136542|NCT02717143|Acute myocarditis|acute myocarditis
136543|NCT02717143|Dilated cardiomyopathy|dilated cardiomyopathy
136544|NCT02717143|Magnetic resonance imaging|magnetic resonance imaging
136545|NCT02717117|Motility|motility
136546|NCT02717117|MRI|mri
136547|NCT02717117|Gut peptides|gut peptides
136548|NCT02717117|Feeding|feeding
136549|NCT02717104|femoropopliteal|femoropopliteal
136550|NCT02717078|diet|diet
136551|NCT02717078|carbohydrate|carbohydrate
136552|NCT02717065|Neuromodulation|neuromodulation
136553|NCT02717065|Noninvasive|noninvasive
136554|NCT02717065|Plasticity|plasticity
136555|NCT02717065|Hearing|hearing
136556|NCT02717065|Hyperacusis|hyperacusis
136557|NCT02717013|Muscle|muscle
136558|NCT02717013|Bone|bone
136559|NCT02717013|Fat|fat
136560|NCT02716974|Lupron|lupron
136561|NCT02716974|Bicalutamide|bicalutamide
136562|NCT02716974|Docetaxel|docetaxel
136563|NCT02716896|cystectomy|cystectomy
136564|NCT02716896|radiation|radiation
136565|NCT02716896|chemotherapy|chemotherapy
136566|NCT02716883|keratitis|keratitis
136567|NCT02716883|AMT|amt
136568|NCT02716883|bacterial keratitis|bacterial keratitis
136569|NCT02716883|medication|medication
136570|NCT02716870|Systematic review and meta-analysis|systematic review and meta-analysis
136571|NCT02716870|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
136572|NCT02716870|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
136573|NCT02716870|Clinical practice guidelines|clinical practice guidelines
136574|NCT02716870|Clinical trials|clinical trials
136575|NCT02716870|Dietary sugars|dietary sugars
136576|NCT02716870|Fructose|fructose
136577|NCT02716870|High fructose corn syrup|high fructose corn syrup
136578|NCT02716870|Fruit|fruit
136579|NCT02716870|Isocaloric|isocaloric
136580|NCT02716870|Hypercaloric|hypercaloric
136581|NCT02716870|Cardiometabolic risk factors|cardiometabolic risk factors
136582|NCT02716870|Triglycerides|triglycerides
136583|NCT02716870|Cholesterol|cholesterol
136584|NCT02716870|Glycemic control|glycemic control
136585|NCT02716870|Insulin resistance|insulin resistance
136586|NCT02716870|Body weight|body weight
136587|NCT02716870|Uric acid|uric acid
136588|NCT02716870|Blood pressure|blood pressure
136589|NCT02716870|Fatty liver|fatty liver
136590|NCT02716870|Fasting|fasting
136591|NCT02716870|Postprandial|postprandial
136592|NCT02716844|Osteoporosis|osteoporosis
136593|NCT02716844|Clinic Pilates Exercise|clinic pilates exercise
136594|NCT02716844|Kinesiophobia|kinesiophobia
136595|NCT02716844|Pain|pain
136596|NCT02716831|Bulimia Nervosa|bulimia nervosa
136597|NCT02716831|Eating Disorders|eating disorders
136598|NCT02716831|Binge Eating|binge eating
136600|NCT02716831|Purging|purging
136601|NCT02716818|Glucocorticoid therapy|glucocorticoid therapy
136602|NCT02716805|autologous stem cell transplant|autologous stem cell transplant
136603|NCT02716805|HDT/ASCT|hdt/asct
136604|NCT02716805|CTLA-4|ctla-4
136605|NCT02716805|PD-L1|pd-l1
136606|NCT02716805|peripheral blood mononuclear cells|peripheral blood mononuclear cells
136607|NCT02716805|PBMC|pbmc
136608|NCT02716805|ASCT|asct
136609|NCT02716766|Sorafenib|sorafenib
136610|NCT02716766|Drug Therapy|drug therapy
136611|NCT02716740|Post-obesity surgery|post-obesity surgery
136612|NCT02716740|Leucine-enriched amino acid supplementation|leucine-enriched amino acid supplementation
136613|NCT02716740|Anabolic substance|anabolic substance
136614|NCT02716740|Physical training|physical training
136615|NCT02716740|Muscular mass|muscular mass
136616|NCT02716740|Loss of weight|loss of weight
136617|NCT02716714|Korean|korean
136618|NCT02716701|Exercise|exercise
136619|NCT02716688|Esophageal cancer|esophageal cancer
136620|NCT02716688|Radiotherapy|radiotherapy
136621|NCT02716688|elder|elder
136622|NCT02716688|S-1|s-1
136623|NCT02716675|HIV-1 Infections|hiv-1 infections
136624|NCT02716649|Trauma|trauma
136625|NCT02716649|ICISS|iciss
136626|NCT02716649|India|india
136627|NCT02716649|ICD-10|icd-10
136628|NCT02716597|albumin, septic shock|albumin, septic shock
136629|NCT02716571|Healthy Subjects|healthy subjects
136630|NCT02716571|Healthy Participants|healthy participants
136631|NCT02716545|Gastrointestinal vascular malformation|gastrointestinal vascular malformation
136632|NCT02716545|Endoscopic Therapy|endoscopic therapy
136633|NCT02716519|Diabetes|diabetes
136634|NCT02716519|diabetic foot ulcer|diabetic foot ulcer
136635|NCT02716519|foot sore|foot sore
136636|NCT02716519|type 2 diabetes|type 2 diabetes
136637|NCT02716519|type 1 diabetes|type 1 diabetes
136638|NCT02716519|DFU|dfu
136639|NCT02716519|pressure ulcers|pressure ulcers
136640|NCT02716519|bed sores|bed sores
136641|NCT02716506|POP surgery|pop surgery
136642|NCT02716493|Telerehabilitation|telerehabilitation
136643|NCT02716480|Nutrition|nutrition
136644|NCT02716480|Physical activity|physical activity
136645|NCT02716480|Bariatric surgery|bariatric surgery
136646|NCT02716480|Obesity|obesity
136647|NCT02716480|Health technology|health technology
136648|NCT02716480|Health-connected devices|health-connected devices
136649|NCT02716467|nursing|nursing
136650|NCT02716467|intercessory prayer|intercessory prayer
136651|NCT02716467|spirituality|spirituality
136652|NCT02716467|clinical trials|clinical trials
136653|NCT02716454|Early surgery|early surgery
136654|NCT02716454|Crohn's disease|crohn's disease
136655|NCT02716454|Step-up therapy|step-up therapy
136656|NCT02716415|neonates|neonates
136657|NCT02716415|infants|infants
136658|NCT02716402|Cyanotic congenital heart disease|cyanotic congenital heart disease
136659|NCT02716402|pulmonary thrombosis|pulmonary thrombosis
136660|NCT02716402|cerebral thrombosis|cerebral thrombosis
136661|NCT02716376|Head and neck neoplasms|head and neck neoplasms
136662|NCT02716376|Radiotherapy|radiotherapy
136663|NCT02716376|Otitis media|otitis media
136664|NCT02716337|human milk target fortification|human milk target fortification
136665|NCT02716324|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
136666|NCT02716324|Shared-Decision Making|shared-decision making
136667|NCT02716324|Care Manager|care manager
136668|NCT02716324|Children|children
136669|NCT02716324|Parents|parents
136670|NCT02716324|Teachers|teachers
136671|NCT02716311|EGFR|egfr
136672|NCT02716311|Lung Cancer|lung cancer
136673|NCT02716285|Irritable Bowel Syndrome|irritable bowel syndrome
136674|NCT02716285|Abdominal pain|abdominal pain
136675|NCT02716285|Targeted Delivery|targeted delivery
136676|NCT02716285|Peppermint oil|peppermint oil
136677|NCT02716272|mesothelioma|mesothelioma
136678|NCT02716272|immunotherapy|immunotherapy
136679|NCT02716272|nivolumab|nivolumab
136680|NCT02716272|ipilimumab|ipilimumab
136681|NCT02716259|Periodontitis|periodontitis
136682|NCT02716259|Cardiovascular diseases|cardiovascular diseases
136683|NCT02716259|Bacteremia|bacteremia
136684|NCT02716259|Scaling and root planing|scaling and root planing
136685|NCT02716259|Flow-mediated dilation|flow-mediated dilation
136686|NCT02716259|carotid intima-media thickness|carotid intima-media thickness
136687|NCT02716259|Porphyromonas gingivalis|porphyromonas gingivalis
136688|NCT02716259|Aggregatibacter actinomycetemcomitans|aggregatibacter actinomycetemcomitans
136689|NCT02716246|MPS IIIA|mps iiia
136690|NCT02716220|DREAMS 2G|dreams 2g
136691|NCT02716220|Scaffold|scaffold
136692|NCT02716220|Drug Eluting Absorbable Metal Scaffold|drug eluting absorbable metal scaffold
136693|NCT02716220|Coronary Artery Disease|coronary artery disease
136694|NCT02716207|Stereotactic Body Radiotherapy (SBRT)|stereotactic body radiotherapy (sbrt)
136695|NCT02716207|CyberKnife|cyberknife
136696|NCT02716207|Dose Escalation|dose escalation
136697|NCT02716181|Atopic Dermatitis|atopic dermatitis
136698|NCT02716181|Topical therapy|topical therapy
136699|NCT02716168|Cancer|cancer
136700|NCT02716168|tele-health|tele-health
136701|NCT02716168|Shared care|shared care
136702|NCT02716168|Continuity|continuity
136703|NCT02716116|NSCLC|nsclc
136704|NCT02716116|EGFR|egfr
136705|NCT02716116|HER2|her2
136706|NCT02716116|human epidermal growth factor receptor 2|human epidermal growth factor receptor 2
136707|NCT02716116|exon 20 insertions|exon 20 insertions
136708|NCT02716116|exon 19 deletions|exon 19 deletions
136709|NCT02716116|exon 21 substitution|exon 21 substitution
136710|NCT02716116|T790M|t790m
136711|NCT02716116|ErbB-2|erbb-2
136712|NCT02716116|Epidermal Growth Factor Receptor|epidermal growth factor receptor
136713|NCT02716103|AL amyloidosis, systemic primary amyloidosis|al amyloidosis, systemic primary amyloidosis
136714|NCT02716064|chronic conditions, self-management, PHR|chronic conditions, self-management, phr
136715|NCT02716038|Non-Small Cell Lung Cancer|non-small cell lung cancer
136716|NCT02716038|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
136717|NCT02716038|Nonsmall Cell Lung Cancer|nonsmall cell lung cancer
136718|NCT02716038|NSCLC|nsclc
136719|NCT02716012|Oligonucleotide|oligonucleotide
136720|NCT02716012|RNA|rna
136721|NCT02716012|saRNA|sarna
136722|NCT02716012|Fibrosis|fibrosis
136723|NCT02716012|Cirrhosis|cirrhosis
136724|NCT02715986|ECT|ect
136725|NCT02715986|Diffusion Tensor Imaging (DTI)|diffusion tensor imaging (dti)
136726|NCT02715986|fMRI|fmri
136727|NCT02715947|Psoriasis Vulgaris|psoriasis vulgaris
136728|NCT02715947|Methotrexate|methotrexate
136729|NCT02715934|Diabetes Education|diabetes education
136730|NCT02715934|Chronic Disease Management|chronic disease management
136731|NCT02715934|Health Care Delivery|health care delivery
136732|NCT02715934|Patient-Centered Medical Home|patient-centered medical home
136733|NCT02715934|Primary Care|primary care
136734|NCT02715895|Infant|infant
136735|NCT02715895|Growth|growth
136736|NCT02715895|Body Weight Changes|body weight changes
136737|NCT02715895|Infant Formula|infant formula
136738|NCT02715895|Randomized Controlled Trial|randomized controlled trial
136739|NCT02715882|Colorectal cancer|colorectal cancer
136740|NCT02715882|TLR5|tlr5
136741|NCT02715882|Immunotherapy|immunotherapy
136742|NCT02715869|Myocardial Preconditioning, inotropic score|myocardial preconditioning, inotropic score
136743|NCT02715856|Bone metastases|bone metastases
136744|NCT02715856|Intramedullary nailing surgery|intramedullary nailing surgery
136745|NCT02715856|IM|im
136746|NCT02715856|Physical tasks|physical tasks
136747|NCT02715856|Surveys|surveys
136748|NCT02715856|Questionnaires|questionnaires
136749|NCT02715856|Smartphone|smartphone
136750|NCT02715856|Tablet|tablet
136751|NCT02715856|Telemedicine|telemedicine
136752|NCT02715856|Telemonitoring|telemonitoring
136753|NCT02715843|CD20|cd20
136754|NCT02715843|immunotoxin|immunotoxin
136755|NCT02715843|NHL|nhl
136756|NCT02715843|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
136757|NCT02715843|lymphoma|lymphoma
136758|NCT02715843|cancer|cancer
136759|NCT02715843|antibodies|antibodies
136760|NCT02715843|immunotherapy|immunotherapy
136761|NCT02715843|safety|safety
136762|NCT02715843|pharmacokinetics|pharmacokinetics
136763|NCT02715843|MT-3724|mt-3724
136764|NCT02715843|relapsed|relapsed
136765|NCT02715843|refractory|refractory
136766|NCT02715817|Stroke|stroke
136767|NCT02715817|Hemiparesis|hemiparesis
136768|NCT02715817|Physical Therapy|physical therapy
136769|NCT02715817|Virtual Reality Exposure Therapy|virtual reality exposure therapy
136770|NCT02715817|Video Games|video games
136771|NCT02715804|Pancreatic ductal adenocarcinoma (PDA)|pancreatic ductal adenocarcinoma (pda)
136772|NCT02715804|Pancreatic ductal carcinoma|pancreatic ductal carcinoma
136773|NCT02715804|PEGylated Recombinant Human Hyaluronidase (PEGPH20)|pegylated recombinant human hyaluronidase (pegph20)
136774|NCT02715804|Nab-paclitaxel|nab-paclitaxel
136775|NCT02715804|Gemcitabine|gemcitabine
136776|NCT02715804|Metastatic|metastatic
136777|NCT02715804|Stage IV|stage iv
136778|NCT02715791|Self-Management|self-management
136779|NCT02715791|Health Connectors|health connectors
136780|NCT02715791|Volunteers|volunteers
136781|NCT02715791|Technology|technology
136782|NCT02715791|Interprofessional team|interprofessional team
136783|NCT02715791|Chronic disease|chronic disease
136784|NCT02715791|Self-efficacy|self-efficacy
136785|NCT02715791|Patient-centredness|patient-centredness
136786|NCT02715791|Community Engagement|community engagement
136787|NCT02715739|Trauma|trauma
136788|NCT02715739|India|india
136789|NCT02715739|ICISS|iciss
136790|NCT02715713|Autonomic neuropathy, Testosterone Deficiency|autonomic neuropathy, testosterone deficiency
136791|NCT02715661|blood flow|blood flow
136792|NCT02715661|brain health|brain health
136793|NCT02715661|exercise|exercise
136794|NCT02715661|endothelial activation|endothelial activation
136795|NCT02715596|head and neck|head and neck
136796|NCT02715596|eicosapentanoic acid|eicosapentanoic acid
136797|NCT02715596|body composition|body composition
136798|NCT02715570|Aspergillus species|aspergillus species
136799|NCT02715570|Filamentous fungi|filamentous fungi
136800|NCT02715570|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors
136801|NCT02715570|Anti-Infective Agents|anti-infective agents
136802|NCT02715570|Antifungal Agents|antifungal agents
136803|NCT02715570|Enzyme Inhibitors|enzyme inhibitors
136804|NCT02715570|Aspergillosis|aspergillosis
136805|NCT02715570|Allergic Bronchopulmonary|allergic bronchopulmonary
136806|NCT02715570|Asthma|asthma
136807|NCT02715544|Intervention|intervention
136808|NCT02715544|Physical activity|physical activity
136809|NCT02715544|Eating habit|eating habit
136810|NCT02715544|Connectedness to nature|connectedness to nature
136811|NCT02715518|Acute ST-segment elevation myocardial infarction|acute st-segment elevation myocardial infarction
136812|NCT02715518|Acute myocardial infarction|acute myocardial infarction
136813|NCT02715518|Fractional flow reserve|fractional flow reserve
136814|NCT02715518|Percutaneous coronary intervention|percutaneous coronary intervention
136815|NCT02715518|Multivessel disease|multivessel disease
136816|NCT02715518|STEMI|stemi
136817|NCT02715518|NSTEMI|nstemi
136818|NCT02715505|Hurler syndrome, MLD, Krabbe, cALD, Hematopoietic Stem Cell Transplantation (HSCT)|hurler syndrome, mld, krabbe, cald, hematopoietic stem cell transplantation (hsct)
136819|NCT02715453|Frailty|frailty
136820|NCT02715453|Acute myocardial infarction|acute myocardial infarction
136821|NCT02715440|Benzodiazepines|benzodiazepines
136822|NCT02715440|drugs|drugs
136823|NCT02715440|withdrawal|withdrawal
136824|NCT02715440|nursing home|nursing home
136825|NCT02715440|elderly|elderly
136826|NCT02715440|therapy elderly|therapy elderly
136827|NCT02715440|Adverse Effect|adverse effect
136828|NCT02715440|pharmacokinetics|pharmacokinetics
136829|NCT02715440|Decreased Drug Tolerance|decreased drug tolerance
136830|NCT02715375|asthma environment|asthma environment
136831|NCT02715362|immunotherapy GPC3 CAR-T HCC|immunotherapy gpc3 car-t hcc
136832|NCT02715349|schizophrenia|schizophrenia
136833|NCT02715349|psychoeducation|psychoeducation
136834|NCT02715349|Vietnam|vietnam
136835|NCT02715336|In vitro fertilization|in vitro fertilization
136836|NCT02715336|IVF|ivf
136837|NCT02715336|Assisted Reproductive Technologies|assisted reproductive technologies
136838|NCT02715336|ART|art
136839|NCT02715336|OHSS|ohss
136840|NCT02715336|Ovarian hyperstimulation|ovarian hyperstimulation
136841|NCT02715336|dual triggering|dual triggering
136842|NCT02715336|GnRH|gnrh
136843|NCT02715323|dry eye|dry eye
136844|NCT02715323|immunological profile|immunological profile
136845|NCT02715323|autoimmune|autoimmune
136846|NCT02715297|glioblastoma|glioblastoma
136847|NCT02715297|GBM|gbm
136848|NCT02715297|radiotherapy|radiotherapy
136849|NCT02715297|Re-irradiation|re-irradiation
136850|NCT02715297|progression|progression
136851|NCT02715284|Metastatic solid tumors|metastatic solid tumors
136852|NCT02715284|Advanced solid tumors|advanced solid tumors
136853|NCT02715284|anti-PD-1|anti-pd-1
136854|NCT02715284|TSR-042|tsr-042
136855|NCT02715284|Immunotherapy|immunotherapy
136856|NCT02715284|PD-1|pd-1
136857|NCT02715284|Endometrial|endometrial
136858|NCT02715284|Non-small cell lung cancer, NSCLC|non-small cell lung cancer, nsclc
136859|NCT02715284|MSI-High|msi-high
136860|NCT02715245|home rehabilitation|home rehabilitation
136861|NCT02715245|Primary Health Care|primary health care
136862|NCT02715245|Physiotherapy|physiotherapy
136863|NCT02715245|chronic disease|chronic disease
136864|NCT02715206|rural adolescents, substance use, prevention, adaptation|rural adolescents, substance use, prevention, adaptation
136865|NCT02715154|Epidural Anaesthesia|epidural anaesthesia
136866|NCT02715154|Cesarean Section|cesarean section
136867|NCT02715154|Dexmedetomidine|dexmedetomidine
136868|NCT02715141|surveillance, molecular stool testing|surveillance, molecular stool testing
136869|NCT02715115|Autism|autism
136870|NCT02715115|Rett's syndrome|rett's syndrome
136871|NCT02715115|Rett disorder|rett disorder
136872|NCT02715115|Rett's disorder|rett's disorder
136873|NCT02715115|Ataxia|ataxia
136874|NCT02715102|lung cancer|lung cancer
136875|NCT02715102|lung neoplasms|lung neoplasms
136876|NCT02715102|lung nodules|lung nodules
136877|NCT02715102|screening tests for cancer|screening tests for cancer
136878|NCT02715089|NGS|ngs
136879|NCT02715089|Liver Neoplasms|liver neoplasms
136880|NCT02715089|Biliary Tract Neoplasms|biliary tract neoplasms
136881|NCT02715089|Hepatobiliary Neoplasms|hepatobiliary neoplasms
136882|NCT02715076|Thoracic Surgery|thoracic surgery
136883|NCT02715076|Thoracic surgery, Video assisted|thoracic surgery, video assisted
136884|NCT02715076|Open Abdominal Surgery|open abdominal surgery
136885|NCT02715076|Anesthesia, General|anesthesia, general
136886|NCT02715050|phototherapy|phototherapy
136887|NCT02715050|photobiostimulation|photobiostimulation
136888|NCT02715050|muscle training|muscle training
136889|NCT02715050|muscular adaptation|muscular adaptation
136890|NCT02715037|fusobacterium necrophorum|fusobacterium necrophorum
136891|NCT02715037|acute tonsillitis|acute tonsillitis
136892|NCT02715037|peritonsillar cellulitis|peritonsillar cellulitis
136893|NCT02715037|infectious mononucleosis|infectious mononucleosis
136894|NCT02715037|microbiology|microbiology
136895|NCT02715037|antibody development|antibody development
136896|NCT02715024|Tamsulosin|tamsulosin
136897|NCT02715024|Solifenacin|solifenacin
136898|NCT02715024|Lower urinary tract symptoms|lower urinary tract symptoms
136899|NCT02715024|Overactive bladder|overactive bladder
136900|NCT02715011|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
136901|NCT02715011|JNJ-63709178|jnj-63709178
136902|NCT02714998|ectopic pregnancy|ectopic pregnancy
136903|NCT02714998|ovarian reserve|ovarian reserve
136904|NCT02714998|salpingectomy|salpingectomy
136905|NCT02714998|methotrexate|methotrexate
136906|NCT02714985|chikungunya virus|chikungunya virus
136907|NCT02714985|RT-PCR|rt-pcr
136908|NCT02714985|urine|urine
136909|NCT02714985|diagnosis|diagnosis
136910|NCT02714946|Thyroid Nodule|thyroid nodule
136911|NCT02714946|Percutaneous radiofrequency ablation (RFA)|percutaneous radiofrequency ablation (rfa)
136912|NCT02714946|Percutaneous laser ablation (LA)|percutaneous laser ablation (la)
136913|NCT02714933|pulmonary|pulmonary
136914|NCT02714933|parenchyma|parenchyma
136915|NCT02714933|MRI sequence Advanced ZTE|mri sequence advanced zte
136916|NCT02714933|chest computed tomography|chest computed tomography
136917|NCT02714920|DNA Repair Enzyme Signature|dna repair enzyme signature
136918|NCT02714920|instrinsic radio- or chemo-resistance|instrinsic radio- or chemo-resistance
136919|NCT02714920|treatment-induced radio- or chemo-resistance|treatment-induced radio- or chemo-resistance
136920|NCT02714894|magnetic resonance imaging|magnetic resonance imaging
136921|NCT02714894|magnetic resonance spectroscopy|magnetic resonance spectroscopy
136922|NCT02714868|repeated measures|repeated measures
136923|NCT02714868|matched comparison|matched comparison
136924|NCT02714868|manualized intervention|manualized intervention
136925|NCT02714868|self-determination|self-determination
136926|NCT02714868|participation|participation
136927|NCT02714868|advocacy|advocacy
136928|NCT02714868|problem-solving|problem-solving
136929|NCT02714868|commuinity participation|commuinity participation
136930|NCT02714868|occupational therapy|occupational therapy
136931|NCT02714868|environment|environment
136932|NCT02714829|Injectable Ceramics Bone Graft Substitute Containing rhBMP-2|injectable ceramics bone graft substitute containing rhbmp-2
136933|NCT02714790|Acute Myeloid Leukemia|acute myeloid leukemia
136934|NCT02714790|Minimal Residual Disease|minimal residual disease
136935|NCT02714790|Wilms Tumor|wilms tumor
136936|NCT02714777|General anesthesia|general anesthesia
136937|NCT02714777|Autonomic nervous system|autonomic nervous system
136938|NCT02714777|Children|children
136939|NCT02714764|Alexander Disease|alexander disease
136940|NCT02714738|Brachial plexus block|brachial plexus block
136941|NCT02714738|Regional anesthesia|regional anesthesia
136942|NCT02714738|Ultrasound|ultrasound
136943|NCT02714725|Dexmedetomidine|dexmedetomidine
136944|NCT02714725|Microcirculation|microcirculation
136945|NCT02714725|On Pump|on pump
136946|NCT02714725|CABG|cabg
136947|NCT02714686|Fertility|fertility
136948|NCT02714686|Total Contraception Prevalence Rate|total contraception prevalence rate
136949|NCT02714686|Family planning methods|family planning methods
136950|NCT02714686|Birth Control|birth control
136951|NCT02714686|Mass Media Campaign|mass media campaign
136952|NCT02714686|Demand for contraception|demand for contraception
136953|NCT02714686|Modern Contraception Prevalence Rate|modern contraception prevalence rate
136954|NCT02714686|Birth intervals|birth intervals
136955|NCT02714647|motor learning|motor learning
136956|NCT02714647|attention|attention
136957|NCT02714647|priming|priming
136958|NCT02714647|rehabilitation|rehabilitation
136959|NCT02714621|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
136960|NCT02714621|High Intensity Focused Ultrasound (HIFU)|high intensity focused ultrasound (hifu)
136961|NCT02714621|Focused Ultrasound Surgery|focused ultrasound surgery
136962|NCT02714595|cefiderocol|cefiderocol
136963|NCT02714595|Bloodstream infections (BSI)|bloodstream infections (bsi)
136964|NCT02714595|Complicated urinary tract infection (cUTI)|complicated urinary tract infection (cuti)
136965|NCT02714595|Ventilator associated pneumonia (VAP)|ventilator associated pneumonia (vap)
136966|NCT02714595|Hospital acquired pneumonia (HAP)|hospital acquired pneumonia (hap)
136967|NCT02714595|Sepsis|sepsis
136968|NCT02714595|multi-drug resistant pathogens|multi-drug resistant pathogens
136969|NCT02714595|S-649266|s-649266
136970|NCT02714595|Gram-negative pathogens|gram-negative pathogens
136971|NCT02714595|Healthcare-associated pneumonia (HCAP)|healthcare-associated pneumonia (hcap)
136972|NCT02714595|carbapenem resistant pathogens|carbapenem resistant pathogens
136973|NCT02714582|Shift report|shift report
136974|NCT02714582|Bedside|bedside
136975|NCT02714582|Nursing|nursing
136976|NCT02714582|Matched controlled trial|matched controlled trial
136977|NCT02714582|Mixed method|mixed method
136978|NCT02714582|Patient participation|patient participation
136979|NCT02714556|Lung volume|lung volume
136980|NCT02714556|Lung Clearance Index|lung clearance index
136981|NCT02714556|Functional Residual Capacity|functional residual capacity
136982|NCT02714556|Respiratory function|respiratory function
136983|NCT02714543|OSMF|osmf
136984|NCT02714543|Aloevera|aloevera
136985|NCT02714543|Hydrocortisone|hydrocortisone
136986|NCT02714543|Hyaluronidase|hyaluronidase
136987|NCT02714504|Prophylaxis|prophylaxis
136988|NCT02714465|Hyperbaric Oxygen Therapy; Gamma Knife Radiosurgery|hyperbaric oxygen therapy; gamma knife radiosurgery
136989|NCT02714452|Person-centred care|person-centred care
136990|NCT02714452|Thriving|thriving
136991|NCT02714452|Satisfaction with care|satisfaction with care
136992|NCT02714452|Residential aged care|residential aged care
136993|NCT02714452|Caring environment|caring environment
136994|NCT02714439|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
136995|NCT02714439|Cervical Cancer Prevention|cervical cancer prevention
136996|NCT02714439|Abnormal Pap test|abnormal pap test
136997|NCT02714439|Positive HPV test|positive hpv test
136998|NCT02714439|History of cervical dysplasia|history of cervical dysplasia
136999|NCT02714439|Colposcopy|colposcopy
137000|NCT02714439|Proflavine|proflavine
137001|NCT02714439|Proflavine hemisulfate|proflavine hemisulfate
137002|NCT02714439|High-Resolution Microendoscopy|high-resolution microendoscopy
137003|NCT02714439|HRME|hrme
137004|NCT02714439|Human papillomavirus|human papillomavirus
137005|NCT02714426|Cognitive Aging|cognitive aging
137006|NCT02714426|Attention|attention
137007|NCT02714426|Mindfulness|mindfulness
137008|NCT02714413|D-allulose|d-allulose
137009|NCT02714413|Caucasian|caucasian
137010|NCT02714413|African American|african american
137011|NCT02714400|Obstructive Sleep Apnea|obstructive sleep apnea
137012|NCT02714400|Arousal threshold|arousal threshold
137013|NCT02714400|Venlafaxine|venlafaxine
137014|NCT02714387|Non traumatic acute brain injury|non traumatic acute brain injury
137015|NCT02714374|GL-ONC1|gl-onc1
137016|NCT02714374|Solid Organ Cancer|solid organ cancer
137017|NCT02714374|Cancer|cancer
137018|NCT02714374|Surgery|surgery
137019|NCT02714374|Oncolytic Virus|oncolytic virus
137020|NCT02714374|Soliris|soliris
137021|NCT02714374|Metastatic melanoma|metastatic melanoma
137022|NCT02714374|Esophageal and gastric adenocarcinoma (Stage III/IV)|esophageal and gastric adenocarcinoma (stage iii/iv)
137023|NCT02714374|Cholangiocarcinoma|cholangiocarcinoma
137024|NCT02714374|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
137025|NCT02714374|Gallbladder cancer|gallbladder cancer
137026|NCT02714374|Colorectal cancer (Stage IV)|colorectal cancer (stage iv)
137027|NCT02714374|High-grade mucinous appendix cancer|high-grade mucinous appendix cancer
137028|NCT02714374|High-grade gastrointestinal neuroendocrine cancer|high-grade gastrointestinal neuroendocrine cancer
137029|NCT02714374|Mesothelioma|mesothelioma
137030|NCT02714374|High-grade soft tissue sarcoma|high-grade soft tissue sarcoma
137031|NCT02714374|Stage III or IV|stage iii or iv
137032|NCT02714361|Iron deficiency|iron deficiency
137033|NCT02714361|Vitamin D|vitamin d
137034|NCT02714361|Iron absorption|iron absorption
137035|NCT02714361|Hepcidin|hepcidin
137036|NCT02714348|Helminth infection|helminth infection
137037|NCT02714348|Vaccination|vaccination
137038|NCT02714322|Adalimumab|adalimumab
137039|NCT02714322|Biologics|biologics
137040|NCT02714322|Biosimilar|biosimilar
137041|NCT02714309|Postprandial glycemia|postprandial glycemia
137042|NCT02714309|Metabolic health measures|metabolic health measures
137043|NCT02714296|colon preparation for endoscopy|colon preparation for endoscopy
137044|NCT02714296|enteral feeding|enteral feeding
137045|NCT02714296|sip feeding|sip feeding
137046|NCT02714296|nutridrink|nutridrink
137047|NCT02714296|nutridrink compact protein|nutridrink compact protein
137048|NCT02714283|nontuberculous mycobacteria|nontuberculous mycobacteria
137049|NCT02714283|corticosteroids|corticosteroids
137050|NCT02714283|macrolides|macrolides
137051|NCT02714283|antibiotics|antibiotics
137052|NCT02714205|Hot flash|hot flash
137053|NCT02714153|Lead extraction|lead extraction
137054|NCT02714153|Superior Vena Cava Tear|superior vena cava tear
137055|NCT02714153|Pacemaker/Defibrillator lead extraction|pacemaker/defibrillator lead extraction
137056|NCT02714127|Human Papillomavirus|human papillomavirus
137057|NCT02714127|Biomarker|biomarker
137058|NCT02714127|Self-sampling|self-sampling
137059|NCT02714127|First-void urine|first-void urine
137060|NCT02714127|Cervicovaginal fluid|cervicovaginal fluid
137061|NCT02714127|Colposcopy|colposcopy
137062|NCT02714114|Antibodies|antibodies
137063|NCT02714114|Vaccination|vaccination
137064|NCT02714114|Self-sampling|self-sampling
137065|NCT02714114|First-void urine|first-void urine
137066|NCT02714114|Serum|serum
137067|NCT02714088|High-intensity interval training|high-intensity interval training
137068|NCT02714088|Functional fitness|functional fitness
137069|NCT02714088|Quality of life|quality of life
137070|NCT02714088|Older adults|older adults
137071|NCT02714062|Adolescent Obesity|adolescent obesity
137072|NCT02714062|Childhood Obesity|childhood obesity
137073|NCT02714062|Qsymia|qsymia
137074|NCT02714062|Pharmacokinetics|pharmacokinetics
137075|NCT02714062|VI-0521|vi-0521
137076|NCT02714062|Phentermine|phentermine
137077|NCT02714062|Topiramate|topiramate
137078|NCT02714049|hypoactive sexual desire disorder|hypoactive sexual desire disorder
137079|NCT02714049|Addyi|addyi
137080|NCT02714049|flibanserin|flibanserin
137081|NCT02714049|low sexual desire|low sexual desire
137082|NCT02714049|HSDD|hsdd
137083|NCT02714036|ALS|als
137084|NCT02714010|EGFR-TKI|egfr-tki
137085|NCT02714010|whole brain radiotherapy|whole brain radiotherapy
137086|NCT02714010|brain metastasis|brain metastasis
137087|NCT02714010|non-small cell lung cancer|non-small cell lung cancer
137088|NCT02713984|HER2 CAR-T|her2 car-t
137089|NCT02713984|safety|safety
137090|NCT02713984|efficiency|efficiency
137091|NCT02713984|refractory and relapsed cancer|refractory and relapsed cancer
137092|NCT02713971|Rehabilitation|rehabilitation
137093|NCT02713971|Balance|balance
137094|NCT02713971|Gait|gait
137095|NCT02713971|Biofeedback|biofeedback
137096|NCT02713958|Telerehabilitation|telerehabilitation
137097|NCT02713958|Elbow fractures|elbow fractures
137098|NCT02713958|Arthrolysis|arthrolysis
137099|NCT02713958|MediTouch|meditouch
137100|NCT02713958|Occupational Therapy|occupational therapy
137101|NCT02713958|Active exercises|active exercises
137102|NCT02713945|Simvastatin|simvastatin
137103|NCT02713945|Ras|ras
137104|NCT02713945|MAPK|mapk
137105|NCT02713932|Aortic valve stenosis|aortic valve stenosis
137106|NCT02713932|Aortic valve regurgitation|aortic valve regurgitation
137107|NCT02713932|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
137108|NCT02713919|Cancer|cancer
137109|NCT02713919|Outpatients|outpatients
137110|NCT02713919|Family Caregivers|family caregivers
137111|NCT02713893|Pharmacokinetics|pharmacokinetics
137112|NCT02713893|Econazole nitrate 1%|econazole nitrate 1%
137113|NCT02713893|Benzydamine HCl 0.12%|benzydamine hcl 0.12%
137114|NCT02713893|Intravaginal cream|intravaginal cream
137115|NCT02713893|Antimycotic|antimycotic
137116|NCT02713893|Tolerability|tolerability
137117|NCT02713880|Peripheral Nervous System Diseases|peripheral nervous system diseases
137118|NCT02713880|Neuromuscular Diseases|neuromuscular diseases
137119|NCT02713880|Metabolism, Inborn Errors|metabolism, inborn errors
137120|NCT02713880|Genetic Diseases, Inborn|genetic diseases, inborn
137121|NCT02713854|Subfertility|subfertility
137122|NCT02713854|In-vitro fertilization|in-vitro fertilization
137123|NCT02713854|BAP-EB|bap-eb
137124|NCT02713854|Endometrial epithelial cells|endometrial epithelial cells
137125|NCT02713854|Repeated implantation failure|repeated implantation failure
137126|NCT02713828|gpNMB-Expressing Squamous Cell Carcinoma of the Lung|gpnmb-expressing squamous cell carcinoma of the lung
137127|NCT02713828|Stage IIIb|stage iiib
137128|NCT02713828|Stage IV|stage iv
137129|NCT02713828|Advanced Squamous Cell Cancer of the Lung|advanced squamous cell cancer of the lung
137130|NCT02713828|Metastatic Squamous Cell Cancer of the Lung|metastatic squamous cell cancer of the lung
137131|NCT02713828|gpNMB-Expressing|gpnmb-expressing
137132|NCT02713828|Glembatumumab Vedotin|glembatumumab vedotin
137133|NCT02713815|Amphetamine-type stimulants|amphetamine-type stimulants
137134|NCT02713815|prefrontal-striatal circuits|prefrontal-striatal circuits
137135|NCT02713815|Glutamate/GABA|glutamate/gaba
137136|NCT02713815|motivational and cognitive intervention|motivational and cognitive intervention
137137|NCT02713815|rTMS|rtms
137139|NCT02713776|High-Output Enterostomy|high-output enterostomy
137140|NCT02713776|Pasireotide|pasireotide
137141|NCT02713776|Somatostatin Analogues|somatostatin analogues
137142|NCT02713763|Sunitinib|sunitinib
137143|NCT02713750|Combined Oral Contraceptives|combined oral contraceptives
137144|NCT02713750|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
137145|NCT02713750|Hormonal Contraception|hormonal contraception
137146|NCT02713750|Human Immunodeficiency Virus|human immunodeficiency virus
137147|NCT02713750|Intrauterine Device|intrauterine device
137148|NCT02713750|Pharmacokinetic|pharmacokinetic
137149|NCT02713750|Sexually Transmitted Diseases|sexually transmitted diseases
137150|NCT02713750|Reproductive Health|reproductive health
137151|NCT02713737|hypoxemia|hypoxemia
137152|NCT02713737|high-flow|high-flow
137153|NCT02713737|atrial fibrillation|atrial fibrillation
137154|NCT02713737|sleep|sleep
137155|NCT02713711|Psoriasis|psoriasis
137156|NCT02713711|balneotherapy|balneotherapy
137157|NCT02713711|phototherapy|phototherapy
137158|NCT02713711|balneophototherapy|balneophototherapy
137159|NCT02713698|Anaesthetics|anaesthetics
137160|NCT02713698|Intravenous|intravenous
137161|NCT02713698|Propofol|propofol
137162|NCT02713698|Pharmacokinetics|pharmacokinetics
137163|NCT02713698|Pharmacodynamics|pharmacodynamics
137164|NCT02713698|Propofol pharmacokinetic-pharmacodynamic model|propofol pharmacokinetic-pharmacodynamic model
137165|NCT02713685|regional anesthesia|regional anesthesia
137166|NCT02713685|lower limb surgery|lower limb surgery
137167|NCT02713685|Bupivacaine|bupivacaine
137168|NCT02713659|Literacy|literacy
137169|NCT02713659|Child Development|child development
137170|NCT02713659|Reading|reading
137171|NCT02713646|MRI|mri
137172|NCT02713646|Virtual Endoscopy|virtual endoscopy
137173|NCT02713646|Pain Measurement|pain measurement
137174|NCT02713620|HBV vaccination, immunity|hbv vaccination, immunity
137175|NCT02713581|Proximal venous thromboembolism|proximal venous thromboembolism
137176|NCT02713568|Macrosomia|macrosomia
137177|NCT02713568|Magnetic Resonance- Estimated Fetal Weight|magnetic resonance- estimated fetal weight
137178|NCT02713568|Ultrasound-Estimated Fetal Weight|ultrasound-estimated fetal weight
137179|NCT02713568|Large-for-date fetus|large-for-date fetus
137180|NCT02713529|Solid Tumor|solid tumor
137181|NCT02713529|Pancreatic Cancer|pancreatic cancer
137182|NCT02713529|Colorectal Cancer|colorectal cancer
137183|NCT02713529|Non-Small Cell Lung Cancer|non-small cell lung cancer
137184|NCT02713516|Anxiety|anxiety
137185|NCT02713516|OCD|ocd
137186|NCT02713516|Obsessive Compulsive Disorder|obsessive compulsive disorder
137187|NCT02713516|Generalized Anxiety|generalized anxiety
137188|NCT02713516|Social Phobia|social phobia
137189|NCT02713516|Separation Anxiety|separation anxiety
137190|NCT02713516|GAD|gad
137191|NCT02713516|Youth|youth
137192|NCT02713516|Teen|teen
137193|NCT02713516|Therapy|therapy
137194|NCT02713451|Oxygen|oxygen
137195|NCT02713438|Physical activity|physical activity
137196|NCT02713438|Planning|planning
137197|NCT02713438|Implementation intention|implementation intention
137198|NCT02713438|Quality of life|quality of life
137199|NCT02713438|Body weight|body weight
137200|NCT02713425|Anxiety|anxiety
137201|NCT02713425|Social Phobia|social phobia
137202|NCT02713425|Separation Anxiety|separation anxiety
137203|NCT02713425|Generalized Anxiety|generalized anxiety
137204|NCT02713425|GAD|gad
137205|NCT02713425|Phobia|phobia
137206|NCT02713425|video game|video game
137207|NCT02713425|teen|teen
137208|NCT02713425|youth|youth
137209|NCT02713425|child|child
137210|NCT02713425|adolescent|adolescent
137211|NCT02713347|Quality of Life|quality of life
137212|NCT02713347|Symptom Assessment|symptom assessment
137213|NCT02713347|Palliative Care|palliative care
137214|NCT02713347|Disease Management|disease management
137215|NCT02713347|Delivery of Health Care|delivery of health care
137216|NCT02713347|Advance Care Planning|advance care planning
137217|NCT02713334|Decision Making|decision making
137218|NCT02713334|Communication|communication
137219|NCT02713334|16-080|16-080
137220|NCT02713321|diabetes|diabetes
137221|NCT02713321|vulnerable populations|vulnerable populations
137222|NCT02713321|comorbidity|comorbidity
137223|NCT02713321|patient-centered outcomes research|patient-centered outcomes research
137224|NCT02713321|Medicaid reform|medicaid reform
137225|NCT02713321|health disparities|health disparities
137226|NCT02713295|Moderate Plaque Psoriasis|moderate plaque psoriasis
137227|NCT02713295|Severe Plaque Psoriasis|severe plaque psoriasis
137228|NCT02713295|Plaque Psoriasis|plaque psoriasis
137229|NCT02713282|Schizophrenia|schizophrenia
137230|NCT02713282|R092670|r092670
137231|NCT02713282|Paliperidone Palmitate|paliperidone palmitate
137232|NCT02713269|Secondary Malignant Neoplasm of Vertebral Column|secondary malignant neoplasm of vertebral column
137233|NCT02713269|Spine Metastases|spine metastases
137234|NCT02713269|Epidural spinal cord compression|epidural spinal cord compression
137235|NCT02713269|Stereotactic spine radiosurgery|stereotactic spine radiosurgery
137236|NCT02713269|SSRS|ssrs
137237|NCT02713269|Thermal ablation|thermal ablation
137238|NCT02713269|Symptom questionnaire|symptom questionnaire
137239|NCT02713269|Surveys|surveys
137240|NCT02713256|Graves' disease|graves' disease
137241|NCT02713256|Hyperthyroidism|hyperthyroidism
137242|NCT02713256|CFZ533|cfz533
137243|NCT02713256|TSH|tsh
137244|NCT02713243|Primary bile acid diarrhea,|primary bile acid diarrhea,
137245|NCT02713243|FXR agonist,|fxr agonist,
137246|NCT02713243|bile acid malabsorption.|bile acid malabsorption.
137247|NCT02713217|depressive disorder|depressive disorder
137248|NCT02713217|alcohol-related disorders|alcohol-related disorders
137249|NCT02713217|telemedicine|telemedicine
137250|NCT02713217|rural health|rural health
137251|NCT02713217|collaborative care|collaborative care
137252|NCT02713217|post-traumatic stress disorder (PTSD)|post-traumatic stress disorder (ptsd)
137253|NCT02713191|Bronchoscopy|bronchoscopy
137254|NCT02713191|Sedation|sedation
137255|NCT02713191|Dexmedetomidine|dexmedetomidine
137256|NCT02713165|Gut Microbiota|gut microbiota
137257|NCT02713139|vaginal|vaginal
137258|NCT02713139|discharge|discharge
137259|NCT02713139|women|women
137260|NCT02713048|Cardiac arrest|cardiac arrest
137261|NCT02713048|Troponin I|troponin i
137262|NCT02713048|coronary anatomy|coronary anatomy
137263|NCT02713022|DEXA Scan|dexa scan
137264|NCT02713022|15-235|15-235
137265|NCT02713009|Maternal body weight|maternal body weight
137266|NCT02713009|Vitamin D|vitamin d
137267|NCT02713009|Pregnancy|pregnancy
137268|NCT02712996|Traumatic Brain Injury|traumatic brain injury
137269|NCT02712996|Attention Deficit|attention deficit
137270|NCT02712996|TBI|tbi
137271|NCT02712996|Vyvanse|vyvanse
137272|NCT02712983|Inhaled tobramycin; tobramycin inhalation powder; bronchiectasis; pulmonary Pseudomonas aeruginosa infection; dose-finding study|inhaled tobramycin; tobramycin inhalation powder; bronchiectasis; pulmonary pseudomonas aeruginosa infection; dose-finding study
137273|NCT02712918|Depression|depression
137274|NCT02712918|Inpatient|inpatient
137275|NCT02712918|Acute|acute
137276|NCT02712918|Brief Behavioral Activation Treatment for Depression|brief behavioral activation treatment for depression
137277|NCT02712905|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
137278|NCT02712905|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
137279|NCT02712905|small cell lung cancer (SCLC)|small cell lung cancer (sclc)
137280|NCT02712905|myelofibrosis (MF)|myelofibrosis (mf)
137281|NCT02712905|solid tumor, lysine-specific demethylase 1 (LSD1) inhibitor|solid tumor, lysine-specific demethylase 1 (lsd1) inhibitor
137282|NCT02712840|Single embryo transfer|single embryo transfer
137283|NCT02712840|Freeze-all|freeze-all
137284|NCT02712840|Fresh|fresh
137285|NCT02712840|Vitrification|vitrification
137286|NCT02712840|Clinical Pregnancy|clinical pregnancy
137287|NCT02712840|Blastocyst|blastocyst
137288|NCT02712827|self-gripping mesh, fibrin glue, total extraperitoneal|self-gripping mesh, fibrin glue, total extraperitoneal
137289|NCT02712801|HIV|hiv
137290|NCT02712801|antiretroviral treatment|antiretroviral treatment
137291|NCT02712801|child|child
137292|NCT02712801|testing|testing
137293|NCT02712788|Subarachnoid Hemorrhage|subarachnoid hemorrhage
137294|NCT02712788|Cerebral Vasospasm|cerebral vasospasm
137295|NCT02712788|Milrinone|milrinone
137296|NCT02712788|Hyperdynamic Therapy|hyperdynamic therapy
137297|NCT02712762|immunological profiles|immunological profiles
137298|NCT02712749|Binaural Beat|binaural beat
137299|NCT02712749|Elderly|elderly
137300|NCT02712749|preoperative medication|preoperative medication
137301|NCT02712736|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
137302|NCT02712723|ER+, HER2-negative breast cancer|er+, her2-negative breast cancer
137303|NCT02712723|Stage II or III|stage ii or iii
137304|NCT02712723|Letrozole|letrozole
137305|NCT02712723|Femara|femara
137306|NCT02712723|Ribociclib|ribociclib
137307|NCT02712723|LEE011|lee011
137308|NCT02712723|Neo-adjuvant|neo-adjuvant
137309|NCT02712710|knee, osteoarthritis, brace|knee, osteoarthritis, brace
137310|NCT02712697|liver-kidney yin deficiency syndrome|liver-kidney yin deficiency syndrome
137311|NCT02712697|primary severe IgA nephropathy|primary severe iga nephropathy
137312|NCT02712697|Lee's grade Ⅲ|lee's grade ⅲ
137313|NCT02712671|Cost-Benefit Analysis|cost-benefit analysis
137314|NCT02712671|Quality of Life|quality of life
137315|NCT02712593|Healthy participants|healthy participants
137316|NCT02712593|Dietary supplement|dietary supplement
137317|NCT02712593|Bioavailability|bioavailability
137318|NCT02712593|Niagen™|niagen™
137319|NCT02712593|Nicotinamide riboside|nicotinamide riboside
137320|NCT02712593|N-methylnicotinamide|n-methylnicotinamide
137321|NCT02712580|pediatric burns|pediatric burns
137322|NCT02712580|deep dermal wounds|deep dermal wounds
137323|NCT02712580|wound healing|wound healing
137324|NCT02712580|ChildPain Measurement|childpain measurement
137325|NCT02712580|Treatment Outcome Wound Healing/physiology|treatment outcome wound healing/physiology
137326|NCT02712580|wireless electric stimulation|wireless electric stimulation
137327|NCT02712580|wireless current stimulation|wireless current stimulation
137328|NCT02712580|wireless technology|wireless technology
137329|NCT02712580|children|children
137330|NCT02712580|conservative treatment|conservative treatment
137331|NCT02712580|deep dermal scalds|deep dermal scalds
137332|NCT02712580|humans|humans
137333|NCT02712580|deep dermal burns|deep dermal burns
137334|NCT02712580|burns|burns
137335|NCT02712580|wound healing process|wound healing process
137336|NCT02712554|Pain|pain
137337|NCT02712554|Nausea|nausea
137338|NCT02712554|Vomiting|vomiting
137339|NCT02712541|Caregiver burden Index|caregiver burden index
137340|NCT02712528|bispectral index|bispectral index
137341|NCT02712528|extubation|extubation
137342|NCT02712528|recovery|recovery
137343|NCT02712528|remifentanil|remifentanil
137344|NCT02712489|HAART-treated participants|haart-treated participants
137345|NCT02712489|Tat|tat
137346|NCT02712489|Therapeutic immunization|therapeutic immunization
137347|NCT02712476|Mannitol|mannitol
137348|NCT02712476|Furosemid|furosemid
137349|NCT02712476|Brain Relaxation|brain relaxation
137350|NCT02712463|Schizophrenia|schizophrenia
137351|NCT02712463|Oral antipsychotics|oral antipsychotics
137352|NCT02712463|Long acting Injectable antipsychotics|long acting injectable antipsychotics
137353|NCT02712450|geriatric|geriatric
137354|NCT02712450|emergency|emergency
137355|NCT02712450|clinical pathway|clinical pathway
137356|NCT02712450|regulation|regulation
137357|NCT02712450|SAMU|samu
137358|NCT02712450|training|training
137359|NCT02712437|Insomnia|insomnia
137360|NCT02712437|Quality of Life|quality of life
137361|NCT02712437|Cognitive behavioral therapy|cognitive behavioral therapy
137362|NCT02712424|Vaccine|vaccine
137363|NCT02712372|AZD4831 oral suspension|azd4831 oral suspension
137364|NCT02712372|Healthy male subjects|healthy male subjects
137365|NCT02712372|Safety|safety
137366|NCT02712372|Tolerability|tolerability
137367|NCT02712372|Pharmacokinetics|pharmacokinetics
137368|NCT02712372|Pharmacodynamics|pharmacodynamics
137369|NCT02712359|Havrix|havrix
137370|NCT02712359|Cross-sectional seroprevalence survey|cross-sectional seroprevalence survey
137371|NCT02712359|Panama|panama
137372|NCT02712359|Long-term persistence|long-term persistence
137373|NCT02712359|Hepatitis|hepatitis
137374|NCT02712346|Sickle Cell Anemia|sickle cell anemia
137375|NCT02712346|Sickle Cell Thalassemia|sickle cell thalassemia
137376|NCT02712346|Sickle Beta Thalassemia|sickle beta thalassemia
137377|NCT02712346|Proteinuria|proteinuria
137378|NCT02712346|Sickle nephropathy|sickle nephropathy
137379|NCT02712333|PM2.5|pm2.5
137380|NCT02712333|air purification|air purification
137381|NCT02712333|randomized controlled trial|randomized controlled trial
137382|NCT02712333|metabolomics|metabolomics
137383|NCT02712333|Metabolites|metabolites
137384|NCT02712333|exhaled nitric oxide|exhaled nitric oxide
137385|NCT02712320|Prostate Neoplasm Cancer Carcinoma|prostate neoplasm cancer carcinoma
137386|NCT02712320|Safety Extension|safety extension
137387|NCT02712294|pulmonary hypertension|pulmonary hypertension
137388|NCT02712294|peripheral muscle electrostimulation|peripheral muscle electrostimulation
137389|NCT02712294|capacity of the exercises|capacity of the exercises
137390|NCT02712294|quality of life|quality of life
137391|NCT02712281|Food Selectivity|food selectivity
137392|NCT02712281|Autism MEAL Plan|autism meal plan
137393|NCT02712281|Parent Education|parent education
137394|NCT02712268|Polypharmacy|polypharmacy
137395|NCT02712268|Clinical decision-making|clinical decision-making
137396|NCT02712255|Physical activity|physical activity
137397|NCT02712255|Quality of life|quality of life
137398|NCT02712255|Planning|planning
137399|NCT02712255|Implementation intentions|implementation intentions
137400|NCT02712255|Cardiovascular disease|cardiovascular disease
137401|NCT02712255|Diabetes|diabetes
137402|NCT02712203|Measles vaccine|measles vaccine
137403|NCT02712203|Priorix|priorix
137404|NCT02712203|Priorix-Tetra|priorix-tetra
137405|NCT02712203|Age at vaccination|age at vaccination
137406|NCT02712177|vaccine safety|vaccine safety
137407|NCT02712177|interaction|interaction
137408|NCT02712164|Split-thickness skin graft|split-thickness skin graft
137409|NCT02712164|STSG|stsg
137410|NCT02712164|donor site|donor site
137411|NCT02712164|negative-pressure wound therapy|negative-pressure wound therapy
137412|NCT02712164|NPWT|npwt
137413|NCT02712164|dressing|dressing
137414|NCT02712151|transversus abdominal plane block|transversus abdominal plane block
137415|NCT02712138|Hyperbilirubinemia|hyperbilirubinemia
137416|NCT02712138|Unconjugated Benign Bilirubinemia|unconjugated benign bilirubinemia
137417|NCT02712060|Ehlers-Danlos Syndrome|ehlers-danlos syndrome
137418|NCT02712060|Obstructive Sleep Apnea|obstructive sleep apnea
137419|NCT02712060|Prevalence|prevalence
137420|NCT02712060|Children|children
137421|NCT02712060|Pediatric|pediatric
137422|NCT02712060|Adolescents|adolescents
137423|NCT02712047|Fluticasone furoate/vilanterol|fluticasone furoate/vilanterol
137424|NCT02712047|Asthma|asthma
137425|NCT02712047|fraction of exhaled nitric oxide|fraction of exhaled nitric oxide
137426|NCT02712047|cross-over|cross-over
137427|NCT02712034|Medication-assisted treatment (MAT)|medication-assisted treatment (mat)
137428|NCT02712034|Buprenorphine|buprenorphine
137429|NCT02712034|Methadone|methadone
137430|NCT02712034|Naltrexone|naltrexone
137431|NCT02712021|Cerebral Palsy|cerebral palsy
137432|NCT02712021|Lycra|lycra
137433|NCT02712021|Motor Function|motor function
137434|NCT02712021|Static Balance|static balance
137435|NCT02711995|botulinum toxin|botulinum toxin
137436|NCT02711995|injection augmentation|injection augmentation
137437|NCT02711995|essential voice tremor|essential voice tremor
137438|NCT02711956|Metastatic Castration-Resistant Prostate Cancer (mCRPC)|metastatic castration-resistant prostate cancer (mcrpc)
137439|NCT02711956|Phase 1b/2a|phase 1b/2a
137440|NCT02711956|Prostate Cancer|prostate cancer
137441|NCT02711956|Pharmacokinetics (PK)|pharmacokinetics (pk)
137442|NCT02711956|ZEN003694|zen003694
137443|NCT02711956|ZEN-3694|zen-3694
137444|NCT02711956|Metastatic Castrate-Resistant Prostate Cancer|metastatic castrate-resistant prostate cancer
137445|NCT02711956|BET inhibitor (BETi)|bet inhibitor (beti)
137446|NCT02711956|Bromodomain|bromodomain
137447|NCT02711956|Pharmacodynamics (PD)|pharmacodynamics (pd)
137448|NCT02711956|Enzalutamide|enzalutamide
137449|NCT02711956|XTANDI|xtandi
137450|NCT02711956|MDV3100|mdv3100
137451|NCT02711956|Epigenetics|epigenetics
137452|NCT02711930|intra-ocular pressure|intra-ocular pressure
137453|NCT02711930|prone ventilation|prone ventilation
137454|NCT02711917|Propofol|propofol
137455|NCT02711917|Sevoflurane|sevoflurane
137456|NCT02711917|Etomidate|etomidate
137457|NCT02711917|Rocuronium|rocuronium
137458|NCT02711917|BIS|bis
137459|NCT02711917|Closed loop infusion system|closed loop infusion system
137460|NCT02711904|Extubation|extubation
137461|NCT02711904|Cough|cough
137462|NCT02711904|Target Controlled Anesthesia (TACAN)|target controlled anesthesia (tacan)
137463|NCT02711891|fingerstick|fingerstick
137464|NCT02711891|opioid|opioid
137465|NCT02711891|heelstick|heelstick
137466|NCT02711891|loperamide|loperamide
137467|NCT02711891|topical opioid|topical opioid
137468|NCT02711826|graft inflammation|graft inflammation
137469|NCT02711826|Treg|treg
137470|NCT02711826|polyclonally expanded Tregs (polyTregs)|polyclonally expanded tregs (polytregs)
137471|NCT02711826|darTregs|dartregs
137472|NCT02711826|calcineurin inhibitors (CNIs)|calcineurin inhibitors (cnis)
137473|NCT02711826|mTOR inhibitors|mtor inhibitors
137474|NCT02711787|Hand|hand
137475|NCT02711787|Paralysis|paralysis
137476|NCT02711787|Stroke|stroke
137477|NCT02711722|Neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
137478|NCT02711709|Intra-abdominal sepsis|intra-abdominal sepsis
137479|NCT02711709|Surgical ICU|surgical icu
137480|NCT02711696|Celiac Disease,|celiac disease,
137481|NCT02711696|Gluten Free Diet|gluten free diet
137482|NCT02711696|Gluten contamination|gluten contamination
137483|NCT02711670|nephrolithiasis|nephrolithiasis
137484|NCT02711670|calcium stones|calcium stones
137485|NCT02711670|kidney stones|kidney stones
137486|NCT02711670|hypercalciuria|hypercalciuria
137487|NCT02711670|thiazide|thiazide
137488|NCT02711657|Fibrocytes|fibrocytes
137489|NCT02711657|Interstitial Lung Diseases|interstitial lung diseases
137490|NCT02711657|Rheumatoid Arthritis|rheumatoid arthritis
137491|NCT02711657|Asthma|asthma
137492|NCT02711644|Pregnancy|pregnancy
137493|NCT02711644|Prenatal|prenatal
137494|NCT02711644|Nutrition|nutrition
137495|NCT02711631|coronary angioplasty|coronary angioplasty
137496|NCT02711631|cardiac rehabilitation|cardiac rehabilitation
137497|NCT02711631|coronary artery bypass graft|coronary artery bypass graft
137498|NCT02711605|ultrasound|ultrasound
137499|NCT02711605|fat|fat
137500|NCT02711592|Orthopaedic Pain Management|orthopaedic pain management
137501|NCT02711566|Rehabilitation|rehabilitation
137502|NCT02711566|Robot-assisted therapy|robot-assisted therapy
137503|NCT02711501|post-operative pain|post-operative pain
137504|NCT02711501|diode laser|diode laser
137505|NCT02711488|school-based intervention|school-based intervention
137506|NCT02711488|sedentary behavior|sedentary behavior
137507|NCT02711488|physical activity|physical activity
137508|NCT02711488|sugar sweetened beverages|sugar sweetened beverages
137509|NCT02711462|Healthy Subjects|healthy subjects
137510|NCT02711449|acute surgery|acute surgery
137511|NCT02711449|laparoscopy|laparoscopy
137512|NCT02711371|addiction|addiction
137513|NCT02711371|cannabis|cannabis
137514|NCT02711371|fMRI|fmri
137515|NCT02711345|LTT462|ltt462
137516|NCT02711345|ERK|erk
137517|NCT02711345|MAPK|mapk
137518|NCT02711345|solid tumor|solid tumor
137519|NCT02711267|Open Flow Microperfusion|open flow microperfusion
137520|NCT02711241|Gastroenteritis|gastroenteritis
137521|NCT02711241|Analgesia|analgesia
137522|NCT02711241|Emergency department|emergency department
137523|NCT02711189|Addiction|addiction
137524|NCT02711189|Oxytocin|oxytocin
137525|NCT02711189|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
137526|NCT02711189|Alcohol|alcohol
137527|NCT02711189|Cue Reactivity|cue reactivity
137528|NCT02711137|Solid tumor|solid tumor
137529|NCT02711137|lymphoma|lymphoma
137530|NCT02711137|leukemia|leukemia
137531|NCT02711137|AML|aml
137532|NCT02711137|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
137533|NCT02711137|multiple myeloma|multiple myeloma
137534|NCT02711137|myeloproliferative neoplasm (MPN)|myeloproliferative neoplasm (mpn)
137535|NCT02711137|MDS/MPN|mds/mpn
137536|NCT02711137|myelofibrosis (MF)|myelofibrosis (mf)
137537|NCT02711137|pancreatic cancer|pancreatic cancer
137538|NCT02711137|colorectal cancer|colorectal cancer
137539|NCT02711137|non-small cell lung cancer|non-small cell lung cancer
137540|NCT02711137|prostate cancer|prostate cancer
137541|NCT02711137|breast cancer|breast cancer
137542|NCT02711137|ovarian cancer|ovarian cancer
137543|NCT02711137|glioblastoma multiforme (GBM)|glioblastoma multiforme (gbm)
137544|NCT02711137|NUT midline carcinoma|nut midline carcinoma
137545|NCT02711137|non-Hodgkin lymphoma|non-hodgkin lymphoma
137546|NCT02711137|diffuse large B-cell lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
137547|NCT02711137|double-hit|double-hit
137548|NCT02711137|triple-hit|triple-hit
137549|NCT02711137|myc|myc
137550|NCT02711137|bromodomain and extra-terminal (BET) inhibitor|bromodomain and extra-terminal (bet) inhibitor
137551|NCT02711124|hemoglobin A1c|hemoglobin a1c
137552|NCT02711124|coronary artery bypass grafting|coronary artery bypass grafting
137553|NCT02711124|impedance aggregometry|impedance aggregometry
137554|NCT02711124|platelet reactivity|platelet reactivity
137555|NCT02711124|clinical outcomes|clinical outcomes
137556|NCT02711098|cardiac arrest|cardiac arrest
137557|NCT02711098|hypothermia|hypothermia
137558|NCT02711098|critical care|critical care
137559|NCT02711059|hyperparathyroidism|hyperparathyroidism
137560|NCT02711059|insulin resistance|insulin resistance
137561|NCT02711020|Depressive symptoms|depressive symptoms
137562|NCT02711020|Fibromyalgia|fibromyalgia
137563|NCT02711020|Cognitive Behavioral Therapy|cognitive behavioral therapy
137564|NCT02711020|Personal Constructs Therapy|personal constructs therapy
137565|NCT02711020|Differential Efficacy|differential efficacy
137566|NCT02711007|osteosarcoma|osteosarcoma
137567|NCT02711007|metastasis|metastasis
137568|NCT02711007|advanced|advanced
137569|NCT02711007|apatinib|apatinib
137570|NCT02710994|Immediate release omeprazole|immediate release omeprazole
137571|NCT02710994|Integrated gastric acidity|integrated gastric acidity
137572|NCT02710981|Sildenafil vaginal gel|sildenafil vaginal gel
137573|NCT02710981|endometrium|endometrium
137574|NCT02710981|clomiphene|clomiphene
137575|NCT02710981|anovulation|anovulation
137576|NCT02710968|FETO|feto
137577|NCT02710916|Optical Coherence Tomography|optical coherence tomography
137578|NCT02710916|Intraocular pressure|intraocular pressure
137579|NCT02710916|Optic Nerve Head|optic nerve head
137580|NCT02710916|Nerve fiber layer|nerve fiber layer
137581|NCT02710916|Bruch Membrane Opening -Minimum Rim Width|bruch membrane opening -minimum rim width
137582|NCT02710903|Periodontitis|periodontitis
137583|NCT02710903|SNP|snp
137584|NCT02710903|Pathogenesis|pathogenesis
137585|NCT02710903|IL29|il29
137586|NCT02710903|IL28B|il28b
137587|NCT02710890|Epilepsy|epilepsy
137588|NCT02710890|pediatric|pediatric
137589|NCT02710890|intravenous|intravenous
137590|NCT02710890|children|children
137591|NCT02710890|Lacosamide|lacosamide
137592|NCT02710890|VIMPAT®|vimpat®
137593|NCT02710890|seizure|seizure
137594|NCT02710877|epidural analgesia|epidural analgesia
137595|NCT02710877|patient controlled analgesia|patient controlled analgesia
137596|NCT02710877|obstetric outcome|obstetric outcome
137597|NCT02710864|Cytomegalovirus|cytomegalovirus
137598|NCT02710851|human papillomavirus vaccine|human papillomavirus vaccine
137599|NCT02710851|condylomata acuminata|condylomata acuminata
137600|NCT02710838|Early gastric cancer|early gastric cancer
137601|NCT02710838|Infrared endoscope|infrared endoscope
137602|NCT02710799|Endocrinology|endocrinology
137603|NCT02710799|Referral list|referral list
137604|NCT02710799|Teleconsultation|teleconsultation
137605|NCT02710799|Telemedicine|telemedicine
137606|NCT02710799|Cluster randomized clinical trial|cluster randomized clinical trial
137607|NCT02710773|Gait|gait
137608|NCT02710773|Randomized controlled trial|randomized controlled trial
137609|NCT02710773|Chronic Stroke|chronic stroke
137610|NCT02710773|Treadmill training|treadmill training
137611|NCT02710760|Biomarkers|biomarkers
137612|NCT02710760|Child Nutrition Sciences|child nutrition sciences
137613|NCT02710760|Economics, Behavioral|economics, behavioral
137614|NCT02710747|warfarin|warfarin
137615|NCT02710747|Chinese patients|chinese patients
137616|NCT02710747|heart valve replacement|heart valve replacement
137617|NCT02710734|Urothelial|urothelial
137618|NCT02710721|Fasting|fasting
137619|NCT02710721|Prostatic Neoplasms|prostatic neoplasms
137620|NCT02710721|Complementary Therapies|complementary therapies
137621|NCT02710721|Urology|urology
137622|NCT02710708|birth control,|birth control,
137623|NCT02710708|contraceptives safety,|contraceptives safety,
137624|NCT02710708|contraceptives efficacy,|contraceptives efficacy,
137625|NCT02710708|moderate acne vulgaris|moderate acne vulgaris
137626|NCT02710682|Lateral Epicondylitis of the elbow|lateral epicondylitis of the elbow
137627|NCT02710682|Tendon Fenestration|tendon fenestration
137628|NCT02710682|Minimally invasive Surgery|minimally invasive surgery
137629|NCT02710682|Ultrasound-guided procedure|ultrasound-guided procedure
137630|NCT02710682|Ultrasonography|ultrasonography
137631|NCT02710682|Elastography|elastography
137632|NCT02710669|ablation|ablation
137633|NCT02710656|Atherosclerosis|atherosclerosis
137634|NCT02710656|SFA|sfa
137635|NCT02710656|Poplitea|poplitea
137636|NCT02710656|Drug coated balloon|drug coated balloon
137637|NCT02710656|Angioplasty|angioplasty
137638|NCT02710656|Restenosis|restenosis
137639|NCT02710656|Peripheral artery disease (PAD)|peripheral artery disease (pad)
137640|NCT02710643|Follicular|follicular
137641|NCT02710643|Lymphoma|lymphoma
137642|NCT02710643|Grade 1|grade 1
137643|NCT02710643|Grade 2|grade 2
137644|NCT02710643|Grade 3A|grade 3a
137645|NCT02710604|chronic hepatitis B(CHB)|chronic hepatitis b(chb)
137646|NCT02710591|Rimeporide|rimeporide
137647|NCT02710578|Alcohol impaired driving|alcohol impaired driving
137648|NCT02710578|Driving simulation|driving simulation
137649|NCT02710578|Residual effects of alcohol|residual effects of alcohol
137650|NCT02710578|Acute psychomotor effects of alcohol|acute psychomotor effects of alcohol
137651|NCT02710578|Young drivers|young drivers
137652|NCT02710565|Endo bronchial ultrasound|endo bronchial ultrasound
137653|NCT02710565|Trans bronchial needle aspiration|trans bronchial needle aspiration
137654|NCT02710565|Cell line|cell line
137655|NCT02710565|Lung cancer|lung cancer
137656|NCT02710552|arterial hypertension|arterial hypertension
137657|NCT02710552|antihypertensive drugs|antihypertensive drugs
137658|NCT02710539|arterial hypertension|arterial hypertension
137659|NCT02710539|antihypertensive drugs|antihypertensive drugs
137660|NCT02710513|beta-glucans|beta-glucans
137661|NCT02710513|gut microbiota|gut microbiota
137662|NCT02710513|p-cresyl sulphate (pCS)|p-cresyl sulphate (pcs)
137663|NCT02710513|indoxyl sulphate (IS)|indoxyl sulphate (is)
137664|NCT02710513|short-chain fatty acid (SCFA)|short-chain fatty acid (scfa)
137665|NCT02710500|LGMD2B|lgmd2b
137666|NCT02710500|Limb Girdle Muscular Dystrophy|limb girdle muscular dystrophy
137667|NCT02710500|Miyoshi|miyoshi
137668|NCT02710500|Gene Transfer|gene transfer
137669|NCT02710500|Dysferlin|dysferlin
137670|NCT02710487|Parkinson's disease, Sleep Benefit|parkinson's disease, sleep benefit
137671|NCT02710474|preterm birth|preterm birth
137672|NCT02710474|NICU|nicu
137673|NCT02710474|neonatal|neonatal
137674|NCT02710474|kangaroo care|kangaroo care
137675|NCT02710474|separation stress|separation stress
137676|NCT02710474|family nurture|family nurture
137677|NCT02710474|maternal confidence|maternal confidence
137678|NCT02710474|maternal competence|maternal competence
137679|NCT02710474|calming cycle|calming cycle
137680|NCT02710474|infant neurodevelopment|infant neurodevelopment
137681|NCT02710474|infant psychological development|infant psychological development
137682|NCT02710474|mother-infant co-regulation|mother-infant co-regulation
137683|NCT02710474|post-partum depression|post-partum depression
137684|NCT02710461|Polyphenols|polyphenols
137685|NCT02710461|Grape|grape
137686|NCT02710461|Pomegranate|pomegranate
137687|NCT02710461|Metabolic syndrome|metabolic syndrome
137688|NCT02710461|Abdominal obesity|abdominal obesity
137689|NCT02710461|Postprandial glucose|postprandial glucose
137690|NCT02710461|Insulin resistance|insulin resistance
137691|NCT02710435|Coronary Sinus|coronary sinus
137692|NCT02710435|Reducer|reducer
137693|NCT02710435|Refractory Angina|refractory angina
137694|NCT02710435|Angina Pectoris|angina pectoris
137695|NCT02710435|Angina Pectoris, Stable|angina pectoris, stable
137696|NCT02710435|Chronic Stable Angina|chronic stable angina
137697|NCT02710435|Persistent Angina|persistent angina
137698|NCT02710435|Neovasc Reducer System|neovasc reducer system
137699|NCT02710435|Refractory Angina Pectoris|refractory angina pectoris
137700|NCT02710435|Coronary Sinus Narrowing|coronary sinus narrowing
137701|NCT02710435|Reversible Ischemic Heart Disease|reversible ischemic heart disease
137702|NCT02710435|Chronic Angina|chronic angina
137703|NCT02710435|End Stage Angina|end stage angina
137704|NCT02710435|Coronary Sinus Reduction|coronary sinus reduction
137705|NCT02710435|Coronary Sinus Reducer|coronary sinus reducer
137706|NCT02710435|Chronic Refractory Angina|chronic refractory angina
137707|NCT02710435|Chronic Refractory Angina Pectoris|chronic refractory angina pectoris
137708|NCT02710422|Prostate Cancer|prostate cancer
137709|NCT02710422|Amniotic Membrane Placement|amniotic membrane placement
137710|NCT02710422|Robotic Assisted Radical Prostatectomy|robotic assisted radical prostatectomy
137711|NCT02710422|RARP|rarp
137712|NCT02710422|Human Amniotic Membrane Allograft|human amniotic membrane allograft
137713|NCT02710409|safety, immunogenicity , quadrivalent influenza vaccine|safety, immunogenicity , quadrivalent influenza vaccine
137714|NCT02710396|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
137715|NCT02710396|Non-Small Cell Lung Cancer|non-small cell lung cancer
137716|NCT02710396|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
137717|NCT02710396|Nonsmall Cell Lung Cancer|nonsmall cell lung cancer
137718|NCT02710396|NSCLC|nsclc
137719|NCT02710396|Cancer of Neck|cancer of neck
137720|NCT02710396|Neoplasms, Head and Neck|neoplasms, head and neck
137721|NCT02710396|Cancer of the Head|cancer of the head
137722|NCT02710396|Cancer of the Head and Neck|cancer of the head and neck
137723|NCT02710396|Head, Neck Neoplasms|head, neck neoplasms
137724|NCT02710396|Bladder Cancer|bladder cancer
137725|NCT02710396|Bladder Neoplasms|bladder neoplasms
137726|NCT02710396|Malignant Tumor of Urinary Bladder|malignant tumor of urinary bladder
137727|NCT02710396|Urinary Bladder Cancer|urinary bladder cancer
137728|NCT02710396|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
137729|NCT02710396|Carcinoma, Transitional Cell|carcinoma, transitional cell
137730|NCT02710370|Bariatric Surgery|bariatric surgery
137731|NCT02710370|Gastric Bypass|gastric bypass
137732|NCT02710370|Obesity/surgery|obesity/surgery
137733|NCT02710370|Endoscopy, Digestive System|endoscopy, digestive system
137734|NCT02710370|Blood Glucose/metabolism|blood glucose/metabolism
137735|NCT02710370|Diabetes Mellitus, Experimental/metabolism|diabetes mellitus, experimental/metabolism
137736|NCT02710370|Energy Metabolism|energy metabolism
137737|NCT02710370|Glucose/metabolism|glucose/metabolism
137738|NCT02710370|Jejunum/metabolism|jejunum/metabolism
137739|NCT02710370|Metabolomics|metabolomics
137740|NCT02710370|Gene Expression|gene expression
137741|NCT02710357|Mandibular Prosthesis Implantation|mandibular prosthesis implantation
137742|NCT02710357|Prostheses and Implants|prostheses and implants
137743|NCT02710357|Denture, Complete, Lower|denture, complete, lower
137744|NCT02710279|Psychiatry|psychiatry
137745|NCT02710279|Depressive disorder|depressive disorder
137746|NCT02710279|Suicide|suicide
137747|NCT02710266|Synthetic Protease Inhibitor|synthetic protease inhibitor
137748|NCT02710266|Hepatectomy|hepatectomy
137749|NCT02710266|Postoperative Complications|postoperative complications
137750|NCT02710253|Metastatic cancer|metastatic cancer
137751|NCT02710253|Prior treatment with immunotherapy agent|prior treatment with immunotherapy agent
137752|NCT02710253|Salvage radiation therapy|salvage radiation therapy
137753|NCT02710253|Radiation therapy|radiation therapy
137755|NCT02710253|Progressive disease|progressive disease
137756|NCT02710253|PD|pd
137757|NCT02710253|Stereotactic radiation|stereotactic radiation
137758|NCT02710253|External beam radiation|external beam radiation
137759|NCT02710253|Whole brain radiation therapy|whole brain radiation therapy
137760|NCT02710253|WBRT|wbrt
137761|NCT02710214|Hot flash|hot flash
137762|NCT02710214|Estrogen|estrogen
137763|NCT02710214|Women|women
137764|NCT02710149|CAR-T|car-t
137765|NCT02710149|Leukemia|leukemia
137766|NCT02710149|Lymphoma|lymphoma
137767|NCT02710136|Asthma|asthma
137768|NCT02710136|Glycerinated German cockroach allergenic extract|glycerinated german cockroach allergenic extract
137769|NCT02710136|Cockroach Nasal Allergen Challenge|cockroach nasal allergen challenge
137770|NCT02710058|support group|support group
137771|NCT02710058|15-246|15-246
137772|NCT02710058|The Arab American Breast Cancer Education and Referral Program (AMBER)|the arab american breast cancer education and referral program (amber)
137773|NCT02710045|Immunity, Innate|immunity, innate
137774|NCT02710045|Immunity, Non-Specific|immunity, non-specific
137775|NCT02710045|Transcriptome|transcriptome
137776|NCT02710045|Antibodies|antibodies
137777|NCT02710045|Cytokines|cytokines
137778|NCT02710045|Immunity, Cellular|immunity, cellular
137779|NCT02710032|Transgender women|transgender women
137780|NCT02710032|HIV Pre-Exposure Prophylaxis|hiv pre-exposure prophylaxis
137781|NCT02710032|Adherence|adherence
137782|NCT02710032|Peru|peru
137783|NCT02710032|Social Networks|social networks
137784|NCT02710019|substance use|substance use
137785|NCT02710019|psychosis|psychosis
137786|NCT02710019|youth|youth
137787|NCT02710019|video game|video game
137788|NCT02710006|Uterus|uterus
137789|NCT02710006|Ultrasound|ultrasound
137790|NCT02709980|Brain Injury|brain injury
137791|NCT02709980|Insomnia|insomnia
137792|NCT02709980|Sleep|sleep
137793|NCT02709941|Obstructive Sleep Apnea|obstructive sleep apnea
137794|NCT02709941|Inspiratory Muscle Strength Training|inspiratory muscle strength training
137795|NCT02709941|Baroreceptor Sensitivity|baroreceptor sensitivity
137796|NCT02709941|Blood Pressure|blood pressure
137797|NCT02709928|Multiple ascending dose|multiple ascending dose
137798|NCT02709850|ANGPTL-3|angptl-3
137799|NCT02709837|bioavailability|bioavailability
137800|NCT02709837|amino acid|amino acid
137801|NCT02709837|carnosine|carnosine
137802|NCT02709837|lycopene|lycopene
137803|NCT02709837|mastication|mastication
137804|NCT02709837|meat|meat
137805|NCT02709798|Shenfu Injection|shenfu injection
137806|NCT02709798|Reperfusion Injury|reperfusion injury
137807|NCT02709798|Myocardial Protection|myocardial protection
137808|NCT02709798|Percutaneous Coronary Intervention|percutaneous coronary intervention
137809|NCT02709746|paediatric patients|paediatric patients
137810|NCT02709733|Virtual Reality|virtual reality
137811|NCT02709733|Negative Symptoms|negative symptoms
137812|NCT02709720|Lung Cancer|lung cancer
137813|NCT02709720|Cancer Lung Disease|cancer lung disease
137814|NCT02709720|NORA|nora
137815|NCT02709720|GECP 15/02|gecp 15/02
137816|NCT02709720|Metronomic administration|metronomic administration
137817|NCT02709707|Diabetes, Blood Sugar|diabetes, blood sugar
137818|NCT02709681|Sickle Cell Disease|sickle cell disease
137819|NCT02709681|Hydroxyurea|hydroxyurea
137820|NCT02709668|MTHFR depression vitamins Homocysteine|mthfr depression vitamins homocysteine
137821|NCT02709655|paediatric|paediatric
137822|NCT02709616|Glioblastoma|glioblastoma
137823|NCT02709616|DC vaccine|dc vaccine
137824|NCT02709616|tumor antigen|tumor antigen
137825|NCT02709616|personalized vaccine|personalized vaccine
137826|NCT02709551|corporate health management|corporate health management
137827|NCT02709551|hrv|hrv
137828|NCT02709551|mindfulness|mindfulness
137829|NCT02709525|hyaluronic acid|hyaluronic acid
137830|NCT02709525|bone repair|bone repair
137831|NCT02709525|dental socket|dental socket
137832|NCT02709525|cone beam computed tomography|cone beam computed tomography
137833|NCT02709512|Malignant Pleural Mesothelioma with Low Argininosuccinate Synthetase 1 Expression|malignant pleural mesothelioma with low argininosuccinate synthetase 1 expression
137834|NCT02709486|Osteoarthritis, pain, tanezumab.|osteoarthritis, pain, tanezumab.
137835|NCT02709473|propofol|propofol
137836|NCT02709473|remifentanil|remifentanil
137837|NCT02709473|rocuronium|rocuronium
137838|NCT02709460|hematoma|hematoma
137839|NCT02709460|complication|complication
137840|NCT02709460|hysterectomy|hysterectomy
137841|NCT02709447|Intimate Partner Violence|intimate partner violence
137842|NCT02709447|Juvenile Delinquency|juvenile delinquency
137843|NCT02709447|Sexual Behavior|sexual behavior
137844|NCT02709421|post-Endoscopic Retrograde cholangiopancreatography pancreatitis|post-endoscopic retrograde cholangiopancreatography pancreatitis
137845|NCT02709421|Risk factors|risk factors
137846|NCT02709421|Indomethacin|indomethacin
137847|NCT02709408|Carbapenem resistance|carbapenem resistance
137848|NCT02709408|Enterobacteriaceae|enterobacteriaceae
137849|NCT02709408|Acinetobacter baumannii|acinetobacter baumannii
137850|NCT02709408|Bloodstream infections|bloodstream infections
137851|NCT02709408|Intrabdominal infections|intrabdominal infections
137852|NCT02709408|Urinary tract infections|urinary tract infections
137853|NCT02709408|Pneumonia|pneumonia
137854|NCT02709408|Risk factors|risk factors
137855|NCT02709408|Outcome|outcome
137856|NCT02709408|Hospitalised patients|hospitalised patients
137857|NCT02709408|Mortality|mortality
137858|NCT02709408|Clinical response|clinical response
137859|NCT02709408|Length of hospital stay|length of hospital stay
137860|NCT02709369|HIRREM|hirrem
137861|NCT02709369|Neuro-technology|neuro-technology
137862|NCT02709369|Closed-loop|closed-loop
137863|NCT02709369|Acoustic stimulation|acoustic stimulation
137864|NCT02709369|Allostatic|allostatic
137865|NCT02709369|heart rate variability|heart rate variability
137866|NCT02709369|baroreflex sensitivity|baroreflex sensitivity
137867|NCT02709369|traumatic brain injury|traumatic brain injury
137868|NCT02709369|sports concussion|sports concussion
137869|NCT02709369|PTSD|ptsd
137870|NCT02709369|hot flashes|hot flashes
137871|NCT02709369|headache|headache
137872|NCT02709369|insomnia|insomnia
137873|NCT02709304|urinary catheter discomfort|urinary catheter discomfort
137874|NCT02709278|BCG|bcg
137875|NCT02709278|Aerosol|aerosol
137876|NCT02709278|Tuberculosis|tuberculosis
137877|NCT02709278|Challenge|challenge
137878|NCT02709226|Brain Tumor|brain tumor
137879|NCT02709226|Astrocytoma|astrocytoma
137880|NCT02709226|GBM|gbm
137881|NCT02709226|Radiation Therapy|radiation therapy
137882|NCT02709213|Inflammatory chronic bowel disease|inflammatory chronic bowel disease
137883|NCT02709213|ICBD|icbd
137884|NCT02709213|Colorectal cancer|colorectal cancer
137885|NCT02709213|Infectious colitis|infectious colitis
137886|NCT02709187|DP-R208|dp-r208
137887|NCT02709174|Pulmonary Embolism|pulmonary embolism
137888|NCT02709174|Pregnancy|pregnancy
137889|NCT02709174|D-Dimer|d-dimer
137890|NCT02709161|neurofeedback|neurofeedback
137891|NCT02709161|major depressive disorder|major depressive disorder
137892|NCT02709161|amygdala|amygdala
137893|NCT02709148|Parkinson's Disease|parkinson's disease
137894|NCT02709070|highly-purified CTL|highly-purified ctl
137895|NCT02709044|Acute pancreatitis|acute pancreatitis
137896|NCT02709044|Fluid resuscitation|fluid resuscitation
137897|NCT02709044|Crystalloids|crystalloids
137898|NCT02709031|Cicletanine|cicletanine
137899|NCT02709031|Magnesium|magnesium
137900|NCT02709031|Metabolic disease|metabolic disease
137901|NCT02709018|posttraumatic stress disorder|posttraumatic stress disorder
137902|NCT02709018|losartan|losartan
137903|NCT02709018|angiotensin receptor blocker|angiotensin receptor blocker
137904|NCT02709005|Bacterial Vaginosis|bacterial vaginosis
137905|NCT02709005|Monolaurin Vaginal Gel|monolaurin vaginal gel
137906|NCT02708992|Azithromycin|azithromycin
137907|NCT02708992|Cefixime|cefixime
137908|NCT02708992|Duration|duration
137909|NCT02708992|High-Dose|high-dose
137910|NCT02708992|Neisseria gonorrhoeae|neisseria gonorrhoeae
137911|NCT02708992|Pharmacokinetics|pharmacokinetics
137912|NCT02708992|Susceptibility|susceptibility
137913|NCT02708979|Stress|stress
137914|NCT02708979|Eating|eating
137915|NCT02708966|Gymnema Sylvestre|gymnema sylvestre
137916|NCT02708966|Glycemic control|glycemic control
137917|NCT02708927|social integration|social integration
137918|NCT02708927|cognitive impairment|cognitive impairment
137919|NCT02708927|emotional processing|emotional processing
137920|NCT02708927|quality of life|quality of life
137921|NCT02708901|Autism Spectrum Disorder|autism spectrum disorder
137922|NCT02708901|Probiotic Vivomixx®|probiotic vivomixx®
137923|NCT02708901|Gastrointestinal Symptoms|gastrointestinal symptoms
137924|NCT02708901|Gut-Brain Axis|gut-brain axis
137925|NCT02708901|Endophenotypes|endophenotypes
137926|NCT02708888|Trunk|trunk
137927|NCT02708888|Biomechanical Phenomena|biomechanical phenomena
137928|NCT02708888|Gait|gait
137929|NCT02708888|Electromyography|electromyography
137930|NCT02708888|Rehabilitation|rehabilitation
137931|NCT02708888|Balance|balance
137932|NCT02708875|Microvascular|microvascular
137933|NCT02708875|Insulin resistance|insulin resistance
137934|NCT02708875|Mixed Meal|mixed meal
137935|NCT02708875|Glucose tolerance|glucose tolerance
137936|NCT02708823|Postoperative delirium|postoperative delirium
137937|NCT02708823|Risk assessment|risk assessment
137938|NCT02708823|Clinical screening tool|clinical screening tool
137939|NCT02708823|Tablet computer|tablet computer
137940|NCT02708810|radiosurgery (RS)|radiosurgery (rs)
137941|NCT02708810|trigeminal neuralgia (TGN)|trigeminal neuralgia (tgn)
137942|NCT02708797|Cerebral autoregulation|cerebral autoregulation
137943|NCT02708797|MRI|mri
137944|NCT02708797|VBM|vbm
137945|NCT02708797|Doppler Transcranial|doppler transcranial
137946|NCT02708784|Glykogen storage disease type 2)|glykogen storage disease type 2)
137947|NCT02708784|Dystrophia Myotonica|dystrophia myotonica
137948|NCT02708784|Muscular disorders|muscular disorders
137949|NCT02708784|MR-imaging|mr-imaging
137950|NCT02708784|Muscle strength|muscle strength
137951|NCT02708784|Myopathies|myopathies
137952|NCT02708745|communication|communication
137953|NCT02708745|immunization|immunization
137954|NCT02708719|COPD|copd
137955|NCT02708719|MID|mid
137956|NCT02708719|1-minute sit-to-stand-test|1-minute sit-to-stand-test
137957|NCT02708706|adhesive capsulitis|adhesive capsulitis
137958|NCT02708706|hyaluronic acid|hyaluronic acid
137959|NCT02708667|non-small cell lung cancer|non-small cell lung cancer
137960|NCT02708667|crizotinib|crizotinib
137961|NCT02708667|hepatic toxicity|hepatic toxicity
137962|NCT02708654|Remote monitoring|remote monitoring
137963|NCT02708654|Incentives|incentives
137964|NCT02708628|scar prevention|scar prevention
137965|NCT02708628|sectio|sectio
137966|NCT02708628|extract of allium cepae|extract of allium cepae
137967|NCT02708628|allantoin|allantoin
137968|NCT02708628|heparin|heparin
137969|NCT02708602|β2-adrenergic receptor|β2-adrenergic receptor
137970|NCT02708602|genetic polymorphisms|genetic polymorphisms
137971|NCT02708602|labor progress|labor progress
137972|NCT02708563|meconium|meconium
137973|NCT02708563|neonatal resuscitation|neonatal resuscitation
137974|NCT02708498|Palliative care|palliative care
137975|NCT02708498|Frail elderly|frail elderly
137976|NCT02708498|Comorbidity|comorbidity
137977|NCT02708498|Staff Development|staff development
137978|NCT02708498|Nursing Homes|nursing homes
137979|NCT02708472|Generalized Anxiety Disorder|generalized anxiety disorder
137980|NCT02708472|synchronized Transcranial Magnetic Stimulation|synchronized transcranial magnetic stimulation
137981|NCT02708472|Anxiety|anxiety
137982|NCT02708472|Neurostimulation|neurostimulation
137983|NCT02708472|TMS|tms
137984|NCT02708446|Second Trimester|second trimester
137985|NCT02708446|Abortion|abortion
137986|NCT02708446|Misoprostol|misoprostol
137987|NCT02708446|Sublingual|sublingual
137988|NCT02708446|Buccal|buccal
137989|NCT02708433|lidocaine, jaw|lidocaine, jaw
137990|NCT02708420|Glidescope|glidescope
137991|NCT02708420|Cardiovascular surgery|cardiovascular surgery
137992|NCT02708420|Macintosh Laryngoscope|macintosh laryngoscope
137993|NCT02708420|Hemodynamic response|hemodynamic response
137994|NCT02708420|Anesthesia|anesthesia
137995|NCT02708381|Population 70 years and older|population 70 years and older
137996|NCT02708381|Geriatric|geriatric
137997|NCT02708381|Oncogeriatric|oncogeriatric
137998|NCT02708381|Senior adult|senior adult
137999|NCT02708368|Chronic Kidney Disease - Mineral Bone Disorder (CKD-MBD)|chronic kidney disease - mineral bone disorder (ckd-mbd)
138000|NCT02708329|Coronary stenosis|coronary stenosis
138001|NCT02708329|Drug-eluting stent|drug-eluting stent
138002|NCT02708329|Coronary angioplasty with stenting|coronary angioplasty with stenting
138003|NCT02708329|Ischemic Heart Disease|ischemic heart disease
138004|NCT02708329|Chronic total occlusion|chronic total occlusion
138005|NCT02708329|Bifurcational lesion|bifurcational lesion
138006|NCT02708329|Bifurcational stenting|bifurcational stenting
138007|NCT02708303|Esophageal Reflux|esophageal reflux
138008|NCT02708303|Gastric Acid Reflux|gastric acid reflux
138009|NCT02708303|Gastric Acid Reflux Disease|gastric acid reflux disease
138010|NCT02708303|Gastro-Esophageal Reflux|gastro-esophageal reflux
138011|NCT02708303|Gastro-oesophageal Reflux|gastro-oesophageal reflux
138012|NCT02708303|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
138013|NCT02708303|Reflux, Gastroesophageal|reflux, gastroesophageal
138014|NCT02708303|Esophageal Hernia|esophageal hernia
138015|NCT02708303|Hernia, Esophageal|hernia, esophageal
138016|NCT02708303|Hernia, Paraesophageal|hernia, paraesophageal
138017|NCT02708303|Hiatal Hernia|hiatal hernia
138018|NCT02708303|Sliding Hiatal Hernia|sliding hiatal hernia
138019|NCT02708303|Sliding Esophageal Hernia|sliding esophageal hernia
138020|NCT02708303|Hernia, Hiatus|hernia, hiatus
138021|NCT02708303|Paraesophageal Hiatal Hernia|paraesophageal hiatal hernia
138022|NCT02708303|Questionnaires|questionnaires
138023|NCT02708277|intrauterine contraceptive device|intrauterine contraceptive device
138024|NCT02708277|intrauterine balloon|intrauterine balloon
138025|NCT02708238|Infantile colics|infantile colics
138026|NCT02708199|Drug resistance malaria|drug resistance malaria
138027|NCT02708199|Myanmar Artemisinin Resistance Containment Zone|myanmar artemisinin resistance containment zone
138028|NCT02708199|Asymptomatic malaria|asymptomatic malaria
138029|NCT02708199|Serology|serology
138030|NCT02708186|Dementia with Lewy bodies|dementia with lewy bodies
138031|NCT02708186|Lewy bodies|lewy bodies
138032|NCT02708186|REM sleep behavior disorder|rem sleep behavior disorder
138033|NCT02708186|Parkinson's disease dementia|parkinson's disease dementia
138034|NCT02708173|vaccine|vaccine
138035|NCT02708173|safety|safety
138036|NCT02708134|Chest compressions|chest compressions
138037|NCT02708134|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
138038|NCT02708069|Autism Spectrum Disorder|autism spectrum disorder
138039|NCT02708056|Sugammadex|sugammadex
138040|NCT02708056|Rocuronium|rocuronium
138041|NCT02708056|Infant patients|infant patients
138042|NCT02708017|Subcostal TAP block|subcostal tap block
138043|NCT02708017|Posterior TAP block|posterior tap block
138044|NCT02708017|Ultrasound|ultrasound
138045|NCT02708017|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
138046|NCT02707991|Continuity of Patient Care|continuity of patient care
138047|NCT02707991|Treatment Cascade|treatment cascade
138048|NCT02707978|Dementia|dementia
138049|NCT02707978|Brain Diseases|brain diseases
138050|NCT02707978|Central Nervous System Diseases|central nervous system diseases
138051|NCT02707978|Mild Cognitive Impairment|mild cognitive impairment
138052|NCT02707978|tauopathies|tauopathies
138053|NCT02707978|Neurodegenerative Disease|neurodegenerative disease
138054|NCT02707965|Generic brittle|generic brittle
138055|NCT02707965|Anti-epileptic drug|anti-epileptic drug
138056|NCT02707965|Bioequivalence|bioequivalence
138057|NCT02707952|Compensated cirrhosis|compensated cirrhosis
138058|NCT02707952|Hepatitis C Genotype 1|hepatitis c genotype 1
138059|NCT02707952|Hepatitis C Genotype 5|hepatitis c genotype 5
138060|NCT02707952|Non-cirrhotic|non-cirrhotic
138061|NCT02707952|Hepatitis C virus|hepatitis c virus
138062|NCT02707952|Hepatitis C Genotype 6|hepatitis c genotype 6
138063|NCT02707952|Hepatitis C Genotype 3|hepatitis c genotype 3
138064|NCT02707952|Hepatitis C Genotype 4|hepatitis c genotype 4
138065|NCT02707952|Renal impairment|renal impairment
138066|NCT02707952|Hepatitis C Genotype 2|hepatitis c genotype 2
138067|NCT02707952|Chronic Hepatitis C|chronic hepatitis c
138068|NCT02707900|Vorinostat|vorinostat
138069|NCT02707900|AGS-004|ags-004
138070|NCT02707900|HIV virus|hiv virus
138071|NCT02707900|AIDS|aids
138072|NCT02707887|Mental Disorders|mental disorders
138073|NCT02707887|Mood Disorders|mood disorders
138074|NCT02707887|Behavioral Activation|behavioral activation
138075|NCT02707861|HIV|hiv
138076|NCT02707861|Resistant|resistant
138077|NCT02707861|Salvage|salvage
138078|NCT02707861|ibalizumab|ibalizumab
138079|NCT02707861|antibody|antibody
138080|NCT02707861|AIDS|aids
138081|NCT02707835|Edema,taping,ultrasound|edema,taping,ultrasound
138082|NCT02707822|tacrolimus|tacrolimus
138083|NCT02707822|pharmacokinetics|pharmacokinetics
138084|NCT02707822|gene polymorphism|gene polymorphism
138085|NCT02707822|clinical factors|clinical factors
138086|NCT02707796|oxygen reserve index, partial oxygen pressure, hemicolectomy|oxygen reserve index, partial oxygen pressure, hemicolectomy
138087|NCT02707783|stable and unstable angina|stable and unstable angina
138088|NCT02707783|bioresorbable vascular scaffold|bioresorbable vascular scaffold
138089|NCT02707783|BVS|bvs
138090|NCT02707783|PCI|pci
138091|NCT02707770|COPD, pulmonary rehabilitation, ambulatory oxygen therapy|copd, pulmonary rehabilitation, ambulatory oxygen therapy
138092|NCT02707757|Haemodialysis|haemodialysis
138093|NCT02707757|Anaemia|anaemia
138094|NCT02707757|Iron|iron
138095|NCT02707757|Erythropoeitin stimulating agents|erythropoeitin stimulating agents
138096|NCT02707744|Heart Failure|heart failure
138097|NCT02707744|Atrial Fibrillation|atrial fibrillation
138098|NCT02707744|Ambulatory ECG monitor|ambulatory ecg monitor
138099|NCT02707718|sepsis|sepsis
138100|NCT02707718|biomarker|biomarker
138101|NCT02707718|prognostic|prognostic
138102|NCT02707718|emergency department|emergency department
138103|NCT02707718|diagnosis|diagnosis
138105|NCT02707692|AIDS|aids
138106|NCT02707692|Immune Stimulation|immune stimulation
138107|NCT02707692|HIV Reservoir|hiv reservoir
138108|NCT02707679|Knee|knee
138109|NCT02707679|Mobilization|mobilization
138110|NCT02707679|Taping|taping
138111|NCT02707679|Function|function
138112|NCT02707679|Balance|balance
138113|NCT02707666|resectable malignant pleural mesothelioma|resectable malignant pleural mesothelioma
138114|NCT02707666|Pembrolizumab|pembrolizumab
138115|NCT02707627|Pediatric|pediatric
138116|NCT02707627|Laser|laser
138117|NCT02707627|Burn|burn
138118|NCT02707627|Scar|scar
138119|NCT02707627|Photothermolysis|photothermolysis
138120|NCT02707601|HIV|hiv
138121|NCT02707601|HCV|hcv
138122|NCT02707601|Antiretroviral therapy|antiretroviral therapy
138123|NCT02707601|HCV direct acting antiviral(s) (DAA)|hcv direct acting antiviral(s) (daa)
138124|NCT02707588|Determine the tolerance and efficacy of Pembrolizumab|determine the tolerance and efficacy of pembrolizumab
138125|NCT02707575|Keratin|keratin
138126|NCT02707575|Ranibizumab|ranibizumab
138127|NCT02707562|Cystic fibrosis G551D mutation|cystic fibrosis g551d mutation
138128|NCT02707562|GLPG1837|glpg1837
138129|NCT02707549|crystalloid solutions|crystalloid solutions
138130|NCT02707549|acid-base imbalance|acid-base imbalance
138131|NCT02707549|water-electrolyte Imbalance|water-electrolyte imbalance
138132|NCT02707523|RSV|rsv
138133|NCT02707523|respiratory support|respiratory support
138134|NCT02707523|RSV induced respiratory failure|rsv induced respiratory failure
138135|NCT02707510|logotherapy|logotherapy
138136|NCT02707510|cognitive behavior therapy|cognitive behavior therapy
138137|NCT02707510|metastatic breast cancer|metastatic breast cancer
138138|NCT02707497|sepsis|sepsis
138139|NCT02707497|thrombocytopenia|thrombocytopenia
138140|NCT02707497|recombinant human thrombopoietin|recombinant human thrombopoietin
138141|NCT02707497|platelet|platelet
138142|NCT02707497|28-day mortality|28-day mortality
138143|NCT02707484|Gastrointestinal vascular malformation|gastrointestinal vascular malformation
138144|NCT02707484|thalidomide|thalidomide
138145|NCT02707484|Small intestinal bleeding|small intestinal bleeding
138146|NCT02707458|apolipoprotein E|apolipoprotein e
138147|NCT02707458|Alzheimer|alzheimer
138148|NCT02707458|pre-clinical|pre-clinical
138149|NCT02707458|pre-symptomatic|pre-symptomatic
138150|NCT02707458|dose-finding|dose-finding
138151|NCT02707458|prevention|prevention
138152|NCT02707432|Cardiovascular Diseases|cardiovascular diseases
138153|NCT02707432|Community-Based Participatory Research|community-based participatory research
138154|NCT02707432|African Americans|african americans
138155|NCT02707419|Total knee replacement|total knee replacement
138156|NCT02707419|Action observation treatment|action observation treatment
138157|NCT02707419|Rehabilitation|rehabilitation
138158|NCT02707393|stem cell transplantation|stem cell transplantation
138159|NCT02707393|pediatrics|pediatrics
138160|NCT02707354|GVHD|gvhd
138161|NCT02707354|confocal endomicroscopy|confocal endomicroscopy
138162|NCT02707341|psoriasis|psoriasis
138163|NCT02707341|disease registry|disease registry
138164|NCT02707328|Gemcitabine|gemcitabine
138165|NCT02707328|Gemzar|gemzar
138166|NCT02707328|CyberKnife|cyberknife
138167|NCT02707328|Cyber knife|cyber knife
138168|NCT02707328|CK|ck
138169|NCT02707328|abraxane|abraxane
138170|NCT02707328|nab-paclitaxel|nab-paclitaxel
138171|NCT02707315|Cyber Knife|cyber knife
138172|NCT02707315|CyberKnife|cyberknife
138173|NCT02707315|Stereotactic Radiosurgery|stereotactic radiosurgery
138174|NCT02707315|CK|ck
138175|NCT02707276|Bipolar Depression|bipolar depression
138176|NCT02707276|Geriatric|geriatric
138177|NCT02707276|Low Field Magnetic Stimulation|low field magnetic stimulation
138178|NCT02707263|heparin|heparin
138179|NCT02707250|pethidine|pethidine
138180|NCT02707250|laparoscopic cholecystectomy|laparoscopic cholecystectomy
138181|NCT02707250|bupivacaine|bupivacaine
138182|NCT02707224|DP-R208|dp-r208
138183|NCT02707172|Diethylhexyl Phthalate|diethylhexyl phthalate
138184|NCT02707172|Hand hygiene|hand hygiene
138185|NCT02707172|Soaps|soaps
138186|NCT02707172|N-of-1 design|n-of-1 design
138187|NCT02707172|Cross-Over Studies|cross-over studies
138188|NCT02707159|Circulating tumor cells|circulating tumor cells
138189|NCT02707159|Nab-paclitaxel|nab-paclitaxel
138190|NCT02707159|Metastatic pancreatic cancer|metastatic pancreatic cancer
138191|NCT02707159|Gemcitabine|gemcitabine
138192|NCT02707120|PRGF, Neurotrophic Keratitis, platelet rich plasma, PRP|prgf, neurotrophic keratitis, platelet rich plasma, prp
138193|NCT02707094|back|back
138194|NCT02707094|pain|pain
138195|NCT02707094|chronic|chronic
138196|NCT02707068|Quality of Life|quality of life
138197|NCT02707068|Self-help intervention|self-help intervention
138198|NCT02707055|Alcohol Consumption|alcohol consumption
138199|NCT02707055|Alcohol Treatment|alcohol treatment
138200|NCT02707055|Alcoholism|alcoholism
138201|NCT02707055|Ghrelin|ghrelin
138202|NCT02707055|Ghrelin Antagonism|ghrelin antagonism
138203|NCT02707042|Microbiome|microbiome
138204|NCT02707042|Amoxicillin|amoxicillin
138205|NCT02707042|Azithromycin|azithromycin
138206|NCT02707042|Metagenome|metagenome
138207|NCT02707042|Metabolic|metabolic
138208|NCT02707029|Screening Protocol|screening protocol
138209|NCT02707029|Pain|pain
138210|NCT02707029|Phenotypes|phenotypes
138211|NCT02707016|Emergence delirium|emergence delirium
138212|NCT02707016|Sevoflurane|sevoflurane
138213|NCT02707016|Pediatric anesthesia|pediatric anesthesia
138214|NCT02707003|Post-operative respiratory distress|post-operative respiratory distress
138215|NCT02706977|Ophthalmology|ophthalmology
138216|NCT02706964|metastasis|metastasis
138217|NCT02706964|3D imaging|3d imaging
138218|NCT02706964|early detection|early detection
138219|NCT02706951|Musculoskeletal Disease|musculoskeletal disease
138220|NCT02706951|Arthritis|arthritis
138221|NCT02706951|Joint Disease|joint disease
138222|NCT02706951|anti-inflammatory agents|anti-inflammatory agents
138223|NCT02706951|antirheumatic agents|antirheumatic agents
138224|NCT02706938|Gastroesophageal reflux disease|gastroesophageal reflux disease
138225|NCT02706938|Head of bed elevation|head of bed elevation
138226|NCT02706938|Quality of life|quality of life
138227|NCT02706938|Nocturnal symptoms|nocturnal symptoms
138228|NCT02706938|Lifestyle measures|lifestyle measures
138229|NCT02706912|Stroke|stroke
138230|NCT02706912|Hemiparesis|hemiparesis
138231|NCT02706912|Activities of Daily Living|activities of daily living
138232|NCT02706912|Virtual World|virtual world
138233|NCT02706912|Occupational Therapy|occupational therapy
138234|NCT02706899|Antibody-Drug Conjugate CD33 Antigen|antibody-drug conjugate cd33 antigen
138235|NCT02706886|PH1|ph1
138236|NCT02706886|Primary Hyperoxaluria|primary hyperoxaluria
138237|NCT02706886|RNAi therapeutic|rnai therapeutic
138238|NCT02706886|siRNA|sirna
138239|NCT02706886|AGT|agt
138240|NCT02706873|Musculoskeletal disease|musculoskeletal disease
138241|NCT02706873|Arthritis|arthritis
138242|NCT02706873|Joint disease|joint disease
138243|NCT02706873|Anti-inflammatory agents|anti-inflammatory agents
138244|NCT02706873|Antirheumatic agents|antirheumatic agents
138245|NCT02706847|Musculoskeletal Disease|musculoskeletal disease
138246|NCT02706847|Arthritis|arthritis
138247|NCT02706847|Joint Disease|joint disease
138248|NCT02706847|Anti-inflammatory agents|anti-inflammatory agents
138249|NCT02706847|Antirheumatic agents|antirheumatic agents
138250|NCT02706834|Drug therapy|drug therapy
138251|NCT02706821|prediabetes|prediabetes
138252|NCT02706821|blood glucose|blood glucose
138253|NCT02706821|clinical trial|clinical trial
138254|NCT02706808|chronic kidney disease|chronic kidney disease
138255|NCT02706808|hemodialysis|hemodialysis
138256|NCT02706808|conservative treatment|conservative treatment
138257|NCT02706808|resistance starch|resistance starch
138258|NCT02706795|Cervical dystonia|cervical dystonia
138259|NCT02706795|Spasmodic torticollis|spasmodic torticollis
138260|NCT02706704|Intravitreal Adalimumab|intravitreal adalimumab
138261|NCT02706704|Subcutaneous Adalimumab|subcutaneous adalimumab
138262|NCT02706678|FK506|fk506
138263|NCT02706678|Renal transplant recipients|renal transplant recipients
138264|NCT02706678|cyclosporin|cyclosporin
138265|NCT02706665|Anesthetics|anesthetics
138266|NCT02706665|Propofol|propofol
138267|NCT02706665|Electroencephalography|electroencephalography
138268|NCT02706665|SEDline monitor|sedline monitor
138269|NCT02706652|Screening|screening
138270|NCT02706652|Genotype|genotype
138271|NCT02706652|Drug Dosing|drug dosing
138272|NCT02706652|Trial Selection|trial selection
138273|NCT02706639|Biospecimen Procurement|biospecimen procurement
138274|NCT02706639|Laboratory Research Specimens|laboratory research specimens
138275|NCT02706639|Sample Collection|sample collection
138276|NCT02706639|Rare Diseases|rare diseases
138277|NCT02706587|Critical illness polyneuropathy|critical illness polyneuropathy
138278|NCT02706587|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
138279|NCT02706574|Eye Tracking|eye tracking
138280|NCT02706574|Blood-based Biomarkers|blood-based biomarkers
138281|NCT02706574|CSF-based Biomarkers|csf-based biomarkers
138282|NCT02706574|Magnetic Resonance Imaging|magnetic resonance imaging
138283|NCT02706574|Computed Tomography Scan|computed tomography scan
138284|NCT02706574|Outcome Measures|outcome measures
138285|NCT02706561|15-317|15-317
138286|NCT02706548|occupational therapy|occupational therapy
138287|NCT02706548|medication adherence|medication adherence
138288|NCT02706548|intervention studies|intervention studies
138289|NCT02706535|Itraconazole|itraconazole
138290|NCT02706535|Rifampicin|rifampicin
138291|NCT02706535|Pharmacokinetics|pharmacokinetics
138292|NCT02706535|Cross-over|cross-over
138293|NCT02706496|aging of elderly|aging of elderly
138294|NCT02706496|falling prevention|falling prevention
138295|NCT02706496|electroencephalography|electroencephalography
138296|NCT02706496|postural control|postural control
138297|NCT02706496|biomechanics|biomechanics
138298|NCT02706470|recurrent miscarriage; immunology|recurrent miscarriage; immunology
138299|NCT02706457|intensive care|intensive care
138300|NCT02706457|functionality|functionality
138301|NCT02706405|PD-L1|pd-l1
138302|NCT02706405|immunotherapy|immunotherapy
138303|NCT02706405|non-Hodgkin lymphoma|non-hodgkin lymphoma
138304|NCT02706353|Melanoma|melanoma
138305|NCT02706353|Metastatic Melanoma|metastatic melanoma
138306|NCT02706353|Intratumoral APX005M|intratumoral apx005m
138307|NCT02706353|Pembrolizumab|pembrolizumab
138308|NCT02706353|Keytruda|keytruda
138309|NCT02706353|MK-3475|mk-3475
138310|NCT02706353|SCH-900475|sch-900475
138311|NCT02706327|orthotic insoles|orthotic insoles
138312|NCT02706327|pain|pain
138313|NCT02706327|quality of life|quality of life
138314|NCT02706327|athletic performance|athletic performance
138315|NCT02706301|colorectal cancer survivor|colorectal cancer survivor
138316|NCT02706301|cancer pain|cancer pain
138317|NCT02706301|psychological distress|psychological distress
138318|NCT02706301|coping skills training|coping skills training
138319|NCT02706301|symptom management|symptom management
138320|NCT02706301|cancer survivorship|cancer survivorship
138321|NCT02706210|Mild Cognitive Impairment|mild cognitive impairment
138322|NCT02706210|Diffusion Tensor Imaging|diffusion tensor imaging
138323|NCT02706197|Electron Paramagnetic Resonance|electron paramagnetic resonance
138324|NCT02706197|Hypoxia|hypoxia
138325|NCT02706197|OxyChip|oxychip
138326|NCT02706184|gastric cancer|gastric cancer
138327|NCT02706184|colorectal cancer|colorectal cancer
138328|NCT02706184|chemotherapy induced diarrhea|chemotherapy induced diarrhea
138329|NCT02706184|5-Fluoruracil|5-fluoruracil
138330|NCT02706184|chemotherapeutic remedy|chemotherapeutic remedy
138331|NCT02706145|social norms|social norms
138332|NCT02706145|youth violence|youth violence
138333|NCT02706145|media|media
138334|NCT02706132|Mesenchymal stromal cells|mesenchymal stromal cells
138335|NCT02706132|Liver Transplantation|liver transplantation
138336|NCT02706132|ABO blood group|abo blood group
138337|NCT02706119|total parenteral nutrition|total parenteral nutrition
138338|NCT02706119|glargine insulin|glargine insulin
138339|NCT02706119|insulin|insulin
138340|NCT02706080|Antithrombotic agents|antithrombotic agents
138341|NCT02706080|VKA|vka
138342|NCT02706080|Direct Oral Anticoagulant|direct oral anticoagulant
138343|NCT02706080|Antiplatelet|antiplatelet
138344|NCT02706080|Bleeding|bleeding
138345|NCT02706080|Emergency|emergency
138346|NCT02706041|Exploratory Lap (Ex Lap)|exploratory lap (ex lap)
138347|NCT02706041|Damage Control Laparotomy (DCL)|damage control laparotomy (dcl)
138348|NCT02706041|Definitive|definitive
138349|NCT02706028|underwater ultrasound|underwater ultrasound
138350|NCT02706028|rheumatoid arthritis|rheumatoid arthritis
138351|NCT02706015|Headache|headache
138352|NCT02706015|Aura|aura
138353|NCT02706015|Migraine|migraine
138354|NCT02705937|xerostomia, Saliva, iatrogenic oral dryness, dairy product|xerostomia, saliva, iatrogenic oral dryness, dairy product
138355|NCT02705898|alcohol use disorders|alcohol use disorders
138356|NCT02705898|physical activity|physical activity
138357|NCT02705898|women's health|women's health
138358|NCT02705885|IgY|igy
138359|NCT02705885|Periodontitis|periodontitis
138360|NCT02705885|Porphyromonas gingivalis|porphyromonas gingivalis
138361|NCT02705885|gingipains|gingipains
138362|NCT02705885|Efficacy|efficacy
138363|NCT02705872|Epidural|epidural
138364|NCT02705872|Programmed intermittent boluses|programmed intermittent boluses
138365|NCT02705872|Cesarian section|cesarian section
138366|NCT02705872|Instrumented delivery|instrumented delivery
138367|NCT02705846|BRCA1|brca1
138368|NCT02705846|BRCA2|brca2
138369|NCT02705846|Lynch Syndrome|lynch syndrome
138370|NCT02705820|Metastatic, Lung Cancer, Switch, Maintenance, Pembrolizumab.|metastatic, lung cancer, switch, maintenance, pembrolizumab.
138371|NCT02705807|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
138372|NCT02705807|safety|safety
138373|NCT02705807|FLOLAN|flolan
138374|NCT02705807|New Thermostable Formulation|new thermostable formulation
138375|NCT02705807|dose adjustment|dose adjustment
138376|NCT02705807|reformulated diluents|reformulated diluents
138377|NCT02705807|currently marketed diluent|currently marketed diluent
138378|NCT02705794|intubation, laryngoscopy|intubation, laryngoscopy
138379|NCT02705768|Neuron-specific enolase (NSE)|neuron-specific enolase (nse)
138380|NCT02705768|Carbamazepine|carbamazepine
138381|NCT02705768|Oxcarbazepine|oxcarbazepine
138382|NCT02705755|Neurogenic Orthostatic Hypotension (nOH)|neurogenic orthostatic hypotension (noh)
138383|NCT02705755|Multiple System Atrophy (MSA)|multiple system atrophy (msa)
138384|NCT02705755|Pure Autonomic Failure|pure autonomic failure
138385|NCT02705755|Parkinson Disease(PD)|parkinson disease(pd)
138386|NCT02705755|nOH|noh
138387|NCT02705755|MSA|msa
138388|NCT02705755|PD|pd
138389|NCT02705755|PAF|paf
138390|NCT02705755|Orthostatic Hypotension|orthostatic hypotension
138391|NCT02705742|Mesenchymal stem cells|mesenchymal stem cells
138392|NCT02705742|Liver cirrhosis|liver cirrhosis
138393|NCT02705742|Hepatitis C|hepatitis c
138394|NCT02705729|dental caries|dental caries
138395|NCT02705729|proximal surfaces|proximal surfaces
138396|NCT02705729|posterior teeth|posterior teeth
138397|NCT02705729|carious lesions|carious lesions
138398|NCT02705729|tooth diseases|tooth diseases
138399|NCT02705729|dental restorations|dental restorations
138400|NCT02705729|glass-ionomer|glass-ionomer
138401|NCT02705664|Onychomycosis|onychomycosis
138402|NCT02705612|Cervical cancer|cervical cancer
138403|NCT02705612|cisplatin|cisplatin
138404|NCT02705612|nimotuzumab|nimotuzumab
138405|NCT02705599|Ischemic stroke|ischemic stroke
138406|NCT02705599|High resolution MRI|high resolution mri
138407|NCT02705599|Perfusion|perfusion
138408|NCT02705599|Mechanism|mechanism
138409|NCT02705586|Movement disorders|movement disorders
138410|NCT02705586|Metabolic Stress|metabolic stress
138411|NCT02705547|Friedreich Ataxia|friedreich ataxia
138412|NCT02705534|Hepatitis C|hepatitis c
138413|NCT02705534|Cirrhosis|cirrhosis
138414|NCT02705534|Sofosbuvir|sofosbuvir
138415|NCT02705534|Ledipasvir|ledipasvir
138416|NCT02705534|Ribavirin|ribavirin
138417|NCT02705521|shoulder|shoulder
138418|NCT02705521|impingement|impingement
138419|NCT02705521|rehabilitation|rehabilitation
138420|NCT02705521|physiotherapy|physiotherapy
138421|NCT02705521|gamification|gamification
138422|NCT02705521|activation|activation
138423|NCT02705521|engagement|engagement
138424|NCT02705508|extranodal natural killer/T-cell lymphoma|extranodal natural killer/t-cell lymphoma
138425|NCT02705508|nasal type|nasal type
138426|NCT02705508|chemotherapy|chemotherapy
138427|NCT02705508|radiotherapy|radiotherapy
138428|NCT02705482|Advanced solid tumors|advanced solid tumors
138429|NCT02705482|MEDI0562|medi0562
138430|NCT02705482|durvalumab|durvalumab
138431|NCT02705482|tremelimumab|tremelimumab
138432|NCT02705482|OX40|ox40
138433|NCT02705482|PD-L1|pd-l1
138434|NCT02705482|CTLA-4|ctla-4
138435|NCT02705482|immuno-oncology|immuno-oncology
138436|NCT02705482|Cancer|cancer
138437|NCT02705469|Metastatic Castration-Resistant Prostate Cancer (mCRPC)|metastatic castration-resistant prostate cancer (mcrpc)
138438|NCT02705469|Phase 1|phase 1
138439|NCT02705469|Prostate Cancer|prostate cancer
138440|NCT02705469|Pharmacokinetics (PK)|pharmacokinetics (pk)
138441|NCT02705469|ZEN003694|zen003694
138442|NCT02705469|ZEN-3694|zen-3694
138443|NCT02705469|Metastatic Castrate-Resistant Prostate Cancer|metastatic castrate-resistant prostate cancer
138444|NCT02705469|BET inhibitor (BETi)|bet inhibitor (beti)
138445|NCT02705469|Bromodomain|bromodomain
138446|NCT02705469|Pharmacodynamics (PD)|pharmacodynamics (pd)
138447|NCT02705469|Epigenetics|epigenetics
138448|NCT02705456|Dental Caries|dental caries
138449|NCT02705456|Tooth Paste|tooth paste
138450|NCT02705456|Orthodontics|orthodontics
138451|NCT02705456|Fluorides|fluorides
138452|NCT02705417|arteriovenous fistula|arteriovenous fistula
138453|NCT02705417|colour Doppler|colour doppler
138454|NCT02705417|physical examination|physical examination
138455|NCT02705417|renal dialysis|renal dialysis
138456|NCT02705417|retrospective studies|retrospective studies
138457|NCT02705404|multifocal|multifocal
138458|NCT02705404|genetic|genetic
138459|NCT02705404|bronchoalveolar carcinoma|bronchoalveolar carcinoma
138460|NCT02705404|adenocarcinoma in situ|adenocarcinoma in situ
138461|NCT02705404|ground glass opacity|ground glass opacity
138462|NCT02705404|next generation sequencing|next generation sequencing
138463|NCT02705378|Intensive care unit|intensive care unit
138464|NCT02705378|ICU|icu
138465|NCT02705378|Critical Illness|critical illness
138466|NCT02705378|Constipation|constipation
138467|NCT02705365|Lung Screening|lung screening
138468|NCT02705365|Low-Dose Computer Tomography|low-dose computer tomography
138469|NCT02705365|Patient Navigation|patient navigation
138470|NCT02705352|Skin graft|skin graft
138471|NCT02705352|5-Fluorouracil|5-fluorouracil
138472|NCT02705352|Periocular reconstruction|periocular reconstruction
138473|NCT02705313|neuroendocrine tumors|neuroendocrine tumors
138474|NCT02705313|177Lu-DOTA0-Tyr3-Octreotate|177lu-dota0-tyr3-octreotate
138475|NCT02705313|PRRT|prrt
138476|NCT02705287|vitamin D|vitamin d
138477|NCT02705287|half life|half life
138478|NCT02705287|kinetics|kinetics
138479|NCT02705261|child|child
138480|NCT02705261|behavior therapy|behavior therapy
138481|NCT02705261|cognitive therapy|cognitive therapy
138482|NCT02705261|parent|parent
138483|NCT02705261|anxiety|anxiety
138484|NCT02705222|Abnormal uterine bleeding|abnormal uterine bleeding
138485|NCT02705222|Dilatation and curettage|dilatation and curettage
138486|NCT02705222|Hysteroscopy|hysteroscopy
138487|NCT02705196|oncolytic|oncolytic
138488|NCT02705196|adenovirus|adenovirus
138489|NCT02705196|pancreatic|pancreatic
138491|NCT02705196|LOKON|lokon
138492|NCT02705196|LOAd703|load703
138493|NCT02705183|surgical treatment|surgical treatment
138494|NCT02705183|post-operative radiotherapy|post-operative radiotherapy
138495|NCT02705183|quality of life|quality of life
138496|NCT02705183|complications|complications
138497|NCT02705183|survival|survival
138498|NCT02705183|long bones|long bones
138499|NCT02705170|index of microvascular resistance|index of microvascular resistance
138500|NCT02705157|long bones|long bones
138501|NCT02705157|survival|survival
138502|NCT02705157|prognosis|prognosis
138503|NCT02705157|treatment|treatment
138504|NCT02705157|quality of life|quality of life
138505|NCT02705131|Cervical radiculopathy|cervical radiculopathy
138506|NCT02705131|Balance chiropractic therapy|balance chiropractic therapy
138507|NCT02705118|radiofrequency ablation|radiofrequency ablation
138508|NCT02705118|image fusion|image fusion
138509|NCT02705105|Metastatic Solid Tumors|metastatic solid tumors
138510|NCT02705105|Advanced Solid Tumors|advanced solid tumors
138511|NCT02705105|KW-0761|kw-0761
138512|NCT02705105|ONO-4538/BMS-936558|ono-4538/bms-936558
138513|NCT02705105|Anti-tumor|anti-tumor
138514|NCT02705105|Mogamulizumab|mogamulizumab
138515|NCT02705105|Nivolumab|nivolumab
138516|NCT02705105|Oncology|oncology
138517|NCT02705105|HCC|hcc
138518|NCT02705105|Hepatocellular carcinoma|hepatocellular carcinoma
138519|NCT02705053|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
138520|NCT02705053|Artificial Pancreas|artificial pancreas
138521|NCT02705053|Autoimmune Diseases|autoimmune diseases
138522|NCT02705053|Diabetes Mellitus|diabetes mellitus
138523|NCT02705053|Hyperglycemia|hyperglycemia
138524|NCT02705053|Hypoglycemia|hypoglycemia
138525|NCT02705040|male osteoporosis|male osteoporosis
138526|NCT02705040|miRNA|mirna
138527|NCT02705040|biomarker|biomarker
138528|NCT02705014|pituitary stalk interruption syndrome|pituitary stalk interruption syndrome
138529|NCT02705014|pulsatile GnRH therapy|pulsatile gnrh therapy
138530|NCT02705014|hypogonadotropic hypogonadism|hypogonadotropic hypogonadism
138531|NCT02705014|hypopituitarism|hypopituitarism
138532|NCT02704975|Dry Needling, Shoulder Stabilization|dry needling, shoulder stabilization
138533|NCT02704962|schizophrenia|schizophrenia
138534|NCT02704962|olanzapine|olanzapine
138535|NCT02704962|trifluoperazine|trifluoperazine
138536|NCT02704962|antipsychotic polypharmacy|antipsychotic polypharmacy
138537|NCT02704949|Urolithiasis|urolithiasis
138538|NCT02704949|Fluoroscopy|fluoroscopy
138539|NCT02704949|Radiation|radiation
138540|NCT02704949|Ureteroscopy|ureteroscopy
138541|NCT02704923|Atropine|atropine
138542|NCT02704923|Pneumonia|pneumonia
138543|NCT02704923|Ventilator|ventilator
138544|NCT02704923|Adults|adults
138545|NCT02704923|Intensive care unit.|intensive care unit.
138546|NCT02704871|SeptiCyte|septicyte
138547|NCT02704858|recurrent glioblastoma|recurrent glioblastoma
138548|NCT02704858|recurrent GBM|recurrent gbm
138549|NCT02704845|Inflammatory back pain|inflammatory back pain
138550|NCT02704845|Ankylosing spondylitis|ankylosing spondylitis
138551|NCT02704845|Non-specific low back pain|non-specific low back pain
138552|NCT02704845|Pain experience|pain experience
138553|NCT02704845|Disability|disability
138554|NCT02704845|Behavioural|behavioural
138555|NCT02704845|Psychological|psychological
138556|NCT02704845|Biopsychosocial|biopsychosocial
138557|NCT02704845|Pain profiles|pain profiles
138558|NCT02704832|Geriatric oncology|geriatric oncology
138559|NCT02704832|Intervention|intervention
138560|NCT02704832|Case management|case management
138561|NCT02704819|Decision Support System|decision support system
138562|NCT02704819|Dizziness|dizziness
138563|NCT02704819|Vertigo|vertigo
138564|NCT02704819|Balance|balance
138565|NCT02704780|Retained placenta|retained placenta
138566|NCT02704780|Misoprostol|misoprostol
138567|NCT02704780|double blind|double blind
138568|NCT02704780|Randomization|randomization
138569|NCT02704780|Haemorrhage|haemorrhage
138570|NCT02704715|postoperative pain|postoperative pain
138571|NCT02704715|general anesthesia|general anesthesia
138572|NCT02704702|Fimasartan|fimasartan
138573|NCT02704676|CA-125|ca-125
138574|NCT02704676|Pre-Eclampsia|pre-eclampsia
138575|NCT02704663|adnexal mass|adnexal mass
138576|NCT02704663|laparoscopy|laparoscopy
138577|NCT02704663|removal route|removal route
138578|NCT02704663|postoperative pain|postoperative pain
138579|NCT02704637|vasospasm|vasospasm
138580|NCT02704624|Crohn Disease|crohn disease
138581|NCT02704624|Fatigue|fatigue
138582|NCT02704624|Osteopenia|osteopenia
138583|NCT02704624|Exercise Tolerance|exercise tolerance
138584|NCT02704624|Vitamin d|vitamin d
138585|NCT02704585|Neonatal resuscitation|neonatal resuscitation
138586|NCT02704585|Pulse oximetry|pulse oximetry
138587|NCT02704572|Herpes zoster vaccine|herpes zoster vaccine
138588|NCT02704572|cell-mediated immunity|cell-mediated immunity
138589|NCT02704533|Plasmodium falciparum|plasmodium falciparum
138590|NCT02704533|PfSPZ Vaccine|pfspz vaccine
138591|NCT02704533|PfSPZ Challenge (NF54)|pfspz challenge (nf54)
138592|NCT02704533|PfSPZ Challenge (7G8)|pfspz challenge (7g8)
138593|NCT02704533|CHMI|chmi
138594|NCT02704520|Rectal Cancer|rectal cancer
138595|NCT02704520|Magnetic Resonance Imaging|magnetic resonance imaging
138596|NCT02704520|Chemoradiotherapy|chemoradiotherapy
138597|NCT02704520|Chemotherapy|chemotherapy
138598|NCT02704520|Diagnostic Imaging|diagnostic imaging
138599|NCT02704507|tretinoin|tretinoin
138600|NCT02704507|topical steroid|topical steroid
138601|NCT02704507|irritation|irritation
138602|NCT02704507|retinoid induced irritation|retinoid induced irritation
138603|NCT02704494|Resveratrol|resveratrol
138604|NCT02704494|Diabetes mellitus|diabetes mellitus
138605|NCT02704494|Diabetes complications|diabetes complications
138606|NCT02704494|Diabetic nephropathies|diabetic nephropathies
138607|NCT02704494|Proteinuria|proteinuria
138608|NCT02704494|Albuminuria|albuminuria
138609|NCT02704494|renal insufficiency|renal insufficiency
138610|NCT02704481|mifepristone|mifepristone
138611|NCT02704481|misoprostol|misoprostol
138612|NCT02704481|medical abortion|medical abortion
138613|NCT02704468|CAVI|cavi
138614|NCT02704468|FGF-21|fgf-21
138615|NCT02704468|arterial stiffness|arterial stiffness
138616|NCT02704468|renal transplant|renal transplant
138617|NCT02704455|children|children
138618|NCT02704442|anesthesiology|anesthesiology
138619|NCT02704442|ophthalmology|ophthalmology
138620|NCT02704416|Ventricular arrhythmias|ventricular arrhythmias
138621|NCT02704416|aborted cardiac arrest|aborted cardiac arrest
138622|NCT02704416|cardiac death|cardiac death
138623|NCT02704403|Elafibranor|elafibranor
138624|NCT02704403|NASH|nash
138625|NCT02704403|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
138626|NCT02704403|Fatty liver disease|fatty liver disease
138627|NCT02704403|Fibrosis|fibrosis
138628|NCT02704390|ORADUR®-Methylphenidate|oradur®-methylphenidate
138629|NCT02704377|Prostate Cancer Survivor|prostate cancer survivor
138630|NCT02704338|Autoimmune Diseases, Treg|autoimmune diseases, treg
138631|NCT02704325|DMD|dmd
138632|NCT02704325|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
138633|NCT02704273|MTM|mtm
138634|NCT02704273|XLMTM|xlmtm
138635|NCT02704208|Antiretroviral Therapy|antiretroviral therapy
138636|NCT02704208|Medication Adherence|medication adherence
138637|NCT02704208|Technology-based Intervention|technology-based intervention
138638|NCT02704195|Parkinson disease|parkinson disease
138639|NCT02704195|Deep brain stimulation|deep brain stimulation
138640|NCT02704195|Freezing of Gait|freezing of gait
138641|NCT02704182|Arthroplasties, Knee Replacement|arthroplasties, knee replacement
138642|NCT02704169|head and neck cancer|head and neck cancer
138643|NCT02704169|H&N cancer|h&n cancer
138644|NCT02704156|Stereotactic body radiation therapy|stereotactic body radiation therapy
138645|NCT02704156|CyberKnife|cyberknife
138646|NCT02704156|Initial treatment|initial treatment
138647|NCT02704130|Therapeutic Embolization|therapeutic embolization
138648|NCT02704130|Ablation Techniques|ablation techniques
138649|NCT02704130|Transarterial Embolization|transarterial embolization
138650|NCT02704130|TAE|tae
138651|NCT02704130|Microwave Ablation|microwave ablation
138652|NCT02704130|MWA|mwa
138653|NCT02704065|amyloidosis|amyloidosis
138654|NCT02704065|renal transplantation|renal transplantation
138655|NCT02704026|Body composition|body composition
138656|NCT02704026|Nutritional status|nutritional status
138657|NCT02704013|Neurotrophins|neurotrophins
138658|NCT02704013|Nerve Growth Factor|nerve growth factor
138659|NCT02704013|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
138660|NCT02704013|Urinary Biomarkers|urinary biomarkers
138661|NCT02704013|Urodynamics|urodynamics
138662|NCT02704013|Anticholinergics|anticholinergics
138663|NCT02704013|Children|children
138664|NCT02703961|CCRT|ccrt
138665|NCT02703961|adjuvant chemotherapy|adjuvant chemotherapy
138666|NCT02703961|cisplatin and docetaxel|cisplatin and docetaxel
138667|NCT02703909|morbid obesity|morbid obesity
138668|NCT02703909|laparoscopic surgery|laparoscopic surgery
138669|NCT02703909|neuromuscular blockade|neuromuscular blockade
138670|NCT02703896|g a, bile reflux. PPIs, H2RAs, prokinetic agents|g a, bile reflux. ppis, h2ras, prokinetic agents
138671|NCT02703831|adult spine deformity|adult spine deformity
138672|NCT02703831|time-driven activity-based costing|time-driven activity-based costing
138673|NCT02703831|three-column posterior osteotomy|three-column posterior osteotomy
138674|NCT02703805|Community program|community program
138675|NCT02703805|Wellness|wellness
138676|NCT02703805|Exercise|exercise
138677|NCT02703805|Physical Activity|physical activity
138678|NCT02703805|Education|education
138679|NCT02703805|Stroke|stroke
138680|NCT02703805|Self-management|self-management
138681|NCT02703779|Multiple Myeloma|multiple myeloma
138682|NCT02703779|Bortezomib|bortezomib
138683|NCT02703779|Autologous|autologous
138684|NCT02703779|Stem Cell|stem cell
138685|NCT02703779|Purging|purging
138686|NCT02703779|In-vivo purging|in-vivo purging
138687|NCT02703779|Ex-vivo purging|ex-vivo purging
138688|NCT02703779|Leukapheresis|leukapheresis
138689|NCT02703779|Contaminated|contaminated
138690|NCT02703779|Stem Cell Harvest|stem cell harvest
138691|NCT02703779|Stem Cell Transplant|stem cell transplant
138692|NCT02703779|Transplantation|transplantation
138693|NCT02703727|polypharmacy|polypharmacy
138694|NCT02703727|polymedication check|polymedication check
138695|NCT02703727|anticoagulation treatment|anticoagulation treatment
138696|NCT02703714|Advanced|advanced
138697|NCT02703714|Locally-advanced|locally-advanced
138698|NCT02703714|Not eligible for resection|not eligible for resection
138699|NCT02703714|Prior chemotherapy treatment|prior chemotherapy treatment
138700|NCT02703701|Patient Satisfaction|patient satisfaction
138701|NCT02703701|Emergency Department efficiency|emergency department efficiency
138702|NCT02703662|Biologic mesh|biologic mesh
138703|NCT02703662|abdominal wall reconstruction|abdominal wall reconstruction
138704|NCT02703649|Aromatase inhibitor|aromatase inhibitor
138705|NCT02703649|induction of ovulation|induction of ovulation
138706|NCT02703636|Alzheimer's disease|alzheimer's disease
138707|NCT02703623|Prostate cancer|prostate cancer
138708|NCT02703623|Metastatic castration-resistant prostate cancer to the bone|metastatic castration-resistant prostate cancer to the bone
138709|NCT02703623|mCRPC|mcrpc
138710|NCT02703623|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
138711|NCT02703623|Biomarkers|biomarkers
138712|NCT02703623|Abiraterone Acetate|abiraterone acetate
138713|NCT02703623|Zytiga|zytiga
138714|NCT02703623|Prednisone|prednisone
138715|NCT02703623|ARN509|arn509
138716|NCT02703623|Ipilimumab|ipilimumab
138717|NCT02703623|Yervoy|yervoy
138718|NCT02703623|BMS-734016|bms-734016
138719|NCT02703623|MDX010|mdx010
138720|NCT02703623|Cabazitaxel|cabazitaxel
138721|NCT02703623|Jevtana|jevtana
138722|NCT02703623|Carboplatin|carboplatin
138723|NCT02703623|Paraplatin|paraplatin
138724|NCT02703610|Pain|pain
138725|NCT02703610|Elderly|elderly
138726|NCT02703597|Cigarette Smoking Behavior|cigarette smoking behavior
138727|NCT02703597|Smoking curiosity|smoking curiosity
138728|NCT02703597|Smoking Cessation|smoking cessation
138729|NCT02703597|Smoking Prevention|smoking prevention
138730|NCT02703597|Health improvement|health improvement
138731|NCT02703597|Smoking prevention interactive experience|smoking prevention interactive experience
138732|NCT02703597|ASPIRE|aspire
138733|NCT02703597|Game-based social activities|game-based social activities
138734|NCT02703597|GSA's|gsa's
138735|NCT02703597|Surveys|surveys
138736|NCT02703597|Questionnaires|questionnaires
138737|NCT02703597|Interviews|interviews
138738|NCT02703584|Double trigger|double trigger
138739|NCT02703571|Trametinib|trametinib
138740|NCT02703571|Ribociclib|ribociclib
138741|NCT02703571|LEE011|lee011
138742|NCT02703571|TMT212|tmt212
138743|NCT02703571|advanced solid tumors|advanced solid tumors
138744|NCT02703571|pancreatic cancer|pancreatic cancer
138745|NCT02703571|KRAS-mutant colorectal cancer|kras-mutant colorectal cancer
138746|NCT02703571|colorectal cancer|colorectal cancer
138747|NCT02703571|advanced pancreatic cancer|advanced pancreatic cancer
138748|NCT02703571|metastatic pancreatic cancer|metastatic pancreatic cancer
138749|NCT02703545|familial pancreas cancer|familial pancreas cancer
138750|NCT02703545|pancreatic cyst|pancreatic cyst
138751|NCT02703532|Therapy|therapy
138752|NCT02703532|Rehabilitation|rehabilitation
138753|NCT02703532|Caregiver|caregiver
138754|NCT02703519|cesarean section, repeat|cesarean section, repeat
138755|NCT02703519|uterine scar tissue|uterine scar tissue
138756|NCT02703519|transvaginal ultrasound|transvaginal ultrasound
138757|NCT02703519|uterine rupture|uterine rupture
138758|NCT02703519|placenta accreta|placenta accreta
138759|NCT02703519|placenta percreta|placenta percreta
138760|NCT02703519|placenta increta|placenta increta
138761|NCT02703467|Exhaled hydrogen sulphide|exhaled hydrogen sulphide
138762|NCT02703428|Abdominal|abdominal
138763|NCT02703428|Aortic|aortic
138764|NCT02703428|Aneurysm|aneurysm
138765|NCT02703415|immune|immune
138766|NCT02703415|interleukin|interleukin
138767|NCT02703415|tramadol|tramadol
138768|NCT02703415|postoperartive analgesia|postoperartive analgesia
138769|NCT02703415|pediatric|pediatric
138770|NCT02703415|caudal bupivacaine|caudal bupivacaine
138771|NCT02703402|low back pain|low back pain
138772|NCT02703402|physical exercise and quality of life|physical exercise and quality of life
138773|NCT02703389|knowledge translation|knowledge translation
138774|NCT02703389|antimicrobial stewardship|antimicrobial stewardship
138775|NCT02703311|Valtech Cardio|valtech cardio
138776|NCT02703311|Cardioband|cardioband
138777|NCT02703311|Mitral Valve|mitral valve
138778|NCT02703298|Advanced Solid Malignancy|advanced solid malignancy
138779|NCT02703298|Safety and Tolerability|safety and tolerability
138780|NCT02703298|Tumor Response|tumor response
138781|NCT02703298|Oncology|oncology
138782|NCT02703272|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
138783|NCT02703272|Ibrutinib|ibrutinib
138784|NCT02703272|JNJ-54179060|jnj-54179060
138785|NCT02703246|Hysterectomy, Vaginal|hysterectomy, vaginal
138786|NCT02703246|Hysterectomy, Abdominal|hysterectomy, abdominal
138787|NCT02703220|sleep apnea|sleep apnea
138788|NCT02703220|chemoresponsiveness|chemoresponsiveness
138789|NCT02703220|cerebrovascular response|cerebrovascular response
138790|NCT02703220|hyperoxia|hyperoxia
138791|NCT02703220|acetazolamide|acetazolamide
138792|NCT02703220|finasteride|finasteride
138793|NCT02703220|apneic threshold|apneic threshold
138794|NCT02703220|carbon-dioxide reserve|carbon-dioxide reserve
138795|NCT02703207|obstructive sleep apnea|obstructive sleep apnea
138796|NCT02703207|COPD|copd
138797|NCT02703207|Overlap syndrome|overlap syndrome
138798|NCT02703207|quality of life|quality of life
138799|NCT02703207|neurocognitive function|neurocognitive function
138800|NCT02703207|sleepiness|sleepiness
138801|NCT02703207|elderly|elderly
138802|NCT02703194|IgG4-related disease|igg4-related disease
138803|NCT02703194|IgG4-related sclerosing cholangitis|igg4-related sclerosing cholangitis
138804|NCT02703194|Mikulicz disease|mikulicz disease
138805|NCT02703194|Pancreatitis|pancreatitis
138806|NCT02703194|Retroperitoneal fibrosis|retroperitoneal fibrosis
138807|NCT02703194|Lymphadenopathy|lymphadenopathy
138808|NCT02703181|Safety|safety
138809|NCT02703181|Dose Escalation|dose escalation
138810|NCT02703181|Repeat Dosing|repeat dosing
138811|NCT02703181|Epelsiban|epelsiban
138812|NCT02703181|Pharmacokinetics|pharmacokinetics
138813|NCT02703181|Healthy Women Volunteers|healthy women volunteers
138814|NCT02703181|Tolerability|tolerability
138815|NCT02703181|Oxytocin|oxytocin
138816|NCT02703168|Dental implants|dental implants
138817|NCT02703142|esophagogastrostomy|esophagogastrostomy
138818|NCT02703142|gastric conduit ischemia|gastric conduit ischemia
138819|NCT02703142|endoscopy|endoscopy
138820|NCT02703129|Migraine|migraine
138821|NCT02703129|Diet quality|diet quality
138822|NCT02703129|Nutritional intervention|nutritional intervention
138823|NCT02703129|Severity of disease|severity of disease
138824|NCT02703129|Depressive symptoms|depressive symptoms
138825|NCT02703116|HIV|hiv
138826|NCT02703116|Substance Use|substance use
138827|NCT02703103|cardiopulmonary resuscitation|cardiopulmonary resuscitation
138828|NCT02703103|chest compression|chest compression
138829|NCT02703103|adult|adult
138830|NCT02703103|simulation|simulation
138831|NCT02703064|Furocyst|furocyst
138832|NCT02703064|PCOS|pcos
138833|NCT02703038|cardiogenic shock|cardiogenic shock
138834|NCT02703038|observatory|observatory
138835|NCT02703025|Obesity, green coffee bean extract, weight management|obesity, green coffee bean extract, weight management
138836|NCT02702973|Characteristic analysis|characteristic analysis
138837|NCT02702960|FL-HCC|fl-hcc
138838|NCT02702960|living donor liver transplant|living donor liver transplant
138839|NCT02702960|HLA matched first degree relative|hla matched first degree relative
138840|NCT02702960|Milan Criteria|milan criteria
138841|NCT02702960|Ephraim Fuchs|ephraim fuchs
138842|NCT02702960|Fibrolamellar Cancer Foundation|fibrolamellar cancer foundation
138843|NCT02702960|fibrolamellar|fibrolamellar
138844|NCT02702960|non-fibrolamellar|non-fibrolamellar
138845|NCT02702947|BPH|bph
138846|NCT02702947|Prunus Domestica extract|prunus domestica extract
138847|NCT02702882|Fenugreek seed extract, hypogonadism, protodioscin, testosterone|fenugreek seed extract, hypogonadism, protodioscin, testosterone
138848|NCT02702869|cleft lip|cleft lip
138849|NCT02702869|cleft palate|cleft palate
138850|NCT02702869|cleft lip and palate|cleft lip and palate
138851|NCT02702869|cleft alveolus|cleft alveolus
138852|NCT02702869|multidisciplinary team|multidisciplinary team
138853|NCT02702869|interdisciplinary team|interdisciplinary team
138854|NCT02702856|Prostate Cancer|prostate cancer
138855|NCT02702856|Gleason Grade|gleason grade
138856|NCT02702856|Prostatic Neoplasms|prostatic neoplasms
138857|NCT02702817|Alzheimer's disease, biomarkers, cognitive decline, pre-clinical|alzheimer's disease, biomarkers, cognitive decline, pre-clinical
138858|NCT02702791|Physical activity|physical activity
138859|NCT02702791|Pulmonary rehabilitation|pulmonary rehabilitation
138860|NCT02702791|COPD|copd
138861|NCT02702778|Polymyalgia Rheumatica (PMR)|polymyalgia rheumatica (pmr)
138862|NCT02702765|sCD163|scd163
138863|NCT02702765|liver cirrhosis|liver cirrhosis
138864|NCT02702765|disease severity|disease severity
138865|NCT02702752|Heart diseases stromal differentiation factor alpha 1|heart diseases stromal differentiation factor alpha 1
138866|NCT02702713|bioactive|bioactive
138867|NCT02702713|enriched foods|enriched foods
138868|NCT02702713|anthocyanins (AC)|anthocyanins (ac)
138869|NCT02702713|beta-glucans (BG)|beta-glucans (bg)
138870|NCT02702713|docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
138871|NCT02702687|Asthma|asthma
138872|NCT02702687|Childhood Asthma|childhood asthma
138873|NCT02702687|Bronchial Diseases|bronchial diseases
138874|NCT02702687|Immune System Diseases|immune system diseases
138875|NCT02702687|Lung Diseases|lung diseases
138876|NCT02702687|Lung Diseases, Obstructive|lung diseases, obstructive
138877|NCT02702687|Respiratory Tract Diseases|respiratory tract diseases
138878|NCT02702687|Peak Flow Meter|peak flow meter
138879|NCT02702687|Symptom Perception|symptom perception
138880|NCT02702687|Illness Representation|illness representation
138881|NCT02702661|Fascia Iliaca Block|fascia iliaca block
138882|NCT02702661|Local Anaesthetic Infiltration|local anaesthetic infiltration
138883|NCT02702661|Hip Arthroscopy|hip arthroscopy
138884|NCT02702648|healthy subjects|healthy subjects
138885|NCT02702648|first-in-man|first-in-man
138886|NCT02702648|safety|safety
138887|NCT02702622|bananas|bananas
138888|NCT02702622|biofortified|biofortified
138889|NCT02702622|carotenoids|carotenoids
138890|NCT02702622|vitamin A|vitamin a
138891|NCT02702583|Myelosuppressive Chemotherapy|myelosuppressive chemotherapy
138892|NCT02702583|Febrile Neutropenia|febrile neutropenia
138893|NCT02702583|Solid Tumors|solid tumors
138894|NCT02702583|Dental Infection|dental infection
138895|NCT02702583|Oral Infection|oral infection
138896|NCT02702557|Frail Elderly|frail elderly
138897|NCT02702557|Elastic Band Exercises|elastic band exercises
138898|NCT02702557|Unsupervised Exercises|unsupervised exercises
138899|NCT02702557|Monitoring Technology|monitoring technology
138900|NCT02702557|Bandcizer|bandcizer
138901|NCT02702557|Adherence|adherence
138902|NCT02702557|Feasibility|feasibility
138903|NCT02702531|Laparoscopic Surgery|laparoscopic surgery
138904|NCT02702531|FloShield Defogging and Cleaning System|floshield defogging and cleaning system
138905|NCT02702531|Clearify Defogging and Cleaning System|clearify defogging and cleaning system
138906|NCT02702531|gynecologic|gynecologic
138907|NCT02702518|rhDNase I, Pulmozyme, oGVHD, Dry Eye|rhdnase i, pulmozyme, ogvhd, dry eye
138908|NCT02702505|Pulp|pulp
138909|NCT02702505|pulpotomies|pulpotomies
138910|NCT02702505|mineral trioxide aggregate|mineral trioxide aggregate
138911|NCT02702492|PAK4|pak4
138912|NCT02702492|KPT-9274|kpt-9274
138913|NCT02702492|Karyopharm|karyopharm
138914|NCT02702492|NHL|nhl
138915|NCT02702492|solid tumors|solid tumors
138916|NCT02702479|Systematic review and meta-analysis|systematic review and meta-analysis
138917|NCT02702479|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
138918|NCT02702479|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
138919|NCT02702479|Clinical practice guidelines|clinical practice guidelines
138920|NCT02702479|Clinical trials|clinical trials
138921|NCT02702479|Dietary sugars|dietary sugars
138922|NCT02702479|Fructose|fructose
138923|NCT02702479|High fructose corn syrup|high fructose corn syrup
138924|NCT02702479|Isocaloric|isocaloric
138925|NCT02702479|Hypercaloric|hypercaloric
138926|NCT02702479|Cardiometabolic Risk Factors|cardiometabolic risk factors
138927|NCT02702479|Triglycerides|triglycerides
138928|NCT02702479|Cholesterol|cholesterol
138929|NCT02702479|Glycemic control|glycemic control
138930|NCT02702479|Body weight|body weight
138931|NCT02702479|Uric acid|uric acid
138932|NCT02702479|Blood pressure|blood pressure
138933|NCT02702479|Fatty liver|fatty liver
138934|NCT02702479|Fasting|fasting
138935|NCT02702479|Postprandial|postprandial
138936|NCT02702466|Upper limb musculoskeletal disorders|upper limb musculoskeletal disorders
138937|NCT02702466|Spa treatment|spa treatment
138938|NCT02702466|Randomized controlled trials|randomized controlled trials
138939|NCT02702466|Education|education
138940|NCT02702466|Self- management|self- management
138941|NCT02702466|Self-care|self-care
138942|NCT02702466|Exercise|exercise
138943|NCT02702466|Non pharmacological treatment|non pharmacological treatment
138944|NCT02702440|Systematic review and meta-analysis|systematic review and meta-analysis
138945|NCT02702440|Sugars|sugars
138946|NCT02702440|Liquid calories|liquid calories
138947|NCT02702440|Solid calories|solid calories
138948|NCT02702440|Clinical trials|clinical trials
138949|NCT02702440|Body weight|body weight
138950|NCT02702440|Body Mass Index|body mass index
138951|NCT02702440|Evidence-base nutrition (EBN)|evidence-base nutrition (ebn)
138952|NCT02702440|Evidence-base medicine (EBM)|evidence-base medicine (ebm)
138953|NCT02702440|Clinical practice guidelines|clinical practice guidelines
138954|NCT02702427|viral infections post HSCT, virus-specific T-cells|viral infections post hsct, virus-specific t-cells
138955|NCT02702414|PD1|pd1
138956|NCT02702414|PD-1|pd-1
138957|NCT02702414|PDL1|pdl1
138958|NCT02702414|PD-L1|pd-l1
138959|NCT02702401|PD1|pd1
138960|NCT02702401|PD-1|pd-1
138961|NCT02702401|PDL1|pdl1
138962|NCT02702401|PD-L1|pd-l1
138963|NCT02702388|Lenvatinib|lenvatinib
138964|NCT02702388|E7080|e7080
138965|NCT02702388|Iodine-131 Refractory Differentiated Thyroid Cancer|iodine-131 refractory differentiated thyroid cancer
138966|NCT02702388|Lenvima|lenvima
138967|NCT02702388|Phase 2|phase 2
138968|NCT02702388|RR-DTC|rr-dtc
138969|NCT02702375|Systematic review and meta-analysis|systematic review and meta-analysis
138970|NCT02702375|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
138971|NCT02702375|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
138972|NCT02702375|Clinical practice guidelines|clinical practice guidelines
138973|NCT02702375|Prospective cohort studies|prospective cohort studies
138974|NCT02702375|Dietary sugars|dietary sugars
138975|NCT02702375|Fructose|fructose
138976|NCT02702375|Sucrose|sucrose
138977|NCT02702375|High fructose corn syrup|high fructose corn syrup
138978|NCT02702375|HFCS|hfcs
138979|NCT02702375|Cohort studies|cohort studies
138980|NCT02702375|Prospective studies|prospective studies
138981|NCT02702375|Diabetes Mellitus|diabetes mellitus
138982|NCT02702375|Metabolic syndrome|metabolic syndrome
138983|NCT02702375|Coronary heart disease|coronary heart disease
138984|NCT02702375|Stroke|stroke
138985|NCT02702375|Hypertension|hypertension
138986|NCT02702375|Gout|gout
138987|NCT02702362|disorders of consciousness|disorders of consciousness
138988|NCT02702362|minimally conscious state|minimally conscious state
138989|NCT02702362|traumatic brain injury|traumatic brain injury
138990|NCT02702362|stroke|stroke
138991|NCT02702362|transcranial direct current stimulation|transcranial direct current stimulation
138992|NCT02702323|hepatocellular carcinoma|hepatocellular carcinoma
138993|NCT02702323|pulmonary metastasis|pulmonary metastasis
138994|NCT02702323|Apatinib|apatinib
138995|NCT02702323|efficacy|efficacy
138996|NCT02702323|safety|safety
138997|NCT02702297|Preterm premature rupture of the membranes|preterm premature rupture of the membranes
138998|NCT02702297|PPROM|pprom
138999|NCT02702297|PROM|prom
139000|NCT02702297|fetal membranes|fetal membranes
139001|NCT02702297|premature rupture|premature rupture
139002|NCT02702297|neonatal early onset sepsis|neonatal early onset sepsis
139003|NCT02702297|amniotic fluid|amniotic fluid
139004|NCT02702297|amniotic infection|amniotic infection
139005|NCT02702297|fetal inflammatory response syndrome|fetal inflammatory response syndrome
139006|NCT02702297|adverse neonatal outcome|adverse neonatal outcome
139007|NCT02702297|FIRS|firs
139008|NCT02702284|Advance Directives|advance directives
139009|NCT02702284|Healthcare power of attorney|healthcare power of attorney
139010|NCT02702258|mindfulness|mindfulness
139011|NCT02702258|blood pressure|blood pressure
139012|NCT02702258|hypertension|hypertension
139013|NCT02702258|prehypertension|prehypertension
139014|NCT02702206|Shoulder pain|shoulder pain
139015|NCT02702206|subdeltoid bursitis|subdeltoid bursitis
139016|NCT02702206|subacromial bursitis|subacromial bursitis
139017|NCT02702206|intra-bursa injection|intra-bursa injection
139018|NCT02702167|brain stimulation|brain stimulation
139019|NCT02702167|rTMS|rtms
139020|NCT02702154|brain stimulation|brain stimulation
139021|NCT02702154|rTMS|rtms
139022|NCT02702141|Non-hodgkin lymphoma|non-hodgkin lymphoma
139023|NCT02702141|Antibody-drug conjugate|antibody-drug conjugate
139024|NCT02702141|CD19|cd19
139025|NCT02702141|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
139026|NCT02702141|DLBCL|dlbcl
139027|NCT02702141|Grade 3 follicular lymphoma|grade 3 follicular lymphoma
139028|NCT02702128|Bleeding perioperative|bleeding perioperative
139029|NCT02702128|EXACYL|exacyl
139030|NCT02702128|Oorthognathism surgery|oorthognathism surgery
139031|NCT02702128|Hematoma|hematoma
139032|NCT02702115|gene specific targeted insertion|gene specific targeted insertion
139033|NCT02702115|Mucopolysaccharidosis I|mucopolysaccharidosis i
139034|NCT02702115|MPS I|mps i
139035|NCT02702115|Hurler-Scheie syndrome|hurler-scheie syndrome
139036|NCT02702115|Hurler|hurler
139037|NCT02702115|Scheie syndrome|scheie syndrome
139038|NCT02702115|gene therapy|gene therapy
139039|NCT02702115|gene editing|gene editing
139040|NCT02702115|zinc finger|zinc finger
139041|NCT02702115|SB-318|sb-318
139042|NCT02702115|rare|rare
139043|NCT02702115|genetic|genetic
139044|NCT02702115|DNA|dna
139045|NCT02702115|Sangamo|sangamo
139046|NCT02702115|Scheie|scheie
139047|NCT02702115|Genome editing|genome editing
139048|NCT02702115|Empowers|empowers
139049|NCT02702115|Hurler syndrome|hurler syndrome
139050|NCT02702076|Apomorphine|apomorphine
139051|NCT02702050|Physiotherapy|physiotherapy
139052|NCT02702050|Mechanical Stimulation|mechanical stimulation
139053|NCT02702050|Mastectomy Scar|mastectomy scar
139054|NCT02702024|efficacy|efficacy
139055|NCT02702024|double incision technique|double incision technique
139056|NCT02702024|uterus preserving surgery|uterus preserving surgery
139057|NCT02701998|Ischemic Stroke|ischemic stroke
139058|NCT02701998|Transient Ischemic Attack|transient ischemic attack
139059|NCT02701998|Physical Activity|physical activity
139060|NCT02701998|Sedentary Behavior|sedentary behavior
139061|NCT02701998|Lifestyle|lifestyle
139062|NCT02701998|Behavior|behavior
139063|NCT02701959|Nitric oxide|nitric oxide
139064|NCT02701959|Dietary intervention trail|dietary intervention trail
139065|NCT02701946|Blood loss|blood loss
139066|NCT02701946|Total knee arthroplasty|total knee arthroplasty
139067|NCT02701946|Bandage|bandage
139068|NCT02701946|Dressing|dressing
139069|NCT02701920|Premature Birth|premature birth
139070|NCT02701920|Infant|infant
139071|NCT02701920|Heart rate|heart rate
139072|NCT02701881|Femoropopliteal Artery|femoropopliteal artery
139073|NCT02701881|Drug-eluting Stent|drug-eluting stent
139074|NCT02701881|Endovascular Therapy|endovascular therapy
139075|NCT02701868|Infant Formula|infant formula
139076|NCT02701829|taxi cab drivers|taxi cab drivers
139077|NCT02701829|high blood pressure|high blood pressure
139078|NCT02701829|16-038|16-038
139079|NCT02701816|Peripheral Artery Disease|peripheral artery disease
139080|NCT02701816|Femoropopliteal Artery|femoropopliteal artery
139081|NCT02701816|Nitinol Stent|nitinol stent
139082|NCT02701816|Restenosis|restenosis
139083|NCT02701777|spike timing dependant plasticity|spike timing dependant plasticity
139084|NCT02701764|laser-assisted in situ keratomileusis|laser-assisted in situ keratomileusis
139085|NCT02701764|dry eye symptoms|dry eye symptoms
139086|NCT02701764|LASIK|lasik
139087|NCT02701764|prevention|prevention
139088|NCT02701712|magnetic resonance|magnetic resonance
139089|NCT02701712|external beam radiotherapy|external beam radiotherapy
139090|NCT02701712|brachytherapy|brachytherapy
139091|NCT02701712|radiotherapy|radiotherapy
139092|NCT02701699|Lung Cancer|lung cancer
139093|NCT02701699|FAZA PET Imaging|faza pet imaging
139094|NCT02701699|Lung Radiotherapy|lung radiotherapy
139095|NCT02701686|smoking cessation|smoking cessation
139096|NCT02701673|Refractory or Relapsed Lymphoma|refractory or relapsed lymphoma
139097|NCT02701673|Busulfan|busulfan
139098|NCT02701673|Busulfex|busulfex
139099|NCT02701673|Myleran|myleran
139100|NCT02701673|Caphosol|caphosol
139101|NCT02701673|Glutamine|glutamine
139102|NCT02701673|Enterex|enterex
139103|NCT02701673|Glutapak-10|glutapak-10
139104|NCT02701673|NutreStore|nutrestore
139105|NCT02701673|Resource|resource
139106|NCT02701673|GlutaSolve|glutasolve
139107|NCT02701673|Sympt-X-G.I.|sympt-x-g.i.
139108|NCT02701673|Sympt-X|sympt-x
139109|NCT02701673|Pyridoxine|pyridoxine
139110|NCT02701673|Belinostat|belinostat
139111|NCT02701673|Azacitidine|azacitidine
139112|NCT02701673|5-azacytidine|5-azacytidine
139113|NCT02701673|5-aza|5-aza
139114|NCT02701673|Azacytidine|azacytidine
139115|NCT02701673|Vidaza|vidaza
139116|NCT02701673|5-AZC|5-azc
139117|NCT02701673|AZA-CR|aza-cr
139118|NCT02701673|Ladakamycin|ladakamycin
139119|NCT02701673|Gemcitabine|gemcitabine
139120|NCT02701673|Gemcitabine Hydrochloride|gemcitabine hydrochloride
139121|NCT02701673|Gemzar|gemzar
139122|NCT02701673|Stem cell transplant|stem cell transplant
139123|NCT02701673|SCT|sct
139124|NCT02701673|Melphalan|melphalan
139125|NCT02701673|Alkeran|alkeran
139126|NCT02701660|Pharmaceutical Care|pharmaceutical care
139127|NCT02701660|Adherence|adherence
139128|NCT02701660|Polypharmacy|polypharmacy
139129|NCT02701660|e-Health|e-health
139130|NCT02701660|opioid substitution therapy|opioid substitution therapy
139131|NCT02701647|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
139132|NCT02701634|Chronic Graft Versus Host Disease (cGVHD)|chronic graft versus host disease (cgvhd)
139133|NCT02701634|newly diagnosed cGVHD|newly diagnosed cgvhd
139134|NCT02701634|immune reconstitution|immune reconstitution
139135|NCT02701634|Immune System Diseases|immune system diseases
139136|NCT02701634|allogeneic stem cell transplantation|allogeneic stem cell transplantation
139137|NCT02701634|SYK inhibitor|syk inhibitor
139138|NCT02701621|Parkinson's disease, aquatic therapy, balance, MIRT|parkinson's disease, aquatic therapy, balance, mirt
139139|NCT02701517|conditioning treatment|conditioning treatment
139140|NCT02701517|alemtuzumab|alemtuzumab
139141|NCT02701517|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
139142|NCT02701517|chronic lymphoproliferative disorders|chronic lymphoproliferative disorders
139143|NCT02701504|sleep apnea|sleep apnea
139144|NCT02701504|coronary artery bypass grafting|coronary artery bypass grafting
139145|NCT02701504|outcomes|outcomes
139146|NCT02701465|Shoulder|shoulder
139147|NCT02701465|Exercise therapy|exercise therapy
139148|NCT02701452|GnRH agonist triggering|gnrh agonist triggering
139149|NCT02701426|Macrosomia|macrosomia
139150|NCT02701426|Weight gain|weight gain
139151|NCT02701426|Participation|participation
139152|NCT02701426|Adhesion|adhesion
139153|NCT02701426|Physical activity|physical activity
139154|NCT02701426|Nutrition|nutrition
139155|NCT02701413|Apex M|apex m
139156|NCT02701413|Postpartum|postpartum
139157|NCT02701413|Pelvic Floor rehabilitation|pelvic floor rehabilitation
139158|NCT02701387|bone implant interaction|bone implant interaction
139159|NCT02701387|implant stability|implant stability
139160|NCT02701387|resonance frequency analysis (RFA)|resonance frequency analysis (rfa)
139161|NCT02701387|implant stability quotient (ISQ)|implant stability quotient (isq)
139162|NCT02701374|TRK-700|trk-700
139163|NCT02701374|Post-Herpetic Neuralgia|post-herpetic neuralgia
139164|NCT02701361|mindfulness|mindfulness
139165|NCT02701361|critical illness|critical illness
139166|NCT02701361|intensive care unit|intensive care unit
139167|NCT02701361|mindfulness-based stress reduction|mindfulness-based stress reduction
139168|NCT02701348|neoadjuvant endocrine|neoadjuvant endocrine
139169|NCT02701335|Osteoarthritis|osteoarthritis
139170|NCT02701335|Hand|hand
139171|NCT02701335|Rehabilitation|rehabilitation
139172|NCT02701322|Velopharyngeal Insufficiency|velopharyngeal insufficiency
139173|NCT02701322|Fluoroscopy|fluoroscopy
139174|NCT02701309|Iron deficiency|iron deficiency
139175|NCT02701309|Child|child
139176|NCT02701309|Infancy|infancy
139177|NCT02701309|Preschool children|preschool children
139966|NCT02696460|debridement|debridement
139178|NCT02701309|iron deficiency anemia|iron deficiency anemia
139179|NCT02701296|Infiltration between popliteal artery and capsule of knee (iPACK)|infiltration between popliteal artery and capsule of knee (ipack)
139180|NCT02701270|Glycemic Index|glycemic index
139181|NCT02701270|Dietary Fiber|dietary fiber
139182|NCT02701257|Bionic Pancreas|bionic pancreas
139183|NCT02701257|Insulin|insulin
139184|NCT02701257|Glucagon|glucagon
139185|NCT02701257|Continuous Glucose Monitor|continuous glucose monitor
139186|NCT02701244|Infiltrating Ductal Carcinoma|infiltrating ductal carcinoma
139187|NCT02701244|Ductal Carcinoma In Situ|ductal carcinoma in situ
139188|NCT02701244|Brachytherapy|brachytherapy
139189|NCT02701244|Breast Neoplasms|breast neoplasms
139190|NCT02701244|Breast Diseases|breast diseases
139191|NCT02701244|Neoplasms|neoplasms
139192|NCT02701244|Neoplasms by Site|neoplasms by site
139193|NCT02701231|lung cancer|lung cancer
139194|NCT02701231|Low-frequency rotating magnetic therapy system|low-frequency rotating magnetic therapy system
139195|NCT02701231|systemic anti-tumor therapy|systemic anti-tumor therapy
139196|NCT02701218|Canalith repositioning procedure (CRP)|canalith repositioning procedure (crp)
139197|NCT02701218|BPPV|bppv
139198|NCT02701205|Plaque Psoriasis|plaque psoriasis
139199|NCT02701205|Skin Disease|skin disease
139200|NCT02701192|coccygodynia|coccygodynia
139201|NCT02701192|coccygectomy|coccygectomy
139202|NCT02701192|coccyx|coccyx
139203|NCT02701179|Lignocaine|lignocaine
139204|NCT02701166|Pruritus|pruritus
139205|NCT02701166|itch|itch
139206|NCT02701166|cholestasis|cholestasis
139207|NCT02701075|peripheral neuropathy|peripheral neuropathy
139208|NCT02701075|traumatic tissue injury|traumatic tissue injury
139209|NCT02701075|radiculopathy|radiculopathy
139210|NCT02701036|sporadic ataxia|sporadic ataxia
139211|NCT02701036|MSAc|msac
139212|NCT02701036|SAOA|saoa
139213|NCT02701036|multiple system atrophy of cerebellar type|multiple system atrophy of cerebellar type
139214|NCT02701036|natural history|natural history
139215|NCT02701010|behavioral therapy|behavioral therapy
139216|NCT02701010|overactive bladder|overactive bladder
139217|NCT02701010|urinary incontinence|urinary incontinence
139218|NCT02700958|Remote ischemic preconditioning|remote ischemic preconditioning
139219|NCT02700958|Contrast-induced Nephropathy|contrast-induced nephropathy
139220|NCT02700958|Stable coronary artery disease|stable coronary artery disease
139221|NCT02700958|Lower extremity arterial disease|lower extremity arterial disease
139222|NCT02700958|Low molecular weight metabolites|low molecular weight metabolites
139223|NCT02700958|Functional properties of arteries|functional properties of arteries
139224|NCT02700932|non-invasive|non-invasive
139225|NCT02700906|Lateral epicondylitis|lateral epicondylitis
139226|NCT02700906|tennis elbow|tennis elbow
139227|NCT02700906|Lidocaine|lidocaine
139228|NCT02700906|corticosteroid|corticosteroid
139229|NCT02700880|wearable cardioverter defibrillator|wearable cardioverter defibrillator
139230|NCT02700880|ischemic cardiomyopathy|ischemic cardiomyopathy
139231|NCT02700880|new onset heart failure|new onset heart failure
139232|NCT02700880|sudden cardiac death|sudden cardiac death
139233|NCT02700867|intraosseous access|intraosseous access
139234|NCT02700867|cardiopulmonary resuscitation|cardiopulmonary resuscitation
139235|NCT02700867|paramedic|paramedic
139236|NCT02700867|simulation|simulation
139237|NCT02700867|cadaver|cadaver
139238|NCT02700854|Hypothermia treatment|hypothermia treatment
139239|NCT02700854|Hypocapnia|hypocapnia
139240|NCT02700854|Inhaled CO2|inhaled co2
139241|NCT02700854|Neuroprotection|neuroprotection
139242|NCT02700828|Hypothermia treatment|hypothermia treatment
139243|NCT02700828|Circulatory failure|circulatory failure
139244|NCT02700828|Neonatal hypotension|neonatal hypotension
139245|NCT02700828|Relative adrenal insufficiency|relative adrenal insufficiency
139246|NCT02700828|Hydrocortisone supplementation|hydrocortisone supplementation
139247|NCT02700802|food insecurity|food insecurity
139248|NCT02700802|informal caregiver health|informal caregiver health
139249|NCT02700802|clinic-to-community linkages|clinic-to-community linkages
139250|NCT02700802|community resources|community resources
139251|NCT02700789|diagnostic accuracy|diagnostic accuracy
139252|NCT02700789|double decidual sac sign|double decidual sac sign
139253|NCT02700789|intrauterine pregnancy|intrauterine pregnancy
139254|NCT02700776|screening mammogram|screening mammogram
139255|NCT02700776|GP88|gp88
139256|NCT02700776|breast cancer|breast cancer
139257|NCT02700763|Brain metastasis|brain metastasis
139258|NCT02700737|cardiovascular modeling|cardiovascular modeling
139259|NCT02700737|aortic coarctation|aortic coarctation
139260|NCT02700737|virtual stenting|virtual stenting
139261|NCT02700698|Mitochondria|mitochondria
139262|NCT02700698|women|women
139263|NCT02700698|muscle|muscle
139264|NCT02700698|PBMC|pbmc
139265|NCT02700672|Ageing|ageing
139266|NCT02700672|Cognition|cognition
139267|NCT02700672|Executive Function|executive function
139268|NCT02700672|Gait|gait
139269|NCT02700620|emotional eating|emotional eating
139270|NCT02700620|restrictive eating|restrictive eating
139271|NCT02700620|body dissatisfaction|body dissatisfaction
139272|NCT02700607|cerebral aneurysm, coiling embolization, blood viscosity|cerebral aneurysm, coiling embolization, blood viscosity
139273|NCT02700555|colorectal cancer|colorectal cancer
139274|NCT02700555|diabetes|diabetes
139275|NCT02700555|metabolic parameters|metabolic parameters
139276|NCT02700555|Surveillance|surveillance
139277|NCT02700542|asthma|asthma
139278|NCT02700542|pest management|pest management
139279|NCT02700503|Diabetes prevention|diabetes prevention
139280|NCT02700503|type 2 diabetes|type 2 diabetes
139281|NCT02700503|prediabetes|prediabetes
139282|NCT02700503|family|family
139283|NCT02700477|Type-2 Diabetic|type-2 diabetic
139284|NCT02700477|HbA1c|hba1c
139286|NCT02700477|PPBS|ppbs
139287|NCT02700477|C-peptide|c-peptide
139288|NCT02700451|IV acetaminophen|iv acetaminophen
139289|NCT02700451|IV Ketorolac|iv ketorolac
139290|NCT02700451|Post-operative analgesia|post-operative analgesia
139291|NCT02700451|Opioid use|opioid use
139292|NCT02700425|Wide QRS|wide qrs
139293|NCT02700425|Ventricular Dyssynchrony|ventricular dyssynchrony
139294|NCT02700399|Rehabilitation|rehabilitation
139295|NCT02700386|Breast|breast
139296|NCT02700386|Cancer|cancer
139297|NCT02700386|Hypofractionated|hypofractionated
139298|NCT02700386|Node-Positive Breast Cancer|node-positive breast cancer
139299|NCT02700386|Radiation Therapy|radiation therapy
139300|NCT02700386|Comprehensive Radiation Therapy|comprehensive radiation therapy
139301|NCT02700360|EC-18|ec-18
139302|NCT02700360|Hematology|hematology
139303|NCT02700360|Cancer|cancer
139304|NCT02700360|Neutropenia|neutropenia
139305|NCT02700334|Prediabetes|prediabetes
139306|NCT02700334|Impaired fasting glucose|impaired fasting glucose
139307|NCT02700334|Hyperglycemia|hyperglycemia
139308|NCT02700334|Impaired glucose tolerance|impaired glucose tolerance
139309|NCT02700334|Glucose intolerance|glucose intolerance
139310|NCT02700334|Dapagliflozin|dapagliflozin
139311|NCT02700334|Sodium glucose cotransporter 2 inhibitor|sodium glucose cotransporter 2 inhibitor
139312|NCT02700334|SGLT2|sglt2
139313|NCT02700321|non severely hypoxemic respiratory failure|non severely hypoxemic respiratory failure
139314|NCT02700321|preoxygenation|preoxygenation
139315|NCT02700321|crash induction|crash induction
139316|NCT02700308|Solid tumors|solid tumors
139317|NCT02700308|Spine metastasis|spine metastasis
139318|NCT02700308|Vertebroplasty|vertebroplasty
139319|NCT02700308|kyphoplasty|kyphoplasty
139320|NCT02700308|randomization|randomization
139321|NCT02700295|Orthokeratology|orthokeratology
139322|NCT02700282|Cystic fibrosis|cystic fibrosis
139323|NCT02700282|Backpack carrying|backpack carrying
139324|NCT02700282|Respiratory function|respiratory function
139325|NCT02700282|Children|children
139326|NCT02700256|surgery|surgery
139327|NCT02700256|15-315|15-315
139328|NCT02700243|Cystic Fibrosis|cystic fibrosis
139329|NCT02700243|Exercise|exercise
139330|NCT02700243|Fitbit|fitbit
139331|NCT02700217|Donor Nephrectomy|donor nephrectomy
139332|NCT02700139|Myopia control, aspheric lenses, children|myopia control, aspheric lenses, children
139333|NCT02700126|propofol|propofol
139334|NCT02700126|total intravenous anesthesia|total intravenous anesthesia
139335|NCT02700126|cerebral aneurysm|cerebral aneurysm
139336|NCT02700126|single nucleotide polymorphism|single nucleotide polymorphism
139337|NCT02700087|Laryngomalacia|laryngomalacia
139338|NCT02700061|Induced Constraint Therapy|induced constraint therapy
139339|NCT02700061|Robotic Occupational Therapy|robotic occupational therapy
139340|NCT02700061|Neuroplasticity|neuroplasticity
139341|NCT02700048|type 1 diabetes|type 1 diabetes
139342|NCT02700048|hypoglycemia|hypoglycemia
139343|NCT02700048|hypoglycemia unawareness|hypoglycemia unawareness
139344|NCT02700035|Intervention|intervention
139345|NCT02700035|Prevention|prevention
139346|NCT02700035|Randomized Controlled Trial|randomized controlled trial
139347|NCT02700035|Bii-Zin-Da-De-Dah|bii-zin-da-de-dah
139348|NCT02700022|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
139349|NCT02700022|Alisertib|alisertib
139350|NCT02699905|Sepsis|sepsis
139351|NCT02699905|Septic Shock|septic shock
139352|NCT02699905|Multiple Organ Dysfunction|multiple organ dysfunction
139353|NCT02699905|FFA2|ffa2
139354|NCT02699905|GPR43|gpr43
139355|NCT02699866|Small diameter implant|small diameter implant
139356|NCT02699840|Meningitis|meningitis
139357|NCT02699840|Meningococcal Meningitis|meningococcal meningitis
139358|NCT02699840|Meningococcal Infections|meningococcal infections
139359|NCT02699840|Menactra®|menactra®
139360|NCT02699840|Meningococcal Vaccine|meningococcal vaccine
139361|NCT02699827|Levobupivacaine|levobupivacaine
139362|NCT02699827|Magnesium|magnesium
139363|NCT02699827|Preeclampsia|preeclampsia
139364|NCT02699827|Epidural|epidural
139365|NCT02699814|Depression|depression
139366|NCT02699814|Children|children
139367|NCT02699814|Anxiety|anxiety
139368|NCT02699775|Botulinum toxin injections|botulinum toxin injections
139369|NCT02699775|Stroke|stroke
139370|NCT02699775|3D motion analysis|3d motion analysis
139371|NCT02699775|Gait pattern|gait pattern
139372|NCT02699762|self rehabilitation|self rehabilitation
139373|NCT02699762|stroke|stroke
139374|NCT02699762|botulinum toxin injection|botulinum toxin injection
139375|NCT02699762|arm functions|arm functions
139376|NCT02699749|Drug Therapy|drug therapy
139377|NCT02699736|HIV|hiv
139378|NCT02699736|HIV-1|hiv-1
139379|NCT02699736|Hepatitis C|hepatitis c
139380|NCT02699736|HCV|hcv
139381|NCT02699736|prospective|prospective
139382|NCT02699736|cohort|cohort
139383|NCT02699736|coinfection|coinfection
139384|NCT02699671|Bioresorbable Vascular Scaffold|bioresorbable vascular scaffold
139385|NCT02699671|Routine Clinical Practice|routine clinical practice
139386|NCT02699671|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
139387|NCT02699671|Coronary Artery Disease|coronary artery disease
139388|NCT02699671|drug eluting stent|drug eluting stent
139389|NCT02699671|acute myocardial infarction|acute myocardial infarction
139390|NCT02699658|levofloxacin|levofloxacin
139391|NCT02699658|population pharmacokinetics|population pharmacokinetics
139392|NCT02699658|pharmacodynamics|pharmacodynamics
139393|NCT02699632|Survey|survey
139394|NCT02699619|Undisplaced|undisplaced
139395|NCT02699606|Tumor|tumor
139396|NCT02699606|Fibroblast Growth Factor Receptor (FGFR)|fibroblast growth factor receptor (fgfr)
139397|NCT02699606|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
139398|NCT02699606|Erdafitinib|erdafitinib
139399|NCT02699606|Urothelial Cancer|urothelial cancer
139400|NCT02699606|Esophageal Cancer|esophageal cancer
139401|NCT02699606|Cholangiocarcinoma|cholangiocarcinoma
139402|NCT02699580|Biodegradable collagen implant|biodegradable collagen implant
139403|NCT02699580|scleral thinning|scleral thinning
139404|NCT02699580|strabismus surgery|strabismus surgery
139405|NCT02699567|taste perception|taste perception
139406|NCT02699567|individual differences|individual differences
139407|NCT02699567|fat|fat
139408|NCT02699567|genetics|genetics
139409|NCT02699541|Diabetes Self-Management Education|diabetes self-management education
139410|NCT02699541|Behavioural change theory|behavioural change theory
139411|NCT02699541|IMB model|imb model
139412|NCT02699541|Diabetes Type 2|diabetes type 2
139413|NCT02699515|MSB0011359C|msb0011359c
139414|NCT02699476|NFL|nfl
139415|NCT02699476|veterans|veterans
139416|NCT02699476|cognitive training|cognitive training
139417|NCT02699476|TBI|tbi
139418|NCT02699476|concussion|concussion
139419|NCT02699437|Preeclampsia|preeclampsia
139420|NCT02699437|Antiphospholipid Antibodies|antiphospholipid antibodies
139421|NCT02699411|ligament anterior cruciate , dry needling, physioterapy, propioception, knee arthroplasty, vastus medialis.|ligament anterior cruciate , dry needling, physioterapy, propioception, knee arthroplasty, vastus medialis.
139422|NCT02699385|Gastroenteritis|gastroenteritis
139423|NCT02699385|Domperidone|domperidone
139424|NCT02699385|Pediatric participants|pediatric participants
139425|NCT02699372|Healthy Volunteers|healthy volunteers
139426|NCT02699359|concussion|concussion
139427|NCT02699359|mild traumatic brain injuries|mild traumatic brain injuries
139428|NCT02699346|concussion|concussion
139429|NCT02699346|mild traumatic brain injuries|mild traumatic brain injuries
139430|NCT02699320|Short bowel syndrome|short bowel syndrome
139431|NCT02699320|Intestinal microbiota|intestinal microbiota
139432|NCT02699320|immune|immune
139433|NCT02699307|physical activity|physical activity
139434|NCT02699294|Pain Threshold|pain threshold
139435|NCT02699294|Pectoralis Minor|pectoralis minor
139436|NCT02699294|Proprioceptive Neuromuscular Facilitation (PNF) Stretching|proprioceptive neuromuscular facilitation (pnf) stretching
139437|NCT02699294|Physiotherapy|physiotherapy
139438|NCT02699294|Rehabilitation|rehabilitation
139439|NCT02699242|Fiberoptic intubation Training Simulation Performance|fiberoptic intubation training simulation performance
139440|NCT02699216|Macular Degeneration|macular degeneration
139441|NCT02699216|Eye Diseases|eye diseases
139442|NCT02699216|Retinal Degeneration|retinal degeneration
139443|NCT02699216|Retinal Diseases|retinal diseases
139444|NCT02699190|Leukodystrophy|leukodystrophy
139445|NCT02699190|White Matter Disease|white matter disease
139446|NCT02699190|Whole Genome Sequencing|whole genome sequencing
139447|NCT02699190|WGS|wgs
139448|NCT02699177|ciliary beat frequency,|ciliary beat frequency,
139449|NCT02699164|non surgical spinal decompression therapy|non surgical spinal decompression therapy
139450|NCT02699164|deep friction massage|deep friction massage
139451|NCT02699164|exercise|exercise
139452|NCT02699099|Children|children
139453|NCT02699099|Infants|infants
139454|NCT02699099|SB257049|sb257049
139455|NCT02699099|Malaria|malaria
139456|NCT02699099|Immunogenicity|immunogenicity
139457|NCT02699099|Surveillance|surveillance
139458|NCT02699099|Efficacy|efficacy
139459|NCT02699099|Safety|safety
139460|NCT02699099|Africa|africa
139461|NCT02699099|Plasmodium falciparum|plasmodium falciparum
139462|NCT02699073|colorectal cancer|colorectal cancer
139463|NCT02699073|metastatic|metastatic
139464|NCT02699073|regorafenib|regorafenib
139465|NCT02699073|CHOI criteria|choi criteria
139466|NCT02699073|RECIST criteria|recist criteria
139467|NCT02699060|GERD|gerd
139468|NCT02699060|Barrett`s esophagus|barrett`s esophagus
139469|NCT02699060|macrophage|macrophage
139470|NCT02699060|FSSG questionnaire|fssg questionnaire
139471|NCT02699047|Gastrointestinal cancer|gastrointestinal cancer
139472|NCT02699047|Fish oil|fish oil
139967|NCT02696460|analgesia|analgesia
139473|NCT02699047|Oxidative stress|oxidative stress
139474|NCT02699047|Inflammation|inflammation
139475|NCT02699047|Quality of life|quality of life
139476|NCT02699047|Nutritional status|nutritional status
139477|NCT02699047|Colorectal cancer|colorectal cancer
139478|NCT02699047|Stomach cancer|stomach cancer
139479|NCT02699047|Chemotherapy|chemotherapy
139480|NCT02699047|polyunsaturated fatty acids n-3|polyunsaturated fatty acids n-3
139481|NCT02699034|real-time MRI|real-time mri
139482|NCT02699034|electrophysiology study|electrophysiology study
139483|NCT02699034|atrial flutter ablation|atrial flutter ablation
139484|NCT02699034|active tracking|active tracking
139485|NCT02699008|clopidogrel；antiplatelet therapy|clopidogrel；antiplatelet therapy
139486|NCT02698982|elderly|elderly
139487|NCT02698982|postoperative cognitive dysfunction|postoperative cognitive dysfunction
139488|NCT02698982|postoperative delirium|postoperative delirium
139489|NCT02698982|depth of anesthesia|depth of anesthesia
139490|NCT02698982|intraoperative blood pressure monitoring|intraoperative blood pressure monitoring
139491|NCT02698969|Sugammadex|sugammadex
139492|NCT02698969|Post-operative residual curarization|post-operative residual curarization
139493|NCT02698969|Diaphragm Ultrasonography|diaphragm ultrasonography
139494|NCT02698956|SAPIEN 3 THV|sapien 3 thv
139495|NCT02698956|TAVI|tavi
139496|NCT02698956|Transfemoral|transfemoral
139497|NCT02698956|Transaortic|transaortic
139498|NCT02698956|Transapical|transapical
139499|NCT02698956|Aortic valve|aortic valve
139500|NCT02698943|cataract; intraocular lens; posterior capsule opacification; glistening; ENVISTA|cataract; intraocular lens; posterior capsule opacification; glistening; envista
139501|NCT02698930|Infective endocarditis|infective endocarditis
139502|NCT02698930|acute kidney injury|acute kidney injury
139503|NCT02698930|dexmedetomidine|dexmedetomidine
139504|NCT02698917|Out-of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
139505|NCT02698917|Resuscitation|resuscitation
139506|NCT02698917|Hypoxia-Ischemia, Brain|hypoxia-ischemia, brain
139507|NCT02698904|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
139508|NCT02698904|Relaxation Technique|relaxation technique
139509|NCT02698904|Anxiety|anxiety
139510|NCT02698891|Early Stage Breast Cancer|early stage breast cancer
139511|NCT02698878|Lupin Protein|lupin protein
139512|NCT02698878|Glucose Metabolism|glucose metabolism
139513|NCT02698878|GLUT4|glut4
139514|NCT02698878|Muscle Unloading|muscle unloading
139515|NCT02698878|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
139516|NCT02698852|Drug eluting stents|drug eluting stents
139517|NCT02698852|Interventional Cardiology|interventional cardiology
139518|NCT02698839|Drug eluting stents|drug eluting stents
139519|NCT02698839|Interventional Cardiology|interventional cardiology
139520|NCT02698826|Cardiac Arrest, Hyperoxia, Ischemia-reperfusion Injury, Reactive Oxygen Species, Oxidative Stress, Neuropsychological Tests|cardiac arrest, hyperoxia, ischemia-reperfusion injury, reactive oxygen species, oxidative stress, neuropsychological tests
139521|NCT02698761|Vaso-Occlusive Crises|vaso-occlusive crises
139522|NCT02698761|Sickle Cell Disease|sickle cell disease
139523|NCT02698761|Decreasing Length of Stay|decreasing length of stay
139524|NCT02698761|Comprehensive Care Plan|comprehensive care plan
139525|NCT02698748|Chloroquine|chloroquine
139526|NCT02698748|Malaria Elimination|malaria elimination
139527|NCT02698748|P.falciparum|p.falciparum
139528|NCT02698748|Clinical Trial|clinical trial
139529|NCT02698748|Mozambique|mozambique
139530|NCT02698748|Adults|adults
139531|NCT02698709|Keratoconus|keratoconus
139532|NCT02698709|Corneal Topography|corneal topography
139533|NCT02698709|Diagnosis|diagnosis
139534|NCT02698709|Keratomileusis, Laser In Situ|keratomileusis, laser in situ
139535|NCT02698696|Cognitive Remediation|cognitive remediation
139536|NCT02698696|Mood disorders|mood disorders
139537|NCT02698696|Neuropsychology|neuropsychology
139538|NCT02698683|Nutrition|nutrition
139539|NCT02698683|Lymphocyte Count|lymphocyte count
139540|NCT02698683|Immunoparalysis|immunoparalysis
139541|NCT02698683|nutritional status of septic patients|nutritional status of septic patients
139542|NCT02698670|Cardiac Arrhythmias|cardiac arrhythmias
139543|NCT02698670|Cardiovascular Disease|cardiovascular disease
139544|NCT02698670|Radiofrequency Ablation|radiofrequency ablation
139545|NCT02698670|Cardiac Mapping|cardiac mapping
139546|NCT02698657|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
139547|NCT02698657|Methotrexate|methotrexate
139548|NCT02698657|ASP5094|asp5094
139549|NCT02698631|Catheter Ablation|catheter ablation
139550|NCT02698631|Radiofrequency|radiofrequency
139551|NCT02698631|Fibrosis|fibrosis
139552|NCT02698631|Late-gadolinium enhanced MRI|late-gadolinium enhanced mri
139553|NCT02698618|Diabetes|diabetes
139554|NCT02698618|IMR|imr
139555|NCT02698618|Microcirculation|microcirculation
139556|NCT02698618|Ticagrelor|ticagrelor
139557|NCT02698618|CFR|cfr
139558|NCT02698618|FFR|ffr
139559|NCT02698618|Coronary microcirculation|coronary microcirculation
139560|NCT02698592|atrial flutter|atrial flutter
139561|NCT02698592|ablation|ablation
139562|NCT02698592|Thermocool SF catheter|thermocool sf catheter
139563|NCT02698579|Adrenoleukodystrophy|adrenoleukodystrophy
139564|NCT02698579|X-linked Adrenoleukodystrophy|x-linked adrenoleukodystrophy
140256|NCT02694588|Vedolizumab|vedolizumab
139565|NCT02698579|Hematopoietic Stem Cells|hematopoietic stem cells
139566|NCT02698553|Major depressive disorder|major depressive disorder
139567|NCT02698553|Extended release Bupropion|extended release bupropion
139568|NCT02698527|lidocaine|lidocaine
139569|NCT02698501|Asthma|asthma
139570|NCT02698501|Airway hyperresponsiveness|airway hyperresponsiveness
139571|NCT02698501|TSLP|tslp
139572|NCT02698501|Mast cell|mast cell
139573|NCT02698501|Eosinophil|eosinophil
139574|NCT02698475|Psoriasis|psoriasis
139575|NCT02698475|Ustekinumab|ustekinumab
139576|NCT02698475|STELARA|stelara
139577|NCT02698462|Advanced neoplasia|advanced neoplasia
139578|NCT02698462|Colorectal cancer|colorectal cancer
139579|NCT02698462|Population screening|population screening
139580|NCT02698462|Family history|family history
139581|NCT02698436|Acne|acne
139582|NCT02698371|composite resins|composite resins
139583|NCT02698371|dental restoration|dental restoration
139584|NCT02698371|adhesives|adhesives
139585|NCT02698371|non-carious cervical lesions|non-carious cervical lesions
139586|NCT02698371|clinical effectiveness|clinical effectiveness
139587|NCT02698371|Adhese universal|adhese universal
139588|NCT02698371|Futurabond U|futurabond u
139589|NCT02698371|Futurabond DC|futurabond dc
139590|NCT02698371|self-etch|self-etch
139591|NCT02698371|multimode/universal|multimode/universal
139592|NCT02698371|clinical trial|clinical trial
139593|NCT02698358|Peripheral artery disease, Iliac artery, nitinol stent, restenosis|peripheral artery disease, iliac artery, nitinol stent, restenosis
139594|NCT02698345|Popliteal artery disease, drug-eluting balloon, angioplasty|popliteal artery disease, drug-eluting balloon, angioplasty
139595|NCT02698319|Triage|triage
139596|NCT02698319|Systematic Triage|systematic triage
139597|NCT02698280|Bevacizumab|bevacizumab
139598|NCT02698280|Nimustine|nimustine
139599|NCT02698280|Pathology, Molecular|pathology, molecular
139600|NCT02698254|Brain cancer|brain cancer
139601|NCT02698254|Recurrent brain tumor|recurrent brain tumor
139602|NCT02698254|Prior radiation treatment to brain|prior radiation treatment to brain
139603|NCT02698254|Radiation therapy|radiation therapy
139604|NCT02698254|XRT|xrt
139605|NCT02698254|Questionnaires|questionnaires
139606|NCT02698254|Surveys|surveys
139733|NCT02697435|Lumbar|lumbar
139607|NCT02698241|Cardiac Resynchronization Therapy Defibrillator (CRT-D)|cardiac resynchronization therapy defibrillator (crt-d)
139608|NCT02698241|heart failure|heart failure
139609|NCT02698241|integrated diagnostics|integrated diagnostics
139610|NCT02698241|chronic medication management|chronic medication management
139611|NCT02698228|anesthesia|anesthesia
139612|NCT02698202|Tomosynthesis,sensitivity,specificity,screening,mammography|tomosynthesis,sensitivity,specificity,screening,mammography
139613|NCT02698176|OTX015|otx015
139614|NCT02698176|MK-8628|mk-8628
139615|NCT02698163|Root Canal Therapy|root canal therapy
139616|NCT02698150|Mitral regurgitation|mitral regurgitation
139617|NCT02698150|Mitraclip|mitraclip
139618|NCT02698150|Remote monitoring|remote monitoring
139619|NCT02698150|Wearables|wearables
139620|NCT02698111|nasopharyngeal carcinoma,donafeinib|nasopharyngeal carcinoma,donafeinib
139621|NCT02698098|Malaysia|malaysia
139622|NCT02698098|Asia|asia
139623|NCT02698098|Southeast Asia|southeast asia
139624|NCT02698098|Compulsory Drug Detention Centers|compulsory drug detention centers
139625|NCT02698098|Compulsory Centers for Drug Users|compulsory centers for drug users
139626|NCT02698098|Methadone|methadone
139627|NCT02698098|Drug Relapse|drug relapse
139628|NCT02698098|Drug and Narcotic Control|drug and narcotic control
139629|NCT02698098|Opiate Substitution Treatment|opiate substitution treatment
139630|NCT02698098|Prisons|prisons
139631|NCT02698085|carpal tunnel syndrome|carpal tunnel syndrome
139632|NCT02698085|physiotherapy|physiotherapy
139633|NCT02698085|manual therapy|manual therapy
139634|NCT02698072|Stiffness|stiffness
139635|NCT02698072|Pain|pain
139636|NCT02698072|Disfunction|disfunction
139637|NCT02698046|Heart failure|heart failure
139638|NCT02698046|Iron|iron
139639|NCT02698046|Anemia|anemia
139640|NCT02698046|Chronic disease|chronic disease
139641|NCT02698033|food allergy|food allergy
139642|NCT02698033|peanut|peanut
139643|NCT02698033|food challenge|food challenge
139644|NCT02698020|Newborn|newborn
139645|NCT02698020|Anesthesia|anesthesia
139646|NCT02698020|Oxygen|oxygen
139647|NCT02698020|Hyperoxia|hyperoxia
139648|NCT02697994|Sterile Water Injection|sterile water injection
139649|NCT02697994|Midwifery|midwifery
139650|NCT02697981|sleeve gastrectomy|sleeve gastrectomy
139651|NCT02697929|Rocuronium|rocuronium
139652|NCT02697916|aspirin|aspirin
139653|NCT02697916|ACSD|acsd
139654|NCT02697916|PCORI|pcori
139655|NCT02697903|Creatine kinase supplementation|creatine kinase supplementation
139656|NCT02697903|C-reactive protein|c-reactive protein
139657|NCT02697903|resistance training|resistance training
139658|NCT02697903|Pomegranate supplementation|pomegranate supplementation
139659|NCT02697903|pomegranate juice|pomegranate juice
139660|NCT02697903|muscle damage response|muscle damage response
139661|NCT02697786|Aortic valve surgery|aortic valve surgery
139662|NCT02697773|osteoarthritis of the knee|osteoarthritis of the knee
139663|NCT02697773|osteoarthritis of the hip|osteoarthritis of the hip
139664|NCT02697773|nerve growth factor inhibitor|nerve growth factor inhibitor
139665|NCT02697773|tanezumab|tanezumab
139666|NCT02697760|cadmium-zinc-telluride，CZT cameras|cadmium-zinc-telluride，czt cameras
139667|NCT02697760|myocardial blood flow，MBF|myocardial blood flow，mbf
139668|NCT02697760|myocardial flow reserve，MFR|myocardial flow reserve，mfr
139669|NCT02697747|Ultrasound|ultrasound
139670|NCT02697747|Palpation|palpation
139671|NCT02697747|Analgesia|analgesia
139672|NCT02697747|Epidural|epidural
139673|NCT02697734|Cushing's disease|cushing's disease
139674|NCT02697734|LCI699|lci699
139675|NCT02697734|osilodrostat|osilodrostat
139676|NCT02697734|Pituitary Gland|pituitary gland
139677|NCT02697734|Adrenocorticotropic|adrenocorticotropic
139678|NCT02697734|Hormone|hormone
139679|NCT02697734|ACTH|acth
139680|NCT02697734|UFC|ufc
139681|NCT02697721|Caregivers|caregivers
139682|NCT02697721|Behavioral symptoms|behavioral symptoms
139683|NCT02697721|Dementia|dementia
139684|NCT02697721|Alzheimer disease|alzheimer disease
139685|NCT02697721|Physical activity|physical activity
139686|NCT02697721|Depressive symptoms|depressive symptoms
139687|NCT02697721|Powerful Tools for Caregivers|powerful tools for caregivers
139688|NCT02697721|Chronic Disease Self-Management Program|chronic disease self-management program
139689|NCT02697695|chronic inflammation|chronic inflammation
139690|NCT02697695|fatty liver index|fatty liver index
139691|NCT02697669|Heart failure|heart failure
139692|NCT02697669|myocardial perfusion|myocardial perfusion
139693|NCT02697669|single-photon emission tomography|single-photon emission tomography
139694|NCT02697643|clinical decision support|clinical decision support
139695|NCT02697643|substance use|substance use
139696|NCT02697643|opioid|opioid
139697|NCT02697630|Uveal melanoma|uveal melanoma
139698|NCT02697591|Solid tumor|solid tumor
139699|NCT02697591|adenocarcinoma of the endometrium|adenocarcinoma of the endometrium
139700|NCT02697591|melanoma, non-small cell lung cancer (NSCLC)|melanoma, non-small cell lung cancer (nsclc)
139701|NCT02697591|renal cell carcinoma (RCC)|renal cell carcinoma (rcc)
139702|NCT02697591|glucocorticoid-induced tumor necrosis factor receptor (GITR)|glucocorticoid-induced tumor necrosis factor receptor (gitr)
139703|NCT02697565|childhood obesity|childhood obesity
139704|NCT02697565|obesity|obesity
139705|NCT02697565|prevention|prevention
139706|NCT02697565|nutrition|nutrition
139707|NCT02697565|health|health
139708|NCT02697565|preschool|preschool
139709|NCT02697565|childcare|childcare
139710|NCT02697565|role model|role model
139711|NCT02697565|pediatric obesity|pediatric obesity
139712|NCT02697565|weight|weight
139713|NCT02697565|overweight|overweight
139714|NCT02697565|early childhood|early childhood
139715|NCT02697565|train the trainer|train the trainer
139716|NCT02697526|radial artery|radial artery
139717|NCT02697526|occlusion|occlusion
139718|NCT02697526|functional|functional
139719|NCT02697526|complications|complications
139720|NCT02697526|consequences|consequences
139721|NCT02697487|Depression|depression
139722|NCT02697487|Cohort|cohort
139723|NCT02697474|Hepatitis B|hepatitis b
139724|NCT02697474|DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine|dtap-ipv-hep b-prp-t hexavalent vaccine
139725|NCT02697474|Euvax-B®|euvax-b®
139726|NCT02697474|Hexaxim®|hexaxim®
139727|NCT02697474|Infanrix® hexa|infanrix® hexa
139728|NCT02697435|Chronic Low Back Pain|chronic low back pain
139729|NCT02697435|Aged|aged
139730|NCT02697435|Elderly|elderly
139731|NCT02697435|Primary Care|primary care
139732|NCT02697435|Assessment|assessment
139734|NCT02697435|Spinal Stenosis|spinal stenosis
139735|NCT02697435|Hip Osteoarthritis|hip osteoarthritis
139736|NCT02697435|Myofascial Pain Syndrome|myofascial pain syndrome
139737|NCT02697435|Fibromyalgia|fibromyalgia
139738|NCT02697435|Depression|depression
139739|NCT02697435|Maladaptive Coping|maladaptive coping
139740|NCT02697435|Lumbar Spinal Stenosis|lumbar spinal stenosis
139741|NCT02697435|Insomnia|insomnia
139742|NCT02697435|Sacroiliac Joint Pain|sacroiliac joint pain
139743|NCT02697435|Lateral Hip and Thigh Pain|lateral hip and thigh pain
139744|NCT02697435|Anxiety|anxiety
139745|NCT02697435|Dementia|dementia
139746|NCT02697435|Recent Leg Length Discrepancy|recent leg length discrepancy
139747|NCT02697422|Smoking (tobacco use)|smoking (tobacco use)
139748|NCT02697422|Peer health coach|peer health coach
139749|NCT02697422|Systolic blood pressure|systolic blood pressure
139750|NCT02697422|Framingham Cardiovascular risk score|framingham cardiovascular risk score
139751|NCT02697422|Lipid|lipid
139752|NCT02697422|Health related quality of life|health related quality of life
139753|NCT02697422|Health care utilization|health care utilization
139754|NCT02697422|Medication adherence|medication adherence
139755|NCT02697422|Physical activity|physical activity
139756|NCT02697422|Nutrition|nutrition
139757|NCT02697422|Alcohol use|alcohol use
139758|NCT02697422|Stress management|stress management
139759|NCT02697396|Social Marketing Campaign|social marketing campaign
139760|NCT02697396|Mexican American Children|mexican american children
139761|NCT02697396|16-069|16-069
139762|NCT02697383|Ixazomib (MLN9708)|ixazomib (mln9708)
139763|NCT02697383|Dexamethasone|dexamethasone
139764|NCT02697383|15-294|15-294
139765|NCT02697370|Haemophilia A prophylaxis pharmacokinetic dosing|haemophilia a prophylaxis pharmacokinetic dosing
139766|NCT02697357|Emotion Regulation Therapy|emotion regulation therapy
139767|NCT02697357|Distress Among Caregivers|distress among caregivers
139768|NCT02697357|15-219|15-219
139769|NCT02697331|Short cervix, twins, progesterone|short cervix, twins, progesterone
139770|NCT02697305|Insulin response|insulin response
139771|NCT02697305|Incretin effect|incretin effect
139772|NCT02697305|GLP-1|glp-1
139773|NCT02697305|GIP|gip
139774|NCT02697305|Valine|valine
139775|NCT02697305|Leucine|leucine
139776|NCT02697305|Isoleucine|isoleucine
139777|NCT02697305|Branched chain amino acids|branched chain amino acids
139778|NCT02697292|Intravenous Immunoglobulin|intravenous immunoglobulin
139779|NCT02697292|VGKC|vgkc
139780|NCT02697292|Autoimmune epilepsy|autoimmune epilepsy
139781|NCT02697292|Gamumex-C|gamumex-c
139782|NCT02697279|Abscess|abscess
139783|NCT02697279|Loop|loop
139784|NCT02697279|Drainage|drainage
139785|NCT02697253|Roux-en-Y Bariatric Surgery|roux-en-y bariatric surgery
139786|NCT02697253|Psychosocial Variables|psychosocial variables
139787|NCT02697253|Behavioral Variables|behavioral variables
139788|NCT02697253|Weight Loss|weight loss
139789|NCT02697253|Food Intake|food intake
139790|NCT02697253|GLP-1|glp-1
139791|NCT02697253|Reinforcing Value of Food|reinforcing value of food
139792|NCT02697253|Exendin 9-39|exendin 9-39
139793|NCT02697240|sickle cell disease|sickle cell disease
139794|NCT02697240|citrulline|citrulline
139795|NCT02697227|Smoking cessation|smoking cessation
139796|NCT02697227|Smoking behavior|smoking behavior
139797|NCT02697227|Behavioral Activation Treatment|behavioral activation treatment
139798|NCT02697227|BATS|bats
139799|NCT02697227|Standard Smoking Cessation Counseling|standard smoking cessation counseling
139800|NCT02697227|SC|sc
139801|NCT02697227|Nicotine Replacement Therapy|nicotine replacement therapy
139802|NCT02697227|NRT|nrt
139803|NCT02697227|Nicotine patch|nicotine patch
139804|NCT02697227|Questionnaires|questionnaires
139805|NCT02697227|Surveys|surveys
139806|NCT02697227|CO Level|co level
139807|NCT02697227|Cotinine Level|cotinine level
139808|NCT02697227|Saliva test|saliva test
139809|NCT02697214|commercial heart rate monitors|commercial heart rate monitors
139810|NCT02697214|accuracy|accuracy
139811|NCT02697214|EKG|ekg
139812|NCT02697214|varying degrees of exertion|varying degrees of exertion
139813|NCT02697201|Mitochondrial Dynamics|mitochondrial dynamics
139814|NCT02697201|Insulin Resistance|insulin resistance
139815|NCT02697188|testosterone|testosterone
139816|NCT02697188|male hypogonadism|male hypogonadism
139817|NCT02697188|low testosterone|low testosterone
139818|NCT02697175|live video-colposcopy|live video-colposcopy
139819|NCT02697175|cervical dysplasia|cervical dysplasia
139820|NCT02697175|anxiety|anxiety
139821|NCT02697175|randomized controlled trial|randomized controlled trial
139822|NCT02697175|colposcopy|colposcopy
139823|NCT02697162|Intermittent catheterisation|intermittent catheterisation
139824|NCT02697162|Antiseptic|antiseptic
139825|NCT02697162|Octenidine chloride|octenidine chloride
139826|NCT02697162|Children|children
139827|NCT02697149|ERCP|ercp
139828|NCT02697149|nonradiation-to-endoscopist|nonradiation-to-endoscopist
139829|NCT02697149|gallstones|gallstones
139830|NCT02697136|Low HDL|low hdl
139831|NCT02697136|Low apoA-I|low apoa-i
139832|NCT02697136|ABCA-1 mutations|abca-1 mutations
139833|NCT02697136|ApoA-I mutations|apoa-i mutations
139834|NCT02697123|Venous Thrombosis|venous thrombosis
139835|NCT02697123|Pregnancy|pregnancy
139836|NCT02697123|postpartum|postpartum
139837|NCT02697123|antepartum|antepartum
139838|NCT02697110|Cognition|cognition
139839|NCT02697110|Brain Stimulation|brain stimulation
139840|NCT02697110|Early Child Development|early child development
139841|NCT02697097|Hip Muscle Strength|hip muscle strength
139842|NCT02697097|FAI|fai
139843|NCT02697071|Ketamine|ketamine
139844|NCT02697071|Migraine|migraine
139845|NCT02697071|Headache|headache
139846|NCT02697071|Emergency Department|emergency department
139847|NCT02697045|Schizophrenia|schizophrenia
139848|NCT02697045|Quality of Life|quality of life
139849|NCT02697045|Functionality|functionality
139850|NCT02697045|Long Acting Injectable|long acting injectable
139851|NCT02697045|Aripiprazole|aripiprazole
139852|NCT02697045|Naturalistic|naturalistic
139853|NCT02697045|Open-label|open-label
139854|NCT02697045|Single Arm|single arm
139855|NCT02697045|Uncontrolled Study|uncontrolled study
139856|NCT02697032|FDHT|fdht
139857|NCT02697032|PET|pet
139858|NCT02697032|Breast cancer|breast cancer
139859|NCT02697032|Bicalutamide|bicalutamide
139986|NCT02696343|orocutaneous|orocutaneous
139860|NCT02697019|Nonsuicidal Self-Injury (NSSI), Deliberate Self-Harm (DSH), Self-harm, Self-injury|nonsuicidal self-injury (nssi), deliberate self-harm (dsh), self-harm, self-injury
139861|NCT02696993|Metastatic Brain Cancer|metastatic brain cancer
139862|NCT02696993|Non-small cell lung cancer with brain metastasis|non-small cell lung cancer with brain metastasis
139863|NCT02696993|NSCLC|nsclc
139864|NCT02696993|Intracranial disease|intracranial disease
139865|NCT02696993|Stereotactic radiosurgery|stereotactic radiosurgery
139866|NCT02696993|SRS|srs
139867|NCT02696993|Whole brain radiation therapy|whole brain radiation therapy
139868|NCT02696993|WBRT|wbrt
139869|NCT02696993|Neurocognitive exam|neurocognitive exam
139870|NCT02696993|Nivolumab|nivolumab
139871|NCT02696993|BMS-936558|bms-936558
139872|NCT02696993|Opdivo|opdivo
139873|NCT02696993|Ipilimumab|ipilimumab
139874|NCT02696993|Yervoy|yervoy
139875|NCT02696993|BMS-734016|bms-734016
139876|NCT02696993|MDX010|mdx010
139877|NCT02696980|obesity|obesity
139878|NCT02696980|asthma|asthma
139879|NCT02696967|Heart Failure|heart failure
139880|NCT02696954|Artemether-lumefantrine|artemether-lumefantrine
139881|NCT02696954|Amodiaquine|amodiaquine
139882|NCT02696954|Primaquine|primaquine
139883|NCT02696902|Pseudomonas aeruginosa, Pneumonia|pseudomonas aeruginosa, pneumonia
139884|NCT02696889|Infertility|infertility
139885|NCT02696889|Premature Ovarian Failure|premature ovarian failure
139886|NCT02696889|Stem Cells|stem cells
139887|NCT02696889|Amenorrhea|amenorrhea
139888|NCT02696876|Cartilage|cartilage
139889|NCT02696876|Mesenchymal stromal cell|mesenchymal stromal cell
139890|NCT02696876|Microfracture|microfracture
139891|NCT02696876|Knee|knee
139892|NCT02696876|Defect|defect
139893|NCT02696876|Injury|injury
139894|NCT02696876|Stem cell|stem cell
139895|NCT02696876|Autologous|autologous
139896|NCT02696876|Minimally manipulated|minimally manipulated
139897|NCT02696850|sinusitis|sinusitis
139898|NCT02696850|rhinosinusitis|rhinosinusitis
139899|NCT02696850|rhinitis|rhinitis
139900|NCT02696850|nasal lavage|nasal lavage
139901|NCT02696811|cancer|cancer
139902|NCT02696811|inflammation|inflammation
139903|NCT02696811|dietary intervention trial|dietary intervention trial
139904|NCT02696798|Ankylosing Spondylitis|ankylosing spondylitis
139905|NCT02696785|Ankylosing Spondylitis|ankylosing spondylitis
139906|NCT02696759|Breast|breast
139907|NCT02696759|Cancer|cancer
139908|NCT02696733|TURBT|turbt
139909|NCT02696733|ultrasound guided|ultrasound guided
139910|NCT02696733|ONB|onb
139911|NCT02696733|interadductor approach|interadductor approach
139912|NCT02696720|lidocaine|lidocaine
139913|NCT02696720|phantom limb pain (PLP)|phantom limb pain (plp)
139914|NCT02696720|Primary/secondary scar hyperalgesia|primary/secondary scar hyperalgesia
139915|NCT02696707|cardiac toxicities|cardiac toxicities
139916|NCT02696668|multisensory exercises|multisensory exercises
139917|NCT02696668|group-based balance exercise programme|group-based balance exercise programme
139918|NCT02696655|transplantation|transplantation
139919|NCT02696642|mesothelin-expressing advanced solid cancers|mesothelin-expressing advanced solid cancers
139920|NCT02696629|Ventilatory control|ventilatory control
139921|NCT02696629|Obstructive sleep apnea|obstructive sleep apnea
139922|NCT02696629|Loop gain|loop gain
139923|NCT02696629|Upper airway|upper airway
139924|NCT02696629|Surgery|surgery
139925|NCT02696603|Health app research|health app research
139926|NCT02696603|mHealth research|mhealth research
139927|NCT02696603|Mobile health research|mobile health research
139928|NCT02696603|Mobile application health research|mobile application health research
139929|NCT02696564|COPD|copd
139930|NCT02696564|emphysema|emphysema
139931|NCT02696564|HRCT|hrct
139932|NCT02696564|losartan|losartan
139933|NCT02696551|Medical education|medical education
139934|NCT02696551|Spondyloarthritis|spondyloarthritis
139935|NCT02696551|Physician action|physician action
139936|NCT02696538|Fall risk|fall risk
139937|NCT02696538|Rehabiliation|rehabiliation
139938|NCT02696538|Physical Therapy|physical therapy
139939|NCT02696538|Functional Gait Assessment|functional gait assessment
139940|NCT02696538|mini-Balance Evaluation Systems Test|mini-balance evaluation systems test
139941|NCT02696538|Berg Balance Scale|berg balance scale
139942|NCT02696538|Psychometric properties|psychometric properties
139943|NCT02696538|Validity|validity
139944|NCT02696538|Inter-rater reliability|inter-rater reliability
139945|NCT02696538|Montreal Cognitive Assessment|montreal cognitive assessment
139946|NCT02696525|Circulating Tumor DNA|circulating tumor dna
139947|NCT02696525|Lung cancer|lung cancer
139948|NCT02696525|lead time|lead time
139949|NCT02696512|Severe Disorders of Consciousness (SDOC)|severe disorders of consciousness (sdoc)
139950|NCT02696512|Coma|coma
139951|NCT02696512|Vegetative State|vegetative state
139952|NCT02696512|Minimally Conscious State|minimally conscious state
139953|NCT02696499|Uremic pruritus|uremic pruritus
139954|NCT02696499|Pruritus|pruritus
139955|NCT02696499|Chronic itch|chronic itch
139956|NCT02696499|Itch|itch
139957|NCT02696499|Hemodialysis|hemodialysis
139958|NCT02696499|End-stage renal disease|end-stage renal disease
139959|NCT02696473|Bioavailability|bioavailability
139960|NCT02696473|Polyacetylenes|polyacetylenes
139961|NCT02696473|Falcarinol|falcarinol
139962|NCT02696473|Falcarindiol|falcarindiol
139963|NCT02696473|Falcarindiol-3-acetate|falcarindiol-3-acetate
139964|NCT02696473|Carrot|carrot
139965|NCT02696473|Biological Availability|biological availability
139968|NCT02696447|Radiation therapy|radiation therapy
139969|NCT02696447|Thrombosis|thrombosis
139970|NCT02696434|naltrexone|naltrexone
139971|NCT02696434|VIVITROL|vivitrol
139972|NCT02696434|buprenorphine|buprenorphine
139973|NCT02696434|opioid|opioid
139974|NCT02696434|addiction|addiction
139975|NCT02696408|Mucositis|mucositis
139976|NCT02696408|Low level laser therapy|low level laser therapy
139977|NCT02696408|Autograft|autograft
139978|NCT02696408|Allograft|allograft
139979|NCT02696382|Veterans|veterans
139980|NCT02696382|Progressive High Intensity Physical Therapy|progressive high intensity physical therapy
139981|NCT02696382|Gait Speed|gait speed
139982|NCT02696382|Acute Hospitalization|acute hospitalization
139983|NCT02696382|Hospital Associated Deconditioning|hospital associated deconditioning
139984|NCT02696356|HLA-A*02|hla-a*02
139985|NCT02696343|somatosensory stimulation|somatosensory stimulation
139987|NCT02696343|gene expression|gene expression
139988|NCT02696291|Dengue|dengue
139989|NCT02696291|Arbovirus Infections|arbovirus infections
139990|NCT02696291|Flaviviridae Infections|flaviviridae infections
139991|NCT02696291|Flavivirus Infections|flavivirus infections
139992|NCT02696291|Hemorrhagic Fevers, Viral|hemorrhagic fevers, viral
139993|NCT02696291|RNA Virus Infections|rna virus infections
139994|NCT02696291|Virus Diseases|virus diseases
139995|NCT02696291|Pharmaceutical Solutions|pharmaceutical solutions
139996|NCT02696291|Pharmacologic Actions|pharmacologic actions
139997|NCT02696291|Therapeutic Uses|therapeutic uses
139998|NCT02696278|gut microbiota|gut microbiota
139999|NCT02696278|obesity|obesity
140000|NCT02696278|toddlers|toddlers
140001|NCT02696278|fiber|fiber
140002|NCT02696278|unsaturated fats|unsaturated fats
140003|NCT02696265|Atrial Fibrillation|atrial fibrillation
140004|NCT02696265|Complex Fractionated Atrial Electrocardiograms|complex fractionated atrial electrocardiograms
140005|NCT02696265|Pulmonary Vein Isolation|pulmonary vein isolation
140006|NCT02696265|Ablation|ablation
140007|NCT02696265|CFAE/spatiotemporal dispersion guided ablation|cfae/spatiotemporal dispersion guided ablation
140008|NCT02696252|Endocrine System Diseases|endocrine system diseases
140009|NCT02696252|Glucose Metabolism Disorders|glucose metabolism disorders
140010|NCT02696252|Metabolic Diseases|metabolic diseases
140011|NCT02696239|vaginal cuff closure|vaginal cuff closure
140012|NCT02696239|Robotic Hysterectomy|robotic hysterectomy
140013|NCT02696200|Concussion|concussion
140014|NCT02696187|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
140015|NCT02696187|Feasibility|feasibility
140016|NCT02696187|Health promotion tool|health promotion tool
140017|NCT02696187|Self management|self management
140018|NCT02696187|Evidence based care|evidence based care
140019|NCT02696187|Knowledge transfer|knowledge transfer
140020|NCT02696187|Implementation|implementation
140021|NCT02696161|platelet rich plasma|platelet rich plasma
140022|NCT02696161|Perineural injection therapy|perineural injection therapy
140023|NCT02696135|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
140024|NCT02696135|clinical outcomes|clinical outcomes
140025|NCT02696135|multi-omics|multi-omics
140026|NCT02696135|risk stratification|risk stratification
140027|NCT02696122|Pain, postoperative|pain, postoperative
140028|NCT02696122|Hernia, abdominal|hernia, abdominal
140029|NCT02696122|Anesthesia, spinal|anesthesia, spinal
140030|NCT02696122|Anesthesia, local|anesthesia, local
140031|NCT02696122|Anesthesia, general|anesthesia, general
140032|NCT02696122|Quality of life|quality of life
140033|NCT02696122|Anesthesia recovery period|anesthesia recovery period
140034|NCT02696122|Personal satisfaction|personal satisfaction
140035|NCT02696122|Postoperative complications|postoperative complications
140036|NCT02696122|Quality of recovery|quality of recovery
140037|NCT02696109|Transition age youth|transition age youth
140038|NCT02696109|Mental health|mental health
140039|NCT02696109|Mental health services|mental health services
140040|NCT02696109|Engagement|engagement
140041|NCT02696070|Pain|pain
140042|NCT02696070|Diabetic Neuropathy|diabetic neuropathy
140043|NCT02696070|Pulsed Electromagnetic Energy Field|pulsed electromagnetic energy field
140044|NCT02696070|PEMF|pemf
140045|NCT02696070|PPDN|ppdn
140046|NCT02696044|Gastrointestinal Disorders|gastrointestinal disorders
140047|NCT02696031|non-radiographic spondyloarthritis|non-radiographic spondyloarthritis
140048|NCT02696031|axial spondyloarthritis|axial spondyloarthritis
140049|NCT02696018|Diaphragm|diaphragm
140050|NCT02696018|Ultrasound|ultrasound
140051|NCT02696018|Critically ill patients|critically ill patients
140052|NCT02695992|Rate control in atrial fibrillation|rate control in atrial fibrillation
140053|NCT02695992|Beta blockers|beta blockers
140054|NCT02695992|Calcium channel blockers|calcium channel blockers
140055|NCT02695992|Permanent atrial fibrillation|permanent atrial fibrillation
140056|NCT02695992|Management of atrial fibrillation|management of atrial fibrillation
140057|NCT02695992|Atrial fibrillation and biomarkers|atrial fibrillation and biomarkers
140058|NCT02695992|Arrhythmias, cardiac|arrhythmias, cardiac
140059|NCT02695992|Heart Diseases|heart diseases
140060|NCT02695992|Pathological processes|pathological processes
140061|NCT02695992|Diltiazem|diltiazem
140062|NCT02695992|Metoprolol|metoprolol
140257|NCT02694588|Infliximab|infliximab
140063|NCT02695992|Adrenergic Agents|adrenergic agents
140064|NCT02695992|Adrenergic Antagonists|adrenergic antagonists
140065|NCT02695992|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists
140066|NCT02695992|Adrenergic beta-Antagonists|adrenergic beta-antagonists
140067|NCT02695992|Anti-Arrhythmia Agents|anti-arrhythmia agents
140068|NCT02695992|Antihypertensive Agents|antihypertensive agents
140069|NCT02695992|Autonomic Agents|autonomic agents
140070|NCT02695992|Cardiovascular Agents|cardiovascular agents
140071|NCT02695992|Membrane Transport Modulators|membrane transport modulators
140072|NCT02695992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
140073|NCT02695992|Neurotransmitter Agents|neurotransmitter agents
140074|NCT02695992|Peripheral Nervous System Agents|peripheral nervous system agents
140075|NCT02695992|Physiological Effects of Drugs|physiological effects of drugs
140076|NCT02695992|Sympatholytics|sympatholytics
140077|NCT02695992|Therapeutic Uses|therapeutic uses
140078|NCT02695992|Vasodilator Agents|vasodilator agents
140079|NCT02695992|Troponins|troponins
140080|NCT02695992|NT-proBNP|nt-probnp
140081|NCT02695992|Biomarkers|biomarkers
140082|NCT02695953|PTSD|ptsd
140083|NCT02695953|biomarker|biomarker
140084|NCT02695953|Cognitive Processing Therapy|cognitive processing therapy
140085|NCT02695914|Inflammatory markers|inflammatory markers
140086|NCT02695901|Plaque index|plaque index
140087|NCT02695901|Melaleuca alternifolia oil.|melaleuca alternifolia oil.
140088|NCT02695901|Nanoparticles|nanoparticles
140089|NCT02695875|Fibromyalgia|fibromyalgia
140090|NCT02695875|Pain|pain
140091|NCT02695875|Postural balance|postural balance
140092|NCT02695875|Physical therapy|physical therapy
140093|NCT02695875|Aquatic therapy|aquatic therapy
140094|NCT02695849|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
140095|NCT02695836|Audit and Feedback|audit and feedback
140096|NCT02695836|Nursing Homes|nursing homes
140097|NCT02695836|Organizational Context|organizational context
140098|NCT02695836|Quality Improvement|quality improvement
140099|NCT02695836|Care Aides|care aides
140100|NCT02695836|Leadership|leadership
140101|NCT02695836|Resident Assessment Instrument (RAI)|resident assessment instrument (rai)
140102|NCT02695836|Alberta Context Tool (ACT)|alberta context tool (act)
140103|NCT02695823|intracranial hypertension|intracranial hypertension
140104|NCT02695823|liver transplantation|liver transplantation
140105|NCT02695823|transcranial Doppler|transcranial doppler
140484|NCT02693613|Kremezin|kremezin
140106|NCT02695823|optic nerve sheath diameter|optic nerve sheath diameter
140107|NCT02695797|Intractable cryptogenic epilepsy with autoimmune antibody|intractable cryptogenic epilepsy with autoimmune antibody
140108|NCT02695797|Immunotherapy|immunotherapy
140109|NCT02695771|bladder tumors|bladder tumors
140110|NCT02695771|urinary tumors|urinary tumors
140111|NCT02695771|non-muscle invasive bladder tumors|non-muscle invasive bladder tumors
140112|NCT02695771|NMIBC|nmibc
140113|NCT02695732|Esophageal and Gastric Varices|esophageal and gastric varices
140114|NCT02695732|Primary Prophylaxis|primary prophylaxis
140115|NCT02695732|Carvedilol|carvedilol
140116|NCT02695732|Endoscopy|endoscopy
140117|NCT02695719|Drug therapy|drug therapy
140118|NCT02695706|Diabetes|diabetes
140119|NCT02695706|Skin acceptability|skin acceptability
140120|NCT02695706|Clinical Research|clinical research
140121|NCT02695680|Lung Cancer|lung cancer
140122|NCT02695680|SBRT|sbrt
140123|NCT02695680|Motion Management|motion management
140124|NCT02695641|Arteriovenous Fistula|arteriovenous fistula
140125|NCT02695641|Arteriovenous Graft|arteriovenous graft
140126|NCT02695641|Bevacizumab|bevacizumab
140127|NCT02695641|Hemodialysis|hemodialysis
140128|NCT02695641|VEGF|vegf
140129|NCT02695641|Avastin|avastin
140130|NCT02695615|cesarean operation|cesarean operation
140131|NCT02695615|Spielberger State Trait Anxiety Inventory|spielberger state trait anxiety inventory
140132|NCT02695615|pain|pain
140133|NCT02695563|Amniocentesis|amniocentesis
140134|NCT02695524|Rehabilitation|rehabilitation
140135|NCT02695524|Shoulder|shoulder
140136|NCT02695498|migraine with aura|migraine with aura
140137|NCT02695498|migraine without aura|migraine without aura
140138|NCT02695498|pain|pain
140139|NCT02695498|controls|controls
140140|NCT02695498|mind-body|mind-body
140141|NCT02695485|dorsal digital island flap|dorsal digital island flap
140142|NCT02695485|sensory reconstruction|sensory reconstruction
140143|NCT02695472|Depression|depression
140144|NCT02695472|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
140145|NCT02695472|Major Depressive Disorder|major depressive disorder
140146|NCT02695472|Neurogenesis|neurogenesis
140147|NCT02695472|Synaptogenesis|synaptogenesis
140148|NCT02695472|NSI-189|nsi-189
140149|NCT02695472|Neuralstem|neuralstem
140150|NCT02695433|Pre-diabetes|pre-diabetes
140151|NCT02695433|Metabolic syndrome|metabolic syndrome
140152|NCT02695433|Matsuda composite index of insulin sensitivity (MISI)|matsuda composite index of insulin sensitivity (misi)
140153|NCT02695433|Blood glucose|blood glucose
140154|NCT02695433|Insulin response|insulin response
140155|NCT02695433|HbA1c|hba1c
140156|NCT02695433|Lipid|lipid
140157|NCT02695433|Inflammation|inflammation
140158|NCT02695420|Heart Failure|heart failure
140159|NCT02695407|artery cannulation|artery cannulation
140160|NCT02695407|haemodynamic monitoring|haemodynamic monitoring
140161|NCT02695342|Balance|balance
140162|NCT02695342|Falls|falls
140163|NCT02695342|Exercise|exercise
140164|NCT02695342|COPD|copd
140165|NCT02695329|navigation system|navigation system
140166|NCT02695329|palm-sized|palm-sized
140167|NCT02695329|total knee arthroplasty|total knee arthroplasty
140168|NCT02695316|Migrants|migrants
140169|NCT02695316|Communication Barriers|communication barriers
140170|NCT02695316|Maternal Health Services|maternal health services
140171|NCT02695316|Health Services Needs and Demand|health services needs and demand
140172|NCT02695316|Access to Health Care|access to health care
140173|NCT02695316|Professional-Patient Relations|professional-patient relations
140174|NCT02695316|Eritrea|eritrea
140175|NCT02695316|Kosovo|kosovo
140176|NCT02695316|Switzerland|switzerland
140177|NCT02695277|Atrial Fibrillation|atrial fibrillation
140178|NCT02695277|Persistent and Longstanding Persistent AF|persistent and longstanding persistent af
140179|NCT02695277|Hybrid Procedure|hybrid procedure
140180|NCT02695277|Catheter Ablation|catheter ablation
140181|NCT02695264|intracranial pressure|intracranial pressure
140182|NCT02695264|intracranial hypertension|intracranial hypertension
140183|NCT02695264|severe traumatic brain injury|severe traumatic brain injury
140184|NCT02695199|Doppler Ultrasound|doppler ultrasound
140185|NCT02695199|Laparoscopic|laparoscopic
140186|NCT02695199|Microscopic Subinguinal Varicocelectomy|microscopic subinguinal varicocelectomy
140187|NCT02695186|Intestinal metaplasia|intestinal metaplasia
140188|NCT02695186|Metabolic syndrome|metabolic syndrome
140189|NCT02695186|Oxidative stress|oxidative stress
140190|NCT02695108|Scapula|scapula
140191|NCT02695108|Neck|neck
140192|NCT02695108|Pain|pain
140193|NCT02695108|Therapy|therapy
140194|NCT02695108|Kinematic|kinematic
140195|NCT02695069|Complete Placenta Previa|complete placenta previa
140196|NCT02695069|Random Placenta Margin Incision|random placenta margin incision
140197|NCT02695069|Cesarean Section|cesarean section
140198|NCT02695069|Hemorrhage|hemorrhage
140199|NCT02694991|surgery|surgery
140200|NCT02694991|outcome|outcome
140201|NCT02694991|pain|pain
140202|NCT02694991|osteopathic manipulative treatment|osteopathic manipulative treatment
140203|NCT02694978|iron deficiency anemia|iron deficiency anemia
140205|NCT02694978|ferumoxytol|ferumoxytol
140206|NCT02694978|ferric carboxymaltose|ferric carboxymaltose
140207|NCT02694978|FCM|fcm
140208|NCT02694978|Injectafer|injectafer
140209|NCT02694926|adrenal crisis|adrenal crisis
140210|NCT02694926|education programme|education programme
140211|NCT02694887|Capillary blood|capillary blood
140212|NCT02694887|Venous blood|venous blood
140213|NCT02694887|Lactate|lactate
140214|NCT02694887|Emergency Department|emergency department
140215|NCT02694874|Adjunctive treatment|adjunctive treatment
140216|NCT02694874|Severe malaria|severe malaria
140217|NCT02694861|Angina Pectoris|angina pectoris
140218|NCT02694861|Angina, Stable|angina, stable
140219|NCT02694861|Chest Pain|chest pain
140220|NCT02694796|Web and smartphone-based physical activity program|web and smartphone-based physical activity program
140221|NCT02694796|Connected devices|connected devices
140222|NCT02694796|Balneotherapy|balneotherapy
140223|NCT02694783|JC VIRUS|jc virus
140224|NCT02694783|Progressive Multifocal Encephalopathy (PML)|progressive multifocal encephalopathy (pml)
140225|NCT02694770|aGvHD|agvhd
140226|NCT02694770|GvHD|gvhd
140227|NCT02694770|sr-aGvHD|sr-agvhd
140228|NCT02694770|biologics|biologics
140229|NCT02694770|monoclonal antibody|monoclonal antibody
140230|NCT02694757|Ostom-i|ostom-i
140231|NCT02694757|OIA device|oia device
140232|NCT02694744|Treatment of Hyperkalemia|treatment of hyperkalemia
140233|NCT02694744|Hyperkalemia|hyperkalemia
140234|NCT02694744|Potassium|potassium
140235|NCT02694744|Chronic Kidney Disease|chronic kidney disease
140236|NCT02694731|Craving|craving
140237|NCT02694731|Mobile Apps|mobile apps
140238|NCT02694705|Oxygen Inhalation Therapy|oxygen inhalation therapy
140239|NCT02694705|Intubation|intubation
140240|NCT02694705|Emergency Medicine|emergency medicine
140241|NCT02694679|social networks, maternal and child health, global health|social networks, maternal and child health, global health
140242|NCT02694653|C/section, Acetaminophen|c/section, acetaminophen
140243|NCT02694640|Breast cancer|breast cancer
140244|NCT02694640|Exercise|exercise
140245|NCT02694640|Physical activity|physical activity
140246|NCT02694640|Community volunteers|community volunteers
140247|NCT02694640|Peer mentors|peer mentors
140248|NCT02694640|Peer coaches|peer coaches
140249|NCT02694640|Social support|social support
140250|NCT02694640|Exercise maintenance|exercise maintenance
140251|NCT02694627|gender, caregiving, MNCH, violence, sexual and reproductive health, parenting|gender, caregiving, mnch, violence, sexual and reproductive health, parenting
140252|NCT02694614|weight loss|weight loss
140253|NCT02694614|individualised dietary coaching|individualised dietary coaching
140254|NCT02694614|smartphone-assisted dietary coaching|smartphone-assisted dietary coaching
140255|NCT02694614|health behavior change|health behavior change
140258|NCT02694562|Metastatic Colorectal Carcinoma|metastatic colorectal carcinoma
140259|NCT02694549|Vascular Closure Devices|vascular closure devices
140260|NCT02694549|Catheterization Closure Devices|catheterization closure devices
140261|NCT02694549|Vascular Access Devices|vascular access devices
140262|NCT02694523|Psoriasis|psoriasis
140263|NCT02694523|Skin Diseases|skin diseases
140264|NCT02694523|Skin Diseases, Papulosquamous|skin diseases, papulosquamous
140265|NCT02694523|Adalimumab|adalimumab
140266|NCT02694523|Anti-Inflammatory Agents|anti-inflammatory agents
140267|NCT02694523|ABBV-066|abbv-066
140268|NCT02694523|BI 655066|bi 655066
140269|NCT02694523|Risankizumab|risankizumab
140270|NCT02694510|Preterm infants|preterm infants
140271|NCT02694510|Oxidative stress|oxidative stress
140272|NCT02694510|Parenteral nutrition|parenteral nutrition
140273|NCT02694497|transmission|transmission
140274|NCT02694497|women|women
140275|NCT02694497|genital|genital
140276|NCT02694497|anorectal|anorectal
140277|NCT02694484|Cytomegalovirus|cytomegalovirus
140278|NCT02694484|Stool sample|stool sample
140279|NCT02694484|Healthy Volunteers|healthy volunteers
140280|NCT02694484|Fecal microbiota transplant|fecal microbiota transplant
140281|NCT02694471|Ageing|ageing
140282|NCT02694471|Physical inactivity|physical inactivity
140283|NCT02694471|Functional decline|functional decline
140284|NCT02694471|Reconditioning|reconditioning
140285|NCT02694458|Vancomycin|vancomycin
140286|NCT02694458|Children|children
140287|NCT02694458|Infection|infection
140288|NCT02694458|Antibiotic|antibiotic
140289|NCT02694458|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
140290|NCT02694458|Population-based pharmacokinetic modeling|population-based pharmacokinetic modeling
140291|NCT02694458|Pharmacokinetics|pharmacokinetics
140292|NCT02694458|Pharmacodynamics|pharmacodynamics
140293|NCT02694458|Bayesian approach|bayesian approach
140294|NCT02694458|Therapeutic drug monitoring|therapeutic drug monitoring
140295|NCT02694432|high blood pressure, systolic, diastolic|high blood pressure, systolic, diastolic
140296|NCT02694432|complementary therapies, meditation|complementary therapies, meditation
140297|NCT02694419|endometrium|endometrium
140298|NCT02694406|Diagnosis|diagnosis
140299|NCT02694367|genetic basis|genetic basis
140300|NCT02694341|Management|management
140301|NCT02694328|Alkermes|alkermes
140302|NCT02694328|ALKS 3831|alks 3831
140303|NCT02694328|Samidorphan|samidorphan
140304|NCT02694328|Schizophrenia|schizophrenia
140305|NCT02694328|Olanzapine|olanzapine
140306|NCT02694328|Weight|weight
140307|NCT02694302|Stroke|stroke
140308|NCT02694250|cervical|cervical
140309|NCT02694250|fusion|fusion
140310|NCT02694250|radiculopathy|radiculopathy
140311|NCT02694250|DTRAX|dtrax
140312|NCT02694224|breast cancer|breast cancer
140313|NCT02694224|triple negative|triple negative
140314|NCT02694224|neoadjuvant|neoadjuvant
140315|NCT02694211|work related stress|work related stress
140316|NCT02694185|Medication Adherence|medication adherence
140317|NCT02694185|Randomized Controlled Trial|randomized controlled trial
140318|NCT02694185|Veterans|veterans
140319|NCT02694172|diabetes mellitus type 2|diabetes mellitus type 2
140320|NCT02694172|healthy subjects|healthy subjects
140321|NCT02694172|human microbiome|human microbiome
140322|NCT02694172|cereal bar|cereal bar
140323|NCT02694146|platelet-rich plasma (PRP)|platelet-rich plasma (prp)
140324|NCT02694146|hyaluronic acid (Hylan G-F 20).|hyaluronic acid (hylan g-f 20).
140325|NCT02694146|NSAIDs|nsaids
140326|NCT02694146|WOMAC|womac
140327|NCT02694133|telerehabilitation|telerehabilitation
140328|NCT02694133|aphasia|aphasia
140329|NCT02694133|speech therapy|speech therapy
140330|NCT02694133|rehabilitation device|rehabilitation device
140331|NCT02694133|visual action therapy|visual action therapy
140332|NCT02694133|naming drills|naming drills
140333|NCT02694094|cholesterol|cholesterol
140334|NCT02694094|seizure|seizure
140335|NCT02694094|epilepsy|epilepsy
140336|NCT02694094|ketogenic|ketogenic
140337|NCT02694094|diet|diet
140338|NCT02694081|reflux|reflux
140339|NCT02694081|residue|residue
140340|NCT02694081|Gastric stasis|gastric stasis
140341|NCT02694081|Emptying time|emptying time
140342|NCT02694068|Peritoneal Dialysis|peritoneal dialysis
140343|NCT02694068|Genetic|genetic
140344|NCT02694068|Peritoneal Membrane|peritoneal membrane
140345|NCT02694068|Peritoneal Equilibrium Test|peritoneal equilibrium test
140346|NCT02694068|Ultrafiltration Capacity|ultrafiltration capacity
140347|NCT02694068|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
140348|NCT02694055|Community Health Workers|community health workers
140349|NCT02694055|Community Case Management|community case management
140350|NCT02694055|Proactive Case Detection|proactive case detection
140351|NCT02694055|Under-five Child Mortality|under-five child mortality
140352|NCT02694055|Access to Health Care|access to health care
140353|NCT02694042|Pediatric inflammatory bowel disease|pediatric inflammatory bowel disease
140354|NCT02694042|Crohn's disease|crohn's disease
140355|NCT02694042|Ulcerative colitis|ulcerative colitis
140356|NCT02694042|Web-based teaching and support|web-based teaching and support
140461|NCT02693665|family|family
140357|NCT02694042|disease self-management|disease self-management
140358|NCT02694042|peer support|peer support
140359|NCT02694016|Remote ischemic preconditioning|remote ischemic preconditioning
140360|NCT02694016|Neuroprotection|neuroprotection
140361|NCT02694003|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
140362|NCT02694003|Fetal Alcohol Spectrum Disorder (FASD)|fetal alcohol spectrum disorder (fasd)
140363|NCT02694003|Cerebral Palsy (CP)|cerebral palsy (cp)
140364|NCT02694003|Attention-Deficit/Hyperactivity Disorder (ADHD)|attention-deficit/hyperactivity disorder (adhd)
140365|NCT02694003|Behavioural Insomnia|behavioural insomnia
140366|NCT02694003|Neurodevelopmental Disorders|neurodevelopmental disorders
140367|NCT02693990|Tumor lining the brain|tumor lining the brain
140368|NCT02693990|Meningioma|meningioma
140369|NCT02693990|Brain Tumor|brain tumor
140370|NCT02693977|OSA|osa
140371|NCT02693977|sleep apnea|sleep apnea
140372|NCT02693977|AT|at
140373|NCT02693977|adenotonsillectomy|adenotonsillectomy
140374|NCT02693977|pediatric|pediatric
140375|NCT02693964|Type 1 Diabetes|type 1 diabetes
140376|NCT02693964|Menopause|menopause
140377|NCT02693964|Cardiovascular Risk|cardiovascular risk
140378|NCT02693964|Bone Density|bone density
140379|NCT02693951|gastric varices|gastric varices
140380|NCT02693951|endoscopic injection of tissue adhesive|endoscopic injection of tissue adhesive
140381|NCT02693938|diabetes|diabetes
140382|NCT02693938|menstrual cycle|menstrual cycle
140383|NCT02693938|insulin|insulin
140384|NCT02693912|efferocytosis|efferocytosis
140385|NCT02693912|macrophage|macrophage
140386|NCT02693873|Osteoarthritis, Hip|osteoarthritis, hip
140387|NCT02693873|Osteoarthritis, Knee|osteoarthritis, knee
140388|NCT02693873|Patient Education|patient education
140389|NCT02693873|Exercise, Neuromuscular|exercise, neuromuscular
140390|NCT02693873|Disease Management|disease management
140391|NCT02693873|Evidence-Based Health Care|evidence-based health care
140392|NCT02693873|Pilot Study|pilot study
140393|NCT02693847|HCV|hcv
140394|NCT02693847|HIV|hiv
140395|NCT02693847|Liver cirrhosis|liver cirrhosis
140396|NCT02693847|Hepatocellular carcinoma|hepatocellular carcinoma
140397|NCT02693847|Liver transplant|liver transplant
140398|NCT02693847|Liver stiffness|liver stiffness
140399|NCT02693847|Transient elastography|transient elastography
140400|NCT02693834|foot drop|foot drop
140401|NCT02693834|Subacute stroke|subacute stroke
140402|NCT02693834|AFO|afo
140403|NCT02693834|gait symmetry|gait symmetry
140404|NCT02693834|Gait endurance|gait endurance
140405|NCT02693821|Gabapentin|gabapentin
140406|NCT02693821|prevention|prevention
140407|NCT02693821|incidence|incidence
140408|NCT02693808|Temporal hollowing|temporal hollowing
140409|NCT02693808|Lateral orbital wall decompression|lateral orbital wall decompression
140410|NCT02693808|Thyroid eye disease|thyroid eye disease
140411|NCT02693795|myocardial infarction|myocardial infarction
140412|NCT02693795|left ventricular remodeling|left ventricular remodeling
140413|NCT02693782|Fibre|fibre
140414|NCT02693782|Wheat Bran Extract|wheat bran extract
140415|NCT02693782|Microbiota|microbiota
140416|NCT02693782|Microbiota metabolites|microbiota metabolites
140417|NCT02693782|Gastrointestinal tolerance|gastrointestinal tolerance
140418|NCT02693743|suicidality|suicidality
140419|NCT02693743|rTMS|rtms
140420|NCT02693743|suicide ideation|suicide ideation
140421|NCT02693730|Irritable Bowel Syndrome|irritable bowel syndrome
140422|NCT02693730|IBS|ibs
140423|NCT02693730|Ulcerative Colitis|ulcerative colitis
140424|NCT02693730|UC|uc
140425|NCT02693730|Inflammatory Bowel Disease|inflammatory bowel disease
140426|NCT02693730|IBD|ibd
140427|NCT02693730|Healthy Control|healthy control
140428|NCT02693730|HC|hc
140429|NCT02693730|Visceral Pain|visceral pain
140430|NCT02693730|Gut|gut
140431|NCT02693730|Neuroimaging|neuroimaging
140432|NCT02693730|fMRI|fmri
140433|NCT02693730|resting state|resting state
140434|NCT02693730|structural MRI|structural mri
140435|NCT02693730|functional MRI|functional mri
140436|NCT02693730|diffusion tensor imaging|diffusion tensor imaging
140437|NCT02693730|MR Spectroscopy|mr spectroscopy
140438|NCT02693717|Cancer of urethra|cancer of urethra
140439|NCT02693717|Cancer of ureters|cancer of ureters
140440|NCT02693717|MTAP-deficient bladder cancer|mtap-deficient bladder cancer
140441|NCT02693717|MTAP wild-type bladder cancer|mtap wild-type bladder cancer
140442|NCT02693717|Metastatic|metastatic
140443|NCT02693717|Pemetrexed|pemetrexed
140444|NCT02693717|LY231514|ly231514
140445|NCT02693717|Alimta|alimta
140446|NCT02693717|MTA|mta
140447|NCT02693717|Multitargeted Antifolate|multitargeted antifolate
140448|NCT02693717|NSC-698037|nsc-698037
140449|NCT02693717|Folic Acid|folic acid
140450|NCT02693717|Folinic Acid|folinic acid
140451|NCT02693717|Vitamin B12|vitamin b12
140452|NCT02693717|Dexamethasone|dexamethasone
140453|NCT02693717|Decadron|decadron
140454|NCT02693678|Proprioception|proprioception
140455|NCT02693678|Doms|doms
140456|NCT02693678|Pain|pain
140457|NCT02693678|Massage|massage
140458|NCT02693678|Diathermy|diathermy
140459|NCT02693665|pediatric advance care planning|pediatric advance care planning
140460|NCT02693665|adolescent|adolescent
140462|NCT02693665|palliative care|palliative care
140463|NCT02693665|end of life|end of life
140464|NCT02693665|communication|communication
140465|NCT02693665|decision making|decision making
140466|NCT02693665|surrogate decision maker|surrogate decision maker
140467|NCT02693665|health care proxy|health care proxy
140468|NCT02693665|intervention|intervention
140469|NCT02693665|randomized clinical trial|randomized clinical trial
140470|NCT02693665|cancer|cancer
140471|NCT02693665|quality of life|quality of life
140472|NCT02693665|spiritual|spiritual
140473|NCT02693665|religion|religion
140474|NCT02693665|treatment congruence|treatment congruence
140475|NCT02693665|treatment preferences|treatment preferences
140476|NCT02693665|FAmily CEntered (FACE) Advance Care Planning|family centered (face) advance care planning
140477|NCT02693639|PANX1|panx1
140478|NCT02693639|Infection|infection
140479|NCT02693639|Liver transplantation|liver transplantation
140480|NCT02693626|mobile phone-based text message interventions|mobile phone-based text message interventions
140481|NCT02693626|'Happy Quit'|'happy quit'
140482|NCT02693626|smoking cessation|smoking cessation
140483|NCT02693613|Drug-drug interaction|drug-drug interaction
140485|NCT02693613|Pharmacokinetics|pharmacokinetics
140486|NCT02693613|ASP1517|asp1517
140487|NCT02693600|Total Trapeziectomy|total trapeziectomy
140488|NCT02693600|Partial Trapeziectomy|partial trapeziectomy
140489|NCT02693600|Ligamentoplasty|ligamentoplasty
140490|NCT02693574|Helicobacter pylori|helicobacter pylori
140491|NCT02693574|Helicobacter Infections|helicobacter infections
140492|NCT02693574|Proton Pump Inhibitors|proton pump inhibitors
140493|NCT02693561|Self-help book|self-help book
140494|NCT02693561|Deep breathing|deep breathing
140495|NCT02693548|Familial Hypercholesterolaemia|familial hypercholesterolaemia
140496|NCT02693548|Prognosis|prognosis
140497|NCT02693548|Cardiovascular disease|cardiovascular disease
140498|NCT02693535|cancer|cancer
140499|NCT02693535|off-label|off-label
140500|NCT02693535|precision medicine|precision medicine
140501|NCT02693535|targeted therapy|targeted therapy
140502|NCT02693496|ResearchKit|researchkit
140503|NCT02693496|CT screening|ct screening
140504|NCT02693496|Early Diagnosis|early diagnosis
140505|NCT02693496|Lung Cancer|lung cancer
140506|NCT02693392|Fenugreek seed extract|fenugreek seed extract
140507|NCT02693392|HbA1c|hba1c
140508|NCT02693392|Blood glucose|blood glucose
140509|NCT02693379|cervical cancer|cervical cancer
140510|NCT02693379|HPV|hpv
140511|NCT02693379|VIA|via
140512|NCT02693379|screening|screening
140513|NCT02693379|smartphone|smartphone
140514|NCT02693379|telemedicine|telemedicine
140515|NCT02693366|bone marrow cells, stem cells, cell therapy|bone marrow cells, stem cells, cell therapy
140516|NCT02693366|Glomerulosclerosis, Focal Segmental|glomerulosclerosis, focal segmental
140517|NCT02693366|Renal Insufficiency, Chronic|renal insufficiency, chronic
140518|NCT02693327|Gut Microbiome|gut microbiome
140519|NCT02693327|Mental Disorder|mental disorder
140520|NCT02693327|Dysbiosis|dysbiosis
140521|NCT02693314|Jarro-Dophilus|jarro-dophilus
140522|NCT02693314|probiotic|probiotic
140523|NCT02693314|microbiota|microbiota
140524|NCT02693314|gastrointestinal|gastrointestinal
140525|NCT02693301|Asthma|asthma
140526|NCT02693301|Respiratory symptoms|respiratory symptoms
140527|NCT02693301|Exercise program|exercise program
140528|NCT02693301|Functional capacity|functional capacity
140529|NCT02693301|Body composition|body composition
140530|NCT02693288|Wrist fracture|wrist fracture
140531|NCT02693288|postoperative pain|postoperative pain
140532|NCT02693288|local anesthesia|local anesthesia
140533|NCT02693275|Community Sampling|community sampling
140534|NCT02693262|defibrillator|defibrillator
140535|NCT02693262|heart failure|heart failure
140536|NCT02693262|ICD|icd
140537|NCT02693262|CRT-D|crt-d
140538|NCT02693262|cardiac resynchronization therapy|cardiac resynchronization therapy
140539|NCT02693262|rate response|rate response
140540|NCT02693262|CLS|cls
140541|NCT02693262|closed-loop stimulation|closed-loop stimulation
140542|NCT02693262|accelerometer|accelerometer
140543|NCT02693262|chronotropic incompetence|chronotropic incompetence
140544|NCT02693249|accidents|accidents
140545|NCT02693249|adolescents|adolescents
140546|NCT02693249|children|children
140547|NCT02693249|posttraumatic cognitions|posttraumatic cognitions
140548|NCT02693223|stroke|stroke
140549|NCT02693197|Hepatic Impairment|hepatic impairment
140550|NCT02693145|HIV/AIDS|hiv/aids
140551|NCT02693145|re-engagement in care|re-engagement in care
140552|NCT02693145|data to care|data to care
140553|NCT02693132|Obesity|obesity
140554|NCT02693132|Exercise|exercise
140555|NCT02693119|LHON|lhon
140556|NCT02693119|Ocuvia™|ocuvia™
140557|NCT02693119|elamipretide|elamipretide
140558|NCT02693119|MTP-131|mtp-131
140559|NCT02693041|Probiotics|probiotics
140560|NCT02693041|inflammation|inflammation
140561|NCT02693041|immunological response|immunological response
140562|NCT02693041|preterm birth|preterm birth
140563|NCT02693041|preeclampsia|preeclampsia
140564|NCT02693028|Microbiome|microbiome
140565|NCT02693028|probiotic|probiotic
140566|NCT02692976|Castration-resistant prostate cancer|castration-resistant prostate cancer
140567|NCT02692976|Dendritic Cells|dendritic cells
140568|NCT02692976|Immunotherapy|immunotherapy
140569|NCT02692976|Vaccines|vaccines
140570|NCT02692937|Neurosurgical Procedures|neurosurgical procedures
140571|NCT02692937|Nerve Block|nerve block
140572|NCT02692937|Exercise therapy|exercise therapy
140573|NCT02692937|Physical Therapy Specialty|physical therapy specialty
140574|NCT02692924|Pregnancy Complications|pregnancy complications
140575|NCT02692924|Ultrasound|ultrasound
140576|NCT02692911|Gallbaldder|gallbaldder
140577|NCT02692911|Cancer|cancer
140578|NCT02692911|Gallstones|gallstones
140579|NCT02692911|Cholecystectomy|cholecystectomy
140580|NCT02692911|Inflammation|inflammation
140581|NCT02692898|Brain Tumor|brain tumor
140582|NCT02692898|Molecular Pathology|molecular pathology
140583|NCT02692898|Clinical Data|clinical data
140584|NCT02692898|Imaging Data|imaging data
140585|NCT02692885|Phenotype|phenotype
140586|NCT02692885|Adipose Tissue|adipose tissue
140587|NCT02692885|Brown Adipose Tissue|brown adipose tissue
140588|NCT02692872|Alpha Thalassemia|alpha thalassemia
140589|NCT02692872|alpha globin|alpha globin
140590|NCT02692846|CONNECTIVE TISSUE DISEASES|connective tissue diseases
140591|NCT02692846|Cardiovascular Disease|cardiovascular disease
140592|NCT02692846|Elastin Gene Mutation|elastin gene mutation
140593|NCT02692846|Multisystem Developmental Disorder|multisystem developmental disorder
140594|NCT02692833|Telomere|telomere
140595|NCT02692833|Telomerase|telomerase
140596|NCT02692833|DNA methylation|dna methylation
140597|NCT02692833|Cell aging|cell aging
140598|NCT02692833|Thoracic Surgery|thoracic surgery
140599|NCT02692820|Preterm|preterm
140600|NCT02692820|Probiotic|probiotic
140601|NCT02692807|hip arthroscopy|hip arthroscopy
140602|NCT02692807|femoroacetabular impingement|femoroacetabular impingement
140603|NCT02692807|exercise therapy after hip arthroscopy|exercise therapy after hip arthroscopy
140604|NCT02692807|rehabilitation after hip arthroscopy|rehabilitation after hip arthroscopy
140605|NCT02692794|sinusitis|sinusitis
140606|NCT02692794|oximetry|oximetry
140607|NCT02692794|paranasal sinus diseases|paranasal sinus diseases
140608|NCT02692781|Obesity|obesity
140609|NCT02692768|total shoulder arthroplasty|total shoulder arthroplasty
140610|NCT02692768|total shoulder replacement|total shoulder replacement
140611|NCT02692768|adult|adult
140612|NCT02692768|reverse shoulder arthroplasty|reverse shoulder arthroplasty
140613|NCT02692755|African American|african american
140614|NCT02692742|Chemotherapy|chemotherapy
140615|NCT02692742|Chemotherapy-induced Neutropenia|chemotherapy-induced neutropenia
140616|NCT02692742|Supportive Care|supportive care
140617|NCT02692742|Myelosuppression|myelosuppression
140618|NCT02692742|CIN|cin
140619|NCT02692703|HCV Treatment Experienced|hcv treatment experienced
140620|NCT02692703|Hepatitis C|hepatitis c
140621|NCT02692703|HCV Genotype 3|hcv genotype 3
140622|NCT02692703|Without cirrhosis|without cirrhosis
140623|NCT02692703|Non-cirrhotic|non-cirrhotic
140624|NCT02692703|HCV Genotype 2|hcv genotype 2
140625|NCT02692703|Renal Transplant|renal transplant
140626|NCT02692703|HCV Treatment Naive|hcv treatment naive
140627|NCT02692703|Post transplant|post transplant
140628|NCT02692703|HCV Genotype 6|hcv genotype 6
140629|NCT02692703|Liver Transplant|liver transplant
140630|NCT02692703|HCV Genotype 5|hcv genotype 5
140631|NCT02692703|HCV Genotype 4|hcv genotype 4
140632|NCT02692703|Kidney Transplant|kidney transplant
140633|NCT02692703|HCV Genotype 1|hcv genotype 1
140634|NCT02692677|Healthy|healthy
140635|NCT02692677|JNJ-42756493|jnj-42756493
140636|NCT02692664|iliac side branch|iliac side branch
140637|NCT02692651|vancomycin|vancomycin
140638|NCT02692651|fidaxomicin|fidaxomicin
140639|NCT02692651|CDI|cdi
140640|NCT02692651|diarrhea|diarrhea
140641|NCT02692599|live attenuated mumps vaccine|live attenuated mumps vaccine
140642|NCT02692599|safety|safety
140643|NCT02692599|immunogenicity|immunogenicity
140644|NCT02692599|infant|infant
140645|NCT02692586|Thromboembolism|thromboembolism
140646|NCT02692586|Thrombectomy|thrombectomy
140647|NCT02692586|Right Heart Strain|right heart strain
140648|NCT02692586|Submassive PE|submassive pe
140649|NCT02692586|Right Ventricle Dysfunction|right ventricle dysfunction
140650|NCT02692586|Massive PE|massive pe
140651|NCT02692560|Sedentary time|sedentary time
140652|NCT02692560|Sit-to-stand transitions|sit-to-stand transitions
140653|NCT02692534|Anesthesia|anesthesia
140654|NCT02692534|Cocaine Use|cocaine use
140655|NCT02692508|cardiovascular MRI|cardiovascular mri
140656|NCT02692508|apical hypertrophic cardiomyopathy|apical hypertrophic cardiomyopathy
140657|NCT02692508|giant negative T-wave|giant negative t-wave
140658|NCT02692508|wall thickness|wall thickness
140659|NCT02692508|Nuclear Magnetic Resonance|nuclear magnetic resonance
140660|NCT02692508|Early Diagnosis|early diagnosis
140661|NCT02692508|Prognosis|prognosis
140662|NCT02692495|body odor|body odor
140663|NCT02692495|halitosis|halitosis
140664|NCT02692495|dysbiosis|dysbiosis
140665|NCT02692495|leaky gut|leaky gut
140666|NCT02692495|microbiome|microbiome
140667|NCT02692495|PATM|patm
140668|NCT02692495|breath odor|breath odor
140669|NCT02692469|Bariatric Surgery, Obesity, Laparoscopy|bariatric surgery, obesity, laparoscopy
140670|NCT02692443|Congenital Heart Disease|congenital heart disease
140671|NCT02692443|Magnetic Brain Resonance|magnetic brain resonance
140672|NCT02692443|CHD|chd
140673|NCT02692443|MRI|mri
140674|NCT02692443|Neurodevelopmental|neurodevelopmental
140675|NCT02692430|Portosystemic Shunt|portosystemic shunt
140676|NCT02692430|Hepatic encephalopathy|hepatic encephalopathy
140677|NCT02692430|Portal hypertension|portal hypertension
140678|NCT02692430|Liver cirrhosis|liver cirrhosis
140679|NCT02692417|hypoactive desire disorder|hypoactive desire disorder
140680|NCT02692417|female sexual dysfunction|female sexual dysfunction
140681|NCT02692417|genital arousal disorder|genital arousal disorder
140682|NCT02692417|sexual|sexual
140683|NCT02692417|dysfunction|dysfunction
140684|NCT02692417|female|female
140685|NCT02692417|arousal|arousal
140686|NCT02692417|electrical stimulation|electrical stimulation
140687|NCT02692417|transcutaneous electrical stimulation|transcutaneous electrical stimulation
140688|NCT02692417|women|women
140689|NCT02692404|Postpartum Depression|postpartum depression
140690|NCT02692404|Perinatal Depression|perinatal depression
140691|NCT02692404|Pregnancy|pregnancy
140692|NCT02692404|Anesthesia|anesthesia
140693|NCT02692404|Obstetric|obstetric
140694|NCT02692404|Pain|pain
140695|NCT02692404|Analgesia|analgesia
140696|NCT02692404|Epidural|epidural
140697|NCT02692404|Midwife|midwife
140698|NCT02692404|Infant Development|infant development
140699|NCT02692404|Pain Management|pain management
140700|NCT02692391|Acute pancreatitis|acute pancreatitis
140701|NCT02692391|Indomethacin|indomethacin
140702|NCT02692391|Organ failure|organ failure
140703|NCT02692391|Prevention|prevention
140704|NCT02692378|Haemodialysis|haemodialysis
140705|NCT02692378|sodium bicarbonate|sodium bicarbonate
140706|NCT02692378|potassium|potassium
140707|NCT02692378|arrhythmia|arrhythmia
140708|NCT02692378|muscle|muscle
140709|NCT02692378|symptoms|symptoms
140710|NCT02692339|Relapsed Multiple Myeloma|relapsed multiple myeloma
140711|NCT02692339|Refractory Multiple Myeloma|refractory multiple myeloma
140712|NCT02692339|Lenalidomide|lenalidomide
140713|NCT02692339|Dexamethasone|dexamethasone
140714|NCT02692339|Observational Study|observational study
140715|NCT02692339|Safety of Len/Dex|safety of len/dex
140716|NCT02692326|intrahepatic cholestasis|intrahepatic cholestasis
140717|NCT02692326|infant newborn|infant newborn
140718|NCT02692326|cyclic parenteral nutrition|cyclic parenteral nutrition
140719|NCT02692313|epinephrine|epinephrine
140720|NCT02692313|counterregulation|counterregulation
140721|NCT02692313|dose responses|dose responses
140722|NCT02692300|anesthesia|anesthesia
140723|NCT02692300|delirium|delirium
140724|NCT02692300|surgery|surgery
140725|NCT02692300|electroencephalography|electroencephalography
140726|NCT02692300|burst suppression|burst suppression
140727|NCT02692300|PTSD|ptsd
140728|NCT02692300|anxiety|anxiety
140729|NCT02692300|depression|depression
140730|NCT02692300|falls|falls
140731|NCT02692274|Point-of-care diagnostics|point-of-care diagnostics
140732|NCT02692274|Rural primary health care|rural primary health care
140733|NCT02692274|Access|access
140734|NCT02692274|Need|need
140735|NCT02692274|Usage|usage
140736|NCT02692274|Maternal Health|maternal health
140737|NCT02692235|carnitine|carnitine
140738|NCT02692235|leucine|leucine
140739|NCT02692222|pulse pressure variation monitoring|pulse pressure variation monitoring
140740|NCT02692222|Captesia|captesia
140741|NCT02692222|cardiac output monitoring|cardiac output monitoring
140742|NCT02692209|Mammography|mammography
140743|NCT02692196|Neurofeedback|neurofeedback
140744|NCT02692196|Emotion processing|emotion processing
140745|NCT02692196|Real-time|real-time
140746|NCT02692196|fMRI|fmri
140747|NCT02692183|Parkinson's disease|parkinson's disease
140748|NCT02692183|ET|et
140749|NCT02692183|EEG|eeg
140750|NCT02692183|FUS|fus
140751|NCT02692183|BNA|bna
140752|NCT02692183|Essential tremor|essential tremor
140753|NCT02692131|Left Ventricle strain, speckle strain|left ventricle strain, speckle strain
140754|NCT02692105|prostate adenocarcinoma|prostate adenocarcinoma
140755|NCT02692105|intermediate risk group|intermediate risk group
140756|NCT02692105|brachytherapy|brachytherapy
140757|NCT02692105|High Dose Rate vs Low Dose Rate|high dose rate vs low dose rate
140758|NCT02692105|Quality of Life|quality of life
140759|NCT02692092|Complications|complications
140760|NCT02692092|Arthroplasty, Hip Replacement|arthroplasty, hip replacement
140761|NCT02692092|Arthroplasty, Knee Replacement|arthroplasty, knee replacement
140762|NCT02692079|Angiogenesis|angiogenesis
140763|NCT02692079|Bilateral infrabony defect|bilateral infrabony defect
140764|NCT02692079|Flap surgery|flap surgery
140765|NCT02692079|Titanium-prepared, platelet-rich ﬁbrin|titanium-prepared, platelet-rich ﬁbrin
140766|NCT02692040|obesity|obesity
140767|NCT02692040|diabetes mellitus|diabetes mellitus
140768|NCT02692040|glucagon-like peptide-1|glucagon-like peptide-1
140769|NCT02692027|Community-based initiation of antiretroviral therapy|community-based initiation of antiretroviral therapy
140770|NCT02692027|Home-based HIV testing and counseling|home-based hiv testing and counseling
140771|NCT02692027|Lesotho|lesotho
140772|NCT02692027|Sub-sahara Africa|sub-sahara africa
140773|NCT02692027|antiretroviral therapy|antiretroviral therapy
140774|NCT02692027|AIDS|aids
140775|NCT02692027|Test and treat|test and treat
140776|NCT02691988|Inhaled corticosteroids|inhaled corticosteroids
140777|NCT02691988|General practice|general practice
140778|NCT02691988|Primary care|primary care
140779|NCT02691988|Pharmacotherapy|pharmacotherapy
140780|NCT02691936|Genitourinary symptoms of menopause|genitourinary symptoms of menopause
140781|NCT02691936|Menopause|menopause
140782|NCT02691936|Atrophic vaginitis|atrophic vaginitis
140783|NCT02691923|High Grade Glioma|high grade glioma
140784|NCT02691923|Low Grade Glioma|low grade glioma
140785|NCT02691923|Brain Tumor|brain tumor
140786|NCT02691910|malaria|malaria
140787|NCT02691910|Plasmodium vivax|plasmodium vivax
140788|NCT02691910|treatment|treatment
140789|NCT02691910|Chloroquine|chloroquine
140790|NCT02691910|Primaquine|primaquine
140791|NCT02691897|Diabetes mellitus|diabetes mellitus
140792|NCT02691897|Melatonin|melatonin
140793|NCT02691897|Blood Glucose|blood glucose
140794|NCT02691897|Therapeutics|therapeutics
140795|NCT02691897|Pineal gland|pineal gland
140796|NCT02691884|Heart Rate, Fetal|heart rate, fetal
140797|NCT02691884|Electronic Fetal Monitoring|electronic fetal monitoring
140798|NCT02691884|Transducers, Pressure|transducers, pressure
140799|NCT02691858|Intussusception|intussusception
140800|NCT02691819|jailed-balloon technique|jailed-balloon technique
140801|NCT02691754|Paracetamol|paracetamol
140802|NCT02691754|PPI|ppi
140803|NCT02691754|Opioids|opioids
140804|NCT02691754|NSAID|nsaid
140805|NCT02691754|Drug Prescription|drug prescription
140806|NCT02691702|Multiple Ascending Dose Study|multiple ascending dose study
140807|NCT02691702|Safety and Tolerability|safety and tolerability
140808|NCT02691702|Pharmacokinetics|pharmacokinetics
140809|NCT02691702|Pharmacodynamics|pharmacodynamics
140810|NCT02691702|Melatonin|melatonin
140811|NCT02691702|Plasma|plasma
140812|NCT02691702|Dim Light Melatonin Onset|dim light melatonin onset
140813|NCT02691676|crystalloids, fluid therapy, Plasmalyte, Ringerfundin|crystalloids, fluid therapy, plasmalyte, ringerfundin
140814|NCT02691663|Geriatric|geriatric
140815|NCT02691663|bicarbonate|bicarbonate
140816|NCT02691650|serum cholinesterase|serum cholinesterase
140817|NCT02691650|plasma cholinesterase|plasma cholinesterase
140818|NCT02691650|pseudocholinesterase|pseudocholinesterase
140819|NCT02691650|systemic inflammation|systemic inflammation
140820|NCT02691650|SIRS|sirs
140821|NCT02691650|polytrauma|polytrauma
140822|NCT02691637|Helicobacter pylori infection|helicobacter pylori infection
140823|NCT02691637|Eradication treatment|eradication treatment
140824|NCT02691637|Reversibility|reversibility
140825|NCT02691637|atrophic gastritis|atrophic gastritis
140826|NCT02691637|intestinal metaplasia|intestinal metaplasia
140827|NCT02691624|Lymphedema of Upper Arm|lymphedema of upper arm
140828|NCT02691624|Breast cancer|breast cancer
140829|NCT02691624|Breast cancer-related Lymphedema|breast cancer-related lymphedema
140830|NCT02691624|Lymphoscintigraphy|lymphoscintigraphy
140831|NCT02691546|Chronic Kidney Diseases|chronic kidney diseases
140832|NCT02691546|Older|older
140833|NCT02691546|Geriatric assessment|geriatric assessment
140834|NCT02691546|Biomarkers|biomarkers
140835|NCT02691533|Acute|acute
140836|NCT02691520|Treatment Resistant Depression|treatment resistant depression
140837|NCT02691507|Eczema, Itchy Skin|eczema, itchy skin
140838|NCT02691494|Elagolix|elagolix
140839|NCT02691494|Elagolix Sodium|elagolix sodium
140840|NCT02691494|Heavy uterine bleeding|heavy uterine bleeding
140841|NCT02691494|Heavy menstrual bleeding|heavy menstrual bleeding
140842|NCT02691494|Leiomyomata|leiomyomata
140843|NCT02691494|Menorrhagia|menorrhagia
140844|NCT02691494|ABT-620|abt-620
140845|NCT02691494|Elagolix + E2/NETA|elagolix + e2/neta
140846|NCT02691494|Elagolix + Norethindrone acetate|elagolix + norethindrone acetate
140847|NCT02691494|HMB|hmb
140848|NCT02691468|one lung ventilation|one lung ventilation
140849|NCT02691468|double lumen endobronchial tube|double lumen endobronchial tube
140850|NCT02691468|displacement|displacement
140851|NCT02691468|Fiberoptic bronchoscope|fiberoptic bronchoscope
140852|NCT02691442|Peripheral nerve block|peripheral nerve block
140853|NCT02691429|Vitreoretinal surgery|vitreoretinal surgery
140854|NCT02691429|euterpe oleracea|euterpe oleracea
140855|NCT02691429|chromovitrectomy|chromovitrectomy
140856|NCT02691325|ELLIPTA|ellipta
140857|NCT02691325|GSK2269557|gsk2269557
140858|NCT02691325|Tolerability|tolerability
140859|NCT02691325|Safety|safety
140860|NCT02691325|Dry powder Inhaler (DPI)|dry powder inhaler (dpi)
140861|NCT02691325|Pharmacokinetics|pharmacokinetics
140862|NCT02691312|type 1 diabetes|type 1 diabetes
140863|NCT02691312|retinopathy|retinopathy
140864|NCT02691299|NSCLC|nsclc
140865|NCT02691260|obesity|obesity
140866|NCT02691260|behavioral intervention|behavioral intervention
140867|NCT02691260|diet|diet
140868|NCT02691247|T1DM|t1dm
140869|NCT02691247|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
140870|NCT02691247|T regulatory cell|t regulatory cell
140871|NCT02691247|Immunotherapy|immunotherapy
140872|NCT02691247|Cell therapy|cell therapy
140873|NCT02691247|T-Reg|t-reg
140874|NCT02691221|Suicidal behavior, Mobile Application, Mobile Health Tool|suicidal behavior, mobile application, mobile health tool
140875|NCT02691208|acupuncture|acupuncture
140876|NCT02691208|breast cancer|breast cancer
140877|NCT02691208|rehabilitation|rehabilitation
140878|NCT02691208|pain|pain
140879|NCT02691195|Ultrasound|ultrasound
140880|NCT02691195|Serratus Plane Block|serratus plane block
140881|NCT02691195|Quality of recovery|quality of recovery
140882|NCT02691156|Hematofluorometer|hematofluorometer
140883|NCT02691130|influenza|influenza
140884|NCT02691130|vaccine|vaccine
140885|NCT02691130|universal|universal
140886|NCT02691130|peptide|peptide
140887|NCT02691130|prime|prime
140888|NCT02691130|boost|boost
140890|NCT02691130|CMI|cmi
140891|NCT02691130|UNISEC|unisec
140892|NCT02691117|Alopecia Areata|alopecia areata
140893|NCT02691117|Garlic concentrate|garlic concentrate
140894|NCT02691052|pancreatic cancer|pancreatic cancer
140895|NCT02691052|metastatic|metastatic
140896|NCT02691026|MPNST|mpnst
140897|NCT02691026|Pembrolizumab|pembrolizumab
140898|NCT02691000|depression|depression
140899|NCT02691000|depressive symptoms|depressive symptoms
140900|NCT02691000|stage b heart failure|stage b heart failure
140901|NCT02691000|bright white light|bright white light
140902|NCT02691000|light therapy|light therapy
140903|NCT02690987|tobacco|tobacco
140904|NCT02690987|GLP1|glp1
140905|NCT02690987|ghrelin|ghrelin
140906|NCT02690987|alcohol|alcohol
140907|NCT02690987|appetite|appetite
140908|NCT02690987|reward|reward
140909|NCT02690987|addiction|addiction
140910|NCT02690987|hormone|hormone
140911|NCT02690987|cigarette|cigarette
140912|NCT02690987|fMRI|fmri
140913|NCT02690974|HFrEF,|hfref,
140914|NCT02690974|ACEi,|acei,
140915|NCT02690974|ACE inhibitor,|ace inhibitor,
140916|NCT02690974|ARBs,|arbs,
140917|NCT02690974|systolic heart failure,|systolic heart failure,
140918|NCT02690974|chronic heart failure,|chronic heart failure,
140919|NCT02690974|CHF,|chf,
140920|NCT02690974|reduced EF,|reduced ef,
140921|NCT02690974|Ejection Fraction|ejection fraction
140922|NCT02690961|Healthy|healthy
140923|NCT02690935|grass pollen|grass pollen
140924|NCT02690935|homeopathy|homeopathy
140925|NCT02690935|placebo|placebo
140926|NCT02690935|quality of life|quality of life
140927|NCT02690909|Uncontrolled Hypertension|uncontrolled hypertension
140928|NCT02690909|Resistant Hypertension|resistant hypertension
140929|NCT02690909|Renal Denervation|renal denervation
140930|NCT02690896|caregiver burden|caregiver burden
140931|NCT02690896|caregiver support groups|caregiver support groups
140932|NCT02690870|tamoxifen|tamoxifen
140933|NCT02690870|clomiphene|clomiphene
140934|NCT02690870|mild stimulation|mild stimulation
140935|NCT02690870|poor ovarian response|poor ovarian response
140936|NCT02690870|clinical pregnancy rate|clinical pregnancy rate
140937|NCT02690831|Asthma|asthma
140938|NCT02690831|Inspiratory Muscle Training|inspiratory muscle training
140939|NCT02690831|Manual Therapies|manual therapies
140940|NCT02690818|Tuberculosis|tuberculosis
140941|NCT02690818|Latent Tuberculosis|latent tuberculosis
140942|NCT02690818|Texting|texting
140943|NCT02690818|Adherence|adherence
140944|NCT02690818|Medication|medication
140945|NCT02690792|Healthy|healthy
140946|NCT02690792|NAFLD|nafld
140947|NCT02690792|NASH|nash
140948|NCT02690792|Liver Metabolism|liver metabolism
140949|NCT02690792|Vitamin E|vitamin e
140950|NCT02690766|Cancer|cancer
140951|NCT02690766|Breast Cancer|breast cancer
140952|NCT02690766|Endometrial cancer,|endometrial cancer,
140953|NCT02690766|Type 2 Diabetes|type 2 diabetes
140954|NCT02690753|Repositioning|repositioning
140955|NCT02690753|Incontinence care|incontinence care
140956|NCT02690753|Prevention|prevention
140957|NCT02690740|titrated quantitative conjunctival provocation test|titrated quantitative conjunctival provocation test
140958|NCT02690727|Fasting|fasting
140959|NCT02690727|Fed condition|fed condition
140960|NCT02690727|Pharmacokinetics|pharmacokinetics
140961|NCT02690701|psoriasis|psoriasis
140962|NCT02690701|plaque psoriasis|plaque psoriasis
140963|NCT02690701|secukinumab|secukinumab
140964|NCT02690701|AIN457|ain457
140965|NCT02690701|biologic|biologic
140966|NCT02690701|monoclonal antibody|monoclonal antibody
140967|NCT02690688|Pulse Pressure Variation|pulse pressure variation
140968|NCT02690688|NIRS|nirs
140969|NCT02690688|Pneumoperitoneum|pneumoperitoneum
140970|NCT02690688|Abdominal surgery|abdominal surgery
140971|NCT02690675|Neurodevelopment|neurodevelopment
140972|NCT02690675|Bayley Scale|bayley scale
140973|NCT02690675|Growth|growth
140974|NCT02690675|Iron fortification|iron fortification
140975|NCT02690662|Obesity|obesity
140976|NCT02690662|Kidney stones|kidney stones
140977|NCT02690662|Diet|diet
140978|NCT02690649|anticoagulants|anticoagulants
140979|NCT02690649|Personal Health Records|personal health records
140980|NCT02690623|hospitalist|hospitalist
140981|NCT02690623|pediatric inpatient care|pediatric inpatient care
140982|NCT02690610|EBUS, Mediastinal lesions, Mediastinal lymph node|ebus, mediastinal lesions, mediastinal lymph node
140983|NCT02690597|Anxiety analogic visual scale|anxiety analogic visual scale
140984|NCT02690597|Pain|pain
140985|NCT02690597|State Trait Inventory anxiety scale|state trait inventory anxiety scale
140986|NCT02690597|Anxiety|anxiety
140987|NCT02690584|Psychotherapy|psychotherapy
140988|NCT02690571|Air Pollution|air pollution
140989|NCT02690571|Biodiesel exhaust|biodiesel exhaust
140990|NCT02690571|Bronchoscopy|bronchoscopy
140991|NCT02690571|Metabolomics|metabolomics
140992|NCT02690558|muscle-invasive|muscle-invasive
140993|NCT02690545|CAR T cells|car t cells
140994|NCT02690545|CD30|cd30
140995|NCT02690545|Lymphoma|lymphoma
140996|NCT02690545|T Lymphocytes|t lymphocytes
140997|NCT02690532|Celiac|celiac
140998|NCT02690532|Gluten|gluten
140999|NCT02690532|Sensitivity|sensitivity
141000|NCT02690532|Permeability|permeability
141001|NCT02690532|Non-celiac gluten intolerance|non-celiac gluten intolerance
141002|NCT02690532|Gastrointestinal Diseases|gastrointestinal diseases
141003|NCT02690532|Digestive System Diseases|digestive system diseases
141004|NCT02690519|Cystic fibrosis S1251N mutation|cystic fibrosis s1251n mutation
141005|NCT02690519|GLPG1837|glpg1837
141006|NCT02690506|pregabalin|pregabalin
141007|NCT02690506|spinal anesthesia|spinal anesthesia
141008|NCT02690480|fulvestrant|fulvestrant
141009|NCT02690480|palbociclib|palbociclib
141010|NCT02690480|metastases|metastases
141011|NCT02690480|postmenopausal|postmenopausal
141012|NCT02690480|breast cancer|breast cancer
141013|NCT02690480|hormone receptor positive|hormone receptor positive
141014|NCT02690467|Insulin therapy|insulin therapy
141015|NCT02690467|Needle|needle
141016|NCT02690454|ticagrelor|ticagrelor
141017|NCT02690454|ticagrelor active metabolite (AR-C124910XX)|ticagrelor active metabolite (ar-c124910xx)
141018|NCT02690454|platelet function tests|platelet function tests
141019|NCT02690454|the flow cytometric VASP assay|the flow cytometric vasp assay
141020|NCT02690454|the VerifyNow® device|the verifynow® device
141021|NCT02690454|the Multiplate® analyzer|the multiplate® analyzer
141022|NCT02690454|pharmacokinetics|pharmacokinetics
141023|NCT02690454|pharmacodynamics|pharmacodynamics
141024|NCT02690454|Multiplate® ADPtest|multiplate® adptest
141025|NCT02690454|VerifyNow® PRUTest™|verifynow® prutest™
141026|NCT02690454|Platelet VASP/P2Y12 assay|platelet vasp/p2y12 assay
141027|NCT02690441|GAD|gad
141028|NCT02690441|CBT|cbt
141029|NCT02690441|Physical exercise|physical exercise
141030|NCT02690441|Older adults|older adults
141031|NCT02690428|Hyperthermia, Induced|hyperthermia, induced
141032|NCT02690428|Laser Coagulation|laser coagulation
141033|NCT02690428|Laser Therapy|laser therapy
141034|NCT02690389|Acupuncture|acupuncture
141035|NCT02690389|Flumazenil|flumazenil
141036|NCT02690389|Narcotrend|narcotrend
141037|NCT02690389|General Anaesthesia|general anaesthesia
141038|NCT02690389|Sedation|sedation
141039|NCT02690337|Advanced solid malignant tumors|advanced solid malignant tumors
141040|NCT02690337|phase 1|phase 1
141041|NCT02690337|oncology|oncology
141042|NCT02690337|refractory|refractory
141043|NCT02690337|no standard treatment|no standard treatment
141044|NCT02690272|kidney transplant|kidney transplant
141045|NCT02690272|psychic process|psychic process
141046|NCT02690259|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
141047|NCT02690233|endothelial dysfunction|endothelial dysfunction
141048|NCT02690233|surgery|surgery
141049|NCT02690233|cardiovascular complications|cardiovascular complications
141050|NCT02690233|EndoPat|endopat
141051|NCT02690233|myocardial injury|myocardial injury
141052|NCT02690233|myocardial infarction|myocardial infarction
141053|NCT02690220|polypropylene mesh|polypropylene mesh
141054|NCT02690220|prolapse|prolapse
141055|NCT02690220|cystocele|cystocele
141056|NCT02690220|surgical mesh|surgical mesh
141057|NCT02690207|Herpes Zoster|herpes zoster
141058|NCT02690207|Safety|safety
141059|NCT02690207|Adults|adults
141060|NCT02690207|Cross-vaccination|cross-vaccination
141061|NCT02690194|Buddhify|buddhify
141062|NCT02690194|Stress|stress
141063|NCT02690194|Anxiety|anxiety
141064|NCT02690194|Relaxation Technique|relaxation technique
141065|NCT02690168|Fasting|fasting
141066|NCT02690168|Carbon-13 Magnetic Resonance Spectroscopy|carbon-13 magnetic resonance spectroscopy
141067|NCT02690168|Neuroimaging|neuroimaging
141068|NCT02690155|Non-valvular atrial fibrillation (NVAF)|non-valvular atrial fibrillation (nvaf)
141069|NCT02690155|Prevention|prevention
141070|NCT02690155|Stroke|stroke
141071|NCT02690129|progesterone|progesterone
141072|NCT02690129|threatened abortion|threatened abortion
141073|NCT02690116|Meditative movement|meditative movement
141074|NCT02690116|Breast cancer survivors|breast cancer survivors
141075|NCT02690116|Qigong|qigong
141076|NCT02690116|Tai Chi Easy|tai chi easy
141077|NCT02690116|Fatigue|fatigue
141078|NCT02690103|Arabinoxylan|arabinoxylan
141079|NCT02690103|HCV|hcv
141080|NCT02690103|Viremia|viremia
141081|NCT02690103|Biobran|biobran
141082|NCT02690103|PEG interferon|peg interferon
141083|NCT02690090|Deep Vein Thrombosis|deep vein thrombosis
141084|NCT02690090|Prophylaxis|prophylaxis
141085|NCT02690090|Critically ill adults|critically ill adults
141086|NCT02690077|Patient Satisfaction|patient satisfaction
141087|NCT02690077|Earlier Family Bond Initiation|earlier family bond initiation
141088|NCT02690077|Maternal and Neonatal Outcomes|maternal and neonatal outcomes
141089|NCT02690064|Endothelial Function|endothelial function
141090|NCT02690064|Maximal Exercise Capacity|maximal exercise capacity
141091|NCT02690064|Flow Mediated Dilation|flow mediated dilation
141092|NCT02690064|Antioxidant|antioxidant
141093|NCT02690064|FEV1|fev1
141094|NCT02690038|AECOPD|aecopd
141095|NCT02690038|COPD|copd
141096|NCT02689999|Gastroesophageal Reflux Disease (GERD), GERD, impedence|gastroesophageal reflux disease (gerd), gerd, impedence
141097|NCT02689986|Cold agglutinin|cold agglutinin
141098|NCT02689986|Cold agglutinin disease|cold agglutinin disease
141099|NCT02689986|Anemia|anemia
141100|NCT02689986|Hemolytic|hemolytic
141101|NCT02689986|Autoimmune|autoimmune
141102|NCT02689986|Bendamustine|bendamustine
141103|NCT02689986|Rituximab|rituximab
141104|NCT02689973|adolescence|adolescence
141105|NCT02689973|body fat|body fat
141106|NCT02689973|physical activity|physical activity
141107|NCT02689973|psychosocial intervention|psychosocial intervention
141108|NCT02689973|self-efficacy|self-efficacy
141109|NCT02689973|planning|planning
141110|NCT02689960|addison disease|addison disease
141111|NCT02689960|adrenal crisis|adrenal crisis
141112|NCT02689960|prednisone|prednisone
141113|NCT02689934|hypercholesterolemia|hypercholesterolemia
141114|NCT02689934|bifidobacterium longum BB536|bifidobacterium longum bb536
141115|NCT02689934|red yeast rice|red yeast rice
141116|NCT02689934|monacolin K|monacolin k
141117|NCT02689934|lactoflorene colesterolo|lactoflorene colesterolo
141118|NCT02689908|Thorax CT|thorax ct
141119|NCT02689908|Low Dose|low dose
141120|NCT02689908|Body Mass Index|body mass index
141121|NCT02689908|Neck Circumference|neck circumference
141122|NCT02689895|adolescents|adolescents
141123|NCT02689895|second line treatment failure|second line treatment failure
141124|NCT02689895|adherence|adherence
141125|NCT02689895|drug resistance|drug resistance
141126|NCT02689882|nicotinamide riboside|nicotinamide riboside
141127|NCT02689882|nicotinamide ribonucleoside|nicotinamide ribonucleoside
141128|NCT02689882|Nicotinamide-Adenine Dinucleotide|nicotinamide-adenine dinucleotide
141129|NCT02689869|indolent lymphoma|indolent lymphoma
141130|NCT02689869|novel agents|novel agents
141131|NCT02689869|chemotherapy free treatment|chemotherapy free treatment
141132|NCT02689869|ibrutinib|ibrutinib
141133|NCT02689869|obinutuzumab|obinutuzumab
141134|NCT02689869|GA101|ga101
141135|NCT02689843|Inflammation|inflammation
141136|NCT02689843|Complement system proteins|complement system proteins
141137|NCT02689843|Homocysteine|homocysteine
141138|NCT02689843|C-Reactive Protein|c-reactive protein
141139|NCT02689843|Cyproterone|cyproterone
141140|NCT02689843|Ethinyl Estradiol|ethinyl estradiol
141141|NCT02689843|Androgen Antagonists|androgen antagonists
141142|NCT02689843|Metformin|metformin
141143|NCT02689843|Thiazolidinediones|thiazolidinediones
141144|NCT02689843|Pioglitazone|pioglitazone
141145|NCT02689817|Pressure ulcer|pressure ulcer
141146|NCT02689817|Monitoring|monitoring
141147|NCT02689817|Pressure|pressure
141148|NCT02689817|Physiologic feedback|physiologic feedback
141149|NCT02689804|Emergency contraception|emergency contraception
141150|NCT02689791|Appetite|appetite
141151|NCT02689791|Food Intake|food intake
141152|NCT02689791|Satiety Hormones|satiety hormones
141153|NCT02689778|Pirfenidone|pirfenidone
141154|NCT02689778|Diabetic nephropathy|diabetic nephropathy
141155|NCT02689752|mass balance|mass balance
141157|NCT02689713|Burn Pain|burn pain
141158|NCT02689713|Hyperalgesia|hyperalgesia
141159|NCT02689713|TRPV1|trpv1
141160|NCT02689713|OLAMs|olams
141161|NCT02689700|Human Cytomegalovirus|human cytomegalovirus
141162|NCT02689700|Varicella Zoster Virus|varicella zoster virus
141163|NCT02689700|Materno-fetal antibody transfer|materno-fetal antibody transfer
141164|NCT02689700|Pregnancy|pregnancy
141165|NCT02689700|Gestational age|gestational age
141166|NCT02689622|Hematology|hematology
141167|NCT02689622|Elderly|elderly
141168|NCT02689622|High Risk Myelodysplastic Syndrome|high risk myelodysplastic syndrome
141169|NCT02689609|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
141170|NCT02689609|Intensity-modulated radiation therapy|intensity-modulated radiation therapy
141171|NCT02689609|Hypothyroidism|hypothyroidism
141172|NCT02689609|Predictors|predictors
141173|NCT02689583|Helicobacter pylori|helicobacter pylori
141174|NCT02689583|Antibiotic resistance|antibiotic resistance
141175|NCT02689583|Sequencing|sequencing
141176|NCT02689583|Mechanism|mechanism
141177|NCT02689583|Cause|cause
141178|NCT02689570|type 1 diabetes|type 1 diabetes
141179|NCT02689570|coronary artery calcifications|coronary artery calcifications
141180|NCT02689570|diastolic dysfunction|diastolic dysfunction
141181|NCT02689570|adipokines|adipokines
141182|NCT02689570|visceral adipose tissue|visceral adipose tissue
141183|NCT02689544|exercise muscle stretching|exercise muscle stretching
141184|NCT02689544|range of motion|range of motion
141185|NCT02689544|dynamometer of muscle strength|dynamometer of muscle strength
141186|NCT02689544|electromyography|electromyography
141187|NCT02689518|AMD|amd
141188|NCT02689518|Wet AMD|wet amd
141189|NCT02689518|Macular degeneration|macular degeneration
141190|NCT02689518|Wet macular degeneration|wet macular degeneration
141191|NCT02689518|Neovascularization|neovascularization
141192|NCT02689518|Retina|retina
141193|NCT02689518|Retinal degeneration|retinal degeneration
141194|NCT02689479|Clinical Islet Transplantation|clinical islet transplantation
141195|NCT02689479|Positron Emission Tomography (PET) Computed Tomography (CT) imaging|positron emission tomography (pet) computed tomography (ct) imaging
141196|NCT02689466|Adult|adult
141197|NCT02689466|Acetylcholine|acetylcholine
141198|NCT02689466|Movement Disorder|movement disorder
141199|NCT02689466|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
141200|NCT02689466|PET Imaging|pet imaging
141201|NCT02689453|T-cell Lymphoproliferative Disorder|t-cell lymphoproliferative disorder
141202|NCT02689453|CD4/CD25 Expressing T-cells in Blood and Lymphoid Tissues|cd4/cd25 expressing t-cells in blood and lymphoid tissues
141203|NCT02689453|Anti-CD52 Monoclonal Antibody|anti-cd52 monoclonal antibody
141204|NCT02689453|Antibody Dependent Cellular Cytotoxicity|antibody dependent cellular cytotoxicity
141205|NCT02689440|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
141206|NCT02689440|CML|cml
141207|NCT02689440|Ph-positive chronic myelogenous leukemia|ph-positive chronic myelogenous leukemia
141208|NCT02689440|BCR-ABL positive chronic myelogenous leukemia|bcr-abl positive chronic myelogenous leukemia
141209|NCT02689440|Dasatinib|dasatinib
141210|NCT02689440|BMS-354825|bms-354825
141211|NCT02689440|Sprycel|sprycel
141212|NCT02689440|Venetoclax|venetoclax
141213|NCT02689440|ABT-199|abt-199
141214|NCT02689440|GDC-0199|gdc-0199
141215|NCT02689427|Breast cancer|breast cancer
141216|NCT02689427|Invasive carcinoma of the breast|invasive carcinoma of the breast
141217|NCT02689427|Triple-negative breast cancer|triple-negative breast cancer
141218|NCT02689427|TNBC|tnbc
141219|NCT02689427|Enzalutamide|enzalutamide
141220|NCT02689427|MDV3100|mdv3100
141221|NCT02689427|XTANDI|xtandi
141222|NCT02689427|Paclitaxel|paclitaxel
141223|NCT02689427|Taxol|taxol
141224|NCT02689414|Atherosclerosis|atherosclerosis
141225|NCT02689401|Esophageal Cancer|esophageal cancer
141226|NCT02689401|lymph nodes tumor|lymph nodes tumor
141227|NCT02689388|analgesia|analgesia
141228|NCT02689388|regional analgesia|regional analgesia
141229|NCT02689388|femoral nerve block|femoral nerve block
141230|NCT02689388|older persons|older persons
141231|NCT02689388|frail|frail
141232|NCT02689362|Diabetes Mellitus Type 2|diabetes mellitus type 2
141233|NCT02689349|hearing|hearing
141234|NCT02689349|implant|implant
141235|NCT02689349|moderate degree|moderate degree
141236|NCT02689349|severe degree|severe degree
141237|NCT02689310|Wound Care|wound care
141238|NCT02689310|Medical Grade Honey|medical grade honey
141239|NCT02689310|Pressure Ulcers|pressure ulcers
141240|NCT02689284|Stomach Cancer|stomach cancer
141241|NCT02689284|Gastroesophageal Junction|gastroesophageal junction
141242|NCT02689284|Gastric Cancer|gastric cancer
141243|NCT02689284|Cancer of the Stomach|cancer of the stomach
141244|NCT02689284|Cancer of Stomach|cancer of stomach
141245|NCT02689284|Stomach|stomach
141246|NCT02689284|Pembrolizumab|pembrolizumab
141247|NCT02689284|Keytruda|keytruda
141248|NCT02689284|HER2+|her2+
141249|NCT02689284|GEJ|gej
141250|NCT02689284|HER2 positive|her2 positive
141251|NCT02689284|Metastatic|metastatic
141252|NCT02689284|Margetuximab|margetuximab
141253|NCT02689284|Immunotherapy|immunotherapy
141254|NCT02689284|Trastuzumab|trastuzumab
141255|NCT02689284|Human epidermal growth factor receptor 2|human epidermal growth factor receptor 2
141256|NCT02689284|Human epidermal growth factor receptor 2-positive|human epidermal growth factor receptor 2-positive
141257|NCT02689284|gastroesophageal junction cancer|gastroesophageal junction cancer
141258|NCT02689284|Pembro|pembro
141259|NCT02689284|PD-L1|pd-l1
141260|NCT02689284|PD-1|pd-1
141262|NCT02689284|Tumor|tumor
141263|NCT02689284|Cancer|cancer
141264|NCT02689271|MRI|mri
141265|NCT02689271|Magnetic resonance imaging|magnetic resonance imaging
141266|NCT02689271|Biomarkers|biomarkers
141267|NCT02689271|Fluidics|fluidics
141268|NCT02689271|Diffusion MRI|diffusion mri
141269|NCT02689219|Antigens, CD30, Embryonal Germ Cell Tumors|antigens, cd30, embryonal germ cell tumors
141270|NCT02689206|Chronic kidney disease|chronic kidney disease
141271|NCT02689206|Efficacy|efficacy
141272|NCT02689206|Erythropoiesis-stimulating agent|erythropoiesis-stimulating agent
141273|NCT02689206|GSK1278863|gsk1278863
141274|NCT02689206|Safety|safety
141275|NCT02689206|Hemodialysis-dependent anemia|hemodialysis-dependent anemia
141276|NCT02689206|Pharmacokinetics|pharmacokinetics
141277|NCT02689193|Proteomics|proteomics
141278|NCT02689193|Rapid Diagnostic Test|rapid diagnostic test
141279|NCT02689193|Salmonellosis|salmonellosis
141280|NCT02689180|heart failure|heart failure
141281|NCT02689180|diuretics|diuretics
141282|NCT02689180|furosemide|furosemide
141283|NCT02689167|renal cell carcinoma|renal cell carcinoma
141284|NCT02689167|sunitinib|sunitinib
141285|NCT02689167|metastatic|metastatic
141286|NCT02689167|schedule|schedule
141287|NCT02689167|toxicity|toxicity
141288|NCT02689167|safety|safety
141289|NCT02689154|Pediatric Obesity|pediatric obesity
141290|NCT02689154|Food Addiction|food addiction
141291|NCT02689154|Mobile Health (mHealth)|mobile health (mhealth)
141292|NCT02689154|Weight Management|weight management
141293|NCT02689141|chronic lymphocytic leukemia CLL|chronic lymphocytic leukemia cll
141294|NCT02689141|untreated chronic lymphocytic leukemia|untreated chronic lymphocytic leukemia
141295|NCT02689141|relapsed chronic lymphocytic leukemia|relapsed chronic lymphocytic leukemia
141296|NCT02689141|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
141297|NCT02689128|Anesthesia|anesthesia
141298|NCT02689128|postoperative|postoperative
141299|NCT02689128|nausea|nausea
141300|NCT02689128|vomiting|vomiting
141301|NCT02689115|Nuclear factor Kappa B|nuclear factor kappa b
141302|NCT02689115|IKK epsilon|ikk epsilon
141303|NCT02689102|Optical coherence tomography|optical coherence tomography
141304|NCT02689102|Confocal laser endomicroscopy|confocal laser endomicroscopy
141305|NCT02689076|Patient transfer|patient transfer
141306|NCT02689076|Patient care management|patient care management
141307|NCT02689076|Health information exchange|health information exchange
141308|NCT02689063|Analgesic|analgesic
141309|NCT02689024|Nerve block|nerve block
141310|NCT02689024|Analgesia|analgesia
141311|NCT02689011|Total Knee Arthroplasty|total knee arthroplasty
141312|NCT02689011|Femoral Nerve Block|femoral nerve block
141313|NCT02689011|Epidural Analgesia|epidural analgesia
141314|NCT02689011|Urinary Retention|urinary retention
141315|NCT02689011|Lumbar Epidural|lumbar epidural
141316|NCT02688998|HER2 negative|her2 negative
141317|NCT02688959|motor attention training|motor attention training
141318|NCT02688959|exercise|exercise
141319|NCT02688959|tai chi|tai chi
141320|NCT02688959|ADHD|adhd
141321|NCT02688855|Bone Growth Stimulator|bone growth stimulator
141322|NCT02688855|Ankle Fracture|ankle fracture
141323|NCT02688829|stents,percutaneous coronary intervention|stents,percutaneous coronary intervention
141324|NCT02688816|visual inspection with acetic acid|visual inspection with acetic acid
141325|NCT02688816|Xpert HPV|xpert hpv
141326|NCT02688816|OncoE6|oncoe6
141327|NCT02688816|screening|screening
141328|NCT02688803|HER2 Negative|her2 negative
141329|NCT02688790|Dalbavancin|dalbavancin
141330|NCT02688790|DALVANCE®|dalvance®
141331|NCT02688790|Suspected or Confirmed Bacterial Infection|suspected or confirmed bacterial infection
141332|NCT02688777|Rehabilitation|rehabilitation
141333|NCT02688777|Gait|gait
141334|NCT02688777|Postural Balance|postural balance
141335|NCT02688777|Exercise|exercise
141336|NCT02688777|Accidental Falls|accidental falls
141337|NCT02688777|Kinesiology, Applied|kinesiology, applied
141338|NCT02688764|PA21|pa21
141339|NCT02688764|phosphate binder|phosphate binder
141340|NCT02688712|IIA|iia
141341|NCT02688712|Xeloda|xeloda
141342|NCT02688712|radiation therapy|radiation therapy
141343|NCT02688712|LY2157299|ly2157299
141344|NCT02688712|tumor resection|tumor resection
141345|NCT02688712|capecitabine|capecitabine
141346|NCT02688712|5FU|5fu
141347|NCT02688712|Fluorouracil|fluorouracil
141348|NCT02688712|IIB|iib
141349|NCT02688712|IIC|iic
141350|NCT02688712|IV|iv
141351|NCT02688712|neoadjuvant|neoadjuvant
141352|NCT02688712|Rectal cancer|rectal cancer
141353|NCT02688712|Immunotherapy|immunotherapy
141354|NCT02688660|Pediatrics|pediatrics
141355|NCT02688660|Neuroimaging|neuroimaging
141356|NCT02688647|Pulmonary Fibrosis|pulmonary fibrosis
141357|NCT02688647|Fibrosis|fibrosis
141358|NCT02688647|Idiopathic Interstitial Pneumonias|idiopathic interstitial pneumonias
141359|NCT02688647|Lung Diseases|lung diseases
141360|NCT02688634|Cleft Palate Surgery|cleft palate surgery
141361|NCT02688634|Antibiotic treatment|antibiotic treatment
141362|NCT02688621|weight loss|weight loss
141363|NCT02688621|financial incentives|financial incentives
141364|NCT02688621|internet weight loss|internet weight loss
141365|NCT02688595|Infant, Newborn|infant, newborn
141366|NCT02688595|Ultrasonography|ultrasonography
141367|NCT02688582|Target Controlled Infusion|target controlled infusion
141368|NCT02688582|Pharmacokinetics|pharmacokinetics
141369|NCT02688582|Cefepime|cefepime
141370|NCT02688582|critically ill patients|critically ill patients
141371|NCT02688556|KCS|kcs
141372|NCT02688556|dry eye|dry eye
141373|NCT02688556|cyclosporine|cyclosporine
141374|NCT02688543|radio frequency treatment|radio frequency treatment
141375|NCT02688543|genicular nerves|genicular nerves
141376|NCT02688543|osteoarthritis of the knee|osteoarthritis of the knee
141377|NCT02688504|labelled medicines|labelled medicines
141378|NCT02688504|drivers involved in serious and non-serious road accidents|drivers involved in serious and non-serious road accidents
141379|NCT02688504|relevance and effectiveness of pictograms on medicines packaging|relevance and effectiveness of pictograms on medicines packaging
141380|NCT02688478|Phthalate|phthalate
141482|NCT02687828|Safety|safety
141381|NCT02688478|Dibutylphthalate (DBP)|dibutylphthalate (dbp)
141382|NCT02688478|Airway responsiveness|airway responsiveness
141383|NCT02688478|Allergies|allergies
141384|NCT02688452|strenuous exercise|strenuous exercise
141385|NCT02688452|muscle soreness|muscle soreness
141386|NCT02688413|Virtual reality|virtual reality
141387|NCT02688413|Stroke|stroke
141388|NCT02688413|Neurorehabilitation|neurorehabilitation
141389|NCT02688413|Upper-limb rehabilitation|upper-limb rehabilitation
141390|NCT02688413|Training games|training games
141391|NCT02688400|Osteoarthritis|osteoarthritis
141392|NCT02688400|Knee|knee
141393|NCT02688400|Osteoarthritis, Knee|osteoarthritis, knee
141394|NCT02688400|Diacerein|diacerein
141395|NCT02688400|Celecoxib|celecoxib
141396|NCT02688400|Phase III|phase iii
141397|NCT02688400|Phase IV|phase iv
141398|NCT02688400|Phase III-IV|phase iii-iv
141399|NCT02688400|Canada|canada
141400|NCT02688400|Spain|spain
141401|NCT02688400|Austria|austria
141402|NCT02688400|Czech Republic|czech republic
141403|NCT02688400|WOMAC|womac
141404|NCT02688387|Ambrisentan|ambrisentan
141405|NCT02688387|Bioavailability|bioavailability
141406|NCT02688387|Tadalafil|tadalafil
141407|NCT02688387|Fixed Dose combination|fixed dose combination
141408|NCT02688322|sulbactam|sulbactam
141409|NCT02688322|pharmacokinetics|pharmacokinetics
141410|NCT02688322|pharmacodynamics|pharmacodynamics
141411|NCT02688322|Acinetobacter infections|acinetobacter infections
141412|NCT02688257|Magnetic Resonance Imaging|magnetic resonance imaging
141413|NCT02688257|Ultrasound|ultrasound
141414|NCT02688257|Breast Cancer|breast cancer
141415|NCT02688244|complicated appendicitis|complicated appendicitis
141416|NCT02688244|laparoscopic appendectomy|laparoscopic appendectomy
141417|NCT02688244|irrigation|irrigation
141418|NCT02688244|suction|suction
141419|NCT02688244|abdominal abscess|abdominal abscess
141420|NCT02688231|Multiple Sclerosis|multiple sclerosis
141421|NCT02688231|Upper limb rehabilitation|upper limb rehabilitation
141422|NCT02688218|exercise|exercise
141423|NCT02688218|artificial pancreas|artificial pancreas
141424|NCT02688218|hypoglycemia|hypoglycemia
141425|NCT02688218|type 1 diabetes|type 1 diabetes
141426|NCT02688205|Cyriax's functional examination|cyriax's functional examination
141427|NCT02688205|Ultrasound|ultrasound
141428|NCT02688205|Correlation|correlation
141429|NCT02688205|Resisted test|resisted test
141430|NCT02688153|Aortic Valve Replacement|aortic valve replacement
141431|NCT02688153|Aortic Stenosis|aortic stenosis
141432|NCT02688153|EDWARDS INTUITY|edwards intuity
141433|NCT02688140|APL|apl
141434|NCT02688140|acute promyelocytic leukemia (M3)|acute promyelocytic leukemia (m3)
141435|NCT02688140|high-risk acute promyelocytic leukemia (APL/AML M3)|high-risk acute promyelocytic leukemia (apl/aml m3)
141436|NCT02688140|acute myeloid leukemia with t(15;17)(q22;q12)|acute myeloid leukemia with t(15;17)(q22;q12)
141437|NCT02688140|newly diagnosed|newly diagnosed
141438|NCT02688140|high-risk|high-risk
141439|NCT02688127|obstetric bleeding placenta previa|obstetric bleeding placenta previa
141440|NCT02688075|Diabetes Mellitus Type 2|diabetes mellitus type 2
141441|NCT02688075|Canagliflozin|canagliflozin
141442|NCT02688075|Observational Study|observational study
141443|NCT02688036|Limited Disease Small Cell Lung Cancer|limited disease small cell lung cancer
141444|NCT02688036|concurrent chemoradiotherapy|concurrent chemoradiotherapy
141445|NCT02688036|dose fractionation|dose fractionation
141446|NCT02688023|5-fluorouracil|5-fluorouracil
141447|NCT02688023|Irinotecan|irinotecan
141448|NCT02688023|Oxaliplatin|oxaliplatin
141449|NCT02688023|Colorectal cancer|colorectal cancer
141450|NCT02688023|neoadjuvant|neoadjuvant
141451|NCT02688023|chemotherapy|chemotherapy
141452|NCT02688010|noise|noise
141453|NCT02688010|sound|sound
141454|NCT02688010|cycled light|cycled light
141455|NCT02688010|preterm infants|preterm infants
141456|NCT02688010|neonatal care|neonatal care
141457|NCT02688010|growth|growth
141458|NCT02688010|visual development|visual development
141459|NCT02687984|Schizophrenia|schizophrenia
141460|NCT02687984|Long-acting Risperidone|long-acting risperidone
141461|NCT02687984|Atrigel|atrigel
141462|NCT02687958|GEP/ NEC|gep/ nec
141463|NCT02687932|Functional Mitral Regurgitation|functional mitral regurgitation
141464|NCT02687932|Ischemic Mitral Regurgitation|ischemic mitral regurgitation
141465|NCT02687919|diet (gluten-free)|diet (gluten-free)
141466|NCT02687919|diet therapy|diet therapy
141467|NCT02687919|quality of life|quality of life
141468|NCT02687893|Sleep|sleep
141469|NCT02687893|Exercise|exercise
141470|NCT02687867|Non-valvular atrial fibrillation (NVAF)|non-valvular atrial fibrillation (nvaf)
141471|NCT02687867|Prevention|prevention
141472|NCT02687867|Stroke|stroke
141473|NCT02687854|Non-valvular atrial fibrillation (NVAF)|non-valvular atrial fibrillation (nvaf)
141474|NCT02687854|Prevention|prevention
141475|NCT02687854|Stroke|stroke
141476|NCT02687841|acute kidney injury|acute kidney injury
141477|NCT02687841|indoxylsulfate|indoxylsulfate
141478|NCT02687841|p-cresol|p-cresol
141479|NCT02687841|AST-120|ast-120
141480|NCT02687828|Intestinal Behcet's disease (BD)|intestinal behcet's disease (bd)
141481|NCT02687828|Adalimumab|adalimumab
141483|NCT02687828|Effectiveness|effectiveness
141484|NCT02687828|AMORE study|amore study
141485|NCT02687815|Vitamin D, severe asthma exacerbations, children|vitamin d, severe asthma exacerbations, children
141486|NCT02687802|respiratory mechanics|respiratory mechanics
141487|NCT02687802|Respiratory Insufficiency|respiratory insufficiency
141488|NCT02687802|artificial, ventilation|artificial, ventilation
141489|NCT02687789|Bacterial Vaginosis|bacterial vaginosis
141490|NCT02687789|BV|bv
141491|NCT02687776|Copeptin, human|copeptin, human
141492|NCT02687763|vaccines|vaccines
141493|NCT02687763|ProQuad|proquad
141494|NCT02687763|immunosuppressed|immunosuppressed
141495|NCT02687763|solid organ transplant|solid organ transplant
141496|NCT02687763|MMRV|mmrv
141497|NCT02687737|Tongue|tongue
141498|NCT02687737|Genioglossus|genioglossus
141499|NCT02687737|genioglossus recruitment|genioglossus recruitment
141500|NCT02687711|Non-interventional (NIS)|non-interventional (nis)
141501|NCT02687711|Epilepsy|epilepsy
141502|NCT02687711|Partial Onset Seizures (POS)|partial onset seizures (pos)
141503|NCT02687711|add-on therapy|add-on therapy
141504|NCT02687685|Skin to Skin Contact|skin to skin contact
141505|NCT02687685|Infant, Newborn|infant, newborn
141506|NCT02687607|Endovascular|endovascular
141507|NCT02687607|Brain aneurysm|brain aneurysm
141508|NCT02687607|Ruptured aneurysm|ruptured aneurysm
141509|NCT02687542|Parkinson Disease|parkinson disease
141510|NCT02687542|Motor Fluctuation|motor fluctuation
141511|NCT02687529|Tuberculosis|tuberculosis
141512|NCT02687529|TB|tb
141513|NCT02687516|Treatment|treatment
141514|NCT02687516|Child|child
141515|NCT02687516|Obesity|obesity
141516|NCT02687516|Behavioral treatment|behavioral treatment
141517|NCT02687503|Immune system|immune system
141518|NCT02687503|Probiotics|probiotics
141519|NCT02687464|Pediatric Surgery|pediatric surgery
141520|NCT02687464|Pediatrics|pediatrics
141521|NCT02687464|Randomized controlled trial,|randomized controlled trial,
141522|NCT02687464|Antibiotics|antibiotics
141523|NCT02687464|Cost effectiveness|cost effectiveness
141524|NCT02687451|Surgical Pain|surgical pain
141525|NCT02687451|Acute Post-Surgical Pain|acute post-surgical pain
141526|NCT02687438|Steroid-eluting implant Mometasone Furoate|steroid-eluting implant mometasone furoate
141527|NCT02687425|Pioglitazone|pioglitazone
141528|NCT02687425|Chronic Myeloid Leukemia|chronic myeloid leukemia
141529|NCT02687412|Fast-track surgery|fast-track surgery
141530|NCT02687412|Gynecological oncology|gynecological oncology
141531|NCT02687412|Hospitalization post-operation|hospitalization post-operation
141532|NCT02687412|Complication|complication
141533|NCT02687399|knee arthroplasty|knee arthroplasty
141534|NCT02687386|Recurrent|recurrent
141535|NCT02687386|Refractory|refractory
141536|NCT02687373|Plasmodium falciparum|plasmodium falciparum
141537|NCT02687373|PfSPZ Vaccine|pfspz vaccine
141538|NCT02687308|Prostatic cancer|prostatic cancer
141539|NCT02687308|Radical prostatectomy|radical prostatectomy
141540|NCT02687308|Minimally invasive prostate cancer surgery|minimally invasive prostate cancer surgery
141541|NCT02687282|Modified Mallampati score|modified mallampati score
141542|NCT02687282|Cesarean delivery|cesarean delivery
141543|NCT02687269|myocardial protection|myocardial protection
141544|NCT02687269|coronary artery bypass grafting|coronary artery bypass grafting
141545|NCT02687243|pediatrics|pediatrics
141546|NCT02687243|anxiety|anxiety
141547|NCT02687243|anesthesia|anesthesia
141548|NCT02687243|preoperative|preoperative
141549|NCT02687217|PerioperativeHyperoxygenation|perioperativehyperoxygenation
141550|NCT02687217|Wound Site Infection|wound site infection
141551|NCT02687217|Appendicitis|appendicitis
141552|NCT02687191|safety, maximum tolerated dose, modified continual reassessment method, intracerebral, hemorrhage, hematoma|safety, maximum tolerated dose, modified continual reassessment method, intracerebral, hemorrhage, hematoma
141553|NCT02687113|ablation|ablation
141554|NCT02687113|fusion|fusion
141555|NCT02687100|intubation|intubation
141556|NCT02687100|intensive care|intensive care
141557|NCT02687100|cardiac surgery|cardiac surgery
141558|NCT02687100|sore throat|sore throat
141559|NCT02687087|Radiotherapy Induced Xerostomia (RIX)|radiotherapy induced xerostomia (rix)
141560|NCT02687074|HFNC|hfnc
141561|NCT02687074|Respiratory Failure|respiratory failure
141562|NCT02687074|Intubation|intubation
141563|NCT02687074|Mortality|mortality
141564|NCT02687061|Recall study|recall study
141565|NCT02687061|Lost to follow-up|lost to follow-up
141566|NCT02687048|mindful meditation|mindful meditation
141567|NCT02687035|S3iCAP|s3icap
141568|NCT02687035|SAPIEN 3|sapien 3
141569|NCT02687035|Transfemoral|transfemoral
141570|NCT02687035|Commander|commander
141571|NCT02687035|Certitude|certitude
141572|NCT02687035|TAVR|tavr
141573|NCT02687035|TAVI|tavi
141574|NCT02687035|Aortic stenosis|aortic stenosis
141575|NCT02687035|THV|thv
141576|NCT02687035|Transcatheter Heart Valve|transcatheter heart valve
141577|NCT02687035|TVT|tvt
141578|NCT02687035|TVTR|tvtr
141579|NCT02687009|colon cancer|colon cancer
141580|NCT02687009|Wnt pathway|wnt pathway
141581|NCT02687009|Frizzled|frizzled
141582|NCT02686996|carnosine|carnosine
141583|NCT02686996|Insulin sensitivity|insulin sensitivity
141584|NCT02686996|low grade inflammation|low grade inflammation
141585|NCT02686996|Oxidative stress|oxidative stress
141586|NCT02686996|Advanced glycation|advanced glycation
141587|NCT02686996|Type 2 diabetes|type 2 diabetes
141588|NCT02686996|Cardiovascular disease|cardiovascular disease
141589|NCT02686970|Family|family
141590|NCT02686970|Quality|quality
141591|NCT02686970|Validate|validate
141592|NCT02686970|ICU|icu
141593|NCT02686944|GIST|gist
141594|NCT02686931|Developmental delayed|developmental delayed
141595|NCT02686931|Orthopedic disease|orthopedic disease
141596|NCT02686931|Longitudinal study|longitudinal study
141597|NCT02686892|Inflamatory bowel disease|inflamatory bowel disease
141598|NCT02686892|Crohns disease|crohns disease
141599|NCT02686892|ulcerative colitis|ulcerative colitis
141600|NCT02686892|incidence|incidence
141601|NCT02686892|epidemiology|epidemiology
141602|NCT02686879|hyperopes|hyperopes
141603|NCT02686879|axial length|axial length
141604|NCT02686879|peripheral defocus|peripheral defocus
141605|NCT02686853|Intrathecal administration|intrathecal administration
141606|NCT02686853|Liposomal amphotericin B|liposomal amphotericin b
141607|NCT02686853|Without Acquired Immune Deficiency Syndrome|without acquired immune deficiency syndrome
141608|NCT02686814|Valvular heart disease|valvular heart disease
141609|NCT02686814|Severe aortic stenosis|severe aortic stenosis
141610|NCT02686814|Aortic valve replacement|aortic valve replacement
141611|NCT02686801|nutrition|nutrition
141612|NCT02686801|prematurity|prematurity
141613|NCT02686801|body composition|body composition
141614|NCT02686788|multiple sclerosis|multiple sclerosis
141615|NCT02686788|relapsing remitting|relapsing remitting
141616|NCT02686788|nonsteroidal anti-inflammatory drug|nonsteroidal anti-inflammatory drug
141617|NCT02686788|contrast enhancing lesions|contrast enhancing lesions
141618|NCT02686762|NASH|nash
141619|NCT02686736|internet-based educational intervention|internet-based educational intervention
141620|NCT02686736|risky sexual behaviors|risky sexual behaviors
141621|NCT02686736|prevention|prevention
141622|NCT02686723|ACL injury|acl injury
141623|NCT02686723|Return to sport|return to sport
141624|NCT02686723|Motion analysis|motion analysis
141625|NCT02686723|Isokinetic evaluation|isokinetic evaluation
141626|NCT02686723|Risk factor|risk factor
141627|NCT02686697|L-Carnosine|l-carnosine
141628|NCT02686697|Schizophrenia|schizophrenia
141629|NCT02686697|Psychosis|psychosis
141630|NCT02686697|Cognition|cognition
141631|NCT02686671|Bursitis|bursitis
141632|NCT02686671|Injections|injections
141633|NCT02686671|Shoulder Pain|shoulder pain
141634|NCT02686658|Geographic Atrophy (GA)|geographic atrophy (ga)
141635|NCT02686658|Dry age-related macular degeneration|dry age-related macular degeneration
141636|NCT02686658|AMD|amd
141637|NCT02686658|Zimura|zimura
141638|NCT02686658|Anti-inflammatory|anti-inflammatory
141639|NCT02686658|complement factor C5 inhibitor|complement factor c5 inhibitor
141640|NCT02686658|ARC1905|arc1905
141641|NCT02686658|avacincaptad pegol|avacincaptad pegol
141642|NCT02686645|Fecal Microbiota Transplantation|fecal microbiota transplantation
141643|NCT02686632|Denture Stomatitis|denture stomatitis
141644|NCT02686632|Denture Erythematous Stomatitis|denture erythematous stomatitis
141645|NCT02686632|Prosthesis Stomatitis|prosthesis stomatitis
141646|NCT02686632|Oral Candidiasis|oral candidiasis
141647|NCT02686632|Palatal inflammation|palatal inflammation
141648|NCT02686593|Clofarabine|clofarabine
141649|NCT02686593|Acute Myeloid Leukemia|acute myeloid leukemia
141650|NCT02686567|transanal drainage tube|transanal drainage tube
141651|NCT02686567|anastomotic leakage|anastomotic leakage
141652|NCT02686567|laparoscopic anterior resection|laparoscopic anterior resection
141653|NCT02686567|rectal cancer|rectal cancer
141654|NCT02686554|Biomarker|biomarker
141655|NCT02686528|total hip arthroplasty|total hip arthroplasty
141656|NCT02686528|hip precautions|hip precautions
141657|NCT02686528|posterior approach|posterior approach
141658|NCT02686515|balance|balance
141659|NCT02686476|Empagliflozin, Fatty Liver Disease|empagliflozin, fatty liver disease
141660|NCT02686463|malignant ovarian cancer|malignant ovarian cancer
141661|NCT02686463|laparoscopy|laparoscopy
141662|NCT02686463|laparotomy|laparotomy
141663|NCT02686437|shoulder dysfunction|shoulder dysfunction
141664|NCT02686437|kinesiology tape|kinesiology tape
141665|NCT02686437|rehabilitation|rehabilitation
141666|NCT02686424|MAGE-A3 protein|mage-a3 protein
141667|NCT02686424|NY-ESO-1 protein|ny-eso-1 protein
141668|NCT02686424|WT1 Proteins|wt1 proteins
141669|NCT02686424|PRAME protein|prame protein
141670|NCT02686411|Benign neoplasms|benign neoplasms
141671|NCT02686411|In situ neoplasms|in situ neoplasms
141672|NCT02686411|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
141673|NCT02686411|Consult with palliative care doctor|consult with palliative care doctor
141674|NCT02686411|Palliative care unit|palliative care unit
141675|NCT02686411|PCU|pcu
141676|NCT02686411|Questionnaires|questionnaires
141677|NCT02686411|Surveys|surveys
141678|NCT02686398|Influenza Vaccines|influenza vaccines
141679|NCT02686398|MF59 oil emulsion|mf59 oil emulsion
141879|NCT02685098|BKA|bka
141680|NCT02686398|End Stage Renal Failure on Dialysis|end stage renal failure on dialysis
141681|NCT02686372|hepatocellular carcinoma|hepatocellular carcinoma
141682|NCT02686359|physiology|physiology
141683|NCT02686359|pain|pain
141684|NCT02686359|analgesia|analgesia
141685|NCT02686359|saliva|saliva
141686|NCT02686359|opiorphin|opiorphin
141687|NCT02686346|Relapsed|relapsed
141688|NCT02686346|Refractory|refractory
141689|NCT02686333|Meditation|meditation
141690|NCT02686333|Dialysis|dialysis
141691|NCT02686320|Rheumatoid arthritis|rheumatoid arthritis
141692|NCT02686320|Elderly|elderly
141693|NCT02686320|infections|infections
141694|NCT02686320|cardio-vascular disease|cardio-vascular disease
141695|NCT02686320|osteoporosis|osteoporosis
141696|NCT02686320|cancer|cancer
141697|NCT02686268|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
141698|NCT02686268|ALS|als
141699|NCT02686268|C9ORF72 gene mutation|c9orf72 gene mutation
141700|NCT02686268|Chromosome 9 open reading frame 72 protein|chromosome 9 open reading frame 72 protein
141701|NCT02686268|Natural history|natural history
141702|NCT02686268|Biomarkers|biomarkers
141703|NCT02686268|Amyotrophic Lateral Sclerosis, Familial|amyotrophic lateral sclerosis, familial
141704|NCT02686268|Amyotrophic Lateral Sclerosis, Sporadic|amyotrophic lateral sclerosis, sporadic
141705|NCT02686268|Frontotemporal Dementia-Amyotrophic Lateral Sclerosis|frontotemporal dementia-amyotrophic lateral sclerosis
141706|NCT02686242|cesarean section|cesarean section
141707|NCT02686242|spinal anesthesia|spinal anesthesia
141708|NCT02686242|general anesthesia|general anesthesia
141709|NCT02686229|Low grade glioma, registry, neurosurgery, brain tumor|low grade glioma, registry, neurosurgery, brain tumor
141710|NCT02686216|F-18 THK-5351 PET|f-18 thk-5351 pet
141711|NCT02686190|Alzheimer; luxtherapy, sleep disturbance, behaviour disturbance|alzheimer; luxtherapy, sleep disturbance, behaviour disturbance
141712|NCT02686177|Type 2 diabetes|type 2 diabetes
141713|NCT02686177|Angiogenesis|angiogenesis
141714|NCT02686177|Liraglutide|liraglutide
141715|NCT02686177|Glucagon like peptide 1 receptor agonist|glucagon like peptide 1 receptor agonist
141716|NCT02686164|Lenvatinib|lenvatinib
141717|NCT02686164|Lenvima|lenvima
141718|NCT02686164|E7080|e7080
141719|NCT02686164|Phase 1|phase 1
141720|NCT02686164|Solid tumors|solid tumors
141721|NCT02686164|Midazolam|midazolam
141722|NCT02686164|CYP3A4|cyp3a4
141723|NCT02686151|Letrozole|letrozole
141724|NCT02686151|OHSS|ohss
141725|NCT02686099|Rigid Fixation|rigid fixation
141726|NCT02686099|Sternal Plating|sternal plating
141727|NCT02686099|Sternal Closure|sternal closure
141728|NCT02686099|Sternalock|sternalock
141729|NCT02686073|BMI|bmi
141730|NCT02686073|progress of labor|progress of labor
141731|NCT02686073|nulliparous women|nulliparous women
141732|NCT02686047|Knee osteoarthritis|knee osteoarthritis
141733|NCT02686047|Hyaluronic acid|hyaluronic acid
141734|NCT02686047|Viscosupplementation|viscosupplementation
141735|NCT02686034|Migraine|migraine
141736|NCT02686034|Non-invasive vagus nerve stimulation|non-invasive vagus nerve stimulation
141737|NCT02686034|Vagus nerve stimulation|vagus nerve stimulation
141738|NCT02686034|Vagal nerve stimulation|vagal nerve stimulation
141739|NCT02686034|gammaCore|gammacore
141740|NCT02686034|episodic migraine|episodic migraine
141741|NCT02685982|Unipolar|unipolar
141742|NCT02685982|Depression|depression
141743|NCT02685982|Depressive Disorder|depressive disorder
141744|NCT02685982|Behavioural Symptoms|behavioural symptoms
141745|NCT02685982|Mood Disorder|mood disorder
141746|NCT02685982|Adjunctive Therapy|adjunctive therapy
141747|NCT02685982|Music Therapy|music therapy
141748|NCT02685982|Brain Stimulation|brain stimulation
141749|NCT02685969|Prevention|prevention
141750|NCT02685969|Positron Emission Tomography|positron emission tomography
141751|NCT02685930|invasive mechanical ventilation|invasive mechanical ventilation
141752|NCT02685878|urinary continence|urinary continence
141753|NCT02685878|prevalence of depression|prevalence of depression
141754|NCT02685878|reproductive outcomes|reproductive outcomes
141755|NCT02685878|quality of life|quality of life
141756|NCT02685878|HIV status|hiv status
141757|NCT02685878|obstetric fistula|obstetric fistula
141758|NCT02685865|pancreatic fluid collection; pancreatic necrosis; stent;|pancreatic fluid collection; pancreatic necrosis; stent;
141759|NCT02685839|frailty syndrome, Intelligent POWER Rehabilitation Cluster Machine, Internet of Things, wearable|frailty syndrome, intelligent power rehabilitation cluster machine, internet of things, wearable
141760|NCT02685826|Open-label|open-label
141761|NCT02685826|Phase 1/2|phase 1/2
141762|NCT02685826|Durvalumab|durvalumab
141763|NCT02685826|MEDI4736|medi4736
141764|NCT02685826|Lenalidomide (Len)|lenalidomide (len)
141765|NCT02685826|Dexamethasone (dex)|dexamethasone (dex)
141766|NCT02685826|Multiple Myeloma|multiple myeloma
141767|NCT02685826|Newly-Diagnosed (NDMM)|newly-diagnosed (ndmm)
141768|NCT02685826|Transplant Non-eligible (TNE)|transplant non-eligible (tne)
141769|NCT02685826|PD-L1|pd-l1
141770|NCT02685813|Ultra sound|ultra sound
141771|NCT02685813|birth defects|birth defects
141772|NCT02685787|Care-giver burden|care-giver burden
141773|NCT02685787|Dementia|dementia
141774|NCT02685787|Alzheimer's disease|alzheimer's disease
141775|NCT02685787|Care-giver depression|care-giver depression
141776|NCT02685787|Care-giver anxiety|care-giver anxiety
141777|NCT02685709|Octreotide Capsules|octreotide capsules
141778|NCT02685709|Acromegaly|acromegaly
141779|NCT02685709|Somatostatin|somatostatin
141780|NCT02685709|Mpowered|mpowered
141781|NCT02685709|OOC-ACM-302|ooc-acm-302
141782|NCT02685683|Crohn's Disease|crohn's disease
141783|NCT02685683|GED-0301|ged-0301
141784|NCT02685683|Open-label|open-label
141785|NCT02685683|Pharmacodynamic|pharmacodynamic
141786|NCT02685683|Mongersen|mongersen
141787|NCT02685644|endometrioma|endometrioma
141788|NCT02685644|laparoscopy|laparoscopy
141789|NCT02685644|anti-mullerian hormone|anti-mullerian hormone
141790|NCT02685644|ovarian reserve|ovarian reserve
141791|NCT02685631|Hepatocellular carcinoma|hepatocellular carcinoma
141792|NCT02685631|Colorectal cancer|colorectal cancer
141793|NCT02685631|Neuroendocrine tumor|neuroendocrine tumor
141794|NCT02685631|Cholangiocarcinoma|cholangiocarcinoma
141795|NCT02685631|Breast cancer|breast cancer
141796|NCT02685631|Tumor of unknown primary|tumor of unknown primary
141797|NCT02685631|Pancreatic cancer|pancreatic cancer
141798|NCT02685605|Glioblastoma|glioblastoma
141799|NCT02685605|Intraoperative Radiotherapy|intraoperative radiotherapy
141800|NCT02685605|Radiotherapy Dose Escalation|radiotherapy dose escalation
141801|NCT02685592|Lentigo Maligna|lentigo maligna
141802|NCT02685592|Photodynamic Therapy|photodynamic therapy
141803|NCT02685592|Hyperspectral Imaging|hyperspectral imaging
141804|NCT02685566|Mammography|mammography
141805|NCT02685540|Anesthesia|anesthesia
141806|NCT02685540|mortality|mortality
141807|NCT02685514|HIFU|hifu
141808|NCT02685514|Graves' disease|graves' disease
141809|NCT02685514|treatment|treatment
141810|NCT02685475|Diabetes mellitus|diabetes mellitus
141811|NCT02685475|Axillary brachial plexus block|axillary brachial plexus block
141812|NCT02685475|Block duration|block duration
141813|NCT02685475|Time-to-first pain|time-to-first pain
141814|NCT02685475|Postoperative analgesia|postoperative analgesia
141815|NCT02685449|diabetes type 1|diabetes type 1
141816|NCT02685449|insulin pump|insulin pump
141817|NCT02685449|prandial insulin requirement|prandial insulin requirement
141818|NCT02685449|pure protein meal|pure protein meal
141819|NCT02685449|high protein meal|high protein meal
141820|NCT02685449|square bolus|square bolus
141821|NCT02685449|square-wave bolus|square-wave bolus
141822|NCT02685449|insulin bolus|insulin bolus
141823|NCT02685449|dietary protein|dietary protein
141824|NCT02685423|Amblyopia|amblyopia
141825|NCT02685423|Lazy Eye|lazy eye
141826|NCT02685423|Anisometropia|anisometropia
141827|NCT02685384|healthcare access|healthcare access
141828|NCT02685384|healthcare utilization|healthcare utilization
141829|NCT02685384|health expenditures|health expenditures
141830|NCT02685384|preventive services|preventive services
141831|NCT02685384|biomarkers|biomarkers
141832|NCT02685358|Stress Disorders, Post-traumatic|stress disorders, post-traumatic
141833|NCT02685358|Primary Health Care|primary health care
141834|NCT02685358|Mobile Applications|mobile applications
141835|NCT02685358|Veterans|veterans
141836|NCT02685345|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
141837|NCT02685345|sitagliptin|sitagliptin
141838|NCT02685345|adult|adult
141839|NCT02685345|Phase 2|phase 2
141840|NCT02685280|rechargeable neurostimulators|rechargeable neurostimulators
141841|NCT02685254|Group Therapy|group therapy
141842|NCT02685254|Structured Skills Training|structured skills training
141843|NCT02685254|Dialectic Behavioural Therapy|dialectic behavioural therapy
141844|NCT02685241|Exhaled breath|exhaled breath
141845|NCT02685241|Biomarker|biomarker
141846|NCT02685215|intensive care unit|intensive care unit
141847|NCT02685215|muscular dystrophy|muscular dystrophy
141848|NCT02685215|mortality|mortality
141849|NCT02685215|prognosis|prognosis
141850|NCT02685215|tracheostomy|tracheostomy
141851|NCT02685202|orofacial pain|orofacial pain
141852|NCT02685202|sleep-disordered breathing|sleep-disordered breathing
141853|NCT02685202|temporomandibular disorder|temporomandibular disorder
141854|NCT02685202|oral appliance|oral appliance
141855|NCT02685202|upper airway collapse|upper airway collapse
141856|NCT02685176|hypothermia|hypothermia
141857|NCT02685176|rewarming|rewarming
141858|NCT02685176|non-shivering|non-shivering
141859|NCT02685150|Endoscopic Tri-Modal Imaging|endoscopic tri-modal imaging
141860|NCT02685150|Gastric juice|gastric juice
141861|NCT02685150|Functional dyspepsia|functional dyspepsia
141862|NCT02685150|Acid reflux disease|acid reflux disease
141863|NCT02685150|Bile reflux|bile reflux
141864|NCT02685137|Kernicterus|kernicterus
141865|NCT02685137|Neonatal Jaundice|neonatal jaundice
141866|NCT02685137|Newborn Jaundice|newborn jaundice
141867|NCT02685111|Breast cancer|breast cancer
141868|NCT02685111|Adjuvant|adjuvant
141869|NCT02685111|Docetaxel|docetaxel
141870|NCT02685111|Adriamycin|adriamycin
141871|NCT02685111|Cyclophosphamide|cyclophosphamide
141872|NCT02685111|Neutropenia|neutropenia
141873|NCT02685111|Filgrastim|filgrastim
141874|NCT02685111|Pegfilgrastim|pegfilgrastim
141875|NCT02685098|Stem cells|stem cells
141877|NCT02685098|Mesenchymal|mesenchymal
141878|NCT02685098|Amputation|amputation
141880|NCT02685098|below knee amputation|below knee amputation
141881|NCT02685098|CHAMP|champ
141882|NCT02685072|Smoking Cessation|smoking cessation
141883|NCT02685072|Nicotine Cessation|nicotine cessation
141884|NCT02685059|breast cancer|breast cancer
141885|NCT02685059|Medi4736|medi4736
141886|NCT02685059|Anti PD-L1|anti pd-l1
141887|NCT02685059|Nab-Paclitaxel|nab-paclitaxel
141888|NCT02685059|Placebo|placebo
141889|NCT02685059|triple negative|triple negative
141890|NCT02685033|Osteomyelitis|osteomyelitis
141891|NCT02685033|dalbavancin|dalbavancin
141892|NCT02685033|antibiotic|antibiotic
141893|NCT02685020|Healthy|healthy
141894|NCT02685020|Human Immunodeficiency Virus|human immunodeficiency virus
141895|NCT02685020|adenovirus serotype 26|adenovirus serotype 26
141896|NCT02685020|Ad26.Mos.HIV|ad26.mos.hiv
141897|NCT02685020|Vaccine|vaccine
141898|NCT02685020|Placebo|placebo
141899|NCT02685020|Glycoprotein|glycoprotein
141900|NCT02685020|IPCAVD010|ipcavd010
141901|NCT02685007|minimal invasive surgery|minimal invasive surgery
141902|NCT02684994|Trauma|trauma
141903|NCT02684994|Sexual assault|sexual assault
141904|NCT02684994|Sexual abuse|sexual abuse
141905|NCT02684994|Physical assault|physical assault
141906|NCT02684994|Physical abuse|physical abuse
141907|NCT02684994|PTSD|ptsd
141908|NCT02684994|Interpersonal Violence|interpersonal violence
141909|NCT02684994|Women|women
141910|NCT02684955|cardiac arrest|cardiac arrest
141911|NCT02684955|near-infrared spectroscopy|near-infrared spectroscopy
141912|NCT02684955|automated infrared pupillometry|automated infrared pupillometry
141913|NCT02684955|prognostication|prognostication
141914|NCT02684942|Meperidine|meperidine
141915|NCT02684942|Fentanyl|fentanyl
141916|NCT02684942|Pain management|pain management
141917|NCT02684942|brachytherapy|brachytherapy
141918|NCT02684929|insulin resistance|insulin resistance
141919|NCT02684929|bcaa|bcaa
141920|NCT02684929|mitochondrial biogenesis|mitochondrial biogenesis
141921|NCT02684916|Chiropractic spinal manipulation|chiropractic spinal manipulation
141922|NCT02684916|Children|children
141923|NCT02684916|Pediatric|pediatric
141924|NCT02684916|Headache|headache
141925|NCT02684903|Child Abuse|child abuse
141926|NCT02684903|Parent Child Interaction Therapy (PCIT)|parent child interaction therapy (pcit)
141927|NCT02684903|Evidenced Based Intervention|evidenced based intervention
141928|NCT02684903|Self-control|self-control
141929|NCT02684877|Fatigue|fatigue
141930|NCT02684877|Quality of life|quality of life
141931|NCT02684877|Critically ill patients|critically ill patients
141932|NCT02684864|biomarker|biomarker
141933|NCT02684864|inflammation|inflammation
141934|NCT02684864|knee|knee
141935|NCT02684864|prognosis|prognosis
141936|NCT02684838|Gliadel, Carmustine wafer implant|gliadel, carmustine wafer implant
141937|NCT02684825|Stroke|stroke
141938|NCT02684825|ischemic stroke|ischemic stroke
141939|NCT02684825|atrial fibrillation|atrial fibrillation
141940|NCT02684825|continuous cardiac monitoring|continuous cardiac monitoring
141941|NCT02684825|insertable cardiac monitoring|insertable cardiac monitoring
141942|NCT02684825|implantable loop recorder|implantable loop recorder
141943|NCT02684825|antithrombotics|antithrombotics
141944|NCT02684825|anticoagulants|anticoagulants
141945|NCT02684825|stroke subtype|stroke subtype
141946|NCT02684825|atherothrombotic stroke|atherothrombotic stroke
141947|NCT02684825|lacunar stroke|lacunar stroke
141948|NCT02684812|antifibrinolytic therapy|antifibrinolytic therapy
141949|NCT02684812|recurrent bleeding|recurrent bleeding
141950|NCT02684812|tranexamic acid|tranexamic acid
141951|NCT02684773|Hemodialysis|hemodialysis
141952|NCT02684773|Left Ventricular Mass|left ventricular mass
141953|NCT02684773|Cardiac Magnetic resonance Imaging|cardiac magnetic resonance imaging
141954|NCT02684760|Inflammatory Bowel Disease|inflammatory bowel disease
141955|NCT02684747|Healthy Volunteers|healthy volunteers
141956|NCT02684747|Sports Medicine|sports medicine
141957|NCT02684747|Athletes|athletes
141958|NCT02684747|Anti-doping|anti-doping
141959|NCT02684734|Ulcerative Colitis|ulcerative colitis
141960|NCT02684734|UC|uc
141961|NCT02684734|Cytomegalovirus|cytomegalovirus
141962|NCT02684734|CMV|cmv
141963|NCT02684721|rehabilitation|rehabilitation
141964|NCT02684721|physical capacity|physical capacity
141965|NCT02684721|quality of life|quality of life
141966|NCT02684695|Magnetic resonance imaging|magnetic resonance imaging
141967|NCT02684695|Imaging biomarker|imaging biomarker
141968|NCT02684695|Diffusion-weighted imaging|diffusion-weighted imaging
141969|NCT02684682|Toothbrushing|toothbrushing
141970|NCT02684682|Gingivitis|gingivitis
141971|NCT02684682|Dental Plaque|dental plaque
141972|NCT02684682|Periodontal Diseases|periodontal diseases
141973|NCT02684682|Clinical Trial|clinical trial
141974|NCT02684669|burn injury|burn injury
141975|NCT02684669|controlled trial|controlled trial
141976|NCT02684669|latent sensitization|latent sensitization
141977|NCT02684669|naloxone|naloxone
141978|NCT02684669|secondary hyperalgesia|secondary hyperalgesia
141979|NCT02684669|volunteers|volunteers
141980|NCT02684656|Oxalate|oxalate
141981|NCT02684656|Inflammation|inflammation
142182|NCT02683291|aged|aged
141982|NCT02684656|Hemodiafiltration|hemodiafiltration
141983|NCT02684656|Hemodialysis|hemodialysis
141984|NCT02684656|Oxalate Blood Sample|oxalate blood sample
141985|NCT02684643|individualised therapy|individualised therapy
141986|NCT02684643|hyperphosphatemia|hyperphosphatemia
141987|NCT02684643|hemodialysis|hemodialysis
141988|NCT02684643|clinical trials|clinical trials
141989|NCT02684643|restricted phosphate diet|restricted phosphate diet
141990|NCT02684643|phosphate binders|phosphate binders
141991|NCT02684565|pre-diabetes|pre-diabetes
141992|NCT02684565|blood glucose regulation|blood glucose regulation
141993|NCT02684565|branching chain amino acids|branching chain amino acids
141994|NCT02684565|diabetes|diabetes
141995|NCT02684565|lower blood sugar|lower blood sugar
141996|NCT02684513|Well-being|well-being
141997|NCT02684513|Quality of Recovery|quality of recovery
141998|NCT02684513|Maternal complications|maternal complications
141999|NCT02684500|aSAH|asah
142000|NCT02684487|vitamin D|vitamin d
142001|NCT02684487|vitamin D3|vitamin d3
142002|NCT02684487|sepsis|sepsis
142003|NCT02684487|severe sepsis|severe sepsis
142004|NCT02684487|critical illness|critical illness
142005|NCT02684487|ICU|icu
142006|NCT02684396|Drug therapy|drug therapy
142007|NCT02684383|Dengue Vaccine|dengue vaccine
142008|NCT02684370|Psoriasis|psoriasis
142009|NCT02684370|Skin Diseases|skin diseases
142010|NCT02684370|Skin Diseases, Papulosquamous|skin diseases, papulosquamous
142011|NCT02684370|ustekinumab|ustekinumab
142012|NCT02684370|Dermatologic Agents|dermatologic agents
142013|NCT02684370|ABBV-066|abbv-066
142014|NCT02684370|BI 655066|bi 655066
142015|NCT02684370|risankizumab|risankizumab
142016|NCT02684357|ABBV-066|abbv-066
142017|NCT02684357|BI 655066|bi 655066
142018|NCT02684357|risankizumab|risankizumab
142019|NCT02684344|Post-Operative Urinary Retention|post-operative urinary retention
142020|NCT02684292|PD1|pd1
142021|NCT02684292|PD-1|pd-1
142022|NCT02684292|PDL1|pdl1
142023|NCT02684292|PD-L1|pd-l1
142024|NCT02684266|neoplasm, Cycline-Dependent Kinase|neoplasm, cycline-dependent kinase
142025|NCT02684253|Nivolumab|nivolumab
142026|NCT02684253|Stereotactic Body Radiotherapy (SBRT)|stereotactic body radiotherapy (sbrt)
142027|NCT02684253|15-253|15-253
142028|NCT02684227|Endometrial cancer|endometrial cancer
142029|NCT02684227|Advanced Stage Endometrioid Endometrial Cancer|advanced stage endometrioid endometrial cancer
142030|NCT02684227|Recurrent Endometrioid Endometrial Cancer|recurrent endometrioid endometrial cancer
142031|NCT02684227|Enzalutamide|enzalutamide
142032|NCT02684227|MDV3100|mdv3100
142033|NCT02684227|XTANDI|xtandi
142034|NCT02684227|Carboplatin|carboplatin
142035|NCT02684227|Paclitaxel|paclitaxel
142036|NCT02684227|Taxol|taxol
142037|NCT02684214|food security|food security
142038|NCT02684201|Phantom Limb|phantom limb
142039|NCT02684201|Upper Amputee|upper amputee
142040|NCT02684201|Electrodes|electrodes
142041|NCT02684201|Implant|implant
142042|NCT02684201|Pain|pain
142043|NCT02684175|Audiometry|audiometry
142044|NCT02684175|Cochlear Implants|cochlear implants
142045|NCT02684175|Adult|adult
142046|NCT02684175|Telemedicine|telemedicine
142047|NCT02684175|Health Services Accessibility|health services accessibility
142048|NCT02684175|Rural Population|rural population
142049|NCT02684175|Technology Assessment, Biomedical|technology assessment, biomedical
142050|NCT02684162|Leukemia|leukemia
142051|NCT02684162|Myeloproliferative Diseases|myeloproliferative diseases
142052|NCT02684162|Acute myelogenous leukemia|acute myelogenous leukemia
142053|NCT02684162|AML|aml
142054|NCT02684162|Myelodysplastic syndrome|myelodysplastic syndrome
142055|NCT02684162|MDS|mds
142056|NCT02684162|Donor lymphocyte infusion|donor lymphocyte infusion
142057|NCT02684162|DLI|dli
142058|NCT02684162|Allogeneic stem cell transplant|allogeneic stem cell transplant
142059|NCT02684162|Stem cell transplantation|stem cell transplantation
142060|NCT02684162|AlloSCT|allosct
142061|NCT02684149|Intensive care|intensive care
142062|NCT02684149|Arterial puncture|arterial puncture
142063|NCT02684149|Cross-over|cross-over
142064|NCT02684149|Relational touch|relational touch
142065|NCT02684149|Pain|pain
142066|NCT02684136|insomnia|insomnia
142067|NCT02684136|fibromyalgia|fibromyalgia
142068|NCT02684136|polysomnography|polysomnography
142069|NCT02684136|pain management|pain management
142070|NCT02684123|Alopecia areata|alopecia areata
142071|NCT02684097|Alopecia, Alopecia Totalis, Alopecia Universalis|alopecia, alopecia totalis, alopecia universalis
142072|NCT02684084|Diabetic Macular Edema|diabetic macular edema
142073|NCT02684084|Ozurdex|ozurdex
142074|NCT02684084|Lucentis|lucentis
142075|NCT02684071|medulloblastoma, ependymoma, AT/RT, embryonal|medulloblastoma, ependymoma, at/rt, embryonal
142076|NCT02684058|Malignant glioma|malignant glioma
142077|NCT02684058|BRAF mutant positive|braf mutant positive
142078|NCT02684058|High grade glioma|high grade glioma
142079|NCT02684058|Low grade glioma|low grade glioma
142080|NCT02684058|Dabrafenib|dabrafenib
142081|NCT02684058|Trametinib|trametinib
142082|NCT02684058|Pediatrics|pediatrics
142083|NCT02684058|Brain neoplasma|brain neoplasma
142084|NCT02684032|PI3K (phosphoinositide 3-kinase)|pi3k (phosphoinositide 3-kinase)
142085|NCT02684032|mTOR (mechanistic target of rapamycin)|mtor (mechanistic target of rapamycin)
142086|NCT02684032|PI3K/mTOR|pi3k/mtor
142087|NCT02684032|metastatic breast cancer (MBC)|metastatic breast cancer (mbc)
142088|NCT02684032|ER+ (estrogen receptor positive)|er+ (estrogen receptor positive)
142089|NCT02684032|HER2- (human epidermal growth factor receptor 2 negative)|her2- (human epidermal growth factor receptor 2 negative)
142090|NCT02684019|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
142091|NCT02684019|sedation|sedation
142092|NCT02684019|dexmedetomidine|dexmedetomidine
142093|NCT02684019|propofol|propofol
142094|NCT02684019|Magnesium sulphate|magnesium sulphate
142095|NCT02684019|Bispectral index monitoring|bispectral index monitoring
142096|NCT02684006|Cancer|cancer
142097|NCT02684006|renal cell cancer|renal cell cancer
142098|NCT02684006|kidney disease|kidney disease
142099|NCT02684006|kidney neoplasms|kidney neoplasms
142100|NCT02684006|axitinib, sunitinib|axitinib, sunitinib
142101|NCT02683915|Acute kidney injury|acute kidney injury
142102|NCT02683915|Perinatal asphyxia|perinatal asphyxia
142103|NCT02683915|Therapeutic hypothermia|therapeutic hypothermia
142104|NCT02683915|Serum NGAL|serum ngal
142105|NCT02683915|Serum cystatin-C|serum cystatin-c
142106|NCT02683902|prediabetes|prediabetes
142107|NCT02683902|tDCS|tdcs
142108|NCT02683902|transcranial direct current stimulation|transcranial direct current stimulation
142109|NCT02683902|obesity|obesity
142110|NCT02683902|diabetes|diabetes
142111|NCT02683876|body odor, malodor, halitosis|body odor, malodor, halitosis
142112|NCT02683837|Intraoperative Neurophysiological Monitoring|intraoperative neurophysiological monitoring
142113|NCT02683837|Reflex, Pupillary|reflex, pupillary
142114|NCT02683837|remifentanil|remifentanil
142115|NCT02683811|adolescence|adolescence
142116|NCT02683811|prevention|prevention
142117|NCT02683811|wellbeing|wellbeing
142118|NCT02683811|evaluation|evaluation
142119|NCT02683811|effectiveness|effectiveness
142120|NCT02683811|school-based program|school-based program
142121|NCT02683798|Weight loss maintenance|weight loss maintenance
142122|NCT02683785|Pain intensity|pain intensity
142123|NCT02683785|Hand Osteoarthritis|hand osteoarthritis
142124|NCT02683785|GSK3196165|gsk3196165
142125|NCT02683785|AUSCAN|auscan
142126|NCT02683785|GM-CSF|gm-csf
142127|NCT02683785|Numerical Rating Scale|numerical rating scale
142128|NCT02683772|NIV, NIPPV, ventilation|niv, nippv, ventilation
142129|NCT02683746|Pharmacodynamics|pharmacodynamics
142130|NCT02683746|Safety|safety
142131|NCT02683746|Albiglutide|albiglutide
142132|NCT02683746|Tolerability|tolerability
142133|NCT02683746|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
142134|NCT02683746|Efficacy|efficacy
142135|NCT02683707|Percutaneous Coronary Intervention|percutaneous coronary intervention
142136|NCT02683707|Blood Platelets|blood platelets
142137|NCT02683707|Fentanyl|fentanyl
142138|NCT02683694|Epiretinal membrane|epiretinal membrane
142139|NCT02683694|lamellar holes of the macula|lamellar holes of the macula
142140|NCT02683694|macular holes|macular holes
142141|NCT02683694|vitreomacular traction syndrome|vitreomacular traction syndrome
142142|NCT02683668|Inhalers|inhalers
142143|NCT02683668|Tiotropium|tiotropium
142144|NCT02683629|Parkinson's Disease|parkinson's disease
142145|NCT02683629|Xenotransplantation|xenotransplantation
142146|NCT02683629|choroid plexus|choroid plexus
142147|NCT02683603|colistin|colistin
142148|NCT02683603|aerosol|aerosol
142149|NCT02683603|ventilator associated pneumonia|ventilator associated pneumonia
142150|NCT02683603|nephrotoxicity|nephrotoxicity
142151|NCT02683603|intravenous|intravenous
142152|NCT02683590|Sternectomie|sternectomie
142153|NCT02683590|Ceramic Implant|ceramic implant
142154|NCT02683590|Bones Tumors|bones tumors
142155|NCT02683538|RFA|rfa
142156|NCT02683525|Allogeneic|allogeneic
142157|NCT02683525|Sitagliptin|sitagliptin
142158|NCT02683499|Tooth preparation|tooth preparation
142159|NCT02683499|Prosthodontics|prosthodontics
142160|NCT02683447|Continuing Medical Education|continuing medical education
142161|NCT02683447|Simulation|simulation
142162|NCT02683447|Non-technical Skills|non-technical skills
142163|NCT02683447|Crisis Resource Management|crisis resource management
142164|NCT02683434|soccer|soccer
142165|NCT02683421|Rheumatoid arthritis|rheumatoid arthritis
142166|NCT02683421|tilmanocept|tilmanocept
142167|NCT02683421|imaging|imaging
142168|NCT02683395|PLX51107|plx51107
142169|NCT02683395|Acute Myeloid Leukemia|acute myeloid leukemia
142170|NCT02683395|Myelodysplastic Syndrome|myelodysplastic syndrome
142171|NCT02683395|Neoplasms|neoplasms
142172|NCT02683369|Non-anemic Iron Deficiency, Iron Supplementation|non-anemic iron deficiency, iron supplementation
142173|NCT02683356|Percutaneous Coronary Intervention|percutaneous coronary intervention
142174|NCT02683356|Stents|stents
142175|NCT02683330|PD|pd
142176|NCT02683330|Parkinson's|parkinson's
142177|NCT02683317|DHA|dha
142178|NCT02683317|Retinopathy of Prematurity|retinopathy of prematurity
142179|NCT02683291|Kidney transplantation|kidney transplantation
142180|NCT02683291|sirolimus|sirolimus
142181|NCT02683291|cytomegalovirus|cytomegalovirus
142183|NCT02683252|Magnetic resonance imaging|magnetic resonance imaging
142184|NCT02683252|perfusion|perfusion
142185|NCT02683252|quantitative|quantitative
142186|NCT02683213|fluoxetine|fluoxetine
142187|NCT02683213|outcome|outcome
142188|NCT02683213|depression|depression
142189|NCT02683213|plasticity|plasticity
142190|NCT02683187|insulin secretion|insulin secretion
142191|NCT02683187|GLP-1|glp-1
142192|NCT02683187|alpha cell|alpha cell
142193|NCT02683187|paracrine effect|paracrine effect
142194|NCT02683187|Glucagon-Like Peptide 1|glucagon-like peptide 1
142195|NCT02683174|syncope|syncope
142196|NCT02683122|Organ dysfunction scores|organ dysfunction scores
142197|NCT02683122|Pneumonia, Ventilator-Associated|pneumonia, ventilator-associated
142198|NCT02683122|Intensive care units|intensive care units
142199|NCT02683070|Catheter-related bladder discomfort|catheter-related bladder discomfort
142200|NCT02683070|Pudendal nerve block|pudendal nerve block
142201|NCT02683070|Tramadol|tramadol
142202|NCT02683070|Randomized controlled trial|randomized controlled trial
142203|NCT02683070|catheter-related bladder discomfort prevention|catheter-related bladder discomfort prevention
142204|NCT02683044|Erectile dysfunction|erectile dysfunction
142205|NCT02683044|Low-Density Shock Waves|low-density shock waves
142206|NCT02683044|Randomized Clinical Trial|randomized clinical trial
142207|NCT02683031|fertilization arrest|fertilization arrest
142208|NCT02683031|Cleavage failure|cleavage failure
142209|NCT02683031|Embryonic development|embryonic development
142210|NCT02683031|Calcium ionophore|calcium ionophore
142211|NCT02683005|treatment|treatment
142212|NCT02683005|pharmacokinetics|pharmacokinetics
142213|NCT02682979|therapeutic limitation code|therapeutic limitation code
142214|NCT02682979|emergency unit admittance|emergency unit admittance
142215|NCT02682966|troponin|troponin
142216|NCT02682966|coronary artery disease|coronary artery disease
142217|NCT02682966|pulmonary embolism|pulmonary embolism
142218|NCT02682966|Computed Tomography Angiography|computed tomography angiography
142219|NCT02682966|postoperative myocardial injury|postoperative myocardial injury
142220|NCT02682927|seizure|seizure
142221|NCT02682927|tonic-atonic|tonic-atonic
142222|NCT02682927|clonic|clonic
142223|NCT02682927|epilepsy|epilepsy
142224|NCT02682927|myoclonic|myoclonic
142225|NCT02682927|encephalopathy|encephalopathy
142226|NCT02682914|Psychological distress|psychological distress
142227|NCT02682914|Stroke etiology|stroke etiology
142228|NCT02682914|Young patients|young patients
142229|NCT02682888|brain functional connectivity changes|brain functional connectivity changes
142230|NCT02682862|tiotropium|tiotropium
142231|NCT02682862|olodaterol|olodaterol
142232|NCT02682862|smoker|smoker
142233|NCT02682862|cigarette|cigarette
142234|NCT02682862|bronchodilator|bronchodilator
142235|NCT02682836|physical activity|physical activity
142236|NCT02682836|chemotherapy|chemotherapy
142237|NCT02682836|fatigue|fatigue
142238|NCT02682810|HIV|hiv
142239|NCT02682810|point-of-care HIV diagnosis|point-of-care hiv diagnosis
142240|NCT02682810|Alere Q|alere q
142241|NCT02682810|diagnostic|diagnostic
142242|NCT02682810|children|children
142243|NCT02682771|gastroplasty, breathing exercices, positive pressure|gastroplasty, breathing exercices, positive pressure
142244|NCT02682758|xenon|xenon
142245|NCT02682758|transpulmonary pressure|transpulmonary pressure
142246|NCT02682758|electrical impedance tomography|electrical impedance tomography
142247|NCT02682758|tidal volume|tidal volume
142248|NCT02682758|esophageal pressure measurement|esophageal pressure measurement
142249|NCT02682732|Acute Myeloid Leukemia|acute myeloid leukemia
142250|NCT02682732|PET/CT Scan|pet/ct scan
142251|NCT02682719|Natriuretic peptide, brain|natriuretic peptide, brain
142252|NCT02682719|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
142253|NCT02682719|Hypertension|hypertension
142254|NCT02682719|Cardiovascular prevention|cardiovascular prevention
142255|NCT02682719|Left atrial volume index|left atrial volume index
142256|NCT02682719|Angiotensin receptor neprilysin inhibitor|angiotensin receptor neprilysin inhibitor
142258|NCT02682719|Valsartan|valsartan
142259|NCT02682719|Sacubitril|sacubitril
142260|NCT02682706|brown adipose tissue|brown adipose tissue
142261|NCT02682706|magnetic resonance imaging|magnetic resonance imaging
142262|NCT02682706|energy expenditure|energy expenditure
142263|NCT02682706|non-shivering thermogenesis|non-shivering thermogenesis
142264|NCT02682680|diabetes|diabetes
142265|NCT02682680|hyperlipidaemia|hyperlipidaemia
142266|NCT02682680|colesevelam|colesevelam
142267|NCT02682680|ezetimibe|ezetimibe
142268|NCT02682680|LDL cholesterol|ldl cholesterol
142269|NCT02682680|glycated hemoglobin|glycated hemoglobin
142270|NCT02682667|Apheresis Products|apheresis products
142271|NCT02682667|Immunological|immunological
142272|NCT02682667|Diverse Malignan|diverse malignan
142273|NCT02682667|Premalignant|premalignant
142274|NCT02682667|Protein|protein
142275|NCT02682654|Pain|pain
142276|NCT02682654|Ankle|ankle
142277|NCT02682654|Knee|knee
142278|NCT02682654|Brace|brace
142279|NCT02682615|Cardiac Index|cardiac index
142280|NCT02682615|Noninvasive|noninvasive
142281|NCT02682615|esCCO|escco
142282|NCT02682615|PiCCO|picco
142283|NCT02682615|Thermodilution|thermodilution
142284|NCT02682602|total hip arthroplasty|total hip arthroplasty
142285|NCT02682589|Complete Mesocolic Excision|complete mesocolic excision
142286|NCT02682589|locally advanced Colon Cancer|locally advanced colon cancer
142287|NCT02682589|Laparoscopic|laparoscopic
142288|NCT02682576|brachial artery ultrasound imaging|brachial artery ultrasound imaging
142289|NCT02682576|flow-mediated dilation|flow-mediated dilation
142290|NCT02682576|endothelium|endothelium
142291|NCT02682563|SGLT-2 inhibition, Renal, Cardiovascular, Type 2 diabetes, forxiga, dapagliflozin|sglt-2 inhibition, renal, cardiovascular, type 2 diabetes, forxiga, dapagliflozin
142292|NCT02682550|polytrauma|polytrauma
142293|NCT02682550|hemorrhagic shock|hemorrhagic shock
142294|NCT02682550|sepsis|sepsis
142295|NCT02682550|MODS|mods
142296|NCT02682537|Resting energy expenditure|resting energy expenditure
142297|NCT02682537|Calorie requirements|calorie requirements
142298|NCT02682537|Indirect Calorimetry|indirect calorimetry
142299|NCT02682511|Ifetroban|ifetroban
142300|NCT02682511|Scleroderma|scleroderma
142301|NCT02682511|Systemic Sclerosis|systemic sclerosis
142302|NCT02682498|Knee Arthroplasty, Total|knee arthroplasty, total
142303|NCT02682498|Liposomal Bupivicaine|liposomal bupivicaine
142304|NCT02682485|Rectal Cancer|rectal cancer
142305|NCT02682485|low anterior resection|low anterior resection
142306|NCT02682485|SES|ses
142307|NCT02682485|SES-DTA|ses-dta
142308|NCT02682485|anastomotic leak|anastomotic leak
142309|NCT02682485|anastomotic healing|anastomotic healing
142310|NCT02682485|intestinal healing|intestinal healing
142311|NCT02682485|anastomosis|anastomosis
142312|NCT02682459|Extracapillary glomerulonephritis|extracapillary glomerulonephritis
142313|NCT02682459|crescentic glomerulonephritis|crescentic glomerulonephritis
142314|NCT02682459|rapidly progressive renal failure|rapidly progressive renal failure
142315|NCT02682459|chronic kidney disease|chronic kidney disease
142316|NCT02682459|ACE-inhibitors|ace-inhibitors
142317|NCT02682459|fibrosis|fibrosis
142318|NCT02682446|Early gastric cancer|early gastric cancer
142319|NCT02682446|endoscopic submucosal dissection|endoscopic submucosal dissection
142320|NCT02682446|serum pepsinogen|serum pepsinogen
142321|NCT02682446|Helicobacter pylori|helicobacter pylori
142322|NCT02682407|IgAN|igan
142323|NCT02682407|MN|mn
142324|NCT02682407|C3 Glomerulopathy|c3 glomerulopathy
142325|NCT02682407|Lupus Nephritis|lupus nephritis
142326|NCT02682394|Cancer of pancreas|cancer of pancreas
142327|NCT02682394|steatosis|steatosis
142328|NCT02682394|MRI|mri
142329|NCT02682381|Teduglutide|teduglutide
142330|NCT02682381|pediatric|pediatric
142331|NCT02682381|GLP-2|glp-2
142332|NCT02682381|parenteral support|parenteral support
142333|NCT02682381|Short Bowel Syndrome|short bowel syndrome
142334|NCT02682381|short gut syndrome|short gut syndrome
142335|NCT02682381|short gut|short gut
142336|NCT02682381|SBS|sbs
142337|NCT02682381|parenteral nutrition|parenteral nutrition
142338|NCT02682368|Surgeon performed ultrasound|surgeon performed ultrasound
142339|NCT02682368|Point of care ultrasound|point of care ultrasound
142340|NCT02682329|Peroxide|peroxide
142341|NCT02682316|undergoing laparotomy|undergoing laparotomy
142342|NCT02682316|15-309|15-309
142343|NCT02682303|Adhesive elastic bandaging|adhesive elastic bandaging
142344|NCT02682303|balance|balance
142345|NCT02682303|posturography|posturography
142346|NCT02682290|SPUTUM|sputum
142347|NCT02682290|RHEOLOGY|rheology
142348|NCT02682277|obesity|obesity
142349|NCT02682277|body weight|body weight
142350|NCT02682277|overweight|overweight
142351|NCT02682277|weight loss|weight loss
142352|NCT02682277|polyglucosamine|polyglucosamine
142353|NCT02682277|L112|l112
142354|NCT02682277|caloric restriction|caloric restriction
142355|NCT02682277|physical activity|physical activity
142356|NCT02682264|acne|acne
142357|NCT02682251|Cardiac Resynchronization Therapy Devices|cardiac resynchronization therapy devices
142358|NCT02682251|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
142359|NCT02682225|Esketamine|esketamine
142360|NCT02682225|Placebo|placebo
142361|NCT02682225|Racemic ketamine|racemic ketamine
142362|NCT02682225|Pharmacokinetics|pharmacokinetics
142363|NCT02682212|Pelvic floor|pelvic floor
142364|NCT02682212|obstetrics|obstetrics
142365|NCT02682212|perineal tear|perineal tear
142366|NCT02682212|physiotherapy|physiotherapy
142367|NCT02682186|Prosthetic breast surgery|prosthetic breast surgery
142368|NCT02682186|Locoregional anesthesia|locoregional anesthesia
142369|NCT02682186|Pectoral nerve block|pectoral nerve block
142370|NCT02682186|Pain|pain
142371|NCT02682186|Postoperative analgesia|postoperative analgesia
142372|NCT02682160|bariatric surgery|bariatric surgery
142373|NCT02682134|Sore Throat|sore throat
142374|NCT02682134|Intubation|intubation
142375|NCT02682134|Xylocaine|xylocaine
142376|NCT02682134|Dexamethasone|dexamethasone
142377|NCT02682108|Hepatitis B|hepatitis b
142378|NCT02682108|Hepatitis C|hepatitis c
142379|NCT02682108|Fibrosis, Liver|fibrosis, liver
142380|NCT02682108|Magnetic Resonance Imaging|magnetic resonance imaging
142381|NCT02682095|Hypertension|hypertension
142382|NCT02682095|Blood Pressure Control|blood pressure control
142383|NCT02682095|Adherence|adherence
142384|NCT02682095|Mixed Methods|mixed methods
142385|NCT02682082|Pancreatic cancer|pancreatic cancer
142386|NCT02682082|Pain Management|pain management
142387|NCT02682082|Celiac plexus neurolysis|celiac plexus neurolysis
142388|NCT02682082|Bupivacaine|bupivacaine
142389|NCT02682082|Palliative treatment|palliative treatment
142390|NCT02682069|Diabetic foot ulcer|diabetic foot ulcer
142391|NCT02682069|venous leg ulcer|venous leg ulcer
142392|NCT02682069|fluorescence imaging|fluorescence imaging
142393|NCT02682069|wound imaging|wound imaging
142394|NCT02682056|Pediatrics|pediatrics
142395|NCT02682056|Endocrinology|endocrinology
142396|NCT02682056|Adolescent|adolescent
142397|NCT02682056|Microneedle|microneedle
142398|NCT02682030|Airway Clearance Devices|airway clearance devices
142399|NCT02682030|High Frequency Chest Compression Devices|high frequency chest compression devices
142400|NCT02682030|Cough Assist|cough assist
142401|NCT02682017|Seaweed|seaweed
142402|NCT02682017|Pork|pork
142403|NCT02682017|Fucoidan|fucoidan
142404|NCT02682017|Laminarin|laminarin
142405|NCT02682017|Functional Food|functional food
142406|NCT02682017|Antioxidant activity|antioxidant activity
142407|NCT02681913|Cardioplegia|cardioplegia
142408|NCT02681913|Cardiac Surgery|cardiac surgery
142409|NCT02681913|Adenosine|adenosine
142410|NCT02681913|Therapeutic Uses|therapeutic uses
142411|NCT02681913|Intermittent warm blood cardioplegia|intermittent warm blood cardioplegia
142412|NCT02681913|Minimally Invasive Surgery|minimally invasive surgery
142413|NCT02681913|minimally invasive mitral valve plasty (mini-MPL)|minimally invasive mitral valve plasty (mini-mpl)
142414|NCT02681913|minimally invasive mitral valve replacement (mini-MVR)|minimally invasive mitral valve replacement (mini-mvr)
142415|NCT02681874|dietary pattern|dietary pattern
142416|NCT02681874|stress|stress
142417|NCT02681874|nutrition|nutrition
142418|NCT02681874|health|health
142419|NCT02681874|obesity|obesity
142420|NCT02681874|children|children
142421|NCT02681874|minority|minority
142422|NCT02681874|pre-schoolers|pre-schoolers
142423|NCT02681861|Pharmacodynamics|pharmacodynamics
142424|NCT02681861|Pharmacokinetics|pharmacokinetics
142425|NCT02681861|ASP6294|asp6294
142426|NCT02681861|Maximum tolerated dose|maximum tolerated dose
142427|NCT02681861|Healthy subjects|healthy subjects
142428|NCT02681848|Primary care attendance|primary care attendance
142429|NCT02681848|All-cause|all-cause
142430|NCT02681848|Cause specific|cause specific
142431|NCT02681848|Hospital attendance|hospital attendance
142432|NCT02681822|Genome-wide association studies|genome-wide association studies
142433|NCT02681822|Environmental factors|environmental factors
142434|NCT02681822|Behavioral Assessment|behavioral assessment
142435|NCT02681822|Pathway analysis|pathway analysis
142436|NCT02681783|aflibercept|aflibercept
142437|NCT02681770|kidney transplantation|kidney transplantation
142438|NCT02681770|adherence|adherence
142439|NCT02681770|quality of life|quality of life
142440|NCT02681770|couples|couples
142441|NCT02681770|fundamental frequency|fundamental frequency
142442|NCT02681770|communication|communication
142443|NCT02681770|social support|social support
142444|NCT02681757|pediatric hand burn|pediatric hand burn
142445|NCT02681757|pediatric foot burn|pediatric foot burn
142446|NCT02681757|mepitel Ag|mepitel ag
142447|NCT02681757|soft cast technique for burn wound heaing|soft cast technique for burn wound heaing
142448|NCT02681718|A1C≥9%|a1c≥9%
142449|NCT02681718|minorities|minorities
142450|NCT02681718|economically disadvantaged|economically disadvantaged
142451|NCT02681692|colonoscopy|colonoscopy
142452|NCT02681692|colonoscopy education|colonoscopy education
142453|NCT02681692|magnetic endoscope imaging|magnetic endoscope imaging
142454|NCT02681692|Colonic Diseases|colonic diseases
142455|NCT02681666|FODMAP Diet|fodmap diet
142456|NCT02681666|Bowel Habit|bowel habit
142457|NCT02681666|Rome IV Criteria|rome iv criteria
142458|NCT02681666|Mindfulness|mindfulness
142459|NCT02681666|Abdominal pain|abdominal pain
142460|NCT02681666|Irritable Bowel Syndrome|irritable bowel syndrome
142461|NCT02681653|Statins|statins
142462|NCT02681653|Septic Shock|septic shock
142463|NCT02681614|Imaging|imaging
142464|NCT02681614|Prostate|prostate
142465|NCT02681614|Multiparametric MRI|multiparametric mri
142466|NCT02681614|brachytherapy|brachytherapy
142467|NCT02681601|Diet, Food, and Nutrition|diet, food, and nutrition
142468|NCT02681588|diabetes, obesity, skinfold, newborn|diabetes, obesity, skinfold, newborn
142469|NCT02681562|olaparib|olaparib
142470|NCT02681510|medication tolerability|medication tolerability
142471|NCT02681497|canagliflozin|canagliflozin
142472|NCT02681497|diabetes|diabetes
142473|NCT02681497|SGLT2|sglt2
142474|NCT02681497|real-world data|real-world data
142475|NCT02681471|Monopolar|monopolar
142476|NCT02681471|Bipolar|bipolar
142477|NCT02681471|TURP syndrome|turp syndrome
142478|NCT02681471|hyponatremia|hyponatremia
142479|NCT02681432|HIPEC|hipec
142480|NCT02681432|ovarian cancer|ovarian cancer
142481|NCT02681432|peritoneal carcinomatosis|peritoneal carcinomatosis
142482|NCT02681393|Physical activity, brochures, telephone support, stroke|physical activity, brochures, telephone support, stroke
142483|NCT02681380|simulated patient|simulated patient
142484|NCT02681380|Balint|balint
142485|NCT02681380|empathy|empathy
142486|NCT02681380|medical student|medical student
142487|NCT02681367|Recurrent implantation failure|recurrent implantation failure
142488|NCT02681367|Freeze all policy|freeze all policy
142489|NCT02681367|endometrial receptivity|endometrial receptivity
142490|NCT02681367|implantation|implantation
142491|NCT02681367|clinical outcome|clinical outcome
142492|NCT02681354|elderly|elderly
142493|NCT02681289|infant|infant
142494|NCT02681289|risk|risk
142495|NCT02681289|rehabilitation|rehabilitation
142496|NCT02681276|Irrigation during root canal treatment|irrigation during root canal treatment
142497|NCT02681276|Sodium Hypochlorite|sodium hypochlorite
142498|NCT02681250|Zirconium|zirconium
142499|NCT02681250|Randomized Controlled Trial|randomized controlled trial
142500|NCT02681250|Dental Implants|dental implants
142501|NCT02681250|Dental Material|dental material
142502|NCT02681250|Titanium|titanium
142503|NCT02681211|migraine headache|migraine headache
142504|NCT02681211|acupuncture|acupuncture
142505|NCT02681198|Healthy|healthy
142506|NCT02681198|Lofexidine|lofexidine
142507|NCT02681198|Paroxetine|paroxetine
142508|NCT02681198|Volunteer|volunteer
142509|NCT02681172|CSF|csf
142510|NCT02681172|Alzheimer's Disease (AD) and related dementia|alzheimer's disease (ad) and related dementia
142511|NCT02681172|HAS recommendations|has recommendations
142512|NCT02681159|Anesthesia|anesthesia
142513|NCT02681146|education|education
142514|NCT02681146|physiotherapy|physiotherapy
142515|NCT02681133|Physical activity level|physical activity level
142516|NCT02681133|Knee osteoarthritis|knee osteoarthritis
142517|NCT02681133|Non pharmacological treatment|non pharmacological treatment
142518|NCT02681133|Survey|survey
142519|NCT02681133|Socio-demographic, clinical variables|socio-demographic, clinical variables
142520|NCT02681133|Barriers, facilitators Fears and beliefs|barriers, facilitators fears and beliefs
142521|NCT02681133|Function|function
142522|NCT02681120|Biomarkers|biomarkers
142523|NCT02681120|Breast imaging|breast imaging
142524|NCT02681107|Radiation therapy|radiation therapy
142525|NCT02681107|Accelerated partial breast irradiation (APBI)|accelerated partial breast irradiation (apbi)
142526|NCT02681107|Breast conserving surgery|breast conserving surgery
142527|NCT02681107|Stage 1|stage 1
142528|NCT02681094|Diabetes Mellitus Type 2,|diabetes mellitus type 2,
142529|NCT02681094|saxagliptin,|saxagliptin,
142530|NCT02681094|dapagliflozin,|dapagliflozin,
142531|NCT02681094|metformin|metformin
142532|NCT02681081|Neuroplasticity|neuroplasticity
142533|NCT02681068|Fecal microbiota transplantation (FMT)|fecal microbiota transplantation (fmt)
142534|NCT02681068|Clostridium difficile associated diarrhea (CDAD)|clostridium difficile associated diarrhea (cdad)
142535|NCT02681055|NASH|nash
142536|NCT02681055|NAFLD|nafld
142537|NCT02681029|Cleavage stage blastocyst transfer cryopreservation|cleavage stage blastocyst transfer cryopreservation
142538|NCT02681016|Calypso|calypso
142539|NCT02681016|Xience|xience
142540|NCT02681016|Coronary stenosis|coronary stenosis
142541|NCT02681016|Drug-eluting stent|drug-eluting stent
142542|NCT02681016|Coronary angioplasty with stenting|coronary angioplasty with stenting
142543|NCT02681016|Ischemic Heart Disease|ischemic heart disease
142544|NCT02680977|Mucuna pruriens|mucuna pruriens
142545|NCT02680977|Levodopa|levodopa
142546|NCT02680951|Pediatric|pediatric
142547|NCT02680951|Adolescent|adolescent
142548|NCT02680912|Bi syndrome|bi syndrome
142549|NCT02680899|science education|science education
142550|NCT02680899|health promotion|health promotion
142551|NCT02680899|mental health promotion|mental health promotion
142552|NCT02680899|stigmatization|stigmatization
142553|NCT02680899|behavioral intervention|behavioral intervention
142554|NCT02680886|Rapid Absorbable Suture Material|rapid absorbable suture material
142555|NCT02680886|Children / Adults|children / adults
142556|NCT02680886|Novosyn Quick|novosyn quick
142557|NCT02680873|type 2 diabetes , obesity , SASI|type 2 diabetes , obesity , sasi
142558|NCT02680847|Pediatric|pediatric
142559|NCT02680847|pain indication|pain indication
142560|NCT02680847|controlled release oxycodone|controlled release oxycodone
142561|NCT02680834|venous stasis ulcer|venous stasis ulcer
142562|NCT02680834|wound|wound
142563|NCT02680834|chronic venous insufficiency|chronic venous insufficiency
142564|NCT02680821|Laxity|laxity
142565|NCT02680821|Knee|knee
142566|NCT02680821|Rupture|rupture
142567|NCT02680821|ALL|all
142568|NCT02680795|UGT1A1*28|ugt1a1*28
142569|NCT02680795|Belinostat|belinostat
142570|NCT02680795|beleodaq|beleodaq
142571|NCT02680795|wild type genotypes|wild type genotypes
142572|NCT02680795|heterozygous genotypes|heterozygous genotypes
142573|NCT02680795|homozygous genotypes|homozygous genotypes
142574|NCT02680782|Healthy Volunteers|healthy volunteers
142575|NCT02680782|Comparison|comparison
142576|NCT02680782|Once-Daily|once-daily
142577|NCT02680782|Twice-Daily|twice-daily
142578|NCT02680782|X4P-001|x4p-001
142579|NCT02680756|Iron Deficiency|iron deficiency
142580|NCT02680756|Anaemia|anaemia
142581|NCT02680756|Crohn's Disease|crohn's disease
142582|NCT02680756|Deficiency Diseases|deficiency diseases
142583|NCT02680756|Inflammatory Bowel Diseases|inflammatory bowel diseases
142584|NCT02680756|Intestinal Diseases|intestinal diseases
142585|NCT02680730|Autonomic nervous system|autonomic nervous system
142586|NCT02680730|Auditory processing disorder|auditory processing disorder
142587|NCT02680730|Social behavior|social behavior
142588|NCT02680691|infratentorial stroke|infratentorial stroke
142589|NCT02680691|robot|robot
142590|NCT02680691|postural balance|postural balance
142591|NCT02680691|Rehabilitation|rehabilitation
142592|NCT02680652|CVID|cvid
142593|NCT02680652|Common Variable Immune Deficiency|common variable immune deficiency
142594|NCT02680639|High-Frequency Ventilation|high-frequency ventilation
142595|NCT02680639|Biphasic Continuous Positive Airway Pressure|biphasic continuous positive airway pressure
142596|NCT02680613|Behaviour Change|behaviour change
142597|NCT02680613|Secondary Prevention|secondary prevention
142598|NCT02680613|mHealth|mhealth
142599|NCT02680587|Prostate Cancer|prostate cancer
142600|NCT02680587|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
142601|NCT02680587|Stereotactic Ablative Radiotherapy|stereotactic ablative radiotherapy
142602|NCT02680587|Oligometastasis|oligometastasis
142603|NCT02680574|vadadustat|vadadustat
142604|NCT02680574|AKB-6548|akb-6548
142605|NCT02680574|Chronic kidney disease|chronic kidney disease
142606|NCT02680574|anemia|anemia
142607|NCT02680574|CKD|ckd
142608|NCT02680574|chronic renal insufficiency|chronic renal insufficiency
142609|NCT02680574|renal impairment|renal impairment
142610|NCT02680574|erythropoietin|erythropoietin
142611|NCT02680574|kidney|kidney
142612|NCT02680574|renal|renal
142613|NCT02680574|oral anemia treatment|oral anemia treatment
142614|NCT02680574|hemoglobin|hemoglobin
142615|NCT02680574|hypoxia-inducible factor|hypoxia-inducible factor
142616|NCT02680574|HIF|hif
142617|NCT02680574|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
142618|NCT02680574|HIF-PHI|hif-phi
142619|NCT02680574|efficacy|efficacy
142620|NCT02680574|safety|safety
142621|NCT02680574|Phase 3|phase 3
142622|NCT02680574|cardiovascular|cardiovascular
142623|NCT02680574|NDD-CKD|ndd-ckd
142624|NCT02680548|ankle pain|ankle pain
142625|NCT02680548|foot pain|foot pain
142626|NCT02680548|methylprednisolone|methylprednisolone
142627|NCT02680548|neuropathic pain|neuropathic pain
142628|NCT02680522|Parkinson's disease|parkinson's disease
142629|NCT02680522|Heart Rate Variability|heart rate variability
142630|NCT02680522|Physiotherapy|physiotherapy
142631|NCT02680496|Robot-Assistance|robot-assistance
142632|NCT02680496|Gait [MeSH]|gait [mesh]
142633|NCT02680496|Energy Consumption|energy consumption
142634|NCT02680496|Cardiorespiratory Load|cardiorespiratory load
142635|NCT02680496|Stroke [MeSH]|stroke [mesh]
142636|NCT02680483|Atrial fibrillation|atrial fibrillation
142637|NCT02680483|Registry|registry
142638|NCT02680483|Middle East|middle east
142639|NCT02680483|Jordan|jordan
142640|NCT02680483|risk factors|risk factors
142641|NCT02680483|in hospital management|in hospital management
142642|NCT02680483|long term management|long term management
142643|NCT02680470|Tuberculosis|tuberculosis
142644|NCT02680470|Management|management
142645|NCT02680470|Observed therapy|observed therapy
142646|NCT02680444|Mindfulness|mindfulness
142647|NCT02680444|Primary Promotion|primary promotion
142648|NCT02680444|Mental Health|mental health
142649|NCT02680444|Well-being|well-being
142650|NCT02680444|Positive Reappraisal|positive reappraisal
142651|NCT02680392|Pulsed and Continuous Radiofrequency Treatment|pulsed and continuous radiofrequency treatment
142652|NCT02680392|Continuous adductor canal block|continuous adductor canal block
142653|NCT02680392|Postoperative pain|postoperative pain
142654|NCT02680392|Functional recovery|functional recovery
142655|NCT02680392|Total Knee Joint Replacement|total knee joint replacement
142656|NCT02680379|Fragile X Syndrome|fragile x syndrome
142657|NCT02680379|Autism|autism
142658|NCT02680379|FMR1|fmr1
142659|NCT02680379|FRAXA|fraxa
142660|NCT02680340|Total Hip Arthroplasty THA|total hip arthroplasty tha
142661|NCT02680314|unripe cervix|unripe cervix
142662|NCT02680301|Wet Wraps|wet wraps
142663|NCT02680301|Topical Steroid|topical steroid
142664|NCT02680288|Psychostimulant, Craving, Cocaine.|psychostimulant, craving, cocaine.
142665|NCT02680275|Chronic endometritis|chronic endometritis
142666|NCT02680275|Miscarriage|miscarriage
142667|NCT02680275|Infertility|infertility
142668|NCT02680262|HPV self-sampling, cervical cancer screening|hpv self-sampling, cervical cancer screening
142669|NCT02680249|Safety, Bioavailability and Pharmacokinetics|safety, bioavailability and pharmacokinetics
142670|NCT02680236|Pain|pain
142671|NCT02680236|Cancer|cancer
142672|NCT02680236|Chemotherapy|chemotherapy
142673|NCT02680236|Anxiety|anxiety
142674|NCT02680236|Depression|depression
142675|NCT02680236|Isolation|isolation
142676|NCT02680197|COPD|copd
142677|NCT02680184|Malignant melanoma|malignant melanoma
142678|NCT02680171|Cognitive Rehabilitation|cognitive rehabilitation
142679|NCT02680171|Prism Adaptation|prism adaptation
142680|NCT02680171|Stroke|stroke
142681|NCT02680171|Spatial Neglect|spatial neglect
142682|NCT02680145|Pessary|pessary
142683|NCT02680145|Prolapse|prolapse
142684|NCT02680145|Cystocele|cystocele
142685|NCT02680106|Nanofibers|nanofibers
142686|NCT02680106|Dressing|dressing
142687|NCT02680106|Donor site|donor site
142688|NCT02680106|Polycaprolactone|polycaprolactone
142689|NCT02680067|Healthy Individual|healthy individual
142690|NCT02680067|Lymphatic Transport|lymphatic transport
142691|NCT02680067|Near InfraRed|near infrared
142692|NCT02680067|Imaging|imaging
142693|NCT02680067|Indocyanine Green|indocyanine green
142694|NCT02680067|ICG|icg
142695|NCT02680067|NIR|nir
142696|NCT02680067|NIR-ICG|nir-icg
142697|NCT02680067|MSImager|msimager
142698|NCT02680067|rheumatoid arthritis|rheumatoid arthritis
142699|NCT02680015|PEERS|peers
142700|NCT02680015|friendships|friendships
142701|NCT02680015|brain|brain
142702|NCT02679989|Insulin sensitivity|insulin sensitivity
142703|NCT02679989|Weight loss|weight loss
142704|NCT02679989|Intermittent fasting|intermittent fasting
142705|NCT02679989|Sympathetic nervous system|sympathetic nervous system
142706|NCT02679950|Next generation genome sequencing|next generation genome sequencing
142707|NCT02679950|Late relapse|late relapse
142708|NCT02679950|Genetic profiles|genetic profiles
142709|NCT02679937|U.S. Military|u.s. military
142710|NCT02679937|Overweight|overweight
142711|NCT02679937|Obesity|obesity
142712|NCT02679937|Service Members|service members
142713|NCT02679937|Prevention|prevention
142714|NCT02679911|Onychomycosis|onychomycosis
142715|NCT02679898|Arterial function|arterial function
142716|NCT02679898|Whole-body vibration training|whole-body vibration training
142717|NCT02679898|Aortic blood pressures|aortic blood pressures
142718|NCT02679898|Wave reflection|wave reflection
142719|NCT02679898|Muscle strength|muscle strength
142720|NCT02679898|Endothelial function|endothelial function
142721|NCT02679898|Blood flow|blood flow
142722|NCT02679872|Non-technical skills|non-technical skills
142723|NCT02679872|Patient safety|patient safety
142724|NCT02679872|Video-assisted thoracoscopic surgery|video-assisted thoracoscopic surgery
142725|NCT02679872|Operating theatre team|operating theatre team
142726|NCT02679872|Operating room|operating room
142727|NCT02679859|Natriuretic Peptide, Brain|natriuretic peptide, brain
142728|NCT02679859|Surgery|surgery
142729|NCT02679846|withdrawal of antiepileptic drugs|withdrawal of antiepileptic drugs
142730|NCT02679846|monitoring VEEG|monitoring veeg
142731|NCT02679846|safety|safety
142732|NCT02679846|adverse event|adverse event
142733|NCT02679846|standardized protocol|standardized protocol
142734|NCT02679833|Cobalamin biomarkers|cobalamin biomarkers
142735|NCT02679833|Anemia|anemia
142736|NCT02679833|Vegan diet|vegan diet
142737|NCT02679833|Subclinical|subclinical
142738|NCT02679833|Metabolic functional markers|metabolic functional markers
142739|NCT02679833|Holotranscobalamin|holotranscobalamin
142740|NCT02679833|Methylmalonic acid|methylmalonic acid
142741|NCT02679755|Hormone receptor positive advanced breast cancer|hormone receptor positive advanced breast cancer
142742|NCT02679742|beta hydroxy beta methylbutyrate|beta hydroxy beta methylbutyrate
142743|NCT02679742|older people|older people
142744|NCT02679742|muscle mass|muscle mass
142745|NCT02679742|muscle strength|muscle strength
142746|NCT02679742|post-acute|post-acute
142747|NCT02679729|inhaled dose|inhaled dose
142748|NCT02679729|intravenous dose|intravenous dose
142749|NCT02679729|healthy subjects|healthy subjects
142750|NCT02679729|safety|safety
142751|NCT02679729|tolerability|tolerability
142752|NCT02679729|pharmacokinetics|pharmacokinetics
142753|NCT02679729|AZD5634|azd5634
142754|NCT02679729|jet nebulizer|jet nebulizer
142755|NCT02679677|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
142756|NCT02679677|Randomized controlled trial|randomized controlled trial
142757|NCT02679677|Physical activity|physical activity
142758|NCT02679638|breast cancer|breast cancer
142759|NCT02679638|treatment choice|treatment choice
142760|NCT02679638|factor|factor
142761|NCT02679638|perception|perception
142762|NCT02679573|Pneumonia|pneumonia
142763|NCT02679560|femur fracture, hip fracture, exparel, liposomal bupivacaine|femur fracture, hip fracture, exparel, liposomal bupivacaine
142764|NCT02679547|Appendix|appendix
142765|NCT02679547|Breastfeeding|breastfeeding
142766|NCT02679547|Adult|adult
142767|NCT02679534|pain|pain
142768|NCT02679534|thoracic surgery|thoracic surgery
142769|NCT02679534|massage|massage
142770|NCT02679521|Extracorporeal Shock Wave Therapy|extracorporeal shock wave therapy
142771|NCT02679521|Painful Heel|painful heel
142772|NCT02679521|Plantar fasciitis|plantar fasciitis
142773|NCT02679508|Esophagitis|esophagitis
142774|NCT02679495|early gastric cancer|early gastric cancer
142775|NCT02679495|lifestyle|lifestyle
142776|NCT02679482|Primary Open Angle Glaucoma|primary open angle glaucoma
142777|NCT02679482|Selective Laser Trabeculoplasty|selective laser trabeculoplasty
142778|NCT02679482|Pattern Scan Laser Trabeculoplasty|pattern scan laser trabeculoplasty
142779|NCT02679443|Lung Adenocarcinoma|lung adenocarcinoma
142780|NCT02679443|Non-squamous NSCLC|non-squamous nsclc
142781|NCT02679443|Chemotherapy|chemotherapy
142782|NCT02679443|Pemetrexed|pemetrexed
142783|NCT02679443|Vitamin B12|vitamin b12
142784|NCT02679443|Folate|folate
142785|NCT02679443|Supplementation|supplementation
142786|NCT02679443|Cytopenia|cytopenia
142787|NCT02679417|Aminotransferase|aminotransferase
142788|NCT02679417|Fibrosis, liver|fibrosis, liver
142789|NCT02679417|Anthropometry|anthropometry
142790|NCT02679417|Exercise|exercise
142791|NCT02679404|Biological aortic valves|biological aortic valves
142792|NCT02679404|Mechanical aortic valves|mechanical aortic valves
142793|NCT02679404|Aortic conduits|aortic conduits
142794|NCT02679404|Sutureless Aortic Valve|sutureless aortic valve
142795|NCT02679391|Abdominoplasty|abdominoplasty
142796|NCT02679391|Early complications|early complications
142797|NCT02679391|Guidelines|guidelines
142798|NCT02679391|Sequelae|sequelae
142799|NCT02679391|bariatric patients|bariatric patients
142800|NCT02679326|Therapeutic ultrasound, Treatment, Plantar fasciitis|therapeutic ultrasound, treatment, plantar fasciitis
142801|NCT02679300|Chronic Low Back Pain|chronic low back pain
142802|NCT02679300|Virtual Reality|virtual reality
142803|NCT02679300|Serious Gaming|serious gaming
142804|NCT02679300|Exercise Therapy|exercise therapy
142805|NCT02679300|Distraction|distraction
142806|NCT02679287|Closed-Loop Control (CLC)|closed-loop control (clc)
142807|NCT02679287|Sensor-Augmented Therapy (SAP)|sensor-augmented therapy (sap)
142808|NCT02679287|USS Virginia|uss virginia
142809|NCT02679287|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
142810|NCT02679287|Insulin Pump|insulin pump
142811|NCT02679287|Artificial Pancreas (AP)|artificial pancreas (ap)
142812|NCT02679274|Aging, Frailty, Hypogonadism|aging, frailty, hypogonadism
142813|NCT02679261|Aortic dilation|aortic dilation
142814|NCT02679261|Statins|statins
142815|NCT02679261|Aortic degeneration|aortic degeneration
142816|NCT02679248|Pre-hypertension|pre-hypertension
142817|NCT02679248|Mild hypertension|mild hypertension
142818|NCT02679248|Dietary supplement|dietary supplement
142819|NCT02679248|Efficacy|efficacy
142820|NCT02679248|Nitric oxide|nitric oxide
142821|NCT02679248|Neo40 Daily|neo40 daily
142822|NCT02679170|ALK+|alk+
142823|NCT02679157|Posttraumatic stress disorder|posttraumatic stress disorder
142824|NCT02679157|Depression|depression
142825|NCT02679157|Anxiety|anxiety
142826|NCT02679157|ADL|adl
142827|NCT02679157|Health-related quality of life|health-related quality of life
142828|NCT02679157|ICU survivorship|icu survivorship
142829|NCT02679131|relapsed/refractory solid tumors|relapsed/refractory solid tumors
142830|NCT02679131|beleodaq|beleodaq
142831|NCT02679131|renal impairment|renal impairment
142832|NCT02679131|belinostat|belinostat
142833|NCT02679131|hematological malignancies|hematological malignancies
142834|NCT02679118|intestinal perforation|intestinal perforation
142835|NCT02679118|bariatric surgery|bariatric surgery
142836|NCT02679118|gastric bypass|gastric bypass
142837|NCT02679118|gastric perforation|gastric perforation
142838|NCT02679118|colonic perforation|colonic perforation
142839|NCT02679092|Induced Abortion|induced abortion
142840|NCT02679092|Mifepristone|mifepristone
142841|NCT02679092|Dilation and Evacuation|dilation and evacuation
142842|NCT02679092|Cervical Preparation|cervical preparation
142843|NCT02679092|Osmotic Dilators|osmotic dilators
142844|NCT02679092|Misoprostol|misoprostol
142845|NCT02678962|Multifocal Intraocular Lenses|multifocal intraocular lenses
142846|NCT02678962|bilateral implantation|bilateral implantation
142847|NCT02678897|Abortion, Drug-Induced|abortion, drug-induced
142848|NCT02678897|Pain Management|pain management
142849|NCT02678884|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
142850|NCT02678884|Radiation therapy|radiation therapy
142851|NCT02678884|Head and Neck Cancers|head and neck cancers
142852|NCT02678871|Aortic Valve Stenosis|aortic valve stenosis
142853|NCT02678871|Left atrial appendage|left atrial appendage
142854|NCT02678858|social cognition|social cognition
142855|NCT02678858|social skills|social skills
142856|NCT02678858|cognitive remediation|cognitive remediation
142857|NCT02678858|functional outcome|functional outcome
142858|NCT02678858|treatment adherence|treatment adherence
142859|NCT02678767|HIV|hiv
142860|NCT02678767|Dementia|dementia
142861|NCT02678767|Neuroimaging|neuroimaging
142862|NCT02678702|Sleep|sleep
142863|NCT02678702|Depression|depression
142864|NCT02678702|Comorbid Insomnia|comorbid insomnia
142865|NCT02678702|Cognitive Behavioral Therapy|cognitive behavioral therapy
142866|NCT02678702|Sleep Restriction|sleep restriction
142867|NCT02678702|Stimulus Control therapy|stimulus control therapy
142868|NCT02678702|Relaxation|relaxation
142869|NCT02678676|Drug Therapy|drug therapy
142870|NCT02678663|Colon polyp|colon polyp
142871|NCT02678663|Polypectomy|polypectomy
142872|NCT02678663|Cold snare|cold snare
142873|NCT02678663|Endoscopic mucosal resection|endoscopic mucosal resection
142874|NCT02678650|Volatile Anesthetics|volatile anesthetics
142875|NCT02678650|MicroRNA|microrna
142876|NCT02678650|Off-pump Coronary Artery Bypass Surgery|off-pump coronary artery bypass surgery
142877|NCT02678650|Internal Mammary Artery|internal mammary artery
142878|NCT02678650|Ascending Aorta|ascending aorta
142879|NCT02678637|MRI|mri
142880|NCT02678637|CCSA|ccsa
142881|NCT02678637|Contractile Cross Sectional Area|contractile cross sectional area
142882|NCT02678637|Strength|strength
142883|NCT02678637|Calf muscle|calf muscle
142884|NCT02678611|Healthy participants|healthy participants
142885|NCT02678611|Dietary supplement|dietary supplement
142886|NCT02678611|Safety|safety
142887|NCT02678611|Tolerability|tolerability
142888|NCT02678611|Older Adults|older adults
142889|NCT02678611|Basis|basis
142890|NCT02678611|Nicotinamide riboside|nicotinamide riboside
142891|NCT02678611|Pterostilbene|pterostilbene
142892|NCT02678598|Micafungin|micafungin
142893|NCT02678598|Candida|candida
142894|NCT02678598|Aspergillosis|aspergillosis
142895|NCT02678598|Antifungal|antifungal
142896|NCT02678572|uveal liver PHP hepatic perfusion chemosaturation Delcath|uveal liver php hepatic perfusion chemosaturation delcath
142897|NCT02678559|Alveolar recruitment manoeuvre|alveolar recruitment manoeuvre
142898|NCT02678559|Lung recruitment|lung recruitment
142899|NCT02678559|Preload dependency|preload dependency
142900|NCT02678559|Cardiac surgery|cardiac surgery
142901|NCT02678559|Transoesophageal echocardiography|transoesophageal echocardiography
142902|NCT02678546|Traditional Chinese Medicine|traditional chinese medicine
142903|NCT02678533|Fanconi Anemia|fanconi anemia
142904|NCT02678533|CD34+ cells mobilization|cd34+ cells mobilization
142905|NCT02678533|G-CSF|g-csf
142906|NCT02678533|Plerixafor|plerixafor
142907|NCT02678533|gene therapy|gene therapy
142908|NCT02678520|Prostate Cancer|prostate cancer
142909|NCT02678520|Post Operative|post operative
142910|NCT02678520|Radiation|radiation
142911|NCT02678520|Prostatectomy|prostatectomy
142912|NCT02678520|3-D CRT|3-d crt
142913|NCT02678520|IMRT|imrt
142915|NCT02678520|CRT|crt
142916|NCT02678520|Conformal Radiation Therapy|conformal radiation therapy
142917|NCT02678520|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
142918|NCT02678520|Hormone|hormone
142919|NCT02678520|Surgery|surgery
142920|NCT02678520|Hormonal Therapy|hormonal therapy
142921|NCT02678494|Spinal Cord Injury|spinal cord injury
142922|NCT02678481|multiparametric magnetic resonance imaging|multiparametric magnetic resonance imaging
142923|NCT02678481|MR-targeted prostate biopsy|mr-targeted prostate biopsy
142924|NCT02678481|saturation TRUS-guided prostate biopsy|saturation trus-guided prostate biopsy
142925|NCT02678455|Dengue Virus|dengue virus
142926|NCT02678416|comparison|comparison
142927|NCT02678403|peripheral artery disease|peripheral artery disease
142928|NCT02678403|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
142929|NCT02678403|walking ability|walking ability
142930|NCT02678403|endothelial function|endothelial function
142931|NCT02678364|Vitamin D-biofortified eggs|vitamin d-biofortified eggs
142932|NCT02678364|Vitamin D status|vitamin d status
142933|NCT02678364|RCT|rct
142934|NCT02678312|Pediatric Heart failure,|pediatric heart failure,
142935|NCT02678312|systemic left ventricle,|systemic left ventricle,
142936|NCT02678312|reduced ejection fraction|reduced ejection fraction
142937|NCT02678286|Abdominoplasty|abdominoplasty
142938|NCT02678286|Pain|pain
142939|NCT02678286|Analgesia|analgesia
142940|NCT02678286|N1539|n1539
142941|NCT02678286|Phase 3|phase 3
142942|NCT02678273|population|population
142943|NCT02678273|Singapore|singapore
142944|NCT02678260|Advanced malignancies|advanced malignancies
142945|NCT02678260|PDR001|pdr001
142946|NCT02678260|Japanese patients|japanese patients
142947|NCT02678260|adults|adults
142948|NCT02678247|prosthesis|prosthesis
142949|NCT02678247|prosthetic socket|prosthetic socket
142950|NCT02678247|transfemoral amputation|transfemoral amputation
142951|NCT02678247|socket comfort|socket comfort
142952|NCT02678247|gait biomechanics|gait biomechanics
142953|NCT02678156|Dura mater substitute|dura mater substitute
142954|NCT02678156|Graft|graft
142955|NCT02678156|Lyoplant|lyoplant
142956|NCT02678156|Lyostypt|lyostypt
142957|NCT02678156|Lyoplant onlay|lyoplant onlay
142958|NCT02678156|Xenograft|xenograft
142959|NCT02678130|Intervertebral disc degeneration|intervertebral disc degeneration
142960|NCT02678130|Bone Disease|bone disease
142961|NCT02678130|Musculoskeletal disease|musculoskeletal disease
142962|NCT02678130|Spinal disease|spinal disease
142963|NCT02678104|Dry Socket|dry socket
142964|NCT02678104|Honey|honey
142965|NCT02678104|Tooth Extraction|tooth extraction
142966|NCT02678078|cancer|cancer
142967|NCT02678078|diagnosis|diagnosis
142968|NCT02678078|biopsy|biopsy
142969|NCT02678078|chemotherapy drugs|chemotherapy drugs
142970|NCT02678078|tumor|tumor
142971|NCT02678052|Drug therapy|drug therapy
142972|NCT02677961|sarcoma|sarcoma
142973|NCT02677961|registry|registry
142974|NCT02677922|Acute Myeloid Leukemia|acute myeloid leukemia
142975|NCT02677922|Leukemia|leukemia
142976|NCT02677922|Azacitidine|azacitidine
142977|NCT02677922|AG-120|ag-120
142978|NCT02677922|AG-221|ag-221
142979|NCT02677909|Parenteral Nutrition|parenteral nutrition
142980|NCT02677909|Critical Care|critical care
142981|NCT02677896|Androgen Deprivation Therapy (ADT)|androgen deprivation therapy (adt)
142982|NCT02677896|Metastatic hormone sensitive prostate cancer|metastatic hormone sensitive prostate cancer
142983|NCT02677896|Xtandi|xtandi
142984|NCT02677896|Enzalutamide|enzalutamide
142985|NCT02677870|Saproterin dihydrochloride|saproterin dihydrochloride
142986|NCT02677870|Kuvan|kuvan
142987|NCT02677870|Amish|amish
142988|NCT02677831|Physical functioning|physical functioning
142989|NCT02677831|Neuropsychiatric Disorders|neuropsychiatric disorders
142990|NCT02677831|Frailty|frailty
142991|NCT02677818|Plasma Factor VIII Levels|plasma factor viii levels
142992|NCT02677818|Ischemic stroke|ischemic stroke
142993|NCT02677818|Antithrombotic therapy|antithrombotic therapy
142994|NCT02677818|Bleeding|bleeding
142995|NCT02677766|Occupational Therapy|occupational therapy
142996|NCT02677766|Complex patients|complex patients
142997|NCT02677766|Randomized controlled trial|randomized controlled trial
142998|NCT02677766|Occupational performance problem|occupational performance problem
142999|NCT02677766|Rehabilitation Complexity Scale|rehabilitation complexity scale
143000|NCT02677740|MRI|mri
143001|NCT02677740|MRS|mrs
143002|NCT02677740|rTMS|rtms
143003|NCT02677727|Cisplatin-based chemotherapy|cisplatin-based chemotherapy
143004|NCT02677727|Chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
143005|NCT02677688|systemic lupus erythematosus|systemic lupus erythematosus
143006|NCT02677688|autologous anti-EBV CTL|autologous anti-ebv ctl
143007|NCT02677688|adoptive therapy|adoptive therapy
143008|NCT02677688|phase 1 -2|phase 1 -2
143009|NCT02677662|Diesel exhaust|diesel exhaust
143010|NCT02677662|Oxidative stress|oxidative stress
143011|NCT02677662|Systemic inflammation|systemic inflammation
143012|NCT02677662|Air pollution|air pollution
143013|NCT02677649|cranberry, microbiome, polyphenols, healthy|cranberry, microbiome, polyphenols, healthy
143014|NCT02677636|Dermatitis, Atopic|dermatitis, atopic
143015|NCT02677636|Eczema|eczema
143016|NCT02677636|Dermatitis|dermatitis
143017|NCT02677636|Pruritus|pruritus
143018|NCT02677636|Genetic Diseases, Inborn|genetic diseases, inborn
143019|NCT02677636|Hypersensitivity|hypersensitivity
143020|NCT02677636|Hypersensitivity, Immediate|hypersensitivity, immediate
143021|NCT02677636|Immune System Diseases|immune system diseases
143022|NCT02677636|Skin Diseases, Eczematous|skin diseases, eczematous
143023|NCT02677636|Skin Diseases, Genetic|skin diseases, genetic
143024|NCT02677636|Skin Diseases|skin diseases
143025|NCT02677636|Itching|itching
143026|NCT02677636|Rash|rash
143027|NCT02677636|Steroid|steroid
143028|NCT02677610|Dermatitis, Atopic|dermatitis, atopic
143029|NCT02677610|Eczema|eczema
143030|NCT02677610|Dermatitis|dermatitis
143031|NCT02677610|Pruritus|pruritus
143032|NCT02677610|Genetic Diseases, Inborn|genetic diseases, inborn
143033|NCT02677610|Hypersensitivity|hypersensitivity
143034|NCT02677610|Hypersensitivity, Immediate|hypersensitivity, immediate
143035|NCT02677610|Immune System Diseases|immune system diseases
143036|NCT02677610|Skin Diseases, Eczematous|skin diseases, eczematous
143037|NCT02677610|Skin Diseases, Genetic|skin diseases, genetic
143038|NCT02677610|Skin Diseases|skin diseases
143039|NCT02677610|Itching|itching
143040|NCT02677610|Rash|rash
143041|NCT02677610|Steroid|steroid
143042|NCT02677584|caffeine|caffeine
143043|NCT02677584|apnea|apnea
143044|NCT02677584|preterm infant|preterm infant
143045|NCT02677558|Pregnancy|pregnancy
143046|NCT02677558|Obesity|obesity
143047|NCT02677558|Echocardiography|echocardiography
143048|NCT02677519|ADHD|adhd
143049|NCT02677519|children|children
143050|NCT02677519|methylphenidate|methylphenidate
143051|NCT02677506|elbow|elbow
143052|NCT02677480|Microflora|microflora
143053|NCT02677480|Probiotics|probiotics
143054|NCT02677480|Hyposalivation|hyposalivation
143055|NCT02677480|Lactobacilli|lactobacilli
143056|NCT02677480|Mutans streptococci|mutans streptococci
143057|NCT02677480|pH-rising components|ph-rising components
143058|NCT02677454|Blood Glucose|blood glucose
143059|NCT02677454|Blood Glucose Self-Monitoring|blood glucose self-monitoring
143060|NCT02677428|Veterans|veterans
143061|NCT02677428|world wide web|world wide web
143062|NCT02677428|Counseling|counseling
143063|NCT02677428|Workman's Compensation|workman's compensation
143064|NCT02677415|Ischemic Stroke|ischemic stroke
143065|NCT02677415|Anesthesia|anesthesia
143066|NCT02677415|Endovascular Procedures|endovascular procedures
143067|NCT02677402|femoral vein|femoral vein
143068|NCT02677402|saphenous vein|saphenous vein
143069|NCT02677402|hydrostatic pressure|hydrostatic pressure
143070|NCT02677402|temperature|temperature
143071|NCT02677402|recovery|recovery
143072|NCT02677363|Elderly|elderly
143073|NCT02677363|Older|older
143074|NCT02677363|Adults|adults
143075|NCT02677363|Resistant Exercise|resistant exercise
143076|NCT02677363|Strength Training|strength training
143077|NCT02677363|Cognitive function|cognitive function
143078|NCT02677324|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
143079|NCT02677324|WM|wm
143080|NCT02677272|Nursing home|nursing home
143081|NCT02677272|emergency department|emergency department
143082|NCT02677272|inappropriate transfer|inappropriate transfer
143083|NCT02677272|elderly|elderly
143084|NCT02677259|luteal phase|luteal phase
143085|NCT02677259|estradiol|estradiol
143086|NCT02677259|pregnancy rate|pregnancy rate
143087|NCT02677246|Bone marrow transplantation|bone marrow transplantation
143088|NCT02677246|Children|children
143089|NCT02677246|Bone complications|bone complications
143090|NCT02677246|Denosumab.|denosumab.
143091|NCT02677181|ATG|atg
143092|NCT02677181|Matched sibling donor|matched sibling donor
143093|NCT02677181|peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
143094|NCT02677168|obstructive sleep apnea|obstructive sleep apnea
143095|NCT02677168|sleep apnea|sleep apnea
143096|NCT02677168|OSA|osa
143097|NCT02677168|cNEP|cnep
143098|NCT02677168|continuous negative external pressure|continuous negative external pressure
143099|NCT02677155|Follicular lymphoma|follicular lymphoma
143100|NCT02677155|Intranodal therapy|intranodal therapy
143101|NCT02677155|Autologous dendritic cells|autologous dendritic cells
143102|NCT02677155|Rituximab|rituximab
143103|NCT02677155|Immunotherapy|immunotherapy
143104|NCT02677155|Cancer vaccine|cancer vaccine
143105|NCT02677155|Anti-PD1|anti-pd1
143106|NCT02677155|Pembrolizumab|pembrolizumab
143107|NCT02677155|Radiotherapy|radiotherapy
143108|NCT02677142|pediatric|pediatric
143109|NCT02677142|Childhood Brain Tumour Survivors|childhood brain tumour survivors
143110|NCT02677142|Social Skills Rating System|social skills rating system
143111|NCT02677142|social skills intervention program (SSIP)|social skills intervention program (ssip)
143112|NCT02677103|Radial shock wave therapy,calcific tendinitis, ultrasound guidance|radial shock wave therapy,calcific tendinitis, ultrasound guidance
143113|NCT02677090|Fiber tolerability|fiber tolerability
143114|NCT02677090|Children|children
143115|NCT02677077|RRMS|rrms
143116|NCT02677077|MRI|mri
143117|NCT02677064|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
143118|NCT02677064|Identify Barriers|identify barriers
143119|NCT02677064|16-024|16-024
143120|NCT02677038|Pancreatic Cancer|pancreatic cancer
143121|NCT02677038|Stage IV pancreatic ductal adenocarcinoma (PDAC) with BRCAness|stage iv pancreatic ductal adenocarcinoma (pdac) with brcaness
143122|NCT02677038|PDAC|pdac
143123|NCT02677038|Metastatic adenocarcinoma of the pancreas|metastatic adenocarcinoma of the pancreas
143124|NCT02677038|Family history of breast cancer|family history of breast cancer
143125|NCT02677038|Family history of ovarian cancer|family history of ovarian cancer
143126|NCT02677038|Family history of pancreatic cancer|family history of pancreatic cancer
143127|NCT02677038|Family history of gastric cancer|family history of gastric cancer
143128|NCT02677038|Family history of prostate cancer|family history of prostate cancer
143129|NCT02677038|Olaparib|olaparib
143130|NCT02677038|Lynparza|lynparza
143131|NCT02677025|HIV|hiv
143132|NCT02677025|Sexual Risk|sexual risk
143133|NCT02677025|Sexually Transmitted Diseases|sexually transmitted diseases
143134|NCT02677025|Substance Abuse|substance abuse
143135|NCT02677025|Violence and Victimization|violence and victimization
143136|NCT02677012|Autologous fat grafting|autologous fat grafting
143137|NCT02677012|AFG|afg
143138|NCT02677012|Reconstructive surgery|reconstructive surgery
143139|NCT02677012|Fatty tissue processing|fatty tissue processing
143140|NCT02676986|Primary Breast Cancer|primary breast cancer
143141|NCT02676986|ER|er
143142|NCT02676986|AR|ar
143143|NCT02676986|TNBC|tnbc
143144|NCT02676973|pelvic organ prolapse|pelvic organ prolapse
143145|NCT02676973|POP|pop
143146|NCT02676973|vault prolapse|vault prolapse
143147|NCT02676973|cystocele|cystocele
143148|NCT02676973|vaginal prolapse|vaginal prolapse
143149|NCT02676973|post-hysterectomy vaginal prolapse|post-hysterectomy vaginal prolapse
143150|NCT02676921|sinus membrane|sinus membrane
143151|NCT02676921|osteogenic|osteogenic
143152|NCT02676908|endovenous ablation|endovenous ablation
143153|NCT02676908|laser|laser
143154|NCT02676908|radiofrequency|radiofrequency
143155|NCT02676908|stockings|stockings
143156|NCT02676882|Depressive Disorder|depressive disorder
143157|NCT02676882|Depression|depression
143158|NCT02676882|Antidepressants|antidepressants
143159|NCT02676882|Pregnancy|pregnancy
143160|NCT02676882|Folate|folate
143161|NCT02676882|Dietary Supplements|dietary supplements
143162|NCT02676882|Omega-3 Fatty Acids|omega-3 fatty acids
143163|NCT02676882|Women's Health|women's health
143164|NCT02676882|Vitamins|vitamins
143165|NCT02676856|acute myeloid leukemia|acute myeloid leukemia
143166|NCT02676856|hematopoietic stem cell microtransplantation|hematopoietic stem cell microtransplantation
143167|NCT02676817|colitis|colitis
143168|NCT02676817|endoscopy|endoscopy
143169|NCT02676804|Exercise|exercise
143170|NCT02676778|Peripheral T-cell lymphoma|peripheral t-cell lymphoma
143171|NCT02676778|Cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
143172|NCT02676778|E7777|e7777
143173|NCT02676778|Phase 2|phase 2
143174|NCT02676765|Allergic rhinitis|allergic rhinitis
143175|NCT02676765|Immunotherapy, Allergen|immunotherapy, allergen
143176|NCT02676765|Sublingual Immunotherapy|sublingual immunotherapy
143177|NCT02676752|head and neck cancer|head and neck cancer
143178|NCT02676752|lymphedema and fibrosis|lymphedema and fibrosis
143179|NCT02676726|extraperitoneal|extraperitoneal
143180|NCT02676726|transperitoneal|transperitoneal
143479|NCT02674815|Colorectal|colorectal
143181|NCT02676726|laparoscopic aortic lymphadenectomy|laparoscopic aortic lymphadenectomy
143182|NCT02676726|endometrial cancer|endometrial cancer
143183|NCT02676726|ovarian cancer|ovarian cancer
143184|NCT02676726|surgical staging|surgical staging
143185|NCT02676713|Traditional Chinese Medicine|traditional chinese medicine
143186|NCT02676713|Chinese Herbal|chinese herbal
143187|NCT02676700|Urinary stress incontinence|urinary stress incontinence
143188|NCT02676700|pelvic floor muscle|pelvic floor muscle
143189|NCT02676700|Kaatsu training|kaatsu training
143190|NCT02676687|surgery, noneloquent area|surgery, noneloquent area
143191|NCT02676661|peri-implant disease|peri-implant disease
143192|NCT02676661|risk factors|risk factors
143193|NCT02676661|prevalence|prevalence
143194|NCT02676622|Crohn's Disease|crohn's disease
143195|NCT02676622|Autologous Hematopoietic Stem cell Transplant|autologous hematopoietic stem cell transplant
143196|NCT02676622|Cyclophosphamide|cyclophosphamide
143197|NCT02676622|IL-2|il-2
143198|NCT02676622|Aldesleukin|aldesleukin
143199|NCT02676622|Proleukin|proleukin
143200|NCT02676622|PCDAI|pcdai
143201|NCT02676609|Type 1 diabetes|type 1 diabetes
143202|NCT02676609|Smart phone application|smart phone application
143203|NCT02676609|carbohydrate counting|carbohydrate counting
143204|NCT02676609|meal insulin dose|meal insulin dose
143205|NCT02676583|pain|pain
143206|NCT02676583|tonsillectomy|tonsillectomy
143207|NCT02676583|tonsillar fossa|tonsillar fossa
143208|NCT02676583|suture|suture
143209|NCT02676583|tonsil fossa closure|tonsil fossa closure
143210|NCT02676544|Prostate Artery Embolization (PAE)|prostate artery embolization (pae)
143211|NCT02676544|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
143212|NCT02676544|Lower Urinary Tract Symptoms (LUTS)|lower urinary tract symptoms (luts)
143213|NCT02676544|PAE|pae
143214|NCT02676544|BPH|bph
143215|NCT02676544|LUTS|luts
143216|NCT02676544|Prostate Artery Embolization|prostate artery embolization
143217|NCT02676544|Embospheres|embospheres
143218|NCT02676531|Walking Meditation|walking meditation
143219|NCT02676531|Vascular Function|vascular function
143220|NCT02676531|Flow-mediated dilatation|flow-mediated dilatation
143221|NCT02676531|Breast Cancer Patients|breast cancer patients
143222|NCT02676531|Anthracyclines Chemotherapy|anthracyclines chemotherapy
143223|NCT02676518|polycystic ovary syndrome|polycystic ovary syndrome
143224|NCT02676518|Serum anti-Mullerian hormone|serum anti-mullerian hormone
143225|NCT02676518|glucose intolerance|glucose intolerance
143226|NCT02676518|metabolic syndrome|metabolic syndrome
143227|NCT02676466|Mobility|mobility
143228|NCT02676440|Oral Health|oral health
143229|NCT02676401|Diabetic Nephropathy|diabetic nephropathy
143230|NCT02676388|Slow Transit Constipation|slow transit constipation
143231|NCT02676388|Freeze-dried, Capsulized FMT|freeze-dried, capsulized fmt
143232|NCT02676388|Fresh FMT|fresh fmt
143233|NCT02676349|mFolfirinox|mfolfirinox
143234|NCT02676349|Chemoradiotherapy|chemoradiotherapy
143235|NCT02676349|Neoadjuvant treatment|neoadjuvant treatment
143236|NCT02676349|Borderline|borderline
143237|NCT02676336|FBC|fbc
143238|NCT02676336|cyclic mastalgia|cyclic mastalgia
143239|NCT02676336|breast discomfort|breast discomfort
143240|NCT02676323|Maximum tolerated dose|maximum tolerated dose
143241|NCT02676323|Childhood leukemia|childhood leukemia
143242|NCT02676323|Hematological malignancies|hematological malignancies
143243|NCT02676297|inhalation|inhalation
143244|NCT02676297|anticholinergic|anticholinergic
143245|NCT02676258|silicone hydrogel daily disposable soft contact lens|silicone hydrogel daily disposable soft contact lens
143246|NCT02676245|Prenatal Education|prenatal education
143247|NCT02676245|Residual Specimens|residual specimens
143248|NCT02676232|Online Intervention|online intervention
143249|NCT02676232|Recurrent Abdominal Pain|recurrent abdominal pain
143250|NCT02676232|Children|children
143251|NCT02676193|Tobacco Smoking|tobacco smoking
143252|NCT02676193|Cigarettes|cigarettes
143253|NCT02676193|Packaging|packaging
143254|NCT02676193|Text messaging|text messaging
143255|NCT02676193|Graphic Images|graphic images
143256|NCT02676193|Sensor-Based Assessments|sensor-based assessments
143257|NCT02676167|HIV prevention|hiv prevention
143258|NCT02676167|men who have sex with men|men who have sex with men
143259|NCT02676167|pre-exposure prophylaxis|pre-exposure prophylaxis
143260|NCT02676167|PrEP|prep
143261|NCT02676167|Greece|greece
143262|NCT02676167|people who inject drugs|people who inject drugs
143263|NCT02676154|Episodic Hypertension|episodic hypertension
143264|NCT02676154|Spinal Cord Injury|spinal cord injury
143265|NCT02676154|Traumatic Spinal Cord Injury|traumatic spinal cord injury
143266|NCT02676154|Blood Pressure|blood pressure
143267|NCT02676154|Fesoterodine|fesoterodine
143268|NCT02676154|Neurogenic Detrusor Overactivity|neurogenic detrusor overactivity
143269|NCT02676154|Autonomic Dysreflexia|autonomic dysreflexia
143270|NCT02676154|Urodynamic Studies|urodynamic studies
143271|NCT02676154|24 Hour Ambulatory Blood Pressure Monitoring|24 hour ambulatory blood pressure monitoring
143272|NCT02676154|Cerebral Blood Flow|cerebral blood flow
143274|NCT02676128|Medication Adherence|medication adherence
143275|NCT02676128|Mobile Health|mobile health
143276|NCT02676115|Cosmetic Wound Healing|cosmetic wound healing
143277|NCT02676115|anterior cruciate ligament (ACL)|anterior cruciate ligament (acl)
143278|NCT02676102|barber shops|barber shops
143279|NCT02676102|organ transplant|organ transplant
143280|NCT02676102|transplants|transplants
143281|NCT02676102|organ donor registration|organ donor registration
143282|NCT02676089|Asthma, Anticholinergics, Triple combination|asthma, anticholinergics, triple combination
143283|NCT02676076|asthma, anticholinergics, triple combination|asthma, anticholinergics, triple combination
143284|NCT02676063|predictive factors|predictive factors
143285|NCT02676063|neurodevelopmental disabilities|neurodevelopmental disabilities
143286|NCT02676011|Atropine|atropine
143287|NCT02676011|Succinycholine|succinycholine
143288|NCT02676011|Laparoscopy|laparoscopy
143289|NCT02676011|Gynecology|gynecology
143290|NCT02675985|Physical Therapy, early intervention|physical therapy, early intervention
143291|NCT02675972|stroke, blood pressure, prognosis|stroke, blood pressure, prognosis
143292|NCT02675959|stem cell transplantation|stem cell transplantation
143293|NCT02675959|sickle cell disease|sickle cell disease
143294|NCT02675959|haploidentical|haploidentical
143295|NCT02675959|defibrotide|defibrotide
143296|NCT02675946|WNT inhibitor|wnt inhibitor
143297|NCT02675920|surveillance|surveillance
143298|NCT02675920|ultrasonography|ultrasonography
143299|NCT02675920|computed tomography|computed tomography
143300|NCT02675907|Bunion|bunion
143301|NCT02675907|Bunionectomy|bunionectomy
143302|NCT02675907|Pain|pain
143303|NCT02675907|Analgesia|analgesia
143304|NCT02675907|N1539|n1539
143305|NCT02675907|Phase 3|phase 3
143306|NCT02675894|RFA|rfa
143307|NCT02675881|RFA|rfa
143308|NCT02675868|noradrenaline|noradrenaline
143309|NCT02675868|vasopressin|vasopressin
143310|NCT02675868|phenylephrine|phenylephrine
143311|NCT02675868|endotoxemia|endotoxemia
143312|NCT02675868|Lipopolysaccharide|lipopolysaccharide
143313|NCT02675868|vasopressor|vasopressor
143314|NCT02675855|Grafix|grafix
143315|NCT02675829|HER2 mutant|her2 mutant
143316|NCT02675829|HER2 amplified|her2 amplified
143317|NCT02675829|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine
143318|NCT02675829|15-335|15-335
143319|NCT02675816|Obstructive Sleep Apnea|obstructive sleep apnea
143320|NCT02675816|OSA|osa
143321|NCT02675816|neurostimulation|neurostimulation
143322|NCT02675816|hypoglossal nerve|hypoglossal nerve
143323|NCT02675816|tongue|tongue
143324|NCT02675816|upper airway stimulation|upper airway stimulation
143325|NCT02675816|surgery|surgery
143326|NCT02675803|Rheumatoid arthritis|rheumatoid arthritis
143327|NCT02675790|hydroxyurea|hydroxyurea
143328|NCT02675790|sub-Saharan Africa|sub-saharan africa
143329|NCT02675790|secondary stroke prevention|secondary stroke prevention
143330|NCT02675777|Alcohol misuse|alcohol misuse
143331|NCT02675777|Unhealthy alcohol use|unhealthy alcohol use
143332|NCT02675777|Alcoholism|alcoholism
143333|NCT02675777|Alcohol dependence|alcohol dependence
143334|NCT02675777|Alcohol abuse|alcohol abuse
143335|NCT02675777|Risky drinking|risky drinking
143336|NCT02675764|hand function|hand function
143337|NCT02675751|myopia|myopia
143338|NCT02675673|Enteral Feeding|enteral feeding
143339|NCT02675673|G-Tube|g-tube
143340|NCT02675673|GJ Tube|gj tube
143341|NCT02675660|kinetic data|kinetic data
143342|NCT02675660|volunteers|volunteers
143343|NCT02675608|vaccine efficacy|vaccine efficacy
143344|NCT02675608|inflammation|inflammation
143345|NCT02675608|aging|aging
143346|NCT02675608|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
143347|NCT02675608|flu vaccine|flu vaccine
143348|NCT02675569|Vascular access|vascular access
143349|NCT02675569|Hemodialysis|hemodialysis
143350|NCT02675569|Kidney failure|kidney failure
143351|NCT02675569|Catheter|catheter
143352|NCT02675569|Fistula|fistula
143353|NCT02675556|Depression|depression
143354|NCT02675530|NMDA|nmda
143355|NCT02675530|glutamate|glutamate
143356|NCT02675530|schizophrenia|schizophrenia
143357|NCT02675504|scary scale|scary scale
143358|NCT02675491|Advanced solid tumor|advanced solid tumor
143359|NCT02675491|DS-6051b|ds-6051b
143360|NCT02675491|ROS1|ros1
143361|NCT02675491|NTRK|ntrk
143362|NCT02675491|refractory to standard therapy|refractory to standard therapy
143363|NCT02675491|no standard therapy|no standard therapy
143364|NCT02675478|AML|aml
143365|NCT02675478|phase 1|phase 1
143366|NCT02675478|oncology|oncology
143367|NCT02675465|Pompe, rhGAA|pompe, rhgaa
143368|NCT02675426|Musculoskeletal Disease|musculoskeletal disease
143369|NCT02675426|Arthritis|arthritis
143370|NCT02675426|Joint Disease|joint disease
143371|NCT02675426|Anti-inflammatory agents|anti-inflammatory agents
143372|NCT02675426|Antirheumatic agents|antirheumatic agents
143373|NCT02675413|Cerebral Spinal Fluid|cerebral spinal fluid
143374|NCT02675413|Dimethyl Fumarate|dimethyl fumarate
143375|NCT02675413|Tecfidera|tecfidera
143376|NCT02675413|Multiple Sclerosis|multiple sclerosis
143377|NCT02675413|Relapsing MS|relapsing ms
143378|NCT02675413|RRMS|rrms
143379|NCT02675413|Mechanism of Action|mechanism of action
143380|NCT02675400|ADHD|adhd
143381|NCT02675400|ADD|add
143480|NCT02674815|Thoracic|thoracic
143382|NCT02675400|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
143383|NCT02675400|Attention|attention
143384|NCT02675400|Hyperactivity|hyperactivity
143385|NCT02675374|Cardiac surgery|cardiac surgery
143386|NCT02675374|cardiopulmonary bypass|cardiopulmonary bypass
143387|NCT02675374|dexchlorpheniramine|dexchlorpheniramine
143388|NCT02675374|H1 blockers|h1 blockers
143389|NCT02675374|norepinephrine|norepinephrine
143390|NCT02675374|histamine release|histamine release
143391|NCT02675361|Transfer to adult care|transfer to adult care
143392|NCT02675361|Continuity of patient care|continuity of patient care
143393|NCT02675361|Transition program|transition program
143394|NCT02675335|Diabetic foot ulcer, Sitagliptin|diabetic foot ulcer, sitagliptin
143395|NCT02675296|outcome|outcome
143396|NCT02675283|Point of care test|point of care test
143397|NCT02675283|Diagnosis|diagnosis
143398|NCT02675283|Case finding|case finding
143399|NCT02675257|Diabetes mellitus|diabetes mellitus
143400|NCT02675257|Affective disorders|affective disorders
143401|NCT02675257|Depressive symptoms|depressive symptoms
143402|NCT02675257|Diabetes distress|diabetes distress
143403|NCT02675257|Hyperglycaemia|hyperglycaemia
143404|NCT02675257|Dysglycaemia|dysglycaemia
143405|NCT02675257|Glycaemic control|glycaemic control
143406|NCT02675257|Self-care behaviour|self-care behaviour
143407|NCT02675257|Quality of Life|quality of life
143408|NCT02675257|Diabetes acceptance|diabetes acceptance
143409|NCT02675257|Diabetes complications|diabetes complications
143410|NCT02675257|Low-grade inflammation|low-grade inflammation
143411|NCT02675257|Inflammatory markers|inflammatory markers
143412|NCT02675257|Stress reactivity|stress reactivity
143413|NCT02675257|Health-care costs|health-care costs
143414|NCT02675244|Tricuspid Valve Regurgitation|tricuspid valve regurgitation
143415|NCT02675192|sarcopenia|sarcopenia
143416|NCT02675192|elderly|elderly
143417|NCT02675192|muscle biopsy|muscle biopsy
143418|NCT02675166|Childhood cancer|childhood cancer
143419|NCT02675166|Sequels|sequels
143420|NCT02675166|Complications|complications
143421|NCT02675166|Surgery|surgery
143422|NCT02675166|Radiotherapy|radiotherapy
143423|NCT02675166|Chemotherapy|chemotherapy
143424|NCT02675166|Cancer|cancer
143425|NCT02675153|Inflammatory Bowel Disease|inflammatory bowel disease
143426|NCT02675153|stenosis|stenosis
143427|NCT02675153|sirolimus|sirolimus
143428|NCT02675153|rapamycin|rapamycin
143429|NCT02675153|stricture|stricture
143430|NCT02675114|Sapien 3|sapien 3
143431|NCT02675114|cardiovascular disease|cardiovascular disease
143432|NCT02675114|heart disease|heart disease
143433|NCT02675114|aortic stenosis|aortic stenosis
143434|NCT02675114|SAVR|savr
143435|NCT02675114|TAVR|tavr
143436|NCT02675088|Extensive Stage Small Cell Lung Cancer|extensive stage small cell lung cancer
143437|NCT02675088|thoracic radiotherapy|thoracic radiotherapy
143438|NCT02675088|radiotherapy regimen|radiotherapy regimen
143439|NCT02675075|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
143440|NCT02675075|Voice|voice
143441|NCT02675075|Voice Quality|voice quality
143442|NCT02675075|Total Lung Capacity|total lung capacity
143443|NCT02675062|Accelerometry|accelerometry
143444|NCT02675062|Osteoarthritis|osteoarthritis
143445|NCT02675062|Habitual physical activity|habitual physical activity
143446|NCT02675062|Sedentary behaviour|sedentary behaviour
143447|NCT02675062|Knee arthroplasty|knee arthroplasty
143448|NCT02675049|Intranasal|intranasal
143449|NCT02675049|Dexmedetomidine|dexmedetomidine
143450|NCT02675049|Anaesthesia|anaesthesia
143451|NCT02675049|Breast Lumpectomy|breast lumpectomy
143452|NCT02675036|ectopiccanine teeth, impacted teeth, tooth eruption, orthodontics|ectopiccanine teeth, impacted teeth, tooth eruption, orthodontics
143453|NCT02674997|Goal setting|goal setting
143454|NCT02674997|Feasibility|feasibility
143455|NCT02674997|Standardized Goal Attainment Scaling menu for Hemophilia (GAS-Hem)|standardized goal attainment scaling menu for hemophilia (gas-hem)
143456|NCT02674997|Patient reported outcome (PRO)|patient reported outcome (pro)
143457|NCT02674997|Goal attainment scaling (GAS)|goal attainment scaling (gas)
143458|NCT02674958|endothelial progenitor cells|endothelial progenitor cells
143459|NCT02674958|aspirin|aspirin
143460|NCT02674958|acetylsalicylic acid|acetylsalicylic acid
143461|NCT02674958|alcohol septal ablation|alcohol septal ablation
143462|NCT02674945|fitbit|fitbit
143463|NCT02674945|activity tracker|activity tracker
143464|NCT02674945|sleep|sleep
143465|NCT02674945|quality of life|quality of life
143466|NCT02674919|Repeated-sprint ability|repeated-sprint ability
143467|NCT02674919|Nordic Hamstring exercise|nordic hamstring exercise
143468|NCT02674919|Eccentric hamstring muscle strength|eccentric hamstring muscle strength
143469|NCT02674893|BMI>27|bmi>27
143470|NCT02674893|Treatment with Liraglutide|treatment with liraglutide
143471|NCT02674841|Adolescent|adolescent
143472|NCT02674841|Physical therapy modalities|physical therapy modalities
143473|NCT02674841|Exercise intervention|exercise intervention
143474|NCT02674841|Auditive feedback|auditive feedback
143475|NCT02674841|Visual feedback|visual feedback
143476|NCT02674815|Exercise|exercise
143477|NCT02674815|Preoperative|preoperative
143478|NCT02674815|High Intensity Interval Training|high intensity interval training
143481|NCT02674815|Postoperative|postoperative
143482|NCT02674802|Reinfection|reinfection
143483|NCT02674802|Eradication therapy|eradication therapy
143484|NCT02674802|C-urea breath test|c-urea breath test
143485|NCT02674802|Helicobacter Pylori|helicobacter pylori
143486|NCT02674789|Exercise|exercise
143487|NCT02674789|Athletes|athletes
143488|NCT02674789|Ionized Magnesium|ionized magnesium
143489|NCT02674789|Variation|variation
143490|NCT02674789|Blood|blood
143491|NCT02674763|Acute Myeloid Leukemia|acute myeloid leukemia
143492|NCT02674763|AML|aml
143493|NCT02674763|IMGN779|imgn779
143494|NCT02674763|ImmunoGen|immunogen
143495|NCT02674763|Phase 1|phase 1
143496|NCT02674763|Relapsed|relapsed
143497|NCT02674763|Refractory|refractory
143498|NCT02674763|CD33|cd33
143499|NCT02674763|Dose Escalation|dose escalation
143500|NCT02674763|Dose Expansion|dose expansion
143501|NCT02674750|DLBCL|dlbcl
143502|NCT02674750|MYC|myc
143503|NCT02674724|Resistance Training|resistance training
143504|NCT02674724|Postural Balance|postural balance
143505|NCT02674724|Exercise|exercise
143506|NCT02674711|patient education|patient education
143507|NCT02674711|low back pain|low back pain
143508|NCT02674711|post-surgical pain|post-surgical pain
143509|NCT02674711|chronic opioid use|chronic opioid use
143510|NCT02674711|Neck Pain|neck pain
143511|NCT02674672|VenaTech® Retrievable Vena Cava Filter|venatech® retrievable vena cava filter
143512|NCT02674672|safety|safety
143513|NCT02674672|efficacy|efficacy
143514|NCT02674659|resistance training, PCSK9, coronary artery bypass|resistance training, pcsk9, coronary artery bypass
143515|NCT02674633|ADHD|adhd
143516|NCT02674594|Anticoagulation|anticoagulation
143517|NCT02674568|SCLC|sclc
143518|NCT02674568|Small Cell Lung Cancer|small cell lung cancer
143519|NCT02674568|DLL3|dll3
143520|NCT02674568|Relapsed|relapsed
143521|NCT02674568|Refractory|refractory
143522|NCT02674555|Phase 1|phase 1
143523|NCT02674555|Metabolism|metabolism
143524|NCT02674555|Excretion|excretion
143525|NCT02674555|Absorption|absorption
143526|NCT02674555|[14C]-radioactivity|[14c]-radioactivity
143527|NCT02674555|Pharmacokinetics|pharmacokinetics
143528|NCT02674555|naquotinib|naquotinib
143529|NCT02674555|Oncology|oncology
143530|NCT02674542|Family planning|family planning
143531|NCT02674542|Birth spacing|birth spacing
143532|NCT02674529|Depression|depression
143533|NCT02674529|Neuroimaging biomarkers|neuroimaging biomarkers
143534|NCT02674529|MDD|mdd
143535|NCT02674529|Neurofeedback|neurofeedback
143536|NCT02674516|antisocial behavior|antisocial behavior
143537|NCT02674516|aggression|aggression
143538|NCT02674516|transcranial direct current stimulation|transcranial direct current stimulation
143539|NCT02674516|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
143540|NCT02674516|associated risk factors|associated risk factors
143541|NCT02674503|Walking|walking
143542|NCT02674503|Hospitalization|hospitalization
143543|NCT02674503|Randomized controlled trial|randomized controlled trial
143544|NCT02674490|aphasia, language|aphasia, language
143545|NCT02674373|gastric cancer|gastric cancer
143546|NCT02674373|biomarker|biomarker
143547|NCT02674373|Circulating tumor DNA|circulating tumor dna
143548|NCT02674373|Chemotherapy|chemotherapy
143549|NCT02674373|Prognosis|prognosis
143550|NCT02674373|Predictive|predictive
143551|NCT02674334|orthopedic procedures|orthopedic procedures
143552|NCT02674321|Tourette Syndrome|tourette syndrome
143553|NCT02674321|adolescents|adolescents
143554|NCT02674308|Drug therapy|drug therapy
143555|NCT02674295|Healthy|healthy
143556|NCT02674295|JNJ-54135419|jnj-54135419
143557|NCT02674295|Esketamine|esketamine
143558|NCT02674282|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
143559|NCT02674282|anterior cruciate ligament|anterior cruciate ligament
143560|NCT02674282|sports medicine|sports medicine
143561|NCT02674282|soccer|soccer
143562|NCT02674282|maximum oxygen uptake|maximum oxygen uptake
143563|NCT02674282|return to play|return to play
143564|NCT02674269|Overactive bladder|overactive bladder
143565|NCT02674269|Botox|botox
143566|NCT02674269|TC-3 Gel|tc-3 gel
143567|NCT02674269|Intravesical|intravesical
143568|NCT02674269|UroGen Pharma|urogen pharma
143569|NCT02674269|Botulinum Toxin|botulinum toxin
143570|NCT02674269|Urgency|urgency
143571|NCT02674269|OAB|oab
143572|NCT02674269|Incontinence|incontinence
143573|NCT02674269|I-QOL|i-qol
143574|NCT02674269|KHQ|khq
143575|NCT02674269|TBS|tbs
143576|NCT02674269|RTG|rtg
143577|NCT02674256|health|health
143578|NCT02674256|age between 18 to 60 years old|age between 18 to 60 years old
143579|NCT02674256|no history of gastrointestinal symptoms or complaints|no history of gastrointestinal symptoms or complaints
143580|NCT02674243|Malignant pleural effusion|malignant pleural effusion
143581|NCT02674243|Pleurodesis|pleurodesis
143582|NCT02674243|Talc|talc
143583|NCT02674243|Iodopovidone solution|iodopovidone solution
143584|NCT02674243|Povidone-iodine|povidone-iodine
143585|NCT02674204|Statin therapy|statin therapy
143586|NCT02674204|trastuzumab|trastuzumab
143783|NCT02672878|Stent|stent
143587|NCT02674191|miniplates ,molar intrusion, hyperdivergent|miniplates ,molar intrusion, hyperdivergent
143588|NCT02674139|post placental-caesarean-IUD|post placental-caesarean-iud
143589|NCT02674126|Cardiac Surgery|cardiac surgery
143590|NCT02674126|Maternal sound|maternal sound
143591|NCT02674126|Cortisol|cortisol
143592|NCT02674126|Blood sugar|blood sugar
143593|NCT02674126|Stress|stress
143594|NCT02674061|PD1|pd1
143595|NCT02674061|PD-1|pd-1
143596|NCT02674061|PDL1|pdl1
143597|NCT02674061|PD-L1|pd-l1
143598|NCT02674035|Abdominoplasty|abdominoplasty
143599|NCT02674035|Sutures|sutures
143600|NCT02674035|Abdominal deformities|abdominal deformities
143601|NCT02674035|Plication|plication
143602|NCT02674035|Monofilament nylon suture|monofilament nylon suture
143603|NCT02674035|Barbed suture|barbed suture
143604|NCT02674022|Maternal Health|maternal health
143605|NCT02674022|Autistic Disorder|autistic disorder
143606|NCT02674022|Metabolism|metabolism
143607|NCT02674022|Folic Acid|folic acid
143608|NCT02673996|antibody|antibody
143609|NCT02673996|autoimmune|autoimmune
143610|NCT02673996|adrenergic|adrenergic
143611|NCT02673996|autonomic|autonomic
143612|NCT02673983|Intestinal|intestinal
143613|NCT02673983|Biopsy|biopsy
143614|NCT02673983|full thickness|full thickness
143615|NCT02673983|endoscopic|endoscopic
143616|NCT02673970|Melanoma|melanoma
143617|NCT02673931|Open Heart Surgery|open heart surgery
143618|NCT02673931|Organ protection|organ protection
143619|NCT02673918|Rehabilitation|rehabilitation
143620|NCT02673918|Home-Based Intervention|home-based intervention
143621|NCT02673905|nasal chondrocytes|nasal chondrocytes
143622|NCT02673905|articular chondral lesions|articular chondral lesions
143623|NCT02673905|tissue engineering|tissue engineering
143624|NCT02673905|femoral condyle|femoral condyle
143625|NCT02673905|trochlea|trochlea
143626|NCT02673892|discharge|discharge
143627|NCT02673892|transitions|transitions
143628|NCT02673892|patient experience|patient experience
143629|NCT02673866|Diabetic Peripheral Neuropathic Pain (DPNP)|diabetic peripheral neuropathic pain (dpnp)
143630|NCT02673866|Diabetes|diabetes
143631|NCT02673866|Pregabalin|pregabalin
143632|NCT02673866|Spontaneous Pain|spontaneous pain
143633|NCT02673866|Hyperalgesia|hyperalgesia
143634|NCT02673866|Allodynia|allodynia
143635|NCT02673866|Average Daily Pain Score (ADPS)|average daily pain score (adps)
143636|NCT02673866|Pain Associated Sleep Interference|pain associated sleep interference
143637|NCT02673853|Supraglottic airway|supraglottic airway
143638|NCT02673853|Mini-dose atracurium|mini-dose atracurium
143639|NCT02673853|Postoperative residual paralysis|postoperative residual paralysis
143640|NCT02673840|dengue fever|dengue fever
143641|NCT02673840|dengue hemorrhagic fever|dengue hemorrhagic fever
143642|NCT02673840|ketotifen|ketotifen
143643|NCT02673840|vascular leakage|vascular leakage
143644|NCT02673840|pleural effusion|pleural effusion
143645|NCT02673840|plasma leakage|plasma leakage
143646|NCT02673801|Referral and Consultation|referral and consultation
143647|NCT02673801|Orthopedics|orthopedics
143648|NCT02673775|Macrophage|macrophage
143649|NCT02673749|Lactose maldigestion|lactose maldigestion
143650|NCT02673749|Dairy intolerance|dairy intolerance
143651|NCT02673749|Intolerance to milk|intolerance to milk
143652|NCT02673749|Intolerance to dairy|intolerance to dairy
143653|NCT02673749|Milk intolerance|milk intolerance
143654|NCT02673749|GI disorder|gi disorder
143655|NCT02673749|Lactose metabolism|lactose metabolism
143656|NCT02673749|GI symptoms after dairy ingestion|gi symptoms after dairy ingestion
143657|NCT02673736|PLX73086|plx73086
143658|NCT02673736|Synovitis, Pigmented Villonodular|synovitis, pigmented villonodular
143659|NCT02673736|Tenosynovial Giant Cell Tumor|tenosynovial giant cell tumor
143660|NCT02673736|Joint Diseases|joint diseases
143661|NCT02673736|Neoplasms|neoplasms
143662|NCT02673736|Synovitis|synovitis
143663|NCT02673723|docozine|docozine
143664|NCT02673697|Sutureless valve|sutureless valve
143665|NCT02673658|infant development, early intervention|infant development, early intervention
143666|NCT02673645|Educational Achievement|educational achievement
143667|NCT02673632|Anti-Müllerian hormone|anti-müllerian hormone
143668|NCT02673632|Ovarian stimulation|ovarian stimulation
143669|NCT02673632|Polycystic ovary syndrome|polycystic ovary syndrome
143670|NCT02673632|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
143671|NCT02673619|Topical|topical
143672|NCT02673619|Palmar Hyperhidrosis|palmar hyperhidrosis
143673|NCT02673619|Umeclidinium|umeclidinium
143674|NCT02673593|Safety|safety
143675|NCT02673593|Pharmacokinetics|pharmacokinetics
143676|NCT02673593|Food Effect|food effect
143677|NCT02673554|Glucose-dependent Insulinotropic Polypeptide (GIP)|glucose-dependent insulinotropic polypeptide (gip)
143678|NCT02673554|Glucagon-Like Peptide 1 (GLP-1)|glucagon-like peptide 1 (glp-1)
143679|NCT02673554|Incretin|incretin
143680|NCT02673554|Insulin secretion|insulin secretion
143681|NCT02673554|Tachyphylaxis|tachyphylaxis
143682|NCT02673528|appendectomy|appendectomy
143683|NCT02673528|laparoscopy|laparoscopy
143684|NCT02673528|laparoscopic assisted appendectomy|laparoscopic assisted appendectomy
143685|NCT02673528|cost utility|cost utility
143686|NCT02673515|Alternate Day Fasting|alternate day fasting
143687|NCT02673502|Carbohydrate drink|carbohydrate drink
143688|NCT02673502|Post operative complication|post operative complication
143689|NCT02673502|insulin resistance|insulin resistance
143690|NCT02673502|Fasting blood glucose|fasting blood glucose
143691|NCT02673437|Acute coronary syndrome|acute coronary syndrome
143692|NCT02673411|elastography|elastography
143693|NCT02673411|ultrasonography|ultrasonography
143694|NCT02673372|Geriatric, Pain, Ketamine, Emergency Medicine|geriatric, pain, ketamine, emergency medicine
143695|NCT02673359|Preterm labor|preterm labor
143696|NCT02673359|Short cervix|short cervix
143697|NCT02673359|Progesterone|progesterone
143698|NCT02673359|Cervical cerclage|cervical cerclage
143699|NCT02673333|Pembrolizumab|pembrolizumab
143700|NCT02673333|15-286|15-286
143701|NCT02673320|Acute Traumatic Cervical Central Cord Syndrom Injury|acute traumatic cervical central cord syndrom injury
143702|NCT02673320|Delay of Surgery|delay of surgery
143703|NCT02673320|Decompressive Surgery|decompressive surgery
143704|NCT02673320|Canal Stenosis|canal stenosis
143705|NCT02673320|Schneider Syndrom|schneider syndrom
143706|NCT02673320|Quality of life|quality of life
143707|NCT02673320|Functional Outcome|functional outcome
143708|NCT02673281|walnuts|walnuts
143709|NCT02673281|brain|brain
143710|NCT02673281|appetite|appetite
143711|NCT02673281|energy intake|energy intake
143712|NCT02673281|obesity|obesity
143713|NCT02673255|Plasma|plasma
143714|NCT02673255|Plasma Donor|plasma donor
143715|NCT02673255|Plasma Donation|plasma donation
143716|NCT02673255|Tetanus|tetanus
143717|NCT02673255|Td|td
143718|NCT02673255|Immunoglobulin|immunoglobulin
143719|NCT02673255|Hyper-immunization|hyper-immunization
143720|NCT02673229|Santyl|santyl
143721|NCT02673229|Burn|burn
143722|NCT02673229|Partial Thickness Burn|partial thickness burn
143723|NCT02673229|Second Degree Burn|second degree burn
143724|NCT02673229|Minor Burn Bacitracin|minor burn bacitracin
143725|NCT02673229|Scar Appearance|scar appearance
143726|NCT02673203|glucose monitoring|glucose monitoring
143727|NCT02673203|hunger levels|hunger levels
143728|NCT02673203|food intake|food intake
143729|NCT02673177|robot-assisted total mesorectal excision(RTME)|robot-assisted total mesorectal excision(rtme)
143730|NCT02673177|laparoscopic total mesorectal excision(LTME)|laparoscopic total mesorectal excision(ltme)
143731|NCT02673177|urinary function|urinary function
143732|NCT02673177|sexual function|sexual function
143733|NCT02673177|sphincter- preservation|sphincter- preservation
143734|NCT02673177|low rectal cancer|low rectal cancer
143735|NCT02673164|Heart failure|heart failure
143736|NCT02673164|stem cell|stem cell
143737|NCT02673164|adipose derived stem cell|adipose derived stem cell
143738|NCT02673164|Stem cell therapy|stem cell therapy
143739|NCT02673164|ischemic heart disease|ischemic heart disease
143740|NCT02673125|Preimplantation Genetic Screening|preimplantation genetic screening
143741|NCT02673112|Concussion|concussion
143742|NCT02673112|mild traumatic brain injury|mild traumatic brain injury
143743|NCT02673112|post concussion syndrome|post concussion syndrome
143744|NCT02673112|child|child
143745|NCT02673099|HDF online|hdf online
143746|NCT02673099|ESRD|esrd
143747|NCT02673099|Hemodialysis|hemodialysis
143748|NCT02673099|oxidative stress|oxidative stress
143749|NCT02673099|quality of life|quality of life
143750|NCT02673099|Hemodialysis treatment|hemodialysis treatment
143751|NCT02673086|retroclavicular approach|retroclavicular approach
143752|NCT02673086|coracoid approach|coracoid approach
143753|NCT02673086|ultrasound|ultrasound
143754|NCT02673086|upper limb surgery|upper limb surgery
143755|NCT02673086|needle visibility|needle visibility
143756|NCT02673086|infraclavicular brachial plexus block|infraclavicular brachial plexus block
143757|NCT02673073|Heart failure|heart failure
143758|NCT02673073|patient's diary|patient's diary
143759|NCT02673073|self awareness|self awareness
143760|NCT02672995|stereotactic radiosurgery,Bevacizumab|stereotactic radiosurgery,bevacizumab
143761|NCT02672969|smoke evacuation system|smoke evacuation system
143762|NCT02672969|surgical smoke|surgical smoke
143763|NCT02672943|Parkinson disease|parkinson disease
143764|NCT02672943|Autonomic nervous system|autonomic nervous system
143765|NCT02672943|MicroRNA|microrna
143766|NCT02672943|Inflammation|inflammation
143767|NCT02672943|Oxidative stress|oxidative stress
143768|NCT02672943|noradrenergic network|noradrenergic network
143769|NCT02672943|Rehabilitation treatment|rehabilitation treatment
143770|NCT02672930|calcium gluconate|calcium gluconate
143771|NCT02672930|hyperpotassemia treatment|hyperpotassemia treatment
143772|NCT02672917|CA19-9 Positive Malignancies|ca19-9 positive malignancies
143773|NCT02672904|vocal cord|vocal cord
143774|NCT02672904|carcinoma|carcinoma
143775|NCT02672904|ktp laser|ktp laser
143776|NCT02672904|co2 laser|co2 laser
143777|NCT02672904|endoscopic surgery|endoscopic surgery
143778|NCT02672891|Postpartum Hemorrhage|postpartum hemorrhage
143779|NCT02672891|Uterine Tamponade|uterine tamponade
143780|NCT02672891|Condom Catheter|condom catheter
143781|NCT02672878|In-stent restenosis|in-stent restenosis
143782|NCT02672878|Bioresorbable vascular scaffold|bioresorbable vascular scaffold
143784|NCT02672878|Drug-eluting stent|drug-eluting stent
143785|NCT02672878|Coronary angiography|coronary angiography
143786|NCT02672852|ABBV-066|abbv-066
143787|NCT02672852|BI 655066|bi 655066
143788|NCT02672852|risankizumab|risankizumab
143789|NCT02672813|Pectoral nerve I and II blocks|pectoral nerve i and ii blocks
143790|NCT02672813|Breast surgery|breast surgery
143791|NCT02672813|Ropivacaine|ropivacaine
143792|NCT02672813|Postoperative opioid consumption|postoperative opioid consumption
143793|NCT02672787|Antihypertensive adherence|antihypertensive adherence
143794|NCT02672787|Emergency medicine|emergency medicine
143795|NCT02672787|Antihypertensives|antihypertensives
143796|NCT02672748|garden|garden
143797|NCT02672748|Native American|native american
143798|NCT02672748|BMI|bmi
143799|NCT02672748|Emotional health|emotional health
143800|NCT02672748|Physical health|physical health
143801|NCT02672735|corrective exercise program|corrective exercise program
143802|NCT02672735|movement efficiency|movement efficiency
143803|NCT02672722|This term was found doing the MeSH search and is the only thing that fits since we will be working with healthy subjects with no conditions.|this term was found doing the mesh search and is the only thing that fits since we will be working with healthy subjects with no conditions.
143804|NCT02672709|Factor Xa Inhibitors|factor xa inhibitors
143805|NCT02672709|Renal Dialysis|renal dialysis
143806|NCT02672696|Navigation|navigation
143807|NCT02672696|Gamma Nail|gamma nail
143808|NCT02672657|Health-Related Quality of life|health-related quality of life
143809|NCT02672657|Cancer|cancer
143810|NCT02672657|Elderly|elderly
143811|NCT02672657|Caregivers|caregivers
143812|NCT02672618|heart failure|heart failure
143813|NCT02672618|infrared thermal imaging|infrared thermal imaging
143814|NCT02672592|Metabolic syndrome X|metabolic syndrome x
143815|NCT02672592|Hypogonadism|hypogonadism
143816|NCT02672592|Testosterone|testosterone
143817|NCT02672592|Inflammation|inflammation
143818|NCT02672592|Obesity|obesity
143819|NCT02672566|Fetal Growth Retardation|fetal growth retardation
143820|NCT02672566|enoxaparin|enoxaparin
143821|NCT02672553|Aortic Valve Replacement|aortic valve replacement
143822|NCT02672553|Minimal Invasive Sternotomy|minimal invasive sternotomy
143823|NCT02672540|Sickle Cell|sickle cell
143824|NCT02672540|Anemia|anemia
143825|NCT02672540|VOC|voc
143826|NCT02672540|Vaso occlusive crisis|vaso occlusive crisis
143827|NCT02672501|immunotherapy|immunotherapy
143828|NCT02672501|CAR-T|car-t
143829|NCT02672501|leukemia|leukemia
143830|NCT02672449|Prostate cancer|prostate cancer
143831|NCT02672449|Carbon ions|carbon ions
143832|NCT02672449|Radiobiology|radiobiology
143833|NCT02672449|Radiotherapy|radiotherapy
143834|NCT02672436|Diabetic Foot Ulcer|diabetic foot ulcer
143835|NCT02672436|Diabetes Mellitus|diabetes mellitus
143836|NCT02672436|Wound Healing|wound healing
143837|NCT02672397|Epidural|epidural
143838|NCT02672397|Ethnicity|ethnicity
143839|NCT02672397|Education|education
143840|NCT02672397|Labor|labor
143841|NCT02672397|obstetrical analgesia|obstetrical analgesia
143842|NCT02672384|Intensive care unit|intensive care unit
143843|NCT02672384|Invasive mechanical ventilation|invasive mechanical ventilation
143844|NCT02672384|Chronic periodontitis|chronic periodontitis
143845|NCT02672384|Point of Care P. gingivalis test|point of care p. gingivalis test
143846|NCT02672358|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
143847|NCT02672358|NSCLC|nsclc
143848|NCT02672358|dabrafenib|dabrafenib
143849|NCT02672358|trametinib|trametinib
143850|NCT02672358|Japanese patients|japanese patients
143851|NCT02672358|BRAF V600E mutation positive metastatic|braf v600e mutation positive metastatic
143852|NCT02672358|stage IV|stage iv
143853|NCT02672345|Sevoflurane|sevoflurane
143854|NCT02672345|MicroRNAs|micrornas
143855|NCT02672345|Inflammatory Response|inflammatory response
143856|NCT02672345|Cytokines|cytokines
143857|NCT02672345|Anesthetics, Inhalation|anesthetics, inhalation
143858|NCT02672345|Macrophage Inflammatory Proteins|macrophage inflammatory proteins
143859|NCT02672267|AMI, hBMMSCs, stem cells,|ami, hbmmscs, stem cells,
143860|NCT02672241|Radiation Therapy|radiation therapy
143861|NCT02672241|Brainstem Tumor in Children|brainstem tumor in children
143862|NCT02672202|Chronic Pain|chronic pain
143863|NCT02672202|Pain Modulation Profile|pain modulation profile
143864|NCT02672202|CPM|cpm
143865|NCT02672202|acute post operative pain|acute post operative pain
143866|NCT02672189|Climacteric symptoms|climacteric symptoms
143867|NCT02672189|Menopause|menopause
143868|NCT02672189|Breast Cancer Survivors|breast cancer survivors
143869|NCT02672189|Internet-based|internet-based
143870|NCT02672189|Cognitive behavioral therapy|cognitive behavioral therapy
143871|NCT02672189|Psychosocial intervention|psychosocial intervention
143872|NCT02672176|Diabetes mellitus|diabetes mellitus
143873|NCT02672176|Motivational Interviewing|motivational interviewing
143874|NCT02672176|Mobile Health Technology|mobile health technology
143875|NCT02672176|Patient-generated Health Data (PGHD)|patient-generated health data (pghd)
143876|NCT02672163|autologous micrografts|autologous micrografts
143877|NCT02672163|heart failure|heart failure
143878|NCT02672163|coronary artery bypass surgery|coronary artery bypass surgery
143879|NCT02672163|cell therapy|cell therapy
143880|NCT02672163|atrial appendage|atrial appendage
143881|NCT02672163|epicardial cell delivery|epicardial cell delivery
143882|NCT02672150|evidence-based practice implementation|evidence-based practice implementation
143883|NCT02672150|system change|system change
143884|NCT02672150|interagency collaboration|interagency collaboration
143885|NCT02672150|substance use|substance use
143886|NCT02672150|treatment services|treatment services
143887|NCT02672150|data-driven decision making|data-driven decision making
143888|NCT02672150|juvenile justice|juvenile justice
143889|NCT02672150|adolescents|adolescents
143890|NCT02672150|justice-involved youth|justice-involved youth
143891|NCT02672150|cluster randomized trial|cluster randomized trial
143892|NCT02672137|myocardial infarction|myocardial infarction
143893|NCT02672137|knowledge transfer|knowledge transfer
143894|NCT02672137|acute coronary syndromes|acute coronary syndromes
143895|NCT02672020|pheochromocytoma|pheochromocytoma
143896|NCT02672020|paraganglioma|paraganglioma
143897|NCT02672020|adrenocortical carcinoma|adrenocortical carcinoma
143898|NCT02672007|Respiratory rate measurement methods.|respiratory rate measurement methods.
143899|NCT02671994|Geriatric Assessment|geriatric assessment
143900|NCT02671994|G8 screening|g8 screening
143901|NCT02671994|Oncologic treatment|oncologic treatment
143902|NCT02671968|CGM|cgm
143903|NCT02671968|hypoglycemic events|hypoglycemic events
143904|NCT02671955|Advanced Cancer|advanced cancer
143905|NCT02671955|JNJ-61610588|jnj-61610588
143906|NCT02671942|roflumilast|roflumilast
143907|NCT02671916|QoL and Survival one year after ICU stay|qol and survival one year after icu stay
143908|NCT02671864|Incretin-based therapy|incretin-based therapy
143909|NCT02671864|GLP1|glp1
143910|NCT02671864|Angiogenesis Inflammation|angiogenesis inflammation
143911|NCT02671864|Hypoglycaemic treatment|hypoglycaemic treatment
143912|NCT02671851|Thoracic Paravertebral Blocks|thoracic paravertebral blocks
143913|NCT02671851|Ultrasound Guidance|ultrasound guidance
143914|NCT02671851|Reduction Mammoplasty|reduction mammoplasty
143915|NCT02671851|Time to First Pain|time to first pain
143916|NCT02671851|Postoperative Analgesia|postoperative analgesia
143917|NCT02671825|Pharmacokinetics|pharmacokinetics
143918|NCT02671812|dental implant|dental implant
143919|NCT02671812|patient satisfaction|patient satisfaction
143920|NCT02671812|treatment outcome|treatment outcome
143921|NCT02671812|cytokine profile|cytokine profile
143922|NCT02671812|risk factor|risk factor
143923|NCT02671812|risk predictor|risk predictor
143924|NCT02671786|Severe Acute Malnutrition|severe acute malnutrition
143925|NCT02671786|Severe Underweight|severe underweight
143926|NCT02671786|IAP Grade III-IV|iap grade iii-iv
143927|NCT02671786|Severe Stunting|severe stunting
143928|NCT02671786|Village Health Workers|village health workers
143929|NCT02671786|MAHAN RUTF & MAHAN Vit-Mim mix|mahan rutf & mahan vit-mim mix
143930|NCT02671773|Microbiota|microbiota
143931|NCT02671760|Short-term insomnia|short-term insomnia
143932|NCT02671760|difficulty sleeping|difficulty sleeping
143933|NCT02671760|sedative|sedative
143934|NCT02671760|hypnotic|hypnotic
143935|NCT02671734|endoscopy|endoscopy
143936|NCT02671682|Immunoadsorption|immunoadsorption
143937|NCT02671682|Plasmapheresis|plasmapheresis
143938|NCT02671656|Uricemia|uricemia
143939|NCT02671630|Cognitive function|cognitive function
143940|NCT02671630|Depression|depression
143941|NCT02671630|Quality of life|quality of life
143942|NCT02671630|Community-based computerized cognitive training program|community-based computerized cognitive training program
143943|NCT02671630|Randomized controlled trial|randomized controlled trial
143944|NCT02671617|Abdominal Cavity|abdominal cavity
143945|NCT02671617|Aged|aged
143946|NCT02671604|acute renal failure|acute renal failure
143947|NCT02671604|prostatectomy|prostatectomy
143948|NCT02671604|minimal invasive surgery|minimal invasive surgery
143949|NCT02671578|nitrous oxide|nitrous oxide
143950|NCT02671578|conscious sedation|conscious sedation
143951|NCT02671578|pain|pain
143952|NCT02671578|anxiety|anxiety
143953|NCT02671565|Intraarticular hyaluronic acid injections|intraarticular hyaluronic acid injections
143954|NCT02671565|Total knee replacement|total knee replacement
143955|NCT02671565|Observational study|observational study
143956|NCT02671565|Intraarticular corticosteroid injections|intraarticular corticosteroid injections
143957|NCT02671565|Comparative effectiveness|comparative effectiveness
143958|NCT02671539|gene therapy|gene therapy
143959|NCT02671539|hereditary retinal degeneration|hereditary retinal degeneration
143960|NCT02671539|rAAV2.REP1|raav2.rep1
143961|NCT02671513|Melanoma|melanoma
143962|NCT02671513|Cycline-Dependent Kinase|cycline-dependent kinase
143963|NCT02671487|Problem Behavior|problem behavior
143964|NCT02671487|Aggression|aggression
143965|NCT02671487|Posttraumatic Stress Disorder|posttraumatic stress disorder
143966|NCT02671487|Adolescents|adolescents
143967|NCT02671448|Homebound|homebound
143968|NCT02671448|Homecare|homecare
143969|NCT02671448|15-022|15-022
143970|NCT02671435|Colorectal cancer, colon cancer, CRC, solid tumors, check point inhibitors, immunotherapy, chemotherapy, metastatic|colorectal cancer, colon cancer, crc, solid tumors, check point inhibitors, immunotherapy, chemotherapy, metastatic
143971|NCT02671396|Virtual Reality|virtual reality
143972|NCT02671396|Postural Stability|postural stability
143973|NCT02671396|Balance Training|balance training
143974|NCT02671396|Parkinson's Disease|parkinson's disease
143975|NCT02671383|Antiretroviral Agents|antiretroviral agents
143976|NCT02671383|Treatment|treatment
143977|NCT02671383|Viral Load|viral load
143978|NCT02671357|pancreatic surgery; neoplasms|pancreatic surgery; neoplasms
143979|NCT02671318|cytomegalovirus|cytomegalovirus
143980|NCT02671318|sirolimus|sirolimus
143981|NCT02671318|cytomegalovirus recurrence|cytomegalovirus recurrence
143982|NCT02671318|kidney transplant|kidney transplant
143983|NCT02671318|conversion|conversion
143984|NCT02671305|delayed cord clamping|delayed cord clamping
143985|NCT02671305|cord milking|cord milking
143986|NCT02671305|bedside neonatal resuscitation|bedside neonatal resuscitation
143987|NCT02671292|Loss of Control Eating|loss of control eating
143988|NCT02671292|Binge Eating|binge eating
143989|NCT02671292|Obesity|obesity
143990|NCT02671292|Prevention|prevention
143991|NCT02671292|Interpersonal Psychotherapy|interpersonal psychotherapy
143992|NCT02671292|Adolescent|adolescent
143993|NCT02671266|Oxytocin|oxytocin
143994|NCT02671266|Body dysmorphic disorder|body dysmorphic disorder
143995|NCT02671266|Obsessive-compulsive disorder|obsessive-compulsive disorder
143996|NCT02671240|Parkinson disease|parkinson disease
143997|NCT02671240|behavioral addiction|behavioral addiction
143998|NCT02671240|akinéto-rigid syndrome|akinéto-rigid syndrome
143999|NCT02671240|dopamine agonist|dopamine agonist
144000|NCT02671214|guar gum|guar gum
144001|NCT02671214|konjac mannan|konjac mannan
144002|NCT02671214|blood glucose|blood glucose
144003|NCT02671214|legume flour|legume flour
144004|NCT02671188|C-C chemokine receptor|c-c chemokine receptor
144005|NCT02671188|Psoriatic arthritis|psoriatic arthritis
144006|NCT02671188|Chemokine (C-C motif) ligand 20|chemokine (c-c motif) ligand 20
144007|NCT02671188|Monoclonal antibody|monoclonal antibody
144008|NCT02671188|psoriasis|psoriasis
144009|NCT02671188|Humanized Immunoglobulin G|humanized immunoglobulin g
144010|NCT02671162|Pruritus|pruritus
144011|NCT02671162|End-Stage Renal Disease|end-stage renal disease
144012|NCT02671110|weight loss treatment|weight loss treatment
144013|NCT02671110|Obesity|obesity
144014|NCT02671084|Sevoflurane|sevoflurane
144015|NCT02671084|Ck-MB|ck-mb
144016|NCT02671071|Cervix Cancer|cervix cancer
144017|NCT02671058|bioavailability|bioavailability
144018|NCT02671045|lung cancer|lung cancer
144019|NCT02671045|genomic profile|genomic profile
144020|NCT02671045|targeted therapy|targeted therapy
144021|NCT02671045|FoundationOne|foundationone
144022|NCT02671032|Cochlear Prosthesis Implantation|cochlear prosthesis implantation
144023|NCT02670980|Retina Implant|retina implant
144024|NCT02670980|Visual Prosthesis|visual prosthesis
144025|NCT02670941|aromatherapy|aromatherapy
144026|NCT02670941|chemotherapy|chemotherapy
144027|NCT02670941|ginger|ginger
144028|NCT02670941|lavender|lavender
144029|NCT02670941|orange|orange
144030|NCT02670941|jojoba|jojoba
144031|NCT02670941|essential oils|essential oils
144032|NCT02670941|cancer|cancer
144033|NCT02670928|Diabetes|diabetes
144034|NCT02670928|lifestyle change|lifestyle change
144035|NCT02670928|weight management|weight management
144036|NCT02670928|control of glycemic in HbA1C and FPG|control of glycemic in hba1c and fpg
144037|NCT02670889|Urea Cycle Disorder|urea cycle disorder
144038|NCT02670850|Mild Cognitive Impairment|mild cognitive impairment
144039|NCT02670850|Family caregiver|family caregiver
144040|NCT02670850|Intervention program|intervention program
144041|NCT02670850|Elders|elders
144042|NCT02670811|Hypertension|hypertension
144043|NCT02670811|Fermented Milk|fermented milk
144044|NCT02670811|Clinical Study|clinical study
144045|NCT02670811|Randomized|randomized
144046|NCT02670811|Double-blind|double-blind
144047|NCT02670798|neuromuscular|neuromuscular
144048|NCT02670798|scoliosis|scoliosis
144049|NCT02670772|Antiretroviral Agents|antiretroviral agents
144050|NCT02670746|Pancreatic Cancer|pancreatic cancer
144051|NCT02670746|Observational|observational
144052|NCT02670746|Nab-Paclitaxel|nab-paclitaxel
144053|NCT02670746|Abraxane|abraxane
144054|NCT02670746|ABI-007|abi-007
144055|NCT02670746|Gemcitabine|gemcitabine
144056|NCT02670746|Non-interventional|non-interventional
144057|NCT02670746|Netherlands|netherlands
144058|NCT02670746|Quality of Life|quality of life
144059|NCT02670733|mechanical ventilation|mechanical ventilation
144060|NCT02670733|positive end-expiratory pressure|positive end-expiratory pressure
144061|NCT02670720|BCX4161|bcx4161
144062|NCT02670720|avoralstat|avoralstat
144063|NCT02670720|HAE|hae
144064|NCT02670720|hereditary angioedema|hereditary angioedema
144065|NCT02670720|prophylaxis|prophylaxis
144066|NCT02670707|vinblastine|vinblastine
144067|NCT02670707|prednisone|prednisone
144068|NCT02670707|cytarabine|cytarabine
144069|NCT02670707|Langerhans Cell Histiocytosis (LCH)|langerhans cell histiocytosis (lch)
144070|NCT02670694|Rett Syndrome|rett syndrome
144071|NCT02670694|Prader-Willi Syndrome|prader-willi syndrome
144072|NCT02670694|Angelman Syndrome|angelman syndrome
144073|NCT02670694|Sleep Problems|sleep problems
144074|NCT02670681|Exercise|exercise
144075|NCT02670681|Aerobic Exercise|aerobic exercise
144076|NCT02670668|BRCA1/2;Mutations;Neoadjuvant chemotherapy;TNBC|brca1/2;mutations;neoadjuvant chemotherapy;tnbc
144077|NCT02670655|Ablative fractional laser|ablative fractional laser
144078|NCT02670655|Iontophoresis|iontophoresis
144079|NCT02670655|Actinic keratosis|actinic keratosis
144080|NCT02670655|Photodynamic therapy|photodynamic therapy
144081|NCT02670629|Pediatric orthopedics|pediatric orthopedics
144082|NCT02670577|stage I|stage i
144083|NCT02670577|stage II|stage ii
144084|NCT02670577|HER2 positive|her2 positive
144085|NCT02670577|Triple Negative|triple negative
144086|NCT02670564|pharmacogenetics|pharmacogenetics
144087|NCT02670564|busulfan|busulfan
144088|NCT02670564|treosulfan|treosulfan
144089|NCT02670564|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
144090|NCT02670564|fludarabine|fludarabine
144091|NCT02670564|pediatric patients|pediatric patients
144092|NCT02670564|TBI|tbi
144093|NCT02670564|leukemia|leukemia
144094|NCT02670564|leukemia, lymphoid|leukemia, lymphoid
144095|NCT02670564|precursor cell lymphoblastic Leukemia-Lymphoma|precursor cell lymphoblastic leukemia-lymphoma
144096|NCT02670564|Immune System disease|immune system disease
144097|NCT02670564|Immunoproliferative Disorders|immunoproliferative disorders
144098|NCT02670564|stem cell transplantation|stem cell transplantation
144099|NCT02670564|children and adolescent|children and adolescent
144100|NCT02670564|high risk acute lymphoblastic leukemia|high risk acute lymphoblastic leukemia
144101|NCT02670564|NCT01949129 add-on|nct01949129 add-on
144102|NCT02670564|ALL SCTped FORUM|all sctped forum
144103|NCT02670525|Recurrent, Refractory, or High Risk Leukemias|recurrent, refractory, or high risk leukemias
144104|NCT02670525|Matched targeted therapy|matched targeted therapy
144105|NCT02670512|End-Stage Renal Disease|end-stage renal disease
144106|NCT02670512|Peritoneal Dialysis|peritoneal dialysis
144107|NCT02670512|Telehomecare|telehomecare
144108|NCT02670512|Telehome Monitoring|telehome monitoring
144109|NCT02670486|Overactive bladder|overactive bladder
144110|NCT02670486|Urge urinary incontinence|urge urinary incontinence
144111|NCT02670486|Urodynamics|urodynamics
144112|NCT02670408|Heart transplant|heart transplant
144113|NCT02670408|global gene expression|global gene expression
144114|NCT02670408|molecular diagnostics|molecular diagnostics
144115|NCT02670395|Healthy|healthy
144116|NCT02670395|JNJ-54416076|jnj-54416076
144117|NCT02670395|Ascending Dose|ascending dose
144118|NCT02670369|Sedentary time|sedentary time
144119|NCT02670369|Sit-to-stand transitions|sit-to-stand transitions
144120|NCT02670356|fish oil|fish oil
144121|NCT02670356|EPA|epa
144122|NCT02670356|DHA|dha
144123|NCT02670356|krill oil|krill oil
144124|NCT02670356|Metabolic Syndrome|metabolic syndrome
144125|NCT02670330|Epidermolysis Bullosa|epidermolysis bullosa
144126|NCT02670330|Simplex|simplex
144127|NCT02670330|Recessive Dystrophic|recessive dystrophic
144128|NCT02670330|Junctional non-Herlitz|junctional non-herlitz
144129|NCT02670317|DLBCL|dlbcl
144130|NCT02670317|large B cell lymphoma|large b cell lymphoma
144131|NCT02670317|NHL|nhl
144132|NCT02670304|letrozole|letrozole
144133|NCT02670304|ovarian hyperstimulating syndrome|ovarian hyperstimulating syndrome
144134|NCT02670291|auditory hallucinations|auditory hallucinations
144135|NCT02670291|schizophrenia|schizophrenia
144136|NCT02670291|cTBS|ctbs
144137|NCT02670291|noninvasive brain stimulation|noninvasive brain stimulation
144138|NCT02670265|malnutrition|malnutrition
144139|NCT02670265|parenteral nutrition|parenteral nutrition
144140|NCT02670265|weight loss|weight loss
144141|NCT02670265|pancreatic cancer|pancreatic cancer
144142|NCT02670265|biliary tract cancer|biliary tract cancer
144143|NCT02670265|quality of life|quality of life
144144|NCT02670226|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
144145|NCT02670226|Muscle metabolism|muscle metabolism
144146|NCT02670226|Metabolomics|metabolomics
144147|NCT02670226|Transcriptomics|transcriptomics
144148|NCT02670200|psychooncology|psychooncology
144149|NCT02670200|mental health support|mental health support
144150|NCT02670200|ICBT|icbt
144151|NCT02670200|supportive treatment for cancer patients|supportive treatment for cancer patients
144152|NCT02670200|depression|depression
144153|NCT02670200|online-therapy|online-therapy
144154|NCT02670200|Psycho-oncological support via internet|psycho-oncological support via internet
144155|NCT02670200|internet-delivered cognitive behavior medicine|internet-delivered cognitive behavior medicine
144156|NCT02670187|MERS CoV, Vaccine, DNA|mers cov, vaccine, dna
144157|NCT02670174|Shoulder impingement syndrome|shoulder impingement syndrome
144158|NCT02670174|Overhead athletes|overhead athletes
144159|NCT02670174|Kinetic chain|kinetic chain
144160|NCT02670174|Exercise treatment|exercise treatment
144161|NCT02670148|Chiropractic Manipulative Therapy|chiropractic manipulative therapy
144162|NCT02670148|Low back pain|low back pain
144163|NCT02670148|Trunk muscle strength|trunk muscle strength
144164|NCT02670148|Balance|balance
144165|NCT02670148|Active military personnel|active military personnel
144166|NCT02670122|Hepatocellular Carcinoma|hepatocellular carcinoma
144167|NCT02670122|TACE|tace
144168|NCT02670096|acetazolamide|acetazolamide
144271|NCT02669303|treatment|treatment
144169|NCT02670096|Treatment Emergent Sleep Disordered Breathing|treatment emergent sleep disordered breathing
144170|NCT02670096|Sleep Apnea|sleep apnea
144171|NCT02670031|Hypertensive Heart Disease|hypertensive heart disease
144172|NCT02670031|Hypertension|hypertension
144173|NCT02670031|Left Ventricular Hypertrophy|left ventricular hypertrophy
144174|NCT02670031|Myocardial Fibrosis|myocardial fibrosis
144175|NCT02670031|Cardiovascular Magnetic Resonance Imaging|cardiovascular magnetic resonance imaging
144176|NCT02669992|Ileostomy|ileostomy
144177|NCT02669979|elderly|elderly
144178|NCT02669979|oral care|oral care
144179|NCT02669966|Kidney Transplantation|kidney transplantation
144180|NCT02669940|Ombitasvir|ombitasvir
144181|NCT02669940|Dasabuvir|dasabuvir
144182|NCT02669940|Paritaprevir|paritaprevir
144183|NCT02669927|hip surgery|hip surgery
144184|NCT02669927|frail older people|frail older people
144185|NCT02669901|Opioid-Related Disorders|opioid-related disorders
144186|NCT02669901|Naloxone|naloxone
144187|NCT02669901|Harm Reduction|harm reduction
144188|NCT02669901|Drug Overdose Deaths|drug overdose deaths
144189|NCT02669901|Opioid Misuse|opioid misuse
144190|NCT02669901|Naloxone Coprescribing|naloxone coprescribing
144191|NCT02669901|Universal Precautions|universal precautions
144192|NCT02669901|Opioid Substance Use Disorder|opioid substance use disorder
144193|NCT02669888|Indigo Naturalis|indigo naturalis
144194|NCT02669888|Atopic Dermatitis|atopic dermatitis
144195|NCT02669888|TCM|tcm
144196|NCT02669823|Diagnosis|diagnosis
144197|NCT02669797|Childhood Obesity|childhood obesity
144198|NCT02669797|Ecological Momentary Intervention|ecological momentary intervention
144199|NCT02669797|Video Feedback|video feedback
144200|NCT02669771|Xtandi|xtandi
144201|NCT02669771|MDV3100|mdv3100
144202|NCT02669771|long term use|long term use
144203|NCT02669771|enzalutamide|enzalutamide
144204|NCT02669758|Alkermes|alkermes
144205|NCT02669758|ALKS 3831|alks 3831
144206|NCT02669758|Samidorphan|samidorphan
144207|NCT02669758|Schizophrenia|schizophrenia
144208|NCT02669758|Safety|safety
144209|NCT02669745|Chinese women|chinese women
144210|NCT02669745|Breast cancer|breast cancer
144211|NCT02669732|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
144212|NCT02669732|Adult|adult
144213|NCT02669732|Developmental Phase II|developmental phase ii
144214|NCT02669719|Lung Cancer|lung cancer
144215|NCT02669719|Chemotherapy|chemotherapy
144216|NCT02669719|Immunotherapy|immunotherapy
144217|NCT02669693|Olives, oleuropein|olives, oleuropein
144218|NCT02669667|MEDI9314|medi9314
144219|NCT02669667|Safety|safety
144220|NCT02669667|Tolerability|tolerability
144221|NCT02669667|Pharmacokinetics|pharmacokinetics
144222|NCT02669667|Immunogenicity|immunogenicity
144223|NCT02669641|Steatosis, Fatty liver, Steatohepatitis|steatosis, fatty liver, steatohepatitis
144224|NCT02669615|multiple myeloma|multiple myeloma
144225|NCT02669615|Melphalan HCl|melphalan hcl
144226|NCT02669615|Autologous Transplantation|autologous transplantation
144227|NCT02669602|Nutritional epidemiology|nutritional epidemiology
144228|NCT02669602|Prospective|prospective
144229|NCT02669589|CRRT|crrt
144230|NCT02669589|AKI|aki
144231|NCT02669589|anticoagulation|anticoagulation
144232|NCT02669589|KDIGO|kdigo
144233|NCT02669576|Breast cancer|breast cancer
144234|NCT02669576|meopausal syptoms|meopausal syptoms
144235|NCT02669576|mind body medecine|mind body medecine
144236|NCT02669576|yoga|yoga
144237|NCT02669576|acupuncture|acupuncture
144238|NCT02669550|Fiberoptic bronchoscope|fiberoptic bronchoscope
144239|NCT02669550|Disposcope endoscope|disposcope endoscope
144240|NCT02669550|Awake orotracheal intubation|awake orotracheal intubation
144241|NCT02669511|DLBCL|dlbcl
144242|NCT02669485|ICG|icg
144243|NCT02669485|colectomy|colectomy
144244|NCT02669485|anastomotic leak|anastomotic leak
144245|NCT02669485|anastomotic leakage rate|anastomotic leakage rate
144246|NCT02669485|surgical decision|surgical decision
144247|NCT02669459|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
144248|NCT02669459|Imiquimod|imiquimod
144249|NCT02669459|Human papillomavirus|human papillomavirus
144250|NCT02669459|quality of life|quality of life
144251|NCT02669459|biological markers|biological markers
144252|NCT02669446|Non interventional study|non interventional study
144253|NCT02669446|Ectoin|ectoin
144254|NCT02669446|Lozenges|lozenges
144255|NCT02669446|pharyngitis|pharyngitis
144256|NCT02669433|Dementia with Lewy bodies|dementia with lewy bodies
144257|NCT02669433|Lewy bodies|lewy bodies
144258|NCT02669433|intepirdine|intepirdine
144259|NCT02669433|RVT-101|rvt-101
144260|NCT02669433|dementia|dementia
144261|NCT02669381|Phenylalanine|phenylalanine
144262|NCT02669381|Direct Amino Acid Oxidation|direct amino acid oxidation
144263|NCT02669381|Stable isotopes|stable isotopes
144264|NCT02669355|White coat physician attire|white coat physician attire
144265|NCT02669342|Infection|infection
144266|NCT02669342|Urinary Catheter|urinary catheter
144267|NCT02669342|Sharklet|sharklet
144268|NCT02669316|diet|diet
144269|NCT02669303|Subacromial injection|subacromial injection
144270|NCT02669303|methylprednisolone|methylprednisolone
144272|NCT02669303|Platelet-rich plasma|platelet-rich plasma
144273|NCT02669264|Loncastuximab tesirine|loncastuximab tesirine
144274|NCT02669251|Optimal Biologic Dose|optimal biologic dose
144275|NCT02669251|Safety|safety
144276|NCT02669251|Chronic Graft-Versus-Host Disease (cGVHD)|chronic graft-versus-host disease (cgvhd)
144277|NCT02669251|Inflammatory Lung Disease|inflammatory lung disease
144278|NCT02669251|FEV1|fev1
144279|NCT02669225|18 F florbetaben|18 f florbetaben
144280|NCT02669225|Sleep Deprivation|sleep deprivation
144281|NCT02669225|rested wakefulness|rested wakefulness
144282|NCT02669225|glymphatic system|glymphatic system
144283|NCT02669212|Chronic Fatigue Syndrome|chronic fatigue syndrome
144284|NCT02669212|Lyme Disease|lyme disease
144285|NCT02669212|Healthy Volunteers|healthy volunteers
144286|NCT02669212|Movement Disorder|movement disorder
144287|NCT02669186|analgesia|analgesia
144288|NCT02669186|cancer|cancer
144289|NCT02669186|natural killer cell|natural killer cell
144290|NCT02669186|opioid|opioid
144291|NCT02669173|Myeloid derived suppressor cells|myeloid derived suppressor cells
144292|NCT02669173|brain tumor|brain tumor
144293|NCT02669173|MDSC|mdsc
144294|NCT02669173|GBM|gbm
144295|NCT02669173|recurrent|recurrent
144296|NCT02669160|Motorized Orthotic Devices|motorized orthotic devices
144297|NCT02669160|Minors|minors
144298|NCT02669160|CP (Cerebral Palsy)|cp (cerebral palsy)
144299|NCT02669160|Exoskeleton Device|exoskeleton device
144300|NCT02669134|cardiac resynchronization therapy|cardiac resynchronization therapy
144301|NCT02669134|optimization|optimization
144302|NCT02669134|heart failure|heart failure
144303|NCT02669134|reverse left ventricular remodeling|reverse left ventricular remodeling
144304|NCT02669121|Drug therapy|drug therapy
144305|NCT02669108|testis|testis
144306|NCT02669108|spermatogenesis|spermatogenesis
144307|NCT02669082|Drug Therapy|drug therapy
144308|NCT02669069|Bi-modal neuromodulation|bi-modal neuromodulation
144309|NCT02669017|Loncastuximab tesirine|loncastuximab tesirine
144310|NCT02669004|Analgesia, Epidural,Pain, Postoperative|analgesia, epidural,pain, postoperative
144311|NCT02668991|Autism Spectrum Disorder|autism spectrum disorder
144312|NCT02668991|Janssen Autism Knowledge Engine|janssen autism knowledge engine
144313|NCT02668991|Autism Behavior Inventory|autism behavior inventory
144314|NCT02668978|lung surgery|lung surgery
144315|NCT02668978|air leak|air leak
144316|NCT02668978|prevention|prevention
144317|NCT02668965|Clinical pregnancy rate|clinical pregnancy rate
144318|NCT02668913|gynaecology|gynaecology
144319|NCT02668913|Oncology|oncology
144320|NCT02668900|Feasibility trial|feasibility trial
144321|NCT02668900|Cardiovascular disease|cardiovascular disease
144322|NCT02668900|Decision Support|decision support
144323|NCT02668900|Patient Decision Aid|patient decision aid
144324|NCT02668900|implantable cardioverter defibrillator|implantable cardioverter defibrillator
144325|NCT02668900|implantable cardioverter defibrillator replacement|implantable cardioverter defibrillator replacement
144326|NCT02668874|Pit and Fissure sealants|pit and fissure sealants
144327|NCT02668874|Isolation|isolation
144328|NCT02668874|permanent teeth|permanent teeth
144329|NCT02668874|children|children
144330|NCT02668874|Isolite®|isolite®
144331|NCT02668874|Dental caries|dental caries
144332|NCT02668848|Stroke|stroke
144333|NCT02668848|Dehydration|dehydration
144334|NCT02668848|Fluid therapy|fluid therapy
144335|NCT02668770|Advanced Cancers|advanced cancers
144336|NCT02668770|Melanoma|melanoma
144337|NCT02668770|Advanced solid malignancies|advanced solid malignancies
144338|NCT02668770|Metastatic|metastatic
144339|NCT02668770|MGN1703|mgn1703
144340|NCT02668770|Ipilimumab|ipilimumab
144341|NCT02668770|Yervoy|yervoy
144342|NCT02668770|BMS-734016|bms-734016
144343|NCT02668770|MDX010|mdx010
144344|NCT02668770|Refractory|refractory
144345|NCT02668770|Relapsed|relapsed
144346|NCT02668718|radiotherapy, adjuvant|radiotherapy, adjuvant
144347|NCT02668718|prostatectomy|prostatectomy
144348|NCT02668692|LEO 80185 gel, calcipotriol, betamethasone|leo 80185 gel, calcipotriol, betamethasone
144349|NCT02668679|Dream Doctors|dream doctors
144350|NCT02668679|Medical Clown|medical clown
144351|NCT02668679|Pediatrics|pediatrics
144352|NCT02668679|Sedation|sedation
144353|NCT02668679|Endoscopy|endoscopy
144354|NCT02668666|Palbociclib|palbociclib
144355|NCT02668666|Tamoxifen|tamoxifen
144356|NCT02668666|CDK4/6 Inhibitor|cdk4/6 inhibitor
144357|NCT02668653|Newly diagnosed Acute Myeloid Leukemia|newly diagnosed acute myeloid leukemia
144358|NCT02668653|FLT3-ITD positive|flt3-itd positive
144359|NCT02668653|Chemotherapy|chemotherapy
144360|NCT02668653|Induction chemotherapy|induction chemotherapy
144361|NCT02668653|Consolidation chemotherapy|consolidation chemotherapy
144362|NCT02668653|Maintenance chemotherapy|maintenance chemotherapy
144363|NCT02668653|Quizartinib|quizartinib
144364|NCT02668653|Receptor tyrosine kinase inhibitor|receptor tyrosine kinase inhibitor
144365|NCT02668653|Feline McDonough sarcoma (FMS)-like tyrosine kinase 3|feline mcdonough sarcoma (fms)-like tyrosine kinase 3
144366|NCT02668653|AC220|ac220
144367|NCT02668653|FLT3-ITD|flt3-itd
144368|NCT02668653|AML|aml
144369|NCT02668640|Quality of life (QOL)|quality of life (qol)
144370|NCT02668640|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
144371|NCT02668640|Work productivity|work productivity
144372|NCT02668640|Adalimumab|adalimumab
144373|NCT02668627|Stroke|stroke
144374|NCT02668627|Collateral status|collateral status
144375|NCT02668627|Endovascular treatment|endovascular treatment
144376|NCT02668614|Detection|detection
144377|NCT02668601|Gestational Diabetes Mellitus|gestational diabetes mellitus
144378|NCT02668601|Childhood Obesity|childhood obesity
144379|NCT02668601|Offspring|offspring
144380|NCT02668575|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
144381|NCT02668562|acute coronary syndrome|acute coronary syndrome
144382|NCT02668562|coronary artery bypass surgery|coronary artery bypass surgery
144383|NCT02668562|ticagrelor|ticagrelor
144384|NCT02668562|antiplatelet therapy|antiplatelet therapy
144385|NCT02668562|platelet function testing|platelet function testing
144386|NCT02668536|sunscreen|sunscreen
144387|NCT02668536|melanoma|melanoma
144388|NCT02668536|improved protection from uv rays|improved protection from uv rays
144389|NCT02668523|Presbyopia|presbyopia
144390|NCT02668523|Corneal Inlay|corneal inlay
144391|NCT02668523|Pseudophakic|pseudophakic
144392|NCT02668523|Pseudophakia|pseudophakia
144393|NCT02668510|Heel Pain|heel pain
144394|NCT02668510|extracorporeal shock wave therapy|extracorporeal shock wave therapy
144395|NCT02668510|ESWT|eswt
144396|NCT02668510|shock wave|shock wave
144397|NCT02668510|Soldiers|soldiers
144398|NCT02668510|Platelet rich plasma|platelet rich plasma
144399|NCT02668510|PRP|prp
144400|NCT02668510|Autologous conditioned plasma|autologous conditioned plasma
144401|NCT02668510|Military|military
144402|NCT02668497|Movement disorders|movement disorders
144403|NCT02668497|Botulinum toxin type A|botulinum toxin type a
144404|NCT02668497|Tremor|tremor
144405|NCT02668497|Kinematics|kinematics
144406|NCT02668484|TAVI|tavi
144407|NCT02668484|trans-femoral|trans-femoral
144408|NCT02668484|Sapien|sapien
144409|NCT02668484|Lotus|lotus
144410|NCT02668445|Concurrent|concurrent
144411|NCT02668445|muscle|muscle
144412|NCT02668445|glycogen|glycogen
144413|NCT02668445|molecular|molecular
144414|NCT02668406|Blood infection, melioidosis, rapid diagnostic test|blood infection, melioidosis, rapid diagnostic test
144415|NCT02668380|Apatinib|apatinib
144416|NCT02668380|metastatic gastric cancer|metastatic gastric cancer
144417|NCT02668380|Non-interventionalStudy|non-interventionalstudy
144418|NCT02668367|Viral Diseases|viral diseases
144419|NCT02668367|Antiviral|antiviral
144420|NCT02668367|Paramyxoviridae Infections|paramyxoviridae infections
144421|NCT02668367|RSV|rsv
144422|NCT02668367|Respiratory Syncytial Virus|respiratory syncytial virus
144423|NCT02668367|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
144424|NCT02668367|Aviragen Therapeutics|aviragen therapeutics
144425|NCT02668367|Aviragen|aviragen
144426|NCT02668354|Childhood Cancer|childhood cancer
144427|NCT02668354|Pediatric Oncology|pediatric oncology
144428|NCT02668354|Infant tumors|infant tumors
144429|NCT02668302|Steroid-eluting implant|steroid-eluting implant
144430|NCT02668302|Mometasone furoate|mometasone furoate
144431|NCT02668276|Prostatic neoplasms|prostatic neoplasms
144432|NCT02668276|Oncotype DX|oncotype dx
144433|NCT02668276|Treatment Decisions|treatment decisions
144434|NCT02668263|Breast cancer|breast cancer
144435|NCT02668263|mastectomy|mastectomy
144436|NCT02668263|seromas|seromas
144437|NCT02668211|osteoarthritis|osteoarthritis
144438|NCT02668211|radiostereometric analysis|radiostereometric analysis
144439|NCT02668211|correction of functional deformity|correction of functional deformity
144440|NCT02668211|procedures|procedures
144441|NCT02668211|total hip arthroplasty|total hip arthroplasty
144442|NCT02668211|musculoskeletal diseases|musculoskeletal diseases
144443|NCT02668198|Endoscopic mucosal resection, residual polyp, near focus imaging|endoscopic mucosal resection, residual polyp, near focus imaging
144444|NCT02668172|pegvisomant|pegvisomant
144445|NCT02668172|pasireotide LAR|pasireotide lar
144446|NCT02668172|long acting somatostatin analogues|long acting somatostatin analogues
144447|NCT02668146|essential tremor|essential tremor
144448|NCT02668146|Perampanel|perampanel
144449|NCT02668146|clinical trial|clinical trial
144450|NCT02668133|zinc deficiency|zinc deficiency
144451|NCT02668133|zinc absorption|zinc absorption
144452|NCT02668120|chronic histiocytic intervillositis|chronic histiocytic intervillositis
144453|NCT02668120|serum alkaline phosphatase|serum alkaline phosphatase
144454|NCT02668120|placenta|placenta
144455|NCT02668120|case-control study|case-control study
144456|NCT02668094|propofol|propofol
144457|NCT02668094|lidocaine|lidocaine
144458|NCT02668094|pregabalin|pregabalin
144459|NCT02668081|Endoscopic sphincterotomy|endoscopic sphincterotomy
144460|NCT02668081|Endoscopic papillary balloon dilation|endoscopic papillary balloon dilation
144461|NCT02668081|Metagenomics|metagenomics
144462|NCT02668068|Pneumoconiosis|pneumoconiosis
144463|NCT02668068|Mesenchymal Stem Cells|mesenchymal stem cells
144464|NCT02668068|whole-lung lavage (WLL)|whole-lung lavage (wll)
144465|NCT02668055|TB4|tb4
144466|NCT02668055|Difficult to heal|difficult to heal
144467|NCT02668029|Oxygen therapy|oxygen therapy
144571|NCT02667379|allergy|allergy
144468|NCT02668003|Prevention trial|prevention trial
144469|NCT02668003|Cognitive Behaviour Therapy|cognitive behaviour therapy
144470|NCT02668003|CWP|cwp
144471|NCT02668003|Chronic widespread pain|chronic widespread pain
144472|NCT02668003|RCT|rct
144473|NCT02668003|Fibromyalgia|fibromyalgia
144474|NCT02668003|Prevention|prevention
144475|NCT02667990|metatarsalgia|metatarsalgia
144476|NCT02667990|pedobar|pedobar
144477|NCT02667990|foot|foot
144478|NCT02667990|stiletto|stiletto
144479|NCT02667990|insoles|insoles
144480|NCT02667977|fluids, pediatric, gastroenteritis|fluids, pediatric, gastroenteritis
144481|NCT02667951|Elderly|elderly
144482|NCT02667951|Dementia|dementia
144483|NCT02667951|Intervention program|intervention program
144484|NCT02667925|ovarian cancer|ovarian cancer
144485|NCT02667925|intraperitoneal chemotherapy|intraperitoneal chemotherapy
144486|NCT02667912|Hypertension, Endovascular Procedures, Catheter Ablation, Renal Artery|hypertension, endovascular procedures, catheter ablation, renal artery
144487|NCT02667899|disorders of consciousness|disorders of consciousness
144488|NCT02667899|deep brain stimulation|deep brain stimulation
144489|NCT02667899|transcranial magnetic stimulation|transcranial magnetic stimulation
144490|NCT02667860|intracorporeal anastomosis|intracorporeal anastomosis
144491|NCT02667860|laparoscopic colectomy|laparoscopic colectomy
144492|NCT02667860|outcomes|outcomes
144493|NCT02667860|length of stay|length of stay
144494|NCT02667860|analgesia|analgesia
144495|NCT02667860|aesthetic|aesthetic
144496|NCT02667860|extracorporeal anastomosis|extracorporeal anastomosis
144497|NCT02667860|laparoscopic|laparoscopic
144498|NCT02667847|preoperative anxiety assessment|preoperative anxiety assessment
144499|NCT02667847|levels of preoperative anxiety using two different scales|levels of preoperative anxiety using two different scales
144500|NCT02667834|social cognition|social cognition
144501|NCT02667834|cognitive remediation|cognitive remediation
144502|NCT02667782|Mindfulness-based interventions|mindfulness-based interventions
144503|NCT02667782|Dementia|dementia
144504|NCT02667782|Caregiving|caregiving
144505|NCT02667782|Burden|burden
144506|NCT02667782|Stress|stress
144507|NCT02667782|Anxiety|anxiety
144508|NCT02667782|Depression|depression
144509|NCT02667782|Community care|community care
144510|NCT02667756|biomarker|biomarker
144511|NCT02667756|inflammation|inflammation
144512|NCT02667756|prognosis|prognosis
144513|NCT02667756|knee|knee
144514|NCT02667743|NSCLC|nsclc
144515|NCT02667743|Paclitaxel Micelles for Injection|paclitaxel micelles for injection
144516|NCT02667691|superoxyde dismutase|superoxyde dismutase
144517|NCT02667691|melon concentrate|melon concentrate
144518|NCT02667691|oxydative stress|oxydative stress
144519|NCT02667691|overweight women|overweight women
144520|NCT02667665|Alzheimer's Disease Dementia|alzheimer's disease dementia
144521|NCT02667652|T2DM|t2dm
144522|NCT02667652|RYGB|rygb
144523|NCT02667652|RCT|rct
144524|NCT02667639|safety|safety
144525|NCT02667639|tolerability|tolerability
144526|NCT02667639|RPH-104|rph-104
144527|NCT02667639|RPH104|rph104
144528|NCT02667626|Breast cancer survivor|breast cancer survivor
144529|NCT02667626|Cancer survivorship|cancer survivorship
144530|NCT02667626|Survivorship care plan|survivorship care plan
144531|NCT02667626|Vaginal dryness|vaginal dryness
144532|NCT02667626|Vulvovaginal atrophy|vulvovaginal atrophy
144533|NCT02667626|Vasomotor symptom|vasomotor symptom
144534|NCT02667626|Infertility|infertility
144535|NCT02667626|Family planning|family planning
144536|NCT02667613|motor skill learning|motor skill learning
144537|NCT02667613|functional changes|functional changes
144538|NCT02667613|neuroplastic changes|neuroplastic changes
144539|NCT02667600|Cesarean|cesarean
144540|NCT02667600|Blood Loss|blood loss
144541|NCT02667600|Triton|triton
144542|NCT02667574|basal cell carcinoma|basal cell carcinoma
144543|NCT02667574|surgery|surgery
144544|NCT02667574|stage|stage
144545|NCT02667574|vismodegib|vismodegib
144546|NCT02667548|percutaneous coronary intervention|percutaneous coronary intervention
144547|NCT02667509|Evolutionary Model|evolutionary model
144548|NCT02667483|Duchenne muscular dystrophy|duchenne muscular dystrophy
144549|NCT02667483|DMD|dmd
144550|NCT02667483|Oligonucleotides, Antisense|oligonucleotides, antisense
144551|NCT02667483|Exon skipping|exon skipping
144552|NCT02667470|Solifenacin|solifenacin
144553|NCT02667470|Overactive bladder|overactive bladder
144554|NCT02667431|SUI|sui
144555|NCT02667418|Clostridium|clostridium
144556|NCT02667418|Difficile|difficile
144557|NCT02667418|Fidaxomicin|fidaxomicin
144558|NCT02667418|Vancomycin|vancomycin
144559|NCT02667418|Recurrent|recurrent
144560|NCT02667418|Pulse|pulse
144561|NCT02667418|Taper|taper
144562|NCT02667392|Stroke|stroke
144563|NCT02667392|Gait|gait
144564|NCT02667392|Walking|walking
144565|NCT02667392|Rehabilitation|rehabilitation
144566|NCT02667392|Exercise|exercise
144567|NCT02667392|Exercise Therapy|exercise therapy
144568|NCT02667392|Physical Therapy Modalities|physical therapy modalities
144569|NCT02667392|Exercise Movement Techniques|exercise movement techniques
144570|NCT02667379|Cat|cat
144572|NCT02667379|dander|dander
144573|NCT02667379|Fel d 1|fel d 1
144574|NCT02667379|Felis domesticus|felis domesticus
144575|NCT02667366|mild and moderate depression|mild and moderate depression
144576|NCT02667353|electroconvulsive|electroconvulsive
144577|NCT02667353|hippocampus|hippocampus
144578|NCT02667353|elderly|elderly
144579|NCT02667353|working mechanism|working mechanism
144580|NCT02667340|exercise|exercise
144581|NCT02667340|carbohydrate|carbohydrate
144582|NCT02667340|Superstarch|superstarch
144583|NCT02667327|diabetic foot ulcer|diabetic foot ulcer
144584|NCT02667327|diabetic complications|diabetic complications
144585|NCT02667327|diabetes|diabetes
144586|NCT02667327|wound healing|wound healing
144587|NCT02667327|Granexin gel|granexin gel
144588|NCT02667327|FirstString Research|firststring research
144589|NCT02667314|Cognition|cognition
144590|NCT02667314|Cognitive Aging|cognitive aging
144591|NCT02667314|Dementia|dementia
144592|NCT02667314|Neurocognitive Disorders|neurocognitive disorders
144593|NCT02667314|Cognitive Therapy|cognitive therapy
144594|NCT02667314|Cognitive Reserve|cognitive reserve
144595|NCT02667314|Cognitive Enrichment|cognitive enrichment
144596|NCT02667314|Jigsaw Puzzles|jigsaw puzzles
144597|NCT02667275|seborrheic keratosis|seborrheic keratosis
144598|NCT02667249|cholecystectomy, check list|cholecystectomy, check list
144599|NCT02667236|seborrheic keratosis|seborrheic keratosis
144600|NCT02667223|pharmacokinetics|pharmacokinetics
144601|NCT02667223|pharmacodynamics|pharmacodynamics
144602|NCT02667223|RN316|rn316
144603|NCT02667223|recombinant human hyaluronidase|recombinant human hyaluronidase
144604|NCT02667145|hand osteoarthritis|hand osteoarthritis
144605|NCT02667145|self care program|self care program
144606|NCT02667145|assistive tecnology|assistive tecnology
144607|NCT02667132|Granulomatous, Mastitis|granulomatous, mastitis
144608|NCT02667132|C17.800.090.968.400|c17.800.090.968.400
144609|NCT02667132|C13.703.844.603.400|c13.703.844.603.400
144610|NCT02667093|Acute Leukemia|acute leukemia
144611|NCT02667093|Acute Myeloid Leukemia|acute myeloid leukemia
144612|NCT02667093|AML|aml
144613|NCT02667080|Semen quality|semen quality
144614|NCT02667080|Sexual Abstinence|sexual abstinence
144615|NCT02667080|sperm motility|sperm motility
144616|NCT02667080|DNA fragmentation|dna fragmentation
144617|NCT02667015|Substance Use Disorders|substance use disorders
144618|NCT02667015|Anxiety|anxiety
144619|NCT02667015|Anxiety Sensitivity|anxiety sensitivity
144620|NCT02667015|Brief Intervention|brief intervention
144621|NCT02667015|Treatment|treatment
144622|NCT02666989|Depression|depression
144623|NCT02666989|Placebo|placebo
144624|NCT02666989|Open-label|open-label
144625|NCT02666989|Clinical practice|clinical practice
144626|NCT02666976|Gastroesophageal reflux, proton pump inhibitors, ilaprazole|gastroesophageal reflux, proton pump inhibitors, ilaprazole
144627|NCT02666963|RTA 901|rta 901
144628|NCT02666963|RTA 901 capsules|rta 901 capsules
144629|NCT02666898|Residual disease|residual disease
144630|NCT02666885|Personalized Medicine|personalized medicine
144631|NCT02666885|Radiation Oncology|radiation oncology
144632|NCT02666885|Functional Imaging|functional imaging
144633|NCT02666885|Biomarker|biomarker
144634|NCT02666885|Decision Support System|decision support system
144635|NCT02666885|Radiomics|radiomics
144636|NCT02666872|Vaccination|vaccination
144637|NCT02666872|Infant|infant
144638|NCT02666872|Parents|parents
144639|NCT02666872|Intention|intention
144640|NCT02666846|UVB Pain Model|uvb pain model
144641|NCT02666846|PK|pk
144642|NCT02666846|Topical|topical
144643|NCT02666846|NSAIDs|nsaids
144644|NCT02666833|Skin Cancer|skin cancer
144645|NCT02666833|Basal Cell Carcinoma|basal cell carcinoma
144646|NCT02666833|Squamous Cell Carcinoma|squamous cell carcinoma
144647|NCT02666833|Mohs Surgery|mohs surgery
144648|NCT02666833|Imaging|imaging
144649|NCT02666807|NF-κB|nf-κb
144650|NCT02666807|Ginger|ginger
144651|NCT02666794|analgesia|analgesia
144652|NCT02666794|fetal bradycardia|fetal bradycardia
144653|NCT02666794|hypertonic uterine|hypertonic uterine
144654|NCT02666781|OSA, Surgery, Postoperative, Rostral Fluid Shift|osa, surgery, postoperative, rostral fluid shift
144655|NCT02666755|Lung Neoplasms digital polymerase chain reaction|lung neoplasms digital polymerase chain reaction
144656|NCT02666716|pharmacokinetics|pharmacokinetics
144657|NCT02666716|fluconazole|fluconazole
144658|NCT02666716|invasive fungal infection|invasive fungal infection
144659|NCT02666716|candidiasis|candidiasis
144660|NCT02666716|intensive care unit|intensive care unit
144661|NCT02666703|cardiac surgery|cardiac surgery
144662|NCT02666703|systemic inflammatory response|systemic inflammatory response
144663|NCT02666703|immunoadsorption|immunoadsorption
144664|NCT02666677|polytrauma, emergency medicine|polytrauma, emergency medicine
144665|NCT02666664|hyperlipidemia|hyperlipidemia
144666|NCT02666664|cholesterol|cholesterol
144667|NCT02666664|heterozygous familial hypercholesterolemia|heterozygous familial hypercholesterolemia
144668|NCT02666664|atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease
144669|NCT02666664|ASCVD|ascvd
144670|NCT02666664|HeFH|hefh
144671|NCT02666664|LDL|ldl
144976|NCT02664870|biomarkers|biomarkers
144672|NCT02666638|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
144673|NCT02666612|Patients|patients
144674|NCT02666599|F-18-FDG|f-18-fdg
144675|NCT02666599|neoplasm|neoplasm
144676|NCT02666599|probe|probe
144677|NCT02666599|positron|positron
144678|NCT02666599|diagnosis|diagnosis
144679|NCT02666599|surgery|surgery
144680|NCT02666599|radioguided surgery|radioguided surgery
144681|NCT02666573|drug therapy|drug therapy
144682|NCT02666573|Photosensitizing Agents|photosensitizing agents
144683|NCT02666573|therapeutic use|therapeutic use
144684|NCT02666560|Auditory Cueing|auditory cueing
144685|NCT02666560|Gait|gait
144686|NCT02666547|68Ga-NODAGA-RGD|68ga-nodaga-rgd
144687|NCT02666547|18F-FDG|18f-fdg
144688|NCT02666547|18F-FET|18f-fet
144689|NCT02666547|PET/CT|pet/ct
144690|NCT02666547|neoangiogenesis|neoangiogenesis
144691|NCT02666534|Ablative fractional laser|ablative fractional laser
144692|NCT02666534|microinvasive squamous cell carcinoma|microinvasive squamous cell carcinoma
144693|NCT02666534|photodynamic therapy|photodynamic therapy
144694|NCT02666521|Primary Health Care|primary health care
144695|NCT02666508|plaque identifying toothpaste|plaque identifying toothpaste
144696|NCT02666508|plaque score|plaque score
144697|NCT02666508|C-reactive protein|c-reactive protein
144698|NCT02666495|Schema Therapy|schema therapy
144699|NCT02666482|smoking|smoking
144700|NCT02666482|stop smoking|stop smoking
144701|NCT02666482|tobacco use cessation|tobacco use cessation
144702|NCT02666469|Hyperbaric oxygen treatment, rehabilitation|hyperbaric oxygen treatment, rehabilitation
144703|NCT02666443|brachial plexus|brachial plexus
144704|NCT02666443|supraclavicular|supraclavicular
144705|NCT02666443|duration|duration
144706|NCT02666443|dexamethasone|dexamethasone
144707|NCT02666443|block|block
144708|NCT02666417|Iron fortification|iron fortification
144709|NCT02666417|Anemia|anemia
144710|NCT02666417|Iron Deficiency|iron deficiency
144711|NCT02666417|Iron Absorption|iron absorption
144712|NCT02666417|Prebiotics|prebiotics
144713|NCT02666417|Stable isotopes|stable isotopes
144714|NCT02666404|Volume Resuscitation|volume resuscitation
144715|NCT02666404|Shock|shock
144716|NCT02666404|Body Impedance Measurement|body impedance measurement
144717|NCT02666404|Renal Resistive Index|renal resistive index
144718|NCT02666404|Acute Kidney Injury|acute kidney injury
144719|NCT02666404|Renal Replacement Therapy|renal replacement therapy
144720|NCT02666378|HER-2 Positive Breast Cancer|her-2 positive breast cancer
144721|NCT02666365|anesthesia|anesthesia
144722|NCT02666365|surgical antimicrobial prophylaxis|surgical antimicrobial prophylaxis
144723|NCT02666365|surgical site infections|surgical site infections
144724|NCT02666339|Hortitherapy|hortitherapy
144725|NCT02666339|Care-garden|care-garden
144726|NCT02666339|Anxiety|anxiety
144727|NCT02666339|Therapeutic alliance|therapeutic alliance
144728|NCT02666326|Acute Coronary Syndrome|acute coronary syndrome
144729|NCT02666326|Prehospital emergency care|prehospital emergency care
144730|NCT02666326|Biological markers|biological markers
144731|NCT02666326|Copeptin|copeptin
144732|NCT02666326|Troponin|troponin
144733|NCT02666326|Rule-out|rule-out
144734|NCT02666326|Point-of-Care systems|point-of-care systems
144735|NCT02666326|Infarction|infarction
144736|NCT02666326|Cardiovascular Diseases|cardiovascular diseases
144737|NCT02666326|Heart Diseases|heart diseases
144738|NCT02666326|Ischemia|ischemia
144739|NCT02666326|Myocardial Ischemia|myocardial ischemia
144740|NCT02666326|copeptins|copeptins
144741|NCT02666326|Troponin T|troponin t
144742|NCT02666326|Diagnostic Techniques (Cardiovascular)|diagnostic techniques (cardiovascular)
144743|NCT02666326|High sensitivity troponin|high sensitivity troponin
144744|NCT02666300|Postoperative sore throat,Anesthesia|postoperative sore throat,anesthesia
144745|NCT02666287|Fluticasone furoate|fluticasone furoate
144746|NCT02666287|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
144747|NCT02666287|Batefenterol|batefenterol
144748|NCT02666287|Dry Powder Inhaler|dry powder inhaler
144749|NCT02666287|Respiratory|respiratory
144750|NCT02666287|Pharmacokinetics|pharmacokinetics
144751|NCT02666287|Ellipta|ellipta
144752|NCT02666287|Healthy Subjects|healthy subjects
144753|NCT02666274|carbapenem resistance|carbapenem resistance
144754|NCT02666274|bacterial carriage|bacterial carriage
144755|NCT02666274|multi-drug resistant gram negative bacteria|multi-drug resistant gram negative bacteria
144756|NCT02666222|hearing loss|hearing loss
144757|NCT02666222|sensorineural|sensorineural
144758|NCT02666222|hearing implant|hearing implant
144759|NCT02666209|Multiple Myeloma|multiple myeloma
144760|NCT02666209|Relapsed Multiple Myeloma|relapsed multiple myeloma
144761|NCT02666209|Refractory Multiple Myeloma|refractory multiple myeloma
144762|NCT02666183|cancer|cancer
144763|NCT02666183|caregiver|caregiver
144764|NCT02666183|videoconferencing|videoconferencing
144765|NCT02666157|atrial fibrillation|atrial fibrillation
144766|NCT02666157|stroke|stroke
144767|NCT02666157|systemic embolism|systemic embolism
144768|NCT02666157|bleeding|bleeding
144769|NCT02666157|oral anticoagulant|oral anticoagulant
144770|NCT02666131|diabetic foot ulcer|diabetic foot ulcer
144977|NCT02664857|Vitamin D|vitamin d
144771|NCT02666131|diabetic complications|diabetic complications
144772|NCT02666131|diabetes|diabetes
144773|NCT02666131|wound healing|wound healing
144774|NCT02666131|Granexin gel|granexin gel
144775|NCT02666131|FirstString Research|firststring research
144776|NCT02666118|pain|pain
144777|NCT02666118|pain management|pain management
144778|NCT02666118|shoulder repair|shoulder repair
144779|NCT02666118|nerve blockade|nerve blockade
144780|NCT02666118|regional anesthesia|regional anesthesia
144781|NCT02666118|pediatrics|pediatrics
144782|NCT02666105|NSCLC|nsclc
144783|NCT02666092|IgE|ige
144784|NCT02666092|Immunoelectrophoresis|immunoelectrophoresis
144785|NCT02666092|Western Blot|western blot
144786|NCT02666092|ImmunoCAP|immunocap
144787|NCT02666079|Wide local excision (WLE) for breast cancer|wide local excision (wle) for breast cancer
144788|NCT02666027|Fluid monitoring|fluid monitoring
144789|NCT02666014|PONV|ponv
144790|NCT02666014|nausea|nausea
144791|NCT02666014|vomiting|vomiting
144792|NCT02666014|sugammadex|sugammadex
144793|NCT02666014|neostigmine|neostigmine
144794|NCT02665988|Transcranial Direct Current Stimulation|transcranial direct current stimulation
144795|NCT02665975|Tinnitus treatment|tinnitus treatment
144796|NCT02665975|Internet-intervention|internet-intervention
144797|NCT02665975|CBT|cbt
144798|NCT02665962|newly diagnosed patients|newly diagnosed patients
144799|NCT02665936|epidural analgesia|epidural analgesia
144800|NCT02665871|vaccine|vaccine
144801|NCT02665871|safety|safety
144802|NCT02665871|intranasal administration|intranasal administration
144803|NCT02665806|Ciclesonide|ciclesonide
144804|NCT02665806|Fluticasone propionate|fluticasone propionate
144805|NCT02665806|Nasal Polyposis|nasal polyposis
144806|NCT02665806|Chronic Sinuitis|chronic sinuitis
144807|NCT02665806|Chronic rhinosinusitis|chronic rhinosinusitis
144808|NCT02665793|Peanut allergy|peanut allergy
144809|NCT02665793|Food allergy|food allergy
144810|NCT02665793|Thresholds|thresholds
144811|NCT02665793|Anaphylaxis|anaphylaxis
144812|NCT02665780|halitosis, periodontal debridement, chemotherapeutics|halitosis, periodontal debridement, chemotherapeutics
144813|NCT02665767|Telesonography, Appendix|telesonography, appendix
144814|NCT02665754|Allergic rhinitis|allergic rhinitis
144815|NCT02665754|Injection, intralymphatic|injection, intralymphatic
144816|NCT02665754|Immunotherapy|immunotherapy
144817|NCT02665754|Dermatophagoides farinae|dermatophagoides farinae
144818|NCT02665754|Dermatophagoides pteronyssinus|dermatophagoides pteronyssinus
144819|NCT02665754|Dogs|dogs
144820|NCT02665754|Cats|cats
144821|NCT02665741|distal colonoscope attachments, colon cancer screening, screening colonoscopy, adenoma detection|distal colonoscope attachments, colon cancer screening, screening colonoscopy, adenoma detection
144822|NCT02665715|Reactive hypoglycemia|reactive hypoglycemia
144823|NCT02665715|Hyperinsulinaemia|hyperinsulinaemia
144824|NCT02665715|Diet|diet
144825|NCT02665715|Glucagon-like Peptide-1|glucagon-like peptide-1
144826|NCT02665715|Glucagon|glucagon
144827|NCT02665715|Peptide YY|peptide yy
144828|NCT02665715|Ghrelin|ghrelin
144829|NCT02665689|Diabetic Macular Edema, Ranibizumab, Visual Acuity, Diabetic Control,|diabetic macular edema, ranibizumab, visual acuity, diabetic control,
144830|NCT02665676|Childhood Cancer|childhood cancer
144831|NCT02665676|Pediatric Oncology|pediatric oncology
144832|NCT02665676|Embryonal Neoplasms|embryonal neoplasms
144833|NCT02665676|Embryonic Neoplasms|embryonic neoplasms
144834|NCT02665676|Embryonic Tumors|embryonic tumors
144835|NCT02665676|Embryonal Tumors|embryonal tumors
144836|NCT02665624|Bowel cleansing|bowel cleansing
144837|NCT02665624|Colonoscopy|colonoscopy
144838|NCT02665624|Stewed apricot juice|stewed apricot juice
144839|NCT02665624|Senna|senna
144840|NCT02665598|Posterior Reversible Encephalopathy Syndrome,Prognosis|posterior reversible encephalopathy syndrome,prognosis
144841|NCT02665585|carotid disease|carotid disease
144842|NCT02665585|stroke|stroke
144843|NCT02665585|stent|stent
144844|NCT02665585|carotid stenting|carotid stenting
144845|NCT02665572|renal transplantation|renal transplantation
144846|NCT02665572|defunctionalized bladder|defunctionalized bladder
144847|NCT02665572|bladder recycling|bladder recycling
144848|NCT02665559|HIV|hiv
144849|NCT02665559|Hypogonadism|hypogonadism
144850|NCT02665559|Metabolic Syndrom|metabolic syndrom
144851|NCT02665559|Reservoirs|reservoirs
144852|NCT02665559|Osteodensitometry|osteodensitometry
144853|NCT02665559|Erectil dysfonction|erectil dysfonction
144854|NCT02665559|Depression|depression
144855|NCT02665546|Dyspnea|dyspnea
144856|NCT02665546|pulmonary hypertension|pulmonary hypertension
144857|NCT02665546|Histiocytosis Langerhans cells|histiocytosis langerhans cells
144858|NCT02665546|exercise test|exercise test
144859|NCT02665533|pain measurement|pain measurement
144860|NCT02665533|edema|edema
144861|NCT02665533|trismus|trismus
144862|NCT02665520|stem cells injections|stem cells injections
144863|NCT02665520|erectile dysfunction|erectile dysfunction
144864|NCT02665507|Photobiomodulation|photobiomodulation
144865|NCT02665507|Aviation|aviation
144866|NCT02665481|Exercise|exercise
144867|NCT02665481|Mindfulness|mindfulness
144868|NCT02665481|Education|education
144869|NCT02665481|Elderly|elderly
144870|NCT02665468|Supported adoption|supported adoption
144871|NCT02665468|Secure messaging|secure messaging
144872|NCT02665468|Patient aligned care team (PACT)|patient aligned care team (pact)
144873|NCT02665468|My HealtheVet Coordinator|my healthevet coordinator
144874|NCT02665455|Diabetes Mellitus|diabetes mellitus
144875|NCT02665455|Sensing Technology|sensing technology
144876|NCT02665442|Esophageal Stylet|esophageal stylet
144877|NCT02665442|EsoSure|esosure
144878|NCT02665442|Atrial Fibrillation|atrial fibrillation
144879|NCT02665442|Catheter Ablation|catheter ablation
144880|NCT02665442|Mechanical esophageal displacement|mechanical esophageal displacement
144881|NCT02665429|Emergency Medicine|emergency medicine
144882|NCT02665390|lung cancer|lung cancer
144883|NCT02665390|Percutaneous cryoablation|percutaneous cryoablation
144884|NCT02665390|treatment of medically inoperable|treatment of medically inoperable
144885|NCT02665338|transcranial magnetic stimulation|transcranial magnetic stimulation
144886|NCT02665338|fMRI|fmri
144887|NCT02665338|cue craving|cue craving
144888|NCT02665325|TSH-suppressive therapy|tsh-suppressive therapy
144889|NCT02665325|cognitive function|cognitive function
144890|NCT02665312|cardiotoxicity|cardiotoxicity
144891|NCT02665312|fluoropyrimidine|fluoropyrimidine
144892|NCT02665312|colorectal cancer|colorectal cancer
144893|NCT02665299|colon cancer|colon cancer
144894|NCT02665299|colon polyps|colon polyps
144895|NCT02665299|colon adenomas|colon adenomas
144896|NCT02665299|colonoscopy|colonoscopy
144897|NCT02665299|circulating tumor DNA|circulating tumor dna
144898|NCT02665234|Dry Eye|dry eye
144899|NCT02665221|Multiple Sclerosis|multiple sclerosis
144900|NCT02665221|erythema|erythema
144901|NCT02665208|cigarettes|cigarettes
144902|NCT02665208|smoking|smoking
144903|NCT02665208|opiate-dependence|opiate-dependence
144904|NCT02665208|alcohol|alcohol
144905|NCT02665208|detoxification|detoxification
144906|NCT02665182|orchitis|orchitis
144907|NCT02665182|testicular diseases|testicular diseases
144908|NCT02665169|Postural Balance|postural balance
144909|NCT02665169|Cost-Benefit Analysis|cost-benefit analysis
144910|NCT02665169|Morbidity|morbidity
144911|NCT02665169|Exercise|exercise
144912|NCT02665143|acute myeloid leukemia|acute myeloid leukemia
144913|NCT02665130|COPD|copd
144914|NCT02665130|Pulmonary rehabilitation|pulmonary rehabilitation
144915|NCT02665117|Hypokalemia|hypokalemia
144916|NCT02665117|Isoprostanes|isoprostanes
144917|NCT02665117|Insulin resistance|insulin resistance
144918|NCT02665117|Aldosterone|aldosterone
144919|NCT02665117|Hepatic fat|hepatic fat
144920|NCT02665117|Muscle Magnesium|muscle magnesium
144921|NCT02665117|Liver fat|liver fat
144922|NCT02665104|Cerebral oxygen saturation|cerebral oxygen saturation
144923|NCT02665104|TCD|tcd
144924|NCT02665104|NIRS|nirs
144925|NCT02665104|Carotid endarterectomy|carotid endarterectomy
144926|NCT02665078|Lung Cancer|lung cancer
144927|NCT02665065|Acute Myeloid Leukemia|acute myeloid leukemia
144928|NCT02665065|Leukemia, Acute Myeloid|leukemia, acute myeloid
144929|NCT02665065|Myeloid Leukemia, Acute|myeloid leukemia, acute
144930|NCT02665065|Bone Marrow Cell Transplantation|bone marrow cell transplantation
144931|NCT02665065|Transplantation, Bone Marrow|transplantation, bone marrow
144932|NCT02665065|HCT|hct
144933|NCT02665065|HSCT|hsct
144934|NCT02665065|Refractory AML|refractory aml
144935|NCT02665065|Relapsed AML|relapsed aml
144936|NCT02665065|BC8|bc8
144937|NCT02665065|I-131|i-131
144938|NCT02665065|Iomab|iomab
144939|NCT02665065|Iomab-B|iomab-b
144940|NCT02665065|CD45|cd45
144941|NCT02665065|Iodine|iodine
144942|NCT02665065|Iodine-131|iodine-131
144943|NCT02665065|131-I|131-i
144944|NCT02665065|AML|aml
144945|NCT02665065|BMT|bmt
144946|NCT02665065|radioimmunotherapy|radioimmunotherapy
144947|NCT02665052|Rehabilitation|rehabilitation
144948|NCT02665052|Motor Recovery|motor recovery
144949|NCT02665052|upper extremity|upper extremity
144950|NCT02664987|pain management, pain control, cancer|pain management, pain control, cancer
144951|NCT02664961|TRC105|trc105
144952|NCT02664961|CD105|cd105
144953|NCT02664961|Endoglin|endoglin
144954|NCT02664961|Angiogenesis inhibitor|angiogenesis inhibitor
144955|NCT02664961|GTN|gtn
144956|NCT02664961|Bevacizumab|bevacizumab
144957|NCT02664961|Avastin|avastin
144958|NCT02664948|early follow-up|early follow-up
144959|NCT02664948|geriatrics|geriatrics
144960|NCT02664935|NSCLC|nsclc
144961|NCT02664935|Lung Cancer|lung cancer
144962|NCT02664935|Adenocarcinoma|adenocarcinoma
144963|NCT02664935|Matrix|matrix
144964|NCT02664935|SMP2|smp2
144965|NCT02664935|Umbrella Trial Design|umbrella trial design
144966|NCT02664935|Multi-arm|multi-arm
144967|NCT02664922|Electrophysiology|electrophysiology
144968|NCT02664922|Anesthetics|anesthetics
144969|NCT02664909|Hip Hemiarthroplasty|hip hemiarthroplasty
144970|NCT02664909|Tranexamic Acid|tranexamic acid
144971|NCT02664909|Topical|topical
144972|NCT02664909|Blood Transfusion|blood transfusion
144973|NCT02664896|Knee pain|knee pain
144974|NCT02664896|Knee Osteoarthritis|knee osteoarthritis
144975|NCT02664870|synovial fluid|synovial fluid
144978|NCT02664857|Postoperative Pain|postoperative pain
144979|NCT02664857|Mental Motor Retardation|mental motor retardation
144980|NCT02664844|Obesity|obesity
144981|NCT02664844|Appetite regulation|appetite regulation
144982|NCT02664844|Insulin sensitivity|insulin sensitivity
144983|NCT02664844|Adolescents|adolescents
144984|NCT02664844|Exercise|exercise
144985|NCT02664831|cardiac arrest|cardiac arrest
144986|NCT02664831|inflammation|inflammation
144987|NCT02664831|obesity|obesity
144988|NCT02664831|neuregulin|neuregulin
144989|NCT02664831|lipids|lipids
144990|NCT02664818|Heart failure|heart failure
144991|NCT02664818|China|china
144992|NCT02664818|Registry|registry
144993|NCT02664818|Characteristic|characteristic
144994|NCT02664818|Outcome|outcome
144995|NCT02664792|Non-small cell lung carcinoma|non-small cell lung carcinoma
144996|NCT02664792|PET/CT|pet/ct
144997|NCT02664792|18F-FDG|18f-fdg
144998|NCT02664766|Heavy drinking|heavy drinking
144999|NCT02664766|Heavy drinking cessation|heavy drinking cessation
145000|NCT02664766|Alcohol abuse|alcohol abuse
145001|NCT02664766|alcohol use disorder|alcohol use disorder
145002|NCT02664740|Phage Therapy|phage therapy
145003|NCT02664727|alcohol|alcohol
145004|NCT02664727|alcohol abuse|alcohol abuse
145005|NCT02664727|alcohol dependence|alcohol dependence
145006|NCT02664727|alcohol use disorder|alcohol use disorder
145007|NCT02664727|heavy drinking|heavy drinking
145008|NCT02664727|alcohol abuse cessation|alcohol abuse cessation
145009|NCT02664714|physiotherapy, perineometer, adherence|physiotherapy, perineometer, adherence
145010|NCT02664688|spondylolisthesis|spondylolisthesis
145011|NCT02664688|low back pain|low back pain
145012|NCT02664688|stabilization exercise|stabilization exercise
145013|NCT02664662|Breast cancer|breast cancer
145014|NCT02664662|Health literacy|health literacy
145015|NCT02664662|Tailored education|tailored education
145016|NCT02664662|Rehabilitation|rehabilitation
145017|NCT02664662|International Classification of Functioning, Disability and Health|international classification of functioning, disability and health
145018|NCT02664649|TAVR|tavr
145019|NCT02664649|Apixaban|apixaban
145020|NCT02664649|Anticoagulant|anticoagulant
145021|NCT02664649|VKA|vka
145022|NCT02664649|Antiplatelet therapy|antiplatelet therapy
145023|NCT02664649|Aortic stenosis|aortic stenosis
145024|NCT02664610|hypertension treatment|hypertension treatment
145025|NCT02664610|stroke prevention|stroke prevention
145026|NCT02664597|ADNEXMR SCORING system|adnexmr scoring system
145027|NCT02664597|MRI|mri
145028|NCT02664597|adnexal masses|adnexal masses
145029|NCT02664519|Chronic Kidney Disease|chronic kidney disease
145030|NCT02664519|Functional sympatholysis|functional sympatholysis
145031|NCT02664519|Exercise training|exercise training
145032|NCT02664519|Exercise intolerance|exercise intolerance
145033|NCT02664519|Handgrip exercise|handgrip exercise
145034|NCT02664519|Near infrared spectroscopy|near infrared spectroscopy
145035|NCT02664519|Lower body negative pressure|lower body negative pressure
145036|NCT02664493|kidney transplantation|kidney transplantation
145037|NCT02664493|subclinical borderline rejection|subclinical borderline rejection
145038|NCT02664493|steroid pulse therapy|steroid pulse therapy
145039|NCT02664480|Salivary Alpha-amylase|salivary alpha-amylase
145040|NCT02664480|ovulation|ovulation
145041|NCT02664454|Elderly|elderly
145042|NCT02664454|Health care organization|health care organization
145043|NCT02664454|Primary care|primary care
145044|NCT02664441|Obesity|obesity
145045|NCT02664441|Drug intervention|drug intervention
145046|NCT02664441|Children|children
145047|NCT02664441|Adolescents|adolescents
145048|NCT02664441|Young adults|young adults
145049|NCT02664441|Hypothalamic lesion|hypothalamic lesion
145050|NCT02664441|Change of weight status|change of weight status
145051|NCT02664441|Food intake|food intake
145052|NCT02664441|Energy expenditure|energy expenditure
145053|NCT02664441|Hormonal changes|hormonal changes
145054|NCT02664441|Glucagon-like peptide-1 agonist|glucagon-like peptide-1 agonist
145055|NCT02664441|Bydureon|bydureon
145056|NCT02664441|Weight Loss|weight loss
145057|NCT02664441|Energy balance|energy balance
145058|NCT02664415|Human Monoclonal Antibody|human monoclonal antibody
145059|NCT02664402|Palliative Care|palliative care
145060|NCT02664402|Pain|pain
145061|NCT02664402|Community Health|community health
145062|NCT02664376|sarcopenia|sarcopenia
145063|NCT02664376|geriatry|geriatry
145064|NCT02664311|Pulmonary Vein Isolation|pulmonary vein isolation
145065|NCT02664311|Jet Ventilation|jet ventilation
145066|NCT02664311|Atrial Fibrillation|atrial fibrillation
145067|NCT02664298|severely atrophic jaw|severely atrophic jaw
145068|NCT02664298|cranial bone-graft|cranial bone-graft
145069|NCT02664298|dental implants|dental implants
145070|NCT02664298|immediate loading|immediate loading
145071|NCT02664298|augmentation maxilla/mandible|augmentation maxilla/mandible
145072|NCT02664298|sinus-floor elevation/sinuslift|sinus-floor elevation/sinuslift
145073|NCT02664298|dental prosthesis|dental prosthesis
145074|NCT02664298|implant supported|implant supported
145075|NCT02664298|provisional implants|provisional implants
145076|NCT02664298|temporary implants|temporary implants
145571|NCT02661490|Norovirus|norovirus
145077|NCT02664298|one-stage surgery|one-stage surgery
145078|NCT02664298|alveolar ridge augmentation|alveolar ridge augmentation
145079|NCT02664298|maxilla|maxilla
145080|NCT02664259|Endobronchial ultrasonography|endobronchial ultrasonography
145081|NCT02664259|Peripheral pulmonary lesions|peripheral pulmonary lesions
145082|NCT02664259|Ultrathin bronchoscopy|ultrathin bronchoscopy
145083|NCT02664246|contrast-induced nephropathy|contrast-induced nephropathy
145084|NCT02664246|Percutaneous coronary intervention|percutaneous coronary intervention
145085|NCT02664246|risk factors|risk factors
145086|NCT02664246|incidence|incidence
145087|NCT02664233|Diabetes|diabetes
145088|NCT02664233|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
145089|NCT02664233|obesity|obesity
145090|NCT02664233|self-monitoring|self-monitoring
145091|NCT02664233|goal setting|goal setting
145092|NCT02664233|mobile health|mobile health
145093|NCT02664233|connected health|connected health
145094|NCT02664220|Povidone-iodine irrigation|povidone-iodine irrigation
145095|NCT02664207|Myelomeningocele repair|myelomeningocele repair
145096|NCT02664207|Open Neural Tube Defect|open neural tube defect
145097|NCT02664207|BMI of 35-40 kg/m2,|bmi of 35-40 kg/m2,
145098|NCT02664207|Open Fetal Surgery|open fetal surgery
145099|NCT02664207|Elevated body mass index|elevated body mass index
145100|NCT02664194|Hypothermia|hypothermia
145101|NCT02664194|Rewarming|rewarming
145102|NCT02664194|Myocardial Infarction|myocardial infarction
145103|NCT02664194|Percutaneous Cornonary Intervention|percutaneous cornonary intervention
145104|NCT02664181|Cancer|cancer
145105|NCT02664181|Nivolumab|nivolumab
145106|NCT02664181|Decitabine|decitabine
145107|NCT02664181|Tetrahydrouridine|tetrahydrouridine
145108|NCT02664155|Renal insufficiency|renal insufficiency
145109|NCT02664155|Direct oral anticoagulants (DOA)|direct oral anticoagulants (doa)
145110|NCT02664155|Deep Vein Thrombosis (DVT)|deep vein thrombosis (dvt)
145111|NCT02664155|Pulmonary Embolism (PE)|pulmonary embolism (pe)
145112|NCT02664155|Venous Thromboembolism (VTE)|venous thromboembolism (vte)
145113|NCT02664155|Heparins|heparins
145114|NCT02664142|General Surgery|general surgery
145115|NCT02664142|Child|child
145116|NCT02664142|Anaesthesia|anaesthesia
145117|NCT02664142|Depth of anaesthesia|depth of anaesthesia
145118|NCT02664142|BIS monitoring|bis monitoring
145119|NCT02664116|Severe Migraine Headache|severe migraine headache
145120|NCT02664090|acute respiratory distress syndrome|acute respiratory distress syndrome
145121|NCT02664090|prone ventilation|prone ventilation
145122|NCT02664090|trans-esophageal doppler|trans-esophageal doppler
145123|NCT02664077|NSABP|nsabp
145124|NCT02664077|Colon cancer|colon cancer
145125|NCT02664077|Regorafenib|regorafenib
145126|NCT02664077|Stage III|stage iii
145127|NCT02664077|Adjuvant therapy|adjuvant therapy
145128|NCT02664064|prediabetes, weight loss, behavior modification|prediabetes, weight loss, behavior modification
145129|NCT02664038|AUD|aud
145130|NCT02664038|Neuropsychology|neuropsychology
145131|NCT02664038|Cognitive Remediation|cognitive remediation
145132|NCT02664025|teaching vaginal examination|teaching vaginal examination
145133|NCT02664012|adoption|adoption
145134|NCT02664012|electronic cigarettes|electronic cigarettes
145135|NCT02664012|e-cigarettes|e-cigarettes
145136|NCT02664012|menthol|menthol
145137|NCT02664012|combustible cigarettes|combustible cigarettes
145138|NCT02664012|nicotine polacrilex|nicotine polacrilex
145139|NCT02664012|own brand cigarette|own brand cigarette
145140|NCT02664012|subjective measures|subjective measures
145141|NCT02664012|pharmacokinetics|pharmacokinetics
145142|NCT02664012|pharmacodynamics|pharmacodynamics
145143|NCT02664012|cigarette|cigarette
145144|NCT02663999|dose proportionality|dose proportionality
145145|NCT02663999|diazepam nasal spray|diazepam nasal spray
145146|NCT02663986|Organization, Time Management, and Planning (OTMP)|organization, time management, and planning (otmp)
145147|NCT02663973|Breast cancer|breast cancer
145148|NCT02663960|Regional citrate anticoagulation|regional citrate anticoagulation
145149|NCT02663960|Protocol|protocol
145150|NCT02663960|Filter lifespan|filter lifespan
145151|NCT02663947|ventriculoperitoneal shunt|ventriculoperitoneal shunt
145152|NCT02663947|optic nerve sheath diameter|optic nerve sheath diameter
145153|NCT02663947|intracranial pressure|intracranial pressure
145154|NCT02663934|HIV, AIDS, Cognition, Memory, Exercise, Stretching|hiv, aids, cognition, memory, exercise, stretching
145155|NCT02663921|Fitzpatrick Skin-Type|fitzpatrick skin-type
145156|NCT02663921|Melanin|melanin
145157|NCT02663921|Ultraviolet Light (UV)|ultraviolet light (uv)
145158|NCT02663882|smoking|smoking
145159|NCT02663882|self control|self control
145160|NCT02663804|Total Knee Arthroplasty|total knee arthroplasty
145161|NCT02663804|Patient Satisfaction|patient satisfaction
145162|NCT02663804|PROMs|proms
145163|NCT02663804|Implant Design|implant design
145164|NCT02663791|Alcohol|alcohol
145165|NCT02663791|Aortic stiffness|aortic stiffness
145166|NCT02663791|Arterial stiffness|arterial stiffness
145167|NCT02663791|Pulse wave velocity|pulse wave velocity
145168|NCT02663791|Longitudinal|longitudinal
145169|NCT02663752|deferasirox|deferasirox
145170|NCT02663752|MDS|mds
145171|NCT02663752|RNA expression|rna expression
145172|NCT02663752|predictive biomarker|predictive biomarker
145173|NCT02663739|Stanford type B aortic dissection|stanford type b aortic dissection
145174|NCT02663739|Malperfusion|malperfusion
145175|NCT02663739|Rupture|rupture
145176|NCT02663739|Acute disease|acute disease
145177|NCT02663739|Endovascular procedures|endovascular procedures
145178|NCT02663726|Physically inactive|physically inactive
145179|NCT02663726|Older adults|older adults
145180|NCT02663713|Pharmacodynamics|pharmacodynamics
145181|NCT02663713|Ticagrelor|ticagrelor
145182|NCT02663713|Clopidogrel|clopidogrel
145183|NCT02663713|MI|mi
145184|NCT02663700|Burkina Faso|burkina faso
145185|NCT02663700|healthy adults|healthy adults
145186|NCT02663700|Irradiated|irradiated
145187|NCT02663700|malaria|malaria
145188|NCT02663700|PfSPZ Vaccine|pfspz vaccine
145189|NCT02663700|Sanaria|sanaria
145190|NCT02663700|Sporozoite|sporozoite
145191|NCT02663700|Vaccine|vaccine
145192|NCT02663674|Coccidioidomycosis|coccidioidomycosis
145193|NCT02663674|FLEET|fleet
145194|NCT02663674|Fluconazole|fluconazole
145195|NCT02663674|Parent Study of 16-0008|parent study of 16-0008
145196|NCT02663674|Pneumonia|pneumonia
145197|NCT02663661|Diabetes Mellitus, Type 1 (T1DM)|diabetes mellitus, type 1 (t1dm)
145198|NCT02663661|TrialNet|trialnet
145199|NCT02663661|Pathway to Prevention (PTP)|pathway to prevention (ptp)
145200|NCT02663661|First and second degree relatives of persons with T1DM|first and second degree relatives of persons with t1dm
145201|NCT02663661|Insulin-glucagon-glucose (IGG)|insulin-glucagon-glucose (igg)
145202|NCT02663648|myeloproliferative disorders|myeloproliferative disorders
145203|NCT02663648|cell cycle regulatory protein|cell cycle regulatory protein
145204|NCT02663609|Cushing's Syndrome|cushing's syndrome
145205|NCT02663609|Mifepristone|mifepristone
145206|NCT02663609|Adrenal|adrenal
145207|NCT02663609|Retrospective|retrospective
145208|NCT02663609|Chart Review|chart review
145209|NCT02663596|Pediatric|pediatric
145210|NCT02663596|Continuous Renal Replacement Therapy|continuous renal replacement therapy
145211|NCT02663596|Dialysis|dialysis
145212|NCT02663596|Therapeutic drug monitoring|therapeutic drug monitoring
145213|NCT02663596|Pharmacokinetics|pharmacokinetics
145214|NCT02663596|Pharmacodynamics|pharmacodynamics
145215|NCT02663583|Oropharynx squamous cell carcinoma|oropharynx squamous cell carcinoma
145216|NCT02663583|OPSCC|opscc
145217|NCT02663583|Actigraph accelerometer|actigraph accelerometer
145218|NCT02663583|MD Anderson Symptom Inventory - Head and Neck module|md anderson symptom inventory - head and neck module
145219|NCT02663583|MDASI-HN|mdasi-hn
145220|NCT02663583|Intensity-Modulated Proton Therapy|intensity-modulated proton therapy
145221|NCT02663583|IMPT|impt
145222|NCT02663583|TransOral Robotic Surgery|transoral robotic surgery
145223|NCT02663583|TORS|tors
145224|NCT02663583|Surveys|surveys
145225|NCT02663583|Questionnaires|questionnaires
145226|NCT02663557|stroke, blood pressure, prognosis|stroke, blood pressure, prognosis
145227|NCT02663544|Diabetes|diabetes
145228|NCT02663544|Metabolic syndrome|metabolic syndrome
145229|NCT02663544|Obesity|obesity
145230|NCT02663544|NAFLD|nafld
145231|NCT02663518|T-Cell|t-cell
145232|NCT02663518|CTCL|ctcl
145233|NCT02663518|PTCL|ptcl
145234|NCT02663518|ALL|all
145235|NCT02663518|Rituximab|rituximab
145236|NCT02663518|Nivolumab|nivolumab
145237|NCT02663518|TTI-621|tti-621
145238|NCT02663518|Solid Tumor|solid tumor
145239|NCT02663518|Hematologic Malignancies|hematologic malignancies
145240|NCT02663518|Lymphoma|lymphoma
145241|NCT02663518|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
145242|NCT02663518|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
145243|NCT02663518|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
145244|NCT02663518|CD47|cd47
145245|NCT02663492|Acupuncture|acupuncture
145246|NCT02663492|electrical stimulation of acupoints|electrical stimulation of acupoints
145247|NCT02663492|chemotherapy|chemotherapy
145248|NCT02663492|Diyu Shengbai Pian|diyu shengbai pian
145249|NCT02663492|nursing care|nursing care
145250|NCT02663466|pilonidal sinus|pilonidal sinus
145251|NCT02663466|Limberg flap|limberg flap
145252|NCT02663466|off-midline closure concept|off-midline closure concept
145253|NCT02663466|recurrence|recurrence
145254|NCT02663453|preterm|preterm
145255|NCT02663453|parenteral nutrition|parenteral nutrition
145256|NCT02663453|cholestasis|cholestasis
145257|NCT02663453|fish oil|fish oil
145258|NCT02663427|pepsinogen Ⅰ|pepsinogen ⅰ
145259|NCT02663427|pepsinogen Ⅱ|pepsinogen ⅱ
145260|NCT02663427|gastric cancer screening|gastric cancer screening
145261|NCT02663427|helicobacter pylori|helicobacter pylori
145262|NCT02663427|gastrin|gastrin
145263|NCT02663375|TAVI|tavi
145264|NCT02663375|Aortic Stenosis|aortic stenosis
145265|NCT02663375|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
145266|NCT02663375|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
145267|NCT02663375|Transapical Access|transapical access
145268|NCT02663362|magnetic resonance imaging|magnetic resonance imaging
145269|NCT02663362|magnetic resonance spectroscopy|magnetic resonance spectroscopy
145270|NCT02663336|masked hypertension, chronic kidney disease|masked hypertension, chronic kidney disease
145271|NCT02663323|Coronary Artery Disease|coronary artery disease
145272|NCT02663323|MeRes-1 Extend|meres-1 extend
145273|NCT02663323|MeRes100|meres100
145274|NCT02663323|Sirolimus Eluting Bioresorbable Vascular Scaffold System|sirolimus eluting bioresorbable vascular scaffold system
145275|NCT02663310|spinal cord injury|spinal cord injury
145276|NCT02663310|Kunming Locomotor Scale|kunming locomotor scale
145277|NCT02663310|surgical decompression|surgical decompression
145278|NCT02663310|untethering|untethering
145279|NCT02663310|weight bearing rehabilitation|weight bearing rehabilitation
145280|NCT02663297|CAR T cells|car t cells
145281|NCT02663297|CD30|cd30
145282|NCT02663297|Lymphoma|lymphoma
145283|NCT02663297|T Lymphocytes|t lymphocytes
145284|NCT02663245|Type 2 diabetes mellitus|type 2 diabetes mellitus
145285|NCT02663245|glycemic control|glycemic control
145286|NCT02663232|V600 BRAF mutation|v600 braf mutation
145287|NCT02663232|Metastatic melanoma|metastatic melanoma
145288|NCT02663219|MSM|msm
145289|NCT02663219|ART|art
145290|NCT02663219|CCM|ccm
145291|NCT02663219|DAIDS|daids
145292|NCT02663219|HPTN|hptn
145293|NCT02663219|ACA|aca
145294|NCT02663219|PAF|paf
145295|NCT02663219|PEP|pep
145296|NCT02663219|RDS|rds
145297|NCT02663206|spastic esophageal disorders|spastic esophageal disorders
145298|NCT02663206|achalasia|achalasia
145299|NCT02663206|diffuse esophageal spasm|diffuse esophageal spasm
145300|NCT02663206|hypercontractile (jackhammer) esophagus|hypercontractile (jackhammer) esophagus
145301|NCT02663206|Botulinum toxin injection|botulinum toxin injection
145302|NCT02663206|peroral endoscopic myotomy|peroral endoscopic myotomy
145303|NCT02663193|Prostate Cancer|prostate cancer
145304|NCT02663193|Observational study|observational study
145305|NCT02663193|Enzalutamide|enzalutamide
145306|NCT02663193|Abiraterone Acetate|abiraterone acetate
145307|NCT02663193|Prednisone|prednisone
145308|NCT02663193|Tolerability|tolerability
145309|NCT02663154|Aromatherapy|aromatherapy
145310|NCT02663102|Safety|safety
145311|NCT02663102|Post-marketing|post-marketing
145312|NCT02663102|Korea|korea
145313|NCT02663102|Drug utilization study|drug utilization study
145314|NCT02663102|Fluarix Tetra|fluarix tetra
145315|NCT02663089|total radioactivity|total radioactivity
145316|NCT02663089|[14C]-GSK961081|[14c]-gsk961081
145317|NCT02663089|Pharmacokinetics|pharmacokinetics
145318|NCT02663089|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
145319|NCT02663089|Microtracer|microtracer
145320|NCT02663063|Complementary and alternative medicine|complementary and alternative medicine
145321|NCT02663063|Hospice Palliative Care|hospice palliative care
145322|NCT02663050|Dysmenorrhea|dysmenorrhea
145323|NCT02663050|kinesio tape|kinesio tape
145324|NCT02663037|Segmentation|segmentation
145325|NCT02663037|Health needs|health needs
145326|NCT02662985|Power Doppler Ultrasonography, Psoriatic Arthritis, Enthesitis, Synovitis, Outcome Measures in Rheumatology, Spondyloarthritis Research Consortium of Canada|power doppler ultrasonography, psoriatic arthritis, enthesitis, synovitis, outcome measures in rheumatology, spondyloarthritis research consortium of canada
145327|NCT02662972|Nerve block|nerve block
145328|NCT02662972|Sphenopalatine Ganglion Block|sphenopalatine ganglion block
145329|NCT02662972|Botulinum Toxins, Type A|botulinum toxins, type a
145330|NCT02662959|Chemotherapy, metastatic gastric cancer, irinotecan|chemotherapy, metastatic gastric cancer, irinotecan
145331|NCT02662907|Head and Neck Cancer|head and neck cancer
145332|NCT02662907|Post-radiotherapy H&N cancer survivors|post-radiotherapy h&n cancer survivors
145333|NCT02662907|Aspiration|aspiration
145334|NCT02662907|Expiratory muscle strength training|expiratory muscle strength training
145335|NCT02662907|EMST|emst
145336|NCT02662907|Dysphagia therapy|dysphagia therapy
145337|NCT02662907|Modified barium swallow|modified barium swallow
145338|NCT02662907|Neurocognitive exams|neurocognitive exams
145339|NCT02662907|Questionnaires|questionnaires
145340|NCT02662907|Surveys|surveys
145341|NCT02662907|Digital Manometer|digital manometer
145342|NCT02662868|Breast cancer|breast cancer
145343|NCT02662868|Metastasis|metastasis
145344|NCT02662842|infusion set|infusion set
145345|NCT02662842|continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
145346|NCT02662829|Lesotho|lesotho
145347|NCT02662829|tuberculosis|tuberculosis
145348|NCT02662829|TB|tb
145349|NCT02662829|HIV|hiv
145350|NCT02662829|adherence|adherence
145351|NCT02662829|community-based intervention|community-based intervention
145352|NCT02662829|retention|retention
145353|NCT02662816|Glutathione|glutathione
145354|NCT02662816|Liver|liver
145355|NCT02662816|Muscle|muscle
145356|NCT02662816|Proton magnetic resonance spectroscopy|proton magnetic resonance spectroscopy
145357|NCT02662816|Healthy human|healthy human
145358|NCT02662803|Generalized Anxiety Disorder|generalized anxiety disorder
145359|NCT02662803|GAD|gad
145360|NCT02662803|physical exercise|physical exercise
145361|NCT02662803|aerobe exercise|aerobe exercise
145362|NCT02662803|mental disorder|mental disorder
145363|NCT02662803|high-intensive aerobe exercise|high-intensive aerobe exercise
145364|NCT02662777|esophageal anastomosis leakage|esophageal anastomosis leakage
145365|NCT02662777|endoscopic vacuum therapy|endoscopic vacuum therapy
145366|NCT02662777|esophageal perforation|esophageal perforation
145572|NCT02661464|Healthy|healthy
145367|NCT02662777|upper gastrointestinal tract|upper gastrointestinal tract
145368|NCT02662777|esophageal leak|esophageal leak
145369|NCT02662777|endoscopy|endoscopy
145370|NCT02662738|Blood glucose|blood glucose
145371|NCT02662725|melanoma|melanoma
145372|NCT02662725|brain metastasis|brain metastasis
145373|NCT02662725|stereotactic radiosurgery|stereotactic radiosurgery
145374|NCT02662725|Ipilimumab|ipilimumab
145375|NCT02662725|survival|survival
145376|NCT02662725|safety|safety
145377|NCT02662725|efficacy|efficacy
145378|NCT02662712|Healthy|healthy
145379|NCT02662712|Hepatitis, Chronic|hepatitis, chronic
145380|NCT02662712|JNJ-56136379|jnj-56136379
145381|NCT02662712|Placebo|placebo
145382|NCT02662699|Anemia|anemia
145383|NCT02662699|Hematologic Diseases|hematologic diseases
145384|NCT02662699|Erythrocytes|erythrocytes
145385|NCT02662699|Hemoglobin|hemoglobin
145386|NCT02662699|Hemolytic|hemolytic
145387|NCT02662686|Embryo Implantation|embryo implantation
145388|NCT02662686|Mitochondrial genes|mitochondrial genes
145389|NCT02662686|Mitochondrial DNA|mitochondrial dna
145390|NCT02662686|MitoScore|mitoscore
145391|NCT02662686|Embryo selection|embryo selection
145392|NCT02662686|Embryo viability|embryo viability
145393|NCT02662686|Embryo biomarker|embryo biomarker
145394|NCT02662686|Diagnosis of embryo viability in euploids embryos|diagnosis of embryo viability in euploids embryos
145395|NCT02662673|HIFU|hifu
145396|NCT02662673|Prostate Cancer|prostate cancer
145397|NCT02662673|Focal|focal
145398|NCT02662673|Quality of life|quality of life
145399|NCT02662673|Index study|index study
145400|NCT02662647|demethylating agent|demethylating agent
145401|NCT02662647|lymphocyte infusion|lymphocyte infusion
145402|NCT02662634|NSCLC|nsclc
145403|NCT02662634|resectable|resectable
145404|NCT02662634|non-small cell lung cancer|non-small cell lung cancer
145405|NCT02662634|immunotherapy|immunotherapy
145406|NCT02662634|autologous|autologous
145407|NCT02662634|dendritic cell|dendritic cell
145408|NCT02662621|personalized care|personalized care
145409|NCT02662621|early diagnosis|early diagnosis
145410|NCT02662621|ovarian cancer|ovarian cancer
145411|NCT02662621|breast cancer|breast cancer
145412|NCT02662621|lung cancer|lung cancer
145413|NCT02662621|Early Detection|early detection
145414|NCT02662621|Cancer [E01.390.500]|cancer [e01.390.500]
145415|NCT02662608|Brontictuzumab|brontictuzumab
145416|NCT02662595|mHealth|mhealth
145417|NCT02662595|mobile phones|mobile phones
145418|NCT02662595|measles vaccination|measles vaccination
145419|NCT02662582|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
145420|NCT02662582|CK-2127107|ck-2127107
145421|NCT02662582|COPD|copd
145422|NCT02662543|rotavirus,|rotavirus,
145423|NCT02662543|acute gastroenteritis|acute gastroenteritis
145424|NCT02662543|vaccination|vaccination
145425|NCT02662543|Estonia|estonia
145426|NCT02662543|impact|impact
145427|NCT02662543|severity scales|severity scales
145428|NCT02662517|Neurotrophins|neurotrophins
145429|NCT02662517|Stem Cells|stem cells
145430|NCT02662517|Prematurity|prematurity
145431|NCT02662504|mesothelioma|mesothelioma
145432|NCT02662504|multimodal treatment|multimodal treatment
145433|NCT02662504|PDT|pdt
145434|NCT02662504|pleura|pleura
145435|NCT02662478|Laparoscopic gastric resection|laparoscopic gastric resection
145436|NCT02662478|gastrointestinal stromal tumor|gastrointestinal stromal tumor
145437|NCT02662478|laparoscopic surgery|laparoscopic surgery
145438|NCT02662465|Interventional|interventional
145439|NCT02662465|Treatment|treatment
145440|NCT02662465|Laser|laser
145441|NCT02662439|Heart Failure|heart failure
145442|NCT02662439|Bioimpedance analysis|bioimpedance analysis
145443|NCT02662439|Fluid overload|fluid overload
145444|NCT02662426|Seasonal Influenza|seasonal influenza
145445|NCT02662426|Lingdancao|lingdancao
145446|NCT02662426|RCT|rct
145447|NCT02662361|peri-implant disease; risk factors; prevalence|peri-implant disease; risk factors; prevalence
145448|NCT02662322|Communication|communication
145449|NCT02662322|Confusion|confusion
145450|NCT02662322|Intravenous Catheterization|intravenous catheterization
145451|NCT02662322|Comfort|comfort
145452|NCT02662309|Muscle invasive bladder cancer|muscle invasive bladder cancer
145453|NCT02662309|Transitional cell carcinoma|transitional cell carcinoma
145454|NCT02662283|IGA Nephropathy|iga nephropathy
145455|NCT02662283|proteinurien|proteinurien
145456|NCT02662283|Reh-acteoside|reh-acteoside
145457|NCT02662283|Prednisolone|prednisolone
145458|NCT02662270|Fibromyalgia|fibromyalgia
145459|NCT02662270|QEEG|qeeg
145460|NCT02662270|Brain activity|brain activity
145461|NCT02662270|fMRI|fmri
145462|NCT02662270|Diagnosis|diagnosis
145463|NCT02662257|Sevoflurane|sevoflurane
145464|NCT02662257|Propofol|propofol
145465|NCT02662257|Aged|aged
145466|NCT02662257|Neoplasm|neoplasm
145467|NCT02662257|Surgical Procedure, Operative|surgical procedure, operative
145468|NCT02662257|Delirium|delirium
145469|NCT02662257|Postoperative Complications|postoperative complications
145470|NCT02662257|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
145882|NCT02660086|Prevention|prevention
145471|NCT02662231|Surgical Site Infection|surgical site infection
145472|NCT02662231|General Surgery|general surgery
145473|NCT02662231|Laparotomy|laparotomy
145474|NCT02662231|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
145475|NCT02662231|Developing Countries|developing countries
145476|NCT02662231|International Cooperation|international cooperation
145477|NCT02662231|Specialties, Surgical|specialties, surgical
145478|NCT02662231|Developed Countries|developed countries
145479|NCT02662231|Quality of Health Care|quality of health care
145480|NCT02662179|Elderly patients|elderly patients
145481|NCT02662179|Onco-geriatrics|onco-geriatrics
145482|NCT02662179|Fried criteria|fried criteria
145483|NCT02662166|bladder cancer|bladder cancer
145484|NCT02662166|MRI|mri
145485|NCT02662166|TUR-BT|tur-bt
145486|NCT02662166|cystectomy|cystectomy
145487|NCT02662166|chemotherapy|chemotherapy
145488|NCT02662075|alternative tobacco products (ATPs)|alternative tobacco products (atps)
145489|NCT02662075|electronic cigarettes|electronic cigarettes
145490|NCT02662062|Non-metastatic muscle invasive bladder cancer|non-metastatic muscle invasive bladder cancer
145491|NCT02662023|Healthy Human Volunteers|healthy human volunteers
145492|NCT02662010|AGEs|ages
145493|NCT02662010|glycemic control|glycemic control
145494|NCT02662010|T2DM|t2dm
145495|NCT02661997|Tai Chi|tai chi
145496|NCT02661997|Wellness|wellness
145497|NCT02661997|Mind-body|mind-body
145498|NCT02661997|Gulf War Illness|gulf war illness
145499|NCT02661997|Gulf War Veteran's Illness|gulf war veteran's illness
145500|NCT02661997|GWVI|gwvi
145501|NCT02661984|FeNO, exhaled nitric oxide|feno, exhaled nitric oxide
145502|NCT02661958|acne vulgaris|acne vulgaris
145503|NCT02661958|acne|acne
145504|NCT02661945|near focus with narrow band imaging|near focus with narrow band imaging
145505|NCT02661945|tumor margin|tumor margin
145506|NCT02661945|indigocarmine chromoendoscopy|indigocarmine chromoendoscopy
145507|NCT02661932|Fertility preservation|fertility preservation
145508|NCT02661932|letrozole|letrozole
145509|NCT02661932|Ovarian stimulation|ovarian stimulation
145510|NCT02661919|Epilepsy|epilepsy
145511|NCT02661919|Seizure|seizure
145512|NCT02661919|Seizures|seizures
145513|NCT02661919|Mattress monitor|mattress monitor
145514|NCT02661919|Bed monitor|bed monitor
145515|NCT02661919|Bed alarm|bed alarm
145516|NCT02661919|Generalized tonic-clonic seizure|generalized tonic-clonic seizure
145517|NCT02661919|GTC|gtc
145518|NCT02661893|Healthy|healthy
145519|NCT02661893|JNJ-42847922|jnj-42847922
145520|NCT02661893|Rifampin|rifampin
145521|NCT02661893|Pharmacokinetics|pharmacokinetics
145522|NCT02661867|Childbirth|childbirth
145523|NCT02661867|Pelvic organ prolapse|pelvic organ prolapse
145524|NCT02661867|Urinary incontinence|urinary incontinence
145525|NCT02661867|Fecal incontinence|fecal incontinence
145526|NCT02661854|Rhinitis / Rhinoconjunctivitis|rhinitis / rhinoconjunctivitis
145527|NCT02661854|Vaccine|vaccine
145528|NCT02661854|Immunotherapy|immunotherapy
145529|NCT02661854|Mite|mite
145530|NCT02661854|Allergy|allergy
145531|NCT02661828|Tapering Antidepressant Regimen|tapering antidepressant regimen
145532|NCT02661828|Antidepressant Discontinuation Syndrome|antidepressant discontinuation syndrome
145533|NCT02661789|Mental health|mental health
145534|NCT02661789|Brain Imaging|brain imaging
145535|NCT02661789|Steroid hormones|steroid hormones
145536|NCT02661789|Serotonin|serotonin
145537|NCT02661789|PET|pet
145538|NCT02661789|MRI|mri
145539|NCT02661789|fMRI|fmri
145540|NCT02661789|human|human
145541|NCT02661789|gender|gender
145542|NCT02661789|risk model|risk model
145543|NCT02661776|natural killer cell|natural killer cell
145544|NCT02661776|head and neck cancer|head and neck cancer
145545|NCT02661776|opioid|opioid
145546|NCT02661763|Rheumatic heart disease|rheumatic heart disease
145547|NCT02661750|Cleansing the colon|cleansing the colon
145548|NCT02661711|Macular Oedema Retinitis Pigmentosa|macular oedema retinitis pigmentosa
145549|NCT02661685|Cancer immunotherapy|cancer immunotherapy
145550|NCT02661685|IFN-γ-producing killer dendritic cell-like cells|ifn-γ-producing killer dendritic cell-like cells
145551|NCT02661685|Natural killer cells|natural killer cells
145552|NCT02661672|Intracranial hemorrhage|intracranial hemorrhage
145553|NCT02661672|Neurosurgery|neurosurgery
145554|NCT02661659|mesothelioma|mesothelioma
145555|NCT02661659|multipeptide vaccine|multipeptide vaccine
145556|NCT02661659|S-588210|s-588210
145557|NCT02661646|Chronic Swelling|chronic swelling
145558|NCT02661646|Leg Lymphedema|leg lymphedema
145559|NCT02661646|Primary Lymphedema|primary lymphedema
145560|NCT02661646|Secondary Lymphedema|secondary lymphedema
145561|NCT02661620|REDAPT Femoral System modular stem implant|redapt femoral system modular stem implant
145562|NCT02661620|Total Hip arthroplasty revision|total hip arthroplasty revision
145563|NCT02661594|TQT|tqt
145564|NCT02661594|amisulpride|amisulpride
145565|NCT02661594|volunteer|volunteer
145566|NCT02661594|ECG|ecg
145567|NCT02661581|Diabetes|diabetes
145568|NCT02661581|Peer Leader Support|peer leader support
145569|NCT02661529|Shunt|shunt
145570|NCT02661529|Echocardiogram|echocardiogram
145573|NCT02661464|Ebola viruses|ebola viruses
145574|NCT02661464|Ebola virus disease (EVD)|ebola virus disease (evd)
145575|NCT02661464|Filoviruses|filoviruses
145576|NCT02661464|Safety|safety
145577|NCT02661464|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
145578|NCT02661464|Modified Vaccinia Virus Ankara ‐ Bavarian Nordic Filo‐vector (MVA‐BN Filo)|modified vaccinia virus ankara ‐ bavarian nordic filo‐vector (mva‐bn filo)
145579|NCT02661464|Hemorrhagic fever|hemorrhagic fever
145580|NCT02661451|Valve|valve
145581|NCT02661438|Usability Test|usability test
145582|NCT02661425|IBS-D|ibs-d
145583|NCT02661425|IBS|ibs
145584|NCT02661412|immediate loading|immediate loading
145585|NCT02661412|biological stability|biological stability
145586|NCT02661412|mechanical stability|mechanical stability
145587|NCT02661412|long-term|long-term
145588|NCT02661412|marginal bone level|marginal bone level
145589|NCT02661412|maxilla|maxilla
145590|NCT02661412|immediate placement|immediate placement
145591|NCT02661412|dental implant|dental implant
145592|NCT02661412|fibre-reinforced provisional fixed prosthesis|fibre-reinforced provisional fixed prosthesis
145593|NCT02661399|CIPN|cipn
145594|NCT02661373|Antimalarial|antimalarial
145595|NCT02661373|First-in-Human|first-in-human
145596|NCT02661373|Pharmacokinetic|pharmacokinetic
145597|NCT02661360|swaddling|swaddling
145598|NCT02661347|First Episode|first episode
145599|NCT02661347|Schizophreniform|schizophreniform
145600|NCT02661347|Schizoaffective Disorder|schizoaffective disorder
145601|NCT02661347|Psychosis|psychosis
145602|NCT02661347|Schizophrenia|schizophrenia
145603|NCT02661347|tDCS|tdcs
145604|NCT02661347|Risperidone|risperidone
145605|NCT02661347|Anti-psychotic medication|anti-psychotic medication
145606|NCT02661334|creatine|creatine
145607|NCT02661334|creatine monohydrate|creatine monohydrate
145608|NCT02661334|supplement|supplement
145609|NCT02661334|exercise|exercise
145610|NCT02661334|fitness|fitness
145611|NCT02661282|Glioblastoma|glioblastoma
145612|NCT02661282|Gliosarcoma|gliosarcoma
145613|NCT02661282|Brain tumor|brain tumor
145614|NCT02661282|Cytomegalovirus stimulated adoptive T cells|cytomegalovirus stimulated adoptive t cells
145615|NCT02661282|CMV|cmv
145616|NCT02661282|Temozolomide|temozolomide
145617|NCT02661282|Temodar|temodar
145618|NCT02661282|TMZ|tmz
145619|NCT02661282|Phone call|phone call
145620|NCT02661282|T cell infusion|t cell infusion
145621|NCT02661282|Surgery|surgery
145622|NCT02661256|pharyngeal swallow|pharyngeal swallow
145623|NCT02661256|airway compromise|airway compromise
145624|NCT02661256|NICU|nicu
145625|NCT02661243|Sjogren's Syndrome|sjogren's syndrome
145626|NCT02661243|Dental Implants|dental implants
145627|NCT02661230|exergaming|exergaming
145628|NCT02661230|intensive care unit|intensive care unit
145629|NCT02661230|feasibility acceptability|feasibility acceptability
145630|NCT02661230|heart|heart
145631|NCT02661230|brain function|brain function
145632|NCT02661217|Acute decompensated heart failure|acute decompensated heart failure
145633|NCT02661217|Reduced ejection fraction|reduced ejection fraction
145634|NCT02661217|Pre-discharge treatment|pre-discharge treatment
145635|NCT02661217|Post-discharge treatment|post-discharge treatment
145636|NCT02661217|Angiotensin receptor neprilysine inhibitor|angiotensin receptor neprilysine inhibitor
145637|NCT02661217|HFrEF|hfref
145638|NCT02661191|asthma|asthma
145639|NCT02661191|vitamin D|vitamin d
145640|NCT02661191|exacerbations|exacerbations
145641|NCT02661191|airway obstruction|airway obstruction
145642|NCT02661178|Parasitic Diseases|parasitic diseases
145643|NCT02661178|Helminthiasis|helminthiasis
145644|NCT02661178|Nematode Infections|nematode infections
145645|NCT02661178|Secernentea Infections|secernentea infections
145646|NCT02661178|Spirurida Infections|spirurida infections
145647|NCT02661178|Filariasis|filariasis
145648|NCT02661178|Skin Diseases, Parasitic|skin diseases, parasitic
145649|NCT02661178|Skin and Connective Tissue Diseases|skin and connective tissue diseases
145650|NCT02661178|Skin Diseases|skin diseases
145651|NCT02661178|Skin Diseases, Infectious|skin diseases, infectious
145652|NCT02661178|Depsipeptides|depsipeptides
145653|NCT02661178|Emodepside|emodepside
145654|NCT02661178|Neglected disease|neglected disease
145655|NCT02661178|Africa|africa
145656|NCT02661178|New drug|new drug
145657|NCT02661178|Oral drug|oral drug
145658|NCT02661178|Parasite|parasite
145659|NCT02661178|Anthelmintic drug|anthelmintic drug
145660|NCT02661178|Cyclooctadepsipeptide|cyclooctadepsipeptide
145661|NCT02661178|Single ascending dose|single ascending dose
145662|NCT02661178|Volunteers|volunteers
145663|NCT02661178|Phase 1|phase 1
145664|NCT02661178|Safety|safety
145665|NCT02661178|Tolerability|tolerability
145666|NCT02661178|Pharmacokinetics|pharmacokinetics
145667|NCT02661178|Relative bioavailability|relative bioavailability
145668|NCT02661178|Onchocerciasis|onchocerciasis
145669|NCT02661139|bisphosphonates and/or targeted therapy by monoclonal antibodies|bisphosphonates and/or targeted therapy by monoclonal antibodies
145670|NCT02661139|jaw reconstruction|jaw reconstruction
145671|NCT02661139|prosthetic rehabilitation|prosthetic rehabilitation
145672|NCT02661139|quality of life|quality of life
145673|NCT02661113|Brain|brain
145674|NCT02661113|CNS Disease|cns disease
145675|NCT02661113|CNS|cns
145676|NCT02661113|Intracranial Supratentorial GBM|intracranial supratentorial gbm
145677|NCT02661113|Gliosarcoma|gliosarcoma
145678|NCT02661113|GS|gs
145679|NCT02661113|Glioblastoma|glioblastoma
145680|NCT02661113|GBM|gbm
145681|NCT02661113|Dasatinib|dasatinib
145682|NCT02661113|Sprycel|sprycel
145683|NCT02661113|Temozolomide|temozolomide
145684|NCT02661113|TMZ|tmz
145685|NCT02661113|Temodar|temodar
145686|NCT02661113|Radiation Therapy|radiation therapy
145687|NCT02661113|Radiotherapy|radiotherapy
145688|NCT02661113|RT|rt
145689|NCT02661100|Vaccine|vaccine
145690|NCT02661100|NY-ESO-1|ny-eso-1
145691|NCT02661100|DEC-205|dec-205
145692|NCT02661100|Poly-ICLC|poly-iclc
145693|NCT02661100|Pembrolizumab|pembrolizumab
145694|NCT02661100|Cancer|cancer
145695|NCT02661087|submucosal myoma|submucosal myoma
145696|NCT02661087|hysteroscopic resection|hysteroscopic resection
145697|NCT02661087|bipolar energy|bipolar energy
145698|NCT02661087|monopolar energy|monopolar energy
145699|NCT02661074|Fisherman|fisherman
145700|NCT02661074|Fish industry|fish industry
145701|NCT02661061|ketamine|ketamine
145702|NCT02661061|glutamate|glutamate
145703|NCT02661061|relapse prevention|relapse prevention
145704|NCT02661035|AML|aml
145705|NCT02661035|ALL|all
145706|NCT02661035|CML|cml
145707|NCT02661035|MDS|mds
145708|NCT02661035|CLL|cll
145709|NCT02661035|SLL|sll
145710|NCT02661035|NHL|nhl
145711|NCT02661009|NSCLC|nsclc
145712|NCT02661009|EGFR|egfr
145713|NCT02661009|EGFR-TKI|egfr-tki
145714|NCT02661009|PCR|pcr
145715|NCT02660970|Iberogast|iberogast
145716|NCT02660970|Acupressure|acupressure
145717|NCT02660970|gut-brain-axis|gut-brain-axis
145718|NCT02660957|Smoking cessation|smoking cessation
145719|NCT02660931|Pediatrics|pediatrics
145720|NCT02660905|HIV-HCV co-infected|hiv-hcv co-infected
145721|NCT02660905|HCV|hcv
145722|NCT02660905|HIV|hiv
145723|NCT02660905|Hep C|hep c
145724|NCT02660905|Hepatitis C|hepatitis c
145725|NCT02660905|HCV positive|hcv positive
145726|NCT02660892|IAAO|iaao
145727|NCT02660892|Threonine|threonine
145728|NCT02660892|Children|children
145729|NCT02660879|Education|education
145730|NCT02660879|Inhaler|inhaler
145731|NCT02660866|intermittent claudication|intermittent claudication
145732|NCT02660866|randomized controlled trial|randomized controlled trial
145733|NCT02660853|Exacerbations|exacerbations
145734|NCT02660814|Chemerin|chemerin
145735|NCT02660814|Interleukin-6|interleukin-6
145736|NCT02660814|Gingival crevicular fluid|gingival crevicular fluid
145737|NCT02660801|spinal manipulation|spinal manipulation
145738|NCT02660801|spinal mobilization|spinal mobilization
145739|NCT02660801|spinal stiffness|spinal stiffness
145740|NCT02660788|6-24 months overdue|6-24 months overdue
145741|NCT02660788|screening mammography|screening mammography
145742|NCT02660775|schizophrenia|schizophrenia
145743|NCT02660736|Albiglutide|albiglutide
145744|NCT02660736|Randomized|randomized
145745|NCT02660736|Pharmacokinetics|pharmacokinetics
145746|NCT02660736|GSK716155|gsk716155
145747|NCT02660736|Bioequivalence study|bioequivalence study
145748|NCT02660723|M01.774.500|m01.774.500
145749|NCT02660723|Volunteers|volunteers
145750|NCT02660710|single arm phase 2|single arm phase 2
145751|NCT02660710|safety and efficacy|safety and efficacy
145752|NCT02660710|R-CHOP|r-chop
145753|NCT02660697|socket preservation, implant site development|socket preservation, implant site development
145754|NCT02660684|Prograf|prograf
145755|NCT02660684|Graft versus host disease|graft versus host disease
145756|NCT02660684|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
145757|NCT02660684|Prophylaxis|prophylaxis
145758|NCT02660684|Peripheral hematopoietic stem cell transplantation|peripheral hematopoietic stem cell transplantation
145759|NCT02660645|Cysview|cysview
145760|NCT02660645|Hexaminolevulinate|hexaminolevulinate
145761|NCT02660645|Hexvix|hexvix
145762|NCT02660645|NMIBC|nmibc
145763|NCT02660645|BLCC|blcc
145764|NCT02660645|Blue Light Cystoscopy with Cysview|blue light cystoscopy with cysview
145765|NCT02660645|Cystoscopy|cystoscopy
145766|NCT02660645|TURBT|turbt
145767|NCT02660645|TUR|tur
145768|NCT02660645|Fluorescent cystoscopy|fluorescent cystoscopy
145769|NCT02660645|Non-muscle invasive bladder cancer (NMIBC)|non-muscle invasive bladder cancer (nmibc)
145770|NCT02660645|Transurethral resection (TUR)|transurethral resection (tur)
145771|NCT02660593|Diabetes Mellitus|diabetes mellitus
145772|NCT02660593|Chinese medicine|chinese medicine
145773|NCT02660593|exercise|exercise
145774|NCT02660593|diet|diet
145775|NCT02660580|Adalimumab|adalimumab
145776|NCT02660580|MSB11022|msb11022
145777|NCT02660580|Psoriasis|psoriasis
145778|NCT02660580|Phase III|phase iii
145779|NCT02660567|postpartum hemorrhage|postpartum hemorrhage
145781|NCT02660567|atonic|atonic
145883|NCT02660086|Food choice|food choice
145782|NCT02660567|new maneuver|new maneuver
145783|NCT02660554|Pneumonia|pneumonia
145784|NCT02660554|Methicillin-Resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
145785|NCT02660554|Polymerase Chain Reaction|polymerase chain reaction
145786|NCT02660554|Intensive care units|intensive care units
145787|NCT02660554|Drug Resistance|drug resistance
145788|NCT02660541|Dressing for burn wounds|dressing for burn wounds
145789|NCT02660515|complete articular distal radius fracture|complete articular distal radius fracture
145790|NCT02660515|wrist arthroscopy|wrist arthroscopy
145791|NCT02660489|CRTH2 antagonist|crth2 antagonist
145792|NCT02660489|Prostaglandin D2 receptor|prostaglandin d2 receptor
145793|NCT02660489|Anti-Asthmatic Agents|anti-asthmatic agents
145794|NCT02660489|OC459|oc459
145795|NCT02660489|Allergic asthma|allergic asthma
145796|NCT02660489|Eosinophilia|eosinophilia
145797|NCT02660476|Diet|diet
145798|NCT02660476|Middle East and North Africa country|middle east and north africa country
145799|NCT02660476|Health|health
145800|NCT02660476|Complication|complication
145801|NCT02660476|Cardiovascular disease|cardiovascular disease
145802|NCT02660476|Obesity|obesity
145803|NCT02660476|Stress|stress
145804|NCT02660476|Obstructive Sleep Apnoea (OSA)|obstructive sleep apnoea (osa)
145805|NCT02660463|incidence|incidence
145806|NCT02660463|risk factors|risk factors
145807|NCT02660437|COPD|copd
145808|NCT02660437|Carbon dioxide partial pressure (pCO2)|carbon dioxide partial pressure (pco2)
145809|NCT02660437|Cerebral blood flow (CBF)|cerebral blood flow (cbf)
145810|NCT02660437|Cognitive dysfunction|cognitive dysfunction
145811|NCT02660437|Mild/Moderate Cognitive Impairment (MCI)|mild/moderate cognitive impairment (mci)
145812|NCT02660437|Pulmonary Rehabilitation (PR)|pulmonary rehabilitation (pr)
145813|NCT02660437|Standardized Mini Mental State Examination (SMMSE)|standardized mini mental state examination (smmse)
145814|NCT02660437|Addenbrooke's Cognitive Examination (ACE-R)|addenbrooke's cognitive examination (ace-r)
145815|NCT02660437|Montreal Cognitive Assessment (MoCA)|montreal cognitive assessment (moca)
145816|NCT02660437|Telephone Interview for Cognitive Status (TICS)|telephone interview for cognitive status (tics)
145817|NCT02660437|Stroop test (Reaction Time)|stroop test (reaction time)
145818|NCT02660411|Sevoflurane|sevoflurane
145819|NCT02660411|Propofol|propofol
145820|NCT02660411|Aged|aged
145821|NCT02660411|Neoplasm|neoplasm
145822|NCT02660411|Surgical Procedure, Operative|surgical procedure, operative
145823|NCT02660411|Long-term survival|long-term survival
145824|NCT02660385|pain|pain
145825|NCT02660385|insomnia|insomnia
145826|NCT02660385|cardiac failure|cardiac failure
145827|NCT02660385|sleep|sleep
145828|NCT02660385|fatigue|fatigue
145829|NCT02660385|heart disease|heart disease
145830|NCT02660385|anxiety|anxiety
145831|NCT02660385|actigraphy|actigraphy
145832|NCT02660385|psychomotor vigilance|psychomotor vigilance
145833|NCT02660385|six minute walk|six minute walk
145834|NCT02660385|depression|depression
145835|NCT02660385|cognitive behavioral therapy|cognitive behavioral therapy
145836|NCT02660385|self-management|self-management
145837|NCT02660385|self-care|self-care
145838|NCT02660346|IL-10|il-10
145839|NCT02660346|MRSA|mrsa
145840|NCT02660346|Bacteremia|bacteremia
145841|NCT02660333|Obesity|obesity
145842|NCT02660333|Inflammation|inflammation
145843|NCT02660333|Nutritional status|nutritional status
145844|NCT02660333|Prebiotic|prebiotic
145845|NCT02660333|Synbiotic|synbiotic
145846|NCT02660307|stress|stress
145847|NCT02660307|work|work
145848|NCT02660307|employees|employees
145849|NCT02660307|mindfulness|mindfulness
145850|NCT02660307|depression|depression
145851|NCT02660307|anxiety|anxiety
145852|NCT02660268|Clinical pathway|clinical pathway
145853|NCT02660268|Infection|infection
145854|NCT02660268|Hip|hip
145855|NCT02660268|Prosthesis|prosthesis
145856|NCT02660255|CBD|cbd
145857|NCT02660255|Epidiolex|epidiolex
145858|NCT02660255|Myoclonic|myoclonic
145859|NCT02660255|Brain Disease|brain disease
145860|NCT02660255|Central Nervous System Disease|central nervous system disease
145861|NCT02660255|GWP42003|gwp42003
145862|NCT02660242|T1D|t1d
145863|NCT02660242|Type 1 Diabetes|type 1 diabetes
145864|NCT02660242|Mini-dose Glucagon|mini-dose glucagon
145865|NCT02660242|Adults|adults
145866|NCT02660242|Exercise|exercise
145867|NCT02660242|Hypoglycemia|hypoglycemia
145868|NCT02660229|Intravenous injection in cancer pain|intravenous injection in cancer pain
145869|NCT02660216|minimally invasive|minimally invasive
145870|NCT02660216|le fort I osteotomy|le fort i osteotomy
145871|NCT02660216|3D virtual treatment planning|3d virtual treatment planning
145872|NCT02660216|accuracy|accuracy
145873|NCT02660203|chest physiotherapy|chest physiotherapy
145874|NCT02660203|post operative period|post operative period
145875|NCT02660203|forced expiration|forced expiration
145876|NCT02660203|pleural drainage duration|pleural drainage duration
145877|NCT02660164|Concussion|concussion
145878|NCT02660125|ICSI|icsi
145879|NCT02660125|endometrial injury|endometrial injury
145880|NCT02660125|implantation rate|implantation rate
145881|NCT02660086|Weight|weight
145884|NCT02660086|Nutrition|nutrition
145885|NCT02660086|Behavior change|behavior change
145886|NCT02660086|Behavioral economics|behavioral economics
145887|NCT02660086|Feedback|feedback
145888|NCT02660086|Incentives|incentives
145889|NCT02660060|Pramipexole|pramipexole
145890|NCT02660060|Bioequivalence|bioequivalence
145891|NCT02660060|Pharmacokinetics|pharmacokinetics
145892|NCT02660047|South Asian descent|south asian descent
145893|NCT02660034|Dose Escalation|dose escalation
145894|NCT02660034|Dose Expansion|dose expansion
145895|NCT02660034|BGB-A317|bgb-a317
145896|NCT02660034|BGB-290|bgb-290
145897|NCT02660021|three-dimensional virtual treatment planning|three-dimensional virtual treatment planning
145898|NCT02660021|orthognathic surgery|orthognathic surgery
145899|NCT02659995|glycemic variability|glycemic variability
145900|NCT02659995|infection|infection
145901|NCT02659956|Multiple Sclerosis|multiple sclerosis
145902|NCT02659956|Longitudinal Prospective Follow-Up|longitudinal prospective follow-up
145903|NCT02659943|Gene Therapy|gene therapy
145904|NCT02659943|Adoptive T Cell Therapy|adoptive t cell therapy
145905|NCT02659943|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
145906|NCT02659943|T-cell infusion|t-cell infusion
145907|NCT02659943|Residual Malignancy|residual malignancy
145908|NCT02659930|HIV|hiv
145909|NCT02659930|AIDS|aids
145910|NCT02659930|Multicentric Castleman Disease|multicentric castleman disease
145911|NCT02659917|glass-ionomer cement|glass-ionomer cement
145912|NCT02659917|atraumatic restorative treatment|atraumatic restorative treatment
145913|NCT02659917|pit and fissure sealants|pit and fissure sealants
145914|NCT02659904|Free gingival graft|free gingival graft
145915|NCT02659904|Palatal donor site healing|palatal donor site healing
145916|NCT02659878|Takotsubo cardiomyopathy;NT-proBNP;urine metanephrine|takotsubo cardiomyopathy;nt-probnp;urine metanephrine
145917|NCT02659852|Hilar malignant biliary obstruction|hilar malignant biliary obstruction
145918|NCT02659852|bilateral metal stent|bilateral metal stent
145919|NCT02659852|stent in stent|stent in stent
145920|NCT02659852|side by side|side by side
145921|NCT02659839|Cancer|cancer
145922|NCT02659839|Intensive care unit|intensive care unit
145923|NCT02659839|Mortality|mortality
145924|NCT02659826|Transcutaneous spinal direct current stimulation|transcutaneous spinal direct current stimulation
145925|NCT02659826|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
145926|NCT02659826|Gait Training|gait training
145927|NCT02659826|Central Nervous System Excitability|central nervous system excitability
145928|NCT02659826|Healthy|healthy
145929|NCT02659813|Orthodontic wires|orthodontic wires
145930|NCT02659774|Smoking cessation interventions|smoking cessation interventions
145931|NCT02659761|Human Immunodeficiency Virus|human immunodeficiency virus
145932|NCT02659761|Injection drug use|injection drug use
145933|NCT02659761|Single-tablet antiretroviral treatment|single-tablet antiretroviral treatment
145934|NCT02659761|Dolutegravir|dolutegravir
145935|NCT02659761|Tolerability|tolerability
145936|NCT02659761|Adherence|adherence
145937|NCT02659761|Efficacy|efficacy
145938|NCT02659748|Bioactive fatty acids|bioactive fatty acids
145939|NCT02659748|Insulin sensitivity|insulin sensitivity
145940|NCT02659748|Diet|diet
145941|NCT02659748|Milk fat|milk fat
145942|NCT02659748|Lipid metabolism|lipid metabolism
145943|NCT02659748|Inflammation markers|inflammation markers
145944|NCT02659748|Fecal microbiota composition|fecal microbiota composition
145945|NCT02659735|Influenza A virus|influenza a virus
145946|NCT02659735|JNJ-63623872|jnj-63623872
145947|NCT02659735|Healthy|healthy
145948|NCT02659722|INTERVERTEBRAL DISC DEGENERATION|intervertebral disc degeneration
145949|NCT02659722|Bone Disease|bone disease
145950|NCT02659722|Musculoskeletal disease|musculoskeletal disease
145951|NCT02659722|Spinal disease|spinal disease
145952|NCT02659709|Glaucoma|glaucoma
145953|NCT02659709|Smartphone|smartphone
145954|NCT02659709|Tablet|tablet
145955|NCT02659709|Application|application
145956|NCT02659631|P-cadherin|p-cadherin
145957|NCT02659631|PF-06671008|pf-06671008
145958|NCT02659631|solid tumors|solid tumors
145959|NCT02659631|lung cancer|lung cancer
145960|NCT02659631|breast cancer|breast cancer
145961|NCT02659631|colorectal cancer|colorectal cancer
145962|NCT02659631|NSCLC|nsclc
145963|NCT02659631|TNBC|tnbc
145964|NCT02659631|CRC|crc
145965|NCT02659631|neoplasms|neoplasms
145966|NCT02659631|Triple negative breast cancer|triple negative breast cancer
145967|NCT02659631|Non-small cell lung cancer|non-small cell lung cancer
145968|NCT02659618|Asthma|asthma
145969|NCT02659605|pre-term birth|pre-term birth
145970|NCT02659605|delayed cord clamping|delayed cord clamping
145971|NCT02659605|skin to skin|skin to skin
145972|NCT02659592|fertility preservation|fertility preservation
145973|NCT02659592|ovarian tissue transplantation|ovarian tissue transplantation
145974|NCT02659592|ovarian endocrine function|ovarian endocrine function
145975|NCT02659592|assisted reproductive technology|assisted reproductive technology
145976|NCT02659592|pregnancy and live birth|pregnancy and live birth
145977|NCT02659579|Shared Book Reading|shared book reading
145978|NCT02659579|Vocabulary|vocabulary
145979|NCT02659579|Language Development|language development
145980|NCT02659579|Young Children|young children
145981|NCT02659579|Randomised Control Trial|randomised control trial
145982|NCT02659566|Markers|markers
145983|NCT02659566|Parasitemia|parasitemia
145984|NCT02659566|Coartem|coartem
145985|NCT02659566|Plasmodium|plasmodium
145986|NCT02659566|Infection|infection
145987|NCT02659553|Liver Transplantation - Steatosis - Fatty Liver|liver transplantation - steatosis - fatty liver
145988|NCT02659540|Ipilimumab|ipilimumab
145989|NCT02659540|Nivolumab|nivolumab
145990|NCT02659540|Radiotherapy|radiotherapy
145991|NCT02659514|Poziotinib|poziotinib
145992|NCT02659514|Metastatic Breast Cancer|metastatic breast cancer
145993|NCT02659514|HER2-positive|her2-positive
145994|NCT02659514|Pan-HER inhibitor|pan-her inhibitor
145995|NCT02659501|Breast reconstruction|breast reconstruction
145996|NCT02659501|Bupivacaine|bupivacaine
145997|NCT02659501|Liposomal bupivacaine|liposomal bupivacaine
145998|NCT02659501|Postoperative analgesia|postoperative analgesia
145999|NCT02659462|Repaired Congenital Heart Disease|repaired congenital heart disease
146000|NCT02659462|Cardio Pulmonary Exercise Testing|cardio pulmonary exercise testing
146001|NCT02659462|Fontan|fontan
146002|NCT02659462|Fontan Palliation|fontan palliation
146003|NCT02659462|functional capacity|functional capacity
146004|NCT02659449|hands|hands
146005|NCT02659436|Cognitive Behavioural Therapy|cognitive behavioural therapy
146006|NCT02659423|Bystanding behaviors|bystanding behaviors
146007|NCT02659423|Campus|campus
146008|NCT02659423|Prevention|prevention
146009|NCT02659423|Sexual Assault|sexual assault
146010|NCT02659423|CampusSave|campussave
146011|NCT02659410|Physiologically based pharmacokinetic modeling|physiologically based pharmacokinetic modeling
146012|NCT02659410|Organic solvents|organic solvents
146013|NCT02659397|LDL-cholesterol|ldl-cholesterol
146014|NCT02659397|Hypercholesterolemia|hypercholesterolemia
146015|NCT02659397|ETC-1002|etc-1002
146016|NCT02659397|Adenosine triphosphate citrate lyase|adenosine triphosphate citrate lyase
146017|NCT02659397|Atorvastatin|atorvastatin
146018|NCT02659358|Advanced solid malignancy|advanced solid malignancy
146019|NCT02659358|Activity monitor|activity monitor
146020|NCT02659358|Biosensor|biosensor
146021|NCT02659358|Fitbit|fitbit
146022|NCT02659358|Patient Reported Outcomes (PRO)|patient reported outcomes (pro)
146023|NCT02659358|Stage 3/4 cancer|stage 3/4 cancer
146024|NCT02659358|Performance Status|performance status
146025|NCT02659358|Eastern Cooperative Oncology Group Performance Status (ECOG-PS)|eastern cooperative oncology group performance status (ecog-ps)
146026|NCT02659345|Art Therapy|art therapy
146027|NCT02659345|Chemotherapy|chemotherapy
146028|NCT02659319|Child overweight|child overweight
146029|NCT02659319|Child obesity|child obesity
146030|NCT02659319|Family dynamics|family dynamics
146031|NCT02659319|Peer relationships|peer relationships
146032|NCT02659319|Family intervention|family intervention
146033|NCT02659319|School intervention|school intervention
146034|NCT02659319|Parenting|parenting
146035|NCT02659293|Multiple myeloma|multiple myeloma
146036|NCT02659293|stem-cell transplant|stem-cell transplant
146037|NCT02659293|Symptomatic myeloma|symptomatic myeloma
146038|NCT02659293|lenalidomide|lenalidomide
146039|NCT02659293|carfilzomib|carfilzomib
146040|NCT02659293|dexamethasone|dexamethasone
146041|NCT02659280|telerehabilitation|telerehabilitation
146042|NCT02659267|Health Promotion|health promotion
146043|NCT02659267|Physical Activity|physical activity
146044|NCT02659267|Eating habits|eating habits
146045|NCT02659267|Health System|health system
146046|NCT02659267|Users from Health Academy Program|users from health academy program
146047|NCT02659254|Drug-Eluting Stents,Absorbable Implants,Stents|drug-eluting stents,absorbable implants,stents
146048|NCT02659241|Molecular results|molecular results
146049|NCT02659241|DNA|dna
146050|NCT02659241|RNA|rna
146051|NCT02659241|Protein expression|protein expression
146052|NCT02659241|AZD1775|azd1775
146053|NCT02659215|Hyaluronic Acid|hyaluronic acid
146054|NCT02659215|Cartilage Repair|cartilage repair
146055|NCT02659215|Knee|knee
146056|NCT02659202|Exercise|exercise
146057|NCT02659202|Heart Failure|heart failure
146058|NCT02659202|Blood Pressure|blood pressure
146059|NCT02659163|cardiometabolic risk|cardiometabolic risk
146060|NCT02659163|obesity|obesity
146061|NCT02659163|mHealth|mhealth
146062|NCT02659163|health behaviors|health behaviors
146063|NCT02659150|tocilizumab|tocilizumab
146064|NCT02659150|subcutaneous injection|subcutaneous injection
146065|NCT02659150|rheumatoid arthritis|rheumatoid arthritis
146066|NCT02659150|plaque inflammation|plaque inflammation
146067|NCT02659150|atherosclerotic plaque|atherosclerotic plaque
146068|NCT02659150|joint inflammation|joint inflammation
146069|NCT02659150|FDG-PET|fdg-pet
146070|NCT02659150|PET-MR|pet-mr
146071|NCT02659150|ACTEMRA|actemra
146072|NCT02659137|LBBB|lbbb
146073|NCT02659137|TAVI|tavi
146074|NCT02659124|facial laser|facial laser
146075|NCT02659124|fraction ablative resurfacing|fraction ablative resurfacing
146076|NCT02659124|total ablative resurfacing|total ablative resurfacing
146077|NCT02659124|EpiFix|epifix
146078|NCT02659124|rhytides|rhytides
146079|NCT02659124|wrinkles|wrinkles
146080|NCT02659124|AmnioFix|amniofix
146081|NCT02659111|Exercise Therapy|exercise therapy
146082|NCT02659098|Best Corrected Visual Acuity|best corrected visual acuity
146083|NCT02659098|Geographic Atrophy|geographic atrophy
146084|NCT02659098|Macular Degeneration|macular degeneration
146085|NCT02659098|CNTO 2476|cnto 2476
146086|NCT02659085|Depressive Disorder, Major|depressive disorder, major
146087|NCT02659085|Antidepressive Agents/adverse effects|antidepressive agents/adverse effects
146088|NCT02659085|Depressive Disorder, Major/drug therapy|depressive disorder, major/drug therapy
146089|NCT02659085|Infusions, Intravenous|infusions, intravenous
146090|NCT02659085|Ketamine/administration & dosage*|ketamine/administration & dosage*
146091|NCT02659085|Ketamine/adverse effects|ketamine/adverse effects
146092|NCT02659085|Treatment Outcome|treatment outcome
146093|NCT02659085|Electroconvulsive therapy|electroconvulsive therapy
146094|NCT02659046|Traumatic Brain Injury|traumatic brain injury
146095|NCT02659033|microbiota|microbiota
146096|NCT02659033|resistant bacteria|resistant bacteria
146097|NCT02659007|yoga|yoga
146098|NCT02659007|balance|balance
146099|NCT02658968|Radioimmunotherapy|radioimmunotherapy
146100|NCT02658968|Lu-177|lu-177
146101|NCT02658968|Phase I study|phase i study
146102|NCT02658968|Betalutin|betalutin
146103|NCT02658968|ARC|arc
146104|NCT02658968|Antibody Radionuclide Conjugate|antibody radionuclide conjugate
146105|NCT02658968|HH1|hh1
146106|NCT02658968|Rituximab|rituximab
146107|NCT02658968|177Lu-DOTA-HH1|177lu-dota-hh1
146108|NCT02658968|Lilotomab|lilotomab
146109|NCT02658968|Lutetium (177Lu)-lilotomab satetraxetan|lutetium (177lu)-lilotomab satetraxetan
146110|NCT02658968|Additional relevant MeSH terms:|additional relevant mesh terms:
146111|NCT02658968|Lymphoma|lymphoma
146112|NCT02658968|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
146113|NCT02658968|Immune System Diseases|immune system diseases
146114|NCT02658968|Immunoproliferative Disorders|immunoproliferative disorders
146115|NCT02658968|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
146116|NCT02658968|Lymphatic Diseases|lymphatic diseases
146117|NCT02658968|Lymphoproliferative Disorders|lymphoproliferative disorders
146118|NCT02658968|Neoplasms|neoplasms
146119|NCT02658968|Neoplasms by Histologic Type|neoplasms by histologic type
146120|NCT02658968|DLBCL|dlbcl
146121|NCT02658968|Refractory DLBCL|refractory dlbcl
146122|NCT02658968|Relapsed DLBCL|relapsed dlbcl
146123|NCT02658955|Abdominal wall closure|abdominal wall closure
146124|NCT02658942|renal stones|renal stones
146125|NCT02658942|lower calyx|lower calyx
146126|NCT02658942|Ureteroscopy|ureteroscopy
146127|NCT02658942|Shockwave lithotripsy|shockwave lithotripsy
146128|NCT02658942|Holmium laser|holmium laser
146129|NCT02658942|Adult|adult
146130|NCT02658942|Kidney|kidney
146131|NCT02658903|Foley|foley
146132|NCT02658903|Infection|infection
146133|NCT02658903|Hospital acquired|hospital acquired
146134|NCT02658903|catheter associated|catheter associated
146135|NCT02658903|urinary|urinary
146136|NCT02658877|Xolair|xolair
146137|NCT02658877|corticosteroids|corticosteroids
146138|NCT02658877|asthma|asthma
146139|NCT02658877|long-acting beta-agonists|long-acting beta-agonists
146140|NCT02658864|lafutidine tablet|lafutidine tablet
146141|NCT02658864|pharmacokinetics|pharmacokinetics
146142|NCT02658864|food|food
146143|NCT02658864|safety|safety
146144|NCT02658864|healthy subjects|healthy subjects
146145|NCT02658851|lymphocele|lymphocele
146146|NCT02658851|pelvic lymph node dissection|pelvic lymph node dissection
146147|NCT02658851|robotic assisted radical prostatectomy|robotic assisted radical prostatectomy
146148|NCT02658851|PLND|plnd
146149|NCT02658851|RARP|rarp
146150|NCT02658851|prostatectomy|prostatectomy
146151|NCT02658851|Patel|patel
146152|NCT02658825|Healthy|healthy
146153|NCT02658825|JNJ-63623872|jnj-63623872
146154|NCT02658825|Moxifloxacin|moxifloxacin
146155|NCT02658812|Breast Cancer|breast cancer
146156|NCT02658812|Inflammatory breast cancer|inflammatory breast cancer
146158|NCT02658812|Non-inflammatory breast cancer|non-inflammatory breast cancer
146159|NCT02658812|Inoperable local recurrence|inoperable local recurrence
146160|NCT02658812|Talimogene laherparepvec|talimogene laherparepvec
146161|NCT02658812|T-VEC|t-vec
146162|NCT02658812|OncoVEX GM-CSF|oncovex gm-csf
146163|NCT02658799|periodontitis|periodontitis
146164|NCT02658799|anti-inflammatory agents|anti-inflammatory agents
146165|NCT02658760|Femoral Fractures|femoral fractures
146166|NCT02658721|Systemic Tramadol|systemic tramadol
146167|NCT02658721|Adjunct Tramadol|adjunct tramadol
146168|NCT02658721|Lidocain|lidocain
146169|NCT02658695|ICSI|icsi
146170|NCT02658695|embryo transfer|embryo transfer
146171|NCT02658695|air bubbles depth|air bubbles depth
146172|NCT02658669|Insomnia|insomnia
146173|NCT02658669|Injury, Brain, Traumatic Mild|injury, brain, traumatic mild
146174|NCT02658656|Exoskeleton|exoskeleton
146175|NCT02658643|biliodigestive anastomosis techniques|biliodigestive anastomosis techniques
146176|NCT02658630|arm rehabilitation|arm rehabilitation
146177|NCT02658630|recovery of function|recovery of function
146178|NCT02658617|Empathy|empathy
146179|NCT02658617|Interoceptive Awareness|interoceptive awareness
146180|NCT02658617|fMRI|fmri
146181|NCT02658617|MRS|mrs
146182|NCT02658591|Food intake|food intake
146183|NCT02658591|Satiety|satiety
146184|NCT02658591|Appetite|appetite
146185|NCT02658591|Glycemia|glycemia
146186|NCT02658591|Faba bean|faba bean
146187|NCT02658591|Protein|protein
146188|NCT02658591|Snack|snack
146189|NCT02658565|Intraoperative Consultation|intraoperative consultation
146190|NCT02658552|HIFU|hifu
146191|NCT02658552|Benign thyroid nodule|benign thyroid nodule
146192|NCT02658552|Low risk|low risk
146193|NCT02658552|New treatment|new treatment
146194|NCT02658539|Body fat distribution|body fat distribution
146195|NCT02658539|Bone mineral density|bone mineral density
146196|NCT02658539|Dual-energy x-ray absorptiometry|dual-energy x-ray absorptiometry
146197|NCT02658526|cognition|cognition
146198|NCT02658526|anesthesia|anesthesia
146199|NCT02658526|surgery|surgery
146200|NCT02658526|stress|stress
146201|NCT02658526|child|child
146202|NCT02658500|early infant feeding|early infant feeding
146203|NCT02658500|infant intestinal flora|infant intestinal flora
146204|NCT02658500|infant health|infant health
146205|NCT02658474|Chronic pain|chronic pain
146206|NCT02658474|Acceptance and Commitment Therapy|acceptance and commitment therapy
146207|NCT02658474|Multidisciplinary treatment|multidisciplinary treatment
146208|NCT02658474|Group treatment|group treatment
146209|NCT02658435|Malaria|malaria
146210|NCT02658435|Retinal|retinal
146211|NCT02658435|Ophthalmic|ophthalmic
146212|NCT02658435|Plasmodium. vivax|plasmodium. vivax
146213|NCT02658435|Tafenoquine|tafenoquine
146214|NCT02658435|Pharmacodynamic|pharmacodynamic
146215|NCT02658409|CCIV|cciv
146216|NCT02658409|quadrivalent cell-culture based influenza vaccine|quadrivalent cell-culture based influenza vaccine
146217|NCT02658409|Influenza vaccine|influenza vaccine
146218|NCT02658409|Vaccination|vaccination
146219|NCT02658396|Multiple Myeloma|multiple myeloma
146220|NCT02658396|Relapsed Multiple Myeloma|relapsed multiple myeloma
146221|NCT02658396|Refractory Multiple Myeloma|refractory multiple myeloma
146222|NCT02658370|physical exercises|physical exercises
146223|NCT02658370|physical therapy|physical therapy
146224|NCT02658370|Wii game console|wii game console
146225|NCT02658370|patients perspective|patients perspective
146226|NCT02658344|Stem cell|stem cell
146227|NCT02658344|adipose tissue derived mesenchymal stem cell|adipose tissue derived mesenchymal stem cell
146228|NCT02658344|osteoarthritis|osteoarthritis
146229|NCT02658344|degenerative arthritis|degenerative arthritis
146230|NCT02658344|biostar|biostar
146231|NCT02658344|Rbio|rbio
146232|NCT02658331|Ebola Virus Disease|ebola virus disease
146233|NCT02658331|Rapid Diagnosis|rapid diagnosis
146234|NCT02658331|Point of care|point of care
146235|NCT02658331|Molecular platform|molecular platform
146236|NCT02658318|peri- and postoperative complications|peri- and postoperative complications
146237|NCT02658318|airway obstruction|airway obstruction
146238|NCT02658318|adapted Furlow palatoplasty|adapted furlow palatoplasty
146239|NCT02658305|transoral approach|transoral approach
146240|NCT02658305|transbuccal approach|transbuccal approach
146241|NCT02658305|postoperative complications|postoperative complications
146242|NCT02658292|fungus|fungus
146243|NCT02658292|antifungal|antifungal
146244|NCT02658292|skin infection|skin infection
146245|NCT02658292|hair infection|hair infection
146246|NCT02658292|dermatophyte|dermatophyte
146247|NCT02658292|scalp|scalp
146248|NCT02658292|skin|skin
146249|NCT02658292|eyebrows|eyebrows
146250|NCT02658292|eyelashes|eyelashes
146251|NCT02658292|hair|hair
146252|NCT02658292|Trichophyton|trichophyton
146253|NCT02658292|Microsporum|microsporum
146254|NCT02658292|Endothrix|endothrix
146255|NCT02658292|spores|spores
146256|NCT02658279|Pembrolizumab (MK-3475)|pembrolizumab (mk-3475)
146257|NCT02658279|15-227|15-227
146258|NCT02658279|Hypermutator Phenotype|hypermutator phenotype
146259|NCT02658266|resistance training|resistance training
146260|NCT02658266|adult|adult
146261|NCT02658266|muscle strength|muscle strength
146262|NCT02658266|muscle endurance|muscle endurance
146263|NCT02658266|muscle metabolism|muscle metabolism
146264|NCT02658253|Placental malaria vaccine|placental malaria vaccine
146265|NCT02658253|Plasmodium|plasmodium
146266|NCT02658253|PRIMALVAC|primalvac
146267|NCT02658240|Nerve block|nerve block
146268|NCT02658240|Periarticular infiltration|periarticular infiltration
146269|NCT02658240|Ropivacaine|ropivacaine
146270|NCT02658240|Pain|pain
146271|NCT02658214|durvalumab, tremelimumab, metastatic, solid tumors, immuno-oncology, first-line chemotherapy, esophageal, pancreatic|durvalumab, tremelimumab, metastatic, solid tumors, immuno-oncology, first-line chemotherapy, esophageal, pancreatic
146272|NCT02658188|Restless legs syndrome patients|restless legs syndrome patients
146273|NCT02658188|ASP8825|asp8825
146274|NCT02658188|XP13512|xp13512
146275|NCT02658110|Postprandial glycemia|postprandial glycemia
146276|NCT02658110|Metabolic health measures|metabolic health measures
146277|NCT02658097|Lung Cancer|lung cancer
146278|NCT02658097|pembrolizumab|pembrolizumab
146279|NCT02658097|focal radiation|focal radiation
146280|NCT02658097|RT|rt
146281|NCT02658084|HER2-Positive|her2-positive
146282|NCT02658084|Metastatic Breast Cancer|metastatic breast cancer
146283|NCT02658071|exfoliative glaucoma|exfoliative glaucoma
146284|NCT02658071|cataract|cataract
146285|NCT02658071|ocular pressure|ocular pressure
146286|NCT02658058|Ultrasound|ultrasound
146287|NCT02658058|Spinal anesthesia|spinal anesthesia
146288|NCT02658058|Elderly|elderly
146289|NCT02658058|Landmark|landmark
146290|NCT02658045|oxygen saturation|oxygen saturation
146291|NCT02658045|monitoring|monitoring
146292|NCT02658045|oximeter|oximeter
146293|NCT02658019|Hepatocellular Carcinoma|hepatocellular carcinoma
146294|NCT02658019|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
146295|NCT02658019|Unresectable Hepatocellular Carcinoma|unresectable hepatocellular carcinoma
146296|NCT02658006|Near Infrared Spectroscopy|near infrared spectroscopy
146297|NCT02658006|Ultrasonography|ultrasonography
146298|NCT02658006|Hepatic vein Doppler|hepatic vein doppler
146299|NCT02658006|Portal vein Doppler|portal vein doppler
146300|NCT02658006|Lung ultrasound|lung ultrasound
146301|NCT02658006|Positive fluid balance|positive fluid balance
146302|NCT02658006|Mixed venous saturation|mixed venous saturation
146303|NCT02657993|Breast Neoplasms|breast neoplasms
146304|NCT02657993|Aromatase Inhibitors|aromatase inhibitors
146305|NCT02657993|Musculoskeletal Pain|musculoskeletal pain
146306|NCT02657993|Hypnosis|hypnosis
146307|NCT02657993|Medication Adherence|medication adherence
146308|NCT02657993|Cost-Benefit Analysis|cost-benefit analysis
146309|NCT02657993|Treatment Outcomes|treatment outcomes
146310|NCT02657980|Major Depressive Disorder|major depressive disorder
146311|NCT02657980|tDCS|tdcs
146312|NCT02657980|MDD|mdd
146313|NCT02657980|transcranial Direct Current Stimulation|transcranial direct current stimulation
146314|NCT02657954|Homeless persons|homeless persons
146315|NCT02657954|Veterans|veterans
146316|NCT02657954|Mental disorders|mental disorders
146317|NCT02657954|Cognition|cognition
146318|NCT02657954|Rehabilitation|rehabilitation
146319|NCT02657941|Schizophrenia|schizophrenia
146320|NCT02657941|Obesity|obesity
146321|NCT02657941|Metabolic Syndrome|metabolic syndrome
146322|NCT02657915|FF-VEP|ff-vep
146323|NCT02657915|mfVEP|mfvep
146324|NCT02657915|Human anti-LINGO-1|human anti-lingo-1
146325|NCT02657915|BIIB033|biib033
146326|NCT02657915|AON|aon
146327|NCT02657889|PARP inhibitor|parp inhibitor
146328|NCT02657889|PD-1|pd-1
146329|NCT02657889|Niraparib|niraparib
146330|NCT02657889|Pembrolizumab|pembrolizumab
146331|NCT02657889|Keynote|keynote
146332|NCT02657889|TOPACIO|topacio
146333|NCT02657837|CF|cf
146334|NCT02657837|Multiple Breath Washout|multiple breath washout
146335|NCT02657837|Lung Clearance Index|lung clearance index
146336|NCT02657837|Pediatrics|pediatrics
146337|NCT02657824|Ejection fraction|ejection fraction
146338|NCT02657824|mitral valve|mitral valve
146339|NCT02657824|e-point septal separation|e-point septal separation
146340|NCT02657811|Time-Lapse Imaging|time-lapse imaging
146341|NCT02657811|Embryo Culture Techniques|embryo culture techniques
146342|NCT02657811|Fertilization in Vitro|fertilization in vitro
146343|NCT02657811|Embryology|embryology
146344|NCT02657811|Assisted Reproductive Techniques|assisted reproductive techniques
146345|NCT02657811|Infertility|infertility
146346|NCT02657811|Preimplantation diagnosis|preimplantation diagnosis
146347|NCT02657772|Target Ultra coils|target ultra coils
146348|NCT02657772|small aneurysms|small aneurysms
146349|NCT02657746|blood pressure monitoring|blood pressure monitoring
146350|NCT02657746|high blood pressure|high blood pressure
146351|NCT02657746|cardiovascular disease|cardiovascular disease
146352|NCT02657746|Antihypertensive agents|antihypertensive agents
146353|NCT02657746|Non-pharmacological treatment|non-pharmacological treatment
146354|NCT02657746|community health care workers|community health care workers
146355|NCT02657746|cost-effectiveness|cost-effectiveness
146356|NCT02657733|Respiratory Conditions for Adults|respiratory conditions for adults
146357|NCT02657720|Respiratory Conditions for Adults|respiratory conditions for adults
146358|NCT02657707|stent|stent
146359|NCT02657707|stenosis|stenosis
146360|NCT02657707|artery|artery
146361|NCT02657707|carotid|carotid
146362|NCT02657668|Irritable Bowel Syndrome|irritable bowel syndrome
146363|NCT02657668|Emotion Focused Therapy|emotion focused therapy
146364|NCT02657668|Stress|stress
146365|NCT02657668|Resilience|resilience
146366|NCT02657668|Coping Strategies|coping strategies
146367|NCT02657655|Parkinson's Disease|parkinson's disease
146368|NCT02657655|Dyskinesia|dyskinesia
146369|NCT02657655|Tremor|tremor
146370|NCT02657655|Symptom Management|symptom management
146371|NCT02657655|Technology|technology
146372|NCT02657655|Wearable Sensors|wearable sensors
146373|NCT02657655|Continuous Monitoring|continuous monitoring
146374|NCT02657655|Mobility|mobility
146375|NCT02657642|drug related problems, elderly|drug related problems, elderly
146376|NCT02657603|Peripheral Nerve Blocks|peripheral nerve blocks
146377|NCT02657577|Women|women
146378|NCT02657577|Infants and Children|infants and children
146379|NCT02657551|Thyroid Cancer|thyroid cancer
146380|NCT02657538|Interproximal caries|interproximal caries
146381|NCT02657538|Enamel caries|enamel caries
146382|NCT02657538|Caries detection|caries detection
146383|NCT02657538|Caries diagnostics|caries diagnostics
146384|NCT02657538|Near-infrared light transillumination|near-infrared light transillumination
146385|NCT02657538|DIAGNOcam|diagnocam
146386|NCT02657512|Rivaroxaban, pharmacokinetics, activated charcoal, poisoning|rivaroxaban, pharmacokinetics, activated charcoal, poisoning
146387|NCT02657499|healthcare access|healthcare access
146388|NCT02657499|utilization|utilization
146389|NCT02657499|expenditures|expenditures
146390|NCT02657499|preventive services|preventive services
146391|NCT02657486|BGJ398|bgj398
146392|NCT02657486|15-090|15-090
146393|NCT02657460|chemotherapy|chemotherapy
146394|NCT02657460|microparticle|microparticle
146395|NCT02657460|malignant pleural effusion|malignant pleural effusion
146396|NCT02657447|Radioimmunotherapy|radioimmunotherapy
146397|NCT02657447|Lu-177|lu-177
146398|NCT02657447|Phase I study|phase i study
146399|NCT02657447|Betalutin|betalutin
146400|NCT02657447|ARC|arc
146401|NCT02657447|Antibody Radionuclide Conjugate|antibody radionuclide conjugate
146402|NCT02657447|HH1|hh1
146403|NCT02657447|Rituximab|rituximab
146404|NCT02657447|177Lu-DOTA-HH1|177lu-dota-hh1
146405|NCT02657447|Lymphoma|lymphoma
146406|NCT02657447|Lymphoma Non-Hodgkin|lymphoma non-hodgkin
146407|NCT02657447|Immune System Diseases|immune system diseases
146408|NCT02657447|Follicular Lymphoma|follicular lymphoma
146409|NCT02657447|Marginal Zone Lymphoma|marginal zone lymphoma
146410|NCT02657447|Lymphoplasmacytoid|lymphoplasmacytoid
146411|NCT02657447|Lymphatic Diseases|lymphatic diseases
146412|NCT02657447|Lymphoproliferative Disorders|lymphoproliferative disorders
146413|NCT02657447|Neoplasms|neoplasms
146414|NCT02657447|Neoplasms by Histological Type|neoplasms by histological type
146415|NCT02657447|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
146416|NCT02657447|Classical Mantle Cell Lymphoma|classical mantle cell lymphoma
146417|NCT02657447|Lilotomab|lilotomab
146418|NCT02657447|Lutetium (177Lu) lilotomab satetraxetan|lutetium (177lu) lilotomab satetraxetan
146419|NCT02657382|Biofeedback|biofeedback
146420|NCT02657382|Myocardial Imaging|myocardial imaging
146421|NCT02657369|Lenvatinib|lenvatinib
146422|NCT02657369|Thyroid Cancer, Anaplastic|thyroid cancer, anaplastic
146423|NCT02657369|Lenvima|lenvima
146424|NCT02657369|E7080|e7080
146425|NCT02657356|Pulmonary Hypertension|pulmonary hypertension
146426|NCT02657356|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
146427|NCT02657356|Connective Tissue Disease-Associated Pulmonary Arterial Hypertension|connective tissue disease-associated pulmonary arterial hypertension
146428|NCT02657356|Bardoxolone methyl|bardoxolone methyl
146429|NCT02657356|PAH|pah
146430|NCT02657356|RTA 402|rta 402
146431|NCT02657356|6-minute walk distance|6-minute walk distance
146432|NCT02657343|Breast Cancer With Positive HER2|breast cancer with positive her2
146433|NCT02657330|Locally Advanced|locally advanced
146434|NCT02657330|Metastatic|metastatic
146435|NCT02657317|chronic pain|chronic pain
146436|NCT02657317|pain management|pain management
146437|NCT02657317|trauma|trauma
146438|NCT02657317|ptsd|ptsd
146439|NCT02657317|tbi|tbi
146440|NCT02657317|opioid medication|opioid medication
146441|NCT02657304|Sleep Apnea|sleep apnea
146442|NCT02657304|CPAP|cpap
146443|NCT02657278|Peripheral arterial disease,|peripheral arterial disease,
146444|NCT02657278|Cardipulmonary Exercise Test|cardipulmonary exercise test
146445|NCT02657252|telangiectasis|telangiectasis
146446|NCT02657252|varicose veins|varicose veins
146447|NCT02657252|veins|veins
146448|NCT02657252|glucose|glucose
146449|NCT02657252|sclerotherapy|sclerotherapy
146450|NCT02657239|Physical Function|physical function
146451|NCT02657213|Diabetes, Type 1|diabetes, type 1
146452|NCT02657213|Hypoglycemia|hypoglycemia
146453|NCT02657213|Insulin Infusion Systems|insulin infusion systems
146454|NCT02657200|miscarriage|miscarriage
146455|NCT02657200|Flanders|flanders
146456|NCT02657200|spontaneous abortion|spontaneous abortion
146457|NCT02657200|KAP|kap
146458|NCT02657200|midwives|midwives
146459|NCT02657174|third molar|third molar
146460|NCT02657174|auriculotherapy|auriculotherapy
146461|NCT02657174|inflammation|inflammation
146462|NCT02657174|pain|pain
146463|NCT02657122|Single ascending dose|single ascending dose
146464|NCT02657122|SAD|sad
146465|NCT02657122|multiple ascending dose|multiple ascending dose
146466|NCT02657122|MAD|mad
146467|NCT02657122|Phase 1|phase 1
146468|NCT02657122|first-in-human|first-in-human
146469|NCT02657122|volunteers|volunteers
146470|NCT02657122|TD-1473|td-1473
146471|NCT02657109|valve replacement|valve replacement
146472|NCT02657109|physical therapy|physical therapy
146473|NCT02657109|early mobilization|early mobilization
146474|NCT02657096|Chronic Periodontitis|chronic periodontitis
146475|NCT02657096|Hybenx|hybenx
146476|NCT02657096|Desiccant agent|desiccant agent
146477|NCT02657096|Healing|healing
146478|NCT02657096|Microbiology|microbiology
146479|NCT02657096|Periodontal Diseases|periodontal diseases
146480|NCT02657096|Periodontitis|periodontitis
146481|NCT02657096|Split-mouth clinical Study|split-mouth clinical study
146482|NCT02657070|Stroke|stroke
146483|NCT02657070|learned non-use|learned non-use
146484|NCT02657070|Virtual Reality|virtual reality
146485|NCT02657070|Hemiparesis|hemiparesis
146486|NCT02657057|neuromodulation|neuromodulation
146487|NCT02657057|electrical estimulation|electrical estimulation
146488|NCT02657057|percutaneous|percutaneous
146489|NCT02657057|transcutaneous|transcutaneous
146490|NCT02657057|OAB|oab
146491|NCT02657044|EMR|emr
146492|NCT02657044|ESD|esd
146493|NCT02657044|endoscopic mucosal resection|endoscopic mucosal resection
146494|NCT02657044|endoscopic submucosal resection|endoscopic submucosal resection
146495|NCT02657044|colorectal adenomas|colorectal adenomas
146496|NCT02657031|Headache, Migraine|headache, migraine
146497|NCT02656992|Bronchiectasis|bronchiectasis
146498|NCT02656992|High-intensity inspiratory muscle training|high-intensity inspiratory muscle training
146499|NCT02656979|Glaucoma|glaucoma
146500|NCT02656979|Blood flow|blood flow
146501|NCT02656979|Pseudoexfoliation|pseudoexfoliation
146502|NCT02656979|Intraocular pressure|intraocular pressure
146503|NCT02656979|Brain perfusion|brain perfusion
146504|NCT02656979|Magnetic Resonance Imaging|magnetic resonance imaging
146505|NCT02656953|VDU workers|vdu workers
146506|NCT02656953|VDU lenses|vdu lenses
146507|NCT02656953|Neck complaints|neck complaints
146508|NCT02656953|Visual complaints|visual complaints
146509|NCT02656940|obesity|obesity
146510|NCT02656940|lipids|lipids
146511|NCT02656940|energy expenditure|energy expenditure
146512|NCT02656940|gene expression|gene expression
146513|NCT02656927|Spinal Cord Injury|spinal cord injury
146514|NCT02656927|Yoga|yoga
146515|NCT02656927|Psychological Flexibility|psychological flexibility
146516|NCT02656927|Mindfulness|mindfulness
146517|NCT02656927|Pain|pain
146518|NCT02656849|Solid Tumor|solid tumor
146519|NCT02656823|ANKYLOS|ankylos
146520|NCT02656823|Simplant|simplant
146521|NCT02656823|maxilla|maxilla
146522|NCT02656823|edentulous|edentulous
146523|NCT02656823|short implants|short implants
146524|NCT02656797|Leishmania major|leishmania major
146525|NCT02656797|Leishmania tropica|leishmania tropica
146526|NCT02656797|Amphotericin B|amphotericin b
146527|NCT02656771|THA|tha
146528|NCT02656771|Hip|hip
146529|NCT02656771|arthroplasties|arthroplasties
146530|NCT02656745|Smoking|smoking
146531|NCT02656745|Cigarette Smoking|cigarette smoking
146532|NCT02656745|Tobacco Smoking|tobacco smoking
146533|NCT02656745|Nicotine|nicotine
146534|NCT02656745|Drug|drug
146535|NCT02656745|Addiction|addiction
146536|NCT02656745|Tobacco|tobacco
146537|NCT02656719|tracheostomy|tracheostomy
146538|NCT02656719|complications|complications
146539|NCT02656719|ultrasound|ultrasound
146540|NCT02656719|bronchoscopy|bronchoscopy
146541|NCT02656706|Adjuvant melanoma|adjuvant melanoma
146542|NCT02656706|Advanced melanoma|advanced melanoma
146543|NCT02656693|Weight Reduction Programs|weight reduction programs
146544|NCT02656693|Weight Loss Programs|weight loss programs
146545|NCT02656693|Obesity|obesity
146546|NCT02656667|COPD pulmonary rehabilitation|copd pulmonary rehabilitation
146547|NCT02656667|neuromuscular electrical stimulation|neuromuscular electrical stimulation
146548|NCT02656667|sit to stand test COPD|sit to stand test copd
146549|NCT02656667|quadriceps strengthening|quadriceps strengthening
146550|NCT02656602|Computer Assisted Instruction|computer assisted instruction
146551|NCT02656602|Patient Counselling|patient counselling
146552|NCT02656602|Endoscopy|endoscopy
146553|NCT02656589|breast cancer|breast cancer
146554|NCT02656589|herceptin|herceptin
146555|NCT02656589|microRNA|microrna
146556|NCT02656576|Human Papillomavirus|human papillomavirus
146557|NCT02656576|oropharynx biopsy|oropharynx biopsy
146558|NCT02656576|tonsillar lesion|tonsillar lesion
146559|NCT02656550|Uterine Transplant|uterine transplant
146560|NCT02656550|AUI|aui
146561|NCT02656550|Rokitansky Syndrome|rokitansky syndrome
146562|NCT02656524|Metastatic colorectal cancer|metastatic colorectal cancer
146563|NCT02656511|immediate antiretroviral therapy|immediate antiretroviral therapy
146564|NCT02656511|hyperacute infection|hyperacute infection
146565|NCT02656498|Tau, neurodegeneration, positron emission computed tomography|tau, neurodegeneration, positron emission computed tomography
146566|NCT02656472|Pediatric Cardiac surgery|pediatric cardiac surgery
146567|NCT02656472|Inflammatory response|inflammatory response
146568|NCT02656472|Tranexamic acid|tranexamic acid
146569|NCT02656472|Epsilon Aminocaproic Acid|epsilon aminocaproic acid
146570|NCT02656459|gene expression|gene expression
146571|NCT02656446|Neuraxial|neuraxial
146572|NCT02656446|Ultrasound|ultrasound
146573|NCT02656433|QEEG|qeeg
146574|NCT02656433|ERP|erp
146575|NCT02656433|tRNS|trns
146576|NCT02656433|Brain injury|brain injury
146577|NCT02656433|Motor Impairment|motor impairment
146578|NCT02656433|Transcranial Brain non-invasive stimulation|transcranial brain non-invasive stimulation
146579|NCT02656433|electroencephalogram|electroencephalogram
146580|NCT02656407|Functional Ultrasound|functional ultrasound
146581|NCT02656407|Intraoperative|intraoperative
146582|NCT02656407|Brain|brain
146583|NCT02656407|Doppler|doppler
146584|NCT02656407|Ultrasound|ultrasound
146585|NCT02656394|ocular surface disease|ocular surface disease
146586|NCT02656394|glaucoma medications|glaucoma medications
146587|NCT02656381|Sarcoidosis|sarcoidosis
146588|NCT02656381|Behcet's Disease|behcet's disease
146589|NCT02656381|Natural History Study|natural history study
146590|NCT02656381|Biological Specimens|biological specimens
146591|NCT02656381|Immune System|immune system
146592|NCT02656355|Gait Initiation|gait initiation
146593|NCT02656355|Freezing of gait|freezing of gait
146594|NCT02656355|Balance training|balance training
146595|NCT02656355|Anticipatory postural adjustments|anticipatory postural adjustments
146596|NCT02656342|OCD|ocd
146597|NCT02656329|Heart Failure (HF)|heart failure (hf)
146598|NCT02656329|Single photon emission computer tomography scan (SPECT)|single photon emission computer tomography scan (spect)
146599|NCT02656329|Implantable cardioverter defibrillator (ICD)|implantable cardioverter defibrillator (icd)
146600|NCT02656329|Left Ventricular ejection fraction (LVEF)|left ventricular ejection fraction (lvef)
146601|NCT02656329|New York Health Association (NYHA)|new york health association (nyha)
146602|NCT02656329|Metaiodobenzylguanidine (mIBG)|metaiodobenzylguanidine (mibg)
146603|NCT02656329|123I-iobenguane|123i-iobenguane
146604|NCT02656329|Heart-to-mediastinal ratio (H/M)|heart-to-mediastinal ratio (h/m)
146605|NCT02656329|ADMIRE-ICD (AdreView Myocardial Imaging for Risk Evaluation - Implantable Cardioverter Defibrillator|admire-icd (adreview myocardial imaging for risk evaluation - implantable cardioverter defibrillator
146606|NCT02656329|All-cause mortality|all-cause mortality
146607|NCT02656329|Cardiac mortality|cardiac mortality
146608|NCT02656251|biofilms|biofilms
146609|NCT02656251|cross over trial|cross over trial
146610|NCT02656251|chlorhexidine|chlorhexidine
146611|NCT02656238|CTEPH|cteph
146612|NCT02656238|Balloon pulmonary angioplasty|balloon pulmonary angioplasty
146613|NCT02656238|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
146614|NCT02656238|Pulmonary endarterectomy|pulmonary endarterectomy
146615|NCT02656238|BPA|bpa
146616|NCT02656238|PEA|pea
146617|NCT02656225|postpartum anemia|postpartum anemia
146618|NCT02656225|hemoglobin|hemoglobin
146619|NCT02656225|iron metabolism|iron metabolism
146620|NCT02656225|Traditional Chinese Medicine|traditional chinese medicine
146621|NCT02656225|Ejiao|ejiao
146622|NCT02656212|epicatechin|epicatechin
146623|NCT02656212|pre-diabetes|pre-diabetes
146624|NCT02656199|Diaphragm|diaphragm
146625|NCT02656199|Ventilators, Mechanical|ventilators, mechanical
146626|NCT02656173|Tamsulosin|tamsulosin
146627|NCT02656173|Overactive bladder|overactive bladder
146628|NCT02656173|Benign prostatic hypertrophy|benign prostatic hypertrophy
146629|NCT02656173|Mirabegron|mirabegron
146630|NCT02656147|Leukemia|leukemia
146631|NCT02656147|Lymphoma|lymphoma
146632|NCT02656147|CAR γδT|car γδt
146633|NCT02656134|Familial Adenomatous Polyposis|familial adenomatous polyposis
146634|NCT02656121|PCOS, vitamin D|pcos, vitamin d
146635|NCT02656082|Discoid lupus erythematosus|discoid lupus erythematosus
146636|NCT02656082|Intradermal injection of etanercept|intradermal injection of etanercept
146637|NCT02656017|kidney disease|kidney disease
146638|NCT02656017|polycystic kidney disease|polycystic kidney disease
146639|NCT02656017|autosomal dominant kidney disease|autosomal dominant kidney disease
146640|NCT02656017|kidney cysts|kidney cysts
146641|NCT02656017|PKD|pkd
146642|NCT02656004|Eucalyptus|eucalyptus
146643|NCT02656004|Autonomic nervous system|autonomic nervous system
146644|NCT02656004|Isometric resistance exercise|isometric resistance exercise
146645|NCT02655991|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
146646|NCT02655991|Ambulatory Care|ambulatory care
146647|NCT02655991|Telemedicine|telemedicine
146648|NCT02655991|Remote Consultation|remote consultation
146649|NCT02655991|Health Services Accessibility|health services accessibility
146650|NCT02655965|Breast cancer|breast cancer
146651|NCT02655965|lumpectomy|lumpectomy
146652|NCT02655965|mastectomy|mastectomy
146653|NCT02655965|PECS bloc|pecs bloc
146654|NCT02655939|Gonarthrosis|gonarthrosis
146655|NCT02655926|OCD|ocd
146656|NCT02655926|DBS|dbs
146657|NCT02655926|Deep Brain Stimulation|deep brain stimulation
146658|NCT02655913|Sodium ascorbate|sodium ascorbate
146659|NCT02655913|Non-Small-Cell Lung cancer|non-small-cell lung cancer
146660|NCT02655913|Oncothermia|oncothermia
146661|NCT02655913|Immune function|immune function
146662|NCT02655913|Life quality|life quality
146663|NCT02655913|Tumor marker|tumor marker
146664|NCT02655913|Survival time|survival time
146665|NCT02655900|Obstetric anal sphincter injury,|obstetric anal sphincter injury,
146666|NCT02655900|Ultrasound diagnosis|ultrasound diagnosis
146667|NCT02655874|Seasonal Influenza|seasonal influenza
146668|NCT02655874|Antibody response|antibody response
146669|NCT02655874|Influenza Vaccines|influenza vaccines
146670|NCT02655874|Hemagglutination Inhibition|hemagglutination inhibition
146671|NCT02655874|Elderly|elderly
146672|NCT02655874|immunosenescence|immunosenescence
146673|NCT02655874|Tropics|tropics
146674|NCT02655848|Popeye|popeye
146675|NCT02655848|Long Head Biceps Tendon|long head biceps tendon
146676|NCT02655848|Arthroscopy|arthroscopy
146677|NCT02655848|Functional result|functional result
146678|NCT02655835|mindfulness|mindfulness
146679|NCT02655835|meditation|meditation
146680|NCT02655835|internet|internet
146681|NCT02655822|NSCLC|nsclc
146682|NCT02655822|MEL|mel
146683|NCT02655822|RCC|rcc
146684|NCT02655822|TNBC|tnbc
146685|NCT02655822|Triple Negative Breast Neoplasms|triple negative breast neoplasms
146686|NCT02655822|Neoplasms|neoplasms
146687|NCT02655822|CRC|crc
146688|NCT02655822|Lung Cancer|lung cancer
146689|NCT02655822|Kidney Cancer|kidney cancer
146690|NCT02655822|Colon Cancer|colon cancer
146691|NCT02655822|Rectal Cancer|rectal cancer
146692|NCT02655822|Skin Cancer|skin cancer
146693|NCT02655822|Breast Cancer|breast cancer
146694|NCT02655822|mCRPC|mcrpc
146695|NCT02655822|Prostate Cancer|prostate cancer
146696|NCT02655796|Accidental Falls|accidental falls
146697|NCT02655796|Risk Assessment|risk assessment
146698|NCT02655796|Frail Elderly|frail elderly
146699|NCT02655783|induction of labor|induction of labor
146700|NCT02655744|Neurobehavioral Assessment|neurobehavioral assessment
146701|NCT02655744|Radiotherapy (RT)|radiotherapy (rt)
146702|NCT02655744|Chemotherapy|chemotherapy
146703|NCT02655744|Neurotoxicity|neurotoxicity
146704|NCT02655718|ACS|acs
146705|NCT02655718|Non obstructive coronary atherosclerosis|non obstructive coronary atherosclerosis
146706|NCT02655705|Cyclosporine|cyclosporine
146707|NCT02655705|Methotrexate|methotrexate
146708|NCT02655692|PTSD|ptsd
146709|NCT02655692|Ketamine|ketamine
146710|NCT02655692|Veteran|veteran
146711|NCT02655692|Military|military
146712|NCT02655692|Clinical Trial|clinical trial
146713|NCT02655679|eczema|eczema
146714|NCT02655640|illness perceptions|illness perceptions
146715|NCT02655627|Type 2 DM|type 2 dm
146716|NCT02655627|internet based exercise training|internet based exercise training
146717|NCT02655627|group exercise training|group exercise training
146718|NCT02655627|glycemic control|glycemic control
146719|NCT02655575|dizziness|dizziness
146720|NCT02655575|cognitive therapy|cognitive therapy
146721|NCT02655575|primary care|primary care
146722|NCT02655575|vestibular rehabilitation|vestibular rehabilitation
146723|NCT02655575|chronic|chronic
146724|NCT02655484|COPD|copd
146725|NCT02655484|noninvasive ventilation|noninvasive ventilation
146726|NCT02655484|exercise|exercise
146727|NCT02655484|CO2 rebreathing|co2 rebreathing
146728|NCT02655458|Multiple Myeloma|multiple myeloma
146729|NCT02655458|Induction Therapy|induction therapy
146730|NCT02655458|Autologous Stem Cell Transplant|autologous stem cell transplant
146731|NCT02655458|ASCT|asct
146732|NCT02655458|Auto-SCT|auto-sct
146733|NCT02655419|cIAIs in hospitalized adults|ciais in hospitalized adults
146734|NCT02655406|Foam sclerotherapy|foam sclerotherapy
146735|NCT02655406|Compression|compression
146736|NCT02655367|MRI|mri
146737|NCT02655367|oats|oats
146738|NCT02655367|porridge|porridge
146739|NCT02655367|satiety|satiety
146740|NCT02655367|GI hormones|gi hormones
146741|NCT02655367|processing|processing
146742|NCT02655341|Dehydration|dehydration
146743|NCT02655341|Primary PCI|primary pci
146744|NCT02655341|Acute Myocardial Infarction|acute myocardial infarction
146745|NCT02655341|Bioimpedance|bioimpedance
146746|NCT02655341|Renal Angiography|renal angiography
146747|NCT02655328|asthma|asthma
146748|NCT02655328|athlete|athlete
146749|NCT02655315|Parkinson|parkinson
146750|NCT02655315|Deferiprone|deferiprone
146751|NCT02655315|Chelation|chelation
146752|NCT02655302|Interleukin-17|interleukin-17
146753|NCT02655302|Interleukin-22|interleukin-22
146754|NCT02655302|Microbiota|microbiota
146755|NCT02655302|Exacerbations|exacerbations
146756|NCT02655302|Immunity|immunity
146757|NCT02655302|Mucosal|mucosal
146758|NCT02655276|microencapsulated glycine|microencapsulated glycine
146759|NCT02655276|attentional performance|attentional performance
146760|NCT02655276|motoric activity|motoric activity
146761|NCT02655276|hyperactivity|hyperactivity
146762|NCT02655198|refractory childhood epilepsy|refractory childhood epilepsy
146763|NCT02655198|Lennox Gastaut syndrome|lennox gastaut syndrome
146764|NCT02655198|fenfluramine|fenfluramine
146765|NCT02655198|anti-epileptic treatment|anti-epileptic treatment
146766|NCT02655185|Lipids|lipids
146767|NCT02655185|Atrial Fibrillation|atrial fibrillation
146768|NCT02655185|Heart Failure|heart failure
146769|NCT02655172|Schizophrenia, affordance,|schizophrenia, affordance,
146770|NCT02655172|perception-action binding,|perception-action binding,
146771|NCT02655172|stimulus-response-compatibility|stimulus-response-compatibility
146772|NCT02655159|Breast Cancer|breast cancer
146773|NCT02655159|Metastatic breast cancer|metastatic breast cancer
146774|NCT02655159|nab-paclitaxel|nab-paclitaxel
146775|NCT02655159|Abraxane|abraxane
146776|NCT02655159|Observational|observational
146777|NCT02655159|Retrospective|retrospective
146778|NCT02655159|AMBER|amber
146779|NCT02655146|Frozen embryo transfer,luteal support, GnRHa|frozen embryo transfer,luteal support, gnrha
146780|NCT02655120|Femoral head necrosis|femoral head necrosis
146781|NCT02655120|Autologous Bone Marrow|autologous bone marrow
146782|NCT02655120|BMP7|bmp7
146783|NCT02655107|blood gas monitoring|blood gas monitoring
146784|NCT02655107|non-invasive|non-invasive
146785|NCT02655107|hemoglobin|hemoglobin
146786|NCT02655094|minimal-invasive surgery, mitral valve|minimal-invasive surgery, mitral valve
146787|NCT02655081|Urinary diversion|urinary diversion
146788|NCT02655081|Bladder Neoplasm|bladder neoplasm
146789|NCT02655081|Nutritional Supplement|nutritional supplement
146790|NCT02655081|Cystectomy|cystectomy
146791|NCT02655068|Head and Neck Cancer|head and neck cancer
146792|NCT02655068|Definitive Therapy|definitive therapy
146793|NCT02655068|Positron Emission Tomography - Computed Tomography (PET/CT)|positron emission tomography - computed tomography (pet/ct)
146794|NCT02655068|Computed Tomography (CT)|computed tomography (ct)
146795|NCT02655055|apheresis|apheresis
146796|NCT02655055|citrate anticoagulation|citrate anticoagulation
146797|NCT02655055|blood donor|blood donor
146798|NCT02655055|bone|bone
146799|NCT02655016|Ovarian Cancer|ovarian cancer
146800|NCT02655016|PARP Inhibitor|parp inhibitor
146801|NCT02655016|HRD|hrd
146802|NCT02655016|HRD positive|hrd positive
146803|NCT02655016|PRIMA|prima
146804|NCT02655016|PRIMA Clinical Trial|prima clinical trial
146805|NCT02655016|PRIMA Study|prima study
146806|NCT02655003|behavioral symptoms|behavioral symptoms
146807|NCT02655003|psychological symptoms|psychological symptoms
146808|NCT02655003|dementia|dementia
146809|NCT02655003|neuropsychiatric symptoms|neuropsychiatric symptoms
146810|NCT02654990|multiple myeloma|multiple myeloma
146811|NCT02654990|relapsed or relapsed/refractory|relapsed or relapsed/refractory
146812|NCT02654990|LBH589|lbh589
146813|NCT02654990|panobinostat|panobinostat
146814|NCT02654990|bortezomib|bortezomib
146815|NCT02654990|dexamethasone|dexamethasone
146816|NCT02654951|Stroke|stroke
146817|NCT02654951|Rehabilitation Robotics|rehabilitation robotics
146818|NCT02654951|Bimanual|bimanual
146819|NCT02654951|Compensatory movements|compensatory movements
146820|NCT02654951|Hemiplegia|hemiplegia
146821|NCT02654951|Kinematics|kinematics
146822|NCT02654951|Reaching|reaching
146823|NCT02654951|Trunk|trunk
146824|NCT02654938|prostate cancer|prostate cancer
146825|NCT02654938|adenovirus|adenovirus
146826|NCT02654938|TLR5|tlr5
146827|NCT02654938|immunotherapy|immunotherapy
146828|NCT02654912|malaria|malaria
146829|NCT02654912|elimination|elimination
146830|NCT02654912|surveillance and response|surveillance and response
146831|NCT02654912|dihydroartemisinin+piperaquine|dihydroartemisinin+piperaquine
146832|NCT02654899|Healthy subjects|healthy subjects
146833|NCT02654899|Single Ascending Dose|single ascending dose
146834|NCT02654899|Hyperlipidemia|hyperlipidemia
146835|NCT02654899|Dyslipidemia|dyslipidemia
146836|NCT02654886|exercise|exercise
146837|NCT02654886|Pompe disease|pompe disease
146838|NCT02654886|Pompe|pompe
146839|NCT02654873|histopathology|histopathology
146840|NCT02654873|gallbladder|gallbladder
146841|NCT02654873|specimen|specimen
146842|NCT02654847|vasopressor|vasopressor
146843|NCT02654847|blood pressure|blood pressure
146844|NCT02654847|Cesarean section|cesarean section
146845|NCT02654847|spinal anesthesia|spinal anesthesia
146846|NCT02654821|Melanoma|melanoma
146847|NCT02654821|TCR|tcr
146848|NCT02654808|gynecology|gynecology
146849|NCT02654808|laparoscopy|laparoscopy
146850|NCT02654808|pneumoperitoneum|pneumoperitoneum
146851|NCT02654808|CO2 absorption|co2 absorption
146852|NCT02654756|Risk Assessment|risk assessment
146853|NCT02654704|Personalized Medicine|personalized medicine
146854|NCT02654704|Precision Medicine|precision medicine
146855|NCT02654691|Chemotherapy|chemotherapy
146856|NCT02654639|Metastatic Colorectal Cancer|metastatic colorectal cancer
146857|NCT02654639|Advanced Colorectal Cancer|advanced colorectal cancer
146858|NCT02654600|cardiac surgery|cardiac surgery
146859|NCT02654600|thoracopulmonary compliance|thoracopulmonary compliance
146860|NCT02654587|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
146861|NCT02654587|NSCLC|nsclc
146862|NCT02654587|Immunotherapy|immunotherapy
146863|NCT02654587|Cancer vaccine|cancer vaccine
146864|NCT02654587|Metastasis|metastasis
146865|NCT02654574|Alzheimer's disease or related disorders|alzheimer's disease or related disorders
146866|NCT02654574|Functional autonomy level|functional autonomy level
146867|NCT02654574|Lawton Instrumental Activities of Daily Living|lawton instrumental activities of daily living
146868|NCT02654574|The Functional autonomy level|the functional autonomy level
146869|NCT02654561|Severe sepsis|severe sepsis
146870|NCT02654561|Disseminated intravascular coagulation|disseminated intravascular coagulation
146871|NCT02654561|Unfractionated heparin|unfractionated heparin
146872|NCT02654535|Systematic review and meta-analysis|systematic review and meta-analysis
146873|NCT02654535|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
146874|NCT02654535|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
146875|NCT02654535|Clinical practice guidelines|clinical practice guidelines
146876|NCT02654535|Clinical trials|clinical trials
146877|NCT02654535|Tree Nuts|tree nuts
146878|NCT02654535|Peanuts|peanuts
146879|NCT02654535|Body weight|body weight
146880|NCT02654535|Prospective cohort studies|prospective cohort studies
146881|NCT02654496|Gut Microbiota|gut microbiota
146882|NCT02654496|Weight Regain|weight regain
146883|NCT02654496|Gastric Bypass|gastric bypass
146884|NCT02654457|Immunohistochemical|immunohistochemical
146885|NCT02654457|Ki-67|ki-67
146886|NCT02654457|Breast cancer|breast cancer
146887|NCT02654457|IHC|ihc
146888|NCT02654444|Immunohistochemical (IHC)|immunohistochemical (ihc)
146889|NCT02654444|Her2/Neu|her2/neu
146890|NCT02654444|Breast cancer|breast cancer
146891|NCT02654431|Immunohistochemical (IHC)|immunohistochemical (ihc)
146892|NCT02654431|ER/PR|er/pr
146893|NCT02654431|Breast cancer|breast cancer
146894|NCT02654418|colonic polyps ≥20 mm,|colonic polyps ≥20 mm,
146895|NCT02654418|adenomas|adenomas
146896|NCT02654418|polyps|polyps
146897|NCT02654405|HDAC inhibitors|hdac inhibitors
146898|NCT02654405|Inflammation|inflammation
146899|NCT02654392|Omega-3|omega-3
146900|NCT02654392|Omega-6|omega-6
146901|NCT02654392|Exercise Performance|exercise performance
146902|NCT02654366|Syringe exchange|syringe exchange
146903|NCT02654366|HIV risk reduction|hiv risk reduction
146904|NCT02654366|Drug-free community support|drug-free community support
146905|NCT02654353|Persistent atrial fibrillation, catheter ablation, outcome|persistent atrial fibrillation, catheter ablation, outcome
146906|NCT02654327|Extracorporeal|extracorporeal
146907|NCT02654327|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
146908|NCT02654327|Protective Lung Ventilation|protective lung ventilation
146909|NCT02654327|Ventilator Induced Lung Injury|ventilator induced lung injury
146910|NCT02654327|Carbon Dioxide Removal|carbon dioxide removal
146912|NCT02654327|Lung Injury|lung injury
146913|NCT02654314|prevention; delirium; in-patients; melatonin,|prevention; delirium; in-patients; melatonin,
146914|NCT02654301|Xylose|xylose
146915|NCT02654301|prediabetes|prediabetes
146916|NCT02654301|postprandial hyperglycemia|postprandial hyperglycemia
146917|NCT02654301|glucose|glucose
146918|NCT02654288|pancreatic cancer|pancreatic cancer
146919|NCT02654288|gemcitabine|gemcitabine
146920|NCT02654288|chemotherapy|chemotherapy
146921|NCT02654288|immunoglobulin G 4|immunoglobulin g 4
146922|NCT02654249|Hemorrhoids grade III and IV|hemorrhoids grade iii and iv
146923|NCT02654249|transanal hemorrhoidal dearterialization|transanal hemorrhoidal dearterialization
146924|NCT02654249|hemorroidectomy|hemorroidectomy
146925|NCT02654249|THD|thd
146926|NCT02654249|LigaSure|ligasure
146927|NCT02654223|Rhinitis / Rhinoconjunctivitis|rhinitis / rhinoconjunctivitis
146928|NCT02654223|Vaccine|vaccine
146929|NCT02654223|Immunotherapy|immunotherapy
146930|NCT02654223|Grass pollen|grass pollen
146931|NCT02654223|Allergy|allergy
146932|NCT02654210|birth cohort|birth cohort
146933|NCT02654210|infectious diseases|infectious diseases
146934|NCT02654210|microbiome|microbiome
146935|NCT02654210|immune system|immune system
146936|NCT02654210|immune response|immune response
146937|NCT02654184|Right lateral|right lateral
146938|NCT02654184|Induction|induction
146939|NCT02654184|Children|children
146940|NCT02654184|Anesthesia|anesthesia
146941|NCT02654171|RSV|rsv
146942|NCT02654171|AK0529|ak0529
146943|NCT02654158|acute upper respiratory infection|acute upper respiratory infection
146944|NCT02654145|mepolizumab|mepolizumab
146945|NCT02654145|Omalizumab|omalizumab
146946|NCT02654145|SGRQ|sgrq
146947|NCT02654145|severe eosinophilic asthma|severe eosinophilic asthma
146948|NCT02654145|ACQ|acq
146949|NCT02654145|exacerbations|exacerbations
146950|NCT02654106|multiple brain metastases|multiple brain metastases
146951|NCT02654106|large brain metastases|large brain metastases
146952|NCT02654106|meningeal metastases|meningeal metastases
146953|NCT02654106|fractionated stereotactic radiotherapy|fractionated stereotactic radiotherapy
146954|NCT02654106|temozolomide|temozolomide
146955|NCT02654054|Elagolix|elagolix
146956|NCT02654054|Elagolix Sodium|elagolix sodium
146957|NCT02654054|Heavy Uterine Bleeding|heavy uterine bleeding
146958|NCT02654054|Heavy Menstrual Bleeding|heavy menstrual bleeding
146959|NCT02654054|Leiomyomata|leiomyomata
146960|NCT02654054|Menorrhagia|menorrhagia
146961|NCT02654054|ABT-620|abt-620
146962|NCT02654054|Elagolix + E2/NETA|elagolix + e2/neta
146963|NCT02654054|Elagolix + Norethindrone Acetate|elagolix + norethindrone acetate
146964|NCT02654054|HMB|hmb
146965|NCT02654015|intracranial hemorrhage|intracranial hemorrhage
146966|NCT02654015|neurosurgery|neurosurgery
146967|NCT02653963|Steroid, Triamcinolone, Ahmed Glaucoma valve|steroid, triamcinolone, ahmed glaucoma valve
146968|NCT02653937|IBS|ibs
146969|NCT02653937|MUPS|mups
146970|NCT02653937|FSS|fss
146971|NCT02653937|shigyakusan|shigyakusan
146972|NCT02653937|Katsumi's points|katsumi's points
146973|NCT02653937|Nakatani's N line|nakatani's n line
146974|NCT02653924|Suture|suture
146975|NCT02653924|bacteria|bacteria
146976|NCT02653911|Acupuncture|acupuncture
146977|NCT02653898|Malaria|malaria
146978|NCT02653898|Antimalarials|antimalarials
146979|NCT02653898|Malaria Elimination|malaria elimination
146980|NCT02653898|Mass Drug Administration|mass drug administration
146981|NCT02653898|Malaria Prophylaxis|malaria prophylaxis
146982|NCT02653898|Mobile population|mobile population
146983|NCT02653898|Drug resistance|drug resistance
146984|NCT02653898|Focused screening and treatment|focused screening and treatment
146985|NCT02653898|Monthly Malaria Prophylaxis|monthly malaria prophylaxis
146986|NCT02653898|Mass screening and treatment|mass screening and treatment
146987|NCT02653898|Primaquine|primaquine
146988|NCT02653898|Malaria transmission|malaria transmission
146989|NCT02653898|Permethrin insecticide|permethrin insecticide
146990|NCT02653898|Thai-Cambodian border|thai-cambodian border
146991|NCT02653898|Cambodia|cambodia
146992|NCT02653898|AFRIMS|afrims
146993|NCT02653885|cardiac surgery|cardiac surgery
146994|NCT02653885|open heart surgery|open heart surgery
146995|NCT02653885|hemogram|hemogram
146996|NCT02653872|Non-randomized|non-randomized
146997|NCT02653872|Verapamil|verapamil
146998|NCT02653872|Itraconazole|itraconazole
146999|NCT02653872|Diltiazem|diltiazem
147000|NCT02653872|Safety|safety
147001|NCT02653872|Tolerability|tolerability
147002|NCT02653872|Pharmacokinetics|pharmacokinetics
147003|NCT02653859|CTC|ctc
147004|NCT02653859|PCR|pcr
147005|NCT02653833|Becker|becker
147006|NCT02653833|Muscular Dystrophy|muscular dystrophy
147007|NCT02653833|Skeletal Muscle|skeletal muscle
147008|NCT02653833|blood flow|blood flow
147009|NCT02653833|Ultrasound|ultrasound
147010|NCT02653807|manual therapy|manual therapy
147011|NCT02653807|osteopathy|osteopathy
147012|NCT02653807|mobilization with movement|mobilization with movement
147013|NCT02653807|ankle|ankle
147014|NCT02653807|stiffness|stiffness
147015|NCT02653794|Juvenile Subjects'characteristics|juvenile subjects'characteristics
147016|NCT02653768|Osteoarthritis, Knee|osteoarthritis, knee
147017|NCT02653768|Exercise|exercise
147018|NCT02653755|Breast Cancer Radiation|breast cancer radiation
147019|NCT02653755|Radiotherapy for Favorable-Risk Breast cancer|radiotherapy for favorable-risk breast cancer
147020|NCT02653755|Radiotherapy Omission|radiotherapy omission
147021|NCT02653729|cognitive behaviour therapy|cognitive behaviour therapy
147022|NCT02653729|first episode|first episode
147023|NCT02653716|New Orleans Intervention Model|new orleans intervention model
147024|NCT02653716|Case Management|case management
147025|NCT02653716|Maltreatment|maltreatment
147026|NCT02653716|Child|child
147027|NCT02653664|Chronic Pain|chronic pain
147028|NCT02653664|Sleep|sleep
147029|NCT02653651|Ketamine|ketamine
147030|NCT02653651|Lidocaine|lidocaine
147031|NCT02653651|Nephrectomy|nephrectomy
147032|NCT02653651|Chronic pain|chronic pain
147033|NCT02653638|Cerebral Vasodilator Function|cerebral vasodilator function
147034|NCT02653638|White Matter Hyperintensity Volume|white matter hyperintensity volume
147035|NCT02653638|Default Mode Network Connectivity|default mode network connectivity
147036|NCT02653638|Cognitive Function|cognitive function
147037|NCT02653638|Cardiorespiratory Fitness|cardiorespiratory fitness
147038|NCT02653638|Aging|aging
147039|NCT02653625|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
147040|NCT02653612|surgery|surgery
147041|NCT02653612|folate receptor|folate receptor
147042|NCT02653586|resilience|resilience
147043|NCT02653586|prevention program|prevention program
147044|NCT02653586|body image|body image
147045|NCT02653586|self esteem|self esteem
147046|NCT02653573|young adult|young adult
147047|NCT02653560|Potassium|potassium
147048|NCT02653560|Magnesium|magnesium
147049|NCT02653560|Citrate|citrate
147050|NCT02653560|DASH|dash
147051|NCT02653547|tinnitus|tinnitus
147052|NCT02653547|transcranial random noise stimulation|transcranial random noise stimulation
147053|NCT02653547|rTMS|rtms
147054|NCT02653547|multisite stimulation|multisite stimulation
147055|NCT02653547|non-invasive brain stimulation|non-invasive brain stimulation
147056|NCT02653534|Kangaroo Mother Care in community|kangaroo mother care in community
147057|NCT02653534|mortality|mortality
147058|NCT02653521|Esophageal Cancer|esophageal cancer
147059|NCT02653521|Adaptive Radiation Therapy|adaptive radiation therapy
147060|NCT02653508|BMI: Body Mass Index|bmi: body mass index
147061|NCT02653508|obesity|obesity
147062|NCT02653508|adolescents|adolescents
147063|NCT02653508|overweight|overweight
147064|NCT02653508|CI:confidence interval|ci:confidence interval
147065|NCT02653508|CDC: Center Disease Control|cdc: center disease control
147066|NCT02653482|heart failure|heart failure
147067|NCT02653482|dapagliflozin|dapagliflozin
147068|NCT02653482|SGLT-2 inhibitors|sglt-2 inhibitors
147069|NCT02653456|excimer laser|excimer laser
147070|NCT02653456|percutaneous catheter|percutaneous catheter
147071|NCT02653456|photoablation|photoablation
147072|NCT02653456|chronic total occlusion|chronic total occlusion
147073|NCT02653456|symptomatic infrainguinal lower extremity vascular disease|symptomatic infrainguinal lower extremity vascular disease
147074|NCT02653443|INTERCEPT|intercept
147075|NCT02653443|Platelet|platelet
147076|NCT02653443|Pathogen Inactivation|pathogen inactivation
147077|NCT02653443|Platelets Components Stored|platelets components stored
147078|NCT02653443|Therapeutic Efficacy|therapeutic efficacy
147079|NCT02653430|obesity|obesity
147080|NCT02653430|BMI|bmi
147081|NCT02653430|efficacy|efficacy
147082|NCT02653430|bariatric surgery|bariatric surgery
147083|NCT02653430|gut flora|gut flora
147084|NCT02653430|fMRI|fmri
147085|NCT02653391|Fuchs' Corneal Endothelial Dystrophy|fuchs' corneal endothelial dystrophy
147086|NCT02653391|FCED|fced
147087|NCT02653391|Ocuvia™|ocuvia™
147088|NCT02653391|MTP-131|mtp-131
147089|NCT02653352|randomized controlled trials|randomized controlled trials
147090|NCT02653352|soft drinks|soft drinks
147091|NCT02653352|hypercholesterolemia|hypercholesterolemia
147092|NCT02653352|serum cholesterol|serum cholesterol
147093|NCT02653352|blood glucose|blood glucose
147094|NCT02653352|overweight|overweight
147095|NCT02653352|carbonated beverages|carbonated beverages
147096|NCT02653339|traditional Chinese medicine|traditional chinese medicine
147097|NCT02653339|Loratadine|loratadine
147098|NCT02653339|questionnaire survey|questionnaire survey
147099|NCT02653326|Tertiary Prevention|tertiary prevention
147100|NCT02653326|Telerehabilitation|telerehabilitation
147101|NCT02653287|Fatigue, Physical Activity, Lupus|fatigue, physical activity, lupus
147102|NCT02653274|MRI|mri
147103|NCT02653274|blood glucose|blood glucose
147104|NCT02653274|satiety|satiety
147105|NCT02653274|breakfast|breakfast
147106|NCT02653274|porridge|porridge
147107|NCT02653274|grains|grains
147108|NCT02653261|tranexamic acid|tranexamic acid
147109|NCT02653261|Transurethral Resection of the Prostate (TURP)|transurethral resection of the prostate (turp)
147110|NCT02653261|Transurethral Resection of a Bladder Tumor (TURBT)|transurethral resection of a bladder tumor (turbt)
147111|NCT02653261|Hemorrhage|hemorrhage
147112|NCT02653261|Blood Transfusion|blood transfusion
147113|NCT02653222|Ethanol Sympathicolysis|ethanol sympathicolysis
147114|NCT02653222|Computer Tomography guidance|computer tomography guidance
147115|NCT02653222|Denervation|denervation
147116|NCT02653222|Kidney Transplantation|kidney transplantation
147117|NCT02653222|Dialysis|dialysis
147118|NCT02653209|Type 2 diabetes|type 2 diabetes
147119|NCT02653209|Stratification|stratification
147120|NCT02653209|Biomarkers|biomarkers
147121|NCT02653209|Pharmacogenetics|pharmacogenetics
147122|NCT02653209|SGLT2 inhibitors|sglt2 inhibitors
147123|NCT02653209|Thiazolidinediones|thiazolidinediones
147124|NCT02653209|DPP4 inhibitors|dpp4 inhibitors
147125|NCT02653170|acute stroke|acute stroke
147126|NCT02653170|care transitions|care transitions
147127|NCT02653170|patient engagement|patient engagement
147128|NCT02653170|patient education|patient education
147129|NCT02653170|caregivers|caregivers
147130|NCT02653170|social workers|social workers
147131|NCT02653157|multidrug resistance|multidrug resistance
147132|NCT02653157|burns|burns
147133|NCT02653157|infections, gram-negative bacilli|infections, gram-negative bacilli
147134|NCT02653157|ventilator-associated pneumonia|ventilator-associated pneumonia
147135|NCT02653157|ventilator-associated tracheobronchitis|ventilator-associated tracheobronchitis
147136|NCT02653157|gram-negative bacilli colonization|gram-negative bacilli colonization
147137|NCT02653144|post operative pain, Dexmedetomidine, Regional anesthesia|post operative pain, dexmedetomidine, regional anesthesia
147138|NCT02653131|Short bowel syndrome|short bowel syndrome
147139|NCT02653105|High risk of cancer, BRCA1 or 2 mutation, Olfactomedine 4|high risk of cancer, brca1 or 2 mutation, olfactomedine 4
147140|NCT02653066|recruitment|recruitment
147141|NCT02653040|Lighting|lighting
147142|NCT02653040|Inpatients|inpatients
147143|NCT02653040|Recovery|recovery
147144|NCT02653040|Sleep|sleep
147145|NCT02653027|Genetics|genetics
147146|NCT02652988|tDCS|tdcs
147147|NCT02652988|chronic pain|chronic pain
147148|NCT02652988|fibromyalgia|fibromyalgia
147149|NCT02652923|ultrasound contrast agent|ultrasound contrast agent
147150|NCT02652923|lymphosonography|lymphosonography
147151|NCT02652923|breast cancer|breast cancer
147152|NCT02652897|bleeding|bleeding
147153|NCT02652897|clotting tests|clotting tests
147154|NCT02652897|neurosurgery|neurosurgery
147155|NCT02652897|clotting time|clotting time
147156|NCT02652897|maximum clot firmness|maximum clot firmness
147157|NCT02652897|kinetics|kinetics
147158|NCT02652897|lysis|lysis
147159|NCT02652897|primary hemostasis|primary hemostasis
147160|NCT02652897|platelet dysfunction|platelet dysfunction
147161|NCT02652897|coagulation|coagulation
147162|NCT02652884|transient hypoparathyroidism|transient hypoparathyroidism
147163|NCT02652884|steroids|steroids
147164|NCT02652884|total thyroidectomy|total thyroidectomy
147165|NCT02652871|Leukemia|leukemia
147166|NCT02652871|Acute Myeloid Leukemia|acute myeloid leukemia
147167|NCT02652871|AML|aml
147168|NCT02652871|Relapsed or Refractory|relapsed or refractory
147169|NCT02652871|Acute myelogenous leukemia|acute myelogenous leukemia
147170|NCT02652871|LY2510924|ly2510924
147171|NCT02652871|Idarubicin|idarubicin
147172|NCT02652871|Idamycin|idamycin
147173|NCT02652871|Cytarabine|cytarabine
147174|NCT02652871|Ara-C|ara-c
147175|NCT02652871|Cytosar|cytosar
147176|NCT02652871|DepoCyt|depocyt
147177|NCT02652871|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
147178|NCT02652819|Chronic Kidney Disease|chronic kidney disease
147179|NCT02652806|Chronic Kidney Disease|chronic kidney disease
147180|NCT02652780|Leber Hereditary Optic Neuropathy|leber hereditary optic neuropathy
147181|NCT02652780|Leber Hereditary Optic Atrophy|leber hereditary optic atrophy
147182|NCT02652780|Heredity Optic Atrophy|heredity optic atrophy
147183|NCT02652780|Eye Diseases|eye diseases
147678|NCT02649764|DepoCyt|depocyt
147184|NCT02652780|Hereditary Eye Diseases|hereditary eye diseases
147185|NCT02652780|Inborn Genetic Disease|inborn genetic disease
147186|NCT02652780|Genetic Therapy|genetic therapy
147187|NCT02652780|Intravitreal Injections|intravitreal injections
147188|NCT02652780|Mitochondrial Disease|mitochondrial disease
147189|NCT02652780|AAV2 Vectors|aav2 vectors
147190|NCT02652780|Nervous System Diseases|nervous system diseases
147191|NCT02652780|Neurodegenerative Disease|neurodegenerative disease
147192|NCT02652780|Heredodegenerative Disorders of the Nervous System|heredodegenerative disorders of the nervous system
147193|NCT02652767|Leber Hereditary Optic Neuropathy|leber hereditary optic neuropathy
147194|NCT02652767|Leber Hereditary Optic Atrophy|leber hereditary optic atrophy
147195|NCT02652767|Heredity Optic Atrophy|heredity optic atrophy
147196|NCT02652767|Eye Diseases|eye diseases
147197|NCT02652767|Hereditary Eye Diseases|hereditary eye diseases
147198|NCT02652767|Inborn Genetic Disease|inborn genetic disease
147199|NCT02652767|Genetic Therapy|genetic therapy
147200|NCT02652767|Intravitreal Injections|intravitreal injections
147201|NCT02652767|Mitochondrial Disease|mitochondrial disease
147202|NCT02652767|AAV2 Vectors|aav2 vectors
147203|NCT02652767|Nervous System Diseases|nervous system diseases
147204|NCT02652767|Neurodegenerative Disease|neurodegenerative disease
147205|NCT02652767|Heredodegenerative Disorders of the Nervous System|heredodegenerative disorders of the nervous system
147206|NCT02652754|Granexin|granexin
147207|NCT02652754|diabetic foot ulcers|diabetic foot ulcers
147208|NCT02652754|pharmacokinetic study|pharmacokinetic study
147209|NCT02652754|FirstString Research|firststring research
147210|NCT02652702|circular stapler-assisted colostomy|circular stapler-assisted colostomy
147211|NCT02652689|pulmonary embolism|pulmonary embolism
147212|NCT02652689|pulmonary disease|pulmonary disease
147213|NCT02652689|Lung Doppler signals|lung doppler signals
147214|NCT02652676|Infant Cardiac Transplantation|infant cardiac transplantation
147215|NCT02652676|End-stage Idiopathic Dilated Cardiomyopathy|end-stage idiopathic dilated cardiomyopathy
147216|NCT02652676|Mechanical Circulatory Device|mechanical circulatory device
147217|NCT02652676|End Stage Dilated Left Ventriculopathy|end stage dilated left ventriculopathy
147218|NCT02652676|Acute-on-Chronic Left Ventricular Failure|acute-on-chronic left ventricular failure
147219|NCT02652663|colorectal cancer|colorectal cancer
147220|NCT02652663|liver|liver
147221|NCT02652663|MRI|mri
147222|NCT02652663|contrast|contrast
147223|NCT02652663|gadoxetic acid|gadoxetic acid
147224|NCT02652650|Healthy|healthy
147225|NCT02652650|JNJ-63623872|jnj-63623872
147226|NCT02652650|Ethinylestradiol|ethinylestradiol
147227|NCT02652650|Norethindrone|norethindrone
147228|NCT02652611|Screw Removal vs. Non-screw removal|screw removal vs. non-screw removal
147229|NCT02652611|Complications|complications
147230|NCT02652611|SI Screw Stabilization|si screw stabilization
147231|NCT02652585|Alcoholism|alcoholism
147232|NCT02652585|alcohol self-administration|alcohol self-administration
147233|NCT02652572|Granexin|granexin
147234|NCT02652572|venous leg ulcer|venous leg ulcer
147235|NCT02652572|pharmacokinetic study|pharmacokinetic study
147236|NCT02652572|FirstString Research|firststring research
147237|NCT02652559|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
147238|NCT02652559|Non-invasive ventilation|non-invasive ventilation
147239|NCT02652559|Home initiation|home initiation
147240|NCT02652546|HIV/AIDS|hiv/aids
147241|NCT02652546|Immune Activation|immune activation
147242|NCT02652546|Anti-Inflammatory|anti-inflammatory
147243|NCT02652546|TNF|tnf
147244|NCT02652546|Phosphodieterase Inhibitor|phosphodieterase inhibitor
147245|NCT02652520|Kidney transplantation|kidney transplantation
147246|NCT02652520|Organ preservation|organ preservation
147247|NCT02652507|Sedation|sedation
147248|NCT02652507|MRI|mri
147249|NCT02652507|Dexmedetomidine|dexmedetomidine
147250|NCT02652507|Ketamine|ketamine
147251|NCT02652507|General anesthesia|general anesthesia
147252|NCT02652507|MRI of Brain|mri of brain
147253|NCT02652507|MRI of Brain/Spine|mri of brain/spine
147254|NCT02652494|Psoriasis|psoriasis
147255|NCT02652494|Observational|observational
147256|NCT02652494|Apremilast|apremilast
147257|NCT02652494|APRIL|april
147258|NCT02652494|Non-Interventional|non-interventional
147259|NCT02652494|The Netherlands|the netherlands
147260|NCT02652455|cutaneous|cutaneous
147261|NCT02652455|unresectable|unresectable
147262|NCT02652455|mucosal metastatic stage III/IV melanoma|mucosal metastatic stage iii/iv melanoma
147263|NCT02652442|dizziness|dizziness
147264|NCT02652442|postural balance|postural balance
147265|NCT02652442|rehabilitation|rehabilitation
147266|NCT02652429|PAH|pah
147267|NCT02652429|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
147268|NCT02652429|Inhaled Nitric Oxide|inhaled nitric oxide
147269|NCT02652429|iNO|ino
147270|NCT02652403|Denture, Complete|denture, complete
147271|NCT02652403|Mouth, Edentulous|mouth, edentulous
147272|NCT02652351|Stem cell|stem cell
147273|NCT02652351|Human Umbilical Cord Mesenchymal Stem Cell|human umbilical cord mesenchymal stem cell
147274|NCT02652351|Mesenchymal Stem Cell|mesenchymal stem cell
147275|NCT02652351|Hepatic Cirrhosis|hepatic cirrhosis
147276|NCT02652338|heart rhythm disturbances and symptoms|heart rhythm disturbances and symptoms
147277|NCT02652338|dietary supplement|dietary supplement
147278|NCT02652312|Dexmedetomidine|dexmedetomidine
147279|NCT02652312|Desflurane|desflurane
147280|NCT02652312|Bispectral Index BIS|bispectral index bis
147281|NCT02652299|Fibrocytes|fibrocytes
147282|NCT02652299|Synovial biopsy|synovial biopsy
147283|NCT02652286|VATS|vats
147284|NCT02652286|Energy sealing|energy sealing
147285|NCT02652247|trauma|trauma
147286|NCT02652247|ventilator|ventilator
147287|NCT02652247|surgical ICU|surgical icu
147288|NCT02652208|decision making|decision making
147289|NCT02652208|decision aids|decision aids
147290|NCT02652208|shared decision making|shared decision making
147291|NCT02652208|stable angina|stable angina
147292|NCT02652208|cardiology|cardiology
147293|NCT02652195|Neural correlates|neural correlates
147294|NCT02652195|oxytocin administration|oxytocin administration
147295|NCT02652156|transversus abdominis plane|transversus abdominis plane
147296|NCT02652156|postoperative|postoperative
147297|NCT02652156|pain|pain
147298|NCT02652143|in vivo culture|in vivo culture
147299|NCT02652130|GVHD, Graft versus Host Disease|gvhd, graft versus host disease
147300|NCT02652104|Advanced|advanced
147301|NCT02652104|Deep brain stimulation|deep brain stimulation
147302|NCT02652091|Adherence|adherence
147303|NCT02652091|Persistence|persistence
147304|NCT02652091|Patient satisfaction|patient satisfaction
147305|NCT02652065|Psoriasis|psoriasis
147306|NCT02652065|Microcirculation|microcirculation
147307|NCT02652065|TRPV1|trpv1
147308|NCT02652026|dental root planing and scaling|dental root planing and scaling
147309|NCT02652026|periodontal disease|periodontal disease
147310|NCT02652026|type 2 diabetes mellitus|type 2 diabetes mellitus
147311|NCT02652026|glycosylated hemoglobin A|glycosylated hemoglobin a
147312|NCT02651974|neoplasm|neoplasm
147313|NCT02651974|colorectal|colorectal
147314|NCT02651974|cancer|cancer
147315|NCT02651974|uninsured|uninsured
147317|NCT02651974|fecal immunochemical test|fecal immunochemical test
147318|NCT02651961|Total hip prosthesis|total hip prosthesis
147319|NCT02651961|Total knee prosthesis|total knee prosthesis
147320|NCT02651961|Chronic infection|chronic infection
147321|NCT02651961|One stage exchange|one stage exchange
147322|NCT02651961|Two stage exchange|two stage exchange
147323|NCT02651961|Cost-effectiveness|cost-effectiveness
147324|NCT02651935|Respiration, Artificial|respiration, artificial
147325|NCT02651935|weaning|weaning
147326|NCT02651935|critical care|critical care
147327|NCT02651922|Nervous restlessness|nervous restlessness
147328|NCT02651922|Pascoflair|pascoflair
147329|NCT02651922|Passiflora incarnata|passiflora incarnata
147330|NCT02651922|Benzodiazepine|benzodiazepine
147331|NCT02651883|Cervical cancer screening|cervical cancer screening
147332|NCT02651883|HPV testing|hpv testing
147333|NCT02651883|Self-collection|self-collection
147334|NCT02651870|Hypertension|hypertension
147335|NCT02651844|Progesterone receptor isoforms|progesterone receptor isoforms
147336|NCT02651844|Antiprogestins|antiprogestins
147337|NCT02651844|Mifepristone|mifepristone
147338|NCT02651844|Neoadjuvant|neoadjuvant
147339|NCT02651844|Breast cancer|breast cancer
147340|NCT02651831|ICMs|icms
147341|NCT02651831|Immune checkpoint modulators|immune checkpoint modulators
147342|NCT02651818|Goiter|goiter
147343|NCT02651818|Thyroid disease|thyroid disease
147344|NCT02651818|Struma|struma
147345|NCT02651805|Palliative Care|palliative care
147346|NCT02651805|Respiratory Secretion|respiratory secretion
147347|NCT02651792|ketamine|ketamine
147348|NCT02651792|propofol|propofol
147349|NCT02651792|pethidine|pethidine
147350|NCT02651792|ERCP|ercp
147351|NCT02651792|endoscopist|endoscopist
147352|NCT02651740|Rifaximin|rifaximin
147353|NCT02651740|Fecal microbiota transplantation|fecal microbiota transplantation
147354|NCT02651740|Gut microbiota|gut microbiota
147355|NCT02651610|PPHM 1401|pphm 1401
147356|NCT02651610|bavituximab|bavituximab
147357|NCT02651610|Peregrine|peregrine
147358|NCT02651610|Breast Cancer|breast cancer
147359|NCT02651610|HER-2 Negative|her-2 negative
147360|NCT02651610|HER2 Negative|her2 negative
147361|NCT02651597|Oatmeal|oatmeal
147362|NCT02651597|Beta glucan|beta glucan
147363|NCT02651597|Postprandial Glycemic Response|postprandial glycemic response
147364|NCT02651597|Blood Glucose|blood glucose
147365|NCT02651571|Knee|knee
147366|NCT02651571|Replacement|replacement
147367|NCT02651571|Prosthesis|prosthesis
147368|NCT02651571|Mobile-bearing|mobile-bearing
147369|NCT02651532|Confocal Laser Endomicroscopy|confocal laser endomicroscopy
147370|NCT02651532|inflammation|inflammation
147371|NCT02651532|Irritable Bowel Syndrome|irritable bowel syndrome
147372|NCT02651519|bispectral index|bispectral index
147373|NCT02651519|regional cerebral oxygen saturation|regional cerebral oxygen saturation
147374|NCT02651519|Stellate-ganglion block|stellate-ganglion block
147375|NCT02651506|Lung cancer biopsy|lung cancer biopsy
147376|NCT02651506|Electromagnetic Navigation Bronchoscopy|electromagnetic navigation bronchoscopy
147377|NCT02651506|Transthoracic Needle Biopsy|transthoracic needle biopsy
147378|NCT02651480|Diet, Vegetarian|diet, vegetarian
147379|NCT02651480|Diet, Fat-Restricted|diet, fat-restricted
147380|NCT02651480|Quality of Life|quality of life
147381|NCT02651480|Glycemic Index|glycemic index
147382|NCT02651454|metabolic syndrome|metabolic syndrome
147383|NCT02651454|Daesiho-tang|daesiho-tang
147384|NCT02651454|Taeeumjowi-tang|taeeumjowi-tang
147385|NCT02651454|Korean medicine|korean medicine
147386|NCT02651441|D-CIK|d-cik
147387|NCT02651441|lung cancer|lung cancer
147388|NCT02651428|Kidney Failure, Chronic|kidney failure, chronic
147389|NCT02651428|Catheter-Related Infections|catheter-related infections
147390|NCT02651428|Central Venous Catheter|central venous catheter
147391|NCT02651415|Metastatic colorectal cancer|metastatic colorectal cancer
147392|NCT02651415|Metastatic colorectal carcinoma|metastatic colorectal carcinoma
147393|NCT02651415|mCRC|mcrc
147394|NCT02651415|Regorafenib|regorafenib
147395|NCT02651415|Stivarga|stivarga
147396|NCT02651415|Perindopril|perindopril
147397|NCT02651415|Perindopril erbumine|perindopril erbumine
147398|NCT02651415|Coversyl|coversyl
147399|NCT02651402|Anxiety Disorders|anxiety disorders
147400|NCT02651402|Internalizing|internalizing
147401|NCT02651402|Anxiety|anxiety
147402|NCT02651389|Digital Orthoptic Platform|digital orthoptic platform
147403|NCT02651389|Vision test|vision test
147404|NCT02651376|Immunodeficiency|immunodeficiency
147405|NCT02651376|Allogenic Mononuclear Cell Transplantation|allogenic mononuclear cell transplantation
147406|NCT02651350|Drug-induced Liver Injury|drug-induced liver injury
147407|NCT02651350|Recurrence|recurrence
147408|NCT02651350|Methylprednisolone|methylprednisolone
147409|NCT02651285|G-CSF|g-csf
147410|NCT02651285|BLASTOCYST|blastocyst
147411|NCT02651285|IVF|ivf
147412|NCT02651272|Pulmonary Hypertension|pulmonary hypertension
147413|NCT02651272|Sickle Cell Disease|sickle cell disease
147414|NCT02651272|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
147415|NCT02651272|Macitentan|macitentan
147416|NCT02651194|Treatment-naïve|treatment-naïve
147417|NCT02651194|HCV Gentoype 2|hcv gentoype 2
147418|NCT02651194|Non-cirrhotic|non-cirrhotic
147419|NCT02651194|Chronic Hepatitis C|chronic hepatitis c
147420|NCT02651194|HCV Gentoype 5|hcv gentoype 5
147421|NCT02651194|HCV Gentoype 4|hcv gentoype 4
147422|NCT02651194|HCV Gentoype 6|hcv gentoype 6
147423|NCT02651194|HCV Gentoype 1|hcv gentoype 1
147424|NCT02651194|Compensated cirrhotic|compensated cirrhotic
147425|NCT02651194|Treatment-experienced|treatment-experienced
147426|NCT02651194|HCV Gentoype 3|hcv gentoype 3
147427|NCT02651168|Diabetic Macular Edema|diabetic macular edema
147428|NCT02651168|Ocular Cytokines|ocular cytokines
147429|NCT02651168|aflibercept|aflibercept
147430|NCT02651168|ranibizumab|ranibizumab
147431|NCT02651155|Drug therapy|drug therapy
147432|NCT02651129|noise|noise
147433|NCT02651129|obstetric|obstetric
147434|NCT02651129|operating rooms|operating rooms
147435|NCT02651116|cough, acute cough, pediatric, Dextromethorphan Hydrobromide, antitussive, ambulatory cough recording device|cough, acute cough, pediatric, dextromethorphan hydrobromide, antitussive, ambulatory cough recording device
147436|NCT02651090|contraindication for CECT|contraindication for cect
147437|NCT02651090|contraindication for CEMRI|contraindication for cemri
147438|NCT02651090|liver pathology|liver pathology
147439|NCT02651090|renal failure|renal failure
147440|NCT02651090|contrast enhanced ultrasound|contrast enhanced ultrasound
147441|NCT02651090|sonazoid|sonazoid
147442|NCT02651077|Endometriosis, chemical contaminants, BFRs|endometriosis, chemical contaminants, bfrs
147443|NCT02651064|Supplemental Nutrition Assistance Program (SNAP)|supplemental nutrition assistance program (snap)
147444|NCT02651064|fruits and vegetables|fruits and vegetables
147445|NCT02651064|price incentive|price incentive
147446|NCT02651051|Postprandial glycemia|postprandial glycemia
147447|NCT02651051|Metabolic health measures|metabolic health measures
147448|NCT02651012|acne|acne
147449|NCT02651012|acne vulgaris|acne vulgaris
147450|NCT02651012|papule|papule
147451|NCT02651012|pustule|pustule
147452|NCT02651012|adolescent acne|adolescent acne
147453|NCT02650973|Bioequivalence|bioequivalence
147454|NCT02650947|Sucralose|sucralose
147455|NCT02650947|Insulin Secretion|insulin secretion
147456|NCT02650947|Insulin Sensitivity|insulin sensitivity
147457|NCT02650947|Incretin|incretin
147458|NCT02650947|Gut Microbiota|gut microbiota
147459|NCT02650947|Food and Eating Behaviour|food and eating behaviour
147460|NCT02650947|Healthy Volunteers|healthy volunteers
147461|NCT02650934|STEMI, Heart Failure, Inflammation, Haptoglobin Polymorphisms, Adverse Remodeling, Genetics, GWAS, MRI|stemi, heart failure, inflammation, haptoglobin polymorphisms, adverse remodeling, genetics, gwas, mri
147462|NCT02650908|Lesion|lesion
147463|NCT02650908|Meniscus|meniscus
147464|NCT02650908|Avivement|avivement
147465|NCT02650908|Suturing area|suturing area
147466|NCT02650882|Respiratory muscles|respiratory muscles
147467|NCT02650882|athletic performance|athletic performance
147468|NCT02650882|handball|handball
147469|NCT02650869|Necrotizing Enterocolitis|necrotizing enterocolitis
147470|NCT02650869|probiotics|probiotics
147471|NCT02650869|very low birth weight|very low birth weight
147472|NCT02650856|Blood loss|blood loss
147473|NCT02650856|Tranexamic acid|tranexamic acid
147474|NCT02650856|Platelet rich plasma|platelet rich plasma
147475|NCT02650856|Total knee arthroplasty|total knee arthroplasty
147476|NCT02650843|Parkinsonism|parkinsonism
147477|NCT02650843|DAT Dopamine transporter|dat dopamine transporter
147478|NCT02650843|SPECT|spect
147479|NCT02650830|type 2 diabetes|type 2 diabetes
147480|NCT02650830|prediabetes|prediabetes
147481|NCT02650830|bile acids profile|bile acids profile
147482|NCT02650830|GLP-1|glp-1
147483|NCT02650830|FGF-19|fgf-19
147484|NCT02650804|Cancer|cancer
147485|NCT02650804|Advanced Pancreatic Cancer|advanced pancreatic cancer
147486|NCT02650778|Breast Cancer|breast cancer
147487|NCT02650778|Automated whole breast ultrasound|automated whole breast ultrasound
147488|NCT02650778|BI-RADS category 3 lesions|bi-rads category 3 lesions
147489|NCT02650765|Brain injury|brain injury
147490|NCT02650765|Head injury|head injury
147491|NCT02650765|Computed tomography|computed tomography
147492|NCT02650765|Emergency department|emergency department
147493|NCT02650752|Lapatinib|lapatinib
147494|NCT02650752|Capecitabine|capecitabine
147495|NCT02650752|HER2|her2
147496|NCT02650752|15-278|15-278
147497|NCT02650687|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
147498|NCT02650687|Elderly, geriatric|elderly, geriatric
147499|NCT02650687|Anesthesia|anesthesia
147500|NCT02650687|Anesthetic depth|anesthetic depth
147501|NCT02650687|Bispectral index monitor|bispectral index monitor
147502|NCT02650687|Function|function
147503|NCT02650687|Recovery after surgery|recovery after surgery
147504|NCT02650687|Surgery|surgery
147505|NCT02650674|glycemic & insulin response|glycemic & insulin response
147506|NCT02650674|SDS|sds
147507|NCT02650674|cereal product|cereal product
147508|NCT02650674|Nutrition|nutrition
147509|NCT02650674|Carbohydrate|carbohydrate
147510|NCT02650674|Absorption|absorption
147511|NCT02650674|Intestine|intestine
147512|NCT02650661|Cancer survivors|cancer survivors
147513|NCT02650648|Humanized Anti-GD2 Antibody Hu3F8|humanized anti-gd2 antibody hu3f8
147514|NCT02650648|Allogeneic Natural Killer Cells|allogeneic natural killer cells
147515|NCT02650648|rIL-2|ril-2
147516|NCT02650648|15-272|15-272
147517|NCT02650622|Metabolism|metabolism
147518|NCT02650622|Genetics|genetics
147519|NCT02650622|Metabolomics|metabolomics
147520|NCT02650622|Genomics|genomics
147521|NCT02650609|chronic subdural hematomas|chronic subdural hematomas
147522|NCT02650609|surgical treatment|surgical treatment
147523|NCT02650609|corticosteroids|corticosteroids
147524|NCT02650570|Cancer|cancer
147525|NCT02650570|Cachexia|cachexia
147526|NCT02650557|coronary slow flow|coronary slow flow
147527|NCT02650557|P-wave dispersion|p-wave dispersion
147528|NCT02650544|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
147529|NCT02650544|Depression|depression
147530|NCT02650544|mirtazapine|mirtazapine
147657|NCT02649790|MM|mm
147531|NCT02650544|patients health questionnaire (PHQ-9)|patients health questionnaire (phq-9)
147532|NCT02650531|Follow up studies|follow up studies
147533|NCT02650531|Risk factors|risk factors
147534|NCT02650518|Catheter-Associated Urinary Tract Infections|catheter-associated urinary tract infections
147535|NCT02650518|Antimicrobial Stewardship|antimicrobial stewardship
147536|NCT02650518|Short-Course Antimicrobials|short-course antimicrobials
147537|NCT02650492|Hyperthermia, Induced|hyperthermia, induced
147538|NCT02650492|Laser Coagulation|laser coagulation
147539|NCT02650492|Laser Therapy|laser therapy
147540|NCT02650453|Stent|stent
147541|NCT02650453|Angioplasty|angioplasty
147542|NCT02650453|Endophlebectomy|endophlebectomy
147543|NCT02650440|robotics|robotics
147544|NCT02650440|locomotion|locomotion
147545|NCT02650440|gait|gait
147546|NCT02650440|walking|walking
147547|NCT02650440|rehabilitation|rehabilitation
147548|NCT02650414|Biological: CART 22|biological: cart 22
147549|NCT02650401|TRK|trk
147550|NCT02650401|Tyrosine kinase|tyrosine kinase
147551|NCT02650401|NTRK|ntrk
147552|NCT02650401|NTRK1|ntrk1
147553|NCT02650401|NTRK2|ntrk2
147554|NCT02650401|NTRK3|ntrk3
147555|NCT02650401|ROS1|ros1
147556|NCT02650401|ALK|alk
147557|NCT02650401|Pediatric|pediatric
147558|NCT02650401|Relapsed|relapsed
147559|NCT02650401|Refractory|refractory
147560|NCT02650401|Solid Tumor|solid tumor
147561|NCT02650401|Metastatic Cancer|metastatic cancer
147562|NCT02650401|Gene rearrangement|gene rearrangement
147563|NCT02650401|Neuroblastoma|neuroblastoma
147564|NCT02650401|Infantile fibrosarcoma|infantile fibrosarcoma
147565|NCT02650401|Secretory breast cancer|secretory breast cancer
147566|NCT02650401|Congenital mesoblastic nephroma|congenital mesoblastic nephroma
147567|NCT02650401|Pontine glioma|pontine glioma
147568|NCT02650401|Brain tumors|brain tumors
147569|NCT02650401|CNS tumors|cns tumors
147570|NCT02650401|Sarcoma|sarcoma
147571|NCT02650401|Ewing sarcoma|ewing sarcoma
147572|NCT02650401|Glial tumors|glial tumors
147573|NCT02650401|Salivary Gland Cancer (MASC)|salivary gland cancer (masc)
147574|NCT02650401|Papillary thyroid cancer|papillary thyroid cancer
147575|NCT02650401|Medulloblastoma|medulloblastoma
147576|NCT02650401|Wilms tumor (anaplastic)|wilms tumor (anaplastic)
147577|NCT02650362|spinal cord stimulation|spinal cord stimulation
147779|NCT02649192|Vitamin Supplements|vitamin supplements
147578|NCT02650362|resting state functional magnetic resonance|resting state functional magnetic resonance
147579|NCT02650362|voxel-based magnetic resonance morphometry|voxel-based magnetic resonance morphometry
147580|NCT02650349|spinal cord stimulation|spinal cord stimulation
147581|NCT02650349|resting state functional magnetic resonance|resting state functional magnetic resonance
147582|NCT02650349|voxel-based magnetic resonance morphometry|voxel-based magnetic resonance morphometry
147583|NCT02650297|Lymphedema secondary to breast cancer|lymphedema secondary to breast cancer
147584|NCT02650297|Breast cancer|breast cancer
147585|NCT02650297|Body image|body image
147586|NCT02650271|adjuvant|adjuvant
147587|NCT02650271|entecavir|entecavir
147588|NCT02650271|hepatocellular carcinoma|hepatocellular carcinoma
147589|NCT02650271|hepatic resection|hepatic resection
147590|NCT02650245|breath|breath
147591|NCT02650245|gastroenterology|gastroenterology
147592|NCT02650245|ammonia|ammonia
147593|NCT02650245|blood|blood
147594|NCT02650245|protein|protein
147595|NCT02650245|cirrhosis|cirrhosis
147596|NCT02650245|encephalopathy|encephalopathy
147597|NCT02650232|Volunteers|volunteers
147598|NCT02650206|diabetes|diabetes
147599|NCT02650206|macrophage|macrophage
147600|NCT02650206|inflammation|inflammation
147601|NCT02650206|adipose tissue|adipose tissue
147602|NCT02650206|weight loss|weight loss
147603|NCT02650206|liraglutide|liraglutide
147604|NCT02650193|HSP-130 Phase 1-2 Study in patients with Breast cancer|hsp-130 phase 1-2 study in patients with breast cancer
147605|NCT02650180|Rehabilitation|rehabilitation
147606|NCT02650154|sedation|sedation
147607|NCT02650154|children|children
147608|NCT02650154|infants|infants
147609|NCT02650154|ketamine|ketamine
147610|NCT02650154|neurotoxicity|neurotoxicity
147611|NCT02650128|Coronary Artery Disease|coronary artery disease
147612|NCT02650128|Calcified Coronary Lesions|calcified coronary lesions
147613|NCT02650128|Coronary Arterial Stenosis|coronary arterial stenosis
147614|NCT02650089|Resistance Exercise|resistance exercise
147615|NCT02650089|Postexercise Hypotension|postexercise hypotension
147616|NCT02650089|Sympathovagal balance|sympathovagal balance
147617|NCT02650089|Professor|professor
147618|NCT02650011|Chronic liver disease|chronic liver disease
147619|NCT02650011|Liver cirrhosis|liver cirrhosis
147620|NCT02649998|Fursemide|fursemide
147621|NCT02649998|Isosorbide Dinitrate|isosorbide dinitrate
147622|NCT02649998|Heart Decompensation|heart decompensation
147623|NCT02649998|Clinical Trials, Randomized|clinical trials, randomized
147624|NCT02649998|Clinical Efficacy|clinical efficacy
147625|NCT02649972|Cobimetinib|cobimetinib
147626|NCT02649972|15-216|15-216
147627|NCT02649959|Autism|autism
147628|NCT02649933|pregnancy|pregnancy
147629|NCT02649933|obstructive sleep apnea|obstructive sleep apnea
147630|NCT02649920|unfavorable cervix|unfavorable cervix
147631|NCT02649920|obese pregnant women|obese pregnant women
147632|NCT02649894|malignant pleural effusion|malignant pleural effusion
147633|NCT02649881|macrophage|macrophage
147634|NCT02649881|vulnerable coronary plaque|vulnerable coronary plaque
147635|NCT02649868|Radio-Opaque Bland Beads|radio-opaque bland beads
147636|NCT02649868|Thermal Ablation|thermal ablation
147637|NCT02649868|Transarterial Embolization|transarterial embolization
147638|NCT02649855|PSA|psa
147639|NCT02649855|Vaccine|vaccine
147640|NCT02649855|Immunotherapy|immunotherapy
147641|NCT02649855|Immune Response|immune response
147642|NCT02649855|Androgen Deprivation Therapy|androgen deprivation therapy
147643|NCT02649829|dendritic cell vaccination|dendritic cell vaccination
147644|NCT02649829|chemo-immunotherapy|chemo-immunotherapy
147645|NCT02649829|Wilms' tumor 1 (WT1)|wilms' tumor 1 (wt1)
147646|NCT02649816|Pit and fissure sealants|pit and fissure sealants
147647|NCT02649816|Dental Caries|dental caries
147648|NCT02649816|Prevention|prevention
147649|NCT02649816|Dental undergraduate students|dental undergraduate students
147650|NCT02649816|patient's caries risk|patient's caries risk
147651|NCT02649803|pediatric|pediatric
147652|NCT02649803|asthma control|asthma control
147653|NCT02649803|community|community
147654|NCT02649790|Multiple Myeloma|multiple myeloma
147655|NCT02649790|Karyopharm|karyopharm
147656|NCT02649790|KPT-8602|kpt-8602
147658|NCT02649790|Phase 1|phase 1
147659|NCT02649790|Relapsed/ Refractory Multiple Myeloma|relapsed/ refractory multiple myeloma
147660|NCT02649790|Myelodysplastic Syndrome|myelodysplastic syndrome
147661|NCT02649790|MDS|mds
147662|NCT02649790|Metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
147663|NCT02649790|mCRPC|mcrpc
147664|NCT02649790|CRC|crc
147665|NCT02649777|oxidative stress|oxidative stress
147666|NCT02649764|Acute Myelogenous Leukemia|acute myelogenous leukemia
147667|NCT02649764|AML|aml
147668|NCT02649764|Relapsed/Refractory|relapsed/refractory
147669|NCT02649764|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
147670|NCT02649764|HRMDS|hrmds
147671|NCT02649764|LY2606368|ly2606368
147672|NCT02649764|Fludarabine|fludarabine
147673|NCT02649764|Fludarabine Phosphate|fludarabine phosphate
147674|NCT02649764|Fludara|fludara
147675|NCT02649764|Cytarabine|cytarabine
147676|NCT02649764|Ara-C|ara-c
147677|NCT02649764|Cytosar|cytosar
147679|NCT02649764|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
147680|NCT02649751|Cystic Fibrosis|cystic fibrosis
147681|NCT02649751|Roscovitine|roscovitine
147682|NCT02649751|Seliciclib|seliciclib
147683|NCT02649751|CYC202|cyc202
147684|NCT02649738|keratoconus|keratoconus
147685|NCT02649738|corneal tissue inlay|corneal tissue inlay
147686|NCT02649699|Primary Brain Cancer|primary brain cancer
147687|NCT02649673|lung carcinoma|lung carcinoma
147688|NCT02649673|topotecan|topotecan
147689|NCT02649673|Hycamtin|hycamtin
147690|NCT02649673|ovarian neoplasms|ovarian neoplasms
147691|NCT02649673|LCL161|lcl161
147692|NCT02649673|IAP inhibitors|iap inhibitors
147693|NCT02649660|Fabry Disease|fabry disease
147694|NCT02649660|Platelets|platelets
147695|NCT02649660|Lipidomics|lipidomics
147696|NCT02649660|Sphingolipids|sphingolipids
147697|NCT02649660|α-Galactosidase A|α-galactosidase a
147698|NCT02649660|Globotriaosylceramide|globotriaosylceramide
147699|NCT02649660|Gb3|gb3
147700|NCT02649660|GL-3|gl-3
147701|NCT02649660|CD77|cd77
147702|NCT02649660|Alpha-galactosidase|alpha-galactosidase
147703|NCT02649660|Platelet activation|platelet activation
147704|NCT02649660|Lysosomal storage disease|lysosomal storage disease
147705|NCT02649660|LysoGb3|lysogb3
147706|NCT02649660|Spingosine-1-Phosphate|spingosine-1-phosphate
147707|NCT02649660|Platelet function|platelet function
147708|NCT02649660|CD62P|cd62p
147709|NCT02649660|P-selectin|p-selectin
147710|NCT02649647|Rectal cancer|rectal cancer
147711|NCT02649647|Neoadjuvant therapy|neoadjuvant therapy
147712|NCT02649647|Chemoradiotherapy|chemoradiotherapy
147713|NCT02649647|Resection margin|resection margin
147714|NCT02649647|Bowel function|bowel function
147715|NCT02649647|Anastomosis|anastomosis
147716|NCT02649634|Motivational Interviewing|motivational interviewing
147717|NCT02649634|Obesity|obesity
147718|NCT02649634|Weight Loss|weight loss
147719|NCT02649634|Behavioral Medicine|behavioral medicine
147720|NCT02649621|Limbal Stem Cell Deficiency Amniotic Membrane Extract Eye Drop in vivo cultivation|limbal stem cell deficiency amniotic membrane extract eye drop in vivo cultivation
147721|NCT02649595|Homeless|homeless
147722|NCT02649595|Homelessness|homelessness
147723|NCT02649595|Respite care|respite care
147724|NCT02649595|EQ-5D|eq-5d
147725|NCT02649595|Quality of life questionnaire|quality of life questionnaire
147726|NCT02649595|Economic evaluation|economic evaluation
147727|NCT02649595|Cost-utility analysis|cost-utility analysis
147728|NCT02649582|Dendritic cells|dendritic cells
147729|NCT02649582|Chemoimmunotherapy|chemoimmunotherapy
147730|NCT02649582|Adjuvant therapy|adjuvant therapy
147731|NCT02649556|Candidate modified risk tobacco product|candidate modified risk tobacco product
147732|NCT02649556|Conventional cigarette|conventional cigarette
147733|NCT02649556|Exposure response|exposure response
147734|NCT02649556|Smoking|smoking
147735|NCT02649556|Tobacco Heating System|tobacco heating system
147736|NCT02649543|Surgical Wound Infection|surgical wound infection
147737|NCT02649543|Negative-Pressure Wound Therapy|negative-pressure wound therapy
147738|NCT02649543|Wound Closure Techniques|wound closure techniques
147739|NCT02649543|Laparotomy.|laparotomy.
147740|NCT02649543|Abdominal Wound Closure Techniques|abdominal wound closure techniques
147741|NCT02649517|decompensated heart failure|decompensated heart failure
147742|NCT02649517|ischemic heart disease|ischemic heart disease
147743|NCT02649517|inflammatory cardiomyopathy|inflammatory cardiomyopathy
147744|NCT02649491|Radiotherapy|radiotherapy
147745|NCT02649491|Chemotherapy|chemotherapy
147746|NCT02649491|Metabonomics|metabonomics
147747|NCT02649491|Electronic Sensing|electronic sensing
147748|NCT02649491|GI Toxicity|gi toxicity
147749|NCT02649452|Whole body Vibration|whole body vibration
147750|NCT02649439|Vaccine|vaccine
147751|NCT02649439|PSA|psa
147752|NCT02649439|Surveillance|surveillance
147753|NCT02649439|Immunotherapy|immunotherapy
147754|NCT02649426|denervation|denervation
147755|NCT02649426|resistant hypertension|resistant hypertension
147756|NCT02649426|essential hypertension|essential hypertension
147757|NCT02649361|Anlotinib|anlotinib
147758|NCT02649335|Non selective beta blockers|non selective beta blockers
147759|NCT02649335|Ascites|ascites
147760|NCT02649309|Ischemic Preconditioning|ischemic preconditioning
147761|NCT02649309|Postconditioning|postconditioning
147762|NCT02649309|Angioplasty|angioplasty
147763|NCT02649270|Tolerability|tolerability
147764|NCT02649270|Safety|safety
147765|NCT02649270|Pharmacokinetic Study|pharmacokinetic study
147766|NCT02649270|preliminary pharmacodynamic study|preliminary pharmacodynamic study
147767|NCT02649270|Humanized Anti-CD6 Monoclonal Antibody(T1h)|humanized anti-cd6 monoclonal antibody(t1h)
147768|NCT02649257|IOL rotation|iol rotation
147769|NCT02649257|capsular tension ring|capsular tension ring
147770|NCT02649257|IOL rotational stability|iol rotational stability
147771|NCT02649218|QGE031|qge031
147772|NCT02649218|chronic|chronic
147773|NCT02649218|spontaneous|spontaneous
147774|NCT02649218|Urticaria|urticaria
147775|NCT02649218|CSU|csu
147776|NCT02649218|adults|adults
147777|NCT02649218|Safety|safety
147778|NCT02649192|Children|children
147982|NCT02648113|Anemia|anemia
147780|NCT02649192|Influenza virus vaccine|influenza virus vaccine
147781|NCT02649166|Essential tremor|essential tremor
147782|NCT02649166|Kinetic tremor|kinetic tremor
147783|NCT02649166|Intention tremor|intention tremor
147784|NCT02649140|24-hour urine|24-hour urine
147785|NCT02649140|Calcium oxalate|calcium oxalate
147787|NCT02649127|exercise|exercise
147788|NCT02649127|biomarker|biomarker
147789|NCT02649088|microcirculation|microcirculation
147790|NCT02649088|tissue oxygenation|tissue oxygenation
147791|NCT02649088|outcome|outcome
147792|NCT02649075|IBD|ibd
147793|NCT02649075|Inflammatory Bowel Disease|inflammatory bowel disease
147794|NCT02649075|Crohn's|crohn's
147795|NCT02649075|Crohns|crohns
147796|NCT02649075|SBI|sbi
147797|NCT02649075|Serum-derived bovine immunoglobulin / protein isolate|serum-derived bovine immunoglobulin / protein isolate
147798|NCT02649075|EnteraGam|enteragam
147799|NCT02649010|Type 1 Diabetes|type 1 diabetes
147800|NCT02649010|Type 2 Diabetes|type 2 diabetes
147801|NCT02649010|Enlite 3 Sensor|enlite 3 sensor
147802|NCT02649010|Continuous Glucose Monitoring|continuous glucose monitoring
147803|NCT02648997|Atypical Meningioma|atypical meningioma
147804|NCT02648997|Anaplastic Meningioma|anaplastic meningioma
147805|NCT02648984|Pulmonary vascular disease|pulmonary vascular disease
147806|NCT02648971|knee|knee
147807|NCT02648971|arthroscopy|arthroscopy
147808|NCT02648971|portal|portal
147809|NCT02648971|meniscus|meniscus
147810|NCT02648971|cartilage injury|cartilage injury
147811|NCT02648932|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
147812|NCT02648932|High-Risk Myelodysplastic Syndrome (MDS)|high-risk myelodysplastic syndrome (mds)
147813|NCT02648932|hematopoietic cell transplantation|hematopoietic cell transplantation
147814|NCT02648932|haplo-cord search|haplo-cord search
147815|NCT02648932|matched unrelated donor search|matched unrelated donor search
147816|NCT02648893|iron|iron
147817|NCT02648893|zinc|zinc
147818|NCT02648893|vitamin A|vitamin a
147819|NCT02648893|biofortified|biofortified
147820|NCT02648893|efficacy|efficacy
147821|NCT02648893|India|india
147822|NCT02648893|infant|infant
147823|NCT02648893|trial|trial
147824|NCT02648880|Exercise|exercise
147825|NCT02648880|Physical Activity|physical activity
147826|NCT02648841|gastric cancer|gastric cancer
147827|NCT02648841|adjuvant chemo-radiotherapy|adjuvant chemo-radiotherapy
147828|NCT02648828|Judgment|judgment
147829|NCT02648828|risk assessment|risk assessment
147830|NCT02648828|clinical deterioration|clinical deterioration
147831|NCT02648828|cardiac arrest|cardiac arrest
147832|NCT02648828|Rothman Index|rothman index
147833|NCT02648815|Necrotizing pancreatitis|necrotizing pancreatitis
147834|NCT02648815|Sepsis|sepsis
147835|NCT02648815|Infection|infection
147836|NCT02648815|Drainage|drainage
147837|NCT02648802|breast-conserving surgery(BCS)|breast-conserving surgery(bcs)
147838|NCT02648802|Cavity shave margin|cavity shave margin
147839|NCT02648802|Proportion of positive margins|proportion of positive margins
147840|NCT02648789|Primary oral cancer|primary oral cancer
147841|NCT02648789|DNA methylation|dna methylation
147842|NCT02648789|Recurrence oral cancer|recurrence oral cancer
147843|NCT02648776|hypnotic agents|hypnotic agents
147844|NCT02648776|sleep disorders|sleep disorders
147845|NCT02648776|elderly|elderly
147846|NCT02648750|self-management|self-management
147847|NCT02648750|rehabilitation|rehabilitation
147848|NCT02648737|Parkinson's disease|parkinson's disease
147849|NCT02648737|Cognitive Behavioural therapy|cognitive behavioural therapy
147850|NCT02648737|generalized anxiety disorder|generalized anxiety disorder
147851|NCT02648737|social phobia|social phobia
147852|NCT02648737|cerebral connectivity|cerebral connectivity
147853|NCT02648724|Advanced Solid Tumor Malignancies|advanced solid tumor malignancies
147854|NCT02648724|MET Gene Amplification|met gene amplification
147855|NCT02648724|MET Amplification|met amplification
147856|NCT02648724|Wild-type|wild-type
147857|NCT02648724|NSCLC|nsclc
147858|NCT02648724|METex14|metex14
147859|NCT02648724|Non-Small Cell Lung Carcinoma|non-small cell lung carcinoma
147860|NCT02648711|solid tumors|solid tumors
147861|NCT02648698|chronic endometritis|chronic endometritis
147862|NCT02648698|CD138|cd138
147863|NCT02648685|post prandial glucose (PPG)|post prandial glucose (ppg)
147864|NCT02648685|basal blood glucose (BBG)|basal blood glucose (bbg)
147865|NCT02648685|overall glycaemia|overall glycaemia
147866|NCT02648633|Brain Cancer|brain cancer
147867|NCT02648633|Immunotherapy|immunotherapy
147868|NCT02648633|Nivolumab|nivolumab
147869|NCT02648633|Radiosurgery|radiosurgery
147870|NCT02648633|Gamma Knife|gamma knife
147871|NCT02648620|Paclitaxel|paclitaxel
147872|NCT02648620|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
147873|NCT02648620|PAD|pad
147874|NCT02648620|Peripheral Artery Disease|peripheral artery disease
147875|NCT02648620|Pharmacokinetics|pharmacokinetics
147876|NCT02648607|Pelvic Girdle Pain|pelvic girdle pain
147877|NCT02648607|Chronic Pelvic Girdle Pain|chronic pelvic girdle pain
147878|NCT02648607|Symphysis Pubis Dysfunction|symphysis pubis dysfunction
147879|NCT02648607|Sacroiliac Joint Dysfunction|sacroiliac joint dysfunction
147880|NCT02648607|Physiotherapy|physiotherapy
147881|NCT02648607|Physical Therapy|physical therapy
147882|NCT02648607|Orthoses|orthoses
147883|NCT02648607|Orthosis|orthosis
147884|NCT02648607|Orthotic Devices|orthotic devices
147885|NCT02648594|lung|lung
147886|NCT02648594|thoracoscopy|thoracoscopy
147887|NCT02648594|hook wire localization|hook wire localization
147888|NCT02648581|Behçet|behçet
147889|NCT02648581|ulcers|ulcers
147890|NCT02648581|uveitis|uveitis
147891|NCT02648581|ustekinumab|ustekinumab
147892|NCT02648581|biologics|biologics
147893|NCT02648568|Sleepwalking|sleepwalking
147894|NCT02648568|sleep terrors|sleep terrors
147895|NCT02648568|arousal disorders|arousal disorders
147896|NCT02648568|F513 (CIM-10)|f513 (cim-10)
147897|NCT02648568|F514 (CIM-10)|f514 (cim-10)
147898|NCT02648529|Benign childhood epilepsy with centro-temporal spikes|benign childhood epilepsy with centro-temporal spikes
147899|NCT02648529|rolandic epilepsy|rolandic epilepsy
147900|NCT02648529|brain development|brain development
147901|NCT02648529|DTI|dti
147902|NCT02648529|functional MRI|functional mri
147903|NCT02648529|structural MRI|structural mri
147904|NCT02648529|idiopathic focal epilepsy|idiopathic focal epilepsy
147905|NCT02648529|cryptogenic epilepsy of childhood|cryptogenic epilepsy of childhood
147906|NCT02648516|Immune Reconstitution|immune reconstitution
147907|NCT02648516|Allogenic HLA-Mismatched Mononuclear Cells Transplantation|allogenic hla-mismatched mononuclear cells transplantation
147908|NCT02648503|Sugammadex|sugammadex
147909|NCT02648503|Post-operative Quality Recovery Scale (PQRS)|post-operative quality recovery scale (pqrs)
147910|NCT02648490|metastatic or recurrent epithelial cancer|metastatic or recurrent epithelial cancer
147911|NCT02648464|Hydroxychloroquine|hydroxychloroquine
147912|NCT02648464|anti-inflammatory|anti-inflammatory
147913|NCT02648464|Myocardial infarction|myocardial infarction
147914|NCT02648464|cardiovascular diseases|cardiovascular diseases
147916|NCT02648438|Bioavailability|bioavailability
147917|NCT02648438|Healthy male subjects|healthy male subjects
147918|NCT02648438|Safety|safety
147919|NCT02648438|Tolerability|tolerability
147920|NCT02648438|Pharmacokinetics|pharmacokinetics
147921|NCT02648438|Monodose inhaler|monodose inhaler
147922|NCT02648438|Multiple-dose dry powder inhaler|multiple-dose dry powder inhaler
147923|NCT02648425|ASLAN001|aslan001
147924|NCT02648399|thyroid carcinoma|thyroid carcinoma
147925|NCT02648399|center lymph node dissection|center lymph node dissection
147926|NCT02648360|exercise|exercise
147927|NCT02648360|diet|diet
147928|NCT02648360|patients, underserved|patients, underserved
147929|NCT02648360|text messaging|text messaging
147930|NCT02648347|vadadustat|vadadustat
147931|NCT02648347|AKB-6548|akb-6548
147932|NCT02648347|Chronic kidney disease|chronic kidney disease
147933|NCT02648347|anemia|anemia
147934|NCT02648347|CKD|ckd
147935|NCT02648347|chronic renal insufficiency|chronic renal insufficiency
147936|NCT02648347|renal impairment|renal impairment
147937|NCT02648347|erythropoietin|erythropoietin
147938|NCT02648347|kidney|kidney
147939|NCT02648347|renal|renal
147940|NCT02648347|oral anemia treatment|oral anemia treatment
147941|NCT02648347|hemoglobin|hemoglobin
147942|NCT02648347|hypoxia-inducible factor|hypoxia-inducible factor
147943|NCT02648347|HIF|hif
147944|NCT02648347|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
147945|NCT02648347|HIF-PHI|hif-phi
147946|NCT02648347|efficacy|efficacy
147947|NCT02648347|safety|safety
147948|NCT02648347|Phase 3|phase 3
147949|NCT02648347|cardiovascular|cardiovascular
147950|NCT02648347|NDD-CKD|ndd-ckd
147951|NCT02648334|Drug-Coated Balloon|drug-coated balloon
147952|NCT02648334|Superficial Femoral artery|superficial femoral artery
147953|NCT02648334|popliteal peripheral Artery|popliteal peripheral artery
147954|NCT02648321|Motivational Interviewing|motivational interviewing
147955|NCT02648321|Exercise|exercise
147956|NCT02648308|Education, Medical|education, medical
147957|NCT02648282|vaccine|vaccine
147958|NCT02648282|immunotherapy|immunotherapy
147959|NCT02648282|antibody|antibody
147960|NCT02648282|PD-1|pd-1
147961|NCT02648282|radiation|radiation
147962|NCT02648256|Pneumocystis jirovecii|pneumocystis jirovecii
147963|NCT02648256|Polymerase Chain Reaction|polymerase chain reaction
147964|NCT02648256|Oropharyngeal Rinse|oropharyngeal rinse
147965|NCT02648243|Qatar|qatar
147966|NCT02648243|Acute Coronary Syndrome|acute coronary syndrome
147967|NCT02648243|Pharmacist|pharmacist
147968|NCT02648243|Medication burden|medication burden
147969|NCT02648243|Mortality|mortality
147970|NCT02648243|Readmission|readmission
147971|NCT02648243|Adherence|adherence
147972|NCT02648243|Impact|impact
147973|NCT02648230|Ischemia|ischemia
147974|NCT02648230|Fractional Flow Reserve|fractional flow reserve
147975|NCT02648230|Stent|stent
147976|NCT02648191|Obesity|obesity
147977|NCT02648191|Bariatric Surgery|bariatric surgery
147978|NCT02648191|No invasive intra-auricular vagus nerve stimulation|no invasive intra-auricular vagus nerve stimulation
147979|NCT02648191|Weight loss|weight loss
147980|NCT02648191|Autonomic nervous system|autonomic nervous system
147981|NCT02648113|Myocardial Infarction|myocardial infarction
147983|NCT02648113|Blood Transfusion|blood transfusion
147984|NCT02648100|Muscle invasive bladder cancer|muscle invasive bladder cancer
147985|NCT02648100|Basal subtype|basal subtype
147986|NCT02648100|Anti-EGFR treatment|anti-egfr treatment
147987|NCT02648100|Nanostring|nanostring
147988|NCT02648074|asthma|asthma
147989|NCT02648074|eosinophils|eosinophils
147990|NCT02648074|airway smooth muscle|airway smooth muscle
147991|NCT02648074|airway remodelling|airway remodelling
147992|NCT02648074|integrins|integrins
147993|NCT02648074|cytokines|cytokines
147994|NCT02648061|Blood circulation|blood circulation
147995|NCT02648061|Follow-up studies|follow-up studies
147996|NCT02648061|Biological markers|biological markers
147997|NCT02648061|Hemodynamics|hemodynamics
147998|NCT02648048|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
147999|NCT02648048|Vismodegib|vismodegib
148000|NCT02648048|Pirfenidone|pirfenidone
148001|NCT02648022|Care Integration|care integration
148002|NCT02648022|Hepatitis C|hepatitis c
148003|NCT02648022|Substance Use Disorder|substance use disorder
148004|NCT02648022|PTSD|ptsd
148005|NCT02647970|Energy metabolism|energy metabolism
148006|NCT02647957|acute ischemic stroke|acute ischemic stroke
148007|NCT02647957|quality|quality
148008|NCT02647866|4083-002|4083-002
148009|NCT02647866|Intestinal Diseases|intestinal diseases
148010|NCT02647866|Ulcerative Colitis|ulcerative colitis
148011|NCT02647866|UC|uc
148012|NCT02647866|Mayo Clinic Scoring|mayo clinic scoring
148013|NCT02647866|Gastrointestinal Tract|gastrointestinal tract
148014|NCT02647840|dysphonia|dysphonia
148015|NCT02647840|voice therapy|voice therapy
148016|NCT02647827|Acupuncture|acupuncture
148017|NCT02647827|Metformin|metformin
148018|NCT02647827|Glucose metabolism|glucose metabolism
148019|NCT02647827|Hba1c|hba1c
148020|NCT02647814|Parent activation|parent activation
148021|NCT02647814|Text-messages|text-messages
148022|NCT02647814|LEP|lep
148023|NCT02647814|Latino populations|latino populations
148024|NCT02647814|pediatrics|pediatrics
148025|NCT02647801|Network approach|network approach
148026|NCT02647801|mindfulness|mindfulness
148027|NCT02647801|self-control|self-control
148028|NCT02647801|ambulatory assessment|ambulatory assessment
148029|NCT02647788|Pain, Postoperative|pain, postoperative
148030|NCT02647775|Thoracoscopic surgery|thoracoscopic surgery
148031|NCT02647723|Omega-3|omega-3
148032|NCT02647723|Fatty acid|fatty acid
148033|NCT02647723|docosahexaenoic|docosahexaenoic
148034|NCT02647723|Pregnant|pregnant
148035|NCT02647723|neurodevelopment|neurodevelopment
148036|NCT02647723|stress|stress
148037|NCT02647723|urban|urban
148038|NCT02647723|african-american|african-american
148039|NCT02647723|supplement|supplement
148040|NCT02647723|nutrition|nutrition
148041|NCT02647723|mental health|mental health
148042|NCT02647710|HIV Prevention|hiv prevention
148043|NCT02647710|Juvenile Justice|juvenile justice
148044|NCT02647710|Sexual Health|sexual health
148045|NCT02647710|Evidence Based Intervention|evidence based intervention
148046|NCT02647697|UCB3491|ucb3491
148047|NCT02647697|Phase 1|phase 1
148048|NCT02647697|Pharmacokinetics|pharmacokinetics
148049|NCT02647697|Radiprodil|radiprodil
148050|NCT02647697|Healthy volunteers|healthy volunteers
148051|NCT02647684|Cancer|cancer
148052|NCT02647684|Parenting|parenting
148053|NCT02647684|Self-directed Triple P|self-directed triple p
148054|NCT02647671|Colon polyp|colon polyp
148055|NCT02647671|Colorectal cancer|colorectal cancer
148056|NCT02647671|Chemoprevention|chemoprevention
148057|NCT02647671|Natural product|natural product
148058|NCT02647658|acute low back pain|acute low back pain
148059|NCT02647658|primary care|primary care
148060|NCT02647658|psychologically informed physical therapy|psychologically informed physical therapy
148061|NCT02647658|cluster randomized pragmatic trial|cluster randomized pragmatic trial
148062|NCT02647658|comparative effectiveness|comparative effectiveness
148063|NCT02647658|secondary prevention|secondary prevention
148064|NCT02647632|HCV genotype 1 or 4|hcv genotype 1 or 4
148065|NCT02647632|failure to DAA|failure to daa
148066|NCT02647619|Primary Dd disase|primary dd disase
148067|NCT02647619|MCP joint|mcp joint
148068|NCT02647580|Growth|growth
148069|NCT02647580|Children|children
148070|NCT02647580|Appetite-regulating hormones|appetite-regulating hormones
148071|NCT02647580|Gut Microbiota|gut microbiota
148072|NCT02647567|Cognitive|cognitive
148073|NCT02647567|Aerobic Exercise|aerobic exercise
148074|NCT02647567|Performance|performance
148075|NCT02647554|sepsis|sepsis
148076|NCT02647554|septic shock|septic shock
148077|NCT02647554|Ulinastatin|ulinastatin
148078|NCT02647554|adult|adult
148079|NCT02647554|China|china
148080|NCT02647541|Children|children
148081|NCT02647541|Congenital heart disease|congenital heart disease
148082|NCT02647541|Nutritional status|nutritional status
148083|NCT02647541|Bioelectrical impedance|bioelectrical impedance
148084|NCT02647476|immunonutrition|immunonutrition
148085|NCT02647476|gastric cancer|gastric cancer
148086|NCT02647476|enteral nutrition|enteral nutrition
148087|NCT02647463|Attachment|attachment
148088|NCT02647463|Cortisol|cortisol
148089|NCT02647463|Parent sensitivity|parent sensitivity
148090|NCT02647411|Prevalence|prevalence
148091|NCT02647411|Myopia|myopia
148092|NCT02647398|Cancer survivors|cancer survivors
148093|NCT02647398|training|training
148094|NCT02647398|exercise|exercise
148095|NCT02647398|cancer-related fatigue|cancer-related fatigue
148096|NCT02647385|serratus anterior plane block|serratus anterior plane block
148097|NCT02647385|pectoral nerve block|pectoral nerve block
148098|NCT02647385|breast surgery|breast surgery
148099|NCT02647385|cancer|cancer
148100|NCT02647385|analgesia|analgesia
148101|NCT02647385|inflammatory cytokines|inflammatory cytokines
148102|NCT02647372|parkinson|parkinson
148103|NCT02647372|deep brain stimulation|deep brain stimulation
148104|NCT02647372|globus pallidus|globus pallidus
148105|NCT02647372|subthalamic nucleus|subthalamic nucleus
148106|NCT02647320|type 2 diabetes mellitus|type 2 diabetes mellitus
148107|NCT02647320|interventional|interventional
148108|NCT02647320|double blind|double blind
148109|NCT02647320|phase 2|phase 2
148110|NCT02647281|Single dose|single dose
148111|NCT02647281|Multiple ascending doses (MAD)|multiple ascending doses (mad)
148112|NCT02647281|Pharmacokinetics|pharmacokinetics
148113|NCT02647281|Safety|safety
148114|NCT02647281|GSK3389404|gsk3389404
148115|NCT02647281|Tolerability|tolerability
148116|NCT02647268|Uterine contraction|uterine contraction
148117|NCT02647268|Oxytocin|oxytocin
148118|NCT02647268|Magnesium sulphate|magnesium sulphate
148119|NCT02647255|crescentic IgA nephropathy|crescentic iga nephropathy
148120|NCT02647255|plasma exchange treatment or plasmapheresis|plasma exchange treatment or plasmapheresis
148121|NCT02647255|randomized controlled trial|randomized controlled trial
148122|NCT02647255|intensive immunosuppressive treatment|intensive immunosuppressive treatment
148123|NCT02647255|methylprednisolone pulse|methylprednisolone pulse
148124|NCT02647216|Mindfulness Based Cognitive Therapy (MBCT)|mindfulness based cognitive therapy (mbct)
148125|NCT02647216|anxiety|anxiety
148126|NCT02647216|depression|depression
148127|NCT02647203|Fluoride toothpaste|fluoride toothpaste
148128|NCT02647203|Root caries|root caries
148129|NCT02647203|Randomized clinical trial|randomized clinical trial
148130|NCT02647190|Erwinia Chrysanthemi Asparaginase|erwinia chrysanthemi asparaginase
148131|NCT02647190|15-107|15-107
148132|NCT02647164|Non-small-cell lung carcinoma|non-small-cell lung carcinoma
148133|NCT02647164|Circulating tumor cells|circulating tumor cells
148134|NCT02647151|Acid Methyl Aminolevulinate (MAL)|acid methyl aminolevulinate (mal)
148135|NCT02647151|Aminolevulinic Gel (ALA) and Actinic Keratosis|aminolevulinic gel (ala) and actinic keratosis
148136|NCT02647112|Bladder cancer|bladder cancer
148137|NCT02647112|Urine|urine
148138|NCT02647112|Methylation|methylation
148139|NCT02647099|Aspirin|aspirin
148140|NCT02647099|PI3K signaling pathway|pi3k signaling pathway
148141|NCT02647086|Eczema|eczema
148142|NCT02647073|Mobile Monitoring|mobile monitoring
148143|NCT02647073|Post-Opioid Consumption|post-opioid consumption
148144|NCT02647073|Vital Signs|vital signs
148145|NCT02647060|cardiopulmonary exercise testing|cardiopulmonary exercise testing
148146|NCT02647060|right ventricle function|right ventricle function
148147|NCT02647060|cardio output|cardio output
148148|NCT02647060|pulmonary hypertension|pulmonary hypertension
148149|NCT02647060|quality of life|quality of life
148150|NCT02647047|spinal analgesia|spinal analgesia
148151|NCT02647047|epidural analgesia|epidural analgesia
148152|NCT02647047|laparotomic liver resection|laparotomic liver resection
148153|NCT02647047|ERAS|eras
148154|NCT02647047|length of stay|length of stay
148155|NCT02647021|physical therapy|physical therapy
148156|NCT02647021|cancer rehabilitation|cancer rehabilitation
148157|NCT02647021|exercise|exercise
148158|NCT02647008|outpatient hysteroscopy, TENS|outpatient hysteroscopy, tens
148159|NCT02646982|Alzheimer's disease|alzheimer's disease
148160|NCT02646982|Vascular function|vascular function
148161|NCT02646982|Neuroinflammation|neuroinflammation
148162|NCT02646956|Sweet Taste|sweet taste
148163|NCT02646956|Psychophysics|psychophysics
148164|NCT02646956|Genetics|genetics
148165|NCT02646956|Diet|diet
148166|NCT02646956|Age|age
148167|NCT02646956|Nonnutritive Sweetener|nonnutritive sweetener
148168|NCT02646943|Cohort|cohort
148169|NCT02646943|Biomarkers|biomarkers
148170|NCT02646943|Cardiomyopathy|cardiomyopathy
148171|NCT02646930|chronic endometritis|chronic endometritis
148172|NCT02646930|invitro fertilization|invitro fertilization
148173|NCT02646930|spontaneous abortion|spontaneous abortion
148174|NCT02646891|Rotavirus Vaccine|rotavirus vaccine
148175|NCT02646878|Type 1 Diabetes|type 1 diabetes
148176|NCT02646878|Type 2 Diabetes|type 2 diabetes
148177|NCT02646878|Harmony Sensor|harmony sensor
148178|NCT02646878|Continuous Glucose Monitoring|continuous glucose monitoring
148179|NCT02646878|CGM|cgm
148180|NCT02646865|social phobia|social phobia
148181|NCT02646865|compassion|compassion
148182|NCT02646865|shame|shame
148183|NCT02646839|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
148184|NCT02646839|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
148185|NCT02646839|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
148186|NCT02646839|KIR-Favorable|kir-favorable
148187|NCT02646839|Haploidentical Transplantation|haploidentical transplantation
148188|NCT02646839|Allogeneic Hematopoietic Cell Transplantation|allogeneic hematopoietic cell transplantation
148189|NCT02646800|Micafungin|micafungin
148190|NCT02646800|Candidiasis|candidiasis
148191|NCT02646800|Aspergillosis|aspergillosis
148192|NCT02646800|Antifungal|antifungal
148193|NCT02646774|Aspergillosis|aspergillosis
148194|NCT02646774|Antifungal|antifungal
148195|NCT02646774|Micafungin|micafungin
148196|NCT02646748|Advanced|advanced
148197|NCT02646670|diabetic macular edema|diabetic macular edema
148198|NCT02646670|aflibercept|aflibercept
148199|NCT02646670|ranibizumab|ranibizumab
148200|NCT02646605|Depression|depression
148201|NCT02646605|AIDS|aids
148202|NCT02646605|HIV|hiv
148203|NCT02646579|Orthopedics|orthopedics
148204|NCT02646527|dignity, end of life, existential, treatment|dignity, end of life, existential, treatment
148205|NCT02646514|Cholangiocarcinoma, radiofrequency ablation, metal stent|cholangiocarcinoma, radiofrequency ablation, metal stent
148206|NCT02646488|cholesterol|cholesterol
148207|NCT02646488|smoking|smoking
148208|NCT02646488|aspirin|aspirin
148209|NCT02646488|chronic care model|chronic care model
148210|NCT02646475|renin-angiotensin system|renin-angiotensin system
148211|NCT02646475|angiotensin|angiotensin
148212|NCT02646475|insulin resistance|insulin resistance
148213|NCT02646475|blood pressure|blood pressure
148214|NCT02646462|pancreas adenocarcinoma, lymph node metastases|pancreas adenocarcinoma, lymph node metastases
148215|NCT02646449|Major Depressive Disorder|major depressive disorder
148216|NCT02646449|Alcohol Use Disorder|alcohol use disorder
148217|NCT02646436|unplanned peritoneal dialysis|unplanned peritoneal dialysis
148218|NCT02646436|unplanned heamodialysis|unplanned heamodialysis
148219|NCT02646423|Trial of labor after cesarean|trial of labor after cesarean
148220|NCT02646423|Elective repeat cesarean delivery|elective repeat cesarean delivery
148221|NCT02646423|Decision tool|decision tool
148222|NCT02646423|Shared decision making|shared decision making
148223|NCT02646410|malaria|malaria
148224|NCT02646410|seasonal malaria chemoprevention|seasonal malaria chemoprevention
148225|NCT02646410|immunity|immunity
148226|NCT02646410|resistance|resistance
148227|NCT02646410|sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
148228|NCT02646410|amodiaquine|amodiaquine
148229|NCT02646410|delivery method|delivery method
148230|NCT02646397|glomerular filtration rate|glomerular filtration rate
148231|NCT02646397|hypertension|hypertension
148232|NCT02646345|Checklist|checklist
148233|NCT02646345|Mortality|mortality
148234|NCT02646345|Latin America|latin america
148235|NCT02646345|Surgery|surgery
148236|NCT02646345|Morbidity|morbidity
148237|NCT02646332|Helicobacter pylori|helicobacter pylori
148238|NCT02646332|Eradication rate|eradication rate
148239|NCT02646306|shoulder|shoulder
148240|NCT02646306|proprioception|proprioception
148241|NCT02646306|movement|movement
148242|NCT02646306|reaching|reaching
148243|NCT02646280|Low back pain|low back pain
148244|NCT02646280|interoceptive awareness|interoceptive awareness
148245|NCT02646280|motor imagery|motor imagery
148246|NCT02646280|massage|massage
148247|NCT02646267|Atrial fibrillation|atrial fibrillation
148248|NCT02646267|Dabigatran|dabigatran
148249|NCT02646267|Warfarin|warfarin
148250|NCT02646267|Anticoagulation|anticoagulation
148251|NCT02646267|Elderly|elderly
148252|NCT02646254|tetralogy of fallot, cardioplegia|tetralogy of fallot, cardioplegia
148253|NCT02646241|stomach neoplasm|stomach neoplasm
148254|NCT02646241|biopsy|biopsy
148255|NCT02646150|Magnetic Resonance perfusion imaging|magnetic resonance perfusion imaging
148256|NCT02646150|distal perfusion|distal perfusion
148257|NCT02646150|Critical Limb Ischemia|critical limb ischemia
148258|NCT02646150|endovascular revascularization|endovascular revascularization
148259|NCT02646111|"Hepatitis C Virus"|"hepatitis c virus"
148260|NCT02646111|"Triple Therapy"|"triple therapy"
148261|NCT02646111|"PI Failure"|"pi failure"
148262|NCT02646111|"Genotype 1"|"genotype 1"
148263|NCT02646098|NHL|nhl
148264|NCT02646098|mantle cell lymphoma|mantle cell lymphoma
148265|NCT02646098|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
148266|NCT02646072|diabetes mellitus|diabetes mellitus
148267|NCT02646072|aqueous humor|aqueous humor
148268|NCT02646072|inflammatory cytokines|inflammatory cytokines
148269|NCT02646072|cystoid macular edema, postoperative|cystoid macular edema, postoperative
148270|NCT02646072|nonsteroidal anti-inflammatory drugs|nonsteroidal anti-inflammatory drugs
148271|NCT02646046|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
148272|NCT02646046|Emergency Medical Services|emergency medical services
148273|NCT02646046|Cell phones|cell phones
148274|NCT02646046|Simulation Training|simulation training
148275|NCT02646033|Intraocular Pressure, Trendelenburg position|intraocular pressure, trendelenburg position
148276|NCT02646020|pruritus|pruritus
148277|NCT02646020|Non-small Cell Lung Cancer|non-small cell lung cancer
148278|NCT02646020|Receptor, Epidermal Growth Factor|receptor, epidermal growth factor
148279|NCT02646020|tyrosine kinase inhibitor|tyrosine kinase inhibitor
148280|NCT02646007|Autologous Cell therapy Kienböck's disease|autologous cell therapy kienböck's disease
148281|NCT02646007|bone marrow derived mesenchymal stromal/stem cell|bone marrow derived mesenchymal stromal/stem cell
148282|NCT02645994|Closed Loop Anesthesia Delivery System|closed loop anesthesia delivery system
148283|NCT02645994|Target Controlled Infusion|target controlled infusion
148284|NCT02645981|Donafeinb|donafeinb
148285|NCT02645981|Sorafenib|sorafenib
148286|NCT02645981|Phase 3|phase 3
148287|NCT02645981|Overall Survival|overall survival
148288|NCT02645968|Pneumology|pneumology
148289|NCT02645968|Registry|registry
148290|NCT02645968|EXCITING|exciting
148291|NCT02645968|Interstitial lung disease|interstitial lung disease
148292|NCT02645968|ILD|ild
148293|NCT02645942|Carnitine|carnitine
148294|NCT02645942|placebo|placebo
148295|NCT02645942|risk factors|risk factors
148296|NCT02645916|Cold Hypersensitivity in the Hands|cold hypersensitivity in the hands
148297|NCT02645916|Korean medicine|korean medicine
148298|NCT02645916|DSGOST|dsgost
148299|NCT02645903|transversus abdominis plane block|transversus abdominis plane block
148300|NCT02645903|living liver transplantation|living liver transplantation
148301|NCT02645903|postoperative analgesia|postoperative analgesia
148302|NCT02645890|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
148303|NCT02645890|Healthy Male Volunteer|healthy male volunteer
148304|NCT02645890|Tamsulosin|tamsulosin
148305|NCT02645890|Tadalafil|tadalafil
148306|NCT02645877|Pre-hospital Care|pre-hospital care
148307|NCT02645877|Diseases Spectrum|diseases spectrum
148308|NCT02645877|Call Demands|call demands
148309|NCT02645877|Emergency Response Time|emergency response time
148310|NCT02645864|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
148311|NCT02645864|Apatinib|apatinib
148312|NCT02645864|Irinotecan|irinotecan
148313|NCT02645851|Fluid Therapy|fluid therapy
148314|NCT02645851|Plasma Substitutes|plasma substitutes
148315|NCT02645851|Fluid Balance|fluid balance
148316|NCT02645838|Motivational Interviewing|motivational interviewing
148317|NCT02645838|Smoking Cessation|smoking cessation
148318|NCT02645825|superficial adenopathy - echography|superficial adenopathy - echography
148319|NCT02645812|Fatigue|fatigue
148320|NCT02645812|Brief Fatigue Inventory (BFI)|brief fatigue inventory (bfi)
148321|NCT02645812|Primary care|primary care
148322|NCT02645812|General Practitioners|general practitioners
148323|NCT02645786|thyroid neoplasms|thyroid neoplasms
148324|NCT02645786|heart|heart
148325|NCT02645786|thyroxine|thyroxine
148326|NCT02645786|thyrotoxicosis|thyrotoxicosis
148327|NCT02645708|RIRS|rirs
148328|NCT02645708|EPVL|epvl
148329|NCT02645708|PDI(Percussion,Diuresis,Inversion)|pdi(percussion,diuresis,inversion)
148330|NCT02645708|Randomized Controlled Trial|randomized controlled trial
148331|NCT02645695|Pulmonary Rehabilitation|pulmonary rehabilitation
148332|NCT02645695|Chest Physiotherapy|chest physiotherapy
148333|NCT02645695|High Frequency Chest Wall Oscillation|high frequency chest wall oscillation
148334|NCT02645682|central venous catheter (CVC)|central venous catheter (cvc)
148335|NCT02645682|catheter-related bloodstream infection (CRBSI)|catheter-related bloodstream infection (crbsi)
148336|NCT02645682|catheter-related thrombosis (CRT)|catheter-related thrombosis (crt)
148337|NCT02645656|Oral Submucous Fibrosis|oral submucous fibrosis
148338|NCT02645656|Curcumin|curcumin
148339|NCT02645643|medical students|medical students
148340|NCT02645643|professionalism|professionalism
148341|NCT02645643|medical education|medical education
148342|NCT02645643|study emotion|study emotion
148343|NCT02645630|Cervical spine|cervical spine
148344|NCT02645630|Spinal manipulation|spinal manipulation
148345|NCT02645604|Artemisinin Combination Therapy (ACT)|artemisinin combination therapy (act)
148346|NCT02645591|Prostate cancer|prostate cancer
148347|NCT02645591|Dehydrated human amnion/chorion membrane|dehydrated human amnion/chorion membrane
148348|NCT02645591|dHACM|dhacm
148349|NCT02645591|Robotic assisted laparoscopic radical prostatectomy|robotic assisted laparoscopic radical prostatectomy
148350|NCT02645591|RARP|rarp
148351|NCT02645591|AmnioFix®|amniofix®
148352|NCT02645591|Sexual function score|sexual function score
148353|NCT02645591|Neurovascular bundle inflammation|neurovascular bundle inflammation
148354|NCT02645591|Questionnaire|questionnaire
148355|NCT02645591|Survey|survey
148356|NCT02645578|Coma|coma
148357|NCT02645578|traumatic brain injury|traumatic brain injury
148358|NCT02645578|median nerve stimulation|median nerve stimulation
148359|NCT02645552|Traumatic brain injury|traumatic brain injury
148360|NCT02645513|mHealth|mhealth
148361|NCT02645513|text message|text message
148362|NCT02645513|case management|case management
148363|NCT02645500|Physical Activity|physical activity
148364|NCT02645500|Family well-being|family well-being
148365|NCT02645448|Resistance Exercise|resistance exercise
148366|NCT02645448|Diabetes Mellitus|diabetes mellitus
148367|NCT02645448|Heart Rate Variability|heart rate variability
148368|NCT02645409|Fluorescence|fluorescence
148369|NCT02645409|Imaging|imaging
148370|NCT02645409|Partial nephrectomy|partial nephrectomy
148371|NCT02645409|Radical nephrectomy|radical nephrectomy
148372|NCT02645396|Cytomegalovirus|cytomegalovirus
148373|NCT02645383|Pattern scan laser|pattern scan laser
148374|NCT02645383|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
148375|NCT02645383|Pain|pain
148376|NCT02645370|Migraine|migraine
148377|NCT02645370|Danzhen|danzhen
148378|NCT02645370|Topiramate|topiramate
148379|NCT02645370|Headache diary APP|headache diary app
148380|NCT02645370|preventive treatment|preventive treatment
148381|NCT02645357|Oncology Patients|oncology patients
148382|NCT02645357|evidence-based|evidence-based
148383|NCT02645357|computerized|computerized
148384|NCT02645357|decision|decision
148385|NCT02645357|support system|support system
148386|NCT02645357|linked|linked
148387|NCT02645357|electronic health records|electronic health records
148388|NCT02645344|Unilateral neglect|unilateral neglect
148389|NCT02645344|Right hemiplegia|right hemiplegia
148390|NCT02645318|Circulating Tumor DNA|circulating tumor dna
148391|NCT02645318|Lung cancer|lung cancer
148392|NCT02645318|Targeted sequencing|targeted sequencing
148393|NCT02645305|Safety and Efficacy|safety and efficacy
148394|NCT02645305|Adipose stem cells|adipose stem cells
148395|NCT02645305|Stem Cell therapy|stem cell therapy
148396|NCT02645279|newborn|newborn
148397|NCT02645279|MRI|mri
148398|NCT02645279|oral 30% glucose|oral 30% glucose
148399|NCT02645253|Safety|safety
148400|NCT02645253|Pharmacokinetics|pharmacokinetics
148401|NCT02645253|Pharmacodynamics|pharmacodynamics
148402|NCT02645253|Glucocorticoid receptor modulator|glucocorticoid receptor modulator
148403|NCT02645253|Healthy male subjects|healthy male subjects
148404|NCT02645201|probiotic|probiotic
148405|NCT02645188|Electromyography|electromyography
148406|NCT02645188|Exercise|exercise
148407|NCT02645175|Paclitaxel|paclitaxel
148408|NCT02645175|docetaxel|docetaxel
148409|NCT02645175|vinorelbine|vinorelbine
148410|NCT02645175|eribulin|eribulin
148411|NCT02645162|Pakistan|pakistan
148412|NCT02645162|Early Child Development, Care and Education|early child development, care and education
148413|NCT02645162|Youth Leaders|youth leaders
148414|NCT02645149|Metastatic Melanoma|metastatic melanoma
148415|NCT02645149|Molecular Testing|molecular testing
148416|NCT02645149|Targeted Therapy|targeted therapy
148417|NCT02645123|spinal mobilization|spinal mobilization
148418|NCT02645123|manual therapy|manual therapy
148419|NCT02645123|gait analysis|gait analysis
148420|NCT02645123|low back pain|low back pain
148421|NCT02645123|chronic|chronic
148422|NCT02645097|Adult|adult
148423|NCT02645097|nerve blocks in foot and ankle surgery|nerve blocks in foot and ankle surgery
148424|NCT02645097|saphenous|saphenous
148425|NCT02645071|physical activity|physical activity
148426|NCT02645071|family well being,|family well being,
148427|NCT02645071|health|health
148428|NCT02645058|Ureterorenoscopy|ureterorenoscopy
148429|NCT02645058|extracorporeal shock waves lithotripsy|extracorporeal shock waves lithotripsy
148430|NCT02645045|Dry eye|dry eye
148431|NCT02645045|Lipiview|lipiview
148432|NCT02645045|Tear Lipid Layer|tear lipid layer
148433|NCT02645045|meibomian gland dysfunction|meibomian gland dysfunction
148434|NCT02645032|Typhoid conjugate vaccine|typhoid conjugate vaccine
148435|NCT02645032|Vi-DT|vi-dt
148436|NCT02645032|Safety|safety
148437|NCT02645032|Immunogenicuty|immunogenicuty
148438|NCT02645006|falls|falls
148439|NCT02645006|elderly|elderly
148440|NCT02645006|Exercise,Physical|exercise,physical
148441|NCT02645006|vitamin d|vitamin d
148442|NCT02645006|home hazards|home hazards
148443|NCT02645006|mediterranean diet|mediterranean diet
148444|NCT02645006|body mass index|body mass index
148445|NCT02645006|lower extremity exercise movement technics|lower extremity exercise movement technics
148446|NCT02645006|vitamin D intake|vitamin d intake
148447|NCT02645006|Short Physical Performance Battery (SPPB o Test de Guralnik)|short physical performance battery (sppb o test de guralnik)
148448|NCT02644980|Target Controlled Infusion|target controlled infusion
148449|NCT02644967|ILLUMINATE- 204|illuminate- 204
148450|NCT02644954|psoriasis|psoriasis
148451|NCT02644954|Metformin|metformin
148452|NCT02644928|Chronic kidney disease|chronic kidney disease
148453|NCT02644928|Bariatric Surgery Candidate|bariatric surgery candidate
148454|NCT02644928|Caloric restriction|caloric restriction
148455|NCT02644915|ischemia-reperfusion(I/R) injury|ischemia-reperfusion(i/r) injury
148456|NCT02644915|Edaravone|edaravone
148457|NCT02644902|Avatar assisted cascade training and supervision|avatar assisted cascade training and supervision
148458|NCT02644902|maternal depression|maternal depression
148459|NCT02644902|postconflict|postconflict
148460|NCT02644902|THP|thp
148461|NCT02644889|Epidermal growth factor receptor(EGFR)|epidermal growth factor receptor(egfr)
148462|NCT02644889|NSCLC|nsclc
148463|NCT02644876|Postoperative pulmonary complications|postoperative pulmonary complications
148464|NCT02644876|Selective anticholinergic bronchodilator|selective anticholinergic bronchodilator
148465|NCT02644876|High risk patients|high risk patients
148466|NCT02644876|Postoperative period|postoperative period
148467|NCT02644876|Postoperative complications|postoperative complications
148468|NCT02644824|Congenital Heart Disease (CHD)|congenital heart disease (chd)
148469|NCT02644824|Cardiopulmonary Bypass (CPB)|cardiopulmonary bypass (cpb)
148470|NCT02644824|Cardiac Index|cardiac index
148471|NCT02644824|Hemodynamics|hemodynamics
148472|NCT02644824|Pediatrics|pediatrics
148473|NCT02644811|Miniscrew|miniscrew
148474|NCT02644811|Temporary anchorage device (TAD)|temporary anchorage device (tad)
148475|NCT02644811|mini-implants|mini-implants
148476|NCT02644811|Miniscrew implant (MSI)|miniscrew implant (msi)
148477|NCT02644798|ARDS|ards
148478|NCT02644798|Gene polymorphism|gene polymorphism
148479|NCT02644785|cardiac by-pass|cardiac by-pass
148480|NCT02644785|protamine|protamine
148481|NCT02644785|tryptase|tryptase
148482|NCT02644785|hypotension|hypotension
148483|NCT02644785|anaphylaxis|anaphylaxis
148484|NCT02644772|Acute Exacerbation of COPD|acute exacerbation of copd
148485|NCT02644772|Clinical problems in COPD|clinical problems in copd
148486|NCT02644759|Stem Cells|stem cells
148487|NCT02644759|Transplantation|transplantation
148488|NCT02644759|Immunomodulation|immunomodulation
148489|NCT02644759|CD34|cd34
148490|NCT02644759|CD133|cd133
148491|NCT02644759|ClinicMACS|clinicmacs
148492|NCT02644746|degenerative lumbar spinal stenosis|degenerative lumbar spinal stenosis
148493|NCT02644746|acupuncture|acupuncture
148494|NCT02644746|randomized controlled trial|randomized controlled trial
148495|NCT02644655|Recurrent B-Cell Tumor|recurrent b-cell tumor
148496|NCT02644655|Refractory B-Cell Tumor|refractory b-cell tumor
148497|NCT02644655|New Cluster of Differentiation Antigen 19-chimeric Antigen Receptor T Cells|new cluster of differentiation antigen 19-chimeric antigen receptor t cells
148498|NCT02644655|safety|safety
148499|NCT02644655|prognosis|prognosis
148500|NCT02644616|tolvaptan|tolvaptan
148501|NCT02644616|safety and efficacy|safety and efficacy
148502|NCT02644616|left heart valves replacement|left heart valves replacement
148503|NCT02644603|Enhanced Recovery After Surgery|enhanced recovery after surgery
148504|NCT02644603|hepatocellular carcinoma|hepatocellular carcinoma
148505|NCT02644590|Melatonin|melatonin
148506|NCT02644590|Nocturnal Hypertension|nocturnal hypertension
148507|NCT02644590|Type 1 Diabetes Melitus|type 1 diabetes melitus
148508|NCT02644577|Metformin|metformin
148509|NCT02644577|antipsychotic-induced metabolic syndrome|antipsychotic-induced metabolic syndrome
148510|NCT02644577|bipolar disorder|bipolar disorder
148511|NCT02644564|Soft tissue shoulder injury|soft tissue shoulder injury
148512|NCT02644564|Rotator cuff tear|rotator cuff tear
148513|NCT02644564|Ultrasonography|ultrasonography
148514|NCT02644538|HBsAg clearance|hbsag clearance
148515|NCT02644525|Cameroon|cameroon
148516|NCT02644525|Filaricidal|filaricidal
148517|NCT02644525|Randomized|randomized
148518|NCT02644525|Ivermectin|ivermectin
148519|NCT02644525|Worm|worm
148520|NCT02644434|Percutaneous Coronary Intervention|percutaneous coronary intervention
148521|NCT02644434|Coronary Bifurcation Intervention|coronary bifurcation intervention
148522|NCT02644434|Randomized Clinical Trial|randomized clinical trial
148523|NCT02644421|Neuropathic Pain|neuropathic pain
148524|NCT02644421|Sciatica|sciatica
148525|NCT02644408|Chemoradiotherapy|chemoradiotherapy
148526|NCT02644408|Esophageal Squamous Cancer|esophageal squamous cancer
148527|NCT02644408|Megestrol|megestrol
148528|NCT02644382|breast cancer|breast cancer
148529|NCT02644382|decision making|decision making
148530|NCT02644382|surgery|surgery
148531|NCT02644382|qualitative|qualitative
148532|NCT02644317|Motor development delay|motor development delay
148534|NCT02644317|flatfoot|flatfoot
148535|NCT02644317|shoe insert|shoe insert
148536|NCT02644291|medulloblastoma|medulloblastoma
148537|NCT02644291|Diffuse Intrinsic Pontine Glioma (DIPG)|diffuse intrinsic pontine glioma (dipg)
148538|NCT02644291|high grade glioma|high grade glioma
148539|NCT02644291|glioblastoma|glioblastoma
148540|NCT02644291|brain stem malignant glioma|brain stem malignant glioma
148541|NCT02644278|VX15-984-001|vx15-984-001
148542|NCT02644278|VX-984|vx-984
148543|NCT02644278|M9831|m9831
148544|NCT02644278|Advanced Solid Tumor|advanced solid tumor
148545|NCT02644278|Pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
148546|NCT02644265|Acute acquired brain injury|acute acquired brain injury
148547|NCT02644265|Disorders of consciousness|disorders of consciousness
148548|NCT02644265|Traumatic brain injury|traumatic brain injury
148549|NCT02644265|Non-traumatic brain injury|non-traumatic brain injury
148550|NCT02644265|Anoxic-ischemic encephalopathy|anoxic-ischemic encephalopathy
148551|NCT02644265|Stroke|stroke
148552|NCT02644265|Vegetative state|vegetative state
148553|NCT02644265|Minimal conscious state|minimal conscious state
148554|NCT02644265|Locked-in syndrome|locked-in syndrome
148555|NCT02644265|Functional magnetic resonance imaging|functional magnetic resonance imaging
148556|NCT02644265|Electroencephalography|electroencephalography
148557|NCT02644174|Obesity|obesity
148558|NCT02644174|Lung function test|lung function test
148559|NCT02644174|Bariatric surgery|bariatric surgery
148560|NCT02644161|stroke|stroke
148561|NCT02644161|depression|depression
148562|NCT02644161|stroke sequelae|stroke sequelae
148563|NCT02644161|acupuncture|acupuncture
148564|NCT02644161|DCEAS|dceas
148565|NCT02644161|CAI|cai
148566|NCT02644161|LAS|las
148567|NCT02644135|Healthy volunteer|healthy volunteer
148568|NCT02644122|advanced cancer|advanced cancer
148569|NCT02644122|metastatic cancer|metastatic cancer
148570|NCT02644122|Squamous Cell Carcinoma of the Head and Neck|squamous cell carcinoma of the head and neck
148571|NCT02644122|SCCHN|scchn
148969|NCT02641587|Confinement|confinement
148572|NCT02644122|gene mutation|gene mutation
148573|NCT02644122|PIK3R1, PIK3R5 and PIK3AP1|pik3r1, pik3r5 and pik3ap1
148574|NCT02644122|PIK3CG|pik3cg
148575|NCT02644122|AKT and mTOR|akt and mtor
148576|NCT02644122|PIK3CA gene|pik3ca gene
148577|NCT02644122|PI-3 kinase inhibitor|pi-3 kinase inhibitor
148578|NCT02644122|PI-3 kinase pathway genes|pi-3 kinase pathway genes
148579|NCT02644096|Rehabilitation|rehabilitation
148580|NCT02644096|RCT|rct
148581|NCT02644096|User Involvement|user involvement
148582|NCT02644096|Self-Rated Health|self-rated health
148583|NCT02644070|Alveolar bone loss|alveolar bone loss
148584|NCT02644070|Alveoloplasty|alveoloplasty
148585|NCT02644070|Bone remodeling|bone remodeling
148586|NCT02644070|Xenograft|xenograft
148587|NCT02644070|Tooth socket|tooth socket
148588|NCT02644070|Dental implant|dental implant
148589|NCT02644044|Progressive multiple sclerosis|progressive multiple sclerosis
148590|NCT02644044|methotrexate|methotrexate
148591|NCT02644031|Instrumentation|instrumentation
148592|NCT02644031|Post-operative pain|post-operative pain
148593|NCT02644031|Root canal preparation|root canal preparation
148594|NCT02644018|Ingavirin|ingavirin
148595|NCT02644018|Common Cold|common cold
148596|NCT02644018|Influenza|influenza
148597|NCT02644018|Acute Respiratory Viral Infections|acute respiratory viral infections
148598|NCT02644018|pediatric clinical trial|pediatric clinical trial
148599|NCT02644018|Imidazolyl ethanamide pentandioic acid|imidazolyl ethanamide pentandioic acid
148600|NCT02643979|Ketamine|ketamine
148601|NCT02643979|Propofol|propofol
148602|NCT02643979|Ketofol|ketofol
148603|NCT02643979|Obese|obese
148604|NCT02643979|Upper gastrointestinal endoscopy|upper gastrointestinal endoscopy
148605|NCT02643979|Sedation|sedation
148606|NCT02643979|Bariatric|bariatric
148607|NCT02643966|whole breast ultrasound|whole breast ultrasound
148608|NCT02643966|digital breast tomosynthesis|digital breast tomosynthesis
148609|NCT02643966|breast density|breast density
148610|NCT02643966|breast cancer screening|breast cancer screening
148611|NCT02643953|Maternal Health|maternal health
148612|NCT02643953|Maternal Mortality|maternal mortality
148613|NCT02643953|Global Health|global health
148614|NCT02643953|RCT|rct
148615|NCT02643940|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
148616|NCT02643940|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
148617|NCT02643940|Cardiac MRI|cardiac mri
148618|NCT02643940|Instantaneous wave-free ratio (iFR)|instantaneous wave-free ratio (ifr)
148619|NCT02643875|myopia control|myopia control
148620|NCT02643875|orthokeratology|orthokeratology
148621|NCT02643823|Human Umbilical Cord Mesenchymal Stem Cell|human umbilical cord mesenchymal stem cell
148622|NCT02643823|Mesenchymal Stem Cell|mesenchymal stem cell
148623|NCT02643823|Rheumatoid Arthritis|rheumatoid arthritis
148624|NCT02643810|exercise training|exercise training
148625|NCT02643797|diabetes|diabetes
148626|NCT02643797|medical assistant|medical assistant
148627|NCT02643797|health coach|health coach
148628|NCT02643797|glycemic control|glycemic control
148629|NCT02643797|pragmatic trial|pragmatic trial
148630|NCT02643784|acute ischemic stroke|acute ischemic stroke
148631|NCT02643771|Dental Scaling|dental scaling
148632|NCT02643771|Blood Glucose|blood glucose
148633|NCT02643771|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
148634|NCT02643758|Myopia control, bifocal soft contact lenses, children|myopia control, bifocal soft contact lenses, children
148635|NCT02643745|acute kidney injury|acute kidney injury
148636|NCT02643745|cardiac surgery|cardiac surgery
148637|NCT02643732|Activity|activity
148638|NCT02643719|migraine|migraine
148639|NCT02643719|topiramate|topiramate
148640|NCT02643706|Aldehyde dehydrogenase 2|aldehyde dehydrogenase 2
148641|NCT02643706|contrast induced nephropathy|contrast induced nephropathy
148642|NCT02643706|Gene polymorphism|gene polymorphism
148643|NCT02643693|Conventional cigarette|conventional cigarette
148644|NCT02643693|Nicotine lactate delivery system|nicotine lactate delivery system
148645|NCT02643693|e-cigarette|e-cigarette
148646|NCT02643693|VUSE|vuse
148647|NCT02643693|Combustible cigarette|combustible cigarette
148648|NCT02643680|Biocellulose|biocellulose
148649|NCT02643680|Silk sericin|silk sericin
148650|NCT02643680|Polyhexamethylene biguanide|polyhexamethylene biguanide
148651|NCT02643680|Split thickness skin graft donor site|split thickness skin graft donor site
148652|NCT02643667|Radical prostatectomy (RP)|radical prostatectomy (rp)
148653|NCT02643654|interleukin-1alpha|interleukin-1alpha
148654|NCT02643641|Grass pollen allergy|grass pollen allergy
148655|NCT02643641|subcutaneous immunotherapy|subcutaneous immunotherapy
148656|NCT02643641|allergy vaccine|allergy vaccine
148657|NCT02643641|dose regimen|dose regimen
148658|NCT02643615|Visual Evoked Potentials|visual evoked potentials
148659|NCT02643589|haploidentical hematopoietic Stem Cell Transplantation Antithymocyte globulin|haploidentical hematopoietic stem cell transplantation antithymocyte globulin
148660|NCT02643589|acute graft-versus-host disease|acute graft-versus-host disease
148661|NCT02643589|antithymocyte globulin|antithymocyte globulin
148662|NCT02643563|Brachial Plexus Block|brachial plexus block
148663|NCT02643563|Anesthetics, Local|anesthetics, local
148664|NCT02643524|Adult|adult
148665|NCT02643524|CAM boot|cam boot
148666|NCT02643524|controlled ankle movement|controlled ankle movement
148667|NCT02643498|Stereotactic Body Radiotherapy (SBRT)|stereotactic body radiotherapy (sbrt)
148668|NCT02643498|15-109|15-109
148669|NCT02643472|neonate|neonate
148670|NCT02643472|newborn|newborn
148671|NCT02643472|neonatal intensive care unit|neonatal intensive care unit
148672|NCT02643472|NICU|nicu
148673|NCT02643472|NICU discharge|nicu discharge
148674|NCT02643472|parent navigator|parent navigator
148675|NCT02643472|peer to peer|peer to peer
148676|NCT02643472|peer coaching|peer coaching
148677|NCT02643459|Triage|triage
148678|NCT02643459|Risk stratification|risk stratification
148679|NCT02643459|Acute care|acute care
148680|NCT02643459|suPAR|supar
148681|NCT02643446|Poliovirus Vaccine, Inactivated|poliovirus vaccine, inactivated
148682|NCT02643446|Poliovirus Vaccine, Oral|poliovirus vaccine, oral
148683|NCT02643446|Immunity|immunity
148684|NCT02643446|Seroconversion|seroconversion
148685|NCT02643433|Immunogenicity|immunogenicity
148686|NCT02643433|Coadministration|coadministration
148687|NCT02643433|Measles|measles
148688|NCT02643433|Rubella|rubella
148689|NCT02643433|Japanese encephalitis|japanese encephalitis
148690|NCT02643433|Vaccine|vaccine
148691|NCT02643420|Neutropenia|neutropenia
148692|NCT02643420|Breast Cancer|breast cancer
148693|NCT02643420|Long-acting Myeloid Growth Factor|long-acting myeloid growth factor
148694|NCT02643420|Early Stage Breast Cancer|early stage breast cancer
148695|NCT02643420|Docetaxel + Cyclophosphamide (TC) chemotherapy|docetaxel + cyclophosphamide (tc) chemotherapy
148696|NCT02643407|squamous cell carcinoma|squamous cell carcinoma
148697|NCT02643407|nedaplatin|nedaplatin
148698|NCT02643407|cisplatin|cisplatin
148699|NCT02643407|docetaxel|docetaxel
148700|NCT02643394|Acetaminophen|acetaminophen
148701|NCT02643394|Postoperative pain|postoperative pain
148702|NCT02643394|Sinus Surgery|sinus surgery
148703|NCT02643381|etomidate|etomidate
148704|NCT02643381|ketamine|ketamine
148705|NCT02643381|endotracheal intubation|endotracheal intubation
148706|NCT02643381|anesthesia induction medications|anesthesia induction medications
148707|NCT02643368|Polio|polio
148708|NCT02643368|Inactivated polio vaccine|inactivated polio vaccine
148709|NCT02643368|oral polio vaccine|oral polio vaccine
148710|NCT02643368|monovalent type 2 oral polio vaccine|monovalent type 2 oral polio vaccine
148711|NCT02643355|Narcotic Withdrawal|narcotic withdrawal
148712|NCT02643355|Opiate Withdrawal|opiate withdrawal
148713|NCT02643355|Emergency Department|emergency department
148714|NCT02643342|myopia control|myopia control
148715|NCT02643342|orthokeratology|orthokeratology
148716|NCT02643303|Durvalumab|durvalumab
148717|NCT02643303|MEDI4736|medi4736
148718|NCT02643303|Tremelimumab|tremelimumab
148719|NCT02643303|PolyICLC|polyiclc
148720|NCT02643303|Hiltonol|hiltonol
148721|NCT02643303|Locally Recurrent Breast Cancer|locally recurrent breast cancer
148722|NCT02643303|Metastatic Melanoma|metastatic melanoma
148723|NCT02643303|In Situ|in situ
148724|NCT02643303|CTLA-4 Antibody|ctla-4 antibody
148725|NCT02643303|PD-L1 Antibody|pd-l1 antibody
148726|NCT02643303|TLR3 Agonist|tlr3 agonist
148727|NCT02643290|Adult Scoliosis|adult scoliosis
148728|NCT02643290|Pain Management|pain management
148729|NCT02643290|Orthosis|orthosis
148730|NCT02643264|insula|insula
148731|NCT02643264|alcohol addiction|alcohol addiction
148732|NCT02643264|transcranial magnetic stimulation|transcranial magnetic stimulation
148733|NCT02643251|Diabetes Mellitus|diabetes mellitus
148734|NCT02643251|Pain|pain
148735|NCT02643251|Foot Pain|foot pain
148736|NCT02643251|Neuropathy|neuropathy
148737|NCT02643160|Trunk Training|trunk training
148738|NCT02643160|Motor Function|motor function
148739|NCT02643147|Heart Failure|heart failure
148740|NCT02643147|Renal Failure|renal failure
148741|NCT02643147|Biomarker guided-therapy|biomarker guided-therapy
148742|NCT02643147|Loop diuretics|loop diuretics
148743|NCT02643147|Carbohydrate antigen 125|carbohydrate antigen 125
148744|NCT02643134|ESWL|eswl
148745|NCT02643134|EPVL|epvl
148746|NCT02643134|PDI(Percussion,Diuresis,Inversion)|pdi(percussion,diuresis,inversion)
148747|NCT02643134|Randomized Controlled Trial(RCT)|randomized controlled trial(rct)
148748|NCT02643108|Lateral episiotomy|lateral episiotomy
148749|NCT02643108|Obstetrical anal sphincter injury|obstetrical anal sphincter injury
148750|NCT02643108|Vacuum extraction|vacuum extraction
148751|NCT02643108|Anal incontinence|anal incontinence
148752|NCT02643069|Frailty|frailty
148753|NCT02643069|Frailty tools|frailty tools
148754|NCT02643069|Clinical settings|clinical settings
148755|NCT02643069|Disability|disability
148756|NCT02643069|Quality of life|quality of life
148757|NCT02643069|Functional Autonomy|functional autonomy
148758|NCT02643043|Next Generation Sequencing|next generation sequencing
148759|NCT02643043|Genomic Analysis|genomic analysis
148760|NCT02643017|cognitive function|cognitive function
148761|NCT02643017|desflurane|desflurane
148762|NCT02643017|dexmedetomidine|dexmedetomidine
148763|NCT02642978|minimally invasive surgery|minimally invasive surgery
148764|NCT02642978|colorectal liver metastasis|colorectal liver metastasis
148765|NCT02642978|robotic surgery|robotic surgery
148766|NCT02642978|Patients with resectable colorectal liver metastasis|patients with resectable colorectal liver metastasis
148767|NCT02642952|arterial stiffness, central hemodynamics|arterial stiffness, central hemodynamics
148768|NCT02642926|menorrhagia|menorrhagia
148769|NCT02642926|higham PBAC score|higham pbac score
148770|NCT02642926|endometrial ablation|endometrial ablation
148771|NCT02642926|bipolar energy|bipolar energy
148772|NCT02642926|monopolar energy|monopolar energy
148773|NCT02642913|Enzalutamide|enzalutamide
148774|NCT02642913|Sorafenib|sorafenib
148775|NCT02642913|15-279|15-279
148776|NCT02642900|Complete denture|complete denture
148777|NCT02642900|Candida spp|candida spp
148778|NCT02642900|Photodynamic therapy|photodynamic therapy
148779|NCT02642887|gingival recession|gingival recession
148780|NCT02642887|tunnel technique|tunnel technique
148781|NCT02642887|Miller Class I and II|miller class i and ii
148782|NCT02642835|mesh|mesh
148783|NCT02642835|pelvic organ prolapse|pelvic organ prolapse
148784|NCT02642822|Cytomegalovirus|cytomegalovirus
148785|NCT02642796|Percutaneous Electric Nerve Stimulation|percutaneous electric nerve stimulation
148786|NCT02642796|Lumbosacral plexus|lumbosacral plexus
148787|NCT02642796|surgical wound|surgical wound
148788|NCT02642796|postoperative analgesia|postoperative analgesia
148789|NCT02642796|transcutaneous electrical stimulation|transcutaneous electrical stimulation
148790|NCT02642783|laxatives|laxatives
148791|NCT02642783|sensory evaluation|sensory evaluation
148792|NCT02642783|acceptability|acceptability
148793|NCT02642783|colonoscopy|colonoscopy
148794|NCT02642770|Transesophageal echocardiography, Speckle tracking strain|transesophageal echocardiography, speckle tracking strain
148795|NCT02642757|alcohol drinking|alcohol drinking
148796|NCT02642757|hazardous alcohol use|hazardous alcohol use
148797|NCT02642757|risky alcohol consumption|risky alcohol consumption
148798|NCT02642757|heavy alcohol consumption|heavy alcohol consumption
148799|NCT02642731|total knee arthroplasty|total knee arthroplasty
148800|NCT02642731|Kidney function|kidney function
148801|NCT02642731|Renal markers|renal markers
148802|NCT02642718|preemptive analgesia|preemptive analgesia
148803|NCT02642718|postoperative pain|postoperative pain
148804|NCT02642718|NSAIDs|nsaids
148805|NCT02642718|ketorolac|ketorolac
148806|NCT02642718|abdominal hysterectomy|abdominal hysterectomy
148807|NCT02642692|ACL reconstruction|acl reconstruction
148808|NCT02642692|Single bundle|single bundle
148809|NCT02642692|Clinical results|clinical results
148810|NCT02642692|Soccer players|soccer players
148811|NCT02642679|Split-thickness skin graft, donor site, chitosan, dressing|split-thickness skin graft, donor site, chitosan, dressing
148812|NCT02642666|Attention|attention
148813|NCT02642666|Hyperactivity|hyperactivity
148814|NCT02642666|Impulsivity|impulsivity
148815|NCT02642666|Yoga|yoga
148816|NCT02642666|Preschool|preschool
148817|NCT02642653|Fra(X) Syndrome|fra(x) syndrome
148818|NCT02642653|Trinucleotide Repeat Expansion|trinucleotide repeat expansion
148819|NCT02642653|Fragile X Syndrome|fragile x syndrome
148820|NCT02642653|Fragile X Mental Retardation Syndrome|fragile x mental retardation syndrome
148821|NCT02642653|Intellectual Disability|intellectual disability
148822|NCT02642653|Parent Implemented Language Intervention (PILI)|parent implemented language intervention (pili)
148823|NCT02642653|FXS|fxs
148824|NCT02642653|Mental Retardation, X-linked|mental retardation, x-linked
148825|NCT02642653|Genetic Diseases, X-linked|genetic diseases, x-linked
148826|NCT02642653|Neurobehavioral Manifestations|neurobehavioral manifestations
148827|NCT02642653|Chromosome Disorders|chromosome disorders
148828|NCT02642601|indomethacin, ICSI, difficult embryo transfer|indomethacin, icsi, difficult embryo transfer
148829|NCT02642562|Intravenous iron|intravenous iron
148830|NCT02642562|PROBE design|probe design
148831|NCT02642536|Veteran|veteran
148832|NCT02642523|natriuretic peptide|natriuretic peptide
148833|NCT02642523|insulin|insulin
148834|NCT02642523|lipolysis|lipolysis
148835|NCT02642523|hormones|hormones
148836|NCT02642523|metabolism|metabolism
148837|NCT02642497|postoperative analgesia|postoperative analgesia
148838|NCT02642497|ketamine|ketamine
148839|NCT02642497|total thyroidectomy|total thyroidectomy
148840|NCT02642471|sentinel lymph node|sentinel lymph node
148841|NCT02642471|pelvic lymphadenectomy|pelvic lymphadenectomy
148842|NCT02642471|cervical carcinoma|cervical carcinoma
148843|NCT02642471|surgery|surgery
148844|NCT02642471|radiotherapy|radiotherapy
148845|NCT02642445|Renal sympathetic denervation;hypertension|renal sympathetic denervation;hypertension
148846|NCT02642432|HCV Genotype 1|hcv genotype 1
148847|NCT02642432|HCV Genotype 4|hcv genotype 4
148848|NCT02642432|HCV Genotype 2|hcv genotype 2
148849|NCT02642432|Cirrhotic|cirrhotic
148850|NCT02642432|Interferon-Free|interferon-free
148851|NCT02642432|Compensated Cirrhosis|compensated cirrhosis
148852|NCT02642432|HCV Genotype 5|hcv genotype 5
148853|NCT02642432|Hepatitis C|hepatitis c
148854|NCT02642432|HCV Genotype 6|hcv genotype 6
148855|NCT02642393|SURE-PD3|sure-pd3
148856|NCT02642393|Parkinson's disease|parkinson's disease
148857|NCT02642393|PD|pd
148858|NCT02642393|Inosine|inosine
148859|NCT02642393|Urate|urate
148860|NCT02642393|Parkinson Study Group (PSG)|parkinson study group (psg)
148861|NCT02642380|ITP|itp
148862|NCT02642380|high-dose dexamethasone|high-dose dexamethasone
148863|NCT02642328|VO2Max|vo2max
148864|NCT02642328|Aerobic Exercise|aerobic exercise
148865|NCT02642328|Physical Conditioning|physical conditioning
148866|NCT02642302|VO2Max|vo2max
148867|NCT02642302|Aerobic Exercise|aerobic exercise
148868|NCT02642302|Physical Conditioning|physical conditioning
148869|NCT02642289|Probiotics|probiotics
148870|NCT02642276|exercise training|exercise training
148871|NCT02642250|safety|safety
148872|NCT02642250|efficacy|efficacy
148873|NCT02642237|Fluenz|fluenz
148874|NCT02642237|innate immune response|innate immune response
148875|NCT02642237|endotoxin tolerance|endotoxin tolerance
148876|NCT02642237|priming|priming
148877|NCT02642224|Violence|violence
148878|NCT02642224|firearm|firearm
148879|NCT02642224|guns|guns
148880|NCT02642224|homicide|homicide
148881|NCT02642224|trauma|trauma
148882|NCT02642224|injury|injury
148883|NCT02642198|NiBP|nibp
148884|NCT02642185|microwave|microwave
148885|NCT02642185|ablation|ablation
148886|NCT02642185|resection|resection
148887|NCT02642185|liver|liver
148888|NCT02642185|colorectal|colorectal
148889|NCT02642185|survival|survival
148890|NCT02642185|metastasis|metastasis
148891|NCT02642172|Inulin, OFS (oligofructose)|inulin, ofs (oligofructose)
148892|NCT02642107|nasopharyngeal carcinoma|nasopharyngeal carcinoma
148893|NCT02642107|elective neck irradiation|elective neck irradiation
148894|NCT02642081|NSAIDs|nsaids
148895|NCT02642081|Heart failure|heart failure
148896|NCT02642081|Acute kidney injury|acute kidney injury
148897|NCT02642068|Drug-naïve Adult ADHD|drug-naïve adult adhd
148898|NCT02642068|Neuropsychology|neuropsychology
148899|NCT02642068|Neurophysiology|neurophysiology
148900|NCT02642068|Neuroimaging|neuroimaging
148901|NCT02642068|Follow-up|follow-up
148902|NCT02642055|ADHD|adhd
148903|NCT02642055|Neurofeedback|neurofeedback
148904|NCT02642055|Biofeedback|biofeedback
148905|NCT02642055|Neuro+|neuro+
148906|NCT02642055|Go/no-go|go/no-go
148907|NCT02642055|Attention training|attention training
148908|NCT02642029|time perception|time perception
148909|NCT02642029|executive function|executive function
148910|NCT02642029|psychosis|psychosis
148911|NCT02642029|mood symptoms|mood symptoms
148912|NCT02642016|KTN0158|ktn0158
148913|NCT02642016|Advanced Cancer|advanced cancer
148914|NCT02642016|Phase 1|phase 1
148915|NCT02642016|Monoclonal Antibody|monoclonal antibody
148916|NCT02642016|Safety and Pharmacokinetics|safety and pharmacokinetics
148917|NCT02641925|Metabolic syndrome|metabolic syndrome
148918|NCT02641925|gastric cancer|gastric cancer
148919|NCT02641925|omentectomy|omentectomy
148920|NCT02641899|Adult|adult
148921|NCT02641899|Male|male
148922|NCT02641899|Female|female
148923|NCT02641899|Volunteers|volunteers
148924|NCT02641886|traditional Chinese medicine granules|traditional chinese medicine granules
148925|NCT02641886|Cognitive Impairment|cognitive impairment
148926|NCT02641886|Acute cerebral infraction|acute cerebral infraction
148927|NCT02641886|prevention|prevention
148928|NCT02641873|metastatic Colorectal Cancer|metastatic colorectal cancer
148929|NCT02641873|mCRC|mcrc
148930|NCT02641847|triple negative breast cancer|triple negative breast cancer
148931|NCT02641847|mRNA-lncRNA signature|mrna-lncrna signature
148932|NCT02641847|chemotherapy|chemotherapy
148933|NCT02641847|high risk|high risk
148934|NCT02641834|diet|diet
148935|NCT02641834|vegetarian|vegetarian
148936|NCT02641834|cardiovascular risk|cardiovascular risk
148937|NCT02641795|cochlear implantation|cochlear implantation
148938|NCT02641795|robotics|robotics
148939|NCT02641795|image guidance|image guidance
148940|NCT02641782|High Risk Neuroblastoma|high risk neuroblastoma
148941|NCT02641756|HIV reservoir|hiv reservoir
148942|NCT02641756|phylogenetic analysis|phylogenetic analysis
148943|NCT02641756|sequencing|sequencing
148944|NCT02641730|Guselkumab|guselkumab
148945|NCT02641730|CNTO 1959|cnto 1959
148946|NCT02641730|Placebo|placebo
148947|NCT02641730|Palmoplantar Pustulosis|palmoplantar pustulosis
148948|NCT02641717|patient-collected|patient-collected
148949|NCT02641717|self-collected|self-collected
148950|NCT02641717|vaginitis|vaginitis
148951|NCT02641717|vaginosis, bacterial|vaginosis, bacterial
148952|NCT02641717|candidiasis|candidiasis
148953|NCT02641717|trichomonas|trichomonas
148954|NCT02641717|vaginal discharge|vaginal discharge
148955|NCT02641678|Atrial Fibrillation|atrial fibrillation
148956|NCT02641678|stroke|stroke
148957|NCT02641678|implantable cardiac monitor|implantable cardiac monitor
148958|NCT02641678|automated ECG analysis|automated ecg analysis
148959|NCT02641652|paroxysmal hypertension|paroxysmal hypertension
148960|NCT02641652|pseudopheochromocytoma|pseudopheochromocytoma
148961|NCT02641626|cardiac arrest|cardiac arrest
148962|NCT02641626|survival|survival
148963|NCT02641626|neurologic prognosis|neurologic prognosis
148964|NCT02641626|coronariography|coronariography
148965|NCT02641626|hypothermia|hypothermia
148966|NCT02641587|Smoking|smoking
148967|NCT02641587|Combustible cigarette|combustible cigarette
148968|NCT02641587|Reduced exposure|reduced exposure
148970|NCT02641587|Ambulatory|ambulatory
148971|NCT02641587|Carbon Heated Tobacco Product|carbon heated tobacco product
148972|NCT02641561|Pancreatitis|pancreatitis
148973|NCT02641561|ERCP|ercp
148974|NCT02641561|Indomethacin|indomethacin
148975|NCT02641561|Lactated ringer's|lactated ringer's
148976|NCT02641522|T1D|t1d
148977|NCT02641522|Type 1 diabetes|type 1 diabetes
148978|NCT02641496|Obstructive Sleep Apnea|obstructive sleep apnea
148979|NCT02641496|PTSD|ptsd
148980|NCT02641496|Posttraumatic Stress Disorder|posttraumatic stress disorder
148981|NCT02641496|Cognitive Behavioral Therapy|cognitive behavioral therapy
148982|NCT02641496|Continuous Positive Airway Pressure|continuous positive airway pressure
148983|NCT02641496|CPAP|cpap
148984|NCT02641496|Cognition|cognition
148985|NCT02641496|Memory|memory
148986|NCT02641496|Quality of Life|quality of life
148987|NCT02641496|Self Efficacy|self efficacy
148988|NCT02641496|CBT|cbt
148989|NCT02641496|OSA|osa
148990|NCT02641496|Sleep Apnea|sleep apnea
148991|NCT02641496|Education|education
148992|NCT02641496|Psychotherapy|psychotherapy
148993|NCT02641496|Post Traumatic Stress Disorder|post traumatic stress disorder
148994|NCT02641496|Post-Traumatic Stress Disorder|post-traumatic stress disorder
148995|NCT02641496|Therapy|therapy
148996|NCT02641457|rubeosis iridis|rubeosis iridis
148997|NCT02641457|glaucoma|glaucoma
148998|NCT02641457|ranibizumab|ranibizumab
148999|NCT02641457|aflibercept|aflibercept
149000|NCT02641431|radiofrequency ablation|radiofrequency ablation
149001|NCT02641431|mapping|mapping
149002|NCT02641431|sudden death|sudden death
149003|NCT02641431|syncope|syncope
149004|NCT02641418|Exercise|exercise
149005|NCT02641405|Gait analysis|gait analysis
149006|NCT02641405|Proprioceptive focal stimulation|proprioceptive focal stimulation
149007|NCT02641405|Parkinson|parkinson
149008|NCT02641392|Crohn's Disease|crohn's disease
149009|NCT02641392|GED 0301|ged 0301
149010|NCT02641392|Mongersen|mongersen
149011|NCT02641392|Safety|safety
149012|NCT02641392|IBD|ibd
149013|NCT02641353|Apremilast|apremilast
149014|NCT02641353|Healthy volunteers|healthy volunteers
149015|NCT02641353|Bioavailability|bioavailability
149016|NCT02641353|Food effect|food effect
149017|NCT02641353|Pharmacokinetic|pharmacokinetic
149018|NCT02641327|Inhospital patients|inhospital patients
149019|NCT02641314|high risk neuroblastoma|high risk neuroblastoma
149020|NCT02641301|obesity|obesity
149021|NCT02641301|Roux-en-Y-gastric bypass|roux-en-y-gastric bypass
149022|NCT02641301|pharmacokinetics|pharmacokinetics
149023|NCT02641301|Pain|pain
149024|NCT02641301|morphine|morphine
149025|NCT02641275|Parental stress|parental stress
149026|NCT02641275|Muscular Dystrophies|muscular dystrophies
149027|NCT02641275|Coping|coping
149028|NCT02641275|Parental support|parental support
149029|NCT02641262|Myocardial Infarction|myocardial infarction
149030|NCT02641262|Angioplasty, Balloon, Coronary|angioplasty, balloon, coronary
149031|NCT02641262|Drug Therapy|drug therapy
149032|NCT02641236|Hematopoietic Stem Cell Transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
149033|NCT02641236|Acute GVH Disease|acute gvh disease
149034|NCT02641210|Chronic periodontitis|chronic periodontitis
149035|NCT02641210|Hepcidin|hepcidin
149036|NCT02641210|Hemoglobin|hemoglobin
149037|NCT02641210|Inflammation|inflammation
149038|NCT02641197|flow-mediated dilation|flow-mediated dilation
149039|NCT02641197|AngioDefender|angiodefender
149040|NCT02641197|device precision|device precision
149041|NCT02641197|repeatability|repeatability
149042|NCT02641197|reproducibility|reproducibility
149043|NCT02641197|cardiovascular diseases|cardiovascular diseases
149044|NCT02641184|Myocardial Infarction|myocardial infarction
149045|NCT02641184|Cardiovascular Diseases|cardiovascular diseases
149046|NCT02641184|Heart Diseases|heart diseases
149047|NCT02641184|Infarction|infarction
149048|NCT02641184|Diabetes|diabetes
149049|NCT02641158|HIV|hiv
149050|NCT02641158|Hepatitis C|hepatitis c
149051|NCT02641158|Substance users|substance users
149052|NCT02641158|Drug users|drug users
149053|NCT02641145|amyloidosis|amyloidosis
149054|NCT02641145|F-18 florbetapir|f-18 florbetapir
149055|NCT02641145|Positron emission tomography|positron emission tomography
149056|NCT02641145|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
149057|NCT02641119|Albumin|albumin
149058|NCT02641119|Resuscitation|resuscitation
149059|NCT02641106|Telemedicine|telemedicine
149060|NCT02641106|Mobile Phone|mobile phone
149061|NCT02641106|Adherence|adherence
149062|NCT02641106|Latent Tuberculosis Infection|latent tuberculosis infection
149063|NCT02641106|Directly Observed Therapy|directly observed therapy
149064|NCT02641106|Video DOT|video dot
149065|NCT02641041|Japanese|japanese
149066|NCT02641041|Single Ascending Dose (SAD)|single ascending dose (sad)
149067|NCT02641041|Multiple Ascending Dose (MAD)|multiple ascending dose (mad)
149068|NCT02641015|UTI|uti
149069|NCT02641002|CC-90002|cc-90002
149070|NCT02641002|Monoclonal|monoclonal
149071|NCT02641002|Antibody|antibody
149072|NCT02641002|CD47|cd47
149073|NCT02641002|Hematologic Cancers|hematologic cancers
149074|NCT02641002|Acute Myeloid Leukemia|acute myeloid leukemia
149075|NCT02641002|AML|aml
149076|NCT02641002|Myelodysplastic syndrome|myelodysplastic syndrome
149077|NCT02641002|MDS|mds
149078|NCT02641002|Blood disorder|blood disorder
149079|NCT02640989|Influenza Vaccine|influenza vaccine
149080|NCT02640989|Safety|safety
149081|NCT02640989|Immunogenicity|immunogenicity
149082|NCT02640976|in vitro fertilization|in vitro fertilization
149083|NCT02640976|controlled ovarian hyperstimulation|controlled ovarian hyperstimulation
149084|NCT02640976|poor ovarian response|poor ovarian response
149085|NCT02640976|estrogen receptor 2 gene polymorphism|estrogen receptor 2 gene polymorphism
149086|NCT02640976|follicle stimulating hormone receptor gene polymorphism|follicle stimulating hormone receptor gene polymorphism
149087|NCT02640976|anti-mullerian hormone|anti-mullerian hormone
149088|NCT02640963|exercise|exercise
149089|NCT02640963|older adults|older adults
149090|NCT02640963|physical performance|physical performance
149091|NCT02640937|Staphylococcus epidermidis|staphylococcus epidermidis
149092|NCT02640937|biofilm formation|biofilm formation
149093|NCT02640937|antibiotic resistance|antibiotic resistance
149094|NCT02640937|Orthopaedic device related infections|orthopaedic device related infections
149095|NCT02640937|risk factor|risk factor
149096|NCT02640924|Hepatocellular carcinoma|hepatocellular carcinoma
149097|NCT02640924|Proton therapy|proton therapy
149098|NCT02640924|Radiation therapy|radiation therapy
149099|NCT02640924|Switching control radiofrequency ablation|switching control radiofrequency ablation
149100|NCT02640872|sarcopenia|sarcopenia
149101|NCT02640872|sarcopenic obesity|sarcopenic obesity
149102|NCT02640872|osteoporosis|osteoporosis
149103|NCT02640872|fracture|fracture
149104|NCT02640872|cardiovascular disease|cardiovascular disease
149105|NCT02640872|mortality|mortality
149106|NCT02640846|Levosimendan|levosimendan
149107|NCT02640846|Milrinone|milrinone
149108|NCT02640846|Myocardial strain|myocardial strain
149109|NCT02640846|Septic cardiomyopathy|septic cardiomyopathy
149110|NCT02640833|Refractory Lymphoma|refractory lymphoma
149111|NCT02640833|Relapsed Leukemia|relapsed leukemia
149112|NCT02640820|HPV|hpv
149113|NCT02640820|Verruca Vulgaris|verruca vulgaris
149114|NCT02640807|sepsis lymphocytopenia IL-7|sepsis lymphocytopenia il-7
149115|NCT02640807|immune reconstitution|immune reconstitution
149116|NCT02640794|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
149117|NCT02640794|Antithrombotic treatment|antithrombotic treatment
149118|NCT02640794|Clopidogrel|clopidogrel
149119|NCT02640794|Aspirin/acetylsalicylic acid|aspirin/acetylsalicylic acid
149120|NCT02640794|Myocardial Infarction|myocardial infarction
149121|NCT02640794|Ischemic stroke|ischemic stroke
149122|NCT02640794|Major bleeding|major bleeding
149123|NCT02640768|in-hospital diabetes|in-hospital diabetes
149124|NCT02640768|clinical and management model|clinical and management model
149125|NCT02640755|Radiolabelled|radiolabelled
149126|NCT02640729|Lewy body dementia|lewy body dementia
149127|NCT02640729|Dementia with Lewy bodies|dementia with lewy bodies
149128|NCT02640729|Parkinson's disease dementia|parkinson's disease dementia
149129|NCT02640729|Lewy bodies|lewy bodies
149130|NCT02640729|Visual hallucinations|visual hallucinations
149131|NCT02640690|Stress Disorders, Post-traumatic|stress disorders, post-traumatic
149132|NCT02640690|Yoga|yoga
149133|NCT02640690|Cognitive Therapy|cognitive therapy
149134|NCT02640690|Chronic Pain|chronic pain
149135|NCT02640690|Veterans|veterans
149136|NCT02640690|cytokines|cytokines
149137|NCT02640690|acoustic startle reflex|acoustic startle reflex
149138|NCT02640664|open-label, long-term, extension study|open-label, long-term, extension study
149139|NCT02640664|intravitreal ranibizumab|intravitreal ranibizumab
149140|NCT02640664|laser ablation therapy|laser ablation therapy
149141|NCT02640664|retinopathy of prematurity|retinopathy of prematurity
149142|NCT02640664|preterm infants|preterm infants
149143|NCT02640664|RAINBOW|rainbow
149144|NCT02640638|Racial disparities|racial disparities
149145|NCT02640625|HIV|hiv
149146|NCT02640625|Probiotics|probiotics
149147|NCT02640625|Microbiota|microbiota
149148|NCT02640625|Mucosal immunology|mucosal immunology
149149|NCT02640625|Gut biopsy|gut biopsy
149150|NCT02640599|Vestibular|vestibular
149151|NCT02640599|Rehabilitation|rehabilitation
149152|NCT02640560|Children|children
149153|NCT02640560|Allergy|allergy
149154|NCT02640560|Peanuts|peanuts
149155|NCT02640560|Hazelnuts|hazelnuts
149156|NCT02640560|Walnuts|walnuts
149157|NCT02640560|Mollusks|mollusks
149158|NCT02640560|Shellfish|shellfish
149159|NCT02640560|Food|food
149160|NCT02640547|Fibrosis|fibrosis
149161|NCT02640547|Chronic Hepatitis C|chronic hepatitis c
149162|NCT02640547|Cirrhosis|cirrhosis
149163|NCT02640547|Work Ability|work ability
149164|NCT02640547|Dasabuvir|dasabuvir
149165|NCT02640547|Quality of Life|quality of life
149166|NCT02640547|Observational Study|observational study
149167|NCT02640547|Paritaprevir/r/Ombitasvir|paritaprevir/r/ombitasvir
149168|NCT02640534|Prostate cancer|prostate cancer
149169|NCT02640534|Cancer of the prostate|cancer of the prostate
149170|NCT02640534|Metformin|metformin
149171|NCT02640534|Enzalutamide|enzalutamide
149172|NCT02640534|Xtandi|xtandi
149173|NCT02640534|castration resistant prostate cancer|castration resistant prostate cancer
149174|NCT02640534|phase II|phase ii
149175|NCT02640534|Androgen deprivation therapy|androgen deprivation therapy
149176|NCT02640495|Treatment Efficacy|treatment efficacy
149177|NCT02640495|drug resistance|drug resistance
149178|NCT02640495|Artemisinin|artemisinin
149179|NCT02640482|Treatment-Naive|treatment-naive
149180|NCT02640482|Hepatitis C Virus Genotype 2|hepatitis c virus genotype 2
149181|NCT02640482|Sofosbuvir (SOF)-Experienced|sofosbuvir (sof)-experienced
149182|NCT02640482|Treatment-Experienced|treatment-experienced
149183|NCT02640482|Non-cirrhotic|non-cirrhotic
149184|NCT02640469|chlorhexidine|chlorhexidine
149185|NCT02640469|sterility|sterility
149186|NCT02640469|sterile hands|sterile hands
149187|NCT02640456|retropharyngeal abscess|retropharyngeal abscess
149188|NCT02640456|parapharyngeal abscess|parapharyngeal abscess
149189|NCT02640456|peritonsillar abscess|peritonsillar abscess
149190|NCT02640456|bacteriology|bacteriology
149191|NCT02640456|Fusobacterium necrophorum|fusobacterium necrophorum
149192|NCT02640417|Nucleotides (uridine, cytidine)|nucleotides (uridine, cytidine)
149193|NCT02640417|Vitamin B1|vitamin b1
149194|NCT02640417|Vitamin B6|vitamin b6
149195|NCT02640417|Vitamin B12|vitamin b12
149196|NCT02640404|Meningitis|meningitis
149197|NCT02640404|Meningococcal Meningitis|meningococcal meningitis
149198|NCT02640404|Meningococcal Infections|meningococcal infections
149199|NCT02640404|Menactra®|menactra®
149200|NCT02640404|Meningococcal Vaccine|meningococcal vaccine
149201|NCT02640391|Ulcerative colitis|ulcerative colitis
149202|NCT02640391|fecal calprotectin|fecal calprotectin
149203|NCT02640391|mucosal healing|mucosal healing
149204|NCT02640365|cancer|cancer
149205|NCT02640365|GERCOR|gercor
149206|NCT02640365|unresectable|unresectable
149207|NCT02640365|MM-398|mm-398
149208|NCT02640365|CPT-11|cpt-11
149209|NCT02640365|colorectal|colorectal
149210|NCT02640365|non colorectal|non colorectal
149211|NCT02640326|Urinary Catheterization|urinary catheterization
149212|NCT02640326|Randomized Controlled Trial|randomized controlled trial
149213|NCT02640326|Thoracic Surgery, Video-Assisted|thoracic surgery, video-assisted
149214|NCT02640326|Quality Improvement|quality improvement
149215|NCT02640326|Evidence-Based Practice|evidence-based practice
149216|NCT02640326|Post-operative complications|post-operative complications
149217|NCT02640313|18F-fluormethylcholine|18f-fluormethylcholine
149218|NCT02640313|[F18] choline|[f18] choline
149219|NCT02640313|[F18] fluormethylcholine|[f18] fluormethylcholine
149220|NCT02640300|antipsychotics, clozapine, schizophrenia, switching strategy|antipsychotics, clozapine, schizophrenia, switching strategy
149221|NCT02640274|Practise Patterns, Nurses'|practise patterns, nurses'
149222|NCT02640274|Directive Counseling|directive counseling
149223|NCT02640274|Self Care|self care
149224|NCT02640261|r-hLH|r-hlh
149225|NCT02640261|Cytokines|cytokines
149226|NCT02640261|Follicular Fluid|follicular fluid
149227|NCT02640235|Hemostasis|hemostasis
149228|NCT02640235|Oxidized Cellulose Strip|oxidized cellulose strip
149229|NCT02640235|Traumacel|traumacel
149230|NCT02640235|Traumastem|traumastem
149231|NCT02640235|Cardiothoracic Surgery|cardiothoracic surgery
149232|NCT02640235|General Surgery|general surgery
149233|NCT02640235|Vascular Surgery|vascular surgery
149234|NCT02640196|Laryngoscope|laryngoscope
149235|NCT02640196|Macintosh|macintosh
149236|NCT02640196|Glidescope|glidescope
149237|NCT02640196|King Vision|king vision
149238|NCT02640196|Airtraq|airtraq
149239|NCT02640196|Double Lumen Tube|double lumen tube
149240|NCT02640157|interferon free|interferon free
149241|NCT02640157|Hepatitis C|hepatitis c
149242|NCT02640157|daclatasvir|daclatasvir
149243|NCT02640157|Sovaldi|sovaldi
149244|NCT02640157|HCV|hcv
149245|NCT02640157|Hepatitis C Virus|hepatitis c virus
149246|NCT02640157|Hepatitis C Genotype 3|hepatitis c genotype 3
149247|NCT02640157|Hep C|hep c
149248|NCT02640157|sofosbuvir|sofosbuvir
149249|NCT02640157|Chronic Hepatitis C|chronic hepatitis c
149250|NCT02640157|Daklinza|daklinza
149251|NCT02640144|Hyaluronic acid|hyaluronic acid
149252|NCT02640144|Knee arthroscopy|knee arthroscopy
149253|NCT02640144|pain reduction|pain reduction
149254|NCT02640144|swelling|swelling
149255|NCT02640144|osteoarthritis|osteoarthritis
149256|NCT02640144|cartilage lesion|cartilage lesion
149257|NCT02640144|rehabilitation following knee arthroscopy|rehabilitation following knee arthroscopy
149258|NCT02640144|Hyaluronic acid injection|hyaluronic acid injection
149259|NCT02640131|prostate cancer|prostate cancer
149260|NCT02640131|radical prostatectomy|radical prostatectomy
149261|NCT02640131|survivorship|survivorship
149262|NCT02640131|quality of life|quality of life
149263|NCT02640131|erectile dysfunction|erectile dysfunction
149264|NCT02640131|sexual dysfunction|sexual dysfunction
149265|NCT02640131|feasibility study|feasibility study
149266|NCT02640079|Cognitive behavioral therapy|cognitive behavioral therapy
149267|NCT02640079|Laboratory pain responsivity|laboratory pain responsivity
149268|NCT02640014|Food allergy|food allergy
149269|NCT02640014|Health-related quality of life (HRQL)|health-related quality of life (hrql)
149270|NCT02640014|Quality-adjusted life-years (QALYs)|quality-adjusted life-years (qalys)
149271|NCT02640014|Oral immunotherapy (OIT)|oral immunotherapy (oit)
149272|NCT02640014|Cow´s milk allergy (CMA)|cow´s milk allergy (cma)
149273|NCT02640014|Milk oral immunotherapy (MOIT)|milk oral immunotherapy (moit)
149274|NCT02639988|type 2 diabetes mellitus|type 2 diabetes mellitus
149275|NCT02639988|Rheumatoid arthritis|rheumatoid arthritis
149276|NCT02639975|Adenosine A3 receptor antagonist|adenosine a3 receptor antagonist
149277|NCT02639962|culprit lesion|culprit lesion
149278|NCT02639962|arteriosclerosis|arteriosclerosis
149279|NCT02639962|cardiac CT|cardiac ct
149280|NCT02639923|TBI|tbi
149281|NCT02639923|microRNA|microrna
149282|NCT02639923|S-100B|s-100b
149283|NCT02639910|CD19|cd19
149284|NCT02639910|MOR208|mor208
149285|NCT02639910|MOR00208|mor00208
149286|NCT02639910|CLL|cll
149287|NCT02639910|SLL|sll
149288|NCT02639910|COSMOS|cosmos
149289|NCT02639871|Huntington disease|huntington disease
149290|NCT02639871|Neuroimaging metabolic biomarker|neuroimaging metabolic biomarker
149291|NCT02639832|Triple Negative Breast Cancer|triple negative breast cancer
149292|NCT02639832|Breast Cancer|breast cancer
149293|NCT02639832|Natural Killer Cells|natural killer cells
149294|NCT02639832|BRCA Mutation|brca mutation
149295|NCT02639819|Intracerebral Hemorrhage|intracerebral hemorrhage
149296|NCT02639819|Stroke|stroke
149297|NCT02639819|Cerebrovascular|cerebrovascular
149298|NCT02639806|stroke|stroke
149299|NCT02639806|endovascular|endovascular
149300|NCT02639806|thrombectomy|thrombectomy
149301|NCT02639806|ischemic stroke|ischemic stroke
149302|NCT02639806|general anesthetic|general anesthetic
149303|NCT02639806|local anesthetic|local anesthetic
149304|NCT02639806|recanalization|recanalization
149305|NCT02639793|arrhythmias, quality of life|arrhythmias, quality of life
149306|NCT02639767|Pemetrexed|pemetrexed
149307|NCT02639767|Cisplatin|cisplatin
149308|NCT02639767|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
149309|NCT02639767|15-304|15-304
149310|NCT02639741|Melatonin|melatonin
149311|NCT02639741|Vitamin C|vitamin c
149312|NCT02639741|Morphine consumption|morphine consumption
149313|NCT02639728|Bowel surgery|bowel surgery
149314|NCT02639728|Postoperative bowel recovery|postoperative bowel recovery
149315|NCT02639702|Clozapine|clozapine
149316|NCT02639702|Dosing|dosing
149317|NCT02639702|Once daily|once daily
149318|NCT02639702|Regimen|regimen
149319|NCT02639702|Schizophrenia|schizophrenia
149320|NCT02639689|Deficits of foot relievers of central origin|deficits of foot relievers of central origin
149321|NCT02639689|Walkaide|walkaide
149322|NCT02639676|Infant|infant
149323|NCT02639676|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
149324|NCT02639676|Premature|premature
149325|NCT02639650|gestational trophoblastic tumor|gestational trophoblastic tumor
149326|NCT02639650|paclitaxel|paclitaxel
149327|NCT02639650|cisplatin|cisplatin
149328|NCT02639650|carboplatin|carboplatin
149329|NCT02639650|chemotherapy|chemotherapy
149330|NCT02639637|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
149331|NCT02639637|Sitagliptin|sitagliptin
149332|NCT02639637|Dipeptidyl Peptidase IV Inhibitors|dipeptidyl peptidase iv inhibitors
149333|NCT02639637|Angiotensin Converting Enzyme Inhibitors|angiotensin converting enzyme inhibitors
149334|NCT02639637|Enalaprilat|enalaprilat
149335|NCT02639637|Neuropeptide Y|neuropeptide y
149336|NCT02639624|hemodialysis|hemodialysis
149337|NCT02639624|kidney|kidney
149338|NCT02639624|dialysis|dialysis
149339|NCT02639611|Breast Expanders|breast expanders
149340|NCT02639598|chronic migraine|chronic migraine
149341|NCT02639598|prophylaxis|prophylaxis
149342|NCT02639598|flunarizine|flunarizine
149343|NCT02639598|topiramate|topiramate
149344|NCT02639585|daclatasvir|daclatasvir
149345|NCT02639585|asunaprevir|asunaprevir
149346|NCT02639533|fibromyalgia|fibromyalgia
149347|NCT02639533|pregabalin|pregabalin
149348|NCT02639533|cortical excitability|cortical excitability
149349|NCT02639533|functional near infrared spectroscopy|functional near infrared spectroscopy
149350|NCT02639520|Uncomplicated urinary tract infection|uncomplicated urinary tract infection
149351|NCT02639481|traumatic brain injury|traumatic brain injury
149352|NCT02639481|stroke|stroke
149353|NCT02639481|disorders of consciousness|disorders of consciousness
149354|NCT02639481|rehabilitation|rehabilitation
149355|NCT02639481|robotic rehabilitation device|robotic rehabilitation device
149356|NCT02639416|severe acute malnutrition|severe acute malnutrition
149357|NCT02639416|polymeric therapeutic formula|polymeric therapeutic formula
149358|NCT02639416|elemental therapeutic formula|elemental therapeutic formula
149359|NCT02639403|Rectal cancer|rectal cancer
149360|NCT02639403|Radiotherapy|radiotherapy
149361|NCT02639403|Occlusion|occlusion
149362|NCT02639390|Robotics|robotics
149363|NCT02639390|upper extremity|upper extremity
149364|NCT02639390|neurorehabilitation|neurorehabilitation
149365|NCT02639390|movement therapy|movement therapy
149366|NCT02639377|Dental Implantation|dental implantation
149367|NCT02639377|Chlorhexidine gluconate|chlorhexidine gluconate
149368|NCT02639338|Chronic|chronic
149369|NCT02639325|Brain Tumor|brain tumor
149370|NCT02639325|Brain Cancer|brain cancer
149371|NCT02639325|Seizure Disorder|seizure disorder
149372|NCT02639325|Seizures|seizures
149373|NCT02639312|Cranofacial|cranofacial
149374|NCT02639312|Microsomia|microsomia
149375|NCT02639312|Mandibular|mandibular
149376|NCT02639312|Facial Defects|facial defects
149377|NCT02639312|Hasburg Jaw|hasburg jaw
149378|NCT02639299|Subjects|subjects
149379|NCT02639299|Venipuncture|venipuncture
149380|NCT02639299|Research|research
149381|NCT02639299|Evaluate|evaluate
149382|NCT02639299|Recruit|recruit
149383|NCT02639286|Lipodystrophy|lipodystrophy
149384|NCT02639286|Hypertriglyceridemia|hypertriglyceridemia
149385|NCT02639273|Nalmefene|nalmefene
149386|NCT02639273|fMRI|fmri
149387|NCT02639273|Incentive Salience|incentive salience
149388|NCT02639273|Reward Processing|reward processing
149389|NCT02639273|Aversive Event Processing|aversive event processing
149390|NCT02639260|Nephrotic Syndrome|nephrotic syndrome
149391|NCT02639260|Glomerular Filtration Rate|glomerular filtration rate
149392|NCT02639260|Sialic Acid|sialic acid
149393|NCT02639260|Proteinuria|proteinuria
149394|NCT02639247|Chronic|chronic
149395|NCT02639208|Breast Cancer I|breast cancer i
149396|NCT02639208|Breast Cancer Stage II|breast cancer stage ii
149397|NCT02639208|Breast Cancer Stage III|breast cancer stage iii
149398|NCT02639182|Axitinib|axitinib
149399|NCT02639182|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
149400|NCT02639182|AGS-16C3F|ags-16c3f
149401|NCT02639169|music therapy|music therapy
149402|NCT02639169|Distress|distress
149403|NCT02639169|Mood|mood
149404|NCT02639169|HSCT|hsct
149405|NCT02639130|Gastric Inhibitory Polypeptide (GIP)|gastric inhibitory polypeptide (gip)
149406|NCT02639130|Glucagon-Like Peptide 1 (GLP-1)|glucagon-like peptide 1 (glp-1)
149407|NCT02639130|DPP-4 inhibition; Exendin [9-39]|dpp-4 inhibition; exendin [9-39]
149408|NCT02639130|Gastric emptying|gastric emptying
149409|NCT02639130|Glucagon|glucagon
149410|NCT02639130|Incretin|incretin
149411|NCT02639130|Insulin Secretion|insulin secretion
149412|NCT02639130|Normal glucose-tolerant|normal glucose-tolerant
149413|NCT02639117|basal cell carcinoma, photodynamic therapy, vismodegib|basal cell carcinoma, photodynamic therapy, vismodegib
149414|NCT02639104|neck pain|neck pain
149415|NCT02639104|cervical lordosis|cervical lordosis
149416|NCT02639104|long thoracic nerve|long thoracic nerve
149417|NCT02639091|Phase 1|phase 1
149418|NCT02639091|Solid tumors|solid tumors
149419|NCT02639091|Mesothelioma|mesothelioma
149420|NCT02639091|Lung cancer|lung cancer
149421|NCT02639091|Pemetrexed|pemetrexed
149422|NCT02639091|Cisplatin|cisplatin
149423|NCT02639078|Single ascending dose|single ascending dose
149424|NCT02639078|volunteers|volunteers
149425|NCT02639078|Phase 1|phase 1
149426|NCT02639078|first-in-human|first-in-human
149427|NCT02639078|TD-0714|td-0714
149428|NCT02639065|Durvalumab|durvalumab
149429|NCT02639065|MEDI4736|medi4736
149430|NCT02639065|PD-L1 inhibitor|pd-l1 inhibitor
149431|NCT02639052|Itch|itch
149432|NCT02639052|Botox|botox
149433|NCT02639052|Healthy Volunteers|healthy volunteers
149434|NCT02638987|Dry needling|dry needling
149435|NCT02638987|office workers|office workers
149436|NCT02638987|myofascial pain|myofascial pain
149437|NCT02638987|electromyography|electromyography
149438|NCT02638961|heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
149439|NCT02638961|physical therapy|physical therapy
149440|NCT02638961|exercise capacity|exercise capacity
149441|NCT02638961|quality of life|quality of life
149442|NCT02638935|Virtual Touch Tissue Imaging|virtual touch tissue imaging
149443|NCT02638935|VTIQ|vtiq
149444|NCT02638935|Elastography|elastography
149445|NCT02638935|Breast Cancer|breast cancer
149446|NCT02638935|BI-RADS|bi-rads
149447|NCT02638935|Differentiation of breast lesions|differentiation of breast lesions
149448|NCT02638935|Breast Lesion|breast lesion
149449|NCT02638909|Gastrointestinal malignancies|gastrointestinal malignancies
149450|NCT02638896|Ankylosing Spondylitis|ankylosing spondylitis
149451|NCT02638896|Etanercept|etanercept
149452|NCT02638896|Sulfasalazine|sulfasalazine
149453|NCT02638896|Efficacy|efficacy
149454|NCT02638896|Safety|safety
149455|NCT02638896|dose|dose
149456|NCT02638896|reduction|reduction
149457|NCT02638857|Recurrence Hepatocellular Carcinoma|recurrence hepatocellular carcinoma
149458|NCT02638857|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
149459|NCT02638857|Dendritic Cell -Precision Multiple Antigen T Cells|dendritic cell -precision multiple antigen t cells
149460|NCT02638857|Transcatheter Arterial Chemoembolization|transcatheter arterial chemoembolization
149461|NCT02638844|echocardiography|echocardiography
149462|NCT02638831|Pain|pain
149463|NCT02638831|Gonarthrosis|gonarthrosis
149464|NCT02638831|Low Back Pain|low back pain
149465|NCT02638831|Ketorolac Tromethamine|ketorolac tromethamine
149466|NCT02638831|Ketoprofen|ketoprofen
149467|NCT02638818|pancreaticoduodenectomy|pancreaticoduodenectomy
149468|NCT02638818|Whipple|whipple
149469|NCT02638779|Septic shock|septic shock
149470|NCT02638779|severe trauma|severe trauma
149471|NCT02638779|severe burn|severe burn
149472|NCT02638779|major surgery|major surgery
149473|NCT02638779|immunosuppression|immunosuppression
149474|NCT02638779|Healthcare-Associated Infections|healthcare-associated infections
149475|NCT02638766|metastatic|metastatic
149476|NCT02638766|unresectable|unresectable
149477|NCT02638766|KIT/PDGFR wild type GIST|kit/pdgfr wild type gist
149478|NCT02638753|non specific chronic low back pain|non specific chronic low back pain
149479|NCT02638753|education on pain neurophysiology|education on pain neurophysiology
149480|NCT02638753|education on pain biology|education on pain biology
149481|NCT02638753|education on pain neuroscience|education on pain neuroscience
149482|NCT02638753|hypnosis|hypnosis
149483|NCT02638727|vascular disease|vascular disease
149484|NCT02638727|endothelial function|endothelial function
149485|NCT02638727|L-Citrulline|l-citrulline
149486|NCT02638714|Optic Neuropathies|optic neuropathies
149487|NCT02638714|Stem Cell Therapy|stem cell therapy
149488|NCT02638675|financial health incentives|financial health incentives
149489|NCT02638675|physical activity|physical activity
149490|NCT02638675|behavioral economics|behavioral economics
149491|NCT02638675|randomized control trial|randomized control trial
149492|NCT02638675|workplace health|workplace health
149493|NCT02638649|lung ultrasound|lung ultrasound
149494|NCT02638636|Cognitive behavior therapy|cognitive behavior therapy
149495|NCT02638636|Randomized controlled trial|randomized controlled trial
149496|NCT02638636|Exposure therapy|exposure therapy
149497|NCT02638636|Fibromyalgia|fibromyalgia
149498|NCT02638623|Knee Arthroplasty|knee arthroplasty
149499|NCT02638623|Hip Arthroplasty|hip arthroplasty
149500|NCT02638584|Ilaprazole|ilaprazole
149501|NCT02638584|Gastric Adenoma|gastric adenoma
149502|NCT02638584|Early Gastric Cancer|early gastric cancer
149503|NCT02638584|Endoscopic Submucosal Dissection|endoscopic submucosal dissection
149504|NCT02638532|Fat Pad|fat pad
149505|NCT02638532|Fat Pad Atrophy|fat pad atrophy
149506|NCT02638532|Foot|foot
149507|NCT02638532|Feet|feet
149508|NCT02638532|Heel|heel
149509|NCT02638532|Forefoot|forefoot
149510|NCT02638506|Headaches, Migraines, Fentanyl|headaches, migraines, fentanyl
149511|NCT02638493|HIV|hiv
149512|NCT02638493|tenofovir-emtricitabine|tenofovir-emtricitabine
149513|NCT02638493|antiretroviral therapy|antiretroviral therapy
149514|NCT02638493|Prevention|prevention
149515|NCT02638493|tenofovir alafenamide|tenofovir alafenamide
149516|NCT02638454|Exercise|exercise
149517|NCT02638454|Anabolic Resistance|anabolic resistance
149518|NCT02638454|Skeletal Muscle|skeletal muscle
149519|NCT02638454|microRNA|microrna
149520|NCT02638441|psychological health|psychological health
149521|NCT02638441|women|women
149522|NCT02638441|anxiety|anxiety
149523|NCT02638441|depression|depression
149524|NCT02638415|HVPG|hvpg
149525|NCT02638402|glycosylation|glycosylation
149526|NCT02638402|mucin|mucin
149527|NCT02638402|receptor tyrosin kinases|receptor tyrosin kinases
149528|NCT02638402|ovarian cancer|ovarian cancer
149529|NCT02638402|endometrial cancer|endometrial cancer
149530|NCT02638376|Keraroconus|keraroconus
149531|NCT02638376|keratectasia|keratectasia
149532|NCT02638376|treatment|treatment
149533|NCT02638350|lung ultrasound|lung ultrasound
149534|NCT02638350|Pulmonary Edema|pulmonary edema
149535|NCT02638350|Respiratory Distress Syndrome|respiratory distress syndrome
149536|NCT02638337|Vulvo-vaginal Atrophy|vulvo-vaginal atrophy
149537|NCT02638337|menopause|menopause
149538|NCT02638259|Biosimilars|biosimilars
149539|NCT02638259|Rheumatoid Arthritis|rheumatoid arthritis
149540|NCT02638259|Etanercept|etanercept
149541|NCT02638233|CHC|chc
149542|NCT02638233|IVDA (intravenous drug abuse)|ivda (intravenous drug abuse)
149543|NCT02638233|Hepatitis C|hepatitis c
149544|NCT02638233|Sofosbuvir|sofosbuvir
149545|NCT02638233|Ledipasvir|ledipasvir
149546|NCT02638233|Opiate Substitution Therapy|opiate substitution therapy
149547|NCT02638220|Cerebrotendinous Xanthomatosis|cerebrotendinous xanthomatosis
149548|NCT02638220|CTX Prevalence Study|ctx prevalence study
149549|NCT02638220|CTX|ctx
149550|NCT02638220|Idiopathic Bilateral Cataracts|idiopathic bilateral cataracts
149551|NCT02638220|Cataracts|cataracts
149552|NCT02638220|Bilateral Cataracts|bilateral cataracts
149553|NCT02638220|Early-Onset Idiopathic Bilateral Cataracts|early-onset idiopathic bilateral cataracts
149554|NCT02638220|Observational Study|observational study
149555|NCT02638220|Ophthalmology|ophthalmology
149556|NCT02638207|Chronic Inflammatory Demyelinating Poly Neuropathy (CIDP)|chronic inflammatory demyelinating poly neuropathy (cidp)
149557|NCT02638194|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
149558|NCT02638194|smoking|smoking
149559|NCT02638194|secondhand smoke|secondhand smoke
149560|NCT02638181|matrix metalloproteinase 13|matrix metalloproteinase 13
149561|NCT02638181|tissue inhibitor of metalloproteinases 3|tissue inhibitor of metalloproteinases 3
149562|NCT02638181|calcium-sensing receptor|calcium-sensing receptor
149563|NCT02638181|trabecular meshwork|trabecular meshwork
149564|NCT02638181|open-angle glaucoma|open-angle glaucoma
149565|NCT02638142|loop diuretic|loop diuretic
149566|NCT02638142|heart failure|heart failure
149567|NCT02638142|renal dysfunction|renal dysfunction
149765|NCT02637206|GSK2894512|gsk2894512
149568|NCT02638142|congestion signs|congestion signs
149569|NCT02638142|BNP|bnp
149570|NCT02638129|Drug therapy|drug therapy
149571|NCT02638116|Ibrutinib|ibrutinib
149572|NCT02638116|Proton pump inhibitors|proton pump inhibitors
149573|NCT02638116|Pharmacokinetics|pharmacokinetics
149574|NCT02638116|Drug Interaction|drug interaction
149575|NCT02638090|advanced lung cancer|advanced lung cancer
149576|NCT02638090|immune therapy naive|immune therapy naive
149577|NCT02638090|immune therapy pre-treated|immune therapy pre-treated
149578|NCT02638090|NSCLC|nsclc
149579|NCT02638090|Stage IV lung cancer|stage iv lung cancer
149580|NCT02638090|pembrolizumab|pembrolizumab
149581|NCT02638090|vorinostat|vorinostat
149582|NCT02638090|immunogenicity|immunogenicity
149583|NCT02638077|Differentiated Thyroid Cancer|differentiated thyroid cancer
149584|NCT02638077|the initial management|the initial management
149585|NCT02638051|Peritoneal Carcinomatosis|peritoneal carcinomatosis
149586|NCT02638051|Malignant Ascites|malignant ascites
149587|NCT02638051|Modulated Electro-Hyperthermia|modulated electro-hyperthermia
149588|NCT02638051|Traditional Chinese Medicine|traditional chinese medicine
149589|NCT02637960|VA106483, fedovapagon, BPH, nocturia, EQUINOC|va106483, fedovapagon, bph, nocturia, equinoc
149590|NCT02637921|bed rest|bed rest
149591|NCT02637921|bone metabolism|bone metabolism
149592|NCT02637908|Mindfulness|mindfulness
149593|NCT02637908|Parents|parents
149594|NCT02637908|Families|families
149595|NCT02637895|PTSD,|ptsd,
149596|NCT02637895|trauma|trauma
149597|NCT02637895|stress disorder|stress disorder
149598|NCT02637895|post-traumatic stress disorder|post-traumatic stress disorder
149599|NCT02637895|anxiety disorder|anxiety disorder
149600|NCT02637869|Health Expenditures|health expenditures
149601|NCT02637869|Prospective Payment System|prospective payment system
149602|NCT02637869|Health Care Utilization|health care utilization
149603|NCT02637869|Health Care Quality, Access, and Evaluation|health care quality, access, and evaluation
149604|NCT02637843|radial|radial
149605|NCT02637843|angiography|angiography
149606|NCT02637843|angioplasty|angioplasty
149607|NCT02637843|randomized|randomized
149608|NCT02637843|sheath|sheath
149609|NCT02637843|slender|slender
149610|NCT02637791|Stroke|stroke
149611|NCT02637791|Rehabilitation|rehabilitation
149612|NCT02637791|Virtual Reality|virtual reality
149613|NCT02637778|nutrient profiles|nutrient profiles
149614|NCT02637778|menu plans|menu plans
149615|NCT02637778|n-3 LC-PUFA|n-3 lc-pufa
149616|NCT02637778|SFA|sfa
149617|NCT02637778|MUFA|mufa
149618|NCT02637778|PUFA|pufa
149619|NCT02637778|cardiovascular risk|cardiovascular risk
149620|NCT02637765|Breast Cancer|breast cancer
149621|NCT02637765|Physical Activity|physical activity
149622|NCT02637765|Quality of life|quality of life
149623|NCT02637752|Pediatric Obesity|pediatric obesity
149624|NCT02637752|Body Mass Index|body mass index
149625|NCT02637752|Dentistry|dentistry
149626|NCT02637739|hysteroscope|hysteroscope
149627|NCT02637726|Total intravenous anesthesia|total intravenous anesthesia
149628|NCT02637726|Target Controlled Infusion|target controlled infusion
149629|NCT02637726|Propofol|propofol
149630|NCT02637726|Bispectral index|bispectral index
149631|NCT02637726|Children|children
149632|NCT02637713|GERD|gerd
149633|NCT02637713|sleeve gastrectomy|sleeve gastrectomy
149634|NCT02637713|reflux|reflux
149635|NCT02637713|morbidly obese|morbidly obese
149636|NCT02637700|Small Fiber Neuropathy|small fiber neuropathy
149637|NCT02637700|Painful Neuropathy|painful neuropathy
149638|NCT02637700|Intravenous Immunoglobulin Therapy|intravenous immunoglobulin therapy
149639|NCT02637687|Pediatric|pediatric
149640|NCT02637687|NTRK1|ntrk1
149641|NCT02637687|NTRK2|ntrk2
149642|NCT02637687|NTRK3|ntrk3
149643|NCT02637687|Fusion|fusion
149644|NCT02637687|Tumors|tumors
149645|NCT02637687|Solid Tumors|solid tumors
149646|NCT02637687|CNS Tumors|cns tumors
149647|NCT02637687|Central Nervous System Tumors|central nervous system tumors
149648|NCT02637687|NTRK Fusion Positive|ntrk fusion positive
149649|NCT02637687|TRKA|trka
149650|NCT02637687|TRKB|trkb
149651|NCT02637687|TRKC|trkc
149652|NCT02637687|Infantile Fibrosarcoma|infantile fibrosarcoma
149653|NCT02637687|NTRK Gene Rearrangements|ntrk gene rearrangements
149654|NCT02637687|TRK Fusion|trk fusion
149655|NCT02637687|NTRK1 fusion|ntrk1 fusion
149656|NCT02637687|NTRK2 fusion|ntrk2 fusion
149657|NCT02637687|NTRK3 fusion|ntrk3 fusion
149658|NCT02637687|NTRK1 gene rearrangement|ntrk1 gene rearrangement
149659|NCT02637687|NTRK2 gene rearrangement|ntrk2 gene rearrangement
149660|NCT02637687|NTRK3 gene rearrangement|ntrk3 gene rearrangement
149661|NCT02637687|ETV6-NTRK3|etv6-ntrk3
149662|NCT02637687|ETV6|etv6
149663|NCT02637687|ETV6 fusion|etv6 fusion
149664|NCT02637687|ETV6 gene rearrangement|etv6 gene rearrangement
149665|NCT02637687|Solid CNS tumor|solid cns tumor
149666|NCT02637687|Primary CNS tumor|primary cns tumor
149667|NCT02637687|Advanced CNS tumor|advanced cns tumor
149668|NCT02637687|Metastatic CNS tumor|metastatic cns tumor
149669|NCT02637687|Metastatic infantile fibrosarcoma|metastatic infantile fibrosarcoma
149670|NCT02637687|Advanced infantile fibrosarcoma|advanced infantile fibrosarcoma
149671|NCT02637687|Fibrosarcoma|fibrosarcoma
149672|NCT02637687|Congenital mesoblastic nephroma|congenital mesoblastic nephroma
149673|NCT02637687|Congenital nephroma|congenital nephroma
149674|NCT02637687|Thyroid|thyroid
149675|NCT02637687|Larotrectinib|larotrectinib
149676|NCT02637687|Solid tumors Cancer of Unknown primary|solid tumors cancer of unknown primary
149677|NCT02637674|allotransplantation|allotransplantation
149678|NCT02637661|earlobe crease|earlobe crease
149679|NCT02637661|acute myocardial infarction|acute myocardial infarction
149680|NCT02637661|risk factor|risk factor
149681|NCT02637635|Mammaplasty|mammaplasty
149682|NCT02637635|Transplantation, Autologous|transplantation, autologous
149683|NCT02637635|Mastectomy|mastectomy
149684|NCT02637635|Breast Implants|breast implants
149685|NCT02637635|Radiotherapy, Adjuvant|radiotherapy, adjuvant
149686|NCT02637622|conjoint analysis|conjoint analysis
149687|NCT02637622|stated-preference methods|stated-preference methods
149688|NCT02637622|patient centered outcome research (PCOR)|patient centered outcome research (pcor)
149689|NCT02637622|community-based participatory research (CBPR)|community-based participatory research (cbpr)
149690|NCT02637622|patient preference|patient preference
149691|NCT02637622|diabetes|diabetes
149692|NCT02637609|conjoint analysis|conjoint analysis
149693|NCT02637609|stated-preference methods|stated-preference methods
149694|NCT02637609|patient centered outcome research (PCOR)|patient centered outcome research (pcor)
149695|NCT02637609|community-based participatory research (CBPR)|community-based participatory research (cbpr)
149696|NCT02637609|patient priority|patient priority
149697|NCT02637609|diabetes|diabetes
149698|NCT02637583|conjugate vaccine|conjugate vaccine
149699|NCT02637583|polysaccharide vaccine|polysaccharide vaccine
149700|NCT02637570|healthy male athletes|healthy male athletes
149701|NCT02637570|18-35 years old|18-35 years old
149702|NCT02637531|IPI-549|ipi-549
149703|NCT02637531|Phase 1|phase 1
149704|NCT02637531|Advanced Solid Tumor|advanced solid tumor
149705|NCT02637531|Non-small cell lung cancer|non-small cell lung cancer
149706|NCT02637531|Melanoma|melanoma
149707|NCT02637531|PI3K|pi3k
149708|NCT02637531|Squamous Cell Cancer of the Head and Neck|squamous cell cancer of the head and neck
149709|NCT02637531|Triple Negative Breast Cancer|triple negative breast cancer
149710|NCT02637531|Adrenocortical Carcinoma|adrenocortical carcinoma
149711|NCT02637531|Mesothelioma|mesothelioma
149712|NCT02637518|Frailty|frailty
149713|NCT02637518|Frailty screening tools|frailty screening tools
149714|NCT02637518|Clinical settings|clinical settings
149715|NCT02637518|Social settings|social settings
149716|NCT02637518|Geriatrics|geriatrics
149717|NCT02637518|Functional autonomy|functional autonomy
149718|NCT02637518|Disability|disability
149719|NCT02637505|Articular cartilage|articular cartilage
149720|NCT02637505|Focal cartilage injury|focal cartilage injury
149721|NCT02637505|Focal cartilage injury in the knee|focal cartilage injury in the knee
149722|NCT02637505|Knee cartilage|knee cartilage
149723|NCT02637505|Microfracture|microfracture
149724|NCT02637505|Debridement|debridement
149725|NCT02637492|Critical limb ischaemia|critical limb ischaemia
149726|NCT02637492|Peripheral occlusive arterial disease|peripheral occlusive arterial disease
149727|NCT02637492|Clinical prediction|clinical prediction
149728|NCT02637492|Ankle pressure|ankle pressure
149729|NCT02637492|Transcutaneous oxygen pressure|transcutaneous oxygen pressure
149730|NCT02637492|Toe pressure|toe pressure
149731|NCT02637492|Microcirculation|microcirculation
149732|NCT02637453|Paroxysmal Atrial Fibrillation;Additional Linear Ablation|paroxysmal atrial fibrillation;additional linear ablation
149733|NCT02637427|Fresh frozen plasma|fresh frozen plasma
149734|NCT02637427|Bleeding|bleeding
149735|NCT02637414|Stress|stress
149736|NCT02637414|Well-being|well-being
149737|NCT02637414|Positive psychology|positive psychology
149738|NCT02637388|Appetite|appetite
149739|NCT02637388|Beta-glucans|beta-glucans
149740|NCT02637388|Energy Intake|energy intake
149741|NCT02637388|Glucagon-Like Peptide 1|glucagon-like peptide 1
149742|NCT02637388|Glucose|glucose
149743|NCT02637388|Insulin|insulin
149744|NCT02637388|Incretins|incretins
149745|NCT02637375|triple-negative breast cancer|triple-negative breast cancer
149746|NCT02637336|Therapies. Autonomic nervous system. Cardiovascular stress|therapies. autonomic nervous system. cardiovascular stress
149747|NCT02637323|osteoarthritis|osteoarthritis
149748|NCT02637323|knee|knee
149749|NCT02637323|pain|pain
149750|NCT02637323|corticosteroid|corticosteroid
149751|NCT02637323|intra-articular|intra-articular
149752|NCT02637323|injection|injection
149753|NCT02637284|Healthy volunteers|healthy volunteers
149754|NCT02637271|Calorie restriction|calorie restriction
149755|NCT02637271|Meal replacement|meal replacement
149756|NCT02637271|fMRI|fmri
149757|NCT02637271|Food-cue reactivity|food-cue reactivity
149758|NCT02637271|Obesity|obesity
149759|NCT02637258|optic nerve sheath diameter|optic nerve sheath diameter
149760|NCT02637258|neurological outcome|neurological outcome
149761|NCT02637258|OHCA|ohca
149762|NCT02637245|diabetic macular edema|diabetic macular edema
149763|NCT02637245|diabetic retinopathy|diabetic retinopathy
149764|NCT02637206|Healthy Japanese|healthy japanese
149766|NCT02637206|skin safety|skin safety
149767|NCT02637180|osteoporosis|osteoporosis
149768|NCT02637180|fracture|fracture
149769|NCT02637180|liaison service|liaison service
149770|NCT02637167|Heart failure|heart failure
149771|NCT02637167|inflammation|inflammation
149772|NCT02637167|rifaximin|rifaximin
149773|NCT02637167|Saccharomyces boulardii|saccharomyces boulardii
149774|NCT02637167|gut microbiota|gut microbiota
149775|NCT02637154|Adolescent|adolescent
149776|NCT02637154|Type 1 diabetes|type 1 diabetes
149777|NCT02637154|Metabolic control|metabolic control
149778|NCT02637154|Motivational interviewing|motivational interviewing
149779|NCT02637141|celiac|celiac
149780|NCT02637141|gluten|gluten
149781|NCT02637141|IL-15|il-15
149782|NCT02637141|AMG 714|amg 714
149783|NCT02637128|MALARIA, FALCIPARUM|malaria, falciparum
149784|NCT02637128|MALAWI|malawi
149785|NCT02637128|ARTEMETHER-LUMEFANTRINE|artemether-lumefantrine
149786|NCT02637128|ARTESUNATE-AMODIAQUINE|artesunate-amodiaquine
149787|NCT02637115|Gut microbiota|gut microbiota
149788|NCT02637115|Akkermansia muciniphila|akkermansia muciniphila
149789|NCT02637076|Xyrem|xyrem
149790|NCT02637076|narcolepsy with cataplexy|narcolepsy with cataplexy
149791|NCT02637076|positron emission tomography|positron emission tomography
149792|NCT02637076|dopamine|dopamine
149793|NCT02637063|Lifestyle behavior change|lifestyle behavior change
149794|NCT02637050|Type IV Pulmonary Hypertension|type iv pulmonary hypertension
149795|NCT02637050|Chronic Thromboembolic Pulmonary Hypertension|chronic thromboembolic pulmonary hypertension
149796|NCT02637050|CTEPH|cteph
149797|NCT02637037|dapagliflozin/metformin XR 5/500 mg|dapagliflozin/metformin xr 5/500 mg
149798|NCT02637037|dapagliflozin/metformin XR10/1000 mg|dapagliflozin/metformin xr10/1000 mg
149799|NCT02637037|bioequivalence|bioequivalence
149800|NCT02637037|fixed dose combination tablets|fixed dose combination tablets
149801|NCT02637037|pharmacokinetic|pharmacokinetic
149802|NCT02637037|type 2 Diabetes Mellitus (T2DM)|type 2 diabetes mellitus (t2dm)
149803|NCT02637037|safety|safety
149804|NCT02637024|Breast Cancer|breast cancer
149805|NCT02637024|DCIS|dcis
149806|NCT02637024|Radiotherapy|radiotherapy
149807|NCT02637024|Partial breast irradiation|partial breast irradiation
149808|NCT02637024|Radiation fractions|radiation fractions
149809|NCT02637011|acute respiratory distress syndrome|acute respiratory distress syndrome
149810|NCT02637011|intensive care medicine|intensive care medicine
149811|NCT02637011|critical illness|critical illness
149812|NCT02637011|long-term outcomes|long-term outcomes
149813|NCT02637011|quality of life|quality of life
149814|NCT02637011|return to work|return to work
149815|NCT02637011|quality of care|quality of care
149816|NCT02636972|TLR2|tlr2
149817|NCT02636972|TLR4|tlr4
149818|NCT02636972|Biomarker|biomarker
149819|NCT02636972|TLR responsiveness|tlr responsiveness
149820|NCT02636972|Peripheral blood responsiveness|peripheral blood responsiveness
149821|NCT02636972|Inflammatory pain|inflammatory pain
149822|NCT02636933|Asthma|asthma
149823|NCT02636933|Allergic Rhinitis|allergic rhinitis
149824|NCT02636933|Children|children
149825|NCT02636933|Atopy|atopy
149826|NCT02636920|Asthma|asthma
149827|NCT02636920|Children|children
149828|NCT02636855|Solid and Hematological Malignancies|solid and hematological malignancies
149829|NCT02636855|Screening|screening
149830|NCT02636855|Metastatic|metastatic
149831|NCT02636855|Previously Treated|previously treated
149832|NCT02636855|NY-ESO-1|ny-eso-1
149833|NCT02636855|MAGE A10|mage a10
149834|NCT02636855|MAGE-A4|mage-a4
149835|NCT02636842|Schizophrenia|schizophrenia
149836|NCT02636842|Schizoaffective Disorder|schizoaffective disorder
149837|NCT02636842|Aripiprazole Lauroxil|aripiprazole lauroxil
149838|NCT02636842|Aripiprazole|aripiprazole
149839|NCT02636842|ALKS 9072|alks 9072
149840|NCT02636842|Alkermes|alkermes
149841|NCT02636803|trichuris|trichuris
149842|NCT02636803|hookworms|hookworms
149843|NCT02636803|Ascaris|ascaris
149844|NCT02636777|low back pain|low back pain
149845|NCT02636777|chronic pain|chronic pain
149846|NCT02636777|self-management|self-management
149847|NCT02636777|longitudinal study|longitudinal study
149848|NCT02636777|predictive modelling|predictive modelling
149849|NCT02636751|Prehabilitation|prehabilitation
149850|NCT02636751|Telemedicine|telemedicine
149851|NCT02636751|Osteoarthritis|osteoarthritis
149852|NCT02636751|Arthroplasty|arthroplasty
149853|NCT02636751|Hip|hip
149854|NCT02636751|Knee|knee
149855|NCT02636725|Advanced Alveolar Soft Part Sarcoma|advanced alveolar soft part sarcoma
149856|NCT02636725|ASPS|asps
149857|NCT02636725|Soft Tissue Sarcomas|soft tissue sarcomas
149858|NCT02636725|STS|sts
149859|NCT02636725|Alveolar Soft Part Sarcoma|alveolar soft part sarcoma
149860|NCT02636686|DMD|dmd
149861|NCT02636686|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
149862|NCT02636686|Drisapersen|drisapersen
149863|NCT02636686|Kyndrisa|kyndrisa
149864|NCT02636686|exon-skipping|exon-skipping
149865|NCT02636686|exon-51|exon-51
149866|NCT02636686|BMN-051-302|bmn-051-302
149867|NCT02636686|051-302|051-302
149868|NCT02636660|Critical care|critical care
150168|NCT02635113|vibration|vibration
149869|NCT02636660|Mechanical Ventilation|mechanical ventilation
149870|NCT02636660|Quality of Life|quality of life
149871|NCT02636660|Stressors|stressors
149872|NCT02636660|Nursing Sensitive Outcomes|nursing sensitive outcomes
149873|NCT02636660|Nursing|nursing
149874|NCT02636647|hepatic encephalopathy|hepatic encephalopathy
149875|NCT02636647|fecal transplant|fecal transplant
149876|NCT02636647|cirrhosis|cirrhosis
149877|NCT02636634|diagnostic strategy|diagnostic strategy
149878|NCT02636634|brain metastases|brain metastases
149879|NCT02636634|radiation necrosis|radiation necrosis
149880|NCT02636634|relapse|relapse
149881|NCT02636634|PET-FET and MSR|pet-fet and msr
149882|NCT02636634|radiosurgery|radiosurgery
149883|NCT02636621|Fatigue|fatigue
149884|NCT02636621|excessive daytime sleepiness|excessive daytime sleepiness
149885|NCT02636621|flow limitation|flow limitation
149886|NCT02636608|Chronic Hepatitis C|chronic hepatitis c
149887|NCT02636608|Dasabuvir|dasabuvir
149888|NCT02636608|Paritaprevir/r/Ombitasvir|paritaprevir/r/ombitasvir
149889|NCT02636608|Observational Study|observational study
149890|NCT02636608|Quality of Life|quality of life
149891|NCT02636608|Fibrosis|fibrosis
149892|NCT02636608|Cirrhosis|cirrhosis
149893|NCT02636608|Work Ability|work ability
149894|NCT02636595|Hepatitis C Genotype 4|hepatitis c genotype 4
149895|NCT02636595|Hepatitis C|hepatitis c
149896|NCT02636595|Chronic Hepatitis C|chronic hepatitis c
149897|NCT02636595|Hepatitis C Genotype 6|hepatitis c genotype 6
149898|NCT02636595|Hepatitis C Genotype 5|hepatitis c genotype 5
149899|NCT02636556|thymoma|thymoma
149900|NCT02636556|thymic carcinoma|thymic carcinoma
149901|NCT02636556|chemoradiotherapy|chemoradiotherapy
149902|NCT02636556|inoperable|inoperable
149903|NCT02636543|genetic diagnosis|genetic diagnosis
149904|NCT02636543|information|information
149905|NCT02636543|letter model|letter model
149906|NCT02636517|Fecal Microbiota transplant|fecal microbiota transplant
149907|NCT02636504|Pulp vitality|pulp vitality
149908|NCT02636504|Pulp testing|pulp testing
149909|NCT02636439|Diastolic heart failure|diastolic heart failure
149910|NCT02636439|Heart Failure|heart failure
149911|NCT02636439|Elderly|elderly
149912|NCT02636439|Obesity|obesity
149913|NCT02636426|phase I study|phase i study
149914|NCT02636426|sorafenib|sorafenib
149915|NCT02636426|high-dose schedule|high-dose schedule
149916|NCT02636426|pharmacokinetics|pharmacokinetics
149917|NCT02636426|drug monitoring|drug monitoring
149918|NCT02636400|Infertility|infertility
149919|NCT02636400|endometriosis|endometriosis
149920|NCT02636348|Calcium|calcium
149921|NCT02636348|Vitamin D|vitamin d
149922|NCT02636322|Lymphoma|lymphoma
149923|NCT02636322|High Risk Diffuse Large B-Cell Lymphoma|high risk diffuse large b-cell lymphoma
149924|NCT02636322|DLBCL|dlbcl
149925|NCT02636322|Rituximab|rituximab
149926|NCT02636322|Rituxan|rituxan
149927|NCT02636322|Ibrutinib|ibrutinib
149928|NCT02636322|PCI-32765|pci-32765
149929|NCT02636322|Imbruvica|imbruvica
149930|NCT02636322|Lenalidomide|lenalidomide
149931|NCT02636322|CC-5013|cc-5013
149932|NCT02636322|Revlimid|revlimid
149933|NCT02636322|Etoposide|etoposide
149934|NCT02636322|VePesid|vepesid
149935|NCT02636322|Prednisone|prednisone
149936|NCT02636322|Vincristine|vincristine
149937|NCT02636322|Oncovin|oncovin
149938|NCT02636322|Cyclophosphamide|cyclophosphamide
149939|NCT02636322|Cytoxan|cytoxan
149940|NCT02636322|Neosar|neosar
149941|NCT02636322|Doxorubicin|doxorubicin
149942|NCT02636322|Hydroxydaunorubicin|hydroxydaunorubicin
149943|NCT02636322|Adriamycin PFS|adriamycin pfs
149944|NCT02636322|Adriamycin RDF|adriamycin rdf
149945|NCT02636322|Adriamycin|adriamycin
149946|NCT02636322|Rubex|rubex
149947|NCT02636309|ergonomics|ergonomics
149948|NCT02636309|multifaceted intervention|multifaceted intervention
149949|NCT02636309|industry|industry
149950|NCT02636309|physiotherapy|physiotherapy
149951|NCT02636309|physical exercises|physical exercises
149952|NCT02636309|workplace|workplace
149953|NCT02636309|acupuncture|acupuncture
149954|NCT02636309|work|work
149955|NCT02636309|quality of life|quality of life
149956|NCT02636309|absenteeism|absenteeism
149957|NCT02636309|efficiency|efficiency
149958|NCT02636309|musculoskeletal pain|musculoskeletal pain
149959|NCT02636309|WMSD|wmsd
149960|NCT02636296|Pilates method|pilates method
149961|NCT02636296|elderly|elderly
149962|NCT02636296|postural balance|postural balance
149963|NCT02636257|Silicone Nasolacrimal Intubation|silicone nasolacrimal intubation
149964|NCT02636257|Dacryocystorhinostomy|dacryocystorhinostomy
149965|NCT02636231|Endostar|endostar
149966|NCT02636231|IMRT|imrt
149967|NCT02636231|recurrent|recurrent
149968|NCT02636231|NPC|npc
149969|NCT02636218|Ketamine|ketamine
149970|NCT02636192|Sodium-glucose co-transporter 2 inhibitors|sodium-glucose co-transporter 2 inhibitors
149971|NCT02636192|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
149972|NCT02636179|In Vitro Fertilization, follow-up of children|in vitro fertilization, follow-up of children
149973|NCT02636166|Pregnancy|pregnancy
149974|NCT02636153|phosphorus,dietary|phosphorus,dietary
150661|NCT02632526|Safety|safety
149975|NCT02636153|circadian rhythm|circadian rhythm
149976|NCT02636153|phosphorus|phosphorus
149977|NCT02636088|Phase II study, clinical trial|phase ii study, clinical trial
149978|NCT02636062|Coronary disease|coronary disease
149979|NCT02636062|Coronary artery disease (CAD)|coronary artery disease (cad)
149980|NCT02636062|Endothelial dysfunction|endothelial dysfunction
149981|NCT02636062|Coronary artery calcium (CAC)|coronary artery calcium (cac)
149982|NCT02636049|pharmacokinetics|pharmacokinetics
149983|NCT02636049|healthy adult volunteer|healthy adult volunteer
149984|NCT02635997|osteoporosis|osteoporosis
149985|NCT02635997|ibandronate|ibandronate
149986|NCT02635997|vitamine D|vitamine d
149987|NCT02635997|calcium|calcium
149988|NCT02635997|bone mineral density|bone mineral density
149989|NCT02635997|health-related quality of life|health-related quality of life
149990|NCT02635971|transcatheter arterial infusion|transcatheter arterial infusion
149991|NCT02635971|randomized controlled trial|randomized controlled trial
149992|NCT02635971|chemotherapy|chemotherapy
149993|NCT02635958|Body Mass Index|body mass index
149994|NCT02635958|BMI|bmi
149995|NCT02635958|InBody|inbody
149996|NCT02635958|iDXA|idxa
149997|NCT02635958|validation|validation
149998|NCT02635945|adenosine A1 receptor antagonist|adenosine a1 receptor antagonist
149999|NCT02635945|adenosine receptor modulator|adenosine receptor modulator
150000|NCT02635945|COPD|copd
150001|NCT02635945|asthma|asthma
150002|NCT02635919|Nicotine addiction|nicotine addiction
150003|NCT02635919|Cigarette smoking|cigarette smoking
150004|NCT02635919|Smoking cessation|smoking cessation
150005|NCT02635919|Quit smoking|quit smoking
150006|NCT02635906|BED REST|bed rest
150007|NCT02635906|CORONARY ANGIOPLASTY|coronary angioplasty
150008|NCT02635893|SCI|sci
150009|NCT02635867|vital pulp|vital pulp
150010|NCT02635867|reversible pulpitis|reversible pulpitis
150011|NCT02635867|pulp capping|pulp capping
150012|NCT02635867|deep cavity|deep cavity
150013|NCT02635867|Management of Deep Dental Caries|management of deep dental caries
150014|NCT02635854|leukocyte and platelet aggregates|leukocyte and platelet aggregates
150015|NCT02635854|platelet activation|platelet activation
150016|NCT02635841|Pantothenate Kinase-Associated Neurodegeneration|pantothenate kinase-associated neurodegeneration
150017|NCT02635841|PKAN|pkan
150018|NCT02635841|Neurodegeneration with Brain Iron Accumulation|neurodegeneration with brain iron accumulation
150019|NCT02635841|NBIA|nbia
150020|NCT02635841|Deferiprone|deferiprone
150021|NCT02635841|Ferriprox|ferriprox
150022|NCT02635828|Palonosetron|palonosetron
150023|NCT02635828|Craniotomy|craniotomy
150024|NCT02635828|Nausea|nausea
150025|NCT02635828|Vomiting|vomiting
150026|NCT02635802|remifentanil|remifentanil
150027|NCT02635802|analgesia|analgesia
150028|NCT02635802|intensive care units|intensive care units
150029|NCT02635789|Sirolimus|sirolimus
150030|NCT02635789|Skin lesions|skin lesions
150031|NCT02635789|TSC|tsc
150032|NCT02635789|Tuberous Sclerosis Complex|tuberous sclerosis complex
150033|NCT02635789|NPC-12G|npc-12g
150034|NCT02635789|Angiofibroma|angiofibroma
150035|NCT02635789|Hypomelanotic macule|hypomelanotic macule
150036|NCT02635789|Plaque|plaque
150037|NCT02635776|AR101 (Characterized Peanut Allergen)|ar101 (characterized peanut allergen)
150038|NCT02635776|Characterized Peanut Allergen|characterized peanut allergen
150039|NCT02635776|CPNA (Characterized Peanut Allergen)|cpna (characterized peanut allergen)
150040|NCT02635776|OIT (oral immunotherapy)|oit (oral immunotherapy)
150041|NCT02635776|Oral Immunotherapy|oral immunotherapy
150042|NCT02635776|Peanut Allergy|peanut allergy
150043|NCT02635776|Allergy|allergy
150044|NCT02635776|Peanut-Allergic Children|peanut-allergic children
150045|NCT02635776|Peanut-Allergic Adults|peanut-allergic adults
150046|NCT02635776|Desensitization|desensitization
150047|NCT02635763|nerve block|nerve block
150048|NCT02635763|general anesthesia|general anesthesia
150049|NCT02635763|hip fracture|hip fracture
150050|NCT02635763|recovery|recovery
150051|NCT02635724|Acute uncomplicated|acute uncomplicated
150052|NCT02635724|Elderly|elderly
150053|NCT02635685|Atrial fibrillation|atrial fibrillation
150054|NCT02635685|Stroke|stroke
150055|NCT02635685|Clinical Decision Support|clinical decision support
150056|NCT02635685|Anticoagulants|anticoagulants
150057|NCT02635672|Solid tumors|solid tumors
150058|NCT02635672|Aggressive non-hodgkin's lymphoma (NHL)|aggressive non-hodgkin's lymphoma (nhl)
150059|NCT02635659|food intake, satiety, satiation, nutrients, ileal brake|food intake, satiety, satiation, nutrients, ileal brake
150060|NCT02635633|partial epilepsy|partial epilepsy
150061|NCT02635633|unifocal neocortical|unifocal neocortical
150062|NCT02635633|treatment resistant|treatment resistant
150063|NCT02635633|transcranial magnetic stimulation|transcranial magnetic stimulation
150064|NCT02635633|thetaburst stimulation|thetaburst stimulation
150065|NCT02635620|e-cigarette, electronic cigarette, lung function|e-cigarette, electronic cigarette, lung function
150066|NCT02635607|GnRH antagonist|gnrh antagonist
150067|NCT02635607|fixed protocol|fixed protocol
150068|NCT02635607|flexible protocol|flexible protocol
150069|NCT02635542|Postoperative Pulmonary Complications|postoperative pulmonary complications
150167|NCT02635113|sensory deficits|sensory deficits
150070|NCT02635542|Residual Neuromuscular Blockade|residual neuromuscular blockade
150071|NCT02635542|Cardiac Surgical Procedures|cardiac surgical procedures
150072|NCT02635503|colorectal cancer|colorectal cancer
150073|NCT02635503|laparoscopic surgery|laparoscopic surgery
150074|NCT02635503|natural orifice specimen extraction|natural orifice specimen extraction
150075|NCT02635503|Inflammatory response|inflammatory response
150076|NCT02635490|prophylactic antibiotics, urinary tract infection.|prophylactic antibiotics, urinary tract infection.
150077|NCT02635451|vitamin c|vitamin c
150078|NCT02635451|Preterm Premature Rupture of Membranes|preterm premature rupture of membranes
150079|NCT02635438|Oropharyngeal Candidiasis|oropharyngeal candidiasis
150080|NCT02635412|Placenta|placenta
150081|NCT02635412|Accreta|accreta
150082|NCT02635412|Morbidly|morbidly
150083|NCT02635412|Adherent Placenta|adherent placenta
150084|NCT02635399|pancreaticoduodenectomy, delayed gastric emptying, duodenojejunopexy|pancreaticoduodenectomy, delayed gastric emptying, duodenojejunopexy
150085|NCT02635386|PCOS|pcos
150086|NCT02635386|GLP1 agonists|glp1 agonists
150087|NCT02635386|SGLT2 inhibitors|sglt2 inhibitors
150088|NCT02635373|Calciphylaxis|calciphylaxis
150089|NCT02635373|Rare disease (ORPHA280062)|rare disease (orpha280062)
150090|NCT02635373|Renal insufficiency|renal insufficiency
150091|NCT02635373|ESRD|esrd
150092|NCT02635373|Calcification|calcification
150093|NCT02635373|Chronic kidney disease|chronic kidney disease
150094|NCT02635373|Dialysis|dialysis
150095|NCT02635373|Vascular disease|vascular disease
150096|NCT02635360|advanced|advanced
150097|NCT02635360|cervical cancer|cervical cancer
150098|NCT02635360|pembrolizumab|pembrolizumab
150099|NCT02635360|chemoradiation|chemoradiation
150100|NCT02635360|immunotherapy|immunotherapy
150101|NCT02635347|Remote ischemic preconditioning|remote ischemic preconditioning
150102|NCT02635347|Remote ischemic perconditioning|remote ischemic perconditioning
150103|NCT02635347|Remote ischemic postconditioning|remote ischemic postconditioning
150104|NCT02635347|Remote ischemic conditioning|remote ischemic conditioning
150105|NCT02635347|Orthotopic liver transplant|orthotopic liver transplant
150106|NCT02635347|Brain Death Organ Donor|brain death organ donor
150107|NCT02635321|MRI|mri
150108|NCT02635321|LGMD|lgmd
150109|NCT02635321|GMPPB|gmppb
150110|NCT02635308|hip fracture|hip fracture
150111|NCT02635308|physical function|physical function
150112|NCT02635308|muscle function|muscle function
150113|NCT02635308|symmetry|symmetry
150114|NCT02635295|Clinical practicum|clinical practicum
150115|NCT02635295|Nursing student|nursing student
150116|NCT02635295|Nurse teacher|nurse teacher
150117|NCT02635295|Mobile technology|mobile technology
150118|NCT02635295|Cooperation|cooperation
150119|NCT02635295|Nurse competence|nurse competence
150120|NCT02635269|Ergometry|ergometry
150121|NCT02635269|Stable isotope tracers|stable isotope tracers
150122|NCT02635256|hypofractionation|hypofractionation
150123|NCT02635256|prostate cancer|prostate cancer
150124|NCT02635256|radiotherapy|radiotherapy
150125|NCT02635230|Atrial Fibrillations|atrial fibrillations
150126|NCT02635230|Heart Valve Prostheses|heart valve prostheses
150127|NCT02635230|Acute Coronary Syndromes|acute coronary syndromes
150128|NCT02635230|Percutaneous Coronary Revascularization|percutaneous coronary revascularization
150129|NCT02635230|Coronary Artery Bypass Grafting|coronary artery bypass grafting
150130|NCT02635230|Coronary Artery Diseases|coronary artery diseases
150131|NCT02635230|Myocardial Infarction|myocardial infarction
150132|NCT02635230|Ischemic stroke|ischemic stroke
150133|NCT02635230|Bleeding|bleeding
150134|NCT02635230|Thrombosis|thrombosis
150135|NCT02635230|Myocardial Ischemia|myocardial ischemia
150136|NCT02635230|Heart Diseases|heart diseases
150137|NCT02635230|Cardiovascular Diseases|cardiovascular diseases
150138|NCT02635230|Embolism and Thrombosis|embolism and thrombosis
150139|NCT02635230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
150140|NCT02635230|Aspirin|aspirin
150141|NCT02635230|Clopidogrel|clopidogrel
150142|NCT02635230|Ticagrelor|ticagrelor
150143|NCT02635230|Prasugrel|prasugrel
150144|NCT02635230|Antithrombotic treatment|antithrombotic treatment
150145|NCT02635230|Oral anticoagulation|oral anticoagulation
150146|NCT02635230|Warfarin|warfarin
150147|NCT02635230|Dabigatran etexilate mesylate|dabigatran etexilate mesylate
150148|NCT02635230|Apixaban|apixaban
150149|NCT02635230|Rivaroxaban|rivaroxaban
150150|NCT02635230|Direct Factor Xa Inhibitors|direct factor xa inhibitors
150151|NCT02635230|Direct Thrombin Inhibitors|direct thrombin inhibitors
150152|NCT02635217|Colonoscopy|colonoscopy
150153|NCT02635217|Esophagogastroduodenoscopy|esophagogastroduodenoscopy
150154|NCT02635217|Patient satisfaction|patient satisfaction
150155|NCT02635217|Bidirectional endoscopies|bidirectional endoscopies
150156|NCT02635191|Helicobacter pylori|helicobacter pylori
150157|NCT02635191|Therapy|therapy
150158|NCT02635191|Children|children
150159|NCT02635139|meal skipping|meal skipping
150160|NCT02635139|isocaloric diet|isocaloric diet
150161|NCT02635139|macronutrient oxidation|macronutrient oxidation
150162|NCT02635139|glucose homeostasis|glucose homeostasis
150163|NCT02635139|arterial stiffness|arterial stiffness
150164|NCT02635113|balance|balance
150166|NCT02635113|falls|falls
150169|NCT02635113|visual acuity|visual acuity
150170|NCT02635113|dizziness|dizziness
150171|NCT02635113|postural control|postural control
150172|NCT02635113|proprioceptive function|proprioceptive function
150173|NCT02635113|stereoacuity|stereoacuity
150174|NCT02635113|depth perception|depth perception
150175|NCT02635113|vestibular dysfunction|vestibular dysfunction
150176|NCT02635100|Sleep Disordered Breathing|sleep disordered breathing
150177|NCT02635100|Sleep Apnea|sleep apnea
150178|NCT02635048|Percutaneous nephrolithotomy|percutaneous nephrolithotomy
150179|NCT02635048|Kidney stones|kidney stones
150180|NCT02635048|Efficacy|efficacy
150181|NCT02635022|Fracture|fracture
150182|NCT02635022|Sarcopenia|sarcopenia
150183|NCT02635022|Osteoporosis|osteoporosis
150184|NCT02635022|Care management|care management
150185|NCT02635022|Medication adherence|medication adherence
150186|NCT02634983|COPD|copd
150187|NCT02634983|Smokers|smokers
150188|NCT02634983|Ex-smokers|ex-smokers
150189|NCT02634970|wet AMD, ranibizumab, aflibercept, neovascularization|wet amd, ranibizumab, aflibercept, neovascularization
150190|NCT02634957|phonomicrosurgery|phonomicrosurgery
150191|NCT02634957|benign vocal fold lesions|benign vocal fold lesions
150192|NCT02634957|voice rest|voice rest
150193|NCT02634957|vhi-10|vhi-10
150194|NCT02634957|CPP|cpp
150195|NCT02634944|Concussion|concussion
150196|NCT02634944|Vestibular|vestibular
150197|NCT02634944|Ocular-Motor|ocular-motor
150198|NCT02634931|Sirolimus|sirolimus
150199|NCT02634931|Skin lesions|skin lesions
150200|NCT02634931|TSC|tsc
150201|NCT02634931|Tuberous Sclerosis Complex|tuberous sclerosis complex
150202|NCT02634931|NPC-12G|npc-12g
150203|NCT02634931|Angiofibroma|angiofibroma
150204|NCT02634931|Hypomelanotic Macule|hypomelanotic macule
150205|NCT02634931|Plaque|plaque
150206|NCT02634918|ultrasound,|ultrasound,
150207|NCT02634918|ultrasonography|ultrasonography
150208|NCT02634918|hemophilic joint|hemophilic joint
150209|NCT02634918|Doppler|doppler
150210|NCT02634905|atopic dermatitis|atopic dermatitis
150211|NCT02634905|Therapeutic patient education|therapeutic patient education
150212|NCT02634905|pediatric dermatology|pediatric dermatology
150213|NCT02634892|Sacral|sacral
150214|NCT02634892|Overlay Mattress|overlay mattress
150215|NCT02634892|Cooling|cooling
150216|NCT02634866|hypertension|hypertension
150217|NCT02634866|exercise|exercise
150218|NCT02634866|diastolic heart failure|diastolic heart failure
150219|NCT02634853|Dry Eye|dry eye
150220|NCT02634840|inferior alveolar nerve|inferior alveolar nerve
150221|NCT02634840|neurosensory disturbance|neurosensory disturbance
150222|NCT02634840|bilateral sagittal spilt osteotomy|bilateral sagittal spilt osteotomy
150223|NCT02634840|mandibular surgery|mandibular surgery
150224|NCT02634840|neurosensory function|neurosensory function
150225|NCT02634801|Fumaderm|fumaderm
150226|NCT02634788|Post-Surgical Pain|post-surgical pain
150227|NCT02634788|Bunionectomy|bunionectomy
150228|NCT02634775|Pediatrics|pediatrics
150229|NCT02634775|Nephrology|nephrology
150230|NCT02634775|Dialysis|dialysis
150231|NCT02634749|Nordic countries|nordic countries
150232|NCT02634749|Eating behavior|eating behavior
150233|NCT02634749|Human microbiome|human microbiome
150234|NCT02634749|Child nutrition|child nutrition
150235|NCT02634749|Metabolic profile|metabolic profile
150236|NCT02634749|Body composition|body composition
150237|NCT02634710|soft tissue sarcoma|soft tissue sarcoma
150238|NCT02634697|Atrial Fibrillation|atrial fibrillation
150239|NCT02634697|Relaxation Response Resiliency Program Intervention|relaxation response resiliency program intervention
150240|NCT02634697|AF Symptom Severity and Burden|af symptom severity and burden
150241|NCT02634697|Stress, Anxiety, Depression and Hostility|stress, anxiety, depression and hostility
150242|NCT02634697|Quality of Life|quality of life
150243|NCT02634697|AF|af
150244|NCT02634697|QOL|qol
150245|NCT02634697|3RP|3rp
150246|NCT02634684|Schizophrenia|schizophrenia
150247|NCT02634684|Schizoaffective Disorder|schizoaffective disorder
150248|NCT02634684|Mental Disorders|mental disorders
150249|NCT02634684|Anti-Dyskinesia Agents|anti-dyskinesia agents
150250|NCT02634684|Antiparkinson Agents|antiparkinson agents
150251|NCT02634684|Central Nervous System Agents|central nervous system agents
150252|NCT02634684|Dopamine Agents|dopamine agents
150253|NCT02634684|Excitatory Amino Acid Agents|excitatory amino acid agents
150254|NCT02634684|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists
150255|NCT02634684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
150256|NCT02634684|Neurotransmitter Agents|neurotransmitter agents
150257|NCT02634684|Pharmacologic Actions|pharmacologic actions
150258|NCT02634684|Physiological Effects of Drugs|physiological effects of drugs
150259|NCT02634684|Therapeutic Uses|therapeutic uses
150260|NCT02634684|Prepulse inhibition|prepulse inhibition
150261|NCT02634684|Neurocognition|neurocognition
150262|NCT02634684|Working memory|working memory
150263|NCT02634684|Dextroamphetamine|dextroamphetamine
150264|NCT02634684|MATRICS Consensus Cognitive Battery|matrics consensus cognitive battery
150265|NCT02634684|Pharmacologic Augmentation of Cognitive Therapies|pharmacologic augmentation of cognitive therapies
150954|NCT02631005|exercise|exercise
150266|NCT02634684|Sensory discrimination learning|sensory discrimination learning
150267|NCT02634684|Targeted Cognitive Training|targeted cognitive training
150268|NCT02634684|rs4680 polymorphism of catechol-O-methyltransferase (COMT)|rs4680 polymorphism of catechol-o-methyltransferase (comt)
150269|NCT02634671|schizophrenia|schizophrenia
150270|NCT02634671|Facial emotions|facial emotions
150271|NCT02634619|urethral stricture|urethral stricture
150272|NCT02634606|Cholesterol|cholesterol
150273|NCT02634593|nutrition|nutrition
150274|NCT02634580|Japanese|japanese
150275|NCT02634580|High cholesterol|high cholesterol
150276|NCT02634580|Treatment of high cholesterol|treatment of high cholesterol
150277|NCT02634580|Lowering cholesterol|lowering cholesterol
150278|NCT02634580|Lowering high cholesterol|lowering high cholesterol
150279|NCT02634580|Hypercholesterolemia|hypercholesterolemia
150280|NCT02634580|Statin intolerant|statin intolerant
150281|NCT02634528|intermediate-acting human isophane insulin, biosimilar|intermediate-acting human isophane insulin, biosimilar
150282|NCT02634515|soluble human insulin, biosimilar|soluble human insulin, biosimilar
150283|NCT02634502|radiofrequency|radiofrequency
150284|NCT02634502|chemotherapy|chemotherapy
150285|NCT02634502|microRNA|microrna
150286|NCT02634489|Bladder outlet obstruction|bladder outlet obstruction
150287|NCT02634489|Overactive bladder|overactive bladder
150288|NCT02634489|Urinary incontinence|urinary incontinence
150289|NCT02634489|Omnic OCAS®|omnic ocas®
150290|NCT02634489|Vesicare®|vesicare®
150291|NCT02634489|Tamsulosin hydrochloride|tamsulosin hydrochloride
150292|NCT02634489|Solifenacin succinate|solifenacin succinate
150293|NCT02634476|Alcohol|alcohol
150294|NCT02634476|Substance use disorder|substance use disorder
150295|NCT02634476|cognitive bias|cognitive bias
150296|NCT02634476|behavioral intervention|behavioral intervention
150297|NCT02634476|computerised training|computerised training
150298|NCT02634463|Immunoassay|immunoassay
150299|NCT02634463|Antipsychotic|antipsychotic
150300|NCT02634463|Aripiprazole|aripiprazole
150301|NCT02634463|Olanzapine|olanzapine
150302|NCT02634463|Paliperidone|paliperidone
150303|NCT02634463|Risperidone|risperidone
150304|NCT02634450|HIV|hiv
150305|NCT02634450|Diagnostic|diagnostic
150306|NCT02634450|children|children
150307|NCT02634424|Hemophilia A|hemophilia a
150308|NCT02634424|Prophylaxy|prophylaxy
150309|NCT02634424|Pharmacokinetic|pharmacokinetic
150310|NCT02634424|Bayesian|bayesian
150311|NCT02634411|Ventilator Associated|ventilator associated
150312|NCT02634411|Pneumonia|pneumonia
150313|NCT02634411|Antibiotic treatment|antibiotic treatment
150314|NCT02634411|Pseudomonas aeruginosa|pseudomonas aeruginosa
150315|NCT02634372|Bipolar Disorder|bipolar disorder
150316|NCT02634372|Traumatic event|traumatic event
150317|NCT02634372|Eye Movement Desensitization Reprocessing|eye movement desensitization reprocessing
150318|NCT02634372|Supportive therapy|supportive therapy
150319|NCT02634372|Relapse prevention|relapse prevention
150320|NCT02634346|Alkermes|alkermes
150321|NCT02634346|ALKS 3831|alks 3831
150322|NCT02634346|Samidorphan|samidorphan
150323|NCT02634346|Schizophrenia|schizophrenia
150324|NCT02634346|Acute Exacerbation of Schizophrenia|acute exacerbation of schizophrenia
150325|NCT02634333|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
150326|NCT02634333|nonproliferative diabetic retinopathy|nonproliferative diabetic retinopathy
150327|NCT02634320|Alkermes|alkermes
150328|NCT02634320|ARISTADA|aristada
150329|NCT02634320|Aripiprazole Lauroxil|aripiprazole lauroxil
150330|NCT02634320|Schizophrenia|schizophrenia
150331|NCT02634307|Multiple Sclerosis|multiple sclerosis
150332|NCT02634307|MS|ms
150333|NCT02634307|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
150334|NCT02634307|RRMS|rrms
150335|NCT02634307|dimethyl fumarate|dimethyl fumarate
150336|NCT02634307|DMF|dmf
150337|NCT02634294|Hematological Neoplasms|hematological neoplasms
150338|NCT02634294|recurrence|recurrence
150339|NCT02634294|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
150340|NCT02634294|peginterferon alfa-2b|peginterferon alfa-2b
150341|NCT02634294|Graft vs Host Disease|graft vs host disease
150342|NCT02634268|randomized controlled trial|randomized controlled trial
150343|NCT02634268|diet|diet
150344|NCT02634268|exercise|exercise
150345|NCT02634268|obesity|obesity
150346|NCT02634268|overweight|overweight
150347|NCT02634268|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
150348|NCT02634268|lifestyle|lifestyle
150349|NCT02634255|rocuronium|rocuronium
150350|NCT02634255|onset time|onset time
150351|NCT02634255|anxiety|anxiety
150352|NCT02634242|Si Wu Tang|si wu tang
150353|NCT02634242|antioxidation|antioxidation
150354|NCT02634242|anthropometric measurements|anthropometric measurements
150355|NCT02634242|liver|liver
150356|NCT02634242|skin|skin
150357|NCT02634229|monogenic diabetes|monogenic diabetes
150358|NCT02634229|MODY|mody
150359|NCT02634229|beta-cell|beta-cell
150360|NCT02634229|insulin secretion|insulin secretion
150361|NCT02634216|Hyperglycemia|hyperglycemia
150362|NCT02634216|Capros|capros
150363|NCT02634216|Type 1 Diabetes|type 1 diabetes
151057|NCT02630446|caregiver|caregiver
150364|NCT02634203|Chronic Thromboembolic Pulmonary Hypertension|chronic thromboembolic pulmonary hypertension
150365|NCT02634203|Balloon Pulmonary Angioplasty|balloon pulmonary angioplasty
150366|NCT02634203|Riociguat|riociguat
150367|NCT02634190|Cervical cancer screening|cervical cancer screening
150368|NCT02634190|High risk Human Papillomavirus|high risk human papillomavirus
150369|NCT02634190|Aptima HPV Assay|aptima hpv assay
150370|NCT02634177|Genotyping|genotyping
150371|NCT02634177|Genecept Assay™|genecept assay™
150372|NCT02634164|leucine|leucine
150373|NCT02634164|isoleucine|isoleucine
150374|NCT02634151|LDL‐C|ldl‐c
150375|NCT02634151|Lipid Regulator|lipid regulator
150376|NCT02634138|Peripheral Vascular Disease|peripheral vascular disease
150377|NCT02634138|Critical Limb Ischaemia|critical limb ischaemia
150378|NCT02634112|anastomotic leakage|anastomotic leakage
150379|NCT02634112|rectal cancer surgery|rectal cancer surgery
150380|NCT02634112|anastomotic leakage predictive score|anastomotic leakage predictive score
150381|NCT02634099|major pediatric surgery|major pediatric surgery
150382|NCT02634099|hemoglobin measurement|hemoglobin measurement
150383|NCT02634086|Coronary artery disease|coronary artery disease
150384|NCT02634086|Percutaneous coronary intervention|percutaneous coronary intervention
150385|NCT02634086|Coronary artery bypass graft|coronary artery bypass graft
150386|NCT02634086|Medication therapy|medication therapy
150387|NCT02634073|Lamivudine|lamivudine
150388|NCT02634073|Safety|safety
150389|NCT02634073|Sorbitol|sorbitol
150390|NCT02634073|Pharmacokinetics|pharmacokinetics
150391|NCT02634060|adalimumab|adalimumab
150392|NCT02634060|fecal calprotectin|fecal calprotectin
150393|NCT02634060|home based|home based
150394|NCT02634047|transesophageal echocardiography|transesophageal echocardiography
150395|NCT02634047|videolaryngoscope|videolaryngoscope
150396|NCT02634047|oropharyngeal injury|oropharyngeal injury
150397|NCT02634008|Pangenotypic|pangenotypic
150398|NCT02634008|Treatment|treatment
150399|NCT02633956|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
150400|NCT02633956|NAFLD|nafld
150401|NCT02633956|Fatty Liver Disease|fatty liver disease
150402|NCT02633956|NASH|nash
150403|NCT02633930|helicobacter pylori|helicobacter pylori
150404|NCT02633930|berberine-containing quadruple therapy|berberine-containing quadruple therapy
150405|NCT02633930|clarithromycin-containing quadruple therapy|clarithromycin-containing quadruple therapy
150406|NCT02633917|Low back pain|low back pain
150407|NCT02633917|Motor control|motor control
150408|NCT02633917|Joint mobilization|joint mobilization
150409|NCT02633904|Hip Dislocation|hip dislocation
150410|NCT02633904|Congenital|congenital
150411|NCT02633904|osteotomy|osteotomy
150412|NCT02633904|Femur Head Necrosis|femur head necrosis
150413|NCT02633891|neuropathies|neuropathies
150414|NCT02633891|metabolic diseases|metabolic diseases
150415|NCT02633891|nervous system diseases|nervous system diseases
150416|NCT02633891|peripheral nervous system diseases|peripheral nervous system diseases
150417|NCT02633865|patient characteristics|patient characteristics
150418|NCT02633852|Diabetic Macular Edema (DME)|diabetic macular edema (dme)
150419|NCT02633852|Aflibercept (EYLEA)|aflibercept (eylea)
150420|NCT02633839|Adults|adults
150421|NCT02633826|alloreactive T cell|alloreactive t cell
150422|NCT02633826|donor-specific antibody|donor-specific antibody
150423|NCT02633813|Bioequivalence|bioequivalence
150424|NCT02633813|Tinea pedis|tinea pedis
150425|NCT02633813|Naftin|naftin
150426|NCT02633800|Squamous cell cancer of the head and neck|squamous cell cancer of the head and neck
150427|NCT02633800|Squamous cell carcinoma|squamous cell carcinoma
150428|NCT02633800|Head and neck cancer|head and neck cancer
150429|NCT02633800|Neoplasms by site|neoplasms by site
150430|NCT02633787|Meningitis|meningitis
150431|NCT02633787|Meningococcal Meningitis|meningococcal meningitis
150432|NCT02633787|Meningococcal Infections|meningococcal infections
150433|NCT02633787|Menactra®|menactra®
150434|NCT02633761|Fetal death|fetal death
150435|NCT02633761|mifepristone|mifepristone
150436|NCT02633761|misoprostol|misoprostol
150437|NCT02633735|Clinical Decision Support|clinical decision support
150438|NCT02633696|Clinical trial|clinical trial
150439|NCT02633696|Phase I|phase i
150440|NCT02633696|Healthy volunteers|healthy volunteers
150441|NCT02633696|Clinical Pharmacology|clinical pharmacology
150442|NCT02633696|Bioavailability|bioavailability
150443|NCT02633696|Silybin|silybin
150444|NCT02633696|Liver Trasplantation|liver trasplantation
150445|NCT02633683|Restless Legs Syndrome|restless legs syndrome
150446|NCT02633683|RLS|rls
150447|NCT02633657|Restless Legs Syndrome|restless legs syndrome
150448|NCT02633657|RLS|rls
150449|NCT02633644|Heart Failure|heart failure
150450|NCT02633644|Cardiovascular Diseases|cardiovascular diseases
150451|NCT02633644|Heart Diseases|heart diseases
150452|NCT02633592|High Resolution Anorectal Manometry|high resolution anorectal manometry
150453|NCT02633592|Magnetic Resonance Imaging|magnetic resonance imaging
150454|NCT02633592|Balloon Expulsion|balloon expulsion
150455|NCT02633592|Position|position
150456|NCT02633579|Healthy volunteers|healthy volunteers
150457|NCT02633566|Flatfoot|flatfoot
150458|NCT02633566|orthoses|orthoses
150459|NCT02633566|children|children
150460|NCT02633553|thymoma|thymoma
150461|NCT02633553|adjuvant radiotherapy|adjuvant radiotherapy
150462|NCT02633553|complete resection|complete resection
150463|NCT02633540|T1a Larynx Cancer|t1a larynx cancer
150464|NCT02633540|T2a Larynx Cancer|t2a larynx cancer
150465|NCT02633514|thymoma|thymoma
150466|NCT02633514|thymic carcinoma|thymic carcinoma
150467|NCT02633514|adjuvant radiotherapy|adjuvant radiotherapy
150468|NCT02633514|adjuvant radiochemotherapy|adjuvant radiochemotherapy
150469|NCT02633514|incomplete resection|incomplete resection
150470|NCT02633475|interleukin-10|interleukin-10
150471|NCT02633475|Polymorphism, Single Nucleotide|polymorphism, single nucleotide
150472|NCT02633449|tDCS|tdcs
150473|NCT02633449|cognitive behavioral therapy|cognitive behavioral therapy
150474|NCT02633436|esophageal cancer|esophageal cancer
150475|NCT02633436|SLC1A5|slc1a5
150476|NCT02633423|Cardiopulmonary bypass|cardiopulmonary bypass
150477|NCT02633423|Mechanical ventilation|mechanical ventilation
150478|NCT02633423|Expiratory Flow Limitation|expiratory flow limitation
150479|NCT02633423|Best PEEP|best peep
150480|NCT02633397|SCD|scd
150481|NCT02633397|Sickle Cell Disease|sickle cell disease
150482|NCT02633397|Riociguat|riociguat
150483|NCT02633397|Adempas|adempas
150484|NCT02633384|Parenteral nutrition associated cholestasis|parenteral nutrition associated cholestasis
150485|NCT02633384|Intravenous lipid emulsions|intravenous lipid emulsions
150486|NCT02633384|Surgical neonates|surgical neonates
150487|NCT02633384|Congenital gastrointestinal abnormalities|congenital gastrointestinal abnormalities
150488|NCT02633358|Acute myocardial infarction, cardiogenic shock|acute myocardial infarction, cardiogenic shock
150489|NCT02633319|Parenting|parenting
150490|NCT02633319|Child maltreatment|child maltreatment
150491|NCT02633319|Economic strengthening|economic strengthening
150492|NCT02633319|Early childhood development|early childhood development
150493|NCT02633319|Cluster randomized controlled trial|cluster randomized controlled trial
150494|NCT02633319|Pilot evaluation|pilot evaluation
150495|NCT02633306|trigeminal region pain|trigeminal region pain
150496|NCT02633293|Treprostinil|treprostinil
150497|NCT02633293|PH|ph
150498|NCT02633293|ILD|ild
150499|NCT02633293|CPFE|cpfe
150500|NCT02633293|6 Minute Walk Test|6 minute walk test
150501|NCT02633267|social anxiety|social anxiety
150502|NCT02633267|unemployment|unemployment
150503|NCT02633267|cognitive behavioral therapy|cognitive behavioral therapy
150504|NCT02633267|group therapy|group therapy
150505|NCT02633267|work|work
150506|NCT02633267|vocation|vocation
150507|NCT02633241|pediatrics|pediatrics
150508|NCT02633241|sedation|sedation
150509|NCT02633241|dexmedetomidine|dexmedetomidine
150510|NCT02633241|propofol|propofol
150511|NCT02633241|MRI|mri
150512|NCT02633228|Multifocal Intraocular Lens|multifocal intraocular lens
150513|NCT02633228|Binocular Trifocality|binocular trifocality
150514|NCT02633228|Cataract Surgery|cataract surgery
150515|NCT02633228|Spectacle Independence|spectacle independence
150516|NCT02633228|Intermediate Vision|intermediate vision
150517|NCT02633228|Photopic Vision|photopic vision
150518|NCT02633228|Mesopic Vision|mesopic vision
150519|NCT02633228|Scotopic Vision|scotopic vision
150520|NCT02633228|Binocular Vision|binocular vision
150521|NCT02633215|motor recovery|motor recovery
150522|NCT02633215|neuroplasticity|neuroplasticity
150523|NCT02633215|chronic|chronic
150524|NCT02633215|human|human
150525|NCT02633215|sensory|sensory
150526|NCT02633202|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
150527|NCT02633202|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
150528|NCT02633202|intermediate risk|intermediate risk
150529|NCT02633202|intensity-modulated radiotherapy|intensity-modulated radiotherapy
150530|NCT02633189|stage IV|stage iv
150531|NCT02633189|stage IIIB|stage iiib
150532|NCT02633189|EGFR mutation|egfr mutation
150533|NCT02633189|non-squamous|non-squamous
150534|NCT02633189|liquid biopsy|liquid biopsy
150535|NCT02633189|erlotinib|erlotinib
150536|NCT02633189|bevacizumab|bevacizumab
150537|NCT02633163|Systemic Lupus Erythematosus|systemic lupus erythematosus
150538|NCT02633163|Stem Cell|stem cell
150539|NCT02633163|Lupus|lupus
150540|NCT02633150|Obesity|obesity
150541|NCT02633150|insulinoresistant|insulinoresistant
150542|NCT02633150|menopausal women|menopausal women
150543|NCT02633150|polyphenol|polyphenol
150544|NCT02633137|Lenalidomide|lenalidomide
150545|NCT02633137|15-196|15-196
150546|NCT02633124|Premature infants|premature infants
150547|NCT02633124|Catheter-related bacteremia|catheter-related bacteremia
150548|NCT02633124|Infusion device|infusion device
150549|NCT02633124|Neonatal intensive care|neonatal intensive care
150550|NCT02633124|Central Venous Catheter|central venous catheter
150551|NCT02633124|Drug Infusion Systems|drug infusion systems
150552|NCT02633111|DNA Sequencing|dna sequencing
150553|NCT02633111|15-180|15-180
150554|NCT02633098|Artesunate|artesunate
150555|NCT02633098|Artemisinins|artemisinins
150556|NCT02633098|Antimalarial|antimalarial
150557|NCT02633098|Neoadjuvant|neoadjuvant
150558|NCT02633098|Pre-operative|pre-operative
150559|NCT02633085|Unicompartment Knee Replacement|unicompartment knee replacement
150560|NCT02633072|Multifocal Intraocular Lens|multifocal intraocular lens
150561|NCT02633072|Binocular Trifocality|binocular trifocality
150562|NCT02633072|Cataract Surgery|cataract surgery
150563|NCT02633072|Spectacle Independence|spectacle independence
150564|NCT02633072|Intermediate Vision|intermediate vision
150565|NCT02633072|Photopic Vision|photopic vision
150566|NCT02633072|Mesopic Vision|mesopic vision
150567|NCT02633072|Scotopic Vision|scotopic vision
150568|NCT02633072|Binocular Vision|binocular vision
150569|NCT02633046|FSGS|fsgs
150570|NCT02633046|primary FSGS|primary fsgs
150571|NCT02633046|idiopathic FSGS|idiopathic fsgs
150572|NCT02632981|Interleukin-32|interleukin-32
150573|NCT02632981|periodontitis|periodontitis
150574|NCT02632955|arteriovenous fistula|arteriovenous fistula
150575|NCT02632955|hemodialysis|hemodialysis
150576|NCT02632955|drug coated balloon|drug coated balloon
150577|NCT02632942|arteriovenous fistula|arteriovenous fistula
150578|NCT02632942|hemodialysis|hemodialysis
150579|NCT02632942|maturation|maturation
150580|NCT02632929|foot ulcer, diabetic|foot ulcer, diabetic
150581|NCT02632929|wound healing|wound healing
150582|NCT02632929|diabetic foot ulcer|diabetic foot ulcer
150583|NCT02632877|pirfenidone|pirfenidone
150584|NCT02632877|Modified oxide diallyl disulfide (MODD)|modified oxide diallyl disulfide (modd)
150585|NCT02632877|ketanserin|ketanserin
150586|NCT02632877|diabetic foot ulcer|diabetic foot ulcer
150587|NCT02632851|inhalation|inhalation
150588|NCT02632851|isotonic saline|isotonic saline
150589|NCT02632851|NaCl solution 0.9 %|nacl solution 0.9 %
150590|NCT02632851|Ectoin|ectoin
150591|NCT02632851|bronchitis|bronchitis
150592|NCT02632851|respiratory tract infection|respiratory tract infection
150593|NCT02632838|Hypertension|hypertension
150594|NCT02632838|mHealth|mhealth
150595|NCT02632838|underserved community|underserved community
150596|NCT02632825|Nasal High Flow|nasal high flow
150597|NCT02632825|gas exchange|gas exchange
150598|NCT02632825|newborn|newborn
150599|NCT02632799|Nasal High Flow|nasal high flow
150600|NCT02632799|CPAP|cpap
150601|NCT02632799|airway pressure|airway pressure
150602|NCT02632799|newborn|newborn
150603|NCT02632786|amyloidosis|amyloidosis
150604|NCT02632786|ntprobnp|ntprobnp
150605|NCT02632786|NEOD001|neod001
150606|NCT02632786|Prothena|prothena
150607|NCT02632786|PRONTO|pronto
150608|NCT02632786|amyloid|amyloid
150609|NCT02632786|plasma cell dyscrasia|plasma cell dyscrasia
150610|NCT02632786|immunotherapy|immunotherapy
150611|NCT02632773|Language Intervention|language intervention
150612|NCT02632773|Parent-Mediated Intervention|parent-mediated intervention
150613|NCT02632734|alveolar bone preservation|alveolar bone preservation
150614|NCT02632734|coral grafting device|coral grafting device
150615|NCT02632708|Acute Myeloid Leukemia|acute myeloid leukemia
150616|NCT02632708|AML|aml
150617|NCT02632708|Untreated AML|untreated aml
150618|NCT02632708|De novo AML|de novo aml
150619|NCT02632708|Secondary AML|secondary aml
150620|NCT02632708|Newly diagnosed AML|newly diagnosed aml
150621|NCT02632708|IDH1|idh1
150622|NCT02632708|IDH2|idh2
150623|NCT02632708|Induction therapy|induction therapy
150624|NCT02632708|Consolidation therapy|consolidation therapy
150625|NCT02632708|IDH|idh
150626|NCT02632682|probe-based confocal laser endomicroscopy|probe-based confocal laser endomicroscopy
150627|NCT02632669|Focal brachytherapy|focal brachytherapy
150628|NCT02632669|Seed implant|seed implant
150629|NCT02632669|Quality of life|quality of life
150630|NCT02632669|Toxicity|toxicity
150631|NCT02632643|TMD|tmd
150632|NCT02632643|HYPERTONIA|hypertonia
150633|NCT02632643|PARAFUNCTIONS|parafunctions
150634|NCT02632643|SENSORIMOTOR APPROACH|sensorimotor approach
150635|NCT02632630|Peripheral Parenteral Nutrition|peripheral parenteral nutrition
150636|NCT02632630|Oral nutritional supplementation|oral nutritional supplementation
150637|NCT02632630|Acute Care hospitals|acute care hospitals
150638|NCT02632617|Heart Valve Diseases|heart valve diseases
150639|NCT02632617|Coronary Artery Disease|coronary artery disease
150640|NCT02632617|Computed Tomographic Angiography|computed tomographic angiography
150641|NCT02632617|Preoperative Procedure|preoperative procedure
150642|NCT02632565|osteoarthritis|osteoarthritis
150643|NCT02632565|lidocaine|lidocaine
150644|NCT02632565|pain|pain
150645|NCT02632565|ultrasound|ultrasound
150646|NCT02632552|care transition|care transition
150647|NCT02632552|technology|technology
150648|NCT02632552|chronic heart failure|chronic heart failure
150649|NCT02632552|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
150650|NCT02632552|virtual nurse|virtual nurse
150651|NCT02632552|texting|texting
150652|NCT02632552|informatics|informatics
150653|NCT02632552|Veterans|veterans
150654|NCT02632539|ventilator associated pneumonia|ventilator associated pneumonia
150655|NCT02632539|Subglottic Secretion Drainage|subglottic secretion drainage
150656|NCT02632539|manual air-impingement operation|manual air-impingement operation
150657|NCT02632526|AZD5718 oral suspension crystalline|azd5718 oral suspension crystalline
150658|NCT02632526|AZD5718 oral suspension amorphous|azd5718 oral suspension amorphous
150659|NCT02632526|Single ascending dose/multiple ascending dose (SAD/MAD)|single ascending dose/multiple ascending dose (sad/mad)
150660|NCT02632526|Placebo-controlled|placebo-controlled
150662|NCT02632526|Tolerability|tolerability
150663|NCT02632526|Pharmacokinetics|pharmacokinetics
150664|NCT02632526|Pharmacodynamics|pharmacodynamics
150665|NCT02632513|continuous ultrasonic irrigation, syringe irrigation|continuous ultrasonic irrigation, syringe irrigation
150666|NCT02632500|Cardio-Pulmonary Resuscitation|cardio-pulmonary resuscitation
150667|NCT02632500|Cardiac Arrest|cardiac arrest
150668|NCT02632500|Training|training
150669|NCT02632474|HIV Infections|hiv infections
150670|NCT02632474|Tenofovir|tenofovir
150671|NCT02632474|Efavirenz|efavirenz
150672|NCT02632461|Diet|diet
150673|NCT02632461|Weight Loss|weight loss
150674|NCT02632461|Tracking|tracking
150675|NCT02632461|Calories|calories
150676|NCT02632448|Metastatic cancer|metastatic cancer
150677|NCT02632448|Advanced cancer|advanced cancer
150678|NCT02632448|Recurrent cancer|recurrent cancer
150679|NCT02632448|Colorectal neoplasms|colorectal neoplasms
150680|NCT02632448|Triple negative breast cancer|triple negative breast cancer
150681|NCT02632448|Ovarian neoplasms|ovarian neoplasms
150682|NCT02632448|Colon neoplasms|colon neoplasms
150683|NCT02632448|Rectal neoplasms|rectal neoplasms
150684|NCT02632448|Triple negative breast neoplasms|triple negative breast neoplasms
150685|NCT02632448|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
150686|NCT02632435|HER2 positive|her2 positive
150687|NCT02632383|Diabetes type 1|diabetes type 1
150688|NCT02632383|Transition|transition
150689|NCT02632383|Telemedicine|telemedicine
150690|NCT02632383|mHealth app|mhealth app
150691|NCT02632383|Youth|youth
150692|NCT02632383|Self-management|self-management
150693|NCT02632370|Malignant Gliomas|malignant gliomas
150694|NCT02632370|5-ALA|5-ala
150695|NCT02632370|tumor resection|tumor resection
150696|NCT02632370|malignant tumor|malignant tumor
150697|NCT02632357|Neurodynamics|neurodynamics
150698|NCT02632344|Laryngeal papilloma, recurrent|laryngeal papilloma, recurrent
150699|NCT02632344|Respiratory papillomatosis|respiratory papillomatosis
150700|NCT02632344|Juvenile-onset recurrent respiratory papillomatosis|juvenile-onset recurrent respiratory papillomatosis
150701|NCT02632344|Human papillomavirus|human papillomavirus
150702|NCT02632344|Virally-related diseases|virally-related diseases
150703|NCT02632331|Food effect|food effect
150704|NCT02632331|Pharmacokinetics|pharmacokinetics
150705|NCT02632331|ASP8825|asp8825
150706|NCT02632331|XP13512|xp13512
150707|NCT02632305|unresectable biliary tract cancer|unresectable biliary tract cancer
150708|NCT02632305|nab-paclitaxel|nab-paclitaxel
150709|NCT02632305|cisplatin|cisplatin
150710|NCT02632305|gemcitabine|gemcitabine
150711|NCT02632279|Parkinson's disease|parkinson's disease
150712|NCT02632279|Deep Brain Stimulation|deep brain stimulation
150713|NCT02632279|Subthalamic nucleus|subthalamic nucleus
150714|NCT02632279|Tryptophan depletion|tryptophan depletion
150715|NCT02632279|Serotonin|serotonin
150716|NCT02632266|prematurity|prematurity
150717|NCT02632266|growth|growth
150718|NCT02632266|nutrition|nutrition
150719|NCT02632266|human milk fortifier|human milk fortifier
150720|NCT02632253|exercise therapy|exercise therapy
150721|NCT02632253|GUCH|guch
150722|NCT02632253|ventricular ejection fraction|ventricular ejection fraction
150723|NCT02632253|HIIT|hiit
150724|NCT02632253|MICE|mice
150725|NCT02632240|gingival recession|gingival recession
150726|NCT02632240|mucogingival surgery|mucogingival surgery
150727|NCT02632240|collagen matrix|collagen matrix
150728|NCT02632240|connective tissue graft|connective tissue graft
150729|NCT02632240|tunnel technique|tunnel technique
150730|NCT02632214|Face processing|face processing
150731|NCT02632214|asymmetry|asymmetry
150732|NCT02632214|deaf|deaf
150733|NCT02632214|fMRI|fmri
150734|NCT02632201|gastric cancer|gastric cancer
150735|NCT02632201|liver metastasis|liver metastasis
150736|NCT02632201|PIK-HER2 cells|pik-her2 cells
150737|NCT02632201|dendritic cell-precision multiple antigen T cells|dendritic cell-precision multiple antigen t cells
150738|NCT02632188|Recurrence|recurrence
150739|NCT02632188|Metastasis|metastasis
150740|NCT02632188|liver cancer|liver cancer
150741|NCT02632175|Ulcerative Colitis|ulcerative colitis
150742|NCT02632149|PINS Vagus Nerve Stimulator|pins vagus nerve stimulator
150743|NCT02632136|Laparoscopic|laparoscopic
150744|NCT02632136|TAP Block|tap block
150745|NCT02632136|Total extra peritoneal Inguinal hernia repair|total extra peritoneal inguinal hernia repair
150746|NCT02632123|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
150747|NCT02632123|outcome|outcome
150748|NCT02632123|prognosis|prognosis
150749|NCT02632123|survival|survival
150750|NCT02632110|Actinic Keratosis|actinic keratosis
150751|NCT02632097|inguinal hernia|inguinal hernia
150752|NCT02632097|mesh fixation|mesh fixation
150753|NCT02632097|glue|glue
150754|NCT02632097|cyanoacrylate|cyanoacrylate
150755|NCT02632097|Lichtenstein|lichtenstein
150756|NCT02632097|ambulatory surgery|ambulatory surgery
150757|NCT02632071|Breast Cancer|breast cancer
150758|NCT02632071|Breast Carcinoma|breast carcinoma
150759|NCT02632071|Breast tumors|breast tumors
150760|NCT02632071|Cancer of the Breast|cancer of the breast
150761|NCT02632071|Malignant tumor of the breast|malignant tumor of the breast
150762|NCT02632071|Metastatic Breast Cancer|metastatic breast cancer
150763|NCT02632071|Unresectable breast cancer|unresectable breast cancer
150764|NCT02632045|Breast Neoplasms|breast neoplasms
150765|NCT02632045|Breast Cancer|breast cancer
150766|NCT02632045|Breast Carcinoma|breast carcinoma
150767|NCT02632045|Breast tumors|breast tumors
150768|NCT02632045|Cancer of the Breast|cancer of the breast
150769|NCT02632032|Type 1 diabetes|type 1 diabetes
150770|NCT02632032|children|children
150771|NCT02632032|diabetes camps|diabetes camps
150772|NCT02632032|glycemic control|glycemic control
150773|NCT02632019|advanced biliary tract malignant tumor|advanced biliary tract malignant tumor
150774|NCT02632019|dendritic cell|dendritic cell
150775|NCT02632019|precision T cell for neo-antigen|precision t cell for neo-antigen
150776|NCT02632006|PIK-PD-1 Cells|pik-pd-1 cells
150777|NCT02632006|dendritic cell-precision multiple antigen T cells|dendritic cell-precision multiple antigen t cells
150778|NCT02632006|advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
150779|NCT02631993|Psoralen|psoralen
150780|NCT02631993|UVA|uva
150781|NCT02631993|Time-to-treatment|time-to-treatment
150782|NCT02631993|GVL|gvl
150783|NCT02631980|Hepcidin|hepcidin
150784|NCT02631967|Crohn disease|crohn disease
150785|NCT02631967|ileocecal resection|ileocecal resection
150786|NCT02631967|anastomosis|anastomosis
150787|NCT02631967|Kono|kono
150788|NCT02631928|biphasic human insulin|biphasic human insulin
150789|NCT02631928|biosimilar|biosimilar
150790|NCT02631902|Community-based intervention|community-based intervention
150791|NCT02631902|Exercise program|exercise program
150792|NCT02631902|Dietary intervention program|dietary intervention program
150793|NCT02631902|Health promotion|health promotion
150794|NCT02631902|Subjective well-being|subjective well-being
150795|NCT02631902|Cardiovascular risk|cardiovascular risk
150796|NCT02631876|Epithelial ovarian cancer|epithelial ovarian cancer
150797|NCT02631876|Fallopian tube cancer|fallopian tube cancer
150798|NCT02631876|Primary peritoneal cancer|primary peritoneal cancer
150799|NCT02631876|IMGN853|imgn853
150800|NCT02631876|ADC|adc
150801|NCT02631876|Antibody drug conjugate|antibody drug conjugate
150802|NCT02631876|ImmunoGen|immunogen
150803|NCT02631876|Antibody|antibody
150804|NCT02631876|Folate receptor alpha|folate receptor alpha
150805|NCT02631876|mirvetuximab soravtansine|mirvetuximab soravtansine
150806|NCT02631876|Phase 3|phase 3
150807|NCT02631876|platinum-resistant|platinum-resistant
150808|NCT02631850|Constraint-induced movement therapy|constraint-induced movement therapy
150809|NCT02631850|gaming|gaming
150810|NCT02631850|virtual reality|virtual reality
150811|NCT02631850|upper extremity|upper extremity
150812|NCT02631850|CI therapy|ci therapy
150813|NCT02631850|rehabilitation|rehabilitation
150814|NCT02631850|stroke|stroke
150815|NCT02631850|hemiparesis|hemiparesis
150816|NCT02631850|therapy|therapy
150817|NCT02631837|NOTES|notes
150818|NCT02631837|Laparoscopic surgery|laparoscopic surgery
150819|NCT02631824|fragility fractures|fragility fractures
150820|NCT02631824|hip fractures|hip fractures
150821|NCT02631824|augmentation|augmentation
150822|NCT02631824|tip-apex distance|tip-apex distance
150823|NCT02631811|acute leukaemia|acute leukaemia
150824|NCT02631811|supportive / palliative care|supportive / palliative care
150825|NCT02631785|ANXIETY|anxiety
150826|NCT02631785|CBT|cbt
150827|NCT02631785|fMRI|fmri
150828|NCT02631785|Fear conditioning|fear conditioning
150829|NCT02631785|Fear extinction|fear extinction
150830|NCT02631759|Acute intraCerebral Haemorrhage, Epileptic seizures, Lévétiracetam|acute intracerebral haemorrhage, epileptic seizures, lévétiracetam
150831|NCT02631720|Chronic Lung Allograft Dysfunction (CLAD)|chronic lung allograft dysfunction (clad)
150832|NCT02631720|Restrictive chronic lung allograft dysfunction (RCLAD)|restrictive chronic lung allograft dysfunction (rclad)
150833|NCT02631720|Bronchiolitis Obliterans Syndrome (BOS)|bronchiolitis obliterans syndrome (bos)
150834|NCT02631720|CLAD risk factors|clad risk factors
150835|NCT02631720|observational study|observational study
150836|NCT02631668|iron deficiency anemia, vitamin C, ferrous succinate|iron deficiency anemia, vitamin c, ferrous succinate
150837|NCT02631629|Vitamin D|vitamin d
150838|NCT02631629|Fortification|fortification
150839|NCT02631616|Prostatic Neoplasma, Castration-Resistant|prostatic neoplasma, castration-resistant
150840|NCT02631616|neuroendocrine differentiation|neuroendocrine differentiation
150841|NCT02631616|68Ga-DOTATET|68ga-dotatet
150842|NCT02631616|PET/CT|pet/ct
150843|NCT02631590|intra-hepatic biliary system|intra-hepatic biliary system
150844|NCT02631590|extra-hepatic biliary system|extra-hepatic biliary system
150845|NCT02631590|gall bladder|gall bladder
150846|NCT02631590|advanced biliary cancer|advanced biliary cancer
150847|NCT02631590|unresectable|unresectable
150848|NCT02631590|locally advanced|locally advanced
150849|NCT02631590|metastatic disease|metastatic disease
150850|NCT02631564|mCRC;TACE;hepatic infusion;raltitrexed|mcrc;tace;hepatic infusion;raltitrexed
150851|NCT02631551|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
150852|NCT02631538|Subcutaneous|subcutaneous
150853|NCT02631538|Rituximab|rituximab
150854|NCT02631538|Intravenous|intravenous
150855|NCT02631538|Safety|safety
150856|NCT02631538|Efficacy|efficacy
150857|NCT02631538|Sjogren's syndrome|sjogren's syndrome
150858|NCT02631538|Belimumab|belimumab
150859|NCT02631525|Airway extubation|airway extubation
150860|NCT02631525|Anesthesia Recovery Period|anesthesia recovery period
150861|NCT02631525|Desflurane|desflurane
150862|NCT02631525|Propofol|propofol
150863|NCT02631525|Intravenous anesthesia|intravenous anesthesia
150864|NCT02631525|Balanced Anesthesia|balanced anesthesia
150865|NCT02631499|Circulating Tumor Cells|circulating tumor cells
150866|NCT02631499|Hepatoectomy|hepatoectomy
150867|NCT02631499|TACE|tace
150868|NCT02631499|prognosis|prognosis
150869|NCT02631499|relapse|relapse
150870|NCT02631499|Chemoembolization, Therapeutic|chemoembolization, therapeutic
150871|NCT02631486|Rotator Cuff Tears|rotator cuff tears
150872|NCT02631447|Metastatic Melanoma|metastatic melanoma
150873|NCT02631447|BRAF mutation|braf mutation
150874|NCT02631408|spinal fusion|spinal fusion
150875|NCT02631408|topical antibiotics|topical antibiotics
150876|NCT02631408|vancomycin|vancomycin
150877|NCT02631408|surgical site infection|surgical site infection
150878|NCT02631395|Exercise movement techniques|exercise movement techniques
150879|NCT02631382|wet cupping Saudi Arabia|wet cupping saudi arabia
150880|NCT02631343|Kangaroo mother care in the community|kangaroo mother care in the community
150881|NCT02631330|Geriatric Assessment|geriatric assessment
150882|NCT02631330|Physical Education and Training|physical education and training
150883|NCT02631317|acute ischemic stroke|acute ischemic stroke
150884|NCT02631317|intravenous rt-PA thrombolysis|intravenous rt-pa thrombolysis
150885|NCT02631317|process reengineering|process reengineering
150886|NCT02631317|door-to-needle time|door-to-needle time
150887|NCT02631304|Postoperative delirium|postoperative delirium
150888|NCT02631304|Cholinesterase activity|cholinesterase activity
150889|NCT02631304|Buturylcholinesterase activity|buturylcholinesterase activity
150890|NCT02631304|Acetylcholinesterase activity|acetylcholinesterase activity
150891|NCT02631304|Elderly patients|elderly patients
150892|NCT02631304|Cardiac surgery|cardiac surgery
150893|NCT02631265|Type 1 diabetes|type 1 diabetes
150894|NCT02631265|Exercise|exercise
150895|NCT02631265|Hypoglycemia|hypoglycemia
150896|NCT02631265|Insulin pump|insulin pump
150897|NCT02631252|Leukemia|leukemia
150898|NCT02631252|Acute Myelogenous|acute myelogenous
150899|NCT02631252|Phase I|phase i
150900|NCT02631252|Mitoxantrone|mitoxantrone
150901|NCT02631252|Etoposide|etoposide
150902|NCT02631252|Hydroxychloroquine|hydroxychloroquine
150903|NCT02631252|Relapsed|relapsed
150904|NCT02631252|Autophagy inhibitor|autophagy inhibitor
150905|NCT02631252|AML|aml
150906|NCT02631252|Relapsed AML|relapsed aml
150907|NCT02631200|Advance Care Planning|advance care planning
150908|NCT02631200|Palliative care|palliative care
150909|NCT02631200|Frail Elderly|frail elderly
150910|NCT02631200|Renal Dialysis|renal dialysis
151292|NCT02629211|AB Device|ab device
150911|NCT02631187|Grade 2 retraction of the pars tensa of the tympanic membrane|grade 2 retraction of the pars tensa of the tympanic membrane
150912|NCT02631187|Grade 3 retraction of the pars tensa of the tympanic membrane|grade 3 retraction of the pars tensa of the tympanic membrane
150913|NCT02631135|Dexmedetomidine|dexmedetomidine
150914|NCT02631135|cognitive functions|cognitive functions
150915|NCT02631135|MMSE|mmse
150916|NCT02631122|Retroclavicular|retroclavicular
150917|NCT02631122|Supraclavicular|supraclavicular
150918|NCT02631122|Diagphram|diagphram
150919|NCT02631122|hemiparesis|hemiparesis
150920|NCT02631122|nerve block|nerve block
150921|NCT02631122|regional anesthesia|regional anesthesia
150922|NCT02631122|anesthesiology|anesthesiology
150923|NCT02631109|Pegaspargase|pegaspargase
150924|NCT02631109|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
150925|NCT02631109|Epstein Barr virus|epstein barr virus
150926|NCT02631070|Luspatercept|luspatercept
150927|NCT02631070|Transfusion dependent|transfusion dependent
150928|NCT02631070|Lower risk|lower risk
150929|NCT02631070|Low risk|low risk
150930|NCT02631070|Myelodysplastic Syndromes|myelodysplastic syndromes
150931|NCT02631070|ESA refractory|esa refractory
150932|NCT02631070|ESA intolerant|esa intolerant
150933|NCT02631070|ESA ineligible|esa ineligible
150934|NCT02631070|ACE-536|ace-536
150935|NCT02631070|Anemia|anemia
150936|NCT02631070|Ring Sideroblasts|ring sideroblasts
150937|NCT02631070|Require Red Blood Cell Transfusions|require red blood cell transfusions
150938|NCT02631070|MEDALIST|medalist
150939|NCT02631070|MDS|mds
150940|NCT02631070|IPSS-R very low/IPSS-R low/IPSS-R intermediate|ipss-r very low/ipss-r low/ipss-r intermediate
150941|NCT02631044|JCAR017|jcar017
150942|NCT02631044|chimeric antigen receptor|chimeric antigen receptor
150943|NCT02631044|non-Hodgkin lymphoma|non-hodgkin lymphoma
150944|NCT02631044|CAR|car
150945|NCT02631044|CAR T cells|car t cells
150946|NCT02631044|autologous T cell therapy|autologous t cell therapy
150947|NCT02631044|cell therapy|cell therapy
150948|NCT02631044|NHL|nhl
150949|NCT02631031|Chronokinetics|chronokinetics
150950|NCT02631031|chronodynamics|chronodynamics
150951|NCT02631031|chronopharmacology|chronopharmacology
150952|NCT02631031|valsartan|valsartan
150953|NCT02631005|systemic lupus erythematosus|systemic lupus erythematosus
150955|NCT02630992|ear infections|ear infections
150956|NCT02630992|antibiotics|antibiotics
150957|NCT02630992|antibiotic resistance|antibiotic resistance
150958|NCT02630992|pediatrics|pediatrics
150959|NCT02630992|infants|infants
150960|NCT02630992|children|children
150961|NCT02630992|amoxicillin-clavulanate|amoxicillin-clavulanate
150962|NCT02630966|Drug therapy|drug therapy
150963|NCT02630953|Physical Activity|physical activity
150964|NCT02630953|Latinas|latinas
150965|NCT02630953|Spanish-language|spanish-language
150966|NCT02630953|Text-Message|text-message
150967|NCT02630953|English-language|english-language
150968|NCT02630953|Exercise|exercise
150969|NCT02630927|Safety and Tolerability|safety and tolerability
150970|NCT02630927|Pharmacokinetic Study|pharmacokinetic study
150971|NCT02630927|Healthy Volunteer|healthy volunteer
150972|NCT02630927|Pyruvate Kinase|pyruvate kinase
150973|NCT02630927|Rare Genetic|rare genetic
150974|NCT02630914|Epicardial surgical removal|epicardial surgical removal
150975|NCT02630914|Closure of the left atrial|closure of the left atrial
150976|NCT02630914|Left atrial appendage (LAA)|left atrial appendage (laa)
150977|NCT02630888|Bipolar Disorder|bipolar disorder
150978|NCT02630888|Memantine|memantine
150979|NCT02630888|Lithium|lithium
150980|NCT02630888|Aripiprazole|aripiprazole
150981|NCT02630888|Quetiapine|quetiapine
150982|NCT02630888|Central Nervous System Agents|central nervous system agents
150983|NCT02630888|Therapeutic Uses|therapeutic uses
150984|NCT02630888|Pharmacologic Actions|pharmacologic actions
150985|NCT02630888|Psychotropic Drugs|psychotropic drugs
150986|NCT02630888|Cognitive effect of drugs|cognitive effect of drugs
150987|NCT02630862|oxidative stress|oxidative stress
150988|NCT02630862|atherosclerosis|atherosclerosis
150989|NCT02630862|carotid stenosis|carotid stenosis
150990|NCT02630862|oxysterols|oxysterols
150991|NCT02630862|vitamin E|vitamin e
150992|NCT02630862|lipid peroxidation|lipid peroxidation
150993|NCT02630862|antioxidants|antioxidants
150994|NCT02630862|aspirin|aspirin
150995|NCT02630862|dipyridamole|dipyridamole
150996|NCT02630836|mesenchymal stromal cells|mesenchymal stromal cells
150997|NCT02630836|stem cells|stem cells
150998|NCT02630836|elderly|elderly
150999|NCT02630836|allogeneic|allogeneic
151000|NCT02630836|bone marrow|bone marrow
151001|NCT02630836|bone regeneration|bone regeneration
151002|NCT02630836|fracture|fracture
151003|NCT02630797|Bone Health|bone health
151004|NCT02630797|Calcium|calcium
151005|NCT02630797|Osteoporosis|osteoporosis
151006|NCT02630797|Polyphenolics|polyphenolics
151007|NCT02630784|Non-invasive ventilation|non-invasive ventilation
151008|NCT02630784|NIV ventilator|niv ventilator
151009|NCT02630784|Exhalation by a calibrated leak|exhalation by a calibrated leak
151010|NCT02630784|ICU ventilator|icu ventilator
151011|NCT02630784|Respiratory acidosis|respiratory acidosis
151012|NCT02630784|ICU|icu
151013|NCT02630758|depression|depression
151014|NCT02630758|yoga|yoga
151015|NCT02630758|mindfulness|mindfulness
151016|NCT02630745|endodontic treatment|endodontic treatment
151017|NCT02630745|open flap debridement|open flap debridement
151018|NCT02630732|Back School|back school
151019|NCT02630732|Brain School|brain school
151020|NCT02630732|Lumbar surgery|lumbar surgery
151021|NCT02630732|Education|education
151022|NCT02630719|headache|headache
151023|NCT02630628|Lupus Nephritis|lupus nephritis
151024|NCT02630628|mycophenolate mofetil|mycophenolate mofetil
151025|NCT02630628|tacrolimus|tacrolimus
151026|NCT02630615|Circulating tumor cells|circulating tumor cells
151027|NCT02630589|tinnitus|tinnitus
151028|NCT02630589|auditory brainstem implant|auditory brainstem implant
151029|NCT02630589|electrical stimulation|electrical stimulation
151030|NCT02630576|electromyography|electromyography
151031|NCT02630576|neuromuscular blockade|neuromuscular blockade
151032|NCT02630550|Cardiac output|cardiac output
151033|NCT02630550|Intraoperative Monitoring|intraoperative monitoring
151034|NCT02630550|Echocardiography, Transesophageal|echocardiography, transesophageal
151035|NCT02630550|Vascular cross-clamping|vascular cross-clamping
151036|NCT02630550|Endarterectomy|endarterectomy
151037|NCT02630550|Monitoring, Physiologic/instrumentation|monitoring, physiologic/instrumentation
151038|NCT02630550|Cardiography, Impedance|cardiography, impedance
151039|NCT02630537|Cytomegalovirus|cytomegalovirus
151040|NCT02630537|Epstein- Barr virus|epstein- barr virus
151041|NCT02630537|Cell-mediated immunity|cell-mediated immunity
151042|NCT02630537|T-Track® CMV|t-track® cmv
151043|NCT02630537|T-Track® EBV|t-track® ebv
151044|NCT02630537|hemodialysis|hemodialysis
151045|NCT02630537|ELISpot|elispot
151046|NCT02630498|pain|pain
151047|NCT02630498|surgical|surgical
151048|NCT02630498|brachial plexus|brachial plexus
151049|NCT02630485|Randomized Controlled Trial|randomized controlled trial
151050|NCT02630459|Migraine Prevention|migraine prevention
151051|NCT02630459|Headache|headache
151052|NCT02630459|Prophylaxis|prophylaxis
151053|NCT02630446|respite care|respite care
151054|NCT02630446|effectiveness|effectiveness
151055|NCT02630446|cost-effectiveness|cost-effectiveness
151056|NCT02630446|support|support
151058|NCT02630446|dementia|dementia
151059|NCT02630446|community-based|community-based
151060|NCT02630433|Biliary pancreatitis|biliary pancreatitis
151061|NCT02630433|Cholecystectomy|cholecystectomy
151062|NCT02630394|sickle cell disease|sickle cell disease
151063|NCT02630394|acute chest syndrome|acute chest syndrome
151064|NCT02630381|high-energy shock waves|high-energy shock waves
151065|NCT02630368|Advanced Soft-tissue Sarcoma|advanced soft-tissue sarcoma
151066|NCT02630368|Advanced Breast Cancer|advanced breast cancer
151067|NCT02630368|Maximum Tolerated Dose|maximum tolerated dose
151068|NCT02630368|Efficacy and safety|efficacy and safety
151069|NCT02630342|Mock Scanner|mock scanner
151070|NCT02630342|Child Life Specialist|child life specialist
151071|NCT02630342|Patient Preparation|patient preparation
151072|NCT02630342|Child, Preschool|child, preschool
151073|NCT02630342|Child|child
151074|NCT02630342|Anxiety|anxiety
151075|NCT02630342|Human|human
151076|NCT02630342|Anesthesia, General|anesthesia, general
151077|NCT02630329|NOTES|notes
151078|NCT02630329|Benign adnexal disease|benign adnexal disease
151079|NCT02630329|Laparoscopy|laparoscopy
151080|NCT02630316|Treprostinil|treprostinil
151082|NCT02630316|ILD|ild
151083|NCT02630316|CPFE|cpfe
151084|NCT02630316|6 Minute Walk Test|6 minute walk test
151085|NCT02630303|light emitting diode-red light|light emitting diode-red light
151086|NCT02630303|LED-RL|led-rl
151087|NCT02630303|high fluence|high fluence
151088|NCT02630303|skin fibrosis|skin fibrosis
151089|NCT02630303|wound healing|wound healing
151090|NCT02630303|scar|scar
151091|NCT02630303|keloid|keloid
151092|NCT02630303|RCT|rct
151093|NCT02630290|Brachial plexus block|brachial plexus block
151094|NCT02630290|Dexmedetomidine|dexmedetomidine
151095|NCT02630290|Ropivacaine|ropivacaine
151096|NCT02630290|ultrasound-guided nerve block|ultrasound-guided nerve block
151097|NCT02630290|supraclavicular brachial plexus block|supraclavicular brachial plexus block
151098|NCT02630277|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
151099|NCT02630277|High Risk PDR|high risk pdr
151100|NCT02630277|aflibercept|aflibercept
151101|NCT02630277|regression of retinal neovascularization|regression of retinal neovascularization
151102|NCT02630264|clinical trial|clinical trial
151103|NCT02630264|Recombinant Human Endostatin Adenovirus|recombinant human endostatin adenovirus
151104|NCT02630264|randomized|randomized
151105|NCT02630251|Cancer|cancer
151106|NCT02630251|Safety|safety
151107|NCT02630251|GSK2820151|gsk2820151
151108|NCT02630251|Dose escalation|dose escalation
151109|NCT02630251|Tolerability|tolerability
151110|NCT02630251|Pharmacodynamics|pharmacodynamics
151111|NCT02630251|Pharmacokinetics|pharmacokinetics
151112|NCT02630238|Exercise|exercise
151113|NCT02630238|Amino Acids, Branched-Chain|amino acids, branched-chain
151114|NCT02630225|case management|case management
151115|NCT02630225|motivational interviewing|motivational interviewing
151116|NCT02630212|Aortic dissection|aortic dissection
151117|NCT02630212|Aldehyde dehydrogenase 2 polymorphism|aldehyde dehydrogenase 2 polymorphism
151118|NCT02630212|Risk factor|risk factor
151119|NCT02630212|aldehyde dehydrogenase 2|aldehyde dehydrogenase 2
151120|NCT02630173|endodontic treatment|endodontic treatment
151121|NCT02630173|scaling|scaling
151122|NCT02630173|root planning|root planning
151123|NCT02630147|Late preterm|late preterm
151124|NCT02630147|Vanilla|vanilla
151125|NCT02630147|Hypoxic intermittent events|hypoxic intermittent events
151126|NCT02630108|HCC|hcc
151127|NCT02630108|TACE|tace
151128|NCT02630108|Thermal Ablation|thermal ablation
151129|NCT02630108|Safety/Efficacy|safety/efficacy
151130|NCT02630095|anticoagulation|anticoagulation
151131|NCT02630082|HIV Preventive Vaccine|hiv preventive vaccine
151132|NCT02630082|HIV Seronegativity|hiv seronegativity
151133|NCT02630082|Immune Response, Mucosal|immune response, mucosal
151134|NCT02630069|amphetamine type stimulant|amphetamine type stimulant
151135|NCT02630069|adolescents|adolescents
151136|NCT02630056|radiotherapy hematologic toxicity pelvic bone marrow|radiotherapy hematologic toxicity pelvic bone marrow
151137|NCT02630004|Mucositis|mucositis
151138|NCT02630004|Head and Neck cancer|head and neck cancer
151139|NCT02630004|Chemoradiation|chemoradiation
151140|NCT02629991|Prader-Willi Syndrome (PWS)|prader-willi syndrome (pws)
151141|NCT02629991|Hyperphagia|hyperphagia
151142|NCT02629978|pulmonary|pulmonary
151143|NCT02629978|lung|lung
151144|NCT02629978|cancer|cancer
151145|NCT02629978|carcinoma|carcinoma
151146|NCT02629978|nodule|nodule
151147|NCT02629978|malignant|malignant
151148|NCT02629978|radiofrequency ablation|radiofrequency ablation
151149|NCT02629978|RFA|rfa
151150|NCT02629952|glucose tolerance|glucose tolerance
151151|NCT02629952|type 2 diabetes|type 2 diabetes
151152|NCT02629952|blueberry tea|blueberry tea
151153|NCT02629900|Weight Loss|weight loss
151154|NCT02629900|Intermittent fasting|intermittent fasting
151155|NCT02629887|supraglottic airway|supraglottic airway
151156|NCT02629887|neonatal resuscitation|neonatal resuscitation
151157|NCT02629887|ventilation|ventilation
151158|NCT02629887|term infant|term infant
151159|NCT02629874|EA-230|ea-230
151466|NCT02628366|Mortality|mortality
151160|NCT02629874|Inflammatory response|inflammatory response
151161|NCT02629874|Kidney Injury|kidney injury
151162|NCT02629874|Endotoxemia|endotoxemia
151163|NCT02629848|Drug therapy|drug therapy
151164|NCT02629809|Leukemia|leukemia
151165|NCT02629809|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
151166|NCT02629809|CLL|cll
151167|NCT02629809|Mutated immunoglobulin heavy chair variable region|mutated immunoglobulin heavy chair variable region
151168|NCT02629809|IGHV|ighv
151169|NCT02629809|non-del(17p) fluorescence in-situ hybridization|non-del(17p) fluorescence in-situ hybridization
151170|NCT02629809|FISH|fish
151171|NCT02629809|Obinutuzumab|obinutuzumab
151172|NCT02629809|GA101|ga101
151173|NCT02629809|Gazyva|gazyva
151174|NCT02629809|Fludarabine|fludarabine
151175|NCT02629809|Fludarabine Phosphate|fludarabine phosphate
151176|NCT02629809|Fludara|fludara
151177|NCT02629809|Cyclophosphamide|cyclophosphamide
151178|NCT02629809|Cytoxan|cytoxan
151179|NCT02629809|Neosar|neosar
151180|NCT02629809|Ibrutinib|ibrutinib
151181|NCT02629809|PCI-32765|pci-32765
151182|NCT02629809|Imbruvica|imbruvica
151183|NCT02629809|Allopurinol|allopurinol
151184|NCT02629809|Lopurin|lopurin
151185|NCT02629809|Zurinol|zurinol
151186|NCT02629809|Zyloprim|zyloprim
151187|NCT02629809|Valacyclovir|valacyclovir
151188|NCT02629809|Valtrex|valtrex
151189|NCT02629796|Biomarker|biomarker
151190|NCT02629796|CIDP|cidp
151191|NCT02629796|IVIG|ivig
151192|NCT02629796|treatment response|treatment response
151193|NCT02629757|High-grade glioma|high-grade glioma
151194|NCT02629757|chemotherapy|chemotherapy
151195|NCT02629757|β-elemene|β-elemene
151196|NCT02629731|foot|foot
151197|NCT02629731|ankle|ankle
151198|NCT02629731|osteoarthritis|osteoarthritis
151199|NCT02629731|flat foot|flat foot
151200|NCT02629718|neoadjuvant chemotherapy|neoadjuvant chemotherapy
151201|NCT02629718|radical surgery|radical surgery
151202|NCT02629718|cervical carcinoma|cervical carcinoma
151203|NCT02629653|carotid endarterectomy|carotid endarterectomy
151204|NCT02629653|stroke|stroke
151205|NCT02629653|hypothermia|hypothermia
151206|NCT02629653|endovascular cooling|endovascular cooling
151207|NCT02629640|vCJD|vcjd
151208|NCT02629640|prion disease|prion disease
151209|NCT02629640|dementia|dementia
151210|NCT02629640|old-age|old-age
151211|NCT02629640|surveillance|surveillance
151212|NCT02629640|brain banking|brain banking
151213|NCT02629640|public health|public health
151214|NCT02629627|Conjugated Linoleic Acid|conjugated linoleic acid
151215|NCT02629627|Leucine|leucine
151216|NCT02629627|visceral fat area|visceral fat area
151217|NCT02629627|Epicardial Fat|epicardial fat
151218|NCT02629627|Hemodinamic Parameters|hemodinamic parameters
151219|NCT02629601|physical activity|physical activity
151220|NCT02629601|financial incentives|financial incentives
151221|NCT02629601|behavioral economics|behavioral economics
151222|NCT02629588|Coma|coma
151223|NCT02629588|Persistent Vegetative State|persistent vegetative state
151224|NCT02629588|Sensory Stimulation|sensory stimulation
151225|NCT02629497|platelets|platelets
151226|NCT02629497|12-lipoxygenase|12-lipoxygenase
151227|NCT02629497|fatty acids|fatty acids
151228|NCT02629497|DGLA|dgla
151229|NCT02629497|DHA|dha
151230|NCT02629497|EPA|epa
151231|NCT02629497|12-LOX|12-lox
151232|NCT02629484|echocardiography|echocardiography
151233|NCT02629484|hip fracture|hip fracture
151234|NCT02629484|surgery|surgery
151235|NCT02629484|outcomes|outcomes
151236|NCT02629432|MRI|mri
151237|NCT02629432|COPD|copd
151238|NCT02629419|STAT3 deficient Hyper IgE syndrome|stat3 deficient hyper ige syndrome
151239|NCT02629419|Gain of function STAT1 defects|gain of function stat1 defects
151240|NCT02629419|Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED)|autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (apeced)
151241|NCT02629419|IL-17/IL-22 autoantibodies from thymoma|il-17/il-22 autoantibodies from thymoma
151242|NCT02629419|Job's Syndrome (Hyperimmunoglobulin E Syndrome, Buckley Syndrome)|job's syndrome (hyperimmunoglobulin e syndrome, buckley syndrome)
151243|NCT02629406|HIF|hif
151244|NCT02629406|hypoxia|hypoxia
151245|NCT02629406|chemoreflex|chemoreflex
151246|NCT02629406|baroreflex|baroreflex
151247|NCT02629406|MIR210|mir210
151248|NCT02629393|Molybdenum Cofactor Deficiency (MoCD)|molybdenum cofactor deficiency (mocd)
151249|NCT02629393|Molybdenum Cofactor (MoCo) biosynthesis|molybdenum cofactor (moco) biosynthesis
151250|NCT02629393|sulfite oxidase (SO)|sulfite oxidase (so)
151251|NCT02629393|S sulfocysteine (SSC)|s sulfocysteine (ssc)
151252|NCT02629393|xanthine oxidoreductase|xanthine oxidoreductase
151253|NCT02629393|aldehyde oxidase|aldehyde oxidase
151254|NCT02629380|meniscectomy|meniscectomy
151255|NCT02629380|hyaluronic acid|hyaluronic acid
151256|NCT02629380|intra-op injection|intra-op injection
151257|NCT02629380|randomized controlled trial|randomized controlled trial
151258|NCT02629380|placebo|placebo
151259|NCT02629341|woman osteopenia osteoporosis enriched calcium vit D yogurt|woman osteopenia osteoporosis enriched calcium vit d yogurt
151260|NCT02629328|CardioCel|cardiocel
151261|NCT02629328|FDA cleared|fda cleared
151262|NCT02629328|Tri-leaflet repair|tri-leaflet repair
151263|NCT02629328|Aortic valves|aortic valves
151264|NCT02629289|HSP-130|hsp-130
151265|NCT02629289|Pharmacodynamic and Pharmacokinetic equivalence|pharmacodynamic and pharmacokinetic equivalence
151266|NCT02629289|Pegfilgrastim|pegfilgrastim
151267|NCT02629276|neck pain|neck pain
151268|NCT02629276|arm pain|arm pain
151269|NCT02629276|neurodynamic tests|neurodynamic tests
151270|NCT02629276|quantitative sensory testing|quantitative sensory testing
151271|NCT02629276|somatosensory profile|somatosensory profile
151272|NCT02629250|proximal femoral fracture|proximal femoral fracture
151273|NCT02629250|goal-directed therapy|goal-directed therapy
151274|NCT02629250|myocardial injury|myocardial injury
151275|NCT02629250|supernormal oxygen delivery|supernormal oxygen delivery
151276|NCT02629250|elders|elders
151277|NCT02629250|stroke volume maximization|stroke volume maximization
151278|NCT02629237|glaucoma surgery|glaucoma surgery
151279|NCT02629237|educational intervention|educational intervention
151280|NCT02629237|satisfaction|satisfaction
151281|NCT02629237|rural|rural
151282|NCT02629224|Impaired renal function|impaired renal function
151283|NCT02629224|Haemodialysis|haemodialysis
151284|NCT02629224|ASP8825|asp8825
151285|NCT02629224|XP13512|xp13512
151286|NCT02629211|Inflammatory Bowel Diseases|inflammatory bowel diseases
151287|NCT02629211|Colitis, Ulcerative|colitis, ulcerative
151288|NCT02629211|Crohn Disease|crohn disease
151289|NCT02629211|Single-Balloon Enteroscopy|single-balloon enteroscopy
151290|NCT02629211|NaviAid AB™ Device|naviaid ab™ device
151291|NCT02629211|NaviAid AB™ Procedure|naviaid ab™ procedure
151293|NCT02629211|Pediatric IBD|pediatric ibd
151294|NCT02629211|Pediatric Enteroscopy|pediatric enteroscopy
151295|NCT02629198|Vitamin D|vitamin d
151296|NCT02629185|Bone|bone
151297|NCT02629185|Vitamin D|vitamin d
151298|NCT02629185|Cardiovascular|cardiovascular
151299|NCT02629172|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
151300|NCT02629172|Paritaprevir|paritaprevir
151301|NCT02629172|Ombitasvir|ombitasvir
151302|NCT02629172|Ritonavir|ritonavir
151303|NCT02629172|Genotype 1|genotype 1
151304|NCT02629159|Musculoskeletal disease|musculoskeletal disease
151305|NCT02629159|Arthritis|arthritis
151306|NCT02629159|Joint disease|joint disease
151307|NCT02629159|Anti-inflammatory agents|anti-inflammatory agents
151308|NCT02629159|Antirheumatic agents|antirheumatic agents
151309|NCT02629146|Midazolam|midazolam
151310|NCT02629146|Fentanyl|fentanyl
151311|NCT02629133|Intimate Partner Violence|intimate partner violence
151312|NCT02629133|Sheltered Battered Women|sheltered battered women
151313|NCT02629133|Substance Use|substance use
151314|NCT02629120|Chronic Granulomatous Disease|chronic granulomatous disease
151315|NCT02629120|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
151316|NCT02629120|Graft Versus Host Disease|graft versus host disease
151317|NCT02629120|Matched Unrelated Donor BMT|matched unrelated donor bmt
151318|NCT02629120|Nonmyeloablative Conditioning Regimen|nonmyeloablative conditioning regimen
151319|NCT02629107|Sleep|sleep
151320|NCT02629107|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
151321|NCT02629107|Electroencephalogram (EEG)|electroencephalogram (eeg)
151322|NCT02629094|Hepatic Steatosis|hepatic steatosis
151323|NCT02629094|Cardiac Steatosis|cardiac steatosis
151324|NCT02629094|Aldosterone|aldosterone
151325|NCT02629094|Eplerenone|eplerenone
151326|NCT02629094|Mineralcorticoid Receptor|mineralcorticoid receptor
151327|NCT02629081|heartburn|heartburn
151328|NCT02629081|GERD|gerd
151329|NCT02629081|NERD|nerd
151330|NCT02629081|non-erosive reflux disease|non-erosive reflux disease
151331|NCT02629068|Adolescent|adolescent
151332|NCT02629068|Social Support|social support
151333|NCT02629068|Social Media|social media
151334|NCT02629068|Parents|parents
151335|NCT02629068|Shame|shame
151336|NCT02629068|Stigma|stigma
151337|NCT02629055|Non-invasive ventilation|non-invasive ventilation
151338|NCT02629055|Respiratory electromyography|respiratory electromyography
151339|NCT02629042|Anesthesia|anesthesia
151340|NCT02629042|Corticosteroids|corticosteroids
151341|NCT02629042|Dental Emergency|dental emergency
151342|NCT02629042|Irreversible Pulpitis|irreversible pulpitis
151343|NCT02629042|Mandibulae|mandibulae
151344|NCT02629042|Pain Management|pain management
151345|NCT02629042|Partial Endodontic Treatment|partial endodontic treatment
151346|NCT02629003|Positron Emission Tomography|positron emission tomography
151347|NCT02629003|Serotonin|serotonin
151348|NCT02629003|5-HT2A|5-ht2a
151349|NCT02629003|Radioligand|radioligand
151350|NCT02629003|Radiation dosimetry|radiation dosimetry
151351|NCT02629003|Radiation dosage|radiation dosage
151352|NCT02628964|smoking|smoking
151353|NCT02628964|cigarettes|cigarettes
151354|NCT02628938|Halitosis|halitosis
151355|NCT02628938|Oral Malodor|oral malodor
151356|NCT02628938|Miswak|miswak
151357|NCT02628938|Salvadora Persica|salvadora persica
151358|NCT02628925|mass screening|mass screening
151359|NCT02628925|Nursing diagnosis|nursing diagnosis
151360|NCT02628925|Psychiatric Status Rating Scale|psychiatric status rating scale
151361|NCT02628912|Cardiopulmonary Fitness|cardiopulmonary fitness
152264|NCT02624219|Trial|trial
151362|NCT02628912|Long-Term Survivors|long-term survivors
151363|NCT02628912|15-277|15-277
151365|NCT02628912|Survivors|survivors
151366|NCT02628886|maternal and neonatal pneumococcal conjugate vaccination|maternal and neonatal pneumococcal conjugate vaccination
151367|NCT02628886|pneumococcal carriage|pneumococcal carriage
151368|NCT02628873|HSG|hsg
151369|NCT02628873|HyCoSy|hycosy
151370|NCT02628873|Contraception|contraception
151371|NCT02628873|Essure|essure
151372|NCT02628873|Saline Infused sonography|saline infused sonography
151373|NCT02628873|SIS|sis
151374|NCT02628873|Air bubbles|air bubbles
151375|NCT02628860|ferric carboxymaltose|ferric carboxymaltose
151376|NCT02628860|Ferinject®|ferinject®
151377|NCT02628860|pancreatoduodenectomy|pancreatoduodenectomy
151378|NCT02628847|stroke|stroke
151379|NCT02628847|rehabilitation|rehabilitation
151380|NCT02628847|motor skills|motor skills
151381|NCT02628847|sildenafil citrate|sildenafil citrate
151382|NCT02628847|White matter|white matter
151383|NCT02628834|Loading|loading
151384|NCT02628834|Gait|gait
151385|NCT02628834|Multiple Sclerosis|multiple sclerosis
151386|NCT02628834|Manual Therapy|manual therapy
151387|NCT02628808|autism|autism
151388|NCT02628808|asperger|asperger
151389|NCT02628808|Pervasive Developmental Disorder No Otherwise Specify|pervasive developmental disorder no otherwise specify
151390|NCT02628808|gene|gene
151391|NCT02628808|polymorphism|polymorphism
151392|NCT02628808|mutation|mutation
151393|NCT02628795|total hip arthroplasty|total hip arthroplasty
151394|NCT02628795|total knee arthroplasty|total knee arthroplasty
151395|NCT02628782|large bore endovascular catheterization procedures|large bore endovascular catheterization procedures
151396|NCT02628782|Vascular Closure Device|vascular closure device
151397|NCT02628769|Solithromycin|solithromycin
151398|NCT02628769|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
151399|NCT02628769|Inflammation|inflammation
151400|NCT02628769|Macrolide|macrolide
151401|NCT02628730|Atrial Fibrillation|atrial fibrillation
151402|NCT02628730|Ablation|ablation
151403|NCT02628730|Pulmonary vein isolation|pulmonary vein isolation
151404|NCT02628730|Ablation Index|ablation index
151405|NCT02628717|Hepatitis C|hepatitis c
151406|NCT02628717|sofosbuvir|sofosbuvir
151407|NCT02628717|ledipasvir|ledipasvir
151408|NCT02628717|daclatasvir|daclatasvir
151409|NCT02628717|simeprevir|simeprevir
151410|NCT02628704|Karyopharm|karyopharm
151411|NCT02628704|selinexor|selinexor
151412|NCT02628704|KPT-330|kpt-330
151413|NCT02628704|multiple myeloma|multiple myeloma
151414|NCT02628704|SCORE|score
151415|NCT02628678|Prebiotic|prebiotic
151416|NCT02628678|FOS|fos
151417|NCT02628678|fructooligosaccharide|fructooligosaccharide
151418|NCT02628678|polyglycan|polyglycan
151419|NCT02628678|microbiome|microbiome
151420|NCT02628678|microbiota|microbiota
151421|NCT02628678|Healthy Volunteers|healthy volunteers
151422|NCT02628652|Microbiome|microbiome
151423|NCT02628652|FOS|fos
151424|NCT02628652|polyglycan|polyglycan
151425|NCT02628652|prebiotic|prebiotic
151426|NCT02628652|Healthy Volunteers|healthy volunteers
151427|NCT02628626|Incontinence|incontinence
151428|NCT02628626|Diarrhea|diarrhea
151429|NCT02628626|Bile acid|bile acid
151430|NCT02628626|Microbiome|microbiome
151431|NCT02628613|Breast cancer|breast cancer
151432|NCT02628613|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
151433|NCT02628613|TEKT4|tekt4
151434|NCT02628587|Acute Coronary Syndrome|acute coronary syndrome
151435|NCT02628587|Clopidogrel|clopidogrel
151436|NCT02628587|Platelet reactivity|platelet reactivity
151437|NCT02628574|Metastatic|metastatic
151438|NCT02628574|Stage III or IV|stage iii or iv
151439|NCT02628574|recurrent|recurrent
151440|NCT02628574|refractory|refractory
151441|NCT02628574|solid tumors|solid tumors
151442|NCT02628535|B7-H3-expressing neoplasms|b7-h3-expressing neoplasms
151443|NCT02628522|ADRC|adrc
151444|NCT02628522|Celution|celution
151445|NCT02628509|Acquired Von Willebrand|acquired von willebrand
151446|NCT02628509|Trans aortic valve replacement|trans aortic valve replacement
151447|NCT02628509|mechanical circulatory support|mechanical circulatory support
151448|NCT02628470|Cervical pain, cervicalgia|cervical pain, cervicalgia
151449|NCT02628457|occupation ratio|occupation ratio
151450|NCT02628457|pseudoatrophy|pseudoatrophy
151451|NCT02628444|Dengue Fever|dengue fever
151452|NCT02628444|Dengue virus|dengue virus
151453|NCT02628444|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
151454|NCT02628444|CYD Dengue Vaccine|cyd dengue vaccine
151455|NCT02628418|Rehabilitation|rehabilitation
151456|NCT02628418|Robotics|robotics
151457|NCT02628392|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
151458|NCT02628392|Adult|adult
151459|NCT02628392|Developmental Phase II|developmental phase ii
151460|NCT02628379|Genomic Testing|genomic testing
151461|NCT02628379|Cancer of Unknown Primary|cancer of unknown primary
151462|NCT02628379|CUP|cup
151463|NCT02628366|Cluster Randomized Controlled Trial|cluster randomized controlled trial
151464|NCT02628366|Personalized Dialysate Temperature|personalized dialysate temperature
151465|NCT02628366|Cardiovascular Events|cardiovascular events
151467|NCT02628353|Cardiovascular diseases|cardiovascular diseases
151468|NCT02628353|endothelial function|endothelial function
151469|NCT02628353|systolic blood pressure|systolic blood pressure
151470|NCT02628353|metabolomics|metabolomics
151471|NCT02628353|cardiovascular risk factor|cardiovascular risk factor
151472|NCT02628353|bioavailability|bioavailability
151473|NCT02628353|phenolic compounds|phenolic compounds
151474|NCT02628353|hypertension|hypertension
151475|NCT02628327|glaucoma care|glaucoma care
151476|NCT02628327|quality of life|quality of life
151477|NCT02628327|patient satisfaction|patient satisfaction
151478|NCT02628301|Obesity|obesity
151479|NCT02628301|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
151480|NCT02628301|Hypercaloric diet|hypercaloric diet
151481|NCT02628301|Microcirculation|microcirculation
151482|NCT02628301|Microvascular dysfunction|microvascular dysfunction
151483|NCT02628301|Insulin Resistance|insulin resistance
151484|NCT02628301|Insulin Sensitivity|insulin sensitivity
151485|NCT02628301|Insulin signaling|insulin signaling
151486|NCT02628262|Macular hole|macular hole
151487|NCT02628236|Actinic keratosis|actinic keratosis
151488|NCT02628223|glaucoma|glaucoma
151489|NCT02628223|Elevated IOP|elevated iop
151490|NCT02628223|Selective Laser Trabeculoplasty|selective laser trabeculoplasty
151491|NCT02628223|SLT|slt
151492|NCT02628223|open angle glaucoma|open angle glaucoma
151493|NCT02628223|ocular hypertension|ocular hypertension
151494|NCT02628223|Glaucoma, Open Angle, Pseudo-exfoliative|glaucoma, open angle, pseudo-exfoliative
151495|NCT02628223|pigment dispersion syndrome|pigment dispersion syndrome
151496|NCT02628223|Pseudoexfoliation|pseudoexfoliation
151497|NCT02628223|IOP ≥ 21 mmHg|iop ≥ 21 mmhg
151498|NCT02628158|Epiretinal membrane|epiretinal membrane
151499|NCT02628145|Sarcopenia|sarcopenia
151500|NCT02628145|aging|aging
151501|NCT02628145|resistance training|resistance training
151502|NCT02628145|physical functioning|physical functioning
151503|NCT02628132|triple negative|triple negative
151504|NCT02628132|breast cancer|breast cancer
151505|NCT02628132|durvalumab|durvalumab
151506|NCT02628132|paclitaxel|paclitaxel
151507|NCT02628132|safety|safety
151508|NCT02628132|efficacy|efficacy
151509|NCT02628132|PD-L1|pd-l1
151510|NCT02628132|PD-1|pd-1
151511|NCT02628132|Metastatic|metastatic
151512|NCT02628132|AstraZeneca|astrazeneca
151513|NCT02628132|MEDI4736|medi4736
151514|NCT02628119|Hemodialysis|hemodialysis
151515|NCT02628119|vascular access|vascular access
151516|NCT02628119|access flow|access flow
151517|NCT02628080|Hypoxia|hypoxia
151518|NCT02628067|PD1|pd1
151519|NCT02628067|PDL1|pdl1
151520|NCT02628067|PD-1|pd-1
151521|NCT02628067|PD-L1|pd-l1
151522|NCT02628067|MSI|msi
151523|NCT02628067|microsatellite instability|microsatellite instability
151524|NCT02628067|MMR|mmr
151525|NCT02628067|mismatch repair|mismatch repair
151526|NCT02628067|anal carcinoma|anal carcinoma
151527|NCT02628067|anal cancer|anal cancer
151528|NCT02628067|biliary adenocarcinoma|biliary adenocarcinoma
151529|NCT02628067|biliary cancer|biliary cancer
151530|NCT02628067|cholangiocarcinoma|cholangiocarcinoma
151531|NCT02628067|bile duct cancer|bile duct cancer
151532|NCT02628067|neuroendocrine tumor|neuroendocrine tumor
151533|NCT02628067|carcinoid tumor|carcinoid tumor
151534|NCT02628067|endometrial carcinoma|endometrial carcinoma
151535|NCT02628067|endometrial cancer|endometrial cancer
151536|NCT02628067|cervical carcinoma|cervical carcinoma
151537|NCT02628067|cervical cancer|cervical cancer
151538|NCT02628067|vulvar carcinoma|vulvar carcinoma
151539|NCT02628067|vulvar cancer|vulvar cancer
151540|NCT02628067|small cell lung carcinoma|small cell lung carcinoma
151541|NCT02628067|small cell lung cancer|small cell lung cancer
151542|NCT02628067|SCLC|sclc
151543|NCT02628067|mesothelioma|mesothelioma
151544|NCT02628067|thyroid carcinoma|thyroid carcinoma
151545|NCT02628067|thyroid cancer|thyroid cancer
151546|NCT02628067|salivary gland carcinoma|salivary gland carcinoma
151547|NCT02628067|salivary gland cancer|salivary gland cancer
151548|NCT02628067|salivary cancer|salivary cancer
151549|NCT02628067|parotid gland cancer|parotid gland cancer
151550|NCT02628067|advanced solid tumors|advanced solid tumors
151551|NCT02628054|PSG|psg
151552|NCT02628054|Typhoid Vaccine|typhoid vaccine
151553|NCT02628054|Depression|depression
151554|NCT02628054|Inflammation|inflammation
151555|NCT02628041|High-Dose-Rate Brachytherapy|high-dose-rate brachytherapy
151556|NCT02628041|HDR Monotherapy|hdr monotherapy
151557|NCT02628041|LDR monotherapy|ldr monotherapy
151558|NCT02628015|Theory of Mind|theory of mind
151559|NCT02628015|Very Low Birthweight Infants|very low birthweight infants
151560|NCT02628002|antigravity treadmill|antigravity treadmill
151561|NCT02628002|bruce protocol|bruce protocol
151562|NCT02628002|stress myocardial perfusion imaging|stress myocardial perfusion imaging
151563|NCT02628002|single photon emission computed tomography|single photon emission computed tomography
151564|NCT02628002|cardiac catheterization|cardiac catheterization
151565|NCT02628002|[E01.370.370.380.500]|[e01.370.370.380.500]
151566|NCT02628002|[E01.370.370.380.250]|[e01.370.370.380.250]
151567|NCT02628002|[E01.370.370.380.140]|[e01.370.370.380.140]
151568|NCT02627937|Pediatric obstructive sleep apnea/hypopnea syndrome|pediatric obstructive sleep apnea/hypopnea syndrome
151569|NCT02627937|Polysomnography|polysomnography
151570|NCT02627924|Rheumatoid Arthritis|rheumatoid arthritis
151571|NCT02627924|Work productivity|work productivity
151572|NCT02627924|patient-reported QoL(Quality of Life)|patient-reported qol(quality of life)
151573|NCT02627898|Green tea extract|green tea extract
151574|NCT02627898|Arterial stiffness|arterial stiffness
151575|NCT02627898|PWVao|pwvao
151576|NCT02627885|internet treatment|internet treatment
151577|NCT02627885|cognitive behavioral therapy|cognitive behavioral therapy
151578|NCT02627885|level of functioning|level of functioning
151579|NCT02627885|quality of life|quality of life
151580|NCT02627833|induced Sputum|induced sputum
151581|NCT02627833|lung clearance index|lung clearance index
151582|NCT02627833|miRNA|mirna
151583|NCT02627833|inflammation|inflammation
151584|NCT02627833|chronic lung disease|chronic lung disease
151585|NCT02627820|Senile|senile
151586|NCT02627820|ATTRwt|attrwt
151587|NCT02627820|wild-type transthyretin amyloidosis|wild-type transthyretin amyloidosis
151588|NCT02627807|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
151589|NCT02627807|Intensity modulated radiotherapy|intensity modulated radiotherapy
151590|NCT02627807|Clinical target volume|clinical target volume
151591|NCT02627807|Clinical trial|clinical trial
151592|NCT02627794|Middle Meatus|middle meatus
151593|NCT02627794|Synechiae|synechiae
151594|NCT02627794|Endoscopic Sinus Surgery|endoscopic sinus surgery
151595|NCT02627794|Silastic spacer|silastic spacer
151596|NCT02627794|Restora™ steroid eluting MM spacer|restora™ steroid eluting mm spacer
151597|NCT02627781|acute appendicitis|acute appendicitis
151598|NCT02627781|Alvarado Score|alvarado score
151599|NCT02627781|negative appendectomy|negative appendectomy
151600|NCT02627781|right abdominal pain|right abdominal pain
151601|NCT02627768|STELARA|stelara
151602|NCT02627768|Psoriatic Arthritis|psoriatic arthritis
151603|NCT02627768|Ustekinumab|ustekinumab
151604|NCT02627755|videolaryngoscopy|videolaryngoscopy
151605|NCT02627755|difficult airway management|difficult airway management
151606|NCT02627716|Psychiatric advanced directives|psychiatric advanced directives
151607|NCT02627716|Joint crisis plan|joint crisis plan
151608|NCT02627716|Schizophrenia|schizophrenia
151609|NCT02627716|Primary care|primary care
151610|NCT02627677|CML|cml
151611|NCT02627677|CP-CML|cp-cml
151612|NCT02627677|Leukemia|leukemia
151613|NCT02627677|Leukemia, Myeloid|leukemia, myeloid
151614|NCT02627677|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
151615|NCT02627677|Neoplasms by Histologic Type|neoplasms by histologic type
151616|NCT02627677|Neoplasms|neoplasms
151617|NCT02627677|Myeloproliferative Disorders|myeloproliferative disorders
151618|NCT02627677|Bone Marrow Diseases|bone marrow diseases
151619|NCT02627677|Hematologic Diseases|hematologic diseases
151620|NCT02627664|Idiopathic early|idiopathic early
151621|NCT02627664|Parkinson's Disease|parkinson's disease
151622|NCT02627638|osteopathy|osteopathy
151623|NCT02627638|complementary therapy|complementary therapy
151624|NCT02627638|symptoms in cancer patients|symptoms in cancer patients
151625|NCT02627625|inhalation|inhalation
151626|NCT02627625|anticholinergic|anticholinergic
151627|NCT02627612|veteran|veteran
151628|NCT02627612|mentorship|mentorship
151629|NCT02627612|Iraq/Afghanistan|iraq/afghanistan
151630|NCT02627612|treatment|treatment
151631|NCT02627612|PTSD|ptsd
151632|NCT02627612|Suicide|suicide
151633|NCT02627612|Criminal Activity|criminal activity
151634|NCT02627599|COPD|copd
151635|NCT02627599|LTOT|ltot
151636|NCT02627599|Long-Term Oxygen Therapy|long-term oxygen therapy
151637|NCT02627599|Oxygen Conserving Device|oxygen conserving device
151638|NCT02627599|Quality of Life|quality of life
151639|NCT02627599|Six Minute Walk Distance|six minute walk distance
151640|NCT02627599|Portable Oxygen Source|portable oxygen source
151641|NCT02627599|Oxygen Saturation|oxygen saturation
151642|NCT02627599|Breath Responsive Variable Bolus Oxygen Conserving Device|breath responsive variable bolus oxygen conserving device
151643|NCT02627599|BRVB-OCD|brvb-ocd
151644|NCT02627599|Pulse Oximetry|pulse oximetry
151645|NCT02627586|exercise therapy|exercise therapy
151646|NCT02627586|left ventricular remodeling|left ventricular remodeling
151647|NCT02627586|ventricular ejection fraction|ventricular ejection fraction
151648|NCT02627586|high-intensity interval training|high-intensity interval training
151649|NCT02627573|Cyclophosphamide|cyclophosphamide
151650|NCT02627573|Thymoglobulin|thymoglobulin
151651|NCT02627573|Myelodysplastic Syndromes|myelodysplastic syndromes
151652|NCT02627573|Immunosuppressive Agents|immunosuppressive agents
151653|NCT02627573|Immune System Diseases|immune system diseases
151654|NCT02627573|Busulfan|busulfan
151655|NCT02627573|Fludarabine|fludarabine
151656|NCT02627573|Tacrolimus|tacrolimus
151657|NCT02627573|Mycophenolate mofetil|mycophenolate mofetil
151658|NCT02627573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
151659|NCT02627573|Myeloablative Agonists|myeloablative agonists
151660|NCT02627573|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
151661|NCT02627573|Allogeneic Transplantation|allogeneic transplantation
151662|NCT02627573|Leukemia, Chronic Myeloid|leukemia, chronic myeloid
151663|NCT02627573|Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative|leukemia, myeloid, chronic, atypical, bcr-abl negative
151664|NCT02627560|Administration, topical|administration, topical
151665|NCT02627560|Tranexamic acid|tranexamic acid
151666|NCT02627560|Postoperative care|postoperative care
151667|NCT02627560|Mastectomy|mastectomy
151668|NCT02627547|Flavanones|flavanones
151669|NCT02627547|Endurance-trained athletes|endurance-trained athletes
151670|NCT02627547|Biological availability|biological availability
151671|NCT02627534|Photodynamic therapy|photodynamic therapy
151672|NCT02627534|Ultrasonic debridement|ultrasonic debridement
151673|NCT02627534|Chronic periodontitis|chronic periodontitis
151674|NCT02627534|Type 2 diabetes|type 2 diabetes
151675|NCT02627508|Autism Spectrum Disorder|autism spectrum disorder
151676|NCT02627508|Autism|autism
151677|NCT02627508|Pregnenolone|pregnenolone
151678|NCT02627495|maladaptive plasticity|maladaptive plasticity
151679|NCT02627495|Limb amputation|limb amputation
151680|NCT02627495|phantom limb pain|phantom limb pain
151681|NCT02627495|tDCS|tdcs
151682|NCT02627495|non-invasive brain stimulation|non-invasive brain stimulation
151683|NCT02627469|Microbiota|microbiota
151684|NCT02627469|aged|aged
151685|NCT02627469|oral health|oral health
151686|NCT02627456|Malaria|malaria
151687|NCT02627456|Cryopreserved|cryopreserved
151688|NCT02627456|Infection|infection
151689|NCT02627456|Human|human
151690|NCT02627456|Immunization|immunization
151692|NCT02627417|Dapsone|dapsone
151693|NCT02627404|Bipolar disorders|bipolar disorders
151694|NCT02627404|Genetic|genetic
151695|NCT02627404|Biomarkers|biomarkers
151696|NCT02627404|Circadian rhythm|circadian rhythm
151697|NCT02627391|Aortic valve|aortic valve
151698|NCT02627391|Stenosis|stenosis
151699|NCT02627391|Surgery|surgery
151700|NCT02627365|ART|art
151701|NCT02627365|mobile messaging|mobile messaging
151702|NCT02627365|behaviour|behaviour
151703|NCT02627365|motivation|motivation
151704|NCT02627352|Glaucoma|glaucoma
151705|NCT02627352|Micropulse Transscleral Cyclophotocoagulation|micropulse transscleral cyclophotocoagulation
151706|NCT02627352|Intraocular Pressure|intraocular pressure
151707|NCT02627339|Contrast Sensitivity|contrast sensitivity
151708|NCT02627326|chlorhexidine|chlorhexidine
151709|NCT02627326|endodontic treatment|endodontic treatment
151710|NCT02627313|Feasibility Studies|feasibility studies
151711|NCT02627300|PID|pid
151712|NCT02627261|residual disease|residual disease
151713|NCT02627235|Physical Activity|physical activity
151714|NCT02627235|Cancer Prevention|cancer prevention
151715|NCT02627222|Pro-vitamin A|pro-vitamin a
151716|NCT02627222|Cassava|cassava
151717|NCT02627222|Vitamin A deficiency|vitamin a deficiency
151718|NCT02627222|Retinol Isotope Dilution|retinol isotope dilution
151719|NCT02627222|Preschool children|preschool children
151720|NCT02627222|Nigeria|nigeria
151721|NCT02627209|Angiotensin converting enzyme|angiotensin converting enzyme
151722|NCT02627209|Lysozyme|lysozyme
151723|NCT02627209|Ankylosing spondylitis|ankylosing spondylitis
151724|NCT02627209|Behcet's disease|behcet's disease
151725|NCT02627209|Sarcoidosis|sarcoidosis
151726|NCT02627209|Syphilis|syphilis
151727|NCT02627209|Tuberculosis|tuberculosis
151728|NCT02627209|Ocular inflammation|ocular inflammation
151729|NCT02627196|Heart Failure|heart failure
151730|NCT02627196|BAROSTIM NEO®|barostim neo®
151731|NCT02627196|Baroreceptor|baroreceptor
151732|NCT02627196|Baroreflex|baroreflex
151733|NCT02627196|Baroreflex Activation Therapy™|baroreflex activation therapy™
151734|NCT02627196|New York Heart Associate Class III Heart Failure|new york heart associate class iii heart failure
151735|NCT02627183|Atrial Fibrillation|atrial fibrillation
151736|NCT02627170|Adults|adults
151737|NCT02627144|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
151738|NCT02627144|Avastin|avastin
151739|NCT02627144|Bevacizumab|bevacizumab
151740|NCT02627131|Autism|autism
151741|NCT02627131|Stem Cells|stem cells
151742|NCT02627105|weight loss|weight loss
151743|NCT02627066|Exercise|exercise
151744|NCT02627066|Nutrition|nutrition
151745|NCT02627066|Hemodialysis|hemodialysis
151746|NCT02627014|Chronic Migraine|chronic migraine
151747|NCT02627014|Temporomandibular Disorders|temporomandibular disorders
151748|NCT02627014|Physical Therapy|physical therapy
151749|NCT02627014|Manual Therapy|manual therapy
151750|NCT02627014|Home physical Therapy|home physical therapy
151751|NCT02626988|Diet Diversity|diet diversity
151752|NCT02626988|Biodiversity|biodiversity
151753|NCT02626988|Agrobiodiversity|agrobiodiversity
151754|NCT02626988|Nutrition|nutrition
151755|NCT02626988|Vietnam|vietnam
151756|NCT02626975|knee|knee
151757|NCT02626975|short hamstring autograft|short hamstring autograft
151758|NCT02626975|ligament|ligament
151759|NCT02626975|MRI|mri
151760|NCT02626962|melanoma|melanoma
151761|NCT02626949|HIV|hiv
151762|NCT02626949|AIDS|aids
151763|NCT02626949|Mindfulness|mindfulness
151764|NCT02626949|Mindfulness-based stress reduction|mindfulness-based stress reduction
151765|NCT02626949|Stress|stress
151766|NCT02626949|Intervention|intervention
151767|NCT02626949|Inflammation|inflammation
151768|NCT02626936|Type 1 diabetes|type 1 diabetes
151769|NCT02626936|Artificial pancreas|artificial pancreas
151770|NCT02626936|Closed-loop system|closed-loop system
151771|NCT02626936|Postprandial glucose control|postprandial glucose control
151772|NCT02626936|Hypoglycemia|hypoglycemia
151773|NCT02626936|Insulin|insulin
151774|NCT02626936|Glucagon|glucagon
151775|NCT02626910|Disability|disability
151776|NCT02626910|Activity of Daily Living|activity of daily living
151777|NCT02626910|Patient Satisfaction|patient satisfaction
151778|NCT02626897|Sarcoidosis|sarcoidosis
151779|NCT02626897|Daily activity|daily activity
151780|NCT02626897|Exercise|exercise
151781|NCT02626897|Accelerometer|accelerometer
151782|NCT02626845|Granulomatosis with Polyangiitis|granulomatosis with polyangiitis
151783|NCT02626845|Wegener's Granulomatosis|wegener's granulomatosis
151784|NCT02626845|GPA|gpa
151785|NCT02626845|Rituximab|rituximab
151786|NCT02626845|Rituxan|rituxan
151787|NCT02626845|ENT GPA|ent gpa
151788|NCT02626832|vasopressin|vasopressin
151789|NCT02626832|AVP|avp
151790|NCT02626832|NMDA|nmda
151791|NCT02626832|osmolality|osmolality
151792|NCT02626819|Obesity|obesity
151793|NCT02626819|Weight Management|weight management
151794|NCT02626819|Primary Care|primary care
151795|NCT02626819|Health Coach|health coach
151796|NCT02626819|iPad|ipad
151797|NCT02626819|Goal Setting|goal setting
151798|NCT02626819|5As|5as
151799|NCT02626819|technology|technology
151800|NCT02626806|exercise test|exercise test
151801|NCT02626806|HS -troponin|hs -troponin
151802|NCT02626806|Coronary artery disease|coronary artery disease
151803|NCT02626793|Plaque psoriasis|plaque psoriasis
151804|NCT02626793|Apremilast|apremilast
151805|NCT02626793|Otezla®|otezla®
151806|NCT02626793|LAPIS-Pso|lapis-pso
151807|NCT02626793|Observational|observational
151808|NCT02626793|CC-10004|cc-10004
151809|NCT02626793|non-interventional|non-interventional
151810|NCT02626793|Germany|germany
151811|NCT02626767|high-intensity interval training|high-intensity interval training
151812|NCT02626767|adolescents|adolescents
151813|NCT02626767|school-based exercise|school-based exercise
151814|NCT02626767|cardiometabolic health|cardiometabolic health
151815|NCT02626754|Sunitinib, 2/1 schedule, Renal cell carcinoma|sunitinib, 2/1 schedule, renal cell carcinoma
151816|NCT02626702|immune modulators|immune modulators
151817|NCT02626702|IVF outcomes|ivf outcomes
151818|NCT02626702|relationship|relationship
151819|NCT02626689|Beta-Thalassemia|beta-thalassemia
151820|NCT02626689|Quality of Life|quality of life
151821|NCT02626689|Healthcare Utilization|healthcare utilization
151822|NCT02626689|Transfusion dependent (TD) β-thalassemia|transfusion dependent (td) β-thalassemia
151823|NCT02626689|Non-transfusion dependent β-thalassemia|non-transfusion dependent β-thalassemia
151824|NCT02626689|Standard of care|standard of care
151825|NCT02626689|TransQoL|transqol
151826|NCT02626689|SF36v2|sf36v2
151827|NCT02626689|Fact-An|fact-an
151828|NCT02626689|NTD beta-thalassemia PRO|ntd beta-thalassemia pro
151829|NCT02626676|renal dialysis, hyperphosphatemia, educational programme|renal dialysis, hyperphosphatemia, educational programme
151830|NCT02626637|children with cancer|children with cancer
151831|NCT02626637|fatigue|fatigue
151832|NCT02626637|physical activity|physical activity
151833|NCT02626598|facial wrinkles|facial wrinkles
151834|NCT02626598|photoaging|photoaging
151835|NCT02626585|rhinoplasty|rhinoplasty
151836|NCT02626585|postrhinoplasty taping|postrhinoplasty taping
151837|NCT02626585|edema|edema
151838|NCT02626585|draping|draping
151839|NCT02626585|postoperative edema|postoperative edema
151840|NCT02626585|nasal skin thickness|nasal skin thickness
151841|NCT02626585|supratip fullness|supratip fullness
151842|NCT02626585|postoperative swelling|postoperative swelling
151843|NCT02626533|Cytokines|cytokines
151844|NCT02626507|ER+/HER2|er+/her2
151845|NCT02626481|Multiple Myeloma|multiple myeloma
151846|NCT02626481|Cancer|cancer
151847|NCT02626481|refractory|refractory
151848|NCT02626481|daratumumab|daratumumab
151849|NCT02626455|Clinical trial, Phase III|clinical trial, phase iii
151850|NCT02626455|Phosphatidylinositol-3-kinase|phosphatidylinositol-3-kinase
151851|NCT02626455|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
151852|NCT02626455|Indolent B-cell non-Hodgkin's lymphoma|indolent b-cell non-hodgkin's lymphoma
151853|NCT02626442|Cognition|cognition
151854|NCT02626442|Exercise|exercise
151855|NCT02626416|Telemedicine|telemedicine
151856|NCT02626403|vegetative state|vegetative state
151857|NCT02626403|minimally conscious state|minimally conscious state
151858|NCT02626403|disorder of consciousness|disorder of consciousness
151859|NCT02626403|transcranial current direct stimulation|transcranial current direct stimulation
151860|NCT02626403|non invasive brain stimulation|non invasive brain stimulation
151861|NCT02626403|neuromodulation|neuromodulation
151862|NCT02626377|Informal caregivers|informal caregivers
151863|NCT02626377|Elderly|elderly
151864|NCT02626377|Quality of life|quality of life
151865|NCT02626377|Cost effectiveness|cost effectiveness
151866|NCT02626377|Cohort study|cohort study
151867|NCT02626377|Randomized study|randomized study
151868|NCT02626351|postnatal|postnatal
151869|NCT02626312|Liver Cancer|liver cancer
151870|NCT02626312|Impaired Liver Function|impaired liver function
151871|NCT02626312|Liver tumors|liver tumors
151872|NCT02626312|Hepatocellular carcinoma|hepatocellular carcinoma
151873|NCT02626312|HCC|hcc
151874|NCT02626312|Cholangiocarcinoma|cholangiocarcinoma
151875|NCT02626312|Liver metastases|liver metastases
151876|NCT02626312|Low functional liver volume|low functional liver volume
151877|NCT02626312|Radiation therapy|radiation therapy
151878|NCT02626312|XRT|xrt
151879|NCT02626312|Chemotherapy|chemotherapy
151880|NCT02626312|Questionnaire|questionnaire
151881|NCT02626312|Survey|survey
151882|NCT02626312|High dose radiotherapy|high dose radiotherapy
151883|NCT02626299|Preterm birth, very low birth weight|preterm birth, very low birth weight
151884|NCT02626286|HIV|hiv
151885|NCT02626286|Men who have sex with men|men who have sex with men
151886|NCT02626273|obesity|obesity
151887|NCT02626273|adolescents|adolescents
151888|NCT02626273|physical activity|physical activity
151889|NCT02626273|adipocytes|adipocytes
151890|NCT02626273|osteocytes|osteocytes
151891|NCT02626273|weight loss|weight loss
151892|NCT02626273|bone|bone
151893|NCT02626273|fat|fat
151894|NCT02626247|elderly|elderly
151895|NCT02626234|cMET, INC280, rosuvastatin, digoxin|cmet, inc280, rosuvastatin, digoxin
151896|NCT02626208|Contraceptive vaginal ring|contraceptive vaginal ring
151897|NCT02626195|malnutrition|malnutrition
151898|NCT02626195|nutrition|nutrition
151899|NCT02626195|nutritional support|nutritional support
151900|NCT02626195|hepatobiliary pancreatic cancer|hepatobiliary pancreatic cancer
151901|NCT02626195|hepatobiliary pancreatic surgery|hepatobiliary pancreatic surgery
151902|NCT02626169|15-epi-lipoxin A4|15-epi-lipoxin a4
151903|NCT02626169|inflammation|inflammation
151904|NCT02626169|atherosclerosis|atherosclerosis
151905|NCT02626156|post healed venous leg ulcer|post healed venous leg ulcer
151906|NCT02626156|posted healed diabetic foot ulcer|posted healed diabetic foot ulcer
151907|NCT02626130|Kidney Cancer|kidney cancer
151908|NCT02626130|Tremelimumab|tremelimumab
151909|NCT02626130|Cryoablation|cryoablation
151910|NCT02626130|Cryoprobe|cryoprobe
151911|NCT02626104|lactoferrin|lactoferrin
151912|NCT02626104|clostridium difficile|clostridium difficile
151913|NCT02626104|antibiotic associated diarrhoea|antibiotic associated diarrhoea
151914|NCT02626104|children|children
151915|NCT02626104|antibiotic therapy|antibiotic therapy
151916|NCT02626104|diarrhoea|diarrhoea
151917|NCT02626091|Anastomotic perfusion|anastomotic perfusion
151918|NCT02626091|ICG Fluorescence|icg fluorescence
151919|NCT02626091|Enhanced reality|enhanced reality
151920|NCT02626091|Left-sided colonic resection|left-sided colonic resection
151921|NCT02626078|Malnutrition|malnutrition
151922|NCT02626078|Food practices|food practices
151923|NCT02626078|Elderly|elderly
151924|NCT02626078|Nursing Home|nursing home
151925|NCT02626078|Aging|aging
151926|NCT02626078|Nutritional status|nutritional status
151927|NCT02626078|Quality of life|quality of life
151928|NCT02626065|Melanoma|melanoma
151929|NCT02626065|Anti-PD1 monoclonal antibodies|anti-pd1 monoclonal antibodies
151930|NCT02626065|Immune modulation|immune modulation
151931|NCT02626065|BRAF|braf
151932|NCT02626052|Skull vibration induced nystagmus test|skull vibration induced nystagmus test
151933|NCT02626052|mastoid vibration test|mastoid vibration test
151934|NCT02626039|Metastatic Breast Cancer|metastatic breast cancer
151935|NCT02626039|CTCs|ctcs
151936|NCT02626039|cfDNA|cfdna
151937|NCT02626039|genomics|genomics
151938|NCT02626039|somatic mutations|somatic mutations
151939|NCT02626000|Recurrent Metastatic Squamous Cell Carcinoma Head and Neck|recurrent metastatic squamous cell carcinoma head and neck
151940|NCT02625987|Appendicectomy, wound complications, skin closure|appendicectomy, wound complications, skin closure
151941|NCT02625961|PD1|pd1
151942|NCT02625961|PDL1|pdl1
151943|NCT02625961|PD-L1|pd-l1
151944|NCT02625961|PD-1|pd-1
151945|NCT02625948|Intracerebral Hemorrhage|intracerebral hemorrhage
151946|NCT02625948|tranexamic acid|tranexamic acid
151947|NCT02625948|spot sign|spot sign
151948|NCT02625935|Prosigna|prosigna
151949|NCT02625935|estrogen receptor positive|estrogen receptor positive
151950|NCT02625935|node negative|node negative
151951|NCT02625935|HER2 negative|her2 negative
151952|NCT02625922|Serelaxin,|serelaxin,
151953|NCT02625922|Chronic heart failure,|chronic heart failure,
151954|NCT02625922|Spiroergometry,|spiroergometry,
151955|NCT02625922|Troponin,|troponin,
151956|NCT02625922|New York Heart Association (NYHA) functional Class II/III,|new york heart association (nyha) functional class ii/iii,
151957|NCT02625922|Left ventricular ejection fraction,|left ventricular ejection fraction,
151958|NCT02625896|Aviation|aviation
151959|NCT02625896|Parachuting|parachuting
151960|NCT02625883|Resuscitation, quality of life|resuscitation, quality of life
151961|NCT02625857|Prostatic Neoplasms, Castration-Resistant|prostatic neoplasms, castration-resistant
151962|NCT02625857|JNJ-64041809|jnj-64041809
151963|NCT02625857|Listeria monocytogenes|listeria monocytogenes
151964|NCT02625831|ficolin-3|ficolin-3
151965|NCT02625831|anti-ficolin-3 antibodies|anti-ficolin-3 antibodies
151966|NCT02625831|lupus nephritis|lupus nephritis
151967|NCT02625831|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
151968|NCT02625831|biomarker|biomarker
151969|NCT02625818|Emergency Services, Psychiatric|emergency services, psychiatric
151970|NCT02625818|Prognosis|prognosis
151971|NCT02625818|Biological markers|biological markers
151972|NCT02625818|Anxiety|anxiety
151973|NCT02625818|Panic|panic
151974|NCT02625818|Psychomotor Agitation|psychomotor agitation
151975|NCT02625818|Self-injurious Behavior|self-injurious behavior
151976|NCT02625792|Post ESD ulcer|post esd ulcer
151977|NCT02625792|Bleeding|bleeding
151978|NCT02625792|Prophylaxis|prophylaxis
151979|NCT02625779|Bipolar depression|bipolar depression
151980|NCT02625779|Cytidine|cytidine
151981|NCT02625779|Creatine|creatine
151982|NCT02625779|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
151983|NCT02625766|Operative vs. Non-operative|operative vs. non-operative
151984|NCT02625766|LC pelvic fracture|lc pelvic fracture
151985|NCT02625766|Complications|complications
151986|NCT02625753|photorefractive keratectomy|photorefractive keratectomy
151987|NCT02625753|pain|pain
151988|NCT02625753|analgesia|analgesia
151989|NCT02625753|opioid|opioid
151990|NCT02625727|knee osteoarthritis|knee osteoarthritis
151991|NCT02625727|hyaluronic acid|hyaluronic acid
151992|NCT02625727|corticosteroid|corticosteroid
151993|NCT02625727|intra-articular injection|intra-articular injection
151994|NCT02625727|therapeutic effect|therapeutic effect
151995|NCT02625701|operative mortality|operative mortality
151996|NCT02625701|myocardial infarct, arrhythmia, heart failure, stroke|myocardial infarct, arrhythmia, heart failure, stroke
151997|NCT02625701|pneumonia, atelectasis, acute lung injury|pneumonia, atelectasis, acute lung injury
151998|NCT02625701|surgical site infection|surgical site infection
151999|NCT02625701|acute kidney injury|acute kidney injury
152000|NCT02625701|body weight|body weight
152001|NCT02625662|muscular dystrophy|muscular dystrophy
152002|NCT02625662|natural history|natural history
152003|NCT02625662|genetic profilling|genetic profilling
152004|NCT02625649|Roux-en-Y gastric bypass|roux-en-y gastric bypass
152005|NCT02625649|obesity|obesity
152006|NCT02625649|type 2 diabetes mellitus|type 2 diabetes mellitus
152007|NCT02625649|diabetic nephropathy|diabetic nephropathy
152008|NCT02625649|diabetic retinopathy|diabetic retinopathy
152009|NCT02625623|Avelumab|avelumab
152010|NCT02625623|Gastric cancer|gastric cancer
152011|NCT02625623|Gastroesophageal junction adenocarcinoma|gastroesophageal junction adenocarcinoma
152012|NCT02625610|Avelumab|avelumab
152013|NCT02625610|Cancer|cancer
152014|NCT02625610|Unresectable|unresectable
152015|NCT02625610|Locally advanced|locally advanced
152016|NCT02625610|Metastatic|metastatic
152017|NCT02625610|Adenocarcinoma of the stomach|adenocarcinoma of the stomach
152018|NCT02625610|Gastro-esophageal junction|gastro-esophageal junction
152019|NCT02625584|Shared Book Reading|shared book reading
152020|NCT02625584|Dialogic Reading|dialogic reading
152021|NCT02625584|Language Development|language development
152022|NCT02625584|Syntax|syntax
152023|NCT02625584|Vocabulary|vocabulary
152024|NCT02625584|Young Children|young children
152025|NCT02625584|Randomised Control Trial|randomised control trial
152026|NCT02625584|Language Intervention|language intervention
152027|NCT02625558|riociguat|riociguat
152028|NCT02625558|saph|saph
152029|NCT02625558|sarcoidosis|sarcoidosis
152030|NCT02625558|sarcoidosis associated pulmonary hypertension|sarcoidosis associated pulmonary hypertension
152031|NCT02625532|Controlled Ovarian stimulation|controlled ovarian stimulation
152032|NCT02625532|Follicular phase|follicular phase
152033|NCT02625532|Luteal phase|luteal phase
152034|NCT02625532|Reproductive Techniques, Assisted|reproductive techniques, assisted
152035|NCT02625519|Controlled ovarian stimulation|controlled ovarian stimulation
152036|NCT02625519|Follicle-stimulating hormone|follicle-stimulating hormone
152037|NCT02625519|Receptor N680S follicle-stimulating hormone receptor (FSHR) gene polymorphism|receptor n680s follicle-stimulating hormone receptor (fshr) gene polymorphism
152038|NCT02625519|Oocyte donors|oocyte donors
152039|NCT02625493|Percutaneous coronary intervention|percutaneous coronary intervention
152040|NCT02625493|Patient Preference|patient preference
152041|NCT02625493|Radial access|radial access
152042|NCT02625493|Femoral access|femoral access
152043|NCT02625493|Coronary angiography|coronary angiography
152044|NCT02625493|Shared decision making|shared decision making
152045|NCT02625467|Keratoconus|keratoconus
152046|NCT02625454|Acetaminophen|acetaminophen
152047|NCT02625454|Labor|labor
152048|NCT02625454|Intrapartum Fever|intrapartum fever
152049|NCT02625454|Maternal Fever|maternal fever
152050|NCT02625454|Fetal Tachycardia|fetal tachycardia
152051|NCT02625454|Intravenous Acetaminophen|intravenous acetaminophen
152052|NCT02625441|Breast cancer|breast cancer
152053|NCT02625441|docetaxel|docetaxel
152054|NCT02625441|pertuzumab|pertuzumab
152055|NCT02625441|trastuzumab|trastuzumab
152056|NCT02625441|HER2|her2
152057|NCT02625402|decision making|decision making
152058|NCT02625402|decision aids|decision aids
152059|NCT02625402|decision quality instruments|decision quality instruments
152060|NCT02625402|osteoarthritis|osteoarthritis
152061|NCT02625402|shared decision making|shared decision making
152062|NCT02625389|scheduled for selective transarterial catheterization|scheduled for selective transarterial catheterization
152063|NCT02625363|Glycemic Index|glycemic index
152064|NCT02625363|Water Intake|water intake
152065|NCT02625363|Glycemic Response|glycemic response
152066|NCT02625350|instant noodle|instant noodle
152067|NCT02625350|water content|water content
152068|NCT02625350|glycemic index|glycemic index
152069|NCT02625350|serving method|serving method
152070|NCT02625298|periapical diseases|periapical diseases
152071|NCT02625298|dental injuries|dental injuries
152073|NCT02625272|hand-assisted laparoscopic surgery|hand-assisted laparoscopic surgery
152074|NCT02625272|right colon cancer|right colon cancer
152075|NCT02625272|complete mesocolic excision|complete mesocolic excision
152076|NCT02625272|no touch isolation|no touch isolation
152077|NCT02625272|recurrence|recurrence
152078|NCT02625272|overall survival|overall survival
152079|NCT02625259|Drug therapy|drug therapy
152080|NCT02625246|bronchiectasis|bronchiectasis
152081|NCT02625246|mesenchymal stem cell|mesenchymal stem cell
152082|NCT02625246|lung|lung
152083|NCT02625246|pulmonary|pulmonary
152084|NCT02625246|interstitial lung disease|interstitial lung disease
152085|NCT02625207|Maraviroc, CYP3A5, pharmacokinetics, pharmacogenomics|maraviroc, cyp3a5, pharmacokinetics, pharmacogenomics
152086|NCT02625181|Decision support|decision support
152087|NCT02625181|Prediction models|prediction models
152088|NCT02625181|PONV|ponv
152089|NCT02625181|prophylaxis|prophylaxis
152090|NCT02625181|Decision Support Systems, Clinical|decision support systems, clinical
152091|NCT02625181|Decision Support Techniques|decision support techniques
152092|NCT02625168|Afatinib|afatinib
152093|NCT02625168|Erlotinib|erlotinib
152094|NCT02625168|Metastatic non-small cell lung cancer|metastatic non-small cell lung cancer
152095|NCT02625168|Efficacy|efficacy
152096|NCT02625168|Safety|safety
152097|NCT02625155|Pharmacogenomics|pharmacogenomics
152098|NCT02625155|Urine Drug Testing|urine drug testing
152099|NCT02625155|antidepressants|antidepressants
152100|NCT02625155|benzodiazepines|benzodiazepines
152101|NCT02625155|opioids|opioids
152102|NCT02625155|muscle relaxants|muscle relaxants
152103|NCT02625155|non-steroidal anti-inflammatory agents|non-steroidal anti-inflammatory agents
152104|NCT02625155|TDRAE|tdrae
152105|NCT02625142|Morning Rounds|morning rounds
152106|NCT02625142|Patient-centered Care|patient-centered care
152107|NCT02625142|Hospital Medicine|hospital medicine
152108|NCT02625142|Pediatrics|pediatrics
152109|NCT02625142|Hospitals, Pediatric|hospitals, pediatric
152110|NCT02625116|Cohort|cohort
152111|NCT02625103|Schizophrenia, Clozapine, TDM, Serum Concentration|schizophrenia, clozapine, tdm, serum concentration
152112|NCT02625090|Drug-resistance|drug-resistance
152113|NCT02625090|focal epilepsy|focal epilepsy
152114|NCT02625090|partial-onset seizures|partial-onset seizures
152115|NCT02625077|Valvuloplasty|valvuloplasty
152116|NCT02625077|Fundoplication|fundoplication
152117|NCT02625077|Acid reflux|acid reflux
152118|NCT02625077|GERD|gerd
152119|NCT02625077|Reflux disease|reflux disease
152120|NCT02625077|Hiatal hernia|hiatal hernia
152121|NCT02625064|ARDS|ards
152122|NCT02625064|biomarkers|biomarkers
152123|NCT02625064|proteomic|proteomic
152124|NCT02625012|Ultraviolet Therapy|ultraviolet therapy
152125|NCT02625012|Vitiligo|vitiligo
152126|NCT02625012|Melanocytes|melanocytes
152127|NCT02625012|Pigmentation|pigmentation
152128|NCT02624999|Head and Neck Cancer|head and neck cancer
152129|NCT02624999|SCCHN|scchn
152130|NCT02624999|R/M SCCHN|r/m scchn
152131|NCT02624999|Carcinoma|carcinoma
152132|NCT02624973|neoadjuvant treatment|neoadjuvant treatment
152133|NCT02624973|personalized medicine|personalized medicine
152134|NCT02624947|RSV|rsv
152135|NCT02624895|"metastatic colorectal cancer gene RAS not mutated WILD TYPE"|"metastatic colorectal cancer gene ras not mutated wild type"
152136|NCT02624882|blistering distal dactylitis|blistering distal dactylitis
152137|NCT02624882|Streptococcus pyogenes|streptococcus pyogenes
152138|NCT02624882|antibiotics|antibiotics
152139|NCT02624869|Hypercholesterolemia|hypercholesterolemia
152140|NCT02624869|Elevated Cholesterol|elevated cholesterol
152141|NCT02624869|High Cholesterol|high cholesterol
152142|NCT02624869|PCSK9 mutations|pcsk9 mutations
152143|NCT02624869|Severe Familial Hypercholesterolemia|severe familial hypercholesterolemia
152144|NCT02624869|evolocumab|evolocumab
152145|NCT02624869|Repatha|repatha
152146|NCT02624869|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
152147|NCT02624869|Homozygous Familial Hypercholesterolemia|homozygous familial hypercholesterolemia
152148|NCT02624869|Pediatric|pediatric
152149|NCT02624869|Paediatric|paediatric
152150|NCT02624856|primary total knee arthroplasty|primary total knee arthroplasty
152151|NCT02624856|liposomal bupivacaine|liposomal bupivacaine
152152|NCT02624804|Diabetes|diabetes
152153|NCT02624791|astigmatism, contact lens, driving|astigmatism, contact lens, driving
152154|NCT02624765|RCT A: Fetal Atrial Flutter without Hydrops|rct a: fetal atrial flutter without hydrops
152155|NCT02624765|RCT B: Fetal Supraventricular Tachycardia without Hydrops|rct b: fetal supraventricular tachycardia without hydrops
152156|NCT02624765|RCT C: Fetal Supraventricular Tachycardia with Hydrops|rct c: fetal supraventricular tachycardia with hydrops
152157|NCT02624752|Oral Nutrition Supplementation|oral nutrition supplementation
152158|NCT02624726|1st line|1st line
152159|NCT02624726|FOLFIRI|folfiri
152160|NCT02624726|Aflibercept|aflibercept
152161|NCT02624726|mCRC|mcrc
152162|NCT02624713|eating disorder|eating disorder
152163|NCT02624713|childhood obesity|childhood obesity
152164|NCT02624713|family based treatment|family based treatment
152165|NCT02624700|ER-negative|er-negative
152166|NCT02624700|PgR-negative|pgr-negative
152167|NCT02624700|Human epidermal growth factor receptor 2 (HER2-negative)|human epidermal growth factor receptor 2 (her2-negative)
152168|NCT02624700|Triple Negative Breast Cancer|triple negative breast cancer
152169|NCT02624700|HER2-negative|her2-negative
152170|NCT02624661|Trigeminal ganglion|trigeminal ganglion
152171|NCT02624661|Glycerol|glycerol
152172|NCT02624661|Nerve block|nerve block
152173|NCT02624648|Sexual Dysfunction|sexual dysfunction
152174|NCT02624648|Postmenopausal women|postmenopausal women
152175|NCT02624648|Sexual desire|sexual desire
152176|NCT02624635|Manual Therapy|manual therapy
152177|NCT02624635|Pain|pain
152178|NCT02624635|Hip|hip
152179|NCT02624635|Muscle Strength|muscle strength
152180|NCT02624622|omphalitis|omphalitis
152181|NCT02624622|neonate|neonate
152182|NCT02624622|developing countries|developing countries
152183|NCT02624596|OCD|ocd
152184|NCT02624583|Fasting|fasting
152185|NCT02624583|Clopidogrel|clopidogrel
152186|NCT02624570|AML|aml
152187|NCT02624570|FLT3|flt3
152188|NCT02624570|ITD|itd
152189|NCT02624570|TKD|tkd
152190|NCT02624570|acute myeloid leukemia|acute myeloid leukemia
152191|NCT02624570|induction|induction
152192|NCT02624570|consolidation|consolidation
152193|NCT02624570|continuation|continuation
152194|NCT02624570|EAP|eap
152195|NCT02624570|ETP|etp
152196|NCT02624570|midostaurin|midostaurin
152197|NCT02624570|PKC412|pkc412
152198|NCT02624557|Hepatic impairment|hepatic impairment
152199|NCT02624557|Healthy volunteers|healthy volunteers
152200|NCT02624557|Clinical pharmacology study|clinical pharmacology study
152201|NCT02624557|BYL719|byl719
152202|NCT02624557|alpelisib|alpelisib
152203|NCT02624531|NACT|nact
152204|NCT02624531|Cervical cancer|cervical cancer
152205|NCT02624531|Fertility sparing|fertility sparing
152206|NCT02624531|Pregnancy|pregnancy
152207|NCT02624531|Treatment Strategy|treatment strategy
152208|NCT02624479|Pharmacokinetics|pharmacokinetics
152209|NCT02624466|Pediatrics|pediatrics
152210|NCT02624466|Nephrology|nephrology
152211|NCT02624466|Dialysis|dialysis
152212|NCT02624453|cryptococcus|cryptococcus
152213|NCT02624453|IMMY LFA|immy lfa
152214|NCT02624453|meningitis|meningitis
152215|NCT02624453|antigen|antigen
152216|NCT02624440|Multiple Myeloma|multiple myeloma
152217|NCT02624440|Infection|infection
152218|NCT02624440|Clarithromycin|clarithromycin
152219|NCT02624440|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
152220|NCT02624427|Glaucoma|glaucoma
152221|NCT02624427|Intraocular Pressure|intraocular pressure
152222|NCT02624388|Genistein|genistein
152223|NCT02624388|Soy|soy
152224|NCT02624388|Chemotherapy side-effects|chemotherapy side-effects
152225|NCT02624388|Pediatric Cancer|pediatric cancer
152226|NCT02624388|Isoflavone|isoflavone
152227|NCT02624362|Odor|odor
152228|NCT02624362|trigger|trigger
152229|NCT02624362|inflammation|inflammation
152230|NCT02624362|nocebo|nocebo
152231|NCT02624336|periodontal disease|periodontal disease
152232|NCT02624336|caries|caries
152233|NCT02624323|ultrasonography|ultrasonography
152234|NCT02624323|catheterization|catheterization
152235|NCT02624323|central line|central line
152236|NCT02624323|mechanical ventilation|mechanical ventilation
152237|NCT02624323|intensive care|intensive care
152238|NCT02624323|axillary vein|axillary vein
152239|NCT02624323|jugular vein|jugular vein
152240|NCT02624323|randomization|randomization
152241|NCT02624297|Coronary artery disease|coronary artery disease
152242|NCT02624297|Chemoreceptors|chemoreceptors
152243|NCT02624297|Sympathetic nerve activity|sympathetic nerve activity
152244|NCT02624297|Exercise|exercise
152245|NCT02624271|gastric cancer|gastric cancer
152246|NCT02624271|gastric precancerous lesions|gastric precancerous lesions
152247|NCT02624271|blood test|blood test
152248|NCT02624232|Anorectal malformation|anorectal malformation
152249|NCT02624232|Anorectal atresia|anorectal atresia
152250|NCT02624232|anorectal stenosis|anorectal stenosis
152251|NCT02624232|Follow-Up Studies|follow-up studies
152252|NCT02624219|A/H5N8|a/h5n8
152253|NCT02624219|AS03|as03
152254|NCT02624219|Controlled|controlled
152255|NCT02624219|Double-Blind|double-blind
152256|NCT02624219|Immunogenicity|immunogenicity
152257|NCT02624219|Inactivated|inactivated
152258|NCT02624219|Influenza|influenza
152259|NCT02624219|MF59|mf59
152260|NCT02624219|Monovalent|monovalent
152261|NCT02624219|Randomized|randomized
152262|NCT02624219|Reactogenicity|reactogenicity
152263|NCT02624219|Safety|safety
152265|NCT02624219|Vaccine|vaccine
152266|NCT02624193|Treatment Adherence|treatment adherence
152267|NCT02624193|Mental Health|mental health
152268|NCT02624193|Well-being|well-being
152269|NCT02624193|Emerging Adults|emerging adults
152270|NCT02624193|Youth|youth
152271|NCT02624128|head and neck cancer|head and neck cancer
152272|NCT02624128|valproic acid|valproic acid
152273|NCT02624128|recurrent|recurrent
152274|NCT02624128|metastatic|metastatic
152275|NCT02624102|Major depressive disorder|major depressive disorder
152276|NCT02624102|Cognitive behavioral therapy|cognitive behavioral therapy
152277|NCT02624102|Trial based cognitive therapy|trial based cognitive therapy
152278|NCT02624102|Behavioral activation|behavioral activation
152279|NCT02624076|unexplained infertility|unexplained infertility
152280|NCT02624076|Acupuncture|acupuncture
152281|NCT02624050|ACEI|acei
152282|NCT02624050|ARB|arb
152283|NCT02624050|Hypotension|hypotension
152284|NCT02624050|General Anesthesia|general anesthesia
152285|NCT02624050|Methohexital|methohexital
152286|NCT02624050|Propofol|propofol
152287|NCT02624037|Inflammatory Bowel Disease, Ulcerative Colitis|inflammatory bowel disease, ulcerative colitis
152288|NCT02624037|Crohn's Disease|crohn's disease
152289|NCT02624037|Pharmacokinetics, Individualized Dosage, Dashboard System|pharmacokinetics, individualized dosage, dashboard system
152290|NCT02624037|Remicade, Infliximab|remicade, infliximab
152291|NCT02623998|Diabetes|diabetes
152292|NCT02623998|Insulin|insulin
152293|NCT02623998|Glargine|glargine
152294|NCT02623998|Metformin|metformin
152295|NCT02623998|Sitagliptin|sitagliptin
152296|NCT02623998|Diet|diet
152297|NCT02623998|Excercise|excercise
152298|NCT02623998|Lifestyle|lifestyle
152299|NCT02623972|inflammatory breast cancer|inflammatory breast cancer
152300|NCT02623972|Human Epidermal Growth Factor 2 Negative Carcinoma of Breast|human epidermal growth factor 2 negative carcinoma of breast
152301|NCT02623959|Advanced Cancers|advanced cancers
152302|NCT02623959|Malignant pleural effusions|malignant pleural effusions
152303|NCT02623959|MPE|mpe
152304|NCT02623959|Indwelling pleural catheter|indwelling pleural catheter
152305|NCT02623959|IPC|ipc
152306|NCT02623959|Questionnaires|questionnaires
152307|NCT02623959|Surveys|surveys
152308|NCT02623959|Fentanyl patch|fentanyl patch
152309|NCT02623959|Fentanyl by vein|fentanyl by vein
152310|NCT02623959|Sublimaze|sublimaze
152311|NCT02623959|Doxycycline|doxycycline
152312|NCT02623959|Vibramycin|vibramycin
152313|NCT02623959|Periostat|periostat
152314|NCT02623959|Doryx|doryx
152315|NCT02623959|:Phone calls|:phone calls
152316|NCT02623946|motor evoked potentials|motor evoked potentials
152317|NCT02623933|HDR monotherapy|hdr monotherapy
152318|NCT02623933|MRI guidance|mri guidance
152319|NCT02623933|Intraprostatic lesion|intraprostatic lesion
152320|NCT02623933|dose paining|dose paining
152321|NCT02623894|Vascular aging.|vascular aging.
152322|NCT02623894|Arterial stiffness.|arterial stiffness.
152323|NCT02623894|Lifestyles.|lifestyles.
152324|NCT02623894|Vascular structure.|vascular structure.
152325|NCT02623894|Telomere length,|telomere length,
152326|NCT02623894|Psychological factors.|psychological factors.
152327|NCT02623894|Inflammatory factors.|inflammatory factors.
152328|NCT02623894|Oxidative stress|oxidative stress
152329|NCT02623881|Cervical pessary|cervical pessary
152330|NCT02623881|Vaginal progesterone|vaginal progesterone
152331|NCT02623881|Twins|twins
152332|NCT02623881|Premature birth|premature birth
152333|NCT02623855|Parks|parks
152334|NCT02623855|Well-being|well-being
152335|NCT02623855|Stress|stress
152336|NCT02623855|Physical Activity|physical activity
152337|NCT02623855|Nature|nature
152338|NCT02623855|Greenspace|greenspace
152339|NCT02623842|urinary incontinence|urinary incontinence
152340|NCT02623842|woman|woman
152341|NCT02623842|radiofrequency|radiofrequency
152342|NCT02623829|scar prophylaxis|scar prophylaxis
152343|NCT02623829|Botulinum Toxin|botulinum toxin
152344|NCT02623764|Alzheimer´s disease|alzheimer´s disease
152345|NCT02623764|Lewy body dementia|lewy body dementia
152346|NCT02623764|Parkinson dementia|parkinson dementia
152347|NCT02623764|EEG|eeg
152348|NCT02623764|Cholinergic index|cholinergic index
152349|NCT02623725|Dengue Fever|dengue fever
152350|NCT02623725|Dengue virus|dengue virus
152351|NCT02623725|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
152352|NCT02623725|CYD Dengue Vaccine|cyd dengue vaccine
152353|NCT02623699|Isis-SOD1Rx|isis-sod1rx
152354|NCT02623699|SOD1|sod1
152355|NCT02623699|ALS|als
152356|NCT02623686|Sleep|sleep
152357|NCT02623686|ICU|icu
152358|NCT02623686|Massage Therapy|massage therapy
152359|NCT02623686|Inhalation Patch|inhalation patch
152360|NCT02623660|Inflammation|inflammation
152361|NCT02623660|Edema|edema
152362|NCT02623660|Arthroplasty|arthroplasty
152363|NCT02623660|Rehabilitation|rehabilitation
152364|NCT02623660|Replacement|replacement
152365|NCT02623660|Knee|knee
152366|NCT02623660|Total Knee Replacement|total knee replacement
152367|NCT02623660|Pain, Postoperative|pain, postoperative
152368|NCT02623660|Exercise Therapy|exercise therapy
152369|NCT02623660|Therapeutics|therapeutics
152370|NCT02623660|Early Ambulation|early ambulation
152371|NCT02623660|Myofunctional Therapy|myofunctional therapy
152372|NCT02623660|Electric Stimulation Therapy|electric stimulation therapy
152373|NCT02623660|Orthopedic Procedures|orthopedic procedures
152374|NCT02623660|Wound Healing|wound healing
152375|NCT02623660|Total Knee Arthroplasty|total knee arthroplasty
152376|NCT02623634|Cuff leak test, relative factors|cuff leak test, relative factors
152377|NCT02623608|type 2 diabetes risk|type 2 diabetes risk
152378|NCT02623608|cardiovascular disease risk|cardiovascular disease risk
152379|NCT02623595|non-small cell lung cancer|non-small cell lung cancer
152380|NCT02623595|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
152381|NCT02623595|Stereotactic body radiotherapy|stereotactic body radiotherapy
152382|NCT02623595|abscopal effect|abscopal effect
152383|NCT02623595|safety|safety
152384|NCT02623595|immunotherapy|immunotherapy
152385|NCT02623556|diagnosis of tuberculosis|diagnosis of tuberculosis
152386|NCT02623556|ESAT6-CFP10|esat6-cfp10
152387|NCT02623556|skin test|skin test
152388|NCT02623556|diagnostic test|diagnostic test
152389|NCT02623530|Nursing|nursing
152390|NCT02623530|Nursing education research|nursing education research
152391|NCT02623530|Critical thinking|critical thinking
152392|NCT02623530|Decision Making|decision making
152393|NCT02623517|CIED|cied
152394|NCT02623517|AF|af
152395|NCT02623517|arrhythmia|arrhythmia
152396|NCT02623517|atrial fibrillation|atrial fibrillation
152397|NCT02623517|cardiac device|cardiac device
152398|NCT02623517|pacemaker|pacemaker
152399|NCT02623517|defibrillator|defibrillator
152400|NCT02623504|Carbamazepine|carbamazepine
152401|NCT02623504|Equetro|equetro
152402|NCT02623504|Bipolar I Disorder|bipolar i disorder
152403|NCT02623504|Bipolar I Disorder in Children|bipolar i disorder in children
152404|NCT02623491|JNJ-55375515|jnj-55375515
152405|NCT02623491|Healthy|healthy
152406|NCT02623491|Placebo|placebo
152407|NCT02623439|hematologic malignancies|hematologic malignancies
152408|NCT02623426|uveitic macular edema|uveitic macular edema
152409|NCT02623426|uveitis|uveitis
152410|NCT02623400|preterm birth|preterm birth
152411|NCT02623400|perinatal stress|perinatal stress
152412|NCT02623400|growth and development|growth and development
152413|NCT02623387|paravertebral block|paravertebral block
152414|NCT02623348|dialysis|dialysis
152415|NCT02623348|end-stage renal disease|end-stage renal disease
152416|NCT02623335|patient decision making|patient decision making
152417|NCT02623335|surgical decision making|surgical decision making
152418|NCT02623335|question prompt list|question prompt list
152419|NCT02623335|shared decision making|shared decision making
152420|NCT02623335|decision support techniques|decision support techniques
152421|NCT02623257|Non-small Cell Lung Cancer|non-small cell lung cancer
152422|NCT02623257|circulating tumor DNA|circulating tumor dna
152423|NCT02623257|amplification refractory mutation system|amplification refractory mutation system
152424|NCT02623244|ovarian endometrioma|ovarian endometrioma
152425|NCT02623244|lower urinary tract symptoms|lower urinary tract symptoms
152426|NCT02623244|sexual dysfunction|sexual dysfunction
152427|NCT02623244|gastrointestinal symptoms|gastrointestinal symptoms
152428|NCT02623218|traumatic brain injury|traumatic brain injury
152429|NCT02623218|acupuncture|acupuncture
152430|NCT02623218|transcranial doppler ultrasound|transcranial doppler ultrasound
152431|NCT02623166|Pneumonia|pneumonia
152432|NCT02623166|Fever|fever
152433|NCT02623166|Diarrhoea|diarrhoea
152434|NCT02623140|Coronary drug eluting stents|coronary drug eluting stents
152435|NCT02623140|Outcomes|outcomes
152436|NCT02623127|Thymic carcinoma|thymic carcinoma
152437|NCT02623127|Sunitinib|sunitinib
152438|NCT02623127|Metastatic|metastatic
152439|NCT02623127|Recurrent|recurrent
152440|NCT02623101|Reflectance confocal microscopy|reflectance confocal microscopy
152441|NCT02623101|Basal cell carcinoma|basal cell carcinoma
152442|NCT02623101|Biopsy|biopsy
152443|NCT02623101|Diagnostics|diagnostics
152444|NCT02623088|Obstructive Sleep Apnea|obstructive sleep apnea
152445|NCT02623088|Endothelial dysfunction|endothelial dysfunction
152446|NCT02623088|Arterial stiffness|arterial stiffness
152447|NCT02623088|PAP therapies|pap therapies
152448|NCT02623049|New oral anticoagulants|new oral anticoagulants
152449|NCT02623049|Blood levels|blood levels
152450|NCT02623049|Octogenarians|octogenarians
152451|NCT02623036|chronotherapy|chronotherapy
152452|NCT02623036|angiotensin converting enzyme inhibitors|angiotensin converting enzyme inhibitors
152453|NCT02623036|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
152454|NCT02623010|Primary CNS lymphoma|primary cns lymphoma
152455|NCT02623010|Ibrutinib|ibrutinib
152456|NCT02623010|Elderly|elderly
152457|NCT02623010|Maintenance|maintenance
152458|NCT02622997|HPV self-sampling|hpv self-sampling
152459|NCT02622971|phototherapy|phototherapy
152460|NCT02622971|cryotherapy|cryotherapy
152461|NCT02622971|exercise|exercise
152462|NCT02622971|fatigue|fatigue
152463|NCT02622971|recovery|recovery
152464|NCT02622958|Social Anxiety Disorder|social anxiety disorder
152465|NCT02622958|Social Phobia|social phobia
152466|NCT02622958|Performance Anxiety|performance anxiety
152467|NCT02622958|Social Anxiety|social anxiety
152468|NCT02622958|Anxiety|anxiety
152469|NCT02622906|Gastrointestinal angiodysplasia|gastrointestinal angiodysplasia
152470|NCT02622906|Pasireotide|pasireotide
152471|NCT02622906|Gastrointestinal bleeding|gastrointestinal bleeding
152472|NCT02622867|Lactobacillus plantarum|lactobacillus plantarum
152473|NCT02622867|Maltodextrin|maltodextrin
152474|NCT02622867|Probiotics|probiotics
152475|NCT02622867|Randomized Controlled Trial|randomized controlled trial
152476|NCT02622854|plasma exchange|plasma exchange
152477|NCT02622854|hypertriglyceridemia|hypertriglyceridemia
152478|NCT02622841|First in man|first in man
152479|NCT02622841|Spinal metastases|spinal metastases
152480|NCT02622841|Stereotactic bodyradiotherapy|stereotactic bodyradiotherapy
152481|NCT02622841|Palliative care|palliative care
152482|NCT02622841|Safety|safety
152483|NCT02622841|Surgical stabilisation|surgical stabilisation
152484|NCT02622828|wheelchairs|wheelchairs
152485|NCT02622828|social participation|social participation
152486|NCT02622815|Hypercoagulation|hypercoagulation
152487|NCT02622815|Thrombosis|thrombosis
152488|NCT02622815|Cancer Risk Assessment|cancer risk assessment
152489|NCT02622815|Cancer Prognosis|cancer prognosis
152490|NCT02622802|ex-vivo placenta perfusion|ex-vivo placenta perfusion
152491|NCT02622802|transplacental transfer|transplacental transfer
152492|NCT02622802|paracetamol|paracetamol
152493|NCT02622802|erythromycin|erythromycin
152494|NCT02622802|azithromycin|azithromycin
152495|NCT02622789|Spinal alignment|spinal alignment
152496|NCT02622789|Kinematics|kinematics
152497|NCT02622789|Pilates|pilates
152498|NCT02622789|Physical Therapy|physical therapy
152499|NCT02622763|Tolerogenic Dendritic Cells|tolerogenic dendritic cells
152500|NCT02622750|triple-branched stent graft|triple-branched stent graft
152501|NCT02622750|total arch replace|total arch replace
152502|NCT02622750|the occluded rate of false lumen|the occluded rate of false lumen
152503|NCT02622737|Parkinson disease|parkinson disease
152504|NCT02622737|Accidental Falls|accidental falls
152505|NCT02622737|Exercise therapy|exercise therapy
152506|NCT02622737|Virtual Reality Exposure Therapy|virtual reality exposure therapy
152507|NCT02622724|ARDS, human|ards, human
152508|NCT02622724|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
152509|NCT02622724|Respiratory Insufficiency|respiratory insufficiency
152510|NCT02622711|breast cancer|breast cancer
152511|NCT02622711|obesity|obesity
152512|NCT02622711|weight control|weight control
152513|NCT02622711|exercise and physical fitness|exercise and physical fitness
152514|NCT02622672|Antioxidation|antioxidation
152515|NCT02622672|Anti-inflammation|anti-inflammation
152516|NCT02622672|Blood glucose|blood glucose
152517|NCT02622672|Blood lipids|blood lipids
152518|NCT02622659|acute upper respiratory infection|acute upper respiratory infection
152519|NCT02622620|dynamic contrast-enhanced MR imaging|dynamic contrast-enhanced mr imaging
152520|NCT02622620|three-dimensional arterial spin labeling|three-dimensional arterial spin labeling
152521|NCT02622620|diffusion-weighted imaging|diffusion-weighted imaging
152522|NCT02622607|ZOL|zol
152523|NCT02622607|Prevention|prevention
152524|NCT02622607|lung cancer|lung cancer
152525|NCT02622529|Awake craniotomy|awake craniotomy
152526|NCT02622529|Psychological consequences|psychological consequences
152527|NCT02622529|Fear and Anxiety|fear and anxiety
152528|NCT02622516|Rehabilitation|rehabilitation
152529|NCT02622516|Physical Therapy Specialty|physical therapy specialty
152530|NCT02622516|Postural Balance|postural balance
152531|NCT02622516|Vertigo|vertigo
152532|NCT02622516|Dizziness|dizziness
152533|NCT02622438|FSHD|fshd
152534|NCT02622438|Usual care performed at Montpellier hospital|usual care performed at montpellier hospital
152535|NCT02622438|Muscle function|muscle function
152536|NCT02622438|Antioxidants|antioxidants
152537|NCT02622438|Oxidative stress|oxidative stress
152538|NCT02622438|Quality of life|quality of life
152539|NCT02622438|Physical activities, development of food-based dietary guidelines|physical activities, development of food-based dietary guidelines
152540|NCT02622438|Co-morbidity|co-morbidity
152541|NCT02622425|Carotenoid|carotenoid
152542|NCT02622425|Bacillus|bacillus
152543|NCT02622425|Microbiota|microbiota
152544|NCT02622425|Cardiovascular health|cardiovascular health
152545|NCT02622412|Quality of Life|quality of life
152546|NCT02622412|Palliative Therapy|palliative therapy
152547|NCT02622412|Outpatient Services|outpatient services
152548|NCT02622386|Psoriasis|psoriasis
152550|NCT02622373|Body composition|body composition
152551|NCT02622308|Arterial leg ulcers|arterial leg ulcers
152552|NCT02622308|Intermittent Negative Pressure|intermittent negative pressure
152553|NCT02622308|Peripheral Circulation|peripheral circulation
152554|NCT02622308|Wound healing|wound healing
152555|NCT02622308|Peripheral blood flow|peripheral blood flow
152556|NCT02622295|metabolism|metabolism
152557|NCT02622295|glucose|glucose
152558|NCT02622295|osteoporosis|osteoporosis
152559|NCT02622295|secondary health conditions|secondary health conditions
152560|NCT02622295|quality of life|quality of life
152561|NCT02622295|standing|standing
152562|NCT02622295|electrical stimulation|electrical stimulation
152563|NCT02622295|diabetes|diabetes
152564|NCT02622295|insulin|insulin
152565|NCT02622295|skeletal muscle|skeletal muscle
152566|NCT02622282|physical activity|physical activity
152567|NCT02622282|physical inactivity|physical inactivity
152568|NCT02622282|PAD|pad
152569|NCT02622282|Diabetes|diabetes
152570|NCT02622282|High blood pressure|high blood pressure
152571|NCT02622282|High cholesterol|high cholesterol
152572|NCT02622282|Smoking|smoking
152573|NCT02622269|Urography|urography
152574|NCT02622269|Radiation dosage|radiation dosage
152575|NCT02622269|image enhancement|image enhancement
152576|NCT02622256|Social Media|social media
152577|NCT02622256|Twitter|twitter
152578|NCT02622256|Hypertension|hypertension
152579|NCT02622256|Cardiovascular|cardiovascular
152580|NCT02622256|CVD|cvd
152581|NCT02622256|HTN|htn
152582|NCT02622230|Uygur Medicine|uygur medicine
152583|NCT02622217|anesthesiology|anesthesiology
152584|NCT02622217|non technical kills|non technical kills
152585|NCT02622191|Glaucoma|glaucoma
152586|NCT02622191|Optical Coherence Tomography|optical coherence tomography
152587|NCT02622191|Primary Open Angle Glaucoma|primary open angle glaucoma
152588|NCT02622191|Visual Field|visual field
152589|NCT02622165|health promotion|health promotion
152590|NCT02622165|nutrition|nutrition
152591|NCT02622165|intervention|intervention
152592|NCT02622165|adolescents|adolescents
152593|NCT02622165|serious game|serious game
152594|NCT02622152|Right lateral|right lateral
152595|NCT02622152|Oxygenation|oxygenation
152596|NCT02622152|Cardiac|cardiac
152597|NCT02622152|Congenital|congenital
152598|NCT02622152|Pediatric|pediatric
152599|NCT02622152|Postoperative|postoperative
152600|NCT02622139|Photoacoustics|photoacoustics
152601|NCT02622139|Optoacoustics|optoacoustics
152602|NCT02622139|Ultrasound|ultrasound
152603|NCT02622126|Preloading|preloading
152604|NCT02622126|Colloid|colloid
152605|NCT02622126|Cesarean section|cesarean section
152606|NCT02622126|D-dimer|d-dimer
152607|NCT02622126|Hypotension|hypotension
152608|NCT02622113|insulin resistance|insulin resistance
152609|NCT02622100|Bioresorbable Vascular Scaffold|bioresorbable vascular scaffold
152610|NCT02622100|Routine Clinical Practice|routine clinical practice
152611|NCT02622100|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
152612|NCT02622100|Coronary Artery Disease|coronary artery disease
152613|NCT02622100|drug eluting stent|drug eluting stent
152614|NCT02622074|PD1|pd1
152615|NCT02622074|PD-1|pd-1
152616|NCT02622074|PDL1|pdl1
152617|NCT02622074|PD-L1|pd-l1
152618|NCT02622074|Triple Negative Breast Cancer|triple negative breast cancer
152619|NCT02622048|Mental Health|mental health
152620|NCT02622048|Psychosis|psychosis
152621|NCT02622048|Parent|parent
152622|NCT02622035|Virtual Reality Technology|virtual reality technology
152623|NCT02622035|Methodology|methodology
152624|NCT02622022|randomised|randomised
152625|NCT02622022|placebo controlled|placebo controlled
152626|NCT02622022|clinical trial|clinical trial
152627|NCT02622009|stable COPD; bronchoalveolar lavage; biopsy; HRV; RSV|stable copd; bronchoalveolar lavage; biopsy; hrv; rsv
152628|NCT02621996|Surface Electromyography|surface electromyography
152629|NCT02621996|Hypotonia|hypotonia
152630|NCT02621996|Patient Positioning|patient positioning
152631|NCT02621983|Schizophrenia|schizophrenia
152632|NCT02621983|Exercise|exercise
152633|NCT02621983|Cognition|cognition
152634|NCT02621905|Prophylaxis|prophylaxis
152635|NCT02621905|Steady-State|steady-state
152636|NCT02621905|Bioavailability|bioavailability
152637|NCT02621866|hypertension|hypertension
152638|NCT02621866|ultraviolet|ultraviolet
152639|NCT02621853|Steatosis|steatosis
152640|NCT02621827|vitamin D|vitamin d
152641|NCT02621827|Africa|africa
152642|NCT02621814|Infant|infant
152643|NCT02621814|Growth|growth
152644|NCT02621814|Body Weight Changes|body weight changes
152645|NCT02621814|Infant Formula|infant formula
152646|NCT02621814|Randomized Controlled Trial|randomized controlled trial
152647|NCT02621788|mind/body medicine|mind/body medicine
152648|NCT02621788|3RP|3rp
152649|NCT02621788|stress management|stress management
152650|NCT02621788|resident burnout|resident burnout
152651|NCT02621775|Stress management|stress management
152652|NCT02621775|Cognitive behavioural therapy (CBT)|cognitive behavioural therapy (cbt)
152653|NCT02621775|Self-help|self-help
152654|NCT02621775|e-health|e-health
152655|NCT02621775|Adjustment disorder with anxiety|adjustment disorder with anxiety
152656|NCT02621736|children|children
152657|NCT02621736|desmopressin|desmopressin
152658|NCT02621736|copeptin|copeptin
152659|NCT02621723|Preventability|preventability
152660|NCT02621697|dual task|dual task
152661|NCT02621697|aging|aging
152662|NCT02621671|Healthy Volunteers|healthy volunteers
152663|NCT02621658|Colorectal Cancer|colorectal cancer
152664|NCT02621658|Colonoscopy|colonoscopy
152665|NCT02621658|Adenoma Detection Rate|adenoma detection rate
152666|NCT02621658|Bowel Preparation|bowel preparation
152667|NCT02621658|Time to Cecal Intubation|time to cecal intubation
152668|NCT02621645|monochorionic|monochorionic
152669|NCT02621645|TRAP|trap
152670|NCT02621645|acardiac twin|acardiac twin
152671|NCT02621632|Compression therapy|compression therapy
152672|NCT02621619|Older adults|older adults
152673|NCT02621619|Elderly|elderly
152674|NCT02621619|Acute pain|acute pain
152675|NCT02621619|IV acetaminophen|iv acetaminophen
152676|NCT02621619|IV hydromorphone|iv hydromorphone
152677|NCT02621619|Analgesia|analgesia
152678|NCT02621619|Adjunctive analgesia|adjunctive analgesia
152679|NCT02621593|Meibomian Gland Dysfunction|meibomian gland dysfunction
152680|NCT02621593|Dry eye symptoms|dry eye symptoms
152681|NCT02621593|Intense Pulsed Light|intense pulsed light
152682|NCT02621580|Panretinal Photocoagulation|panretinal photocoagulation
152683|NCT02621554|Memory|memory
152684|NCT02621554|Resveratrol|resveratrol
152685|NCT02621554|elderly|elderly
152686|NCT02621554|cognition|cognition
152687|NCT02621541|neuroendocrine tumor|neuroendocrine tumor
152688|NCT02621541|pancreas|pancreas
152689|NCT02621541|diagnosis|diagnosis
152690|NCT02621541|positron emission tomography|positron emission tomography
152691|NCT02621528|CeraFlex occluder|ceraflex occluder
152692|NCT02621515|Nivolumab|nivolumab
152693|NCT02621515|Brain metastasis|brain metastasis
152694|NCT02621515|Melanoma|melanoma
152695|NCT02621502|Quinoa|quinoa
152696|NCT02621502|Satiety|satiety
152697|NCT02621502|Visual analogue scale|visual analogue scale
152698|NCT02621502|Cross-over studies|cross-over studies
152699|NCT02621489|Glucagon-like peptide-1|glucagon-like peptide-1
152700|NCT02621489|Endothelialization|endothelialization
152701|NCT02621489|Cardiac Function|cardiac function
152702|NCT02621489|Exenatide|exenatide
152703|NCT02621489|Optical Coherence Tomography|optical coherence tomography
152704|NCT02621450|chronic renal failure|chronic renal failure
152705|NCT02621450|hypertension|hypertension
152706|NCT02621450|ampulatory blood pressure|ampulatory blood pressure
152707|NCT02621437|pain|pain
152708|NCT02621437|quality of life|quality of life
152709|NCT02621437|osteopathy|osteopathy
152710|NCT02621437|oncology|oncology
152711|NCT02621437|surgery|surgery
152712|NCT02621437|breast|breast
152713|NCT02621424|dementia|dementia
152714|NCT02621424|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
152715|NCT02621424|RTMS|rtms
152716|NCT02621424|CVLT|cvlt
152717|NCT02621411|Substance abuse|substance abuse
152718|NCT02621411|Emergency operation|emergency operation
152719|NCT02621411|Preoperative screen|preoperative screen
152720|NCT02621320|Vitamin D|vitamin d
152721|NCT02621320|Exercise Performance|exercise performance
152722|NCT02621320|Wheelchair Athletes|wheelchair athletes
152723|NCT02621320|Indoor sports|indoor sports
152724|NCT02621320|Wingate|wingate
152725|NCT02621320|Isokinetic Dynamometer|isokinetic dynamometer
152726|NCT02621307|postprandial glycemia|postprandial glycemia
152727|NCT02621307|subjective appetite|subjective appetite
152728|NCT02621307|Salba|salba
152729|NCT02621307|Flax|flax
152730|NCT02621294|Protein|protein
152731|NCT02621294|indicator amino acid oxidation method|indicator amino acid oxidation method
152732|NCT02621294|athletes|athletes
152733|NCT02621281|hypothermic machine perfusion|hypothermic machine perfusion
152734|NCT02621281|Kidney Transplantation|kidney transplantation
152735|NCT02621281|Delayed graft function|delayed graft function
152736|NCT02621281|perfusion pressure|perfusion pressure
152737|NCT02621229|Optimal rate of refeeding|optimal rate of refeeding
152738|NCT02621229|inpatients|inpatients
152739|NCT02621229|hospitalized|hospitalized
152740|NCT02621216|percutaneous coronary intervention|percutaneous coronary intervention
152741|NCT02621190|circulating tumor cells|circulating tumor cells
152742|NCT02621190|predictive factor|predictive factor
152743|NCT02621151|combination therapy|combination therapy
152744|NCT02621151|immunotherapy|immunotherapy
152745|NCT02621151|immune checkpoint inhibition|immune checkpoint inhibition
152746|NCT02621099|handheld gamma camera|handheld gamma camera
152747|NCT02621086|Oligosaccharide, Tolerability,|oligosaccharide, tolerability,
152748|NCT02621073|lower extremity|lower extremity
152749|NCT02621073|status-post ORIF|status-post orif
152750|NCT02621060|Chlorogenic acid|chlorogenic acid
152751|NCT02621060|Control glucose|control glucose
152752|NCT02621060|Insulin Secretion|insulin secretion
152753|NCT02621060|Insulin Sensitivity|insulin sensitivity
152754|NCT02621047|Healthy volunteer|healthy volunteer
152755|NCT02621047|Alectinib|alectinib
152756|NCT02621047|Hepatic impairment|hepatic impairment
152757|NCT02621034|Root canal treatment|root canal treatment
152758|NCT02621034|pain|pain
152759|NCT02621034|endodontic instruments|endodontic instruments
152760|NCT02621021|Melanoma|melanoma
152761|NCT02621021|Skin Cancer|skin cancer
152762|NCT02621021|Immunotherapy|immunotherapy
152763|NCT02621021|Cell Therapy|cell therapy
152764|NCT02621008|diabetes|diabetes
152765|NCT02621008|hypertension|hypertension
152766|NCT02621008|obesity|obesity
152767|NCT02621008|mobile phone|mobile phone
152768|NCT02621008|stress|stress
152769|NCT02621008|healthy living|healthy living
152770|NCT02621008|pre-diabetes|pre-diabetes
152771|NCT02620995|hypertension|hypertension
152772|NCT02620995|endothelial dysfunction|endothelial dysfunction
152773|NCT02620995|erectile dysfunction|erectile dysfunction
152774|NCT02620995|sildenafil|sildenafil
152775|NCT02620982|Shockwave|shockwave
152776|NCT02620982|vascular ED|vascular ed
152777|NCT02620982|Organic ED|organic ed
152778|NCT02620969|Paediatrics|paediatrics
152779|NCT02620969|Haemodialysis|haemodialysis
152780|NCT02620969|Kinetics|kinetics
152781|NCT02620943|Anemia|anemia
152782|NCT02620943|Pregnancy Outcome|pregnancy outcome
152783|NCT02620943|Pregnancy|pregnancy
152784|NCT02620943|Dietary Diversity|dietary diversity
152785|NCT02620943|Birth Weight|birth weight
152786|NCT02620930|Sleep Disorders|sleep disorders
152787|NCT02620930|Sleep Apnea|sleep apnea
152788|NCT02620930|Apnea-Hypopnea Index (AHI)|apnea-hypopnea index (ahi)
152789|NCT02620930|Respiratory Disturbance Index (RDI)|respiratory disturbance index (rdi)
152790|NCT02620917|type 1 diabetes|type 1 diabetes
152791|NCT02620917|CSII|csii
152792|NCT02620904|mifepristone|mifepristone
152793|NCT02620904|randomized controlled trial|randomized controlled trial
152794|NCT02620904|vaginal delivery|vaginal delivery
152795|NCT02620904|progesterone receptor modulator|progesterone receptor modulator
152796|NCT02620904|induction of labor|induction of labor
152797|NCT02620891|helium oxygen mixture|helium oxygen mixture
152798|NCT02620891|Meconium aspiration syndrome|meconium aspiration syndrome
152799|NCT02620878|Artificial pancreas|artificial pancreas
152800|NCT02620878|SAP therapy|sap therapy
152801|NCT02620878|children|children
152802|NCT02620878|adolescents|adolescents
152803|NCT02620878|type 1 diabetes|type 1 diabetes
152804|NCT02620852|Breast screening|breast screening
152805|NCT02620852|mammography|mammography
152806|NCT02620852|prevention|prevention
152807|NCT02620852|risk assessment|risk assessment
152809|NCT02620852|Breast cancer|breast cancer
152810|NCT02620852|Wisdom|wisdom
152811|NCT02620839|CDKN2A-p16 Positive|cdkn2a-p16 positive
152812|NCT02620839|Locally Advanced Solid Neoplasm|locally advanced solid neoplasm
152813|NCT02620839|Metastatic Malignant Solid Neoplasm|metastatic malignant solid neoplasm
152814|NCT02620813|acne|acne
152815|NCT02620813|sebaceous gland|sebaceous gland
152816|NCT02620813|lipid|lipid
152817|NCT02620813|sebum|sebum
152818|NCT02620800|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
152819|NCT02620800|Adenocarcinoma|adenocarcinoma
152820|NCT02620800|Open-label|open-label
152821|NCT02620800|Phase 1/2|phase 1/2
152822|NCT02620800|Metronomic|metronomic
152823|NCT02620800|Chemotherapy|chemotherapy
152824|NCT02620800|ABI-007|abi-007
152825|NCT02620800|nab-paclitaxel|nab-paclitaxel
152826|NCT02620800|Abraxane|abraxane
152827|NCT02620800|gemcitabine|gemcitabine
152828|NCT02620800|Gemzar|gemzar
152829|NCT02620800|bevacizumab|bevacizumab
152830|NCT02620800|Avastin|avastin
152831|NCT02620800|5-Fluorouracil (5-FU)|5-fluorouracil (5-fu)
152832|NCT02620800|leucovorin|leucovorin
152833|NCT02620800|oxaliplatin|oxaliplatin
152834|NCT02620800|Eloxatin|eloxatin
152835|NCT02620735|Exercise, health coaching, RCT, telehealth,|exercise, health coaching, rct, telehealth,
152836|NCT02620722|tourniquet|tourniquet
152837|NCT02620722|safety|safety
152838|NCT02620722|personalized|personalized
152839|NCT02620722|surgery|surgery
152840|NCT02620709|Native Hawaiians|native hawaiians
152841|NCT02620709|Community-based participatory research|community-based participatory research
152842|NCT02620709|Health disparities|health disparities
152843|NCT02620709|Minority populations|minority populations
152844|NCT02620709|Chronic disease|chronic disease
152845|NCT02620683|lidocaine, jaw|lidocaine, jaw
152846|NCT02620670|Physical Activity|physical activity
152847|NCT02620670|Glycemic Variability|glycemic variability
152848|NCT02620644|no retinopathy|no retinopathy
152849|NCT02620631|Morphine|morphine
152850|NCT02620631|TKA|tka
152851|NCT02620631|Pain|pain
152852|NCT02620631|TKR|tkr
152853|NCT02620631|Arthroplasty|arthroplasty
152854|NCT02620618|Safety|safety
152855|NCT02620618|Efficacy|efficacy
152856|NCT02620618|intravitreal infliximab|intravitreal infliximab
152857|NCT02620618|ocular behcets|ocular behcets
152858|NCT02620618|refractory posterior uveitis|refractory posterior uveitis
152859|NCT02620605|Cabergoline|cabergoline
152860|NCT02620605|Ovarian Hyper Stimulation Syndrome (OHSS)|ovarian hyper stimulation syndrome (ohss)
152861|NCT02620592|Healthy Subject|healthy subject
152862|NCT02620592|ZYDPLA1|zydpla1
152863|NCT02620592|DPPIV inhibitor|dppiv inhibitor
152864|NCT02620592|Pharmacokinetics|pharmacokinetics
152865|NCT02620592|Safety|safety
152866|NCT02620579|Personalized Pharmaceutical|personalized pharmaceutical
152867|NCT02620579|Personalized Education|personalized education
152868|NCT02620566|caudal block|caudal block
152869|NCT02620566|local wound infiltration|local wound infiltration
152870|NCT02620566|hernia repair|hernia repair
152871|NCT02620553|Type 1 Diabetes|type 1 diabetes
152872|NCT02620553|Diabetes|diabetes
152873|NCT02620553|Autoimmune Diabetes|autoimmune diabetes
152874|NCT02620540|Broselow Tape|broselow tape
152875|NCT02620540|Weight estimation|weight estimation
152876|NCT02620540|Patient safety|patient safety
152877|NCT02620527|Circulating Tumor DNA|circulating tumor dna
152878|NCT02620527|Cancer|cancer
152879|NCT02620527|Neoplasms|neoplasms
152880|NCT02620527|Genomic Testing|genomic testing
152881|NCT02620527|FoundationOne|foundationone
152882|NCT02620527|Cell Free DNA|cell free dna
152883|NCT02620527|ctDNA|ctdna
152884|NCT02620527|cfDNA|cfdna
152885|NCT02620514|Digestive Disease and Disorders|digestive disease and disorders
152886|NCT02620514|Inflammation|inflammation
152887|NCT02620501|EGD|egd
152888|NCT02620501|topical lidocaine|topical lidocaine
152889|NCT02620501|recovery time|recovery time
152890|NCT02620501|intravenous sedation|intravenous sedation
152891|NCT02620488|Pain Perception|pain perception
152892|NCT02620488|Autonomic Nervous System|autonomic nervous system
152893|NCT02620488|Sickle Cell Disease|sickle cell disease
152894|NCT02620488|Hypnosis|hypnosis
152895|NCT02620488|Guided Imagery|guided imagery
152896|NCT02620462|Postural Balance|postural balance
152897|NCT02620462|Pain|pain
152898|NCT02620462|Gait|gait
152899|NCT02620462|Physical Activity Level|physical activity level
152900|NCT02620449|phosphorus|phosphorus
152901|NCT02620449|fibroblast growth factor 23|fibroblast growth factor 23
152902|NCT02620449|diet|diet
152903|NCT02620436|Maternal & Child Health|maternal & child health
152904|NCT02620436|Mother Shelters|mother shelters
152905|NCT02620436|Maternity Waiting Homes|maternity waiting homes
152906|NCT02620423|Pancreatic|pancreatic
152907|NCT02620423|Cancer|cancer
152908|NCT02620423|REOLYSIN®|reolysin®
152909|NCT02620423|Chemotherapy|chemotherapy
152910|NCT02620423|Pembrolizumab|pembrolizumab
152911|NCT02620423|KEYTRUDA®|keytruda®
152912|NCT02620423|Pelareorep|pelareorep
152913|NCT02620423|Reovirus|reovirus
152914|NCT02620423|Oncolytic virus|oncolytic virus
152915|NCT02620410|OAB|oab
152916|NCT02620384|Metolazone|metolazone
152917|NCT02620384|Heart Failure|heart failure
152918|NCT02620358|Mechanical Ventilation|mechanical ventilation
152919|NCT02620358|Weaning|weaning
152920|NCT02620345|Fibroids|fibroids
152921|NCT02620319|bronchoscopy|bronchoscopy
152922|NCT02620319|polydioxanone|polydioxanone
152923|NCT02620319|absorbable implants|absorbable implants
152924|NCT02620319|stents|stents
152925|NCT02620280|Triple Negative Breast Cancer|triple negative breast cancer
152926|NCT02620267|Mismatch Negativity|mismatch negativity
152927|NCT02620267|Transcranial Direct Current Stimulation|transcranial direct current stimulation
152928|NCT02620267|MMN|mmn
152929|NCT02620267|tDCS|tdcs
152930|NCT02620254|mastocytosis|mastocytosis
152931|NCT02620254|cutaneous mastocytosis|cutaneous mastocytosis
152932|NCT02620254|urticaria pigmentosa|urticaria pigmentosa
152933|NCT02620254|telangiectasia macularis eruptiva perstans (TMEP)|telangiectasia macularis eruptiva perstans (tmep)
152934|NCT02620254|diffuse cutaneous mastocytosis|diffuse cutaneous mastocytosis
152935|NCT02620254|solitary cutaneous mastocytosis|solitary cutaneous mastocytosis
152936|NCT02620254|systemic mastocytosis|systemic mastocytosis
152937|NCT02620254|indolent systemic mastocytosis|indolent systemic mastocytosis
152938|NCT02620254|smoldering systemic mastocytosis|smoldering systemic mastocytosis
152939|NCT02620254|aggressive systemic mastocytosis|aggressive systemic mastocytosis
152940|NCT02620254|systemic mastocytosis with associated clonal hematologic non-mast cell lineage disease|systemic mastocytosis with associated clonal hematologic non-mast cell lineage disease
152941|NCT02620254|mast cell leukemia|mast cell leukemia
152942|NCT02620241|gastro-oesophageal reflux|gastro-oesophageal reflux
152943|NCT02620241|intrapulmonary percussive ventilation|intrapulmonary percussive ventilation
152944|NCT02620241|positioning|positioning
152945|NCT02620228|Bioimpedance|bioimpedance
152947|NCT02620228|Liver tumour|liver tumour
152948|NCT02620228|Biopsy needle guidance|biopsy needle guidance
152949|NCT02620202|Troponin|troponin
152950|NCT02620202|Myocardial infarction|myocardial infarction
152951|NCT02620150|HIV|hiv
152952|NCT02620150|AIDS|aids
152953|NCT02620150|Depression|depression
152954|NCT02620150|SSRI|ssri
152955|NCT02620150|Escitalopram|escitalopram
152956|NCT02620150|Immunity|immunity
152957|NCT02620085|Graves' disease|graves' disease
152958|NCT02620085|Hyperthyroidism|hyperthyroidism
152959|NCT02620085|Personality traits|personality traits
152960|NCT02620072|Type 1 diabetes|type 1 diabetes
152961|NCT02620072|T1D|t1d
152962|NCT02620072|diabetes mellitus|diabetes mellitus
152963|NCT02620072|oral insulin|oral insulin
152964|NCT02620072|oral tolerance|oral tolerance
152965|NCT02620072|autoantigen|autoantigen
152966|NCT02620072|self tolerance|self tolerance
152967|NCT02620072|prevention|prevention
152968|NCT02620072|at risk for developing type 1 diabetes|at risk for developing type 1 diabetes
152969|NCT02620072|juvenile diabetes|juvenile diabetes
152970|NCT02620072|dysglycemia|dysglycemia
152971|NCT02620059|Postpartum Period|postpartum period
152972|NCT02620046|Drug therapy|drug therapy
152973|NCT02620033|Prostatectomy|prostatectomy
152974|NCT02620033|Yoga therapy|yoga therapy
152975|NCT02620033|Health related quality of life|health related quality of life
152976|NCT02620007|Adult|adult
152977|NCT02620007|AIEC|aiec
152978|NCT02619994|MDR tuberculosis|mdr tuberculosis
152979|NCT02619994|linezolid|linezolid
152980|NCT02619994|delamanid|delamanid
152981|NCT02619994|Korea|korea
152982|NCT02619968|Chronic renal failure|chronic renal failure
152983|NCT02619968|Arteriovenous fistula|arteriovenous fistula
152984|NCT02619968|Isometric exercises|isometric exercises
152985|NCT02619968|Vascular endothelium|vascular endothelium
152986|NCT02619955|hepcidin deficiency|hepcidin deficiency
152987|NCT02619955|genetic|genetic
152988|NCT02619955|except C282Y Homozygosity|except c282y homozygosity
152989|NCT02619942|Right colon cancer, Survival, Laparoscopic surgery|right colon cancer, survival, laparoscopic surgery
152990|NCT02619929|Oral Vinorelbine|oral vinorelbine
152991|NCT02619929|Advanced Non-Small-Cell Lung Cancer|advanced non-small-cell lung cancer
152992|NCT02619929|Metastatic Breast Cancer|metastatic breast cancer
152993|NCT02619916|Cancer|cancer
152994|NCT02619916|Depression|depression
152995|NCT02619916|MBCT|mbct
152996|NCT02619916|CBT|cbt
152997|NCT02619890|Adult Glioma|adult glioma
152998|NCT02619890|MRI|mri
152999|NCT02619838|Double Arthrodesis|double arthrodesis
153000|NCT02619838|Triple Arthrodesis|triple arthrodesis
153001|NCT02619838|Subtalar Arthrodesis|subtalar arthrodesis
153002|NCT02619825|Child|child
153003|NCT02619799|magnesium sulphate|magnesium sulphate
153004|NCT02619799|intrathecal route|intrathecal route
153005|NCT02619799|midazolam|midazolam
153006|NCT02619773|Colorectal Surgery|colorectal surgery
153007|NCT02619760|Percutaneous Coronary Intervention|percutaneous coronary intervention
153008|NCT02619760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
153009|NCT02619747|pH monitoring|ph monitoring
153010|NCT02619734|Cell Therapy|cell therapy
153011|NCT02619734|Sickle cell disease|sickle cell disease
153012|NCT02619734|Autologous implantation|autologous implantation
153013|NCT02619734|Mesenchymal stromal cell|mesenchymal stromal cell
153014|NCT02619734|Edothelial Progenitor cell|edothelial progenitor cell
153015|NCT02619721|PINS SNS OAB|pins sns oab
153016|NCT02619708|immersive preoperative experience|immersive preoperative experience
153017|NCT02619695|ketoprofen|ketoprofen
153018|NCT02619695|gel|gel
153019|NCT02619695|low back pain|low back pain
153020|NCT02619695|emergency department|emergency department
153021|NCT02619669|Neoadjuvant|neoadjuvant
153022|NCT02619669|TAK-228 (MLN0128)|tak-228 (mln0128)
153023|NCT02619669|Letrozole|letrozole
153024|NCT02619669|ER+|er+
153025|NCT02619669|HER2-|her2-
153026|NCT02619656|PEG|peg
153027|NCT02619656|CO2 insufflation|co2 insufflation
153028|NCT02619656|Room Air insufflation|room air insufflation
153029|NCT02619656|pneumoperitoneum|pneumoperitoneum
153030|NCT02619617|Cluster Headache|cluster headache
153031|NCT02619617|Patient Diary collection of headache pain|patient diary collection of headache pain
153032|NCT02619578|Transcutaneous electric acupoint stimulation (TEAS)|transcutaneous electric acupoint stimulation (teas)
153033|NCT02619578|gynecological laparoscopic surgery|gynecological laparoscopic surgery
153034|NCT02619578|QoQ-40|qoq-40
153035|NCT02619578|MMSE|mmse
153036|NCT02619578|VAS|vas
153037|NCT02619565|Myelodysplastic syndromes|myelodysplastic syndromes
153038|NCT02619565|mutations|mutations
153039|NCT02619565|overall survival|overall survival
153040|NCT02619565|prognosis|prognosis
153041|NCT02619513|Paravertebral Blocks|paravertebral blocks
153042|NCT02619513|Dexmedetomidine|dexmedetomidine
153043|NCT02619513|Analgesia|analgesia
153044|NCT02619513|Inflammatory response|inflammatory response
153045|NCT02619513|Thoracotomy|thoracotomy
153046|NCT02619474|Parent Satisfaction|parent satisfaction
153047|NCT02619474|Patient Satisfaction|patient satisfaction
153048|NCT02619474|Whiteboard|whiteboard
153049|NCT02619474|Communication|communication
153050|NCT02619448|inoperable|inoperable
153051|NCT02619448|Solitary [T1bN0, T2aN0, T2bN0] lesion measuring 2-7 cm|solitary [t1bn0, t2an0, t2bn0] lesion measuring 2-7 cm
153052|NCT02619435|RAS-mutant|ras-mutant
153053|NCT02619422|Cardiac rehabilitation programs|cardiac rehabilitation programs
153054|NCT02619422|Adherence to secondary preventive measures|adherence to secondary preventive measures
153055|NCT02619422|Acute coronary syndrome|acute coronary syndrome
153056|NCT02619422|More intensive cardiac rehabilitation program in less time|more intensive cardiac rehabilitation program in less time
153057|NCT02619396|radiofrequency power|radiofrequency power
153058|NCT02619396|lesion size index|lesion size index
153059|NCT02619396|esophageal temperature alerts|esophageal temperature alerts
153061|NCT02619383|hyperbaric oxygen|hyperbaric oxygen
153062|NCT02619383|DCE|dce
153063|NCT02619383|ED|ed
153064|NCT02619383|erectile dysfunction|erectile dysfunction
153065|NCT02619370|advance care planning|advance care planning
153066|NCT02619370|advance directive|advance directive
153067|NCT02619370|caregiving|caregiving
153068|NCT02619357|Asthma|asthma
153069|NCT02619357|wearable physical activity monitor|wearable physical activity monitor
153070|NCT02619357|step counts|step counts
153071|NCT02619357|Exercise|exercise
153072|NCT02619357|energy expenditure|energy expenditure
153073|NCT02619357|COPD|copd
153074|NCT02619357|indirect calorimetry|indirect calorimetry
153075|NCT02619318|Balancing Everyday Life (BEL)|balancing everyday life (bel)
153076|NCT02619318|activity-based lifestyle intervention|activity-based lifestyle intervention
153077|NCT02619318|standard occupational therapy|standard occupational therapy
153078|NCT02619292|cancer survivor|cancer survivor
153079|NCT02619292|immune function|immune function
153080|NCT02619266|Cancer Anorexia Cachexia Syndrome|cancer anorexia cachexia syndrome
153081|NCT02619266|Acupuncture|acupuncture
153082|NCT02619266|Megestrol acetate|megestrol acetate
153083|NCT02619266|Poor Appetite|poor appetite
153084|NCT02619266|Anorexia|anorexia
153085|NCT02619266|Randomized Controlled Trial|randomized controlled trial
153086|NCT02619253|Immunotherapy|immunotherapy
153087|NCT02619253|Safety|safety
153088|NCT02619253|Pharmacodynamics|pharmacodynamics
153089|NCT02619253|Efficacy|efficacy
153090|NCT02619214|Oxidative Stress|oxidative stress
153091|NCT02619214|Oxygen|oxygen
153092|NCT02619214|General Anesthesia|general anesthesia
153093|NCT02619201|vomiting in children|vomiting in children
153094|NCT02619201|ondansetron|ondansetron
153095|NCT02619201|metoclopramide|metoclopramide
153096|NCT02619201|antiemetics|antiemetics
153097|NCT02619188|Nutrition|nutrition
153098|NCT02619188|Hyperemesis gravidarum|hyperemesis gravidarum
153099|NCT02619188|Prealbumin|prealbumin
153100|NCT02619188|Questionnaire|questionnaire
153101|NCT02619162|breast cancer non metastatic|breast cancer non metastatic
153102|NCT02619162|adjuvant letrozole|adjuvant letrozole
153103|NCT02619162|Nintedanib BIFF1120|nintedanib biff1120
153104|NCT02619136|Blood Transfusion|blood transfusion
153105|NCT02619123|breast density|breast density
153106|NCT02619123|breast cancer|breast cancer
153107|NCT02619123|risk-based screening|risk-based screening
153108|NCT02619123|Tailored breast cancer screening|tailored breast cancer screening
153109|NCT02619123|premenopausal women|premenopausal women
153110|NCT02619110|Chronic Stroke|chronic stroke
153111|NCT02619110|cardiopulmonary|cardiopulmonary
153112|NCT02619110|Berg Balance Scale (BBS)|berg balance scale (bbs)
153113|NCT02619084|Tourette Syndrome|tourette syndrome
153114|NCT02619084|Subthalamic Nucleus|subthalamic nucleus
153115|NCT02619084|STN|stn
153116|NCT02619084|Deep Brain Stimulation|deep brain stimulation
153117|NCT02619084|DBS|dbs
153118|NCT02619084|Tic|tic
153119|NCT02619084|Obsessive-compulsive disorders|obsessive-compulsive disorders
153120|NCT02619071|acute myeloid leukemia- refractory AML- relapsed AML- precision medecine-|acute myeloid leukemia- refractory aml- relapsed aml- precision medecine-
153121|NCT02619058|NKT|nkt
153122|NCT02619058|metastatic melanoma|metastatic melanoma
153123|NCT02619032|remifentanil|remifentanil
153124|NCT02619032|fentanyl|fentanyl
153125|NCT02619032|dental surgery|dental surgery
153126|NCT02619006|Anemia, Iron-Deficiency|anemia, iron-deficiency
153127|NCT02619006|Myelination|myelination
153128|NCT02619006|Ferritin|ferritin
153129|NCT02619006|Umbilical cord clamping|umbilical cord clamping
153130|NCT02619006|Umbilical Cord Milking|umbilical cord milking
153131|NCT02619006|Placental Transfusion|placental transfusion
153132|NCT02619006|Brain Development|brain development
153133|NCT02618993|mandibular nerve block|mandibular nerve block
153134|NCT02618993|mandibular osteotomy|mandibular osteotomy
153135|NCT02618980|acute coronary syndrome|acute coronary syndrome
153136|NCT02618980|gastrointestinal bleeding|gastrointestinal bleeding
153137|NCT02618980|endoscopy|endoscopy
153138|NCT02618967|Lupus|lupus
153139|NCT02618967|Healthy Volunteer|healthy volunteer
153140|NCT02618967|Safety Study|safety study
153141|NCT02618967|Placebo Control|placebo control
153142|NCT02618967|Phase 1|phase 1
153143|NCT02618954|Rheumatoid arthritis|rheumatoid arthritis
153144|NCT02618954|Articular ultrasound|articular ultrasound
153145|NCT02618954|Synovitis|synovitis
153146|NCT02618954|Relapse risk|relapse risk
153147|NCT02618928|HCV|hcv
153148|NCT02618928|Chronic Hepatitis C|chronic hepatitis c
153149|NCT02618915|gene therapy|gene therapy
153150|NCT02618915|Hemophilia B|hemophilia b
153151|NCT02618902|patient safety|patient safety
153152|NCT02618902|tolerogenic dendritic cells|tolerogenic dendritic cells
153153|NCT02618902|tolDC|toldc
153154|NCT02618850|metabolic response|metabolic response
153155|NCT02618850|chemotherapy|chemotherapy
153156|NCT02618850|PET|pet
153157|NCT02618837|NSTEMI|nstemi
153158|NCT02618837|NSTEACS|nsteacs
153159|NCT02618837|prasugrel|prasugrel
153160|NCT02618837|ticagrelor|ticagrelor
153161|NCT02618837|Downstream versus Upstream strategy|downstream versus upstream strategy
153162|NCT02618811|sarcopenia|sarcopenia
153163|NCT02618811|myosteatosis|myosteatosis
153164|NCT02618811|enhanced recovery after surgery|enhanced recovery after surgery
153165|NCT02618811|colorectal cancer|colorectal cancer
153166|NCT02618811|minimally invasive surgery|minimally invasive surgery
153167|NCT02618811|complications|complications
153168|NCT02618798|chronic liver disease|chronic liver disease
153169|NCT02618798|CLD|cld
153170|NCT02618798|platelet function|platelet function
153171|NCT02618785|Hysterosalpingography|hysterosalpingography
153172|NCT02618785|antispasmodic drug|antispasmodic drug
153173|NCT02618785|infertile women|infertile women
153174|NCT02618772|Pediatrics|pediatrics
153175|NCT02618772|Laceration|laceration
153176|NCT02618772|Anxiety|anxiety
153177|NCT02618772|Anti-Anxiety Agents|anti-anxiety agents
153178|NCT02618746|Telemonitoring|telemonitoring
153179|NCT02618746|Home Rehabilitation|home rehabilitation
153180|NCT02618746|Exacerbations|exacerbations
153181|NCT02618746|Physical Activity|physical activity
153182|NCT02618746|COPD|copd
153183|NCT02618720|Antimicrobial prophylaxis|antimicrobial prophylaxis
153184|NCT02618720|Colorectal surgery|colorectal surgery
153185|NCT02618720|Surgical Site Infection|surgical site infection
153186|NCT02618720|Postoperative morbidity|postoperative morbidity
153187|NCT02618707|Lactate|lactate
153188|NCT02618707|Congenital cardiac defect|congenital cardiac defect
153189|NCT02618707|CPB|cpb
153190|NCT02618707|Pediatric|pediatric
153191|NCT02618694|adrenal|adrenal
153192|NCT02618694|supra-renal|supra-renal
153193|NCT02618694|adrenalectomy|adrenalectomy
153194|NCT02618694|retroperitoneoscopy|retroperitoneoscopy
153195|NCT02618694|posterior retroperitoneoscopy|posterior retroperitoneoscopy
153196|NCT02618694|Laparoscopic adrenalectomy|laparoscopic adrenalectomy
153197|NCT02618681|earlobe crease|earlobe crease
153198|NCT02618681|acute myocardial infarction|acute myocardial infarction
153199|NCT02618655|TBDs；diagnosis|tbds；diagnosis
153200|NCT02618603|Stroke|stroke
153201|NCT02618603|Should pain|should pain
153202|NCT02618603|Botulinum Toxin|botulinum toxin
153203|NCT02618590|non-small cell lung cancer|non-small cell lung cancer
153204|NCT02618590|EGFR mutant type|egfr mutant type
153205|NCT02618590|first/second line EGFR-TKI|first/second line egfr-tki
153206|NCT02618577|Anticoagulation|anticoagulation
153207|NCT02618577|atrial high rate episodes|atrial high rate episodes
153208|NCT02618577|Atrial Fibrillation|atrial fibrillation
153209|NCT02618577|VKA|vka
153210|NCT02618577|NOAC|noac
153211|NCT02618551|Thermoplasty|thermoplasty
153212|NCT02618551|Severe asthma|severe asthma
153213|NCT02618551|Dynamic hyperinflation|dynamic hyperinflation
153214|NCT02618499|birth|birth
153215|NCT02618499|oxytocin|oxytocin
153216|NCT02618499|placental transfusion|placental transfusion
153217|NCT02618499|umbilical cord clamping|umbilical cord clamping
153218|NCT02618473|Coronary computed tomography angiography|coronary computed tomography angiography
153219|NCT02618473|motion artifacts|motion artifacts
153220|NCT02618473|motion correction algorithm|motion correction algorithm
153221|NCT02618473|diagnostic utility|diagnostic utility
153222|NCT02618460|Non-contrast enhanced MRI|non-contrast enhanced mri
153223|NCT02618460|healthy volunteers|healthy volunteers
153224|NCT02618460|renal diffusion|renal diffusion
153225|NCT02618460|renal perfusion|renal perfusion
153226|NCT02618369|High Intensity Focused Ultrasound|high intensity focused ultrasound
153227|NCT02618317|renal dialysis|renal dialysis
153228|NCT02618304|Meibomian gland dysfunction|meibomian gland dysfunction
153229|NCT02618304|Lipiview|lipiview
153230|NCT02618304|Tear Lipid Layer|tear lipid layer
153231|NCT02618291|primary health care|primary health care
153232|NCT02618265|stroke|stroke
153233|NCT02618265|secondary prevention|secondary prevention
153234|NCT02618265|platelet response polymorphism|platelet response polymorphism
153235|NCT02618265|mobile terminal|mobile terminal
153236|NCT02618252|difficult IV access|difficult iv access
153237|NCT02618252|ultrasound|ultrasound
153238|NCT02618252|veinviewer|veinviewer
153239|NCT02618252|near infrared device|near infrared device
153240|NCT02618239|intestinal gas|intestinal gas
153241|NCT02618239|Healthy subjects|healthy subjects
153242|NCT02618239|microbiota|microbiota
153243|NCT02618239|prebiotics|prebiotics
153244|NCT02618226|Traumatic Brain Injury|traumatic brain injury
153245|NCT02618226|TBI|tbi
153246|NCT02618226|Optic nerve ultrasound|optic nerve ultrasound
153247|NCT02618226|ONUS|onus
153248|NCT02618226|Intracranial pressure|intracranial pressure
153249|NCT02618226|ICP|icp
153250|NCT02618226|Intracranial hypertension|intracranial hypertension
153251|NCT02618213|Continuous Positive Airway Pressure|continuous positive airway pressure
153252|NCT02618213|High Flow Oxygenation therapy|high flow oxygenation therapy
153253|NCT02618213|Bronchiolitis|bronchiolitis
153254|NCT02618213|Children|children
153255|NCT02618200|Prostate cancer|prostate cancer
153256|NCT02618200|Computer-Aided Diagnosis|computer-aided diagnosis
153257|NCT02618161|EBRT and HDR Brachytherapy|ebrt and hdr brachytherapy
153258|NCT02618109|B acute lymphoblastic leukemia|b acute lymphoblastic leukemia
153259|NCT02618109|leukemia relapse|leukemia relapse
153260|NCT02618109|pediatric onco-hematology|pediatric onco-hematology
153261|NCT02618096|membrane sweeping|membrane sweeping
153262|NCT02618096|dinoprostone|dinoprostone
153263|NCT02618096|multiparas|multiparas
153264|NCT02618096|labor induction|labor induction
153265|NCT02618096|cesarean delivery|cesarean delivery
153266|NCT02618044|Gastroesophageal reflux|gastroesophageal reflux
153267|NCT02618044|Obesity|obesity
153268|NCT02618044|Esophageal manometry|esophageal manometry
153269|NCT02618044|24 H impedance pH-monitoring|24 h impedance ph-monitoring
153270|NCT02618044|Laparoscopic Roux-en-Y Gastric Bypass|laparoscopic roux-en-y gastric bypass
153271|NCT02618031|capillary index score|capillary index score
153272|NCT02618031|acute ischemic stroke|acute ischemic stroke
153273|NCT02618031|collateral circulation|collateral circulation
153274|NCT02618031|cerebral ischemia|cerebral ischemia
153275|NCT02618031|diagnostic imaging|diagnostic imaging
153276|NCT02618018|astigmatism|astigmatism
153277|NCT02618018|toric intraocular lens|toric intraocular lens
153278|NCT02618005|Astronauts|astronauts
153279|NCT02618005|Probiotics|probiotics
153280|NCT02618005|Immune function|immune function
153281|NCT02618005|Intestinal microbiota|intestinal microbiota
153282|NCT02617966|Retina|retina
153283|NCT02617966|Retinal Degeneration|retinal degeneration
153284|NCT02617966|Retinitis Pigmentosa|retinitis pigmentosa
153285|NCT02617966|Stargardt's Disease|stargardt's disease
153286|NCT02617966|Dark Adaptation|dark adaptation
153287|NCT02617953|Tinnitus|tinnitus
153288|NCT02617953|EEG|eeg
153289|NCT02617953|ERP|erp
153290|NCT02617940|dental caries|dental caries
153291|NCT02617940|primary tooth|primary tooth
153292|NCT02617940|resin-based sealants|resin-based sealants
153293|NCT02617914|ARDS|ards
153294|NCT02617914|PEEP|peep
153295|NCT02617914|ECMO|ecmo
153296|NCT02617901|Bone age|bone age
153297|NCT02617901|Greulich & Pyle|greulich & pyle
153298|NCT02617901|TW3|tw3
153299|NCT02617901|Radiography|radiography
153300|NCT02617901|Dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
153301|NCT02617888|radiation|radiation
153302|NCT02617888|cardiac computed tomography|cardiac computed tomography
153303|NCT02617888|CCTA|ccta
153304|NCT02617888|breast shielding|breast shielding
153305|NCT02617888|Myocardial perfusion scintigraphy|myocardial perfusion scintigraphy
153306|NCT02617888|MPS|mps
153307|NCT02617888|Invasive coronary angiography|invasive coronary angiography
153308|NCT02617888|ICA|ica
153309|NCT02617875|Pre-hospital|pre-hospital
153310|NCT02617875|Emergency medical system|emergency medical system
153311|NCT02617875|Telemedicine|telemedicine
153312|NCT02617875|Tele consultation|tele consultation
153313|NCT02617875|Remote treatment|remote treatment
153314|NCT02617862|Diagnostic imaging|diagnostic imaging
153315|NCT02617862|Retina|retina
153316|NCT02617862|Pediatrics|pediatrics
153317|NCT02617810|Healthy|healthy
153318|NCT02617810|JNJ-42847922|jnj-42847922
153319|NCT02617810|Midazolam|midazolam
153320|NCT02617810|Warfarin|warfarin
153321|NCT02617810|Pharmacokinetics|pharmacokinetics
153322|NCT02617797|Urinary Stress Incontinence|urinary stress incontinence
153323|NCT02617797|Radiofrequency|radiofrequency
153324|NCT02617797|Women|women
153325|NCT02617758|Healthy|healthy
153326|NCT02617758|Bioequivalence Study|bioequivalence study
153327|NCT02617758|JNJ-35685-AAA-G021|jnj-35685-aaa-g021
153328|NCT02617758|DURAGESIC|duragesic
153329|NCT02617745|Stupp protocol, glioblastoma, thrombocytopenia|stupp protocol, glioblastoma, thrombocytopenia
153330|NCT02617732|glucose variability|glucose variability
153331|NCT02617732|continuous glucose mornitoring system|continuous glucose mornitoring system
153332|NCT02617732|traditional Chinese medicine|traditional chinese medicine
153333|NCT02617706|Anorectal surgeries|anorectal surgeries
153334|NCT02617706|infection|infection
153335|NCT02617706|topical oxygen|topical oxygen
153336|NCT02617680|Desflurane|desflurane
153337|NCT02617680|end tidal concentration|end tidal concentration
153338|NCT02617680|age|age
153339|NCT02617680|anesthesia|anesthesia
153340|NCT02617641|Secondary Prevention|secondary prevention
153341|NCT02617641|Walking|walking
153342|NCT02617641|Health Behavior|health behavior
153343|NCT02617641|Internet|internet
153344|NCT02617641|eHealth|ehealth
153345|NCT02617641|Computer-Assisted Instruction|computer-assisted instruction
153346|NCT02617641|Multicenter Study|multicenter study
153347|NCT02617641|Randomized Controlled Trial|randomized controlled trial
153348|NCT02617641|Intervention Studies|intervention studies
153349|NCT02617641|Motivation|motivation
153350|NCT02617641|Self Efficacy|self efficacy
153351|NCT02617641|Theory, Nursing|theory, nursing
153352|NCT02617641|Theory, Psychological|theory, psychological
153353|NCT02617641|Nursing Research|nursing research
153354|NCT02617628|opioid addiction|opioid addiction
153355|NCT02617615|MB-110|mb-110
153356|NCT02617602|Congenital heart defect|congenital heart defect
153357|NCT02617602|Cardiopulmonary bypass|cardiopulmonary bypass
153358|NCT02617602|Goal directed therapy|goal directed therapy
153359|NCT02617602|Acute heart failure|acute heart failure
153360|NCT02617563|spondylolisthesis|spondylolisthesis
153361|NCT02617563|CD Horizon® Spinal Systems|cd horizon® spinal systems
153362|NCT02617563|minimal invasive|minimal invasive
153363|NCT02617563|Spinal Fusion|spinal fusion
153364|NCT02617563|MAST procedure|mast procedure
153365|NCT02617563|Lumbar fusion|lumbar fusion
153366|NCT02617524|dedicated sheath|dedicated sheath
153367|NCT02617498|living donor liver transplantation|living donor liver transplantation
153368|NCT02617459|Safety|safety
153369|NCT02617459|efficacy|efficacy
153370|NCT02617459|Levobetaxolol eye drops|levobetaxolol eye drops
153371|NCT02617459|Chinese patients|chinese patients
153372|NCT02617446|safety|safety
153373|NCT02617446|efficacy|efficacy
153374|NCT02617446|istaroxime|istaroxime
153375|NCT02617407|Dental Plaque|dental plaque
153376|NCT02617407|Gingivitis|gingivitis
153377|NCT02617407|Bacterial Infection|bacterial infection
153378|NCT02617407|Oral Hygiene|oral hygiene
153379|NCT02617407|HSCT|hsct
153380|NCT02617407|Oral Microbiome|oral microbiome
153381|NCT02617368|Keratoconus, Corneal crosslinking, Fourier Analysis of Topographic Data|keratoconus, corneal crosslinking, fourier analysis of topographic data
153382|NCT02617342|Intervention|intervention
153383|NCT02617342|Autism Spectrum Disorder|autism spectrum disorder
153384|NCT02617342|Social Skills|social skills
153385|NCT02617329|Extracorporeal shock wave therapy (ESWT), Neck Pain|extracorporeal shock wave therapy (eswt), neck pain
153386|NCT02617316|running speeds, strike patterns|running speeds, strike patterns
153387|NCT02617303|elderly|elderly
153388|NCT02617303|accidental falls|accidental falls
153389|NCT02617303|osteoporosis|osteoporosis
153390|NCT02617303|fractures|fractures
153391|NCT02617303|Primary Care|primary care
153392|NCT02617303|Randomized clinical trial|randomized clinical trial
153393|NCT02617303|Otago exercise programme|otago exercise programme
153394|NCT02617290|Coronary Artery Disease (CAD)|coronary artery disease (cad)
153395|NCT02617290|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
153396|NCT02617277|AZD1775|azd1775
153397|NCT02617277|MEDI4736|medi4736
153398|NCT02617277|AZD1775 + MEDI4736|azd1775 + medi4736
153399|NCT02617277|Advanced Solid Tumours|advanced solid tumours
153400|NCT02617277|Durvalumab|durvalumab
153401|NCT02617238|arterial stiffness|arterial stiffness
153402|NCT02617238|cardiovascular risk|cardiovascular risk
153403|NCT02617238|cardiovascular events|cardiovascular events
153404|NCT02617238|renal events|renal events
153405|NCT02617212|dental implant|dental implant
153406|NCT02617212|bone preservation|bone preservation
153407|NCT02617212|definitive abutment|definitive abutment
153408|NCT02617212|one abutment one time|one abutment one time
153409|NCT02617199|epidural anesthesia|epidural anesthesia
153410|NCT02617199|pain management|pain management
153411|NCT02617199|microcirculation|microcirculation
153412|NCT02617160|Insulin Pump Treatment|insulin pump treatment
153413|NCT02617160|Type 1 Diabetes|type 1 diabetes
153414|NCT02617160|Insulin Pump Setting|insulin pump setting
153415|NCT02617160|Pump Advisor|pump advisor
153416|NCT02617108|uterine septum|uterine septum
153417|NCT02617108|intrauterine adhesions|intrauterine adhesions
153418|NCT02617108|Foley balloon|foley balloon
153419|NCT02617082|breast cancer|breast cancer
153420|NCT02617082|partial breast irradiation|partial breast irradiation
153421|NCT02617082|DCIS|dcis
153422|NCT02617069|Atrial fibrillation|atrial fibrillation
153423|NCT02617069|botulinum toxin|botulinum toxin
153424|NCT02617056|electrodermal response|electrodermal response
153425|NCT02617043|breast cancer|breast cancer
153426|NCT02617043|hypofractionated whole breast irradiation|hypofractionated whole breast irradiation
153427|NCT02617017|Parkinson disease|parkinson disease
153428|NCT02617017|Levodopa induce dyskinesia|levodopa induce dyskinesia
153429|NCT02616952|Stress urinary incontinence|stress urinary incontinence
153430|NCT02616952|Chinese Herb|chinese herb
153431|NCT02616952|Traditional Chinese medicine|traditional chinese medicine
153432|NCT02616952|Pelvic floor muscle training|pelvic floor muscle training
153433|NCT02616939|Multidetector computed tomography|multidetector computed tomography
153434|NCT02616926|hepatocellular carcinoma|hepatocellular carcinoma
153435|NCT02616926|hepatectomy|hepatectomy
153436|NCT02616926|transarterial chemoembolization|transarterial chemoembolization
153437|NCT02616926|radiofrequency ablation|radiofrequency ablation
153438|NCT02616874|HIV infection|hiv infection
153439|NCT02616874|Early treatment|early treatment
153440|NCT02616874|Romidepsin|romidepsin
153441|NCT02616874|HDACi|hdaci
153442|NCT02616874|Therapeutic Vaccines|therapeutic vaccines
153443|NCT02616874|HIVconsv|hivconsv
153444|NCT02616874|HIV reservoir|hiv reservoir
153445|NCT02616874|Population PK/PD analysis|population pk/pd analysis
153446|NCT02616848|Everolimus|everolimus
153447|NCT02616848|eribulin|eribulin
153448|NCT02616822|hypertension|hypertension
153449|NCT02616822|endothelium|endothelium
153450|NCT02616822|resveratrol|resveratrol
153451|NCT02616822|clinical trials|clinical trials
153452|NCT02616783|HIV 1 Infection|hiv 1 infection
153453|NCT02616783|HIV|hiv
153454|NCT02616783|Virologically-Suppressed|virologically-suppressed
153455|NCT02616744|aromatase inhibitors|aromatase inhibitors
153456|NCT02616744|breast cancer|breast cancer
153457|NCT02616744|bone mineral density|bone mineral density
153458|NCT02616692|HCC|hcc
153459|NCT02616692|Patient preferences|patient preferences
153460|NCT02616666|Type 2 diabetes mellitus|type 2 diabetes mellitus
153461|NCT02616666|Randomised|randomised
153462|NCT02616666|Pragmatic|pragmatic
153463|NCT02616666|Standard of Care|standard of care
153464|NCT02616666|Dapagliflozin|dapagliflozin
153465|NCT02616666|FORXIGA|forxiga
153466|NCT02616640|Multiple Myeloma|multiple myeloma
153467|NCT02616640|Relapsed|relapsed
153468|NCT02616640|Refractory|refractory
153469|NCT02616640|MEDI4736|medi4736
153470|NCT02616640|Durvalumab|durvalumab
153471|NCT02616640|Pomalidomide (POM)|pomalidomide (pom)
153472|NCT02616640|Dexamethasone (DEX)|dexamethasone (dex)
153473|NCT02616640|PD-L1|pd-l1
153474|NCT02616627|bone mineral density|bone mineral density
153475|NCT02616627|chronic dialysis|chronic dialysis
153476|NCT02616627|end-stage renal disease|end-stage renal disease
153477|NCT02616627|body composition analysis|body composition analysis
153478|NCT02616627|sarcopenia|sarcopenia
153479|NCT02616588|advanced stage cancer,|advanced stage cancer,
153480|NCT02616588|patient navigator,|patient navigator,
153481|NCT02616588|social work|social work
153482|NCT02616575|home care|home care
153483|NCT02616575|monitoring system|monitoring system
153484|NCT02616575|risk assessment|risk assessment
153485|NCT02616575|telehealth|telehealth
153486|NCT02616536|Flipped classroom|flipped classroom
153487|NCT02616536|Teaching methods|teaching methods
153488|NCT02616536|Knowledge gain|knowledge gain
153489|NCT02616523|dexmedetomidine|dexmedetomidine
153490|NCT02616523|lidocaine|lidocaine
153491|NCT02616523|neuropathic pain|neuropathic pain
153492|NCT02616523|laparoscopic intestine resection|laparoscopic intestine resection
153493|NCT02616523|cognitive function|cognitive function
153494|NCT02616497|aspirin|aspirin
153495|NCT02616497|triflusal|triflusal
153496|NCT02616497|antiplatelet drugs|antiplatelet drugs
153497|NCT02616497|atherothrombosis|atherothrombosis
153498|NCT02616497|secondary prevention|secondary prevention
153499|NCT02616497|bleeding|bleeding
153500|NCT02616484|Sodium Dichloroacetate|sodium dichloroacetate
153501|NCT02616484|Treatment of PDCD with Dichloroacetate|treatment of pdcd with dichloroacetate
153502|NCT02616471|Cheese|cheese
153503|NCT02616471|Dairy|dairy
153504|NCT02616471|Saturated fat|saturated fat
153505|NCT02616471|Blood lipid concentrations|blood lipid concentrations
153506|NCT02616471|Lipoprotein particle size|lipoprotein particle size
153507|NCT02616471|Metabolic Syndrome|metabolic syndrome
153508|NCT02616471|Insulin sensitivity|insulin sensitivity
153509|NCT02616471|Blood glucose concentrations|blood glucose concentrations
153510|NCT02616445|Xanamem|xanamem
153511|NCT02616432|Tomosynthesis|tomosynthesis
153512|NCT02616432|Digital Breast Tomosynthesis (DBT)|digital breast tomosynthesis (dbt)
153513|NCT02616432|Breast Imaging|breast imaging
153514|NCT02616432|Full-field digital mammography|full-field digital mammography
153515|NCT02616432|Breast screening|breast screening
153516|NCT02616419|Emergency Department|emergency department
153517|NCT02616419|Procedural pain|procedural pain
153518|NCT02616419|Procedural anxiety|procedural anxiety
153519|NCT02616419|Needle-related procedures|needle-related procedures
153520|NCT02616419|Clinical Nursing Research|clinical nursing research
153521|NCT02616419|Nursing practice|nursing practice
153522|NCT02616419|Non-pharmacological method|non-pharmacological method
153523|NCT02616406|recovery of function|recovery of function
153524|NCT02616380|Quality of life (QOL)|quality of life (qol)
153525|NCT02616380|Work productivity|work productivity
153526|NCT02616380|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
153527|NCT02616354|Pharmacokinetics; pharmacodynamic; imipenem; sepsis|pharmacokinetics; pharmacodynamic; imipenem; sepsis
153528|NCT02616315|Drug therapy|drug therapy
153529|NCT02616302|Drug therapy|drug therapy
153530|NCT02616276|Glycemic Index|glycemic index
153531|NCT02616276|Postprandial Period|postprandial period
153532|NCT02616276|Vascular Stiffness|vascular stiffness
153533|NCT02616276|Blood glucose|blood glucose
153534|NCT02616276|Cognition|cognition
153535|NCT02616237|Chinese population|chinese population
153536|NCT02616237|acupressure|acupressure
153537|NCT02616237|physical activity|physical activity
153538|NCT02616237|nutrition|nutrition
153539|NCT02616237|Facebook|facebook
153540|NCT02616198|glass ionomers|glass ionomers
153541|NCT02616198|surface coating|surface coating
153542|NCT02616198|clinical trial|clinical trial
153543|NCT02616120|Herbal therapy|herbal therapy
153544|NCT02616120|Parkinson's Disease|parkinson's disease
153545|NCT02616120|Non-motor Symptoms|non-motor symptoms
153546|NCT02616120|Randomized controlled trial|randomized controlled trial
153547|NCT02616107|Caregiver|caregiver
153548|NCT02616107|Self-management|self-management
153549|NCT02616107|Care options|care options
153550|NCT02616107|Goals of care|goals of care
153551|NCT02616107|Breast cancer|breast cancer
153552|NCT02616107|Palliative care|palliative care
153553|NCT02616081|Urinary Bladder|urinary bladder
153554|NCT02616081|Neurogenic|neurogenic
153555|NCT02616081|Quality of Life|quality of life
153556|NCT02616081|Spinal cord injury|spinal cord injury
153557|NCT02616081|incontinence|incontinence
153558|NCT02616081|Bladder|bladder
153559|NCT02616042|Centella asiatica|centella asiatica
153560|NCT02616042|bamboo salt|bamboo salt
153561|NCT02616042|dentifrice|dentifrice
153562|NCT02616003|Morbid Obesity|morbid obesity
153563|NCT02616003|Giant Obese|giant obese
153564|NCT02616003|Preoperative Procedure|preoperative procedure
153565|NCT02616003|Liraglutide|liraglutide
153566|NCT02616003|Leucine|leucine
153567|NCT02615977|Pavlovian conditioning, Operant conditioning|pavlovian conditioning, operant conditioning
153568|NCT02615977|Pavlovian-to-instrumental transfer|pavlovian-to-instrumental transfer
153569|NCT02615977|Functional imaging|functional imaging
153570|NCT02615977|Relapse risk|relapse risk
153571|NCT02615977|Behavioural Intervention|behavioural intervention
153572|NCT02615951|Regulatory B cells (Breg)|regulatory b cells (breg)
153573|NCT02615951|Genes|genes
153574|NCT02615951|Cell surface proteins|cell surface proteins
153575|NCT02615951|Nutrient transporters|nutrient transporters
153576|NCT02615951|Chemokine receptors|chemokine receptors
153577|NCT02615899|Older Adults, Falls|older adults, falls
153578|NCT02615886|rice bran|rice bran
153579|NCT02615886|infants|infants
153580|NCT02615886|stool metabolome|stool metabolome
153581|NCT02615886|stool microbiome|stool microbiome
153582|NCT02615886|dietary intervention|dietary intervention
153583|NCT02615873|Parkinson's Disease|parkinson's disease
153584|NCT02615873|Fluctuating Parkinson's Disease|fluctuating parkinson's disease
153585|NCT02615873|Carbidopa|carbidopa
153586|NCT02615873|Levodopa|levodopa
153587|NCT02615873|Accordion|accordion
153588|NCT02615860|HIV-infection|hiv-infection
153589|NCT02615860|anal cancer (AC)|anal cancer (ac)
153590|NCT02615860|anal cancer prevention|anal cancer prevention
153591|NCT02615860|anal dysplasia|anal dysplasia
153592|NCT02615860|anal intraepithelial neoplasia (AIN)|anal intraepithelial neoplasia (ain)
153593|NCT02615860|human papillomavirus (HPV)|human papillomavirus (hpv)
153594|NCT02615860|HPV-induced anal cancer precursor lesions|hpv-induced anal cancer precursor lesions
153595|NCT02615860|electrocautery (ECA)|electrocautery (eca)
153596|NCT02615860|topical trichloroacetic acid (TCA) treatment.|topical trichloroacetic acid (tca) treatment.
153597|NCT02615704|Brilique treatment adherence via electronic device application (APP)|brilique treatment adherence via electronic device application (app)
153598|NCT02615678|neuropathy|neuropathy
153599|NCT02615678|peripheral|peripheral
153600|NCT02615678|chemotherapy|chemotherapy
153601|NCT02615678|breast cancer|breast cancer
153602|NCT02615665|NK-cells|nk-cells
153603|NCT02615665|T-cells|t-cells
153604|NCT02615639|HPDC-T cells|hpdc-t cells
153605|NCT02615639|CHB|chb
153606|NCT02615639|immuno therapy|immuno therapy
153607|NCT02615626|Visfatin|visfatin
153608|NCT02615626|GCF|gcf
153609|NCT02615626|serum|serum
153610|NCT02615626|Non-surgical Periodontal Treatment.|non-surgical periodontal treatment.
153611|NCT02615613|Hedonics, Ghrelin, Hunger|hedonics, ghrelin, hunger
153612|NCT02615600|tinnitus|tinnitus
153613|NCT02615600|transcranial random noise stimulation|transcranial random noise stimulation
153614|NCT02615600|tRNS|trns
153615|NCT02615600|auditory cortex|auditory cortex
153616|NCT02615600|non-invasive brain stimulation|non-invasive brain stimulation
153617|NCT02615587|non-valvular Atrial Fibrillation|non-valvular atrial fibrillation
153618|NCT02615561|Safety|safety
153619|NCT02615561|Efficacy|efficacy
153620|NCT02615561|Atopic dermatitis|atopic dermatitis
153621|NCT02615561|Cosmetic products|cosmetic products
153622|NCT02615548|exercises|exercises
153623|NCT02615535|traumatic brain injury|traumatic brain injury
153624|NCT02615522|primary TKR|primary tkr
153625|NCT02615496|Health Care Surveys|health care surveys
153626|NCT02615496|Vascular Endothelial Growth Factor|vascular endothelial growth factor
153627|NCT02615470|Pneumococcal Vaccines|pneumococcal vaccines
153628|NCT02615470|Shingles|shingles
153629|NCT02615470|Pharmacy|pharmacy
153630|NCT02615470|Vaccine|vaccine
153631|NCT02615470|Immunization|immunization
153632|NCT02615444|Metabolic Syndrome X|metabolic syndrome x
153633|NCT02615444|Overweight|overweight
153634|NCT02615444|Waist Circumference|waist circumference
153635|NCT02615444|Blood Pressure|blood pressure
153636|NCT02615444|Cholesterol|cholesterol
153637|NCT02615444|Oat beta glucan|oat beta glucan
153638|NCT02615392|RCT|rct
153639|NCT02615392|Park Prescription|park prescription
153640|NCT02615392|Park Use|park use
153641|NCT02615392|Physical Activity|physical activity
153642|NCT02615392|Health Promotion|health promotion
153643|NCT02615392|Health Behavior|health behavior
153644|NCT02615392|Mental Well-Being|mental well-being
153645|NCT02615392|Body composition|body composition
153646|NCT02615392|Blood levels|blood levels
153647|NCT02615392|Accelerometry|accelerometry
153648|NCT02615392|Improving general physical and mental health|improving general physical and mental health
153649|NCT02615379|instrumented spinal fusion|instrumented spinal fusion
153650|NCT02615379|infection|infection
153651|NCT02615379|topical oxygen|topical oxygen
153652|NCT02615340|delirium|delirium
153653|NCT02615340|melatonin|melatonin
153654|NCT02615340|pharmacokinetics|pharmacokinetics
153655|NCT02615340|feasibility|feasibility
153656|NCT02615340|prevention|prevention
153657|NCT02615327|Fiber|fiber
153658|NCT02615327|Polydextrose|polydextrose
153659|NCT02615327|Glycemic Index|glycemic index
153660|NCT02615314|migraine|migraine
153661|NCT02615314|benign paroxysmal positional vertigo|benign paroxysmal positional vertigo
153662|NCT02615288|Vitamin D|vitamin d
153663|NCT02615275|Head and Neck Cancer|head and neck cancer
153664|NCT02615275|Bioelectrical impedance analysis|bioelectrical impedance analysis
153665|NCT02615275|BIA|bia
153666|NCT02615275|Eight-electrode BIA device|eight-electrode bia device
153667|NCT02615275|SECA mBCA|seca mbca
153668|NCT02615275|Computed tomography|computed tomography
153669|NCT02615275|CT|ct
153769|NCT02614729|Cognitive Function|cognitive function
153670|NCT02615275|Positron emission tomography|positron emission tomography
153671|NCT02615275|PET|pet
153672|NCT02615275|Symptom questionnaire|symptom questionnaire
153673|NCT02615275|Survey|survey
153674|NCT02615275|Radiation therapy|radiation therapy
153675|NCT02615275|RT|rt
153676|NCT02615275|XRT|xrt
153677|NCT02615262|Pediatric cardiac surgery|pediatric cardiac surgery
153678|NCT02615262|Dexamethasone|dexamethasone
153679|NCT02615262|Steroids|steroids
153680|NCT02615262|Cardiopulmonary bypass|cardiopulmonary bypass
153681|NCT02615262|Congenital heart defects|congenital heart defects
153682|NCT02615262|Infants|infants
153683|NCT02615197|PTSD|ptsd
153684|NCT02615197|Multi-diagnostic|multi-diagnostic
153685|NCT02615197|Dialectical Behavior Therapy|dialectical behavior therapy
153686|NCT02615197|Prolonged Exposure Therapy|prolonged exposure therapy
153687|NCT02615184|Drug therapy|drug therapy
153688|NCT02615158|Feeding practices|feeding practices
153689|NCT02615158|Diet|diet
153690|NCT02615158|Physical activity|physical activity
153691|NCT02615158|Prevention|prevention
153692|NCT02615145|Chronic Hepatitis C|chronic hepatitis c
153693|NCT02615145|Dasabuvir|dasabuvir
153694|NCT02615145|Ombitasvir+Paritaprevir+Ritonavir|ombitasvir+paritaprevir+ritonavir
153695|NCT02615145|Observational Study|observational study
153696|NCT02615145|Quality of life|quality of life
153697|NCT02615145|Work-ability|work-ability
153698|NCT02615145|Fibrosis|fibrosis
153699|NCT02615145|Cirrhosis|cirrhosis
153700|NCT02615119|heartbeat|heartbeat
153701|NCT02615119|respiration|respiration
153702|NCT02615119|interoception|interoception
153703|NCT02615119|anxiety|anxiety
153704|NCT02615119|eating|eating
153705|NCT02615106|Radiation Therapy|radiation therapy
153706|NCT02615106|Neuroblastoma|neuroblastoma
153707|NCT02615067|Diagnostic|diagnostic
153708|NCT02615067|Active surveillance|active surveillance
153709|NCT02615067|Very low risk|very low risk
153710|NCT02615067|Imaging|imaging
153711|NCT02615067|PSMA|psma
153712|NCT02615067|SPECT/CT|spect/ct
153713|NCT02615067|99mTc|99mtc
153714|NCT02615067|Newly Diagnosed|newly diagnosed
153715|NCT02615067|Prostatectomy|prostatectomy
153716|NCT02615067|Biopsy|biopsy
153717|NCT02615054|Cardiovascular Impairment|cardiovascular impairment
153718|NCT02615054|15-258|15-258
153719|NCT02615041|Meropenem|meropenem
153720|NCT02615041|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
153721|NCT02615041|population pharmacokinetics|population pharmacokinetics
153722|NCT02615041|pharmacokinetics|pharmacokinetics
153723|NCT02615041|pharmacodynamics|pharmacodynamics
153724|NCT02615028|Force plate, Balance ability|force plate, balance ability
153725|NCT02615015|Deoxyribonuclease|deoxyribonuclease
153726|NCT02615002|Cognition|cognition
153727|NCT02615002|mild Alzheimer's disease|mild alzheimer's disease
153728|NCT02615002|Sleep|sleep
153729|NCT02614989|Tremor|tremor
153730|NCT02614989|Thalamotomy|thalamotomy
153731|NCT02614963|Irritable Bowel Syndrome|irritable bowel syndrome
153732|NCT02614963|Clostridium Butyricum|clostridium butyricum
153733|NCT02614911|Early Onset Entheropathy|early onset entheropathy
153734|NCT02614833|Hormone receptor positive|hormone receptor positive
153735|NCT02614820|Ischemic preconditioning|ischemic preconditioning
153736|NCT02614820|sefety|sefety
153737|NCT02614820|efficacy|efficacy
153738|NCT02614820|DMD|dmd
153739|NCT02614807|Dietary Supplement|dietary supplement
153740|NCT02614794|Tucatinib|tucatinib
153741|NCT02614794|Capecitabine|capecitabine
153742|NCT02614794|Trastuzumab|trastuzumab
153743|NCT02614794|Xeloda|xeloda
153744|NCT02614794|Herceptin|herceptin
153745|NCT02614794|Breast Cancer|breast cancer
153746|NCT02614794|ARRY-380|arry-380
153747|NCT02614794|ONT-380|ont-380
153748|NCT02614794|HER2 Positive Breast Carcinoma|her2 positive breast carcinoma
153749|NCT02614794|HER2 Positive Locally Advanced Breast Cancer|her2 positive locally advanced breast cancer
153750|NCT02614794|HER-2 Positive Breast Cancer|her-2 positive breast cancer
153751|NCT02614794|HER-2 Positive Breast Carcinoma|her-2 positive breast carcinoma
153752|NCT02614794|HER-2 Positive Locally Advanced Breast Cancer|her-2 positive locally advanced breast cancer
153753|NCT02614794|Recurrent Breast Carcinoma|recurrent breast carcinoma
153754|NCT02614794|Stage IV Breast Cancer|stage iv breast cancer
153755|NCT02614794|Metastatic Breast Cancer|metastatic breast cancer
153756|NCT02614794|Breast Carcinoma|breast carcinoma
153757|NCT02614794|Metastatic Malignant Neoplasm in the Brain|metastatic malignant neoplasm in the brain
153758|NCT02614794|Brain Metastases in Breast Cancer|brain metastases in breast cancer
153759|NCT02614794|Asymptomatic Brain Metastases in Breast Cancer|asymptomatic brain metastases in breast cancer
153760|NCT02614794|Low Symptomatic Brain Metastases in Breast Cancer|low symptomatic brain metastases in breast cancer
153761|NCT02614768|Glucose Monitoring System|glucose monitoring system
153762|NCT02614755|Older Adults Volunteers|older adults volunteers
153763|NCT02614755|Seniors|seniors
153764|NCT02614755|Brain Performance Test|brain performance test
153765|NCT02614729|High Protein|high protein
153766|NCT02614729|Satiety|satiety
153767|NCT02614729|Appetite Control|appetite control
153768|NCT02614729|Protein Distribution|protein distribution
153770|NCT02614729|Ad libitum Food Intake|ad libitum food intake
153771|NCT02614729|Obesity prevention|obesity prevention
153772|NCT02614729|Obesity treatment|obesity treatment
153773|NCT02614703|Barrett's Esophagus|barrett's esophagus
153774|NCT02614703|Acetic Acid Chromoendoscopy|acetic acid chromoendoscopy
153775|NCT02614690|Fracture of the upper limb|fracture of the upper limb
153776|NCT02614677|Disability Evaluation System|disability evaluation system
153777|NCT02614677|SF-12|sf-12
153778|NCT02614677|ICF model|icf model
153779|NCT02614612|Acute Graft Versus Host Disease|acute graft versus host disease
153780|NCT02614599|ADD|add
153781|NCT02614599|ADHD|adhd
153782|NCT02614599|Proteins|proteins
153783|NCT02614599|Dietary|dietary
153784|NCT02614599|Nutrition|nutrition
153785|NCT02614599|QEEG|qeeg
153786|NCT02614599|ERP|erp
153787|NCT02614599|ICA|ica
153788|NCT02614586|Drug Therapy|drug therapy
153789|NCT02614573|Dependent|dependent
153790|NCT02614573|Aged, 80 and over|aged, 80 and over
153791|NCT02614573|Aged|aged
153792|NCT02614560|acute myeloid leukemia|acute myeloid leukemia
153793|NCT02614560|AML|aml
153794|NCT02614560|antibody-drug conjugate|antibody-drug conjugate
153795|NCT02614521|Pulmonary veins ablation|pulmonary veins ablation
153796|NCT02614521|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
153797|NCT02614482|Children|children
153798|NCT02614482|Antimuscarinics|antimuscarinics
153799|NCT02614482|Antocholinergics|antocholinergics
153800|NCT02614482|Overactive bladder|overactive bladder
153801|NCT02614443|Depression|depression
153802|NCT02614443|Anxiety|anxiety
153803|NCT02614443|Stress|stress
153804|NCT02614443|Online interventions|online interventions
153805|NCT02614443|University students|university students
153806|NCT02614443|CBT|cbt
153807|NCT02614430|Rehabilitation|rehabilitation
153808|NCT02614430|Prediction|prediction
153809|NCT02614430|Inflammation|inflammation
153810|NCT02614404|Plasmodium falciparum|plasmodium falciparum
153811|NCT02614404|Uncomplicated malarial|uncomplicated malarial
153812|NCT02614404|imatinib mesylate|imatinib mesylate
153813|NCT02614404|antimalarials|antimalarials
153814|NCT02614391|Procedural pain|procedural pain
153815|NCT02614391|Phlebotomy|phlebotomy
153816|NCT02614391|Distraction|distraction
153817|NCT02614391|Videogame|videogame
153818|NCT02614391|Computer tablet|computer tablet
153819|NCT02614391|Child|child
153820|NCT02614378|abortive effect|abortive effect
153821|NCT02614326|Depression|depression
153822|NCT02614326|Cognitive risk factors|cognitive risk factors
153823|NCT02614326|Autobiographical memory|autobiographical memory
153824|NCT02614326|Cognitive bias|cognitive bias
153825|NCT02614326|Relapse prevention|relapse prevention
153826|NCT02614313|Fructose|fructose
153827|NCT02614313|Irritable Bowel Syndrome|irritable bowel syndrome
153828|NCT02614313|Breath test|breath test
153829|NCT02614313|Placebo|placebo
153830|NCT02614300|pulmonary rehabilitation|pulmonary rehabilitation
153831|NCT02614300|chest physiotherapy|chest physiotherapy
153832|NCT02614300|non-cystic fibrosis bronchiectasis|non-cystic fibrosis bronchiectasis
153833|NCT02614300|exercise tolerance|exercise tolerance
153834|NCT02614300|bronchiectasis|bronchiectasis
153835|NCT02614300|respiratory therapy|respiratory therapy
153836|NCT02614287|prevention|prevention
153837|NCT02614287|prophylaxis|prophylaxis
153838|NCT02614287|headache|headache
153839|NCT02614274|knee|knee
153840|NCT02614274|pain|pain
153841|NCT02614274|osteoarthritis|osteoarthritis
153842|NCT02614274|nutraceutical|nutraceutical
153843|NCT02614274|nutrition|nutrition
153844|NCT02614274|supplement|supplement
153845|NCT02614274|non-surgical|non-surgical
153846|NCT02614274|biomarker|biomarker
153847|NCT02614274|joint health|joint health
153848|NCT02614261|prevention|prevention
153849|NCT02614261|prophylaxis|prophylaxis
153850|NCT02614261|headache|headache
153851|NCT02614235|Cardiac Arrhythmia|cardiac arrhythmia
153852|NCT02614235|Syncope|syncope
153853|NCT02614235|Ambulatory Electrocardiography Monitoring|ambulatory electrocardiography monitoring
153854|NCT02614222|Computer Assisted Instrument Guidance (CAIG)|computer assisted instrument guidance (caig)
153855|NCT02614222|Peripheral Nerve Block|peripheral nerve block
153856|NCT02614222|Clear Guide ONE|clear guide one
153857|NCT02614222|Needle path|needle path
153858|NCT02614222|Needle Guidance|needle guidance
153859|NCT02614222|Ultrasound|ultrasound
153860|NCT02614209|ED|ed
153861|NCT02614209|BNP|bnp
153862|NCT02614196|prevention|prevention
153863|NCT02614196|prophylaxis|prophylaxis
153864|NCT02614196|headache|headache
153865|NCT02614183|prevention|prevention
153866|NCT02614183|prophylaxis|prophylaxis
153867|NCT02614183|headache|headache
153868|NCT02614157|rectal cancer|rectal cancer
153869|NCT02614157|lateral lymph node dissection|lateral lymph node dissection
153870|NCT02614157|neoadjuvant chemoradiation|neoadjuvant chemoradiation
153871|NCT02614157|total mesorectal excision|total mesorectal excision
153872|NCT02614157|surgery|surgery
153873|NCT02614157|recurrence|recurrence
153874|NCT02614157|metastasis|metastasis
153875|NCT02614157|overall survival|overall survival
153876|NCT02614144|Hospital Acquired Pneumonia|hospital acquired pneumonia
153877|NCT02614144|Mortality|mortality
153878|NCT02614118|Endodontic treatment|endodontic treatment
153879|NCT02614118|non steroid|non steroid
153880|NCT02614118|pain|pain
153881|NCT02614118|pre medication|pre medication
153882|NCT02614092|Mild Cognitive Impairment|mild cognitive impairment
153883|NCT02614092|memory impairment|memory impairment
153884|NCT02614092|Physical Activity|physical activity
153885|NCT02614092|Exercise|exercise
153886|NCT02614092|Cognitive Training|cognitive training
153887|NCT02614092|Veterans|veterans
153888|NCT02614092|Older Adults|older adults
153889|NCT02614079|lumbago|lumbago
153890|NCT02614079|low back pain|low back pain
153891|NCT02614079|leg pain|leg pain
153892|NCT02614040|crystalloid|crystalloid
153893|NCT02614040|acute kidney injury|acute kidney injury
153894|NCT02614001|breathing training, congestive heart failure, stroke|breathing training, congestive heart failure, stroke
153895|NCT02613988|Glioblastoma|glioblastoma
153896|NCT02613988|MRI|mri
153897|NCT02613988|standard treatment|standard treatment
153898|NCT02613949|fibromyalgia|fibromyalgia
153899|NCT02613949|pain|pain
153900|NCT02613949|stimulation|stimulation
153901|NCT02613936|traumatic brain injury|traumatic brain injury
153902|NCT02613936|post concussive symptoms|post concussive symptoms
153903|NCT02613936|depression|depression
153904|NCT02613936|executive dysfunction|executive dysfunction
153905|NCT02613936|brain stimulation|brain stimulation
153906|NCT02613923|Breast Cancer|breast cancer
153907|NCT02613923|GO! to sleep|go! to sleep
153908|NCT02613923|sleep|sleep
153909|NCT02613910|Ofatumumab|ofatumumab
153910|NCT02613910|Pemphigus Vulgaris|pemphigus vulgaris
153911|NCT02613910|Long-Term Extension Study|long-term extension study
153912|NCT02613845|Postoperative delirium|postoperative delirium
153913|NCT02613845|Cardiac surgery|cardiac surgery
153914|NCT02613845|Cardiopulmonary bypass|cardiopulmonary bypass
153915|NCT02613845|Risk factor|risk factor
153916|NCT02613832|Noncooperative patients|noncooperative patients
153917|NCT02613806|Dexmedetomidine|dexmedetomidine
153918|NCT02613806|Coughing Response|coughing response
153919|NCT02613806|Postoperative Recovery Quality|postoperative recovery quality
153920|NCT02613806|Thyroid Surgery|thyroid surgery
153921|NCT02613793|Preterm pre-eclampsia|preterm pre-eclampsia
153922|NCT02613793|Neurological dysfunction|neurological dysfunction
153923|NCT02613793|Saccadic reaction time|saccadic reaction time
153924|NCT02613728|Colorectal cancer|colorectal cancer
153925|NCT02613728|Colorectal cancer surgery|colorectal cancer surgery
153926|NCT02613728|Polyp(s)|polyp(s)
153927|NCT02613728|Accelerated Enhanced Recovery|accelerated enhanced recovery
153928|NCT02613728|RecoverMI|recovermi
153929|NCT02613728|Fluid diary|fluid diary
153930|NCT02613728|Questionnaires|questionnaires
153931|NCT02613728|Surveys|surveys
153932|NCT02613728|RecoverMI device|recovermi device
153933|NCT02613715|Flavonoids|flavonoids
153934|NCT02613715|Anthocyanins|anthocyanins
153935|NCT02613715|Blackberry Juice|blackberry juice
153936|NCT02613715|Bioavailability|bioavailability
153937|NCT02613715|Obesity|obesity
153938|NCT02613702|Free gingival graft|free gingival graft
153939|NCT02613702|keratinized gingival tissue|keratinized gingival tissue
153940|NCT02613689|smokeless tobacco, text message, tobacco cessation, tobacco|smokeless tobacco, text message, tobacco cessation, tobacco
153941|NCT02613637|lung cancer|lung cancer
153942|NCT02613637|registry study|registry study
153943|NCT02613637|Biological Disease Profile|biological disease profile
153944|NCT02613624|KMC in community|kmc in community
153945|NCT02613559|Neovascular Age-Related Macular Degeneration, Subfoveal CNV, TK001|neovascular age-related macular degeneration, subfoveal cnv, tk001
153946|NCT02613546|cognitive-behavioral psychotherapy|cognitive-behavioral psychotherapy
153947|NCT02613546|Sexual Dysfunctions|sexual dysfunctions
153948|NCT02613546|Women|women
153949|NCT02613520|PfSPZ Vaccine|pfspz vaccine
153950|NCT02613520|Plasmodium falciparum|plasmodium falciparum
153951|NCT02613494|clozapine|clozapine
153952|NCT02613494|hypersalivation|hypersalivation
153953|NCT02613494|refractory schizophrenia|refractory schizophrenia
153954|NCT02613468|Pregnancy|pregnancy
153955|NCT02613468|Low birth weight|low birth weight
153956|NCT02613468|Gingivitis|gingivitis
153957|NCT02613468|Inflammation|inflammation
153958|NCT02613468|Periodontitis|periodontitis
153959|NCT02613390|Epidural metastasis|epidural metastasis
153960|NCT02613390|Magnetic resonance imaging|magnetic resonance imaging
153962|NCT02613390|Guidance system|guidance system
153963|NCT02613390|Spinal surgery|spinal surgery
153964|NCT02613390|Questionnaires|questionnaires
153965|NCT02613390|Surveys|surveys
153966|NCT02613377|Transfusion-related acute lung injury, Red Blood Cell|transfusion-related acute lung injury, red blood cell
153967|NCT02613351|Exercise Tolerance|exercise tolerance
153968|NCT02613351|Lung Diseases, Obstructive|lung diseases, obstructive
153969|NCT02613325|Melanoma|melanoma
153970|NCT02613325|Imaging|imaging
153971|NCT02613325|Pigmented Lesions|pigmented lesions
153972|NCT02613325|Melanoma Management|melanoma management
153973|NCT02613247|Viscosupplementation|viscosupplementation
153974|NCT02613247|Hyaluronic acid|hyaluronic acid
153975|NCT02613247|Synvisc|synvisc
153976|NCT02613247|Synvisc-One|synvisc-one
153977|NCT02613247|Patellofemoral pain syndrome|patellofemoral pain syndrome
153978|NCT02613247|PFPS|pfps
153979|NCT02613247|Anterior knee pain|anterior knee pain
153980|NCT02613247|Runner's knee|runner's knee
153981|NCT02613234|Epilepsy|epilepsy
153982|NCT02613234|128-Channel EEG|128-channel eeg
153983|NCT02613234|Dipole Localization|dipole localization
153984|NCT02613234|Transcranial Direct Current Stimulation|transcranial direct current stimulation
153985|NCT02613221|Metastatic colorectal cancer, Panitumumab, TAS-102|metastatic colorectal cancer, panitumumab, tas-102
153986|NCT02613195|Ischemia-Reperfusion Injury|ischemia-reperfusion injury
153987|NCT02613195|oxidative stress|oxidative stress
153988|NCT02613195|organ preservation|organ preservation
153989|NCT02613195|Hydrogen|hydrogen
153990|NCT02613195|Kidney Transplantation|kidney transplantation
153991|NCT02613169|M. tuberculosis infection|m. tuberculosis infection
153992|NCT02613169|isoniazid|isoniazid
153993|NCT02613169|HIV-exposed infants|hiv-exposed infants
153994|NCT02613156|laparoscopic|laparoscopic
153995|NCT02613156|hepatocellular carcinoma|hepatocellular carcinoma
153996|NCT02613156|recurrence|recurrence
153997|NCT02613143|malignant glaucoma|malignant glaucoma
153998|NCT02613143|zonulo-hyaloido-vitrectomy|zonulo-hyaloido-vitrectomy
153999|NCT02613091|volunteers|volunteers
154000|NCT02613078|Children|children
154001|NCT02613078|Functional Abdominal Pain Syndrome|functional abdominal pain syndrome
154002|NCT02613078|Irritable Bowel Syndrome|irritable bowel syndrome
154003|NCT02613078|Gut-Directed Hypnotherapy|gut-directed hypnotherapy
154004|NCT02613078|Probiotic|probiotic
154005|NCT02613065|Ad libitum|ad libitum
154006|NCT02613065|Energy balance|energy balance
154007|NCT02613065|Protein|protein
154008|NCT02613039|oral contraceptives|oral contraceptives
154009|NCT02613039|female sexuality|female sexuality
154010|NCT02613026|Breast tumor|breast tumor
154011|NCT02613026|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
154012|NCT02613026|Pathological complete remission|pathological complete remission
154013|NCT02612987|CBT|cbt
154014|NCT02612987|Internet based|internet based
154015|NCT02612974|Qurse mafasil|qurse mafasil
154016|NCT02612974|leech therapy|leech therapy
154017|NCT02612974|Hirudinaria granulosa|hirudinaria granulosa
154018|NCT02612961|Mechanically ventilated patients|mechanically ventilated patients
154019|NCT02612961|Normal Saline|normal saline
154020|NCT02612961|Tracheostomy Tube Suctioning|tracheostomy tube suctioning
154021|NCT02612922|Influenza|influenza
154022|NCT02612909|Avian Influenza|avian influenza
154023|NCT02612909|A/H5N1 vaccine|a/h5n1 vaccine
154024|NCT02612909|IVAC|ivac
154025|NCT02612896|Taenia solium|taenia solium
154026|NCT02612896|control|control
154027|NCT02612896|elimination|elimination
154028|NCT02612896|One Health|one health
154029|NCT02612883|Flux measurement|flux measurement
154030|NCT02612870|Breast Cancer|breast cancer
154031|NCT02612870|Sentinel Node|sentinel node
154032|NCT02612870|Sentinel Node Biopsy|sentinel node biopsy
154033|NCT02612870|Breast Surgery|breast surgery
154034|NCT02612857|dermatomyositis|dermatomyositis
154035|NCT02612857|IMO-8400|imo-8400
154036|NCT02612857|Pioneer|pioneer
154037|NCT02612818|coelioscopy|coelioscopy
154038|NCT02612766|celiac disease|celiac disease
154039|NCT02612766|oat|oat
154040|NCT02612766|gluten free diet|gluten free diet
154041|NCT02612753|Aphasia|aphasia
154042|NCT02612753|Speaking therapy|speaking therapy
154043|NCT02612753|Language therapy|language therapy
154044|NCT02612753|transcranial Direct current stimulation|transcranial direct current stimulation
154045|NCT02612740|Bio Oss|bio oss
154046|NCT02612740|critical-size defect|critical-size defect
154047|NCT02612740|bone grafting|bone grafting
154048|NCT02612740|cyst|cyst
154049|NCT02612740|CT bone analysis|ct bone analysis
154050|NCT02612740|alveolar bone|alveolar bone
154051|NCT02612727|Hyperbilirubinemia, Neonatal|hyperbilirubinemia, neonatal
154052|NCT02612714|diabetes|diabetes
154053|NCT02612714|hypercholesterolemia|hypercholesterolemia
154054|NCT02612714|sexual dysfunction|sexual dysfunction
154055|NCT02612714|statin|statin
154056|NCT02612714|testosterone|testosterone
154057|NCT02612701|Myocardial perfusion|myocardial perfusion
154058|NCT02612701|Electronic cigarettes|electronic cigarettes
154059|NCT02612701|Cigarettes|cigarettes
154060|NCT02612701|Cigarette smoking|cigarette smoking
154061|NCT02612688|Advance Care Planning|advance care planning
154062|NCT02612688|Advance Directives|advance directives
154063|NCT02612688|Alzheimer Disease|alzheimer disease
154064|NCT02612688|Dementia|dementia
154065|NCT02612688|Do-Not-Resuscitate Orders|do-not-resuscitate orders
154066|NCT02612688|Enteral Nutrition|enteral nutrition
154067|NCT02612688|Heart Failure|heart failure
154068|NCT02612688|Hospices|hospices
154069|NCT02612688|Hospitalization|hospitalization
154070|NCT02612688|Instructional Films and Videos|instructional films and videos
154071|NCT02612688|Intubation|intubation
154072|NCT02612688|Nursing Homes|nursing homes
154073|NCT02612688|Parenteral Nutrition|parenteral nutrition
154074|NCT02612688|Pragmatic Clinical Trials|pragmatic clinical trials
154075|NCT02612688|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
154076|NCT02612688|Randomized Controlled Trials|randomized controlled trials
154077|NCT02612688|Resuscitation Orders|resuscitation orders
154078|NCT02612688|Skilled Nursing Facilities|skilled nursing facilities
154079|NCT02612662|AZD4076|azd4076
154080|NCT02612662|Healthy male subjects|healthy male subjects
154081|NCT02612662|Safety|safety
154082|NCT02612662|Subcutaneous|subcutaneous
154083|NCT02612662|Tolerability|tolerability
154084|NCT02612649|Irritable bowel syndrome|irritable bowel syndrome
154085|NCT02612649|YM060|ym060
154086|NCT02612649|Ramosetron|ramosetron
154087|NCT02612649|Survey|survey
154088|NCT02612636|Delirium|delirium
154089|NCT02612636|Ear Plug|ear plug
154090|NCT02612636|Eye Mask|eye mask
154091|NCT02612636|Mechanical ventilation|mechanical ventilation
154092|NCT02612636|Sleep|sleep
154093|NCT02612597|before and after bedrest|before and after bedrest
154094|NCT02612597|healthy untrained|healthy untrained
154095|NCT02612597|before and after exercise training|before and after exercise training
154096|NCT02612558|Warm antibody autoimmune hemolytic anemia (AIHA)|warm antibody autoimmune hemolytic anemia (aiha)
154097|NCT02612545|Plasmodium Falciparum|plasmodium falciparum
154098|NCT02612545|Artemisinin Combination Therapy|artemisinin combination therapy
154099|NCT02612545|Triple Artemisinin Combination Therapy|triple artemisinin combination therapy
154100|NCT02612545|Piperaquine|piperaquine
154101|NCT02612545|Mefloquine|mefloquine
154102|NCT02612493|obesity surgery|obesity surgery
154103|NCT02612493|type I diabetes|type i diabetes
154104|NCT02612493|weight loss|weight loss
154105|NCT02612493|insulin dosage|insulin dosage
154106|NCT02612493|postsurgery metabolic changes|postsurgery metabolic changes
154107|NCT02612480|endotoxin|endotoxin
154108|NCT02612480|LPS|lps
154109|NCT02612480|ticagrelor|ticagrelor
154110|NCT02612480|clopidogrel|clopidogrel
154111|NCT02612480|acetylsalicyclic acid|acetylsalicyclic acid
154112|NCT02612480|placebo|placebo
154113|NCT02612467|start back tool|start back tool
154114|NCT02612467|stratified care|stratified care
154115|NCT02612467|targeted treatment|targeted treatment
154116|NCT02612454|Eczema|eczema
154117|NCT02612441|stroke|stroke
154118|NCT02612389|COPD|copd
154119|NCT02612389|Qigong|qigong
154120|NCT02612389|ANS|ans
154121|NCT02612389|Meditative Movement|meditative movement
154122|NCT02612389|Flight Attendants|flight attendants
154123|NCT02612389|Secondhand Smoke|secondhand smoke
154124|NCT02612389|Nicotine|nicotine
154125|NCT02612389|Blood Pressure|blood pressure
154126|NCT02612389|6 minute walk test|6 minute walk test
154127|NCT02612363|septic shock|septic shock
154128|NCT02612363|sedation|sedation
154129|NCT02612363|microcirculation|microcirculation
154130|NCT02612350|ctDNA|ctdna
154131|NCT02612350|high risk for developing cancer|high risk for developing cancer
154132|NCT02612350|Plasma|plasma
154133|NCT02612350|Relative Risk|relative risk
154134|NCT02612350|Early Detection of Cancer|early detection of cancer
154135|NCT02612350|Cancer Screening Tests|cancer screening tests
154136|NCT02612350|Cancer Screening|cancer screening
154137|NCT02612337|Meniere's Disease|meniere's disease
154138|NCT02612337|Vertigo|vertigo
154139|NCT02612324|adolescents|adolescents
154140|NCT02612324|teen pregnancy prevention|teen pregnancy prevention
154141|NCT02612324|sexually transmitted infections prevention|sexually transmitted infections prevention
154142|NCT02612324|place-based programs|place-based programs
154143|NCT02612324|health education|health education
154144|NCT02612298|Essential Hypertension|essential hypertension
154145|NCT02612298|Arotinolol|arotinolol
154146|NCT02612298|Morning Blood Pressure|morning blood pressure
154147|NCT02612233|Pain|pain
154148|NCT02612220|liver resection|liver resection
154149|NCT02612181|dexmedetomidine|dexmedetomidine
154150|NCT02612181|microcirculation|microcirculation
154151|NCT02612181|septic shock|septic shock
154152|NCT02612168|Diagnosis|diagnosis
154153|NCT02612168|skin imaging|skin imaging
154154|NCT02612155|Hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
154155|NCT02612155|autologous cord blood cells|autologous cord blood cells
154156|NCT02612155|newborn infants|newborn infants
154157|NCT02612129|NPC1|npc1
154158|NCT02612129|Niemann-Pick Type C|niemann-pick type c
154159|NCT02612129|Niemann-Pick|niemann-pick
154160|NCT02612129|arimoclomol|arimoclomol
154161|NCT02612129|lysosomal storage disorder|lysosomal storage disorder
154162|NCT02612129|lysosomal storage disease|lysosomal storage disease
154163|NCT02612129|NPC2|npc2
154164|NCT02612129|NP-C|np-c
154165|NCT02612103|Biochemical markers|biochemical markers
154166|NCT02612090|Nutrition|nutrition
154167|NCT02612090|Polyphenols|polyphenols
154168|NCT02612090|Berries|berries
154169|NCT02612090|Lipid Panels|lipid panels
154170|NCT02612051|patients|patients
154171|NCT02612051|FTIH|ftih
154172|NCT02612051|healthy volunteers|healthy volunteers
154173|NCT02612051|GSK3008348|gsk3008348
154174|NCT02612051|[18F]-FBA-A20FMDV2|[18f]-fba-a20fmdv2
154175|NCT02612051|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
154176|NCT02612051|PET|pet
154177|NCT02612038|Obstructive sleep apnea|obstructive sleep apnea
154178|NCT02612038|Expiratory flow limitation|expiratory flow limitation
154179|NCT02612012|breast cancer|breast cancer
154180|NCT02612012|positive sentinel lymph nodes|positive sentinel lymph nodes
154181|NCT02612012|axillary radiotherapy|axillary radiotherapy
154182|NCT02611999|Physicians' ordering behavior with price information|physicians' ordering behavior with price information
154183|NCT02611986|Airway management|airway management
154184|NCT02611986|video laryngoscope|video laryngoscope
154185|NCT02611973|Essential Thrombocythemia|essential thrombocythemia
154186|NCT02611973|Aspirin|aspirin
154187|NCT02611960|PD-1|pd-1
154188|NCT02611960|PD1|pd1
154189|NCT02611960|PD-L1|pd-l1
154190|NCT02611960|PDL1|pdl1
154191|NCT02611947|emphysema|emphysema
154192|NCT02611947|airway remodelling|airway remodelling
154193|NCT02611947|multidetector computed tomography|multidetector computed tomography
154194|NCT02611921|Ketamine|ketamine
154195|NCT02611921|Social Impairment|social impairment
154196|NCT02611921|Autism|autism
154197|NCT02611921|Autistic Disorder|autistic disorder
154198|NCT02611908|CLL|cll
154199|NCT02611908|cancer|cancer
154200|NCT02611908|obinutuzumab|obinutuzumab
154201|NCT02611908|ibrutinib|ibrutinib
154202|NCT02611908|SLL|sll
154203|NCT02611895|Aviremic HIV-1 infected patients|aviremic hiv-1 infected patients
154204|NCT02611895|HAART|haart
154205|NCT02611895|Integrase inhibitor Raltegravir|integrase inhibitor raltegravir
154206|NCT02611895|Ongoing HIV infection|ongoing hiv infection
154207|NCT02611856|twin to twin,|twin to twin,
154208|NCT02611856|transfusion syndrome|transfusion syndrome
154209|NCT02611843|peer support|peer support
154210|NCT02611843|web-based treatment|web-based treatment
154211|NCT02611843|veterans|veterans
154212|NCT02611843|PTSD|ptsd
154213|NCT02611843|Substance Use Disorders|substance use disorders
154214|NCT02611830|Drug therapy|drug therapy
154215|NCT02611817|Drug therapy|drug therapy
154216|NCT02611791|Treatment by Pulsed Radio Frequency, Collagen, Female|treatment by pulsed radio frequency, collagen, female
154217|NCT02611713|Advanced Parkinson's Disease|advanced parkinson's disease
154218|NCT02611713|Duodopa/Duopa|duodopa/duopa
154219|NCT02611713|carbidopa levodopa enteral suspension (CLES)|carbidopa levodopa enteral suspension (cles)
154220|NCT02611713|levodopa-carbidopa intestinal gel (LCIG)|levodopa-carbidopa intestinal gel (lcig)
154221|NCT02611713|OFF time|off time
154222|NCT02611713|motor and non-motor symptoms|motor and non-motor symptoms
154223|NCT02611713|dyskinesia|dyskinesia
154224|NCT02611713|tremor|tremor
154225|NCT02611713|Quality of Life|quality of life
154226|NCT02611713|Observational|observational
154227|NCT02611713|Long-term|long-term
154228|NCT02611713|Caregiver Burden|caregiver burden
154229|NCT02611713|effectiveness|effectiveness
154230|NCT02611713|fluctuations|fluctuations
154231|NCT02611635|non-valvular Atrial Fibrillation|non-valvular atrial fibrillation
154232|NCT02611635|Patient treatment preference|patient treatment preference
154233|NCT02611635|NOAC|noac
154234|NCT02611635|VKA|vka
154235|NCT02611583|TENS|tens
154236|NCT02611570|Lung cancer|lung cancer
154237|NCT02611570|Low dose computed tomography|low dose computed tomography
154238|NCT02611570|Screening|screening
154239|NCT02611570|Non-smoker|non-smoker
154240|NCT02611570|Gender issue|gender issue
154241|NCT02611557|MRI|mri
154242|NCT02611557|lymphedema|lymphedema
154243|NCT02611557|manual lymphatic drainage|manual lymphatic drainage
154244|NCT02611544|Fear of Cancer Recurrence|fear of cancer recurrence
154245|NCT02611544|Fear of Cancer Return|fear of cancer return
154246|NCT02611544|Breast Cancer Survivor|breast cancer survivor
154247|NCT02611544|Breast Cancer Remission|breast cancer remission
154248|NCT02611518|Healthy|healthy
154249|NCT02611518|JNJ-54861911|jnj-54861911
154250|NCT02611518|Rosuvastatin|rosuvastatin
154251|NCT02611518|Metformin|metformin
154252|NCT02611505|Healthy|healthy
154253|NCT02611505|Esketamine|esketamine
154254|NCT02611505|Hepatic Impairment|hepatic impairment
154255|NCT02611505|Pharmacokinetics|pharmacokinetics
154256|NCT02611479|patient reported outcomes|patient reported outcomes
154257|NCT02611466|Osteoarthritis|osteoarthritis
154258|NCT02611466|ASP7962|asp7962
154259|NCT02611453|choledocholithiasis|choledocholithiasis
154260|NCT02611453|ERCP|ercp
154261|NCT02611453|cholangiography|cholangiography
154262|NCT02611453|biliary stricture|biliary stricture
154263|NCT02611453|bile ducts|bile ducts
154264|NCT02611453|carbon dioxide|carbon dioxide
154265|NCT02611440|ischemic stroke|ischemic stroke
154266|NCT02611440|medication adherence|medication adherence
154267|NCT02611440|cardiovascular disease prevention|cardiovascular disease prevention
154268|NCT02611427|spine|spine
154269|NCT02611427|lumbar|lumbar
154270|NCT02611427|postoperative|postoperative
154271|NCT02611427|physical activity|physical activity
154272|NCT02611414|functional dyspepsia|functional dyspepsia
154273|NCT02611414|tDCS|tdcs
154274|NCT02611401|multiple sclerosis|multiple sclerosis
154275|NCT02611401|depression|depression
154276|NCT02611401|mindfulness|mindfulness
154785|NCT02608268|TIM-3|tim-3
154277|NCT02611336|Left Ventricular Hypertrophy|left ventricular hypertrophy
154278|NCT02611336|Diastolic Dysfunction|diastolic dysfunction
154279|NCT02611336|Myocardial Fibrosis|myocardial fibrosis
154280|NCT02611336|Acromegaly|acromegaly
154281|NCT02611297|Cryoprobes|cryoprobes
154282|NCT02611297|Cryobiopsy|cryobiopsy
154283|NCT02611297|Transbronchial lung biopsy|transbronchial lung biopsy
154284|NCT02611284|Beractant|beractant
154285|NCT02611284|Feasibility Studies|feasibility studies
154286|NCT02611284|Infant, Premature|infant, premature
154287|NCT02611284|Noninvasive Ventilation|noninvasive ventilation
154288|NCT02611258|Left Ventricular Hypertrophy|left ventricular hypertrophy
154289|NCT02611258|Diastolic Dysfunction|diastolic dysfunction
154290|NCT02611258|Myocardial Fibrosis|myocardial fibrosis
154291|NCT02611258|Cushing's Syndrome|cushing's syndrome
154292|NCT02611245|Thoracic Duct|thoracic duct
154293|NCT02611245|Sentinel lymph node biopsy|sentinel lymph node biopsy
154294|NCT02611232|Diabetes Type 1|diabetes type 1
154295|NCT02611232|Diabetes, Insulin-Dependent|diabetes, insulin-dependent
154296|NCT02611232|Liraglutide|liraglutide
154297|NCT02611232|Preclinical Type 1 Diabetes|preclinical type 1 diabetes
154298|NCT02611232|GLP-1 Analogue|glp-1 analogue
154299|NCT02611206|rTMS|rtms
154300|NCT02611167|mesenchymal stem cells|mesenchymal stem cells
154301|NCT02611154|Healthy Volunteers|healthy volunteers
154302|NCT02611154|Sports Medicine|sports medicine
154303|NCT02611154|Men's Health|men's health
154304|NCT02611154|Athletes|athletes
154305|NCT02611154|Anti-Doping|anti-doping
154306|NCT02611141|Retromolar Intubation|retromolar intubation
154307|NCT02611115|Pulmonary Embolism|pulmonary embolism
154308|NCT02611115|Multidetector Computed Tomography|multidetector computed tomography
154309|NCT02611115|Radiation Dosage|radiation dosage
154310|NCT02611115|Contrast Media|contrast media
154311|NCT02611115|Individualized Medicine|individualized medicine
154312|NCT02611089|Muscle connective tissue|muscle connective tissue
154313|NCT02611089|Small leucine-rich proteoglycans|small leucine-rich proteoglycans
154314|NCT02611089|Limb development|limb development
154315|NCT02611076|smoking cessation|smoking cessation
154316|NCT02611076|self-help|self-help
154317|NCT02611076|Spanish language|spanish language
154318|NCT02611063|allogeneic stem cell transplant|allogeneic stem cell transplant
154319|NCT02611050|patient decision aid|patient decision aid
154320|NCT02611050|multi-vessel coronary artery disease|multi-vessel coronary artery disease
154321|NCT02611037|MPM|mpm
154322|NCT02611037|Unresectable|unresectable
154323|NCT02611037|Respiratory|respiratory
154324|NCT02611037|Intrathoracic|intrathoracic
154325|NCT02611037|Transarterial|transarterial
154326|NCT02611037|Chemoperfusion|chemoperfusion
154327|NCT02611024|lurbinectedin|lurbinectedin
154328|NCT02611024|PM01183|pm01183
154329|NCT02611024|tumors|tumors
154330|NCT02611024|cancer|cancer
154331|NCT02611024|Pharma Mar|pharma mar
154332|NCT02611011|Congo Red Dot Test|congo red dot test
154333|NCT02610985|Imaging, Three-Dimensional|imaging, three-dimensional
154334|NCT02610985|Hysterectomy|hysterectomy
154335|NCT02610985|laparoscopic hysterectomy|laparoscopic hysterectomy
154336|NCT02610972|Congo Red test GV-005|congo red test gv-005
154337|NCT02610946|pediatric|pediatric
154338|NCT02610946|adolescent|adolescent
154339|NCT02610946|compliance|compliance
154340|NCT02610933|vascular calcification|vascular calcification
154341|NCT02610933|hemodialysis|hemodialysis
154342|NCT02610933|rivaroxaban|rivaroxaban
154343|NCT02610933|vitamin K2|vitamin k2
154344|NCT02610894|postoperative symptom management|postoperative symptom management
154345|NCT02610894|symptom management|symptom management
154346|NCT02610894|mHealth application|mhealth application
154347|NCT02610868|Cerebral Palsy|cerebral palsy
154348|NCT02610868|ALS|als
154349|NCT02610868|Stroke|stroke
154350|NCT02610868|Neuroleptics|neuroleptics
154351|NCT02610803|stroke|stroke
154352|NCT02610803|ischemic stroke|ischemic stroke
154353|NCT02610803|recurrent stroke|recurrent stroke
154354|NCT02610803|atrial fibrillation|atrial fibrillation
154355|NCT02610803|premature atrial complexes|premature atrial complexes
154356|NCT02610803|heart rhythm monitoring|heart rhythm monitoring
154357|NCT02610803|cardiac telemetry|cardiac telemetry
154358|NCT02610790|connected bracelets, footsteps|connected bracelets, footsteps
154359|NCT02610777|Drug Therapy|drug therapy
154360|NCT02610764|Circulating Tumor Cells|circulating tumor cells
154361|NCT02610764|Response evaluation|response evaluation
154362|NCT02610751|Maternal Smoking|maternal smoking
154363|NCT02610751|Female Fetal Testosterone|female fetal testosterone
154364|NCT02610751|Anogenital Distance|anogenital distance
154365|NCT02610751|Maternal Testosterone|maternal testosterone
154366|NCT02610751|Maternal Cotinine|maternal cotinine
154367|NCT02610712|ketamine|ketamine
154368|NCT02610712|treatment-resistant|treatment-resistant
154369|NCT02610712|depression|depression
154370|NCT02610712|spectroscopy|spectroscopy
154371|NCT02610712|neuroinflammation|neuroinflammation
154372|NCT02610686|Plasmodium vivax|plasmodium vivax
154373|NCT02610686|recurrence|recurrence
154374|NCT02610686|drug resistance|drug resistance
154375|NCT02610634|Parkinson's disease|parkinson's disease
154376|NCT02610634|Older adults|older adults
154377|NCT02610634|Vision|vision
154378|NCT02610634|Cognition|cognition
154379|NCT02610634|Visual cues|visual cues
154380|NCT02610634|Eye-tracking|eye-tracking
154381|NCT02610634|Gait|gait
154382|NCT02610634|Saccades|saccades
154383|NCT02610634|Dual task|dual task
154384|NCT02610634|Visual sampling|visual sampling
154385|NCT02610621|Clinically node negative|clinically node negative
154386|NCT02610621|T1 and T2 invasive breast cancer|t1 and t2 invasive breast cancer
154387|NCT02610595|Idiopathic Membranous Nephropathy|idiopathic membranous nephropathy
154388|NCT02610595|Jianpiyiqi Recipe|jianpiyiqi recipe
154389|NCT02610595|Huoxuejiedu Recipe|huoxuejiedu recipe
154390|NCT02610595|Effectiveness|effectiveness
154391|NCT02610595|Safety|safety
154392|NCT02610582|CNGA3-linked|cnga3-linked
154393|NCT02610569|Colonic capsule|colonic capsule
154394|NCT02610569|ulcerative colitis|ulcerative colitis
154395|NCT02610569|mucosal healing|mucosal healing
154396|NCT02610569|endoscopic score|endoscopic score
154397|NCT02610556|NPC|npc
154398|NCT02610556|concurrent chemotherapy|concurrent chemotherapy
154399|NCT02610556|docetaxel|docetaxel
154400|NCT02610556|cisplatin|cisplatin
154401|NCT02610543|Primary Sjögren's Syndrome|primary sjögren's syndrome
154402|NCT02610530|type 2 diabetes|type 2 diabetes
154403|NCT02610530|metabolic surgery|metabolic surgery
154404|NCT02610530|medical treatment|medical treatment
154405|NCT02610517|Hazardous alcohol use|hazardous alcohol use
154406|NCT02610517|Computer based intervention (CBI)|computer based intervention (cbi)
154407|NCT02610517|Pharmacotherapy|pharmacotherapy
154408|NCT02610504|degenerative arthritis|degenerative arthritis
154409|NCT02610465|Computed Tomography|computed tomography
154410|NCT02610465|Image Reconstruction|image reconstruction
154411|NCT02610465|Iterative Reconstruction|iterative reconstruction
154412|NCT02610452|clown therapy|clown therapy
154413|NCT02610387|tDCS|tdcs
154414|NCT02610387|stroke|stroke
154415|NCT02610387|Spasticity|spasticity
154416|NCT02610374|Gut microbiota composition|gut microbiota composition
154417|NCT02610348|Hepatitis B|hepatitis b
154418|NCT02610348|Hexaxim®|hexaxim®
154419|NCT02610348|Hexyon®|hexyon®
154420|NCT02610348|Hexacima®|hexacima®
154421|NCT02610348|Prevnar®|prevnar®
154422|NCT02610348|DTaP-IPV-HB-Hib hexavalent vaccine|dtap-ipv-hb-hib hexavalent vaccine
154423|NCT02610335|lumbar spinal stenosis|lumbar spinal stenosis
154424|NCT02610309|family-based crisis intervention|family-based crisis intervention
154425|NCT02610309|adolescent suicide|adolescent suicide
154426|NCT02610283|AKI|aki
154427|NCT02610270|Sport|sport
154428|NCT02610270|fatty acid|fatty acid
154429|NCT02610270|omega 3|omega 3
154430|NCT02610257|Parkinson's disease|parkinson's disease
154431|NCT02610257|Freezing of gait|freezing of gait
154432|NCT02610257|Motor blocks|motor blocks
154433|NCT02610257|Somatosensory|somatosensory
154434|NCT02610257|Proprioception|proprioception
154435|NCT02610257|Muscle vibration|muscle vibration
154436|NCT02610257|Handwriting|handwriting
154437|NCT02610231|Parkinson's disease|parkinson's disease
154438|NCT02610231|Moderate to Severe Parkinson's Disease|moderate to severe parkinson's disease
154439|NCT02610218|Cell free DNA|cell free dna
154440|NCT02610218|Circulating tumor cell|circulating tumor cell
154441|NCT02610218|Therapeutic efficacy|therapeutic efficacy
154442|NCT02610205|Caring touch|caring touch
154443|NCT02610205|Tactile massage|tactile massage
154444|NCT02610205|Healing touch|healing touch
154445|NCT02610192|Autologous Protein Solution|autologous protein solution
154446|NCT02610192|Patellofemoral Osteoarthritis|patellofemoral osteoarthritis
154447|NCT02610192|Female|female
154448|NCT02610114|Assisted reproductive technology (ART)|assisted reproductive technology (art)
154449|NCT02610114|zygotes|zygotes
154450|NCT02610114|Z-score (Zygote Score)|z-score (zygote score)
154451|NCT02610114|Infertility|infertility
154452|NCT02610088|Diabetes|diabetes
154453|NCT02610088|Atherosclerosis|atherosclerosis
154454|NCT02610088|Cardiovascular disease|cardiovascular disease
154455|NCT02610088|Endothelial dysfunction|endothelial dysfunction
154456|NCT02610088|Vascular function|vascular function
154457|NCT02610088|Dapagliflozin|dapagliflozin
154458|NCT02610088|Gliclazide|gliclazide
154459|NCT02610075|AZD1775|azd1775
154460|NCT02610075|Metastatic solid tumors|metastatic solid tumors
154461|NCT02610075|Ovarian cancer|ovarian cancer
154462|NCT02610062|AML|aml
154463|NCT02610062|Acute Myeloid Leukemia|acute myeloid leukemia
154464|NCT02610049|PTSD|ptsd
154465|NCT02610036|diabetes|diabetes
154466|NCT02610036|foot ulcer|foot ulcer
154467|NCT02610010|NPC|npc
154468|NCT02610010|concurrent chemotherapy|concurrent chemotherapy
154469|NCT02610010|IMRT|imrt
154470|NCT02610010|stage II|stage ii
154471|NCT02609997|Intraocular lens|intraocular lens
154472|NCT02609984|immunotherapy|immunotherapy
154473|NCT02609984|CMB305|cmb305
154474|NCT02609984|LV305|lv305
154475|NCT02609984|GLA-SE|gla-se
154476|NCT02609984|Atezolizumab|atezolizumab
154477|NCT02609984|NY-ESO-1|ny-eso-1
154478|NCT02609971|Anterior cruciate ligament|anterior cruciate ligament
154479|NCT02609971|Neuromuscular Performance and balance|neuromuscular performance and balance
154480|NCT02609945|Migraine attacks|migraine attacks
154481|NCT02609932|Interferon-gamma|interferon-gamma
154482|NCT02609932|innate immunity|innate immunity
154483|NCT02609919|study of contrast reaction in children under 2 years of age|study of contrast reaction in children under 2 years of age
154484|NCT02609919|safety|safety
154485|NCT02609906|proximal humerus|proximal humerus
154486|NCT02609906|AO 11-A3 fracture|ao 11-a3 fracture
154487|NCT02609906|MultiLoc|multiloc
154488|NCT02609906|Philos augmented|philos augmented
154489|NCT02609893|HCV|hcv
154490|NCT02609880|Psycho-Oncology|psycho-oncology
154491|NCT02609880|Psychoneuroimmunology|psychoneuroimmunology
154492|NCT02609880|Cognitive Behavioral Therapy|cognitive behavioral therapy
154493|NCT02609880|Gynecologic Cancer|gynecologic cancer
154494|NCT02609880|Insomnia|insomnia
154495|NCT02609880|Pain|pain
154496|NCT02609880|Distress|distress
154497|NCT02609880|Cortisol|cortisol
154498|NCT02609880|Cytokines|cytokines
154499|NCT02609854|herniated disc|herniated disc
154500|NCT02609854|sustained acoustic medicine|sustained acoustic medicine
154501|NCT02609854|ultrasound|ultrasound
154502|NCT02609854|CLBP|clbp
154503|NCT02609828|Metastatic cancer bone pain|metastatic cancer bone pain
154504|NCT02609828|Multiple myeloma|multiple myeloma
154505|NCT02609789|Systemic Lupus Erythematosus|systemic lupus erythematosus
154506|NCT02609789|JNJ-55920839|jnj-55920839
154507|NCT02609789|Healthy Volunteers|healthy volunteers
154508|NCT02609789|CNTO 6358|cnto 6358
154509|NCT02609776|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
154510|NCT02609776|JNJ-61186372|jnj-61186372
154511|NCT02609776|First-in-Human|first-in-human
154512|NCT02609776|Human Bispecific Epidermal Growth Factor Receptor (EGFR)|human bispecific epidermal growth factor receptor (egfr)
154513|NCT02609776|cMet Antibody|cmet antibody
154514|NCT02609737|Radiolabeled Somatostatin Antagonists|radiolabeled somatostatin antagonists
154515|NCT02609737|68Ga-DOTA-JR11|68ga-dota-jr11
154516|NCT02609737|177Lu-DOTA-JR11|177lu-dota-jr11
154517|NCT02609737|Pet scan|pet scan
154518|NCT02609737|CT scan|ct scan
154519|NCT02609737|15-161|15-161
154520|NCT02609724|breast cancer|breast cancer
154521|NCT02609724|lymphedema|lymphedema
154522|NCT02609724|manual lymph drainage|manual lymph drainage
154523|NCT02609724|near infrared fluorescence imaging|near infrared fluorescence imaging
154524|NCT02609698|Stent|stent
154525|NCT02609698|Polymer-free|polymer-free
154526|NCT02609698|Antiplatelet therapy|antiplatelet therapy
154527|NCT02609698|Clopidogrel|clopidogrel
154528|NCT02609698|DES|des
154529|NCT02609698|DAPT|dapt
154530|NCT02609685|Thyroid cancer|thyroid cancer
154531|NCT02609685|Active surveillance|active surveillance
154532|NCT02609685|PTMC|ptmc
154533|NCT02609672|Exercise|exercise
154534|NCT02609672|Resilience|resilience
154535|NCT02609659|Chronic Hepatitis C Infection|chronic hepatitis c infection
154536|NCT02609646|Anti-Infective Agents|anti-infective agents
154537|NCT02609646|Pharmacokinetics|pharmacokinetics
154538|NCT02609646|Critically ill patients|critically ill patients
154539|NCT02609594|human amniotic membrane|human amniotic membrane
154540|NCT02609594|compression therapy|compression therapy
154541|NCT02609594|venous leg ulcer|venous leg ulcer
154542|NCT02609581|Non Interventional Study|non interventional study
154543|NCT02609581|NIS|nis
154544|NCT02609581|sublingual immunotherapy|sublingual immunotherapy
154545|NCT02609581|allergen|allergen
154546|NCT02609581|Mites|mites
154547|NCT02609568|Children|children
154548|NCT02609568|Head injury|head injury
154549|NCT02609568|Salivary biomarker|salivary biomarker
154550|NCT02609568|Trauma Brain Injury|trauma brain injury
154551|NCT02609555|TEM|tem
154552|NCT02609555|Rectopexy|rectopexy
154553|NCT02609555|rectal prolapse|rectal prolapse
154554|NCT02609542|oral language|oral language
154555|NCT02609542|STOL|stol
154556|NCT02609542|memory|memory
154557|NCT02609542|eye tracking|eye tracking
154558|NCT02609529|Irritable Bowel Syndrome|irritable bowel syndrome
154559|NCT02609529|Pediatrics|pediatrics
154560|NCT02609529|Nutrition|nutrition
154561|NCT02609516|Multimorbidity|multimorbidity
154562|NCT02609516|Health inequalities|health inequalities
154563|NCT02609516|Ageing|ageing
154564|NCT02609516|Mortality|mortality
154565|NCT02609477|Recreational stimulant users|recreational stimulant users
154566|NCT02609477|Recreational Drug Users|recreational drug users
154567|NCT02609451|quality of life|quality of life
154568|NCT02609451|feasibility|feasibility
154569|NCT02609451|safety|safety
154570|NCT02609451|protective ileostomy closure|protective ileostomy closure
154571|NCT02609438|worksite|worksite
154572|NCT02609438|intervention|intervention
154573|NCT02609438|sitting|sitting
154574|NCT02609399|Influenza|influenza
154575|NCT02609399|Antiviral treatment|antiviral treatment
154576|NCT02609399|Emergency department|emergency department
154577|NCT02609399|Influenza therapeutics|influenza therapeutics
154578|NCT02609399|Rapid influenza testing|rapid influenza testing
154579|NCT02609386|Head and Neck Neoplasms|head and neck neoplasms
154889|NCT02607449|MDR TB|mdr tb
154580|NCT02609386|Immunotherapy|immunotherapy
154581|NCT02609386|Cancer|cancer
154582|NCT02609386|Oral Cavity|oral cavity
154583|NCT02609373|shiftwork|shiftwork
154584|NCT02609373|sleep hygiene|sleep hygiene
154585|NCT02609373|prevention|prevention
154586|NCT02609373|intervention|intervention
154587|NCT02609373|occupational|occupational
154588|NCT02609373|biological|biological
154589|NCT02609373|breast cancer|breast cancer
154590|NCT02609373|lifestyle|lifestyle
154591|NCT02609360|Acute Respiratory Failure|acute respiratory failure
154592|NCT02609360|ARDS|ards
154593|NCT02609360|ECMO|ecmo
154594|NCT02609360|Lung transplantation|lung transplantation
154595|NCT02609360|Acid-Base Equilibrium|acid-base equilibrium
154596|NCT02609347|Manual Therapy|manual therapy
154597|NCT02609347|Ankle Fracture|ankle fracture
154598|NCT02609347|Hindfoot Fracture|hindfoot fracture
154599|NCT02609321|Paravertebral|paravertebral
154600|NCT02609321|Single injection|single injection
154601|NCT02609321|Breast surgery|breast surgery
154602|NCT02609321|Analgesia|analgesia
154603|NCT02609308|ankle sprain|ankle sprain
154604|NCT02609308|platelet-rich plasma|platelet-rich plasma
154605|NCT02609308|ankle injuries|ankle injuries
154606|NCT02609295|α-linolenic acid|α-linolenic acid
154607|NCT02609295|perilla oil|perilla oil
154608|NCT02609295|aPTT|aptt
154609|NCT02609295|Collagen-epinephrine closure time|collagen-epinephrine closure time
154610|NCT02609295|Lp-PLA2|lp-pla2
154611|NCT02609282|Sedentary behaviour|sedentary behaviour
154612|NCT02609282|sitting|sitting
154613|NCT02609282|workplace|workplace
154614|NCT02609282|prompts|prompts
154615|NCT02609256|Intracranial hypertension|intracranial hypertension
154616|NCT02609256|cerebral herniation|cerebral herniation
154617|NCT02609256|Stereotactic infarct tissue aspiration|stereotactic infarct tissue aspiration
154618|NCT02609256|fatality|fatality
154619|NCT02609256|disability|disability
154620|NCT02609243|prediabetes|prediabetes
154621|NCT02609243|diabetes mellitus type 2|diabetes mellitus type 2
154622|NCT02609243|obesity|obesity
154623|NCT02609243|NAFLD|nafld
154624|NCT02609243|dyslipoproteinemia|dyslipoproteinemia
154625|NCT02609217|elective|elective
154626|NCT02609217|cesarean|cesarean
154627|NCT02609178|artificial crown|artificial crown
154628|NCT02609178|biomorphic|biomorphic
154629|NCT02609178|functional generated path|functional generated path
154630|NCT02609178|muscle-action theory|muscle-action theory
154631|NCT02609178|anatomic theory|anatomic theory
154632|NCT02609126|osteoarthritis|osteoarthritis
154633|NCT02609126|knee|knee
154634|NCT02609113|Carpal Tunnel Syndrome|carpal tunnel syndrome
154635|NCT02609074|bone substitute|bone substitute
154636|NCT02609074|CPC|cpc
154637|NCT02609074|rhBMP-2|rhbmp-2
154638|NCT02609048|PBC|pbc
154639|NCT02609022|Myasthenia Gravis|myasthenia gravis
154640|NCT02609022|CV-MG01 therapeutic vaccine|cv-mg01 therapeutic vaccine
154641|NCT02609022|Acetylcholine receptor mimetic peptides|acetylcholine receptor mimetic peptides
154642|NCT02609022|Safety|safety
154643|NCT02609022|Immunogenic response|immunogenic response
154644|NCT02609022|First-in-Human|first-in-human
154645|NCT02609022|Proof-of-Concept|proof-of-concept
154646|NCT02609022|Myasterix|myasterix
154647|NCT02609009|Back Pain|back pain
154648|NCT02609009|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
154649|NCT02609009|Spinal Manipulation|spinal manipulation
154650|NCT02608983|Seaweed|seaweed
154651|NCT02608983|Hydrocolloid|hydrocolloid
154652|NCT02608983|Functional Food|functional food
154653|NCT02608983|Dietary Fibre|dietary fibre
154654|NCT02608983|Prebiotic|prebiotic
154655|NCT02608983|Low molecular weight polysaccharides|low molecular weight polysaccharides
154656|NCT02608983|Alginate|alginate
154657|NCT02608983|Agar|agar
154658|NCT02608983|HYFFI|hyffi
154659|NCT02608983|Low molecular weight seaweed derived hydrocolloids as functional food ingredients|low molecular weight seaweed derived hydrocolloids as functional food ingredients
154660|NCT02608983|subjects|subjects
154661|NCT02608931|delta-9-tetrahydrocannabinol (THC)|delta-9-tetrahydrocannabinol (thc)
154662|NCT02608892|Breastfeeding|breastfeeding
154663|NCT02608892|Skin to skin care|skin to skin care
154664|NCT02608892|Sucrose|sucrose
154665|NCT02608892|Newborn screening|newborn screening
154666|NCT02608892|Blood test|blood test
154667|NCT02608892|Neonate|neonate
154668|NCT02608892|Infant|infant
154669|NCT02608892|Knowledge translation|knowledge translation
154670|NCT02608879|proinflammatory cytokines|proinflammatory cytokines
154671|NCT02608879|microbiome|microbiome
154672|NCT02608879|radiation therapy|radiation therapy
154673|NCT02608866|stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
154674|NCT02608866|spine metastasis|spine metastasis
154675|NCT02608840|slow-wave sleep|slow-wave sleep
154676|NCT02608840|cognition|cognition
154677|NCT02608840|auditory stimulation|auditory stimulation
154678|NCT02608827|Hypertension; slow breathing; sympathetic nerve activity|hypertension; slow breathing; sympathetic nerve activity
154679|NCT02608788|postoperative sore throat|postoperative sore throat
154680|NCT02608788|American Society of Anesthesiologists status|american society of anesthesiologists status
154681|NCT02608788|general anesthesia|general anesthesia
154682|NCT02608788|post-anesthesia care unit(PACU)|post-anesthesia care unit(pacu)
154683|NCT02608775|ANI|ani
154684|NCT02608775|SPI|spi
154685|NCT02608775|Autonomic balance|autonomic balance
154686|NCT02608775|Nociception measurement|nociception measurement
154687|NCT02608762|Pediatric brain tumors|pediatric brain tumors
154688|NCT02608762|Radiation therapy|radiation therapy
154689|NCT02608762|Neurobehavioral functions|neurobehavioral functions
154690|NCT02608762|Proton radiotherapy|proton radiotherapy
154691|NCT02608749|Osteoporosis|osteoporosis
154692|NCT02608749|Fall|fall
154693|NCT02608749|Fracture|fracture
154694|NCT02608749|Sacopenia|sacopenia
154695|NCT02608749|Body Composition|body composition
154696|NCT02608736|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
154697|NCT02608736|histone deacetylases|histone deacetylases
154698|NCT02608736|valproic acid|valproic acid
154699|NCT02608736|acetylation|acetylation
154700|NCT02608736|chemoprevention|chemoprevention
154701|NCT02608736|DNA methyltransferase|dna methyltransferase
154702|NCT02608736|methylation|methylation
154703|NCT02608723|shock wave|shock wave
154704|NCT02608723|plantar fasciitis|plantar fasciitis
154705|NCT02608723|placebo effect|placebo effect
154706|NCT02608723|nocebo effect|nocebo effect
154707|NCT02608684|immunotherapy|immunotherapy
154708|NCT02608684|platinum-resistant ovarian cancer|platinum-resistant ovarian cancer
154709|NCT02608684|immune checkpoint inhibitors|immune checkpoint inhibitors
154710|NCT02608671|Episiotomy|episiotomy
154711|NCT02608671|continuous suture|continuous suture
154712|NCT02608671|Skin adhesive tape|skin adhesive tape
154713|NCT02608658|Cirrhosis|cirrhosis
154714|NCT02608658|Ascites|ascites
154715|NCT02608658|SBP|sbp
154716|NCT02608632|Renal denervation|renal denervation
154717|NCT02608632|Ablation|ablation
154718|NCT02608619|18F-fluorocholine|18f-fluorocholine
154719|NCT02608619|Pet imaging|pet imaging
154720|NCT02608619|Biopsy|biopsy
154721|NCT02608619|15-268|15-268
154722|NCT02608580|pediatric hospital care|pediatric hospital care
154723|NCT02608580|adult hospital care|adult hospital care
154724|NCT02608580|sickle cell disease|sickle cell disease
154725|NCT02608554|Polycystic ovary sybdrome|polycystic ovary sybdrome
154726|NCT02608554|Taichi|taichi
154727|NCT02608541|Multiple Rib Fractures, Frail Chest|multiple rib fractures, frail chest
154728|NCT02608476|acne|acne
154729|NCT02608463|neuropathic pain|neuropathic pain
154730|NCT02608463|pregnancy|pregnancy
154731|NCT02608450|acne|acne
154732|NCT02608437|melanoma|melanoma
154733|NCT02608437|ipilimumab|ipilimumab
154734|NCT02608437|SGI-110|sgi-110
154735|NCT02608424|Foot mechanical stimulation|foot mechanical stimulation
154736|NCT02608424|Autonomic nervous system|autonomic nervous system
154737|NCT02608424|Inflammation|inflammation
154738|NCT02608424|Parkinson's disease|parkinson's disease
154739|NCT02608424|Spectral analysis|spectral analysis
154740|NCT02608424|Heart rate variability|heart rate variability
154741|NCT02608424|Blood pressure variability|blood pressure variability
154742|NCT02608398|obesity|obesity
154743|NCT02608398|weight-loss|weight-loss
154744|NCT02608398|metabonomics|metabonomics
154745|NCT02608398|gut microbiome|gut microbiome
154746|NCT02608372|Seaweed|seaweed
154747|NCT02608372|Insulin|insulin
154748|NCT02608372|Glucose tolerance|glucose tolerance
154749|NCT02608372|C-peptide|c-peptide
154750|NCT02608372|Appetide|appetide
154751|NCT02608372|Metabolomics|metabolomics
154752|NCT02608359|Post-Marketing Surveillance|post-marketing surveillance
154753|NCT02608359|Abiraterone Acetate|abiraterone acetate
154754|NCT02608359|Zytiga|zytiga
154755|NCT02608346|Circulating tumor DNA|circulating tumor dna
154756|NCT02608346|BRCA1 mutation|brca1 mutation
154757|NCT02608346|Circulating tumor cells|circulating tumor cells
154758|NCT02608333|Early intervention|early intervention
154759|NCT02608333|ESDM|esdm
154760|NCT02608333|behavioral and developmental intervention|behavioral and developmental intervention
154761|NCT02608320|Healthy|healthy
154762|NCT02608320|JNJ-35685-AAA-G016|jnj-35685-aaa-g016
154763|NCT02608320|JNJ-35685-AAA-G021|jnj-35685-aaa-g021
154764|NCT02608320|DURAGESIC|duragesic
154765|NCT02608320|Fentanyl|fentanyl
154766|NCT02608307|Treatment Decision-Making|treatment decision-making
154767|NCT02608307|Adolescents and Young Adult Oncology|adolescents and young adult oncology
154768|NCT02608294|stroke|stroke
154769|NCT02608294|gait|gait
154770|NCT02608294|balance|balance
154771|NCT02608281|Spectral Mammography|spectral mammography
154772|NCT02608281|Dual energy|dual energy
154773|NCT02608281|Contrast enhanced|contrast enhanced
154774|NCT02608268|Solid tumors|solid tumors
154775|NCT02608268|Melanoma|melanoma
154776|NCT02608268|Non small cell lung cancer|non small cell lung cancer
154777|NCT02608268|NSCLC|nsclc
154778|NCT02608268|Renal cell carcinoma|renal cell carcinoma
154779|NCT02608268|RCC|rcc
154780|NCT02608268|Phase I-Ib/II|phase i-ib/ii
154781|NCT02608268|MBG453|mbg453
154782|NCT02608268|PDR001|pdr001
154783|NCT02608268|Checkpoint inhibitor|checkpoint inhibitor
154784|NCT02608268|PD-1|pd-1
154786|NCT02608164|Healthy adults|healthy adults
154787|NCT02608151|neurodevelopement|neurodevelopement
154788|NCT02608151|Very preterm infant|very preterm infant
154789|NCT02608138|iodine|iodine
154790|NCT02608138|urine|urine
154791|NCT02608138|children|children
154792|NCT02608138|schools|schools
154793|NCT02608138|cognitive performance|cognitive performance
154794|NCT02608138|salt fortification|salt fortification
154795|NCT02608125|FGFR|fgfr
154796|NCT02608099|Atrial fibrillation|atrial fibrillation
154797|NCT02608099|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
154798|NCT02608099|Catheter ablation|catheter ablation
154799|NCT02608099|Apixaban|apixaban
154800|NCT02608099|Warfarin|warfarin
154801|NCT02608099|Harvard Clinical Research Institute|harvard clinical research institute
154802|NCT02608086|PTSD|ptsd
154803|NCT02608086|Trauma|trauma
154804|NCT02608086|Emergency|emergency
154805|NCT02608086|RCT|rct
154806|NCT02608086|Psychological First Aid|psychological first aid
154807|NCT02608021|Alzheimer's Disease|alzheimer's disease
154808|NCT02608021|MRI|mri
154809|NCT02608008|3D-Ultrasound|3d-ultrasound
154810|NCT02608008|Live X-rays|live x-rays
154811|NCT02608008|EchoNavigator System|echonavigator system
154812|NCT02607982|Esophageal cancer|esophageal cancer
154813|NCT02607982|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
154814|NCT02607982|Oxaliplatin|oxaliplatin
154815|NCT02607982|Paclitaxel|paclitaxel
154816|NCT02607982|Survival|survival
154817|NCT02607982|Toxicity|toxicity
154818|NCT02607969|Deformational Plagiocephaly,Treatment,Compliance|deformational plagiocephaly,treatment,compliance
154819|NCT02607956|HIV|hiv
154820|NCT02607943|acute stroke|acute stroke
154821|NCT02607943|hyperglycemia|hyperglycemia
154822|NCT02607943|regular insulin|regular insulin
154823|NCT02607943|long-acting insulin|long-acting insulin
154824|NCT02607930|HIV|hiv
154825|NCT02607917|Cardiovascular Disease|cardiovascular disease
154826|NCT02607904|Cannabidiol|cannabidiol
154827|NCT02607904|GWP42003-P|gwp42003-p
154828|NCT02607904|Epidiolex|epidiolex
154829|NCT02607904|Stiripentol|stiripentol
154830|NCT02607904|Valproate|valproate
154831|NCT02607891|Cannabidiol|cannabidiol
154832|NCT02607891|GWP42003-P|gwp42003-p
154833|NCT02607891|Epidiolex|epidiolex
154834|NCT02607891|Stiripentol|stiripentol
154835|NCT02607891|Valproate|valproate
154836|NCT02607878|Cardiac arrest|cardiac arrest
154837|NCT02607878|Coma|coma
154838|NCT02607878|Prognosis|prognosis
154839|NCT02607878|Automated pupillometry|automated pupillometry
154840|NCT02607878|EEG|eeg
154841|NCT02607878|Evoked potentials|evoked potentials
154842|NCT02607878|Targeted Temperature Management (TTM)|targeted temperature management (ttm)
154843|NCT02607852|Patient Reported Outcomes Measure|patient reported outcomes measure
154844|NCT02607852|Burns|burns
154845|NCT02607839|lipid handling by the gut and liver|lipid handling by the gut and liver
154846|NCT02607813|LXH254, CRAF, MAPK, solid tumor, PDR001|lxh254, craf, mapk, solid tumor, pdr001
154847|NCT02607800|Chronic Hepatitis C Infection|chronic hepatitis c infection
154848|NCT02607787|Exercise Rehabilitation|exercise rehabilitation
154849|NCT02607774|Plaque psoriasis|plaque psoriasis
154850|NCT02607774|disease-drug-drug-interaction|disease-drug-drug-interaction
154851|NCT02607774|midazolam|midazolam
154852|NCT02607774|secukinumab|secukinumab
154853|NCT02607761|infertility|infertility
154854|NCT02607761|fertility awareness|fertility awareness
154855|NCT02607761|health interventions|health interventions
154856|NCT02607761|young adults|young adults
154857|NCT02607748|18F-NaF PET|18f-naf pet
154858|NCT02607748|18F-sodium fluoride PET|18f-sodium fluoride pet
154859|NCT02607748|Coronary CTA|coronary cta
154860|NCT02607735|Chronic Hepatitis C Infection|chronic hepatitis c infection
154861|NCT02607644|Intubation|intubation
154862|NCT02607644|Ventilation|ventilation
154863|NCT02607644|Cardiac arrest|cardiac arrest
154864|NCT02607644|prehospital|prehospital
154865|NCT02607644|Laryngeal Masks|laryngeal masks
154866|NCT02607644|Laryngeal Tube|laryngeal tube
154867|NCT02607644|airway management|airway management
154868|NCT02607631|Thymic epithelial tumors|thymic epithelial tumors
154869|NCT02607631|Pembrolizumab|pembrolizumab
154870|NCT02607605|lung cancer|lung cancer
154871|NCT02607605|leptomeningeal metastases|leptomeningeal metastases
154872|NCT02607605|cell-free DNA|cell-free dna
154873|NCT02607592|Non-Small-Cell Lung cancer|non-small-cell lung cancer
154874|NCT02607592|overall toxicity value|overall toxicity value
154875|NCT02607566|Diabetes|diabetes
154876|NCT02607566|Yoga|yoga
154877|NCT02607566|Walking|walking
154878|NCT02607566|Stress|stress
154879|NCT02607540|Chemoradiotherapy|chemoradiotherapy
154880|NCT02607540|Esophageal Squamous Cancer|esophageal squamous cancer
154881|NCT02607540|Cisplatin-5-fluorouracil|cisplatin-5-fluorouracil
154882|NCT02607501|coil embolization|coil embolization
154883|NCT02607501|bifurcation|bifurcation
154884|NCT02607488|Obese patients|obese patients
154885|NCT02607488|Undergoing bariatric surgery|undergoing bariatric surgery
154886|NCT02607475|telesonography|telesonography
154887|NCT02607475|ultrasound|ultrasound
154888|NCT02607475|robotic telesonography|robotic telesonography
154890|NCT02607449|Tuberculosis|tuberculosis
154891|NCT02607410|Type 2 diabetes|type 2 diabetes
154892|NCT02607410|sitagliptin|sitagliptin
154893|NCT02607410|NPH insulin|nph insulin
154894|NCT02607410|GLP-1|glp-1
154895|NCT02607371|Patient treatment preference|patient treatment preference
154896|NCT02607371|Non-valvular Atrial Fibrillation|non-valvular atrial fibrillation
154897|NCT02607371|NOAC|noac
154898|NCT02607371|VKA|vka
154899|NCT02607358|Clopidogrel|clopidogrel
154900|NCT02607358|acetacylic acid|acetacylic acid
154901|NCT02607358|antiplatelet therapy|antiplatelet therapy
154902|NCT02607358|HOTPR|hotpr
154903|NCT02607358|VerifyNow|verifynow
154904|NCT02607332|single-center|single-center
154905|NCT02607332|prospective|prospective
154906|NCT02607332|single-arm|single-arm
154907|NCT02607332|open-label|open-label
154908|NCT02607332|phase II|phase ii
154909|NCT02607319|Recurrent Implantation Failure|recurrent implantation failure
154910|NCT02607319|Implantation|implantation
154911|NCT02607319|low molecular weight heparin|low molecular weight heparin
154912|NCT02607319|In vitro Fertilization|in vitro fertilization
154913|NCT02607319|Assisted Reproductive Technology|assisted reproductive technology
154914|NCT02607319|Pregnancy|pregnancy
154915|NCT02607293|Polycystic Ovary Syndrome|polycystic ovary syndrome
154916|NCT02607293|Gonadotropin releasing hormone agonist (GnRH-a)|gonadotropin releasing hormone agonist (gnrh-a)
154917|NCT02607293|Gonal-f|gonal-f
154918|NCT02607293|Assisted Reproductive Technology|assisted reproductive technology
154919|NCT02607280|Diabetic peripheral neuropathic pain|diabetic peripheral neuropathic pain
154920|NCT02607280|post-herpetic neuralgia|post-herpetic neuralgia
154921|NCT02607280|renal impairment|renal impairment
154922|NCT02607267|EOSS|eoss
154923|NCT02607267|Metabolic Surgery|metabolic surgery
154924|NCT02607267|postoperative outcome|postoperative outcome
154925|NCT02607267|30 - day mortality|30 - day mortality
154926|NCT02607241|drug-coated balloon|drug-coated balloon
154927|NCT02607241|bioresorbable scaffold|bioresorbable scaffold
154928|NCT02607241|fractional flow reserve|fractional flow reserve
154929|NCT02607241|optical coherence tomography|optical coherence tomography
154930|NCT02607150|Spinal Fusion|spinal fusion
154931|NCT02607150|Cerebral Oxygenation|cerebral oxygenation
154932|NCT02607150|Blood Transfusion|blood transfusion
154933|NCT02607124|DIPG|dipg
154934|NCT02607111|Dalteparin|dalteparin
154935|NCT02607111|Dosage|dosage
154936|NCT02607111|Home Hemodialysis|home hemodialysis
154937|NCT02607072|APREMEC, aspirin, colorectal cancer, adjuvant therapy, recurrence, metastasis, survival|apremec, aspirin, colorectal cancer, adjuvant therapy, recurrence, metastasis, survival
154938|NCT02607046|rehabilitation|rehabilitation
154939|NCT02607046|exercise training|exercise training
154940|NCT02607033|Exercise|exercise
154941|NCT02607033|Weight Loss|weight loss
154942|NCT02607033|Mobility Limitation|mobility limitation
154943|NCT02607007|Dairy|dairy
154944|NCT02607007|Post-prandial Glycemia|post-prandial glycemia
154945|NCT02607007|Satiety|satiety
154946|NCT02607007|Food Intake|food intake
154947|NCT02607007|Insulin|insulin
154948|NCT02607007|Milk|milk
154949|NCT02607007|Greek yogurt|greek yogurt
154950|NCT02607007|Cheese|cheese
154951|NCT02607007|Soy beverage|soy beverage
154952|NCT02606994|oral mucositis|oral mucositis
154953|NCT02606994|chemotherapy|chemotherapy
154954|NCT02606994|toothpaste|toothpaste
154955|NCT02606981|Water treatment|water treatment
154956|NCT02606981|Child growth|child growth
154957|NCT02606981|Enteric infection|enteric infection
154958|NCT02606955|Bioimpedance|bioimpedance
154959|NCT02606955|Dry weight|dry weight
154960|NCT02606955|Hemodialysis|hemodialysis
154961|NCT02606955|Resistance|resistance
154962|NCT02606942|chondromalacia patellae (CMP)|chondromalacia patellae (cmp)
154963|NCT02606942|patella|patella
154964|NCT02606916|Once-daily Simultaneous Modulated Accelerated Radiotherapy|once-daily simultaneous modulated accelerated radiotherapy
154965|NCT02606916|S-1|s-1
154966|NCT02606916|DDP|ddp
154967|NCT02606916|elderly patients|elderly patients
154968|NCT02606890|Magnetic Resonance Imaging|magnetic resonance imaging
154969|NCT02606890|Stroke Lesion Pattern|stroke lesion pattern
154970|NCT02606890|Atrial Fibrillation|atrial fibrillation
154971|NCT02606890|Stroke|stroke
154972|NCT02606851|Proton Pump Inhibitor, GERD, GERD Q|proton pump inhibitor, gerd, gerd q
154973|NCT02606799|Esophagectomy Inflammation Hemoperfusion Cytokines|esophagectomy inflammation hemoperfusion cytokines
154974|NCT02606786|stabilization exercises|stabilization exercises
154975|NCT02606773|vitamin C supplementation|vitamin c supplementation
154976|NCT02606760|Nail psoriasis|nail psoriasis
154977|NCT02606747|DPN|dpn
154978|NCT02606747|fall|fall
154979|NCT02606747|fMRI|fmri
154980|NCT02606747|balance|balance
154981|NCT02606721|Food Hypersensitivity|food hypersensitivity
154982|NCT02606721|Oral Food Challenge|oral food challenge
154983|NCT02606721|Skin Prick Test|skin prick test
154984|NCT02606721|Food Biomarkers|food biomarkers
154985|NCT02606695|Spine Surgery Patients|spine surgery patients
154986|NCT02606682|Phase 1|phase 1
154987|NCT02606682|Safety|safety
154988|NCT02606682|Tolerability|tolerability
155085|NCT02606110|ReBuilder|rebuilder
154989|NCT02606682|Pharmacokinetics|pharmacokinetics
154990|NCT02606682|Parkinson's Disease|parkinson's disease
154991|NCT02606630|Relapsing multiple sclerosis|relapsing multiple sclerosis
154992|NCT02606617|Mosapride|mosapride
154993|NCT02606617|blood glucose|blood glucose
154994|NCT02606617|serum lipid|serum lipid
154995|NCT02606604|Functional Electrical Stimulation|functional electrical stimulation
154996|NCT02606604|Cycling|cycling
154997|NCT02606591|Electroencephalograph|electroencephalograph
154998|NCT02606591|EEG|eeg
154999|NCT02606591|Hair sample|hair sample
155000|NCT02606591|Cognitive tests|cognitive tests
155001|NCT02606591|Cortisol analysis|cortisol analysis
155002|NCT02606591|Brain activity|brain activity
155003|NCT02606591|Stress hormones|stress hormones
155004|NCT02606552|drug eluting stent|drug eluting stent
155005|NCT02606552|atrial appendage closure|atrial appendage closure
155006|NCT02606539|gestaional trophoblastic neoplasm|gestaional trophoblastic neoplasm
155007|NCT02606539|hystrectomy|hystrectomy
155008|NCT02606539|chemotherapy|chemotherapy
155009|NCT02606539|methotrxate|methotrxate
155010|NCT02606513|Computed Tomography Urography|computed tomography urography
155011|NCT02606513|Magnetic Resonance Urography|magnetic resonance urography
155012|NCT02606487|CF|cf
155013|NCT02606487|Exacerbation|exacerbation
155014|NCT02606487|Hyerpolarized xenon MRI|hyerpolarized xenon mri
155015|NCT02606487|Pediatrics|pediatrics
155016|NCT02606487|Lung Clearance Index|lung clearance index
155017|NCT02606461|Advanced unresectable dedifferentiated liposarcoma|advanced unresectable dedifferentiated liposarcoma
155018|NCT02606461|selinexor|selinexor
155019|NCT02606461|KCP-330|kcp-330
155020|NCT02606461|Karyopharm|karyopharm
155021|NCT02606461|Phase 2 / 3|phase 2 / 3
155022|NCT02606461|dedifferentiated liposarcoma|dedifferentiated liposarcoma
155023|NCT02606461|liposarcoma|liposarcoma
155024|NCT02606448|pain control|pain control
155025|NCT02606448|patient satisfaction|patient satisfaction
155026|NCT02606448|liposomal bupivacaine|liposomal bupivacaine
155027|NCT02606448|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
155028|NCT02606422|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
155029|NCT02606422|neurodegeneration|neurodegeneration
155030|NCT02606422|language therapy|language therapy
155031|NCT02606422|Primary Progressive Aphasia (PPA)|primary progressive aphasia (ppa)
155032|NCT02606370|Unstable Shoes;Trunk muscles;Lumbar lordosis;Low Back Pain|unstable shoes;trunk muscles;lumbar lordosis;low back pain
155033|NCT02606318|Occupational Therapy|occupational therapy
155034|NCT02606318|Quality of Life|quality of life
155035|NCT02606305|Epithelial ovarian cancer|epithelial ovarian cancer
155036|NCT02606305|Fallopian tube cancer|fallopian tube cancer
155037|NCT02606305|Primary peritoneal cancer|primary peritoneal cancer
155038|NCT02606305|IMGN853|imgn853
155039|NCT02606305|ADC|adc
155040|NCT02606305|Antibody drug conjugate|antibody drug conjugate
155041|NCT02606305|ImmunoGen|immunogen
155042|NCT02606305|Antibody|antibody
155043|NCT02606305|Phase 1|phase 1
155044|NCT02606305|Folate receptor alpha|folate receptor alpha
155045|NCT02606253|loop diuretics|loop diuretics
155046|NCT02606253|thiazide diuretics|thiazide diuretics
155047|NCT02606253|vasopressin antagonists|vasopressin antagonists
155048|NCT02606253|diuretic resistance|diuretic resistance
155049|NCT02606253|heart failure|heart failure
155050|NCT02606227|Pregnant smokers|pregnant smokers
155051|NCT02606227|smoking cessation|smoking cessation
155052|NCT02606227|financial incentives|financial incentives
155053|NCT02606227|control group|control group
155054|NCT02606227|randomized study|randomized study
155055|NCT02606214|Tuberculosis|tuberculosis
155056|NCT02606214|TBA-354|tba-354
155057|NCT02606214|Pulmonary Tuberculosis|pulmonary tuberculosis
155058|NCT02606214|TB|tb
155059|NCT02606201|stress urinary incontinence|stress urinary incontinence
155060|NCT02606201|intrinsic sphincter deficiency|intrinsic sphincter deficiency
155061|NCT02606201|myofiber|myofiber
155062|NCT02606201|autologous|autologous
155063|NCT02606201|skeletal muscle precursor cells|skeletal muscle precursor cells
155064|NCT02606201|autologous serum|autologous serum
155065|NCT02606188|Modified High-flow nasal cannula|modified high-flow nasal cannula
155066|NCT02606188|Bronchoscopy|bronchoscopy
155067|NCT02606188|Oxygen therapy|oxygen therapy
155068|NCT02606175|health literacy|health literacy
155069|NCT02606175|patient medication knowledge|patient medication knowledge
155070|NCT02606175|kidney transplantation|kidney transplantation
155071|NCT02606175|medication adherence|medication adherence
155072|NCT02606175|kidney transplant|kidney transplant
155073|NCT02606175|renal transplantation|renal transplantation
155074|NCT02606149|Lung cancer|lung cancer
155075|NCT02606149|chemotherapy outcome|chemotherapy outcome
155076|NCT02606149|ethics|ethics
155077|NCT02606149|information|information
155078|NCT02606136|Duchenne|duchenne
155079|NCT02606136|muscular|muscular
155080|NCT02606136|dystrophy|dystrophy
155081|NCT02606136|DMD|dmd
155082|NCT02606136|non-ambulatory|non-ambulatory
155083|NCT02606123|Prostate Cancer|prostate cancer
155084|NCT02606123|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
155086|NCT02606110|breast cancer|breast cancer
155087|NCT02606110|chemotherapy induced|chemotherapy induced
155088|NCT02606084|Renal Impairment|renal impairment
155089|NCT02606084|Healthy|healthy
155090|NCT02606084|Esketamine|esketamine
155091|NCT02606071|cardiac resynchronization therapy|cardiac resynchronization therapy
155092|NCT02606071|multipoint left ventricular pacing|multipoint left ventricular pacing
155093|NCT02606045|menorrhagia|menorrhagia
155094|NCT02606045|VWD|vwd
155095|NCT02606032|Fecal Microbiota Transplant|fecal microbiota transplant
155096|NCT02606032|Antibiotics|antibiotics
155097|NCT02606019|Pentraxin 3|pentraxin 3
155098|NCT02606019|Vascular Endothelial Growth Factor|vascular endothelial growth factor
155099|NCT02606019|dengue|dengue
155100|NCT02606006|Physical Therapy Modalities|physical therapy modalities
155101|NCT02606006|Motivation|motivation
155102|NCT02606006|Patient Participation|patient participation
155103|NCT02606006|Animal Assisted Therapy|animal assisted therapy
155104|NCT02605993|complement inhibitor|complement inhibitor
155105|NCT02605967|PDR001,|pdr001,
155106|NCT02605967|nasopharyngeal cancer,|nasopharyngeal cancer,
155107|NCT02605967|moderately differentiated/undifferentiated,|moderately differentiated/undifferentiated,
155108|NCT02605967|locally advanced,|locally advanced,
155109|NCT02605967|recurrent or metastatic NPC,|recurrent or metastatic npc,
155110|NCT02605967|after first- line platinum-based therapy|after first- line platinum-based therapy
155111|NCT02605954|HIV 1 Infection|hiv 1 infection
155112|NCT02605954|HIV|hiv
155113|NCT02605954|Virologically-Suppressed|virologically-suppressed
155114|NCT02605954|Antiretroviral agents|antiretroviral agents
155115|NCT02605941|DNA methylation|dna methylation
155116|NCT02605941|Cervical cancer|cervical cancer
155117|NCT02605928|Arthritis|arthritis
155118|NCT02605928|Bioimpedance|bioimpedance
155119|NCT02605928|Glucocorticoid|glucocorticoid
155120|NCT02605928|Intra-articular injection|intra-articular injection
155121|NCT02605928|Needle Guidance|needle guidance
155122|NCT02605902|Chronic tic disorders|chronic tic disorders
155123|NCT02605902|Tourette syndrome|tourette syndrome
155124|NCT02605876|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
155125|NCT02605863|Enzalutamide|enzalutamide
155126|NCT02605863|Non-Muscle Invasive Bladder Cancer|non-muscle invasive bladder cancer
155127|NCT02605863|Androgen Deprivation Therapy|androgen deprivation therapy
155128|NCT02605850|heart health|heart health
155129|NCT02605811|limited small cell lung cancer|limited small cell lung cancer
155130|NCT02605811|brain metastases|brain metastases
155131|NCT02605811|prophylactic cranial radiotherapy|prophylactic cranial radiotherapy
155132|NCT02605811|temozolomide|temozolomide
155133|NCT02605785|PSP|psp
155134|NCT02605733|Premature infant|premature infant
155135|NCT02605733|Amplitude integrated EEG|amplitude integrated eeg
155136|NCT02605733|Near-infrared spectroscopy|near-infrared spectroscopy
155137|NCT02605707|Endothelial Progenitor Cells|endothelial progenitor cells
155138|NCT02605707|Transplantation|transplantation
155139|NCT02605707|Stroke|stroke
155140|NCT02605681|midkine|midkine
155141|NCT02605681|endothelial injury|endothelial injury
155142|NCT02605681|sepsis|sepsis
155143|NCT02605668|Anxiety Disorders|anxiety disorders
155144|NCT02605668|Extinction Learning|extinction learning
155145|NCT02605668|Optimized Extinction|optimized extinction
155146|NCT02605668|Behavioral Therapy|behavioral therapy
155147|NCT02605668|Massed Confrontation|massed confrontation
155148|NCT02605668|Social Anxiety Disorder|social anxiety disorder
155149|NCT02605668|Specific Phobia|specific phobia
155150|NCT02605668|Panic Disorder|panic disorder
155151|NCT02605668|Agoraphobia|agoraphobia
155152|NCT02605655|obesity|obesity
155153|NCT02605655|hyperlipidemia|hyperlipidemia
155154|NCT02605655|hyperglycemia|hyperglycemia
155155|NCT02605642|Inflectra|inflectra
155156|NCT02605642|Infliximab|infliximab
155157|NCT02605642|Observational|observational
155158|NCT02605642|Remicade|remicade
155159|NCT02605603|Gaucher Type 1, Gaucher Type 2, Gaucher Type 3|gaucher type 1, gaucher type 2, gaucher type 3
155160|NCT02605577|late preterm infants|late preterm infants
155161|NCT02605577|nutrition|nutrition
155162|NCT02605577|systemic management|systemic management
155163|NCT02605525|IgAN|igan
155164|NCT02605512|Radiotherapy|radiotherapy
155165|NCT02605512|Echocardiography|echocardiography
155166|NCT02605512|Strain strain rate|strain strain rate
155167|NCT02605512|Coronary computed tomography angiography|coronary computed tomography angiography
155168|NCT02605512|Segments of coronary arteries|segments of coronary arteries
155169|NCT02605512|Subclinical functional and anatomical cardiac lesions|subclinical functional and anatomical cardiac lesions
155170|NCT02605512|Biomarkers|biomarkers
155171|NCT02605512|Heart dosimetry|heart dosimetry
155172|NCT02605486|palbociclib|palbociclib
155173|NCT02605486|bicalutamide|bicalutamide
155174|NCT02605486|AR(+)|ar(+)
155175|NCT02605486|15-207|15-207
155176|NCT02605473|Melanoma|melanoma
155177|NCT02605473|Malignant melanoma|malignant melanoma
155178|NCT02605473|Unresectable|unresectable
155179|NCT02605473|Decitabine|decitabine
155180|NCT02605473|PEG Interferon Alpha-2b|peg interferon alpha-2b
155181|NCT02605473|PEG Intron|peg intron
155182|NCT02605473|5-Aza-Deoxycytidine|5-aza-deoxycytidine
155183|NCT02605473|Dacogen|dacogen
155184|NCT02605460|Bone Marrow Transplantation|bone marrow transplantation
155185|NCT02605460|Conditioning Regimen|conditioning regimen
155186|NCT02605434|Parkinson's Disease|parkinson's disease
155187|NCT02605434|Fluctuating Parkinson's Disease|fluctuating parkinson's disease
155188|NCT02605434|Advanced Parkinson's Disease|advanced parkinson's disease
155189|NCT02605434|Carbidopa|carbidopa
155190|NCT02605434|Levodopa|levodopa
155191|NCT02605434|Accordion|accordion
155192|NCT02605434|Accordance|accordance
155193|NCT02605421|High-risk neuroblastoma|high-risk neuroblastoma
155194|NCT02605421|Neuroblastoma|neuroblastoma
155195|NCT02605421|Myeloablative chemotherapy|myeloablative chemotherapy
155320|NCT02604576|functional dyspepsia|functional dyspepsia
155196|NCT02605421|Myeloablative consolidation chemotherapy|myeloablative consolidation chemotherapy
155197|NCT02605421|Autologous peripheral blood stem cell rescue|autologous peripheral blood stem cell rescue
155198|NCT02605421|PBSC|pbsc
155199|NCT02605421|Autologous stem cell rescue|autologous stem cell rescue
155200|NCT02605395|Bioequivalence|bioequivalence
155201|NCT02605395|Fed condition|fed condition
155202|NCT02605395|PARIET 20 mg|pariet 20 mg
155203|NCT02605395|IDIAZOLE 20mg|idiazole 20mg
155204|NCT02605395|Rabeprazole|rabeprazole
155205|NCT02605382|Dental Implantation|dental implantation
155206|NCT02605382|Chlorhexidine gluconate|chlorhexidine gluconate
155207|NCT02605356|Radium-223 dichloride|radium-223 dichloride
155208|NCT02605356|bortezomib|bortezomib
155209|NCT02605356|dexamethasone|dexamethasone
155210|NCT02605356|early relapsed multiple myeloma|early relapsed multiple myeloma
155211|NCT02605356|combination therapy multiple myeloma|combination therapy multiple myeloma
155213|NCT02605343|pharmacogenetic testing|pharmacogenetic testing
155214|NCT02605343|Pain Management|pain management
155215|NCT02605343|AltheaDx|altheadx
155216|NCT02605343|Post-Operative Pain Management|post-operative pain management
155217|NCT02605317|Emergency Physicians|emergency physicians
155218|NCT02605317|Consulting Physicians|consulting physicians
155219|NCT02605317|WhatsApp|whatsapp
155220|NCT02605278|Primary Health Care, Patient Education, Care Managament|primary health care, patient education, care managament
155221|NCT02605265|Neoadjuvant Chemoradiation|neoadjuvant chemoradiation
155222|NCT02605265|Irinotecan|irinotecan
155223|NCT02605265|UGT1A1|ugt1a1
155224|NCT02605252|Chronic hepatitis B|chronic hepatitis b
155225|NCT02605252|Peginterferon alfa-2b|peginterferon alfa-2b
155226|NCT02605252|Nucleotide analogue|nucleotide analogue
155227|NCT02605200|Diabetes|diabetes
155228|NCT02605200|Endocrinology|endocrinology
155229|NCT02605200|Pediatrics|pediatrics
155230|NCT02605187|cesarean|cesarean
155231|NCT02605187|postoperative pain|postoperative pain
155232|NCT02605187|patient choice|patient choice
155233|NCT02605161|Blood brain barrier|blood brain barrier
155234|NCT02605161|movement disorder|movement disorder
155235|NCT02605161|deep brain stimulation|deep brain stimulation
155236|NCT02605161|essential tremor|essential tremor
155237|NCT02605161|cervical dystonia|cervical dystonia
155238|NCT02605161|magnetic resonance imaging|magnetic resonance imaging
155239|NCT02605161|neostriatum|neostriatum
155240|NCT02605148|Islet autoimmunity|islet autoimmunity
155241|NCT02605148|gluten free diet|gluten free diet
155242|NCT02605148|prediabetes|prediabetes
155243|NCT02605148|prevention|prevention
155244|NCT02605148|type 1 diabetes|type 1 diabetes
155245|NCT02605148|glucose tolerance test|glucose tolerance test
155246|NCT02605122|pneumonia|pneumonia
155247|NCT02605122|macrolide|macrolide
155248|NCT02605122|pediatric|pediatric
155249|NCT02605109|MERS-CoV|mers-cov
155250|NCT02605109|Infection control|infection control
155251|NCT02605109|Case-control studies|case-control studies
155252|NCT02605096|suspected scaphoid fracture|suspected scaphoid fracture
155253|NCT02605083|Cancer|cancer
155254|NCT02605083|Neoplasm|neoplasm
155255|NCT02605083|Solid Tumor|solid tumor
155256|NCT02605083|Breast|breast
155257|NCT02605083|Head and Neck|head and neck
155258|NCT02605083|Lung|lung
155259|NCT02605083|Pancreatic|pancreatic
155260|NCT02605083|Hepatic|hepatic
155261|NCT02605083|Melanoma|melanoma
155262|NCT02605083|Colon|colon
155263|NCT02605083|Renal|renal
155264|NCT02605083|Thyroid|thyroid
155265|NCT02605083|Prostate|prostate
155266|NCT02605083|Ovarian|ovarian
155267|NCT02605083|MNK1|mnk1
155268|NCT02605083|MNK2|mnk2
155269|NCT02605083|eIF4E|eif4e
155270|NCT02605005|interscalene block, general anesthesia, shoulder arthroscopy, cerebral oxygen saturation, beach chair position|interscalene block, general anesthesia, shoulder arthroscopy, cerebral oxygen saturation, beach chair position
155271|NCT02604992|Comparative Bioavailability|comparative bioavailability
155272|NCT02604966|P. falciparum|p. falciparum
155273|NCT02604966|resistance to artemisinin|resistance to artemisinin
155274|NCT02604966|Central Vietnam|central vietnam
155275|NCT02604953|glaucoma|glaucoma
155276|NCT02604953|VEP|vep
155277|NCT02604953|PERG|perg
155278|NCT02604953|SD-tVEP|sd-tvep
155279|NCT02604953|ss-PERG|ss-perg
155280|NCT02604940|Postoperative narcotic requirements|postoperative narcotic requirements
155281|NCT02604940|Dexmedetomidine|dexmedetomidine
155282|NCT02604940|Bariatric Surgery|bariatric surgery
155283|NCT02604901|medication adherence|medication adherence
155284|NCT02604901|community pharmacies|community pharmacies
155285|NCT02604901|screening and brief intervention|screening and brief intervention
155286|NCT02604888|Baldness|baldness
155287|NCT02604888|Alopecia Areata|alopecia areata
155288|NCT02604888|Alopecia|alopecia
155289|NCT02604888|Hair loss|hair loss
155290|NCT02604784|Pressurized Intra Peritoneal Air-flow Chemotherapy (PIPAC)|pressurized intra peritoneal air-flow chemotherapy (pipac)
155291|NCT02604784|Chemotherapy|chemotherapy
155292|NCT02604784|Peritoneal Carcinomatosis|peritoneal carcinomatosis
155293|NCT02604758|Alcoholics [M01.066]|alcoholics [m01.066]
155294|NCT02604745|degenerative mitral regurgitation|degenerative mitral regurgitation
155295|NCT02604667|Biomarkers|biomarkers
155296|NCT02604667|Mechanisms|mechanisms
155297|NCT02604667|Transcranial Doppler|transcranial doppler
155298|NCT02604641|skin rejuvenation|skin rejuvenation
155299|NCT02604641|anti-ageing effects|anti-ageing effects
155300|NCT02604641|minimal erythema dose|minimal erythema dose
155301|NCT02604641|dermis structure|dermis structure
155302|NCT02604641|physiological skin condition|physiological skin condition
155303|NCT02604641|wrinkling|wrinkling
155304|NCT02604641|dry skin|dry skin
155305|NCT02604628|Pneumonia|pneumonia
155306|NCT02604628|Antibiotic Stewardship|antibiotic stewardship
155307|NCT02604628|Stepped wedge|stepped wedge
155308|NCT02604628|Antibiotic|antibiotic
155309|NCT02604615|Chemoradiotherapy|chemoradiotherapy
155310|NCT02604615|Esophageal Squamous Cancer|esophageal squamous cancer
155311|NCT02604615|Capecitabine and oxaliplatin|capecitabine and oxaliplatin
155312|NCT02604615|Chinese|chinese
155313|NCT02604615|Randomized Controlled Trials|randomized controlled trials
155314|NCT02604602|PPH|pph
155315|NCT02604589|Catheters, Indwelling|catheters, indwelling
155316|NCT02604589|Infusion Pumps|infusion pumps
155317|NCT02604589|Anesthesia, Local|anesthesia, local
155318|NCT02604589|Analgesia, Patient-Controlled|analgesia, patient-controlled
155319|NCT02604589|Bupivacaine|bupivacaine
155321|NCT02604524|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
155322|NCT02604524|Artificial Pancreas (AP)|artificial pancreas (ap)
155323|NCT02604524|Sensor-Augmented Pump (SAP) Therapy|sensor-augmented pump (sap) therapy
155324|NCT02604524|Closed Loop Control|closed loop control
155325|NCT02604524|Insulin Pump|insulin pump
155326|NCT02604524|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
155327|NCT02604511|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
155328|NCT02604485|Hypoglycemia|hypoglycemia
155329|NCT02604485|Congenital Hyperinsulinism|congenital hyperinsulinism
155330|NCT02604472|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
155331|NCT02604472|induction chemotherapy|induction chemotherapy
155332|NCT02604472|concurrent chemoradiotherapy|concurrent chemoradiotherapy
155333|NCT02604446|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
155334|NCT02604446|Analgesics|analgesics
155335|NCT02604446|Administration and dosage|administration and dosage
155336|NCT02604446|Knee|knee
155337|NCT02604446|Postoperational care|postoperational care
155338|NCT02604446|Pain management|pain management
155339|NCT02604433|ACE-536|ace-536
155340|NCT02604433|Safety|safety
155341|NCT02604433|Efficacy|efficacy
155342|NCT02604433|Placebo|placebo
155343|NCT02604433|Red Blood Cell Transfusions|red blood cell transfusions
155344|NCT02604433|Beta -Thalassemia|beta -thalassemia
155345|NCT02604394|Rheolytic Thrombectomy|rheolytic thrombectomy
155346|NCT02604394|Percutaneous Coronary Intervention|percutaneous coronary intervention
155347|NCT02604394|Angioplasty|angioplasty
155348|NCT02604394|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
155349|NCT02604394|Myocardial Salvage Index|myocardial salvage index
155350|NCT02604394|STEMI, ST elevation Myocardial Infarction|stemi, st elevation myocardial infarction
155351|NCT02604394|Corrected TIMI Frame Count, cTFC|corrected timi frame count, ctfc
155352|NCT02604394|Index of microcirculatory resistance, thermodilution, IMR|index of microcirculatory resistance, thermodilution, imr
155353|NCT02604381|Osteoarthritis|osteoarthritis
155354|NCT02604381|Knee|knee
155355|NCT02604381|Glucosamine Sulfate|glucosamine sulfate
155356|NCT02604381|Ginkgo Biloba|ginkgo biloba
155357|NCT02604381|WOMAC|womac
155358|NCT02604381|Joint Health Wellness|joint health wellness
155359|NCT02604381|Interleukin-1-beta|interleukin-1-beta
155360|NCT02604368|hemoglobin SS|hemoglobin ss
155361|NCT02604368|hemoglobin SC|hemoglobin sc
155362|NCT02604368|hemoglobin S/β°-thalassemia|hemoglobin s/β°-thalassemia
155363|NCT02604329|low level laser therapy|low level laser therapy
155364|NCT02604329|oral mucositis|oral mucositis
155365|NCT02604329|child|child
155366|NCT02604316|Overweight and Obesity|overweight and obesity
155367|NCT02604316|Appetite|appetite
155368|NCT02604316|Gut hormones and obesity|gut hormones and obesity
155369|NCT02604316|Arabinoxylan, Beta-Glucan|arabinoxylan, beta-glucan
155370|NCT02604316|SmartPill|smartpill
155371|NCT02604303|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
155372|NCT02604303|RhoA|rhoa
155373|NCT02604303|Biomarker|biomarker
155374|NCT02604290|Kinesio taping|kinesio taping
155375|NCT02604290|Neuromuscular taping|neuromuscular taping
155376|NCT02604290|Targeted treatment|targeted treatment
155377|NCT02604290|Chronic low back pain|chronic low back pain
155378|NCT02604290|Randomised controlled trial|randomised controlled trial
155379|NCT02604277|Psychology|psychology
155380|NCT02604238|Pulmonary Embolism at intermediate risk|pulmonary embolism at intermediate risk
155381|NCT02604225|Anaethesiology|anaethesiology
155382|NCT02604186|Spasticity|spasticity
155383|NCT02604186|Botulinum Toxin|botulinum toxin
155384|NCT02604186|Hereditary Spastic Paraplegia|hereditary spastic paraplegia
155385|NCT02604134|silver nitrate|silver nitrate
155386|NCT02604134|children|children
155387|NCT02604134|dental caries|dental caries
155388|NCT02604134|medical management|medical management
155389|NCT02604134|quality of life|quality of life
155390|NCT02604121|oral cavity|oral cavity
155391|NCT02604121|cancerous and precancerous lesions|cancerous and precancerous lesions
155392|NCT02604108|physical activity|physical activity
155393|NCT02604108|healthy diet|healthy diet
155394|NCT02604095|Acanthosis nigricans|acanthosis nigricans
155395|NCT02604095|Obesity|obesity
155396|NCT02604069|Breast reconstruction|breast reconstruction
155397|NCT02604069|Breast cancer|breast cancer
155398|NCT02604069|Microsurgery|microsurgery
155399|NCT02604069|Continuous flap monitor|continuous flap monitor
155400|NCT02604043|supraglottic pH|supraglottic ph
155401|NCT02604017|HCV GT1|hcv gt1
155402|NCT02604017|Non-cirrhotic|non-cirrhotic
155403|NCT02604017|RBV Free|rbv free
155404|NCT02604017|Without cirrhosis|without cirrhosis
155405|NCT02604017|Chronic Hepatitis C|chronic hepatitis c
155406|NCT02604017|Hepatitis C Genotype 1 (GT1)|hepatitis c genotype 1 (gt1)
155407|NCT02604017|IFN free|ifn free
155408|NCT02604017|Hepatitis C|hepatitis c
155409|NCT02604017|Ribavirin Free|ribavirin free
155410|NCT02604017|Interferon (IFN) Free|interferon (ifn) free
155411|NCT02604017|HCV|hcv
155412|NCT02604017|Hepatitis C virus|hepatitis c virus
155413|NCT02604017|DAA|daa
155414|NCT02604004|lamivudine|lamivudine
155415|NCT02604004|bioequivalence test|bioequivalence test
155416|NCT02604004|pharmacokinetics|pharmacokinetics
155417|NCT02604004|high-performance liquid chromatography|high-performance liquid chromatography
155418|NCT02604004|3TC|3tc
155419|NCT02604004|LC-MS/MS|lc-ms/ms
155420|NCT02604004|mass spectrometry|mass spectrometry
155421|NCT02603991|children and adolescents|children and adolescents
155422|NCT02603991|Prospective cohort study|prospective cohort study
155423|NCT02603991|vagus nerve stimulation|vagus nerve stimulation
155424|NCT02603991|PINS|pins
155425|NCT02603952|Influenza|influenza
155426|NCT02603952|Influenza A|influenza a
155427|NCT02603952|Flu|flu
155428|NCT02603952|Flu A|flu a
155429|NCT02603939|Pain|pain
155430|NCT02603939|Magnetic resonance imaging|magnetic resonance imaging
155431|NCT02603913|Pre-eclampsia|pre-eclampsia
155432|NCT02603913|Pregnancy induced hypertension|pregnancy induced hypertension
155433|NCT02603913|Preterm birth|preterm birth
155434|NCT02603913|Intra-uterine growth restriction|intra-uterine growth restriction
155435|NCT02603913|Oxidative stress|oxidative stress
155436|NCT02603900|Adductor Canal Catheter|adductor canal catheter
155437|NCT02603900|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
155438|NCT02603900|Local infiltration of analgesia|local infiltration of analgesia
155439|NCT02603887|Smoldering Multiple Myeloma|smoldering multiple myeloma
155440|NCT02603887|SMM|smm
155441|NCT02603887|Intermediate or high-risk|intermediate or high-risk
155442|NCT02603887|Pembrolizumab|pembrolizumab
155443|NCT02603887|Keytruda|keytruda
155444|NCT02603887|MK-3475|mk-3475
155445|NCT02603887|SCH-900475|sch-900475
155446|NCT02603874|Fluoroscopy|fluoroscopy
155447|NCT02603874|Spinal Fusion|spinal fusion
155448|NCT02603874|Wrong Level Surgery|wrong level surgery
155449|NCT02603848|Inguinal surgery|inguinal surgery
155450|NCT02603848|Hernia Repair|hernia repair
155451|NCT02603848|Orchidopexy|orchidopexy
155452|NCT02603848|Hydrocele|hydrocele
155453|NCT02603848|Pediatric|pediatric
155454|NCT02603848|Post-operative pain|post-operative pain
155455|NCT02603848|Morphine sulfate|morphine sulfate
155456|NCT02603848|Ibuprofen|ibuprofen
155457|NCT02603835|SSO2 Therapy|sso2 therapy
155458|NCT02603835|Acute myocardial infarction|acute myocardial infarction
155459|NCT02603835|Anterior myocardial infarction|anterior myocardial infarction
155460|NCT02603835|SuperSaturated oxygen delivery|supersaturated oxygen delivery
155461|NCT02603835|Left main coronary artery|left main coronary artery
155462|NCT02603835|Myocardial infarction|myocardial infarction
155463|NCT02603835|Heart attack|heart attack
155464|NCT02603835|Percutaneous coronary intervention|percutaneous coronary intervention
155465|NCT02603835|Cardiac catheterization laboratory|cardiac catheterization laboratory
155467|NCT02603835|Stent|stent
155468|NCT02603835|Stenting|stenting
155469|NCT02603835|Stents|stents
155470|NCT02603835|Angioplasty|angioplasty
155471|NCT02603835|LMCA|lmca
155472|NCT02603835|Delivery of supersaturated oxygen (SSO2) therapy for the treatment of anterior acute myocardial infarction|delivery of supersaturated oxygen (sso2) therapy for the treatment of anterior acute myocardial infarction
155473|NCT02603796|3-Dimensional|3-dimensional
155474|NCT02603796|continuous positive airway pressure|continuous positive airway pressure
155475|NCT02603796|nasal changes|nasal changes
155476|NCT02603757|Vitamin D|vitamin d
155477|NCT02603744|Premature ovarian failure adipose derived stromal cells intraovarian injection|premature ovarian failure adipose derived stromal cells intraovarian injection
155478|NCT02603718|Stroke|stroke
155479|NCT02603718|On-line EEG|on-line eeg
155480|NCT02603718|BEI index|bei index
155481|NCT02603718|Attention|attention
155482|NCT02603718|Rehabilitation|rehabilitation
155483|NCT02603705|chronic pain|chronic pain
155484|NCT02603705|opioid|opioid
155485|NCT02603705|oxycodone|oxycodone
155486|NCT02603705|non cancer pain|non cancer pain
155487|NCT02603705|moderate to severe|moderate to severe
155488|NCT02603692|Newly diagnosed brain tumor|newly diagnosed brain tumor
155489|NCT02603692|Progressive brain tumor|progressive brain tumor
155490|NCT02603692|PROMIS|promis
155491|NCT02603692|Quality of life|quality of life
155492|NCT02603679|Cyclin-Dependent Kinase Inhibitor p16|cyclin-dependent kinase inhibitor p16
155493|NCT02603666|cystic fibrosis|cystic fibrosis
155494|NCT02603666|elastography|elastography
155495|NCT02603666|liver biopsy|liver biopsy
155496|NCT02603614|Chronic Heart Failure|chronic heart failure
155497|NCT02603614|Renal Insufficiency|renal insufficiency
155498|NCT02603614|Natriuretic Peptides|natriuretic peptides
155499|NCT02603614|Cenderitide|cenderitide
155500|NCT02603601|Randomized controlled trial|randomized controlled trial
155501|NCT02603601|Mindfulness|mindfulness
155502|NCT02603601|Obesity|obesity
155503|NCT02603588|Acupuncture|acupuncture
155504|NCT02603588|Sphenopalatine ganglion|sphenopalatine ganglion
155505|NCT02603588|Nasal ventilation|nasal ventilation
155506|NCT02603588|Neuropeptides|neuropeptides
155507|NCT02603575|Caspofungin|caspofungin
155508|NCT02603575|corticosteroids|corticosteroids
155509|NCT02603575|Pneumocystis Pneumonia|pneumocystis pneumonia
155510|NCT02603575|Immunocompromised|immunocompromised
155511|NCT02603575|Non-HIV|non-hiv
155512|NCT02603575|respiratory failure|respiratory failure
155513|NCT02603562|FSHD|fshd
155514|NCT02603536|Text Messaging|text messaging
155515|NCT02603536|Harm Reduction|harm reduction
155516|NCT02603523|accidental falls|accidental falls
155517|NCT02603523|older people|older people
155518|NCT02603523|dance|dance
155519|NCT02603523|randomized controlled trial|randomized controlled trial
155520|NCT02603497|ASP015K|asp015k
155521|NCT02603497|impaired renal function|impaired renal function
155522|NCT02603497|Pharmacokinetics|pharmacokinetics
155523|NCT02603471|HIV+|hiv+
155524|NCT02603471|Alcohol dependence|alcohol dependence
155525|NCT02603471|Mobile Technology|mobile technology
155526|NCT02603458|Schizophrenia|schizophrenia
155527|NCT02603458|Naurex|naurex
155528|NCT02603458|Intravenous Treatment|intravenous treatment
155529|NCT02603458|NRX-1074|nrx-1074
155530|NCT02603445|BCL201|bcl201
155531|NCT02603445|idelalisib|idelalisib
155532|NCT02603445|Follicular lymphoma|follicular lymphoma
155533|NCT02603445|FL|fl
155534|NCT02603445|mantle cell lymphoma|mantle cell lymphoma
155535|NCT02603445|MCL|mcl
155536|NCT02603432|Bladder cancer|bladder cancer
155537|NCT02603432|Urologic neoplasms|urologic neoplasms
155538|NCT02603432|urothelial carcinoma|urothelial carcinoma
155539|NCT02603432|PD-L1|pd-l1
155540|NCT02603432|programmed cell death protein|programmed cell death protein
155541|NCT02603432|maintenance treatment|maintenance treatment
155542|NCT02603419|classical Hodgkins Lymphoma (relapsed/refractory)|classical hodgkins lymphoma (relapsed/refractory)
155543|NCT02603419|post-allogeneic HSCT|post-allogeneic hsct
155544|NCT02603419|anti PD-L1|anti pd-l1
155545|NCT02603419|Phase 1|phase 1
155546|NCT02603419|PK|pk
155547|NCT02603419|Receptor occupancy|receptor occupancy
155548|NCT02603419|Immunophenotypic biomarkers|immunophenotypic biomarkers
155549|NCT02603393|COPD, QVA149|copd, qva149
155550|NCT02603380|Delirium|delirium
155551|NCT02603380|Feasibility study|feasibility study
155552|NCT02603380|software application|software application
155553|NCT02603380|qualitative|qualitative
155554|NCT02603328|Cerebral cavernous malformation|cerebral cavernous malformation
155555|NCT02603328|Statins|statins
155556|NCT02603328|MRI|mri
155557|NCT02603328|Permeability|permeability
155558|NCT02603328|Quantitative susceptibility mapping|quantitative susceptibility mapping
155559|NCT02603302|rectal cancer|rectal cancer
155560|NCT02603302|radiotherapy|radiotherapy
155561|NCT02603302|escalated dose|escalated dose
155562|NCT02603302|interval|interval
155563|NCT02603276|hypercholesterolemia|hypercholesterolemia
155564|NCT02603276|dietary supplements|dietary supplements
155565|NCT02603276|red yeast rice|red yeast rice
155566|NCT02603276|plant sterols|plant sterols
155567|NCT02603263|social norms|social norms
155568|NCT02603263|healthy eating|healthy eating
155569|NCT02603263|vegetables|vegetables
155570|NCT02603263|field study|field study
155571|NCT02603250|Anemia|anemia
155572|NCT02603250|Iron deficiency|iron deficiency
155573|NCT02603250|noninvasive anemia screening|noninvasive anemia screening
155574|NCT02603211|breast cancer|breast cancer
155575|NCT02603198|third molar|third molar
155576|NCT02603198|tooth extraction|tooth extraction
155577|NCT02603198|impacted tooth|impacted tooth
155578|NCT02603185|Phase 1, Healthy subjects|phase 1, healthy subjects
155579|NCT02603172|GSK3039294|gsk3039294
155580|NCT02603172|GSK2315698|gsk2315698
155581|NCT02603172|systemic amyloidosis|systemic amyloidosis
155582|NCT02603172|CPHPC|cphpc
155583|NCT02603172|dose-escalation|dose-escalation
155584|NCT02603159|Chemoradiotherapy|chemoradiotherapy
155585|NCT02603159|Esophageal Squamous Cancer|esophageal squamous cancer
155586|NCT02603159|Capecitabine|capecitabine
155587|NCT02603146|RA prevention|ra prevention
155588|NCT02603146|hydroxychloroquine (HCQ)|hydroxychloroquine (hcq)
155589|NCT02603146|anti-CCP|anti-ccp
155590|NCT02603133|healthcare|healthcare
155591|NCT02603133|burnout|burnout
155592|NCT02603133|resilience|resilience
155593|NCT02603133|fatigue|fatigue
155594|NCT02603133|NICU|nicu
155595|NCT02603133|safety culture|safety culture
155596|NCT02603133|quality of care|quality of care
155597|NCT02603081|Meniere's|meniere's
155598|NCT02603081|hearing loss|hearing loss
155599|NCT02603081|vertigo|vertigo
155600|NCT02603081|tinnitus|tinnitus
155601|NCT02603081|ebselen|ebselen
155602|NCT02603055|Safety|safety
155603|NCT02603055|immunogenicity|immunogenicity
155604|NCT02603055|Hepatitis E|hepatitis e
155605|NCT02603029|skin rejuvenation|skin rejuvenation
155606|NCT02603029|anti-ageing effects|anti-ageing effects
155607|NCT02603029|minimal erythema dose|minimal erythema dose
155608|NCT02603029|dermis structure|dermis structure
155609|NCT02603029|physiological skin condition|physiological skin condition
155610|NCT02603029|wrinkling|wrinkling
155611|NCT02603016|Clinical Nutrition|clinical nutrition
155612|NCT02603003|Circulating tumor cells(CTCs)|circulating tumor cells(ctcs)
155613|NCT02603003|Traditional Chinese Medicine(TCM)|traditional chinese medicine(tcm)
155614|NCT02603003|Myeloid-derived suppressor cells(MDSCs)|myeloid-derived suppressor cells(mdscs)
155615|NCT02602990|Cerebral|cerebral
155616|NCT02602990|Arteriovenous|arteriovenous
155617|NCT02602990|Malformation|malformation
155618|NCT02602990|Embolization|embolization
155619|NCT02602990|Endovascular|endovascular
155620|NCT02602977|inflammation|inflammation
155621|NCT02602977|remote ischemic preconditioning|remote ischemic preconditioning
155622|NCT02602938|aspirin|aspirin
155623|NCT02602938|circulating tumor cells|circulating tumor cells
155624|NCT02602938|metastatic breast cancer|metastatic breast cancer
155625|NCT02602938|metastatic colorectal cancer|metastatic colorectal cancer
155626|NCT02602899|PINS|pins
155627|NCT02602899|Deep Brain Stimulator|deep brain stimulator
155628|NCT02602899|Refractory Epilepsy|refractory epilepsy
155629|NCT02602899|Anterior Thalamic Nucleus|anterior thalamic nucleus
155630|NCT02602860|SV2A|sv2a
155631|NCT02602860|Levetiracetam|levetiracetam
155632|NCT02602860|Brivaracetam|brivaracetam
155633|NCT02602860|PET|pet
155634|NCT02602847|Liver transplantation|liver transplantation
155635|NCT02602847|HBV|hbv
155636|NCT02602847|cccDNA|cccdna
155637|NCT02602834|exercise test|exercise test
155638|NCT02602834|biological markers|biological markers
155639|NCT02602808|acute pancreatitis|acute pancreatitis
155640|NCT02602808|non-coding RNA|non-coding rna
155641|NCT02602808|biological markers|biological markers
155642|NCT02602808|receiver operating characteristic curve|receiver operating characteristic curve
155643|NCT02602795|Opiate Dependence|opiate dependence
155644|NCT02602795|Sexually Transmitted Diseases|sexually transmitted diseases
155645|NCT02602795|HIV|hiv
155646|NCT02602795|Extended release naltrexone|extended release naltrexone
155647|NCT02602756|Choroid Melanoma|choroid melanoma
155648|NCT02602743|sedation|sedation
155649|NCT02602743|remifentanyl|remifentanyl
155650|NCT02602743|pediatric patient|pediatric patient
155651|NCT02602743|colonoscopy|colonoscopy
155652|NCT02602730|Cigarette smoking|cigarette smoking
155653|NCT02602730|Smoking, Tobacco|smoking, tobacco
155654|NCT02602730|postpartum|postpartum
155655|NCT02602730|internet|internet
155656|NCT02602730|interactive|interactive
155657|NCT02602730|coach|coach
155658|NCT02602717|follicular origin|follicular origin
155659|NCT02602691|Heart transplantation|heart transplantation
155660|NCT02602691|AlloMap® gene expression profiling test|allomap® gene expression profiling test
155661|NCT02602691|Medico-economic study|medico-economic study
155662|NCT02602678|Children.|children.
155663|NCT02602678|prone position|prone position
155664|NCT02602678|acute viral bronchiolitis|acute viral bronchiolitis
155665|NCT02602678|syncytial virus|syncytial virus
155666|NCT02602678|work of breathing|work of breathing
155667|NCT02602678|intrinsic PEEP|intrinsic peep
155668|NCT02602665|catheter placement|catheter placement
155669|NCT02602652|geometric mean titer|geometric mean titer
155670|NCT02602652|seroprotection|seroprotection
155671|NCT02602652|live attenuated chimeric JE vaccine|live attenuated chimeric je vaccine
155672|NCT02602652|JE-CV|je-cv
155673|NCT02602652|SA14-14-2 vaccine|sa14-14-2 vaccine
155674|NCT02602626|Human Papillomavirus|human papillomavirus
155675|NCT02602626|HPV|hpv
155676|NCT02602626|Postpartum|postpartum
155784|NCT02602145|flexion|flexion
155677|NCT02602587|acute myeloid leukemia|acute myeloid leukemia
155678|NCT02602587|Dendrogenin A|dendrogenin a
155679|NCT02602587|5,6-cholesterol epoxide|5,6-cholesterol epoxide
155680|NCT02602587|6-oxo-cholestane-3beta|6-oxo-cholestane-3beta
155681|NCT02602587|5alpha-diol|5alpha-diol
155682|NCT02602587|cholesterol epoxide hydrolase|cholesterol epoxide hydrolase
155683|NCT02602587|oxysterols|oxysterols
155684|NCT02602574|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
155685|NCT02602574|Pancreatitis|pancreatitis
155686|NCT02602574|Heat-Shock Proteins|heat-shock proteins
155687|NCT02602574|Pentraxin 3 protein|pentraxin 3 protein
155688|NCT02602574|C-Reactive Protein|c-reactive protein
155689|NCT02602574|procalcitonin|procalcitonin
155690|NCT02602574|Interleukin-1 beta|interleukin-1 beta
155691|NCT02602574|Leukocytes, Mononuclear|leukocytes, mononuclear
155692|NCT02602574|Killer Cells, Natural|killer cells, natural
155693|NCT02602574|natural-killer group 2, member D receptor|natural-killer group 2, member d receptor
155694|NCT02602561|HMB|hmb
155695|NCT02602561|beta-hydroxy-beta-methylbutyrate|beta-hydroxy-beta-methylbutyrate
155696|NCT02602561|ACL|acl
155697|NCT02602561|surgery|surgery
155698|NCT02602561|muscle mass|muscle mass
155699|NCT02602548|Propionibacterium acnes|propionibacterium acnes
155700|NCT02602548|shoulder surgery|shoulder surgery
155701|NCT02602548|infection|infection
155702|NCT02602496|Diet|diet
155703|NCT02602496|Whole grain|whole grain
155704|NCT02602496|Fruits|fruits
155705|NCT02602496|Vegetables|vegetables
155706|NCT02602496|Gut health|gut health
155707|NCT02602496|Anti-inflammatory|anti-inflammatory
155708|NCT02602483|temporomandibular|temporomandibular
155709|NCT02602483|joint|joint
155710|NCT02602483|pain|pain
155711|NCT02602483|ibuprofen|ibuprofen
155712|NCT02602483|magnesium|magnesium
155713|NCT02602483|vitamin C|vitamin c
155714|NCT02602457|Atrial Fibrillation|atrial fibrillation
155715|NCT02602444|ticagrelor|ticagrelor
155716|NCT02602444|STEMI|stemi
155717|NCT02602444|NSTEMI|nstemi
155718|NCT02602444|pharmacokinetics|pharmacokinetics
155719|NCT02602444|pharmacodynamics|pharmacodynamics
155720|NCT02602431|laser|laser
155721|NCT02602431|third molar|third molar
155722|NCT02602431|low laser|low laser
155723|NCT02602431|inflammatory response|inflammatory response
155724|NCT02602418|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
155725|NCT02602418|working memory training|working memory training
155726|NCT02602418|brain function|brain function
155727|NCT02602418|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
155728|NCT02602405|Outcome Assessment (Health Care)|outcome assessment (health care)
155729|NCT02602405|Return to work|return to work
155730|NCT02602405|Registries|registries
155731|NCT02602405|Norway|norway
155732|NCT02602392|Self management|self management
155733|NCT02602392|Education|education
155734|NCT02602392|Children|children
155735|NCT02602392|Caregivers|caregivers
155736|NCT02602392|Health Care Providers|health care providers
155737|NCT02602379|Pain|pain
155738|NCT02602379|Monitoring|monitoring
155739|NCT02602379|Analgesia Nociception Index|analgesia nociception index
155740|NCT02602379|NoL|nol
155741|NCT02602379|Nociception Level|nociception level
155742|NCT02602379|Remifentanil|remifentanil
155743|NCT02602366|HIV|hiv
155744|NCT02602366|DCE|dce
155745|NCT02602366|MPT|mpt
155746|NCT02602366|Microbicide|microbicide
155747|NCT02602327|radioembolization|radioembolization
155748|NCT02602327|Yttrium-90|yttrium-90
155749|NCT02602327|90Y|90y
155750|NCT02602327|Resin microspheres|resin microspheres
155751|NCT02602327|Tas-102|tas-102
155752|NCT02602327|Lonsurf|lonsurf
155753|NCT02602327|SIR-Sphere|sir-sphere
155754|NCT02602314|Chronic myeloid leukemia|chronic myeloid leukemia
155755|NCT02602314|Nilotinib|nilotinib
155756|NCT02602314|Imatinib|imatinib
155757|NCT02602301|oxytocin|oxytocin
155758|NCT02602223|Alveolar Ridge Augmentation|alveolar ridge augmentation
155759|NCT02602223|Tooth Socket|tooth socket
155760|NCT02602223|Guided Tissue Regeneration|guided tissue regeneration
155761|NCT02602223|Membranes|membranes
155762|NCT02602210|cirrhosis|cirrhosis
155763|NCT02602210|liver|liver
155764|NCT02602210|corticosteroids|corticosteroids
155765|NCT02602210|hypotension|hypotension
155766|NCT02602210|sepsis|sepsis
155767|NCT02602210|cortisol|cortisol
155768|NCT02602197|Paracetamol|paracetamol
155769|NCT02602197|Dexketoprofen|dexketoprofen
155770|NCT02602197|postoperative pain|postoperative pain
155771|NCT02602197|septoplasty|septoplasty
155772|NCT02602184|skin regeneration|skin regeneration
155773|NCT02602184|re-epithelialization|re-epithelialization
155774|NCT02602184|split thickness wounds|split thickness wounds
155775|NCT02602184|Abdominoplasty|abdominoplasty
155776|NCT02602158|breath test|breath test
155777|NCT02602158|lipid emulsions|lipid emulsions
155778|NCT02602158|MRI|mri
155779|NCT02602158|gastric emptying|gastric emptying
155780|NCT02602145|femoral|femoral
155781|NCT02602145|popliteal|popliteal
155782|NCT02602145|stent|stent
155783|NCT02602145|modeling|modeling
155785|NCT02602132|INDWELLING URINARY CATHETER|indwelling urinary catheter
155786|NCT02602132|CLAMPING|clamping
155787|NCT02602132|REMOVAL|removal
155788|NCT02602106|Aquatic activities|aquatic activities
155789|NCT02602106|Aerobic exercise|aerobic exercise
155790|NCT02602106|Resistance exercise|resistance exercise
155791|NCT02602106|Pregnancy|pregnancy
155792|NCT02602106|Maternal weight gain|maternal weight gain
155793|NCT02602106|birthweight|birthweight
155794|NCT02602093|Lumbar Disk Herniation|lumbar disk herniation
155795|NCT02602093|Percutaneous Transforaminal Endoscopic Discectomy|percutaneous transforaminal endoscopic discectomy
155796|NCT02602093|Micro Discectomy|micro discectomy
155797|NCT02602093|Minimal Invasive Spine Surgery|minimal invasive spine surgery
155798|NCT02602054|persistent ductus arteriosus|persistent ductus arteriosus
155799|NCT02602054|preterm infants|preterm infants
155800|NCT02602054|surgical treatment|surgical treatment
155801|NCT02602054|pharmacological treatment|pharmacological treatment
155802|NCT02602028|Familial Mediterranean Fever|familial mediterranean fever
155803|NCT02602028|Colchicine|colchicine
155804|NCT02602002|Remifentanil, Pharmacodynamic Pain assessments, Intravenous, South Korea|remifentanil, pharmacodynamic pain assessments, intravenous, south korea
155805|NCT02601976|PegInterferon alpha-2a|peginterferon alpha-2a
155806|NCT02601976|Ribavirin|ribavirin
155807|NCT02601976|Hepatitis C Virus|hepatitis c virus
155808|NCT02601976|Sustained Virological Response|sustained virological response
155809|NCT02601976|End of Treatment Response|end of treatment response
155810|NCT02601976|Unipeg|unipeg
155811|NCT02601976|Ribazole|ribazole
155812|NCT02601924|Anesthesia|anesthesia
155813|NCT02601924|injection|injection
155814|NCT02601924|pain|pain
155815|NCT02601924|pressure massage|pressure massage
155816|NCT02601924|topical gel|topical gel
155817|NCT02601911|Failure|failure
155818|NCT02601911|Injection|injection
155819|NCT02601911|Ketorolac|ketorolac
155820|NCT02601911|Premedication|premedication
155821|NCT02601885|Relapsing-remitting|relapsing-remitting
155822|NCT02601885|Secondary progressive|secondary progressive
155823|NCT02601885|Relapsing forms|relapsing forms
155824|NCT02601833|Caries|caries
155825|NCT02601833|Cavity|cavity
155826|NCT02601820|patient-reported outcomes|patient-reported outcomes
155827|NCT02601820|observational|observational
155828|NCT02601820|HCV|hcv
155829|NCT02601820|Hepatitis|hepatitis
155830|NCT02601820|Hepatitis C|hepatitis c
155831|NCT02601820|Chronic Liver Disease|chronic liver disease
155832|NCT02601820|Liver Disease|liver disease
155833|NCT02601820|Liver|liver
155834|NCT02601820|Infectious Disease|infectious disease
155835|NCT02601820|Hep C|hep c
155836|NCT02601820|HepC|hepc
155837|NCT02601820|PROs|pros
155838|NCT02601807|Back|back
155839|NCT02601807|Pain|pain
155840|NCT02601807|PSWT|pswt
155841|NCT02601807|ActiPatch|actipatch
155842|NCT02601807|Pulsed shortwave therapy|pulsed shortwave therapy
155843|NCT02601794|Breast Cancer|breast cancer
155844|NCT02601794|mHealth|mhealth
155845|NCT02601794|Mindfulness|mindfulness
155846|NCT02601794|Complementary Therapies|complementary therapies
155847|NCT02601781|Bioresorbable Vascular Scaffold (BVS)|bioresorbable vascular scaffold (bvs)
155848|NCT02601781|STEMI|stemi
155849|NCT02601781|Primary PCI|primary pci
155850|NCT02601768|ASD II|asd ii
155851|NCT02601768|transcatheter closure|transcatheter closure
155852|NCT02601768|percutaneous closure|percutaneous closure
155853|NCT02601768|3D TEE|3d tee
155854|NCT02601768|balloon-sizing|balloon-sizing
155855|NCT02601742|zinc|zinc
155856|NCT02601742|Duration|duration
155857|NCT02601729|Type 1 diabetes|type 1 diabetes
155858|NCT02601729|real-time continuous glucose monitoring|real-time continuous glucose monitoring
155859|NCT02601729|observational study|observational study
155860|NCT02601729|insulin pump|insulin pump
155861|NCT02601729|Belgium|belgium
155862|NCT02601716|Plasmodium falciparum|plasmodium falciparum
155863|NCT02601716|PfSPZ Vaccine|pfspz vaccine
155864|NCT02601716|Sporozoites|sporozoites
155865|NCT02601716|Controlled Human Malaria Infection|controlled human malaria infection
155866|NCT02601690|Rye Grass|rye grass
155867|NCT02601690|Ragweed|ragweed
155868|NCT02601690|Cat|cat
155869|NCT02601690|House Dust Mite|house dust mite
155870|NCT02601677|Obsessive Compulsive Disorder|obsessive compulsive disorder
155871|NCT02601677|Deep Brain Stimulation|deep brain stimulation
155872|NCT02601677|Nucleus accumbens|nucleus accumbens
155873|NCT02601651|Totally Extraperitoneal Inguinal Hernioplasty|totally extraperitoneal inguinal hernioplasty
155874|NCT02601651|Lidocaine infusion|lidocaine infusion
155875|NCT02601651|Postoperative opioid consumption|postoperative opioid consumption
155876|NCT02601625|Tolerability|tolerability
155877|NCT02601625|Anifrolumab|anifrolumab
155878|NCT02601625|Subcutaneous injection|subcutaneous injection
155879|NCT02601625|Intravenous infusion|intravenous infusion
155880|NCT02601599|Smoking Cessation|smoking cessation
155881|NCT02601599|Tobacco Use Cessation|tobacco use cessation
155882|NCT02601599|Motivational Interviewing|motivational interviewing
155883|NCT02601599|Students, Medical|students, medical
155884|NCT02601599|Randomized Controlled Trial|randomized controlled trial
155885|NCT02601560|Coronary Artery Disease|coronary artery disease
155886|NCT02601560|CAD|cad
155887|NCT02601547|Positron-Emission Tomography|positron-emission tomography
155888|NCT02601547|chemotherapy-induced brain damage|chemotherapy-induced brain damage
155889|NCT02601547|neuro-cognitive function alteration|neuro-cognitive function alteration
155890|NCT02601534|sedentary behaviour|sedentary behaviour
155891|NCT02601534|physical activity|physical activity
155892|NCT02601508|deep NM block|deep nm block
155893|NCT02601508|Surgeon's satisfaction|surgeon's satisfaction
155894|NCT02601508|bridion|bridion
155895|NCT02601482|Glycemic control|glycemic control
155896|NCT02601482|exercise|exercise
155897|NCT02601482|Interval Training|interval training
155898|NCT02601456|Amputation, Traumatic|amputation, traumatic
155899|NCT02601456|Biomechanics|biomechanics
155900|NCT02601456|Asymmetry|asymmetry
155901|NCT02601456|Amputee Running|amputee running
155902|NCT02601456|Prolonged Effort|prolonged effort
155903|NCT02601417|Cholangitis|cholangitis
155904|NCT02601417|Bile culture|bile culture
155905|NCT02601391|STEPPS-HI|stepps-hi
155906|NCT02601391|personality disorder|personality disorder
155907|NCT02601391|evaluation|evaluation
155908|NCT02601391|forensic|forensic
155909|NCT02601378|Uveal melanoma|uveal melanoma
155910|NCT02601378|Metastatic uveal melanoma|metastatic uveal melanoma
155911|NCT02601378|Phase I|phase i
155912|NCT02601378|LXS196|lxs196
155913|NCT02601378|PKC inhibitor|pkc inhibitor
155914|NCT02601378|HDM201|hdm201
155915|NCT02601378|HDM2 inhibitor|hdm2 inhibitor
155916|NCT02601378|dose escalation|dose escalation
155917|NCT02601339|spectroscopy, Near-Infrared|spectroscopy, near-infrared
155918|NCT02601300|Ulcerative Colitis|ulcerative colitis
155919|NCT02601300|GED-0301|ged-0301
155920|NCT02601300|Mongersen|mongersen
155921|NCT02601300|Efficacy|efficacy
155922|NCT02601300|Safety|safety
155923|NCT02601261|pregnant|pregnant
155924|NCT02601261|gestational ages|gestational ages
155925|NCT02601261|hospitalized|hospitalized
155926|NCT02601261|problem of pregnancy|problem of pregnancy
155927|NCT02601248|safety, PK|safety, pk
155928|NCT02601235|nasal congestion|nasal congestion
155929|NCT02601222|chronic eczema|chronic eczema
155930|NCT02601222|efficacy and safety|efficacy and safety
155931|NCT02601222|Runzao zhiyang capsule|runzao zhiyang capsule
155932|NCT02601196|Leiomyoma|leiomyoma
155933|NCT02601196|Infertility|infertility
155934|NCT02601196|IVF|ivf
155935|NCT02601196|Ulipristal acetate|ulipristal acetate
155936|NCT02601183|brain temperture，thrombolysis，early diagnosis|brain temperture，thrombolysis，early diagnosis
155937|NCT02601170|Platelet Rich Plasma|platelet rich plasma
155938|NCT02601170|Hemophilia|hemophilia
155939|NCT02601170|Hemophilic arthropathy|hemophilic arthropathy
155940|NCT02601157|stent|stent
155941|NCT02601157|polymer|polymer
155942|NCT02601157|antiplatelet therapy|antiplatelet therapy
155943|NCT02601157|clopidogrel|clopidogrel
155944|NCT02601144|DBS|dbs
155945|NCT02601144|VFS|vfs
155946|NCT02601144|FOG|fog
155947|NCT02601131|platelet count|platelet count
155948|NCT02601131|platelet transfusion|platelet transfusion
155949|NCT02601131|complement factors|complement factors
155950|NCT02601131|endothelial markers|endothelial markers
155951|NCT02601131|stem cell transplantation|stem cell transplantation
155952|NCT02601105|gotu kola|gotu kola
155953|NCT02601105|centella asiatica|centella asiatica
155954|NCT02601092|Mini Gastric Bypass|mini gastric bypass
155955|NCT02601092|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
155956|NCT02601092|RCT|rct
155957|NCT02601079|Biopsy|biopsy
155958|NCT02601079|Diagnostics|diagnostics
155959|NCT02601079|Genetic analysis|genetic analysis
155960|NCT02601066|LMNA|lmna
155961|NCT02601066|Sudden Death|sudden death
155962|NCT02601066|Neuromuscular|neuromuscular
155963|NCT02601040|Safety|safety
155964|NCT02601040|Immunogenicity|immunogenicity
155965|NCT02601040|Vaccine|vaccine
155966|NCT02601040|Hepatitis A|hepatitis a
155967|NCT02601014|Hormone-Resistant Prostate Cancer|hormone-resistant prostate cancer
155968|NCT02601014|Prostate Carcinoma Metastatic in the Bone|prostate carcinoma metastatic in the bone
155969|NCT02600988|Graft-Versus-Host-Disease|graft-versus-host-disease
155970|NCT02600988|post-allogeneic transplant|post-allogeneic transplant
155971|NCT02600988|haematopoietic progenitors|haematopoietic progenitors
155972|NCT02600949|Pancreatic cancer|pancreatic cancer
155973|NCT02600949|Colorectal Cancer|colorectal cancer
155974|NCT02600949|Pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
155975|NCT02600949|PDA|pda
155976|NCT02600949|CRC|crc
155977|NCT02600949|Personalized peptide vaccine|personalized peptide vaccine
155978|NCT02600949|Phone call|phone call
155979|NCT02600949|Advanced/metastatic|advanced/metastatic
155980|NCT02600936|venous outflow obstruction|venous outflow obstruction
155981|NCT02600936|peripheral venous disease|peripheral venous disease
155982|NCT02600936|vein stent|vein stent
155983|NCT02600936|Wallstent|wallstent
155984|NCT02600936|registry|registry
155985|NCT02600936|May Thurner|may thurner
155986|NCT02600923|palbociclib, ibrance, breast cancer|palbociclib, ibrance, breast cancer
155987|NCT02600910|Manual Wheelchair|manual wheelchair
155988|NCT02600910|Shoulder injury|shoulder injury
155989|NCT02600910|Shoulder function|shoulder function
155990|NCT02600910|rotator cuff|rotator cuff
155991|NCT02600910|Tendinopathy|tendinopathy
155992|NCT02600910|Spinal cord injury|spinal cord injury
155993|NCT02600910|Shoulder pain|shoulder pain
155994|NCT02600910|Shoulder impingement|shoulder impingement
155995|NCT02600871|Abscess|abscess
155996|NCT02600871|Antiseptic|antiseptic
155997|NCT02600871|Provodine|provodine
155998|NCT02600871|Povidone-Iodine|povidone-iodine
155999|NCT02600819|end stage renal disease (ESRD)|end stage renal disease (esrd)
156000|NCT02600819|hemodialysis (HD)|hemodialysis (hd)
156001|NCT02600819|open-label|open-label
156002|NCT02600819|HIV-1 Infection|hiv-1 infection
156003|NCT02600806|Community-acquired pneumonia|community-acquired pneumonia
156004|NCT02600806|Procalcitonin|procalcitonin
156005|NCT02600806|Outpatients|outpatients
156006|NCT02600806|Outcomes|outcomes
156007|NCT02600806|Azithromycin|azithromycin
156008|NCT02600806|Fluoroquinolones|fluoroquinolones
156009|NCT02600780|Febuxostat|febuxostat
156010|NCT02600780|Efficacy|efficacy
156011|NCT02600780|Safety|safety
156012|NCT02600780|Allopurinol|allopurinol
156013|NCT02600780|Hyperuricemia|hyperuricemia
156014|NCT02600780|Zurig|zurig
156015|NCT02600780|Getz Pharma|getz pharma
156016|NCT02600754|older adults, depressive symptoms, psychosocial treatment|older adults, depressive symptoms, psychosocial treatment
156017|NCT02600741|Schizophrenia|schizophrenia
156018|NCT02600741|Caregiver|caregiver
156019|NCT02600741|Psycho-education and skills training|psycho-education and skills training
156020|NCT02600741|Paliperidone Palmitate|paliperidone palmitate
156021|NCT02600741|Oral Antipsychotic|oral antipsychotic
156022|NCT02600728|Parkinson Disease|parkinson disease
156023|NCT02600728|Gait|gait
156024|NCT02600728|cues|cues
156025|NCT02600728|memory|memory
156026|NCT02600728|training|training
156027|NCT02600702|Home base exercise|home base exercise
156028|NCT02600689|Pulmonary rehab|pulmonary rehab
156029|NCT02600689|Exergame|exergame
156030|NCT02600689|Home-based|home-based
156031|NCT02600637|stroke|stroke
156032|NCT02600637|depression|depression
156033|NCT02600637|anxiety|anxiety
156034|NCT02600637|mindfulness|mindfulness
156035|NCT02600637|meditation|meditation
156036|NCT02600572|balance, postural|balance, postural
156037|NCT02600572|postural equilibrium|postural equilibrium
156038|NCT02600572|mental speed|mental speed
156039|NCT02600572|isometric exercise|isometric exercise
156040|NCT02600572|eccentric exercise|eccentric exercise
156041|NCT02600559|Otitis media|otitis media
156042|NCT02600559|Ear infection|ear infection
156043|NCT02600559|Tympanostomy tubes|tympanostomy tubes
156044|NCT02600533|minority group recruitment|minority group recruitment
156045|NCT02600533|stages of implementation|stages of implementation
156046|NCT02600533|clinical trials education|clinical trials education
156047|NCT02600481|standard-pressure pneumoperitoneum|standard-pressure pneumoperitoneum
156048|NCT02600481|prolonged pneumoperitoneum|prolonged pneumoperitoneum
156049|NCT02600481|myocardial injuries|myocardial injuries
156050|NCT02600481|troponin T(TnT)|troponin t(tnt)
156051|NCT02600481|Trendelenburg position|trendelenburg position
156052|NCT02600481|chest CT scan|chest ct scan
156053|NCT02600481|low-pressure pneumoperitoneum|low-pressure pneumoperitoneum
156054|NCT02600481|robot-assisted surgery|robot-assisted surgery
156055|NCT02600442|Neoadjuvant Therapy|neoadjuvant therapy
156056|NCT02600442|Chemotherapy|chemotherapy
156057|NCT02600442|Positron-Emission Tomography|positron-emission tomography
156058|NCT02600442|PET-CT|pet-ct
156059|NCT02600442|FDG|fdg
156060|NCT02600442|Fluorodeoxyglucose|fluorodeoxyglucose
156061|NCT02600442|Diagnosis|diagnosis
156062|NCT02600442|Prognosis|prognosis
156063|NCT02600442|Pathological complete response|pathological complete response
156064|NCT02600442|molecular biology|molecular biology
156065|NCT02600442|proliferation genes|proliferation genes
156066|NCT02600429|Neurotrophic Keratopathy|neurotrophic keratopathy
156067|NCT02600429|NK|nk
156068|NCT02600403|Visual Evoked Potentials|visual evoked potentials
156069|NCT02600403|Optical Coherence Tomography|optical coherence tomography
156070|NCT02600403|Visual Fields|visual fields
156071|NCT02600390|Leg Ulcer|leg ulcer
156072|NCT02600390|LU|lu
156073|NCT02600390|SANGUINATE|sanguinate
156074|NCT02600390|QOL|qol
156075|NCT02600390|SCD|scd
156076|NCT02600390|Sickle Cell Disease|sickle cell disease
156077|NCT02600390|Sickle Cell|sickle cell
156078|NCT02600390|Anemia|anemia
156079|NCT02600390|Leg Wound|leg wound
156080|NCT02600390|Leg|leg
156081|NCT02600390|Skin Lesion|skin lesion
156082|NCT02600364|Aneurysm|aneurysm
156083|NCT02600364|intracerebral|intracerebral
156084|NCT02600364|stroke|stroke
156085|NCT02600364|p64|p64
156086|NCT02600351|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
156087|NCT02600351|Ledipasvir/Sofosbuvir|ledipasvir/sofosbuvir
156088|NCT02600351|Ribavirin|ribavirin
156089|NCT02600338|Systematic review and meta-analysis|systematic review and meta-analysis
156289|NCT02599116|microbiome|microbiome
156090|NCT02600338|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
156091|NCT02600338|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
156092|NCT02600338|Clinical practice guidelines|clinical practice guidelines
156093|NCT02600338|Clinical trials|clinical trials
156094|NCT02600338|Legumes|legumes
156095|NCT02600338|Beans, peas, chickpeas, lentils, soy, peanuts, lupins|beans, peas, chickpeas, lentils, soy, peanuts, lupins
156096|NCT02600338|Cardiometabolic risk factors|cardiometabolic risk factors
156097|NCT02600338|Blood pressure|blood pressure
156098|NCT02600325|Acute Hepatitis C|acute hepatitis c
156099|NCT02600325|Human Immunodeficiency virus|human immunodeficiency virus
156100|NCT02600325|Grazoprevir|grazoprevir
156101|NCT02600325|Elbasvir|elbasvir
156102|NCT02600286|Physical medicine and rehabilitation|physical medicine and rehabilitation
156103|NCT02600286|Neurology|neurology
156104|NCT02600260|thrombophilia|thrombophilia
156105|NCT02600260|thrombosis|thrombosis
156106|NCT02600260|Pregnancy, High-Risk|pregnancy, high-risk
156107|NCT02600260|venous thrombosis|venous thrombosis
156108|NCT02600260|enoxaparin|enoxaparin
156109|NCT02600260|risk assessment|risk assessment
156110|NCT02600260|deep vein thrombosis|deep vein thrombosis
156111|NCT02600260|pulmonary embolism|pulmonary embolism
156112|NCT02600260|hospitalization|hospitalization
156113|NCT02600247|Total knee arthroplasty|total knee arthroplasty
156114|NCT02600247|Duloxetine|duloxetine
156115|NCT02600221|ACOS|acos
156116|NCT02600195|Intensive Care, Neonatal|intensive care, neonatal
156117|NCT02600195|Nosocomial Infections|nosocomial infections
156118|NCT02600195|Quality Improvement|quality improvement
156119|NCT02600182|Thoracic surgery|thoracic surgery
156120|NCT02600182|Non-invasive ventilation|non-invasive ventilation
156121|NCT02600182|Physiotherapy|physiotherapy
156122|NCT02600143|Melanoma|melanoma
156123|NCT02600143|Colitis|colitis
156124|NCT02600143|Ipilimumab|ipilimumab
156125|NCT02600143|Nivolumab|nivolumab
156126|NCT02600143|Pembrolizumab|pembrolizumab
156127|NCT02600091|Anxiety|anxiety
156128|NCT02600091|Depression|depression
156129|NCT02600091|Type 1 Diabetes|type 1 diabetes
156130|NCT02600091|Mindfulness-based Cognitive Therapy|mindfulness-based cognitive therapy
156131|NCT02600091|Glycaemic control|glycaemic control
156132|NCT02600078|hypoxia|hypoxia
156133|NCT02600078|ataxia|ataxia
156134|NCT02600013|incomplete motor SCI|incomplete motor sci
156135|NCT02600013|robotic gait training|robotic gait training
156136|NCT02600013|exoskeleton|exoskeleton
156137|NCT02600013|rehabilitation tool|rehabilitation tool
156138|NCT02600013|EKSO-GT|ekso-gt
156139|NCT02599961|Glut 1 DS|glut 1 ds
156140|NCT02599935|Nutritional status|nutritional status
156141|NCT02599935|MNA|mna
156142|NCT02599935|GSA|gsa
156143|NCT02599909|Tumor Microenvironment|tumor microenvironment
156144|NCT02599909|100 Trillion Microbial Cells|100 trillion microbial cells
156145|NCT02599909|Liver Tumors|liver tumors
156146|NCT02599909|Intestinal Microbiota|intestinal microbiota
156147|NCT02599909|Immune Regulation|immune regulation
156148|NCT02599896|Dose Escalation|dose escalation
156149|NCT02599896|HIV Prevention|hiv prevention
156150|NCT02599896|Broadly HIV-1 Neutralizing Activity|broadly hiv-1 neutralizing activity
156151|NCT02599896|Open-Label|open-label
156152|NCT02599896|Half-Life|half-life
156153|NCT02599883|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
156154|NCT02599883|Diagnostic Imaging|diagnostic imaging
156155|NCT02599883|Disease Management|disease management
156156|NCT02599883|Clinical Decision Support Systems|clinical decision support systems
156157|NCT02599883|Cost-Utility Analysis|cost-utility analysis
156158|NCT02599870|PGx|pgx
156159|NCT02599870|pharmacogenetic testing|pharmacogenetic testing
156160|NCT02599870|IDgenetix|idgenetix
156161|NCT02599870|Pain Management|pain management
156162|NCT02599870|AltheaDx|altheadx
156163|NCT02599870|Post-Operative Pain Management|post-operative pain management
156164|NCT02599844|acute kidney injury|acute kidney injury
156165|NCT02599831|Electrical pudendal nerve stimulation|electrical pudendal nerve stimulation
156166|NCT02599831|Pelvic floor muscle training|pelvic floor muscle training
156167|NCT02599831|Transanal electrical stimulation|transanal electrical stimulation
156168|NCT02599831|Post radical prostatectomy incontinence|post radical prostatectomy incontinence
156169|NCT02599831|Comparative study|comparative study
156170|NCT02599792|Safety and Pharmacokinetics|safety and pharmacokinetics
156171|NCT02599779|Renal cell cancer|renal cell cancer
156172|NCT02599779|SBRT|sbrt
156173|NCT02599779|Pembrolizumab|pembrolizumab
156174|NCT02599766|animal assisted intervention, brain injury, rehabilitation|animal assisted intervention, brain injury, rehabilitation
156175|NCT02599740|Blood glucose|blood glucose
156176|NCT02599727|balance, postural|balance, postural
156177|NCT02599727|postural equilibrium|postural equilibrium
156178|NCT02599727|heart rate|heart rate
156179|NCT02599727|blood pressure|blood pressure
156180|NCT02599727|pulse oxygenation|pulse oxygenation
156181|NCT02599727|mental speed|mental speed
156182|NCT02599714|AZD2014|azd2014
156183|NCT02599714|Palbociclib|palbociclib
156184|NCT02599714|Fulvestrant|fulvestrant
156185|NCT02599714|Hormonal Therapy|hormonal therapy
156584|NCT02597374|mu rhythm|mu rhythm
156186|NCT02599714|Estrogen Receptor Positive|estrogen receptor positive
156187|NCT02599714|Breast Cancer|breast cancer
156188|NCT02599701|Delta Sleep|delta sleep
156189|NCT02599701|Growth Hormone|growth hormone
156190|NCT02599701|IGF-1|igf-1
156191|NCT02599675|Muscle|muscle
156192|NCT02599675|Vitamin D|vitamin d
156193|NCT02599675|Strength|strength
156194|NCT02599675|Endurance|endurance
156195|NCT02599675|Muscle fiber|muscle fiber
156196|NCT02599662|Cancer|cancer
156197|NCT02599662|Intraoperative Radiation Therapy - IORT|intraoperative radiation therapy - iort
156198|NCT02599649|Myelodysplastic syndrome|myelodysplastic syndrome
156199|NCT02599649|MDS|mds
156200|NCT02599649|Low or intermediate-1 MDS|low or intermediate-1 mds
156201|NCT02599649|High Risk MDS|high risk mds
156202|NCT02599649|Lirilumab|lirilumab
156203|NCT02599649|Nivolumab|nivolumab
156204|NCT02599649|BMS-936558|bms-936558
156205|NCT02599649|Opdivo|opdivo
156206|NCT02599649|Azacitidine|azacitidine
156207|NCT02599649|5-azacytidine|5-azacytidine
156208|NCT02599649|5-aza|5-aza
156209|NCT02599649|Vidaza|vidaza
156210|NCT02599649|5-AZC|5-azc
156211|NCT02599649|AZA-CR|aza-cr
156212|NCT02599649|Ladakamycin|ladakamycin
156213|NCT02599649|NSC-102816|nsc-102816
156214|NCT02599649|Azacytidine|azacytidine
156215|NCT02599623|Incarcerated|incarcerated
156216|NCT02599623|Anesthesia|anesthesia
156217|NCT02599623|Hernia|hernia
156218|NCT02599610|labor, vaginal examination, transperineal ultrasound, pain, anxiety|labor, vaginal examination, transperineal ultrasound, pain, anxiety
156219|NCT02599584|behaviour|behaviour
156220|NCT02599558|EOE|eoe
156221|NCT02599532|Apixaban|apixaban
156222|NCT02599532|Pharmacokinetics|pharmacokinetics
156223|NCT02599532|Pharmacodynamics|pharmacodynamics
156224|NCT02599506|breast cancer|breast cancer
156225|NCT02599506|fear of recurrence|fear of recurrence
156226|NCT02599506|longitudinal study|longitudinal study
156227|NCT02599506|radiation therapy|radiation therapy
156228|NCT02599506|emotional concerns|emotional concerns
156229|NCT02599506|trajectory|trajectory
156230|NCT02599506|psychological constructs|psychological constructs
156231|NCT02599506|diary keeping|diary keeping
156232|NCT02599480|HFpEF|hfpef
156233|NCT02599480|left ventricular hypertrophy|left ventricular hypertrophy
156234|NCT02599480|cardiac remodeling,|cardiac remodeling,
156235|NCT02599467|Nerve Pain|nerve pain
156236|NCT02599467|Electromyography|electromyography
156237|NCT02599467|Median Nerve|median nerve
156238|NCT02599467|Breast Neoplasms|breast neoplasms
156239|NCT02599415|psoriasis patients referred to receive TL01 NB-UVB therapy|psoriasis patients referred to receive tl01 nb-uvb therapy
156240|NCT02599389|in-stent restenosis; drug-coated balloons; Excimer Laser, cost effectiveness study, quality of life|in-stent restenosis; drug-coated balloons; excimer laser, cost effectiveness study, quality of life
156241|NCT02599350|Ventilation|ventilation
156242|NCT02599350|Gas exchange|gas exchange
156243|NCT02599350|V/Q ratio|v/q ratio
156244|NCT02599350|Requirement for mechanical ventilation|requirement for mechanical ventilation
156245|NCT02599337|bioequivalence|bioequivalence
156246|NCT02599311|pelvic organ prolapse|pelvic organ prolapse
156247|NCT02599298|sleep|sleep
156248|NCT02599298|treatment|treatment
156249|NCT02599259|Stroke|stroke
156250|NCT02599259|Oral anticoagulants|oral anticoagulants
156251|NCT02599259|NOAC|noac
156252|NCT02599259|wireless monitoring|wireless monitoring
156253|NCT02599259|Warfarin|warfarin
156254|NCT02599259|Xarelto|xarelto
156255|NCT02599259|compliance|compliance
156256|NCT02599259|adherence|adherence
156257|NCT02599259|monitoring|monitoring
156258|NCT02599259|directly observed therapy|directly observed therapy
156259|NCT02599259|DOT|dot
156260|NCT02599259|mobile device|mobile device
156261|NCT02599259|electronic monitoring|electronic monitoring
156262|NCT02599259|artificial intelligence|artificial intelligence
156263|NCT02599259|oral anticoagulation therapy|oral anticoagulation therapy
156264|NCT02599259|adherence monitoring methods|adherence monitoring methods
156265|NCT02599259|nonadherence|nonadherence
156266|NCT02599259|non-adherence|non-adherence
156267|NCT02599246|Home ventilator|home ventilator
156268|NCT02599246|FiO2|fio2
156269|NCT02599246|O2|o2
156270|NCT02599246|NIV|niv
156271|NCT02599246|COPD|copd
156272|NCT02599233|pain trajectory|pain trajectory
156273|NCT02599181|Perineural cathether|perineural cathether
156274|NCT02599181|Catheter infection|catheter infection
156275|NCT02599168|dexmedetomidine|dexmedetomidine
156276|NCT02599168|propofol|propofol
156277|NCT02599168|BIS|bis
156278|NCT02599168|CLADS|clads
156279|NCT02599155|crystalloid|crystalloid
156280|NCT02599155|colloid|colloid
156281|NCT02599155|children|children
156282|NCT02599155|infant|infant
156283|NCT02599155|cardiac surgery|cardiac surgery
156284|NCT02599142|radiotherapy immobilisation|radiotherapy immobilisation
156285|NCT02599142|open-face shells|open-face shells
156286|NCT02599129|Alopecia areata|alopecia areata
156287|NCT02599116|cytoreductive surgery|cytoreductive surgery
156288|NCT02599116|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
156290|NCT02599090|Glioblastoma|glioblastoma
156291|NCT02599090|Gliosarcoma|gliosarcoma
156292|NCT02599090|Brain Cancer|brain cancer
156293|NCT02599090|Sorafenib|sorafenib
156294|NCT02599090|Temozolomide|temozolomide
156295|NCT02599090|Radiation|radiation
156296|NCT02599090|Radiotherapy|radiotherapy
156297|NCT02599090|XRT|xrt
156298|NCT02599077|oral contraceptives|oral contraceptives
156299|NCT02599077|endometrioma|endometrioma
156300|NCT02599077|dienogest|dienogest
156301|NCT02599064|Age-related macular degeneration|age-related macular degeneration
156302|NCT02599064|RXI-109|rxi-109
156303|NCT02599064|NVAMD|nvamd
156304|NCT02599064|Retinal scarring|retinal scarring
156305|NCT02599064|Subretinal scarring|subretinal scarring
156306|NCT02599064|Retinal fibrosis|retinal fibrosis
156307|NCT02599064|Subretinal fibrosis|subretinal fibrosis
156308|NCT02599064|Eye diseases|eye diseases
156309|NCT02599038|NAFLD|nafld
156310|NCT02599038|NASH|nash
156311|NCT02599038|Serine|serine
156312|NCT02599038|Glutathione|glutathione
156313|NCT02599025|Cerebral palsy|cerebral palsy
156314|NCT02599025|passive cycling|passive cycling
156315|NCT02599025|autonomic control system|autonomic control system
156316|NCT02598986|glycemic index, pita bread, phosphorus, potassium, magnesium|glycemic index, pita bread, phosphorus, potassium, magnesium
156317|NCT02598973|Parkinson Disease|parkinson disease
156318|NCT02598973|exercise|exercise
156319|NCT02598947|posterior shoulder tightness|posterior shoulder tightness
156320|NCT02598947|shoulder impingement syndrome|shoulder impingement syndrome
156321|NCT02598947|Glenohumeral joint|glenohumeral joint
156322|NCT02598947|exercise|exercise
156323|NCT02598921|Assisted reproductive technology|assisted reproductive technology
156324|NCT02598882|Elderly|elderly
156325|NCT02598882|Videogame|videogame
156326|NCT02598882|energy expenditure|energy expenditure
156327|NCT02598882|electromyography|electromyography
156328|NCT02598882|rehabilitation|rehabilitation
156329|NCT02598869|Triamcinolone acetonide|triamcinolone acetonide
156330|NCT02598856|Emergency Treatment|emergency treatment
156331|NCT02598856|Morphine Derivates|morphine derivates
156332|NCT02598856|Heroin|heroin
156333|NCT02598856|Antidotes|antidotes
156334|NCT02598856|Administration, Intravenous|administration, intravenous
156335|NCT02598856|Pharmacology|pharmacology
156336|NCT02598856|Naloxone|naloxone
156337|NCT02598856|Healthy volunteers|healthy volunteers
156338|NCT02598856|Administration, intramuscular|administration, intramuscular
156339|NCT02598856|Administration, intranasal|administration, intranasal
156340|NCT02598830|Cachexia|cachexia
156341|NCT02598830|Vitamin D|vitamin d
156342|NCT02598830|Muscle|muscle
156343|NCT02598830|Strength training|strength training
156344|NCT02598804|Physical activity level|physical activity level
156345|NCT02598804|Knee osteoarthritis|knee osteoarthritis
156346|NCT02598804|Randomized controlled trials|randomized controlled trials
156347|NCT02598804|Alternate month design study|alternate month design study
156348|NCT02598804|Self-management|self-management
156349|NCT02598804|Self-care|self-care
156350|NCT02598804|Education and exercise in knee osteoarthritis|education and exercise in knee osteoarthritis
156351|NCT02598804|Education|education
156352|NCT02598804|Non pharmacological treatment|non pharmacological treatment
156353|NCT02598791|incretin hormones|incretin hormones
156354|NCT02598791|GIP|gip
156355|NCT02598791|GLP-1|glp-1
156356|NCT02598765|Glaucoma|glaucoma
156357|NCT02598765|Trabeculectomy|trabeculectomy
156358|NCT02598765|Eye Disease|eye disease
156359|NCT02598765|Intraocular Pressure|intraocular pressure
156360|NCT02598765|Visual Acuity|visual acuity
156361|NCT02598752|functional performance testing|functional performance testing
156362|NCT02598752|exercise fitness testing|exercise fitness testing
156363|NCT02598752|15-274|15-274
156364|NCT02598739|Physical exercise|physical exercise
156365|NCT02598739|Psoriatic arthritis|psoriatic arthritis
156366|NCT02598739|Quality of life|quality of life
156367|NCT02598700|total hip arthroplasty|total hip arthroplasty
156368|NCT02598700|imaging|imaging
156369|NCT02598700|arthritis|arthritis
156370|NCT02598700|surgical technique|surgical technique
156371|NCT02598674|acute kidney injury|acute kidney injury
156372|NCT02598661|Myelodysplastic Syndromes|myelodysplastic syndromes
156373|NCT02598661|Imetelstat|imetelstat
156374|NCT02598648|FXR|fxr
156375|NCT02598648|RIPK3|ripk3
156376|NCT02598648|Neonates|neonates
156377|NCT02598648|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
156378|NCT02598648|Acute Lung Injury|acute lung injury
156379|NCT02598635|Cholecalciferol|cholecalciferol
156380|NCT02598635|peritoneal dialysis|peritoneal dialysis
156381|NCT02598635|FGF23|fgf23
156382|NCT02598635|Calcium|calcium
156383|NCT02598635|Phosphorus|phosphorus
156384|NCT02598609|Adverse event|adverse event
156385|NCT02598609|Neonatal Intensive Care Unit|neonatal intensive care unit
156386|NCT02598609|Catheter-related Bloodstream Infection (CRBSI) nos|catheter-related bloodstream infection (crbsi) nos
156387|NCT02598609|Extravasation injury|extravasation injury
156388|NCT02598609|Medication error|medication error
156484|NCT02597868|breast cancer|breast cancer
156389|NCT02598609|Central venous catheter complication|central venous catheter complication
156390|NCT02598609|Unprogrammed extubation|unprogrammed extubation
156391|NCT02598596|Refractory gout|refractory gout
156392|NCT02598596|Chronic gout|chronic gout
156393|NCT02598583|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
156394|NCT02598583|PNH|pnh
156395|NCT02598583|complement inhibitor|complement inhibitor
156396|NCT02598570|Relapsed Lymphoma|relapsed lymphoma
156397|NCT02598570|Phosphoinositide 3-kinase (PI3K) Inhibitor|phosphoinositide 3-kinase (pi3k) inhibitor
156398|NCT02598570|Duvelisib|duvelisib
156399|NCT02598570|Japanese|japanese
156400|NCT02598570|Refractory Lymphoma|refractory lymphoma
156401|NCT02598518|Integrating Combined Therapies|integrating combined therapies
156402|NCT02598518|Alcohol Use Disorder|alcohol use disorder
156403|NCT02598518|Mental Health Disorder|mental health disorder
156404|NCT02598492|Mechanical Ventilator|mechanical ventilator
156405|NCT02598479|Cancer|cancer
156406|NCT02598479|Insulin Potentiation Low Dose Chemotherapy|insulin potentiation low dose chemotherapy
156407|NCT02598479|IPT|ipt
156408|NCT02598479|IPTLD|iptld
156409|NCT02598479|Nutrition therapy|nutrition therapy
156410|NCT02598427|Breast Cancer|breast cancer
156411|NCT02598427|HER2 Positive|her2 positive
156412|NCT02598427|HER2+|her2+
156413|NCT02598427|Brain Metastases|brain metastases
156414|NCT02598427|Metastatic Breast Cancer|metastatic breast cancer
156415|NCT02598427|Intrathecal Treatment|intrathecal treatment
156416|NCT02598427|Lumbar Puncture|lumbar puncture
156417|NCT02598427|Pertuzumab|pertuzumab
156418|NCT02598427|Trastuzumab|trastuzumab
156419|NCT02598427|Advanced Breast Cancer|advanced breast cancer
156420|NCT02598427|Duke University|duke university
156421|NCT02598414|Colorectal Disease|colorectal disease
156422|NCT02598414|Robotic Surgery|robotic surgery
156423|NCT02598414|Indocyanine Green Fluorescence Imaging|indocyanine green fluorescence imaging
156424|NCT02598414|Anastomotic Leak|anastomotic leak
156425|NCT02598414|Short-term Outcomes|short-term outcomes
156426|NCT02598388|Healthy|healthy
156427|NCT02598388|Vaccine|vaccine
156428|NCT02598388|Ebola viruses|ebola viruses
156429|NCT02598388|Ebola virus disease (EVD)|ebola virus disease (evd)
156430|NCT02598388|Filoviruses|filoviruses
156431|NCT02598388|Hemorrhagic fever|hemorrhagic fever
156432|NCT02598388|Monovalent vaccine|monovalent vaccine
156433|NCT02598388|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
156434|NCT02598388|Modified Vaccinia Virus Ankara - Bavarian Nordic (MVA-BN) Filo-vector|modified vaccinia virus ankara - bavarian nordic (mva-bn) filo-vector
156435|NCT02598388|Safety|safety
156436|NCT02598388|Immunogenicity|immunogenicity
156437|NCT02598375|Early reached target enteral nutrition in PICU feeding intolerance IFABP|early reached target enteral nutrition in picu feeding intolerance ifabp
156438|NCT02598362|ciprofloxacin|ciprofloxacin
156439|NCT02598362|pharmacokinetics|pharmacokinetics
156440|NCT02598362|excretion|excretion
156441|NCT02598362|clearance|clearance
156442|NCT02598362|infant|infant
156443|NCT02598362|children|children
156444|NCT02598362|adolescent|adolescent
156445|NCT02598349|Unresectable|unresectable
156446|NCT02598349|Borderline resectable|borderline resectable
156447|NCT02598336|Structured Light Plethysmography|structured light plethysmography
156448|NCT02598336|Spirometry|spirometry
156449|NCT02598336|Pneumotachograph|pneumotachograph
156450|NCT02598297|Ruxolitinib|ruxolitinib
156451|NCT02598297|INC424|inc424
156452|NCT02598297|early myelofibrosis|early myelofibrosis
156453|NCT02598297|High molecular risk mutations|high molecular risk mutations
156454|NCT02598297|HMR|hmr
156455|NCT02598284|Preventive measures|preventive measures
156456|NCT02598284|Quality Improvement|quality improvement
156457|NCT02598271|Acute Kidney Injury|acute kidney injury
156458|NCT02598271|Cardiac Surgery|cardiac surgery
156459|NCT02598258|Sauna|sauna
156460|NCT02598258|Cold water bath|cold water bath
156461|NCT02598245|urinary incontinence, CESA, VASA, TOT, TVT|urinary incontinence, cesa, vasa, tot, tvt
156462|NCT02598219|Sentinel node|sentinel node
156463|NCT02598206|food effect|food effect
156464|NCT02598206|healthy volunteers|healthy volunteers
156465|NCT02598206|pharmacokinetics|pharmacokinetics
156466|NCT02598206|CCR2i|ccr2i
156467|NCT02598141|Protheses, nails, screws or plates|protheses, nails, screws or plates
156468|NCT02598115|collaborative pharmaceutical care|collaborative pharmaceutical care
156469|NCT02598089|Seasonal Influenza|seasonal influenza
156470|NCT02598089|Trivalent Vaccine|trivalent vaccine
156471|NCT02598089|Inactivated Vaccine|inactivated vaccine
156472|NCT02598050|postoperative health outcomes|postoperative health outcomes
156473|NCT02598050|older surgical patients|older surgical patients
156474|NCT02598037|Obesity|obesity
156475|NCT02598037|Polymorphism|polymorphism
156476|NCT02598037|Hormones|hormones
156477|NCT02597985|Frailty|frailty
156478|NCT02597959|ergonomic risk factors|ergonomic risk factors
156479|NCT02597959|allied health professionals|allied health professionals
156480|NCT02597959|surgical care|surgical care
156481|NCT02597881|natural history|natural history
156482|NCT02597868|therapy|therapy
156483|NCT02597868|Capecitabine|capecitabine
156485|NCT02597842|Postoperative nausea and vomiting|postoperative nausea and vomiting
156486|NCT02597842|TEAS|teas
156487|NCT02597829|Inflammatory Bowel Disease|inflammatory bowel disease
156488|NCT02597829|Mucosal Healing|mucosal healing
156489|NCT02597829|Certolizumab pegol|certolizumab pegol
156490|NCT02597803|Dry Eye Syndrome|dry eye syndrome
156491|NCT02597803|Dry Eye|dry eye
156492|NCT02597803|DES|des
156493|NCT02597790|endothelial function|endothelial function
156494|NCT02597790|cardiovascular risk|cardiovascular risk
156495|NCT02597790|HIV|hiv
156496|NCT02597790|Hepatitis C|hepatitis c
156497|NCT02597790|metabolic disease|metabolic disease
156498|NCT02597790|inflammation|inflammation
156499|NCT02597764|Diaphragmatic breathing (DB)|diaphragmatic breathing (db)
156500|NCT02597764|Bladder and bowel disorders (BBD)|bladder and bowel disorders (bbd)
156501|NCT02597764|Autonomic nervous system (ANS)|autonomic nervous system (ans)
156502|NCT02597764|Heart rate variability (HRV)|heart rate variability (hrv)
156503|NCT02597764|Deep breathing|deep breathing
156504|NCT02597764|Randomized controlled trial (RCT)|randomized controlled trial (rct)
156505|NCT02597751|DCD|dcd
156506|NCT02597751|Neuroimaging|neuroimaging
156507|NCT02597751|Rehabilitation|rehabilitation
156508|NCT02597725|Urodynamics|urodynamics
156509|NCT02597725|Late effects|late effects
156510|NCT02597725|Urinary Incontinence|urinary incontinence
156511|NCT02597712|acid reflux|acid reflux
156512|NCT02597712|intragastric pH|intragastric ph
156513|NCT02597712|gastrin|gastrin
156514|NCT02597712|hypergastrinemia|hypergastrinemia
156515|NCT02597699|Termination of pregnancy|termination of pregnancy
156516|NCT02597699|Feticide|feticide
156517|NCT02597699|Fetal pain|fetal pain
156518|NCT02597699|Remifentanil Ultiva®|remifentanil ultiva®
156519|NCT02597699|Fetal asystole|fetal asystole
156520|NCT02597699|Fetopathologic analysis|fetopathologic analysis
156521|NCT02597660|patellar tendinopathy|patellar tendinopathy
156522|NCT02597660|somatropin|somatropin
156523|NCT02597660|jumper's knee|jumper's knee
156524|NCT02597647|immunology|immunology
156525|NCT02597647|Microbiota|microbiota
156526|NCT02597582|LigaSure|ligasure
156527|NCT02597582|Neck dissection|neck dissection
156528|NCT02597582|Operative duration|operative duration
156529|NCT02597582|Postoperative drainage|postoperative drainage
156530|NCT02597582|Postoperative pain|postoperative pain
156531|NCT02597569|stroke|stroke
156532|NCT02597569|Cognitive Orientation to daily Occupational Performance|cognitive orientation to daily occupational performance
156533|NCT02597569|health services accessibility|health services accessibility
156534|NCT02597569|cognitive impairment|cognitive impairment
156535|NCT02597569|rehabilitation|rehabilitation
156536|NCT02597569|integrated knowledge translation|integrated knowledge translation
156537|NCT02597569|interrupted time series|interrupted time series
156538|NCT02597569|The CO-OP Approach|the co-op approach
156539|NCT02597556|Albendazole|albendazole
156540|NCT02597556|Ancylostoma duodenale|ancylostoma duodenale
156541|NCT02597556|Ascariasis lumbricoides|ascariasis lumbricoides
156542|NCT02597556|Coinfection|coinfection
156543|NCT02597556|Diarrhea|diarrhea
156544|NCT02597556|Helminths|helminths
156545|NCT02597556|Necator americanus|necator americanus
156546|NCT02597556|Microbiota|microbiota
156547|NCT02597556|Trichuris trichiura|trichuris trichiura
156548|NCT02597543|heart transplantation|heart transplantation
156549|NCT02597543|cardiac MRI|cardiac mri
156550|NCT02597543|graft rejection|graft rejection
156551|NCT02597543|nonspecific allograft dysfunction|nonspecific allograft dysfunction
156552|NCT02597543|allograft vasculopathy|allograft vasculopathy
156553|NCT02597530|TEAS|teas
156554|NCT02597530|anesthesia|anesthesia
156555|NCT02597517|gastritis|gastritis
156556|NCT02597517|chromoendoscopy|chromoendoscopy
156557|NCT02597517|magnification|magnification
156558|NCT02597517|Helicobacter pylori|helicobacter pylori
156559|NCT02597517|Atrophic gastritis|atrophic gastritis
156560|NCT02597491|Smoking,|smoking,
156561|NCT02597491|Smoking cessation|smoking cessation
156562|NCT02597491|Sequential, multiple assignment, randomized trials (SMART)|sequential, multiple assignment, randomized trials (smart)
156563|NCT02597491|Lung cancer screening|lung cancer screening
156564|NCT02597478|Advanced Cancers|advanced cancers
156565|NCT02597478|Fentanyl Sublingual Spray|fentanyl sublingual spray
156566|NCT02597478|Fentanyl SL Spray|fentanyl sl spray
156567|NCT02597478|FSS|fss
156568|NCT02597478|Questionnaires|questionnaires
156569|NCT02597478|Surveys|surveys
156570|NCT02597478|Mental Abilities Test|mental abilities test
156571|NCT02597478|Phone Call|phone call
156572|NCT02597478|Shuttle Walk Test|shuttle walk test
156573|NCT02597452|breast lump|breast lump
156574|NCT02597452|breast exam|breast exam
156575|NCT02597452|breast cancer screening|breast cancer screening
156576|NCT02597452|breast lump detection|breast lump detection
156577|NCT02597439|Ultra-high risk|ultra-high risk
156578|NCT02597439|UHR|uhr
156579|NCT02597439|psychosis|psychosis
156580|NCT02597426|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
156581|NCT02597426|Intensity-Modulated Radiotherapy|intensity-modulated radiotherapy
156582|NCT02597426|Post treatment|post treatment
156583|NCT02597374|Electroencephalography|electroencephalography
156585|NCT02597374|Sensorimotor Cortex|sensorimotor cortex
156586|NCT02597374|Unilateral Cerebral Palsy|unilateral cerebral palsy
156587|NCT02597374|Child|child
156588|NCT02597361|Ehlers-Danlos syndrome, vascular type|ehlers-danlos syndrome, vascular type
156589|NCT02597361|Type 2 Angiotensin Receptor Blockers|type 2 angiotensin receptor blockers
156590|NCT02597348|Liver|liver
156591|NCT02597348|Metastasis|metastasis
156592|NCT02597348|Colorectal cancer|colorectal cancer
156593|NCT02597348|Liver transplantation|liver transplantation
156594|NCT02597335|Glioma|glioma
156595|NCT02597335|IDH1/IDH2 mutation|idh1/idh2 mutation
156596|NCT02597335|Spectroscopy MRI|spectroscopy mri
156597|NCT02597335|D-2-hydroxyglutarate|d-2-hydroxyglutarate
156598|NCT02597335|Free circulating DNA|free circulating dna
156599|NCT02597322|Axitinib|axitinib
156600|NCT02597322|T2a Renal tumor|t2a renal tumor
156601|NCT02597322|organ confined tumors|organ confined tumors
156602|NCT02597322|nephron sparing surgery|nephron sparing surgery
156603|NCT02597322|nephron sparing procedure|nephron sparing procedure
156604|NCT02597322|radical nephrectomy|radical nephrectomy
156605|NCT02597283|Bifurcation lesions|bifurcation lesions
156606|NCT02597283|Percutaneous coronary intervention|percutaneous coronary intervention
156607|NCT02597283|Randomized controlled trial|randomized controlled trial
156608|NCT02597270|Hepatitis C virus|hepatitis c virus
156609|NCT02597257|Lidocaine infusion therapy|lidocaine infusion therapy
156610|NCT02597244|Lumbar foraminal stenosis|lumbar foraminal stenosis
156611|NCT02597231|Delirium|delirium
156612|NCT02597231|Melatonin|melatonin
156613|NCT02597218|Hepatectomy|hepatectomy
156614|NCT02597218|Prophylaxis|prophylaxis
156615|NCT02597205|Medical adherence|medical adherence
156616|NCT02597205|Lifestyle modification|lifestyle modification
156617|NCT02597205|Mobile Health|mobile health
156618|NCT02597205|Secondary Prevention|secondary prevention
156619|NCT02597192|gingivitis|gingivitis
156620|NCT02597192|gingival inflammation|gingival inflammation
156621|NCT02597192|probiotics|probiotics
156622|NCT02597192|Bacillus|bacillus
156623|NCT02597075|Colorectal Cancer|colorectal cancer
156624|NCT02597075|Metastatic Colorectal Cancer|metastatic colorectal cancer
156625|NCT02597075|Physical Activity|physical activity
156626|NCT02597075|Quality of life|quality of life
156627|NCT02597036|Advanced, Angiopoietin|advanced, angiopoietin
156628|NCT02596997|Adenovirus Brincidofovir|adenovirus brincidofovir
156629|NCT02596984|Intensive Care Unit|intensive care unit
156630|NCT02596984|Shock|shock
156631|NCT02596984|Antifungal agent|antifungal agent
156632|NCT02596984|Pharmacokinetics|pharmacokinetics
156633|NCT02596984|Sepsis|sepsis
156634|NCT02596932|Intrapartum|intrapartum
156635|NCT02596893|Crohn's Disease|crohn's disease
156636|NCT02596893|GED-0301|ged-0301
156637|NCT02596893|Mongersen|mongersen
156639|NCT02596893|Safety|safety
156640|NCT02596893|Efficacy|efficacy
156641|NCT02596880|Hepatitis C|hepatitis c
156642|NCT02596880|Cirrhosis|cirrhosis
156643|NCT02596880|Sofosbuvir|sofosbuvir
156644|NCT02596880|Daclatasvir|daclatasvir
156645|NCT02596880|Ribavirin|ribavirin
156646|NCT02596867|B adrenergic pathway|b adrenergic pathway
156647|NCT02596867|B Blocker|b blocker
156648|NCT02596841|Lung diffusing capacity|lung diffusing capacity
156649|NCT02596841|Idiopathic Interstitial Pneumonias|idiopathic interstitial pneumonias
156650|NCT02596828|molecular targeted therapy|molecular targeted therapy
156651|NCT02596828|protein kinase inhibitor|protein kinase inhibitor
156652|NCT02596828|mTOR Inhibitor|mtor inhibitor
156653|NCT02596828|cytostatic topoisomerase-I-inhibitor|cytostatic topoisomerase-i-inhibitor
156654|NCT02596828|temozolomide|temozolomide
156655|NCT02596828|irinotecan|irinotecan
156656|NCT02596828|dasatinib|dasatinib
156657|NCT02596828|rapamycin|rapamycin
156658|NCT02596802|Fetoscopic Endoluminal Tracheal Occlusion|fetoscopic endoluminal tracheal occlusion
156659|NCT02596802|Congenital Diaphragmatic Hernia|congenital diaphragmatic hernia
156660|NCT02596763|Off-label prescription|off-label prescription
156661|NCT02596763|Alcoholism|alcoholism
156662|NCT02596763|Pharmacovigilance|pharmacovigilance
156663|NCT02596763|Pharmacoepidemiology|pharmacoepidemiology
156664|NCT02596763|Baclofen|baclofen
156665|NCT02596737|health|health
156666|NCT02596737|work|work
156667|NCT02596737|lifestyle|lifestyle
156668|NCT02596737|behavior|behavior
156669|NCT02596737|management|management
156670|NCT02596737|stress|stress
156671|NCT02596737|physical activity|physical activity
156672|NCT02596737|nutrition|nutrition
156673|NCT02596737|mortality|mortality
156674|NCT02596737|morbidity|morbidity
156675|NCT02596737|public health|public health
156676|NCT02596724|Breast Cancer|breast cancer
156677|NCT02596724|Neoadjuvant therapy for breast cancer|neoadjuvant therapy for breast cancer
156678|NCT02596711|Cancer Prevention|cancer prevention
156679|NCT02596711|Tobacco Use Cessation|tobacco use cessation
156680|NCT02596711|Nicotine Patch|nicotine patch
156681|NCT02596711|NRT|nrt
156682|NCT02596711|Questionnaires|questionnaires
156683|NCT02596711|Surveys|surveys
156684|NCT02596711|Carbon Monoxide Test|carbon monoxide test
156685|NCT02596711|CO|co
156686|NCT02596711|Health Education|health education
156687|NCT02596711|Handouts|handouts
156688|NCT02596711|Pamphlets|pamphlets
156689|NCT02596711|Counseling sessions|counseling sessions
156690|NCT02596698|Mood Disorder|mood disorder
156691|NCT02596672|physical activity|physical activity
156692|NCT02596672|older adults|older adults
156693|NCT02596672|retirement homes|retirement homes
156694|NCT02596672|walking|walking
156695|NCT02596672|feasibility study|feasibility study
156696|NCT02596659|lateral epicondylosis|lateral epicondylosis
156697|NCT02596659|lateral epicondylitis|lateral epicondylitis
156698|NCT02596659|shockwave|shockwave
156699|NCT02596659|sonoelastography|sonoelastography
156700|NCT02596659|tennis elbow|tennis elbow
156701|NCT02596659|pain intensity|pain intensity
156702|NCT02596659|grip strength|grip strength
156703|NCT02596659|upper limb function|upper limb function
156704|NCT02596659|stiffness of common extensor tendon|stiffness of common extensor tendon
156705|NCT02596620|Helicobacter pylori|helicobacter pylori
156706|NCT02596620|Proton pump inhibitor|proton pump inhibitor
156707|NCT02596620|Eradication|eradication
156708|NCT02596607|ischemic stroke, acute phase, thrombolysis, management times|ischemic stroke, acute phase, thrombolysis, management times
156709|NCT02596594|IUGR|iugr
156710|NCT02596594|severe IUGR|severe iugr
156711|NCT02596594|brain sparing|brain sparing
156712|NCT02596594|fetal nutrition|fetal nutrition
156713|NCT02596594|Prolongation|prolongation
156714|NCT02596594|pregnancy|pregnancy
156715|NCT02596594|neonatal outcome|neonatal outcome
156716|NCT02596581|periodontitis|periodontitis
156717|NCT02596581|diabetes mellitus|diabetes mellitus
156718|NCT02596581|chemerin|chemerin
156719|NCT02596581|interleukin-6|interleukin-6
156720|NCT02596503|young adults|young adults
156721|NCT02596503|adolescents|adolescents
156722|NCT02596490|Non-Small Cell Lung Cancer|non-small cell lung cancer
156723|NCT02596490|NSCLC|nsclc
156724|NCT02596490|Couples-based meditation program|couples-based meditation program
156725|NCT02596490|Couples-based cancer-related discussion program|couples-based cancer-related discussion program
156726|NCT02596490|Questionnaires|questionnaires
156727|NCT02596490|Surveys|surveys
156728|NCT02596490|Metastatic lung cancer|metastatic lung cancer
156729|NCT02596490|Quality of life|quality of life
156730|NCT02596490|QOL|qol
156731|NCT02596477|Heart failure|heart failure
156732|NCT02596412|children|children
156733|NCT02596412|botulinum toxin|botulinum toxin
156734|NCT02596412|augmented reality|augmented reality
156735|NCT02596412|Pain|pain
156736|NCT02596399|Healthy volunteers|healthy volunteers
156737|NCT02596399|DSTA4637S|dsta4637s
156738|NCT02596360|Antinociception|antinociception
156739|NCT02596360|Freeze-induced hyperalgesia model|freeze-induced hyperalgesia model
156740|NCT02596360|Dextromethorphan|dextromethorphan
156741|NCT02596360|NMDA-receptors|nmda-receptors
156742|NCT02596360|Pharmacogenetic|pharmacogenetic
156743|NCT02596360|CYP3A4 gene|cyp3a4 gene
156744|NCT02596360|MDR1 gene|mdr1 gene
156745|NCT02596334|HIV-1 infected patient|hiv-1 infected patient
156746|NCT02596334|monotherapy|monotherapy
156747|NCT02596334|dolutegravir|dolutegravir
156748|NCT02596321|House Dust Mite|house dust mite
156749|NCT02596308|Plague vaccine|plague vaccine
156750|NCT02596308|Immunogenicity|immunogenicity
156751|NCT02596308|Safety|safety
156752|NCT02596282|neonatal male circumcision|neonatal male circumcision
156753|NCT02596282|Clinical officers vs Nurse midwives|clinical officers vs nurse midwives
156754|NCT02596282|Rakai, Uganda|rakai, uganda
156755|NCT02596282|acceptability and safety of neonatal male circumcision|acceptability and safety of neonatal male circumcision
156756|NCT02596243|CIN2, CIN2/3, CIN3|cin2, cin2/3, cin3
156757|NCT02596243|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
156758|NCT02596243|High-Risk HPV|high-risk hpv
156759|NCT02596243|HPV infection|hpv infection
156760|NCT02596243|precancer Diseases|precancer diseases
156761|NCT02596243|Double Blind|double blind
156762|NCT02596243|Safety/Efficacy|safety/efficacy
156763|NCT02596217|ABBV-066|abbv-066
156764|NCT02596217|BI 655066|bi 655066
156765|NCT02596217|risankizumab|risankizumab
156766|NCT02596165|validation|validation
156767|NCT02596165|pulse wave analysis|pulse wave analysis
156768|NCT02596165|blood pressure monitoring|blood pressure monitoring
156769|NCT02596152|balance|balance
156770|NCT02596152|strength|strength
156771|NCT02596152|barriers towards exercise|barriers towards exercise
156772|NCT02596152|quality of life|quality of life
156773|NCT02596152|body dissatisfaction|body dissatisfaction
156774|NCT02596152|executive functions|executive functions
156775|NCT02596152|eating behavior|eating behavior
156776|NCT02596152|fitness|fitness
156777|NCT02596126|Polypill|polypill
156778|NCT02596126|Prevention of Secondary Cardiovascular Disease|prevention of secondary cardiovascular disease
156779|NCT02596126|Cardiovascular Disease|cardiovascular disease
156780|NCT02596126|Myocardial Infarction|myocardial infarction
156781|NCT02596126|Cardiovascular Combination Polypill AAR|cardiovascular combination polypill aar
156782|NCT02596126|Cardiovascular Disease in the Elderly|cardiovascular disease in the elderly
156783|NCT02596126|Adherence|adherence
156784|NCT02596126|SECURE|secure
156785|NCT02596126|Elderly|elderly
156786|NCT02596126|Secondary Cardiovascular Disease|secondary cardiovascular disease
156787|NCT02596126|Secondary Cardiovascular Prevention|secondary cardiovascular prevention
156788|NCT02596126|Randomized Cardiovascular Trial|randomized cardiovascular trial
156789|NCT02596126|Randomized Trial|randomized trial
156790|NCT02596126|Cardiovascular Polypill|cardiovascular polypill
156791|NCT02596113|colorectal cancer|colorectal cancer
156792|NCT02596113|genes involved in carcinogenesis of the colon|genes involved in carcinogenesis of the colon
156793|NCT02596113|screening colorectal cancer|screening colorectal cancer
156794|NCT02596100|Bioequivalence|bioequivalence
156795|NCT02596009|COPD|copd
156796|NCT02595983|FAP|fap
156797|NCT02595983|Familial Amyloidotic Polyneuropathy|familial amyloidotic polyneuropathy
156798|NCT02595983|ATTR Amyloidosis|attr amyloidosis
156799|NCT02595983|Orthotopic Liver Transplant|orthotopic liver transplant
156800|NCT02595983|RNAi therapeutic|rnai therapeutic
156801|NCT02595970|Psoriasis|psoriasis
156802|NCT02595970|Secukinumab|secukinumab
156803|NCT02595970|Simplified Psoriasis Index|simplified psoriasis index
156804|NCT02595970|CAIN457A|cain457a
156805|NCT02595970|AIN457AFR01|ain457afr01
156806|NCT02595970|AIN457A|ain457a
156807|NCT02595957|Exome Sequencing|exome sequencing
156808|NCT02595957|Incidental or Secondary Findings|incidental or secondary findings
156809|NCT02595853|Upper GastroIntestinal bleeding, endoscopy, Hemospray|upper gastrointestinal bleeding, endoscopy, hemospray
156810|NCT02595827|Pediatrics|pediatrics
156811|NCT02595827|Epidemiology|epidemiology
156812|NCT02595827|Fever|fever
156813|NCT02595827|Democratic Republic of the Congo|democratic republic of the congo
156814|NCT02595827|Randomized Controlled Trial|randomized controlled trial
156815|NCT02595814|Registry|registry
156816|NCT02595814|Heart failure|heart failure
156817|NCT02595814|Hospitalized|hospitalized
156818|NCT02595814|Global|global
156819|NCT02595814|Morbidity|morbidity
156820|NCT02595814|Mortality|mortality
156821|NCT02595814|Quality of life|quality of life
156822|NCT02595814|AHF|ahf
156823|NCT02595775|endoscopy measures|endoscopy measures
156824|NCT02595775|audit and feedback|audit and feedback
156825|NCT02595775|quality improvement|quality improvement
156826|NCT02595775|randomized controlled trial|randomized controlled trial
156827|NCT02595775|Colonoscopy|colonoscopy
157072|NCT02594267|PTCL|ptcl
156828|NCT02595710|Cryptogenic Chronic Hepatitis|cryptogenic chronic hepatitis
156829|NCT02595710|Bartonellosis|bartonellosis
156830|NCT02595684|Obesity|obesity
156831|NCT02595684|Tadalfil|tadalfil
156832|NCT02595684|Insulin secretion|insulin secretion
156833|NCT02595684|Insulin sensitivity|insulin sensitivity
156834|NCT02595671|Digital coaching|digital coaching
156835|NCT02595671|Sustainable weight loss|sustainable weight loss
156836|NCT02595671|Self-determination theory|self-determination theory
156837|NCT02595671|Obesity|obesity
156838|NCT02595671|Overweight|overweight
156839|NCT02595671|Diet|diet
156840|NCT02595671|Physical activity|physical activity
156841|NCT02595645|colorectal adenoma|colorectal adenoma
156842|NCT02595645|colorectal cancer|colorectal cancer
156843|NCT02595645|next generation sequencing|next generation sequencing
156844|NCT02595645|liquid biopsy|liquid biopsy
156845|NCT02595645|screening colonoscopy|screening colonoscopy
156846|NCT02595645|surveillance strategies|surveillance strategies
156848|NCT02595619|Extracorporeal Carbon Dioxide Removal|extracorporeal carbon dioxide removal
156849|NCT02595619|Renal Replacement Therapy|renal replacement therapy
156850|NCT02595619|Mechanical Ventilation|mechanical ventilation
156851|NCT02595606|dry eye syndromes|dry eye syndromes
156852|NCT02595606|diabetes mellitus|diabetes mellitus
156853|NCT02595593|Trauma|trauma
156854|NCT02595593|Rib Plate|rib plate
156855|NCT02595593|Rib Fixation|rib fixation
156856|NCT02595580|Blood Glucose Self-Monitoring|blood glucose self-monitoring
156857|NCT02595567|Liver disease|liver disease
156858|NCT02595567|Pleural effusion|pleural effusion
156859|NCT02595554|Cervical cancer, Stage IIB, Neoadjuvant chemotherapy|cervical cancer, stage iib, neoadjuvant chemotherapy
156860|NCT02595541|pediatric|pediatric
156861|NCT02595541|cardiac|cardiac
156862|NCT02595541|sildenfil|sildenfil
156863|NCT02595541|milrinone|milrinone
156864|NCT02595541|pulmonary hypertension|pulmonary hypertension
156865|NCT02595489|Leukodystrophy|leukodystrophy
156866|NCT02595489|ABCD1|abcd1
156867|NCT02595489|Demyelination|demyelination
156868|NCT02595489|Inflammation|inflammation
156869|NCT02595489|ALD|ald
156870|NCT02595489|Vitamin D|vitamin d
156871|NCT02595489|Oxidative Stress|oxidative stress
156872|NCT02595489|X- linked|x- linked
156873|NCT02595489|Adrenoleukodystrophy|adrenoleukodystrophy
156874|NCT02595476|analgesia|analgesia
156875|NCT02595476|pupillometry|pupillometry
156876|NCT02595476|general anesthesia|general anesthesia
156877|NCT02595450|Non-small cell lung cancer|non-small cell lung cancer
156878|NCT02595437|dialysis|dialysis
156879|NCT02595437|pediatric|pediatric
156880|NCT02595437|chronic kidney disease|chronic kidney disease
156881|NCT02595411|Children|children
156882|NCT02595411|Rehabilitation|rehabilitation
156883|NCT02595411|Upper Limb|upper limb
156884|NCT02595411|Assessments|assessments
156885|NCT02595411|Outcome Measures|outcome measures
156886|NCT02595398|Uveitis|uveitis
156887|NCT02595398|UME|ume
156888|NCT02595398|Posterior Uveitis|posterior uveitis
156889|NCT02595398|Anterior Uveitis|anterior uveitis
156890|NCT02595398|Intermediate Uveitis|intermediate uveitis
156891|NCT02595398|Panuveitis|panuveitis
156892|NCT02595398|Non-infectious Uveitis|non-infectious uveitis
156893|NCT02595398|Triamcinolone|triamcinolone
156894|NCT02595398|Choroid|choroid
156895|NCT02595398|Choroidal Injection|choroidal injection
156896|NCT02595398|Suprachoroidal|suprachoroidal
156897|NCT02595398|Microneedle|microneedle
156898|NCT02595398|Microinjection|microinjection
156899|NCT02595359|endophthalmitis|endophthalmitis
156900|NCT02595359|antibiotic therapy|antibiotic therapy
156901|NCT02595359|cataract surgery|cataract surgery
156902|NCT02595359|prevention|prevention
156903|NCT02595333|repeat cesarean section|repeat cesarean section
156904|NCT02595333|pain|pain
156905|NCT02595320|breast, gastrointestinal,capecitabine, cancer, metastatic|breast, gastrointestinal,capecitabine, cancer, metastatic
156906|NCT02595307|Risk Recall|risk recall
156907|NCT02595307|Pamphlet|pamphlet
156908|NCT02595307|Brochure|brochure
156909|NCT02595307|Patient satisfaction|patient satisfaction
156910|NCT02595307|Informed Consent|informed consent
156911|NCT02595281|Ovarian Carcinoma|ovarian carcinoma
156912|NCT02595281|neoadjuvant|neoadjuvant
156913|NCT02595281|ROMA|roma
156914|NCT02595281|Ca125|ca125
156915|NCT02595281|HE4|he4
156916|NCT02595281|biomarker|biomarker
156917|NCT02595268|Healthy|healthy
156918|NCT02595268|Pitavastatin|pitavastatin
156919|NCT02595268|JNJ-63623872|jnj-63623872
156920|NCT02595255|chemotherapy/GnRH analogues/lymphoma/children/fertility|chemotherapy/gnrh analogues/lymphoma/children/fertility
156921|NCT02595203|Bioavailability|bioavailability
156922|NCT02595190|Sacral perineurial cysts(Tarlov Cysts)|sacral perineurial cysts(tarlov cysts)
156923|NCT02595190|Resting state functional magnetic resonance imaging (rfMRI)|resting state functional magnetic resonance imaging (rfmri)
156924|NCT02595190|VAS|vas
156925|NCT02595190|Medicine conservative treatment|medicine conservative treatment
156926|NCT02595190|Surgical treatment|surgical treatment
156927|NCT02595177|multifocal IOL|multifocal iol
156928|NCT02595177|monovision|monovision
156929|NCT02595177|hybrid monovision|hybrid monovision
156930|NCT02595177|spectacles independence|spectacles independence
156931|NCT02595151|Probe-based confocal laser endomicroscopy|probe-based confocal laser endomicroscopy
156932|NCT02595151|chronic atrophic antral gastritis|chronic atrophic antral gastritis
156933|NCT02595151|microcirculatory dynamics|microcirculatory dynamics
156934|NCT02595138|zoledronic acid|zoledronic acid
156935|NCT02595138|triple-negative breast cancer|triple-negative breast cancer
156936|NCT02595138|adjuvant treatment|adjuvant treatment
156937|NCT02595125|intrauterine device|intrauterine device
156938|NCT02595125|contraceptive method|contraceptive method
156939|NCT02595125|direct technique|direct technique
156940|NCT02595125|torpedo technique|torpedo technique
156941|NCT02595125|verbal numeric scale|verbal numeric scale
156942|NCT02595112|staphylococcal infections|staphylococcal infections
156943|NCT02595112|nasal carriage|nasal carriage
156944|NCT02595112|nasal cavity|nasal cavity
156945|NCT02595112|Staphylococcus aureus|staphylococcus aureus
156946|NCT02595060|acute lung injury, molgramostim, GM-CSF, pneumonia, barrier restoration|acute lung injury, molgramostim, gm-csf, pneumonia, barrier restoration
156947|NCT02595047|Self-regeneration, in vivo tissue prefabrication,|self-regeneration, in vivo tissue prefabrication,
156948|NCT02595021|Total or subtotal colectomy|total or subtotal colectomy
156949|NCT02595021|Ovarian cancer|ovarian cancer
156950|NCT02595021|Complications|complications
156951|NCT02595021|One-year disease-free survival|one-year disease-free survival
156952|NCT02595021|Stage IIIc|stage iiic
156953|NCT02595021|Stage IV|stage iv
156954|NCT02594982|Delirium|delirium
156955|NCT02594982|intensive care nursing|intensive care nursing
156956|NCT02594982|Acute acquired brain injury|acute acquired brain injury
156957|NCT02594982|neurointensive care|neurointensive care
156958|NCT02594982|Intensive care delirium screening checklist|intensive care delirium screening checklist
156959|NCT02594982|Confusion Assessment Method for the ICU|confusion assessment method for the icu
156960|NCT02594969|atopic dermatitis|atopic dermatitis
156961|NCT02594956|nasogastric decompression|nasogastric decompression
156962|NCT02594943|Diagnostics|diagnostics
156963|NCT02594943|Biopsy|biopsy
156964|NCT02594943|Diffuse gastric cancer|diffuse gastric cancer
156965|NCT02594930|synovial biopsy|synovial biopsy
156966|NCT02594930|knee arthroplasty|knee arthroplasty
156967|NCT02594930|infection|infection
156968|NCT02594904|G6PD Deficiency|g6pd deficiency
156969|NCT02594904|Neonatal Hyperbilirubinemia|neonatal hyperbilirubinemia
156970|NCT02594904|Yinzhihuang Oral Liquid|yinzhihuang oral liquid
156971|NCT02594904|Indirect Bilirubin|indirect bilirubin
156972|NCT02594891|cholangitis|cholangitis
156973|NCT02594891|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
156974|NCT02594891|complication|complication
156975|NCT02594878|Chronic non-bacterial osteomyelitis|chronic non-bacterial osteomyelitis
156976|NCT02594878|Chronic recurrent multifocal osteomyelitis|chronic recurrent multifocal osteomyelitis
156977|NCT02594878|Non- bacterial osteomyelitis|non- bacterial osteomyelitis
156978|NCT02594878|SAPHO syndrome|sapho syndrome
156979|NCT02594878|Whole body MRI|whole body mri
156980|NCT02594878|Pamidronate|pamidronate
156981|NCT02594878|Inflammatory bone disease|inflammatory bone disease
156982|NCT02594878|Autoinflammatory disease|autoinflammatory disease
156983|NCT02594865|Enteral Nutrition|enteral nutrition
156984|NCT02594865|Continuous Glucose Monitoring|continuous glucose monitoring
156985|NCT02594839|interstitial lung disease|interstitial lung disease
156986|NCT02594839|idiopathic interstitial pneumonia|idiopathic interstitial pneumonia
156987|NCT02594839|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
156988|NCT02594839|stem cells|stem cells
156989|NCT02594800|Atherosclerotic Intracranial Arterial Stenosis|atherosclerotic intracranial arterial stenosis
156990|NCT02594800|Intensive Rosuvastatin Therapy|intensive rosuvastatin therapy
156991|NCT02594800|Computed Tomography Perfusion (CTP)|computed tomography perfusion (ctp)
156992|NCT02594735|Juvenile dermatomyositis|juvenile dermatomyositis
156993|NCT02594735|inflammatory myopathies|inflammatory myopathies
156994|NCT02594735|Orencia|orencia
156995|NCT02594735|Abatacept|abatacept
156996|NCT02594722|COPD|copd
156997|NCT02594722|Functional Electrical Stimulation Cycling|functional electrical stimulation cycling
156998|NCT02594722|Pulmonary Rehabilitation|pulmonary rehabilitation
156999|NCT02594696|Major depression and Cancer|major depression and cancer
157000|NCT02594696|Schizophrenia and Cancer|schizophrenia and cancer
157001|NCT02594696|Bipolar disorder and Cancer|bipolar disorder and cancer
157002|NCT02594696|Lung Cancer|lung cancer
157003|NCT02594696|Breast Cancer|breast cancer
157004|NCT02594696|Head and Neck cancer|head and neck cancer
157005|NCT02594696|GI cancer|gi cancer
157006|NCT02594696|Schizophrenia|schizophrenia
157007|NCT02594696|Bipolar disorder|bipolar disorder
157008|NCT02594670|acupoints|acupoints
157009|NCT02594670|insomnia|insomnia
157010|NCT02594670|acupuncture|acupuncture
157011|NCT02594670|randomized controlled trial|randomized controlled trial
157012|NCT02594657|Eccentric|eccentric
157013|NCT02594657|Ergometer|ergometer
157014|NCT02594657|Pedal rate|pedal rate
157015|NCT02594657|Oxygen consumption|oxygen consumption
157016|NCT02594657|Only health volunteers|only health volunteers
157017|NCT02594631|Urethral stones|urethral stones
157018|NCT02594631|Acute Cacular urinary retention|acute cacular urinary retention
157019|NCT02594631|Extracorporeal Shock Wave Lithotripsy (ESWL)|extracorporeal shock wave lithotripsy (eswl)
157020|NCT02594631|Visual lithotripsy|visual lithotripsy
157021|NCT02594631|bladder stone|bladder stone
157022|NCT02594592|Osteoporosis|osteoporosis
157023|NCT02594592|Osteoporosis Self-Assessment Tool|osteoporosis self-assessment tool
157024|NCT02594592|One-Minute Osteoporosis Risk Test|one-minute osteoporosis risk test
157025|NCT02594592|Asians|asians
157026|NCT02594566|Cytomegalovirus|cytomegalovirus
157027|NCT02594566|Vaccine|vaccine
157028|NCT02594566|Congenital Infection|congenital infection
157029|NCT02594553|Antibiotics|antibiotics
157030|NCT02594553|Children|children
157031|NCT02594553|General Practitioner|general practitioner
157032|NCT02594553|GP|gp
157033|NCT02594553|After-hours care|after-hours care
157034|NCT02594553|Out-of-hours care|out-of-hours care
157035|NCT02594553|Booklet|booklet
157036|NCT02594553|Primary Health Care|primary health care
157037|NCT02594553|Child|child
157038|NCT02594527|Older people|older people
157039|NCT02594527|Physical activity|physical activity
157040|NCT02594527|Hospital|hospital
157041|NCT02594514|cardiovascular risk|cardiovascular risk
157042|NCT02594514|metabolic profile|metabolic profile
157043|NCT02594488|Myocardial infarction|myocardial infarction
157044|NCT02594488|Autonomic nervous system|autonomic nervous system
157045|NCT02594488|Risk stratification|risk stratification
157046|NCT02594488|Implantable cardiac monitor|implantable cardiac monitor
157047|NCT02594488|Sudden cardiac death|sudden cardiac death
157048|NCT02594488|ECG|ecg
157049|NCT02594475|endoscopic retrograde cholangiopancreatography, position|endoscopic retrograde cholangiopancreatography, position
157050|NCT02594462|contraception|contraception
157051|NCT02594462|Anemia, Sickle Cell|anemia, sickle cell
157052|NCT02594449|Pharmacodynamic Study of BCS|pharmacodynamic study of bcs
157053|NCT02594436|Actinic Keratosis|actinic keratosis
157054|NCT02594436|topical|topical
157055|NCT02594436|ingenol mebutate|ingenol mebutate
157056|NCT02594436|Picato®|picato®
157057|NCT02594384|Phase 1|phase 1
157058|NCT02594384|Safety|safety
157059|NCT02594384|Apilimod dimesylate|apilimod dimesylate
157060|NCT02594384|Pharmacokinetics|pharmacokinetics
157061|NCT02594384|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
157062|NCT02594384|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
157063|NCT02594358|Caffeine|caffeine
157064|NCT02594332|eosinophilic asthma|eosinophilic asthma
157065|NCT02594332|mepolizumab|mepolizumab
157066|NCT02594332|treatment|treatment
157067|NCT02594306|drug addiction|drug addiction
157068|NCT02594306|Heroin|heroin
157069|NCT02594306|craving|craving
157070|NCT02594306|event related potential|event related potential
157071|NCT02594306|crystal methamphetamine|crystal methamphetamine
157073|NCT02594267|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
157074|NCT02594267|Folotyn|folotyn
157075|NCT02594267|Pralatrexate|pralatrexate
157076|NCT02594267|CHOP|chop
157077|NCT02594241|Ventral hernia|ventral hernia
157078|NCT02594241|Abdominal wall reconstruction|abdominal wall reconstruction
157079|NCT02594241|Enhanced recovery after surgery|enhanced recovery after surgery
157080|NCT02594241|Steroid|steroid
157081|NCT02594215|Overgrowth|overgrowth
157082|NCT02594202|Specimen Collection|specimen collection
157083|NCT02594202|Carcinogenesis|carcinogenesis
157084|NCT02594202|Prognostic Biomarkers|prognostic biomarkers
157085|NCT02594202|Molecular Mechanims|molecular mechanims
157086|NCT02594202|Cell Lines|cell lines
157087|NCT02594189|Influenza A|influenza a
157088|NCT02594189|H3N2|h3n2
157089|NCT02594189|Challenge Model|challenge model
157090|NCT02594189|Influenza|influenza
157091|NCT02594189|Human Challenge|human challenge
157092|NCT02594176|Osteoarthritis|osteoarthritis
157093|NCT02594176|Pain|pain
157094|NCT02594176|NSAID|nsaid
157095|NCT02594176|Sequessome|sequessome
157096|NCT02594137|Decompressive craniectomy|decompressive craniectomy
157097|NCT02594137|Brain Edema|brain edema
157098|NCT02594124|Spinal Muscular Atrophy|spinal muscular atrophy
157100|NCT02594124|SMN|smn
157101|NCT02594124|SMNRx|smnrx
157102|NCT02594124|ISIS-SMNRx|isis-smnrx
157103|NCT02594124|ISIS-SMN Rx|isis-smn rx
157104|NCT02594124|ISIS 396443|isis 396443
157105|NCT02594124|SHINE|shine
157106|NCT02594124|IONIS-SMNRx|ionis-smnrx
157107|NCT02594124|IONIS-SMN Rx|ionis-smn rx
157108|NCT02594124|Spinraza|spinraza
157109|NCT02594124|nusinersen|nusinersen
157110|NCT02594111|inflammation|inflammation
157111|NCT02594111|percutaneous coronary intervention|percutaneous coronary intervention
157112|NCT02594111|coronary artery disease|coronary artery disease
157113|NCT02594111|colchicine|colchicine
157114|NCT02594098|Atopic dermatitis|atopic dermatitis
157115|NCT02594098|extrinsic atopic dermatitis|extrinsic atopic dermatitis
157116|NCT02594098|intrinsic atopic dermatitis|intrinsic atopic dermatitis
157117|NCT02594059|endothelial function, idiopathic pulmonary fibrosis|endothelial function, idiopathic pulmonary fibrosis
157118|NCT02594020|suspected caries|suspected caries
157119|NCT02594020|initial enamel lesions|initial enamel lesions
157120|NCT02594007|telehealth|telehealth
157121|NCT02594007|heart failure|heart failure
157122|NCT02593994|Onyx|onyx
157123|NCT02593994|drug eluting stent|drug eluting stent
157124|NCT02593994|Routine Clinical Practice|routine clinical practice
157125|NCT02593994|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
157126|NCT02593994|Coronary Artery Disease|coronary artery disease
157127|NCT02593981|sleep|sleep
157128|NCT02593981|fruit|fruit
157129|NCT02593981|honey|honey
157130|NCT02593981|geriatric|geriatric
157131|NCT02593929|squamous cell carcinoma|squamous cell carcinoma
157132|NCT02593929|head and neck cancer|head and neck cancer
157133|NCT02593929|operable|operable
157134|NCT02593903|Antibiotic Prophylaxis|antibiotic prophylaxis
157135|NCT02593890|Breast Cancer|breast cancer
157136|NCT02593890|Breast Surgery|breast surgery
157137|NCT02593890|Mastectomy|mastectomy
157138|NCT02593890|Lumpectomy|lumpectomy
157139|NCT02593890|Post-operative|post-operative
157140|NCT02593890|Bra|bra
157141|NCT02593890|Lingerie|lingerie
157142|NCT02593890|Body Image|body image
157143|NCT02593890|Psycho-social|psycho-social
157144|NCT02593890|Impact|impact
157145|NCT02593877|Trauma|trauma
157146|NCT02593877|Hemostasis|hemostasis
157147|NCT02593877|Resuscitation|resuscitation
157148|NCT02593877|Coagulopathy|coagulopathy
157149|NCT02593877|Transfusion|transfusion
157150|NCT02593851|Respiratory Syncytial Virus Infections|respiratory syncytial virus infections
157151|NCT02593851|JNJ-53718678|jnj-53718678
157152|NCT02593851|Placebo|placebo
157153|NCT02593851|Infants|infants
157154|NCT02593812|Learning|learning
157155|NCT02593812|Practice|practice
157156|NCT02593799|Liver cirrhosis|liver cirrhosis
157157|NCT02593799|Esophageal and Gastric Varices|esophageal and gastric varices
157158|NCT02593799|Endoscopy|endoscopy
157159|NCT02593773|Interferon gamma|interferon gamma
157160|NCT02593747|Allergy|allergy
157161|NCT02593708|HER2+|her2+
157162|NCT02593695|Anorexia Nervosa|anorexia nervosa
157163|NCT02593695|Deep Brain Stimulation|deep brain stimulation
157164|NCT02593695|Nucleus accumbens|nucleus accumbens
157165|NCT02593656|protein ingestion|protein ingestion
157166|NCT02593656|resistance exercise|resistance exercise
157167|NCT02593656|interval exercise|interval exercise
157168|NCT02593656|stretching exercise|stretching exercise
157169|NCT02593656|endurance exercise|endurance exercise
157170|NCT02593643|Major Depressive Disorder|major depressive disorder
157171|NCT02593643|Bipolar Disorder|bipolar disorder
157172|NCT02593643|Depression|depression
157173|NCT02593643|Suicide|suicide
157174|NCT02593643|Suicidal Ideation|suicidal ideation
157175|NCT02593643|Ketamine|ketamine
157176|NCT02593643|Midazolam|midazolam
157177|NCT02593643|Inpatients|inpatients
157178|NCT02593617|Energy Drinks|energy drinks
157179|NCT02593617|Alcohol Drinking|alcohol drinking
157180|NCT02593617|Substance Use|substance use
157181|NCT02593604|Hidradenitis suppurativa|hidradenitis suppurativa
157182|NCT02593604|Wide excision|wide excision
157183|NCT02593604|Quality of Life|quality of life
157184|NCT02593604|Sexual Function|sexual function
157185|NCT02593539|APDS|apds
157186|NCT02593539|Safety|safety
157187|NCT02593539|Pharmacokinetics|pharmacokinetics
157188|NCT02593539|GSK2269557|gsk2269557
157189|NCT02593539|PASLI|pasli
157190|NCT02593513|Embryo Transfer|embryo transfer
157191|NCT02593513|Embryo Selection Criteria for Implantation|embryo selection criteria for implantation
157192|NCT02593513|Assisted Reproductive Technology|assisted reproductive technology
157193|NCT02593500|Bioequivalence, budesonide,|bioequivalence, budesonide,
157194|NCT02593487|Coronary Artery Disease|coronary artery disease
157195|NCT02593487|Hyperlipidemia|hyperlipidemia
157196|NCT02593487|Rosuvastatin|rosuvastatin
157197|NCT02593487|Lipoproteins|lipoproteins
157198|NCT02593487|high-density lipoprotein|high-density lipoprotein
157199|NCT02593487|HDL2|hdl2
157200|NCT02593474|Adolescent|adolescent
157201|NCT02593474|Youth|youth
157202|NCT02593461|Embryo Transfer|embryo transfer
157203|NCT02593461|Embryo Selection Criteria for Implantation|embryo selection criteria for implantation
157204|NCT02593461|Assisted Reproductive Technology|assisted reproductive technology
157205|NCT02593448|Cardiopulmonary Bypass|cardiopulmonary bypass
157206|NCT02593448|Anoxia|anoxia
157207|NCT02593435|BRCA1/2 gene mutation|brca1/2 gene mutation
157208|NCT02593435|Breast Cancer|breast cancer
157209|NCT02593435|Chinese high risk group|chinese high risk group
157210|NCT02593422|ovarian cancer|ovarian cancer
157211|NCT02593422|expressive writing|expressive writing
157212|NCT02593422|writing interventions|writing interventions
157213|NCT02593422|psychosocial support|psychosocial support
157214|NCT02593409|HIV-1|hiv-1
157215|NCT02593409|pre-exposure prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
157216|NCT02593409|immune response|immune response
157217|NCT02593396|sexual dysfunctions|sexual dysfunctions
157218|NCT02593396|erectile dysfunctions|erectile dysfunctions
157219|NCT02593396|hypoactive sexual desire dysfunctions|hypoactive sexual desire dysfunctions
157220|NCT02593383|safety|safety
157221|NCT02593383|efficacy|efficacy
157222|NCT02593370|Hip surgery anesthesia|hip surgery anesthesia
157223|NCT02593370|Perioperative analgesia|perioperative analgesia
157224|NCT02593357|endothelial function|endothelial function
157225|NCT02593357|COPD|copd
157226|NCT02593357|pulmonary function|pulmonary function
157227|NCT02593344|asthma, endothelial function|asthma, endothelial function
157228|NCT02593318|energy metabolism|energy metabolism
157229|NCT02593318|oxaloacetate|oxaloacetate
157230|NCT02593305|nitrate|nitrate
157231|NCT02593305|blood flow|blood flow
157232|NCT02593305|blood pressure|blood pressure
157233|NCT02593305|vascular function|vascular function
157234|NCT02593305|hypoxia|hypoxia
157235|NCT02593292|Clinical pathway|clinical pathway
157236|NCT02593292|Electronic Health Records|electronic health records
157237|NCT02593292|Maternal Health Services & administration|maternal health services & administration
157238|NCT02593292|Patient Access to Records|patient access to records
157239|NCT02593292|Patient Satisfaction|patient satisfaction
157240|NCT02593292|Prenatal Care/methods|prenatal care/methods
157241|NCT02593279|Asthma|asthma
157242|NCT02593279|phenotype|phenotype
157243|NCT02593279|small|small
157244|NCT02593279|airway|airway
157245|NCT02593279|proximal|proximal
157246|NCT02593279|dysfunction|dysfunction
157247|NCT02593266|Prevention|prevention
157248|NCT02593266|Family|family
157249|NCT02593266|Intervention|intervention
157250|NCT02593266|Depression|depression
157251|NCT02593266|Children|children
157252|NCT02593253|Quality Improvement|quality improvement
157253|NCT02593253|Quality Indicators, Health Care|quality indicators, health care
157254|NCT02593253|Hospital Medicine|hospital medicine
157255|NCT02593240|Energy|energy
157256|NCT02593240|Presenteeism|presenteeism
157257|NCT02593240|Absenteeism|absenteeism
157258|NCT02593240|Cardiometabolic health|cardiometabolic health
157259|NCT02593240|Obesity|obesity
157260|NCT02593240|Overweight|overweight
157261|NCT02593240|Weight Loss|weight loss
157262|NCT02593240|Quality of Life|quality of life
157263|NCT02593240|Weight Control|weight control
157264|NCT02593240|Eating Behavior|eating behavior
157265|NCT02593240|Food Cravings|food cravings
157266|NCT02593240|Hunger|hunger
157267|NCT02593240|Worksite Wellness|worksite wellness
157268|NCT02593227|TNBC|tnbc
157269|NCT02593214|Condoms, Female|condoms, female
157270|NCT02593214|Contraception, Barrier|contraception, barrier
157271|NCT02593175|Triple-Negative Breast Cancer|triple-negative breast cancer
157272|NCT02593175|TNBC|tnbc
157273|NCT02593175|Panitumumab|panitumumab
157274|NCT02593175|Vectibix|vectibix
157275|NCT02593175|Paclitaxel|paclitaxel
157276|NCT02593175|Taxol|taxol
157277|NCT02593175|Carboplatin|carboplatin
157278|NCT02593175|Paraplatin|paraplatin
157279|NCT02593175|Biopsy|biopsy
157280|NCT02593175|Fine-needle aspiration|fine-needle aspiration
157281|NCT02593175|FNA|fna
157282|NCT02593136|Vitamins|vitamins
157283|NCT02593136|Public Health|public health
157284|NCT02593136|Nutrition|nutrition
157285|NCT02593123|Donor Type (Matched Related Donor or Matched Unrelated Donor)|donor type (matched related donor or matched unrelated donor)
157286|NCT02593084|Resistance Training|resistance training
157287|NCT02593084|Exercise|exercise
157288|NCT02593084|Walking|walking
157289|NCT02593084|Safety|safety
157290|NCT02593084|Feasibility Studies|feasibility studies
157291|NCT02593058|Anhedonia|anhedonia
157292|NCT02593058|Apathy|apathy
157293|NCT02593058|Negative symptoms|negative symptoms
157294|NCT02593058|Anticipatory pleasure|anticipatory pleasure
157295|NCT02593058|Savoring|savoring
157296|NCT02593032|hemoglobin A1c protein, human > 7.5|hemoglobin a1c protein, human > 7.5
157297|NCT02593006|Joint Diseases|joint diseases
157298|NCT02593006|Juvenile Arthritis|juvenile arthritis
157299|NCT02593006|treatment|treatment
157300|NCT02593006|biologic therapy|biologic therapy
157301|NCT02593006|comparative effectiveness|comparative effectiveness
157302|NCT02592967|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
157303|NCT02592967|JNJ-64041757|jnj-64041757
157304|NCT02592967|Listeria monocytogenes|listeria monocytogenes
157305|NCT02592928|eHealth|ehealth
157306|NCT02592928|Spirometry|spirometry
157307|NCT02592928|Lung Function|lung function
157308|NCT02592928|Primary Care|primary care
157309|NCT02592928|Telehealth|telehealth
157310|NCT02592928|Integrated Care|integrated care
157311|NCT02592902|recurrent respiratory papillomatosis|recurrent respiratory papillomatosis
157312|NCT02592902|extra oesophageal reflux|extra oesophageal reflux
157313|NCT02592902|laryngeal cyst|laryngeal cyst
157314|NCT02592902|phonosurgery|phonosurgery
157315|NCT02592902|oesophageal impedance|oesophageal impedance
157316|NCT02592889|MITRAL REGURGITATION|mitral regurgitation
157317|NCT02592876|Antibodies, Monoclonal|antibodies, monoclonal
157318|NCT02592876|Antibody-Drug Conjugate|antibody-drug conjugate
157319|NCT02592876|Antigens, CD19|antigens, cd19
157320|NCT02592876|Autologous Stem Cell Transplant|autologous stem cell transplant
157321|NCT02592876|Drug Therapy|drug therapy
157322|NCT02592876|Follicular Lymphoma Grade 3b|follicular lymphoma grade 3b
157323|NCT02592876|Hematologic Diseases|hematologic diseases
157324|NCT02592876|Immune System Diseases|immune system diseases
157325|NCT02592876|Immunoproliferative Disorders|immunoproliferative disorders
157326|NCT02592876|Immunotherapy|immunotherapy
157327|NCT02592876|Lymphatic Diseases|lymphatic diseases
157328|NCT02592876|Lymphoma|lymphoma
157329|NCT02592876|Lymphoma, B-Cell|lymphoma, b-cell
157330|NCT02592876|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
157331|NCT02592876|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
157332|NCT02592876|Monomethylauristatin F|monomethylauristatin f
157333|NCT02592876|Neoplasms|neoplasms
157334|NCT02592876|Neoplasms by Histologic Type|neoplasms by histologic type
157335|NCT02592876|Transformed Lymphoma / DLBCL|transformed lymphoma / dlbcl
157336|NCT02592876|Rituximab|rituximab
157337|NCT02592876|Ifosfamide|ifosfamide
157338|NCT02592876|Carboplatin|carboplatin
157339|NCT02592876|Etoposide|etoposide
157340|NCT02592850|Osteopathic manipulative treatment|osteopathic manipulative treatment
157341|NCT02592850|Frequent Episodic Tension-Type Headache|frequent episodic tension-type headache
157342|NCT02592850|Randomized Controlled Trial|randomized controlled trial
157343|NCT02592837|Endobronchial ultrasound|endobronchial ultrasound
157344|NCT02592837|EBUS|ebus
157345|NCT02592837|TBNA|tbna
157346|NCT02592837|Mediastinal ymphadenopathy|mediastinal ymphadenopathy
157347|NCT02592837|Hilar lymphadenopathy|hilar lymphadenopathy
157348|NCT02592837|Lung cancer|lung cancer
157349|NCT02592824|glutamate, heart failure, coronary artery bypass surgery|glutamate, heart failure, coronary artery bypass surgery
157350|NCT02592811|Cholangiopancreatography|cholangiopancreatography
157351|NCT02592811|therapeutic strategy|therapeutic strategy
157352|NCT02592811|Endoscopic Retrograde|endoscopic retrograde
157353|NCT02592772|menthol|menthol
157354|NCT02592772|nicotine|nicotine
157355|NCT02592772|reduced nicotine|reduced nicotine
157356|NCT02592772|smoking|smoking
157357|NCT02592772|cigarette|cigarette
157358|NCT02592772|cigarettes|cigarettes
157359|NCT02592772|men smoking|men smoking
157360|NCT02592772|smoking research|smoking research
157361|NCT02592772|nicotine dependence|nicotine dependence
157362|NCT02592720|Acute Coronary Syndromes|acute coronary syndromes
157363|NCT02592720|Fractional Flow Reserve|fractional flow reserve
157364|NCT02592720|Percutaneous Coronary Intervention|percutaneous coronary intervention
157365|NCT02592681|menstrual migraine|menstrual migraine
157366|NCT02592681|acupuncture|acupuncture
157367|NCT02592681|acupressure|acupressure
157368|NCT02592655|tourniquet|tourniquet
157369|NCT02592655|arterial|arterial
157370|NCT02592655|pre-hospital|pre-hospital
157371|NCT02592655|SOFTT-W|softt-w
157372|NCT02592655|Battle Wrap|battle wrap
157373|NCT02592655|windlass|windlass
157374|NCT02592655|exsanguination|exsanguination
157375|NCT02592655|hemorrhage|hemorrhage
157376|NCT02592655|amputation|amputation
157377|NCT02592642|lumbar spinal stenosis|lumbar spinal stenosis
157378|NCT02592642|neurogenic claudication|neurogenic claudication
157379|NCT02592642|non-operative|non-operative
157380|NCT02592642|treatment|treatment
157381|NCT02592642|outcomes|outcomes
157382|NCT02592642|clinical trial|clinical trial
157383|NCT02592629|subacromial injection|subacromial injection
157384|NCT02592629|rotator cuff disease|rotator cuff disease
157385|NCT02592629|steroid injection|steroid injection
157386|NCT02592616|Exercise|exercise
157387|NCT02592616|Appetite|appetite
157388|NCT02592616|Energy intake|energy intake
157389|NCT02592603|Serrated lesions|serrated lesions
157390|NCT02592603|Surveillance|surveillance
157391|NCT02592603|Colorectal cancer|colorectal cancer
157392|NCT02592603|Endocuff|endocuff
157393|NCT02592603|Sessile serrated adenoma|sessile serrated adenoma
157394|NCT02592603|Colonoscopy|colonoscopy
157395|NCT02592590|Exercise|exercise
157396|NCT02592590|Physical Activity|physical activity
157397|NCT02592590|Smartphone|smartphone
157398|NCT02592590|Technology|technology
157399|NCT02592577|Previously Treated|previously treated
157400|NCT02592577|Cell Therapy|cell therapy
157401|NCT02592577|T Cell Therapy|t cell therapy
157402|NCT02592577|MAGE-A10|mage-a10
157403|NCT02592577|Immuno-oncology|immuno-oncology
157404|NCT02592577|T Cell Receptor|t cell receptor
157405|NCT02592577|Metastatic|metastatic
157406|NCT02592564|Magnetic Resonance Imaging|magnetic resonance imaging
157407|NCT02592564|Cognitive Behavior Therapy|cognitive behavior therapy
157408|NCT02592564|Telomerase|telomerase
157409|NCT02592564|Telomere Length, Mean Leukocyte|telomere length, mean leukocyte
157410|NCT02592538|Biliary duct carcinoma;|biliary duct carcinoma;
157411|NCT02592538|radiofrequency ablation|radiofrequency ablation
157412|NCT02592538|S-1|s-1
157413|NCT02592512|Hypoxia|hypoxia
157414|NCT02592512|hypercapnia|hypercapnia
157415|NCT02592499|HM III|hm iii
157416|NCT02592499|survival|survival
157417|NCT02592499|LVAD|lvad
157418|NCT02592486|quadrivalent influenza vaccine|quadrivalent influenza vaccine
157419|NCT02592486|23-valent pneumococcal vaccine|23-valent pneumococcal vaccine
157420|NCT02592486|immunogenicity|immunogenicity
157421|NCT02592473|Prostate Artery Embolization (PAE)|prostate artery embolization (pae)
157422|NCT02592473|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
157423|NCT02592473|Lower Urinary Tract Symptoms (LUTS)|lower urinary tract symptoms (luts)
157424|NCT02592473|BPH|bph
157425|NCT02592473|PAE|pae
157426|NCT02592473|LUTS|luts
157427|NCT02592473|Prostatic Artery Embolization|prostatic artery embolization
157428|NCT02592447|CML|cml
157429|NCT02592447|chronic phase CML|chronic phase cml
157430|NCT02592447|leukemia|leukemia
157431|NCT02592434|Arthritis|arthritis
157432|NCT02592434|Pediatric|pediatric
157433|NCT02592434|Tofacitinib|tofacitinib
157434|NCT02592434|Long-term|long-term
157435|NCT02592434|JIA|jia
157436|NCT02592434|polyarticular|polyarticular
157437|NCT02592434|CP-690,550|cp-690,550
157438|NCT02592434|Xeljanz|xeljanz
157439|NCT02592395|pancreatic adenocarcinoma|pancreatic adenocarcinoma
157440|NCT02592395|electrochemotherapy|electrochemotherapy
157441|NCT02592395|electroporation|electroporation
157442|NCT02592395|radiogenomics|radiogenomics
157443|NCT02592395|imaging|imaging
157444|NCT02592395|magnetic resonance spectroscopy|magnetic resonance spectroscopy
157445|NCT02592356|Full-body dual-energy x-ray absorptiometry|full-body dual-energy x-ray absorptiometry
157446|NCT02592356|DXA|dxa
157447|NCT02592356|Body measurement|body measurement
157448|NCT02592356|Weight of participant|weight of participant
157449|NCT02592356|Questionnaires|questionnaires
157450|NCT02592356|Surveys|surveys
157451|NCT02592356|Chemotherapy|chemotherapy
157452|NCT02592356|Advanced Cancers|advanced cancers
157453|NCT02592356|Endocrine Tumor|endocrine tumor
157454|NCT02592343|fecal microbiota transplantation|fecal microbiota transplantation
157455|NCT02592343|lyophilized|lyophilized
157456|NCT02592330|CALEC|calec
157457|NCT02592330|Limbal Stem Cell Deficiency|limbal stem cell deficiency
157458|NCT02592330|LSCD|lscd
157459|NCT02592317|JNJ-56021927|jnj-56021927
157460|NCT02592317|Prostatic Neoplasms, Castration-Resistant|prostatic neoplasms, castration-resistant
157461|NCT02592291|Mobile health|mobile health
157462|NCT02592291|Apps|apps
157463|NCT02592291|Applications|applications
157464|NCT02592291|Smart phone|smart phone
157465|NCT02592291|mHealth|mhealth
157466|NCT02592291|Chronic and Complex Conditions|chronic and complex conditions
157467|NCT02592291|Self-Management|self-management
157468|NCT02592291|Self-Care|self-care
157469|NCT02592278|Dental Caries|dental caries
157470|NCT02592278|Fluoride Varnish|fluoride varnish
157471|NCT02592278|Preschool child|preschool child
157472|NCT02592278|Prevention|prevention
157473|NCT02592239|Functional brain MRI|functional brain mri
157474|NCT02592239|functional dyspepsia|functional dyspepsia
157475|NCT02592239|hedonic response|hedonic response
157476|NCT02592200|Female|female
157477|NCT02592200|Constipation|constipation
157478|NCT02592200|Lactobacillus gasseri DSM 27123|lactobacillus gasseri dsm 27123
157479|NCT02592200|Probiotics|probiotics
157480|NCT02592187|Life-logging|life-logging
157481|NCT02592187|Cognitive Training|cognitive training
157482|NCT02592187|Mild Cognitive Impairment|mild cognitive impairment
157483|NCT02592187|Memory|memory
157484|NCT02592187|Information and communications technology (ICT) in healthcare|information and communications technology (ict) in healthcare
157485|NCT02592187|Portable camera|portable camera
157486|NCT02592135|Acute Cardiac Insufficiency|acute cardiac insufficiency
157487|NCT02592135|Acute Heart Failure|acute heart failure
157488|NCT02592122|Mechanical ventilation|mechanical ventilation
157489|NCT02592122|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
157490|NCT02592122|Airway resistance|airway resistance
157491|NCT02592122|Bronchial dilation test|bronchial dilation test
157492|NCT02592109|Complementary Feeding Recommendation|complementary feeding recommendation
157493|NCT02592109|Linear Programming|linear programming
157494|NCT02592109|Nutritional Status|nutritional status
157495|NCT02592109|Omega-3 Fatty Acids|omega-3 fatty acids
157496|NCT02592109|Malondialdehyde|malondialdehyde
157497|NCT02592109|alpha-Tocopherol|alpha-tocopherol
157498|NCT02592096|safety and bioavailability|safety and bioavailability
157499|NCT02592083|Neoadjuvant Therapy|neoadjuvant therapy
157500|NCT02592083|Cyclin-Dependent Kinase Inhibitor p16|cyclin-dependent kinase inhibitor p16
157501|NCT02592044|pain|pain
157502|NCT02592044|anxiety|anxiety
157503|NCT02592044|Catheterization, Peripheral|catheterization, peripheral
157504|NCT02592005|pollution|pollution
157505|NCT02591979|Sleep Apnea Syndrome|sleep apnea syndrome
157506|NCT02591979|Primary Health Care|primary health care
157507|NCT02591940|cardiovascular modeling|cardiovascular modeling
157508|NCT02591940|aortic coarctation|aortic coarctation
157509|NCT02591940|aortic valve disease|aortic valve disease
157510|NCT02591927|myocardial infarction|myocardial infarction
157511|NCT02591927|glucose-insulin-potassium|glucose-insulin-potassium
157512|NCT02591901|Spinal Cord Injuries|spinal cord injuries
157513|NCT02591901|Multiple Sclerosis|multiple sclerosis
157514|NCT02591901|Transverse Myelitis|transverse myelitis
157515|NCT02591901|Neurogenic Bladder Dysfunction|neurogenic bladder dysfunction
157516|NCT02591901|Feasibility Study|feasibility study
157517|NCT02591901|Urinary Tract Infection|urinary tract infection
157518|NCT02591875|Cardiac Catheter Ablation|cardiac catheter ablation
157519|NCT02591875|Cardiac Arrhythmias|cardiac arrhythmias
157520|NCT02591875|Atrial Flutter|atrial flutter
157521|NCT02591836|LDL‐C|ldl‐c
157522|NCT02591836|Lipid Regulator|lipid regulator
157523|NCT02591797|pain|pain
157524|NCT02591797|Infant Behavior|infant behavior
157525|NCT02591797|Heart rate|heart rate
157526|NCT02591797|Dental Anxiety|dental anxiety
157527|NCT02591784|nimotuzumab esophageal radiotherapy|nimotuzumab esophageal radiotherapy
157528|NCT02591771|Adrenaline|adrenaline
157529|NCT02591771|Extra Corporeal Life Support|extra corporeal life support
157530|NCT02591771|Inotropes|inotropes
157531|NCT02591758|Hexo-Skin|hexo-skin
157532|NCT02591758|Hexoskin|hexoskin
157533|NCT02591758|NOVA-SKIN|nova-skin
157534|NCT02591758|angina|angina
157535|NCT02591758|biometric vest|biometric vest
157536|NCT02591706|Single missing tooth|single missing tooth
157537|NCT02591706|Implants|implants
157538|NCT02591706|Peri-implant bone remodeling|peri-implant bone remodeling
157539|NCT02591706|Bone thickness|bone thickness
157540|NCT02591706|Thickness of soft tissue|thickness of soft tissue
157541|NCT02591693|Family Caregivers|family caregivers
157542|NCT02591693|Occupational Therapy|occupational therapy
157543|NCT02591693|Activities of Daily Living|activities of daily living
157544|NCT02591667|Colorectal cancer|colorectal cancer
157545|NCT02591667|Peritoneal metastasis|peritoneal metastasis
157546|NCT02591667|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
157547|NCT02591667|5-Fluorouracil|5-fluorouracil
157548|NCT02591667|Oxaliplatin|oxaliplatin
157549|NCT02591667|Irinotecan|irinotecan
157550|NCT02591667|Bevacizumab|bevacizumab
157551|NCT02591667|Histopathological response|histopathological response
157552|NCT02591654|FLT|flt
157553|NCT02591654|Pembrolizumab|pembrolizumab
157554|NCT02591654|Metastatic Melanoma|metastatic melanoma
157555|NCT02591654|MK-3475|mk-3475
157556|NCT02591641|pre-hospital transport|pre-hospital transport
157557|NCT02591641|shear force|shear force
157558|NCT02591641|tissue interface pressure|tissue interface pressure
157559|NCT02591628|Hypertension|hypertension
157560|NCT02591628|Thiazide diuretics|thiazide diuretics
157561|NCT02591589|Hyperoxia|hyperoxia
157562|NCT02591589|Delirium|delirium
157563|NCT02591589|Normoxic|normoxic
157564|NCT02591589|t-MoCA|t-moca
157565|NCT02591576|Diabetes|diabetes
157566|NCT02591576|ST-elevation myocardial infarction (STEMI)|st-elevation myocardial infarction (stemi)
157567|NCT02591576|non-STEMI|non-stemi
157568|NCT02591576|Excess mortality|excess mortality
157569|NCT02591576|Relative survival|relative survival
157570|NCT02591550|chronic cough|chronic cough
157571|NCT02591550|cough reflex sensitivity|cough reflex sensitivity
157572|NCT02591550|transient receptor potential vanilloid 1|transient receptor potential vanilloid 1
157573|NCT02591550|transient receptor potential ankyrin 1|transient receptor potential ankyrin 1
157574|NCT02591498|cognitive training|cognitive training
157575|NCT02591485|PTSD prevention|ptsd prevention
157576|NCT02591485|Acute stress disorder|acute stress disorder
157577|NCT02591485|Attention training|attention training
157578|NCT02591485|Cognitive bias modification|cognitive bias modification
157579|NCT02591459|Autism|autism
157580|NCT02591446|TMS|tms
157581|NCT02591446|Autism Spectrum Disorders|autism spectrum disorders
157582|NCT02591446|Plasticity|plasticity
157583|NCT02591407|Continuous Epidural Analgesia|continuous epidural analgesia
157584|NCT02591407|Transversus Abdominis Plane block|transversus abdominis plane block
157585|NCT02591381|urinary stress incontinence|urinary stress incontinence
157586|NCT02591355|Platelet Rich Plasma|platelet rich plasma
157587|NCT02591355|Hair Loss|hair loss
157588|NCT02591342|femoral neck fracture|femoral neck fracture
157589|NCT02591342|hip arthroplasty|hip arthroplasty
157590|NCT02591342|complication|complication
157591|NCT02591342|periprosthetic femoral fracture|periprosthetic femoral fracture
157592|NCT02591316|nutrition|nutrition
157593|NCT02591316|physical activity|physical activity
157594|NCT02591316|breast cancer survivor|breast cancer survivor
157595|NCT02591316|cognition|cognition
157596|NCT02591303|Insomnia|insomnia
157597|NCT02591303|Stress|stress
157598|NCT02591303|Real-life stressful events|real-life stressful events
157599|NCT02591290|Meningitis|meningitis
157600|NCT02591290|Meningococcal Meningitis|meningococcal meningitis
157601|NCT02591290|Meningococcal Infections|meningococcal infections
157602|NCT02591290|Menactra®|menactra®
157603|NCT02591290|Meningococcal Vaccine|meningococcal vaccine
157604|NCT02591277|Hepatitis C virus|hepatitis c virus
157605|NCT02591277|observational|observational
157606|NCT02591277|post-marketing|post-marketing
157607|NCT02591277|ledipasvir/sofosbuvir|ledipasvir/sofosbuvir
157608|NCT02591277|Japan|japan
157609|NCT02591238|smoking|smoking
157610|NCT02591238|melatonin|melatonin
157611|NCT02591238|vascular injury|vascular injury
157612|NCT02591225|left atrial thrombus size|left atrial thrombus size
157613|NCT02591225|transesophageale echocardiography|transesophageale echocardiography
157614|NCT02591225|silent cerebral embolism|silent cerebral embolism
157615|NCT02591212|Bystanding behaviors|bystanding behaviors
157616|NCT02591212|Campus|campus
157617|NCT02591212|Prevention|prevention
157618|NCT02591212|Sexual Assault|sexual assault
157619|NCT02591212|CampusSave|campussave
157620|NCT02591173|Autonomic|autonomic
157621|NCT02591173|Hypertension|hypertension
157622|NCT02591173|Renin-Angiotensin System|renin-angiotensin system
157623|NCT02591134|weight loss|weight loss
157624|NCT02591134|NNS|nns
157625|NCT02591134|beverages|beverages
157626|NCT02591134|diet|diet
157627|NCT02591134|appetite|appetite
157628|NCT02591134|satiety|satiety
157629|NCT02591134|weight control|weight control
157630|NCT02591108|train of four|train of four
157631|NCT02591108|neuromuscular blockade|neuromuscular blockade
157632|NCT02591108|surgery|surgery
157633|NCT02591069|Vagus nerve stimulation|vagus nerve stimulation
157634|NCT02591069|vegetative state|vegetative state
157635|NCT02591069|minimally conscious state|minimally conscious state
157636|NCT02591069|akinetic mutism|akinetic mutism
157637|NCT02591069|consciousness|consciousness
157638|NCT02591069|connectivity|connectivity
157639|NCT02591043|Pelvic|pelvic
157640|NCT02591043|Treatment Outcome|treatment outcome
157641|NCT02591030|Bile Duct Cancer|bile duct cancer
157642|NCT02591030|phase II/III|phase ii/iii
157643|NCT02591030|Modified folfirinox|modified folfirinox
157644|NCT02591030|Gemcis|gemcis
157645|NCT02591004|Neuroprotection|neuroprotection
157646|NCT02591004|calcium channel blockers|calcium channel blockers
157647|NCT02591004|magnesium sulhate|magnesium sulhate
157648|NCT02591004|Middle cerebral artery doppler|middle cerebral artery doppler
157649|NCT02590978|gallstone pancreatitis|gallstone pancreatitis
157650|NCT02590978|mild acute pancreatitis|mild acute pancreatitis
157651|NCT02590978|adult|adult
157652|NCT02590952|safety, PK|safety, pk
157653|NCT02590926|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
157654|NCT02590913|fructose|fructose
157655|NCT02590913|metabolism|metabolism
157656|NCT02590913|acute|acute
157657|NCT02590900|pharmacokinetics|pharmacokinetics
157658|NCT02590900|pregnancy|pregnancy
157659|NCT02590900|oral contraceptives|oral contraceptives
157660|NCT02590900|oestradiol|oestradiol
157661|NCT02590874|Mild Cognitive Impairment|mild cognitive impairment
157662|NCT02590874|Cognition|cognition
157663|NCT02590874|Memory|memory
157664|NCT02590874|Depression|depression
157665|NCT02590874|Depressive disorder|depressive disorder
157666|NCT02590874|Antidepressive agents|antidepressive agents
157667|NCT02590874|Duloxetine|duloxetine
157668|NCT02590874|Cymbalta|cymbalta
157669|NCT02590874|Selective serotonin and norepinephrine uptake inhibitors|selective serotonin and norepinephrine uptake inhibitors
157670|NCT02590861|Partial Dentures|partial dentures
157671|NCT02590861|Dental Implants|dental implants
157672|NCT02590861|Quality of Life|quality of life
157673|NCT02590861|Partial Edentulism|partial edentulism
157674|NCT02590848|Walnut intake|walnut intake
157675|NCT02590848|Brain development|brain development
157676|NCT02590848|Nutritional intervention|nutritional intervention
157677|NCT02590848|Healthy adolescents|healthy adolescents
157678|NCT02590835|Adult patients|adult patients
157679|NCT02590835|Patient demand for orthodontic treatment|patient demand for orthodontic treatment
157680|NCT02590822|Diabetes|diabetes
157681|NCT02590822|T2DM|t2dm
157682|NCT02590822|young adults|young adults
157683|NCT02590822|heart|heart
157684|NCT02590822|weight loss|weight loss
157685|NCT02590822|MRI|mri
157686|NCT02590822|exercise|exercise
157687|NCT02590822|diastolic function|diastolic function
157688|NCT02590809|Left ventricular obstruction|left ventricular obstruction
157689|NCT02590796|Delirium|delirium
157690|NCT02590796|Inattention|inattention
157691|NCT02590796|Medical device|medical device
157692|NCT02590796|Software application|software application
157693|NCT02590796|Validation study|validation study
157694|NCT02590796|Diagnosis|diagnosis
157695|NCT02590796|Dementia|dementia
157696|NCT02590783|treatment|treatment
157697|NCT02590757|non-invasive ventilation|non-invasive ventilation
157698|NCT02590757|non-invasive neurally adjusted ventilatory assist|non-invasive neurally adjusted ventilatory assist
157699|NCT02590757|nasal continuous positive airway pressure|nasal continuous positive airway pressure
157700|NCT02590744|Emergence Agitation|emergence agitation
157701|NCT02590744|eye patch|eye patch
157702|NCT02590744|preschool children|preschool children
157703|NCT02590653|STEMI|stemi
157704|NCT02590653|myocardial strain|myocardial strain
157705|NCT02590653|atorvastatin|atorvastatin
157706|NCT02590627|Parasite clearance, Treatment failure|parasite clearance, treatment failure
157707|NCT02590601|PPCM|ppcm
157708|NCT02590601|Bromocriptine|bromocriptine
157709|NCT02590601|Peripartum cardiomyopathy|peripartum cardiomyopathy
157710|NCT02590588|IgM-associated AL amyloidosis|igm-associated al amyloidosis
157711|NCT02590575|extracorporeal CO2 removal|extracorporeal co2 removal
157712|NCT02590575|renal replacement therapy|renal replacement therapy
157713|NCT02590575|Prismalung|prismalung
157714|NCT02590575|ARDS|ards
157715|NCT02590575|hypercapnia|hypercapnia
157716|NCT02590575|Changes in the arterial pCO2 value|changes in the arterial pco2 value
157717|NCT02590575|ventilated|ventilated
157718|NCT02590575|Hypercapnic|hypercapnic
157719|NCT02590549|Keratoconus|keratoconus
157720|NCT02590549|riboflavin|riboflavin
157721|NCT02590549|corneal collagen crosslinking|corneal collagen crosslinking
157722|NCT02590549|intrasromal ring|intrasromal ring
157723|NCT02590536|Sildenafil|sildenafil
157724|NCT02590536|Fetal growth Restriction|fetal growth restriction
157725|NCT02590536|Umbilical Artery Doppler|umbilical artery doppler
157726|NCT02590510|Intrathecal chemotherapy|intrathecal chemotherapy
157727|NCT02590471|Angioplasty with stenting of the superficial femoral artery|angioplasty with stenting of the superficial femoral artery
157728|NCT02590471|Fasciotomy in Hunter's channel|fasciotomy in hunter's channel
157729|NCT02590471|Breakage of stent|breakage of stent
157730|NCT02590458|Breast Cancer|breast cancer
157731|NCT02590458|Short Breast MRI Scan|short breast mri scan
157732|NCT02590458|SBMRI|sbmri
157733|NCT02590458|Routine MRI|routine mri
157734|NCT02590458|High risk for breast cancer|high risk for breast cancer
157735|NCT02590458|Screening|screening
157736|NCT02590432|Immunogenicity|immunogenicity
157737|NCT02590432|Irritable Bowel Syndrome with Constipation|irritable bowel syndrome with constipation
157738|NCT02590432|Chronic Idiopathic Constipation|chronic idiopathic constipation
157739|NCT02590432|Linaclotide|linaclotide
157740|NCT02590432|Linzess|linzess
157741|NCT02590406|Morbid Obesity|morbid obesity
157742|NCT02590406|Bariatric Surgery|bariatric surgery
157743|NCT02590406|Pre-Oxygenation|pre-oxygenation
157744|NCT02590406|Anesthesia Induction|anesthesia induction
157745|NCT02590406|Positive pressure ventilation|positive pressure ventilation
157746|NCT02590406|Non hypoxic apnea time|non hypoxic apnea time
157747|NCT02590406|Positive-Pressure Respiration|positive-pressure respiration
157748|NCT02590406|Anesthesia, General|anesthesia, general
157749|NCT02590393|Nicotine addiction|nicotine addiction
157750|NCT02590393|Cigarette smoking|cigarette smoking
157751|NCT02590393|E-cigarettes|e-cigarettes
157752|NCT02590380|Adolescent|adolescent
157753|NCT02590380|paediatric|paediatric
157754|NCT02590380|pediatric|pediatric
157755|NCT02590380|scoliosis|scoliosis
157756|NCT02590380|spine deformity|spine deformity
157757|NCT02590367|oxaliplatin-induced peripheral neuropathy|oxaliplatin-induced peripheral neuropathy
157758|NCT02590367|HD6610 granule|hd6610 granule
157759|NCT02590367|colorectal cancer|colorectal cancer
157760|NCT02590354|Treatment interruption|treatment interruption
157761|NCT02590354|functional cure|functional cure
157762|NCT02590341|myocarditis|myocarditis
157763|NCT02590341|children|children
157764|NCT02590341|adolescents|adolescents
157765|NCT02590341|registry|registry
157766|NCT02590341|multi-center|multi-center
157767|NCT02590341|pediatric|pediatric
157768|NCT02590341|heart failure|heart failure
157769|NCT02590341|inflammatory heart disease|inflammatory heart disease
157770|NCT02590341|inflammatory cardiomyopathy|inflammatory cardiomyopathy
157771|NCT02590328|Neonatal Screening|neonatal screening
157772|NCT02590328|Severe Combined Immunodeficiency|severe combined immunodeficiency
157773|NCT02590328|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
157774|NCT02590328|DNA Repair-Deficiency Disorders|dna repair-deficiency disorders
157775|NCT02590328|T-cell Receptor Excision Circle|t-cell receptor excision circle
157776|NCT02590315|BC|bc
157777|NCT02590302|Clinical pathway|clinical pathway
157778|NCT02590302|Mental Health|mental health
157779|NCT02590302|Emergency Department|emergency department
157780|NCT02590302|Paediatric|paediatric
157781|NCT02590302|Risk assessment|risk assessment
157782|NCT02590302|Service integration|service integration
157783|NCT02590302|Transitions in care|transitions in care
157784|NCT02590302|Implementation|implementation
157785|NCT02590302|Scoring tools|scoring tools
157786|NCT02590302|Clinical Pathway Evaluation|clinical pathway evaluation
157787|NCT02590276|frontotemporal Dementia|frontotemporal dementia
157788|NCT02590276|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
157789|NCT02590276|Biomarkers|biomarkers
157790|NCT02590276|brain Imaging PET|brain imaging pet
157791|NCT02590263|WHO grade III|who grade iii
157792|NCT02590263|WHO grade IV|who grade iv
157793|NCT02590237|Laryngoscopy|laryngoscopy
157794|NCT02590237|Video Laryngoscopy|video laryngoscopy
157795|NCT02590211|experimental study|experimental study
157796|NCT02590211|cognitive mechanisms|cognitive mechanisms
157797|NCT02590211|poker|poker
157798|NCT02590211|cognitive remediation therapy|cognitive remediation therapy
157799|NCT02590133|Refractory Nasopharyngeal Carcinoma, Endostar, 5-Fu|refractory nasopharyngeal carcinoma, endostar, 5-fu
157800|NCT02590081|Normal saline|normal saline
157801|NCT02590081|Destrose 5%|destrose 5%
157802|NCT02590081|Blood pressure|blood pressure
157803|NCT02590081|Interdialytic weight gain|interdialytic weight gain
157804|NCT02590081|thirst level|thirst level
157805|NCT02590081|End Stage Renal Failure|end stage renal failure
157806|NCT02589990|health|health
157807|NCT02589990|muscle strength|muscle strength
157808|NCT02589990|exercise genomics|exercise genomics
157809|NCT02589977|magnetic resonance imaging|magnetic resonance imaging
157810|NCT02589977|positron-emission tomography|positron-emission tomography
157811|NCT02589977|echocardiography|echocardiography
157812|NCT02589977|myocardial blood flow|myocardial blood flow
157813|NCT02589977|energy metabolism|energy metabolism
157814|NCT02589964|probiotics|probiotics
157815|NCT02589964|antibiotic associated diarrhea|antibiotic associated diarrhea
157816|NCT02589964|clostridium difficile|clostridium difficile
157817|NCT02589925|deep brain stimulation|deep brain stimulation
157818|NCT02589925|subthalamic nucleus|subthalamic nucleus
157819|NCT02589925|Nucleus basalis Meynert|nucleus basalis meynert
157820|NCT02589886|Self-help|self-help
157821|NCT02589886|Education|education
157822|NCT02589886|e-Health|e-health
157823|NCT02589873|Lifestyle Intervention|lifestyle intervention
157824|NCT02589873|Workplace|workplace
157825|NCT02589873|Diabetes Prevention|diabetes prevention
157826|NCT02589860|Stem Cell Transplantation|stem cell transplantation
157827|NCT02589847|Clostridium difficile|clostridium difficile
157828|NCT02589847|C diff|c diff
157829|NCT02589847|CDI|cdi
157830|NCT02589847|CDAD|cdad
157831|NCT02589847|Fecal transplant|fecal transplant
157832|NCT02589847|Fecal Microbiota transplant|fecal microbiota transplant
157833|NCT02589847|diarrhea|diarrhea
157834|NCT02589847|FMT|fmt
157835|NCT02589847|microbiota restoration therapy|microbiota restoration therapy
157836|NCT02589847|microbiota suspension|microbiota suspension
157837|NCT02589847|fecal bacteriotherapy|fecal bacteriotherapy
157838|NCT02589847|C diff diarrhea|c diff diarrhea
157839|NCT02589808|pre-operative|pre-operative
157840|NCT02589808|transthoracic echocardiography|transthoracic echocardiography
157841|NCT02589808|handheld|handheld
157842|NCT02589795|safety|safety
157843|NCT02589795|immunogenicity|immunogenicity
157844|NCT02589795|HIV vaccine|hiv vaccine
157845|NCT02589782|bedaquiline|bedaquiline
157846|NCT02589782|Nitroimidazoles|nitroimidazoles
157847|NCT02589782|diarylquinolines|diarylquinolines
157848|NCT02589782|linezolid|linezolid
157849|NCT02589782|clofazimine|clofazimine
157850|NCT02589782|pretomanid|pretomanid
157851|NCT02589782|moxifloxacin|moxifloxacin
157852|NCT02589756|obesity|obesity
157853|NCT02589756|persistent organic pollutants|persistent organic pollutants
157854|NCT02589756|metabolic syndrome|metabolic syndrome
157855|NCT02589743|clinical trial|clinical trial
157856|NCT02589743|pit and fissure sealants|pit and fissure sealants
157857|NCT02589743|tooth eruption|tooth eruption
157858|NCT02589743|retention|retention
157859|NCT02589743|adhesive system|adhesive system
157860|NCT02589743|intermediary layer|intermediary layer
157861|NCT02589730|Smartphone app|smartphone app
157862|NCT02589730|diabetic management|diabetic management
157863|NCT02589730|lifestyle behaviors|lifestyle behaviors
157864|NCT02589730|medication management|medication management
157865|NCT02589678|AIDS|aids
157866|NCT02589678|Immunology|immunology
157867|NCT02589678|Public Health|public health
157868|NCT02589678|Female sex workers|female sex workers
157869|NCT02589678|Single mothers|single mothers
157870|NCT02589665|IL-23 antibody|il-23 antibody
157871|NCT02589652|Pegylated interferon|pegylated interferon
157872|NCT02589652|Entecavir|entecavir
157873|NCT02589600|Bone loss|bone loss
157874|NCT02589600|Frail Geriatric Women|frail geriatric women
157875|NCT02589600|Nursing Home Patients|nursing home patients
157876|NCT02589600|Long-term Care Patients|long-term care patients
157877|NCT02589600|Osteoporosis|osteoporosis
157878|NCT02589600|Osteoporotic Fractures|osteoporotic fractures
157879|NCT02589561|hearing loss|hearing loss
157880|NCT02589561|hearing aids|hearing aids
157881|NCT02589548|Hodgkin Lymphoma|hodgkin lymphoma
157882|NCT02589548|Hodgkin Disease|hodgkin disease
157883|NCT02589509|Event-related potentials|event-related potentials
157884|NCT02589509|Attention|attention
157885|NCT02589509|Cognitive rehabilitation|cognitive rehabilitation
157886|NCT02589509|Independent activities of daily living|independent activities of daily living
157887|NCT02589470|cognitive rehabilitation|cognitive rehabilitation
157888|NCT02589470|memory|memory
157889|NCT02589470|epilepsy|epilepsy
157890|NCT02589457|Chronic Hepatitis B virus, HIV-1 infection|chronic hepatitis b virus, hiv-1 infection
157891|NCT02589457|Healthy Male Volunteer|healthy male volunteer
157892|NCT02589457|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
157893|NCT02589444|Clinical Endocrinology|clinical endocrinology
157894|NCT02589444|Immunology|immunology
157895|NCT02589444|Inflammation|inflammation
157896|NCT02589444|Microbiology|microbiology
157897|NCT02589444|Respiratory Disorders|respiratory disorders
157898|NCT02589444|Vitamins|vitamins
157899|NCT02589431|hypothalamo pituitary adrenal axis|hypothalamo pituitary adrenal axis
157900|NCT02589418|Manual acupuncture|manual acupuncture
157901|NCT02589418|Experimental dental pain|experimental dental pain
157902|NCT02589418|Psychophysics|psychophysics
157903|NCT02589418|Autonomic nervous system|autonomic nervous system
157904|NCT02589418|Subjective pain ratings|subjective pain ratings
157905|NCT02589379|postoperative pancreatic fistula|postoperative pancreatic fistula
157906|NCT02589379|soft and hard pancreas|soft and hard pancreas
157907|NCT02589366|Lymphoseek|lymphoseek
157908|NCT02589366|endometrial cancer|endometrial cancer
157909|NCT02589366|sentinel lymph node|sentinel lymph node
157910|NCT02589366|lymph node dissection|lymph node dissection
157911|NCT02589275|TNX-102 SL|tnx-102 sl
157912|NCT02589275|bedtime|bedtime
157913|NCT02589275|sublingual|sublingual
157914|NCT02589275|3-month|3-month
157915|NCT02589275|long term safety|long term safety
157916|NCT02589275|long term efficacy|long term efficacy
157917|NCT02589275|Fibromyalgia|fibromyalgia
157918|NCT02589236|Cystic Fibrosis|cystic fibrosis
157919|NCT02589236|N91115|n91115
157920|NCT02589236|Cavosonstat|cavosonstat
157921|NCT02589223|multisensory stimulation|multisensory stimulation
157922|NCT02589210|Diabetes Mellitus|diabetes mellitus
157923|NCT02589210|Foot Disease|foot disease
157924|NCT02589210|Foot Ulcer|foot ulcer
157925|NCT02589197|osteoarthritis|osteoarthritis
157926|NCT02589197|correction of functional deformity|correction of functional deformity
157927|NCT02589197|procedures|procedures
157928|NCT02589197|traumatic osteoarthritis|traumatic osteoarthritis
157929|NCT02589197|degenerative osteoarthritis|degenerative osteoarthritis
157930|NCT02589197|total knee arthroplasty|total knee arthroplasty
157931|NCT02589197|Healthy Volunteers|healthy volunteers
157932|NCT02589197|electromyography|electromyography
157933|NCT02589197|Musculoskeletal Diseases|musculoskeletal diseases
157934|NCT02589184|balance, postural|balance, postural
157935|NCT02589184|postural equilibrium|postural equilibrium
157936|NCT02589184|pain scale|pain scale
157937|NCT02589184|range of motion|range of motion
157938|NCT02589145|Blood And Marrow Transplantation|blood and marrow transplantation
157939|NCT02589145|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
157940|NCT02589145|DLBCL|dlbcl
157941|NCT02589145|Busulfan|busulfan
157942|NCT02589145|Busulfex|busulfex
157943|NCT02589145|Myleran|myleran
157944|NCT02589145|Lenalidomide|lenalidomide
157945|NCT02589145|CC-5013|cc-5013
157946|NCT02589145|Revlimid|revlimid
157947|NCT02589145|Vorinostat|vorinostat
157948|NCT02589145|SAHA|saha
157949|NCT02589145|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
157950|NCT02589145|MSK-390|msk-390
157951|NCT02589145|Zolinza|zolinza
157952|NCT02589145|Gemcitabine|gemcitabine
157953|NCT02589145|Gemcitabine Hydrochloride|gemcitabine hydrochloride
157954|NCT02589145|Gemzar|gemzar
157955|NCT02589145|Melphalan|melphalan
157956|NCT02589145|Alkeran|alkeran
157957|NCT02589145|Rituximab|rituximab
157958|NCT02589145|Rituxan|rituxan
157959|NCT02589145|Dexamethasone|dexamethasone
157960|NCT02589145|Decadron|decadron
157961|NCT02589145|Glutamine|glutamine
157962|NCT02589145|Enterex|enterex
157963|NCT02589145|Glutapack-10|glutapack-10
157964|NCT02589145|NutreStore|nutrestore
157965|NCT02589145|Resource|resource
157966|NCT02589145|GlutaSolve|glutasolve
157967|NCT02589145|Sympt-X G.I.|sympt-x g.i.
157968|NCT02589145|Symptx-X|symptx-x
157969|NCT02589145|Pyridoxine|pyridoxine
157970|NCT02589145|Enoxaparin|enoxaparin
157971|NCT02589145|Lovenox Injection|lovenox injection
157972|NCT02589145|Palifermin|palifermin
157973|NCT02589145|Kepivance|kepivance
157974|NCT02589119|cryptoglandular|cryptoglandular
157975|NCT02589119|perianal fistula|perianal fistula
158072|NCT02588508|pain|pain
157976|NCT02589119|cryptoglandular perianal fistulas|cryptoglandular perianal fistulas
157977|NCT02589106|Anisotropic Textile Braces|anisotropic textile braces
157978|NCT02589093|Analgesia|analgesia
157979|NCT02589093|Monitoring|monitoring
157980|NCT02589093|Analgesia Nociception Index|analgesia nociception index
157981|NCT02589093|ANI|ani
157982|NCT02589093|PhysioDoloris|physiodoloris
157983|NCT02589093|Pain|pain
157984|NCT02589041|intraneural sciatic block|intraneural sciatic block
157985|NCT02589028|diabetes mellitus|diabetes mellitus
157986|NCT02589028|incretin hormone|incretin hormone
157987|NCT02589028|glucose level|glucose level
157988|NCT02589028|GLP-1|glp-1
157989|NCT02589028|GIP|gip
157990|NCT02589028|premeal protein|premeal protein
157991|NCT02589015|morbid obesity|morbid obesity
157992|NCT02589015|neck circumference|neck circumference
157993|NCT02589015|difficult mask ventilation|difficult mask ventilation
157994|NCT02589015|difficult laryngoscopy|difficult laryngoscopy
157995|NCT02589002|sucralose|sucralose
157996|NCT02589002|insulin sensitivity|insulin sensitivity
157997|NCT02589002|beta-cell response|beta-cell response
157998|NCT02589002|appetite regulating hormone|appetite regulating hormone
157999|NCT02588976|Activated clotting time|activated clotting time
158000|NCT02588976|Sonoclot|sonoclot
158001|NCT02588963|upper respiratory tract infections|upper respiratory tract infections
158002|NCT02588963|lower respiratory tract infections|lower respiratory tract infections
158003|NCT02588963|health promotion|health promotion
158004|NCT02588963|respiratory physiotherapy|respiratory physiotherapy
158005|NCT02588963|infant|infant
158006|NCT02588937|Entecavir, EntecaBell ODT., Hepatitis B|entecavir, entecabell odt., hepatitis b
158007|NCT02588924|Parkinson Disease|parkinson disease
158008|NCT02588924|ENVIRONMENTAL AND OCCUPATIONAL EXPOSURE TO METALS|environmental and occupational exposure to metals
158009|NCT02588911|Radiofrequency Catheter Ablation|radiofrequency catheter ablation
158010|NCT02588911|Operative Surgical Procedure|operative surgical procedure
158011|NCT02588911|Saphenous Vein|saphenous vein
158012|NCT02588885|physical therapy|physical therapy
158013|NCT02588885|psychotherapy|psychotherapy
158014|NCT02588885|dysfunctional sexual behavior|dysfunctional sexual behavior
158015|NCT02588885|pelvic pain|pelvic pain
158016|NCT02588885|posttraumatic stress|posttraumatic stress
158017|NCT02588885|PTSD|ptsd
158018|NCT02588885|chronic pain|chronic pain
158019|NCT02588872|platelet-rich plasma|platelet-rich plasma
158020|NCT02588872|hyaluronic acid|hyaluronic acid
158021|NCT02588859|T2DM, Diabetes|t2dm, diabetes
158022|NCT02588846|Prostate|prostate
158023|NCT02588846|Radiotherapy|radiotherapy
158024|NCT02588846|IGRT|igrt
158025|NCT02588846|VMAT|vmat
158026|NCT02588846|Image-guided radiation therapy|image-guided radiation therapy
158027|NCT02588846|Volumetric modulated arc therapy|volumetric modulated arc therapy
158028|NCT02588846|Adaptive radiotherapy|adaptive radiotherapy
158029|NCT02588820|HIV|hiv
158030|NCT02588794|sepsis, acute kidney injury , CytoSorb|sepsis, acute kidney injury , cytosorb
158031|NCT02588768|Low-level laser therapy|low-level laser therapy
158032|NCT02588768|Light emitting diodes|light emitting diodes
158033|NCT02588768|Rugby|rugby
158034|NCT02588768|Field test|field test
158035|NCT02588768|Photobiomodulation|photobiomodulation
158036|NCT02588755|Chemoembolization|chemoembolization
158037|NCT02588755|Therapeutic|therapeutic
158038|NCT02588755|Tegafur|tegafur
158039|NCT02588742|elderly ICU patients|elderly icu patients
158040|NCT02588729|Gestational diabetes|gestational diabetes
158041|NCT02588729|app|app
158042|NCT02588729|RCT|rct
158043|NCT02588729|diet|diet
158044|NCT02588729|physical activity|physical activity
158045|NCT02588716|Hepatectomy, Surgical Blood Loss, terlipressin|hepatectomy, surgical blood loss, terlipressin
158046|NCT02588677|Amyotrophic Lateral Sclerosis (ALS) - masitinib|amyotrophic lateral sclerosis (als) - masitinib
158047|NCT02588664|Early Supported Discharge|early supported discharge
158048|NCT02588651|Lymphoma|lymphoma
158049|NCT02588651|Leukemia|leukemia
158050|NCT02588651|Brentuximab Vedotin|brentuximab vedotin
158051|NCT02588638|NGS|ngs
158052|NCT02588638|Quality of life|quality of life
158053|NCT02588638|Diagnosis|diagnosis
158054|NCT02588638|Rare disease|rare disease
158055|NCT02588638|Next-generation sequencing|next-generation sequencing
158056|NCT02588612|Previously Treated|previously treated
158057|NCT02588612|Cell Therapy|cell therapy
158058|NCT02588612|T Cell Therapy|t cell therapy
158059|NCT02588612|NY-ESO-1|ny-eso-1
158060|NCT02588612|Immuno-oncology|immuno-oncology
158061|NCT02588612|T Cell Receptor|t cell receptor
158062|NCT02588586|HIV|hiv
158063|NCT02588586|3BNC117|3bnc117
158064|NCT02588586|Broadly neutralizing antibody|broadly neutralizing antibody
158065|NCT02588560|lymphoma, hepatitis C virus, chemotherapy|lymphoma, hepatitis c virus, chemotherapy
158066|NCT02588547|Shivering|shivering
158067|NCT02588547|Granisetron|granisetron
158068|NCT02588547|Spinal|spinal
158069|NCT02588547|Cesarean section|cesarean section
158070|NCT02588534|etanercept, healthy subject,open-label, randomized, auto-injection, bioequivalence, pharmacokinetic|etanercept, healthy subject,open-label, randomized, auto-injection, bioequivalence, pharmacokinetic
158071|NCT02588508|perineal tear|perineal tear
158073|NCT02588508|pelvic floor|pelvic floor
158074|NCT02588508|Labour|labour
158075|NCT02588495|Ultrasound|ultrasound
158076|NCT02588495|Gastric area|gastric area
158077|NCT02588495|Accuracy|accuracy
158078|NCT02588495|Aspirate|aspirate
158079|NCT02588482|electroencephalography (EEG)|electroencephalography (eeg)
158080|NCT02588482|mismatch negativity (MMN)|mismatch negativity (mmn)
158081|NCT02588469|pediatric obesity|pediatric obesity
158082|NCT02588469|obstructive sleep apnea|obstructive sleep apnea
158083|NCT02588469|physical exercise|physical exercise
158084|NCT02588469|compression socks|compression socks
158085|NCT02588469|rostral fluid shift|rostral fluid shift
158086|NCT02588391|premature birth; executive function; preschool|premature birth; executive function; preschool
158087|NCT02588365|Attention Deficit Hyperactivity Disorder; executive function; preschool|attention deficit hyperactivity disorder; executive function; preschool
158088|NCT02588339|Hematologic disorder|hematologic disorder
158089|NCT02588339|allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
158090|NCT02588326|Bioequivalence|bioequivalence
158091|NCT02588326|Suspension nasal spray|suspension nasal spray
158092|NCT02588326|Mometasone furoate|mometasone furoate
158093|NCT02588326|Pharmacokinetics|pharmacokinetics
158094|NCT02588326|Particle size distribution|particle size distribution
158095|NCT02588274|Chronic prostatitis|chronic prostatitis
158096|NCT02588274|chronic pelvic pain syndrome|chronic pelvic pain syndrome
158097|NCT02588274|acupuncture|acupuncture
158098|NCT02588274|placebo needle|placebo needle
158099|NCT02588274|randomized controlled trial|randomized controlled trial
158100|NCT02588261|erlotinib|erlotinib
158101|NCT02588261|EGFR mutation|egfr mutation
158102|NCT02588261|naquotinib|naquotinib
158103|NCT02588261|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
158104|NCT02588261|ASP8273|asp8273
158105|NCT02588261|gefitinib|gefitinib
158106|NCT02588183|atrial fibrillation|atrial fibrillation
158107|NCT02588183|catheter ablation|catheter ablation
158108|NCT02588183|pulmonary vein|pulmonary vein
158109|NCT02588183|cryoenergy|cryoenergy
158110|NCT02588183|cryoablation|cryoablation
158111|NCT02588183|ArcticFront|arcticfront
158112|NCT02588157|Rapid sequence induction intubation|rapid sequence induction intubation
158113|NCT02588157|McGrath X-Blade|mcgrath x-blade
158114|NCT02588157|Glidescope|glidescope
158115|NCT02588157|Macintosh|macintosh
158116|NCT02588144|Parkinson's disease|parkinson's disease
158117|NCT02588144|freezing of gait|freezing of gait
158118|NCT02588144|deep brain stimulation|deep brain stimulation
158119|NCT02588144|substantia nigra pars reticulata|substantia nigra pars reticulata
158120|NCT02588144|subthalamic nucleus|subthalamic nucleus
158121|NCT02588131|tremelimumab|tremelimumab
158122|NCT02588131|anti-PD-L1 MEDI4736 (Durvalumab)|anti-pd-l1 medi4736 (durvalumab)
158123|NCT02588131|malignant mesothelioma|malignant mesothelioma
158124|NCT02588105|Phase I, open label study; safety and efficacy of AZD0156; ATM inhibitor|phase i, open label study; safety and efficacy of azd0156; atm inhibitor
158125|NCT02588092|Camidanlumab tesirine|camidanlumab tesirine
158126|NCT02588079|Dental Fear|dental fear
158127|NCT02588079|Dental Phobia|dental phobia
158128|NCT02588079|Internet based cognitive behavioral therapy|internet based cognitive behavioral therapy
158129|NCT02588079|specific phobia|specific phobia
158130|NCT02588079|children and adolescents anxiety|children and adolescents anxiety
158131|NCT02588079|Self Efficacy|self efficacy
158132|NCT02588040|Chronic Lateral Epicondylitis|chronic lateral epicondylitis
158133|NCT02588040|Leukocyte- and Platelet-Rich Plasma|leukocyte- and platelet-rich plasma
158134|NCT02588040|Recover-L-PRP|recover-l-prp
158135|NCT02587988|Erectile dysfunction & Hypertension|erectile dysfunction & hypertension
158136|NCT02587949|acute cerebrovascular stroke|acute cerebrovascular stroke
158137|NCT02587936|Chronic|chronic
158138|NCT02587936|Risk prediction model|risk prediction model
158139|NCT02587936|Quality Improvement (QI)|quality improvement (qi)
158140|NCT02587936|Pragmatic trial|pragmatic trial
158141|NCT02587936|Cluster randomization|cluster randomization
158142|NCT02587936|Collaborative care|collaborative care
158143|NCT02587936|clinical informatics|clinical informatics
158144|NCT02587936|Chronic kidney disease|chronic kidney disease
158145|NCT02587936|hypertension|hypertension
158146|NCT02587936|high BP|high bp
158147|NCT02587936|diabetes|diabetes
158148|NCT02587897|Ultrasonography|ultrasonography
158149|NCT02587897|Nerve Conduction Velocity|nerve conduction velocity
158150|NCT02587897|Ergonomics|ergonomics
158151|NCT02587897|Work Related Injury|work related injury
158152|NCT02587897|Cumulative Trauma Disorders|cumulative trauma disorders
158153|NCT02587884|Recurrence|recurrence
158154|NCT02587884|Microvascular Invasion|microvascular invasion
158155|NCT02587884|Aspartate beta-hydroxylase|aspartate beta-hydroxylase
158156|NCT02587858|NBIA|nbia
158157|NCT02587858|PKAN|pkan
158158|NCT02587858|brain iron|brain iron
158159|NCT02587858|Neurodegeneration with Brain Iron Accumulation|neurodegeneration with brain iron accumulation
158160|NCT02587858|Hallervorden Spatz Syndrome|hallervorden spatz syndrome
158161|NCT02587858|Pantothenate Kinase Associated Neurodegeneration|pantothenate kinase associated neurodegeneration
158162|NCT02587858|PLAN|plan
158163|NCT02587858|INAD|inad
159466|NCT02579811|Kidney|kidney
158164|NCT02587858|PLA2G6-associated neurodegeneration|pla2g6-associated neurodegeneration
158165|NCT02587858|BPAN|bpan
158166|NCT02587858|Beta-propeller Protein-associated neurodegenration|beta-propeller protein-associated neurodegenration
158167|NCT02587858|WDR45|wdr45
158168|NCT02587858|PLA2G6|pla2g6
158169|NCT02587845|total hip arthroplasty|total hip arthroplasty
158170|NCT02587845|transexamic acid|transexamic acid
158171|NCT02587832|cpap|cpap
158172|NCT02587832|HHHFNC|hhhfnc
158174|NCT02587832|ELBW|elbw
158175|NCT02587806|RRMS|rrms
158176|NCT02587793|Hepatocellular Carcinoma|hepatocellular carcinoma
158177|NCT02587793|primary culture|primary culture
158178|NCT02587793|fine-needle aspiration|fine-needle aspiration
158179|NCT02587793|cancer-associated fibroblast|cancer-associated fibroblast
158180|NCT02587741|type 2 diabetes mellitus|type 2 diabetes mellitus
158181|NCT02587741|Diabetic Retinopathy|diabetic retinopathy
158182|NCT02587741|glucose fluctuation|glucose fluctuation
158183|NCT02587741|oxidative stress|oxidative stress
158184|NCT02587741|Insulin|insulin
158185|NCT02587741|Oral drugs|oral drugs
158186|NCT02587728|Carpal Tunnel Syndrome|carpal tunnel syndrome
158187|NCT02587728|Amyloidosis|amyloidosis
158188|NCT02587715|RRMS|rrms
158189|NCT02587702|Term Infants|term infants
158190|NCT02587624|atrial fibrillation|atrial fibrillation
158191|NCT02587624|catheter ablation|catheter ablation
158192|NCT02587624|remote magnetic navigation|remote magnetic navigation
158193|NCT02587598|leukemia|leukemia
158194|NCT02587598|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
158195|NCT02587598|myelodysplastic/myeloproliferative neoplasms (MDS/MPN)|myelodysplastic/myeloproliferative neoplasms (mds/mpn)
158196|NCT02587598|myelofibrosis (MF)|myelofibrosis (mf)
158197|NCT02587598|lymphoproliferative disorders|lymphoproliferative disorders
158198|NCT02587598|acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
158199|NCT02587598|lymphomas|lymphomas
158200|NCT02587598|multiple myeloma (MM)|multiple myeloma (mm)
158201|NCT02587598|PIM kinases|pim kinases
158202|NCT02587559|physical therapy|physical therapy
158203|NCT02587546|laryngeal carcinoma|laryngeal carcinoma
158204|NCT02587546|bilateral vocal cord paralysis|bilateral vocal cord paralysis
158205|NCT02587546|laryngotracheal stenosis|laryngotracheal stenosis
158206|NCT02587546|laser treatment|laser treatment
158207|NCT02587546|decannulation|decannulation
158208|NCT02587546|voice|voice
158209|NCT02587546|swallowing|swallowing
158210|NCT02587533|Baroreflex|baroreflex
158211|NCT02587533|Chemoreflex|chemoreflex
158212|NCT02587533|Autonomic nervous system|autonomic nervous system
158213|NCT02587533|Sympathetic activity|sympathetic activity
158214|NCT02587533|Muscle sympathetic nerve activity (MSNA)|muscle sympathetic nerve activity (msna)
158215|NCT02587533|Microneurography|microneurography
158216|NCT02587533|Electrical baroreflex stimulation|electrical baroreflex stimulation
158217|NCT02587533|Resistant hypertension|resistant hypertension
158218|NCT02587533|Device-based therapy|device-based therapy
158219|NCT02587520|Tetanus|tetanus
158220|NCT02587520|Diphtheria|diphtheria
158221|NCT02587520|Pertussis|pertussis
158222|NCT02587520|SP0173|sp0173
158223|NCT02587520|Tdap vaccine|tdap vaccine
158224|NCT02587481|Acute coronary syndrom|acute coronary syndrom
158225|NCT02587481|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
158226|NCT02587481|Myocardial infarction|myocardial infarction
158227|NCT02587481|Blood based biomarkers|blood based biomarkers
158228|NCT02587468|phenolics|phenolics
158229|NCT02587468|absorption|absorption
158230|NCT02587468|fruit & vegetable concentrate|fruit & vegetable concentrate
158231|NCT02587468|Bioavailability of phenolic compounds|bioavailability of phenolic compounds
158232|NCT02587455|Non-small cell carcinoma|non-small cell carcinoma
158233|NCT02587442|Acute Radiation Syndrome|acute radiation syndrome
158234|NCT02587442|ARS|ars
158235|NCT02587442|Amifostine|amifostine
158236|NCT02587442|Radio-protectants|radio-protectants
158237|NCT02587416|Pharmacokinetics|pharmacokinetics
158238|NCT02587416|Lipid Regulator|lipid regulator
158239|NCT02587390|Pharmacokinetics|pharmacokinetics
158240|NCT02587390|Lipid Regulator|lipid regulator
158241|NCT02587364|Pharmacokinetics|pharmacokinetics
158242|NCT02587364|Lipid Regulator|lipid regulator
158243|NCT02587351|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
158244|NCT02587351|COPD|copd
158245|NCT02587351|Exacerbation|exacerbation
158246|NCT02587351|Lung function|lung function
158247|NCT02587351|Cardiac|cardiac
158248|NCT02587351|Cardiovascular|cardiovascular
158249|NCT02587351|Beta blockers|beta blockers
158250|NCT02587351|Metoprolol succinate|metoprolol succinate
158251|NCT02587351|Smoking|smoking
158252|NCT02587338|Subjective Memory Impairment|subjective memory impairment
158253|NCT02587338|tDCS|tdcs
158254|NCT02587338|NIRS|nirs
158255|NCT02587338|Cognitive Training|cognitive training
158256|NCT02587338|Working Memory|working memory
158257|NCT02587286|mHealth|mhealth
158258|NCT02587286|Telemedicine|telemedicine
158259|NCT02587286|Randomized Controlled Trial|randomized controlled trial
158260|NCT02587286|Glucose control|glucose control
158261|NCT02587273|Critical care|critical care
158262|NCT02587273|Intensive Care|intensive care
158263|NCT02587273|Fentanyl|fentanyl
158264|NCT02587273|Pharmacokinetics|pharmacokinetics
158265|NCT02587273|Multiple Organ Failure|multiple organ failure
158266|NCT02587260|P2Y12 inhibitors|p2y12 inhibitors
158267|NCT02587260|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
158268|NCT02587260|Endothelial function|endothelial function
158269|NCT02587260|Adenosine measurement in human subject|adenosine measurement in human subject
158270|NCT02587260|Endopath|endopath
158271|NCT02587234|motor recovery|motor recovery
158272|NCT02587234|chronic|chronic
158273|NCT02587234|human|human
158274|NCT02587234|sensory|sensory
158275|NCT02587234|afferent input|afferent input
158276|NCT02587234|motor training|motor training
158277|NCT02587208|circumcision|circumcision
158278|NCT02587208|plastibell|plastibell
158279|NCT02587208|infants|infants
158280|NCT02587208|open sleeve|open sleeve
158281|NCT02587195|Multiple Sclerosis|multiple sclerosis
158282|NCT02587169|liposarcoma|liposarcoma
158283|NCT02587169|leiomyosarcoma|leiomyosarcoma
158284|NCT02587169|retroperitoneum|retroperitoneum
158285|NCT02587169|chondrosarcoma|chondrosarcoma
158286|NCT02587156|Required dietary protein|required dietary protein
158287|NCT02587156|Amino acid|amino acid
158288|NCT02587156|Splanchnic extraction|splanchnic extraction
158289|NCT02587130|intractable pain|intractable pain
158290|NCT02587130|pressure ulcer|pressure ulcer
158291|NCT02587130|bed sore|bed sore
158292|NCT02587130|palliative medicine|palliative medicine
158293|NCT02587130|ketamine|ketamine
158294|NCT02587130|pain management|pain management
158295|NCT02587117|Antioxidant|antioxidant
158296|NCT02587117|Lycopene|lycopene
158297|NCT02587117|Prednisolone|prednisolone
158298|NCT02587104|Diabetes Mellitus|diabetes mellitus
158299|NCT02587104|Foot Diseases|foot diseases
158300|NCT02587104|Foot Ulcer|foot ulcer
158301|NCT02587078|Haemodynamic stabilization|haemodynamic stabilization
158302|NCT02587052|biopsy-proven acute rejection|biopsy-proven acute rejection
158303|NCT02587052|graft loss|graft loss
158304|NCT02587052|graft survival|graft survival
158305|NCT02587039|delirium|delirium
158306|NCT02587039|heart|heart
158307|NCT02587039|valve|valve
158308|NCT02587039|graft|graft
158309|NCT02587039|surgery|surgery
158310|NCT02587039|coronary|coronary
158311|NCT02587026|Biorepository|biorepository
158312|NCT02587026|Precision Genomics|precision genomics
158313|NCT02587000|adenomyosis|adenomyosis
158314|NCT02587000|ulipristal acetate|ulipristal acetate
158315|NCT02587000|sonography|sonography
158316|NCT02587000|Magnetic resonance imaging [MRI]|magnetic resonance imaging [mri]
158317|NCT02587000|Pictorial Blood-loss Assessment Chart [PBAC]|pictorial blood-loss assessment chart [pbac]
158318|NCT02586987|Selumetinib|selumetinib
158319|NCT02586987|Tremelimumab|tremelimumab
158320|NCT02586987|MEDI4736|medi4736
158321|NCT02586987|Safety|safety
158322|NCT02586987|Tolerability|tolerability
158323|NCT02586987|Pharmacokinetics|pharmacokinetics
158324|NCT02586987|Patients with advanced solid tumours|patients with advanced solid tumours
158325|NCT02586987|Disease progression|disease progression
158326|NCT02586974|CO2 insufflation|co2 insufflation
158327|NCT02586974|robot assisted radical prostatectomy|robot assisted radical prostatectomy
158328|NCT02586974|laparoscopy|laparoscopy
158329|NCT02586974|hypothermia|hypothermia
158330|NCT02586974|cytokine response|cytokine response
158331|NCT02586961|randomized prospective study|randomized prospective study
158332|NCT02586961|complication rate|complication rate
158333|NCT02586961|bronchiolitis|bronchiolitis
158334|NCT02586961|children|children
158335|NCT02586948|extracorporeal CO2 removal|extracorporeal co2 removal
158336|NCT02586935|ASD|asd
158337|NCT02586935|Autism|autism
158338|NCT02586909|Alzheimer's disease|alzheimer's disease
158339|NCT02586909|RVT-101|rvt-101
158340|NCT02586909|donepezil|donepezil
158341|NCT02586883|Dilation of the Bronchi|dilation of the bronchi
158342|NCT02586883|Bronchial potential difference|bronchial potential difference
158343|NCT02586883|Dilation of the Bronchi (DDB)|dilation of the bronchi (ddb)
158344|NCT02586857|Glioblastoma Multiforme|glioblastoma multiforme
158345|NCT02586857|GBM|gbm
158346|NCT02586844|NET|net
158347|NCT02586844|PanNET|pannet
158348|NCT02586844|Molecular profiling|molecular profiling
158349|NCT02586844|Transcriptome sequencing|transcriptome sequencing
158350|NCT02586831|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
158351|NCT02586831|Hypoglycemia|hypoglycemia
158352|NCT02586831|Autoimmune Diseases|autoimmune diseases
158353|NCT02586831|Diabetes Mellitus|diabetes mellitus
158354|NCT02586805|DX-2930|dx-2930
158355|NCT02586805|Hereditary Angioedema|hereditary angioedema
158356|NCT02586805|Dyax|dyax
158357|NCT02586792|H7N7|h7n7
158358|NCT02586792|H7N9|h7n9
158359|NCT02586792|Influenza|influenza
158360|NCT02586792|Intramusclar|intramusclar
158361|NCT02586792|Non-adjuvanted|non-adjuvanted
158362|NCT02586792|Open-Label|open-label
158363|NCT02586792|sub-study|sub-study
158364|NCT02586792|Vaccine|vaccine
158365|NCT02586779|Referral and consultation|referral and consultation
158366|NCT02586779|emergency department|emergency department
158367|NCT02586779|WhatsApp|whatsapp
158368|NCT02586766|Youth Violence|youth violence
158369|NCT02586727|Radiation Retinopathy|radiation retinopathy
158370|NCT02586727|aflibercept|aflibercept
158371|NCT02586688|child depression|child depression
158372|NCT02586688|depression|depression
158373|NCT02586688|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
158374|NCT02586688|Adolescent Major Depressive Disorder|adolescent major depressive disorder
158375|NCT02586688|TMS|tms
158376|NCT02586688|adolescent depression|adolescent depression
158377|NCT02586675|ER+ breast cancer|er+ breast cancer
158378|NCT02586675|PR+ breast cancer|pr+ breast cancer
158379|NCT02586675|hormone receptor positive|hormone receptor positive
158380|NCT02586675|HER2- breast cancer|her2- breast cancer
158381|NCT02586675|HER2 negative|her2 negative
158382|NCT02586675|locally advanced|locally advanced
158383|NCT02586675|metastatic|metastatic
158384|NCT02586662|scapular dyskinesis|scapular dyskinesis
158385|NCT02586662|kinematics|kinematics
158386|NCT02586649|tiotropium bromide|tiotropium bromide
158387|NCT02586636|Metformin|metformin
158388|NCT02586636|OCT1|oct1
158389|NCT02586610|Pembrolizumab|pembrolizumab
158390|NCT02586610|Chemoradiation|chemoradiation
158391|NCT02586610|Anti-PD-1 Antibody|anti-pd-1 antibody
158392|NCT02586610|MK-3475|mk-3475
158393|NCT02586597|Stroke|stroke
158394|NCT02586597|PAS|pas
158395|NCT02586597|TMS|tms
158396|NCT02586597|cortical excitability|cortical excitability
158397|NCT02586597|plasticity|plasticity
158398|NCT02586584|Patient-Reported Outcome, Antiretroviral Therapy|patient-reported outcome, antiretroviral therapy
158399|NCT02586571|Body Composition|body composition
158400|NCT02586571|Breast Feeding|breast feeding
158401|NCT02586571|Growth|growth
158402|NCT02586571|Infant|infant
158403|NCT02586571|Milk, Human|milk, human
158404|NCT02586571|Nutritional Sciences|nutritional sciences
158405|NCT02586571|Weaning|weaning
158406|NCT02586532|Detection|detection
158407|NCT02586532|Cancer|cancer
158408|NCT02586532|Antibody|antibody
158409|NCT02586532|Biopsy|biopsy
158410|NCT02586532|Registry|registry
158411|NCT02586519|wearable technology|wearable technology
158412|NCT02586519|Orpyx|orpyx
158413|NCT02586519|SurroSense Rx|surrosense rx
158414|NCT02586519|smart insole|smart insole
158415|NCT02586519|TCC|tcc
158416|NCT02586519|total contact cast|total contact cast
158417|NCT02586519|insole|insole
158418|NCT02586519|removable cast walker|removable cast walker
158419|NCT02586519|RCW|rcw
158420|NCT02586506|correct use of inhaler|correct use of inhaler
158421|NCT02586506|dose left|dose left
158422|NCT02586506|ease of use|ease of use
158423|NCT02586506|ELLIPTA|ellipta
158424|NCT02586506|Asthma|asthma
158425|NCT02586493|Placebo|placebo
158426|NCT02586493|ELLIPTA inhaler|ellipta inhaler
158427|NCT02586493|Correct use|correct use
158428|NCT02586493|COPD|copd
158429|NCT02586493|Ease of use|ease of use
158430|NCT02586480|bradycardia|bradycardia
158431|NCT02586454|Transmuscular quadratus lumborum block, total abdominal hysterectomy|transmuscular quadratus lumborum block, total abdominal hysterectomy
158432|NCT02586441|Bispectral index (BIS)|bispectral index (bis)
158433|NCT02586441|EEG|eeg
158434|NCT02586441|Depth of anesthesia|depth of anesthesia
158435|NCT02586415|endovascular|endovascular
158436|NCT02586415|endovascular procedure|endovascular procedure
158437|NCT02586415|Mechanical Thrombectomy|mechanical thrombectomy
158438|NCT02586402|ESAs CKD|esas ckd
158439|NCT02586363|Entecavir|entecavir
158440|NCT02586363|Food effect|food effect
158441|NCT02586363|Cavir Tab 0.5mg|cavir tab 0.5mg
158442|NCT02586363|Baraclude Tab. 0.5mg|baraclude tab. 0.5mg
158443|NCT02586285|S-Adenosyl Methionine|s-adenosyl methionine
158444|NCT02586285|Recurrence|recurrence
158445|NCT02586272|Embryo Transfer|embryo transfer
158446|NCT02586272|assisted reproductive technology|assisted reproductive technology
158447|NCT02586246|CDP870|cdp870
158448|NCT02586246|Rheumatoid arthritis|rheumatoid arthritis
158449|NCT02586246|Long-term|long-term
158450|NCT02586233|Acute Ischemic Stroke in the anterior circulation|acute ischemic stroke in the anterior circulation
158451|NCT02586207|Larynx|larynx
158452|NCT02586207|Squamous Cell|squamous cell
158453|NCT02586207|Oral cavity|oral cavity
158454|NCT02586207|Oropharynx|oropharynx
158455|NCT02586207|Hypopharynx|hypopharynx
158456|NCT02586194|Impaired hepatic function|impaired hepatic function
158457|NCT02586194|Pharmacokinetics|pharmacokinetics
158458|NCT02586194|ASP015K|asp015k
158459|NCT02586168|Insulin Resistance|insulin resistance
158460|NCT02586168|Lipid Regulator|lipid regulator
158461|NCT02586142|spasticity|spasticity
158462|NCT02586142|claw toe|claw toe
158463|NCT02586142|ultrasounds guidance|ultrasounds guidance
158464|NCT02586142|botulinum toxin|botulinum toxin
158465|NCT02586142|stretching exercise|stretching exercise
158466|NCT02586090|Pediatric Obesity|pediatric obesity
158467|NCT02586090|Lifestyle Intervention|lifestyle intervention
158468|NCT02586090|Family-based Intervention|family-based intervention
158469|NCT02586090|Motivational Interviewing|motivational interviewing
158470|NCT02586064|posttraumatic stress disorder|posttraumatic stress disorder
158471|NCT02586064|Veterans|veterans
158472|NCT02586064|Psychotherapy|psychotherapy
158473|NCT02586064|Randomized Controlled Trial|randomized controlled trial
158474|NCT02585999|Hormonal contraception, hormone pharmacokinetics|hormonal contraception, hormone pharmacokinetics
158475|NCT02585973|AZD1775|azd1775
158476|NCT02585973|Cisplatin|cisplatin
158477|NCT02585973|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
158478|NCT02585973|HNSCC|hnscc
158479|NCT02585973|Chemoradiotherapy|chemoradiotherapy
158480|NCT02585973|Radiotherapy|radiotherapy
158481|NCT02585973|CRT|crt
158482|NCT02585947|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
158483|NCT02585947|Tenofovir|tenofovir
158484|NCT02585934|Alzheimer's disease|alzheimer's disease
158485|NCT02585934|RVT-101|rvt-101
158486|NCT02585934|donepezil|donepezil
158487|NCT02585934|intepirdine|intepirdine
158488|NCT02585934|dementia|dementia
158489|NCT02585921|Urban Health|urban health
158490|NCT02585895|LDL-C Apheresis|ldl-c apheresis
158491|NCT02585895|Hypercholesterolemia|hypercholesterolemia
158492|NCT02585895|Elevated Cholesterol|elevated cholesterol
158493|NCT02585895|High Cholesterol|high cholesterol
158494|NCT02585895|PCSK9 mutations|pcsk9 mutations
158495|NCT02585895|Severe Familial Hypercholesterolemia|severe familial hypercholesterolemia
158496|NCT02585895|evolocumab|evolocumab
158497|NCT02585895|Repatha|repatha
158498|NCT02585869|Lipid Regulator|lipid regulator
158499|NCT02585869|TG|tg
158500|NCT02585856|Biliary duct carcinoma|biliary duct carcinoma
158501|NCT02585856|Photodynamic therapy|photodynamic therapy
158502|NCT02585843|Heart Failure|heart failure
158503|NCT02585843|Mineralocorticoid receptor antagonists|mineralocorticoid receptor antagonists
158504|NCT02585843|Loop diuretic resistance|loop diuretic resistance
158505|NCT02585817|Cardiac Implantable Electronic Devices|cardiac implantable electronic devices
158506|NCT02585804|FSGS, SGLT2, chronic kidney disease, GFR, proteinuria|fsgs, sglt2, chronic kidney disease, gfr, proteinuria
158507|NCT02585791|electronic cigarette|electronic cigarette
158508|NCT02585791|airway inflammation|airway inflammation
158509|NCT02585791|nasal potential difference|nasal potential difference
158510|NCT02585726|Varicose Veins|varicose veins
158511|NCT02585726|Great Saphenous Vein|great saphenous vein
158512|NCT02585726|Venous Insufficiency|venous insufficiency
158513|NCT02585687|Liver Perfusion MRI, Hepatocellular carcinoma|liver perfusion mri, hepatocellular carcinoma
158514|NCT02585622|Diabetic Kidney Disease|diabetic kidney disease
158515|NCT02585622|Mesenchymal Stromal Cells (MSC)|mesenchymal stromal cells (msc)
158516|NCT02585622|immune response|immune response
158517|NCT02585622|allogeneic|allogeneic
158518|NCT02585622|disease progression|disease progression
158519|NCT02585609|Sleep|sleep
158520|NCT02585583|Deep Brain|deep brain
158521|NCT02585583|Essential tremor|essential tremor
158522|NCT02585583|Parkinson Disease|parkinson disease
158523|NCT02585583|Tremor|tremor
158524|NCT02585583|Radiosurgery|radiosurgery
158525|NCT02585583|Thalamotomy|thalamotomy
158526|NCT02585583|deep brain stimulation|deep brain stimulation
158527|NCT02585583|DBS|dbs
158528|NCT02585583|intractable, drug resistant, invalidating tremor|intractable, drug resistant, invalidating tremor
158529|NCT02585570|shoulder|shoulder
158530|NCT02585570|phenylephrine|phenylephrine
158531|NCT02585570|hypotension|hypotension
158532|NCT02585544|genital prolapse|genital prolapse
158533|NCT02585544|day-care management|day-care management
158534|NCT02585544|vaginal route|vaginal route
158535|NCT02585544|prosthetic reinforcement|prosthetic reinforcement
158536|NCT02585531|Bronchiolitis|bronchiolitis
158537|NCT02585531|Dexamethasone|dexamethasone
158538|NCT02585531|Epinephrine|epinephrine
158539|NCT02585531|Hypertonic saline|hypertonic saline
158540|NCT02585427|Diabetes|diabetes
158541|NCT02585427|Obesity|obesity
158542|NCT02585427|metabolic disorders|metabolic disorders
158543|NCT02585388|pretreated metastatic breast cancer|pretreated metastatic breast cancer
158544|NCT02585362|palliative|palliative
158545|NCT02585336|Sugar-Sweetened beverages|sugar-sweetened beverages
158546|NCT02585336|Metabolic health|metabolic health
158547|NCT02585336|Soft drinks|soft drinks
158548|NCT02585323|Physical activity|physical activity
158549|NCT02585323|Osteoarthritis|osteoarthritis
158550|NCT02585323|Knee|knee
158551|NCT02585323|Exercise|exercise
158552|NCT02585323|Arthritis|arthritis
158553|NCT02585310|PRBC transfusion|prbc transfusion
158554|NCT02585310|CABGs|cabgs
158555|NCT02585245|Hospital Nutrition screens|hospital nutrition screens
158556|NCT02585232|Behavioral sciences|behavioral sciences
158557|NCT02585232|Counseling|counseling
158558|NCT02585232|Intervention Studies|intervention studies
158559|NCT02585232|Cognitive Behavioral Therapy|cognitive behavioral therapy
158560|NCT02585232|Telemedicine|telemedicine
158561|NCT02585232|Mindfulness|mindfulness
158562|NCT02585206|Mobile Phone|mobile phone
158563|NCT02585206|Text Messaging|text messaging
158564|NCT02585206|Internet|internet
158565|NCT02585206|Tobacco Use|tobacco use
158566|NCT02585180|Ventilator-associated pneumonia|ventilator-associated pneumonia
158567|NCT02585180|Surveillance|surveillance
158568|NCT02585180|Subglottic-secretions|subglottic-secretions
158569|NCT02585180|Critically ill patients|critically ill patients
158570|NCT02585180|Prevention|prevention
158571|NCT02585167|VAAFT|vaaft
158572|NCT02585167|anal fistula|anal fistula
158573|NCT02585167|sphincter reconstruction|sphincter reconstruction
158574|NCT02585154|Deep Brain Stimulation|deep brain stimulation
158575|NCT02585128|Delirium|delirium
158576|NCT02585128|Transcatheter Aortic Valve Implantation|transcatheter aortic valve implantation
158577|NCT02585128|Elderly|elderly
158578|NCT02585102|Vegetables|vegetables
158579|NCT02585089|Hypertension|hypertension
158580|NCT02585089|active biopeptide|active biopeptide
158581|NCT02585089|cardiovascular pathophysiology|cardiovascular pathophysiology
158582|NCT02585089|angiotensin converting enzyme inhibition|angiotensin converting enzyme inhibition
158583|NCT02585089|cured-pork ham|cured-pork ham
158584|NCT02585076|Stroke prevention|stroke prevention
158585|NCT02585076|Risk assessment|risk assessment
158586|NCT02585063|independent prescribing,|independent prescribing,
158587|NCT02585063|optometrist|optometrist
158588|NCT02585063|acute care|acute care
158589|NCT02585050|do not attempt resuscitation|do not attempt resuscitation
158590|NCT02585050|neurological outcome|neurological outcome
158591|NCT02585050|live discharged ratio|live discharged ratio
158592|NCT02585024|smoking|smoking
158593|NCT02585024|cytisine|cytisine
158594|NCT02585024|Pharmacokinetics|pharmacokinetics
158595|NCT02585011|Hemiarthroplasty|hemiarthroplasty
158596|NCT02585011|Anesthesia, Local|anesthesia, local
158597|NCT02585011|Pain, Postoperative|pain, postoperative
158598|NCT02584972|Postural control|postural control
158599|NCT02584972|Gait|gait
158600|NCT02584972|Children|children
158601|NCT02584972|Autism Spectrum Disorder|autism spectrum disorder
158602|NCT02584933|ALK|alk
158603|NCT02584933|Malignancies|malignancies
158604|NCT02584907|Critically ill|critically ill
158605|NCT02584907|Diet|diet
158606|NCT02584907|Blood glucose|blood glucose
158607|NCT02584894|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
158608|NCT02584894|trauma exposure|trauma exposure
158609|NCT02584894|Repeated transcranial magnetic stimulation|repeated transcranial magnetic stimulation
158610|NCT02584855|Spondyloarthritis|spondyloarthritis
158611|NCT02584855|Spondylarthropathy|spondylarthropathy
158612|NCT02584816|BRV-PV|brv-pv
158613|NCT02584816|Rotavirus vaccine|rotavirus vaccine
158614|NCT02584816|lot-to-lot consistency|lot-to-lot consistency
158615|NCT02584816|interference with routine immunization|interference with routine immunization
158616|NCT02584790|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
158617|NCT02584790|Narrow band imaging|narrow band imaging
158618|NCT02584777|Post-essential thrombocythemia myelofibrosis|post-essential thrombocythemia myelofibrosis
158619|NCT02584777|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
158620|NCT02584738|Asthma|asthma
158621|NCT02584738|Exacerbation|exacerbation
158622|NCT02584738|Nebulization|nebulization
158623|NCT02584738|Magnesium|magnesium
158624|NCT02584738|Pediatric|pediatric
158625|NCT02584725|Tranexamic Acid|tranexamic acid
158626|NCT02584725|Total Joint Arthroplasty|total joint arthroplasty
158627|NCT02584725|Intraoperative Blood Loss|intraoperative blood loss
158628|NCT02584660|Rivaroxaban|rivaroxaban
158629|NCT02584660|JNJ39039039|jnj39039039
158630|NCT02584660|Pulmonary embolism|pulmonary embolism
158631|NCT02584647|Unresectable|unresectable
158632|NCT02584634|Non-Small Cell Lung Cancer|non-small cell lung cancer
158633|NCT02584634|NSCLC|nsclc
158634|NCT02584634|ALK|alk
158635|NCT02584634|avelumab|avelumab
158636|NCT02584634|crizotinib|crizotinib
158637|NCT02584634|PF-06463922|pf-06463922
158638|NCT02584595|Tachycardia|tachycardia
158639|NCT02584595|Ventricular Tachycardia|ventricular tachycardia
158640|NCT02584595|Cardiac Arrhythmias|cardiac arrhythmias
158641|NCT02584595|Cardiovascular Diseases|cardiovascular diseases
158642|NCT02584595|Heart Diseases|heart diseases
158643|NCT02584582|Glucagon|glucagon
158644|NCT02584582|Glukagon-like peptide-1 (GLP-1)|glukagon-like peptide-1 (glp-1)
158645|NCT02584582|GLP-1 receptor agonist (GLP-1RA)|glp-1 receptor agonist (glp-1ra)
158646|NCT02584582|Incretins|incretins
158647|NCT02584569|Drug therapy|drug therapy
158648|NCT02584530|ultrasound|ultrasound
158649|NCT02584530|PICC line|picc line
158650|NCT02584530|neonate|neonate
158651|NCT02584517|Vasculitis|vasculitis
158652|NCT02584517|Autoimmune disease|autoimmune disease
158653|NCT02584517|Connective tissue disease|connective tissue disease
158654|NCT02584517|Polymyalgia rheumatica|polymyalgia rheumatica
158655|NCT02584517|Musculoskeletal Diseases|musculoskeletal diseases
158656|NCT02584517|Immune disorder|immune disorder
158657|NCT02584517|Rheumatic disease|rheumatic disease
158658|NCT02584504|Non-statin LMT|non-statin lmt
158659|NCT02584504|Low dose statin|low dose statin
158660|NCT02584478|Dual receptor Tyrosine Kinase Inhibitor|dual receptor tyrosine kinase inhibitor
158661|NCT02584478|Anti-angiogenic therapy|anti-angiogenic therapy
158662|NCT02584478|Combination Therapy|combination therapy
158663|NCT02584439|ivabradine|ivabradine
158664|NCT02584439|heart rate|heart rate
158665|NCT02584439|aging|aging
158666|NCT02584439|visco-elasticity|visco-elasticity
158667|NCT02584426|Cefazolin|cefazolin
158668|NCT02584400|prostatic tumors|prostatic tumors
158669|NCT02584400|[18F]HX4 Pet imaging|[18f]hx4 pet imaging
158670|NCT02584400|hypoxia|hypoxia
158671|NCT02584400|phase II trial|phase ii trial
158672|NCT02584400|esophageal tumors|esophageal tumors
158673|NCT02584400|rectal tumors|rectal tumors
158674|NCT02584400|brain metastases|brain metastases
158675|NCT02584400|primary brain tumors|primary brain tumors
158676|NCT02584374|iliac vein compression|iliac vein compression
158677|NCT02584361|Hearing loss|hearing loss
158678|NCT02584361|Cochlear implant|cochlear implant
158679|NCT02584348|ultrasound, antrum, pulmonary aspiration, emergency surgery|ultrasound, antrum, pulmonary aspiration, emergency surgery
158680|NCT02584335|wound treatment|wound treatment
158681|NCT02584335|lidocaine|lidocaine
158682|NCT02584335|pain reduction|pain reduction
158683|NCT02584335|local anesthetic|local anesthetic
158684|NCT02584283|Liver Transplantation|liver transplantation
158685|NCT02584283|Donation after Circulatory Death|donation after circulatory death
158686|NCT02584283|Machine Perfusion|machine perfusion
158687|NCT02584270|palatal drop prosthesis|palatal drop prosthesis
158688|NCT02584231|Desmopressin|desmopressin
158689|NCT02584231|Paediatrics|paediatrics
158690|NCT02584231|urinary concentration test|urinary concentration test
158691|NCT02584205|inspiratory muscle training|inspiratory muscle training
158692|NCT02584205|obstructive sleep apnea|obstructive sleep apnea
158693|NCT02584205|functional capacity|functional capacity
158694|NCT02584179|mpMRI, significant cancer|mpmri, significant cancer
158695|NCT02584166|Morbidity|morbidity
158696|NCT02584166|Mortality|mortality
158697|NCT02584166|conferences|conferences
158698|NCT02584166|human science|human science
158699|NCT02584153|Hernia|hernia
158700|NCT02584153|Ventral|ventral
158701|NCT02584153|Incisional|incisional
158702|NCT02584153|Abdominal|abdominal
158703|NCT02584153|Herniorrhaphy|herniorrhaphy
158704|NCT02584153|Recurrence|recurrence
158705|NCT02584153|laparotomy|laparotomy
158706|NCT02584153|prevention|prevention
158707|NCT02584140|PrEP|prep
158708|NCT02584140|Pre-exposure Prophylaxis|pre-exposure prophylaxis
158709|NCT02584140|HIV Prevention|hiv prevention
158710|NCT02584127|Smoking|smoking
158711|NCT02584127|cessation|cessation
158712|NCT02584127|Internet program|internet program
158713|NCT02584101|Acceptance and Commitment Therapy|acceptance and commitment therapy
158714|NCT02584088|NovaSure|novasure
158715|NCT02584088|Ablation|ablation
158716|NCT02584088|Menorrhagia|menorrhagia
158717|NCT02584088|Endometrium|endometrium
158718|NCT02584049|Osteopathic treatment|osteopathic treatment
158719|NCT02584049|Care-induced Pain|care-induced pain
158720|NCT02584049|Pain|pain
158721|NCT02584049|Elderly|elderly
158722|NCT02584036|influenza|influenza
158723|NCT02584036|vaccine|vaccine
158724|NCT02584036|public health|public health
158725|NCT02584036|preventable disease|preventable disease
158726|NCT02584036|vaccine history|vaccine history
158727|NCT02584036|point-of-care|point-of-care
158728|NCT02584023|ultrasonography|ultrasonography
158729|NCT02584023|infant|infant
158730|NCT02584023|perioperative period|perioperative period
158731|NCT02584023|general anesthesia|general anesthesia
158732|NCT02584010|Postoperative scars|postoperative scars
158733|NCT02584010|Cicatrix|cicatrix
158734|NCT02584010|Cicatrization|cicatrization
158735|NCT02583997|To suture or not to suture....|to suture or not to suture....
158736|NCT02583997|Tooth extraction|tooth extraction
158737|NCT02583997|Third molar|third molar
158738|NCT02583971|Direct current cardioversion|direct current cardioversion
158739|NCT02583971|Medical management|medical management
158740|NCT02583971|Atrial fibrillation ablation|atrial fibrillation ablation
158741|NCT02583945|acute kidney injury|acute kidney injury
158742|NCT02583945|hemodynamic stabilisation|hemodynamic stabilisation
158743|NCT02583945|nephrotoxic medication|nephrotoxic medication
158744|NCT02583932|Randomized controlled trial|randomized controlled trial
158745|NCT02583932|Psychological|psychological
158746|NCT02583932|Meaning|meaning
158747|NCT02583932|Existential|existential
158748|NCT02583932|Quality of life|quality of life
158749|NCT02583932|Intervention|intervention
158750|NCT02583932|Cancer|cancer
158751|NCT02583932|Advanced disease|advanced disease
158752|NCT02583932|New diagnosis|new diagnosis
158753|NCT02583880|nutritional status|nutritional status
158754|NCT02583880|malnutrition|malnutrition
158755|NCT02583880|energy intake|energy intake
158756|NCT02583880|caloric deficit|caloric deficit
158758|NCT02583880|hospital|hospital
158759|NCT02583880|enteral nutrition|enteral nutrition
158760|NCT02583880|parenteral nutrition|parenteral nutrition
158761|NCT02583880|nutrition|nutrition
158762|NCT02583854|Coronary angiography|coronary angiography
158763|NCT02583854|Transradial|transradial
158764|NCT02583854|Patient experience|patient experience
158765|NCT02583854|VAS|vas
158766|NCT02583854|Compression device|compression device
158767|NCT02583802|MHD|mhd
158768|NCT02583802|ear pills|ear pills
159467|NCT02579811|Cancer|cancer
158769|NCT02583802|Shengmai capsule|shengmai capsule
158770|NCT02583802|Chinese medicine treatment|chinese medicine treatment
158771|NCT02583776|continuous glucose monitoring (cgm)|continuous glucose monitoring (cgm)
158772|NCT02583776|neonatal hypoglycemia|neonatal hypoglycemia
158773|NCT02583776|very low birth weight infants (VLBWI)|very low birth weight infants (vlbwi)
158774|NCT02583776|preterm infants|preterm infants
158775|NCT02583763|pro-brain natriuretic peptide (1-76)|pro-brain natriuretic peptide (1-76)
158776|NCT02583763|Insulin-Like Growth Factor Binding Proteins|insulin-like growth factor binding proteins
158777|NCT02583763|Insulin-Like Growth Factor I|insulin-like growth factor i
158778|NCT02583763|Echocardiography|echocardiography
158779|NCT02583763|Velocity Vector Imaging|velocity vector imaging
158780|NCT02583763|Heart Function Tests|heart function tests
158781|NCT02583750|glucose metabolism|glucose metabolism
158782|NCT02583750|sleep deprivation|sleep deprivation
158783|NCT02583737|bone|bone
158784|NCT02583737|maxillary sinus|maxillary sinus
158785|NCT02583672|Gaucher Disease|gaucher disease
158786|NCT02583659|Gastric cancer|gastric cancer
158787|NCT02583659|First-line chemotherapy|first-line chemotherapy
158788|NCT02583659|Biomarker|biomarker
158789|NCT02583646|Obesity|obesity
158790|NCT02583646|Puberty|puberty
158791|NCT02583646|Ultrasound|ultrasound
158792|NCT02583646|Pediatric|pediatric
158793|NCT02583620|high myopia|high myopia
158794|NCT02583568|breast cancer|breast cancer
158795|NCT02583568|image-guided surgery|image-guided surgery
158796|NCT02583555|Quality of Life|quality of life
158797|NCT02583555|Health Care Utilization|health care utilization
158798|NCT02583542|breast|breast
158799|NCT02583542|lung|lung
158800|NCT02583542|squamous|squamous
158801|NCT02583542|KRAS|kras
158802|NCT02583542|AZD|azd
158803|NCT02583542|selumetinib|selumetinib
158804|NCT02583529|Parkinson Disease|parkinson disease
158805|NCT02583529|Neurogenic Overactive Bladder|neurogenic overactive bladder
158806|NCT02583529|Posterior Tibial Nerve Electrostimulation|posterior tibial nerve electrostimulation
158807|NCT02583503|Total knee arthroplasty|total knee arthroplasty
158808|NCT02583503|Total knee replacement|total knee replacement
158809|NCT02583503|TKA|tka
158810|NCT02583503|TKR|tkr
158811|NCT02583490|Electroconvulsive Therapy|electroconvulsive therapy
158812|NCT02583490|Low Pulse Amplitude Focal Electroconvulsive Therapy|low pulse amplitude focal electroconvulsive therapy
158813|NCT02583490|ECT|ect
158814|NCT02583490|Depression|depression
158815|NCT02583490|Suicidal Ideation|suicidal ideation
158816|NCT02583477|Pancreatic Ductal Adenocarcinoma, PDAC, immunotherapy, PDL1, AZD5069, MEDI4736|pancreatic ductal adenocarcinoma, pdac, immunotherapy, pdl1, azd5069, medi4736
158817|NCT02583438|Gut Microbiota|gut microbiota
158818|NCT02583438|inflammatory marker|inflammatory marker
158819|NCT02583438|Glucose and lipid metabolism|glucose and lipid metabolism
158820|NCT02583399|Pediatric (Birth to less than 6 months of age)|pediatric (birth to less than 6 months of age)
158821|NCT02583399|Pain|pain
158822|NCT02583399|Fever|fever
158823|NCT02583386|mobility|mobility
158824|NCT02583386|falls|falls
158825|NCT02583386|fall prevention|fall prevention
158826|NCT02583386|gait and balance|gait and balance
158827|NCT02583386|automatic fall detector|automatic fall detector
158828|NCT02583373|Pneumonia|pneumonia
158829|NCT02583373|Streptococcus pneumoniae|streptococcus pneumoniae
158830|NCT02583373|Pneumolysin|pneumolysin
158831|NCT02583360|Infant|infant
158832|NCT02583360|Feeding difficulties|feeding difficulties
158833|NCT02583360|Dysphagia|dysphagia
158834|NCT02583334|acupuncture|acupuncture
158835|NCT02583334|fibromyalgia|fibromyalgia
158836|NCT02583334|rheumatism|rheumatism
158837|NCT02583334|clinical trial|clinical trial
158838|NCT02583321|chlorhexidine gluconate|chlorhexidine gluconate
158839|NCT02583321|oral care|oral care
158840|NCT02583321|mechanical ventilation|mechanical ventilation
158841|NCT02583321|critically ill patients|critically ill patients
158842|NCT02583321|tracheal secretions|tracheal secretions
158843|NCT02583321|subglottic secretions|subglottic secretions
158844|NCT02583308|Ventilator-associated pneumonia|ventilator-associated pneumonia
158845|NCT02583308|Surveillance|surveillance
158846|NCT02583308|Subglottic-secretions|subglottic-secretions
158847|NCT02583308|Critically ill patients|critically ill patients
158848|NCT02583308|Prevention|prevention
158849|NCT02583295|Awareness|awareness
158850|NCT02583295|Cardiac Surgery|cardiac surgery
158851|NCT02583295|Maternal|maternal
158852|NCT02583295|Pediatric|pediatric
158853|NCT02583295|Sound|sound
158854|NCT02583295|Music|music
158855|NCT02583243|Opioid dependence|opioid dependence
158856|NCT02583243|HIV/AIDS|hiv/aids
158857|NCT02583243|Hepatitis C|hepatitis c
158858|NCT02583243|Severe mental illness|severe mental illness
158859|NCT02583243|Injection Drug Use|injection drug use
158860|NCT02583230|Antidepressant Medication|antidepressant medication
158861|NCT02583230|Adherence|adherence
158862|NCT02583230|Mobile Smartphone Intervention|mobile smartphone intervention
158863|NCT02583230|Telemedicine|telemedicine
158864|NCT02583230|Primary Care|primary care
158865|NCT02583217|Laryngeal mask|laryngeal mask
158866|NCT02583217|Ketamine|ketamine
158867|NCT02583217|Remifentanyl|remifentanyl
158868|NCT02583165|advanced solid tumors|advanced solid tumors
158869|NCT02583165|immunotherapy|immunotherapy
158870|NCT02583165|immuno-oncology|immuno-oncology
158871|NCT02583139|Children, Moderate and/or highly emetogenic chemotherapy|children, moderate and/or highly emetogenic chemotherapy
158872|NCT02583126|Teenager|teenager
158873|NCT02583126|moderate and/or highly emetogenic chemotherapy|moderate and/or highly emetogenic chemotherapy
158874|NCT02583113|Total Knee Replacement|total knee replacement
158875|NCT02583113|Unicompartment Knee Replacement|unicompartment knee replacement
158876|NCT02583087|Barrett esophagus|barrett esophagus
158877|NCT02583087|Esophageal adenocarcinoma|esophageal adenocarcinoma
158878|NCT02583087|Endoscopic submucosal dissection|endoscopic submucosal dissection
158879|NCT02583074|deep brain stimulation|deep brain stimulation
158880|NCT02583074|Subthalamic Nucleus|subthalamic nucleus
158881|NCT02583074|dystonia|dystonia
158882|NCT02583035|cancer|cancer
158883|NCT02583035|geriatric|geriatric
158884|NCT02582996|Headache|headache
158885|NCT02582996|Aura|aura
158886|NCT02582996|Migraine|migraine
158887|NCT02582996|Moderate to Severe|moderate to severe
158888|NCT02582957|ARDS|ards
158889|NCT02582957|Shock Lung|shock lung
158890|NCT02582957|Acute Chest Syndrome|acute chest syndrome
158891|NCT02582957|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
158892|NCT02582957|Respiratory insufficiency|respiratory insufficiency
158893|NCT02582957|Trauma|trauma
158894|NCT02582918|Randomized Controlled Trial|randomized controlled trial
158895|NCT02582918|Mass Screening|mass screening
158896|NCT02582905|Alcohol Use Disorder|alcohol use disorder
158897|NCT02582905|Bipolar Disorder|bipolar disorder
158898|NCT02582905|Mood|mood
158899|NCT02582905|Alcohol craving|alcohol craving
158900|NCT02582905|Pregnenolone|pregnenolone
158901|NCT02582905|Citicoline|citicoline
158902|NCT02582879|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
158903|NCT02582879|CLL|cll
158904|NCT02582879|Small Lymphocytic Leukemia|small lymphocytic leukemia
158905|NCT02582879|SLL|sll
158906|NCT02582866|Lacosamide|lacosamide
158907|NCT02582866|Vimpat|vimpat
158908|NCT02582866|Epilepsy|epilepsy
158909|NCT02582866|Partial onset seizures|partial onset seizures
158910|NCT02582866|Tonic-clonic seizures|tonic-clonic seizures
158911|NCT02582866|Monotherapy|monotherapy
158912|NCT02582866|AED|aed
158913|NCT02582853|GBS|gbs
158914|NCT02582853|AIDP|aidp
158915|NCT02582853|Spinal fluid|spinal fluid
158916|NCT02582853|sCD163|scd163
158917|NCT02582840|Japanese patients with type 1 diabetes with inadequate glycemic control on insulin|japanese patients with type 1 diabetes with inadequate glycemic control on insulin
158918|NCT02582827|Advanced Solid Tumors|advanced solid tumors
158919|NCT02582827|solid tumor|solid tumor
158920|NCT02582827|lymphoma|lymphoma
158921|NCT02582814|Japanese patients with type 1 diabetes with inadequate glycemic control on insulin|japanese patients with type 1 diabetes with inadequate glycemic control on insulin
158922|NCT02582801|PET/CT|pet/ct
158923|NCT02582801|Alfatide Ⅱ|alfatide ⅱ
158924|NCT02582801|breast cancer|breast cancer
158925|NCT02582762|Nail gel|nail gel
158926|NCT02582762|Nail surface abnormality|nail surface abnormality
158927|NCT02582762|Efficacy|efficacy
158928|NCT02582749|Androgen Deprivation Therapy|androgen deprivation therapy
158929|NCT02582749|Androgen Receptor Antagonist|androgen receptor antagonist
158930|NCT02582749|Radium-223 Dichloride|radium-223 dichloride
158931|NCT02582749|Placebo|placebo
158932|NCT02582736|Antipsychotics|antipsychotics
158933|NCT02582736|Drug side effects|drug side effects
158934|NCT02582736|Psychosis|psychosis
158935|NCT02582736|Hyperglycemic emergencies|hyperglycemic emergencies
158936|NCT02582736|Diabetes|diabetes
158937|NCT02582736|Epidemiology|epidemiology
158938|NCT02582736|Database research|database research
158939|NCT02582736|CNODES|cnodes
158940|NCT02582697|Germ Cell|germ cell
158941|NCT02582697|Intermediate and poor-risk metastatic germ cell tumours|intermediate and poor-risk metastatic germ cell tumours
158942|NCT02582671|Real World Effectiveness|real world effectiveness
158943|NCT02582658|Paritaprevir|paritaprevir
158944|NCT02582658|Dasabuvir|dasabuvir
158945|NCT02582658|Ombitasvir|ombitasvir
158946|NCT02582658|Chronic Hepatitis C|chronic hepatitis c
158947|NCT02582658|HCV|hcv
158948|NCT02582645|impaction|impaction
158949|NCT02582645|impacted canine|impacted canine
158950|NCT02582645|palatally|palatally
158951|NCT02582645|open window|open window
158952|NCT02582645|closed window|closed window
158953|NCT02582645|management|management
158954|NCT02582632|Hepatitis C Virus|hepatitis c virus
158955|NCT02582632|Interferon-Free|interferon-free
158956|NCT02582632|Ribavirin-Free|ribavirin-free
158957|NCT02582632|Hepatitis C|hepatitis c
158958|NCT02582632|Hepatitis C Genotype 1b|hepatitis c genotype 1b
158959|NCT02582619|Spinal Cord Injury and Employment|spinal cord injury and employment
158960|NCT02582606|Insulin Resistance|insulin resistance
158961|NCT02582606|Meal pattern|meal pattern
158962|NCT02582606|Obese|obese
158963|NCT02582593|Cognitive Aging|cognitive aging
158964|NCT02582593|Neuromodulation|neuromodulation
158965|NCT02582593|Low Level Light Therapy|low level light therapy
158966|NCT02582593|Near Infrared Light|near infrared light
158967|NCT02582593|Neurostimulation|neurostimulation
158968|NCT02582580|pelvic floor|pelvic floor
158969|NCT02582580|perineal trauma|perineal trauma
158970|NCT02582580|physiotherapy|physiotherapy
158971|NCT02582580|perineal integrity|perineal integrity
158972|NCT02582567|Pregnant Women|pregnant women
158973|NCT02582567|Quality of Life|quality of life
158974|NCT02582567|Exercise|exercise
158975|NCT02582567|Sleep|sleep
158976|NCT02582567|Fetal Research|fetal research
158977|NCT02582567|Diet, Mediterranean|diet, mediterranean
158978|NCT02582567|Physical Fitness|physical fitness
158979|NCT02582567|Oxidative stress|oxidative stress
158980|NCT02582567|Inflammation|inflammation
158981|NCT02582528|cognitive remediation|cognitive remediation
158982|NCT02582528|cognition|cognition
158983|NCT02582528|youth|youth
158984|NCT02582528|mental health|mental health
158985|NCT02582528|functional outcome|functional outcome
158986|NCT02582515|d-cycloserine|d-cycloserine
158987|NCT02582515|comprehensive behavioral intervention for tics|comprehensive behavioral intervention for tics
158988|NCT02582515|habit reversal training|habit reversal training
158989|NCT02582502|Hyperbaric Oxygen|hyperbaric oxygen
158990|NCT02582502|HBOT|hbot
158991|NCT02582502|Hyperbaric Chamber|hyperbaric chamber
158992|NCT02582502|Pressurized Oxygen|pressurized oxygen
158993|NCT02582489|Mesenchymal stem cells|mesenchymal stem cells
158994|NCT02582489|Bone marrow aspirate concentrate|bone marrow aspirate concentrate
158995|NCT02582476|Hypokalemic Periodic Paralysis|hypokalemic periodic paralysis
158996|NCT02582476|Bumetanide|bumetanide
158997|NCT02582476|Periodic Paralysis|periodic paralysis
158998|NCT02582463|Risk Assessment|risk assessment
158999|NCT02582463|Hospitals|hospitals
159000|NCT02582463|Pharmacists|pharmacists
159001|NCT02582463|Medication Systems|medication systems
159002|NCT02582463|Patient Selection|patient selection
159003|NCT02582463|Prognosis research|prognosis research
159004|NCT02582450|Haemophilia|haemophilia
159005|NCT02582450|Adherence of Treatment|adherence of treatment
159006|NCT02582450|Knowledge of Illness|knowledge of illness
159007|NCT02582450|Medical-patient Relationship|medical-patient relationship
159008|NCT02582450|Illness Behavior|illness behavior
159009|NCT02582450|Treatment Difficulties|treatment difficulties
159010|NCT02582450|Veritas|veritas
159011|NCT02582437|Minimum Alveolar Concentration|minimum alveolar concentration
159012|NCT02582411|Healthy Subjects|healthy subjects
159013|NCT02582385|Amyotrophic lateral sclerosis (ALS)|amyotrophic lateral sclerosis (als)
159014|NCT02582385|Cytokines|cytokines
159015|NCT02582385|Neuropathology|neuropathology
159016|NCT02582359|Acute Myeloid Leukemia|acute myeloid leukemia
159017|NCT02582346|MRI|mri
159018|NCT02582346|Neurography|neurography
159019|NCT02582346|Tractography|tractography
159020|NCT02582346|Pelvic nerves|pelvic nerves
159021|NCT02582203|Ceftaroline fosamil|ceftaroline fosamil
159022|NCT02582203|Vancomycin|vancomycin
159023|NCT02582203|Acute bacterial skin and skin structure infections|acute bacterial skin and skin structure infections
159024|NCT02582203|Methicillin-resistant S. aureus|methicillin-resistant s. aureus
159025|NCT02582190|electrical cardioversion|electrical cardioversion
159026|NCT02582190|persistent atrial fibrillation|persistent atrial fibrillation
159027|NCT02582177|Fungal infection|fungal infection
159028|NCT02582177|Skin infection|skin infection
159029|NCT02582177|Dermatophytoses|dermatophytoses
159030|NCT02582164|Optical Coherence Tomography (OCT)|optical coherence tomography (oct)
159031|NCT02582164|Swept Source OCT|swept source oct
159032|NCT02582138|physical frailty|physical frailty
159033|NCT02582138|sarcopenia|sarcopenia
159034|NCT02582138|exercise|exercise
159035|NCT02582138|nutrition|nutrition
159036|NCT02582138|information and communications technology|information and communications technology
159037|NCT02582125|ONO-4538|ono-4538
159038|NCT02582125|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
159039|NCT02582047|influenza vaccine|influenza vaccine
159040|NCT02582047|pneumococcal vaccine|pneumococcal vaccine
159041|NCT02582047|simultaneous vaccination|simultaneous vaccination
159042|NCT02582034|Optimized Dosimetry versus standard Dosimetry|optimized dosimetry versus standard dosimetry
159043|NCT02582034|Internal Radiation Therapy|internal radiation therapy
159044|NCT02582021|Microvascular Coronary Dysfunction (MCD)|microvascular coronary dysfunction (mcd)
159045|NCT02582021|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
159046|NCT02582021|Coronary angiography|coronary angiography
159047|NCT02582021|Coronary Vascular Dysfunction (CVD)|coronary vascular dysfunction (cvd)
159048|NCT02581995|Diabetic macular edema|diabetic macular edema
159049|NCT02581995|Intravitreal injection|intravitreal injection
159050|NCT02581982|Urothelial cancer|urothelial cancer
159051|NCT02581982|Bladder cancer|bladder cancer
159052|NCT02581982|Immunotherapy|immunotherapy
159053|NCT02581982|Paclitaxel|paclitaxel
159054|NCT02581969|Hemophilia A, Congenital|hemophilia a, congenital
159055|NCT02581956|Immunology|immunology
159056|NCT02581891|Neovascular age-related macular degeneration|neovascular age-related macular degeneration
159057|NCT02581891|nAMD)|namd)
159058|NCT02581878|Thorium-227|thorium-227
159059|NCT02581878|BAY1862864 Injection|bay1862864 injection
159060|NCT02581878|Safety|safety
159061|NCT02581878|Pharmacokinetics|pharmacokinetics
159062|NCT02581878|CD22|cd22
159063|NCT02581878|Radioimmunotherapy|radioimmunotherapy
159064|NCT02581839|eribulin|eribulin
159065|NCT02581839|central nervous system|central nervous system
159066|NCT02581839|CNS|cns
159067|NCT02581839|Eribulin Mesylate|eribulin mesylate
159068|NCT02581839|Halaven|halaven
159069|NCT02581813|Bone health|bone health
159070|NCT02581813|Body composition|body composition
159071|NCT02581813|Dairy foods|dairy foods
159072|NCT02581813|Exercise|exercise
159073|NCT02581813|inflammation|inflammation
159074|NCT02581813|nutrition intervention|nutrition intervention
159075|NCT02581813|weight management|weight management
159076|NCT02581774|induction|induction
159077|NCT02581774|cesarean delivery|cesarean delivery
159078|NCT02581761|Hemodynamically stable women >18 years old|hemodynamically stable women >18 years old
159079|NCT02581761|with abnormal plateauing serum βHCG|with abnormal plateauing serum βhcg
159080|NCT02581735|Haemophilia|haemophilia
159081|NCT02581735|Adherence|adherence
159082|NCT02581735|Prophylaxis treatment|prophylaxis treatment
159083|NCT02581735|Quality of Life|quality of life
159084|NCT02581735|Illness Behavior|illness behavior
159085|NCT02581735|Veritas-Pro questionnaire|veritas-pro questionnaire
159086|NCT02581735|uPatient|upatient
159087|NCT02581722|PrePex, Male Circumcision, HIV Prevention, Adolescents|prepex, male circumcision, hiv prevention, adolescents
159088|NCT02581709|Feasibility study|feasibility study
159089|NCT02581709|Cognition|cognition
159090|NCT02581709|Chemotherapy|chemotherapy
159091|NCT02581709|Neoplasms|neoplasms
159092|NCT02581670|oligometastatic breast cancer|oligometastatic breast cancer
159093|NCT02581618|ischemic preconditioning|ischemic preconditioning
159094|NCT02581618|myocardial injury|myocardial injury
159095|NCT02581618|percutaneous coronary intervention|percutaneous coronary intervention
159096|NCT02581592|Hepatic Impairment|hepatic impairment
159097|NCT02581592|Hepatitis|hepatitis
159098|NCT02581592|Liver Cirrhosis|liver cirrhosis
159099|NCT02581579|Tuberculosis|tuberculosis
159100|NCT02581579|Tregs|tregs
159101|NCT02581579|Tolerance|tolerance
159102|NCT02581579|Probiotic|probiotic
159103|NCT02581579|Mycobacteria|mycobacteria
159104|NCT02581540|Troponin|troponin
159105|NCT02581540|High Sensitivity Troponin T|high sensitivity troponin t
159106|NCT02581540|MACE|mace
159107|NCT02581540|risk stratification|risk stratification
159108|NCT02581540|suspected cardiac chest pain|suspected cardiac chest pain
159109|NCT02581540|Acute Coronary Syndrome|acute coronary syndrome
159110|NCT02581540|GRACE|grace
159111|NCT02581540|TIMI|timi
159112|NCT02581540|HEART|heart
159113|NCT02581514|decision algorithm|decision algorithm
159114|NCT02581501|Xeloda|xeloda
159115|NCT02581501|Gemcitabine|gemcitabine
159116|NCT02581501|Abraxane|abraxane
159117|NCT02581501|Pancreatic Cancer|pancreatic cancer
159118|NCT02581501|Metastatic Cancer|metastatic cancer
159119|NCT02581501|Phase I|phase i
159120|NCT02581501|5-FU|5-fu
159121|NCT02581501|Capecitabine|capecitabine
159122|NCT02581501|Gemzar|gemzar
159123|NCT02581501|NAB-Paclitaxel|nab-paclitaxel
159124|NCT02581501|Chemotherapy|chemotherapy
159125|NCT02581488|Diabetes|diabetes
159126|NCT02581488|diabetic foot ulcer|diabetic foot ulcer
159127|NCT02581488|foot sore|foot sore
159128|NCT02581488|type 2 diabetes|type 2 diabetes
159129|NCT02581488|type 1 diabetes|type 1 diabetes
159130|NCT02581488|neuropathy|neuropathy
159131|NCT02581488|DFU|dfu
159132|NCT02581475|Adenoma detection rate|adenoma detection rate
159133|NCT02581475|Colonoscopy|colonoscopy
159134|NCT02581475|Withdrawal time|withdrawal time
159135|NCT02581449|omega-3 fatty acids|omega-3 fatty acids
159136|NCT02581449|hemodialysis|hemodialysis
159137|NCT02581449|oxidative stress|oxidative stress
159138|NCT02581449|dyslipidemia|dyslipidemia
159139|NCT02581436|Prediction test|prediction test
159140|NCT02581436|genetic transcription profile|genetic transcription profile
159141|NCT02581436|Transplant follow-up|transplant follow-up
159142|NCT02581436|Chronic index|chronic index
159143|NCT02581436|Graft Function|graft function
159144|NCT02581410|Zostavax®|zostavax®
159145|NCT02581410|≥ 65 years of age|≥ 65 years of age
159146|NCT02581410|Herpes Zoster|herpes zoster
159147|NCT02581410|Shingles|shingles
159148|NCT02581410|Immunogenicity|immunogenicity
159149|NCT02581410|Safety|safety
159150|NCT02581397|cough|cough
159151|NCT02581397|expectorant|expectorant
159152|NCT02581397|upper respiratory tract infections|upper respiratory tract infections
159153|NCT02581397|respiratory tract infections|respiratory tract infections
159154|NCT02581397|antitussive agents|antitussive agents
159155|NCT02581384|Ewing Sarcoma|ewing sarcoma
159156|NCT02581384|Rhabdomyosarcoma|rhabdomyosarcoma
159157|NCT02581384|Wilms Tumor|wilms tumor
159158|NCT02581384|Rhabdomyosarcoma of Mediastinum|rhabdomyosarcoma of mediastinum
159159|NCT02581384|Ewing's Sarcoma Metastatic|ewing's sarcoma metastatic
159160|NCT02581384|Ewing Family of Tumors|ewing family of tumors
159468|NCT02579811|Axitinib|axitinib
159161|NCT02581384|Ewing's Tumor Metastatic|ewing's tumor metastatic
159162|NCT02581384|Osteosarcoma, Metastatic|osteosarcoma, metastatic
159163|NCT02581384|Osteosarcoma in Children|osteosarcoma in children
159164|NCT02581384|Rhabdoid Tumor|rhabdoid tumor
159165|NCT02581384|Lung Metastasis|lung metastasis
159166|NCT02581384|Radiation for Children|radiation for children
159167|NCT02581384|SBRT for children|sbrt for children
159168|NCT02581384|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
159169|NCT02581384|Pulmonary Metastasis|pulmonary metastasis
159170|NCT02581384|Lung Metastasis in Children|lung metastasis in children
159171|NCT02581384|Pulmonary Metastasis in Children|pulmonary metastasis in children
159172|NCT02581384|Comfort Care|comfort care
159173|NCT02581384|Palliative Care|palliative care
159174|NCT02581371|Cerebrolysin|cerebrolysin
159175|NCT02581371|neuroplasticity|neuroplasticity
159176|NCT02581371|upper limb|upper limb
159177|NCT02581371|middle cerebral artery|middle cerebral artery
159178|NCT02581371|NBS|nbs
159179|NCT02581371|navigation brain stimulation|navigation brain stimulation
159180|NCT02581371|paretic limb|paretic limb
159181|NCT02581371|stroke|stroke
159182|NCT02581371|ischemic stroke|ischemic stroke
159183|NCT02581371|rehabilitation|rehabilitation
159184|NCT02581371|Frenchay Arm Test|frenchay arm test
159185|NCT02581371|NBS eXimia Nexstim|nbs eximia nexstim
159186|NCT02581371|Barthel index|barthel index
159187|NCT02581358|scoliosis|scoliosis
159188|NCT02581358|spinal deformity|spinal deformity
159189|NCT02581358|Cobb angle|cobb angle
159190|NCT02581358|assessment|assessment
159191|NCT02581358|ultrasound|ultrasound
159192|NCT02581345|Moderate to severe chronic plaque psoriasis|moderate to severe chronic plaque psoriasis
159193|NCT02581345|Psoriasis|psoriasis
159194|NCT02581332|behavioral intervention|behavioral intervention
159195|NCT02581254|Snare|snare
159196|NCT02581254|Polypectomy|polypectomy
159197|NCT02581241|QT interval prolongation|qt interval prolongation
159198|NCT02581215|mFOLFIRINOX|mfolfirinox
159199|NCT02581215|Ramucirumab|ramucirumab
159200|NCT02581202|antiretroviral therapy|antiretroviral therapy
159201|NCT02581189|Chronic Hepatitis C|chronic hepatitis c
159202|NCT02581189|Effectiveness|effectiveness
159203|NCT02581189|Influence of adherence|influence of adherence
159204|NCT02581189|Genotype 1 or 4|genotype 1 or 4
159205|NCT02581189|Patient reported outcomes|patient reported outcomes
159206|NCT02581163|Effectiveness|effectiveness
159207|NCT02581163|Influence of adherence|influence of adherence
159208|NCT02581150|Outpatient hospitalization|outpatient hospitalization
159209|NCT02581150|Randomized trial|randomized trial
159210|NCT02581150|Peripheral arterial disease|peripheral arterial disease
159211|NCT02581150|Endovascular treatment|endovascular treatment
159212|NCT02581150|Health Economics|health economics
159213|NCT02581124|JTZ-951|jtz-951
159214|NCT02581124|Lapatinib|lapatinib
159215|NCT02581124|Pharmacokinetics|pharmacokinetics
159216|NCT02581085|Tocotrienol|tocotrienol
159217|NCT02581085|Vitamin E|vitamin e
159218|NCT02581059|Regorafenib|regorafenib
159219|NCT02581059|American Ginseng|american ginseng
159220|NCT02581059|Fatigue|fatigue
159221|NCT02581020|Hepatitis C|hepatitis c
159222|NCT02581020|Follow-up|follow-up
159223|NCT02581020|Observation|observation
159224|NCT02581020|Japanese|japanese
159225|NCT02581007|CML|cml
159226|NCT02581007|AML|aml
159227|NCT02581007|MDS|mds
159228|NCT02581007|ALL|all
159229|NCT02581007|CLL/CPL|cll/cpl
159230|NCT02581007|HD|hd
159231|NCT02581007|NHL|nhl
159232|NCT02581007|MPS|mps
159233|NCT02581007|CMML|cmml
159234|NCT02581007|MM|mm
159235|NCT02580994|Extended Disease Small Cell Lung Cancer|extended disease small cell lung cancer
159236|NCT02580994|phase II|phase ii
159237|NCT02580994|randomized|randomized
159238|NCT02580994|pembrolizumab|pembrolizumab
159239|NCT02580994|cross-over|cross-over
159240|NCT02580994|etoposide|etoposide
159241|NCT02580994|cisplatin|cisplatin
159242|NCT02580994|carboplatin|carboplatin
159243|NCT02580994|rechallenge|rechallenge
159244|NCT02580981|Cancer|cancer
159245|NCT02580981|Oncology|oncology
159246|NCT02580981|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
159247|NCT02580981|ALL|all
159248|NCT02580981|Genomics|genomics
159249|NCT02580981|Genetics|genetics
159250|NCT02580981|Sequencing|sequencing
159251|NCT02580981|DNA|dna
159252|NCT02580981|RNA|rna
159253|NCT02580981|Ph-like|ph-like
159254|NCT02580968|Electroacupuncture therapy|electroacupuncture therapy
159255|NCT02580968|Migraine|migraine
159256|NCT02580968|Acupuncture Therapy|acupuncture therapy
159257|NCT02580929|Radiotherapy|radiotherapy
159258|NCT02580929|General Surgery|general surgery
159259|NCT02580916|non-melanoma skin cancer|non-melanoma skin cancer
159260|NCT02580916|outcome assessment|outcome assessment
159261|NCT02580916|quality of life|quality of life
159262|NCT02580877|oral insulin|oral insulin
159263|NCT02580838|Stroke|stroke
159264|NCT02580838|Spasticity|spasticity
159265|NCT02580838|OnabotulinumtoxinA|onabotulinumtoxina
159266|NCT02580825|Childhood obesity|childhood obesity
159778|NCT02578004|Difficult|difficult
159267|NCT02580825|Ground reaction force|ground reaction force
159268|NCT02580825|Knee pain|knee pain
159269|NCT02580812|Perinatal listeriosis|perinatal listeriosis
159270|NCT02580812|Neurological impairment|neurological impairment
159271|NCT02580812|Sepsis|sepsis
159272|NCT02580812|Prematurity|prematurity
159273|NCT02580812|Neurotropism|neurotropism
159274|NCT02580812|Listeria monocytogenes|listeria monocytogenes
159275|NCT02580812|Intellectual Quotient|intellectual quotient
159276|NCT02580773|Sickle cell disease|sickle cell disease
159277|NCT02580773|Anemia|anemia
159278|NCT02580773|Rare disease|rare disease
159279|NCT02580773|Reanimation|reanimation
159280|NCT02580773|Prophylactic anticoagulation|prophylactic anticoagulation
159281|NCT02580760|Silicone|silicone
159282|NCT02580760|Transgender|transgender
159283|NCT02580760|Dermatology|dermatology
159284|NCT02580760|Blood contamination|blood contamination
159285|NCT02580760|Adverse event after injection|adverse event after injection
159286|NCT02580734|burning mouth syndrome|burning mouth syndrome
159287|NCT02580734|treatment|treatment
159288|NCT02580734|oral chronic pain|oral chronic pain
159289|NCT02580721|mucosal tissue thickness|mucosal tissue thickness
159290|NCT02580721|dental implant|dental implant
159291|NCT02580721|marginal bone loss|marginal bone loss
159292|NCT02580721|soft tissue|soft tissue
159293|NCT02580643|Autologous Protein Solution|autologous protein solution
159294|NCT02580643|Osteoarthritis|osteoarthritis
159295|NCT02580643|Intra-articular Injection|intra-articular injection
159296|NCT02580630|Strength training, injection, glucocorticoid|strength training, injection, glucocorticoid
159297|NCT02580565|sickle cell disease|sickle cell disease
159298|NCT02580552|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
159299|NCT02580552|CTCL|ctcl
159300|NCT02580552|Mycosis Fungoides|mycosis fungoides
159301|NCT02580552|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
159302|NCT02580552|CLL|cll
159303|NCT02580552|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
159304|NCT02580552|DLBCL|dlbcl
159305|NCT02580552|Adult T-cell leukemia/lymphoma|adult t-cell leukemia/lymphoma
159306|NCT02580552|ATLL|atll
159307|NCT02580539|Allogeneic Transplantation|allogeneic transplantation
159308|NCT02580539|T cell|t cell
159309|NCT02580539|Epstein-Barr Virus|epstein-barr virus
159310|NCT02580513|Circadian Rhythm|circadian rhythm
159311|NCT02580513|Circadian Misalignment|circadian misalignment
159312|NCT02580513|Insulin Sensitivity|insulin sensitivity
159313|NCT02580500|Epidural anesthesia|epidural anesthesia
159314|NCT02580500|Spinal anesthesia|spinal anesthesia
159315|NCT02580500|pilonidal dermoid sinus|pilonidal dermoid sinus
159316|NCT02580487|acute appendicitis|acute appendicitis
159317|NCT02580487|pain management|pain management
159318|NCT02580487|analgesics|analgesics
159319|NCT02580487|pediatric patients|pediatric patients
159320|NCT02580487|laparoscopy|laparoscopy
159321|NCT02580487|open surgery|open surgery
159322|NCT02580461|family caregivers|family caregivers
159323|NCT02580461|cancer|cancer
159324|NCT02580461|exercise intervention|exercise intervention
159325|NCT02580461|center based|center based
159326|NCT02580448|Breast Cancer|breast cancer
159327|NCT02580448|Breast|breast
159328|NCT02580448|Advanced Breast Cancer|advanced breast cancer
159329|NCT02580448|Metastatic Breast Cancer|metastatic breast cancer
159330|NCT02580448|CYP17|cyp17
159331|NCT02580448|Male Breast Cancer|male breast cancer
159332|NCT02580448|Triple Negative Cancer|triple negative cancer
159333|NCT02580448|ER+ Breast Cancer|er+ breast cancer
159334|NCT02580435|multiple sclerosis|multiple sclerosis
159335|NCT02580435|microbiome|microbiome
159336|NCT02580435|prediction|prediction
159337|NCT02580435|outcome|outcome
159338|NCT02580422|Echocardiography|echocardiography
159339|NCT02580409|health care utilization|health care utilization
159340|NCT02580409|health care costs|health care costs
159341|NCT02580383|Radiofrequency ablation|radiofrequency ablation
159342|NCT02580383|RF-MB|rf-mb
159343|NCT02580383|Lumbar RF|lumbar rf
159344|NCT02580383|Facet joint syndrome|facet joint syndrome
159345|NCT02580383|Multifidus twitching|multifidus twitching
159346|NCT02580383|Sensory stimulation|sensory stimulation
159347|NCT02580370|REALISE 1|realise 1
159348|NCT02580357|Connective tissue graft|connective tissue graft
159349|NCT02580357|Gingival recession|gingival recession
159350|NCT02580357|Low level laser therapy|low level laser therapy
159351|NCT02580305|SUVN-502|suvn-502
159352|NCT02580305|5-HT6|5-ht6
159353|NCT02580305|Phase 2|phase 2
159354|NCT02580305|Cognition|cognition
159355|NCT02580305|Donepezil|donepezil
159356|NCT02580305|Memantine|memantine
159357|NCT02580305|Alzheimer's Disease|alzheimer's disease
159358|NCT02580279|Breast Neoplasms|breast neoplasms
159359|NCT02580279|prevention & control|prevention & control
159360|NCT02580279|Epigallocatechin gallate|epigallocatechin gallate
159361|NCT02580279|Dermatitis|dermatitis
159362|NCT02580266|Kidney|kidney
159363|NCT02580266|Diabetes|diabetes
159364|NCT02580240|septic shock|septic shock
159365|NCT02580240|hydrocortisone|hydrocortisone
159366|NCT02580240|mortality|mortality
159367|NCT02580227|Tranexamic Acid|tranexamic acid
159368|NCT02580227|Blood Transfusions|blood transfusions
159369|NCT02580188|Neuromuscular blockade|neuromuscular blockade
159370|NCT02580188|Sugammadex|sugammadex
159371|NCT02580188|Laparoscopic surgery|laparoscopic surgery
159372|NCT02580188|Intra abdominal pressure alarm|intra abdominal pressure alarm
159373|NCT02580136|Esthesioneuroblastoma|esthesioneuroblastoma
159374|NCT02580136|Tumor|tumor
159375|NCT02580136|Skull Base Surgery|skull base surgery
159376|NCT02580136|Sinonasal Cancer|sinonasal cancer
159377|NCT02580110|no specific condition|no specific condition
159378|NCT02580097|Arterial Spin Labeling|arterial spin labeling
159379|NCT02580097|Ischemic stroke|ischemic stroke
159380|NCT02580097|Collateral Circulation|collateral circulation
159381|NCT02580097|Perfusion imaging|perfusion imaging
159382|NCT02580084|atherosclerosis of the peripheral arteries|atherosclerosis of the peripheral arteries
159383|NCT02580084|Aorta-femoral Bypass|aorta-femoral bypass
159384|NCT02580084|Hybrid Intervention|hybrid intervention
159385|NCT02580084|Iliac Arteries With Stenting and Plasty of the Common Femoral Artery|iliac arteries with stenting and plasty of the common femoral artery
159386|NCT02580084|plastic arteries with lesions of the common femoral artery and deep femoral artery|plastic arteries with lesions of the common femoral artery and deep femoral artery
159387|NCT02580071|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
159388|NCT02580071|Chinese Herbal Medicine|chinese herbal medicine
159389|NCT02580071|immune reconstitution|immune reconstitution
159390|NCT02580071|clinical trial|clinical trial
159391|NCT02580071|ALL|all
159392|NCT02580071|AML|aml
159393|NCT02580058|platinum resistant|platinum resistant
159394|NCT02580058|platinum refractory|platinum refractory
159395|NCT02580045|metastatic cancer|metastatic cancer
159396|NCT02580045|lumbar puncture|lumbar puncture
159397|NCT02580045|advanced cancer|advanced cancer
159398|NCT02580045|brain metastases|brain metastases
159399|NCT02580045|chemotherapy|chemotherapy
159400|NCT02580045|endocrine therapy|endocrine therapy
159401|NCT02580045|HER2 targeted therapy|her2 targeted therapy
159402|NCT02580045|immune therapy|immune therapy
159403|NCT02580045|anti-cancer therapy|anti-cancer therapy
159404|NCT02580045|blood brain barrier|blood brain barrier
159405|NCT02580045|pharmacokinetics|pharmacokinetics
159406|NCT02580045|Duke University|duke university
159407|NCT02580045|brain metastasis|brain metastasis
159408|NCT02580019|Cellular therapy|cellular therapy
159409|NCT02580019|Stroke|stroke
159410|NCT02580019|Neuronal Plasticity|neuronal plasticity
159411|NCT02580019|Recovery|recovery
159412|NCT02580019|umbilical cord mesenchymal stem cells|umbilical cord mesenchymal stem cells
159413|NCT02580019|Transplantation|transplantation
159414|NCT02580019|Cardiovascular Diseases|cardiovascular diseases
159415|NCT02580019|Ischemia|ischemia
159416|NCT02580019|Brain Infarction|brain infarction
159417|NCT02580019|Brain Ischemia|brain ischemia
159418|NCT02580019|Cerebrovascular Disorders|cerebrovascular disorders
159419|NCT02579993|Cornea|cornea
159420|NCT02579993|Limbal stem cell|limbal stem cell
159421|NCT02579967|Haploidentical|haploidentical
159422|NCT02579967|Autoimmunity|autoimmunity
159423|NCT02579967|Immune Dysregulation|immune dysregulation
159424|NCT02579967|Congenital|congenital
159425|NCT02579967|Opportunistic Infection|opportunistic infection
159426|NCT02579941|Hyperfibrinolysis|hyperfibrinolysis
159427|NCT02579941|Pregnant women at term|pregnant women at term
159428|NCT02579941|Tranexamic acid|tranexamic acid
159429|NCT02579928|Ketamine|ketamine
159430|NCT02579928|Depression|depression
159431|NCT02579928|Major Depressive Disorder|major depressive disorder
159432|NCT02579928|Anxiety|anxiety
159433|NCT02579928|School refusal|school refusal
159434|NCT02579928|Suicide|suicide
159435|NCT02579928|Generalized Anxiety|generalized anxiety
159436|NCT02579928|Suicidal Ideation|suicidal ideation
159437|NCT02579902|Irritable Bowel Syndrome|irritable bowel syndrome
159438|NCT02579902|inflammation|inflammation
159439|NCT02579902|oxidative stress|oxidative stress
159440|NCT02579902|clinical signs|clinical signs
159441|NCT02579902|vitamin D3|vitamin d3
159442|NCT02579889|Closed Loop Stimulation|closed loop stimulation
159443|NCT02579889|Atrial Fibrillation|atrial fibrillation
159444|NCT02579889|Stroke|stroke
159445|NCT02579889|Heart Failure|heart failure
159446|NCT02579889|Pacemaker|pacemaker
159447|NCT02579889|ICD|icd
159448|NCT02579876|Milk Allergy|milk allergy
159449|NCT02579876|Viaskin Milk|viaskin milk
159450|NCT02579876|Epicutaneous ImmunoTherapy (EPIT)|epicutaneous immunotherapy (epit)
159451|NCT02579876|Eosinophilic Esophagitis|eosinophilic esophagitis
159452|NCT02579876|Milk-Induced Eosinophilic Esophagitis|milk-induced eosinophilic esophagitis
159453|NCT02579863|PD1|pd1
159454|NCT02579863|PD-1|pd-1
159455|NCT02579863|PD-L1|pd-l1
159456|NCT02579863|PDL1|pdl1
159457|NCT02579850|COPD|copd
159458|NCT02579850|COPD Exacerbation|copd exacerbation
159459|NCT02579850|EXACT-PRO|exact-pro
159460|NCT02579837|screening|screening
159461|NCT02579824|Myeloma|myeloma
159462|NCT02579824|Relapsed and/or Refractory|relapsed and/or refractory
159463|NCT02579824|Multiple Myeloma|multiple myeloma
159464|NCT02579824|MM|mm
159465|NCT02579824|DS-3032b|ds-3032b
159469|NCT02579811|Pd-1 inhibitor|pd-1 inhibitor
159470|NCT02579811|Pd-L1 inhibitor|pd-l1 inhibitor
159471|NCT02579798|Bariatric surgery|bariatric surgery
159472|NCT02579798|Post-surgery hypoxemia|post-surgery hypoxemia
159473|NCT02579798|Obesity|obesity
159474|NCT02579785|Family Planning|family planning
159475|NCT02579785|Abortion|abortion
159476|NCT02579785|mHealth|mhealth
159477|NCT02579785|Behaviour Change Communication|behaviour change communication
159478|NCT02579785|Menstrual Regulation|menstrual regulation
159479|NCT02579785|Postabortion|postabortion
159480|NCT02579785|Bangladesh|bangladesh
159481|NCT02579759|PXT3003|pxt3003
159482|NCT02579746|hypertension|hypertension
159483|NCT02579746|immigrant|immigrant
159484|NCT02579746|dietary intervention|dietary intervention
159485|NCT02579746|lifestyle modification|lifestyle modification
159486|NCT02579720|Recurrent Grass Pollen Allergy|recurrent grass pollen allergy
159487|NCT02579720|Pollinex® Quattro|pollinex® quattro
159488|NCT02579707|Healthy Volunteers|healthy volunteers
159489|NCT02579681|Cognition|cognition
159490|NCT02579681|Tecfidera|tecfidera
159491|NCT02579681|RRMS|rrms
159492|NCT02579681|BG00012|bg00012
159493|NCT02579642|Moderate to severe depression|moderate to severe depression
159494|NCT02579642|Monopolar|monopolar
159495|NCT02579642|Bipolar|bipolar
159496|NCT02579642|Ketamine|ketamine
159497|NCT02579642|ECT|ect
159498|NCT02579642|Electroconvulsive therapy|electroconvulsive therapy
159499|NCT02579642|NMDA|nmda
159500|NCT02579629|Analgesia|analgesia
159501|NCT02579629|Cesarean section|cesarean section
159502|NCT02579629|Opiates|opiates
159503|NCT02579616|Lenvatinib|lenvatinib
159504|NCT02579616|E7080|e7080
159505|NCT02579616|Unresectable biliary tract cancer|unresectable biliary tract cancer
159506|NCT02579616|BTC|btc
159507|NCT02579616|Gemcitabine-based combination chemotherapy|gemcitabine-based combination chemotherapy
159508|NCT02579616|Lenvima|lenvima
159509|NCT02579538|Total Knee Arthroplasty|total knee arthroplasty
159510|NCT02579538|Thoracotomy|thoracotomy
159511|NCT02579538|Mastectomy|mastectomy
159512|NCT02579538|Video-Assisted Thoracoscopic Surgery (VATS)|video-assisted thoracoscopic surgery (vats)
159513|NCT02579538|Persistent Pain|persistent pain
159514|NCT02579538|Cognitive Flexibility|cognitive flexibility
159515|NCT02579525|septic shock|septic shock
159516|NCT02579525|tissue perfusion|tissue perfusion
159517|NCT02579525|macrocirculatory|macrocirculatory
159518|NCT02579525|mean arterial pressure|mean arterial pressure
159519|NCT02579525|vasopressor use|vasopressor use
159520|NCT02579525|days alive free of organ support|days alive free of organ support
159521|NCT02579499|Coronary artery disease|coronary artery disease
159522|NCT02579499|LDL choelsterol|ldl choelsterol
159523|NCT02579499|Statin|statin
159524|NCT02579473|Continuous dopaminergic stimulation|continuous dopaminergic stimulation
159525|NCT02579460|Barrett's esophagus|barrett's esophagus
159526|NCT02579460|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
159527|NCT02579434|CYP3A|cyp3a
159528|NCT02579408|NAFLD|nafld
159529|NCT02579408|LDLT|ldlt
159530|NCT02579408|steatosis|steatosis
159531|NCT02579408|CAP|cap
159532|NCT02579408|transient elastography|transient elastography
159533|NCT02579382|HBV|hbv
159534|NCT02579382|Hepatitis|hepatitis
159535|NCT02579382|Liver Disease|liver disease
159536|NCT02579369|Epidermolysis Bullosa|epidermolysis bullosa
159537|NCT02579369|stem cell|stem cell
159538|NCT02579317|Baroreflex mechanism|baroreflex mechanism
159539|NCT02579317|Alcohol Use Disorder|alcohol use disorder
159540|NCT02579317|Substance Use Disorder|substance use disorder
159541|NCT02579317|Heart Rate Variability|heart rate variability
159542|NCT02579317|Breathing|breathing
159543|NCT02579291|Stroke|stroke
159544|NCT02579291|Dry needling|dry needling
159545|NCT02579291|Spasticity|spasticity
159546|NCT02579291|Motor function|motor function
159547|NCT02579291|Stabilometry|stabilometry
159548|NCT02579278|EMVI|emvi
159549|NCT02579278|Extramural Venous Invasion|extramural venous invasion
159550|NCT02579278|mrEMVI|mremvi
159551|NCT02579278|Rectal Cancer|rectal cancer
159552|NCT02579278|ctDNA|ctdna
159553|NCT02579278|Neoplasm DNA|neoplasm dna
159554|NCT02579278|MRI|mri
159555|NCT02579265|Parenteral nutrition|parenteral nutrition
159556|NCT02579265|Neonates|neonates
159557|NCT02579265|Infants|infants
159558|NCT02579265|Lipid emulsions|lipid emulsions
159559|NCT02579265|Intravenous|intravenous
159560|NCT02579252|vaccine|vaccine
159561|NCT02579252|tau protein|tau protein
159562|NCT02579252|active|active
159563|NCT02579252|immunization|immunization
159564|NCT02579252|KLH|klh
159565|NCT02579252|immunotherapy|immunotherapy
159566|NCT02579252|tau|tau
159567|NCT02579239|LGMD2B|lgmd2b
159568|NCT02579239|FSHD|fshd
159569|NCT02579226|AZD2811|azd2811
159570|NCT02579226|Advanced solid tumours|advanced solid tumours
159571|NCT02579226|Small-cell lung cancer|small-cell lung cancer
159572|NCT02579213|electronic nose|electronic nose
159573|NCT02579213|abnormal fetal karyotype|abnormal fetal karyotype
159574|NCT02579161|Percutaneous Nephrolithotomy|percutaneous nephrolithotomy
159575|NCT02579161|Kidney Stones|kidney stones
159576|NCT02579161|Antibiotics|antibiotics
159577|NCT02579148|erectile dysfunction|erectile dysfunction
159578|NCT02579148|stem cell|stem cell
159579|NCT02579148|collagen scaffold|collagen scaffold
159580|NCT02579135|Condoms|condoms
159581|NCT02579135|Sexual Abstinence|sexual abstinence
159582|NCT02579135|Sexual Communication|sexual communication
159583|NCT02579122|Reviparin|reviparin
159584|NCT02579122|Bridging|bridging
159585|NCT02579122|Phenprocoumon|phenprocoumon
159586|NCT02579096|Gout|gout
159587|NCT02579096|Allopurinol|allopurinol
159588|NCT02579096|Febuxostat|febuxostat
159590|NCT02579070|Diabetic Foot|diabetic foot
159591|NCT02579070|foot temperature|foot temperature
159592|NCT02579070|diabetic foot ulcer|diabetic foot ulcer
159593|NCT02579057|Congestive heart failure|congestive heart failure
159594|NCT02579057|Furosemide|furosemide
159595|NCT02579031|Percutaneous Coronary Intervention|percutaneous coronary intervention
159596|NCT02579031|Stents|stents
159597|NCT02579031|Drug-Eluting Stents|drug-eluting stents
159598|NCT02579031|Coronary Artery Disease|coronary artery disease
159599|NCT02579031|Acute Coronary Syndrome|acute coronary syndrome
159600|NCT02579018|Anorexia Nervosa|anorexia nervosa
159601|NCT02579018|Exercise|exercise
159602|NCT02579018|Healthy Adults|healthy adults
159603|NCT02579018|Physical Activity|physical activity
159604|NCT02579005|Radiation|radiation
159605|NCT02579005|Immune response|immune response
159606|NCT02579005|Anti-tumor|anti-tumor
159607|NCT02579005|Lung Cancer|lung cancer
159608|NCT02578992|intubating stylet|intubating stylet
159609|NCT02578992|head and neck position|head and neck position
159610|NCT02578979|atrial fibrillation|atrial fibrillation
159611|NCT02578979|ischemic stroke|ischemic stroke
159612|NCT02578979|electrocardiogram|electrocardiogram
159613|NCT02578979|holter|holter
159614|NCT02578966|Early Childhood Caries|early childhood caries
159615|NCT02578966|Randomized clinical trial|randomized clinical trial
159616|NCT02578966|Motivational Interviewing|motivational interviewing
159617|NCT02578953|Bioequivalence|bioequivalence
159618|NCT02578953|Fasted state|fasted state
159619|NCT02578953|Japanese male healthy subjects|japanese male healthy subjects
159620|NCT02578953|Dutasteride|dutasteride
159621|NCT02578914|allergic conjunctivitis|allergic conjunctivitis
159622|NCT02578914|seasonal allergies|seasonal allergies
159623|NCT02578914|ragweed allergy|ragweed allergy
159624|NCT02578914|grass allergy|grass allergy
159625|NCT02578914|tree allergy|tree allergy
159626|NCT02578914|NS2|ns2
159627|NCT02578914|Aldeyra|aldeyra
159628|NCT02578901|Thrombocytopenia|thrombocytopenia
159629|NCT02578901|Tranexamic Acid|tranexamic acid
159630|NCT02578901|TXA|txa
159631|NCT02578901|Chemotherapy induced thrombocytopenia|chemotherapy induced thrombocytopenia
159632|NCT02578875|Sequence Technique|sequence technique
159633|NCT02578875|Infectious Disease|infectious disease
159634|NCT02578875|Pathogen Detection|pathogen detection
159635|NCT02578875|Diagnostic|diagnostic
159636|NCT02578836|Weight Loss|weight loss
159637|NCT02578836|Overweight|overweight
159638|NCT02578836|Endoscopic treatment for obesity|endoscopic treatment for obesity
159639|NCT02578823|Targeted Temperature Management(TTM)|targeted temperature management(ttm)
159640|NCT02578823|in-hospital cardiac arrest(IHCA)|in-hospital cardiac arrest(ihca)
159641|NCT02578823|restoration of spontaneous circulation(ROSC)|restoration of spontaneous circulation(rosc)
159642|NCT02578823|unconsciousness|unconsciousness
159643|NCT02578823|brain injury|brain injury
159644|NCT02578797|Castration-Resistant Prostate Cancer (CRPC)|castration-resistant prostate cancer (crpc)
159645|NCT02578797|Prostatic Neoplasms|prostatic neoplasms
159646|NCT02578797|Genital Diseases, Male|genital diseases, male
159647|NCT02578797|Genital Neoplasms, Male|genital neoplasms, male
159648|NCT02578797|Neoplasms|neoplasms
159649|NCT02578797|Neoplasms by Site|neoplasms by site
159650|NCT02578797|Prostatic Diseases|prostatic diseases
159651|NCT02578797|Urogenital Neoplasms|urogenital neoplasms
159652|NCT02578784|Dialysis|dialysis
159653|NCT02578758|Transdiagnostic Internet-based Protocol|transdiagnostic internet-based protocol
159654|NCT02578758|Positive affect regulation|positive affect regulation
159655|NCT02578706|HIV|hiv
159656|NCT02578706|Aspirin|aspirin
159657|NCT02578706|Clopidogrel|clopidogrel
159658|NCT02578706|Platelet|platelet
159659|NCT02578706|Inflammation|inflammation
159660|NCT02578706|Cardiovascular disease|cardiovascular disease
159661|NCT02578706|Arachidonic acid|arachidonic acid
159662|NCT02578706|Cyclooxygenase inhibitor|cyclooxygenase inhibitor
159663|NCT02578706|ADP inhibitor|adp inhibitor
159664|NCT02578706|Immune activation|immune activation
159665|NCT02578706|Monocyte|monocyte
159666|NCT02578706|Coagulation|coagulation
159667|NCT02578706|Thrombogenicity|thrombogenicity
159668|NCT02578680|PD1|pd1
159669|NCT02578680|PD-1|pd-1
159670|NCT02578680|PDL1|pdl1
159671|NCT02578680|PD-L1|pd-l1
159672|NCT02578680|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
159673|NCT02578641|Nasopharyngeal Carcinoma (NPC)|nasopharyngeal carcinoma (npc)
159674|NCT02578641|NPC|npc
159675|NCT02578641|immunotherapy|immunotherapy
159873|NCT02577406|CC-90007|cc-90007
159676|NCT02578641|Nasopharyngeal Cancer|nasopharyngeal cancer
159677|NCT02578641|Nose Cancer|nose cancer
159678|NCT02578641|Cell therapy|cell therapy
159679|NCT02578641|Head and Neck Cancer|head and neck cancer
159680|NCT02578641|Cytotoxic T Lymphocytes|cytotoxic t lymphocytes
159681|NCT02578641|chemotherapy|chemotherapy
159682|NCT02578641|Epstein-Barr Virus|epstein-barr virus
159683|NCT02578576|Diagnostic Techniques|diagnostic techniques
159684|NCT02578576|Digestive System|digestive system
159685|NCT02578550|Immunodeficiency Virus Type 1, Human|immunodeficiency virus type 1, human
159686|NCT02578550|Darunavir|darunavir
159687|NCT02578550|Cobicistat|cobicistat
159688|NCT02578550|Emtricitabine|emtricitabine
159689|NCT02578550|Tenofovir alafenamide|tenofovir alafenamide
159690|NCT02578550|Healthy participants|healthy participants
159691|NCT02578537|Ticagrelor|ticagrelor
159692|NCT02578537|Pharmacokinetics|pharmacokinetics
159693|NCT02578537|NSTE-ACS|nste-acs
159694|NCT02578537|CKD|ckd
159695|NCT02578524|cataract satisfaction|cataract satisfaction
159696|NCT02578511|Acute Lymphoblastic Leukemia in Complete Remission|acute lymphoblastic leukemia in complete remission
159697|NCT02578511|Lymphoblastic Lymphoma in Complete Remission|lymphoblastic lymphoma in complete remission
159698|NCT02578511|Mixed Phenotype Acute Leukemia in Complete Remission|mixed phenotype acute leukemia in complete remission
159699|NCT02578511|IXAZOMIB|ixazomib
159700|NCT02578511|POMP/D|pomp/d
159701|NCT02578511|Phase I|phase i
159702|NCT02578511|Early Phase|early phase
159703|NCT02578511|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
159704|NCT02578511|Lymphoblastic Lymphoma|lymphoblastic lymphoma
159705|NCT02578511|Mixed Phenotype Acute Leukemia|mixed phenotype acute leukemia
159706|NCT02578511|ALL|all
159707|NCT02578498|glucagon|glucagon
159708|NCT02578498|Carbohydrate diet|carbohydrate diet
159709|NCT02578472|Healthy|healthy
159710|NCT02578472|JNJ-42847922|jnj-42847922
159711|NCT02578472|zolpidem|zolpidem
159712|NCT02578472|Placebo|placebo
159713|NCT02578459|Cancer pain|cancer pain
159714|NCT02578459|Intrathecal therapy|intrathecal therapy
159715|NCT02578459|Pain|pain
159716|NCT02578459|Pancreatic cancer|pancreatic cancer
159717|NCT02578433|Mindful Self Compassion short form|mindful self compassion short form
159718|NCT02578433|Progressive Muscle Relaxation|progressive muscle relaxation
159719|NCT02578394|Gout|gout
159720|NCT02578394|Kidney|kidney
159721|NCT02578394|Depo-Medrone|depo-medrone
159722|NCT02578394|Anakinra|anakinra
159723|NCT02578381|pressure wire|pressure wire
159724|NCT02578381|coronary angiogram|coronary angiogram
159725|NCT02578381|validation|validation
159726|NCT02578368|gastric cancer|gastric cancer
159727|NCT02578368|perioperative|perioperative
159728|NCT02578368|FLOT|flot
159729|NCT02578368|limited metastatic|limited metastatic
159730|NCT02578368|GEJ cancer|gej cancer
159731|NCT02578355|Atherosclerosis|atherosclerosis
159732|NCT02578355|Coronary Artery Disease|coronary artery disease
159733|NCT02578355|Cardiovascular Disease|cardiovascular disease
159734|NCT02578355|Coronary Computed Tomographic Angiography|coronary computed tomographic angiography
159735|NCT02578355|CCTA|ccta
159736|NCT02578355|Myocardial Infarction|myocardial infarction
159737|NCT02578355|MI|mi
159738|NCT02578355|OPeRA|opera
159739|NCT02578329|Mediterranean diet|mediterranean diet
159740|NCT02578329|blood fatty acid|blood fatty acid
159741|NCT02578329|Coronary Artery Disease|coronary artery disease
159742|NCT02578316|Advanced Solid Tumors|advanced solid tumors
159743|NCT02578316|Lymphomas|lymphomas
159744|NCT02578303|sleep apnea|sleep apnea
159745|NCT02578303|phase-contrast MRI|phase-contrast mri
159746|NCT02578303|cerebral blood flow|cerebral blood flow
159747|NCT02578303|vascular risk factor|vascular risk factor
159748|NCT02578303|dementia|dementia
159749|NCT02578290|decision support systems|decision support systems
159750|NCT02578290|clinical|clinical
159751|NCT02578238|Korea|korea
159752|NCT02578238|Humira|humira
159753|NCT02578238|Pediatric Crohn's Disease|pediatric crohn's disease
159754|NCT02578225|Heart|heart
159755|NCT02578225|Chronic|chronic
159756|NCT02578225|Failure|failure
159757|NCT02578225|MI|mi
159758|NCT02578225|real life|real life
159759|NCT02578225|Turkey|turkey
159760|NCT02578160|pain|pain
159761|NCT02578160|infant behaviour|infant behaviour
159762|NCT02578160|heart rate|heart rate
159763|NCT02578160|dental anxiety|dental anxiety
159764|NCT02578147|risky sexual behavior|risky sexual behavior
159765|NCT02578147|early intervention|early intervention
159766|NCT02578121|Relapsed|relapsed
159767|NCT02578121|Response Rate|response rate
159768|NCT02578121|Progression free|progression free
159769|NCT02578082|Renal Impairment|renal impairment
159770|NCT02578082|Renal Insufficiency|renal insufficiency
159771|NCT02578069|Ischemic Stroke|ischemic stroke
159772|NCT02578069|Intracranial Stenting|intracranial stenting
159773|NCT02578056|pelvic organ prolapse|pelvic organ prolapse
159774|NCT02578056|urinary incontinence|urinary incontinence
159775|NCT02578017|Sickle Cell Disease|sickle cell disease
159776|NCT02578017|Hydroxyurea|hydroxyurea
159777|NCT02578017|Adherence|adherence
159779|NCT02578004|environmental, microbial, immunological and genetic factors|environmental, microbial, immunological and genetic factors
159780|NCT02578004|significantly different|significantly different
159781|NCT02577965|ST segment Elevation Myocardial Infarction|st segment elevation myocardial infarction
159782|NCT02577965|Optical Coherence Tomography|optical coherence tomography
159783|NCT02577965|Percutaneous Coronary Intervention|percutaneous coronary intervention
159784|NCT02577965|Thrombus histopathology|thrombus histopathology
159785|NCT02577965|Gender differences|gender differences
159786|NCT02577952|lipodystrophy|lipodystrophy
159787|NCT02577952|lipodystrophy, congenital generalized|lipodystrophy, congenital generalized
159788|NCT02577952|Berardinelli-Seip Congenital Lipodystrophy|berardinelli-seip congenital lipodystrophy
159789|NCT02577952|Congenital generalized lipodystrophy|congenital generalized lipodystrophy
159790|NCT02577952|generalized lipodystrophy|generalized lipodystrophy
159791|NCT02577952|lipodystrophy, familial partial|lipodystrophy, familial partial
159792|NCT02577952|partial lipodystrophy|partial lipodystrophy
159793|NCT02577952|lipodystrophy, partial, acquired|lipodystrophy, partial, acquired
159794|NCT02577952|acquired lipodystrophy|acquired lipodystrophy
159795|NCT02577913|contraception|contraception
159796|NCT02577913|contraceptive patch|contraceptive patch
159797|NCT02577913|Levonorgestrel|levonorgestrel
159798|NCT02577913|gestodene|gestodene
159799|NCT02577913|safety|safety
159800|NCT02577900|foot ulcer and honey and silver|foot ulcer and honey and silver
159801|NCT02577861|limbal stem cells deficinecy, LSCD, ocular burn|limbal stem cells deficinecy, lscd, ocular burn
159802|NCT02577848|Glucagon-like peptide-1|glucagon-like peptide-1
159803|NCT02577848|Non-ST-segment elevation myocardial infarction|non-st-segment elevation myocardial infarction
159804|NCT02577848|Left ventricular ejection fraction|left ventricular ejection fraction
159805|NCT02577835|Hypertension|hypertension
159806|NCT02577835|Arterial Stiffness|arterial stiffness
159807|NCT02577835|Ambulatory blood pressure|ambulatory blood pressure
159808|NCT02577796|radial artery spasm|radial artery spasm
159809|NCT02577796|radial artery occlusion|radial artery occlusion
159810|NCT02577796|radial access|radial access
159811|NCT02577783|Doxorubicin Hydrochloride|doxorubicin hydrochloride
159812|NCT02577770|Acupuncture|acupuncture
159813|NCT02577770|caffeine|caffeine
159814|NCT02577770|pain|pain
159815|NCT02577757|Languages network|languages network
159816|NCT02577757|Functional MRI|functional mri
159817|NCT02577744|Electrical Impedance Tomography|electrical impedance tomography
159818|NCT02577731|Trauma|trauma
159819|NCT02577705|food insecurity|food insecurity
159820|NCT02577705|adverse childhood experiences|adverse childhood experiences
159821|NCT02577705|violence exposure|violence exposure
159822|NCT02577705|trauma|trauma
159823|NCT02577705|poverty|poverty
159824|NCT02577705|TANF|tanf
159825|NCT02577705|assets|assets
159826|NCT02577705|depression|depression
159827|NCT02577705|randomized control trial|randomized control trial
159828|NCT02577679|Dentistry|dentistry
159829|NCT02577653|balance, postural|balance, postural
159830|NCT02577653|postural equilibrium|postural equilibrium
159831|NCT02577614|Cardiopulmonary Bypass|cardiopulmonary bypass
159832|NCT02577614|Aortic Valve Repair|aortic valve repair
159833|NCT02577614|Coronary Re-Implantation|coronary re-implantation
159834|NCT02577614|Deep Hypothermic Circulatory Arrest|deep hypothermic circulatory arrest
159835|NCT02577614|Factor VIII Inhibitor Bypass Activity|factor viii inhibitor bypass activity
159836|NCT02577614|Transfusion|transfusion
159837|NCT02577601|Emergency contraception|emergency contraception
159838|NCT02577601|Birth Control Pills|birth control pills
159839|NCT02577588|p53 Antigen|p53 antigen
159840|NCT02577588|T cell therapy|t cell therapy
159841|NCT02577588|autologous|autologous
159842|NCT02577588|Adoptive Cellular Immunotherapy|adoptive cellular immunotherapy
159843|NCT02577575|Oxytocin|oxytocin
159844|NCT02577575|Syntocinon|syntocinon
159845|NCT02577575|Social Cognition|social cognition
159846|NCT02577575|Schizophrenia|schizophrenia
159847|NCT02577549|Knee Pain|knee pain
159848|NCT02577549|Exercise|exercise
159849|NCT02577549|Diet|diet
159850|NCT02577549|Weight Loss|weight loss
159851|NCT02577536|Pregnancy outcome|pregnancy outcome
159852|NCT02577536|Neonatal outcome|neonatal outcome
159853|NCT02577536|Birth weight|birth weight
159854|NCT02577536|Weight gain|weight gain
159855|NCT02577536|Physical disability|physical disability
159856|NCT02577510|Lateral Femoral Cutaneous Nerve Block|lateral femoral cutaneous nerve block
159857|NCT02577510|Meralgia Parasthetica|meralgia parasthetica
159858|NCT02577510|nerve stimulator|nerve stimulator
159859|NCT02577510|ultrasound|ultrasound
159860|NCT02577484|Fractional Flow Reserve|fractional flow reserve
159861|NCT02577484|Rapid Exchange|rapid exchange
159862|NCT02577484|Catheter|catheter
159863|NCT02577471|Constipation|constipation
159864|NCT02577471|pregnancy|pregnancy
159865|NCT02577471|delivery|delivery
159866|NCT02577432|spinal anesthesia|spinal anesthesia
159867|NCT02577419|breast milk|breast milk
159868|NCT02577419|chylothorax|chylothorax
159869|NCT02577419|infants|infants
159870|NCT02577419|cardiac surgery|cardiac surgery
159871|NCT02577419|modified fat breast milk|modified fat breast milk
159872|NCT02577406|AG-221|ag-221
159874|NCT02577406|Efficacy|efficacy
159875|NCT02577406|Safety|safety
159876|NCT02577406|Leukemia|leukemia
159877|NCT02577406|Acute myeloid meukemia|acute myeloid meukemia
159878|NCT02577406|Isocitrate dehydrogenase 2 mutation|isocitrate dehydrogenase 2 mutation
159879|NCT02577406|Enasidenib|enasidenib
159880|NCT02577393|Lung Neoplasms|lung neoplasms
159881|NCT02577393|esophagitis|esophagitis
159882|NCT02577393|Prevention & Control|prevention & control
159883|NCT02577393|Epigallocatechin Gallate|epigallocatechin gallate
159884|NCT02577367|Hypothyroidism|hypothyroidism
159885|NCT02577367|Tube Feeding|tube feeding
159886|NCT02577341|Nimotuzumab, Chemoradiotherapy,Squamous Cell Lung Cancer|nimotuzumab, chemoradiotherapy,squamous cell lung cancer
159887|NCT02577289|simultaneous implantation|simultaneous implantation
159888|NCT02577289|Dental implant|dental implant
159889|NCT02577289|Open sinus Lifting|open sinus lifting
159890|NCT02577289|PRF|prf
159891|NCT02577289|platelet rich fibrin (PRF)|platelet rich fibrin (prf)
159892|NCT02577276|stroke|stroke
159893|NCT02577276|remote monitoring|remote monitoring
159894|NCT02577276|hemiparesis|hemiparesis
159895|NCT02577250|ketamine|ketamine
159896|NCT02577250|stress disorders, post-traumatic|stress disorders, post-traumatic
159897|NCT02577250|stress disorders, traumatic|stress disorders, traumatic
159898|NCT02577250|anxiety disorders|anxiety disorders
159899|NCT02577250|mental disorders|mental disorders
159900|NCT02577250|adjuvants, anesthesia|adjuvants, anesthesia
159901|NCT02577250|analgesics|analgesics
159902|NCT02577250|anesthetics|anesthetics
159903|NCT02577250|anesthetics, dissociative|anesthetics, dissociative
159904|NCT02577250|anesthetics, general|anesthetics, general
159905|NCT02577250|anesthetics, intravenous|anesthetics, intravenous
159906|NCT02577250|excitatory amino acid agents|excitatory amino acid agents
159907|NCT02577250|excitatory amino acid antagonists|excitatory amino acid antagonists
159908|NCT02577250|hypnotics and sedatives|hypnotics and sedatives
159909|NCT02577250|molecular mechanisms of pharmacological action|molecular mechanisms of pharmacological action
159910|NCT02577250|neurotransmitter agents|neurotransmitter agents
159911|NCT02577250|peripheral nervous system agents|peripheral nervous system agents
159912|NCT02577250|pharmacologic actions|pharmacologic actions
159913|NCT02577250|physiological effects of drugs|physiological effects of drugs
159914|NCT02577250|psychotropic drugs|psychotropic drugs
159915|NCT02577250|sensory system agents|sensory system agents
159916|NCT02577250|central nervous system agents|central nervous system agents
159917|NCT02577250|central nervous system depressants|central nervous system depressants
159918|NCT02577250|depression|depression
159919|NCT02577250|depressive disorder|depressive disorder
159920|NCT02577250|depressive disorder, treatment-resistant|depressive disorder, treatment-resistant
159921|NCT02577250|behavioral symptoms|behavioral symptoms
159922|NCT02577250|mood disorders|mood disorders
159923|NCT02577250|therapeutic uses|therapeutic uses
159924|NCT02577237|caregiver|caregiver
159925|NCT02577237|simulation|simulation
159926|NCT02577224|Patient-led care|patient-led care
159927|NCT02577224|Botulinum toxin|botulinum toxin
159928|NCT02577224|Dystonia|dystonia
159929|NCT02577224|Randomised controlled trial|randomised controlled trial
159930|NCT02577224|Acceptability|acceptability
159931|NCT02577211|Critically ill|critically ill
159932|NCT02577211|Enteral nutrition|enteral nutrition
159933|NCT02577172|Testicular cancer|testicular cancer
159934|NCT02577172|Physical Exercise|physical exercise
159935|NCT02577172|Chemotherapy|chemotherapy
159936|NCT02577159|sodium-glucose cotransporter 2 inhibitor|sodium-glucose cotransporter 2 inhibitor
159937|NCT02577159|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
159938|NCT02577159|dyslipidemia|dyslipidemia
159939|NCT02577159|remnants|remnants
159940|NCT02577159|apolipoprotein B-48|apolipoprotein b-48
159941|NCT02577146|stone|stone
159942|NCT02577146|ureter|ureter
159943|NCT02577146|ultrasound|ultrasound
159944|NCT02577133|colic|colic
159945|NCT02577133|probiotic|probiotic
159946|NCT02577133|Lactobacillus reuteri|lactobacillus reuteri
159947|NCT02577133|prevention|prevention
159948|NCT02577120|Epiceram|epiceram
159949|NCT02577120|Ceramiseal|ceramiseal
159950|NCT02577107|Age-related macular degeneration,|age-related macular degeneration,
159951|NCT02577107|ranibizumab,|ranibizumab,
159952|NCT02577107|conbercept,|conbercept,
159953|NCT02577107|plasma VEGF|plasma vegf
159954|NCT02577107|PK|pk
159955|NCT02577094|CD22 positive- lymphoblastic leukemia-RIT-Yttrium|cd22 positive- lymphoblastic leukemia-rit-yttrium
159956|NCT02577055|Multiple leiomyoma|multiple leiomyoma
159957|NCT02577055|Uterine Artery Embolization|uterine artery embolization
159958|NCT02577055|Surgery|surgery
159959|NCT02577055|childbearing age|childbearing age
159960|NCT02577055|Fertility|fertility
159961|NCT02577055|Noninferiority trial|noninferiority trial
159962|NCT02577042|Raltegravir|raltegravir
159963|NCT02577042|protease inhibitors|protease inhibitors
159964|NCT02577042|darunavir|darunavir
159965|NCT02577042|inflammation|inflammation
159966|NCT02577042|statins|statins
159967|NCT02577042|comorbidities|comorbidities
159968|NCT02576990|PD1|pd1
159969|NCT02576990|PD-1|pd-1
159970|NCT02576990|PDL1|pdl1
159971|NCT02576990|PD-L1|pd-l1
159972|NCT02576977|PDL1|pdl1
159973|NCT02576977|PD1|pd1
159974|NCT02576977|Multiple Myeloma|multiple myeloma
159975|NCT02576938|Atopic Eczema|atopic eczema
159976|NCT02576912|Cannabis|cannabis
159977|NCT02576912|Marijuana|marijuana
159978|NCT02576912|THC|thc
159979|NCT02576912|Pregnenolone|pregnenolone
159980|NCT02576912|Psychotic Disorders|psychotic disorders
159981|NCT02576912|PREG|preg
159982|NCT02576899|smoking cessation|smoking cessation
159983|NCT02576899|posttraumatic stress disorder|posttraumatic stress disorder
159984|NCT02576899|tobacco|tobacco
159985|NCT02576899|treatment|treatment
159986|NCT02576899|smoking|smoking
159987|NCT02576899|mindfulness|mindfulness
159988|NCT02576899|acceptance|acceptance
159989|NCT02576899|functioning|functioning
159990|NCT02576886|supine|supine
159991|NCT02576886|prone|prone
159992|NCT02576886|myocardial perfusion imaging|myocardial perfusion imaging
159993|NCT02576886|radiation exposure|radiation exposure
159994|NCT02576886|pre-screening tool|pre-screening tool
159995|NCT02576873|Survival|survival
159996|NCT02576873|Hemodiafiltration|hemodiafiltration
159997|NCT02576873|End-stage renal disease|end-stage renal disease
159998|NCT02576873|Hemodialysis|hemodialysis
159999|NCT02576821|Amnesia, Alzheimer, hippocampal sclerosis, fronto-temporal lobar degeneration|amnesia, alzheimer, hippocampal sclerosis, fronto-temporal lobar degeneration
160000|NCT02576795|Haemophilia A|haemophilia a
160001|NCT02576795|Gene Therapy|gene therapy
160002|NCT02576795|Clotting Disorders|clotting disorders
160003|NCT02576795|Blood Disorder|blood disorder
160004|NCT02576782|regional anesthesia|regional anesthesia
160005|NCT02576782|dexamethasone|dexamethasone
160006|NCT02576782|bupivacaine|bupivacaine
160007|NCT02576782|femoral|femoral
160008|NCT02576782|sciatic|sciatic
160009|NCT02576769|Basal cell carcinoma|basal cell carcinoma
160010|NCT02576769|Pigmentation|pigmentation
160011|NCT02576769|Melanocyte|melanocyte
160012|NCT02576769|Melanin|melanin
160013|NCT02576769|Skin cancer|skin cancer
160014|NCT02576756|Risk on aspiration|risk on aspiration
160015|NCT02576756|Postoperative|postoperative
160016|NCT02576756|Difficult Intubation|difficult intubation
160017|NCT02576743|Stroke|stroke
160018|NCT02576743|AVM|avm
160019|NCT02576743|Aneurysm|aneurysm
160020|NCT02576717|MS|ms
160021|NCT02576717|RMS|rms
160022|NCT02576717|Multiple Sclerosis|multiple sclerosis
160023|NCT02576717|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
160024|NCT02576691|cardiac arrest|cardiac arrest
160025|NCT02576691|percutaneous coronary intervention|percutaneous coronary intervention
160026|NCT02576691|cardiogenic shock|cardiogenic shock
160027|NCT02576691|outcome|outcome
160028|NCT02576678|Psoriasis|psoriasis
160029|NCT02576678|Moderate to Severe Plaque Psoriasis|moderate to severe plaque psoriasis
160030|NCT02576678|Plaque Psoriasis|plaque psoriasis
160031|NCT02576678|CC-10004|cc-10004
160032|NCT02576678|Apremilast|apremilast
160033|NCT02576678|Pharmacokinetics|pharmacokinetics
160034|NCT02576678|Open-label|open-label
160035|NCT02576678|Safety|safety
160036|NCT02576678|Pediatric|pediatric
160037|NCT02576665|Anaplastic Astrocytoma, Glioblastoma|anaplastic astrocytoma, glioblastoma
160038|NCT02576652|bone biopsy|bone biopsy
160039|NCT02576652|tetracycline|tetracycline
160040|NCT02576652|demeclocycline|demeclocycline
160041|NCT02576652|total hip replacement|total hip replacement
160042|NCT02576639|Alzheimer's Disease,|alzheimer's disease,
160043|NCT02576639|Amyloid Beta,|amyloid beta,
160044|NCT02576639|cerebrospinal fluid,|cerebrospinal fluid,
160045|NCT02576639|beta secretase|beta secretase
160046|NCT02576626|Nebulizer|nebulizer
160047|NCT02576626|DPI|dpi
160048|NCT02576626|COPD|copd
160049|NCT02576626|indacaterol|indacaterol
160050|NCT02576626|ipratropium|ipratropium
160051|NCT02576626|glycopyrronium|glycopyrronium
160052|NCT02576626|salbutamol|salbutamol
160053|NCT02576626|Breezhaler|breezhaler
160054|NCT02576626|Nebuliser|nebuliser
160055|NCT02576626|Hyperinflation|hyperinflation
160056|NCT02576626|Dyspnea|dyspnea
160057|NCT02576626|SABA|saba
160058|NCT02576626|short-acting muscarinic antagonists (SAMA)|short-acting muscarinic antagonists (sama)
160059|NCT02576626|long-acting beta2-agonist (LABA)|long-acting beta2-agonist (laba)
160060|NCT02576626|LAMA|lama
160061|NCT02576626|FEV1|fev1
160062|NCT02576574|Avelumab|avelumab
160063|NCT02576574|MSB0010718C|msb0010718c
160064|NCT02576574|Non-Small Cell Lung Cancer|non-small cell lung cancer
160065|NCT02576561|human papillomavirus|human papillomavirus
160066|NCT02576561|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
160067|NCT02576561|Cold Knife Conization|cold knife conization
160068|NCT02576561|hysterectomy|hysterectomy
160069|NCT02576561|Loop Electrosurgical Excision Procedure|loop electrosurgical excision procedure
160070|NCT02576561|LEEP|leep
160071|NCT02576561|HSIL|hsil
160072|NCT02576561|High-Grade Squamous Intraepithelial Lesion|high-grade squamous intraepithelial lesion
160073|NCT02576496|phase 1 clinical trial|phase 1 clinical trial
160074|NCT02576496|multiple myeloma|multiple myeloma
160075|NCT02576496|Hodgkin's lymphoma|hodgkin's lymphoma
160076|NCT02576496|peripheral T-cell lymphoma|peripheral t-cell lymphoma
160077|NCT02576496|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
160078|NCT02576470|swallowing|swallowing
160079|NCT02576470|stroke|stroke
160080|NCT02576470|dysphagia|dysphagia
160081|NCT02576470|deglutition|deglutition
160082|NCT02576431|NTRK Fusion Positive|ntrk fusion positive
160083|NCT02576431|LOXO-101|loxo-101
160084|NCT02576431|Loxo|loxo
160085|NCT02576431|TRK|trk
160086|NCT02576431|TRK Fusion|trk fusion
160087|NCT02576431|NTRK1|ntrk1
160088|NCT02576431|NTRK2|ntrk2
160089|NCT02576431|NTRK3|ntrk3
160090|NCT02576431|TRKA|trka
160091|NCT02576431|TRKB|trkb
160092|NCT02576431|TRKC|trkc
160093|NCT02576431|ETV6|etv6
160094|NCT02576431|NTRK|ntrk
160095|NCT02576431|larotrectinib|larotrectinib
160096|NCT02576431|fusion|fusion
160097|NCT02576431|tumors|tumors
160098|NCT02576431|CNS tumors|cns tumors
160099|NCT02576431|solid tumors|solid tumors
160100|NCT02576431|central nervous system tumors|central nervous system tumors
160101|NCT02576431|solid CNS tumors|solid cns tumors
160102|NCT02576431|primary CNS tumor|primary cns tumor
160103|NCT02576431|Advanced CNS tumor|advanced cns tumor
160104|NCT02576431|Metastatic CNS tumor|metastatic cns tumor
160105|NCT02576431|NTRK1 fusion|ntrk1 fusion
160106|NCT02576431|NTRK2 fusion|ntrk2 fusion
160107|NCT02576431|NTRK3 fusion|ntrk3 fusion
160108|NCT02576431|ETV6-NTRK3|etv6-ntrk3
160109|NCT02576431|ETV6 fusion|etv6 fusion
160110|NCT02576418|Partosure TTD test|partosure ttd test
160111|NCT02576418|CL|cl
160112|NCT02576418|ART|art
160113|NCT02576418|SN|sn
160114|NCT02576418|SP|sp
160115|NCT02576418|PPV|ppv
160116|NCT02576418|NPV|npv
160117|NCT02576379|Helicopter Emergency Medical System|helicopter emergency medical system
160118|NCT02576379|Mortality|mortality
160119|NCT02576379|Labour market affiliation|labour market affiliation
160120|NCT02576379|Modified Rankin Scale|modified rankin scale
160121|NCT02576327|Lymphoma|lymphoma
160122|NCT02576327|Aprepitant|aprepitant
160123|NCT02576327|Chemotherapy-induced nausea and vomiting (CINV)|chemotherapy-induced nausea and vomiting (cinv)
160124|NCT02576327|Autologous Hematopoietic Stem Cell Transplantation|autologous hematopoietic stem cell transplantation
160125|NCT02576327|Hematological Malignancies|hematological malignancies
160126|NCT02576301|AML|aml
160127|NCT02576301|MDS|mds
160128|NCT02576288|Sitagliptin|sitagliptin
160129|NCT02576288|Brachial artery flow mediated dilation|brachial artery flow mediated dilation
160130|NCT02576288|Carotid stiffness|carotid stiffness
160131|NCT02576288|Pro-inflammatory|pro-inflammatory
160132|NCT02576288|Pro-atherogenic|pro-atherogenic
160133|NCT02576288|M1 macrophages|m1 macrophages
160134|NCT02576275|Phase 3|phase 3
160135|NCT02576275|iNHL|inhl
160136|NCT02576275|Follicular Lymphoma|follicular lymphoma
160137|NCT02576275|FL|fl
160138|NCT02576275|PI3K|pi3k
160139|NCT02576275|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
160140|NCT02576275|SLL|sll
160141|NCT02576275|Marginal Zone Lymphoma|marginal zone lymphoma
160142|NCT02576275|MZL|mzl
160143|NCT02576249|osteoarthritis|osteoarthritis
160144|NCT02576249|injection|injection
160145|NCT02576249|steroid|steroid
160146|NCT02576249|anesthetic|anesthetic
160147|NCT02576236|Naïve patient|naïve patient
160148|NCT02576236|Suspicion of H pylori infection|suspicion of h pylori infection
160149|NCT02576236|Endoscopy|endoscopy
160150|NCT02576236|Antibiotics therapeutic strategies|antibiotics therapeutic strategies
160151|NCT02576236|Urea breath test|urea breath test
160152|NCT02576223|Peripheral Nerve Blocks|peripheral nerve blocks
160153|NCT02576197|mild to moderate|mild to moderate
160154|NCT02576197|probiotic|probiotic
160155|NCT02576184|Incisional hernia|incisional hernia
160156|NCT02576184|Stoma|stoma
160157|NCT02576184|rectal cancer|rectal cancer
160158|NCT02576184|synthetic mesh|synthetic mesh
160159|NCT02576184|biologic mesh|biologic mesh
160160|NCT02576171|cognitive behavioral therapy;|cognitive behavioral therapy;
160161|NCT02576171|guided self-help|guided self-help
160162|NCT02576171|adolescent|adolescent
160163|NCT02576067|Atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease
160164|NCT02576067|Inflammation reduction|inflammation reduction
160165|NCT02576041|driving simulator|driving simulator
160166|NCT02576028|Total Hip Replacement|total hip replacement
160167|NCT02576028|Manipulation Therapy|manipulation therapy
160168|NCT02576002|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
160169|NCT02575989|Trauma|trauma
160170|NCT02575989|Prehospital|prehospital
160171|NCT02575989|Hypothermia|hypothermia
160172|NCT02575976|Rehabilitation|rehabilitation
160173|NCT02575976|Coronary artery disease|coronary artery disease
160174|NCT02575976|Patient Education|patient education
160175|NCT02575976|Randomized Controlled Trial|randomized controlled trial
160176|NCT02575976|Protocol|protocol
160177|NCT02575937|low glycemic diet|low glycemic diet
160178|NCT02575937|diabetes|diabetes
160179|NCT02575924|media|media
160180|NCT02575924|blastocyst|blastocyst
160181|NCT02575924|male infertility|male infertility
160182|NCT02575924|poor responders|poor responders
160183|NCT02575924|pgs|pgs
160184|NCT02575859|HIPEC|hipec
160185|NCT02575859|peritoneal lavage|peritoneal lavage
160186|NCT02575833|Angina|angina
160187|NCT02575833|Stable Angina|stable angina
160188|NCT02575833|Cardiovascular Disease|cardiovascular disease
160189|NCT02575833|Exercise-induced Angina|exercise-induced angina
160190|NCT02575807|Ovarian cancer|ovarian cancer
160191|NCT02575807|Fallopian cancer|fallopian cancer
160192|NCT02575807|Primary peritoneal cancer|primary peritoneal cancer
160193|NCT02575755|Azithromycin|azithromycin
160194|NCT02575755|Piperaquine|piperaquine
160195|NCT02575755|IPTp|iptp
160196|NCT02575755|Pharmacokinetics|pharmacokinetics
160197|NCT02575755|Efficacy|efficacy
160198|NCT02575729|carpal tunnel syndrome|carpal tunnel syndrome
160199|NCT02575729|local steroid injection|local steroid injection
160200|NCT02575729|sonography|sonography
160201|NCT02575729|sonography-guided|sonography-guided
160202|NCT02575716|McGrath®|mcgrath®
160203|NCT02575716|Videolaryngoscope|videolaryngoscope
160204|NCT02575716|intubating condition|intubating condition
160205|NCT02575716|muscle relaxant|muscle relaxant
160206|NCT02575716|intubation|intubation
160207|NCT02575690|spirulina, placebo, obesity,antihypertensive treatment|spirulina, placebo, obesity,antihypertensive treatment
160208|NCT02575677|labor pain|labor pain
160209|NCT02575677|oxycodone|oxycodone
160210|NCT02575664|Pain|pain
160211|NCT02575664|Arthroplasty|arthroplasty
160212|NCT02575664|Buprenorphine|buprenorphine
160213|NCT02575651|PARP|parp
160214|NCT02575651|Advanced Solid Malignancies|advanced solid malignancies
160215|NCT02575651|Fluzoparib|fluzoparib
160216|NCT02575651|Ovarian Cancer|ovarian cancer
160217|NCT02575651|BRCA|brca
160218|NCT02575625|Liver steatosis|liver steatosis
160219|NCT02575625|Steatohepatitis|steatohepatitis
160220|NCT02575625|Fibroscan|fibroscan
160221|NCT02575599|Self-management|self-management
160222|NCT02575599|web-based|web-based
160223|NCT02575599|quantitative approach|quantitative approach
160224|NCT02575586|Trigger Points|trigger points
160225|NCT02575586|Dry needling|dry needling
160226|NCT02575586|Torque|torque
160227|NCT02575586|H-Reflex|h-reflex
160228|NCT02575573|resuscitation decision|resuscitation decision
160229|NCT02575560|Progression-Free Survival|progression-free survival
160230|NCT02575547|Nutritional Status|nutritional status
160231|NCT02575547|Locoregionally Advanced Nasopharyngeal Carcinoma|locoregionally advanced nasopharyngeal carcinoma
160232|NCT02575534|anti-arrhythmic therapy|anti-arrhythmic therapy
160233|NCT02575482|SUVN-D4010|suvn-d4010
160234|NCT02575482|serotonin 4 (5-HT4) receptor|serotonin 4 (5-ht4) receptor
160235|NCT02575482|first in human|first in human
160236|NCT02575482|safety|safety
160237|NCT02575482|pharmacokinetics|pharmacokinetics
160238|NCT02575482|tolerability|tolerability
160239|NCT02575482|single dose|single dose
160240|NCT02575482|repeat dose|repeat dose
160241|NCT02575417|advance care planning|advance care planning
160242|NCT02575417|end-of-life care|end-of-life care
160243|NCT02575417|health games|health games
160244|NCT02575417|Family caregivers|family caregivers
160245|NCT02575417|Advance directives|advance directives
160246|NCT02575404|Metastatic|metastatic
160247|NCT02575404|Keytruda|keytruda
160248|NCT02575404|pembrolizumab|pembrolizumab
160249|NCT02575404|GR-MD-02|gr-md-02
160250|NCT02575404|Galactoarabino-rhamnogalacturonate|galactoarabino-rhamnogalacturonate
160251|NCT02575404|Immunotherapy|immunotherapy
160252|NCT02575391|L-Glutamine|l-glutamine
160253|NCT02575391|chemotherapy|chemotherapy
160254|NCT02575391|radiotherapy|radiotherapy
160255|NCT02575391|therapeutic toxicity|therapeutic toxicity
160256|NCT02575378|Metastatic Colorectal Cancer|metastatic colorectal cancer
160257|NCT02575378|Maintenance Treatment|maintenance treatment
160258|NCT02575378|Chinese Traditional Medicine|chinese traditional medicine
160259|NCT02575378|Clinical Trial|clinical trial
160260|NCT02575378|efficacy|efficacy
160261|NCT02575378|safety|safety
160262|NCT02575365|RRMS,|rrms,
160263|NCT02575365|Cognition,|cognition,
160264|NCT02575365|brain,|brain,
160265|NCT02575365|Fingolimod,|fingolimod,
160266|NCT02575365|Multiple Sclerosis,|multiple sclerosis,
160267|NCT02575365|neurodegeneration,|neurodegeneration,
160268|NCT02575365|Brain atrophy,|brain atrophy,
160269|NCT02575365|gray matter atrophy,|gray matter atrophy,
160270|NCT02575365|thalamic atrophy,|thalamic atrophy,
160271|NCT02575365|biomarkers,|biomarkers,
160272|NCT02575365|BICAMS Battery,|bicams battery,
160273|NCT02575352|Bone Substitute|bone substitute
160274|NCT02575352|Calcium Phosphate Cement|calcium phosphate cement
160275|NCT02575352|GRAFTYS|graftys
160276|NCT02575352|GRAFTYS®HBS|graftys®hbs
160277|NCT02575352|GRAFTYS®QUICKSET|graftys®quickset
160278|NCT02575352|Bone void filler|bone void filler
160279|NCT02575352|Bone growth|bone growth
160280|NCT02575352|Registry|registry
160281|NCT02575352|Bone defect|bone defect
160282|NCT02575352|Revision arthroplasty|revision arthroplasty
160283|NCT02575352|Arthrodesis|arthrodesis
160284|NCT02575339|MLN0128|mln0128
160285|NCT02575339|Sapanisertib|sapanisertib
160286|NCT02575339|TORC1/2 inhibitor|torc1/2 inhibitor
160287|NCT02575339|INK128|ink128
160288|NCT02575339|Nexavar|nexavar
160289|NCT02575339|Sorafenib|sorafenib
160290|NCT02575326|Asthma, Body Mass Idex, BMI, Overweight, Obesity|asthma, body mass idex, bmi, overweight, obesity
160291|NCT02575313|L-Glutamine|l-glutamine
160292|NCT02575313|chemotherapy|chemotherapy
160293|NCT02575313|radiotherapy|radiotherapy
160294|NCT02575313|therapeutic toxicity|therapeutic toxicity
160295|NCT02575300|neuroendocrine tumors (NETs)|neuroendocrine tumors (nets)
160296|NCT02575300|gastroenteropancreatic NETs|gastroenteropancreatic nets
160297|NCT02575300|pancreatic NETs|pancreatic nets
160298|NCT02575300|gastrointestinal (GI) tract NET|gastrointestinal (gi) tract net
160299|NCT02575300|advanced carcinoid tumors|advanced carcinoid tumors
160300|NCT02575274|Peri-implantitis|peri-implantitis
160301|NCT02575274|Peri-implant disease|peri-implant disease
160302|NCT02575274|Dental implants|dental implants
160303|NCT02575274|Guided bone regeneration|guided bone regeneration
160304|NCT02575261|CAR-T cell immunotherapy|car-t cell immunotherapy
160305|NCT02575261|EphA2|epha2
160306|NCT02575261|malignant glioma|malignant glioma
160307|NCT02575248|dienogest|dienogest
160308|NCT02575248|infertility|infertility
160309|NCT02575248|endometriosis|endometriosis
160310|NCT02575235|Sarcopenia|sarcopenia
160311|NCT02575235|Cetylpyridinium chloride|cetylpyridinium chloride
160312|NCT02575222|Immunotherapy|immunotherapy
160313|NCT02575222|PD-1|pd-1
160314|NCT02575222|anti-PD-1|anti-pd-1
160315|NCT02575222|antibody|antibody
160316|NCT02575222|Kidney Cancer|kidney cancer
160317|NCT02575222|RCC|rcc
160318|NCT02575222|non-metastatic|non-metastatic
160319|NCT02575196|Cardiac arrest|cardiac arrest
160320|NCT02575196|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
160321|NCT02575196|CPR|cpr
160322|NCT02575196|cerebral blood flow|cerebral blood flow
160323|NCT02575196|cerebral perfusion|cerebral perfusion
160324|NCT02575183|Waterpipe smoking|waterpipe smoking
160325|NCT02575183|Nicotine dependence|nicotine dependence
160326|NCT02575183|Smoking cessation|smoking cessation
160327|NCT02575183|Varinecline, Chantix therapy|varinecline, chantix therapy
160328|NCT02575183|Behavioral therapy|behavioral therapy
160329|NCT02575170|amino acid|amino acid
160330|NCT02575170|cesarean delivery|cesarean delivery
160331|NCT02575170|hypothermia|hypothermia
160332|NCT02575131|satiety|satiety
160333|NCT02575131|overweight|overweight
160334|NCT02575131|breakfast|breakfast
160335|NCT02575131|ecological validity|ecological validity
160336|NCT02575105|Bispectral Index Hydrocephalus|bispectral index hydrocephalus
160337|NCT02575092|Hyperhomocysteinemia|hyperhomocysteinemia
160338|NCT02575092|Coronary angiography|coronary angiography
160339|NCT02575092|Percutaneous coronary intervention|percutaneous coronary intervention
160340|NCT02575092|Hypertension|hypertension
160341|NCT02575092|Contrast-induced nephropathy|contrast-induced nephropathy
160342|NCT02575066|pazopanib|pazopanib
160343|NCT02575066|radiotherapy|radiotherapy
160344|NCT02575053|latex allergy|latex allergy
160345|NCT02575053|latex hypersensitivity|latex hypersensitivity
160346|NCT02575053|powder free latex surgical gloves|powder free latex surgical gloves
160347|NCT02575053|latex safe protocol|latex safe protocol
160348|NCT02575001|Type 1 diabetes|type 1 diabetes
160349|NCT02575001|Children and adolescents|children and adolescents
160350|NCT02575001|Stress|stress
160351|NCT02575001|Genetic factors|genetic factors
160352|NCT02575001|Psychological background|psychological background
160353|NCT02574988|drug allergy|drug allergy
160354|NCT02574988|drug hypersensitivity|drug hypersensitivity
160355|NCT02574988|adverse drug reactions|adverse drug reactions
160356|NCT02574988|severe cutaneous adverse reactions|severe cutaneous adverse reactions
160357|NCT02574949|radiation|radiation
160358|NCT02574949|fluoroscopy|fluoroscopy
160359|NCT02574949|diagnostic|diagnostic
160360|NCT02574936|karydakis modification|karydakis modification
160361|NCT02574936|pilonidal sinus|pilonidal sinus
160362|NCT02574936|complication|complication
160363|NCT02574923|Cerebral Palsy|cerebral palsy
160364|NCT02574923|Stem Cells|stem cells
160365|NCT02574871|Stress|stress
160366|NCT02574871|Chronic stress|chronic stress
160367|NCT02574871|Perceived stress|perceived stress
160368|NCT02574871|Psychological distress|psychological distress
160369|NCT02574832|Pain|pain
160370|NCT02574832|Surgery|surgery
160371|NCT02574832|Pregnancy|pregnancy
160372|NCT02574832|Anesthesia|anesthesia
160373|NCT02574819|opioid-induced constipation|opioid-induced constipation
160374|NCT02574806|BNP|bnp
160375|NCT02574806|Reference values|reference values
160376|NCT02574806|Newborn|newborn
160377|NCT02574806|Ventricular function|ventricular function
160378|NCT02574806|Stress|stress
160379|NCT02574806|Pediatrics|pediatrics
160380|NCT02574806|Biomarkers|biomarkers
160381|NCT02574793|Glucose Fluctuation|glucose fluctuation
160382|NCT02574793|GH-Secreting Adenoma|gh-secreting adenoma
160383|NCT02574793|Cushing Syndrome|cushing syndrome
160384|NCT02574780|lymphedema|lymphedema
160385|NCT02574780|complex physical therapy|complex physical therapy
160386|NCT02574780|muscle strength|muscle strength
160387|NCT02574767|Weight gain, Fatty Acids, Omega-3|weight gain, fatty acids, omega-3
160388|NCT02574754|warfarin|warfarin
160389|NCT02574754|pharmacokinetics|pharmacokinetics
160390|NCT02574754|bioequivalence|bioequivalence
160391|NCT02574754|healthy volunteer|healthy volunteer
160392|NCT02574728|Pediatrics|pediatrics
160393|NCT02574728|Brain Tumors|brain tumors
160394|NCT02574728|Neuroblastoma|neuroblastoma
160395|NCT02574728|Osteosarcoma|osteosarcoma
160396|NCT02574728|Ewing's Sarcoma|ewing's sarcoma
160397|NCT02574728|Rhabdomyosarcoma|rhabdomyosarcoma
160398|NCT02574728|Wilms Tumors|wilms tumors
160399|NCT02574728|Soft Tissue Sarcomas|soft tissue sarcomas
160400|NCT02574702|superficial surgical site infection|superficial surgical site infection
160401|NCT02574702|loop ileostomy|loop ileostomy
160402|NCT02574702|Ileostomy closure|ileostomy closure
160403|NCT02574689|Physical Activity|physical activity
160404|NCT02574689|Cancer Prevention|cancer prevention
160405|NCT02574637|MEDI2070|medi2070
160406|NCT02574637|inflammatory bowel disease|inflammatory bowel disease
160407|NCT02574637|moderate to severe Crohn's Disease|moderate to severe crohn's disease
160408|NCT02574637|IL-23|il-23
160409|NCT02574598|PDL1|pdl1
160410|NCT02574598|monoclonal antibody|monoclonal antibody
160411|NCT02574585|Spinal cord injury|spinal cord injury
160412|NCT02574585|Paraplegia|paraplegia
160413|NCT02574585|Stem cells|stem cells
160414|NCT02574585|Mesenchymal cells|mesenchymal cells
160415|NCT02574572|Spinal cord injury|spinal cord injury
160416|NCT02574572|Mesenchymal cells|mesenchymal cells
160417|NCT02574572|Stem cells|stem cells
160418|NCT02574559|Caregiver|caregiver
160419|NCT02574559|Stress|stress
160420|NCT02574559|Depression|depression
160421|NCT02574559|Autism Spectrum Disorder|autism spectrum disorder
160422|NCT02574559|Compassion Meditation|compassion meditation
160423|NCT02574546|Mastectomy|mastectomy
160424|NCT02574533|Immunotherapy|immunotherapy
160425|NCT02574533|PD-1 inhibitor|pd-1 inhibitor
160426|NCT02574533|Keytruda|keytruda
160427|NCT02574533|checkpoint inhibitor|checkpoint inhibitor
160428|NCT02574533|vaccine|vaccine
160429|NCT02574533|FANG|fang
160430|NCT02574533|Vigil|vigil
160431|NCT02574520|Post-operative pain|post-operative pain
160432|NCT02574520|opioid|opioid
160433|NCT02574520|opioid reduction|opioid reduction
160434|NCT02574520|laparoscopic cholecystectomy|laparoscopic cholecystectomy
160435|NCT02574520|laparoscopic surgery|laparoscopic surgery
160436|NCT02574520|bupivacaine|bupivacaine
160437|NCT02574520|extended release|extended release
160438|NCT02574520|locally acting analgesic|locally acting analgesic
160439|NCT02574507|breast cancer|breast cancer
160440|NCT02574507|weight management|weight management
160441|NCT02574507|couples|couples
160442|NCT02574507|symptom management|symptom management
160443|NCT02574481|atherosclerosis|atherosclerosis
160444|NCT02574481|Superficial Femoral Artery (SFA)|superficial femoral artery (sfa)
160445|NCT02574481|Proximal Popliteal Artery (PPA)|proximal popliteal artery (ppa)
160446|NCT02574481|lower extremities|lower extremities
160447|NCT02574481|stenting|stenting
160448|NCT02574481|paclitaxel|paclitaxel
160449|NCT02574468|Dexamethasone|dexamethasone
160450|NCT02574468|Direct pulp capping|direct pulp capping
160451|NCT02574468|MTA|mta
160452|NCT02574468|pulpotomy|pulpotomy
160453|NCT02574442|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
160454|NCT02574442|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
160455|NCT02574442|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
160456|NCT02574442|adenocarcinoma in situ|adenocarcinoma in situ
160457|NCT02574429|Borderline Personality Disorder|borderline personality disorder
160458|NCT02574429|Posttraumatic Stress Disorder|posttraumatic stress disorder
160459|NCT02574429|Cognitive Processing Therapy|cognitive processing therapy
160460|NCT02574429|Group Therapy|group therapy
160461|NCT02574429|Comorbidity|comorbidity
160462|NCT02574429|Dialectical Behavior Therapy|dialectical behavior therapy
160463|NCT02574416|Health behaviour|health behaviour
160464|NCT02574416|Health outcomes|health outcomes
160465|NCT02574416|Diet quality|diet quality
160466|NCT02574416|Physical function|physical function
160467|NCT02574416|Lifestyle|lifestyle
160468|NCT02574416|Older adults|older adults
160469|NCT02574403|atypical hemolytic uremic syndrome (aHUS)|atypical hemolytic uremic syndrome (ahus)
160470|NCT02574403|eculizumab discontinuation|eculizumab discontinuation
160471|NCT02574390|ALS|als
160472|NCT02574390|stem cell|stem cell
160473|NCT02574390|biomarker|biomarker
160474|NCT02574390|disease progression|disease progression
160475|NCT02574364|abdomen CT|abdomen ct
160476|NCT02574364|open appendicectomy|open appendicectomy
160477|NCT02574312|Mechanical Axis Alignment|mechanical axis alignment
160478|NCT02574312|Knee Arthroplasty, Total|knee arthroplasty, total
160479|NCT02574299|dyslexia|dyslexia
160480|NCT02574299|training|training
160481|NCT02574299|auditory rehabilitation|auditory rehabilitation
160482|NCT02574299|hearing loss|hearing loss
160483|NCT02574299|evoked potentials|evoked potentials
160484|NCT02574299|dichotic|dichotic
160485|NCT02574299|plasticity|plasticity
160486|NCT02574299|noise|noise
160487|NCT02574247|Audiology|audiology
160488|NCT02574247|Auditory Pathways|auditory pathways
160489|NCT02574247|Auditory Perception|auditory perception
160490|NCT02574247|Brain Stem|brain stem
160491|NCT02574247|Cochlea|cochlea
160492|NCT02574247|Ear, Inner|ear, inner
160493|NCT02574247|Efferent Pathways|efferent pathways
160494|NCT02574247|Hair Cells, Auditory, Outer|hair cells, auditory, outer
160495|NCT02574247|Learning|learning
160496|NCT02574247|Neurons, Efferent|neurons, efferent
160497|NCT02574247|Speech Perception|speech perception
160498|NCT02574234|Postoperative cognitive disorders POCD|postoperative cognitive disorders pocd
160499|NCT02574234|inflammation|inflammation
160500|NCT02574234|Surgery|surgery
160501|NCT02574208|Adult outpatients|adult outpatients
160502|NCT02574208|Paris, France|paris, france
160503|NCT02574195|Diabetes Mellitus|diabetes mellitus
160504|NCT02574195|microvascular complications|microvascular complications
160505|NCT02574195|macrovascular complications|macrovascular complications
160506|NCT02574195|epidemiology|epidemiology
160507|NCT02574195|Russia|russia
160508|NCT02574182|Mild Cognitive Impairment|mild cognitive impairment
160509|NCT02574182|Magnetic Resonance Imaging|magnetic resonance imaging
160510|NCT02574169|Alveolar Recruitment Maneuvers (ARM)|alveolar recruitment maneuvers (arm)
160511|NCT02574169|Continuous Positive Airway Pressure (CPAP)|continuous positive airway pressure (cpap)
160512|NCT02574169|Extended Sigh (eSigh)|extended sigh (esigh)
160513|NCT02574143|Prognosis|prognosis
160514|NCT02574143|Prospective Study|prospective study
160515|NCT02574143|Quality of Life|quality of life
160516|NCT02574143|Radiology|radiology
160517|NCT02574143|Rehabilitation|rehabilitation
160518|NCT02574143|Registry;|registry;
160519|NCT02574143|Signs and Symptoms|signs and symptoms
160520|NCT02574143|Therapy|therapy
160521|NCT02574143|Bronchiectiasis|bronchiectiasis
160522|NCT02574143|Diagnosis|diagnosis
160523|NCT02574143|Epidemiology|epidemiology
160524|NCT02574143|Etiology|etiology
160525|NCT02574143|Longitudinal Study|longitudinal study
160526|NCT02574143|Microbiology|microbiology
160527|NCT02574104|Intensive Care Units, Neonatal|intensive care units, neonatal
160528|NCT02574104|Patient simulation|patient simulation
160529|NCT02574104|Interdisciplinary Communication|interdisciplinary communication
160530|NCT02574104|Human factors|human factors
160531|NCT02574104|Hazard Analysis and Critical Control Points|hazard analysis and critical control points
160532|NCT02574091|EGFR inhibitor|egfr inhibitor
160533|NCT02574091|topical agent|topical agent
160534|NCT02574091|psoriasis|psoriasis
160535|NCT02574091|phase 1|phase 1
160536|NCT02574065|crying|crying
160537|NCT02574065|colicky|colicky
160538|NCT02574065|infants|infants
160539|NCT02574065|Lactobacillus reuteri DSM 17938|lactobacillus reuteri dsm 17938
160540|NCT02574052|Menu Labelling;|menu labelling;
160541|NCT02574052|Nutrition Education;|nutrition education;
160542|NCT02574052|dietary assessment tools;|dietary assessment tools;
160543|NCT02574039|volunteers|volunteers
160544|NCT02574039|oat|oat
160545|NCT02574039|phenolic acid|phenolic acid
160546|NCT02574039|bioavailability|bioavailability
160547|NCT02574026|MEG|meg
160548|NCT02574026|EEG|eeg
160549|NCT02574026|MRI|mri
160550|NCT02574026|Brain mapping|brain mapping
160551|NCT02574026|functional imaging|functional imaging
160552|NCT02574026|brain computer interface|brain computer interface
160553|NCT02573974|undernutrition|undernutrition
160554|NCT02573974|gastrointestinal cancer|gastrointestinal cancer
160555|NCT02573974|skeletal muscle|skeletal muscle
160556|NCT02573974|energy metabolism|energy metabolism
160557|NCT02573948|People who inject drugs|people who inject drugs
160558|NCT02573948|Vietnam|vietnam
160559|NCT02573948|Community support groups|community support groups
160560|NCT02573935|Multiple Myeloma|multiple myeloma
160561|NCT02573935|Clarithromycin|clarithromycin
160562|NCT02573935|Induction Chemotherapy|induction chemotherapy
160563|NCT02573935|Transplantation, Autologous|transplantation, autologous
160564|NCT02573922|constipation|constipation
160565|NCT02573922|opioid|opioid
160566|NCT02573922|Oxycodone|oxycodone
160567|NCT02573922|Oxycodone-naloxone|oxycodone-naloxone
160568|NCT02573922|spine surgery|spine surgery
160569|NCT02573896|relapsed refractory neuroblastoma|relapsed refractory neuroblastoma
160570|NCT02573883|Vulva|vulva
160571|NCT02573883|Lichen Sclerosus|lichen sclerosus
160572|NCT02573883|Fractionated Carbon Dioxide Laser|fractionated carbon dioxide laser
160573|NCT02573883|Mona Lisa Laser|mona lisa laser
160574|NCT02573883|Clobetasol Proprionate|clobetasol proprionate
160575|NCT02573883|Vulvodynia|vulvodynia
160576|NCT02573870|COPD|copd
160577|NCT02573870|DPI|dpi
160578|NCT02573870|Batefenterol|batefenterol
160579|NCT02573870|Fluticasone Furoate|fluticasone furoate
160580|NCT02573857|Induced blood stage malaria|induced blood stage malaria
160581|NCT02573857|Transmission|transmission
160582|NCT02573857|Gametocytemia|gametocytemia
160583|NCT02573844|irritable bowel syndrome|irritable bowel syndrome
160584|NCT02573844|abdominal pain|abdominal pain
160585|NCT02573844|rome III criteria|rome iii criteria
160586|NCT02573844|abdominal distension|abdominal distension
160587|NCT02573844|consistency of stools|consistency of stools
160588|NCT02573844|stool frequency|stool frequency
160589|NCT02573844|meteorism|meteorism
160590|NCT02573844|flatulence|flatulence
160591|NCT02573844|abdominal discomfort|abdominal discomfort
160592|NCT02573844|proklama|proklama
160593|NCT02573844|probiotics|probiotics
160594|NCT02573844|alga klamath|alga klamath
160595|NCT02573844|aphanizomenon flos-aquae|aphanizomenon flos-aquae
160596|NCT02573844|prebiotics|prebiotics
160597|NCT02573844|colitis ulcerosa|colitis ulcerosa
160598|NCT02573831|labor|labor
160599|NCT02573831|pain|pain
160600|NCT02573831|oxycodone|oxycodone
160601|NCT02573831|placenta|placenta
160602|NCT02573818|sedation for EGD and colonoscopy procedures|sedation for egd and colonoscopy procedures
160603|NCT02573805|nocturnal penile tumescence and rigidity|nocturnal penile tumescence and rigidity
160604|NCT02573805|erectile dysfunction|erectile dysfunction
160605|NCT02573805|Chinese males|chinese males
160606|NCT02573792|First onset of optical neuritis|first onset of optical neuritis
160607|NCT02573779|human milk|human milk
160608|NCT02573779|enteral nutrition|enteral nutrition
160609|NCT02573779|microbiome|microbiome
160610|NCT02573779|Microbiota|microbiota
160611|NCT02573766|Neurofeedback training|neurofeedback training
160612|NCT02573766|EEG|eeg
160613|NCT02573766|electroencephalograph|electroencephalograph
160614|NCT02573766|Questionnaires|questionnaires
160615|NCT02573766|Surveys|surveys
160616|NCT02573766|Chemotherapy-Induced Peripheral Neuropathy|chemotherapy-induced peripheral neuropathy
160617|NCT02573766|CIPN|cipn
160618|NCT02573740|Mild Cognitive Impairment|mild cognitive impairment
160619|NCT02573740|Alzheimer's Disease|alzheimer's disease
160620|NCT02573714|Ketamine|ketamine
160621|NCT02573714|Intranasal|intranasal
160622|NCT02573714|Pain crisis|pain crisis
160623|NCT02573714|Vasoocclusive Pain|vasoocclusive pain
160624|NCT02573714|Sickle cell disease|sickle cell disease
160625|NCT02573701|Schizophrenia|schizophrenia
160626|NCT02573701|Adolescents|adolescents
160627|NCT02573701|Treatment|treatment
160628|NCT02573701|Guidelines|guidelines
160629|NCT02573688|Obesity|obesity
160630|NCT02573688|Metabolic Syndrome X|metabolic syndrome x
160631|NCT02573688|Interdisciplinary Studies|interdisciplinary studies
160632|NCT02573675|hemodialysis|hemodialysis
160633|NCT02573675|peritoneal dialysis|peritoneal dialysis
160634|NCT02573662|Metabolic complications|metabolic complications
160635|NCT02573662|Type 2 diabetes|type 2 diabetes
160636|NCT02573662|Sedentary lifestyle|sedentary lifestyle
160637|NCT02573662|Low grade inflammation|low grade inflammation
160638|NCT02573662|Lipid metabolism|lipid metabolism
160639|NCT02573662|Glucose metabolism|glucose metabolism
160640|NCT02573662|Bone metabolism|bone metabolism
160641|NCT02573662|Physical inactivity|physical inactivity
160642|NCT02573623|Immunology diagnosis test|immunology diagnosis test
160643|NCT02573623|Children|children
160644|NCT02573623|Zambia|zambia
160645|NCT02573571|single nucleotide polymorphisms|single nucleotide polymorphisms
160646|NCT02573571|cytokines|cytokines
160647|NCT02573571|microbiome|microbiome
160648|NCT02573545|liver|liver
160649|NCT02573532|myocardial ischemia/diagnosis|myocardial ischemia/diagnosis
160650|NCT02573532|myocardial ischemia/epidemiology|myocardial ischemia/epidemiology
160651|NCT02573532|perioperative|perioperative
160652|NCT02573532|perioperative complications/diagnosis|perioperative complications/diagnosis
160653|NCT02573532|prognosis|prognosis
160654|NCT02573519|11C Donepezil PET/CT scan|11c donepezil pet/ct scan
160655|NCT02573519|3D-Transit|3d-transit
160656|NCT02573519|Diabetes Mellitus|diabetes mellitus
160657|NCT02573519|Gastrointestinal motility disorder|gastrointestinal motility disorder
160658|NCT02573519|Diabetic autonomic neuropathy|diabetic autonomic neuropathy
160659|NCT02573506|Non-small cell lung cancer|non-small cell lung cancer
160660|NCT02573506|Split-course Chemoradiotherapy|split-course chemoradiotherapy
160661|NCT02573506|Consolidation chemotherapy|consolidation chemotherapy
160662|NCT02573480|youth violence, intervention, emergency medicine|youth violence, intervention, emergency medicine
160663|NCT02573467|sporadic inclusion body myositis,|sporadic inclusion body myositis,
160664|NCT02573467|muscle wasting,|muscle wasting,
160665|NCT02573467|extension study,|extension study,
160666|NCT02573467|BYM338,|bym338,
160667|NCT02573467|bimagrumab,|bimagrumab,
160668|NCT02573428|Autism Spectrum Disorder|autism spectrum disorder
160669|NCT02573428|Eye Gaze|eye gaze
160670|NCT02573428|Remote Eye Gaze Tracking|remote eye gaze tracking
160671|NCT02573428|Autism|autism
160672|NCT02573402|electric stimulation|electric stimulation
160673|NCT02573402|urodynamic study|urodynamic study
160674|NCT02573389|pancreatic fistula, pancreatectomy, endoscopic stenting, pancreatic stenting, distal pancreatectomy|pancreatic fistula, pancreatectomy, endoscopic stenting, pancreatic stenting, distal pancreatectomy
160675|NCT02573376|HIV|hiv
160676|NCT02573376|Hepatitis C|hepatitis c
160677|NCT02573376|Drug Abuse|drug abuse
160678|NCT02573376|Hepatitis C Virus|hepatitis c virus
160679|NCT02573376|sofosbuvir|sofosbuvir
160680|NCT02573376|ledipasvir|ledipasvir
160681|NCT02573376|pharmacology|pharmacology
160682|NCT02573376|pharmacokinetics|pharmacokinetics
160683|NCT02573324|Newly Diagnosed Glioblastoma|newly diagnosed glioblastoma
160684|NCT02573324|Epithelial Growth Factor Receptor (EGFR)|epithelial growth factor receptor (egfr)
160685|NCT02573324|Temozolomide|temozolomide
160686|NCT02573324|ABT-414|abt-414
160687|NCT02573324|Radiology Therapy Oncology Group|radiology therapy oncology group
160688|NCT02573324|Antibody Drug Conjugate|antibody drug conjugate
160689|NCT02573324|Brain Tumor|brain tumor
160690|NCT02573324|Brain Tumor Group|brain tumor group
160691|NCT02573324|EGFRvIII|egfrviii
160692|NCT02573324|EGFR Amplified|egfr amplified
160693|NCT02573324|First Line Therapy|first line therapy
160694|NCT02573324|Brain Cancer|brain cancer
160695|NCT02573298|cryotherapy|cryotherapy
160696|NCT02573298|power Doppler score|power doppler score
160697|NCT02573298|synovial fluid cytokines|synovial fluid cytokines
160698|NCT02573298|pain VAS|pain vas
160699|NCT02573259|efficacy|efficacy
160700|NCT02573259|safety|safety
160701|NCT02573259|pharmacokinetics|pharmacokinetics
160702|NCT02573259|pharmacodynamics|pharmacodynamics
160703|NCT02573259|open label|open label
160704|NCT02573259|dose response|dose response
160705|NCT02573259|multiple ascending dose|multiple ascending dose
160706|NCT02573259|immunogenicity|immunogenicity
160707|NCT02573259|recommended phase 2 dose|recommended phase 2 dose
160708|NCT02573259|subcutaneous|subcutaneous
160709|NCT02573246|neurostimulation|neurostimulation
160710|NCT02573246|cognitive restructuring|cognitive restructuring
160711|NCT02573246|TMS|tms
160712|NCT02573246|emotion regulation|emotion regulation
160713|NCT02573246|MRI|mri
160714|NCT02573246|Emotional Memory Task|emotional memory task
160715|NCT02573246|Reappraisal|reappraisal
160716|NCT02573246|Distraction|distraction
160717|NCT02573194|Appetite|appetite
160718|NCT02573194|Amino acids|amino acids
160719|NCT02573194|Protein Source|protein source
160720|NCT02573168|Pharmacogenomic|pharmacogenomic
160721|NCT02573168|Pharmacogenomic Testing|pharmacogenomic testing
160722|NCT02573168|Pharmacogenomics|pharmacogenomics
160723|NCT02573168|Genetic Testing|genetic testing
160724|NCT02573168|Genetics|genetics
160725|NCT02573168|GeneSight|genesight
160726|NCT02573168|Enhanced GeneSight|enhanced genesight
160727|NCT02573168|Psychotropic|psychotropic
160728|NCT02573155|Pharmacokinetics|pharmacokinetics
160729|NCT02573155|Pharmacodynamics|pharmacodynamics
160730|NCT02573155|AZD8871|azd8871
160731|NCT02573155|Safety|safety
160732|NCT02573155|Tolerability|tolerability
160733|NCT02573155|mild persistent asthma|mild persistent asthma
160734|NCT02573155|moderate to severe COPD|moderate to severe copd
160735|NCT02573142|obesity|obesity
160736|NCT02573142|treatment|treatment
160737|NCT02573142|community|community
160738|NCT02573142|integrated|integrated
160739|NCT02573129|cardiovascular disease risk|cardiovascular disease risk
160740|NCT02573129|Mediterranean diet|mediterranean diet
160741|NCT02573129|red meat|red meat
160742|NCT02573116|obstructive sleep apnea|obstructive sleep apnea
160743|NCT02573116|endothelial dysfunction|endothelial dysfunction
160744|NCT02573116|periodontitis|periodontitis
160745|NCT02573090|Occlusal caries|occlusal caries
160746|NCT02573090|Resin based fissure sealant|resin based fissure sealant
160747|NCT02573090|Composite resin restoration|composite resin restoration
160748|NCT02573090|Effectiveness|effectiveness
160749|NCT02573090|Longevity|longevity
160750|NCT02573077|Hyponatremia due to SIADH|hyponatremia due to siadh
160751|NCT02573077|Cancer|cancer
160752|NCT02573038|Aflibercept|aflibercept
160753|NCT02573038|choroidal neovascularization|choroidal neovascularization
160754|NCT02573038|angioid streaks|angioid streaks
160755|NCT02573038|young patient|young patient
160756|NCT02572999|Aged|aged
160757|NCT02572999|Frail|frail
160758|NCT02572999|Functional decline|functional decline
160759|NCT02572999|Impairment|impairment
160760|NCT02572999|valvular heart disease|valvular heart disease
160761|NCT02572999|Cohort|cohort
160762|NCT02572999|risk factors|risk factors
160763|NCT02572947|Dolutegravir|dolutegravir
160764|NCT02572947|HIV infection|hiv infection
160765|NCT02572947|Anti-Retroviral Agents|anti-retroviral agents
160766|NCT02572947|HIV Integrase Inhibitors|hiv integrase inhibitors
160767|NCT02572947|Integrase Inhibitors|integrase inhibitors
160768|NCT02572947|Pharmacologic Actions|pharmacologic actions
160769|NCT02572947|Therapeutic Uses|therapeutic uses
160770|NCT02572934|Testicular cancer|testicular cancer
160771|NCT02572934|Survivorship|survivorship
160772|NCT02572934|late adverse treatment effects|late adverse treatment effects
160773|NCT02572921|Positive Psychotherapy|positive psychotherapy
160774|NCT02572921|Depression|depression
160775|NCT02572921|Happiness|happiness
160776|NCT02572908|wheat, IBS, gluten, ATI|wheat, ibs, gluten, ati
160777|NCT02572895|Cranberry|cranberry
160778|NCT02572895|Proanthocyanidins|proanthocyanidins
160779|NCT02572895|Urinary catabolites|urinary catabolites
160780|NCT02572882|hemodialysis|hemodialysis
160781|NCT02572882|p-inulin|p-inulin
160782|NCT02572882|gut microbiome|gut microbiome
160783|NCT02572869|Mandible Reconstruction|mandible reconstruction
160784|NCT02572869|Fibula Osteomyocutaneous Free Flaps|fibula osteomyocutaneous free flaps
160785|NCT02572869|Quality of Life|quality of life
160786|NCT02572869|15-244|15-244
160787|NCT02572856|Feasibility|feasibility
160788|NCT02572856|continuous glucose monitor|continuous glucose monitor
160789|NCT02572856|surgery|surgery
160790|NCT02572843|NSCLC|nsclc
160791|NCT02572843|lung cancer|lung cancer
160792|NCT02572843|MEDI4736|medi4736
160793|NCT02572843|non-small cell lung cancer|non-small cell lung cancer
160794|NCT02572843|immunotherapy|immunotherapy
160795|NCT02572843|anti-PD-L1|anti-pd-l1
160796|NCT02572830|Reconsolidation|reconsolidation
160797|NCT02572830|EMDR|emdr
160798|NCT02572830|PTSD|ptsd
160799|NCT02572817|Anti-Influenza Immune Plasma|anti-influenza immune plasma
160800|NCT02572804|bladder cancer-cystectomy|bladder cancer-cystectomy
160801|NCT02572804|rectus sheath catheter|rectus sheath catheter
160802|NCT02572804|epidural|epidural
160803|NCT02572713|Parkinson's Disease|parkinson's disease
160804|NCT02572713|alpha-synuclein|alpha-synuclein
160805|NCT02572713|biomarker|biomarker
160806|NCT02572687|metastatic|metastatic
160807|NCT02572687|advanced|advanced
160808|NCT02572687|immuno-oncology|immuno-oncology
160809|NCT02572687|vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
160810|NCT02572687|angiogenesis|angiogenesis
160811|NCT02572687|PD-1|pd-1
160812|NCT02572687|PD-L1|pd-l1
160813|NCT02572674|Bipolar disorder|bipolar disorder
160814|NCT02572674|relapse risk factors|relapse risk factors
160815|NCT02572674|prospective follow up|prospective follow up
160816|NCT02572661|Radiotherapy, Sentinel Node Mapping, Spect|radiotherapy, sentinel node mapping, spect
160817|NCT02572648|Cardiomyopathy|cardiomyopathy
160818|NCT02572648|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
160819|NCT02572635|Pneumococcal Infection|pneumococcal infection
160820|NCT02572635|Phase I|phase i
160821|NCT02572635|Immunogenicity|immunogenicity
160822|NCT02572635|Safety|safety
160823|NCT02572635|Vaccination|vaccination
160824|NCT02572622|exercise|exercise
160825|NCT02572622|deep friction massage|deep friction massage
160826|NCT02572622|spinal decompression|spinal decompression
160827|NCT02572622|non-surgical spinal decompression|non-surgical spinal decompression
160828|NCT02572596|Hematopoietic Stem Cell Mobilization|hematopoietic stem cell mobilization
160829|NCT02572596|Thrombopoietin|thrombopoietin
160830|NCT02572583|Reconciling Exterior and Interior Therapy|reconciling exterior and interior therapy
160831|NCT02572583|Influenza|influenza
160832|NCT02572570|Adult dental care|adult dental care
160833|NCT02572557|Spray Cryotherapy|spray cryotherapy
160834|NCT02572544|young healthy adults|young healthy adults
160835|NCT02572544|single pinhole glasses|single pinhole glasses
160836|NCT02572544|multiple pinhole glasses|multiple pinhole glasses
160837|NCT02572531|Lactobacillus reuteri|lactobacillus reuteri
160838|NCT02572531|Wound Healing|wound healing
160839|NCT02572531|Third Molar|third molar
160840|NCT02572531|Postoperative Complications|postoperative complications
160841|NCT02572518|immunity yellow fever vaccine|immunity yellow fever vaccine
160842|NCT02572505|HIV-Discordant|hiv-discordant
160843|NCT02572505|Preexposure Prophylaxis|preexposure prophylaxis
160844|NCT02572492|Multiple Myeloma|multiple myeloma
160845|NCT02572492|Recurrence|recurrence
160846|NCT02572492|Carfilzomib|carfilzomib
160847|NCT02572492|Salvage Therapy|salvage therapy
160848|NCT02572492|Transplantation, Autologous|transplantation, autologous
160849|NCT02572479|fatty acids, amyotrophic lateral sclerosis, nutrient status|fatty acids, amyotrophic lateral sclerosis, nutrient status
160850|NCT02572466|high-sensitive troponin-I|high-sensitive troponin-i
160851|NCT02572466|End-stage renal disease|end-stage renal disease
160852|NCT02572466|hemodialysis|hemodialysis
160853|NCT02572440|Aortic arch surgery; Blood conservation; aPRP|aortic arch surgery; blood conservation; aprp
160854|NCT02572401|Human immunodeficiency virus|human immunodeficiency virus
160855|NCT02572401|Sexually transmitted disease|sexually transmitted disease
160856|NCT02572401|Behavioral intervention|behavioral intervention
160857|NCT02572401|Randomized controlled trial|randomized controlled trial
160858|NCT02572401|Text messages|text messages
160859|NCT02572401|Social cognitive theory|social cognitive theory
160860|NCT02572401|Theory of planned behavior|theory of planned behavior
160861|NCT02572401|Sexual behavior|sexual behavior
160862|NCT02572401|African Americans|african americans
160863|NCT02572401|Men|men
160864|NCT02572349|Healthy Subjects|healthy subjects
160865|NCT02572310|total knee arthroplasty|total knee arthroplasty
160866|NCT02572297|epilepsy|epilepsy
160867|NCT02572297|SUDEP|sudep
160868|NCT02572297|SpO2|spo2
160869|NCT02572284|Stereotactic Body Radiation Therapy (SBRT)|stereotactic body radiation therapy (sbrt)
160870|NCT02572284|High Risk Prostate Cancer|high risk prostate cancer
160871|NCT02572284|Preoperative SBRT|preoperative sbrt
160872|NCT02572284|Prostate Adenocarcinoma|prostate adenocarcinoma
160873|NCT02572284|Prostatectomy|prostatectomy
160874|NCT02572284|Quality of Life|quality of life
160875|NCT02572271|Autologous augmentation|autologous augmentation
160876|NCT02572271|Mastopexy|mastopexy
160877|NCT02572271|Massive weight loss|massive weight loss
160878|NCT02572245|Healthy Subjects|healthy subjects
160879|NCT02572245|Device|device
160880|NCT02572245|PK|pk
160881|NCT02572245|Phase 1|phase 1
160882|NCT02572245|Bioequivalence|bioequivalence
160883|NCT02572245|Adalimumab|adalimumab
160884|NCT02572245|Single Dose|single dose
160885|NCT02572193|achalasia|achalasia
160886|NCT02572193|surgery|surgery
160887|NCT02572167|Monomethyl auristatin E|monomethyl auristatin e
160888|NCT02572167|Antigens, CD30|antigens, cd30
160889|NCT02572167|Antibody-Drug Conjugate|antibody-drug conjugate
160890|NCT02572167|Antibodies, Monoclonal|antibodies, monoclonal
160891|NCT02572167|Immunotherapy|immunotherapy
160892|NCT02572167|Autologous stem cell transplant|autologous stem cell transplant
160893|NCT02572115|After-Hours Care|after-hours care
160894|NCT02572115|Primary Care|primary care
160895|NCT02572115|Emergency Medical Services/utilization|emergency medical services/utilization
160896|NCT02572115|Denmark|denmark
160897|NCT02572115|Questionnaires|questionnaires
160898|NCT02572115|Patient Satisfaction|patient satisfaction
160899|NCT02572115|Patient feeling of safety|patient feeling of safety
160900|NCT02572115|Triage/standards|triage/standards
160901|NCT02572115|Referral and Consultation/statistics & numerical data|referral and consultation/statistics & numerical data
160902|NCT02572115|Humans|humans
160903|NCT02572115|Male|male
160904|NCT02572115|Female|female
160905|NCT02572115|Hotlines|hotlines
160906|NCT02572115|telenursing|telenursing
160907|NCT02572115|Night Care/utilization|night care/utilization
160908|NCT02572115|postal service|postal service
160909|NCT02572102|ECG|ecg
160910|NCT02572102|Blood Pressure|blood pressure
160911|NCT02572102|Energy Drinks|energy drinks
160912|NCT02572102|Panax Ginseng|panax ginseng
160913|NCT02572037|Premature ejaculation|premature ejaculation
160914|NCT02572037|Dapoxetine|dapoxetine
160915|NCT02572037|local anaesthetics|local anaesthetics
160916|NCT02572037|nerve electrophysiology|nerve electrophysiology
160917|NCT02572011|Lower limb amputation|lower limb amputation
160918|NCT02572011|Transtibial|transtibial
160919|NCT02572011|Balance|balance
160920|NCT02572011|Postural Control|postural control
160921|NCT02572011|Limits of Stability|limits of stability
160922|NCT02572011|Rehabilitation|rehabilitation
160923|NCT02572011|Home-based intervention|home-based intervention
160924|NCT02572011|Nintendo Wii|nintendo wii
160925|NCT02572011|Balance Board|balance board
160926|NCT02571985|Zenith aortoiliac aneurysm|zenith aortoiliac aneurysm
160927|NCT02571985|iliac aneurysm|iliac aneurysm
160928|NCT02571985|branch|branch
160929|NCT02571985|connections|connections
160930|NCT02571985|endovascular graft|endovascular graft
160931|NCT02571985|graft-iliac bifurcation|graft-iliac bifurcation
160932|NCT02571985|Aneurysm|aneurysm
160933|NCT02571985|Vascular Diseases|vascular diseases
160934|NCT02571985|Cardiovascular Diseases|cardiovascular diseases
160935|NCT02571972|dorzolamide-timolol|dorzolamide-timolol
160936|NCT02571972|topical aqueous suppression|topical aqueous suppression
160937|NCT02571972|neovascular age-related macular degeneration|neovascular age-related macular degeneration
160938|NCT02571972|macular edema|macular edema
160939|NCT02571972|intravitreal injection|intravitreal injection
160940|NCT02571972|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
160941|NCT02571959|Obesity|obesity
160942|NCT02571959|Pharmacology|pharmacology
160943|NCT02571959|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination
160944|NCT02571933|Pediatrics|pediatrics
160945|NCT02571933|Pain Scale|pain scale
160946|NCT02571933|Faces Pain Scale - Revised|faces pain scale - revised
160947|NCT02571933|Cameroon|cameroon
160948|NCT02571920|cardiac surgery|cardiac surgery
160949|NCT02571920|cardiac output|cardiac output
160950|NCT02571907|Zenith aortoiliac aneurysm|zenith aortoiliac aneurysm
160951|NCT02571907|Iliac aneurysm|iliac aneurysm
160952|NCT02571907|Branch|branch
160953|NCT02571907|Connections|connections
160954|NCT02571907|Endovascular graft|endovascular graft
160955|NCT02571907|Graft-iliac bifurcation|graft-iliac bifurcation
160956|NCT02571907|Aneurysm|aneurysm
160957|NCT02571907|Vascular Diseases|vascular diseases
160958|NCT02571907|Cardiovascular Diseases|cardiovascular diseases
160959|NCT02571881|constipation|constipation
160960|NCT02571881|oxycodone|oxycodone
160961|NCT02571881|caesarean section|caesarean section
160962|NCT02571855|insomnia|insomnia
160963|NCT02571855|Pharmacokinetics|pharmacokinetics
160964|NCT02571855|Safety|safety
160965|NCT02571855|Pharmacodynamics|pharmacodynamics
160966|NCT02571855|Healthy|healthy
160967|NCT02571842|Recurrent IgA nephropathy|recurrent iga nephropathy
160968|NCT02571842|Rituximab|rituximab
160969|NCT02571829|Liposarcoma|liposarcoma
160970|NCT02571829|Soft tissue sarcoma|soft tissue sarcoma
160971|NCT02571829|CDK4|cdk4
160972|NCT02571829|CDK6|cdk6
160973|NCT02571829|LEE011|lee011
160974|NCT02571829|ribociclib|ribociclib
160975|NCT02571816|ASP2215|asp2215
160976|NCT02571816|Healthy|healthy
160977|NCT02571816|Hepatic Impairment|hepatic impairment
160978|NCT02571816|Mild Hepatic Impairment|mild hepatic impairment
160979|NCT02571816|Moderate Hepatic Impairment|moderate hepatic impairment
160980|NCT02571803|coronary artery disease|coronary artery disease
160981|NCT02571803|atherosclerosis|atherosclerosis
160982|NCT02571803|DASH diet|dash diet
160983|NCT02571790|Patient with Generalized Anxiety Disorders|patient with generalized anxiety disorders
160984|NCT02571777|Asthma|asthma
160985|NCT02571725|Ovarian cancer|ovarian cancer
160986|NCT02571725|Fallopian tube cancer|fallopian tube cancer
160987|NCT02571725|Peritoneal cancer|peritoneal cancer
160988|NCT02571725|PARP|parp
160989|NCT02571725|BRCA|brca
160990|NCT02571725|Immunotherapy|immunotherapy
160991|NCT02571725|Olaparib|olaparib
160992|NCT02571725|Tremelimumab|tremelimumab
160993|NCT02571725|CTLA4|ctla4
160994|NCT02571673|Survivorship|survivorship
160995|NCT02571673|Quality of Life|quality of life
160996|NCT02571673|HN-STAR web-based|hn-star web-based
160997|NCT02571673|15-245|15-245
160998|NCT02571660|vitamin d levels|vitamin d levels
160999|NCT02571660|exacerbation of asthma|exacerbation of asthma
161000|NCT02571660|asthma control|asthma control
161001|NCT02571634|intranasal fentanyl|intranasal fentanyl
161002|NCT02571634|conscious sedation|conscious sedation
161003|NCT02571608|Type 2 diabetes mellitus, Metformin, peri-operative|type 2 diabetes mellitus, metformin, peri-operative
161004|NCT02571595|HIV - Human Immunodeficiency Virus|hiv - human immunodeficiency virus
161005|NCT02571595|digital cognitive behavioural therapy for insomnia (dCBT-I)|digital cognitive behavioural therapy for insomnia (dcbt-i)
161006|NCT02571595|insomnia|insomnia
161007|NCT02571595|cognitive Impairment|cognitive impairment
161008|NCT02571595|concentration|concentration
161009|NCT02571595|productivity|productivity
161010|NCT02571582|Predictors of mortality|predictors of mortality
161011|NCT02571543|Ibuprofen|ibuprofen
161012|NCT02571543|IVF|ivf
161013|NCT02571543|minimal stimulation|minimal stimulation
161014|NCT02571543|modified natural-cycle|modified natural-cycle
161015|NCT02571543|nonsteroidal anti-inflammatory drug (NSAID)|nonsteroidal anti-inflammatory drug (nsaid)
161016|NCT02571543|Anti-Inflammatory Agents, Non-Steroidal/therapeutic use|anti-inflammatory agents, non-steroidal/therapeutic use
161017|NCT02571543|Oocyte Retrieval|oocyte retrieval
161018|NCT02571543|Ovarian Follicle/drug effects|ovarian follicle/drug effects
161019|NCT02571517|Respiratory viral infection.|respiratory viral infection.
161020|NCT02571517|Respiratory syncytial virus bronchiolitis|respiratory syncytial virus bronchiolitis
161021|NCT02571517|METHYLPREDNISOLONE SODIUM SUCCINATE|methylprednisolone sodium succinate
161022|NCT02571504|HIV - Human Immunodeficiency Virus|hiv - human immunodeficiency virus
161023|NCT02571504|Memory|memory
161024|NCT02571504|Concentration|concentration
161025|NCT02571478|Military Couples|military couples
161026|NCT02571478|Marriage|marriage
161027|NCT02571478|Primary Care|primary care
161028|NCT02571478|Marriage Intervention|marriage intervention
161029|NCT02571478|Air Force|air force
161030|NCT02571465|functional hemodynamic parameter|functional hemodynamic parameter
161031|NCT02571465|passive leg raising|passive leg raising
161032|NCT02571465|stroke volume variation|stroke volume variation
161033|NCT02571465|pulse pressure variation|pulse pressure variation
161034|NCT02571452|Veteran|veteran
161035|NCT02571452|Insomnia|insomnia
161036|NCT02571452|Primary Healthcare|primary healthcare
161037|NCT02571439|TAP block, post-cesarean analgesia|tap block, post-cesarean analgesia
161038|NCT02571413|animated cartoon-aided teaching|animated cartoon-aided teaching
161039|NCT02571413|oral presentation|oral presentation
161040|NCT02571413|allergic rhinitis|allergic rhinitis
161041|NCT02571413|intranasal corticosteroid|intranasal corticosteroid
161042|NCT02571413|how to use intranasal corticosteroid|how to use intranasal corticosteroid
161043|NCT02571400|Risk|risk
161044|NCT02571400|Opioid analgesics|opioid analgesics
161045|NCT02571400|Opioid-related disorders|opioid-related disorders
161046|NCT02571400|Surgery|surgery
161047|NCT02571400|Post-operative care|post-operative care
161048|NCT02571400|Post-operative period|post-operative period
161049|NCT02571400|Post-operative complications|post-operative complications
161050|NCT02571400|Opioid Use disorders|opioid use disorders
161051|NCT02571400|Pain, post-operative|pain, post-operative
161052|NCT02571400|Opiate Addiction|opiate addiction
161053|NCT02571387|Motivation|motivation
161054|NCT02571387|Impulsive eating|impulsive eating
161055|NCT02571387|Mindfulness|mindfulness
161056|NCT02571387|Self-help|self-help
161057|NCT02571387|Physical activity|physical activity
161058|NCT02571387|Weight-loss|weight-loss
161059|NCT02571374|symbiotic|symbiotic
161060|NCT02571374|colorectal cancer|colorectal cancer
161061|NCT02571361|Acetaminophen|acetaminophen
161062|NCT02571361|Ibuprofen|ibuprofen
161063|NCT02571361|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
161064|NCT02571309|Self-management|self-management
161065|NCT02571309|Asthma|asthma
161066|NCT02571309|Patient education|patient education
161067|NCT02571309|Health literacy|health literacy
161068|NCT02571309|Health-related quality of life|health-related quality of life
161069|NCT02571309|Asthma control|asthma control
161070|NCT02571309|Adherence|adherence
161071|NCT02571296|Preterm Birth|preterm birth
161072|NCT02571296|Oral Micronized Progesterone|oral micronized progesterone
161073|NCT02571283|Total Knee Arthroplasty|total knee arthroplasty
161074|NCT02571283|Total Knee Replacement|total knee replacement
161075|NCT02571283|Exparel|exparel
161076|NCT02571283|Cocktail Injection|cocktail injection
161077|NCT02571283|Pain Management|pain management
161078|NCT02571270|Exercise|exercise
161079|NCT02571270|quality of life|quality of life
161080|NCT02571270|healthy|healthy
161081|NCT02571270|cardiac remodeling|cardiac remodeling
161082|NCT02571257|LDL-C|ldl-c
161083|NCT02571257|Lipid Regulator|lipid regulator
161084|NCT02571244|Tobacco Use Disorder|tobacco use disorder
161085|NCT02571244|Hospitalized patients|hospitalized patients
161086|NCT02571244|Text message|text message
161087|NCT02571244|Motivational Interview|motivational interview
161088|NCT02571244|Substance-Related Disorders|substance-related disorders
161089|NCT02571244|Behaviors and Mental Disorders|behaviors and mental disorders
161090|NCT02571218|atrial fibrillation|atrial fibrillation
161091|NCT02571218|mapping|mapping
161092|NCT02571218|substrate|substrate
161093|NCT02571218|ablation|ablation
161094|NCT02571205|testosterone|testosterone
161095|NCT02571205|pubertal delay|pubertal delay
161096|NCT02571192|ADME|adme
161097|NCT02571179|Labor pain|labor pain
161098|NCT02571179|Fentanyl|fentanyl
161099|NCT02571179|Transmucosal|transmucosal
161100|NCT02571153|Intravenous anesthesia|intravenous anesthesia
161101|NCT02571153|Postoperative nausea vomiting|postoperative nausea vomiting
161102|NCT02571153|Postoperative pain|postoperative pain
161103|NCT02571153|Patient satisfaction|patient satisfaction
161104|NCT02571153|Quality of health care|quality of health care
161105|NCT02571153|Ketamine|ketamine
161106|NCT02571114|Glycemic Responses|glycemic responses
161107|NCT02571114|Metabolic Responses|metabolic responses
161108|NCT02571114|Males|males
161109|NCT02571114|Females|females
161110|NCT02571101|Clomipramine|clomipramine
161111|NCT02571101|Premature ejaculation|premature ejaculation
161112|NCT02571101|CDFR0812|cdfr0812
161113|NCT02571101|Sildenafil|sildenafil
161114|NCT02571088|Sickle Cell Hemoglobin C Disease|sickle cell hemoglobin c disease
161115|NCT02571088|Sports Training|sports training
161116|NCT02571088|Hemoglobin S Disease|hemoglobin s disease
161117|NCT02571088|Lactate|lactate
161118|NCT02571075|auricular|auricular
161119|NCT02571075|acupuncture|acupuncture
161120|NCT02571075|pain|pain
161121|NCT02571062|bioequivalence|bioequivalence
161122|NCT02571036|Gastrointestinal stromal tumors (GIST)|gastrointestinal stromal tumors (gist)
161123|NCT02571036|systemic mastocytosis (SM)|systemic mastocytosis (sm)
161124|NCT02571036|PDGFR-alpha|pdgfr-alpha
161125|NCT02571036|KIT|kit
161126|NCT02571036|mast cell leukemia (MCL)|mast cell leukemia (mcl)
161127|NCT02571036|mast cell disease (MCD)|mast cell disease (mcd)
161128|NCT02571036|DCC-2618|dcc-2618
161129|NCT02571036|melanoma|melanoma
161130|NCT02571036|aggressive systemic mastocytosis (ASM)|aggressive systemic mastocytosis (asm)
161131|NCT02571023|Skull Base Trauma|skull base trauma
161132|NCT02571023|microscope surgery|microscope surgery
161133|NCT02571023|neuroendoscope surgery|neuroendoscope surgery
161134|NCT02571010|static mechanical allodynia|static mechanical allodynia
161135|NCT02571010|somatosensory rehabilitation|somatosensory rehabilitation
161136|NCT02571010|vibrotactile stimulation|vibrotactile stimulation
161137|NCT02570997|Alzheimer's Disease|alzheimer's disease
161138|NCT02570997|Mild Cognitive Impairment|mild cognitive impairment
161139|NCT02570971|mannitol|mannitol
161140|NCT02570971|treatment|treatment
161141|NCT02570958|robotic surgery|robotic surgery
161142|NCT02570958|indocyanine green|indocyanine green
161143|NCT02570958|electromagnetic navigational bronchoscopy|electromagnetic navigational bronchoscopy
161144|NCT02570932|Adult Autologous Bone Marrow Mesenchymal Cells Expanded|adult autologous bone marrow mesenchymal cells expanded
161145|NCT02570932|chronic spinal cord injury (SCI)|chronic spinal cord injury (sci)
161146|NCT02570919|Prostate cancer|prostate cancer
161147|NCT02570919|IGRT|igrt
161148|NCT02570919|Hypofractionation|hypofractionation
161149|NCT02570919|Extreme|extreme
161150|NCT02570919|Single Fraction|single fraction
161151|NCT02570919|Urethral Sparing|urethral sparing
161152|NCT02570919|MRI|mri
161153|NCT02570893|Esophageal cancer;adjuvant therapy;chemotherapy;radiotherapy|esophageal cancer;adjuvant therapy;chemotherapy;radiotherapy
161154|NCT02570867|glaucoma|glaucoma
161155|NCT02570867|brain function|brain function
161156|NCT02570867|fMRI|fmri
161157|NCT02570854|Anemia|anemia
161158|NCT02570841|Heat pain threshold|heat pain threshold
161159|NCT02570841|Cold pain threshold|cold pain threshold
161160|NCT02570841|Mechanical pain threshold|mechanical pain threshold
161161|NCT02570841|High dose Capsaicin|high dose capsaicin
161162|NCT02570828|healthy neonate, tachypnea, thermal imaging, pneumonia|healthy neonate, tachypnea, thermal imaging, pneumonia
161163|NCT02570815|lung cancer|lung cancer
161164|NCT02570815|segmentectomy|segmentectomy
161165|NCT02570815|robotic surgery|robotic surgery
161166|NCT02570815|near-infrared fluorescent|near-infrared fluorescent
161167|NCT02570815|IC-GREEN|ic-green
161168|NCT02570815|indocyanine green|indocyanine green
161169|NCT02570815|early-stage lung cancer|early-stage lung cancer
161170|NCT02570776|Helicobacter pylori|helicobacter pylori
161171|NCT02570776|UBT|ubt
161172|NCT02570776|Sensitivity|sensitivity
161173|NCT02570776|specificity|specificity
161174|NCT02570776|prevalence|prevalence
161175|NCT02570763|neurostimulation|neurostimulation
161176|NCT02570763|comorbidity|comorbidity
161177|NCT02570763|tDCS|tdcs
161178|NCT02570763|CBT|cbt
161179|NCT02570763|anxiety|anxiety
161180|NCT02570763|alcohol|alcohol
161181|NCT02570685|Gratitude Intervention|gratitude intervention
161182|NCT02570685|positive emotion|positive emotion
161183|NCT02570685|friendships|friendships
161184|NCT02570685|positive psychology|positive psychology
161185|NCT02570685|life satisfaction|life satisfaction
161186|NCT02570659|WAD|wad
161187|NCT02570659|Whiplash|whiplash
161188|NCT02570659|Information Video|information video
161189|NCT02570633|Migraine|migraine
161190|NCT02570633|Ginger|ginger
161191|NCT02570633|Prophylactic treatment|prophylactic treatment
161192|NCT02570594|Cognition|cognition
161193|NCT02570594|Autobiographical|autobiographical
161194|NCT02570594|memoryCognitive|memorycognitive
161195|NCT02570594|remediation|remediation
161196|NCT02570581|volonteeres|volonteeres
161197|NCT02570568|Venepuncture|venepuncture
161198|NCT02570568|Transillumination|transillumination
161199|NCT02570555|driving|driving
161200|NCT02570542|CD34+ Cell Dose|cd34+ cell dose
161201|NCT02570542|Autologous Stem Cell Transplantation|autologous stem cell transplantation
161202|NCT02570542|15-193|15-193
161203|NCT02570529|Pancreatic cancer|pancreatic cancer
161204|NCT02570529|Chemoradiotherapy|chemoradiotherapy
161205|NCT02570529|Gastrointestinal toxicity|gastrointestinal toxicity
161206|NCT02570529|Albis|albis
161207|NCT02570516|Indigo carmine chromoendoscopy|indigo carmine chromoendoscopy
161208|NCT02570516|Narrow band imaging|narrow band imaging
161209|NCT02570516|Colonoscopy|colonoscopy
161210|NCT02570490|fusidic acid|fusidic acid
161211|NCT02570490|skin infection|skin infection
161212|NCT02570451|cognitive impairment|cognitive impairment
161213|NCT02570451|post surgical outcomes|post surgical outcomes
161214|NCT02570451|elective joint replacement surgery|elective joint replacement surgery
161215|NCT02570438|postoperative outcomes|postoperative outcomes
161216|NCT02570438|older surgical patients|older surgical patients
161217|NCT02570386|In-vitro fertilization|in-vitro fertilization
161218|NCT02570386|frozen thawed embryo transfer|frozen thawed embryo transfer
161219|NCT02570386|fresh embryo transfer|fresh embryo transfer
161220|NCT02570373|Healthy|healthy
161221|NCT02570373|Guselkumab|guselkumab
161222|NCT02570347|Snake Envenomation|snake envenomation
161223|NCT02570347|Antibiotic Prophylaxis|antibiotic prophylaxis
161224|NCT02570347|Viperidae|viperidae
161225|NCT02570334|early ART|early art
161226|NCT02570334|neurocognitive evaluation|neurocognitive evaluation
161227|NCT02570321|Cornea|cornea
161228|NCT02570321|Ulcer|ulcer
161229|NCT02570321|Infectious keratitis|infectious keratitis
161230|NCT02570321|Bacterial|bacterial
161231|NCT02570321|Fungal|fungal
161232|NCT02570295|Army|army
161233|NCT02570295|Sport|sport
161234|NCT02570295|Physical Fitness|physical fitness
161235|NCT02570295|Injuries|injuries
161236|NCT02570295|Psychological Tests|psychological tests
161237|NCT02570295|Attrition|attrition
161238|NCT02570282|Female|female
161239|NCT02570256|stroke|stroke
161240|NCT02570256|upper extremity|upper extremity
161241|NCT02570256|motor exploration|motor exploration
161242|NCT02570256|error augmentation|error augmentation
161243|NCT02570256|robotic rehabilitation|robotic rehabilitation
161244|NCT02570243|heparin|heparin
161245|NCT02570243|radial artery|radial artery
161246|NCT02570230|Thoracotomy|thoracotomy
161247|NCT02570230|Postoperative pain|postoperative pain
161248|NCT02570230|Ketamine|ketamine
161249|NCT02570217|NCPAP, High Flow Nasal Cannula, pretem infants, NICU|ncpap, high flow nasal cannula, pretem infants, nicu
161250|NCT02570178|clinical trial|clinical trial
161251|NCT02570178|accidental falls|accidental falls
161252|NCT02570178|postural balance|postural balance
161253|NCT02570178|elderly|elderly
161254|NCT02570178|primary Health Care|primary health care
161255|NCT02570165|efficacy|efficacy
161256|NCT02570165|dry powder inhaler|dry powder inhaler
161257|NCT02570165|vilanterol|vilanterol
161258|NCT02570165|batefenterol|batefenterol
161259|NCT02570152|Dengue|dengue
161260|NCT02570152|Non-laboratory confirmed dengue (non-LCD)|non-laboratory confirmed dengue (non-lcd)
161261|NCT02570152|Acute febrile illness (AFI)|acute febrile illness (afi)
161262|NCT02570152|Laboratory confirmed dengue (LCD)|laboratory confirmed dengue (lcd)
161263|NCT02570126|Immunogenicity|immunogenicity
161264|NCT02570126|Varicella|varicella
161265|NCT02570126|Safety|safety
161266|NCT02570126|Human serum albumin|human serum albumin
161267|NCT02570126|Healthy children|healthy children
161268|NCT02570126|12 to 23 months|12 to 23 months
161269|NCT02570100|Cancer Stem Cells|cancer stem cells
161270|NCT02570087|Coronary ChronicTotal Occlusion|coronary chronictotal occlusion
161271|NCT02570087|Coronary Angioplasty|coronary angioplasty
161272|NCT02570087|Reduced Ejection Fraction|reduced ejection fraction
161273|NCT02570061|recruitment|recruitment
161677|NCT02567851|PET scans|pet scans
161274|NCT02570061|comprehension|comprehension
161275|NCT02570061|satisfaction|satisfaction
161276|NCT02570061|informed consent|informed consent
161277|NCT02570061|telephone|telephone
161278|NCT02570035|Mirabegron|mirabegron
161279|NCT02570035|Overactive Bladder|overactive bladder
161280|NCT02570035|Cardiovascular Disease|cardiovascular disease
161281|NCT02570022|Pain control|pain control
161282|NCT02570022|liposomal bupivacaine|liposomal bupivacaine
161283|NCT02570022|exparel|exparel
161284|NCT02570022|shoulder arthroplasty|shoulder arthroplasty
161285|NCT02570009|couples|couples
161286|NCT02570009|weight loss treatment|weight loss treatment
161287|NCT02570009|home environment|home environment
161288|NCT02569970|Epilepsy|epilepsy
161289|NCT02569970|SUDEP|sudep
161290|NCT02569970|fluoxetine|fluoxetine
161291|NCT02569970|placebo|placebo
161292|NCT02569970|SpO2|spo2
161293|NCT02569918|Neuroplasticity|neuroplasticity
161294|NCT02569918|Sensory Feedback|sensory feedback
161295|NCT02569918|Transcutaneous electrical stimulation|transcutaneous electrical stimulation
161296|NCT02569918|Robotic hand|robotic hand
161297|NCT02569905|flurbiprofen|flurbiprofen
161298|NCT02569905|Parecoxib sodium|parecoxib sodium
161299|NCT02569905|Postoperative Shivering|postoperative shivering
161300|NCT02569879|Boostrix™|boostrix™
161301|NCT02569879|Bagota|bagota
161302|NCT02569879|maternal vaccination|maternal vaccination
161303|NCT02569879|Pertussis|pertussis
161304|NCT02569879|Mortality|mortality
161305|NCT02569879|Morbidity|morbidity
161306|NCT02569866|plastic surgery|plastic surgery
161307|NCT02569866|mammaplasty|mammaplasty
161308|NCT02569866|wound infection|wound infection
161309|NCT02569866|prophylaxis|prophylaxis
161310|NCT02569827|Uncomplicated Dengue Fever|uncomplicated dengue fever
161311|NCT02569827|Treatment|treatment
161312|NCT02569827|Phase Ib/IIa|phase ib/iia
161313|NCT02569827|single centre|single centre
161314|NCT02569827|double-blind|double-blind
161315|NCT02569827|placebo-controlled|placebo-controlled
161316|NCT02569827|parallel-group dose ranging trial|parallel-group dose ranging trial
161317|NCT02569827|Modipafant|modipafant
161318|NCT02569827|Celgosivir|celgosivir
161319|NCT02569788|re-irradiation|re-irradiation
161320|NCT02569788|carbon ion radiotherapy|carbon ion radiotherapy
161321|NCT02569775|Cerebral Palsy|cerebral palsy
161322|NCT02569775|Stem Cells|stem cells
161323|NCT02569762|Non-Nutritive Sweeteners|non-nutritive sweeteners
161324|NCT02569762|Artificial Sweeteners|artificial sweeteners
161325|NCT02569762|Glucose Metabolism|glucose metabolism
161326|NCT02569762|Microbiota|microbiota
161327|NCT02569762|Dysbiosis|dysbiosis
161328|NCT02569671|Dental Implants, Single-Tooth|dental implants, single-tooth
161329|NCT02569645|Rectal cancer|rectal cancer
161330|NCT02569645|Rosuvastatin|rosuvastatin
161331|NCT02569632|Meningococcal Vaccines|meningococcal vaccines
161332|NCT02569632|Neisseria Meningitidis|neisseria meningitidis
161333|NCT02569632|Factor H-binding Protein|factor h-binding protein
161334|NCT02569619|Physical Activity|physical activity
161335|NCT02569619|Mental Health|mental health
161336|NCT02569619|Physical Exercise|physical exercise
161337|NCT02569619|Mental disorder|mental disorder
161338|NCT02569619|Promotion|promotion
161339|NCT02569606|consumption of blood|consumption of blood
161340|NCT02569606|consumption of coagulation products|consumption of coagulation products
161341|NCT02569606|coagulation algorithm|coagulation algorithm
161342|NCT02569606|trauma related transfusion|trauma related transfusion
161343|NCT02569580|anti-lice treatment|anti-lice treatment
161344|NCT02569567|Smart-Shear Wave(SSW)|smart-shear wave(ssw)
161345|NCT02569567|Transient Elastography(TE)|transient elastography(te)
161346|NCT02569567|Liver cirrhosis|liver cirrhosis
161347|NCT02569554|PF-06463922|pf-06463922
161348|NCT02569554|rabeprazole|rabeprazole
161349|NCT02569554|proton pump inhibitor (PPI)|proton pump inhibitor (ppi)
161350|NCT02569554|pharmacokinetics(PK)|pharmacokinetics(pk)
161351|NCT02569554|food effect|food effect
161352|NCT02569541|fusidic acid|fusidic acid
161353|NCT02569541|prosthetic joint infections|prosthetic joint infections
161354|NCT02569541|bone infections|bone infections
161355|NCT02569541|osteomyelitis|osteomyelitis
161356|NCT02569528|atrial fibrillation|atrial fibrillation
161357|NCT02569528|anticoagulation|anticoagulation
161358|NCT02569476|BGB-3111|bgb-3111
161359|NCT02569476|Obinutuzumab|obinutuzumab
161360|NCT02569476|B-cell|b-cell
161361|NCT02569476|Lymphoma|lymphoma
161362|NCT02569476|Leukemia|leukemia
161363|NCT02569476|Therapeutic uses|therapeutic uses
161364|NCT02569450|Surgery|surgery
161365|NCT02569450|Performance|performance
161366|NCT02569450|Outcome|outcome
161367|NCT02569450|Control chart|control chart
161368|NCT02569437|doxycycline|doxycycline
161369|NCT02569437|oral methylprednisone|oral methylprednisone
161370|NCT02569437|sinusitis with nasal polyps|sinusitis with nasal polyps
161371|NCT02569424|PEEP level|peep level
161372|NCT02569424|Trendelenburg position|trendelenburg position
161373|NCT02569424|cross-sectional area of the jugular and subclavian veins|cross-sectional area of the jugular and subclavian veins
161374|NCT02569424|central venous catheter|central venous catheter
161375|NCT02569398|Alzheimer disease|alzheimer disease
161376|NCT02569398|JNJ-54861911|jnj-54861911
161377|NCT02569398|Dementia|dementia
161378|NCT02569385|Weaning TTE|weaning tte
161379|NCT02569385|patients in prolonged weaning|patients in prolonged weaning
161380|NCT02569346|Triumeq|triumeq
161381|NCT02569346|Pharmacokinetics|pharmacokinetics
161382|NCT02569346|Crushing|crushing
161383|NCT02569346|Drip feed|drip feed
161384|NCT02569333|ulcerative colitis|ulcerative colitis
161385|NCT02569333|inflammatory bowel disease|inflammatory bowel disease
161386|NCT02569333|education|education
161387|NCT02569333|patient-reported outcomes|patient-reported outcomes
161388|NCT02569307|At Risk of Mental State|at risk of mental state
161389|NCT02569307|Prodromal Phase|prodromal phase
161390|NCT02569307|Psychosis|psychosis
161391|NCT02569294|group interventions|group interventions
161392|NCT02569294|emotional distress|emotional distress
161393|NCT02569294|breast cancer|breast cancer
161394|NCT02569294|yoga|yoga
161395|NCT02569294|hypnosis|hypnosis
161396|NCT02569294|cognitive-behavioral therapy|cognitive-behavioral therapy
161397|NCT02569281|Subacromial pain syndrome|subacromial pain syndrome
161398|NCT02569281|Eccentric exercise|eccentric exercise
161399|NCT02569281|Pressure pain|pressure pain
161400|NCT02569281|US-guided percutaneous electrolysis|us-guided percutaneous electrolysis
161401|NCT02569268|Arteriosclerosis|arteriosclerosis
161402|NCT02569268|Vascular function|vascular function
161403|NCT02569268|Vascular disease early detection system|vascular disease early detection system
161404|NCT02569229|children|children
161405|NCT02569229|cystic fibrosis|cystic fibrosis
161406|NCT02569229|glucose intolerance|glucose intolerance
161407|NCT02569229|continuous glucose measurement|continuous glucose measurement
161408|NCT02569216|Electrical Inhibition|electrical inhibition
161409|NCT02569216|Preterm Birth|preterm birth
161410|NCT02569216|Premature Birth|premature birth
161411|NCT02569216|Preterm Labor|preterm labor
161412|NCT02569216|Premature Labor|premature labor
161413|NCT02569216|tocolytic|tocolytic
161414|NCT02569216|uterus|uterus
161415|NCT02569177|myocardial infarction|myocardial infarction
161416|NCT02569177|cardiac surgery|cardiac surgery
161417|NCT02569177|troponin|troponin
161418|NCT02569177|heart-type fatty acid binding protein|heart-type fatty acid binding protein
161419|NCT02569138|Balance|balance
161420|NCT02569138|Footwear|footwear
161421|NCT02569138|Shoes|shoes
161422|NCT02569138|Falls|falls
161423|NCT02569125|segmental overgrowth syndrome|segmental overgrowth syndrome
161424|NCT02569099|stroke survivors|stroke survivors
161425|NCT02569099|caregivers|caregivers
161426|NCT02569099|burden of care|burden of care
161427|NCT02569099|quality of life|quality of life
161428|NCT02569099|function|function
161429|NCT02569099|community reintegration|community reintegration
161430|NCT02569099|caregiver training|caregiver training
161431|NCT02569086|Sepsis|sepsis
161432|NCT02569086|Therapeutic Drug Monitoring|therapeutic drug monitoring
161433|NCT02569086|Beta-lactams|beta-lactams
161434|NCT02569086|Pharmacokinetics|pharmacokinetics
161435|NCT02569073|Functional Chest Pain|functional chest pain
161436|NCT02569073|Non-Cardiac Chest Pain|non-cardiac chest pain
161437|NCT02569073|Esophageal Hypersensitivity|esophageal hypersensitivity
161438|NCT02569060|diabetes mellitus|diabetes mellitus
161439|NCT02569060|community intervention|community intervention
161440|NCT02569060|intervention|intervention
161441|NCT02569060|randomized|randomized
161442|NCT02569060|dietary intervention|dietary intervention
161443|NCT02569060|self-management support|self-management support
161444|NCT02569060|food bank|food bank
161445|NCT02569047|Atraumatic Restorative Treatment|atraumatic restorative treatment
161446|NCT02569047|Occlusoproximal|occlusoproximal
161447|NCT02569047|Primary Teeth|primary teeth
161448|NCT02569047|Glass Ionomer Cements|glass ionomer cements
161449|NCT02569047|Hall Technique|hall technique
161450|NCT02569021|Parkinsons Disease|parkinsons disease
161451|NCT02569021|Essential Tremor|essential tremor
161452|NCT02569021|DBS|dbs
161453|NCT02569021|Depp Brain Stimulation|depp brain stimulation
161454|NCT02569008|Fluid Challenge|fluid challenge
161455|NCT02569008|Mean systemic filling pressure|mean systemic filling pressure
161456|NCT02569008|Fluid therapy|fluid therapy
161457|NCT02568995|postoperative pain|postoperative pain
161458|NCT02568995|morphine|morphine
161459|NCT02568995|total hip arthroplasty|total hip arthroplasty
161460|NCT02568995|femoral nerve block|femoral nerve block
161461|NCT02568982|Cushing's disease|cushing's disease
161462|NCT02568982|Quality of life|quality of life
161463|NCT02568982|Metabolic|metabolic
161464|NCT02568982|patients with Cushing's disease|patients with cushing's disease
161465|NCT02568982|cardiovascular|cardiovascular
161466|NCT02568982|thromboembolic|thromboembolic
161467|NCT02568982|bone complications|bone complications
161468|NCT02568969|Cardiosurgery, lactate|cardiosurgery, lactate
161469|NCT02568943|multiple myelome, MM, expanded treatment, panobinostat, bortezomib, dexamethasone, relapsed, refractory, LBH589|multiple myelome, mm, expanded treatment, panobinostat, bortezomib, dexamethasone, relapsed, refractory, lbh589
161470|NCT02568930|quality of life heart failure mechanical support transplant|quality of life heart failure mechanical support transplant
161471|NCT02568917|Dental Atraumatic Restorative Treatment|dental atraumatic restorative treatment
161472|NCT02568917|Composite Resins|composite resins
161473|NCT02568917|Primary Teeth|primary teeth
161474|NCT02568917|Permanent Teeth|permanent teeth
161475|NCT02568917|Clinical Effectiveness|clinical effectiveness
161476|NCT02568917|Cost Analysis|cost analysis
161477|NCT02568878|Depression|depression
161478|NCT02568878|Anxiety|anxiety
161479|NCT02568878|Methamphetamine dependence|methamphetamine dependence
161480|NCT02568852|D-dimer|d-dimer
161481|NCT02568852|Fibrinogen|fibrinogen
161482|NCT02568852|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
161483|NCT02568839|Neoadjuvant therapy|neoadjuvant therapy
161484|NCT02568826|Low Back Pain|low back pain
161485|NCT02568826|Muscle relaxant|muscle relaxant
161486|NCT02568813|epilepsy|epilepsy
161487|NCT02568813|depression|depression
161488|NCT02568813|mood disorder|mood disorder
161489|NCT02568813|anxiety|anxiety
161490|NCT02568813|cyclothymia|cyclothymia
161491|NCT02568813|Behavioral neuropsychiatric features|behavioral neuropsychiatric features
161492|NCT02568787|NAFLD|nafld
161493|NCT02568787|cytokines|cytokines
161494|NCT02568787|interleukin (IL)|interleukin (il)
161495|NCT02568787|interferon (IFN)|interferon (ifn)
161496|NCT02568787|liver function test (LFTS)|liver function test (lfts)
161497|NCT02568787|nutrition|nutrition
161498|NCT02568787|bran arabinoxylan compound (RBAC)|bran arabinoxylan compound (rbac)
161499|NCT02568787|tumor necrosis factor -- type I receptor (TNF-RI)|tumor necrosis factor -- type i receptor (tnf-ri)
161500|NCT02568787|TNF-RII (tumor necrosis factor -- type II receptor (TNF-RII)|tnf-rii (tumor necrosis factor -- type ii receptor (tnf-rii)
161501|NCT02568774|Post-stroke|post-stroke
161502|NCT02568761|Snoring|snoring
161503|NCT02568761|Sleep apnea|sleep apnea
161504|NCT02568761|Obstructive sleep apnea|obstructive sleep apnea
161505|NCT02568761|Speech therapy|speech therapy
161506|NCT02568761|Injection snoreplasty|injection snoreplasty
161507|NCT02568761|Ethanol|ethanol
161508|NCT02568761|Oropharyngeal exercises|oropharyngeal exercises
161509|NCT02568735|Dexketoprofen|dexketoprofen
161510|NCT02568735|Etoricoxib|etoricoxib
161511|NCT02568735|hip arthroplasty|hip arthroplasty
161512|NCT02568735|pain|pain
161513|NCT02568722|Renal replacement therapy|renal replacement therapy
161514|NCT02568722|Acute kidney injury|acute kidney injury
161515|NCT02568722|Dialysis|dialysis
161516|NCT02568722|Hemodialysis|hemodialysis
161517|NCT02568722|Critical illness|critical illness
161518|NCT02568709|Oxytocin|oxytocin
161519|NCT02568709|Syntocinon|syntocinon
161520|NCT02568709|Social Cognition|social cognition
161521|NCT02568709|Schizophrenia|schizophrenia
161522|NCT02568709|Magnetoencephalography (MEG)|magnetoencephalography (meg)
161523|NCT02568696|kidney transplantation|kidney transplantation
161524|NCT02568696|renal transplantation|renal transplantation
161525|NCT02568696|fibrinolysis|fibrinolysis
161526|NCT02568696|cell mediated rejection|cell mediated rejection
161527|NCT02568696|coagulation|coagulation
161528|NCT02568696|delayed graft function|delayed graft function
161529|NCT02568696|Halloran criteria|halloran criteria
161530|NCT02568696|graft rejection|graft rejection
161531|NCT02568696|thrombin generation|thrombin generation
161532|NCT02568696|fibrin generation|fibrin generation
161533|NCT02568683|DLBCL|dlbcl
161534|NCT02568683|Relapsed|relapsed
161535|NCT02568683|Refractory|refractory
161536|NCT02568644|Migraine|migraine
161537|NCT02568644|Ginger|ginger
161538|NCT02568644|Acute treatment|acute treatment
161539|NCT02568631|Autistic Disorder|autistic disorder
161540|NCT02568618|Military|military
161541|NCT02568618|Genomics|genomics
161542|NCT02568618|Pain|pain
161543|NCT02568605|Dietary intervention|dietary intervention
161544|NCT02568605|Prebiotic fibre|prebiotic fibre
161545|NCT02568605|Weight loss|weight loss
161546|NCT02568605|Gut microbiota|gut microbiota
161547|NCT02568605|Obesity|obesity
161548|NCT02568605|Liver fat|liver fat
161549|NCT02568605|Hepatic fibrosis|hepatic fibrosis
161550|NCT02568540|Hepatitis C|hepatitis c
161551|NCT02568540|Smartphone|smartphone
161552|NCT02568540|app|app
161553|NCT02568540|Tracker|tracker
161554|NCT02568540|C Tracker|c tracker
161555|NCT02568527|LSCD|lscd
161556|NCT02568527|SLET|slet
161557|NCT02568527|Donor Human Amniotic Membrane (hAM)|donor human amniotic membrane (ham)
161558|NCT02568527|PLGA|plga
161559|NCT02568514|mhealth|mhealth
161560|NCT02568514|text messaging|text messaging
161561|NCT02568514|secure text messaging|secure text messaging
161562|NCT02568514|communication|communication
161563|NCT02568501|diabetes|diabetes
161564|NCT02568501|adolescent|adolescent
161565|NCT02568501|young adult|young adult
161566|NCT02568501|behavioral economics|behavioral economics
161567|NCT02568501|financial incentives|financial incentives
161568|NCT02568501|social incentives|social incentives
161569|NCT02568475|nursing home residents, decision aid, acute care transfers|nursing home residents, decision aid, acute care transfers
161570|NCT02568462|Stents|stents
161571|NCT02568462|Angioplasty|angioplasty
161572|NCT02568462|Coronary Vessels|coronary vessels
161573|NCT02568462|Coronary Artery Disease|coronary artery disease
161574|NCT02568462|Angina Pectoris|angina pectoris
161575|NCT02568462|Myocardial Ischemia|myocardial ischemia
161576|NCT02568462|Myocardial Infarction|myocardial infarction
161577|NCT02568462|Myocardial Revascularization|myocardial revascularization
161578|NCT02568410|Mast Cells|mast cells
161579|NCT02568410|Blood Platelets|blood platelets
161580|NCT02568410|cardiac surgical procedures|cardiac surgical procedures
161581|NCT02568371|biobank|biobank
161582|NCT02568371|DNA|dna
161583|NCT02568371|genetic|genetic
161584|NCT02568371|young adults|young adults
161585|NCT02568371|cohort study|cohort study
161586|NCT02568345|Dose-Response Relationship|dose-response relationship
161587|NCT02568345|Drug|drug
161588|NCT02568345|Obesity|obesity
161589|NCT02568345|Cyclodextrins|cyclodextrins
161590|NCT02568267|Entrectinib|entrectinib
161591|NCT02568267|RXDX-101|rxdx-101
161592|NCT02568267|TrkA|trka
161593|NCT02568267|TrkB|trkb
161594|NCT02568267|TrkC|trkc
161595|NCT02568267|NTRK1|ntrk1
161596|NCT02568267|NTRK2|ntrk2
161597|NCT02568267|NTRK3|ntrk3
161598|NCT02568267|ROS1|ros1
161599|NCT02568267|ALK|alk
161600|NCT02568267|Trk Fusions|trk fusions
161601|NCT02568267|NTRK Gene Rearrangements|ntrk gene rearrangements
161602|NCT02568267|ROS1 Fusions|ros1 fusions
161603|NCT02568267|ROS1 Gene Rearrangements|ros1 gene rearrangements
161604|NCT02568267|ALK Fusions|alk fusions
161605|NCT02568267|ALK Gene Rearrangements|alk gene rearrangements
161606|NCT02568267|Basket study|basket study
161607|NCT02568267|Non-small cell lung cancer|non-small cell lung cancer
161608|NCT02568267|Colorectal cancer|colorectal cancer
161609|NCT02568267|Salivary gland cancers|salivary gland cancers
161610|NCT02568267|Primary brain tumors|primary brain tumors
161611|NCT02568267|Melanoma|melanoma
161612|NCT02568267|Sarcomas|sarcomas
161613|NCT02568267|Papillary thyroid cancer|papillary thyroid cancer
161614|NCT02568267|Renal cell cancer|renal cell cancer
161615|NCT02568267|Pancreatic cancer|pancreatic cancer
161616|NCT02568267|Breast cancer|breast cancer
161617|NCT02568267|Cholangiocarcinoma|cholangiocarcinoma
161618|NCT02568267|Head & Neck cancers|head & neck cancers
161619|NCT02568267|Ovarian cancer|ovarian cancer
161620|NCT02568267|Neuroendocrine tumors|neuroendocrine tumors
161621|NCT02568267|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
161622|NCT02568241|Interferon Alfa-2b|interferon alfa-2b
161623|NCT02568241|Relapse|relapse
161624|NCT02568241|Donor lymphocyte infusion|donor lymphocyte infusion
161625|NCT02568228|Triacylglycerols|triacylglycerols
161626|NCT02568228|Omega-3 fatty acids|omega-3 fatty acids
161627|NCT02568228|Krill oil|krill oil
161628|NCT02568228|Fish|fish
161629|NCT02568228|Healthy Volunteers|healthy volunteers
161630|NCT02568215|HIV-1 Infections|hiv-1 infections
161631|NCT02568189|Sepsis|sepsis
161632|NCT02568189|Gastroenteritis|gastroenteritis
161633|NCT02568189|Dehydration|dehydration
161634|NCT02568189|Ultrasound|ultrasound
161635|NCT02568189|Ultrasonography|ultrasonography
161636|NCT02568189|Inferior Vena Cava|inferior vena cava
161637|NCT02568176|Healthy|healthy
161638|NCT02568176|Pharmacokinetics|pharmacokinetics
161639|NCT02568176|Esketamine|esketamine
161640|NCT02568176|JNJ-54135419|jnj-54135419
161641|NCT02568176|Midazolam|midazolam
161642|NCT02568176|Bupropion|bupropion
161643|NCT02568137|mobile health|mobile health
161644|NCT02568137|Behavior change|behavior change
161645|NCT02568137|Africa|africa
161646|NCT02568124|Tranexamic acid|tranexamic acid
161647|NCT02568124|Cyklokapron|cyklokapron
161648|NCT02568124|Conservative management|conservative management
161649|NCT02568124|Medical management|medical management
161650|NCT02568111|erythema|erythema
161651|NCT02568111|PLEGRIDY|plegridy
161652|NCT02568111|injection site reaction (ISR)|injection site reaction (isr)
161653|NCT02568111|MS|ms
161654|NCT02568111|RRMS|rrms
161655|NCT02568098|Drug combination|drug combination
161656|NCT02568098|Ivermectin|ivermectin
161657|NCT02568098|Primaquine|primaquine
161658|NCT02568098|Dihydroartemisinin-Piperaquine|dihydroartemisinin-piperaquine
161659|NCT02568098|Albendazole|albendazole
161660|NCT02568098|Pharmacokinetics|pharmacokinetics
161661|NCT02568098|Mosquito-Lethal Effect|mosquito-lethal effect
161662|NCT02568098|Healthy adult subject|healthy adult subject
161663|NCT02568072|exercise|exercise
161664|NCT02568072|cardiac remodelling|cardiac remodelling
161665|NCT02568072|left ventricular non-compaction cardiomyopathy|left ventricular non-compaction cardiomyopathy
161666|NCT02568046|Metastatic Colorectal Cancer|metastatic colorectal cancer
161667|NCT02567981|chronic undernutrition|chronic undernutrition
161668|NCT02567981|anemia|anemia
161669|NCT02567981|micronutrient supplement|micronutrient supplement
161670|NCT02567955|HPV vaccines, interchangeable use|hpv vaccines, interchangeable use
161671|NCT02567877|hypothyroidism|hypothyroidism
161672|NCT02567877|deiodinase polymorphism|deiodinase polymorphism
161673|NCT02567877|cognitive function|cognitive function
161674|NCT02567877|thyroidectomy|thyroidectomy
161675|NCT02567877|levothyroxine|levothyroxine
161676|NCT02567851|Brentuximab Vedotin|brentuximab vedotin
161678|NCT02567851|Lymphoma|lymphoma
161679|NCT02567825|ear infection|ear infection
161680|NCT02567825|antibiotics|antibiotics
161681|NCT02567825|infants|infants
161682|NCT02567825|children|children
161683|NCT02567825|pediatrics|pediatrics
161684|NCT02567825|tympanostomy tubes|tympanostomy tubes
161685|NCT02567799|Lung Neoplasms|lung neoplasms
161686|NCT02567773|Itraconazole|itraconazole
161687|NCT02567773|GSK2881078|gsk2881078
161688|NCT02567773|CYP3A4|cyp3a4
161689|NCT02567773|Selective Androgen Receptor Modulator|selective androgen receptor modulator
161690|NCT02567773|Safety|safety
161691|NCT02567773|Pharmacokinetics|pharmacokinetics
161692|NCT02567773|Tolerability|tolerability
161693|NCT02567760|MP1|mp1
161694|NCT02567760|cognitive enhancing effect|cognitive enhancing effect
161695|NCT02567760|menopausal women|menopausal women
161696|NCT02567747|Colombia|colombia
161697|NCT02567747|otitis|otitis
161698|NCT02567747|Database|database
161699|NCT02567747|pneumonia|pneumonia
161700|NCT02567734|irreversible electroporation|irreversible electroporation
161701|NCT02567734|ablation|ablation
161702|NCT02567734|neoplasms|neoplasms
161703|NCT02567734|cancer|cancer
161704|NCT02567734|carcinoma|carcinoma
161705|NCT02567734|NanoKnife|nanoknife
161706|NCT02567734|Ablation Techniques|ablation techniques
161707|NCT02567721|Post-authorisation safety study (PASS)|post-authorisation safety study (pass)
161708|NCT02567721|Adverse Drug Reaction Reporting Systems|adverse drug reaction reporting systems
161709|NCT02567721|Post marketing product surveillance|post marketing product surveillance
161710|NCT02567721|European Medicines Agency (EMA)|european medicines agency (ema)
161711|NCT02567721|Influenza Vaccine|influenza vaccine
161712|NCT02567721|Computerized Medical Record System|computerized medical record system
161713|NCT02567721|United Kingdom|united kingdom
161714|NCT02567721|Primary Health Care|primary health care
161715|NCT02567708|GSK2269557|gsk2269557
161716|NCT02567708|Asthma|asthma
161717|NCT02567708|Pharmacokinetics|pharmacokinetics
161718|NCT02567708|Safety|safety
161719|NCT02567708|Adults|adults
161720|NCT02567708|DISKUS Dry Powder Inhaler|diskus dry powder inhaler
161721|NCT02567708|Efficacy|efficacy
161722|NCT02567682|anemia, sickle cell|anemia, sickle cell
161723|NCT02567669|radiotherapy|radiotherapy
161724|NCT02567656|CTCL|ctcl
161725|NCT02567656|PTCL|ptcl
161726|NCT02567656|RP6530|rp6530
161727|NCT02567643|Brain|brain
161728|NCT02567643|CNS|cns
161729|NCT02567643|Metastases|metastases
161730|NCT02567630|Cerebral Palsy|cerebral palsy
161731|NCT02567630|physical|physical
161732|NCT02567630|sensory|sensory
161733|NCT02567630|motor impairments|motor impairments
161734|NCT02567630|upper extremity|upper extremity
161735|NCT02567630|Constraint-Induced Movement Therapy|constraint-induced movement therapy
161736|NCT02567617|Polyphenols, Prostaglandin E2, hormonal contraceptives|polyphenols, prostaglandin e2, hormonal contraceptives
161737|NCT02567591|pre liver transplantation patients|pre liver transplantation patients
161738|NCT02567552|endometrial receptivity|endometrial receptivity
161739|NCT02567552|endometrial predecidualization|endometrial predecidualization
161740|NCT02567552|endometrial genomics|endometrial genomics
161741|NCT02567552|endometrial receptivity array|endometrial receptivity array
161742|NCT02567526|food and fluid intake|food and fluid intake
161743|NCT02567526|nursing home residents|nursing home residents
161744|NCT02567526|staffing|staffing
161745|NCT02567513|food and fluid intake|food and fluid intake
161746|NCT02567513|nursing homes|nursing homes
161747|NCT02567500|emotional|emotional
161748|NCT02567500|auditory hallucinations|auditory hallucinations
161749|NCT02567500|non-psychotic children|non-psychotic children
161750|NCT02567474|chronic lung disease|chronic lung disease
161751|NCT02567461|dual antiplatelet therapy|dual antiplatelet therapy
161752|NCT02567461|clopidogrel|clopidogrel
161753|NCT02567461|aspirin|aspirin
161754|NCT02567461|edoxaban|edoxaban
161755|NCT02567448|Obstructive Sleep Apnea|obstructive sleep apnea
161756|NCT02567448|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
161757|NCT02567448|Overlap syndrome|overlap syndrome
161758|NCT02567448|Pcrit|pcrit
161759|NCT02567448|Critical closing pressure|critical closing pressure
161760|NCT02567383|head and neck cancer|head and neck cancer
161761|NCT02567383|hyperthermia, Thermotron RF-8|hyperthermia, thermotron rf-8
161762|NCT02567383|radiotherapy|radiotherapy
161763|NCT02567370|Schizophrenia or Schizoaffective Disorder|schizophrenia or schizoaffective disorder
161764|NCT02567357|change triggered temper outbursts|change triggered temper outbursts
161765|NCT02567357|parent training|parent training
161766|NCT02567357|autism|autism
161767|NCT02567357|intellectual disability|intellectual disability
161768|NCT02567357|Prader-Willi syndrome|prader-willi syndrome
161769|NCT02567357|Fragile X syndrome|fragile x syndrome
161770|NCT02567357|web-based training|web-based training
161771|NCT02567357|Down syndrome|down syndrome
161772|NCT02567344|Cannabis|cannabis
161773|NCT02567344|rTMS|rtms
161774|NCT02567344|Craving|craving
161775|NCT02567344|Decision making|decision making
161776|NCT02567318|Pain|pain
161777|NCT02567318|Secondary hyperalgesia|secondary hyperalgesia
161778|NCT02567318|Healthy volunteers|healthy volunteers
161779|NCT02567318|Magnetic Resonance Imaging|magnetic resonance imaging
161780|NCT02567292|Digestive Disease and Disorders|digestive disease and disorders
161781|NCT02567292|Neonatal|neonatal
161782|NCT02567292|Pediatric Disorders|pediatric disorders
161783|NCT02567253|Cytoreductive surgery|cytoreductive surgery
161784|NCT02567253|(H)ipec|(h)ipec
161785|NCT02567253|Ovarian cancer|ovarian cancer
161786|NCT02567253|Cisplatin|cisplatin
161787|NCT02567253|Peritoneal carcinomatosis|peritoneal carcinomatosis
161788|NCT02567253|Pharmacokinetics|pharmacokinetics
161789|NCT02567253|Pharmacodynamics|pharmacodynamics
161790|NCT02567214|dyspnea|dyspnea
161791|NCT02567214|exercise|exercise
161792|NCT02567214|shuttle test|shuttle test
161793|NCT02567214|long-acting β2-agonists|long-acting β2-agonists
161794|NCT02567214|longacting muscarinic antagonist|longacting muscarinic antagonist
161795|NCT02567214|indacaterol|indacaterol
161796|NCT02567214|glycopyrronium|glycopyrronium
161797|NCT02567214|tiotropium|tiotropium
161798|NCT02567201|Voluntary attention|voluntary attention
161799|NCT02567201|Electroencephalogram|electroencephalogram
161800|NCT02567201|Brain-computer interface|brain-computer interface
161801|NCT02567201|Disorders of consciousness|disorders of consciousness
161802|NCT02567162|Intracerebral hemorrhage|intracerebral hemorrhage
161803|NCT02567162|Hemorrhagic stroke|hemorrhagic stroke
161804|NCT02567162|Intraparenchymal hemorrhage|intraparenchymal hemorrhage
161805|NCT02567162|Cerebrovascular disease|cerebrovascular disease
161806|NCT02567162|Stroke|stroke
161807|NCT02567149|Wart|wart
161808|NCT02567110|Mid-life Depression|mid-life depression
161809|NCT02567110|Bipolar Disorder|bipolar disorder
161810|NCT02567110|DSM-5 MDE|dsm-5 mde
161811|NCT02567110|Inflammation|inflammation
161812|NCT02567110|CNS Glutamate|cns glutamate
161813|NCT02567084|Bone substitute|bone substitute
161814|NCT02567084|benign bone cyst|benign bone cyst
161815|NCT02567084|ceramic|ceramic
161816|NCT02567084|remodelling|remodelling
161817|NCT02567071|C-section|c-section
161818|NCT02567071|Microbiota|microbiota
161819|NCT02567058|Achilles tendon|achilles tendon
161820|NCT02567045|Immunochemical fecal occult blood test|immunochemical fecal occult blood test
161821|NCT02567045|Colonoscopy|colonoscopy
161822|NCT02567045|Screening uptake|screening uptake
161823|NCT02567045|Screening participation|screening participation
161824|NCT02567045|Familiar risk|familiar risk
161825|NCT02567045|Colorectal Cancer|colorectal cancer
161826|NCT02567032|Oxytocin|oxytocin
161827|NCT02567032|Syntocinon|syntocinon
161828|NCT02567032|Social Cognition|social cognition
161829|NCT02567032|Schizophrenia|schizophrenia
161830|NCT02567006|vaccines|vaccines
161831|NCT02567006|reminders|reminders
161832|NCT02567006|immunization timeliness|immunization timeliness
161833|NCT02567006|vaccine coverage|vaccine coverage
161834|NCT02566980|depression|depression
161835|NCT02566980|mood disorder|mood disorder
161836|NCT02566980|post-partum depression|post-partum depression
161837|NCT02566980|suicidality|suicidality
161838|NCT02566980|post-partum suicidality|post-partum suicidality
161839|NCT02566980|perinatal depression|perinatal depression
161840|NCT02566980|perinatal mood disorder|perinatal mood disorder
161841|NCT02566980|inflammation|inflammation
161842|NCT02566980|kynurenine pathway|kynurenine pathway
161843|NCT02566980|glutamate|glutamate
161844|NCT02566954|radiology|radiology
161845|NCT02566954|3D measurement|3d measurement
161846|NCT02566954|lower limb|lower limb
161847|NCT02566941|critical illness polyneuropathy|critical illness polyneuropathy
161848|NCT02566941|critical illness myopathy|critical illness myopathy
161849|NCT02566941|neuromuscular electrical stimulation|neuromuscular electrical stimulation
161850|NCT02566941|intensive care unit acquired weakness|intensive care unit acquired weakness
161975|NCT02566135|C-LMA|c-lma
161851|NCT02566941|prevention of critical illness polyneuropathy|prevention of critical illness polyneuropathy
161852|NCT02566928|Methicillin-Resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
161853|NCT02566928|Recurrence|recurrence
161854|NCT02566928|Practice Based Research Network|practice based research network
161855|NCT02566928|Community Health Workers/Promotoras|community health workers/promotoras
161856|NCT02566928|Decolonization and Decontamination|decolonization and decontamination
161857|NCT02566928|Staphylococcal Skin Infections|staphylococcal skin infections
161858|NCT02566928|Household Transmission|household transmission
161859|NCT02566889|Pediatric Inflammatory Bowel Disease|pediatric inflammatory bowel disease
161860|NCT02566889|Infliximab|infliximab
161861|NCT02566889|Pediatric Participants|pediatric participants
161862|NCT02566889|Pediatric Ulcerative Colitis|pediatric ulcerative colitis
161863|NCT02566889|Pediatric Crohn's Disease|pediatric crohn's disease
161864|NCT02566889|Dose Escalation|dose escalation
161865|NCT02566876|Children|children
161866|NCT02566876|Abdominal Pain|abdominal pain
161867|NCT02566876|Functional Dyspepsia|functional dyspepsia
161868|NCT02566876|Irritable Bowel Syndrome|irritable bowel syndrome
161869|NCT02566876|Quality of Life|quality of life
161870|NCT02566863|dexmedetomidine|dexmedetomidine
161871|NCT02566863|heart rate|heart rate
161872|NCT02566863|heart rate variability|heart rate variability
161873|NCT02566837|ultrasound|ultrasound
161874|NCT02566837|Electrical stimulation guidance|electrical stimulation guidance
161875|NCT02566837|botulinum toxin|botulinum toxin
161876|NCT02566772|Prostate Cancer|prostate cancer
161877|NCT02566759|Drug therapy|drug therapy
161878|NCT02566733|remifentanil|remifentanil
161879|NCT02566720|amantadine|amantadine
161880|NCT02566720|tractography|tractography
161881|NCT02566720|mri|mri
161882|NCT02566720|coma|coma
161883|NCT02566720|abi|abi
161884|NCT02566720|tbi|tbi
161885|NCT02566720|traumatic brain injury|traumatic brain injury
161886|NCT02566720|acquired brain injury|acquired brain injury
161887|NCT02566668|Asthma|asthma
161888|NCT02566668|Severe Asthma|severe asthma
161889|NCT02566668|IL-10|il-10
161890|NCT02566668|IL-27|il-27
161891|NCT02566668|IL-13|il-13
161892|NCT02566668|Epithelial Cells|epithelial cells
161893|NCT02566668|T lymphocytes|t lymphocytes
161894|NCT02566668|Interferon-g|interferon-g
161895|NCT02566629|microbiota community|microbiota community
161896|NCT02566629|IBS|ibs
161897|NCT02566603|ITP|itp
161898|NCT02566603|Thrombocytopenia|thrombocytopenia
161899|NCT02566577|Chronic anemia|chronic anemia
161900|NCT02566577|Cardiopulmonary testing|cardiopulmonary testing
161901|NCT02566577|Transfusion-dependent anemia|transfusion-dependent anemia
161902|NCT02566551|Prostatic artery embolization|prostatic artery embolization
161903|NCT02566551|Transurethral resection of the prostate|transurethral resection of the prostate
161904|NCT02566538|Cohort study|cohort study
161905|NCT02566538|psychometric tests|psychometric tests
161906|NCT02566538|cognitive function|cognitive function
161907|NCT02566538|cardiovascular risk|cardiovascular risk
161908|NCT02566538|prediction algorithm|prediction algorithm
161909|NCT02566525|CytoSorb device|cytosorb device
161910|NCT02566525|Plasma free hemoglobin|plasma free hemoglobin
161911|NCT02566525|inflammation|inflammation
161912|NCT02566525|extracorporeal bypass|extracorporeal bypass
161913|NCT02566512|Tracheostomy|tracheostomy
161914|NCT02566512|weaning|weaning
161915|NCT02566512|respiratory failure|respiratory failure
161916|NCT02566512|cough strength|cough strength
161917|NCT02566499|Medical imaging|medical imaging
161918|NCT02566499|Microwaves|microwaves
161919|NCT02566473|Patient reported outcomes|patient reported outcomes
161920|NCT02566473|Osteoarthritis|osteoarthritis
161921|NCT02566473|Total joint replacement|total joint replacement
161922|NCT02566460|Lactate clearance|lactate clearance
161923|NCT02566460|systemic central venous oxygen saturation|systemic central venous oxygen saturation
161924|NCT02566460|septic shock|septic shock
161925|NCT02566460|haemodynamic therapy|haemodynamic therapy
161926|NCT02566434|Dietary Supplements|dietary supplements
161927|NCT02566395|Stem Cell Transplantation|stem cell transplantation
161928|NCT02566395|Haploidentical Donors|haploidentical donors
161929|NCT02566369|Efficacy|efficacy
161930|NCT02566369|Safety|safety
161931|NCT02566369|Acne vulgaris|acne vulgaris
161932|NCT02566356|Oxytocin|oxytocin
161933|NCT02566356|Syntocinon|syntocinon
161934|NCT02566356|Social Cognition|social cognition
161935|NCT02566356|Schizophrenia|schizophrenia
161936|NCT02566356|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
161937|NCT02566343|Spirometry|spirometry
161938|NCT02566343|Exercise Test|exercise test
161939|NCT02566343|Blood Gas Analysis|blood gas analysis
161940|NCT02566343|Respiratory Function Tests|respiratory function tests
161941|NCT02566343|Diagnostic Techniques, Respiratory System|diagnostic techniques, respiratory system
161942|NCT02566343|Surgical Procedures, Operative|surgical procedures, operative
161943|NCT02566330|EndoBarrier|endobarrier
161944|NCT02566330|Duodenojejunal Bypass Liner|duodenojejunal bypass liner
161945|NCT02566291|laryngeal mask|laryngeal mask
161946|NCT02566291|airway leakage|airway leakage
161947|NCT02566291|airway morbidity|airway morbidity
161948|NCT02566278|Obstructive Sleep Apnea|obstructive sleep apnea
161949|NCT02566278|Pcrit|pcrit
161950|NCT02566278|Upper airway collapsibility|upper airway collapsibility
161951|NCT02566265|influenza|influenza
161952|NCT02566265|multiple myeloma|multiple myeloma
161953|NCT02566265|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
161954|NCT02566252|Safety|safety
161955|NCT02566252|tolerability|tolerability
161956|NCT02566239|aging|aging
161957|NCT02566239|ORCATECH|orcatech
161958|NCT02566239|Oregon Center for Aging & Technology|oregon center for aging & technology
161959|NCT02566239|Life Lab|life lab
161960|NCT02566239|Living Lab|living lab
161961|NCT02566239|in-home assessment|in-home assessment
161962|NCT02566239|technology and aging|technology and aging
161963|NCT02566213|volunteers|volunteers
161964|NCT02566200|Acute coronary syndrome|acute coronary syndrome
161965|NCT02566200|Cardiology|cardiology
161966|NCT02566174|Cancer Caregivers|cancer caregivers
161967|NCT02566174|Cancer Patients|cancer patients
161968|NCT02566174|Role Adjustment|role adjustment
161969|NCT02566174|Mutuality|mutuality
161970|NCT02566174|Well-Being|well-being
161971|NCT02566161|Genetics|genetics
161972|NCT02566161|Genomics|genomics
161973|NCT02566148|Life-event survey|life-event survey
161974|NCT02566148|observational survey among migrants in France|observational survey among migrants in france
161976|NCT02566135|I-gel|i-gel
161977|NCT02566135|ventilating bougie|ventilating bougie
161978|NCT02566135|intubation|intubation
161979|NCT02566096|major abdominal cancer|major abdominal cancer
161980|NCT02566070|Enteral feeding|enteral feeding
161981|NCT02566070|Continuous gastric feeding|continuous gastric feeding
161982|NCT02566070|Bolus gastric feeding|bolus gastric feeding
161983|NCT02566044|Cystic Fibrosis|cystic fibrosis
161984|NCT02566031|COPD|copd
161985|NCT02566031|open-label|open-label
161986|NCT02566031|QVA149|qva149
161987|NCT02566031|symptomatic|symptomatic
161988|NCT02566031|tiotropium|tiotropium
161989|NCT02566018|elderly|elderly
161990|NCT02566005|Misoprostol|misoprostol
161991|NCT02566005|Induction|induction
161992|NCT02566005|Foley|foley
161993|NCT02565992|Pembrolizumab|pembrolizumab
161994|NCT02565992|Coxsackievirus A21|coxsackievirus a21
161995|NCT02565992|melanoma|melanoma
161996|NCT02565992|CAVATAK|cavatak
161997|NCT02565992|CVA21|cva21
161998|NCT02565992|checkpoint inhibitor|checkpoint inhibitor
161999|NCT02565979|Resveratrol|resveratrol
162000|NCT02565979|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
162001|NCT02565979|Insulin Resistance|insulin resistance
162002|NCT02565979|Metabolic Diseases|metabolic diseases
162003|NCT02565979|Glucose Metabolism Disorders|glucose metabolism disorders
162004|NCT02565953|Vascular access devices obstruction|vascular access devices obstruction
162005|NCT02565927|Trachea|trachea
162006|NCT02565927|Stent|stent
162007|NCT02565927|Intraluminal brachytherapy|intraluminal brachytherapy
162008|NCT02565888|Hepatitis C|hepatitis c
162009|NCT02565888|HIV|hiv
162010|NCT02565888|atazanavir|atazanavir
162011|NCT02565888|ritonavir|ritonavir
162012|NCT02565888|daclatasvir|daclatasvir
162013|NCT02565888|cobicistat|cobicistat
162014|NCT02565875|Efficiency, Organizational|efficiency, organizational
162015|NCT02565875|Simulation|simulation
162016|NCT02565875|Communication|communication
162017|NCT02565875|Laparoscopy|laparoscopy
162018|NCT02565875|Medical Education|medical education
162019|NCT02565862|HCV|hcv
162020|NCT02565862|Diabetes Mellitus|diabetes mellitus
162021|NCT02565862|Daclatasvir|daclatasvir
162022|NCT02565862|Metformin|metformin
162023|NCT02565862|drug-drug interaction|drug-drug interaction
162024|NCT02565862|pharmacokinetics|pharmacokinetics
162025|NCT02565836|Vitamin K 1|vitamin k 1
162026|NCT02565836|prothrombin complex concentrates|prothrombin complex concentrates
162027|NCT02565836|warfarin|warfarin
162028|NCT02565823|Exercise|exercise
162029|NCT02565797|Decubitus Ulcer, Peri-operative, support surface, alternating pressure, neurosurgery|decubitus ulcer, peri-operative, support surface, alternating pressure, neurosurgery
162030|NCT02565771|Childhood cancer|childhood cancer
162031|NCT02565771|Cancer|cancer
162032|NCT02565771|Sequels|sequels
162033|NCT02565771|Surgery|surgery
162034|NCT02565771|Complications|complications
162035|NCT02565771|Chemotherapy|chemotherapy
162036|NCT02565771|Radiotherapy|radiotherapy
162037|NCT02565758|Cancer|cancer
162038|NCT02565758|Advanced Solid Tumors|advanced solid tumors
162039|NCT02565758|Neoplasm|neoplasm
162040|NCT02565758|Undifferentiated pleomorphic sarcoma|undifferentiated pleomorphic sarcoma
162041|NCT02565758|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
162042|NCT02565758|carcinoma of the breast|carcinoma of the breast
162043|NCT02565758|antibody drug conjugate|antibody drug conjugate
162044|NCT02565745|Prevention|prevention
162045|NCT02565745|Pressure ulcers|pressure ulcers
162046|NCT02565745|Clinical trial|clinical trial
162047|NCT02565745|Nursing|nursing
162048|NCT02565706|Fruit, vegetables, income, WIC program, farmers' market|fruit, vegetables, income, wic program, farmers' market
162049|NCT02565680|acute urticaria|acute urticaria
162050|NCT02565680|glucocorticoids|glucocorticoids
162051|NCT02565680|antihistamines|antihistamines
162052|NCT02565680|prurit|prurit
162053|NCT02565680|itch score|itch score
162054|NCT02565680|rash|rash
162055|NCT02565667|low rectal carcinoma|low rectal carcinoma
162056|NCT02565667|anastomosis|anastomosis
162057|NCT02565667|anterior rectal resection|anterior rectal resection
162058|NCT02565654|Irritable bowel syndrome(IBS)|irritable bowel syndrome(ibs)
162059|NCT02565654|Small intestinal bacterial overgrowth (SIBO)|small intestinal bacterial overgrowth (sibo)
162060|NCT02565654|Rifaximin|rifaximin
162061|NCT02565602|Calcium metabolism|calcium metabolism
162062|NCT02565602|Osteoporosis|osteoporosis
162063|NCT02565602|Postmenopausal women|postmenopausal women
162064|NCT02565576|CFZ533, Myasthenia Gravis|cfz533, myasthenia gravis
162065|NCT02565563|EMDR|emdr
162066|NCT02565563|Mechanisms|mechanisms
162067|NCT02565563|Eye Movement Desensitisation Reprocessing|eye movement desensitisation reprocessing
162068|NCT02565550|Microbiota Community|microbiota community
162069|NCT02565550|FODMAPs|fodmaps
162070|NCT02565550|IBS|ibs
162071|NCT02565524|schizophrenia|schizophrenia
162072|NCT02565524|early dissociative disorder|early dissociative disorder
162073|NCT02565524|genetic|genetic
162166|NCT02564978|Geographic Atrophy|geographic atrophy
162167|NCT02564978|Minocycline|minocycline
162074|NCT02565511|Randomization, Placebo controlled, Parallel-group, APOE4 Homozygotes, Preclinical Alzheimer's Disease (AD), Aβ lowering|randomization, placebo controlled, parallel-group, apoe4 homozygotes, preclinical alzheimer's disease (ad), aβ lowering
162075|NCT02565498|Soft tissue sarcoma|soft tissue sarcoma
162076|NCT02565498|Extremity|extremity
162077|NCT02565498|Preoperative radiotherapy|preoperative radiotherapy
162078|NCT02565498|Postoperative radiotherapy|postoperative radiotherapy
162079|NCT02565485|pulse pressure|pulse pressure
162080|NCT02565485|fetal heart rate|fetal heart rate
162081|NCT02565485|epidural analgesia|epidural analgesia
162082|NCT02565485|hypotension|hypotension
162083|NCT02565485|preload|preload
162084|NCT02565485|fluid bolus|fluid bolus
162085|NCT02565485|central hypovolemia|central hypovolemia
162086|NCT02565459|Mesenchymal stromal cells|mesenchymal stromal cells
162087|NCT02565459|kidney transplantation|kidney transplantation
162088|NCT02565459|tolerance|tolerance
162089|NCT02565433|brain metastases|brain metastases
162090|NCT02565433|Gamma Knife|gamma knife
162091|NCT02565433|Radiosurgery|radiosurgery
162092|NCT02565433|Quality of Life|quality of life
162093|NCT02565355|Pediatric Gastroenterology|pediatric gastroenterology
162094|NCT02565342|Clavicle|clavicle
162095|NCT02565303|cesarean delivery|cesarean delivery
162096|NCT02565303|ropivacaine|ropivacaine
162097|NCT02565303|minimum effective dose|minimum effective dose
162098|NCT02565303|dose-response relationship|dose-response relationship
162099|NCT02565303|intrathecal|intrathecal
162100|NCT02565303|intervertebral space|intervertebral space
162101|NCT02565290|polyunsaturated fatty acid|polyunsaturated fatty acid
162102|NCT02565290|fetal ductus arteriosus|fetal ductus arteriosus
162103|NCT02565290|inflammation|inflammation
162104|NCT02565251|sepsis|sepsis
162105|NCT02565251|hemodynamic monitoring|hemodynamic monitoring
162106|NCT02565251|septic shock|septic shock
162107|NCT02565251|volemic resuscitation|volemic resuscitation
162108|NCT02565251|fluid resuscitation|fluid resuscitation
162109|NCT02565212|Montelukast|montelukast
162110|NCT02565212|Sniffin' Sticks test|sniffin' sticks test
162111|NCT02565212|allergic rhinitis|allergic rhinitis
162112|NCT02565212|mometasone furoate|mometasone furoate
162113|NCT02565199|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
162114|NCT02565173|glaucoma|glaucoma
162115|NCT02565173|primary open-angle glaucoma|primary open-angle glaucoma
162116|NCT02565173|ocular hypertension|ocular hypertension
162117|NCT02565173|adenosine agonist|adenosine agonist
162118|NCT02565173|eye drop|eye drop
162119|NCT02565173|trabodenoson|trabodenoson
162120|NCT02565173|trabecular meshwork|trabecular meshwork
162121|NCT02565147|STEMI, infarct size, CMR, bivalirudin|stemi, infarct size, cmr, bivalirudin
162122|NCT02565121|Olfactory perception|olfactory perception
162123|NCT02565121|Adrenal cortex hormones|adrenal cortex hormones
162124|NCT02565121|Steroids|steroids
162125|NCT02565121|Education|education
162126|NCT02565108|Cannabidiol|cannabidiol
162127|NCT02565108|GWP42003-P|gwp42003-p
162128|NCT02565108|Clobazam|clobazam
162129|NCT02565108|Epidiolex|epidiolex
162130|NCT02565082|Hemostatic potential|hemostatic potential
162131|NCT02565082|Sickle cell disease|sickle cell disease
162132|NCT02565082|Thrombin generation test|thrombin generation test
162133|NCT02565056|Acceptance and Commitment Therapy|acceptance and commitment therapy
162134|NCT02565043|Negative Pressure Wound Therapy|negative pressure wound therapy
162135|NCT02565030|Chronic thromboembolic Pulmonary Hypertension|chronic thromboembolic pulmonary hypertension
162136|NCT02565030|Distal Chronic thromboembolic Pulmonary Hypertension|distal chronic thromboembolic pulmonary hypertension
162137|NCT02565030|Proximal Chronic thromboembolic Pulmonary Hypertension|proximal chronic thromboembolic pulmonary hypertension
162138|NCT02565030|Operable disease|operable disease
162139|NCT02565030|In-operable disease|in-operable disease
162140|NCT02565030|Pulmonary Endarterectomy|pulmonary endarterectomy
162141|NCT02565030|PH specific targeted therapy|ph specific targeted therapy
162142|NCT02565030|Phosphodiesterase type 5 Inhibitors|phosphodiesterase type 5 inhibitors
162143|NCT02565030|Endothelin Receptor Antagonist|endothelin receptor antagonist
162144|NCT02565030|Prostacyclin analogues|prostacyclin analogues
162145|NCT02565030|Soluble Guanylate cyclase stimulator|soluble guanylate cyclase stimulator
162146|NCT02565030|Sildenafil|sildenafil
162147|NCT02565030|Tadalafil|tadalafil
162148|NCT02565030|Bosentan|bosentan
162149|NCT02565030|Ambrisentan|ambrisentan
162150|NCT02565030|Macitentan|macitentan
162151|NCT02565030|Iloprost|iloprost
162152|NCT02565030|Riociguat|riociguat
162153|NCT02565030|Idiopathic Pulmonary Arterial Hypertension|idiopathic pulmonary arterial hypertension
162154|NCT02565017|IBM Watson|ibm watson
162155|NCT02565017|Clinical Decision Support System|clinical decision support system
162156|NCT02565017|Patient Preferences|patient preferences
162157|NCT02565017|15-226|15-226
162158|NCT02565004|Genetic|genetic
162159|NCT02565004|Sample Collection|sample collection
162160|NCT02564991|Alcoholism|alcoholism
162161|NCT02564991|MRI|mri
162162|NCT02564991|Structural MRI|structural mri
162163|NCT02564991|Cerebellum|cerebellum
162164|NCT02564978|Age-Related Macular Degeneration|age-related macular degeneration
162165|NCT02564978|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
162168|NCT02564978|Atrophic Macular Degeneration|atrophic macular degeneration
162169|NCT02564965|Acute Necrotizing Pancreatitis|acute necrotizing pancreatitis
162170|NCT02564965|Walled-Off Pancreatic Necrosis|walled-off pancreatic necrosis
162171|NCT02564952|Cannabidiol|cannabidiol
162172|NCT02564952|GWP42003-P|gwp42003-p
162173|NCT02564952|Clobazam|clobazam
162174|NCT02564952|Epidiolex|epidiolex
162175|NCT02564939|prevention|prevention
162176|NCT02564926|DM|dm
162177|NCT02564913|tongue diagnosis|tongue diagnosis
162178|NCT02564913|heart rate variability|heart rate variability
162179|NCT02564913|nailfold videocapillaroscopy|nailfold videocapillaroscopy
162180|NCT02564900|Advanced solid tumors|advanced solid tumors
162181|NCT02564900|phase 1|phase 1
162182|NCT02564900|oncology|oncology
162183|NCT02564900|HER2|her2
162184|NCT02564900|Antibody drug conjugate (ADC)|antibody drug conjugate (adc)
162185|NCT02564887|dysphagia|dysphagia
162186|NCT02564887|oral pharyngeal cancer|oral pharyngeal cancer
162187|NCT02564887|Iowa Oral Performance Instrument (IOPI)|iowa oral performance instrument (iopi)
162188|NCT02564887|IOPI|iopi
162189|NCT02564861|pharmacokinetics|pharmacokinetics
162190|NCT02564848|Clinical T1-2N0 ER+|clinical t1-2n0 er+
162191|NCT02564848|Invasive breast cancer|invasive breast cancer
162192|NCT02564848|estrogen-positive|estrogen-positive
162193|NCT02564822|migraine disorders|migraine disorders
162194|NCT02564822|cortical excitability|cortical excitability
162195|NCT02564822|transcranial magnetic stimulation|transcranial magnetic stimulation
162196|NCT02564822|electroencephalography|electroencephalography
162197|NCT02564796|Erythropoetin|erythropoetin
162198|NCT02564796|Cyanotic Heart Disease|cyanotic heart disease
162199|NCT02564796|Transfusion|transfusion
162200|NCT02564796|Congenital Heart Disease|congenital heart disease
162201|NCT02564731|children|children
162202|NCT02564731|prognosis|prognosis
162203|NCT02564718|Pediatric|pediatric
162204|NCT02564679|bariatric surgery|bariatric surgery
162205|NCT02564679|sleeve gastrectomy|sleeve gastrectomy
162206|NCT02564666|hepatocellular carcinoma|hepatocellular carcinoma
162207|NCT02564666|sorafenib|sorafenib
162208|NCT02564666|telephone counseling|telephone counseling
162209|NCT02564640|videolaryngoscope|videolaryngoscope
162210|NCT02564640|direct laryngoscope|direct laryngoscope
162211|NCT02564640|hemodynamic changes|hemodynamic changes
162212|NCT02564640|elderly patients|elderly patients
162213|NCT02564601|intervention|intervention
162214|NCT02564601|cognition|cognition
162215|NCT02564601|aging|aging
162216|NCT02564601|piano training|piano training
162217|NCT02564601|computer brain training|computer brain training
162218|NCT02564575|Ebolavirus|ebolavirus
162219|NCT02564562|PF-06463922|pf-06463922
162220|NCT02564562|[14C]PF-06463922|[14c]pf-06463922
162221|NCT02564562|Human ADME|human adme
162222|NCT02564562|Radiolabel|radiolabel
162223|NCT02564562|Mass Balance|mass balance
162224|NCT02564562|Pharmacokinetics|pharmacokinetics
162225|NCT02564549|low risk prostate cancer|low risk prostate cancer
162226|NCT02564523|Healthy|healthy
162227|NCT02564523|Vaccine|vaccine
162228|NCT02564523|Ebola viruses|ebola viruses
162229|NCT02564523|Ebola virus disease (EVD)|ebola virus disease (evd)
162230|NCT02564523|Filoviruses|filoviruses
162231|NCT02564523|Hemorrhagic fever|hemorrhagic fever
162232|NCT02564523|Monovalent vaccine|monovalent vaccine
162233|NCT02564523|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
162234|NCT02564523|Modified Vaccinia Virus Ankara - Bavarian Nordic (MVA-BN) Filo-vector|modified vaccinia virus ankara - bavarian nordic (mva-bn) filo-vector
162235|NCT02564523|Safety|safety
162236|NCT02564523|Immunogenicity|immunogenicity
162237|NCT02564484|Cancer Therapy|cancer therapy
162238|NCT02564484|Pharmacogenomics|pharmacogenomics
162239|NCT02564484|Drug Response|drug response
162240|NCT02564484|Genetic Variants|genetic variants
162241|NCT02564484|Vincristine-Induced Neuropathy|vincristine-induced neuropathy
162242|NCT02564484|Cancer Survivor|cancer survivor
162243|NCT02564432|amputee|amputee
162244|NCT02564354|Cystic Fibrosis|cystic fibrosis
162245|NCT02564354|CF|cf
162246|NCT02564354|ΔF508|δf508
162247|NCT02564354|CFTR|cftr
162248|NCT02564354|QR-010|qr-010
162249|NCT02564354|antisense oligonucleotide|antisense oligonucleotide
162250|NCT02564354|RNA therapy|rna therapy
162251|NCT02564354|F508del|f508del
162252|NCT02564354|NPD|npd
162253|NCT02564354|nasal potential difference|nasal potential difference
162254|NCT02564341|HIV Infection|hiv infection
162255|NCT02564341|Pain|pain
162256|NCT02564341|Collaborative Care|collaborative care
162257|NCT02564341|Chronic Opioid Therapy|chronic opioid therapy
162258|NCT02564341|Addiction|addiction
162259|NCT02564341|Analgesics, Opioid|analgesics, opioid
162260|NCT02564328|Stroke|stroke
162261|NCT02564328|Bone Marrow Mesenchymal Stem Cell|bone marrow mesenchymal stem cell
162262|NCT02564328|Transplantation|transplantation
162263|NCT02564315|Smoking|smoking
162264|NCT02564315|Cessation|cessation
162265|NCT02564315|Tobacco|tobacco
162266|NCT02564315|Relapse|relapse
162267|NCT02564302|PVI|pvi
162268|NCT02564302|Atrial Fibrillation|atrial fibrillation
162269|NCT02564302|MUSE Headband|muse headband
162270|NCT02564302|Mindfulness|mindfulness
162271|NCT02564289|microvesicles, microparticles|microvesicles, microparticles
162272|NCT02564289|Plethysmography|plethysmography
162273|NCT02564289|Snus|snus
162274|NCT02564289|Arterial Stiffness|arterial stiffness
162275|NCT02564289|EPC|epc
162276|NCT02564276|Indocyanine Green|indocyanine green
162277|NCT02564276|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
162278|NCT02564263|PD1|pd1
162279|NCT02564263|PD-L1|pd-l1
162280|NCT02564263|PDL1|pdl1
162281|NCT02564263|Gene expression profiling (GEP)|gene expression profiling (gep)
162282|NCT02564237|Group A streptococcal|group a streptococcal
162283|NCT02564198|relapsed pediatric solid tumors|relapsed pediatric solid tumors
162284|NCT02564198|unspecified childhood solid tumor|unspecified childhood solid tumor
162285|NCT02564198|brain and central nervous system tumors|brain and central nervous system tumors
162286|NCT02564159|malnutrition|malnutrition
162287|NCT02564159|muscle ultrasound|muscle ultrasound
162288|NCT02564159|intensive care unit|intensive care unit
162289|NCT02564159|mechanical ventilation|mechanical ventilation
162290|NCT02564159|albumin|albumin
162291|NCT02564159|prealbumin|prealbumin
162292|NCT02564159|nutrition|nutrition
162293|NCT02564055|Vehicle-Controlled|vehicle-controlled
162294|NCT02564055|GSK2894512|gsk2894512
162295|NCT02564055|Double blind|double blind
162296|NCT02564055|Dose-finding|dose-finding
162297|NCT02564055|Atopic Dermatitis|atopic dermatitis
162298|NCT02564042|Double blind|double blind
162299|NCT02564042|Dose-finding|dose-finding
162300|NCT02564042|Vehicle-Controlled|vehicle-controlled
162301|NCT02564042|GSK2894512|gsk2894512
162302|NCT02564042|Plaque Psoriasis|plaque psoriasis
162303|NCT02563977|Breast reconstruction|breast reconstruction
162304|NCT02563977|Deep inferior epigastric perforator flap|deep inferior epigastric perforator flap
162305|NCT02563977|Abdominal wall morbidity|abdominal wall morbidity
162306|NCT02563977|Plastic and reconstructive surgery|plastic and reconstructive surgery
162307|NCT02563964|Myocardial infarction|myocardial infarction
162308|NCT02563964|vulnerable plaque|vulnerable plaque
162309|NCT02563964|Positron emission tomography (PET)|positron emission tomography (pet)
162310|NCT02563964|Cardiac magnetic resonance imaging (CMR)|cardiac magnetic resonance imaging (cmr)
162311|NCT02563964|Biomarkers|biomarkers
162312|NCT02563951|Nausea|nausea
162313|NCT02563951|Vomiting|vomiting
162314|NCT02563951|Chemotherapy|chemotherapy
162315|NCT02563951|Radiation therapy|radiation therapy
162316|NCT02563925|Brain Irradiation|brain irradiation
162317|NCT02563925|Tremelimumab|tremelimumab
162318|NCT02563925|15-038|15-038
162319|NCT02563912|Children|children
162320|NCT02563912|resuscitation|resuscitation
162321|NCT02563912|simulation|simulation
162322|NCT02563912|medication error|medication error
162323|NCT02563899|Primary Axillary Hyperhidrosis|primary axillary hyperhidrosis
162324|NCT02563899|GSK573719|gsk573719
162325|NCT02563899|Hyperhidrosis Disease Severity Scale (HDSS)|hyperhidrosis disease severity scale (hdss)
162326|NCT02563899|Topical|topical
162327|NCT02563899|PRO|pro
162328|NCT02563899|Hyperhidrosis Symptom Severity Measure (HSSM)|hyperhidrosis symptom severity measure (hssm)
162329|NCT02563899|Umeclidinium|umeclidinium
162330|NCT02563821|Termination of pregancy|termination of pregancy
162331|NCT02563821|Third trimester|third trimester
162332|NCT02563821|Programmed intermittent epidural bolus|programmed intermittent epidural bolus
162333|NCT02563821|Continuous epidural infusion|continuous epidural infusion
162334|NCT02563821|Epidural analgesia|epidural analgesia
162335|NCT02563821|Legally induced abortion|legally induced abortion
162336|NCT02563795|Spinal anesthesia|spinal anesthesia
162337|NCT02563795|Cesarean|cesarean
162338|NCT02563795|Maternal hypotension|maternal hypotension
162339|NCT02563769|Cocaine|cocaine
162340|NCT02563769|Clavulanic Acid|clavulanic acid
162341|NCT02563756|Medial gonarthritis, knee osteoarthritis,|medial gonarthritis, knee osteoarthritis,
162342|NCT02563756|Muscle function, muscle mass, muscle atrophy|muscle function, muscle mass, muscle atrophy
162343|NCT02563756|Total knee arthroplasty (TKA)|total knee arthroplasty (tka)
162344|NCT02563756|Unicondylar knee arthroplasty (UKA)|unicondylar knee arthroplasty (uka)
162345|NCT02563756|Total knee replacement (TKR)|total knee replacement (tkr)
162346|NCT02563756|Unicondylar knee replacement (UKR)|unicondylar knee replacement (ukr)
162347|NCT02563756|Health-related quality of life (HRQoL)|health-related quality of life (hrqol)
162348|NCT02563756|Patient related outcome measurements (PROMs)|patient related outcome measurements (proms)
162349|NCT02563743|Sick-leave|sick-leave
162350|NCT02563743|Return to work|return to work
162351|NCT02563743|Occupational health|occupational health
162352|NCT02563743|Common mental disorder|common mental disorder
162353|NCT02563743|Depression|depression
162354|NCT02563743|Anxiety disorders|anxiety disorders
162355|NCT02563743|Adjustment disorders|adjustment disorders
162356|NCT02563743|Problem solving therapy|problem solving therapy
162357|NCT02563743|Occupational Health Services|occupational health services
162358|NCT02563743|Randomized controlled trial|randomized controlled trial
162359|NCT02563743|Intervention studies|intervention studies
162461|NCT02563288|opioids|opioids
162360|NCT02563743|Occupational stress|occupational stress
162361|NCT02563730|Cryobiopsy|cryobiopsy
162362|NCT02563730|lung biopsy|lung biopsy
162363|NCT02563730|interstitial lung disease|interstitial lung disease
162364|NCT02563717|Resuscitation|resuscitation
162365|NCT02563717|Positive-Pressure Respiration|positive-pressure respiration
162366|NCT02563717|Infant, Extremely Premature|infant, extremely premature
162367|NCT02563717|Continuous Positive Airway Pressure|continuous positive airway pressure
162368|NCT02563717|Intubation|intubation
162369|NCT02563704|Artesunate|artesunate
162370|NCT02563704|Quinine|quinine
162371|NCT02563704|Efficacy|efficacy
162372|NCT02563704|Malaria|malaria
162373|NCT02563704|Children|children
162374|NCT02563704|Cameroon|cameroon
162375|NCT02563652|Abdomen/surgery|abdomen/surgery
162376|NCT02563652|Biological markers|biological markers
162377|NCT02563652|Length of stay|length of stay
162378|NCT02563652|Postoperative care|postoperative care
162379|NCT02563652|Anesthesia recovery period|anesthesia recovery period
162380|NCT02563652|Prognosis|prognosis
162381|NCT02563639|newly diagnosed|newly diagnosed
162382|NCT02563639|paroxysmal|paroxysmal
162383|NCT02563639|persistent|persistent
162384|NCT02563626|coronary artery aneurysm|coronary artery aneurysm
162385|NCT02563626|prognosis|prognosis
162386|NCT02563626|outcomes|outcomes
162387|NCT02563626|management|management
162388|NCT02563626|incidence|incidence
162389|NCT02563626|heart failure|heart failure
162390|NCT02563626|acute coronary syndrome|acute coronary syndrome
162391|NCT02563626|death|death
162392|NCT02563613|community-based intervention|community-based intervention
162393|NCT02563613|family holistic health|family holistic health
162394|NCT02563613|positive psychology|positive psychology
162395|NCT02563613|physical exercise|physical exercise
162396|NCT02563613|healthy diet|healthy diet
162397|NCT02563587|Laughter|laughter
162398|NCT02563587|children|children
162399|NCT02563587|postoperative|postoperative
162400|NCT02563587|pain|pain
162401|NCT02563587|anxiety|anxiety
162402|NCT02563587|cortisol|cortisol
162403|NCT02563574|Alcohol and brain function|alcohol and brain function
162404|NCT02563574|HIV and brain function|hiv and brain function
162405|NCT02563574|Motivational Interviewing|motivational interviewing
162406|NCT02563561|Bladder Cancer|bladder cancer
162407|NCT02563561|Non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
162408|NCT02563561|Apaziquone|apaziquone
162409|NCT02563561|TURBT|turbt
162410|NCT02563561|Stage Ta, G1-G2|stage ta, g1-g2
162411|NCT02563522|non healing ulcers|non healing ulcers
162412|NCT02563522|VM202|vm202
162413|NCT02563522|Diabetic ulcers|diabetic ulcers
162414|NCT02563522|foot ulcers|foot ulcers
162415|NCT02563509|HIV|hiv
162416|NCT02563509|cellular immunity therapy|cellular immunity therapy
162417|NCT02563509|functional cure|functional cure
162418|NCT02563496|pharmacokinetic|pharmacokinetic
162419|NCT02563496|pediatric|pediatric
162420|NCT02563496|Tafenoquine|tafenoquine
162421|NCT02563496|Plasmodium vivax Malaria|plasmodium vivax malaria
162422|NCT02563496|G6PD deficiency|g6pd deficiency
162423|NCT02563483|caregivers|caregivers
162424|NCT02563483|anxiety|anxiety
162425|NCT02563483|depression|depression
162426|NCT02563483|yoga|yoga
162427|NCT02563483|meditation|meditation
162428|NCT02563483|stress|stress
162429|NCT02563457|diabetic patients|diabetic patients
162430|NCT02563457|periodontal treatment|periodontal treatment
162431|NCT02563457|glycaemic control|glycaemic control
162432|NCT02563444|Diagnostic (Biopsy) or Therapeutic Procedure (Infiltration, Ablation)|diagnostic (biopsy) or therapeutic procedure (infiltration, ablation)
162433|NCT02563431|shoulder pain|shoulder pain
162434|NCT02563431|prevention program|prevention program
162435|NCT02563418|video oculography|video oculography
162436|NCT02563405|alpha receptor blocker|alpha receptor blocker
162437|NCT02563405|uric acid|uric acid
162438|NCT02563405|CCB|ccb
162439|NCT02563405|blood pressure variability|blood pressure variability
162440|NCT02563366|kidney transplantation|kidney transplantation
162441|NCT02563366|mesenchymal stem cell therapy|mesenchymal stem cell therapy
162442|NCT02563366|poor early graft function|poor early graft function
162443|NCT02563366|delayed graft function|delayed graft function
162444|NCT02563366|ischemia reperfusion injury|ischemia reperfusion injury
162445|NCT02563366|donation after cardiac death|donation after cardiac death
162446|NCT02563353|whole body vibration|whole body vibration
162447|NCT02563353|PTH|pth
162448|NCT02563340|kidney transplantation|kidney transplantation
162449|NCT02563340|antibody-mediated rejection|antibody-mediated rejection
162450|NCT02563340|mesenchymal stem cell therapy|mesenchymal stem cell therapy
162451|NCT02563340|donor specific antibody|donor specific antibody
162452|NCT02563340|acute rejection|acute rejection
162453|NCT02563314|Noninvasive Ventilation|noninvasive ventilation
162454|NCT02563314|Pulmonary Disease|pulmonary disease
162455|NCT02563314|Chronic Obstructive|chronic obstructive
162456|NCT02563314|Renal Doppler|renal doppler
162457|NCT02563314|Oxygen|oxygen
162458|NCT02563314|Hypercapnia|hypercapnia
162459|NCT02563288|esmolol|esmolol
162460|NCT02563288|dexmedetomidine|dexmedetomidine
162462|NCT02563197|Device study|device study
162463|NCT02563197|Peak inspiratory flow rate|peak inspiratory flow rate
162464|NCT02563197|Non-cystic fibrosis bronchiectasis|non-cystic fibrosis bronchiectasis
162465|NCT02563197|T-326 Inhaler|t-326 inhaler
162466|NCT02563171|visceral adipose-specific serpin|visceral adipose-specific serpin
162467|NCT02563171|intelectin 1 (omentin)|intelectin 1 (omentin)
162468|NCT02563171|Tumor Necrosis Factor-alpha|tumor necrosis factor-alpha
162469|NCT02563158|liver resection|liver resection
162470|NCT02563158|blood inflow control|blood inflow control
162471|NCT02563158|ischemia-reperfusion injury|ischemia-reperfusion injury
162472|NCT02563158|inflammatory response|inflammatory response
162473|NCT02563158|randomized controlled trial|randomized controlled trial
162474|NCT02563145|Real-time fMRI feedback|real-time fmri feedback
162475|NCT02563132|colonoscopy|colonoscopy
162476|NCT02563132|carbon dioxide|carbon dioxide
162477|NCT02563132|inflammatory bowel disease|inflammatory bowel disease
162478|NCT02563093|Influenza|influenza
162479|NCT02563093|Fluzone® Quadrivalent, Influenza Vaccine|fluzone® quadrivalent, influenza vaccine
162480|NCT02563093|Fluzone® Intradermal Quadrivalent, Influenza Vaccine|fluzone® intradermal quadrivalent, influenza vaccine
162481|NCT02563093|Fluzone® High Dose, Influenza Vaccine|fluzone® high dose, influenza vaccine
162482|NCT02563080|exocrine insufficiency|exocrine insufficiency
162483|NCT02563080|acute pancreatitis|acute pancreatitis
162484|NCT02563080|severe|severe
162485|NCT02563080|moderately severe|moderately severe
162486|NCT02563067|Asthma|asthma
162487|NCT02563067|QAW039|qaw039
162488|NCT02563028|Visual Evoked Potentials|visual evoked potentials
162489|NCT02563028|Microdiscectomy|microdiscectomy
162490|NCT02563028|SightSaver|sightsaver
162491|NCT02563015|Infant|infant
162492|NCT02563015|Vitamin D|vitamin d
162493|NCT02563015|Deficiency|deficiency
162494|NCT02563015|Lean Mass|lean mass
162495|NCT02563002|PD1|pd1
162496|NCT02563002|PDL1|pdl1
162497|NCT02563002|PD-L1|pd-l1
162498|NCT02562924|MEDIHONEY|medihoney
162499|NCT02562924|Chronic Rhinosinusitis With Nasal Polyposis|chronic rhinosinusitis with nasal polyposis
162500|NCT02562924|Functional Endoscopic Sinus Surgery|functional endoscopic sinus surgery
162501|NCT02562911|cystic fibrosis|cystic fibrosis
162502|NCT02562911|menstrual cycle|menstrual cycle
162503|NCT02562911|puberty|puberty
162504|NCT02562885|Benign epilepsy with centro-temporal spikes|benign epilepsy with centro-temporal spikes
162505|NCT02562885|Continuous spike waves in slow wave sleep|continuous spike waves in slow wave sleep
162506|NCT02562885|Electroencephalography|electroencephalography
162507|NCT02562885|Sleep, slow wave|sleep, slow wave
162508|NCT02562872|Controlled|controlled
162509|NCT02562872|Human|human
162510|NCT02562872|Malaria|malaria
162511|NCT02562872|Infection|infection
162512|NCT02562872|Healthy|healthy
162513|NCT02562872|Volunteer|volunteer
162514|NCT02562846|electroconvulsive therapy|electroconvulsive therapy
162515|NCT02562846|response prediction|response prediction
162516|NCT02562846|cognitive side effects|cognitive side effects
162517|NCT02562833|Osteoarthritis|osteoarthritis
162518|NCT02562833|Self-management|self-management
162519|NCT02562833|Multi-Component Exercise|multi-component exercise
162520|NCT02562807|Urinary Incontinence|urinary incontinence
162521|NCT02562807|Urinary Incontinence, Stress|urinary incontinence, stress
162522|NCT02562807|Lower Urinary Tract Symptoms|lower urinary tract symptoms
162523|NCT02562794|refugee|refugee
162524|NCT02562781|postoperative complications|postoperative complications
162525|NCT02562781|postoperative cognitive dysfunction|postoperative cognitive dysfunction
162526|NCT02562781|oxygen|oxygen
162527|NCT02562755|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
162528|NCT02562755|Pexastimogene Devacirepvec (Pexa-Vec)|pexastimogene devacirepvec (pexa-vec)
162529|NCT02562755|Sorafenib|sorafenib
162530|NCT02562755|GM-CSF therapy|gm-csf therapy
162531|NCT02562755|Thymidine Kinase-Deactivated Vaccinia Virus|thymidine kinase-deactivated vaccinia virus
162532|NCT02562755|Oncology|oncology
162533|NCT02562755|Recombinant Vaccinia Virus|recombinant vaccinia virus
162534|NCT02562755|Oncolytic Virus Therapy|oncolytic virus therapy
162535|NCT02562755|Oncolytic virotherapy|oncolytic virotherapy
162536|NCT02562742|Hepatitis C virus|hepatitis c virus
162537|NCT02562742|observational|observational
162538|NCT02562742|post-marketing|post-marketing
162539|NCT02562742|sofosbuvir|sofosbuvir
162540|NCT02562742|Infection|infection
162541|NCT02562729|Cervical cancer; Nerve-sparing hysterectomy; simplified|cervical cancer; nerve-sparing hysterectomy; simplified
162542|NCT02562690|Coronary Artery Disease|coronary artery disease
162543|NCT02562690|Myocardial Ischemia|myocardial ischemia
162544|NCT02562690|Arterial Occlusive Diseases|arterial occlusive diseases
162545|NCT02562690|Coronary Thrombosis|coronary thrombosis
162546|NCT02562651|STEMI, adverse LVR (left ventricular remodeling), MMPs, Doxycycline|stemi, adverse lvr (left ventricular remodeling), mmps, doxycycline
162547|NCT02562638|NPO|npo
162548|NCT02562638|NBM|nbm
162549|NCT02562638|pre-procedure|pre-procedure
162550|NCT02562638|cardiac|cardiac
162551|NCT02562599|Induction Chemotherapy|induction chemotherapy
162552|NCT02562599|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
162553|NCT02562586|Suction|suction
162554|NCT02562586|Arthroplasty|arthroplasty
162555|NCT02562586|Replacement|replacement
162556|NCT02562586|Hip|hip
162557|NCT02562534|ECG|ecg
162558|NCT02562534|MRI|mri
162559|NCT02562534|rythm troubles|rythm troubles
162560|NCT02562534|conductive troubles|conductive troubles
162561|NCT02562534|ECG artifacts|ecg artifacts
162562|NCT02562534|Database|database
162563|NCT02562508|Human Papilloma Virus 16|human papilloma virus 16
162564|NCT02562508|Human Papilloma Virus 18|human papilloma virus 18
162565|NCT02562508|vaccine|vaccine
162566|NCT02562508|adolescent girl|adolescent girl
162567|NCT02562508|bridging trial|bridging trial
162568|NCT02562508|non-inferiority|non-inferiority
162569|NCT02562495|severe cerebral pathology|severe cerebral pathology
162570|NCT02562495|Ultrasound|ultrasound
162571|NCT02562495|thickness of the quadriceps|thickness of the quadriceps
162572|NCT02562482|Antibody Response|antibody response
162573|NCT02562482|Immune Response|immune response
162574|NCT02562482|Healthy Volunteer|healthy volunteer
162575|NCT02562482|Vaccine-Mediated Protection|vaccine-mediated protection
162576|NCT02562482|Chikungunya Virus|chikungunya virus
162577|NCT02562482|Vaccines, Virus-like Particles|vaccines, virus-like particles
162578|NCT02562456|Dental Atraumatic Restorative Treatment|dental atraumatic restorative treatment
162579|NCT02562456|Composite Resins|composite resins
162580|NCT02562456|Primary Teeth|primary teeth
162581|NCT02562456|Clinical Efficacy|clinical efficacy
162582|NCT02562456|Cost Analysis|cost analysis
162583|NCT02562443|Myelodysplastic Syndrome|myelodysplastic syndrome
162584|NCT02562443|MDS|mds
162585|NCT02562430|Placebo response|placebo response
162586|NCT02562391|atrial fibrillation|atrial fibrillation
162587|NCT02562391|ablation|ablation
162588|NCT02562391|thoracoscopy|thoracoscopy
162589|NCT02562391|left atrial appendage|left atrial appendage
162590|NCT02562365|adjuvent chemotherapy|adjuvent chemotherapy
162591|NCT02562365|ovarian cancer|ovarian cancer
162592|NCT02562352|polypharmacy|polypharmacy
162593|NCT02562352|multimorbidity|multimorbidity
162594|NCT02562352|randomized controlled trial|randomized controlled trial
162595|NCT02562352|drug discontinuation|drug discontinuation
162596|NCT02562352|patient preference|patient preference
162598|NCT02562274|Menopause|menopause
162599|NCT02562274|Cognitive impairment|cognitive impairment
162600|NCT02562274|Working memory|working memory
162601|NCT02562274|Bone formation markers|bone formation markers
162602|NCT02562274|Osteoporosis|osteoporosis
162603|NCT02562261|sepsis|sepsis
162604|NCT02562261|platelet|platelet
162605|NCT02562261|platelet reactivity|platelet reactivity
162606|NCT02562261|P2Y12|p2y12
162607|NCT02562235|Pulmonary arterial hypertension|pulmonary arterial hypertension
162608|NCT02562222|migraine disorders|migraine disorders
162609|NCT02562222|transcranial direct current stimulation|transcranial direct current stimulation
162610|NCT02562222|electric stimulation therapy|electric stimulation therapy
162611|NCT02562222|pain|pain
162612|NCT02562222|rehabilitation|rehabilitation
162613|NCT02562209|Obesity|obesity
162614|NCT02562209|Abdominal adiposity|abdominal adiposity
162615|NCT02562209|High protein diet|high protein diet
162616|NCT02562196|migraine disorders|migraine disorders
162617|NCT02562196|transcranial direct current stimulation|transcranial direct current stimulation
162618|NCT02562196|electric stimulation therapy|electric stimulation therapy
162619|NCT02562196|pain|pain
162620|NCT02562170|breast|breast
162621|NCT02562170|reconstruction|reconstruction
162622|NCT02562170|mesh|mesh
162623|NCT02562170|acellular dermal matrix|acellular dermal matrix
162624|NCT02562131|PET-MR|pet-mr
162625|NCT02562131|recidive|recidive
162626|NCT02562131|PET/MR imaging|pet/mr imaging
162627|NCT02562131|18F-Fluciclovine|18f-fluciclovine
162628|NCT02562131|radical treatment|radical treatment
162629|NCT02562131|recurrence|recurrence
162630|NCT02562105|Intensive care unit|intensive care unit
162631|NCT02562105|Hematological malignancy|hematological malignancy
162632|NCT02562105|Acute respiratory failure|acute respiratory failure
162633|NCT02562105|Prognosis|prognosis
162634|NCT02562105|Mechanical ventilation|mechanical ventilation
162635|NCT02562092|AIDS|aids
162636|NCT02562092|Health Promotion|health promotion
162637|NCT02562079|T lymphocyte|t lymphocyte
162638|NCT02562079|OX40/OX40L|ox40/ox40l
162639|NCT02562040|Pediatrics|pediatrics
162640|NCT02562040|Primary Snoring|primary snoring
162641|NCT02562040|Adenotonsillectomy|adenotonsillectomy
162642|NCT02562001|Spinal Cord Injuries|spinal cord injuries
162643|NCT02562001|gait training|gait training
162644|NCT02562001|robotic|robotic
162645|NCT02562001|Lokomat|lokomat
162646|NCT02562001|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
162647|NCT02562001|transcranial direct-current stimulation|transcranial direct-current stimulation
162648|NCT02562001|Electroencephalography|electroencephalography
162649|NCT02562001|Functional near-infrared spectroscopy|functional near-infrared spectroscopy
162650|NCT02561975|Double pulmonary diffusing capacity to carbon monoxyd (CO) associated to nitric oxide (NO)|double pulmonary diffusing capacity to carbon monoxyd (co) associated to nitric oxide (no)
162651|NCT02561975|Evolution of membrane and capillar damages|evolution of membrane and capillar damages
162652|NCT02561975|Early pronostic value of congenital heart disease|early pronostic value of congenital heart disease
162653|NCT02561962|Multiple Myeloma|multiple myeloma
162654|NCT02561962|Relapsed Multiple Myeloma|relapsed multiple myeloma
162655|NCT02561962|Refractory Multiple Myeloma|refractory multiple myeloma
162656|NCT02561949|Depression/therapy|depression/therapy
162657|NCT02561949|Developing Countries|developing countries
162658|NCT02561949|Interpersonal Relations|interpersonal relations
162659|NCT02561949|Life Change Events|life change events
162660|NCT02561949|Psychotherapy, group|psychotherapy, group
162661|NCT02561949|Resilience, Psychological|resilience, psychological
162662|NCT02561949|Sierra Leone|sierra leone
162663|NCT02561949|Survivors/psychology|survivors/psychology
162664|NCT02561949|Social Adjustment|social adjustment
162665|NCT02561949|Social Behavior|social behavior
162666|NCT02561949|War|war
162667|NCT02561936|Healthy|healthy
162668|NCT02561936|EUDRANT|eudrant
162669|NCT02561936|Rilpivirine|rilpivirine
162670|NCT02561923|Healthy|healthy
162671|NCT02561923|Rivaroxaban|rivaroxaban
162672|NCT02561923|XARELTO|xarelto
162673|NCT02561910|Inguinal hernia repair|inguinal hernia repair
162674|NCT02561910|laparoscopic inguinal hernia repair|laparoscopic inguinal hernia repair
162675|NCT02561910|TAPP|tapp
162676|NCT02561871|Ad26.RSV.FA2 (JNJ-61187165-AAA)|ad26.rsv.fa2 (jnj-61187165-aaa)
162677|NCT02561871|Ad35.RSV.FA2 (JNJ-61187191-AAA)|ad35.rsv.fa2 (jnj-61187191-aaa)
162678|NCT02561871|Healthy participants|healthy participants
162679|NCT02561858|Renal Ammonium ;uric acid|renal ammonium ;uric acid
162680|NCT02561845|Effectiveness of statins, on lipid goal attainment and lipid parameters in Percutaneous Coronary Intervention patients|effectiveness of statins, on lipid goal attainment and lipid parameters in percutaneous coronary intervention patients
162681|NCT02561832|breast cancer|breast cancer
162682|NCT02561819|Short Bowel Syndrome|short bowel syndrome
162683|NCT02561819|Congenital Short Bowel Syndrome|congenital short bowel syndrome
162684|NCT02561819|Body Composition|body composition
162685|NCT02561819|Parenteral Nutrition|parenteral nutrition
162686|NCT02561819|Intestinal Failure|intestinal failure
162687|NCT02561780|Mental Health Knowledge|mental health knowledge
162688|NCT02561780|Stigma|stigma
162689|NCT02561780|Mental Health Literacy|mental health literacy
162690|NCT02561767|kidney transplantation|kidney transplantation
162691|NCT02561767|mesenchymal stem cell|mesenchymal stem cell
162692|NCT02561767|donation after citizen's death|donation after citizen's death
162693|NCT02561767|ischemia reperfusion injury|ischemia reperfusion injury
162694|NCT02561767|renal function recovery|renal function recovery
162695|NCT02561754|Diet|diet
162696|NCT02561754|Obesity|obesity
162697|NCT02561754|Adolescents|adolescents
162698|NCT02561754|Intellectual and Developmental Disability|intellectual and developmental disability
162699|NCT02561728|Helmet|helmet
162700|NCT02561728|Hangar|hangar
162701|NCT02561728|P-Pod|p-pod
162702|NCT02561728|Plagiocephaly|plagiocephaly
162703|NCT02561728|Surgery|surgery
162704|NCT02561715|Parkinson's|parkinson's
162705|NCT02561715|Anosognosia|anosognosia
162706|NCT02561715|DBS|dbs
162707|NCT02561715|Deep Brain Surgery|deep brain surgery
162708|NCT02561689|Occlusal caries|occlusal caries
162709|NCT02561689|Resin fissure sealant|resin fissure sealant
162710|NCT02561689|Longevity|longevity
162711|NCT02561689|Effectiveness|effectiveness
162712|NCT02561676|Mindfulness|mindfulness
162713|NCT02561676|Spinal Cord Injury|spinal cord injury
162714|NCT02561663|microcirculation|microcirculation
162715|NCT02561663|blood pressure|blood pressure
162716|NCT02561663|pulse wave analysis|pulse wave analysis
162717|NCT02561663|pulse wave velocity|pulse wave velocity
162718|NCT02561637|Case management|case management
162719|NCT02561624|mHealth|mhealth
162720|NCT02561624|Text message|text message
162721|NCT02561611|Pedal Desk|pedal desk
162722|NCT02561611|Workplace Intervention|workplace intervention
162723|NCT02561611|Physical Activity|physical activity
162724|NCT02561611|Energy Expenditure|energy expenditure
162725|NCT02561546|concurrent|concurrent
162726|NCT02561520|platelet rich plasma|platelet rich plasma
162727|NCT02561520|platelet poor plasma|platelet poor plasma
162728|NCT02561520|ocular GVHD|ocular gvhd
162729|NCT02561455|Advanced solid tumors|advanced solid tumors
162730|NCT02561455|Acute myeloid leukemia|acute myeloid leukemia
162731|NCT02561455|gilteritinib|gilteritinib
162732|NCT02561455|ASP2215|asp2215
162733|NCT02561416|Fibromyalgia syndrome|fibromyalgia syndrome
162734|NCT02561416|Mindfulness (MBSR)|mindfulness (mbsr)
162735|NCT02561416|Neuroimaging|neuroimaging
162736|NCT02561416|Cytokines|cytokines
162737|NCT02561416|Randomized Controlled Trial|randomized controlled trial
162738|NCT02561416|Cost-effectiveness|cost-effectiveness
162739|NCT02561416|Psychoeducation (FibroQol)|psychoeducation (fibroqol)
162740|NCT02561403|traumatic brain injury (TBI)|traumatic brain injury (tbi)
162741|NCT02561403|aging|aging
162742|NCT02561403|cognitive training|cognitive training
162743|NCT02561403|Cognitive Aging|cognitive aging
162744|NCT02561377|resistance training|resistance training
162745|NCT02561377|Prediabetic state|prediabetic state
162746|NCT02561377|Metabolomics|metabolomics
162747|NCT02561364|Fetal Biophysical Profile|fetal biophysical profile
162748|NCT02561351|bronchial asthma|bronchial asthma
162848|NCT02560922|Knee Osteoarthritis|knee osteoarthritis
162749|NCT02561351|fractional exhaled nitric oxide (FeNO)|fractional exhaled nitric oxide (feno)
162750|NCT02561351|asthma exacerbation|asthma exacerbation
162751|NCT02561338|GKA,T2DM,HMS5552|gka,t2dm,hms5552
162752|NCT02561325|Blood pressure|blood pressure
162753|NCT02561325|Sodium Chloride|sodium chloride
162754|NCT02561325|Sodium Bicarbonate|sodium bicarbonate
162755|NCT02561299|Drug-coated Balloons|drug-coated balloons
162756|NCT02561299|Calcified Lesions|calcified lesions
162757|NCT02561299|Orbital Atherectomy|orbital atherectomy
162758|NCT02561299|Below the Knee|below the knee
162759|NCT02561299|Paclitaxel|paclitaxel
162760|NCT02561299|Lutonix 014 Drug-coated Balloon|lutonix 014 drug-coated balloon
162761|NCT02561286|Human immunodeficiency virus|human immunodeficiency virus
162762|NCT02561286|Sexually transmitted disease|sexually transmitted disease
162763|NCT02561286|Men who have sex with men|men who have sex with men
162764|NCT02561286|African Americans|african americans
162765|NCT02561286|Behavioral intervention|behavioral intervention
162766|NCT02561286|Randomized controlled trial|randomized controlled trial
162767|NCT02561286|Sexual behavior|sexual behavior
162768|NCT02561286|Mediation analysis|mediation analysis
162769|NCT02561286|Social cognitive theory|social cognitive theory
162770|NCT02561286|Theory of planned behavior|theory of planned behavior
162771|NCT02561247|Acute Kidney Injury|acute kidney injury
162772|NCT02561247|Continuous Renal Replacement Therapy|continuous renal replacement therapy
162773|NCT02561247|Blood Urea Nitrogen (BUN)|blood urea nitrogen (bun)
162774|NCT02561247|Prismaflex|prismaflex
162775|NCT02561247|Pediatric|pediatric
162776|NCT02561221|primary care|primary care
162777|NCT02561221|pragmatic trial|pragmatic trial
162778|NCT02561221|weight loss|weight loss
162779|NCT02561221|overweight|overweight
162780|NCT02561221|diet|diet
162781|NCT02561221|physical activity|physical activity
162782|NCT02561221|PCORI|pcori
162783|NCT02561208|Patient adherence|patient adherence
162784|NCT02561208|Mobile Health|mobile health
162785|NCT02561208|HPV DNA Tests|hpv dna tests
162786|NCT02561208|Self-collected|self-collected
162787|NCT02561195|Clostridium difficile, Vaccine.|clostridium difficile, vaccine.
162788|NCT02561169|antiviral|antiviral
162789|NCT02561169|oseltamivir|oseltamivir
162790|NCT02561156|Drug therapy|drug therapy
162791|NCT02561143|cachexia|cachexia
162792|NCT02561143|nutrition supplementation|nutrition supplementation
162793|NCT02561143|IAtta|iatta
162794|NCT02561143|palliative care|palliative care
162795|NCT02561143|quality of life|quality of life
162796|NCT02561130|Diabetes|diabetes
162797|NCT02561130|Insulin|insulin
162798|NCT02561130|Glargine|glargine
162799|NCT02561130|Metformin|metformin
162800|NCT02561130|Forxiga|forxiga
162801|NCT02561130|Diet|diet
162802|NCT02561130|Exercise|exercise
162803|NCT02561130|Lifestyle|lifestyle
162804|NCT02561104|cataract|cataract
162805|NCT02561104|phacoemulsification|phacoemulsification
162806|NCT02561104|laser-assisted surgery|laser-assisted surgery
162807|NCT02561104|femtosecond laser|femtosecond laser
162808|NCT02561091|Deafness|deafness
162809|NCT02561091|Hearing Loss, Sensorineural|hearing loss, sensorineural
162810|NCT02561091|Ear Diseases|ear diseases
162811|NCT02561091|Hearing Disorders|hearing disorders
162812|NCT02561091|Otorhinolaryngologic Diseases|otorhinolaryngologic diseases
162813|NCT02561091|Sensation Disorders|sensation disorders
162814|NCT02561091|Signs and Symptoms|signs and symptoms
162815|NCT02561091|Hearing and Speech impairment|hearing and speech impairment
162816|NCT02561091|Hearing Loss, Unilateral|hearing loss, unilateral
162817|NCT02561078|insulin pumps|insulin pumps
162818|NCT02561078|concentrated insulin|concentrated insulin
162819|NCT02561078|OmniPod|omnipod
162820|NCT02561065|Health Lifestyle|health lifestyle
162821|NCT02561065|Lifestyle Risk Reduction|lifestyle risk reduction
162822|NCT02561065|Health Behavior|health behavior
162823|NCT02561065|Sedentary Lifestyle|sedentary lifestyle
162824|NCT02561065|Intervention Studies|intervention studies
162825|NCT02561065|Cardiovascular risk in office workers|cardiovascular risk in office workers
162826|NCT02561065|Motivational Interview|motivational interview
162827|NCT02561065|Preventive health services|preventive health services
162828|NCT02561065|Health education|health education
162829|NCT02561065|Physical activity|physical activity
162830|NCT02561065|Dietary behaviour intervention|dietary behaviour intervention
162831|NCT02561065|Workplace|workplace
162832|NCT02561026|Frozen plasma|frozen plasma
162833|NCT02561026|INR|inr
162834|NCT02561026|procedures|procedures
162835|NCT02561000|Platelets|platelets
162836|NCT02561000|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
162837|NCT02561000|Protease-Activated Receptor 1|protease-activated receptor 1
162838|NCT02561000|Hemorrhage|hemorrhage
162839|NCT02560961|Kinesio Taping|kinesio taping
162840|NCT02560961|Soccer|soccer
162841|NCT02560961|Hop Test|hop test
162842|NCT02560961|Vertical Jump|vertical jump
162843|NCT02560935|primary stroke prevention|primary stroke prevention
162844|NCT02560935|hydroxyurea|hydroxyurea
162845|NCT02560935|low income country|low income country
162846|NCT02560935|sub-Saharan Africa|sub-saharan africa
162847|NCT02560922|Osteoarthritis|osteoarthritis
162849|NCT02560922|Hip Osteoarthritis|hip osteoarthritis
162850|NCT02560896|Family|family
162851|NCT02560896|History|history
162852|NCT02560896|Pancreas|pancreas
162853|NCT02560896|Cancer|cancer
162854|NCT02560896|Genetic|genetic
162855|NCT02560883|Hairy Cell|hairy cell
162856|NCT02560857|Quantiferon-Monitor|quantiferon-monitor
162857|NCT02560857|organ rejection|organ rejection
162858|NCT02560857|global immunity|global immunity
162859|NCT02560831|Osteoarthritis|osteoarthritis
162860|NCT02560831|Therapeutic exercises|therapeutic exercises
162861|NCT02560831|Pain|pain
162862|NCT02560831|Muscle strength|muscle strength
162863|NCT02560831|Postural balance|postural balance
162864|NCT02560818|splice profiles of messenger RNA|splice profiles of messenger rna
162865|NCT02560779|TRC105|trc105
162866|NCT02560779|CD105|cd105
162867|NCT02560779|Endoglin|endoglin
162868|NCT02560779|Angiogenesis inhibitor|angiogenesis inhibitor
162869|NCT02560779|HCC|hcc
162870|NCT02560779|TKI|tki
162871|NCT02560779|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
162872|NCT02560779|Sorafenib|sorafenib
162873|NCT02560779|Nexavar|nexavar
162874|NCT02560766|Restless Leg Syndrome|restless leg syndrome
162875|NCT02560766|RLS|rls
162876|NCT02560727|Inflammatory Bowel Diseases|inflammatory bowel diseases
162877|NCT02560727|Fecal Microbiota Transplantation|fecal microbiota transplantation
162878|NCT02560727|transendoscopic enteral tubing|transendoscopic enteral tubing
162879|NCT02560714|sacroiliac joint fusion|sacroiliac joint fusion
162880|NCT02560714|SIJ Fusion|sij fusion
162881|NCT02560714|SI Joint|si joint
162882|NCT02560714|SIJ|sij
162883|NCT02560701|high-deductible health plans|high-deductible health plans
162884|NCT02560701|medication adherence|medication adherence
162885|NCT02560688|drug interaction|drug interaction
162886|NCT02560688|clopidogrel|clopidogrel
162887|NCT02560688|healthy subjects|healthy subjects
162888|NCT02560675|Whiplash Injury Pain|whiplash injury pain
162889|NCT02560675|Chronic Pain|chronic pain
162890|NCT02560675|TBI|tbi
162891|NCT02560662|Breast cancer, physical exercise, recovery|breast cancer, physical exercise, recovery
162892|NCT02560636|Muscle Invasive|muscle invasive
162893|NCT02560636|Metastatic|metastatic
162894|NCT02560636|Advanced|advanced
162895|NCT02560623|Barrett's|barrett's
162896|NCT02560623|esophagus|esophagus
162897|NCT02560623|reflux|reflux
162898|NCT02560623|esophageal adenocarcinoma|esophageal adenocarcinoma
162899|NCT02560597|epilepsy|epilepsy
162900|NCT02560597|epilepsia partialis continua|epilepsia partialis continua
162901|NCT02560597|status epilepticus|status epilepticus
162902|NCT02560597|treatment resistant|treatment resistant
162903|NCT02560597|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
162904|NCT02560584|Non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
162905|NCT02560584|NMIBC|nmibc
162906|NCT02560584|Cysview|cysview
162907|NCT02560558|Immunosuppression|immunosuppression
162908|NCT02560558|Transplantation Immunology|transplantation immunology
162909|NCT02560532|aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
162910|NCT02560532|cerebral vasospasm|cerebral vasospasm
162911|NCT02560532|clazosentan|clazosentan
162912|NCT02560519|human serum albumin solution|human serum albumin solution
162913|NCT02560519|Cardiopulmonary Bypass|cardiopulmonary bypass
162914|NCT02560493|BMIz|bmiz
162915|NCT02560493|Exergaming|exergaming
162916|NCT02560493|Cardiovascular Disease|cardiovascular disease
162917|NCT02560480|groin pain, groin injury, magnetic resonance imaging|groin pain, groin injury, magnetic resonance imaging
162918|NCT02560454|Cognitive Remediation|cognitive remediation
162919|NCT02560454|Working Memory Training|working memory training
162920|NCT02560454|Cognitive training|cognitive training
162921|NCT02560428|Mixed Methods|mixed methods
162922|NCT02560428|Cardiovascular Health|cardiovascular health
162923|NCT02560428|Implementation Evaluation|implementation evaluation
162924|NCT02560428|Cardiovascular Prevention Screening|cardiovascular prevention screening
162925|NCT02560415|Autism Spectrum Disorder|autism spectrum disorder
162926|NCT02560415|Serious Game|serious game
162927|NCT02560415|Controlled trial|controlled trial
162928|NCT02560415|Denver model|denver model
162929|NCT02560402|Glomerular hyperfiltration|glomerular hyperfiltration
162930|NCT02560402|Renal Resistive Index (RRI)|renal resistive index (rri)
162931|NCT02560389|Posttraumatic Stress Disorder|posttraumatic stress disorder
162932|NCT02560389|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
162933|NCT02560389|Levodopa (L-DOPA)|levodopa (l-dopa)
162934|NCT02560389|Exposure Therapy|exposure therapy
162935|NCT02560389|Fear Extinction|fear extinction
162936|NCT02560376|PET/CT|pet/ct
162937|NCT02560376|glucagon-like peptide-1 receptor (GLP-1R) imaging|glucagon-like peptide-1 receptor (glp-1r) imaging
162938|NCT02560363|AZD9977|azd9977
162939|NCT02560363|Safety|safety
162940|NCT02560363|Tolerability|tolerability
162941|NCT02560363|Pharmacokinetics|pharmacokinetics
162942|NCT02560363|Food effect|food effect
162943|NCT02560363|AZD9977 capsules|azd9977 capsules
162944|NCT02560363|AZD9977 suspension|azd9977 suspension
162945|NCT02560350|adipose-derived stem cells|adipose-derived stem cells
163629|NCT02556177|MRI|mri
162946|NCT02560350|small intestinal submucosa|small intestinal submucosa
162947|NCT02560350|adipocyte-containing hypodermis|adipocyte-containing hypodermis
162948|NCT02560337|Ovarian cancer|ovarian cancer
162949|NCT02560337|Relapse|relapse
162950|NCT02560337|Recurrence|recurrence
162951|NCT02560337|Chemotherapy resistance|chemotherapy resistance
162952|NCT02560324|Ramelteon|ramelteon
162953|NCT02560324|Nicotine|nicotine
162954|NCT02560324|Nicotine dependence|nicotine dependence
162955|NCT02560324|Insomnia|insomnia
162956|NCT02560324|Tobacco Dependence|tobacco dependence
162957|NCT02560285|Risk assessment|risk assessment
162958|NCT02560285|Mortality|mortality
162959|NCT02560285|Morbidity|morbidity
162960|NCT02560285|Risk factor|risk factor
162961|NCT02560272|vaccine|vaccine
162962|NCT02560272|haemophilus influenzae type b|haemophilus influenzae type b
162963|NCT02560259|knee pain|knee pain
162964|NCT02560246|Microbiome|microbiome
162965|NCT02560233|Neurofeedback|neurofeedback
162966|NCT02560233|Stress|stress
162967|NCT02560233|fMRI|fmri
162968|NCT02560233|Real-time fMRI Neurofeedback|real-time fmri neurofeedback
162969|NCT02560233|Anterior cingulate cortex|anterior cingulate cortex
162970|NCT02560233|Hypothalamic-pituitary-adrenal axis|hypothalamic-pituitary-adrenal axis
162971|NCT02560233|Cortisol|cortisol
162972|NCT02560233|EEG|eeg
162973|NCT02560233|Heart rate variability|heart rate variability
162974|NCT02560233|Blood pressure|blood pressure
162975|NCT02560233|Simultaneous EEG/fMRI|simultaneous eeg/fmri
162976|NCT02560181|recurrent prostate cancer, HDR whole gland salvage|recurrent prostate cancer, hdr whole gland salvage
162977|NCT02560168|Coronary artery disease|coronary artery disease
162978|NCT02560168|iECG|iecg
162979|NCT02560168|MyoVista|myovista
162980|NCT02560168|Heart Test Labs|heart test labs
162981|NCT02560168|Wavelet analysis|wavelet analysis
162982|NCT02560168|Surface electrocardiogram|surface electrocardiogram
162983|NCT02560155|Orthopedic surgery|orthopedic surgery
162984|NCT02560155|Surgical site infection|surgical site infection
162985|NCT02560155|Decolonization|decolonization
162986|NCT02560155|Staphylococcus aureus|staphylococcus aureus
162987|NCT02560129|recovery|recovery
162988|NCT02560129|ICU|icu
162989|NCT02560129|clinic|clinic
162990|NCT02560129|survivor|survivor
162991|NCT02560129|physical function|physical function
162992|NCT02560116|Pulmonary artery systolic pressure|pulmonary artery systolic pressure
162993|NCT02560116|Optison|optison
162994|NCT02560090|Diabetes|diabetes
162995|NCT02560077|cognitive|cognitive
162996|NCT02560077|memory|memory
162997|NCT02560077|physical fitness|physical fitness
162998|NCT02560077|psychological fitness|psychological fitness
162999|NCT02560077|elderly|elderly
163000|NCT02560077|middle aged|middle aged
163001|NCT02560051|Prostate Cancer|prostate cancer
163002|NCT02560051|Advanced|advanced
163003|NCT02560051|Local Failures|local failures
163004|NCT02560038|Urothelial Cancer|urothelial cancer
163005|NCT02560038|Bladder Cancer|bladder cancer
163006|NCT02560038|Metastatic|metastatic
163007|NCT02560025|Acute Myeloid Leukemia|acute myeloid leukemia
163008|NCT02560012|Renal Cell Carcinoma|renal cell carcinoma
163009|NCT02560012|RCC|rcc
163010|NCT02560012|Personalized therapy|personalized therapy
163011|NCT02560012|targeted inhibitors|targeted inhibitors
163012|NCT02559999|Healthy Volunteers|healthy volunteers
163013|NCT02559999|Pain|pain
163014|NCT02559999|EEG|eeg
163015|NCT02559973|Buprenorphine|buprenorphine
163016|NCT02559973|opioid use disorder|opioid use disorder
163017|NCT02559921|Recombinant Human Rabies Immunoglobin (rhRIG)|recombinant human rabies immunoglobin (rhrig)
163018|NCT02559869|Biofluid|biofluid
163019|NCT02559869|ALS|als
163020|NCT02559869|MRI|mri
163021|NCT02559869|PET|pet
163022|NCT02559869|Imaging|imaging
163023|NCT02559869|Biomarkers|biomarkers
163024|NCT02559869|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
163025|NCT02559869|TRACK ALS|track als
163026|NCT02559869|pathology|pathology
163027|NCT02559843|pomegranate|pomegranate
163028|NCT02559843|diabetes|diabetes
163029|NCT02559843|oxidative stress|oxidative stress
163030|NCT02559817|Irritable Bowel Syndrome with Constipation in children|irritable bowel syndrome with constipation in children
163031|NCT02559817|Linzess|linzess
163032|NCT02559791|Reslizumab|reslizumab
163033|NCT02559791|Eosinophils|eosinophils
163034|NCT02559791|Asthma|asthma
163035|NCT02559791|Airway inflammation|airway inflammation
163036|NCT02559791|Prednisone|prednisone
163037|NCT02559765|physiotherapy|physiotherapy
163038|NCT02559765|progressive multiple sclerosis|progressive multiple sclerosis
163039|NCT02559765|rehabilitation|rehabilitation
163040|NCT02559765|rehabilitation services|rehabilitation services
163041|NCT02559739|Stroke|stroke
163042|NCT02559739|Ischemic Attack, Transient|ischemic attack, transient
163043|NCT02559739|Cardiovascular Diseases|cardiovascular diseases
163044|NCT02559739|Sleep Apnea Syndromes|sleep apnea syndromes
163045|NCT02559739|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
163046|NCT02559739|Insomnia|insomnia
163047|NCT02559739|Restless Legs Syndrome|restless legs syndrome
163048|NCT02559739|Sleep Deprivation|sleep deprivation
163049|NCT02559726|Hypertrophic cardiomyopathy, hyper-synchronicity, outflow-tract obstruction, dual chamber pacing|hypertrophic cardiomyopathy, hyper-synchronicity, outflow-tract obstruction, dual chamber pacing
163050|NCT02559713|Lactation|lactation
163051|NCT02559713|Lactating Women|lactating women
163052|NCT02559713|Vedolizumab|vedolizumab
163053|NCT02559713|Colitis Ulcerative|colitis ulcerative
163054|NCT02559713|Crohn Disease|crohn disease
163055|NCT02559713|Crohn's|crohn's
163056|NCT02559700|Healthy Ageing|healthy ageing
163057|NCT02559687|Programmed Cell Death-1 (PD-1)|programmed cell death-1 (pd-1)
163058|NCT02559687|PD1|pd1
163059|NCT02559687|Programmed Cell Death-Ligand 1 (PD-L1)|programmed cell death-ligand 1 (pd-l1)
163060|NCT02559687|Programmed Cell Death-Ligand 2 (PD-L2)|programmed cell death-ligand 2 (pd-l2)
163061|NCT02559687|PDL1|pdl1
163062|NCT02559687|PDL2|pdl2
163063|NCT02559674|Pancreas|pancreas
163064|NCT02559674|Pancreatic|pancreatic
163065|NCT02559674|Cancer|cancer
163066|NCT02559674|Advanced Pancreatic Cancer|advanced pancreatic cancer
163067|NCT02559674|Immunotherapy|immunotherapy
163068|NCT02559674|Immunotherapeutic|immunotherapeutic
163069|NCT02559674|Interleukin-15|interleukin-15
163070|NCT02559674|Gemcitabine|gemcitabine
163071|NCT02559674|Nab-paclitaxel|nab-paclitaxel
163072|NCT02559674|Solid Tumor|solid tumor
163073|NCT02559674|Metastatic Disease|metastatic disease
163074|NCT02559674|Combination Immunotherapy|combination immunotherapy
163075|NCT02559583|Multiple Myeloma|multiple myeloma
163076|NCT02559583|chronic lymphocytic leukemia|chronic lymphocytic leukemia
163077|NCT02559583|Non-Hodgkin lymphoma|non-hodgkin lymphoma
163078|NCT02559570|Functional constipation in children|functional constipation in children
163079|NCT02559570|Linzess|linzess
163080|NCT02559544|failed prior endocrine therapy|failed prior endocrine therapy
163081|NCT02559518|Cerebellum|cerebellum
163082|NCT02559518|Transcranial Direct Current Stimulation|transcranial direct current stimulation
163083|NCT02559518|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
163084|NCT02559518|Motor Learning|motor learning
163085|NCT02559518|Serial Reaction Time Task|serial reaction time task
163086|NCT02559518|HandwritingTask|handwritingtask
163087|NCT02559505|natural influenza infection|natural influenza infection
163088|NCT02559505|live attenuated influenza vaccination (LAIV)|live attenuated influenza vaccination (laiv)
163089|NCT02559505|inactivated influenza vaccination (IIV)|inactivated influenza vaccination (iiv)
163090|NCT02559505|infants|infants
163091|NCT02559505|children|children
163092|NCT02559466|pharmaco-resistant depressed patients|pharmaco-resistant depressed patients
163093|NCT02559427|sleep apnea|sleep apnea
163094|NCT02559427|Venous Insufficiency|venous insufficiency
163095|NCT02559427|SPA treatment|spa treatment
163096|NCT02559401|Eloquent cortex|eloquent cortex
163097|NCT02559349|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
163098|NCT02559349|SBRT|sbrt
163099|NCT02559336|Palliative Care|palliative care
163100|NCT02559336|Cancer|cancer
163101|NCT02559336|Health Services Research|health services research
163102|NCT02559310|Pneumonia|pneumonia
163103|NCT02559310|CABP|cabp
163104|NCT02559310|CAP|cap
163105|NCT02559310|Community acquired bacterial pneumonia|community acquired bacterial pneumonia
163106|NCT02559297|Regulatory T cells|regulatory t cells
163107|NCT02559297|Sevoflurane|sevoflurane
163108|NCT02559297|Desflurane|desflurane
163109|NCT02559297|Cytokines|cytokines
163110|NCT02559297|Flow cytometry|flow cytometry
163111|NCT02559297|Living Donor Kidney Transplant|living donor kidney transplant
163112|NCT02559284|Saline Solution, Isotonic / Administration & dosage|saline solution, isotonic / administration & dosage
163113|NCT02559284|Therapeutic Irrigation / methods|therapeutic irrigation / methods
163114|NCT02559284|Postoperative Care / methods|postoperative care / methods
163115|NCT02559284|Quality of life|quality of life
163116|NCT02559180|Diabetes|diabetes
163117|NCT02559180|Macular Edema|macular edema
163118|NCT02559180|Diabetic Retinopathy|diabetic retinopathy
163119|NCT02559141|haemodynamic optimization|haemodynamic optimization
163120|NCT02559141|cardiac index|cardiac index
163121|NCT02559141|non-invasive|non-invasive
163122|NCT02559141|pulse pressure variation|pulse pressure variation
163123|NCT02559128|Insulin Resistance|insulin resistance
163124|NCT02559128|Chronic Heart Failure|chronic heart failure
163125|NCT02559128|Type 2 Diabetes|type 2 diabetes
163126|NCT02559128|Endothelial Dysfunction|endothelial dysfunction
163127|NCT02559115|68Ga-RM2|68ga-rm2
163128|NCT02559115|PET/CT scan|pet/ct scan
163129|NCT02559115|Gastrin Releasing Peptide Receptor (GRPr)|gastrin releasing peptide receptor (grpr)
163130|NCT02559115|14-146|14-146
163131|NCT02559102|Dexmedetomidine sedation|dexmedetomidine sedation
163132|NCT02559102|General anaesthesia|general anaesthesia
163133|NCT02559102|Neurodevelopment|neurodevelopment
163134|NCT02559102|Infants|infants
163135|NCT02559102|Neonates|neonates
163136|NCT02559076|Overweight|overweight
163137|NCT02559076|Obesity|obesity
163138|NCT02559076|Preschool children|preschool children
163139|NCT02559076|United Arab Emirates|united arab emirates
163140|NCT02559076|Dietary patterns|dietary patterns
163141|NCT02559076|BMI z-scores|bmi z-scores
163142|NCT02559063|cognitive training|cognitive training
163143|NCT02559063|speed of processing|speed of processing
163144|NCT02559063|neuroplasticity|neuroplasticity
163145|NCT02559063|cognitive aging|cognitive aging
163146|NCT02559037|acupuncture|acupuncture
163147|NCT02559037|moxibustion|moxibustion
163148|NCT02559037|intestinal microbiota|intestinal microbiota
163149|NCT02559037|Mucosal immunity|mucosal immunity
163150|NCT02559024|Metastatic colorectal cancer|metastatic colorectal cancer
163151|NCT02559024|liver lesion|liver lesion
163152|NCT02559024|anti-OX40 antibody|anti-ox40 antibody
163153|NCT02559024|MEDI6469|medi6469
163154|NCT02559024|Immunotherapy|immunotherapy
163155|NCT02559011|Arrhythmias, Cardiac|arrhythmias, cardiac
163156|NCT02559011|Transcatheter Aortic Valve implantation|transcatheter aortic valve implantation
163157|NCT02559011|Aortic Valve Stenosis|aortic valve stenosis
163158|NCT02558985|Pulmonary Compliance|pulmonary compliance
163159|NCT02558985|Casting|casting
163160|NCT02558972|Postural Tachycardia Syndrome (POTS)|postural tachycardia syndrome (pots)
163161|NCT02558972|Vasovagal Syncope (VVS)|vasovagal syncope (vvs)
163162|NCT02558972|Fainting|fainting
163163|NCT02558972|Orthostatic Intolerance|orthostatic intolerance
163164|NCT02558972|Droxidopa|droxidopa
163165|NCT02558972|Northera|northera
163166|NCT02558933|Fetal Alcohol Syndrome|fetal alcohol syndrome
163167|NCT02558933|Prenatal exposure|prenatal exposure
163168|NCT02558933|Biomarkers|biomarkers
163169|NCT02558933|Oxidative stress|oxidative stress
163170|NCT02558933|Epigallocatechin gallate|epigallocatechin gallate
163171|NCT02558920|Systematic review and meta-analysis|systematic review and meta-analysis
163172|NCT02558920|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
163173|NCT02558920|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
163174|NCT02558920|Clinical practice guidelines|clinical practice guidelines
163175|NCT02558920|Clinical trials|clinical trials
163176|NCT02558920|Dietary sugars|dietary sugars
163177|NCT02558920|Fructose|fructose
163178|NCT02558920|Sucrose|sucrose
163179|NCT02558920|High fructose corn syrup|high fructose corn syrup
163180|NCT02558920|Isocaloric|isocaloric
163181|NCT02558920|Hypercaloric|hypercaloric
163182|NCT02558920|Body weight|body weight
163183|NCT02558920|Prospective cohort studies|prospective cohort studies
163184|NCT02558907|geriatrics|geriatrics
163185|NCT02558907|cancer|cancer
163186|NCT02558907|MMS test|mms test
163187|NCT02558907|MoCA test|moca test
163188|NCT02558907|cognitive evaluation|cognitive evaluation
163189|NCT02558894|Pancreatic Ductal Adenocarcinoma, PDAC|pancreatic ductal adenocarcinoma, pdac
163190|NCT02558881|screening|screening
163191|NCT02558881|colorectal cancer|colorectal cancer
163192|NCT02558881|colon capsule|colon capsule
163193|NCT02558881|virtual colonoscopy|virtual colonoscopy
163194|NCT02558855|Thrust Joint Manipulation|thrust joint manipulation
163195|NCT02558855|Non-thrust Joint Manipulation|non-thrust joint manipulation
163196|NCT02558855|Transversus Abdominis|transversus abdominis
163197|NCT02558829|Adult Growth Hormone Deficiency|adult growth hormone deficiency
163198|NCT02558803|HPV Vaccinations|hpv vaccinations
163199|NCT02558803|Quadrivalent Vaccine|quadrivalent vaccine
163200|NCT02558790|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
163201|NCT02558790|ADHD|adhd
163202|NCT02558790|Attention Deficit Disorder|attention deficit disorder
163203|NCT02558790|ADD|add
163204|NCT02558790|Magnesium|magnesium
163205|NCT02558777|Delirium|delirium
163206|NCT02558777|Pilot Study|pilot study
163207|NCT02558777|Nurse intervention|nurse intervention
163208|NCT02558777|Hospitalization|hospitalization
163209|NCT02558751|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
163210|NCT02558751|aging HIV|aging hiv
163211|NCT02558738|dermatitis and irritations at the outer ear canal|dermatitis and irritations at the outer ear canal
163212|NCT02558738|prevention of subacute otitis externa|prevention of subacute otitis externa
163213|NCT02558712|screening|screening
163214|NCT02558712|tele-ophthalmology|tele-ophthalmology
163215|NCT02558686|trigger points|trigger points
163216|NCT02558686|disability|disability
163217|NCT02558686|post-dry needling soreness|post-dry needling soreness
163218|NCT02558686|eccentric exercise|eccentric exercise
163219|NCT02558673|Trimethylamine-N-oxide|trimethylamine-n-oxide
163220|NCT02558673|Biomarkers|biomarkers
163221|NCT02558673|Production|production
163222|NCT02558673|Metabolism|metabolism
163223|NCT02558673|Gut microbiome|gut microbiome
163224|NCT02558673|Healthy|healthy
163225|NCT02558660|Supplemental Nutrition Incentive Program (SNAP)|supplemental nutrition incentive program (snap)
163226|NCT02558660|economic incentive|economic incentive
163227|NCT02558621|Robotic Spinal Fusion Surgery|robotic spinal fusion surgery
163228|NCT02558608|Prime Spontaneous Pneumothorax|prime spontaneous pneumothorax
163229|NCT02558608|recurrence|recurrence
163230|NCT02558595|PKD|pkd
163231|NCT02558595|Kidney disease|kidney disease
163232|NCT02558595|Vitamin B3|vitamin b3
163233|NCT02558582|Pulmonary arterial hypertension|pulmonary arterial hypertension
163234|NCT02558582|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
163235|NCT02558582|Rehabilitation|rehabilitation
163236|NCT02558582|Oxygen|oxygen
163237|NCT02558569|fentanyl, scalp block|fentanyl, scalp block
163238|NCT02558556|Laparoscopic cholecystectomy (LC)|laparoscopic cholecystectomy (lc)
163239|NCT02558556|Indocyanine green (ICG)|indocyanine green (icg)
163240|NCT02558556|Near-Infrared Fluorescence Imaging (NIRF)|near-infrared fluorescence imaging (nirf)
163241|NCT02558556|Critical View of Safety (CVS)|critical view of safety (cvs)
163242|NCT02558517|Systemic Lupus Erythematosus|systemic lupus erythematosus
163243|NCT02558517|Corticosteroids|corticosteroids
163244|NCT02558517|Chronic disease|chronic disease
163245|NCT02558491|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
163246|NCT02558491|Artificial Pancreas Project (APP)|artificial pancreas project (app)
163247|NCT02558491|Diabetes Assistant (DiAs)|diabetes assistant (dias)
163248|NCT02558491|Insulin Pump|insulin pump
163249|NCT02558491|Continuous Glucose Monitor|continuous glucose monitor
163250|NCT02558491|Exercise|exercise
163251|NCT02558491|Glucose Variability|glucose variability
163252|NCT02558491|Decision Support System|decision support system
163253|NCT02558491|Multiple Daily Injections (MDI)|multiple daily injections (mdi)
163254|NCT02558478|Whole exome sequencing|whole exome sequencing
163255|NCT02558465|Xarelto, rivaroxaban, VTE, PE, DVT, Japan, PMS, SDUI|xarelto, rivaroxaban, vte, pe, dvt, japan, pms, sdui
163256|NCT02558452|elderly kidney transplant recipient|elderly kidney transplant recipient
163257|NCT02558452|registry|registry
163258|NCT02558452|tacrolimus once daily|tacrolimus once daily
163259|NCT02558426|Chronic Venous Disease|chronic venous disease
163260|NCT02558426|Estrogen receptors|estrogen receptors
163261|NCT02558426|GPER|gper
163262|NCT02558413|Viral Diseases|viral diseases
163263|NCT02558413|Antiviral|antiviral
163264|NCT02558413|Paramyxoviridae Infections|paramyxoviridae infections
163265|NCT02558413|RSV|rsv
163266|NCT02558413|Respiratory Syncytial Virus|respiratory syncytial virus
163267|NCT02558413|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
163268|NCT02558413|Aviragen Therapeutics|aviragen therapeutics
163269|NCT02558413|Aviragen|aviragen
163270|NCT02558348|Dual receptor Tyrosine Kinase Inhibitor|dual receptor tyrosine kinase inhibitor
163271|NCT02558348|Anti-angiogenic therapy|anti-angiogenic therapy
163272|NCT02558257|Advanced Cancers|advanced cancers
163273|NCT02558257|Survey|survey
163274|NCT02558257|Questionnaire|questionnaire
163275|NCT02558244|Childhood Cancer|childhood cancer
163276|NCT02558244|Image-defined Risk Factors|image-defined risk factors
163277|NCT02558244|Pediatric Oncology|pediatric oncology
163278|NCT02558192|LGG|lgg
163279|NCT02558192|Probiotics|probiotics
163280|NCT02558192|nosocomial infection prevention|nosocomial infection prevention
163281|NCT02558192|pediatrics|pediatrics
163282|NCT02558166|Acute Kidney Injury (AKI)|acute kidney injury (aki)
163283|NCT02558166|Renal Resistive Index (RRI)|renal resistive index (rri)
163284|NCT02558153|drug eluting balloon|drug eluting balloon
163285|NCT02558153|percutaneous balloon angioplasty|percutaneous balloon angioplasty
163286|NCT02558127|asthma|asthma
163287|NCT02558127|cystic fibrosis|cystic fibrosis
163288|NCT02558101|Screening|screening
163289|NCT02558101|Early detection|early detection
163290|NCT02558101|Health inequality|health inequality
163291|NCT02558101|Uptake|uptake
163292|NCT02558088|salmeterol|salmeterol
163293|NCT02558088|pharmacokinetics|pharmacokinetics
163294|NCT02558088|doping|doping
163295|NCT02558088|beta2-agonists|beta2-agonists
163296|NCT02558088|long-acting beta2-agonists|long-acting beta2-agonists
163297|NCT02558062|Ventilator Associated Pneumonia|ventilator associated pneumonia
163298|NCT02558062|Distal lung|distal lung
163299|NCT02558049|Patient decision aid|patient decision aid
163300|NCT02558036|Head Neck Position Videolaryngoscopy|head neck position videolaryngoscopy
163301|NCT02558023|PRE-ECLAMPSIA|pre-eclampsia
163302|NCT02558023|URAPIDIL|urapidil
163303|NCT02558023|NICARDIPINE|nicardipine
163304|NCT02558010|Methadone|methadone
163305|NCT02558010|Gabapentin|gabapentin
163306|NCT02558010|Postoperative Pain|postoperative pain
163307|NCT02558010|Posterior Spinal Fusion|posterior spinal fusion
163308|NCT02558010|Pediatric|pediatric
163309|NCT02557997|HIV reservoir|hiv reservoir
163310|NCT02557997|HIV-1 DNA|hiv-1 dna
163311|NCT02557997|Immune activation|immune activation
163312|NCT02557997|Monocyte function|monocyte function
163313|NCT02557997|Activation biomarkers|activation biomarkers
163314|NCT02557984|Dopamine|dopamine
163315|NCT02557984|Opioid|opioid
163316|NCT02557984|Reward|reward
163317|NCT02557958|COPD, pulmonary disease|copd, pulmonary disease
163318|NCT02557932|PPI standard triple therapy|ppi standard triple therapy
163319|NCT02557932|Bismuth quadruple therapy|bismuth quadruple therapy
163320|NCT02557932|Helicobacter|helicobacter
163321|NCT02557906|Acellular dermal matrix|acellular dermal matrix
163322|NCT02557906|ADM|adm
163323|NCT02557906|SurgiMend|surgimend
163324|NCT02557906|Breast reconstruction|breast reconstruction
163325|NCT02557906|Immediate breast reconstruction|immediate breast reconstruction
163326|NCT02557906|Autologous reconstruction|autologous reconstruction
163327|NCT02557906|Biological mesh|biological mesh
163328|NCT02557867|dexmedetomidine|dexmedetomidine
163329|NCT02557867|pharmacokinetic|pharmacokinetic
163330|NCT02557867|obesity|obesity
163331|NCT02557841|Cerebellum|cerebellum
163709|NCT02555657|PDL1|pdl1
163430|NCT02557204|success rate|success rate
163332|NCT02557841|Transcranial Direct Current Stimulation|transcranial direct current stimulation
163333|NCT02557841|Motor Learning|motor learning
163334|NCT02557841|Serial Reaction Time Task|serial reaction time task
163335|NCT02557841|Handwriting|handwriting
163336|NCT02557815|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
163337|NCT02557815|Emotion Regulation|emotion regulation
163338|NCT02557815|Craving|craving
163339|NCT02557789|Absolute bioavailability|absolute bioavailability
163340|NCT02557789|Pharmacokinetics|pharmacokinetics
163341|NCT02557776|BRCA1|brca1
163342|NCT02557776|BRCA2|brca2
163343|NCT02557776|hereditary breast cancer|hereditary breast cancer
163344|NCT02557776|genetic counseling|genetic counseling
163345|NCT02557763|Oxford UKA|oxford uka
163346|NCT02557763|anterior knee pain|anterior knee pain
163347|NCT02557763|lateral facet of patella|lateral facet of patella
163348|NCT02557750|Childhood Cancer|childhood cancer
163349|NCT02557750|Pediatric Oncology|pediatric oncology
163350|NCT02557737|stroke|stroke
163351|NCT02557737|upper extremity|upper extremity
163352|NCT02557737|spasticity|spasticity
163353|NCT02557737|botulinum toxin|botulinum toxin
163354|NCT02557737|ultrasonography|ultrasonography
163355|NCT02557737|electric stimulation|electric stimulation
163356|NCT02557711|spasticity|spasticity
163357|NCT02557711|stroke|stroke
163358|NCT02557711|ultrasound elastography|ultrasound elastography
163359|NCT02557711|acoustic radiation force impulse|acoustic radiation force impulse
163360|NCT02557659|Low Profile|low profile
163361|NCT02557659|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
163362|NCT02557659|Endovascular|endovascular
163363|NCT02557594|Hepatitis B|hepatitis b
163364|NCT02557568|nasal carriage|nasal carriage
163365|NCT02557568|Staphylococcus aureus|staphylococcus aureus
163366|NCT02557568|hemodialysis patients|hemodialysis patients
163367|NCT02557542|Varicose Veins; One Stop Clinic|varicose veins; one stop clinic
163368|NCT02557529|Head and Neck Cancer|head and neck cancer
163369|NCT02557529|Concomitant chemoradiotherapy|concomitant chemoradiotherapy
163370|NCT02557529|Exercise Training|exercise training
163371|NCT02557529|Progressive Resistance Training|progressive resistance training
163372|NCT02557529|Weight loss|weight loss
163373|NCT02557529|Lean Body Mass|lean body mass
163374|NCT02557529|Body Composition|body composition
163375|NCT02557503|TACE; oxaliplatin; fluorouracil; liver cancer|tace; oxaliplatin; fluorouracil; liver cancer
163376|NCT02557490|TACE; hepatic artery infusion; oxaliplatin; raltitrexed|tace; hepatic artery infusion; oxaliplatin; raltitrexed
163377|NCT02557464|semantic memory|semantic memory
163378|NCT02557464|eye movements|eye movements
163379|NCT02557464|reading|reading
163380|NCT02557438|Bone|bone
163381|NCT02557438|Child Health|child health
163382|NCT02557438|Nutrition|nutrition
163383|NCT02557425|malaria|malaria
163384|NCT02557425|infant|infant
163385|NCT02557425|pregnancy|pregnancy
163386|NCT02557425|prophylaxis|prophylaxis
163387|NCT02557425|dihyroartemisinin-piperaquine|dihyroartemisinin-piperaquine
163388|NCT02557425|sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
163389|NCT02557425|behavior|behavior
163390|NCT02557425|neurodevelopment|neurodevelopment
163391|NCT02557425|cognitive|cognitive
163392|NCT02557399|Clindamycin|clindamycin
163393|NCT02557399|Gel|gel
163394|NCT02557399|Benzoyl Peroxide|benzoyl peroxide
163395|NCT02557399|Acne Vulgaris|acne vulgaris
163396|NCT02557386|Cruciate ligament surgery|cruciate ligament surgery
163397|NCT02557386|Adductor canal|adductor canal
163398|NCT02557386|Nerve block|nerve block
163399|NCT02557373|rice bran|rice bran
163400|NCT02557373|infants|infants
163401|NCT02557373|stool metabolome and microbiome|stool metabolome and microbiome
163402|NCT02557373|dietary intervention|dietary intervention
163403|NCT02557360|liver injury|liver injury
163404|NCT02557360|detoxification|detoxification
163405|NCT02557360|S-adenosyl-L-methionine|s-adenosyl-l-methionine
163406|NCT02557360|quality of life|quality of life
163407|NCT02557334|Strawberry Powder|strawberry powder
163408|NCT02557334|Cardiovascular Disease Risk Factors|cardiovascular disease risk factors
163409|NCT02557269|Pollenosis|pollenosis
163410|NCT02557269|Congestion|congestion
163411|NCT02557269|Mucoadhesive Treatment|mucoadhesive treatment
163412|NCT02557269|Nasal Decongestant|nasal decongestant
163413|NCT02557269|Nasal Antihistamine|nasal antihistamine
163414|NCT02557269|Nasal Corticosteroid|nasal corticosteroid
163415|NCT02557256|Childhood Cancer|childhood cancer
163416|NCT02557256|Abdominal Tumors|abdominal tumors
163417|NCT02557256|Pelvic Tumors|pelvic tumors
163418|NCT02557256|Pediatric Oncology|pediatric oncology
163419|NCT02557243|Childhood Cancer|childhood cancer
163420|NCT02557243|Soft Tissue Tumors|soft tissue tumors
163421|NCT02557243|Bone Tumors|bone tumors
163422|NCT02557243|Extremity Tumor|extremity tumor
163423|NCT02557243|Pediatric Oncology|pediatric oncology
163424|NCT02557230|Childhood Cancer|childhood cancer
163425|NCT02557230|Genitourinary tumors|genitourinary tumors
163426|NCT02557230|urogenital tumors|urogenital tumors
163427|NCT02557230|Pediatric Oncology|pediatric oncology
163428|NCT02557204|nasogastric tube insertion|nasogastric tube insertion
163429|NCT02557204|Video laryngoscope|video laryngoscope
163431|NCT02557165|Muscle regeneration|muscle regeneration
163432|NCT02557113|cement leakage|cement leakage
163433|NCT02557113|cement augmentation|cement augmentation
163434|NCT02557113|vertebral body fracture|vertebral body fracture
163435|NCT02557113|vertebral cavity|vertebral cavity
163436|NCT02557113|vertebroplasty|vertebroplasty
163437|NCT02557048|Childhood Cancer|childhood cancer
163438|NCT02557048|Head and Neck Tumors|head and neck tumors
163439|NCT02557048|Pediatric Oncology|pediatric oncology
163440|NCT02557022|Systematic review and meta-analysis|systematic review and meta-analysis
163441|NCT02557022|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
163442|NCT02557022|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
163443|NCT02557022|Clinical practice guidelines|clinical practice guidelines
163444|NCT02557022|Glycemic index|glycemic index
163445|NCT02557022|Glycemic load|glycemic load
163446|NCT02557022|Body weight|body weight
163447|NCT02557022|Cardiovascular risk factors|cardiovascular risk factors
163448|NCT02557022|Cardiovascular disease|cardiovascular disease
163449|NCT02557009|Hemodynamics|hemodynamics
163450|NCT02557009|Central Venous Pressure|central venous pressure
163451|NCT02557009|Pulmonary Artery Pressure|pulmonary artery pressure
163452|NCT02557009|Cardiac Output|cardiac output
163453|NCT02556983|Appendicitis|appendicitis
163454|NCT02556983|Tomography, X-Ray Computed|tomography, x-ray computed
163455|NCT02556983|Receiver operating characteristic (ROC) Curve|receiver operating characteristic (roc) curve
163456|NCT02556983|Computer Simulation|computer simulation
163457|NCT02556944|Depth of focus|depth of focus
163458|NCT02556931|immunosuppression|immunosuppression
163459|NCT02556931|nonmyeloablative|nonmyeloablative
163460|NCT02556931|non-myeloablative|non-myeloablative
163461|NCT02556931|allogeneic|allogeneic
163462|NCT02556931|tacrolimus|tacrolimus
163463|NCT02556931|peripheral blood|peripheral blood
163464|NCT02556931|cyclophosphamide|cyclophosphamide
163465|NCT02556931|mycophenolate mofetil|mycophenolate mofetil
163466|NCT02556918|Coronary artery bypass graft surgery (CABG)|coronary artery bypass graft surgery (cabg)
163467|NCT02556918|Type 2 Diabetes|type 2 diabetes
163468|NCT02556905|Multiple Myeloma|multiple myeloma
163469|NCT02556905|Revlimid|revlimid
163470|NCT02556905|Lenalidomide|lenalidomide
163471|NCT02556905|Observational|observational
163472|NCT02556905|Korea|korea
163473|NCT02556905|Post Marketing Surveillance[PMS]|post marketing surveillance[pms]
163474|NCT02556892|Lymphocytic Leukemia|lymphocytic leukemia
163475|NCT02556892|Ibrutinib|ibrutinib
163476|NCT02556892|PCI-32765|pci-32765
163477|NCT02556892|JNJ-54179060|jnj-54179060
163478|NCT02556879|Liver transplantation|liver transplantation
163479|NCT02556879|Graft failure|graft failure
163480|NCT02556879|Donor specific antibodies|donor specific antibodies
163481|NCT02556853|Ultrasound|ultrasound
163482|NCT02556853|Double lumen tube|double lumen tube
163483|NCT02556840|Monogenic diabetes|monogenic diabetes
163484|NCT02556840|maturity-onset diabetes of the young|maturity-onset diabetes of the young
163485|NCT02556840|MODY|mody
163486|NCT02556840|Pregnancy|pregnancy
163487|NCT02556840|Gestational diabetes|gestational diabetes
163488|NCT02556840|Glucokinase|glucokinase
163489|NCT02556840|Insulin therapy during pregnancy|insulin therapy during pregnancy
163490|NCT02556840|Evaluation of fetal growth by ultrasonography measurements|evaluation of fetal growth by ultrasonography measurements
163491|NCT02556827|demodex|demodex
163492|NCT02556827|oxidative stress|oxidative stress
163493|NCT02556827|reflectance confocal microscopy|reflectance confocal microscopy
163494|NCT02556814|ITP|itp
163495|NCT02556814|Caffeic Acid|caffeic acid
163496|NCT02556814|dexamethasone|dexamethasone
163497|NCT02556801|Sublingual immunotherapy|sublingual immunotherapy
163498|NCT02556801|Dose range finding|dose range finding
163499|NCT02556801|Grass pollen|grass pollen
163500|NCT02556801|Allergic rhinitis/rhinoconjunctivitis|allergic rhinitis/rhinoconjunctivitis
163501|NCT02556801|Immunogenicity|immunogenicity
163502|NCT02556788|Efficacy|efficacy
163503|NCT02556788|Safety|safety
163504|NCT02556788|Acne vulgaris|acne vulgaris
163505|NCT02556762|Esophageal cancer|esophageal cancer
163506|NCT02556762|Simultaneous modulated accelerated boost|simultaneous modulated accelerated boost
163507|NCT02556762|Standard dose radiotherapy|standard dose radiotherapy
163508|NCT02556762|Chemotherapy|chemotherapy
163509|NCT02556762|Survival|survival
163510|NCT02556749|Cranberries|cranberries
163511|NCT02556749|blood pressure|blood pressure
163512|NCT02556749|cholesterol|cholesterol
163513|NCT02556749|SphygmoCor|sphygmocor
163514|NCT02556736|gene therapy|gene therapy
163515|NCT02556736|optogenetics|optogenetics
163516|NCT02556736|channelrhodopsin|channelrhodopsin
163517|NCT02556736|retina|retina
163518|NCT02556736|retinitis pigmentosa|retinitis pigmentosa
163519|NCT02556710|Osteoarthritis|osteoarthritis
163520|NCT02556710|Osteoarthritis of the Knee|osteoarthritis of the knee
163521|NCT02556684|Breast-Specific Gamma Imaging|breast-specific gamma imaging
163522|NCT02556684|Locally Advanced Breast Cancer|locally advanced breast cancer
163523|NCT02556684|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
163524|NCT02556684|BSGI|bsgi
163525|NCT02556658|Smartpilot View|smartpilot view
163526|NCT02556658|Hip fracture surgery|hip fracture surgery
163527|NCT02556658|Depth of anaesthesia|depth of anaesthesia
163528|NCT02556658|Intraoperative hypotension|intraoperative hypotension
163529|NCT02556658|Quality of anaesthesia|quality of anaesthesia
163530|NCT02556645|Combat|combat
163531|NCT02556645|Psychological Treatment|psychological treatment
163532|NCT02556645|Military|military
163533|NCT02556645|Psychotherapy|psychotherapy
163534|NCT02556645|Trauma|trauma
163535|NCT02556645|Posttraumatic Stress|posttraumatic stress
163536|NCT02556645|Posttraumatic Stress Disorder|posttraumatic stress disorder
163537|NCT02556619|Liver Cancer|liver cancer
163538|NCT02556619|Randomized Control Trial|randomized control trial
163539|NCT02556619|Palliative Care|palliative care
163540|NCT02556619|Liver Cell Carcinoma|liver cell carcinoma
163541|NCT02556619|Palliative Therapy|palliative therapy
163542|NCT02556606|ketamine|ketamine
163543|NCT02556606|depression|depression
163544|NCT02556606|treatment resistant|treatment resistant
163545|NCT02556606|treatment resistant depression|treatment resistant depression
163546|NCT02556606|late life depression|late life depression
163547|NCT02556606|depression in the elderly|depression in the elderly
163548|NCT02556606|geriatric depression|geriatric depression
163549|NCT02556593|Non-Small Cell Lung Cancer|non-small cell lung cancer
163550|NCT02556593|IMRT|imrt
163551|NCT02556593|erlotinib|erlotinib
163552|NCT02556593|whole-brain radiotherapy|whole-brain radiotherapy
163553|NCT02556580|albumin|albumin
163554|NCT02556580|surgery|surgery
163555|NCT02556580|inflammation|inflammation
163556|NCT02556580|volume kinetics|volume kinetics
163557|NCT02556567|Sleep patterns|sleep patterns
163558|NCT02556567|Physical activity|physical activity
163559|NCT02556567|Fitbit|fitbit
163560|NCT02556515|CMC1|cmc1
163561|NCT02556515|arthritis|arthritis
163562|NCT02556515|degenerative arthritis|degenerative arthritis
163563|NCT02556515|thumb|thumb
163564|NCT02556515|interpositional arthroplasty|interpositional arthroplasty
163565|NCT02556515|total joint replacement|total joint replacement
163566|NCT02556489|immunological memory|immunological memory
163567|NCT02556476|critical care|critical care
163568|NCT02556476|intensive care|intensive care
163569|NCT02556476|health related quality of life|health related quality of life
163570|NCT02556476|cost benefit analysis|cost benefit analysis
163571|NCT02556463|MEDI9197|medi9197
163572|NCT02556463|TLR 7/8 Agonist|tlr 7/8 agonist
163573|NCT02556463|Durvalumab|durvalumab
163574|NCT02556463|MEDI4736|medi4736
163575|NCT02556463|Imfinzi|imfinzi
163576|NCT02556437|Subcutaneous immunoglobulin|subcutaneous immunoglobulin
163577|NCT02556437|MMN|mmn
163578|NCT02556424|Ophthalmology|ophthalmology
163579|NCT02556424|Uveitic macular edema|uveitic macular edema
163580|NCT02556424|Triamcinolone subconjunctival injection|triamcinolone subconjunctival injection
163581|NCT02556424|Dexamethasone intraocular implant|dexamethasone intraocular implant
163582|NCT02556372|AIH|aih
163583|NCT02556372|JKB-122|jkb-122
163584|NCT02556372|autoimmune|autoimmune
163585|NCT02556372|hepatitis|hepatitis
163586|NCT02556346|CD20|cd20
163587|NCT02556346|immunotoxin|immunotoxin
163588|NCT02556346|CLL|cll
163589|NCT02556346|SLL|sll
163590|NCT02556346|leukemia|leukemia
163591|NCT02556346|lymphocytic lymphoma|lymphocytic lymphoma
163592|NCT02556346|lymphocytic leukemia|lymphocytic leukemia
163593|NCT02556346|MT-3724|mt-3724
163594|NCT02556346|relapsed|relapsed
163595|NCT02556346|refractory|refractory
163596|NCT02556346|immunotherapy|immunotherapy
163597|NCT02556346|cancer|cancer
163598|NCT02556346|antibodies|antibodies
163599|NCT02556346|safety|safety
163600|NCT02556346|pharmacokinetics|pharmacokinetics
163601|NCT02556333|TAF|taf
163602|NCT02556333|F/TAF|f/taf
163603|NCT02556333|antiretroviral therapy|antiretroviral therapy
163604|NCT02556333|TDF|tdf
163605|NCT02556333|directly observed therapy|directly observed therapy
163606|NCT02556294|HIV risk behavior|hiv risk behavior
163607|NCT02556268|Single-Dose, Open-Label, Non-Blinded, Non-Placebo-|single-dose, open-label, non-blinded, non-placebo-
163608|NCT02556268|Controlled, Stratified Design|controlled, stratified design
163609|NCT02556255|Peripheral Arterial Disease|peripheral arterial disease
163610|NCT02556255|Peripheral Artery Disease|peripheral artery disease
163611|NCT02556255|PAD|pad
163612|NCT02556255|Atherosclerosis|atherosclerosis
163613|NCT02556255|Arterial Occlusive Diseases|arterial occlusive diseases
163614|NCT02556255|Peripheral Vascular Diseases|peripheral vascular diseases
163615|NCT02556255|PVD|pvd
163616|NCT02556242|vector control|vector control
163617|NCT02556242|insecticide|insecticide
163618|NCT02556229|Aflibercept|aflibercept
163619|NCT02556229|inflammatory choroidal neovascularization|inflammatory choroidal neovascularization
163620|NCT02556229|young patient|young patient
163621|NCT02556216|bone biopsy; bone density|bone biopsy; bone density
163622|NCT02556203|TAVR|tavr
163623|NCT02556203|TAVI|tavi
163624|NCT02556203|Transfemoral aortic valve implantation|transfemoral aortic valve implantation
163625|NCT02556177|TBI|tbi
163626|NCT02556177|MR|mr
163627|NCT02556177|mTBI|mtbi
163628|NCT02556177|NFL|nfl
163630|NCT02556164|Electroacupuncture|electroacupuncture
163631|NCT02556164|Body Worn Sensor|body worn sensor
163632|NCT02556164|Gait|gait
163633|NCT02556164|Balance|balance
163634|NCT02556138|Intragastric Balloon|intragastric balloon
163635|NCT02556138|ORBERA Intragastric Balloon|orbera intragastric balloon
163636|NCT02556138|Weight Loss|weight loss
163637|NCT02556138|BMI >35|bmi >35
163638|NCT02556125|SCI|sci
163639|NCT02556125|Respiratory impairment|respiratory impairment
163640|NCT02556125|Diaphragm pacing|diaphragm pacing
163641|NCT02556125|Diaphragm stimulation|diaphragm stimulation
163642|NCT02556073|asthma control|asthma control
163643|NCT02556073|adherence|adherence
163644|NCT02556073|asthma self management plan|asthma self management plan
163645|NCT02556073|airway inflammation|airway inflammation
163646|NCT02556060|ketamine use disorder|ketamine use disorder
163647|NCT02556060|lamotrigine|lamotrigine
163648|NCT02556060|craving|craving
163649|NCT02556008|Children|children
163650|NCT02556008|Epilepsy|epilepsy
163651|NCT02556008|Cannabidiol|cannabidiol
163652|NCT02555995|AMD|amd
163653|NCT02555995|OCT|oct
163654|NCT02555982|Essential Head tremor|essential head tremor
163655|NCT02555982|Botulinum toxin injections|botulinum toxin injections
163656|NCT02555982|Quality of life|quality of life
163657|NCT02555982|Embarrassment assessment|embarrassment assessment
163658|NCT02555956|Macular grid|macular grid
163659|NCT02555956|Subthreshold|subthreshold
163660|NCT02555956|diabetic macular edema|diabetic macular edema
163661|NCT02555956|decrease in visual acuity|decrease in visual acuity
163662|NCT02555891|Prescriptions|prescriptions
163663|NCT02555891|Epidemiology|epidemiology
163664|NCT02555891|Health Administration Databases|health administration databases
163665|NCT02555891|Elderly|elderly
163666|NCT02555891|STOPP/START criteria|stopp/start criteria
163667|NCT02555878|Cancer|cancer
163668|NCT02555878|Rivaroxaban|rivaroxaban
163669|NCT02555878|Venous thromboembolism|venous thromboembolism
163670|NCT02555865|etiology|etiology
163671|NCT02555865|children|children
163672|NCT02555852|Proton Pump Inhibitors|proton pump inhibitors
163673|NCT02555852|Pneumonia|pneumonia
163674|NCT02555852|NSAIDs|nsaids
163675|NCT02555852|Histamine H2 Antagonists|histamine h2 antagonists
163676|NCT02555852|Drug safety|drug safety
163677|NCT02555839|Relapsed Multiple Myeloma|relapsed multiple myeloma
163678|NCT02555839|Refractory Multiple Myeloma|refractory multiple myeloma
163679|NCT02555839|Pomalidomide|pomalidomide
163680|NCT02555839|Imnovid|imnovid
163681|NCT02555839|Non-interventional|non-interventional
163682|NCT02555813|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
163683|NCT02555813|nab-Paclitaxel|nab-paclitaxel
163684|NCT02555813|Gemcitabine|gemcitabine
163685|NCT02555813|Non-interventional|non-interventional
163686|NCT02555800|Laryngeal papillomatosis|laryngeal papillomatosis
163687|NCT02555800|Cidofovir|cidofovir
163688|NCT02555800|Bevacizumab|bevacizumab
163689|NCT02555800|Recurrent respiratory papillomatosis|recurrent respiratory papillomatosis
163690|NCT02555787|FK506E|fk506e
163691|NCT02555787|Tacrolimus|tacrolimus
163692|NCT02555787|Observational|observational
163693|NCT02555787|Kidney transplantation|kidney transplantation
163694|NCT02555787|Advagraf|advagraf
163695|NCT02555774|subjective memory impairment|subjective memory impairment
163696|NCT02555774|cognitive training|cognitive training
163697|NCT02555735|pancreatic cancer|pancreatic cancer
163698|NCT02555696|Metastatic Breast Cancer|metastatic breast cancer
163699|NCT02555696|nab-paclitaxel|nab-paclitaxel
163700|NCT02555696|Abraxane|abraxane
163701|NCT02555683|Asthma|asthma
163702|NCT02555683|QAW039|qaw039
163703|NCT02555670|Muscles|muscles
163704|NCT02555670|Intensive Care|intensive care
163705|NCT02555670|Tomography, X-Ray Computed|tomography, x-ray computed
163706|NCT02555670|Electric Impedance|electric impedance
163707|NCT02555657|PD1|pd1
163708|NCT02555657|PD-1|pd-1
163710|NCT02555657|PD-LI|pd-li
163711|NCT02555644|cancer|cancer
163712|NCT02555631|type 2 diabetes|type 2 diabetes
163713|NCT02555631|prevention|prevention
163714|NCT02555631|men|men
163715|NCT02555618|Vaccine|vaccine
163716|NCT02555605|children|children
163717|NCT02555605|dexmedetomidine|dexmedetomidine
163718|NCT02555605|magnetic resonance imaging scans|magnetic resonance imaging scans
163719|NCT02555605|deep sedation|deep sedation
163720|NCT02555605|adverse respiratory events|adverse respiratory events
163721|NCT02555553|Cognitive behavioral therapy guided self-help|cognitive behavioral therapy guided self-help
163722|NCT02555553|Mobile Mental Health|mobile mental health
163723|NCT02555553|Binge Eating|binge eating
163724|NCT02555553|Cognitive Behavioral Therapy|cognitive behavioral therapy
163725|NCT02555553|Eating Disorder Treatment|eating disorder treatment
163726|NCT02555553|Self-monitoring|self-monitoring
163727|NCT02555553|Eating Disorders|eating disorders
163728|NCT02555553|Ecological Momentary Intervention|ecological momentary intervention
163729|NCT02555501|children|children
163730|NCT02555501|cancer|cancer
163731|NCT02555501|stomatitis|stomatitis
163732|NCT02555501|clinical trial|clinical trial
164133|NCT02552901|AHF|ahf
163733|NCT02555501|laser therapy, low-level|laser therapy, low-level
163734|NCT02555501|methylene blue|methylene blue
163735|NCT02555501|photochemotherapy|photochemotherapy
163736|NCT02555475|Hepatitis C|hepatitis c
163737|NCT02555475|primary care|primary care
163738|NCT02555397|Prostate Cancer|prostate cancer
163739|NCT02555397|Locally Recurrent|locally recurrent
163740|NCT02555397|Gene Therapy|gene therapy
163741|NCT02555397|IL-12|il-12
163742|NCT02555397|Adenovirus|adenovirus
163743|NCT02555371|Severe eosinophilic asthma|severe eosinophilic asthma
163744|NCT02555371|mepolizumab|mepolizumab
163745|NCT02555371|asthma exacerbation|asthma exacerbation
163746|NCT02555358|Resectable advanced gastric cancer|resectable advanced gastric cancer
163747|NCT02555345|classic asthma, cough variant asthma,eosinophilic bronchitis|classic asthma, cough variant asthma,eosinophilic bronchitis
163748|NCT02555319|Pulmonary Valve|pulmonary valve
163749|NCT02555319|Transcatheter Pulmonary Valve|transcatheter pulmonary valve
163750|NCT02555319|Congenital Heart Disease|congenital heart disease
163751|NCT02555306|Macular Degeneration|macular degeneration
163752|NCT02555293|Liver resection|liver resection
163753|NCT02555293|fibrosis|fibrosis
163754|NCT02555293|inflammation|inflammation
163755|NCT02555293|Rifaximin|rifaximin
163756|NCT02555267|geriatric assessment|geriatric assessment
163757|NCT02555267|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
163758|NCT02555267|activity of daily living|activity of daily living
163759|NCT02555267|instrumental activity of daily living|instrumental activity of daily living
163760|NCT02555267|Charlson's comorbidity index|charlson's comorbidity index
163761|NCT02555254|cardiac arrest|cardiac arrest
163762|NCT02555254|targeted temperature management|targeted temperature management
163763|NCT02555254|hypothermia induced|hypothermia induced
163764|NCT02555254|shockable rhythm|shockable rhythm
163765|NCT02555241|ASD, Children|asd, children
163766|NCT02555228|simethicone|simethicone
163767|NCT02555228|gastroscopy|gastroscopy
163768|NCT02555228|McNalley score|mcnalley score
163769|NCT02555215|Pediatrics|pediatrics
163770|NCT02555202|dyspnea|dyspnea
163771|NCT02555163|bladder cancer, laser|bladder cancer, laser
163772|NCT02555137|chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
163773|NCT02555137|pulmonary embolism|pulmonary embolism
163774|NCT02555137|pulmonary hypertension|pulmonary hypertension
163775|NCT02555137|screening|screening
163776|NCT02555137|echocardiography|echocardiography
163777|NCT02555124|Healthy|healthy
163778|NCT02555124|JNJ-42847922|jnj-42847922
163779|NCT02555111|thrombosis|thrombosis
163780|NCT02555072|Yellow Fever Vaccine, immunity evolution|yellow fever vaccine, immunity evolution
163781|NCT02555059|Ciprofloxacin|ciprofloxacin
163782|NCT02555059|Japan|japan
163783|NCT02555059|Post-marketing surveillance|post-marketing surveillance
163784|NCT02555046|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
163785|NCT02555046|Endovascular Procedures|endovascular procedures
163786|NCT02555046|Local Anesthesia|local anesthesia
163787|NCT02555046|General Anesthesia|general anesthesia
163788|NCT02555033|Instability resistance training|instability resistance training
163789|NCT02555033|unstable surface|unstable surface
163790|NCT02555033|elderly people|elderly people
163791|NCT02554994|ASPRA cohort|aspra cohort
163792|NCT02554994|multifactorial intervention|multifactorial intervention
163793|NCT02554994|Medicaid services|medicaid services
163794|NCT02554994|Geriatric disorder|geriatric disorder
163795|NCT02554994|Short Physical Performance Battery|short physical performance battery
163796|NCT02554929|Social Anxiety Disorder|social anxiety disorder
163797|NCT02554929|Selective Mutism|selective mutism
163798|NCT02554929|CBT|cbt
163799|NCT02554929|preschool anxiety disorders|preschool anxiety disorders
163800|NCT02554916|Mobility decline|mobility decline
163801|NCT02554903|LVAD|lvad
163802|NCT02554890|Acute|acute
163803|NCT02554890|Heart Failure|heart failure
163804|NCT02554890|reduced ejection fraction|reduced ejection fraction
163805|NCT02554890|NTproBNP|ntprobnp
163806|NCT02554890|Heart failure with reduced ejection fraction (HFREF)|heart failure with reduced ejection fraction (hfref)
163807|NCT02554838|Specific phobia|specific phobia
163808|NCT02554838|Fear of Falling|fear of falling
163809|NCT02554838|Life-space area|life-space area
163810|NCT02554812|anti PD-L1|anti pd-l1
163811|NCT02554812|anti 4-1BB|anti 4-1bb
163812|NCT02554812|OX40 agonist|ox40 agonist
163813|NCT02554812|anti M-CSF|anti m-csf
163814|NCT02554812|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
163815|NCT02554812|melanoma|melanoma
163816|NCT02554812|squamous cell carcinoma of head and neck (SCCHN)|squamous cell carcinoma of head and neck (scchn)
163817|NCT02554812|triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
163818|NCT02554812|gastric cancer|gastric cancer
163819|NCT02554812|Small cell lung cancer (SCLC)|small cell lung cancer (sclc)
163820|NCT02554812|bladder cancer|bladder cancer
163821|NCT02554812|platinum resistant ovarian cancer|platinum resistant ovarian cancer
163822|NCT02554812|TGCT/PVNS|tgct/pvns
163823|NCT02554786|QMF149, Mometasone furoate (MF), asthma|qmf149, mometasone furoate (mf), asthma
163824|NCT02554773|Hemophilia|hemophilia
163825|NCT02554773|RNAi therapeutic|rnai therapeutic
163826|NCT02554721|Healthy Volunteers|healthy volunteers
163827|NCT02554708|Aneurysm|aneurysm
163828|NCT02554708|bifurcation|bifurcation
163829|NCT02554708|wide neck|wide neck
163830|NCT02554708|pCONus|pconus
163831|NCT02554708|intracerebral|intracerebral
163832|NCT02554708|stroke|stroke
163833|NCT02554695|adrenergic|adrenergic
163834|NCT02554682|Adolescent Health|adolescent health
163835|NCT02554682|Sexual Health|sexual health
163836|NCT02554682|Parent-Teen Communication|parent-teen communication
163837|NCT02554682|Teen Driving|teen driving
163838|NCT02554682|Alcohol Prevention|alcohol prevention
163839|NCT02554669|Blood glucose (indicated by interstitial glucose)|blood glucose (indicated by interstitial glucose)
163840|NCT02554669|Markers of systemic inflammation|markers of systemic inflammation
163841|NCT02554643|intermittent exercise|intermittent exercise
163842|NCT02554643|continuous exercise|continuous exercise
163843|NCT02554643|blood glucose|blood glucose
163844|NCT02554643|intramyocellular lipids|intramyocellular lipids
163845|NCT02554643|diabetes|diabetes
163846|NCT02554643|gene expression|gene expression
163847|NCT02554617|healthy people|healthy people
163848|NCT02554617|fractional exhaled nitric oxide (FeNo)|fractional exhaled nitric oxide (feno)
163849|NCT02554617|factors|factors
163850|NCT02554604|HDL|hdl
163851|NCT02554604|Preeclampsia|preeclampsia
163852|NCT02554604|saliva|saliva
163853|NCT02554578|mHealth|mhealth
163854|NCT02554578|multidisciplinary team|multidisciplinary team
163855|NCT02554578|immunosuppressive medication|immunosuppressive medication
163856|NCT02554578|pharmaceutical care|pharmaceutical care
163857|NCT02554578|adherence|adherence
163858|NCT02554578|heart transplant|heart transplant
163859|NCT02554578|recipients|recipients
163860|NCT02554565|Patients with cervical cancer|patients with cervical cancer
163861|NCT02554552|Osteoarthritis|osteoarthritis
163862|NCT02554526|hemophilia A|hemophilia a
163863|NCT02554526|inhibitor|inhibitor
163864|NCT02554526|bypassing therapy|bypassing therapy
163865|NCT02554526|factor VIII|factor viii
163866|NCT02554513|Apraxia of Speech|apraxia of speech
163867|NCT02554513|Treatment|treatment
163868|NCT02554487|stroke|stroke
163869|NCT02554487|sleep disordered breathing|sleep disordered breathing
163870|NCT02554487|sleep apnea|sleep apnea
163871|NCT02554487|infarct volume|infarct volume
163872|NCT02554487|penumbra|penumbra
163873|NCT02554474|Physical activity|physical activity
163874|NCT02554474|Exercise|exercise
163875|NCT02554474|Rheumatoid|rheumatoid
163876|NCT02554474|Arthritis|arthritis
163877|NCT02554474|Lupus|lupus
163878|NCT02554474|SLE|sle
163879|NCT02554448|Circulating Tumor Cells|circulating tumor cells
163880|NCT02554448|rectal Neoplasms|rectal neoplasms
163881|NCT02554448|neoadjuvant otherapy|neoadjuvant otherapy
163882|NCT02554435|physical activity|physical activity
163883|NCT02554435|activity monitor|activity monitor
163884|NCT02554435|older adults|older adults
163885|NCT02554435|5 A's counseling|5 a's counseling
163886|NCT02554409|Fluzone Quadrivalent Intradermal Influenza Vaccine|fluzone quadrivalent intradermal influenza vaccine
163887|NCT02554409|Pregnancy Registry|pregnancy registry
163888|NCT02554409|Influenza|influenza
163889|NCT02554396|ophthalmology|ophthalmology
163890|NCT02554396|vision|vision
163891|NCT02554396|ocular|ocular
163892|NCT02554383|pediatrics|pediatrics
163893|NCT02554383|antibiotics|antibiotics
163894|NCT02554383|placebo|placebo
163895|NCT02554344|CIN3|cin3
163896|NCT02554344|Squamous CIN3|squamous cin3
163897|NCT02554331|Gait|gait
163898|NCT02554331|REM sleep behavior disorder|rem sleep behavior disorder
163899|NCT02554331|Parkinson's disease|parkinson's disease
163900|NCT02554331|Follow-up|follow-up
163901|NCT02554318|Tempeh|tempeh
163902|NCT02554318|Body weight|body weight
163903|NCT02554318|Handgrip strength|handgrip strength
163904|NCT02554318|6MWT|6mwt
163905|NCT02554318|Supplementation|supplementation
163906|NCT02554318|Wasting|wasting
163907|NCT02554305|efficacy and safety of fusion Oxygenation System|efficacy and safety of fusion oxygenation system
163908|NCT02554305|isolated Coronary Artery Bypass Grafting|isolated coronary artery bypass grafting
163909|NCT02554305|Bypass Grafting|bypass grafting
163910|NCT02554227|Spondylodiscitis|spondylodiscitis
163911|NCT02554227|erosive osteochondrosis|erosive osteochondrosis
163912|NCT02554227|infection|infection
163913|NCT02554227|cytokine profiles|cytokine profiles
163914|NCT02554227|lumbar spine|lumbar spine
163915|NCT02554201|pudendal nerve modulation|pudendal nerve modulation
163916|NCT02554201|transanal/transvaginal electrical stimulation|transanal/transvaginal electrical stimulation
163917|NCT02554188|Dietary Intervention|dietary intervention
163918|NCT02554188|Fasting-mimicking|fasting-mimicking
163919|NCT02554188|Influenza Vaccines|influenza vaccines
163920|NCT02554175|Propofol|propofol
163921|NCT02554175|Schnider model|schnider model
163922|NCT02554162|Satiety, appetite, wholegrain rye|satiety, appetite, wholegrain rye
163923|NCT02554149|total hip|total hip
163924|NCT02554149|stem version|stem version
163925|NCT02554149|replacement|replacement
163926|NCT02554149|hip|hip
164026|NCT02553525|Subthalamic Nucleus|subthalamic nucleus
163927|NCT02554097|laparoscopic transcystic common bile duct exploration|laparoscopic transcystic common bile duct exploration
163928|NCT02554097|laparoscopic common bile duct exploration|laparoscopic common bile duct exploration
163929|NCT02554097|endoscopic sphincterotomy,|endoscopic sphincterotomy,
163930|NCT02554097|cost-effective analysis|cost-effective analysis
163931|NCT02554058|Spinal cord injury|spinal cord injury
163932|NCT02554058|rehabilitation|rehabilitation
163933|NCT02554058|cycling|cycling
163934|NCT02554032|antegrade cerebral perfusion|antegrade cerebral perfusion
163935|NCT02554032|innominate artery cannulation|innominate artery cannulation
163936|NCT02554032|axillary artery cannulation|axillary artery cannulation
163937|NCT02554032|aortic surgery|aortic surgery
163938|NCT02554032|deep hypothermic circulatory arrest|deep hypothermic circulatory arrest
163939|NCT02554019|SLE, Lupus|sle, lupus
163940|NCT02554019|IL10, IL-10, BT063, BT-063|il10, il-10, bt063, bt-063
163941|NCT02553993|Stroke|stroke
163942|NCT02553993|Cognition|cognition
163943|NCT02553993|Exergames|exergames
163944|NCT02553993|Weight shifting|weight shifting
163945|NCT02553993|Balance|balance
163946|NCT02553993|Rehabilitation|rehabilitation
163947|NCT02553980|Physical activity|physical activity
163948|NCT02553980|Information technology|information technology
163949|NCT02553980|Middle-aged|middle-aged
163950|NCT02553980|Health promotion|health promotion
163951|NCT02553967|functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
163952|NCT02553967|Breast reconstructive surgery|breast reconstructive surgery
163953|NCT02553967|Breast Q questionnaire|breast q questionnaire
163954|NCT02553954|Mechanisms of Senescence|mechanisms of senescence
163955|NCT02553954|Senescence markers|senescence markers
163956|NCT02553915|Omega-3|omega-3
163957|NCT02553915|EPA|epa
163958|NCT02553915|Depression|depression
163959|NCT02553915|Overweight|overweight
163960|NCT02553915|Inflammation|inflammation
163961|NCT02553915|Eicosapentaenoic acid|eicosapentaenoic acid
163962|NCT02553902|Positional therapy|positional therapy
163963|NCT02553902|MAD|mad
163964|NCT02553902|Oral appliance|oral appliance
163965|NCT02553902|Sleep position trainer|sleep position trainer
163966|NCT02553902|POSA|posa
163967|NCT02553876|neurostimulation|neurostimulation
163968|NCT02553876|dorsal root ganglion|dorsal root ganglion
163969|NCT02553876|hand pain|hand pain
163970|NCT02553876|upper limb pain|upper limb pain
163971|NCT02553863|chemotherapy induced peripheral neuropathy|chemotherapy induced peripheral neuropathy
163972|NCT02553863|acupuncture|acupuncture
163973|NCT02553863|pain|pain
163974|NCT02553863|cost-effectiveness|cost-effectiveness
163975|NCT02553837|Healthy Volunteers|healthy volunteers
163976|NCT02553824|binge eating|binge eating
163977|NCT02553824|bulimia nervosa|bulimia nervosa
163978|NCT02553824|binge eating disorder|binge eating disorder
163979|NCT02553824|eating disorder treatment|eating disorder treatment
163980|NCT02553811|carpal tunnel syndrome|carpal tunnel syndrome
163981|NCT02553811|clinical examination|clinical examination
163982|NCT02553811|diagnosis|diagnosis
163983|NCT02553811|clinical trial|clinical trial
163984|NCT02553811|median nerve compression|median nerve compression
163985|NCT02553811|accuracy|accuracy
163986|NCT02553811|ultrasonography|ultrasonography
163987|NCT02553811|electromyography|electromyography
163988|NCT02553811|electrodiagnostic testing|electrodiagnostic testing
163989|NCT02553785|BioVentrix|bioventrix
163990|NCT02553785|Revivent|revivent
163991|NCT02553785|Revivent TC|revivent tc
163992|NCT02553759|observed action|observed action
163993|NCT02553759|range of motion|range of motion
163994|NCT02553759|mirror neuron|mirror neuron
163995|NCT02553746|Ultrasound|ultrasound
163996|NCT02553746|Spinal anesthesia|spinal anesthesia
163997|NCT02553746|Epidural anesthesia|epidural anesthesia
163998|NCT02553733|Dietary nitrate supplementation|dietary nitrate supplementation
163999|NCT02553733|Beetroot juice|beetroot juice
164000|NCT02553720|Post thrombotic syndrome|post thrombotic syndrome
164001|NCT02553720|Chronic venous insufficiency|chronic venous insufficiency
164002|NCT02553694|OSA, Apnea|osa, apnea
164003|NCT02553668|Proteomics|proteomics
164004|NCT02553668|Oxygen|oxygen
164005|NCT02553668|Pathways|pathways
164006|NCT02553642|Tumor Mutation|tumor mutation
164007|NCT02553642|Nivolumab|nivolumab
164008|NCT02553642|Nivolumab plus Ipilimumab|nivolumab plus ipilimumab
164009|NCT02553642|Predicted Neo-antigen Burden|predicted neo-antigen burden
164010|NCT02553642|15-126|15-126
164011|NCT02553590|Non Interventional Study|non interventional study
164012|NCT02553590|NIS|nis
164013|NCT02553590|sublingual immunotherapy|sublingual immunotherapy
164014|NCT02553590|allergen|allergen
164015|NCT02553590|tree|tree
164016|NCT02553590|birch|birch
164017|NCT02553590|alder|alder
164018|NCT02553577|prenatal|prenatal
164019|NCT02553577|cytokines|cytokines
164020|NCT02553538|cancer screening|cancer screening
164021|NCT02553538|patient navigation|patient navigation
164022|NCT02553525|Deep Brain Stimulation|deep brain stimulation
164023|NCT02553525|Movement Disorders|movement disorders
164024|NCT02553525|Parkinson Disease|parkinson disease
164025|NCT02553525|Essential Tremor|essential tremor
164027|NCT02553525|Globus Pallidus|globus pallidus
164028|NCT02553525|Thalamus|thalamus
164029|NCT02553525|Tremor|tremor
164030|NCT02553525|Bradykinesia|bradykinesia
164031|NCT02553525|Temporal Pattern|temporal pattern
164032|NCT02553525|Electrical Stimulation|electrical stimulation
164033|NCT02553525|Neuromodulation|neuromodulation
164034|NCT02553525|PD|pd
164035|NCT02553525|ET|et
164036|NCT02553525|MS|ms
164037|NCT02553525|STN|stn
164038|NCT02553525|GPi|gpi
164039|NCT02553525|DBS|dbs
164040|NCT02553525|Nervous System Diseases|nervous system diseases
164041|NCT02553525|Neurodegenerative Diseases|neurodegenerative diseases
164042|NCT02553499|Solid tumor|solid tumor
164043|NCT02553499|PD1|pd1
164044|NCT02553499|PD-L1|pd-l1
164045|NCT02553499|PDL1|pdl1
164046|NCT02553486|adoption|adoption
164047|NCT02553486|children|children
164048|NCT02553486|quality of life|quality of life
164049|NCT02553460|Infants|infants
164050|NCT02553434|pigtail catheter|pigtail catheter
164051|NCT02553434|small-bore catheter|small-bore catheter
164052|NCT02553434|trauma|trauma
164053|NCT02553434|hemothorax|hemothorax
164054|NCT02553421|infiltration|infiltration
164055|NCT02553421|extravasation|extravasation
164056|NCT02553421|peripheral intravenous therapy|peripheral intravenous therapy
164057|NCT02553356|Female Subjects|female subjects
164058|NCT02553343|Influenza|influenza
164059|NCT02553343|High-Dose Quadrivalent Influenza Vaccine|high-dose quadrivalent influenza vaccine
164060|NCT02553343|High-Dose Trivalent Influenza Vaccine|high-dose trivalent influenza vaccine
164061|NCT02553330|Hair loss|hair loss
164062|NCT02553330|alopecia areata|alopecia areata
164063|NCT02553330|alopecia totalis|alopecia totalis
164064|NCT02553330|alopecia universalis|alopecia universalis
164065|NCT02553330|JAK inhibitors|jak inhibitors
164066|NCT02553330|topical hair growth|topical hair growth
164067|NCT02553278|abdominoplasty|abdominoplasty
164068|NCT02553265|Familial dysautonomia (HSAN III)|familial dysautonomia (hsan iii)
164069|NCT02553265|Norepinephrine|norepinephrine
164070|NCT02553265|Sympathetic nervous system|sympathetic nervous system
164071|NCT02553265|Autonomic nervous system|autonomic nervous system
164072|NCT02553265|Blood pressure variability|blood pressure variability
164073|NCT02553265|Hypertension|hypertension
164074|NCT02553265|Carbidopa/Lodosyn|carbidopa/lodosyn
164075|NCT02553265|Afferent baroreflex failure|afferent baroreflex failure
164076|NCT02553265|Clinical trial|clinical trial
164077|NCT02553252|post traumatic stress disorder (PTSD)|post traumatic stress disorder (ptsd)
164078|NCT02553252|Sudarshan Kriya Yoga (SKY)|sudarshan kriya yoga (sky)
164079|NCT02553239|Atrial Fibrillation|atrial fibrillation
164080|NCT02553239|Paroxysmal|paroxysmal
164081|NCT02553239|Cryoablation|cryoablation
164082|NCT02553226|Active phase of labour|active phase of labour
164083|NCT02553226|Discontinuation|discontinuation
164084|NCT02553226|Caesarean section|caesarean section
164085|NCT02553200|intubated patients|intubated patients
164086|NCT02553200|secretion clearance|secretion clearance
164087|NCT02553200|lung function|lung function
164088|NCT02553200|breathing exercise|breathing exercise
164089|NCT02553161|Depression|depression
164090|NCT02553148|prevalence|prevalence
164091|NCT02553148|epidemiology|epidemiology
164092|NCT02553148|palliative care|palliative care
164093|NCT02553148|pediatric|pediatric
164094|NCT02553135|choroideremia, gene therapy|choroideremia, gene therapy
164095|NCT02553122|Blood Loss|blood loss
164096|NCT02553122|Tranexamic Acid|tranexamic acid
164097|NCT02553122|Evicel|evicel
164098|NCT02553109|small paraclinoid|small paraclinoid
164099|NCT02553096|exacerbations|exacerbations
164100|NCT02553096|self-management support|self-management support
164101|NCT02553096|software application|software application
164102|NCT02553031|Application of MR-PET|application of mr-pet
164103|NCT02553005|Acupuncture|acupuncture
164104|NCT02553005|Rheumatoid Arthritis|rheumatoid arthritis
164105|NCT02553005|Quality of life|quality of life
164106|NCT02553005|Hand Strength|hand strength
164107|NCT02552979|atopic dermatitis|atopic dermatitis
164108|NCT02552979|atopic patch test|atopic patch test
164109|NCT02552927|PDA|pda
164110|NCT02552927|Jaundice|jaundice
164111|NCT02552927|Phototherapy|phototherapy
164112|NCT02552914|Colli-Pee|colli-pee
164113|NCT02552914|STI|sti
164114|NCT02552914|first-void urine|first-void urine
164115|NCT02552901|hepatic|hepatic
164116|NCT02552901|liver|liver
164117|NCT02552901|LFT|lft
164118|NCT02552901|hepatic assessment|hepatic assessment
164119|NCT02552901|ICG dye|icg dye
164120|NCT02552901|indocyanine green dye|indocyanine green dye
164121|NCT02552901|Diagnostic Green|diagnostic green
164122|NCT02552901|Pulsion|pulsion
164123|NCT02552901|Akorn|akorn
164124|NCT02552901|Cardiox|cardiox
164125|NCT02552901|anazen|anazen
164126|NCT02552901|essence|essence
164127|NCT02552901|dye detection monitor|dye detection monitor
164128|NCT02552901|Earpads|earpads
164129|NCT02552901|flow sensor|flow sensor
164130|NCT02552901|scaphoid fossa|scaphoid fossa
164131|NCT02552901|liver disease|liver disease
164132|NCT02552901|acute hepatic failure|acute hepatic failure
164134|NCT02552901|NASH|nash
164135|NCT02552901|hepatitis C|hepatitis c
164136|NCT02552901|cirrhosis|cirrhosis
164137|NCT02552901|MELD|meld
164138|NCT02552901|pulse dye densitometry|pulse dye densitometry
164139|NCT02552901|liver transplant|liver transplant
164140|NCT02552901|fluorescence|fluorescence
164141|NCT02552901|near infra-red|near infra-red
164142|NCT02552901|serial blood draws|serial blood draws
164143|NCT02552901|PDR|pdr
164144|NCT02552901|plasma disappearance rate|plasma disappearance rate
164145|NCT02552901|R15|r15
164146|NCT02552901|k coefficient|k coefficient
164147|NCT02552901|transcutaneously|transcutaneously
164148|NCT02552901|liver donor|liver donor
164149|NCT02552901|liver dysfunction|liver dysfunction
164150|NCT02552901|Child-Pugh|child-pugh
164151|NCT02552901|AST|ast
164152|NCT02552901|ALT|alt
164153|NCT02552901|GGT|ggt
164154|NCT02552901|alk phos|alk phos
164155|NCT02552901|prothrombin time|prothrombin time
164156|NCT02552901|albumin|albumin
164157|NCT02552901|serum ICG|serum icg
164158|NCT02552901|liver function tests|liver function tests
164159|NCT02552888|Endothelial Dysfunction|endothelial dysfunction
164160|NCT02552888|Inflammation|inflammation
164161|NCT02552875|Acceleromyography|acceleromyography
164162|NCT02552875|staircase phenomenon|staircase phenomenon
164163|NCT02552875|tetanic stimulation|tetanic stimulation
164164|NCT02552797|Shared Decision Making|shared decision making
164165|NCT02552797|CAMHS|camhs
164166|NCT02552758|violence|violence
164167|NCT02552758|PET|pet
164168|NCT02552758|omega-3 fatty acid|omega-3 fatty acid
164169|NCT02552758|schizophrenia|schizophrenia
164170|NCT02552758|patient|patient
164171|NCT02552719|Injustice Experience|injustice experience
164172|NCT02552719|Questionnaire|questionnaire
164173|NCT02552719|Validation|validation
164174|NCT02552719|German translation|german translation
164175|NCT02552706|probiotics|probiotics
164176|NCT02552706|preterm very low birth weight infants|preterm very low birth weight infants
164177|NCT02552706|necrotizing enterocolitis|necrotizing enterocolitis
164178|NCT02552706|gut microflora|gut microflora
164179|NCT02552706|TLR|tlr
164180|NCT02552706|NF-KB|nf-kb
164181|NCT02552706|inflammatory factors|inflammatory factors
164182|NCT02552693|Enhancing retention|enhancing retention
164183|NCT02552680|Work-Related Musculoskeletal Disorders|work-related musculoskeletal disorders
164184|NCT02552680|Quality of life|quality of life
164185|NCT02552680|Health Education|health education
164186|NCT02552667|Asthma|asthma
164187|NCT02552667|Allergic rhinitis|allergic rhinitis
164188|NCT02552628|Wilson's Disease|wilson's disease
164189|NCT02552628|Deep Brain Stimulation|deep brain stimulation
164190|NCT02552628|dystonia|dystonia
164191|NCT02552615|scoliosis, verticality perception, body symmetry|scoliosis, verticality perception, body symmetry
164192|NCT02552602|HIV|hiv
164193|NCT02552602|Multivitamins|multivitamins
164194|NCT02552589|clinical trial, phase III|clinical trial, phase iii
164195|NCT02552589|plaque index|plaque index
164196|NCT02552589|gingivitis index|gingivitis index
164197|NCT02552589|fluoride|fluoride
164198|NCT02552589|toothpaste|toothpaste
164199|NCT02552550|squamous cell carcinoma of the oropharynx|squamous cell carcinoma of the oropharynx
164200|NCT02552550|swallowing, speech|swallowing, speech
164201|NCT02552550|quality of life|quality of life
164202|NCT02552524|pathological gambling|pathological gambling
164203|NCT02552524|rTMS|rtms
164204|NCT02552524|cognitive tests|cognitive tests
164205|NCT02552524|autonomic nervous system|autonomic nervous system
164206|NCT02552524|craving|craving
164207|NCT02552472|Asthma|asthma
164208|NCT02552472|Inhaler Use|inhaler use
164209|NCT02552472|Adherence|adherence
164210|NCT02552472|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
164211|NCT02552459|dexmedetomidine|dexmedetomidine
164212|NCT02552459|patient controlled analgesia|patient controlled analgesia
164213|NCT02552433|nutritional deficiencies|nutritional deficiencies
164214|NCT02552433|plastic surgery|plastic surgery
164215|NCT02552433|post-bariatric|post-bariatric
164216|NCT02552433|protein|protein
164217|NCT02552433|skin surplus|skin surplus
164218|NCT02552420|infrared thermal imaging|infrared thermal imaging
164219|NCT02552420|deep venous thrombosis|deep venous thrombosis
164220|NCT02552407|thrombectomy|thrombectomy
164221|NCT02552407|acute coronary syndromes|acute coronary syndromes
164222|NCT02552407|percutaneous coronary intervention|percutaneous coronary intervention
164223|NCT02552407|STEMI|stemi
164224|NCT02552381|Cancer|cancer
164225|NCT02552381|Thromboembolic event|thromboembolic event
164226|NCT02552381|Fibrin Structure|fibrin structure
164227|NCT02552381|LMWH|lmwh
164228|NCT02552368|Stroke Rehabilitation|stroke rehabilitation
164229|NCT02552368|BCI|bci
164230|NCT02552368|Stroke|stroke
164231|NCT02552368|Upper Extremity Rehabilitation|upper extremity rehabilitation
164232|NCT02552368|paresis|paresis
164233|NCT02552368|hemiparesis|hemiparesis
164234|NCT02552329|mild cognitive impairment|mild cognitive impairment
164235|NCT02552329|Tai Chi|tai chi
164236|NCT02552329|cognitive functions|cognitive functions
164237|NCT02552316|microbiome|microbiome
164238|NCT02552316|bacteria|bacteria
164239|NCT02552316|NB-UVB Phototherapy|nb-uvb phototherapy
164240|NCT02552316|light therapy|light therapy
164241|NCT02552277|Diabetic|diabetic
164242|NCT02552277|PDA-002|pda-002
164243|NCT02552277|Placenta-Derived Cells|placenta-derived cells
164244|NCT02552277|Peripheral neuropathy|peripheral neuropathy
164245|NCT02552277|Neuropathy|neuropathy
164246|NCT02552277|Double-Blind|double-blind
164247|NCT02552277|Safety|safety
164248|NCT02552277|Efficacy|efficacy
164249|NCT02552277|Human Placenta-derived Cells|human placenta-derived cells
164250|NCT02552238|Lumason|lumason
164251|NCT02552238|Dobutamine stress echo|dobutamine stress echo
164252|NCT02552238|stress echo|stress echo
164253|NCT02552238|coronary artery disease|coronary artery disease
164254|NCT02552225|laryngeal sensory neuropathy, chronic laryngeal neuropathy|laryngeal sensory neuropathy, chronic laryngeal neuropathy
164255|NCT02552212|Axial Spondyloarthritis|axial spondyloarthritis
164256|NCT02552212|axSpA|axspa
164257|NCT02552212|Ankylosing Spondylitis|ankylosing spondylitis
164258|NCT02552212|Anti TNF-alpha|anti tnf-alpha
164259|NCT02552212|Certolizumab Pegol|certolizumab pegol
164260|NCT02552212|Nr-axSpA|nr-axspa
164261|NCT02552212|Non-radiographic|non-radiographic
164262|NCT02552212|Spondylarthropathies|spondylarthropathies
164263|NCT02552212|Arthritis|arthritis
164264|NCT02552212|Spinal Diseases|spinal diseases
164265|NCT02552212|Immunosuppressive Agents|immunosuppressive agents
164266|NCT02552160|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
164267|NCT02552160|Fixed-dose Combination|fixed-dose combination
164268|NCT02552160|LAMA/LABA (Long Acting Beta2-Agonists / Long Acting Muscarinic Antagonists)|lama/laba (long acting beta2-agonists / long acting muscarinic antagonists)
164269|NCT02552160|Inhaler|inhaler
164270|NCT02552160|Aclidinium/Formoterol|aclidinium/formoterol
164271|NCT02552160|Glycopyrronium/Indacaterol|glycopyrronium/indacaterol
164272|NCT02552160|Umeclidinium/Vilanterol|umeclidinium/vilanterol
164273|NCT02552147|Autism spectrum disorder|autism spectrum disorder
164274|NCT02552147|Aggression|aggression
164275|NCT02552147|Irritability|irritability
164276|NCT02552147|Nicotine|nicotine
164277|NCT02552147|Nicotinic acetylcholine receptor|nicotinic acetylcholine receptor
164278|NCT02552147|Nicotinic agonist|nicotinic agonist
164279|NCT02552147|Adult autism|adult autism
164280|NCT02552134|Access to physical activity resources, community based exercise programme, sports-clubs, health resort,|access to physical activity resources, community based exercise programme, sports-clubs, health resort,
164281|NCT02552121|ovary cancer|ovary cancer
164282|NCT02552121|cervix cancer|cervix cancer
164283|NCT02552121|endometrium cancer|endometrium cancer
164284|NCT02552121|bladder cancer|bladder cancer
164285|NCT02552121|prostate cancer (CRPC)|prostate cancer (crpc)
164286|NCT02552121|esophagus cancer|esophagus cancer
164287|NCT02552121|lung cancer (NSCLC)|lung cancer (nsclc)
164288|NCT02552108|Cognitive-behavioural therapy|cognitive-behavioural therapy
164289|NCT02552056|Child Adolescent Mental Integration PHC Traditional Healers|child adolescent mental integration phc traditional healers
164290|NCT02552043|Cystic fibrosis|cystic fibrosis
164291|NCT02552043|Exercise capacity|exercise capacity
164292|NCT02552043|Interactive gaming console|interactive gaming console
164293|NCT02552043|Pulmonary rehabilitation|pulmonary rehabilitation
164294|NCT02552017|adenoma detection rate|adenoma detection rate
164295|NCT02552017|Endocuff|endocuff
164296|NCT02552017|Endocuff Vision|endocuff vision
164297|NCT02552017|colonoscopy|colonoscopy
164298|NCT02552017|bowel cancer screening|bowel cancer screening
164299|NCT02552017|bowel cancer|bowel cancer
164300|NCT02552004|pCLE|pcle
164301|NCT02552004|Digestive surgery|digestive surgery
164302|NCT02552004|Endocrine surgery|endocrine surgery
164303|NCT02551991|Pancreatic cancer|pancreatic cancer
164304|NCT02551991|MM-398|mm-398
164305|NCT02551991|Metastatic pancreatic cancer|metastatic pancreatic cancer
164306|NCT02551991|First line pancreatic cancer treatment|first line pancreatic cancer treatment
164307|NCT02551978|obesity|obesity
164308|NCT02551978|child|child
164309|NCT02551978|primary prevention|primary prevention
164310|NCT02551978|serious game|serious game
164311|NCT02551978|nutrition|nutrition
164312|NCT02551978|physical activity|physical activity
164313|NCT02551978|psychosocial|psychosocial
164314|NCT02551978|stress|stress
164315|NCT02551978|knowledge|knowledge
164316|NCT02551978|diet|diet
164317|NCT02551965|Cancer|cancer
164318|NCT02551965|Patient|patient
164319|NCT02551965|Oncology|oncology
164320|NCT02551965|Caregiver|caregiver
164321|NCT02551952|Games|games
164322|NCT02551952|Cognitive Tests|cognitive tests
164323|NCT02551952|General Anesthesia|general anesthesia
164324|NCT02551952|Surgery|surgery
164325|NCT02551913|Psychological Theory|psychological theory
164326|NCT02551913|adolescents|adolescents
164327|NCT02551900|Type 2 Diabetes|type 2 diabetes
164328|NCT02551900|Vascular Function|vascular function
164329|NCT02551900|Water Exercise|water exercise
164330|NCT02551900|Warm Water|warm water
164331|NCT02551900|Cold Water|cold water
164332|NCT02551887|HPV Vaccinations|hpv vaccinations
164720|NCT02549534|Paclitaxel|paclitaxel
164333|NCT02551887|Quadrivalent Vaccine|quadrivalent vaccine
164334|NCT02551848|Movement disorders|movement disorders
164335|NCT02551848|Botulinum toxin type A|botulinum toxin type a
164336|NCT02551848|Kinematics|kinematics
164337|NCT02551835|ODIN|odin
164338|NCT02551835|Meta-analysis|meta-analysis
164339|NCT02551835|Cholecalciferol|cholecalciferol
164341|NCT02551835|Subgroup effects|subgroup effects
164342|NCT02551822|Urge Urinary Incontinence, sacral neuromodulation|urge urinary incontinence, sacral neuromodulation
164343|NCT02551796|lenticule extraction|lenticule extraction
164344|NCT02551796|laser in situ keratomileusis|laser in situ keratomileusis
164345|NCT02551796|femtosecond laser-assisted laser in situ keratomileusis|femtosecond laser-assisted laser in situ keratomileusis
164346|NCT02551796|tear|tear
164347|NCT02551796|inflammatory mediators|inflammatory mediators
164348|NCT02551783|urethral stricture|urethral stricture
164349|NCT02551783|urethroplasty|urethroplasty
164350|NCT02551783|buccal mucosa|buccal mucosa
164351|NCT02551783|graft|graft
164352|NCT02551757|Rehabilitation|rehabilitation
164353|NCT02551757|Continuous Positive Airway Pressure|continuous positive airway pressure
164354|NCT02551744|histamine-2 receptor antagonist|histamine-2 receptor antagonist
164355|NCT02551744|proton pump inhibitor|proton pump inhibitor
164356|NCT02551744|thienopyridine|thienopyridine
164357|NCT02551744|clopidogrel|clopidogrel
164358|NCT02551744|prevention|prevention
164359|NCT02551679|Stem cells|stem cells
164360|NCT02551679|Endothelial progenitor cells|endothelial progenitor cells
164361|NCT02551679|Autologous cells|autologous cells
164362|NCT02551679|Vascular disease|vascular disease
164363|NCT02551679|Peripheral arterial disease|peripheral arterial disease
164364|NCT02551679|Regenerative medicine|regenerative medicine
164365|NCT02551653|Idiopathic Pulmonary Arterial Hypertension|idiopathic pulmonary arterial hypertension
164366|NCT02551653|Biodistribution|biodistribution
164367|NCT02551653|Positron Emission Tomography|positron emission tomography
164368|NCT02551653|[11C]-GSK2256098|[11c]-gsk2256098
164369|NCT02551653|Healthy subjects|healthy subjects
164370|NCT02551614|lipopolysaccharide|lipopolysaccharide
164371|NCT02551614|COPD|copd
164372|NCT02551614|neutrophil|neutrophil
164373|NCT02551601|subfoveal choroidal thickness|subfoveal choroidal thickness
164374|NCT02551601|optical coherence tomography|optical coherence tomography
164375|NCT02551601|enhanced depth imaging|enhanced depth imaging
164376|NCT02551588|fibrosis|fibrosis
164377|NCT02551588|Magnetic resonance imaging|magnetic resonance imaging
164378|NCT02551549|Subjects|subjects
164379|NCT02551536|Allergic rhinitis|allergic rhinitis
164380|NCT02551536|montelukast|montelukast
164381|NCT02551536|fexofenadine|fexofenadine
164382|NCT02551536|levocetrizine|levocetrizine
164383|NCT02551510|Skin Adhesive|skin adhesive
164384|NCT02551510|Suture|suture
164385|NCT02551510|Port Incisions|port incisions
164386|NCT02551497|volunteer drug interaction study|volunteer drug interaction study
164387|NCT02551471|Locally advanced rectal cancer|locally advanced rectal cancer
164388|NCT02551471|Fixed primary rectal cancer|fixed primary rectal cancer
164389|NCT02551471|Pelvic recurrence|pelvic recurrence
164390|NCT02551471|Benchmarking France Australia|benchmarking france australia
164391|NCT02551432|pembrolizumab|pembrolizumab
164392|NCT02551432|paclitaxel|paclitaxel
164393|NCT02551419|mild cognitive impairment|mild cognitive impairment
164394|NCT02551419|ketones|ketones
164395|NCT02551419|medium chain triglycerides|medium chain triglycerides
164396|NCT02551419|Positron emission tomography|positron emission tomography
164397|NCT02551419|magnetic resonance imaging|magnetic resonance imaging
164398|NCT02551419|cognition|cognition
164399|NCT02551419|brain|brain
164400|NCT02551419|neuroimaging|neuroimaging
164401|NCT02551406|nocturnal hypoventilation|nocturnal hypoventilation
164402|NCT02551406|capno-oxymetry|capno-oxymetry
164403|NCT02551393|Older adults|older adults
164404|NCT02551393|Home Blood Pressure Monitoring|home blood pressure monitoring
164405|NCT02551367|letrozole|letrozole
164406|NCT02551354|Labor, Obstetric|labor, obstetric
164407|NCT02551354|pain|pain
164408|NCT02551354|pupil diameter|pupil diameter
164409|NCT02551354|Visual Analogic Scale (VAS)|visual analogic scale (vas)
164410|NCT02551341|prostatectomy|prostatectomy
164411|NCT02551341|robotic|robotic
164412|NCT02551315|Intra-cortical pore volume|intra-cortical pore volume
164413|NCT02551315|HR-pQCT|hr-pqct
164414|NCT02551315|DXA|dxa
164415|NCT02551315|bone mineral density|bone mineral density
164416|NCT02551315|bone turnover markers|bone turnover markers
164417|NCT02551315|urinary pentosidine|urinary pentosidine
164418|NCT02551289|MRI|mri
164419|NCT02551289|Gluten|gluten
164420|NCT02551289|Imaging|imaging
164421|NCT02551289|Enteropathy-Associated T-Cell Lymphoma|enteropathy-associated t-cell lymphoma
164422|NCT02551263|Breast Cancer|breast cancer
164423|NCT02551263|Eribulin|eribulin
164424|NCT02551263|HER2-negative|her2-negative
164425|NCT02551263|hormone-resistant|hormone-resistant
164426|NCT02551263|inoperable|inoperable
164427|NCT02551263|recurrent metastatic|recurrent metastatic
164428|NCT02551250|hepatocellular carcinoma|hepatocellular carcinoma
164429|NCT02551250|surveillance|surveillance
164430|NCT02551250|liver cirrhosis|liver cirrhosis
164431|NCT02551250|ultrasonography|ultrasonography
164432|NCT02551250|magnetic resonance imaging|magnetic resonance imaging
164433|NCT02551237|Elderly patient|elderly patient
164434|NCT02551237|Radiotherapy|radiotherapy
164435|NCT02551237|Radio chemotherapy|radio chemotherapy
164436|NCT02551237|Neoadjuvant treatment|neoadjuvant treatment
164437|NCT02551224|COPD|copd
164438|NCT02551198|polyethylene glycol with ascorbic acid|polyethylene glycol with ascorbic acid
164439|NCT02551198|oral sulfate solution|oral sulfate solution
164440|NCT02551198|bowel preparation|bowel preparation
164441|NCT02551159|programmed cell death ligand 1 (PD-L1), MEDI4736, Cytotoxic T-lymphocyte-associated antigen 4 {CTLA-4}, PFS, SCCHN|programmed cell death ligand 1 (pd-l1), medi4736, cytotoxic t-lymphocyte-associated antigen 4 {ctla-4}, pfs, scchn
164442|NCT02551133|Dexamethasone|dexamethasone
164443|NCT02551133|mastectomy|mastectomy
164444|NCT02551133|persistent surgical pain|persistent surgical pain
164445|NCT02551120|Idiopathic hypoparathyroidism|idiopathic hypoparathyroidism
164446|NCT02551120|Autosomal dominant hypocalcaemia|autosomal dominant hypocalcaemia
164447|NCT02551120|Pseudohypoparathyroidism|pseudohypoparathyroidism
164448|NCT02551120|Quality of Life|quality of life
164449|NCT02551120|Bone Mineral Density|bone mineral density
164450|NCT02551120|Muscle strength|muscle strength
164451|NCT02551120|Cardiovascular indices|cardiovascular indices
164452|NCT02551055|Drug Therapy|drug therapy
164453|NCT02551042|Digital Ulcers|digital ulcers
164454|NCT02551042|Raynauds Phenomenon|raynauds phenomenon
164455|NCT02551042|Factor XIII|factor xiii
164456|NCT02551029|Magnetic Resonance Imaging|magnetic resonance imaging
164457|NCT02551029|Brainstem|brainstem
164458|NCT02551029|Solitary Nucleus|solitary nucleus
164459|NCT02551029|Visceral Nervous System|visceral nervous system
164460|NCT02551029|Transient Receptor Potential Channels|transient receptor potential channels
164461|NCT02550977|Contraception|contraception
164462|NCT02550977|Transdermal contraceptive patch|transdermal contraceptive patch
164463|NCT02550977|Safety|safety
164464|NCT02550977|Efficacy|efficacy
164465|NCT02550977|Pharmacokinetic|pharmacokinetic
164466|NCT02550964|Autoimmune Disease|autoimmune disease
164467|NCT02550964|Rheumatoid Arthritis|rheumatoid arthritis
164468|NCT02550964|Systemic Lupus Erythematosus|systemic lupus erythematosus
164469|NCT02550964|Hydroxychloroquine(HCQ)|hydroxychloroquine(hcq)
164470|NCT02550964|Chloroquine(CQ)|chloroquine(cq)
164471|NCT02550964|Toxic Maculopathy|toxic maculopathy
164472|NCT02550925|Cancer survivors|cancer survivors
164473|NCT02550886|Work Burden|work burden
164474|NCT02550886|Ambulatory Orthopedic Surgery|ambulatory orthopedic surgery
164475|NCT02550886|Anesthesiology|anesthesiology
164476|NCT02550886|Perioperative Care|perioperative care
164477|NCT02550860|intravenous fat emulsions|intravenous fat emulsions
164478|NCT02550860|parenteral nutrition|parenteral nutrition
164479|NCT02550860|skin barrier function|skin barrier function
164480|NCT02550860|essential fatty acids|essential fatty acids
164481|NCT02550860|transepidermal water loss|transepidermal water loss
164482|NCT02550847|MR/PET|mr/pet
164483|NCT02550847|pancreatic cancer|pancreatic cancer
164484|NCT02550834|Core stability|core stability
164485|NCT02550834|Indoors curling exercises|indoors curling exercises
164486|NCT02550834|Motivation|motivation
164487|NCT02550821|Physical activity levels|physical activity levels
164488|NCT02550821|Bronchiectasis|bronchiectasis
164489|NCT02550782|perineural dexmedetomidine|perineural dexmedetomidine
164490|NCT02550782|infraclavicular perineural catheter|infraclavicular perineural catheter
164491|NCT02550782|postoperative analgesia|postoperative analgesia
164492|NCT02550769|Transanal NOTES|transanal notes
164493|NCT02550769|Transanal TME|transanal tme
164494|NCT02550769|Laparoscopic Low Anterior Resection|laparoscopic low anterior resection
164495|NCT02550769|Surgery|surgery
164496|NCT02550743|Stage II|stage ii
164497|NCT02550743|Stage III|stage iii
164498|NCT02550743|Stage IV|stage iv
164499|NCT02550743|metastatic|metastatic
164500|NCT02550717|Low-dose Acetylsalicylic Acid,|low-dose acetylsalicylic acid,
164501|NCT02550717|Bleeding,|bleeding,
164502|NCT02550717|The Health Improvement Network (THIN),|the health improvement network (thin),
164503|NCT02550717|Cardiovascular|cardiovascular
164504|NCT02550717|Secondary prevention of cardiovascular events|secondary prevention of cardiovascular events
164505|NCT02550704|Irritable Bowel syndrome|irritable bowel syndrome
164506|NCT02550704|Intestinal permeability|intestinal permeability
164507|NCT02550704|Visceral hypersensitivity|visceral hypersensitivity
164508|NCT02550704|Low grade inflammation|low grade inflammation
164509|NCT02550678|Untreated nBCC|untreated nbcc
164510|NCT02550678|Low-Risk|low-risk
164511|NCT02550665|Alzheimer's disease|alzheimer's disease
164512|NCT02550665|donepezil|donepezil
164513|NCT02550626|delirium|delirium
164514|NCT02550626|alpha synucleinopathy|alpha synucleinopathy
164515|NCT02550626|spine surgery|spine surgery
164516|NCT02550613|MR/PET, hepatocellular carcinoma, HCC|mr/pet, hepatocellular carcinoma, hcc
164517|NCT02550600|ARDS|ards
164518|NCT02550600|Acute lung impairment|acute lung impairment
164519|NCT02550600|Extracorporeal lung assist|extracorporeal lung assist
164520|NCT02550600|ECMO|ecmo
164521|NCT02550600|ECLA|ecla
164522|NCT02550600|Murray-score|murray-score
164523|NCT02550600|SOFA-score|sofa-score
164524|NCT02550587|Patient Satisfaction|patient satisfaction
164525|NCT02550587|anesthesia Care|anesthesia care
164526|NCT02550561|Posterior tibial nerve stimulation|posterior tibial nerve stimulation
164527|NCT02550561|PTNS|ptns
164528|NCT02550561|IC|ic
164529|NCT02550548|Incretins|incretins
164530|NCT02550548|GLP-1|glp-1
164531|NCT02550548|GIP|gip
164532|NCT02550548|hyperglycemic clamp|hyperglycemic clamp
164533|NCT02550535|Gene Therapy|gene therapy
164534|NCT02550535|WT1 TCR|wt1 tcr
164535|NCT02550535|Gene modified T cels|gene modified t cels
164536|NCT02550522|without associated head injury|without associated head injury
164537|NCT02550509|stroke|stroke
164538|NCT02550509|Botulinum toxin|botulinum toxin
164539|NCT02550509|Muscle alterations|muscle alterations
164540|NCT02550483|Healthy volunteers|healthy volunteers
164541|NCT02550444|Clonidine|clonidine
164542|NCT02550444|Anesthesia, Obstetrical|anesthesia, obstetrical
164543|NCT02550379|Social Anxiety|social anxiety
164544|NCT02550379|Social Phobia|social phobia
164545|NCT02550379|Depression|depression
164546|NCT02550379|Emotion Recognition Training|emotion recognition training
164547|NCT02550366|Cardiac MRI|cardiac mri
164548|NCT02550366|Accelerate imaging|accelerate imaging
164549|NCT02550366|coronary artery disease|coronary artery disease
164550|NCT02550353|lenticule extraction|lenticule extraction
164551|NCT02550353|femtosecond laser-assisted laser in situ keratomileusis|femtosecond laser-assisted laser in situ keratomileusis
164552|NCT02550353|tear|tear
164553|NCT02550353|inflammatory mediators|inflammatory mediators
164554|NCT02550340|Arrhythmia|arrhythmia
164555|NCT02550340|Alcohol|alcohol
164556|NCT02550340|ECG|ecg
164557|NCT02550327|resectable|resectable
164558|NCT02550327|potentially resectable|potentially resectable
164559|NCT02550327|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
164560|NCT02550327|PDAC|pdac
164561|NCT02550301|mean platelet volume|mean platelet volume
164562|NCT02550262|Epidural|epidural
164563|NCT02550262|Labor analgesia|labor analgesia
164564|NCT02550262|Programmed intermittent epidural bolus|programmed intermittent epidural bolus
164565|NCT02550236|Children|children
164566|NCT02550236|Obesity|obesity
164567|NCT02550236|Pregnancy|pregnancy
164568|NCT02550236|Growth|growth
164569|NCT02550236|Lifestyle|lifestyle
164570|NCT02550236|Metabolic and cardiovascular health|metabolic and cardiovascular health
164571|NCT02550236|Birth|birth
164572|NCT02550236|Development|development
164573|NCT02550210|Breast Conserving Surgery|breast conserving surgery
164574|NCT02550210|Breast Imaging|breast imaging
164575|NCT02550210|Breast Diagnostics|breast diagnostics
164576|NCT02550197|Influenza|influenza
164577|NCT02550197|Quadrivalent influenza vaccine|quadrivalent influenza vaccine
164578|NCT02550197|Trivalent influenza vaccine|trivalent influenza vaccine
164579|NCT02550184|Patients with symptoms of acute respiratory problems|patients with symptoms of acute respiratory problems
164580|NCT02550171|Biobank|biobank
164581|NCT02550171|Genetics|genetics
164582|NCT02550171|DNA|dna
164583|NCT02550171|Cohort|cohort
164584|NCT02550171|normal control|normal control
164585|NCT02550158|Crohn's Disease|crohn's disease
164586|NCT02550158|Ulcerative Colitis|ulcerative colitis
164587|NCT02550158|Educational program|educational program
164588|NCT02550158|Inflammatory Bowel Disease|inflammatory bowel disease
164589|NCT02550158|Psycho-pedagogic score|psycho-pedagogic score
164590|NCT02550158|IBD|ibd
164591|NCT02550145|Hyperinsulinemic|hyperinsulinemic
164592|NCT02550145|post-bariatric surgery|post-bariatric surgery
164593|NCT02550132|electromyography|electromyography
164594|NCT02550132|biomechanical phenomena|biomechanical phenomena
164595|NCT02550132|dose-response relationship|dose-response relationship
164596|NCT02550132|musculoskeletal manipulations|musculoskeletal manipulations
164597|NCT02550132|spinal manipulation|spinal manipulation
164598|NCT02550106|CHRONIC SPONTANEOUS URTICARIA, OMALIZUMAB, URTICARIA CONTROL TEST|chronic spontaneous urticaria, omalizumab, urticaria control test
164599|NCT02550093|Volunteers|volunteers
164600|NCT02550067|HIV infection|hiv infection
164601|NCT02550067|DepoLevonorgestrel|depolevonorgestrel
164602|NCT02550067|Contraception|contraception
164603|NCT02550067|DMPA|dmpa
164604|NCT02550067|Copper IUD|copper iud
164605|NCT02550067|Levonorgestrel implant|levonorgestrel implant
164606|NCT02550067|IUD|iud
164607|NCT02550041|Bronchitis aspergillus|bronchitis aspergillus
164608|NCT02550041|cystic fibrosis|cystic fibrosis
164609|NCT02550028|Neonates|neonates
164610|NCT02550028|Seizure|seizure
164611|NCT02550015|Exercise training|exercise training
164612|NCT02550015|Oxygen consumption|oxygen consumption
164613|NCT02549989|LY3023414|ly3023414
164614|NCT02549989|15-079|15-079
164615|NCT02549989|Persistent Endometrial Cancer|persistent endometrial cancer
164616|NCT02549976|Crohn's Disease|crohn's disease
164617|NCT02549976|Digestive Damage|digestive damage
164618|NCT02549976|Lemann Index|lemann index
164619|NCT02549950|Accelerated orthodontic tooth movement (AOTM)|accelerated orthodontic tooth movement (aotm)
164620|NCT02549950|Peizo-corticission|peizo-corticission
164621|NCT02549924|Resveratrol|resveratrol
164622|NCT02549924|Glycemic Variability|glycemic variability
164623|NCT02549924|MAGE|mage
164624|NCT02549911|chemotherapy|chemotherapy
164625|NCT02549911|surgery|surgery
164626|NCT02549911|Surgically-Created Resection Cavity|surgically-created resection cavity
164627|NCT02549911|Adverse Reaction to Drug|adverse reaction to drug
164628|NCT02549885|Migraine disorders|migraine disorders
164629|NCT02549885|Muscle stretching exercises|muscle stretching exercises
164630|NCT02549872|Dementia|dementia
164631|NCT02549872|Validity|validity
164632|NCT02549872|Mortality|mortality
164633|NCT02549872|Electronic health records|electronic health records
164634|NCT02549859|DBS|dbs
164635|NCT02549859|Low frequency stimulation|low frequency stimulation
164636|NCT02549859|Dysphagia|dysphagia
164637|NCT02549859|Freezing of gait|freezing of gait
164638|NCT02549833|low-grade glioma|low-grade glioma
164639|NCT02549833|WHO grade II|who grade ii
164640|NCT02549833|vaccine|vaccine
164641|NCT02549833|immunotherapy|immunotherapy
164642|NCT02549833|glioma|glioma
164643|NCT02549820|Congenital Diaphragmatic Hernia|congenital diaphragmatic hernia
164644|NCT02549820|Tracheal Occlusion|tracheal occlusion
164645|NCT02549807|Vascular hemiplegia|vascular hemiplegia
164646|NCT02549807|2D ultrasound|2d ultrasound
164647|NCT02549807|Muscle elasticity|muscle elasticity
164648|NCT02549807|Pennation angle|pennation angle
164649|NCT02549794|low concentration contrast agent|low concentration contrast agent
164650|NCT02549794|Low dose contrast agent|low dose contrast agent
164651|NCT02549794|computed tomography|computed tomography
164652|NCT02549781|pathological gambler|pathological gambler
164653|NCT02549781|Go-Nogo test|go-nogo test
164654|NCT02549768|Dexmedetomidine|dexmedetomidine
164655|NCT02549768|Pituitary|pituitary
164656|NCT02549768|Transsphenoidal|transsphenoidal
164657|NCT02549768|Cortisol|cortisol
164658|NCT02549742|Electrochemotherapy|electrochemotherapy
164659|NCT02549742|head neck cancer|head neck cancer
164660|NCT02549742|bleomycin|bleomycin
164661|NCT02549716|Acetaminophen|acetaminophen
164662|NCT02549716|interleukin-6|interleukin-6
164663|NCT02549716|interleukin-1|interleukin-1
164664|NCT02549716|thromboxane A2|thromboxane a2
164665|NCT02549703|multiple sclerosis|multiple sclerosis
164666|NCT02549703|progressive multiple sclerosis|progressive multiple sclerosis
164667|NCT02549703|mitochondria|mitochondria
164668|NCT02549703|neurodegeneration|neurodegeneration
164669|NCT02549690|IVF, Testosterone gel, DHEA, poor responder.|ivf, testosterone gel, dhea, poor responder.
164670|NCT02549664|Hypertrophic Cardiomyopathy (HCM)|hypertrophic cardiomyopathy (hcm)
164671|NCT02549664|Long QT Syndrome (LQTS)|long qt syndrome (lqts)
164672|NCT02549651|DLBCL|dlbcl
164673|NCT02549651|MEDI4736|medi4736
164674|NCT02549651|durvalumab|durvalumab
164675|NCT02549651|tremelimumab|tremelimumab
164676|NCT02549651|AZD9150|azd9150
164677|NCT02549651|anti-PD-L1|anti-pd-l1
164678|NCT02549651|anti-CTLA-4|anti-ctla-4
164679|NCT02549651|immunotherapy|immunotherapy
164680|NCT02549651|IMTC|imtc
164681|NCT02549651|STAT3|stat3
164682|NCT02549625|Single right ventricular failure|single right ventricular failure
164683|NCT02549612|Conductive hearing loss|conductive hearing loss
164684|NCT02549612|middle ear pressure equalization|middle ear pressure equalization
164685|NCT02549612|middle ear effusion|middle ear effusion
164686|NCT02549599|Digital and mobile health|digital and mobile health
164687|NCT02549599|Sexual and reproductive health|sexual and reproductive health
164688|NCT02549599|Adolescents and young adults|adolescents and young adults
164689|NCT02549586|solid organ transplant|solid organ transplant
164690|NCT02549586|immune tolerance|immune tolerance
164691|NCT02549586|autologous stem cell transplant|autologous stem cell transplant
164692|NCT02549586|blood and marrow transplant|blood and marrow transplant
164693|NCT02549586|autoimmune disease|autoimmune disease
164694|NCT02549573|Motor Symptoms|motor symptoms
164695|NCT02549573|Parkinson's disease|parkinson's disease
164696|NCT02549573|Apokyn|apokyn
164697|NCT02549573|Apomorphine|apomorphine
164698|NCT02549573|PD|pd
164699|NCT02549560|tDCS|tdcs
164700|NCT02549560|Cardiac Surgery|cardiac surgery
164701|NCT02549547|anxiety|anxiety
164702|NCT02549547|depression|depression
164703|NCT02549547|exercise|exercise
164704|NCT02549547|group|group
164705|NCT02549547|group medical visit|group medical visit
164706|NCT02549547|mood disorder|mood disorder
164707|NCT02549547|physical activity|physical activity
164708|NCT02549547|primary care|primary care
164709|NCT02549534|Taxane|taxane
164710|NCT02549534|Neuropathy|neuropathy
164711|NCT02549534|Chemotherapy-Induced Peripheral Neuropathy (CIPN)|chemotherapy-induced peripheral neuropathy (cipn)
164712|NCT02549534|Breast Cancer|breast cancer
164713|NCT02549534|Local skin heating|local skin heating
164714|NCT02549534|Axon reflex|axon reflex
164715|NCT02549534|Axon flare|axon flare
164716|NCT02549534|Total Neuropathy Score (TNS)|total neuropathy score (tns)
164717|NCT02549534|Laser Doppler Flowmetry (LDF)|laser doppler flowmetry (ldf)
164718|NCT02549534|Laser Speckle Contrast Imaging (LSCI)|laser speckle contrast imaging (lsci)
164719|NCT02549534|Full-field laser perfusion imaging (FLPI)|full-field laser perfusion imaging (flpi)
164721|NCT02549534|Taxol|taxol
164722|NCT02549521|calcium|calcium
164723|NCT02549521|magnesium|magnesium
164724|NCT02549521|vitamin D|vitamin d
164725|NCT02549521|bone turnover markers|bone turnover markers
164726|NCT02549482|Central volume deficit|central volume deficit
164727|NCT02549482|Head-up tilt|head-up tilt
164728|NCT02549482|Systolic pressure variation|systolic pressure variation
164729|NCT02549456|natural orifice surgery|natural orifice surgery
164730|NCT02549456|natural orifice specimen extraction|natural orifice specimen extraction
164731|NCT02549456|taTME|tatme
164732|NCT02549443|Catabolic response|catabolic response
164733|NCT02549443|Amino Acids|amino acids
164734|NCT02549443|Insulin|insulin
164735|NCT02549430|Advanced breast cancer|advanced breast cancer
164736|NCT02549430|Postmenopausal|postmenopausal
164737|NCT02549430|ER positive|er positive
164738|NCT02549430|Her2 negative|her2 negative
164739|NCT02549378|microcirculation|microcirculation
164740|NCT02549378|confocal microscopy|confocal microscopy
164741|NCT02549378|hypocapnia|hypocapnia
164742|NCT02549326|Vitamin D|vitamin d
164743|NCT02549313|brain lesion|brain lesion
164744|NCT02549313|intracranial pressure|intracranial pressure
164745|NCT02549313|cerebral perfusion pressure|cerebral perfusion pressure
164746|NCT02549300|connective tissue massage|connective tissue massage
164747|NCT02549300|adolescent tension-type headache|adolescent tension-type headache
164748|NCT02549274|Cervicalgia|cervicalgia
164749|NCT02549274|self-rehabilitation|self-rehabilitation
164750|NCT02549274|physiotherapy|physiotherapy
164751|NCT02549261|nimotuzumab|nimotuzumab
164752|NCT02549261|non-small cell lung cancer|non-small cell lung cancer
164753|NCT02549261|radiochemotherapy|radiochemotherapy
164754|NCT02549261|stage IIIA/IIIB non-small cell lung cancer|stage iiia/iiib non-small cell lung cancer
164755|NCT02549248|Interstitial Lung Diseases|interstitial lung diseases
164756|NCT02549248|nanoparticles|nanoparticles
164757|NCT02549248|lung|lung
164758|NCT02549248|broncho-alveolar lavage|broncho-alveolar lavage
164759|NCT02549248|bronchial washings|bronchial washings
164760|NCT02549235|IVF|ivf
164761|NCT02549235|Miscarriage|miscarriage
164762|NCT02549235|Uterine septum|uterine septum
164763|NCT02549222|pathogen reduction|pathogen reduction
164764|NCT02549222|INTERCEPT|intercept
164765|NCT02549222|platelet|platelet
164766|NCT02549222|pulmonary|pulmonary
164767|NCT02549222|ARDS|ards
164768|NCT02549222|hematology|hematology
164769|NCT02549222|oncology|oncology
164770|NCT02549222|assisted ventilation|assisted ventilation
164771|NCT02549222|transfusion of platelet components|transfusion of platelet components
164772|NCT02549222|hematology-oncology patients|hematology-oncology patients
164773|NCT02549209|Pembrolizumab|pembrolizumab
164774|NCT02549209|Keytruda|keytruda
164775|NCT02549209|Anti-Programmed [Cell] Death Protein 1 (PD-1) Antibody|anti-programmed [cell] death protein 1 (pd-1) antibody
164776|NCT02549209|Carboplatin|carboplatin
164777|NCT02549209|Paclitaxel|paclitaxel
164778|NCT02549183|Spinal Cord Stimulation|spinal cord stimulation
164779|NCT02549170|Autoimmune Diseases|autoimmune diseases
164780|NCT02549170|Polyneuropathies|polyneuropathies
164781|NCT02549170|Nervous System Diseases|nervous system diseases
164782|NCT02549170|Peripheral Nervous System Diseases|peripheral nervous system diseases
164783|NCT02549170|Polyradiculoneuropathy|polyradiculoneuropathy
164784|NCT02549170|Autoimmune Diseases of the Nervous System|autoimmune diseases of the nervous system
164785|NCT02549170|Immunoglobulins|immunoglobulins
164786|NCT02549170|Immune System Diseases|immune system diseases
164787|NCT02549170|Demyelinating Diseases|demyelinating diseases
164788|NCT02549170|Polyradiculoneuropathy, Chronic Inflammatory Demyelinating|polyradiculoneuropathy, chronic inflammatory demyelinating
164789|NCT02549170|Neuromuscular Diseases|neuromuscular diseases
164790|NCT02549144|HDL biochemical composition and function|hdl biochemical composition and function
164791|NCT02549105|EMLA CREAM|emla cream
164792|NCT02549105|LIDOCAINE INFILTERATION|lidocaine infilteration
164793|NCT02549105|PAIN RELIEF|pain relief
164794|NCT02549092|levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
164795|NCT02549092|levodopa|levodopa
164796|NCT02549092|carbidopa|carbidopa
164797|NCT02549092|Advanced Parkinson's Disease|advanced parkinson's disease
164798|NCT02549092|Non-Motor Symptom Scale NMSS|non-motor symptom scale nmss
164799|NCT02549092|Parkinson's Disease Sleep Scale PDSS-2|parkinson's disease sleep scale pdss-2
164800|NCT02549092|efficacy|efficacy
164801|NCT02549066|cardiopulmonary bypass|cardiopulmonary bypass
164802|NCT02549066|renal blood flow|renal blood flow
164803|NCT02549066|renal function|renal function
164804|NCT02549066|renal oxygenation|renal oxygenation
164805|NCT02549001|Onychomycosis|onychomycosis
164806|NCT02549001|Nail fungus|nail fungus
164807|NCT02548975|Cardiac surgery|cardiac surgery
164808|NCT02548975|Risk factors|risk factors
164809|NCT02548975|Postoperative delirium|postoperative delirium
164810|NCT02548962|Multiple Myeloma|multiple myeloma
164811|NCT02548962|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
164812|NCT02548962|PCI-32765|pci-32765
164813|NCT02548962|Pomalidomide|pomalidomide
164814|NCT02548962|Dexamethasone|dexamethasone
164815|NCT02548962|Relapsed Refractory Multiple Myeloma|relapsed refractory multiple myeloma
164816|NCT02548962|Ibrutinib|ibrutinib
164817|NCT02548936|Cholesterol, LDL|cholesterol, ldl
164818|NCT02548936|Carotid Intima-Media Thickness|carotid intima-media thickness
164819|NCT02548936|Atherosclerosis|atherosclerosis
164820|NCT02548936|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination
164821|NCT02548936|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
164822|NCT02548897|Parkinson's Disease with Freezing of Gait Symptoms|parkinson's disease with freezing of gait symptoms
164823|NCT02548858|Perineorrhaphy|perineorrhaphy
164824|NCT02548858|Pelvic organ prolapse|pelvic organ prolapse
164825|NCT02548858|Vaginal or abdominal reconstruction|vaginal or abdominal reconstruction
164826|NCT02548858|Body image|body image
164827|NCT02548845|hyponatremia|hyponatremia
164828|NCT02548845|SIADH|siadh
164829|NCT02548845|Oncologic patients|oncologic patients
164830|NCT02548832|Berberine|berberine
164831|NCT02548832|Bezafibrate|bezafibrate
164832|NCT02548806|Clonidine|clonidine
164833|NCT02548793|Cardiac Arrest|cardiac arrest
164834|NCT02548793|CPR|cpr
164835|NCT02548793|Family-centered Care|family-centered care
164836|NCT02548793|Health Literacy|health literacy
164837|NCT02548793|Health Education|health education
164838|NCT02548793|Education Dissemination|education dissemination
164839|NCT02548780|unresectable|unresectable
164840|NCT02548767|High fructose corn syrup|high fructose corn syrup
164841|NCT02548767|Sugar|sugar
164842|NCT02548754|atrial fibrillation|atrial fibrillation
164843|NCT02548754|neuromodulation|neuromodulation
164844|NCT02548754|inflammation|inflammation
164845|NCT02548741|Metformin|metformin
164846|NCT02548741|diabetes|diabetes
164847|NCT02548741|type 2 diabetes|type 2 diabetes
164848|NCT02548741|diabetes complications|diabetes complications
164849|NCT02548741|methylglyoxal|methylglyoxal
164850|NCT02548741|Prediabetes|prediabetes
164851|NCT02548728|Opioid Dependence|opioid dependence
164852|NCT02548728|Opioid Withdrawal|opioid withdrawal
164853|NCT02548728|Opioid|opioid
164854|NCT02548728|Oxytocin|oxytocin
164855|NCT02548728|OT (oxytocin)|ot (oxytocin)
164856|NCT02548728|Intranasal administration|intranasal administration
164857|NCT02548715|thyroxine|thyroxine
164858|NCT02548715|Otolaryngology|otolaryngology
164859|NCT02548702|Sport|sport
164860|NCT02548702|type 2 diabetes|type 2 diabetes
164861|NCT02548702|community intervention programme|community intervention programme
164862|NCT02548702|Fit4life|fit4life
164863|NCT02548702|Exercise|exercise
164864|NCT02548689|alopecia|alopecia
164865|NCT02548689|hair loss|hair loss
164866|NCT02548663|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
164867|NCT02548663|sport therapy|sport therapy
164868|NCT02548663|osteopathic manual treatment|osteopathic manual treatment
164869|NCT02548663|muscle oxidative metabolism|muscle oxidative metabolism
164870|NCT02548650|myocardial infarction|myocardial infarction
164871|NCT02548650|diabetes mellitus|diabetes mellitus
164872|NCT02548650|vorapaxar|vorapaxar
164873|NCT02548650|peripheral arterial disease|peripheral arterial disease
164874|NCT02548585|MEDI0382, diabetes|medi0382, diabetes
164875|NCT02548572|Transcorneal Electrical Stimulation|transcorneal electrical stimulation
164876|NCT02548572|TES|tes
164877|NCT02548572|Retinitis Pigmentosa|retinitis pigmentosa
164878|NCT02548572|RP|rp
164879|NCT02548416|Atelectasis|atelectasis
164880|NCT02548416|Positive End-Expiratory Pressure|positive end-expiratory pressure
164881|NCT02548416|Oxygenation|oxygenation
164882|NCT02548416|Anaesthesia|anaesthesia
164883|NCT02548416|Computed tomography|computed tomography
164884|NCT02548403|Bowel preparation|bowel preparation
164885|NCT02548403|Simethicone|simethicone
164886|NCT02548403|Polyethylene glycol with ascorbic acid|polyethylene glycol with ascorbic acid
164887|NCT02548390|Phase 1/1b|phase 1/1b
164888|NCT02548390|open-label|open-label
164889|NCT02548390|dose-escalation|dose-escalation
164890|NCT02548390|pharmacokinetics|pharmacokinetics
164891|NCT02548390|solid tumor|solid tumor
164892|NCT02548390|metastatic cancer|metastatic cancer
164893|NCT02548390|chemotherapy|chemotherapy
164894|NCT02548390|nano formulation|nano formulation
164895|NCT02548390|alkylator|alkylator
164896|NCT02548377|Head and Neck Neoplasms|head and neck neoplasms
164897|NCT02548377|Surgical Flaps|surgical flaps
164898|NCT02548377|Ischemic Preconditioning|ischemic preconditioning
164899|NCT02548377|Hemostasis|hemostasis
164900|NCT02548377|Thrombosis|thrombosis
164901|NCT02548377|Immune System|immune system
164902|NCT02548377|Reperfusion Injury|reperfusion injury
164903|NCT02548364|Vitamin D|vitamin d
164904|NCT02548364|Myocardial Infarction|myocardial infarction
164905|NCT02548364|Ventricular remodeling|ventricular remodeling
164906|NCT02548364|Biomarkers|biomarkers
164907|NCT02548351|Non Alcoholic Steatohepatitis, fatty liver disease, NASH|non alcoholic steatohepatitis, fatty liver disease, nash
164908|NCT02548312|Readers' perceptions|readers' perceptions
164909|NCT02548299|Diabetes|diabetes
164910|NCT02548299|Cooking|cooking
164911|NCT02548299|Nutrition|nutrition
164912|NCT02548299|Lifestyle Medicine|lifestyle medicine
164913|NCT02548286|Hypertension|hypertension
164914|NCT02548286|Healthy male volunteer|healthy male volunteer
165612|NCT02543931|curcumin|curcumin
164915|NCT02548286|Candesartan, Amlodipine|candesartan, amlodipine
164916|NCT02548273|Corneal endothelium|corneal endothelium
164917|NCT02548273|phacoemulsification|phacoemulsification
164918|NCT02548247|Stool frequency|stool frequency
164919|NCT02548247|Bowel motor function|bowel motor function
164920|NCT02548247|Orafti® Inulin|orafti® inulin
164921|NCT02548247|Dietary Fiber|dietary fiber
164922|NCT02548234|Stroke|stroke
164923|NCT02548234|Randomized control trial|randomized control trial
164924|NCT02548234|Mirror therapy|mirror therapy
164925|NCT02548234|Bilateral arm training|bilateral arm training
164926|NCT02548234|Comparative efficacy research|comparative efficacy research
164927|NCT02548234|Neurorehabilitation|neurorehabilitation
164928|NCT02548221|Thoracentesis|thoracentesis
164929|NCT02548221|Pleural Effusions|pleural effusions
164930|NCT02548221|Transthoracic echocardiogram|transthoracic echocardiogram
164931|NCT02548221|Lung volume measurements|lung volume measurements
164932|NCT02548195|GEMOX|gemox
164933|NCT02548195|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
164934|NCT02548195|adjuvant therapy|adjuvant therapy
164935|NCT02548195|oxaliplatin|oxaliplatin
164936|NCT02548195|gemcitabine|gemcitabine
164937|NCT02548195|capecitabine|capecitabine
164938|NCT02548195|curative surgery|curative surgery
164939|NCT02548169|Dendritic Cell Vaccine|dendritic cell vaccine
164940|NCT02548169|FOLFIRINOX|folfirinox
164941|NCT02548169|nab-paclitaxel|nab-paclitaxel
164942|NCT02548169|gemcitabine|gemcitabine
164943|NCT02548117|Testosterone therapy|testosterone therapy
164944|NCT02548117|erythrocytosis|erythrocytosis
164945|NCT02548117|finasteride|finasteride
164946|NCT02548091|non invasive ventilation|non invasive ventilation
164947|NCT02548091|reperfusion pulmonary edema|reperfusion pulmonary edema
164948|NCT02548091|chronic thrombolic pulmonary hypertension|chronic thrombolic pulmonary hypertension
164949|NCT02548091|pulmonary artery angioplasty|pulmonary artery angioplasty
164950|NCT02548078|Protection against Ebola Zaire virus|protection against ebola zaire virus
164951|NCT02548065|Fibromyalgia Syndrome|fibromyalgia syndrome
164952|NCT02548065|Balneotherapy|balneotherapy
164953|NCT02548065|Vetriolo Water|vetriolo water
165454|NCT02544880|PDE5 Inhibition|pde5 inhibition
164954|NCT02548052|retinoic acid receptor-related orphan receptor (ROR) gamma inverse agonist|retinoic acid receptor-related orphan receptor (ror) gamma inverse agonist
164955|NCT02548052|Plaque type psoriasis|plaque type psoriasis
164956|NCT02548052|psoriasis plaque test|psoriasis plaque test
164957|NCT02548052|Topical|topical
164958|NCT02548052|GSK2981278|gsk2981278
164959|NCT02548039|Anovulatory|anovulatory
164960|NCT02548039|Clomiphene|clomiphene
164961|NCT02548026|meal frequency|meal frequency
164962|NCT02548026|eating frequency|eating frequency
164963|NCT02548026|ingestive frequency|ingestive frequency
164964|NCT02548026|positive energy balance|positive energy balance
164965|NCT02548026|satiety|satiety
164966|NCT02548026|appetite|appetite
164967|NCT02548026|hunger|hunger
164968|NCT02547987|breast cancer|breast cancer
164969|NCT02547987|triple negative|triple negative
164970|NCT02547987|TNBC|tnbc
164971|NCT02547987|triple negative breast cancer|triple negative breast cancer
164972|NCT02547974|Safety|safety
164973|NCT02547974|Immunogenicity|immunogenicity
164974|NCT02547974|Reactogenicity|reactogenicity
164975|NCT02547961|breast cancer|breast cancer
164976|NCT02547961|HER2|her2
164977|NCT02547961|CAR-T cell|car-t cell
164978|NCT02547948|CD19|cd19
164979|NCT02547948|CAR T Cells|car t cells
164980|NCT02547948|Lymphoma|lymphoma
164981|NCT02547922|lupus, nephritis, randomized, placebo, anifrolumab, safety, efficacy, adult|lupus, nephritis, randomized, placebo, anifrolumab, safety, efficacy, adult
164982|NCT02547896|codeine|codeine
164983|NCT02547896|diclofenac|diclofenac
164984|NCT02547896|impacted third molar tooth|impacted third molar tooth
164985|NCT02547883|Statins|statins
164986|NCT02547883|Elderly|elderly
164987|NCT02547883|Mortality|mortality
164988|NCT02547883|Quality of life|quality of life
164989|NCT02547883|Randomized trial|randomized trial
164990|NCT02547883|Cost effectiveness study|cost effectiveness study
164991|NCT02547883|Primary care|primary care
164992|NCT02547870|Rilpivirine|rilpivirine
164993|NCT02547870|Healthy participants|healthy participants
164994|NCT02547857|Pelvic ultrasound|pelvic ultrasound
164995|NCT02547857|Transvaginal ultrasound|transvaginal ultrasound
164996|NCT02547818|Early stage AD|early stage ad
164997|NCT02547818|MCI|mci
164998|NCT02547818|aMCI|amci
164999|NCT02547818|prodromal|prodromal
165000|NCT02547818|Memory loss|memory loss
165001|NCT02547818|Memory problems|memory problems
165002|NCT02547818|Aging|aging
165003|NCT02547818|Early Alzheimer's Disease|early alzheimer's disease
165004|NCT02547818|Early AD|early ad
165005|NCT02547805|Urine Oxalate|urine oxalate
165006|NCT02547805|Nephrolithiasis|nephrolithiasis
165007|NCT02547805|Kidney Stones|kidney stones
165008|NCT02547805|Hyperoxaluria|hyperoxaluria
165009|NCT02547805|Enteric Hyperoxaluria|enteric hyperoxaluria
165010|NCT02547805|Idiopathic Hyperoxaluria|idiopathic hyperoxaluria
165011|NCT02547805|Urological Diseases|urological diseases
165012|NCT02547805|Kidney Diseases|kidney diseases
165013|NCT02547805|Supersaturation|supersaturation
165014|NCT02547805|Dietary Oxalate|dietary oxalate
165015|NCT02547792|Influenza B|influenza b
165016|NCT02547779|crystalloid|crystalloid
165017|NCT02547779|acute kidney injury|acute kidney injury
165018|NCT02547766|Ventricular Assist Device|ventricular assist device
165019|NCT02547766|Recovery of Function|recovery of function
165020|NCT02547753|Tooth extraction|tooth extraction
165021|NCT02547753|Antibiotic prophylaxis|antibiotic prophylaxis
165022|NCT02547753|Postoperative complications|postoperative complications
165023|NCT02547740|macula|macula
165024|NCT02547740|visual fields|visual fields
165025|NCT02547740|optical coherence tomography|optical coherence tomography
165026|NCT02547740|glaucoma progression|glaucoma progression
165027|NCT02547740|retinal ganglion cells|retinal ganglion cells
165028|NCT02547727|rabies vaccination|rabies vaccination
165029|NCT02547714|cyclosporine A|cyclosporine a
165030|NCT02547610|MR/PET in the evaluation|mr/pet in the evaluation
165031|NCT02547610|patients|patients
165032|NCT02547597|Beta-blockers|beta-blockers
165033|NCT02547597|Anti-anginal effect|anti-anginal effect
165034|NCT02547597|Lipid metabolism|lipid metabolism
165035|NCT02547597|Glucose metabolism|glucose metabolism
165036|NCT02547571|Outpatient|outpatient
165037|NCT02547558|Indacaterol|indacaterol
165038|NCT02547558|Pulmonary gas exchange|pulmonary gas exchange
165039|NCT02547558|Long-acting bronchodilators|long-acting bronchodilators
165040|NCT02547532|COPD|copd
165041|NCT02547532|alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
165042|NCT02547532|microbioma|microbioma
165043|NCT02547519|Type 1 diabetes|type 1 diabetes
165044|NCT02547519|T1D|t1d
165045|NCT02547519|diabetes mellitus|diabetes mellitus
165046|NCT02547519|oral insulin|oral insulin
165047|NCT02547519|oral tolerance|oral tolerance
165048|NCT02547519|autoantigen|autoantigen
165049|NCT02547519|self tolerance|self tolerance
165050|NCT02547519|prevention|prevention
165051|NCT02547519|at risk for developing type 1 diabetes|at risk for developing type 1 diabetes
165052|NCT02547519|juvenile diabetes|juvenile diabetes
165053|NCT02547506|cardiorespiratory fitness|cardiorespiratory fitness
165054|NCT02547506|group exercise|group exercise
165055|NCT02547493|Vaccination against Pneumococcal|vaccination against pneumococcal
165056|NCT02547493|Naïve Abatacept patients|naïve abatacept patients
165057|NCT02547480|liver|liver
165058|NCT02547480|metastatic|metastatic
165059|NCT02547467|mortality|mortality
165060|NCT02547415|Pain, Chronic|pain, chronic
165061|NCT02547415|children|children
165062|NCT02547376|Telomeres|telomeres
165063|NCT02547376|Telomerase|telomerase
165064|NCT02547376|Alternative lengthening of Telomeres Mechanism|alternative lengthening of telomeres mechanism
165065|NCT02547285|biomechanics of walking|biomechanics of walking
165066|NCT02547285|footwear|footwear
165067|NCT02547272|Intensive care|intensive care
165068|NCT02547272|S Aureus|s aureus
165069|NCT02547259|schizophrenia|schizophrenia
165070|NCT02547259|memory|memory
165071|NCT02547259|pain|pain
165072|NCT02547246|bulimia|bulimia
165073|NCT02547246|repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
165074|NCT02547194|coronary artery bypass grafting|coronary artery bypass grafting
165075|NCT02547194|saphenous vein|saphenous vein
165076|NCT02547194|no-touch technique|no-touch technique
165077|NCT02547181|Fracture|fracture
165078|NCT02547181|Follow-up|follow-up
165079|NCT02547181|metacarpal|metacarpal
165080|NCT02547168|Atrial Fibrillation|atrial fibrillation
165081|NCT02547168|Symptomatic Atrial Fibrillation|symptomatic atrial fibrillation
165082|NCT02547168|Asymptomatic Atrial Fibrillation|asymptomatic atrial fibrillation
165083|NCT02547168|Lung Resection|lung resection
165084|NCT02547168|Ambulatory Cardiac Monitor|ambulatory cardiac monitor
165085|NCT02547142|Prospective Pre-Post Evaluation|prospective pre-post evaluation
165086|NCT02547142|Early Palliative care|early palliative care
165087|NCT02547142|FACT-E questionnaire|fact-e questionnaire
165088|NCT02547142|HADS questionnaire|hads questionnaire
165089|NCT02547142|Patient Health Questionnaire-9 (PHQ-9)|patient health questionnaire-9 (phq-9)
165090|NCT02547103|Chlorhexidine gluconate|chlorhexidine gluconate
165091|NCT02547103|Mupirocin ointment|mupirocin ointment
165092|NCT02547103|Normal saline|normal saline
165093|NCT02547103|Peritonitis|peritonitis
165094|NCT02547103|Peritoneal dialysis|peritoneal dialysis
165095|NCT02547064|intubation|intubation
165096|NCT02547064|stylet|stylet
165097|NCT02547064|videolaryngoscope|videolaryngoscope
165098|NCT02547038|Helicobacter pylori|helicobacter pylori
165099|NCT02547038|Eradication rate|eradication rate
165100|NCT02547025|Helicobacter pylori|helicobacter pylori
165101|NCT02547025|third-line therapy|third-line therapy
165102|NCT02547025|antibiotic susceptibility|antibiotic susceptibility
165103|NCT02547025|Eradication|eradication
165104|NCT02547012|Helicobacter pylori|helicobacter pylori
165105|NCT02547012|Eradication rate|eradication rate
165106|NCT02547012|Rescue treatment|rescue treatment
165107|NCT02546999|Botulinum Toxins, Type A|botulinum toxins, type a
165108|NCT02546999|Walking|walking
165109|NCT02546986|CC-486|cc-486
165110|NCT02546986|Azacitidine|azacitidine
165111|NCT02546986|Oral azacitidine|oral azacitidine
165112|NCT02546986|Methyltransferase inhibitor|methyltransferase inhibitor
165113|NCT02546986|Hypomethylation|hypomethylation
165114|NCT02546986|Hypomethylating agent|hypomethylating agent
165115|NCT02546986|Epigenetic|epigenetic
165116|NCT02546986|MK-3475|mk-3475
165117|NCT02546986|Pembrolizumab|pembrolizumab
165118|NCT02546986|Keytruda|keytruda
165119|NCT02546986|PD-1|pd-1
165120|NCT02546986|PD-L1|pd-l1
165121|NCT02546986|ImmunotherapyAdvanced non-small cell lung cancer|immunotherapyadvanced non-small cell lung cancer
165122|NCT02546986|Metastatic non-small cell lung cancer|metastatic non-small cell lung cancer
165123|NCT02546986|Non-small cell lung cancer|non-small cell lung cancer
165124|NCT02546986|NSCLC|nsclc
165125|NCT02546986|Merck Pembrolizumab (Keynote-117)|merck pembrolizumab (keynote-117)
165126|NCT02546960|Healthy|healthy
165127|NCT02546960|JNJ-63871860|jnj-63871860
165128|NCT02546960|ExPEC4V|expec4v
165129|NCT02546947|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
165130|NCT02546947|Neuromuscular Blocking Agents|neuromuscular blocking agents
165131|NCT02546947|Atracurium|atracurium
165132|NCT02546947|Mechanical ventilation|mechanical ventilation
165133|NCT02546947|ARDS|ards
165134|NCT02546947|partial pressure of oxygen(PaO2) /inspired oxygen (FiO2) < 200|partial pressure of oxygen(pao2) /inspired oxygen (fio2) < 200
165135|NCT02546947|Positive End Expiratory Pressure (PEEP) > 5 since less than 48 hrs|positive end expiratory pressure (peep) > 5 since less than 48 hrs
165136|NCT02546934|triple negative breast cancer|triple negative breast cancer
165137|NCT02546934|fine line chemotherapy|fine line chemotherapy
165138|NCT02546921|IgE antibody|ige antibody
165139|NCT02546921|Folate receptor|folate receptor
165140|NCT02546921|Cancer Immunotherapy|cancer immunotherapy
165141|NCT02546921|First in class|first in class
165142|NCT02546908|Prostatic Neoplasms|prostatic neoplasms
165143|NCT02546908|Non-interventional|non-interventional
165144|NCT02546908|Observational|observational
165145|NCT02546895|head and neck cancer patients|head and neck cancer patients
165146|NCT02546895|clinical data|clinical data
165147|NCT02546895|tissue collection|tissue collection
165148|NCT02546895|prospective registration|prospective registration
165149|NCT02546895|patients|patients
165150|NCT02546882|stromal vascular fraction|stromal vascular fraction
165151|NCT02546882|skin graft|skin graft
165152|NCT02546843|rocuronium|rocuronium
165153|NCT02546843|sugammadex|sugammadex
165154|NCT02546843|pediatric anesthesia|pediatric anesthesia
165155|NCT02546843|cisatracurium|cisatracurium
165156|NCT02546843|surgical conditions|surgical conditions
165157|NCT02546817|Treatment|treatment
165158|NCT02546817|Tx|tx
165159|NCT02546817|Prevent|prevent
165160|NCT02546778|Radio frequency|radio frequency
165161|NCT02546778|Female|female
165162|NCT02546778|Humans|humans
165163|NCT02546778|Esthetics|esthetics
165164|NCT02546765|analgesics|analgesics
165165|NCT02546765|cardiac surgery|cardiac surgery
165166|NCT02546765|sedation|sedation
165167|NCT02546739|Leukemia|leukemia
165168|NCT02546739|Lymphoma|lymphoma
165169|NCT02546739|CAR T|car t
165170|NCT02546726|heat therapy|heat therapy
165171|NCT02546726|steam-room|steam-room
165172|NCT02546726|aerobic exercise|aerobic exercise
165173|NCT02546726|hypertension|hypertension
165174|NCT02546726|multiple behavior change|multiple behavior change
165175|NCT02546726|lifestyle modification|lifestyle modification
165176|NCT02546713|dental implants|dental implants
165177|NCT02546687|Anastomotic Leak|anastomotic leak
165178|NCT02546687|Esophagectomy Gastric Pull-up|esophagectomy gastric pull-up
165179|NCT02546674|Chronic Myeloid Leukemia|chronic myeloid leukemia
165180|NCT02546674|Nilotinib|nilotinib
165181|NCT02546674|Molecular Response|molecular response
165182|NCT02546674|MR4.5|mr4.5
165183|NCT02546661|Durvalumab|durvalumab
165184|NCT02546661|Olaparib|olaparib
165185|NCT02546661|Vistusertib|vistusertib
165186|NCT02546661|Muscle invasive bladder cancer|muscle invasive bladder cancer
165187|NCT02546661|MIBC|mibc
165188|NCT02546661|BISCAY|biscay
165189|NCT02546661|MEDI4736|medi4736
165190|NCT02546661|AZD4547|azd4547
165191|NCT02546661|AZD2281|azd2281
165192|NCT02546661|AZD1775|azd1775
165193|NCT02546661|AZD2014|azd2014
165194|NCT02546661|AZD9150|azd9150
165195|NCT02546622|Factor|factor
165196|NCT02546622|Coagulation|coagulation
165197|NCT02546622|Inhibitor|inhibitor
165198|NCT02546622|HTC|htc
165199|NCT02546622|Bleeding|bleeding
165200|NCT02546557|CABG|cabg
165201|NCT02546557|Coronary Artery Bypass Grafting|coronary artery bypass grafting
165202|NCT02546544|Linsitinib|linsitinib
165203|NCT02546544|anti-IGF-1R/IR|anti-igf-1r/ir
165204|NCT02546544|Ewing Sarcoma|ewing sarcoma
165205|NCT02546544|dual IGF-1R/IR inhibition|dual igf-1r/ir inhibition
165206|NCT02546544|Relapsed Ewing Sarcoma|relapsed ewing sarcoma
165207|NCT02546544|Refractory Ewing Sarcoma|refractory ewing sarcoma
165208|NCT02546544|Metastatic Ewing Sarcoma|metastatic ewing sarcoma
165209|NCT02546518|Conductive hearing loss|conductive hearing loss
165210|NCT02546518|Middle ear effusion|middle ear effusion
165211|NCT02546518|Middle ear pressure equalization|middle ear pressure equalization
165212|NCT02546505|Consumer behavior|consumer behavior
165213|NCT02546505|Nutrition Labeling|nutrition labeling
165214|NCT02546479|Mortality|mortality
165215|NCT02546479|Radiation|radiation
165216|NCT02546479|Spine deformities|spine deformities
165217|NCT02546466|low back pain|low back pain
165218|NCT02546466|functional taping|functional taping
165219|NCT02546466|balance|balance
165220|NCT02546466|posture|posture
165221|NCT02546466|rehabilitation|rehabilitation
165222|NCT02546466|psychosocial factors|psychosocial factors
165223|NCT02546466|minimal intervention strategy|minimal intervention strategy
165224|NCT02546453|high risk solid tumor pediatric, genetic alteration, Metastatic solid tumor pediatric|high risk solid tumor pediatric, genetic alteration, metastatic solid tumor pediatric
165225|NCT02546414|Platelet count/spleen diameter ratio|platelet count/spleen diameter ratio
165226|NCT02546414|China|china
165227|NCT02546375|Bosutinib|bosutinib
165228|NCT02546375|chronic myeloid leukaemia|chronic myeloid leukaemia
165229|NCT02546375|retrospective|retrospective
165230|NCT02546375|observational|observational
165231|NCT02546349|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
165232|NCT02546349|airway inflammation|airway inflammation
165233|NCT02546349|eosinophilic airway inflammation|eosinophilic airway inflammation
165234|NCT02546349|exhaled nitric oxide|exhaled nitric oxide
165235|NCT02546336|Ultrasound Guidance|ultrasound guidance
165236|NCT02546336|Cooled Radiofrequency|cooled radiofrequency
165237|NCT02546336|Hip Denervation|hip denervation
165238|NCT02546323|Rosuvastatin 20 mg treatment, Carotid Intima-Media Thickness, Chinese subjects, Subclinical atherosclerosis|rosuvastatin 20 mg treatment, carotid intima-media thickness, chinese subjects, subclinical atherosclerosis
165239|NCT02546297|LAMA,ICS+LABA|lama,ics+laba
165240|NCT02546284|CMML|cmml
165241|NCT02546258|Fungal Nail|fungal nail
165242|NCT02546232|locally advanced breast cancer|locally advanced breast cancer
165243|NCT02546232|metastatic breast cancer|metastatic breast cancer
165244|NCT02546219|eosinophilic esophagitis|eosinophilic esophagitis
165246|NCT02546219|integrins|integrins
165247|NCT02546206|Bifidobacterium|bifidobacterium
165248|NCT02546206|Gingivitis|gingivitis
165249|NCT02546206|Gingival crevicular fluid|gingival crevicular fluid
165250|NCT02546206|Interleukin-1beta|interleukin-1beta
165251|NCT02546206|Probiotics|probiotics
165252|NCT02546180|Patient education|patient education
165253|NCT02546180|Preoperative anxiety|preoperative anxiety
165254|NCT02546154|Iron|iron
165255|NCT02546154|Anaemia|anaemia
165256|NCT02546154|Anaemia, Iron-Deficiency|anaemia, iron-deficiency
165257|NCT02546154|Kidney Diseases|kidney diseases
165258|NCT02546154|Inflammatory Bowel Diseases|inflammatory bowel diseases
165259|NCT02546154|Fatigue|fatigue
165260|NCT02546076|Keloid|keloid
165261|NCT02546076|Hypertrophic scars|hypertrophic scars
165262|NCT02546076|Er-YAG Lasers|er-yag lasers
165263|NCT02546050|Gut microbiota|gut microbiota
165264|NCT02546050|metformin|metformin
165265|NCT02546050|Metabolism|metabolism
165266|NCT02546050|Metagenomics|metagenomics
165267|NCT02546050|Metabolomics|metabolomics
165268|NCT02546037|coagulation|coagulation
165269|NCT02546037|haemodialysis|haemodialysis
165270|NCT02546024|Major depressive disorder|major depressive disorder
165271|NCT02546024|late-onset|late-onset
165272|NCT02546024|treatment response|treatment response
165273|NCT02546024|predictors|predictors
165274|NCT02546024|moderators|moderators
165275|NCT02545998|Telehealthcare|telehealthcare
165276|NCT02545985|sirolimus|sirolimus
165277|NCT02545985|coronary stent|coronary stent
165278|NCT02545985|Prolim|prolim
165279|NCT02545972|immunosuppression|immunosuppression
165280|NCT02545959|Intrathecal Rituximab|intrathecal rituximab
165281|NCT02545959|intrathecal chemotherapy|intrathecal chemotherapy
165282|NCT02545959|cerebrospinal fluid|cerebrospinal fluid
165283|NCT02545959|lumbar puncture|lumbar puncture
165284|NCT02545959|Physiological Effects of Drugs|physiological effects of drugs
165285|NCT02545959|Rituximab|rituximab
165286|NCT02545946|traditional incision and drainage|traditional incision and drainage
165287|NCT02545946|minimally invasive incision and drainage|minimally invasive incision and drainage
165288|NCT02545946|vessel loop|vessel loop
165289|NCT02545946|emergency department|emergency department
165290|NCT02545946|pediatrics|pediatrics
165291|NCT02545933|prasugrel|prasugrel
165292|NCT02545933|ticagrelor|ticagrelor
165293|NCT02545933|vorapaxar|vorapaxar
165294|NCT02545920|haemodialysis|haemodialysis
165295|NCT02545920|hypotension|hypotension
165296|NCT02545907|Amyloidosis|amyloidosis
165297|NCT02545907|AL Amyloidosis|al amyloidosis
165298|NCT02545855|myAIRVO2|myairvo2
165299|NCT02545855|high-flow nasal cannula therapy|high-flow nasal cannula therapy
165300|NCT02545855|home oxygen therapy|home oxygen therapy
165301|NCT02545855|HOT|hot
165302|NCT02545790|coarctation of aorta|coarctation of aorta
165303|NCT02545790|aortic stenosis|aortic stenosis
165304|NCT02545790|biomarkers|biomarkers
165305|NCT02545790|cardiac hypertrophy|cardiac hypertrophy
165306|NCT02545777|Acute gouty arthritis|acute gouty arthritis
165307|NCT02545777|tonifying spleen and descending the turbid|tonifying spleen and descending the turbid
165308|NCT02545777|soaking|soaking
166490|NCT02538328|obesity|obesity
165309|NCT02545777|wet wrapping|wet wrapping
165310|NCT02545764|Gait Analysis|gait analysis
165311|NCT02545764|Knee Adduction Moment|knee adduction moment
165312|NCT02545764|Physiotherapy|physiotherapy
165313|NCT02545764|Obesity|obesity
165314|NCT02545751|Esophageal cancer|esophageal cancer
165315|NCT02545751|Metastatic esophageal cancer|metastatic esophageal cancer
165316|NCT02545751|Radiotherapy|radiotherapy
165317|NCT02545751|Thymalfasin|thymalfasin
165318|NCT02545751|ZADAXIN's®|zadaxin's®
165319|NCT02545751|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
165320|NCT02545725|Colorectal Cancer|colorectal cancer
165321|NCT02545725|Quality of life|quality of life
165322|NCT02545725|Questionnaires|questionnaires
165323|NCT02545712|Ethanol|ethanol
165324|NCT02545712|Propylene glycol|propylene glycol
165325|NCT02545712|Benzyl alcohol|benzyl alcohol
165326|NCT02545712|Acesulfam potassium|acesulfam potassium
165327|NCT02545712|Aspartame|aspartame
165328|NCT02545712|Glycerin|glycerin
165329|NCT02545712|Sorbitol|sorbitol
165330|NCT02545712|Methyl-p-hydroxybenzoate|methyl-p-hydroxybenzoate
165331|NCT02545712|Propanyl-p-hydroxybenzoate|propanyl-p-hydroxybenzoate
165332|NCT02545712|Patients|patients
165333|NCT02545699|Adenoma|adenoma
165334|NCT02545699|Polyp|polyp
165335|NCT02545699|CRC|crc
165336|NCT02545699|Colonoscopy|colonoscopy
165337|NCT02545699|Detection Yield|detection yield
165338|NCT02545673|Intervention Studies|intervention studies
165339|NCT02545673|Access to Health Care|access to health care
165340|NCT02545673|Social Stigma|social stigma
165341|NCT02545673|Social Support|social support
165342|NCT02545634|probiotic|probiotic
165343|NCT02545634|ADHD|adhd
165344|NCT02545634|anxiety|anxiety
165345|NCT02545634|digestive health|digestive health
165346|NCT02545634|children|children
165347|NCT02545634|attention deficit|attention deficit
165348|NCT02545634|gut brain axis|gut brain axis
165349|NCT02545634|nutritional supplement|nutritional supplement
165350|NCT02545634|microbiome|microbiome
165351|NCT02545621|Receptor for advanced glycation end products (RAGE)|receptor for advanced glycation end products (rage)
165352|NCT02545621|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
165353|NCT02545621|Monocyte/Macrophage activation|monocyte/macrophage activation
165354|NCT02545621|Fluorescence-Activated Cell Sorting (FACS) analysis|fluorescence-activated cell sorting (facs) analysis
165355|NCT02545621|Thioredoxin interacting protein (TXNIP)|thioredoxin interacting protein (txnip)
165356|NCT02545621|NOD-like receptor family, pyrin domain containing 3 (NLRP3)|nod-like receptor family, pyrin domain containing 3 (nlrp3)
165357|NCT02545621|Inflammasome|inflammasome
165358|NCT02545595|General anaesthesia|general anaesthesia
165359|NCT02545595|Curarization with rocuronium|curarization with rocuronium
165360|NCT02545556|Liver Cancer|liver cancer
165361|NCT02545556|HepaSphere|hepasphere
165362|NCT02545556|cryosurgery|cryosurgery
165363|NCT02545530|renal dialysis|renal dialysis
165364|NCT02545530|hypertension|hypertension
165365|NCT02545530|clonidine|clonidine
165366|NCT02545504|Gastroesophageal junction (GEJ)|gastroesophageal junction (gej)
165367|NCT02545504|Stomach cancer|stomach cancer
165368|NCT02545491|CCD|ccd
165369|NCT02545491|Child development|child development
165370|NCT02545491|daycare|daycare
165371|NCT02545491|caregiver|caregiver
165372|NCT02545478|septic shock|septic shock
165373|NCT02545478|infection|infection
165374|NCT02545478|inflammation|inflammation
165375|NCT02545478|pathologic process|pathologic process
165376|NCT02545478|biomarkers|biomarkers
165377|NCT02545465|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
165378|NCT02545465|Inoperable Chronic Thromboembolic Pulmonary Hypertension|inoperable chronic thromboembolic pulmonary hypertension
165379|NCT02545465|Persistent Chronic Thromboembolic Pulmonary Hypertension|persistent chronic thromboembolic pulmonary hypertension
165380|NCT02545465|Recurrent Chronic Thromboembolic Pulmonary Hypertension|recurrent chronic thromboembolic pulmonary hypertension
165381|NCT02545465|Switch of therapy|switch of therapy
165382|NCT02545465|Titration phase|titration phase
165383|NCT02545465|Retrospective chart review|retrospective chart review
165384|NCT02545439|Alkermes|alkermes
165385|NCT02545439|Samidorphan|samidorphan
165386|NCT02545439|ALKS 5461|alks 5461
165387|NCT02545439|Healthy Volunteer|healthy volunteer
165388|NCT02545439|Pharmacokinetics|pharmacokinetics
165389|NCT02545426|myocardial stunning|myocardial stunning
165390|NCT02545426|dialysate calcium concentration|dialysate calcium concentration
165391|NCT02545426|nutritional status|nutritional status
165392|NCT02545426|hemodinamic|hemodinamic
165393|NCT02545426|hemodialysis|hemodialysis
165394|NCT02545374|chronic wound|chronic wound
165395|NCT02545374|tablet|tablet
165396|NCT02545374|telemedicine|telemedicine
165397|NCT02545374|wounds consultation|wounds consultation
165398|NCT02545374|Smartphone|smartphone
165399|NCT02545296|In-vitro Diagnostics|in-vitro diagnostics
165400|NCT02545296|paediatrics|paediatrics
165401|NCT02545270|Surgery, Laparoscopic|surgery, laparoscopic
165402|NCT02545270|surgical rating scale|surgical rating scale
165403|NCT02545257|Aged people|aged people
165404|NCT02545257|Home care|home care
165405|NCT02545257|Drug related problems, DRPs|drug related problems, drps
165406|NCT02545257|Coordinated medication management model|coordinated medication management model
165407|NCT02545244|Gingivitis, Black Tea, Green Tea,Chlorhexidine, Biofilm,|gingivitis, black tea, green tea,chlorhexidine, biofilm,
165408|NCT02545218|Perineum. Perineorraphy. Pelvic floor exercise.|perineum. perineorraphy. pelvic floor exercise.
165409|NCT02545205|Rehabilitation|rehabilitation
165410|NCT02545205|Robotics|robotics
165411|NCT02545192|PTSD|ptsd
165412|NCT02545166|Stroke|stroke
165413|NCT02545166|Purines|purines
165414|NCT02545166|SMARTChip|smartchip
165415|NCT02545166|Ischaemia|ischaemia
165416|NCT02545166|Carotid endarterectomy|carotid endarterectomy
165417|NCT02545166|Biosensor|biosensor
165418|NCT02545140|risk factors|risk factors
165419|NCT02545140|screening|screening
165420|NCT02545140|adolescents|adolescents
165421|NCT02545127|inadequate milk production|inadequate milk production
165422|NCT02545114|Hyponatremia|hyponatremia
165423|NCT02545114|SIADH, stroke|siadh, stroke
165424|NCT02545114|SAH; ICH|sah; ich
165425|NCT02545114|AIS|ais
165426|NCT02545101|Hyponatremia due to SIADH|hyponatremia due to siadh
165427|NCT02545101|tolvaptan|tolvaptan
165428|NCT02545088|Rehabilitation|rehabilitation
165429|NCT02545088|Robotics|robotics
165430|NCT02545049|Type 2 Diabetes|type 2 diabetes
165431|NCT02545049|Kidney diseases|kidney diseases
165432|NCT02545036|chronic kidney disease|chronic kidney disease
165433|NCT02545036|Daycare|daycare
165434|NCT02545036|Traditional Chinese Medicine(TCM)|traditional chinese medicine(tcm)
165435|NCT02544984|prophylactic macrolides|prophylactic macrolides
165436|NCT02544984|RSV|rsv
165437|NCT02544984|chronic lung disease|chronic lung disease
165438|NCT02544984|respiratory infections|respiratory infections
165439|NCT02544958|Enlarged pores|enlarged pores
165440|NCT02544958|Er:YAG laser|er:yag laser
165441|NCT02544945|Radiotherapy|radiotherapy
165442|NCT02544932|anticoagulant|anticoagulant
165443|NCT02544932|atherosclerosis|atherosclerosis
165444|NCT02544932|endothelium|endothelium
165445|NCT02544919|SMOF|smof
165446|NCT02544919|neurological complications|neurological complications
165447|NCT02544919|neurotoxicity|neurotoxicity
165448|NCT02544919|liver transplantation|liver transplantation
165449|NCT02544919|Lipid emulsions|lipid emulsions
165450|NCT02544906|recipients|recipients
165451|NCT02544880|HNSCC|hnscc
165452|NCT02544880|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
165453|NCT02544880|Tadalafil|tadalafil
165455|NCT02544880|Anti-MUC1 Vaccine|anti-muc1 vaccine
165456|NCT02544880|Recurrent Head and Neck Squamous Cell Carcinoma|recurrent head and neck squamous cell carcinoma
165457|NCT02544880|Recurrent HNSCC|recurrent hnscc
165458|NCT02544880|Second primary site disease stage III|second primary site disease stage iii
165459|NCT02544880|Second primary site disease stage IV|second primary site disease stage iv
165460|NCT02544880|Anti-Influenza Vaccine|anti-influenza vaccine
165461|NCT02544854|Pharmacokinetics, pharmacodynamics, propofol, pediatrics|pharmacokinetics, pharmacodynamics, propofol, pediatrics
165462|NCT02544828|Osteoarthritis|osteoarthritis
165463|NCT02544828|knee arthroplasty|knee arthroplasty
165464|NCT02544828|iron|iron
165465|NCT02544815|digoxin, eficacy, safety|digoxin, eficacy, safety
165466|NCT02544776|pco|pco
165467|NCT02544776|Amlodipine|amlodipine
165468|NCT02544737|Esophageal cancer|esophageal cancer
165469|NCT02544737|Metastatic esophageal cancer|metastatic esophageal cancer
165470|NCT02544737|Apatinib|apatinib
165471|NCT02544724|Relapsed|relapsed
165472|NCT02544724|Refractory|refractory
165473|NCT02544724|DLBCL|dlbcl
165474|NCT02544724|Chemotherapy|chemotherapy
165475|NCT02544711|Pelvis|pelvis
165476|NCT02544711|Surgical resection|surgical resection
165477|NCT02544711|Patient specific instrument|patient specific instrument
165478|NCT02544698|vaccine|vaccine
165479|NCT02544698|safety|safety
165480|NCT02544685|Febrile neutropenia|febrile neutropenia
165481|NCT02544685|Synbiotic|synbiotic
165482|NCT02544685|Probiotic|probiotic
165483|NCT02544685|Prebiotic|prebiotic
165484|NCT02544685|Safety|safety
165485|NCT02544685|Cancer|cancer
165486|NCT02544685|Oncology|oncology
165487|NCT02544685|Chemotherapy|chemotherapy
165488|NCT02544685|Symbiotic|symbiotic
165489|NCT02544659|Treatment|treatment
165490|NCT02544659|Bisphosphonates|bisphosphonates
165491|NCT02544659|Response rate|response rate
165492|NCT02544646|trabeculectomy|trabeculectomy
165493|NCT02544633|Mirati|mirati
165494|NCT02544633|MGCD265|mgcd265
165495|NCT02544633|MET|met
165496|NCT02544633|NSCLC|nsclc
165497|NCT02544607|Ketamine|ketamine
165498|NCT02544607|Depression|depression
165499|NCT02544607|Anxious Depression|anxious depression
165500|NCT02544607|MRI|mri
165501|NCT02544568|high fat|high fat
165502|NCT02544568|high protein|high protein
165503|NCT02544568|high carbohydrate|high carbohydrate
165504|NCT02544568|insulin|insulin
165505|NCT02544568|glucose|glucose
165506|NCT02544555|Peripheral arterial disease|peripheral arterial disease
165507|NCT02544555|Atherosclerosis|atherosclerosis
165508|NCT02544555|Intraluminal approach|intraluminal approach
165509|NCT02544555|Subintimal approach|subintimal approach
165510|NCT02544542|Mild Hypothermia|mild hypothermia
165511|NCT02544542|Hypoxic-Ischemic Encephalopathy|hypoxic-ischemic encephalopathy
165512|NCT02544516|Schizophrenia|schizophrenia
165513|NCT02544516|motor and sensory perceptions|motor and sensory perceptions
165514|NCT02544490|Sepsis|sepsis
165515|NCT02544490|MicroRNAs|micrornas
165516|NCT02544490|Diagnosis|diagnosis
165517|NCT02544490|Prognosis|prognosis
165518|NCT02544464|osteoarthritis|osteoarthritis
165519|NCT02544464|knee arthroplasty|knee arthroplasty
165520|NCT02544464|iron|iron
165521|NCT02544412|Mindfulness|mindfulness
165522|NCT02544412|School Teachers|school teachers
165523|NCT02544412|preservice teachers|preservice teachers
165524|NCT02544412|teacher education|teacher education
165525|NCT02544399|Bone microarchitecture|bone microarchitecture
165526|NCT02544399|Playing golf|playing golf
165527|NCT02544399|Walkers|walkers
165528|NCT02544386|bone microarchitecture|bone microarchitecture
165529|NCT02544386|hemiplegia|hemiplegia
165530|NCT02544373|OSA|osa
165531|NCT02544373|Obstructive Sleep Apnea|obstructive sleep apnea
165532|NCT02544373|Cognition|cognition
165533|NCT02544373|Cognitive Dysfunction|cognitive dysfunction
165534|NCT02544373|Memory|memory
165535|NCT02544373|Positive Aiway Pressure|positive aiway pressure
165536|NCT02544373|CPAP|cpap
165537|NCT02544373|MS|ms
165538|NCT02544360|photoaging mobile apps|photoaging mobile apps
165539|NCT02544360|adolescent smoking|adolescent smoking
165540|NCT02544360|tobacco prevention|tobacco prevention
165541|NCT02544360|school-based prevention|school-based prevention
165542|NCT02544360|adolescent health|adolescent health
165543|NCT02544360|school health|school health
165544|NCT02544360|smoking|smoking
165545|NCT02544360|tobacco|tobacco
165546|NCT02544347|vaspin|vaspin
165547|NCT02544347|omentin|omentin
165548|NCT02544347|diabetes mellitus|diabetes mellitus
165549|NCT02544347|chronic periodontitis|chronic periodontitis
165550|NCT02544347|tumor-necrosis factor alfa|tumor-necrosis factor alfa
165551|NCT02544347|gingival crevicular fluid|gingival crevicular fluid
165552|NCT02544334|Rheumatoid arthritis|rheumatoid arthritis
165553|NCT02544334|Metagenome|metagenome
165554|NCT02544334|microbiome|microbiome
165555|NCT02544308|Solitary, Bone|solitary, bone
165556|NCT02544282|Analgesics|analgesics
165557|NCT02544282|Opioid|opioid
165558|NCT02544282|Mastectomy|mastectomy
165559|NCT02544282|Segmental Mastectomy|segmental mastectomy
165560|NCT02544282|Pecs II|pecs ii
165561|NCT02544269|Lumbosacral plexus blockade|lumbosacral plexus blockade
165562|NCT02544269|Continuous spinal anesthesia|continuous spinal anesthesia
165563|NCT02544269|Hemodynamics|hemodynamics
165564|NCT02544256|Microcirculation|microcirculation
165565|NCT02544256|Mild Hypothermia, Induced|mild hypothermia, induced
165566|NCT02544256|Subarachnoid Hemorrhage, Aneurysmal|subarachnoid hemorrhage, aneurysmal
165567|NCT02544256|Aneurysmal Clipping|aneurysmal clipping
165568|NCT02544256|Vasospasms|vasospasms
165569|NCT02544230|granulocyte transfusions|granulocyte transfusions
165570|NCT02544191|azoospermia nonobstructive|azoospermia nonobstructive
165571|NCT02544191|male infertility|male infertility
165572|NCT02544178|radiotherapy|radiotherapy
165573|NCT02544178|neurocognitive defect|neurocognitive defect
165574|NCT02544178|leukoencephalopathy|leukoencephalopathy
165575|NCT02544165|smoking|smoking
165576|NCT02544165|caffeine intake|caffeine intake
165577|NCT02544165|haemodynamic parameters|haemodynamic parameters
165578|NCT02544165|Advanced Glycation End Products (AGEs)|advanced glycation end products (ages)
165579|NCT02544165|Non-invasive measurements devices|non-invasive measurements devices
165580|NCT02544087|fire-heat syndrome|fire-heat syndrome
165581|NCT02544087|blood stasis syndrome|blood stasis syndrome
165582|NCT02544087|method of clearing heat|method of clearing heat
165583|NCT02544087|method of promoting blood circulation|method of promoting blood circulation
165584|NCT02544048|Immune|immune
165585|NCT02544048|Parasitemia|parasitemia
165586|NCT02544048|Menactra|menactra
165587|NCT02544048|Polymerase Chain Reaction (PCR)|polymerase chain reaction (pcr)
165588|NCT02544048|Coartem|coartem
165589|NCT02544035|Childhood Growth and Development|childhood growth and development
165590|NCT02544035|Development|development
165591|NCT02544022|Pain Scale|pain scale
165593|NCT02544022|Tool Validation|tool validation
165594|NCT02544022|Cognitive Interviews|cognitive interviews
165595|NCT02544009|Energy Expenditure|energy expenditure
165596|NCT02544009|Obesity|obesity
165597|NCT02544009|Behavioral Weight Loss Treatment|behavioral weight loss treatment
165598|NCT02543996|Sample Collection|sample collection
165599|NCT02543996|Laboratory Research Specimens|laboratory research specimens
165600|NCT02543996|Biospecimen Procurement|biospecimen procurement
165601|NCT02543996|Rare Diseases|rare diseases
165602|NCT02543983|Neurobiology|neurobiology
165603|NCT02543983|Suicide|suicide
165604|NCT02543983|Ketamine|ketamine
165605|NCT02543983|Major Depression Disorder|major depression disorder
165606|NCT02543983|Biomarkers|biomarkers
165607|NCT02543957|ERCP|ercp
165608|NCT02543957|Cholangitis|cholangitis
165609|NCT02543957|Bacteremia|bacteremia
165610|NCT02543957|Antibiotics|antibiotics
165611|NCT02543931|turmeric|turmeric
165613|NCT02543931|curcuminoids|curcuminoids
165614|NCT02543931|arthritis|arthritis
165615|NCT02543931|methotrexate|methotrexate
165616|NCT02543892|Vaccine|vaccine
165617|NCT02543879|AML|aml
165618|NCT02543879|BET Inhibitor|bet inhibitor
165619|NCT02543879|FT-1101|ft-1101
165620|NCT02543879|Acute Leukemia|acute leukemia
165621|NCT02543879|Myelodysplastic Syndrome|myelodysplastic syndrome
165622|NCT02543879|NHL|nhl
165623|NCT02543879|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
165624|NCT02543840|Quality Improvement|quality improvement
165625|NCT02543840|Organization of Services|organization of services
165626|NCT02543840|Implementation|implementation
165627|NCT02543827|Vaccine|vaccine
165628|NCT02543827|Recurrent Urinary Tract Infections (RUTI)|recurrent urinary tract infections (ruti)
165629|NCT02543788|optic neuritis|optic neuritis
165630|NCT02543788|vision|vision
165631|NCT02543788|quality of life|quality of life
165632|NCT02543788|pathophysiology|pathophysiology
165633|NCT02543775|Cervical Cancer|cervical cancer
165634|NCT02543775|Sentinel Lymph Node|sentinel lymph node
165635|NCT02543775|Lymphadenectomy|lymphadenectomy
165636|NCT02543762|Chromoendoscopy|chromoendoscopy
165637|NCT02543762|Ulcerative Colitis|ulcerative colitis
165638|NCT02543762|Crohn disease|crohn disease
165639|NCT02543762|Colorectal Neoplasia|colorectal neoplasia
165640|NCT02543749|CML|cml
165641|NCT02543749|DC vaccine|dc vaccine
165642|NCT02543723|medication adherence, telehealth strategies, nurse coaching|medication adherence, telehealth strategies, nurse coaching
165643|NCT02543684|glycemic response|glycemic response
165644|NCT02543684|diabetes|diabetes
165645|NCT02543684|insulinemic response|insulinemic response
165646|NCT02543684|mixed meals|mixed meals
165647|NCT02543684|glycemic index|glycemic index
165648|NCT02543671|vitamin D status|vitamin d status
165649|NCT02543671|25-hydroxyvitamin D|25-hydroxyvitamin d
165650|NCT02543671|cheese|cheese
165651|NCT02543671|Randomized controlled trial|randomized controlled trial
165652|NCT02543671|postmenopausal women|postmenopausal women
165653|NCT02543671|enriched|enriched
165654|NCT02543671|vitamin D3|vitamin d3
165655|NCT02543658|Acute Pancreatitis|acute pancreatitis
165656|NCT02543658|Intra-abdominal hypertension|intra-abdominal hypertension
165657|NCT02543658|Abdominal compartment syndrome|abdominal compartment syndrome
165658|NCT02543658|Curative Effect|curative effect
165659|NCT02543658|Security|security
165660|NCT02543658|Neostigmine|neostigmine
165661|NCT02543632|heart failure|heart failure
165662|NCT02543632|parachute|parachute
165663|NCT02543632|partitioning device|partitioning device
165664|NCT02543593|tDCS|tdcs
165665|NCT02543567|Ebola viruses|ebola viruses
165666|NCT02543567|Ebola virus disease (EVD)|ebola virus disease (evd)
165667|NCT02543567|Filoviruses|filoviruses
165668|NCT02543567|Monovalent vaccine|monovalent vaccine
165669|NCT02543567|Safety|safety
165670|NCT02543567|Immunogenicity|immunogenicity
165671|NCT02543567|Ebola vaccine|ebola vaccine
165672|NCT02543567|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
165673|NCT02543567|Modified Vaccinia Virus Ankara ‐ Bavarian Nordic Filo‐vector (MVA‐BN Filo)|modified vaccinia virus ankara ‐ bavarian nordic filo‐vector (mva‐bn filo)
165674|NCT02543567|Healthy participants|healthy participants
165675|NCT02543541|Palliative Care|palliative care
165676|NCT02543541|Supportive Care|supportive care
165677|NCT02543541|Caregiver|caregiver
165678|NCT02543541|Phase I|phase i
165679|NCT02543515|following hysteroscopy|following hysteroscopy
165680|NCT02543502|Periodontitis|periodontitis
165681|NCT02543502|atherosclerosis|atherosclerosis
165682|NCT02543502|Heart Disease|heart disease
165683|NCT02543476|PD-L1 status, biomarkers, prevalence, SCCHN, overall survival|pd-l1 status, biomarkers, prevalence, scchn, overall survival
165684|NCT02543450|Chronic stroke|chronic stroke
165685|NCT02543450|Participation|participation
165686|NCT02543450|Walking ability|walking ability
165687|NCT02543385|S Ketamine|s ketamine
165688|NCT02543385|Morphine|morphine
165689|NCT02543385|Consumption|consumption
165690|NCT02543372|concerned significant other|concerned significant other
165691|NCT02543372|problem gambling|problem gambling
165692|NCT02543372|internet-delivered cognitive-behavioral therapy|internet-delivered cognitive-behavioral therapy
165693|NCT02543372|behavioral couples therapy|behavioral couples therapy
165694|NCT02543359|Training|training
165695|NCT02543359|Implementation|implementation
165696|NCT02543359|Community-Based Mental Health Services|community-based mental health services
165697|NCT02543359|Parent-Child Interaction Therapy|parent-child interaction therapy
165698|NCT02543359|Children|children
165699|NCT02543333|Acute Asthma,|acute asthma,
165700|NCT02543320|Head and Neck Cancer|head and neck cancer
165701|NCT02543320|LORETA|loreta
165702|NCT02543320|Low Resolution Electromagnetic Tomography|low resolution electromagnetic tomography
165703|NCT02543320|Pain|pain
165704|NCT02543320|Radiotherapy|radiotherapy
165705|NCT02543320|Electroencephalograph|electroencephalograph
165706|NCT02543320|EEG|eeg
165707|NCT02543320|Questionnaires|questionnaires
165708|NCT02543320|Surveys|surveys
167082|NCT02534051|pregnancy|pregnancy
165709|NCT02543320|Neurofeedback training|neurofeedback training
165710|NCT02543307|Hip Replacement|hip replacement
165711|NCT02543307|Spinal Diseases|spinal diseases
165712|NCT02543307|Rotator Cuff Reconstruction|rotator cuff reconstruction
165713|NCT02543307|Nursing|nursing
165714|NCT02543307|Nurse-led|nurse-led
165715|NCT02543307|Pathways|pathways
165716|NCT02543307|Patient Satisfaction|patient satisfaction
165717|NCT02543307|Quality of Nursing Care|quality of nursing care
165718|NCT02543294|Heart Failure|heart failure
165719|NCT02543294|Echocardiogram|echocardiogram
165720|NCT02543294|ECHO|echo
165721|NCT02543294|Electrocardiogram|electrocardiogram
165723|NCT02543294|Questionnaire|questionnaire
165724|NCT02543294|Survey|survey
165725|NCT02543294|Telephone Follow-Up|telephone follow-up
165726|NCT02543294|HF|hf
165727|NCT02543294|Cancer treatment induced left ventricular dysfunction|cancer treatment induced left ventricular dysfunction
165728|NCT02543294|CILVD|cilvd
165729|NCT02543294|Left ventricular ejection fraction|left ventricular ejection fraction
165730|NCT02543294|LVEF|lvef
165731|NCT02543268|Ebola viruses|ebola viruses
165732|NCT02543268|Ebola virus disease (EVD)|ebola virus disease (evd)
165733|NCT02543268|Filoviruses|filoviruses
165734|NCT02543268|Monovalent vaccine|monovalent vaccine
165735|NCT02543268|Safety|safety
165736|NCT02543268|Immunogenicity|immunogenicity
165737|NCT02543268|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
165738|NCT02543268|Modified Vaccinia Virus Ankara ‐ Bavarian Nordic Filo‐vector (MVA‐BN Filo)|modified vaccinia virus ankara ‐ bavarian nordic filo‐vector (mva‐bn filo)
165739|NCT02543268|Healthy participants|healthy participants
165740|NCT02543255|High risk|high risk
165741|NCT02543242|Urinary Incontinence|urinary incontinence
165742|NCT02543242|Stress Urinary Incontinence|stress urinary incontinence
165743|NCT02543242|Urge Incontinence|urge incontinence
165744|NCT02543242|Mixed Urinary Incontience|mixed urinary incontience
165745|NCT02543242|Female Pelvic Health|female pelvic health
165746|NCT02543216|fatty acids, FADS gene, genotype, diet|fatty acids, fads gene, genotype, diet
165747|NCT02543203|Relaxation|relaxation
165748|NCT02543190|Care Transition|care transition
165749|NCT02543190|Readmission|readmission
165750|NCT02543190|Rehospitalization|rehospitalization
165751|NCT02543177|NSTEMI, CKD|nstemi, ckd
165752|NCT02543164|Glycemic Index|glycemic index
165753|NCT02543164|glycemic response|glycemic response
165754|NCT02543151|Biliary stricture|biliary stricture
165755|NCT02543151|Cholangioscopy|cholangioscopy
165756|NCT02543151|Spyglass|spyglass
165757|NCT02543151|Liver transplant|liver transplant
165758|NCT02543125|very low birth weight|very low birth weight
165759|NCT02543125|respiratory distress|respiratory distress
165760|NCT02543125|NHFOV|nhfov
165761|NCT02543125|NIPPV|nippv
165762|NCT02543099|endothelial function|endothelial function
165763|NCT02543099|policosanol|policosanol
165764|NCT02543099|efficacy|efficacy
165765|NCT02543099|safety|safety
165766|NCT02543086|Phase 1, malaria, inoculum, P. falciparum, KAE609, Piperaquine|phase 1, malaria, inoculum, p. falciparum, kae609, piperaquine
165767|NCT02543021|Colitis|colitis
165768|NCT02543021|Dysplasia|dysplasia
165769|NCT02543021|Chromoendoscopy|chromoendoscopy
165770|NCT02543008|Asymptomatic individuals|asymptomatic individuals
165771|NCT02542982|tDCS|tdcs
165772|NCT02542982|motor recovery|motor recovery
165773|NCT02542956|Tummy tuck (abdominoplasty)|tummy tuck (abdominoplasty)
165774|NCT02542956|Breast Surgery|breast surgery
165775|NCT02542930|Non-small cell lung cancer|non-small cell lung cancer
165776|NCT02542930|Metastatic Non-small cell lung cancer|metastatic non-small cell lung cancer
165777|NCT02542930|Radiotherapy|radiotherapy
165778|NCT02542930|Thymalfasin|thymalfasin
165779|NCT02542930|ZADAXIN's®|zadaxin's®
165780|NCT02542891|e-health|e-health
165781|NCT02542891|depressive disorder|depressive disorder
165782|NCT02542891|cost-effectiveness|cost-effectiveness
165783|NCT02542891|Cognitive behavioral treatment|cognitive behavioral treatment
165784|NCT02542878|myofascial release|myofascial release
165785|NCT02542878|back extensors endurance|back extensors endurance
165786|NCT02542878|foam roller|foam roller
165787|NCT02542878|sport|sport
165788|NCT02542852|HIV-1|hiv-1
165789|NCT02542839|Botulinum Toxin|botulinum toxin
165790|NCT02542839|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
165791|NCT02542826|Pulmonary Rehabilitation|pulmonary rehabilitation
165792|NCT02542826|3-minute constant rate shuttle walk test|3-minute constant rate shuttle walk test
165793|NCT02542826|3-minute constant rate step test|3-minute constant rate step test
165794|NCT02542826|Dyspnea|dyspnea
165795|NCT02542813|Pharmacokinetics|pharmacokinetics
165796|NCT02542813|safety|safety
165797|NCT02542813|tolerability|tolerability
165798|NCT02542813|oxytocin|oxytocin
165799|NCT02542787|MS|ms
165800|NCT02542787|Spasticity|spasticity
165801|NCT02542787|VSN16R|vsn16r
165802|NCT02542774|Diabetes mellitus|diabetes mellitus
165803|NCT02542774|Stroke|stroke
165804|NCT02542774|Myocardial infarction|myocardial infarction
165805|NCT02542774|Stable angina pectoris|stable angina pectoris
165806|NCT02542774|Heart failure|heart failure
165807|NCT02542774|Quality of care|quality of care
165808|NCT02542748|norepinephrine|norepinephrine
165809|NCT02542748|ephedrine|ephedrine
165810|NCT02542722|lifestyle modification|lifestyle modification
165811|NCT02542722|olive oil|olive oil
165812|NCT02542722|Mediterranean diet|mediterranean diet
165813|NCT02542683|congenital heart diseases|congenital heart diseases
165814|NCT02542683|cognition|cognition
165815|NCT02542683|adaptive behavior|adaptive behavior
165816|NCT02542683|physical activity|physical activity
165817|NCT02542683|neurodevelopment|neurodevelopment
165818|NCT02542644|Fuchs' Endothelial Dystrophy, DMEK|fuchs' endothelial dystrophy, dmek
165819|NCT02542618|Depression|depression
165820|NCT02542618|Treatment|treatment
165821|NCT02542618|IBSR|ibsr
165822|NCT02542618|CBT|cbt
165823|NCT02542605|Migraine|migraine
165824|NCT02542605|Headache|headache
165825|NCT02542605|Migraine Headache|migraine headache
165826|NCT02542605|Headache, Migraine|headache, migraine
165827|NCT02542605|Amgen|amgen
165828|NCT02542592|Glucocorticoids|glucocorticoids
165829|NCT02542592|Immune Signaling|immune signaling
165830|NCT02542592|Recovery|recovery
165831|NCT02542592|Hip arthroplasty, total|hip arthroplasty, total
165832|NCT02542540|Osteogenesis Imperfecta|osteogenesis imperfecta
165833|NCT02542540|physical exercise training|physical exercise training
165834|NCT02542540|Wii|wii
165835|NCT02542540|muscular strength|muscular strength
165836|NCT02542514|PCNSL|pcnsl
165837|NCT02542514|IOL|iol
165838|NCT02542462|mechanisms for intussusception|mechanisms for intussusception
165839|NCT02542462|rotavirus vaccine|rotavirus vaccine
165840|NCT02542449|Green tea|green tea
165841|NCT02542449|weight maintenance|weight maintenance
165842|NCT02542449|obesity|obesity
165843|NCT02542449|fat mass|fat mass
165844|NCT02542384|abdominal surgery|abdominal surgery
165845|NCT02542384|laparoscopy|laparoscopy
165846|NCT02542384|Hysterectomy|hysterectomy
165847|NCT02542384|Prostatectomy|prostatectomy
165848|NCT02542384|Hemi-colectomy|hemi-colectomy
165849|NCT02542384|Ventral Hernia repair|ventral hernia repair
165850|NCT02542384|CR845|cr845
165851|NCT02542384|analgesic|analgesic
165852|NCT02542384|kappa opioid|kappa opioid
165853|NCT02542384|partial bowel resection|partial bowel resection
165854|NCT02542371|HIV|hiv
165855|NCT02542371|Atherosclerosis|atherosclerosis
165856|NCT02542371|Tilmanocept|tilmanocept
165857|NCT02542345|Cardiac Multislice CT|cardiac multislice ct
165858|NCT02542345|MRI coronarography|mri coronarography
165859|NCT02542332|lung cancer screening|lung cancer screening
165860|NCT02542332|statistical background|statistical background
165861|NCT02542306|Blood loss|blood loss
165862|NCT02542306|coagulopathy|coagulopathy
165863|NCT02542306|fibrinogen concentrate|fibrinogen concentrate
165864|NCT02542306|transfusion|transfusion
165865|NCT02542293|NSCLC|nsclc
165866|NCT02542293|PDL1|pdl1
165867|NCT02542293|MEDI4736|medi4736
165868|NCT02542293|Durvalumab|durvalumab
165869|NCT02542293|Tremelimumab|tremelimumab
165870|NCT02542293|OS|os
165871|NCT02542267|Bare Metal Stent|bare metal stent
165872|NCT02542267|In-Stent Restenosis|in-stent restenosis
165873|NCT02542241|Open abdomen|open abdomen
165874|NCT02542241|hypertonic saline solution|hypertonic saline solution
165875|NCT02542241|intensive care|intensive care
165876|NCT02542228|Immune Deficiency, antibody|immune deficiency, antibody
165877|NCT02542228|Quality of Life survey|quality of life survey
165878|NCT02542176|Metabolic Syndrome|metabolic syndrome
165879|NCT02542176|Grape|grape
165880|NCT02542176|HDL|hdl
165881|NCT02542176|Lipoproteins|lipoproteins
165882|NCT02542137|Small cell lung cancer|small cell lung cancer
165883|NCT02542137|Metastatic small cell lung cancer|metastatic small cell lung cancer
165884|NCT02542137|ZADAXIN|zadaxin
165885|NCT02542137|radiotherapy|radiotherapy
165886|NCT02542137|Thymalfasin|thymalfasin
165887|NCT02542124|CTCL|ctcl
165888|NCT02542124|Total Skin Electron Beam Therapy (TSEBT)|total skin electron beam therapy (tsebt)
165889|NCT02542124|Mycosis fungoides|mycosis fungoides
165890|NCT02542124|Sézary syndrome|sézary syndrome
165891|NCT02542124|recombinant human Interleukin-12 (rHuIL-12)|recombinant human interleukin-12 (rhuil-12)
165892|NCT02542124|T Cell|t cell
165893|NCT02542111|diffuse large b-cell lymphoma|diffuse large b-cell lymphoma
165894|NCT02542085|incisional hernia|incisional hernia
165895|NCT02542085|laparoscopic repair|laparoscopic repair
165896|NCT02542085|hybrid repair|hybrid repair
165897|NCT02542085|seroma|seroma
165898|NCT02542085|recurrent hernia|recurrent hernia
165899|NCT02542033|postprandial glycemia; apple juice; sugar reduction; glucose oxidase|postprandial glycemia; apple juice; sugar reduction; glucose oxidase
165900|NCT02542007|intracoronary stent|intracoronary stent
165901|NCT02542007|drug eluting stent|drug eluting stent
165902|NCT02542007|sirolimus|sirolimus
165903|NCT02542007|endothelial progenitor cells|endothelial progenitor cells
165904|NCT02541981|Heart transplant|heart transplant
165905|NCT02541981|renal insufficiency|renal insufficiency
165906|NCT02541955|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
165907|NCT02541955|Musculoskeletal ultrasound (MSUS)|musculoskeletal ultrasound (msus)
165908|NCT02541929|Alzheimer's disease|alzheimer's disease
165909|NCT02541929|Docosahexaenoic acid|docosahexaenoic acid
165910|NCT02541929|brain health|brain health
165911|NCT02541929|memory|memory
165912|NCT02541929|fish oil|fish oil
165913|NCT02541929|cognition|cognition
165914|NCT02541929|DHA|dha
165915|NCT02541929|omega 3 fatty acid|omega 3 fatty acid
165916|NCT02541929|brain|brain
165917|NCT02541916|Transplantation Tolerance|transplantation tolerance
165918|NCT02541916|Immune Tolerance|immune tolerance
165919|NCT02541916|Transplantation|transplantation
165920|NCT02541916|Liver Transplantation|liver transplantation
165921|NCT02541916|Biological Markers|biological markers
165922|NCT02541916|Gene Expression|gene expression
165923|NCT02541916|Immunosuppression|immunosuppression
165924|NCT02541916|Immunology|immunology
165925|NCT02541916|Multiplex Polymerase Chain Reaction|multiplex polymerase chain reaction
165926|NCT02541916|Real-Time Polymerase Chain Reaction|real-time polymerase chain reaction
165927|NCT02541903|Epidermal growth factor receptor (EGFR),|epidermal growth factor receptor (egfr),
165928|NCT02541903|Human Papillomavirus (HPV)|human papillomavirus (hpv)
165929|NCT02541903|Penile squamous cell carcinoma (PSCC)|penile squamous cell carcinoma (pscc)
165930|NCT02541903|Gilotrif|gilotrif
165931|NCT02541890|Rehabilitation|rehabilitation
165932|NCT02541890|Return to Work|return to work
165933|NCT02541864|Helicobacter pylori|helicobacter pylori
165934|NCT02541864|Hybrid therapy|hybrid therapy
165935|NCT02541864|Bismuth containing quadruple therapy|bismuth containing quadruple therapy
165936|NCT02541864|Eradication|eradication
165937|NCT02541838|Autonomic Neuropathy|autonomic neuropathy
165938|NCT02541838|diabetes|diabetes
165939|NCT02541838|balance control|balance control
165940|NCT02541825|transjugular intrahepatic portosystemic shunt|transjugular intrahepatic portosystemic shunt
165941|NCT02541812|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
165942|NCT02541812|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
165943|NCT02541812|Error processing|error processing
165944|NCT02541799|informed consent|informed consent
165945|NCT02541799|telemedicine|telemedicine
165946|NCT02541799|research methods|research methods
165947|NCT02541786|dexlansoprazole MR|dexlansoprazole mr
165948|NCT02541786|rabeprazole|rabeprazole
165949|NCT02541786|Helicobacter pylori|helicobacter pylori
165950|NCT02541786|triple therapy|triple therapy
165951|NCT02541773|Chronic Heart Failure|chronic heart failure
165952|NCT02541773|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
165953|NCT02541773|Vascular Biomarker|vascular biomarker
165954|NCT02541773|miRNA|mirna
165955|NCT02541773|Extracellular Matrix|extracellular matrix
165956|NCT02541773|Brain Natruetic Peptide|brain natruetic peptide
165957|NCT02541773|Growth Degradation Factor-15|growth degradation factor-15
165958|NCT02541773|Body Composition|body composition
165959|NCT02541734|SPECT|spect
165960|NCT02541734|radiopeptides|radiopeptides
165961|NCT02541734|gelofusine|gelofusine
165962|NCT02541734|Beta cell|beta cell
165963|NCT02541695|Experimental challenge trial|experimental challenge trial
165964|NCT02541669|Drug therapy|drug therapy
165965|NCT02541656|Preload dependence indices|preload dependence indices
165966|NCT02541656|pulse pressure variation|pulse pressure variation
165967|NCT02541656|plethysmographic waveform of pulse oximetry variation|plethysmographic waveform of pulse oximetry variation
165968|NCT02541656|stroke volume variation|stroke volume variation
165969|NCT02541656|laparoscopy|laparoscopy
165970|NCT02541656|pneumoperitoneum|pneumoperitoneum
165971|NCT02541643|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
165972|NCT02541630|Mindfulness|mindfulness
165973|NCT02541591|post cardiac arrest|post cardiac arrest
165974|NCT02541591|hemodynamics|hemodynamics
165975|NCT02541578|stroke, acute; gait, complexity|stroke, acute; gait, complexity
165976|NCT02541552|Knee arthroscopy|knee arthroscopy
165977|NCT02541552|Quadriceps weakness|quadriceps weakness
165978|NCT02541552|ropivacaine|ropivacaine
165979|NCT02541552|saphenous nerve block|saphenous nerve block
165980|NCT02541552|Adductor canal|adductor canal
165981|NCT02541526|amphetamine type stimulant dependence|amphetamine type stimulant dependence
165982|NCT02541526|mirtazepine|mirtazepine
165983|NCT02541513|paliparidone|paliparidone
165984|NCT02541513|amphetamine type stimulant dependence|amphetamine type stimulant dependence
165985|NCT02541500|minocycline|minocycline
165986|NCT02541500|amphetamine type stimulant dependence|amphetamine type stimulant dependence
165987|NCT02541474|Controlled trial|controlled trial
165988|NCT02541474|Matched|matched
165989|NCT02541474|Before-After design|before-after design
165990|NCT02541474|Prospective|prospective
165991|NCT02541474|complex interventions|complex interventions
165992|NCT02541461|Procedure: Laparoscopic gastrectomy with Billroth I|procedure: laparoscopic gastrectomy with billroth i
165993|NCT02541461|Procedure: Laparoscopic gastrectomy with Roux-en-Y|procedure: laparoscopic gastrectomy with roux-en-y
165994|NCT02541461|Other: Body composition measurement|other: body composition measurement
165995|NCT02541461|Other: Lipid profile|other: lipid profile
165996|NCT02541435|Radiotherapy|radiotherapy
165997|NCT02541435|Biological markers|biological markers
165998|NCT02541435|Magnetic resonance imaging|magnetic resonance imaging
165999|NCT02541435|Echocardiography|echocardiography
166000|NCT02541435|Tomography, X-Ray Computed|tomography, x-ray computed
166001|NCT02541435|Risk factors|risk factors
166002|NCT02541435|Heart|heart
166003|NCT02541435|Quality of Life|quality of life
166004|NCT02541409|directly observed therapy|directly observed therapy
166005|NCT02541409|sofosbuvir|sofosbuvir
166006|NCT02541409|ribavirin|ribavirin
166007|NCT02541409|pegylated interferon|pegylated interferon
166008|NCT02541409|resource-limited setting|resource-limited setting
166009|NCT02541396|Bunion|bunion
166010|NCT02541396|Bunionectomy|bunionectomy
166011|NCT02541383|Untreated Multiple Myeloma|untreated multiple myeloma
166012|NCT02541383|daratumumab|daratumumab
166013|NCT02541357|Colorectal Surgery|colorectal surgery
166014|NCT02541331|IgE-dependent asthma|ige-dependent asthma
166015|NCT02541318|peri-menopausal women|peri-menopausal women
166016|NCT02541318|sleep disturbances|sleep disturbances
166017|NCT02541318|Dao-in exercise|dao-in exercise
166018|NCT02541318|body constitution|body constitution
166019|NCT02541305|falls prevention|falls prevention
166020|NCT02541305|proprioception|proprioception
166021|NCT02541305|physical condition|physical condition
166022|NCT02541266|Imaging|imaging
166023|NCT02541266|Questionnaire|questionnaire
166024|NCT02541240|resilience|resilience
166025|NCT02541240|optimism|optimism
166026|NCT02541240|stress|stress
166027|NCT02541240|coping|coping
166028|NCT02541240|curriculum|curriculum
166029|NCT02541201|Plant sterols|plant sterols
166030|NCT02541201|Low-Density Lipoprotein Cholesterol|low-density lipoprotein cholesterol
166031|NCT02541201|Phytosterols|phytosterols
166032|NCT02541188|Breast cancer|breast cancer
166033|NCT02541175|Electrocardiography|electrocardiography
166034|NCT02541175|Automation|automation
166035|NCT02541175|Arrhythmias, Cardiac|arrhythmias, cardiac
166036|NCT02541175|Atrial Fibrillation|atrial fibrillation
166037|NCT02541175|Atrial Flutter|atrial flutter
166038|NCT02541175|Atrial Premature Complexes|atrial premature complexes
166039|NCT02541175|Esophagus|esophagus
166040|NCT02541136|exercise|exercise
166041|NCT02541136|resilience|resilience
166042|NCT02541136|physiotherapy|physiotherapy
166043|NCT02541136|fMRI|fmri
166044|NCT02541123|Traumatic Brain Injury|traumatic brain injury
166045|NCT02541123|Head Injury|head injury
166046|NCT02541084|Age-related macular degeneration|age-related macular degeneration
166047|NCT02541084|Caregiver burden|caregiver burden
166048|NCT02541084|Anti-vascular endothelial growth factor (VEGF) therapy|anti-vascular endothelial growth factor (vegf) therapy
166049|NCT02541058|Velocardiofacial Syndrome|velocardiofacial syndrome
166050|NCT02541058|Shprintzen Syndrome|shprintzen syndrome
166051|NCT02541058|Conotruncal Defects|conotruncal defects
166052|NCT02541058|Chromosomal Abnormalities|chromosomal abnormalities
166053|NCT02541058|22q, 22q.11.2|22q, 22q.11.2
166054|NCT02541058|deletion|deletion
166055|NCT02541058|duplication|duplication
166056|NCT02541045|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
166057|NCT02541045|metadoxine|metadoxine
166058|NCT02541045|efficacy|efficacy
166059|NCT02541045|therapy|therapy
166060|NCT02541019|C23.888.821.712.700|c23.888.821.712.700
166061|NCT02541006|FEV1|fev1
166062|NCT02541006|FVC|fvc
166063|NCT02541006|AUC 0-24|auc 0-24
166064|NCT02541006|bronchodilator efficacy|bronchodilator efficacy
166065|NCT02541006|tiotropium|tiotropium
166066|NCT02540993|Type 2 Diabetes|type 2 diabetes
166067|NCT02540993|Kidney diseases|kidney diseases
166068|NCT02540967|Contrast enhancement in the following MR imaging|contrast enhancement in the following mr imaging
166069|NCT02540967|Brain and spine|brain and spine
166070|NCT02540967|Body and extremities|body and extremities
166071|NCT02540967|Gadobutrol|gadobutrol
166072|NCT02540954|Age-related macular degeneration (AMD)|age-related macular degeneration (amd)
166073|NCT02540954|Eylea treatment|eylea treatment
166074|NCT02540954|Treat and Extend|treat and extend
166075|NCT02540954|Intravitreal|intravitreal
166076|NCT02540902|Knee replacement|knee replacement
166077|NCT02540902|Knee arthroplasty|knee arthroplasty
166078|NCT02540902|All-polyethylene tibia|all-polyethylene tibia
166079|NCT02540902|Bone density|bone density
166080|NCT02540863|myofascial pain syndrome|myofascial pain syndrome
166081|NCT02540863|exercise therapy|exercise therapy
166082|NCT02540863|randomized controlled trial|randomized controlled trial
166083|NCT02540850|septin 9|septin 9
166084|NCT02540850|SEPT9|sept9
166085|NCT02540850|colorectal cancer|colorectal cancer
166086|NCT02540850|CRC|crc
166087|NCT02540850|screening|screening
166088|NCT02540850|methylation|methylation
166089|NCT02540850|adenoma|adenoma
166090|NCT02540850|polyps|polyps
166091|NCT02540850|FIT|fit
166092|NCT02540850|FOBT|fobt
166093|NCT02540850|colonoscopy|colonoscopy
166094|NCT02540824|Apatinib|apatinib
166095|NCT02540824|RET|ret
166096|NCT02540824|gene fusion|gene fusion
166097|NCT02540824|Non-small Cell Lung Cancer|non-small cell lung cancer
166098|NCT02540798|Anxiety|anxiety
166099|NCT02540798|Urodynamics|urodynamics
166100|NCT02540798|Symptom reproducibility|symptom reproducibility
166101|NCT02540798|Lower urinary tract symptoms|lower urinary tract symptoms
166102|NCT02540798|Women|women
166103|NCT02540785|Refractive Surgical Procedures|refractive surgical procedures
166104|NCT02540785|small-incision lenticule extraction|small-incision lenticule extraction
166105|NCT02540785|lenticule extraction|lenticule extraction
166106|NCT02540785|inflammatory mediators|inflammatory mediators
166107|NCT02540772|Confabulations|confabulations
166108|NCT02540772|Neuropsychological rehabilitation|neuropsychological rehabilitation
166109|NCT02540772|Memory|memory
166110|NCT02540759|Buglossoides arvensis|buglossoides arvensis
166111|NCT02540759|vegetable oil|vegetable oil
166112|NCT02540759|omega-3 fatty acids|omega-3 fatty acids
166113|NCT02540759|participants|participants
166114|NCT02540746|Emotional Dysregulation|emotional dysregulation
166115|NCT02540746|Early Intervention|early intervention
166116|NCT02540746|Youth Mental Health|youth mental health
166117|NCT02540746|Staging|staging
166118|NCT02540746|Motivational Enhancement|motivational enhancement
166119|NCT02540746|Family Connections|family connections
166120|NCT02540746|Family Skills Training|family skills training
166121|NCT02540733|cerebral infarction|cerebral infarction
166122|NCT02540733|diabetes|diabetes
166123|NCT02540733|rehabilitation|rehabilitation
166124|NCT02540733|MRI|mri
166125|NCT02540681|Transtibial amputation|transtibial amputation
166126|NCT02540681|Prosthetic fit|prosthetic fit
166127|NCT02540681|Prosthetic alignment|prosthetic alignment
166128|NCT02540655|Stem Cells|stem cells
166129|NCT02540655|Adult Stem Cells|adult stem cells
166130|NCT02540655|Spinocerebellar Ataxia|spinocerebellar ataxia
166131|NCT02540655|Steminent|steminent
166132|NCT02540629|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
166133|NCT02540629|Emergency Medicine|emergency medicine
166134|NCT02540616|MdDS|mdds
166135|NCT02540616|TES|tes
166136|NCT02540616|TMS|tms
166137|NCT02540590|microcirculation|microcirculation
166138|NCT02540590|wound healing|wound healing
166139|NCT02540590|tunnel technique|tunnel technique
166140|NCT02540590|gingival recession|gingival recession
166141|NCT02540590|Mucograft|mucograft
166142|NCT02540590|laser speckle contrast analyzer|laser speckle contrast analyzer
166143|NCT02540538|Adjuvants, immunologic|adjuvants, immunologic
166144|NCT02540538|Interleukin-2|interleukin-2
166145|NCT02540538|Hepatitis B vaccines|hepatitis b vaccines
166146|NCT02540538|Non-responders|non-responders
166147|NCT02540525|stress incontinence|stress incontinence
166148|NCT02540525|transobturator sling|transobturator sling
166149|NCT02540525|single-incision mini-sling|single-incision mini-sling
166150|NCT02540499|lung cancer|lung cancer
166151|NCT02540499|breath hold|breath hold
166152|NCT02540499|radiotherapy|radiotherapy
166153|NCT02540486|Type 2 diabetes|type 2 diabetes
166154|NCT02540486|T2DM|t2dm
166155|NCT02540473|Resilience|resilience
166156|NCT02540447|Liver transplantation|liver transplantation
166157|NCT02540447|Graft rinse|graft rinse
166158|NCT02540447|Ischemia reperfusion injury|ischemia reperfusion injury
166159|NCT02540434|Hypofibrinogenemia|hypofibrinogenemia
166160|NCT02540434|ROTEM|rotem
166161|NCT02540434|Cardiac Surgery|cardiac surgery
166162|NCT02540434|Concentrated Fibrinogen|concentrated fibrinogen
166163|NCT02540421|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
166164|NCT02540421|human papillomavirus|human papillomavirus
166165|NCT02540421|conization|conization
166166|NCT02540408|Occupational COPD|occupational copd
166167|NCT02540408|Pathophysiology|pathophysiology
166168|NCT02540408|Exercise limitation|exercise limitation
166169|NCT02540408|Pulmonary hyperinflation|pulmonary hyperinflation
166170|NCT02540408|Arterial stiffness|arterial stiffness
166171|NCT02540395|Kidney transplantation|kidney transplantation
166172|NCT02540395|Immunosuppression|immunosuppression
166173|NCT02540395|IFN-γ|ifn-γ
166174|NCT02540382|TIPS|tips
166175|NCT02540382|Hepatocellular Carcinoma|hepatocellular carcinoma
166176|NCT02540382|Portasystemic Shunt|portasystemic shunt
166177|NCT02540369|Diabetic macular edema|diabetic macular edema
166178|NCT02540369|Wet Age-related macular degeneration|wet age-related macular degeneration
166179|NCT02540343|Translation|translation
166180|NCT02540343|Validation|validation
166181|NCT02540343|Orebro-G|orebro-g
166182|NCT02540291|E7046|e7046
166183|NCT02540291|Advanced malignancies|advanced malignancies
166184|NCT02540291|malignancies|malignancies
166185|NCT02540265|Bunion|bunion
166186|NCT02540265|Bunionectomy|bunionectomy
166187|NCT02540265|Pain|pain
166188|NCT02540265|Analgesia|analgesia
166189|NCT02540265|N1539|n1539
166190|NCT02540252|Lower Limb Amputation|lower limb amputation
166191|NCT02540252|Nutrition|nutrition
166192|NCT02540252|Eating|eating
166193|NCT02540252|Inflammation|inflammation
166194|NCT02540252|Nursing|nursing
166195|NCT02540226|Tranexamic Acid|tranexamic acid
166196|NCT02540226|Total Knee Arthroplasty|total knee arthroplasty
166197|NCT02540226|Total Knee Replacement|total knee replacement
166198|NCT02540187|haemophilia|haemophilia
166199|NCT02540187|TFPI|tfpi
166200|NCT02540187|thrombin generation|thrombin generation
166201|NCT02540187|hemorrhagic score|hemorrhagic score
166202|NCT02540174|alcohol and tobacco consumption|alcohol and tobacco consumption
166203|NCT02540174|addiction treatment|addiction treatment
166204|NCT02540161|Sym004|sym004
166205|NCT02540161|Glioblastoma|glioblastoma
166206|NCT02540161|Desjardins|desjardins
166207|NCT02540161|Pro00063483|pro00063483
166208|NCT02540161|Symphogen|symphogen
166209|NCT02540161|Duke Cancer Institute|duke cancer institute
166210|NCT02540135|high grade glioma|high grade glioma
166211|NCT02540135|glioblastoma multiforme|glioblastoma multiforme
166212|NCT02540135|anaplastic astrocytoma|anaplastic astrocytoma
166213|NCT02540135|flourescein|flourescein
166214|NCT02540135|flourescence-guided surgery|flourescence-guided surgery
166215|NCT02540135|intraoperative MRI|intraoperative mri
166216|NCT02540135|iMRI|imri
166217|NCT02540109|Stroke|stroke
166218|NCT02540109|Anomia|anomia
166219|NCT02540096|mental practice|mental practice
166220|NCT02540096|motor imagery|motor imagery
166221|NCT02540096|hemiparesis|hemiparesis
166222|NCT02540096|stroke|stroke
166223|NCT02540096|gait|gait
166224|NCT02540096|mobility|mobility
166225|NCT02540070|Adductor canal Block|adductor canal block
166226|NCT02540070|ultrasound|ultrasound
166227|NCT02540070|periarticular injections|periarticular injections
166228|NCT02540070|Dexmedetomidine|dexmedetomidine
166229|NCT02540018|DEB, drug-eluting balloon, Paclitaxel, peripheral artery disease|deb, drug-eluting balloon, paclitaxel, peripheral artery disease
166230|NCT02539979|IV Paracetamol|iv paracetamol
166231|NCT02539979|Radiofrequency Lesion/Ablation of medial branch nerve|radiofrequency lesion/ablation of medial branch nerve
166232|NCT02539979|Preventative Pain Management|preventative pain management
166233|NCT02539940|Below-the-knee|below-the-knee
166234|NCT02539914|Virtual reality|virtual reality
166235|NCT02539914|Motor and cognitive rehabilitation|motor and cognitive rehabilitation
166236|NCT02539914|Positive emotion stimuli|positive emotion stimuli
166237|NCT02539901|cochlear implant|cochlear implant
166238|NCT02539901|Developmental Psychology|developmental psychology
166239|NCT02539901|cognitive development|cognitive development
166240|NCT02539901|communicative development|communicative development
166241|NCT02539901|perceptual development|perceptual development
166242|NCT02539901|deaf child|deaf child
166243|NCT02539875|Effectiveness of quit immediately (QI) and cut down to quit (CDTQ) interventions in achieving smoking abstinence|effectiveness of quit immediately (qi) and cut down to quit (cdtq) interventions in achieving smoking abstinence
166244|NCT02539862|Insomnia|insomnia
166245|NCT02539862|behavioral and cognitive therapies|behavioral and cognitive therapies
166246|NCT02539836|children's obesity|children's obesity
166247|NCT02539836|gut microbiome|gut microbiome
166248|NCT02539836|body mass index|body mass index
166249|NCT02539836|fruit and vegetable fermentation extraction|fruit and vegetable fermentation extraction
166250|NCT02539836|dietary nutrition intervention|dietary nutrition intervention
166251|NCT02539784|stimulation|stimulation
166252|NCT02539771|vaso-occlusive crisis|vaso-occlusive crisis
166253|NCT02539771|obstructive sleep apnea|obstructive sleep apnea
166254|NCT02539771|priapism|priapism
166255|NCT02539758|acute angle closure|acute angle closure
166256|NCT02539758|ocular massage|ocular massage
166257|NCT02539745|vitamin D|vitamin d
166258|NCT02539745|primary open- angle glaucoma|primary open- angle glaucoma
166259|NCT02539732|Weaning|weaning
166260|NCT02539732|Spontaneous breathing trial|spontaneous breathing trial
166261|NCT02539732|Neurally-adjusted ventilator assist|neurally-adjusted ventilator assist
166262|NCT02539732|Electrical activity of the diaphragm|electrical activity of the diaphragm
166263|NCT02539719|Platinum-Resistant|platinum-resistant
166264|NCT02539719|Refractory|refractory
166265|NCT02539680|Phosphate transporter|phosphate transporter
166266|NCT02539680|CKD|ckd
166267|NCT02539680|duodenal biopsies|duodenal biopsies
166268|NCT02539602|High school|high school
166269|NCT02539602|Longitudnal|longitudnal
166270|NCT02539602|Sexual initiation|sexual initiation
166271|NCT02539602|Contraception|contraception
166272|NCT02539602|Adolescents|adolescents
166273|NCT02539602|Pregnancy prevention|pregnancy prevention
166274|NCT02539602|Sexual health|sexual health
166275|NCT02539576|pharmacokinetics|pharmacokinetics
166276|NCT02539576|Healthy subjects|healthy subjects
166277|NCT02539576|Abacavir/dolutegravir/lamivudine|abacavir/dolutegravir/lamivudine
166278|NCT02539576|Japanese|japanese
166279|NCT02539576|Fixed-dose combination|fixed-dose combination
166280|NCT02539576|safety|safety
166281|NCT02539563|labor duration|labor duration
166282|NCT02539550|PF-06266047|pf-06266047
166283|NCT02539550|safety|safety
166284|NCT02539550|tolerability|tolerability
166285|NCT02539550|pharmacokinetics|pharmacokinetics
166286|NCT02539550|first-in-human|first-in-human
166287|NCT02539550|healthy volunteers|healthy volunteers
166288|NCT02539550|PDE4|pde4
166289|NCT02539550|phosphodiesterase-4|phosphodiesterase-4
166290|NCT02539537|locally advanced pancreatic carcinoma|locally advanced pancreatic carcinoma
166291|NCT02539537|FOLFIRINOX|folfirinox
166292|NCT02539524|clinical impact|clinical impact
166293|NCT02539524|anxiety|anxiety
166294|NCT02539524|quality of life|quality of life
166295|NCT02539524|Yoga|yoga
166296|NCT02539498|Primary Hyperparathyroidism|primary hyperparathyroidism
166297|NCT02539498|Parathyroid Hormone|parathyroid hormone
166298|NCT02539498|High-Resolution peripheral Quantitative Computed Tomography|high-resolution peripheral quantitative computed tomography
166299|NCT02539498|Bone densitometry|bone densitometry
166300|NCT02539498|Bone microarchitecture|bone microarchitecture
166301|NCT02539446|Aging|aging
166302|NCT02539446|External focus|external focus
166303|NCT02539446|Internal focus|internal focus
166304|NCT02539446|Attention|attention
166305|NCT02539446|Posture balance|posture balance
166306|NCT02539446|Parkinson's disease|parkinson's disease
166307|NCT02539407|β-lactam antibiotics|β-lactam antibiotics
166308|NCT02539407|Children|children
166309|NCT02539407|Anti-infectives|anti-infectives
166310|NCT02539407|Aminoglycosides, glycopeptides|aminoglycosides, glycopeptides
166311|NCT02539407|Fluoroquinolone|fluoroquinolone
166312|NCT02539407|Fungal|fungal
166313|NCT02539407|Antiviral|antiviral
166314|NCT02539394|Anterior Cervical Discectomy and Fusion|anterior cervical discectomy and fusion
166315|NCT02539394|Dysphagia|dysphagia
166316|NCT02539394|ACDF|acdf
166317|NCT02539368|Infliximab|infliximab
166318|NCT02539368|Observational|observational
166319|NCT02539368|Follow-up|follow-up
166320|NCT02539368|Safety|safety
166321|NCT02539368|Effectiveness|effectiveness
166322|NCT02539355|Insulin resistance|insulin resistance
166323|NCT02539355|Diabetes|diabetes
166324|NCT02539355|Cancer|cancer
166325|NCT02539355|Obesity|obesity
166326|NCT02539355|Inflammation|inflammation
166327|NCT02539342|Oral Mucositis|oral mucositis
166328|NCT02539342|Cancer|cancer
166329|NCT02539342|Chemotherapy|chemotherapy
166330|NCT02539329|neuropathy|neuropathy
166331|NCT02539329|antibodies antiFGFR3|antibodies antifgfr3
166332|NCT02539329|Biological diagnostic criteria|biological diagnostic criteria
166333|NCT02539316|Parenteral Nutrition|parenteral nutrition
166334|NCT02539290|Unexplained infertility|unexplained infertility
166335|NCT02539290|Infertility|infertility
166336|NCT02539290|Tubal flushing|tubal flushing
166337|NCT02539290|Uterine flushing|uterine flushing
166338|NCT02539290|Live birth|live birth
166339|NCT02539290|Pregnancy|pregnancy
166340|NCT02539290|Randomized controlled trial|randomized controlled trial
166341|NCT02539290|Saline|saline
166342|NCT02539290|Physiological saline|physiological saline
166343|NCT02539264|All patients registered for A PSG|all patients registered for a psg
166344|NCT02539264|polysomnography|polysomnography
166345|NCT02539251|Early Child Development|early child development
166346|NCT02539251|Ages and Stages Questionnaire _3|ages and stages questionnaire _3
166347|NCT02539251|Validation|validation
166348|NCT02539238|Medical Education|medical education
166349|NCT02539238|cardiopulmonary resuscitation|cardiopulmonary resuscitation
166350|NCT02539238|feedback|feedback
166351|NCT02539238|cost-effectiveness analysis|cost-effectiveness analysis
166352|NCT02539212|microwave|microwave
166353|NCT02539212|radiofrequency|radiofrequency
166354|NCT02539212|ablation|ablation
166355|NCT02539160|coronary artery disease|coronary artery disease
166356|NCT02539160|diabetes mellitus|diabetes mellitus
166357|NCT02539160|chronic kidney disease|chronic kidney disease
166358|NCT02539160|ticagrelor|ticagrelor
166359|NCT02539147|lipopolysaccharide|lipopolysaccharide
166360|NCT02539147|sepsis|sepsis
166361|NCT02539147|caspase-4 and -5|caspase-4 and -5
166362|NCT02539147|monocytes|monocytes
166363|NCT02539147|IL-1β and IL-1α|il-1β and il-1α
166364|NCT02539134|Drug therapy|drug therapy
166365|NCT02539121|Labor|labor
166366|NCT02539121|Acupuncture|acupuncture
166367|NCT02539121|Postpartum hemorrhage|postpartum hemorrhage
166368|NCT02539121|Placental expulsion time|placental expulsion time
166369|NCT02539121|Postpartum blood loss|postpartum blood loss
166370|NCT02539108|Influenza|influenza
166371|NCT02539108|Influenza virus vaccine|influenza virus vaccine
166372|NCT02539108|Fluzone® Quadrivalent Influenza Vaccine (No Preservative)|fluzone® quadrivalent influenza vaccine (no preservative)
166373|NCT02539095|intra-articular injection|intra-articular injection
166374|NCT02539095|intra-articular collagen injection|intra-articular collagen injection
166375|NCT02539095|collagen|collagen
166376|NCT02539095|knee joint pain|knee joint pain
166377|NCT02539082|collagen|collagen
166378|NCT02539082|collagen injection|collagen injection
166379|NCT02539082|plantar fasciitis|plantar fasciitis
166380|NCT02539069|cartilage defects|cartilage defects
166381|NCT02539069|Chondron|chondron
166382|NCT02539069|Autologous cultured Chondrocyte|autologous cultured chondrocyte
166383|NCT02539069|arthroscopy|arthroscopy
166384|NCT02539056|cartilage defects|cartilage defects
166385|NCT02539056|Chondron|chondron
166386|NCT02539056|Autologous cultured Chondrocyte|autologous cultured chondrocyte
166387|NCT02539043|Lipolysis|lipolysis
166388|NCT02539043|Subcutaneous Fat, Abdominal/metabolism|subcutaneous fat, abdominal/metabolism
166389|NCT02539043|Subcutaneous Fat, Abdominal/ultrasonography|subcutaneous fat, abdominal/ultrasonography
166390|NCT02539043|High-Intensity Focused Ultrasound Ablation/methods|high-intensity focused ultrasound ablation/methods
166391|NCT02539043|Waist Circumference|waist circumference
166392|NCT02539043|Pilot Projects|pilot projects
166393|NCT02539043|Subcutaneous Fat|subcutaneous fat
166394|NCT02539043|High-Intensity Focused Ultrasound Ablation|high-intensity focused ultrasound ablation
166395|NCT02539043|Adiposity|adiposity
166396|NCT02539030|Cartilage defect of knee|cartilage defect of knee
166397|NCT02539030|microfracture|microfracture
166398|NCT02539030|modified microfracture|modified microfracture
166399|NCT02539030|collagen|collagen
166400|NCT02539017|cellular immune therapy|cellular immune therapy
166401|NCT02539017|triple negative breast cancer|triple negative breast cancer
166402|NCT02539017|adjuvant therapy|adjuvant therapy
166403|NCT02539004|kidney stones|kidney stones
166404|NCT02539004|ureteral stones|ureteral stones
166405|NCT02538991|Bulkamid|bulkamid
166406|NCT02538991|Tension-Free Vaginal Tape|tension-free vaginal tape
166407|NCT02538991|Women|women
166408|NCT02538978|CLI|cli
166409|NCT02538965|Lenalidomide|lenalidomide
166410|NCT02538965|Revlimid|revlimid
166411|NCT02538965|Pediatric|pediatric
166412|NCT02538965|Relapsed or Refractory|relapsed or refractory
166413|NCT02538965|Acute Myeloid Leukemia|acute myeloid leukemia
166414|NCT02538965|Leukemia|leukemia
166415|NCT02538952|GeneXpert|genexpert
166416|NCT02538952|Tuberculosis|tuberculosis
166417|NCT02538952|Human immunodeficiency virus|human immunodeficiency virus
166418|NCT02538952|Diagnostic accuracy|diagnostic accuracy
166419|NCT02538952|Impact|impact
166420|NCT02538939|Calcific tendinitis, Shoulder, Needle lavage, Sodium thiosulfate|calcific tendinitis, shoulder, needle lavage, sodium thiosulfate
166421|NCT02538913|Exercise|exercise
166422|NCT02538913|Pelvic floor|pelvic floor
166423|NCT02538913|Prehabilitation|prehabilitation
166424|NCT02538913|Fecal incontinence|fecal incontinence
166425|NCT02538913|Urinary incontinence|urinary incontinence
166426|NCT02538913|Sexual dysfunction, physiological|sexual dysfunction, physiological
166427|NCT02538900|peripheral arterial disease, peripheral artery disease, PAD, exercise|peripheral arterial disease, peripheral artery disease, pad, exercise
166428|NCT02538822|aortic aneurysm|aortic aneurysm
166429|NCT02538822|thoracic ascending aorta|thoracic ascending aorta
166430|NCT02538822|ATA|ata
166431|NCT02538822|dynamic imaging|dynamic imaging
166432|NCT02538822|mechanical testing|mechanical testing
166433|NCT02538796|Anorexia Nervosa|anorexia nervosa
166434|NCT02538796|Cognition|cognition
166435|NCT02538796|Conscious|conscious
166436|NCT02538796|Non-Conscious|non-conscious
166437|NCT02538705|Diabetic foot syndrome|diabetic foot syndrome
166438|NCT02538705|Ulcers|ulcers
166439|NCT02538679|transversus abdominis plane block|transversus abdominis plane block
166440|NCT02538679|tap block|tap block
166441|NCT02538679|regional anesthesia|regional anesthesia
166442|NCT02538679|colorectal surgery|colorectal surgery
166443|NCT02538653|glycemic & insulin response, SDS, cereal product, Nutrition|glycemic & insulin response, sds, cereal product, nutrition
166444|NCT02538640|Nutrition, glycemic response, cereal products|nutrition, glycemic response, cereal products
166445|NCT02538627|Heregulin-positive|heregulin-positive
166446|NCT02538627|EGFR|egfr
166447|NCT02538627|ErbB3|erbb3
166448|NCT02538627|Phase I|phase i
166449|NCT02538627|Oncology|oncology
166450|NCT02538627|Cancer|cancer
166451|NCT02538627|IGF-1|igf-1
166452|NCT02538627|MEKinhibitor|mekinhibitor
166453|NCT02538627|IGF-1R inhibitor|igf-1r inhibitor
166454|NCT02538627|KRAS|kras
166455|NCT02538627|NRAS|nras
166456|NCT02538601|Post Traumatic Stress Disorder|post traumatic stress disorder
166457|NCT02538601|PTSD|ptsd
166458|NCT02538601|Cigarette Smoking|cigarette smoking
166459|NCT02538601|Lower Respiratory Symptoms|lower respiratory symptoms
166460|NCT02538601|Cognitive Behavioral Therapy|cognitive behavioral therapy
166461|NCT02538601|CBT|cbt
166462|NCT02538601|Transdiagnostic Treatments|transdiagnostic treatments
166463|NCT02538601|World Trade Center|world trade center
166464|NCT02538588|Healthy Volunteers|healthy volunteers
166465|NCT02538575|Cystic Fibrosis|cystic fibrosis
166466|NCT02538575|Adults|adults
166467|NCT02538575|6-minute walk test|6-minute walk test
166468|NCT02538497|NBO|nbo
166469|NCT02538497|The Newborn Behavioral Observation|the newborn behavioral observation
166470|NCT02538497|postpartum depression|postpartum depression
166471|NCT02538497|postnatal depression|postnatal depression
166472|NCT02538497|child development|child development
166473|NCT02538497|parent-child interaction|parent-child interaction
166474|NCT02538458|Saline Solution, Hypertonic (3 %)|saline solution, hypertonic (3 %)
166475|NCT02538458|Infant|infant
166476|NCT02538445|Schizophrenia|schizophrenia
166477|NCT02538445|Memory|memory
166478|NCT02538445|Cognition|cognition
166479|NCT02538432|Disease Progression|disease progression
166480|NCT02538432|Non-Responsive Disease|non-responsive disease
166481|NCT02538432|Advanced Disease|advanced disease
166482|NCT02538406|Adenoma|adenoma
166483|NCT02538406|withdrawal time|withdrawal time
166484|NCT02538406|Colonoscopy|colonoscopy
166485|NCT02538380|Lung cancer|lung cancer
166486|NCT02538380|Adrenal gland metastasis|adrenal gland metastasis
166487|NCT02538354|Riboflavin (vitamin B2)|riboflavin (vitamin b2)
166488|NCT02538354|Faecalibacterium prausnitzii|faecalibacterium prausnitzii
166489|NCT02538328|laparoscopy|laparoscopy
166491|NCT02538328|harmonic scalpel|harmonic scalpel
166492|NCT02538328|ligasure|ligasure
166493|NCT02538315|[18F]FODPA, Parkinson's, PET/CT, Stem Cell transplantation|[18f]fodpa, parkinson's, pet/ct, stem cell transplantation
166494|NCT02538302|Minirin|minirin
166495|NCT02538302|Oxybutynin|oxybutynin
166496|NCT02538302|Nocturnal enuresis|nocturnal enuresis
166497|NCT02538289|Dyspnea|dyspnea
166498|NCT02538289|Palliative Care|palliative care
166499|NCT02538289|Heart Failure|heart failure
166500|NCT02538289|Chronic Pulmonary Disease|chronic pulmonary disease
166501|NCT02538289|Opioids|opioids
166502|NCT02538276|carotid endarterectomy, carotid stenosis, carotid stenting|carotid endarterectomy, carotid stenosis, carotid stenting
166503|NCT02538250|Oral nutritional supplement|oral nutritional supplement
166504|NCT02538250|supplementation|supplementation
166505|NCT02538250|adult patients|adult patients
166506|NCT02538224|Periodontitis|periodontitis
166507|NCT02538224|doxycycline/ketoprofen topical gel therapeutic|doxycycline/ketoprofen topical gel therapeutic
166508|NCT02538198|lenalidomide (CC-5013)|lenalidomide (cc-5013)
166509|NCT02538198|maintenance|maintenance
166510|NCT02538198|15-129|15-129
166511|NCT02538172|Cell-mediated immunity|cell-mediated immunity
166512|NCT02538172|Antiviral prophylaxis|antiviral prophylaxis
166513|NCT02538172|Transplantation|transplantation
166514|NCT02538159|Non-tunneled Central venous catheter|non-tunneled central venous catheter
166515|NCT02538159|Bacteraemia|bacteraemia
166516|NCT02538159|Peripherally inserted central venous catheter|peripherally inserted central venous catheter
166517|NCT02538146|pain|pain
166518|NCT02538146|depression|depression
166519|NCT02538146|cytokines|cytokines
166520|NCT02538146|well-being|well-being
166521|NCT02538133|99mTc-Exametazime (HMPAO)-Labeled Leukocytes|99mtc-exametazime (hmpao)-labeled leukocytes
166522|NCT02538133|suspected subdiaphragmatic vascular prosthesis infection|suspected subdiaphragmatic vascular prosthesis infection
166523|NCT02538133|diagnosis|diagnosis
166524|NCT02538094|Cognitive Enhancement|cognitive enhancement
166525|NCT02538094|tDCS|tdcs
166526|NCT02538094|stimulation|stimulation
166527|NCT02538094|MS|ms
166528|NCT02538094|Multiple Sclerosis|multiple sclerosis
166529|NCT02538094|Encephalitis|encephalitis
166530|NCT02538081|schizophrenia|schizophrenia
166531|NCT02538081|olanzapine|olanzapine
166532|NCT02538081|risperidone|risperidone
166533|NCT02538081|alpha 7 nicotinic receptors|alpha 7 nicotinic receptors
166534|NCT02538081|cognition|cognition
166535|NCT02538068|Purpose in Life|purpose in life
166536|NCT02538068|Self-determination|self-determination
166537|NCT02538068|Physical activity|physical activity
166538|NCT02538068|Self-monitoring|self-monitoring
166539|NCT02538068|Behavior change|behavior change
166540|NCT02538055|Community Health Workers|community health workers
166541|NCT02538055|Diabetes Mellitus|diabetes mellitus
166542|NCT02538055|Chronic Pain|chronic pain
166543|NCT02538029|Dual tasking|dual tasking
166544|NCT02538016|Cystinuria|cystinuria
166545|NCT02538016|Kidney Stones|kidney stones
166546|NCT02537964|chlorhexidine|chlorhexidine
166547|NCT02537951|autofluorescent flavoprotein imaging, capsaicin|autofluorescent flavoprotein imaging, capsaicin
166548|NCT02537925|COX-2 inhibitors|cox-2 inhibitors
166549|NCT02537925|radiosensitivity|radiosensitivity
166550|NCT02537925|nasopharyngeal carcinoma|nasopharyngeal carcinoma
166551|NCT02537912|peanut skin|peanut skin
166552|NCT02537912|body fat|body fat
166553|NCT02537912|blood glucose|blood glucose
166554|NCT02537912|waistline|waistline
166555|NCT02537912|body weight|body weight
166556|NCT02537886|PCOR|pcor
166557|NCT02537873|Cocaine Use Disorder|cocaine use disorder
166558|NCT02537847|Sitafloxacin|sitafloxacin
166559|NCT02537847|Extended-Spectrum ß-lactamase-producing Escherichia coli|extended-spectrum ß-lactamase-producing escherichia coli
166560|NCT02537847|Treatment for Acute Pyelonephritis|treatment for acute pyelonephritis
166561|NCT02537847|Ertapenem|ertapenem
166562|NCT02537795|Deep Brain Stimulation|deep brain stimulation
166563|NCT02537795|Anterior Capsulotomy|anterior capsulotomy
166564|NCT02537782|Cardiac Resynchronisation Therapy|cardiac resynchronisation therapy
166565|NCT02537782|Heart Failure|heart failure
166566|NCT02537782|Left ventricular dyssynchrony|left ventricular dyssynchrony
166567|NCT02537782|Echocardiography|echocardiography
166568|NCT02537782|Apical rocking|apical rocking
166569|NCT02537782|Septal flash|septal flash
166570|NCT02537769|LVAD|lvad
166571|NCT02537769|Tricuspid regurgitation|tricuspid regurgitation
166572|NCT02537769|Heart failure|heart failure
166573|NCT02537769|Transplant|transplant
166574|NCT02537769|3D transesophageal echocardiography (TEE)|3d transesophageal echocardiography (tee)
166575|NCT02537769|2D transesophageal echocardiography (TEE)|2d transesophageal echocardiography (tee)
166576|NCT02537769|Mild|mild
166577|NCT02537769|Moderate|moderate
166578|NCT02537743|Patient Reported Outcomes|patient reported outcomes
166579|NCT02537704|Obesity|obesity
166580|NCT02537704|Translational|translational
166581|NCT02537704|Diabetes Prevention Program|diabetes prevention program
166582|NCT02537704|Group Lifestyle Balance Program|group lifestyle balance program
166583|NCT02537652|Central blood pressure|central blood pressure
166584|NCT02537652|Transient ischaemic attack|transient ischaemic attack
166585|NCT02537639|Simulator in transesophageal echocardiography|simulator in transesophageal echocardiography
166586|NCT02537613|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
166587|NCT02537600|BRAF mutation|braf mutation
166588|NCT02537600|Brain metastasis|brain metastasis
166589|NCT02537600|Cobimetinib + Vemurafenib combination treatment|cobimetinib + vemurafenib combination treatment
166590|NCT02537587|Blood glucose|blood glucose
166591|NCT02537587|Blood insulin|blood insulin
166592|NCT02537587|Humans|humans
166593|NCT02537587|Postprandial|postprandial
166594|NCT02537587|Carbohydrate|carbohydrate
166595|NCT02537587|Protein|protein
166596|NCT02537587|Resistant starch|resistant starch
166597|NCT02537587|Sugar|sugar
166598|NCT02537574|Alkermes|alkermes
166599|NCT02537574|Buprenorphine|buprenorphine
166600|NCT02537574|Naltrexone|naltrexone
166601|NCT02537574|Vivitrol|vivitrol
166602|NCT02537574|Opioid Use|opioid use
166603|NCT02537574|Opiates|opiates
166604|NCT02537574|Dependence|dependence
166605|NCT02537574|Abuse|abuse
166606|NCT02537574|Heroin|heroin
166607|NCT02537574|Painkillers|painkillers
166608|NCT02537574|Substance Abuse|substance abuse
166609|NCT02537496|Alzheimer's Disease|alzheimer's disease
166610|NCT02537496|Brain stimulation|brain stimulation
166611|NCT02537496|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
166612|NCT02537496|Neuroplasticity|neuroplasticity
166613|NCT02537496|cognitive enhancement|cognitive enhancement
166614|NCT02537496|TMS-EEG|tms-eeg
166615|NCT02537496|rTMS|rtms
166616|NCT02537496|PAS|pas
166617|NCT02537431|KRN23|krn23
166618|NCT02537431|Fibroblast growth factor 23 (FGF23)|fibroblast growth factor 23 (fgf23)
166619|NCT02537431|XLH|xlh
166620|NCT02537431|X-linked Hypophosphatemia|x-linked hypophosphatemia
166621|NCT02537379|Hepatitis C virus|hepatitis c virus
166622|NCT02537379|observational|observational
166623|NCT02537379|post-marketing|post-marketing
166624|NCT02537379|sofosbuvir|sofosbuvir
166625|NCT02537353|Upper gastrointestinal bleeding|upper gastrointestinal bleeding
166626|NCT02537353|Hemospray|hemospray
166627|NCT02537353|Endoscopic hemostasis|endoscopic hemostasis
166628|NCT02537340|PET/MR|pet/mr
166629|NCT02537340|MRI|mri
166630|NCT02537340|Rectal cancer|rectal cancer
166631|NCT02537340|EMVI|emvi
166632|NCT02537340|FDG|fdg
166633|NCT02537327|Recurrent caries|recurrent caries
166634|NCT02537327|Secondary caries|secondary caries
166635|NCT02537327|Dental composite|dental composite
166636|NCT02537327|Dental amalgam|dental amalgam
166637|NCT02537314|Normal Body Weight|normal body weight
166638|NCT02537301|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
166639|NCT02537301|social networking|social networking
166640|NCT02537301|group chat|group chat
166641|NCT02537288|VA106483|va106483
166642|NCT02537288|fedovapagon|fedovapagon
166643|NCT02537288|males|males
166644|NCT02537288|females|females
166645|NCT02537288|moxifloxacin|moxifloxacin
166646|NCT02537288|TQT|tqt
166647|NCT02537288|QT/QTC|qt/qtc
166648|NCT02537288|ECG|ecg
166649|NCT02537288|Nocturia|nocturia
166650|NCT02537262|carbohydrate|carbohydrate
166651|NCT02537262|quality of recovery(QOR) 40|quality of recovery(qor) 40
166652|NCT02537262|enhanced recovery after surgery(ERAS)|enhanced recovery after surgery(eras)
166653|NCT02537249|dexmedetomidine|dexmedetomidine
166654|NCT02537249|quality of recovery|quality of recovery
166655|NCT02537236|Omega-3 Fatty Acids|omega-3 fatty acids
166656|NCT02537236|Therapeutic Lifestyle Changes|therapeutic lifestyle changes
166657|NCT02537236|Human Immunodeficiency Virus|human immunodeficiency virus
166658|NCT02537236|Cardiac Risk|cardiac risk
166659|NCT02537236|Dyslipidemia|dyslipidemia
166660|NCT02537171|Apatinib|apatinib
166661|NCT02537171|Locally Advanced Gastric Cancer|locally advanced gastric cancer
166662|NCT02537171|Metastatic Gastric Cancer|metastatic gastric cancer
166663|NCT02537158|sorafenib|sorafenib
166664|NCT02537158|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
166665|NCT02537158|hepatocellular carcinoma|hepatocellular carcinoma
166666|NCT02537158|microvascular invasion|microvascular invasion
166667|NCT02537145|compliance|compliance
166668|NCT02537145|do-it-yourself methodology|do-it-yourself methodology
166669|NCT02537145|pilot|pilot
166670|NCT02537145|human microbiome|human microbiome
166671|NCT02537132|Non Invasive Ventilation (NIV)|non invasive ventilation (niv)
166672|NCT02537132|Amyotrophic Lateral sclerosis (ALS)|amyotrophic lateral sclerosis (als)
166673|NCT02537132|adaptation|adaptation
166674|NCT02537132|home care|home care
166675|NCT02537106|Brain Tumors|brain tumors
166676|NCT02537106|Microcirculation|microcirculation
166677|NCT02537106|Osmotherapy|osmotherapy
166678|NCT02537106|Hypertonic NaCl|hypertonic nacl
166679|NCT02537106|Natremia|natremia
166680|NCT02537080|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
166681|NCT02537080|Nimodipin|nimodipin
166682|NCT02537080|Anesthesia|anesthesia
166683|NCT02537067|a partial cartilage defect of ankle|a partial cartilage defect of ankle
166684|NCT02537067|Chondron|chondron
166685|NCT02537067|Autologus Chondrocyte|autologus chondrocyte
166686|NCT02537054|Choroidal neovascularization|choroidal neovascularization
166687|NCT02537054|Angioid streaks|angioid streaks
166688|NCT02537054|Pseudoxanthoma Elasticum|pseudoxanthoma elasticum
166689|NCT02537054|vascular endothelial growth factor|vascular endothelial growth factor
166690|NCT02537054|aflibercept|aflibercept
166691|NCT02537028|MSC2364447C|msc2364447c
166692|NCT02537028|Phase 1|phase 1
166693|NCT02537028|BTK inhibitor|btk inhibitor
166694|NCT02537028|Systemic Lupus Erythematosus|systemic lupus erythematosus
166695|NCT02537028|M2951|m2951
166696|NCT02537028|Lupus|lupus
166697|NCT02537002|PF-05230907|pf-05230907
166698|NCT02537002|Pharmacokinetics|pharmacokinetics
166699|NCT02537002|Pharmacodynamic|pharmacodynamic
166700|NCT02537002|Immunogenicity|immunogenicity
166701|NCT02536989|peptic ulcer bleeding|peptic ulcer bleeding
166702|NCT02536989|blood clot|blood clot
166703|NCT02536989|dose|dose
166704|NCT02536976|mirabegron|mirabegron
166705|NCT02536950|bionic pancreas|bionic pancreas
166706|NCT02536950|closed-loop control|closed-loop control
166707|NCT02536950|artificial pancreas|artificial pancreas
166708|NCT02536885|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
166709|NCT02536885|Blood pressure|blood pressure
166710|NCT02536885|Anesthesia|anesthesia
166711|NCT02536872|infection overactive bladder|infection overactive bladder
166712|NCT02536846|Healthy volunteers|healthy volunteers
166713|NCT02536846|antipsychotic drugs|antipsychotic drugs
166714|NCT02536846|brain metabolism|brain metabolism
166715|NCT02536833|OA|oa
166716|NCT02536833|Samumed|samumed
166717|NCT02536781|Anthocyanin|anthocyanin
166718|NCT02536781|Inflammation|inflammation
166719|NCT02536781|Orthodontic treatment|orthodontic treatment
166720|NCT02536768|Medication adherence|medication adherence
166721|NCT02536768|ART|art
166722|NCT02536768|Counseling|counseling
166723|NCT02536768|Adherence Guidelines for Chronic Diseases (HIV, TB and NCDs)|adherence guidelines for chronic diseases (hiv, tb and ncds)
166724|NCT02536742|Breast Cancer|breast cancer
166725|NCT02536742|Metastatic|metastatic
166726|NCT02536742|HER2 negative|her2 negative
166727|NCT02536742|Palbociclib|palbociclib
166728|NCT02536716|Dental Implant|dental implant
166729|NCT02536690|propofol|propofol
166730|NCT02536690|midazolam|midazolam
166731|NCT02536690|remifentanil|remifentanil
166732|NCT02536690|combination|combination
166733|NCT02536690|synergic|synergic
166734|NCT02536690|pharmacodynamics|pharmacodynamics
166735|NCT02536690|Loss of consciousness|loss of consciousness
166736|NCT02536677|Acute Chest Pain|acute chest pain
166737|NCT02536677|Acute Coronary Syndrome|acute coronary syndrome
166738|NCT02536677|Evaluation and Management|evaluation and management
166739|NCT02536677|Decision Aid|decision aid
166740|NCT02536677|Healthcare Utilization|healthcare utilization
166741|NCT02536651|validation studies, patient-reported outcome measures|validation studies, patient-reported outcome measures
166742|NCT02536638|urine protein|urine protein
166743|NCT02536638|pregnancy|pregnancy
166744|NCT02536638|pyelonephritis|pyelonephritis
166745|NCT02536638|kidney infection|kidney infection
166746|NCT02536625|everolimus|everolimus
166747|NCT02536625|NK|nk
166748|NCT02536625|metastatic|metastatic
166749|NCT02536612|Motivation|motivation
166750|NCT02536612|Behavioral Economics|behavioral economics
166751|NCT02536612|Conditional Economic Incentives|conditional economic incentives
166752|NCT02536612|Conditional cash transfers|conditional cash transfers
166753|NCT02536612|Contingency management|contingency management
166754|NCT02536599|Febrile Neutropenia|febrile neutropenia
166755|NCT02536599|Childhood Cancer|childhood cancer
166756|NCT02536599|Pediatric Oncology|pediatric oncology
166757|NCT02536599|Fever|fever
166758|NCT02536599|Neutropenia|neutropenia
166759|NCT02536573|Total hip replacement|total hip replacement
166760|NCT02536560|intestinal microbiota|intestinal microbiota
166761|NCT02536560|antibiotics|antibiotics
166762|NCT02536560|infant|infant
166763|NCT02536560|allergy|allergy
166764|NCT02536547|Clinical pulmonary infection score|clinical pulmonary infection score
166765|NCT02536547|sepsis|sepsis
166766|NCT02536547|lung ultrasound|lung ultrasound
166767|NCT02536547|ventilator-associated pneumonia|ventilator-associated pneumonia
166768|NCT02536534|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
166769|NCT02536534|Chronic Thromboembolic Pulmonary Hypertension (CTEPH)|chronic thromboembolic pulmonary hypertension (cteph)
166770|NCT02536456|screening|screening
166771|NCT02536456|counseling|counseling
166772|NCT02536456|follow-up|follow-up
166773|NCT02536456|cardiovascular disease|cardiovascular disease
166774|NCT02536456|population-based project|population-based project
166775|NCT02536456|China|china
166776|NCT02536443|heart failure|heart failure
166777|NCT02536443|prognosis|prognosis
166778|NCT02536443|clinical characteristics|clinical characteristics
166779|NCT02536430|Infra alveolar nerve block|infra alveolar nerve block
166780|NCT02536430|Ketorolac|ketorolac
166781|NCT02536430|Success rate|success rate
166782|NCT02536417|Melatonin|melatonin
166783|NCT02536417|Delirium prevention|delirium prevention
166784|NCT02536417|End-of-life|end-of-life
166785|NCT02536352|Fluoride Supplementation|fluoride supplementation
166786|NCT02536352|Prenatal Vitamin|prenatal vitamin
166787|NCT02536352|Pregnancy Nutrition|pregnancy nutrition
166788|NCT02536352|Prenatal Nutrition|prenatal nutrition
166789|NCT02536287|secondary hyperparathyroidism|secondary hyperparathyroidism
166790|NCT02536287|total parathyroidectomy|total parathyroidectomy
166791|NCT02536287|autotransplantation|autotransplantation
166792|NCT02536287|morbidity|morbidity
166793|NCT02536287|recurrence|recurrence
166794|NCT02536287|postoperative hypocalcemia|postoperative hypocalcemia
166795|NCT02536261|Prolactinoma|prolactinoma
166796|NCT02536261|dopamine agonist|dopamine agonist
166797|NCT02536261|withdrawal|withdrawal
166798|NCT02536261|cavernous sinus|cavernous sinus
166799|NCT02536248|sitagliptin|sitagliptin
166800|NCT02536248|diabetes|diabetes
166801|NCT02536248|inflammation|inflammation
166802|NCT02536196|Cerebral protection, aortic stenosis, transcatheter aortic valve implantation, TAVI, TriGuard, Keystone Heart|cerebral protection, aortic stenosis, transcatheter aortic valve implantation, tavi, triguard, keystone heart
166803|NCT02536183|Solid tumors|solid tumors
166804|NCT02536183|relapsed pediatric solid tumors|relapsed pediatric solid tumors
166805|NCT02536183|high intensity focused ultrasound|high intensity focused ultrasound
166806|NCT02536183|Lyso-thermosensitive liposomal doxorubicin|lyso-thermosensitive liposomal doxorubicin
166807|NCT02536183|ThermoDox|thermodox
166808|NCT02536183|relapsed sarcoma|relapsed sarcoma
166809|NCT02536183|Ewing Sarcoma family of tumors|ewing sarcoma family of tumors
166810|NCT02536183|Osteosarcoma|osteosarcoma
166811|NCT02536183|Neuroblastoma|neuroblastoma
166812|NCT02536183|Wilms Tumor|wilms tumor
166813|NCT02536183|Hepatic Tumor|hepatic tumor
166814|NCT02536183|Germ Cell Tumors|germ cell tumors
166815|NCT02536170|Arginine Therapy|arginine therapy
166816|NCT02536157|Volar plate|volar plate
166817|NCT02536144|colon capsule|colon capsule
166818|NCT02536144|magnetic|magnetic
166819|NCT02536144|maneuverability|maneuverability
166820|NCT02536144|colonoscopy|colonoscopy
166821|NCT02536131|Psychosomatics|psychosomatics
166822|NCT02536131|Gastroenterology|gastroenterology
166823|NCT02536131|Psychoneuroimmunology|psychoneuroimmunology
166824|NCT02536105|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
166825|NCT02536105|ADHD|adhd
166826|NCT02536053|[E04.100.814.603]|[e04.100.814.603]
166827|NCT02536040|silver diamine fluoride|silver diamine fluoride
166828|NCT02536040|diammine silver fluoride|diammine silver fluoride
166829|NCT02536040|children|children
166830|NCT02536027|continuous venovenous hemofiltration|continuous venovenous hemofiltration
166831|NCT02536027|neutrophil gelatinase-associated lipocalin|neutrophil gelatinase-associated lipocalin
166832|NCT02536027|sepsis|sepsis
166833|NCT02536027|acute kidney injury|acute kidney injury
166834|NCT02536014|Dexmedetomidine|dexmedetomidine
166835|NCT02536014|pneumoperitoneum|pneumoperitoneum
166836|NCT02536014|trendelenburg position|trendelenburg position
166837|NCT02536014|QTc interval|qtc interval
166838|NCT02536014|Tp-e interval|tp-e interval
166839|NCT02536014|robotic prostatectomy|robotic prostatectomy
166840|NCT02536001|Vaginal mesh|vaginal mesh
166841|NCT02536001|Total vaginal length|total vaginal length
166842|NCT02536001|Quality of life|quality of life
166843|NCT02535988|Colorectal Cancer|colorectal cancer
166844|NCT02535988|Metastatic Colorectal Cancer|metastatic colorectal cancer
166845|NCT02535988|ZADAXIN|zadaxin
166846|NCT02535988|Abscopal Effect|abscopal effect
166847|NCT02535988|Radiotherapy|radiotherapy
166848|NCT02535962|PFAPA|pfapa
166849|NCT02535936|Cerebral Palsy|cerebral palsy
166850|NCT02535923|Schizophrenia and Disorders with Psychotic Feature|schizophrenia and disorders with psychotic feature
166851|NCT02535923|Mental Disorders|mental disorders
166852|NCT02535923|Insomnia Disorder|insomnia disorder
166853|NCT02535910|vitamin D3|vitamin d3
166854|NCT02535910|25(OH)D3|25(oh)d3
166855|NCT02535910|vitamin D status|vitamin d status
166856|NCT02535910|risk factors of cardiovascular diease|risk factors of cardiovascular diease
166857|NCT02535884|Huntington Disease|huntington disease
166858|NCT02535884|DBS|dbs
166859|NCT02535884|Chorea|chorea
166860|NCT02535858|Anxiety|anxiety
166861|NCT02535832|Rheumatoid Arthritis|rheumatoid arthritis
166862|NCT02535819|Cataract surgery|cataract surgery
166863|NCT02535806|Relapsed, Refractory|relapsed, refractory
166864|NCT02535767|Primaquine|primaquine
166865|NCT02535741|Knee Replacement|knee replacement
166866|NCT02535741|Arthroplasty|arthroplasty
166867|NCT02535728|Frail Elderly|frail elderly
166868|NCT02535728|Cardiac Surgical Procedure|cardiac surgical procedure
166869|NCT02535728|Risk Assessment|risk assessment
166870|NCT02535728|Quality of Life|quality of life
166871|NCT02535715|Oral Insulin|oral insulin
166872|NCT02535702|fMRI|fmri
166873|NCT02535702|EEG|eeg
166874|NCT02535689|Anti-DNA Antibody|anti-dna antibody
166875|NCT02535689|Tofacitinib|tofacitinib
166876|NCT02535689|Lupus|lupus
166877|NCT02535689|Safety|safety
166878|NCT02535676|schizophrenia|schizophrenia
166879|NCT02535676|transcranial stimulation|transcranial stimulation
166880|NCT02535663|rhamnogalacturonan|rhamnogalacturonan
166881|NCT02535663|Natural killer cell activity|natural killer cell activity
166882|NCT02535663|interleukin-12|interleukin-12
166883|NCT02535663|interferon-gamma|interferon-gamma
166884|NCT02535663|immune function|immune function
166885|NCT02535663|inflammatory|inflammatory
166886|NCT02535572|Electroconvulsive Therapy|electroconvulsive therapy
166887|NCT02535546|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
166888|NCT02535546|Streptococcus pneumoniae|streptococcus pneumoniae
166889|NCT02535546|Pneumonia|pneumonia
166890|NCT02535546|Pneumococcal conjugate vaccine-13 (PCV-13)|pneumococcal conjugate vaccine-13 (pcv-13)
166891|NCT02535546|Pneumococcal polysaccharide vaccine-23 (PPV-23)|pneumococcal polysaccharide vaccine-23 (ppv-23)
166892|NCT02535546|Pneumococcal vaccine|pneumococcal vaccine
166893|NCT02535533|Kidney cancer|kidney cancer
166894|NCT02535533|Selenium (Se)|selenium (se)
166895|NCT02535507|pyrotinib|pyrotinib
166896|NCT02535507|HER2|her2
166897|NCT02535507|Non-small Cell Lung Cancer|non-small cell lung cancer
166898|NCT02535507|Phase II|phase ii
166899|NCT02535481|epidermal graft|epidermal graft
166900|NCT02535481|suction blister|suction blister
166901|NCT02535481|blister graft|blister graft
166902|NCT02535481|suction graft|suction graft
166903|NCT02535481|Epidermis/su, tr [Surgery, Transplantation]|epidermis/su, tr [surgery, transplantation]
166904|NCT02535390|cognitive remediation|cognitive remediation
166905|NCT02535390|vocational outcomes|vocational outcomes
166906|NCT02535377|Cryodamage|cryodamage
166907|NCT02535377|microarrays|microarrays
166908|NCT02535377|Insemination|insemination
166909|NCT02535377|sperm|sperm
166910|NCT02535364|acute lymphoblastic leukemia|acute lymphoblastic leukemia
166911|NCT02535364|ALL|all
166912|NCT02535364|chimeric antigen receptor|chimeric antigen receptor
166913|NCT02535364|CAR|car
166914|NCT02535364|CAR T cells|car t cells
166915|NCT02535364|JCAR015|jcar015
166916|NCT02535364|autologous T cell therapy|autologous t cell therapy
166917|NCT02535364|cell therapy|cell therapy
166918|NCT02535351|Clear cell Metastatic renal cell carcinoma|clear cell metastatic renal cell carcinoma
166919|NCT02535351|Cytoreductive nephrectomy|cytoreductive nephrectomy
166920|NCT02535351|First line treatment|first line treatment
166921|NCT02535299|telomere-telomerase|telomere-telomerase
166922|NCT02535299|Par-4|par-4
166923|NCT02535299|GLP-1|glp-1
166924|NCT02535299|metformin|metformin
166925|NCT02535273|dexmedetomidine|dexmedetomidine
166926|NCT02535273|prone position|prone position
166927|NCT02535273|spine surgery|spine surgery
166928|NCT02535273|Minimally invasive|minimally invasive
166929|NCT02535273|local anesthesia|local anesthesia
166930|NCT02535260|Pregnancy|pregnancy
166931|NCT02535221|Premenopausal Patients|premenopausal patients
166932|NCT02535221|Estrogen Receptor-Positive HER2 negative|estrogen receptor-positive her2 negative
166933|NCT02535169|at risk for type 2 diabetes|at risk for type 2 diabetes
166934|NCT02535169|currently has type 2 diabetes|currently has type 2 diabetes
166935|NCT02535065|Low Profile|low profile
166936|NCT02535065|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
166937|NCT02535065|Endovascular|endovascular
166938|NCT02535039|Elderly|elderly
166939|NCT02535039|cognitive retention disorder|cognitive retention disorder
166940|NCT02535039|methylprednisolone|methylprednisolone
166941|NCT02534974|Critical care|critical care
166942|NCT02534974|Trauma patients|trauma patients
166943|NCT02534961|Hepatocellular carcinoma|hepatocellular carcinoma
166944|NCT02534961|Radiofrequency ablation|radiofrequency ablation
166945|NCT02534961|Antibiotics|antibiotics
166946|NCT02534948|mindfulness|mindfulness
166947|NCT02534948|MABT|mabt
166948|NCT02534948|social anxiety|social anxiety
166949|NCT02534948|mindfulness and acceptance|mindfulness and acceptance
166950|NCT02534948|group therapy|group therapy
166951|NCT02534935|Phase 2 Immunogenicity|phase 2 immunogenicity
166952|NCT02534935|Safety|safety
166953|NCT02534935|Tolerability Study|tolerability study
166954|NCT02534935|rLP2086 Vaccine|rlp2086 vaccine
166955|NCT02534935|Healthy Toddlers|healthy toddlers
166956|NCT02534935|Neisseria meningitidis|neisseria meningitidis
166957|NCT02534935|Duration of Immunogenicity|duration of immunogenicity
166958|NCT02534909|PNH|pnh
166959|NCT02534870|Volunteer|volunteer
166960|NCT02534857|randomized double blinded study|randomized double blinded study
166961|NCT02534857|live birth rate|live birth rate
166962|NCT02534857|IVF treatment|ivf treatment
166963|NCT02534857|brief incubation of oocytes and sperm|brief incubation of oocytes and sperm
166964|NCT02534844|Niemann-Pick Type C1 (NPC1) Disease|niemann-pick type c1 (npc1) disease
166965|NCT02534844|neurologic disease|neurologic disease
166966|NCT02534844|gross motor dysfunction|gross motor dysfunction
166967|NCT02534844|fine motor dysfunction|fine motor dysfunction
166968|NCT02534844|dysphagia|dysphagia
166969|NCT02534844|swallowing problems|swallowing problems
166970|NCT02534844|cognitive dysfunction|cognitive dysfunction
166971|NCT02534844|gait abnormalities|gait abnormalities
166972|NCT02534844|pediatrics|pediatrics
166973|NCT02534727|Tuberculosis|tuberculosis
166974|NCT02534727|Non-Tuberculous Mycobacterim|non-tuberculous mycobacterim
166975|NCT02534727|Xpert/MDR-RIF|xpert/mdr-rif
166976|NCT02534727|TDM|tdm
166977|NCT02534701|stroke|stroke
166978|NCT02534701|clot retrieval system|clot retrieval system
166979|NCT02534701|recanalization|recanalization
166980|NCT02534649|Molecular profiling|molecular profiling
166981|NCT02534649|Genomic alteration|genomic alteration
166982|NCT02534649|Advanced cancer|advanced cancer
166983|NCT02534610|preemptive|preemptive
166984|NCT02534610|postoperative pain|postoperative pain
166985|NCT02534610|etoricoxib|etoricoxib
166986|NCT02534584|acute kidney injury|acute kidney injury
166987|NCT02534584|outcome|outcome
166988|NCT02534584|mortality|mortality
166989|NCT02534584|care-bundle|care-bundle
166990|NCT02534558|MicroRNA-29|microrna-29
166991|NCT02534558|shoulder stiffness|shoulder stiffness
166992|NCT02534558|mir-29a|mir-29a
166993|NCT02534545|Intracranial atherosclerotic stenosis|intracranial atherosclerotic stenosis
166994|NCT02534545|ischemia|ischemia
166995|NCT02534545|remote ischemic conditioning|remote ischemic conditioning
166996|NCT02534545|stroke|stroke
166997|NCT02534532|Atrial fibrillation screening|atrial fibrillation screening
166998|NCT02534506|Advanced malignant tumors|advanced malignant tumors
166999|NCT02534506|Metastatic malignant tumors|metastatic malignant tumors
167000|NCT02534480|Amyloid|amyloid
167001|NCT02534415|Antiinflammatory|antiinflammatory
167002|NCT02534415|Gingiva|gingiva
167003|NCT02534415|Hyaluronic acid|hyaluronic acid
167004|NCT02534415|Palate|palate
167005|NCT02534415|Transplants|transplants
167006|NCT02534415|Wound healing|wound healing
167007|NCT02534402|Biomarkers|biomarkers
167008|NCT02534402|Genomics|genomics
167009|NCT02534402|Prednisone|prednisone
167010|NCT02534389|rectal cancer|rectal cancer
167011|NCT02534389|inflammation|inflammation
167012|NCT02534389|omega-3|omega-3
167013|NCT02534389|fish oil|fish oil
167014|NCT02534389|nutritional status|nutritional status
167015|NCT02534376|prostatectomy, cholesterol, statin|prostatectomy, cholesterol, statin
167016|NCT02534363|Cognition|cognition
167017|NCT02534363|Psychosis|psychosis
167018|NCT02534363|Antipsychotic Agents|antipsychotic agents
167019|NCT02534363|Treatment|treatment
167020|NCT02534363|Effectiveness|effectiveness
167021|NCT02534363|Aripiprazole|aripiprazole
167022|NCT02534363|Quetiapine|quetiapine
167023|NCT02534363|Ziprasidone|ziprasidone
167024|NCT02534363|Neurocognition|neurocognition
167025|NCT02534350|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
167026|NCT02534350|Antiviral|antiviral
167027|NCT02534350|Lung Transplant|lung transplant
167028|NCT02534324|Hypertension|hypertension
167029|NCT02534324|Emergency|emergency
167030|NCT02534298|single sided deafness.|single sided deafness.
167031|NCT02534298|Auditory plasticity|auditory plasticity
167032|NCT02534298|Asymmetrical hearing loss|asymmetrical hearing loss
167033|NCT02534298|Cochlear implants|cochlear implants
167034|NCT02534298|Inter hemispheric asymmetry|inter hemispheric asymmetry
167035|NCT02534298|Lateralization index|lateralization index
167036|NCT02534298|Dichotic hearing|dichotic hearing
167037|NCT02534285|Anesthesia, Inhalation|anesthesia, inhalation
167038|NCT02534285|Hearing|hearing
167039|NCT02534285|Noise, Occupational|noise, occupational
167040|NCT02534246|Core tissue biopsy|core tissue biopsy
167041|NCT02534246|Core needle biopsy|core needle biopsy
167042|NCT02534246|EUS|eus
167043|NCT02534246|Fine needle biopsy|fine needle biopsy
167044|NCT02534246|Fine needle aspiration|fine needle aspiration
167045|NCT02534233|barrett's esophagus with dysplasia|barrett's esophagus with dysplasia
167046|NCT02534233|early esophageal cancer|early esophageal cancer
167047|NCT02534220|Toothbrushing|toothbrushing
167048|NCT02534220|Oral hygiene|oral hygiene
167049|NCT02534220|Dental hygiene|dental hygiene
167050|NCT02534194|Gestation|gestation
167051|NCT02534194|Premature|premature
167052|NCT02534194|Infants|infants
167053|NCT02534181|Refeeding Syndrome|refeeding syndrome
167054|NCT02534181|Cancer|cancer
167055|NCT02534168|genetic polymorphisms|genetic polymorphisms
167056|NCT02534155|MitraClip®|mitraclip®
167057|NCT02534155|MR|mr
167058|NCT02534155|DMR|dmr
167059|NCT02534155|high-risk patients|high-risk patients
167060|NCT02534155|mitral regurgitation|mitral regurgitation
167061|NCT02534155|surgery|surgery
167062|NCT02534155|intermediate risk patients|intermediate risk patients
167063|NCT02534129|breast cancer|breast cancer
167064|NCT02534129|radiation|radiation
167065|NCT02534129|dermatitis|dermatitis
167066|NCT02534116|abdominal reconstruction|abdominal reconstruction
167067|NCT02534090|Premature|premature
167068|NCT02534090|Preterm|preterm
167069|NCT02534090|Necrotizing|necrotizing
167070|NCT02534090|Enterocolitis|enterocolitis
167071|NCT02534090|NIRS|nirs
167072|NCT02534077|omegaven|omegaven
167073|NCT02534077|cholestasis|cholestasis
167074|NCT02534077|parenteral nutrition associated liver disease|parenteral nutrition associated liver disease
167075|NCT02534064|Menopause|menopause
167076|NCT02534064|Osteoporosis|osteoporosis
167077|NCT02534064|Hip fractures|hip fractures
167078|NCT02534064|vitamin D deficiency|vitamin d deficiency
167079|NCT02534051|clinical care path|clinical care path
167080|NCT02534051|care pathway|care pathway
167081|NCT02534051|obesity|obesity
167083|NCT02534038|Disinhibition|disinhibition
167084|NCT02533986|Berry|berry
167085|NCT02533986|Inflammation|inflammation
167086|NCT02533986|Cognition|cognition
167087|NCT02533986|Polyphenols|polyphenols
167088|NCT02533986|Appetite|appetite
167089|NCT02533986|Glucose metabolism|glucose metabolism
167090|NCT02533960|Registry of Acute Stroke Under Novel Oral Anticoagulants|registry of acute stroke under novel oral anticoagulants
167091|NCT02533947|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
167092|NCT02533947|Hematological Malignancies|hematological malignancies
167093|NCT02533947|Exercise Intervention|exercise intervention
167094|NCT02533947|Cognitive Function|cognitive function
167095|NCT02533947|Fatigue|fatigue
167096|NCT02533947|Randomized Controlled Trial|randomized controlled trial
167097|NCT02533934|HIV|hiv
167098|NCT02533934|Hepatitis C|hepatitis c
167099|NCT02533934|Liver Disease|liver disease
167100|NCT02533934|HCV Treatment|hcv treatment
167101|NCT02533934|transplant|transplant
167102|NCT02533921|Palliative Care|palliative care
167103|NCT02533921|Parkinson's Disease|parkinson's disease
167104|NCT02533869|low-dose computed tomography|low-dose computed tomography
167105|NCT02533817|Fructose|fructose
167106|NCT02533817|Insulin|insulin
167107|NCT02533817|Postprandial lipemia|postprandial lipemia
167108|NCT02533817|Ambulatory blood pressure|ambulatory blood pressure
167109|NCT02533817|Ethnicity|ethnicity
167110|NCT02533804|health|health
167111|NCT02533804|wellness|wellness
167112|NCT02533804|life expectancy|life expectancy
167113|NCT02533804|quality of life|quality of life
167114|NCT02533804|performance|performance
167115|NCT02533804|religion|religion
167116|NCT02533804|skin|skin
167117|NCT02533804|cardiovascular|cardiovascular
167118|NCT02533804|joints|joints
167119|NCT02533804|bone|bone
167120|NCT02533804|respiration|respiration
167121|NCT02533804|pain|pain
167122|NCT02533804|nervous system diseases|nervous system diseases
167123|NCT02533804|oral health|oral health
167124|NCT02533804|behavior|behavior
167125|NCT02533804|child|child
167126|NCT02533804|depression|depression
167127|NCT02533804|mood|mood
167128|NCT02533804|panic|panic
167129|NCT02533804|sleep|sleep
167130|NCT02533804|stress|stress
167131|NCT02533804|nutrition|nutrition
167132|NCT02533804|exercise|exercise
167133|NCT02533804|life change events|life change events
167134|NCT02533804|personality|personality
167135|NCT02533804|employment|employment
167136|NCT02533804|social networking|social networking
167137|NCT02533804|time management|time management
167138|NCT02533804|residence characteristics|residence characteristics
167139|NCT02533791|Safety|safety
167140|NCT02533791|immunogenicity|immunogenicity
167141|NCT02533791|Ebola vaccine|ebola vaccine
167142|NCT02533791|boosting|boosting
167143|NCT02533765|Cisplatin-resistant|cisplatin-resistant
167144|NCT02533765|Neoplasms, Germ Cell and Embryonal|neoplasms, germ cell and embryonal
167145|NCT02533765|Salvage treatment|salvage treatment
167146|NCT02533765|olaparib|olaparib
167147|NCT02533752|Left Atrial Appendage Closure|left atrial appendage closure
167148|NCT02533752|Watchman device|watchman device
167149|NCT02533752|LAA Closure|laa closure
167150|NCT02533726|Bed Sores|bed sores
167151|NCT02533726|Bedsores|bedsores
167152|NCT02533726|Decubitus Ulcer|decubitus ulcer
167153|NCT02533726|Pressure Sore|pressure sore
167154|NCT02533713|rehabilitation|rehabilitation
167155|NCT02533713|bone strength|bone strength
167156|NCT02533713|quality of life|quality of life
167157|NCT02533687|prostate|prostate
167158|NCT02533687|transurethral resection|transurethral resection
167159|NCT02533687|bipolar|bipolar
167160|NCT02533687|monopolar|monopolar
167161|NCT02533661|Effectiveness|effectiveness
167162|NCT02533661|Genes|genes
167163|NCT02533661|Intervention|intervention
167164|NCT02533661|Neurodevelopment|neurodevelopment
167165|NCT02533661|Prematurity|prematurity
167166|NCT02533661|Preschool Age|preschool age
167167|NCT02533648|Type 2 diabetes mellitus, oxidative stress|type 2 diabetes mellitus, oxidative stress
167168|NCT02533648|insulin sensitivity|insulin sensitivity
167169|NCT02533648|insulin resistance|insulin resistance
167170|NCT02533648|mitochondrial dysfunction|mitochondrial dysfunction
167171|NCT02533648|skeletal muscle|skeletal muscle
167172|NCT02533648|xanthine oxidase|xanthine oxidase
167173|NCT02533648|allopurinol|allopurinol
167174|NCT02533622|progressive mobility|progressive mobility
167175|NCT02533583|pulse oximetry|pulse oximetry
167176|NCT02533583|clinical assessment|clinical assessment
167177|NCT02533583|neonate|neonate
167178|NCT02533583|lung disease|lung disease
167179|NCT02533570|Lupus|lupus
167180|NCT02533557|brachial plexus block|brachial plexus block
167181|NCT02533557|nerve stimulator|nerve stimulator
167182|NCT02533557|ultrasound|ultrasound
167183|NCT02533544|tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
167184|NCT02533505|Respiratory|respiratory
167185|NCT02533505|COPD|copd
167186|NCT02533505|O2 Consumption|o2 consumption
167187|NCT02533492|total knee replacement|total knee replacement
167188|NCT02533492|vicryl plus|vicryl plus
167189|NCT02533492|surgical site infection|surgical site infection
167190|NCT02533453|Type 2 Diabetes Mellitus, T2DM, GLP-1, GLP-1 Once weekly, Exenatide|type 2 diabetes mellitus, t2dm, glp-1, glp-1 once weekly, exenatide
167191|NCT02533414|kidney stone|kidney stone
167192|NCT02533414|retrograde intrarenal surgery|retrograde intrarenal surgery
167193|NCT02533414|ureteral access sheath|ureteral access sheath
167194|NCT02533414|kidney function|kidney function
167195|NCT02533388|transcutaneous electrical acupoint stimulation|transcutaneous electrical acupoint stimulation
167196|NCT02533388|stress response|stress response
167197|NCT02533375|efficacy|efficacy
167198|NCT02533375|safety|safety
167199|NCT02533349|laryngopharyngeal reflux disease|laryngopharyngeal reflux disease
167200|NCT02533349|prokinetics|prokinetics
167201|NCT02533349|proton pump inhibitor|proton pump inhibitor
167202|NCT02533336|Malaria control|malaria control
167450|NCT02532153|Ketamine|ketamine
167203|NCT02533336|Insecticide treated durable Wall Liners|insecticide treated durable wall liners
167204|NCT02533336|Malaria incidence|malaria incidence
167205|NCT02533336|Randomized Trial|randomized trial
167206|NCT02533323|NK/T-cell lymphoma|nk/t-cell lymphoma
167207|NCT02533323|induction chemotherapy|induction chemotherapy
167208|NCT02533323|survival|survival
167209|NCT02533310|Specific phobia|specific phobia
167210|NCT02533310|Exposure therapy|exposure therapy
167211|NCT02533310|Virtual reality|virtual reality
167212|NCT02533310|Randomized controlled trial|randomized controlled trial
167213|NCT02533297|standardization,|standardization,
167214|NCT02533297|performance clinical skills|performance clinical skills
167215|NCT02533297|nursing|nursing
167216|NCT02533297|learning curve|learning curve
167217|NCT02533271|rectal cancer|rectal cancer
167218|NCT02533271|short-term radiotherapy|short-term radiotherapy
167219|NCT02533271|neoadjuvant chemotherapy|neoadjuvant chemotherapy
167220|NCT02533271|total mesorectal excision|total mesorectal excision
167221|NCT02533258|advanced renal cell carcinoma, disease progression, sunitinib, interferon alpha|advanced renal cell carcinoma, disease progression, sunitinib, interferon alpha
167222|NCT02533245|Exercise Training|exercise training
167223|NCT02533245|Quality of Life|quality of life
167224|NCT02533245|Patient Reported Outcomes|patient reported outcomes
167225|NCT02533245|Organ Transplantation|organ transplantation
167226|NCT02533232|Schizophrenia|schizophrenia
167227|NCT02533232|Anti-inflammatory|anti-inflammatory
167228|NCT02533232|Clozapine|clozapine
167229|NCT02533232|Minocycline|minocycline
167230|NCT02533232|Psychosis NOS|psychosis nos
167231|NCT02533219|Hyperinsulinemic hypoglycemia|hyperinsulinemic hypoglycemia
167232|NCT02533219|PET/CT|pet/ct
167233|NCT02533219|PET/MRI|pet/mri
167234|NCT02533219|[18F]-DOPA|[18f]-dopa
167235|NCT02533219|PET/MR|pet/mr
167236|NCT02533219|Congenital Hyperinsulinism|congenital hyperinsulinism
167237|NCT02533193|enhanced recovery after surgery protocal|enhanced recovery after surgery protocal
167238|NCT02533193|laparoscopic hepatectomy|laparoscopic hepatectomy
167239|NCT02533180|Liver allograft recipient|liver allograft recipient
167240|NCT02533180|Immunosuppression withdrawal|immunosuppression withdrawal
167241|NCT02533180|Calcineurin inhibitor (CNI) based immunosuppression|calcineurin inhibitor (cni) based immunosuppression
167242|NCT02533180|Living Donor (of the Respective Liver Transplant Recipient)|living donor (of the respective liver transplant recipient)
167243|NCT02533141|Investigation of the changes of flicker induced vasodilatation before, during and after withdrawal of therapy with simvastatin|investigation of the changes of flicker induced vasodilatation before, during and after withdrawal of therapy with simvastatin
167244|NCT02533128|Intraoperative blood pressure|intraoperative blood pressure
167245|NCT02533128|Triple low|triple low
167246|NCT02533128|Anesthetic overdose|anesthetic overdose
167247|NCT02533128|Major adverse cardiac events (MACE)|major adverse cardiac events (mace)
167248|NCT02533128|Myocardial injury after noncardiac surgery (MINS)|myocardial injury after noncardiac surgery (mins)
167249|NCT02533128|Perioperative risk stratification|perioperative risk stratification
167250|NCT02533128|Brain-type natriuretic peptide (BNP)|brain-type natriuretic peptide (bnp)
167251|NCT02533128|High-sensitivity cardiac Troponin I (hs-cTnI)|high-sensitivity cardiac troponin i (hs-ctni)
167252|NCT02533115|VYXEOS|vyxeos
167253|NCT02533102|Pharmacokinetics|pharmacokinetics
167254|NCT02533102|E7050|e7050
167255|NCT02533102|Healthy Subjects|healthy subjects
167256|NCT02533050|obstructive sleep apnea|obstructive sleep apnea
167257|NCT02533050|acute coronary event|acute coronary event
167258|NCT02533050|cognitive functions|cognitive functions
167259|NCT02533050|Continuous positive airway pressure night|continuous positive airway pressure night
167260|NCT02533011|Sepsis|sepsis
167261|NCT02533011|Heparin Binding Protein|heparin binding protein
167262|NCT02532998|Pharmacodynamics|pharmacodynamics
167263|NCT02532998|AZD9977|azd9977
167264|NCT02532998|Safety|safety
167265|NCT02532998|Tolerability|tolerability
167266|NCT02532998|Pharmacokinetics|pharmacokinetics
167267|NCT02532998|Eplerenone|eplerenone
167268|NCT02532998|Fludrocortisone|fludrocortisone
167269|NCT02532985|Gastrointestinal tolerability|gastrointestinal tolerability
167270|NCT02532985|dietary fiber|dietary fiber
167271|NCT02532985|clinical trial|clinical trial
167272|NCT02532985|healthy subjects|healthy subjects
167273|NCT02532933|Replacement, Knee|replacement, knee
167274|NCT02532920|Natural history|natural history
167275|NCT02532920|Atopic dermatitis|atopic dermatitis
167276|NCT02532920|Atopic march|atopic march
167277|NCT02532907|HCV|hcv
167278|NCT02532894|endothelial dysfunction|endothelial dysfunction
167279|NCT02532894|microvesicles|microvesicles
167280|NCT02532894|endothelial progenitor cells|endothelial progenitor cells
167281|NCT02532894|electronic cigarettes|electronic cigarettes
167282|NCT02532842|Schizophrenia|schizophrenia
167283|NCT02532842|Paliperidone palmitate|paliperidone palmitate
167284|NCT02532816|stunting|stunting
167285|NCT02532816|indonesia|indonesia
167286|NCT02532803|Cancer|cancer
167287|NCT02532803|Rectum|rectum
167288|NCT02532803|Rectal Cancer|rectal cancer
167289|NCT02532803|Polyps|polyps
167290|NCT02532790|Mild proteinuria|mild proteinuria
167291|NCT02532764|cystic fibrosis|cystic fibrosis
167292|NCT02532764|ΔF508|δf508
167293|NCT02532764|RNA therapies|rna therapies
167294|NCT02532764|antisense oligonucleotide|antisense oligonucleotide
167295|NCT02532764|CFTR|cftr
167296|NCT02532764|F508del|f508del
167297|NCT02532764|CF|cf
167298|NCT02532764|RNA therapy|rna therapy
167299|NCT02532738|efficacy of MSC|efficacy of msc
167300|NCT02532738|refractory|refractory
167301|NCT02532725|heat stress response|heat stress response
167302|NCT02532725|cardiopulmonary exercise test|cardiopulmonary exercise test
167303|NCT02532725|men|men
167304|NCT02532725|middle aged|middle aged
167305|NCT02532725|heat-shock response|heat-shock response
167306|NCT02532712|EC-18|ec-18
167307|NCT02532712|Hematology|hematology
167308|NCT02532712|Cancer|cancer
167309|NCT02532712|Neutropenia|neutropenia
167310|NCT02532699|Antrodia cinnamomea mycelia|antrodia cinnamomea mycelia
167311|NCT02532699|blood pressure|blood pressure
167312|NCT02532699|adenosine|adenosine
167313|NCT02532699|antrosterol|antrosterol
167314|NCT02532699|clinical trial|clinical trial
167315|NCT02532699|gamma-aminobutyric acid|gamma-aminobutyric acid
167316|NCT02532686|Treatment resistant|treatment resistant
167317|NCT02532686|DAAOI|daaoi
167318|NCT02532686|NMDA|nmda
167319|NCT02532634|ramosetron|ramosetron
167320|NCT02532634|palonosetron|palonosetron
167321|NCT02532634|chemotherapy induced nausea and vomiting|chemotherapy induced nausea and vomiting
167322|NCT02532582|nerve compression|nerve compression
167323|NCT02532530|Aortic valve replacement with or without CABG|aortic valve replacement with or without cabg
167324|NCT02532517|CODMAN ENTERPRISE® Vascular Reconstruction Device|codman enterprise® vascular reconstruction device
167325|NCT02532517|Wide Neck, Intracranial, Saccular Aneurysms|wide neck, intracranial, saccular aneurysms
167326|NCT02532517|Cerebral Aneurysms|cerebral aneurysms
167327|NCT02532504|postnatal depression|postnatal depression
167328|NCT02532504|Cognitive behaviour Therapy|cognitive behaviour therapy
167329|NCT02532504|Traditional Birth Attendants|traditional birth attendants
167330|NCT02532504|low income country|low income country
167331|NCT02532491|Psychosis|psychosis
167332|NCT02532491|Antipsychotic Agents|antipsychotic agents
167333|NCT02532491|Treatment|treatment
167334|NCT02532491|Effectiveness|effectiveness
167335|NCT02532491|Aripiprazole|aripiprazole
167336|NCT02532491|Risperidone|risperidone
167337|NCT02532452|Epstein-Barr Virus (EBV)|epstein-barr virus (ebv)
167338|NCT02532452|Adenovirus (ADV)|adenovirus (adv)
167339|NCT02532452|Cytomegalovirus (CMV)|cytomegalovirus (cmv)
167340|NCT02532452|T-Cells|t-cells
167341|NCT02532452|Donor|donor
167342|NCT02532452|BK virus (BKV)|bk virus (bkv)
167343|NCT02532439|fracture osteoporosis|fracture osteoporosis
167344|NCT02532439|bone microarchitecture|bone microarchitecture
167345|NCT02532439|Inflammatory joint diseases|inflammatory joint diseases
167346|NCT02532439|Bone fragility|bone fragility
167347|NCT02532439|Rheumatoid Arthritis|rheumatoid arthritis
167348|NCT02532439|Spondyloarthritis|spondyloarthritis
167349|NCT02532439|Primary Hyperparathyroidism|primary hyperparathyroidism
167350|NCT02532439|constitutional thinness|constitutional thinness
167351|NCT02532439|anorexia nervosa|anorexia nervosa
167352|NCT02532426|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
167353|NCT02532426|Muscle biopsy|muscle biopsy
167354|NCT02532426|Chronic hypoxia|chronic hypoxia
167355|NCT02532426|OXYPHEN|oxyphen
167356|NCT02532426|Oxydative phenotype|oxydative phenotype
167357|NCT02532426|Exercise|exercise
167358|NCT02532400|Breast Neoplasms|breast neoplasms
167359|NCT02532400|Neoadjuvant Endocrine Therapy|neoadjuvant endocrine therapy
167360|NCT02532400|Ovarian Function Suppression|ovarian function suppression
167361|NCT02532400|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
167362|NCT02532374|nicotine absorption|nicotine absorption
167363|NCT02532374|nicotine containing product|nicotine containing product
167364|NCT02532374|adult smoker|adult smoker
167365|NCT02532374|Nicorette|nicorette
167366|NCT02532374|nicotine delivery system|nicotine delivery system
167367|NCT02532361|Sterilization|sterilization
167368|NCT02532361|Hysteroscopic Device Placement|hysteroscopic device placement
167369|NCT02532361|Tubal Ligation|tubal ligation
167370|NCT02532348|Human Immunodeficiency Virus|human immunodeficiency virus
167371|NCT02532348|HIV|hiv
167372|NCT02532348|antiretroviral therapy|antiretroviral therapy
167373|NCT02532348|platelets|platelets
167374|NCT02532348|Immune activation|immune activation
167375|NCT02532348|Inflammatory state|inflammatory state
167376|NCT02532335|FXR|fxr
167377|NCT02532335|bile acids|bile acids
167378|NCT02532335|FGF19|fgf19
167379|NCT02532335|C4|c4
167380|NCT02532335|gut microbiota|gut microbiota
167381|NCT02532335|Pharmacodynamics of FXR activation in the small bowel|pharmacodynamics of fxr activation in the small bowel
167382|NCT02532309|Rosuvastatin|rosuvastatin
167383|NCT02532309|Carotid Atherosclerosis plaque|carotid atherosclerosis plaque
167384|NCT02532309|Crestor|crestor
167385|NCT02532309|Rosuvastatin calcium|rosuvastatin calcium
167386|NCT02532283|Influenza A virus|influenza a virus
167387|NCT02532283|JNJ-63623872|jnj-63623872
167388|NCT02532283|Oseltamivir|oseltamivir
167389|NCT02532270|obstetric|obstetric
167390|NCT02532270|anesthesia|anesthesia
167391|NCT02532270|hypotension|hypotension
167392|NCT02532270|arterial pressure|arterial pressure
167393|NCT02532270|measurement techniques|measurement techniques
167394|NCT02532257|Lymphoma|lymphoma
167395|NCT02532257|Follicular Lymphoma|follicular lymphoma
167396|NCT02532257|FL|fl
167397|NCT02532257|Previously untreated|previously untreated
167398|NCT02532257|Lenalidomide|lenalidomide
167399|NCT02532257|CC-5013|cc-5013
167400|NCT02532257|Revlimid|revlimid
167401|NCT02532257|Rituximab|rituximab
167402|NCT02532257|Rituxan|rituxan
167403|NCT02532257|Ibrutinib|ibrutinib
167404|NCT02532257|PCI-32765|pci-32765
167405|NCT02532257|Imbruvica|imbruvica
167406|NCT02532244|distal hereditary motor neuronopathy|distal hereditary motor neuronopathy
167407|NCT02532231|Leukemia|leukemia
167408|NCT02532231|Acute myeloid leukemia|acute myeloid leukemia
167409|NCT02532231|AML|aml
167410|NCT02532231|High risk for relapse|high risk for relapse
167411|NCT02532231|Nivolumab|nivolumab
167412|NCT02532231|BMS-936558|bms-936558
167413|NCT02532231|Opdivo|opdivo
167414|NCT02532192|Lymphoma|lymphoma
167415|NCT02532192|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
167416|NCT02532192|DLBCL|dlbcl
167417|NCT02532192|Relapsed|relapsed
167418|NCT02532192|Refractory|refractory
167419|NCT02532192|Belinostat|belinostat
167420|NCT02532192|Rituximab|rituximab
167421|NCT02532192|Rituxan|rituxan
167422|NCT02532192|Cisplatin|cisplatin
167423|NCT02532192|Platinol-AQ|platinol-aq
167424|NCT02532192|Platinol|platinol
167425|NCT02532192|CDDP|cddp
167426|NCT02532192|Cytarabine|cytarabine
167427|NCT02532192|Ara-C|ara-c
167428|NCT02532192|Cytosar|cytosar
167429|NCT02532192|DepoCyt|depocyt
167430|NCT02532192|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
167431|NCT02532192|Dexamethasone|dexamethasone
167432|NCT02532192|Decadron|decadron
167433|NCT02532192|Ciprofloxacin|ciprofloxacin
167434|NCT02532192|Ciprofloxacin hydrochloride|ciprofloxacin hydrochloride
167435|NCT02532192|Cipro|cipro
167436|NCT02532192|Fluconazole|fluconazole
167437|NCT02532192|Diflucan|diflucan
167438|NCT02532179|subcutaneous immunotherapy (SCIT)|subcutaneous immunotherapy (scit)
167439|NCT02532179|glycerinated mouse allergenic extract|glycerinated mouse allergenic extract
167440|NCT02532179|mouse specific IgE|mouse specific ige
167441|NCT02532179|mouse specific IgG and IgG4|mouse specific igg and igg4
167442|NCT02532179|mouse prick skin test wheal|mouse prick skin test wheal
167443|NCT02532166|narrow band imaging|narrow band imaging
167444|NCT02532166|Chromoendoscopy|chromoendoscopy
167445|NCT02532166|Lugol|lugol
167446|NCT02532153|Suicidal Ideation|suicidal ideation
167447|NCT02532153|Suicide|suicide
167448|NCT02532153|Suicidal Thoughts|suicidal thoughts
167449|NCT02532153|Depression|depression
167451|NCT02532127|Low-dose risk|low-dose risk
167452|NCT02532075|COPD|copd
167453|NCT02532075|Respiratory Muscle Warm Up|respiratory muscle warm up
167454|NCT02532062|lung cancer risk|lung cancer risk
167455|NCT02532062|cigarette smokers|cigarette smokers
167456|NCT02532049|Malaria|malaria
167457|NCT02532049|Vaccine|vaccine
167458|NCT02532049|Immune Response|immune response
167459|NCT02532036|MVA85A|mva85a
167460|NCT02532036|Tuberculosis|tuberculosis
167461|NCT02532036|Vaccine|vaccine
167462|NCT02532036|Aerosol|aerosol
167463|NCT02532023|omega 3 fatty acid|omega 3 fatty acid
167464|NCT02532023|curcumin|curcumin
167465|NCT02532023|COX-2|cox-2
167466|NCT02532023|iNOs|inos
167467|NCT02532023|VCAM-1|vcam-1
167468|NCT02532023|ICAM-1|icam-1
167469|NCT02532023|IL-1β|il-1β
167470|NCT02532023|IL-6|il-6
167471|NCT02532023|TNF-α|tnf-α
167472|NCT02532023|hsCRP|hscrp
167473|NCT02532023|migraine|migraine
167474|NCT02531997|self-image|self-image
167475|NCT02531997|sexual health|sexual health
167476|NCT02531997|breast cancer|breast cancer
167477|NCT02531997|gynecologic cancer|gynecologic cancer
167478|NCT02531997|ovarian cancer|ovarian cancer
167479|NCT02531997|cervical cancer|cervical cancer
167480|NCT02531997|uterine cancer|uterine cancer
167481|NCT02531997|mind body|mind body
167482|NCT02531997|hypnotic relaxation therapy|hypnotic relaxation therapy
167483|NCT02531997|hypnosis|hypnosis
167484|NCT02531997|progressive muscle relaxation|progressive muscle relaxation
167485|NCT02531971|Bioequivalence|bioequivalence
167486|NCT02531971|Therapeutic Equivalency|therapeutic equivalency
167487|NCT02531945|topography|topography
167488|NCT02531945|cobb angle|cobb angle
167489|NCT02531932|advanced triple negative breast cancer|advanced triple negative breast cancer
167490|NCT02531919|tumor acidity|tumor acidity
167491|NCT02531893|Irritability|irritability
167492|NCT02531893|Disruptive Mood|disruptive mood
167493|NCT02531893|Tantrums|tantrums
167494|NCT02531893|Frustration|frustration
167495|NCT02531893|Interpretation Bias|interpretation bias
167496|NCT02531893|Emotional Judgment|emotional judgment
167497|NCT02531893|Cognitive-Behavioral|cognitive-behavioral
167498|NCT02531893|Exposure|exposure
167499|NCT02531893|Research Psychotherapy|research psychotherapy
167501|NCT02531880|Manganese Enhanced MRI|manganese enhanced mri
167502|NCT02531880|Seizure Disorder|seizure disorder
167503|NCT02531880|Seizures|seizures
167504|NCT02531880|Epileptic Focus|epileptic focus
167505|NCT02531867|HPP|hpp
167506|NCT02531867|Bone Disease|bone disease
167507|NCT02531867|Soft Bones|soft bones
167508|NCT02531867|Low Alkaline Phosphatase|low alkaline phosphatase
167509|NCT02531867|Genetic Metabolic Disorder|genetic metabolic disorder
167510|NCT02531867|Alkaline Phosphatase|alkaline phosphatase
167511|NCT02531867|Rickets|rickets
167512|NCT02531867|Osteomalacia|osteomalacia
167513|NCT02531815|safety|safety
167514|NCT02531815|tolerability|tolerability
167515|NCT02531815|pharmacokinetics|pharmacokinetics
167516|NCT02531815|pharmacodynamics|pharmacodynamics
167517|NCT02531815|Phase 1|phase 1
167518|NCT02531815|first in human|first in human
167519|NCT02531815|monoclonal antibody|monoclonal antibody
167520|NCT02531815|tissue factor pathway inhibitor|tissue factor pathway inhibitor
167521|NCT02531815|japanese|japanese
167522|NCT02531802|ETEC diarrhea|etec diarrhea
167523|NCT02531802|Escherichia Coli (ETEC)|escherichia coli (etec)
167524|NCT02531776|Diabetes|diabetes
167525|NCT02531776|Needle|needle
167526|NCT02531776|Pen needle|pen needle
167527|NCT02531763|mHealth|mhealth
167528|NCT02531763|behavioral economics|behavioral economics
167529|NCT02531763|social incentives|social incentives
167530|NCT02531750|Metabolism|metabolism
167531|NCT02531750|Bone metabolism|bone metabolism
167532|NCT02531750|Glucose Metabolism|glucose metabolism
167533|NCT02531750|Lipid metabolism|lipid metabolism
167534|NCT02531750|Low grade inflamation|low grade inflamation
167535|NCT02531724|acute kidney injury|acute kidney injury
167536|NCT02531724|cardiac surgery|cardiac surgery
167537|NCT02531724|renal blood flow|renal blood flow
167538|NCT02531724|levosimendan|levosimendan
167539|NCT02531711|Lumbosacral|lumbosacral
167540|NCT02531711|radicular|radicular
167541|NCT02531685|dmLT|dmlt
167542|NCT02531685|Enteric|enteric
167543|NCT02531685|Escherichia coli Infections|escherichia coli infections
167544|NCT02531685|Shigella|shigella
167545|NCT02531685|Toxin LTR192G/L211A|toxin ltr192g/l211a
167546|NCT02531672|11C-choline|11c-choline
167547|NCT02531672|Positron Emission Tomography|positron emission tomography
167548|NCT02531672|15-117|15-117
167549|NCT02531646|pulmonary nodule|pulmonary nodule
167550|NCT02531633|Giant Cell Arteritis, Sirukumab, Prednisone|giant cell arteritis, sirukumab, prednisone
167551|NCT02531620|prehabilitation|prehabilitation
167552|NCT02531620|colorectal surgery|colorectal surgery
167553|NCT02531555|chronic periodontitis|chronic periodontitis
167554|NCT02531555|dental scaling|dental scaling
167555|NCT02531555|gingival crevicular fluid|gingival crevicular fluid
167556|NCT02531555|lasers|lasers
167557|NCT02531555|periodontal pocket|periodontal pocket
167558|NCT02531555|root planing|root planing
167559|NCT02531516|Prostatic neoplasms|prostatic neoplasms
167560|NCT02531516|Prostate Cancer|prostate cancer
167561|NCT02531516|High-Risk prostate cancer|high-risk prostate cancer
167562|NCT02531516|JNJ-56021927|jnj-56021927
167563|NCT02531516|Apalutamide|apalutamide
167564|NCT02531516|ATLAS|atlas
167565|NCT02531516|Radiation|radiation
167566|NCT02531516|Long-term hormone therapy|long-term hormone therapy
167567|NCT02531516|Localized or locally advanced prostate cancer|localized or locally advanced prostate cancer
167568|NCT02531516|Janssen|janssen
167569|NCT02531503|Asthma remission|asthma remission
167570|NCT02531503|Predicting factors|predicting factors
167571|NCT02531503|Children|children
167572|NCT02531464|family caregiver|family caregiver
167573|NCT02531464|quality of life|quality of life
167574|NCT02531464|supportive care|supportive care
167575|NCT02531464|distress screening|distress screening
167576|NCT02531464|needs assessment|needs assessment
167577|NCT02531451|Muscle mass|muscle mass
167578|NCT02531451|strength|strength
167579|NCT02531451|NSAID|nsaid
167580|NCT02531451|Ibuprofen|ibuprofen
167581|NCT02531451|resistance exercise|resistance exercise
167582|NCT02531425|TNBC|tnbc
167583|NCT02531425|Triple Negative Breast Cancer|triple negative breast cancer
167584|NCT02531412|Acute kidney injury|acute kidney injury
167585|NCT02531412|Critically ill cancer patients|critically ill cancer patients
167586|NCT02531412|Spironolactone|spironolactone
167587|NCT02531399|flicker induced changes|flicker induced changes
167588|NCT02531399|total volumetric retinal blood flow|total volumetric retinal blood flow
167589|NCT02531308|diffuse large b-cell lymphoma (DLBCL),|diffuse large b-cell lymphoma (dlbcl),
167590|NCT02531308|lymphoma|lymphoma
167591|NCT02531282|Patient education as topic|patient education as topic
167592|NCT02531282|Health promotion|health promotion
167593|NCT02531282|Patient participation|patient participation
167594|NCT02531282|Self efficacy|self efficacy
167595|NCT02531256|Laryngeal Mask Airway|laryngeal mask airway
167596|NCT02531243|prodrome|prodrome
167597|NCT02531243|family therapy|family therapy
167598|NCT02531243|clinical high risk|clinical high risk
167599|NCT02531204|ASP1585|asp1585
167600|NCT02531204|Bioequivalence|bioequivalence
167601|NCT02531204|Pharmacodynamic|pharmacodynamic
167602|NCT02531204|Phosphate binder|phosphate binder
167603|NCT02531204|Bixalomer|bixalomer
167604|NCT02531204|urinary phosphorus excretion|urinary phosphorus excretion
167605|NCT02531191|ASP015K|asp015k
167606|NCT02531191|JAK inhibitor|jak inhibitor
167607|NCT02531191|bioequivalence study|bioequivalence study
167608|NCT02531178|Rheumatoid Arthritis|rheumatoid arthritis
167609|NCT02531139|Cerebrovascular Circulation|cerebrovascular circulation
167610|NCT02531139|Anesthesia|anesthesia
167611|NCT02531139|Blood pressure|blood pressure
167612|NCT02531139|Peripheral Arterial Diseases|peripheral arterial diseases
167613|NCT02531074|Mobile Applications|mobile applications
167614|NCT02531061|Rheumatoid Arthritis|rheumatoid arthritis
167615|NCT02531061|bDMARDs|bdmards
167616|NCT02531061|biotherapy|biotherapy
167617|NCT02531061|remission|remission
167618|NCT02531061|erosion|erosion
167619|NCT02531048|healthy volunteers|healthy volunteers
167620|NCT02530957|Intubation|intubation
167621|NCT02530957|Preoxygenation|preoxygenation
167622|NCT02530957|Complications|complications
167623|NCT02530957|Non invasive ventilation|non invasive ventilation
167624|NCT02530957|High flow nasal cannula|high flow nasal cannula
167625|NCT02530944|Lupus|lupus
167626|NCT02530944|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
167627|NCT02530944|genetic|genetic
167628|NCT02530944|online|online
167629|NCT02530944|genome wide association|genome wide association
167630|NCT02530944|systemic lupus erythematosus|systemic lupus erythematosus
167631|NCT02530944|genome wide association study (GWAS)|genome wide association study (gwas)
167632|NCT02530918|DS-7080a Monoclonal Antibody|ds-7080a monoclonal antibody
167633|NCT02530905|Duchenne muscular dystrophy|duchenne muscular dystrophy
167634|NCT02530905|Exon Skipping|exon skipping
167635|NCT02530892|embryo|embryo
167636|NCT02530892|in vitro fertilization|in vitro fertilization
167637|NCT02530892|IVF|ivf
167638|NCT02530840|imbalanced diabetic patients|imbalanced diabetic patients
167639|NCT02530840|HbA1c|hba1c
167640|NCT02530840|peers|peers
167641|NCT02530827|energy expenditure|energy expenditure
167642|NCT02530827|doubly labeled water|doubly labeled water
167643|NCT02530827|accelerometer|accelerometer
167644|NCT02530827|HIV|hiv
167645|NCT02530827|lipodystrophy syndrome.|lipodystrophy syndrome.
167646|NCT02530814|organochlorine compounds|organochlorine compounds
167647|NCT02530814|pesticides|pesticides
167648|NCT02530788|Heart Failure|heart failure
167649|NCT02530788|Cardiac Surgery|cardiac surgery
167650|NCT02530788|Ventricular Assist Device|ventricular assist device
167651|NCT02530788|Selenium|selenium
167652|NCT02530762|Gastrointestinal tolerability|gastrointestinal tolerability
167653|NCT02530762|dietary fiber|dietary fiber
167654|NCT02530762|clinical trial|clinical trial
167655|NCT02530762|healthy subjects|healthy subjects
167656|NCT02530749|Surgery|surgery
167657|NCT02530749|Frailty|frailty
167658|NCT02530736|Gait speed|gait speed
167659|NCT02530736|Pulmonary Rehabilitation|pulmonary rehabilitation
167660|NCT02530723|power training|power training
167661|NCT02530723|high-speed training|high-speed training
167662|NCT02530723|high-velocity training|high-velocity training
167663|NCT02530723|function|function
167664|NCT02530723|older adults|older adults
167665|NCT02530723|older women|older women
167666|NCT02530697|Leishmaniasis|leishmaniasis
167667|NCT02530697|Mucocutaneous|mucocutaneous
167668|NCT02530697|Miltefosine|miltefosine
167669|NCT02530697|Pentoxifylline|pentoxifylline
167670|NCT02530671|multi-directional power toothbrush|multi-directional power toothbrush
167671|NCT02530671|manual toothbrush|manual toothbrush
167672|NCT02530658|Genetic Predisposition|genetic predisposition
167673|NCT02530658|Pediatric|pediatric
167674|NCT02530658|Genomic Analysis|genomic analysis
167675|NCT02530658|Heritable Disease|heritable disease
167676|NCT02530658|Cancer Risk|cancer risk
167677|NCT02530658|Genetic Counseling|genetic counseling
167678|NCT02530658|DNA|dna
167679|NCT02530658|Clinical Genomics|clinical genomics
167680|NCT02530658|Clinical Decision-Making|clinical decision-making
167681|NCT02530658|Treatment Planning|treatment planning
167682|NCT02530632|microperfusion|microperfusion
167683|NCT02530632|temperature|temperature
167684|NCT02530632|near-infrared spectroscopy|near-infrared spectroscopy
167685|NCT02530632|anesthesia|anesthesia
167794|NCT02530307|fMRI|fmri
167686|NCT02530632|total intravenous anaesthesia|total intravenous anaesthesia
167687|NCT02530580|GABA modulator|gaba modulator
167688|NCT02530580|AZD7325|azd7325
167689|NCT02530580|Object manipulation|object manipulation
167690|NCT02530580|Cutaneous sensation|cutaneous sensation
167691|NCT02530580|Manual dexterity|manual dexterity
167692|NCT02530567|portal pressure|portal pressure
167693|NCT02530567|portosystemic pressure gradient|portosystemic pressure gradient
167694|NCT02530567|azygos blood flow|azygos blood flow
167695|NCT02530554|Pilot Projects|pilot projects
167696|NCT02530515|Leukemia|leukemia
167697|NCT02530515|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
167698|NCT02530515|CLL|cll
167699|NCT02530515|T-cells|t-cells
167700|NCT02530515|Immune cells|immune cells
167701|NCT02530515|Rituximab|rituximab
167702|NCT02530515|Rituxan|rituxan
167703|NCT02530515|Cyclophosphamide|cyclophosphamide
167704|NCT02530515|Cytoxan|cytoxan
167705|NCT02530515|Neosar|neosar
167706|NCT02530515|Fludarabine Phosphate|fludarabine phosphate
167707|NCT02530515|Fludarabine|fludarabine
167708|NCT02530515|Fludara|fludara
167709|NCT02530515|Bendamustine|bendamustine
167710|NCT02530515|Bendamustine Hydrochloride|bendamustine hydrochloride
167711|NCT02530515|Bendamustine HCL|bendamustine hcl
167712|NCT02530515|CEP-18083|cep-18083
167713|NCT02530515|SDX-105|sdx-105
167714|NCT02530515|Treanda|treanda
167715|NCT02530515|Lenalidomide|lenalidomide
167716|NCT02530515|CC-5013|cc-5013
167717|NCT02530515|Revlimid|revlimid
167718|NCT02530489|Breast Cancer|breast cancer
167719|NCT02530489|Triple negative breast cancer|triple negative breast cancer
167720|NCT02530489|TNBC|tnbc
167721|NCT02530489|Invasive adenocarcinoma of the breast|invasive adenocarcinoma of the breast
167722|NCT02530489|MPDL3280A|mpdl3280a
167723|NCT02530489|Nab-paclitaxel|nab-paclitaxel
167724|NCT02530489|Paclitaxel|paclitaxel
167725|NCT02530489|Abraxane|abraxane
167726|NCT02530489|ABI-007|abi-007
167727|NCT02530476|Leukemia|leukemia
167728|NCT02530476|Acute myeloid leukemia|acute myeloid leukemia
167729|NCT02530476|AML|aml
167730|NCT02530476|Relapsed/Refractory|relapsed/refractory
167731|NCT02530476|FLT3-ITD mutation|flt3-itd mutation
167732|NCT02530476|FLT3-mutated high-risk myelodysplastic syndrome|flt3-mutated high-risk myelodysplastic syndrome
167733|NCT02530476|MDS|mds
167734|NCT02530476|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
167735|NCT02530476|CMML|cmml
167736|NCT02530476|Selinexor|selinexor
167737|NCT02530476|KPT-330|kpt-330
167738|NCT02530476|Sorafenib|sorafenib
167739|NCT02530476|Nexavar|nexavar
167740|NCT02530476|BAY 43-9006|bay 43-9006
167741|NCT02530476|FLT3-inhibitor therapy|flt3-inhibitor therapy
167742|NCT02530463|Leukemia|leukemia
167743|NCT02530463|Myelodysplastic syndrome|myelodysplastic syndrome
167744|NCT02530463|MDS|mds
167745|NCT02530463|Nivolumab|nivolumab
167746|NCT02530463|BMS-936558|bms-936558
167747|NCT02530463|Opdivo|opdivo
167748|NCT02530463|Ipilimumab|ipilimumab
167749|NCT02530463|Yervoy|yervoy
167750|NCT02530463|BMS-734016|bms-734016
167751|NCT02530463|MDX010|mdx010
167752|NCT02530463|5-azacitidine|5-azacitidine
167753|NCT02530463|Azacitidine|azacitidine
167754|NCT02530463|5-AZA|5-aza
167755|NCT02530463|Vidaza|vidaza
167756|NCT02530463|5-AZC|5-azc
167757|NCT02530463|AZA-CR|aza-cr
167758|NCT02530463|Ladakamycin|ladakamycin
167759|NCT02530463|NSC-102816|nsc-102816
167760|NCT02530463|Azacytidine|azacytidine
167761|NCT02530450|children|children
167762|NCT02530450|poor adherence|poor adherence
167763|NCT02530450|continuous glucose monitoring|continuous glucose monitoring
167764|NCT02530437|Esophageal Cancer|esophageal cancer
167765|NCT02530437|Adenocarcinoma of the Esophagus|adenocarcinoma of the esophagus
167766|NCT02530437|Adenocarcinoma of the Gastroesophageal Junction|adenocarcinoma of the gastroesophageal junction
167767|NCT02530437|Chemoradiation|chemoradiation
167768|NCT02530437|LY2940680|ly2940680
167769|NCT02530437|Paclitaxel (Protein-Bound)|paclitaxel (protein-bound)
167770|NCT02530437|Taxol|taxol
167771|NCT02530437|Carboplatin|carboplatin
167772|NCT02530437|Paraplatin|paraplatin
167773|NCT02530437|Radiation therapy|radiation therapy
167774|NCT02530437|XRT|xrt
167775|NCT02530437|External beam|external beam
167776|NCT02530437|Endoscopy|endoscopy
167777|NCT02530424|HER2-positive|her2-positive
167778|NCT02530424|ER-positive|er-positive
167779|NCT02530424|invasive|invasive
167780|NCT02530424|CDK4,6|cdk4,6
167781|NCT02530424|Palbociclib|palbociclib
167782|NCT02530424|neoadjuvant treatment|neoadjuvant treatment
167783|NCT02530411|Hormone resistance|hormone resistance
167784|NCT02530411|vandetanib|vandetanib
167785|NCT02530411|fulvestrant|fulvestrant
167786|NCT02530359|septic acute kidney injury|septic acute kidney injury
167787|NCT02530359|pirfenidone|pirfenidone
167788|NCT02530320|Palbociclib|palbociclib
167789|NCT02530320|oligodendroglioma|oligodendroglioma
167790|NCT02530320|oligoastrocytoma anaplastic|oligoastrocytoma anaplastic
167791|NCT02530307|Stroke,|stroke,
167792|NCT02530307|Rehabilitation|rehabilitation
167793|NCT02530307|Ischemic|ischemic
167795|NCT02530268|psoriatic arthritis|psoriatic arthritis
167796|NCT02530268|spondyloarthritis|spondyloarthritis
167797|NCT02530268|disease registry|disease registry
167798|NCT02530255|retinal amyloid|retinal amyloid
167799|NCT02530255|Retinal amyloid index|retinal amyloid index
167800|NCT02530255|Alzheimer disease|alzheimer disease
167801|NCT02530255|telomere attrition|telomere attrition
167802|NCT02530255|telomere activation|telomere activation
167803|NCT02530242|Sickle Cell Anemia|sickle cell anemia
167804|NCT02530229|periprosthetic joint infection|periprosthetic joint infection
167805|NCT02530229|septic arthritis|septic arthritis
167806|NCT02530203|post-operative atrial fibrillation|post-operative atrial fibrillation
167807|NCT02530203|spinal cord stimulation|spinal cord stimulation
167808|NCT02530203|CABG|cabg
167809|NCT02530177|Alopecia|alopecia
167810|NCT02530177|Skin Aging|skin aging
167811|NCT02530177|Nail Changes|nail changes
167812|NCT02530177|Hair Changes|hair changes
167813|NCT02530177|15-198|15-198
167814|NCT02530164|tDCS|tdcs
167815|NCT02530164|SSRI|ssri
167816|NCT02530151|Hip arthroscopy|hip arthroscopy
167817|NCT02530151|Intra-articular injection|intra-articular injection
167818|NCT02530151|Morphine|morphine
167819|NCT02530151|Clonidine|clonidine
167820|NCT02530073|congenital diaphragmatic hernia|congenital diaphragmatic hernia
167821|NCT02530073|FETO|feto
167822|NCT02530073|tracheal occlusion|tracheal occlusion
167823|NCT02530060|Healthy|healthy
167824|NCT02530060|Rilpivirine|rilpivirine
167825|NCT02530060|Tenofovir|tenofovir
167826|NCT02530060|Emtricitabine|emtricitabine
167827|NCT02530060|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
167828|NCT02530047|Ovarian cancer|ovarian cancer
167829|NCT02530047|Epithelial ovarian cancer|epithelial ovarian cancer
167830|NCT02530047|Mesenchymal Stem Cells Secreting Interferon Beta|mesenchymal stem cells secreting interferon beta
167831|NCT02530047|MSC-INFb|msc-infb
167832|NCT02530047|Questionnaires|questionnaires
167833|NCT02530047|Surveys|surveys
167834|NCT02530034|Leukemia|leukemia
167835|NCT02530034|Advanced Hematologic Malignancies|advanced hematologic malignancies
167836|NCT02530034|Myelodysplastic syndrome|myelodysplastic syndrome
167837|NCT02530034|MDS|mds
167838|NCT02530034|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
167839|NCT02530034|CMML|cmml
167840|NCT02530034|Acute myeloid leukemia|acute myeloid leukemia
167842|NCT02530034|Myelofibrosis|myelofibrosis
167843|NCT02530034|Hu8F4|hu8f4
167844|NCT02530021|Ischemic heart disease|ischemic heart disease
167845|NCT02530021|Heart rate variability|heart rate variability
167846|NCT02530021|Exercise Strss Test|exercise strss test
167847|NCT02529956|Psoriasis|psoriasis
167848|NCT02529956|UCB4940|ucb4940
167849|NCT02529943|Spinal Stenosis|spinal stenosis
167850|NCT02529943|Motor Evoked Potential|motor evoked potential
167851|NCT02529930|HSIL|hsil
167852|NCT02529930|CIN 2/3|cin 2/3
167853|NCT02529930|Therapeutic DNA vaccine|therapeutic dna vaccine
167854|NCT02529930|Human Papillomavirus|human papillomavirus
167855|NCT02529930|Immunotherapy|immunotherapy
167856|NCT02529891|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
167857|NCT02529891|COPD|copd
167858|NCT02529891|Volatile Organic Compounds|volatile organic compounds
167859|NCT02529891|Exacerbation|exacerbation
167860|NCT02529878|gastric caner|gastric caner
167861|NCT02529878|Apatinib|apatinib
167862|NCT02529878|S1|s1
167863|NCT02529878|conversion therapy|conversion therapy
167864|NCT02529878|metastatic gastric cancer|metastatic gastric cancer
167865|NCT02529865|Cell Transplantation|cell transplantation
167866|NCT02529852|Lymphoma|lymphoma
167867|NCT02529852|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
167868|NCT02529852|DLBCL|dlbcl
167869|NCT02529852|Lenalidomide|lenalidomide
167870|NCT02529852|CC-5013|cc-5013
167871|NCT02529852|Revlimid|revlimid
167872|NCT02529852|Obinutuzumab|obinutuzumab
167873|NCT02529852|GA101|ga101
167874|NCT02529852|Gazyva|gazyva
167875|NCT02529852|Cyclophosphamide|cyclophosphamide
167876|NCT02529852|Cytoxan|cytoxan
167877|NCT02529852|Neosar|neosar
167878|NCT02529852|Doxorubicin|doxorubicin
167879|NCT02529852|Doxorubicin Hydrochloride|doxorubicin hydrochloride
167880|NCT02529852|Adriamycin PFS|adriamycin pfs
167881|NCT02529852|Adriamycin RDF|adriamycin rdf
167882|NCT02529852|Adriamycin|adriamycin
167883|NCT02529852|Rubex|rubex
167884|NCT02529852|Vincristine|vincristine
167885|NCT02529852|Prednisone|prednisone
167886|NCT02529839|MS|ms
167887|NCT02529839|BMT|bmt
167888|NCT02529826|Cancer-affected prepubertal boys|cancer-affected prepubertal boys
167889|NCT02529813|Leukemia|leukemia
167890|NCT02529813|Lymphoma|lymphoma
167891|NCT02529813|Advanced Lymphoid Malignancies|advanced lymphoid malignancies
167892|NCT02529813|CD19+ lymphoid malignancy|cd19+ lymphoid malignancy
167893|NCT02529813|Multiple myeloma|multiple myeloma
167894|NCT02529813|MM|mm
167895|NCT02529813|CD19-specific T cells|cd19-specific t cells
167896|NCT02529813|Chimeric Antigen Receptor T cells|chimeric antigen receptor t cells
167897|NCT02529813|CAR T cells|car t cells
167898|NCT02529813|Autologous|autologous
167899|NCT02529813|Allogeneic|allogeneic
167900|NCT02529813|Fludarabine|fludarabine
167901|NCT02529813|Fludarabine phosphate|fludarabine phosphate
167902|NCT02529813|Cyclophosphamide|cyclophosphamide
167903|NCT02529813|Cytoxan|cytoxan
167904|NCT02529813|Neosar|neosar
167905|NCT02529813|nonviral|nonviral
167906|NCT02529813|non-viral|non-viral
167907|NCT02529813|DNA plasmids|dna plasmids
167908|NCT02529761|HCC|hcc
167909|NCT02529761|sorafenib|sorafenib
167910|NCT02529761|TACE|tace
167911|NCT02529761|overall survival|overall survival
167912|NCT02529696|accelerometer|accelerometer
167913|NCT02529696|RASS|rass
167914|NCT02529683|Nuvaring|nuvaring
167915|NCT02529683|contraceptive vaginal ring|contraceptive vaginal ring
167916|NCT02529683|Kenya|kenya
167917|NCT02529683|adherence|adherence
167918|NCT02529683|acceptability|acceptability
167919|NCT02529683|immunological effects|immunological effects
167920|NCT02529670|Low Level Laser Therapy|low level laser therapy
167921|NCT02529670|Low Back Pain|low back pain
167922|NCT02529670|Diagnosis|diagnosis
167923|NCT02529670|Genetic|genetic
167924|NCT02529670|Clinical trial|clinical trial
167925|NCT02529657|Lower Level Laser Therapy (LLLT)|lower level laser therapy (lllt)
167926|NCT02529657|inflammation|inflammation
167927|NCT02529657|cytokines|cytokines
167928|NCT02529657|wound healing|wound healing
167929|NCT02529657|laminectomy|laminectomy
167930|NCT02529657|clinical study|clinical study
167931|NCT02529644|HIV Screening|hiv screening
167932|NCT02529644|African American|african american
167933|NCT02529644|Church|church
167934|NCT02529631|Polyglucosamine|polyglucosamine
167935|NCT02529631|L 112|l 112
167936|NCT02529631|overweight,|overweight,
167937|NCT02529631|obesity|obesity
167938|NCT02529631|orlistat|orlistat
167939|NCT02529631|weight reduction|weight reduction
167940|NCT02529605|dietary supplement|dietary supplement
167941|NCT02529605|pharmacokinetics|pharmacokinetics
167942|NCT02529605|Healthy Volunteers|healthy volunteers
167943|NCT02529592|Sickness behavior|sickness behavior
167944|NCT02529592|Cytokines|cytokines
167945|NCT02529592|Psychoneuroimmunology|psychoneuroimmunology
167946|NCT02529579|adoptive Cellular Immunotherapy|adoptive cellular immunotherapy
167947|NCT02529579|patient safety|patient safety
167948|NCT02529579|therapeutic effect|therapeutic effect
167949|NCT02529566|Lumbar Degenerative Disc Disease|lumbar degenerative disc disease
167950|NCT02529566|Degenerative Spinal Conditions|degenerative spinal conditions
167951|NCT02529566|Adjacent Segment Disease|adjacent segment disease
167952|NCT02529566|Autologous Bone Marrow|autologous bone marrow
167953|NCT02529566|Lower Back Pain|lower back pain
167954|NCT02529566|Chronic Lower Back Pain|chronic lower back pain
167955|NCT02529566|Stem Cells|stem cells
167956|NCT02529566|Lumbar disk|lumbar disk
167957|NCT02529566|Mesenchymal Stem Cells|mesenchymal stem cells
167958|NCT02529566|Stabilization|stabilization
167959|NCT02529566|CLBP|clbp
167960|NCT02529566|Autograft|autograft
167961|NCT02529566|Allograft|allograft
167962|NCT02529566|Autograft versus Allograft|autograft versus allograft
167963|NCT02529566|Facet Joint|facet joint
167964|NCT02529566|Radicular Pain|radicular pain
167965|NCT02529566|Adipose|adipose
167966|NCT02529566|Disc Replacement|disc replacement
167967|NCT02529566|Facet Joint Replacement|facet joint replacement
167968|NCT02529553|bladder cancer|bladder cancer
167969|NCT02529540|Myopia|myopia
167970|NCT02529540|self-refraction|self-refraction
167971|NCT02529540|glasses|glasses
167972|NCT02529540|spectacles|spectacles
167973|NCT02529514|Baclofen|baclofen
167974|NCT02529514|Cardiac Surgery|cardiac surgery
167975|NCT02529514|Polysomnography|polysomnography
167976|NCT02529514|Intensive Care Units|intensive care units
167977|NCT02529514|Sleep|sleep
167978|NCT02529449|ASP1941|asp1941
167979|NCT02529449|type 1 diabetes mellitus|type 1 diabetes mellitus
167980|NCT02529449|SGLT2 inhibitor|sglt2 inhibitor
167981|NCT02529436|overuse antidepressant|overuse antidepressant
167982|NCT02529436|dementia|dementia
167983|NCT02529423|food intake|food intake
167984|NCT02529423|food-related behaviour|food-related behaviour
167985|NCT02529423|obesity|obesity
167986|NCT02529423|socioeconomic environment|socioeconomic environment
167987|NCT02529423|depression|depression
167988|NCT02529423|nutritional strategies|nutritional strategies
167989|NCT02529397|Working Memory Training, Weight Loss,|working memory training, weight loss,
167990|NCT02529384|Breast magnetic resonance imaging|breast magnetic resonance imaging
167991|NCT02529384|Diffusion-weighted imaging|diffusion-weighted imaging
167992|NCT02529384|Multiple b-value diffusion weighted imaging|multiple b-value diffusion weighted imaging
167993|NCT02529358|Maintenance intervention|maintenance intervention
167994|NCT02529358|Text messages|text messages
167995|NCT02529358|Emotion Regulation|emotion regulation
167996|NCT02529332|Endoscopic Sellar/Parasellar Tumor Resection|endoscopic sellar/parasellar tumor resection
167997|NCT02529319|atrial fibrillation|atrial fibrillation
167998|NCT02529319|ablation|ablation
168000|NCT02529280|Latinas|latinas
168001|NCT02529280|Breast Cancer|breast cancer
168002|NCT02529280|Clinical Trials|clinical trials
168003|NCT02529280|Participation|participation
168004|NCT02529267|Cohort Studies|cohort studies
168005|NCT02529267|intimate partner violence|intimate partner violence
168006|NCT02529267|orthopaedic surgery|orthopaedic surgery
168007|NCT02529267|epidemiology|epidemiology
168008|NCT02529267|outcomes in fracture care|outcomes in fracture care
168009|NCT02529254|post graduate surgical education|post graduate surgical education
168010|NCT02529254|video coaching|video coaching
168011|NCT02529254|Surgical education|surgical education
168012|NCT02529254|coaching|coaching
168013|NCT02529202|Dexmedetomidine|dexmedetomidine
168014|NCT02529202|Neonate|neonate
168015|NCT02529202|Pharmacokinetics|pharmacokinetics
168016|NCT02529202|Therapeutic Hypothermia|therapeutic hypothermia
168017|NCT02529202|Hypoxic-ischemic Encephalopathy|hypoxic-ischemic encephalopathy
168018|NCT02529202|Adrenergic Agents|adrenergic agents
168019|NCT02529202|Adrenergic Agonists|adrenergic agonists
168020|NCT02529202|Analgesics|analgesics
168021|NCT02529202|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists
168022|NCT02529202|Central Nervous System Agents|central nervous system agents
168023|NCT02529202|Central Nervous System Depressants|central nervous system depressants
168024|NCT02529189|Stable Angina|stable angina
168025|NCT02529189|Angioplasty|angioplasty
168026|NCT02529189|Optical Coherence Tomography|optical coherence tomography
168027|NCT02529189|Nitrate|nitrate
168028|NCT02529176|telemetry|telemetry
168029|NCT02529176|cardiac monitoring|cardiac monitoring
168030|NCT02529163|Integrated Care Pathway|integrated care pathway
168031|NCT02529163|Acute Psychotic Episode|acute psychotic episode
168032|NCT02529163|Randomised Control Trial|randomised control trial
168033|NCT02529124|Ageing|ageing
168034|NCT02529124|Body Composition|body composition
168035|NCT02529124|Nutrition|nutrition
168036|NCT02529124|Physical Activity|physical activity
168037|NCT02529111|Atrial Septal Defects (ASD)|atrial septal defects (asd)
168038|NCT02529111|Percutaneous closure|percutaneous closure
168039|NCT02529098|functional magnetic resonance imaging|functional magnetic resonance imaging
168040|NCT02529098|Lens implantation|lens implantation
168041|NCT02529098|pseudophakia|pseudophakia
168042|NCT02529020|mouthguard|mouthguard
168043|NCT02529020|ventilation|ventilation
168044|NCT02529020|anaerobic power|anaerobic power
168045|NCT02529020|ergogenic effects|ergogenic effects
168046|NCT02529007|Colonoscopy|colonoscopy
168047|NCT02529007|early cancer detection|early cancer detection
168048|NCT02529007|cancer screening|cancer screening
168049|NCT02528994|Dietary supplements|dietary supplements
168050|NCT02528994|Metabolism|metabolism
168051|NCT02528981|GBS|gbs
168052|NCT02528981|Probiotics|probiotics
168053|NCT02528981|Group B Streptococcal|group b streptococcal
168054|NCT02528981|Pregnancy|pregnancy
168055|NCT02528968|Pharmacokinetic dosing|pharmacokinetic dosing
168056|NCT02528968|Haemophilia|haemophilia
168057|NCT02528955|Head and neck cancer|head and neck cancer
168058|NCT02528955|postoperative|postoperative
168059|NCT02528955|radiotherapy|radiotherapy
168060|NCT02528955|de-intensification|de-intensification
168061|NCT02528942|Lung cancer|lung cancer
168062|NCT02528942|Radiation therapy|radiation therapy
168063|NCT02528942|4DCT-ventilation imaging|4dct-ventilation imaging
168064|NCT02528890|group B streptococcus|group b streptococcus
168065|NCT02528890|GBS|gbs
168066|NCT02528864|biomarker|biomarker
168067|NCT02528864|cancer metabolism|cancer metabolism
168068|NCT02528864|chemical exchange saturation transfer|chemical exchange saturation transfer
168069|NCT02528864|endometrial cancer|endometrial cancer
168070|NCT02528864|diffusion-weighted imaging|diffusion-weighted imaging
168071|NCT02528864|magnetic resonance spectroscopy|magnetic resonance spectroscopy
168072|NCT02528864|uterine malignancy|uterine malignancy
168073|NCT02528851|CPAP|cpap
168074|NCT02528851|preterm|preterm
168075|NCT02528851|cardiac output|cardiac output
168076|NCT02528838|Myeloma|myeloma
168077|NCT02528838|Non-interventional|non-interventional
168078|NCT02528838|Observational|observational
168079|NCT02528838|Lenalidomide|lenalidomide
168080|NCT02528838|REVIEW|review
168081|NCT02528838|Post-authorization|post-authorization
168082|NCT02528838|Netherlands|netherlands
168083|NCT02528786|Drug therapy|drug therapy
168084|NCT02528734|pneumothorax|pneumothorax
168085|NCT02528708|fibrinogen concentrate|fibrinogen concentrate
168086|NCT02528708|coagulation|coagulation
168087|NCT02528695|18F-FDG PET/CT|18f-fdg pet/ct
168088|NCT02528695|Adipose tissue|adipose tissue
168089|NCT02528695|type 2 diabetes|type 2 diabetes
168090|NCT02528682|dendritic cells|dendritic cells
168091|NCT02528682|PD-L1/L2 silencing|pd-l1/l2 silencing
168092|NCT02528682|vaccination|vaccination
168093|NCT02528682|stem cell transplantation|stem cell transplantation
168094|NCT02528682|minor histocompatibility antigens|minor histocompatibility antigens
168095|NCT02528669|accelerometer|accelerometer
168096|NCT02528669|patient ambulation|patient ambulation
168097|NCT02528656|Pectus Excavatum|pectus excavatum
168098|NCT02528656|Pectus Carinatum|pectus carinatum
168099|NCT02528656|Vacuum Bell|vacuum bell
168100|NCT02528656|Dynamic compression system|dynamic compression system
168101|NCT02528656|Hearth variability|hearth variability
168102|NCT02528656|Autonomic Nervous System|autonomic nervous system
168103|NCT02528643|MDV3100|mdv3100
168104|NCT02528643|advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
168105|NCT02528643|enzalutamide|enzalutamide
168106|NCT02528643|Xtandi|xtandi
168107|NCT02528643|ASP9785|asp9785
168108|NCT02528604|Catheter Ablation|catheter ablation
168109|NCT02528604|Permanent pacemaker|permanent pacemaker
168110|NCT02528604|AV node ablation|av node ablation
168111|NCT02528604|Electrical Cardioversion|electrical cardioversion
168112|NCT02528604|Implantable loop recorder|implantable loop recorder
168113|NCT02528591|patient|patient
168114|NCT02528591|renal transplant|renal transplant
168115|NCT02528578|healthy volunteers|healthy volunteers
168116|NCT02528539|Prevention|prevention
168117|NCT02528539|lymphedema|lymphedema
168118|NCT02528539|acupuncture|acupuncture
168119|NCT02528539|self-management|self-management
168120|NCT02528526|Hypoxia|hypoxia
168121|NCT02528526|Pancreatic Neoplasms|pancreatic neoplasms
168122|NCT02528526|Hepatocellular Cancer|hepatocellular cancer
168123|NCT02528526|Cholangiocarcinoma|cholangiocarcinoma
168124|NCT02528526|Colorectal Neoplasms|colorectal neoplasms
168125|NCT02528526|Treatment|treatment
168126|NCT02528513|sedation|sedation
168127|NCT02528513|Midazolam|midazolam
168128|NCT02528513|Propofol|propofol
168129|NCT02528513|Dexmedetomidine|dexmedetomidine
168130|NCT02528487|Pulmonary Rehabilitation|pulmonary rehabilitation
168131|NCT02528487|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
168132|NCT02528487|Psychiatric Disorders|psychiatric disorders
168133|NCT02528461|Sofosbuvir|sofosbuvir
168134|NCT02528461|Direct acting anti-viral treatment|direct acting anti-viral treatment
168135|NCT02528461|liver cirrhosis|liver cirrhosis
168136|NCT02528448|Vasoactive hormones|vasoactive hormones
168137|NCT02528448|bio markers|bio markers
168138|NCT02528448|salt regulation|salt regulation
168139|NCT02528448|Renal variables|renal variables
168140|NCT02528435|Methotrexate|methotrexate
168141|NCT02528383|Postmenopausal Women on Aromatase Inhibitors|postmenopausal women on aromatase inhibitors
168142|NCT02528383|Vagifem|vagifem
168143|NCT02528370|COPD exacerbation|copd exacerbation
168144|NCT02528370|Telemedicine|telemedicine
168145|NCT02528370|Intervention Studies|intervention studies
168146|NCT02528370|Patient Readmission|patient readmission
168147|NCT02528357|mAb|mab
168148|NCT02528357|GSK3174998|gsk3174998
168149|NCT02528357|anticancer agent|anticancer agent
168150|NCT02528357|checkpoint|checkpoint
168151|NCT02528357|OX40|ox40
168152|NCT02528357|Pembrolizumab|pembrolizumab
168153|NCT02528357|MK-3475-167|mk-3475-167
168154|NCT02528357|solid tumor|solid tumor
168155|NCT02528357|immunotherapy|immunotherapy
168156|NCT02528357|KEYNOTE-167|keynote-167
168157|NCT02528357|monoclonal antibody|monoclonal antibody
168158|NCT02528357|antitumor|antitumor
168159|NCT02528344|High Intensity Interval Training|high intensity interval training
168160|NCT02528331|Transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
168161|NCT02528331|Cognitive behavioral therapy (CBT)|cognitive behavioral therapy (cbt)
168162|NCT02528305|High-intensity Interval Training|high-intensity interval training
168163|NCT02528292|Rheumatoid Arthritis|rheumatoid arthritis
168164|NCT02528292|Anti-TNF|anti-tnf
168165|NCT02528292|Ultrasound|ultrasound
168166|NCT02528292|Synovial histomorphology|synovial histomorphology
168167|NCT02528292|Ectopic Lymphoneogenesis|ectopic lymphoneogenesis
168168|NCT02528279|Plasmodium ovale|plasmodium ovale
168169|NCT02528279|relapse|relapse
168170|NCT02528279|artemether-lumefantrine|artemether-lumefantrine
168171|NCT02528279|mixed species malaria|mixed species malaria
168172|NCT02528279|non-falciparum malaria|non-falciparum malaria
168173|NCT02528253|Chronic low back pain|chronic low back pain
168174|NCT02528253|Chronic pain|chronic pain
168175|NCT02528240|platelets|platelets
168176|NCT02528201|Ankylosing Spondylitis|ankylosing spondylitis
168177|NCT02528201|Celecoxib|celecoxib
168178|NCT02528201|Diclofenac|diclofenac
168179|NCT02528162|gestational diabetes|gestational diabetes
168180|NCT02528162|education|education
168181|NCT02528149|Fibromuscular Dysplasia|fibromuscular dysplasia
168182|NCT02528149|dysplastic renal artery aneurysm|dysplastic renal artery aneurysm
168183|NCT02528149|renal artery aneurysms|renal artery aneurysms
168184|NCT02528149|non atheromatous|non atheromatous
168185|NCT02528149|dysplastic|dysplastic
168186|NCT02528149|anatomopathologic|anatomopathologic
168187|NCT02528149|genetic|genetic
168188|NCT02528123|Small incision lenticule extraction (SMILE)|small incision lenticule extraction (smile)
168189|NCT02528123|Femtosecond laser|femtosecond laser
168190|NCT02528084|rotator cuff, shoulder, rehabilitation, yoga|rotator cuff, shoulder, rehabilitation, yoga
168191|NCT02528071|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
168192|NCT02528071|ALS|als
168193|NCT02528071|Diaphragmatic Endurance Test|diaphragmatic endurance test
168194|NCT02528058|Myopic traction maculopathy|myopic traction maculopathy
168195|NCT02528045|Myopic traction maculopathy|myopic traction maculopathy
168196|NCT02528032|Left ventricular dysfunction|left ventricular dysfunction
168197|NCT02528032|Other cardiac dysrhythmias|other cardiac dysrhythmias
168198|NCT02528006|Spasmodic Dysphonia|spasmodic dysphonia
168199|NCT02528006|Type 2 Thyroplasty|type 2 thyroplasty
168200|NCT02528006|Titanium Bridges|titanium bridges
168201|NCT02528006|Operation|operation
168202|NCT02527980|electronic cigarettes|electronic cigarettes
168203|NCT02527980|nicotine dependence|nicotine dependence
168204|NCT02527980|smoking|smoking
168205|NCT02527980|tobacco use|tobacco use
168206|NCT02527967|colorectal cancer|colorectal cancer
168207|NCT02527967|enhanced recovery after surgery|enhanced recovery after surgery
168208|NCT02527967|perioperative care|perioperative care
168209|NCT02527967|fast-track surgery|fast-track surgery
168210|NCT02527967|laparoscopy|laparoscopy
168211|NCT02527967|minimally invasive surgery|minimally invasive surgery
168212|NCT02527967|complications|complications
168213|NCT02527954|Y-chromosome microdeletions|y-chromosome microdeletions
168214|NCT02527954|aneuploidy|aneuploidy
168215|NCT02527954|embryos|embryos
168216|NCT02527954|spermatozoa|spermatozoa
168217|NCT02527941|Genital immunology|genital immunology
168218|NCT02527941|HIV susceptibility|hiv susceptibility
168219|NCT02527941|Microbiome|microbiome
168220|NCT02527941|Bacterial vaginosis|bacterial vaginosis
168221|NCT02527941|Virus entry assay|virus entry assay
168222|NCT02527928|pharmacoeconomics|pharmacoeconomics
168223|NCT02527902|IGA Glomerulonephritis|iga glomerulonephritis
168224|NCT02527902|Autonomic nervous system|autonomic nervous system
168225|NCT02527902|ANS|ans
168226|NCT02527889|Exercise|exercise
168227|NCT02527889|blood flow velocity|blood flow velocity
168228|NCT02527889|tissue oxygenation|tissue oxygenation
168229|NCT02527889|BCRL|bcrl
168230|NCT02527876|Exercise|exercise
168231|NCT02527876|Smoking|smoking
168232|NCT02527863|Tolvaptan|tolvaptan
168233|NCT02527863|L-NMMA|l-nmma
168234|NCT02527863|ADPKD|adpkd
168235|NCT02527824|biliary tract neoplasm|biliary tract neoplasm
168236|NCT02527824|oxaliplatin|oxaliplatin
168237|NCT02527824|irinotecan|irinotecan
168238|NCT02527824|S-1|s-1
168239|NCT02527811|ulinastatin|ulinastatin
168240|NCT02527811|CPB|cpb
168241|NCT02527811|pediatric|pediatric
168242|NCT02527785|stomach neoplasm|stomach neoplasm
168243|NCT02527785|oxaliplatin|oxaliplatin
168244|NCT02527785|irinotecan|irinotecan
168245|NCT02527785|S-1|s-1
168246|NCT02527720|Mindfulness|mindfulness
168247|NCT02527720|Therapy|therapy
168248|NCT02527720|Problem Drinking|problem drinking
168249|NCT02527720|Breathing-based mindfulness training|breathing-based mindfulness training
168250|NCT02527694|Emergency medical services|emergency medical services
168251|NCT02527694|Resuscitation|resuscitation
168252|NCT02527512|Scoliosis|scoliosis
168253|NCT02527512|Spine fusion|spine fusion
168254|NCT02527512|0.35% povidone-iodine|0.35% povidone-iodine
168255|NCT02527486|COPD|copd
168256|NCT02527486|Asthma|asthma
168257|NCT02527486|ACOS|acos
168258|NCT02527486|Bronchiectasis|bronchiectasis
168259|NCT02527460|Inflammation|inflammation
168260|NCT02527460|Cognitive Function|cognitive function
168261|NCT02527460|HIV|hiv
168262|NCT02527447|Measurable Residual Disease|measurable residual disease
168263|NCT02527447|Relapsed/Refractory AML|relapsed/refractory aml
168264|NCT02527447|Salvage Chemotherapy|salvage chemotherapy
168265|NCT02527434|Urothelial bladder cancer, Triple-negative breast cancer, Pancreatic ductal adenocarcinoma, Advanced Solid Tumors, Tremelimumab, MEDI4736, ORR|urothelial bladder cancer, triple-negative breast cancer, pancreatic ductal adenocarcinoma, advanced solid tumors, tremelimumab, medi4736, orr
168266|NCT02527395|Experimental pain|experimental pain
168267|NCT02527395|Men|men
168268|NCT02527369|Fat Reduction|fat reduction
168269|NCT02527369|Lipolysis|lipolysis
168270|NCT02527330|Myocardial iron deposition|myocardial iron deposition
168271|NCT02527330|T2* imaging|t2* imaging
168272|NCT02527330|heart failure|heart failure
168273|NCT02527317|Early|early
168274|NCT02527291|Cytomegalovirus|cytomegalovirus
168275|NCT02527291|Interleukin|interleukin
168276|NCT02527291|Polymerase Chain Reaction|polymerase chain reaction
168277|NCT02527291|CMV antibodies|cmv antibodies
168278|NCT02527252|Massage|massage
168279|NCT02527252|Craniosacral|craniosacral
168280|NCT02527252|Disability Evaluation|disability evaluation
168281|NCT02527252|Randomized Controlled Trial|randomized controlled trial
168282|NCT02527187|Immune System Diseases|immune system diseases
168283|NCT02527187|Prick Test|prick test
168284|NCT02527187|Betula verrucosa|betula verrucosa
168285|NCT02527135|SMS|sms
168286|NCT02527135|Text messages|text messages
168287|NCT02527135|Young women|young women
168288|NCT02527135|HIV|hiv
168289|NCT02527122|Immune System Diseases|immune system diseases
168290|NCT02527122|Prick Test|prick test
168291|NCT02527122|Dermatophagoides pteronyssinus|dermatophagoides pteronyssinus
168292|NCT02527122|Dermatophagoides farinae|dermatophagoides farinae
168293|NCT02527096|dolutegravir(Tivicay®)|dolutegravir(tivicay®)
168294|NCT02527096|lamivudine(Epivir®)|lamivudine(epivir®)
168295|NCT02527096|HIV-1|hiv-1
168296|NCT02527096|efficacy|efficacy
168297|NCT02527096|safety|safety
168298|NCT02527057|Diffusion-weighted magnetic resonance imaging|diffusion-weighted magnetic resonance imaging
168398|NCT02526576|Adipose Derived Stem Cells|adipose derived stem cells
168299|NCT02527057|Preoperative concurrent chemoradiation|preoperative concurrent chemoradiation
168300|NCT02527057|Response|response
168301|NCT02527044|Coronary Artery Bypass|coronary artery bypass
168302|NCT02527044|Flow Reserve|flow reserve
168303|NCT02527031|Emergency Medical Services|emergency medical services
168304|NCT02527031|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
168305|NCT02527018|OBGYN|obgyn
168306|NCT02527018|Nexfin|nexfin
168307|NCT02527018|Hypertensive|hypertensive
168308|NCT02527018|Hemodynamic|hemodynamic
168309|NCT02527005|IPT|ipt
168310|NCT02527005|malaria|malaria
168311|NCT02527005|pregnant|pregnant
168312|NCT02527005|HIV positive|hiv positive
168313|NCT02526979|OAB|oab
168314|NCT02526979|overactive bladder|overactive bladder
168315|NCT02526979|Myrbetric|myrbetric
168316|NCT02526979|neurogenic detrusor overactivity|neurogenic detrusor overactivity
168317|NCT02526979|Betanis|betanis
168318|NCT02526979|Myrbetriq|myrbetriq
168319|NCT02526979|NDO|ndo
168320|NCT02526979|YM178|ym178
168321|NCT02526979|mirabegron|mirabegron
168322|NCT02526979|Betmiga|betmiga
168323|NCT02526953|anal cancer|anal cancer
168324|NCT02526953|chemoradiation|chemoradiation
168325|NCT02526953|intensity-modulated radiotherapy|intensity-modulated radiotherapy
168326|NCT02526953|paclitaxel|paclitaxel
168327|NCT02526940|Human Immunodeficiency Virus|human immunodeficiency virus
168328|NCT02526940|HIV|hiv
168329|NCT02526940|HAART|haart
168330|NCT02526940|Highly Active antiretroviral therapy|highly active antiretroviral therapy
168331|NCT02526940|GALT|galt
168332|NCT02526940|Gut Associated Lymphoid Tissue|gut associated lymphoid tissue
168333|NCT02526940|reservoir|reservoir
168334|NCT02526940|rectum|rectum
168335|NCT02526927|Anorexia Nervosa|anorexia nervosa
168336|NCT02526927|microarchitecture|microarchitecture
168337|NCT02526927|prepubertal|prepubertal
168338|NCT02526914|social cognition|social cognition
168339|NCT02526914|oxytocin|oxytocin
168340|NCT02526914|vasopressin|vasopressin
168341|NCT02526914|decision making|decision making
168342|NCT02526914|social decision making|social decision making
168343|NCT02526914|economic games|economic games
168344|NCT02526888|pharmacokinetic|pharmacokinetic
168345|NCT02526888|interaction|interaction
168346|NCT02526875|hypertension, Telmisartan/S-Amlodipine|hypertension, telmisartan/s-amlodipine
168347|NCT02526862|noninvasive mechanical ventilation (NIVM)|noninvasive mechanical ventilation (nivm)
168348|NCT02526862|continuous positive airway pressure (CPAP) ventilation|continuous positive airway pressure (cpap) ventilation
168349|NCT02526862|bilevel positive airway pressure (BIPAP) ventilation|bilevel positive airway pressure (bipap) ventilation
168350|NCT02526862|pressure ulcer (PU)|pressure ulcer (pu)
168351|NCT02526862|nursing assessment|nursing assessment
168352|NCT02526849|Fecal Microbiota Transplantation|fecal microbiota transplantation
168353|NCT02526849|Slow Transit Constipation|slow transit constipation
168354|NCT02526849|Randomized Controlled Trial|randomized controlled trial
168355|NCT02526836|colon cancer mesocolic excision central ligation|colon cancer mesocolic excision central ligation
168356|NCT02526810|glargine|glargine
168357|NCT02526810|continuous subcutaneous insulin injection|continuous subcutaneous insulin injection
168358|NCT02526810|blood glucose control|blood glucose control
168359|NCT02526810|blood glucose fluctuation|blood glucose fluctuation
168360|NCT02526810|Oxidative Stress|oxidative stress
168361|NCT02526797|prostate biopsy|prostate biopsy
168362|NCT02526797|prostate cancer|prostate cancer
168363|NCT02526797|Magnetic resonance imaging|magnetic resonance imaging
168364|NCT02526797|Neoplasm staging|neoplasm staging
168365|NCT02526771|lymph node dissection|lymph node dissection
168366|NCT02526758|Pulmonary disease|pulmonary disease
168367|NCT02526758|chronic obstructive|chronic obstructive
168368|NCT02526758|small airway|small airway
168369|NCT02526745|vaccine|vaccine
168370|NCT02526745|safety|safety
168371|NCT02526745|immunogenicity|immunogenicity
168372|NCT02526732|NASH|nash
168373|NCT02526732|fatty Liver|fatty liver
168374|NCT02526732|VO2 max|vo2 max
168375|NCT02526732|M30 antigen|m30 antigen
168376|NCT02526719|bilateral prophylactic mastectomies|bilateral prophylactic mastectomies
168377|NCT02526719|immediate breast reconstruction|immediate breast reconstruction
168378|NCT02526719|nipple sparing|nipple sparing
168379|NCT02526719|BRCA1 Protein|brca1 protein
168380|NCT02526706|Bleb filtration|bleb filtration
168381|NCT02526706|VisionBlue|visionblue
168382|NCT02526680|OrCam|orcam
168383|NCT02526680|Low-vision device|low-vision device
168384|NCT02526680|End-stage glaucoma|end-stage glaucoma
168385|NCT02526641|Direct acting antiviral treatment|direct acting antiviral treatment
168386|NCT02526641|sCD163|scd163
168387|NCT02526641|Portal hypertension|portal hypertension
168388|NCT02526641|Metabolic liver function|metabolic liver function
168389|NCT02526641|Cirrhosis|cirrhosis
168390|NCT02526628|Testosterone|testosterone
168391|NCT02526628|Neurocognition|neurocognition
168392|NCT02526615|rosiglitazone|rosiglitazone
168393|NCT02526615|metformin|metformin
168394|NCT02526615|muscle|muscle
168395|NCT02526576|Facial Atrophy|facial atrophy
168396|NCT02526576|Autologous|autologous
168397|NCT02526576|Adult|adult
168399|NCT02526576|Stromal Vascular Fraction|stromal vascular fraction
168400|NCT02526576|Collagenase|collagenase
168401|NCT02526550|Live attenuated Japanese Encephalitis vaccine|live attenuated japanese encephalitis vaccine
168402|NCT02526550|IMOJEV|imojev
168403|NCT02526550|CD.JEVAX|cd.jevax
168404|NCT02526550|Booster|booster
168405|NCT02526550|Thai children|thai children
168406|NCT02526550|Immunogenicity|immunogenicity
168407|NCT02526550|Safety|safety
168408|NCT02526550|Interchangeability|interchangeability
168409|NCT02526550|Hepatitis A vaccine|hepatitis a vaccine
168410|NCT02526550|Vaccination or Other Immunization Procedure|vaccination or other immunization procedure
168411|NCT02526537|Gefitinib|gefitinib
168412|NCT02526537|NSCLC|nsclc
168413|NCT02526537|postoperative|postoperative
168414|NCT02526537|stage Ib|stage ib
168415|NCT02526537|Relapse Free Survival in 2 years|relapse free survival in 2 years
168416|NCT02526485|heparin|heparin
168417|NCT02526485|thrombocytopenia|thrombocytopenia
168418|NCT02526485|genomics|genomics
168419|NCT02526472|embryo transfer, in vitro fertilization|embryo transfer, in vitro fertilization
168420|NCT02526446|Chinese|chinese
168421|NCT02526446|caregiver stress|caregiver stress
168422|NCT02526446|self-administered acupressure|self-administered acupressure
168423|NCT02526433|depression|depression
168424|NCT02526433|mental wellbeing|mental wellbeing
168425|NCT02526433|motherhood|motherhood
168426|NCT02526433|music|music
168427|NCT02526433|alternative therapies|alternative therapies
168428|NCT02526420|VRS-317|vrs-317
168429|NCT02526420|Long Acting Growth Hormone|long acting growth hormone
168430|NCT02526420|Versartis|versartis
168431|NCT02526420|somavaratan|somavaratan
168432|NCT02526420|Growth Hormone Deficiency|growth hormone deficiency
168433|NCT02526420|Adult Growth Hormone Deficiency|adult growth hormone deficiency
168434|NCT02526420|AGHD|aghd
168435|NCT02526420|Growth Hormone Replacement|growth hormone replacement
168436|NCT02526420|Growth Hormone Replacement Therapy|growth hormone replacement therapy
168437|NCT02526420|XTEN|xten
168438|NCT02526407|postnatal depression|postnatal depression
168439|NCT02526407|mental wellbeing|mental wellbeing
168440|NCT02526407|baby blues|baby blues
168441|NCT02526407|mothers|mothers
168442|NCT02526407|music|music
168443|NCT02526407|alternative therapies|alternative therapies
168444|NCT02526355|Maternal depression|maternal depression
168445|NCT02526355|Mobile phone based intervention|mobile phone based intervention
168446|NCT02526355|Learning Through Play|learning through play
168447|NCT02526355|CBT|cbt
168448|NCT02526355|Intelligent Real Time Therapy|intelligent real time therapy
168449|NCT02526316|cervical cancer|cervical cancer
168450|NCT02526316|vulvar cancer|vulvar cancer
168451|NCT02526316|vaginal cancer|vaginal cancer
168452|NCT02526316|penile cancer|penile cancer
168453|NCT02526316|anal cancer|anal cancer
168454|NCT02526316|head and neck cancer|head and neck cancer
168455|NCT02526277|RLS|rls
168456|NCT02526264|stoma|stoma
168457|NCT02526264|quality of life|quality of life
168458|NCT02526251|IBD|ibd
168459|NCT02526251|Fecal calprotectin|fecal calprotectin
168460|NCT02526251|Microbiome|microbiome
168461|NCT02526251|Dysbiosis|dysbiosis
168462|NCT02526251|Disease activity|disease activity
168463|NCT02526251|telemedicine|telemedicine
168464|NCT02526238|transcranial magnetic stimulation|transcranial magnetic stimulation
168465|NCT02526238|trunk rotation|trunk rotation
168466|NCT02526225|acute ischemic stroke|acute ischemic stroke
168467|NCT02526225|safety and effectiveness|safety and effectiveness
168468|NCT02526225|Ginkgo diterpene lactone meglumine injection|ginkgo diterpene lactone meglumine injection
168469|NCT02526212|opioid use disorder|opioid use disorder
168470|NCT02526212|group counseling|group counseling
168471|NCT02526212|office-based buprenorphine treatment|office-based buprenorphine treatment
168472|NCT02526199|Local anesthetics|local anesthetics
168473|NCT02526199|Perineural nerve blocks|perineural nerve blocks
168474|NCT02526199|Perineurial Dexamethasone|perineurial dexamethasone
168475|NCT02526160|KRN23|krn23
168476|NCT02526160|Fibroblast growth factor 23 (FGF23)|fibroblast growth factor 23 (fgf23)
168477|NCT02526160|XLH|xlh
168478|NCT02526160|X-linked hypophosphatemia|x-linked hypophosphatemia
168479|NCT02526134|Laying of medical devices (radio opaque markers)|laying of medical devices (radio opaque markers)
168480|NCT02526095|Esophagus|esophagus
168481|NCT02526095|Surgery|surgery
168482|NCT02526082|cardiovascular disease|cardiovascular disease
168483|NCT02526082|frailty|frailty
168484|NCT02526082|quality of life|quality of life
168485|NCT02526082|mortality|mortality
168486|NCT02526082|prevention|prevention
168487|NCT02526030|psychosis|psychosis
168488|NCT02526030|antipsychotic agents|antipsychotic agents
168489|NCT02526030|treatment|treatment
168490|NCT02526030|effectiveness|effectiveness
168491|NCT02526004|Cystic Fibrosis|cystic fibrosis
168492|NCT02526004|Microbiome|microbiome
168493|NCT02526004|Stratified Antibacterial therapy|stratified antibacterial therapy
168494|NCT02526004|Resistance|resistance
168495|NCT02526004|Pathogen Host Interaction|pathogen host interaction
168496|NCT02525991|schizophrenia|schizophrenia
168497|NCT02525991|bipolar disorder|bipolar disorder
168498|NCT02525978|Heart Rate|heart rate
168499|NCT02525965|Wide resection margin|wide resection margin
168500|NCT02525965|Recurrence|recurrence
168501|NCT02525965|Early-stage hepatocellular carcinoma|early-stage hepatocellular carcinoma
168502|NCT02525952|Carcinoma, Hepatocellular|carcinoma, hepatocellular
168503|NCT02525952|Hepatectomy|hepatectomy
168504|NCT02525952|Transarterial Chemoembolization|transarterial chemoembolization
168505|NCT02525952|Scoring System|scoring system
168506|NCT02525913|Breast|breast
168507|NCT02525913|Mastectomy|mastectomy
168508|NCT02525874|Tecfidera|tecfidera
168509|NCT02525874|DMF|dmf
168510|NCT02525874|dimethyl fumarate|dimethyl fumarate
168511|NCT02525757|Lung Cancer|lung cancer
168512|NCT02525757|Non-small cell lung cancer|non-small cell lung cancer
168513|NCT02525757|NSCLC|nsclc
168514|NCT02525757|Unresectable|unresectable
168515|NCT02525757|MPDL3280A|mpdl3280a
168516|NCT02525757|Carboplatin|carboplatin
168517|NCT02525757|Paraplatin|paraplatin
168518|NCT02525757|Paclitaxel|paclitaxel
168519|NCT02525757|Taxol|taxol
168520|NCT02525757|Radiation therapy|radiation therapy
168521|NCT02525757|XRT|xrt
168522|NCT02525731|HIV Infection|hiv infection
168523|NCT02525731|Pain|pain
168524|NCT02525731|Chronic Opioid Therapy|chronic opioid therapy
168525|NCT02525731|Addiction|addiction
168526|NCT02525731|Analgesics, Opioid|analgesics, opioid
168527|NCT02525718|Breast Reconstruction|breast reconstruction
168528|NCT02525718|Mastectomy|mastectomy
168529|NCT02525705|infants|infants
168530|NCT02525705|oesophageal atresia|oesophageal atresia
168531|NCT02525705|dumping syndrome|dumping syndrome
168532|NCT02525705|prevalence|prevalence
168533|NCT02525705|Type III and IV|type iii and iv
168534|NCT02525705|Oral glucose tolerance test|oral glucose tolerance test
168535|NCT02525705|early hyperglycemia|early hyperglycemia
168536|NCT02525705|late hypoglycemia|late hypoglycemia
168537|NCT02525653|Albumin-Bound|albumin-bound
168538|NCT02525653|Paclitaxel|paclitaxel
168539|NCT02525653|Gemcitabine|gemcitabine
168540|NCT02525653|15-054|15-054
168541|NCT02525640|Single sided hearing loss|single sided hearing loss
168542|NCT02525640|Single sided deafness|single sided deafness
168543|NCT02525640|Hearing loss music appreciation|hearing loss music appreciation
168544|NCT02525536|Drug Therapy|drug therapy
168545|NCT02525510|Mild Hypothermia|mild hypothermia
168546|NCT02525510|Machine Perfusion|machine perfusion
168547|NCT02525510|Kidney Transplantation|kidney transplantation
168548|NCT02525497|Automated PD|automated pd
168549|NCT02525497|Effectiveness|effectiveness
168550|NCT02525497|Safety|safety
168551|NCT02525497|Manipulability|manipulability
168552|NCT02525458|antimicrobial|antimicrobial
168553|NCT02525458|biofilms|biofilms
168554|NCT02525458|acrylic resin|acrylic resin
168555|NCT02525458|polymethyl methacrylate|polymethyl methacrylate
168556|NCT02525458|confocal laser scanning microscopy|confocal laser scanning microscopy
168557|NCT02525458|split-mouth design|split-mouth design
168558|NCT02525458|quaternary ammonium methacryloxy silicate|quaternary ammonium methacryloxy silicate
168559|NCT02525445|placebo effects|placebo effects
168560|NCT02525445|communication|communication
168561|NCT02525445|acupuncture therapy|acupuncture therapy
168562|NCT02525445|relaxation|relaxation
168563|NCT02525432|Mesenchymal Stromal Cells, Multipotent|mesenchymal stromal cells, multipotent
168564|NCT02525432|Multipotent Mesenchymal Stromal Cells|multipotent mesenchymal stromal cells
168565|NCT02525432|Stem Cells, Mesenchymal|stem cells, mesenchymal
168566|NCT02525393|Rehabilitation|rehabilitation
168567|NCT02525393|Non Invasive Brain Stimulation|non invasive brain stimulation
168568|NCT02525380|Transarterial chemoembolization|transarterial chemoembolization
168569|NCT02525380|Doxorubicin-Eluting-Bead Embolization|doxorubicin-eluting-bead embolization
168570|NCT02525380|DC Bead TACE|dc bead tace
168571|NCT02525380|Hepatocellular carcinoma|hepatocellular carcinoma
168572|NCT02525367|Parkinson's disease|parkinson's disease
168573|NCT02525367|Multiple Sclerosis|multiple sclerosis
168574|NCT02525367|Depressed Elderly|depressed elderly
168575|NCT02525367|Cognitive Dysfunction|cognitive dysfunction
168576|NCT02525367|Online Cognitive Training|online cognitive training
168577|NCT02525354|arachidonic aci|arachidonic aci
168578|NCT02525354|adiposity|adiposity
168579|NCT02525354|atopy|atopy
168580|NCT02525341|Yoga|yoga
168581|NCT02525341|exercises|exercises
168582|NCT02525341|knee osteoarthritis|knee osteoarthritis
168583|NCT02525341|older adults|older adults
168584|NCT02525328|Constitutional Thinness|constitutional thinness
168585|NCT02525328|linkage study|linkage study
168586|NCT02525328|genome wide scan (GWAS)|genome wide scan (gwas)
168587|NCT02525315|Schizophrenia|schizophrenia
168588|NCT02525315|auditory hallucinations|auditory hallucinations
168589|NCT02525315|TMS|tms
168590|NCT02525302|DMD|dmd
168591|NCT02525302|neuromuscular|neuromuscular
168592|NCT02525302|Duchenne|duchenne
168593|NCT02525289|mobility|mobility
168594|NCT02525289|coronary artery bypass|coronary artery bypass
168595|NCT02525289|positioning|positioning
168596|NCT02525289|body|body
168597|NCT02525263|Neo-Kidney Augment|neo-kidney augment
168598|NCT02525263|Type 2 Diabetes|type 2 diabetes
168599|NCT02525263|Chronic Kidney Disease|chronic kidney disease
168600|NCT02525263|Cell Therapy|cell therapy
168601|NCT02525250|Acute myeloid leukemia or myelodysplasic syndrome|acute myeloid leukemia or myelodysplasic syndrome
168602|NCT02525198|Mild cognitive impairment|mild cognitive impairment
168603|NCT02525198|Subjective memory impairment|subjective memory impairment
168604|NCT02525198|Dementia|dementia
168605|NCT02525198|Flavonoids|flavonoids
168606|NCT02525198|Fatty acids|fatty acids
168607|NCT02525198|Cognition|cognition
168608|NCT02525198|Gut microflora|gut microflora
168609|NCT02525172|immune modulation therapy|immune modulation therapy
168610|NCT02525172|acid α-glucosidase|acid α-glucosidase
168611|NCT02525172|antibody|antibody
168612|NCT02525159|3,3'-diindolylmethane|3,3'-diindolylmethane
168613|NCT02525159|premenopause|premenopause
168614|NCT02525159|2-hydroxyestrone|2-hydroxyestrone
168615|NCT02525146|HIV|hiv
168616|NCT02525146|Reengagement in HIV Care|reengagement in hiv care
168617|NCT02525146|ARTAS|artas
168618|NCT02525133|post operative pain|post operative pain
168619|NCT02525133|hernioplasty|hernioplasty
168620|NCT02525133|bupivacaine|bupivacaine
168621|NCT02525120|Disc herniation|disc herniation
168622|NCT02525120|Herniated disc|herniated disc
168623|NCT02525120|Triojection|triojection
168624|NCT02525120|Ozone|ozone
168625|NCT02525120|Lumbar spine|lumbar spine
168626|NCT02525120|Leg pain|leg pain
168627|NCT02525107|Prevention of Vaso Occlusive Painful Crisis|prevention of vaso occlusive painful crisis
168628|NCT02525094|Eczema|eczema
168629|NCT02525081|Microvascular Angina|microvascular angina
168630|NCT02525081|therapy|therapy
168631|NCT02525068|enzalutamide|enzalutamide
168632|NCT02525068|AZD5363|azd5363
168633|NCT02525068|Prostate|prostate
168634|NCT02525055|Flu|flu
168635|NCT02525055|Influenza|influenza
168636|NCT02525055|Human Viral Challenge Model|human viral challenge model
168637|NCT02525055|Wild-Type|wild-type
168638|NCT02525055|H3N2|h3n2
168639|NCT02525055|H1N1|h1n1
168640|NCT02525055|Universal Influenza Vaccine|universal influenza vaccine
168641|NCT02525055|intra-seasonal vaccines|intra-seasonal vaccines
168642|NCT02525055|antiviral|antiviral
168643|NCT02525042|Ankylosing Spondylitis|ankylosing spondylitis
168644|NCT02525042|Dendritic cells (DC)|dendritic cells (dc)
168645|NCT02525042|RNA|rna
168646|NCT02525042|Axial spondyloarthritis|axial spondyloarthritis
168647|NCT02525042|Lod score|lod score
168648|NCT02525042|Human leucocyte antigen (HLA-B27)|human leucocyte antigen (hla-b27)
168649|NCT02525029|GVHD|gvhd
168650|NCT02525016|Bariatric surgery, lidocaine, plasmatic concentration, MonoEthylGlycineXylidide (MEGx), safety|bariatric surgery, lidocaine, plasmatic concentration, monoethylglycinexylidide (megx), safety
168651|NCT02525003|vitamin D|vitamin d
168652|NCT02525003|Serum 25-hydroxyvitamin D|serum 25-hydroxyvitamin d
168653|NCT02525003|vitamin D2|vitamin d2
168654|NCT02525003|UV-irradiated yeast|uv-irradiated yeast
168655|NCT02525003|serum 25-hydroxyvitamin D3|serum 25-hydroxyvitamin d3
168656|NCT02525003|serum 25-hydroxyvitamin D2|serum 25-hydroxyvitamin d2
168657|NCT02525003|randomized controlled trial|randomized controlled trial
168658|NCT02525003|vitamin D3|vitamin d3
168659|NCT02525003|bioavailability|bioavailability
168660|NCT02524990|Medical abortion|medical abortion
168661|NCT02524990|pregnancy tests|pregnancy tests
168662|NCT02524964|left ventricular remodeling|left ventricular remodeling
168663|NCT02524964|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
168664|NCT02524964|acute myocardial infarction|acute myocardial infarction
168665|NCT02524938|Dietary polyphenols|dietary polyphenols
168666|NCT02524938|Protein glycation|protein glycation
168667|NCT02524925|fast track surgery|fast track surgery
168668|NCT02524925|eras program|eras program
168669|NCT02524925|hepatectomy|hepatectomy
168670|NCT02524925|pancreatectomy|pancreatectomy
168671|NCT02524925|NPY|npy
168672|NCT02524925|ACTH/Cortsiosol|acth/cortsiosol
168673|NCT02524925|postoperative stress|postoperative stress
168674|NCT02524899|Schizotypal Personality Disorder|schizotypal personality disorder
168675|NCT02524899|SPD|spd
168676|NCT02524899|cognitive remediation therapy|cognitive remediation therapy
168677|NCT02524899|CRT|crt
168678|NCT02524899|guanfacine|guanfacine
168679|NCT02524899|cognitive impairment|cognitive impairment
168680|NCT02524899|working memory|working memory
168681|NCT02524899|pharmacological cognitive enhancing agent|pharmacological cognitive enhancing agent
168682|NCT02524899|neuropsychological testing|neuropsychological testing
168683|NCT02524899|schizophrenia spectrum disorders|schizophrenia spectrum disorders
168684|NCT02524899|Personality Disorders|personality disorders
168685|NCT02524886|Deep Brain Simulation|deep brain simulation
168686|NCT02524886|Psychiatric|psychiatric
168687|NCT02524886|Side-effects|side-effects
168688|NCT02524860|Prostate Cancer|prostate cancer
168689|NCT02524860|Biopsy|biopsy
168690|NCT02524860|Focal Healthcare|focal healthcare
168691|NCT02524860|Fusion Targeted Biopsy|fusion targeted biopsy
168692|NCT02524860|High Risk Cancer|high risk cancer
168693|NCT02524860|Imaging|imaging
168694|NCT02524860|Diagnostic|diagnostic
168695|NCT02524860|Ultrasound|ultrasound
168795|NCT02524015|contraversive pushing|contraversive pushing
168696|NCT02524860|Multiparametric Magnetic Resonance Imaging (MP-MRI)|multiparametric magnetic resonance imaging (mp-mri)
168697|NCT02524860|MRI-Ultrasound Fusion|mri-ultrasound fusion
168698|NCT02524860|Focal-Fusion Bx|focal-fusion bx
168699|NCT02524834|Thoracoabdominal lesions|thoracoabdominal lesions
168700|NCT02524795|Omega 3, Cytokines, Adipokines, Systemic lupus erythematosus|omega 3, cytokines, adipokines, systemic lupus erythematosus
168701|NCT02524782|MEDI-4166, diabetes|medi-4166, diabetes
168702|NCT02524769|Urge Urinary Incontinence|urge urinary incontinence
168703|NCT02524769|Urinary Incontinence|urinary incontinence
168704|NCT02524756|nerve sparing radical hysterectomy|nerve sparing radical hysterectomy
168705|NCT02524743|Rocuronium|rocuronium
168706|NCT02524743|lidocaine|lidocaine
168707|NCT02524743|acetaminophen,|acetaminophen,
168708|NCT02524743|pain|pain
168709|NCT02524743|injection|injection
168710|NCT02524717|Hepatic Impairment|hepatic impairment
168711|NCT02524717|JNJ-56021927|jnj-56021927
168712|NCT02524704|Cystic fibrosis|cystic fibrosis
168713|NCT02524704|Electrical Impedance Tomography|electrical impedance tomography
168714|NCT02524626|Vagus nerve stimulation|vagus nerve stimulation
168715|NCT02524626|Postoperative ileus|postoperative ileus
168716|NCT02524561|mammographic density|mammographic density
168717|NCT02524561|abnormal mammogram|abnormal mammogram
168718|NCT02524561|biopsy|biopsy
168719|NCT02524548|Aromatase inhibitors|aromatase inhibitors
168720|NCT02524548|Reminder Systems|reminder systems
168721|NCT02524522|Integrated Pulmonary Index|integrated pulmonary index
168722|NCT02524522|automated protocol-driven weaning|automated protocol-driven weaning
168723|NCT02524522|pulmonary recruitment maneuver|pulmonary recruitment maneuver
168724|NCT02524509|Chonodron|chonodron
168725|NCT02524509|Microfracture|microfracture
168726|NCT02524509|autologous cultured chondrocyte|autologous cultured chondrocyte
168727|NCT02524509|cartilage defect of knee|cartilage defect of knee
168728|NCT02524444|Intermittent preventive therapy|intermittent preventive therapy
168729|NCT02524444|malaria|malaria
168730|NCT02524444|pregnant|pregnant
168731|NCT02524444|HIV positive|hiv positive
168732|NCT02524444|Prevention|prevention
168733|NCT02524431|Mitochondria|mitochondria
168734|NCT02524431|trabeculectomy|trabeculectomy
168735|NCT02524431|trabecular meshwork|trabecular meshwork
168736|NCT02524431|Glaucoma surgery|glaucoma surgery
168737|NCT02524418|Main Pancreatic Duct|main pancreatic duct
168738|NCT02524392|independent medical evaluation|independent medical evaluation
168739|NCT02524392|sick leave|sick leave
168740|NCT02524392|sickness absence|sickness absence
168741|NCT02524392|physician primary care|physician primary care
168742|NCT02524392|general practitioner|general practitioner
168743|NCT02524392|family physician|family physician
168744|NCT02524366|Stress Urinary Incontinence|stress urinary incontinence
168745|NCT02524366|Artificial Urinary Sphincter|artificial urinary sphincter
168746|NCT02524353|cardiac surgery|cardiac surgery
168747|NCT02524340|JIA|jia
168748|NCT02524340|Arthritis|arthritis
168749|NCT02524340|pJIA|pjia
168750|NCT02524340|PCATS|pcats
168751|NCT02524301|anorexia nervosa|anorexia nervosa
168752|NCT02524301|opioid receptors|opioid receptors
168753|NCT02524301|Positron emission tomography (PET)|positron emission tomography (pet)
168754|NCT02524301|diprenorphine|diprenorphine
168755|NCT02524262|atrohpic gastritis|atrohpic gastritis
168756|NCT02524262|acetaldehyde|acetaldehyde
168757|NCT02524262|ethanol|ethanol
168758|NCT02524262|L-cysteine|l-cysteine
168759|NCT02524236|BPH, OAB, Botox, dose response|bph, oab, botox, dose response
168760|NCT02524223|medically assisted procreation|medically assisted procreation
168761|NCT02524210|volunteers|volunteers
168762|NCT02524197|Hip|hip
168763|NCT02524197|Knee|knee
168764|NCT02524197|Arthritis|arthritis
168765|NCT02524197|pain|pain
168766|NCT02524197|CR845|cr845
168767|NCT02524197|kappa opioid|kappa opioid
168768|NCT02524171|crime|crime
168769|NCT02524171|mental health|mental health
168770|NCT02524171|substance abuse|substance abuse
168771|NCT02524171|homelessness|homelessness
168772|NCT02524171|Veterans|veterans
168773|NCT02524158|Yoga|yoga
168774|NCT02524158|Mind-Body Therapies|mind-body therapies
168775|NCT02524158|Chronic Low Back Pain|chronic low back pain
168776|NCT02524158|Military Veterans|military veterans
168777|NCT02524158|VA patients|va patients
168778|NCT02524080|Ambulance|ambulance
168779|NCT02524080|Trust|trust
168780|NCT02524080|Patients|patients
168781|NCT02524080|Healthcare chain|healthcare chain
168782|NCT02524054|Dyspnea|dyspnea
168783|NCT02524054|Hospitalized patients|hospitalized patients
168784|NCT02524054|Ambulatory outpatients|ambulatory outpatients
168785|NCT02524054|Shortness of breath|shortness of breath
168786|NCT02524054|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
168787|NCT02524054|Pulmonary disease|pulmonary disease
168788|NCT02524041|Hyperparathyroidism|hyperparathyroidism
168789|NCT02524041|microarchitecture|microarchitecture
168790|NCT02524041|periostin|periostin
168791|NCT02524028|Atrial Fibrillation|atrial fibrillation
168792|NCT02524028|fMRI|fmri
168793|NCT02524015|stroke|stroke
168794|NCT02524015|pusher syndrome|pusher syndrome
168796|NCT02524015|lateropulsion|lateropulsion
168797|NCT02524015|rehabilitation|rehabilitation
168798|NCT02524015|physical therapy|physical therapy
168799|NCT02524002|Abnormal Labor|abnormal labor
168800|NCT02524002|Prolonged Induction|prolonged induction
168801|NCT02524002|Ketosis|ketosis
168802|NCT02524002|Diet|diet
168803|NCT02523989|arsenic|arsenic
168804|NCT02523989|heavy metal|heavy metal
168805|NCT02523976|Acute|acute
168806|NCT02523976|Leukemia|leukemia
168807|NCT02523976|Lymphoid|lymphoid
168808|NCT02523976|Philadelphia chromosome|philadelphia chromosome
168809|NCT02523976|dasatinib|dasatinib
168810|NCT02523963|family work shop|family work shop
168811|NCT02523937|Pulmonary Embolism|pulmonary embolism
168812|NCT02523937|Deep Venous Thrombosis|deep venous thrombosis
168813|NCT02523937|Soluble Fibrin|soluble fibrin
168814|NCT02523937|D-Dimers|d-dimers
168815|NCT02523937|Low and intermediate clinical probability|low and intermediate clinical probability
168816|NCT02523911|Suprep|suprep
168817|NCT02523911|Simethicone|simethicone
168818|NCT02523911|Colorectal cancer screening|colorectal cancer screening
168819|NCT02523911|Routine colonoscopy|routine colonoscopy
168820|NCT02523911|sodium sulfate/potassium sulfate/magnesium sulfate|sodium sulfate/potassium sulfate/magnesium sulfate
168821|NCT02523911|Bowel cleansing|bowel cleansing
168822|NCT02523911|Mass screening|mass screening
168823|NCT02523898|Clomiphene|clomiphene
168824|NCT02523898|infertility|infertility
168825|NCT02523898|insuline resistant|insuline resistant
168826|NCT02523898|metformine|metformine
168827|NCT02523898|PCOS|pcos
168828|NCT02523885|Pneumonia, Bacterial [C01.252.620]|pneumonia, bacterial [c01.252.620]
168829|NCT02523885|Bronchopneumonia [C08.381.677.127]|bronchopneumonia [c08.381.677.127]
168830|NCT02523885|Pleuropneumonia [C08.730.610.473]|pleuropneumonia [c08.730.610.473]
168831|NCT02523885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
168832|NCT02523872|Fluid overload|fluid overload
168833|NCT02523872|Acute respiratory failure|acute respiratory failure
168834|NCT02523872|Acute respiratory distress syndrome|acute respiratory distress syndrome
168835|NCT02523872|Medication administration|medication administration
168836|NCT02523846|IV-Patient Controlled Analgesia (IV-PCA)|iv-patient controlled analgesia (iv-pca)
168837|NCT02523846|background morphine infusion|background morphine infusion
168838|NCT02523846|patient re-education|patient re-education
168839|NCT02523781|preeclampsia|preeclampsia
168840|NCT02523781|information pamphlet|information pamphlet
168841|NCT02523781|patient education|patient education
168842|NCT02523755|epidural analgesia for labor|epidural analgesia for labor
168843|NCT02523755|respiratory function|respiratory function
168844|NCT02523755|electrical impedance tomography|electrical impedance tomography
168845|NCT02523729|lactation|lactation
168846|NCT02523729|human milk|human milk
168847|NCT02523729|maltz|maltz
168848|NCT02523729|antioxidant|antioxidant
168849|NCT02523716|Hypoxic conditioning|hypoxic conditioning
168850|NCT02523716|Cardio pulmonary exercise testing|cardio pulmonary exercise testing
168851|NCT02523651|Periodontal Diseases|periodontal diseases
168852|NCT02523651|Bone Regeneration|bone regeneration
168853|NCT02523651|Dental Pulp Stem Cell|dental pulp stem cell
168854|NCT02523638|Pegylated-Proline-interferon alpha-2b (AOP2014)|pegylated-proline-interferon alpha-2b (aop2014)
168855|NCT02523638|Polycythemia Vera|polycythemia vera
168856|NCT02523638|PEN-PV|pen-pv
168857|NCT02523638|PROUD-PV|proud-pv
168858|NCT02523638|CONTINUATION-PV|continuation-pv
168859|NCT02523638|AOP Orphan|aop orphan
168860|NCT02523638|Polycythemia|polycythemia
168861|NCT02523638|Hematologic Diseases|hematologic diseases
168862|NCT02523638|Myeloproliferative Disorders|myeloproliferative disorders
168863|NCT02523638|Bone Marrow Diseases|bone marrow diseases
168864|NCT02523638|Interferon-alpha|interferon-alpha
168865|NCT02523638|Peginterferon alfa-2b|peginterferon alfa-2b
168866|NCT02523625|Ultrasound|ultrasound
168867|NCT02523599|post operative pain|post operative pain
168868|NCT02523599|hernioplasty|hernioplasty
168869|NCT02523599|bupivacaine|bupivacaine
168870|NCT02523586|oxygen concentration|oxygen concentration
168871|NCT02523586|oxygen therapy|oxygen therapy
168872|NCT02523586|oxygen delivery|oxygen delivery
168873|NCT02523586|oxygen masks|oxygen masks
168874|NCT02523560|Telerehabilitation|telerehabilitation
168875|NCT02523560|Home Monitoring|home monitoring
168876|NCT02523560|Heart Failure|heart failure
168877|NCT02523547|entecavir|entecavir
168878|NCT02523495|Molecular Targeted Therapy|molecular targeted therapy
168879|NCT02523495|metastasis colorectal cancer|metastasis colorectal cancer
168880|NCT02523495|biomarker|biomarker
168881|NCT02523482|Prescriptions|prescriptions
168882|NCT02523482|Epidemiology|epidemiology
168883|NCT02523482|STOPP/START Criteria|stopp/start criteria
168884|NCT02523482|Beers Criteria|beers criteria
168885|NCT02523456|Early warning score|early warning score
168886|NCT02523456|Cardiac arrest|cardiac arrest
168887|NCT02523443|Epidural Analgesia|epidural analgesia
168888|NCT02523443|Intravenous Patient Controlled|intravenous patient controlled
168889|NCT02523443|15-148|15-148
168890|NCT02523430|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
168891|NCT02523430|HepaSphere|hepasphere
168892|NCT02523417|Breast Cancer|breast cancer
168893|NCT02523417|HepaSphere|hepasphere
168894|NCT02523404|Lung Cancer|lung cancer
168895|NCT02523404|HepaSphere|hepasphere
168896|NCT02523378|Advanced Cancers|advanced cancers
168897|NCT02523378|Recurrent|recurrent
168898|NCT02523378|Locally advanced|locally advanced
168899|NCT02523378|Metastatic|metastatic
168900|NCT02523378|Edmonton Symptom Assessment Scale|edmonton symptom assessment scale
168901|NCT02523378|ESAS|esas
168902|NCT02523378|Survey|survey
168903|NCT02523378|Interview|interview
168904|NCT02523378|Symptom questionnaire|symptom questionnaire
168905|NCT02523365|Cervical Carcinoma|cervical carcinoma
168906|NCT02523365|HepaSphere|hepasphere
168907|NCT02523326|Genomic DNA|genomic dna
168908|NCT02523326|chronic periodontitis|chronic periodontitis
168909|NCT02523326|saliva|saliva
168910|NCT02523326|mouthwash|mouthwash
168912|NCT02523326|genotyping|genotyping
168913|NCT02523326|sequencing|sequencing
168914|NCT02523235|moderate pain|moderate pain
168915|NCT02523235|severe pain|severe pain
168916|NCT02523235|surgery|surgery
168917|NCT02523235|postop analgesia|postop analgesia
168918|NCT02523235|TKA|tka
168919|NCT02523235|adductor catheter|adductor catheter
168920|NCT02523235|poplital catheter|poplital catheter
168921|NCT02523235|foot/ankle surgery|foot/ankle surgery
168922|NCT02523222|dextrose gel|dextrose gel
168923|NCT02523222|newborn hypoglycemia|newborn hypoglycemia
168924|NCT02523222|late preterm infant|late preterm infant
168925|NCT02523222|large for gestational age|large for gestational age
168926|NCT02523222|small for gestational age|small for gestational age
168927|NCT02523222|prophylactic|prophylactic
168928|NCT02523222|neonatal hypoglycemia|neonatal hypoglycemia
168929|NCT02523209|Osteoporosis|osteoporosis
168930|NCT02523209|chronic kidney disease|chronic kidney disease
168931|NCT02523209|kidney transplantation|kidney transplantation
168932|NCT02523209|fracture risk|fracture risk
168933|NCT02523196|Hepatic Venous Pressure Gradient (HVPG) testing|hepatic venous pressure gradient (hvpg) testing
168934|NCT02523196|HepQuant-SHUNT|hepquant-shunt
168935|NCT02523196|Liver Function|liver function
168936|NCT02523183|Epilepsy|epilepsy
168937|NCT02523183|Marijuana|marijuana
168938|NCT02523144|Transthoracic echocardiography|transthoracic echocardiography
168939|NCT02523144|echo|echo
168940|NCT02523144|TTE|tte
168941|NCT02523131|Type 1 diabetes|type 1 diabetes
168942|NCT02523131|Closed-loop glucose control|closed-loop glucose control
168943|NCT02523131|Artificial Pancreas|artificial pancreas
168944|NCT02523131|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
168945|NCT02523131|Continuous glucose monitoring|continuous glucose monitoring
168946|NCT02523131|threshold suspend|threshold suspend
168947|NCT02523131|predictive low glucose suspend|predictive low glucose suspend
168948|NCT02523092|sarcoidosis|sarcoidosis
168949|NCT02523092|Acthar|acthar
168950|NCT02523092|CXCL9|cxcl9
168951|NCT02523092|chemokine ligand 9|chemokine ligand 9
168952|NCT02523053|Hepatocellular Carcinoma|hepatocellular carcinoma
168953|NCT02523053|Recurrence|recurrence
168954|NCT02523053|Microvascular Invasion|microvascular invasion
168955|NCT02523053|5-Fluorouracil|5-fluorouracil
168956|NCT02523040|Langerhans cell histiocytosis (LCH)|langerhans cell histiocytosis (lch)
168957|NCT02523040|Erdheim-Chester disease (ECD)|erdheim-chester disease (ecd)
168958|NCT02523040|Histiocytic Sarcoma (HS)|histiocytic sarcoma (hs)
168959|NCT02522988|cancer-related fatigue|cancer-related fatigue
168960|NCT02522975|biosimilar epoetin|biosimilar epoetin
168961|NCT02522975|efficacy|efficacy
168962|NCT02522975|safety|safety
168963|NCT02522975|immunogenicity|immunogenicity
168964|NCT02522975|renal anaemia|renal anaemia
168965|NCT02522962|physical therapy|physical therapy
168966|NCT02522962|group-based|group-based
168967|NCT02522962|core stability|core stability
168969|NCT02522962|movement quality|movement quality
168970|NCT02522962|somatosensory stimulation|somatosensory stimulation
168971|NCT02522962|coordination|coordination
168972|NCT02522923|Physical Therapy Modalities|physical therapy modalities
168973|NCT02522923|Primary Care|primary care
168974|NCT02522923|Health Services Research|health services research
168975|NCT02522884|Angioplasty|angioplasty
168976|NCT02522884|Peripheral Artery Disease|peripheral artery disease
168977|NCT02522884|PAD|pad
168978|NCT02522884|Lesion|lesion
168979|NCT02522884|Claudication|claudication
168980|NCT02522858|premedication|premedication
168981|NCT02522858|dexmedetomidine|dexmedetomidine
168982|NCT02522858|anesthesia, spinal|anesthesia, spinal
168983|NCT02522845|Varicose Veins|varicose veins
168984|NCT02522845|Compression Stockings|compression stockings
168985|NCT02522845|Laser Ablation|laser ablation
168986|NCT02522845|Catheter Ablation, Radiofrequency|catheter ablation, radiofrequency
168987|NCT02522819|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
168988|NCT02522819|acute stroke|acute stroke
168989|NCT02522819|apnea-hypopnea index (AHI)|apnea-hypopnea index (ahi)
168990|NCT02522806|Endometrial biopsy|endometrial biopsy
168991|NCT02522806|previous ovarian hyperstimulation cycle|previous ovarian hyperstimulation cycle
168992|NCT02522806|first IVF|first ivf
168993|NCT02522806|antagonist protocol|antagonist protocol
168994|NCT02522806|clinical pregnancy rate|clinical pregnancy rate
168995|NCT02522793|skin lesion|skin lesion
168996|NCT02522728|Knee|knee
168997|NCT02522728|Arthroplasty|arthroplasty
168998|NCT02522728|Implant|implant
168999|NCT02522689|kidney stone|kidney stone
169000|NCT02522689|percutaneous nephrolithotripsy|percutaneous nephrolithotripsy
169001|NCT02522689|ultra-mini PCNL|ultra-mini pcnl
169002|NCT02522689|micro PCNL|micro pcnl
169003|NCT02522676|kidney stone|kidney stone
169004|NCT02522676|percutaneous nephrolithotripsy|percutaneous nephrolithotripsy
169005|NCT02522676|retrograde intrarenal surgery|retrograde intrarenal surgery
169006|NCT02522676|extracorporeal shock wave lithotripsy|extracorporeal shock wave lithotripsy
169007|NCT02522676|mini PCNL|mini pcnl
169008|NCT02522676|ultra-mini PCNL|ultra-mini pcnl
169009|NCT02522676|micro PCNL|micro pcnl
169010|NCT02522663|telephone support|telephone support
169011|NCT02522663|discharge management|discharge management
169012|NCT02522663|readmission|readmission
169013|NCT02522663|aortic valve replacement|aortic valve replacement
169014|NCT02522650|amiloride|amiloride
169015|NCT02522650|proteinuric kidney disease|proteinuric kidney disease
169016|NCT02522650|urokinase plasminogen activator receptor|urokinase plasminogen activator receptor
169017|NCT02522650|proteinuria|proteinuria
169018|NCT02522637|exercise|exercise
169019|NCT02522637|training|training
169020|NCT02522637|endurance|endurance
169021|NCT02522624|Health insurance|health insurance
169022|NCT02522624|Health services accessibility|health services accessibility
169023|NCT02522624|Decision making|decision making
169024|NCT02522624|Health literacy|health literacy
169025|NCT02522611|Palliative Care|palliative care
169026|NCT02522611|Adults|adults
169027|NCT02522611|Cancer Pain|cancer pain
169028|NCT02522611|Nerve Block|nerve block
169029|NCT02522611|Quality of Life|quality of life
169030|NCT02522585|expectant management|expectant management
169031|NCT02522585|p16|p16
169032|NCT02522585|immunohistochemistry|immunohistochemistry
169033|NCT02522585|regression|regression
169034|NCT02522585|progression|progression
169035|NCT02522585|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
169036|NCT02522572|Renal Transplantation|renal transplantation
169037|NCT02522572|Desensitization|desensitization
169038|NCT02522572|plerixafor|plerixafor
169039|NCT02522572|bortezomib|bortezomib
169040|NCT02522520|Undergoing chemotherapy|undergoing chemotherapy
169041|NCT02522520|Exercise intervention|exercise intervention
169042|NCT02522520|Health counselling|health counselling
169043|NCT02522520|Symptom management|symptom management
169044|NCT02522481|Lumason|lumason
169045|NCT02522481|Dobutamine stress echo|dobutamine stress echo
169046|NCT02522481|stress echo|stress echo
169047|NCT02522481|coronary artery disease|coronary artery disease
169048|NCT02522455|Flow-cycled pressure-support ventilation|flow-cycled pressure-support ventilation
169049|NCT02522403|distal radius fracture|distal radius fracture
169050|NCT02522403|laser acupuncture|laser acupuncture
169051|NCT02522403|rehabilitation|rehabilitation
169052|NCT02522390|data collection|data collection
169053|NCT02522390|personal health services|personal health services
169054|NCT02522390|personal health records|personal health records
169055|NCT02522390|do-it-yourself|do-it-yourself
169056|NCT02522390|nutrition researchers|nutrition researchers
169057|NCT02522390|cohort studies|cohort studies
169058|NCT02522390|databases, factual|databases, factual
169059|NCT02522390|self-quantification methods|self-quantification methods
169060|NCT02522377|Ketamine|ketamine
169061|NCT02522377|Electroconvulsive Therapy|electroconvulsive therapy
169062|NCT02522377|Major Depressive Disorder|major depressive disorder
169063|NCT02522377|Treatment Resistant Depression|treatment resistant depression
169064|NCT02522377|electroconvulsive treatment|electroconvulsive treatment
169065|NCT02522377|Severe depression|severe depression
169066|NCT02522364|Postoperative atrial fibrillation|postoperative atrial fibrillation
169067|NCT02522364|Dysfunction Following Cardiac Surgery|dysfunction following cardiac surgery
169068|NCT02522312|Dry Eye|dry eye
169069|NCT02522299|double-blind|double-blind
169070|NCT02522299|PI3Kdelta|pi3kdelta
169071|NCT02522299|GSK2269557|gsk2269557
169072|NCT02522299|exacerbation|exacerbation
169073|NCT02522299|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
169074|NCT02522299|randomised|randomised
169075|NCT02522299|placebo-controlled|placebo-controlled
169076|NCT02522286|patient engagement|patient engagement
169077|NCT02522286|physician's role|physician's role
169078|NCT02522286|patient- centered care|patient- centered care
169079|NCT02522286|communication|communication
169080|NCT02522273|Obstetric|obstetric
169081|NCT02522273|Midwifery|midwifery
169082|NCT02522273|Fetal blood sample|fetal blood sample
169083|NCT02522273|Lactate|lactate
169084|NCT02522273|Handheld meter|handheld meter
169085|NCT02522260|Breast cancer, chemotherapy, symptoms, optimal training|breast cancer, chemotherapy, symptoms, optimal training
169086|NCT02522234|Neutropenia|neutropenia
169087|NCT02522234|Chemotherapy|chemotherapy
169088|NCT02522221|chronic anticoagulation|chronic anticoagulation
169089|NCT02522221|vitamin K antagonist|vitamin k antagonist
169090|NCT02522221|mechanical heart valve|mechanical heart valve
169091|NCT02522221|CYP2C9|cyp2c9
169092|NCT02522221|warfarin|warfarin
169093|NCT02522221|tecarfarin|tecarfarin
169094|NCT02522221|chronic kidney disease|chronic kidney disease
169095|NCT02522195|shift work|shift work
169096|NCT02522195|nutritional status|nutritional status
169097|NCT02522195|nursing professionals|nursing professionals
169098|NCT02522195|meal distribution|meal distribution
169099|NCT02522195|food intake|food intake
169100|NCT02522182|Cardiovascular Secondary Prevention|cardiovascular secondary prevention
169101|NCT02522182|Nurse's Role|nurse's role
169102|NCT02522143|self-harm|self-harm
169103|NCT02522143|self-mutilation|self-mutilation
169104|NCT02522143|cutting|cutting
169105|NCT02522117|Kidney Transplantation|kidney transplantation
169106|NCT02522117|Atorvastatin|atorvastatin
169107|NCT02522117|Human Leukocyte Antigens|human leukocyte antigens
169108|NCT02522117|Interleukin|interleukin
169109|NCT02522104|Pharmacokinetics of Hydroxyurea|pharmacokinetics of hydroxyurea
169110|NCT02522078|misoprostol|misoprostol
169111|NCT02522078|abortion|abortion
169112|NCT02522065|Hypokinesia|hypokinesia
169113|NCT02522065|Patient Outcome Assessment|patient outcome assessment
169114|NCT02522013|post-dural puncture headache|post-dural puncture headache
169115|NCT02522013|Aminophylline|aminophylline
169116|NCT02521948|MANTA|manta
169117|NCT02521948|Arterial Closure Device|arterial closure device
169118|NCT02521948|Large Bore Closure Device|large bore closure device
169119|NCT02521909|Root Canal length|root canal length
169120|NCT02521909|Electronic apex locator|electronic apex locator
169121|NCT02521909|Endodontics|endodontics
169122|NCT02521870|Skin Cancer|skin cancer
169123|NCT02521870|Skin Tumors|skin tumors
169124|NCT02521870|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
169125|NCT02521870|Cancer Immunotherapy|cancer immunotherapy
169126|NCT02521857|Alkermes|alkermes
169127|NCT02521857|Samidorphan|samidorphan
169128|NCT02521857|ALKS 5461|alks 5461
169129|NCT02521857|Healthy Volunteer|healthy volunteer
169130|NCT02521857|Pharmacokinetics|pharmacokinetics
169131|NCT02521844|solid tumors|solid tumors
169132|NCT02521844|responsive to Wnt signalling regulation|responsive to wnt signalling regulation
169133|NCT02521831|Circumcision|circumcision
169134|NCT02521818|cognition|cognition
169135|NCT02521818|dementia|dementia
169136|NCT02521818|neuropsychological|neuropsychological
169137|NCT02521818|elderly|elderly
169138|NCT02521818|nutrition|nutrition
169139|NCT02521818|diet|diet
169140|NCT02521805|Appetite|appetite
169141|NCT02521805|Protein|protein
169142|NCT02521805|Protein quality|protein quality
169143|NCT02521805|Dietary fibre|dietary fibre
169144|NCT02521805|Satiety|satiety
169145|NCT02521792|Open-label study|open-label study
169146|NCT02521792|Clinical trial Phase 2|clinical trial phase 2
169147|NCT02521792|Efficacy and safety|efficacy and safety
169148|NCT02521792|Heterotopic ossification|heterotopic ossification
169149|NCT02521792|Fibrodysplasia Ossificans Progressiva|fibrodysplasia ossificans progressiva
169150|NCT02521792|Flare-up|flare-up
169151|NCT02521792|Palovarotene|palovarotene
169152|NCT02521792|Retinoic acid receptor agonist|retinoic acid receptor agonist
169153|NCT02521792|Retinoic acid receptor gamma agonist|retinoic acid receptor gamma agonist
169154|NCT02521792|Clementia|clementia
169155|NCT02521792|Myositis Ossificans Progressiva|myositis ossificans progressiva
169156|NCT02521792|Munchmeyer's Disease|munchmeyer's disease
169157|NCT02521792|FOP|fop
169158|NCT02521779|Inflammation|inflammation
169159|NCT02521779|Endotoxemia|endotoxemia
169160|NCT02521779|Lipopolysaccharide|lipopolysaccharide
169161|NCT02521779|Diet|diet
169162|NCT02521779|Fat|fat
169163|NCT02521779|Postprandial|postprandial
169164|NCT02521753|Polycystic ovary syndrome|polycystic ovary syndrome
169165|NCT02521753|Obesity|obesity
169166|NCT02521753|Metformin|metformin
169167|NCT02521753|Magnesium|magnesium
169168|NCT02521753|Polyunsaturated fatty acids|polyunsaturated fatty acids
169169|NCT02521740|biological marker|biological marker
169170|NCT02521740|frailty|frailty
169171|NCT02521740|burden|burden
169172|NCT02521740|nutrition|nutrition
169173|NCT02521740|elderly|elderly
169174|NCT02521714|Revlimid|revlimid
169175|NCT02521714|lenalidomide|lenalidomide
169176|NCT02521714|bioavailability|bioavailability
169177|NCT02521714|healthy volunteers|healthy volunteers
169178|NCT02521714|food effect|food effect
169179|NCT02521714|pharmacokinetics|pharmacokinetics
169180|NCT02521662|Electronic Cigarettes|electronic cigarettes
169181|NCT02521662|Nicotine Patch|nicotine patch
169182|NCT02521662|Smoking Cessation|smoking cessation
169183|NCT02521649|Gastric Cancer|gastric cancer
169184|NCT02521649|G17DT|g17dt
169185|NCT02521649|PAS|pas
169186|NCT02521649|Insegia|insegia
169187|NCT02521649|Gastrimmune|gastrimmune
169188|NCT02521623|Acelullar Dermal Matrix|acelullar dermal matrix
169189|NCT02521623|Immediate Breast Reconstruction|immediate breast reconstruction
169190|NCT02521623|Breast Implant|breast implant
169191|NCT02521584|Liver transplant recipient|liver transplant recipient
169291|NCT02520817|Zinc|zinc
169192|NCT02521558|Cognitive rehabilitation|cognitive rehabilitation
169193|NCT02521558|Mobile electronic application|mobile electronic application
169194|NCT02521558|Memory tasks|memory tasks
169195|NCT02521545|Oral Remyelination|oral remyelination
169196|NCT02521519|Facet induced pain|facet induced pain
169197|NCT02521519|Myofascial pain|myofascial pain
169198|NCT02521519|Trigger points|trigger points
169199|NCT02521519|Low back pain|low back pain
169200|NCT02521454|policing|policing
169201|NCT02521454|resilience|resilience
169202|NCT02521454|implicit bias|implicit bias
169203|NCT02521454|violence|violence
169204|NCT02521441|Neutropenia|neutropenia
169205|NCT02521441|Myelotoxic Chemotherapy|myelotoxic chemotherapy
169206|NCT02521441|G-CSF|g-csf
169207|NCT02521363|Implantable Microdevice|implantable microdevice
169208|NCT02521363|In Vivo Drug Sensitivity Testing|in vivo drug sensitivity testing
169209|NCT02521363|HER2-Positive|her2-positive
169210|NCT02521363|Triple Negative|triple negative
169211|NCT02521363|15-127|15-127
169212|NCT02521350|Acute Kidney Injury|acute kidney injury
169213|NCT02521350|Surgery|surgery
169214|NCT02521350|Perioperative care|perioperative care
169215|NCT02521311|multiple sclerosis|multiple sclerosis
169216|NCT02521311|eye pain|eye pain
169217|NCT02521311|vision loss|vision loss
169218|NCT02521259|anesthetic depth|anesthetic depth
169219|NCT02521259|emergence agitation|emergence agitation
169220|NCT02521220|L-citrulline|l-citrulline
169221|NCT02521220|Endothelial dysfunction|endothelial dysfunction
169222|NCT02521194|Advanced Cancers|advanced cancers
169223|NCT02521194|Inpatient occupational therapy|inpatient occupational therapy
169224|NCT02521194|Questionnaire|questionnaire
169225|NCT02521194|Survey|survey
169226|NCT02521168|euthyroid sick syndrome|euthyroid sick syndrome
169227|NCT02521168|cardiopulmonary bypass|cardiopulmonary bypass
169228|NCT02521168|congenital heart disease|congenital heart disease
169229|NCT02521168|time to extubation|time to extubation
169230|NCT02521155|Oral health literacy intervention|oral health literacy intervention
169231|NCT02521155|oral hygiene behavior|oral hygiene behavior
169232|NCT02521142|OCT Angiography|oct angiography
169233|NCT02521116|retinal oxygenation|retinal oxygenation
169234|NCT02521116|retinal vessel diameters|retinal vessel diameters
169235|NCT02521116|Dynamic vessel analyzer (DVA)|dynamic vessel analyzer (dva)
169236|NCT02521116|Oxymap T1|oxymap t1
169237|NCT02521077|Ascorbic Acid|ascorbic acid
169238|NCT02521077|Breast Neoplasms|breast neoplasms
169239|NCT02521077|Fatigue|fatigue
169240|NCT02521064|IBD|ibd
169241|NCT02521064|enteral nutrition|enteral nutrition
169242|NCT02521064|corticosteroids|corticosteroids
169243|NCT02521051|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
169244|NCT02521051|Anaplastic lymphoma kinase|anaplastic lymphoma kinase
169245|NCT02521051|ALK|alk
169246|NCT02521051|Brain metastases|brain metastases
169247|NCT02521012|Depression|depression
169248|NCT02521012|Depressive symptoms|depressive symptoms
169249|NCT02521012|Vitamin D|vitamin d
169250|NCT02521012|Intervention|intervention
169251|NCT02520986|Sexually transmitted disease|sexually transmitted disease
169252|NCT02520986|Genital Warts|genital warts
169253|NCT02520986|Venereal Warts|venereal warts
169254|NCT02520960|Catheter Ablation|catheter ablation
169255|NCT02520960|Pulmonary Vein Isolation|pulmonary vein isolation
169256|NCT02520960|Radiofrequency|radiofrequency
169257|NCT02520947|desflurane|desflurane
169258|NCT02520947|BIS|bis
169259|NCT02520947|coronary artery bypass grafting surgery|coronary artery bypass grafting surgery
169260|NCT02520934|Enzyme Replacement Therapy|enzyme replacement therapy
169261|NCT02520934|Miglustat|miglustat
169262|NCT02520934|Gaucher Disease|gaucher disease
169263|NCT02520921|Diabetes mellitus|diabetes mellitus
169264|NCT02520921|Acute coronary syndrome|acute coronary syndrome
169265|NCT02520921|Coronary artery disease|coronary artery disease
169266|NCT02520921|Aspirin|aspirin
169267|NCT02520921|Secondary prevention|secondary prevention
169268|NCT02520895|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
169269|NCT02520895|Non-Hodgkin lymphoma|non-hodgkin lymphoma
169270|NCT02520895|Follicular Lymphoma|follicular lymphoma
169271|NCT02520895|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
169272|NCT02520895|MALT Lymphoma|malt lymphoma
169273|NCT02520895|T Cell Lymphoma|t cell lymphoma
169274|NCT02520895|Immune Repertoire|immune repertoire
169275|NCT02520895|Infection|infection
169276|NCT02520895|relapse|relapse
169277|NCT02520895|survival|survival
169278|NCT02520895|treatment response|treatment response
169279|NCT02520895|VJ rearrangement|vj rearrangement
169280|NCT02520882|PET/CT|pet/ct
169281|NCT02520882|Bombesin|bombesin
169282|NCT02520882|gastrin-releasing peptide receptor|gastrin-releasing peptide receptor
169283|NCT02520882|68Gallium labeling|68gallium labeling
169284|NCT02520830|blueberry polyphenols|blueberry polyphenols
169285|NCT02520830|Polyphenol metabolites|polyphenol metabolites
169286|NCT02520830|endothelial function|endothelial function
169287|NCT02520830|Molecular mechanisms of action|molecular mechanisms of action
169288|NCT02520830|Vascular function|vascular function
169289|NCT02520830|Healthy men|healthy men
169290|NCT02520817|Antioxidants|antioxidants
169292|NCT02520817|Truck drivers|truck drivers
169293|NCT02520804|balanced salt solution|balanced salt solution
169294|NCT02520765|Obesity Index, ICSI|obesity index, icsi
169295|NCT02520752|cMET, INC280, caffeine, midazolam|cmet, inc280, caffeine, midazolam
169296|NCT02520739|olive oil|olive oil
169297|NCT02520739|phenolic compounds|phenolic compounds
169298|NCT02520739|triterpenes|triterpenes
169299|NCT02520739|oxidation and inflammation|oxidation and inflammation
169300|NCT02520726|Posttraumatic stress disorder|posttraumatic stress disorder
169301|NCT02520726|PTSD|ptsd
169302|NCT02520726|Sertraline|sertraline
169303|NCT02520726|Burns|burns
169304|NCT02520713|Pediatric Solid Tumor|pediatric solid tumor
169305|NCT02520648|Back pain|back pain
169306|NCT02520648|Manual therapy|manual therapy
169307|NCT02520635|prognosis|prognosis
169308|NCT02520635|supra-early chemotherapy|supra-early chemotherapy
169309|NCT02520609|Metabolomics|metabolomics
169310|NCT02520609|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
169311|NCT02520609|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
169312|NCT02520609|Energy Expenditure|energy expenditure
169313|NCT02520596|Raspberries|raspberries
169314|NCT02520596|Anthocyanins|anthocyanins
169315|NCT02520596|Ellagitannins|ellagitannins
169316|NCT02520596|Metabolites|metabolites
169317|NCT02520557|Epilepsy|epilepsy
169318|NCT02520557|Genetic associations with severe Cutaneous Adverse Reactions|genetic associations with severe cutaneous adverse reactions
169319|NCT02520492|intracranial pressure|intracranial pressure
169320|NCT02520479|extranodal natural killer/T-cell lymphoma|extranodal natural killer/t-cell lymphoma
169321|NCT02520479|nasal type|nasal type
169322|NCT02520479|radiotherapy|radiotherapy
169323|NCT02520479|chemotherapy|chemotherapy
169324|NCT02520440|Citrulline|citrulline
169325|NCT02520440|GIF|gif
169326|NCT02520440|MOF|mof
169327|NCT02520440|Calprotectina|calprotectina
169328|NCT02520440|intraabdominal pressure|intraabdominal pressure
169329|NCT02520427|Amgen|amgen
169330|NCT02520427|Phase 1|phase 1
169331|NCT02520427|Clinical Trial|clinical trial
169332|NCT02520427|Oncology/Hematology|oncology/hematology
169333|NCT02520427|Relapsed/Refractory AML|relapsed/refractory aml
169334|NCT02520427|Immunotherapy|immunotherapy
169335|NCT02520310|Mitral Regurgitation|mitral regurgitation
169336|NCT02520310|mitral valve surgery|mitral valve surgery
169337|NCT02520310|AVJ-514 Delivery System|avj-514 delivery system
169338|NCT02520310|Symptomatic Heart Failure|symptomatic heart failure
169339|NCT02520310|Heart Valve Disease|heart valve disease
169340|NCT02520297|Pain|pain
169341|NCT02520297|Long bone|long bone
169342|NCT02520297|Fracture|fracture
169343|NCT02520271|Mood Disorders|mood disorders
169344|NCT02520271|Motivational Interview|motivational interview
169345|NCT02520271|Behavioral Activation|behavioral activation
169346|NCT02520258|artificial sweeteners|artificial sweeteners
169347|NCT02520258|obesity|obesity
169348|NCT02520258|diabetes|diabetes
169349|NCT02520258|metabolic syndrome|metabolic syndrome
169350|NCT02520258|aspartame|aspartame
169351|NCT02520232|chronic exercise|chronic exercise
169352|NCT02520232|genetic polymorphisms|genetic polymorphisms
169353|NCT02520232|brain imagery|brain imagery
169354|NCT02520232|executive functions|executive functions
169355|NCT02520232|alzheimer's disease|alzheimer's disease
169356|NCT02520219|Peripheral T-cell lymphomas,Endostar|peripheral t-cell lymphomas,endostar
169357|NCT02520193|Early mobilisation|early mobilisation
169358|NCT02520193|Invasive ventilation|invasive ventilation
169359|NCT02520193|Ventilator free days|ventilator free days
169360|NCT02520193|Intensive Care Unit|intensive care unit
169361|NCT02520167|Gestational weight gain|gestational weight gain
169362|NCT02520154|Ovarian Cancer|ovarian cancer
169363|NCT02520154|Metastatic Ovarian Cancer|metastatic ovarian cancer
169364|NCT02520154|High-grade epithelial non-mucinous ovarian cancer|high-grade epithelial non-mucinous ovarian cancer
169365|NCT02520154|Advanced stage ovarian cancer|advanced stage ovarian cancer
169366|NCT02520154|Carboplatin|carboplatin
169367|NCT02520154|Paraplatin|paraplatin
169368|NCT02520154|Paclitaxel|paclitaxel
169369|NCT02520154|Taxol|taxol
169370|NCT02520154|Pembrolizumab|pembrolizumab
169371|NCT02520154|Keytruda|keytruda
169372|NCT02520154|MK-3475|mk-3475
169373|NCT02520154|SCH-900475|sch-900475
169374|NCT02520141|Biliary cancer|biliary cancer
169375|NCT02520141|Advanced biliary cancers|advanced biliary cancers
169376|NCT02520141|Intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
169377|NCT02520141|Extrahepatic cholangiocarcinoma|extrahepatic cholangiocarcinoma
169378|NCT02520141|Gallbladder cancer|gallbladder cancer
169379|NCT02520141|Received prior chemotherapy|received prior chemotherapy
169380|NCT02520141|Ramucirumab|ramucirumab
169381|NCT02520141|IMC-1121B|imc-1121b
169382|NCT02520128|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
169383|NCT02520128|Radiotherapy|radiotherapy
169384|NCT02520089|platelet-rich plasma|platelet-rich plasma
169385|NCT02520089|bone grafting|bone grafting
169386|NCT02520089|pseudoarthrosis|pseudoarthrosis
169387|NCT02520076|Islet Transplantation|islet transplantation
169388|NCT02520063|hormone-receptor positive breast cancer|hormone-receptor positive breast cancer
169389|NCT02520063|Her2 negative breast cancer|her2 negative breast cancer
169390|NCT02520063|neoadjuvant|neoadjuvant
169391|NCT02520063|everolimus|everolimus
169392|NCT02520063|TRC105|trc105
169393|NCT02520063|letrozole|letrozole
169394|NCT02520050|Type 2 diabetes|type 2 diabetes
169395|NCT02520050|Obesity|obesity
169396|NCT02520050|Nutrition|nutrition
169397|NCT02520050|Medical Nutrition Therapy|medical nutrition therapy
169398|NCT02520037|Fluid responsiveness|fluid responsiveness
169399|NCT02520037|Volume responsiveness|volume responsiveness
169400|NCT02520037|Hemodynamics|hemodynamics
169401|NCT02520024|self-directed care|self-directed care
169402|NCT02520024|serious mental illness|serious mental illness
169403|NCT02520011|Refractory AML|refractory aml
169404|NCT02520011|Relapsed AML|relapsed aml
169405|NCT02520011|AML|aml
169406|NCT02520011|Newly diagnosed high-risk AML|newly diagnosed high-risk aml
169407|NCT02519998|Biomarkers|biomarkers
169408|NCT02519998|Electrocardiography|electrocardiography
169409|NCT02519998|Balance|balance
169410|NCT02519998|Neuropsychiatric assessment|neuropsychiatric assessment
169411|NCT02519998|Cortisol|cortisol
169412|NCT02519998|Calcitonin-gene-related peptide|calcitonin-gene-related peptide
169413|NCT02519998|Electroencephalography|electroencephalography
169414|NCT02519998|Optical coherence tomography|optical coherence tomography
169415|NCT02519998|Von Frey Testing|von frey testing
169416|NCT02519985|VHF digital ultrasound|vhf digital ultrasound
169417|NCT02519985|Corneal thickness|corneal thickness
169418|NCT02519985|Epithelial thickness|epithelial thickness
169419|NCT02519985|Angle diameter|angle diameter
169420|NCT02519985|Sulcus diameter|sulcus diameter
169421|NCT02519985|Anterior chamber depth|anterior chamber depth
169422|NCT02519985|Repeatability|repeatability
169423|NCT02519985|Reproducibility|reproducibility
169424|NCT02519972|Low dose CT screening|low dose ct screening
169425|NCT02519972|Family history of lung cancer|family history of lung cancer
169426|NCT02519946|Heart Transplantation|heart transplantation
169427|NCT02519946|Tonometry|tonometry
169428|NCT02519946|Exercise Test|exercise test
169429|NCT02519946|Diet|diet
169430|NCT02519946|Cardiovascular Physiology|cardiovascular physiology
169431|NCT02519946|Telemedicine|telemedicine
169432|NCT02519946|Pediatrics|pediatrics
169433|NCT02519946|Health Behavior|health behavior
169434|NCT02519946|Physical Fitness|physical fitness
169435|NCT02519946|Exercise Movement Techniques|exercise movement techniques
169436|NCT02519946|Adolescent Behavior|adolescent behavior
169437|NCT02519946|Child Behavior|child behavior
169438|NCT02519933|hemodialysis|hemodialysis
169439|NCT02519933|vascular access|vascular access
169440|NCT02519907|Nerve Stimulation|nerve stimulation
169441|NCT02519907|Neuroplasticity|neuroplasticity
169442|NCT02519907|Sensory Feedback|sensory feedback
169443|NCT02519881|cartilage defect in ankle|cartilage defect in ankle
169444|NCT02519881|microfracture|microfracture
169445|NCT02519881|modified microfracture using collagen|modified microfracture using collagen
169446|NCT02519881|collagen|collagen
169447|NCT02519868|Neuromodulation|neuromodulation
169448|NCT02519868|Local anaesthetics|local anaesthetics
169449|NCT02519829|Suture|suture
169450|NCT02519829|Skin staples|skin staples
169451|NCT02519829|Vicryl|vicryl
169452|NCT02519829|Monocryl|monocryl
169453|NCT02519816|post stem cell transplantation|post stem cell transplantation
169454|NCT02519816|Steroid refractory|steroid refractory
169455|NCT02519816|dependent chronic|dependent chronic
169456|NCT02519777|HIV-Associated Neurocognitive Disorder|hiv-associated neurocognitive disorder
169457|NCT02519764|volunteer runners who are participating in the 2015 Mont Blanc Ultra Trail|volunteer runners who are participating in the 2015 mont blanc ultra trail
169458|NCT02519764|hydration protocol|hydration protocol
169459|NCT02519764|natremia|natremia
169460|NCT02519764|Volunteers|volunteers
169461|NCT02519725|Family|family
169462|NCT02519725|PTSD|ptsd
169463|NCT02519725|Anxiety disorders|anxiety disorders
169464|NCT02519725|Depression disorders|depression disorders
169465|NCT02519725|Qualitative research|qualitative research
169466|NCT02519712|Induction Chemotherapy|induction chemotherapy
169467|NCT02519712|G-CSF-Mobilized Stem Cells|g-csf-mobilized stem cells
169468|NCT02519712|Haploidentical Related Donors|haploidentical related donors
169469|NCT02519712|15-141|15-141
169470|NCT02519660|Ralydan|ralydan
169471|NCT02519660|EMLA cream|emla cream
169472|NCT02519660|Procedural pain|procedural pain
169473|NCT02519660|Phlebotomy|phlebotomy
169474|NCT02519660|Child|child
169475|NCT02519634|Super-Mini Percutaneous Nephrolithotomy|super-mini percutaneous nephrolithotomy
169477|NCT02519634|Retrograde Intrarenal Surgery|retrograde intrarenal surgery
169478|NCT02519634|RIRS|rirs
169479|NCT02519634|Randomized Controlled Trial|randomized controlled trial
169480|NCT02519634|RCT|rct
169481|NCT02519621|diabetic ulcer|diabetic ulcer
169482|NCT02519621|pressure ulcer|pressure ulcer
169483|NCT02519621|chronic or traumatic wound|chronic or traumatic wound
169484|NCT02519621|sub-acute or dehisced wound|sub-acute or dehisced wound
169485|NCT02519608|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
169486|NCT02519608|stable coronary artery disease|stable coronary artery disease
169487|NCT02519608|ticagrelor|ticagrelor
169488|NCT02519608|clopidogrel|clopidogrel
169489|NCT02519608|endothelial function|endothelial function
169490|NCT02519608|inflammation|inflammation
169491|NCT02519608|platelet reactivity|platelet reactivity
169492|NCT02519595|Procedural sedation|procedural sedation
169493|NCT02519595|ketamine|ketamine
169494|NCT02519595|children|children
169495|NCT02519582|Colorectal Cancer|colorectal cancer
169496|NCT02519582|S100A4|s100a4
169497|NCT02519556|Probiotics|probiotics
169498|NCT02519556|Inflammation|inflammation
169499|NCT02519556|Awareness|awareness
169500|NCT02519556|Immune tolerance|immune tolerance
169501|NCT02519543|insulin resistance|insulin resistance
169502|NCT02519530|Positive Youth Development|positive youth development
169503|NCT02519530|Teen Outreach|teen outreach
169504|NCT02519530|Teen Pregnancy Prevention|teen pregnancy prevention
169505|NCT02519504|Galactose-1-phosphate uridylyltransferase deficiency|galactose-1-phosphate uridylyltransferase deficiency
169506|NCT02519504|Cognitive disorders|cognitive disorders
169507|NCT02519478|football|football
169508|NCT02519478|Training Techniques|training techniques
169509|NCT02519478|education|education
169510|NCT02519478|Athletic Injuries|athletic injuries
169511|NCT02519478|Brain Concussion|brain concussion
169512|NCT02519465|nasal cannula|nasal cannula
169513|NCT02519465|Inhalation Devices|inhalation devices
169514|NCT02519452|Multiple Myeloma|multiple myeloma
169515|NCT02519452|Daratumumab (JNJ-54767414)|daratumumab (jnj-54767414)
169516|NCT02519452|Recombinant Human Hyaluronidase|recombinant human hyaluronidase
169517|NCT02519439|Partial Onset Seizures|partial onset seizures
169518|NCT02519439|complex partial seizures|complex partial seizures
169519|NCT02519439|simple partial seizures|simple partial seizures
169520|NCT02519439|anticonvulsant|anticonvulsant
169521|NCT02519439|ganaxolone|ganaxolone
169522|NCT02519439|neurosteroid|neurosteroid
169523|NCT02519439|Marinus|marinus
169524|NCT02519439|epilepsy|epilepsy
169525|NCT02519426|Third molar|third molar
169526|NCT02519426|Classification|classification
169527|NCT02519426|Inferior alveolar nerve|inferior alveolar nerve
169528|NCT02519426|Lingual nerve injuries|lingual nerve injuries
169529|NCT02519426|Mandibular canal|mandibular canal
169530|NCT02519413|lymphocyte|lymphocyte
169531|NCT02519413|serious infections|serious infections
169532|NCT02519413|opportunistic infections|opportunistic infections
169533|NCT02519413|Relapsing Forms|relapsing forms
169534|NCT02519400|amitriptyline|amitriptyline
169535|NCT02519400|cyp2d6|cyp2d6
169536|NCT02519400|cyp2c19|cyp2c19
169537|NCT02519374|Fiber tolerability|fiber tolerability
169538|NCT02519374|Children|children
169539|NCT02519361|elderly|elderly
169540|NCT02519361|immune response|immune response
169541|NCT02519361|acute infection|acute infection
169542|NCT02519348|Hepatocellular Carcinoma|hepatocellular carcinoma
169543|NCT02519348|Immunotherapy|immunotherapy
169544|NCT02519348|Antibodies, Monoclonal|antibodies, monoclonal
169545|NCT02519348|Tremelimumab|tremelimumab
169546|NCT02519348|MEDI4736|medi4736
169547|NCT02519348|Durvalumab|durvalumab
169548|NCT02519335|cardiopulmonary bypass|cardiopulmonary bypass
169549|NCT02519335|ischemia reperfusion injury|ischemia reperfusion injury
169550|NCT02519322|Melanoma|melanoma
169551|NCT02519322|Oligometastatic melanoma|oligometastatic melanoma
169552|NCT02519322|Resectable|resectable
169553|NCT02519322|Nivolumab|nivolumab
169554|NCT02519322|BMS-936558|bms-936558
169555|NCT02519322|Opdivo|opdivo
169556|NCT02519322|Ipilimumab|ipilimumab
169557|NCT02519322|Yervoy|yervoy
169558|NCT02519322|BMS-734016|bms-734016
169559|NCT02519322|MDX010|mdx010
169560|NCT02519283|AHF|ahf
169561|NCT02519283|HF|hf
169562|NCT02519283|ED|ed
169563|NCT02519283|ER|er
169564|NCT02519283|Emergency Department|emergency department
169565|NCT02519283|Emergency Room|emergency room
169566|NCT02519257|CAD|cad
169567|NCT02519257|VHD|vhd
169568|NCT02519257|Thy-1|thy-1
169569|NCT02519244|Multiple Sclerosis|multiple sclerosis
169570|NCT02519244|Ambulation|ambulation
169571|NCT02519244|Rehabilitation|rehabilitation
169572|NCT02519244|Wearable Robotic Devices|wearable robotic devices
169573|NCT02519231|IUD|iud
169574|NCT02519231|naproxen|naproxen
169575|NCT02519231|bleeding|bleeding
169576|NCT02519153|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors
169577|NCT02519153|PDE5i|pde5i
169578|NCT02519153|Sildinafil|sildinafil
169579|NCT02519140|Gastric cancer|gastric cancer
169580|NCT02519140|colon cancer|colon cancer
169581|NCT02519140|EMR|emr
169582|NCT02519140|biopsy|biopsy
169583|NCT02519140|bariatric surgery|bariatric surgery
169584|NCT02519114|M Myeloma|m myeloma
169585|NCT02519114|KIR ligand mismatch|kir ligand mismatch
169586|NCT02519114|Haploidentical|haploidentical
169587|NCT02519088|Homologous Blood Transfusion|homologous blood transfusion
169588|NCT02519088|Total Hip Replacement|total hip replacement
169589|NCT02519088|Patient Blood Management|patient blood management
169590|NCT02519075|Hepatocarcinoma|hepatocarcinoma
169591|NCT02519075|TARE|tare
169592|NCT02519075|response assessment|response assessment
169593|NCT02519062|Carcinoma|carcinoma
169594|NCT02519062|Non-Small-Cell Lung|non-small-cell lung
169595|NCT02519062|FDG PET|fdg pet
169596|NCT02519062|hypoxia markers|hypoxia markers
169597|NCT02519062|immune markers|immune markers
169598|NCT02519049|Mesothelioma|mesothelioma
169599|NCT02519049|11C-methionine PET|11c-methionine pet
169600|NCT02519049|talc pleurodesis|talc pleurodesis
169601|NCT02519036|Huntington's Disease|huntington's disease
169602|NCT02519036|HTTRx|httrx
169603|NCT02519036|Early Manifest Huntington's Disease|early manifest huntington's disease
169604|NCT02518997|Preterm Infants|preterm infants
169605|NCT02518997|Bedside Reading aloud|bedside reading aloud
169606|NCT02518997|Parental wellbeing|parental wellbeing
169607|NCT02518997|Parental Bonding|parental bonding
169608|NCT02518997|cardio-respiratory stability|cardio-respiratory stability
169609|NCT02518945|Type 1 Diabetes|type 1 diabetes
169610|NCT02518945|Liraglutide|liraglutide
169611|NCT02518945|Dapagliflozin|dapagliflozin
169612|NCT02518945|Triple Therapy|triple therapy
169613|NCT02518919|Children|children
169614|NCT02518919|Emergency Department|emergency department
169615|NCT02518919|Sedation|sedation
169616|NCT02518906|Psychotherapy|psychotherapy
169617|NCT02518906|psychotherapy process|psychotherapy process
169618|NCT02518906|therapeutic alliance|therapeutic alliance
169619|NCT02518906|psychotherapeutic change|psychotherapeutic change
169620|NCT02518906|psychophysiology|psychophysiology
169621|NCT02518893|Military Personnel|military personnel
169622|NCT02518893|Air Force Personnel|air force personnel
169623|NCT02518893|Army Personnel|army personnel
169624|NCT02518893|Navy Personnel|navy personnel
169625|NCT02518893|Armed Forces Personnel|armed forces personnel
169626|NCT02518893|Marines|marines
169627|NCT02518893|Soldiers|soldiers
169628|NCT02518893|Sailors|sailors
169629|NCT02518893|Airmen|airmen
169630|NCT02518893|Decision Making|decision making
169631|NCT02518893|Research Subjects|research subjects
169632|NCT02518893|Life Experiences|life experiences
169633|NCT02518893|Patient Participation|patient participation
169634|NCT02518893|Refusal to Participate|refusal to participate
169635|NCT02518893|Healthcare Research|healthcare research
169636|NCT02518893|Qualitative Research|qualitative research
169637|NCT02518893|Interview|interview
169638|NCT02518893|Interviews, Telephone|interviews, telephone
169639|NCT02518893|Ethics, Research|ethics, research
169640|NCT02518867|Cerebral palsy|cerebral palsy
169641|NCT02518867|Transcranial magnetic stimulation|transcranial magnetic stimulation
169642|NCT02518841|ThermaWedge TM|thermawedge tm
169643|NCT02518841|stretches|stretches
169644|NCT02518828|Acute Heart Failure|acute heart failure
169645|NCT02518802|Gefitinib|gefitinib
169646|NCT02518802|Pemetrexed|pemetrexed
169647|NCT02518802|Synchronous therapy|synchronous therapy
169648|NCT02518802|Adjuvent therapy|adjuvent therapy
169649|NCT02518789|myoclonus|myoclonus
169650|NCT02518789|Etomidate|etomidate
169651|NCT02518789|Dexmedetomidine|dexmedetomidine
169652|NCT02518750|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
169653|NCT02518750|Salvage Regimen|salvage regimen
169654|NCT02518750|Re-Induction Therapy|re-induction therapy
169655|NCT02518750|Multi-agent chemotherapy|multi-agent chemotherapy
169656|NCT02518737|Glucose-dependent Insulinotropic Polypeptide|glucose-dependent insulinotropic polypeptide
169657|NCT02518737|Receptor Deficiency|receptor deficiency
169658|NCT02518711|symptoms of ADHD|symptoms of adhd
169659|NCT02518698|Castrated resistant prostate cancer|castrated resistant prostate cancer
169660|NCT02518698|Patients with bone metastases|patients with bone metastases
169661|NCT02518685|Obesity|obesity
169662|NCT02518685|Weight loss|weight loss
169663|NCT02518685|Device|device
169664|NCT02518685|Non-surgical|non-surgical
169665|NCT02518685|Endoscopic|endoscopic
169666|NCT02518685|TransPyloric Shuttle|transpyloric shuttle
169667|NCT02518685|TPS|tps
169668|NCT02518659|hypomagnesemia|hypomagnesemia
169669|NCT02518659|hypocalcemia|hypocalcemia
169670|NCT02518659|inulin|inulin
169671|NCT02518659|FOS|fos
169672|NCT02518659|PPI|ppi
169673|NCT02518659|proton-pump inhibitors|proton-pump inhibitors
169674|NCT02518646|Delirium|delirium
169675|NCT02518646|Intensive care unit|intensive care unit
169676|NCT02518646|Adult|adult
169677|NCT02518646|Clinical prediction|clinical prediction
169678|NCT02518633|obesity|obesity
169679|NCT02518633|hypoxia|hypoxia
169680|NCT02518633|adipose tissue|adipose tissue
169681|NCT02518607|Safety and Tolerability|safety and tolerability
169682|NCT02518607|Male Volunteers|male volunteers
169683|NCT02518594|women|women
169684|NCT02518594|cervical length of less than 30 millimeters|cervical length of less than 30 millimeters
169685|NCT02518594|carrying twins|carrying twins
169686|NCT02518594|short cervix|short cervix
169687|NCT02518516|Statins, HMG-CoA|statins, hmg-coa
169688|NCT02518516|Acute kidney injury|acute kidney injury
169689|NCT02518516|Kidney diseases|kidney diseases
169690|NCT02518516|Renal failure|renal failure
169691|NCT02518503|Diabetes Mellitus|diabetes mellitus
169692|NCT02518503|Statins|statins
169693|NCT02518503|HMG-CoA reductase inhibitors|hmg-coa reductase inhibitors
169694|NCT02518477|breast cancer surgery|breast cancer surgery
169695|NCT02518477|axillary lymph node dissection|axillary lymph node dissection
169696|NCT02518477|resistance training|resistance training
169697|NCT02518477|breast cancer related lymphedema|breast cancer related lymphedema
169698|NCT02518464|headache|headache
169699|NCT02518464|chronic|chronic
169700|NCT02518464|migraine|migraine
169701|NCT02518464|right to left shunt|right to left shunt
169702|NCT02518451|antihypertensive|antihypertensive
169703|NCT02518451|bioequivalence|bioequivalence
169704|NCT02518451|formulation|formulation
169705|NCT02518451|pharmakokinetic|pharmakokinetic
169706|NCT02518451|valsartan|valsartan
169707|NCT02518451|subjects|subjects
169708|NCT02518451|Fasting conditions|fasting conditions
169709|NCT02518438|Tramadol|tramadol
169710|NCT02518438|Postoperative analgesia|postoperative analgesia
169711|NCT02518438|Infiltration|infiltration
169712|NCT02518438|Cesarean section|cesarean section
169713|NCT02518412|Alzheimers disease|alzheimers disease
169714|NCT02518412|Transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
169715|NCT02518412|Neuromodulation|neuromodulation
169716|NCT02518412|Neuropsychology|neuropsychology
169717|NCT02518399|Blood vessels|blood vessels
169718|NCT02518399|Heat|heat
169719|NCT02518399|Cardiovascular diseases|cardiovascular diseases
169720|NCT02518386|emergency department|emergency department
169721|NCT02518386|epidemiology|epidemiology
169722|NCT02518386|prehospital care|prehospital care
169723|NCT02518386|dispatch|dispatch
169724|NCT02518386|acute self poisoning|acute self poisoning
169725|NCT02518360|NON SPECIFIC LOW BACK PAIN|non specific low back pain
169726|NCT02518360|OSTEOPATHY|osteopathy
169727|NCT02518360|FOOT PRESSURE PLATFORM|foot pressure platform
169728|NCT02518360|POSTURAL BALANCE|postural balance
169729|NCT02518334|type two diabetes|type two diabetes
169730|NCT02518334|glycemic control|glycemic control
169731|NCT02518321|Toileting|toileting
169732|NCT02518321|Technology-Assisted Toilets|technology-assisted toilets
169733|NCT02518321|Rehabilitation|rehabilitation
169734|NCT02518321|Assistive Devices|assistive devices
169735|NCT02518321|Activities of Daily Living|activities of daily living
169736|NCT02518282|high-sensitivity troponin T|high-sensitivity troponin t
169737|NCT02518282|Acute myocardial infarction|acute myocardial infarction
169738|NCT02518282|Heart valvular surgery|heart valvular surgery
169739|NCT02518282|Cardiac surgery|cardiac surgery
169740|NCT02518269|hip|hip
169741|NCT02518269|arthroplasty|arthroplasty
169742|NCT02518269|G7|g7
169743|NCT02518269|EchoBimetric|echobimetric
169744|NCT02518269|E1|e1
169745|NCT02518269|ceramic|ceramic
169746|NCT02518269|Arcom XL|arcom xl
169747|NCT02518256|Neoplasms|neoplasms
169748|NCT02518256|Glandular and Epithelial|glandular and epithelial
169749|NCT02518256|Ovarian Neoplasms|ovarian neoplasms
169750|NCT02518256|Ovarian cancer|ovarian cancer
169751|NCT02518204|cognitive assessment|cognitive assessment
169752|NCT02518204|neuropsychological assessment|neuropsychological assessment
169753|NCT02518204|Brain Performance Test|brain performance test
169754|NCT02518204|computerized assessment|computerized assessment
169755|NCT02518191|GnRHa|gnrha
169756|NCT02518191|ovarian function|ovarian function
169757|NCT02518191|anti-mullerian hormone|anti-mullerian hormone
169758|NCT02518178|NFC|nfc
169759|NCT02518178|randomization|randomization
169760|NCT02518178|RCT|rct
169761|NCT02518178|mHealth|mhealth
169762|NCT02518178|maternal and child health|maternal and child health
169763|NCT02518165|Cognitive Domain: Speed|cognitive domain: speed
169764|NCT02518165|Cognitive Domain: Reaction Time|cognitive domain: reaction time
169765|NCT02518165|Cognitive Domain: Attention|cognitive domain: attention
169766|NCT02518165|Cognitive Domain: Executive Function|cognitive domain: executive function
169767|NCT02518165|Cognitive Domain Memory|cognitive domain memory
169768|NCT02518165|Sleep Quality|sleep quality
169769|NCT02518165|Sleep Efficiency|sleep efficiency
169770|NCT02518139|Chronic Obstructive Pulmonary Disease, COPD|chronic obstructive pulmonary disease, copd
169771|NCT02518126|LIF IUGR|lif iugr
169772|NCT02518087|CPB|cpb
169773|NCT02518087|oXiris®|oxiris®
169774|NCT02518087|CS-AKI|cs-aki
169775|NCT02518087|SIRS|sirs
169776|NCT02518087|Cytokines|cytokines
169777|NCT02518087|LPS|lps
169778|NCT02518087|AKI|aki
169779|NCT02518074|volunteers|volunteers
169780|NCT02518061|Glioma; 11C-Methionine PET|glioma; 11c-methionine pet
169781|NCT02518048|Psoriasis|psoriasis
169782|NCT02518022|Type 1 Diabetes mellitus|type 1 diabetes mellitus
169783|NCT02518022|Hypoglycemia|hypoglycemia
169784|NCT02518022|continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
169785|NCT02518022|Alcohol|alcohol
169786|NCT02518022|continuous glucose monitoring system|continuous glucose monitoring system
169787|NCT02518022|Nutrition|nutrition
169788|NCT02517983|chronic respiratory diseases phenotyping|chronic respiratory diseases phenotyping
169789|NCT02517970|infant feeding|infant feeding
169790|NCT02517970|breast-feeding|breast-feeding
169791|NCT02517970|bottle-feeding|bottle-feeding
169792|NCT02517970|feeding interactions|feeding interactions
169793|NCT02517970|maternal feeding practices|maternal feeding practices
169794|NCT02517957|Xiashi surgical|xiashi surgical
169795|NCT02517944|Familial hypercholesterolemia|familial hypercholesterolemia
169796|NCT02517918|Advanced solid tumor|advanced solid tumor
169797|NCT02517918|Bone metastasis and advanced pretreated osteosarcoma|bone metastasis and advanced pretreated osteosarcoma
169798|NCT02517918|Phase I trial|phase i trial
169799|NCT02517918|Dose escalation and expansion cohort|dose escalation and expansion cohort
169800|NCT02517918|Biomarkers study|biomarkers study
169801|NCT02517879|ITNs|itns
169802|NCT02517879|malaria prevention|malaria prevention
169803|NCT02517866|Drug therapy|drug therapy
169804|NCT02517827|common femoral artery|common femoral artery
169805|NCT02517827|drug-coated balloon|drug-coated balloon
169806|NCT02517827|surgical endarterectomy|surgical endarterectomy
169807|NCT02517801|anthocyanins|anthocyanins
169808|NCT02517801|Post-menopausal women|post-menopausal women
169809|NCT02517801|endothelial function|endothelial function
169810|NCT02517801|vascular function|vascular function
169811|NCT02517775|polyphenols|polyphenols
169812|NCT02517775|vascular function|vascular function
169813|NCT02517775|endothelial function|endothelial function
169814|NCT02517775|cranberry|cranberry
169815|NCT02517775|healthy|healthy
169816|NCT02517723|Borderline Personality Disorder|borderline personality disorder
169817|NCT02517723|comorbid Posttraumatic Stress Disorder|comorbid posttraumatic stress disorder
169818|NCT02517723|Narrative Exposure Therapy|narrative exposure therapy
169819|NCT02517723|Dialectical-Behavioral Therapy|dialectical-behavioral therapy
169820|NCT02517684|Crohn's disease|crohn's disease
169821|NCT02517684|pediatric|pediatric
169822|NCT02517684|infliximab|infliximab
169823|NCT02517684|top-down|top-down
169824|NCT02517684|TISKids|tiskids
169825|NCT02517671|Fitness|fitness
169826|NCT02517671|Run time|run time
169827|NCT02517671|VO2max|vo2max
169828|NCT02517671|VEGF|vegf
169829|NCT02517671|Central blood pressure|central blood pressure
169830|NCT02517671|Augmentation Index|augmentation index
169831|NCT02517671|Pulse wave analysis|pulse wave analysis
169832|NCT02517632|Physical activity|physical activity
169833|NCT02517632|Cardiac rehabilitation|cardiac rehabilitation
169834|NCT02517619|Iontophoresis|iontophoresis
169835|NCT02517619|Ophthalmology|ophthalmology
169836|NCT02517619|Non-Infectious Anterior Segment Uveitis|non-infectious anterior segment uveitis
169837|NCT02517593|BCRAT|bcrat
169838|NCT02517593|IBIS|ibis
169839|NCT02517593|PRS|prs
169840|NCT02517593|breast cancer|breast cancer
169841|NCT02517593|Tyrer-Cuzick|tyrer-cuzick
169968|NCT02516605|Primary Biliary Cirrhosis, PBC|primary biliary cirrhosis, pbc
169969|NCT02516605|Primary Biliary Cholangitis|primary biliary cholangitis
169842|NCT02517554|meet National Comprehensive Cancer Network® criteria for cancer genetic testing for breast, ovarian and colorectal cancers|meet national comprehensive cancer network® criteria for cancer genetic testing for breast, ovarian and colorectal cancers
169843|NCT02517528|(HCV) Infection|(hcv) infection
169844|NCT02517528|Compensated Cirrhosis|compensated cirrhosis
169845|NCT02517515|HCV Infection|hcv infection
169846|NCT02517515|Chronic Hepatitis C Virus|chronic hepatitis c virus
169847|NCT02517515|Hepatitis C Virus (HCV) Genotype 1b|hepatitis c virus (hcv) genotype 1b
169848|NCT02517502|DHA|dha
169849|NCT02517502|Omega-3|omega-3
169850|NCT02517502|neoadjuvant chemotherapy|neoadjuvant chemotherapy
169851|NCT02517502|chemotherapy|chemotherapy
169852|NCT02517502|breast cancer|breast cancer
169853|NCT02517489|Community-Acquired Pneumonia (CAP)|community-acquired pneumonia (cap)
169854|NCT02517489|Hydrocortisone|hydrocortisone
169855|NCT02517489|Corticosteroids|corticosteroids
169856|NCT02517463|Emergency contraception|emergency contraception
169857|NCT02517463|ulipristal acetate|ulipristal acetate
169858|NCT02517463|efficacy|efficacy
169859|NCT02517450|Subjects|subjects
169860|NCT02517411|COPD|copd
169861|NCT02517411|physiotherapy|physiotherapy
169862|NCT02517411|Stable disease|stable disease
169863|NCT02517398|Solid tumor|solid tumor
169864|NCT02517398|MSB0011359C (M7824)|msb0011359c (m7824)
169865|NCT02517398|Metastatic or Locally Advanced Solid Tumors|metastatic or locally advanced solid tumors
169866|NCT02517346|CPAP compliance|cpap compliance
169867|NCT02517346|Telemonitoring|telemonitoring
169868|NCT02517346|Standard management|standard management
169869|NCT02517346|Cost effectiveness|cost effectiveness
169870|NCT02517333|Motor skill proficiency|motor skill proficiency
169871|NCT02517333|movement difficulties|movement difficulties
169872|NCT02517333|Developmental Coordination Disorder (DCD)|developmental coordination disorder (dcd)
169873|NCT02517333|Low physical fitness|low physical fitness
169874|NCT02517320|Diabetic Nephropathy|diabetic nephropathy
169875|NCT02517294|Nasotracheal intubation|nasotracheal intubation
169876|NCT02517294|adenoid size|adenoid size
169877|NCT02517294|epistaxis|epistaxis
169878|NCT02517294|nasopharyngeal mucosal injury|nasopharyngeal mucosal injury
169879|NCT02517255|ST segment elevation myocardial infarction|st segment elevation myocardial infarction
169880|NCT02517255|Failed Thrombolysis|failed thrombolysis
169881|NCT02517255|Rescue Percutaneous Coronary Intervention|rescue percutaneous coronary intervention
169882|NCT02517255|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
169883|NCT02517229|volunteers|volunteers
169884|NCT02517216|volunteers|volunteers
169885|NCT02517190|volunteers|volunteers
169886|NCT02517177|volunteers|volunteers
169887|NCT02517151|iron|iron
169888|NCT02517151|fatigue|fatigue
169889|NCT02517151|crohn's disease|crohn's disease
169890|NCT02517151|ulcerative colitis|ulcerative colitis
169891|NCT02517151|IBD|ibd
169892|NCT02517138|volunteers|volunteers
169893|NCT02517112|volunteers|volunteers
169894|NCT02517099|Preschool|preschool
169895|NCT02517099|Wheeze|wheeze
169896|NCT02517099|Moderate|moderate
169897|NCT02517099|Severe|severe
169898|NCT02517086|blood circulation|blood circulation
169899|NCT02517073|mechanical ventilation|mechanical ventilation
169900|NCT02517073|epidemiology|epidemiology
169901|NCT02517073|intensive care unit|intensive care unit
169902|NCT02517073|national survey|national survey
169903|NCT02517060|Social perceptions|social perceptions
169904|NCT02517008|non-monetary incentive|non-monetary incentive
169905|NCT02517008|institutional delivery|institutional delivery
169906|NCT02516982|mHealth|mhealth
169907|NCT02516982|Telemedicine|telemedicine
169908|NCT02516982|Perinatal depression|perinatal depression
169909|NCT02516982|Screening|screening
169910|NCT02516982|Edinburgh Postnatal Depression Scale|edinburgh postnatal depression scale
169911|NCT02516982|Whooley Questions|whooley questions
169912|NCT02516982|Data collection|data collection
169913|NCT02516982|Mood disorders|mood disorders
169914|NCT02516982|Mental health|mental health
169915|NCT02516982|Antenatal care|antenatal care
169916|NCT02516982|Prenatal Care|prenatal care
169917|NCT02516956|Breakfast|breakfast
169918|NCT02516956|Food choices|food choices
169919|NCT02516956|Lunch|lunch
169920|NCT02516956|Eating habits|eating habits
169921|NCT02516956|Appetite|appetite
169922|NCT02516956|Neural activation|neural activation
169923|NCT02516956|Attention|attention
169924|NCT02516956|Glucose|glucose
169925|NCT02516956|Insulin|insulin
169926|NCT02516956|fMRI|fmri
169927|NCT02516943|Arterial blood gas analysis|arterial blood gas analysis
169928|NCT02516930|health promotion|health promotion
169929|NCT02516930|crowdsourcing|crowdsourcing
169930|NCT02516904|Subjects|subjects
169931|NCT02516891|treatment|treatment
169932|NCT02516891|stent|stent
169933|NCT02516891|coronary bifurcations lesions|coronary bifurcations lesions
169934|NCT02516878|acupuncture|acupuncture
169935|NCT02516878|Chinese Medicine|chinese medicine
169936|NCT02516878|obesity|obesity
169937|NCT02516865|postpartum|postpartum
169938|NCT02516865|physical activity|physical activity
169939|NCT02516852|community development; poultry; animal-source food; stunting|community development; poultry; animal-source food; stunting
169940|NCT02516839|Overweight|overweight
169941|NCT02516839|Obesity|obesity
169942|NCT02516839|Overeating|overeating
169943|NCT02516839|Body Mass Index|body mass index
169944|NCT02516839|Weight|weight
169945|NCT02516839|Treatment|treatment
169946|NCT02516839|Cravings|cravings
169947|NCT02516839|Intervention|intervention
169948|NCT02516839|Behavioral Treatment|behavioral treatment
169949|NCT02516813|M3814|m3814
169950|NCT02516813|Advanced solid tumors|advanced solid tumors
169951|NCT02516813|DNA-PK Inhibitor|dna-pk inhibitor
169952|NCT02516813|Radiotherapy|radiotherapy
169953|NCT02516813|Chemotherapy|chemotherapy
169954|NCT02516787|volunteers|volunteers
169955|NCT02516761|Fibromyalgia|fibromyalgia
169956|NCT02516748|optical diagnosis|optical diagnosis
169957|NCT02516748|narrow band image|narrow band image
169958|NCT02516644|Parkinson Disease|parkinson disease
169959|NCT02516644|Mobility|mobility
169960|NCT02516644|Balance|balance
169961|NCT02516644|Virtual Reality|virtual reality
169962|NCT02516644|treadmill training|treadmill training
169963|NCT02516631|Labour, induced|labour, induced
169964|NCT02516631|Misoprostol|misoprostol
169965|NCT02516631|Pharmacokinetics|pharmacokinetics
169966|NCT02516631|Cardiotocography|cardiotocography
169967|NCT02516631|Safety|safety
169970|NCT02516566|Positive end-expiratory pressure ventilation|positive end-expiratory pressure ventilation
169971|NCT02516566|Optic nerve sheath diameter|optic nerve sheath diameter
169972|NCT02516540|hereditary breast and ovarian cancer (HBOC)|hereditary breast and ovarian cancer (hboc)
169973|NCT02516540|BRCA1/2 mutation carriers|brca1/2 mutation carriers
169974|NCT02516540|Mediterranean diet|mediterranean diet
169975|NCT02516540|Structured exercise training|structured exercise training
169976|NCT02516540|prevention|prevention
169977|NCT02516514|Blood culture|blood culture
169978|NCT02516514|Bacteremia|bacteremia
169979|NCT02516514|Single sampling|single sampling
169980|NCT02516501|Ketogenic Diet|ketogenic diet
169981|NCT02516501|Body composition|body composition
169982|NCT02516501|Radiation therapy|radiation therapy
169983|NCT02516436|Bunavail|bunavail
169984|NCT02516436|Suboxone|suboxone
169985|NCT02516436|Heroin|heroin
169986|NCT02516436|Zubsolv|zubsolv
169987|NCT02516436|Buprenorphine|buprenorphine
169988|NCT02516436|Naloxone|naloxone
169989|NCT02516436|Opioids|opioids
169990|NCT02516436|Addiction|addiction
169991|NCT02516436|Induction|induction
169992|NCT02516397|body fat mass reduction|body fat mass reduction
169993|NCT02516384|Fecal Microbiota Transplantation|fecal microbiota transplantation
169994|NCT02516384|Ulcerative Colitis|ulcerative colitis
169995|NCT02516345|Physical activity|physical activity
169996|NCT02516345|Financial incentives|financial incentives
169997|NCT02516345|Children|children
169998|NCT02516345|Parents|parents
169999|NCT02516345|RCT|rct
170000|NCT02516345|Wireless pedometer|wireless pedometer
170001|NCT02516306|Presbyopia|presbyopia
170002|NCT02516306|Vision|vision
170003|NCT02516306|UNR844|unr844
170004|NCT02516280|Total knee replacement|total knee replacement
170005|NCT02516280|Cold|cold
170006|NCT02516280|Neurocryostimulation|neurocryostimulation
170007|NCT02516280|CO2 cryotherapy|co2 cryotherapy
170008|NCT02516280|mobility|mobility
170009|NCT02516267|platelet aggregability|platelet aggregability
170010|NCT02516267|acute coronary syndrome|acute coronary syndrome
170011|NCT02516267|coronary artery bypass graft|coronary artery bypass graft
170012|NCT02516254|vitamin D|vitamin d
170013|NCT02516254|fortified bread|fortified bread
170014|NCT02516254|efficacy|efficacy
170015|NCT02516254|Vitamin D Deficiency|vitamin d deficiency
170016|NCT02516241|Urothelial Cancer|urothelial cancer
170017|NCT02516241|Phase III|phase iii
170018|NCT02516189|Microcirculation|microcirculation
170019|NCT02516189|Electromyography|electromyography
170020|NCT02516189|Motor Activity|motor activity
170021|NCT02516176|stroke|stroke
170022|NCT02516176|cerebral vascular accident|cerebral vascular accident
170023|NCT02516176|balance|balance
170024|NCT02516176|treadmill|treadmill
170025|NCT02516176|falls|falls
170026|NCT02516176|hemiparesis|hemiparesis
170027|NCT02516150|Type 1 Diabetes|type 1 diabetes
170028|NCT02516150|Bionic Pancreas|bionic pancreas
170029|NCT02516150|Artificial Pancreas|artificial pancreas
170030|NCT02516150|Insulin|insulin
170031|NCT02516150|Glucagon|glucagon
170032|NCT02516150|Alcohol|alcohol
170033|NCT02516150|Alcohol Clamp|alcohol clamp
170034|NCT02516137|Dry needling|dry needling
170035|NCT02516124|Autoimmune diseases|autoimmune diseases
170036|NCT02516124|Systemic sclerosis|systemic sclerosis
170037|NCT02516124|Autologous Hematopoietic stem cell transplant|autologous hematopoietic stem cell transplant
170038|NCT02516072|remote ischemic preconditioning|remote ischemic preconditioning
170039|NCT02516059|thoracic epidural analgesia|thoracic epidural analgesia
170040|NCT02516059|oxycodone|oxycodone
170041|NCT02516059|oral naloxone|oral naloxone
170042|NCT02516059|radical cystectomy|radical cystectomy
170043|NCT02516059|bowel function|bowel function
170044|NCT02516059|pain|pain
170045|NCT02516033|Atrial Fibrillation|atrial fibrillation
170046|NCT02516033|Hybrid Ablation|hybrid ablation
170047|NCT02516033|Efficacy|efficacy
170048|NCT02516033|Risk Profile|risk profile
170049|NCT02516033|Biomarkers|biomarkers
170050|NCT02516020|IVF|ivf
170051|NCT02516020|ICSI|icsi
170052|NCT02516020|culture media|culture media
170053|NCT02516020|sequential|sequential
170054|NCT02515981|tobacco dependence|tobacco dependence
170055|NCT02515981|smoking cessation|smoking cessation
170056|NCT02515981|mental health|mental health
170057|NCT02515981|cardiovascular disease|cardiovascular disease
170058|NCT02515981|obesity|obesity
170059|NCT02515955|Healthy|healthy
170060|NCT02515955|JNJ-54175446|jnj-54175446
170061|NCT02515929|Oligomeric Proanthocyanidins|oligomeric proanthocyanidins
170062|NCT02515929|Periodontal Disease|periodontal disease
170063|NCT02515903|Endoscopy|endoscopy
170064|NCT02515903|Intracerebral hemorrhage|intracerebral hemorrhage
170065|NCT02515903|surgery|surgery
170066|NCT02515903|stereotactic aspiration|stereotactic aspiration
170067|NCT02515903|Key-hole approach|key-hole approach
170068|NCT02515903|Intracerebral hemorrhage surgical treatment|intracerebral hemorrhage surgical treatment
170069|NCT02515903|Transparent endoscopic sheath|transparent endoscopic sheath
170070|NCT02515903|Agitation-aspiration device|agitation-aspiration device
170071|NCT02515890|midazolam|midazolam
170072|NCT02515890|dexmedetomidine|dexmedetomidine
170073|NCT02515890|memory|memory
170074|NCT02515890|ketamine|ketamine
170075|NCT02515864|Male and Female Volunteers|male and female volunteers
170076|NCT02515786|Chronic respiratory failure|chronic respiratory failure
170077|NCT02515786|Oxygen therapy|oxygen therapy
170078|NCT02515786|Nasal catheter|nasal catheter
170079|NCT02515786|Mucociliary clearance|mucociliary clearance
170080|NCT02515747|Lipoprotein(a)|lipoprotein(a)
170081|NCT02515747|coronary artery bypass grafting (CABG)|coronary artery bypass grafting (cabg)
170082|NCT02515747|apo(a)|apo(a)
170083|NCT02515747|prognosis|prognosis
170084|NCT02515747|myocardial infarction|myocardial infarction
170085|NCT02515747|cardiovascular death|cardiovascular death
170086|NCT02515747|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
170087|NCT02515734|FOLFOXIRI|folfoxiri
170088|NCT02515734|Bmab|bmab
170089|NCT02515734|Cmab|cmab
170090|NCT02515617|Ventilator-associated pneumonia|ventilator-associated pneumonia
170091|NCT02515617|Subglottic-secretions drainage|subglottic-secretions drainage
170395|NCT02513784|Mouthwash|mouthwash
170092|NCT02515617|Critically ill patients|critically ill patients
170093|NCT02515617|Cost-utility analysis|cost-utility analysis
170094|NCT02515617|Prevention|prevention
170095|NCT02515591|Healthy volunteer|healthy volunteer
170096|NCT02515591|Respiratory|respiratory
170097|NCT02515591|Bronchoalveolar lavage|bronchoalveolar lavage
170098|NCT02515578|Primary Health Care|primary health care
170099|NCT02515578|Cardiovascular Diseases|cardiovascular diseases
170100|NCT02515578|Quality Improvement|quality improvement
170101|NCT02515565|pneumonia|pneumonia
170102|NCT02515565|Exacerbation|exacerbation
170103|NCT02515565|physiotherapy|physiotherapy
170104|NCT02515565|hospitalization|hospitalization
170105|NCT02515539|Transcatheter Mitral Valve Replacement|transcatheter mitral valve replacement
170106|NCT02515539|Mitral Regurgitation|mitral regurgitation
170107|NCT02515539|Mitral Insufficiency|mitral insufficiency
170108|NCT02515539|Transapical|transapical
170109|NCT02515539|Transfemoral|transfemoral
170110|NCT02515513|Pancreas|pancreas
170111|NCT02515513|Pancreas Cancer|pancreas cancer
170112|NCT02515513|Muscle Biopsy|muscle biopsy
170113|NCT02515513|Cachexia|cachexia
170114|NCT02515513|Muscle Cachexia|muscle cachexia
170115|NCT02515500|cigarette reduction|cigarette reduction
170116|NCT02515500|digital health|digital health
170117|NCT02515500|mobile health|mobile health
170118|NCT02515500|technology|technology
170119|NCT02515500|Quitbit|quitbit
170120|NCT02515500|mHealth|mhealth
170121|NCT02515500|smoking cessation|smoking cessation
170122|NCT02515500|quit smoking|quit smoking
170123|NCT02515500|self-regulation|self-regulation
170124|NCT02515487|Post-chemotherapy|post-chemotherapy
170125|NCT02515487|cognitive impairment|cognitive impairment
170126|NCT02515474|Cholangiopancreatography|cholangiopancreatography
170127|NCT02515474|Endoscopic|endoscopic
170128|NCT02515474|Common bile duct|common bile duct
170129|NCT02515474|Complication|complication
170130|NCT02515474|Recurrence|recurrence
170131|NCT02515474|Laparoscopic|laparoscopic
170132|NCT02515461|Diabetes mellitus|diabetes mellitus
170133|NCT02515461|Low energy shockwave therapy|low energy shockwave therapy
170134|NCT02515461|Chronic Renal Insufficiency|chronic renal insufficiency
170135|NCT02515448|VAP|vap
170136|NCT02515448|Critical care|critical care
170137|NCT02515448|Pharmacokinetics|pharmacokinetics
170138|NCT02515448|Gentamicin|gentamicin
170139|NCT02515435|apatinib|apatinib
170140|NCT02515435|NSCLC|nsclc
170141|NCT02515435|safety|safety
170142|NCT02515435|efficacy|efficacy
170143|NCT02515422|Caesarean Section|caesarean section
170144|NCT02515409|Obstructive Sleep Apnea Syndrome (OSAS)|obstructive sleep apnea syndrome (osas)
170145|NCT02515409|Heated Humidified High Flow Nasal Cannula (HHHNC)|heated humidified high flow nasal cannula (hhhnc)
170146|NCT02515409|Continues positive airway pressure (CPAP)|continues positive airway pressure (cpap)
170147|NCT02515409|Children|children
170148|NCT02515409|Non invasive ventilation|non invasive ventilation
170149|NCT02515409|Treatment|treatment
170150|NCT02515383|Adolescent Cancer|adolescent cancer
170151|NCT02515383|MD Anderson Symptom Inventory (modified for adolescent use)|md anderson symptom inventory (modified for adolescent use)
170152|NCT02515383|MDASI|mdasi
170153|NCT02515383|Surveys|surveys
170154|NCT02515383|Questionnaires|questionnaires
170155|NCT02515383|Interviews|interviews
170156|NCT02515383|Symptoms|symptoms
170157|NCT02515370|Option B plus|option b plus
170158|NCT02515370|HIV infected women|hiv infected women
170159|NCT02515357|Sleep Disorders|sleep disorders
170160|NCT02515357|Metabolic Syndrome|metabolic syndrome
170161|NCT02515357|Mediterranean Diet|mediterranean diet
170162|NCT02515357|Mediterranean Lifestyle|mediterranean lifestyle
170163|NCT02515344|Patients|patients
170164|NCT02515344|early detection of cancer|early detection of cancer
170165|NCT02515344|patient compliance|patient compliance
170166|NCT02515331|resistant hypertension|resistant hypertension
170167|NCT02515318|COPD|copd
170168|NCT02515318|Exacerbation|exacerbation
170169|NCT02515318|Hospitalisation|hospitalisation
170170|NCT02515318|Physiotherapy|physiotherapy
170171|NCT02515292|IUGR (intrauterine growth restriction)|iugr (intrauterine growth restriction)
170172|NCT02515292|IGF2 (insulin-like growth factor 2)|igf2 (insulin-like growth factor 2)
170173|NCT02515292|morbidity|morbidity
170174|NCT02515266|protein|protein
170175|NCT02515266|growth|growth
170176|NCT02515266|head circumference|head circumference
170177|NCT02515253|Breast Pain|breast pain
170178|NCT02515253|Mastalgia|mastalgia
170179|NCT02515253|Bras|bras
170180|NCT02515253|Breast Support|breast support
170181|NCT02515227|peptide|peptide
170182|NCT02515227|vaccine|vaccine
170183|NCT02515227|Montanide ISA-51|montanide isa-51
170184|NCT02515227|pembrolizumab|pembrolizumab
170185|NCT02515227|PD-1|pd-1
170186|NCT02515227|KEYTRUDA|keytruda
170187|NCT02515214|bariatric surgery|bariatric surgery
170188|NCT02515214|reproduction|reproduction
170189|NCT02515175|HSV|hsv
170190|NCT02515175|Herpes|herpes
170191|NCT02515175|Genital Herpes|genital herpes
170192|NCT02515175|Vaccine|vaccine
170193|NCT02515162|conization|conization
170194|NCT02515162|LLETZ|lletz
170195|NCT02515162|cervical dysplasia|cervical dysplasia
170196|NCT02515162|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
170197|NCT02515162|Fischer cone biopsy excisor|fischer cone biopsy excisor
170198|NCT02515162|loop electrosurgical excision procedure|loop electrosurgical excision procedure
170199|NCT02515149|linkage to care|linkage to care
170200|NCT02515149|point of care diagnostics|point of care diagnostics
170201|NCT02515149|point of care CD4|point of care cd4
170202|NCT02515149|HIV care cascade|hiv care cascade
170203|NCT02515149|Kenya|kenya
170204|NCT02515123|intensive care unit|intensive care unit
170205|NCT02515123|malnutrition|malnutrition
170206|NCT02515123|GI motility|gi motility
170207|NCT02515123|nutritional intake|nutritional intake
170208|NCT02515110|lumpectomy|lumpectomy
170209|NCT02515110|mastectomy without reconstruction|mastectomy without reconstruction
170210|NCT02515110|mastectomy with reconstruction|mastectomy with reconstruction
170211|NCT02515110|Estrogen Receptor Negative|estrogen receptor negative
170212|NCT02515110|Estrogen Receptor Positive|estrogen receptor positive
170213|NCT02515110|HER2/Neu Negative|her2/neu negative
170214|NCT02515110|HER2/Neu Positive|her2/neu positive
170215|NCT02515110|Progesterone Receptor Negative|progesterone receptor negative
170216|NCT02515110|Progesterone Receptor Positive|progesterone receptor positive
170217|NCT02515110|Stage IA Breast Cancer|stage ia breast cancer
170218|NCT02515110|Stage IB Breast Cancer|stage ib breast cancer
170219|NCT02515110|Stage IIA Breast Cancer|stage iia breast cancer
170220|NCT02515110|Stage IIB Breast Cancer|stage iib breast cancer
170221|NCT02515110|Stage IIIA Breast Cancer|stage iiia breast cancer
170222|NCT02515084|recurrence Thyroid cancer|recurrence thyroid cancer
170223|NCT02515084|18F-FDG PET-CT|18f-fdg pet-ct
170224|NCT02515084|diffusion-weighted Magnetic Resonance Imaging|diffusion-weighted magnetic resonance imaging
170225|NCT02515045|Cataract|cataract
170226|NCT02515045|Surgery|surgery
170227|NCT02515045|Prophylaxis|prophylaxis
170228|NCT02515019|Anaesthetics inhalation|anaesthetics inhalation
170229|NCT02515019|Bispectral index|bispectral index
170230|NCT02515019|Cardiopulmonary bypass|cardiopulmonary bypass
170231|NCT02514993|Sternal fracture|sternal fracture
170232|NCT02514993|Thoracic spine fracture|thoracic spine fracture
170233|NCT02514993|Thoracic cage injury|thoracic cage injury
170235|NCT02514967|Lupus|lupus
170236|NCT02514967|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
170237|NCT02514967|Autoimmune Diseases|autoimmune diseases
170238|NCT02514967|A-623|a-623
170239|NCT02514967|Blisibimod|blisibimod
170240|NCT02514967|Nephritis|nephritis
170241|NCT02514902|Lateral Flow Device (LFD)|lateral flow device (lfd)
170242|NCT02514902|Acute Stroke|acute stroke
170243|NCT02514902|Traumatic Brain Injury (TBI)|traumatic brain injury (tbi)
170244|NCT02514902|Point of Care (POC)|point of care (poc)
170245|NCT02514902|Biomarker|biomarker
170246|NCT02514824|recurrent merkel cell carcinoma|recurrent merkel cell carcinoma
170247|NCT02514824|metastatic merkel cell carcinoma|metastatic merkel cell carcinoma
170248|NCT02514798|COPD|copd
170249|NCT02514798|HFNC|hfnc
170250|NCT02514798|work of breathing|work of breathing
170251|NCT02514746|Japanese Encephalitis Vaccines|japanese encephalitis vaccines
170252|NCT02514746|Flavivirus Infections|flavivirus infections
170253|NCT02514733|kidney|kidney
170254|NCT02514733|transplant|transplant
170255|NCT02514655|Tracheal intubation|tracheal intubation
170256|NCT02514655|Cuff pressure|cuff pressure
170257|NCT02514655|Ventilator-acquired pneumonia|ventilator-acquired pneumonia
170258|NCT02514655|Intensive care unit|intensive care unit
170259|NCT02514655|Tracheal injuries|tracheal injuries
170260|NCT02514629|Hypogonadism|hypogonadism
170261|NCT02514629|Obesity|obesity
170262|NCT02514629|Erectile Dysfunction|erectile dysfunction
170263|NCT02514629|Testosterone|testosterone
170264|NCT02514629|Metformin|metformin
170265|NCT02514629|Weight Loss|weight loss
170266|NCT02514629|Insulin Resistance|insulin resistance
170267|NCT02514616|Reflux|reflux
170268|NCT02514616|Reflux disease|reflux disease
170269|NCT02514616|Gastroesophageal reflux disease|gastroesophageal reflux disease
170270|NCT02514616|Lower esophageal sphincter stimulation|lower esophageal sphincter stimulation
170271|NCT02514603|Neoplasm metastasis|neoplasm metastasis
170272|NCT02514603|Checkpoint Kinase 1|checkpoint kinase 1
170273|NCT02514603|CHK1|chk1
170274|NCT02514603|CHK1 inhibitor|chk1 inhibitor
170275|NCT02514551|stomach cancer|stomach cancer
170276|NCT02514512|Lung Cancer|lung cancer
170277|NCT02514512|Stereotactic Ablative Radiotherapy (SABR)|stereotactic ablative radiotherapy (sabr)
170278|NCT02514512|MLC Tracking|mlc tracking
170279|NCT02514512|Radiotherapy|radiotherapy
170280|NCT02514499|patients|patients
170281|NCT02514460|stents|stents
170282|NCT02514460|atherectomy|atherectomy
170283|NCT02514460|femoral artery|femoral artery
170284|NCT02514460|popliteal artery|popliteal artery
170285|NCT02514447|SCLC|sclc
170286|NCT02514421|pancreatic adenocarcinoma|pancreatic adenocarcinoma
170287|NCT02514421|electrochemotherapy|electrochemotherapy
170288|NCT02514421|electroporation|electroporation
170289|NCT02514421|radiogenomics|radiogenomics
170290|NCT02514421|imaging|imaging
170291|NCT02514421|magnetic resonance spectroscopy|magnetic resonance spectroscopy
170292|NCT02514395|linguistic validation|linguistic validation
170293|NCT02514395|KOOS|koos
170294|NCT02514395|Marathi translation|marathi translation
170295|NCT02514356|behavioral economics|behavioral economics
170296|NCT02514356|antiretroviral adherence|antiretroviral adherence
170297|NCT02514356|SMS|sms
170298|NCT02514356|mobile health (mHealth)|mobile health (mhealth)
170299|NCT02514356|Adolescents|adolescents
170300|NCT02514356|Uganda|uganda
170301|NCT02514356|HIV|hiv
170302|NCT02514343|radius fracture|radius fracture
170303|NCT02514343|magnesium sulfate|magnesium sulfate
170304|NCT02514343|rehabilitation|rehabilitation
170305|NCT02514343|bupivacaine|bupivacaine
170306|NCT02514330|Drop Jump|drop jump
170307|NCT02514330|High Intensity Interval Training|high intensity interval training
170308|NCT02514330|Muscle Fatigue|muscle fatigue
170309|NCT02514330|Aerobic Performance|aerobic performance
170310|NCT02514278|Organ preservation|organ preservation
170311|NCT02514278|Local excision|local excision
170312|NCT02514278|Radiochemotherapy|radiochemotherapy
170313|NCT02514278|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
170314|NCT02514278|Folfirinox|folfirinox
170315|NCT02514278|Tumour response|tumour response
170316|NCT02514265|pelvic pain, bladder pain|pelvic pain, bladder pain
170317|NCT02514252|Advanced Cancers|advanced cancers
170318|NCT02514252|Metastatic|metastatic
170319|NCT02514252|Recurrent cancer|recurrent cancer
170320|NCT02514252|Incurable cancer|incurable cancer
170321|NCT02514252|Fentanyl sublingual spray|fentanyl sublingual spray
170322|NCT02514252|FSS|fss
170323|NCT02514252|Questionnaires|questionnaires
170324|NCT02514252|Surveys|surveys
170325|NCT02514252|Mental ability tests|mental ability tests
170326|NCT02514252|Phone calls|phone calls
170327|NCT02514252|Study diary|study diary
170328|NCT02514252|Pain control|pain control
170329|NCT02514226|microbiology|microbiology
170330|NCT02514226|halitosis|halitosis
170331|NCT02514213|PSA|psa
170332|NCT02514187|Osteogenesis|osteogenesis
170333|NCT02514161|Smokers|smokers
170334|NCT02514161|Maximum Inspiratory Pressure|maximum inspiratory pressure
170335|NCT02514148|patient education|patient education
170336|NCT02514148|therapeutic exercise|therapeutic exercise
170337|NCT02514148|manual therapy|manual therapy
170338|NCT02514109|neuronopathy|neuronopathy
170339|NCT02514109|antibodies|antibodies
170340|NCT02514109|Clinical and biological diagnostic criteria|clinical and biological diagnostic criteria
170341|NCT02514083|Ibrutinib|ibrutinib
170342|NCT02514083|Fludarabine|fludarabine
170343|NCT02514083|BTK Inhibitor|btk inhibitor
170344|NCT02514083|T-Cell Modulation|t-cell modulation
170345|NCT02514070|LDL-C|ldl-c
170346|NCT02514070|Omega-3 Fatty Acid|omega-3 fatty acid
170347|NCT02514070|PCSK9|pcsk9
170348|NCT02514070|HDL-C|hdl-c
170349|NCT02514018|Varicella-Zoster Virus|varicella-zoster virus
170350|NCT02514018|Immune Activation|immune activation
170351|NCT02514018|HIV Vaccine|hiv vaccine
170352|NCT02514018|Mucosal Immunity|mucosal immunity
170353|NCT02514005|Trigger points|trigger points
170354|NCT02514005|Manual therapy|manual therapy
170355|NCT02514005|Patellofemoral syndrome|patellofemoral syndrome
170356|NCT02514005|Dry needling|dry needling
170357|NCT02513992|ictal SPECT|ictal spect
170358|NCT02513979|Angiotensin type II receptor (AT2R) antagonists|angiotensin type ii receptor (at2r) antagonists
170359|NCT02513979|Acute postoperative pain|acute postoperative pain
170360|NCT02513979|Chronic postoperative pain|chronic postoperative pain
170361|NCT02513979|Abdominal surgery|abdominal surgery
170362|NCT02513953|Endometriosis|endometriosis
170363|NCT02513953|Mesosalpinx|mesosalpinx
170364|NCT02513953|Broad Ligament|broad ligament
170365|NCT02513953|Laparoscopy|laparoscopy
170366|NCT02513940|Torsades de pointes|torsades de pointes
170367|NCT02513940|Testosterone|testosterone
170368|NCT02513940|Progesterone|progesterone
170369|NCT02513940|Clinical trial|clinical trial
170370|NCT02513940|Risk reduction|risk reduction
170371|NCT02513940|Electrocardiography|electrocardiography
170372|NCT02513927|Blood pressure variability|blood pressure variability
170373|NCT02513927|CCB|ccb
170374|NCT02513927|beta-receptor blockers|beta-receptor blockers
170375|NCT02513927|heart rate|heart rate
170376|NCT02513914|endovascular neurosurgery|endovascular neurosurgery
170377|NCT02513901|Chidamide|chidamide
170378|NCT02513901|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
170379|NCT02513901|HIV-1 Reservoir|hiv-1 reservoir
170380|NCT02513901|Chronic HIV infections|chronic hiv infections
170381|NCT02513901|Antiretroviral Therapy|antiretroviral therapy
170382|NCT02513901|HIV Eradication|hiv eradication
170383|NCT02513862|autologous platelet rich plasma|autologous platelet rich plasma
170384|NCT02513862|deep hypothermic circulatory arrest|deep hypothermic circulatory arrest
170385|NCT02513862|transfusion|transfusion
170386|NCT02513849|esophagus|esophagus
170387|NCT02513849|gastroscopy|gastroscopy
170388|NCT02513849|tamoxifen|tamoxifen
170389|NCT02513836|opioids|opioids
170390|NCT02513823|blood pressure|blood pressure
170391|NCT02513823|vitamin D|vitamin d
170392|NCT02513784|Microbiome|microbiome
170393|NCT02513784|Esophagus|esophagus
170394|NCT02513784|Endoscopy|endoscopy
170396|NCT02513771|Sitagliptin|sitagliptin
170397|NCT02513771|Inflammation|inflammation
170398|NCT02513771|Immune activation|immune activation
170399|NCT02513771|Viral suppression|viral suppression
170400|NCT02513771|HIV-1|hiv-1
170401|NCT02513771|Immunology biomarkers|immunology biomarkers
170402|NCT02513771|sCD14|scd14
170403|NCT02513758|HIV patients|hiv patients
170404|NCT02513758|Genital HIV penetration|genital hiv penetration
170405|NCT02513745|cataract|cataract
170406|NCT02513745|toric|toric
170407|NCT02513745|phacoemulsification|phacoemulsification
170408|NCT02513732|Drug Eluting Stent|drug eluting stent
170409|NCT02513732|Coronary Stent|coronary stent
170410|NCT02513732|Everolimus|everolimus
170411|NCT02513732|Stent Thrombosis|stent thrombosis
170412|NCT02513719|drug eluting stent|drug eluting stent
170413|NCT02513719|stent|stent
170414|NCT02513719|real world|real world
170415|NCT02513693|Anesthesia|anesthesia
170416|NCT02513693|Rocuronium|rocuronium
170417|NCT02513693|Sugammadex|sugammadex
170418|NCT02513693|Neostigmine|neostigmine
170419|NCT02513693|TOF|tof
170420|NCT02513693|Radical Prostatectomy|radical prostatectomy
170421|NCT02513693|Robotic Surgery|robotic surgery
170422|NCT02513693|Accelerometry|accelerometry
170423|NCT02513680|Skin Aging|skin aging
170424|NCT02513680|laser phototherapy|laser phototherapy
170425|NCT02513680|Rejuvenation|rejuvenation
170426|NCT02513680|Infrared Rays/therapeutic use|infrared rays/therapeutic use
170427|NCT02513680|Female|female
170428|NCT02513680|Humans|humans
170429|NCT02513680|Esthetics|esthetics
170430|NCT02513680|Phototherapy|phototherapy
170431|NCT02513680|facial rejuvenation|facial rejuvenation
170432|NCT02513654|tolerability|tolerability
170433|NCT02513654|repeat dosing|repeat dosing
170434|NCT02513654|safety|safety
170435|NCT02513654|healthy Chinese subjects|healthy chinese subjects
170436|NCT02513654|Pharmacokinetics|pharmacokinetics
170437|NCT02513654|lamotrigine|lamotrigine
170438|NCT02513628|Cardiac arrest|cardiac arrest
170439|NCT02513628|neuroprognostication|neuroprognostication
170440|NCT02513628|optic nerve sheath diameter|optic nerve sheath diameter
170441|NCT02513628|outcome|outcome
170442|NCT02513628|ultrasonography|ultrasonography
170443|NCT02513615|Fibrosis|fibrosis
170444|NCT02513615|Peritoneal Dialysis|peritoneal dialysis
170445|NCT02513615|Epigenetics|epigenetics
170446|NCT02513615|Peritoneal membrane injury|peritoneal membrane injury
170447|NCT02513615|Glucose exposure|glucose exposure
170448|NCT02513602|implantology|implantology
170449|NCT02513602|kidney|kidney
170450|NCT02513602|renal disease|renal disease
170451|NCT02513602|edentulism|edentulism
170452|NCT02513602|tooth loss|tooth loss
170453|NCT02513589|Positron emission tomography|positron emission tomography
170454|NCT02513589|Carotid plaque|carotid plaque
170455|NCT02513589|Inflammation|inflammation
170456|NCT02513589|Stroke|stroke
170457|NCT02513576|Sternal instability|sternal instability
170458|NCT02513576|physical therapy|physical therapy
170459|NCT02513576|Respiratory muscle strength|respiratory muscle strength
170460|NCT02513563|Squamous cell lung cancer|squamous cell lung cancer
170461|NCT02513524|hypertension|hypertension
170462|NCT02513524|adherence|adherence
170463|NCT02513524|resistant hypertension|resistant hypertension
170464|NCT02513524|blood pressure|blood pressure
170465|NCT02513524|non-adherence|non-adherence
170466|NCT02513511|difficult airway|difficult airway
170467|NCT02513511|awake intubation|awake intubation
170468|NCT02513485|Inflammation|inflammation
170469|NCT02513485|Anhedonia|anhedonia
170470|NCT02513485|Psychomotor retardation|psychomotor retardation
170471|NCT02513472|Eribulin Mesylate|eribulin mesylate
170472|NCT02513472|Pembrolizumab|pembrolizumab
170473|NCT02513472|Metastatic Triple-Negative Breast Cancer|metastatic triple-negative breast cancer
170474|NCT02513472|mTNBC|mtnbc
170475|NCT02513459|ABBV-066|abbv-066
170476|NCT02513459|BI 655066|bi 655066
170477|NCT02513459|risankizumab|risankizumab
170478|NCT02513433|Lumbar epidural anaesthesia|lumbar epidural anaesthesia
170479|NCT02513420|levator ani avulsion|levator ani avulsion
170480|NCT02513420|perineal muscle training|perineal muscle training
170481|NCT02513420|pelvic floor ultrasound|pelvic floor ultrasound
170482|NCT02513394|HR+/HER2- breast cancer|hr+/her2- breast cancer
170483|NCT02513394|Palbociclib|palbociclib
170484|NCT02513368|aesthetic|aesthetic
170485|NCT02513368|connective tissue graft|connective tissue graft
170486|NCT02513368|mucosa thickness|mucosa thickness
170487|NCT02513355|Non-small cell lung cancer,Endostar|non-small cell lung cancer,endostar
170488|NCT02513342|Endostar,Advanced lung squamous carcinoma|endostar,advanced lung squamous carcinoma
170489|NCT02513329|Breast Cancer|breast cancer
170490|NCT02513329|Anti-estrogens|anti-estrogens
170491|NCT02513329|Hot Flushes|hot flushes
170492|NCT02513329|Tamoxifen|tamoxifen
170493|NCT02513329|Aromatase inhibitors|aromatase inhibitors
170494|NCT02513329|Hot Flashes|hot flashes
170495|NCT02513316|Microbleeds|microbleeds
170496|NCT02513303|Dialysis|dialysis
170497|NCT02513303|End Stage Renal Disease|end stage renal disease
170498|NCT02513303|End Stage Kidney Disease|end stage kidney disease
170499|NCT02513303|ESRD|esrd
170500|NCT02513303|Chronic Kidney Failure|chronic kidney failure
170501|NCT02513303|Chronic Renal Failure|chronic renal failure
170502|NCT02513303|Chronic Kidney Disease|chronic kidney disease
170503|NCT02513303|Hemodialysis|hemodialysis
170504|NCT02513303|Vascular Access|vascular access
170505|NCT02513303|Arteriovenous Fistula|arteriovenous fistula
170506|NCT02513303|AV Fistula|av fistula
170507|NCT02513303|AVF|avf
170508|NCT02513303|Nephrology|nephrology
170509|NCT02513303|Vascular Surgery|vascular surgery
170510|NCT02513303|Dialysis Access|dialysis access
170511|NCT02513290|quality of life|quality of life
170512|NCT02513290|allergic rhinitis|allergic rhinitis
170513|NCT02513290|bilastine|bilastine
170514|NCT02513290|loratadine|loratadine
170515|NCT02513290|clinical trial|clinical trial
170516|NCT02513277|type 2 diabetes|type 2 diabetes
170517|NCT02513277|impaired glucose regulation|impaired glucose regulation
170518|NCT02513277|intellectual disability|intellectual disability
170519|NCT02513277|learning disability|learning disability
170520|NCT02513277|screening|screening
170521|NCT02513277|prevention|prevention
170522|NCT02513277|lifestyle education|lifestyle education
170523|NCT02513264|Registry|registry
170524|NCT02513264|Asthma|asthma
170525|NCT02513264|Inner City Asthma Consortium (ICAC) study eligibility|inner city asthma consortium (icac) study eligibility
170526|NCT02513212|Sensitivity|sensitivity
170527|NCT02513199|Hepatocellular Carcinoma|hepatocellular carcinoma
170528|NCT02513199|Trans-Arterial Chemoembolization|trans-arterial chemoembolization
170529|NCT02513199|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
170530|NCT02513199|HCC|hcc
170531|NCT02513199|TACE|tace
170532|NCT02513199|SBRT|sbrt
170533|NCT02513173|low back pain|low back pain
170534|NCT02513173|verbal instruction|verbal instruction
170535|NCT02513173|lumbar multifidus|lumbar multifidus
170536|NCT02513173|ultrasound imaging|ultrasound imaging
170537|NCT02513173|Muscle thickness|muscle thickness
170538|NCT02513134|IOL power calculations|iol power calculations
170539|NCT02513134|Intraoperative|intraoperative
170540|NCT02513134|OCT|oct
170541|NCT02513134|Refractive outcome|refractive outcome
170542|NCT02513134|Biometry|biometry
170543|NCT02513121|NAFLD|nafld
170544|NCT02513121|Steatohepatitis|steatohepatitis
170545|NCT02513121|NASH|nash
170546|NCT02513121|Liver|liver
170547|NCT02513121|Diet|diet
170548|NCT02513121|Pediatric|pediatric
170549|NCT02513121|Adolescent|adolescent
170550|NCT02513056|non-conditional pacemakers|non-conditional pacemakers
170551|NCT02513056|implantable cardioverter defibrillator|implantable cardioverter defibrillator
170552|NCT02513017|partially randomized clinical trial|partially randomized clinical trial
170553|NCT02513017|cardiovascular disease|cardiovascular disease
170554|NCT02513017|insomnia|insomnia
170555|NCT02513017|preference|preference
170556|NCT02513017|acceptability|acceptability
170557|NCT02512978|myocardial infarction|myocardial infarction
170558|NCT02512978|hypothyroidism|hypothyroidism
170559|NCT02512978|levothyroxine|levothyroxine
170560|NCT02512978|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
170561|NCT02512978|myocardial perfusion/metabolism radionuclide imaging|myocardial perfusion/metabolism radionuclide imaging
170562|NCT02512978|myocardial fibrosis|myocardial fibrosis
170563|NCT02512978|myocardial perfusion/metabolism|myocardial perfusion/metabolism
170564|NCT02512978|cardiac function|cardiac function
170565|NCT02512952|Periodontal regeneration|periodontal regeneration
170566|NCT02512952|Growth factors|growth factors
170567|NCT02512939|tuberculosis|tuberculosis
170568|NCT02512939|diagnostic test|diagnostic test
170569|NCT02512926|Solid Tumors|solid tumors
170570|NCT02512926|Leukemia|leukemia
170571|NCT02512926|Relapsed|relapsed
170572|NCT02512926|Refractory|refractory
170573|NCT02512913|Smoking Cessation|smoking cessation
170574|NCT02512913|Intervention|intervention
170575|NCT02512913|Pregnancy|pregnancy
170576|NCT02512913|Postnatal|postnatal
170577|NCT02512900|Asthma|asthma
170578|NCT02512887|Hypospadias|hypospadias
170579|NCT02512887|Caudal Block|caudal block
170580|NCT02512887|Dorsal Penile Block|dorsal penile block
170581|NCT02512887|Anesthesia|anesthesia
170582|NCT02512887|Complications|complications
170583|NCT02512887|Post-operative|post-operative
170584|NCT02512887|Urethrocutaneous Fistula|urethrocutaneous fistula
170585|NCT02512887|Glans dehiscence|glans dehiscence
170586|NCT02512861|Bupivacaine|bupivacaine
170587|NCT02512861|Cardiac Surgery|cardiac surgery
170588|NCT02512861|Pediatrics|pediatrics
170589|NCT02512861|Nerve Block|nerve block
170590|NCT02512848|postmenopause|postmenopause
170591|NCT02512848|endometrial sampling|endometrial sampling
170592|NCT02512848|vaginal bleeding|vaginal bleeding
170593|NCT02512835|Primary health care|primary health care
170594|NCT02512835|Public health|public health
170595|NCT02512835|Medical Informatics|medical informatics
170596|NCT02512835|Social Determinants of Health|social determinants of health
170597|NCT02512822|radiofrequency|radiofrequency
170598|NCT02512822|submental fat|submental fat
170599|NCT02512822|fat reduction|fat reduction
170600|NCT02512822|body contouring|body contouring
170601|NCT02512796|Liver transplantation|liver transplantation
170602|NCT02512796|Renal transplantation|renal transplantation
170603|NCT02512796|Pancreas transplantation|pancreas transplantation
170604|NCT02512783|Propofol|propofol
170605|NCT02512783|Lidocaine|lidocaine
170606|NCT02512783|Intravenous propofol|intravenous propofol
170607|NCT02512757|Neoplasms, Lung|neoplasms, lung
170608|NCT02512757|Pulmonary Neoplasms|pulmonary neoplasms
170609|NCT02512757|Pulmonary Cancer|pulmonary cancer
170610|NCT02512744|Tracheostomy|tracheostomy
170611|NCT02512744|Decannulation|decannulation
170612|NCT02512744|Adult airway management|adult airway management
170613|NCT02512718|intravenous fat emulsions|intravenous fat emulsions
170614|NCT02512718|fish oil lipid emulsion|fish oil lipid emulsion
170615|NCT02512692|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
170616|NCT02512692|cholangiocarcinoma|cholangiocarcinoma
170617|NCT02512692|90Y TARE|90y tare
170618|NCT02512692|radioembolization|radioembolization
170619|NCT02512692|gemcitabine and cisplatin|gemcitabine and cisplatin
170620|NCT02512679|Hematopoietic Stem Cell Transplantation Pediatrics,|hematopoietic stem cell transplantation pediatrics,
170621|NCT02512679|stem cell transplantation|stem cell transplantation
170622|NCT02512679|bone marrow transplantation|bone marrow transplantation
170623|NCT02512679|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
170624|NCT02512679|Allogeneic Transplantation|allogeneic transplantation
170625|NCT02512679|pediatrics|pediatrics
170626|NCT02512679|Combined Immune Deficiency|combined immune deficiency
170627|NCT02512679|Chronic Granulomatous disease|chronic granulomatous disease
170628|NCT02512666|Hematologic malignancy|hematologic malignancy
170629|NCT02512653|Allergy to Cupressus pollen|allergy to cupressus pollen
170630|NCT02512640|Pressure-controlled ventilation|pressure-controlled ventilation
170631|NCT02512640|Volume-controlled ventilation|volume-controlled ventilation
170632|NCT02512640|Laparoscopy|laparoscopy
170633|NCT02512640|Oxidative stress|oxidative stress
170634|NCT02512627|mild cognitive impairment|mild cognitive impairment
170635|NCT02512627|exercise|exercise
170636|NCT02512627|cognitive training|cognitive training
170637|NCT02512575|AZD9567|azd9567
170638|NCT02512575|Healthy subjects|healthy subjects
170639|NCT02512575|Phase 1|phase 1
170640|NCT02512575|placebo controlled|placebo controlled
170641|NCT02512575|single ascending dose|single ascending dose
170642|NCT02512575|Pharmacokinetics|pharmacokinetics
170643|NCT02512575|Pharmacodynamics|pharmacodynamics
170644|NCT02512575|Rheumatoid Arthritis|rheumatoid arthritis
170645|NCT02512549|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
170646|NCT02512549|rehabiltation|rehabiltation
170647|NCT02512523|Type 2 diabetes mellitus|type 2 diabetes mellitus
170648|NCT02512523|CGMS|cgms
170649|NCT02512523|Teneligliptin|teneligliptin
170650|NCT02512523|Sitagliptin|sitagliptin
170651|NCT02512510|Chronic Obstructive Pulmonary Disease, COPD|chronic obstructive pulmonary disease, copd
170652|NCT02512497|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
170653|NCT02512497|CTCL|ctcl
170654|NCT02512497|T-Prolymphocytic Leukemia|t-prolymphocytic leukemia
170655|NCT02512497|T-PLL|t-pll
170656|NCT02512497|T-Large Granulocytic Leukemia|t-large granulocytic leukemia
170657|NCT02512497|T-LGL|t-lgl
170658|NCT02512497|T-Lymphoblastic Leukemia/Lymphoma|t-lymphoblastic leukemia/lymphoma
170659|NCT02512497|T-ALL|t-all
170660|NCT02512497|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
170661|NCT02512497|PTCL|ptcl
170662|NCT02512497|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
170663|NCT02512497|Romidepsin|romidepsin
170664|NCT02512497|Istodax|istodax
170665|NCT02512497|Depsipeptide|depsipeptide
170666|NCT02512497|FK228|fk228
170667|NCT02512497|Busulfan|busulfan
170668|NCT02512497|Busulfex|busulfex
170669|NCT02512497|Myleran|myleran
170670|NCT02512497|Fludarabine|fludarabine
170671|NCT02512497|Fludarabine phosphate|fludarabine phosphate
170672|NCT02512497|Fludara|fludara
170673|NCT02512484|tuberculosis|tuberculosis
170674|NCT02512484|accident and emergency|accident and emergency
170675|NCT02512471|minimum effective volume|minimum effective volume
170676|NCT02512471|ropivacaine|ropivacaine
170677|NCT02512471|ultrasound-guided supraclavicular block|ultrasound-guided supraclavicular block
170678|NCT02512419|Physical Activity|physical activity
170679|NCT02512419|Latinos|latinos
170680|NCT02512419|Mexican American Men|mexican american men
170681|NCT02512419|Spanish-Language|spanish-language
170682|NCT02512419|Text-Message|text-message
170683|NCT02512406|Tourette Syndrome|tourette syndrome
170684|NCT02512406|Tics|tics
170685|NCT02512341|Computer Aided Auscultation (CAA)|computer aided auscultation (caa)
170686|NCT02512341|Electronic Stethoscope|electronic stethoscope
170687|NCT02512341|Phonocardiography|phonocardiography
170688|NCT02512341|Heart Auscultation|heart auscultation
170689|NCT02512328|Colonoscopy|colonoscopy
170690|NCT02512328|new media|new media
170691|NCT02512328|APP|app
170692|NCT02512328|colonoscopy preparation|colonoscopy preparation
170693|NCT02512328|SPA|spa
170694|NCT02512328|smartphone application|smartphone application
170999|NCT02510274|ASP3325|asp3325
170695|NCT02512315|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
170696|NCT02512315|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
170697|NCT02512315|Concurrent chemoradiation|concurrent chemoradiation
170698|NCT02512315|Distant metastasis|distant metastasis
170699|NCT02512315|Survival|survival
170700|NCT02512302|COPD|copd
170701|NCT02512276|Medication Non-adherence|medication non-adherence
170702|NCT02512276|Hyperlipidemia|hyperlipidemia
170703|NCT02512276|Diabetes|diabetes
170704|NCT02512276|Hypertension|hypertension
170705|NCT02512237|HER2|her2
170706|NCT02512237|breast cancer|breast cancer
170707|NCT02512237|ADC|adc
170708|NCT02512237|antibody drug conjugate|antibody drug conjugate
170709|NCT02512237|elevated HER2 expression|elevated her2 expression
170710|NCT02512224|parenteral nutrition|parenteral nutrition
170711|NCT02512224|enteral nutrition|enteral nutrition
170712|NCT02512211|Hemophilia|hemophilia
170713|NCT02512211|Validation|validation
170714|NCT02512211|Questionnaires|questionnaires
170715|NCT02512211|Activities|activities
170716|NCT02512211|Sport|sport
170717|NCT02512211|Patients|patients
170718|NCT02512198|Professional Practice|professional practice
170719|NCT02512198|General Practitioners|general practitioners
170720|NCT02512198|Inappropriate Prescribing|inappropriate prescribing
170721|NCT02512198|Persuasive Communication|persuasive communication
170722|NCT02512198|Information Theory|information theory
170723|NCT02512198|Feedback|feedback
170724|NCT02512185|Prostate cancer|prostate cancer
170725|NCT02512185|Chemotherapy|chemotherapy
170726|NCT02512185|mCRPC|mcrpc
170727|NCT02512159|Diabetic foot ulcer|diabetic foot ulcer
170728|NCT02512159|Foot care|foot care
170729|NCT02512159|Wound management|wound management
170731|NCT02512146|Ionotropic glutamate receptors|ionotropic glutamate receptors
170732|NCT02512133|MIGS|migs
170733|NCT02512133|SLT|slt
170734|NCT02512094|Barthel index|barthel index
170735|NCT02512094|Hip fracture|hip fracture
170736|NCT02512094|Validity|validity
170737|NCT02512094|Reliability|reliability
170738|NCT02512081|Sciatica|sciatica
170739|NCT02512081|Patient Experience|patient experience
170740|NCT02512081|Investigations|investigations
170741|NCT02512081|Qualitative Research|qualitative research
170742|NCT02512016|Pelvic floor|pelvic floor
170743|NCT02511990|HIV|hiv
170744|NCT02511990|10-1074|10-1074
170745|NCT02511990|Monoclonal Antibody|monoclonal antibody
170746|NCT02511977|Dental Prosthesis|dental prosthesis
170747|NCT02511977|Implant-Supported|implant-supported
170748|NCT02511964|Aerobic Exercise|aerobic exercise
170749|NCT02511964|HIT,|hit,
170750|NCT02511964|VO2Max|vo2max
170751|NCT02511964|Performance|performance
170752|NCT02511951|postoperative pancreatic fistula|postoperative pancreatic fistula
170753|NCT02511951|postoperative hospital stay time|postoperative hospital stay time
170754|NCT02511951|anastomosis time|anastomosis time
170755|NCT02511951|reoperation rate|reoperation rate
170756|NCT02511951|morbidity|morbidity
170757|NCT02511951|pancreaticojejunostomy|pancreaticojejunostomy
170758|NCT02511951|pancreaticoduodenectomy|pancreaticoduodenectomy
170759|NCT02511938|childhood obesity|childhood obesity
170760|NCT02511938|restaurant|restaurant
170761|NCT02511938|away from home foods|away from home foods
170762|NCT02511925|Critical care|critical care
170763|NCT02511925|Feedback|feedback
170764|NCT02511899|Microcirculation|microcirculation
170765|NCT02511899|Endothelial function|endothelial function
170766|NCT02511899|Metabolism|metabolism
170767|NCT02511899|Cardiovascular Disease|cardiovascular disease
170768|NCT02511899|human study|human study
170769|NCT02511899|healthy subjects|healthy subjects
170770|NCT02511899|Mangifera indica|mangifera indica
170771|NCT02511899|Careless|careless
170772|NCT02511886|Alcoholism|alcoholism
170773|NCT02511886|Alcohol Abuse|alcohol abuse
170774|NCT02511886|Alcohol Addiction|alcohol addiction
170775|NCT02511886|Alcohol Dependence|alcohol dependence
170776|NCT02511886|Alcohol Induced Disorders|alcohol induced disorders
170777|NCT02511886|Alcoholic Intoxication|alcoholic intoxication
170778|NCT02511873|Fycompa|fycompa
170779|NCT02511873|Small Fiber Neuropathy|small fiber neuropathy
170780|NCT02511873|SFN|sfn
170781|NCT02511873|Neuropathy|neuropathy
170782|NCT02511873|Pain|pain
170783|NCT02511847|Breast Cancer|breast cancer
170784|NCT02511847|EGFR|egfr
170785|NCT02511847|Afatinib|afatinib
170786|NCT02511847|Paclitaxel|paclitaxel
170787|NCT02511847|Pathologic complete remission|pathologic complete remission
170788|NCT02511808|Drinking|drinking
170789|NCT02511808|Alcohol Problems|alcohol problems
170790|NCT02511808|Alcoholism|alcoholism
170791|NCT02511808|Reduced Drinking|reduced drinking
170792|NCT02511808|Problematic Drinking|problematic drinking
170793|NCT02511808|Non-Abstinence-based Drinking|non-abstinence-based drinking
170794|NCT02511808|Controlled Drinking|controlled drinking
170795|NCT02511808|Heavy Drinking|heavy drinking
170796|NCT02511795|AZD1775|azd1775
170797|NCT02511795|Olaparib|olaparib
170798|NCT02511795|AZD1775 plus Olaparib|azd1775 plus olaparib
171100|NCT02509702|Screening|screening
170799|NCT02511795|Refractory Solid Tumours|refractory solid tumours
170800|NCT02511795|Relapsed Small Cell Lung Cancer (SCLC)|relapsed small cell lung cancer (sclc)
170801|NCT02511782|children|children
170802|NCT02511782|bone marrow transplant|bone marrow transplant
170803|NCT02511782|GVHD|gvhd
170804|NCT02511756|Perfusion-computed tomography|perfusion-computed tomography
170805|NCT02511730|Mammography|mammography
170806|NCT02511704|Nicotine|nicotine
170807|NCT02511704|Electronic cigarette|electronic cigarette
170808|NCT02511704|Cigarette|cigarette
170809|NCT02511639|Hormone receptor positive|hormone receptor positive
170810|NCT02511639|HER2 negative|her2 negative
170811|NCT02511626|endometriosis|endometriosis
170812|NCT02511626|quality of life|quality of life
170813|NCT02511626|professional activity|professional activity
170814|NCT02511626|pain|pain
170815|NCT02511626|infertility|infertility
170816|NCT02511626|sexuality|sexuality
170817|NCT02511626|partnership|partnership
170818|NCT02511626|anxiety|anxiety
170819|NCT02511626|depression|depression
170820|NCT02511626|stress|stress
170821|NCT02511626|childhood trauma|childhood trauma
170822|NCT02511626|medical support|medical support
170823|NCT02511626|dyspareunia|dyspareunia
170824|NCT02511600|Lung Diseases|lung diseases
170825|NCT02511600|Mesothelioma|mesothelioma
170826|NCT02511600|Pleurectomy decortication|pleurectomy decortication
170827|NCT02511600|Progel|progel
170828|NCT02511600|Talcum powder|talcum powder
170829|NCT02511600|Pain questionnaires|pain questionnaires
170830|NCT02511600|Surveys|surveys
170831|NCT02511600|Intraoperative air leaks|intraoperative air leaks
170832|NCT02511600|IAL|ial
170833|NCT02511574|progesterone|progesterone
170834|NCT02511574|uterine cervix|uterine cervix
170835|NCT02511574|cervical pessary|cervical pessary
170836|NCT02511561|Otitis externa|otitis externa
170837|NCT02511561|Swimmer's ear|swimmer's ear
170838|NCT02511561|Ear infection|ear infection
170839|NCT02511509|Schizophrenia|schizophrenia
170840|NCT02511509|Electroconvulsive Therapy|electroconvulsive therapy
170841|NCT02511509|Bifrontal ECT|bifrontal ect
170842|NCT02511509|Bitemporal ECT|bitemporal ect
170843|NCT02511509|Cognitive functions|cognitive functions
170844|NCT02511509|Postictal delirium|postictal delirium
170845|NCT02511483|COMT|comt
170846|NCT02511483|Beta-blocker|beta-blocker
170847|NCT02511483|Hemicolectomy|hemicolectomy
170848|NCT02511470|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
170849|NCT02511470|Pediatric simulation study|pediatric simulation study
170850|NCT02511470|Metronome|metronome
170851|NCT02511444|GBS|gbs
170852|NCT02511444|GBS culture|gbs culture
170853|NCT02511444|GBS PCR|gbs pcr
170854|NCT02511444|GBS colonization|gbs colonization
170855|NCT02511431|Delta Hepatitis|delta hepatitis
170856|NCT02511431|Hepatitis D|hepatitis d
170857|NCT02511431|Liver Disease|liver disease
170858|NCT02511431|Hepatitis D Virus|hepatitis d virus
170859|NCT02511431|Chronic Hepatitis|chronic hepatitis
170860|NCT02511405|rGBM|rgbm
170861|NCT02511405|Recurrent Glioblastoma|recurrent glioblastoma
170862|NCT02511405|Recurrent GBM|recurrent gbm
170863|NCT02511366|ileal brake|ileal brake
170864|NCT02511353|malaria|malaria
170865|NCT02511353|plasmodium|plasmodium
170866|NCT02511353|dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
170867|NCT02511353|ivermectin|ivermectin
170868|NCT02511327|Pertussis|pertussis
170869|NCT02511327|Pregnancy|pregnancy
170870|NCT02511327|Vaccination|vaccination
170871|NCT02511327|Preterm|preterm
170872|NCT02511327|Breast milk|breast milk
170873|NCT02511327|Humoral immune response|humoral immune response
170874|NCT02511327|Cellular immune response|cellular immune response
170875|NCT02511327|Maternal antibodies|maternal antibodies
170876|NCT02511314|Nursing homes|nursing homes
170877|NCT02511314|quasi-experimental|quasi-experimental
170878|NCT02511314|mixed methods|mixed methods
170879|NCT02511314|parallel study|parallel study
170880|NCT02511314|urinary incontinence|urinary incontinence
170881|NCT02511288|hematologic test|hematologic test
170882|NCT02511275|parenchymal clamping|parenchymal clamping
170883|NCT02511275|microdialysis technique|microdialysis technique
170884|NCT02511275|partial nephrectomy|partial nephrectomy
170885|NCT02511249|neonatal arterial ischemic stroke|neonatal arterial ischemic stroke
170886|NCT02511249|language development|language development
170887|NCT02511249|global intellectual functioning|global intellectual functioning
170888|NCT02511249|motor abilities|motor abilities
170889|NCT02511197|PET|pet
170890|NCT02511197|lung injury|lung injury
170891|NCT02511197|integrin receptor|integrin receptor
170892|NCT02511184|crizotinib|crizotinib
170893|NCT02511184|pembrolizumab|pembrolizumab
170894|NCT02511184|ALK-positive NSCLC|alk-positive nsclc
170895|NCT02511184|Lung Cancer|lung cancer
170896|NCT02511184|ALK-translocated NSCLC|alk-translocated nsclc
170897|NCT02511184|Non Small Cell Lung Cancer|non small cell lung cancer
170898|NCT02511158|Anterior Cruciate Ligament, Posterior Cruciate Ligament, Medial Collateral Ligament, Lateral Collateral Ligament|anterior cruciate ligament, posterior cruciate ligament, medial collateral ligament, lateral collateral ligament
170899|NCT02511145|volunteers|volunteers
170900|NCT02511132|Ewing's Sarcoma Family of Tumors, ESFT, Sarcoma|ewing's sarcoma family of tumors, esft, sarcoma
170901|NCT02511132|Soft Tissue Sarcoma|soft tissue sarcoma
170902|NCT02511106|Stage IB-IIA-IIIA Non-Small Cell Lung Cancer; EGFRm+; Ex19Del; L858R; AZD9291; Phase III, adjuvant chemotherapy; complete tumour resection; EGFR-TKI|stage ib-iia-iiia non-small cell lung cancer; egfrm+; ex19del; l858r; azd9291; phase iii, adjuvant chemotherapy; complete tumour resection; egfr-tki
170903|NCT02511093|Hypertension|hypertension
170904|NCT02511093|Team-based care|team-based care
170905|NCT02511093|Collaboration|collaboration
170906|NCT02511093|Healthcare professionals|healthcare professionals
170907|NCT02511093|Healthcare services|healthcare services
170908|NCT02511080|Spot-on; perioperative hypothermia.|spot-on; perioperative hypothermia.
170909|NCT02511054|Immunogenicity|immunogenicity
170910|NCT02511054|Liver Stage|liver stage
170911|NCT02511054|Parasites|parasites
170912|NCT02511054|Blood|blood
170913|NCT02511054|Infection|infection
170914|NCT02511041|CDG|cdg
170915|NCT02511041|PGM3|pgm3
170916|NCT02511041|Immune|immune
170917|NCT02511028|MRI|mri
170918|NCT02511028|Multiple Sclerosis|multiple sclerosis
170919|NCT02511028|Healthy Volunteer|healthy volunteer
170920|NCT02511015|Early Onset Parkinson's Disease|early onset parkinson's disease
170921|NCT02511015|Cellular Quality Control Programs|cellular quality control programs
170922|NCT02511015|Mitochondria|mitochondria
170923|NCT02511015|Neuroinflammation|neuroinflammation
170924|NCT02511015|Immunology|immunology
170925|NCT02511002|Influenza|influenza
170926|NCT02511002|Hemagglutinin (HA)|hemagglutinin (ha)
170927|NCT02511002|Post Influenza Challenge|post influenza challenge
170928|NCT02511002|Neuranimidase (NA)|neuranimidase (na)
170929|NCT02511002|Influenza Illness|influenza illness
170930|NCT02510989|Syndromic obesity|syndromic obesity
170931|NCT02510989|Genes|genes
170932|NCT02510989|Exome|exome
170933|NCT02510963|Vertical infection transmission|vertical infection transmission
170934|NCT02510963|Tenofovir|tenofovir
170935|NCT02510937|pulmonary fibrosis|pulmonary fibrosis
170936|NCT02510937|pharmacokinetic|pharmacokinetic
170937|NCT02510937|pharmacodynamics|pharmacodynamics
170938|NCT02510937|CC-90001|cc-90001
170939|NCT02510937|Safety|safety
170940|NCT02510924|Intubation|intubation
170941|NCT02510924|Airtraq|airtraq
170942|NCT02510924|General anesthesia|general anesthesia
170943|NCT02510924|Difficult airway|difficult airway
170944|NCT02510911|colectomy|colectomy
170945|NCT02510911|laparoscopy|laparoscopy
170946|NCT02510911|caffeine|caffeine
170947|NCT02510885|neovascular age-related macular degeneration|neovascular age-related macular degeneration
170948|NCT02510885|age-related macular degeneration|age-related macular degeneration
170949|NCT02510885|diabetic retinopathy|diabetic retinopathy
170950|NCT02510885|SD-OCT|sd-oct
170951|NCT02510885|Angiography|angiography
170952|NCT02510885|diabetic macular edema|diabetic macular edema
170953|NCT02510846|Polyhandicap|polyhandicap
170954|NCT02510846|Behavior disorders|behavior disorders
170955|NCT02510846|Educative program|educative program
170956|NCT02510846|Caregivers|caregivers
170957|NCT02510846|Quality of life.|quality of life.
170958|NCT02510833|Parkinson Disease|parkinson disease
170959|NCT02510833|Physical Therapy Modalities|physical therapy modalities
170960|NCT02510833|Quality of Life|quality of life
170961|NCT02510833|Self Care|self care
170962|NCT02510768|alba|alba
170963|NCT02510664|Adolescence|adolescence
170964|NCT02510664|Adherence|adherence
170965|NCT02510651|: non-segmental vitiligo|: non-segmental vitiligo
170966|NCT02510651|melanocyte-keratinocyte suspension|melanocyte-keratinocyte suspension
170967|NCT02510651|cryoblebbing|cryoblebbing
170968|NCT02510651|CO2 laser|co2 laser
170969|NCT02510612|Dexmedetomidine|dexmedetomidine
170970|NCT02510612|Diabetic|diabetic
170971|NCT02510612|glycometabolism|glycometabolism
170972|NCT02510612|sedation|sedation
170973|NCT02510599|NASH|nash
170974|NCT02510599|Liver disease|liver disease
170975|NCT02510508|addiction|addiction
170976|NCT02510508|substance abuse|substance abuse
170977|NCT02510508|alcohol|alcohol
170978|NCT02510508|drugs|drugs
170979|NCT02510508|community reinforcement|community reinforcement
170980|NCT02510508|family treatment|family treatment
170981|NCT02510508|randomized control trial|randomized control trial
170982|NCT02510495|Sphincterotomy|sphincterotomy
170983|NCT02510495|Dilatation|dilatation
170984|NCT02510495|Common bile duct|common bile duct
170985|NCT02510495|Pancreatitis|pancreatitis
170986|NCT02510482|cardiac biomarkers|cardiac biomarkers
170987|NCT02510443|Permanent contraception method|permanent contraception method
170988|NCT02510443|Contraceptive device|contraceptive device
170989|NCT02510391|modular|modular
170990|NCT02510391|anxiety|anxiety
170991|NCT02510391|preschool|preschool
170992|NCT02510391|exposure and response prevention|exposure and response prevention
170993|NCT02510391|Cognitive behavioral therapy|cognitive behavioral therapy
170994|NCT02510352|Rotator cuff tear|rotator cuff tear
170995|NCT02510352|MRI|mri
170996|NCT02510287|analgesia, epidural|analgesia, epidural
170997|NCT02510287|labor pain|labor pain
170998|NCT02510287|patient satisfaction|patient satisfaction
171000|NCT02510274|pharmacokinetics|pharmacokinetics
171001|NCT02510274|pharmacodynamics|pharmacodynamics
171002|NCT02510274|Chronic Kidney Disease|chronic kidney disease
171003|NCT02510274|Hyperphosphatemia|hyperphosphatemia
171004|NCT02510261|RNAi therapeutic|rnai therapeutic
171005|NCT02510261|FAP|fap
171006|NCT02510261|Familial Amyloid Polyneuropathy|familial amyloid polyneuropathy
171007|NCT02510261|TTR|ttr
171008|NCT02510261|Transthyretin|transthyretin
171009|NCT02510261|Amyloidosis|amyloidosis
171010|NCT02510235|Dry Eye|dry eye
171011|NCT02510222|child|child
171012|NCT02510209|Teen pregnancy|teen pregnancy
171013|NCT02510183|Acupressure|acupressure
171014|NCT02510183|Perioperative Care|perioperative care
171015|NCT02510183|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
171016|NCT02510183|Nursing Care Management|nursing care management
171017|NCT02510170|Fetus|fetus
171018|NCT02510170|Skull|skull
171019|NCT02510170|ultrasonography|ultrasonography
171020|NCT02510157|sugammadex|sugammadex
171021|NCT02510157|dexamethasone|dexamethasone
171022|NCT02510157|neuromuscular blockade|neuromuscular blockade
171023|NCT02510118|ChangTai Keli|changtai keli
171024|NCT02510118|Colon cancer|colon cancer
171025|NCT02510105|Critical Care|critical care
171026|NCT02510105|ARDS|ards
171027|NCT02510105|Intrapulmonary Percussive Ventilation|intrapulmonary percussive ventilation
171028|NCT02510105|VDR4|vdr4
171029|NCT02510105|Lung aeration|lung aeration
171030|NCT02510105|CT scan|ct scan
171031|NCT02510066|Pancreatic Cancer|pancreatic cancer
171032|NCT02510066|Pain|pain
171033|NCT02510066|Acupuncture|acupuncture
171034|NCT02510040|Convergence Insufficiency|convergence insufficiency
171035|NCT02510040|Divergence Insufficiency|divergence insufficiency
171036|NCT02510040|Small-angle Hypertropia|small-angle hypertropia
171037|NCT02510040|Strabismus|strabismus
171038|NCT02510027|HPV testing|hpv testing
171039|NCT02510027|Triage|triage
171040|NCT02510027|Mexico|mexico
171041|NCT02510027|Cervical cancer screening|cervical cancer screening
171042|NCT02510001|RASMT CRC|rasmt crc
171043|NCT02510001|RASWT/c-MET CRC|raswt/c-met crc
171044|NCT02510001|Dose Escalation|dose escalation
171045|NCT02510001|Histologically or cytologically confirmed|histologically or cytologically confirmed
171046|NCT02510001|Dose Expansion|dose expansion
171047|NCT02509988|Nutrition|nutrition
171048|NCT02509988|Glucose metabolism|glucose metabolism
171049|NCT02509988|Body composition|body composition
171050|NCT02509975|embolization|embolization
171051|NCT02509975|prostate|prostate
171052|NCT02509962|Energy metabolism|energy metabolism
171053|NCT02509962|Glucose tolerance|glucose tolerance
171054|NCT02509962|Blood pressure|blood pressure
171055|NCT02509962|Immunoregulation|immunoregulation
171056|NCT02509923|Male Subjects|male subjects
171057|NCT02509910|Major abdominal surgery|major abdominal surgery
171058|NCT02509910|Goal directed therapy|goal directed therapy
171059|NCT02509897|Hypoxia training|hypoxia training
171060|NCT02509897|Activity energy expenditure|activity energy expenditure
171061|NCT02509897|Immunoregulation|immunoregulation
171062|NCT02509897|Energy Metabolism|energy metabolism
171063|NCT02509897|Exercise|exercise
171064|NCT02509884|Alveolar Echinococcosis (AE)|alveolar echinococcosis (ae)
171065|NCT02509884|Echinococcus multilocularis|echinococcus multilocularis
171066|NCT02509884|antiparasitic treatment|antiparasitic treatment
171067|NCT02509884|surgery|surgery
171068|NCT02509884|classification|classification
171069|NCT02509884|staging|staging
171070|NCT02509884|prospective cohort study|prospective cohort study
171071|NCT02509871|Body composition|body composition
171072|NCT02509858|Diabetes mellitus, thyroxine|diabetes mellitus, thyroxine
171073|NCT02509832|Therapeutic Hypothermia (TH)|therapeutic hypothermia (th)
171074|NCT02509832|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
171075|NCT02509832|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
171076|NCT02509819|rehabilitation|rehabilitation
171077|NCT02509819|IDEO|ideo
171078|NCT02509780|Vichy|vichy
171079|NCT02509780|urine alkalization|urine alkalization
171080|NCT02509767|Contraceptive Methods|contraceptive methods
171081|NCT02509767|Female Contraception|female contraception
171082|NCT02509767|Contraceptive satisfaction|contraceptive satisfaction
171083|NCT02509767|Injectable contraception|injectable contraception
171084|NCT02509767|Birth control|birth control
171085|NCT02509754|atrial fibrillation|atrial fibrillation
171086|NCT02509754|congestive heart failure|congestive heart failure
171087|NCT02509754|catheter ablation|catheter ablation
171088|NCT02509754|rate control|rate control
171089|NCT02509754|left ventricular function|left ventricular function
171090|NCT02509741|obesity|obesity
171091|NCT02509741|nutrition|nutrition
171092|NCT02509741|intervention|intervention
171093|NCT02509741|food replacement|food replacement
171094|NCT02509741|IOT|iot
171095|NCT02509728|choline|choline
171096|NCT02509728|docosahexaenoic acid|docosahexaenoic acid
171097|NCT02509715|thyroidectomy|thyroidectomy
171098|NCT02509715|nerve monitoring|nerve monitoring
171099|NCT02509702|Mobile health|mobile health
171101|NCT02509702|Early detection of cancer|early detection of cancer
171102|NCT02509702|HPV|hpv
171103|NCT02509702|SMS intervention|sms intervention
171104|NCT02509702|RCT|rct
171105|NCT02509702|Tanzania|tanzania
171106|NCT02509689|mTBI|mtbi
171107|NCT02509689|cognition disorders|cognition disorders
171108|NCT02509689|post-concussive syndrome|post-concussive syndrome
171109|NCT02509689|neuroplasticity|neuroplasticity
171111|NCT02509689|biofeedback|biofeedback
171112|NCT02509689|stress disorder/post-traumatic|stress disorder/post-traumatic
171113|NCT02509689|depression|depression
171114|NCT02509676|dynamic stretching training|dynamic stretching training
171115|NCT02509676|muscle tendon unit|muscle tendon unit
171116|NCT02509676|ultrasound|ultrasound
171117|NCT02509650|Exome sequencing|exome sequencing
171118|NCT02509650|Skin disease|skin disease
171119|NCT02509650|Familial lipomatosis|familial lipomatosis
171120|NCT02509637|Respiratory System|respiratory system
171121|NCT02509637|Physical Therapy Modalities|physical therapy modalities
171122|NCT02509611|Yoga|yoga
171123|NCT02509611|Parkinson's disease|parkinson's disease
171124|NCT02509611|redox status|redox status
171125|NCT02509611|motor function|motor function
171126|NCT02509559|Receptors, Adrenergic|receptors, adrenergic
171127|NCT02509559|Propranolol|propranolol
171128|NCT02509533|Vacuum Assisted Closure|vacuum assisted closure
171129|NCT02509520|Nutritional supplementation|nutritional supplementation
171130|NCT02509520|Neuromuscular Electric Stimulation|neuromuscular electric stimulation
171131|NCT02509520|ICU acquired weakness|icu acquired weakness
171132|NCT02509520|Post ICU Syndrome|post icu syndrome
171133|NCT02509520|sarcopenia|sarcopenia
171134|NCT02509507|Liver tumours|liver tumours
171135|NCT02509494|Vaccine|vaccine
171136|NCT02509494|Ebola|ebola
171137|NCT02509494|Ebola virus disease|ebola virus disease
171138|NCT02509494|EVD|evd
171139|NCT02509494|Hemorrhagic fever|hemorrhagic fever
171140|NCT02509494|Sierra Leone|sierra leone
171141|NCT02509494|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
171142|NCT02509494|Safety|safety
171143|NCT02509494|Immunogenicity|immunogenicity
171144|NCT02509494|Modified Vaccinia Virus Ankara ‐ Bavarian Nordic Filo‐vector|modified vaccinia virus ankara ‐ bavarian nordic filo‐vector
171145|NCT02509494|(MVA‐BN Filo)|(mva‐bn filo)
171146|NCT02509481|malaria|malaria
171147|NCT02509481|lymphatic filariasis|lymphatic filariasis
171148|NCT02509481|mosquito|mosquito
171149|NCT02509481|ivermectin|ivermectin
171150|NCT02509481|mass drug administration|mass drug administration
171151|NCT02509455|Balance control|balance control
171152|NCT02509455|Body-mounted sensors|body-mounted sensors
171153|NCT02509455|Balance Measures|balance measures
171154|NCT02509442|mapping brain functions|mapping brain functions
171155|NCT02509442|Direct electric stimulation (DES)|direct electric stimulation (des)
171156|NCT02509442|potential evoked|potential evoked
171157|NCT02509429|T1DM|t1dm
171158|NCT02509429|Type 1 Diabetes|type 1 diabetes
171159|NCT02509429|Artificial Pancreas|artificial pancreas
171160|NCT02509429|DiAs platform|dias platform
171161|NCT02509416|endoscopic ultrasound|endoscopic ultrasound
171162|NCT02509416|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
171163|NCT02509416|competency|competency
171164|NCT02509403|Perineal hygiene|perineal hygiene
171165|NCT02509403|Hygiene wipes|hygiene wipes
171166|NCT02509403|Hygiene Towels|hygiene towels
171167|NCT02509403|Safety|safety
171168|NCT02509403|Essential oils|essential oils
171169|NCT02509403|Natural Health Product|natural health product
171170|NCT02509390|Fibrinogen level|fibrinogen level
171171|NCT02509390|Hyperfibrinogenemia|hyperfibrinogenemia
171172|NCT02509390|Trauma|trauma
171173|NCT02509390|Thrombosis risk|thrombosis risk
171174|NCT02509377|Fetal Surgery|fetal surgery
171175|NCT02509377|Open Fetal Surgery|open fetal surgery
171176|NCT02509377|Elevated BMI|elevated bmi
171177|NCT02509377|Body Mass Index|body mass index
171178|NCT02509377|Spina Bifida|spina bifida
171179|NCT02509364|AE-IPF|ae-ipf
171180|NCT02509312|Analgesia, Obstetrical|analgesia, obstetrical
171181|NCT02509312|Blood Loss, Surgical|blood loss, surgical
171182|NCT02509312|Analgesics, Opioid/administration & dosage|analgesics, opioid/administration & dosage
171183|NCT02509312|Cyclooxygenase Inhibitors/administration & dosage|cyclooxygenase inhibitors/administration & dosage
171184|NCT02509312|Cesarean Section|cesarean section
171185|NCT02509312|Female|female
171186|NCT02509312|Humans|humans
171187|NCT02509312|Ketorolac/administration & dosage|ketorolac/administration & dosage
171188|NCT02509312|Hydromorphone/administration & dosage|hydromorphone/administration & dosage
171189|NCT02509312|Pain, Postoperative/drug therapy|pain, postoperative/drug therapy
171190|NCT02509312|Pregnancy|pregnancy
171191|NCT02509312|Morphine/administration & dosage|morphine/administration & dosage
171192|NCT02509299|COPD|copd
171193|NCT02509299|Quality of life|quality of life
171194|NCT02509299|Perceived health status|perceived health status
171195|NCT02509286|Esophageal neoplasms|esophageal neoplasms
171196|NCT02509286|gastro-esophageal junction neoplasms|gastro-esophageal junction neoplasms
171197|NCT02509286|adenocarcinoma|adenocarcinoma
171198|NCT02509286|esophagectomy|esophagectomy
171199|NCT02509286|surgery|surgery
171200|NCT02509286|radiotherapy|radiotherapy
171201|NCT02509286|chemotherapy|chemotherapy
171202|NCT02509260|colorectal surgery|colorectal surgery
171203|NCT02509247|sleep apnea|sleep apnea
171204|NCT02509247|CPAP|cpap
171205|NCT02509247|telemonitoring|telemonitoring
171206|NCT02509247|telecare|telecare
171207|NCT02509234|pediatric sarcomas|pediatric sarcomas
171208|NCT02509234|Ewing sarcoma|ewing sarcoma
171209|NCT02509234|rhabdomyosarcoma|rhabdomyosarcoma
171210|NCT02509234|soft tissue sarcoma|soft tissue sarcoma
171211|NCT02509208|iliac crest bone graft|iliac crest bone graft
171212|NCT02509208|ICBG|icbg
171213|NCT02509208|pelvic osteotomy|pelvic osteotomy
171214|NCT02509208|spinal fusion|spinal fusion
171215|NCT02509208|hemostasis|hemostasis
171216|NCT02509208|haemostasis|haemostasis
171217|NCT02509208|hemostatic|hemostatic
171218|NCT02509208|haemostatic|haemostatic
171219|NCT02509208|dextran|dextran
171220|NCT02509208|SurgiClot|surgiclot
171221|NCT02509208|cancellous bone bleeding|cancellous bone bleeding
171222|NCT02509182|Hyperoxia|hyperoxia
171223|NCT02509182|One-Lung Ventilation|one-lung ventilation
171224|NCT02509182|Thoracic Surgery|thoracic surgery
171225|NCT02509182|Anesthesiology|anesthesiology
171226|NCT02509156|Cardiomyopathy|cardiomyopathy
171227|NCT02509156|AIC|aic
171228|NCT02509156|Anthracyclines|anthracyclines
171229|NCT02509156|Chemotherapy|chemotherapy
171230|NCT02509156|Allogeneic|allogeneic
171231|NCT02509156|Mesenchymal stem cells|mesenchymal stem cells
171232|NCT02509156|MSCs|mscs
171233|NCT02509156|Cancer survivors|cancer survivors
171234|NCT02509156|Breast Cancer|breast cancer
171235|NCT02509156|Leukemia|leukemia
171236|NCT02509156|Lymphoma|lymphoma
171237|NCT02509156|Sarcoma|sarcoma
171238|NCT02509143|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
171239|NCT02509143|Colorectal Neoplasms|colorectal neoplasms
171240|NCT02509130|Severe Asthma|severe asthma
171241|NCT02509130|Asthma|asthma
171242|NCT02509130|Specialised Asthma Care|specialised asthma care
171243|NCT02509130|Asthma Care|asthma care
171244|NCT02509117|Alzheimer's disease|alzheimer's disease
171245|NCT02509104|Bioavailability|bioavailability
171246|NCT02509104|Dutasteride|dutasteride
171247|NCT02509104|Healthy Male Subjects|healthy male subjects
171248|NCT02509104|Fixed Dose Combination|fixed dose combination
171249|NCT02509078|ARDS|ards
171250|NCT02509078|neuromuscular blocker|neuromuscular blocker
171251|NCT02509078|cisatracurium|cisatracurium
171252|NCT02509065|bionic pancreas|bionic pancreas
171253|NCT02509065|artificial pancreas|artificial pancreas
171254|NCT02509065|insulin|insulin
171255|NCT02509065|glucagon|glucagon
171256|NCT02509065|continuous glucose monitor (CGM)|continuous glucose monitor (cgm)
171257|NCT02509065|insulin pump|insulin pump
171258|NCT02509065|outpatient|outpatient
171259|NCT02509039|CC-122|cc-122
171260|NCT02509039|Phase1|phase1
171261|NCT02509039|solid tumor|solid tumor
171262|NCT02509039|non-Hodgkin's lymphom|non-hodgkin's lymphom
171263|NCT02509026|non-radiographic axial spondyloarthritis|non-radiographic axial spondyloarthritis
171264|NCT02509013|chronic kidney disease|chronic kidney disease
171265|NCT02509013|stable coronary heart disease|stable coronary heart disease
171266|NCT02509013|prevalence|prevalence
171267|NCT02508987|Obesity|obesity
171268|NCT02508987|oxidative stress|oxidative stress
171269|NCT02508987|antioxidants|antioxidants
171270|NCT02508987|periodontal disease|periodontal disease
171271|NCT02508961|Physical Activity|physical activity
171272|NCT02508961|Exercise|exercise
171273|NCT02508961|Physiotherapy|physiotherapy
171274|NCT02508948|airway management|airway management
171275|NCT02508948|critically ill|critically ill
171276|NCT02508948|hemodynamic management|hemodynamic management
171277|NCT02508948|intubation|intubation
171278|NCT02508948|prospective study|prospective study
171279|NCT02508948|risk factors|risk factors
171280|NCT02508909|Videoassisted surgery|videoassisted surgery
171281|NCT02508883|Cancer|cancer
171282|NCT02508883|hemorrhage|hemorrhage
171283|NCT02508883|endoscopy|endoscopy
171284|NCT02508883|gastrointestinal hemorrhage|gastrointestinal hemorrhage
171285|NCT02508857|pain, postoperative|pain, postoperative
171286|NCT02508857|anesthesia adjuvants|anesthesia adjuvants
171287|NCT02508857|magnesium sulfate|magnesium sulfate
171288|NCT02508844|Probiotics|probiotics
171289|NCT02508844|Vivomixx®|vivomixx®
171290|NCT02508844|Microbiota|microbiota
171291|NCT02508831|Bilateral amputation|bilateral amputation
171292|NCT02508831|upper limb|upper limb
171293|NCT02508831|allograft|allograft
171294|NCT02508779|Diabetes|diabetes
171295|NCT02508779|Blood Glucose Management|blood glucose management
171296|NCT02508779|Preconception|preconception
171297|NCT02508779|Hypoglycemia|hypoglycemia
171298|NCT02508779|Women with diabetes|women with diabetes
171299|NCT02508766|Postural Control|postural control
171300|NCT02508766|Plantar Stimulation|plantar stimulation
171301|NCT02508766|Volunteers|volunteers
171302|NCT02508753|QT/QTc Intervals|qt/qtc intervals
171303|NCT02508701|HPV|hpv
171304|NCT02508701|Message Design|message design
171305|NCT02508701|Adolescent Males|adolescent males
171306|NCT02508688|hepatic hydrothorax|hepatic hydrothorax
171307|NCT02508688|thoracoscopic surgery|thoracoscopic surgery
171308|NCT02508688|diaphragmatic defect|diaphragmatic defect
171309|NCT02508675|injury|injury
171310|NCT02508675|risk factors|risk factors
171311|NCT02508675|outcome|outcome
171312|NCT02508675|costs|costs
171313|NCT02508662|Advanced Cancers|advanced cancers
171314|NCT02508662|Solid Tumors|solid tumors
171315|NCT02508662|Genomic Mutations|genomic mutations
171316|NCT02508662|FDA Approved Off-Label Chemotherapy|fda approved off-label chemotherapy
171317|NCT02508662|Refractory|refractory
171318|NCT02508623|Portal hypertension|portal hypertension
171319|NCT02508623|liver cirrhosis|liver cirrhosis
171320|NCT02508623|Rifaximin|rifaximin
171321|NCT02508597|Smoking cessation intervention|smoking cessation intervention
171322|NCT02508571|Infant, Premature|infant, premature
171323|NCT02508571|Intervention Studies|intervention studies
171324|NCT02508571|Bottle feeding|bottle feeding
171325|NCT02508532|2L GIST|2l gist
171326|NCT02508532|GIST second line|gist second line
171327|NCT02508532|GIST gleevec|gist gleevec
171328|NCT02508532|GIST imatinib|gist imatinib
171329|NCT02508532|Second-line GIST clinical trial|second-line gist clinical trial
171330|NCT02508532|BLU-285|blu-285
171331|NCT02508532|BLU 285|blu 285
171332|NCT02508532|BLUE-285|blue-285
171333|NCT02508532|BLUE 285|blue 285
171334|NCT02508532|Avapritinib|avapritinib
171335|NCT02508532|GIST imatinib relapse|gist imatinib relapse
171336|NCT02508532|GIST gleevec relapse|gist gleevec relapse
171337|NCT02508532|GIST KIT|gist kit
171338|NCT02508532|GIST relapse|gist relapse
171339|NCT02508532|GIST refractory|gist refractory
171340|NCT02508532|GIST imatinib intolerance|gist imatinib intolerance
171341|NCT02508532|GIST TKI treatment|gist tki treatment
171342|NCT02508532|GIST tyrosine kinase inhibitor treatment|gist tyrosine kinase inhibitor treatment
171343|NCT02508532|GIST TKI|gist tki
171344|NCT02508532|GIST tyrosine kinase inhibitor|gist tyrosine kinase inhibitor
171345|NCT02508532|Advanced GIST|advanced gist
171346|NCT02508532|GIST mutations|gist mutations
171347|NCT02508532|GIST treatments|gist treatments
171348|NCT02508532|Blueprint GIST|blueprint gist
171349|NCT02508532|Relapsed GIST clinical trial|relapsed gist clinical trial
171350|NCT02508532|Refractory GIST clinical trial|refractory gist clinical trial
171351|NCT02508532|KIT-mutant GIST|kit-mutant gist
171352|NCT02508532|cancer gist|cancer gist
171353|NCT02508532|gastrointestinal stromal tumor|gastrointestinal stromal tumor
171354|NCT02508532|gist cancer|gist cancer
171355|NCT02508532|PDGFRA|pdgfra
171356|NCT02508506|ALKS 5461|alks 5461
171357|NCT02508506|Alkermes|alkermes
171358|NCT02508506|Samidorphan|samidorphan
171359|NCT02508506|Renal Impairment|renal impairment
171360|NCT02508506|Pharmacokinetics|pharmacokinetics
171361|NCT02508506|Buprenorphine|buprenorphine
171362|NCT02508480|Stigma|stigma
171363|NCT02508480|Community Integration|community integration
171364|NCT02508467|Liver cancer|liver cancer
171365|NCT02508467|FGF19 gene amplification|fgf19 gene amplification
171366|NCT02508467|FGF19 overexpression|fgf19 overexpression
171367|NCT02508467|FGF19 upregulation|fgf19 upregulation
171368|NCT02508467|Cyclin D1 (CCND1) gene amplification|cyclin d1 (ccnd1) gene amplification
171369|NCT02508467|Cyclin D1 (CCND1) copy number gain|cyclin d1 (ccnd1) copy number gain
171370|NCT02508467|BLU-554|blu-554
171371|NCT02508467|FGFR4|fgfr4
171372|NCT02508467|Hepatocellular carcinoma|hepatocellular carcinoma
171373|NCT02508467|Liver Disease|liver disease
171374|NCT02508467|Liver Neoplasms|liver neoplasms
171375|NCT02508454|Prevention|prevention
171376|NCT02508454|Screening|screening
171377|NCT02508454|Biobanking|biobanking
171378|NCT02508441|Neoplasms|neoplasms
171379|NCT02508441|Solid Tumors|solid tumors
171380|NCT02508441|Advanced Malignancy|advanced malignancy
171381|NCT02508441|Cancer|cancer
171382|NCT02508428|Osteolysis|osteolysis
171383|NCT02508428|Polyethylene|polyethylene
171384|NCT02508428|Crosslinked Polyethylene|crosslinked polyethylene
171385|NCT02508428|Total Hip Replacement|total hip replacement
171386|NCT02508428|Marathon|marathon
171387|NCT02508415|obesity|obesity
171388|NCT02508415|periodontal disease|periodontal disease
171389|NCT02508415|intervention|intervention
171390|NCT02508389|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
171391|NCT02508389|oral cavity|oral cavity
171392|NCT02508389|oropharynx|oropharynx
171393|NCT02508389|intensity-modulated radiation therapy|intensity-modulated radiation therapy
171394|NCT02508389|chemotherapy|chemotherapy
171395|NCT02508389|oral mucositis|oral mucositis
171396|NCT02508389|superoxide dismutase|superoxide dismutase
171397|NCT02508389|radioprotection|radioprotection
171398|NCT02508376|adjuvants|adjuvants
171399|NCT02508376|AP10-602|ap10-602
171400|NCT02508376|GLA-SE|gla-se
171401|NCT02508376|ID93|id93
171402|NCT02508376|Tuberculosis|tuberculosis
171403|NCT02508376|vaccine|vaccine
171404|NCT02508363|Taxi drivers|taxi drivers
171405|NCT02508363|Health care access|health care access
171406|NCT02508363|15-163|15-163
171407|NCT02508311|Tetraplegia|tetraplegia
171408|NCT02508311|High Paraplegia|high paraplegia
171409|NCT02508298|ICG|icg
171410|NCT02508298|ARFI|arfi
171411|NCT02508298|portal hypertension|portal hypertension
171412|NCT02508298|cirrhosis|cirrhosis
171413|NCT02508298|diagnostic study|diagnostic study
171414|NCT02508272|Transcriptome profiling|transcriptome profiling
171415|NCT02508259|mitochondria|mitochondria
171416|NCT02508259|purinergic signaling|purinergic signaling
171417|NCT02508259|cell danger response|cell danger response
171418|NCT02508194|RSV|rsv
171419|NCT02508194|Older adults|older adults
171420|NCT02508194|MEDI7510|medi7510
171421|NCT02508194|Vaccine|vaccine
171422|NCT02508194|Efficacy|efficacy
171423|NCT02508181|intra ocular pressure|intra ocular pressure
171424|NCT02508181|I-gel|i-gel
171425|NCT02508181|LMA Supreme|lma supreme
171426|NCT02508181|strabismus surgery|strabismus surgery
171427|NCT02508168|Drug therapy|drug therapy
171428|NCT02508129|Insomnia|insomnia
171429|NCT02508129|hypertension|hypertension
171430|NCT02508129|blood pressure|blood pressure
171431|NCT02508129|sleep|sleep
171432|NCT02508129|behavioral treatment|behavioral treatment
171433|NCT02508129|Cognitive Behavioral Treatment of Insomnia (CBTI)|cognitive behavioral treatment of insomnia (cbti)
171434|NCT02508129|Brief Behavioral Treatment of Insomnia (BBTI)|brief behavioral treatment of insomnia (bbti)
171435|NCT02508129|pragmatic trial|pragmatic trial
171436|NCT02508129|internet|internet
171437|NCT02508116|pharmacogenetics|pharmacogenetics
171438|NCT02508116|clopidogrel|clopidogrel
171439|NCT02508116|genotype|genotype
171440|NCT02508103|Premenstrual Dysphoric Disorder|premenstrual dysphoric disorder
171441|NCT02508103|Premenstrual Syndrome|premenstrual syndrome
171442|NCT02508103|PMS|pms
171443|NCT02508103|PMDD|pmdd
171444|NCT02508038|alpha beta depleted|alpha beta depleted
171445|NCT02508038|alphabeta|alphabeta
171446|NCT02508038|TCR alpha beta depleted|tcr alpha beta depleted
171447|NCT02508038|alpha beta|alpha beta
171448|NCT02508038|haploidentical|haploidentical
171449|NCT02508038|Zoledronate|zoledronate
171450|NCT02508038|Zoledronic acid|zoledronic acid
171451|NCT02508038|Pediatric cancers|pediatric cancers
171452|NCT02508038|alfa beta|alfa beta
171453|NCT02508038|αβ T cell depleted HSCT|αβ t cell depleted hsct
171454|NCT02508038|alpha beta T cell and B cell depleted HSCT|alpha beta t cell and b cell depleted hsct
171455|NCT02508038|haploidentical HSCT|haploidentical hsct
171456|NCT02508025|disability evaluation|disability evaluation
171457|NCT02508025|psychosocial factors|psychosocial factors
171458|NCT02508012|anti-TNF|anti-tnf
171459|NCT02508012|Immuno-monitoring|immuno-monitoring
171460|NCT02508012|Anti-drug antibody (ADAb)|anti-drug antibody (adab)
171461|NCT02508012|Inflammatory bowel disease (IBD)|inflammatory bowel disease (ibd)
171462|NCT02508012|Crohn's disease|crohn's disease
171463|NCT02508012|Ulcerative colitis|ulcerative colitis
171464|NCT02507973|Mechanical Ventilation|mechanical ventilation
171465|NCT02507973|Intracranial Pressure|intracranial pressure
171466|NCT02507973|Airway Pressure Release Ventilation|airway pressure release ventilation
171467|NCT02507934|Dry Eye|dry eye
171468|NCT02507908|neuroendocrine tumors|neuroendocrine tumors
171469|NCT02507908|5-hydroxyindolacetic acid|5-hydroxyindolacetic acid
171470|NCT02507908|serotonin|serotonin
171471|NCT02507908|isotope-dilution massa-spectrometer|isotope-dilution massa-spectrometer
171472|NCT02507895|Stroke|stroke
171473|NCT02507895|lower extremeties|lower extremeties
171474|NCT02507895|Brain-computer interface|brain-computer interface
171475|NCT02507895|Motor imagery|motor imagery
171476|NCT02507895|Rehabilitation|rehabilitation
171477|NCT02507895|TMS|tms
171478|NCT02507843|Vitamin D|vitamin d
171479|NCT02507817|LIF,Magnesium Sulphate|lif,magnesium sulphate
171480|NCT02507791|Fitbit|fitbit
171481|NCT02507791|Obesity|obesity
171482|NCT02507791|Pediatrics|pediatrics
171483|NCT02507778|Lung|lung
171484|NCT02507778|Cancer|cancer
171485|NCT02507778|Biomarkers|biomarkers
171486|NCT02507778|Early detection|early detection
171487|NCT02507778|Circulating tumor cell|circulating tumor cell
171488|NCT02507765|SBRT|sbrt
171489|NCT02507713|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
171490|NCT02507713|Ultrasonography|ultrasonography
171491|NCT02507713|Motor neurons|motor neurons
171492|NCT02507713|Neuromuscular diseases|neuromuscular diseases
171493|NCT02507713|Fasciculation|fasciculation
171494|NCT02507700|nerve block|nerve block
171495|NCT02507674|appendicitis|appendicitis
171496|NCT02507674|pediatric|pediatric
171497|NCT02507674|ultrasound|ultrasound
171498|NCT02507635|cytokines|cytokines
171499|NCT02507635|persistent allergic rhinitis|persistent allergic rhinitis
171500|NCT02507635|H1 antihistamines|h1 antihistamines
171501|NCT02507583|Brain Tumor|brain tumor
171502|NCT02507583|Glioma|glioma
171503|NCT02507583|Newly Diagnosed|newly diagnosed
171504|NCT02507557|Therapy, Fluid|therapy, fluid
171505|NCT02507557|Digestive System Surgical Procedures|digestive system surgical procedures
171506|NCT02507557|Postoperative Complications|postoperative complications
171507|NCT02507544|Advanced Solid Malignancy|advanced solid malignancy
171508|NCT02507544|Safety and Tolerability|safety and tolerability
171509|NCT02507544|Tumor Response|tumor response
171510|NCT02507544|Hematology|hematology
171511|NCT02507544|Oncology|oncology
171512|NCT02507518|lung cancer, PET, progression free survival|lung cancer, pet, progression free survival
171513|NCT02507492|POMC, LEPR, PCSK1|pomc, lepr, pcsk1
171514|NCT02507466|locomotion|locomotion
171515|NCT02507453|volunteers|volunteers
171516|NCT02507427|Prostate cancer, robot, nerve mapping and monitoring|prostate cancer, robot, nerve mapping and monitoring
171517|NCT02507414|Mesenteric Traction Syndrome|mesenteric traction syndrome
171518|NCT02507414|Upper gastrointestinal cancer surgery|upper gastrointestinal cancer surgery
171519|NCT02507388|AMD|amd
171520|NCT02507388|nAMD|namd
171521|NCT02507388|wetAMD|wetamd
171522|NCT02507388|Age-Related Macular Degeneration|age-related macular degeneration
171523|NCT02507375|Non-Squamous|non-squamous
171524|NCT02507362|keratoconus , corneal collagen cross-linking|keratoconus , corneal collagen cross-linking
171525|NCT02507349|serious mental illness|serious mental illness
171526|NCT02507349|mental health services research|mental health services research
171527|NCT02507349|measurement-based care|measurement-based care
171528|NCT02507349|shared decision making|shared decision making
171529|NCT02507349|psychiatric medication management|psychiatric medication management
171530|NCT02507349|community psychiatry|community psychiatry
171531|NCT02507349|comparative effectiveness research|comparative effectiveness research
171532|NCT02507349|mixed methods research|mixed methods research
171533|NCT02507336|Mantle Cell Lymphoma (MCL)|mantle cell lymphoma (mcl)
171534|NCT02507336|Non-Hodgkin's Lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
171535|NCT02507258|osteoarthritis|osteoarthritis
171536|NCT02507258|avascular necrosis|avascular necrosis
171537|NCT02507258|correction of functional deformity|correction of functional deformity
171538|NCT02507258|painful hip dysplasia|painful hip dysplasia
171539|NCT02507258|protrusio acetabuli|protrusio acetabuli
171540|NCT02507258|rheumatoid arthritis|rheumatoid arthritis
171541|NCT02507258|ankylosis|ankylosis
171542|NCT02507245|GHD|ghd
171543|NCT02507232|glioma|glioma
171544|NCT02507232|temozolomide|temozolomide
171545|NCT02507232|brain|brain
171546|NCT02507232|NovoTTF-200A|novottf-200a
171547|NCT02507232|cancer|cancer
171548|NCT02507232|low-grade glioma|low-grade glioma
171549|NCT02507206|schizotypal personality disorder|schizotypal personality disorder
171550|NCT02507206|cognitive impairment|cognitive impairment
171551|NCT02507206|working memory|working memory
171552|NCT02507206|Dopamine Agonists|dopamine agonists
171553|NCT02507206|Cognition Disorders|cognition disorders
171554|NCT02507206|Personality Disorders|personality disorders
171555|NCT02507206|Delirium|delirium
171556|NCT02507206|Dementia|dementia
171557|NCT02507206|Amnestic|amnestic
171558|NCT02507206|Cognitive Disorders|cognitive disorders
171559|NCT02507206|Mental Disorders|mental disorders
171560|NCT02507206|Dihydrexidine|dihydrexidine
171561|NCT02507206|Dopamine A|dopamine a
171562|NCT02507180|Clinical Decision Rule|clinical decision rule
171563|NCT02507180|Ultrasound|ultrasound
171564|NCT02507180|Suspected Deep Vein Thrombosis|suspected deep vein thrombosis
171565|NCT02507180|D-Dimer|d-dimer
171566|NCT02507154|cetuximab|cetuximab
171567|NCT02507154|NK cells|nk cells
171568|NCT02507154|nasopharyngeal cancer|nasopharyngeal cancer
171569|NCT02507154|head and neck squamous cell cancer|head and neck squamous cell cancer
171570|NCT02507141|Reflectance Confocal Microscopy|reflectance confocal microscopy
171571|NCT02507141|15-128|15-128
171572|NCT02507050|Ivabradine|ivabradine
171573|NCT02507050|Microvascular dysfunction|microvascular dysfunction
171574|NCT02507050|PCI|pci
171575|NCT02507050|Procedural related myocardial injury|procedural related myocardial injury
171576|NCT02507050|IMR|imr
171577|NCT02507050|Index of Microvascular Resistance|index of microvascular resistance
171578|NCT02506998|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
171579|NCT02506998|Dialyzable Leukocyte Extracts|dialyzable leukocyte extracts
171580|NCT02506985|Rivaroxaban|rivaroxaban
171581|NCT02506985|CDT (Catheter directed thrombolysis)|cdt (catheter directed thrombolysis)
171582|NCT02506985|PE (pulmonary embolism)|pe (pulmonary embolism)
171583|NCT02506985|NETs|nets
171584|NCT02506985|factor Xa|factor xa
171585|NCT02506972|Blood glucose|blood glucose
171586|NCT02506972|Humans|humans
171587|NCT02506972|Postprandial|postprandial
171588|NCT02506972|Sugar|sugar
171589|NCT02506972|Carbohydrate|carbohydrate
171590|NCT02506972|Oat beta-glucan|oat beta-glucan
171591|NCT02506959|Multiple myeloma (MM)|multiple myeloma (mm)
171592|NCT02506959|MM|mm
171593|NCT02506959|Refractory|refractory
171594|NCT02506959|Relapsed|relapsed
171595|NCT02506959|Stem Cell Transplant|stem cell transplant
171596|NCT02506959|Busulfan|busulfan
171597|NCT02506959|Busulfex|busulfex
171598|NCT02506959|Myleran|myleran
171599|NCT02506959|Palifermin|palifermin
171600|NCT02506959|Kepivance|kepivance
171601|NCT02506959|Panobinostat|panobinostat
171602|NCT02506959|LBH589B|lbh589b
171603|NCT02506959|Gemcitabine|gemcitabine
171604|NCT02506959|Gemcitabine Hydrochloride|gemcitabine hydrochloride
171605|NCT02506959|Gemzar|gemzar
171606|NCT02506959|Melphalan|melphalan
171607|NCT02506959|Alkeran|alkeran
171608|NCT02506959|Dexamethasone|dexamethasone
171609|NCT02506959|Decadron|decadron
171610|NCT02506959|Pyridoxine|pyridoxine
171611|NCT02506959|Caphosol|caphosol
171612|NCT02506959|Glutamine|glutamine
171613|NCT02506959|Enterex|enterex
171614|NCT02506959|Glutapak|glutapak
171615|NCT02506959|NutreStore|nutrestore
171616|NCT02506959|Resource|resource
171617|NCT02506959|GlutaSolve|glutasolve
171618|NCT02506959|Sympt-X|sympt-x
171619|NCT02506946|Polycystic Ovary Syndrome|polycystic ovary syndrome
171620|NCT02506946|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
171621|NCT02506946|Adolescents|adolescents
171622|NCT02506946|Young Women|young women
171623|NCT02506946|MRI|mri
171624|NCT02506946|MRS|mrs
171625|NCT02506946|DXA|dxa
171626|NCT02506946|Hirsutism|hirsutism
171627|NCT02506946|Amenorrhea|amenorrhea
171628|NCT02506946|Metabolic syndrome|metabolic syndrome
171629|NCT02506946|Dyslipidemia|dyslipidemia
171630|NCT02506946|Percentage liver fat|percentage liver fat
171631|NCT02506920|Postprandial lipemia|postprandial lipemia
171632|NCT02506920|glycemic response|glycemic response
171633|NCT02506881|darbepoetin alfa|darbepoetin alfa
171634|NCT02506881|pharmacokinetics|pharmacokinetics
171635|NCT02506881|pharmacodynamics|pharmacodynamics
171636|NCT02506881|healthy volunteers|healthy volunteers
171637|NCT02506868|darbepoetin alfa|darbepoetin alfa
171638|NCT02506842|Pancreatic Cancer|pancreatic cancer
171639|NCT02506842|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
171640|NCT02506842|AG|ag
171641|NCT02506842|OFF|off
171642|NCT02506842|Second-Line Adjuvant Therapy|second-line adjuvant therapy
171643|NCT02506829|Inpatients|inpatients
171644|NCT02506790|Melatonin, metformin, toremifene|melatonin, metformin, toremifene
171645|NCT02506777|Melatonin, metformin, chemotherapy|melatonin, metformin, chemotherapy
171646|NCT02506738|telemonitoring|telemonitoring
171647|NCT02506738|mHealth|mhealth
171648|NCT02506738|functional status|functional status
171649|NCT02506738|older people|older people
171650|NCT02506725|prenatal care|prenatal care
171651|NCT02506725|pregnancy|pregnancy
171652|NCT02506725|prematurity|prematurity
171653|NCT02506673|Audiovisual Aids|audiovisual aids
171654|NCT02506673|Perioperative Period|perioperative period
171655|NCT02506673|Anxiety|anxiety
171656|NCT02506634|symptom|symptom
171657|NCT02506608|Neuroplasticty, Sensory Feedback|neuroplasticty, sensory feedback
171658|NCT02506556|Pi3K pathway|pi3k pathway
171659|NCT02506543|Adolescent Health|adolescent health
171660|NCT02506543|Ethiopia|ethiopia
171661|NCT02506543|Sexual Violence|sexual violence
171662|NCT02506530|lymphedema|lymphedema
171663|NCT02506530|breast cancer|breast cancer
171664|NCT02506517|HER pathway aberrations|her pathway aberrations
171665|NCT02506439|Vitamin D|vitamin d
171666|NCT02506439|Cholecalciferol|cholecalciferol
171667|NCT02506439|Dose-response|dose-response
171668|NCT02506439|Randomized Controlled Trial|randomized controlled trial
171669|NCT02506439|Pregnancy|pregnancy
171670|NCT02506439|Cord blood|cord blood
171671|NCT02506439|Serum 25-hydroxyvitamin D|serum 25-hydroxyvitamin d
171672|NCT02506439|Vitamin D Deficiency|vitamin d deficiency
171673|NCT02506439|Nutrition|nutrition
171674|NCT02506439|Dietary intervention study|dietary intervention study
171675|NCT02506426|Chronic Sinusitis|chronic sinusitis
171676|NCT02506426|Chronic Rhinosinusitis|chronic rhinosinusitis
171677|NCT02506426|Endoscopic sinus surgery|endoscopic sinus surgery
171678|NCT02506426|Septoplasty|septoplasty
171679|NCT02506413|Maternal and Newborn Health|maternal and newborn health
171680|NCT02506361|TOP2α|top2α
171681|NCT02506361|anthracyclines|anthracyclines
171682|NCT02506361|taxanes|taxanes
171683|NCT02506361|non dose-dense chemotherapy|non dose-dense chemotherapy
171684|NCT02506335|Liver disease|liver disease
171685|NCT02506335|cardiomyopathy|cardiomyopathy
171686|NCT02506335|congenital heart disease|congenital heart disease
171687|NCT02506322|Bipolar I Disorder|bipolar i disorder
171688|NCT02506322|Bipolar II Disorder|bipolar ii disorder
171689|NCT02506322|Relapse Prevention|relapse prevention
171690|NCT02506296|type 2 diabetes|type 2 diabetes
171691|NCT02506296|endogenous insulin secretion|endogenous insulin secretion
171692|NCT02506283|cryotherapy|cryotherapy
171693|NCT02506283|recovery|recovery
171694|NCT02506283|athletic performance|athletic performance
171695|NCT02506283|maximum voluntary contraction|maximum voluntary contraction
171696|NCT02506283|rated perceived exertion|rated perceived exertion
171697|NCT02506283|delayed onset muscle soreness|delayed onset muscle soreness
171698|NCT02506283|jump performance|jump performance
171699|NCT02506244|Atrial Fibrillation|atrial fibrillation
171700|NCT02506244|Wearable device|wearable device
171701|NCT02506244|Wristband|wristband
171702|NCT02506244|ECG Patch|ecg patch
171703|NCT02506244|Strokes|strokes
171704|NCT02506244|Asymptomatic|asymptomatic
171705|NCT02506244|Heart Rhythm|heart rhythm
171706|NCT02506244|Home Monitoring|home monitoring
171707|NCT02506231|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
171708|NCT02506231|GVHD prophylaxis|gvhd prophylaxis
171709|NCT02506231|Methotrexate|methotrexate
171710|NCT02506231|Folinic acid|folinic acid
171711|NCT02506231|Leucovorin|leucovorin
171712|NCT02506231|Mucositis|mucositis
171713|NCT02506192|Gulf War Illness|gulf war illness
171714|NCT02506192|Chronic Inflammation|chronic inflammation
171715|NCT02506192|Delayed-Release Prednisone|delayed-release prednisone
171716|NCT02506192|Health-Related Quality of Life|health-related quality of life
171717|NCT02506179|Real-life effect|real-life effect
171718|NCT02506179|Adalimumab|adalimumab
171719|NCT02506179|Patient reported outcomes (PRO)|patient reported outcomes (pro)
171720|NCT02506179|Moderate to severe ulcerative colitis (UC)|moderate to severe ulcerative colitis (uc)
171721|NCT02506179|Ulcerative colitis (UC)|ulcerative colitis (uc)
171722|NCT02506166|sleep apnea|sleep apnea
171723|NCT02506166|sleep disordered breathing|sleep disordered breathing
171724|NCT02506166|sudden cardiac death|sudden cardiac death
171725|NCT02506166|heart failure|heart failure
171726|NCT02506166|ischemic cardiomyopathy|ischemic cardiomyopathy
171727|NCT02506166|implantable cardioverter-defibrillator (ICD) therapy|implantable cardioverter-defibrillator (icd) therapy
171728|NCT02506166|cardiac resynchronization therapy (CRT)|cardiac resynchronization therapy (crt)
171729|NCT02506166|risk stratification|risk stratification
171730|NCT02506166|positive airway pressure therapy|positive airway pressure therapy
171731|NCT02506166|SERVE-HF|serve-hf
171732|NCT02506140|minor stroke|minor stroke
171733|NCT02506140|transient ischemic attack|transient ischemic attack
171734|NCT02506140|ticagrelor|ticagrelor
171735|NCT02506140|clopidogrel|clopidogrel
171736|NCT02506140|dual anti-platelet therapy|dual anti-platelet therapy
171737|NCT02506140|platelet reactivity|platelet reactivity
171738|NCT02506127|TBS, MDD, Sham-controlled, neuromodulation, TMS|tbs, mdd, sham-controlled, neuromodulation, tms
171739|NCT02506114|prostate|prostate
171740|NCT02506062|ischemic preconditioning|ischemic preconditioning
171741|NCT02506062|Raynaud's Phenomenon|raynaud's phenomenon
171742|NCT02506062|(RP)|(rp)
171743|NCT02506036|Treatment|treatment
171744|NCT02506036|Social-Cognitive Training|social-cognitive training
171745|NCT02506036|Web-based|web-based
171746|NCT02506036|Right Hemisphere Stroke|right hemisphere stroke
171747|NCT02506036|Frontotemporal Dementia|frontotemporal dementia
171748|NCT02506036|Right Sided Cerebral Hemisphere Cerebrovascular Accident|right sided cerebral hemisphere cerebrovascular accident
171749|NCT02506023|Factor VIII antigen|factor viii antigen
171750|NCT02506023|von Willebrand factor (vWF) antigen|von willebrand factor (vwf) antigen
171751|NCT02506023|Mutation type|mutation type
171752|NCT02506010|Hypoxia|hypoxia
171753|NCT02505984|oxytocin, bonding|oxytocin, bonding
171754|NCT02505984|child development|child development
171755|NCT02505971|hemangioma, propranolol, nadolol|hemangioma, propranolol, nadolol
171756|NCT02505958|insulin resistance, obesity, caloric intake|insulin resistance, obesity, caloric intake
171757|NCT02505945|Esophageal Reflux|esophageal reflux
171758|NCT02505945|Gastric Acid Reflux Disease|gastric acid reflux disease
171759|NCT02505945|Heartburn|heartburn
171760|NCT02505932|Shoulder instability|shoulder instability
171761|NCT02505919|Lower Urinary Tract Symptoms (LUTS)|lower urinary tract symptoms (luts)
171762|NCT02505906|Late toxicity|late toxicity
171763|NCT02505906|Simultaneous integrated boost (SIB)|simultaneous integrated boost (sib)
171764|NCT02505906|Radiotherapy|radiotherapy
171765|NCT02505880|Hypnosis|hypnosis
171766|NCT02505880|Pediatric surgery|pediatric surgery
171767|NCT02505880|Anesthesia|anesthesia
171768|NCT02505854|Obesity|obesity
171769|NCT02505854|Probiotic|probiotic
171770|NCT02505854|Symbiotic|symbiotic
171771|NCT02505854|Weight loss|weight loss
171772|NCT02505854|Gut microbiota|gut microbiota
171773|NCT02505854|Bifidobacterium lactis|bifidobacterium lactis
171774|NCT02505854|Fructooligosaccharide|fructooligosaccharide
171775|NCT02505854|Blood sugar|blood sugar
171776|NCT02505854|Lipemia|lipemia
171777|NCT02505841|Appendectomy|appendectomy
171778|NCT02505841|Laparoscopy|laparoscopy
171779|NCT02505841|pediatric surgery|pediatric surgery
171780|NCT02505828|Arthritis|arthritis
171781|NCT02505828|septic|septic
171782|NCT02505828|Juvenile idiopathic arthritis|juvenile idiopathic arthritis
171783|NCT02505828|diagnosis|diagnosis
171784|NCT02505828|proteomic|proteomic
171785|NCT02505828|cytokine|cytokine
171786|NCT02505828|monocytes|monocytes
171787|NCT02505802|Stroke|stroke
171788|NCT02505802|Botulinum Toxins|botulinum toxins
171789|NCT02505802|Muscle Spasticity|muscle spasticity
171790|NCT02505802|Gait|gait
171791|NCT02505789|Epstein-Barr Virus|epstein-barr virus
171792|NCT02505789|Post-transplant lymphoproliferative disease (PTLD)|post-transplant lymphoproliferative disease (ptld)
171793|NCT02505789|Infection|infection
171794|NCT02505789|Cell Transplants|cell transplants
171795|NCT02505789|Herpesvirus 4, Human|herpesvirus 4, human
171796|NCT02505711|Agriculture|agriculture
171797|NCT02505711|Food|food
171798|NCT02505711|Micronutrients|micronutrients
171799|NCT02505711|Pregnancy|pregnancy
171800|NCT02505711|Infants|infants
171801|NCT02505711|Women's groups|women's groups
171802|NCT02505711|Bangladesh|bangladesh
171803|NCT02505698|Breast Imaging|breast imaging
171804|NCT02505698|Mammography|mammography
171805|NCT02505698|Anatomical Imaging|anatomical imaging
171806|NCT02505685|Lung|lung
171807|NCT02505685|Cancer|cancer
171808|NCT02505685|Biomarkers|biomarkers
171809|NCT02505685|PET-CT|pet-ct
171810|NCT02505685|Early detection|early detection
171811|NCT02505672|Vestibular function|vestibular function
171812|NCT02505672|chemoradiotherapy|chemoradiotherapy
171813|NCT02505659|Anterior cruciate ligament rupture|anterior cruciate ligament rupture
171814|NCT02505659|Preoperative re-education|preoperative re-education
171815|NCT02505659|Knee functional performance|knee functional performance
171816|NCT02505659|Anterior cruciate ligament surgery|anterior cruciate ligament surgery
171817|NCT02505659|Single-leg hop for distance test performance|single-leg hop for distance test performance
171818|NCT02505646|circulatory failure|circulatory failure
171819|NCT02505646|fluid responsiveness|fluid responsiveness
171820|NCT02505646|abdominal compression|abdominal compression
171821|NCT02505633|brachial plexus block|brachial plexus block
171822|NCT02505633|nerve stimulator|nerve stimulator
171823|NCT02505633|ultrasound|ultrasound
171824|NCT02505620|Neurocognitive function|neurocognitive function
171825|NCT02505620|OSAS|osas
171826|NCT02505594|Obstructive Sleep Apnea|obstructive sleep apnea
171827|NCT02505594|Vasoreactivity|vasoreactivity
171828|NCT02505594|Endothelial function|endothelial function
171829|NCT02505594|Exercise|exercise
171830|NCT02505581|Postoperative Wound Infection|postoperative wound infection
171831|NCT02505581|Surgical Wound Infection|surgical wound infection
171832|NCT02505581|Colorectal Surgery Infection Prophylaxis|colorectal surgery infection prophylaxis
171833|NCT02505568|Behcet Disease|behcet disease
171834|NCT02505568|Infliximab|infliximab
171835|NCT02505568|Adult participants|adult participants
171836|NCT02505555|feasibility|feasibility
171837|NCT02505555|accuracy|accuracy
171838|NCT02505555|tolerability|tolerability
171839|NCT02505555|four dimensional hysterosalpingo-contrast sonography|four dimensional hysterosalpingo-contrast sonography
171840|NCT02505542|Axial Spondyloarthritis|axial spondyloarthritis
171841|NCT02505542|axSpA|axspa
171842|NCT02505542|Ankylosing Spondylitis|ankylosing spondylitis
171843|NCT02505542|Anti TNF-alpha|anti tnf-alpha
171844|NCT02505542|Certolizumab Pegol|certolizumab pegol
171845|NCT02505542|Remission|remission
171846|NCT02505542|Spondylarthropathies|spondylarthropathies
171847|NCT02505542|Arthritis|arthritis
171848|NCT02505542|Spinal Diseases|spinal diseases
171849|NCT02505542|Immunosuppressive Agents|immunosuppressive agents
171850|NCT02505529|Aging|aging
171851|NCT02505529|Muscle|muscle
171852|NCT02505529|Weakness|weakness
171853|NCT02505529|Sarcopenia|sarcopenia
171854|NCT02505529|Dynapenia|dynapenia
171855|NCT02505516|pathology|pathology
171856|NCT02505503|Claudication|claudication
171857|NCT02505503|Footwear|footwear
171858|NCT02505503|Shoes|shoes
171859|NCT02505503|Walking capacity|walking capacity
171860|NCT02505503|Walking distance|walking distance
171861|NCT02505490|Lunch|lunch
171862|NCT02505490|Television|television
171863|NCT02505490|Macaroni and Cheese|macaroni and cheese
171864|NCT02505490|Salad tossed in dressing|salad tossed in dressing
171865|NCT02505477|schiozphrenia|schiozphrenia
171866|NCT02505477|cognition|cognition
171867|NCT02505477|negative symptoms|negative symptoms
171868|NCT02505477|glutamate|glutamate
171869|NCT02505477|glutathione|glutathione
171870|NCT02505477|N-acetylcysteine|n-acetylcysteine
171871|NCT02505451|Metabolic syndrome|metabolic syndrome
171872|NCT02505451|diabetes|diabetes
171873|NCT02505451|myocardial function|myocardial function
171874|NCT02505451|dobutamine|dobutamine
171875|NCT02505399|Rotational Atherectomy|rotational atherectomy
171876|NCT02505399|clopidogrel|clopidogrel
171877|NCT02505399|thrombosis|thrombosis
171878|NCT02505399|ticagrelor|ticagrelor
171879|NCT02505386|Ertapenem|ertapenem
171880|NCT02505386|Subcutaneously|subcutaneously
171881|NCT02505386|Aged|aged
171882|NCT02505386|Elderly|elderly
171883|NCT02505386|Pharmacokinetics|pharmacokinetics
171884|NCT02505373|Brief Therapy|brief therapy
171885|NCT02505373|Attempted Suicide|attempted suicide
171886|NCT02505373|Therapeutic Alliance|therapeutic alliance
171887|NCT02505373|Suicidal Ideation|suicidal ideation
171888|NCT02505373|Suicide|suicide
171889|NCT02505373|ASSIP|assip
171890|NCT02505321|insulin resistance|insulin resistance
171891|NCT02505321|physiology|physiology
171892|NCT02505321|genetics|genetics
171893|NCT02505321|gene variants|gene variants
171894|NCT02505321|pathogenesis|pathogenesis
171895|NCT02505321|type 2 diabetes|type 2 diabetes
171896|NCT02505321|fat|fat
171897|NCT02505321|polygenic lipodystrophy|polygenic lipodystrophy
171898|NCT02505308|insulin|insulin
171899|NCT02505308|proinsulin|proinsulin
171900|NCT02505308|genotype|genotype
171901|NCT02505308|beta cells|beta cells
171902|NCT02505308|physiology|physiology
171903|NCT02505308|genetics|genetics
171904|NCT02505308|pathogenesis|pathogenesis
171905|NCT02505308|rare variants|rare variants
171906|NCT02505308|type 2 diabetes|type 2 diabetes
171907|NCT02505282|Orthostatic hypotension|orthostatic hypotension
171908|NCT02505282|Vitamin K|vitamin k
171909|NCT02505269|limited stage|limited stage
171910|NCT02505269|Hodgkin's disease|hodgkin's disease
171911|NCT02505269|non-bulky|non-bulky
171912|NCT02505243|ribavirin|ribavirin
171913|NCT02505243|direct-acting antivirals|direct-acting antivirals
171914|NCT02505243|pharmacokinetics|pharmacokinetics
171915|NCT02505243|therapeutic drug monitoring|therapeutic drug monitoring
171916|NCT02505217|platelet reactivity, thrombin generation|platelet reactivity, thrombin generation
171917|NCT02505204|clonidine|clonidine
171918|NCT02505204|paravertebral block|paravertebral block
171919|NCT02505204|hemodynamic stability|hemodynamic stability
171920|NCT02505191|Pharmacokinetics|pharmacokinetics
171921|NCT02505178|Depression|depression
171922|NCT02505178|Depressive Disorder|depressive disorder
171923|NCT02505178|Depressive Disorder, Major|depressive disorder, major
171924|NCT02505178|Mental Disorders|mental disorders
171925|NCT02505178|Mood Disorders|mood disorders
171926|NCT02505178|Behavioural Symptoms|behavioural symptoms
171927|NCT02505178|Problem Solving Therapy|problem solving therapy
171928|NCT02505165|Intervention|intervention
171929|NCT02505165|Illness Uncertainty|illness uncertainty
171930|NCT02505165|Childhood Cancer|childhood cancer
171931|NCT02505165|Solid Tumor|solid tumor
171932|NCT02505165|Leukemia|leukemia
171933|NCT02505165|Lymphoma|lymphoma
171934|NCT02505165|Brain Tumor|brain tumor
171935|NCT02505165|Randomized clinical trial|randomized clinical trial
171936|NCT02505165|Parental uncertainty management intervention|parental uncertainty management intervention
171937|NCT02505165|Parent|parent
171938|NCT02505165|Oncology|oncology
171939|NCT02505165|Pediatric|pediatric
171940|NCT02505152|Hypertension, Portal|hypertension, portal
171941|NCT02505152|Portal Vein, Cavernous Transformation Of|portal vein, cavernous transformation of
171942|NCT02505152|Portosystemic shunt|portosystemic shunt
171943|NCT02505152|Radiology, Interventional|radiology, interventional
171944|NCT02505139|nasopharyngeal carcinoma|nasopharyngeal carcinoma
171945|NCT02505139|distant metastasis|distant metastasis
171946|NCT02505139|circulating tumor cells|circulating tumor cells
171947|NCT02505139|outcome prediction|outcome prediction
171948|NCT02505113|Portal Vein, Cavernous Transformation Of|portal vein, cavernous transformation of
171949|NCT02505113|Hypertension, Portal|hypertension, portal
171950|NCT02505100|threat of premature birth|threat of premature birth
171951|NCT02505087|Selenoprotein N-related myopathy|selenoprotein n-related myopathy
171952|NCT02505087|biomarkers|biomarkers
171953|NCT02505087|washout|washout
171954|NCT02505087|N-ACETYLCYSTEINE|n-acetylcysteine
171955|NCT02505074|mitral valve|mitral valve
171956|NCT02505074|tricuspid valve|tricuspid valve
171957|NCT02505074|Melody valve|melody valve
171958|NCT02505035|Palliative care|palliative care
171959|NCT02505035|Pragmatic trial|pragmatic trial
171960|NCT02505022|Cognition|cognition
171961|NCT02505022|Early mental illness|early mental illness
171962|NCT02505022|Role functioning|role functioning
171963|NCT02505009|Therapeutic Uses|therapeutic uses
171964|NCT02505009|Entecavir|entecavir
171965|NCT02505009|Tenofovir|tenofovir
171966|NCT02505009|Engerix-B|engerix-b
171967|NCT02505009|DNA Virus Infections|dna virus infections
171968|NCT02505009|Antiviral Agents|antiviral agents
171969|NCT02505009|Vaccination|vaccination
171970|NCT02504996|sciatalgia|sciatalgia
171971|NCT02504996|emergency department|emergency department
171972|NCT02504996|paracetamol|paracetamol
171973|NCT02504996|morphine|morphine
171974|NCT02504983|SNPs|snps
171975|NCT02504970|Anesthesia|anesthesia
171976|NCT02504970|Quality Improvement|quality improvement
171977|NCT02504957|Photodynamic therapy|photodynamic therapy
171978|NCT02504944|Retinopathy of prematurity|retinopathy of prematurity
171979|NCT02504944|Propranolol|propranolol
171980|NCT02504944|Newborn|newborn
171981|NCT02504944|Eye Drops|eye drops
171982|NCT02504944|Retinal angiogenesis|retinal angiogenesis
171983|NCT02504944|Retinal neovascularization|retinal neovascularization
171984|NCT02504931|PTSD|ptsd
171985|NCT02504931|Alcohol|alcohol
171986|NCT02504931|Dual Diagnosis|dual diagnosis
171987|NCT02504931|Sertraline|sertraline
171988|NCT02504931|SSRI|ssri
171989|NCT02504918|Plasmodium Falciparum|plasmodium falciparum
171990|NCT02504918|Regulatory|regulatory
171991|NCT02504918|Chemoprevention|chemoprevention
171992|NCT02504918|Coartem|coartem
171993|NCT02504918|Parasitemia|parasitemia
171994|NCT02504905|Parietal Lobe|parietal lobe
171995|NCT02504905|Plasticity|plasticity
171996|NCT02504905|Cerebellum|cerebellum
171997|NCT02504905|Dystonia|dystonia
171998|NCT02504905|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
171999|NCT02504892|Overall Response Rate|overall response rate
172000|NCT02504892|Hereditary Cancer Syndrome|hereditary cancer syndrome
172001|NCT02504892|mTOR Therapy Naive|mtor therapy naive
172002|NCT02504879|Osteosclerosis|osteosclerosis
172003|NCT02504879|Hyperostosis|hyperostosis
172101|NCT02504216|Rivaroxaban|rivaroxaban
172004|NCT02504866|Aerobic Exercise Training|aerobic exercise training
172005|NCT02504866|Balance|balance
172007|NCT02504853|Eosinophilic Esophagitis|eosinophilic esophagitis
172008|NCT02504853|Loeys-Dietz Syndrome|loeys-dietz syndrome
172009|NCT02504853|TGFbeta|tgfbeta
172010|NCT02504840|Multiple Sclerosis|multiple sclerosis
172011|NCT02504840|Clinically Isolated Syndrome|clinically isolated syndrome
172012|NCT02504840|CNS Inflammatory Demyellnation|cns inflammatory demyellnation
172013|NCT02504840|Radiologically Isolated Syndrome|radiologically isolated syndrome
172014|NCT02504827|pharmacokinetics|pharmacokinetics
172015|NCT02504827|ceftazidime/avibactam|ceftazidime/avibactam
172016|NCT02504814|nasal high flow|nasal high flow
172017|NCT02504801|primary lung cancer patients|primary lung cancer patients
172018|NCT02504788|Whole Brain Radiotherapy (WBRT)|whole brain radiotherapy (wbrt)
172019|NCT02504788|Neurocognitive Functions (NCFs)|neurocognitive functions (ncfs)
172020|NCT02504788|Hippocampus|hippocampus
172021|NCT02504788|Hippocampus Sparing during Whole Brain Radiotherapy (HS-WBRT)|hippocampus sparing during whole brain radiotherapy (hs-wbrt)
172022|NCT02504749|GIT motility|git motility
172023|NCT02504749|General anaesthesia|general anaesthesia
172024|NCT02504749|spinal anaesthesia|spinal anaesthesia
172025|NCT02504736|LDL cholesterol|ldl cholesterol
172026|NCT02504736|A1c|a1c
172027|NCT02504736|High risk South Asians|high risk south asians
172028|NCT02504736|Colesevelam|colesevelam
172029|NCT02504723|Gastric varices|gastric varices
172030|NCT02504723|cyanoacrylate|cyanoacrylate
172031|NCT02504723|carvedilol|carvedilol
172032|NCT02504710|Musculoskeletal Manipulations|musculoskeletal manipulations
172033|NCT02504710|Learning|learning
172034|NCT02504710|Feedback|feedback
172035|NCT02504710|Kinematics|kinematics
172036|NCT02504710|Inertial Sensor|inertial sensor
172037|NCT02504684|varicose veins|varicose veins
172038|NCT02504684|endovenous laser treatment|endovenous laser treatment
172039|NCT02504684|endovenous thermal ablation|endovenous thermal ablation
172040|NCT02504684|saphenous vein|saphenous vein
172041|NCT02504671|DMARD-IR|dmard-ir
172042|NCT02504671|GSK3196165|gsk3196165
172043|NCT02504671|Rheumatoid Arthritis|rheumatoid arthritis
172044|NCT02504658|adolescents text messages eating exercise self-efficacy diabetes|adolescents text messages eating exercise self-efficacy diabetes
172045|NCT02504632|platelet activation|platelet activation
172046|NCT02504632|transcatheter aortic valve implantation|transcatheter aortic valve implantation
172047|NCT02504593|Quality Assurance|quality assurance
172048|NCT02504593|Monitoring & Evaluation|monitoring & evaluation
172049|NCT02504593|Malaria rapid diagnostic test (RDT)|malaria rapid diagnostic test (rdt)
172050|NCT02504593|Community-based malaria diagnosis|community-based malaria diagnosis
172051|NCT02504593|Community health workers|community health workers
172052|NCT02504567|Catheter Ablation|catheter ablation
172053|NCT02504567|Radiofrequency|radiofrequency
172054|NCT02504567|Laser|laser
172055|NCT02504567|Atrial Fibrillation|atrial fibrillation
172056|NCT02504554|children|children
172057|NCT02504541|Hypogonadism|hypogonadism
172058|NCT02504541|Testosterone enanthate|testosterone enanthate
172059|NCT02504528|asthma|asthma
172060|NCT02504528|allergy|allergy
172061|NCT02504528|bronchial hyperresponsiveness|bronchial hyperresponsiveness
172062|NCT02504528|provocation|provocation
172063|NCT02504502|Whole Genome Sequencing|whole genome sequencing
172064|NCT02504502|Laboratory Report|laboratory report
172065|NCT02504502|Patient Centered|patient centered
172066|NCT02504502|Communication of Results|communication of results
172067|NCT02504502|Patient Provider Communication|patient provider communication
172068|NCT02504476|Schizophrenia or Schizoaffective Disorder|schizophrenia or schizoaffective disorder
172069|NCT02504463|Alkermes|alkermes
172070|NCT02504463|Samidorphan|samidorphan
172071|NCT02504463|ALKS 33|alks 33
172072|NCT02504463|Healthy Volunteer|healthy volunteer
172073|NCT02504463|Pharmacokinetics|pharmacokinetics
172074|NCT02504450|Bipolar 1 disorder|bipolar 1 disorder
172075|NCT02504450|schizophrenia|schizophrenia
172076|NCT02504424|Tissue Expansion|tissue expansion
172077|NCT02504424|Tissue Expander|tissue expander
172078|NCT02504424|Breast Tissue Expansion|breast tissue expansion
172079|NCT02504424|Breast Tissue Expander|breast tissue expander
172080|NCT02504424|Breast Reconstruction|breast reconstruction
172081|NCT02504424|2 Stage Breast Reconstruction|2 stage breast reconstruction
172082|NCT02504372|NSCLC|nsclc
172083|NCT02504372|PDL1|pdl1
172084|NCT02504372|PD-L1|pd-l1
172085|NCT02504372|PDL|pdl
172086|NCT02504359|BEAM|beam
172087|NCT02504359|allogeneic|allogeneic
172088|NCT02504359|myeloma|myeloma
172089|NCT02504359|ixazomib|ixazomib
172090|NCT02504359|transplant|transplant
172091|NCT02504359|plasma cell leukemia|plasma cell leukemia
172092|NCT02504333|metastatic pancreatic adenocarcinoma|metastatic pancreatic adenocarcinoma
172093|NCT02504333|Nab-paclitaxel|nab-paclitaxel
172094|NCT02504333|Gemcitabine|gemcitabine
172095|NCT02504333|modified FOLFOX|modified folfox
172096|NCT02504320|Drug therapy|drug therapy
172097|NCT02504255|Crohn disease|crohn disease
172098|NCT02504255|inflammatory biomarkers|inflammatory biomarkers
172099|NCT02504255|immunologic markers|immunologic markers
172100|NCT02504255|calprotectin|calprotectin
172102|NCT02504216|Xarelto|xarelto
172103|NCT02504216|Aspirin|aspirin
172104|NCT02504216|Acetylic salicylic acid|acetylic salicylic acid
172105|NCT02504216|Anticoagulant|anticoagulant
172106|NCT02504216|Peripheral artery disease|peripheral artery disease
172107|NCT02504216|Peripheral arterial disease|peripheral arterial disease
172108|NCT02504216|Revascularization|revascularization
172109|NCT02504216|Acute limb ischemia|acute limb ischemia
172110|NCT02504216|Amputation|amputation
172111|NCT02504216|Cardiovascular events|cardiovascular events
172112|NCT02504190|Lymphoma|lymphoma
172113|NCT02504190|TEAM conditioning|team conditioning
172114|NCT02504190|autologous stem cells transplantation|autologous stem cells transplantation
172115|NCT02504164|midazolam|midazolam
172116|NCT02504164|satisfaction|satisfaction
172117|NCT02504164|endoscopic submucosal dissection|endoscopic submucosal dissection
172118|NCT02504099|Chronic Hepatitis C Infection|chronic hepatitis c infection
172119|NCT02504099|Early Stage Hepatocellular Carcinoma|early stage hepatocellular carcinoma
172120|NCT02504073|Clinical Reasoning|clinical reasoning
172121|NCT02504073|Physiotherapists|physiotherapists
172122|NCT02504060|diarrhea|diarrhea
172123|NCT02504060|abdominal pain|abdominal pain
172124|NCT02504047|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
172125|NCT02504034|Portal Vein, Cavernous Transformation Of|portal vein, cavernous transformation of
172126|NCT02504034|Hypertension, Portal|hypertension, portal
172127|NCT02504034|Radiology, Interventional|radiology, interventional
172128|NCT02504034|Portalsystemic shunt|portalsystemic shunt
172129|NCT02504008|bisphosphonate|bisphosphonate
172130|NCT02504008|CRPS|crps
172131|NCT02504008|RSD|rsd
172132|NCT02504008|non-opioid|non-opioid
172133|NCT02504008|CRPS-1|crps-1
172134|NCT02504008|acute on chronic pain|acute on chronic pain
172135|NCT02504008|chronic pain|chronic pain
172136|NCT02504008|zoledronic acid|zoledronic acid
172137|NCT02503969|Colorectal Cancer|colorectal cancer
172138|NCT02503969|Mass Screening|mass screening
172139|NCT02503969|Uptake|uptake
172140|NCT02503969|Morbidity|morbidity
172141|NCT02503969|Mental Health|mental health
172142|NCT02503943|GLP-1|glp-1
172143|NCT02503943|Masked hypertension|masked hypertension
172144|NCT02503943|Lipid metabolism|lipid metabolism
172145|NCT02503917|Imaging, Ultrasound|imaging, ultrasound
172146|NCT02503917|Image-guided radiotherapy|image-guided radiotherapy
172147|NCT02503917|Cancer|cancer
172148|NCT02503904|Pharmacology|pharmacology
172149|NCT02503904|Lidocaine|lidocaine
172150|NCT02503904|Epinephrine|epinephrine
172151|NCT02503904|Cefazolin|cefazolin
172152|NCT02503904|Metronidazole|metronidazole
172153|NCT02503904|Infection|infection
172154|NCT02503904|prevention|prevention
172155|NCT02503904|prophylaxis|prophylaxis
172156|NCT02503904|SSI|ssi
172157|NCT02503904|Surgery|surgery
172158|NCT02503904|Complications|complications
172159|NCT02503865|Metabolic syndrome|metabolic syndrome
172160|NCT02503865|Diabetes mellitus,|diabetes mellitus,
172161|NCT02503865|Hypertension|hypertension
172162|NCT02503865|Overweight|overweight
172163|NCT02503865|analimentary detoxication|analimentary detoxication
172164|NCT02503852|Female Pattern Baldness|female pattern baldness
172165|NCT02503852|Male Pattern Baldness|male pattern baldness
172166|NCT02503852|Genetic Alopecia|genetic alopecia
172167|NCT02503852|Androgenic Alopecia|androgenic alopecia
172168|NCT02503852|Hair Loss|hair loss
172169|NCT02503839|Host-modulating therapy|host-modulating therapy
172170|NCT02503839|Vaccine|vaccine
172171|NCT02503839|Cyclooxygenase inhibitors|cyclooxygenase inhibitors
172172|NCT02503813|brain death|brain death
172173|NCT02503813|apnea challenge test|apnea challenge test
172174|NCT02503787|chronic pain|chronic pain
172175|NCT02503787|intractable pain|intractable pain
172176|NCT02503787|failed back surgery syndrome|failed back surgery syndrome
172177|NCT02503774|Solid Tumours, MEDI9447, MEDI4736, durvalumab, CD73, PD-L1, EGFRm NSCLC|solid tumours, medi9447, medi4736, durvalumab, cd73, pd-l1, egfrm nsclc
172178|NCT02503761|meropenem|meropenem
172179|NCT02503761|infusion|infusion
172180|NCT02503761|late-onset sepsis|late-onset sepsis
172181|NCT02503761|newborn|newborn
172182|NCT02503761|management|management
172183|NCT02503735|CKD|ckd
172184|NCT02503735|HCV|hcv
172185|NCT02503696|Inflammatory Bowel Disease|inflammatory bowel disease
172186|NCT02503696|Cancer|cancer
172187|NCT02503696|Colorectal Cancer|colorectal cancer
172188|NCT02503696|Neoplasm|neoplasm
172189|NCT02503696|Colorectal Neoplasm|colorectal neoplasm
172190|NCT02503696|Intestinal Neoplasms|intestinal neoplasms
172191|NCT02503696|Gastrointestinal Neoplasms|gastrointestinal neoplasms
172192|NCT02503696|Digestive System Neoplasms|digestive system neoplasms
172193|NCT02503696|Neoplasms by Site|neoplasms by site
172194|NCT02503696|Neoplasms|neoplasms
172195|NCT02503696|Digestive System Diseases|digestive system diseases
172196|NCT02503696|Gastrointestinal Diseases|gastrointestinal diseases
172197|NCT02503696|Colonic Diseases|colonic diseases
172198|NCT02503696|Intestinal Diseases|intestinal diseases
172199|NCT02503696|Rectal Diseases|rectal diseases
172200|NCT02503683|RNAi therapeutic|rnai therapeutic
172201|NCT02503683|AAT|aat
172202|NCT02503683|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
172203|NCT02503657|tipelukast|tipelukast
172204|NCT02503657|IPF|ipf
172205|NCT02503657|fibrosis|fibrosis
172206|NCT02503657|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
172207|NCT02503644|diffuse cutaneous systemic sclerosis|diffuse cutaneous systemic sclerosis
172208|NCT02503644|scleroderma|scleroderma
172209|NCT02503644|IVA337|iva337
172210|NCT02503644|dcSSc|dcssc
172211|NCT02503631|Cancer|cancer
172212|NCT02503631|Colorectal Cancer|colorectal cancer
172213|NCT02503631|Neoplasm|neoplasm
172214|NCT02503631|Colorectal Neoplasm|colorectal neoplasm
172215|NCT02503631|Intestinal Neoplasms|intestinal neoplasms
172216|NCT02503631|Gastrointestinal Neoplasms|gastrointestinal neoplasms
172217|NCT02503631|Digestive System Neoplasms|digestive system neoplasms
172218|NCT02503631|Neoplasms by Site|neoplasms by site
172219|NCT02503631|Neoplasms|neoplasms
172220|NCT02503631|Digestive System Diseases|digestive system diseases
172221|NCT02503631|Gastrointestinal Diseases|gastrointestinal diseases
172222|NCT02503631|Colonic Diseases|colonic diseases
172223|NCT02503631|Intestinal Diseases|intestinal diseases
172224|NCT02503631|Rectal Diseases|rectal diseases
172225|NCT02503605|Biosimilar|biosimilar
172226|NCT02503605|ovarian stimulation|ovarian stimulation
172227|NCT02503605|oocyte donor|oocyte donor
172228|NCT02503579|Brain-derived neurotropic factor|brain-derived neurotropic factor
172229|NCT02503579|Executive function|executive function
172230|NCT02503566|CAV|cav
172231|NCT02503566|OCT|oct
172232|NCT02503566|heart rate|heart rate
172233|NCT02503566|antibodies|antibodies
172234|NCT02503553|option grid|option grid
172235|NCT02503553|neurosurgery|neurosurgery
172236|NCT02503553|cerebral aneurysm|cerebral aneurysm
172237|NCT02503540|macular edema|macular edema
172239|NCT02503540|diabetic macular edema|diabetic macular edema
172240|NCT02503527|Enteral nutrition|enteral nutrition
172241|NCT02503527|Tube feeding|tube feeding
172242|NCT02503527|Diet, carbohydrate-restricted|diet, carbohydrate-restricted
172243|NCT02503527|Diabetes|diabetes
172244|NCT02503527|Aneurysmal Subarachnoid Hemorrhage|aneurysmal subarachnoid hemorrhage
172245|NCT02503527|Blood glucose|blood glucose
172246|NCT02503527|Insulin|insulin
172247|NCT02503501|Memory|memory
172248|NCT02503501|Insulin glulisine|insulin glulisine
172249|NCT02503501|Alzheimer's disease|alzheimer's disease
172250|NCT02503501|Mild Cognitive Impairment|mild cognitive impairment
172251|NCT02503501|Intranasal insulin|intranasal insulin
172252|NCT02503501|Cognition Disorders|cognition disorders
172253|NCT02503488|Appetitive Aggression|appetitive aggression
172254|NCT02503462|HIV|hiv
172255|NCT02503462|darunavir|darunavir
172256|NCT02503462|ritonavir|ritonavir
172257|NCT02503462|cobicistat|cobicistat
172258|NCT02503462|CSF|csf
172259|NCT02503462|pharmacokinetics|pharmacokinetics
172260|NCT02503449|Pulmonary Cryptococcosis|pulmonary cryptococcosis
172261|NCT02503436|Ovarian Cancer, Fallopian Tube Cancer, primary peritoneal cancer, BRCA1 Gene, BRCA2 Gene|ovarian cancer, fallopian tube cancer, primary peritoneal cancer, brca1 gene, brca2 gene
172262|NCT02503423|cervical cancer|cervical cancer
172263|NCT02503423|HNSCC|hnscc
172264|NCT02503423|CTCL|ctcl
172265|NCT02503423|PTCL|ptcl
172266|NCT02503423|DLBCL|dlbcl
172267|NCT02503410|back|back
172268|NCT02503410|pain|pain
172269|NCT02503345|Kidney Stones|kidney stones
172270|NCT02503345|Nephrolithiasis|nephrolithiasis
172271|NCT02503345|Urine Oxalate|urine oxalate
172272|NCT02503345|Hyperoxaluria|hyperoxaluria
172273|NCT02503345|Enteric Hyperoxaluria|enteric hyperoxaluria
172274|NCT02503345|Idiopathic Hyperoxaluria|idiopathic hyperoxaluria
172275|NCT02503345|Urological Diseases|urological diseases
172276|NCT02503345|Kidney Diseases|kidney diseases
172277|NCT02503345|Dietary Oxalate|dietary oxalate
172278|NCT02503280|Cardiovascular|cardiovascular
172279|NCT02503280|Secondary|secondary
172280|NCT02503267|antithrombin III deficiency|antithrombin iii deficiency
172281|NCT02503267|congenital heart diseases|congenital heart diseases
172282|NCT02503254|Smoking|smoking
172283|NCT02503254|Modified risk tobacco product|modified risk tobacco product
172284|NCT02503254|Conventional cigarette|conventional cigarette
172285|NCT02503254|Reduced exposure|reduced exposure
172286|NCT02503254|Confinement|confinement
172287|NCT02503254|Carbon Heated Tobacco Product|carbon heated tobacco product
172288|NCT02503215|Hemodialysis|hemodialysis
172289|NCT02503215|Obstructive sleep apnea|obstructive sleep apnea
172290|NCT02503215|Compression stockings|compression stockings
172291|NCT02503189|Dry eye syndromes|dry eye syndromes
172292|NCT02503189|Corneal diseases|corneal diseases
172293|NCT02503189|Conjunctival diseases|conjunctival diseases
172294|NCT02503176|Dry eye syndromes|dry eye syndromes
172295|NCT02503176|Corneal diseases|corneal diseases
172296|NCT02503176|Conjunctival diseases|conjunctival diseases
172297|NCT02503163|Dry eye syndromes|dry eye syndromes
172298|NCT02503163|Corneal diseases|corneal diseases
172299|NCT02503163|Conjunctival diseases|conjunctival diseases
172300|NCT02503150|Colorectal Cancer|colorectal cancer
172301|NCT02503150|Tumor Therapeutic Vaccine|tumor therapeutic vaccine
172302|NCT02503150|Dendritic Cell|dendritic cell
172303|NCT02503137|male pattern baldness|male pattern baldness
172304|NCT02503137|SM04554|sm04554
172305|NCT02503137|AGA|aga
172306|NCT02503111|Men who have sex with men|men who have sex with men
172307|NCT02503111|Human immunodeficiency virus|human immunodeficiency virus
172308|NCT02503111|Human papillomavirus|human papillomavirus
172309|NCT02503111|Anal intraepithelial neoplasia|anal intraepithelial neoplasia
172310|NCT02503111|Squamous cell carcinoma|squamous cell carcinoma
172311|NCT02503111|High-resolution anoscopy|high-resolution anoscopy
172312|NCT02503111|Anal cancer|anal cancer
172313|NCT02503111|High-risk oncogenic|high-risk oncogenic
172314|NCT02503111|Intraepithelial lesion|intraepithelial lesion
172315|NCT02503111|Low-risk non-oncogenic|low-risk non-oncogenic
172316|NCT02503111|Dysplasia|dysplasia
172317|NCT02503111|High-grade squamous intraepithelial lesion|high-grade squamous intraepithelial lesion
172318|NCT02503111|Low-grade squamous intraepithelial lesion|low-grade squamous intraepithelial lesion
172319|NCT02503111|Ablative therapy|ablative therapy
172320|NCT02503111|Electrocautery|electrocautery
172321|NCT02503111|Infrared coagulation|infrared coagulation
172322|NCT02503111|Active surveillance|active surveillance
172323|NCT02503098|Eating Disorders|eating disorders
172324|NCT02503098|Cognitive Behavioral Therapy|cognitive behavioral therapy
172325|NCT02503098|Mobile Phone|mobile phone
172326|NCT02503098|Smartphone|smartphone
172327|NCT02503098|App|app
172328|NCT02503098|Binge Eating Disorder|binge eating disorder
172329|NCT02503098|Bulimia Nervosa|bulimia nervosa
172330|NCT02503098|Signal Detection Analysis|signal detection analysis
172331|NCT02503085|Ibuprofen|ibuprofen
172332|NCT02503072|ARV adherence|arv adherence
172333|NCT02503020|Arachidonic acid|arachidonic acid
172334|NCT02503020|Omega-6/omega-3 ratio|omega-6/omega-3 ratio
172335|NCT02503020|Preterm infants nutrition|preterm infants nutrition
172336|NCT02502981|CKD|ckd
172337|NCT02502981|left ventricle|left ventricle
172338|NCT02502981|aldosterone|aldosterone
172339|NCT02502981|spironolactone|spironolactone
172340|NCT02502955|Quality Control|quality control
172341|NCT02502955|Cardiosurgery|cardiosurgery
172342|NCT02502955|Cardiology|cardiology
172343|NCT02502955|Vascular Surgery|vascular surgery
172344|NCT02502955|ICU|icu
172345|NCT02502942|Obstructive Sleep Apnea|obstructive sleep apnea
172346|NCT02502942|Exercise|exercise
172347|NCT02502942|Upper airway muscle|upper airway muscle
172348|NCT02502929|Diabetes|diabetes
172349|NCT02502929|Depression|depression
172350|NCT02502929|Medication therapy management|medication therapy management
172351|NCT02502929|Community health workers|community health workers
172352|NCT02502929|Cambodian|cambodian
172353|NCT02502929|Refugee|refugee
172354|NCT02502929|Prevention|prevention
172355|NCT02502890|asthma|asthma
172356|NCT02502890|nested case-control study|nested case-control study
172357|NCT02502890|difficult-to-control asthma|difficult-to-control asthma
172358|NCT02502890|asthma exacerbations|asthma exacerbations
172359|NCT02502890|cold symptoms|cold symptoms
172360|NCT02502890|gene expression|gene expression
172361|NCT02502838|overactive bladder|overactive bladder
172362|NCT02502838|pelvic organ prolapse|pelvic organ prolapse
172363|NCT02502838|TVT|tvt
172364|NCT02502812|bioequivalence|bioequivalence
172365|NCT02502812|SB224326|sb224326
172366|NCT02502812|clopidogrel|clopidogrel
172367|NCT02502812|Relative bioavailability|relative bioavailability
172368|NCT02502786|Humanized Monoclonal Antibody 3F8 (Hu3F8)|humanized monoclonal antibody 3f8 (hu3f8)
172369|NCT02502786|Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF)|granulocyte-macrophage colony stimulating factor (gm-csf)
172370|NCT02502786|15-096|15-096
172371|NCT02502773|Goal-directed therapy|goal-directed therapy
172372|NCT02502773|Fluid loading|fluid loading
172373|NCT02502773|Abdominal surgery|abdominal surgery
172374|NCT02502773|Postoperative morbidity|postoperative morbidity
172375|NCT02502773|Postoperative mortality|postoperative mortality
172376|NCT02502773|Individualized goal-directed fluid therapy|individualized goal-directed fluid therapy
172377|NCT02502773|Elective or emergency abdominal surgery|elective or emergency abdominal surgery
172378|NCT02502773|General Anesthesia|general anesthesia
172379|NCT02502773|Moderate-to-high risk surgical patients|moderate-to-high risk surgical patients
172380|NCT02502760|Postoperative Complications|postoperative complications
172381|NCT02502760|Perioperative Care|perioperative care
172382|NCT02502760|Colorectal Surgery|colorectal surgery
172383|NCT02502760|Frail Elderly|frail elderly
172384|NCT02502734|inhaled corticosteroids|inhaled corticosteroids
172385|NCT02502734|pediatric subjects|pediatric subjects
172386|NCT02502734|asthma|asthma
172387|NCT02502734|fluticasone furoate|fluticasone furoate
172388|NCT02502721|Male|male
172389|NCT02502708|glioblastoma multiforme|glioblastoma multiforme
172390|NCT02502708|glioma|glioma
172391|NCT02502708|gliosarcoma|gliosarcoma
172392|NCT02502708|malignant brain tumor|malignant brain tumor
172393|NCT02502708|ependymoma|ependymoma
172394|NCT02502708|medulloblastoma|medulloblastoma
172395|NCT02502695|VATS Lobectomy and Segmentectomy for Lung Cancer|vats lobectomy and segmentectomy for lung cancer
172396|NCT02502695|Lung Cancer|lung cancer
172397|NCT02502682|Chlorhexidine bathing|chlorhexidine bathing
172398|NCT02502669|acne|acne
172399|NCT02502669|nodulocystic|nodulocystic
172400|NCT02502669|finasteride|finasteride
172401|NCT02502669|5 alpha reductase inhibitor|5 alpha reductase inhibitor
172402|NCT02502656|RAS mutation|ras mutation
172403|NCT02502656|DNA|dna
172404|NCT02502656|Colorectal Cancer|colorectal cancer
172405|NCT02502643|Safety and Efficacy|safety and efficacy
172406|NCT02502643|Thoracic Surgery|thoracic surgery
172407|NCT02502617|Psychopathology|psychopathology
172408|NCT02502617|Cognition|cognition
172409|NCT02502617|Depression|depression
172410|NCT02502617|Nutrition|nutrition
172411|NCT02502617|Cortisol|cortisol
172412|NCT02502617|Anorexia nervosa|anorexia nervosa
172413|NCT02502604|Cognitive Remediation|cognitive remediation
172414|NCT02502604|Goal Management Training|goal management training
172415|NCT02502604|Major Depressive Disorder|major depressive disorder
172416|NCT02502604|Post-traumatic Stress Disorder|post-traumatic stress disorder
172417|NCT02502604|Neuropsychological Functioning|neuropsychological functioning
172418|NCT02502578|Triglyceride Deposit Cardiomyovasculopathy|triglyceride deposit cardiomyovasculopathy
172419|NCT02502552|Crohn's Disease|crohn's disease
172420|NCT02502552|Ulcerative Colitis|ulcerative colitis
172421|NCT02502552|Inflammatory Bowel Disease|inflammatory bowel disease
172422|NCT02502552|anti-glycan antibodies|anti-glycan antibodies
172423|NCT02502552|antibodies stability|antibodies stability
172424|NCT02502552|mucosal healing|mucosal healing
172425|NCT02502552|predictive markers|predictive markers
172426|NCT02502539|Juvenile idiopathic arthritis|juvenile idiopathic arthritis
172427|NCT02502539|Physical exercise|physical exercise
172428|NCT02502539|Pro-anti-inflammatory balance|pro-anti-inflammatory balance
172429|NCT02502539|Interleukins|interleukins
172430|NCT02502539|miRNA|mirna
172431|NCT02502539|Calgranulins|calgranulins
172432|NCT02502487|Analgesia|analgesia
172433|NCT02502487|Cystoscopy|cystoscopy
172434|NCT02502487|Dorsal nerve of penis|dorsal nerve of penis
172435|NCT02502487|Nerve block|nerve block
172436|NCT02502487|Ropivacaine|ropivacaine
172437|NCT02502474|staphylococcus aureus|staphylococcus aureus
172438|NCT02502474|digestive carriage|digestive carriage
172439|NCT02502474|mucosal colonization|mucosal colonization
172440|NCT02502448|rotational thromboelastometry|rotational thromboelastometry
172441|NCT02502448|cardiac surgery|cardiac surgery
172442|NCT02502448|acute normovolemic hemodilution|acute normovolemic hemodilution
172443|NCT02502422|Laryngeal mask airway|laryngeal mask airway
172444|NCT02502409|Hemophilia B|hemophilia b
172445|NCT02502409|Hemophilia B with Inhibitors|hemophilia b with inhibitors
172446|NCT02502396|Cancer|cancer
172447|NCT02502396|Deep-vein thrombosis of the lower and upper extremities|deep-vein thrombosis of the lower and upper extremities
172448|NCT02502396|Pulmonary embolism|pulmonary embolism
172449|NCT02502396|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
172450|NCT02502396|Chart review|chart review
172451|NCT02502396|VTE|vte
172452|NCT02502396|NVAF|nvaf
172453|NCT02502396|Rivaroxaban|rivaroxaban
172454|NCT02502383|Adolescent|adolescent
172455|NCT02502383|Overweight|overweight
172456|NCT02502383|Obesity|obesity
172457|NCT02502383|Weight loss|weight loss
172458|NCT02502383|Nutrition|nutrition
172459|NCT02502383|Physical Activity|physical activity
172460|NCT02502383|School-based|school-based
172461|NCT02502383|Primary care|primary care
172462|NCT02502383|Motivational Interviewing|motivational interviewing
172463|NCT02502357|pain control|pain control
172464|NCT02502357|healing statements|healing statements
172465|NCT02502357|pelvic prolapse|pelvic prolapse
172466|NCT02502344|insulin resistance|insulin resistance
172467|NCT02502344|abnormal glucose tolerance|abnormal glucose tolerance
172468|NCT02502344|DM prevention|dm prevention
172469|NCT02502331|Oral Cholera Vaccine|oral cholera vaccine
172470|NCT02502331|immunogenicity|immunogenicity
172471|NCT02502331|safety|safety
172472|NCT02502318|Proven or suspected lung cancer treated by lobectomy|proven or suspected lung cancer treated by lobectomy
172473|NCT02502305|health literacy|health literacy
172474|NCT02502305|attitude|attitude
172475|NCT02502305|motivation|motivation
172476|NCT02502292|Health Literacy|health literacy
172477|NCT02502292|Health Ageing|health ageing
172478|NCT02502292|Health Literacy Interventions|health literacy interventions
172479|NCT02502292|IROHLA|irohla
172480|NCT02502292|Photo Novel Study|photo novel study
172482|NCT02502240|Latin American|latin american
172483|NCT02502227|mindfulness|mindfulness
172484|NCT02502227|psychological stress|psychological stress
172485|NCT02502227|wellness programs|wellness programs
172486|NCT02502227|cortisol|cortisol
172487|NCT02502214|Preimplantation Genetic Diagnosis|preimplantation genetic diagnosis
172488|NCT02502214|PGD|pgd
172489|NCT02502214|Next-Generation Sequencing|next-generation sequencing
172490|NCT02502214|NGS|ngs
172491|NCT02502214|Single-Gene disorders|single-gene disorders
172492|NCT02502214|Cystic Fibrosis|cystic fibrosis
172493|NCT02502214|CFTR|cftr
172494|NCT02502214|Single-cell analysis|single-cell analysis
172495|NCT02502214|PCR|pcr
172496|NCT02502214|SNP|snp
172497|NCT02502214|Whole Genome Amplification|whole genome amplification
172498|NCT02502201|six-minute walk|six-minute walk
172499|NCT02502188|Healthy Subjects|healthy subjects
172500|NCT02502188|Severe Plaque Psoriasis|severe plaque psoriasis
172501|NCT02502188|Moderate|moderate
172502|NCT02502188|Phase 1|phase 1
172503|NCT02502188|Safety|safety
172504|NCT02502188|Tolerability|tolerability
172505|NCT02502188|CC-90005|cc-90005
172506|NCT02502175|Opium tincture|opium tincture
172507|NCT02502175|opium|opium
172508|NCT02502175|methadone|methadone
172509|NCT02502175|opioid dependence|opioid dependence
172510|NCT02502175|opiate dependence|opiate dependence
172511|NCT02502175|clinical trial|clinical trial
172512|NCT02502175|Iran|iran
172513|NCT02502149|rFVIIIFc|rfviiifc
172514|NCT02502149|Eloctate|eloctate
172515|NCT02502149|Hemophilia|hemophilia
172516|NCT02502136|CO2 insufflation|co2 insufflation
172517|NCT02502110|Atrial Fibrillation|atrial fibrillation
172518|NCT02502110|statin|statin
172519|NCT02502110|radiofrequency ablation|radiofrequency ablation
172520|NCT02502006|Non-steroidal Anti-inflammatory Drugs|non-steroidal anti-inflammatory drugs
172521|NCT02502006|Healthy volunteers|healthy volunteers
172522|NCT02502006|Celecoxib|celecoxib
172523|NCT02502006|Naproxen|naproxen
172524|NCT02502006|Prostaglandin|prostaglandin
172525|NCT02502006|Cyclooxygenase|cyclooxygenase
172526|NCT02501980|Screening|screening
172527|NCT02501980|Hepatocellular Cancer|hepatocellular cancer
172528|NCT02501980|Biomarker|biomarker
172529|NCT02501980|Mortality rate|mortality rate
172530|NCT02501967|multiple chronic conditions|multiple chronic conditions
172531|NCT02501941|Ketamine|ketamine
172532|NCT02501941|Cortical Spreading Depolarization|cortical spreading depolarization
172533|NCT02501941|Cortical Spreading Depression|cortical spreading depression
172534|NCT02501928|neurogenic detrusor overactivity|neurogenic detrusor overactivity
172535|NCT02501928|fesoterodine|fesoterodine
172536|NCT02501928|Japan|japan
172537|NCT02501915|Muscle|muscle
172538|NCT02501902|Ibrance, palbociclib, Abraxane, nab-paclitaxel, pancreas,|ibrance, palbociclib, abraxane, nab-paclitaxel, pancreas,
172539|NCT02501889|obesity|obesity
172540|NCT02501889|overweight|overweight
172541|NCT02501889|weight loss|weight loss
172542|NCT02501889|satiety|satiety
172543|NCT02501889|walnuts|walnuts
172544|NCT02501889|gastrointestinal peptides|gastrointestinal peptides
172545|NCT02501876|The risk of progession|the risk of progession
172546|NCT02501876|patients|patients
172547|NCT02501850|Lipoprotein (a)|lipoprotein (a)
172548|NCT02501837|Healthy women|healthy women
172549|NCT02501811|Heart Failure|heart failure
172550|NCT02501811|Ischemia|ischemia
172551|NCT02501811|Autologous Stem Cells|autologous stem cells
172552|NCT02501811|LV dysfunction|lv dysfunction
172553|NCT02501811|Mesenchymal Stem Cells|mesenchymal stem cells
172554|NCT02501811|ckit Cardiac Stem Cells|ckit cardiac stem cells
172555|NCT02501811|Combination Cell Therapy|combination cell therapy
172556|NCT02501811|LV function|lv function
172557|NCT02501811|Functional status|functional status
172558|NCT02501798|ADHD|adhd
172559|NCT02501798|Methylphenidate|methylphenidate
172560|NCT02501798|Academic|academic
172561|NCT02501798|Motivation|motivation
172562|NCT02501785|Quality of Life|quality of life
172563|NCT02501785|Patient care givers|patient care givers
172564|NCT02501785|15-145|15-145
172565|NCT02501785|Ambulatory Extended Recovery|ambulatory extended recovery
172566|NCT02501746|Group medical care|group medical care
172567|NCT02501746|Microfinance|microfinance
172568|NCT02501746|Hypertension|hypertension
172569|NCT02501746|Community-based intervention|community-based intervention
172570|NCT02501746|Global health|global health
172571|NCT02501733|Total Knee Replacement|total knee replacement
172572|NCT02501733|Total Knee Arthroplasty|total knee arthroplasty
172573|NCT02501720|burn|burn
172574|NCT02501720|hand|hand
172575|NCT02501720|flexion contracture|flexion contracture
172576|NCT02501720|tourniquet|tourniquet
172577|NCT02501720|tumescent technique|tumescent technique
172578|NCT02501720|children|children
172579|NCT02501707|echocardiography|echocardiography
172580|NCT02501707|radiation-induced lung injury|radiation-induced lung injury
172581|NCT02501707|prognostic|prognostic
172582|NCT02501707|chemo radiotherapy|chemo radiotherapy
172583|NCT02501707|non-small cell lung cancer|non-small cell lung cancer
172584|NCT02501707|NSCLC|nsclc
172585|NCT02501681|sublingual microcirculation|sublingual microcirculation
172586|NCT02501681|cardiovascular surgery|cardiovascular surgery
172587|NCT02501616|SGLT2 inhibitor|sglt2 inhibitor
172588|NCT02501564|Osteoarthritis|osteoarthritis
172589|NCT02501564|NAPROXEN SODIUM|naproxen sodium
172590|NCT02501551|Malignant melanoma|malignant melanoma
172591|NCT02501551|C-KIT mutation|c-kit mutation
172592|NCT02501525|renal stone|renal stone
172593|NCT02501525|retrograde intrarenal surgery|retrograde intrarenal surgery
172594|NCT02501525|ureteral access sheath|ureteral access sheath
172595|NCT02501525|pain|pain
172596|NCT02501512|transesophageal signal|transesophageal signal
172597|NCT02501512|swallowing|swallowing
172598|NCT02501512|newborn|newborn
172599|NCT02501486|adrenal insufficiency|adrenal insufficiency
172600|NCT02501486|adverse drug reaction|adverse drug reaction
172601|NCT02501486|corticosteroid|corticosteroid
172602|NCT02501473|follicular lymphoma|follicular lymphoma
172603|NCT02501473|fNHL|fnhl
172604|NCT02501473|low-grade lymphoma|low-grade lymphoma
172605|NCT02501473|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
172606|NCT02501473|follicular NHL|follicular nhl
172607|NCT02501473|Marginal Zone|marginal zone
172608|NCT02501460|Adult cancer survivors|adult cancer survivors
172609|NCT02501460|Exercise|exercise
172610|NCT02501460|Dietary supplementation|dietary supplementation
172611|NCT02501434|aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
172612|NCT02501434|unfractionated heparin|unfractionated heparin
172613|NCT02501434|neurobehavioral manifestations|neurobehavioral manifestations
172614|NCT02501434|delayed ischemic neurological deficits|delayed ischemic neurological deficits
172615|NCT02501434|cerebral aneurysm|cerebral aneurysm
172616|NCT02501434|coil embolization|coil embolization
172617|NCT02501434|Montreal Cognitive Assessment|montreal cognitive assessment
172618|NCT02501421|vaccine|vaccine
172619|NCT02501421|influenza vector|influenza vector
172620|NCT02501421|tuberculosis|tuberculosis
172621|NCT02501382|Fasciitis|fasciitis
172622|NCT02501382|Fasciitis, Necrotizing|fasciitis, necrotizing
172623|NCT02501382|Soft tissue infections|soft tissue infections
172624|NCT02501382|Fournier's gangrene|fournier's gangrene
172625|NCT02501382|Immunopathogenesis|immunopathogenesis
172626|NCT02501356|prebiotic|prebiotic
172627|NCT02501356|dietary supplement|dietary supplement
172628|NCT02501343|Glucose metabolism|glucose metabolism
172629|NCT02501343|Potential renal acid load|potential renal acid load
172630|NCT02501343|Postprandial glycemia|postprandial glycemia
172631|NCT02501343|Body acid-base homeostasis|body acid-base homeostasis
172632|NCT02501343|Sodium bicarbonate|sodium bicarbonate
172633|NCT02501330|Drug use investigation in Japan|drug use investigation in japan
172634|NCT02501317|urinary incontinence|urinary incontinence
172635|NCT02501317|physical therapy|physical therapy
172636|NCT02501317|rehabilitation|rehabilitation
172637|NCT02501317|pelvic floor|pelvic floor
172638|NCT02501317|perineum|perineum
172639|NCT02501317|conservative treatment|conservative treatment
172640|NCT02501265|Nicotine addiction|nicotine addiction
172641|NCT02501265|Cigarette smoking|cigarette smoking
172642|NCT02501265|Bupropion|bupropion
172643|NCT02501265|Varenicline|varenicline
172644|NCT02501265|Adaptive Approach|adaptive approach
172645|NCT02501265|Nicotine Patch|nicotine patch
172646|NCT02501265|Chantix|chantix
172647|NCT02501252|Community|community
172648|NCT02501252|Skilled birth attendance|skilled birth attendance
172649|NCT02501252|Rural|rural
172650|NCT02501252|Ethiopia|ethiopia
172651|NCT02501226|Psychiatry|psychiatry
172652|NCT02501226|Depression|depression
172653|NCT02501226|Psychoeducation|psychoeducation
172654|NCT02501226|Randomized controlled trial|randomized controlled trial
172655|NCT02501226|Treatment adherence|treatment adherence
172656|NCT02501226|Remission|remission
172657|NCT02501213|Diuretic|diuretic
172658|NCT02501213|Malignant ascites|malignant ascites
172659|NCT02501200|Dyslipidemia|dyslipidemia
172660|NCT02501200|CKD-391|ckd-391
172661|NCT02501200|Atorvastatin|atorvastatin
172662|NCT02501200|Ezetimibe|ezetimibe
172663|NCT02501174|Geriatric oncology|geriatric oncology
172664|NCT02501148|Embolic protection|embolic protection
172665|NCT02501148|Carotid artery stenting|carotid artery stenting
172666|NCT02501135|Femoral nerve blocks|femoral nerve blocks
172667|NCT02501135|children|children
172668|NCT02501135|knee and thigh surgery|knee and thigh surgery
172669|NCT02501122|Quality|quality
172670|NCT02501122|hospital care|hospital care
172671|NCT02501122|adenotonsillectomy|adenotonsillectomy
172672|NCT02501109|Aripiprazole|aripiprazole
172673|NCT02501109|Oral Soluble Film|oral soluble film
172674|NCT02501109|Schizophrenia|schizophrenia
172675|NCT02501096|Lenvatinib|lenvatinib
172676|NCT02501096|Lenvima|lenvima
172677|NCT02501096|E7080|e7080
172678|NCT02501096|Phase 1b/2|phase 1b/2
172679|NCT02501096|Pembrolizumab|pembrolizumab
172680|NCT02501096|Solid tumors|solid tumors
172681|NCT02501083|cardiomyopathy|cardiomyopathy
172682|NCT02501083|echocardiography|echocardiography
172683|NCT02501083|prognosis|prognosis
172684|NCT02501083|respiratory|respiratory
172685|NCT02501083|home mechanical ventilation|home mechanical ventilation
172686|NCT02501083|vital capacity|vital capacity
172687|NCT02501083|maximal inspiratory pressure|maximal inspiratory pressure
172688|NCT02501083|maximal expiratory pressure|maximal expiratory pressure
172689|NCT02501070|Percutaneous Coronary Intervention|percutaneous coronary intervention
172690|NCT02501070|Angioplasty|angioplasty
172691|NCT02501070|Stent|stent
172692|NCT02501070|Community Networks|community networks
172693|NCT02501057|Human Immunodeficiency Virus|human immunodeficiency virus
172694|NCT02501057|Unsafe Drinking|unsafe drinking
172695|NCT02501057|Antiretroviral Therapy (ART)|antiretroviral therapy (art)
172696|NCT02501031|Flaxseed|flaxseed
172697|NCT02501031|Postmenopause|postmenopause
172698|NCT02501031|Hormones|hormones
172699|NCT02501031|Lignans|lignans
172700|NCT02501031|No Evidence of Disease|no evidence of disease
172701|NCT02501018|CLI|cli
172702|NCT02500979|Type 1 Diabetes Mellitus; Pramlintide|type 1 diabetes mellitus; pramlintide
172703|NCT02500966|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
172704|NCT02500966|stenosis|stenosis
172705|NCT02500966|cervix|cervix
172706|NCT02500966|medical device|medical device
172707|NCT02500966|inventories|inventories
172708|NCT02500966|Uterine Cervix|uterine cervix
172709|NCT02500966|Intrauterine Devices|intrauterine devices
172710|NCT02500966|intrauterine|intrauterine
172711|NCT02500966|conization|conization
172712|NCT02500966|loop electrosurgical excision|loop electrosurgical excision
172713|NCT02500953|ASP3325|asp3325
172714|NCT02500953|pharmacokinetics|pharmacokinetics
172715|NCT02500953|pharmacodynamics|pharmacodynamics
172716|NCT02500927|ASP8273|asp8273
172717|NCT02500927|Non-Small Cell Lung Cancer|non-small cell lung cancer
172718|NCT02500927|EGFR Tyrosine Kinase Inhibitor|egfr tyrosine kinase inhibitor
172719|NCT02500927|EGFR Mutation|egfr mutation
172720|NCT02500914|small cell lung cancer|small cell lung cancer
172721|NCT02500901|Enzalutamide|enzalutamide
172722|NCT02500901|Niraparib|niraparib
172723|NCT02500901|PARP-1 inhibitor|parp-1 inhibitor
172724|NCT02500901|PARP-2 inhibitor|parp-2 inhibitor
172725|NCT02500901|Castrate-Resistant Prostate Cancer|castrate-resistant prostate cancer
172726|NCT02500888|OCD|ocd
172727|NCT02500888|Neurosurgery|neurosurgery
172728|NCT02500888|Radiosurgery|radiosurgery
172729|NCT02500875|Negative-Pressure Wound Therapy|negative-pressure wound therapy
172730|NCT02500875|Topical Negative Pressure Therapy|topical negative pressure therapy
172731|NCT02500875|Sodium Hypochlorite|sodium hypochlorite
172732|NCT02500862|Eye|eye
172733|NCT02500862|Imaging|imaging
172734|NCT02500849|Gene therapy|gene therapy
172735|NCT02500849|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
172736|NCT02500849|HIV Infections|hiv infections
172737|NCT02500849|Retroviridae Infections|retroviridae infections
172738|NCT02500849|RNA Virus Infections|rna virus infections
172739|NCT02500849|Virus Diseases|virus diseases
172740|NCT02500849|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
172741|NCT02500849|Sexually Transmitted Diseases|sexually transmitted diseases
172742|NCT02500849|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
172743|NCT02500849|Immune System Diseases|immune system diseases
172744|NCT02500849|Busulfan|busulfan
172745|NCT02500849|Pharmacologic Actions|pharmacologic actions
172746|NCT02500836|Ear|ear
172747|NCT02500836|Nose|nose
172748|NCT02500836|Throat|throat
172749|NCT02500823|Mitochondrial DNA copy number|mitochondrial dna copy number
172750|NCT02500823|Peripheral blood cells|peripheral blood cells
172751|NCT02500810|neurotoxicity|neurotoxicity
172752|NCT02500810|chemotherapy|chemotherapy
172753|NCT02500810|monosialoganglioside|monosialoganglioside
172754|NCT02500810|prevention|prevention
172755|NCT02500758|Surgical scrubbing|surgical scrubbing
172756|NCT02500758|Chlorhexidine digluconate|chlorhexidine digluconate
172757|NCT02500758|Parachlorometaxylenol|parachlorometaxylenol
172758|NCT02500719|Posttraumatic Stress Disorder|posttraumatic stress disorder
172759|NCT02500719|Neurofeedback|neurofeedback
172760|NCT02500719|fMRI|fmri
172761|NCT02500719|Skin Conductance Response|skin conductance response
172762|NCT02500693|Lung Cancer, Screening, COPD|lung cancer, screening, copd
172763|NCT02500680|Influenza|influenza
172764|NCT02500680|Adjuvant|adjuvant
172765|NCT02500667|N91115|n91115
172766|NCT02500667|Rifampin|rifampin
172767|NCT02500667|drug interaction|drug interaction
172768|NCT02500667|Cavosonstat|cavosonstat
172769|NCT02500654|Peri-implantitis|peri-implantitis
172770|NCT02500654|Regenerative therapy|regenerative therapy
172771|NCT02500654|Surgical therapy|surgical therapy
172772|NCT02500654|Enamel matrix derivative|enamel matrix derivative
172773|NCT02500654|Peri-implant microflora|peri-implant microflora
172774|NCT02500654|Peri-implant fluid|peri-implant fluid
172775|NCT02500641|Biological Markers|biological markers
172776|NCT02500641|Cardiovascular disease|cardiovascular disease
172777|NCT02500641|Humans|humans
172778|NCT02500641|Pulse Wave Velocity|pulse wave velocity
172779|NCT02500641|Cardiovascular risk factors|cardiovascular risk factors
172780|NCT02500641|Allopurinol|allopurinol
172781|NCT02500641|Pulse Wave Analysis|pulse wave analysis
172782|NCT02500641|Thiazoles|thiazoles
172783|NCT02500641|Inflammation|inflammation
172784|NCT02500641|Uric acid|uric acid
172785|NCT02500641|Febuxostat|febuxostat
172786|NCT02500641|Oxidative stress|oxidative stress
172787|NCT02500641|Tumor Necrosis Factor|tumor necrosis factor
172788|NCT02500641|Arthritis|arthritis
172789|NCT02500641|Hyperuricemia|hyperuricemia
172790|NCT02500628|metformin|metformin
172791|NCT02500628|mitochondria|mitochondria
172792|NCT02500628|complex 1|complex 1
172793|NCT02500628|fibromyalgia|fibromyalgia
172794|NCT02500628|neurogenic pain|neurogenic pain
172795|NCT02500628|diabetes|diabetes
172796|NCT02500628|tardive dyskinesia|tardive dyskinesia
172797|NCT02500628|heart rate variability|heart rate variability
172798|NCT02500602|PTSD|ptsd
172799|NCT02500602|alcohol use disorders|alcohol use disorders
172800|NCT02500602|posttraumatic stress disorder|posttraumatic stress disorder
172801|NCT02500602|AUD|aud
172802|NCT02500602|Veteran|veteran
172803|NCT02500602|substance use disorders|substance use disorders
172804|NCT02500602|SUD|sud
172805|NCT02500589|smoking|smoking
172806|NCT02500589|tobacco|tobacco
172807|NCT02500576|Melanoma|melanoma
172808|NCT02500576|Metastatic|metastatic
172809|NCT02500576|Cyclophosphamide|cyclophosphamide
172810|NCT02500576|Cytoxan|cytoxan
172811|NCT02500576|Neosar|neosar
172812|NCT02500576|Mesna|mesna
172813|NCT02500576|Mesnex|mesnex
172814|NCT02500576|Fludarabine|fludarabine
172815|NCT02500576|Fludarabine phosphate|fludarabine phosphate
172816|NCT02500576|MK-3475|mk-3475
172817|NCT02500576|Keytruda|keytruda
172818|NCT02500576|Pembrolizumab|pembrolizumab
172819|NCT02500576|SCH-900475|sch-900475
172820|NCT02500576|IL-2|il-2
172821|NCT02500576|Aldesleukin|aldesleukin
172822|NCT02500576|Interleukin-2|interleukin-2
172823|NCT02500576|Proleukin|proleukin
172824|NCT02500576|TIL|til
172825|NCT02500576|T-cells|t-cells
172826|NCT02500576|Questionnaires|questionnaires
172827|NCT02500576|Surveys|surveys
172828|NCT02500576|Phone calls|phone calls
172829|NCT02500550|Haploidentical stem cell transplantation|haploidentical stem cell transplantation
172830|NCT02500550|Graft versus host disease|graft versus host disease
172831|NCT02500550|Immune reconstitution|immune reconstitution
172832|NCT02500550|Alloreactive T-cells|alloreactive t-cells
172833|NCT02500550|Photodynamic treatment|photodynamic treatment
172834|NCT02500550|Hematologic malignancy|hematologic malignancy
172835|NCT02500550|Transplant-related mortality|transplant-related mortality
172836|NCT02500485|SHR3824 SP2086 drug-drug interaction|shr3824 sp2086 drug-drug interaction
172837|NCT02500472|Tobacco|tobacco
172838|NCT02500472|Smoking|smoking
172839|NCT02500459|Topotecan|topotecan
172840|NCT02500459|Cleveland Multiport Catheter|cleveland multiport catheter
172841|NCT02500459|Cancer|cancer
172842|NCT02500433|Cerebral palsy|cerebral palsy
172843|NCT02500433|child|child
172844|NCT02500433|rehabilitation|rehabilitation
172845|NCT02500433|video games|video games
172846|NCT02500433|virtual reality.|virtual reality.
172847|NCT02500420|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
172848|NCT02500420|Stress MRI|stress mri
172849|NCT02500420|Cardiac MRI|cardiac mri
172850|NCT02500420|Stress echocardiography|stress echocardiography
172851|NCT02500420|T1 mapping|t1 mapping
172852|NCT02500420|2D strain|2d strain
172853|NCT02500394|renal replacement therapy|renal replacement therapy
172854|NCT02500381|Duchenne muscular dystrophy|duchenne muscular dystrophy
172855|NCT02500381|Exon Skipping|exon skipping
172856|NCT02500381|DMD|dmd
172857|NCT02500381|Exon 53|exon 53
172858|NCT02500381|Exon 45|exon 45
172859|NCT02500381|Ambulatory|ambulatory
172860|NCT02500381|Pediatric|pediatric
172861|NCT02500342|Thyroid Dysfunction|thyroid dysfunction
172862|NCT02500342|Fatigue|fatigue
172863|NCT02500342|Randomized Controlled Trial|randomized controlled trial
172864|NCT02500342|Thyroxine|thyroxine
172865|NCT02500342|Hypothyroidism|hypothyroidism
172866|NCT02500316|Growth hormone deficiency (GHD)|growth hormone deficiency (ghd)
172867|NCT02500316|r-hGH|r-hgh
172868|NCT02500316|Long-acting|long-acting
172869|NCT02500303|Amputation|amputation
172870|NCT02500290|ACS|acs
172871|NCT02500277|thoracoscopy|thoracoscopy
172872|NCT02500277|pleuroscopy|pleuroscopy
172873|NCT02500277|semirigid thoracoscopy|semirigid thoracoscopy
172874|NCT02500277|flexible cryoprobe|flexible cryoprobe
172875|NCT02500277|cryobiopsy|cryobiopsy
172876|NCT02500277|pleural biopsy|pleural biopsy
172877|NCT02500251|Transplantation|transplantation
172878|NCT02500251|belimumab|belimumab
172879|NCT02500251|Velcade|velcade
172880|NCT02500225|Etomidate|etomidate
172881|NCT02500225|Sevoflurane|sevoflurane
172882|NCT02500199|HER2 positive|her2 positive
172883|NCT02500173|radiotherapy|radiotherapy
172884|NCT02500173|side effects|side effects
172885|NCT02500147|Polycystic Ovary Syndrome|polycystic ovary syndrome
172886|NCT02500147|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
172887|NCT02500147|Adolescents|adolescents
172888|NCT02500147|Young Women|young women
172889|NCT02500147|MRI|mri
172890|NCT02500147|MRS|mrs
172891|NCT02500147|DXA|dxa
172892|NCT02500147|PNPLA3|pnpla3
172893|NCT02500147|Metformin|metformin
172894|NCT02500147|Randomized Clinical Trial|randomized clinical trial
172895|NCT02500147|Placebo|placebo
172896|NCT02500147|Hirsutism|hirsutism
172897|NCT02500147|Acne|acne
172898|NCT02500147|Amenorrhea|amenorrhea
172899|NCT02500147|Metabolic Syndrome|metabolic syndrome
172900|NCT02500147|Dyslipidemia|dyslipidemia
172901|NCT02500147|Percentage liver fat|percentage liver fat
172902|NCT02500121|Pembrolizumab|pembrolizumab
172903|NCT02500121|PD-1 Inhibitor|pd-1 inhibitor
172904|NCT02500108|Domperidone|domperidone
172905|NCT02500108|Ventricular Tachyarrhythmia|ventricular tachyarrhythmia
172906|NCT02500108|Sudden cardiac death|sudden cardiac death
172907|NCT02500108|Pharmacotherapy|pharmacotherapy
172908|NCT02500108|Adverse events|adverse events
172909|NCT02500082|citrate transporter deficiency|citrate transporter deficiency
172910|NCT02500082|SLC13A5 gene|slc13a5 gene
172911|NCT02500082|citric acid cycle|citric acid cycle
172912|NCT02500082|energy metabolism|energy metabolism
172913|NCT02500056|Inguinal hernia|inguinal hernia
172914|NCT02500056|Chronic pain|chronic pain
172915|NCT02500056|Mesh|mesh
172916|NCT02500056|Lichtenstein hernioplasty|lichtenstein hernioplasty
172917|NCT02500043|Gastric Cancer|gastric cancer
172918|NCT02500043|Metastatic Gastric Cancer|metastatic gastric cancer
172919|NCT02499965|Topical Anesthetic|topical anesthetic
172920|NCT02499965|Ethyl Chloride|ethyl chloride
172921|NCT02499965|Pain Reduction|pain reduction
172922|NCT02499965|IV cannulation|iv cannulation
172923|NCT02499952|Pembrolizumab|pembrolizumab
172924|NCT02499952|MK-3475|mk-3475
172925|NCT02499952|PMNSGCT|pmnsgct
172926|NCT02499952|PD-L1|pd-l1
172927|NCT02499952|Non Seminomatous Germ Cell Tumors|non seminomatous germ cell tumors
172928|NCT02499848|MRI Lesion|mri lesion
172929|NCT02499848|transperineal injection|transperineal injection
172930|NCT02499848|prostate biopsies|prostate biopsies
172931|NCT02499822|Hypertension|hypertension
172932|NCT02499822|Blood pressure variability|blood pressure variability
172933|NCT02499822|Home systolic blood pressure|home systolic blood pressure
172934|NCT02499822|Organ damage|organ damage
172935|NCT02499822|Nifedipine GITS|nifedipine gits
172936|NCT02499822|Ramipril|ramipril
172937|NCT02499809|Vibration therapy|vibration therapy
172938|NCT02499809|Recovery from exercise|recovery from exercise
172939|NCT02499796|Invasive mechanical ventilation|invasive mechanical ventilation
172940|NCT02499796|Humidifying devices|humidifying devices
172941|NCT02499796|Respiratory mechanics|respiratory mechanics
172942|NCT02499783|China|china
172943|NCT02499783|Tumor necrosis factor (TNF)-alpha|tumor necrosis factor (tnf)-alpha
172944|NCT02499783|Biologic|biologic
172945|NCT02499770|Small Cell Lung Cancer|small cell lung cancer
172946|NCT02499770|CDK 4/6 Inhibitor|cdk 4/6 inhibitor
172947|NCT02499757|Perception|perception
172948|NCT02499757|brain response|brain response
172949|NCT02499757|nicotine|nicotine
172950|NCT02499757|taste|taste
172951|NCT02499744|NIPPV|nippv
172952|NCT02499744|HHFNC|hhfnc
172953|NCT02499744|RDS|rds
172954|NCT02499744|neonate|neonate
172955|NCT02499731|physical activity|physical activity
172956|NCT02499731|nutrition|nutrition
172957|NCT02499731|social network|social network
172958|NCT02499718|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
172959|NCT02499718|Non-invasive positive pressure ventilation|non-invasive positive pressure ventilation
172960|NCT02499718|quality of life|quality of life
172961|NCT02499718|long-term oxygen therapy|long-term oxygen therapy
172962|NCT02499666|Exercise Capacity|exercise capacity
172963|NCT02499666|Chronic Total Occlusion|chronic total occlusion
172964|NCT02499653|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
172965|NCT02499653|Non Invasive Ventilation (NIV)|non invasive ventilation (niv)
172966|NCT02499653|Acceptance|acceptance
172967|NCT02499653|Adherence|adherence
172968|NCT02499653|Clinical Psychology|clinical psychology
172969|NCT02499640|Recovery of function|recovery of function
172970|NCT02499640|Autonomic nervous system|autonomic nervous system
172971|NCT02499640|Heart rate variability|heart rate variability
172972|NCT02499640|Cryotherapy|cryotherapy
172973|NCT02499640|Immersion|immersion
172974|NCT02499627|Lymphoma|lymphoma
172975|NCT02499627|Hodgkin|hodgkin
172976|NCT02499627|PTCL|ptcl
172977|NCT02499627|CD30+|cd30+
172978|NCT02499614|MET amplification|met amplification
172979|NCT02499614|ROS1 translocation|ros1 translocation
172980|NCT02499614|Crizotinib|crizotinib
172981|NCT02499601|Heart Failure with Preserved Ejection Fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
172982|NCT02499601|Heart Failure (HF)|heart failure (hf)
172983|NCT02499601|New York Heart Association functional Class (NYHA f. Cl)|new york heart association functional class (nyha f. cl)
172984|NCT02499575|Exparel|exparel
172985|NCT02499575|bupivacaine|bupivacaine
172986|NCT02499575|Hallux valgus deformity|hallux valgus deformity
172987|NCT02499575|bunionectomy|bunionectomy
172988|NCT02499536|Atelectasis|atelectasis
172989|NCT02499536|Postoperative|postoperative
172990|NCT02499536|Lung ultrasound|lung ultrasound
172991|NCT02499510|femoropopliteal disease|femoropopliteal disease
172992|NCT02499510|restenosis|restenosis
172993|NCT02499497|Prostate Cancer|prostate cancer
172994|NCT02499432|Evidence Based Psychotherapy|evidence based psychotherapy
172995|NCT02499432|Implementation|implementation
172997|NCT02499393|newborn|newborn
172998|NCT02499393|therapeutic hypothermia|therapeutic hypothermia
172999|NCT02499393|magnesium sulphate|magnesium sulphate
173000|NCT02499380|RePneu|repneu
173001|NCT02499380|Coil|coil
173002|NCT02499380|LVRC|lvrc
173003|NCT02499380|PneumRx|pneumrx
173004|NCT02499367|triple negative|triple negative
173005|NCT02499367|metastatic|metastatic
173006|NCT02499341|Tramadol|tramadol
173007|NCT02499341|Ketamine|ketamine
173008|NCT02499341|Morphine|morphine
173009|NCT02499328|Carcinoma of the Head and Neck|carcinoma of the head and neck
173010|NCT02499276|mechanical ventilation|mechanical ventilation
173011|NCT02499276|pressure support ventilation|pressure support ventilation
173012|NCT02499276|NAVA|nava
173013|NCT02499276|PAV|pav
173014|NCT02499276|variable ventilation|variable ventilation
173015|NCT02499276|patient ventilator asynchrony|patient ventilator asynchrony
173016|NCT02499263|Adalimumab trough level|adalimumab trough level
173017|NCT02499263|Fecal Calprotectin|fecal calprotectin
173018|NCT02499263|Fecal microbiota|fecal microbiota
173019|NCT02499250|refractory angina pectoris|refractory angina pectoris
173020|NCT02499250|remote ischemic conditioning|remote ischemic conditioning
173021|NCT02499250|life quality|life quality
173022|NCT02499250|anxiety|anxiety
173023|NCT02499250|depression|depression
173024|NCT02499250|inflammation|inflammation
173025|NCT02499237|osteoporosis|osteoporosis
173026|NCT02499237|denosumab|denosumab
173027|NCT02499237|zoledronic acid|zoledronic acid
173028|NCT02499237|bone mineral density|bone mineral density
173029|NCT02499237|bone markers|bone markers
173030|NCT02499211|obesity|obesity
173031|NCT02499211|health disparities|health disparities
173032|NCT02499211|healthy food marketing|healthy food marketing
173033|NCT02499211|food environments|food environments
173034|NCT02499211|marketing environments|marketing environments
173035|NCT02499211|food access|food access
173036|NCT02499211|food purchase decision making|food purchase decision making
173037|NCT02499198|Nornicotine|nornicotine
173038|NCT02499198|Tobacco|tobacco
173039|NCT02499198|N'-nitrosonornicotine|n'-nitrosonornicotine
173040|NCT02499198|NNN|nnn
173041|NCT02499185|Biomarker|biomarker
173042|NCT02499185|Intra Abdominal Surgery|intra abdominal surgery
173043|NCT02499185|AKI|aki
173044|NCT02499172|Adverse pregnancy outcome|adverse pregnancy outcome
173045|NCT02499159|Exparel|exparel
173046|NCT02499159|Thoracoscopy|thoracoscopy
173047|NCT02499159|Bupivicaine|bupivicaine
173048|NCT02499159|Liposomal|liposomal
173049|NCT02499146|Palbociclib|palbociclib
173050|NCT02499146|PD-0332991|pd-0332991
173051|NCT02499146|pharmacokinetics|pharmacokinetics
173052|NCT02499146|breast cancer patients|breast cancer patients
173053|NCT02499146|Chinese|chinese
173054|NCT02499120|palbociclib, cetuximab, human papillomavirus, squamous cell carcinoma, head and neck cancer|palbociclib, cetuximab, human papillomavirus, squamous cell carcinoma, head and neck cancer
173055|NCT02499107|food intake|food intake
173056|NCT02499107|satiety|satiety
173057|NCT02499107|blood glucose|blood glucose
173058|NCT02499107|potato|potato
173059|NCT02499107|insulin|insulin
173060|NCT02499081|Relapsed|relapsed
173061|NCT02499081|Refractory|refractory
173062|NCT02499081|Proteasome Inhibitor|proteasome inhibitor
173063|NCT02499055|anxiety|anxiety
173064|NCT02499055|behaviour therapy|behaviour therapy
173065|NCT02499055|computer assisted therapy|computer assisted therapy
173066|NCT02499055|psychotherapy|psychotherapy
173067|NCT02499042|post-resuscitation|post-resuscitation
173068|NCT02499042|oxygen therapy|oxygen therapy
173069|NCT02499042|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
173070|NCT02499016|Appendicitis|appendicitis
173071|NCT02499016|Appendectomy|appendectomy
173072|NCT02499016|Single-incision|single-incision
173073|NCT02499003|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
173074|NCT02499003|Follicular lymphoma|follicular lymphoma
173075|NCT02499003|Transformed indolent lymphoma|transformed indolent lymphoma
173076|NCT02498977|Liver|liver
173077|NCT02498977|Transplant|transplant
173078|NCT02498977|Immunosuppression|immunosuppression
173079|NCT02498964|cardiac anesthesia simulation,NASA task load index|cardiac anesthesia simulation,nasa task load index
173080|NCT02498938|Pulmonary disease,chronic obstructive,|pulmonary disease,chronic obstructive,
173081|NCT02498938|generalized chronic periodontitis|generalized chronic periodontitis
173082|NCT02498938|SERPINA1 gene polymorphism|serpina1 gene polymorphism
173083|NCT02498912|T Cells|t cells
173084|NCT02498912|Cyclophosphamide|cyclophosphamide
173085|NCT02498912|MUC16ecto antigen|muc16ecto antigen
173086|NCT02498912|Intraperitoneal Infusion|intraperitoneal infusion
173087|NCT02498912|15-014|15-014
173088|NCT02498899|Advanced Cancers|advanced cancers
173089|NCT02498899|Video|video
173090|NCT02498899|Questionnaires|questionnaires
173091|NCT02498899|Surveys|surveys
173092|NCT02498873|VO2Max|vo2max
173093|NCT02498873|Physical Conditioning|physical conditioning
173094|NCT02498873|Aerobic Exercise|aerobic exercise
173095|NCT02498873|Performance|performance
173096|NCT02498860|adenocarcinoma|adenocarcinoma
173097|NCT02498860|lung|lung
173098|NCT02498860|adjuvant chemotherapy|adjuvant chemotherapy
173099|NCT02498860|pemetrexed|pemetrexed
173100|NCT02498860|cisplatin|cisplatin
173101|NCT02498860|surgery|surgery
173102|NCT02498834|Communication|communication
173103|NCT02498834|provider|provider
173104|NCT02498834|caregiver|caregiver
173105|NCT02498834|adolescent|adolescent
173106|NCT02498821|PICC|picc
173107|NCT02498821|central catheter|central catheter
173108|NCT02498821|vascular access|vascular access
173109|NCT02498808|Interferon lambda|interferon lambda
173110|NCT02498808|Interleukin-29|interleukin-29
173111|NCT02498808|Neutrophil|neutrophil
173112|NCT02498795|Intratissue Percutaneous Electrolysis|intratissue percutaneous electrolysis
173113|NCT02498795|Dry needling|dry needling
173114|NCT02498795|Eccentric exercise|eccentric exercise
173115|NCT02498795|Patella|patella
173116|NCT02498782|Chagas Disease|chagas disease
173117|NCT02498782|Dosage forms|dosage forms
173118|NCT02498782|Regimens|regimens
173119|NCT02498769|Cardiac Surgery|cardiac surgery
173120|NCT02498769|Postoperative Complications|postoperative complications
173121|NCT02498769|Autonomic Nerve Block|autonomic nerve block
173122|NCT02498730|bipolar disorder|bipolar disorder
173123|NCT02498730|VO2max|vo2max
173124|NCT02498730|aerobic exercise|aerobic exercise
173125|NCT02498691|endometriosis|endometriosis
173126|NCT02498691|preterm delivery|preterm delivery
173127|NCT02498691|caesarean|caesarean
173128|NCT02498691|Pregnancy outcomes of women with or without endometriosis|pregnancy outcomes of women with or without endometriosis
173129|NCT02498665|Wilms' Tumor 1|wilms' tumor 1
173130|NCT02498665|Vaccine|vaccine
173131|NCT02498665|Neoplasms|neoplasms
173132|NCT02498639|balloon aortic valvuloplasty|balloon aortic valvuloplasty
173133|NCT02498639|rapid ventricular pacing|rapid ventricular pacing
173134|NCT02498639|outcome|outcome
173135|NCT02498626|mixed venous saturation|mixed venous saturation
173136|NCT02498626|open heart surgery|open heart surgery
173137|NCT02498626|children|children
173138|NCT02498600|Phase II Randomized Trial of Nivolumab with or without Ipilimumab in Patients with Persistent or Recurrent Epithelial Ovarian|phase ii randomized trial of nivolumab with or without ipilimumab in patients with persistent or recurrent epithelial ovarian
173139|NCT02498600|Primary Peritoneal or Fallopian|primary peritoneal or fallopian
173140|NCT02498600|Tube Cancer|tube cancer
173141|NCT02498587|Severe Acute Respiratory Infection|severe acute respiratory infection
173142|NCT02498496|COPD|copd
173143|NCT02498496|AECOPD|aecopd
173144|NCT02498496|Magnesium Sulfate|magnesium sulfate
173145|NCT02498496|Acute exacerbation of COPD|acute exacerbation of copd
173146|NCT02498496|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
173147|NCT02498496|ED|ed
173148|NCT02498496|ER|er
173149|NCT02498496|Emergency Department|emergency department
173150|NCT02498483|Infant|infant
173151|NCT02498457|maintenance hemodialysis patients|maintenance hemodialysis patients
173152|NCT02498457|coronary artery calcification|coronary artery calcification
173153|NCT02498457|low calcium dialysate|low calcium dialysate
173154|NCT02498457|effects|effects
173155|NCT02498457|safety|safety
173156|NCT02498444|Fontan|fontan
173157|NCT02498444|Treprostinil|treprostinil
173158|NCT02498444|Remodulin|remodulin
173159|NCT02498444|Single ventricle|single ventricle
173160|NCT02498431|irisin|irisin
173161|NCT02498431|myocardial infarction|myocardial infarction
173162|NCT02498431|coronary|coronary
173163|NCT02498392|Major Depressive Disorder|major depressive disorder
173164|NCT02498392|Depression|depression
173165|NCT02498392|Anxiety symptoms|anxiety symptoms
173166|NCT02498392|JNJ-42165279|jnj-42165279
173167|NCT02498379|novel radiotracer|novel radiotracer
173168|NCT02498379|biodistribution|biodistribution
173169|NCT02498379|safety|safety
173170|NCT02498340|G6PD|g6pd
173171|NCT02498340|genotype|genotype
173172|NCT02498340|phenotype|phenotype
173173|NCT02498340|diet restriction|diet restriction
173174|NCT02498327|Chronic|chronic
173175|NCT02498314|Manual therapy|manual therapy
173176|NCT02498314|Hip osteoarthritis|hip osteoarthritis
173177|NCT02498314|Mobilization|mobilization
173178|NCT02498301|travelers' diarrhea|travelers' diarrhea
173179|NCT02498301|military|military
173180|NCT02498301|enteric illness|enteric illness
173181|NCT02498301|gastrointestinal|gastrointestinal
173182|NCT02498288|capsule|capsule
173183|NCT02498288|Isotretinoin|isotretinoin
173184|NCT02498288|Bioequivalence|bioequivalence
173185|NCT02498262|Severe Mobility and Manipulation Impairments|severe mobility and manipulation impairments
173186|NCT02498249|Low-Level Laser Therapy|low-level laser therapy
173187|NCT02498249|trapezius muscle|trapezius muscle
173188|NCT02498249|neck pain|neck pain
173189|NCT02498236|Psychosis|psychosis
173190|NCT02498236|Schizophrenia|schizophrenia
173191|NCT02498236|Oxytocin|oxytocin
173192|NCT02498210|IVM|ivm
173193|NCT02498210|HIPPO signaling|hippo signaling
173194|NCT02498171|Labour analgesia|labour analgesia
173195|NCT02498171|Intrathecal morphine|intrathecal morphine
173196|NCT02498171|Bupivacaine|bupivacaine
173197|NCT02498171|Fentanyl|fentanyl
173198|NCT02498132|Mobile Technologies|mobile technologies
173199|NCT02498119|Type 2 DM|type 2 dm
173200|NCT02498119|lipid bodies|lipid bodies
173201|NCT02498106|nutrition|nutrition
173202|NCT02498106|aggression|aggression
173203|NCT02498106|n-3 fatty acids|n-3 fatty acids
173204|NCT02498106|psychiatry|psychiatry
173205|NCT02498106|inpatients admitted >2 years|inpatients admitted >2 years
173206|NCT02498093|Resistance training|resistance training
173207|NCT02498093|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
173208|NCT02498093|Professional-Patient Relations|professional-patient relations
173209|NCT02498093|Evidence-based practice|evidence-based practice
173210|NCT02498080|Drug eluting balloons|drug eluting balloons
173211|NCT02498080|Critical limb ischemia|critical limb ischemia
173212|NCT02498080|Infra-popliteal arteries|infra-popliteal arteries
173213|NCT02498080|Percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
173214|NCT02498041|Ultrathin Nasal Endoscopy|ultrathin nasal endoscopy
173215|NCT02498041|Barrett's Esophagus|barrett's esophagus
173216|NCT02498041|Transnasal Endoscopy|transnasal endoscopy
173217|NCT02498028|cervical fusion|cervical fusion
173218|NCT02498028|cervical arthroplasty|cervical arthroplasty
173219|NCT02498028|cervicobrachial pain|cervicobrachial pain
173220|NCT02498002|Diet|diet
173221|NCT02498002|Fasting|fasting
173222|NCT02498002|Intermittent Fasting|intermittent fasting
173223|NCT02498002|Alternate-day Fasting|alternate-day fasting
173224|NCT02498002|Physical Activity|physical activity
173225|NCT02498002|Glucose|glucose
173226|NCT02498002|Insulin|insulin
173227|NCT02498002|Appetite|appetite
173228|NCT02497989|Male circumcision|male circumcision
173229|NCT02497989|Demand creation|demand creation
173230|NCT02497976|Interstitial|interstitial
173231|NCT02497976|Cystitis|cystitis
173232|NCT02497976|Bladder|bladder
173233|NCT02497976|Pain|pain
173234|NCT02497950|HeartMate 3|heartmate 3
173235|NCT02497950|LVAS|lvas
173236|NCT02497950|LVAD|lvad
173237|NCT02497950|Heart-assist devices|heart-assist devices
173238|NCT02497950|Thoratec Corporation|thoratec corporation
173239|NCT02497937|GSK2798745|gsk2798745
173240|NCT02497937|TRPV4 Channel Blocker|trpv4 channel blocker
173241|NCT02497937|Pharmacodynamics|pharmacodynamics
173242|NCT02497937|Adults|adults
173243|NCT02497937|Congestive Heart Failure|congestive heart failure
173244|NCT02497911|Adductor Canal Catheter|adductor canal catheter
173245|NCT02497911|Intraarticular Catheter|intraarticular catheter
173246|NCT02497911|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
173247|NCT02497885|MERS|mers
173248|NCT02497885|healthcare personnel|healthcare personnel
173249|NCT02497859|Weight Reduction|weight reduction
173250|NCT02497859|Weight Loss Diet|weight loss diet
173251|NCT02497859|Satiety Response|satiety response
173252|NCT02497859|Insulin|insulin
173253|NCT02497859|Glucagon-Like Peptide 1|glucagon-like peptide 1
173254|NCT02497859|PYY (3-36) peptide|pyy (3-36) peptide
173255|NCT02497859|Ghrelin|ghrelin
173256|NCT02497859|Glucose|glucose
173257|NCT02497859|Eggs|eggs
173258|NCT02497859|Protein|protein
173259|NCT02497859|Energy Intake|energy intake
173260|NCT02497859|Breakfast|breakfast
173261|NCT02497846|Hyaluronic acid|hyaluronic acid
173262|NCT02497846|MiconJet needle|miconjet needle
173263|NCT02497807|Tourette syndrome|tourette syndrome
173264|NCT02497807|Iron deficiency|iron deficiency
173265|NCT02497794|chew gum|chew gum
173266|NCT02497794|bowel movements|bowel movements
173267|NCT02497794|cesarean section|cesarean section
173268|NCT02497781|Complicated urinary tract infections (cUTIs)|complicated urinary tract infections (cutis)
173269|NCT02497768|mastication|mastication
173270|NCT02497768|pistachios|pistachios
173271|NCT02497768|brazils|brazils
173272|NCT02497768|participants|participants
173273|NCT02497729|Endotracheal Intubation|endotracheal intubation
173274|NCT02497729|Checklist|checklist
173275|NCT02497729|Positioning|positioning
173276|NCT02497690|Cochlear Implant|cochlear implant
173277|NCT02497690|Hearing Aid|hearing aid
173278|NCT02497690|Telemedicine|telemedicine
173279|NCT02497677|parental sensitivity|parental sensitivity
173280|NCT02497677|child attachment|child attachment
173281|NCT02497664|Radiotherapy|radiotherapy
173282|NCT02497664|Active Breathing Control Technique|active breathing control technique
173283|NCT02497651|Smoking|smoking
173284|NCT02497651|Diabetes|diabetes
173285|NCT02497651|Incretin hormones|incretin hormones
173286|NCT02497651|Glucose tolerance|glucose tolerance
173287|NCT02497638|metformin|metformin
173288|NCT02497638|atorvastatin|atorvastatin
173289|NCT02497638|prostate-specific antigen|prostate-specific antigen
173290|NCT02497638|biochemical recurrence|biochemical recurrence
173291|NCT02497625|Low back pain|low back pain
173292|NCT02497625|Empathy|empathy
173293|NCT02497625|Subgroups|subgroups
173294|NCT02497625|Minimal intervention|minimal intervention
173295|NCT02497547|Atrophy|atrophy
173296|NCT02497547|Pathological Conditions, Anatomical|pathological conditions, anatomical
173297|NCT02497547|Oxytocin|oxytocin
173298|NCT02497547|Oxytocics|oxytocics
173299|NCT02497534|ataxia|ataxia
173300|NCT02497534|neuromuscular|neuromuscular
173301|NCT02497521|polycystic kidney disease|polycystic kidney disease
173302|NCT02497521|autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
173303|NCT02497521|ADPKD|adpkd
173304|NCT02497521|Tolvaptan|tolvaptan
173305|NCT02497521|Jinarc|jinarc
173306|NCT02497508|progressive disease after at least 1 course of chemotherapy|progressive disease after at least 1 course of chemotherapy
173307|NCT02497495|Immersion|immersion
173308|NCT02497495|Recovery of Function|recovery of function
173309|NCT02497495|Lactate|lactate
173310|NCT02497495|Creatine Kinase|creatine kinase
173311|NCT02497495|Musculoskeletal Pain|musculoskeletal pain
173312|NCT02497469|Drug Therapy|drug therapy
173313|NCT02497456|HIV|hiv
173314|NCT02497456|Counselling|counselling
173315|NCT02497456|Care|care
173316|NCT02497456|antiretroviral therapy|antiretroviral therapy
173317|NCT02497456|linkage|linkage
173318|NCT02497456|Uganda|uganda
173319|NCT02497456|Africa|africa
173320|NCT02497443|drug-resistant symptomatic epilepsy|drug-resistant symptomatic epilepsy
173321|NCT02497443|seizure|seizure
173322|NCT02497443|autologous mesenchymal stem cells|autologous mesenchymal stem cells
173323|NCT02497443|safety|safety
173324|NCT02497443|remission|remission
173325|NCT02497443|electroencephalography|electroencephalography
173326|NCT02497443|refractory symptomatic epilepsy|refractory symptomatic epilepsy
173327|NCT02497443|autologous MSC|autologous msc
173328|NCT02497443|efficacy|efficacy
173329|NCT02497417|ARIES Clostridium difficile|aries clostridium difficile
173330|NCT02497378|Multiple Myeloma|multiple myeloma
173331|NCT02497378|Daratumumab|daratumumab
173332|NCT02497378|JNJ-54767414|jnj-54767414
173333|NCT02497378|Bortezomib|bortezomib
173334|NCT02497378|Dexamethasone|dexamethasone
173335|NCT02497365|keratits|keratits
173336|NCT02497365|besifloxacin|besifloxacin
173337|NCT02497339|Smoking cessation interventions|smoking cessation interventions
173338|NCT02497339|mindfulness training|mindfulness training
173339|NCT02497326|second degree burns|second degree burns
173340|NCT02497326|heparin|heparin
173341|NCT02497326|topical|topical
173342|NCT02497300|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists
173343|NCT02497300|Mineralocorticoid Effects|mineralocorticoid effects
173344|NCT02497287|Treatment-resistant Depression|treatment-resistant depression
173345|NCT02497287|Esketamine|esketamine
173346|NCT02497287|Oral Antidepressant|oral antidepressant
173347|NCT02497274|bariatric surgery|bariatric surgery
173348|NCT02497274|taste perception|taste perception
173349|NCT02497274|lipid receptors|lipid receptors
173350|NCT02497261|Food Allergy|food allergy
173351|NCT02497261|Peanut|peanut
173352|NCT02497261|Sensitization|sensitization
173353|NCT02497261|Child|child
173354|NCT02497261|Double-blind placebo-controlled challenge|double-blind placebo-controlled challenge
173355|NCT02497261|Prospective cohort|prospective cohort
173356|NCT02497248|Atrial Fibrillation|atrial fibrillation
173357|NCT02497248|Pulmonary Vein Ablation|pulmonary vein ablation
173358|NCT02497248|Mitral stenosis|mitral stenosis
173359|NCT02497248|Body surface mapping|body surface mapping
173360|NCT02497235|Drug therapy, Positron Emission Tomography, Brain enzyme occupancy, Cholesterol 24S-hydroxylase, CH24H|drug therapy, positron emission tomography, brain enzyme occupancy, cholesterol 24s-hydroxylase, ch24h
173361|NCT02497196|TPCS|tpcs
173362|NCT02497196|tDCS|tdcs
173363|NCT02497196|visceral pain|visceral pain
173364|NCT02497196|pancreatitis|pancreatitis
173365|NCT02497196|healthy subjects|healthy subjects
173366|NCT02497196|pelvic pain|pelvic pain
173367|NCT02497196|neuromodulation|neuromodulation
173368|NCT02497196|non-invasive brain stimulation|non-invasive brain stimulation
173369|NCT02497157|bevacizumab|bevacizumab
173370|NCT02497157|oxaliplatin|oxaliplatin
173371|NCT02497157|irinotecan|irinotecan
173372|NCT02497157|hydrochloride hydrate|hydrochloride hydrate
173373|NCT02497157|fluorouracil|fluorouracil
173374|NCT02497157|levofolinate calcium|levofolinate calcium
173375|NCT02497144|interstitial lung disease|interstitial lung disease
173376|NCT02497144|neuromuscular electrical stimulation|neuromuscular electrical stimulation
173377|NCT02497144|exercise capacity|exercise capacity
173378|NCT02497144|quality of life|quality of life
173379|NCT02497131|PTCL|ptcl
173380|NCT02497131|CD30+|cd30+
173381|NCT02497118|lung cancer Anti angiogenesis therapy survival|lung cancer anti angiogenesis therapy survival
173382|NCT02497105|Epilepsy|epilepsy
173383|NCT02497105|Intractable Seizures|intractable seizures
173384|NCT02497105|Ketogenic Diet|ketogenic diet
173385|NCT02497105|Biochemical Profiles|biochemical profiles
173386|NCT02497079|Bronchoscopy|bronchoscopy
173387|NCT02497079|Ultrasonography|ultrasonography
173388|NCT02497079|Tuberculous lymphadenitis|tuberculous lymphadenitis
173389|NCT02497079|Polymerase chain reaction|polymerase chain reaction
173390|NCT02497079|Sensitivity and specificity|sensitivity and specificity
173391|NCT02497066|topical|topical
173392|NCT02497066|compound|compound
173393|NCT02497066|pain|pain
173394|NCT02497053|MPM|mpm
173395|NCT02497040|anaesthesia|anaesthesia
173396|NCT02497040|local anaesthesia|local anaesthesia
173397|NCT02497040|hemodynamics|hemodynamics
173398|NCT02497040|bupivacaine|bupivacaine
173399|NCT02497040|levobupivacaine|levobupivacaine
173400|NCT02497027|pharmacogenetic, pharmacogenomic, depressive, mental health|pharmacogenetic, pharmacogenomic, depressive, mental health
173401|NCT02496988|Cytokine-Induced Killer Cells|cytokine-induced killer cells
173402|NCT02496988|Milignant Gliomas|milignant gliomas
173403|NCT02496988|Temozolomide|temozolomide
173404|NCT02496962|sleep deprivation|sleep deprivation
173405|NCT02496936|Energy Expenditure|energy expenditure
173406|NCT02496936|Appetite|appetite
173407|NCT02496936|Satiety|satiety
173408|NCT02496923|prophylactic NHFO|prophylactic nhfo
173409|NCT02496923|risk of developing postoperative pulmonary complications|risk of developing postoperative pulmonary complications
173410|NCT02496923|reduces hospital length of stay|reduces hospital length of stay
173411|NCT02496884|chronic kidney disease|chronic kidney disease
173412|NCT02496884|. α2δ ligands|. α2δ ligands
173413|NCT02496884|mirogabalin|mirogabalin
173414|NCT02496884|pain relief|pain relief
173415|NCT02496884|kidney metabolism|kidney metabolism
173416|NCT02496858|Young Patient|young patient
173417|NCT02496858|Genetic Characteristics|genetic characteristics
173418|NCT02496832|Hypoxia|hypoxia
173419|NCT02496832|18F-FAZA|18f-faza
173420|NCT02496832|18F-Fluoroazomycin arabinoside|18f-fluoroazomycin arabinoside
173421|NCT02496832|Positron emission tomography|positron emission tomography
173422|NCT02496832|PET|pet
173423|NCT02496832|Participating in study EMR200592-001|participating in study emr200592-001
173424|NCT02496819|Children|children
173425|NCT02496806|Polyphenols|polyphenols
173426|NCT02496806|Absorption|absorption
173427|NCT02496806|Metabolism|metabolism
173428|NCT02496806|Phlorotannins|phlorotannins
173429|NCT02496806|Seaweeds|seaweeds
173430|NCT02496767|fast skeletal troponin activator|fast skeletal troponin activator
173431|NCT02496767|tirasemtiv|tirasemtiv
173432|NCT02496767|CK-2017357|ck-2017357
173433|NCT02496767|double-blind|double-blind
173434|NCT02496767|randomized|randomized
173435|NCT02496767|placebo-controlled|placebo-controlled
173436|NCT02496741|isocitrate dehydrogenase 1/2 mutation|isocitrate dehydrogenase 1/2 mutation
173437|NCT02496741|metformin|metformin
173438|NCT02496741|chloroquine|chloroquine
173439|NCT02496728|Mobile Health|mobile health
173440|NCT02496728|Smartphone|smartphone
173441|NCT02496728|Cardiovascular health|cardiovascular health
173442|NCT02496728|College students|college students
173443|NCT02496728|Smoking|smoking
173444|NCT02496728|Physical activity|physical activity
173445|NCT02496728|Diet|diet
173446|NCT02496728|BMI|bmi
173447|NCT02496728|Blood pressure|blood pressure
173448|NCT02496728|Cholesterol|cholesterol
173449|NCT02496728|Glucose|glucose
173450|NCT02496728|Text|text
173451|NCT02496728|Facebook|facebook
173452|NCT02496728|Instagram|instagram
173453|NCT02496728|Push Notifications|push notifications
173454|NCT02496728|Ecological Momentary Assessment|ecological momentary assessment
173455|NCT02496702|exergaming|exergaming
173456|NCT02496702|Senior Fitness Test|senior fitness test
173457|NCT02496689|HPP|hpp
173458|NCT02496689|Bone Disease|bone disease
173459|NCT02496689|Soft Bones|soft bones
173460|NCT02496689|Low Alkaline Phosphatase|low alkaline phosphatase
173461|NCT02496689|genetic metabolic disorder|genetic metabolic disorder
173462|NCT02496689|alkaline phosphatase|alkaline phosphatase
173463|NCT02496689|rickets|rickets
173464|NCT02496689|osteomalacia|osteomalacia
173465|NCT02496676|Lymphoma|lymphoma
173466|NCT02496676|Epstein-Barr Virus|epstein-barr virus
173467|NCT02496676|Immunodeficiency|immunodeficiency
173468|NCT02496676|MAGT1 Gene|magt1 gene
173469|NCT02496676|Intracellular Magnesium|intracellular magnesium
173470|NCT02496650|alcohol withdrawal state|alcohol withdrawal state
173471|NCT02496650|dexmedetomidine|dexmedetomidine
173472|NCT02496650|benzodiasepines|benzodiasepines
173473|NCT02496650|intensive care|intensive care
173474|NCT02496637|Obesity|obesity
173475|NCT02496637|Eating Disorders|eating disorders
173476|NCT02496637|Appetite regulation|appetite regulation
173477|NCT02496637|Eating Regulation|eating regulation
173478|NCT02496611|Obesity|obesity
173479|NCT02496611|Pharmacotherapy|pharmacotherapy
173480|NCT02496611|GLP-1|glp-1
173481|NCT02496611|Children|children
173482|NCT02496611|Exenatide|exenatide
173483|NCT02496611|BYDUREON|bydureon
173484|NCT02496611|Weight Loss|weight loss
173485|NCT02496611|Maintenance|maintenance
173486|NCT02496598|Reproductive Techniques, Assisted|reproductive techniques, assisted
173487|NCT02496598|Ovarian Follicle|ovarian follicle
173488|NCT02496585|Nintedanib (BIBF 1120)|nintedanib (bibf 1120)
173489|NCT02496585|Prednisone|prednisone
173490|NCT02496585|Radiation Pneumonitis|radiation pneumonitis
173491|NCT02496572|Tuberculosis, multidrug resistant|tuberculosis, multidrug resistant
173492|NCT02496572|Short-course regimen|short-course regimen
173493|NCT02496572|Medecins sans Frontieres, MSF|medecins sans frontieres, msf
173494|NCT02496572|Uzbekistan, Ministry of Health|uzbekistan, ministry of health
173495|NCT02496559|C-reactive Protein|c-reactive protein
173496|NCT02496559|Primary Health Care|primary health care
173497|NCT02496559|Child Welfare|child welfare
173498|NCT02496559|After-Hours Care|after-hours care
173499|NCT02496559|Anti-Bacterial Agents|anti-bacterial agents
173500|NCT02496559|Drug Prescriptions|drug prescriptions
173501|NCT02496520|dendritic cell vaccination|dendritic cell vaccination
173502|NCT02496520|sarcoma|sarcoma
173503|NCT02496520|central nervous system tumor|central nervous system tumor
173504|NCT02496520|childhood|childhood
173505|NCT02496520|adolescent|adolescent
173506|NCT02496520|immunotherapy|immunotherapy
173507|NCT02496507|sitting|sitting
173508|NCT02496507|intervention|intervention
173509|NCT02496507|desks|desks
173510|NCT02496507|workplace|workplace
173511|NCT02496507|cardiovascular|cardiovascular
173512|NCT02496507|metabolic|metabolic
173513|NCT02496507|qualitative|qualitative
173514|NCT02496507|randomised controlled trial|randomised controlled trial
173515|NCT02496468|childhood asthma|childhood asthma
173516|NCT02496468|preschool wheeze|preschool wheeze
173517|NCT02496468|adult asthma|adult asthma
173518|NCT02496468|transition|transition
173519|NCT02496468|phenotype|phenotype
173520|NCT02496468|endotype|endotype
173521|NCT02496468|trajectory|trajectory
173522|NCT02496455|NAV1.7 Voltage-Gated Sodium Channel|nav1.7 voltage-gated sodium channel
173523|NCT02496455|pain, postoperative|pain, postoperative
173524|NCT02496455|cesarean section|cesarean section
173525|NCT02496442|Transurethral Resection of Prostate|transurethral resection of prostate
173526|NCT02496442|Cystoscopy|cystoscopy
173527|NCT02496442|PCNL|pcnl
173528|NCT02496442|RERAS|reras
173529|NCT02496442|Urethroscopy|urethroscopy
173530|NCT02496403|buprenorphine-naloxone combination|buprenorphine-naloxone combination
173531|NCT02496403|Suboxone|suboxone
173532|NCT02496403|Buprenorphine|buprenorphine
173533|NCT02496403|Substance Use|substance use
173534|NCT02496403|Behavioral intervention|behavioral intervention
173535|NCT02496403|Opioid partial agonist|opioid partial agonist
173536|NCT02496403|medication assisted therapy|medication assisted therapy
173537|NCT02496403|opioid addiction|opioid addiction
173538|NCT02496390|Fecal Microbial Transplantation|fecal microbial transplantation
173539|NCT02496390|Gut microbiome|gut microbiome
173540|NCT02496390|Metabolic disorders|metabolic disorders
173541|NCT02496390|Obesity|obesity
173542|NCT02496377|Anaemia|anaemia
173543|NCT02496377|Iron deficiency|iron deficiency
173544|NCT02496377|Ferric carboxymaltose|ferric carboxymaltose
173545|NCT02496377|Patient blood management|patient blood management
173546|NCT02496377|Hip arthroplasty|hip arthroplasty
173547|NCT02496377|Knee arthroplasty|knee arthroplasty
173548|NCT02496364|Tranexamic Acid|tranexamic acid
173549|NCT02496364|Scoliosis|scoliosis
173550|NCT02496364|bleeding control|bleeding control
173551|NCT02496351|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
173552|NCT02496338|Menopause|menopause
173553|NCT02496338|Quality of Life|quality of life
173554|NCT02496338|Marital Satisfaction|marital satisfaction
173555|NCT02496338|training|training
173556|NCT02496325|Pudendal nerve block|pudendal nerve block
173557|NCT02496325|Ultrasound guided|ultrasound guided
173558|NCT02496325|Transperineal puncture|transperineal puncture
173559|NCT02496325|Perineal surgery|perineal surgery
173560|NCT02496325|children|children
173561|NCT02496312|Apathy|apathy
173562|NCT02496312|Goal-directed behavior|goal-directed behavior
173563|NCT02496312|Quantitative evaluation|quantitative evaluation
173564|NCT02496312|Sensor|sensor
173565|NCT02496312|Ethogram|ethogram
173566|NCT02496299|COMPARISSON|comparisson
173567|NCT02496299|CAUDAL BLOCK|caudal block
173568|NCT02496299|BUPIVACAINE|bupivacaine
173569|NCT02496299|DEXAMETHASONE|dexamethasone
173570|NCT02496286|Necessary paracentesis for symptom control|necessary paracentesis for symptom control
173571|NCT02496273|Dendritic Cells|dendritic cells
173572|NCT02496273|Cytotoxic T-Lymphocytes|cytotoxic t-lymphocytes
173573|NCT02496273|Adeno-Associated Virus|adeno-associated virus
173574|NCT02496260|Magnetic resonance imaging|magnetic resonance imaging
173575|NCT02496260|Cardiac function|cardiac function
173576|NCT02496260|Breast Cancer|breast cancer
173577|NCT02496247|malnutrition|malnutrition
173578|NCT02496247|undernutrition|undernutrition
173579|NCT02496247|Z-score|z-score
173580|NCT02496247|Guinea-Bissau|guinea-bissau
173581|NCT02496247|food aid|food aid
173582|NCT02496234|Coronary Artery Bypass Graft Surgery|coronary artery bypass graft surgery
173583|NCT02496234|Acute kidney injury|acute kidney injury
173584|NCT02496234|Renal failure|renal failure
173585|NCT02496234|Biomarker|biomarker
173586|NCT02496221|Cholecystokinin|cholecystokinin
173587|NCT02496221|ultrasonography|ultrasonography
173588|NCT02496221|Albiglutide|albiglutide
173589|NCT02496221|Gallbladder ejection fraction|gallbladder ejection fraction
173590|NCT02496169|PTCA|ptca
173591|NCT02496169|stenosis|stenosis
173592|NCT02496169|sirolimus|sirolimus
173593|NCT02496169|stent|stent
173594|NCT02496156|type 1 diabetes mellitus|type 1 diabetes mellitus
173595|NCT02496156|adolescence|adolescence
173596|NCT02496156|adherence|adherence
173597|NCT02496156|insulin pump|insulin pump
173598|NCT02496156|continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
173599|NCT02496156|continuous glucose monitor|continuous glucose monitor
173600|NCT02496156|shared medical decision making|shared medical decision making
173601|NCT02496143|Healthy Volunteers|healthy volunteers
173602|NCT02496143|Phase I|phase i
173603|NCT02496143|Placebo controlled|placebo controlled
173604|NCT02496143|Single Ascending Dose|single ascending dose
173605|NCT02496143|PK|pk
173606|NCT02496143|Oral administration|oral administration
173607|NCT02496143|Softgel|softgel
173608|NCT02496130|minilaparotomy|minilaparotomy
173609|NCT02496130|morcellation|morcellation
173610|NCT02496130|laparoscopy|laparoscopy
173611|NCT02496104|Preterm|preterm
173612|NCT02496104|Infant|infant
173613|NCT02496104|Habituation|habituation
173614|NCT02496104|APIB|apib
173615|NCT02496065|breast cancer|breast cancer
173616|NCT02496065|BLZ-100|blz-100
173617|NCT02496065|Tumor Paint|tumor paint
173618|NCT02496065|breast tumors|breast tumors
173619|NCT02496052|amnion graft|amnion graft
173620|NCT02496052|New biological barrier system|new biological barrier system
173621|NCT02496039|PBA|pba
173622|NCT02496039|involuntary crying|involuntary crying
173623|NCT02496039|involuntary laughing|involuntary laughing
173624|NCT02496000|Diabetes Mellitus type 2|diabetes mellitus type 2
173625|NCT02496000|Metformin|metformin
173626|NCT02496000|oral insulin|oral insulin
173627|NCT02495974|Xtandi|xtandi
173628|NCT02495974|Enzalutamide|enzalutamide
173629|NCT02495974|Prostate cancer|prostate cancer
173630|NCT02495974|Metastatic castration resistant prostate cancer|metastatic castration resistant prostate cancer
173631|NCT02495961|hyperlipidemias|hyperlipidemias
173632|NCT02495961|hyperglycemia|hyperglycemia
173633|NCT02495961|hypertension|hypertension
173634|NCT02495961|leptin|leptin
173635|NCT02495961|hyperhomocysteinemia|hyperhomocysteinemia
173636|NCT02495935|TES|tes
173637|NCT02495935|Transcorneal Electrical Stimulation|transcorneal electrical stimulation
173638|NCT02495935|Amblyopia|amblyopia
173639|NCT02495909|paediatric schistosomiasis|paediatric schistosomiasis
173640|NCT02495909|morbidity|morbidity
173641|NCT02495909|immunology|immunology
173642|NCT02495883|Essential Tremor|essential tremor
173643|NCT02495883|Magnetic Resonance Imaging|magnetic resonance imaging
173644|NCT02495883|Therapy|therapy
173645|NCT02495883|Alcohol|alcohol
173646|NCT02495883|Propranolol|propranolol
173647|NCT02495844|UCB0942|ucb0942
173648|NCT02495844|Treatment-resistant focal epilepsy|treatment-resistant focal epilepsy
173649|NCT02495844|Partial seizures|partial seizures
173650|NCT02495844|Seizure therapy|seizure therapy
173651|NCT02495831|PK study|pk study
173652|NCT02495818|Rotator cuff syndrome|rotator cuff syndrome
173653|NCT02495818|supraspinatus tendonitis|supraspinatus tendonitis
173654|NCT02495818|suprascapular nerve block|suprascapular nerve block
173655|NCT02495818|ultrasound guided|ultrasound guided
173656|NCT02495818|supraspinatus|supraspinatus
173657|NCT02495805|a continuous proximal adductor canal block (ACB)|a continuous proximal adductor canal block (acb)
173658|NCT02495805|continuous femoral nerve block (FNB)|continuous femoral nerve block (fnb)
173659|NCT02495779|PrEP|prep
173660|NCT02495779|HIV|hiv
173661|NCT02495779|MSM|msm
173662|NCT02495779|Men Having Sex With Men|men having sex with men
173663|NCT02495779|Episodic PrEP|episodic prep
173664|NCT02495779|Adherence|adherence
173665|NCT02495779|Episodic HIV Risk|episodic hiv risk
173666|NCT02495766|Multiple sclerosis|multiple sclerosis
173667|NCT02495766|Bone marrow mesenchymal stromal cells|bone marrow mesenchymal stromal cells
173668|NCT02495766|Stem cells|stem cells
173669|NCT02495766|Nervous System Diseases|nervous system diseases
173670|NCT02495766|Demyelinating Diseases|demyelinating diseases
173671|NCT02495766|Autoimmune Diseases|autoimmune diseases
173672|NCT02495753|cesarean section|cesarean section
173673|NCT02495753|wound infection|wound infection
173674|NCT02495753|vaginal cleansing|vaginal cleansing
173675|NCT02495753|endometritis|endometritis
173676|NCT02495727|Step-reduction model|step-reduction model
173677|NCT02495727|Reduced activity|reduced activity
173678|NCT02495727|Atrophy|atrophy
173679|NCT02495727|Skeletal Muscle|skeletal muscle
173680|NCT02495727|Sarcopenia|sarcopenia
173681|NCT02495727|Dynapenia|dynapenia
173682|NCT02495714|Exercise|exercise
173683|NCT02495714|Diet|diet
173684|NCT02495714|Learning|learning
173685|NCT02495688|General Anesthesia|general anesthesia
173686|NCT02495688|Regional Anesthesia|regional anesthesia
173687|NCT02495662|Vascular access|vascular access
173688|NCT02495662|Hemodialysis|hemodialysis
173689|NCT02495662|Arteriovenous shunt|arteriovenous shunt
173690|NCT02495662|Arteriovenous fistula|arteriovenous fistula
173691|NCT02495662|Maturation|maturation
173692|NCT02495662|Liposomal prednisolone|liposomal prednisolone
173693|NCT02495662|PEG-liposomal prednisolone sodium phosphate|peg-liposomal prednisolone sodium phosphate
173694|NCT02495662|Radio-cephalic|radio-cephalic
173695|NCT02495662|Shunt|shunt
173696|NCT02495610|NPH|nph
173697|NCT02495610|Gait analysis|gait analysis
173698|NCT02495610|neuropsychology|neuropsychology
173699|NCT02495610|micturition diary|micturition diary
173700|NCT02495610|MRI|mri
173701|NCT02495597|bronchial inflammation|bronchial inflammation
173702|NCT02495597|Bronchiolitis obliterans|bronchiolitis obliterans
173703|NCT02495597|Sputum|sputum
173704|NCT02495597|Blood|blood
173705|NCT02495597|Inflammation|inflammation
173706|NCT02495597|adaptive immune system|adaptive immune system
173707|NCT02495597|innate immune system|innate immune system
173708|NCT02495584|Vitamin D|vitamin d
173709|NCT02495584|Fortified milk|fortified milk
173710|NCT02495584|Supplementation|supplementation
173711|NCT02495584|UV exposure|uv exposure
173712|NCT02495584|Winter|winter
173713|NCT02495584|Healthy adults|healthy adults
173714|NCT02495584|Body Composition|body composition
173715|NCT02495584|Muscle function|muscle function
173716|NCT02495584|Blood pressure|blood pressure
173717|NCT02495571|ALS and Dysphagia|als and dysphagia
173718|NCT02495571|ALS and cough|als and cough
173719|NCT02495571|cough reflex test|cough reflex test
173720|NCT02495558|Cough Reflex test|cough reflex test
173721|NCT02495558|Decannulation|decannulation
173722|NCT02495545|spinal cord injury (SCI)|spinal cord injury (sci)
173723|NCT02495532|Neoplasm Metastasis|neoplasm metastasis
173724|NCT02495532|Colorectal Neoplasms|colorectal neoplasms
173725|NCT02495532|Lymph Nodes|lymph nodes
173726|NCT02495532|Lymph Node Revealing Solution|lymph node revealing solution
173727|NCT02495506|Cardiac surgery|cardiac surgery
173728|NCT02495506|bleeding|bleeding
173729|NCT02495506|platelet transfusion|platelet transfusion
173730|NCT02495480|disposable sheath|disposable sheath
173731|NCT02495480|intubation|intubation
173732|NCT02495480|colonoscopy|colonoscopy
173733|NCT02495428|Bandage|bandage
173734|NCT02495428|Treadmill|treadmill
173735|NCT02495428|Lactate Acid|lactate acid
173736|NCT02495389|urinary urgency incontinence|urinary urgency incontinence
173737|NCT02495376|YACS|yacs
173738|NCT02495376|cancer|cancer
173739|NCT02495376|MBSR|mbsr
173740|NCT02495311|adenomyosis|adenomyosis
173741|NCT02495311|uterine myoma|uterine myoma
173742|NCT02495311|lower urinary tract symptoms|lower urinary tract symptoms
173743|NCT02495311|sexual dysfunction|sexual dysfunction
173744|NCT02495311|gastrointestinal symptom|gastrointestinal symptom
173745|NCT02495298|Fascial manipulation|fascial manipulation
173746|NCT02495298|Carpal Tunnel Syndrome|carpal tunnel syndrome
173747|NCT02495285|pediatric patients gelatine|pediatric patients gelatine
173748|NCT02495272|Postpartum hemorrhage|postpartum hemorrhage
173749|NCT02495272|Third stage of labour|third stage of labour
173750|NCT02495272|Oxytocin|oxytocin
173751|NCT02495272|Uterotonics|uterotonics
173752|NCT02495272|Active management of third stage of labour|active management of third stage of labour
174005|NCT02493985|Space flight|space flight
173753|NCT02495259|Double-lumen endobronchial tube|double-lumen endobronchial tube
173754|NCT02495259|Laryngoscopy|laryngoscopy
173755|NCT02495259|intubating stylet|intubating stylet
173756|NCT02495233|Erlotinib|erlotinib
173758|NCT02495233|NSCLC|nsclc
173759|NCT02495233|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
173760|NCT02495220|dexmedetomidine|dexmedetomidine
173761|NCT02495220|subtenon anesthesia|subtenon anesthesia
173762|NCT02495220|postoperative pain|postoperative pain
173763|NCT02495220|pov|pov
173764|NCT02495194|Promotion of psychological well-being|promotion of psychological well-being
173765|NCT02495194|Horticultural therapy|horticultural therapy
173766|NCT02495194|Randomized Controlled Trial|randomized controlled trial
173767|NCT02495194|Gardening|gardening
173768|NCT02495194|Elderly|elderly
173769|NCT02495129|Primary Sjögren's syndrome|primary sjögren's syndrome
173770|NCT02495129|Sicca syndrome|sicca syndrome
173771|NCT02495129|Salivary glands|salivary glands
173772|NCT02495129|Positron Emission Tomography|positron emission tomography
173773|NCT02495129|B cell depletion|b cell depletion
173774|NCT02495103|Dose-Escalation|dose-escalation
173775|NCT02495103|Maximum Tolerated Dose|maximum tolerated dose
173776|NCT02495103|Safety|safety
173777|NCT02495103|Overall Response|overall response
173778|NCT02495090|Hypospadias|hypospadias
173779|NCT02495090|exome sequencing|exome sequencing
173780|NCT02495090|genital malformation|genital malformation
173781|NCT02495077|Kidney Transplantation|kidney transplantation
173782|NCT02495077|infliximab|infliximab
173783|NCT02495077|Tissue Donors|tissue donors
173784|NCT02495077|Remicade|remicade
173785|NCT02495077|Induction Therapy|induction therapy
173786|NCT02495077|Deceased Donor Kidney Transplant Recipients|deceased donor kidney transplant recipients
173787|NCT02495051|gastroesophageal reflux|gastroesophageal reflux
173788|NCT02495051|barrett esophagus|barrett esophagus
173789|NCT02495038|combination|combination
173790|NCT02495038|rocuronium|rocuronium
173791|NCT02495038|cisatracurium|cisatracurium
173792|NCT02495038|neuromuscular blockade monitoring|neuromuscular blockade monitoring
173793|NCT02495038|drug synergism|drug synergism
173794|NCT02495012|efficacy|efficacy
173795|NCT02495012|safety|safety
173796|NCT02495012|STEMI|stemi
173797|NCT02494999|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
173798|NCT02494999|immunogenicity|immunogenicity
173799|NCT02494999|safety|safety
173800|NCT02494986|Human immunodeficiency virus type 1|human immunodeficiency virus type 1
173801|NCT02494986|Rilpivirine|rilpivirine
173802|NCT02494986|Roll-over study|roll-over study
173803|NCT02494960|smoking cessation intervention|smoking cessation intervention
173804|NCT02494947|Coronary Angiography|coronary angiography
173805|NCT02494947|Exercise|exercise
173806|NCT02494921|Metastatic|metastatic
173807|NCT02494921|Castration-Resistant|castration-resistant
173808|NCT02494908|Parkinson Disease|parkinson disease
173809|NCT02494908|MRI|mri
173810|NCT02494882|Ruxolitinib|ruxolitinib
173811|NCT02494882|Dasatinib|dasatinib
173812|NCT02494882|Dexamethasone|dexamethasone
173813|NCT02494882|14-272|14-272
173814|NCT02494869|Aerobic Training|aerobic training
173815|NCT02494869|Exercise|exercise
173816|NCT02494869|Gene Expression|gene expression
173817|NCT02494869|15-093|15-093
173818|NCT02494856|Naproxen|naproxen
173819|NCT02494856|Lower third molar|lower third molar
173820|NCT02494856|Oral Surgery|oral surgery
173821|NCT02494856|Esomeprazole|esomeprazole
173822|NCT02494830|Anesthetic Drugs|anesthetic drugs
173823|NCT02494817|HIV prevention|hiv prevention
173824|NCT02494817|Toolkit|toolkit
173825|NCT02494817|Male couples|male couples
173826|NCT02494817|Sexual agreements|sexual agreements
173827|NCT02494804|Cytokine-Induced Killer Cells|cytokine-induced killer cells
173828|NCT02494804|Milignant Gliomas|milignant gliomas
173829|NCT02494804|Temozolomide|temozolomide
173830|NCT02494778|Huntington's disease, pridopidine|huntington's disease, pridopidine
173831|NCT02494765|I-gelTM|i-geltm
173832|NCT02494765|Ambu® AuraOnceTM|ambu® auraoncetm
173833|NCT02494765|supraglottic devices|supraglottic devices
173834|NCT02494765|laryngeal mask effects on airway|laryngeal mask effects on airway
173835|NCT02494765|3D magnetic resonance imaging|3d magnetic resonance imaging
173836|NCT02494752|Contour deformities of face|contour deformities of face
173837|NCT02494752|autologous fat grafting|autologous fat grafting
173838|NCT02494752|Post traumatic facial contour defects|post traumatic facial contour defects
173839|NCT02494739|antioxidant|antioxidant
173840|NCT02494739|oxidative stress|oxidative stress
173841|NCT02494739|inflammation|inflammation
173842|NCT02494739|polyphenols|polyphenols
173843|NCT02494739|yogurt|yogurt
173844|NCT02494726|Ischemic stroke|ischemic stroke
173845|NCT02494726|ICH stroke|ich stroke
173846|NCT02494726|TEG|teg
173847|NCT02494726|Thromboelastography|thromboelastography
173848|NCT02494726|Stroke|stroke
173849|NCT02494713|Advanced Prostate Cancer|advanced prostate cancer
173850|NCT02494713|Neoadjuvant|neoadjuvant
173851|NCT02494713|Hormone therapy|hormone therapy
173852|NCT02494713|ADT|adt
173853|NCT02494713|Androgen Deprivation Therapy|androgen deprivation therapy
173854|NCT02494713|Chemotherapy|chemotherapy
173855|NCT02494713|Radical Prostatectomy|radical prostatectomy
173856|NCT02494700|Lymphoma|lymphoma
173857|NCT02494700|Low grade B lymphocyte (B cell) lymphoma|low grade b lymphocyte (b cell) lymphoma
173858|NCT02494700|Mantle cell lymphoma involving the ocular adnexa|mantle cell lymphoma involving the ocular adnexa
173859|NCT02494700|Limited and advanced stage|limited and advanced stage
173860|NCT02494700|Ocular adnexa|ocular adnexa
173861|NCT02494700|Radiation therapy|radiation therapy
173862|NCT02494700|XRT|xrt
173863|NCT02494661|Public Health|public health
173864|NCT02494661|Community|community
173865|NCT02494661|Obesity|obesity
173866|NCT02494661|Hispanic|hispanic
173867|NCT02494661|Women|women
173868|NCT02494661|Nutrition|nutrition
173869|NCT02494661|Mindfulness and stress|mindfulness and stress
173870|NCT02494661|Food shopping|food shopping
173871|NCT02494648|Obstructive sleep apnea|obstructive sleep apnea
173872|NCT02494648|Resistive inspiratory muscle training|resistive inspiratory muscle training
173873|NCT02494648|Coronary artery disease|coronary artery disease
173874|NCT02494648|Cardiac rehabilitation|cardiac rehabilitation
173875|NCT02494583|Gastric carcinoma|gastric carcinoma
173876|NCT02494583|Gastric cancer|gastric cancer
173877|NCT02494583|Gastroesophageal junction cancer|gastroesophageal junction cancer
173878|NCT02494583|Gastroesophageal junction carcinoma|gastroesophageal junction carcinoma
173880|NCT02494583|PD-1|pd-1
173881|NCT02494583|PDL1|pdl1
173882|NCT02494583|PD-L1|pd-l1
173883|NCT02494544|knee implant|knee implant
173884|NCT02494544|knee replacement|knee replacement
173885|NCT02494544|total knee replacement|total knee replacement
173886|NCT02494531|Alzheimer Disease|alzheimer disease
173887|NCT02494531|PET|pet
173888|NCT02494531|diagnosis|diagnosis
173889|NCT02494531|MCI|mci
173890|NCT02494531|illiterate|illiterate
173891|NCT02494518|stroke|stroke
173892|NCT02494518|aerobic exercise|aerobic exercise
173893|NCT02494518|forced exercise|forced exercise
173894|NCT02494518|repetitive task practice|repetitive task practice
173895|NCT02494518|arm function|arm function
173896|NCT02494518|upper extremity|upper extremity
173897|NCT02494505|chronic inflammatory demyelinating polyradiculopathy|chronic inflammatory demyelinating polyradiculopathy
173898|NCT02494505|intravenous immunoglobulin (IVIG)|intravenous immunoglobulin (ivig)
173899|NCT02494505|withdrawal|withdrawal
173900|NCT02494505|quality of life|quality of life
173901|NCT02494505|Clinical trial|clinical trial
173902|NCT02494505|cost|cost
173903|NCT02494492|Uveitis|uveitis
173904|NCT02494492|Lymphocyte cells|lymphocyte cells
173905|NCT02494492|lymphocyte T regulator|lymphocyte t regulator
173906|NCT02494492|vitreous haze|vitreous haze
173907|NCT02494492|intravitreal injection|intravitreal injection
173908|NCT02494479|Psoriasis|psoriasis
173909|NCT02494479|Topical Psoriasis|topical psoriasis
173910|NCT02494479|Mild Psoriasis|mild psoriasis
173911|NCT02494479|Moderate Psoriasis|moderate psoriasis
173912|NCT02494479|Active Psoriasis|active psoriasis
173913|NCT02494479|Plaque Psoriasis|plaque psoriasis
173914|NCT02494479|Skin Diseases|skin diseases
173915|NCT02494466|Airway Resistance|airway resistance
173916|NCT02494466|montelukast sodium|montelukast sodium
173917|NCT02494466|laryngeal mask airway|laryngeal mask airway
173918|NCT02494427|Crowns|crowns
173919|NCT02494427|Inlays|inlays
173920|NCT02494427|Onlays|onlays
173921|NCT02494414|Cardiac arrest|cardiac arrest
173922|NCT02494414|outcome|outcome
173923|NCT02494414|neurological status|neurological status
173924|NCT02494401|systemic sclerosis|systemic sclerosis
173925|NCT02494401|ssc|ssc
173926|NCT02494375|Sleep|sleep
173927|NCT02494375|glycemic control|glycemic control
173928|NCT02494375|type 1 diabetes|type 1 diabetes
173929|NCT02494375|amylase|amylase
173930|NCT02494375|body composition|body composition
173931|NCT02494375|lean|lean
173932|NCT02494375|overweight|overweight
173933|NCT02494375|obese|obese
173934|NCT02494362|Hand exercises|hand exercises
173935|NCT02494362|Hand function|hand function
173936|NCT02494362|Computer based exercises|computer based exercises
173937|NCT02494362|Therapeutic gaming|therapeutic gaming
173938|NCT02494349|α1-blockers|α1-blockers
173939|NCT02494349|antimuscarinic agent|antimuscarinic agent
173940|NCT02494323|Dual Channel Functional Electrical Stimulation|dual channel functional electrical stimulation
173941|NCT02494323|dropfoot, balanced dorsiflexion|dropfoot, balanced dorsiflexion
173942|NCT02494284|Coronary artery disease|coronary artery disease
173943|NCT02494284|Dual antiplatelet platelet therapy|dual antiplatelet platelet therapy
173944|NCT02494284|Drug eluting stent|drug eluting stent
173945|NCT02494258|CC-486|cc-486
173946|NCT02494258|Oral Azacitidine|oral azacitidine
173947|NCT02494258|Solid tumors|solid tumors
173948|NCT02494258|hematological disorders|hematological disorders
173949|NCT02494258|rollover study|rollover study
173950|NCT02494245|Rehabilitation|rehabilitation
173951|NCT02494245|Intervention|intervention
173952|NCT02494245|Walking|walking
173953|NCT02494232|minor blunt thoracic trauma|minor blunt thoracic trauma
173954|NCT02494232|physical examination|physical examination
173955|NCT02494219|Group A streptococcal pharyngitis|group a streptococcal pharyngitis
173956|NCT02494219|Rapid streptococcal test|rapid streptococcal test
173957|NCT02494219|Throat swab culture|throat swab culture
173958|NCT02494206|QBX258|qbx258
173959|NCT02494206|human monoclonal antibodies|human monoclonal antibodies
173960|NCT02494206|VAK694|vak694
173961|NCT02494206|QAX576|qax576
173962|NCT02494206|15-085|15-085
173963|NCT02494180|fentanyl|fentanyl
173964|NCT02494180|midazolam|midazolam
173965|NCT02494180|pethidine|pethidine
173966|NCT02494180|diazepam|diazepam
173967|NCT02494167|Acute Myeloid Leukemia|acute myeloid leukemia
173968|NCT02494167|Myelodysplastic Syndrome|myelodysplastic syndrome
173969|NCT02494167|MultiTAA Specific T cells|multitaa specific t cells
173970|NCT02494128|Child health service|child health service
173971|NCT02494128|Family health|family health
173972|NCT02494128|Nurse|nurse
173973|NCT02494128|Education|education
173974|NCT02494128|Parental group|parental group
173975|NCT02494128|Group leadership|group leadership
173976|NCT02494128|Health promotion|health promotion
173977|NCT02494102|Obstructive Sleep Apnea|obstructive sleep apnea
173978|NCT02494102|General Anesthesia|general anesthesia
173979|NCT02494102|Modafinil|modafinil
173980|NCT02494089|in situ simulation|in situ simulation
173981|NCT02494089|in hospital cardiac arrest|in hospital cardiac arrest
173982|NCT02494089|clinical audit|clinical audit
173983|NCT02494089|education|education
173984|NCT02494089|patient simulation|patient simulation
173985|NCT02494063|cervical cancer|cervical cancer
173986|NCT02494063|sentinel lymph node|sentinel lymph node
173987|NCT02494063|lymphadenectomy|lymphadenectomy
173988|NCT02494050|Depression|depression
173989|NCT02494050|Bipolar Disorder|bipolar disorder
173990|NCT02494050|Anhedonia|anhedonia
173991|NCT02494050|Women|women
173992|NCT02494024|PSP|psp
173993|NCT02494024|C2N-8E12|c2n-8e12
173994|NCT02494024|tauopathy|tauopathy
173995|NCT02494024|Progressive Supranuclear Palsy|progressive supranuclear palsy
173996|NCT02494024|Steele Richardson Olszewski Syndrome|steele richardson olszewski syndrome
173997|NCT02494024|Humanized anti-tau antibody|humanized anti-tau antibody
173998|NCT02494011|Colles' Fracture; CKCE; Russian current|colles' fracture; ckce; russian current
173999|NCT02493998|Sanfilippo Syndrome Type B|sanfilippo syndrome type b
174000|NCT02493985|Brain physiology|brain physiology
174001|NCT02493985|Intracranial pressure|intracranial pressure
174002|NCT02493985|Cognition|cognition
174003|NCT02493985|Cerebrovascular|cerebrovascular
174004|NCT02493985|Head down tilt|head down tilt
174006|NCT02493972|ovarian cancer|ovarian cancer
174007|NCT02493972|peritoneal carcinosis|peritoneal carcinosis
174008|NCT02493972|manual exploration|manual exploration
174009|NCT02493972|surgery|surgery
174010|NCT02493972|GelPort|gelport
174011|NCT02493959|PYY|pyy
174012|NCT02493959|Degradation|degradation
174013|NCT02493959|kinetics|kinetics
174014|NCT02493959|men|men
174015|NCT02493920|Respiratory Distress Syndrome, Newborn|respiratory distress syndrome, newborn
174016|NCT02493920|Delivery Room|delivery room
174017|NCT02493920|Resuscitation|resuscitation
174018|NCT02493920|Premature birth|premature birth
174019|NCT02493920|Infant, Newborn|infant, newborn
174020|NCT02493920|Respiration Artificial|respiration artificial
174021|NCT02493894|Bowel preparation|bowel preparation
174022|NCT02493894|perioperative bleeding|perioperative bleeding
174023|NCT02493894|lumbar fusion|lumbar fusion
174024|NCT02493881|Motor function of the extralaryngeal branches|motor function of the extralaryngeal branches
174025|NCT02493881|intraoperative neuromonitoring|intraoperative neuromonitoring
174026|NCT02493881|recurrent laryngeal nerve|recurrent laryngeal nerve
174027|NCT02493868|Treatment-resistant Depression|treatment-resistant depression
174028|NCT02493868|Esketamine|esketamine
174029|NCT02493868|Placebo|placebo
174030|NCT02493868|Oral Antidepressant|oral antidepressant
174031|NCT02493868|Relapse prevention|relapse prevention
174032|NCT02493855|Treatment naive|treatment naive
174033|NCT02493855|HCV|hcv
174034|NCT02493855|Interferon free|interferon free
174035|NCT02493855|Hepatitis C Genotype 1a|hepatitis c genotype 1a
174036|NCT02493855|Chronic Hepatitis C|chronic hepatitis c
174037|NCT02493855|Hepatitis C|hepatitis c
174038|NCT02493842|Nerve Stimulation|nerve stimulation
174039|NCT02493842|Neuroplasticity|neuroplasticity
174040|NCT02493842|Sensory Feedback|sensory feedback
174041|NCT02493790|cognitive dysfunction|cognitive dysfunction
174042|NCT02493790|Activity of Daily Living|activity of daily living
174043|NCT02493790|interference|interference
174044|NCT02493790|rehabilitation|rehabilitation
174045|NCT02493790|cognitive-motor dual task|cognitive-motor dual task
174046|NCT02493751|Cancer, renal cell cancer, kidney disease, kidney neoplasms, axitinib|cancer, renal cell cancer, kidney disease, kidney neoplasms, axitinib
174047|NCT02493673|Continuous Positive Airway Pressure|continuous positive airway pressure
174048|NCT02493673|Stroke|stroke
174049|NCT02493673|Cerebrovascular reactivity|cerebrovascular reactivity
174050|NCT02493673|Brain oxygenation|brain oxygenation
174051|NCT02493660|Massive Rotator Cuff Tear|massive rotator cuff tear
174052|NCT02493660|Arthroscopy|arthroscopy
174053|NCT02493660|Shoulder Joint|shoulder joint
174054|NCT02493660|Rotator cuff partial repair|rotator cuff partial repair
174055|NCT02493634|Magnetic Resonance spectroscopy|magnetic resonance spectroscopy
174056|NCT02493634|Aortic Arch|aortic arch
174057|NCT02493621|Pain, Postoperative|pain, postoperative
174058|NCT02493621|Nerve Block|nerve block
174059|NCT02493621|Anesthesia, Epidural|anesthesia, epidural
174060|NCT02493582|CIK|cik
174061|NCT02493582|Apatinib|apatinib
174062|NCT02493582|Lung Adenocarcinoma|lung adenocarcinoma
174063|NCT02493569|Breast cancer, hospital, epidemiology, diagnosis, treatment|breast cancer, hospital, epidemiology, diagnosis, treatment
174064|NCT02493556|Phototherapy|phototherapy
174065|NCT02493556|Plyometric exercise|plyometric exercise
174066|NCT02493556|Muscle recovery|muscle recovery
174067|NCT02493543|autoantibodies|autoantibodies
174068|NCT02493530|MDS/MPN|mds/mpn
174069|NCT02493504|Heparin|heparin
174070|NCT02493491|dysphonia|dysphonia
174071|NCT02493491|dysphagia|dysphagia
174072|NCT02493491|neurogenic|neurogenic
174073|NCT02493491|vocal fold augmentation|vocal fold augmentation
174074|NCT02493491|VFA|vfa
174075|NCT02493491|vocal fold insufficiency|vocal fold insufficiency
174076|NCT02493491|Prolaryn|prolaryn
174077|NCT02493491|Radiesse|radiesse
174078|NCT02493491|Coaptite|coaptite
174079|NCT02493491|voice|voice
174080|NCT02493491|Parkinson's Disease|parkinson's disease
174081|NCT02493491|Multiple Sclerosis|multiple sclerosis
174082|NCT02493491|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
174083|NCT02493491|ALS|als
174084|NCT02493491|MS|ms
174085|NCT02493491|calcium hydroxylapatite|calcium hydroxylapatite
174086|NCT02493491|hyaluronic acid|hyaluronic acid
174087|NCT02493478|Intubation|intubation
174088|NCT02493478|Advanced airway intervention|advanced airway intervention
174089|NCT02493478|Intensive care unit|intensive care unit
174090|NCT02493465|everolimus|everolimus
174091|NCT02493465|left ventricular hypertrophy|left ventricular hypertrophy
174092|NCT02493439|Best Possible Self|best possible self
174093|NCT02493439|Positive Psychology|positive psychology
174094|NCT02493439|Romanian Immigrants|romanian immigrants
174095|NCT02493439|Optimism|optimism
174096|NCT02493439|Future Thinking|future thinking
174097|NCT02493413|psychoneuroimmunology|psychoneuroimmunology
174098|NCT02493413|stress|stress
174099|NCT02493413|lymphocyte population|lymphocyte population
174100|NCT02493413|personality type|personality type
174101|NCT02493413|obesity|obesity
174102|NCT02493413|heart rate variability|heart rate variability
174103|NCT02493413|awareness|awareness
174104|NCT02493400|Follow up|follow up
174105|NCT02493400|Exercise|exercise
174106|NCT02493400|Rehabilitation|rehabilitation
174107|NCT02493387|Physiotherapist led group-based exercise|physiotherapist led group-based exercise
174108|NCT02493387|Physical activity|physical activity
174109|NCT02493387|Atrial fibrillation|atrial fibrillation
174110|NCT02493348|Fibromyalgia|fibromyalgia
174111|NCT02493348|Rhythmic Sensory Stimulation|rhythmic sensory stimulation
174112|NCT02493348|Gamma Stimulation|gamma stimulation
174113|NCT02493283|dapsone|dapsone
174114|NCT02493283|blood leucocytes|blood leucocytes
174115|NCT02493283|pharmacokinetics|pharmacokinetics
174116|NCT02493283|metabolism|metabolism
174117|NCT02493270|smoking cessation|smoking cessation
174118|NCT02493270|tobacco|tobacco
174119|NCT02493270|dental|dental
174120|NCT02493270|periodontal|periodontal
174121|NCT02493257|nonallergic irritant rhinitis|nonallergic irritant rhinitis
174122|NCT02493257|nasal congestion|nasal congestion
174123|NCT02493257|rhinorrhea|rhinorrhea
174124|NCT02493218|mindfulness|mindfulness
174125|NCT02493218|intervention|intervention
174126|NCT02493218|african american|african american
174127|NCT02493218|youth|youth
174128|NCT02493218|stress|stress
174129|NCT02493218|poverty|poverty
174130|NCT02493205|Implantable Cardiac Monitor|implantable cardiac monitor
174131|NCT02493205|Stent|stent
174132|NCT02493192|Parturition|parturition
174133|NCT02493192|Humanizing Deliver|humanizing deliver
174134|NCT02493192|Labor Pain|labor pain
174135|NCT02493192|Natural Childbirth|natural childbirth
174136|NCT02493192|Labor Onset|labor onset
174137|NCT02493192|First Labor Stage|first labor stage
174138|NCT02493192|Birth ball|birth ball
174139|NCT02493192|meperidine|meperidine
174140|NCT02493192|pethidine|pethidine
174141|NCT02493140|Weight management|weight management
174142|NCT02493140|cashew apple extract|cashew apple extract
174143|NCT02493140|overweight|overweight
174144|NCT02493101|Periostin staining|periostin staining
174145|NCT02493101|Urine periostin level|urine periostin level
174146|NCT02493101|Lupus nephritis|lupus nephritis
174147|NCT02493101|IgA nephropathy|iga nephropathy
174148|NCT02493075|atrial fibrillation|atrial fibrillation
174149|NCT02493075|Catheter Ablation|catheter ablation
174150|NCT02493075|contact force|contact force
174151|NCT02493075|Chinese-specific|chinese-specific
174152|NCT02493062|Hysterotomy|hysterotomy
174153|NCT02493062|Myelomeningocele|myelomeningocele
174154|NCT02493062|Open fetal surgery|open fetal surgery
174155|NCT02493062|Sonohysterogram|sonohysterogram
174156|NCT02493049|Multiple Sclerosis|multiple sclerosis
174157|NCT02493049|Domperidone|domperidone
174158|NCT02493049|Relapsing-Remitting MS|relapsing-remitting ms
174159|NCT02493049|Demyelinating disease|demyelinating disease
174160|NCT02493049|Remyelination|remyelination
174161|NCT02493023|Bronchoscopy|bronchoscopy
174162|NCT02493023|Bronchoscopes|bronchoscopes
174163|NCT02493010|Virtual Reality Exposure Therapy|virtual reality exposure therapy
174164|NCT02493010|Computerized Cognitive Behavioral Therapy|computerized cognitive behavioral therapy
174165|NCT02493010|Public Speaking|public speaking
174166|NCT02493010|Social Phobia|social phobia
174167|NCT02493010|Biofeedback|biofeedback
174168|NCT02492997|body fat|body fat
174169|NCT02492984|FVIII inhibitor|fviii inhibitor
174170|NCT02492971|Assistive technology|assistive technology
174171|NCT02492971|functional needs|functional needs
174172|NCT02492971|system usability|system usability
174173|NCT02492945|Tennis elbow|tennis elbow
174174|NCT02492945|Polydeoxyribonucleotides|polydeoxyribonucleotides
174175|NCT02492945|Prolotherapy|prolotherapy
174176|NCT02492945|Randomized controlled trial|randomized controlled trial
174177|NCT02492945|Visual analogue scale|visual analogue scale
174178|NCT02492945|disability|disability
174179|NCT02492945|ultrasonography|ultrasonography
174180|NCT02492919|cardiac surgery|cardiac surgery
174181|NCT02492919|risk factors|risk factors
174182|NCT02492919|infection|infection
174183|NCT02492880|stimulation|stimulation
174184|NCT02492880|implantable|implantable
174185|NCT02492880|pulse generator|pulse generator
174186|NCT02492880|back pain|back pain
174187|NCT02492880|chronic pain|chronic pain
174188|NCT02492880|leg pain|leg pain
174189|NCT02492854|Lower Extremity Bypass|lower extremity bypass
174190|NCT02492854|Surgical Site Infection|surgical site infection
174191|NCT02492854|Wound Dressing|wound dressing
174192|NCT02492854|Negative Pressure Wound Dressing|negative pressure wound dressing
174193|NCT02492841|dentin substitute|dentin substitute
174194|NCT02492841|vital pulp therapy|vital pulp therapy
174195|NCT02492841|Biodentine|biodentine
174196|NCT02492841|caries|caries
174197|NCT02492789|immunotherapy|immunotherapy
174198|NCT02492789|solid tumor|solid tumor
174199|NCT02492789|PD-1 blockade|pd-1 blockade
174200|NCT02492776|Volunteers|volunteers
174201|NCT02492737|acute myeloid leukemia|acute myeloid leukemia
174202|NCT02492737|AML|aml
174203|NCT02492737|myelodysplastic syndrome|myelodysplastic syndrome
174204|NCT02492737|MDS|mds
174205|NCT02492737|dual mutation|dual mutation
174206|NCT02492737|MPN|mpn
174207|NCT02492737|AITL|aitl
174208|NCT02492737|hematologic malignancies|hematologic malignancies
174209|NCT02492737|IDH1|idh1
174210|NCT02492737|IDH2|idh2
174211|NCT02492737|AG-881|ag-881
174212|NCT02492724|cervical spine|cervical spine
174213|NCT02492724|total disc replacement (cTDR)|total disc replacement (ctdr)
174214|NCT02492724|degenerative disc disease|degenerative disc disease
174215|NCT02492724|activ® C|activ® c
174216|NCT02492724|clinical outcome|clinical outcome
174217|NCT02492724|long-term results|long-term results
174218|NCT02492724|NDI|ndi
174219|NCT02492724|VAS|vas
174220|NCT02492724|heterotopic ossification (HO)|heterotopic ossification (ho)
175623|NCT02484183|hypoxemia|hypoxemia
174221|NCT02492724|range of motion (ROM)|range of motion (rom)
174222|NCT02492724|adjacent segment degeneration|adjacent segment degeneration
174223|NCT02492698|Probiotic|probiotic
174224|NCT02492698|Weight loss|weight loss
174225|NCT02492698|Lp-PLA2|lp-pla2
174226|NCT02492685|Quantitative analysis|quantitative analysis
174227|NCT02492685|contrast enhanced endoscopic ultrasonography|contrast enhanced endoscopic ultrasonography
174228|NCT02492659|femtosecond laser|femtosecond laser
174229|NCT02492633|Smoking cessation|smoking cessation
174230|NCT02492633|Smoke-free housing|smoke-free housing
174231|NCT02492633|Affordable housing|affordable housing
174232|NCT02492633|Second-hand smoke|second-hand smoke
174233|NCT02492633|Tobacco control|tobacco control
174234|NCT02492620|ferric citrate|ferric citrate
174235|NCT02492620|phosphate|phosphate
174236|NCT02492620|kidney|kidney
174237|NCT02492607|Women|women
174238|NCT02492607|DCIS|dcis
174239|NCT02492607|Active surveillance|active surveillance
174240|NCT02492607|Standard treatment|standard treatment
174241|NCT02492581|Selincro|selincro
174242|NCT02492581|cohort|cohort
174243|NCT02492581|real-life|real-life
174244|NCT02492581|total alcohol consumption|total alcohol consumption
174245|NCT02492581|heavy drinking days|heavy drinking days
174246|NCT02492581|clinical global impression-severity|clinical global impression-severity
174247|NCT02492581|EQ5D|eq5d
174248|NCT02492581|AQoLS|aqols
174249|NCT02492581|Sheehan disability scale|sheehan disability scale
174250|NCT02492568|recurrent|recurrent
174251|NCT02492568|NSCLC|nsclc
174252|NCT02492568|pembrolizumab|pembrolizumab
174253|NCT02492568|SBRT|sbrt
174254|NCT02492555|IBD|ibd
174255|NCT02492555|Telemedicine|telemedicine
174256|NCT02492555|At-home monitoring|at-home monitoring
174257|NCT02492555|Disease activity|disease activity
174258|NCT02492555|fecal calprotectin|fecal calprotectin
174259|NCT02492542|electrical stimulation|electrical stimulation
174260|NCT02492542|urinary incontinence|urinary incontinence
174261|NCT02492529|Alzheimer, Recognition Memory, Mild Cognitive Impairment, fMRI|alzheimer, recognition memory, mild cognitive impairment, fmri
174262|NCT02492516|adipose tissue mesenchymal stem cell intravenous injection ALS|adipose tissue mesenchymal stem cell intravenous injection als
174263|NCT02492503|recurrent or metastatic carcinoma cervix chemotherapy|recurrent or metastatic carcinoma cervix chemotherapy
174264|NCT02492490|Kidney transplantation|kidney transplantation
174265|NCT02492490|DCD|dcd
174266|NCT02492490|Stromal Vascular Fraction|stromal vascular fraction
174267|NCT02492490|MSC|msc
174268|NCT02492451|intrauterine insemination|intrauterine insemination
174269|NCT02492451|pregnancy rate|pregnancy rate
174270|NCT02492451|endometrial injury|endometrial injury
174271|NCT02492438|pneumococcal vaccination|pneumococcal vaccination
174272|NCT02492438|dialysis|dialysis
174273|NCT02492438|immune response|immune response
174274|NCT02492425|Community Acquired Pneumonia|community acquired pneumonia
174275|NCT02492425|Healthcare Associated Pneumonia|healthcare associated pneumonia
174276|NCT02492399|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
174277|NCT02492399|mitral valve|mitral valve
174278|NCT02492399|SAM syndrome|sam syndrome
174279|NCT02492386|bioabsorbable vascular scaffold|bioabsorbable vascular scaffold
174280|NCT02492386|erectile dysfunction|erectile dysfunction
174281|NCT02492373|Post inflammatory hyperpigmentation|post inflammatory hyperpigmentation
174282|NCT02492373|topical high potency steroid|topical high potency steroid
174283|NCT02492373|Qs NdYAG laser|qs ndyag laser
174284|NCT02492360|Peripheral Neuropathies|peripheral neuropathies
174285|NCT02492360|Testicular Cancer|testicular cancer
174286|NCT02492360|Cisplatin|cisplatin
174287|NCT02492360|Pharmacogenomics|pharmacogenomics
174288|NCT02492308|kidney|kidney
174289|NCT02492308|transplantation|transplantation
174290|NCT02492308|MSC|msc
174291|NCT02492217|Ankylosing Spondylitis|ankylosing spondylitis
174292|NCT02492217|adalimumab|adalimumab
174293|NCT02492217|TNF-alpha agents|tnf-alpha agents
174294|NCT02492217|spondyloarthritis|spondyloarthritis
174295|NCT02492217|biologic therapies|biologic therapies
174296|NCT02492217|AS|as
174297|NCT02492217|biomarkers|biomarkers
174298|NCT02492217|efficacy prediction|efficacy prediction
174299|NCT02492191|Smart Phones|smart phones
174300|NCT02492191|Ambulatory Care|ambulatory care
174301|NCT02492191|Outcome and Process Assessment|outcome and process assessment
174302|NCT02492165|Japanese Encephalitis|japanese encephalitis
174303|NCT02492165|Japanese encephalitis chimeric virus vaccine|japanese encephalitis chimeric virus vaccine
174304|NCT02492165|IMOJEV®|imojev®
174305|NCT02492165|Live attenuated vaccine|live attenuated vaccine
174306|NCT02492152|women|women
174307|NCT02492152|active labor|active labor
174308|NCT02492126|Chronic Cough|chronic cough
174309|NCT02492126|Gastroesophageal Reflux|gastroesophageal reflux
174310|NCT02492126|Esophageal Motility|esophageal motility
174311|NCT02492126|Cough Sensitivity|cough sensitivity
174312|NCT02492113|Mechanical ventilation|mechanical ventilation
174313|NCT02492113|Positive end-expiratory pressure|positive end-expiratory pressure
174314|NCT02492113|Work of breathing|work of breathing
174315|NCT02492113|Morbidly obese|morbidly obese
174614|NCT02489864|mean arterial pressure|mean arterial pressure
174316|NCT02492100|Sexual Dysfunction Post-Bone Marrow Transplant|sexual dysfunction post-bone marrow transplant
174317|NCT02492087|topical|topical
174318|NCT02492087|tranexamic acid|tranexamic acid
174319|NCT02492087|haemostasis|haemostasis
174320|NCT02492087|caesarean section|caesarean section
174321|NCT02492087|bleeding|bleeding
174322|NCT02492087|postpartum hemorrhage|postpartum hemorrhage
174323|NCT02492087|prophylactic|prophylactic
174324|NCT02492074|delta-9-tetrahydrocannabinol|delta-9-tetrahydrocannabinol
174325|NCT02492074|cannabidiol|cannabidiol
174326|NCT02492074|COMT|comt
174327|NCT02492061|couples' HCT married couples|couples' hct married couples
174328|NCT02492061|Rakai|rakai
174329|NCT02492061|Uganda|uganda
174330|NCT02492035|Hypertension|hypertension
174331|NCT02492035|lifestyle|lifestyle
174332|NCT02492035|clinical trials|clinical trials
174333|NCT02492035|primary care setting|primary care setting
174334|NCT02491996|desire model|desire model
174335|NCT02491983|metastatic breast cancer|metastatic breast cancer
174336|NCT02491983|Endocrine receptors positive|endocrine receptors positive
174337|NCT02491983|HER-2 negative|her-2 negative
174338|NCT02491957|Energy Expenditure|energy expenditure
174339|NCT02491957|Physical Endurance|physical endurance
174340|NCT02491957|Muscle Stength|muscle stength
174341|NCT02491957|Metabolism|metabolism
174342|NCT02491931|Cardiac Surgical Procedures|cardiac surgical procedures
174343|NCT02491931|Cardiovascular Surgical Procedures|cardiovascular surgical procedures
174344|NCT02491931|Dietary Supplements|dietary supplements
174345|NCT02491931|Glutamine|glutamine
174346|NCT02491931|TROPONIN I|troponin i
174347|NCT02491931|cardiopulmonary bypass|cardiopulmonary bypass
174348|NCT02491879|mechanical low back pain|mechanical low back pain
174349|NCT02491879|emergency department|emergency department
174350|NCT02491879|ketoprofen|ketoprofen
174351|NCT02491879|gel|gel
174352|NCT02491840|gastric cancer|gastric cancer
174353|NCT02491840|cardia cancer|cardia cancer
174354|NCT02491827|optical biopsy|optical biopsy
174355|NCT02491814|Dairy|dairy
174356|NCT02491814|Breakfast cereal|breakfast cereal
174357|NCT02491814|Postprandial Glycemia|postprandial glycemia
174358|NCT02491814|Satiety|satiety
174359|NCT02491814|Food Intake|food intake
174360|NCT02491814|Milk|milk
174361|NCT02491814|Yogurt|yogurt
174362|NCT02491814|Soy|soy
174363|NCT02491814|Almond|almond
174364|NCT02491801|Dairy|dairy
174365|NCT02491801|Milk|milk
174366|NCT02491801|Yogurt|yogurt
174367|NCT02491801|Cheese|cheese
174368|NCT02491801|Postprandial glycaemia|postprandial glycaemia
174369|NCT02491801|Satiety|satiety
174370|NCT02491801|Food Intake|food intake
174371|NCT02491801|Elderly|elderly
174372|NCT02491801|Prevention and Treatment|prevention and treatment
174373|NCT02491762|Serratus Anterior|serratus anterior
174374|NCT02491762|Accessory Respiratory|accessory respiratory
174375|NCT02491762|Tissue Expander|tissue expander
174376|NCT02491762|Respiratory Function Tests|respiratory function tests
174377|NCT02491749|Cardiac anesthesia|cardiac anesthesia
174378|NCT02491749|ultra fast track|ultra fast track
174379|NCT02491749|ICU stay|icu stay
174380|NCT02491710|Surgical education|surgical education
174381|NCT02491710|Laparoscopy|laparoscopy
174382|NCT02491710|Laparoscopic suturing|laparoscopic suturing
174383|NCT02491697|DC-CIK|dc-cik
174384|NCT02491697|Breast cancer|breast cancer
174385|NCT02491697|Capecitabine|capecitabine
174386|NCT02491684|asthma|asthma
174387|NCT02491684|Upper Respiratory Tract Infection|upper respiratory tract infection
174388|NCT02491684|exacerbation|exacerbation
174389|NCT02491684|Interferon|interferon
174390|NCT02491684|efficacy|efficacy
174391|NCT02491684|safety|safety
174392|NCT02491684|prevention|prevention
174393|NCT02491671|Prevention PAL Prolonged Air Leak (PAL)|prevention pal prolonged air leak (pal)
174394|NCT02491671|Lung Resection|lung resection
174395|NCT02491671|Thoracic Surgery|thoracic surgery
174396|NCT02491671|Post-operative Thoracic Air Leak|post-operative thoracic air leak
174397|NCT02491645|Autistic spectrum disorder|autistic spectrum disorder
174398|NCT02491645|Sensory processing abnormalities|sensory processing abnormalities
174399|NCT02491645|Sensory interventions|sensory interventions
174400|NCT02491645|occupational therapy|occupational therapy
174401|NCT02491632|Advanced Cancers|advanced cancers
174402|NCT02491632|Dexamethasone|dexamethasone
174403|NCT02491632|Decadron|decadron
174404|NCT02491632|Exercise|exercise
174405|NCT02491632|Physical activity|physical activity
174406|NCT02491632|Questionnaires|questionnaires
174407|NCT02491632|Surveys|surveys
174408|NCT02491632|Physical activity tests|physical activity tests
174409|NCT02491632|Phone calls|phone calls
174410|NCT02491619|Angle class III|angle class iii
174411|NCT02491619|tomography|tomography
174412|NCT02491619|tooth inclination|tooth inclination
174413|NCT02491619|bone thickness|bone thickness
174414|NCT02491593|fecal occult blood|fecal occult blood
174415|NCT02491554|Deep Brain Stimulation|deep brain stimulation
174416|NCT02491554|Essential tremor|essential tremor
174417|NCT02491554|DISTINCT|distinct
174615|NCT02489864|type 2 HRS|type 2 hrs
174418|NCT02491554|MR-tractography guided DBS implantation|mr-tractography guided dbs implantation
174419|NCT02491554|Conventional AC-PC based DBS implantation|conventional ac-pc based dbs implantation
174420|NCT02491515|Osteoporosis|osteoporosis
174421|NCT02491515|BMD|bmd
174422|NCT02491515|denosumab|denosumab
174423|NCT02491515|previous therapy|previous therapy
174424|NCT02491489|Manual therapy|manual therapy
174425|NCT02491476|Safety|safety
174426|NCT02491476|Electrodes|electrodes
174427|NCT02491476|Device|device
174428|NCT02491476|StereoElectroencephalograph|stereoelectroencephalograph
174429|NCT02491476|Epileptogenic zone|epileptogenic zone
174430|NCT02491476|Fast ripples|fast ripples
174431|NCT02491463|Reactogenicity|reactogenicity
174432|NCT02491463|Safety|safety
174433|NCT02491463|Respiratory syncytial virus (RSV)|respiratory syncytial virus (rsv)
174434|NCT02491463|Vaccine|vaccine
174435|NCT02491463|Immunogenicity|immunogenicity
174436|NCT02491424|Osseointegration|osseointegration
174437|NCT02491424|Direct skeletal attachment|direct skeletal attachment
174438|NCT02491385|Thoracic epidural analgesia|thoracic epidural analgesia
174439|NCT02491385|bowel function recovery|bowel function recovery
174440|NCT02491333|polycystic ovary syndrome|polycystic ovary syndrome
174441|NCT02491333|acupuncture|acupuncture
174442|NCT02491333|insulin resistance|insulin resistance
174443|NCT02491333|HOMA-IR|homa-ir
174444|NCT02491333|metformin|metformin
174445|NCT02491320|polycystic ovary syndrome|polycystic ovary syndrome
174446|NCT02491320|acupuncture|acupuncture
174447|NCT02491320|pre-treatment|pre-treatment
174448|NCT02491320|Letrozole|letrozole
174449|NCT02491320|Live Birth|live birth
174450|NCT02491294|School|school
174451|NCT02491294|Family|family
174452|NCT02491294|Fruit and Vegetables|fruit and vegetables
174453|NCT02491294|Cooking|cooking
174454|NCT02491294|Physical Activity|physical activity
174455|NCT02491281|Primary Osteoarthritis, Total Knee Replacement, cartilage|primary osteoarthritis, total knee replacement, cartilage
174456|NCT02491242|HIV|hiv
174457|NCT02491242|dolutegravir|dolutegravir
174458|NCT02491242|intolerance|intolerance
174459|NCT02491242|dual therapies|dual therapies
174460|NCT02491229|non-alcoholic fatty liver disease (NAFLD)|non-alcoholic fatty liver disease (nafld)
174461|NCT02491229|Obesity|obesity
174462|NCT02491229|Hepafast|hepafast
174463|NCT02491216|Frailty|frailty
174464|NCT02491216|Frail elderly|frail elderly
174465|NCT02491216|Acupressure|acupressure
174466|NCT02491216|Pragmatic Randomised Controlled Trial|pragmatic randomised controlled trial
174467|NCT02491203|Virtual reality|virtual reality
174468|NCT02491203|telerehabilitation|telerehabilitation
174469|NCT02491203|Stroke rehabilitation|stroke rehabilitation
174470|NCT02491177|HIV Transmission|hiv transmission
174471|NCT02491177|Prevention of Mother to Child Transmission|prevention of mother to child transmission
174472|NCT02491177|Linkage to care|linkage to care
174473|NCT02491177|Retention in care|retention in care
174474|NCT02491177|Community Mentor Mothers|community mentor mothers
174475|NCT02491177|Mobile phone text messaging|mobile phone text messaging
174476|NCT02491177|Antiretroviral therapy adherence|antiretroviral therapy adherence
174477|NCT02491177|Infant Health|infant health
174478|NCT02491177|Maternal CD4/viral loads|maternal cd4/viral loads
174479|NCT02491177|Early infant diagnosis|early infant diagnosis
174480|NCT02491177|Acceptability of interventions|acceptability of interventions
174481|NCT02491177|Vertical transmission|vertical transmission
174482|NCT02491138|participants|participants
174483|NCT02491086|intervention, nicotine replacement sampling, smoking cessation, smoking hotspots|intervention, nicotine replacement sampling, smoking cessation, smoking hotspots
174484|NCT02491034|Depression|depression
174485|NCT02491034|Hispanics|hispanics
174486|NCT02491034|Stigma|stigma
174487|NCT02491034|Barriers to Treatment|barriers to treatment
174488|NCT02491008|Thyroid Dysfunction|thyroid dysfunction
174489|NCT02491008|Bone mineral density|bone mineral density
174490|NCT02491008|Osteoporosis|osteoporosis
174491|NCT02491008|Fractures, Bone|fractures, bone
174492|NCT02491008|Randomized Controlled Trial|randomized controlled trial
174493|NCT02490995|children|children
174494|NCT02490969|copeptin|copeptin
174495|NCT02490969|rule out marker, emergency department, cheast pain unit|rule out marker, emergency department, cheast pain unit
174496|NCT02490969|emergency department|emergency department
174497|NCT02490969|chest pain unit|chest pain unit
174498|NCT02490956|Diagnostic immunization with rabies vaccine|diagnostic immunization with rabies vaccine
174499|NCT02490956|Primary immunodeficiency|primary immunodeficiency
174500|NCT02490943|peginterferon beta-1a|peginterferon beta-1a
174501|NCT02490943|MS (Multiple Sclerosis)|ms (multiple sclerosis)
174502|NCT02490943|Injection Site Reaction Erythema|injection site reaction erythema
174503|NCT02490930|lymphopenia|lymphopenia
174504|NCT02490917|Female urinary incontinence|female urinary incontinence
174505|NCT02490917|Sphincter deficiency|sphincter deficiency
174506|NCT02490904|Kidney transplantation|kidney transplantation
174507|NCT02490904|Eplerenone|eplerenone
174508|NCT02490891|Lymphoma, angiogenesis, PET scan|lymphoma, angiogenesis, pet scan
174509|NCT02490839|Helicobacter pylori|helicobacter pylori
174510|NCT02490839|high dose dual therapy|high dose dual therapy
175321|NCT02485821|Misoprostol|misoprostol
174511|NCT02490839|bismuth-containing quadruple therapy|bismuth-containing quadruple therapy
174512|NCT02490839|antibiotic resistance|antibiotic resistance
174513|NCT02490826|Speech Sound Disorders|speech sound disorders
174514|NCT02490826|Tabletop|tabletop
174515|NCT02490826|Digital|digital
174516|NCT02490813|Fish allergy|fish allergy
174517|NCT02490813|shrimp allergy|shrimp allergy
174518|NCT02490813|crab allergy|crab allergy
174519|NCT02490813|traditional Chinese medicine|traditional chinese medicine
174520|NCT02490761|Geriatrics|geriatrics
174521|NCT02490761|Nutritional Status|nutritional status
174522|NCT02490761|Hospitalisation|hospitalisation
174523|NCT02490722|Patient education|patient education
174524|NCT02490722|Empowerment|empowerment
174525|NCT02490709|Rectal neoplasms|rectal neoplasms
174526|NCT02490709|Colorectal neoplasms|colorectal neoplasms
174527|NCT02490709|Local excision|local excision
174528|NCT02490696|PET scan|pet scan
174529|NCT02490696|FAZA|faza
174530|NCT02490696|F-Miso|f-miso
174531|NCT02490696|hypoxia|hypoxia
174532|NCT02490696|lung cancer|lung cancer
174533|NCT02490631|skin flora|skin flora
174534|NCT02490605|Postural balance|postural balance
174535|NCT02490605|Temporomandibular disorders|temporomandibular disorders
174536|NCT02490605|Splints|splints
174537|NCT02490579|video messaging|video messaging
174538|NCT02490579|exercise|exercise
174539|NCT02490579|diet|diet
174540|NCT02490579|weight gain|weight gain
174541|NCT02490579|pregnancy|pregnancy
174542|NCT02490566|chronic condition|chronic condition
174543|NCT02490566|telehealth|telehealth
174544|NCT02490566|nutrition|nutrition
174545|NCT02490566|exercise|exercise
174546|NCT02490553|air pollution|air pollution
174547|NCT02490553|epidemiological survey|epidemiological survey
174548|NCT02490553|representative sample|representative sample
174549|NCT02490540|opioids|opioids
174550|NCT02490540|analgesia|analgesia
174551|NCT02490540|pain|pain
174552|NCT02490540|anesthesia|anesthesia
174553|NCT02490527|myopathy|myopathy
174554|NCT02490527|muscular weakness|muscular weakness
174555|NCT02490527|cramping|cramping
174556|NCT02490527|fatigue|fatigue
174557|NCT02490488|ovarian cancer|ovarian cancer
174558|NCT02490462|Cerebral Palsy|cerebral palsy
174559|NCT02490462|Physical Therapy|physical therapy
174560|NCT02490462|Family-centered Care|family-centered care
174561|NCT02490384|Cervical cerclage|cervical cerclage
174562|NCT02490345|gabapentin|gabapentin
174563|NCT02490319|radiation pneumonitis|radiation pneumonitis
174564|NCT02490319|lung cancer|lung cancer
174565|NCT02490319|prediction models|prediction models
174566|NCT02490319|genetic variants|genetic variants
174567|NCT02490241|pregnant|pregnant
174568|NCT02490241|female|female
174569|NCT02490241|women|women
174570|NCT02490241|lithium|lithium
174571|NCT02490241|bipolar|bipolar
174572|NCT02490228|female|female
174573|NCT02490228|minimally invasive surgery|minimally invasive surgery
174574|NCT02490150|Corifollitropin alfa|corifollitropin alfa
174575|NCT02490150|Stimulation protocol|stimulation protocol
174576|NCT02490124|Diabetes Type 1|diabetes type 1
174577|NCT02490124|Vascular Function|vascular function
174578|NCT02490098|Type 1 diabetes|type 1 diabetes
174579|NCT02490098|Closed-loop system|closed-loop system
174580|NCT02490098|Artificial pancreas|artificial pancreas
174581|NCT02490098|Insulin|insulin
174582|NCT02490098|Glucagon|glucagon
174583|NCT02490098|Hypoglycemia|hypoglycemia
174584|NCT02490098|Postprandial glucose|postprandial glucose
174585|NCT02490085|Type 2 diabetes|type 2 diabetes
174586|NCT02490085|Closed-loop strategy|closed-loop strategy
174587|NCT02490085|Artificial pancreas|artificial pancreas
174588|NCT02490085|Insulin|insulin
174589|NCT02490085|Elderly|elderly
174590|NCT02490085|Multiple daily injections|multiple daily injections
174591|NCT02490085|Hypoglycemia|hypoglycemia
174592|NCT02490046|D mannose|d mannose
174593|NCT02490046|multiple sclerosis|multiple sclerosis
174594|NCT02490046|recurrent urinary infections|recurrent urinary infections
174595|NCT02490020|Renal transplantation|renal transplantation
174596|NCT02490020|mesenchymal stem cell|mesenchymal stem cell
174597|NCT02490020|Transplantation Rejection|transplantation rejection
174598|NCT02490020|donation after cardiac death|donation after cardiac death
174599|NCT02490007|Acellular pertussis vaccine|acellular pertussis vaccine
174600|NCT02490007|whole cell pertussis vaccine|whole cell pertussis vaccine
174601|NCT02490007|IgE-mediated food allergy|ige-mediated food allergy
174602|NCT02489916|Metastatic Colorectal Cancer|metastatic colorectal cancer
174603|NCT02489916|CM4307|cm4307
174604|NCT02489916|Previously treated metastatic colorectal cancer|previously treated metastatic colorectal cancer
174605|NCT02489903|Epigenetics|epigenetics
174606|NCT02489903|resensitization|resensitization
174607|NCT02489903|Platinum doublets|platinum doublets
174608|NCT02489903|lung cancer|lung cancer
174609|NCT02489903|Ovarian epithelial cancer|ovarian epithelial cancer
174610|NCT02489877|multiple sclerosis|multiple sclerosis
174611|NCT02489877|HERV-W virus|herv-w virus
174612|NCT02489877|Herpesviridae family|herpesviridae family
174613|NCT02489864|Terlipressin|terlipressin
174616|NCT02489838|Liver Neoplasma|liver neoplasma
174617|NCT02489838|Lung Radiation dose|lung radiation dose
174618|NCT02489825|randomized controlled trial|randomized controlled trial
174619|NCT02489825|vertebral fracture|vertebral fracture
174620|NCT02489825|osteoporosis|osteoporosis
174621|NCT02489825|vertebroplasty|vertebroplasty
174622|NCT02489825|augmentation|augmentation
174623|NCT02489812|children|children
174624|NCT02489812|behavior|behavior
174625|NCT02489812|anxiety|anxiety
174626|NCT02489812|dentistry|dentistry
174627|NCT02489799|advance care planning|advance care planning
174628|NCT02489773|Lucica|lucica
174629|NCT02489773|glycated albumin|glycated albumin
174631|NCT02489773|fructosamine|fructosamine
174632|NCT02489760|Etanercept|etanercept
174633|NCT02489760|Adalimumab|adalimumab
174634|NCT02489760|Ankylosing Spondylitis|ankylosing spondylitis
174635|NCT02489760|Switch Study|switch study
174636|NCT02489747|cognitive function|cognitive function
174637|NCT02489747|CNT|cnt
174638|NCT02489747|memory function|memory function
174639|NCT02489747|Triticum aestivum L|triticum aestivum l
174640|NCT02489747|wheat bran|wheat bran
174641|NCT02489734|sevoflurane|sevoflurane
174642|NCT02489734|emergence delirium|emergence delirium
174643|NCT02489734|preschool|preschool
174644|NCT02489721|peripherally inserted central venous catheter|peripherally inserted central venous catheter
174645|NCT02489721|depp vein thrombosis|depp vein thrombosis
174646|NCT02489721|related blood stream infections|related blood stream infections
174647|NCT02489721|midline|midline
174648|NCT02489708|Bronchiolitis|bronchiolitis
174649|NCT02489708|Cough|cough
174650|NCT02489708|Ear Infection|ear infection
174651|NCT02489708|Respiratory Infection|respiratory infection
174652|NCT02489708|Wheezing|wheezing
174653|NCT02489708|Clinical Decision Support Systems|clinical decision support systems
174654|NCT02489695|locally advanced or metastatic|locally advanced or metastatic
174655|NCT02489656|Double loop ureteral stent|double loop ureteral stent
174656|NCT02489656|USSQ|ussq
174657|NCT02489656|Quality of life|quality of life
174658|NCT02489656|Pain|pain
174659|NCT02489604|neuroendocrine tumors|neuroendocrine tumors
174660|NCT02489578|Community Acquired Pneumonia|community acquired pneumonia
174661|NCT02489578|health care associated pneumonia|health care associated pneumonia
174662|NCT02489565|Coronary Artery Disease|coronary artery disease
174663|NCT02489565|stable|stable
174664|NCT02489565|Telemedicine|telemedicine
174665|NCT02489565|Patient Discharge|patient discharge
174666|NCT02489539|Aortic aneurysm|aortic aneurysm
174667|NCT02489539|Abdominal aorta|abdominal aorta
174668|NCT02489539|Stent graft|stent graft
174669|NCT02489539|Aneurysm|aneurysm
174670|NCT02489539|Vascular Diseases|vascular diseases
174671|NCT02489539|Cardiovascular Diseases|cardiovascular diseases
174672|NCT02489500|AL Amyloidosis|al amyloidosis
174673|NCT02489500|Stem Cell Transplantation|stem cell transplantation
174674|NCT02489448|Breast Cancer|breast cancer
174675|NCT02489383|Asthma|asthma
174676|NCT02489383|Continuous Exercise Training|continuous exercise training
174677|NCT02489383|interval Exercise Training|interval exercise training
174678|NCT02489383|Clinical Control|clinical control
174679|NCT02489383|Inflammation|inflammation
174680|NCT02489370|home care|home care
174681|NCT02489370|telecare|telecare
174682|NCT02489370|telehealth|telehealth
174683|NCT02489370|telemonitoring|telemonitoring
174684|NCT02489370|chronic heart failure|chronic heart failure
174685|NCT02489370|randomized controlled trial|randomized controlled trial
174686|NCT02489370|Congestive Heart Failure|congestive heart failure
174687|NCT02489370|telemedicine|telemedicine
174688|NCT02489331|Dyslipidemias|dyslipidemias
174689|NCT02489318|Prostate Cancer|prostate cancer
174690|NCT02489318|JNJ-56021927|jnj-56021927
174691|NCT02489318|Androgen Deprivation Therapy|androgen deprivation therapy
174692|NCT02489318|ARN-509|arn-509
174693|NCT02489318|Apalutamide|apalutamide
174694|NCT02489318|TITAN|titan
174695|NCT02489318|Metastatic Hormone-sensitive Prostate Cancer|metastatic hormone-sensitive prostate cancer
174696|NCT02489305|Depressive Disorder, Major|depressive disorder, major
174697|NCT02489305|Depression|depression
174698|NCT02489305|Anti-Depressant|anti-depressant
174699|NCT02489305|Observational|observational
174700|NCT02489292|Urea Cycle Disorder|urea cycle disorder
174701|NCT02489292|UCD|ucd
174702|NCT02489292|cell therapy|cell therapy
174703|NCT02489292|stem cell|stem cell
174704|NCT02489279|Attention deficit hyperactivity disorder.|attention deficit hyperactivity disorder.
174705|NCT02489279|Attention training|attention training
174706|NCT02489279|Mobile devices|mobile devices
174707|NCT02489279|Brain training|brain training
174708|NCT02489266|Melanoma|melanoma
174709|NCT02489266|Immunotherapy|immunotherapy
174710|NCT02489227|PsO|pso
174711|NCT02489214|donafenib|donafenib
174712|NCT02489201|donafenib|donafenib
174713|NCT02489188|gait asymmetry|gait asymmetry
174714|NCT02489188|joint angles|joint angles
174715|NCT02489175|Parastomal hernia|parastomal hernia
174716|NCT02489175|prevention|prevention
174717|NCT02489175|stomaplasty|stomaplasty
174718|NCT02489175|ring|ring
174719|NCT02489149|food insecurity|food insecurity
174720|NCT02489136|spiritist passe|spiritist passe
174721|NCT02489136|laying of hands|laying of hands
174722|NCT02489136|newborn|newborn
174723|NCT02489136|adult|adult
174724|NCT02489136|conditions|conditions
174725|NCT02489110|Alzheimer's Disease|alzheimer's disease
174726|NCT02489110|Dementia|dementia
174727|NCT02489110|caregiving|caregiving
174728|NCT02489110|caregiver|caregiver
174729|NCT02489110|coping|coping
174730|NCT02489110|coping with caregiving|coping with caregiving
174731|NCT02489110|stress|stress
174732|NCT02489110|Hispanic caregiver|hispanic caregiver
174733|NCT02489110|Latino caregiver|latino caregiver
174734|NCT02489084|Head and Neck neoplasms|head and neck neoplasms
174735|NCT02489084|Genome-wide association study|genome-wide association study
174736|NCT02489084|Polymorphism, single nucleotide|polymorphism, single nucleotide
174737|NCT02489084|Toxicity|toxicity
174738|NCT02489019|Anesthesia|anesthesia
174739|NCT02489019|Fentanyl|fentanyl
174740|NCT02489019|Elderly|elderly
174741|NCT02488980|Falciparum Parasitaemia, Malaria|falciparum parasitaemia, malaria
174742|NCT02488954|Ulcerative colitis|ulcerative colitis
174743|NCT02488954|Probiotics|probiotics
174744|NCT02488954|treatments|treatments
174745|NCT02488954|Propionibacterium freudenreichii|propionibacterium freudenreichii
174746|NCT02488941|Liver Function Tests|liver function tests
174747|NCT02488941|Blood Coagulation|blood coagulation
174748|NCT02488928|NSCLC|nsclc
174749|NCT02488928|EBUS|ebus
174750|NCT02488928|elastography|elastography
174751|NCT02488928|predictive value|predictive value
174752|NCT02488928|strain|strain
174753|NCT02488915|Brain|brain
174754|NCT02488915|Brain Clot|brain clot
174755|NCT02488915|Brain Diseases|brain diseases
174756|NCT02488915|Brain Infarction|brain infarction
174757|NCT02488915|Cerebral Ischemia|cerebral ischemia
174758|NCT02488915|Cerebrovascular Disorders|cerebrovascular disorders
174759|NCT02488915|EmboTrap® Revascularization Device|embotrap® revascularization device
174760|NCT02488915|EmboTrap|embotrap
174761|NCT02488915|Ischemia|ischemia
174762|NCT02488915|Ischemic|ischemic
174763|NCT02488915|Ischemic Stroke|ischemic stroke
174764|NCT02488915|Mechanical Thrombectomy|mechanical thrombectomy
174765|NCT02488915|Neurovascular Intervention|neurovascular intervention
174766|NCT02488915|Revascularization|revascularization
174767|NCT02488915|Stent Retriever|stent retriever
174769|NCT02488915|Vascular Diseases|vascular diseases
174770|NCT02488915|Neuravi|neuravi
174771|NCT02488889|Chantix|chantix
174772|NCT02488876|Cardiac surgery|cardiac surgery
174773|NCT02488876|Tissue sample database|tissue sample database
174774|NCT02488876|Inflammatory responds|inflammatory responds
174775|NCT02488863|Older adults|older adults
174776|NCT02488863|Chronic Pain|chronic pain
174777|NCT02488863|Musculoskeletal|musculoskeletal
174778|NCT02488850|immune monitoring|immune monitoring
174779|NCT02488850|T cell activation|t cell activation
174780|NCT02488850|early stage|early stage
174781|NCT02488837|Deep Brain Stimulation|deep brain stimulation
174782|NCT02488824|Quadriplegia|quadriplegia
174783|NCT02488824|Paraplegia|paraplegia
174784|NCT02488824|Spinal Cord Injury|spinal cord injury
174785|NCT02488824|Body Temperature Regulation|body temperature regulation
174786|NCT02488824|Mild Cognitive Impairment|mild cognitive impairment
174787|NCT02488785|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
174788|NCT02488785|Telehealth|telehealth
174789|NCT02488785|Hispanics|hispanics
174790|NCT02488785|Latinos|latinos
174791|NCT02488785|Self-Care|self-care
174792|NCT02488785|Mobile Health|mobile health
174793|NCT02488785|mHealth|mhealth
174794|NCT02488772|sleep quality|sleep quality
174795|NCT02488772|emergency department|emergency department
174796|NCT02488733|type 2 diabetes mellitus|type 2 diabetes mellitus
174797|NCT02488733|obesity|obesity
174798|NCT02488733|laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
174799|NCT02488733|bariatric surgery|bariatric surgery
174800|NCT02488733|metabolic surgery|metabolic surgery
174801|NCT02488720|amyloid imaging|amyloid imaging
174802|NCT02488720|biomarkers|biomarkers
174803|NCT02488720|cognition|cognition
174804|NCT02488720|longitudinal|longitudinal
174805|NCT02488720|cognitive decline|cognitive decline
174806|NCT02488720|observational|observational
174807|NCT02488707|low rectal cancer|low rectal cancer
174808|NCT02488707|minimally invasive colorectal surgery|minimally invasive colorectal surgery
174809|NCT02488707|trans-anal endoscopic microsurgery|trans-anal endoscopic microsurgery
174810|NCT02488707|TEM|tem
174811|NCT02488707|intersphincteric resection|intersphincteric resection
174812|NCT02488707|ISR|isr
174813|NCT02488707|subtotal intersphincteric resection|subtotal intersphincteric resection
174814|NCT02488707|total intersphincteric resection|total intersphincteric resection
174815|NCT02488707|trans-anal trans-abdominal resection|trans-anal trans-abdominal resection
174816|NCT02488707|laparoscopic intersphincteric resection|laparoscopic intersphincteric resection
174817|NCT02488707|anal sphincter preservation|anal sphincter preservation
174818|NCT02488707|total mesorectal excision|total mesorectal excision
174819|NCT02488707|TME|tme
174820|NCT02488707|TATA|tata
174821|NCT02488707|laparoscopic total mesorectal excision|laparoscopic total mesorectal excision
174822|NCT02488707|external sphincter preservation|external sphincter preservation
174823|NCT02488707|Neoadjuvant chemo-radiotherapy for rectal cancer|neoadjuvant chemo-radiotherapy for rectal cancer
174824|NCT02488707|fit patients for minimally invasive surgery|fit patients for minimally invasive surgery
174825|NCT02488668|Transcutaneous Electrical Stimulation|transcutaneous electrical stimulation
174826|NCT02488668|Neuroplasticity|neuroplasticity
174827|NCT02488668|Sensory Feedback|sensory feedback
174828|NCT02488642|Isosorbide dinitrate gel solution|isosorbide dinitrate gel solution
174829|NCT02488642|late intrauterine death|late intrauterine death
174830|NCT02488642|nitric oxide donors|nitric oxide donors
174831|NCT02488629|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
174832|NCT02488616|Closed-loop system|closed-loop system
174833|NCT02488616|Artificial pancreas|artificial pancreas
174834|NCT02488616|Type 1 diabetes|type 1 diabetes
174835|NCT02488616|Hypoglycemia|hypoglycemia
174836|NCT02488616|Insulin|insulin
174837|NCT02488603|Breast Neoplasms|breast neoplasms
174838|NCT02488603|Tamoxifen|tamoxifen
174839|NCT02488603|Decision Aids|decision aids
174840|NCT02488564|HER-2 Positive Breast Cancer|her-2 positive breast cancer
174841|NCT02488564|operable breast cancer|operable breast cancer
174842|NCT02488564|locally advanced breast cancer|locally advanced breast cancer
174843|NCT02488564|no prior therapy|no prior therapy
174844|NCT02488564|pCR|pcr
174845|NCT02488525|Acquired Von Willebrand|acquired von willebrand
174846|NCT02488525|Gastro-intestinal bleeding|gastro-intestinal bleeding
174847|NCT02488525|LVAD|lvad
174848|NCT02488512|Relapsed/refractory diffuse large b cell|relapsed/refractory diffuse large b cell
174849|NCT02488512|Relapsed/refractory mantle cell lymphomas|relapsed/refractory mantle cell lymphomas
174850|NCT02488512|DLBCL|dlbcl
174851|NCT02488512|MCL|mcl
174852|NCT02488512|90Y-DOTATOC|90y-dotatoc
174853|NCT02488512|SSR-positive tumour|ssr-positive tumour
174854|NCT02488499|Disruptive Behaviour Disorder|disruptive behaviour disorder
174855|NCT02488499|Psychosocial|psychosocial
174856|NCT02488499|Group Treatment|group treatment
174857|NCT02488473|Volunteers|volunteers
174858|NCT02488460|Motor Activity|motor activity
174859|NCT02488460|Cognition|cognition
174860|NCT02488460|Academic Acheivement|academic acheivement
174861|NCT02488460|Preadolescent Children|preadolescent children
174862|NCT02488447|Allergy|allergy
174863|NCT02488447|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
174864|NCT02488447|Immunotherapy|immunotherapy
174865|NCT02488447|Life Quality|life quality
174866|NCT02488447|Adherence|adherence
174867|NCT02488434|ICSI|icsi
174868|NCT02488434|sperm selection|sperm selection
174869|NCT02488434|fertile chip|fertile chip
174870|NCT02488434|ıcsı outcomes|ıcsı outcomes
174871|NCT02488395|Parkinson's disease|parkinson's disease
174872|NCT02488395|Non-motor symptoms|non-motor symptoms
174873|NCT02488395|Visual deficits|visual deficits
174874|NCT02488395|Superior colliculus|superior colliculus
174875|NCT02488395|fMRI|fmri
174876|NCT02488382|lymphoma|lymphoma
174877|NCT02488382|multiple myeloma|multiple myeloma
174878|NCT02488382|stem cell mobilization|stem cell mobilization
174879|NCT02488382|autologous stem cell transplantation|autologous stem cell transplantation
174880|NCT02488369|Children and adolescents|children and adolescents
174881|NCT02488343|Multiple Sclerosis|multiple sclerosis
174882|NCT02488343|Adherence|adherence
174883|NCT02488343|Therapies|therapies
174884|NCT02488343|Psychological Intervention|psychological intervention
174885|NCT02488317|Chronic Kidney Disease|chronic kidney disease
174886|NCT02488317|Hemodialysis|hemodialysis
174887|NCT02488317|Peritoneal Dialysis|peritoneal dialysis
174888|NCT02488304|HRCT|hrct
174889|NCT02488304|High Resolution Computed Tomography scans|high resolution computed tomography scans
174890|NCT02488304|Functional Respiratory Imaging|functional respiratory imaging
174891|NCT02488304|FRI|fri
174892|NCT02488304|Computed Tomography|computed tomography
174893|NCT02488304|CT|ct
174894|NCT02488304|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
174895|NCT02488304|BOS|bos
174896|NCT02488304|Lung Transplant|lung transplant
174897|NCT02488291|Epidural|epidural
174898|NCT02488291|Analgesia labor|analgesia labor
174899|NCT02488291|Perinatal|perinatal
174900|NCT02488291|anesthesia|anesthesia
174901|NCT02488278|Glucose blood measurements, glucometers ,audio communication|glucose blood measurements, glucometers ,audio communication
174902|NCT02488265|Parkinson´s disease|parkinson´s disease
174903|NCT02488265|Physicaltherapy|physicaltherapy
174904|NCT02488265|Postural Balance|postural balance
174905|NCT02488265|Gait|gait
174906|NCT02488265|Rehabilitation|rehabilitation
174907|NCT02488252|Chinese Medicine|chinese medicine
174908|NCT02488252|ACEI|acei
174909|NCT02488252|ARB|arb
174910|NCT02488252|Pragmatic trial|pragmatic trial
174911|NCT02488213|Nutritional Counseling|nutritional counseling
174912|NCT02488213|Diet|diet
174913|NCT02488187|Breast Cancer|breast cancer
174914|NCT02488187|MRI|mri
174915|NCT02488187|Mammogram|mammogram
174916|NCT02488187|Whole Breast Sonogram|whole breast sonogram
174917|NCT02488187|ABUS|abus
174918|NCT02488161|Colorectal cancer|colorectal cancer
174919|NCT02488161|Risk factors|risk factors
174920|NCT02488161|Adverse events|adverse events
174921|NCT02488161|Predictive models|predictive models
174922|NCT02488122|Bone Mineral Density|bone mineral density
174923|NCT02488122|Isometric Exercise|isometric exercise
174924|NCT02488122|Bone Growth|bone growth
174925|NCT02488109|anorexia nervosa|anorexia nervosa
174926|NCT02488109|eating disorders|eating disorders
174927|NCT02488109|refeeding|refeeding
174928|NCT02488109|adolescent medicine|adolescent medicine
174929|NCT02488109|nutritional rehabilitation|nutritional rehabilitation
174930|NCT02488083|non-invasive|non-invasive
174931|NCT02488031|SCA, dysmetria|sca, dysmetria
174932|NCT02488018|Glycemic index|glycemic index
174933|NCT02488018|honey|honey
174934|NCT02488018|reference glucose|reference glucose
174935|NCT02488005|Inflammatory Bowel Disease|inflammatory bowel disease
174936|NCT02488005|Small Bowel|small bowel
174937|NCT02488005|Crohn's Disease|crohn's disease
174938|NCT02488005|Small Bowel Ultrasound|small bowel ultrasound
174939|NCT02487966|tDCS|tdcs
174940|NCT02487966|Mirror Therapy|mirror therapy
174941|NCT02487966|Phantom Limb Pain|phantom limb pain
174942|NCT02487966|Traumatic amputation|traumatic amputation
174943|NCT02487953|Nicotine addiction|nicotine addiction
174944|NCT02487953|Cigarette smoking|cigarette smoking
174945|NCT02487953|Smoking cessation|smoking cessation
174946|NCT02487953|Nicotine patches|nicotine patches
174947|NCT02487953|E-cigarettes|e-cigarettes
174948|NCT02487940|Recurrent implantation failure|recurrent implantation failure
174949|NCT02487940|IVF|ivf
174950|NCT02487940|ICSI|icsi
174951|NCT02487940|Intralipid|intralipid
174952|NCT02487914|Drug Delivery|drug delivery
174953|NCT02487914|Iontophoresis|iontophoresis
174954|NCT02487914|Lidocaine|lidocaine
174955|NCT02487914|Pressure|pressure
174956|NCT02487914|Tactile perception|tactile perception
174957|NCT02487901|arthrodesiss|arthrodesiss
174958|NCT02487901|cervical vertebra|cervical vertebra
174959|NCT02487901|laminoplasty|laminoplasty
174960|NCT02487888|Genetic Variation|genetic variation
174961|NCT02487888|Genetic Polymorphism|genetic polymorphism
174962|NCT02487888|Polymorphism, Single Nucleotide|polymorphism, single nucleotide
174963|NCT02487888|Genetic Association Studies|genetic association studies
174964|NCT02487888|Healthcare Utilization|healthcare utilization
174965|NCT02487875|Sit-to-stand test|sit-to-stand test
174966|NCT02487875|Muscle strength|muscle strength
174967|NCT02487875|Pulmonary rehabilitation|pulmonary rehabilitation
174968|NCT02487836|Laying of the biliary stent|laying of the biliary stent
174969|NCT02487771|DHA|dha
174970|NCT02487771|childhood development|childhood development
174971|NCT02487745|Cocaine|cocaine
174972|NCT02487745|Methadone|methadone
174973|NCT02487745|Employment|employment
174974|NCT02487745|Opioids|opioids
174975|NCT02487732|Diabetic Patients With Non-ST Elevation|diabetic patients with non-st elevation
174976|NCT02487719|Iron deficiecy|iron deficiecy
174977|NCT02487719|pregnancy|pregnancy
174978|NCT02487719|prenatal care|prenatal care
174979|NCT02487706|Hemodialysis|hemodialysis
174980|NCT02487706|HIV-infection|hiv-infection
174981|NCT02487654|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
174982|NCT02487654|Pulmonary vein isolation|pulmonary vein isolation
174983|NCT02487654|Ganglionic plexi|ganglionic plexi
174984|NCT02487654|Radiofrequency|radiofrequency
174985|NCT02487654|late gadolinium enhancement cardiac MR imaging|late gadolinium enhancement cardiac mr imaging
174986|NCT02487654|High Frequency Stimulation|high frequency stimulation
174987|NCT02487641|Ultrasound|ultrasound
174988|NCT02487641|mid-trimester|mid-trimester
174989|NCT02487641|Obesity|obesity
174990|NCT02487641|pregnancy|pregnancy
174991|NCT02487615|Glycaemia|glycaemia
174992|NCT02487615|Subclinical Atherosclerosis|subclinical atherosclerosis
174993|NCT02487615|Carotid Doppler Ultrasound|carotid doppler ultrasound
174994|NCT02487615|Carotid Plaque|carotid plaque
174995|NCT02487615|Intima Media Thickness|intima media thickness
174996|NCT02487615|Ankle Brachial Index|ankle brachial index
174997|NCT02487615|Exercise Stress Test|exercise stress test
174998|NCT02487615|Coronary Calcium Score|coronary calcium score
174999|NCT02487615|Insulinemia|insulinemia
175000|NCT02487615|Leptin|leptin
175001|NCT02487615|Inflammation|inflammation
175002|NCT02487615|Resistin|resistin
175003|NCT02487615|Tumor Necrosis Factor alpha|tumor necrosis factor alpha
175004|NCT02487615|Phospholipase A2, Group VII|phospholipase a2, group vii
175005|NCT02487615|Body Mass Index|body mass index
175006|NCT02487615|Adipose Tissue Function|adipose tissue function
175007|NCT02487615|Single Gene Polymorphism|single gene polymorphism
175008|NCT02487589|Falls|falls
175009|NCT02487589|Elderly|elderly
175010|NCT02487589|e-Health|e-health
175011|NCT02487589|Telemedicine|telemedicine
175012|NCT02487563|Isolated thrombocytopenia|isolated thrombocytopenia
175013|NCT02487563|decitabine|decitabine
175015|NCT02487550|Renal neoplasma|renal neoplasma
175016|NCT02487550|CIK cells|cik cells
175017|NCT02487537|incretin release|incretin release
175018|NCT02487524|Neuropathic Pain|neuropathic pain
175019|NCT02487524|Breast Cancer|breast cancer
175020|NCT02487524|Post surgical|post surgical
175021|NCT02487498|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
175022|NCT02487472|France|france
175023|NCT02487472|Post-herpetic neuralgia|post-herpetic neuralgia
175024|NCT02487472|Herpes zoster|herpes zoster
175025|NCT02487472|Economic burden of disease|economic burden of disease
175026|NCT02487459|acute lymphoblastic leukemia|acute lymphoblastic leukemia
175027|NCT02487459|acute myeloid leukemia|acute myeloid leukemia
175028|NCT02487459|chronic myeloid leukemia|chronic myeloid leukemia
175029|NCT02487459|myelodysplastic syndrome|myelodysplastic syndrome
175030|NCT02487459|non-hodgkin lymphoma|non-hodgkin lymphoma
175031|NCT02487459|hodgkin lymphoma|hodgkin lymphoma
175032|NCT02487446|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
175033|NCT02487433|food effect|food effect
175034|NCT02487433|pharmacokinetics|pharmacokinetics
175035|NCT02487433|healthy volunteers|healthy volunteers
175036|NCT02487381|delta-9-tetrahydrocannabinol|delta-9-tetrahydrocannabinol
175037|NCT02487381|cannabidiol|cannabidiol
175038|NCT02487381|COMT|comt
175039|NCT02487381|Volunteers|volunteers
175040|NCT02487355|dexmedetomidine|dexmedetomidine
175041|NCT02487355|magnesium sulphate|magnesium sulphate
175042|NCT02487342|Dairy|dairy
175043|NCT02487342|appetite|appetite
175044|NCT02487342|feeding behaviour|feeding behaviour
175045|NCT02487329|Direct pulp capping|direct pulp capping
175046|NCT02487329|Er,Cr:YSGG laser|er,cr:ysgg laser
175047|NCT02487329|Tricalcium silicate|tricalcium silicate
175048|NCT02487316|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
175049|NCT02487316|anaplastic lymphoma kinase rearrangement|anaplastic lymphoma kinase rearrangement
175050|NCT02487316|crizotinib|crizotinib
175051|NCT02487316|CHOP chemotherapy|chop chemotherapy
175052|NCT02487303|Acetaminophen|acetaminophen
175053|NCT02487303|Pain, Postoperative|pain, postoperative
175054|NCT02487303|Analgesia, Obstetrical|analgesia, obstetrical
175055|NCT02487303|Cesarean Section|cesarean section
175056|NCT02487290|AAA|aaa
175057|NCT02487290|Endoleak|endoleak
175058|NCT02487277|Pancreatic|pancreatic
175059|NCT02487251|Obesity|obesity
175060|NCT02487251|Family Mealtimes|family mealtimes
175061|NCT02487251|Prevention|prevention
175062|NCT02487238|Microbiome|microbiome
175063|NCT02487238|Microbiota|microbiota
175064|NCT02487238|Fecal Microbial Transplant|fecal microbial transplant
175065|NCT02487238|FMT|fmt
175066|NCT02487238|Pediatrics|pediatrics
175067|NCT02487238|Gastroenterology|gastroenterology
175068|NCT02487238|IBD|ibd
175069|NCT02487238|Inflammatory Bowel Disease|inflammatory bowel disease
175070|NCT02487238|Ulcerative Colitis|ulcerative colitis
175071|NCT02487238|UC|uc
175072|NCT02487238|Inflammatory Bowel Disease Unclassified|inflammatory bowel disease unclassified
175073|NCT02487238|IBD-U|ibd-u
175074|NCT02487238|Rebiotix|rebiotix
175075|NCT02487238|RBX2660|rbx2660
175076|NCT02487212|fractional laser|fractional laser
175077|NCT02487212|hypertrophic scar|hypertrophic scar
175078|NCT02487212|topical corticosteroid|topical corticosteroid
175079|NCT02487212|laser assisted delivery systems|laser assisted delivery systems
175080|NCT02487199|hepatitis C infection|hepatitis c infection
175081|NCT02487199|hepatitis C|hepatitis c
175082|NCT02487199|severe kidney disease|severe kidney disease
175083|NCT02487199|chronic kidney disease|chronic kidney disease
175084|NCT02487199|Genotype 1a|genotype 1a
175085|NCT02487199|Genotype 4|genotype 4
175086|NCT02487199|treatment experienced|treatment experienced
175087|NCT02487199|interferon|interferon
175088|NCT02487199|IFN|ifn
175089|NCT02487199|pegIFN|pegifn
175090|NCT02487186|Chronic periodontitis|chronic periodontitis
175091|NCT02487186|Local doxycycline|local doxycycline
175092|NCT02487186|Ultrasonic debridement|ultrasonic debridement
175093|NCT02487186|PLGA microspheres|plga microspheres
175094|NCT02487186|Microbiologic assessment|microbiologic assessment
175095|NCT02487147|Live Attenuated Influenza Vaccine (FluMist)|live attenuated influenza vaccine (flumist)
175096|NCT02487147|Free Air Portable Air Powered Respirator|free air portable air powered respirator
175097|NCT02487147|N95 Respirator|n95 respirator
175098|NCT02487147|Personal Protective Equipment|personal protective equipment
175099|NCT02487147|Viral Transmission|viral transmission
175100|NCT02487121|weight loss|weight loss
175101|NCT02487095|RB1 Inactivation|rb1 inactivation
175102|NCT02487095|Kinase Inhibitor|kinase inhibitor
175103|NCT02487095|DNA Damage Response Network|dna damage response network
175104|NCT02487095|MYC And CCNE1 Activation|myc and ccne1 activation
175105|NCT02487095|Defective ATM-p53 Signaling Pathway|defective atm-p53 signaling pathway
175106|NCT02487082|Autism Spectrum Disorder|autism spectrum disorder
175107|NCT02487082|Children|children
175108|NCT02487082|Melatonin|melatonin
175109|NCT02487082|Donepezil|donepezil
175110|NCT02487082|Sleep disorder|sleep disorder
175111|NCT02487056|Heart Failure|heart failure
175112|NCT02487056|Diagnosis|diagnosis
175113|NCT02487056|Management|management
175114|NCT02487043|Caries prevention|caries prevention
175115|NCT02487043|Early Childhood Caries|early childhood caries
175523|NCT02484651|PQRS|pqrs
175116|NCT02487030|HCV genotype 4 (GT-4)|hcv genotype 4 (gt-4)
175117|NCT02487030|HCV|hcv
175118|NCT02487030|Sustained Virologic Response|sustained virologic response
175119|NCT02487030|Direct Acting Antiviral|direct acting antiviral
175120|NCT02487030|Combination Therapy|combination therapy
175121|NCT02487030|GS-7977|gs-7977
175122|NCT02487030|GS-5885|gs-5885
175123|NCT02487030|Ribavirin|ribavirin
175124|NCT02487030|Sofosbuvir|sofosbuvir
175125|NCT02487030|ledipasvir|ledipasvir
175126|NCT02487030|Hepatitis C|hepatitis c
175127|NCT02487030|Hepatitis C, Chronic|hepatitis c, chronic
175128|NCT02487030|Liver Diseases|liver diseases
175129|NCT02487030|Virus Diseases|virus diseases
175130|NCT02487030|Antiviral Agents|antiviral agents
175131|NCT02486965|VAS|vas
175132|NCT02486965|thermode test|thermode test
175133|NCT02486965|training program|training program
175134|NCT02486965|6MWT|6mwt
175135|NCT02486913|Primary prevention|primary prevention
175136|NCT02486913|National Health Service Health Check|national health service health check
175137|NCT02486900|Craving|craving
175138|NCT02486900|Cue Reactivity|cue reactivity
175139|NCT02486900|Neurofeedback|neurofeedback
175140|NCT02486887|telemonitoring|telemonitoring
175141|NCT02486874|Human acellular dermal matrix, burns, wound healing|human acellular dermal matrix, burns, wound healing
175142|NCT02486861|Tomography, Optical Coherence|tomography, optical coherence
175143|NCT02486848|Hairloss|hairloss
175144|NCT02486848|Female Pattern Hair Loss|female pattern hair loss
175145|NCT02486848|Androgenetic Alopecia|androgenetic alopecia
175146|NCT02486848|Minoxidil|minoxidil
175147|NCT02486822|Labor scale|labor scale
175148|NCT02486822|Partograph|partograph
175149|NCT02486822|Spontaneous labor|spontaneous labor
175150|NCT02486822|Primigravida|primigravida
175151|NCT02486744|Acthar|acthar
175152|NCT02486744|Dialysis|dialysis
175153|NCT02486744|Kidney|kidney
175154|NCT02486744|Non-Diabetic|non-diabetic
175155|NCT02486731|Hormonal sensitivity|hormonal sensitivity
175156|NCT02486731|bone growth|bone growth
175157|NCT02486705|ptsd|ptsd
175158|NCT02486705|family|family
175159|NCT02486705|caregiver|caregiver
175160|NCT02486705|burden|burden
175161|NCT02486692|Mental Health|mental health
175162|NCT02486692|PTSD|ptsd
175163|NCT02486692|Stigma|stigma
175164|NCT02486692|Peer Education|peer education
175165|NCT02486692|Web Education|web education
175166|NCT02486692|Self Help|self help
175167|NCT02486653|tamsulosin|tamsulosin
175168|NCT02486653|randomized controlled trials as topic|randomized controlled trials as topic
175169|NCT02486653|double-blind method|double-blind method
175170|NCT02486653|random allocation|random allocation
175171|NCT02486653|placebos|placebos
175172|NCT02486653|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists
175173|NCT02486653|urinary retention|urinary retention
175174|NCT02486653|urinary tract infections|urinary tract infections
175175|NCT02486653|urinary catheters|urinary catheters
175176|NCT02486653|catheter-related infections|catheter-related infections
175177|NCT02486653|postoperative complications|postoperative complications
175178|NCT02486640|RRMS, CIS|rrms, cis
175179|NCT02486627|cUTI|cuti
175180|NCT02486627|AP|ap
175181|NCT02486627|ACHN-490|achn-490
175182|NCT02486627|anti-infective|anti-infective
175183|NCT02486627|anti-bacterial|anti-bacterial
175184|NCT02486627|antibiotic|antibiotic
175185|NCT02486627|anti-microbial|anti-microbial
175186|NCT02486627|UTI|uti
175187|NCT02486627|bacterial infection|bacterial infection
175188|NCT02486627|Gram-negative|gram-negative
175189|NCT02486588|Financial incentives|financial incentives
175190|NCT02486588|Messaging|messaging
175191|NCT02486575|Residents|residents
175192|NCT02486575|Training|training
175193|NCT02486575|simulation|simulation
175194|NCT02486575|mentoring|mentoring
175195|NCT02486575|proctor|proctor
175196|NCT02486562|Multiple Sclerosis|multiple sclerosis
175197|NCT02486562|MS|ms
175198|NCT02486549|Pain|pain
175199|NCT02486549|Anesthesia Recovery Period|anesthesia recovery period
175200|NCT02486549|Brachial Plexus|brachial plexus
175201|NCT02486536|capsule endoscopy|capsule endoscopy
175202|NCT02486536|polyethylene glycol|polyethylene glycol
175203|NCT02486536|bowel preparation solutions|bowel preparation solutions
175204|NCT02486523|SAM, severe acute malnutrition|sam, severe acute malnutrition
175205|NCT02486510|HIV-1|hiv-1
175206|NCT02486510|CCR5 coreceptors|ccr5 coreceptors
175207|NCT02486510|Maraviroc|maraviroc
175208|NCT02486497|Pancreatic cancer|pancreatic cancer
175209|NCT02486497|Adjuvant chemotherapy|adjuvant chemotherapy
175210|NCT02486497|hENT1|hent1
175211|NCT02486497|Gemcitabine|gemcitabine
175212|NCT02486484|macular degeneration|macular degeneration
175213|NCT02486484|diabetic retinopathy|diabetic retinopathy
175214|NCT02486484|macular edema|macular edema
175215|NCT02486484|retinal vein occlusion|retinal vein occlusion
175216|NCT02486484|choroidal neovascularization|choroidal neovascularization
175217|NCT02486471|cervical dysplasia|cervical dysplasia
175218|NCT02486471|colposcopy|colposcopy
175219|NCT02486471|haemostatic procedure|haemostatic procedure
175220|NCT02486471|biopsy of the cervix uteri|biopsy of the cervix uteri
175221|NCT02486458|Fluoride|fluoride
175222|NCT02486458|Biofilm fluid|biofilm fluid
175223|NCT02486458|Calcium fluoride|calcium fluoride
175224|NCT02486458|Topical|topical
175225|NCT02486445|Deep venous thrombosis|deep venous thrombosis
175226|NCT02486445|Rivaroxaban|rivaroxaban
175227|NCT02486406|Hepatitis C Virus|hepatitis c virus
175228|NCT02486406|Hepatitis C Genotype 1|hepatitis c genotype 1
175229|NCT02486406|Hepatitis C Genotype 4|hepatitis c genotype 4
175230|NCT02486406|Pediatric|pediatric
175231|NCT02486341|continuous glucose monitoring system|continuous glucose monitoring system
175232|NCT02486341|basal insulin|basal insulin
175233|NCT02486341|diabetes mellitus|diabetes mellitus
175234|NCT02486341|elderly|elderly
175235|NCT02486328|Cognitive dysfunction|cognitive dysfunction
175236|NCT02486328|Colonoscopy|colonoscopy
175237|NCT02486328|Sedation|sedation
175238|NCT02486315|coronary bifurcation|coronary bifurcation
175239|NCT02486315|coronary stent|coronary stent
175240|NCT02486289|Mercury toxicity poisoning|mercury toxicity poisoning
175241|NCT02486263|infant|infant
175242|NCT02486263|esophagitis|esophagitis
175243|NCT02486263|neonate|neonate
175244|NCT02486263|GERD|gerd
175245|NCT02486237|diabetes mellitus|diabetes mellitus
175246|NCT02486237|complications|complications
175247|NCT02486237|prevalence|prevalence
175248|NCT02486224|deep sea mineral water|deep sea mineral water
175249|NCT02486224|exercise recovery|exercise recovery
175250|NCT02486224|hydration|hydration
175251|NCT02486224|salivary osmolar concentration|salivary osmolar concentration
175252|NCT02486224|urinary osmolar concentration|urinary osmolar concentration
175253|NCT02486211|heart arrest|heart arrest
175254|NCT02486211|resuscitation|resuscitation
175255|NCT02486211|seizures|seizures
175256|NCT02486211|hypothermia, induced|hypothermia, induced
175257|NCT02486211|Amantadine|amantadine
175258|NCT02486198|Gastrointestinal cancer|gastrointestinal cancer
175259|NCT02486198|oxaliplatin|oxaliplatin
175260|NCT02486198|neurotoxicity|neurotoxicity
175261|NCT02486120|Genetic Counseling|genetic counseling
175262|NCT02486120|Clinical Decision-Making|clinical decision-making
175263|NCT02486107|cervical vertebra|cervical vertebra
175264|NCT02486107|surgery|surgery
175265|NCT02486107|tubular retractor|tubular retractor
175266|NCT02486107|endoscope|endoscope
175267|NCT02486094|Imaging, Magnetic Resonance|imaging, magnetic resonance
175268|NCT02486094|Rectal Cancer|rectal cancer
175269|NCT02486094|Apoptosis|apoptosis
175270|NCT02486094|Proliferation|proliferation
175271|NCT02486094|Cancer|cancer
175272|NCT02486094|Tissue Study|tissue study
175273|NCT02486081|Assistive device|assistive device
175274|NCT02486081|the disabled|the disabled
175275|NCT02486081|special education|special education
175276|NCT02486081|movement analysis|movement analysis
175277|NCT02486081|system development|system development
175278|NCT02486055|Study safety of BPM31510 in healthy subjects|study safety of bpm31510 in healthy subjects
175279|NCT02486042|ROP|rop
175280|NCT02486042|Premature infant|premature infant
175281|NCT02486016|Bioequivalence|bioequivalence
175282|NCT02486016|Therapeutic Equivalency|therapeutic equivalency
175283|NCT02485990|Fallopian Tube|fallopian tube
175284|NCT02485990|Epithelial Ovarian|epithelial ovarian
175285|NCT02485990|EOC|eoc
175286|NCT02485977|Pulmonary hypertension|pulmonary hypertension
175287|NCT02485977|Magnetic Resonance Imaging|magnetic resonance imaging
175288|NCT02485964|Vaccine|vaccine
175289|NCT02485951|deep anterior lamellar keratoplasty|deep anterior lamellar keratoplasty
175290|NCT02485951|big-bubble technique|big-bubble technique
175291|NCT02485951|peripheral air injection|peripheral air injection
175292|NCT02485951|keratoconus|keratoconus
175293|NCT02485938|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
175294|NCT02485938|Cardiomyopathy|cardiomyopathy
175295|NCT02485925|Interventional|interventional
175296|NCT02485925|Radiofrequency ablation|radiofrequency ablation
175297|NCT02485925|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
175298|NCT02485925|Catheter ablation|catheter ablation
175299|NCT02485912|Ebola|ebola
175300|NCT02485912|vaccine|vaccine
175301|NCT02485912|safety|safety
175302|NCT02485912|immunogenicity|immunogenicity
175303|NCT02485899|Late infantile Neuronal Ceroid Lipofuscinosis Type 2|late infantile neuronal ceroid lipofuscinosis type 2
175304|NCT02485899|LINCL|lincl
175305|NCT02485899|NCL2|ncl2
175306|NCT02485899|CLN2|cln2
175307|NCT02485899|Jansky-Bielschowsky disease|jansky-bielschowsky disease
175308|NCT02485886|PET|pet
175309|NCT02485886|interstitial pulmonary fibrosis (IPF)|interstitial pulmonary fibrosis (ipf)
175310|NCT02485886|cysteine cathepsins|cysteine cathepsins
175311|NCT02485886|macrophage|macrophage
175312|NCT02485873|Non-valvular atrial fibrillation (NVAF)|non-valvular atrial fibrillation (nvaf)
175313|NCT02485873|Pevention|pevention
175314|NCT02485873|Stroke|stroke
175315|NCT02485860|pilonidal cysts|pilonidal cysts
175316|NCT02485860|Cavity wound|cavity wound
175317|NCT02485860|long healing|long healing
175318|NCT02485860|honey|honey
175319|NCT02485847|Eye Diseases|eye diseases
175320|NCT02485821|Estradiol|estradiol
175322|NCT02485821|Induction of labor|induction of labor
175323|NCT02485821|Cervical ripening|cervical ripening
175324|NCT02485821|Bishop score|bishop score
175325|NCT02485808|Lower Urinary Tract Symptoms|lower urinary tract symptoms
175326|NCT02485808|Bladder Symptoms|bladder symptoms
175327|NCT02485808|Overactive Bladder|overactive bladder
175328|NCT02485808|Urinary Urgency|urinary urgency
175329|NCT02485808|Lower Urinary Tract Dysfunction|lower urinary tract dysfunction
175330|NCT02485795|Pain Management|pain management
175331|NCT02485795|Genetic Variation|genetic variation
175332|NCT02485795|Genetic Polymorphism|genetic polymorphism
175333|NCT02485795|Polymorphism, Single Nucleotide Genetic Association Studies|polymorphism, single nucleotide genetic association studies
175334|NCT02485795|Healthcare Utilization|healthcare utilization
175335|NCT02485756|Drug interactions|drug interactions
175336|NCT02485743|satiation|satiation
175337|NCT02485743|satiety|satiety
175338|NCT02485743|weight loss|weight loss
175339|NCT02485743|maintained weight loss|maintained weight loss
175340|NCT02485730|Prevention|prevention
175341|NCT02485730|Cohort Analysis|cohort analysis
175342|NCT02485730|Healthy Participants|healthy participants
175343|NCT02485678|ambulatory toxicity management|ambulatory toxicity management
175344|NCT02485678|adjuvant or neoadjuvant chemotherapy|adjuvant or neoadjuvant chemotherapy
175345|NCT02485665|Prostate cancer|prostate cancer
175346|NCT02485665|Robot-assisted laparoscopic surgery|robot-assisted laparoscopic surgery
175347|NCT02485665|Radical prostatectomy|radical prostatectomy
175348|NCT02485665|Post-prostatectomy incontinence|post-prostatectomy incontinence
175349|NCT02485665|Pelvic floor muscle exercise|pelvic floor muscle exercise
175350|NCT02485665|Extracorporeal biofeedback device|extracorporeal biofeedback device
175351|NCT02485652|NSCLC|nsclc
175352|NCT02485652|EGFR-TKI|egfr-tki
175353|NCT02485652|non small cell lung cancer|non small cell lung cancer
175354|NCT02485652|HM61713|hm61713
175355|NCT02485652|T790M-positive|t790m-positive
175356|NCT02485652|lung cancer|lung cancer
175357|NCT02485652|Phase II|phase ii
175358|NCT02485652|Olmutinib|olmutinib
175359|NCT02485639|HA-specific plasmablasts|ha-specific plasmablasts
175360|NCT02485639|humoral immunity|humoral immunity
175361|NCT02485639|influenza|influenza
175362|NCT02485639|memory B cells|memory b cells
175363|NCT02485626|Anthracyclines|anthracyclines
175364|NCT02485600|Cadence|cadence
175365|NCT02485600|Duodopa|duodopa
175366|NCT02485600|Parkinson's disease|parkinson's disease
175367|NCT02485600|LCIG|lcig
175368|NCT02485600|Levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
175369|NCT02485600|Observational|observational
175370|NCT02485587|Arousal Biofeedback|arousal biofeedback
175371|NCT02485587|Electrodermal activity|electrodermal activity
175372|NCT02485574|Bone bridging|bone bridging
175373|NCT02485574|Arthrodesis|arthrodesis
175374|NCT02485574|Lumbar|lumbar
175375|NCT02485574|Cage|cage
175376|NCT02485561|Colon cancer screening|colon cancer screening
175377|NCT02485561|Colorectal cancer screening|colorectal cancer screening
175378|NCT02485561|Colonoscopy|colonoscopy
175379|NCT02485561|Sigmoidoscopy|sigmoidoscopy
175380|NCT02485561|Stool blood test|stool blood test
175381|NCT02485561|Narrative|narrative
175382|NCT02485522|fecal incontinence|fecal incontinence
175383|NCT02485522|diet|diet
175384|NCT02485522|nutrition|nutrition
175385|NCT02485522|metabolites|metabolites
175386|NCT02485522|stool|stool
175387|NCT02485522|FI|fi
175388|NCT02485379|Prostate cancer|prostate cancer
175389|NCT02485379|Multiparametric MRI|multiparametric mri
175390|NCT02485379|Prostate biopsy|prostate biopsy
175391|NCT02485379|Targeted biopsy|targeted biopsy
175392|NCT02485379|Comparative study|comparative study
175393|NCT02485366|Rejuvenated packed red blood cells|rejuvenated packed red blood cells
175394|NCT02485353|Vosaroxin|vosaroxin
175395|NCT02485353|Cytarabine|cytarabine
175396|NCT02485353|Remission Induction|remission induction
175397|NCT02485353|Safety|safety
175398|NCT02485353|Progression-Free Survival|progression-free survival
175399|NCT02485353|Mortality Rate|mortality rate
175400|NCT02485353|Length of Stay|length of stay
175401|NCT02485314|children|children
175402|NCT02485314|disability|disability
175403|NCT02485314|family|family
175404|NCT02485314|participation|participation
175405|NCT02485301|Protection against Ebola Zaire virus|protection against ebola zaire virus
175406|NCT02485275|AIS|ais
175407|NCT02485275|ICAS|icas
175408|NCT02485275|CSVD|csvd
175409|NCT02485262|Protease inhibitor treatment|protease inhibitor treatment
175410|NCT02485249|Iontophoresis|iontophoresis
175411|NCT02485249|Macular Edema|macular edema
175412|NCT02485249|Ophthalmology|ophthalmology
175413|NCT02485223|Multiple Sclerosis|multiple sclerosis
175414|NCT02485223|MS|ms
175415|NCT02485223|Diagnostic test|diagnostic test
175416|NCT02485223|Central veins|central veins
175417|NCT02485223|MRI|mri
175418|NCT02485210|photodynamic therapy , Endodontic treatment|photodynamic therapy , endodontic treatment
175419|NCT02485197|Muscle Metabolic Function|muscle metabolic function
175420|NCT02485197|Vitamin D Status|vitamin d status
175421|NCT02485197|25(OH)D|25(oh)d
175422|NCT02485197|Older Adults|older adults
175423|NCT02485158|Subjective Effects|subjective effects
175424|NCT02485158|Alcohol|alcohol
175425|NCT02485158|Amphetamine|amphetamine
175426|NCT02485158|THC|thc
175427|NCT02485158|Personality|personality
175428|NCT02485145|Topical|topical
175429|NCT02485145|Hand osteoarthritis|hand osteoarthritis
175430|NCT02485132|Type 2 diabetes|type 2 diabetes
175431|NCT02485132|Sulfonylurea|sulfonylurea
175432|NCT02485132|Hypoglycemia|hypoglycemia
175433|NCT02485132|Quality of life|quality of life
175434|NCT02485119|BAY 94-9343|bay 94-9343
175435|NCT02485119|Anetumab ravtansine|anetumab ravtansine
175436|NCT02485119|ADC (Antibody Drug Conjugate)|adc (antibody drug conjugate)
175437|NCT02485119|Phase I|phase i
175438|NCT02485119|Japan|japan
175439|NCT02485119|solid cancers|solid cancers
175440|NCT02485119|Advanced, refractory solid tumors|advanced, refractory solid tumors
175441|NCT02485119|mesothelin|mesothelin
175442|NCT02485119|endometrial|endometrial
175443|NCT02485119|adenocarcinoma of lung|adenocarcinoma of lung
175444|NCT02485119|gastrointestinal, ovarian, pancreatic, cholangio, mesothelioma and triple negative breast cancers|gastrointestinal, ovarian, pancreatic, cholangio, mesothelioma and triple negative breast cancers
175445|NCT02485080|hepatitis C|hepatitis c
175446|NCT02485080|liver transplantation|liver transplantation
175447|NCT02485080|genotype 1|genotype 1
175448|NCT02485067|Overactive Bladder|overactive bladder
175449|NCT02485067|Tolterodine (Detrusitol)|tolterodine (detrusitol)
175450|NCT02485067|Pilocarpine|pilocarpine
175451|NCT02485041|Dapoxetine|dapoxetine
175452|NCT02485041|Mirodenafil|mirodenafil
175453|NCT02485041|DDI study|ddi study
175454|NCT02485028|Dapoxetine|dapoxetine
175455|NCT02485028|Mirodenafil|mirodenafil
175456|NCT02485028|DDI study|ddi study
175457|NCT02485015|CIK|cik
175458|NCT02485015|gastric cancer|gastric cancer
175459|NCT02485015|Apatinib|apatinib
175460|NCT02485002|kidney|kidney
175461|NCT02485002|kidney stone|kidney stone
175462|NCT02485002|NGAL|ngal
175463|NCT02485002|ureterorenoscopy|ureterorenoscopy
175464|NCT02485002|intrarenal surgery|intrarenal surgery
175465|NCT02485002|kidney function|kidney function
175466|NCT02484976|Family Based Behavioral Treatment|family based behavioral treatment
175467|NCT02484976|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
175468|NCT02484976|Childhood Obesity|childhood obesity
175469|NCT02484976|Satiety|satiety
175470|NCT02484976|BMI z-score|bmi z-score
175471|NCT02484976|Impulsive|impulsive
175472|NCT02484976|Non-obese controls|non-obese controls
175473|NCT02484976|Visual food cues|visual food cues
175474|NCT02484976|Leptin|leptin
175475|NCT02484976|Hormones|hormones
175476|NCT02484950|Mesenchymal stem cells|mesenchymal stem cells
175477|NCT02484937|Pain management|pain management
175478|NCT02484911|chemotherapy nausea vomiting|chemotherapy nausea vomiting
175479|NCT02484885|Magnetic Resonance Imaging|magnetic resonance imaging
175480|NCT02484885|Pulmonary Function|pulmonary function
175481|NCT02484872|Inflammation|inflammation
175482|NCT02484872|Glasgow score|glasgow score
175483|NCT02484872|Intensive Care Unit|intensive care unit
175484|NCT02484872|Emergency|emergency
175485|NCT02484859|Drug: remifentanil|drug: remifentanil
175486|NCT02484859|Drug: tramadol|drug: tramadol
175487|NCT02484859|Drug: metoprolol|drug: metoprolol
175488|NCT02484859|Functional endoscopic sinus surgery|functional endoscopic sinus surgery
175489|NCT02484859|Controlled hypotension|controlled hypotension
175490|NCT02484833|First line|first line
175491|NCT02484833|metastatic colorectal cancer|metastatic colorectal cancer
175492|NCT02484833|Cetuximab|cetuximab
175493|NCT02484833|strategy study|strategy study
175494|NCT02484820|Preterm Birth|preterm birth
175495|NCT02484820|pessary|pessary
175496|NCT02484820|threatened preterm labor|threatened preterm labor
175497|NCT02484794|Eating Disorders|eating disorders
175498|NCT02484794|Smartphone|smartphone
175499|NCT02484794|App|app
175500|NCT02484794|Mobile Health|mobile health
175501|NCT02484794|Recovery Record|recovery record
175502|NCT02484794|Cognitive Behavioural Therapy|cognitive behavioural therapy
175503|NCT02484794|Outpatient Program|outpatient program
175504|NCT02484794|Self Monitoring|self monitoring
175505|NCT02484781|Gait disorder|gait disorder
175506|NCT02484781|Resurfacing Hip Arthroplasty|resurfacing hip arthroplasty
175507|NCT02484781|Total Hip Arthroplasty|total hip arthroplasty
175508|NCT02484729|AZD9977|azd9977
175509|NCT02484729|Safety|safety
175510|NCT02484729|Tolerability|tolerability
175511|NCT02484729|Pharmacokinetics|pharmacokinetics
175512|NCT02484729|First-in-human|first-in-human
175513|NCT02484729|Single Ascending Dose|single ascending dose
175514|NCT02484729|Regional absorption|regional absorption
175515|NCT02484729|Healthy male subjects|healthy male subjects
175516|NCT02484716|Hemorrhagic Hereditary Telangiectasia (HHT)|hemorrhagic hereditary telangiectasia (hht)
175517|NCT02484716|Antiangiogenic therapy|antiangiogenic therapy
175518|NCT02484716|Timolol|timolol
175519|NCT02484651|deep neuromuscular block|deep neuromuscular block
175520|NCT02484651|sugammadex|sugammadex
175521|NCT02484651|stability of anesthesia|stability of anesthesia
175522|NCT02484651|suppression of EMG activity|suppression of emg activity
175524|NCT02484651|General Anesthesia|general anesthesia
175525|NCT02484651|Quality of Recovery|quality of recovery
175526|NCT02484625|snacking|snacking
175527|NCT02484625|food intake|food intake
175528|NCT02484625|satiety|satiety
175529|NCT02484625|obesity|obesity
175530|NCT02484625|type-2 diabetes|type-2 diabetes
175531|NCT02484599|Eating Disorders|eating disorders
175532|NCT02484599|Anorexia Nervosa|anorexia nervosa
175533|NCT02484599|Attention bias|attention bias
175534|NCT02484599|Attention bias modification|attention bias modification
175535|NCT02484586|Presbyopia|presbyopia
175536|NCT02484586|Refractive error|refractive error
175537|NCT02484586|Contact lens|contact lens
175538|NCT02484573|Cirrhosis|cirrhosis
175539|NCT02484573|Variceal Bleeding|variceal bleeding
175540|NCT02484573|Non-selective beta blocker|non-selective beta blocker
175541|NCT02484573|Intestinal Permeability|intestinal permeability
175542|NCT02484573|Gene expression|gene expression
175543|NCT02484573|Bacterial translocation|bacterial translocation
175544|NCT02484560|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
175545|NCT02484560|Neuromuscular Diseases|neuromuscular diseases
175546|NCT02484560|Muscular Dystrophy|muscular dystrophy
175547|NCT02484560|Genetic Diseases, X-linked|genetic diseases, x-linked
175548|NCT02484560|Musculoskeletal Diseases|musculoskeletal diseases
175549|NCT02484560|Nervous System Diseases|nervous system diseases
175550|NCT02484547|Aducanumab|aducanumab
175551|NCT02484547|BIIB037|biib037
175552|NCT02484534|Coagulation Factor|coagulation factor
175553|NCT02484534|cirrhosis|cirrhosis
175554|NCT02484508|Guli capsule|guli capsule
175555|NCT02484508|knee osteoarthritis|knee osteoarthritis
175556|NCT02484508|Changing of WOMAC and VAS score|changing of womac and vas score
175557|NCT02484495|Complementary feeding recommendation|complementary feeding recommendation
175558|NCT02484495|Program evaluation|program evaluation
175559|NCT02484495|Process and impact evaluation|process and impact evaluation
175560|NCT02484456|Major Depression|major depression
175561|NCT02484456|Glycine Receptor Antagonist|glycine receptor antagonist
175562|NCT02484456|4-Chlorokyneurenine|4-chlorokyneurenine
175563|NCT02484456|Treatment Resistant|treatment resistant
175564|NCT02484456|Glutamatergic System|glutamatergic system
175565|NCT02484417|Neutralizing Antibody|neutralizing antibody
175566|NCT02484417|Viral Shedding|viral shedding
175567|NCT02484417|Mucosal Immune Reponse|mucosal immune reponse
175568|NCT02484417|Upper Respiratory Infection|upper respiratory infection
175569|NCT02484404|Immune Checkpoint Inhibitor|immune checkpoint inhibitor
175570|NCT02484404|PARP Inhibitor|parp inhibitor
175571|NCT02484404|VEGFR Inhibitor|vegfr inhibitor
175572|NCT02484378|ACS|acs
175573|NCT02484378|IVUS|ivus
175574|NCT02484378|HDL|hdl
175575|NCT02484365|Hemoglobins|hemoglobins
175576|NCT02484365|Monitoring, Outpatient|monitoring, outpatient
175577|NCT02484365|Preoperative Period|preoperative period
175578|NCT02484365|Pediatrics|pediatrics
175579|NCT02484352|dosage of oxycodone during intubation|dosage of oxycodone during intubation
175580|NCT02484326|ST-elevation myocardial infarction|st-elevation myocardial infarction
175581|NCT02484326|Cardiac rupture|cardiac rupture
175582|NCT02484326|Risk assessment|risk assessment
175583|NCT02484300|loop gain|loop gain
175584|NCT02484300|chemoreflex control|chemoreflex control
175585|NCT02484300|melatonin|melatonin
175586|NCT02484300|antioxidant|antioxidant
175587|NCT02484300|obstructive sleep apnea|obstructive sleep apnea
175588|NCT02484300|ventilatory control|ventilatory control
175589|NCT02484274|iron-deficiency|iron-deficiency
175590|NCT02484274|iron-deficiency anemia|iron-deficiency anemia
175591|NCT02484274|infants and toddlers|infants and toddlers
175592|NCT02484274|industrialised countries|industrialised countries
175593|NCT02484274|population-based study|population-based study
175594|NCT02484274|prevalence and risk factors|prevalence and risk factors
175595|NCT02484274|screening strategies|screening strategies
175596|NCT02484274|diagnosis markers|diagnosis markers
175597|NCT02484274|primary prevention|primary prevention
175598|NCT02484261|childhood leukemia|childhood leukemia
175599|NCT02484261|relapsed leukemia|relapsed leukemia
175600|NCT02484261|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
175601|NCT02484235|obesity|obesity
175602|NCT02484235|exercise|exercise
175603|NCT02484235|HIIT|hiit
175604|NCT02484235|Vo2|vo2
175605|NCT02484235|kinetics|kinetics
175606|NCT02484222|adenotonsillectomy|adenotonsillectomy
175607|NCT02484222|fentanyl|fentanyl
175608|NCT02484209|diabetes|diabetes
175609|NCT02484209|frailty|frailty
175610|NCT02484209|aged|aged
175611|NCT02484209|metformin|metformin
175612|NCT02484209|sulphonylurea|sulphonylurea
175613|NCT02484209|hypoglycaemia|hypoglycaemia
175614|NCT02484183|bubble continuous positive airway pressure (CPAP)|bubble continuous positive airway pressure (cpap)
175615|NCT02484183|pneumonia|pneumonia
175616|NCT02484183|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
175617|NCT02484183|malnutrition|malnutrition
175618|NCT02484183|Malawi|malawi
175619|NCT02484183|Africa|africa
175620|NCT02484183|Noninvasive Ventilation|noninvasive ventilation
175621|NCT02484183|child|child
175622|NCT02484183|pediatric|pediatric
175624|NCT02484170|Mannitol|mannitol
175625|NCT02484170|cream|cream
175626|NCT02484170|neuropathic pain|neuropathic pain
175627|NCT02484157|Whole Blood Coagulation Time|whole blood coagulation time
175628|NCT02484157|cardiac surgery|cardiac surgery
175629|NCT02484144|information|information
175630|NCT02484144|coronarography|coronarography
175631|NCT02484144|understanding|understanding
175632|NCT02484131|Osteoporosis|osteoporosis
175633|NCT02484131|DXA Screening|dxa screening
175634|NCT02484131|Women|women
175635|NCT02484131|Breast Cancer|breast cancer
175636|NCT02484131|Survivors|survivors
175637|NCT02484131|Educational materials|educational materials
175638|NCT02484131|Personal choices on delivery methods|personal choices on delivery methods
175639|NCT02484092|Hemophilia B|hemophilia b
175640|NCT02484092|Blood Coagulation Disorders|blood coagulation disorders
175641|NCT02484092|Gene Therapy|gene therapy
175642|NCT02484092|Gene Transfer|gene transfer
175643|NCT02484092|Factor IX Deficiency|factor ix deficiency
175644|NCT02484092|Factor IX Gene|factor ix gene
175645|NCT02484092|Factor IX Protein|factor ix protein
175646|NCT02484092|Vector|vector
175647|NCT02484092|AAV|aav
175648|NCT02484066|Virtual bronchoscopic navigation|virtual bronchoscopic navigation
175649|NCT02484066|Endobronchial ultrasound|endobronchial ultrasound
175650|NCT02484066|Guide Sheath|guide sheath
175651|NCT02484066|Transbronchial biopsy|transbronchial biopsy
175652|NCT02484066|Peripheral pulmonary lesions|peripheral pulmonary lesions
175653|NCT02484053|adult and pediatric cancers|adult and pediatric cancers
175654|NCT02484053|blood disorders|blood disorders
175655|NCT02484053|lymphoma|lymphoma
175656|NCT02484053|graft-versus-host-disease|graft-versus-host-disease
175657|NCT02484053|diseases of the immune system|diseases of the immune system
175658|NCT02484040|tumor response|tumor response
175659|NCT02484040|toxicity|toxicity
175660|NCT02484040|recurrence|recurrence
175661|NCT02484040|chemoradiotherpy|chemoradiotherpy
175662|NCT02484040|rectum|rectum
175663|NCT02484027|acute ischemic stroke|acute ischemic stroke
175664|NCT02484027|mRS|mrs
175665|NCT02484027|rosuvastatin|rosuvastatin
175666|NCT02484001|Eslicarbazepine acetate|eslicarbazepine acetate
175667|NCT02484001|BIA 2-093|bia 2-093
175668|NCT02484001|Epilepsy|epilepsy
175669|NCT02483975|Fluticasone Furoate|fluticasone furoate
175670|NCT02483975|Asthma|asthma
175671|NCT02483975|HPA axis|hpa axis
175672|NCT02483975|Children|children
175673|NCT02483975|Inhaled corticosteroid|inhaled corticosteroid
175674|NCT02483962|Chronic|chronic
175675|NCT02483923|serratus anterior block|serratus anterior block
175676|NCT02483923|ultrasound|ultrasound
175677|NCT02483923|breast cancer|breast cancer
175678|NCT02483923|postoperative pain|postoperative pain
175679|NCT02483910|School-age children|school-age children
175680|NCT02483910|Pediatrics|pediatrics
175681|NCT02483910|Direct Instruction-Language for Learning|direct instruction-language for learning
175682|NCT02483884|Bombesin|bombesin
175683|NCT02483884|Gastrin-Releasing Peptide|gastrin-releasing peptide
175684|NCT02483884|Prostatic Neoplasms|prostatic neoplasms
175685|NCT02483884|Genital Diseases, Male|genital diseases, male
175686|NCT02483884|Genital Neoplasms, Male|genital neoplasms, male
175687|NCT02483884|Neoplasms|neoplasms
175688|NCT02483884|Neoplasms by Site|neoplasms by site
175689|NCT02483884|Urogenital Neoplasms|urogenital neoplasms
175690|NCT02483884|Gastrointestinal Agents|gastrointestinal agents
175691|NCT02483884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
175692|NCT02483884|Neurotransmitter Agents|neurotransmitter agents
175693|NCT02483884|Pharmacologic Actions|pharmacologic actions
175694|NCT02483884|Physiological Effects of Drugs|physiological effects of drugs
175695|NCT02483884|Therapeutic Uses|therapeutic uses
175696|NCT02483871|Estrogen Receptor Positive|estrogen receptor positive
175697|NCT02483858|oncology, solid tumors|oncology, solid tumors
175698|NCT02483819|Elderly patient|elderly patient
175699|NCT02483819|NICOM|nicom
175700|NCT02483819|TURP|turp
175701|NCT02483767|Premenopausal Breast Cancer|premenopausal breast cancer
175702|NCT02483767|Preservation of Ovarian Function|preservation of ovarian function
175703|NCT02483767|Gonadotropin-Releasing Hormone Agonist|gonadotropin-releasing hormone agonist
175704|NCT02483728|Metal Allergy|metal allergy
175705|NCT02483715|Helicobacter pylori|helicobacter pylori
175706|NCT02483715|high dose dual therapy|high dose dual therapy
175707|NCT02483715|bismuth-containing quadruple therapy|bismuth-containing quadruple therapy
175708|NCT02483715|antibiotic resistance|antibiotic resistance
175709|NCT02483702|Irradiated Blood|irradiated blood
175710|NCT02483702|Non-Irradiated Blood|non-irradiated blood
175711|NCT02483702|graft versus host disease|graft versus host disease
175712|NCT02483702|TA-GVHD|ta-gvhd
175713|NCT02483702|potassium|potassium
175714|NCT02483702|Blood transfusion|blood transfusion
175715|NCT02483689|Post Operative Pain|post operative pain
175716|NCT02483689|Appendicitis|appendicitis
175717|NCT02483689|Appendectomy|appendectomy
175718|NCT02483689|Local Anesthetic|local anesthetic
175719|NCT02483689|Saline|saline
175720|NCT02483689|Pain Management|pain management
175721|NCT02483689|Surgery|surgery
175722|NCT02483689|Recovery|recovery
175723|NCT02483676|Rehabilitation|rehabilitation
175724|NCT02483676|Robotics|robotics
175725|NCT02483676|Gait|gait
175726|NCT02483663|Twins|twins
175727|NCT02483663|Obesity|obesity
175728|NCT02483663|Appetite|appetite
175729|NCT02483637|spray cryotherapy|spray cryotherapy
175730|NCT02483637|cryotherapy|cryotherapy
175731|NCT02483637|chronic bronchitis|chronic bronchitis
175732|NCT02483637|airflow restrictions|airflow restrictions
175733|NCT02483611|Onset|onset
175734|NCT02483611|Recovery|recovery
175735|NCT02483611|Lidocaine|lidocaine
175736|NCT02483611|Cisatracurium|cisatracurium
175737|NCT02483611|Magnesium sulfate|magnesium sulfate
175738|NCT02483611|Isotonic solution|isotonic solution
175739|NCT02483598|buspirone|buspirone
175740|NCT02483598|pharmacokinetics|pharmacokinetics
175741|NCT02483598|Cytochrome P450 3A4|cytochrome p450 3a4
175742|NCT02483585|Migraine|migraine
175743|NCT02483585|Headache|headache
175744|NCT02483585|Episodic|episodic
175745|NCT02483585|Prevention|prevention
175746|NCT02483585|Prophylaxis|prophylaxis
175747|NCT02483559|Sleep|sleep
175748|NCT02483559|Photoreceptor Cells, Vertebrate|photoreceptor cells, vertebrate
175749|NCT02483559|Melatonin|melatonin
175750|NCT02483546|Medical education|medical education
175751|NCT02483546|simulation|simulation
175752|NCT02483546|ACLS|acls
175753|NCT02483520|Family caregiver|family caregiver
175754|NCT02483507|Ultrasound guidance|ultrasound guidance
175755|NCT02483507|Vascular access|vascular access
175756|NCT02483507|Pediatric anesthesia|pediatric anesthesia
175757|NCT02483494|Telemedicine|telemedicine
175758|NCT02483494|Advanced Practice Nurse|advanced practice nurse
175759|NCT02483481|sinusoidal obstruction syndrome|sinusoidal obstruction syndrome
175760|NCT02483481|ultrasound elastography|ultrasound elastography
175761|NCT02483481|bone marrow transplant|bone marrow transplant
175762|NCT02483429|Vertigo|vertigo
175763|NCT02483429|Dizziness|dizziness
175764|NCT02483429|Unsteadiness|unsteadiness
175765|NCT02483429|Stroke|stroke
175766|NCT02483429|Vestibular neuritis|vestibular neuritis
175767|NCT02483429|Benign paroxysmal positional vertigo|benign paroxysmal positional vertigo
175768|NCT02483429|Vestibulo-ocular reflex|vestibulo-ocular reflex
175769|NCT02483429|Video-oculography|video-oculography
175770|NCT02483429|Emergency department|emergency department
175771|NCT02483403|Magnetic Resonance Imaging|magnetic resonance imaging
175772|NCT02483403|Pulmonary Function|pulmonary function
175773|NCT02483403|Volunteers|volunteers
175774|NCT02483390|palliative care|palliative care
175775|NCT02483390|e-health|e-health
175776|NCT02483390|e-therapy|e-therapy
175777|NCT02483390|psychosocial services|psychosocial services
175778|NCT02483377|Sign or Symptom|sign or symptom
175779|NCT02483351|Blood Transfusion|blood transfusion
175780|NCT02483338|Psychometric validity|psychometric validity
175781|NCT02483338|Pain scale|pain scale
175782|NCT02483338|Postoperative|postoperative
175783|NCT02483338|Children|children
175784|NCT02483312|Recurrent|recurrent
175785|NCT02483299|response to therapy|response to therapy
175786|NCT02483286|Osteoporosis|osteoporosis
175787|NCT02483286|Fall|fall
175788|NCT02483286|Fracture|fracture
175789|NCT02483286|sarcopenia|sarcopenia
175790|NCT02483286|Exercise|exercise
175791|NCT02483273|Conjunctival microcirculation|conjunctival microcirculation
175792|NCT02483273|Sublingual microcirculation|sublingual microcirculation
175793|NCT02483273|Sidestream Dark Field (SDF) microscopy|sidestream dark field (sdf) microscopy
175794|NCT02483247|Neoplasms|neoplasms
175795|NCT02483195|Hair loss|hair loss
175796|NCT02483195|Post Menopausal|post menopausal
175797|NCT02483182|Herpes labialis, Cold sores, ZEP-3 ointment|herpes labialis, cold sores, zep-3 ointment
175798|NCT02483169|ischemic stroke|ischemic stroke
175799|NCT02483169|intracranial hemorrhage|intracranial hemorrhage
175800|NCT02483169|cilostazol|cilostazol
175801|NCT02483169|probucol|probucol
175802|NCT02483169|intima media thickness|intima media thickness
175803|NCT02483156|HCV|hcv
175804|NCT02483156|Sofosbuvir|sofosbuvir
175805|NCT02483156|Ribavirin|ribavirin
175806|NCT02483143|contrast media|contrast media
175807|NCT02483143|pulmonary embolism|pulmonary embolism
175808|NCT02483143|N-acetylcysteine|n-acetylcysteine
175809|NCT02483104|ABT-888|abt-888
175810|NCT02483104|BRCA|brca
175811|NCT02483104|Primary peritoneal cancer|primary peritoneal cancer
175812|NCT02483104|carboplatin|carboplatin
175813|NCT02483104|Fallopian tube|fallopian tube
175814|NCT02483104|Poly (ADP-ribose) polymerase (PARP)|poly (adp-ribose) polymerase (parp)
175815|NCT02483104|paclitaxel|paclitaxel
175816|NCT02483104|Ovarian cancer|ovarian cancer
175817|NCT02483104|veliparib|veliparib
175818|NCT02483091|Knowledge translation|knowledge translation
175819|NCT02483091|Clinical practice guidelines|clinical practice guidelines
175820|NCT02483091|Multimodal care|multimodal care
175821|NCT02483091|Brief Action Planning|brief action planning
175822|NCT02483091|Feasibility outcomes|feasibility outcomes
175823|NCT02483065|dementia|dementia
175824|NCT02483065|hospital admission|hospital admission
175825|NCT02483065|mortality|mortality
175826|NCT02483065|health-related quality of life|health-related quality of life
175827|NCT02483065|activities of daily living|activities of daily living
175828|NCT02483052|lobectomy|lobectomy
175829|NCT02483052|spray cryotherapy|spray cryotherapy
175830|NCT02483052|lung cancer|lung cancer
175831|NCT02483039|Acute kidney injury|acute kidney injury
175832|NCT02483039|Chronic kidney disease|chronic kidney disease
175833|NCT02483039|Quality improvement|quality improvement
175834|NCT02483013|whitening dentifrices|whitening dentifrices
175835|NCT02483013|color alteration|color alteration
175836|NCT02483013|tooth sensitivity|tooth sensitivity
175837|NCT02482987|dental|dental
175838|NCT02482987|extraction|extraction
175839|NCT02482987|socket preservation|socket preservation
175840|NCT02482987|ridge preservation|ridge preservation
175841|NCT02482987|implant site preparation|implant site preparation
175842|NCT02482974|Liver transplantation|liver transplantation
175843|NCT02482974|Everolimus|everolimus
175844|NCT02482974|Sirolimus|sirolimus
175845|NCT02482974|Treatment outcome|treatment outcome
175846|NCT02482974|Safety|safety
175847|NCT02482948|Debridement|debridement
175848|NCT02482948|collagenase|collagenase
175849|NCT02482948|leptospermum honey|leptospermum honey
175850|NCT02482922|feasibility studies|feasibility studies
175851|NCT02482922|intervention|intervention
175852|NCT02482922|Pre-Hypertensive|pre-hypertensive
175853|NCT02482922|Pre-Hyperlipidemia|pre-hyperlipidemia
175854|NCT02482844|TAVI|tavi
175855|NCT02482844|de novo and persistent LBBB|de novo and persistent lbbb
175856|NCT02482844|electrophysiology|electrophysiology
175857|NCT02482844|Holter|holter
175858|NCT02482844|pacemaker|pacemaker
175859|NCT02482831|Sciatic nerve block|sciatic nerve block
175860|NCT02482831|block duration|block duration
175861|NCT02482831|Semmes Weinstein monofilaments|semmes weinstein monofilaments
175862|NCT02482831|fasting blood glucose|fasting blood glucose
175863|NCT02482831|nerve block|nerve block
175864|NCT02482831|sensory block duration|sensory block duration
175865|NCT02482831|motor block duration|motor block duration
175866|NCT02482818|chronic cough|chronic cough
175867|NCT02482818|cough hypersensitivity|cough hypersensitivity
175868|NCT02482818|Lyrica|lyrica
175869|NCT02482818|Pregabalin|pregabalin
175870|NCT02482818|cough reflex sensitivity|cough reflex sensitivity
175871|NCT02482792|Musculoskeletal disorders|musculoskeletal disorders
175872|NCT02482792|Psychosomatic|psychosomatic
175873|NCT02482792|Pain|pain
175874|NCT02482753|Chidamide|chidamide
175875|NCT02482753|breast cancer|breast cancer
175876|NCT02482753|exemestane|exemestane
175877|NCT02482753|Estrogen Receptor|estrogen receptor
175878|NCT02482740|Uterine Cervical Neoplasms|uterine cervical neoplasms
175879|NCT02482740|antiestrogens|antiestrogens
175880|NCT02482727|Blood Flow Restriction|blood flow restriction
175881|NCT02482727|Occlusion training|occlusion training
175882|NCT02482727|Distal radius fracture|distal radius fracture
175883|NCT02482714|Quality of Life|quality of life
175884|NCT02482714|Physical Activity|physical activity
175885|NCT02482701|EMR|emr
175886|NCT02482701|EAC|eac
175887|NCT02482701|Barrett's Neoplasia|barrett's neoplasia
175888|NCT02482701|Multiband Mucosectomy|multiband mucosectomy
175889|NCT02482675|Dairy|dairy
175890|NCT02482675|Milk|milk
175891|NCT02482675|Glucose|glucose
175892|NCT02482675|Postprandial|postprandial
175893|NCT02482675|Hyperglycemia|hyperglycemia
175894|NCT02482675|Prediabetes|prediabetes
175895|NCT02482675|Blood glucose|blood glucose
175896|NCT02482675|Oxidative stress|oxidative stress
175897|NCT02482675|Vascular health|vascular health
175898|NCT02482675|Vascular function|vascular function
175899|NCT02482662|Diagnosis|diagnosis
175900|NCT02482636|infant immunisations|infant immunisations
175901|NCT02482636|vaccines|vaccines
175902|NCT02482636|paediatric|paediatric
175903|NCT02482636|pneumococcal|pneumococcal
175904|NCT02482636|meningococcal|meningococcal
175905|NCT02482623|Dementia|dementia
175906|NCT02482623|neuropsychiatric symptoms|neuropsychiatric symptoms
175907|NCT02482623|implementation science|implementation science
175908|NCT02482623|depression|depression
175909|NCT02482623|pain|pain
175910|NCT02482610|Dairy|dairy
175911|NCT02482610|Milk|milk
175912|NCT02482610|Glucose|glucose
175913|NCT02482610|Postprandial|postprandial
175914|NCT02482610|Hyperglycemia|hyperglycemia
175915|NCT02482610|Prediabetes|prediabetes
175916|NCT02482610|Blood glucose|blood glucose
175917|NCT02482610|Oxidative stress|oxidative stress
175918|NCT02482610|Vascular health|vascular health
175919|NCT02482610|Vascular function|vascular function
175920|NCT02482571|Functional MRS|functional mrs
175921|NCT02482571|Glutamate|glutamate
175922|NCT02482558|Glycaemic Index|glycaemic index
175923|NCT02482558|NAFLD|nafld
175924|NCT02482558|Glycogen|glycogen
175925|NCT02482558|Liver|liver
175926|NCT02482558|Diet|diet
175927|NCT02482532|Melanoma|melanoma
175928|NCT02482532|metastatic|metastatic
175929|NCT02482532|relapsed|relapsed
175930|NCT02482532|refractory|refractory
175931|NCT02482506|African American|african american
175932|NCT02482506|Overweight|overweight
175933|NCT02482506|Adults|adults
175934|NCT02482480|SLEEP|sleep
175935|NCT02482480|APNEA|apnea
175936|NCT02482480|EXERCISE|exercise
175937|NCT02482467|ovarian cyst|ovarian cyst
175938|NCT02482467|prenatal diagnosis|prenatal diagnosis
175939|NCT02482467|puberty|puberty
175940|NCT02482454|radiofrequency ablation|radiofrequency ablation
175941|NCT02482454|cytokine-induced killer cells|cytokine-induced killer cells
175942|NCT02482454|cholangiocarcinoma|cholangiocarcinoma
175943|NCT02482441|Advanced Solid Tumors and in Combination|advanced solid tumors and in combination
175944|NCT02482441|FOLFIRI for Patients with Previously Treated Metastatic|folfiri for patients with previously treated metastatic
175945|NCT02482441|Colorectal Cancer|colorectal cancer
175946|NCT02482428|human papilloma virus (HPV), Genital Warts, Sexually transmitted disease (STD), viral disease|human papilloma virus (hpv), genital warts, sexually transmitted disease (std), viral disease
175947|NCT02482415|Palliative Care|palliative care
175948|NCT02482415|Randomized controlled trial|randomized controlled trial
175949|NCT02482415|Family caregivers|family caregivers
175950|NCT02482415|Intervention|intervention
175951|NCT02482415|Family|family
175952|NCT02482415|Intervention studies|intervention studies
175953|NCT02482415|Home Care|home care
175954|NCT02482311|AZD1775|azd1775
175955|NCT02482311|Ovarian cancer (BRCA1/2 mutation)|ovarian cancer (brca1/2 mutation)
175956|NCT02482311|Ovarian cancer (PARP-failure)|ovarian cancer (parp-failure)
175957|NCT02482311|Triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
175958|NCT02482311|Small-cell lung cancer (SCLC)|small-cell lung cancer (sclc)
175959|NCT02482311|Solid tumours|solid tumours
175960|NCT02482298|Sickle cell disease|sickle cell disease
175961|NCT02482298|Young adults|young adults
175962|NCT02482298|Hestia2|hestia2
175963|NCT02482298|Ticagrelor|ticagrelor
175964|NCT02482233|electronic cigarette|electronic cigarette
175965|NCT02482233|nicotine replacement therapy|nicotine replacement therapy
175966|NCT02482233|smoking cessation|smoking cessation
175967|NCT02482233|perioperative|perioperative
175968|NCT02482194|Spinal cord injury|spinal cord injury
175969|NCT02482194|mesenchymal stem cells|mesenchymal stem cells
175970|NCT02482194|transplantation|transplantation
175971|NCT02482181|diffusion weighted magnetic resonance imaging|diffusion weighted magnetic resonance imaging
175972|NCT02482168|immunotherapy|immunotherapy
175973|NCT02482168|CD40|cd40
175974|NCT02482155|pharmacokinetics|pharmacokinetics
175975|NCT02482155|MOMENTACT|momentact
175976|NCT02482155|ibuprofen 400 mg|ibuprofen 400 mg
175977|NCT02482155|oral|oral
175978|NCT02482155|granules|granules
175979|NCT02482142|phosphorus|phosphorus
175980|NCT02482142|lean|lean
175981|NCT02482142|obese|obese
175982|NCT02482142|energy expenditure|energy expenditure
175983|NCT02482129|Acute anterior uveitis|acute anterior uveitis
175984|NCT02482129|LME636|lme636
175985|NCT02482116|malaria|malaria
175986|NCT02482116|pneumonia|pneumonia
175987|NCT02482116|Nigeria|nigeria
175988|NCT02482116|IMCI|imci
175989|NCT02482116|diagnosis|diagnosis
175990|NCT02482103|Therapy resistant hypertension|therapy resistant hypertension
175991|NCT02482051|Carbapenem-resistant Enterobacteriaceae|carbapenem-resistant enterobacteriaceae
175992|NCT02482051|Accelerate ID/AST|accelerate id/ast
175993|NCT02482025|Medications|medications
175994|NCT02482025|Hospitalization|hospitalization
175995|NCT02482025|Electronic medical records|electronic medical records
175996|NCT02482012|research|research
175997|NCT02482012|vulnerable population|vulnerable population
175998|NCT02482012|45 CFR 46.406|45 cfr 46.406
175999|NCT02481999|Depth of anesthesia|depth of anesthesia
176000|NCT02481973|PMS|pms
176001|NCT02481973|Homoeopathy|homoeopathy
176002|NCT02481973|Grant Bentley Method|grant bentley method
176003|NCT02481934|Recurrent multiple myeloma|recurrent multiple myeloma
176004|NCT02481934|NK cells|nk cells
176005|NCT02481934|cell therapy|cell therapy
176006|NCT02481934|NKAE|nkae
176007|NCT02481934|Relapsed multiple myeloma|relapsed multiple myeloma
176008|NCT02481921|heart failure|heart failure
176009|NCT02481921|self-management|self-management
176010|NCT02481921|group intervention|group intervention
176011|NCT02481908|AECOPD|aecopd
176012|NCT02481908|left ventricular dysfunction|left ventricular dysfunction
176013|NCT02481908|valsalva maneuver|valsalva maneuver
176014|NCT02481908|systolic time intervals|systolic time intervals
176015|NCT02481895|cognition|cognition
176016|NCT02481895|psychosocial functioning|psychosocial functioning
176017|NCT02481869|Closed|closed
176018|NCT02481869|unilateral|unilateral
176019|NCT02481869|pilon|pilon
176020|NCT02481843|Hyperoxia|hyperoxia
176021|NCT02481843|Microcirculation|microcirculation
176022|NCT02481843|Erythropoietin|erythropoietin
176023|NCT02481843|Normobaric Oxygen Paradox|normobaric oxygen paradox
176024|NCT02481804|diet|diet
176025|NCT02481804|vitamin|vitamin
176026|NCT02481778|Radiotherapy|radiotherapy
176027|NCT02481778|Cardiac|cardiac
176028|NCT02481778|Toxicity|toxicity
176029|NCT02481752|Tobacco Use|tobacco use
176634|NCT02478294|Warfarin|warfarin
176030|NCT02481752|Nicotine Dependence|nicotine dependence
176031|NCT02481739|endometriosis|endometriosis
176032|NCT02481739|fertility|fertility
176033|NCT02481739|endometriosis surgery|endometriosis surgery
176034|NCT02481726|68Ga|68ga
176035|NCT02481726|Alfatide II|alfatide ii
176036|NCT02481726|RGD|rgd
176037|NCT02481726|αvβ3|αvβ3
176038|NCT02481726|PET/CT|pet/ct
176039|NCT02481713|psychosis|psychosis
176040|NCT02481713|adherence|adherence
176041|NCT02481713|motivation|motivation
176042|NCT02481674|Prodromal Stage|prodromal stage
176043|NCT02481674|Early Manifest Stage|early manifest stage
176044|NCT02481635|Blood Vessels|blood vessels
176045|NCT02481635|Reconstructive Surgery|reconstructive surgery
176046|NCT02481622|HIV infection|hiv infection
176047|NCT02481622|vaginal tissues|vaginal tissues
176048|NCT02481622|uterine tissues|uterine tissues
176049|NCT02481609|Loss of Smell|loss of smell
176050|NCT02481609|Olfaction|olfaction
176051|NCT02481609|Hyposmia|hyposmia
176052|NCT02481596|family|family
176053|NCT02481596|support|support
176054|NCT02481596|diet|diet
176055|NCT02481596|exercise|exercise
176056|NCT02481596|social|social
176057|NCT02481583|levosulpiride|levosulpiride
176058|NCT02481583|pharmacokinetics|pharmacokinetics
176059|NCT02481583|adverse effects|adverse effects
176060|NCT02481583|bioavailability|bioavailability
176061|NCT02481570|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
176062|NCT02481570|Scoliosis surgery|scoliosis surgery
176063|NCT02481570|Pharmacokinetic simulation|pharmacokinetic simulation
176064|NCT02481518|Cisplatin nephrotoxicity|cisplatin nephrotoxicity
176065|NCT02481518|Acute kidney injury|acute kidney injury
176066|NCT02481492|Circumcision, Male|circumcision, male
176067|NCT02481492|Shang Ring|shang ring
176068|NCT02481492|Children|children
176069|NCT02481492|Foreskin|foreskin
176070|NCT02481466|Arterial plaque|arterial plaque
176071|NCT02481466|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
176072|NCT02481466|Portfolio diet|portfolio diet
176073|NCT02481466|Dietary modification|dietary modification
176074|NCT02481466|Dietary trials|dietary trials
176075|NCT02481466|hypercholesterolemia|hypercholesterolemia
176076|NCT02481466|diabetes|diabetes
176077|NCT02481466|exercise|exercise
176078|NCT02481466|cardiovascular disease risk|cardiovascular disease risk
176079|NCT02481466|glycemic index (GI)|glycemic index (gi)
176080|NCT02481466|Carotid Ultrasound|carotid ultrasound
176081|NCT02481466|Dietary Approaches to Stop Hypertension (DASH) diet|dietary approaches to stop hypertension (dash) diet
176082|NCT02481440|umbilical cord mesenchymal stem cells|umbilical cord mesenchymal stem cells
176083|NCT02481440|spinal cord injury|spinal cord injury
176084|NCT02481427|Total|total
176085|NCT02481427|Unicondylar|unicondylar
176086|NCT02481427|Osteoarthritis|osteoarthritis
176087|NCT02481427|Arthroplasty|arthroplasty
176088|NCT02481427|Replacement|replacement
176089|NCT02481427|Knee|knee
176090|NCT02481414|HSIL, CIN II/III|hsil, cin ii/iii
176091|NCT02481401|cardiovascular health|cardiovascular health
176092|NCT02481401|behavior change|behavior change
176093|NCT02481401|community-based|community-based
176094|NCT02481401|family-based|family-based
176095|NCT02481401|prevention|prevention
176096|NCT02481375|iron|iron
176097|NCT02481375|ferritin|ferritin
176098|NCT02481375|soluble transferrin receptor|soluble transferrin receptor
176099|NCT02481375|hepcidin|hepcidin
176100|NCT02481375|reticulocyte count|reticulocyte count
176101|NCT02481375|hemoglobin|hemoglobin
176102|NCT02481375|supplementation|supplementation
176103|NCT02481349|Glioma|glioma
176104|NCT02481349|Hatha yoga|hatha yoga
176105|NCT02481349|Questionnaires|questionnaires
176106|NCT02481349|Surveys|surveys
176107|NCT02481336|Chemotherapy|chemotherapy
176108|NCT02481336|Peripheral Neuropathy|peripheral neuropathy
176109|NCT02481323|cerebral small vessel disease|cerebral small vessel disease
176110|NCT02481323|cerebrovascular reactivity|cerebrovascular reactivity
176111|NCT02481323|cilostazol|cilostazol
176112|NCT02481323|isosorbide mononitrate|isosorbide mononitrate
176113|NCT02481297|Leukemia|leukemia
176114|NCT02481297|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
176115|NCT02481297|CLL|cll
176116|NCT02481297|Refractory/Relapsed|refractory/relapsed
176117|NCT02481297|Untreated with high-risk molecular features|untreated with high-risk molecular features
176118|NCT02481297|Small lymphocytic leukemia|small lymphocytic leukemia
176119|NCT02481297|SLL|sll
176120|NCT02481297|Lirilumab|lirilumab
176121|NCT02481297|Rituximab|rituximab
176122|NCT02481297|Rituxan|rituxan
176123|NCT02481284|Breast reconstruction|breast reconstruction
176124|NCT02481284|Deep inferior epigastric artery perforator flap|deep inferior epigastric artery perforator flap
176125|NCT02481284|Skin perfusion|skin perfusion
176126|NCT02481284|Plastic and reconstructive surgery|plastic and reconstructive surgery
176127|NCT02481271|cholecystectomy|cholecystectomy
176128|NCT02481258|Stenosis|stenosis
176129|NCT02481258|Aortic Valve|aortic valve
176130|NCT02481258|Aorta|aorta
176131|NCT02481258|Calcified|calcified
176132|NCT02481258|Calcific|calcific
176133|NCT02481258|Calcification|calcification
176134|NCT02481245|Bipolar Disorder|bipolar disorder
176135|NCT02481245|Bezafibrate|bezafibrate
176136|NCT02481245|Depressive Episode|depressive episode
176137|NCT02481219|Polyps|polyps
176138|NCT02481219|Capsule endoscopy|capsule endoscopy
176139|NCT02481219|Bowel preparation regimen|bowel preparation regimen
176140|NCT02481219|Average risk patients for colorectal cancer screening|average risk patients for colorectal cancer screening
176141|NCT02481206|Ventricular Tachycardia|ventricular tachycardia
176142|NCT02481193|Cisatracurium|cisatracurium
176143|NCT02481193|Myalgia|myalgia
176144|NCT02481193|Fasciculation|fasciculation
176145|NCT02481193|Succinylcholine|succinylcholine
176146|NCT02481167|Aged|aged
176147|NCT02481167|Meibomian Glands|meibomian glands
176148|NCT02481167|dry eye|dry eye
176149|NCT02481167|Elderly|elderly
176150|NCT02481154|Glioma|glioma
176151|NCT02481154|IDH1|idh1
176152|NCT02481154|IDH2|idh2
176153|NCT02481154|Dual Mutation|dual mutation
176154|NCT02481154|AG-881|ag-881
176155|NCT02481128|lymphoscintigraphy|lymphoscintigraphy
176156|NCT02481128|sentinel lymph node biopsy|sentinel lymph node biopsy
176157|NCT02481076|malleolar fractures|malleolar fractures
176158|NCT02481076|ORIF|orif
176159|NCT02481076|compression|compression
176160|NCT02481076|infection|infection
176161|NCT02481076|wound dehisence|wound dehisence
176162|NCT02481063|Eccentric|eccentric
176163|NCT02481063|Running|running
176164|NCT02481063|Muscle|muscle
176165|NCT02481063|Tendon|tendon
176166|NCT02481063|Ultrasound|ultrasound
176167|NCT02481063|Thermography|thermography
176168|NCT02481050|Eribulin Mesylate|eribulin mesylate
176169|NCT02481050|Human Epidermal Growth Factor Receptor 2|human epidermal growth factor receptor 2
176170|NCT02481050|Metastatic Breast Cancer|metastatic breast cancer
176171|NCT02481050|HER2-Negative|her2-negative
176172|NCT02481024|Qualitative|qualitative
176173|NCT02481024|Care transition|care transition
176174|NCT02481024|Medication|medication
176175|NCT02481011|Fibrinolytic agents|fibrinolytic agents
176176|NCT02481011|Adverse effects|adverse effects
176177|NCT02481011|Registries|registries
176178|NCT02481011|Incidence|incidence
176179|NCT02481011|Risk assessment|risk assessment
176180|NCT02480985|Pituitary Disorders|pituitary disorders
176181|NCT02480985|Traumatic Brain Injury|traumatic brain injury
176182|NCT02480985|Critical Care|critical care
176183|NCT02480985|Outcome Research|outcome research
176184|NCT02480985|Risk Factors|risk factors
176185|NCT02480985|Patient Oriented Research|patient oriented research
176186|NCT02480972|fibrosis|fibrosis
176187|NCT02480972|cirrhosis|cirrhosis
176188|NCT02480972|MRI|mri
176189|NCT02480946|Rheumatoid Arthritis|rheumatoid arthritis
176190|NCT02480946|Osteoclastogenesis inhibitor|osteoclastogenesis inhibitor
176191|NCT02480946|Anti-Inflammatory Agent|anti-inflammatory agent
176192|NCT02480946|Musculoskeletal Diseases|musculoskeletal diseases
176193|NCT02480946|Joint Diseases|joint diseases
176194|NCT02480920|Atrial fibrillation Drug Adherence|atrial fibrillation drug adherence
176195|NCT02480920|New Oral Anticoagulants|new oral anticoagulants
176196|NCT02480920|Drug Adherence|drug adherence
176197|NCT02480907|eating disorders|eating disorders
176198|NCT02480907|caregivers|caregivers
176199|NCT02480907|parents|parents
176200|NCT02480907|skills training|skills training
176201|NCT02480907|workshops|workshops
176202|NCT02480907|support|support
176203|NCT02480907|internet|internet
176204|NCT02480907|online|online
176205|NCT02480907|family|family
176206|NCT02480868|Primary or secondary osteoarthritis|primary or secondary osteoarthritis
176207|NCT02480868|fusion of the ankle|fusion of the ankle
176208|NCT02480855|work related stress|work related stress
176209|NCT02480855|questionnaire|questionnaire
176210|NCT02480855|early identification|early identification
176211|NCT02480842|Breast Neoplasms|breast neoplasms
176212|NCT02480842|Mammaplasty|mammaplasty
176213|NCT02480842|Breast Implantation|breast implantation
176214|NCT02480842|Range of Motion, Articular|range of motion, articular
176215|NCT02480842|Shoulder Joint|shoulder joint
176216|NCT02480842|Physical Therapy Modalities|physical therapy modalities
176217|NCT02480803|Parkinson|parkinson
176218|NCT02480803|Parkinson's Disease|parkinson's disease
176219|NCT02480803|Deep Brain Stimulation|deep brain stimulation
176220|NCT02480803|levodopa-carbidopa|levodopa-carbidopa
176221|NCT02480803|Duodopa|duodopa
176222|NCT02480803|continuous intrajejunal infusion|continuous intrajejunal infusion
176223|NCT02480764|Drug therapy|drug therapy
176224|NCT02480751|Chronic Renal Failure|chronic renal failure
176225|NCT02480751|Prostaglandin|prostaglandin
176226|NCT02480751|Prostacyclin|prostacyclin
176227|NCT02480751|Glomerular Disease; Nephrosclerosis|glomerular disease; nephrosclerosis
176228|NCT02480738|subjective cognitive impairment|subjective cognitive impairment
176229|NCT02480725|CJD|cjd
176230|NCT02480725|CSF|csf
176231|NCT02480725|prion|prion
176232|NCT02480725|thrombin|thrombin
176233|NCT02480673|Metabolic Syndrome X|metabolic syndrome x
176234|NCT02480673|Chia|chia
176235|NCT02480673|Dyslipidemia|dyslipidemia
176236|NCT02480660|Hospitalized|hospitalized
176237|NCT02480660|adolescents|adolescents
176238|NCT02480660|knowledge|knowledge
176239|NCT02480660|transition|transition
176240|NCT02480660|educational intervention|educational intervention
176241|NCT02480634|zoledronic acid|zoledronic acid
176242|NCT02480634|radiotherapy|radiotherapy
176243|NCT02480595|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
176244|NCT02480595|AAA|aaa
176245|NCT02480595|Endovascular|endovascular
176246|NCT02480595|EVAR|evar
176247|NCT02480595|Stent|stent
176248|NCT02480595|Stent Graft|stent graft
176249|NCT02480595|High Angle|high angle
176250|NCT02480595|Tortuous|tortuous
176251|NCT02480556|blood loss; caesarean section ; manual placental separation|blood loss; caesarean section ; manual placental separation
176252|NCT02480530|Medication Adherence|medication adherence
176253|NCT02480530|Reciprocal Peer|reciprocal peer
176254|NCT02480530|Telemonitoring|telemonitoring
176255|NCT02480517|Hypertension|hypertension
176256|NCT02480517|Renal Denervation|renal denervation
176257|NCT02480478|Intrahepatic Cholestasis of Pregnancy|intrahepatic cholestasis of pregnancy
176258|NCT02480439|Drug Therapy|drug therapy
176259|NCT02480413|Broselow Tape|broselow tape
176260|NCT02480413|Weight estimation|weight estimation
176261|NCT02480413|Patient safety|patient safety
176262|NCT02480400|MDD|mdd
176263|NCT02480400|Escitalopram|escitalopram
176264|NCT02480400|Placebo|placebo
176265|NCT02480361|Acupuncture|acupuncture
176266|NCT02480361|Gastric cancer|gastric cancer
176267|NCT02480322|metabolic alterations|metabolic alterations
176268|NCT02480257|intervention|intervention
176269|NCT02480257|emotion regulation|emotion regulation
176270|NCT02480257|fMRI|fmri
176271|NCT02480257|mindfulness|mindfulness
176272|NCT02480257|yoga-based movement|yoga-based movement
176273|NCT02480231|Tension-Free Vaginal Tape|tension-free vaginal tape
176274|NCT02480231|Suburethral Slings|suburethral slings
176275|NCT02480231|Midurethral Slings|midurethral slings
176276|NCT02480231|Mid-urethral sling|mid-urethral sling
176277|NCT02480231|urinary retention|urinary retention
176278|NCT02480218|cognition|cognition
176279|NCT02480218|tamoxifen|tamoxifen
176280|NCT02480218|aromatase inhibitors|aromatase inhibitors
176281|NCT02480205|CPAP|cpap
176282|NCT02480205|NIV|niv
176283|NCT02480205|NIPPV|nippv
176284|NCT02480205|Edi|edi
176285|NCT02480192|Vasomotor|vasomotor
176286|NCT02480192|Symptoms|symptoms
176287|NCT02480179|functional MRI|functional mri
176288|NCT02480179|appetite|appetite
176289|NCT02480179|neurofeedback|neurofeedback
176290|NCT02480166|hepatitis C, genotype 6|hepatitis c, genotype 6
176291|NCT02480153|Phase 3|phase 3
176292|NCT02480153|adalimumab|adalimumab
176293|NCT02480153|rheumatoid arthritis|rheumatoid arthritis
176294|NCT02480140|Self-regulation|self-regulation
176295|NCT02480140|Constraint-induced movement therapy|constraint-induced movement therapy
176296|NCT02480140|Stroke|stroke
176297|NCT02480140|Functional recovery|functional recovery
176298|NCT02480140|Randomized controlled trial|randomized controlled trial
176299|NCT02480101|influenza vaccine pandemic|influenza vaccine pandemic
176300|NCT02480075|Genetic Variation|genetic variation
176301|NCT02480075|Genetic Polymorphism|genetic polymorphism
176302|NCT02480075|Polymorphism, Single Nucleotide|polymorphism, single nucleotide
176303|NCT02480075|Genetic Association Studies|genetic association studies
176304|NCT02480062|Decision Support System|decision support system
176305|NCT02480062|mHealth|mhealth
176306|NCT02480062|Primary Health Care|primary health care
176307|NCT02480062|Non-communicable diseases|non-communicable diseases
176308|NCT02480036|IORT|iort
176309|NCT02480036|Kyphoplasty|kyphoplasty
176310|NCT02480036|Spine|spine
176311|NCT02480036|Cancer|cancer
176312|NCT02479997|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
176313|NCT02479997|Indocyanine green (ICG)|indocyanine green (icg)
176314|NCT02479997|Radioisotope (RI)|radioisotope (ri)
176315|NCT02479997|Near infrared fluorescence camera|near infrared fluorescence camera
176316|NCT02479984|staging laparoscopy|staging laparoscopy
176317|NCT02479984|pancreatic cancer|pancreatic cancer
176318|NCT02479984|biliary cancer|biliary cancer
176319|NCT02479958|Photochemotherapy|photochemotherapy
176320|NCT02479958|Bacteria|bacteria
176321|NCT02479932|Extra-peritoneal cesarean|extra-peritoneal cesarean
176322|NCT02479932|Intra-peritoneal cesarean|intra-peritoneal cesarean
176323|NCT02479919|theta burst stimulation|theta burst stimulation
176324|NCT02479919|Social Cognition|social cognition
176325|NCT02479919|Schizophrenia|schizophrenia
176326|NCT02479919|transcranial magnetic stimulation|transcranial magnetic stimulation
176327|NCT02479906|Post-Traumatic Stress Disorder|post-traumatic stress disorder
176328|NCT02479906|PTSD|ptsd
176329|NCT02479906|dTMS|dtms
176330|NCT02479893|cold snare polypectomy|cold snare polypectomy
176331|NCT02479893|APC|apc
176332|NCT02479893|hot snare polypectomy|hot snare polypectomy
176333|NCT02479815|Complementary feeding recommendation|complementary feeding recommendation
176334|NCT02479815|Program evaluation|program evaluation
176335|NCT02479815|Process and impact evaluation|process and impact evaluation
176728|NCT02477566|pcos|pcos
176336|NCT02479815|Micronutrient powder (MNP) safety|micronutrient powder (mnp) safety
176337|NCT02479802|plasma exchange|plasma exchange
176338|NCT02479802|albumin|albumin
176339|NCT02479789|Intravenous Lidocaine|intravenous lidocaine
176340|NCT02479789|Recurrent laryngeal nerve|recurrent laryngeal nerve
176341|NCT02479789|Intra operative nerve monitoring|intra operative nerve monitoring
176342|NCT02479789|Thyroidectomy|thyroidectomy
176343|NCT02479763|Epidural waveform analysis|epidural waveform analysis
176344|NCT02479763|Loss of resistance|loss of resistance
176345|NCT02479737|Chest tube|chest tube
176346|NCT02479737|chest drainage|chest drainage
176347|NCT02479737|retained blood complications|retained blood complications
176348|NCT02479737|chest tube clogging|chest tube clogging
176349|NCT02479737|hemothorax|hemothorax
176350|NCT02479737|tamponade|tamponade
176351|NCT02479737|heart surgery|heart surgery
176352|NCT02479737|pleural effusion|pleural effusion
176353|NCT02479737|intensive care|intensive care
176354|NCT02479724|continuous, non-invasive|continuous, non-invasive
176355|NCT02479711|glass ionomer|glass ionomer
176356|NCT02479711|bulk fill composite|bulk fill composite
176357|NCT02479698|Stem cell transplant|stem cell transplant
176358|NCT02479698|Human Leukocyte Antigen|human leukocyte antigen
176359|NCT02479698|HLA|hla
176360|NCT02479698|BK specific CTL lines|bk specific ctl lines
176361|NCT02479698|BK-CTLs|bk-ctls
176362|NCT02479698|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
176363|NCT02479698|HSCT|hsct
176364|NCT02479698|BK Infection|bk infection
176365|NCT02479698|Cytotoxic T lymphocytes|cytotoxic t lymphocytes
176366|NCT02479698|CTLs|ctls
176367|NCT02479698|Myeloablative|myeloablative
176368|NCT02479698|Non-myeloablative|non-myeloablative
176369|NCT02479698|Graft Versus Host Disease|graft versus host disease
176370|NCT02479698|GVHD|gvhd
176371|NCT02479672|breathing tube placement|breathing tube placement
176372|NCT02479672|VideoTrac® laryngoscope|videotrac® laryngoscope
176373|NCT02479672|direct laryngoscopy|direct laryngoscopy
176374|NCT02479659|Immunizations|immunizations
176375|NCT02479646|Pegfilgrastim|pegfilgrastim
176376|NCT02479646|G-CSF|g-csf
176377|NCT02479646|Pharmacokinetics|pharmacokinetics
176378|NCT02479646|Pharmacodynamics|pharmacodynamics
176379|NCT02479633|prognostic factors|prognostic factors
176380|NCT02479607|Breast Cancer|breast cancer
176381|NCT02479607|Cytostatic Agents|cytostatic agents
176382|NCT02479607|Nursing|nursing
176383|NCT02479607|Health Literacy|health literacy
176384|NCT02479607|Quality of Life|quality of life
176385|NCT02479607|Oncology Nursing|oncology nursing
176386|NCT02479607|Self Care|self care
176387|NCT02479607|Symptom Management|symptom management
176388|NCT02479607|Participatory Care|participatory care
176389|NCT02479607|Person-centered Care|person-centered care
176390|NCT02479607|Information and Communication Technology|information and communication technology
176391|NCT02479607|Patient-reported symptoms|patient-reported symptoms
176392|NCT02479607|Mobile device|mobile device
176393|NCT02479594|competence-feedback|competence-feedback
176394|NCT02479581|Enhanced Recovery after Surgery|enhanced recovery after surgery
176395|NCT02479568|Cardiovascular disease|cardiovascular disease
176396|NCT02479568|biomarkers|biomarkers
176397|NCT02479568|transcriptomics|transcriptomics
176398|NCT02479568|orange juice|orange juice
176399|NCT02479568|hesperidin|hesperidin
176400|NCT02479568|systolic blood pressure|systolic blood pressure
176401|NCT02479568|metabolomics|metabolomics
176402|NCT02479568|cardiovascular risk factor|cardiovascular risk factor
176403|NCT02479542|Negative-Pressure Wound Therapy|negative-pressure wound therapy
176404|NCT02479542|Wound Healing|wound healing
176405|NCT02479542|Global Health|global health
176406|NCT02479542|Cameroon|cameroon
176407|NCT02479516|Diabetes screening|diabetes screening
176408|NCT02479516|Health Promotion|health promotion
176409|NCT02479516|Low and Middle Income Countries|low and middle income countries
176410|NCT02479516|CHAP|chap
176411|NCT02479503|antibiotic prophylaxis heart transplantation|antibiotic prophylaxis heart transplantation
176412|NCT02479490|metastatic renal cancer|metastatic renal cancer
176413|NCT02479490|failure of VEGFR_TKI|failure of vegfr_tki
176414|NCT02479490|prednisone|prednisone
176415|NCT02479490|everolimus|everolimus
176416|NCT02479477|Public Health|public health
176417|NCT02479477|Nursing Staff, Hospital|nursing staff, hospital
176418|NCT02479464|AssureRx|assurerx
176419|NCT02479464|Algorithm|algorithm
176420|NCT02479464|Major depressive disorder|major depressive disorder
176421|NCT02479451|End stage renal disease|end stage renal disease
176422|NCT02479451|Olfaction|olfaction
176423|NCT02479451|Dialysis|dialysis
176424|NCT02479451|Hemodialysis|hemodialysis
176425|NCT02479451|Malnutrition|malnutrition
176426|NCT02479425|pressure ulcer|pressure ulcer
176427|NCT02479425|Positioning|positioning
176428|NCT02479412|Mild to moderate asthma|mild to moderate asthma
176429|NCT02479412|FEV1|fev1
176430|NCT02479412|efficacy|efficacy
176431|NCT02479412|safety|safety
176432|NCT02479399|Suglat|suglat
176433|NCT02479399|SGLT-2 inhibitor|sglt-2 inhibitor
176434|NCT02479399|Ipragliflozin L-Proline|ipragliflozin l-proline
176435|NCT02479399|ASP1941 long-term use|asp1941 long-term use
176436|NCT02479347|General surgery|general surgery
176437|NCT02479347|Postoperative|postoperative
176438|NCT02479334|Spices|spices
176439|NCT02479334|Functional food|functional food
176440|NCT02479334|Cardiometabolic risk|cardiometabolic risk
176441|NCT02479334|Metabolic syndrome|metabolic syndrome
176442|NCT02479334|Inflammation|inflammation
176443|NCT02479334|Peripheral blood mononuclear cell|peripheral blood mononuclear cell
176444|NCT02479334|Acute|acute
176445|NCT02479321|Perioperative Goal-Directed Hemodynamic Therapy|perioperative goal-directed hemodynamic therapy
176446|NCT02479321|Fluid therapy|fluid therapy
176447|NCT02479321|Aged|aged
176448|NCT02479321|Perioperative complications|perioperative complications
176449|NCT02479321|Survival|survival
176450|NCT02479308|Alkermes|alkermes
176451|NCT02479308|Samidorphan|samidorphan
176452|NCT02479308|ALKS 5461|alks 5461
176453|NCT02479308|QT/QTc|qt/qtc
176454|NCT02479308|Buprenorphine|buprenorphine
176455|NCT02479308|Pharmacodynamics|pharmacodynamics
176456|NCT02479269|Brain Natriuretic Peptide|brain natriuretic peptide
176457|NCT02479269|aerobic execise|aerobic execise
176458|NCT02479269|C- Reactive Protein|c- reactive protein
176459|NCT02479256|PCOS|pcos
176460|NCT02479256|Induction of ovulation|induction of ovulation
176461|NCT02479256|Clomiphene citrate|clomiphene citrate
176462|NCT02479256|Tamoxifen|tamoxifen
176463|NCT02479243|Arterial Spin Labeling|arterial spin labeling
176464|NCT02479243|MRI|mri
176465|NCT02479243|Atherosclerotic Stenosis|atherosclerotic stenosis
176466|NCT02479243|Collateral Circulation|collateral circulation
176467|NCT02479243|Ischemic stroke|ischemic stroke
176468|NCT02479230|vaccine|vaccine
176469|NCT02479230|breast cancer|breast cancer
176470|NCT02479230|metastatic|metastatic
176471|NCT02479204|safety|safety
176472|NCT02479204|heart rate|heart rate
176473|NCT02479204|pharmacokinetics|pharmacokinetics
176474|NCT02479191|Abdominal|abdominal
176475|NCT02479191|Aortic|aortic
176476|NCT02479191|Aneurysm|aneurysm
176477|NCT02479152|Mechanical CPR|mechanical cpr
176478|NCT02479152|Hemodynamics|hemodynamics
176479|NCT02479126|Interstitial Lung Disease|interstitial lung disease
176480|NCT02479126|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
176481|NCT02479126|Electronic Health Records|electronic health records
176482|NCT02479126|Computed Tomography|computed tomography
176483|NCT02479126|Mortality|mortality
176484|NCT02479126|Hospitalization|hospitalization
176485|NCT02479126|Acute care visits|acute care visits
176486|NCT02479126|Anti-inflammatory drug therapies|anti-inflammatory drug therapies
176487|NCT02479113|GDM|gdm
176488|NCT02479113|Maternal Hypertriglyceridaemia|maternal hypertriglyceridaemia
176489|NCT02479100|Contrast Enhanced Spectral Mammography|contrast enhanced spectral mammography
176490|NCT02479100|Breast|breast
176491|NCT02479100|Cancer|cancer
176492|NCT02479100|Diagnosis|diagnosis
176493|NCT02479100|Patient management|patient management
176494|NCT02479087|von Willebrand Factor|von willebrand factor
176495|NCT02479087|Factor VIII|factor viii
176496|NCT02479087|Hemorrhage|hemorrhage
176497|NCT02479087|Immune Tolerance|immune tolerance
176498|NCT02479087|Hemophilia A|hemophilia a
176499|NCT02479074|Chronic|chronic
176500|NCT02479061|Observationnal study|observationnal study
176501|NCT02479061|Prevalence|prevalence
176502|NCT02479061|Palliative care|palliative care
176503|NCT02479061|Anti cancer center|anti cancer center
176504|NCT02479048|satiety/appetite|satiety/appetite
176505|NCT02479048|glycemic response|glycemic response
176506|NCT02479048|cardiometabolic risk|cardiometabolic risk
176507|NCT02479035|insulin sensitive|insulin sensitive
176508|NCT02479035|insulin resistant|insulin resistant
176509|NCT02479035|red raspberry|red raspberry
176510|NCT02479035|polyphenols|polyphenols
176511|NCT02479035|bioavailability|bioavailability
176512|NCT02478996|perioperative|perioperative
176513|NCT02478996|internet-based|internet-based
176514|NCT02478996|exercise program|exercise program
176515|NCT02478957|mastocytosis|mastocytosis
176516|NCT02478957|cromolyn sodium|cromolyn sodium
176517|NCT02478944|Inflammatory bowel disease|inflammatory bowel disease
176518|NCT02478944|Manometry|manometry
176519|NCT02478892|high risk|high risk
176520|NCT02478892|specifically those with BRCA1/2 mutations|specifically those with brca1/2 mutations
176521|NCT02478827|Cognitive Training|cognitive training
176522|NCT02478827|Working Memory|working memory
176523|NCT02478827|Processing Speed|processing speed
176524|NCT02478788|ADHD|adhd
176525|NCT02478775|obesity|obesity
176526|NCT02478775|fertility|fertility
176527|NCT02478775|infertility|infertility
176528|NCT02478775|reproductive hormones|reproductive hormones
176529|NCT02478762|Foetal glycated hemoglobin|foetal glycated hemoglobin
176530|NCT02478762|Glycemic objectives treatment|glycemic objectives treatment
176531|NCT02478736|postoperative delirium|postoperative delirium
176532|NCT02478736|on-pump cardiac surgery|on-pump cardiac surgery
176533|NCT02478736|cerebral oximetry|cerebral oximetry
176534|NCT02478736|cerebral blood flow velosity|cerebral blood flow velosity
176535|NCT02478723|requiring therapy|requiring therapy
176537|NCT02478697|tobacco smoking behavior|tobacco smoking behavior
176538|NCT02478697|employment|employment
176539|NCT02478697|job-seeking|job-seeking
176540|NCT02478697|tobacco cessation|tobacco cessation
176541|NCT02478697|transtheoretical model|transtheoretical model
176542|NCT02478697|behavior change|behavior change
176543|NCT02478684|delayed cord clamping|delayed cord clamping
176544|NCT02478684|premature infants|premature infants
176545|NCT02478684|randomized study|randomized study
176546|NCT02478684|hematocrit|hematocrit
176547|NCT02478658|irisin|irisin
176548|NCT02478658|resistance training|resistance training
176549|NCT02478658|physical fitness|physical fitness
176550|NCT02478658|Volunteers|volunteers
176551|NCT02478632|tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
176552|NCT02478632|dolutegravir plus rilpivirine|dolutegravir plus rilpivirine
176553|NCT02478632|two-drug regimen|two-drug regimen
176554|NCT02478632|bone mineral density|bone mineral density
176555|NCT02478632|dual energy X-ray absorptiometry (DEXA)|dual energy x-ray absorptiometry (dexa)
176556|NCT02478632|Human Immunodeficiency Virus-1|human immunodeficiency virus-1
176557|NCT02478632|nucleoside reverse transcriptase inhibitor -sparing regimen|nucleoside reverse transcriptase inhibitor -sparing regimen
176558|NCT02478632|integrase inhibitor|integrase inhibitor
176559|NCT02478619|Obesity|obesity
176560|NCT02478619|Respiratory Muscle Training|respiratory muscle training
176561|NCT02478619|Bariatric Surgery|bariatric surgery
176562|NCT02478619|Breathing exercises|breathing exercises
176563|NCT02478619|Gastroplasty|gastroplasty
176564|NCT02478606|Lower Extremity|lower extremity
176565|NCT02478606|Muscle Stretching Exercises|muscle stretching exercises
176566|NCT02478606|Muscle Strength|muscle strength
176567|NCT02478606|Static Stretching|static stretching
176568|NCT02478606|Proprioceptive Neuromuscular Facilitation (PNF) Stretching|proprioceptive neuromuscular facilitation (pnf) stretching
176569|NCT02478606|Muscle Strength Dynamometer|muscle strength dynamometer
176570|NCT02478593|Education|education
176571|NCT02478593|Geriatric|geriatric
176572|NCT02478593|Benzodiazepine|benzodiazepine
176573|NCT02478593|Prevalence|prevalence
176574|NCT02478580|Obstructive Sleep Apnea|obstructive sleep apnea
176575|NCT02478580|Anesthesia Recovery Period|anesthesia recovery period
176576|NCT02478554|Fetal growth restriction|fetal growth restriction
176577|NCT02478554|macrosomia|macrosomia
176578|NCT02478541|triglycerides|triglycerides
176579|NCT02478541|glucose|glucose
176580|NCT02478541|fructose|fructose
176581|NCT02478541|fatty acids|fatty acids
176582|NCT02478515|ranibizumab|ranibizumab
176583|NCT02478515|PRN regimen|prn regimen
176584|NCT02478515|macular edema|macular edema
176585|NCT02478515|branch retinal vein occlusion|branch retinal vein occlusion
176586|NCT02478502|testicular cancer|testicular cancer
176587|NCT02478502|cisplatin resistancy|cisplatin resistancy
176588|NCT02478489|alcohol|alcohol
176589|NCT02478489|heavy drinking|heavy drinking
176590|NCT02478489|naltrexone|naltrexone
176591|NCT02478489|hospital|hospital
176592|NCT02478489|alcohol use disorder|alcohol use disorder
176593|NCT02478489|alcohol dependence|alcohol dependence
176594|NCT02478489|comparative effectiveness|comparative effectiveness
176595|NCT02478463|Cabotegravir|cabotegravir
176596|NCT02478463|Pharmacokinetic|pharmacokinetic
176597|NCT02478463|Healthy Adult Volunteers|healthy adult volunteers
176598|NCT02478463|GSK1265744|gsk1265744
176599|NCT02478437|Lumbar Facet Syndrome|lumbar facet syndrome
176600|NCT02478411|muscle weakness|muscle weakness
176601|NCT02478411|rehabilitation|rehabilitation
176602|NCT02478411|intensive care|intensive care
176603|NCT02478411|mechanical ventilation|mechanical ventilation
176604|NCT02478411|cyclo ergometer|cyclo ergometer
176605|NCT02478411|physiotherapy|physiotherapy
176606|NCT02478385|Birth environment|birth environment
176607|NCT02478385|oxytocin|oxytocin
176608|NCT02478385|epidural|epidural
176609|NCT02478385|analgesia|analgesia
176610|NCT02478385|home-like|home-like
176611|NCT02478372|local infiltration analgesia|local infiltration analgesia
176612|NCT02478372|Epidural|epidural
176613|NCT02478372|Enhanced Recovery|enhanced recovery
176614|NCT02478372|Total Knee Arthroplasty|total knee arthroplasty
176615|NCT02478333|Healthy|healthy
176616|NCT02478333|ALS-008176|als-008176
176617|NCT02478333|Japanese adult participants|japanese adult participants
176618|NCT02478320|Advanced Cancers|advanced cancers
176619|NCT02478320|CDKN2A-Deficient Advanced Solid Cancers|cdkn2a-deficient advanced solid cancers
176620|NCT02478320|Advanced or metastatic cancer.|advanced or metastatic cancer.
176621|NCT02478320|Ilorasertib|ilorasertib
176622|NCT02478320|ABT-348|abt-348
176623|NCT02478307|chronic low back pain|chronic low back pain
176624|NCT02478307|mindfulness meditation|mindfulness meditation
176625|NCT02478307|cognitive therapy|cognitive therapy
176626|NCT02478307|mindfulness-based cognitive therapy|mindfulness-based cognitive therapy
176627|NCT02478307|efficacy|efficacy
176628|NCT02478307|mechanisms|mechanisms
176629|NCT02478307|coping|coping
176630|NCT02478294|Atrial Fibrillation|atrial fibrillation
176631|NCT02478294|Stroke|stroke
176632|NCT02478294|Systemic embolism|systemic embolism
176633|NCT02478294|Left atrial appendage excision|left atrial appendage excision
176635|NCT02478268|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
176636|NCT02478268|xenon gas|xenon gas
176637|NCT02478255|Radiation induced lung injury|radiation induced lung injury
176638|NCT02478255|Xenon gas|xenon gas
176639|NCT02478255|hyperpolarized|hyperpolarized
176640|NCT02478229|Liver transplant|liver transplant
176641|NCT02478229|Genotype 1 HCV infection|genotype 1 hcv infection
176642|NCT02478229|Sofosbuvir (SOF)/ Ledipasvir (LDV)|sofosbuvir (sof)/ ledipasvir (ldv)
176643|NCT02478229|Sustained virological response (SVR12 )|sustained virological response (svr12 )
176644|NCT02478203|Airtraq|airtraq
176645|NCT02478203|Glidescope|glidescope
176646|NCT02478203|pediatric|pediatric
176647|NCT02478203|face-to-face|face-to-face
176648|NCT02478177|Anticoagulant|anticoagulant
176649|NCT02478177|Stroke|stroke
176650|NCT02478177|Ischemic Stroke|ischemic stroke
176651|NCT02478177|Intracerebral hemorrhage|intracerebral hemorrhage
176652|NCT02478151|Deceased donor liver transplant|deceased donor liver transplant
176653|NCT02478151|Normothermic machine perfusion|normothermic machine perfusion
176654|NCT02478125|metastatic castrate resistant prostate cancer|metastatic castrate resistant prostate cancer
176655|NCT02478112|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
176656|NCT02478112|Balloon implant|balloon implant
176657|NCT02478099|MPDL3280A|mpdl3280a
176658|NCT02478099|bladder cancer|bladder cancer
176659|NCT02478099|non small cell lung cancer|non small cell lung cancer
176660|NCT02478099|triple negative breast cancer|triple negative breast cancer
176661|NCT02478086|amino acids|amino acids
176662|NCT02478086|renal function|renal function
176663|NCT02478086|extreme premature|extreme premature
176664|NCT02478060|Allergy|allergy
176665|NCT02478060|Birch|birch
176666|NCT02478060|Rhinitis|rhinitis
176667|NCT02478060|Rhinoconjuntivitis|rhinoconjuntivitis
176668|NCT02478060|SPIRE|spire
176669|NCT02478060|Toleromune|toleromune
176670|NCT02478047|to Evaluate the Effectiveness of Acupucnture in the Management of Chemotherapy-induced Nausea and Vomiting|to evaluate the effectiveness of acupucnture in the management of chemotherapy-induced nausea and vomiting
176671|NCT02478021|effects of cortisol on cognition|effects of cortisol on cognition
176672|NCT02478008|Transcatheter Mitral Valve Replacement|transcatheter mitral valve replacement
176673|NCT02478008|Mitral Regurgitation|mitral regurgitation
176674|NCT02478008|Mitral Insufficiency|mitral insufficiency
176675|NCT02478008|Transapical|transapical
176676|NCT02477995|Immunogenicity|immunogenicity
176677|NCT02477995|Safety|safety
176678|NCT02477995|DTaP Vaccine|dtap vaccine
176679|NCT02477982|Propofol|propofol
176680|NCT02477982|Cardiopulmonary Bypass|cardiopulmonary bypass
176681|NCT02477982|Pharmacokinetics|pharmacokinetics
176682|NCT02477982|Obesity|obesity
176683|NCT02477956|vitamin D|vitamin d
176684|NCT02477956|obesity|obesity
176685|NCT02477956|bariatric surgery|bariatric surgery
176686|NCT02477917|allergy|allergy
176687|NCT02477917|SCIT|scit
176688|NCT02477904|Autism|autism
176689|NCT02477904|Autism Spectrum Disorder|autism spectrum disorder
176690|NCT02477904|Ketogenic Diet|ketogenic diet
176691|NCT02477904|Biochemical Profiles|biochemical profiles
176692|NCT02477891|Multiple myeloma|multiple myeloma
176693|NCT02477891|Daratumumab|daratumumab
176694|NCT02477891|Early access|early access
176695|NCT02477878|Adult leukemias and myelodysplasia|adult leukemias and myelodysplasia
176696|NCT02477878|Adult lymphomas|adult lymphomas
176697|NCT02477878|Adult multiple myeloma|adult multiple myeloma
176698|NCT02477852|tuberculosis|tuberculosis
176699|NCT02477852|spinal|spinal
176700|NCT02477852|general|general
176701|NCT02477852|operation|operation
176702|NCT02477852|drug|drug
176703|NCT02477852|therapy|therapy
176704|NCT02477839|epilepsy, children, partial-onset seizures, Lacosamide, LCM, pediatric|epilepsy, children, partial-onset seizures, lacosamide, lcm, pediatric
176705|NCT02477800|BIIB037|biib037
176706|NCT02477800|Aducanumab|aducanumab
176707|NCT02477787|HLA-haploidentical hematopoietic cell transplantation|hla-haploidentical hematopoietic cell transplantation
176708|NCT02477787|natural killer cells|natural killer cells
176709|NCT02477774|Anterolateral Thigh|anterolateral thigh
176710|NCT02477670|Negative Symptoms|negative symptoms
176711|NCT02477670|Schizophrenia|schizophrenia
176712|NCT02477670|AVP-786|avp-786
176713|NCT02477657|Adult patients with refractory malignant ascites secondary to GU or GI malignancy.|adult patients with refractory malignant ascites secondary to gu or gi malignancy.
176714|NCT02477644|Advanced FIGO IIIB|advanced figo iiib
176715|NCT02477644|IV high grade serious ovarian cancer|iv high grade serious ovarian cancer
176716|NCT02477644|endometrioid ovarian cancer|endometrioid ovarian cancer
176717|NCT02477644|standard first-line treatment|standard first-line treatment
176718|NCT02477644|platinum-taxane chemotherapy|platinum-taxane chemotherapy
176719|NCT02477644|bevacizumab|bevacizumab
176720|NCT02477644|olaparib|olaparib
176721|NCT02477644|placebo|placebo
176722|NCT02477631|Myelodysplastic syndrome|myelodysplastic syndrome
176723|NCT02477631|oxidative stress|oxidative stress
176724|NCT02477631|labile plasma iron|labile plasma iron
176725|NCT02477592|long standing persistent atrial fibrillation|long standing persistent atrial fibrillation
176726|NCT02477592|novel approach|novel approach
176727|NCT02477592|ablation|ablation
176729|NCT02477566|Long acting Triptorelin|long acting triptorelin
176730|NCT02477566|Short acting Triptorelin|short acting triptorelin
176731|NCT02477566|In Vitro Fertilization|in vitro fertilization
176732|NCT02477553|decision aid|decision aid
176733|NCT02477553|cancer screening|cancer screening
176734|NCT02477553|colorectal neoplasm|colorectal neoplasm
176735|NCT02477553|decision making|decision making
176736|NCT02477553|risk communication|risk communication
176737|NCT02477553|numeracy|numeracy
176738|NCT02477553|health literacy|health literacy
176739|NCT02477527|atripla|atripla
176740|NCT02477527|stribild|stribild
176741|NCT02477527|dreams|dreams
176742|NCT02477501|Spinal anesthesia|spinal anesthesia
176743|NCT02477501|cesarean|cesarean
176744|NCT02477501|blood pressure|blood pressure
176745|NCT02477501|Norepinephrine|norepinephrine
176746|NCT02477501|Ephedrine|ephedrine
176747|NCT02477488|Allopurinol|allopurinol
176748|NCT02477488|Renal Dialysis|renal dialysis
176749|NCT02477475|reflux esophagitis|reflux esophagitis
176750|NCT02477475|Nexium|nexium
176751|NCT02477449|safety|safety
176752|NCT02477449|istaroxime|istaroxime
176753|NCT02477423|Microbiome|microbiome
176754|NCT02477423|Antibiotics|antibiotics
176755|NCT02477410|porcine protein|porcine protein
176756|NCT02477410|appetite|appetite
176757|NCT02477410|muscle protein synthesis|muscle protein synthesis
176758|NCT02477410|gastrointestinal hormones|gastrointestinal hormones
176759|NCT02477397|Spiromax|spiromax
176760|NCT02477397|Budesonide/formoterol|budesonide/formoterol
176761|NCT02477397|COPD|copd
176762|NCT02477397|exacerbations|exacerbations
176763|NCT02477397|SMART|smart
176764|NCT02477345|Cholestasis|cholestasis
176765|NCT02477345|Parenteral Nutrition|parenteral nutrition
176766|NCT02477345|Liver disease|liver disease
176767|NCT02477332|QGE031|qge031
176768|NCT02477332|omalizumab|omalizumab
176769|NCT02477332|chronic|chronic
176770|NCT02477332|spontaneous|spontaneous
176771|NCT02477332|urticaria|urticaria
176772|NCT02477332|adults|adults
176773|NCT02477332|CSU|csu
176774|NCT02477293|Hyeonggaeyeongyo-tang|hyeonggaeyeongyo-tang
176775|NCT02477293|Chronic rhinitis|chronic rhinitis
176776|NCT02477293|Pattern identification|pattern identification
176777|NCT02477293|Korean medicine|korean medicine
176778|NCT02477254|lupus|lupus
176779|NCT02477241|overactive bladder syndrome|overactive bladder syndrome
176780|NCT02477241|urgency urinary incontinence|urgency urinary incontinence
176781|NCT02477241|fMRI|fmri
176782|NCT02477241|urodynamics|urodynamics
176783|NCT02477215|Multiple Myeloma|multiple myeloma
176784|NCT02477202|Mirena® IUD's|mirena® iud's
176785|NCT02477202|Women|women
176786|NCT02477202|risk-reducing salpingo-oophorectomy|risk-reducing salpingo-oophorectomy
176787|NCT02477202|risk-reducing salpingectomy|risk-reducing salpingectomy
176788|NCT02477163|Nephropathy induced by drugs medicaments and biological substances|nephropathy induced by drugs medicaments and biological substances
176789|NCT02477163|Other nephritis and nephropathy not specified as acute or chronic|other nephritis and nephropathy not specified as acute or chronic
176790|NCT02477150|lupus|lupus
176791|NCT02477137|Prostate Cancer|prostate cancer
176792|NCT02477137|Nursing|nursing
176793|NCT02477137|Health Literacy|health literacy
176794|NCT02477137|Quality of Life|quality of life
176795|NCT02477137|Radiotherapy|radiotherapy
176796|NCT02477137|Oncology Nursing|oncology nursing
176797|NCT02477137|Self Care|self care
176798|NCT02477137|Symptom Management|symptom management
176799|NCT02477137|Participatory Care|participatory care
176800|NCT02477137|Person-centered Care|person-centered care
176801|NCT02477137|Information and Communication Technology|information and communication technology
176802|NCT02477137|Patient-reported symptoms|patient-reported symptoms
176803|NCT02477137|Mobile device|mobile device
176804|NCT02477111|Endovascular repair|endovascular repair
176805|NCT02477098|rectus sheath block|rectus sheath block
176806|NCT02477098|cytokines|cytokines
176807|NCT02477098|sleep|sleep
176808|NCT02477085|Labor|labor
176809|NCT02477085|induction|induction
176810|NCT02477085|delivery|delivery
176811|NCT02477085|prostaglandins|prostaglandins
176812|NCT02477085|oxytocin|oxytocin
176813|NCT02477085|amniotomy|amniotomy
176814|NCT02477085|balloon catheter|balloon catheter
176815|NCT02477059|Hand OA|hand oa
176816|NCT02477059|Tocilizumab|tocilizumab
176817|NCT02477059|Osteoarthritis|osteoarthritis
176818|NCT02477059|Interleukin-6|interleukin-6
176819|NCT02477020|Drug Therapy|drug therapy
176820|NCT02477007|Paediatric emergency|paediatric emergency
176821|NCT02477007|pain|pain
176822|NCT02477007|long-bones fractures|long-bones fractures
176823|NCT02477007|morphine|morphine
176824|NCT02477007|ibuprofen|ibuprofen
176825|NCT02477007|paracetamol|paracetamol
176826|NCT02477007|children|children
176827|NCT02476994|Essential Fatty Acids (EFA)|essential fatty acids (efa)
176828|NCT02476994|Parenteral Nutrition|parenteral nutrition
176829|NCT02476994|Clinolipid/Clinoleic|clinolipid/clinoleic
176830|NCT02476994|Parenteral Nutrition Associated Cholestasis (PNAC)|parenteral nutrition associated cholestasis (pnac)
177126|NCT02475317|Volunteer|volunteer
176831|NCT02476994|Parenteral Nutrition Associated Liver Disease (PNALD)|parenteral nutrition associated liver disease (pnald)
176832|NCT02476994|Intestinal Failure Associated Liver Disease (IFALD)|intestinal failure associated liver disease (ifald)
176833|NCT02476994|Phytosterols|phytosterols
176834|NCT02476994|Intralipid|intralipid
176835|NCT02476994|Infants/Preterm Infants|infants/preterm infants
176836|NCT02476994|FADS1 and FADS2|fads1 and fads2
176837|NCT02476994|Short Bowel Syndrome|short bowel syndrome
176838|NCT02476994|Cancer Nutrition|cancer nutrition
176839|NCT02476994|Olive Oil Emulsion|olive oil emulsion
176840|NCT02476994|Soybean Oil Emulsion|soybean oil emulsion
176841|NCT02476955|ARQ 092|arq 092
176842|NCT02476955|Carboplatin|carboplatin
176843|NCT02476955|Paclitaxel|paclitaxel
176844|NCT02476955|AKT inhibitor in combination therapy|akt inhibitor in combination therapy
176845|NCT02476955|Targeted therapy|targeted therapy
176846|NCT02476955|Molecular therapy|molecular therapy
176847|NCT02476955|Tyrosine kinase inhibitor (TKI)|tyrosine kinase inhibitor (tki)
176848|NCT02476955|Receptor tyrosine kinase (RTK)|receptor tyrosine kinase (rtk)
176849|NCT02476955|Biomarkers|biomarkers
176850|NCT02476955|Phase 1 - Phase I|phase 1 - phase i
176851|NCT02476955|Solid tumors|solid tumors
176852|NCT02476955|Metastatic solid tumors|metastatic solid tumors
176853|NCT02476955|Recurrent solid tumors|recurrent solid tumors
176854|NCT02476955|Ovarian cancer|ovarian cancer
176855|NCT02476955|Endometrial cancer|endometrial cancer
176856|NCT02476955|Cervical cancer|cervical cancer
176857|NCT02476955|Triple-negative breast cancer|triple-negative breast cancer
176858|NCT02476955|AKT kinases|akt kinases
176859|NCT02476955|AKT pathway|akt pathway
176860|NCT02476955|AKT signaling|akt signaling
176861|NCT02476955|AKT inhibitor|akt inhibitor
176862|NCT02476955|AKT pan inhibitor|akt pan inhibitor
176863|NCT02476955|Chemotherapy|chemotherapy
176864|NCT02476955|PI3K/AKT/mTOR signaling pathway|pi3k/akt/mtor signaling pathway
176865|NCT02476955|AKT1|akt1
176866|NCT02476955|AKT2|akt2
176867|NCT02476955|AKT3|akt3
176868|NCT02476955|Phase I Clinical Trial|phase i clinical trial
176869|NCT02476955|Clinical oncology|clinical oncology
176870|NCT02476955|Tumor|tumor
176871|NCT02476955|AKT1 inhibitor|akt1 inhibitor
176872|NCT02476955|AKT2 inhibitor|akt2 inhibitor
176873|NCT02476955|AKT3 inhibitor|akt3 inhibitor
176874|NCT02476955|AKT1 mutation|akt1 mutation
176875|NCT02476955|AKT2 mutation|akt2 mutation
176876|NCT02476955|AKT3 mutation|akt3 mutation
176877|NCT02476955|AKT1 amplification|akt1 amplification
176878|NCT02476955|AKT2 amplification|akt2 amplification
176879|NCT02476955|AKT3 amplification|akt3 amplification
176880|NCT02476955|Anastrozole|anastrozole
176881|NCT02476955|Estrogen receptor positive|estrogen receptor positive
176882|NCT02476955|PIK3CA mutation|pik3ca mutation
176883|NCT02476929|Electronic nose|electronic nose
176884|NCT02476929|Nasal nitrous oxide|nasal nitrous oxide
176885|NCT02476929|Allergic Rhinitis|allergic rhinitis
176886|NCT02476929|Non-Allergic Rhinitis|non-allergic rhinitis
176887|NCT02476929|Nasal polyps|nasal polyps
176888|NCT02476916|Pyruvate Kinase Deficiency|pyruvate kinase deficiency
176889|NCT02476916|Hemolytic anemia|hemolytic anemia
176890|NCT02476916|Protein Kinase R (PKR)|protein kinase r (pkr)
176891|NCT02476916|Drive PK|drive pk
176892|NCT02476877|comorbidity|comorbidity
176893|NCT02476877|epidemiology|epidemiology
176894|NCT02476877|mental illness|mental illness
176895|NCT02476877|drug abuse|drug abuse
176896|NCT02476864|macitentan|macitentan
176897|NCT02476864|biocomparison|biocomparison
176898|NCT02476864|safety|safety
176899|NCT02476851|Blood Donation|blood donation
176900|NCT02476851|Whole Blood|whole blood
176901|NCT02476838|hand injury|hand injury
176902|NCT02476838|hand amputation|hand amputation
176903|NCT02476838|hand amputee|hand amputee
176904|NCT02476838|hand surgery|hand surgery
176905|NCT02476825|volunteers|volunteers
176906|NCT02476773|Hookworm Vaccine|hookworm vaccine
176907|NCT02476773|Na-APR-1 (M74)/Alhydrogel® Hookworm Vaccine|na-apr-1 (m74)/alhydrogel® hookworm vaccine
176908|NCT02476773|Na-GST-1/Alhydrogel® Hookworm Vaccine|na-gst-1/alhydrogel® hookworm vaccine
176909|NCT02476760|Incretins|incretins
176910|NCT02476760|Antidiabetic agents|antidiabetic agents
176911|NCT02476760|Pancreatitis|pancreatitis
176912|NCT02476747|Colonic polyp|colonic polyp
176913|NCT02476734|REDIRECTED AUTOLOGOUS CART- 19 T-CELL IMMUNOTHERAPY|redirected autologous cart- 19 t-cell immunotherapy
176914|NCT02476721|pulmonary embolism|pulmonary embolism
176915|NCT02476721|emergency department|emergency department
176916|NCT02476708|schizophrenia|schizophrenia
176917|NCT02476708|schizoaffective disorder|schizoaffective disorder
176918|NCT02476708|cognition|cognition
176919|NCT02476708|curcumin|curcumin
176921|NCT02476682|Sessile serrated polyps|sessile serrated polyps
176922|NCT02476682|Advanced mucosal neoplasia|advanced mucosal neoplasia
176923|NCT02476669|plasma EBV DNA|plasma ebv dna
176924|NCT02476669|biomarker|biomarker
176925|NCT02476669|intensity-modulated radiation therapy|intensity-modulated radiation therapy
176926|NCT02476617|Treatment naive|treatment naive
176927|NCT02476617|Interferon free|interferon free
176928|NCT02476617|HCV|hcv
176929|NCT02476617|Chronic Hepatitis C|chronic hepatitis c
176930|NCT02476617|Hepatitis C Genotype 1a|hepatitis c genotype 1a
176931|NCT02476617|Hepatitis C|hepatitis c
176932|NCT02476617|pegylated-interferon (pegIFN)/ribavirin (RBV) experienced|pegylated-interferon (pegifn)/ribavirin (rbv) experienced
176933|NCT02476604|prevention|prevention
176934|NCT02476604|adult|adult
176935|NCT02476604|student|student
176936|NCT02476591|Resource utilization|resource utilization
176937|NCT02476591|intensive care unit|intensive care unit
176938|NCT02476578|Hypocholesterolemia|hypocholesterolemia
176939|NCT02476578|Frail Elderly|frail elderly
176940|NCT02476578|Aged|aged
176941|NCT02476578|Aged, 80 and over|aged, 80 and over
176942|NCT02476578|Cholesterol|cholesterol
176943|NCT02476578|Clinical Laboratory Information Systems|clinical laboratory information systems
176944|NCT02476578|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
176945|NCT02476578|diet therapy|diet therapy
176946|NCT02476578|Anticholesteremic Agents|anticholesteremic agents
176947|NCT02476578|Health Services for the Aged|health services for the aged
176948|NCT02476578|Hypoglycemic Agents|hypoglycemic agents
176949|NCT02476578|Hypoglycemia|hypoglycemia
176950|NCT02476565|Intubation|intubation
176951|NCT02476461|percutanepus needle fasciotomy|percutanepus needle fasciotomy
176952|NCT02476461|xiapex|xiapex
176953|NCT02476461|clostridium histolyticum|clostridium histolyticum
176954|NCT02476448|ureteral jet|ureteral jet
176955|NCT02476448|pelvic surgery|pelvic surgery
176956|NCT02476448|cystoscopy|cystoscopy
176957|NCT02476435|Depersonalization|depersonalization
176958|NCT02476435|Derealization|derealization
176959|NCT02476435|Embodiment|embodiment
176960|NCT02476435|Emotional numbing|emotional numbing
176961|NCT02476435|Transcranial magnetic stimulation|transcranial magnetic stimulation
176962|NCT02476435|Angular gyrus|angular gyrus
176963|NCT02476435|Temporo-parietal junction|temporo-parietal junction
176964|NCT02476422|Diclofenac potassium|diclofenac potassium
176965|NCT02476422|Post-operative dental pain|post-operative dental pain
176966|NCT02476422|Moderate to severe pain|moderate to severe pain
176967|NCT02476409|congestive heart failure|congestive heart failure
176968|NCT02476409|tolvaptan|tolvaptan
176969|NCT02476409|copeptin|copeptin
176970|NCT02476331|Cognitive training|cognitive training
176971|NCT02476331|Working memory|working memory
176972|NCT02476331|Emotion regulation|emotion regulation
176973|NCT02476266|resistance training|resistance training
176974|NCT02476266|strength training|strength training
176975|NCT02476266|balance|balance
176976|NCT02476266|muscle strength|muscle strength
176977|NCT02476253|acidosis|acidosis
176978|NCT02476253|shock|shock
176979|NCT02476253|sodium bicarbonate|sodium bicarbonate
176980|NCT02476253|renal replacement therapy|renal replacement therapy
176981|NCT02476240|Exercise|exercise
176982|NCT02476240|Attention|attention
176983|NCT02476227|atrial fibrillation|atrial fibrillation
176984|NCT02476227|pulmonary vein isolation|pulmonary vein isolation
176985|NCT02476227|RF ablation|rf ablation
176986|NCT02476214|group prenatal care, group guidance|group prenatal care, group guidance
176987|NCT02476201|Heart Failure|heart failure
176988|NCT02476201|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
176989|NCT02476201|Quadripolar Left Ventricular Lead|quadripolar left ventricular lead
176990|NCT02476201|Multipoint Pacing|multipoint pacing
176991|NCT02476201|Hemodynamic Response|hemodynamic response
176992|NCT02476188|Neutrophil extracellular traps, stroke|neutrophil extracellular traps, stroke
176993|NCT02476175|mirabegron|mirabegron
176994|NCT02476175|antimuscarinics|antimuscarinics
176995|NCT02476175|beta 3 agonist|beta 3 agonist
176996|NCT02476175|overactive bladder|overactive bladder
176997|NCT02476175|children|children
176998|NCT02476162|Childhood Cancer Survivor|childhood cancer survivor
176999|NCT02476162|Cancer Prevention and Control|cancer prevention and control
177000|NCT02476162|Blood Pressure Monitoring|blood pressure monitoring
177001|NCT02476162|Pre-Hypertension|pre-hypertension
177002|NCT02476136|individual patient data meta-analysis|individual patient data meta-analysis
177003|NCT02476136|anxiety disorder|anxiety disorder
177004|NCT02476136|antidepressants|antidepressants
177005|NCT02476136|selective serotonin reuptake inhibitors|selective serotonin reuptake inhibitors
177006|NCT02476136|serotonin-norepinephrine reuptake inhibitors|serotonin-norepinephrine reuptake inhibitors
177007|NCT02476110|Oral nutritive supplements|oral nutritive supplements
177008|NCT02476110|Nutritional risk screening|nutritional risk screening
177009|NCT02476110|Homecare|homecare
177010|NCT02476097|esomeprazole randomized study|esomeprazole randomized study
177011|NCT02476097|proton pump inhibitor|proton pump inhibitor
177012|NCT02476097|gastric acid rebound|gastric acid rebound
177013|NCT02476097|randomized study|randomized study
177014|NCT02476097|esomeprazole|esomeprazole
177015|NCT02476071|HIV prevention|hiv prevention
177016|NCT02476071|Demand for voluntary male circumcision|demand for voluntary male circumcision
177017|NCT02476058|Major Depressive Disorder|major depressive disorder
177018|NCT02476058|JNJ-42847922|jnj-42847922
177019|NCT02476058|Diphenhydramine|diphenhydramine
177020|NCT02476058|Placebo|placebo
177021|NCT02476045|metastatic colorectal cancer|metastatic colorectal cancer
177022|NCT02476045|RAS wild-type|ras wild-type
177023|NCT02476045|maintenance therapy|maintenance therapy
177024|NCT02476045|panitumumab|panitumumab
177025|NCT02476019|Obesity|obesity
177026|NCT02476019|Energy Expenditure|energy expenditure
177027|NCT02475993|Sickle Cell Disease|sickle cell disease
177028|NCT02475980|Adolescent|adolescent
177029|NCT02475980|Contraception|contraception
177030|NCT02475980|Counseling|counseling
177031|NCT02475967|E-Learning|e-learning
177032|NCT02475967|coronary artery disease|coronary artery disease
177033|NCT02475967|telerehabilitation|telerehabilitation
177034|NCT02475967|e-health|e-health
177035|NCT02475954|Depression|depression
177036|NCT02475954|Telehealth|telehealth
177037|NCT02475954|Parkinson's Disease|parkinson's disease
177038|NCT02475954|Veterans|veterans
177039|NCT02475954|Care-partners|care-partners
177040|NCT02475954|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
177041|NCT02475954|Caregiver|caregiver
177042|NCT02475941|geriatric fractures|geriatric fractures
177043|NCT02475915|Treatment interruption|treatment interruption
177044|NCT02475915|Controlling HIV|controlling hiv
177045|NCT02475902|prevention and control|prevention and control
177046|NCT02475824|ERCP|ercp
177047|NCT02475824|Sedation|sedation
177048|NCT02475824|safety|safety
177049|NCT02475811|3D ultrasonography|3d ultrasonography
177050|NCT02475811|fetal Lung Volume|fetal lung volume
177051|NCT02475811|neonatal respiratory function|neonatal respiratory function
177052|NCT02475798|Zenith aortoiliac aneurysm|zenith aortoiliac aneurysm
177053|NCT02475798|Iliac aneurysm|iliac aneurysm
177054|NCT02475798|Branch|branch
177055|NCT02475798|Connections|connections
177056|NCT02475798|Endovascular graft|endovascular graft
177057|NCT02475798|Graft-iliac bifurcation|graft-iliac bifurcation
177058|NCT02475798|Aneurysm|aneurysm
177059|NCT02475798|Vascular Diseases|vascular diseases
177060|NCT02475798|Cardiovascular Diseases|cardiovascular diseases
177061|NCT02475785|Forsus Fatigue Resistant Device|forsus fatigue resistant device
177062|NCT02475785|Class II|class ii
177063|NCT02475785|anchorage|anchorage
177064|NCT02475785|FFRD|ffrd
177065|NCT02475785|mini plates|mini plates
177066|NCT02475785|fixed functional appliance|fixed functional appliance
177067|NCT02475772|ovarian cancer|ovarian cancer
177068|NCT02475772|recurrent|recurrent
177069|NCT02475772|chemotherapy|chemotherapy
177070|NCT02475772|intraperitoneal|intraperitoneal
177071|NCT02475772|cisplatin|cisplatin
177072|NCT02475772|doxorubicin|doxorubicin
177073|NCT02475746|drug interaction, PF-06372865, itraconazole|drug interaction, pf-06372865, itraconazole
177074|NCT02475707|leukemia|leukemia
177075|NCT02475707|lymphoblastic|lymphoblastic
177077|NCT02475707|multiTAA-specific T cells|multitaa-specific t cells
177078|NCT02475707|HSCT|hsct
177079|NCT02475590|Sleeve gastrectomy|sleeve gastrectomy
177080|NCT02475590|Roux-en-Y gastric bypass|roux-en-y gastric bypass
177081|NCT02475590|Excess weight loss|excess weight loss
177082|NCT02475590|Quality of life|quality of life
177083|NCT02475577|telemedicine|telemedicine
177084|NCT02475577|heart failure|heart failure
177085|NCT02475577|home blood pressure monitoring|home blood pressure monitoring
177086|NCT02475564|resveratrol|resveratrol
177087|NCT02475512|elderly|elderly
177088|NCT02475512|long-term care|long-term care
177089|NCT02475499|Incretins|incretins
177090|NCT02475499|Antidiabetic agents|antidiabetic agents
177091|NCT02475499|Pancreatic Cancer|pancreatic cancer
177092|NCT02475486|Rheumatoid Arthritis|rheumatoid arthritis
177093|NCT02475486|sympathetic nervous system|sympathetic nervous system
177094|NCT02475486|SNA|sna
177095|NCT02475486|fatigue|fatigue
177096|NCT02475473|Volunteers|volunteers
177097|NCT02475460|HeartMate 3|heartmate 3
177098|NCT02475460|LVAS|lvas
177099|NCT02475460|LVAD|lvad
177100|NCT02475460|Heart-assist Devices|heart-assist devices
177101|NCT02475460|Advanced|advanced
177102|NCT02475460|Ventricular Dysfunction|ventricular dysfunction
177103|NCT02475460|refractory left ventricular|refractory left ventricular
177104|NCT02475460|Thoratec Corporation|thoratec corporation
177105|NCT02475434|Human Milk|human milk
177106|NCT02475434|Prematurity|prematurity
177107|NCT02475434|Nutrition|nutrition
177108|NCT02475421|Diabetes|diabetes
177109|NCT02475421|Glucagon|glucagon
177110|NCT02475421|Metabolic clearance rate of glucagon|metabolic clearance rate of glucagon
177111|NCT02475408|Circulation, Collateral|circulation, collateral
177112|NCT02475408|Coronary Artery Disease|coronary artery disease
177113|NCT02475408|Internal Mammary-Coronary Artery Anastomosis|internal mammary-coronary artery anastomosis
177114|NCT02475408|Ischemia|ischemia
177115|NCT02475395|Male Fertility|male fertility
177116|NCT02475395|Male Infertility|male infertility
177117|NCT02475395|Fertility|fertility
177118|NCT02475395|Sperm|sperm
177119|NCT02475395|Sperm Concentration|sperm concentration
177120|NCT02475369|pancreatic enzyme supplementation|pancreatic enzyme supplementation
177121|NCT02475356|Mirena|mirena
177122|NCT02475356|Heavy Menstrual Bleeding|heavy menstrual bleeding
177123|NCT02475356|Dysmenorrhea|dysmenorrhea
177124|NCT02475356|Japan|japan
177125|NCT02475356|Post-marketing surveillance|post-marketing surveillance
177127|NCT02475278|Drug therapy|drug therapy
177128|NCT02475265|Anorexia Nervosa|anorexia nervosa
177129|NCT02475265|Osteoporosis|osteoporosis
177130|NCT02475265|Eating Disorder|eating disorder
177131|NCT02475265|Disordered Eating|disordered eating
177132|NCT02475265|Estrogen|estrogen
177133|NCT02475265|Bone|bone
177134|NCT02475239|Benign Paroxysmal Positional Vertigo, Postural Restriction|benign paroxysmal positional vertigo, postural restriction
177135|NCT02475226|Traumatic Brain Injury|traumatic brain injury
177136|NCT02475226|Brain Damage|brain damage
177137|NCT02475226|Mortality|mortality
177138|NCT02475226|C10.228.140.199|c10.228.140.199
177139|NCT02475213|Malanoma, Non small cell lung cancer, SCCHN|malanoma, non small cell lung cancer, scchn
177140|NCT02475213|Other B7-H3 expressing cancers|other b7-h3 expressing cancers
177141|NCT02475187|TEG|teg
177142|NCT02475187|MEA|mea
177143|NCT02475187|Thrombotic events|thrombotic events
177144|NCT02475187|VTE|vte
177145|NCT02475187|LMWH|lmwh
177146|NCT02475187|Hip fractures|hip fractures
177147|NCT02475161|Healthy|healthy
177148|NCT02475161|Rabeprazole|rabeprazole
177149|NCT02475161|JNJ-42847922|jnj-42847922
177150|NCT02475148|JNJ-54175446|jnj-54175446
177151|NCT02475148|Healthy|healthy
177152|NCT02475135|Immunodeficiency Virus Type 1, Human|immunodeficiency virus type 1, human
177153|NCT02475135|Immunodeficiency Virus Type 2, Human|immunodeficiency virus type 2, human
177154|NCT02475135|Darunavir|darunavir
177155|NCT02475135|Cobicistat|cobicistat
177156|NCT02475135|Tenofovir Alafenamide|tenofovir alafenamide
177157|NCT02475135|Emtricitabine|emtricitabine
177158|NCT02475135|Elvitegravir|elvitegravir
177159|NCT02475122|Measurement of azygos blood flow|measurement of azygos blood flow
177160|NCT02475109|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
177161|NCT02475083|Stroke|stroke
177162|NCT02475083|Virtual reality|virtual reality
177163|NCT02475083|Balance|balance
177164|NCT02475083|Falls|falls
177165|NCT02475057|Prostate Cancer|prostate cancer
177166|NCT02475057|Cardiovascular disease|cardiovascular disease
177167|NCT02475057|Degarelix|degarelix
177168|NCT02475044|post-concussion|post-concussion
177169|NCT02475044|Cognitive-Behavioral Theray|cognitive-behavioral theray
177170|NCT02475044|parenting|parenting
177171|NCT02475031|transversus abdominis plane block|transversus abdominis plane block
177172|NCT02475018|Shuhua Milk|shuhua milk
177173|NCT02475018|plant sterol esters|plant sterol esters
177174|NCT02475018|serum cholesterol|serum cholesterol
177175|NCT02475018|human|human
177176|NCT02475005|self management app|self management app
177177|NCT02475005|headache|headache
177178|NCT02475005|adolescent|adolescent
177179|NCT02474992|HIV|hiv
177180|NCT02474992|Social network|social network
177181|NCT02474992|Social support|social support
177182|NCT02474992|Disclosure|disclosure
177183|NCT02474992|Stigma|stigma
177184|NCT02474992|Kenya|kenya
177185|NCT02474979|Pressure ulcer|pressure ulcer
177186|NCT02474979|Prevention|prevention
177187|NCT02474979|Pressure mapping|pressure mapping
177188|NCT02474953|Curcumin|curcumin
177189|NCT02474953|Pharmacokinetic|pharmacokinetic
177190|NCT02474940|Multiple Sclerosis|multiple sclerosis
177191|NCT02474940|Chronic Pain|chronic pain
177192|NCT02474940|Chronic Fatigue|chronic fatigue
177193|NCT02474940|Autoimmune Diseases|autoimmune diseases
177194|NCT02474940|Autoimmune Diseases of the Nervous System|autoimmune diseases of the nervous system
177195|NCT02474940|Central Nervous System Diseases|central nervous system diseases
177196|NCT02474940|Demyelinating Autoimmune Diseases, CNS|demyelinating autoimmune diseases, cns
177197|NCT02474940|Demyelinating Diseases|demyelinating diseases
177198|NCT02474927|antibody-mediated rejection|antibody-mediated rejection
177199|NCT02474927|lung transplant|lung transplant
177200|NCT02474927|Carfilzomib|carfilzomib
177201|NCT02474901|Shedding|shedding
177202|NCT02474901|Immunogenicity|immunogenicity
177203|NCT02474901|Safety|safety
177204|NCT02474901|HIV infected|hiv infected
177205|NCT02474901|Children|children
177206|NCT02474901|Young adults|young adults
177207|NCT02474875|Fibromyalgia|fibromyalgia
177208|NCT02474875|Patient education|patient education
177209|NCT02474875|Central sensitization|central sensitization
177210|NCT02474836|Allergy|allergy
177211|NCT02474810|central venous catheters|central venous catheters
177212|NCT02474810|hemodialysis|hemodialysis
177213|NCT02474810|thrombosis|thrombosis
177214|NCT02474810|tissue plasminogen activator|tissue plasminogen activator
177215|NCT02474797|Ultrasonography|ultrasonography
177216|NCT02474797|Diaphragm|diaphragm
177217|NCT02474797|Lung ultrasound|lung ultrasound
177218|NCT02474797|Sepsis|sepsis
177219|NCT02474797|Critical care|critical care
177220|NCT02474797|Chest physiotherapy|chest physiotherapy
177221|NCT02474745|second stage of labor|second stage of labor
177222|NCT02474745|pushing techniques|pushing techniques
177223|NCT02474719|nephrology|nephrology
177224|NCT02474719|extra-renal purification|extra-renal purification
177225|NCT02474719|peritoneal dialysis|peritoneal dialysis
177226|NCT02474706|cefoxitin Patient safety|cefoxitin patient safety
177227|NCT02474706|Infectious diseases|infectious diseases
177228|NCT02474706|Extended-Spectrum β-lactamases E.coli|extended-spectrum β-lactamases e.coli
177229|NCT02474706|Antibiotics|antibiotics
177230|NCT02474680|depression|depression
177231|NCT02474680|Major Depressive Disorder|major depressive disorder
177232|NCT02474680|MDD|mdd
177233|NCT02474680|mental health|mental health
177234|NCT02474680|pharmacogenomics|pharmacogenomics
177235|NCT02474680|personalized medicine|personalized medicine
177236|NCT02474680|precision medicine|precision medicine
177237|NCT02474680|anti-depressants|anti-depressants
177238|NCT02474667|DGF|dgf
177239|NCT02474667|Delayed Graft Function|delayed graft function
177240|NCT02474667|Renal Transplantation|renal transplantation
177241|NCT02474667|Deseased Donor Kidney|deseased donor kidney
177242|NCT02474667|BB3|bb3
177243|NCT02474667|Kidney Transplantation|kidney transplantation
177244|NCT02474667|Acute Kidney Injury|acute kidney injury
177245|NCT02474641|Breast cancer|breast cancer
177246|NCT02474641|Hypofractionation with SIB|hypofractionation with sib
177247|NCT02474641|Non-inferiority|non-inferiority
177248|NCT02474641|adjuvant radiotherapy with simultaneous integrated boost|adjuvant radiotherapy with simultaneous integrated boost
177249|NCT02474628|Physiological Phenomena|physiological phenomena
177250|NCT02474615|Apicoectomy|apicoectomy
177251|NCT02474615|Oral surgery|oral surgery
177252|NCT02474615|Biocompatible materials|biocompatible materials
177253|NCT02474615|Dental Cements|dental cements
177254|NCT02474615|Translational Medical Research|translational medical research
177255|NCT02474602|phototherapy|phototherapy
177256|NCT02474602|strength training|strength training
177257|NCT02474602|photobiostimulation|photobiostimulation
177258|NCT02474602|muscle development|muscle development
177259|NCT02474589|Treatment|treatment
177260|NCT02474589|orthopoxvirus|orthopoxvirus
177261|NCT02474589|smallpox|smallpox
177262|NCT02474563|Multiple Myeloma|multiple myeloma
177263|NCT02474563|Bortezomib|bortezomib
177264|NCT02474563|Melphalan|melphalan
177265|NCT02474563|Prednisone|prednisone
177266|NCT02474550|diffuse large b cell lymphoma|diffuse large b cell lymphoma
177267|NCT02474550|peg-filgrastim|peg-filgrastim
177268|NCT02474550|febrile neutropenia|febrile neutropenia
177269|NCT02474537|hepatic impairment,|hepatic impairment,
177270|NCT02474537|INC280,|inc280,
177271|NCT02474537|Oral cMET Inhibitor,|oral cmet inhibitor,
177272|NCT02474537|Non-Cancer|non-cancer
177273|NCT02474524|Psychosis|psychosis
177274|NCT02474524|Schizophrenia|schizophrenia
177275|NCT02474524|Self-management|self-management
177276|NCT02474524|Recovery|recovery
177277|NCT02474524|Tablet computer|tablet computer
177278|NCT02474524|Digital health|digital health
177279|NCT02474524|Internet|internet
177280|NCT02474524|Online|online
177281|NCT02474524|Peer support|peer support
177282|NCT02474498|Regenerative therapy|regenerative therapy
177283|NCT02474498|Randomized clinical trial (RCT)|randomized clinical trial (rct)
177284|NCT02474498|Enamel matrix derivative|enamel matrix derivative
177285|NCT02474498|Hydroxyapatite-beta tricalcium phosphate|hydroxyapatite-beta tricalcium phosphate
177286|NCT02474498|Buccal furcation|buccal furcation
177287|NCT02474485|bioresorbable vascular scaffold|bioresorbable vascular scaffold
177288|NCT02474485|Absorb|absorb
177289|NCT02474485|drug eluting balloon|drug eluting balloon
177290|NCT02474485|percutaneous coronary intervention|percutaneous coronary intervention
177291|NCT02474472|Midline Laparotomy|midline laparotomy
177292|NCT02474472|Sternotomy|sternotomy
177293|NCT02474472|Thoracotomy|thoracotomy
177294|NCT02474472|Thoracoabdominal Incision|thoracoabdominal incision
177295|NCT02474459|Deep Brain Stimulation|deep brain stimulation
177296|NCT02474459|DBS|dbs
177297|NCT02474459|STN|stn
177298|NCT02474459|GPi|gpi
177299|NCT02474459|Globus pallidus|globus pallidus
177300|NCT02474459|Subthalamic nucleus|subthalamic nucleus
177301|NCT02474459|Neuromodulation|neuromodulation
177302|NCT02474407|Seizures|seizures
177303|NCT02474407|Epilepsy|epilepsy
177304|NCT02474355|NSCLC|nsclc
177305|NCT02474355|EGFRm|egfrm
177306|NCT02474355|T790M|t790m
177307|NCT02474329|Parkinson's disease|parkinson's disease
177308|NCT02474329|Ambulatory monitoring|ambulatory monitoring
177309|NCT02474329|Disease progression|disease progression
177310|NCT02474303|Truvada|truvada
177311|NCT02474303|EMTRICITABINE/TENOFOVIR DISPROXIL FUMARATE|emtricitabine/tenofovir disproxil fumarate
177312|NCT02474303|HIV PREEXPOSURE PROPHYLAXIS (PrEP)|hiv preexposure prophylaxis (prep)
177313|NCT02474303|Female Sex Workers|female sex workers
177314|NCT02474290|Acute Myeloid Leukemia|acute myeloid leukemia
177315|NCT02474290|FLT3-ITD|flt3-itd
177316|NCT02474290|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
177317|NCT02474238|Iridotomy|iridotomy
177318|NCT02474225|intraocular pressure|intraocular pressure
177319|NCT02474225|intravitreal|intravitreal
177320|NCT02474212|Venous thromboembolism|venous thromboembolism
177321|NCT02474212|pulmonary embolism|pulmonary embolism
177322|NCT02474212|thromboprophylaxis|thromboprophylaxis
177323|NCT02474212|anticoagulant|anticoagulant
177324|NCT02474212|anti-FXa|anti-fxa
177325|NCT02474212|low-molecular weight heparin|low-molecular weight heparin
177326|NCT02474212|enoxaparin|enoxaparin
177327|NCT02474199|Regulatory T Cells ( Treg)|regulatory t cells ( treg)
177328|NCT02474199|Donor Alloantigen Reactive Tregs (darTregs)|donor alloantigen reactive tregs (dartregs)
177329|NCT02474199|Liver Transplant|liver transplant
177330|NCT02474199|Alloantigen Reactive Tregs|alloantigen reactive tregs
177331|NCT02474199|Calcineurin Inhibitors (CNI)|calcineurin inhibitors (cni)
177332|NCT02474199|immunosuppressants (IS)|immunosuppressants (is)
177333|NCT02474186|breast|breast
177334|NCT02474186|cancer|cancer
177335|NCT02474186|metastatic|metastatic
177336|NCT02474186|breast cancer|breast cancer
177337|NCT02474186|metastatic breast cancer|metastatic breast cancer
177338|NCT02474186|radiation|radiation
177339|NCT02474186|radiotherapy|radiotherapy
177340|NCT02474186|radiation therapy|radiation therapy
177341|NCT02474186|abscopal|abscopal
177342|NCT02474186|abscopal effect|abscopal effect
177343|NCT02474186|T-cell|t-cell
177344|NCT02474186|GM-CSF|gm-csf
177345|NCT02474186|anti-tumor|anti-tumor
177346|NCT02474186|immune|immune
177347|NCT02474186|immune response|immune response
177348|NCT02474186|capecitabine|capecitabine
177349|NCT02474186|xeloda|xeloda
177350|NCT02474186|taxol|taxol
177351|NCT02474186|paclitaxel|paclitaxel
177352|NCT02474186|other solid metastatic tumor|other solid metastatic tumor
177353|NCT02474108|atrial fibrillation|atrial fibrillation
177354|NCT02474108|radiofrequency ablation|radiofrequency ablation
177355|NCT02474108|prevention of AF|prevention of af
177356|NCT02474108|mitral valve|mitral valve
177357|NCT02474108|left atrium enlargement|left atrium enlargement
177358|NCT02474108|cryoablation|cryoablation
177359|NCT02474056|decreased blood volume vein volume flow ultrasound exam|decreased blood volume vein volume flow ultrasound exam
177360|NCT02474043|Injection drug use|injection drug use
177361|NCT02474017|Inhaler|inhaler
177362|NCT02474017|Adolescent|adolescent
177363|NCT02473978|During Labor|during labor
177364|NCT02473978|Complicating Anesthesia or Other Sedation|complicating anesthesia or other sedation
177365|NCT02473978|Cerebral|cerebral
177366|NCT02473926|Physical Activity|physical activity
177367|NCT02473926|Physical Function|physical function
177368|NCT02473926|Physical Impairment|physical impairment
177369|NCT02473926|Sedentary Lifestyle|sedentary lifestyle
177370|NCT02473887|ondansetron|ondansetron
177371|NCT02473887|palatability|palatability
177372|NCT02473887|vomiting|vomiting
177373|NCT02473861|exercise training|exercise training
177374|NCT02473861|breast cancer|breast cancer
177375|NCT02473861|taxane chemotherapy|taxane chemotherapy
177376|NCT02473861|peripheral neuropathy|peripheral neuropathy
177377|NCT02473861|fatigue|fatigue
177378|NCT02473861|autonomic function|autonomic function
177379|NCT02473835|T-lymphocyte|t-lymphocyte
177380|NCT02473835|Adipose tissue|adipose tissue
177381|NCT02473835|Inflammation|inflammation
177382|NCT02473835|Calorie restriction|calorie restriction
177383|NCT02473822|anterior cruciate ligament|anterior cruciate ligament
177384|NCT02473822|Tape Locking Screw|tape locking screw
177385|NCT02473822|LCA|lca
177386|NCT02473822|joint trauma|joint trauma
177387|NCT02473796|home based child care|home based child care
177388|NCT02473770|Registry|registry
177389|NCT02473770|Exposures|exposures
177390|NCT02473770|Biological Specimens|biological specimens
177391|NCT02473770|Occupational Health|occupational health
177392|NCT02473757|Recombinant DNA Product|recombinant dna product
177393|NCT02473757|Laboratory Evaluation|laboratory evaluation
177394|NCT02473757|NIH Office of Biotechnology Activities|nih office of biotechnology activities
177395|NCT02473757|Gamma-Retroviral Vectors|gamma-retroviral vectors
177396|NCT02473744|lower limb edema|lower limb edema
177397|NCT02473744|subcutaneous drainage|subcutaneous drainage
177398|NCT02473744|bioelectrical impedance|bioelectrical impedance
177399|NCT02473744|quality of life|quality of life
177400|NCT02473731|CDX3379|cdx3379
177401|NCT02473705|Geriatric|geriatric
177402|NCT02473705|bicarbonate|bicarbonate
177403|NCT02473705|omega polyunsaturated fatty acids|omega polyunsaturated fatty acids
177404|NCT02473705|exercise capacity|exercise capacity
177405|NCT02473679|First Responder|first responder
177406|NCT02473679|BLS|bls
177407|NCT02473679|AED|aed
177408|NCT02473679|Resuscitation|resuscitation
177409|NCT02473666|Patient Blood Management|patient blood management
177410|NCT02473666|Red Blood Cells|red blood cells
177411|NCT02473666|Platelet|platelet
177412|NCT02473627|Pharmacokinetics|pharmacokinetics
177413|NCT02473601|mivacurium chloramine|mivacurium chloramine
177414|NCT02473601|patients with liver cirrhosis|patients with liver cirrhosis
177415|NCT02473601|muscle relaxation effect|muscle relaxation effect
177416|NCT02473575|Caffeine, running, performance|caffeine, running, performance
177417|NCT02473562|Parkinson's disease|parkinson's disease
177418|NCT02473562|Varenicline|varenicline
177419|NCT02473562|Excessive daytime sleepiness|excessive daytime sleepiness
177420|NCT02473549|motor|motor
177421|NCT02473549|rehabilitation|rehabilitation
177422|NCT02473549|transcranial direct current stimulation|transcranial direct current stimulation
177423|NCT02473523|Fatigue|fatigue
177424|NCT02473523|Pain Alleviation|pain alleviation
177425|NCT02473523|Emotional Wellbeing|emotional wellbeing
177426|NCT02473523|Physical Wellbeing|physical wellbeing
177427|NCT02473523|Yoga|yoga
177428|NCT02473510|Trivalent|trivalent
177429|NCT02473510|Influenza|influenza
177430|NCT02473510|FluMist Quadrivalent|flumist quadrivalent
177431|NCT02473510|Vaccine|vaccine
177432|NCT02473510|Prevention|prevention
177433|NCT02473510|Healthy|healthy
177434|NCT02473497|chromosomal rearrangement|chromosomal rearrangement
177435|NCT02473497|activating mutation|activating mutation
177436|NCT02473497|activating genetic alteration|activating genetic alteration
177437|NCT02473497|genetic aberration|genetic aberration
177438|NCT02473497|ALK|alk
177439|NCT02473497|ROS1|ros1
177440|NCT02473497|cMET|cmet
177441|NCT02473497|crizotinib|crizotinib
177442|NCT02473497|oral formulation|oral formulation
177443|NCT02473484|High Grade Glioma|high grade glioma
177444|NCT02473484|Proteomics|proteomics
177445|NCT02473484|MALDI-MSI|maldi-msi
177446|NCT02473471|Micro-Osteoperforation (MOPs)|micro-osteoperforation (mops)
177447|NCT02473471|regional acceleratory phenomenon (RAP)|regional acceleratory phenomenon (rap)
177448|NCT02473471|Malocculsion|malocculsion
177449|NCT02473458|Licorice|licorice
177450|NCT02473458|Glycyrrhizic acid|glycyrrhizic acid
177451|NCT02473458|Ischemic Stroke|ischemic stroke
177452|NCT02473458|Acute|acute
177453|NCT02473445|Inherited mitochondrial disease|inherited mitochondrial disease
177454|NCT02473445|Leigh Syndrome|leigh syndrome
177455|NCT02473445|Leber's Hereditary Optic Neuropathy (LHON)|leber's hereditary optic neuropathy (lhon)
177456|NCT02473445|Myoclonic epilepsy and ragged-red fibers (MERFF)|myoclonic epilepsy and ragged-red fibers (merff)
177457|NCT02473445|Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like syndrome (MELAS)|mitochondrial encephalomyopathy, lactic acidosis, and stroke-like syndrome (melas)
177458|NCT02473445|Kearn-Sayre syndrome|kearn-sayre syndrome
177459|NCT02473445|Polymerase gamma (POLG) -related disorders|polymerase gamma (polg) -related disorders
177460|NCT02473445|Mitochondrial neurogastrointestinal encephalopathy syndrome (MNGIE)|mitochondrial neurogastrointestinal encephalopathy syndrome (mngie)
177461|NCT02473432|respiratory muscle training|respiratory muscle training
177462|NCT02473432|neuromuscular electrical stimulation|neuromuscular electrical stimulation
177463|NCT02473432|oropharyngeal dysphagia|oropharyngeal dysphagia
177464|NCT02473432|stroke|stroke
177465|NCT02473432|rehabilitation|rehabilitation
177466|NCT02473419|Medical food|medical food
177467|NCT02473419|ADHD|adhd
177468|NCT02473419|Vayarin|vayarin
177469|NCT02473419|Fish Oil|fish oil
177470|NCT02473380|glioma|glioma
177471|NCT02473380|fluorescence spectroscopy|fluorescence spectroscopy
177472|NCT02473341|Bovine Colostrum|bovine colostrum
177473|NCT02473341|Corticosteriods|corticosteriods
177474|NCT02473341|Endotoxin|endotoxin
177475|NCT02473341|MELD|meld
177476|NCT02473341|mDF|mdf
177477|NCT02473328|dose reduction study|dose reduction study
177478|NCT02473289|Depressive disorder, major|depressive disorder, major
177479|NCT02473289|Sirukumab|sirukumab
177480|NCT02473263|Severe septic syndrome|severe septic syndrome
177481|NCT02473263|mobile intensive care unit|mobile intensive care unit
177482|NCT02473263|strategy|strategy
177483|NCT02473263|antibiotics|antibiotics
177484|NCT02473263|hemodynamic optimization|hemodynamic optimization
177485|NCT02473237|COPD|copd
177486|NCT02473237|biomass|biomass
177487|NCT02473224|challenge|challenge
177488|NCT02473224|GII.2|gii.2
177489|NCT02473224|HID50|hid50
177490|NCT02473224|Norovirus|norovirus
177491|NCT02473224|Snow Mountain filtrate|snow mountain filtrate
177492|NCT02473198|Total Knee Arthroplasty|total knee arthroplasty
177493|NCT02473198|Amide Local Anesthetic|amide local anesthetic
177494|NCT02473172|Weaning from mechanical ventilation|weaning from mechanical ventilation
177495|NCT02473159|Near-infrared fluorescence|near-infrared fluorescence
177496|NCT02473159|Indocyanine green, ICG|indocyanine green, icg
177497|NCT02473159|breast cancer|breast cancer
177498|NCT02473146|AML|aml
177499|NCT02473146|untreated|untreated
177500|NCT02473146|60-80 years old|60-80 years old
177501|NCT02473146|favorable and intermediate karyotype|favorable and intermediate karyotype
177502|NCT02473133|radiotherapy|radiotherapy
177503|NCT02473133|dose redistribution|dose redistribution
177504|NCT02473133|boost|boost
177505|NCT02473120|metastatic|metastatic
177506|NCT02473120|ESR1|esr1
177507|NCT02473120|aromatase inhibitor|aromatase inhibitor
177508|NCT02473120|breast cancer|breast cancer
177509|NCT02473107|Dental caries|dental caries
177510|NCT02473107|Primary tooth|primary tooth
177511|NCT02473107|Caries Detection|caries detection
177512|NCT02473094|Metformin|metformin
177513|NCT02473094|Rectal Cancer|rectal cancer
177514|NCT02473094|Rectum|rectum
177515|NCT02473094|Radiotherapy|radiotherapy
177516|NCT02473094|Capecitabine|capecitabine
177517|NCT02473094|Neoadjuvant|neoadjuvant
177518|NCT02473094|Adenocarcinoma|adenocarcinoma
177519|NCT02473094|Carcinoma|carcinoma
177520|NCT02473081|Type 2 diabetes|type 2 diabetes
177521|NCT02473081|Minimal psychological intervention|minimal psychological intervention
177522|NCT02473081|Glycemic control|glycemic control
177523|NCT02473081|Depressive symptoms|depressive symptoms
178023|NCT02470299|GTPase|gtpase
177524|NCT02473081|Problem Area in Diabetes|problem area in diabetes
177525|NCT02473081|Middle-aged and older adults|middle-aged and older adults
177526|NCT02473081|HbA1c protein, human|hba1c protein, human
177527|NCT02473068|CPAP|cpap
177528|NCT02473055|kangaroo care|kangaroo care
177529|NCT02473055|sleep|sleep
177530|NCT02473055|heart rate|heart rate
177531|NCT02473055|respiratory rate|respiratory rate
177532|NCT02473055|preterm infant|preterm infant
177533|NCT02473042|Post-operative nausea and vomiting|post-operative nausea and vomiting
177534|NCT02473042|PONV|ponv
177535|NCT02473042|Breast cancer|breast cancer
177536|NCT02473042|Neuromuscular blockade monitor|neuromuscular blockade monitor
177537|NCT02473042|NMBM|nmbm
177538|NCT02473042|Breast cancer surgery|breast cancer surgery
177539|NCT02473042|Prophylactic anti-emetics|prophylactic anti-emetics
177540|NCT02473042|Electrical stimulation|electrical stimulation
177541|NCT02473042|Zofran|zofran
177542|NCT02473042|Ondansetron|ondansetron
177543|NCT02473042|Dexamethasone|dexamethasone
177544|NCT02473042|Decadron|decadron
177545|NCT02473042|Phenergan|phenergan
177546|NCT02473042|Promethazine|promethazine
177547|NCT02473042|Phenazine|phenazine
177548|NCT02473042|Phencen|phencen
177549|NCT02473042|Prometh|prometh
177550|NCT02473042|Prorex|prorex
177551|NCT02473042|V-Gan|v-gan
177552|NCT02473042|Pepcid|pepcid
177553|NCT02473042|Famotidine|famotidine
177554|NCT02473042|Questionnaire|questionnaire
177555|NCT02473042|Survey|survey
177556|NCT02473016|Classical Trigeminal Neuralgia|classical trigeminal neuralgia
177557|NCT02473003|Breast cancer|breast cancer
177558|NCT02473003|prostate cancer|prostate cancer
177559|NCT02473003|colorectal cancer|colorectal cancer
177560|NCT02473003|fatigue|fatigue
177561|NCT02473003|physical exercise|physical exercise
177562|NCT02473003|randomised trial|randomised trial
177563|NCT02473003|intervention|intervention
177564|NCT02472990|DMD|dmd
177565|NCT02472990|morphological predictive factors|morphological predictive factors
177566|NCT02472990|Mechanical|mechanical
177567|NCT02472938|Relapsing remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
177568|NCT02472912|Pharmacokinetics|pharmacokinetics
177569|NCT02472912|Adalimumab|adalimumab
177570|NCT02472912|Biosimilar Pharmaceuticals|biosimilar pharmaceuticals
177571|NCT02472899|Geriatrics|geriatrics
177572|NCT02472899|Neurocognitive Disorder|neurocognitive disorder
177573|NCT02472899|Biomarkers|biomarkers
177574|NCT02472899|Immunology|immunology
177575|NCT02472886|HCV genotype 1|hcv genotype 1
177576|NCT02472886|HCV|hcv
177577|NCT02472886|Sustained Virologic Response|sustained virologic response
177578|NCT02472886|Direct Acting Antiviral|direct acting antiviral
177579|NCT02472886|Combination Therapy|combination therapy
177580|NCT02472886|GS-7977|gs-7977
177581|NCT02472886|GS-5885|gs-5885
177582|NCT02472886|Ribavirin|ribavirin
177583|NCT02472886|Sofosbuvir|sofosbuvir
177584|NCT02472886|ledipasvir|ledipasvir
177585|NCT02472886|Hepatitis C|hepatitis c
177586|NCT02472886|Hepatitis C, Chronic|hepatitis c, chronic
177587|NCT02472886|Liver Diseases|liver diseases
177588|NCT02472886|Virus Diseases|virus diseases
177589|NCT02472886|Antiviral Agents|antiviral agents
177590|NCT02472886|HCV/HIV co-infection|hcv/hiv co-infection
177591|NCT02472873|endometrioma|endometrioma
177592|NCT02472873|endometriosis|endometriosis
177593|NCT02472873|sclerotherapy|sclerotherapy
177594|NCT02472873|ethanol|ethanol
177595|NCT02472873|aspiration|aspiration
177596|NCT02472873|laparoscopy|laparoscopy
177597|NCT02472860|Autism Spectrum Disorder|autism spectrum disorder
177598|NCT02472860|Neuroplasticity-based Cognitive Training|neuroplasticity-based cognitive training
177599|NCT02472847|Marinol|marinol
177600|NCT02472847|Dronabinol|dronabinol
177601|NCT02472847|Fear extinction|fear extinction
177602|NCT02472847|Healthy volunteers|healthy volunteers
177603|NCT02472834|Carbamylation|carbamylation
177604|NCT02472834|Albumin|albumin
177605|NCT02472834|Protein structure|protein structure
177606|NCT02472834|Kidney disease|kidney disease
177607|NCT02472795|Systemic lupus erythematosus|systemic lupus erythematosus
177608|NCT02472782|osteoporosis|osteoporosis
177609|NCT02472782|quality of life|quality of life
177610|NCT02472782|adherence|adherence
177611|NCT02472782|treatment|treatment
177612|NCT02472743|Phototherapy|phototherapy
177613|NCT02472730|Colonoscopy|colonoscopy
177614|NCT02472730|Training Techniques|training techniques
177615|NCT02472730|Endoscopy, Gastrointestinal|endoscopy, gastrointestinal
177616|NCT02472717|liraglutide, GLP-1 receptor agonists|liraglutide, glp-1 receptor agonists
177617|NCT02472704|celiac disease|celiac disease
177618|NCT02472704|lymphocytic enteritis|lymphocytic enteritis
177619|NCT02472704|non-celiac gluten sensitivity|non-celiac gluten sensitivity
177620|NCT02472704|double-blind gluten rechallenge|double-blind gluten rechallenge
177621|NCT02472691|relapse after allogeneic transplantation|relapse after allogeneic transplantation
177622|NCT02472691|MDS|mds
177623|NCT02472691|AML|aml
177624|NCT02472691|CMML|cmml
177625|NCT02472691|DLI|dli
177626|NCT02472691|Azacitidine|azacitidine
177627|NCT02472691|Lenalidomide|lenalidomide
177628|NCT02472691|C04.557.337.539.275|c04.557.337.539.275
177629|NCT02472691|C15.378.190.625|c15.378.190.625
177630|NCT02472691|C04.557.337.539.522|c04.557.337.539.522
177631|NCT02472665|pediatric|pediatric
177632|NCT02472665|plasma-derived FVIII concentrate|plasma-derived fviii concentrate
177633|NCT02472613|Post－Stroke Depression|post－stroke depression
177634|NCT02472613|Acupunture|acupunture
177635|NCT02472613|Fluoxetine|fluoxetine
177636|NCT02472613|RCT|rct
177637|NCT02472600|extended spectrum beta-lactamase producing enterobacteriaceae|extended spectrum beta-lactamase producing enterobacteriaceae
177638|NCT02472600|carbapenemase producing enterobacteriaceae|carbapenemase producing enterobacteriaceae
177639|NCT02472600|multidrug resistant bacteria|multidrug resistant bacteria
177640|NCT02472574|Intracerebral Hemorrhage|intracerebral hemorrhage
177641|NCT02472574|minimally invasive surgery|minimally invasive surgery
177642|NCT02472574|recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
177643|NCT02472574|Dose-effect Relationship|dose-effect relationship
177644|NCT02472561|Cardiology|cardiology
177645|NCT02472561|Vascular|vascular
177646|NCT02472561|Peripheral Artery Disease|peripheral artery disease
177647|NCT02472561|Artery|artery
177648|NCT02472561|Mobile Health|mobile health
177649|NCT02472561|Exercise|exercise
177650|NCT02472561|PAD|pad
177651|NCT02472535|HoFH|hofh
177652|NCT02472509|Ursodeoxycholic acid (UDCA)|ursodeoxycholic acid (udca)
177653|NCT02472509|White blood cells (WBC)|white blood cells (wbc)
177654|NCT02472509|Alanine Transaminase (ALT)|alanine transaminase (alt)
177905|NCT02471118|Inflammatory Type|inflammatory type
177655|NCT02472509|Alkaline Phosphatase (ALP)|alkaline phosphatase (alp)
177656|NCT02472509|Aspartate Aminotransferase (AST)|aspartate aminotransferase (ast)
177657|NCT02472509|Gamma-Glutamyl Transpeptidase (GGT)|gamma-glutamyl transpeptidase (ggt)
177658|NCT02472509|Lactate dehydrogenase (LDH)|lactate dehydrogenase (ldh)
177659|NCT02472509|Low-Density Lipoprotein (LDL)|low-density lipoprotein (ldl)
177660|NCT02472509|High-Density Lipoprotein (HDL)|high-density lipoprotein (hdl)
177661|NCT02472509|Glucose-6-phosphate dehydrogenase (G6PD)|glucose-6-phosphate dehydrogenase (g6pd)
177662|NCT02472509|Ultrasound (US)|ultrasound (us)
177663|NCT02472470|rTMS|rtms
177664|NCT02472470|Depression|depression
177665|NCT02472470|Youth|youth
177666|NCT02472470|TBS|tbs
177667|NCT02472470|Brain Stimulation|brain stimulation
177668|NCT02472470|Electrophysiology|electrophysiology
177669|NCT02472470|Imaging|imaging
177670|NCT02472431|ADRC|adrc
177671|NCT02472431|Adipose-Derived Regenerative Cells|adipose-derived regenerative cells
177672|NCT02472431|Fat Tissue|fat tissue
177673|NCT02472431|Stem Cells|stem cells
177674|NCT02472431|Erectile Dysfunction|erectile dysfunction
177675|NCT02472431|Arteriogenic Impotence|arteriogenic impotence
177676|NCT02472431|Venogenic Impotence|venogenic impotence
177677|NCT02472431|Vasculogenic Impotence|vasculogenic impotence
177678|NCT02472431|Male Impotence|male impotence
177679|NCT02472431|Male Sexual Impotence|male sexual impotence
177680|NCT02472392|EWINGS, SARCOMA|ewings, sarcoma
177681|NCT02472379|Immune System|immune system
177682|NCT02472379|Behavioral Sciences|behavioral sciences
177683|NCT02472379|Women's Health|women's health
177684|NCT02472379|Health Psychology|health psychology
177685|NCT02472379|Writing|writing
177686|NCT02472353|breast|breast
177687|NCT02472353|cancer|cancer
177688|NCT02472353|doxorubicin|doxorubicin
177689|NCT02472353|metformin|metformin
177690|NCT02472353|cardiotoxicity|cardiotoxicity
177691|NCT02472353|ejection fraction|ejection fraction
177692|NCT02472353|LVEF|lvef
177693|NCT02472288|urinary retention|urinary retention
177694|NCT02472288|poststroke|poststroke
177695|NCT02472288|electroacupuncture|electroacupuncture
177696|NCT02472288|randomized controlled trial|randomized controlled trial
177697|NCT02472288|effectiveness|effectiveness
177698|NCT02472288|safety|safety
177699|NCT02472262|Environmental|environmental
177700|NCT02472262|Enteric|enteric
177701|NCT02472249|TACE|tace
177702|NCT02472249|CT perfusion|ct perfusion
177703|NCT02472249|Liver blood flow|liver blood flow
177704|NCT02472236|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
177705|NCT02472223|"Pink Eye"|"pink eye"
177706|NCT02472197|Endometrial polyp|endometrial polyp
177707|NCT02472197|Hysteroscopic resection|hysteroscopic resection
177708|NCT02472197|Morcellation|morcellation
177709|NCT02472184|Office hysteroscopy|office hysteroscopy
177710|NCT02472184|Endometrial biopsy|endometrial biopsy
177711|NCT02472184|Abnormal uterine bleeding|abnormal uterine bleeding
177712|NCT02472184|Uterine fibroids|uterine fibroids
177713|NCT02472171|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
177714|NCT02472171|blueberries|blueberries
177715|NCT02472158|Bandages|bandages
177716|NCT02472158|Central Venous Catheters|central venous catheters
177717|NCT02472158|Catheter-Related Infections|catheter-related infections
177718|NCT02472145|Leukemia, myeloid, acute|leukemia, myeloid, acute
177719|NCT02472145|DACOGEN|dacogen
177720|NCT02472145|Decitabine|decitabine
177721|NCT02472145|JNJ-56022473|jnj-56022473
177722|NCT02472145|CLS362|cls362
177723|NCT02472132|Central Venous Catheter|central venous catheter
178024|NCT02470299|cancer|cancer
177724|NCT02472132|Point Of Care Ultra Sound|point of care ultra sound
177725|NCT02472132|Sub Clavian Vein|sub clavian vein
177726|NCT02472132|Internal Jugular Vein|internal jugular vein
177727|NCT02472132|Trans Thoracic Echocardiography|trans thoracic echocardiography
177728|NCT02472119|Celiac disease|celiac disease
177729|NCT02472119|Gluten-free diet|gluten-free diet
177730|NCT02472119|Wheat flour treatment|wheat flour treatment
177731|NCT02472119|Microbial transglutaminase|microbial transglutaminase
177732|NCT02472119|Lysine Ethyl Ester|lysine ethyl ester
177733|NCT02472119|Celiac Disease Treatment|celiac disease treatment
177734|NCT02472106|Aortic Valve|aortic valve
177735|NCT02472106|TAVI|tavi
177736|NCT02472106|Stenosis|stenosis
177737|NCT02472093|Postural exercise|postural exercise
177738|NCT02472093|Back pain|back pain
177739|NCT02472093|Tender points|tender points
177740|NCT02472093|Fibromyalgia|fibromyalgia
177741|NCT02472093|Perceptive rehabilitation|perceptive rehabilitation
177742|NCT02472067|Musculoskeletal Injury|musculoskeletal injury
177743|NCT02472067|physical therapy|physical therapy
177744|NCT02472067|psychological intervention|psychological intervention
177745|NCT02472067|risk factors|risk factors
177746|NCT02472054|hemophagocytic lymphohistiocytosis (HLH)|hemophagocytic lymphohistiocytosis (hlh)
177747|NCT02472054|Alemtuzumab (CAMPATH®)|alemtuzumab (campath®)
177748|NCT02472041|chest drain|chest drain
177749|NCT02472028|Cerebrovascular Disorders|cerebrovascular disorders
177750|NCT02472028|Stroke|stroke
177751|NCT02472028|Antihypertensive Agents|antihypertensive agents
177752|NCT02472028|Arterial Pressure|arterial pressure
177753|NCT02472028|Memory Disorders|memory disorders
177754|NCT02472015|neuropsychiatric symptoms|neuropsychiatric symptoms
177755|NCT02472015|dementia|dementia
177756|NCT02472015|telemedicine|telemedicine
177757|NCT02472015|long-term care facilities|long-term care facilities
177758|NCT02472002|Transplant coronary diseases|transplant coronary diseases
177759|NCT02472002|Mesenchymal cell therapy|mesenchymal cell therapy
177760|NCT02472002|Administration of CSM by NOGA system|administration of csm by noga system
177761|NCT02472002|Coronary disease in heart transplant patients|coronary disease in heart transplant patients
177762|NCT02471989|FODMAP|fodmap
177763|NCT02471989|Diet|diet
177764|NCT02471989|pH-impedance monitoring|ph-impedance monitoring
177765|NCT02471976|Leonetti law|leonetti law
177766|NCT02471976|palliative care|palliative care
177767|NCT02471963|Empagliflozin|empagliflozin
177768|NCT02471963|Diabetes mellitus|diabetes mellitus
177769|NCT02471963|Macro- and Microcirculation|macro- and microcirculation
177770|NCT02471963|Vascular Improvement|vascular improvement
177771|NCT02471963|Endothelium function|endothelium function
177772|NCT02471937|Streptococcus agalactiae|streptococcus agalactiae
177773|NCT02471937|Group B Streptococcus|group b streptococcus
177774|NCT02471937|Neonates|neonates
177775|NCT02471937|colonization|colonization
177776|NCT02471937|meningitis|meningitis
177777|NCT02471937|Clonal Complex CC17|clonal complex cc17
177778|NCT02471937|microbiota|microbiota
177779|NCT02471937|next generation sequencing (NGS)|next generation sequencing (ngs)
177780|NCT02471924|Pregnant women|pregnant women
177781|NCT02471911|DLBCL|dlbcl
177782|NCT02471911|Aggressive|aggressive
177783|NCT02471911|Diffuse|diffuse
177784|NCT02471911|Large|large
177785|NCT02471885|remote ischaemic conditioning|remote ischaemic conditioning
177786|NCT02471885|remote ischemic conditioning|remote ischemic conditioning
177787|NCT02471885|cardio-oncology|cardio-oncology
177788|NCT02471885|anthracycline|anthracycline
177789|NCT02471885|troponin|troponin
177790|NCT02471885|chemotherapy|chemotherapy
177791|NCT02471885|myocardial reperfusion injury|myocardial reperfusion injury
177792|NCT02471833|Hypertension|hypertension
177793|NCT02471833|Prevention|prevention
177794|NCT02471833|Family History|family history
177795|NCT02471833|inflammation|inflammation
177796|NCT02471833|blood brain barrier|blood brain barrier
177797|NCT02471833|amyloid|amyloid
177798|NCT02471820|Multiple Myeloma|multiple myeloma
177799|NCT02471794|Type II Diabetes|type ii diabetes
177800|NCT02471794|Personalized Health Planning|personalized health planning
177801|NCT02471794|Shared Medical Appointments|shared medical appointments
177802|NCT02471781|Aortic Aneurysm|aortic aneurysm
177803|NCT02471781|Aneurysm|aneurysm
177804|NCT02471781|Vascular Prosthesis|vascular prosthesis
177805|NCT02471781|Vascular Disease|vascular disease
177806|NCT02471781|Blood Vessel Prosthesis Implantation|blood vessel prosthesis implantation
177807|NCT02471768|central pressure|central pressure
177808|NCT02471768|Gensini score|gensini score
177809|NCT02471768|pulsatility|pulsatility
177810|NCT02471768|coronary artery disease|coronary artery disease
177811|NCT02471755|electro-acupuncture|electro-acupuncture
177812|NCT02471755|menopause|menopause
177813|NCT02471755|menopausal transition symptoms|menopausal transition symptoms
177814|NCT02471755|efficacy|efficacy
177815|NCT02471755|RCT|rct
177816|NCT02471755|placebo control|placebo control
177817|NCT02471729|Cardio-Renal Syndrome|cardio-renal syndrome
177818|NCT02471729|Chronic Heart Failure|chronic heart failure
177819|NCT02471729|Renal Denervation|renal denervation
177820|NCT02471729|Sympathetic activation|sympathetic activation
177821|NCT02471729|Heart Failure|heart failure
177822|NCT02471729|Cardiovascular Diseases|cardiovascular diseases
177823|NCT02471729|Heart Diseases|heart diseases
177824|NCT02471716|Diffuse Type Tenosynovial Giant Cell Tumor (dt-TGCT)|diffuse type tenosynovial giant cell tumor (dt-tgct)
177825|NCT02471703|Total Hip Arthroplasty|total hip arthroplasty
177826|NCT02471703|Total Hip Replacement|total hip replacement
177827|NCT02471703|Inflammatory Joint Disease|inflammatory joint disease
177828|NCT02471703|Non-Inflammatory Joint Disease|non-inflammatory joint disease
177829|NCT02471690|Volunteers|volunteers
177830|NCT02471677|Ovarian stimulation|ovarian stimulation
177831|NCT02471677|corifollitropin alfa|corifollitropin alfa
177832|NCT02471677|GnRH antagonist protocol|gnrh antagonist protocol
177833|NCT02471677|high responders|high responders
177834|NCT02471677|follitropin beta|follitropin beta
177835|NCT02471664|Percutaneous mitral valve repair|percutaneous mitral valve repair
177836|NCT02471664|Coronary sinus annuloplasty|coronary sinus annuloplasty
177837|NCT02471664|Mitral loop cerclage|mitral loop cerclage
177838|NCT02471625|Controls|controls
177839|NCT02471599|IgA nephropathy|iga nephropathy
177840|NCT02471599|tonsillitis|tonsillitis
177841|NCT02471599|tonsil provocation test|tonsil provocation test
177842|NCT02471599|Tonsillectomy|tonsillectomy
177843|NCT02471573|IVF|ivf
177844|NCT02471573|Freeze-all|freeze-all
177845|NCT02471573|frozen embryo transfer|frozen embryo transfer
177846|NCT02471573|fresh transfer|fresh transfer
177847|NCT02471560|Microbiota|microbiota
177848|NCT02471560|DMF|dmf
177849|NCT02471560|Gastro intestinal|gastro intestinal
177850|NCT02471560|MS|ms
177851|NCT02471547|Recurrence|recurrence
177852|NCT02471495|NMIBC|nmibc
177853|NCT02471495|Non-Muscle-Invasive Bladder Cancer|non-muscle-invasive bladder cancer
177854|NCT02471495|Nonmuscle Invasive Bladder Cancer|nonmuscle invasive bladder cancer
177855|NCT02471495|BCG refractory|bcg refractory
177856|NCT02471495|BCG failure|bcg failure
177857|NCT02471495|Carcinoma in situ|carcinoma in situ
177858|NCT02471495|CIS|cis
177859|NCT02471482|Near Infra Red Spectrometry|near infra red spectrometry
177860|NCT02471482|Cerebral oxygenation|cerebral oxygenation
177861|NCT02471482|Mozart music|mozart music
177862|NCT02471404|Diabetes Mellitus Type 2,|diabetes mellitus type 2,
177863|NCT02471404|metformin,|metformin,
177864|NCT02471404|saxagliptin,|saxagliptin,
177865|NCT02471404|dapagliflozin,|dapagliflozin,
177866|NCT02471404|glimepiride,|glimepiride,
177867|NCT02471404|inadequate glycaemic control|inadequate glycaemic control
177868|NCT02471378|Assay|assay
177869|NCT02471378|Women|women
177870|NCT02471378|Infected|infected
177871|NCT02471378|Antibodies|antibodies
177872|NCT02471365|Exposure Assessment|exposure assessment
177873|NCT02471365|Questionnaire|questionnaire
177874|NCT02471365|Product Use|product use
177875|NCT02471365|Biomonitoring|biomonitoring
177876|NCT02471352|Dermatologic Condition|dermatologic condition
177877|NCT02471352|Skin Disease|skin disease
177878|NCT02471352|Biospecimen|biospecimen
177879|NCT02471352|Healthy Volunteers|healthy volunteers
177880|NCT02471352|Merkel Cell Carcinoma|merkel cell carcinoma
177881|NCT02471339|Psychological Intervention|psychological intervention
177882|NCT02471339|Coping|coping
177883|NCT02471339|Mindfulness|mindfulness
177884|NCT02471339|Randomized|randomized
177885|NCT02471326|HIV Neutralizing Antibodies|hiv neutralizing antibodies
177886|NCT02471326|HIV Therapy|hiv therapy
177887|NCT02471313|Cross-Sectional Imaging|cross-sectional imaging
177888|NCT02471313|Chemoembolization|chemoembolization
177889|NCT02471313|Radiation Therapy|radiation therapy
177890|NCT02471313|Tumor Hypoxia|tumor hypoxia
177891|NCT02471313|PET Imaging|pet imaging
177892|NCT02471300|Asthma|asthma
177893|NCT02471300|Inflammasome|inflammasome
177894|NCT02471300|Fasting|fasting
177895|NCT02471300|Airflow Obstruction|airflow obstruction
177896|NCT02471287|Ocular Genetic Diseases|ocular genetic diseases
177897|NCT02471287|GENETIC DISEASE|genetic disease
177898|NCT02471144|pediatric, chronic severe plaque psoriasis, secukinumab, etanercept|pediatric, chronic severe plaque psoriasis, secukinumab, etanercept
177899|NCT02471131|WATCHMAN|watchman
177900|NCT02471131|Atrial Fibrillation|atrial fibrillation
177901|NCT02471131|Hybrid Ablation|hybrid ablation
177902|NCT02471131|Safety|safety
177903|NCT02471131|Feasibility|feasibility
177904|NCT02471131|Stroke Prevention|stroke prevention
177906|NCT02471092|satiety|satiety
177907|NCT02471092|glycemia|glycemia
177908|NCT02471092|milk protein|milk protein
177909|NCT02471079|Radiation-induced health problems|radiation-induced health problems
177910|NCT02471079|Cardiovascular events|cardiovascular events
177911|NCT02471079|Lung toxicity|lung toxicity
177912|NCT02471053|Exercise|exercise
177913|NCT02471053|Quality of Life|quality of life
177914|NCT02471053|Complementary Therapies|complementary therapies
177915|NCT02471053|Neoadjuvant Therapy|neoadjuvant therapy
177916|NCT02471053|Feasibility Studies|feasibility studies
177917|NCT02471040|brain metabolism|brain metabolism
177918|NCT02471040|cognitive function|cognitive function
177919|NCT02471027|Locally advanced cervical cancer|locally advanced cervical cancer
177920|NCT02471027|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
177921|NCT02471027|Disease-free survival|disease-free survival
177922|NCT02471027|Overall survival|overall survival
177923|NCT02471014|Pneumovax23|pneumovax23
177924|NCT02471014|Obesity|obesity
177925|NCT02471001|concentration|concentration
177926|NCT02471001|Isoflurane|isoflurane
177927|NCT02471001|cardioprotective|cardioprotective
177928|NCT02471001|cardioplegia|cardioplegia
177929|NCT02471001|heart surgery|heart surgery
177930|NCT02471001|Disorder|disorder
177931|NCT02471001|Heart|heart
177932|NCT02471001|Functional|functional
177933|NCT02471001|Postoperative|postoperative
177934|NCT02470949|body weight|body weight
177935|NCT02470949|Hispanics|hispanics
177936|NCT02470949|Energy Intake|energy intake
177937|NCT02470949|Social Status|social status
177938|NCT02470923|Smoking cessation|smoking cessation
177939|NCT02470923|Nicotine|nicotine
177940|NCT02470923|Spirometry|spirometry
177941|NCT02470923|Internal medicine|internal medicine
177942|NCT02470910|Prostate Cancer|prostate cancer
177943|NCT02470910|Stage I-III prostate adenocarcinoma|stage i-iii prostate adenocarcinoma
177944|NCT02470806|Venous leg ulcer|venous leg ulcer
177945|NCT02470806|ulcer|ulcer
177946|NCT02470806|venous stasis|venous stasis
177947|NCT02470806|compression|compression
177948|NCT02470806|diabetic foot ulcers|diabetic foot ulcers
177949|NCT02470806|dfu|dfu
177950|NCT02470806|vlu|vlu
177951|NCT02470793|Corneal Endothelial Cell Loss|corneal endothelial cell loss
177952|NCT02470793|Fuchs' Endothelial Dystrophy|fuchs' endothelial dystrophy
177953|NCT02470793|Lamellar Keratoplasty|lamellar keratoplasty
177954|NCT02470793|Descemet Stripping Endothelial Keratoplasty|descemet stripping endothelial keratoplasty
177955|NCT02470793|Descemet Membrane Endothelial Keratoplasty|descemet membrane endothelial keratoplasty
177956|NCT02470793|Minimal Surgical Procedure|minimal surgical procedure
177957|NCT02470728|patient readmission|patient readmission
177958|NCT02470728|pain relief units|pain relief units
177959|NCT02470728|pain centers|pain centers
177960|NCT02470728|multidisciplinary pain clinics|multidisciplinary pain clinics
177961|NCT02470728|multidisciplinary pain centers|multidisciplinary pain centers
177962|NCT02470728|pain clinics|pain clinics
177963|NCT02470728|hospital readmission|hospital readmission
177964|NCT02470728|emergencies|emergencies
177965|NCT02470728|emergency medicine|emergency medicine
177966|NCT02470728|critical care|critical care
177967|NCT02470728|emergency treatment|emergency treatment
177968|NCT02470728|opioid|opioid
177969|NCT02470728|acute pain service|acute pain service
177970|NCT02470715|genetic sequencing|genetic sequencing
177971|NCT02470715|genome|genome
177972|NCT02470715|cancer|cancer
177973|NCT02470715|DNA|dna
177974|NCT02470715|RNA|rna
177975|NCT02470715|protein|protein
177976|NCT02470715|metabolite|metabolite
177977|NCT02470702|Volunteers|volunteers
177978|NCT02470650|comparative effectiveness|comparative effectiveness
177979|NCT02470598|Automated Peritoneal Dialysis|automated peritoneal dialysis
177980|NCT02470598|Adapted APD (aAPD)|adapted apd (aapd)
177981|NCT02470598|Hydration status|hydration status
177982|NCT02470598|Residual Renal Function|residual renal function
177983|NCT02470598|Ultrafiltration|ultrafiltration
177984|NCT02470585|Veliparib|veliparib
177985|NCT02470585|Carboplatin|carboplatin
177986|NCT02470585|Paclitaxel|paclitaxel
177987|NCT02470585|Overall Survival|overall survival
177988|NCT02470585|ABT-888|abt-888
177989|NCT02470585|Randomized|randomized
177990|NCT02470585|Poly Adenosine Diphosphate (ADP) - Ribose Polymerase (PARP)|poly adenosine diphosphate (adp) - ribose polymerase (parp)
177991|NCT02470585|Ovarian|ovarian
177992|NCT02470585|BRCA|brca
177993|NCT02470546|Hepatic encephalopathy|hepatic encephalopathy
177994|NCT02470546|Metformin|metformin
177995|NCT02470546|Liver cirrhosis|liver cirrhosis
177996|NCT02470481|Psoriatic arthritis|psoriatic arthritis
177997|NCT02470468|Immunotherapy|immunotherapy
177998|NCT02470468|Metastatic|metastatic
177999|NCT02470468|NSCLC|nsclc
178000|NCT02470468|Biological|biological
178001|NCT02470468|Lung Cancer|lung cancer
178002|NCT02470468|Vaccine|vaccine
178003|NCT02470455|Atorvastatin|atorvastatin
178004|NCT02470455|Prediabetics|prediabetics
178005|NCT02470455|HbA1c|hba1c
178006|NCT02470416|duodenal|duodenal
178007|NCT02470416|ampulla|ampulla
178008|NCT02470403|dysglycemic, normoglycemic, prediabetes, type 2 diabetes mellitus|dysglycemic, normoglycemic, prediabetes, type 2 diabetes mellitus
178009|NCT02470390|Volunteer|volunteer
178010|NCT02470390|Pharmacokenetics (PK) (plasma and Cerebrospinal Fluid [CSF])|pharmacokenetics (pk) (plasma and cerebrospinal fluid [csf])
178011|NCT02470377|MdDS|mdds
178012|NCT02470377|TMS|tms
178013|NCT02470377|fMRI|fmri
178014|NCT02470377|EEG|eeg
178015|NCT02470364|Myasthenia gravis|myasthenia gravis
178016|NCT02470364|Quality of life|quality of life
178017|NCT02470325|Cerebral palsy|cerebral palsy
178018|NCT02470325|Genetic neurodegenerative diseases|genetic neurodegenerative diseases
178019|NCT02470312|utility of MediGuide system|utility of mediguide system
178020|NCT02470312|CRT|crt
178021|NCT02470312|EP|ep
178022|NCT02470299|ketorolac|ketorolac
178025|NCT02470299|peritoneal|peritoneal
178026|NCT02470299|fallopian|fallopian
178027|NCT02470299|ovarian|ovarian
178028|NCT02470273|Melanoma|melanoma
178029|NCT02470260|Diabetes|diabetes
178030|NCT02470260|Pre-diabetes|pre-diabetes
178031|NCT02470260|Cognition|cognition
178032|NCT02470260|Depressive symptoms|depressive symptoms
178033|NCT02470247|Transcatheter Aortic Valve Implantation|transcatheter aortic valve implantation
178034|NCT02470234|ADHD|adhd
178035|NCT02470234|Children|children
178036|NCT02470234|Pharmacokinetics|pharmacokinetics
178037|NCT02470221|goal-directed fluid therapy|goal-directed fluid therapy
178038|NCT02470221|intraoperative hemodynamics|intraoperative hemodynamics
178039|NCT02470221|postoperative complications|postoperative complications
178040|NCT02470208|Cytomegalovirus reactivation in stem cell transplant|cytomegalovirus reactivation in stem cell transplant
178041|NCT02470182|sleep apnea|sleep apnea
178042|NCT02470182|snoring|snoring
178043|NCT02470156|community based participatory research|community based participatory research
178044|NCT02470156|healthy eating|healthy eating
178045|NCT02470156|physical activity|physical activity
178046|NCT02470156|obesity|obesity
178047|NCT02470143|Human-computer interaction|human-computer interaction
178048|NCT02470143|Fear|fear
178049|NCT02470143|Motivation|motivation
178050|NCT02470143|Usability|usability
178051|NCT02470130|simulation|simulation
178052|NCT02470130|anxiety|anxiety
178053|NCT02470130|debriefing|debriefing
178054|NCT02470130|memorization|memorization
178055|NCT02470104|children|children
178056|NCT02470104|bone marrow transplant|bone marrow transplant
178057|NCT02470104|autologous|autologous
178058|NCT02470104|allogeneic|allogeneic
178059|NCT02470104|breastmilk|breastmilk
178060|NCT02470104|hematopoietic stem cell transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
178061|NCT02470078|extubation|extubation
178062|NCT02470065|NSCLC|nsclc
178063|NCT02470065|Early stage|early stage
178064|NCT02470065|Phase II|phase ii
178065|NCT02470065|Randomized|randomized
178066|NCT02470065|EGFR mutated|egfr mutated
178067|NCT02470052|Endobronchial Valves|endobronchial valves
178068|NCT02470052|Intrabronchial Valves|intrabronchial valves
178069|NCT02470052|Bronchial Valve|bronchial valve
178070|NCT02470052|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
178071|NCT02470052|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
178072|NCT02470052|Bronchoscopic Lung Volume Reduction|bronchoscopic lung volume reduction
178073|NCT02470052|Emphysema|emphysema
178074|NCT02470052|Pulmonary Emphysema|pulmonary emphysema
178075|NCT02470052|Lung Diseases|lung diseases
178076|NCT02470052|Respiratory Tract Disease|respiratory tract disease
178077|NCT02470013|Malnutrition|malnutrition
178078|NCT02470013|Geriatrics|geriatrics
178079|NCT02470013|Enteral Nutrition|enteral nutrition
178080|NCT02470000|myofascial pain|myofascial pain
178081|NCT02470000|neck|neck
178082|NCT02470000|laser|laser
178083|NCT02470000|elastography|elastography
178084|NCT02470000|shear wave velocity|shear wave velocity
178085|NCT02470000|randomized control trial|randomized control trial
178086|NCT02470000|Intravascular Laser Irradiation of Blood|intravascular laser irradiation of blood
178087|NCT02469987|safety|safety
178088|NCT02469987|tolerability|tolerability
178089|NCT02469987|immunogenicity|immunogenicity
178090|NCT02469987|MYL-1402O|myl-1402o
178092|NCT02469987|Avastin®|avastin®
178093|NCT02469987|biosimilarity|biosimilarity
178094|NCT02469987|male|male
178095|NCT02469974|Myelofibrosis|myelofibrosis
178096|NCT02469974|RUXOLITINIB|ruxolitinib
178097|NCT02469974|Autologous stem cell transplant|autologous stem cell transplant
178098|NCT02469948|spasticity|spasticity
178099|NCT02469948|botulinum toxin|botulinum toxin
178100|NCT02469948|ultrasonography guidance|ultrasonography guidance
178101|NCT02469948|electric stimulation guidance|electric stimulation guidance
178102|NCT02469948|stroke|stroke
178103|NCT02469935|Validation|validation
178104|NCT02469935|Surgeon-performed ultrasound|surgeon-performed ultrasound
178105|NCT02469935|Gallstones|gallstones
178106|NCT02469909|Decannulation|decannulation
178107|NCT02469909|tracheostomy|tracheostomy
178108|NCT02469896|ALS|als
178109|NCT02469896|tocilizumab|tocilizumab
178110|NCT02469896|biomarker|biomarker
178111|NCT02469870|Parents of children who have autism|parents of children who have autism
178112|NCT02469870|video-conferencing|video-conferencing
178113|NCT02469870|Applied Behavior Analysis|applied behavior analysis
178114|NCT02469870|Acceptance Commitment Training|acceptance commitment training
178115|NCT02469870|optimism training|optimism training
178116|NCT02469870|Positive Behavior Support|positive behavior support
178117|NCT02469857|AB103|ab103
178118|NCT02469857|Necrotizing fasciitis|necrotizing fasciitis
178119|NCT02469818|pocus|pocus
178120|NCT02469818|ultrasonography|ultrasonography
178121|NCT02469818|glenohumeral dislocation|glenohumeral dislocation
178122|NCT02469792|Anterior cruciate ligament|anterior cruciate ligament
178123|NCT02469792|Ligament rupture|ligament rupture
178124|NCT02469792|Intraarticular injection|intraarticular injection
178125|NCT02469792|ADRC|adrc
178126|NCT02469792|Adipose-derived regenerative cells|adipose-derived regenerative cells
178127|NCT02469792|Adipose tissue|adipose tissue
178128|NCT02469792|Stem cells|stem cells
178129|NCT02469779|Tobacco Prevention|tobacco prevention
178130|NCT02469779|ASPIRE Website|aspire website
178131|NCT02469779|Surveys|surveys
178132|NCT02469779|Questionnaires|questionnaires
178133|NCT02469779|Focus Groups|focus groups
178134|NCT02469779|Health Interactive Website|health interactive website
178135|NCT02469766|ureteral stones|ureteral stones
178136|NCT02469766|ureter|ureter
178137|NCT02469766|ureteroscopy|ureteroscopy
178138|NCT02469766|flexible|flexible
178139|NCT02469766|SWL|swl
178140|NCT02469753|NSAIDs|nsaids
178141|NCT02469753|Anti-TNF|anti-tnf
178142|NCT02469753|syndesmophytes|syndesmophytes
178143|NCT02469753|mSASSS|msasss
178144|NCT02469740|Ticagrelor|ticagrelor
178145|NCT02469740|Clopidogrel|clopidogrel
178146|NCT02469740|Coronary Artery Disease|coronary artery disease
178147|NCT02469740|Percutaneous Coronary Intervention|percutaneous coronary intervention
178148|NCT02469740|Acute Coronary Syndrome|acute coronary syndrome
178149|NCT02469714|Patient Navigator|patient navigator
178150|NCT02469714|Integrated Care|integrated care
178151|NCT02469714|Latino|latino
178152|NCT02469714|Mental health and wellness|mental health and wellness
178153|NCT02469714|Physical health and wellness|physical health and wellness
178154|NCT02469688|cedar pollinosis|cedar pollinosis
178155|NCT02469688|immunological response,|immunological response,
178156|NCT02469688|ASP4070|asp4070
178157|NCT02469688|vaccine|vaccine
178158|NCT02469675|Spinal Cord Injuries|spinal cord injuries
178159|NCT02469675|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
178160|NCT02469675|Transcranial magnetic stimulation, single pulse|transcranial magnetic stimulation, single pulse
178161|NCT02469675|non-invasive brain stimulation|non-invasive brain stimulation
178162|NCT02469662|Total Elbow Arthroplasty|total elbow arthroplasty
178163|NCT02469662|TEA|tea
178164|NCT02469662|Elbow Arthroplasty|elbow arthroplasty
178165|NCT02469662|Elbow Replacement|elbow replacement
178166|NCT02469662|Advanced Rheumatoid Arthritis|advanced rheumatoid arthritis
178167|NCT02469662|Post-Traumatic Arthritis|post-traumatic arthritis
178168|NCT02469662|Degenerative Arthritis|degenerative arthritis
178169|NCT02469662|Elbow Joint Destruction|elbow joint destruction
178170|NCT02469662|Post-Traumatic Lesions or Bone Loss|post-traumatic lesions or bone loss
178171|NCT02469662|Ankylosed Joints|ankylosed joints
178172|NCT02469662|Acute Comminuted Articular Fracture|acute comminuted articular fracture
178173|NCT02469662|significantly compromises daily living activities|significantly compromises daily living activities
178174|NCT02469662|degree of joint or soft tissue damage precludes reliable osteosynthesis|degree of joint or soft tissue damage precludes reliable osteosynthesis
178175|NCT02469662|precludes less radical procedures, including 13-C3 fractures of the distal humerus|precludes less radical procedures, including 13-c3 fractures of the distal humerus
178176|NCT02469610|Post surgical pain|post surgical pain
178177|NCT02469584|prolapse|prolapse
178178|NCT02469584|anterior colporrhaphy|anterior colporrhaphy
178179|NCT02469545|depression|depression
178180|NCT02469545|microbiota-gut-brain axis|microbiota-gut-brain axis
178181|NCT02469545|Lactobacillus Plantarum 299v|lactobacillus plantarum 299v
178182|NCT02469545|probiotic|probiotic
178183|NCT02469480|MCRC|mcrc
178184|NCT02469480|iron substitution|iron substitution
178185|NCT02469480|iron deficiency anemia|iron deficiency anemia
178186|NCT02469467|phosphate binder|phosphate binder
178187|NCT02469467|dialysis|dialysis
178188|NCT02469454|etonogestrel-implant|etonogestrel-implant
178189|NCT02469454|newborn|newborn
178190|NCT02469454|growth|growth
178191|NCT02469454|Child Development|child development
178192|NCT02469441|coffee|coffee
178193|NCT02469441|postoperative ileus|postoperative ileus
178194|NCT02469441|colorectal surgery|colorectal surgery
178195|NCT02469428|Controlled human exposure study|controlled human exposure study
178196|NCT02469428|Ozone|ozone
178197|NCT02469428|Inflammation|inflammation
178198|NCT02469415|Leukemia|leukemia
178199|NCT02469415|Myelodysplastic syndromes|myelodysplastic syndromes
178200|NCT02469415|MDS|mds
178201|NCT02469415|Lower-risk|lower-risk
178202|NCT02469415|Pacritinib|pacritinib
178203|NCT02469415|5-azacitidine|5-azacitidine
178204|NCT02469415|Azacitidine|azacitidine
178205|NCT02469415|5-azacytidine|5-azacytidine
178206|NCT02469415|Vidaza|vidaza
178207|NCT02469415|5-AZC|5-azc
178208|NCT02469415|AZA-CR|aza-cr
178209|NCT02469415|Ladakamycin|ladakamycin
178210|NCT02469415|NSC-102816|nsc-102816
178211|NCT02469415|Azacytidine|azacytidine
178212|NCT02469415|Decitabine|decitabine
178213|NCT02469415|Dacogen|dacogen
178214|NCT02469402|reduced|reduced
178215|NCT02469402|protein|protein
178216|NCT02469402|formula|formula
178217|NCT02469402|Alpha-lactalbumin|alpha-lactalbumin
178218|NCT02469402|infant|infant
178219|NCT02469389|Schizophrenia|schizophrenia
178220|NCT02469389|Negative Symptoms|negative symptoms
178221|NCT02469363|Macintosh laryngoscope|macintosh laryngoscope
178222|NCT02469363|McCoy laryngoscope|mccoy laryngoscope
178223|NCT02469363|C-Mac videolaryngoscope|c-mac videolaryngoscope
178928|NCT02465489|deferiprone|deferiprone
178224|NCT02469363|McGrath videolaryngoscope|mcgrath videolaryngoscope
178225|NCT02469363|Hemodynamic parameters|hemodynamic parameters
178226|NCT02469350|Gait and balance disorders|gait and balance disorders
178227|NCT02469350|serious game|serious game
178228|NCT02469311|infection; arthroplasty; chlorhexidine; hip; knee|infection; arthroplasty; chlorhexidine; hip; knee
178229|NCT02469298|acute, uncomplicated influenza|acute, uncomplicated influenza
178230|NCT02469298|Danirixin|danirixin
178231|NCT02469298|oseltamivir|oseltamivir
178232|NCT02469285|Fatty acids|fatty acids
178233|NCT02469285|Lipids|lipids
178234|NCT02469285|Nitroso compounds|nitroso compounds
178235|NCT02469285|Lipid metabolism|lipid metabolism
178236|NCT02469285|Gut metabolism|gut metabolism
178237|NCT02469259|oxytocin|oxytocin
178238|NCT02469259|PTSD|ptsd
178239|NCT02469259|Alcohol Use Disorder|alcohol use disorder
178240|NCT02469259|social cognition|social cognition
178241|NCT02469259|craving|craving
178242|NCT02469259|fear-potentiated startle|fear-potentiated startle
178243|NCT02469246|HIV|hiv
178244|NCT02469246|HIV-1 Positive|hiv-1 positive
178245|NCT02469246|Virologically-Suppressed|virologically-suppressed
178246|NCT02469220|Diet|diet
178247|NCT02469220|low FODMAP|low fodmap
178248|NCT02469220|UC|uc
178249|NCT02469220|IBS|ibs
178250|NCT02469207|regenerative medicine|regenerative medicine
178251|NCT02469207|stem cells|stem cells
178252|NCT02469207|immunomodulatory|immunomodulatory
178253|NCT02469207|induced pluripotent stem cells|induced pluripotent stem cells
178254|NCT02469207|gut physiology|gut physiology
178255|NCT02469129|positron emission tomography (PET) imaging|positron emission tomography (pet) imaging
178256|NCT02469129|poly(ADP-ribose) polymerase 1 (PARP1)|poly(adp-ribose) polymerase 1 (parp1)
178257|NCT02469129|[18F]FluorThanatrace ([18F]FTT)|[18f]fluorthanatrace ([18f]ftt)
178258|NCT02469129|PARP1 inhibitors|parp1 inhibitors
178259|NCT02469129|cancer treatments|cancer treatments
178260|NCT02469103|capsule colonoscopy|capsule colonoscopy
178261|NCT02469103|ulcerative colitis|ulcerative colitis
178262|NCT02469077|Chronic Low Back Pain|chronic low back pain
178263|NCT02469064|mechanical ventilation|mechanical ventilation
178264|NCT02469064|respiratory muscle|respiratory muscle
178265|NCT02469064|weaning|weaning
178266|NCT02469064|training|training
178267|NCT02469064|Intensive care|intensive care
178268|NCT02469012|chronic hepatitis C|chronic hepatitis c
178269|NCT02469012|antiviral treatment|antiviral treatment
178270|NCT02469012|interferon-free|interferon-free
178271|NCT02469012|neurocognitive performance|neurocognitive performance
178272|NCT02469012|emotional state|emotional state
178273|NCT02469012|quality of life|quality of life
178274|NCT02468999|Intranasal insulin|intranasal insulin
178275|NCT02468986|Rheumatoid Arthritis|rheumatoid arthritis
178276|NCT02468973|health behavior|health behavior
178277|NCT02468973|consultation|consultation
178278|NCT02468973|undergraduate|undergraduate
178279|NCT02468960|Coronary Artery Disease|coronary artery disease
178280|NCT02468960|OPN NC|opn nc
178281|NCT02468960|Angina|angina
178282|NCT02468960|Stable|stable
178283|NCT02468960|Unstable|unstable
178284|NCT02468947|Neonatal sepsis|neonatal sepsis
178285|NCT02468934|electrical stimulation|electrical stimulation
178286|NCT02468934|neurostimulation|neurostimulation
178287|NCT02468934|neuromodulation|neuromodulation
178288|NCT02468934|TKA pain|tka pain
178289|NCT02468934|pain following total knee replacement|pain following total knee replacement
178290|NCT02468934|total knee arthroplasty|total knee arthroplasty
178291|NCT02468921|Goitre|goitre
178292|NCT02468921|thyroid disease|thyroid disease
178293|NCT02468921|struma|struma
178294|NCT02468895|Myositis|myositis
178295|NCT02468895|Idiopathic inflammatory myopathy|idiopathic inflammatory myopathy
178296|NCT02468895|Antibodies|antibodies
178297|NCT02468895|Genetics|genetics
178298|NCT02468895|Biomarkers|biomarkers
178299|NCT02468882|Breast cancer|breast cancer
178300|NCT02468882|Radiotherapy|radiotherapy
178301|NCT02468882|Toxicity|toxicity
178302|NCT02468882|Outcomes|outcomes
178303|NCT02468882|Watercress|watercress
178304|NCT02468869|Recall|recall
178305|NCT02468869|Discharge communication|discharge communication
178306|NCT02468869|Satisfaction|satisfaction
178307|NCT02468869|Adherence|adherence
178308|NCT02468869|Information structuring|information structuring
178309|NCT02468869|Empathy skills|empathy skills
178310|NCT02468843|Deep brain stimulation|deep brain stimulation
178311|NCT02468843|DBS|dbs
178312|NCT02468843|Dystonia|dystonia
178313|NCT02468843|DYT1|dyt1
178314|NCT02468830|mirabegron|mirabegron
178315|NCT02468830|antimuscarinics|antimuscarinics
178316|NCT02468830|beta 3 agonist|beta 3 agonist
178317|NCT02468830|overactive bladder|overactive bladder
178318|NCT02468830|children|children
178319|NCT02468817|parathyroid hormone (PTH)|parathyroid hormone (pth)
178320|NCT02468817|bone mineral density (BMD)|bone mineral density (bmd)
178321|NCT02468804|Parkinson's|parkinson's
178322|NCT02468804|Non-parkinsons|non-parkinsons
178323|NCT02468791|Rheumatoid Arthritis|rheumatoid arthritis
178324|NCT02468791|Autoimmune Diseases|autoimmune diseases
178325|NCT02468791|Rituximab|rituximab
178326|NCT02468791|Immune System Diseases|immune system diseases
178327|NCT02468791|Joint Diseases|joint diseases
178328|NCT02468791|Rheumatic Diseases|rheumatic diseases
178329|NCT02468778|HeartMate PHP|heartmate php
178330|NCT02468778|High Risk PCI|high risk pci
178331|NCT02468778|Left Ventricular Dysfunction|left ventricular dysfunction
178332|NCT02468778|Thoratec Corporation|thoratec corporation
178333|NCT02468713|Omega-3|omega-3
178334|NCT02468713|Blood lipid profiles|blood lipid profiles
178335|NCT02468713|DHA|dha
178336|NCT02468713|EPA|epa
178337|NCT02468713|Triglyceride|triglyceride
178338|NCT02468713|Glucose|glucose
178339|NCT02468713|Insulin|insulin
178340|NCT02468713|LDL|ldl
178341|NCT02468713|TPN|tpn
178342|NCT02468687|Relapsed/Refractory|relapsed/refractory
178343|NCT02468674|Sarcopenia, muscle wasting, elderly, strength, physical|sarcopenia, muscle wasting, elderly, strength, physical
178344|NCT02468674|function, lean body mass, gait speed|function, lean body mass, gait speed
178345|NCT02468661|Non-Small Cell Lung Cancer|non-small cell lung cancer
178346|NCT02468648|Oral Therapy|oral therapy
178347|NCT02468648|Liver Biopsy|liver biopsy
178348|NCT02468648|Chronic Hepatitis C|chronic hepatitis c
178349|NCT02468635|Pulmonary rehabilitation|pulmonary rehabilitation
178350|NCT02468635|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
178351|NCT02468635|physical ability|physical ability
178352|NCT02468635|pulmonary function|pulmonary function
178353|NCT02468635|quality of daily life|quality of daily life
178354|NCT02468596|Axonal excitability|axonal excitability
178355|NCT02468596|Neuropathy|neuropathy
178356|NCT02468596|QTRAC|qtrac
178357|NCT02468596|anti-MAG|anti-mag
178358|NCT02468596|Electrophysiology|electrophysiology
178359|NCT02468583|Osteoarthritis|osteoarthritis
178360|NCT02468583|Post-traumatic|post-traumatic
178361|NCT02468583|Knee|knee
178362|NCT02468583|Pain|pain
178363|NCT02468583|Corticosteroid|corticosteroid
178364|NCT02468583|Intra-articular|intra-articular
178365|NCT02468583|Injection|injection
178366|NCT02468570|PKU|pku
178367|NCT02468570|PEG-PAL|peg-pal
178368|NCT02468570|Pegvaliase|pegvaliase
178369|NCT02468570|BMN 165|bmn 165
178370|NCT02468570|rAv-PAL PEG|rav-pal peg
178371|NCT02468570|PRISM 302|prism 302
178372|NCT02468570|PRISM 303|prism 303
178373|NCT02468570|BioMarin|biomarin
178374|NCT02468570|165-302|165-302
178375|NCT02468557|Relapsed/refractory pancreatic ductal adenocarcinoma|relapsed/refractory pancreatic ductal adenocarcinoma
178376|NCT02468557|Previously untreated pancreatic ductal adenocarcinoma|previously untreated pancreatic ductal adenocarcinoma
178377|NCT02468544|Engagement in care|engagement in care
178378|NCT02468544|mHealth|mhealth
178379|NCT02468531|Xenon|xenon
178380|NCT02468531|Standford A acute aortic dissection|standford a acute aortic dissection
178381|NCT02468505|Structured transition support program|structured transition support program
178382|NCT02468505|Transition 'as usual'|transition 'as usual'
178383|NCT02468492|Knee Osteoarthritis|knee osteoarthritis
178384|NCT02468492|Platelet Rich Plasma|platelet rich plasma
178385|NCT02468492|Mechanism of Action|mechanism of action
178386|NCT02468492|Stem Cells|stem cells
178387|NCT02468492|Synovial Fluid|synovial fluid
178388|NCT02468479|Liver cirrhosis|liver cirrhosis
178389|NCT02468466|suicide|suicide
178390|NCT02468466|prevention|prevention
178391|NCT02468453|velos|velos
178392|NCT02468453|Vascular|vascular
178393|NCT02468453|Rejuvenation|rejuvenation
178394|NCT02468440|renal insufficiency|renal insufficiency
178395|NCT02468440|kidney transplant|kidney transplant
178396|NCT02468440|educational therapy|educational therapy
178397|NCT02468414|Peritoneal Dialysis|peritoneal dialysis
178398|NCT02468414|End Stage Renal Disease|end stage renal disease
178399|NCT02468414|Anemia|anemia
178400|NCT02468388|maltitol|maltitol
178401|NCT02468388|xylitol|xylitol
178402|NCT02468388|quantitative light-induced fluorescence|quantitative light-induced fluorescence
178403|NCT02468388|saliva pH|saliva ph
178404|NCT02468388|re-mineralization|re-mineralization
178405|NCT02468388|dental caries|dental caries
178406|NCT02468362|Intersphincteric resection|intersphincteric resection
178407|NCT02468362|laparoscopic rectal rescetion|laparoscopic rectal rescetion
178408|NCT02468362|total mesorectal excsison|total mesorectal excsison
178409|NCT02468349|Acute Myocardial Infarction|acute myocardial infarction
178410|NCT02468349|Telemedicine|telemedicine
178411|NCT02468349|Readmissions|readmissions
178412|NCT02468336|Physiology|physiology
178413|NCT02468323|PONV|ponv
178414|NCT02468323|Palonosetron|palonosetron
178415|NCT02468323|Ondansetron|ondansetron
178416|NCT02468323|Cesarean section|cesarean section
178417|NCT02468310|Maternal mortality|maternal mortality
178418|NCT02468310|Neonatal mortality|neonatal mortality
178419|NCT02468310|Neonatal morbidity|neonatal morbidity
178420|NCT02468310|Text messaging|text messaging
178421|NCT02468310|Clinical decision making|clinical decision making
178422|NCT02468310|Maternal Morbidity|maternal morbidity
178423|NCT02468271|Clinimetrics|clinimetrics
178424|NCT02468271|Lung function|lung function
178425|NCT02468271|Lung clearance index|lung clearance index
178426|NCT02468258|Assisted Reproduction|assisted reproduction
178427|NCT02468245|Nursing intervention|nursing intervention
178428|NCT02468245|compliance|compliance
178429|NCT02468232|chronic heart failure|chronic heart failure
178430|NCT02468232|cardiovascular death|cardiovascular death
178431|NCT02468232|hospitalization|hospitalization
178432|NCT02468232|outcome study|outcome study
178433|NCT02468232|worsening heart failure|worsening heart failure
178434|NCT02468232|NT-proBNP|nt-probnp
178435|NCT02468232|NYHA|nyha
178436|NCT02468232|KCCQ|kccq
178437|NCT02468232|HF-rEF|hf-ref
178438|NCT02468219|aortic stenosis|aortic stenosis
178439|NCT02468219|aortic valve replacement|aortic valve replacement
178440|NCT02468219|transcatheter aortic valve implantation|transcatheter aortic valve implantation
178441|NCT02468219|frailty|frailty
178442|NCT02468219|cardiac rehabilitation|cardiac rehabilitation
178443|NCT02468193|Cushing's syndrome|cushing's syndrome
178444|NCT02468193|osilodrostat|osilodrostat
178445|NCT02468193|LCI699|lci699
178446|NCT02468193|ectopic corticotropin syndrome|ectopic corticotropin syndrome
178447|NCT02468193|adrenal adenoma|adrenal adenoma
178448|NCT02468193|adrenal carcinoma|adrenal carcinoma
178449|NCT02468193|ACTH-Independent Macronodular Adrenal Hyperplasia|acth-independent macronodular adrenal hyperplasia
178450|NCT02468193|AIMAH|aimah
178451|NCT02468193|Primary Pigmented Nodular Adrenal Dysplasia|primary pigmented nodular adrenal dysplasia
178452|NCT02468193|PPNAD|ppnad
178453|NCT02468128|Analgesic|analgesic
178454|NCT02468128|Opioids|opioids
178455|NCT02468128|Pain relief after surgery|pain relief after surgery
178456|NCT02468128|Dinalbuphine|dinalbuphine
178457|NCT02468128|Sebacoyl Dinalbuphine Ester|sebacoyl dinalbuphine ester
178458|NCT02468128|SDE|sde
178459|NCT02468128|SDN|sdn
178460|NCT02468128|LT1001|lt1001
178461|NCT02468102|Rivaroxaban|rivaroxaban
178462|NCT02468102|Venous Thrombosis/Pulmonary Embolism|venous thrombosis/pulmonary embolism
178463|NCT02468102|Stroke Prevention in Atrial Fibrillation|stroke prevention in atrial fibrillation
178464|NCT02468102|Anticoagulants|anticoagulants
178465|NCT02468102|Hematologic Agents|hematologic agents
178466|NCT02468102|Therapeutic Uses|therapeutic uses
178467|NCT02468102|Observational|observational
178468|NCT02468102|Pulmonary Embolism|pulmonary embolism
178469|NCT02468102|Venous Thrombosis|venous thrombosis
178470|NCT02468102|Venous Thromboembolism|venous thromboembolism
178471|NCT02468102|Intracranial Hemorrhages|intracranial hemorrhages
178472|NCT02468102|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
178473|NCT02468076|ERCP|ercp
178474|NCT02468076|radiofrequency ablation|radiofrequency ablation
178475|NCT02468076|obstructive jaundice|obstructive jaundice
178476|NCT02468050|Anxiety|anxiety
178477|NCT02468050|Depression|depression
178478|NCT02468050|Exercise|exercise
178479|NCT02468050|Breast Cancer|breast cancer
178480|NCT02468050|Biopsy|biopsy
178481|NCT02468050|Screening|screening
178482|NCT02468050|Diagnosis|diagnosis
178483|NCT02468037|iron|iron
178484|NCT02468037|diabetes|diabetes
178485|NCT02468037|phlebotomy|phlebotomy
178486|NCT02467998|meaningful use|meaningful use
178487|NCT02467998|electronic health records|electronic health records
178488|NCT02467998|structured language|structured language
178489|NCT02467998|NPWT|npwt
178490|NCT02467998|PQRS|pqrs
178491|NCT02467985|gynecological laparoscopic surgery|gynecological laparoscopic surgery
178492|NCT02467972|Hunger and satiety|hunger and satiety
178493|NCT02467972|Hormones gastrointestinal|hormones gastrointestinal
178494|NCT02467972|Bowel movements|bowel movements
178495|NCT02467959|emergency ultrasound|emergency ultrasound
178496|NCT02467959|acute appendicitis|acute appendicitis
178497|NCT02467959|bedside ultrasound|bedside ultrasound
178498|NCT02467920|exenatide|exenatide
178499|NCT02467920|glargine|glargine
178500|NCT02467920|aspart 30|aspart 30
178501|NCT02467894|Adherence|adherence
178502|NCT02467894|Exercise|exercise
178503|NCT02467881|Physical Activity|physical activity
178504|NCT02467881|Sedentary|sedentary
178505|NCT02467881|Lifestyle Intervention|lifestyle intervention
178506|NCT02467868|Pegfilgrastim|pegfilgrastim
178507|NCT02467868|Granulocyte Colony Stimulating Factor (G-CSF)|granulocyte colony stimulating factor (g-csf)
178508|NCT02467868|Breast Cancer|breast cancer
178509|NCT02467868|Neutropenia|neutropenia
178510|NCT02467855|Drug therapy|drug therapy
178511|NCT02467842|Influenza vaccine|influenza vaccine
178512|NCT02467842|Quadrivalent|quadrivalent
178513|NCT02467842|Inactivated cell culture-derived|inactivated cell culture-derived
178514|NCT02467829|Cerebral Palsy|cerebral palsy
178515|NCT02467829|Walking Aids|walking aids
178516|NCT02467816|Secondary schools|secondary schools
178517|NCT02467816|School lunch|school lunch
178518|NCT02467816|Plate waste|plate waste
178519|NCT02467803|humeral fracture|humeral fracture
178520|NCT02467803|exercise|exercise
178521|NCT02467803|musculoskeletal manipulations|musculoskeletal manipulations
178522|NCT02467777|orthopaedics|orthopaedics
178523|NCT02467777|post-operative warming|post-operative warming
178524|NCT02467764|Knee|knee
178525|NCT02467764|Knee osteoarthritis|knee osteoarthritis
178526|NCT02467764|Knee replacement|knee replacement
178527|NCT02467764|Hip|hip
178528|NCT02467764|Hip osteoarthritis|hip osteoarthritis
178529|NCT02467764|Hip replacement|hip replacement
178530|NCT02467725|Preimplantation Embryo Development|preimplantation embryo development
178531|NCT02467712|Fongal infection|fongal infection
178532|NCT02467712|joint prosthesis|joint prosthesis
178533|NCT02467712|prosthetic reconstruction|prosthetic reconstruction
178534|NCT02467699|Knee|knee
178535|NCT02467699|Knee osteoarthritis|knee osteoarthritis
178536|NCT02467699|Knee replacement|knee replacement
178537|NCT02467621|Stress ulcer prophylaxis|stress ulcer prophylaxis
178538|NCT02467621|Proton pump inhibitor|proton pump inhibitor
178539|NCT02467621|Pneumonia|pneumonia
178540|NCT02467621|Clostridium difficile infection|clostridium difficile infection
178541|NCT02467608|HUEXC030|huexc030
178542|NCT02467608|Pulmonary Tuberculosis|pulmonary tuberculosis
178543|NCT02467595|no muscle relaxant|no muscle relaxant
178544|NCT02467595|rocuronium|rocuronium
178545|NCT02467595|intubation condition|intubation condition
178546|NCT02467595|tracheal intubation|tracheal intubation
178547|NCT02467595|operating room time|operating room time
178548|NCT02467595|low-dose rocuronium|low-dose rocuronium
178549|NCT02467582|Aspirin|aspirin
178550|NCT02467582|colon cancer|colon cancer
178551|NCT02467582|stage II|stage ii
178552|NCT02467582|stage III|stage iii
178553|NCT02467582|PIK3CA|pik3ca
178554|NCT02467582|double-blind|double-blind
178555|NCT02467582|placebo|placebo
178556|NCT02467582|Adjuvant Treatment|adjuvant treatment
178557|NCT02467556|CRPS|crps
178558|NCT02467556|intervention|intervention
178559|NCT02467556|multimodal|multimodal
178560|NCT02467543|Primary dysmenorrhea|primary dysmenorrhea
178561|NCT02467543|Viburnum opulus 3X|viburnum opulus 3x
178562|NCT02467543|Homoeopathic|homoeopathic
178563|NCT02467530|end stage renal disease|end stage renal disease
178564|NCT02467530|peritoneal dialysis (PD)|peritoneal dialysis (pd)
178565|NCT02467530|advanced glycation end products|advanced glycation end products
178566|NCT02467530|Gut Microbiota Inflammation|gut microbiota inflammation
178567|NCT02467517|Neuropathic pain|neuropathic pain
178568|NCT02467517|Ketamine|ketamine
178569|NCT02467517|Magnesium sulfate|magnesium sulfate
178570|NCT02467517|Quality of life|quality of life
178571|NCT02467517|Anxiety and depression|anxiety and depression
178572|NCT02467517|Mood and sleep|mood and sleep
178573|NCT02467491|Exercise|exercise
178574|NCT02467491|Technology|technology
178575|NCT02467491|Aging|aging
178576|NCT02467478|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
178577|NCT02467478|Endothelial cells|endothelial cells
178578|NCT02467478|Cellular biomarker|cellular biomarker
178579|NCT02467478|endothelial dysfunction|endothelial dysfunction
178580|NCT02467478|CD34+|cd34+
178581|NCT02467478|Impaired renal function|impaired renal function
178582|NCT02467465|Fasciosis plantar|fasciosis plantar
178583|NCT02467465|physiotherapy|physiotherapy
178584|NCT02467465|fascitis plantar|fascitis plantar
178585|NCT02467465|dry needling|dry needling
178586|NCT02467439|unaware intervention;|unaware intervention;
178587|NCT02467439|contract sexual partner referral|contract sexual partner referral
178588|NCT02467439|peer referral|peer referral
178589|NCT02467426|Mesothelioma, malignant|mesothelioma, malignant
178590|NCT02467426|Chemotherapy|chemotherapy
178591|NCT02467413|Alzheimer's Disease|alzheimer's disease
178592|NCT02467413|Vascular Dementia|vascular dementia
178593|NCT02467400|bone formation|bone formation
178594|NCT02467387|Non-ischemic Heart Failure|non-ischemic heart failure
178595|NCT02467387|Stem Cells|stem cells
178597|NCT02467374|Neuroimaging|neuroimaging
178598|NCT02467374|Fear Extinction|fear extinction
178599|NCT02467374|Behavior Therapy|behavior therapy
178600|NCT02467361|Neoplasms|neoplasms
178601|NCT02467296|Sodium|sodium
178602|NCT02467296|outcomes|outcomes
178603|NCT02467283|chronic periodontitis|chronic periodontitis
178604|NCT02467283|genetics|genetics
178605|NCT02467283|microarray analysis|microarray analysis
178606|NCT02467283|gingiva|gingiva
178607|NCT02467283|genes|genes
178608|NCT02467283|inflammation|inflammation
178609|NCT02467270|Chronic Phase Chronic Myeloid Leukemia|chronic phase chronic myeloid leukemia
178610|NCT02467270|Molecular Response|molecular response
178611|NCT02467270|CML|cml
178612|NCT02467270|Leukemia|leukemia
178613|NCT02467270|Leukemia, Myeloid|leukemia, myeloid
178614|NCT02467270|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
178615|NCT02467270|Neoplasms by Histologic Type|neoplasms by histologic type
178616|NCT02467270|Neoplasms|neoplasms
178617|NCT02467270|Myeloproliferative Disorders|myeloproliferative disorders
178618|NCT02467270|Bone Marrow Diseases|bone marrow diseases
178619|NCT02467270|Hematologic Diseases|hematologic diseases
178620|NCT02467270|CP-CML|cp-cml
178621|NCT02467244|Hypothyroidism|hypothyroidism
178622|NCT02467244|Serum adiponectin|serum adiponectin
178623|NCT02467244|hsCRP|hscrp
178624|NCT02467244|Homeostatic Model Assessment (HOMA-IR)|homeostatic model assessment (homa-ir)
178625|NCT02467244|Quantitative Insulin Sensitivity Check Index (QUICKI)|quantitative insulin sensitivity check index (quicki)
178728|NCT02466854|Acute Coronary Syndrome|acute coronary syndrome
178626|NCT02467244|Cardiovascular risk assessment scoring (Framingham scoring)|cardiovascular risk assessment scoring (framingham scoring)
178627|NCT02467244|Levothyroxin|levothyroxin
178628|NCT02467231|new diagnosis of cancer|new diagnosis of cancer
178629|NCT02467231|chemotherapy|chemotherapy
178630|NCT02467231|oncofertility|oncofertility
178631|NCT02467231|alkylating agent|alkylating agent
178632|NCT02467231|fertility preservation|fertility preservation
178633|NCT02467231|fertility after cancer|fertility after cancer
178634|NCT02467231|late effects|late effects
178635|NCT02467218|Hyperbaric Oxygen Treatment|hyperbaric oxygen treatment
178636|NCT02467218|Fibromyalgia|fibromyalgia
178637|NCT02467218|Global Function|global function
178638|NCT02467218|Sleep|sleep
178639|NCT02467218|Chronic Pain|chronic pain
178640|NCT02467218|Depression|depression
178641|NCT02467218|Anxiety|anxiety
178642|NCT02467205|Physical Activity|physical activity
178643|NCT02467179|Arrhythmia|arrhythmia
178644|NCT02467179|cavo-tricuspid isthmus|cavo-tricuspid isthmus
178645|NCT02467179|atrial fibrillation|atrial fibrillation
178646|NCT02467179|atrial fibrillation ablation|atrial fibrillation ablation
178647|NCT02467166|esophagoscopy|esophagoscopy
178648|NCT02467166|atrial fibrillation ablation|atrial fibrillation ablation
178649|NCT02467166|radio frequency catheter ablation|radio frequency catheter ablation
178650|NCT02467166|esophageal lesion|esophageal lesion
178651|NCT02467166|arrhythmia|arrhythmia
178652|NCT02467166|atrial fibrillation|atrial fibrillation
178653|NCT02467166|AF|af
178654|NCT02467166|esophageal damage|esophageal damage
178655|NCT02467153|Sarcopenia|sarcopenia
178656|NCT02467153|Older adult|older adult
178657|NCT02467153|Vitamin D|vitamin d
178658|NCT02467153|Physical activity|physical activity
178659|NCT02467153|Muscle atrophy|muscle atrophy
178660|NCT02467153|Muscle strength|muscle strength
178661|NCT02467153|Physical function|physical function
178662|NCT02467153|Frailty|frailty
178663|NCT02467153|Osteoporosis|osteoporosis
178664|NCT02467140|Inguinal hernia repair|inguinal hernia repair
178665|NCT02467140|Hernia|hernia
178666|NCT02467140|ProGrib self-fixating mesh|progrib self-fixating mesh
178667|NCT02467140|Biological mesh|biological mesh
178668|NCT02467140|Tack fixation|tack fixation
178669|NCT02467101|cicatricial alopecia|cicatricial alopecia
178670|NCT02467101|treatment|treatment
178671|NCT02467101|placebo|placebo
178672|NCT02467101|double-blind|double-blind
178673|NCT02467088|PMS|pms
178674|NCT02467088|Individualised homoeopathic treatment|individualised homoeopathic treatment
178675|NCT02467088|Indian females|indian females
178676|NCT02467075|CT, iodinated contrast, contrast-induced AKI, kidney injury|ct, iodinated contrast, contrast-induced aki, kidney injury
178677|NCT02467062|4D flow|4d flow
178678|NCT02467049|ECG|ecg
178679|NCT02467049|Ultrasound|ultrasound
178680|NCT02467049|Peripherally Inserted Central Catheters|peripherally inserted central catheters
178681|NCT02467049|PICC|picc
178682|NCT02467036|overweight children|overweight children
178683|NCT02467036|overweight parents|overweight parents
178684|NCT02467036|eating in the absence of hunger|eating in the absence of hunger
178685|NCT02467036|families with overweight child|families with overweight child
178686|NCT02467036|bmi|bmi
178687|NCT02467036|body mass index|body mass index
178688|NCT02467036|treatment|treatment
178689|NCT02467036|behavioral treatment|behavioral treatment
178690|NCT02467036|family based treatment|family based treatment
178691|NCT02467036|experiments|experiments
178692|NCT02467036|intervention|intervention
178693|NCT02467036|psychophysiological response to food cues|psychophysiological response to food cues
178694|NCT02467023|chronic critical illness|chronic critical illness
178695|NCT02467023|strength training|strength training
178696|NCT02467023|exercise|exercise
178697|NCT02467023|sepsis|sepsis
178698|NCT02467023|mechanical ventilation|mechanical ventilation
178699|NCT02467010|Bortezomib|bortezomib
178700|NCT02467010|cyclophosphamide|cyclophosphamide
178701|NCT02467010|dexamethason|dexamethason
178702|NCT02467010|multiple myeloma|multiple myeloma
178703|NCT02466997|Vitiligo|vitiligo
178704|NCT02466997|Tacrolimus|tacrolimus
178705|NCT02466997|Face|face
178706|NCT02466984|metoclopramide|metoclopramide
178707|NCT02466984|subcutaneous route|subcutaneous route
178708|NCT02466984|palliative care|palliative care
178709|NCT02466984|pharmacology|pharmacology
178710|NCT02466984|bioavailability|bioavailability
178711|NCT02466984|nausea|nausea
178712|NCT02466984|vomiting|vomiting
178713|NCT02466958|depressed|depressed
178714|NCT02466958|older adults|older adults
178715|NCT02466958|antidepressants|antidepressants
178716|NCT02466958|depression|depression
178717|NCT02466958|MDD|mdd
178718|NCT02466919|Helicobacter pylori|helicobacter pylori
178719|NCT02466906|Stage III colon cancer|stage iii colon cancer
178720|NCT02466906|rhGM-CSF|rhgm-csf
178721|NCT02466906|Immunotherapy|immunotherapy
178722|NCT02466906|Surgery|surgery
178723|NCT02466906|Adjuvant chemotherapy|adjuvant chemotherapy
178724|NCT02466880|Type 2|type 2
178725|NCT02466880|NIDDM|niddm
178726|NCT02466867|Ringworm|ringworm
178727|NCT02466854|Bleeding|bleeding
178729|NCT02466854|percutaneous coronary intervention|percutaneous coronary intervention
178730|NCT02466854|1 year follow up|1 year follow up
178731|NCT02466815|Healthy|healthy
178732|NCT02466815|JNJ-42756493|jnj-42756493
178733|NCT02466802|Advanced|advanced
178734|NCT02466789|Bleeding Disorder, inherited|bleeding disorder, inherited
178735|NCT02466789|Von Willebrands Disease|von willebrands disease
178736|NCT02466789|Hematologic Test|hematologic test
178737|NCT02466789|VWF|vwf
178738|NCT02466789|VWD|vwd
178739|NCT02466763|round window|round window
178740|NCT02466763|cochlear implants|cochlear implants
178741|NCT02466763|cochleostomy|cochleostomy
178742|NCT02466737|axillary surgery|axillary surgery
178743|NCT02466737|sentinel lymph node biopsy|sentinel lymph node biopsy
178744|NCT02466711|gastric motility|gastric motility
178745|NCT02466698|Colectomy|colectomy
178746|NCT02466698|Surgical Procedures, Operative|surgical procedures, operative
178747|NCT02466685|Bipolar|bipolar
178748|NCT02466685|Depression|depression
178749|NCT02466685|Cognition|cognition
178750|NCT02466685|Cognitive|cognitive
178751|NCT02466659|IXT|ixt
178752|NCT02466646|Periodontal Debridement|periodontal debridement
178753|NCT02466646|Gingival Crevicular Fluid|gingival crevicular fluid
178754|NCT02466646|Aggressive Periodontitis|aggressive periodontitis
178755|NCT02466646|Interleukin-1beta|interleukin-1beta
178756|NCT02466646|Interleukin-17|interleukin-17
178757|NCT02466620|Body Weight|body weight
178758|NCT02466620|Resuscitation|resuscitation
178759|NCT02466620|Pediatric weight estimation|pediatric weight estimation
178760|NCT02466607|Retinal function|retinal function
178761|NCT02466568|advanced|advanced
178762|NCT02466568|metastatic|metastatic
178763|NCT02466568|lung disease|lung disease
178764|NCT02466568|adenocarcinoma|adenocarcinoma
178765|NCT02466568|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
178766|NCT02466542|Esmolol|esmolol
178767|NCT02466542|Pain|pain
178768|NCT02466542|Anesthesia|anesthesia
178769|NCT02466542|Analgesia|analgesia
178770|NCT02466529|type 1 spinal muscular atrophy (SMA)|type 1 spinal muscular atrophy (sma)
178771|NCT02466516|GS-4997|gs-4997
178772|NCT02466516|Non-alcoholic fatty liver disease (NAFLD)|non-alcoholic fatty liver disease (nafld)
178773|NCT02466516|Fibrosis|fibrosis
178774|NCT02466516|Simtuzumab|simtuzumab
178775|NCT02466477|Pharmacogenomic|pharmacogenomic
178776|NCT02466477|Pharmacogenomic Testing|pharmacogenomic testing
178777|NCT02466477|Pharmacogenomics|pharmacogenomics
178778|NCT02466477|Genetic Testing|genetic testing
178779|NCT02466477|Genetics|genetics
178780|NCT02466477|Major Depressive Disorder|major depressive disorder
178781|NCT02466477|GeneSight|genesight
178782|NCT02466477|Enhanced GeneSight|enhanced genesight
178783|NCT02466477|Psychotropic|psychotropic
178784|NCT02466438|Antibiotics|antibiotics
178785|NCT02466438|Piperacillin-tazobactam|piperacillin-tazobactam
178786|NCT02466438|Resistant bacteria|resistant bacteria
178787|NCT02466412|smoking|smoking
178788|NCT02466412|nicotine absorption|nicotine absorption
178789|NCT02466412|potential modified risk tobacco product|potential modified risk tobacco product
178790|NCT02466412|cigarette|cigarette
178791|NCT02466412|Carbon Heated Tobacco Product|carbon heated tobacco product
178792|NCT02466373|clonidine|clonidine
178793|NCT02466373|pharmacodynamics|pharmacodynamics
178794|NCT02466373|pharmacokinetics|pharmacokinetics
178795|NCT02466373|intensive care|intensive care
178796|NCT02466373|delirium|delirium
178797|NCT02466360|Non-specific chronic lower back pain|non-specific chronic lower back pain
178798|NCT02466360|Physical activity|physical activity
178799|NCT02466360|Self-exercises|self-exercises
178800|NCT02466360|Brakes|brakes
178801|NCT02466360|Levers|levers
178802|NCT02466360|Adhesion|adhesion
178803|NCT02466360|Self-care|self-care
178804|NCT02466321|Inverse Reverse Shoulder|inverse reverse shoulder
178805|NCT02466308|sustained acoustic medicine|sustained acoustic medicine
178806|NCT02466308|therapeutic ultrasound|therapeutic ultrasound
178807|NCT02466308|SAM|sam
178808|NCT02466308|LITUS|litus
178809|NCT02466269|Facial Nerve Injuries|facial nerve injuries
178810|NCT02466256|Intraocular lens implantation|intraocular lens implantation
178811|NCT02466243|JBT-101, lenabasum, dermatomyositis|jbt-101, lenabasum, dermatomyositis
178812|NCT02466230|Magnetic stimulation of the brain|magnetic stimulation of the brain
178813|NCT02466230|Antidepressant mechanisms|antidepressant mechanisms
178814|NCT02466217|Auto-immune disease|auto-immune disease
178815|NCT02466217|Auto-inflammatory disease|auto-inflammatory disease
178816|NCT02466217|Omics|omics
178817|NCT02466217|System biology|system biology
178818|NCT02466191|nystagmus|nystagmus
178819|NCT02466191|pharmacological trial|pharmacological trial
178820|NCT02466191|multiple sclerosis|multiple sclerosis
178821|NCT02466191|oscillopsia|oscillopsia
178822|NCT02466165|cardiometabolic risk|cardiometabolic risk
178823|NCT02466165|physical exercise|physical exercise
178824|NCT02466152|PK|pk
178825|NCT02466152|GSK2894512|gsk2894512
178826|NCT02466152|Atopic Dermatitis|atopic dermatitis
178827|NCT02466139|microbiology|microbiology
178828|NCT02466139|c reactive protein|c reactive protein
178829|NCT02466139|urgent cardiac surgery|urgent cardiac surgery
178830|NCT02466126|Depression|depression
178831|NCT02466126|brief Cognitive Behavioral Therapy (bCBT)|brief cognitive behavioral therapy (bcbt)
178832|NCT02466126|Randomized Controlled Trial|randomized controlled trial
178833|NCT02466074|Acetazolamide|acetazolamide
178834|NCT02466074|Lesions|lesions
178835|NCT02466074|Neurodegeneration|neurodegeneration
178836|NCT02466074|Repair|repair
178837|NCT02466061|BMI >= 30 kg/m2|bmi >= 30 kg/m2
178838|NCT02466048|spinal fusion|spinal fusion
178839|NCT02466048|bone graft|bone graft
178840|NCT02466048|collagen|collagen
178841|NCT02466009|Colorectal cancer|colorectal cancer
178842|NCT02466009|metastatic colorectal cancer|metastatic colorectal cancer
178843|NCT02466009|colorectal adenocarcinoma|colorectal adenocarcinoma
178844|NCT02465996|barrier dysfunction|barrier dysfunction
178845|NCT02465996|functional dyspepsia|functional dyspepsia
178846|NCT02465996|Confocal Laser Endomicroscopic|confocal laser endomicroscopic
178847|NCT02465996|therapeutic response|therapeutic response
178848|NCT02465983|Pancreatic Cancer|pancreatic cancer
178849|NCT02465983|CAR / CART|car / cart
178850|NCT02465983|T cells|t cells
178851|NCT02465983|Immunotherapy|immunotherapy
178852|NCT02465983|Gene therapy|gene therapy
178853|NCT02465983|Redirected T cells|redirected t cells
178854|NCT02465983|Autologous T cells|autologous t cells
178855|NCT02465970|Transcranial Direct Current Stimulation|transcranial direct current stimulation
178856|NCT02465957|Merkel Cell Carcinoma|merkel cell carcinoma
178857|NCT02465957|Neukoplast|neukoplast
178858|NCT02465957|NK-92|nk-92
178859|NCT02465957|Natural Killer Cell|natural killer cell
178860|NCT02465957|MCC|mcc
178861|NCT02465957|aNK|ank
178862|NCT02465944|inflammation|inflammation
178863|NCT02465931|Informed Consent|informed consent
178864|NCT02465931|Fragile X Syndrome|fragile x syndrome
178865|NCT02465931|Tablets|tablets
178866|NCT02465931|Decisional Capacity|decisional capacity
178867|NCT02465892|cancer|cancer
178868|NCT02465892|stress|stress
178869|NCT02465892|chronic pain|chronic pain
178870|NCT02465892|anxiety|anxiety
178871|NCT02465892|coping|coping
178872|NCT02465892|balance|balance
178873|NCT02465892|online course|online course
178874|NCT02465892|psychosocial|psychosocial
178875|NCT02465892|support|support
178876|NCT02465892|tools|tools
178877|NCT02465879|Psoriatic arthritis|psoriatic arthritis
178878|NCT02465879|Ankylosing spondylitis|ankylosing spondylitis
178879|NCT02465879|Rheumatoid arthritis|rheumatoid arthritis
178880|NCT02465879|Seronegative|seronegative
178881|NCT02465866|Plasma concentration|plasma concentration
178882|NCT02465866|Time to plasma concentration|time to plasma concentration
178883|NCT02465866|Elimination rate constant|elimination rate constant
178884|NCT02465866|Elimination half life|elimination half life
178885|NCT02465866|Area under the curve|area under the curve
178886|NCT02465853|hemiplegic shoulder pain|hemiplegic shoulder pain
178887|NCT02465853|quality of Life|quality of life
178888|NCT02465853|stroke|stroke
178889|NCT02465840|rehabilitation|rehabilitation
178890|NCT02465840|functional MRI|functional mri
178891|NCT02465814|Uterine fibroids|uterine fibroids
178892|NCT02465814|Heavy Menstrual Bleeding|heavy menstrual bleeding
178893|NCT02465788|Helos|helos
178894|NCT02465788|Hair Removal|hair removal
178895|NCT02465788|Hair Reduction|hair reduction
178896|NCT02465775|non-invasive|non-invasive
178897|NCT02465762|non-invasive|non-invasive
178898|NCT02465749|Retinitis Pigmentosa|retinitis pigmentosa
178899|NCT02465749|oxygen|oxygen
178900|NCT02465749|blue light|blue light
178901|NCT02465723|Intravoxel Incoherent Motion (IVIM)|intravoxel incoherent motion (ivim)
178902|NCT02465723|Diffusion-weighted Magnetic Resonance|diffusion-weighted magnetic resonance
178903|NCT02465723|Acid Sphingomyelinase/Ceramide Pathway Activation|acid sphingomyelinase/ceramide pathway activation
178904|NCT02465723|15-104|15-104
178905|NCT02465710|pelvic organ prolapse|pelvic organ prolapse
178906|NCT02465710|pelvic floor reconstruction surgery|pelvic floor reconstruction surgery
178907|NCT02465710|transvaginal mesh surgery|transvaginal mesh surgery
178908|NCT02465710|Women|women
178909|NCT02465710|Surgical treatment|surgical treatment
178910|NCT02465697|Borderline Personality Disorder|borderline personality disorder
178911|NCT02465697|Avoidant Personality Disorder|avoidant personality disorder
178912|NCT02465697|Brain Imaging|brain imaging
178913|NCT02465658|uterine prolapse|uterine prolapse
178914|NCT02465658|cervical elongation|cervical elongation
178915|NCT02465658|pelvic floor reconstruction surgery|pelvic floor reconstruction surgery
178916|NCT02465541|Cancer Survivors|cancer survivors
178918|NCT02465541|Endometrial Cancer|endometrial cancer
178919|NCT02465528|ALK|alk
178920|NCT02465528|NSCLC|nsclc
178921|NCT02465528|hematological malignancy|hematological malignancy
178922|NCT02465515|cardiovascular events /outcomes|cardiovascular events /outcomes
178923|NCT02465515|Type 2 diabetes mellitus|type 2 diabetes mellitus
178924|NCT02465515|albiglutide|albiglutide
178925|NCT02465515|glucagon-like peptide-1 receptor agonist|glucagon-like peptide-1 receptor agonist
178926|NCT02465502|Colorectal cancer|colorectal cancer
178927|NCT02465502|Regorafenib|regorafenib
178929|NCT02465489|deferiprone extended release formulation|deferiprone extended release formulation
178930|NCT02465489|pharmacokinetics|pharmacokinetics
178931|NCT02465476|skin disease|skin disease
178932|NCT02465476|telemedicine|telemedicine
178933|NCT02465463|fecal microbiota transplant|fecal microbiota transplant
178934|NCT02465463|probiotic|probiotic
178935|NCT02465450|JBT-101, Lenabasum, Cystic Fibrosis|jbt-101, lenabasum, cystic fibrosis
178936|NCT02465424|quality of life questionnaires|quality of life questionnaires
178937|NCT02465398|Fracture shoulder arthroplasty|fracture shoulder arthroplasty
178938|NCT02465398|Three or four part fracture|three or four part fracture
178939|NCT02465398|Hemiarthroplasty|hemiarthroplasty
178940|NCT02465398|Multi-center|multi-center
178941|NCT02465398|Europe|europe
178942|NCT02465398|Non-controlled|non-controlled
178943|NCT02465398|Anatomical reconstruction|anatomical reconstruction
178944|NCT02465398|Proximal|proximal
178945|NCT02465372|Physical Activity|physical activity
178946|NCT02465372|Youth|youth
178947|NCT02465372|School Health|school health
178948|NCT02465346|acute stroke|acute stroke
178949|NCT02465346|prehospital|prehospital
178950|NCT02465346|treatment|treatment
178951|NCT02465333|heel|heel
178952|NCT02465333|atrophy|atrophy
178953|NCT02465333|fat|fat
178954|NCT02465333|adipose tissue|adipose tissue
178955|NCT02465333|fat pad|fat pad
178956|NCT02465307|Consciousness|consciousness
178957|NCT02465307|Alertness|alertness
178958|NCT02465307|Cognition|cognition
178959|NCT02465307|Activity level|activity level
178960|NCT02465307|Delirium|delirium
178961|NCT02465307|Hyperactive delirium|hyperactive delirium
178962|NCT02465307|Hypoactive delirium|hypoactive delirium
178963|NCT02465307|Facial expression|facial expression
178964|NCT02465307|Posture|posture
178965|NCT02465307|Intensive care unit|intensive care unit
178966|NCT02465294|Probiotics|probiotics
178967|NCT02465294|Weight loss|weight loss
178968|NCT02465294|Body composition|body composition
178969|NCT02465255|Acute Abdominal Pain|acute abdominal pain
178970|NCT02465255|Sublingual Analgesia|sublingual analgesia
178971|NCT02465255|Children|children
178972|NCT02465255|Ketorolac|ketorolac
178973|NCT02465255|Tramadol|tramadol
178974|NCT02465255|Paracetamol|paracetamol
178975|NCT02465255|Analgesia|analgesia
178976|NCT02465216|Tuberculosis|tuberculosis
178977|NCT02465216|TB|tb
178978|NCT02465216|Pulmonary|pulmonary
178979|NCT02465216|Vaccine|vaccine
178980|NCT02465216|Adjuvant|adjuvant
178981|NCT02465203|Hepatitis C, chronic|hepatitis c, chronic
178982|NCT02465190|Vaccine|vaccine
178983|NCT02465190|Effectiveness|effectiveness
178984|NCT02465190|Influenza|influenza
178985|NCT02465177|Unhealthy alcohol use|unhealthy alcohol use
178986|NCT02465177|ICU survivors|icu survivors
178987|NCT02465177|Alcohol use disorder|alcohol use disorder
178988|NCT02465177|SBIRT|sbirt
178989|NCT02465177|Screening, brief intervention, and referral to treatment|screening, brief intervention, and referral to treatment
178990|NCT02465034|Neural plasticity|neural plasticity
178991|NCT02465034|Noninvasive brain stimulation|noninvasive brain stimulation
178992|NCT02465034|Motor cortex|motor cortex
178993|NCT02465021|Satiety|satiety
178994|NCT02465021|Food intake|food intake
178995|NCT02465021|Breakfast cereals/snacks|breakfast cereals/snacks
178996|NCT02465021|Postprandial glycemia|postprandial glycemia
178997|NCT02465008|postoperative|postoperative
178998|NCT02465008|Patient-reported|patient-reported
178999|NCT02464995|Asthma,|asthma,
179000|NCT02464995|Asthma exacerbation|asthma exacerbation
179001|NCT02464995|Bronchial thermoplasty|bronchial thermoplasty
179002|NCT02464969|VTE, thromboembolism, thrombosis, embolism, apixaban, Eliquis|vte, thromboembolism, thrombosis, embolism, apixaban, eliquis
179003|NCT02464943|Aorta|aorta
179004|NCT02464943|Thoracic|thoracic
179005|NCT02464943|Aortic dissection|aortic dissection
179006|NCT02464943|Type B|type b
179007|NCT02464943|DeBakey type III|debakey type iii
179008|NCT02464943|Endovascular|endovascular
179009|NCT02464930|Blood|blood
179010|NCT02464930|Cytology|cytology
179011|NCT02464930|Esophagus|esophagus
179012|NCT02464930|microRNA|microrna
179013|NCT02464891|Atypical Hemolytic Uremic Syndrome|atypical hemolytic uremic syndrome
179014|NCT02464891|CCX168|ccx168
179015|NCT02464891|dialysis|dialysis
179016|NCT02464891|C5aR antagonist|c5ar antagonist
179017|NCT02464865|thiamine deficiency|thiamine deficiency
179018|NCT02464865|obese children|obese children
179019|NCT02464865|Thai|thai
179020|NCT02464839|Fungal nails and feet infection|fungal nails and feet infection
179021|NCT02464839|Onychomycosis|onychomycosis
179022|NCT02464839|Hallux valgus|hallux valgus
179023|NCT02464826|Onychomycosis|onychomycosis
179024|NCT02464826|Chronic paronychia|chronic paronychia
179025|NCT02464826|Treatment|treatment
179026|NCT02464813|pregabalin|pregabalin
179027|NCT02464813|idiopathic scoliosis|idiopathic scoliosis
179028|NCT02464800|diabetic retinopathy|diabetic retinopathy
179029|NCT02464787|antioxidants|antioxidants
179030|NCT02464787|carotenoids|carotenoids
179031|NCT02464787|diet|diet
179032|NCT02464774|Breast Cancer|breast cancer
179033|NCT02464774|Triple-Negative Breast Cancer|triple-negative breast cancer
179034|NCT02464774|Breast-Conserving Therapy|breast-conserving therapy
179035|NCT02464774|Mastectomy|mastectomy
179036|NCT02464774|Recurrence|recurrence
179037|NCT02464735|Sleep disruption|sleep disruption
179038|NCT02464735|Spontaneous breathing trial|spontaneous breathing trial
179039|NCT02464735|Weaning|weaning
179040|NCT02464722|Remifentanil|remifentanil
179041|NCT02464722|Dexmedetomidine|dexmedetomidine
179042|NCT02464722|Endoscopic sinus surgery|endoscopic sinus surgery
179043|NCT02464709|Actinic Keratosis|actinic keratosis
179044|NCT02464709|Photodynamic Therapy|photodynamic therapy
179045|NCT02464709|Natural Daylight|natural daylight
179046|NCT02464696|Hematological Malignancies|hematological malignancies
179047|NCT02464696|Hypoxemic Respiratory Failure|hypoxemic respiratory failure
179048|NCT02464696|Blood cancer|blood cancer
179049|NCT02464696|Non-invasive positive pressure ventilation|non-invasive positive pressure ventilation
179050|NCT02464696|NIPPV|nippv
179051|NCT02464696|High flow nasal cannula oxygen therapy|high flow nasal cannula oxygen therapy
179052|NCT02464670|Ebola|ebola
179053|NCT02464670|Vaccine|vaccine
179054|NCT02464657|Leukemia|leukemia
179055|NCT02464657|Acute myeloid leukemia|acute myeloid leukemia
179056|NCT02464657|AML|aml
179057|NCT02464657|Myelodysplastic Syndrome|myelodysplastic syndrome
179058|NCT02464657|MDS|mds
179059|NCT02464657|High-risk|high-risk
179060|NCT02464657|Nivolumab|nivolumab
179061|NCT02464657|BMS-936558|bms-936558
179062|NCT02464657|Opdivo|opdivo
179063|NCT02464657|Idarubicin|idarubicin
179064|NCT02464657|Idamycin|idamycin
179065|NCT02464657|Cytarabine|cytarabine
179066|NCT02464657|Ara-C|ara-c
179067|NCT02464657|Cytosar|cytosar
179068|NCT02464657|DepoCyt|depocyt
179069|NCT02464657|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
179070|NCT02464657|Solu-Medrol|solu-medrol
179071|NCT02464657|Methylprednisolone|methylprednisolone
179072|NCT02464657|Depo-Medrol|depo-medrol
179073|NCT02464657|Medrol|medrol
179074|NCT02464657|Dexamethasone|dexamethasone
179075|NCT02464657|Decadron|decadron
179076|NCT02464644|On-line Questionnaire|on-line questionnaire
179077|NCT02464644|No travel|no travel
179078|NCT02464644|Health|health
179079|NCT02464644|Medicines|medicines
179080|NCT02464644|Drugs|drugs
179081|NCT02464644|Lifestyle|lifestyle
179082|NCT02464644|Family|family
179083|NCT02464644|Help for others|help for others
179084|NCT02464644|Rare condition|rare condition
179085|NCT02464644|General population|general population
179086|NCT02464618|Colonoscopy|colonoscopy
179087|NCT02464618|Upper endoscopy|upper endoscopy
179088|NCT02464618|Adherence|adherence
179089|NCT02464618|Disparities|disparities
179090|NCT02464592|Cryoprobes|cryoprobes
179091|NCT02464592|Transbronchial lung biopsy|transbronchial lung biopsy
179092|NCT02464592|Cryobiopsy|cryobiopsy
179093|NCT02464579|breastfeeding rate|breastfeeding rate
179094|NCT02464579|preterm infant|preterm infant
179095|NCT02464579|neonatal intensive care unit|neonatal intensive care unit
179096|NCT02464553|Low Back Pain Pain|low back pain pain
179097|NCT02464553|Periradicular therapy|periradicular therapy
179098|NCT02464553|Spinal Stenosis with neurologic changes|spinal stenosis with neurologic changes
179099|NCT02464540|laminate veneers|laminate veneers
179100|NCT02464540|luting agent|luting agent
179101|NCT02464527|Stimulus-stimulus pairing|stimulus-stimulus pairing
179102|NCT02464514|Obesity|obesity
179103|NCT02464514|Orexigen|orexigen
179104|NCT02464514|Insulin|insulin
179105|NCT02464514|Leptin|leptin
179106|NCT02464514|Adiponectin|adiponectin
179107|NCT02464514|Growth hormone replacement|growth hormone replacement
179108|NCT02464501|PAD|pad
179109|NCT02464501|COPPER-A|copper-a
179110|NCT02464501|Peripheral Arterial Disease|peripheral arterial disease
179111|NCT02464501|OPC|opc
179112|NCT02464501|Occlusion Perfusion Catheter|occlusion perfusion catheter
179113|NCT02464501|Paclitaxel|paclitaxel
179114|NCT02464501|Pressana|pressana
179115|NCT02464501|Precision Delivery System|precision delivery system
179116|NCT02464488|Anticoagulants|anticoagulants
179117|NCT02464488|Factor Xa Inhibitors|factor xa inhibitors
179118|NCT02464488|Antithrombins|antithrombins
179119|NCT02464488|Pharmacokinetics|pharmacokinetics
179120|NCT02464488|Aged, 80 years and older|aged, 80 years and older
179121|NCT02464475|osteopathic manipulative treatment|osteopathic manipulative treatment
179122|NCT02464475|interoception|interoception
179123|NCT02464462|serum calcidiol|serum calcidiol
179124|NCT02464462|T2DM|t2dm
179125|NCT02464462|vitamin D3 supplementation|vitamin d3 supplementation
179126|NCT02464462|post-menopausal women|post-menopausal women
179127|NCT02464462|ethnic diverse|ethnic diverse
179128|NCT02464462|calcium supplementation|calcium supplementation
179129|NCT02464449|Cognitive Behavioral Therapy|cognitive behavioral therapy
179130|NCT02464449|Mobile Health Technology|mobile health technology
179131|NCT02464449|Patient Care Management|patient care management
179132|NCT02464436|RP|rp
179133|NCT02464410|Opioid analgesics|opioid analgesics
179134|NCT02464410|Primary care|primary care
179135|NCT02464410|Veterans|veterans
179136|NCT02464410|Motivational interviewing|motivational interviewing
179137|NCT02464410|Cognitive behavioral therapy|cognitive behavioral therapy
179138|NCT02464410|Self-efficacy|self-efficacy
179139|NCT02464410|Behavioral symptoms|behavioral symptoms
179140|NCT02464410|Injuries|injuries
179141|NCT02464410|Opioid Safety|opioid safety
179142|NCT02464397|Vascular healing of coronary stents in patients with acute coronary syndrome|vascular healing of coronary stents in patients with acute coronary syndrome
179143|NCT02464384|ultrasound and cartilage biodegradation markers|ultrasound and cartilage biodegradation markers
179144|NCT02464371|muscle weakness|muscle weakness
179145|NCT02464371|microRNAs|micrornas
179146|NCT02464371|septic shock|septic shock
179147|NCT02464358|HPV|hpv
179148|NCT02464345|BED|bed
179149|NCT02464345|Binge Eating Disorer|binge eating disorer
179150|NCT02464345|BN|bn
179151|NCT02464345|Bulimia Nervosa|bulimia nervosa
179152|NCT02464345|Obesity|obesity
179153|NCT02464332|soft tissue sarcoma|soft tissue sarcoma
179154|NCT02464332|BLZ-100|blz-100
179155|NCT02464332|Tumor Paint|tumor paint
179156|NCT02464306|recipients|recipients
179157|NCT02464293|depression|depression
179158|NCT02464293|anxiety|anxiety
179159|NCT02464293|stress|stress
179160|NCT02464280|Tomosynthesis|tomosynthesis
179161|NCT02464280|osteosynthetic implant|osteosynthetic implant
179162|NCT02464280|CT|ct
179163|NCT02464280|monitoring|monitoring
179164|NCT02464267|patient reported outcome instrument|patient reported outcome instrument
179165|NCT02464254|Physical activity, positive affect, older adults, aging|physical activity, positive affect, older adults, aging
179166|NCT02464228|PTCL|ptcl
179167|NCT02464228|Lymphoma|lymphoma
179168|NCT02464228|AITL|aitl
179169|NCT02464215|gastric cancer|gastric cancer
179170|NCT02464215|D2|d2
179171|NCT02464215|laparoscopic|laparoscopic
179172|NCT02464215|open|open
179173|NCT02464215|surgery|surgery
179174|NCT02464202|Tooth autotransplantation|tooth autotransplantation
179175|NCT02464202|stereolithography tooth replica|stereolithography tooth replica
179176|NCT02464202|CBCT|cbct
179177|NCT02464202|Outcome|outcome
179178|NCT02464176|Arthroplasty, Hip, Replacement|arthroplasty, hip, replacement
179179|NCT02464176|Anesthesia, Local|anesthesia, local
179180|NCT02464176|Anesthesia Conduction|anesthesia conduction
179181|NCT02464176|Bupivacaine|bupivacaine
179182|NCT02464176|Dexamethasone|dexamethasone
179183|NCT02464176|Preanesthetic Medications|preanesthetic medications
179184|NCT02464176|Nerve Block|nerve block
179185|NCT02464176|Lumbar Plexus Block|lumbar plexus block
179186|NCT02464176|Analgesia|analgesia
179187|NCT02464176|Glucocorticoids|glucocorticoids
179188|NCT02464176|Local Anesthetics|local anesthetics
179189|NCT02464163|Influenza|influenza
179190|NCT02464150|gluten|gluten
179191|NCT02464150|antigen-specific T cells|antigen-specific t cells
179192|NCT02464150|transcriptome|transcriptome
179193|NCT02464098|Hematological Malignancies|hematological malignancies
179194|NCT02464098|Solid Tumors|solid tumors
179195|NCT02464098|Hematopoietic Stem Cell Transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
179196|NCT02464098|Childhood Cancer|childhood cancer
179197|NCT02464098|Polymerase Chain Reaction (PCR)|polymerase chain reaction (pcr)
179198|NCT02464085|Stroke|stroke
179199|NCT02464085|Upper limb|upper limb
179200|NCT02464085|Neuroplastic change|neuroplastic change
179201|NCT02464085|Longitudinal|longitudinal
179202|NCT02464085|Function|function
179203|NCT02464072|Parathyroidectomy|parathyroidectomy
179204|NCT02464072|Renal Insufficiency, Chronic|renal insufficiency, chronic
179205|NCT02464059|cathelicidin|cathelicidin
179206|NCT02464059|vitamin D|vitamin d
179207|NCT02464046|Insomnia|insomnia
179208|NCT02464046|JNJ-42847922|jnj-42847922
179209|NCT02464046|Placebo|placebo
179210|NCT02464033|Diamyd|diamyd
179211|NCT02464033|Diabetes|diabetes
179212|NCT02464033|Juvenile Diabetes|juvenile diabetes
179213|NCT02464033|Diabetes Type 1|diabetes type 1
179214|NCT02464033|Type 1 Diabetes|type 1 diabetes
179215|NCT02464033|Autoimmune Diabetes|autoimmune diabetes
179216|NCT02464033|Insulin Dependent Diabetes|insulin dependent diabetes
179217|NCT02464033|Type 1 Diabetes MellitusType 1 Diabetes Mellitus|type 1 diabetes mellitustype 1 diabetes mellitus
179218|NCT02464033|rhGAD65|rhgad65
179219|NCT02464033|GAD65|gad65
179220|NCT02464033|GAD-Alum|gad-alum
179221|NCT02464033|Diabetes Mellitus|diabetes mellitus
179222|NCT02464033|Diabetes mellitus Type 1|diabetes mellitus type 1
179223|NCT02464033|Glucose Metabolism Disorders|glucose metabolism disorders
179224|NCT02464033|Metabolic Diseases|metabolic diseases
179225|NCT02464033|Vitamin D|vitamin d
179226|NCT02464033|Etanercept|etanercept
179227|NCT02463955|flexible endoscopy|flexible endoscopy
179228|NCT02463929|Diphenhydramine|diphenhydramine
179229|NCT02463929|emergence agitation|emergence agitation
179230|NCT02463929|pediatric anesthesia|pediatric anesthesia
179231|NCT02463929|PAEDS|paeds
179232|NCT02463929|Withdrawal|withdrawal
179233|NCT02463903|Adaptation, Psychological|adaptation, psychological
179234|NCT02463903|Heart Failure|heart failure
179235|NCT02463903|Intervention Studies|intervention studies
179236|NCT02463903|Quality of Life|quality of life
179237|NCT02463903|Hospital Readmission|hospital readmission
179238|NCT02463903|Depression|depression
179239|NCT02463903|Anxiety|anxiety
179240|NCT02463890|Sleep Apnea Syndromes|sleep apnea syndromes
179241|NCT02463890|Sleep Apnea, Obstructives|sleep apnea, obstructives
179242|NCT02463890|Training|training
179243|NCT02463864|frailty|frailty
179244|NCT02463864|older adult|older adult
179245|NCT02463864|hospital|hospital
179246|NCT02463864|exercise|exercise
179247|NCT02463864|randomised control trial|randomised control trial
179248|NCT02463864|functional decline|functional decline
179249|NCT02463851|Ablation|ablation
179250|NCT02463851|Multi-electrode catheter PVAC|multi-electrode catheter pvac
179251|NCT02463851|Single-tip catheter Contact Force|single-tip catheter contact force
179252|NCT02463851|Holter|holter
179253|NCT02463838|Medi-Cal|medi-cal
179254|NCT02463838|Health Plan|health plan
179255|NCT02463838|Frequent Users|frequent users
179256|NCT02463838|Heavy users|heavy users
179257|NCT02463838|Care Coordination|care coordination
179258|NCT02463838|Managed Care|managed care
179259|NCT02463838|Case Management|case management
179260|NCT02463838|Mental Health|mental health
179261|NCT02463838|Substance Use|substance use
179262|NCT02463838|Emergency Department|emergency department
179263|NCT02463799|prostatic neoplasms|prostatic neoplasms
179264|NCT02463799|castration-resistant|castration-resistant
179265|NCT02463799|bone metastasis|bone metastasis
179266|NCT02463799|radium-223|radium-223
179267|NCT02463799|sipuleucel-T|sipuleucel-t
179268|NCT02463773|ARDS, PEEP, Critical Care Ultrasound|ards, peep, critical care ultrasound
179269|NCT02463747|Neutropenic fever|neutropenic fever
179270|NCT02463747|extended infusion|extended infusion
179271|NCT02463747|beta-lactam|beta-lactam
179272|NCT02463747|empiric antibiotic treatment|empiric antibiotic treatment
179273|NCT02463721|sbp|sbp
179274|NCT02463721|culture|culture
179275|NCT02463708|Care Giver|care giver
179276|NCT02463708|Dementia|dementia
179277|NCT02463695|partial vestibular deficit|partial vestibular deficit
179278|NCT02463695|cortical vestibular evoked potential|cortical vestibular evoked potential
179279|NCT02463682|Artificial Pancreas|artificial pancreas
179280|NCT02463682|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
179281|NCT02463682|Autoimmune Diseases|autoimmune diseases
179282|NCT02463682|Diabetes Mellitus|diabetes mellitus
179283|NCT02463682|Endocrine System Diseases|endocrine system diseases
179284|NCT02463682|Glucose Metabolism Disorders|glucose metabolism disorders
179285|NCT02463682|Immune System Diseases|immune system diseases
179286|NCT02463682|Metabolic Diseases|metabolic diseases
179287|NCT02463669|Point-of-care ultrasound|point-of-care ultrasound
179288|NCT02463630|basilar invagination|basilar invagination
179289|NCT02463630|atlantoaxial dislocation|atlantoaxial dislocation
179290|NCT02463630|surgery|surgery
179291|NCT02463630|restoration technique|restoration technique
179292|NCT02463591|Direct Thrombin Inhibitor|direct thrombin inhibitor
179293|NCT02463591|Prothrombin Complex Concentrate|prothrombin complex concentrate
179294|NCT02463591|Dabigatran Etexilate|dabigatran etexilate
179295|NCT02463591|Beriplex|beriplex
179296|NCT02463591|Shed Blood|shed blood
179297|NCT02463591|Washed Blood|washed blood
179298|NCT02463591|Fibrinopeptide A|fibrinopeptide a
179299|NCT02463578|Pneumococcal infection|pneumococcal infection
179300|NCT02463578|Invasive pneumococcal disease (IPD)|invasive pneumococcal disease (ipd)
179301|NCT02463578|Pneumococcal vaccine|pneumococcal vaccine
179302|NCT02463578|Vaccinology|vaccinology
179303|NCT02463578|Immunocompromised|immunocompromised
179304|NCT02463578|Auto-immune diseases|auto-immune diseases
179305|NCT02463578|Systemic vasculitis|systemic vasculitis
179306|NCT02463578|ANCA-associated vasculitis|anca-associated vasculitis
179307|NCT02463565|nutritional assessment|nutritional assessment
179308|NCT02463565|food survey|food survey
179309|NCT02463565|hospitalized patients|hospitalized patients
179310|NCT02463565|hospital food|hospital food
179311|NCT02463539|Pneumococcal infection|pneumococcal infection
179312|NCT02463539|Invasive pneumococcal disease (IPD)|invasive pneumococcal disease (ipd)
179313|NCT02463539|Pneumococcal vaccine|pneumococcal vaccine
179314|NCT02463539|Systemic vasculitis|systemic vasculitis
179315|NCT02463539|ANCA-associated vasculitis|anca-associated vasculitis
179316|NCT02463539|Vaccinology|vaccinology
179317|NCT02463539|Immunocompromised|immunocompromised
179318|NCT02463539|Auto-immune disease|auto-immune disease
179319|NCT02463526|Shoulder Impingement Syndrome|shoulder impingement syndrome
179320|NCT02463526|Mulligan's Mobilization with Movement|mulligan's mobilization with movement
179321|NCT02463526|Physical Therapy|physical therapy
179322|NCT02463513|Riboflavin|riboflavin
179323|NCT02463513|Blood pressure|blood pressure
179324|NCT02463513|MTHFR|mthfr
179325|NCT02463513|Methylenetetrahydrofolate reductase|methylenetetrahydrofolate reductase
179326|NCT02463448|Underactive Bladder|underactive bladder
179327|NCT02463435|nutritional management|nutritional management
179328|NCT02463435|olive oil|olive oil
179329|NCT02463435|weight loss|weight loss
179330|NCT02463435|body composition|body composition
179331|NCT02463435|nutrigenomics|nutrigenomics
179332|NCT02463435|polymorphisms|polymorphisms
179333|NCT02463435|cardiovascular risk|cardiovascular risk
179334|NCT02463435|sarcopenia|sarcopenia
179335|NCT02463435|inflammation|inflammation
179336|NCT02463435|food intake|food intake
179337|NCT02463435|sedentary lifestyle|sedentary lifestyle
179338|NCT02463435|patient adherence|patient adherence
179339|NCT02463435|bone density|bone density
179340|NCT02463396|MBCT|mbct
179341|NCT02463396|Mindfulness|mindfulness
179342|NCT02463396|ADHD|adhd
179343|NCT02463383|PPAR-gamma|ppar-gamma
179344|NCT02463383|estrogens|estrogens
179345|NCT02463383|NSAIDS|nsaids
179346|NCT02463383|polymorphism|polymorphism
179347|NCT02463383|metabolomics|metabolomics
179348|NCT02463357|Exercise, Aerobic|exercise, aerobic
179349|NCT02463357|Cognitive Function|cognitive function
179350|NCT02463344|Dry AMD|dry amd
179351|NCT02463344|Geographic atrophy|geographic atrophy
179352|NCT02463344|ASP7316|asp7316
179353|NCT02463331|autoimmune hepatitis|autoimmune hepatitis
179354|NCT02463331|chloroquine|chloroquine
179355|NCT02463331|treatment|treatment
179356|NCT02463318|Multiple sclerosis|multiple sclerosis
179357|NCT02463318|SIRT1|sirt1
179358|NCT02463318|MnSOD|mnsod
179359|NCT02463318|Catalase|catalase
179360|NCT02463318|Oxidative stress|oxidative stress
179361|NCT02463318|Antioxidant enzyme|antioxidant enzyme
179362|NCT02463305|Colitis, ulcerative|colitis, ulcerative
179363|NCT02463305|Inflammatory bowel diseases|inflammatory bowel diseases
179364|NCT02463292|quality of life|quality of life
179365|NCT02463292|young adults|young adults
179366|NCT02463292|congenital heart disease|congenital heart disease
179367|NCT02463266|Primary Care|primary care
179368|NCT02463266|Elderly|elderly
179369|NCT02463266|Depression|depression
179370|NCT02463253|Renal Biopsy|renal biopsy
179371|NCT02463253|elevated serum creatinine|elevated serum creatinine
179372|NCT02463253|proteinuria|proteinuria
179373|NCT02463201|Sleep Apnea, Obstructive|sleep apnea, obstructive
179374|NCT02463201|Pediatric Obesity|pediatric obesity
179375|NCT02463188|Sleep|sleep
179376|NCT02463188|Substance Use|substance use
179377|NCT02463188|Adolescents|adolescents
179378|NCT02463175|Fluid Therapy;|fluid therapy;
179379|NCT02463175|Transesophageal Doppler|transesophageal doppler
179380|NCT02463149|School health|school health
179381|NCT02463136|Adolescence|adolescence
179382|NCT02463136|Brain Development|brain development
179383|NCT02463136|Neuroimaging|neuroimaging
179384|NCT02463136|Neurofeedback|neurofeedback
179385|NCT02463136|Anxiety|anxiety
179386|NCT02463110|Acute Coronary Syndrome|acute coronary syndrome
179387|NCT02463110|Depression|depression
179388|NCT02463110|Coronary Artery Disease|coronary artery disease
179389|NCT02463110|Myocardial Infarction|myocardial infarction
179390|NCT02463110|Percutaneous Coronary Intervention|percutaneous coronary intervention
179391|NCT02463019|hepatitis B virus|hepatitis b virus
179392|NCT02463019|tenofovir|tenofovir
179393|NCT02462967|Liver Cirrhosis|liver cirrhosis
179394|NCT02462954|Contraception|contraception
179395|NCT02462954|Vaginal Gel|vaginal gel
179396|NCT02462954|Diaphragm|diaphragm
179397|NCT02462941|Heart transplant|heart transplant
179398|NCT02462941|Adenosine|adenosine
179399|NCT02462941|Pediatrics|pediatrics
179400|NCT02462863|Diabetes|diabetes
179401|NCT02462863|fish oil|fish oil
179402|NCT02462863|arginine|arginine
179403|NCT02462863|hyperglycemia|hyperglycemia
179404|NCT02462850|Pain|pain
179405|NCT02462850|Nausea|nausea
179406|NCT02462850|Vomiting|vomiting
179407|NCT02462837|Ureteral Stents|ureteral stents
179408|NCT02462837|Pain and Discomfort|pain and discomfort
179409|NCT02462837|Bladder Storage Symptoms|bladder storage symptoms
179410|NCT02462824|Peripheral Artery Disease|peripheral artery disease
179411|NCT02462824|Peripheral Arterial Disease|peripheral arterial disease
179412|NCT02462824|PAD|pad
179413|NCT02462811|Pain|pain
179414|NCT02462811|Nausea|nausea
179415|NCT02462811|Vomiting|vomiting
179416|NCT02462785|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
179417|NCT02462785|Adolescents|adolescents
179418|NCT02462785|Carbohydrate Counting|carbohydrate counting
179419|NCT02462785|Glycemic Control|glycemic control
179420|NCT02462785|Self-Management|self-management
179421|NCT02462785|T1DM|t1dm
179422|NCT02462772|Cabotegravir|cabotegravir
179423|NCT02462772|safety|safety
179424|NCT02462772|long-acting injectable|long-acting injectable
179425|NCT02462772|HIV prevention|hiv prevention
179426|NCT02462772|acceptability|acceptability
179427|NCT02462759|EMBRACE|embrace
179428|NCT02462759|Spinal Muscular Atrophy|spinal muscular atrophy
179429|NCT02462759|SMA|sma
179430|NCT02462746|Postpartum|postpartum
179431|NCT02462746|Dietary Supplements|dietary supplements
179432|NCT02462746|Breastfeeding Women|breastfeeding women
179433|NCT02462733|Self-control|self-control
179434|NCT02462733|Preschoolers|preschoolers
179435|NCT02462733|Tools of the Mind|tools of the mind
179436|NCT02462733|Playing to Learn|playing to learn
179437|NCT02462681|ketamine|ketamine
179438|NCT02462681|adjuvant|adjuvant
179439|NCT02462681|paravertebral block|paravertebral block
179440|NCT02462668|Bronchoscopy|bronchoscopy
179441|NCT02462668|Intubation|intubation
179442|NCT02462668|Noninvasive positive pressure ventilation|noninvasive positive pressure ventilation
179443|NCT02462642|Brahmi, Cognition, Anxiety, Pharmacokinetics|brahmi, cognition, anxiety, pharmacokinetics
179444|NCT02462629|central nervous system tumor|central nervous system tumor
179445|NCT02462629|BLZ-100|blz-100
179446|NCT02462629|pediatrics|pediatrics
179447|NCT02462629|Tumor Paint|tumor paint
179448|NCT02462629|brain cancer|brain cancer
179449|NCT02462629|tozuleristide|tozuleristide
179450|NCT02462616|risk analysis|risk analysis
179451|NCT02462616|general Chinese population|general chinese population
179452|NCT02462616|cardiovascular autonomic neuropathy|cardiovascular autonomic neuropathy
179453|NCT02462603|Parkinson's Disease|parkinson's disease
179454|NCT02462603|PD|pd
179455|NCT02462603|EPI-589|epi-589
179456|NCT02462603|EPI589|epi589
179457|NCT02462590|Probiotics|probiotics
179458|NCT02462590|Ventilator Associated Pneumonia|ventilator associated pneumonia
179459|NCT02462590|Infections|infections
179460|NCT02462590|C-Difficile|c-difficile
179461|NCT02462590|Antibiotic-associated Diarrhea|antibiotic-associated diarrhea
179462|NCT02462590|Diarrhea|diarrhea
179463|NCT02462577|Local morphine|local morphine
179464|NCT02462577|Postmastectomy pain|postmastectomy pain
179465|NCT02462564|peritoneal surface malignancies|peritoneal surface malignancies
179466|NCT02462564|Post operative cognitive dysfunction|post operative cognitive dysfunction
179467|NCT02462551|Depression|depression
179468|NCT02462551|Treatment Resistant Depression|treatment resistant depression
179469|NCT02462525|relapsed multiple myeloma|relapsed multiple myeloma
179470|NCT02462525|antibody drug conjugate|antibody drug conjugate
179471|NCT02462525|refractory multiple myeloma|refractory multiple myeloma
179472|NCT02462512|Elastography|elastography
179473|NCT02462512|Thyroid nodule|thyroid nodule
179474|NCT02462473|Schizophrenia|schizophrenia
179475|NCT02462473|Schizoaffective Disorder|schizoaffective disorder
179476|NCT02462473|Aripiprazole|aripiprazole
179477|NCT02462473|Olanzapine|olanzapine
179478|NCT02462473|Paliperidone|paliperidone
179479|NCT02462473|Quetiapine|quetiapine
179480|NCT02462473|Risperidone|risperidone
179481|NCT02462473|Liquid Chromatography-Tandem Mass Spectrometry|liquid chromatography-tandem mass spectrometry
179482|NCT02462460|Breast MRI|breast mri
179483|NCT02462460|T1 weighted and diffusion weighted MR|t1 weighted and diffusion weighted mr
179484|NCT02462460|screening pancreatic|screening pancreatic
179485|NCT02462460|screening ovarian|screening ovarian
179486|NCT02462460|15-120|15-120
179487|NCT02462447|prostate|prostate
179488|NCT02462447|cancer|cancer
179489|NCT02462447|biopsy|biopsy
179490|NCT02462447|PET|pet
179491|NCT02462434|Pediatric palliative care|pediatric palliative care
179492|NCT02462421|SGLT2|sglt2
179493|NCT02462421|SLC5A2|slc5a2
179494|NCT02462421|SLC5A4|slc5a4
179495|NCT02462421|SLC5A9|slc5a9
179496|NCT02462421|SLC2A9|slc2a9
179497|NCT02462421|GLUT9|glut9
179498|NCT02462421|SGLT3|sglt3
179499|NCT02462421|SGLT4|sglt4
179500|NCT02462421|pharmacogenomics|pharmacogenomics
179501|NCT02462356|CVATS|cvats
179502|NCT02462356|UVATS|uvats
179503|NCT02462356|perioperative effect|perioperative effect
179504|NCT02462356|ergonomic influence|ergonomic influence
179505|NCT02462330|Mesenchymal stem cells|mesenchymal stem cells
179506|NCT02462330|ischemic cardiomyopathy|ischemic cardiomyopathy
179507|NCT02462330|NogaStar XP system catheter|nogastar xp system catheter
179508|NCT02462317|Spasticity|spasticity
179509|NCT02462317|Post stroke motor recovery|post stroke motor recovery
179510|NCT02462317|Botulinum toxin|botulinum toxin
179511|NCT02462317|Baclofen|baclofen
179512|NCT02462317|Pharmacological modulation|pharmacological modulation
179513|NCT02462304|Diabetic Macula Edema|diabetic macula edema
179514|NCT02462304|End-Point-Management|end-point-management
179515|NCT02462304|ranibizumab|ranibizumab
179516|NCT02462304|bevacizumab|bevacizumab
179517|NCT02462291|Neurological Disorders|neurological disorders
179518|NCT02462291|Non Pharmacological Treatment|non pharmacological treatment
179519|NCT02462291|Ecological Therapy|ecological therapy
179520|NCT02462278|Fertility|fertility
179521|NCT02462278|Continuous temperature monitor|continuous temperature monitor
179522|NCT02462278|Basal Body Temperature|basal body temperature
179523|NCT02462278|Natural family planning|natural family planning
179524|NCT02462239|Muscle-invasive bladder cancer|muscle-invasive bladder cancer
179525|NCT02462239|Bladder cancer|bladder cancer
179526|NCT02462239|PET imaging|pet imaging
179527|NCT02462239|FDG|fdg
179528|NCT02462213|Cardiac amyloidosis|cardiac amyloidosis
179529|NCT02462213|Cardiac MRI|cardiac mri
179530|NCT02462213|Infiltrative cardiomyopathies|infiltrative cardiomyopathies
179531|NCT02462187|genital warts|genital warts
179532|NCT02462187|perianal warts|perianal warts
179533|NCT02462174|anesthesia|anesthesia
179534|NCT02462174|analgesia|analgesia
179535|NCT02462174|caudal|caudal
179536|NCT02462174|ketamine|ketamine
179537|NCT02462174|bupivacaine|bupivacaine
179538|NCT02462148|Anesthesia|anesthesia
180245|NCT02457845|Gliosarcoma|gliosarcoma
179539|NCT02462148|Anesthesia, Conduction|anesthesia, conduction
179540|NCT02462148|Anesthesia, Local|anesthesia, local
179541|NCT02462148|Bupivacaine|bupivacaine
179542|NCT02462148|Dexamethasone|dexamethasone
179543|NCT02462148|Saphenous|saphenous
179544|NCT02462148|Adductor Canal|adductor canal
179545|NCT02462148|Nerve Block|nerve block
179546|NCT02462148|Analgesia|analgesia
179547|NCT02462148|Preanesthetic Medication|preanesthetic medication
179548|NCT02462148|Perioperative Period|perioperative period
179549|NCT02462148|Peripheral Nerve Block|peripheral nerve block
179550|NCT02462135|Mild cognitive impairment|mild cognitive impairment
179551|NCT02462135|Memory training|memory training
179552|NCT02462135|Randomized controlled study|randomized controlled study
179553|NCT02462044|Computed tomography|computed tomography
179554|NCT02462044|Coronary CTA|coronary cta
179555|NCT02462044|Contrast media|contrast media
179556|NCT02462018|Cerebral Palsy|cerebral palsy
179557|NCT02462018|Muscle Spasticity|muscle spasticity
179558|NCT02462018|Orthoses|orthoses
179559|NCT02462018|Functional Electrical Stimulation|functional electrical stimulation
179560|NCT02462018|Prospective|prospective
179561|NCT02461992|FVIII activity|fviii activity
179562|NCT02461953|hemodialysis|hemodialysis
179563|NCT02461953|hemoperfusion|hemoperfusion
179564|NCT02461953|quality of life|quality of life
179565|NCT02461940|Sexual behavior|sexual behavior
179566|NCT02461940|condom use|condom use
179567|NCT02461940|secondary abstinence|secondary abstinence
179568|NCT02461914|Type 2 diabetes mellitus|type 2 diabetes mellitus
179569|NCT02461901|clostridium difficile|clostridium difficile
179570|NCT02461901|environment|environment
179571|NCT02461901|contamination|contamination
179572|NCT02461901|fidaxomicin|fidaxomicin
179573|NCT02461888|Relapsed|relapsed
179574|NCT02461888|Refractory|refractory
179575|NCT02461888|Cyclophosphamide|cyclophosphamide
179576|NCT02461888|Dexamethasone|dexamethasone
179577|NCT02461875|OHSS|ohss
179578|NCT02461875|Infertility|infertility
179579|NCT02461875|Cabergoline|cabergoline
179580|NCT02461875|GnRH antagonist|gnrh antagonist
179581|NCT02461875|IVF-ET|ivf-et
179582|NCT02461862|Contraception|contraception
179583|NCT02461862|Contraception Behavior|contraception behavior
179584|NCT02461862|Intra uterine device|intra uterine device
179585|NCT02461862|Intra uterine System|intra uterine system
179587|NCT02461862|IUS|ius
179588|NCT02461862|Acute Pain|acute pain
179589|NCT02461771|AMD|amd
179590|NCT02461771|Wet AMD|wet amd
179591|NCT02461771|Neovascular AMD|neovascular amd
179592|NCT02461745|VIEKIRA PAK|viekira pak
179593|NCT02461732|posttraumatic stress disorder|posttraumatic stress disorder
179594|NCT02461732|PTSD|ptsd
179595|NCT02461732|substance dependence|substance dependence
179596|NCT02461732|substance use|substance use
179597|NCT02461706|Drug resistant epilepsy|drug resistant epilepsy
179598|NCT02461693|Vigilance|vigilance
179599|NCT02461693|Mood|mood
179600|NCT02461693|Randomized Controlled Trial|randomized controlled trial
179601|NCT02461693|Probability|probability
179602|NCT02461680|partial section of the flexor tendons|partial section of the flexor tendons
179603|NCT02461667|alendronate, metformin|alendronate, metformin
179604|NCT02461641|amniotic tissue|amniotic tissue
179605|NCT02461641|diabetic foot ulcer|diabetic foot ulcer
179606|NCT02461641|Affinity|affinity
179607|NCT02461641|NuShield|nushield
179608|NCT02461628|Malaria|malaria
179609|NCT02461628|Antimalarial subsidy|antimalarial subsidy
179610|NCT02461628|Malaria rapid diagnostic test (RDT)|malaria rapid diagnostic test (rdt)
179611|NCT02461628|Public-private partnership|public-private partnership
179612|NCT02461628|Community health workers|community health workers
179613|NCT02461615|Pulmonary Surfactant|pulmonary surfactant
179614|NCT02461615|Rare Lung Disease|rare lung disease
179615|NCT02461615|Registry|registry
179616|NCT02461602|Warfarin|warfarin
179617|NCT02461576|HIV-1|hiv-1
179618|NCT02461550|Irreversible Electroporation Ablation|irreversible electroporation ablation
179619|NCT02461550|15-001|15-001
179620|NCT02461498|Warfarin|warfarin
179621|NCT02461485|adults|adults
179622|NCT02461485|moderate constipation|moderate constipation
179623|NCT02461472|risk factors|risk factors
179624|NCT02461472|risk analysis|risk analysis
179625|NCT02461472|diabetic cardiovascular autonomic neuropathy|diabetic cardiovascular autonomic neuropathy
179626|NCT02461472|general Chinese population|general chinese population
179627|NCT02461459|Tuberous Sclerosis Complex|tuberous sclerosis complex
179628|NCT02461459|TSC|tsc
179629|NCT02461459|Autism|autism
179630|NCT02461459|ASD|asd
179631|NCT02461459|Intellectual Disability|intellectual disability
179632|NCT02461459|ID|id
179633|NCT02461459|MRI|mri
179634|NCT02461446|germline heterozygous PTEN mutations|germline heterozygous pten mutations
179635|NCT02461446|MRI|mri
179636|NCT02461446|10q23.3|10q23.3
179637|NCT02461446|ASD|asd
179638|NCT02461446|Autism|autism
179639|NCT02461446|Macrocephaly|macrocephaly
179640|NCT02461446|PTEN Hamartoma Tumor Syndrome|pten hamartoma tumor syndrome
179641|NCT02461446|PTEN|pten
179642|NCT02461433|Obesity|obesity
179643|NCT02461433|Obese|obese
179644|NCT02461433|surgical site infection|surgical site infection
179645|NCT02461433|closed incisions|closed incisions
179646|NCT02461433|negative pressure therapy|negative pressure therapy
179647|NCT02461420|Phelan-McDermid Syndrome|phelan-mcdermid syndrome
179648|NCT02461420|PMS|pms
179649|NCT02461420|Genotype|genotype
179650|NCT02461420|Phenotype|phenotype
179651|NCT02461420|Natural History|natural history
179652|NCT02461420|Mapping|mapping
179653|NCT02461420|22q13 Deletion Syndrome|22q13 deletion syndrome
179654|NCT02461420|SHANK3|shank3
179655|NCT02461420|Autism Spectrum Disorder|autism spectrum disorder
179656|NCT02461420|ASD|asd
179657|NCT02461420|Intellectual Disability|intellectual disability
179658|NCT02461420|ID|id
179659|NCT02461381|Bayesian estimation, short-term heart rate variability, diabetic cardiovascular autonomic neuropathy, diagnostic performance|bayesian estimation, short-term heart rate variability, diabetic cardiovascular autonomic neuropathy, diagnostic performance
179660|NCT02461381|Diagnostic performance|diagnostic performance
179661|NCT02461381|short-term heart rate variability|short-term heart rate variability
179662|NCT02461381|diabetic cardiovascular autonomic neuropathy|diabetic cardiovascular autonomic neuropathy
179663|NCT02461381|DCAN|dcan
179664|NCT02461342|Genetic|genetic
179665|NCT02461342|environment|environment
179666|NCT02461342|interaction analysis|interaction analysis
179667|NCT02461342|cardiovascular autonomic neuropathy|cardiovascular autonomic neuropathy
179668|NCT02461342|CAN|can
179669|NCT02461329|Hip Replacement, Total|hip replacement, total
179670|NCT02461329|Gelatine solution|gelatine solution
179671|NCT02461329|Balanced Crystaloid Solution|balanced crystaloid solution
179672|NCT02461329|Volume therapy|volume therapy
179673|NCT02461329|Platelet aggregation|platelet aggregation
179674|NCT02461303|Klinefelter|klinefelter
179675|NCT02461303|Spermatogenesis|spermatogenesis
179676|NCT02461303|Puberty|puberty
179677|NCT02461303|Fertility|fertility
179678|NCT02461277|postoperative care|postoperative care
179679|NCT02461277|exercise test|exercise test
179680|NCT02461277|early ambulation|early ambulation
179681|NCT02461277|Fast-track|fast-track
179682|NCT02461251|Thromboelastometry|thromboelastometry
179683|NCT02461251|Obstetric Hemorrhage|obstetric hemorrhage
179684|NCT02461251|Blood Component Transfusion|blood component transfusion
179685|NCT02461212|HepaFat-Scan|hepafat-scan
179686|NCT02461212|Liver Disease|liver disease
179687|NCT02461212|Pediatrics|pediatrics
179688|NCT02461199|Fecal microbiota transplantation|fecal microbiota transplantation
179689|NCT02461199|Gut colonization|gut colonization
179690|NCT02461199|Multidrug-resistant bacteria|multidrug-resistant bacteria
179691|NCT02461199|Blood disorders|blood disorders
179692|NCT02461199|Drug Resistance, Multiple|drug resistance, multiple
179693|NCT02461199|Disease Eradication|disease eradication
179694|NCT02461186|Arterolane-piperaquine|arterolane-piperaquine
179695|NCT02461186|Dehydroartemisinin-piperaquine|dehydroartemisinin-piperaquine
179696|NCT02461186|therapeutic efficacy|therapeutic efficacy
179697|NCT02461186|Uncomplicated falciparum malaria|uncomplicated falciparum malaria
179698|NCT02461186|Artemisinin-resistant|artemisinin-resistant
179699|NCT02461160|Drug therapy|drug therapy
179700|NCT02461134|GVHD|gvhd
179701|NCT02461134|ponesimod|ponesimod
179702|NCT02461121|Acute Myeloid Leukemia|acute myeloid leukemia
179703|NCT02461121|microtransplantationHLA-mismatched microtransplantation|microtransplantationhla-mismatched microtransplantation
179704|NCT02461121|nonmyeloablative stem cell transplantation|nonmyeloablative stem cell transplantation
179705|NCT02461121|graft-versus-host disease|graft-versus-host disease
179706|NCT02461108|Public policy|public policy
179707|NCT02461108|Food choice|food choice
179708|NCT02461108|Nutrition labeling|nutrition labeling
179709|NCT02461108|Fat tax|fat tax
179710|NCT02461108|Vegetable subsidy|vegetable subsidy
179711|NCT02461108|Behavioral economics|behavioral economics
179712|NCT02461108|Health behavior|health behavior
179713|NCT02461069|dimethyl fumarate|dimethyl fumarate
179714|NCT02461056|ibuprofen|ibuprofen
179715|NCT02461056|hydromorphone|hydromorphone
179716|NCT02461056|drug interactions|drug interactions
179717|NCT02461043|esophageal cancer|esophageal cancer
179718|NCT02461043|adjuvant chemotherapy|adjuvant chemotherapy
179719|NCT02461043|esophageal surgery|esophageal surgery
179720|NCT02461043|paclitaxel|paclitaxel
179721|NCT02461030|Dentin hypersensitivity|dentin hypersensitivity
179722|NCT02461030|Periodontal disease|periodontal disease
179723|NCT02461030|Arginine|arginine
179724|NCT02461017|intubation|intubation
179725|NCT02461017|ventilation|ventilation
179726|NCT02461017|airway|airway
179727|NCT02461017|airleak|airleak
179728|NCT02461004|Dyslipidemia|dyslipidemia
179729|NCT02461004|CKD-391|ckd-391
179730|NCT02461004|Atorvastatin|atorvastatin
179731|NCT02461004|Ezetimibe|ezetimibe
179732|NCT02460978|Dapagliflozin|dapagliflozin
179733|NCT02460978|Efficacy|efficacy
179734|NCT02460978|Safety|safety
179735|NCT02460978|Add on to insulin|add on to insulin
179736|NCT02460978|Oral Antidiabetic|oral antidiabetic
179737|NCT02460978|Type 1 diabetes|type 1 diabetes
179738|NCT02460952|Pulmonary Embolism;|pulmonary embolism;
179739|NCT02460952|perioperative period;|perioperative period;
179740|NCT02460952|general anesthesia|general anesthesia
179741|NCT02460939|Pulmonary Vessel Disease|pulmonary vessel disease
179742|NCT02460939|metabolism of small molecules|metabolism of small molecules
179743|NCT02460926|Scaling and root planning|scaling and root planning
179744|NCT02460926|C-reactive protein|c-reactive protein
179745|NCT02460913|acupuncture|acupuncture
179746|NCT02460913|morphine|morphine
179747|NCT02460913|acute pain|acute pain
179748|NCT02460887|nasopharyngeal carcinoma|nasopharyngeal carcinoma
179749|NCT02460887|induction chemotherapy|induction chemotherapy
179750|NCT02460874|Brain Metastases|brain metastases
179751|NCT02460874|Stereotactic Radiosurgery|stereotactic radiosurgery
179752|NCT02460874|Glyburide|glyburide
179753|NCT02460861|Prostate Cancer|prostate cancer
179754|NCT02460861|Molecular staging|molecular staging
179755|NCT02460861|GSTP1|gstp1
179756|NCT02460861|Surgical margins|surgical margins
179757|NCT02460861|prostatovesiculectomy|prostatovesiculectomy
179758|NCT02460848|Malnutrition|malnutrition
179759|NCT02460848|Severe Acute Malnutrition|severe acute malnutrition
179760|NCT02460848|Cash Transfer|cash transfer
179761|NCT02460848|Democratic Republic of Congo|democratic republic of congo
179762|NCT02460848|Cluster randomize trial|cluster randomize trial
179763|NCT02460796|Parkinson's disease|parkinson's disease
179764|NCT02460796|Quality of life|quality of life
179765|NCT02460796|Gait velocity|gait velocity
179766|NCT02460796|Capacity|capacity
179767|NCT02460783|Biomarkers|biomarkers
179768|NCT02460783|Diabetes|diabetes
179769|NCT02460783|Obesity|obesity
179770|NCT02460783|Dementia of the Alzheimer Type|dementia of the alzheimer type
179771|NCT02460783|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
179772|NCT02460770|Left Ventricular Assist Device|left ventricular assist device
179773|NCT02460770|stem cell therapy|stem cell therapy
179774|NCT02460770|ischemic heart failure|ischemic heart failure
179775|NCT02460757|glottic movement|glottic movement
179776|NCT02460757|emphysema|emphysema
179777|NCT02460757|copd|copd
179778|NCT02460757|vocal cord|vocal cord
179779|NCT02460744|Breast cancer|breast cancer
179780|NCT02460744|hypofractionation|hypofractionation
179781|NCT02460744|radiotherapy|radiotherapy
179783|NCT02460731|Young Plasma|young plasma
179784|NCT02460718|diabetes mellitus|diabetes mellitus
179785|NCT02460718|peer support|peer support
179786|NCT02460718|pragmatic clinical trial|pragmatic clinical trial
179787|NCT02460666|depressed|depressed
179788|NCT02460666|older adults|older adults
179789|NCT02460666|Major Depressive Disorder|major depressive disorder
179790|NCT02460666|Tai-Chi|tai-chi
179791|NCT02460666|geriatric|geriatric
179792|NCT02460653|High flow nasal cannula|high flow nasal cannula
179793|NCT02460653|Oxygen therapy|oxygen therapy
179794|NCT02460653|Ventilation|ventilation
179795|NCT02460640|Minimally invasive surgery|minimally invasive surgery
179796|NCT02460640|Partial nephrectomy|partial nephrectomy
179797|NCT02460627|Arthroscopy|arthroscopy
179798|NCT02460627|Meniscus|meniscus
179799|NCT02460627|Lidocaine|lidocaine
179800|NCT02460614|bronchiolitis|bronchiolitis
179801|NCT02460614|respiratory physiotherapy|respiratory physiotherapy
179802|NCT02460614|pediatrics|pediatrics
179803|NCT02460614|rhinopharyngeal clearance|rhinopharyngeal clearance
179804|NCT02460575|Safety|safety
179805|NCT02460562|resin denture base|resin denture base
179806|NCT02460549|therapeutic patient education|therapeutic patient education
179807|NCT02460549|insulinoresistance|insulinoresistance
179808|NCT02460549|empowerment|empowerment
179809|NCT02460549|prostate cancer|prostate cancer
179810|NCT02460549|oral endocrine therapy|oral endocrine therapy
179811|NCT02460549|side effects|side effects
179812|NCT02460536|attention bias modification treatment|attention bias modification treatment
179813|NCT02460536|attention training|attention training
179814|NCT02460536|anxiety disorders|anxiety disorders
179815|NCT02460536|clinical trials|clinical trials
179816|NCT02460471|Radiotherapy|radiotherapy
179817|NCT02460471|Palliative Care|palliative care
179818|NCT02460471|IMRT|imrt
179819|NCT02460458|Factor VIII|factor viii
179820|NCT02460458|Hemorrhage|hemorrhage
179821|NCT02460458|von Willebrand Diseases|von willebrand diseases
179822|NCT02460458|von Willebrand Factor|von willebrand factor
179823|NCT02460445|Functional hyperandrogenism|functional hyperandrogenism
179824|NCT02460445|Polycystic ovary syndrome|polycystic ovary syndrome
179825|NCT02460445|Idiopathic hyperandrogenism|idiopathic hyperandrogenism
179826|NCT02460445|Iron tissue depots|iron tissue depots
179827|NCT02460445|Phlebotomy|phlebotomy
179828|NCT02460445|Insulin resistance|insulin resistance
179829|NCT02460445|Carbohydrate metabolism|carbohydrate metabolism
179830|NCT02460445|Blood pressure|blood pressure
179831|NCT02460445|Autonomic dysfunction|autonomic dysfunction
179832|NCT02460445|Oxidative stress|oxidative stress
179833|NCT02460445|Blood clotting tests|blood clotting tests
179834|NCT02460445|Efficacy|efficacy
179835|NCT02460445|Side effects|side effects
179836|NCT02460445|Randomized clinical trial|randomized clinical trial
179837|NCT02460432|Drug-eluting Biliary stent|drug-eluting biliary stent
179838|NCT02460432|Covered metalic stent|covered metalic stent
179839|NCT02460419|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
179840|NCT02460419|metastasis|metastasis
179841|NCT02460419|capecitabine|capecitabine
179842|NCT02460406|strength training|strength training
179843|NCT02460406|virtual reality|virtual reality
179844|NCT02460406|plyometric exercises|plyometric exercises
179845|NCT02460406|cerebral palsy|cerebral palsy
179846|NCT02460406|hemiplegic|hemiplegic
179847|NCT02460393|tolerance|tolerance
179848|NCT02460393|safety and pharmacokinetic characteristics|safety and pharmacokinetic characteristics
179849|NCT02460367|Non-small Cell Lung Cancer|non-small cell lung cancer
179850|NCT02460367|Vaccine Therapy|vaccine therapy
179851|NCT02460367|Immunotherapy|immunotherapy
179852|NCT02460367|Second line therapy|second line therapy
179853|NCT02460367|Progressive|progressive
179854|NCT02460367|Relapsed|relapsed
179855|NCT02460367|IDO|ido
179856|NCT02460367|IDO Inhibitor|ido inhibitor
179857|NCT02460354|Congenital nephrogenic diabetes insipidus|congenital nephrogenic diabetes insipidus
179858|NCT02460341|fMRI|fmri
179859|NCT02460341|Brain function|brain function
179860|NCT02460341|Sensory processing|sensory processing
179861|NCT02460315|time of cholecystectomy after ERCP|time of cholecystectomy after ercp
179862|NCT02460276|Mantle cell lymphoma|mantle cell lymphoma
179863|NCT02460276|Relapsed mantle cell lymphoma|relapsed mantle cell lymphoma
179864|NCT02460276|Lenalidomide|lenalidomide
179865|NCT02460276|Rituximab|rituximab
179866|NCT02460276|Ibrutinib|ibrutinib
179867|NCT02460276|Response duration|response duration
179868|NCT02460276|Complete remission rate|complete remission rate
179869|NCT02460276|Quality of life|quality of life
179870|NCT02460276|Overall survival|overall survival
179871|NCT02460276|Safety|safety
179872|NCT02460250|Tissue and Organ Harvesting|tissue and organ harvesting
179873|NCT02460250|Liver graft|liver graft
179874|NCT02460250|Brain Death|brain death
179875|NCT02460250|FibroScan®|fibroscan®
179876|NCT02460237|HPV|hpv
179877|NCT02460224|Non-small cell lung cancer|non-small cell lung cancer
179878|NCT02460224|Melanoma|melanoma
179879|NCT02460224|Renal cancer|renal cancer
179880|NCT02460224|Mesothelioma|mesothelioma
179881|NCT02460224|Triple Negative Breast|triple negative breast
179882|NCT02460224|TNBC|tnbc
179883|NCT02460224|Renal|renal
179884|NCT02460211|Cardiovascular Disease|cardiovascular disease
179885|NCT02460211|Vitamin D|vitamin d
179886|NCT02460211|Open Heart Surgery|open heart surgery
179887|NCT02460198|PD1|pd1
179888|NCT02460198|PD-1|pd-1
179889|NCT02460198|PDL1|pdl1
179890|NCT02460198|PD-L1|pd-l1
179891|NCT02460198|MSI-H|msi-h
179892|NCT02460198|MSI|msi
179893|NCT02460172|bi lateral|bi lateral
179894|NCT02460172|knee surgery|knee surgery
179895|NCT02460172|arthroplasty|arthroplasty
179896|NCT02460172|orthopedics|orthopedics
179897|NCT02460081|PDA-002|pda-002
179898|NCT02460081|Diabetic Foot Ulcer|diabetic foot ulcer
179899|NCT02460081|Peripheral arterial disease|peripheral arterial disease
179900|NCT02460081|Phase 2|phase 2
179901|NCT02460081|Randomized|randomized
179902|NCT02460068|melanoma brain metastases|melanoma brain metastases
179903|NCT02460068|nivolumab|nivolumab
179904|NCT02460068|ipilimumab|ipilimumab
179905|NCT02460055|EGD Dysphagia|egd dysphagia
179906|NCT02460055|ETT Intubation dysphagia|ett intubation dysphagia
179907|NCT02459990|Hypertension malformation fetal mortality|hypertension malformation fetal mortality
179908|NCT02459964|Advanced Cancers|advanced cancers
179909|NCT02459964|Pain|pain
179910|NCT02459964|Fentanyl nasal spray|fentanyl nasal spray
179911|NCT02459964|Hydromorphone hydrochloride|hydromorphone hydrochloride
179912|NCT02459964|Phone call|phone call
179913|NCT02459964|Numeric Rating Scale|numeric rating scale
179914|NCT02459964|NRS|nrs
179915|NCT02459951|Muscle Spasticity|muscle spasticity
179916|NCT02459951|Botox A|botox a
179917|NCT02459951|Upper limb hemiplegia|upper limb hemiplegia
179918|NCT02459912|Prostate|prostate
179919|NCT02459912|Minimally|minimally
179920|NCT02459912|Low-Risk|low-risk
179921|NCT02459912|Invasive|invasive
179922|NCT02459912|Cancer|cancer
179923|NCT02459886|alpha synuclein|alpha synuclein
179924|NCT02459886|PD|pd
179925|NCT02459860|depression|depression
179926|NCT02459860|randomized behavioral trial|randomized behavioral trial
179927|NCT02459860|aged|aged
179928|NCT02459860|Latinos|latinos
179929|NCT02459860|Spanish-speaking|spanish-speaking
179930|NCT02459860|chronic medical conditions|chronic medical conditions
179931|NCT02459834|Allulose|allulose
179932|NCT02459834|Fructose|fructose
179933|NCT02459834|Dose Response|dose response
179934|NCT02459834|Catalytic Dose|catalytic dose
179935|NCT02459834|Carbohydrate metabolism|carbohydrate metabolism
179936|NCT02459834|Randomized clinical trials|randomized clinical trials
179937|NCT02459821|Multiple sclerosis|multiple sclerosis
179938|NCT02459821|Gait rehabilitation|gait rehabilitation
179939|NCT02459821|Quality of life|quality of life
179940|NCT02459821|Stair climbing|stair climbing
179942|NCT02459782|Ultrasound guided peribulbar anesthesia|ultrasound guided peribulbar anesthesia
179943|NCT02459756|anthocyanins|anthocyanins
179944|NCT02459756|bioavailability|bioavailability
179945|NCT02459743|Hematological malignancies|hematological malignancies
179946|NCT02459743|Next Generation Sequencing|next generation sequencing
179947|NCT02459743|Genotype-phenotype correlations|genotype-phenotype correlations
179948|NCT02459743|Prognosis|prognosis
179949|NCT02459743|Diagnosis|diagnosis
179950|NCT02459730|Dental caries|dental caries
179951|NCT02459730|glass ionomer cement|glass ionomer cement
179952|NCT02459730|ART|art
179953|NCT02459704|Gingival Recession|gingival recession
179954|NCT02459704|Semilunar flap|semilunar flap
179955|NCT02459704|Enamel matrix derivative|enamel matrix derivative
179956|NCT02459704|Periodontal regeneration|periodontal regeneration
179957|NCT02459691|prediabetes|prediabetes
179958|NCT02459691|metabolic syndrome|metabolic syndrome
179959|NCT02459691|lifestyle|lifestyle
179960|NCT02459691|behavior change|behavior change
179961|NCT02459691|primary care|primary care
179962|NCT02459691|latinos|latinos
179963|NCT02459691|diet|diet
179964|NCT02459691|physical activity|physical activity
179965|NCT02459652|Borderline Resectable Pancreatic Cancer|borderline resectable pancreatic cancer
179966|NCT02459639|Chronic Widespread Pain|chronic widespread pain
179967|NCT02459639|Telomere length|telomere length
179968|NCT02459639|Multimodal rehabilitation|multimodal rehabilitation
179969|NCT02459639|Integrative care|integrative care
179970|NCT02459639|Existential aspects|existential aspects
179971|NCT02459613|Radionuclide imaging|radionuclide imaging
179972|NCT02459613|Annexin|annexin
179973|NCT02459600|Eye surgery|eye surgery
179974|NCT02459600|Children|children
179975|NCT02459587|Self-Injurious Behavior|self-injurious behavior
179976|NCT02459587|suicide prevention|suicide prevention
179977|NCT02459574|Heart Failure|heart failure
179978|NCT02459561|Obesity|obesity
179979|NCT02459561|Diabetes|diabetes
179980|NCT02459561|Overweight|overweight
179981|NCT02459561|Medical device|medical device
179982|NCT02459561|Endobarrier|endobarrier
179983|NCT02459561|Clinical trial|clinical trial
179984|NCT02459561|Diet|diet
179985|NCT02459561|Exercise|exercise
179986|NCT02459561|Body weight|body weight
179987|NCT02459561|Medical therapy|medical therapy
179988|NCT02459561|Medicine|medicine
179989|NCT02459561|Device|device
179990|NCT02459561|Randomised|randomised
179991|NCT02459561|Control|control
179992|NCT02459561|Intervention|intervention
179993|NCT02459561|EndoBarrier Medical device|endobarrier medical device
179994|NCT02459548|OSA|osa
179995|NCT02459548|CPAP treatment|cpap treatment
179996|NCT02459548|Primary care|primary care
179997|NCT02459548|Efficacy|efficacy
179998|NCT02459535|incretin release|incretin release
179999|NCT02459522|Bayesian estimation|bayesian estimation
180000|NCT02459522|short-term heart rate variability|short-term heart rate variability
180001|NCT02459522|cardiovascular autonomic neuropathy|cardiovascular autonomic neuropathy
180002|NCT02459522|diagnostic performance|diagnostic performance
180003|NCT02459509|Sedation|sedation
180004|NCT02459509|dexmedetomidine|dexmedetomidine
180005|NCT02459509|pediatric|pediatric
180006|NCT02459509|preoperative period|preoperative period
180007|NCT02459470|Fluid Responsiveness|fluid responsiveness
180008|NCT02459470|Pulse Pressure Variation|pulse pressure variation
180009|NCT02459470|Stroke Volume Variation|stroke volume variation
180010|NCT02459457|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
180011|NCT02459457|concurrent chemoradiotherapy|concurrent chemoradiotherapy
180012|NCT02459457|paclitaxel|paclitaxel
180013|NCT02459457|cisplatin|cisplatin
180014|NCT02459457|carboplatin|carboplatin
180015|NCT02459457|fluorouracil|fluorouracil
180016|NCT02459444|Respiratory Muscles|respiratory muscles
180017|NCT02459444|Muscle Weakness|muscle weakness
180018|NCT02459444|Hospitalization|hospitalization
180019|NCT02459444|Length of Stay|length of stay
180020|NCT02459444|Mortality|mortality
180021|NCT02459418|Afolia|afolia
180022|NCT02459418|Follitropin|follitropin
180023|NCT02459405|Colorectal surgery|colorectal surgery
180024|NCT02459405|Near infrared|near infrared
180025|NCT02459405|Indocyanine green|indocyanine green
180026|NCT02459405|anastomotic leak|anastomotic leak
180027|NCT02459405|Prevention of leak|prevention of leak
180028|NCT02459392|Epiduroscopy,|epiduroscopy,
180029|NCT02459392|Failed back surgery syndrome|failed back surgery syndrome
180030|NCT02459392|Spinal Stenosis with neurologic changes|spinal stenosis with neurologic changes
180031|NCT02459366|Thoracolumbar fascia|thoracolumbar fascia
180032|NCT02459366|Mechanical properties|mechanical properties
180033|NCT02459366|Low back pain|low back pain
180034|NCT02459353|dapagliflozin|dapagliflozin
180035|NCT02459353|glucose variability|glucose variability
180036|NCT02459327|Infant behavior|infant behavior
180037|NCT02459327|Child behavior|child behavior
180038|NCT02459327|Parenting|parenting
180039|NCT02459327|Child rearing|child rearing
180040|NCT02459327|Depression|depression
180041|NCT02459327|Personal satisfaction|personal satisfaction
180042|NCT02459327|Randomized controlled trials|randomized controlled trials
180043|NCT02459327|Intervention studies|intervention studies
180044|NCT02459327|Behavioral symptoms|behavioral symptoms
180045|NCT02459327|Social behavior|social behavior
180046|NCT02459288|Acute coronary syndrome|acute coronary syndrome
180047|NCT02459288|Chronic kidney disease|chronic kidney disease
180048|NCT02459288|End-Stage Renal Disease|end-stage renal disease
180049|NCT02459288|eGFR|egfr
180050|NCT02459288|Ticagrelor|ticagrelor
180051|NCT02459288|Clopidogrel|clopidogrel
180052|NCT02459275|feeding protocol|feeding protocol
180053|NCT02459275|enteral nutrition protocol|enteral nutrition protocol
180054|NCT02459275|critically ill|critically ill
180055|NCT02459275|surgical ICU|surgical icu
180056|NCT02459275|enteral nutrition|enteral nutrition
180057|NCT02459275|nutrition therapy|nutrition therapy
180058|NCT02459223|Nutritional intervention|nutritional intervention
180059|NCT02459223|iron deficiency anemia|iron deficiency anemia
180060|NCT02459210|clinical high risk for psychosis|clinical high risk for psychosis
180061|NCT02459210|psychosis prodrome|psychosis prodrome
180062|NCT02459210|cognitive remediation|cognitive remediation
180063|NCT02459210|psychosis prevention|psychosis prevention
180064|NCT02459197|Pain|pain
180065|NCT02459184|preventive medicine|preventive medicine
180066|NCT02459184|social determinants of health|social determinants of health
180067|NCT02459184|primary health care|primary health care
180068|NCT02459184|poverty|poverty
180069|NCT02459184|income|income
180070|NCT02459184|health promotion|health promotion
180071|NCT02459132|High-intensity interval training|high-intensity interval training
180072|NCT02459132|VO2peak|vo2peak
180073|NCT02459132|Brachial flow-mediated dilation|brachial flow-mediated dilation
180074|NCT02459132|Carotid-femoral pulse wave velocity|carotid-femoral pulse wave velocity
180075|NCT02459132|Carotid intima-media thickness|carotid intima-media thickness
180076|NCT02459132|Carotid distensibility|carotid distensibility
180077|NCT02459132|Respiratory sinus arrhythmia|respiratory sinus arrhythmia
180078|NCT02459119|urothelial cancer|urothelial cancer
180079|NCT02459119|Regorafenib|regorafenib
180080|NCT02459106|micro-RNA|micro-rna
180081|NCT02459106|insulin resistance|insulin resistance
180082|NCT02459093|wound complications|wound complications
180083|NCT02459080|Chronic Obstructive Pulmonary Disease, COPD|chronic obstructive pulmonary disease, copd
180084|NCT02459054|Artificial Heart|artificial heart
180085|NCT02459054|Biventricular Heart Failure|biventricular heart failure
180086|NCT02459054|SynCardia|syncardia
180087|NCT02459002|Advanced lung cancer|advanced lung cancer
180088|NCT02459002|NSCLC|nsclc
180089|NCT02459002|palliative care|palliative care
180090|NCT02458989|Thyroidectomy|thyroidectomy
180091|NCT02458989|Thyroid surgery|thyroid surgery
180092|NCT02458989|Scalpel|scalpel
180093|NCT02458989|Electrocautery|electrocautery
180094|NCT02458976|Scar|scar
180095|NCT02458976|Pulsed-dye laser|pulsed-dye laser
180096|NCT02458976|PDL|pdl
180097|NCT02458963|PCOS|pcos
180098|NCT02458963|Clomiphene citrate resistant|clomiphene citrate resistant
180099|NCT02458963|Gonadotropin|gonadotropin
180100|NCT02458963|IVF|ivf
180101|NCT02458950|Anorexia nervosa|anorexia nervosa
180102|NCT02458950|Siriraj Hospital|siriraj hospital
180103|NCT02458950|Thai|thai
180104|NCT02458937|Leukemia|leukemia
180105|NCT02458937|Hodgkin Disease|hodgkin disease
180106|NCT02458937|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
180107|NCT02458937|Sickle Cell Disease|sickle cell disease
180108|NCT02458937|Hip Core Decompression|hip core decompression
180109|NCT02458937|Function Outcomes|function outcomes
180110|NCT02458885|myocardial infarction|myocardial infarction
180111|NCT02458885|observational registry|observational registry
180112|NCT02458885|mortality|mortality
180113|NCT02458872|Clinical Alarms|clinical alarms
180114|NCT02458872|Patient Safety|patient safety
180115|NCT02458859|Chronic|chronic
180116|NCT02458859|Subacute|subacute
180117|NCT02458833|Obesity|obesity
180118|NCT02458833|Nutrition|nutrition
180119|NCT02458833|Home Food Preparation|home food preparation
180120|NCT02458833|Home Food Environment|home food environment
180121|NCT02458833|Peer Mentoring|peer mentoring
180122|NCT02458833|Early Head Start|early head start
180123|NCT02458833|Cooking|cooking
180124|NCT02458833|Diet|diet
180125|NCT02458820|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
180126|NCT02458820|Return of Spontaneous Circulation|return of spontaneous circulation
180127|NCT02458820|ROSC|rosc
180128|NCT02458820|Electroencephalogram|electroencephalogram
180129|NCT02458742|spinal anesthesia|spinal anesthesia
180130|NCT02458742|intrathecal morphine|intrathecal morphine
180131|NCT02458742|transurethral resection of prostate|transurethral resection of prostate
180132|NCT02458742|postoperative pain|postoperative pain
180133|NCT02458729|Tranexamic Acid|tranexamic acid
180134|NCT02458729|Total Knee Arthroplasty|total knee arthroplasty
180135|NCT02458729|Rivaroxaban|rivaroxaban
180136|NCT02458703|workload|workload
180137|NCT02458703|oxygen level|oxygen level
180138|NCT02458703|oxygen consumption|oxygen consumption
180139|NCT02458703|breathing reserve|breathing reserve
180140|NCT02458703|ventilatory efficiency|ventilatory efficiency
180141|NCT02458690|Primary Care|primary care
180142|NCT02458690|Older Adults|older adults
180143|NCT02458690|Antidepressant Medications|antidepressant medications
180144|NCT02458690|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
180145|NCT02458690|Computer-Based Psychotherapy|computer-based psychotherapy
180146|NCT02458612|cerebral palsy|cerebral palsy
180147|NCT02458612|mirror therapy|mirror therapy
180148|NCT02458612|strength training|strength training
180149|NCT02458560|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
180150|NCT02458560|Aortic Stenosis|aortic stenosis
180151|NCT02458534|Simulated manikin|simulated manikin
180152|NCT02458508|MC4R|mc4r
180153|NCT02458508|chemotherapy|chemotherapy
180154|NCT02458508|radiotherapy|radiotherapy
180155|NCT02458495|Internet|internet
180156|NCT02458495|Mobile Health|mobile health
180157|NCT02458495|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
180158|NCT02458495|Medication Adherence|medication adherence
180159|NCT02458495|Psychological Theory|psychological theory
180160|NCT02458482|Children|children
180161|NCT02458482|Positive Airway Pressure|positive airway pressure
180162|NCT02458482|Nebulizer|nebulizer
180163|NCT02458482|Moderate|moderate
180164|NCT02458482|Acute|acute
180165|NCT02458482|AccuPAP|accupap
180166|NCT02458417|Ablative laser|ablative laser
180167|NCT02458417|Fractional laser|fractional laser
180168|NCT02458417|Vitiligo|vitiligo
180169|NCT02458417|Piebaldism|piebaldism
180170|NCT02458417|Cell suspension grafting|cell suspension grafting
180171|NCT02458391|Breast Cancer|breast cancer
180172|NCT02458391|Lymphedema|lymphedema
180173|NCT02458365|Violence|violence
180174|NCT02458365|Bullying|bullying
180175|NCT02458365|Social skills|social skills
180176|NCT02458365|Prevention & control|prevention & control
180177|NCT02458365|Adolescent|adolescent
180178|NCT02458339|Brain tumor|brain tumor
180179|NCT02458339|Malignant Fourth Ventricular Brain Tumors|malignant fourth ventricular brain tumors
180180|NCT02458326|Migraine|migraine
180181|NCT02458326|Fibromyalgia|fibromyalgia
180182|NCT02458326|Aerobic exercise|aerobic exercise
180183|NCT02458300|Bronchiolitis|bronchiolitis
180184|NCT02458300|Chest|chest
180185|NCT02458300|Physical therapy|physical therapy
180186|NCT02458287|mixed dyslipidemia|mixed dyslipidemia
180187|NCT02458248|Chronic Kidney Disease|chronic kidney disease
180188|NCT02458248|Sodium Reduction|sodium reduction
180189|NCT02458248|eGFR 30-60ml/min/1.73m2|egfr 30-60ml/min/1.73m2
180190|NCT02458235|pediatric leukemia myelodysplastic syndrome azacitidine|pediatric leukemia myelodysplastic syndrome azacitidine
180191|NCT02458209|PK, bococizumab, comparability, LDL-C|pk, bococizumab, comparability, ldl-c
180192|NCT02458196|IgG4 related disease|igg4 related disease
180193|NCT02458196|IgG4-RD|igg4-rd
180194|NCT02458196|Response rate|response rate
180195|NCT02458196|Relapse|relapse
180196|NCT02458170|Rheumatoid arthritis|rheumatoid arthritis
180197|NCT02458170|Synovial tissue|synovial tissue
180198|NCT02458170|Joint destruction|joint destruction
180199|NCT02458170|Inflammation|inflammation
180200|NCT02458157|ICU|icu
180201|NCT02458157|Intensive|intensive
180202|NCT02458157|CRRT|crrt
180203|NCT02458157|Fluid Removal|fluid removal
180204|NCT02458157|AKI|aki
180205|NCT02458157|Critical Care|critical care
180206|NCT02458131|community-based participatory research|community-based participatory research
180207|NCT02458131|adolescents|adolescents
180208|NCT02458118|chronic|chronic
180209|NCT02458118|pancreatitis|pancreatitis
180210|NCT02458118|secretin|secretin
180211|NCT02458118|Blood flow|blood flow
180212|NCT02458105|Acceptance and commitment therapy|acceptance and commitment therapy
180213|NCT02458105|Cognitive behavior therapy|cognitive behavior therapy
180214|NCT02458053|African American|african american
180215|NCT02458053|male|male
180216|NCT02458053|couples|couples
180217|NCT02458053|randomized control trial|randomized control trial
180218|NCT02458014|Leukemia|leukemia
180219|NCT02458014|B-cell Lineage Acute Lymphocytic Leukemia|b-cell lineage acute lymphocytic leukemia
180220|NCT02458014|Positive minimal residual disease|positive minimal residual disease
180221|NCT02458014|MRD|mrd
180222|NCT02458014|Acute lymphocytic leukemia|acute lymphocytic leukemia
180223|NCT02458014|ALL|all
180224|NCT02458014|Blinatumomab|blinatumomab
180225|NCT02458014|Blinacyto|blinacyto
180226|NCT02458014|Phone calls|phone calls
180227|NCT02457949|Social Assistance|social assistance
180228|NCT02457949|Drug Use|drug use
180229|NCT02457949|Drug-Related harm|drug-related harm
180230|NCT02457923|mobile phone counselling|mobile phone counselling
180231|NCT02457923|infant feeding|infant feeding
180232|NCT02457923|nutrition|nutrition
180233|NCT02457897|Brown Adipose Tissue|brown adipose tissue
180234|NCT02457897|Liothyronine|liothyronine
180235|NCT02457897|Insulin Receptors|insulin receptors
180236|NCT02457884|Diabetic macular oedema|diabetic macular oedema
180237|NCT02457884|Perceptual learning|perceptual learning
180238|NCT02457884|Chinese|chinese
180239|NCT02457884|Hong Kong|hong kong
180240|NCT02457858|Type 1 Diabetes|type 1 diabetes
180241|NCT02457858|Islet Transplant|islet transplant
180242|NCT02457845|Brain Tumor, Recurrent|brain tumor, recurrent
180243|NCT02457845|Glioma|glioma
180244|NCT02457845|Glioblastoma|glioblastoma
180246|NCT02457845|Anaplastic Astrocytoma|anaplastic astrocytoma
180247|NCT02457845|Oligodendroglioma|oligodendroglioma
180248|NCT02457845|Rhabdoid Tumor|rhabdoid tumor
180249|NCT02457845|Cerebral Primitive Neuroectodermal Tumor|cerebral primitive neuroectodermal tumor
180250|NCT02457845|PNET|pnet
180251|NCT02457845|Ependymoma|ependymoma
180252|NCT02457845|Germ Cell Tumor|germ cell tumor
180253|NCT02457845|Choroid Plexus Carcinoma|choroid plexus carcinoma
180254|NCT02457845|Oncolytic Virus Therapy|oncolytic virus therapy
180255|NCT02457845|Virotherapy, Oncolytic|virotherapy, oncolytic
180256|NCT02457845|Immunotherapy|immunotherapy
180257|NCT02457845|Central Nervous System Agents|central nervous system agents
180258|NCT02457845|Antineoplastic Agents|antineoplastic agents
180259|NCT02457845|Neoplasms|neoplasms
180260|NCT02457845|Pediatric|pediatric
180261|NCT02457845|Pediatrics|pediatrics
180262|NCT02457832|Magnetic Resonance Imaging|magnetic resonance imaging
180263|NCT02457832|Neurology|neurology
180264|NCT02457832|Neurosciences|neurosciences
180265|NCT02457832|Physical Medicine|physical medicine
180266|NCT02457832|Parkinson Disease|parkinson disease
180267|NCT02457832|Rehabilitation|rehabilitation
180268|NCT02457806|Dental Anesthesia|dental anesthesia
180269|NCT02457780|PTSD|ptsd
180270|NCT02457780|Trauma|trauma
180271|NCT02457780|World Trade Center|world trade center
180272|NCT02457780|Respiratory|respiratory
180273|NCT02457780|Mind-Body|mind-body
180274|NCT02457741|Mechanical ventilation|mechanical ventilation
180275|NCT02457741|PEEP|peep
180276|NCT02457741|Respiratory mechanics|respiratory mechanics
180277|NCT02457741|End-expiratory lung volume|end-expiratory lung volume
180278|NCT02457689|Human Immunodeficiency Virus|human immunodeficiency virus
180279|NCT02457689|Immunodeficiency Virus, Human|immunodeficiency virus, human
180280|NCT02457676|Self-Regulation Training|self-regulation training
180281|NCT02457676|Neuroimaging|neuroimaging
180282|NCT02457676|Response Inhibition|response inhibition
180283|NCT02457676|Behavioral Regulation|behavioral regulation
180284|NCT02457676|Emotional Regulation|emotional regulation
180285|NCT02457663|Burns|burns
180286|NCT02457637|chronic liver disease|chronic liver disease
180287|NCT02457637|acute liver injury|acute liver injury
180288|NCT02457637|acute decompensation|acute decompensation
180289|NCT02457637|multiple organ failures|multiple organ failures
180290|NCT02457637|acute on chronic liver failure|acute on chronic liver failure
180291|NCT02457624|gastric cancer|gastric cancer
180292|NCT02457624|chronic atrophic gastritis|chronic atrophic gastritis
180293|NCT02457624|intestinal metaplasia|intestinal metaplasia
180294|NCT02457546|Fibrin sealant|fibrin sealant
180295|NCT02457546|CSF leak|csf leak
180296|NCT02457494|CALVIH|calvih
180297|NCT02457494|Renal stone|renal stone
180298|NCT02457494|HIV1|hiv1
180299|NCT02457494|Renal colic|renal colic
180300|NCT02457494|Atazanavir|atazanavir
180301|NCT02457494|Crystalluria|crystalluria
180302|NCT02457494|Chronic Kidney Disease|chronic kidney disease
180303|NCT02457494|Calcium Oxalate|calcium oxalate
180304|NCT02457481|Embryo Culture Techniques|embryo culture techniques
180305|NCT02457481|Embryonic Development|embryonic development
180306|NCT02457468|coflex|coflex
180307|NCT02457468|interlaminar stabilization|interlaminar stabilization
180308|NCT02457468|lumbar spinal stenosis|lumbar spinal stenosis
180309|NCT02457468|neurogenic claudication|neurogenic claudication
180310|NCT02457468|decompression|decompression
180311|NCT02457455|inflight emergencies|inflight emergencies
180312|NCT02457442|Anesthetics, Inhalation|anesthetics, inhalation
180313|NCT02457442|Anesthetics, Intravenous|anesthetics, intravenous
180314|NCT02457442|Analgesics, Opioid|analgesics, opioid
180315|NCT02457429|Gastro-oesophageal reflux|gastro-oesophageal reflux
180316|NCT02457429|Children|children
180317|NCT02457429|Dx-pH Pharyngeal probe|dx-ph pharyngeal probe
180318|NCT02457429|GORD|gord
180319|NCT02457429|Trans-nasal catheter|trans-nasal catheter
180320|NCT02457416|Peanut allergy|peanut allergy
180321|NCT02457416|Oral immunotherapy|oral immunotherapy
180322|NCT02457390|contrast enhanced laparoscopic ultrasound|contrast enhanced laparoscopic ultrasound
180323|NCT02457390|CE-LUS|ce-lus
180324|NCT02457390|LUS|lus
180325|NCT02457390|robot assisted CRC resection|robot assisted crc resection
180326|NCT02457377|recurrent abortion|recurrent abortion
180327|NCT02457377|cerclage|cerclage
180328|NCT02457377|laparoscopy|laparoscopy
180329|NCT02457377|cervical imcompetence|cervical imcompetence
180330|NCT02457364|non-operative management|non-operative management
180331|NCT02457351|Phase 1|phase 1
180332|NCT02457351|Advanced solid tumor|advanced solid tumor
180333|NCT02457351|pan-CDK inhibitor|pan-cdk inhibitor
180334|NCT02457351|Drug-drug Interaction|drug-drug interaction
180335|NCT02457338|C-section|c-section
180336|NCT02457338|Infants|infants
180337|NCT02457338|Probiotic|probiotic
180338|NCT02457338|B. infantis|b. infantis
180339|NCT02457338|Microbiota|microbiota
180340|NCT02457338|Gut|gut
180341|NCT02457338|Breast milk|breast milk
180342|NCT02457338|Vaginal|vaginal
180343|NCT02457325|Articaine|articaine
180344|NCT02457325|Lower third molar|lower third molar
180345|NCT02457325|Oral Surgery|oral surgery
180346|NCT02457299|Esophagectomy|esophagectomy
180347|NCT02457299|Gastric Conduit|gastric conduit
180348|NCT02457299|Esophageal Cancer|esophageal cancer
180349|NCT02457273|PDNC(Poorly Differentiated Neuroendocrine Carcinomas)|pdnc(poorly differentiated neuroendocrine carcinomas)
180350|NCT02457273|TLC-388 (Lipotecan®)|tlc-388 (lipotecan®)
180351|NCT02457247|Drug therapy|drug therapy
180352|NCT02457234|fruits and vegetables|fruits and vegetables
180353|NCT02457234|cultural immersion|cultural immersion
180354|NCT02457221|Tacrolimus|tacrolimus
180355|NCT02457221|Cyclophosphamide|cyclophosphamide
180356|NCT02457221|Prograf|prograf
180357|NCT02457221|lupus nephritis|lupus nephritis
180358|NCT02457208|pharmacokinetics|pharmacokinetics
180359|NCT02457195|PONV|ponv
180360|NCT02457195|anesthesia|anesthesia
180361|NCT02457195|granisetron|granisetron
180362|NCT02457156|Pancreatico-jejunostomy|pancreatico-jejunostomy
180363|NCT02457156|Pancreato-duodenectomy|pancreato-duodenectomy
180364|NCT02457156|Cattell-Warren anastomosis|cattell-warren anastomosis
180365|NCT02457156|Blumgart anastomosis|blumgart anastomosis
180366|NCT02457143|recall|recall
180367|NCT02457143|income-related disparities|income-related disparities
180368|NCT02457143|cancer screening|cancer screening
180369|NCT02457117|CyberKnife|cyberknife
180370|NCT02457117|Partial breast irradiation|partial breast irradiation
180371|NCT02457117|accelerated partial breast irradiation|accelerated partial breast irradiation
180372|NCT02457117|breast sbrt|breast sbrt
180373|NCT02457091|multiple sclerosis|multiple sclerosis
180374|NCT02457091|exercise|exercise
180375|NCT02457091|home-based|home-based
180376|NCT02457091|training|training
180377|NCT02457091|fitness|fitness
180378|NCT02457078|nutritional supplements|nutritional supplements
180379|NCT02457078|lutein|lutein
180380|NCT02457078|DHA|dha
180381|NCT02457078|vitamin E|vitamin e
180382|NCT02457078|infant brain development|infant brain development
180383|NCT02457065|survivors|survivors
180384|NCT02457065|family|family
180385|NCT02457052|Medical device|medical device
180386|NCT02457039|Chemo-brain|chemo-brain
180387|NCT02457039|Drug-Related Side Effects and Adverse Reactions|drug-related side effects and adverse reactions
180388|NCT02457039|Mild Cognitive Impairment|mild cognitive impairment
180389|NCT02457039|Breast cancer|breast cancer
180390|NCT02457026|neovascular age-related macular degeneration|neovascular age-related macular degeneration
180391|NCT02457026|age-related macular degeneration|age-related macular degeneration
180392|NCT02457026|verteporfin|verteporfin
180393|NCT02457026|persistent disease activity|persistent disease activity
180394|NCT02457026|photodynamic therapy|photodynamic therapy
180395|NCT02457026|Aflibercept|aflibercept
180396|NCT02457000|Sleep|sleep
180397|NCT02457000|Skin|skin
180398|NCT02457000|Circadian Rhythm|circadian rhythm
180399|NCT02456961|Collagen crosslinking (CXL)|collagen crosslinking (cxl)
180400|NCT02456961|Standard corneal crosslinking (CXL)|standard corneal crosslinking (cxl)
180401|NCT02456961|Transepithelial CXL|transepithelial cxl
180402|NCT02456961|Iontophoresis|iontophoresis
180403|NCT02456961|Riboflavin|riboflavin
180404|NCT02456948|treatment resistant depression|treatment resistant depression
180405|NCT02456948|inflammation|inflammation
180406|NCT02456948|microglia|microglia
180407|NCT02456948|minocycline|minocycline
180408|NCT02456922|Type 1 Diabetes|type 1 diabetes
180409|NCT02456922|Type 2 Diabetes|type 2 diabetes
180410|NCT02456922|Harmony 1|harmony 1
180411|NCT02456896|Oxcarbazepine|oxcarbazepine
180412|NCT02456896|Brain Derived Neurotrophic Factor|brain derived neurotrophic factor
180413|NCT02456896|Bipolar disorder|bipolar disorder
180414|NCT02456896|Neuroprotection|neuroprotection
180415|NCT02456883|ASP2215|asp2215
180416|NCT02456883|14C-labeled gilteritinib|14c-labeled gilteritinib
180417|NCT02456883|Advanced Solid Tumors|advanced solid tumors
180418|NCT02456883|Pharmacokinetics|pharmacokinetics
180419|NCT02456883|gilteritinib|gilteritinib
180420|NCT02456870|Adipose tissue|adipose tissue
180421|NCT02456870|Overfeeding|overfeeding
180422|NCT02456857|Breast cancer|breast cancer
180423|NCT02456857|Triple-Negative Breast Cancer|triple-negative breast cancer
180424|NCT02456857|TNBC|tnbc
180425|NCT02456857|Tumors insensitive to standard neoadjuvant chemotherapy|tumors insensitive to standard neoadjuvant chemotherapy
180426|NCT02456857|Temsirolimus|temsirolimus
180427|NCT02456857|CCI-779|cci-779
180428|NCT02456857|Torisel|torisel
180429|NCT02456857|Liposomal Doxorubicin|liposomal doxorubicin
180430|NCT02456857|Doxil|doxil
180431|NCT02456857|Doxorubicin Hydrochloride (Liposomal)|doxorubicin hydrochloride (liposomal)
180432|NCT02456857|Bevacizumab|bevacizumab
180433|NCT02456857|Avastin|avastin
180434|NCT02456857|Anti-VEGF Monoclonal Antibody|anti-vegf monoclonal antibody
180435|NCT02456857|rhuMAb-VEGF|rhumab-vegf
180436|NCT02456818|Colonization|colonization
180437|NCT02456818|Multi-resistant gram negative bacteria|multi-resistant gram negative bacteria
180438|NCT02456818|Infection control measures|infection control measures
180439|NCT02456818|Hand hygiene program|hand hygiene program
180440|NCT02456818|Contact precautions|contact precautions
180441|NCT02456818|Immunocompromised host|immunocompromised host
180442|NCT02456792|PCOS|pcos
181342|NCT02450994|emphysema|emphysema
180443|NCT02456792|Clomiphene citrate resistant|clomiphene citrate resistant
180444|NCT02456792|LOD|lod
180445|NCT02456792|IVF|ivf
180446|NCT02456779|pepsin|pepsin
180447|NCT02456779|peptest|peptest
180448|NCT02456779|GERD|gerd
180449|NCT02456779|NERD|nerd
180450|NCT02456779|diagnostic|diagnostic
180451|NCT02456766|FibroTouch|fibrotouch
180452|NCT02456766|acoustic attenuation parameter|acoustic attenuation parameter
180453|NCT02456766|liver biopsy|liver biopsy
180454|NCT02456766|hepatic steatosis|hepatic steatosis
180455|NCT02456753|in labor|in labor
180456|NCT02456753|Ultrasonography|ultrasonography
180457|NCT02456753|clinical examination|clinical examination
180458|NCT02456753|Prenatal|prenatal
180459|NCT02456740|Migraine|migraine
180460|NCT02456740|Headache|headache
180461|NCT02456740|Prevention|prevention
180462|NCT02456740|Prophylaxis|prophylaxis
180463|NCT02456727|Acupuncture|acupuncture
180464|NCT02456727|Group/Community Acupuncture|group/community acupuncture
180465|NCT02456727|Individual Acupuncture|individual acupuncture
180466|NCT02456727|Chronic Pain|chronic pain
180467|NCT02456727|Underserved|underserved
180468|NCT02456727|Urban Primary Care|urban primary care
180469|NCT02456727|Osteoarthritis|osteoarthritis
180470|NCT02456727|Back Pain|back pain
180471|NCT02456727|Neck Pain|neck pain
180472|NCT02456714|Cholangiocarcinoma|cholangiocarcinoma
180473|NCT02456714|FOLFIRINOX|folfirinox
180474|NCT02456714|Phase II study|phase ii study
180475|NCT02456701|CDX3379|cdx3379
180476|NCT02456675|Refractory Hodgkin lymphoma|refractory hodgkin lymphoma
180477|NCT02456675|Relapsed Hodgkin Lymphoma|relapsed hodgkin lymphoma
180478|NCT02456649|lumpectomy margins|lumpectomy margins
180479|NCT02456636|Weight loss|weight loss
180480|NCT02456636|Weight management|weight management
180481|NCT02456636|Diabetes|diabetes
180482|NCT02456636|Heart disease|heart disease
180483|NCT02456597|Peripheral Nerve Blocks|peripheral nerve blocks
180484|NCT02456584|depot medroxyprogesterone acetate (DMPA)|depot medroxyprogesterone acetate (dmpa)
180485|NCT02456584|confidence interval (CI)|confidence interval (ci)
180486|NCT02456584|Subcutaneous (sub-Q)|subcutaneous (sub-q)
180487|NCT02456584|Intrauterine device (IUD)|intrauterine device (iud)
180488|NCT02456584|Levonorgestrel (LNG)|levonorgestrel (lng)
180489|NCT02456584|intrauterine system (IUS)|intrauterine system (ius)
180490|NCT02456558|HIV infection|hiv infection
180491|NCT02456558|antiretroviral drugs|antiretroviral drugs
180492|NCT02456558|deferiprone|deferiprone
180493|NCT02456558|pharmacokinetics|pharmacokinetics
180494|NCT02456519|children|children
180495|NCT02456519|surgery|surgery
180496|NCT02456428|Incretins|incretins
180497|NCT02456428|Antidiabetic Agents|antidiabetic agents
180498|NCT02456428|Heart Failure|heart failure
180499|NCT02456389|Probable cancer|probable cancer
180500|NCT02456389|Proven cancer|proven cancer
180501|NCT02456389|Elective cancer surgery|elective cancer surgery
180502|NCT02456389|Postoperative death|postoperative death
180503|NCT02456389|Postoperative complications|postoperative complications
180504|NCT02456389|Healthcare utilization|healthcare utilization
180505|NCT02456389|Quality of life|quality of life
180506|NCT02456389|Adjuvant therapy|adjuvant therapy
180507|NCT02456389|Disease-free survival|disease-free survival
180508|NCT02456389|Overall survival|overall survival
180509|NCT02456376|Sensor Fusion|sensor fusion
180510|NCT02456376|Stochastic Resonance Stimulation|stochastic resonance stimulation
180511|NCT02456376|Sensory deficits|sensory deficits
180512|NCT02456376|Postural Control|postural control
180513|NCT02456363|Adalimumab|adalimumab
180514|NCT02456363|NSAIDs|nsaids
180515|NCT02456363|safety|safety
180516|NCT02456363|efficacy|efficacy
180517|NCT02456337|Gingival Recession|gingival recession
180518|NCT02456337|Coronally advanced flap|coronally advanced flap
180519|NCT02456337|Periodontal regeneration|periodontal regeneration
180520|NCT02456324|Fistula, Anorectal|fistula, anorectal
180521|NCT02456311|VATS|vats
180522|NCT02456311|Energy sealing|energy sealing
180523|NCT02456298|Telehealth|telehealth
180524|NCT02456298|Applied behavior analysis|applied behavior analysis
180525|NCT02456272|Otosclerosis|otosclerosis
180526|NCT02456272|Surgical treatment|surgical treatment
180527|NCT02456272|Hearing aids|hearing aids
180528|NCT02456259|internal jugular vein patency|internal jugular vein patency
180529|NCT02456259|MICS|mics
180530|NCT02456259|neck cannula|neck cannula
180531|NCT02456259|Jugular veins|jugular veins
180532|NCT02456246|Stereotactive Body Radiation Therapy (SBRT)|stereotactive body radiation therapy (sbrt)
180533|NCT02456246|Lung Fibrosis|lung fibrosis
180534|NCT02456246|FLT-PET|flt-pet
180535|NCT02456246|NSCLC|nsclc
180536|NCT02456233|rotor|rotor
180537|NCT02456233|FIRM|firm
180538|NCT02456233|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
180539|NCT02456233|persistent atrial fibrillation|persistent atrial fibrillation
180540|NCT02456233|atrial tachyarrhythmia|atrial tachyarrhythmia
180541|NCT02456233|ablation|ablation
180542|NCT02456233|contact mapping|contact mapping
180543|NCT02456233|clinical trial|clinical trial
180544|NCT02456233|signal processing|signal processing
180545|NCT02456220|Herbst appliance|herbst appliance
180546|NCT02456220|Computed tomography|computed tomography
180547|NCT02456220|3D imaging|3d imaging
180548|NCT02456220|Growth and development|growth and development
180549|NCT02456220|Orthodontic Appliances, Functional|orthodontic appliances, functional
180550|NCT02456168|Lupus|lupus
180551|NCT02456168|SLE|sle
180552|NCT02456155|bedside placement|bedside placement
180553|NCT02456155|nasal jejunal tube|nasal jejunal tube
180554|NCT02456155|ultrasound|ultrasound
180555|NCT02456155|severe acute pancreatitis|severe acute pancreatitis
180556|NCT02456155|endoscope|endoscope
180557|NCT02456155|efficacy|efficacy
180558|NCT02456155|safety|safety
180559|NCT02456129|Clinical Trial, Phase I|clinical trial, phase i
180688|NCT02455115|Renal blood flow|renal blood flow
180560|NCT02456077|MCV4: Meningococcal Conjugate Vaccine|mcv4: meningococcal conjugate vaccine
180561|NCT02456077|HPV: Human Papillomavirus|hpv: human papillomavirus
180562|NCT02456051|Pancreatic Carcinoma|pancreatic carcinoma
180563|NCT02456051|New-Onset Diabetes|new-onset diabetes
180564|NCT02456051|Adrenomedullin|adrenomedullin
180565|NCT02456051|Early Diagnosis|early diagnosis
180566|NCT02456051|Biological Markers|biological markers
180567|NCT02456012|peptic ulcer hemorrhage|peptic ulcer hemorrhage
180568|NCT02456012|comorbidity|comorbidity
180569|NCT02456012|clinical trial|clinical trial
180570|NCT02455973|obesity|obesity
180571|NCT02455973|overweight|overweight
180572|NCT02455947|Burnout|burnout
180573|NCT02455947|Teachers|teachers
180574|NCT02455947|Meditation|meditation
180575|NCT02455947|IBSR|ibsr
180576|NCT02455947|"The Work"|"the work"
180577|NCT02455947|Byron Katie|byron katie
180578|NCT02455895|Blepharitis|blepharitis
180579|NCT02455856|Healthy|healthy
180580|NCT02455856|Itraconazole|itraconazole
180581|NCT02455856|JNJ-42847922|jnj-42847922
180582|NCT02455843|microwave ablation|microwave ablation
180583|NCT02455843|chemotherapy|chemotherapy
180584|NCT02455830|Neonatal encephalopathy|neonatal encephalopathy
180585|NCT02455830|Hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
180586|NCT02455830|Newborn infants|newborn infants
180587|NCT02455830|Cytokines|cytokines
180588|NCT02455830|Trophic factors|trophic factors
180589|NCT02455791|Breast Cancer|breast cancer
180590|NCT02455791|Triple negative breast cancer|triple negative breast cancer
180591|NCT02455791|HER2 amplified breast cancer|her2 amplified breast cancer
180592|NCT02455791|Ultrasound-guided biopsy|ultrasound-guided biopsy
180593|NCT02455791|Fine needle aspirate|fine needle aspirate
180594|NCT02455791|FNA|fna
180595|NCT02455791|Core biopsy|core biopsy
180596|NCT02455752|LE-TME|le-tme
180597|NCT02455752|Laparoscopic rectal resection|laparoscopic rectal resection
180598|NCT02455752|Retroperitoneal resection|retroperitoneal resection
180599|NCT02455739|intestinal function|intestinal function
180600|NCT02455739|chewing gum|chewing gum
180601|NCT02455726|Peripheral Arterial Disease|peripheral arterial disease
180602|NCT02455726|Magnesium Oxide|magnesium oxide
180603|NCT02455726|Pain|pain
180604|NCT02455687|Bronchial asthma|bronchial asthma
180605|NCT02455687|Magnesium Sulfate|magnesium sulfate
180606|NCT02455687|Inhaled budesonide|inhaled budesonide
180607|NCT02455674|weight estimation|weight estimation
180608|NCT02455674|emergency|emergency
180609|NCT02455674|child|child
180610|NCT02455635|Office Hysteroscopy|office hysteroscopy
180611|NCT02455635|tubal patency|tubal patency
180612|NCT02455635|infertility|infertility
180613|NCT02455635|Lower Abdominal Pain|lower abdominal pain
180614|NCT02455609|dexmedetomidine|dexmedetomidine
180615|NCT02455609|ketamine|ketamine
180616|NCT02455609|postoperative pain|postoperative pain
180617|NCT02455596|Novaferon|novaferon
180618|NCT02455596|Recombinant anti-tumor and anti-virus protein for injection|recombinant anti-tumor and anti-virus protein for injection
180619|NCT02455596|Carcinoid Tumor|carcinoid tumor
180620|NCT02455596|Pancreatic Neuroendocrine Tumor|pancreatic neuroendocrine tumor
180621|NCT02455583|HIV prevention|hiv prevention
180622|NCT02455583|Sexual activity biomarker|sexual activity biomarker
180623|NCT02455583|Youth|youth
180624|NCT02455583|Adolescents|adolescents
180625|NCT02455570|Endoscopic Ultrasound|endoscopic ultrasound
180626|NCT02455570|Quality Management|quality management
180627|NCT02455570|Education and training|education and training
180628|NCT02455570|Safety|safety
180629|NCT02455570|Learning curve|learning curve
180630|NCT02455544|Urine congophilia|urine congophilia
180631|NCT02455518|pain|pain
180632|NCT02455505|Cancer Care and Bereavement|cancer care and bereavement
180633|NCT02455505|Supportive Care|supportive care
180634|NCT02455505|15-095|15-095
180635|NCT02455492|Mortality|mortality
180636|NCT02455492|Perioperative period|perioperative period
180637|NCT02455492|Elective surgical procedures|elective surgical procedures
180638|NCT02455479|cocaine vaccine|cocaine vaccine
180639|NCT02455479|cocaine dependence|cocaine dependence
180640|NCT02455479|Cocaine|cocaine
180641|NCT02455440|esmolol|esmolol
180642|NCT02455440|anesthetics|anesthetics
180643|NCT02455427|transcranial direct current stimulation|transcranial direct current stimulation
180644|NCT02455427|conventional physical therapy|conventional physical therapy
180645|NCT02455401|Postoperative Vomiting|postoperative vomiting
180646|NCT02455388|Nutrition|nutrition
180647|NCT02455388|Obesity|obesity
180648|NCT02455388|Pediatric|pediatric
180649|NCT02455375|Puumala virus|puumala virus
180650|NCT02455375|diagnostic|diagnostic
180651|NCT02455375|France|france
180652|NCT02455336|tetraplegia|tetraplegia
180653|NCT02455336|paraplegia|paraplegia
180654|NCT02455336|hypertriglyceridemia|hypertriglyceridemia
180655|NCT02455336|hyperlipidemia|hyperlipidemia
180656|NCT02455336|peroxisome proliferator-activated receptor alpha|peroxisome proliferator-activated receptor alpha
180657|NCT02455323|Efficacy|efficacy
180658|NCT02455323|Tension-type headache|tension-type headache
180659|NCT02455323|Manual therapy|manual therapy
180660|NCT02455284|MRI|mri
180661|NCT02455284|Tractography|tractography
180662|NCT02455284|white|white
180663|NCT02455284|physiology|physiology
180664|NCT02455284|analysis|analysis
180665|NCT02455284|matter|matter
180666|NCT02455284|tracts|tracts
180667|NCT02455271|Insomnia|insomnia
180668|NCT02455258|Inactivity|inactivity
180669|NCT02455180|Critical Care|critical care
180670|NCT02455167|HCV|hcv
180671|NCT02455167|Hepatitis C|hepatitis c
180672|NCT02455154|Chinese Traditional Medicine|chinese traditional medicine
180673|NCT02455154|Osteoporosis|osteoporosis
180674|NCT02455154|adjuvant endocrine therapy|adjuvant endocrine therapy
180675|NCT02455154|early breast cancer|early breast cancer
180676|NCT02455141|chemptherapy|chemptherapy
180677|NCT02455141|triple negative|triple negative
180678|NCT02455141|taxanes|taxanes
180679|NCT02455141|carboplatin|carboplatin
180680|NCT02455128|Anxiety|anxiety
180681|NCT02455128|Fear|fear
180682|NCT02455128|Colorectal Surgery|colorectal surgery
180683|NCT02455128|Colorectal Neoplasms|colorectal neoplasms
180684|NCT02455115|Acute kidney injury|acute kidney injury
180685|NCT02455115|Liver transplantation|liver transplantation
180686|NCT02455115|Postoperative care|postoperative care
180687|NCT02455115|Glomerular filtration rate|glomerular filtration rate
180689|NCT02455115|Vasopressor|vasopressor
180690|NCT02455115|Norepinephrine|norepinephrine
180691|NCT02455102|Prevention|prevention
180692|NCT02455102|Anticoagulation|anticoagulation
180693|NCT02455102|Electronic warning system|electronic warning system
180694|NCT02455089|Flare|flare
180695|NCT02455089|Therapeutic adjustments|therapeutic adjustments
180696|NCT02455089|Biological Marker|biological marker
180697|NCT02455089|Immunologic Marker|immunologic marker
180698|NCT02455089|Prognosis|prognosis
180699|NCT02455076|Hypoglycemia|hypoglycemia
180700|NCT02455037|Concussion|concussion
180701|NCT02455037|Contact sport|contact sport
180702|NCT02455037|Collision sport|collision sport
180703|NCT02455037|Neck strengthening|neck strengthening
180704|NCT02455024|Leukemia|leukemia
180705|NCT02455024|Leukemia, Myeloid|leukemia, myeloid
180706|NCT02455024|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
180707|NCT02455024|ponatinib|ponatinib
180708|NCT02455024|Pharmacologic Actions|pharmacologic actions
180709|NCT02455024|Protein Kinase Inhibitors|protein kinase inhibitors
180710|NCT02455024|Risk factor|risk factor
180711|NCT02455024|Leukemia, Myelogenous, Chronic|leukemia, myelogenous, chronic
180712|NCT02455024|CML|cml
180713|NCT02455024|CP-CML|cp-cml
180714|NCT02455024|Iclusig|iclusig
180715|NCT02455024|AP24534|ap24534
180716|NCT02455024|AP-CML|ap-cml
180717|NCT02455024|BP-CML|bp-cml
180718|NCT02455024|Ph+ALL|ph+all
180719|NCT02454998|Unilateral complete cleft lip|unilateral complete cleft lip
180720|NCT02454998|Alveolar bone graft|alveolar bone graft
180721|NCT02454946|Blood Group Antigens|blood group antigens
180722|NCT02454946|erectile dysfunction|erectile dysfunction
180723|NCT02454933|Phase III Open Label Study; AZD9291 plus MEDI4736 versus AZD9291 Monotherapy; NSCLC After Previous EGFR TKI Therapy; T790M Mutation Positive Tumours.|phase iii open label study; azd9291 plus medi4736 versus azd9291 monotherapy; nsclc after previous egfr tki therapy; t790m mutation positive tumours.
180724|NCT02454920|Strabismus|strabismus
180725|NCT02454920|Optical Coherence Tomography|optical coherence tomography
180726|NCT02454920|Extraocular muscles|extraocular muscles
180727|NCT02454868|Remifentanil|remifentanil
180728|NCT02454868|Intubation|intubation
180729|NCT02454868|Children|children
180730|NCT02454855|quality of life|quality of life
180731|NCT02454855|melatonin|melatonin
180732|NCT02454855|Elderly patient|elderly patient
180733|NCT02454842|TH-4000|th-4000
180734|NCT02454842|low-oxygen conditions|low-oxygen conditions
180735|NCT02454842|hypoxia|hypoxia
180736|NCT02454842|non-small cell lung cancer|non-small cell lung cancer
180737|NCT02454842|NSCLC|nsclc
180738|NCT02454842|squamous cell carcinoma|squamous cell carcinoma
180739|NCT02454842|Tarloxotinib|tarloxotinib
180740|NCT02454829|Ovarian cortex cryopreservation|ovarian cortex cryopreservation
180741|NCT02454829|ovarian function|ovarian function
180742|NCT02454790|Acute toxicity|acute toxicity
180743|NCT02454790|Late toxicity|late toxicity
180744|NCT02454790|Prediction models|prediction models
180745|NCT02454738|pulmonary tuberculosis|pulmonary tuberculosis
180746|NCT02454738|chest|chest
180747|NCT02454738|ultralow dose computed tomography|ultralow dose computed tomography
180748|NCT02454725|HIV Testing|hiv testing
180749|NCT02454725|Latino|latino
180750|NCT02454712|Prodrug|prodrug
180751|NCT02454712|PF614|pf614
180752|NCT02454712|oxycodone extended-release|oxycodone extended-release
180753|NCT02454712|oral|oral
180754|NCT02454699|antiviral|antiviral
180755|NCT02454699|ascending dose|ascending dose
180756|NCT02454699|Cytomegalovirus|cytomegalovirus
180757|NCT02454699|food effect|food effect
180758|NCT02454699|Herpesviridae|herpesviridae
180759|NCT02454699|MBX-400|mbx-400
180760|NCT02454686|Complications after hepatectomy|complications after hepatectomy
180761|NCT02454673|Radiotherapy|radiotherapy
180762|NCT02454673|Neoadjuvant therapy|neoadjuvant therapy
180763|NCT02454673|Pharmacodynamics|pharmacodynamics
180764|NCT02454673|Pharmacokinetics|pharmacokinetics
180765|NCT02454673|Nonlinear Dynamics|nonlinear dynamics
180766|NCT02454660|adherence|adherence
180767|NCT02454660|hypertension|hypertension
180768|NCT02454660|mobile technology|mobile technology
180769|NCT02454660|intervention|intervention
180770|NCT02454647|Radiotherapy|radiotherapy
180771|NCT02454647|Neoadjuvant therapy|neoadjuvant therapy
180772|NCT02454647|Induction chemotherapy|induction chemotherapy
180773|NCT02454647|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
180774|NCT02454647|Preoperative factors|preoperative factors
180775|NCT02454647|Dynamic factors|dynamic factors
180776|NCT02454647|Prognostic Factor|prognostic factor
180777|NCT02454634|IDH1R132H|idh1r132h
180778|NCT02454634|peptide vaccine|peptide vaccine
180779|NCT02454634|immunotherapy|immunotherapy
180780|NCT02454634|IDH1R132H-mutated glioma|idh1r132h-mutated glioma
180781|NCT02454556|Assisted reproduction technologies|assisted reproduction technologies
180782|NCT02454556|Follicle stimulating hormone (FSH).|follicle stimulating hormone (fsh).
180783|NCT02454543|metastatic|metastatic
180784|NCT02454543|prostatectomy|prostatectomy
180785|NCT02454543|androgen deprivation|androgen deprivation
180786|NCT02454543|best systemic therapy|best systemic therapy
180787|NCT02454504|Sugammadex|sugammadex
180788|NCT02454504|Delayed Emergence from Anesthesia|delayed emergence from anesthesia
180789|NCT02454504|Curare|curare
180790|NCT02454504|Robotic Surgical Procedures|robotic surgical procedures
180791|NCT02454491|percutaneous coronary interventions|percutaneous coronary interventions
180792|NCT02454491|radial artery access|radial artery access
180793|NCT02454491|access site complications|access site complications
180794|NCT02454491|verapamil|verapamil
180795|NCT02454491|heparin|heparin
180796|NCT02454478|lenvatinib|lenvatinib
180797|NCT02454478|Everolimus|everolimus
180798|NCT02454478|Carcinoma|carcinoma
180799|NCT02454478|Unresectable advanced renal cell carcinoma|unresectable advanced renal cell carcinoma
180800|NCT02454478|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
180801|NCT02454452|Varicose Veins|varicose veins
180802|NCT02454439|Heart Failure with reduced ejection fraction (<35%)|heart failure with reduced ejection fraction (<35%)
180803|NCT02454439|Cardiac Resynchronisation Therapy|cardiac resynchronisation therapy
180804|NCT02454439|Non specific intraventricular conduction|non specific intraventricular conduction
180805|NCT02454439|Efficacy|efficacy
180806|NCT02454439|Life expectancy expected to exceed one year with a good functional status|life expectancy expected to exceed one year with a good functional status
180807|NCT02454439|QRS morphology : NICD according to the AHA/ACCF/HRS Recommendations (non-LBBB and non-RBBB):|qrs morphology : nicd according to the aha/accf/hrs recommendations (non-lbbb and non-rbbb):
180808|NCT02454439|QRS duration > 130 ms|qrs duration > 130 ms
180809|NCT02454426|Depression|depression
180810|NCT02454426|Heart disease|heart disease
180811|NCT02454413|dentures hygiene|dentures hygiene
180812|NCT02454413|biofilm formation|biofilm formation
180813|NCT02454413|oral health|oral health
180814|NCT02454400|physical therapy|physical therapy
180815|NCT02454400|lumbar spine surgery|lumbar spine surgery
180816|NCT02454400|pre-surgical intervention|pre-surgical intervention
180817|NCT02454400|RCT|rct
180818|NCT02454374|Physiotherapy|physiotherapy
180819|NCT02454374|Knee Loading|knee loading
180820|NCT02454374|Randomised Controlled Trial|randomised controlled trial
180821|NCT02454374|Pain|pain
180822|NCT02454361|Safety|safety
180823|NCT02454361|tolerability|tolerability
180824|NCT02454361|pharmacokinetics|pharmacokinetics
180825|NCT02454361|KBP-7072|kbp-7072
180826|NCT02454348|septic shock|septic shock
180827|NCT02454348|vasopressin|vasopressin
180828|NCT02454348|norepinephrine|norepinephrine
180829|NCT02454296|Laminaria|laminaria
180830|NCT02454270|First-in-Human|first-in-human
180831|NCT02454270|B-Cell Chronic Lymphocytic Leukemia|b-cell chronic lymphocytic leukemia
180832|NCT02454270|Diffuse Large-Cell Lymphoma|diffuse large-cell lymphoma
180833|NCT02454270|Follicular Lymphoma|follicular lymphoma
180834|NCT02454270|Mantle-Cell Lymphoma|mantle-cell lymphoma
180835|NCT02454270|Acute Lymphoid Leukemia|acute lymphoid leukemia
180836|NCT02454270|Dose Escalation Study|dose escalation study
180837|NCT02454270|Duvortuxizumab|duvortuxizumab
180838|NCT02454231|EPC|epc
180839|NCT02454231|CD34+|cd34+
180840|NCT02454231|CD14+CD34low|cd14+cd34low
180841|NCT02454218|Fibromyalgia|fibromyalgia
180842|NCT02454218|Transcranial direct current stimulation|transcranial direct current stimulation
180843|NCT02454192|Evidence-based intervention|evidence-based intervention
180844|NCT02454192|Implementation|implementation
180845|NCT02454192|Underserved communities|underserved communities
180846|NCT02454127|nutrition|nutrition
180847|NCT02454127|popular diets|popular diets
180848|NCT02454127|weight loss|weight loss
180849|NCT02454127|lifestyle|lifestyle
180850|NCT02454127|counseling|counseling
180851|NCT02454114|Pneumonia|pneumonia
180852|NCT02454114|Community|community
180853|NCT02454114|Hospital|hospital
180854|NCT02454114|Respiratory|respiratory
180855|NCT02454114|Infection|infection
180856|NCT02454088|Volume|volume
180857|NCT02454088|Hands|hands
180858|NCT02454088|Filler|filler
180859|NCT02454088|Radiesse|radiesse
180860|NCT02454088|Calcium hydroxylapatite|calcium hydroxylapatite
180861|NCT02454075|YF476|yf476
180862|NCT02454075|netazepide|netazepide
180863|NCT02454075|gastric carcinoids|gastric carcinoids
180864|NCT02454075|Zollinger-Ellison syndrome|zollinger-ellison syndrome
180865|NCT02454062|Phase I|phase i
180866|NCT02454062|Solid Tumors|solid tumors
180867|NCT02454062|Pharmacokinetics|pharmacokinetics
180868|NCT02454062|Pharmacodynamics|pharmacodynamics
180869|NCT02454062|MTD|mtd
180870|NCT02454023|Stroke|stroke
180871|NCT02454023|Transient ischemic attack|transient ischemic attack
180872|NCT02454023|Obstructive sleep apnea|obstructive sleep apnea
180873|NCT02454023|Portable sleep monitor|portable sleep monitor
180874|NCT02454023|Screening|screening
180875|NCT02453997|lupus nephritis|lupus nephritis
180876|NCT02453997|mycophenolic acid|mycophenolic acid
180877|NCT02453997|pharmacokinetics|pharmacokinetics
180878|NCT02453997|pharmacogenomics|pharmacogenomics
180879|NCT02453984|89Zr-MPLD3280A-PET|89zr-mpld3280a-pet
180880|NCT02453984|triple-negative breast cancer|triple-negative breast cancer
180881|NCT02453984|non small cell lung cancer|non small cell lung cancer
180882|NCT02453984|bladder cancer|bladder cancer
180883|NCT02453971|alcohol consumption|alcohol consumption
180884|NCT02453971|binge drinking|binge drinking
180885|NCT02453971|web-based personalized feedback program|web-based personalized feedback program
180886|NCT02453971|students|students
180887|NCT02453958|Injury|injury
180888|NCT02453958|Brain|brain
180889|NCT02453958|Traumatic Mild|traumatic mild
180890|NCT02453958|Mild Traumatic Brain Injury|mild traumatic brain injury
180891|NCT02453945|pain|pain
180892|NCT02453945|comfort|comfort
180893|NCT02453945|healing|healing
180894|NCT02453945|quality of life|quality of life
180895|NCT02453932|Vascular dementia|vascular dementia
180896|NCT02453932|Tianzhi granule|tianzhi granule
180897|NCT02453932|Herbal medicine|herbal medicine
180898|NCT02453932|Randomized controlled trial|randomized controlled trial
180899|NCT02453932|Three arms|three arms
180900|NCT02453919|functional cardiac abnormality|functional cardiac abnormality
180901|NCT02453919|morphologic cardiac abnormality|morphologic cardiac abnormality
180902|NCT02453919|blood pressure abnormality|blood pressure abnormality
180903|NCT02453893|Iloperidone|iloperidone
180904|NCT02453893|Risperidone|risperidone
180905|NCT02453893|PANSS|panss
180906|NCT02453880|anxiety|anxiety
180907|NCT02453880|depression|depression
180908|NCT02453880|chronic illness|chronic illness
180909|NCT02453880|teen|teen
180910|NCT02453880|young adult|young adult
180911|NCT02453867|kidney transplantation|kidney transplantation
180912|NCT02453867|senior kidney transplant recipients|senior kidney transplant recipients
180913|NCT02453867|tacrolimus once daily|tacrolimus once daily
180914|NCT02453867|reduced immunosuppression|reduced immunosuppression
180915|NCT02453867|recipients >65 years|recipients >65 years
180916|NCT02453867|Senior|senior
180917|NCT02453802|Tranexamic Acid|tranexamic acid
180918|NCT02453802|Total Knee Arthroplasty|total knee arthroplasty
180919|NCT02453802|Rivaroxaban|rivaroxaban
180920|NCT02453789|alginate oligosaccharide|alginate oligosaccharide
180921|NCT02453789|cystic fibrosis|cystic fibrosis
180922|NCT02453789|Burkholderia|burkholderia
180923|NCT02453789|aztreonam|aztreonam
180924|NCT02453776|Crohns Disease|crohns disease
180925|NCT02453776|Ulcerative Colitis|ulcerative colitis
180926|NCT02453776|Infliximab|infliximab
180927|NCT02453776|Sustained|sustained
180928|NCT02453776|Remission|remission
180929|NCT02453776|Inflammatory bowel disease|inflammatory bowel disease
180930|NCT02453776|IBD|ibd
180931|NCT02453763|Transcranial direct current stimulation|transcranial direct current stimulation
180932|NCT02453763|Noninvasive brain stimulation|noninvasive brain stimulation
180933|NCT02453763|Brain|brain
180934|NCT02453763|Central Nervous System Diseases|central nervous system diseases
180935|NCT02453763|Nervous System Diseases|nervous system diseases
180936|NCT02453763|Parkinson disease|parkinson disease
180937|NCT02453763|Stroke|stroke
180938|NCT02453763|Epilepsy|epilepsy
180939|NCT02453763|Depression|depression
180940|NCT02453763|Schizophrenia|schizophrenia
180941|NCT02453763|Brain imaging|brain imaging
180942|NCT02453763|Electrical impedance tomography|electrical impedance tomography
180943|NCT02453763|Magnetic resonance electrical impedance tomography|magnetic resonance electrical impedance tomography
180944|NCT02453763|Diffusion tensor imaging|diffusion tensor imaging
180945|NCT02453763|Functional magnetic imaging|functional magnetic imaging
180946|NCT02453763|Rehabilitation|rehabilitation
180947|NCT02453750|Congenital Diaphragmatic Hernia|congenital diaphragmatic hernia
180948|NCT02453750|Airway Inflammation|airway inflammation
180949|NCT02453750|Asthma|asthma
180950|NCT02453750|Hypersaline|hypersaline
180951|NCT02453750|Pediatrics|pediatrics
180952|NCT02453737|Proton|proton
180953|NCT02453737|Brachytherapy|brachytherapy
180954|NCT02453737|Partial Breast Irradiation|partial breast irradiation
180955|NCT02453737|3D Conformal Photon|3d conformal photon
180956|NCT02453724|Ultrasonography|ultrasonography
180957|NCT02453724|Lung|lung
180958|NCT02453724|Hemorrhage|hemorrhage
180959|NCT02453724|Point of care ultrasound|point of care ultrasound
180960|NCT02453698|Stop task|stop task
180961|NCT02453698|modulatory effect of MPH|modulatory effect of mph
180962|NCT02453698|bottom-up and top-down|bottom-up and top-down
180963|NCT02453698|cognitive processes|cognitive processes
180964|NCT02453633|Appointment reminder|appointment reminder
180965|NCT02453633|Attendance|attendance
180966|NCT02453633|No-show|no-show
180967|NCT02453594|PD1|pd1
180968|NCT02453594|PD-1|pd-1
180969|NCT02453594|PDL1|pdl1
180970|NCT02453594|PD-L1|pd-l1
180971|NCT02453542|hemophilia|hemophilia
180972|NCT02453542|inhibitors|inhibitors
180973|NCT02453542|thrombin|thrombin
180974|NCT02453529|plasma concentration|plasma concentration
180975|NCT02453529|pulmonary concentration|pulmonary concentration
180976|NCT02453516|Serratus Block|serratus block
180977|NCT02453516|Breast Surgery|breast surgery
180978|NCT02453503|Lichen planus|lichen planus
180979|NCT02453503|Mucoadhesive film|mucoadhesive film
180980|NCT02453503|licorice|licorice
180981|NCT02453490|Colorectal Cancer|colorectal cancer
180982|NCT02453490|liver metastasis|liver metastasis
180983|NCT02453490|neoadjuvant chemotherapy|neoadjuvant chemotherapy
180984|NCT02453477|Beta thalassemia|beta thalassemia
180985|NCT02453477|Gene therapy|gene therapy
180986|NCT02453477|Lentiviral vector|lentiviral vector
180987|NCT02453451|MitraClip|mitraclip
180988|NCT02453451|atrial septal defect|atrial septal defect
180989|NCT02453451|iatrogenic|iatrogenic
180990|NCT02453425|renal blood flow|renal blood flow
180991|NCT02453425|renal oxygenation|renal oxygenation
180992|NCT02453425|glomerular filtration rate|glomerular filtration rate
180993|NCT02453425|filtration fraction|filtration fraction
180994|NCT02453425|blood pressure|blood pressure
180995|NCT02453412|Arteriovenous fistulae (AVFs)|arteriovenous fistulae (avfs)
180996|NCT02453412|Non-maturation|non-maturation
180997|NCT02453412|Computational simulation|computational simulation
180998|NCT02453386|Motor fluctuations|motor fluctuations
180999|NCT02453386|Off time|off time
181000|NCT02453386|On time|on time
181001|NCT02453386|Dyskinesia|dyskinesia
181002|NCT02453360|Anesthesia|anesthesia
181003|NCT02453360|Analgesia|analgesia
181004|NCT02453347|Stable chronic medical conditions|stable chronic medical conditions
181005|NCT02453347|No current alcohol or substance abuse|no current alcohol or substance abuse
181006|NCT02453347|Alpha Stim|alpha stim
181007|NCT02453321|Continuous Femoral Nerve Block|continuous femoral nerve block
181008|NCT02453321|Continuous Adductor Canal Block|continuous adductor canal block
181009|NCT02453308|Artemisinin combination Therapies|artemisinin combination therapies
181010|NCT02453295|Lymphedema|lymphedema
181011|NCT02453295|Arm Disability|arm disability
181012|NCT02453295|Cancer Survivorship|cancer survivorship
181013|NCT02453295|Intervention|intervention
181014|NCT02453282|NSCLC, PD-L1, MEDI4736, Tremelimumab, PFS, OS|nsclc, pd-l1, medi4736, tremelimumab, pfs, os
181015|NCT02453269|Obesity|obesity
181016|NCT02453269|Children|children
181017|NCT02453269|Health Colective|health colective
181018|NCT02453243|Suicide screening in the ED|suicide screening in the ed
181019|NCT02453243|Safety Planning|safety planning
181020|NCT02453217|severe mental illness|severe mental illness
181021|NCT02453217|physical health screening|physical health screening
181022|NCT02453217|randomised controlled trial|randomised controlled trial
181023|NCT02453217|health behaviour change|health behaviour change
181024|NCT02453178|physical activity|physical activity
181025|NCT02453178|aging|aging
181026|NCT02453178|cognition|cognition
181027|NCT02453178|brain|brain
181028|NCT02453178|exercise|exercise
181029|NCT02453165|vaginal dehiscence|vaginal dehiscence
181030|NCT02453152|myotubular myopathy|myotubular myopathy
181031|NCT02453152|respiratory muscles|respiratory muscles
181032|NCT02453152|natural history|natural history
181033|NCT02453126|Eosinophilic Esophagitis|eosinophilic esophagitis
181034|NCT02453126|Esophageal Stricture|esophageal stricture
181035|NCT02453048|Pertussis|pertussis
181036|NCT02453048|Colonization|colonization
181037|NCT02453048|Vaccine|vaccine
181038|NCT02453048|Immune response|immune response
181039|NCT02453048|BPZE1|bpze1
181040|NCT02453048|Infection|infection
181041|NCT02453048|Bordetella pertussis|bordetella pertussis
181042|NCT02453048|B. pertussis|b. pertussis
181043|NCT02453048|respiratory Tract Infection|respiratory tract infection
181044|NCT02453035|bioresorbable scaffold|bioresorbable scaffold
181045|NCT02453035|CAD|cad
181046|NCT02453022|Bioavailability|bioavailability
181047|NCT02453022|Omeprazole|omeprazole
181048|NCT02453022|Danirixin|danirixin
181049|NCT02453022|Food Effect|food effect
181050|NCT02453022|Pharmacokinetics|pharmacokinetics
181051|NCT02452996|GNbAC1|gnbac1
181052|NCT02452996|Multiple Sclerosis|multiple sclerosis
181053|NCT02452996|Multiple Sclerosis Associated Retrovirus (MSRV)|multiple sclerosis associated retrovirus (msrv)
181054|NCT02452996|MSRV-Envelope protein|msrv-envelope protein
181055|NCT02452996|Monoclonal antibody|monoclonal antibody
181056|NCT02452983|Anemia|anemia
181057|NCT02452983|Leukemia|leukemia
181058|NCT02452983|Hematologic diseases|hematologic diseases
181059|NCT02452983|Cytopenias|cytopenias
181060|NCT02452983|Bone marrow diseases|bone marrow diseases
181061|NCT02452983|Preleukemia|preleukemia
181062|NCT02452944|nerve stimulator, obturator nerve, ultrasound|nerve stimulator, obturator nerve, ultrasound
181063|NCT02452918|skin infection|skin infection
181064|NCT02452892|Depression|depression
181065|NCT02452892|Major depression|major depression
181066|NCT02452892|Low-field magnetic stimulation|low-field magnetic stimulation
181067|NCT02452892|LFMS|lfms
181068|NCT02452840|neovascular age-related macular degeneration|neovascular age-related macular degeneration
181069|NCT02452840|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
181070|NCT02452840|verteporfin|verteporfin
181071|NCT02452840|photodynamic therapy|photodynamic therapy
181072|NCT02452840|persistent disease activity|persistent disease activity
181073|NCT02452710|Fatigue in Cancer Survivors|fatigue in cancer survivors
181074|NCT02452697|Nonmyeloablative|nonmyeloablative
181075|NCT02452697|Stem Cell|stem cell
181076|NCT02452697|Transplant|transplant
181077|NCT02452684|Insomnia|insomnia
181078|NCT02452658|Fast food literacy|fast food literacy
181079|NCT02452645|Food|food
181080|NCT02452645|Nutrition|nutrition
181081|NCT02452645|Physical Activity|physical activity
181082|NCT02452645|Family|family
181083|NCT02452645|Child Care|child care
181084|NCT02452645|Home|home
181085|NCT02452645|Environment|environment
181086|NCT02452632|ASP1941|asp1941
181087|NCT02452632|Type 2 diabetes mellitus|type 2 diabetes mellitus
181088|NCT02452619|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
181089|NCT02452619|brain trauma|brain trauma
181090|NCT02452619|cognitive impairment|cognitive impairment
181091|NCT02452606|Stalevo|stalevo
181092|NCT02452606|sleep disturbance|sleep disturbance
181093|NCT02452606|central circadian clock|central circadian clock
181094|NCT02452606|narcolepsy|narcolepsy
181095|NCT02452593|incontinence; pelvic floor exercises; neuromodulation|incontinence; pelvic floor exercises; neuromodulation
181096|NCT02452580|Kangaroo Mother Care|kangaroo mother care
181097|NCT02452580|Neonatal Intensive Care Units|neonatal intensive care units
181098|NCT02452580|Postnatal growth|postnatal growth
181099|NCT02452541|Traumatic Brain Injury|traumatic brain injury
181100|NCT02452541|Critically ill Patients|critically ill patients
181101|NCT02452541|Death|death
181102|NCT02452541|Head Injury|head injury
181103|NCT02452541|TBI-Prognosis|tbi-prognosis
181104|NCT02452541|Critical Care Medicine|critical care medicine
181105|NCT02452541|Withdrawal of Life Sustaining Therapy|withdrawal of life sustaining therapy
181106|NCT02452541|Prognosis|prognosis
181107|NCT02452541|Prognostic Evaluation|prognostic evaluation
181108|NCT02452541|Outcome Research|outcome research
181109|NCT02452541|Mortality|mortality
181110|NCT02452541|Decision-making|decision-making
181111|NCT02452528|Hepatitis B Virus|hepatitis b virus
181112|NCT02452528|Chronic Hepatitis B|chronic hepatitis b
181113|NCT02452528|HBV|hbv
181114|NCT02452502|stroke|stroke
181115|NCT02452502|thrombolytic therapy|thrombolytic therapy
181116|NCT02452502|atorvastatin|atorvastatin
181117|NCT02452489|Different acupoints compatibility|different acupoints compatibility
181118|NCT02452437|oxycodone|oxycodone
181119|NCT02452437|hemodialysis|hemodialysis
181120|NCT02452411|Internet|internet
181121|NCT02452411|Adjustment disorders|adjustment disorders
181122|NCT02452411|Homework assignments|homework assignments
181123|NCT02452411|Cognitive-Behavioral treatment|cognitive-behavioral treatment
181124|NCT02452411|Online therapy|online therapy
181125|NCT02452411|Emotional Regulation|emotional regulation
181126|NCT02452411|ICT's|ict's
181127|NCT02452398|Hair removal|hair removal
181128|NCT02452398|depilation|depilation
181129|NCT02452398|epilation|epilation
181130|NCT02452372|RNAi therapeutic|rnai therapeutic
181131|NCT02452372|Porphyria|porphyria
181132|NCT02452372|AIP|aip
181133|NCT02452359|stretch marks|stretch marks
181134|NCT02452346|MDS|mds
181135|NCT02452333|Excisional breast biopsy|excisional breast biopsy
181136|NCT02452333|Oncoplastic surgery|oncoplastic surgery
181137|NCT02452333|Oncoplastic reconstruction|oncoplastic reconstruction
181138|NCT02452333|Breast conserving surgery|breast conserving surgery
181139|NCT02452333|Tezel method of breast volume measurement|tezel method of breast volume measurement
181140|NCT02452320|bariatric|bariatric
181141|NCT02452320|Post-operative nausea and vomiting|post-operative nausea and vomiting
181142|NCT02452320|laparoscopic Sleeve gastrectomy|laparoscopic sleeve gastrectomy
181143|NCT02452320|intravenous acetaminophen|intravenous acetaminophen
181144|NCT02452294|Brain|brain
181145|NCT02452281|Therapeutically Unresectable|therapeutically unresectable
181146|NCT02452281|Stage III or Stage IV|stage iii or stage iv
181147|NCT02452281|Malignant Melanoma|malignant melanoma
181148|NCT02452281|Advanced Melanoma|advanced melanoma
181149|NCT02452203|floating|floating
181150|NCT02452203|interoception|interoception
181151|NCT02452177|parenteral nutrition associated liver disease|parenteral nutrition associated liver disease
181152|NCT02452177|vitamin D|vitamin d
181153|NCT02452177|short bowel syndrome|short bowel syndrome
181154|NCT02452177|farnesoid X receptor|farnesoid x receptor
181155|NCT02452177|cholestasis|cholestasis
181156|NCT02452164|otoscopy|otoscopy
181157|NCT02452164|otitis media|otitis media
181158|NCT02452164|cellphone|cellphone
181159|NCT02452164|family|family
181160|NCT02452151|Inflectra|inflectra
181161|NCT02452151|Infliximab|infliximab
181162|NCT02452151|Biosimilar|biosimilar
181163|NCT02452099|DMSO|dmso
181164|NCT02452099|cryopreservation|cryopreservation
181165|NCT02452099|autologous transplantation|autologous transplantation
181166|NCT02452099|hematopoietic stem cells|hematopoietic stem cells
181167|NCT02452099|hematological malignancies|hematological malignancies
181168|NCT02452073|low triiodothyronine syndrome|low triiodothyronine syndrome
181169|NCT02452073|chronic radiation enteritis|chronic radiation enteritis
181170|NCT02452073|triiodothyronine|triiodothyronine
181171|NCT02452073|thyroxine|thyroxine
181172|NCT02452073|thyroid stimulating hormone|thyroid stimulating hormone
181173|NCT02452060|perioperative period|perioperative period
181174|NCT02452060|pain|pain
181175|NCT02452060|gastric bypass|gastric bypass
181176|NCT02452008|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
181177|NCT02452008|enzalutamide|enzalutamide
181178|NCT02452008|LY2157299|ly2157299
181179|NCT02452008|TGF-β receptor inhibitor|tgf-β receptor inhibitor
181180|NCT02451943|leiomyosarcoma|leiomyosarcoma
181181|NCT02451943|soft tissue sarcoma (STS)|soft tissue sarcoma (sts)
181182|NCT02451943|advanced soft tissue sarcoma|advanced soft tissue sarcoma
181183|NCT02451943|metastatic soft tissue sarcoma|metastatic soft tissue sarcoma
181184|NCT02451943|liposarcoma|liposarcoma
181185|NCT02451943|undifferentiated pleomorphic sarcoma|undifferentiated pleomorphic sarcoma
181186|NCT02451943|doxorubicin|doxorubicin
181187|NCT02451917|Glargine insulin|glargine insulin
181188|NCT02451917|Chronic Kidney Disease|chronic kidney disease
181189|NCT02451917|CGMS|cgms
181190|NCT02451904|Pathogenesis|pathogenesis
181191|NCT02451904|Microvascular function|microvascular function
181192|NCT02451904|Metabolic dysregulation|metabolic dysregulation
181193|NCT02451904|Metabolomics|metabolomics
181194|NCT02451878|shyness|shyness
181195|NCT02451878|internet|internet
181196|NCT02451878|self-help|self-help
181197|NCT02451878|psychology|psychology
181198|NCT02451878|wellbeing|wellbeing
181199|NCT02451839|Crohn Disease|crohn disease
181200|NCT02451839|Arthritis, Rheumatoid|arthritis, rheumatoid
181201|NCT02451839|Psoriasis|psoriasis
181202|NCT02451839|Patient Outcome Assessment|patient outcome assessment
181203|NCT02451839|Adalimumab|adalimumab
181204|NCT02451839|Global Health|global health
181205|NCT02451839|Quality of Life|quality of life
181206|NCT02451826|ovulation inhibition|ovulation inhibition
181207|NCT02451826|endometrial changes|endometrial changes
181208|NCT02451826|bleeding patterns|bleeding patterns
181209|NCT02451813|opening injection pressure|opening injection pressure
181210|NCT02451813|femoral nerve block|femoral nerve block
181211|NCT02451813|fascia iliaca|fascia iliaca
181212|NCT02451813|ultrasound guided nerve block|ultrasound guided nerve block
181213|NCT02451774|pediatric|pediatric
181214|NCT02451774|apoptosis|apoptosis
181215|NCT02451761|chromosomal rearrangement|chromosomal rearrangement
181216|NCT02451761|next generation sequencing|next generation sequencing
181217|NCT02451761|intellectual disability|intellectual disability
181218|NCT02451761|multiple congenital anomalies|multiple congenital anomalies
181219|NCT02451761|gene disruption|gene disruption
181220|NCT02451735|female breast cancer|female breast cancer
181221|NCT02451735|bilateral breast cancer|bilateral breast cancer
181222|NCT02451735|triple negative breast cancer|triple negative breast cancer
181223|NCT02451735|breast cancer diagnosis|breast cancer diagnosis
181224|NCT02451735|BRCA 1|brca 1
181225|NCT02451735|BRCA 2|brca 2
181226|NCT02451735|psychoeducational intervention (PEI)|psychoeducational intervention (pei)
181227|NCT02451735|genetic counseling|genetic counseling
181228|NCT02451735|hereditary breast and ovarian cancer (HBOC)|hereditary breast and ovarian cancer (hboc)
181229|NCT02451735|cancer education materials|cancer education materials
181230|NCT02451683|SCI|sci
181231|NCT02451631|Mobile Application|mobile application
181232|NCT02451631|Diabetes management|diabetes management
181233|NCT02451618|Perinatal Depression|perinatal depression
181234|NCT02451605|surgery|surgery
181235|NCT02451592|Fungemia|fungemia
181236|NCT02451592|Hematologic malignancies|hematologic malignancies
181237|NCT02451579|Actinic Keratoses|actinic keratoses
181238|NCT02451579|Photodynamic Therapy|photodynamic therapy
181239|NCT02451579|PDT|pdt
181240|NCT02451579|Blue Light|blue light
181241|NCT02451566|Abdominal|abdominal
181242|NCT02451566|Aortic|aortic
181243|NCT02451566|Aneurysm|aneurysm
181244|NCT02451540|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
181245|NCT02451540|dynamics hyperinflation|dynamics hyperinflation
181246|NCT02451540|Computed Tomography scan|computed tomography scan
181247|NCT02451540|CT scan|ct scan
181248|NCT02451540|Functional Respiratory Imaging|functional respiratory imaging
181249|NCT02451540|FRI|fri
181250|NCT02451540|Roflumilast|roflumilast
181251|NCT02451540|PRO|pro
181252|NCT02451514|Antibody persistence|antibody persistence
181253|NCT02451514|Young Adults|young adults
181254|NCT02451514|Healthy Adolescents|healthy adolescents
181255|NCT02451514|MenABCWY vaccine|menabcwy vaccine
181256|NCT02451514|Booster response|booster response
181257|NCT02451514|MenABCWY+OMV|menabcwy+omv
181258|NCT02451475|Pregabalin|pregabalin
181259|NCT02451475|Fibromyalgia|fibromyalgia
181260|NCT02451462|hematopoietic stem cell transplant|hematopoietic stem cell transplant
181261|NCT02451462|bone marrow transplant|bone marrow transplant
181262|NCT02451449|Celiac disease|celiac disease
181263|NCT02451449|Infertility|infertility
181264|NCT02451449|Prevalence study|prevalence study
181265|NCT02451436|Adolescents, sleep, media use, obesity, type 2 diabetes|adolescents, sleep, media use, obesity, type 2 diabetes
181266|NCT02451423|Non-metastatic|non-metastatic
181267|NCT02451423|Bladder|bladder
181268|NCT02451410|Nutrition|nutrition
181269|NCT02451410|Physical activity|physical activity
181270|NCT02451410|Overweight|overweight
181271|NCT02451410|Obesity|obesity
181272|NCT02451410|Malnutrition|malnutrition
181273|NCT02451371|Schizophrenia|schizophrenia
181274|NCT02451371|Refractory auditory hallucination|refractory auditory hallucination
181275|NCT02451371|tDCS|tdcs
181276|NCT02451358|Influenza|influenza
181277|NCT02451358|Quadrivalent Inactivated Influenza Vaccine (QIV)|quadrivalent inactivated influenza vaccine (qiv)
181278|NCT02451345|Prostate cancer|prostate cancer
181279|NCT02451345|Tranformative Impact Award|tranformative impact award
181280|NCT02451345|Early stage|early stage
181281|NCT02451345|Active Surveillance|active surveillance
181282|NCT02451345|Decision aid|decision aid
181283|NCT02451345|Coaching session|coaching session
181284|NCT02451345|Personalized|personalized
181285|NCT02451345|UCSF|ucsf
181286|NCT02451345|validation|validation
181287|NCT02451319|RIRS, holmium, 1-2 cm,stones,kidney|rirs, holmium, 1-2 cm,stones,kidney
181288|NCT02451293|Depression|depression
181289|NCT02451293|Acute Coronary Syndrome|acute coronary syndrome
181290|NCT02451293|Anxiety|anxiety
181291|NCT02451293|Sleep|sleep
181292|NCT02451293|Circadian|circadian
181293|NCT02451280|stroke rehabilitation|stroke rehabilitation
181294|NCT02451280|robot-assisted therapy|robot-assisted therapy
181295|NCT02451280|hybrid therapy|hybrid therapy
181296|NCT02451267|neck pain|neck pain
181297|NCT02451267|aerobic exercise|aerobic exercise
181298|NCT02451267|cervical pain|cervical pain
181299|NCT02451241|Acupuncture|acupuncture
181300|NCT02451228|Pharmacokinetics|pharmacokinetics
181301|NCT02451228|Pharmacodynamics|pharmacodynamics
181302|NCT02451228|Preterm labor|preterm labor
181303|NCT02451228|Preterm birth|preterm birth
181304|NCT02451228|Estradiol|estradiol
181305|NCT02451228|Indomethacin|indomethacin
181306|NCT02451228|Pregnancy|pregnancy
181307|NCT02451228|Short Cervix|short cervix
181308|NCT02451228|CYP2C9 Genotype|cyp2c9 genotype
181309|NCT02451202|"surgical conditions"|"surgical conditions"
181310|NCT02451202|"deep neuromuscular blockade"|"deep neuromuscular blockade"
181311|NCT02451202|"deep neuromuscular paralysis"|"deep neuromuscular paralysis"
181312|NCT02451189|Obesity|obesity
181313|NCT02451189|Weight maintenance|weight maintenance
181314|NCT02451189|Appetite|appetite
181315|NCT02451189|Energy intake|energy intake
181316|NCT02451189|Dietary fibre|dietary fibre
181317|NCT02451189|Short-chain fatty acids|short-chain fatty acids
181318|NCT02451189|Fermentation|fermentation
181319|NCT02451189|Overweight|overweight
181320|NCT02451150|Drug therapy|drug therapy
181321|NCT02451124|Barrett|barrett
181322|NCT02451124|Cancer|cancer
181323|NCT02451124|Screening|screening
181324|NCT02451111|Rituximab|rituximab
181325|NCT02451111|Ibrutinib|ibrutinib
181326|NCT02451111|Follicular Lymphoma|follicular lymphoma
181327|NCT02451085|hip|hip
181328|NCT02451085|surgery|surgery
181329|NCT02451085|Replacement|replacement
181330|NCT02451059|community resource|community resource
181331|NCT02451059|well-child care visit|well-child care visit
181332|NCT02451059|low-income|low-income
181333|NCT02451046|Liver transplantation|liver transplantation
181334|NCT02451046|Primary dysfunction|primary dysfunction
181335|NCT02451033|Regenerative medicine|regenerative medicine
181336|NCT02451020|healthy volunteers|healthy volunteers
181337|NCT02451020|acclimatization|acclimatization
181338|NCT02451020|sleep|sleep
181339|NCT02451020|hypoxia|hypoxia
181340|NCT02450994|airway disease|airway disease
181341|NCT02450994|bronchitis|bronchitis
181343|NCT02450994|lung|lung
181344|NCT02450994|treatment|treatment
181345|NCT02450994|sleep|sleep
181346|NCT02450968|airway disease|airway disease
181347|NCT02450968|bronchitis|bronchitis
181348|NCT02450968|emphysema|emphysema
181349|NCT02450968|lung|lung
181350|NCT02450968|treatment|treatment
181351|NCT02450955|Tension-type headache|tension-type headache
181352|NCT02450955|manual therapy|manual therapy
181353|NCT02450955|disability|disability
181354|NCT02450955|spinal manipulation|spinal manipulation
181355|NCT02450929|post operative|post operative
181356|NCT02450929|pneumonia|pneumonia
181357|NCT02450929|vascular|vascular
181358|NCT02450929|orthopedic|orthopedic
181359|NCT02450929|urologic|urologic
181360|NCT02450929|neurologic|neurologic
181361|NCT02450916|work-related injury|work-related injury
181362|NCT02450916|occupational disease|occupational disease
181363|NCT02450916|workers' compensation|workers' compensation
181364|NCT02450916|psychological|psychological
181365|NCT02450916|policy|policy
181366|NCT02450903|Non-Small-Cell Lung Cancer, ALK, LDK378|non-small-cell lung cancer, alk, ldk378
181367|NCT02450890|ORADUR®-Methylphenidate|oradur®-methylphenidate
181368|NCT02450877|Children|children
181369|NCT02450877|Young Adults|young adults
181370|NCT02450877|Azacitidine|azacitidine
181371|NCT02450877|Acute Myeloid Leukemia|acute myeloid leukemia
181372|NCT02450877|Molecular Relapse|molecular relapse
181373|NCT02450877|Vidaza|vidaza
181374|NCT02450877|AZA-AML-004|aza-aml-004
181375|NCT02450864|Stiffness of Shoulder, Not Elsewhere Classified|stiffness of shoulder, not elsewhere classified
181376|NCT02450851|Rare Diseases|rare diseases
181377|NCT02450851|Undiagnosed Disease|undiagnosed disease
181378|NCT02450838|Dengue Vaccine|dengue vaccine
181379|NCT02450812|mCRPC|mcrpc
181380|NCT02450773|postpartum|postpartum
181381|NCT02450773|preeclampsia|preeclampsia
181382|NCT02450773|gestational hypertension|gestational hypertension
181383|NCT02450747|Visual Acuity|visual acuity
181384|NCT02450734|ultrasound-guided intermediate cervical plexus block|ultrasound-guided intermediate cervical plexus block
181385|NCT02450721|atherosclerosis|atherosclerosis
181386|NCT02450721|biomarkers|biomarkers
181387|NCT02450721|carotid artery stenosis|carotid artery stenosis
181388|NCT02450721|ischemic stroke.|ischemic stroke.
181389|NCT02450708|Allogeneic Hematopoietic Cell Donors|allogeneic hematopoietic cell donors
181390|NCT02450708|KIR and HLA Genotypes|kir and hla genotypes
181391|NCT02450708|15-059|15-059
181392|NCT02450695|rTMS|rtms
181393|NCT02450695|treatment refractory|treatment refractory
181394|NCT02450695|treatment resistant|treatment resistant
181395|NCT02450695|SSRI|ssri
181396|NCT02450695|clomipramine|clomipramine
181397|NCT02450669|Intubation|intubation
181398|NCT02450669|Extubation|extubation
181399|NCT02450669|Weaning|weaning
181400|NCT02450669|Mechanical ventilation|mechanical ventilation
181401|NCT02450617|Complex PTSD|complex ptsd
181402|NCT02450604|Prevalence Study|prevalence study
181403|NCT02450604|Fabry's disease|fabry's disease
181404|NCT02450604|Chronic pain|chronic pain
181405|NCT02450591|Sensitizing EGFR Mutations|sensitizing egfr mutations
181406|NCT02450591|Erlotinib|erlotinib
181407|NCT02450591|Surgery|surgery
181408|NCT02450591|Radiation Therapy|radiation therapy
181409|NCT02450591|15-067|15-067
181410|NCT02450552|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
181411|NCT02450552|ALS|als
181412|NCT02450552|Lou Gehrig|lou gehrig
181413|NCT02450539|patient reported outcomes (PRO)|patient reported outcomes (pro)
181414|NCT02450539|patient focused outcomes (PFO)|patient focused outcomes (pfo)
181415|NCT02450539|biomarkers|biomarkers
181416|NCT02450539|CDK 4 and 6|cdk 4 and 6
181417|NCT02450513|adalimumab|adalimumab
181418|NCT02450513|anti-TNF|anti-tnf
181419|NCT02450513|pharmacokinetics|pharmacokinetics
181420|NCT02450513|trough level|trough level
181421|NCT02450513|immunogenicity|immunogenicity
181422|NCT02450487|Piroxicam|piroxicam
181423|NCT02450487|Pharmacogenetic|pharmacogenetic
181424|NCT02450487|Lower Third molar|lower third molar
181425|NCT02450448|Renal Neoplasms|renal neoplasms
181426|NCT02450448|Circulating Tumor Cells|circulating tumor cells
181427|NCT02450435|Prostatic Neoplasms|prostatic neoplasms
181428|NCT02450435|Circulating TUmor Cells|circulating tumor cells
181429|NCT02450422|Colorectal Neoplasms|colorectal neoplasms
181430|NCT02450422|Circulating Tumor Cells|circulating tumor cells
181431|NCT02450409|Total knee arthroplasty|total knee arthroplasty
181432|NCT02450409|Midflexion instability|midflexion instability
181433|NCT02450409|Gap technique|gap technique
181434|NCT02450409|Anatomical alignment|anatomical alignment
181435|NCT02450396|Rare diseases|rare diseases
181436|NCT02450396|pregnancy|pregnancy
181437|NCT02450396|pregnancy,|pregnancy,
181438|NCT02450357|Breast Neoplasms|breast neoplasms
181439|NCT02450357|Circulating Tumor Cells|circulating tumor cells
181440|NCT02450279|Aerosol delivery|aerosol delivery
181562|NCT02449733|South Africa|south africa
181441|NCT02450279|Invasive mechanical ventilation|invasive mechanical ventilation
181442|NCT02450279|Jet Nebulizer|jet nebulizer
181443|NCT02450279|Vibrating-Mesh nebulizer|vibrating-mesh nebulizer
181444|NCT02450266|Primary disease|primary disease
181445|NCT02450266|multiparametric MRI|multiparametric mri
181446|NCT02450266|targeted prostate biopsy|targeted prostate biopsy
181447|NCT02450266|MRI/ultrasound fusion-guided prostate biopsy|mri/ultrasound fusion-guided prostate biopsy
181448|NCT02450266|systematic transrectal ultrasound-guided prostate biopsy|systematic transrectal ultrasound-guided prostate biopsy
181449|NCT02450253|Vascular cognitive impairment|vascular cognitive impairment
181450|NCT02450240|Depression|depression
181451|NCT02450240|Anxiety|anxiety
181452|NCT02450240|Eating Disorders|eating disorders
181453|NCT02450240|Substance Use|substance use
181454|NCT02450240|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
181455|NCT02450240|Genetics|genetics
181456|NCT02450240|Behavior|behavior
181457|NCT02450240|Mental Health|mental health
181458|NCT02450214|Ketamine|ketamine
181459|NCT02450214|Magnesium|magnesium
181460|NCT02450214|Analgesia|analgesia
181461|NCT02450214|Liposuction|liposuction
181462|NCT02450214|Lipoabdominoplasty|lipoabdominoplasty
181463|NCT02450214|Preemptive analgesia|preemptive analgesia
181464|NCT02450188|Erectile Dysfunction|erectile dysfunction
181465|NCT02450188|PDE5 inhibitors|pde5 inhibitors
181466|NCT02450188|Cognitive-behavioral Sex Therapy|cognitive-behavioral sex therapy
181467|NCT02450175|Platelet Activation|platelet activation
181468|NCT02450175|metastasis|metastasis
181469|NCT02450110|spinal cord stimulation|spinal cord stimulation
181470|NCT02450110|heart failure|heart failure
181471|NCT02450110|autonomic regulation|autonomic regulation
181472|NCT02450110|BNP|bnp
181473|NCT02450110|left ventricle systolic dysfunction|left ventricle systolic dysfunction
181474|NCT02450071|Pre-hospital|pre-hospital
181475|NCT02450071|Out-of-hospital|out-of-hospital
181476|NCT02450071|Prehospital emergency care (MeSH)|prehospital emergency care (mesh)
181477|NCT02450071|Emergency medical services (MeSH)|emergency medical services (mesh)
181478|NCT02450071|Helicopter emergency medical service|helicopter emergency medical service
181479|NCT02450071|Critical care (MeSH)|critical care (mesh)
181480|NCT02450071|Airway management (MeSH)|airway management (mesh)
181481|NCT02450071|Endotracheal intubation (MeSH)|endotracheal intubation (mesh)
181482|NCT02450071|Difficult endotracheal intubation|difficult endotracheal intubation
181483|NCT02450071|Complications (MeSH)|complications (mesh)
181484|NCT02450071|Patient safety|patient safety
181485|NCT02450058|early breast cancer|early breast cancer
181486|NCT02450058|adjuvant chemotherapy|adjuvant chemotherapy
181487|NCT02450058|FEC|fec
181488|NCT02450058|paclitaxel|paclitaxel
181489|NCT02449993|diagnostic study|diagnostic study
181490|NCT02449993|analysis of estrogen receptor|analysis of estrogen receptor
181491|NCT02449993|progesterone receptor|progesterone receptor
181492|NCT02449993|Human epidermal growth factor receptor 2|human epidermal growth factor receptor 2
181493|NCT02449993|Ki-67|ki-67
181494|NCT02449980|Spontaneous Pneumothorax|spontaneous pneumothorax
181495|NCT02449980|Video Assisted Thoracoscopic Surgery|video assisted thoracoscopic surgery
181496|NCT02449980|Tube Thoracostomy|tube thoracostomy
181497|NCT02449980|Pediatric Surgery|pediatric surgery
181498|NCT02449967|Pancreatic Cancer|pancreatic cancer
181499|NCT02449967|HepaSphere|hepasphere
181500|NCT02449954|Stress and Immune Responses|stress and immune responses
181501|NCT02449954|morphine|morphine
181502|NCT02449954|tramadol|tramadol
181503|NCT02449954|ketorolac|ketorolac
181504|NCT02449941|Stomach Neoplasms|stomach neoplasms
181505|NCT02449941|proton pump inhibitor|proton pump inhibitor
181506|NCT02449941|endoscopic submucosal dissection|endoscopic submucosal dissection
181507|NCT02449941|Helicobacter pylori|helicobacter pylori
181508|NCT02449941|Gastritis, Atrophic|gastritis, atrophic
181509|NCT02449928|Severe Sepsis with Septic Shock, Lactate|severe sepsis with septic shock, lactate
181510|NCT02449915|sacrocolpopexy|sacrocolpopexy
181511|NCT02449915|rectocele repair|rectocele repair
181512|NCT02449902|VVA|vva
181513|NCT02449902|Postmenopausal|postmenopausal
181514|NCT02449902|Painful Sex|painful sex
181515|NCT02449863|Lung ultrasound|lung ultrasound
181516|NCT02449863|Mechanical ventilation|mechanical ventilation
181517|NCT02449863|Respiratory distress syndrome|respiratory distress syndrome
181518|NCT02449863|Transient tachypnea of the newborn|transient tachypnea of the newborn
181519|NCT02449850|In-utero environment|in-utero environment
181520|NCT02449850|Asthma|asthma
181521|NCT02449850|Allergic diseases|allergic diseases
181522|NCT02449850|Food allergy|food allergy
181523|NCT02449850|Birth cohort study|birth cohort study
181524|NCT02449850|Primary prevention|primary prevention
181525|NCT02449850|Intervention study|intervention study
181526|NCT02449850|Atopic dermatitis|atopic dermatitis
181527|NCT02449850|Rhinitis|rhinitis
181528|NCT02449850|Allergy|allergy
181529|NCT02449850|Lung function|lung function
181530|NCT02449850|Non-communicable diseases|non-communicable diseases
181531|NCT02449850|Foetal growth|foetal growth
181532|NCT02449850|Obesity|obesity
181533|NCT02449850|Cardiovascular disease|cardiovascular disease
181534|NCT02449850|Diabetes|diabetes
181535|NCT02449850|Blood pressure|blood pressure
181536|NCT02449850|Anthropometric|anthropometric
181537|NCT02449850|Trans epidermic water loss|trans epidermic water loss
181538|NCT02449824|neoadjuvant chemotherapy|neoadjuvant chemotherapy
181539|NCT02449824|magnetic resonance imaging|magnetic resonance imaging
181540|NCT02449798|Difficult IV access|difficult iv access
181541|NCT02449798|AccuCath|accucath
181542|NCT02449798|IV outcomes|iv outcomes
181543|NCT02449798|patient satisfaction|patient satisfaction
181544|NCT02449785|Cystic fibrosis|cystic fibrosis
181545|NCT02449785|MRI|mri
181546|NCT02449785|UTE|ute
181547|NCT02449785|CT|ct
181548|NCT02449785|Exacerbation|exacerbation
181549|NCT02449785|Quality of life|quality of life
181550|NCT02449785|Pulmonary function|pulmonary function
181551|NCT02449772|N04.452.442.422.336|n04.452.442.422.336
181552|NCT02449746|Schizophrenia|schizophrenia
181553|NCT02449746|Psychosis|psychosis
181554|NCT02449746|Mental Health|mental health
181555|NCT02449746|Autoimmunity|autoimmunity
181556|NCT02449746|Psychoneuroimmunology|psychoneuroimmunology
181557|NCT02449733|voluntary counseling and testing (VCT)|voluntary counseling and testing (vct)
181558|NCT02449733|couples voluntary counseling and testing (CVCT)|couples voluntary counseling and testing (cvct)
181559|NCT02449733|pre-exposure prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
181560|NCT02449733|homosexuality|homosexuality
181561|NCT02449733|male|male
181563|NCT02449720|intraperitoneal|intraperitoneal
181564|NCT02449720|ropivacaine|ropivacaine
181565|NCT02449720|bowel resection|bowel resection
181566|NCT02449720|local anaesthetic|local anaesthetic
181567|NCT02449720|recovery|recovery
181568|NCT02449681|squamous cell carcinoma|squamous cell carcinoma
181569|NCT02449681|the head and neck|the head and neck
181570|NCT02449681|skin|skin
181571|NCT02449681|TH-4000|th-4000
181572|NCT02449681|Hypoxia|hypoxia
181573|NCT02449681|Tarloxotinib|tarloxotinib
181574|NCT02449668|Acupuncture|acupuncture
181575|NCT02449668|Shoulder pain|shoulder pain
181576|NCT02449668|Impingement syndrome|impingement syndrome
181577|NCT02449668|Rotator cuff tendinitis|rotator cuff tendinitis
181578|NCT02449668|Traditional Chinese medicine (TCM)|traditional chinese medicine (tcm)
181579|NCT02449642|luteinizing hormone pulsatility|luteinizing hormone pulsatility
181580|NCT02449642|estradiol level|estradiol level
181581|NCT02449642|progesterone level|progesterone level
181583|NCT02449629|Transgender|transgender
181584|NCT02449629|HIV Continuum of Care|hiv continuum of care
181585|NCT02449616|Sickle cell|sickle cell
181586|NCT02449616|vaso-occlusive crisis|vaso-occlusive crisis
181587|NCT02449603|Chinese population|chinese population
181588|NCT02449590|Onion|onion
181589|NCT02449590|Cardiovascular disease|cardiovascular disease
181590|NCT02449590|metabolomics|metabolomics
181591|NCT02449590|Gene expression|gene expression
181592|NCT02449590|Biomarker|biomarker
181593|NCT02449577|Metabolomics|metabolomics
181594|NCT02449577|Beer|beer
181595|NCT02449577|Biomarker|biomarker
181596|NCT02449577|Glucose response|glucose response
181597|NCT02449577|Insulin response|insulin response
181598|NCT02449486|Requirement of postoperative pain medication|requirement of postoperative pain medication
181599|NCT02449473|Asthma|asthma
181600|NCT02449473|Reactive Airways|reactive airways
181601|NCT02449473|Respiratory Tract Disease|respiratory tract disease
181602|NCT02449473|Obstructive Tract Disease|obstructive tract disease
181603|NCT02449473|Lung Diseases|lung diseases
181604|NCT02449460|hypertension|hypertension
181605|NCT02449460|epidemiology|epidemiology
181606|NCT02449460|glucose|glucose
181607|NCT02449460|body mass index|body mass index
181608|NCT02449460|lipids|lipids
181609|NCT02449460|smoking|smoking
181610|NCT02449460|coronary artery disease|coronary artery disease
181611|NCT02449460|arterial stiffness|arterial stiffness
181612|NCT02449460|carotid ultrasound|carotid ultrasound
181613|NCT02449447|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
181614|NCT02449447|Blended treatment|blended treatment
181615|NCT02449447|Cognitive behavior Therapy (CBT)|cognitive behavior therapy (cbt)
181616|NCT02449447|Face-to-face|face-to-face
181617|NCT02449447|internet-based treatment|internet-based treatment
181618|NCT02449421|trauma|trauma
181619|NCT02449382|continuous venovenous hemofiltration|continuous venovenous hemofiltration
181620|NCT02449382|conventional treatment|conventional treatment
181621|NCT02449382|mortality|mortality
181622|NCT02449382|acute severe hypernatremia|acute severe hypernatremia
181623|NCT02449356|Prone position ventilation|prone position ventilation
181624|NCT02449356|Endotracheal intubation|endotracheal intubation
181625|NCT02449356|Displacement|displacement
181626|NCT02449317|contrast induced acute kidney injury|contrast induced acute kidney injury
181627|NCT02449317|bioimpedance|bioimpedance
181628|NCT02449304|endometrial ablation, heavy menstrual bleeding, novosure|endometrial ablation, heavy menstrual bleeding, novosure
181629|NCT02449278|advanced-stage DLBCL|advanced-stage dlbcl
181630|NCT02449278|ISRT|isrt
181631|NCT02449278|chemotherapy|chemotherapy
181632|NCT02449265|limited-stage DLBCL|limited-stage dlbcl
181633|NCT02449265|consolidation involved-site radiotherapy|consolidation involved-site radiotherapy
181634|NCT02449265|Chemotherapy|chemotherapy
181635|NCT02449252|limited stage FL|limited stage fl
181636|NCT02449252|Involved-site Radiotherapy|involved-site radiotherapy
181637|NCT02449252|Chemotherapy|chemotherapy
181638|NCT02449239|Urinary Bladder Cancer|urinary bladder cancer
181639|NCT02449239|Non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
181640|NCT02449239|Bladder Neoplasm|bladder neoplasm
181641|NCT02449239|Bladder Tumor|bladder tumor
181642|NCT02449239|CIS|cis
181643|NCT02449239|Papillary bladder cancer|papillary bladder cancer
181644|NCT02449239|High grade bladder cancer|high grade bladder cancer
181645|NCT02449200|cervical radiculopathy|cervical radiculopathy
181646|NCT02449200|exercise|exercise
181647|NCT02449200|manual therapy|manual therapy
181648|NCT02449200|tape|tape
181649|NCT02449174|C. difficile|c. difficile
181650|NCT02449174|Fecal Microbiota transplantation|fecal microbiota transplantation
181651|NCT02449161|endometrial ablation|endometrial ablation
181652|NCT02449148|energy restriction|energy restriction
181653|NCT02449148|fasting|fasting
181654|NCT02449148|intermittent fast|intermittent fast
181655|NCT02449148|cancer prevention|cancer prevention
181656|NCT02449148|subcutaneous fat tissue gene expression|subcutaneous fat tissue gene expression
181657|NCT02449135|Pancreatic Cancer|pancreatic cancer
181658|NCT02449135|Nano drug|nano drug
181659|NCT02449122|Lung Cancer|lung cancer
181660|NCT02449122|Nano drug|nano drug
181661|NCT02449109|Liver Cancer|liver cancer
181662|NCT02449109|Nano drug|nano drug
181663|NCT02449083|MRI|mri
181664|NCT02449083|Shunt|shunt
181665|NCT02449083|COPD|copd
181666|NCT02449083|Dynamic T2 Preparation Puls|dynamic t2 preparation puls
181667|NCT02449083|new sequences|new sequences
181668|NCT02449083|magnet resonance imaging|magnet resonance imaging
181669|NCT02449083|ventricular septal defect|ventricular septal defect
181670|NCT02449083|Atrial septal defect|atrial septal defect
181671|NCT02449070|Nicorandil|nicorandil
181672|NCT02449070|Cardiac MRI|cardiac mri
181673|NCT02449044|Hyponatremia|hyponatremia
181674|NCT02449018|COPD,|copd,
181675|NCT02449018|chronic bronchitis,|chronic bronchitis,
181676|NCT02449018|inflammation,|inflammation,
181677|NCT02449018|airway,|airway,
181678|NCT02449018|LCI,|lci,
181679|NCT02449018|pulmonary function test,|pulmonary function test,
181680|NCT02449018|lung function,|lung function,
181681|NCT02449018|controlled clinical trial,|controlled clinical trial,
181682|NCT02449018|randomized,|randomized,
181683|NCT02449018|airflow,|airflow,
181684|NCT02449018|smoker|smoker
181685|NCT02449005|regeneration|regeneration
181686|NCT02449005|stem cells|stem cells
181687|NCT02449005|infrabony periodontal defect|infrabony periodontal defect
181688|NCT02449005|fibrin glue|fibrin glue
181689|NCT02449005|collagen fleece|collagen fleece
181690|NCT02448992|Neurobehavioral Assessments|neurobehavioral assessments
181691|NCT02448992|Neurocognitive Functions (NCF)|neurocognitive functions (ncf)
181692|NCT02448992|Prophylactic Cranial Irradiation (PCI)|prophylactic cranial irradiation (pci)
181693|NCT02448992|Hippocampus|hippocampus
181694|NCT02448992|Hippocampal-Sparing PCI|hippocampal-sparing pci
181695|NCT02448953|Without cervical lymph node involvement|without cervical lymph node involvement
181696|NCT02448940|probiotics|probiotics
181697|NCT02448940|Lactobacillus|lactobacillus
181699|NCT02448940|body composition|body composition
181700|NCT02448927|transcatheter aortic valve implantation|transcatheter aortic valve implantation
181701|NCT02448927|Balloon aortic valvuloplasty|balloon aortic valvuloplasty
181702|NCT02448927|Aortic stenosis|aortic stenosis
181703|NCT02448927|TAVI|tavi
181704|NCT02448927|TAVR (transcatheter aortic valve replacement)|tavr (transcatheter aortic valve replacement)
181705|NCT02448927|CoreValve|corevalve
181706|NCT02448927|BAV|bav
181707|NCT02448927|Evolut R|evolut r
181708|NCT02448862|IV-PCA|iv-pca
181709|NCT02448862|Elderly patients|elderly patients
181710|NCT02448862|Yound adults|yound adults
181711|NCT02448862|Side effect|side effect
181712|NCT02448862|Postoperative pain|postoperative pain
181713|NCT02448862|Postoperative nausea and vomiting|postoperative nausea and vomiting
181714|NCT02448849|Autologous|autologous
181715|NCT02448849|nonunion fracture|nonunion fracture
181716|NCT02448849|bone marrow|bone marrow
181717|NCT02448849|mesenchymal|mesenchymal
181718|NCT02448849|stromal cell|stromal cell
181719|NCT02448849|platelet lysate product|platelet lysate product
181720|NCT02448823|HIV|hiv
181721|NCT02448823|combined prevention|combined prevention
181722|NCT02448823|demand generation|demand generation
181723|NCT02448784|Donepezil Hydrochloride|donepezil hydrochloride
181724|NCT02448784|ARICEPT|aricept
181725|NCT02448784|Dementia|dementia
181726|NCT02448784|Lewy bodies|lewy bodies
181727|NCT02448784|Dementia with Lewy bodies|dementia with lewy bodies
181728|NCT02448784|Post-marketing surveillance|post-marketing surveillance
181729|NCT02448771|Unresectable locally advanced invasive breast cancer|unresectable locally advanced invasive breast cancer
181730|NCT02448771|Metastatic invasive breast cancer|metastatic invasive breast cancer
181731|NCT02448758|mutation|mutation
181732|NCT02448732|ACM-1|acm-1
181733|NCT02448732|intravitreal injection|intravitreal injection
181734|NCT02448732|neovascularization|neovascularization
181735|NCT02448706|hearing aid|hearing aid
181736|NCT02448693|endoscopic mucosal resection|endoscopic mucosal resection
181737|NCT02448693|piecemeal polypectomy scar|piecemeal polypectomy scar
181738|NCT02448693|colorectal neoplasms|colorectal neoplasms
181739|NCT02448693|Narrow Band Imaging|narrow band imaging
181740|NCT02448693|chromoendoscopy|chromoendoscopy
181741|NCT02448641|ischemic stroke|ischemic stroke
181742|NCT02448641|chronic stroke|chronic stroke
181743|NCT02448641|fixed motor deficits|fixed motor deficits
181744|NCT02448628|Hypertension|hypertension
181745|NCT02448628|moderate renal impairment|moderate renal impairment
181746|NCT02448628|mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
181747|NCT02448628|CS-3150|cs-3150
181748|NCT02448628|Japanese|japanese
181749|NCT02448615|Kenya|kenya
181750|NCT02448615|Cohort|cohort
181751|NCT02448602|Different acupoints compatibility|different acupoints compatibility
181752|NCT02448589|Advanced Solid Tumors|advanced solid tumors
181753|NCT02448589|Dose Escalation|dose escalation
181754|NCT02448589|Dose Expansion|dose expansion
181755|NCT02448589|MTD|mtd
181756|NCT02448589|TAS-119|tas-119
181757|NCT02448589|Aurora A Kinase Inhibitor|aurora a kinase inhibitor
181758|NCT02448576|phase 3 randomized controlled trial|phase 3 randomized controlled trial
181759|NCT02448576|prophylactic cranial irradiation|prophylactic cranial irradiation
181760|NCT02448576|triple negative breast cancer|triple negative breast cancer
181761|NCT02448576|brain metastasis|brain metastasis
181762|NCT02448576|advanced breast cancer|advanced breast cancer
181763|NCT02448563|Pregnancy|pregnancy
181764|NCT02448563|African American|african american
181765|NCT02448563|Weight Management Program|weight management program
181766|NCT02448563|Behavioral Modifications|behavioral modifications
181767|NCT02448537|Metastatic Sarcoma|metastatic sarcoma
181768|NCT02448537|Unresectable Sarcoma|unresectable sarcoma
181769|NCT02448537|PM01183|pm01183
181770|NCT02448524|Treatment|treatment
181771|NCT02448524|patients|patients
181772|NCT02448524|primary in situ CHD (de novo) lesions|primary in situ chd (de novo) lesions
181773|NCT02448511|ozone gas|ozone gas
181774|NCT02448511|ulcer|ulcer
181775|NCT02448511|infected ulcer|infected ulcer
181776|NCT02448433|Phototherapy|phototherapy
181777|NCT02448433|Light|light
181778|NCT02448433|Depression|depression
181779|NCT02448433|Sleep and circadian disturbances|sleep and circadian disturbances
181780|NCT02448433|Youth|youth
181781|NCT02448407|Knee osteoarthritis|knee osteoarthritis
181782|NCT02448407|Platelet-rich plasma|platelet-rich plasma
181783|NCT02448407|Pain's treatment|pain's treatment
181784|NCT02448394|community support workers|community support workers
181785|NCT02448394|retention in care|retention in care
181786|NCT02448381|CTCL|ctcl
181787|NCT02448381|Mycosis fungoides|mycosis fungoides
181788|NCT02448381|Hypericin|hypericin
181789|NCT02448381|SGX301|sgx301
181790|NCT02448381|MF|mf
181791|NCT02448355|OCT|oct
181792|NCT02448342|Heart Failure|heart failure
181793|NCT02448342|Remote Patient Monitoring|remote patient monitoring
181794|NCT02448342|Non Invasive Lung Fluid Status Monitor|non invasive lung fluid status monitor
181795|NCT02448290|gastric adenocarcinoma patients with low/high MEK signature,|gastric adenocarcinoma patients with low/high mek signature,
181796|NCT02448277|Macintosh laryngoscope, Pentax, Glidescope|macintosh laryngoscope, pentax, glidescope
181797|NCT02448264|kallikrein inhibitor|kallikrein inhibitor
181798|NCT02448264|oral prophylaxis|oral prophylaxis
181799|NCT02448264|BioCryst|biocryst
181800|NCT02448264|first-in-human|first-in-human
181801|NCT02448264|hereditary angioedema|hereditary angioedema
181802|NCT02448238|Human Immunodeficiency Virus|human immunodeficiency virus
181803|NCT02448238|probiotic|probiotic
181804|NCT02448238|microbial translocation|microbial translocation
181805|NCT02448238|immune activation|immune activation
181806|NCT02448238|inflammation|inflammation
181807|NCT02448238|VSL#3|vsl#3
181808|NCT02448238|Mali|mali
181809|NCT02448238|Africa|africa
181810|NCT02448212|PET|pet
181811|NCT02448212|Receptor Occupancy|receptor occupancy
181812|NCT02448199|pain|pain
181813|NCT02448199|Knee|knee
181814|NCT02448147|Heart failure|heart failure
181815|NCT02448147|Exercise|exercise
181816|NCT02448147|Biomarkers|biomarkers
181817|NCT02448147|Sympathetic Nervous System|sympathetic nervous system
181818|NCT02448147|MicroRNA|microrna
181819|NCT02448121|Cell therapy|cell therapy
181820|NCT02448121|Sickle cell disease|sickle cell disease
181821|NCT02448121|Hip Osteonecrosis|hip osteonecrosis
181822|NCT02448121|Autologous implantation|autologous implantation
181823|NCT02448121|Mesenchymal stromal cell|mesenchymal stromal cell
181824|NCT02448121|Humeral Osteonecrosis|humeral osteonecrosis
181825|NCT02448121|Knee Osteonecrosis|knee osteonecrosis
181826|NCT02448121|Ankle Osteonecrosis|ankle osteonecrosis
181827|NCT02448095|Chronic myeloid leukemia|chronic myeloid leukemia
181828|NCT02448095|Philadelphia positive|philadelphia positive
181829|NCT02448095|Compassionate use|compassionate use
181830|NCT02448082|Dandruff|dandruff
181831|NCT02448082|Pityriasis capitis|pityriasis capitis
181832|NCT02448082|Ichthyol® Pale|ichthyol® pale
181833|NCT02448082|Sodium shale oil sulponate 1%|sodium shale oil sulponate 1%
181834|NCT02448043|brittleness|brittleness
181835|NCT02448030|Metaboreflex|metaboreflex
181836|NCT02448030|Variation of blood flow|variation of blood flow
181837|NCT02448030|Functional electrical stimulation|functional electrical stimulation
181838|NCT02448030|Isometric exercise.|isometric exercise.
181839|NCT02448004|Healthy|healthy
181840|NCT02448004|JNJ-63623872|jnj-63623872
181841|NCT02448004|14C-JNJ-63623872|14c-jnj-63623872
181842|NCT02447965|Rectus Sheath Blocks|rectus sheath blocks
181843|NCT02447965|Abdominal Surgery|abdominal surgery
181844|NCT02447952|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
181845|NCT02447952|Biotelemetry|biotelemetry
181846|NCT02447939|pharmacokinetics|pharmacokinetics
181847|NCT02447939|trametinib|trametinib
181848|NCT02447939|cutaneous melanoma|cutaneous melanoma
181849|NCT02447939|dabrafenib|dabrafenib
181850|NCT02447939|safety|safety
181851|NCT02447926|leukapheresis|leukapheresis
181852|NCT02447926|regulatory T cells|regulatory t cells
181853|NCT02447926|liver transplantation|liver transplantation
181854|NCT02447913|Family planning|family planning
181855|NCT02447913|Voucher|voucher
181856|NCT02447913|Immunisations|immunisations
181857|NCT02447835|Metabolic Disorders|metabolic disorders
181858|NCT02447809|microRNA|microrna
181859|NCT02447809|Platelet|platelet
181860|NCT02447809|Clopidogrel low response|clopidogrel low response
181861|NCT02447796|(AVF)|(avf)
181862|NCT02447796|surgery|surgery
181863|NCT02447783|Flavanols|flavanols
181864|NCT02447783|Cocoa flavanols|cocoa flavanols
181865|NCT02447783|Blood pressure|blood pressure
181866|NCT02447783|Platelet Function|platelet function
181867|NCT02447770|Flavanols|flavanols
181868|NCT02447770|Cocoa flavanols|cocoa flavanols
181869|NCT02447770|Blood pressure|blood pressure
181870|NCT02447770|Platelet Function|platelet function
181871|NCT02447757|Remifentanil, delivery, childbirth, analgesia, parturition, confinement|remifentanil, delivery, childbirth, analgesia, parturition, confinement
181872|NCT02447744|depression|depression
181873|NCT02447744|anxiety|anxiety
181874|NCT02447744|early life stress|early life stress
181875|NCT02447731|respiratory insufficiency|respiratory insufficiency
181876|NCT02447692|Proportional Assist Ventilation|proportional assist ventilation
181877|NCT02447692|Pressure Support Ventilation|pressure support ventilation
181878|NCT02447692|Weaning|weaning
181879|NCT02447666|Azacitidine|azacitidine
181880|NCT02447666|Myelodysplastic syndrome|myelodysplastic syndrome
181881|NCT02447666|Juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
181882|NCT02447666|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
181883|NCT02447666|Vidaza|vidaza
181884|NCT02447666|Hypomethylating agent|hypomethylating agent
181885|NCT02447640|Volunteers|volunteers
181886|NCT02447614|follow up|follow up
181887|NCT02447614|Primary Snoring|primary snoring
181888|NCT02447614|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
181889|NCT02447588|intrauterine insemination|intrauterine insemination
181890|NCT02447588|progesterone|progesterone
181891|NCT02447549|IMRT|imrt
181892|NCT02447549|IGRT|igrt
181893|NCT02447549|Muscle invasive|muscle invasive
181894|NCT02447549|Adaptive Radiotherapy|adaptive radiotherapy
181895|NCT02447536|Immunization|immunization
181896|NCT02447536|Morbidity|morbidity
181897|NCT02447536|Mortality|mortality
181898|NCT02447536|BCG|bcg
181899|NCT02447484|female sex workers|female sex workers
181900|NCT02447484|HIV sexual risk reduction|hiv sexual risk reduction
181901|NCT02447484|behavior maintenance|behavior maintenance
181902|NCT02447484|text messaging|text messaging
181903|NCT02447458|Drug therapy|drug therapy
181904|NCT02447432|Invasive disease by Streptococcus pneumoniae (S. pneumoniae) (including sepsis, meningitis, pneumonia, bacteraemia and acute otitis media)|invasive disease by streptococcus pneumoniae (s. pneumoniae) (including sepsis, meningitis, pneumonia, bacteraemia and acute otitis media)
181905|NCT02447432|Infants|infants
181906|NCT02447432|Multidose|multidose
181907|NCT02447432|Haemophilus influenzae|haemophilus influenzae
181908|NCT02447432|Streptococcus pneumoniae|streptococcus pneumoniae
181909|NCT02447432|Preservative|preservative
181910|NCT02447432|Safety|safety
181911|NCT02447432|Pneumonia|pneumonia
181912|NCT02447432|Immunogenicity|immunogenicity
181913|NCT02447432|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
181914|NCT02447432|Acute otitis media caused by non-typeable Haemophilus influenzae (NTHi).|acute otitis media caused by non-typeable haemophilus influenzae (nthi).
181915|NCT02447432|Respiratory tract infections|respiratory tract infections
181916|NCT02447367|α1-blockers|α1-blockers
181917|NCT02447367|antimuscarinic agent|antimuscarinic agent
181918|NCT02447315|Pilocarpine|pilocarpine
181919|NCT02447289|Dental caries|dental caries
181920|NCT02447289|Moderate sedation|moderate sedation
181921|NCT02447263|Liver Cancer|liver cancer
181922|NCT02447263|HepaSphere|hepasphere
181923|NCT02447250|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
181924|NCT02447250|very low birth weight|very low birth weight
181925|NCT02447250|albuterol|albuterol
181926|NCT02447250|pulmonary function test|pulmonary function test
181927|NCT02447237|liquid diet|liquid diet
181928|NCT02447237|solid diet|solid diet
181929|NCT02447224|appendicitis|appendicitis
182037|NCT02446587|perfusion|perfusion
181930|NCT02447224|non operative management|non operative management
181931|NCT02447224|appendectomy|appendectomy
181932|NCT02447185|Lucentis|lucentis
181933|NCT02447185|Ranibizumab|ranibizumab
181934|NCT02447185|Triamcinolone Acetonide|triamcinolone acetonide
181935|NCT02447185|Vitrectomy|vitrectomy
181936|NCT02447185|PDR|pdr
181937|NCT02447185|25-Gauge Vitrectomy|25-gauge vitrectomy
181938|NCT02447159|Nigeria|nigeria
181939|NCT02447159|Developing Countries|developing countries
181940|NCT02447159|Hospitals, Maternity/Utilization|hospitals, maternity/utilization
181941|NCT02447159|Hospitals/Economics|hospitals/economics
181942|NCT02447159|HIV|hiv
181943|NCT02447133|no known ocular pathology|no known ocular pathology
181944|NCT02447120|Volunteers with Healthy Eyes|volunteers with healthy eyes
181945|NCT02447107|Chronic Pain|chronic pain
181946|NCT02447107|Technology|technology
181947|NCT02447107|Mobile Phone Applications|mobile phone applications
181948|NCT02447094|ischemic|ischemic
181949|NCT02447094|tPA|tpa
181950|NCT02447094|tele-medicine|tele-medicine
181951|NCT02447094|robot|robot
181952|NCT02447094|tele-stroke|tele-stroke
181953|NCT02447042|sepsis|sepsis
181954|NCT02447042|Fluids|fluids
181955|NCT02447042|Mean systemic filling pressure|mean systemic filling pressure
181956|NCT02447029|abortion|abortion
181957|NCT02447029|pain management|pain management
181958|NCT02447003|PD1|pd1
181959|NCT02447003|PD-1|pd-1
181960|NCT02447003|PDL1|pdl1
181961|NCT02447003|PD-L1|pd-l1
181962|NCT02446977|ischemic|ischemic
181963|NCT02446977|stroke|stroke
181964|NCT02446977|vitamin B2|vitamin b2
181965|NCT02446938|mechanical ventilation|mechanical ventilation
181966|NCT02446938|esophageal pressure|esophageal pressure
181967|NCT02446938|catheter position|catheter position
181968|NCT02446938|validation|validation
181969|NCT02446912|Active Systemic Lupus Erythematosus|active systemic lupus erythematosus
181970|NCT02446899|Active Systemic Lupus Erythematosus|active systemic lupus erythematosus
181971|NCT02446886|Multiple Sclerosis|multiple sclerosis
181972|NCT02446886|MS|ms
181973|NCT02446886|RRMS|rrms
181974|NCT02446886|SPMS|spms
181975|NCT02446886|ACTH|acth
181976|NCT02446873|children|children
181977|NCT02446873|Ecuador|ecuador
181978|NCT02446873|rural|rural
181979|NCT02446873|poor|poor
181980|NCT02446847|HIV|hiv
181981|NCT02446847|3BNC117|3bnc117
181982|NCT02446847|Broadly neutralizing antibody|broadly neutralizing antibody
181983|NCT02446834|PCOS|pcos
181984|NCT02446834|intensive lifestyle intervention|intensive lifestyle intervention
181985|NCT02446834|IGT|igt
181986|NCT02446834|drugs treatment|drugs treatment
181987|NCT02446795|Renal cell carcinoma|renal cell carcinoma
181988|NCT02446795|Isoquercetin|isoquercetin
181989|NCT02446795|kidney cancer|kidney cancer
181990|NCT02446795|sunitinib|sunitinib
181991|NCT02446795|fatigue|fatigue
181992|NCT02446782|thoracoscopy|thoracoscopy
181993|NCT02446782|pleuroscopy|pleuroscopy
181994|NCT02446782|antibiotic prophylaxis|antibiotic prophylaxis
181995|NCT02446782|pleural effusion|pleural effusion
181996|NCT02446756|Osteoarthritis|osteoarthritis
181997|NCT02446756|MRI|mri
181998|NCT02446756|Cartilage|cartilage
181999|NCT02446756|Acupuncture|acupuncture
182000|NCT02446743|Nervous System Diseases|nervous system diseases
182001|NCT02446743|Meningitis|meningitis
182002|NCT02446743|Central Nervous System Diseases|central nervous system diseases
182003|NCT02446717|Hepatitis C|hepatitis c
182004|NCT02446717|HCV Genotype 6|hcv genotype 6
182005|NCT02446717|HCV GT1|hcv gt1
182006|NCT02446717|Interferon (IFN) free|interferon (ifn) free
182007|NCT02446717|HCV Genotype 5|hcv genotype 5
182008|NCT02446717|HCV|hcv
182009|NCT02446717|HCV GT4|hcv gt4
182010|NCT02446717|HCV Genotype 4|hcv genotype 4
182011|NCT02446717|Chronic Hepatitis C|chronic hepatitis c
182012|NCT02446717|Chronic HCV|chronic hcv
182013|NCT02446717|Hepatitis C Genotype 1|hepatitis c genotype 1
182014|NCT02446717|HCV GT5|hcv gt5
182015|NCT02446717|HCV Genotype 1|hcv genotype 1
182016|NCT02446704|Small Cell Lung Cancer|small cell lung cancer
182017|NCT02446704|SCLC|sclc
182018|NCT02446678|Gastrointestinal bleeding|gastrointestinal bleeding
182019|NCT02446678|emergency department|emergency department
182020|NCT02446678|PillCam ESO2|pillcam eso2
182021|NCT02446652|Advanced cervical cancer|advanced cervical cancer
182022|NCT02446652|Epigenetic therapy|epigenetic therapy
182023|NCT02446652|Randomized phase III|randomized phase iii
182024|NCT02446626|Lyme Disease|lyme disease
182025|NCT02446626|Ixodes scapularis|ixodes scapularis
182026|NCT02446626|Borrelia Burgdorferi|borrelia burgdorferi
182027|NCT02446626|Post treatment|post treatment
182028|NCT02446626|Infection|infection
182029|NCT02446613|Allergic Rhinitis|allergic rhinitis
182030|NCT02446613|Nasal allergen challenge|nasal allergen challenge
182031|NCT02446613|Allergic Asthma|allergic asthma
182032|NCT02446613|Effect on Allergen Reactivity|effect on allergen reactivity
182033|NCT02446587|endovascular therapy|endovascular therapy
182034|NCT02446587|thrombectomy|thrombectomy
182035|NCT02446587|selection|selection
182036|NCT02446587|imaging|imaging
182038|NCT02446587|collaterals|collaterals
182039|NCT02446587|ASPECTS|aspects
182040|NCT02446574|chemoradiation|chemoradiation
182041|NCT02446574|dose escalation|dose escalation
182042|NCT02446561|Healthy Volunteer|healthy volunteer
182043|NCT02446561|Pharmacokinetics|pharmacokinetics
182044|NCT02446548|direct renin inhibitor|direct renin inhibitor
182045|NCT02446548|kidney transplantation|kidney transplantation
182046|NCT02446548|albuminuria|albuminuria
182047|NCT02446496|Bioequivalence|bioequivalence
182048|NCT02446496|film coated tablets|film coated tablets
182049|NCT02446496|cefadroxil|cefadroxil
182050|NCT02446483|Idiazole 20mg|idiazole 20mg
182051|NCT02446483|PARIET 20 mg|pariet 20 mg
182052|NCT02446483|Rabeprazole|rabeprazole
182053|NCT02446483|bioequivalence|bioequivalence
182054|NCT02446470|calcaneus|calcaneus
182055|NCT02446470|fracture fixation, internal|fracture fixation, internal
182056|NCT02446457|Lymphoma|lymphoma
182057|NCT02446457|Follicular lymphoma|follicular lymphoma
182058|NCT02446457|FL|fl
182059|NCT02446457|Relapsed|relapsed
182060|NCT02446457|Rituximab|rituximab
182061|NCT02446457|Rituxan|rituxan
182062|NCT02446457|Pembrolizumab|pembrolizumab
182063|NCT02446457|Keytruda|keytruda
182064|NCT02446457|MK-3475|mk-3475
182065|NCT02446457|SCH-900475|sch-900475
182066|NCT02446457|Lenalidomide|lenalidomide
182067|NCT02446457|CC-5013|cc-5013
182068|NCT02446457|Revlimid|revlimid
182069|NCT02446457|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
182070|NCT02446457|DLBCL|dlbcl
182071|NCT02446444|High risk|high risk
182072|NCT02446444|clinically localised prostate cancer|clinically localised prostate cancer
182073|NCT02446431|Metronomic Drug Therapy|metronomic drug therapy
182074|NCT02446418|dry powder inahler|dry powder inahler
182075|NCT02446418|vilanerol|vilanerol
182076|NCT02446418|efficacy|efficacy
182077|NCT02446418|safety|safety
182078|NCT02446418|fluticasone furoate|fluticasone furoate
182079|NCT02446418|quality of life|quality of life
182080|NCT02446405|metastatic prostate cancer|metastatic prostate cancer
182081|NCT02446405|prostate cancer|prostate cancer
182082|NCT02446405|prostate cancer treatment|prostate cancer treatment
182083|NCT02446405|enzalutamide|enzalutamide
182084|NCT02446353|Male Volunteers|male volunteers
182085|NCT02446340|ShK-186|shk-186
182086|NCT02446340|dalazatide|dalazatide
182087|NCT02446340|Kv1.3|kv1.3
182088|NCT02446340|SHK|shk
182089|NCT02446301|Nalbuphine|nalbuphine
182090|NCT02446301|SDE|sde
182091|NCT02446301|dinalbuphine|dinalbuphine
182092|NCT02446301|SDN|sdn
182093|NCT02446301|pain|pain
182094|NCT02446301|LT1001|lt1001
182095|NCT02446275|efficacy, manual therapy, migraine, quality of life|efficacy, manual therapy, migraine, quality of life
182096|NCT02446262|Pain|pain
182097|NCT02446262|Visual Analogue Pain Scale|visual analogue pain scale
182098|NCT02446262|Placebo|placebo
182099|NCT02446262|Affective Neuroscience|affective neuroscience
182100|NCT02446262|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
182101|NCT02446249|Gene Therapy|gene therapy
182102|NCT02446249|Xerostomia|xerostomia
182103|NCT02446223|Actinic Keratosis AKs Chest Pre-Cancer|actinic keratosis aks chest pre-cancer
182104|NCT02446210|SCI|sci
182105|NCT02446210|Neural Control|neural control
182106|NCT02446210|Bilateral Movement|bilateral movement
182107|NCT02446210|TMS|tms
182108|NCT02446184|urethral obstruction|urethral obstruction
182109|NCT02446184|posterior urethral valves|posterior urethral valves
182110|NCT02446184|lower urinary tract obstruction|lower urinary tract obstruction
182111|NCT02446171|naloxegol tablet crushed|naloxegol tablet crushed
182112|NCT02446171|naloxegol oral solution|naloxegol oral solution
182113|NCT02446171|naloxegol whole tablet|naloxegol whole tablet
182114|NCT02446171|relative bioavailability|relative bioavailability
182115|NCT02446171|Phase I|phase i
182116|NCT02446171|healthy subjects|healthy subjects
182117|NCT02446106|Monosodium L-Glutamate (MSG)|monosodium l-glutamate (msg)
182118|NCT02446106|Satiety|satiety
182119|NCT02446106|Soups|soups
182120|NCT02446106|Energy Intake|energy intake
182121|NCT02446106|Snack Intake|snack intake
182122|NCT02446093|pancreas|pancreas
182123|NCT02446093|pancreatic adenocarcinoma|pancreatic adenocarcinoma
182124|NCT02446093|GMCI|gmci
182125|NCT02446093|AdV-tk|adv-tk
182126|NCT02446093|aglatimagene besadenovec|aglatimagene besadenovec
182127|NCT02446080|Constipation|constipation
182128|NCT02446080|Probiotics|probiotics
182129|NCT02446080|Women|women
182130|NCT02446067|Transcranial Doppler (TCD) sonography|transcranial doppler (tcd) sonography
182131|NCT02446067|rTMS|rtms
182132|NCT02446067|Cerebral hemodynamics|cerebral hemodynamics
182133|NCT02446054|T2DM, type II diabetes Mellitus, HbA1c|t2dm, type ii diabetes mellitus, hba1c
182134|NCT02446041|COPD|copd
182135|NCT02446041|Chronic Bronchitis|chronic bronchitis
182136|NCT02446041|Pulmonary Emphysema|pulmonary emphysema
182137|NCT02446002|Volunteer|volunteer
182138|NCT02445989|HIV|hiv
182139|NCT02445989|Contraceptive Vaginal Ring|contraceptive vaginal ring
182140|NCT02445989|Bacterial Vaginosis|bacterial vaginosis
182141|NCT02445976|mCRPC|mcrpc
182142|NCT02445976|metastatic|metastatic
182143|NCT02445976|castration-resistant prostate cancer|castration-resistant prostate cancer
182144|NCT02445950|Coaching|coaching
182145|NCT02445950|Well-being|well-being
182146|NCT02445950|Digital Health|digital health
182147|NCT02445950|Profiling|profiling
182148|NCT02445950|Customer Satisfaction|customer satisfaction
182149|NCT02445950|User Experience|user experience
182150|NCT02445950|Occupational Health|occupational health
182151|NCT02445950|Lifestyle|lifestyle
182152|NCT02445950|Psychological Stress|psychological stress
182153|NCT02445950|Cost-Effectiveness|cost-effectiveness
182154|NCT02445950|Guideline Adherence|guideline adherence
182155|NCT02445937|decision making for incapacitated patients|decision making for incapacitated patients
182156|NCT02445937|intensive care|intensive care
182157|NCT02445937|surrogate decision making|surrogate decision making
182158|NCT02445937|patient centered care|patient centered care
182159|NCT02445937|palliative care|palliative care
182160|NCT02445924|genetic signature|genetic signature
182161|NCT02445924|non-small cell lung cancer|non-small cell lung cancer
182162|NCT02445924|micro RNA|micro rna
182163|NCT02445898|Glucocorticoid|glucocorticoid
182164|NCT02445898|Orthostatic Intolerance|orthostatic intolerance
182165|NCT02445898|Heart Rate Variability|heart rate variability
182166|NCT02445898|Hip arthroplasty, total|hip arthroplasty, total
182167|NCT02445885|Myocardial infarction|myocardial infarction
182168|NCT02445885|Late presenters|late presenters
182169|NCT02445885|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
182170|NCT02445885|Reperfusion|reperfusion
182171|NCT02445885|Angioplasty|angioplasty
182172|NCT02445885|Duration of ischemia|duration of ischemia
182173|NCT02445885|Cardiovascular magnetic resonance imaging|cardiovascular magnetic resonance imaging
182174|NCT02445872|Nausea|nausea
182175|NCT02445872|Vomiting|vomiting
182176|NCT02445872|Chemotherapy-induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
182177|NCT02445872|CINV|cinv
182178|NCT02445872|Aprepitant|aprepitant
182179|NCT02445872|Lung cancer|lung cancer
182180|NCT02445859|Antibiotic|antibiotic
182181|NCT02445859|prophylaxis|prophylaxis
182182|NCT02445859|surgical site infection|surgical site infection
182183|NCT02445833|Obesity|obesity
182184|NCT02445833|Internet intervention|internet intervention
182185|NCT02445833|Cardiovascular disease|cardiovascular disease
182186|NCT02445833|Hypertension|hypertension
182187|NCT02445833|Lifestyle intervention|lifestyle intervention
182188|NCT02445833|Weight loss treatment|weight loss treatment
182189|NCT02445755|Neonates|neonates
182190|NCT02445755|Bilicare System|bilicare system
182191|NCT02445742|Chronic Myeloblastic Leukaemia|chronic myeloblastic leukaemia
182192|NCT02445729|Cesarean Section|cesarean section
182193|NCT02445729|Wound Healing|wound healing
182194|NCT02445677|TENS|tens
182195|NCT02445677|chronic pain|chronic pain
182196|NCT02445677|rehabilitation|rehabilitation
182197|NCT02445664|Patient education|patient education
182198|NCT02445664|Video intervention|video intervention
182199|NCT02445651|Integrative Medicine|integrative medicine
182200|NCT02445651|Alternative Medicine|alternative medicine
182201|NCT02445651|Complementary Medicine|complementary medicine
182202|NCT02445651|Parkinson's disease|parkinson's disease
182203|NCT02445651|Neurodegenerative Diseases|neurodegenerative diseases
182204|NCT02445651|Idiopathic Parkinson's disease|idiopathic parkinson's disease
182205|NCT02445651|Single Photon Emission Computed Tomography (SPECT)|single photon emission computed tomography (spect)
182206|NCT02445651|Central Nervous System Diseases|central nervous system diseases
182207|NCT02445651|Movement Disorders|movement disorders
182208|NCT02445651|Nervous System Diseases|nervous system diseases
182209|NCT02445651|Brain Diseases|brain diseases
182210|NCT02445651|Oral supplements|oral supplements
182211|NCT02445651|N-acetyl cysteine|n-acetyl cysteine
182212|NCT02445612|fundus flavimaculatus|fundus flavimaculatus
182213|NCT02445612|ASP7316|asp7316
182214|NCT02445612|SMD|smd
182215|NCT02445612|long term follow-up|long term follow-up
182216|NCT02445612|juvenile macular dystrophy|juvenile macular dystrophy
182217|NCT02445599|thoracotomy|thoracotomy
182218|NCT02445599|pain management|pain management
182219|NCT02445599|analgesia|analgesia
182220|NCT02445599|postoperative care|postoperative care
182221|NCT02445599|premedication|premedication
182222|NCT02445599|preventive|preventive
182223|NCT02445573|stress urinary incontinence|stress urinary incontinence
182224|NCT02445573|electroacupuncture|electroacupuncture
182225|NCT02445573|efficacy|efficacy
182226|NCT02445560|probiotics|probiotics
182227|NCT02445560|prebiotics|prebiotics
182228|NCT02445560|high protein diet|high protein diet
182229|NCT02445560|microbiota|microbiota
182230|NCT02445534|Cell Therapy|cell therapy
182231|NCT02445456|Rectal cancer|rectal cancer
182232|NCT02445456|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
182233|NCT02445417|Perinatal depression|perinatal depression
182234|NCT02445378|Aromatherapy|aromatherapy
182235|NCT02445378|essential oils|essential oils
182236|NCT02445378|Acute Leukemia|acute leukemia
182237|NCT02445365|Ulcerative colitis|ulcerative colitis
182238|NCT02445365|Remote ischemic conditioning|remote ischemic conditioning
182239|NCT02445339|Alcohol Dependence|alcohol dependence
182240|NCT02445339|Alcohol Use Disorder|alcohol use disorder
182241|NCT02445339|Care Management|care management
182242|NCT02445339|Case Management|case management
182243|NCT02445339|Emergency Care Services|emergency care services
182244|NCT02445339|Emergency Department|emergency department
182245|NCT02445339|Emergency Room|emergency room
182246|NCT02445339|Extended-release naltrexone|extended-release naltrexone
182247|NCT02445339|Frequent Users|frequent users
182248|NCT02445339|Health Care Utilization|health care utilization
182249|NCT02445339|Medical Management|medical management
182250|NCT02445339|Naltrexone|naltrexone
182251|NCT02445339|Population Health|population health
182252|NCT02445339|Public Health|public health
182253|NCT02445339|Vivitrol|vivitrol
182254|NCT02445339|XR-NTX|xr-ntx
182255|NCT02445339|XR-NTX+CM|xr-ntx+cm
182256|NCT02445339|Alcoholism|alcoholism
182257|NCT02445339|Alcohol-Related Disorders|alcohol-related disorders
182258|NCT02445339|Central Nervous System Agents|central nervous system agents
182259|NCT02445339|Chemically-Induced Disorders|chemically-induced disorders
182260|NCT02445339|Clinical Trial|clinical trial
182261|NCT02445339|Emergency Medicine|emergency medicine
182262|NCT02445339|Mental Disorders|mental disorders
182263|NCT02445339|Narcotic Antagonists|narcotic antagonists
182264|NCT02445339|Peripheral Nervous System Agents|peripheral nervous system agents
182265|NCT02445339|Pharmacologic Actions|pharmacologic actions
182266|NCT02445339|Physiological Effects of Drugs|physiological effects of drugs
182267|NCT02445339|Sensory System Agents|sensory system agents
182268|NCT02445339|Substance-Related Disorders|substance-related disorders
182269|NCT02445300|dressing|dressing
182270|NCT02445300|TKA|tka
182271|NCT02445261|MOBILE PHONE ON AND IN AND|mobile phone on and in and
182272|NCT02445261|UMBILICAL ARTERY DOPPLER|umbilical artery doppler
182273|NCT02445261|FETAL CARDIOTOCOGRAPHY|fetal cardiotocography
182274|NCT02445261|GROWTH RESTRICTED FETUS|growth restricted fetus
182275|NCT02445261|NORMAL GROWTH FETUS|normal growth fetus
182276|NCT02445248|Diffuse large B-cell lymphoma,|diffuse large b-cell lymphoma,
182277|NCT02445248|DLBCL,|dlbcl,
182278|NCT02445248|Relapsed/refractory,|relapsed/refractory,
182279|NCT02445248|CTL019|ctl019
182280|NCT02445248|CART19|cart19
182281|NCT02445248|CART|cart
182282|NCT02445248|CAR T cells|car t cells
182283|NCT02445248|Chimeric antigen receptor|chimeric antigen receptor
182284|NCT02445235|pain|pain
182285|NCT02445235|wound care|wound care
182286|NCT02445235|fungal infections|fungal infections
182287|NCT02445235|scars|scars
182288|NCT02445235|chronic pain|chronic pain
182289|NCT02445235|outcomes|outcomes
182290|NCT02445235|PRO|pro
182291|NCT02445209|HER2-negative gastric and GEJ adenocarcinoma|her2-negative gastric and gej adenocarcinoma
182292|NCT02445209|first-line palliative chemotherapy|first-line palliative chemotherapy
182293|NCT02445209|EOX|eox
182294|NCT02445209|mDCF|mdcf
182295|NCT02445209|efficacy|efficacy
182296|NCT02445209|safety|safety
182297|NCT02445170|Diabetes|diabetes
182298|NCT02445170|amputation|amputation
182299|NCT02445170|below-knee|below-knee
182300|NCT02445170|transmetatarsal|transmetatarsal
182301|NCT02445170|[M01.150.100]|[m01.150.100]
182302|NCT02445170|[C19.246.099]|[c19.246.099]
182303|NCT02445157|Gait speed|gait speed
182304|NCT02445157|Functional outcome measure|functional outcome measure
182305|NCT02445144|Inflammation|inflammation
182306|NCT02445144|Blood Flow|blood flow
182307|NCT02445144|Cognition|cognition
182308|NCT02445131|CLL|cll
182309|NCT02445118|adipose, allograft|adipose, allograft
182310|NCT02445092|Intrauterine insemination|intrauterine insemination
182311|NCT02445092|Insemination catheter prewashing|insemination catheter prewashing
182312|NCT02445092|Pregnancy outcome|pregnancy outcome
182313|NCT02445066|Vitamin D|vitamin d
182314|NCT02445053|Cystic Fibrosis|cystic fibrosis
182315|NCT02445040|High Frequency Oscillatory Ventilation|high frequency oscillatory ventilation
182316|NCT02445040|Infant, Very Low Birth Weight|infant, very low birth weight
182317|NCT02445040|Periventricular Leukomalacia|periventricular leukomalacia
182318|NCT02445040|Intraventricular Hemorrhage|intraventricular hemorrhage
182319|NCT02445040|multi-center study|multi-center study
182320|NCT02445027|Primary Care|primary care
182321|NCT02445027|Healthy|healthy
182322|NCT02445014|Barrett's|barrett's
182323|NCT02445014|GERD|gerd
182324|NCT02445014|Capsule|capsule
182325|NCT02445014|SECM|secm
182326|NCT02444988|crystalloid|crystalloid
182327|NCT02444988|acute kidney injury|acute kidney injury
182328|NCT02444975|Urinary Tract Infections|urinary tract infections
182329|NCT02444975|Water intake|water intake
182330|NCT02444936|solid tumor|solid tumor
182331|NCT02444936|chemotherapy|chemotherapy
182332|NCT02444936|vaccine|vaccine
182333|NCT02444923|Corneal rigid gas permeable contact lenses|corneal rigid gas permeable contact lenses
182334|NCT02444923|Scleral rigid gas permeable contact lenses|scleral rigid gas permeable contact lenses
182335|NCT02444923|Custom Scleral contact lenses|custom scleral contact lenses
182336|NCT02444923|Irregular cornea|irregular cornea
182337|NCT02444923|Keratoconus|keratoconus
182338|NCT02444923|Pellucid marginal degeneration|pellucid marginal degeneration
182339|NCT02444923|Post keratoplasty irregular cornea|post keratoplasty irregular cornea
182340|NCT02444923|Post refractive surgery irregular cornea|post refractive surgery irregular cornea
182341|NCT02444923|Traumatic irregular cornea|traumatic irregular cornea
182342|NCT02444910|KDT501|kdt501
182343|NCT02444910|Diabetes|diabetes
182344|NCT02444910|Diabetes Mellitus|diabetes mellitus
182345|NCT02444910|Type 2|type 2
182346|NCT02444910|KinDex|kindex
182347|NCT02444897|Gastric cancer|gastric cancer
182348|NCT02444897|epidural|epidural
182350|NCT02444897|laparoscopy|laparoscopy
182351|NCT02444871|IgM-enriched immunoglobulins|igm-enriched immunoglobulins
182352|NCT02444871|endotoxin activity assay|endotoxin activity assay
182353|NCT02444871|thrombelastometry|thrombelastometry
182354|NCT02444871|aggregometry|aggregometry
182355|NCT02444858|paraquat poisoning|paraquat poisoning
182356|NCT02444858|lung injury|lung injury
182357|NCT02444858|stem cell therapy|stem cell therapy
182358|NCT02444858|human umbilical cord mesenchymal stem cell|human umbilical cord mesenchymal stem cell
182359|NCT02444858|phase 1/2 clinical study|phase 1/2 clinical study
182360|NCT02444858|allogeneic stem cell transplantation|allogeneic stem cell transplantation
182361|NCT02444819|HM61713|hm61713
182362|NCT02444819|Epidermal Growth Factor Receptor mutation positive NSCLC|epidermal growth factor receptor mutation positive nsclc
182363|NCT02444819|olmutinib|olmutinib
182364|NCT02444806|Sleep disordered breathing|sleep disordered breathing
182365|NCT02444806|Domiciliary NIV|domiciliary niv
182366|NCT02444741|Lung Cancer|lung cancer
182367|NCT02444741|Non-small cell lung cancer|non-small cell lung cancer
182368|NCT02444741|NSCLC|nsclc
182369|NCT02444741|Metastatic|metastatic
182370|NCT02444741|Pembrolizumab|pembrolizumab
182371|NCT02444741|Keytruda|keytruda
182372|NCT02444741|MK-3475|mk-3475
182373|NCT02444741|SCH-900475|sch-900475
182374|NCT02444741|Stereotactic body radiation therapy|stereotactic body radiation therapy
182375|NCT02444741|SBRT|sbrt
182376|NCT02444741|Wide-field radiation therapy|wide-field radiation therapy
182377|NCT02444741|WFRT|wfrt
182378|NCT02444741|Radiation therapy|radiation therapy
182379|NCT02444741|XRT|xrt
182380|NCT02444728|thrombocytopenia|thrombocytopenia
182381|NCT02444728|systemic lupus erythematosus|systemic lupus erythematosus
182382|NCT02444728|hydroxychloroquine|hydroxychloroquine
182383|NCT02444728|cyclophosphamide|cyclophosphamide
182384|NCT02444728|remission|remission
182385|NCT02444715|Lifestyle coaching|lifestyle coaching
182386|NCT02444715|Phone-based system|phone-based system
182387|NCT02444715|CVD prevention|cvd prevention
182388|NCT02444715|Patient-centered decision support|patient-centered decision support
182389|NCT02444702|spinal stenosis, clinical predictors rules, MRI, fusion, low back pain|spinal stenosis, clinical predictors rules, mri, fusion, low back pain
182390|NCT02444689|Blood pressure|blood pressure
182391|NCT02444689|Cardiovascular disease|cardiovascular disease
182392|NCT02444689|Children|children
182393|NCT02444689|Adolescent|adolescent
182394|NCT02444689|Pediatrics|pediatrics
182395|NCT02444689|End-organ damage|end-organ damage
182396|NCT02444650|Correlation|correlation
182397|NCT02444650|pulse wave velocity measurement|pulse wave velocity measurement
182398|NCT02444650|tonometry|tonometry
182399|NCT02444624|necrotizing enterocolitis|necrotizing enterocolitis
182400|NCT02444624|Clostridium|clostridium
182401|NCT02444624|premature birth|premature birth
182402|NCT02444611|neonates|neonates
182403|NCT02444611|BCG|bcg
182404|NCT02444611|Hepatitis B vaccine|hepatitis b vaccine
182405|NCT02444611|vaccines|vaccines
182406|NCT02444611|immunity|immunity
182407|NCT02444611|immune response|immune response
182408|NCT02444611|Bacille- Calmette-Guerin|bacille- calmette-guerin
182409|NCT02444598|wounds|wounds
182410|NCT02444598|negative-pressure wound therapy|negative-pressure wound therapy
182411|NCT02444598|conflict|conflict
182412|NCT02444598|gunshot wound|gunshot wound
182413|NCT02444598|blast injuries|blast injuries
182414|NCT02444598|civilian|civilian
182415|NCT02444598|war|war
182416|NCT02444559|Volunteers|volunteers
182417|NCT02444533|Liposomal Bupivacaine|liposomal bupivacaine
182418|NCT02444481|Mycotic Vaginitis|mycotic vaginitis
182419|NCT02444455|cellular therapy|cellular therapy
182420|NCT02444455|acute lung injury|acute lung injury
182421|NCT02444455|acute respiratory distress snydrome|acute respiratory distress snydrome
182422|NCT02444455|human umbilical cord mesenchymal stem cell|human umbilical cord mesenchymal stem cell
182423|NCT02444455|phase 1/2 clinical study|phase 1/2 clinical study
182424|NCT02444455|allogeneic stem cell transplantation|allogeneic stem cell transplantation
182425|NCT02444455|ALI|ali
182426|NCT02444455|ARDS|ards
182427|NCT02444442|Renal denervation|renal denervation
182428|NCT02444442|Blood pressure|blood pressure
182429|NCT02444442|Cardiovascular risk|cardiovascular risk
182430|NCT02444442|Target organ damage|target organ damage
182431|NCT02444442|Sympathetic activity|sympathetic activity
182432|NCT02444442|Non-compliance|non-compliance
182433|NCT02444429|Screening renal biopsy|screening renal biopsy
182434|NCT02444429|Immunosuppression|immunosuppression
182435|NCT02444403|HIV|hiv
182436|NCT02444403|Viral hepatitis|viral hepatitis
182437|NCT02444403|HCV|hcv
182438|NCT02444403|Needle-stick injury|needle-stick injury
182439|NCT02444403|Needle/syringes|needle/syringes
182440|NCT02444403|Structural intervention|structural intervention
182441|NCT02444403|Stepped wedge|stepped wedge
182442|NCT02444403|Police|police
182443|NCT02444403|Occupational safety|occupational safety
182444|NCT02444403|Police Training|police training
182445|NCT02444390|Failed non steroidal aromatases inhibitors|failed non steroidal aromatases inhibitors
182446|NCT02444390|Eligible for everolimus+exemestane|eligible for everolimus+exemestane
182447|NCT02444364|diabetes|diabetes
182448|NCT02444364|bone loss|bone loss
182449|NCT02444364|Bone Density|bone density
182450|NCT02444325|group prenatal care|group prenatal care
182451|NCT02444325|CenteringPregnancy|centeringpregnancy
182452|NCT02444325|diabetes|diabetes
182453|NCT02444312|Caregiving|caregiving
182454|NCT02444312|Benefit Finding|benefit finding
182455|NCT02444312|Writing Intervention|writing intervention
182456|NCT02444273|liver diseases|liver diseases
182457|NCT02444273|liver transplantation|liver transplantation
182458|NCT02444273|preoperative care|preoperative care
182459|NCT02444273|physical therapy|physical therapy
182460|NCT02444260|Inguinal Hernia,|inguinal hernia,
182461|NCT02444260|Local Anesthesia|local anesthesia
182462|NCT02444260|Randomized Clinical trial|randomized clinical trial
182463|NCT02444260|HERNIOPLASTY|hernioplasty
182464|NCT02444221|Atrial Fibrillation|atrial fibrillation
182465|NCT02444221|Rivaroxaban|rivaroxaban
182466|NCT02444221|Stroke|stroke
182467|NCT02444195|gynecologic cancer|gynecologic cancer
182468|NCT02444195|guided imagery|guided imagery
182469|NCT02444195|postoperative distress|postoperative distress
182470|NCT02444195|perioperative distress|perioperative distress
182471|NCT02444143|Kidney|kidney
182472|NCT02444143|Immunosuppression|immunosuppression
182473|NCT02444143|Transplant|transplant
182474|NCT02444130|multifocality|multifocality
182475|NCT02444130|monovision|monovision
182476|NCT02444117|neurophysiology|neurophysiology
182477|NCT02444104|Left Ventricular Assist Device|left ventricular assist device
182478|NCT02444091|Chronic Fatigue Syndrome|chronic fatigue syndrome
182479|NCT02444091|Myalgic Encephalomyelitis (ME)|myalgic encephalomyelitis (me)
182480|NCT02444091|Cyclophosphamide|cyclophosphamide
182481|NCT02444091|Immunomodulatory treatment|immunomodulatory treatment
182482|NCT02444091|CFS|cfs
182483|NCT02444078|Alzheimer Disease|alzheimer disease
182484|NCT02444078|Dementia|dementia
182485|NCT02444078|Physical activity|physical activity
182486|NCT02444078|Functional ability|functional ability
182487|NCT02444078|Disability|disability
182488|NCT02444078|Functional limitation|functional limitation
182489|NCT02444065|Cognitive behavior therapy|cognitive behavior therapy
182490|NCT02444065|Motivational interviewing|motivational interviewing
182491|NCT02444065|Bulimia nervosa|bulimia nervosa
182492|NCT02444065|Rapid response|rapid response
182493|NCT02444013|Contrast induced nephropathy|contrast induced nephropathy
182494|NCT02444000|chemotherapy|chemotherapy
182495|NCT02444000|PCV|pcv
182496|NCT02444000|radiotherapy|radiotherapy
182497|NCT02444000|post operative treatment|post operative treatment
182498|NCT02444000|anaplastic gliomas|anaplastic gliomas
182499|NCT02444000|1p/19q codeletion|1p/19q codeletion
182500|NCT02444000|cognition|cognition
182501|NCT02443987|Tension-Free Vaginal Tape|tension-free vaginal tape
182502|NCT02443961|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
182503|NCT02443961|pulmonary hypertension|pulmonary hypertension
182504|NCT02443961|stem cell therapy|stem cell therapy
182505|NCT02443961|mesenchymal stem cells|mesenchymal stem cells
182506|NCT02443961|very low weight preterm babies|very low weight preterm babies
182507|NCT02443922|type 2 diabetes|type 2 diabetes
182508|NCT02443922|beta cell function|beta cell function
182509|NCT02443922|meal tolerance test (MTT)|meal tolerance test (mtt)
182510|NCT02443922|maximal stimulation test (MaxStim)|maximal stimulation test (maxstim)
182511|NCT02443922|method standardization|method standardization
182512|NCT02443922|insulin secretion|insulin secretion
182513|NCT02443922|prediabetes|prediabetes
182514|NCT02443922|insulin sensitivity|insulin sensitivity
182515|NCT02443922|glimepiride|glimepiride
182516|NCT02443922|sitagliptin|sitagliptin
182517|NCT02443922|metformin|metformin
182518|NCT02443909|Holmium Laser|holmium laser
182519|NCT02443909|Kidney Stones|kidney stones
182520|NCT02443909|RIRS|rirs
182521|NCT02443883|stomach cancer|stomach cancer
182522|NCT02443844|BPH|bph
182523|NCT02443844|bladder cancer|bladder cancer
182524|NCT02443844|treatment|treatment
182525|NCT02443844|recurrence|recurrence
182526|NCT02443844|progression|progression
182527|NCT02443831|high risk relapsed CD19+ hematological malignancies|high risk relapsed cd19+ hematological malignancies
182528|NCT02443766|Integrative Medicine|integrative medicine
182529|NCT02443766|Alternative Medicine|alternative medicine
182530|NCT02443766|Complementary Medicine|complementary medicine
182531|NCT02443766|Meditation Retreat|meditation retreat
182532|NCT02443766|Ignatian Retreat|ignatian retreat
182533|NCT02443766|Single Photon Emission Computed Tomography (SPECT)|single photon emission computed tomography (spect)
182534|NCT02443766|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
182535|NCT02443766|Wellbeing|wellbeing
182536|NCT02443766|General Health|general health
182537|NCT02443740|First in human|first in human
182538|NCT02443740|Single Ascending Dose Study|single ascending dose study
182539|NCT02443740|Safety and Tolerability|safety and tolerability
182540|NCT02443740|Pharmacokinetics|pharmacokinetics
182541|NCT02443740|Plasma|plasma
182542|NCT02443740|Cerebrospinal Fluid|cerebrospinal fluid
182543|NCT02443714|Needle-Free Jet Injection|needle-free jet injection
182544|NCT02443714|Insulin Lispro|insulin lispro
182545|NCT02443714|pharmacokinetics|pharmacokinetics
182546|NCT02443714|pharmacodynamics|pharmacodynamics
182547|NCT02443636|Depression|depression
182548|NCT02443636|Mental Health|mental health
182549|NCT02443636|Registry|registry
182550|NCT02443636|Reliability|reliability
182551|NCT02443636|Post Traumatic Stress Disorder|post traumatic stress disorder
182552|NCT02443636|Bipolar Disorder|bipolar disorder
182553|NCT02443636|Mood disorder|mood disorder
182554|NCT02443636|Suicide|suicide
182555|NCT02443610|Postpartum Hemorrhage|postpartum hemorrhage
182556|NCT02443610|Venous Thromboembolism|venous thromboembolism
182557|NCT02443610|Pregnancy|pregnancy
182558|NCT02443597|ultrasound|ultrasound
182559|NCT02443597|trisomy screening|trisomy screening
182560|NCT02443597|obesity|obesity
182561|NCT02443584|depression|depression
182562|NCT02443584|pharmacogenetics|pharmacogenetics
182563|NCT02443584|pharmacogenomics|pharmacogenomics
182564|NCT02443584|major depressive disorder|major depressive disorder
182565|NCT02443584|genetics|genetics
182566|NCT02443584|anti-depressants|anti-depressants
182567|NCT02443571|observational study|observational study
182568|NCT02443558|Robotics|robotics
182569|NCT02443558|Cerebral cortex|cerebral cortex
182570|NCT02443558|Brain waves|brain waves
182571|NCT02443558|Electroencephalography|electroencephalography
182572|NCT02443558|Rehabilitation|rehabilitation
182573|NCT02443558|Brain-Computer Interfaces|brain-computer interfaces
182574|NCT02443545|Iron overload|iron overload
182575|NCT02443545|Sickle cell disease|sickle cell disease
182576|NCT02443545|Deferiprone|deferiprone
182577|NCT02443545|Ferriprox|ferriprox
182578|NCT02443545|Iron chelation|iron chelation
182579|NCT02443519|Mindfulness|mindfulness
182580|NCT02443519|MBCT|mbct
182581|NCT02443519|Cognitive Therapy|cognitive therapy
182582|NCT02443519|Disability|disability
182583|NCT02443428|Breast Cancer|breast cancer
182584|NCT02443402|Non diabetic hyperglycemia|non diabetic hyperglycemia
182585|NCT02443389|nephrotoxic|nephrotoxic
182586|NCT02443389|Fluid overload|fluid overload
182587|NCT02443389|Acute renal failure|acute renal failure
182588|NCT02443389|Prematurity|prematurity
182589|NCT02443389|Risk factors|risk factors
182590|NCT02443389|Epidemiology|epidemiology
182591|NCT02443324|immuno-oncology|immuno-oncology
182592|NCT02443324|Vascular Endothelial Growth Factor (VEGF)|vascular endothelial growth factor (vegf)
182593|NCT02443324|angiogenesis|angiogenesis
182594|NCT02443324|PD-1|pd-1
182595|NCT02443324|carcinoma of the bladder|carcinoma of the bladder
182596|NCT02443324|carcinoma of the urethra|carcinoma of the urethra
182597|NCT02443324|carcinoma of the ureter|carcinoma of the ureter
182598|NCT02443324|carcinoma of the renal pelvis|carcinoma of the renal pelvis
182599|NCT02443324|carcinoma of the biliary tract|carcinoma of the biliary tract
182600|NCT02443298|ABBV-066|abbv-066
182601|NCT02443298|BI 655066|bi 655066
182602|NCT02443298|risankizumab|risankizumab
182603|NCT02443259|NAPI|napi
182604|NCT02443259|late preterm|late preterm
182605|NCT02443207|Toothache|toothache
182606|NCT02443207|Quality of life|quality of life
182607|NCT02443207|Oral Health|oral health
182608|NCT02443207|Children|children
182609|NCT02443194|depression|depression
182610|NCT02443194|glioblastoma|glioblastoma
182611|NCT02443181|Essential tremor; closed-loop DBS|essential tremor; closed-loop dbs
182612|NCT02443168|Pharmacokinetic|pharmacokinetic
182613|NCT02443168|Healthy|healthy
182614|NCT02443168|Male|male
182615|NCT02443168|AG-221|ag-221
182616|NCT02443168|[14C]|[14c]
182617|NCT02443168|Single dose|single dose
182618|NCT02443168|Oral|oral
182619|NCT02443168|Intravenous|intravenous
182620|NCT02443142|mild TBI|mild tbi
182621|NCT02443142|concussion|concussion
182622|NCT02443142|post-concussion syndrome|post-concussion syndrome
182623|NCT02443103|pilot study|pilot study
182624|NCT02443103|guanabenz acetate|guanabenz acetate
182625|NCT02443090|secondary hypogonadism|secondary hypogonadism
182626|NCT02443090|sexual dysfunction|sexual dysfunction
182627|NCT02443090|erectile dysfunction|erectile dysfunction
182628|NCT02443064|Pharmacokinetics/pharmacodynamics|pharmacokinetics/pharmacodynamics
182629|NCT02443064|vancomycin|vancomycin
182630|NCT02443064|blood stream infections|blood stream infections
182631|NCT02443064|Chinese patients|chinese patients
182632|NCT02443064|MRSA|mrsa
182633|NCT02443038|patient fall|patient fall
182634|NCT02443038|yoga|yoga
182635|NCT02443038|balance|balance
182636|NCT02443012|Diabetic Macular Edema|diabetic macular edema
182637|NCT02443012|Nepafenac|nepafenac
182638|NCT02443012|Laser therapy|laser therapy
182639|NCT02443012|Clinically significant macular edema|clinically significant macular edema
182640|NCT02443012|Adjunct Treatment|adjunct treatment
182641|NCT02443012|Topical Nepafenac|topical nepafenac
182642|NCT02442986|weaning failure|weaning failure
182643|NCT02442986|polyneuropathy|polyneuropathy
182644|NCT02442986|encephalopathy|encephalopathy
182645|NCT02442986|sepsis|sepsis
182646|NCT02442947|stress when dressed|stress when dressed
182647|NCT02442947|protective garment|protective garment
182648|NCT02442947|work clothes|work clothes
182649|NCT02442934|Critical Care|critical care
182650|NCT02442934|Critical Care Nursing|critical care nursing
182651|NCT02442934|Discomfort|discomfort
182652|NCT02442934|Sleep deprivation|sleep deprivation
182653|NCT02442934|Noise|noise
182654|NCT02442934|Thirst|thirst
182655|NCT02442934|Pain|pain
182656|NCT02442895|mature oocytes|mature oocytes
182657|NCT02442895|antral follicles count|antral follicles count
182658|NCT02442895|follicle stimulating hormone|follicle stimulating hormone
182659|NCT02442895|antimullerian hormone|antimullerian hormone
182660|NCT02442882|Brain Concussion|brain concussion
182661|NCT02442882|Balance|balance
182662|NCT02442882|Locomotion|locomotion
182663|NCT02442882|Mild Traumatic Brain Injury|mild traumatic brain injury
182664|NCT02442869|Suicide|suicide
182665|NCT02442817|DPP-4 Inhibitor|dpp-4 inhibitor
182666|NCT02442817|Linagliptin|linagliptin
182667|NCT02442817|SDF1-α|sdf1-α
182668|NCT02442804|Pomegranate|pomegranate
182669|NCT02442804|Stroke|stroke
182670|NCT02442804|Neuropsychology|neuropsychology
182671|NCT02442791|Cardiac arrest|cardiac arrest
182672|NCT02442791|GLP-1|glp-1
182673|NCT02442791|Neuroprotection|neuroprotection
182674|NCT02442752|Drug therapy|drug therapy
182675|NCT02442739|Ketamine|ketamine
182676|NCT02442739|Prevention of depression|prevention of depression
182677|NCT02442726|Heat Injury|heat injury
182678|NCT02442726|Humans|humans
182679|NCT02442726|Laser Stimulation|laser stimulation
182680|NCT02442726|Quantitative Sensory Testing|quantitative sensory testing
182681|NCT02442726|Reaction Time|reaction time
182682|NCT02442726|Secondary Hyperalgesia|secondary hyperalgesia
182683|NCT02442726|Thermal Thresholds|thermal thresholds
182684|NCT02442713|Polysomnograph|polysomnograph
182685|NCT02442713|fluvoxamine|fluvoxamine
182686|NCT02442700|HIV-infected patients with dyslipidemia and receiving atazanavir/ritonavir|hiv-infected patients with dyslipidemia and receiving atazanavir/ritonavir
182687|NCT02442674|Hyponatremia|hyponatremia
182688|NCT02442674|Euvolemic|euvolemic
182689|NCT02442674|Hypervolemic|hypervolemic
182690|NCT02442674|Serum sodium|serum sodium
182691|NCT02442674|Dilutional hyponatremia|dilutional hyponatremia
182692|NCT02442674|Electrolyte abnormality|electrolyte abnormality
182693|NCT02442674|Electrolyte imbalance|electrolyte imbalance
182694|NCT02442674|Metabolic disease|metabolic disease
182695|NCT02442674|Water-Electrolyte Imbalance|water-electrolyte imbalance
182696|NCT02442648|Renal Transplantation|renal transplantation
182697|NCT02442648|Carfilzomib|carfilzomib
182698|NCT02442648|Kyprolis|kyprolis
182699|NCT02442648|Desensitization|desensitization
182700|NCT02442622|de Quervain's disease|de quervain's disease
182701|NCT02442622|de Quervain's tenosynovitis.|de quervain's tenosynovitis.
182702|NCT02442622|ASTYM|astym
182703|NCT02442622|de Quervain's treatment|de quervain's treatment
182704|NCT02442609|internet|internet
182705|NCT02442609|anesthesia|anesthesia
182706|NCT02442609|information|information
182707|NCT02442609|surgery|surgery
182708|NCT02442609|question|question
182709|NCT02442596|Abdominal sepsis|abdominal sepsis
182710|NCT02442596|Sepsis|sepsis
182711|NCT02442596|Septic shock|septic shock
182712|NCT02442596|Epidemiology|epidemiology
182713|NCT02442596|Etiology|etiology
182714|NCT02442596|Microbiology|microbiology
182715|NCT02442596|Abdomen|abdomen
182716|NCT02442596|Intra-abdominal|intra-abdominal
182717|NCT02442596|Infection|infection
182718|NCT02442596|Gastrointestinal tract|gastrointestinal tract
182719|NCT02442596|Perforation|perforation
182720|NCT02442596|Peritonitis|peritonitis
182721|NCT02442596|Pancreas|pancreas
182722|NCT02442596|Biliary tract|biliary tract
182723|NCT02442596|Megacolon|megacolon
182724|NCT02442583|colorectal cancer|colorectal cancer
182725|NCT02442583|survivor|survivor
182726|NCT02442583|exercise|exercise
182727|NCT02442583|physical activity|physical activity
182728|NCT02442583|sedentary|sedentary
182729|NCT02442570|alpha B-crystallin|alpha b-crystallin
182730|NCT02442570|immune tolerance|immune tolerance
182731|NCT02442557|alpha B-crystallin|alpha b-crystallin
182732|NCT02442557|immune tolerance|immune tolerance
182733|NCT02442518|placenta accreta|placenta accreta
182734|NCT02442518|placenta previa|placenta previa
182735|NCT02442518|ultrasound|ultrasound
182736|NCT02442505|Atrial Fibrillation; Pacemaker; Device-detected|atrial fibrillation; pacemaker; device-detected
182737|NCT02442492|sildenafil|sildenafil
182738|NCT02442492|IUGR|iugr
182739|NCT02442492|FGR|fgr
182740|NCT02442492|STRIDER|strider
182741|NCT02442479|exercise|exercise
182742|NCT02442479|resistance training|resistance training
182743|NCT02442479|muscle strength|muscle strength
182744|NCT02442479|muscle hypertrophy|muscle hypertrophy
182745|NCT02442440|anisodamine|anisodamine
182746|NCT02442440|septic shock|septic shock
182747|NCT02442427|Respiratory syncytial virus|respiratory syncytial virus
182748|NCT02442427|Palivizumab|palivizumab
182749|NCT02442427|Bronchiolitis|bronchiolitis
182750|NCT02442427|Treatment|treatment
182751|NCT02442414|Cancer|cancer
182752|NCT02442414|Advanced Solid Tumors|advanced solid tumors
182753|NCT02442414|EGFR|egfr
182754|NCT02442414|HER2|her2
182755|NCT02442414|HER3|her3
182756|NCT02442414|HER4|her4
182757|NCT02442414|ALK mutations|alk mutations
182758|NCT02442414|irreversible tyrosine kinase inhibitor|irreversible tyrosine kinase inhibitor
182759|NCT02442414|Metastatic Non Small Cell Lung Cancer|metastatic non small cell lung cancer
182760|NCT02442414|Gastric Cancer|gastric cancer
182761|NCT02442414|Colorectal Cancer|colorectal cancer
182762|NCT02442388|pain|pain
182763|NCT02442388|root canal therapy|root canal therapy
182764|NCT02442388|endodontics|endodontics
182765|NCT02442388|file|file
182766|NCT02442375|head and neck cancer|head and neck cancer
182767|NCT02442375|accelerated radiotherapy|accelerated radiotherapy
182768|NCT02442375|dose reduction|dose reduction
182769|NCT02442375|dose de-escalation|dose de-escalation
182770|NCT02442375|elective lymph nodes|elective lymph nodes
182771|NCT02442375|FDG-PET|fdg-pet
182772|NCT02442349|Phase II, Open Label, Single-arm study, Safety and Efficacy of AZD9291, Asia Pacific, NSCLC with T790M mutation within the Epidermal Growth Factor Receptor Gene|phase ii, open label, single-arm study, safety and efficacy of azd9291, asia pacific, nsclc with t790m mutation within the epidermal growth factor receptor gene
182773|NCT02442310|deferiprone|deferiprone
182774|NCT02442310|deferiprone delayed release formulation|deferiprone delayed release formulation
182775|NCT02442310|pharmacokinetics|pharmacokinetics
182776|NCT02442297|Glioblastoma|glioblastoma
182777|NCT02442297|T cells Expressing HER2-specific Chimeric Antigen Receptors|t cells expressing her2-specific chimeric antigen receptors
182778|NCT02442297|HER2-specific T cells|her2-specific t cells
182779|NCT02442297|intracranial injection|intracranial injection
182780|NCT02442284|Chronic Hepatitis C|chronic hepatitis c
182781|NCT02442284|Interferon-Free|interferon-free
182782|NCT02442284|Hepatitis C Genotype 1|hepatitis c genotype 1
182783|NCT02442284|Hepatitis C Virus|hepatitis c virus
182784|NCT02442284|Hepatitis C|hepatitis c
182785|NCT02442284|Cirrhosis|cirrhosis
182786|NCT02442271|Chronic Hepatitis C|chronic hepatitis c
182787|NCT02442271|Hepatitis C Treatment Naive|hepatitis c treatment naive
182788|NCT02442271|Hepatitis C Genotype 1|hepatitis c genotype 1
182789|NCT02442271|Hepatitis C Treatment Experienced|hepatitis c treatment experienced
182790|NCT02442271|Hepatitis C Virus|hepatitis c virus
182791|NCT02442258|Renal Impairment|renal impairment
182792|NCT02442219|gluten|gluten
182793|NCT02442219|Tetramer|tetramer
182794|NCT02442206|QVA149, cardiac function, ventricular enddiastolic volume, hyperinflated COPD patients|qva149, cardiac function, ventricular enddiastolic volume, hyperinflated copd patients
182795|NCT02442154|early tracheostomy|early tracheostomy
182796|NCT02442154|severe head injury|severe head injury
182797|NCT02442154|endotracheal intubation|endotracheal intubation
182798|NCT02442141|Near-Infrared Spectroscopy|near-infrared spectroscopy
182799|NCT02442141|Cerebral|cerebral
182800|NCT02442141|Infants|infants
182801|NCT02442141|Anesthesia|anesthesia
182802|NCT02442141|Neurodevelopmental|neurodevelopmental
182803|NCT02442128|Fentany|fentany
182804|NCT02442128|intubation|intubation
182805|NCT02442128|sevoflurane|sevoflurane
182806|NCT02442128|children|children
182807|NCT02442128|Propofol|propofol
182808|NCT02442115|Autism|autism
182809|NCT02442115|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
182810|NCT02442115|Tummy Troubles|tummy troubles
182811|NCT02442115|Constipation|constipation
182812|NCT02442115|GI Disorders|gi disorders
182813|NCT02442115|Gastrointestinal Disorders|gastrointestinal disorders
182814|NCT02442115|Gastrointestinal|gastrointestinal
182815|NCT02442115|Oxidative Stress|oxidative stress
182816|NCT02442115|Stomach problems|stomach problems
182817|NCT02442115|Behaviors|behaviors
182818|NCT02442115|Autistic|autistic
182819|NCT02442115|ASD|asd
182820|NCT02442115|MET gene|met gene
182821|NCT02442115|GID|gid
182822|NCT02442115|Pediatric|pediatric
182823|NCT02442115|Pediatric GI disorders|pediatric gi disorders
182824|NCT02442115|Children with Autism|children with autism
182825|NCT02442115|functional constipation|functional constipation
182826|NCT02442102|deglutition disorders|deglutition disorders
182827|NCT02442102|therapeutics|therapeutics
182828|NCT02442102|rehabilitation|rehabilitation
182829|NCT02442102|outcome assessment|outcome assessment
182830|NCT02442102|intubation|intubation
182831|NCT02442102|critical care|critical care
182832|NCT02442102|larynx|larynx
182833|NCT02442102|voice|voice
182834|NCT02442089|mHealth|mhealth
182835|NCT02442089|eHealth|ehealth
182836|NCT02442089|Health Systems|health systems
182837|NCT02442089|Health Technology|health technology
182838|NCT02442089|No Show|no show
182839|NCT02442089|Non-attendance|non-attendance
182840|NCT02442089|Chile|chile
182841|NCT02442089|Randomized controlled trial|randomized controlled trial
182842|NCT02442089|Efficiency, Organizational|efficiency, organizational
182843|NCT02442089|Pediatric Hospitals|pediatric hospitals
182844|NCT02442089|Global Health|global health
182845|NCT02442089|Referral and Consultation|referral and consultation
182846|NCT02442089|Health Care Systems|health care systems
182847|NCT02442089|Community Health Systems|community health systems
182848|NCT02442089|Health Information Systems|health information systems
182849|NCT02442089|Integrated Health Care Systems|integrated health care systems
182850|NCT02442089|Community Medicine|community medicine
182851|NCT02442076|Skin vibration|skin vibration
182852|NCT02442076|Acupuncture needle vibration|acupuncture needle vibration
182853|NCT02442050|CABG|cabg
182854|NCT02442050|valve surgery|valve surgery
182855|NCT02442050|cardioplegia|cardioplegia
182856|NCT02442050|heart surgery|heart surgery
182857|NCT02442050|cardiac surgery|cardiac surgery
182858|NCT02442050|Cardio-Pulmonary Bypass|cardio-pulmonary bypass
182859|NCT02442050|myocardial arrest|myocardial arrest
182860|NCT02442050|coronary artery bypass graft|coronary artery bypass graft
182861|NCT02442050|CPB|cpb
182862|NCT02442037|cellular therapy|cellular therapy
182863|NCT02442037|active ulcerative colitis|active ulcerative colitis
182864|NCT02442037|phase 1/2 clinical study|phase 1/2 clinical study
182865|NCT02442037|human umbilical cord mesenchymal stem cell|human umbilical cord mesenchymal stem cell
182866|NCT02442037|allogeneic stem cell transplantation|allogeneic stem cell transplantation
182867|NCT02442037|UC|uc
182868|NCT02442024|diabetes mellitus|diabetes mellitus
182869|NCT02442024|diet|diet
182870|NCT02442024|nutrient sensing|nutrient sensing
182871|NCT02442011|Hematology Biobank|hematology biobank
182872|NCT02441998|Colorectal Cancer|colorectal cancer
182873|NCT02441998|Diminutive Polyps|diminutive polyps
182874|NCT02441998|Narrow Band Imaging|narrow band imaging
182875|NCT02441998|Colonic Polyps|colonic polyps
182876|NCT02441998|colonoscopy|colonoscopy
182877|NCT02441998|diagnostic imaging|diagnostic imaging
182878|NCT02441998|optical diagnosis|optical diagnosis
182879|NCT02441985|Primary orthostatic tremor|primary orthostatic tremor
182880|NCT02441946|cyclin-dependent kinase (CDK) 4/6 inhibitor|cyclin-dependent kinase (cdk) 4/6 inhibitor
182881|NCT02441946|CDK 4 and 6 inhibitor|cdk 4 and 6 inhibitor
182882|NCT02441907|Diabetic Macular Edema|diabetic macular edema
182883|NCT02441907|Ocular Cytokines|ocular cytokines
182884|NCT02441907|Triamcinolone Acetonide|triamcinolone acetonide
182885|NCT02441881|Radiofrequency ablation|radiofrequency ablation
182886|NCT02441881|varicose veins|varicose veins
182887|NCT02441881|endothermal ablation|endothermal ablation
182888|NCT02441881|RFITT|rfitt
182889|NCT02441881|Venefit|venefit
182890|NCT02441842|β-blocker|β-blocker
182891|NCT02441842|ACE inhibitor|ace inhibitor
182892|NCT02441842|Stress|stress
182893|NCT02441842|Craniotomy|craniotomy
182894|NCT02441842|Postop hypertension|postop hypertension
182895|NCT02441842|neurosurgical patients|neurosurgical patients
182896|NCT02441829|Renal Impairment|renal impairment
182897|NCT02441816|wet AMD|wet amd
182898|NCT02441816|neovascular AMD|neovascular amd
182899|NCT02441803|Leukemia|leukemia
182900|NCT02441803|Acute myeloid leukemia|acute myeloid leukemia
182901|NCT02441803|AML|aml
182902|NCT02441803|Refractory|refractory
182903|NCT02441803|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
182904|NCT02441803|AHSCT|ahsct
182905|NCT02441803|Busulfan|busulfan
182906|NCT02441803|Busulfex|busulfex
182907|NCT02441803|Myleran|myleran
182908|NCT02441803|Fludarabine|fludarabine
182909|NCT02441803|Fludarabine Phosphate|fludarabine phosphate
182910|NCT02441803|Fludara|fludara
182911|NCT02441803|Clofarabine|clofarabine
182912|NCT02441803|Clofarex|clofarex
182913|NCT02441803|Clolar|clolar
182914|NCT02441803|Total body irradiation|total body irradiation
182915|NCT02441803|TBI|tbi
182916|NCT02441803|XRT|xrt
182917|NCT02441803|Thymoglobulin|thymoglobulin
182918|NCT02441803|ATG (Rabbit)|atg (rabbit)
182919|NCT02441803|Rabbit antithymocyte Globulin|rabbit antithymocyte globulin
182920|NCT02441803|Rabbit Antilymphocyte Globulin|rabbit antilymphocyte globulin
182921|NCT02441803|Rabbit ATG|rabbit atg
182922|NCT02441803|rATG|ratg
182923|NCT02441803|Stem cell infusion|stem cell infusion
182924|NCT02441803|Cyclophosphamide|cyclophosphamide
182925|NCT02441803|Cytoxan|cytoxan
182926|NCT02441803|Neosar|neosar
182927|NCT02441803|Tacrolimus|tacrolimus
182928|NCT02441803|Prograf|prograf
182929|NCT02441803|Mycophenolate mofetil|mycophenolate mofetil
182930|NCT02441803|MMF|mmf
182931|NCT02441803|CellCept|cellcept
182932|NCT02441803|Decitabine|decitabine
182933|NCT02441803|Dacogen|dacogen
182934|NCT02441803|Cytarabine|cytarabine
182935|NCT02441803|Ara-C|ara-c
182936|NCT02441803|Cytosar|cytosar
182937|NCT02441803|DepoCyt|depocyt
182938|NCT02441803|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
182939|NCT02441803|Idarubicin|idarubicin
182940|NCT02441803|Idamycin|idamycin
182941|NCT02441790|5th metacarpal|5th metacarpal
182942|NCT02441790|EAROM|earom
182943|NCT02441790|standard immobilization|standard immobilization
182944|NCT02441790|Boxer's Fracture|boxer's fracture
182945|NCT02441790|hand function|hand function
182946|NCT02441790|DASH|dash
182947|NCT02441790|trauma|trauma
182948|NCT02441777|retinal imaging|retinal imaging
182949|NCT02441777|optical imaging|optical imaging
182950|NCT02441777|optical coherence tomography|optical coherence tomography
182951|NCT02441777|polarization sensitive coherence tomography|polarization sensitive coherence tomography
182952|NCT02441764|Halaven|halaven
182953|NCT02441764|Eribulin Mesylate|eribulin mesylate
182954|NCT02441764|locally advanced or metastatic breast cancer|locally advanced or metastatic breast cancer
182955|NCT02441751|Electrocardiography|electrocardiography
182956|NCT02441751|Hemorrhage|hemorrhage
182957|NCT02441751|Monitoring, Intraoperative|monitoring, intraoperative
182958|NCT02441738|Atrial Fibrillation|atrial fibrillation
182959|NCT02441738|Hybrid Ablation|hybrid ablation
182960|NCT02441738|Catheter Ablation|catheter ablation
182961|NCT02441686|Multiple Myeloma|multiple myeloma
182962|NCT02441673|Postanaesthetic shivering|postanaesthetic shivering
182963|NCT02441673|Subarachnoid block|subarachnoid block
182964|NCT02441673|Tramadol|tramadol
182965|NCT02441673|Nefopam|nefopam
182966|NCT02441621|fluid responsiveness|fluid responsiveness
182967|NCT02441621|diastolic dysfunction|diastolic dysfunction
182968|NCT02441621|left ventricular|left ventricular
182969|NCT02441556|thrombectomy|thrombectomy
182970|NCT02441556|rt-PA|rt-pa
182971|NCT02441556|stroke|stroke
182972|NCT02441556|endovascular treatment|endovascular treatment
182973|NCT02441556|randomized|randomized
182974|NCT02441530|vitamin D|vitamin d
182975|NCT02441517|Xtandi|xtandi
182976|NCT02441517|Metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
182977|NCT02441517|Metastatic|metastatic
182978|NCT02441517|Prostate Cancer|prostate cancer
182979|NCT02441517|Chemotherapy|chemotherapy
182980|NCT02441517|Castration-resistant|castration-resistant
182981|NCT02441517|Enzalutamide|enzalutamide
182982|NCT02441504|Exercise training|exercise training
182983|NCT02441504|microvascular rarefaction|microvascular rarefaction
182984|NCT02441478|cooperative behavior, therapy adherence, fMRI|cooperative behavior, therapy adherence, fmri
182985|NCT02441452|Nuss procedure|nuss procedure
182986|NCT02441452|postoperative care|postoperative care
182987|NCT02441452|early ambulation|early ambulation
182988|NCT02441426|Cognitive development|cognitive development
182989|NCT02441426|Diarrheal disease|diarrheal disease
182990|NCT02441426|Enteric infections|enteric infections
182991|NCT02441426|Malnutrition|malnutrition
182992|NCT02441426|Vaccine Response|vaccine response
182993|NCT02441426|Enteropathy|enteropathy
182994|NCT02441426|Antibiotic use|antibiotic use
182995|NCT02441426|Micronutrients|micronutrients
182996|NCT02441426|Breast feeding|breast feeding
182997|NCT02441426|Gut inflammation|gut inflammation
182998|NCT02441413|HRCT|hrct
182999|NCT02441413|High Resolution Computed Tomography scans|high resolution computed tomography scans
183000|NCT02441413|Functional Respiratory Imaging|functional respiratory imaging
183002|NCT02441413|Computed Tomography|computed tomography
183003|NCT02441413|CT|ct
183004|NCT02441413|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
183005|NCT02441413|BOS|bos
183006|NCT02441413|Lung Transplant|lung transplant
183007|NCT02441400|GERD|gerd
183008|NCT02441400|LES Pressure|les pressure
183009|NCT02441400|Electrical Stimulation|electrical stimulation
183010|NCT02441387|depression|depression
183011|NCT02441387|elderly|elderly
183012|NCT02441387|remission|remission
183013|NCT02441387|treatment response|treatment response
183014|NCT02441387|predictors of response|predictors of response
183015|NCT02441387|cognitive decline|cognitive decline
183016|NCT02441387|structural neuroimage|structural neuroimage
183017|NCT02441387|genetic polymorphism|genetic polymorphism
183018|NCT02441387|psychoeducation|psychoeducation
183019|NCT02441374|Stroke|stroke
183020|NCT02441374|Hemiparesis|hemiparesis
183021|NCT02441374|Upper limb|upper limb
183022|NCT02441348|Voice Therapy|voice therapy
183023|NCT02441348|Muscle Tension Dysphonia|muscle tension dysphonia
183024|NCT02441348|Lesions|lesions
183025|NCT02441309|Metastatic and/or Recurrent Osteosarcoma|metastatic and/or recurrent osteosarcoma
183026|NCT02441283|Chronic hepatitis C|chronic hepatitis c
183027|NCT02441283|Hepatitis C virus|hepatitis c virus
183028|NCT02441283|Sustained virologic response|sustained virologic response
183029|NCT02441283|Hepatitis C|hepatitis c
183030|NCT02441283|Direct Acting Antiviral|direct acting antiviral
183031|NCT02441257|Gastroesophageal Reflux|gastroesophageal reflux
183032|NCT02441257|Laryngeal Mask Airway|laryngeal mask airway
183033|NCT02441257|Control Ventilation|control ventilation
183034|NCT02441257|Spontaneous Ventilation|spontaneous ventilation
183035|NCT02441205|High Intensity Interval Training|high intensity interval training
183036|NCT02441192|physical training|physical training
183037|NCT02441192|aerobic training|aerobic training
183038|NCT02441192|resistance training|resistance training
183039|NCT02441179|acute intermittent hypoxia|acute intermittent hypoxia
183040|NCT02441179|rehabilitation|rehabilitation
183041|NCT02441179|spinal cord injury|spinal cord injury
183042|NCT02441166|Bone marrow tryptase|bone marrow tryptase
183043|NCT02441166|cutaneous mastocytosis|cutaneous mastocytosis
183044|NCT02441140|Stage III Ovarian Cancer|stage iii ovarian cancer
183045|NCT02441140|Stage IV Ovarian Cancer|stage iv ovarian cancer
183046|NCT02441127|free gingival graft|free gingival graft
183047|NCT02441127|diode laser|diode laser
183048|NCT02441127|donor site|donor site
183049|NCT02441127|mucogingival surgery|mucogingival surgery
183050|NCT02441101|Cardiac Resynchronization therapy|cardiac resynchronization therapy
183051|NCT02441075|patients|patients
183052|NCT02441075|BMT|bmt
183053|NCT02441075|cyclosporine|cyclosporine
183054|NCT02441075|tacrolimus|tacrolimus
183055|NCT02441075|HSCT|hsct
183056|NCT02441049|Latino|latino
183057|NCT02441049|Hispanic|hispanic
183058|NCT02441049|Diet|diet
183059|NCT02441049|Family health|family health
183060|NCT02441049|Promotora|promotora
183061|NCT02441049|Intervention|intervention
183062|NCT02441036|Gene expression and protein production|gene expression and protein production
183063|NCT02441023|type 2 diabetes mellitus|type 2 diabetes mellitus
183064|NCT02441023|nutritional therapy|nutritional therapy
183065|NCT02441023|health education|health education
183066|NCT02441023|self-management|self-management
183067|NCT02441023|multimedia|multimedia
183068|NCT02440997|aromatherapy, peppermint|aromatherapy, peppermint
183069|NCT02440984|enteric nervous system|enteric nervous system
183070|NCT02440984|anorectal disorder|anorectal disorder
183071|NCT02440984|barostat anorectal|barostat anorectal
183072|NCT02440984|physiology|physiology
183073|NCT02440984|spina bifida|spina bifida
183074|NCT02440971|Adaptive Servo Ventilation|adaptive servo ventilation
183075|NCT02440971|Acute decompensated heart failure|acute decompensated heart failure
183076|NCT02440971|SleepMinder|sleepminder
183077|NCT02440971|ApneaLink Plus|apnealink plus
183078|NCT02440971|Sleep disordered breathing|sleep disordered breathing
183079|NCT02440971|Natriuretic peptide|natriuretic peptide
183080|NCT02440932|low Phenylalanine diet|low phenylalanine diet
183081|NCT02440932|PKU supplements|pku supplements
183082|NCT02440932|diet induced thermogenesis|diet induced thermogenesis
183083|NCT02440932|appetite|appetite
183084|NCT02440932|body weight|body weight
183085|NCT02440919|Respiratory mechanics|respiratory mechanics
183086|NCT02440919|Oxygenation|oxygenation
183087|NCT02440919|Suction|suction
183088|NCT02440919|Mechanical ventilation|mechanical ventilation
183089|NCT02440919|Respiratory therapy|respiratory therapy
183090|NCT02440919|Capnography|capnography
183091|NCT02440919|Pulmonary Ventilation|pulmonary ventilation
183092|NCT02440906|Asthma|asthma
183093|NCT02440906|Cerebrovascular Disease|cerebrovascular disease
183094|NCT02440906|Intracranial Injury|intracranial injury
183095|NCT02440906|Neoplasms|neoplasms
183096|NCT02440906|Heart Failure|heart failure
183097|NCT02440906|HIV/AIDs|hiv/aids
183098|NCT02440906|Hereditary and Degenerative Diseases of the Central Nervous System|hereditary and degenerative diseases of the central nervous system
183099|NCT02440906|Disorders of the Peripheral Nervous System|disorders of the peripheral nervous system
183100|NCT02440906|Rheumatoid Arthritis and Other Inflammatory Polyarthropathies|rheumatoid arthritis and other inflammatory polyarthropathies
183101|NCT02440906|History of hepatitis C|history of hepatitis c
183102|NCT02440906|Schizophrenia|schizophrenia
183103|NCT02440906|Episodic Mood Disorders|episodic mood disorders
183104|NCT02440906|Delusional Disorders|delusional disorders
183105|NCT02440906|Other Non-Organic Psychoses|other non-organic psychoses
183106|NCT02440906|Organic Psychotic Conditions|organic psychotic conditions
183107|NCT02440906|Neurotic Disorders|neurotic disorders
183108|NCT02440906|Other Non-Psychotic Mental Disorders|other non-psychotic mental disorders
183109|NCT02440893|Corus CAD|corus cad
183110|NCT02440893|ASGES|asges
183111|NCT02440893|Age/Sex/Gene Expression Score|age/sex/gene expression score
183112|NCT02440893|Gene Expression|gene expression
183113|NCT02440893|GES|ges
183114|NCT02440893|CAD|cad
183115|NCT02440893|CVD|cvd
183116|NCT02440893|CHD|chd
183117|NCT02440893|Precision Medicine|precision medicine
183118|NCT02440893|Coronary Artery Disease|coronary artery disease
183119|NCT02440893|Angina Pectoris|angina pectoris
183120|NCT02440893|Chest Pain|chest pain
183121|NCT02440893|Cardiovascular Disease|cardiovascular disease
183122|NCT02440893|Coronary Heart Disease|coronary heart disease
183123|NCT02440893|Metformin|metformin
183124|NCT02440867|theta burst stimulation|theta burst stimulation
183125|NCT02440867|Social Cognition|social cognition
183126|NCT02440867|MRSI|mrsi
183127|NCT02440867|Schizophrenia|schizophrenia
183128|NCT02440867|transcranial magnetic stimulation|transcranial magnetic stimulation
183129|NCT02440841|VA106483|va106483
183130|NCT02440841|fedovapagon|fedovapagon
183131|NCT02440841|drug-drug interaction|drug-drug interaction
183132|NCT02440841|DDI|ddi
183133|NCT02440841|males|males
183134|NCT02440841|rifampicin|rifampicin
183135|NCT02440841|rifampin|rifampin
183136|NCT02440841|itraconazole|itraconazole
183137|NCT02440841|CYP3A4|cyp3a4
183138|NCT02440841|pharmacokinetics|pharmacokinetics
183139|NCT02440841|PK|pk
183140|NCT02440815|Psychotherapy|psychotherapy
183141|NCT02440815|Problem Solving Therapy (PST)|problem solving therapy (pst)
183142|NCT02440815|Depression|depression
183143|NCT02440815|Major Depression|major depression
183144|NCT02440815|Major Depressive Disorder|major depressive disorder
183145|NCT02440815|Late Life Depression|late life depression
183146|NCT02440815|Multimodal imaging|multimodal imaging
183147|NCT02440815|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
183148|NCT02440815|Cerebral blood flow|cerebral blood flow
183149|NCT02440815|Cortical atrophy|cortical atrophy
183150|NCT02440815|White matter lesion|white matter lesion
183151|NCT02440763|Natural History|natural history
183152|NCT02440737|Newly diagnosed|newly diagnosed
183153|NCT02440737|Cancer patient|cancer patient
183154|NCT02440737|Caregiver|caregiver
183155|NCT02440737|Support person|support person
183156|NCT02440724|winged stents|winged stents
183157|NCT02440724|Self-expandable Metal Stents(SEMS)|self-expandable metal stents(sems)
183158|NCT02440724|partial covered|partial covered
183159|NCT02440724|uncovered|uncovered
183160|NCT02440724|endoscopic insertion|endoscopic insertion
183161|NCT02440685|DLBCL|dlbcl
183162|NCT02440685|FL|fl
183163|NCT02440685|MCL|mcl
183164|NCT02440685|PTCL|ptcl
183165|NCT02440685|MF|mf
183166|NCT02440685|CLL|cll
183167|NCT02440672|Osteoarthritis|osteoarthritis
183168|NCT02440672|TKA|tka
183169|NCT02440672|Degenerative Knee Disease|degenerative knee disease
183170|NCT02440659|Chronic Kidney Disease|chronic kidney disease
183171|NCT02440659|Hemodialysis|hemodialysis
183172|NCT02440659|Peritoneal Dialysis|peritoneal dialysis
183173|NCT02440646|Computed tomography angiography|computed tomography angiography
183174|NCT02440646|Quantitative coronary angiography|quantitative coronary angiography
183175|NCT02440646|Coronary artery disease|coronary artery disease
183176|NCT02440646|Natural history of atherosclerosis|natural history of atherosclerosis
183177|NCT02440646|Radiocontrast-induced thyroid dysfunction|radiocontrast-induced thyroid dysfunction
183178|NCT02440646|Contrast-induced nephropathy|contrast-induced nephropathy
183179|NCT02440646|Plaque burden|plaque burden
183180|NCT02440646|Glagovian artery remodeling|glagovian artery remodeling
183181|NCT02440646|Radiation dose|radiation dose
183182|NCT02440646|SYNTAX score|syntax score
183183|NCT02440646|Fractional flow reserve|fractional flow reserve
183184|NCT02440620|Heart failure related to medical treatment of breast cancer|heart failure related to medical treatment of breast cancer
183185|NCT02440607|Randomization|randomization
183186|NCT02440607|cognitive aids types|cognitive aids types
183187|NCT02440607|aids|aids
183188|NCT02440594|Primary Care|primary care
183189|NCT02440594|Depression|depression
183190|NCT02440594|Elderly|elderly
183191|NCT02440555|diabetes, capillary blood glucose, self-administered questionnaire|diabetes, capillary blood glucose, self-administered questionnaire
183192|NCT02440542|Nerve block|nerve block
183193|NCT02440542|Ankle|ankle
183194|NCT02440542|Talus|talus
183195|NCT02440542|Pain, Postoperative|pain, postoperative
183196|NCT02440516|Standardized|standardized
183197|NCT02440516|Physical therapy|physical therapy
183198|NCT02440516|occupational therapy|occupational therapy
183199|NCT02440516|quality of life|quality of life
183200|NCT02440516|disability|disability
183201|NCT02440516|activities of daily living|activities of daily living
183202|NCT02440516|ambulatory therapy|ambulatory therapy
183203|NCT02440516|multiple sclerosis|multiple sclerosis
183204|NCT02440464|Multiple Myeloma|multiple myeloma
183205|NCT02440464|Allogeneic Transplant|allogeneic transplant
183206|NCT02440464|Maintenance Therapy|maintenance therapy
183207|NCT02440464|Anti-Myeloma Agents|anti-myeloma agents
183208|NCT02440464|Hematologic Disorders|hematologic disorders
183209|NCT02440438|Clostridium difficile, recurrence, relapse, antibodies, immune response, prognosis|clostridium difficile, recurrence, relapse, antibodies, immune response, prognosis
183210|NCT02440425|platinum resistant|platinum resistant
183211|NCT02440425|recurrent|recurrent
183212|NCT02440425|persistent|persistent
183213|NCT02440425|epithelial|epithelial
183214|NCT02440425|ovarian|ovarian
183215|NCT02440425|fallopian tube|fallopian tube
183216|NCT02440425|primary peritoneal|primary peritoneal
183217|NCT02440425|carcinoma|carcinoma
183218|NCT02440412|Massage|massage
183219|NCT02440412|Stress|stress
183220|NCT02440412|salivary cortisol|salivary cortisol
183221|NCT02440360|chronic homelessness|chronic homelessness
183222|NCT02440347|local anesthesia|local anesthesia
183223|NCT02440347|articaine|articaine
183224|NCT02440347|AMSA|amsa
183225|NCT02440334|cryosurgery|cryosurgery
183226|NCT02440334|ultrasonography|ultrasonography
183227|NCT02440282|patients|patients
183228|NCT02440256|Cost-effectiveness|cost-effectiveness
183229|NCT02440256|Opioid substitution treatment|opioid substitution treatment
183230|NCT02440256|Integrated care|integrated care
183231|NCT02440256|HIV|hiv
183232|NCT02440256|HAART|haart
183233|NCT02440256|Testing|testing
183234|NCT02440256|Linkage to care|linkage to care
183235|NCT02440256|Treatment adherence|treatment adherence
183236|NCT02440230|adjuvant endocrine therapy|adjuvant endocrine therapy
183237|NCT02440230|safety|safety
183238|NCT02440230|Exemestane|exemestane
183239|NCT02440230|ovarian function suppression|ovarian function suppression
183240|NCT02440230|anastrozole|anastrozole
183241|NCT02440204|sevoflurane|sevoflurane
183242|NCT02440204|remifentanil|remifentanil
183243|NCT02440204|intubation without using muscle relaxants|intubation without using muscle relaxants
183244|NCT02440178|leukemia|leukemia
183245|NCT02440178|induction|induction
183246|NCT02440178|prophylaxis|prophylaxis
183247|NCT02440178|antifungal|antifungal
183248|NCT02440178|micafungin|micafungin
183249|NCT02440178|phase II|phase ii
183250|NCT02440165|nutrition|nutrition
183251|NCT02440165|nurse|nurse
183252|NCT02440165|intervention|intervention
183253|NCT02440165|malnutrition|malnutrition
183254|NCT02440126|Multiple Sclerosis|multiple sclerosis
183255|NCT02440126|immunological|immunological
183256|NCT02440126|biomarkers|biomarkers
183257|NCT02440126|observational|observational
183258|NCT02440126|Relapsing|relapsing
183259|NCT02440126|Remitting Multiple Sclerosis|remitting multiple sclerosis
183260|NCT02440100|Phase 1|phase 1
183261|NCT02440100|Multiple doses of PF-06648671|multiple doses of pf-06648671
183262|NCT02440100|safety, tolerability, PK|safety, tolerability, pk
183263|NCT02440100|plasma and CSF abeta|plasma and csf abeta
183264|NCT02440100|drug interaction|drug interaction
183265|NCT02440074|Lumbar pain|lumbar pain
183266|NCT02440074|Mesenchymal Stem Cells|mesenchymal stem cells
183267|NCT02440061|Ghrelin|ghrelin
183268|NCT02440061|age, BMI, and gender matched controls|age, bmi, and gender matched controls
183269|NCT02440048|extraction|extraction
183270|NCT02440048|Bond Apatite|bond apatite
183271|NCT02440035|Healthy Participants|healthy participants
183272|NCT02440035|Ad35.RSV.FA2|ad35.rsv.fa2
183273|NCT02440035|JNJ-61187191|jnj-61187191
183274|NCT02439996|Kawasaki disease IVIG|kawasaki disease ivig
183275|NCT02439970|kidney transplant allograft|kidney transplant allograft
183276|NCT02439970|recipients|recipients
183277|NCT02439944|Nicotine Patch|nicotine patch
183278|NCT02439944|Nicotine Mouth Spray|nicotine mouth spray
183279|NCT02439944|Smoking Cessation|smoking cessation
183280|NCT02439944|Quit Smoking|quit smoking
183281|NCT02439944|Abstinence|abstinence
183282|NCT02439944|Dependence|dependence
183283|NCT02439944|Nicotine|nicotine
183284|NCT02439944|Tobacco|tobacco
183285|NCT02439944|Transdermal Nicotine Replacement Therapy|transdermal nicotine replacement therapy
183286|NCT02439944|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
183287|NCT02439944|Neuroimaging|neuroimaging
183288|NCT02439944|Cue Reactivity|cue reactivity
183289|NCT02439944|Resting State|resting state
183290|NCT02439944|BOLD fMRI|bold fmri
183291|NCT02439905|inflammatory cytokine|inflammatory cytokine
183292|NCT02439905|protective effect|protective effect
183293|NCT02439905|Dexmedetomidine|dexmedetomidine
183294|NCT02439905|Precedex|precedex
183295|NCT02439905|one lung ventilation|one lung ventilation
183296|NCT02439905|ischemia-reperfusion|ischemia-reperfusion
183297|NCT02439892|Radiotherapy|radiotherapy
183298|NCT02439892|Exercise|exercise
183299|NCT02439892|Diet therapy|diet therapy
183300|NCT02439892|Rehabilitation|rehabilitation
183301|NCT02439892|Patient Compliance|patient compliance
183302|NCT02439892|Feasibility Studies|feasibility studies
183303|NCT02439892|Sample Size|sample size
183304|NCT02439892|Patient satisfaction|patient satisfaction
183305|NCT02439853|primary progressive aphasia|primary progressive aphasia
183306|NCT02439853|progressive nonfluent aphasia|progressive nonfluent aphasia
183307|NCT02439853|progressive aphasia|progressive aphasia
183308|NCT02439853|frontotemporal dementia|frontotemporal dementia
183309|NCT02439853|frontotemporal lobar degeneration|frontotemporal lobar degeneration
183310|NCT02439827|Lifestyle|lifestyle
183311|NCT02439827|Intervention|intervention
183312|NCT02439827|Motor Activity|motor activity
183313|NCT02439827|Mediating Variables|mediating variables
183314|NCT02439827|Mental Health|mental health
183315|NCT02439827|Obesity|obesity
183316|NCT02439827|Adolescent Health|adolescent health
183317|NCT02439827|School|school
183318|NCT02439827|Health Promotion|health promotion
183319|NCT02439827|Brazil|brazil
183320|NCT02439801|PEEP|peep
183321|NCT02439801|compliance|compliance
183322|NCT02439801|peak airway pressures|peak airway pressures
183323|NCT02439788|Neuroblastoma|neuroblastoma
183324|NCT02439788|Natural Killer T Cells|natural killer t cells
183325|NCT02439788|Gene Therapy|gene therapy
183326|NCT02439788|Chimeric Antigen Receptor|chimeric antigen receptor
183327|NCT02439775|Uncontrolled hypertension|uncontrolled hypertension
183328|NCT02439775|Renal denervation|renal denervation
183329|NCT02439762|Veterans|veterans
183330|NCT02439762|Cognitive Behavioral Therapy|cognitive behavioral therapy
183331|NCT02439749|Uncontrolled hypertension|uncontrolled hypertension
183332|NCT02439749|Renal denervation|renal denervation
183333|NCT02439736|Traumatic Brain Injury|traumatic brain injury
183334|NCT02439736|Head Injury|head injury
183335|NCT02439723|Regorafenib|regorafenib
183336|NCT02439723|Lean body mass|lean body mass
183337|NCT02439723|Proton pump inhibitors pharmacokinetics|proton pump inhibitors pharmacokinetics
183338|NCT02439684|HbA1c|hba1c
183339|NCT02439684|Diagnostic accuracy|diagnostic accuracy
183340|NCT02439684|Diabetes Mellitus|diabetes mellitus
183341|NCT02439684|Chinese|chinese
183342|NCT02439684|Impaired fasting glucose|impaired fasting glucose
183343|NCT02439671|Transition Support Program for young adults|transition support program for young adults
183344|NCT02439658|genetic research|genetic research
183345|NCT02439645|genetic research|genetic research
183346|NCT02439606|GlideRite|gliderite
183347|NCT02439606|Stylet|stylet
183348|NCT02439606|Parker|parker
183349|NCT02439606|orotracheal|orotracheal
183350|NCT02439606|intubation|intubation
183351|NCT02439606|GlideScope|glidescope
183352|NCT02439593|Pancreas|pancreas
183353|NCT02439593|chemoradiotherapy|chemoradiotherapy
183354|NCT02439593|hyperthermia|hyperthermia
183355|NCT02439580|Patients|patients
183356|NCT02439580|After Surgery|after surgery
183357|NCT02439567|Cirrhosis|cirrhosis
183358|NCT02439567|Chronic hepatitis C|chronic hepatitis c
183359|NCT02439567|Clinically significant portal hypertension|clinically significant portal hypertension
183360|NCT02439567|Portal hypertension|portal hypertension
183361|NCT02439567|Elastography|elastography
183362|NCT02439567|Antiviral therapy|antiviral therapy
183363|NCT02439541|cellular therapy|cellular therapy
183364|NCT02439541|Chronic ischemic heart disease|chronic ischemic heart disease
183365|NCT02439541|phase 1/2 clinical study|phase 1/2 clinical study
183366|NCT02439541|human umbilical cord mesenchymal stem cell|human umbilical cord mesenchymal stem cell
183367|NCT02439541|ischemic heart disease|ischemic heart disease
183368|NCT02439541|allogeneic stem cell transplantation|allogeneic stem cell transplantation
183369|NCT02439528|pulmonary fibrosis|pulmonary fibrosis
183370|NCT02439528|syndrome|syndrome
183371|NCT02439528|genetic|genetic
183372|NCT02439528|emphysema|emphysema
183373|NCT02439515|post-acute stroke|post-acute stroke
183374|NCT02439515|functional electrical stimulation|functional electrical stimulation
183375|NCT02439515|biofeedback|biofeedback
183376|NCT02439515|balance|balance
183377|NCT02439515|cycling|cycling
183378|NCT02439515|rehabilitation|rehabilitation
183379|NCT02439515|gait|gait
183380|NCT02439476|Multiple myeloma|multiple myeloma
183381|NCT02439476|ASCT|asct
183382|NCT02439476|plerixafor|plerixafor
183383|NCT02439476|stem cell mobilization|stem cell mobilization
183384|NCT02439476|Salvage ASCT using plerixafor-based stem cell mobilization in relapsed multiple myeloma|salvage asct using plerixafor-based stem cell mobilization in relapsed multiple myeloma
183385|NCT02439450|lung|lung
183386|NCT02439450|cancer|cancer
183387|NCT02439450|gp96|gp96
183388|NCT02439450|vaccine|vaccine
183389|NCT02439450|immunotherapy|immunotherapy
183390|NCT02439450|Heat Biologics|heat biologics
183391|NCT02439450|Nivolumab|nivolumab
183392|NCT02439450|checkpoint inhibitor|checkpoint inhibitor
183393|NCT02439385|Curcumin|curcumin
183394|NCT02439385|Avastin|avastin
183395|NCT02439385|FOLFIRI|folfiri
183396|NCT02439385|Colorectal cancer|colorectal cancer
183397|NCT02439385|Unresectable metastasis|unresectable metastasis
183398|NCT02439346|Advanced solid tumors|advanced solid tumors
183399|NCT02439346|Docetaxel|docetaxel
183400|NCT02439346|mitogen-activated protein (MAP) kinase-interacting serine / threonine-protein kinase 1, also known as Mnk1 (MKNK1 inhibitor)|mitogen-activated protein (map) kinase-interacting serine / threonine-protein kinase 1, also known as mnk1 (mknk1 inhibitor)
183401|NCT02439346|Taxanes|taxanes
183402|NCT02439346|Non-small cell lung cancer|non-small cell lung cancer
183403|NCT02439333|Acute exacerbation of chronic obstructive pulmonary disease|acute exacerbation of chronic obstructive pulmonary disease
183404|NCT02439333|Nasal high flow therapy|nasal high flow therapy
183405|NCT02439333|Oxygen therapy|oxygen therapy
183406|NCT02439307|Rifaximin|rifaximin
183407|NCT02439307|Minimal hepatic encephalopathy|minimal hepatic encephalopathy
183408|NCT02439294|Recent acute myocardial infarction|recent acute myocardial infarction
183409|NCT02439294|Obstructive sleep apnée (syndrome)|obstructive sleep apnée (syndrome)
183410|NCT02439294|Ventricular remodeling|ventricular remodeling
183411|NCT02439294|Continuous Positive Airway Pressure|continuous positive airway pressure
183412|NCT02439281|Ropivacaine|ropivacaine
183413|NCT02439281|Anesthesia adjuncts|anesthesia adjuncts
183414|NCT02439281|clonidine|clonidine
183415|NCT02439281|laparoscopic appendectomy|laparoscopic appendectomy
183416|NCT02439281|rectus sheath block|rectus sheath block
183417|NCT02439242|stroke volume, haemodynamic, fluid resucitation|stroke volume, haemodynamic, fluid resucitation
183418|NCT02439216|Muscular Dystrophies|muscular dystrophies
183419|NCT02439216|Musculoskeletal Diseases|musculoskeletal diseases
183420|NCT02439216|Nervous System Diseases|nervous system diseases
183421|NCT02439216|Neuromuscular Diseases|neuromuscular diseases
183422|NCT02439216|Duchenne muscular dystrophy|duchenne muscular dystrophy
183423|NCT02439216|DMD|dmd
183424|NCT02439216|dystrophin|dystrophin
183425|NCT02439216|dystrophy|dystrophy
183426|NCT02439216|Duchenne|duchenne
183427|NCT02439203|Parkinson Disease|parkinson disease
183428|NCT02439203|Levodopa Induced Dyskinesia (LID)|levodopa induced dyskinesia (lid)
183429|NCT02439203|Dyskinesia|dyskinesia
183430|NCT02439177|Blood glucose monitoring system|blood glucose monitoring system
183431|NCT02439177|System Accuracy|system accuracy
183432|NCT02439164|sedation|sedation
183433|NCT02439164|eloquent area glioma|eloquent area glioma
183434|NCT02439164|neurologic function|neurologic function
183435|NCT02439151|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
183436|NCT02439138|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
183437|NCT02439125|levodopa|levodopa
183438|NCT02439125|dyskinesia|dyskinesia
183439|NCT02439125|parkinsons disease|parkinsons disease
183440|NCT02439125|PD|pd
183441|NCT02439112|Exercise|exercise
183442|NCT02439112|Physical Function|physical function
183443|NCT02439112|Physical Activity|physical activity
183444|NCT02439112|Quality of Life|quality of life
183445|NCT02439112|Pain|pain
183446|NCT02439112|Bone Disease|bone disease
183447|NCT02439086|rectal cancer|rectal cancer
183448|NCT02439086|neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
183449|NCT02439086|long course radiotherapy|long course radiotherapy
183450|NCT02439086|response|response
183451|NCT02439047|reconstructive surgery|reconstructive surgery
183452|NCT02439047|abdominal surgery|abdominal surgery
183453|NCT02439034|pain management|pain management
183454|NCT02439034|brachytherapy|brachytherapy
183455|NCT02439008|liver metastases of colorectal cancer|liver metastases of colorectal cancer
183456|NCT02439008|metastases of melanoma or renal cancer|metastases of melanoma or renal cancer
183457|NCT02438969|Alcohol|alcohol
183458|NCT02438969|Alcohol Dependence|alcohol dependence
183459|NCT02438969|Stress|stress
183460|NCT02438969|Fear Conditioning|fear conditioning
183461|NCT02438917|Hepatitis C|hepatitis c
183462|NCT02438917|Cirrhosis|cirrhosis
183463|NCT02438917|Biomarkers|biomarkers
183464|NCT02438917|Fibrosis|fibrosis
183465|NCT02438904|Blood And Marrow Transplantation|blood and marrow transplantation
183466|NCT02438904|Stem cell transplantation|stem cell transplantation
183467|NCT02438904|SCT|sct
183468|NCT02438904|Poor graft function|poor graft function
183469|NCT02438904|CD34+ cell infusion|cd34+ cell infusion
183470|NCT02438865|Upper Tract Urothelial Carcinoma|upper tract urothelial carcinoma
183471|NCT02438865|Intravesical Chemotherapy|intravesical chemotherapy
183472|NCT02438865|Epirubicin|epirubicin
183473|NCT02438865|Urothelial Carcinoma|urothelial carcinoma
183474|NCT02438800|Postpartum Period|postpartum period
183475|NCT02438787|Ankylosing Spondylitis|ankylosing spondylitis
183476|NCT02438787|Ustekinumab|ustekinumab
183477|NCT02438787|Golimumab|golimumab
183478|NCT02438787|STELARA|stelara
183479|NCT02438774|Post-harvest practices , complementary foods|post-harvest practices , complementary foods
183480|NCT02438774|aflatoxins and fumonisins exposure,|aflatoxins and fumonisins exposure,
183481|NCT02438774|Maize, breast milk|maize, breast milk
183482|NCT02438774|child growth, Tanzania|child growth, tanzania
183483|NCT02438761|Acute Myeloid Leukemia|acute myeloid leukemia
183484|NCT02438761|Myelodysplastic Syndrome|myelodysplastic syndrome
183485|NCT02438761|PIK/Akt/mTor|pik/akt/mtor
183486|NCT02438748|Oxidized Phosphatidylcholines|oxidized phosphatidylcholines
183487|NCT02438735|ovarian endometriomas|ovarian endometriomas
183488|NCT02438735|AMH|amh
183489|NCT02438735|ovarian reserve|ovarian reserve
183490|NCT02438670|Artificial Pancreas|artificial pancreas
183491|NCT02438670|Type 1 Diabetes|type 1 diabetes
183492|NCT02438670|MPC|mpc
183493|NCT02438670|PID|pid
183494|NCT02438631|placenta|placenta
183495|NCT02438631|placental passage|placental passage
183496|NCT02438605|Nellix|nellix
183497|NCT02438605|EVAS|evas
183498|NCT02438605|EVAR|evar
183499|NCT02438605|Dynamic CT|dynamic ct
183500|NCT02438605|Dyna CT|dyna ct
183501|NCT02438592|Continuum of care|continuum of care
183502|NCT02438579|Hypertonic saline|hypertonic saline
183503|NCT02438579|nasal irrigation|nasal irrigation
183504|NCT02438579|gargling|gargling
183505|NCT02438579|URTI|urti
183506|NCT02438566|Tranexamic Acid|tranexamic acid
183507|NCT02438566|Blood Loss|blood loss
183508|NCT02438566|Total Hip Replacement|total hip replacement
183509|NCT02438566|Bilateral Knee Replacement|bilateral knee replacement
183510|NCT02438540|acupuncture|acupuncture
183511|NCT02438540|obesity|obesity
183512|NCT02438540|type 2 diabetic mellitus|type 2 diabetic mellitus
183513|NCT02438540|insulin sensitivity|insulin sensitivity
183514|NCT02438540|metformin|metformin
183515|NCT02438540|inflammatory factor|inflammatory factor
183516|NCT02438540|adipokines|adipokines
183517|NCT02438540|lipid profile|lipid profile
183518|NCT02438501|low-dose involved field radiotherapy|low-dose involved field radiotherapy
183519|NCT02438501|recurrent|recurrent
183520|NCT02438501|advanced|advanced
183521|NCT02438501|follicular lymphoma|follicular lymphoma
183522|NCT02438462|Pulmonary Embolism|pulmonary embolism
183523|NCT02438462|Soluble Fibrin|soluble fibrin
183524|NCT02438462|D-Dimers|d-dimers
183525|NCT02438462|Clinical Probability Score|clinical probability score
183526|NCT02438462|Imaging|imaging
183527|NCT02438449|breast reconstruction|breast reconstruction
183528|NCT02438449|mastectomy|mastectomy
184035|NCT02435355|Sleep apnea|sleep apnea
183529|NCT02438449|health-related quality of life|health-related quality of life
183530|NCT02438449|Health Utilities Index|health utilities index
183531|NCT02438449|HUI|hui
183532|NCT02438449|prospective|prospective
183533|NCT02438449|quality-adjusted life years|quality-adjusted life years
183534|NCT02438449|QALY|qaly
183535|NCT02438410|infliximab|infliximab
183536|NCT02438410|remicade|remicade
183537|NCT02438410|IBD|ibd
183538|NCT02438410|Colitis, Ulcerative|colitis, ulcerative
183539|NCT02438371|pregnancy|pregnancy
183540|NCT02438371|preterm labor|preterm labor
183541|NCT02438371|tocolysis|tocolysis
183542|NCT02438293|rhinovirus|rhinovirus
183543|NCT02438293|cardiac surgery|cardiac surgery
183544|NCT02438293|paediatric|paediatric
183545|NCT02438293|respiratory infection|respiratory infection
183546|NCT02438293|children|children
183547|NCT02438280|Orthodontic|orthodontic
183548|NCT02438280|Orthodontic treatment|orthodontic treatment
183549|NCT02438280|Accelerated orthodontics|accelerated orthodontics
183550|NCT02438280|Vibration|vibration
183551|NCT02438241|Pain Measurement|pain measurement
183552|NCT02438241|Electric Stimulation|electric stimulation
183553|NCT02438241|Spirometry|spirometry
183554|NCT02438241|Manometry|manometry
183555|NCT02438228|cardiac output|cardiac output
183556|NCT02438228|transpulmonary thermodilution|transpulmonary thermodilution
183557|NCT02438228|pulse contour analysis|pulse contour analysis
183558|NCT02438228|G09.330.380.124|g09.330.380.124
183559|NCT02438215|PD|pd
183560|NCT02438215|Parkinson's Disease|parkinson's disease
183561|NCT02438189|Type 1 Diabetes|type 1 diabetes
183562|NCT02438189|Hypoglycemia|hypoglycemia
183563|NCT02438189|Hyperglycemia|hyperglycemia
183564|NCT02438189|Artificial Pancreas|artificial pancreas
183565|NCT02438163|Theta Burst Stimulation|theta burst stimulation
183566|NCT02438150|Disaster|disaster
183567|NCT02438150|Training|training
183568|NCT02438137|Obstructive Sleep Apnea|obstructive sleep apnea
183569|NCT02438137|OSA|osa
183570|NCT02438137|sleep apnea|sleep apnea
183571|NCT02438137|snoring|snoring
183572|NCT02438137|dimethyl fumarate|dimethyl fumarate
183573|NCT02438137|CPAP|cpap
183574|NCT02438137|continuous positive airway pressure|continuous positive airway pressure
183575|NCT02438124|Parkinson's disease|parkinson's disease
183576|NCT02438124|Rhythmic auditory stimulation|rhythmic auditory stimulation
183577|NCT02438124|Gait|gait
183578|NCT02438098|Rivaroxaban|rivaroxaban
183579|NCT02438098|Obesity|obesity
183580|NCT02438098|Bariatric surgery|bariatric surgery
183581|NCT02438098|Pharmacokinetics|pharmacokinetics
183582|NCT02438098|Pharmacodynamics|pharmacodynamics
183583|NCT02438085|acute coronary syndromes|acute coronary syndromes
183584|NCT02438085|outcome|outcome
183585|NCT02438085|medical management|medical management
183586|NCT02438085|comorbidities|comorbidities
183587|NCT02438085|registry|registry
183588|NCT02438072|antidepressive agent|antidepressive agent
183589|NCT02438072|drug metabolism|drug metabolism
183590|NCT02438072|CYP450|cyp450
183591|NCT02438072|P-glycoprotein|p-glycoprotein
183592|NCT02438072|Phenotypic study|phenotypic study
183593|NCT02438059|Inequality in health|inequality in health
183594|NCT02438059|workplace health promotion|workplace health promotion
183595|NCT02438059|internet|internet
183596|NCT02438059|mobile app|mobile app
183597|NCT02438059|weight loss|weight loss
183598|NCT02438059|intervention|intervention
183599|NCT02438059|randomized controlled trial|randomized controlled trial
183600|NCT02438046|Connective Tissue Grafts|connective tissue grafts
183601|NCT02438046|Wound healing|wound healing
183602|NCT02438046|Biomaterials|biomaterials
183603|NCT02438046|Pain|pain
183604|NCT02438046|Clinical Trials|clinical trials
183605|NCT02438046|Mucogingival Surgery|mucogingival surgery
183606|NCT02438033|Deep Brain Stimulation|deep brain stimulation
183607|NCT02438033|Globus Pallidus|globus pallidus
183608|NCT02438033|GPi|gpi
183609|NCT02438033|PC+S|pc+s
183610|NCT02438020|Acanthosis nigricans|acanthosis nigricans
183611|NCT02438020|obesity|obesity
183612|NCT02438020|children|children
183613|NCT02438020|metformin|metformin
183614|NCT02437942|Athletic injuries|athletic injuries
183615|NCT02437942|chronic|chronic
183616|NCT02437942|rehabilitation|rehabilitation
183617|NCT02437942|diagnosis|diagnosis
183618|NCT02437942|biomechanics|biomechanics
183619|NCT02437916|Melanoma|melanoma
183620|NCT02437916|Non-small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
183621|NCT02437916|Squamous Cell Carcinoma|squamous cell carcinoma
183622|NCT02437916|Carcinoma|carcinoma
183623|NCT02437916|Head and Neck|head and neck
183624|NCT02437916|Transitional Cell Carinoma (TCC)|transitional cell carinoma (tcc)
183625|NCT02437916|Bladder|bladder
183626|NCT02437916|Colorectal|colorectal
183627|NCT02437916|Colorectal Cancer (CRC)|colorectal cancer (crc)
183628|NCT02437903|voluma temporal, facial, volume loss|voluma temporal, facial, volume loss
183629|NCT02437877|Respiration|respiration
183630|NCT02437877|Learning|learning
183631|NCT02437877|Speech|speech
183632|NCT02437877|Language and Hearing Sciences|language and hearing sciences
183633|NCT02437799|Pulse oximeter|pulse oximeter
183634|NCT02437799|Caesarean section|caesarean section
183635|NCT02437799|hypotension|hypotension
183636|NCT02437799|Spinal anaesthesia|spinal anaesthesia
183637|NCT02437773|OCD|ocd
183638|NCT02437747|clinical trial|clinical trial
183639|NCT02437708|regenerative endodontics|regenerative endodontics
183640|NCT02437708|platelet rich fibrin|platelet rich fibrin
183641|NCT02437695|Robotic Surgical Procedures|robotic surgical procedures
183642|NCT02437695|Trendelenburg Position|trendelenburg position
183643|NCT02437682|Gastro-esophageal Reflux Disease|gastro-esophageal reflux disease
183644|NCT02437682|Proton pump inhibitor|proton pump inhibitor
183645|NCT02437669|Intranasal|intranasal
183646|NCT02437669|Hydromorphone|hydromorphone
183647|NCT02437669|Pediatric|pediatric
183648|NCT02437669|Emergency department|emergency department
183649|NCT02437656|Radiochemotherapy|radiochemotherapy
183650|NCT02437656|Metformin|metformin
183651|NCT02437656|Rectal cancer|rectal cancer
183652|NCT02437617|Advanced cancers|advanced cancers
183653|NCT02437617|Tumor tissue|tumor tissue
183654|NCT02437617|Genomic profile test|genomic profile test
183655|NCT02437617|Analysis of treatment outcomes|analysis of treatment outcomes
183656|NCT02437617|Molecular profiling|molecular profiling
183657|NCT02437617|Molecular alteration|molecular alteration
183658|NCT02437591|ASP2819|asp2819
183659|NCT02437591|PAR-101|par-101
183660|NCT02437591|OPT-80|opt-80
183661|NCT02437591|Inflammatory Bowel Disease (IBD)|inflammatory bowel disease (ibd)
183662|NCT02437591|Clostridium difficile Infection (CDI)|clostridium difficile infection (cdi)
183663|NCT02437591|fidaxomicin|fidaxomicin
183664|NCT02437591|Dificlir|dificlir
183665|NCT02437578|vitamin d|vitamin d
183666|NCT02437578|fertility|fertility
183667|NCT02437578|markers|markers
183668|NCT02437578|endocrine disruption|endocrine disruption
183669|NCT02437578|reproduction|reproduction
183670|NCT02437552|Cardiac Surgery, Coronary Artery Bypass, Exercise Movement Techniques|cardiac surgery, coronary artery bypass, exercise movement techniques
183671|NCT02437526|Cure|cure
183672|NCT02437526|Analytic treatment interruption|analytic treatment interruption
183673|NCT02437513|Dysphagia|dysphagia
183674|NCT02437513|Aspiration|aspiration
183675|NCT02437513|Laryngeal cancer|laryngeal cancer
183676|NCT02437474|vegan diet|vegan diet
183677|NCT02437474|lacto-ovo-vegetarian diet|lacto-ovo-vegetarian diet
183678|NCT02437474|cancer|cancer
183679|NCT02437474|tumor remission|tumor remission
183680|NCT02437461|knee synovitis|knee synovitis
183681|NCT02437461|triamcinolone hexacetonide|triamcinolone hexacetonide
183682|NCT02437461|treatment response|treatment response
183683|NCT02437448|Mass spectrometry|mass spectrometry
183684|NCT02437448|Exhaled breath analysis|exhaled breath analysis
183685|NCT02437435|assisted reproduction|assisted reproduction
183686|NCT02437435|physical therapy|physical therapy
183687|NCT02437435|manual therapy|manual therapy
183688|NCT02437435|uterine artery|uterine artery
183689|NCT02437435|Vascularization Index (VI)|vascularization index (vi)
183690|NCT02437435|Doppler ultrasonography|doppler ultrasonography
183691|NCT02437435|vocal|vocal
183692|NCT02437409|Ischemic, Acute|ischemic, acute
183693|NCT02437357|Psychotherapy, Group|psychotherapy, group
183694|NCT02437357|Metacognition|metacognition
183695|NCT02437357|Cognitive Bias|cognitive bias
183696|NCT02437331|Advanced heart failure|advanced heart failure
183697|NCT02437331|diseased experience|diseased experience
183698|NCT02437318|HR+|hr+
183699|NCT02437318|HER2-negative|her2-negative
183700|NCT02437318|advanced breast cancer|advanced breast cancer
183701|NCT02437318|alpelisib|alpelisib
183702|NCT02437318|fulvestrant|fulvestrant
183703|NCT02437318|PI3K|pi3k
183704|NCT02437318|Phase III|phase iii
183705|NCT02437318|ER+|er+
183706|NCT02437318|PgR+|pgr+
183707|NCT02437318|men|men
183708|NCT02437318|postmenopausal|postmenopausal
183709|NCT02437318|aromatase inhibitor|aromatase inhibitor
183710|NCT02437318|neoplasms|neoplasms
183711|NCT02437305|Melanoma|melanoma
183712|NCT02437305|People of Color|people of color
183713|NCT02437279|Palpable|palpable
183714|NCT02437279|Stage III|stage iii
183715|NCT02437279|Skin melanoma|skin melanoma
183716|NCT02437279|Ipilimumab|ipilimumab
183717|NCT02437279|Nivolumab|nivolumab
183718|NCT02437279|Surgery|surgery
183719|NCT02437253|Mucopolysaccharidosis|mucopolysaccharidosis
183720|NCT02437253|Inflammation|inflammation
183721|NCT02437253|Tumor necrosis factor - alpha inhibitor|tumor necrosis factor - alpha inhibitor
183722|NCT02437240|Pilates-based exercise|pilates-based exercise
183723|NCT02437240|respiratory mechanics|respiratory mechanics
183724|NCT02437240|cardiopulmonary physical therapy|cardiopulmonary physical therapy
183725|NCT02437240|sternotomy|sternotomy
183726|NCT02437175|pelvic pain|pelvic pain
183727|NCT02437175|quality of life|quality of life
183728|NCT02437175|adenomyosis|adenomyosis
183729|NCT02437162|Axial Spondyloarthritis|axial spondyloarthritis
183730|NCT02437162|Ustekinumab|ustekinumab
183731|NCT02437162|Golimumab|golimumab
183732|NCT02437162|Stelara|stelara
183733|NCT02437149|Texting and driving|texting and driving
184036|NCT02435355|education|education
183734|NCT02437149|Teenager and driving|teenager and driving
183735|NCT02437149|Distracted Driving Campaign|distracted driving campaign
183736|NCT02437123|mHealth|mhealth
183737|NCT02437123|Indigenous|indigenous
183738|NCT02437123|HIV prevention|hiv prevention
183739|NCT02437123|substance use|substance use
183740|NCT02437110|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
183741|NCT02437110|Virus|virus
183742|NCT02437110|Antiretroviral Therapy|antiretroviral therapy
183743|NCT02437071|Radiotherapy|radiotherapy
183744|NCT02437071|Ablation|ablation
183745|NCT02437071|Pembrolizumab|pembrolizumab
183746|NCT02437071|15-069|15-069
183747|NCT02437071|Metastatic Colorectal Cancer Patients|metastatic colorectal cancer patients
183748|NCT02437032|GDF-9|gdf-9
183749|NCT02437032|BMP-15|bmp-15
183750|NCT02437032|Steroids|steroids
183751|NCT02437032|Apoptosis rate|apoptosis rate
183752|NCT02437032|Endocrinology|endocrinology
183753|NCT02437019|PCI-32765|pci-32765
183754|NCT02437019|Ibrutinib|ibrutinib
183755|NCT02437019|Early access program|early access program
183756|NCT02437019|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
183757|NCT02437019|Relapsed or refractory chronic lymphocytic leukemia|relapsed or refractory chronic lymphocytic leukemia
183758|NCT02437006|stroke|stroke
183759|NCT02437006|exercise capacity|exercise capacity
183760|NCT02436993|Neoadjuvant Treatment|neoadjuvant treatment
183761|NCT02436993|Carboplatin|carboplatin
183762|NCT02436993|Paclitaxel|paclitaxel
183763|NCT02436993|Pertuzumab|pertuzumab
183764|NCT02436993|Trastuzumab|trastuzumab
183765|NCT02436993|Bevacizumab|bevacizumab
183766|NCT02436980|premedication|premedication
183767|NCT02436980|ERCP|ercp
183768|NCT02436980|midazolam|midazolam
183769|NCT02436980|tramadol|tramadol
183770|NCT02436980|cognitive|cognitive
183771|NCT02436928|H7N9 Influenza|h7n9 influenza
183772|NCT02436928|Avian influenza A|avian influenza a
183773|NCT02436928|cell culture derived|cell culture derived
183774|NCT02436915|Slow gait|slow gait
183775|NCT02436915|Executive function|executive function
183776|NCT02436915|Transcranial direct current stimulation|transcranial direct current stimulation
183777|NCT02436876|Osteosynthesis|osteosynthesis
183778|NCT02436876|Complications|complications
183779|NCT02436876|Infection or Inflammation|infection or inflammation
183780|NCT02436876|Orthopedic|orthopedic
183781|NCT02436876|Device|device
183782|NCT02436876|Fracture|fracture
183783|NCT02436876|Osteomyelitis|osteomyelitis
183784|NCT02436863|Laminectomy|laminectomy
183785|NCT02436863|Laminoplasty|laminoplasty
183786|NCT02436863|Internal fixation|internal fixation
183787|NCT02436863|deformity|deformity
183788|NCT02436850|Thoracentesis|thoracentesis
183789|NCT02436850|Pocket Ultrasound Device|pocket ultrasound device
183790|NCT02436850|Ultrasound|ultrasound
183791|NCT02436850|Soroka University Medical Center|soroka university medical center
183792|NCT02436850|Physical Examination|physical examination
183793|NCT02436850|Ethical Committee|ethical committee
183794|NCT02436824|topical patch|topical patch
183795|NCT02436824|chronic low back pain|chronic low back pain
183796|NCT02436811|Health literacy|health literacy
183797|NCT02436811|Pregnant women|pregnant women
183798|NCT02436811|Feeding behaviour|feeding behaviour
183799|NCT02436811|Oral health|oral health
183800|NCT02436811|Child|child
183801|NCT02436798|QT prolongation|qt prolongation
183802|NCT02436798|Genomic biomarkers|genomic biomarkers
183803|NCT02436785|music therapy|music therapy
183804|NCT02436785|pain management|pain management
183805|NCT02436785|self efficacy|self efficacy
183806|NCT02436785|patient education|patient education
183807|NCT02436785|relaxation|relaxation
183808|NCT02436746|Von Recklinghausen's disease|von recklinghausen's disease
183809|NCT02436746|Bourneville's disease|bourneville's disease
183810|NCT02436746|Cognitive variability|cognitive variability
183811|NCT02436746|Loss of heterozygosity|loss of heterozygosity
183812|NCT02436733|pleural mesothelioma|pleural mesothelioma
183813|NCT02436733|phase II|phase ii
183814|NCT02436733|randomized|randomized
183815|NCT02436733|surgery|surgery
183816|NCT02436733|chemotherapy|chemotherapy
183817|NCT02436733|feasibility|feasibility
183818|NCT02436694|Dexamethasone|dexamethasone
183819|NCT02436694|Perineural|perineural
183820|NCT02436655|aortic stenosis|aortic stenosis
183821|NCT02436655|normal ejection fraction|normal ejection fraction
183822|NCT02436655|asymptomatic|asymptomatic
183823|NCT02436629|Red beetroot juice|red beetroot juice
183824|NCT02436629|High intensity intermittent exercise|high intensity intermittent exercise
183825|NCT02436629|Nitrite|nitrite
183826|NCT02436629|Soccer|soccer
183827|NCT02436616|EEG|eeg
183828|NCT02436616|Preterm Infants|preterm infants
183829|NCT02436616|Neonate|neonate
183830|NCT02436616|wireless|wireless
183831|NCT02436603|Irritable Bowel Syndrome|irritable bowel syndrome
183832|NCT02436603|IBS|ibs
183833|NCT02436603|Mind-Body Training|mind-body training
183834|NCT02436603|Integrative Medicine|integrative medicine
183835|NCT02436603|FODMAP|fodmap
183836|NCT02436590|osteoarthritis|osteoarthritis
183837|NCT02436590|knee|knee
183838|NCT02436590|pulsed electromagnetic fields|pulsed electromagnetic fields
183839|NCT02436590|PEMF|pemf
183840|NCT02436577|ticagrelor orodispersible tablet|ticagrelor orodispersible tablet
183841|NCT02436577|ticagrelor immediate-release tablet|ticagrelor immediate-release tablet
183842|NCT02436577|bioequivalence|bioequivalence
183843|NCT02436577|Phase I|phase i
183844|NCT02436577|healthy Japanese subjects|healthy japanese subjects
183845|NCT02436564|pancreas|pancreas
183846|NCT02436564|stem cells|stem cells
183847|NCT02436564|tumours|tumours
183848|NCT02436564|in vitro models|in vitro models
183849|NCT02436564|organoids|organoids
183850|NCT02436564|cancer,|cancer,
183851|NCT02436564|bile duct|bile duct
183852|NCT02436564|liver|liver
183853|NCT02436538|anti-Müllerian hormone (AMH)|anti-müllerian hormone (amh)
183854|NCT02436538|Mullerian anomalies|mullerian anomalies
183855|NCT02436538|ICSI|icsi
183856|NCT02436447|Renal Impairment, Renal function, MTP-131, Bendavia™|renal impairment, renal function, mtp-131, bendavia™
183857|NCT02436434|Pulsed radiofrequency, osteoarthritis|pulsed radiofrequency, osteoarthritis
183858|NCT02436395|gastric cancer|gastric cancer
183859|NCT02436395|gastrectomy|gastrectomy
183860|NCT02436395|laparotomy|laparotomy
183861|NCT02436395|SSIs|ssis
183862|NCT02436395|povidone-iodine|povidone-iodine
183863|NCT02436395|normal saline|normal saline
183864|NCT02436369|diabetic patients|diabetic patients
183865|NCT02436369|flaxseed|flaxseed
183866|NCT02436369|lipid profile|lipid profile
183867|NCT02436369|cardiovascular risc factors|cardiovascular risc factors
183868|NCT02436343|left ventricular functions|left ventricular functions
183869|NCT02436343|pregnancy|pregnancy
183870|NCT02436343|obesity|obesity
183871|NCT02436330|Exergaming, Weight management|exergaming, weight management
183872|NCT02436317|Point Of Care Ultrasonography|point of care ultrasonography
183873|NCT02436317|Soroka University Medical Center|soroka university medical center
183874|NCT02436317|Heart Failure|heart failure
183875|NCT02436317|cardiovascular|cardiovascular
183876|NCT02436278|Gait speed|gait speed
183877|NCT02436278|Mortality|mortality
183878|NCT02436278|Morbidity|morbidity
183879|NCT02436265|Neuraxial|neuraxial
183880|NCT02436265|Caudal|caudal
183881|NCT02436265|Block|block
183882|NCT02436265|Anesthesia|anesthesia
183883|NCT02436265|Dexamethasone|dexamethasone
183884|NCT02436252|Myelodysplastic Syndrome|myelodysplastic syndrome
183885|NCT02436252|MDS|mds
183886|NCT02436226|PCOS|pcos
183887|NCT02436226|Clomiphene citrate resistant|clomiphene citrate resistant
183888|NCT02436226|HCG|hcg
183889|NCT02436213|workload|workload
183890|NCT02436213|oxygen level|oxygen level
183891|NCT02436213|oxygen consumption|oxygen consumption
183892|NCT02436213|breathing reserve|breathing reserve
183893|NCT02436213|ventilatory efficiency|ventilatory efficiency
183894|NCT02436200|Intermittent Claudication|intermittent claudication
183895|NCT02436200|IC|ic
183896|NCT02436200|Peripheral Arterial Disease|peripheral arterial disease
183897|NCT02436200|Peripheral Vascular Disease|peripheral vascular disease
183898|NCT02436200|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
183899|NCT02436187|NSTEMI|nstemi
183900|NCT02436187|excess mortality|excess mortality
183901|NCT02436187|evidence-based care|evidence-based care
183902|NCT02436187|MINAP|minap
183903|NCT02436161|Heart Failure|heart failure
183904|NCT02436161|Comorbidity|comorbidity
183905|NCT02436161|Patient Care Management|patient care management
183906|NCT02436161|Primary Health Care|primary health care
183907|NCT02436161|Delivery of Health Care, Integrated|delivery of health care, integrated
183908|NCT02436148|PEQ validation study, Finland|peq validation study, finland
183909|NCT02436122|Prostate cancer|prostate cancer
183910|NCT02436122|Preoperative|preoperative
183911|NCT02436122|Glycemic control|glycemic control
183912|NCT02436122|Hemoglobin A1c|hemoglobin a1c
183913|NCT02436122|Pathologic outcomes|pathologic outcomes
183914|NCT02436122|Oncological outcomes|oncological outcomes
183915|NCT02436122|Treatment Outcome|treatment outcome
183916|NCT02436122|Hemoglobin A1c Protein, Human|hemoglobin a1c protein, human
183917|NCT02436096|Pain|pain
183918|NCT02436096|Sleep|sleep
183919|NCT02436070|Pediatrics|pediatrics
183920|NCT02436070|Emergency Medicine|emergency medicine
183921|NCT02436070|Text messaging|text messaging
183922|NCT02436044|Hepatocellular Carcinoma|hepatocellular carcinoma
183923|NCT02436044|Locally advanced stge|locally advanced stge
183924|NCT02436044|HAIC|haic
183925|NCT02436044|FOLFOX4|folfox4
183926|NCT02436044|Locally advanced|locally advanced
183927|NCT02436018|Sedation|sedation
183928|NCT02436018|Low pulse oximetry|low pulse oximetry
183929|NCT02436018|Upper gastrointestinal endoscopy|upper gastrointestinal endoscopy
183930|NCT02436018|WEI NASAL JET|wei nasal jet
183931|NCT02435979|wrist|wrist
183932|NCT02435979|proximal strengthening|proximal strengthening
183933|NCT02435979|hand therapy|hand therapy
183934|NCT02435953|Hepatocellular Carcinoma,TACE,Chemoembolization, RFA,Intermediate-stage|hepatocellular carcinoma,tace,chemoembolization, rfa,intermediate-stage
183935|NCT02435940|inherited retinal degenerative disease|inherited retinal degenerative disease
184037|NCT02435355|compliance|compliance
183936|NCT02435940|retinitis pigmentosa|retinitis pigmentosa
183937|NCT02435940|Usher|usher
183938|NCT02435940|Leber|leber
183939|NCT02435940|Bardet-Biedl|bardet-biedl
183940|NCT02435940|Batten|batten
183941|NCT02435940|Best|best
183942|NCT02435940|cone dystrophy|cone dystrophy
183943|NCT02435940|cone-rod dystrophy|cone-rod dystrophy
183944|NCT02435940|choroideremia|choroideremia
183945|NCT02435940|congenital night blindness|congenital night blindness
183946|NCT02435940|enhanced s-cone|enhanced s-cone
183947|NCT02435940|cone monochromacy|cone monochromacy
183948|NCT02435940|Goldmann-Favre|goldmann-favre
183949|NCT02435940|Kearns-Sayre|kearns-sayre
183950|NCT02435940|Refsum|refsum
183951|NCT02435940|retinoschisis|retinoschisis
183952|NCT02435940|rod-cone dystrophy|rod-cone dystrophy
183953|NCT02435940|rod dystrophy|rod dystrophy
183954|NCT02435940|rod monochromacy|rod monochromacy
183955|NCT02435940|Sorsby pseudoinflammatory dystrophy|sorsby pseudoinflammatory dystrophy
183956|NCT02435940|stargardt|stargardt
183957|NCT02435940|achromatopsia|achromatopsia
183958|NCT02435940|juvenile inherited macular degeneration|juvenile inherited macular degeneration
183959|NCT02435940|cone dichromacy|cone dichromacy
183960|NCT02435940|cone trichromacy|cone trichromacy
183961|NCT02435940|Charcot-Marie-Tooth|charcot-marie-tooth
183962|NCT02435940|albipunctate dystrophy|albipunctate dystrophy
183963|NCT02435901|Reduced Intensity Conditioning Regimen|reduced intensity conditioning regimen
183964|NCT02435888|Resting energy expenditure|resting energy expenditure
183965|NCT02435888|Predictive equations|predictive equations
183966|NCT02435888|Overweight|overweight
183967|NCT02435875|hypertension|hypertension
183968|NCT02435875|perioperative|perioperative
183969|NCT02435875|baroreflex sensitivity|baroreflex sensitivity
183970|NCT02435862|Vitreolysis of the Vitreous|vitreolysis of the vitreous
183971|NCT02435849|Pediatric|pediatric
183972|NCT02435849|ALL|all
183973|NCT02435849|Cell therapy|cell therapy
183974|NCT02435810|Neuroinflammation|neuroinflammation
183975|NCT02435810|Infections|infections
183976|NCT02435797|nicorandil|nicorandil
183977|NCT02435797|primary percutaneous coronary intervention|primary percutaneous coronary intervention
183978|NCT02435797|acute ST segment elevation myocardial infarction|acute st segment elevation myocardial infarction
183979|NCT02435797|thrombus aspiration|thrombus aspiration
183980|NCT02435784|2-COM|2-com
183981|NCT02435745|Ehlers-Danlos Syndrome|ehlers-danlos syndrome
183982|NCT02435745|Obstructive Sleep Apnea|obstructive sleep apnea
183983|NCT02435745|Prevalence|prevalence
183984|NCT02435745|Aortic Aneurysm|aortic aneurysm
183985|NCT02435719|HCAIs|hcais
183986|NCT02435719|Handgel|handgel
183987|NCT02435719|Hospital|hospital
183988|NCT02435719|Effectiveness|effectiveness
183989|NCT02435706|Dental implants|dental implants
183990|NCT02435706|surgical flap|surgical flap
183991|NCT02435706|esthetics|esthetics
183992|NCT02435706|alveolar process|alveolar process
183993|NCT02435693|pharmaceutical care|pharmaceutical care
183994|NCT02435680|MCS110; carboplatin; gemcitabine; TNBC; TAMs|mcs110; carboplatin; gemcitabine; tnbc; tams
183995|NCT02435667|Resistance Training|resistance training
183996|NCT02435667|Exercise|exercise
183997|NCT02435667|Heart Failure preserved Ejection Fraction|heart failure preserved ejection fraction
183998|NCT02435654|Genes Polymorphisms|genes polymorphisms
183999|NCT02435654|Plasma Concentration|plasma concentration
184000|NCT02435602|endoscopy, gastrointestinal|endoscopy, gastrointestinal
184001|NCT02435602|cancer screening|cancer screening
184002|NCT02435576|Acute toxicity|acute toxicity
184003|NCT02435576|Late toxicity|late toxicity
184004|NCT02435576|NTCP models|ntcp models
184005|NCT02435563|Anti-HIV Agents|anti-hiv agents
184006|NCT02435563|cardiovascular agents|cardiovascular agents
184007|NCT02435563|drug interactions|drug interactions
184008|NCT02435537|analgesia|analgesia
184009|NCT02435537|intrathecal|intrathecal
184010|NCT02435537|opioids|opioids
184011|NCT02435537|morphine|morphine
184012|NCT02435537|dexmedetomidine|dexmedetomidine
184013|NCT02435524|Breast Feeding, Exclusive|breast feeding, exclusive
184014|NCT02435524|Infant Nutrition|infant nutrition
184015|NCT02435524|Burkina Faso|burkina faso
184016|NCT02435511|agent-based modeling|agent-based modeling
184017|NCT02435511|community resources|community resources
184018|NCT02435511|simulation modeling|simulation modeling
184019|NCT02435511|information intervention|information intervention
184020|NCT02435511|clinic-to-community linkages|clinic-to-community linkages
184021|NCT02435485|degerative lumbar spondylolisthesis|degerative lumbar spondylolisthesis
184022|NCT02435485|rehabilitation|rehabilitation
184023|NCT02435485|balance|balance
184024|NCT02435472|Active Surveillance|active surveillance
184025|NCT02435472|Exercise|exercise
184026|NCT02435472|Prostate cancer|prostate cancer
184027|NCT02435472|Life style|life style
184028|NCT02435472|Survey|survey
184029|NCT02435472|Personalized exercise|personalized exercise
184030|NCT02435472|Exercise trainer|exercise trainer
184031|NCT02435433|liver cancer|liver cancer
184032|NCT02435420|Total Hip Arthroplasty|total hip arthroplasty
184033|NCT02435420|EMPERION Modular Stem|emperion modular stem
184034|NCT02435420|Survivorship|survivorship
184038|NCT02435355|CPAP|cpap
184039|NCT02435342|ShK-186|shk-186
184040|NCT02435342|dalazatide|dalazatide
184041|NCT02435342|psoriasis|psoriasis
184042|NCT02435342|Kv1.3,|kv1.3,
184043|NCT02435342|autoimmune|autoimmune
184044|NCT02435316|Education|education
184045|NCT02435290|prediction|prediction
184046|NCT02435290|prescribing error|prescribing error
184047|NCT02435290|risk factors|risk factors
184048|NCT02435277|Diabetes|diabetes
184049|NCT02435212|New formulation, deferasirox, chelation, iron overload, compliance, satisfaction, palatability, PRO, PK, safety, PK/PD, ICL670|new formulation, deferasirox, chelation, iron overload, compliance, satisfaction, palatability, pro, pk, safety, pk/pd, icl670
184050|NCT02435186|p53 gene|p53 gene
184051|NCT02435186|chemotherapy|chemotherapy
184052|NCT02435186|recurrent|recurrent
184053|NCT02435186|epithelial|epithelial
184054|NCT02435186|ovarian cancer|ovarian cancer
184055|NCT02435186|fallopian tube cancer|fallopian tube cancer
184056|NCT02435186|primary peritoneal cancer|primary peritoneal cancer
184057|NCT02435173|APDS PASLI PI3Kdelta|apds pasli pi3kdelta
184058|NCT02435108|MET poisitivity is defined as at least half of tumor cells show weak, moderate or high staining|met poisitivity is defined as at least half of tumor cells show weak, moderate or high staining
184059|NCT02435095|Schizophrenia|schizophrenia
184060|NCT02435095|Maintenance treatment, Intermittent treatment|maintenance treatment, intermittent treatment
184061|NCT02435095|Brain volume|brain volume
184062|NCT02435095|Antipsychotics|antipsychotics
184063|NCT02435082|Concussion|concussion
184064|NCT02435082|Vascular Assessment|vascular assessment
184065|NCT02435082|Vascular Regulation|vascular regulation
184066|NCT02435082|mild Traumatic Brain Injury, mTBI|mild traumatic brain injury, mtbi
184067|NCT02435082|Traumatic Brain Injury, TBI|traumatic brain injury, tbi
184068|NCT02435082|Cerebrovascular Regulation|cerebrovascular regulation
184069|NCT02435082|Cerebral Blood Flow|cerebral blood flow
184070|NCT02435082|Cerebral Blood Flow Velocity, CBFV|cerebral blood flow velocity, cbfv
184071|NCT02435082|Cerebral Blood Flow Velocity Variability|cerebral blood flow velocity variability
184072|NCT02435082|Cerebrovascular Assessment|cerebrovascular assessment
184073|NCT02435069|cecostomy|cecostomy
184074|NCT02435069|appendicostomy|appendicostomy
184075|NCT02435056|medication overuse headache|medication overuse headache
184076|NCT02435056|health care system|health care system
184077|NCT02435030|NP-C|np-c
184078|NCT02435030|LSD|lsd
184079|NCT02435030|lysosomal storage disorder|lysosomal storage disorder
184080|NCT02435030|lysosomal storage disease|lysosomal storage disease
184081|NCT02435030|NPC2|npc2
184082|NCT02435030|NPC1|npc1
184083|NCT02435030|Niemann-Pick Type C|niemann-pick type c
184084|NCT02435030|Niemann-Pick,|niemann-pick,
184085|NCT02435030|Arimoclomol|arimoclomol
184086|NCT02435017|kidney disease|kidney disease
184087|NCT02435017|recommended dietary allowances|recommended dietary allowances
184088|NCT02435017|nutrition assessment|nutrition assessment
184089|NCT02435017|food|food
184090|NCT02435017|dietary proteins|dietary proteins
184091|NCT02435017|Vitamin D|vitamin d
184092|NCT02435017|dietary fats|dietary fats
184093|NCT02435017|ethnology|ethnology
184094|NCT02435017|Continental Population Groups|continental population groups
184095|NCT02435017|Phosphorus, dietary|phosphorus, dietary
184096|NCT02435017|Phosphorus/analysis|phosphorus/analysis
184097|NCT02434991|trouble swallowing|trouble swallowing
184098|NCT02434991|food sticking|food sticking
184099|NCT02434991|Achalasia|achalasia
184100|NCT02434965|Neonates|neonates
184101|NCT02434965|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
184102|NCT02434965|human placental-derived stem cells|human placental-derived stem cells
184103|NCT02434965|autologous|autologous
184104|NCT02434952|Malaria, Falciparum|malaria, falciparum
184105|NCT02434952|G6PD deficiency|g6pd deficiency
184106|NCT02434952|Primaquine|primaquine
184107|NCT02434952|Asia|asia
184108|NCT02434926|fetoscopy|fetoscopy
184109|NCT02434926|fetal surgery|fetal surgery
184110|NCT02434926|anesthetic complications|anesthetic complications
184111|NCT02434913|Proximal interphalangeal joint deformity|proximal interphalangeal joint deformity
184112|NCT02434913|Arthroplasty|arthroplasty
184113|NCT02434822|Cholera|cholera
184114|NCT02434822|Shanchol™|shanchol™
184115|NCT02434822|Cholera Vaccine|cholera vaccine
184116|NCT02434809|Respiratory Motion-Corrected Cone-Beam CT|respiratory motion-corrected cone-beam ct
184117|NCT02434809|Radiation|radiation
184118|NCT02434809|14-225|14-225
184119|NCT02434796|Intimate Partner Violence|intimate partner violence
184120|NCT02434796|Gender-Based Violence|gender-based violence
184121|NCT02434796|Gender|gender
184122|NCT02434796|HIV|hiv
184123|NCT02434783|Blood circulation|blood circulation
184124|NCT02434783|Blood vessels|blood vessels
184125|NCT02434783|Mitochondria|mitochondria
184126|NCT02434783|Muscle, skeletal|muscle, skeletal
184127|NCT02434783|Legs|legs
184128|NCT02434783|Energy metabolism|energy metabolism
184129|NCT02434731|Procedural pain|procedural pain
184130|NCT02434731|Phlebotomy|phlebotomy
184131|NCT02434731|Intellectual Disability|intellectual disability
184132|NCT02434731|Child|child
184133|NCT02434731|Buzzy|buzzy
184134|NCT02434705|Eosinophilic|eosinophilic
184135|NCT02434692|Primary Open Angle Glaucoma|primary open angle glaucoma
184136|NCT02434692|POAG|poag
184137|NCT02434692|Glaucoma|glaucoma
184138|NCT02434692|Cataract|cataract
184139|NCT02434692|Surgery|surgery
184140|NCT02434692|Ocular Pressure|ocular pressure
184141|NCT02434679|antibiotics resistance integrons|antibiotics resistance integrons
184142|NCT02434679|neonatology newborns|neonatology newborns
184143|NCT02434679|digestive acquisition|digestive acquisition
184144|NCT02434679|dynamic of the acquisition of integrons|dynamic of the acquisition of integrons
184145|NCT02434627|Becker|becker
184146|NCT02434627|Dystrophy|dystrophy
184147|NCT02434601|Non-carious cervical lesions|non-carious cervical lesions
184148|NCT02434601|Randomized clinical trial|randomized clinical trial
184149|NCT02434601|Permanent dental restoration|permanent dental restoration
184150|NCT02434601|Dentin|dentin
184151|NCT02434601|Adhesion|adhesion
184152|NCT02434601|Restoration|restoration
184153|NCT02434601|Sensitivity|sensitivity
184154|NCT02434601|Prophylaxis|prophylaxis
184155|NCT02434601|Randomized|randomized
184156|NCT02434575|Lower Urinary Tract Symptoms|lower urinary tract symptoms
184157|NCT02434575|Prostatic artery embolisation|prostatic artery embolisation
184158|NCT02434575|Transurethral resection of the prostate|transurethral resection of the prostate
184159|NCT02434575|Benign prostatic hyperplasia|benign prostatic hyperplasia
184160|NCT02434575|Benign prostatic enlargement|benign prostatic enlargement
184161|NCT02434549|Randomized Controlled Trial|randomized controlled trial
184162|NCT02434549|Placebo Controlled|placebo controlled
184163|NCT02434549|Double Blinded|double blinded
184164|NCT02434549|Botulinum Toxin Type A|botulinum toxin type a
184165|NCT02434549|Adults|adults
184166|NCT02434549|Pain|pain
184167|NCT02434549|Spasticity|spasticity
184168|NCT02434549|Cerebral Palsy, Spastic|cerebral palsy, spastic
184169|NCT02434549|Dysport|dysport
184170|NCT02434536|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
184171|NCT02434536|Disease Exacerbation Clinical Prediction Rule|disease exacerbation clinical prediction rule
184172|NCT02434536|Decision Analysis|decision analysis
184173|NCT02434523|laryngeal sensory neuropathy|laryngeal sensory neuropathy
184174|NCT02434510|Infection|infection
184175|NCT02434510|Total Knee Arthroplasty|total knee arthroplasty
184176|NCT02434510|Total Hip Arthroplasty|total hip arthroplasty
184177|NCT02434510|Splash Basins|splash basins
184178|NCT02434497|LDL-C|ldl-c
184179|NCT02434497|HoFH|hofh
184180|NCT02434497|Hyperlipidemia|hyperlipidemia
184181|NCT02434484|Symbenda|symbenda
184182|NCT02434484|Non-Hodgkin's lymphomas|non-hodgkin's lymphomas
184183|NCT02434484|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
184184|NCT02434484|Multiple myeloma|multiple myeloma
184185|NCT02434484|Bendamustine Hydrochloride|bendamustine hydrochloride
184186|NCT02434458|fibromyalgia,|fibromyalgia,
184187|NCT02434458|polyneuropathy|polyneuropathy
184188|NCT02434458|small fiber neuropathy|small fiber neuropathy
184189|NCT02434458|rheumatoid arthritis|rheumatoid arthritis
184190|NCT02434458|sudomotor|sudomotor
184191|NCT02434406|Anxiety|anxiety
184192|NCT02434406|Anxiety disorders|anxiety disorders
184193|NCT02434406|Mental health|mental health
184194|NCT02434406|Postpartum period|postpartum period
184195|NCT02434406|maternal welfare|maternal welfare
184196|NCT02434406|internet|internet
184197|NCT02434406|intervention studies|intervention studies
184198|NCT02434406|feasibility studies|feasibility studies
184199|NCT02434406|randomized controlled trial|randomized controlled trial
184200|NCT02434406|patient acceptance of health care|patient acceptance of health care
184201|NCT02434393|Depression|depression
184202|NCT02434393|Late Life Depression|late life depression
184203|NCT02434393|LLD|lld
184204|NCT02434393|amyloid imaging|amyloid imaging
184205|NCT02434393|biomarkers|biomarkers
184206|NCT02434380|Vitamin D|vitamin d
184207|NCT02434380|Bone mineral content|bone mineral content
184208|NCT02434380|Knee-heel length|knee-heel length
184209|NCT02434380|Middle East|middle east
184210|NCT02434367|Cancer|cancer
184211|NCT02434354|Clinical stage III (nodal and/or intransit disease) or resectable stage IV melanoma (MEL), with or without prior treatment|clinical stage iii (nodal and/or intransit disease) or resectable stage iv melanoma (mel), with or without prior treatment
184212|NCT02434328|AMD|amd
184213|NCT02434328|CNV|cnv
184214|NCT02434328|IVT|ivt
184215|NCT02434315|Diabetes Mellitus|diabetes mellitus
184216|NCT02434315|Sensing Technology|sensing technology
184217|NCT02434289|Older adults|older adults
184218|NCT02434289|Dietary protein|dietary protein
184219|NCT02434289|Resistance exercise|resistance exercise
184220|NCT02434289|Feasibility study|feasibility study
184221|NCT02434289|Physical functioning|physical functioning
184222|NCT02434289|Real-life setting|real-life setting
184223|NCT02434250|Open angle glaucoma|open angle glaucoma
184224|NCT02434250|Ocular hypertension|ocular hypertension
184225|NCT02434250|Cataract|cataract
184226|NCT02434250|Selective Laser Trabeculoplasty|selective laser trabeculoplasty
184227|NCT02434250|Eximer Laser Trabeculectomy|eximer laser trabeculectomy
184228|NCT02434250|Phacoemulsification Cataract Extraction|phacoemulsification cataract extraction
184229|NCT02434224|Music therapy|music therapy
184230|NCT02434224|premature infant|premature infant
184231|NCT02434224|brain development|brain development
184232|NCT02434198|pulmonary rehabilitation|pulmonary rehabilitation
184233|NCT02434198|balance assessment|balance assessment
184234|NCT02434198|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
184235|NCT02434185|Musculoskeletal Physiological Phenomena|musculoskeletal physiological phenomena
184236|NCT02434185|Postmenopause|postmenopause
184237|NCT02434185|Muscle Strength|muscle strength
184238|NCT02434185|Absorptiometry, Photon|absorptiometry, photon
184239|NCT02434172|HIV|hiv
184240|NCT02434172|Cryptococcus|cryptococcus
184241|NCT02434172|Lateral Flow Assay|lateral flow assay
184242|NCT02434172|sub-Saharan Africa|sub-saharan africa
184243|NCT02434172|Screening|screening
184244|NCT02434172|treatment|treatment
184245|NCT02434172|cryptococcal meningitis|cryptococcal meningitis
184246|NCT02434120|MRI|mri
184247|NCT02434120|Orbital neoplasm|orbital neoplasm
184248|NCT02434107|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
184249|NCT02434107|Lymph Node Excision|lymph node excision
184250|NCT02434094|Diabetes Assistant (DiAs)|diabetes assistant (dias)
184251|NCT02434094|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
184252|NCT02434094|Insulin Pump|insulin pump
184253|NCT02434094|Human Factors|human factors
184254|NCT02434094|Focus Group|focus group
184255|NCT02434094|Artificial Pancreas (AP)|artificial pancreas (ap)
184256|NCT02434094|eDAPT (electronic Diabetes Artificial Pancreas Training)|edapt (electronic diabetes artificial pancreas training)
184257|NCT02434081|NSCLC|nsclc
184258|NCT02434081|IIIA/B|iiia/b
184259|NCT02434068|kidney calculi|kidney calculi
184260|NCT02434068|followup studies|followup studies
184261|NCT02434042|probiotic|probiotic
184262|NCT02434042|children|children
184263|NCT02434042|gastrointestinal|gastrointestinal
184264|NCT02434042|upper respiratory|upper respiratory
184265|NCT02434016|Diaphragm|diaphragm
184266|NCT02434016|Mechanical ventilation|mechanical ventilation
184267|NCT02434003|3D reconstruction|3d reconstruction
184268|NCT02434003|AIS|ais
184269|NCT02434003|Computer models|computer models
184270|NCT02434003|Spinal Deformity|spinal deformity
184271|NCT02433990|Congenital Heart Disease|congenital heart disease
184272|NCT02433990|Acquired Cardiovascular Disease|acquired cardiovascular disease
184273|NCT02433977|Asthma|asthma
184274|NCT02433977|Obesity|obesity
184275|NCT02433977|conjugated linolenic acid|conjugated linolenic acid
184276|NCT02433977|nitrate|nitrate
184277|NCT02433977|nitrite|nitrite
184278|NCT02433977|nutritional supplements|nutritional supplements
184279|NCT02433964|laser|laser
184280|NCT02433964|LED|led
184281|NCT02433964|PRICE|price
184282|NCT02433964|pain|pain
184283|NCT02433964|edema|edema
184284|NCT02433951|exercise tolerance|exercise tolerance
184285|NCT02433925|resveratrol|resveratrol
184286|NCT02433925|oxidative stress|oxidative stress
184287|NCT02433925|inflammation|inflammation
184288|NCT02433873|Microbiota|microbiota
184289|NCT02433873|Body weight|body weight
184290|NCT02433873|Digestive system|digestive system
184291|NCT02433847|mosapride|mosapride
184292|NCT02433821|Mechanical Neck Pain|mechanical neck pain
184293|NCT02433821|Pain|pain
184294|NCT02433821|Function|function
184295|NCT02433821|Quality of life|quality of life
184296|NCT02433821|Pilates|pilates
184297|NCT02433795|Marginal zone B-cell lymphoma|marginal zone b-cell lymphoma
184298|NCT02433795|bendamustine plus rituximab|bendamustine plus rituximab
184299|NCT02433782|Haemophilia|haemophilia
184300|NCT02433782|Arthropathy|arthropathy
184301|NCT02433782|Pain|pain
184302|NCT02433782|Range of motion|range of motion
184303|NCT02433782|Miofascial techniques|miofascial techniques
184304|NCT02433743|HIV/AIDS|hiv/aids
184305|NCT02433743|RUTF|rutf
184306|NCT02433743|fat free mass|fat free mass
184307|NCT02433743|anemia|anemia
184308|NCT02433743|zinc|zinc
184309|NCT02433743|Senegal|senegal
184310|NCT02433717|schizophrenia|schizophrenia
184311|NCT02433717|schizoaffective disorder|schizoaffective disorder
184312|NCT02433717|pharmacogenetics|pharmacogenetics
184313|NCT02433717|pharmacokinetics|pharmacokinetics
184314|NCT02433717|event-related potentials|event-related potentials
184315|NCT02433717|paliperidone|paliperidone
184316|NCT02433691|(An)aerobic exercise|(an)aerobic exercise
184317|NCT02433691|memory training|memory training
184318|NCT02433691|cognitive benefits|cognitive benefits
184319|NCT02433652|Dengue Vaccine|dengue vaccine
184320|NCT02433639|advanced biliary tract cancer, TH-302|advanced biliary tract cancer, th-302
184321|NCT02433613|Pulmonary Vein Isolation|pulmonary vein isolation
184322|NCT02433613|Phased Radiofrequency Ablation|phased radiofrequency ablation
184323|NCT02433574|radiosurgery|radiosurgery
184324|NCT02433574|Neoadjuvant Therapy|neoadjuvant therapy
184325|NCT02433548|Analgesia|analgesia
184326|NCT02433548|Emergency medicine|emergency medicine
184327|NCT02433548|Anesthesia, Regional|anesthesia, regional
184328|NCT02433535|severe asthma|severe asthma
184329|NCT02433535|simvastatin|simvastatin
184330|NCT02433535|allergic airway inflammation|allergic airway inflammation
184331|NCT02433522|ANCA-associated vasculitides|anca-associated vasculitides
184332|NCT02433522|Maintenance treatment|maintenance treatment
184333|NCT02433522|Rituximab|rituximab
184334|NCT02433522|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
184335|NCT02433522|Microscopic polyangiitis|microscopic polyangiitis
184336|NCT02433509|acute ischemic stroke|acute ischemic stroke
184337|NCT02433509|umbilical cord blood|umbilical cord blood
184338|NCT02433496|Opioid|opioid
184339|NCT02433483|Adolescent|adolescent
184340|NCT02433483|Children|children
184341|NCT02433483|Microtransplant|microtransplant
184342|NCT02433483|Leukemia|leukemia
184343|NCT02433457|Healthy Volunteers|healthy volunteers
184344|NCT02433457|CC-292|cc-292
184345|NCT02433457|Open-Label|open-label
184346|NCT02433457|Bioavailability Pharmacokinetics|bioavailability pharmacokinetics
184347|NCT02433457|Phase I|phase i
184348|NCT02433444|Biosensing Techniques|biosensing techniques
184349|NCT02433431|mindfulness|mindfulness
184350|NCT02433431|psychological stress|psychological stress
184351|NCT02433431|immune marker|immune marker
184352|NCT02433431|wellness programs|wellness programs
184353|NCT02433431|mobile applications|mobile applications
184354|NCT02433431|cortisol|cortisol
184355|NCT02433405|Serum Amyloid A|serum amyloid a
184356|NCT02433405|Fetuin-A|fetuin-a
184357|NCT02433405|gingival crevicular fluid|gingival crevicular fluid
184358|NCT02433405|serum|serum
184359|NCT02433405|periodontal diseases|periodontal diseases
184360|NCT02433392|drug-eluting beads|drug-eluting beads
184361|NCT02433392|irinotecan hydrochloride|irinotecan hydrochloride
184362|NCT02433353|PTSD|ptsd
184363|NCT02433353|posttraumatic stress disorder|posttraumatic stress disorder
184364|NCT02433353|venlafaxine|venlafaxine
184365|NCT02433353|EMDR|emdr
184366|NCT02433353|eye movement desensitization reprocessing|eye movement desensitization reprocessing
184367|NCT02433353|antidepressant|antidepressant
184368|NCT02433353|psychotherapy|psychotherapy
184369|NCT02433340|Tolerability|tolerability
184370|NCT02433340|Methotrexate|methotrexate
184371|NCT02433340|Safety|safety
184372|NCT02433327|Paediatric Early Warning System|paediatric early warning system
184373|NCT02433327|trigger tool|trigger tool
184374|NCT02433327|screening tool|screening tool
184375|NCT02433327|risk assessment|risk assessment
184376|NCT02433327|early recognition|early recognition
184377|NCT02433301|chemotherapy|chemotherapy
184378|NCT02433301|GEJ cancer|gej cancer
184379|NCT02433301|PET/MR-imaging|pet/mr-imaging
184380|NCT02433288|smart phone-based|smart phone-based
184381|NCT02433288|rosuvastatin|rosuvastatin
184382|NCT02433288|duration of treatment|duration of treatment
184383|NCT02433288|Treatment adherence|treatment adherence
184384|NCT02433223|outreach nursing|outreach nursing
184385|NCT02433223|respiratory nursing guidelines|respiratory nursing guidelines
184386|NCT02433197|Testicular cancer|testicular cancer
184387|NCT02433197|Germ cell cancer|germ cell cancer
184388|NCT02433197|Physical exercise|physical exercise
184389|NCT02433197|Cancer-related fatigue|cancer-related fatigue
184390|NCT02433197|Chemotherapy|chemotherapy
184391|NCT02433197|Clinical rules|clinical rules
184392|NCT02433197|Metabolomics|metabolomics
184393|NCT02433184|Etanercept|etanercept
184394|NCT02433184|treat to target|treat to target
184395|NCT02433184|Disease Modifying Antirheumatic Drugs (DMARDs)|disease modifying antirheumatic drugs (dmards)
184396|NCT02433171|regrowth|regrowth
184397|NCT02433171|radiosurgery|radiosurgery
184398|NCT02433171|radiation necrosis|radiation necrosis
184399|NCT02433158|Rivipansel|rivipansel
184400|NCT02433158|GMI-1070|gmi-1070
184401|NCT02433158|Selectin Inhibitor|selectin inhibitor
184403|NCT02433158|VOC|voc
184404|NCT02433145|ADHD in preschoolers|adhd in preschoolers
184405|NCT02433145|neuropsychological functions|neuropsychological functions
184406|NCT02433145|behavior inhibition|behavior inhibition
184407|NCT02433145|family function and parenting|family function and parenting
184408|NCT02433132|Cystic fibrosis|cystic fibrosis
184409|NCT02433132|Adults|adults
184410|NCT02433132|Atypical form|atypical form
184411|NCT02433132|Nasal brushing|nasal brushing
184412|NCT02433132|Epithelial cells|epithelial cells
184413|NCT02433132|Ion transport|ion transport
184414|NCT02433106|Balance|balance
184415|NCT02433106|Exercise|exercise
184416|NCT02433054|deep vein thrombosis|deep vein thrombosis
184417|NCT02433054|chronic venous disease|chronic venous disease
184418|NCT02433054|May-Thurner syndrome|may-thurner syndrome
184419|NCT02433054|venous stent|venous stent
184420|NCT02433041|Postoperative delirium|postoperative delirium
184421|NCT02433041|Cortisol|cortisol
184422|NCT02433041|NSE|nse
184423|NCT02433041|S-100beta|s-100beta
184424|NCT02433041|MMSE|mmse
184425|NCT02433041|Nu-DESC|nu-desc
184426|NCT02433041|ICDSC|icdsc
184427|NCT02433041|DOS|dos
184428|NCT02433041|Haloperidol|haloperidol
184429|NCT02433041|Ketamine|ketamine
184430|NCT02433041|Combination of Haloperidol and Ketamine|combination of haloperidol and ketamine
184431|NCT02433041|Placebo|placebo
184432|NCT02433041|Prevention of|prevention of
184536|NCT02432365|Paclitaxel|paclitaxel
184433|NCT02433028|MS key phases of disease evolution|ms key phases of disease evolution
184434|NCT02433028|MS New Treatment Options|ms new treatment options
184435|NCT02433015|Electronic Cigarette|electronic cigarette
184436|NCT02433002|eGFR|egfr
184437|NCT02433002|CKD|ckd
184438|NCT02433002|Cystatin|cystatin
184439|NCT02433002|Creatinine|creatinine
184440|NCT02433002|Albuminuria|albuminuria
184441|NCT02432989|Exercise Therapy|exercise therapy
184442|NCT02432989|Concussion Management|concussion management
184443|NCT02432989|Concussion Recovery|concussion recovery
184444|NCT02432976|Quality of Life|quality of life
184445|NCT02432976|Cardiac Surgery|cardiac surgery
184446|NCT02432976|Coronary Artery Bypass Graft Surgery|coronary artery bypass graft surgery
184447|NCT02432976|Incretin mimetic|incretin mimetic
184448|NCT02432976|Exenatide|exenatide
184449|NCT02432937|Corever|corever
184450|NCT02432937|hypertension|hypertension
184451|NCT02432885|cardiac magnetic resonance|cardiac magnetic resonance
184452|NCT02432885|myocardial fibrosis|myocardial fibrosis
184453|NCT02432885|muscular dystrophies|muscular dystrophies
184454|NCT02432820|Prostate Cancer|prostate cancer
184455|NCT02432768|Anaplerotic diet|anaplerotic diet
184456|NCT02432768|McArdle Disease|mcardle disease
184457|NCT02432768|Glycogen Storage Disease|glycogen storage disease
184458|NCT02432768|Triheptanoin|triheptanoin
184459|NCT02432755|home-based rehabilitation|home-based rehabilitation
184460|NCT02432755|stroke|stroke
184461|NCT02432755|combination therapy|combination therapy
184462|NCT02432755|client-centered approach|client-centered approach
184463|NCT02432755|post-acute|post-acute
184464|NCT02432742|hyaluronic acid, comparative study, NLF|hyaluronic acid, comparative study, nlf
184465|NCT02432729|smoking cessation|smoking cessation
184466|NCT02432729|smoking abstinence|smoking abstinence
184467|NCT02432729|clinical, biological and functional changes|clinical, biological and functional changes
184468|NCT02432729|one year|one year
184469|NCT02432729|healthy smokers|healthy smokers
184470|NCT02432729|quit smoking|quit smoking
184471|NCT02432703|Social Anxiety Disorder|social anxiety disorder
184472|NCT02432703|JNJ-42165279|jnj-42165279
184473|NCT02432690|Neoplasms|neoplasms
184474|NCT02432677|tDCS|tdcs
184475|NCT02432677|Opioid|opioid
184476|NCT02432677|Pain|pain
184477|NCT02432677|Pain threshold|pain threshold
184478|NCT02432651|oxidative stress|oxidative stress
184479|NCT02432651|hops|hops
184480|NCT02432651|xanthohumol|xanthohumol
184481|NCT02432651|DNA damage|dna damage
184482|NCT02432651|cancer|cancer
184483|NCT02432625|Osteogenesis Imperfecta|osteogenesis imperfecta
184484|NCT02432625|Collagen|collagen
184485|NCT02432625|Brittle Bone Disorder|brittle bone disorder
184486|NCT02432625|Rare Disease Clinical Research Network|rare disease clinical research network
184487|NCT02432625|COL1A2|col1a2
184488|NCT02432599|F18-choline|f18-choline
184489|NCT02432586|T1DM|t1dm
184490|NCT02432586|Diabetes|diabetes
184491|NCT02432586|Child|child
184492|NCT02432586|Toddler|toddler
184493|NCT02432573|timing|timing
184494|NCT02432560|Lymphangioleiomyomatosis|lymphangioleiomyomatosis
184495|NCT02432560|LAM|lam
184496|NCT02432560|rare lung|rare lung
184497|NCT02432560|Rare Lung Disease|rare lung disease
184498|NCT02432547|Diabetic|diabetic
184499|NCT02432547|Macular Oedema|macular oedema
184500|NCT02432547|Retinopathy|retinopathy
184501|NCT02432521|stroke|stroke
184502|NCT02432521|transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
184503|NCT02432521|Electroencephalography (EEG)|electroencephalography (eeg)
184504|NCT02432521|Cerebrovascular Accident|cerebrovascular accident
184505|NCT02432521|Brain Vascular Accident|brain vascular accident
184506|NCT02432508|acupuncture|acupuncture
184507|NCT02432508|laser|laser
184508|NCT02432508|uremic pruritus|uremic pruritus
184509|NCT02432508|randomized clinical trial|randomized clinical trial
184510|NCT02432482|Tobacco|tobacco
184511|NCT02432482|Cigarette|cigarette
184512|NCT02432482|HIV|hiv
184513|NCT02432482|Treatment|treatment
184514|NCT02432482|Mobile|mobile
184515|NCT02432482|Smartphone|smartphone
184516|NCT02432469|coronary artery bypass|coronary artery bypass
184517|NCT02432469|medication adherence|medication adherence
184518|NCT02432469|secondary prevention|secondary prevention
184519|NCT02432469|mobile applications|mobile applications
184520|NCT02432443|Motor Skills|motor skills
184521|NCT02432443|Pre-literacy Skills|pre-literacy skills
184522|NCT02432443|Early Intervention|early intervention
184523|NCT02432430|N05.300.150.410|n05.300.150.410
184524|NCT02432430|practice guideline|practice guideline
184525|NCT02432430|D20.215.894.899.290.130|d20.215.894.899.290.130
184526|NCT02432430|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
184527|NCT02432417|Glioblastoma|glioblastoma
184528|NCT02432417|Autophagy|autophagy
184529|NCT02432417|EGFR|egfr
184530|NCT02432417|EGFRvIII|egfrviii
184531|NCT02432417|Chloroquine|chloroquine
184532|NCT02432417|Radiotherapy|radiotherapy
184533|NCT02432417|Temozolomide|temozolomide
184534|NCT02432404|HSV-2|hsv-2
184535|NCT02432404|Contraceptive Vaginal Ring|contraceptive vaginal ring
184537|NCT02432365|Cisplatin|cisplatin
184538|NCT02432365|Cervical cancer|cervical cancer
184539|NCT02432365|Radical hysterectomy|radical hysterectomy
184540|NCT02432365|Neoadjuvant|neoadjuvant
184541|NCT02432339|immune system|immune system
184542|NCT02432339|RENIN-ANGIOTENSIN SYSTEM|renin-angiotensin system
184543|NCT02432326|Neoplasms|neoplasms
184544|NCT02432300|Traumatic Brain Injury|traumatic brain injury
184545|NCT02432300|Alexithymia|alexithymia
184546|NCT02432300|Emotions|emotions
184547|NCT02432287|aging|aging
184548|NCT02432287|metformin|metformin
184549|NCT02432287|prediabetes|prediabetes
184550|NCT02432274|E7080|e7080
184551|NCT02432274|Lenvatinib|lenvatinib
184552|NCT02432274|Solid malignancies|solid malignancies
184553|NCT02432274|Osteosarcoma|osteosarcoma
184554|NCT02432274|Differentiated Thyroid Cancer|differentiated thyroid cancer
184555|NCT02432261|spermatogenesis|spermatogenesis
184556|NCT02432261|androgen|androgen
184557|NCT02432261|male contraception|male contraception
184558|NCT02432248|DHEA|dhea
184559|NCT02432248|live birth rate|live birth rate
184560|NCT02432248|poor ovarian responder|poor ovarian responder
184561|NCT02432235|Camidanlumab tesirine|camidanlumab tesirine
184562|NCT02432196|Mitral Valve Repair|mitral valve repair
184563|NCT02432196|Transapical|transapical
184564|NCT02432196|artificial chordae|artificial chordae
184565|NCT02432183|individual|individual
184566|NCT02432144|MPS 7|mps 7
184567|NCT02432144|Sly Syndrome|sly syndrome
184568|NCT02432144|MPS VII|mps vii
184569|NCT02432144|Enzyme Replacement Therapy|enzyme replacement therapy
184570|NCT02432144|Rare Disease|rare disease
184571|NCT02432144|Mucopolysaccharidosis Type 7|mucopolysaccharidosis type 7
184572|NCT02432144|Lysosomal Storage Disease|lysosomal storage disease
184573|NCT02432144|Metabolic Disorder|metabolic disorder
184574|NCT02432092|Cardiomegaly|cardiomegaly
184575|NCT02432092|Cardiovascular Diseases|cardiovascular diseases
184576|NCT02432092|Heart Diseases|heart diseases
184577|NCT02432092|Systolic dysfunction|systolic dysfunction
184578|NCT02432092|Diastolic dysfunction|diastolic dysfunction
184579|NCT02432092|Ventricular hypertrophy|ventricular hypertrophy
184580|NCT02432092|Heart failure|heart failure
184581|NCT02432079|Abnormalities, Multiple|abnormalities, multiple
184582|NCT02432079|Asplenia|asplenia
184583|NCT02432079|Bilary Atresia|bilary atresia
184584|NCT02432079|Birth Defect|birth defect
184585|NCT02432079|Cardiovascular Abnormalities|cardiovascular abnormalities
184586|NCT02432079|Cardiovascular Diseases|cardiovascular diseases
184587|NCT02432079|Congenital Abnormalities|congenital abnormalities
184588|NCT02432079|Congenital Heart Disease|congenital heart disease
184589|NCT02432079|Dextrocardia Syndrome|dextrocardia syndrome
184590|NCT02432079|Disturbed Internal Organ Positioning|disturbed internal organ positioning
184591|NCT02432079|Genetics|genetics
184592|NCT02432079|Genetic Testing|genetic testing
184593|NCT02432079|Heart Defects, Congenital|heart defects, congenital
184594|NCT02432079|Heart Diseases|heart diseases
184595|NCT02432079|Heterotaxy syndrome|heterotaxy syndrome
184596|NCT02432079|Intestinal malrotation|intestinal malrotation
184597|NCT02432079|Laterality|laterality
184598|NCT02432079|Left Atrial Isomerism|left atrial isomerism
184599|NCT02432079|Pediatrics|pediatrics
184600|NCT02432079|Polysplenia|polysplenia
184601|NCT02432079|Right Atrial Isomerism|right atrial isomerism
184602|NCT02432079|Splenic Diseases|splenic diseases
184603|NCT02432079|Cilia|cilia
184604|NCT02432079|Situs inversus|situs inversus
184605|NCT02432079|Dextrocardia|dextrocardia
184606|NCT02432066|Smoking|smoking
184607|NCT02432066|Smoking Cessation|smoking cessation
184608|NCT02432053|FK506|fk506
184609|NCT02432053|Advagraf|advagraf
184610|NCT02432053|Tacrolimus|tacrolimus
184611|NCT02432053|Transplantation|transplantation
184612|NCT02432040|chronic plaque psoriasis|chronic plaque psoriasis
184613|NCT02432040|psoriasis|psoriasis
184614|NCT02432040|atorvastatin|atorvastatin
184615|NCT02432040|psoriasis area and severity index|psoriasis area and severity index
184616|NCT02432040|betamethasone valerate|betamethasone valerate
184617|NCT02431988|Relapsed|relapsed
184618|NCT02431988|refractory|refractory
184619|NCT02431988|DLBCL|dlbcl
184620|NCT02431975|HIV|hiv
184621|NCT02431975|infant|infant
184622|NCT02431975|antiretroviral therapy, highly active|antiretroviral therapy, highly active
184623|NCT02431975|antiretroviral agents|antiretroviral agents
184624|NCT02431962|Lung Cancer|lung cancer
184625|NCT02431962|Screening|screening
184626|NCT02431962|Computed Tomography|computed tomography
184627|NCT02431949|Music|music
184628|NCT02431949|Amusia|amusia
184629|NCT02431936|Stress|stress
184630|NCT02431936|Blood Pressure|blood pressure
184631|NCT02431936|Salt Sensitivity|salt sensitivity
184632|NCT02431936|Renin-Angiotensin-Aldosterone System|renin-angiotensin-aldosterone system
184633|NCT02431936|Sympathetic Nervous System|sympathetic nervous system
184634|NCT02431923|Sequelae|sequelae
184635|NCT02431923|Seroprevalence|seroprevalence
184636|NCT02431923|Household Contacts|household contacts
184637|NCT02431910|Electromyography|electromyography
184638|NCT02431910|Baropodometry|baropodometry
184639|NCT02431910|Torque|torque
184640|NCT02431897|Pelvic Organ Prolapse|pelvic organ prolapse
184641|NCT02431897|Pelvic Floor Disorders|pelvic floor disorders
184642|NCT02431897|Therapy, Estrogen Replacement|therapy, estrogen replacement
184643|NCT02431897|Estrogens, Conjugated|estrogens, conjugated
184644|NCT02431871|Developmental dysplasia of the hip|developmental dysplasia of the hip
184645|NCT02431871|Hip dysplasia|hip dysplasia
184646|NCT02431871|Occlusal defect|occlusal defect
184647|NCT02431858|Nerve block|nerve block
184648|NCT02431858|Catheter|catheter
184649|NCT02431858|Catheter over needle|catheter over needle
184650|NCT02431858|Femoral Nerve|femoral nerve
184651|NCT02431858|Anaesthesia|anaesthesia
184652|NCT02431858|[E04.525.210.550]|[e04.525.210.550]
184653|NCT02431858|[E02.148]|[e02.148]
184654|NCT02431845|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
184655|NCT02431845|Pharmacogenetics|pharmacogenetics
184656|NCT02431832|Elderly|elderly
184657|NCT02431819|Peripheral Arterial Disease|peripheral arterial disease
184658|NCT02431819|Progressive compressive stockings|progressive compressive stockings
184659|NCT02431793|Opioids|opioids
184660|NCT02431780|Neonatal Seizures|neonatal seizures
184661|NCT02431780|Decision Support Algorithm|decision support algorithm
184662|NCT02431780|EEG|eeg
184663|NCT02431741|Presence of at least one exuding malignant (fungating) wound in need for antimicrobial treatment|presence of at least one exuding malignant (fungating) wound in need for antimicrobial treatment
184664|NCT02431728|Melatonin|melatonin
184665|NCT02431728|Post-acute withdrawal symptoms|post-acute withdrawal symptoms
184666|NCT02431728|Anxiety|anxiety
184667|NCT02431728|Depression|depression
184668|NCT02431728|Insomnia|insomnia
184669|NCT02431728|Stress|stress
184670|NCT02431728|Substance withdrawal syndrome|substance withdrawal syndrome
184671|NCT02431702|Paliperidone Palmitate|paliperidone palmitate
184672|NCT02431702|Oral Antipsychotics|oral antipsychotics
184673|NCT02431702|Schizophrenia|schizophrenia
184674|NCT02431702|Psychotic Disorders|psychotic disorders
184675|NCT02431702|Cognition in Schizophrenia|cognition in schizophrenia
184676|NCT02431702|Brain intracortical myelin volume|brain intracortical myelin volume
184677|NCT02431702|Personal and Social Performance|personal and social performance
184678|NCT02431702|Disease Modification|disease modification
184679|NCT02431663|refractory convulsive status epilepticus|refractory convulsive status epilepticus
184680|NCT02431663|ketamine|ketamine
184681|NCT02431663|conventional anesthetics|conventional anesthetics
184682|NCT02431663|children|children
184683|NCT02431650|Induced blood stage malaria|induced blood stage malaria
184684|NCT02431650|Transmission|transmission
184685|NCT02431650|Mosquito feeding|mosquito feeding
184686|NCT02431650|OZ439|oz439
184687|NCT02431650|Primaquine|primaquine
184688|NCT02431650|Piperaquine|piperaquine
184689|NCT02431650|Artefonomel|artefonomel
184690|NCT02431637|Induced blood stage malaria|induced blood stage malaria
184691|NCT02431637|Transmission|transmission
184692|NCT02431637|Standard membrane feeding assay|standard membrane feeding assay
184693|NCT02431624|Healthy Volunteer|healthy volunteer
184694|NCT02431585|abdominal pain|abdominal pain
184695|NCT02431585|gluten free diet|gluten free diet
184696|NCT02431585|functional gastrointestinal disorders|functional gastrointestinal disorders
184697|NCT02431572|Intracranial Tumors|intracranial tumors
184698|NCT02431572|Glioblastoma|glioblastoma
184699|NCT02431572|Melanoma|melanoma
184700|NCT02431559|Ovarian Cancer|ovarian cancer
184701|NCT02431559|Motolimod|motolimod
184702|NCT02431559|Immunotherapy|immunotherapy
184703|NCT02431559|PD-L1|pd-l1
184704|NCT02431559|MEDI4736|medi4736
184705|NCT02431559|Pegylated|pegylated
184706|NCT02431559|Liposomal|liposomal
184707|NCT02431559|Doxorubicin|doxorubicin
184708|NCT02431559|PLD|pld
184709|NCT02431559|TLR-8|tlr-8
184710|NCT02431559|Durvalumab|durvalumab
184711|NCT02431546|Cardiology|cardiology
184712|NCT02431546|Vascular|vascular
184713|NCT02431546|CAD|cad
184714|NCT02431546|Duke|duke
184715|NCT02431546|Cardiac Rehabilitation|cardiac rehabilitation
184716|NCT02431546|Prevention|prevention
184717|NCT02431546|CVD|cvd
184718|NCT02431546|Mobile Health|mobile health
184719|NCT02431546|Exercise|exercise
184720|NCT02431533|IBS-D|ibs-d
184721|NCT02431533|diarrhea predominant|diarrhea predominant
184722|NCT02431520|Patient Compliance|patient compliance
184723|NCT02431520|HPV-DNA probes|hpv-dna probes
184724|NCT02431520|Papanicolaou test|papanicolaou test
184725|NCT02431520|Cervical cancer|cervical cancer
184726|NCT02431507|apnea|apnea
184727|NCT02431507|sleep apnea|sleep apnea
184728|NCT02431507|magnetic sleep apnea device|magnetic sleep apnea device
184729|NCT02431507|hyoid bone|hyoid bone
184730|NCT02431455|Bariatric Surgery|bariatric surgery
184731|NCT02431455|obesity, morbid|obesity, morbid
184732|NCT02431455|incentive spirometry|incentive spirometry
184733|NCT02431442|Heterozygous|heterozygous
184734|NCT02431442|MC4R deficiency|mc4r deficiency
184735|NCT02431442|associated|associated
184736|NCT02431429|leishmaniasis|leishmaniasis
184737|NCT02431429|miltefosine|miltefosine
184738|NCT02431429|spermiogram|spermiogram
184739|NCT02431416|females|females
184740|NCT02431416|ghrelin|ghrelin
184741|NCT02431416|GnRH|gnrh
184742|NCT02431416|randomized, controlled study|randomized, controlled study
184743|NCT02431416|children|children
184744|NCT02431390|RAPAELⓇ Smart Glove digital treatment system|rapaelⓡ smart glove digital treatment system
184745|NCT02431390|Rehabilitation|rehabilitation
184746|NCT02431390|Stroke|stroke
184747|NCT02431390|Upper limbs|upper limbs
184748|NCT02431377|infant formula|infant formula
184749|NCT02431364|KPT-335|kpt-335
184750|NCT02431364|Verdinexor|verdinexor
184751|NCT02431364|Karyopharm|karyopharm
184752|NCT02431364|First-in-Human|first-in-human
184753|NCT02431364|Adult Subjects|adult subjects
184754|NCT02431351|KPT-330|kpt-330
184755|NCT02431351|Karyopharm|karyopharm
184756|NCT02431351|Selinexor|selinexor
184757|NCT02431351|SIER|sier
184758|NCT02431351|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
184759|NCT02431351|Erythropoietin (EPO)|erythropoietin (epo)
184760|NCT02431351|Refractory|refractory
184761|NCT02431338|Remote ischemic conditioning|remote ischemic conditioning
184762|NCT02431338|Cost-effectiveness analysis|cost-effectiveness analysis
184763|NCT02431325|HIV|hiv
184764|NCT02431325|Atherosclerosis|atherosclerosis
184765|NCT02431325|Microbial Translocation|microbial translocation
184766|NCT02431325|Teduglutide|teduglutide
184767|NCT02431325|Gastrointestinal Permeability|gastrointestinal permeability
184768|NCT02431325|Inflammation|inflammation
184769|NCT02431312|Chronic HBV|chronic hbv
184770|NCT02431312|immunotherapy|immunotherapy
184771|NCT02431312|DNA vaccine|dna vaccine
184772|NCT02431312|electroporation|electroporation
184773|NCT02431286|nausea and vomiting, postoperative|nausea and vomiting, postoperative
184774|NCT02431286|emesis, postoperative|emesis, postoperative
184775|NCT02431273|TDF|tdf
184776|NCT02431273|FTC|ftc
184777|NCT02431273|MVC|mvc
184778|NCT02431273|TDF-FTC|tdf-ftc
184779|NCT02431273|TDF-FTC-MVC|tdf-ftc-mvc
184780|NCT02431273|IVR|ivr
184781|NCT02431273|ARV|arv
184782|NCT02431260|solid tumor|solid tumor
184783|NCT02431260|lymphoma|lymphoma
184784|NCT02431260|BET bromodomain inhibitor|bet bromodomain inhibitor
184785|NCT02431260|BRD|brd
184786|NCT02431260|Diffuse large B-cell lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
184787|NCT02431260|Burkitt's lymphoma|burkitt's lymphoma
184788|NCT02431260|c-MYC|c-myc
184789|NCT02431260|colorectal cancer|colorectal cancer
184790|NCT02431260|Non-small cell lung cancer|non-small cell lung cancer
184791|NCT02431260|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
184792|NCT02431260|castration-resistant prostate cancer|castration-resistant prostate cancer
184793|NCT02431260|breast cancer|breast cancer
184794|NCT02431260|NUT midline carcinoma|nut midline carcinoma
184795|NCT02431260|leukemia|leukemia
184796|NCT02431260|acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
184797|NCT02431260|atypical chronic myeloid leukemia (aCML)|atypical chronic myeloid leukemia (acml)
184798|NCT02431260|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
184799|NCT02431260|myeloproliferative neoplasms|myeloproliferative neoplasms
184800|NCT02431260|myelofibrosis (MF)|myelofibrosis (mf)
184801|NCT02431260|multiple myeloma (MM)|multiple myeloma (mm)
184802|NCT02431260|CMML|cmml
184803|NCT02431260|MDS/MPN-U|mds/mpn-u
184804|NCT02431260|RARS-T|rars-t
184805|NCT02431247|Immunodeficiency Virus Type 1, Human|immunodeficiency virus type 1, human
184806|NCT02431247|Darunavir|darunavir
184807|NCT02431247|Cobicistat|cobicistat
184808|NCT02431247|Tenofovir Alafenamide|tenofovir alafenamide
184809|NCT02431247|Emtricitabine|emtricitabine
184810|NCT02431247|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
184811|NCT02431234|Type 2 diabetes|type 2 diabetes
184812|NCT02431234|Arterial calcification|arterial calcification
184813|NCT02431234|Mediacalcosis|mediacalcosis
184814|NCT02431234|Calcium score|calcium score
184815|NCT02431221|perhexiline|perhexiline
184816|NCT02431221|HCM|hcm
184817|NCT02431221|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
184818|NCT02431221|CPEX|cpex
184819|NCT02431195|obesity|obesity
184820|NCT02431195|bariatric surgery|bariatric surgery
184821|NCT02431195|physical activity|physical activity
184822|NCT02431195|eating habits|eating habits
184823|NCT02431156|presbyopia|presbyopia
184824|NCT02431156|monovision|monovision
184825|NCT02431156|activities of daily living,|activities of daily living,
184826|NCT02431156|pseudophakic|pseudophakic
184827|NCT02431130|Training Program|training program
184828|NCT02431091|Optical Coherence Tomography|optical coherence tomography
184829|NCT02431078|CTCs|ctcs
184830|NCT02431078|ZEB1|zeb1
184831|NCT02431078|gastric cancer|gastric cancer
184832|NCT02431065|Rectus sheath block|rectus sheath block
184833|NCT02431065|Single port laparoscopy|single port laparoscopy
184834|NCT02431026|induced mild hypothermia|induced mild hypothermia
184835|NCT02431026|cervical cooling collar|cervical cooling collar
184836|NCT02431026|mri brain thermometry|mri brain thermometry
184837|NCT02431026|MRI thermometry|mri thermometry
184838|NCT02431026|rate-of-cooling|rate-of-cooling
184839|NCT02431026|Excel Cryo Cooling Collar|excel cryo cooling collar
184840|NCT02431013|Drug-drug interaction|drug-drug interaction
184841|NCT02431013|Pharmacokinetics|pharmacokinetics
184842|NCT02430961|Critical Care|critical care
184843|NCT02430961|Palliative Care|palliative care
184844|NCT02430948|Screening|screening
184845|NCT02430948|Shared Decision Making|shared decision making
184846|NCT02430935|Psychosis|psychosis
184847|NCT02430935|Psychosis NOS|psychosis nos
184848|NCT02430935|Schizophrenia|schizophrenia
184849|NCT02430935|Schizoaffective Disorder|schizoaffective disorder
184850|NCT02430935|Early Intervention|early intervention
184851|NCT02430896|Neuropsychological|neuropsychological
184852|NCT02430896|neuroimaging|neuroimaging
184853|NCT02430896|genetic markers|genetic markers
184854|NCT02430896|treatment response predictor|treatment response predictor
184855|NCT02430883|pain, RIRS, kidney|pain, rirs, kidney
184856|NCT02430870|Drug therapy|drug therapy
184857|NCT02430844|acute kidney injury|acute kidney injury
184858|NCT02430844|radiographic contrast|radiographic contrast
184859|NCT02430844|critically ill|critically ill
184860|NCT02430844|biomarker|biomarker
184861|NCT02430818|ketamine|ketamine
184862|NCT02430818|emergency medicine|emergency medicine
184863|NCT02430818|orthopedics|orthopedics
184864|NCT02430805|hypertension|hypertension
184865|NCT02430805|microinflammation and oxidative stress|microinflammation and oxidative stress
184866|NCT02430805|renal disease|renal disease
184867|NCT02430805|heart failure|heart failure
184868|NCT02430805|genetics markers|genetics markers
184869|NCT02430805|genomics markers|genomics markers
184870|NCT02430805|proteomics markers|proteomics markers
184871|NCT02430792|Prostatic Neoplasms|prostatic neoplasms
184872|NCT02430792|Exercise|exercise
184873|NCT02430792|Football|football
184874|NCT02430792|Quality of Life|quality of life
184875|NCT02430779|irreversible electroporation|irreversible electroporation
184876|NCT02430779|Unresectable Renal Pelvic and Ureteral Neoplasms|unresectable renal pelvic and ureteral neoplasms
184877|NCT02430766|irreversible electroporation|irreversible electroporation
184878|NCT02430766|Unresectable Lymph Node Metastases|unresectable lymph node metastases
184879|NCT02430753|irreversible electroporation|irreversible electroporation
184880|NCT02430753|Lung Neoplasms|lung neoplasms
184881|NCT02430753|Respiratory Function Insufficiency|respiratory function insufficiency
184882|NCT02430740|Fertilization in Vitro|fertilization in vitro
184883|NCT02430740|antagonist protocol|antagonist protocol
184884|NCT02430740|antral follicle count|antral follicle count
184885|NCT02430740|Anti-Mullerian Hormone|anti-mullerian hormone
184886|NCT02430740|Reproductive Techniques, Assisted|reproductive techniques, assisted
184887|NCT02430714|Thyroid Cancer|thyroid cancer
184888|NCT02430714|Lenvima|lenvima
184889|NCT02430714|Post-marketing surveillance|post-marketing surveillance
184890|NCT02430714|LEN01T|len01t
184891|NCT02430714|All-Patient Investigation|all-patient investigation
184892|NCT02430714|Lenvatinib Mesylate|lenvatinib mesylate
184893|NCT02430701|irreversible electroporation|irreversible electroporation
184894|NCT02430701|Unresectable Esophageal Neoplasms|unresectable esophageal neoplasms
184895|NCT02430688|irreversible electroporation|irreversible electroporation
184896|NCT02430688|Unresectable Extremities|unresectable extremities
184897|NCT02430675|irreversible electroporation|irreversible electroporation
184898|NCT02430675|Unresectable Laryngeal Neoplasms|unresectable laryngeal neoplasms
184899|NCT02430662|irreversible electroporation|irreversible electroporation
184900|NCT02430662|Unresectable Gallbladder Neoplasms|unresectable gallbladder neoplasms
184901|NCT02430649|irreversible electroporation|irreversible electroporation
184902|NCT02430649|Unresectable Prostatic Neoplasms|unresectable prostatic neoplasms
184903|NCT02430636|irreversible electroporation|irreversible electroporation
184904|NCT02430636|Unresectable Stomach Neoplasms|unresectable stomach neoplasms
184905|NCT02430623|irreversible electroporation|irreversible electroporation
184906|NCT02430623|Unresectable Urinary Neoplasms|unresectable urinary neoplasms
184907|NCT02430610|irreversible electroporation|irreversible electroporation
184908|NCT02430610|Unresectable Uterine Cervical Neoplasms|unresectable uterine cervical neoplasms
184909|NCT02430597|irreversible electroporation|irreversible electroporation
184910|NCT02430597|Hilus Pulmonary Neoplasms|hilus pulmonary neoplasms
184911|NCT02430545|Glasdegib|glasdegib
184912|NCT02430545|PF-04449913|pf-04449913
184913|NCT02430545|Drug-drug interaction|drug-drug interaction
184914|NCT02430545|CYP3A4 inducer|cyp3a4 inducer
184915|NCT02430545|Pharmacokinetics|pharmacokinetics
184916|NCT02430532|INSPIRE|inspire
184917|NCT02430532|SPMS|spms
184918|NCT02430532|Tecfidera|tecfidera
184919|NCT02430532|BG00012|bg00012
184920|NCT02430519|Chronic Periodontitis|chronic periodontitis
184921|NCT02430519|Clinical Parameters|clinical parameters
184922|NCT02430519|Furcation defects|furcation defects
184923|NCT02430519|Radiographic bone fill|radiographic bone fill
184924|NCT02430493|ACS|acs
184925|NCT02430480|Multiparametric MRI|multiparametric mri
184926|NCT02430480|Prostatectomy|prostatectomy
184927|NCT02430480|Focal Prostate Cancer|focal prostate cancer
184928|NCT02430480|Normal Testosterone|normal testosterone
184929|NCT02430480|Non Metastatic|non metastatic
184930|NCT02430454|ICU|icu
184931|NCT02430454|decision making|decision making
184932|NCT02430402|Climatotherapy|climatotherapy
184933|NCT02430389|hemodynamic stability|hemodynamic stability
184934|NCT02430389|remifentanil|remifentanil
184935|NCT02430376|Non-Muscle Myosin|non-muscle myosin
184936|NCT02430363|pembrolizumab|pembrolizumab
184937|NCT02430363|MK-3475|mk-3475
184938|NCT02430363|Glioblastoma|glioblastoma
184939|NCT02430363|Gliosarcoma|gliosarcoma
184940|NCT02430363|Suppressor of the PI3K/Akt pathways|suppressor of the pi3k/akt pathways
184941|NCT02430363|Pictilisib|pictilisib
184942|NCT02430363|GDC-0941|gdc-0941
184943|NCT02430363|BEZ235|bez235
184944|NCT02430363|NVP-BEZ235|nvp-bez235
184945|NCT02430363|Ipatasertib|ipatasertib
184946|NCT02430363|GDC-0068|gdc-0068
184947|NCT02430311|Chinese Patients|chinese patients
184948|NCT02430285|biliary stone|biliary stone
184949|NCT02430285|cholelithiasis|cholelithiasis
184950|NCT02430285|pancreatitis|pancreatitis
184951|NCT02430285|EUS|eus
184952|NCT02430285|ERCP|ercp
184953|NCT02430285|early|early
184954|NCT02430285|choledocholithiasis|choledocholithiasis
184955|NCT02430272|Child|child
184956|NCT02430272|outpatient|outpatient
184957|NCT02430272|premedication|premedication
184958|NCT02430259|rifapentine|rifapentine
184959|NCT02430259|isoniazid|isoniazid
184960|NCT02430259|QuantiFERON Gold In-Tube|quantiferon gold in-tube
184961|NCT02430259|tuberculin skin test|tuberculin skin test
184962|NCT02430207|Pulmonary Embolism|pulmonary embolism
184963|NCT02430207|Temporary Pacing|temporary pacing
184964|NCT02430207|Femoral Vein|femoral vein
184965|NCT02430207|Subclavian Vein|subclavian vein
184966|NCT02430168|Stone|stone
184967|NCT02430168|RIRs|rirs
184968|NCT02430168|PCNL|pcnl
184969|NCT02430168|Pain|pain
184970|NCT02430155|condom-loaded Foley's catheter|condom-loaded foley's catheter
184971|NCT02430155|Bakri balloon|bakri balloon
184972|NCT02430155|primary atonic postpartum hemorrhage|primary atonic postpartum hemorrhage
184973|NCT02430142|microcirculation|microcirculation
184974|NCT02430142|oxygen uptake|oxygen uptake
184975|NCT02430142|hypoxia|hypoxia
184976|NCT02430142|adenosine|adenosine
184977|NCT02430142|central venous saturation|central venous saturation
184978|NCT02430142|hypoxanthine|hypoxanthine
184979|NCT02430142|laserdoppler|laserdoppler
184980|NCT02430103|Breast Cancer|breast cancer
184981|NCT02430103|Preservation of Ovarian Reserve Function|preservation of ovarian reserve function
184982|NCT02430090|regionel anesthesia|regionel anesthesia
184983|NCT02430090|levobupivacaine|levobupivacaine
184984|NCT02430090|ceserean section|ceserean section
184985|NCT02430077|Hepatic Steatosis|hepatic steatosis
184986|NCT02430051|sensory processing|sensory processing
184987|NCT02430051|oral care|oral care
184988|NCT02430051|electrodermal activity|electrodermal activity
184989|NCT02430051|cooperation|cooperation
184990|NCT02430051|anxiety|anxiety
184991|NCT02430051|distress|distress
184992|NCT02430051|stress|stress
184993|NCT02430051|behavior|behavior
184994|NCT02430051|occupational therapy|occupational therapy
184995|NCT02430038|transperineal ultrasound|transperineal ultrasound
184996|NCT02430038|labour|labour
184997|NCT02430038|sonopartogram|sonopartogram
184998|NCT02430038|prediction model|prediction model
184999|NCT02430025|Cardiovascular Diseases|cardiovascular diseases
185000|NCT02430025|Vascular Diseases|vascular diseases
185001|NCT02430025|Acute Coronary Syndrome|acute coronary syndrome
185002|NCT02430025|Chest Pain|chest pain
185003|NCT02430025|Heart Diseases|heart diseases
185004|NCT02430025|Myocardial Ischemia|myocardial ischemia
185005|NCT02430025|Pathologic Processes|pathologic processes
185006|NCT02430012|coronary artery bypass grafting|coronary artery bypass grafting
185007|NCT02430012|quality improvement|quality improvement
185008|NCT02430012|secondary preventions|secondary preventions
185009|NCT02429986|Adaptive Servo-Ventilation|adaptive servo-ventilation
185010|NCT02429986|Chronic Heart Failure|chronic heart failure
185011|NCT02429986|Central Sleep Apnea Syndrome|central sleep apnea syndrome
185012|NCT02429986|Central and Obstructive Sleep Apnea Syndrome|central and obstructive sleep apnea syndrome
185013|NCT02429986|Complex Sleep Apnea Syndrome|complex sleep apnea syndrome
185014|NCT02429986|Hunter-Cheyne-Stokes Breathing|hunter-cheyne-stokes breathing
185015|NCT02429986|Periodic Breathing|periodic breathing
185016|NCT02429973|Osteosarcoma|osteosarcoma
185017|NCT02429960|Nociception|nociception
185018|NCT02429960|Analgesia|analgesia
185019|NCT02429960|Intraoperative|intraoperative
185020|NCT02429960|Monitoring|monitoring
185021|NCT02429947|Charcot Marie Tooth disease|charcot marie tooth disease
185022|NCT02429947|CMT|cmt
185023|NCT02429947|HMSN|hmsn
185024|NCT02429947|HMN|hmn
185025|NCT02429947|HSN|hsn
185026|NCT02429934|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
185027|NCT02429934|Abatacept (Orencia)|abatacept (orencia)
185028|NCT02429934|Arthritis|arthritis
185029|NCT02429921|dietary intervention|dietary intervention
185030|NCT02429921|arsenic poisoning|arsenic poisoning
185031|NCT02429921|high-Se lentils|high-se lentils
185032|NCT02429895|Methotrexate|methotrexate
185033|NCT02429895|Efficacy|efficacy
185034|NCT02429895|Safety|safety
185232|NCT02428907|colonoscopy|colonoscopy
185035|NCT02429882|Ankylosing Spondyloarthritis; non-radiographic axial spondyloarthritis|ankylosing spondyloarthritis; non-radiographic axial spondyloarthritis
185036|NCT02429843|Non-squamous cell lung cancer|non-squamous cell lung cancer
185037|NCT02429843|Non-squamous non-small cell lung cancer|non-squamous non-small cell lung cancer
185038|NCT02429843|vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
185039|NCT02429843|TRC105|trc105
185040|NCT02429830|gastroesophageal reflux disease|gastroesophageal reflux disease
185041|NCT02429830|GERD|gerd
185042|NCT02429830|obesity|obesity
185043|NCT02429830|LSG|lsg
185044|NCT02429830|Laparoscopic Sleeve Gastrectomy|laparoscopic sleeve gastrectomy
185045|NCT02429817|Pulmonary aerosol distribution|pulmonary aerosol distribution
185046|NCT02429817|SPECT-CT analysis|spect-ct analysis
185047|NCT02429817|High flow nasal cannula|high flow nasal cannula
185048|NCT02429817|Vibrating-mesh nebulizer|vibrating-mesh nebulizer
185049|NCT02429817|Jet nebulizer|jet nebulizer
185050|NCT02429791|two-drug regimen|two-drug regimen
185051|NCT02429791|virologically-suppressed|virologically-suppressed
185052|NCT02429791|dolutegravir plus rilpivirine|dolutegravir plus rilpivirine
185053|NCT02429791|integrase inhibitor|integrase inhibitor
185054|NCT02429791|protease inhibitor|protease inhibitor
185055|NCT02429791|NNRTI-sparing|nnrti-sparing
185056|NCT02429791|non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
185057|NCT02429791|HIV|hiv
185058|NCT02429791|nucleoside reverse transcriptase inhibitors|nucleoside reverse transcriptase inhibitors
185059|NCT02429752|inspiratory muscle training|inspiratory muscle training
185060|NCT02429752|low back pain|low back pain
185061|NCT02429752|respiration|respiration
185062|NCT02429752|breathing|breathing
185063|NCT02429739|Working Memory Training, computerized|working memory training, computerized
185064|NCT02429739|Dyslexia|dyslexia
185065|NCT02429739|Reading fluency|reading fluency
185066|NCT02429739|Reading comprehension|reading comprehension
185067|NCT02429726|malignant pleural effusion, p53 gene therapy, cisplatin|malignant pleural effusion, p53 gene therapy, cisplatin
185068|NCT02429713|tourniquet|tourniquet
185069|NCT02429713|total knee arthroplasty|total knee arthroplasty
185070|NCT02429713|blood loss|blood loss
185071|NCT02429674|Depression|depression
185072|NCT02429674|Adolescence|adolescence
185073|NCT02429648|AF|af
185074|NCT02429635|Exercise|exercise
185075|NCT02429635|lifestyle diseases|lifestyle diseases
185076|NCT02429635|well-being|well-being
185077|NCT02429596|antiepileptic drugs|antiepileptic drugs
185078|NCT02429596|generic substitution|generic substitution
185079|NCT02429570|meclofenamate|meclofenamate
185080|NCT02429570|15-068|15-068
185081|NCT02429557|autonomic failure|autonomic failure
185082|NCT02429557|orthostatic hypotension|orthostatic hypotension
185083|NCT02429557|compression garments|compression garments
185084|NCT02429557|treatment|treatment
185085|NCT02429544|Breast cancer|breast cancer
185086|NCT02429544|Stage IV breast cancer|stage iv breast cancer
185087|NCT02429544|Metastatic|metastatic
185088|NCT02429544|Residential group programs|residential group programs
185089|NCT02429544|Questionnaires|questionnaires
185090|NCT02429544|Surveys|surveys
185091|NCT02429544|EEG|eeg
185092|NCT02429544|Computer testing|computer testing
185093|NCT02429544|Saliva test|saliva test
185094|NCT02429544|Study diary|study diary
185095|NCT02429544|Actigraph|actigraph
185096|NCT02429531|Pneumovax 23|pneumovax 23
185097|NCT02429531|Typhim Vi|typhim vi
185098|NCT02429531|allohemagglutinins|allohemagglutinins
185099|NCT02429518|leishmaniasis|leishmaniasis
185100|NCT02429518|miltefosine|miltefosine
185101|NCT02429518|EKG|ekg
185102|NCT02429492|Pathophysiology|pathophysiology
185103|NCT02429492|Spinal interneurons|spinal interneurons
185104|NCT02429492|Electrophysiology|electrophysiology
185105|NCT02429492|EMG|emg
185106|NCT02429492|transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
185107|NCT02429479|Advance Care Planning|advance care planning
185108|NCT02429479|Living Will|living will
185109|NCT02429479|Family Caregiver|family caregiver
185110|NCT02429479|Advance Directive|advance directive
185111|NCT02429479|Surrogate Decision Maker|surrogate decision maker
185112|NCT02429479|Proxy|proxy
185113|NCT02429479|Self-Efficacy|self-efficacy
185114|NCT02429466|testicular germ cell tumor|testicular germ cell tumor
185115|NCT02429466|ovarian germ cell tumor|ovarian germ cell tumor
185116|NCT02429466|platinum refractory|platinum refractory
185117|NCT02429466|cisplatin|cisplatin
185118|NCT02429466|SGI110|sgi110
185119|NCT02429466|Guadecitabine|guadecitabine
185120|NCT02429453|Warfarin|warfarin
185121|NCT02429453|Traumatic intracranial hemorrhage|traumatic intracranial hemorrhage
185122|NCT02429453|prothrombin complex concentrate|prothrombin complex concentrate
185123|NCT02429453|fresh frozen plasma|fresh frozen plasma
185124|NCT02429453|Spontaneous intracranial hemorrhage|spontaneous intracranial hemorrhage
185125|NCT02429427|Primary Breast Cancer|primary breast cancer
185126|NCT02429427|Celecoxib|celecoxib
185127|NCT02429414|Surgical Procedure|surgical procedure
185128|NCT02429414|Fiberoptic bronchoscopy|fiberoptic bronchoscopy
185129|NCT02429414|FOB|fob
185130|NCT02429414|Non-Video Double Lumen Tube|non-video double lumen tube
185131|NCT02429414|DLT|dlt
185132|NCT02429414|Video Double Lumen Tube|video double lumen tube
185133|NCT02429414|VDLT|vdlt
185134|NCT02429401|binge drinking|binge drinking
185135|NCT02429401|heavy drinking|heavy drinking
185136|NCT02429388|Heart failure|heart failure
185137|NCT02429388|Spironolactone|spironolactone
185138|NCT02429388|Diuretics|diuretics
185139|NCT02429375|Mocetinostat (MGCD0103)|mocetinostat (mgcd0103)
185140|NCT02429375|Brentuximab Vedotin (SGN-35)|brentuximab vedotin (sgn-35)
185141|NCT02429375|Relapsed|relapsed
185142|NCT02429375|Refractory|refractory
185143|NCT02429323|induction|induction
185144|NCT02429323|pediatrics|pediatrics
185145|NCT02429323|sevoflurane|sevoflurane
185146|NCT02429323|intubation time|intubation time
185147|NCT02429310|Intermittent Claudication|intermittent claudication
185148|NCT02429310|IC|ic
185149|NCT02429310|Peripheral Arterial Disease|peripheral arterial disease
185150|NCT02429310|Peripheral Vascular Disease|peripheral vascular disease
185151|NCT02429310|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
185152|NCT02429310|Lower Limb Arterial Disease|lower limb arterial disease
185153|NCT02429310|Supervised Exercise Therapy|supervised exercise therapy
185154|NCT02429310|Supervised Exercise Programme|supervised exercise programme
185155|NCT02429310|Exercise Therapy|exercise therapy
185156|NCT02429297|Hypertension|hypertension
185157|NCT02429297|Diabetes|diabetes
185158|NCT02429297|mHealth|mhealth
185159|NCT02429297|Interactive Voice Response|interactive voice response
185160|NCT02429297|Bolivia|bolivia
185161|NCT02429297|Chronic disease|chronic disease
185162|NCT02429284|Chronic Thromboembolic Pulmonary Hypertension (CTEPH)|chronic thromboembolic pulmonary hypertension (cteph)
185163|NCT02429284|Pulmonary Endarterectomy (PEA)|pulmonary endarterectomy (pea)
185164|NCT02429284|Pulmonary Thromboendarterectomy (PTE)|pulmonary thromboendarterectomy (pte)
185165|NCT02429284|Pulmonary Hypertension|pulmonary hypertension
185166|NCT02429284|Balloon Pulmonary Angioplasty (BPA)|balloon pulmonary angioplasty (bpa)
185167|NCT02429271|undergoing thrombolysis|undergoing thrombolysis
185168|NCT02429245|Knee|knee
185169|NCT02429245|Knee osteoarthritis|knee osteoarthritis
185170|NCT02429245|Knee replacement|knee replacement
185171|NCT02429232|Pioglitazone|pioglitazone
185172|NCT02429232|Linagliptin|linagliptin
185173|NCT02429232|Diabetes mellitus|diabetes mellitus
185174|NCT02429232|Diabetic macular edema|diabetic macular edema
185175|NCT02429232|Kidney|kidney
185176|NCT02429154|spectroscopy, near-infrared|spectroscopy, near-infrared
185177|NCT02429154|Infant|infant
185178|NCT02429154|Anesthesia, general|anesthesia, general
185179|NCT02429128|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
185180|NCT02429115|peer mentoring|peer mentoring
185181|NCT02429115|chronic kidney disease|chronic kidney disease
185182|NCT02429115|quality of life|quality of life
185183|NCT02429115|pcori|pcori
185184|NCT02429115|caregiver burden|caregiver burden
185185|NCT02429102|Phase 1|phase 1
185186|NCT02429102|Healthy subjects|healthy subjects
185187|NCT02429102|Pharmacokinetics of MT-8554|pharmacokinetics of mt-8554
185188|NCT02429089|recurrent|recurrent
185189|NCT02429089|metastatic|metastatic
185190|NCT02429063|Solid Tumors|solid tumors
185191|NCT02429050|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
185192|NCT02429050|Dyspnea|dyspnea
185193|NCT02429050|Breathlessness|breathlessness
185194|NCT02429050|Morphine|morphine
185195|NCT02429050|Opioid|opioid
185196|NCT02429050|Symptom Management|symptom management
185197|NCT02429037|p53|p53
185198|NCT02429037|gene therapy|gene therapy
185199|NCT02429037|head and neck cancer|head and neck cancer
185200|NCT02429024|Diabetes Mellitus|diabetes mellitus
185201|NCT02429024|A1c|a1c
185202|NCT02429011|depression|depression
185203|NCT02429011|MRI|mri
185204|NCT02429011|treatment-resistant|treatment-resistant
185205|NCT02429011|imaging|imaging
185206|NCT02429011|ketamine|ketamine
185207|NCT02428985|Riociguat|riociguat
185208|NCT02428985|Adempas|adempas
185209|NCT02428985|soluble guanylate cyclase (sGC) stimulator|soluble guanylate cyclase (sgc) stimulator
185210|NCT02428985|Pulmonary arterial hypertension|pulmonary arterial hypertension
185211|NCT02428985|Japan|japan
185212|NCT02428985|Post-marketing surveillance|post-marketing surveillance
185213|NCT02428972|brain tumor|brain tumor
185214|NCT02428972|quality of life|quality of life
185215|NCT02428972|cognition|cognition
185216|NCT02428972|anesthetic technique|anesthetic technique
185217|NCT02428959|Amyl Nitrite|amyl nitrite
185218|NCT02428959|High Resolution Manometry|high resolution manometry
185219|NCT02428946|Insulin Sensitivity|insulin sensitivity
185220|NCT02428946|obesity|obesity
185221|NCT02428946|dopamine|dopamine
185222|NCT02428933|Brown Adipose Tissue|brown adipose tissue
185223|NCT02428933|Obesity|obesity
185224|NCT02428933|Insulin Sensitivity|insulin sensitivity
185225|NCT02428933|Dopamine|dopamine
185226|NCT02428920|cardiovascular health|cardiovascular health
185227|NCT02428920|behavior change|behavior change
185228|NCT02428920|community-based|community-based
185229|NCT02428920|prevention|prevention
185230|NCT02428907|simulation training|simulation training
185231|NCT02428907|minimal sedation|minimal sedation
185233|NCT02428907|patient satisfaction|patient satisfaction
185234|NCT02428907|teamwork|teamwork
185235|NCT02428907|team training|team training
185236|NCT02428907|patient safety|patient safety
185237|NCT02428881|onabotulinumtoxin A|onabotulinumtoxin a
185238|NCT02428868|hip fracture|hip fracture
185239|NCT02428868|anemia|anemia
185240|NCT02428868|blood transfusion|blood transfusion
185241|NCT02428868|tranexamic acid|tranexamic acid
185242|NCT02428868|intravenous iron|intravenous iron
185243|NCT02428855|Cholangiocarcinoma|cholangiocarcinoma
185244|NCT02428842|Cervical cancer|cervical cancer
185245|NCT02428842|Tumor biopsies|tumor biopsies
185246|NCT02428842|Standard treatment|standard treatment
185247|NCT02428842|Molecular profile|molecular profile
185248|NCT02428842|Next Generation Sequencing|next generation sequencing
185249|NCT02428829|hip|hip
185250|NCT02428829|replacement|replacement
185251|NCT02428829|arthroplasty|arthroplasty
185252|NCT02428829|total|total
185253|NCT02428829|orthopaedic|orthopaedic
185254|NCT02428829|rehabiliation|rehabiliation
185255|NCT02428829|physiotherapy|physiotherapy
185256|NCT02428829|therapy|therapy
185257|NCT02428816|differential diagnosis|differential diagnosis
185258|NCT02428816|multimodal MRI|multimodal mri
185259|NCT02428816|Parkinson's Disease|parkinson's disease
185260|NCT02428816|Multiple System Atrophy|multiple system atrophy
185261|NCT02428803|Peritoneal Dialysis|peritoneal dialysis
185262|NCT02428777|Hysteroscopy|hysteroscopy
185263|NCT02428751|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
185264|NCT02428751|liposomal doxorubicin|liposomal doxorubicin
185265|NCT02428751|doxorubicin|doxorubicin
185266|NCT02428751|event-free survival|event-free survival
185267|NCT02428738|Influenza Vaccine|influenza vaccine
185268|NCT02428738|Text Message|text message
185269|NCT02428673|Osteopenia|osteopenia
185270|NCT02428673|spinal muscular atrophy|spinal muscular atrophy
185271|NCT02428673|cerebral palsy|cerebral palsy
185272|NCT02428673|muscular dystrophy|muscular dystrophy
185273|NCT02428673|spina bifida|spina bifida
185274|NCT02428673|Rett Syndrome|rett syndrome
185275|NCT02428660|Polypharmacy|polypharmacy
185276|NCT02428660|Chronic conditions|chronic conditions
185277|NCT02428660|Drug Therapy Problems|drug therapy problems
185278|NCT02428660|Medication Therapy Management|medication therapy management
185279|NCT02428660|Medication-Related Problems|medication-related problems
185280|NCT02428660|CYP3A4|cyp3a4
185281|NCT02428660|CYP3A5|cyp3a5
185282|NCT02428660|Drug-drug interactions|drug-drug interactions
185283|NCT02428660|Drug-gene interactions|drug-gene interactions
185284|NCT02428660|Drug-drug-gene interactions|drug-drug-gene interactions
185285|NCT02428660|Adverse Drug Reactions|adverse drug reactions
185286|NCT02428660|Activities of Daily Living|activities of daily living
185287|NCT02428647|growth|growth
185288|NCT02428647|plasma zinc concentration|plasma zinc concentration
185289|NCT02428634|Cardiovascular health promotion|cardiovascular health promotion
185290|NCT02428634|Children|children
185291|NCT02428634|School intervention|school intervention
185292|NCT02428621|early orthodontic treatment|early orthodontic treatment
185293|NCT02428621|activator|activator
185294|NCT02428621|removable appliance|removable appliance
185295|NCT02428621|Twicare®|twicare®
185296|NCT02428621|Herbst appliance|herbst appliance
185297|NCT02428608|Glabellar Lines|glabellar lines
185298|NCT02428608|Botulinum toxin, Type A|botulinum toxin, type a
185299|NCT02428582|endovascular treatment|endovascular treatment
185300|NCT02428582|arterial occlusive disease|arterial occlusive disease
185301|NCT02428582|bare metal stent|bare metal stent
185302|NCT02428582|polytetrafluoroethylene covered stent|polytetrafluoroethylene covered stent
185303|NCT02428569|shared decision making|shared decision making
185304|NCT02428569|patient education|patient education
185305|NCT02428569|decision aids|decision aids
185306|NCT02428556|Decision making|decision making
185307|NCT02428543|FLT3-ITD patients in first complete remission|flt3-itd patients in first complete remission
185308|NCT02428517|acute lymphoblastic leukemia|acute lymphoblastic leukemia
185309|NCT02428517|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
185310|NCT02428517|alternative hematopoietic stem cell donor|alternative hematopoietic stem cell donor
185311|NCT02428517|busulfan|busulfan
185312|NCT02428517|antithymocyte globulin|antithymocyte globulin
185313|NCT02428504|Questionnaire|questionnaire
185314|NCT02428491|Diphtheria|diphtheria
185315|NCT02428491|Tetanus|tetanus
185316|NCT02428491|Pertussis|pertussis
185317|NCT02428491|Poliomyelitis|poliomyelitis
185318|NCT02428491|Hepatitis B|hepatitis b
185319|NCT02428491|DTaP-IPV-Hep B-PRP-T Combined Vaccine (Hexaxim™)|dtap-ipv-hep b-prp-t combined vaccine (hexaxim™)
185320|NCT02428452|autism|autism
185321|NCT02428452|Autism SPectrum Disorder|autism spectrum disorder
185322|NCT02428452|early intervention|early intervention
185323|NCT02428452|infant|infant
185324|NCT02428452|toddler|toddler
185325|NCT02428452|early identification|early identification
185326|NCT02428452|pivotal response training (PRT)|pivotal response training (prt)
185327|NCT02428452|control group|control group
185328|NCT02428452|treatment group|treatment group
185329|NCT02428452|at risk|at risk
185330|NCT02428452|social communication|social communication
185331|NCT02428452|positive affect|positive affect
185332|NCT02428452|smiling|smiling
185333|NCT02428439|genetic markers|genetic markers
185334|NCT02428439|predictors|predictors
185335|NCT02428439|Antidepressive Agents|antidepressive agents
185336|NCT02428439|Suicidal Ideation|suicidal ideation
185337|NCT02428439|Adolescent|adolescent
185338|NCT02428426|Mucosal Microbiome|mucosal microbiome
185339|NCT02428426|gastric intestinal metaplasia|gastric intestinal metaplasia
185340|NCT02428426|duodenum|duodenum
185341|NCT02428413|Waste Anesthetic Gas (WAG)|waste anesthetic gas (wag)
185342|NCT02428387|caregivers|caregivers
185343|NCT02428387|intervention|intervention
185344|NCT02428387|health related quality of life|health related quality of life
185345|NCT02428387|dementia|dementia
185347|NCT02428374|Ventricular function, left|ventricular function, left
185348|NCT02428309|Tregs|tregs
185349|NCT02428296|Clinical Trial|clinical trial
185350|NCT02428296|Congenital Malformations|congenital malformations
185351|NCT02428296|Overgrowth|overgrowth
185352|NCT02428296|Pilot Drug Treatment Trial|pilot drug treatment trial
185353|NCT02428257|hip fracture|hip fracture
185354|NCT02428257|elderly|elderly
185355|NCT02428257|continous spinal anesthesia|continous spinal anesthesia
185356|NCT02428257|hypobaric bupivacaine|hypobaric bupivacaine
185357|NCT02428257|isobaric bupivacaine|isobaric bupivacaine
185358|NCT02428257|hypotension|hypotension
185359|NCT02428244|Smoking|smoking
185360|NCT02428244|Cessation|cessation
185361|NCT02428244|Trauma|trauma
185362|NCT02428244|Fracture|fracture
185363|NCT02428244|Complications|complications
185364|NCT02428218|Randomized|randomized
185365|NCT02428218|Ages 10-17|ages 10-17
185366|NCT02428218|Pediatrics|pediatrics
185367|NCT02428218|Placebo controlled|placebo controlled
185368|NCT02428218|Relapse-Remitting|relapse-remitting
185369|NCT02428218|Multiple Sclerosis|multiple sclerosis
185370|NCT02428218|Safety|safety
185371|NCT02428218|Efficacy|efficacy
185372|NCT02428218|BG00012|bg00012
185373|NCT02428179|Surgical site infection|surgical site infection
185374|NCT02428179|Intraoperative briefings|intraoperative briefings
185375|NCT02428179|Mortality|mortality
185376|NCT02428179|Wound closure|wound closure
185377|NCT02428179|Surgical procedure|surgical procedure
185378|NCT02428166|crosslinking|crosslinking
185379|NCT02428166|keratoconus|keratoconus
185380|NCT02428166|keratometry|keratometry
185381|NCT02428166|pachymetry|pachymetry
185382|NCT02428166|pentacam|pentacam
185383|NCT02428153|static stretching|static stretching
185384|NCT02428153|dynamic stretching|dynamic stretching
185385|NCT02428153|muscle-tendon unit|muscle-tendon unit
185386|NCT02428153|ultrasound|ultrasound
185387|NCT02428153|Subjects|subjects
185388|NCT02428140|ischemic stroke|ischemic stroke
185389|NCT02428140|atrial fibrillation|atrial fibrillation
185390|NCT02428140|etiologic investigations|etiologic investigations
185391|NCT02428140|secondary prevention|secondary prevention
185392|NCT02428140|anticoagulation|anticoagulation
185393|NCT02428140|arrhythmias|arrhythmias
185394|NCT02428140|embolic stroke, undetermined etiology|embolic stroke, undetermined etiology
185395|NCT02428140|implantable loop recorder|implantable loop recorder
185396|NCT02428140|external loop recorder|external loop recorder
185397|NCT02428062|Post-operative complications|post-operative complications
185398|NCT02428062|Mild cognitive impairment|mild cognitive impairment
185399|NCT02428062|Delirium|delirium
185400|NCT02428036|TBI-1401(HF10)|tbi-1401(hf10)
185401|NCT02428036|HF10|hf10
185402|NCT02428036|HSV-1|hsv-1
185403|NCT02428036|Oncolytic virus|oncolytic virus
185404|NCT02428036|Oncolytic virotherapy|oncolytic virotherapy
185405|NCT02428036|Phase I|phase i
185406|NCT02428036|Melanoma|melanoma
185407|NCT02428036|Intratumoral administration|intratumoral administration
185408|NCT02428023|Thalassemia|thalassemia
185409|NCT02428023|trait|trait
185410|NCT02428023|coronary|coronary
185411|NCT02428023|stroke|stroke
185412|NCT02427997|Virtual Reality|virtual reality
185413|NCT02427997|Treadmill|treadmill
185414|NCT02427997|Multiple Sclerosis|multiple sclerosis
185415|NCT02427984|Internal Left Hip Prosthesis|internal left hip prosthesis
185416|NCT02427984|Internal Right Hip Prosthesis|internal right hip prosthesis
185417|NCT02427958|Drug Therapy|drug therapy
185418|NCT02427945|Information provision|information provision
185419|NCT02427932|Pharmacokinetics (PK)|pharmacokinetics (pk)
185420|NCT02427932|Pharmacodynamics (PD)|pharmacodynamics (pd)
185421|NCT02427919|G-CSF|g-csf
185422|NCT02427919|G-CSF receptor|g-csf receptor
185423|NCT02427919|AML|aml
185424|NCT02427919|refractory AML|refractory aml
185425|NCT02427919|Neutropenic fever|neutropenic fever
185426|NCT02427919|salvage chemotherapy|salvage chemotherapy
185427|NCT02427906|cirrhosis|cirrhosis
185428|NCT02427906|gut microbiota|gut microbiota
185429|NCT02427906|transjugular portosystemic shunt|transjugular portosystemic shunt
185430|NCT02427906|hepatic encephalopathy|hepatic encephalopathy
185431|NCT02427893|immunotherapy|immunotherapy
185432|NCT02427893|Vemurafenib|vemurafenib
185433|NCT02427893|Cobimetinib|cobimetinib
185434|NCT02427880|Edema|edema
185435|NCT02427880|Nephrotic syndrome|nephrotic syndrome
185436|NCT02427880|Acetazolamide|acetazolamide
185437|NCT02427880|Furosemide|furosemide
185438|NCT02427867|remote ischemic preconditioning|remote ischemic preconditioning
185439|NCT02427867|non cardiac surgery|non cardiac surgery
185440|NCT02427867|myocardial ischemia|myocardial ischemia
185441|NCT02427854|Major delivery complications|major delivery complications
185442|NCT02427854|Perineal injuries|perineal injuries
185443|NCT02427854|episiotomy|episiotomy
185444|NCT02427789|Physical exercise|physical exercise
185445|NCT02427789|Biomarkers|biomarkers
185446|NCT02427789|Neuroprotection|neuroprotection
185447|NCT02427789|ergospirometry|ergospirometry
185448|NCT02427789|Major Depressive Disorder|major depressive disorder
185449|NCT02427763|Removable Orthodontic Appliance;|removable orthodontic appliance;
185450|NCT02427763|malocclusion|malocclusion
185451|NCT02427763|Streptococcus mutans|streptococcus mutans
185452|NCT02427763|Lactobacillus|lactobacillus
185453|NCT02427763|Epithelium|epithelium
185454|NCT02427737|Magnetic Resonance Imaging|magnetic resonance imaging
185455|NCT02427737|Patient satisfaction|patient satisfaction
185456|NCT02427737|Diagnostic Imaging|diagnostic imaging
185457|NCT02427711|Reduction of blood loss for revisions of knee arthroplasty|reduction of blood loss for revisions of knee arthroplasty
185458|NCT02427711|blood transfusions|blood transfusions
185459|NCT02427711|Readmission|readmission
185460|NCT02427711|Bipolar sealer|bipolar sealer
185461|NCT02427672|antisocial behavior|antisocial behavior
185462|NCT02427672|aggression|aggression
185463|NCT02427672|transcranial direct current stimulation|transcranial direct current stimulation
185464|NCT02427672|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
185465|NCT02427672|associated risk factors|associated risk factors
185466|NCT02427659|VRD|vrd
185467|NCT02427659|Virtual Reality as Distraction during Procedure|virtual reality as distraction during procedure
185468|NCT02427659|Burn Wound Care|burn wound care
185469|NCT02427646|Kinematics|kinematics
185470|NCT02427646|Botulinum toxin type A|botulinum toxin type a
185471|NCT02427633|recovery position|recovery position
185472|NCT02427633|comatose|comatose
185473|NCT02427633|resource limited|resource limited
185474|NCT02427620|Lymphoma|lymphoma
185475|NCT02427620|Mantle cell lymphoma|mantle cell lymphoma
185476|NCT02427620|MCL|mcl
185477|NCT02427620|B-lymphocyte antigen|b-lymphocyte antigen
185478|NCT02427620|CD20|cd20
185479|NCT02427620|Ibrutinib|ibrutinib
185480|NCT02427620|PCI-32765|pci-32765
185481|NCT02427620|Imbruvica|imbruvica
185482|NCT02427620|Rituximab|rituximab
185483|NCT02427620|Rituxan|rituxan
185484|NCT02427620|Cyclophosphamide|cyclophosphamide
185485|NCT02427620|Cytoxan|cytoxan
185486|NCT02427620|Neosar|neosar
185487|NCT02427620|Vincristine|vincristine
185488|NCT02427620|Mesna|mesna
185489|NCT02427620|Mesnex|mesnex
185490|NCT02427620|Dexamethasone|dexamethasone
185491|NCT02427620|Decadron|decadron
185492|NCT02427620|Doxorubicin|doxorubicin
185493|NCT02427620|Doxorubicin hydrochloride|doxorubicin hydrochloride
185494|NCT02427620|Adriamycin PFS|adriamycin pfs
185495|NCT02427620|Adriamycin RDF|adriamycin rdf
185496|NCT02427620|Adriamycin|adriamycin
185497|NCT02427620|Rubex|rubex
185498|NCT02427620|G-CSF|g-csf
185499|NCT02427620|Filgrastim|filgrastim
185500|NCT02427620|Neupogen|neupogen
185501|NCT02427620|Methotrexate|methotrexate
185502|NCT02427620|Cytarabine|cytarabine
185503|NCT02427620|Ara-C|ara-c
185504|NCT02427620|Cytosar|cytosar
185505|NCT02427620|DepoCyt|depocyt
185506|NCT02427620|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
185507|NCT02427620|Citrovorum|citrovorum
185508|NCT02427620|Leucovorin|leucovorin
185509|NCT02427620|Wellcovorin|wellcovorin
185510|NCT02427607|Epilepsy|epilepsy
185511|NCT02427607|Perampanel|perampanel
185512|NCT02427594|Kidney Diseases|kidney diseases
185513|NCT02427594|Renal Insufficiency, Chronic|renal insufficiency, chronic
185514|NCT02427594|Dietary nonvolatile acid load|dietary nonvolatile acid load
185515|NCT02427594|Blood pressure|blood pressure
185516|NCT02427594|Urine net acid excretion|urine net acid excretion
185517|NCT02427568|Anxiety|anxiety
185518|NCT02427568|MDMA|mdma
185519|NCT02427568|Life-threatening illness|life-threatening illness
185520|NCT02427568|psychotherapy|psychotherapy
185521|NCT02427542|Randomized Controlled Trial|randomized controlled trial
185522|NCT02427529|hcg|hcg
185523|NCT02427503|asthma|asthma
185524|NCT02427503|sinonasal polyposis|sinonasal polyposis
185525|NCT02427503|eosinophilic bronchial inflammation|eosinophilic bronchial inflammation
185526|NCT02427503|endoscopic sinus surgery|endoscopic sinus surgery
185527|NCT02427490|Palliative Care|palliative care
185528|NCT02427490|Caregivers|caregivers
185529|NCT02427490|Medical Oncology|medical oncology
185530|NCT02427464|diabetic|diabetic
185531|NCT02427464|neuropathy|neuropathy
185532|NCT02427464|shooting pain|shooting pain
185533|NCT02427464|burning pain|burning pain
185534|NCT02427464|pins and needles pain|pins and needles pain
185535|NCT02427464|foot pain|foot pain
185536|NCT02427464|ViroMed|viromed
185537|NCT02427438|video|video
185538|NCT02427438|handout|handout
185539|NCT02427438|home program|home program
185540|NCT02427438|stabilization|stabilization
185541|NCT02427438|strengthening|strengthening
185542|NCT02427438|core|core
185543|NCT02427425|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
185544|NCT02427425|Pain|pain
185545|NCT02427412|Tranexamic Acid|tranexamic acid
185546|NCT02427412|Knee Arthroplasty|knee arthroplasty
185547|NCT02427412|Blood loss|blood loss
185548|NCT02427412|Blood transfusion|blood transfusion
185549|NCT02427412|Thrombolic complication|thrombolic complication
185550|NCT02427412|Total blood loss 24 h after ended surgery.|total blood loss 24 h after ended surgery.
185551|NCT02427412|Total blood loss 2 days after ended surgery.|total blood loss 2 days after ended surgery.
185552|NCT02427386|Endometriosis|endometriosis
185553|NCT02427386|Pelvic pain|pelvic pain
185554|NCT02427386|Homeopathy|homeopathy
185555|NCT02427386|RCT|rct
185556|NCT02427373|bioavailability|bioavailability
185557|NCT02427373|fish oil|fish oil
185558|NCT02427373|krill oil|krill oil
185559|NCT02427360|Retrospective Studies|retrospective studies
185560|NCT02427360|Clinical Efficacy|clinical efficacy
185561|NCT02427321|Cystoscopy|cystoscopy
185562|NCT02427321|Bladder cancer|bladder cancer
185563|NCT02427321|Bladder imaging|bladder imaging
185564|NCT02427308|leishmaniasis|leishmaniasis
185565|NCT02427308|miltefosine|miltefosine
185566|NCT02427308|pregnancy|pregnancy
185567|NCT02427269|Barrett's Esophagus|barrett's esophagus
185568|NCT02427269|Esophageal Cancer|esophageal cancer
185569|NCT02427269|Intramucosal Adenocarcinoma|intramucosal adenocarcinoma
185570|NCT02427230|Pelvic Floor Muscle Training|pelvic floor muscle training
185571|NCT02427230|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
185572|NCT02427230|Urinary Incontinence|urinary incontinence
185573|NCT02427230|Spinal Cord Injury|spinal cord injury
185574|NCT02427204|Hepatitis C infection|hepatitis c infection
185575|NCT02427204|Hepatitis C treatment|hepatitis c treatment
185576|NCT02427191|Chronic plantar fasciitis|chronic plantar fasciitis
185577|NCT02427191|Heel pain|heel pain
185578|NCT02427178|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
185579|NCT02427178|MNGIE|mngie
185580|NCT02427178|Stem Cell transplant|stem cell transplant
185581|NCT02427113|TMD|tmd
185582|NCT02427113|Music Medicine|music medicine
185583|NCT02427113|Vibroacousitc Therapy|vibroacousitc therapy
185584|NCT02427100|Homeless|homeless
185585|NCT02427100|Randomized Controlled Trial|randomized controlled trial
185586|NCT02427100|Diet|diet
185587|NCT02427100|Physical Activity|physical activity
185588|NCT02427087|Nonalcoholic fatty liver|nonalcoholic fatty liver
185589|NCT02427087|Physical activity|physical activity
185590|NCT02427087|NAFLD|nafld
185591|NCT02427087|Anthropometry|anthropometry
185592|NCT02427087|Body Composition|body composition
185593|NCT02427048|Clinical Practice Guidelines|clinical practice guidelines
185594|NCT02427022|evidence based practices, critical time intervention|evidence based practices, critical time intervention
185595|NCT02426944|atrial fibrillation|atrial fibrillation
185596|NCT02426944|cardioembolic event|cardioembolic event
185597|NCT02426944|stroke|stroke
185598|NCT02426944|left atrial appendage closure|left atrial appendage closure
185599|NCT02426944|novel anticoagulants|novel anticoagulants
185600|NCT02426931|retrograde intrarenal surgery|retrograde intrarenal surgery
185601|NCT02426931|flexible ureteroscopy|flexible ureteroscopy
185602|NCT02426931|renal calculi|renal calculi
185603|NCT02426892|Solid Tumors|solid tumors
185604|NCT02426892|HPV-16 Positive Incurable Solid Tumors|hpv-16 positive incurable solid tumors
185605|NCT02426892|ISA101|isa101
185606|NCT02426892|HPV-16 vaccination|hpv-16 vaccination
185607|NCT02426892|Nivolumab|nivolumab
185608|NCT02426892|BMS-936558|bms-936558
185609|NCT02426892|Opdivo|opdivo
185610|NCT02426879|three-field lymphadenectomy|three-field lymphadenectomy
185611|NCT02426879|cervical metastases|cervical metastases
185612|NCT02426879|esophagectomy|esophagectomy
185613|NCT02426853|Cancer Prevention|cancer prevention
185614|NCT02426853|Sun protection|sun protection
185615|NCT02426853|Photograph|photograph
185616|NCT02426853|UV photograph|uv photograph
185617|NCT02426853|Ultraviolet|ultraviolet
185618|NCT02426853|Pamphlets|pamphlets
185619|NCT02426853|Handouts|handouts
185620|NCT02426853|Questionnaires|questionnaires
185621|NCT02426853|Surveys|surveys
185622|NCT02426853|Skin cancer risk behaviors|skin cancer risk behaviors
185623|NCT02426840|Adverse bone health|adverse bone health
185624|NCT02426840|Bone demineralization|bone demineralization
185625|NCT02426840|HIV-infection|hiv-infection
185626|NCT02426840|Children|children
185627|NCT02426840|Adolescents|adolescents
185628|NCT02426840|Calcium|calcium
185629|NCT02426840|Vitamin D|vitamin d
185630|NCT02426840|Supplementation|supplementation
185631|NCT02426814|Patient Compliance|patient compliance
185632|NCT02426814|Mobile Applications|mobile applications
185633|NCT02426801|Patient Compliance|patient compliance
185634|NCT02426801|Mobile Applications|mobile applications
185635|NCT02426801|Medication Adherence|medication adherence
185636|NCT02426788|medically unexplained|medically unexplained
185637|NCT02426788|fibromyalgia|fibromyalgia
185638|NCT02426788|PoTS|pots
185639|NCT02426788|non-cardiac chest pain|non-cardiac chest pain
185640|NCT02426788|CFS|cfs
185641|NCT02426788|IBS|ibs
185642|NCT02426788|functional neurological|functional neurological
185643|NCT02426788|chronic pain|chronic pain
185644|NCT02426788|hyperventilation|hyperventilation
185645|NCT02426788|unexplained cough|unexplained cough
185646|NCT02426762|skin sealant|skin sealant
185647|NCT02426762|laparoscopic surgery|laparoscopic surgery
185648|NCT02426762|surgical site infection|surgical site infection
185649|NCT02426762|wound healing|wound healing
185650|NCT02426736|Shoulder Joint|shoulder joint
185651|NCT02426736|Arthroscopy|arthroscopy
185652|NCT02426736|Ambulatory surgical procedures|ambulatory surgical procedures
185653|NCT02426736|Pain, Postoperative|pain, postoperative
185654|NCT02426736|Brachial Plexus Block|brachial plexus block
185655|NCT02426736|Corticosteroid|corticosteroid
185656|NCT02426736|Dexamethasone|dexamethasone
185657|NCT02426736|Bupivacaine|bupivacaine
185658|NCT02426736|Perineural|perineural
185659|NCT02426710|ablation, atrial flutter, intracardiac echocardiography|ablation, atrial flutter, intracardiac echocardiography
185660|NCT02426697|bone metastasis, radiotherapy, pain, prevention|bone metastasis, radiotherapy, pain, prevention
185661|NCT02426684|End Stage Renal Disease|end stage renal disease
185662|NCT02426684|Kidney Transplant|kidney transplant
185663|NCT02426684|Desensitization|desensitization
185664|NCT02426684|Highly Sensitized|highly sensitized
185665|NCT02426684|Antibodies|antibodies
185666|NCT02426671|neuromodulation|neuromodulation
185667|NCT02426671|Minimum Masking Level|minimum masking level
185668|NCT02426645|Biomarkers|biomarkers
185669|NCT02426645|Sepsis|sepsis
185670|NCT02426645|Multi organ dysfunction|multi organ dysfunction
185671|NCT02426645|Immunomonitoring|immunomonitoring
185672|NCT02426645|CEUS|ceus
185673|NCT02426632|Healthy|healthy
185674|NCT02426632|JNJ-53718678|jnj-53718678
185675|NCT02426606|Lentils|lentils
185676|NCT02426606|Post-prandial|post-prandial
185677|NCT02426606|Glycemic response|glycemic response
185678|NCT02426606|Insulin response|insulin response
185679|NCT02426606|Diabetes|diabetes
185680|NCT02426606|Mixed meal|mixed meal
185681|NCT02426606|Glycemia|glycemia
185682|NCT02426606|Slowly digestible starch|slowly digestible starch
185683|NCT02426606|Post-prandial glycemia|post-prandial glycemia
185684|NCT02426593|CHF|chf
185685|NCT02426593|Heart Failure|heart failure
185686|NCT02426567|Crohn's Disease|crohn's disease
185687|NCT02426567|Exclusive Enteral Nutrition|exclusive enteral nutrition
185688|NCT02426567|Dietary Treatment|dietary treatment
185689|NCT02426567|Gut microbiota|gut microbiota
185690|NCT02426541|Diabetes Mellitus|diabetes mellitus
185691|NCT02426541|Dapagliflozin|dapagliflozin
185692|NCT02426541|Placebo|placebo
185693|NCT02426541|Insulin resistance|insulin resistance
185694|NCT02426541|Insulin sensitivity|insulin sensitivity
185695|NCT02426476|heart rate variability|heart rate variability
185696|NCT02426476|biofeedback|biofeedback
185697|NCT02426476|chronic pain|chronic pain
185698|NCT02426476|Veterans|veterans
185699|NCT02426463|Neonatal intensive care|neonatal intensive care
185700|NCT02426463|need for intratracheal intubation|need for intratracheal intubation
185701|NCT02426437|Acute Exacerbation of COPD (AECOPD)|acute exacerbation of copd (aecopd)
185702|NCT02426437|COPD|copd
185703|NCT02426437|Emphysema|emphysema
185704|NCT02426437|Chronic Bronchitis|chronic bronchitis
185705|NCT02426424|c-PAP|c-pap
185706|NCT02426398|EEG|eeg
185707|NCT02426372|Ulcerative Colitis|ulcerative colitis
185708|NCT02426372|Inflammatory Bowel Disease|inflammatory bowel disease
185709|NCT02426346|Adolescent; Adolescent obesity; Community-based; Overweight|adolescent; adolescent obesity; community-based; overweight
185710|NCT02426307|Thrombosis|thrombosis
185711|NCT02426307|Cardiovascular disease|cardiovascular disease
185712|NCT02426307|Oral anticoagulation|oral anticoagulation
185713|NCT02426307|bioprosthesis|bioprosthesis
185714|NCT02426307|Multidetector Computed Tomography|multidetector computed tomography
185715|NCT02426268|cardiac surgery|cardiac surgery
185716|NCT02426268|cerebral oximetry|cerebral oximetry
185717|NCT02426268|lower extremity oximetry|lower extremity oximetry
185718|NCT02426255|Severe trauma|severe trauma
185719|NCT02426255|traumatic Brain injury|traumatic brain injury
185720|NCT02426255|Hemorrhage|hemorrhage
185721|NCT02426242|brain-injury|brain-injury
185722|NCT02426242|extubation|extubation
185723|NCT02426229|SSc|ssc
185724|NCT02426229|systemic sclerosis|systemic sclerosis
185725|NCT02426229|cutaneous systemic sclerosis|cutaneous systemic sclerosis
185726|NCT02426216|prostate cancer|prostate cancer
185727|NCT02426216|chemoprevention|chemoprevention
185728|NCT02426216|biomarker|biomarker
185729|NCT02426203|Echocardiography|echocardiography
185730|NCT02426177|postpartum hypertension|postpartum hypertension
185731|NCT02426177|labetalol in postpartum hypertension|labetalol in postpartum hypertension
185732|NCT02426177|nifedipine in postpartum hypertension|nifedipine in postpartum hypertension
185733|NCT02426125|carcinoma of the bladder|carcinoma of the bladder
185734|NCT02426125|carcinoma of the urethra|carcinoma of the urethra
185735|NCT02426125|carcinoma the of ureter|carcinoma the of ureter
185736|NCT02426125|carcinoma of the renal pelvis|carcinoma of the renal pelvis
185737|NCT02426125|transitional cell carcinoma|transitional cell carcinoma
185738|NCT02426125|transitional cell tumor|transitional cell tumor
185739|NCT02426125|RANGE|range
185740|NCT02426125|bladder cancer|bladder cancer
185741|NCT02426099|Resistant hypertension|resistant hypertension
185742|NCT02426099|diabetes mellitus|diabetes mellitus
185743|NCT02426099|Spironolactone|spironolactone
185744|NCT02426099|African|african
185745|NCT02426086|Myelofibrosis|myelofibrosis
185746|NCT02426086|JNJ-63935937|jnj-63935937
185747|NCT02426086|Imetelstat|imetelstat
185748|NCT02426073|Inflammaging|inflammaging
185749|NCT02426047|seizures|seizures
185750|NCT02426047|epilepsy|epilepsy
185751|NCT02426047|catamenial|catamenial
185752|NCT02426047|ketogenic diet|ketogenic diet
185753|NCT02426047|modified Atkins diet|modified atkins diet
185754|NCT02426047|intractable epilepsy|intractable epilepsy
185755|NCT02426047|medically refractory epilepsy|medically refractory epilepsy
185756|NCT02426047|adult|adult
185757|NCT02426047|medium chain triglyceride|medium chain triglyceride
185758|NCT02426034|Advanced|advanced
185759|NCT02426034|Metastatic|metastatic
185760|NCT02425995|ACL|acl
185761|NCT02425995|Hidden lesions of the medial meniscus|hidden lesions of the medial meniscus
185762|NCT02425995|Chronic knee instability|chronic knee instability
185763|NCT02425995|Intercondylar and posteromedial arthroscopy|intercondylar and posteromedial arthroscopy
185764|NCT02425995|Arthroscopic Posteromedial and Intercondylar portal|arthroscopic posteromedial and intercondylar portal
185765|NCT02425995|Diagnosis capacity of hidden lesions of the medial meniscus|diagnosis capacity of hidden lesions of the medial meniscus
185766|NCT02425982|Tennis Elbow|tennis elbow
185767|NCT02425982|Lateral elbow pain|lateral elbow pain
185768|NCT02425982|Latera epicondylitis|latera epicondylitis
185769|NCT02425930|gastric cancer|gastric cancer
185770|NCT02425930|complement system|complement system
185771|NCT02425930|overal survival|overal survival
185772|NCT02425904|Langerhans Cell Histiocytosis|langerhans cell histiocytosis
185773|NCT02425865|UC, IBD|uc, ibd
185774|NCT02425839|shear wave elastography|shear wave elastography
185775|NCT02425839|surface electromyogram|surface electromyogram
185776|NCT02425839|masseter|masseter
185777|NCT02425826|Parapsoriasis|parapsoriasis
185778|NCT02425826|Plaque Psoriasis|plaque psoriasis
185779|NCT02425826|CC-10004|cc-10004
185780|NCT02425826|Apremilast|apremilast
185781|NCT02425826|Moderate Plaque Psoriasis|moderate plaque psoriasis
185782|NCT02425826|Safety|safety
185783|NCT02425787|Loss of a child|loss of a child
185784|NCT02425787|Grief|grief
185785|NCT02425774|Prucalopride|prucalopride
185786|NCT02425774|Vagus Nerve Stimulation|vagus nerve stimulation
185787|NCT02425774|Postoperative Ileus|postoperative ileus
185788|NCT02425761|Cerebrospinal Fluid Shunts|cerebrospinal fluid shunts
185789|NCT02425761|Randomized Controlled Trial|randomized controlled trial
185790|NCT02425748|γδ T Cell, non small lung cancer, Without EGFR Mutation|γδ t cell, non small lung cancer, without egfr mutation
185791|NCT02425735|Immunotherapy, γδ T Cell, heptocellular liver cancer|immunotherapy, γδ t cell, heptocellular liver cancer
185792|NCT02425722|ASP0456|asp0456
185793|NCT02425722|linaclotide|linaclotide
185794|NCT02425722|chronic constipation|chronic constipation
185795|NCT02425696|right-to-left shunt|right-to-left shunt
185796|NCT02425696|contrast-enhanced transcranial Doppler|contrast-enhanced transcranial doppler
185797|NCT02425696|migraine|migraine
185798|NCT02425696|silent cerebral infarction|silent cerebral infarction
185799|NCT02425683|Colon Cancer|colon cancer
185800|NCT02425683|Rectal Cancer|rectal cancer
185801|NCT02425683|Colorectal Cancer|colorectal cancer
185802|NCT02425683|Stage IIIC Colorectal Cancer|stage iiic colorectal cancer
185803|NCT02425670|Brain attack|brain attack
185804|NCT02425670|stroke|stroke
185805|NCT02425670|Ischemic stroke|ischemic stroke
185806|NCT02425670|stem cell therapy|stem cell therapy
185807|NCT02425657|Education|education
185808|NCT02425657|Training|training
185809|NCT02425657|Fast track|fast track
185810|NCT02425657|Colonoscopy|colonoscopy
185811|NCT02425644|relapsing multiple sclerosis|relapsing multiple sclerosis
185812|NCT02425631|SI joint fusion|si joint fusion
185813|NCT02425631|SI joint pain|si joint pain
185814|NCT02425631|SI joint|si joint
185815|NCT02425631|SI joint treatment|si joint treatment
185816|NCT02425631|SI joint disease|si joint disease
185817|NCT02425631|Sacroiliac joint|sacroiliac joint
185818|NCT02425631|Simmetry|simmetry
185819|NCT02425566|autonomic nervous system|autonomic nervous system
185820|NCT02425566|hypertension|hypertension
185821|NCT02425566|ganglionic blocker|ganglionic blocker
185822|NCT02425566|trimethaphan|trimethaphan
185823|NCT02425566|splanchnic circulation|splanchnic circulation
185824|NCT02425566|capacitance|capacitance
185825|NCT02425553|Diet|diet
185826|NCT02425553|Reflux|reflux
185827|NCT02425553|Dyspepsia|dyspepsia
185828|NCT02425553|Symptoms|symptoms
185829|NCT02425553|Alcohol|alcohol
185830|NCT02425540|Pelvic MRI|pelvic mri
185831|NCT02425527|Brain Injuries|brain injuries
185832|NCT02425527|Traumatic Brain Injury|traumatic brain injury
185833|NCT02425527|Video Games|video games
185834|NCT02425514|Anterior cervical discectomy and fusion|anterior cervical discectomy and fusion
185835|NCT02425514|NovoMax|novomax
185836|NCT02425514|Bioactive Glass-ceramic Intervertebral Spacer|bioactive glass-ceramic intervertebral spacer
185837|NCT02425501|Aflibercept|aflibercept
185838|NCT02425501|anti-VEGF|anti-vegf
185839|NCT02425488|Nursing|nursing
185840|NCT02425488|Outcome and Process Assessment|outcome and process assessment
185841|NCT02425488|Cardiac Resynchronization Therapy Devices|cardiac resynchronization therapy devices
185842|NCT02425488|Heart Failure|heart failure
185843|NCT02425488|Education|education
185844|NCT02425475|Dermoscopy|dermoscopy
185845|NCT02425449|succinylcholine|succinylcholine
185846|NCT02425449|depolarizing muscle relaxants|depolarizing muscle relaxants
185847|NCT02425449|pharmacologic effects|pharmacologic effects
185848|NCT02425410|Diabetes Mellitus|diabetes mellitus
185849|NCT02425410|Insulin-Dependent|insulin-dependent
185850|NCT02425410|Virus Diseases|virus diseases
185851|NCT02425410|Questionnaires|questionnaires
185852|NCT02425410|Risk assessment|risk assessment
185853|NCT02425410|Genome-Wide Association Study|genome-wide association study
185854|NCT02425397|Ototoxicity|ototoxicity
185855|NCT02425397|platinum derivatives|platinum derivatives
185856|NCT02425397|paediatrics|paediatrics
185857|NCT02425397|oncology|oncology
185858|NCT02425397|clinical research|clinical research
185859|NCT02425384|adolescent|adolescent
185860|NCT02425384|physical activity|physical activity
185861|NCT02425384|accelerometer|accelerometer
185862|NCT02425358|cell therapy|cell therapy
185863|NCT02425358|BMC|bmc
185864|NCT02425358|timing|timing
185865|NCT02425345|Physical Activity|physical activity
185866|NCT02425345|National Institute of Aging Go4Life|national institute of aging go4life
185867|NCT02425345|Postmenopausal Women|postmenopausal women
185868|NCT02425345|Balance|balance
185869|NCT02425345|Strength|strength
185870|NCT02425345|Exercise|exercise
185871|NCT02425345|Cardiovascular Disease|cardiovascular disease
185872|NCT02425345|Stroke|stroke
185873|NCT02425345|Mortality|mortality
185874|NCT02425345|Myocardial Infarction|myocardial infarction
185875|NCT02425345|Falls|falls
185876|NCT02425345|Venous Thromboembolic Event|venous thromboembolic event
185877|NCT02425345|Peripheral Artery Disease|peripheral artery disease
185878|NCT02425345|Physical Function|physical function
185879|NCT02425345|Mobility|mobility
185880|NCT02425345|Coronary Artery Bypass Graft (CABG)|coronary artery bypass graft (cabg)
185881|NCT02425345|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
185882|NCT02425345|Hip Fractures|hip fractures
185883|NCT02425345|Cardiovascular Mortality|cardiovascular mortality
185884|NCT02425332|Spinal Cord Injury|spinal cord injury
185885|NCT02425332|adaptive control|adaptive control
185886|NCT02425332|assessment|assessment
185887|NCT02425332|assist-as-needed|assist-as-needed
185888|NCT02425332|walking ability|walking ability
185889|NCT02425332|Lokomat|lokomat
185890|NCT02425306|peptide|peptide
185891|NCT02425306|vaccine|vaccine
185892|NCT02425306|adjuvant|adjuvant
185893|NCT02425306|polyICLC|polyiclc
185894|NCT02425306|cyclophosphamide|cyclophosphamide
185895|NCT02425306|Montanide ISA-51|montanide isa-51
185896|NCT02425267|Telerehabilitation|telerehabilitation
185897|NCT02425241|Vaccine|vaccine
185898|NCT02425241|DNA|dna
185899|NCT02425241|HIV-1|hiv-1
185900|NCT02425241|Serum amyloid P component (SAP)|serum amyloid p component (sap)
185901|NCT02425241|Clinical trial|clinical trial
185902|NCT02425241|Vaccination|vaccination
185903|NCT02425241|Prophylaxis|prophylaxis
185904|NCT02425241|Adult male|adult male
185905|NCT02425228|targeted biopsy|targeted biopsy
185906|NCT02425228|conventional biopsy|conventional biopsy
185907|NCT02425228|cognitive biopsy|cognitive biopsy
185908|NCT02425215|Hyperbaric Oxygen Treatment|hyperbaric oxygen treatment
185909|NCT02425215|Late radiation injury|late radiation injury
185910|NCT02425215|Adult|adult
185911|NCT02425215|Malignancy|malignancy
185912|NCT02425215|Quality of Life|quality of life
185913|NCT02425215|Chronic Pain|chronic pain
185914|NCT02425202|pediatric|pediatric
185915|NCT02425202|obstructive sleep apnea|obstructive sleep apnea
185916|NCT02425202|tonsillectomy|tonsillectomy
185917|NCT02425202|analgesia|analgesia
185918|NCT02425176|botulinum toxin|botulinum toxin
185919|NCT02425176|sialorrhoea|sialorrhoea
185920|NCT02425176|drooling|drooling
185921|NCT02425163|Prostate Cancer|prostate cancer
185922|NCT02425163|Shear Wave Elastography|shear wave elastography
185923|NCT02425163|Prostate|prostate
185924|NCT02425163|Prostate Biopsy|prostate biopsy
185925|NCT02425150|Keratoconus|keratoconus
185926|NCT02425150|Corneal crosslinking|corneal crosslinking
185927|NCT02425150|Corneal biomechanics|corneal biomechanics
185928|NCT02425150|Corneal densitometry|corneal densitometry
185929|NCT02425150|Scheimpflug photography|scheimpflug photography
185930|NCT02425111|Drug therapy|drug therapy
185931|NCT02425098|Drug therapy|drug therapy
185932|NCT02425085|retinectomy|retinectomy
185933|NCT02425085|endodiathermy|endodiathermy
185934|NCT02425085|inferior|inferior
185935|NCT02425085|retinal redetachment|retinal redetachment
185936|NCT02425072|Cancer|cancer
185937|NCT02425072|Brain|brain
185938|NCT02425072|Lung|lung
185939|NCT02425072|Small-cell|small-cell
185940|NCT02425059|irreversible electroporation|irreversible electroporation
185941|NCT02425059|Unresectable Rectal Neoplasms|unresectable rectal neoplasms
185942|NCT02425046|family|family
185943|NCT02425033|POEM|poem
185944|NCT02425033|Minimally invasive surgery|minimally invasive surgery
185945|NCT02425033|Achalasia|achalasia
185946|NCT02425033|Spastic esophageal disorders|spastic esophageal disorders
185947|NCT02425020|Supplement|supplement
185948|NCT02425020|performance|performance
185949|NCT02425020|whey|whey
185950|NCT02425020|meat|meat
185951|NCT02425020|protein|protein
185952|NCT02424994|Morbidity|morbidity
185953|NCT02424994|Mortality|mortality
185954|NCT02424994|Health care utilization|health care utilization
185955|NCT02424994|Cohort|cohort
185956|NCT02424994|Epidemiology|epidemiology
185957|NCT02424994|Cardiovascular diseases|cardiovascular diseases
185958|NCT02424968|Healthy Stem Cell Donor|healthy stem cell donor
185959|NCT02424955|Liver cancer|liver cancer
185960|NCT02424955|Hepatocellular Carcinoma|hepatocellular carcinoma
185961|NCT02424955|Liver imaging|liver imaging
185962|NCT02424955|Stereotactic Ablative Radiotherapy|stereotactic ablative radiotherapy
185963|NCT02424955|SABR|sabr
185964|NCT02424929|Deep Brain Stimulation|deep brain stimulation
185965|NCT02424916|Onco-dermatology|onco-dermatology
185966|NCT02424916|Adoptive transfer|adoptive transfer
185967|NCT02424916|Immunotherapy|immunotherapy
185968|NCT02424903|infection|infection
185969|NCT02424903|prosthesis|prosthesis
185970|NCT02424903|hip|hip
185971|NCT02424903|knee|knee
185972|NCT02424903|shoulder|shoulder
185973|NCT02424877|rheumatoid arthritis|rheumatoid arthritis
185974|NCT02424877|drug treatment|drug treatment
185975|NCT02424877|compliance|compliance
185976|NCT02424877|outcome|outcome
185977|NCT02424864|4D PET-CT|4d pet-ct
185978|NCT02424851|myeloma|myeloma
185979|NCT02424851|multiple myeloma|multiple myeloma
185980|NCT02424851|chronic kidney disease|chronic kidney disease
185981|NCT02424851|renal failure|renal failure
185982|NCT02424851|bortezomib|bortezomib
185983|NCT02424851|Velcade|velcade
185984|NCT02424851|thalidomide|thalidomide
185985|NCT02424851|bendamustine|bendamustine
185986|NCT02424851|dexamethasone|dexamethasone
185987|NCT02424851|serum free light chains|serum free light chains
185988|NCT02424851|proteosomal inhibition|proteosomal inhibition
185989|NCT02424851|immunomodulatory|immunomodulatory
185990|NCT02424825|diet|diet
185991|NCT02424825|cooking|cooking
185992|NCT02424825|multiple sclerosis|multiple sclerosis
185993|NCT02424825|fatigue|fatigue
185994|NCT02424812|handwashing|handwashing
185995|NCT02424812|behavior|behavior
185996|NCT02424799|Urticaria|urticaria
185997|NCT02424799|SYK Inhibitor|syk inhibitor
185998|NCT02424786|Adherence|adherence
185999|NCT02424786|Polypharmacy|polypharmacy
186000|NCT02424786|Elderly|elderly
186001|NCT02424786|Chronic kidney disease|chronic kidney disease
186002|NCT02424734|Late-onset Sepsis|late-onset sepsis
186003|NCT02424708|Reduced Glutathione|reduced glutathione
186004|NCT02424708|Intranasal|intranasal
186005|NCT02424708|(in)GSH|(in)gsh
186006|NCT02424708|Parkinson's Disease|parkinson's disease
186007|NCT02424708|Glutathione|glutathione
186008|NCT02424708|Uptake|uptake
186009|NCT02424708|central nervous system|central nervous system
186010|NCT02424695|Cortical arousal intensity|cortical arousal intensity
186011|NCT02424695|RLS|rls
186012|NCT02424695|Heart rate|heart rate
186013|NCT02424695|Blood pressure|blood pressure
186014|NCT02424695|PLMs|plms
186015|NCT02424630|sono-guided interscalene brachial plexus block|sono-guided interscalene brachial plexus block
186016|NCT02424630|arthroscopy-guided suprascapular nerve block|arthroscopy-guided suprascapular nerve block
186017|NCT02424630|arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
186018|NCT02424630|postoperative pain|postoperative pain
186019|NCT02424591|Anesthesia Recovery Period|anesthesia recovery period
186020|NCT02424591|Spinal Fusion|spinal fusion
186021|NCT02424552|severe asthma|severe asthma
186022|NCT02424552|vitamin D|vitamin d
186023|NCT02424552|treatment|treatment
186024|NCT02424539|Seasonal|seasonal
186025|NCT02424539|Fluticasone Furoate|fluticasone furoate
186026|NCT02424539|Perennial|perennial
186027|NCT02424539|Allergic Rhinitis|allergic rhinitis
186028|NCT02424539|Nasal Spray|nasal spray
186029|NCT02424526|cerebral palsy|cerebral palsy
186030|NCT02424526|treadmill training|treadmill training
186031|NCT02424526|walking|walking
186032|NCT02424487|Initial pressure|initial pressure
186033|NCT02424487|changes of intracuff pressure|changes of intracuff pressure
186034|NCT02424487|infants and children|infants and children
186035|NCT02424474|cell free fetal DNA|cell free fetal dna
186036|NCT02424474|general population|general population
186037|NCT02424474|screening|screening
186038|NCT02424474|trisomy 21|trisomy 21
186039|NCT02424474|IVF|ivf
186040|NCT02424435|Friedreich Ataxia|friedreich ataxia
186041|NCT02424435|FRDA|frda
186042|NCT02424422|Corrective Orthodontics|corrective orthodontics
186043|NCT02424422|CBCT|cbct
186044|NCT02424422|Rapid Maxillary Expansion|rapid maxillary expansion
186045|NCT02424422|Cone Beam Computed Tomography|cone beam computed tomography
186046|NCT02424422|Hyrax Expansion|hyrax expansion
186047|NCT02424422|Craniofacial Sutures|craniofacial sutures
186048|NCT02424409|Asthma|asthma
186049|NCT02424409|Relapse|relapse
186050|NCT02424409|Therapeutic counselling|therapeutic counselling
186051|NCT02424409|Protocol of care|protocol of care
186052|NCT02424396|Interleukin 2, IL2|interleukin 2, il2
186053|NCT02424396|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
186054|NCT02424396|Autoimmune diseases|autoimmune diseases
186055|NCT02424396|Regulatory T cells, Tregs|regulatory t cells, tregs
186056|NCT02424370|Aortic stenosis|aortic stenosis
186057|NCT02424370|TAVR|tavr
186058|NCT02424370|Frailty|frailty
186059|NCT02424370|Elderly|elderly
186060|NCT02424357|Adjustable strabismus surgery|adjustable strabismus surgery
186061|NCT02424357|suture contamination|suture contamination
186062|NCT02424357|5%povidone iodine|5%povidone iodine
186063|NCT02424344|COPD|copd
186064|NCT02424331|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
186065|NCT02424331|Respiratory mechanics|respiratory mechanics
186066|NCT02424331|Plethysmography|plethysmography
186067|NCT02424331|Diaphragm|diaphragm
186068|NCT02424331|Respiratory muscles|respiratory muscles
186069|NCT02424331|Breathing exercises|breathing exercises
186070|NCT02424292|Breast cancer|breast cancer
186071|NCT02424292|Physcial activity/exercise|physcial activity/exercise
186072|NCT02424292|anti-hormonal treatment|anti-hormonal treatment
186073|NCT02424279|pancreatic cancer|pancreatic cancer
186074|NCT02424279|pain|pain
186075|NCT02424279|splanchnicectomy|splanchnicectomy
186076|NCT02424266|Tear film|tear film
186077|NCT02424266|Imaging|imaging
186078|NCT02424266|Tomogrophy|tomogrophy
186079|NCT02424266|dry eye|dry eye
186080|NCT02424201|uterine atony|uterine atony
186081|NCT02424175|Fecal Transplant|fecal transplant
186082|NCT02424175|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
186083|NCT02424175|Fecal Microbiota Transplantation|fecal microbiota transplantation
186084|NCT02424110|bipolar radiofrequency ablation|bipolar radiofrequency ablation
186085|NCT02424110|argon beam coagulator|argon beam coagulator
186086|NCT02424097|Prevention|prevention
186087|NCT02424071|melatonin's|melatonin's
186088|NCT02424071|quality of recovery|quality of recovery
186089|NCT02424032|Neck pain|neck pain
186090|NCT02424032|stabilization exercise|stabilization exercise
186091|NCT02424032|connective tissue massage|connective tissue massage
186092|NCT02424006|keratoplasty|keratoplasty
186093|NCT02424006|bioengineered cornea|bioengineered cornea
186094|NCT02424006|donor cornea|donor cornea
186095|NCT02423993|Type 1 diabetes mellitus|type 1 diabetes mellitus
186096|NCT02423993|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
186097|NCT02423993|Quality of life|quality of life
186098|NCT02423993|Therapeutic education|therapeutic education
186099|NCT02423993|Insulin pump|insulin pump
186100|NCT02423941|Liver Transplantation|liver transplantation
186101|NCT02423941|Retrograde Reperfusion|retrograde reperfusion
186102|NCT02423941|Graft dysfunction|graft dysfunction
186103|NCT02423941|Randomized study|randomized study
186104|NCT02423928|immunotherapy|immunotherapy
186105|NCT02423928|cryoablation|cryoablation
186106|NCT02423928|prostate cancer|prostate cancer
186107|NCT02423928|dendritic cell|dendritic cell
186108|NCT02423915|Leukemia|leukemia
186109|NCT02423915|Lymphoma|lymphoma
186110|NCT02423915|Advanced hematologic malignancies|advanced hematologic malignancies
186111|NCT02423915|Graft versus host disease|graft versus host disease
186112|NCT02423915|GVHD|gvhd
186113|NCT02423915|Fucosylated umbilical cord blood Regulatory T cells|fucosylated umbilical cord blood regulatory t cells
186114|NCT02423915|CB|cb
186115|NCT02423915|Tregs|tregs
186116|NCT02423915|T cells|t cells
186117|NCT02423915|Cord blood transplant|cord blood transplant
186118|NCT02423915|Total body radiation|total body radiation
186119|NCT02423915|TBI|tbi
186120|NCT02423915|Radiation therapy|radiation therapy
186121|NCT02423915|XRT|xrt
186122|NCT02423915|Rituximab|rituximab
186123|NCT02423915|Rituxan|rituxan
186124|NCT02423915|Fludarabine|fludarabine
186125|NCT02423915|Fludarabine phosphate|fludarabine phosphate
186126|NCT02423915|Fludara|fludara
186127|NCT02423915|Cyclophosphamide|cyclophosphamide
186128|NCT02423915|Cytoxan|cytoxan
186129|NCT02423915|Neosar|neosar
186130|NCT02423915|Mycophenolate|mycophenolate
186131|NCT02423915|Mycophenolate mofetil|mycophenolate mofetil
186132|NCT02423915|MMF|mmf
186133|NCT02423915|CellCept|cellcept
186134|NCT02423915|Sirolimus|sirolimus
186135|NCT02423915|Rapamune|rapamune
186136|NCT02423915|G-CSF|g-csf
186137|NCT02423915|Filgrastim|filgrastim
186138|NCT02423915|Neupogen|neupogen
186241|NCT02423356|doxorubicin|doxorubicin
186139|NCT02423889|Hypofractionated radiotherapy|hypofractionated radiotherapy
186140|NCT02423889|SBRT|sbrt
186141|NCT02423863|Cancer|cancer
186142|NCT02423863|Immunotherapy|immunotherapy
186143|NCT02423863|Intratumoral Injection|intratumoral injection
186144|NCT02423863|Multicenter Study|multicenter study
186145|NCT02423863|Autovaccination|autovaccination
186146|NCT02423863|Solid Tumors|solid tumors
186147|NCT02423850|Diabetic foot ulcers|diabetic foot ulcers
186148|NCT02423850|Leg ulcers|leg ulcers
186149|NCT02423850|Ulcer healing|ulcer healing
186150|NCT02423850|Ulcer measurement|ulcer measurement
186151|NCT02423850|Ulcer area|ulcer area
186152|NCT02423850|Ulcer volume|ulcer volume
186153|NCT02423850|3D measurement|3d measurement
186154|NCT02423837|follicular lymphoma|follicular lymphoma
186155|NCT02423837|bendamustine|bendamustine
186156|NCT02423837|rituximab|rituximab
186157|NCT02423798|Diabetes|diabetes
186158|NCT02423798|Glucose sensor|glucose sensor
186159|NCT02423798|Sensor accuracy and performance|sensor accuracy and performance
186160|NCT02423798|CGM|cgm
186161|NCT02423759|Chemoprevention|chemoprevention
186162|NCT02423733|depression|depression
186163|NCT02423733|dysthymia|dysthymia
186164|NCT02423733|cognitive behavioural therapy|cognitive behavioural therapy
186165|NCT02423733|CBT|cbt
186166|NCT02423733|problem-solving therapy|problem-solving therapy
186167|NCT02423733|PST|pst
186168|NCT02423733|waitlist|waitlist
186169|NCT02423733|secondary mental health care|secondary mental health care
186170|NCT02423733|mental health|mental health
186171|NCT02423733|e-therapy|e-therapy
186172|NCT02423733|computerized therapy|computerized therapy
186173|NCT02423668|cataract surgery|cataract surgery
186174|NCT02423668|biometry|biometry
186175|NCT02423668|second eye refinement|second eye refinement
186176|NCT02423668|effective lens position|effective lens position
186177|NCT02423642|Acute Kidney Injury Requiring Continuous Renal Replacement Therapy|acute kidney injury requiring continuous renal replacement therapy
186178|NCT02423616|MIP|mip
186179|NCT02423616|Hand Grip|hand grip
186180|NCT02423616|Correlation|correlation
186181|NCT02423616|Inspiratory Pressure|inspiratory pressure
186182|NCT02423616|Hand Grip Force|hand grip force
186183|NCT02423603|Triple Negative Breast Cancer|triple negative breast cancer
186184|NCT02423603|Metastatic|metastatic
186185|NCT02423603|AKT Inhibitor|akt inhibitor
186186|NCT02423603|Advanced|advanced
186187|NCT02423603|AZD5363|azd5363
186188|NCT02423603|Paclitaxel|paclitaxel
186189|NCT02423603|PAKT|pakt
186190|NCT02423590|Squamous|squamous
186191|NCT02423590|Lung|lung
186192|NCT02423590|Apatorsen|apatorsen
186193|NCT02423577|antiviral|antiviral
186194|NCT02423577|influenza|influenza
186195|NCT02423577|challenge|challenge
186196|NCT02423564|Probiotic|probiotic
186197|NCT02423564|Digesta-Lac|digesta-lac
186198|NCT02423564|Occasional Constipation|occasional constipation
186199|NCT02423564|Constipation|constipation
186200|NCT02423551|Gut microbiota|gut microbiota
186201|NCT02423551|Intestinal permeability|intestinal permeability
186202|NCT02423551|Gut barrier integrity|gut barrier integrity
186203|NCT02423525|glioblastoma|glioblastoma
186204|NCT02423525|astrocytoma|astrocytoma
186205|NCT02423525|oligodendroglioma|oligodendroglioma
186206|NCT02423525|mixed oligoastrocytoma|mixed oligoastrocytoma
186207|NCT02423525|low grade gliomas|low grade gliomas
186208|NCT02423525|brain metastases|brain metastases
186209|NCT02423525|meningiomas|meningiomas
186210|NCT02423525|leptomeningeal metastases|leptomeningeal metastases
186211|NCT02423512|Inflammatory Bowel Diseases|inflammatory bowel diseases
186212|NCT02423512|Vedolizumab|vedolizumab
186213|NCT02423512|Ulcerative Colitis|ulcerative colitis
186214|NCT02423512|Crohn's Disease|crohn's disease
186215|NCT02423512|MADCAM1|madcam1
186216|NCT02423512|integrin alpha4beta7|integrin alpha4beta7
186217|NCT02423499|Autism Spectrum Disorder|autism spectrum disorder
186218|NCT02423499|Bipolar Disorder|bipolar disorder
186219|NCT02423499|Emotions|emotions
186220|NCT02423460|Ulcerative Colitis|ulcerative colitis
186221|NCT02423460|Healthy Controls|healthy controls
186222|NCT02423460|Crohn's Disease|crohn's disease
186223|NCT02423434|Corneal Confocal Microscopy|corneal confocal microscopy
186224|NCT02423434|Diabetes Mellitus|diabetes mellitus
186225|NCT02423434|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
186226|NCT02423434|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
186227|NCT02423434|Diabetic Neuropathy|diabetic neuropathy
186228|NCT02423434|Diabetes Complications|diabetes complications
186229|NCT02423382|silicone oil|silicone oil
186230|NCT02423382|retinal saturation|retinal saturation
186231|NCT02423382|retinal blood flow|retinal blood flow
186232|NCT02423382|retinal detachment|retinal detachment
186233|NCT02423369|S-100B protein|s-100b protein
186234|NCT02423369|Neuron-specific Enolase|neuron-specific enolase
186235|NCT02423356|breast cancer|breast cancer
186236|NCT02423356|sarcoma|sarcoma
186237|NCT02423356|lymphoma|lymphoma
186238|NCT02423356|echocardiography|echocardiography
186239|NCT02423356|cardiotoxicity|cardiotoxicity
186240|NCT02423356|pharmacogenetics|pharmacogenetics
186242|NCT02423356|chemotherapy|chemotherapy
186243|NCT02423291|PMLBCL|pmlbcl
186244|NCT02423291|Brentuximab Vedotin|brentuximab vedotin
186245|NCT02423291|CD30-positive|cd30-positive
186246|NCT02423291|Mediastinal Lymphoma|mediastinal lymphoma
186247|NCT02423278|gastrectomy|gastrectomy
186248|NCT02423278|lymphadenectomy|lymphadenectomy
186249|NCT02423278|gastric cancer|gastric cancer
186250|NCT02423278|adjuvant chemotherapy|adjuvant chemotherapy
186251|NCT02423278|overall survival|overall survival
186252|NCT02423265|Chronic total coronary occlusions|chronic total coronary occlusions
186253|NCT02423265|Ranolazine|ranolazine
186254|NCT02423252|Critical illness|critical illness
186255|NCT02423252|Intervention|intervention
186256|NCT02423252|RCT|rct
186257|NCT02423252|Relaxation|relaxation
186258|NCT02423252|Guided imagery|guided imagery
186259|NCT02423252|Touch/Massage|touch/massage
186260|NCT02423252|Music listening|music listening
186261|NCT02423252|Neuropeptides|neuropeptides
186262|NCT02423252|Inflammatory molecules|inflammatory molecules
186263|NCT02423252|Post-traumatic stress|post-traumatic stress
186264|NCT02423252|Critical care nurse|critical care nurse
186265|NCT02423252|Psychocognitive nursing intervention|psychocognitive nursing intervention
186266|NCT02423252|Interpersonal support|interpersonal support
186267|NCT02423213|OCT|oct
186268|NCT02423213|image-guided surgery|image-guided surgery
186269|NCT02423213|ophthalmic surgery|ophthalmic surgery
186270|NCT02423187|Stomach ulcer|stomach ulcer
186271|NCT02423187|Duodenal ulcer|duodenal ulcer
186272|NCT02423187|Rabeprazole|rabeprazole
186273|NCT02423187|Recurrence|recurrence
186274|NCT02423161|OCT|oct
186275|NCT02423161|image-guided surgery|image-guided surgery
186276|NCT02423161|vitreoretinal surgery|vitreoretinal surgery
186277|NCT02423161|corneal surgery|corneal surgery
186278|NCT02423148|Lung Cancer|lung cancer
186279|NCT02423096|biomarker|biomarker
186280|NCT02423096|neuroendocrine|neuroendocrine
186281|NCT02423096|metabolite|metabolite
186282|NCT02423096|cognitive functioning|cognitive functioning
186283|NCT02423096|clinical symptoms|clinical symptoms
186284|NCT02423096|schizophrenia|schizophrenia
186285|NCT02423083|Neuroprotection|neuroprotection
186286|NCT02423083|Multiple Sclerosis|multiple sclerosis
186287|NCT02423083|Clinical Trial|clinical trial
186288|NCT02423083|Safety and Tolerability|safety and tolerability
186289|NCT02423070|Cell-free DNA|cell-free dna
186290|NCT02423070|Acute Rejection|acute rejection
186291|NCT02423070|Thoracic Organ Transplantation|thoracic organ transplantation
186292|NCT02423070|Non-Invasive Testing|non-invasive testing
186293|NCT02423070|Chronic Rejection|chronic rejection
186294|NCT02423057|Pharmacodynamics|pharmacodynamics
186295|NCT02423057|DNA Methylation|dna methylation
186296|NCT02423057|Pharmacokinetics|pharmacokinetics
186297|NCT02423057|Nucleoside Analogue|nucleoside analogue
186298|NCT02423057|Epigenetics|epigenetics
186299|NCT02423044|Anxiety|anxiety
186300|NCT02423044|fMRI|fmri
186301|NCT02423044|Virtual Reality|virtual reality
186302|NCT02423044|Shock Threat|shock threat
186303|NCT02423044|Healthy Volunteer|healthy volunteer
186304|NCT02423031|Physiological Measures|physiological measures
186305|NCT02423031|Emotional Context|emotional context
186306|NCT02423031|Pediatric|pediatric
186307|NCT02423031|Distresss Screening|distresss screening
186308|NCT02423005|Stress urinary incontinence|stress urinary incontinence
186309|NCT02423005|Neurotech Vital Compact|neurotech vital compact
186310|NCT02423005|1h Provacative Pad Test|1h provacative pad test
186311|NCT02423005|Neuroelectrical Muscle Stimulation (NEMS)|neuroelectrical muscle stimulation (nems)
186312|NCT02422992|Iron metabolism|iron metabolism
186313|NCT02422992|MRI|mri
186314|NCT02422992|risk factors|risk factors
186315|NCT02422992|haptoglobin phenotype|haptoglobin phenotype
186316|NCT02422953|Stunting|stunting
186317|NCT02422953|Wasting|wasting
186318|NCT02422953|Underweight|underweight
186319|NCT02422927|C-Reactive Protein|c-reactive protein
186320|NCT02422927|Endothelial Microparticles|endothelial microparticles
186321|NCT02422927|Endothelium|endothelium
186322|NCT02422927|Nutraceutical|nutraceutical
186323|NCT02422927|Cholesterol|cholesterol
186324|NCT02422888|ST elevation myocardial infarction|st elevation myocardial infarction
186325|NCT02422888|Percutaneous coronary intervention|percutaneous coronary intervention
186326|NCT02422888|Endothelial function|endothelial function
186327|NCT02422888|Ticagrelor|ticagrelor
186328|NCT02422888|Prasugrel|prasugrel
186329|NCT02422875|Sjögren's Syndrome|sjögren's syndrome
186330|NCT02422875|Scleroderma|scleroderma
186331|NCT02422875|Myositis|myositis
186332|NCT02422875|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
186333|NCT02422875|Rheumatoid Arthritis|rheumatoid arthritis
186334|NCT02422875|Inflammatory Arthritis|inflammatory arthritis
186335|NCT02422875|Undifferentiated Connective Tissue Disease|undifferentiated connective tissue disease
186336|NCT02422875|Idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
186337|NCT02422875|Graft vs Host Disease|graft vs host disease
186338|NCT02422875|Autoimmune Lymphoproliferative Syndrome|autoimmune lymphoproliferative syndrome
186339|NCT02422875|Immunoglobulin G4 (IgG4)-related disease|immunoglobulin g4 (igg4)-related disease
186340|NCT02422875|Hepatitis C|hepatitis c
186341|NCT02422875|Epstein Barr Virus (infectious mononucleosis - EBV)|epstein barr virus (infectious mononucleosis - ebv)
186342|NCT02422875|Sepsis|sepsis
186343|NCT02422875|Guillain-Barre syndrome|guillain-barre syndrome
186344|NCT02422875|Mycoplasma pneumoniae|mycoplasma pneumoniae
186345|NCT02422875|Human Immunodeficiency Virus|human immunodeficiency virus
186346|NCT02422862|Physiotherapy|physiotherapy
186347|NCT02422862|Manual Therapy|manual therapy
186348|NCT02422849|Patient admission|patient admission
186349|NCT02422836|photodamage|photodamage
186350|NCT02422836|fine lines|fine lines
186351|NCT02422836|wrinkles|wrinkles
186352|NCT02422836|dyschromia|dyschromia
186353|NCT02422823|anesthesia|anesthesia
186354|NCT02422823|volumes|volumes
186355|NCT02422823|articaine|articaine
186356|NCT02422823|Inferior alveolar nerve block|inferior alveolar nerve block
186357|NCT02422797|HIV|hiv
186358|NCT02422797|NNRTI-sparing|nnrti-sparing
186359|NCT02422797|two-drug regimen|two-drug regimen
186360|NCT02422797|nucleoside reverse transcriptase inhibitors|nucleoside reverse transcriptase inhibitors
186361|NCT02422797|protease inhibitor|protease inhibitor
186362|NCT02422797|integrase inhibitor|integrase inhibitor
186363|NCT02422797|non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
186364|NCT02422797|dolutegravir plus rilpivirine|dolutegravir plus rilpivirine
186365|NCT02422797|virologically-suppressed|virologically-suppressed
186366|NCT02422784|Vitamin D insufficient|vitamin d insufficient
186367|NCT02422784|rooibos tea|rooibos tea
186368|NCT02422784|calcium|calcium
186369|NCT02422758|hypothermia|hypothermia
186370|NCT02422758|perioperative nursing|perioperative nursing
186371|NCT02422758|prewarming|prewarming
186372|NCT02422758|prevention and control|prevention and control
186373|NCT02422745|Cocoa extract multivitamins cardiovascular disease cancer|cocoa extract multivitamins cardiovascular disease cancer
186374|NCT02422732|NF1|nf1
186375|NCT02422732|Children|children
186376|NCT02422732|Reading disability|reading disability
186377|NCT02422732|Morphological and functional MRI|morphological and functional mri
186378|NCT02422732|Genetic analysis|genetic analysis
186379|NCT02422719|Chronic myeloid leukemia|chronic myeloid leukemia
186380|NCT02422719|Intolerance|intolerance
186381|NCT02422719|Resitance|resitance
186382|NCT02422719|Radotinib|radotinib
186383|NCT02422693|hydrotherapy|hydrotherapy
186384|NCT02422693|aquatic|aquatic
186385|NCT02422680|Quality assurance|quality assurance
186386|NCT02422680|Caecum intubation rate|caecum intubation rate
186387|NCT02422680|Patient satisfaction|patient satisfaction
186388|NCT02422667|Orthopedics|orthopedics
186389|NCT02422667|Outcome Assessment|outcome assessment
186390|NCT02422628|EGFR inhibitor|egfr inhibitor
186391|NCT02422628|EGFR mutation|egfr mutation
186392|NCT02422628|EGFR|egfr
186393|NCT02422628|adenocarcinoma|adenocarcinoma
186394|NCT02422628|EGFR TKI|egfr tki
186395|NCT02422628|treatment|treatment
186396|NCT02422628|Non small cell|non small cell
186397|NCT02422615|HR-positive|hr-positive
186398|NCT02422615|HER2-negative|her2-negative
186399|NCT02422615|Advanced breast cancer|advanced breast cancer
186400|NCT02422615|LEE011|lee011
186401|NCT02422615|ribociclib|ribociclib
186402|NCT02422615|fulvestrant|fulvestrant
186403|NCT02422615|faslodex|faslodex
186404|NCT02422615|CDK|cdk
186405|NCT02422615|CDK4|cdk4
186406|NCT02422615|CDK6|cdk6
186407|NCT02422615|CDK4/6|cdk4/6
186408|NCT02422615|CDK4/6 inhibitor|cdk4/6 inhibitor
186409|NCT02422615|Phase III|phase iii
186410|NCT02422615|ER-positive|er-positive
186411|NCT02422615|PR-positive|pr-positive
186412|NCT02422615|Postmenopausal|postmenopausal
186413|NCT02422615|Men|men
186414|NCT02422602|Patients|patients
186415|NCT02422602|treated by Rivaroxaban|treated by rivaroxaban
186416|NCT02422589|ALK-positive advanced tumors,|alk-positive advanced tumors,
186417|NCT02422589|midazolam,|midazolam,
186418|NCT02422589|warfarin,|warfarin,
186419|NCT02422589|ceritinib,|ceritinib,
186420|NCT02422589|ALK,|alk,
186421|NCT02422589|CYP3A-4,|cyp3a-4,
186422|NCT02422589|Drug drug intereaction|drug drug intereaction
186423|NCT02422563|neoadjuvant chemotherapy|neoadjuvant chemotherapy
186424|NCT02422563|FIGO IB2, FIGO IIB|figo ib2, figo iib
186425|NCT02422563|chemo-radiation|chemo-radiation
186426|NCT02422563|dose dense chemotherapy|dose dense chemotherapy
186427|NCT02422563|cisplatin|cisplatin
186428|NCT02422563|paclitaxel|paclitaxel
186429|NCT02422563|carboplatin|carboplatin
186430|NCT02422563|ifosfamide|ifosfamide
186431|NCT02422550|MRI|mri
186432|NCT02422550|15-073|15-073
186433|NCT02422550|participants undergoing radiation therapy|participants undergoing radiation therapy
186434|NCT02422524|Hepatic|hepatic
186435|NCT02422524|impairment|impairment
186436|NCT02422524|PA-824|pa-824
186437|NCT02422524|Pharmacokinetics|pharmacokinetics
186438|NCT02422524|Safety|safety
186439|NCT02422524|Tuberculosis|tuberculosis
186440|NCT02422511|Genome Sequencing|genome sequencing
186441|NCT02422511|Exome Sequencing|exome sequencing
186442|NCT02422511|Newborn Screening|newborn screening
186546|NCT02421965|mHealth|mhealth
186443|NCT02422511|Childhood Onset Genetic Conditions|childhood onset genetic conditions
186444|NCT02422498|Treated with Concurrent Cisplatin|treated with concurrent cisplatin
186445|NCT02422498|Treated with Radiation Therapy|treated with radiation therapy
186446|NCT02422498|Homologous Recombination Repair Status|homologous recombination repair status
186447|NCT02422498|Biomarker of Response|biomarker of response
186448|NCT02422498|15-032|15-032
186449|NCT02422498|Patients|patients
186450|NCT02422485|Salsalate|salsalate
186451|NCT02422446|Endothelial function|endothelial function
186452|NCT02422446|Eicosapentaenoic acid|eicosapentaenoic acid
186453|NCT02422446|Triglycerides|triglycerides
186454|NCT02422433|EGD|egd
186455|NCT02422433|OFDI|ofdi
186456|NCT02422433|Barrett's Esophagus|barrett's esophagus
186457|NCT02422433|Imaging|imaging
186458|NCT02422420|Diabetes Prevention|diabetes prevention
186459|NCT02422420|Financial Incentives|financial incentives
186460|NCT02422420|Medicaid|medicaid
186461|NCT02422420|Motivation|motivation
186462|NCT02422381|NSCLC|nsclc
186463|NCT02422381|lung cancer|lung cancer
186464|NCT02422381|Gemzar|gemzar
186465|NCT02422381|Pembrolizumab|pembrolizumab
186466|NCT02422381|Anti-PD-1|anti-pd-1
186467|NCT02422381|Immunotherapy|immunotherapy
186468|NCT02422368|Graves' ophthalmopathy|graves' ophthalmopathy
186469|NCT02422368|Antioxidant|antioxidant
186470|NCT02422368|Activity|activity
186471|NCT02422368|Severity|severity
186472|NCT02422355|hip|hip
186473|NCT02422355|femoral neck|femoral neck
186474|NCT02422355|Garden classification|garden classification
186475|NCT02422355|healing|healing
186476|NCT02422355|cut-out|cut-out
186477|NCT02422355|iatrogenic fracture|iatrogenic fracture
186478|NCT02422355|implant|implant
186479|NCT02422355|rotational stability|rotational stability
186480|NCT02422355|minimal invasive|minimal invasive
186481|NCT02422329|Advanced Cancers|advanced cancers
186482|NCT02422329|Constipation|constipation
186483|NCT02422329|Recurrent cancer|recurrent cancer
186484|NCT02422329|Locally advanced cancer|locally advanced cancer
186485|NCT02422329|Metastatic cancer|metastatic cancer
186486|NCT02422329|Video|video
186487|NCT02422329|Fact sheet|fact sheet
186488|NCT02422329|Questionnaires|questionnaires
186489|NCT02422329|Surveys|surveys
186490|NCT02422303|Depression|depression
186491|NCT02422303|Gynecoligical surgery|gynecoligical surgery
186492|NCT02422303|Ketamine|ketamine
186493|NCT02422290|Obsessive Compulsive Disorder|obsessive compulsive disorder
186494|NCT02422290|Ketamine|ketamine
186495|NCT02422290|Glutamate|glutamate
186496|NCT02422290|OCD treatment|ocd treatment
186497|NCT02422290|OCD medication|ocd medication
186498|NCT02422277|Cystoprostatectomy|cystoprostatectomy
186499|NCT02422277|Sexual function|sexual function
186500|NCT02422277|Phosphodiestrase 5 inhibitors|phosphodiestrase 5 inhibitors
186501|NCT02422277|Low intensity extracorporeal shock wave therapy|low intensity extracorporeal shock wave therapy
186502|NCT02422277|Erectile dysfunction|erectile dysfunction
186503|NCT02422277|Penile rehabilitation|penile rehabilitation
186504|NCT02422212|metabolism|metabolism
186505|NCT02422212|Diet Induced Thermogenesis|diet induced thermogenesis
186506|NCT02422212|weight regain|weight regain
186507|NCT02422212|energy expenditure|energy expenditure
186508|NCT02422212|bariatric|bariatric
186509|NCT02422186|Depressive Disorder, Treatment-Resistant|depressive disorder, treatment-resistant
186510|NCT02422186|Esketamine|esketamine
186511|NCT02422186|Oral Antidepressant|oral antidepressant
186512|NCT02422186|Elderly Participants|elderly participants
186513|NCT02422134|Pregnancy|pregnancy
186514|NCT02422134|implantation|implantation
186515|NCT02422134|Cytokine|cytokine
186516|NCT02422108|RANKL|rankl
186517|NCT02422082|Osteopenia|osteopenia
186518|NCT02422082|Lactobacillus reuteri|lactobacillus reuteri
186519|NCT02422082|Volumetric bone mineral density|volumetric bone mineral density
186520|NCT02422056|Cleft Palate|cleft palate
186521|NCT02422056|Hemorrhage|hemorrhage
186522|NCT02422056|Palatoplasty|palatoplasty
186523|NCT02422043|adolescence|adolescence
186524|NCT02422030|Male Volunteers|male volunteers
186525|NCT02422017|Leg ulcer|leg ulcer
186526|NCT02422017|wound|wound
186527|NCT02422017|topical timolol|topical timolol
186528|NCT02422004|Rehabilitation|rehabilitation
186529|NCT02422004|Weight-bearing|weight-bearing
186530|NCT02422004|Range of motion|range of motion
186531|NCT02421978|Cognitive dysfunction|cognitive dysfunction
186532|NCT02421978|Inflammation|inflammation
186533|NCT02421978|Fatigue|fatigue
186534|NCT02421978|Decreased motivation|decreased motivation
186535|NCT02421965|Schizophrenia|schizophrenia
186536|NCT02421965|Schizoaffective Disorder|schizoaffective disorder
186537|NCT02421965|Bipolar Disorder|bipolar disorder
186538|NCT02421965|Major Depressive Disorder|major depressive disorder
186539|NCT02421965|Mobile Application|mobile application
186540|NCT02421965|Smartphone|smartphone
186541|NCT02421965|SMI|smi
186542|NCT02421965|Illness Self-Management|illness self-management
186543|NCT02421965|EHealth|ehealth
186544|NCT02421965|E-Health|e-health
186545|NCT02421965|Health Technology|health technology
186547|NCT02421965|m-Health|m-health
186548|NCT02421939|ASP2215|asp2215
186549|NCT02421939|Relapsed Acute Myeloid Leukemia|relapsed acute myeloid leukemia
186550|NCT02421939|FLT3 Mutation|flt3 mutation
186551|NCT02421939|gilteritinib|gilteritinib
186552|NCT02421939|Refractory Acute Myeloid Leukemia|refractory acute myeloid leukemia
186553|NCT02421939|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
186554|NCT02421874|Patient care team|patient care team
186555|NCT02421874|Care management|care management
186556|NCT02421874|Electronic health records|electronic health records
186557|NCT02421861|anxiety|anxiety
186558|NCT02421861|intensive care unit|intensive care unit
186559|NCT02421861|critical care|critical care
186560|NCT02421848|Body composition|body composition
186561|NCT02421848|Sarcopenia|sarcopenia
186562|NCT02421848|Cirrhotic with Ascites|cirrhotic with ascites
186563|NCT02421796|n Non-Celiac Wheat Sensitivity|n non-celiac wheat sensitivity
186564|NCT02421796|Malnutrition|malnutrition
186565|NCT02421796|Celiac disease|celiac disease
186566|NCT02421796|Irritable Bowel Syndrome|irritable bowel syndrome
186567|NCT02421783|Non-celiac wheat sensitivity|non-celiac wheat sensitivity
186568|NCT02421783|Multiple food allergy|multiple food allergy
186569|NCT02421783|Body mass index|body mass index
186570|NCT02421783|Osteoporosis|osteoporosis
186571|NCT02421757|Transcutaneous Magnetic Stimulation|transcutaneous magnetic stimulation
186572|NCT02421757|placebo|placebo
186573|NCT02421744|rehabilitation|rehabilitation
186574|NCT02421744|Multiple Sclerosis|multiple sclerosis
186575|NCT02421744|mobility|mobility
186576|NCT02421744|gait|gait
186577|NCT02421744|task-oriented training|task-oriented training
186578|NCT02421731|Rehabilitation|rehabilitation
186579|NCT02421731|Gait|gait
186580|NCT02421718|Acute toxicity|acute toxicity
186581|NCT02421718|Late toxicity|late toxicity
186582|NCT02421718|Prediction models|prediction models
186583|NCT02421679|PTSD|ptsd
186584|NCT02421679|Military-related PTSD and other related conditions|military-related ptsd and other related conditions
186585|NCT02421679|open-label extension|open-label extension
186586|NCT02421653|Micronutrient powders|micronutrient powders
186587|NCT02421653|MNP|mnp
186588|NCT02421653|Weaning|weaning
186589|NCT02421653|Home fortification|home fortification
186590|NCT02421653|Iodine|iodine
186591|NCT02421653|Iodine deficiency|iodine deficiency
186592|NCT02421653|Iodine Deficiency Disorder|iodine deficiency disorder
186593|NCT02421653|IDD|idd
186594|NCT02421653|Infant|infant
186595|NCT02421653|Growth|growth
186596|NCT02421653|Iodised oil|iodised oil
186597|NCT02421627|moxibustion|moxibustion
186598|NCT02421627|irritable bowel syndrome|irritable bowel syndrome
186599|NCT02421627|Magnetic Resonance Imaging|magnetic resonance imaging
186600|NCT02421614|acute respiratory failure|acute respiratory failure
186601|NCT02421614|lung|lung
186602|NCT02421614|enteral feeding|enteral feeding
186603|NCT02421614|feeding composition|feeding composition
186604|NCT02421614|olive|olive
186605|NCT02421614|high fat|high fat
186606|NCT02421549|Remote Monitoring|remote monitoring
186607|NCT02421549|Remote Care|remote care
186608|NCT02421549|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
186609|NCT02421549|Pacemaker|pacemaker
186610|NCT02421549|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
186611|NCT02421523|Exercise|exercise
186612|NCT02421523|Strength training|strength training
186613|NCT02421510|High level of sugar (glucose) in the blood|high level of sugar (glucose) in the blood
186614|NCT02421484|Phase I clinical trial|phase i clinical trial
186615|NCT02421484|stem cell|stem cell
186616|NCT02421484|mesenchymal stromal cell|mesenchymal stromal cell
186617|NCT02421484|mesenchymal stem cell|mesenchymal stem cell
186618|NCT02421471|Actinic Keratosis|actinic keratosis
186619|NCT02421471|topical treatment|topical treatment
186620|NCT02421471|ingenol mebutate|ingenol mebutate
186621|NCT02421432|trananal TME|trananal tme
186622|NCT02421432|safety|safety
186623|NCT02421432|efficacy|efficacy
186624|NCT02421432|difficult cases|difficult cases
186625|NCT02421419|flexor tendon entrapment|flexor tendon entrapment
186626|NCT02421419|snapping finger|snapping finger
186627|NCT02421419|trigger digits|trigger digits
186628|NCT02421419|trigger thumb|trigger thumb
186629|NCT02421393|Bone quality|bone quality
186630|NCT02421393|Bone strength|bone strength
186631|NCT02421393|Fractures|fractures
186632|NCT02421393|Muscle strength|muscle strength
186633|NCT02421393|Gait and balance|gait and balance
186634|NCT02421393|Musculo-skeletal symptoms|musculo-skeletal symptoms
186635|NCT02421393|Falls|falls
186636|NCT02421380|Hyperpolarized Pyruvate|hyperpolarized pyruvate
186637|NCT02421380|MRI|mri
186638|NCT02421380|14-205|14-205
186639|NCT02421354|Myeloproliferative Diseases|myeloproliferative diseases
186640|NCT02421354|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
186641|NCT02421354|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
186642|NCT02421354|MF|mf
186643|NCT02421354|Nivolumab|nivolumab
186644|NCT02421354|BMS-936558|bms-936558
186645|NCT02421354|Questionnaire|questionnaire
186646|NCT02421354|Survey|survey
186647|NCT02421354|Phone call|phone call
186648|NCT02421341|Heart, Cardiovascular|heart, cardiovascular
186649|NCT02421341|Pulmonary|pulmonary
186650|NCT02421341|Skeletal Muscle|skeletal muscle
186651|NCT02421341|Exercise|exercise
186652|NCT02421315|OCD|ocd
186653|NCT02421315|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
186654|NCT02421315|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
186655|NCT02421289|CYP2B6 polymorphism|cyp2b6 polymorphism
186656|NCT02421289|efavirenz|efavirenz
186657|NCT02421289|Thai|thai
186658|NCT02421289|HIV-infected patient|hiv-infected patient
186659|NCT02421289|pharmacogenomic|pharmacogenomic
186660|NCT02421263|Psilocybin|psilocybin
186661|NCT02421263|Pharmacologic Actions|pharmacologic actions
186662|NCT02421263|Psychotropic Drugs|psychotropic drugs
186663|NCT02421224|Smoking Cessation|smoking cessation
186664|NCT02421224|Incentives|incentives
186665|NCT02421224|Health Behavior|health behavior
186666|NCT02421224|Smoking|smoking
186667|NCT02421224|Work-site|work-site
186668|NCT02421211|Hepatitis C, Chronic|hepatitis c, chronic
186669|NCT02421211|Simeprevir|simeprevir
186670|NCT02421211|Ledipasvir|ledipasvir
186671|NCT02421211|Sofosbuvir|sofosbuvir
186672|NCT02421198|Intervention Studies|intervention studies
186673|NCT02421185|Carcinoma, Hepatocellular|carcinoma, hepatocellular
186674|NCT02421185|JNJ 42756493|jnj 42756493
186675|NCT02421185|a pan-Fibroblast Growth Factor Receptor Tyrosine Kinase Inhibitor|a pan-fibroblast growth factor receptor tyrosine kinase inhibitor
186676|NCT02421172|Hidradenitis Suppurativa|hidradenitis suppurativa
186677|NCT02421159|HIV/AIDS|hiv/aids
186678|NCT02421159|vulnerable populations|vulnerable populations
186679|NCT02421159|heterosexuals at high risk|heterosexuals at high risk
186680|NCT02421159|peer-driven intervention|peer-driven intervention
186681|NCT02421159|tailored intervention|tailored intervention
186682|NCT02421159|African-American|african-american
186683|NCT02421159|Latino/Hispanic|latino/hispanic
186684|NCT02421159|Seek, test, treat, and retain (STTR)|seek, test, treat, and retain (sttr)
186685|NCT02421159|Brooklyn|brooklyn
186686|NCT02421133|Care transition program|care transition program
186687|NCT02421133|Patient readmission|patient readmission
186688|NCT02421133|Transition Nurse|transition nurse
186689|NCT02421133|Stepped wedge|stepped wedge
186690|NCT02421133|elderly|elderly
186691|NCT02421081|CD34|cd34
186692|NCT02421081|CD133|cd133
186693|NCT02421081|CD309|cd309
186694|NCT02421081|Radial Artery|radial artery
186695|NCT02421081|Ulnar Artery|ulnar artery
186696|NCT02421081|Lymphoid Cell|lymphoid cell
186697|NCT02421081|blood levels|blood levels
186698|NCT02421081|endothelial progenitor cells|endothelial progenitor cells
186699|NCT02421081|stem cells|stem cells
186700|NCT02421068|Paracetamol|paracetamol
186701|NCT02421068|Fentanyl|fentanyl
186702|NCT02421068|Phenobarbital|phenobarbital
186703|NCT02421068|Doxapram|doxapram
186704|NCT02421068|Midazolam|midazolam
186705|NCT02421068|Sildenafil|sildenafil
186706|NCT02421068|Levetiracetam|levetiracetam
186707|NCT02421068|Pharmacokinetics|pharmacokinetics
186708|NCT02421068|Pharmacology|pharmacology
186709|NCT02421068|Fluconazole|fluconazole
186710|NCT02421068|Ibuprofen|ibuprofen
186711|NCT02421055|Bariatric Surgery|bariatric surgery
186712|NCT02421055|Gastric Bypass|gastric bypass
186713|NCT02421055|Sleeve Gastrectomy|sleeve gastrectomy
186714|NCT02421055|Gastroplasty|gastroplasty
186715|NCT02421042|Hepatic Impairment|hepatic impairment
186716|NCT02421042|Hepatic Function|hepatic function
186717|NCT02421029|gadolinium|gadolinium
186718|NCT02421029|calcium disodium ethylenediaminetetraacetic acid (EDTA)|calcium disodium ethylenediaminetetraacetic acid (edta)
186719|NCT02421029|heavy metal toxicity|heavy metal toxicity
186720|NCT02421016|De novo stenosis|de novo stenosis
186721|NCT02421016|bioresorbable polymer coating|bioresorbable polymer coating
186722|NCT02421016|bioresorbable polymer backbone|bioresorbable polymer backbone
186723|NCT02421003|heart surgery blood|heart surgery blood
186724|NCT02420990|ADHD|adhd
186725|NCT02420990|Adolescents|adolescents
186726|NCT02420990|Substance Use Disorders|substance use disorders
186727|NCT02420977|radiotracer|radiotracer
186728|NCT02420964|injectable|injectable
186729|NCT02420964|teaching methods|teaching methods
186730|NCT02420951|Knee|knee
186731|NCT02420951|Arthroplasty|arthroplasty
186732|NCT02420951|Bupivacaine|bupivacaine
186733|NCT02420951|Anesthetics, Local|anesthetics, local
186734|NCT02420938|Leukemia|leukemia
186735|NCT02420938|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
186736|NCT02420938|CLL|cll
186737|NCT02420938|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
186738|NCT02420938|SLL|sll
186739|NCT02420938|Refractory/relapsed|refractory/relapsed
186740|NCT02420938|High-risk molecular features|high-risk molecular features
186741|NCT02420938|Rituximab|rituximab
186742|NCT02420938|Rituxan|rituxan
186743|NCT02420938|Urelumab|urelumab
186744|NCT02420925|Gastroparesis|gastroparesis
186745|NCT02420925|Celiac Plexus Block|celiac plexus block
186746|NCT02420912|Leukemia|leukemia
186855|NCT02420717|BMS-354825|bms-354825
186747|NCT02420912|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
186748|NCT02420912|CLL|cll
186749|NCT02420912|Relapsed|relapsed
186750|NCT02420912|Refractory|refractory
186751|NCT02420912|High-risk|high-risk
186752|NCT02420912|Untreated|untreated
186753|NCT02420912|Nivolumab|nivolumab
186754|NCT02420912|BMS-936558|bms-936558
186755|NCT02420912|Opdivo|opdivo
186756|NCT02420912|Ibrutinib|ibrutinib
186757|NCT02420912|PCI-32765|pci-32765
186758|NCT02420912|Imbruvica|imbruvica
186759|NCT02420899|IVUS|ivus
186760|NCT02420899|ACS|acs
186761|NCT02420886|In Vitro culture of human embryos|in vitro culture of human embryos
186762|NCT02420873|Leukemia|leukemia
186763|NCT02420873|Hematological malignancy|hematological malignancy
186764|NCT02420873|Myelofibrosis|myelofibrosis
186765|NCT02420873|MF|mf
186766|NCT02420873|Blastic plasmacytoid dendritic cell neoplasm|blastic plasmacytoid dendritic cell neoplasm
186767|NCT02420873|BPDCN|bpdcn
186768|NCT02420873|CD56 tumor marker|cd56 tumor marker
186769|NCT02420873|Acute myeloid leukemia|acute myeloid leukemia
186770|NCT02420873|AML|aml
186771|NCT02420873|Natural-killer leukemia|natural-killer leukemia
186772|NCT02420873|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
186773|NCT02420873|ALL|all
186774|NCT02420873|CD56 expressing hematological malignancy|cd56 expressing hematological malignancy
186775|NCT02420873|IMGN901|imgn901
186776|NCT02420873|Lorvotuzumab mertansine|lorvotuzumab mertansine
186777|NCT02420860|Myeloma|myeloma
186778|NCT02420860|Multiple myeloma|multiple myeloma
186779|NCT02420860|MM|mm
186780|NCT02420860|Post autologous stem cell transplantation|post autologous stem cell transplantation
186781|NCT02420860|ASCT|asct
186782|NCT02420860|Elotuzumab|elotuzumab
186783|NCT02420860|Lenalidomide|lenalidomide
186784|NCT02420860|CC-5013|cc-5013
186785|NCT02420860|Revlimid|revlimid
186786|NCT02420860|Dexamethasone|dexamethasone
186787|NCT02420860|Decadron|decadron
186788|NCT02420860|Diphenhydramine|diphenhydramine
186789|NCT02420860|Benadryl|benadryl
186790|NCT02420860|Ranitidine|ranitidine
186791|NCT02420860|Ranitidine hydrochloride|ranitidine hydrochloride
186792|NCT02420860|Zantac|zantac
186793|NCT02420860|Symptom questionnaire|symptom questionnaire
186794|NCT02420860|Survey|survey
186795|NCT02420847|Bladder cancer|bladder cancer
186796|NCT02420847|Urothelial cancer|urothelial cancer
186797|NCT02420847|Transitional cell carcinoma of the urothelium|transitional cell carcinoma of the urothelium
186798|NCT02420847|Metastatic|metastatic
186799|NCT02420847|Locally unresectable|locally unresectable
186800|NCT02420847|Ixazomib|ixazomib
186801|NCT02420847|Gemcitabine|gemcitabine
186802|NCT02420847|Gemcitabine hydrochloride|gemcitabine hydrochloride
186803|NCT02420847|Gemzar|gemzar
186804|NCT02420847|Doxorubicin|doxorubicin
186805|NCT02420847|Doxorubicin hydrochloride|doxorubicin hydrochloride
186806|NCT02420847|Adriamycin PFS|adriamycin pfs
186807|NCT02420847|Adriamycin RDF|adriamycin rdf
186808|NCT02420847|Adriamycin|adriamycin
186809|NCT02420847|Rubex|rubex
186810|NCT02420808|CAD|cad
186811|NCT02420808|STEMI|stemi
186812|NCT02420808|non STEMI|non stemi
186813|NCT02420808|Unstable angina|unstable angina
186814|NCT02420808|Greece|greece
186815|NCT02420795|Lymphoma|lymphoma
186816|NCT02420795|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
186817|NCT02420795|Relapsed/Refractory|relapsed/refractory
186818|NCT02420795|NHL|nhl
186819|NCT02420795|Mantle cell lymphoma|mantle cell lymphoma
186820|NCT02420795|MCL|mcl
186821|NCT02420795|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
186822|NCT02420795|DLBCL|dlbcl
186823|NCT02420795|Transformed large cell lymphoma|transformed large cell lymphoma
186824|NCT02420795|TLCL|tlcl
186825|NCT02420795|ONC201|onc201
186826|NCT02420795|Phone call|phone call
186827|NCT02420782|Pharmacokinetics|pharmacokinetics
186828|NCT02420782|ASP6282|asp6282
186829|NCT02420782|Pharmacodynamics|pharmacodynamics
186830|NCT02420782|Drug-drug interaction|drug-drug interaction
186831|NCT02420782|Midazolam|midazolam
186832|NCT02420782|Safety and tolerability|safety and tolerability
186833|NCT02420782|Healthy volunteers|healthy volunteers
186834|NCT02420782|Itraconazole|itraconazole
186835|NCT02420769|CA 125|ca 125
186836|NCT02420769|Progesterone|progesterone
186837|NCT02420769|Doppler|doppler
186838|NCT02420769|Corpus Luteum|corpus luteum
186839|NCT02420743|PTD|ptd
186840|NCT02420717|Leukemia|leukemia
186841|NCT02420717|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
186842|NCT02420717|ALL|all
186843|NCT02420717|Philadelphia Chromosome (Ph)-Like|philadelphia chromosome (ph)-like
186844|NCT02420717|Relapsed|relapsed
186845|NCT02420717|Refractory|refractory
186846|NCT02420717|6-mercaptopurine|6-mercaptopurine
186847|NCT02420717|Mercaptopurine|mercaptopurine
186848|NCT02420717|6-MP|6-mp
186849|NCT02420717|Purinethol|purinethol
186850|NCT02420717|Ruxolitinib|ruxolitinib
186851|NCT02420717|Jakafi|jakafi
186852|NCT02420717|INCB018424|incb018424
186853|NCT02420717|INC424|inc424
186854|NCT02420717|Dasatinib|dasatinib
186856|NCT02420717|Sprycel|sprycel
186857|NCT02420717|Rituximab|rituximab
186858|NCT02420717|Rituxan|rituxan
186859|NCT02420717|G-CSF|g-csf
186860|NCT02420717|Filgrastim|filgrastim
186861|NCT02420717|Neupogen|neupogen
186862|NCT02420717|Pegfilgrastim|pegfilgrastim
186863|NCT02420717|Neulasta|neulasta
186864|NCT02420717|PEG-G-CSF|peg-g-csf
186865|NCT02420717|Methotrexate|methotrexate
186866|NCT02420717|Cytarabine|cytarabine
186867|NCT02420717|Ara-C|ara-c
186868|NCT02420717|Cytosar|cytosar
186869|NCT02420717|DepoCyt|depocyt
186870|NCT02420717|Cytosine|cytosine
186871|NCT02420717|Arabinosine Hydrochloride|arabinosine hydrochloride
186872|NCT02420717|Cyclophosphamide|cyclophosphamide
186873|NCT02420717|Cytoxan|cytoxan
186874|NCT02420717|Neosar|neosar
186875|NCT02420717|Mesna|mesna
186876|NCT02420717|Mesnex|mesnex
186877|NCT02420717|Doxorubicin|doxorubicin
186878|NCT02420717|Doxorubucin hydrochloride|doxorubucin hydrochloride
186879|NCT02420717|Adriamycin PFS|adriamycin pfs
186880|NCT02420717|Adriamycin RDF|adriamycin rdf
186881|NCT02420717|Adriamycin|adriamycin
186882|NCT02420717|Rubex|rubex
186883|NCT02420717|Vincristine|vincristine
186884|NCT02420717|Dexamethasone|dexamethasone
186885|NCT02420717|Decadron|decadron
186886|NCT02420717|Solumedrol|solumedrol
186887|NCT02420717|Methylprednisolone|methylprednisolone
186888|NCT02420717|Depo-medrol|depo-medrol
186889|NCT02420717|Medrol|medrol
186890|NCT02420717|Solu-medrol|solu-medrol
186891|NCT02420717|Prednisone|prednisone
186892|NCT02420717|Leucovorin|leucovorin
186893|NCT02420717|Citrovorum|citrovorum
186894|NCT02420717|Wellcovorin|wellcovorin
186896|NCT02420704|endometrial thickness|endometrial thickness
186897|NCT02420704|cleavage stage embryo|cleavage stage embryo
186898|NCT02420704|blastocyst stage embryo|blastocyst stage embryo
186899|NCT02420704|Ongoing pregnancy rate|ongoing pregnancy rate
186900|NCT02420691|Gastrointestinal cancer|gastrointestinal cancer
186901|NCT02420691|Foregut neuroendocrine tumors|foregut neuroendocrine tumors
186902|NCT02420691|NET|net
186903|NCT02420691|Thymic|thymic
186904|NCT02420691|Bronchopulmonary|bronchopulmonary
186905|NCT02420691|Gastric|gastric
186906|NCT02420691|Duodenal|duodenal
186907|NCT02420691|Pancreatic|pancreatic
186908|NCT02420691|LEE011|lee011
186909|NCT02420665|Cervical Cancer|cervical cancer
186910|NCT02420665|Cervical Dysplasia|cervical dysplasia
186911|NCT02420665|Abnormal Pap test|abnormal pap test
186912|NCT02420665|Positive human papillomavirus test|positive human papillomavirus test
186913|NCT02420665|HPV|hpv
186914|NCT02420665|Visual inspection with acetic acid|visual inspection with acetic acid
186915|NCT02420665|VIA|via
186916|NCT02420665|Colposcopy|colposcopy
186917|NCT02420665|Proflavine|proflavine
186918|NCT02420665|Acetic acid|acetic acid
186919|NCT02420665|High-Resolution Microendoscopy|high-resolution microendoscopy
186920|NCT02420665|HRME|hrme
186921|NCT02420665|Phone call|phone call
186922|NCT02420613|Diffuse Intrinsic Pontine Glioma|diffuse intrinsic pontine glioma
186923|NCT02420613|DIPG|dipg
186924|NCT02420613|Newly Diagnosed|newly diagnosed
186925|NCT02420613|Progressive|progressive
186926|NCT02420613|Pediatrics|pediatrics
186927|NCT02420613|Vorinostat|vorinostat
186928|NCT02420613|SAHA|saha
186929|NCT02420613|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
186930|NCT02420613|MSK-390|msk-390
186931|NCT02420613|Zolinza|zolinza
186932|NCT02420613|Temsirolimus|temsirolimus
186933|NCT02420613|CCI-779|cci-779
186934|NCT02420613|Torisel|torisel
186935|NCT02420613|Radiation therapy|radiation therapy
186936|NCT02420613|XRT|xrt
186937|NCT02420600|Circulating tumor cells|circulating tumor cells
186938|NCT02420600|Head and neck cancer|head and neck cancer
186939|NCT02420600|PD-1|pd-1
186940|NCT02420600|natural killer cells|natural killer cells
186941|NCT02420600|cytotoxic T lymphocytes|cytotoxic t lymphocytes
186942|NCT02420587|Prostate Cancer|prostate cancer
186943|NCT02420587|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
186944|NCT02420587|Castration resistant prostate cancer metastatic to bone|castration resistant prostate cancer metastatic to bone
186945|NCT02420587|mCRPC|mcrpc
186946|NCT02420587|AMG 208|amg 208
186947|NCT02420587|Questionnaire|questionnaire
186948|NCT02420587|Survey|survey
186949|NCT02420561|Depression|depression
186950|NCT02420561|Substance-Related Disorders|substance-related disorders
186951|NCT02420561|Mental Health|mental health
186952|NCT02420535|Dementia|dementia
186953|NCT02420535|Alzheimer's Disease|alzheimer's disease
186954|NCT02420535|Caregivers|caregivers
186955|NCT02420535|Behavioral|behavioral
186956|NCT02420535|Caregiver burden|caregiver burden
186957|NCT02420496|Parental nutrition|parental nutrition
186958|NCT02420496|associated|associated
186959|NCT02420470|diabetes|diabetes
186960|NCT02420470|neural and vessel alteration|neural and vessel alteration
186961|NCT02420470|prodromal stage|prodromal stage
186962|NCT02420457|Fitness devices|fitness devices
186963|NCT02420418|Tobacco use disorder and bipolar disorders|tobacco use disorder and bipolar disorders
186964|NCT02420418|N-acetylcysteine|n-acetylcysteine
186965|NCT02420418|Oxidative stress|oxidative stress
186966|NCT02420418|inflammation|inflammation
186967|NCT02420405|Gene testing|gene testing
186968|NCT02420405|Endobronchial ultrasound (EBUS)|endobronchial ultrasound (ebus)
186969|NCT02420405|Next-generation sequencing (NGS)|next-generation sequencing (ngs)
186970|NCT02420405|Small biopsies|small biopsies
186971|NCT02420379|DMD|dmd
186972|NCT02420379|Duchenne muscular dystrophy|duchenne muscular dystrophy
186973|NCT02420379|eteplirsen|eteplirsen
186974|NCT02420379|Dystrophin|dystrophin
186975|NCT02420379|exon 51|exon 51
186976|NCT02420353|muscle atrophy|muscle atrophy
186977|NCT02420353|growth hormone|growth hormone
186978|NCT02420353|ACL tear|acl tear
186979|NCT02420340|Serious Mental Illness|serious mental illness
186980|NCT02420340|Psychosocial Rehabilitation|psychosocial rehabilitation
186981|NCT02420327|nicotine|nicotine
186982|NCT02420327|galantamine|galantamine
186983|NCT02420327|attention|attention
186984|NCT02420327|cognition|cognition
186985|NCT02420327|non-smoker|non-smoker
186986|NCT02420314|Ascorbate|ascorbate
186987|NCT02420314|Ascorbic acid|ascorbic acid
186988|NCT02420314|Vitamin C|vitamin c
186989|NCT02420314|NSCLC|nsclc
186990|NCT02420314|Non Small Cell Lung Cancer|non small cell lung cancer
186991|NCT02420314|carboplatin|carboplatin
186992|NCT02420314|paclitaxel|paclitaxel
186993|NCT02420288|Pregnancy|pregnancy
186994|NCT02420288|Fetoplacental growth|fetoplacental growth
186995|NCT02420288|Physical exercise|physical exercise
186996|NCT02420288|Pregnant|pregnant
186997|NCT02420288|Placental development|placental development
186998|NCT02420288|Active pregnancy|active pregnancy
186999|NCT02420275|brain injury|brain injury
187000|NCT02420275|blue enriched withe bright light therapy|blue enriched withe bright light therapy
187001|NCT02420275|sequel fatigue|sequel fatigue
187002|NCT02420236|Exercise therapy|exercise therapy
187003|NCT02420236|Resistance training|resistance training
187004|NCT02420236|Multidisciplinary treatment|multidisciplinary treatment
187005|NCT02420223|Recipients|recipients
187006|NCT02420197|Exercise therapy|exercise therapy
187007|NCT02420197|Resistance training|resistance training
187008|NCT02420197|Multidisciplinary treatment|multidisciplinary treatment
187009|NCT02420171|In Vitro|in vitro
187010|NCT02420171|embryo quality|embryo quality
187011|NCT02420171|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
187012|NCT02420158|Irritable Bowel Syndrome|irritable bowel syndrome
187013|NCT02420158|Vagal nerve stimulation|vagal nerve stimulation
187014|NCT02420158|Quality of life|quality of life
187015|NCT02420119|Iron Therapy|iron therapy
187016|NCT02420119|serum phosphates|serum phosphates
187017|NCT02420119|vitamin D|vitamin d
187018|NCT02420106|cervical dystonia|cervical dystonia
187019|NCT02420106|neck pain|neck pain
187020|NCT02420106|OMM|omm
187021|NCT02420106|spasmodic torticollis|spasmodic torticollis
187022|NCT02420067|von Hippel-Lindau disease|von hippel-lindau disease
187023|NCT02420067|Endolymphatic sac tumors|endolymphatic sac tumors
187024|NCT02420067|Audiological examination|audiological examination
187025|NCT02420067|MRI|mri
187026|NCT02420067|Surveillance|surveillance
187027|NCT02420054|intermittent fasting|intermittent fasting
187028|NCT02420054|alternate day fasting|alternate day fasting
187029|NCT02420054|diabetes mellitus|diabetes mellitus
187030|NCT02420054|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
187031|NCT02420054|insulin sensitivity|insulin sensitivity
187032|NCT02420041|Sacroiliac Joint Injection|sacroiliac joint injection
187033|NCT02420041|Fluoroscopy|fluoroscopy
187034|NCT02420041|Ultrasound|ultrasound
187035|NCT02419989|Nontuberculous Mycobacteria|nontuberculous mycobacteria
187036|NCT02419963|microbiome|microbiome
187037|NCT02419963|biomarkers|biomarkers
187038|NCT02419963|Vitamin D|vitamin d
187039|NCT02419963|Serotonin|serotonin
187040|NCT02419950|inguinal hernia|inguinal hernia
187041|NCT02419950|TEP|tep
187042|NCT02419950|chronic pain|chronic pain
187043|NCT02419950|male sex|male sex
187044|NCT02419950|mesh fixation|mesh fixation
187045|NCT02419950|quality of life|quality of life
187046|NCT02419950|national register|national register
187047|NCT02419911|gastrointestinal|gastrointestinal
187048|NCT02419911|gynecologic|gynecologic
187049|NCT02419911|urologic|urologic
187050|NCT02419911|bariatric|bariatric
187051|NCT02419911|laparoscopic surgery|laparoscopic surgery
187052|NCT02419898|Feasibility|feasibility
187053|NCT02419885|finger amputation|finger amputation
187054|NCT02419885|composite graft|composite graft
187055|NCT02419885|adipo-fascia flap|adipo-fascia flap
187056|NCT02419859|Diabetes Mellitus|diabetes mellitus
187057|NCT02419859|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
187058|NCT02419859|Glucose Metabolism Disorders|glucose metabolism disorders
187059|NCT02419859|Metabolic Diseases|metabolic diseases
187060|NCT02419859|Endocrine System Diseases|endocrine system diseases
187061|NCT02419859|Insulin|insulin
187062|NCT02419859|Continuous subcutaneous insulin infusion (CSII)|continuous subcutaneous insulin infusion (csii)
187063|NCT02419859|Insulin pumps|insulin pumps
187064|NCT02419846|Informed Decision Making|informed decision making
187065|NCT02419846|Prostate|prostate
187066|NCT02419846|Cancer|cancer
187067|NCT02419833|non-STEMI|non-stemi
187068|NCT02419833|immediate|immediate
187069|NCT02419833|delayed|delayed
187070|NCT02419833|PCI|pci
187071|NCT02419807|Near Infrared Fluorescence Imaging|near infrared fluorescence imaging
187072|NCT02419807|Indocyanine Green|indocyanine green
187073|NCT02419807|axillary lymph node mapping|axillary lymph node mapping
187074|NCT02419807|Mastectomy, Segmental|mastectomy, segmental
187075|NCT02419807|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
187076|NCT02419807|Lumpectomy|lumpectomy
187077|NCT02419768|Long-range autocorrelations|long-range autocorrelations
187078|NCT02419768|Variability|variability
187079|NCT02419768|Physical Exercise|physical exercise
187080|NCT02419768|Parkinson's Disease|parkinson's disease
187081|NCT02419768|ICF|icf
187082|NCT02419755|Infant leukemia|infant leukemia
187083|NCT02419755|ALL|all
187084|NCT02419755|AML|aml
187085|NCT02419755|Biphenotypic leukemia|biphenotypic leukemia
187086|NCT02419755|Pediatric|pediatric
187087|NCT02419729|Vulvovaginal atrophy|vulvovaginal atrophy
187088|NCT02419729|Menopause|menopause
187089|NCT02419729|Fractional CO2 laser|fractional co2 laser
187090|NCT02419729|Estrogen cream|estrogen cream
187091|NCT02419716|colorectal cancer|colorectal cancer
187092|NCT02419716|Colorectal cancer screening|colorectal cancer screening
187093|NCT02419677|radiofrequency ablation|radiofrequency ablation
187094|NCT02419677|cytokine-induced killer cells|cytokine-induced killer cells
187095|NCT02419677|colorectal cancer iver metastases|colorectal cancer iver metastases
187096|NCT02419664|pituitary|pituitary
187097|NCT02419664|pituitary adenomas|pituitary adenomas
187098|NCT02419664|Ga-PET|ga-pet
187099|NCT02419664|Acromegaly|acromegaly
187100|NCT02419664|TSHomas|tshomas
187101|NCT02419664|Cushing|cushing
187102|NCT02419651|out patient hysteroscopy|out patient hysteroscopy
187103|NCT02419638|relapsing-remitting MS|relapsing-remitting ms
187104|NCT02419638|lesions|lesions
187105|NCT02419638|treatment|treatment
187106|NCT02419573|cardiac arrest|cardiac arrest
187107|NCT02419573|cardiopulmonary resuscitation|cardiopulmonary resuscitation
187108|NCT02419573|laryngeal tube|laryngeal tube
187109|NCT02419573|endotracheal intubation|endotracheal intubation
187110|NCT02419573|non-traumatic Out of Hospital Cardiac Arrest (OOHCA)|non-traumatic out of hospital cardiac arrest (oohca)
187111|NCT02419560|Relapsed|relapsed
187112|NCT02419560|Laboratory biomarker research|laboratory biomarker research
187113|NCT02419560|Pharmacologic study|pharmacologic study
187114|NCT02419560|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
187115|NCT02419560|BCL-2 inhibitor|bcl-2 inhibitor
187116|NCT02419547|Ventricular tachycardia|ventricular tachycardia
187117|NCT02419547|ventricular tachycardia ablation|ventricular tachycardia ablation
187118|NCT02419547|effects of anesthesia on VT induction|effects of anesthesia on vt induction
187119|NCT02419547|programed stimulation|programed stimulation
187120|NCT02419534|Pediatric, fissure in ano|pediatric, fissure in ano
187121|NCT02419495|Advanced cancers|advanced cancers
187122|NCT02419495|Malignant neoplasms|malignant neoplasms
187123|NCT02419495|Paclitaxel|paclitaxel
187124|NCT02419495|Taxol|taxol
187125|NCT02419495|Eribulin|eribulin
187126|NCT02419495|E7389|e7389
187127|NCT02419495|Doxorubicin|doxorubicin
187128|NCT02419495|Doxorubicin Hydrochloride|doxorubicin hydrochloride
187129|NCT02419495|Adriamycin PFS|adriamycin pfs
187130|NCT02419495|Adriamycin RDF|adriamycin rdf
187131|NCT02419495|Adriamycin|adriamycin
187132|NCT02419495|Rubex|rubex
187133|NCT02419495|Cyclophosphamide|cyclophosphamide
187134|NCT02419495|Cytoxan|cytoxan
187135|NCT02419495|Neosar|neosar
187136|NCT02419495|Pemetrexed|pemetrexed
187137|NCT02419495|LY231514|ly231514
187138|NCT02419495|Alimta|alimta
187139|NCT02419495|MTA|mta
187140|NCT02419495|Multitargeted Antifolate|multitargeted antifolate
187141|NCT02419495|NSC-698037|nsc-698037
187142|NCT02419495|Topotecan|topotecan
187143|NCT02419495|Hycamtin|hycamtin
187144|NCT02419495|Selinexor|selinexor
187145|NCT02419495|KPT-330|kpt-330
187146|NCT02419495|Carboplatin|carboplatin
187147|NCT02419495|Paraplatin|paraplatin
187148|NCT02419495|Irinotecan|irinotecan
187149|NCT02419495|CPT-11|cpt-11
187150|NCT02419495|Camptosar|camptosar
187151|NCT02419495|5-FU|5-fu
187152|NCT02419495|Fluorouracil|fluorouracil
187153|NCT02419495|5-Fluorouracil|5-fluorouracil
187154|NCT02419495|Adrucil|adrucil
187155|NCT02419495|Efudex|efudex
187156|NCT02419495|Capecitabine|capecitabine
187157|NCT02419495|Xeloda|xeloda
187158|NCT02419495|Oxaliplatin|oxaliplatin
187159|NCT02419495|Eloxatin|eloxatin
187160|NCT02419495|Olaparib|olaparib
187161|NCT02419495|Lynparza|lynparza
187162|NCT02419495|Pembrolizumab|pembrolizumab
187163|NCT02419495|Keytruda|keytruda
187164|NCT02419495|MK-3475|mk-3475
187165|NCT02419495|SCH-900475|sch-900475
187166|NCT02419495|Nivolumab|nivolumab
187167|NCT02419495|BMS-936558|bms-936558
187168|NCT02419495|Opdivo|opdivo
187169|NCT02419482|Exercise therapy|exercise therapy
187376|NCT02418481|her2-|her2-
187170|NCT02419482|Reproductive Physiological Processes|reproductive physiological processes
187171|NCT02419482|Fertility|fertility
187172|NCT02419469|Leukemia|leukemia
187173|NCT02419469|Precursor-B acute lymphoblastic leukemia|precursor-b acute lymphoblastic leukemia
187174|NCT02419469|ALL|all
187175|NCT02419469|Lymphoblastic lymphoma|lymphoblastic lymphoma
187176|NCT02419469|LL|ll
187177|NCT02419469|Lymphoma|lymphoma
187178|NCT02419469|Cytarabine|cytarabine
187179|NCT02419469|Ara-C|ara-c
187180|NCT02419469|Cytosar|cytosar
187181|NCT02419469|DepoCyt|depocyt
187182|NCT02419469|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
187183|NCT02419469|Daunorubicin|daunorubicin
187184|NCT02419469|Daunorubicin Hydrochloride|daunorubicin hydrochloride
187185|NCT02419469|Cerubidine|cerubidine
187186|NCT02419469|Daunomycin|daunomycin
187187|NCT02419469|DNR|dnr
187188|NCT02419469|Vincristine|vincristine
187189|NCT02419469|Prednisone|prednisone
187190|NCT02419469|PEG asparaginase|peg asparaginase
187191|NCT02419469|Pegaspargase|pegaspargase
187192|NCT02419469|Oncaspar|oncaspar
187193|NCT02419469|Polyethylene glycol conjugated lasparaginase-H|polyethylene glycol conjugated lasparaginase-h
187194|NCT02419469|Ofatumumab|ofatumumab
187195|NCT02419469|Arzerra|arzerra
187196|NCT02419469|Rituximab|rituximab
187197|NCT02419469|Rituxan|rituxan
187198|NCT02419469|Methotrexate|methotrexate
187199|NCT02419469|Cyclophosphamide|cyclophosphamide
187200|NCT02419469|Cytoxan|cytoxan
187201|NCT02419469|Neosar|neosar
187202|NCT02419469|Mercaptopurine|mercaptopurine
187203|NCT02419469|6-mercaptopurine|6-mercaptopurine
187204|NCT02419469|Purinethol|purinethol
187205|NCT02419469|6-MP|6-mp
187206|NCT02419469|Doxorubicin|doxorubicin
187207|NCT02419469|Doxorubicin hydrochloride|doxorubicin hydrochloride
187208|NCT02419469|Adriamycin PFS|adriamycin pfs
187209|NCT02419469|Adriamycin RDF|adriamycin rdf
187210|NCT02419469|Adriamycin|adriamycin
187211|NCT02419469|Rubex|rubex
187212|NCT02419469|Dexamethasone|dexamethasone
187213|NCT02419469|Decadron|decadron
187214|NCT02419469|Thioguanine|thioguanine
187215|NCT02419469|6-thioguanine|6-thioguanine
187216|NCT02419443|inguinal hernia repair, chronic pain|inguinal hernia repair, chronic pain
187217|NCT02419430|well-being|well-being
187218|NCT02419430|stress|stress
187219|NCT02419430|resilience|resilience
187220|NCT02419430|self-compassion|self-compassion
187221|NCT02419391|RSV Vaccines|rsv vaccines
187222|NCT02419391|Respiratory Syncytial Virus Vaccines|respiratory syncytial virus vaccines
187223|NCT02419365|Primary Ciliary Dyskinesia (PCD)|primary ciliary dyskinesia (pcd)
187224|NCT02419352|Cognitive function|cognitive function
187225|NCT02419326|couples|couples
187226|NCT02419326|relationships|relationships
187227|NCT02419326|binge eating|binge eating
187228|NCT02419326|eating disorder|eating disorder
187229|NCT02419326|couple therapy|couple therapy
187230|NCT02419313|Tremor|tremor
187231|NCT02419313|Parkinson|parkinson
187232|NCT02419313|botulinum|botulinum
187233|NCT02419313|Xeomin|xeomin
187234|NCT02419287|ALK|alk
187235|NCT02419287|crizotinib|crizotinib
187236|NCT02419274|asthma|asthma
187237|NCT02419274|phenotype|phenotype
187238|NCT02419274|childhood|childhood
187239|NCT02419274|adulthood|adulthood
187240|NCT02419261|knee surgery|knee surgery
187241|NCT02419261|anterior cruciate ligament surgery|anterior cruciate ligament surgery
187242|NCT02419261|nerve block|nerve block
187243|NCT02419235|Refractory hypertension|refractory hypertension
187244|NCT02419235|Homoeopathy|homoeopathy
187245|NCT02419235|Homoeopathic complex|homoeopathic complex
187246|NCT02419235|Amylenum nitrosum 6cH|amylenum nitrosum 6ch
187247|NCT02419235|Crataegus oxyacantha 6cH|crataegus oxyacantha 6ch
187248|NCT02419235|Natrum muriaticum 6cH|natrum muriaticum 6ch
187249|NCT02419235|Scutellaria lateriflora 6cH|scutellaria lateriflora 6ch
187250|NCT02419209|Low sexual desire|low sexual desire
187251|NCT02419209|Perimenopause|perimenopause
187252|NCT02419209|Homeopathy|homeopathy
187253|NCT02419209|Hypoactive Sexual Desire Disorder|hypoactive sexual desire disorder
187254|NCT02419183|Mild Cognitive Impairment|mild cognitive impairment
187255|NCT02419183|Self-Administered Memory Screening Test With Automated Reporting (SAMSTAR)|self-administered memory screening test with automated reporting (samstar)
187256|NCT02419183|Rey Auditory Verbal Learning Test (RAVLT)|rey auditory verbal learning test (ravlt)
187257|NCT02419183|Word List Recall (WLR)|word list recall (wlr)
187258|NCT02419157|Cervical lesions|cervical lesions
187259|NCT02419157|Clinical trial|clinical trial
187260|NCT02419157|Self-etch adhesive|self-etch adhesive
187261|NCT02419144|older adults;|older adults;
187262|NCT02419144|oral hygiene;|oral hygiene;
187263|NCT02419144|adapted motivational interviewing|adapted motivational interviewing
187264|NCT02419118|Myeloma|myeloma
187265|NCT02419118|monoclonal antibody|monoclonal antibody
187266|NCT02419118|Daratumumab|daratumumab
187267|NCT02419105|Falls|falls
187268|NCT02419105|hypogonadal men|hypogonadal men
187269|NCT02419105|Seniors|seniors
187270|NCT02419105|Testosterone|testosterone
187271|NCT02419105|Colecalciferol|colecalciferol
187272|NCT02419092|Inflammation|inflammation
187273|NCT02419092|Insulin resistance|insulin resistance
187274|NCT02419092|Bariatric surgery|bariatric surgery
187275|NCT02419053|Surgical safety checklist|surgical safety checklist
187276|NCT02419053|perioperative complications|perioperative complications
187277|NCT02419053|pediatric|pediatric
187278|NCT02419040|shoulder pain|shoulder pain
187279|NCT02419040|rotator cuff|rotator cuff
187280|NCT02419040|calcific tendonitis|calcific tendonitis
187281|NCT02419040|barbotage|barbotage
187282|NCT02419027|GI Flora|gi flora
187283|NCT02419014|cranial electrotherapy|cranial electrotherapy
187284|NCT02419014|cranial electrical stimulation|cranial electrical stimulation
187285|NCT02419014|restless legs syndrome|restless legs syndrome
187286|NCT02418962|PfSPZ Vaccine|pfspz vaccine
187287|NCT02418949|hand|hand
187288|NCT02418949|rehabilitation|rehabilitation
187289|NCT02418949|active movement training|active movement training
187290|NCT02418949|passive cyclical stretching|passive cyclical stretching
187291|NCT02418936|Waardenburg syndrome|waardenburg syndrome
187292|NCT02418936|Large vestibular aqueduct syndrome|large vestibular aqueduct syndrome
187293|NCT02418936|Diagnosis|diagnosis
187294|NCT02418936|copy number variation|copy number variation
187295|NCT02418936|Multiplex polymerase chain reaction|multiplex polymerase chain reaction
187296|NCT02418910|bipolar|bipolar
187297|NCT02418910|self assessment|self assessment
187298|NCT02418910|prospective randomized trial|prospective randomized trial
187299|NCT02418897|Fatigue|fatigue
187300|NCT02418897|multiple sclerosis|multiple sclerosis
187301|NCT02418897|neuromuscular junction|neuromuscular junction
187302|NCT02418897|SFEMG|sfemg
187303|NCT02418871|cataract|cataract
187304|NCT02418871|presbyopia|presbyopia
187305|NCT02418858|Essential tremor|essential tremor
187306|NCT02418858|DBS|dbs
187307|NCT02418832|Azoospermia|azoospermia
187308|NCT02418832|Rete Testis|rete testis
187309|NCT02418832|TEFNA|tefna
187310|NCT02418806|Family Caregivers|family caregivers
187311|NCT02418806|Psychotherapy Group|psychotherapy group
187312|NCT02418793|Hemophilia|hemophilia
187313|NCT02418793|Factor VII|factor vii
187314|NCT02418793|Factor VIIa|factor viia
187315|NCT02418793|Inhibitors|inhibitors
187316|NCT02418793|Long Acting|long acting
187317|NCT02418728|obesity|obesity
187318|NCT02418728|adipose tissue lipolysis|adipose tissue lipolysis
187319|NCT02418728|lipolysis|lipolysis
187320|NCT02418728|microdialysis|microdialysis
187321|NCT02418728|atrial natriuretic peptide|atrial natriuretic peptide
187322|NCT02418702|depression|depression
187323|NCT02418702|suicide|suicide
187324|NCT02418702|ketamine|ketamine
187325|NCT02418702|rapid intravenous bolus|rapid intravenous bolus
187326|NCT02418702|sub-anesthetic dose|sub-anesthetic dose
187327|NCT02418702|double-blind placebo control|double-blind placebo control
187328|NCT02418676|Human insulin|human insulin
187329|NCT02418676|Hydroxypropyl-beta-cyclodextrin|hydroxypropyl-beta-cyclodextrin
187330|NCT02418676|Pressure Ulcer|pressure ulcer
187331|NCT02418676|Wound Healing|wound healing
187332|NCT02418676|Gel|gel
187333|NCT02418663|fluid responsiveness|fluid responsiveness
187334|NCT02418663|enhanced recovery program|enhanced recovery program
187335|NCT02418650|volunteers|volunteers
187336|NCT02418637|worksite|worksite
187337|NCT02418637|screen|screen
187338|NCT02418637|migrant|migrant
187339|NCT02418637|agricultural|agricultural
187340|NCT02418637|worker|worker
187341|NCT02418637|hypertension|hypertension
187342|NCT02418637|Hyperlipidemia|hyperlipidemia
187343|NCT02418637|diabetes|diabetes
187344|NCT02418637|feasibility|feasibility
187345|NCT02418624|breast cancer 1, early onset (BRCA1)|breast cancer 1, early onset (brca1)
187346|NCT02418624|breast cancer 2, early onset (BRCA2)|breast cancer 2, early onset (brca2)
187347|NCT02418624|homologous recombination deficiency|homologous recombination deficiency
187348|NCT02418624|carboplatin|carboplatin
187349|NCT02418624|olaparib|olaparib
187350|NCT02418598|Adeno-associated virus|adeno-associated virus
187351|NCT02418598|Aromatic L-amino acid decarboxylase|aromatic l-amino acid decarboxylase
187352|NCT02418598|AAV-hAADC-2|aav-haadc-2
187353|NCT02418598|AAV-2|aav-2
187354|NCT02418598|Gene Therapy|gene therapy
187355|NCT02418598|Gene Transfer|gene transfer
187356|NCT02418598|Parkinson Disease|parkinson disease
187357|NCT02418598|Basal Ganglia Disease|basal ganglia disease
187358|NCT02418598|Brain Disease|brain disease
187359|NCT02418585|Treatment-resistant Depression|treatment-resistant depression
187360|NCT02418585|Esketamine|esketamine
187361|NCT02418585|Placebo|placebo
187362|NCT02418585|Oral Antidepressant|oral antidepressant
187363|NCT02418559|Healthy|healthy
187364|NCT02418559|JNJ-63623872|jnj-63623872
187365|NCT02418559|Japanese Adult Participants|japanese adult participants
187366|NCT02418533|infertility|infertility
187367|NCT02418533|in vitro fertilization|in vitro fertilization
187368|NCT02418533|fertility|fertility
187369|NCT02418533|preimplantation genetic screening|preimplantation genetic screening
187370|NCT02418533|embryo|embryo
187371|NCT02418533|PGS|pgs
187372|NCT02418533|Eeva|eeva
187373|NCT02418533|IVF|ivf
187374|NCT02418481|γδ T Cell|γδ t cell
187375|NCT02418481|breast cancer|breast cancer
187377|NCT02418481|er-|er-
187378|NCT02418481|pr-|pr-
187379|NCT02418468|COPD, FEV1, indacaterol|copd, fev1, indacaterol
187380|NCT02418455|MPS 7|mps 7
187381|NCT02418455|Sly Syndrome|sly syndrome
187382|NCT02418455|MPS VII|mps vii
187383|NCT02418455|Enzyme Replacement Therapy|enzyme replacement therapy
187384|NCT02418455|Rare Disease|rare disease
187385|NCT02418455|Mucopolysaccharidosis type 7|mucopolysaccharidosis type 7
187386|NCT02418455|Lysosomal Storage Disease|lysosomal storage disease
187387|NCT02418455|Metabolic Disorder|metabolic disorder
187388|NCT02418442|Systemic Arthritis|systemic arthritis
187389|NCT02418442|Oligoarthritis|oligoarthritis
187390|NCT02418442|Polyarthritis (Rheumatoid Factor Negative)|polyarthritis (rheumatoid factor negative)
187391|NCT02418442|Polyarthritis (Rheumatoid Factor Positive)|polyarthritis (rheumatoid factor positive)
187392|NCT02418442|Psoriatic Arthritis|psoriatic arthritis
187393|NCT02418442|Enthesitis Related Arthritis (ERA)|enthesitis related arthritis (era)
187394|NCT02418442|Undifferianted Arthritis|undifferianted arthritis
187395|NCT02418442|CARRA Consensus Treatment Plans|carra consensus treatment plans
187396|NCT02418442|FROST|frost
187397|NCT02418429|fat oxidation|fat oxidation
187398|NCT02418429|hunger|hunger
187399|NCT02418429|resistant starch|resistant starch
187400|NCT02418429|whey protein|whey protein
187401|NCT02418377|Obesity|obesity
187402|NCT02418377|Genetics|genetics
187403|NCT02418377|Whole exome sequencing|whole exome sequencing
187404|NCT02418377|Children|children
187405|NCT02418351|RRMS|rrms
187406|NCT02418325|RRMS|rrms
187407|NCT02418312|histamine-2 receptor antagonist|histamine-2 receptor antagonist
187408|NCT02418312|peptic ulcer|peptic ulcer
187409|NCT02418312|thienopyridine|thienopyridine
187410|NCT02418312|prevention|prevention
187411|NCT02418299|urinary incontinence|urinary incontinence
187412|NCT02418299|Er:YAG laser|er:yag laser
187413|NCT02418286|Low Back Pain|low back pain
187414|NCT02418286|Korean Rehabilitation Clinic|korean rehabilitation clinic
187415|NCT02418286|Patient Registry|patient registry
187416|NCT02418273|denosumab|denosumab
187417|NCT02418273|pediatric|pediatric
187418|NCT02418273|rheumatology|rheumatology
187419|NCT02418273|osteoporosis|osteoporosis
187420|NCT02418273|glucocorticoid|glucocorticoid
187421|NCT02418260|Humerus|humerus
187422|NCT02418260|shaft|shaft
187423|NCT02418260|diaphyseal|diaphyseal
187424|NCT02418260|fractures|fractures
187425|NCT02418247|radioactive iodine therapy|radioactive iodine therapy
187426|NCT02418247|ablation|ablation
187427|NCT02418247|thyroid cancer|thyroid cancer
187428|NCT02418234|Non-small Cell Lung Cancer|non-small cell lung cancer
187429|NCT02418234|circulating tumor DNA|circulating tumor dna
187430|NCT02418234|T790M|t790m
187431|NCT02418234|amplification refractory mutation system|amplification refractory mutation system
187432|NCT02418234|digital droplet PCR|digital droplet pcr
187433|NCT02418221|histamine, biogenic amines, diamine oxidase|histamine, biogenic amines, diamine oxidase
187434|NCT02418195|Depression|depression
187435|NCT02418195|Ketamine|ketamine
187436|NCT02418195|Suicide Attempt|suicide attempt
187437|NCT02418195|Suicidal Ideation|suicidal ideation
187438|NCT02418195|Suicidality|suicidality
187439|NCT02418182|Analgesic|analgesic
187440|NCT02418182|Pain Control|pain control
187441|NCT02418182|IVF|ivf
187442|NCT02418182|Tylenol|tylenol
187443|NCT02418182|Acetaminophen|acetaminophen
187444|NCT02418182|Egg Retrieval|egg retrieval
187445|NCT02418182|iv vitro Fertilization|iv vitro fertilization
187446|NCT02418117|Stereolitographic guide|stereolitographic guide
187447|NCT02418117|flapless surgery|flapless surgery
187448|NCT02418117|dental implants|dental implants
187449|NCT02418091|patients with moderate DKD and uncontrolled HTN|patients with moderate dkd and uncontrolled htn
187450|NCT02418065|Physical exercises|physical exercises
187451|NCT02418065|Oral nutritional supplementation|oral nutritional supplementation
187452|NCT02418065|Multimodal|multimodal
187453|NCT02418065|Hemodialysis|hemodialysis
187454|NCT02418065|Protein-Energy Wasting|protein-energy wasting
187455|NCT02418052|esophageal cancer|esophageal cancer
187456|NCT02418052|minimally invasive esophagectomy|minimally invasive esophagectomy
187457|NCT02418052|anastomotic leak|anastomotic leak
187458|NCT02418052|neck flexion|neck flexion
187459|NCT02418039|Minimal hepatic encephalopathy|minimal hepatic encephalopathy
187460|NCT02418039|Nutrition|nutrition
187461|NCT02418013|Frailty|frailty
187462|NCT02418013|Umbilical cord blood|umbilical cord blood
187463|NCT02418013|Plasma|plasma
187464|NCT02418013|Randomized trial|randomized trial
187465|NCT02418013|Double-blinded trial|double-blinded trial
187466|NCT02418013|Placebo-controlled trial|placebo-controlled trial
187467|NCT02417974|Prevention|prevention
187468|NCT02417974|Recurrence|recurrence
187469|NCT02417974|Fecal Microbiota Therapy|fecal microbiota therapy
187470|NCT02417961|Asthma,|asthma,
187471|NCT02417961|Bronchial Diseases,|bronchial diseases,
187472|NCT02417961|Respiratory Tract Diseases,|respiratory tract diseases,
187473|NCT02417961|Lung Diseases,|lung diseases,
187474|NCT02417961|Obstructive Lung Diseases,|obstructive lung diseases,
187475|NCT02417961|Benralizumab|benralizumab
187476|NCT02417909|Obesity|obesity
187477|NCT02417909|quality of life|quality of life
187478|NCT02417909|teenagers|teenagers
187479|NCT02417909|psychological impact|psychological impact
187480|NCT02417896|Acute kidney injury|acute kidney injury
187481|NCT02417896|Spironolactone|spironolactone
187482|NCT02417883|Furosemide|furosemide
187483|NCT02417883|Interstitial Fibrosis|interstitial fibrosis
187484|NCT02417870|Transplantation|transplantation
187485|NCT02417870|interleukin-2|interleukin-2
187486|NCT02417870|IL-2|il-2
187487|NCT02417870|Kidney|kidney
187488|NCT02417870|Renal|renal
187489|NCT02417857|Single İncision Laparoscopic Surgery|single incision laparoscopic surgery
187490|NCT02417857|Conventional Laparoscopic Surgery|conventional laparoscopic surgery
187491|NCT02417792|psoriasis|psoriasis
187492|NCT02417792|microbiota|microbiota
187493|NCT02417766|Genetic Testing|genetic testing
187494|NCT02417766|Secondary Findings|secondary findings
187495|NCT02417766|Immune-Mediated Disorders|immune-mediated disorders
187496|NCT02417766|Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal in|pediatric autoimmune neuropsychiatric disorders associated with streptococcal in
187497|NCT02417766|Whole Exome Sequencing|whole exome sequencing
187498|NCT02417753|PARACENTESIS|paracentesis
187499|NCT02417753|STAT3 Antisense Oligonucleotide|stat3 antisense oligonucleotide
187501|NCT02417753|AZD9150|azd9150
187502|NCT02417753|Surgical Resection|surgical resection
187503|NCT02417740|Portal Hypertension|portal hypertension
187504|NCT02417740|Portal Fibrosis|portal fibrosis
187505|NCT02417740|Liver Disease|liver disease
187506|NCT02417740|Varices|varices
187507|NCT02417740|Splenomegaly|splenomegaly
187508|NCT02417727|MEMORY TESTING|memory testing
187509|NCT02417727|Biomarkers|biomarkers
187510|NCT02417727|Learning|learning
187511|NCT02417714|Computed Tomography|computed tomography
187512|NCT02417714|Radiation Reduction|radiation reduction
187513|NCT02417714|Iterative Reconstruction|iterative reconstruction
187514|NCT02417688|carotid atherosclerosis, PET imaging agent|carotid atherosclerosis, pet imaging agent
187515|NCT02417675|Option B+|option b+
187516|NCT02417675|Adherence Club|adherence club
187517|NCT02417675|Postpartum|postpartum
187518|NCT02417675|Breastfeeding|breastfeeding
187519|NCT02417675|Mother-to-child transmission|mother-to-child transmission
187520|NCT02417662|NSCLC|nsclc
187521|NCT02417662|Stereotactic Ablative Radiotherapy|stereotactic ablative radiotherapy
187522|NCT02417662|Radiotherapy|radiotherapy
187523|NCT02417662|Randomised|randomised
187524|NCT02417662|Controlled|controlled
187525|NCT02417662|Oligometastatic|oligometastatic
187526|NCT02417610|Polynucleotide|polynucleotide
187527|NCT02417610|Hyaluronic acid|hyaluronic acid
187528|NCT02417610|Intra articular injection|intra articular injection
187529|NCT02417597|hepatitis E|hepatitis e
187530|NCT02417571|Chronic kidney disease|chronic kidney disease
187531|NCT02417571|Blood pressure|blood pressure
187532|NCT02417571|ambulatory blood pressure|ambulatory blood pressure
187533|NCT02417571|glomerular filtration rate|glomerular filtration rate
187534|NCT02417519|Coffee|coffee
187535|NCT02417519|Chlorogenic acid|chlorogenic acid
187536|NCT02417519|Insulin|insulin
187537|NCT02417519|Appetite|appetite
187538|NCT02417519|Metabolomics|metabolomics
187539|NCT02417506|Acute pain|acute pain
187540|NCT02417506|Herbal|herbal
187541|NCT02417506|VAS|vas
187542|NCT02417506|Stop watch|stop watch
187543|NCT02417493|Food allergy|food allergy
187544|NCT02417493|self-management|self-management
187545|NCT02417493|epinephrine self-injection|epinephrine self-injection
187546|NCT02417493|ntervention|ntervention
187547|NCT02417493|adolescents|adolescents
187548|NCT02417467|Electronic cigarette|electronic cigarette
187549|NCT02417467|E-cigarette|e-cigarette
187550|NCT02417467|Smoking cessation|smoking cessation
187551|NCT02417454|probiotic|probiotic
187552|NCT02417454|stress|stress
187553|NCT02417454|emotion psychophysiology|emotion psychophysiology
187554|NCT02417454|brain-body-gut interactions|brain-body-gut interactions
187555|NCT02417441|TiLE|tile
187556|NCT02417441|Embryo Assessment|embryo assessment
187557|NCT02417441|Pregnancy|pregnancy
187558|NCT02417441|Implantation|implantation
187559|NCT02417441|Fertilization|fertilization
187560|NCT02417428|Muscle function|muscle function
187561|NCT02417428|Functional capacity|functional capacity
187562|NCT02417415|Supine hypertension|supine hypertension
187563|NCT02417415|Autonomic failure|autonomic failure
187564|NCT02417415|Heat intolerance|heat intolerance
187565|NCT02417415|Orthostatic hypotension|orthostatic hypotension
187566|NCT02417415|Heat stress|heat stress
187567|NCT02417402|back pain|back pain
187568|NCT02417402|low back pain|low back pain
187569|NCT02417402|chronic low back pain|chronic low back pain
187570|NCT02417389|primary hyperparathyroidism|primary hyperparathyroidism
187571|NCT02417389|hypercalcemia|hypercalcemia
187572|NCT02417389|osteoporosis|osteoporosis
187573|NCT02417389|bone turnover|bone turnover
187574|NCT02417389|bone mineral density|bone mineral density
187575|NCT02417389|fractures|fractures
187576|NCT02417376|Coronary heart disease|coronary heart disease
187577|NCT02417376|Periodontitis|periodontitis
187578|NCT02417376|C-reactive protein|c-reactive protein
187579|NCT02417376|Blood pressure|blood pressure
187580|NCT02417363|biomarkers|biomarkers
187581|NCT02417363|renal disease|renal disease
187582|NCT02417363|periodontitis|periodontitis
187583|NCT02417324|medulloblastoma|medulloblastoma
187584|NCT02417324|ependymoma|ependymoma
187585|NCT02417324|pineoblastoma|pineoblastoma
187586|NCT02417324|CNS-PNET|cns-pnet
187587|NCT02417311|Engineered Heart Tissue (EHT)|engineered heart tissue (eht)
187588|NCT02417311|human induced pluripotent stem cells (hiPSC)|human induced pluripotent stem cells (hipsc)
187589|NCT02417298|ketamine|ketamine
187590|NCT02417298|pain|pain
187591|NCT02417298|sickle cell disorder|sickle cell disorder
187592|NCT02417285|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
187593|NCT02417285|Diffused Large B-Cell Lymphoma|diffused large b-cell lymphoma
187594|NCT02417285|Phase 1B|phase 1b
187595|NCT02417285|Open-Label|open-label
187596|NCT02417285|Safety and Efficacy|safety and efficacy
187597|NCT02417285|CC-122|cc-122
187598|NCT02417285|Obinutuzumab|obinutuzumab
187599|NCT02417285|GA101|ga101
187600|NCT02417285|Relapsed|relapsed
187601|NCT02417285|Refractory|refractory
187602|NCT02417272|Total Disc Replacement|total disc replacement
187603|NCT02417272|Anterior Cervical Decompression and Fusion|anterior cervical decompression and fusion
187604|NCT02417259|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
187605|NCT02417246|pharmacokinetics|pharmacokinetics
187606|NCT02417246|pharmacodynamics|pharmacodynamics
187607|NCT02417246|pharmacogenetics|pharmacogenetics
187608|NCT02417233|HIV-positive|hiv-positive
187609|NCT02417233|adherence|adherence
187610|NCT02417233|engagement to care|engagement to care
187611|NCT02417233|mHealth|mhealth
187612|NCT02417233|SMS|sms
187613|NCT02417233|peer navigation|peer navigation
187614|NCT02417233|retention|retention
187615|NCT02417207|hepatitis B immune globulin (HBIG)|hepatitis b immune globulin (hbig)
187616|NCT02417207|liver transplantation|liver transplantation
187617|NCT02417207|hepatitis B|hepatitis b
187618|NCT02417207|entecavir|entecavir
187619|NCT02417194|Renal cell carcinoma|renal cell carcinoma
187620|NCT02417194|hemoglobin A1c protein|hemoglobin a1c protein
187621|NCT02417194|Pathologic outcomes|pathologic outcomes
187622|NCT02417194|Oncological outcomes|oncological outcomes
187623|NCT02417194|Nephrectomy|nephrectomy
187624|NCT02417181|Physician assistants|physician assistants
187625|NCT02417181|Out-of-hours medical care|out-of-hours medical care
187626|NCT02417181|Primary healthcare|primary healthcare
187627|NCT02417181|Emergency Medical Services|emergency medical services
187628|NCT02417155|Autonomic Nerve System|autonomic nerve system
187629|NCT02417155|Epinephrin|epinephrin
187630|NCT02417155|Hyperventilation|hyperventilation
187631|NCT02417155|Hypoventilation|hypoventilation
187632|NCT02417064|Treatment-resistant Depression|treatment-resistant depression
187633|NCT02417064|Esketamine|esketamine
187634|NCT02417064|Placebo|placebo
187635|NCT02417064|Oral Antidepressant|oral antidepressant
187636|NCT02417051|Psychological Resilience|psychological resilience
187637|NCT02417051|Perceived Stress|perceived stress
187638|NCT02417051|Psychological Stress|psychological stress
187639|NCT02417051|Disaster Worker|disaster worker
187640|NCT02417051|Superstorm Sandy|superstorm sandy
187641|NCT02417051|Mental Health|mental health
187642|NCT02417051|Prevention|prevention
187643|NCT02417038|Postoperative Respiratory Monitoring|postoperative respiratory monitoring
187644|NCT02417038|Neuraxial Opioid Administration for Cesarean Delivery|neuraxial opioid administration for cesarean delivery
187645|NCT02417025|Military|military
187646|NCT02417025|Health Service Delivery|health service delivery
187647|NCT02417025|Telepsychology|telepsychology
187648|NCT02417025|Prolonged Exposure|prolonged exposure
187649|NCT02417025|Off-duty Activity of Military Personnel|off-duty activity of military personnel
187650|NCT02417012|lifestyle|lifestyle
187651|NCT02417012|exercise|exercise
187652|NCT02417012|physical activity|physical activity
187653|NCT02417012|diet|diet
187654|NCT02417012|glycemic control|glycemic control
187655|NCT02417012|hba1c|hba1c
187656|NCT02417012|glucose lowering drugs|glucose lowering drugs
187657|NCT02416999|glioma|glioma
187658|NCT02416999|high-grade glioma|high-grade glioma
187659|NCT02416960|female infertility|female infertility
187660|NCT02416960|glycemic index|glycemic index
187661|NCT02416960|leptin|leptin
187662|NCT02416960|ghrelin|ghrelin
187663|NCT02416960|overweight|overweight
187664|NCT02416960|obesity|obesity
187665|NCT02416960|in vitro fertilization|in vitro fertilization
187666|NCT02416947|Soluble Corn Fiber|soluble corn fiber
187667|NCT02416947|Osteoporosis|osteoporosis
187668|NCT02416947|Bone Loss|bone loss
187669|NCT02416921|Facebook|facebook
187670|NCT02416921|Weight Gain Prevention|weight gain prevention
187671|NCT02416921|Women's Health|women's health
187672|NCT02416921|Online|online
187673|NCT02416921|Weight Gain|weight gain
187674|NCT02416921|Weight Loss|weight loss
187675|NCT02416921|Female Contraception|female contraception
187676|NCT02416921|Obesity|obesity
187677|NCT02416921|Body Weight|body weight
187678|NCT02416921|Internet|internet
187679|NCT02416882|active|active
187680|NCT02416882|not active|not active
187681|NCT02416882|normal body weight|normal body weight
187682|NCT02416869|Dexamethasone|dexamethasone
187683|NCT02416869|Lower third molar surgery|lower third molar surgery
187684|NCT02416856|Aphasia|aphasia
187685|NCT02416856|Brain|brain
187686|NCT02416856|Stimulation|stimulation
187687|NCT02416856|Communication|communication
187688|NCT02416856|Stroke|stroke
187689|NCT02416856|Speech Disorders|speech disorders
187690|NCT02416856|Communications Disorders|communications disorders
187691|NCT02416856|Neurobehavioral Manifestations|neurobehavioral manifestations
187692|NCT02416856|Neurologic Manifestations|neurologic manifestations
187693|NCT02416856|Nervous System Diseases|nervous system diseases
187694|NCT02416856|Signs and Symptoms|signs and symptoms
187695|NCT02416843|Adipose tissue|adipose tissue
187696|NCT02416843|metabolism|metabolism
187697|NCT02416843|inflammation|inflammation
187698|NCT02416843|post-prandial|post-prandial
187699|NCT02416843|human|human
187700|NCT02416830|embolization|embolization
187701|NCT02416830|visceral Aneurysms|visceral aneurysms
187702|NCT02416830|Prospective Registry|prospective registry
187703|NCT02416817|Thrombelastography|thrombelastography
187704|NCT02416817|Massive Transfusion|massive transfusion
187705|NCT02416817|Major Trauma|major trauma
187706|NCT02416817|Blood products|blood products
187707|NCT02416817|Thromboelastometry|thromboelastometry
187708|NCT02416804|buprenorphine|buprenorphine
187709|NCT02416804|transdermal system|transdermal system
187710|NCT02416804|Pain, postoperative|pain, postoperative
187711|NCT02416804|Quality of life|quality of life
187712|NCT02416804|Spinal stenosis|spinal stenosis
187713|NCT02416804|Posterior lumbar fusion|posterior lumbar fusion
187714|NCT02416791|robotic therapy|robotic therapy
187715|NCT02416791|transcranial direct current stimulation|transcranial direct current stimulation
187716|NCT02416778|COPD|copd
187717|NCT02416778|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
187718|NCT02416778|Iron deficiency|iron deficiency
187719|NCT02416778|6 Minute-Walking-Test|6 minute-walking-test
187720|NCT02416765|Closed-loop strategy|closed-loop strategy
187721|NCT02416765|Artificial pancreas|artificial pancreas
187722|NCT02416765|Postprandial glucose|postprandial glucose
187723|NCT02416765|Insulin|insulin
187724|NCT02416765|Glucagon|glucagon
187725|NCT02416765|Hypoglycemia|hypoglycemia
187726|NCT02416765|Type 1 diabetes|type 1 diabetes
187727|NCT02416752|remifentanil|remifentanil
187728|NCT02416752|head and neck surgery|head and neck surgery
187729|NCT02416752|recovery pofile|recovery pofile
187730|NCT02416752|Opioid induced hyperalgesia|opioid induced hyperalgesia
187731|NCT02416752|post operative pain|post operative pain
187732|NCT02416739|EGFR mutated lung cancer|egfr mutated lung cancer
187733|NCT02416726|Gene testing|gene testing
187734|NCT02416726|Next-generation sequecing|next-generation sequecing
187735|NCT02416726|Primary tumor|primary tumor
187736|NCT02416726|Metastatic lymph node|metastatic lymph node
187737|NCT02416726|Peripheral blood|peripheral blood
187738|NCT02416713|Driving|driving
187739|NCT02416713|Teens|teens
187740|NCT02416713|Texting|texting
187741|NCT02416713|Cellphone|cellphone
187742|NCT02416713|DriveID|driveid
187743|NCT02416713|Motor vehicle accident|motor vehicle accident
187744|NCT02416700|Dental prosthesis|dental prosthesis
187745|NCT02416700|Patients|patients
187746|NCT02416700|Osseointegrated implants|osseointegrated implants
187747|NCT02416674|abdominal wall|abdominal wall
187748|NCT02416674|vascularized composite allotransplantation|vascularized composite allotransplantation
187749|NCT02416661|Gaucher Disease type 1|gaucher disease type 1
187750|NCT02416661|Lymphatic Diseases|lymphatic diseases
187751|NCT02416661|Lipid Metabolism, Inborn Errors|lipid metabolism, inborn errors
187752|NCT02416661|Lipid Metabolism Disorders|lipid metabolism disorders
187753|NCT02416661|Lipidoses|lipidoses
187754|NCT02416648|Adult HIV patients|adult hiv patients
187755|NCT02416648|Knowledge|knowledge
187756|NCT02416648|Attitudes|attitudes
187757|NCT02416648|Sexual behaviors|sexual behaviors
187758|NCT02416635|Liver Neoplasms|liver neoplasms
187759|NCT02416635|Circulating Tumor Cells|circulating tumor cells
187760|NCT02416622|XLRS|xlrs
187761|NCT02416622|maculoschisis|maculoschisis
187762|NCT02416622|retinal degeneration|retinal degeneration
187763|NCT02416622|RS1|rs1
187764|NCT02416622|adeno-associated virus|adeno-associated virus
187765|NCT02416622|gene therapy|gene therapy
187766|NCT02416622|AAV|aav
187767|NCT02416609|Locally advanced pancreatic cancer|locally advanced pancreatic cancer
187768|NCT02416609|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
187769|NCT02416609|Chemopotentiator|chemopotentiator
187770|NCT02416609|Low dose radiotherapy|low dose radiotherapy
187771|NCT02416609|Hyper-Radiosensitivity|hyper-radiosensitivity
187772|NCT02416596|ICSI|icsi
187773|NCT02416596|IVF|ivf
187774|NCT02416596|hysteroscopy|hysteroscopy
187775|NCT02416596|Supervision|supervision
187776|NCT02416596|In-vitro Fertilization|in-vitro fertilization
187777|NCT02416583|membrane sweeping|membrane sweeping
187778|NCT02416583|dinoprostone|dinoprostone
187779|NCT02416583|nulliparas|nulliparas
187780|NCT02416583|labor induction|labor induction
187781|NCT02416570|Clarithromycin|clarithromycin
187782|NCT02416544|Overweight|overweight
187783|NCT02416544|Obesity|obesity
187784|NCT02416544|Caloric Restriction|caloric restriction
187785|NCT02416544|Diet, Reducing|diet, reducing
187786|NCT02416544|Diet, Sodium-Restricted|diet, sodium-restricted
187787|NCT02416544|Body Weight Changes|body weight changes
187788|NCT02416544|Energy intake|energy intake
187789|NCT02416544|Feeding Behavior|feeding behavior
187790|NCT02416531|Vulvar lichen sclerosus|vulvar lichen sclerosus
187791|NCT02416531|Photodynamic therapy|photodynamic therapy
187792|NCT02416531|Low-level laser therapy|low-level laser therapy
187793|NCT02416531|Clobetasol propionate|clobetasol propionate
187794|NCT02416518|Cancer|cancer
187795|NCT02416518|Malignancy|malignancy
187796|NCT02416518|Genomic|genomic
187797|NCT02416518|Molecular|molecular
187798|NCT02416479|medication adherence|medication adherence
187799|NCT02416479|outcomes|outcomes
187800|NCT02416479|intervention|intervention
187801|NCT02416479|randomized controlled trial|randomized controlled trial
187802|NCT02416466|Colorectal cancer|colorectal cancer
187803|NCT02416466|Liver metastases|liver metastases
187804|NCT02416466|Breast cancer|breast cancer
187805|NCT02416466|Gastric cancer|gastric cancer
187806|NCT02416466|Pancreas cancer|pancreas cancer
187807|NCT02416466|Carcinoembryonic antigen|carcinoembryonic antigen
187808|NCT02416466|CAR-T|car-t
187809|NCT02416466|Immunotherapy|immunotherapy
187810|NCT02416453|Healthy|healthy
187811|NCT02416453|Ebola viruses|ebola viruses
187812|NCT02416453|Ebola Viral Disease (EVD)|ebola viral disease (evd)
187813|NCT02416453|Filoviruses|filoviruses
187814|NCT02416453|Monovalent vaccine|monovalent vaccine
187815|NCT02416453|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
187816|NCT02416453|Modified Vaccinia Virus Ankara - Bavarian Nordic Filo-vector (MVA-BN Filo)|modified vaccinia virus ankara - bavarian nordic filo-vector (mva-bn filo)
187817|NCT02416453|Safety|safety
187818|NCT02416453|Immunogenicity|immunogenicity
187819|NCT02416440|South African|south african
187820|NCT02416440|urban African|urban african
187821|NCT02416440|diabetes|diabetes
187822|NCT02416440|prevalence|prevalence
187823|NCT02416440|risk factors|risk factors
187824|NCT02416440|genetics|genetics
187825|NCT02416427|Atorvastatin|atorvastatin
187826|NCT02416427|TAZ|taz
187827|NCT02416427|Hippo pathway|hippo pathway
187828|NCT02416427|ki67|ki67
187829|NCT02416401|healthy|healthy
187830|NCT02416401|aging|aging
187831|NCT02416401|cognition|cognition
187832|NCT02416401|age-related cognitive decline|age-related cognitive decline
187833|NCT02416362|Postural Balance|postural balance
187834|NCT02416362|Electromyography|electromyography
187835|NCT02416362|Torque|torque
187836|NCT02416349|Stroke|stroke
187837|NCT02416349|Stretching|stretching
187838|NCT02416349|Respiratory muscle|respiratory muscle
187839|NCT02416349|Ventilatory pattern|ventilatory pattern
187840|NCT02416349|Optoelectronic plethysmography|optoelectronic plethysmography
187841|NCT02416336|sentinel lymph node|sentinel lymph node
187842|NCT02416336|lymphoscintigraphy|lymphoscintigraphy
187843|NCT02416336|intraoperative gamma camera|intraoperative gamma camera
187844|NCT02416310|TEAS|teas
187845|NCT02416310|cesarean section|cesarean section
187846|NCT02416310|gastrointestinal function|gastrointestinal function
187847|NCT02416297|malocclusion|malocclusion
187848|NCT02416297|accelerated tooth movement|accelerated tooth movement
187849|NCT02416297|Tomography|tomography
187850|NCT02416297|Extraction|extraction
187851|NCT02416258|Psoriasis|psoriasis
187852|NCT02416232|melanoma|melanoma
187853|NCT02416232|dabrafenib|dabrafenib
187854|NCT02416232|trametinib|trametinib
187855|NCT02416232|BRAF V600E/K mutation|braf v600e/k mutation
187856|NCT02416219|Cricoid cartilage, cricoid pressure, obstetric|cricoid cartilage, cricoid pressure, obstetric
187857|NCT02416206|Multiple myeloma|multiple myeloma
187858|NCT02416206|hematopoietic stem cell transplant|hematopoietic stem cell transplant
187859|NCT02416193|Diabetes|diabetes
187860|NCT02416193|Cognition|cognition
187861|NCT02416193|Functioning|functioning
187862|NCT02416180|EVOHALER|evohaler
187863|NCT02416180|Asthma|asthma
187864|NCT02416180|SERETIDE|seretide
187865|NCT02416180|DISKUS Inhaler|diskus inhaler
187866|NCT02416180|MDI|mdi
187867|NCT02416154|interferon-epsilon|interferon-epsilon
187868|NCT02416154|female reproductive tract|female reproductive tract
187869|NCT02416154|neopterin|neopterin
187870|NCT02416154|menstrual cycle|menstrual cycle
187871|NCT02416115|PONV|ponv
187872|NCT02416115|ramosetron|ramosetron
187873|NCT02416115|naloxone|naloxone
187874|NCT02416089|Tampostat|tampostat
187875|NCT02416089|Tamponade|tamponade
187876|NCT02416089|Postpartum hemorrhage|postpartum hemorrhage
187877|NCT02416076|Ulthera® System|ulthera® system
187878|NCT02416076|Ultherapy®|ultherapy®
187879|NCT02416076|Ulthera, Inc.|ulthera, inc.
187880|NCT02416050|Cocaine|cocaine
187881|NCT02416050|Dependence|dependence
187882|NCT02416050|Abstinence|abstinence
187883|NCT02416050|Prediction|prediction
187884|NCT02416050|Model|model
187885|NCT02416050|Humans|humans
187886|NCT02416050|MRI|mri
187887|NCT02416050|Cognitive|cognitive
187888|NCT02416050|Impulsivity|impulsivity
187889|NCT02416050|Craving|craving
187890|NCT02416037|ARDS|ards
187891|NCT02416037|prone position|prone position
187892|NCT02416037|PEEP|peep
187893|NCT02416037|mechanical ventilation|mechanical ventilation
187894|NCT02416024|angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
187895|NCT02416024|anesthesia|anesthesia
187896|NCT02416011|e-cigarette|e-cigarette
187897|NCT02416011|nicotine dependence|nicotine dependence
187898|NCT02415998|TEE|tee
187899|NCT02415985|pharmacokinetics of rifabutin|pharmacokinetics of rifabutin
187900|NCT02415985|HIV/TB co-infection|hiv/tb co-infection
187901|NCT02415985|resource limited setting|resource limited setting
187902|NCT02415985|AUC|auc
187903|NCT02415985|Cmax|cmax
187904|NCT02415985|Cmin|cmin
187905|NCT02415985|Ctrough|ctrough
187906|NCT02415972|ultrasound imaging|ultrasound imaging
187907|NCT02415972|acute ischemic stroke|acute ischemic stroke
187908|NCT02415972|cerebral perfusion measurement in acute ischemic stroke|cerebral perfusion measurement in acute ischemic stroke
187909|NCT02415959|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
187910|NCT02415946|regenerative medicine|regenerative medicine
187911|NCT02415946|bone substitutes|bone substitutes
187912|NCT02415946|sinus floor augmentation|sinus floor augmentation
187913|NCT02415933|Burkina Faso|burkina faso
187914|NCT02415933|West Africa|west africa
187915|NCT02415933|Children|children
187916|NCT02415933|Child Abuse|child abuse
187917|NCT02415933|Child Mental Health|child mental health
187918|NCT02415933|Economic Empowerment|economic empowerment
187919|NCT02415933|Women's Empowerment|women's empowerment
187920|NCT02415933|Domestic Violence|domestic violence
187921|NCT02415933|Child and Family Well-being|child and family well-being
187922|NCT02415933|Child Separation|child separation
187923|NCT02415933|Child Labor|child labor
187924|NCT02415933|Child Maltreatment|child maltreatment
187925|NCT02415920|Investigating oxytocin's effects|investigating oxytocin's effects
187926|NCT02415920|human communication|human communication
187927|NCT02415881|Panitumumab|panitumumab
187928|NCT02415881|Optical Imaging|optical imaging
187929|NCT02415868|Vaginal Microbiota|vaginal microbiota
187930|NCT02415842|Supra-seasonal influenza vaccine|supra-seasonal influenza vaccine
187931|NCT02415842|Pandemic|pandemic
187932|NCT02415842|Exploratory|exploratory
187933|NCT02415842|Protein epitopes|protein epitopes
187934|NCT02415842|Laboratory evaluation|laboratory evaluation
187935|NCT02415842|Retrospective|retrospective
187936|NCT02415829|Neoajuvant chemotherapy|neoajuvant chemotherapy
187937|NCT02415816|Pediatric|pediatric
187938|NCT02415816|Whole body DWI MRI|whole body dwi mri
187939|NCT02415803|low-dose ticagrelor|low-dose ticagrelor
187940|NCT02415803|clopidogrel|clopidogrel
187941|NCT02415803|Chinese patients with NSTE-ACS|chinese patients with nste-acs
187942|NCT02415803|platelet reactivity|platelet reactivity
187943|NCT02415803|inhibition of platelet aggregation|inhibition of platelet aggregation
187944|NCT02415790|E2027|e2027
187945|NCT02415790|Healthy Adult and Elderly Subjects|healthy adult and elderly subjects
187946|NCT02415790|Pharmacokinetics/Pharmacodynamics|pharmacokinetics/pharmacodynamics
187947|NCT02415738|Near infrared spectroscopy|near infrared spectroscopy
187948|NCT02415738|Cerebral oxygenation|cerebral oxygenation
187949|NCT02415738|Acute respiratory distress syndrom|acute respiratory distress syndrom
187950|NCT02415738|Prone positioning|prone positioning
187951|NCT02415712|Pharmacotherapy|pharmacotherapy
187952|NCT02415686|Dravet syndrome|dravet syndrome
187953|NCT02415686|Sudden Unexpected Death in Epilepsy (SUDEP)|sudden unexpected death in epilepsy (sudep)
187954|NCT02415686|Arrhythmias|arrhythmias
187955|NCT02415673|Orthodontics|orthodontics
187956|NCT02415673|Nitinol|nitinol
187957|NCT02415660|trigger point dry needling|trigger point dry needling
187958|NCT02415660|thoracic spine manipulation|thoracic spine manipulation
187959|NCT02415660|deep cervical extensor muscle|deep cervical extensor muscle
187960|NCT02415660|deep cervical flexor muscle|deep cervical flexor muscle
187961|NCT02415660|shear wave elastography|shear wave elastography
187962|NCT02415647|children|children
187963|NCT02415647|mental health|mental health
187964|NCT02415647|family genetic study|family genetic study
187965|NCT02415621|metastatic|metastatic
187966|NCT02415621|castration resistant|castration resistant
187967|NCT02415621|abiraterone therapy|abiraterone therapy
187968|NCT02415582|Hypertension|hypertension
187969|NCT02415582|Bloodpressure|bloodpressure
187970|NCT02415582|Post-exercise hypotension|post-exercise hypotension
187971|NCT02415582|Combined exercise|combined exercise
187972|NCT02415582|Aerobic exercise|aerobic exercise
187973|NCT02415582|Resistance exercise|resistance exercise
187974|NCT02415582|Aging|aging
187975|NCT02415582|Elderly|elderly
187976|NCT02415582|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
187977|NCT02415569|bowel cleansing|bowel cleansing
187978|NCT02415569|bisacodyl|bisacodyl
187979|NCT02415569|polyethyleneglycol|polyethyleneglycol
187980|NCT02415569|colonoscopy|colonoscopy
187981|NCT02415569|the bristol stool form scale|the bristol stool form scale
187982|NCT02415556|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
187983|NCT02415556|Intranasal Insulin|intranasal insulin
187984|NCT02415556|Placebo|placebo
187985|NCT02415556|Memory|memory
187986|NCT02415556|Gait|gait
187987|NCT02415556|Non diabetic older controls|non diabetic older controls
187988|NCT02415517|Cognitive training|cognitive training
187989|NCT02415517|Cognitive impairment|cognitive impairment
187990|NCT02415517|Heart failure|heart failure
187991|NCT02415517|Cognition|cognition
187992|NCT02415504|Care transition|care transition
187993|NCT02415504|Behavioural and psychological symptoms of dementia|behavioural and psychological symptoms of dementia
187994|NCT02415504|BPSD|bpsd
187995|NCT02415504|Dementia|dementia
187996|NCT02415504|Persons with dementia|persons with dementia
187997|NCT02415504|Discharge processes|discharge processes
187998|NCT02415491|TGA|tga
187999|NCT02415491|ASO|aso
188000|NCT02415491|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
188001|NCT02415491|young adulthood|young adulthood
188002|NCT02415478|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
188003|NCT02415478|endoscopic lung volume reduction|endoscopic lung volume reduction
188004|NCT02415478|Endobronchial valve|endobronchial valve
188005|NCT02415478|physical capacity|physical capacity
188006|NCT02415478|quality of life|quality of life
188007|NCT02415465|Knee|knee
188008|NCT02415465|Replacement|replacement
188009|NCT02415452|relationship|relationship
188010|NCT02415452|retinal artery lesions|retinal artery lesions
188011|NCT02415452|long-term outcomes|long-term outcomes
188012|NCT02415439|Safety|safety
188013|NCT02415439|tolerability|tolerability
188014|NCT02415439|pharmacokinetics|pharmacokinetics
188015|NCT02415439|adult|adult
188016|NCT02415439|volunteers|volunteers
188017|NCT02415413|Smoldering multiple myeloma|smoldering multiple myeloma
188018|NCT02415413|Carfilzomib|carfilzomib
188019|NCT02415413|Lenalidomide|lenalidomide
188020|NCT02415413|Melphalan|melphalan
188021|NCT02415413|Dexamethasone|dexamethasone
188022|NCT02415413|Autologous stem cell transplantation|autologous stem cell transplantation
188023|NCT02415361|Parents|parents
188024|NCT02415361|Follow-Up Studies|follow-up studies
188025|NCT02415309|Melatonin|melatonin
188026|NCT02415309|Lumbar medial branch block (LMBB)|lumbar medial branch block (lmbb)
188027|NCT02415309|Anxiety|anxiety
188028|NCT02415309|Interventional Pain|interventional pain
188029|NCT02415309|Pain Procedure|pain procedure
188030|NCT02415296|gambling disorder|gambling disorder
188031|NCT02415296|screening model|screening model
188032|NCT02415296|online gambling|online gambling
188033|NCT02415296|clinical validation|clinical validation
188034|NCT02415257|Vestibular schwannoma|vestibular schwannoma
188035|NCT02415257|acoustic neuroma|acoustic neuroma
188036|NCT02415257|cerebellopontine angle tumour|cerebellopontine angle tumour
188037|NCT02415257|gentamicin|gentamicin
188038|NCT02415257|rehabilitation|rehabilitation
188039|NCT02415257|postural balance|postural balance
188040|NCT02415244|ultrasound|ultrasound
188041|NCT02415231|humor laughter C reactive protein|humor laughter c reactive protein
188042|NCT02415205|Pain and stress assessment in premature infants|pain and stress assessment in premature infants
188043|NCT02415192|safety data|safety data
188044|NCT02415192|hypertension therapy|hypertension therapy
188045|NCT02415179|Newly diagnosed asthma|newly diagnosed asthma
188046|NCT02415179|peripheral airway function|peripheral airway function
188047|NCT02415127|Interferon gamma|interferon gamma
188048|NCT02415114|Coenzyme Q10|coenzyme q10
188049|NCT02415114|Resveratrol|resveratrol
188050|NCT02415114|Statin|statin
188051|NCT02415101|Adenocarcinoma|adenocarcinoma
188052|NCT02415101|Squamous cell carcinoma|squamous cell carcinoma
188053|NCT02415101|Gastroesophageal Junction|gastroesophageal junction
188054|NCT02415088|Nerve block|nerve block
188055|NCT02415075|Return to work, state of subjective health, medical rehabilitation, motivational interviewing|return to work, state of subjective health, medical rehabilitation, motivational interviewing
188056|NCT02415062|Parkinson's disease|parkinson's disease
188057|NCT02415062|dementia|dementia
188058|NCT02415036|HCC|hcc
188059|NCT02415036|ICC|icc
188060|NCT02415036|Percutaneous hepatic perfusion|percutaneous hepatic perfusion
188061|NCT02414997|RIPC (remote ischemic preconditioning)|ripc (remote ischemic preconditioning)
188062|NCT02414997|primary hypertension stage I|primary hypertension stage i
188063|NCT02414997|vascular function|vascular function
188064|NCT02414997|microRNA-126|microrna-126
188065|NCT02414997|microRNA-34a|microrna-34a
188066|NCT02414984|Rheumatoid Arthritis|rheumatoid arthritis
188067|NCT02414984|Golimumab|golimumab
188068|NCT02414984|Observational|observational
188069|NCT02414984|Compliance|compliance
188070|NCT02414971|cancer related fatigue|cancer related fatigue
188071|NCT02414971|prostate cancer|prostate cancer
188072|NCT02414971|mitochondria|mitochondria
188073|NCT02414932|ketamine|ketamine
188074|NCT02414932|electroconvulsive therapy|electroconvulsive therapy
188075|NCT02414932|glutamate|glutamate
188076|NCT02414906|Goal Directed Therapy|goal directed therapy
188077|NCT02414906|Acute Kidney Injury|acute kidney injury
188078|NCT02414880|Sugammadex|sugammadex
188079|NCT02414880|Neostigmine|neostigmine
188080|NCT02414880|Rocuronium|rocuronium
188081|NCT02414880|Cirrhosis|cirrhosis
188082|NCT02414880|Liver resection|liver resection
188083|NCT02414880|Neuromuscular|neuromuscular
188084|NCT02414841|radiocephalic|radiocephalic
188085|NCT02414841|arteriovenous fistula|arteriovenous fistula
188086|NCT02414841|AVF|avf
188087|NCT02414841|hemodialysis|hemodialysis
188088|NCT02414841|PRT-201|prt-201
188089|NCT02414841|vonapanitase|vonapanitase
188090|NCT02414841|vascular access|vascular access
188091|NCT02414841|kidney|kidney
188092|NCT02414841|renal|renal
188093|NCT02414841|PATENCY-2|patency-2
188094|NCT02414841|secondary patency|secondary patency
188095|NCT02414841|fistula abandonment|fistula abandonment
188096|NCT02414841|use for hemodialysis|use for hemodialysis
188097|NCT02414789|erythema migrans|erythema migrans
188098|NCT02414789|Lyme|lyme
188099|NCT02414789|early diagnosis|early diagnosis
188100|NCT02414789|skin biomarkers|skin biomarkers
188101|NCT02414789|proteomics diagnostic|proteomics diagnostic
188102|NCT02414789|mass spectrometry|mass spectrometry
188103|NCT02414750|Vemurafenib/cobimetinib (GDC-0973)|vemurafenib/cobimetinib (gdc-0973)
188104|NCT02414750|Melanoma|melanoma
188105|NCT02414750|Positron Emission Tomography|positron emission tomography
188106|NCT02414750|Tumor Characteristics|tumor characteristics
188107|NCT02414750|Response monitoring|response monitoring
188108|NCT02414750|Resistance prediction|resistance prediction
188109|NCT02414750|molecular targeted therapy|molecular targeted therapy
188110|NCT02414711|Depression|depression
188111|NCT02414711|Primary care|primary care
188112|NCT02414711|General Practitioners|general practitioners
188113|NCT02414685|poor-prognosis germ cell cancer, paclitaxel, ifosfamid and cisplatin regimen, tumor marker decline|poor-prognosis germ cell cancer, paclitaxel, ifosfamid and cisplatin regimen, tumor marker decline
188114|NCT02414672|psychosocial intervention|psychosocial intervention
188115|NCT02414672|advanced lung cancer|advanced lung cancer
188116|NCT02414672|caregivers|caregivers
188117|NCT02414672|self-care|self-care
188118|NCT02414633|Psoriatic Arthritis|psoriatic arthritis
188119|NCT02414620|Efficacy|efficacy
188120|NCT02414620|Dental Vibe Unit|dental vibe unit
188121|NCT02414620|Reduction|reduction
188122|NCT02414620|Elimination|elimination
188123|NCT02414620|Dental Anesthetic Injection|dental anesthetic injection
188124|NCT02414607|Elderberry juice|elderberry juice
188125|NCT02414607|Alzheimer's|alzheimer's
188126|NCT02414607|Inflammation|inflammation
188127|NCT02414555|Fluid Management|fluid management
188128|NCT02414516|HDAC|hdac
188129|NCT02414516|Epigenetic|epigenetic
188130|NCT02414516|Histone|histone
188131|NCT02414516|Acetylation|acetylation
188132|NCT02414503|oxytocin|oxytocin
188133|NCT02414503|social cognition|social cognition
188134|NCT02414490|CIDP|cidp
188135|NCT02414477|tobacco toxicants|tobacco toxicants
188136|NCT02414477|smokeless tobacco|smokeless tobacco
188137|NCT02414477|nitrosamines|nitrosamines
188138|NCT02414477|tobacco specific nitrosamines (TSNAs)|tobacco specific nitrosamines (tsnas)
188139|NCT02414464|tooth bleaching|tooth bleaching
188140|NCT02414464|adolescent|adolescent
188141|NCT02414464|clinical trial|clinical trial
188142|NCT02414451|Propranolol|propranolol
188143|NCT02414425|Fecal Incontinence|fecal incontinence
188144|NCT02414425|Botulinum Toxin A|botulinum toxin a
188145|NCT02414425|Rectal injection|rectal injection
188146|NCT02414412|Ulmus macrocarpa water extract|ulmus macrocarpa water extract
188147|NCT02414412|immunity|immunity
188148|NCT02414399|post-discharge mortality|post-discharge mortality
188149|NCT02414399|morbidity and mortality prevention|morbidity and mortality prevention
188150|NCT02414399|azithromycin|azithromycin
188151|NCT02414399|linear growth|linear growth
188152|NCT02414386|Vitamin D|vitamin d
188153|NCT02414386|Continuous Renal Replacement Therapy|continuous renal replacement therapy
188154|NCT02414386|Multi Organ Failure|multi organ failure
188155|NCT02414386|Acute Kidney Injury|acute kidney injury
188156|NCT02414386|Critical Care|critical care
188157|NCT02414386|Citrate anticoagulation|citrate anticoagulation
188158|NCT02414373|urination|urination
188159|NCT02414373|analgesia, epidural|analgesia, epidural
188160|NCT02414373|local anesthetics|local anesthetics
188161|NCT02414360|Review Literature as Topic|review literature as topic
188162|NCT02414347|Dementia|dementia
188163|NCT02414347|Tauopathies|tauopathies
188164|NCT02414347|Brain Diseases|brain diseases
188165|NCT02414347|Central Nervous System Diseases|central nervous system diseases
188166|NCT02414347|Mild Cognitive Impairment|mild cognitive impairment
188167|NCT02414347|Nervous System Diseases|nervous system diseases
188168|NCT02414347|Neurodegenerative Disease|neurodegenerative disease
188169|NCT02414334|Oligometastases|oligometastases
188170|NCT02414334|Stereotactic ablative radiotherapy (SABR)|stereotactic ablative radiotherapy (sabr)
188171|NCT02414334|Metastatic tumours|metastatic tumours
188172|NCT02414308|Erectile dysfunction, Peyronie's disease, stem cell|erectile dysfunction, peyronie's disease, stem cell
188173|NCT02414295|Stem cell|stem cell
188174|NCT02414295|Kleinfelter syndrome|kleinfelter syndrome
188175|NCT02414295|Azoospermia|azoospermia
188176|NCT02414295|Sterility|sterility
188177|NCT02414295|Infertility|infertility
188178|NCT02414282|Dementia|dementia
188179|NCT02414282|Brain Diseases|brain diseases
188180|NCT02414282|mild cognitive impairment|mild cognitive impairment
188181|NCT02414282|Central Nervous System Diseases|central nervous system diseases
188182|NCT02414282|Neurodegenerative Disease|neurodegenerative disease
188183|NCT02414269|modified T cells|modified t cells
188184|NCT02414269|cyclophosphamide|cyclophosphamide
188185|NCT02414269|CAR T cells|car t cells
188186|NCT02414269|15-007|15-007
188187|NCT02414269|CAR|car
188188|NCT02414269|immunotherapy|immunotherapy
188189|NCT02414256|breast surgery|breast surgery
188190|NCT02414230|fronto-temporal dementia|fronto-temporal dementia
188191|NCT02414230|Tauopathies|tauopathies
188192|NCT02414230|Nervous System Diseases|nervous system diseases
188193|NCT02414230|Neurodegenerative Diseases|neurodegenerative diseases
188194|NCT02414217|numeracy|numeracy
188195|NCT02414217|health literacy|health literacy
188196|NCT02414204|Arteriovenous Fistulas (AVFS)|arteriovenous fistulas (avfs)
188197|NCT02414204|Hemodialysis Fistula Maturation (HFM)|hemodialysis fistula maturation (hfm)
188198|NCT02414204|Flow-Mediated Dilation (FMD)|flow-mediated dilation (fmd)
188199|NCT02414204|Nitroglycerin-Mediated (NMD)|nitroglycerin-mediated (nmd)
188200|NCT02414204|Venous Plethysmography (VP)|venous plethysmography (vp)
188201|NCT02414191|Feedback|feedback
188202|NCT02414191|Temperature management|temperature management
188203|NCT02414191|Anesthesia|anesthesia
188204|NCT02414178|Dementia|dementia
188205|NCT02414178|Brain Diseases|brain diseases
188206|NCT02414178|Central Nervous System Diseases|central nervous system diseases
188207|NCT02414178|Mild Cognitive Impairment|mild cognitive impairment
188208|NCT02414178|nervous system diseases|nervous system diseases
188209|NCT02414178|Neurodegenerative Disease|neurodegenerative disease
188210|NCT02414165|Recurrence|recurrence
188211|NCT02414139|Non Small Cell Lung|non small cell lung
188212|NCT02414139|Non Small Cell Lung Cancer|non small cell lung cancer
188213|NCT02414139|Non-small cell lung cancer|non-small cell lung cancer
188214|NCT02414139|NSCLC|nsclc
188215|NCT02414139|INC280|inc280
188216|NCT02414139|EGFR wild-type (wt)|egfr wild-type (wt)
188217|NCT02414139|advanced non-small cell lung cancer|advanced non-small cell lung cancer
188218|NCT02414139|advanced/metastatic disease|advanced/metastatic disease
188219|NCT02414139|Non-small cell lung carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
188220|NCT02414139|treatment of lung cancer after first metastasis|treatment of lung cancer after first metastasis
188221|NCT02414139|lung cancer|lung cancer
188222|NCT02414139|lung adenocarcinoma|lung adenocarcinoma
188223|NCT02414139|Non small cell lung carcinoma|non small cell lung carcinoma
188224|NCT02414139|MET exon 14 deletion|met exon 14 deletion
188225|NCT02414139|MET exon 14 skipping|met exon 14 skipping
188226|NCT02414139|MET exon 14 mutation|met exon 14 mutation
188227|NCT02414139|MET mutation|met mutation
188228|NCT02414139|MET amplification|met amplification
188229|NCT02414139|MET inhibitor|met inhibitor
188230|NCT02414139|MET dysregulation|met dysregulation
188231|NCT02414139|MET activation|met activation
188232|NCT02414139|MET signaling|met signaling
188233|NCT02414139|MET pathway|met pathway
188234|NCT02414139|met|met
188235|NCT02414139|cMET|cmet
188236|NCT02414126|Heart failure|heart failure
188237|NCT02414126|child|child
188238|NCT02414126|work of breathing|work of breathing
188239|NCT02414126|cardiac function|cardiac function
188240|NCT02414126|sleep|sleep
188241|NCT02414126|polysomnography|polysomnography
188242|NCT02414126|CPAP|cpap
188243|NCT02414087|flat foot|flat foot
188244|NCT02414087|therapeutic effect|therapeutic effect
188245|NCT02414087|insoles|insoles
188246|NCT02414087|children|children
188247|NCT02414061|Postprandial glycemia|postprandial glycemia
188248|NCT02414061|metabolic health measures|metabolic health measures
188249|NCT02414048|Hypoxia|hypoxia
188250|NCT02414048|Head and neck cancer|head and neck cancer
188251|NCT02414035|atrial fibrillation|atrial fibrillation
188252|NCT02414035|anticoagulation|anticoagulation
188253|NCT02414035|Dabigatran|dabigatran
188254|NCT02413996|Virtual Reality Therapy|virtual reality therapy
188255|NCT02413996|Rehabilitation|rehabilitation
188256|NCT02413996|Total Knee Replacement|total knee replacement
188257|NCT02413996|Knee Arthroplasty|knee arthroplasty
188258|NCT02413996|Exercise|exercise
188259|NCT02413996|Arthritis|arthritis
188260|NCT02413996|Rheumatic Disease|rheumatic disease
188261|NCT02413970|OSA|osa
188262|NCT02413970|Neurostimulation|neurostimulation
188263|NCT02413970|Hypoglossal nerve|hypoglossal nerve
188264|NCT02413970|Tongue|tongue
188265|NCT02413970|Upper airway stimulation|upper airway stimulation
188266|NCT02413970|Surgery|surgery
188267|NCT02413957|Elderly Patients|elderly patients
188268|NCT02413957|Medication Safety|medication safety
188269|NCT02413957|Pharmaceutical Care|pharmaceutical care
188270|NCT02413957|Medication Reconciliation|medication reconciliation
188271|NCT02413931|tuberculosis|tuberculosis
188272|NCT02413931|MDR-TB|mdr-tb
188273|NCT02413918|mixed episode|mixed episode
188274|NCT02413866|body composition|body composition
188275|NCT02413866|anthropometry|anthropometry
188276|NCT02413840|COPD|copd
188277|NCT02413840|Baduanjin qigong|baduanjin qigong
188278|NCT02413840|depression|depression
188279|NCT02413840|anxiety|anxiety
188280|NCT02413827|Yervoy™, CDX-1401|yervoy™, cdx-1401
188281|NCT02413801|Psoriasis|psoriasis
188282|NCT02413801|PDUS|pdus
188283|NCT02413788|adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
188284|NCT02413788|inflammatory markers|inflammatory markers
188285|NCT02413788|exercise|exercise
188286|NCT02413749|Psoriatic Arthritis|psoriatic arthritis
188287|NCT02413723|intubation|intubation
188288|NCT02413723|critical care|critical care
188289|NCT02413723|laryngoscope|laryngoscope
188290|NCT02413723|videolaryngoscope|videolaryngoscope
188291|NCT02413723|intratracheal|intratracheal
188292|NCT02413658|Phenytoin|phenytoin
188293|NCT02413658|Skin graft donor site|skin graft donor site
188294|NCT02413658|Clean surgical site|clean surgical site
188295|NCT02413658|Wound model|wound model
188296|NCT02413632|HIV-positive MSM (men who have sex with men)|hiv-positive msm (men who have sex with men)
188297|NCT02413632|asymptomatic sexually transmitted infections|asymptomatic sexually transmitted infections
188298|NCT02413632|screening|screening
188299|NCT02413606|follow up care|follow up care
188300|NCT02413606|satisfaction with care|satisfaction with care
188301|NCT02413593|HCV genotype 3 (GT-3)|hcv genotype 3 (gt-3)
188302|NCT02413593|HCV|hcv
188303|NCT02413593|Sustained Virologic Response|sustained virologic response
188304|NCT02413593|Direct Acting Antiviral|direct acting antiviral
188305|NCT02413593|GS-7977|gs-7977
188306|NCT02413593|GS-5885|gs-5885
188307|NCT02413593|Ribavirin|ribavirin
188308|NCT02413593|Sofosbuvir|sofosbuvir
188309|NCT02413593|Ledipasvir|ledipasvir
188310|NCT02413593|Hepatitis C|hepatitis c
188311|NCT02413593|Hepatitis C, Chronic|hepatitis c, chronic
188312|NCT02413554|acetylcholinesterase inhibitors|acetylcholinesterase inhibitors
188313|NCT02413554|rivastigmine patch|rivastigmine patch
188314|NCT02413554|post-operational delirium|post-operational delirium
188315|NCT02413528|Patient Compliance|patient compliance
188316|NCT02413528|Mobile Applications|mobile applications
188317|NCT02413489|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
188318|NCT02413489|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
188319|NCT02413489|Lymphoma, Follicular|lymphoma, follicular
188320|NCT02413489|Daratumumab|daratumumab
188321|NCT02413476|robotic-assisted gastrectomy|robotic-assisted gastrectomy
188322|NCT02413476|laparoscopic-assisted gastrectomy|laparoscopic-assisted gastrectomy
188323|NCT02413476|gastric cancer|gastric cancer
188324|NCT02413450|induced Pluripotent Stem Cells (iPSC)|induced pluripotent stem cells (ipsc)
188325|NCT02413450|Channelopathies|channelopathies
188326|NCT02413450|Catecholaminergic|catecholaminergic
188327|NCT02413450|Arrhythmogenic|arrhythmogenic
188328|NCT02413437|contrast-enhanced ultrasound|contrast-enhanced ultrasound
188329|NCT02413437|biopsy|biopsy
188330|NCT02413424|sucralose|sucralose
188331|NCT02413411|Arthroplasty|arthroplasty
188332|NCT02413411|Osteoarthritis|osteoarthritis
188333|NCT02413411|Replacement|replacement
188334|NCT02413411|Intervention|intervention
188335|NCT02413385|lifestyle intervention|lifestyle intervention
188336|NCT02413385|physical activity|physical activity
188337|NCT02413385|exercise|exercise
188338|NCT02413385|eHealth|ehealth
188339|NCT02413385|technology|technology
188340|NCT02413385|coaching|coaching
188341|NCT02413385|healthy eating|healthy eating
188342|NCT02413372|First Line Therapy|first line therapy
188343|NCT02413372|NASH|nash
188344|NCT02413333|Contact lens solution|contact lens solution
188345|NCT02413320|TNBC, breast cancer, neoadjuvant, carboplatin, docetaxel, paclitaxel, doxorubicin, cyclophosphamide|tnbc, breast cancer, neoadjuvant, carboplatin, docetaxel, paclitaxel, doxorubicin, cyclophosphamide
188346|NCT02413307|Compassion Focused Therapy|compassion focused therapy
188347|NCT02413281|Healthy Volunteer|healthy volunteer
188348|NCT02413281|Abuse Liability|abuse liability
188349|NCT02413281|ALKS 5461|alks 5461
188350|NCT02413281|Alkermes|alkermes
188351|NCT02413255|Drug therapy|drug therapy
188352|NCT02413242|S. aureus|s. aureus
188353|NCT02413242|P. aeruginosa|p. aeruginosa
188354|NCT02413242|Colonization|colonization
188355|NCT02413242|Pneumonia|pneumonia
188356|NCT02413242|ICU|icu
188357|NCT02413216|Tic Disorder|tic disorder
188358|NCT02413216|Tourette|tourette
188359|NCT02413216|Motor tic|motor tic
188360|NCT02413216|Vocal tic|vocal tic
188361|NCT02413216|Habit reversal training|habit reversal training
188362|NCT02413216|CBIT|cbit
188363|NCT02413216|TicHelper|tichelper
188364|NCT02413216|Behavior Therapy|behavior therapy
188365|NCT02413203|lipidomics|lipidomics
188366|NCT02413203|ex vivo human whole blood assay|ex vivo human whole blood assay
188367|NCT02413203|celecoxib|celecoxib
188368|NCT02413203|selective COX-2 inhibitor|selective cox-2 inhibitor
188369|NCT02413164|Schizophrenia|schizophrenia
188370|NCT02413164|Mental Health|mental health
188371|NCT02413164|Physical Therapy|physical therapy
188372|NCT02413164|Quality of life|quality of life
188373|NCT02413164|Stigma|stigma
188374|NCT02413164|Positive and negative symptoms|positive and negative symptoms
188375|NCT02413164|Physical fitness|physical fitness
188376|NCT02413164|Physical activity|physical activity
188377|NCT02413151|Exercise training|exercise training
188378|NCT02413151|Cardiac resynchronization therapy|cardiac resynchronization therapy
188379|NCT02413151|Autonomic nervous system modulation|autonomic nervous system modulation
188380|NCT02413151|Chronic Heart failure|chronic heart failure
188381|NCT02413138|GHD|ghd
188382|NCT02413112|Aging|aging
188383|NCT02413112|Sarcopenia|sarcopenia
188384|NCT02413112|Resistance training|resistance training
188385|NCT02413112|Strength|strength
188386|NCT02413112|Muscle mass|muscle mass
188387|NCT02413086|diabetic foot ulcer|diabetic foot ulcer
188388|NCT02413086|early-stage amputation|early-stage amputation
188389|NCT02413086|external therapy of herbs chitosan|external therapy of herbs chitosan
188390|NCT02413086|wound surface healing|wound surface healing
188391|NCT02413073|whole body vibration|whole body vibration
188392|NCT02413073|kidney disease|kidney disease
188393|NCT02413034|antibiotic|antibiotic
188394|NCT02413021|Acute Myeloid Leukemia|acute myeloid leukemia
188395|NCT02413021|Acute Lymphoid Leukemia|acute lymphoid leukemia
188396|NCT02413021|deferasirox|deferasirox
188397|NCT02412995|sea buckthorn|sea buckthorn
188398|NCT02412995|strawberry|strawberry
188399|NCT02412995|glucose response|glucose response
188400|NCT02412995|satiety|satiety
188401|NCT02412995|metabolomics|metabolomics
188402|NCT02412995|intake biomarker|intake biomarker
188403|NCT02412956|mHealth|mhealth
188404|NCT02412904|follicular stimulating hormone|follicular stimulating hormone
188405|NCT02412904|human menopausal gonadotrophin|human menopausal gonadotrophin
188406|NCT02412904|Recombinant follicular stimulating hormone (rFSH)|recombinant follicular stimulating hormone (rfsh)
188407|NCT02412904|Gonadotrophin releasing hormone (GnRH) antagonists|gonadotrophin releasing hormone (gnrh) antagonists
188408|NCT02412904|GnRH agonist|gnrh agonist
188409|NCT02412904|in vitro fertilization|in vitro fertilization
188410|NCT02412904|controled ovarian stimulation|controled ovarian stimulation
188411|NCT02412904|number of mature oocytes|number of mature oocytes
188412|NCT02412891|introduction of urinary catheter|introduction of urinary catheter
188413|NCT02412865|mhealth|mhealth
188414|NCT02412852|neuropathy|neuropathy
188415|NCT02412826|pancreatitis|pancreatitis
188416|NCT02412826|acoustic|acoustic
188417|NCT02412826|sensor|sensor
188418|NCT02412813|hypersensitivity|hypersensitivity
188419|NCT02412813|metal sensitivity|metal sensitivity
188420|NCT02412813|arthroplasty|arthroplasty
188421|NCT02412813|implant-related hypersensitivity|implant-related hypersensitivity
188422|NCT02412813|metal-on-metal implants|metal-on-metal implants
188423|NCT02412813|knee revision|knee revision
188424|NCT02412800|Extravascular lung water|extravascular lung water
188425|NCT02412800|Pulmonary vascualr permeability index|pulmonary vascualr permeability index
188426|NCT02412800|Liver transplantation|liver transplantation
188427|NCT02412774|diet beverages|diet beverages
188428|NCT02412774|water|water
188429|NCT02412774|diabetes|diabetes
188430|NCT02412774|weight loss|weight loss
188431|NCT02412774|insulin sensitivity|insulin sensitivity
188432|NCT02412761|Anti-hypertensive medications|anti-hypertensive medications
188433|NCT02412761|Pediatrics|pediatrics
188434|NCT02412761|N-of-1 trial|n-of-1 trial
188435|NCT02412748|Non-Resident|non-resident
188436|NCT02412748|Fathers|fathers
188437|NCT02412748|African American|african american
188438|NCT02412735|Chronic Lumbar Back Pain|chronic lumbar back pain
188439|NCT02412735|Low back pain|low back pain
188440|NCT02412735|Back pain|back pain
188441|NCT02412735|Degenerative Disc Disease|degenerative disc disease
188442|NCT02412735|Injection of Degenerated Lumbar Disc|injection of degenerated lumbar disc
188443|NCT02412735|Intervertebral Disc Degeneration|intervertebral disc degeneration
188444|NCT02412735|Bone Diseases|bone diseases
188445|NCT02412735|Musculoskeletal Diseases|musculoskeletal diseases
188446|NCT02412735|Nervous System Diseases|nervous system diseases
188447|NCT02412735|Neurologic Manifestations|neurologic manifestations
188448|NCT02412735|Pain|pain
188449|NCT02412735|Spinal Diseases|spinal diseases
188450|NCT02412735|Stem Cells|stem cells
188451|NCT02412735|Adult Stem Cells|adult stem cells
188452|NCT02412735|Allogeneic Mesenchymal Precursor cells (MPCs)|allogeneic mesenchymal precursor cells (mpcs)
188453|NCT02412735|Mesoblast|mesoblast
188454|NCT02412735|Hyaluronic Acid|hyaluronic acid
188455|NCT02412735|Pharmaceutical Solutions|pharmaceutical solutions
188456|NCT02412735|Adjuvants, Immunologic|adjuvants, immunologic
188457|NCT02412735|Immunologic Factors|immunologic factors
188458|NCT02412735|Pharmacologic Actions|pharmacologic actions
188459|NCT02412735|Protective Agents|protective agents
188460|NCT02412735|rexlemestrocel-L|rexlemestrocel-l
188461|NCT02412735|Viscosupplements|viscosupplements
188462|NCT02412722|Drug therapy|drug therapy
188463|NCT02412709|Long QT Syndrome|long qt syndrome
188464|NCT02412709|LQTS|lqts
188465|NCT02412709|genetic testing|genetic testing
188466|NCT02412709|ECG|ecg
188867|NCT02410434|transgender|transgender
188467|NCT02412709|saliva testing|saliva testing
188468|NCT02412696|placental morphology|placental morphology
188469|NCT02412696|CPAP|cpap
188470|NCT02412696|placental secretory function|placental secretory function
188471|NCT02412592|HBeAg positive|hbeag positive
188472|NCT02412592|interferon|interferon
188473|NCT02412592|peginterferon|peginterferon
188474|NCT02412592|HBeAg seroconversion|hbeag seroconversion
188475|NCT02412592|sustained viral response|sustained viral response
188476|NCT02412592|relapse|relapse
188477|NCT02412579|HCC|hcc
188478|NCT02412579|Liver Cancer|liver cancer
188479|NCT02412566|cholestasis|cholestasis
188480|NCT02412566|growth failure|growth failure
188481|NCT02412566|intravenous fat emulsion|intravenous fat emulsion
188482|NCT02412566|SMOF|smof
188483|NCT02412514|polio|polio
188484|NCT02412514|inactivated poliovirus vaccine|inactivated poliovirus vaccine
188485|NCT02412514|oral poliovirus vaccine|oral poliovirus vaccine
188486|NCT02412514|IPV|ipv
188487|NCT02412514|OPV|opv
188488|NCT02412462|Phase I|phase i
188489|NCT02412462|Clusterin|clusterin
188490|NCT02412462|Epithelial-to-Mesenchymal Transition (EMT)|epithelial-to-mesenchymal transition (emt)
188491|NCT02412462|Circulating Tumor Cells (CTC)|circulating tumor cells (ctc)
188492|NCT02412462|EMT and Stem Cell Biomarkers|emt and stem cell biomarkers
188493|NCT02412462|Pharmacokinetics|pharmacokinetics
188494|NCT02412449|Pharmacokinetics|pharmacokinetics
188495|NCT02412449|Anemia|anemia
188496|NCT02412449|Chronic kidney disease|chronic kidney disease
188497|NCT02412449|CKD|ckd
188498|NCT02412449|Renal impairment|renal impairment
188499|NCT02412449|Chronic renal insufficiency|chronic renal insufficiency
188500|NCT02412449|Ferrous sulfate|ferrous sulfate
188501|NCT02412449|Iron|iron
188502|NCT02412449|End stage renal disease|end stage renal disease
188503|NCT02412449|Dialysis|dialysis
188504|NCT02412449|Oral anemia treatment|oral anemia treatment
188505|NCT02412449|Bioavailability|bioavailability
188506|NCT02412449|Erythropoietin|erythropoietin
188507|NCT02412449|Hypoxia-inducible factor|hypoxia-inducible factor
188508|NCT02412449|Volunteers|volunteers
188509|NCT02412410|laborist|laborist
188510|NCT02412410|efficacy|efficacy
188511|NCT02412410|sleep|sleep
188512|NCT02412410|fatigue|fatigue
188513|NCT02412410|SAFTE|safte
188514|NCT02412410|cognition|cognition
188515|NCT02412397|Shoulder|shoulder
188516|NCT02412384|Lung Neoplasms|lung neoplasms
188517|NCT02412384|Circulating Tumor Cells|circulating tumor cells
188518|NCT02412371|veliparib|veliparib
188519|NCT02412371|PARP inhibitor|parp inhibitor
188520|NCT02412371|ABT-888|abt-888
188521|NCT02412371|first line|first line
188522|NCT02412371|previously untreated|previously untreated
188523|NCT02412371|stage III|stage iii
188524|NCT02412371|non-small cell lung cancer|non-small cell lung cancer
188525|NCT02412371|radiotherapy|radiotherapy
188526|NCT02412371|paclitaxel|paclitaxel
188527|NCT02412371|carboplatin|carboplatin
188528|NCT02412358|toothbrushing|toothbrushing
188529|NCT02412358|plaque control|plaque control
188530|NCT02412358|gingivitis|gingivitis
188531|NCT02412345|Erectile Dysfunction|erectile dysfunction
188532|NCT02412345|Shockwave therapy|shockwave therapy
188533|NCT02412345|Renal Transplant|renal transplant
188534|NCT02412345|Male|male
188535|NCT02412345|Renal Transplant Recipients|renal transplant recipients
188536|NCT02412332|advanced COPD (stage III)|advanced copd (stage iii)
188537|NCT02412332|Adult stem cells|adult stem cells
188538|NCT02412332|Cell therapy|cell therapy
188539|NCT02412319|HBeAg positive chronic hepatitis B|hbeag positive chronic hepatitis b
188540|NCT02412319|HBeAg serum conversion rate|hbeag serum conversion rate
188541|NCT02412319|HBeAg serum disappearance rate|hbeag serum disappearance rate
188542|NCT02412319|HBeAg and HBsAg titer|hbeag and hbsag titer
188543|NCT02412306|Amgen|amgen
188544|NCT02412293|Perinatal|perinatal
188545|NCT02412293|neonatal|neonatal
188546|NCT02412293|newborn|newborn
188547|NCT02412293|mortality|mortality
188548|NCT02412189|Anesthesia|anesthesia
188549|NCT02412189|Blood pressure|blood pressure
188550|NCT02412189|Plasma volume|plasma volume
188551|NCT02412189|Vasopressor agents|vasopressor agents
188552|NCT02412189|Continuous noninvasive hemoglobin measurement|continuous noninvasive hemoglobin measurement
188553|NCT02412189|Coronary artery bypass|coronary artery bypass
188554|NCT02412176|pacemaker|pacemaker
188555|NCT02412176|dyssynchrony|dyssynchrony
188556|NCT02412176|apical pacing|apical pacing
188557|NCT02412176|mid-septum|mid-septum
188558|NCT02412098|Hepatic Impairment|hepatic impairment
188559|NCT02412085|golimumab|golimumab
188560|NCT02412085|ulcerative colitis|ulcerative colitis
188561|NCT02412085|steroid-dependent|steroid-dependent
188562|NCT02412072|Endometrial hyperplasia|endometrial hyperplasia
188563|NCT02412072|Progesterone|progesterone
188564|NCT02412072|LNG-IUS|lng-ius
188565|NCT02412072|dilatation & curettage|dilatation & curettage
188566|NCT02412072|endometrial aspiration sampling|endometrial aspiration sampling
188567|NCT02412046|Pressure ulcer|pressure ulcer
188568|NCT02412046|Interface pressure|interface pressure
189064|NCT02409264|Females|females
188569|NCT02412046|Pressure mapping device|pressure mapping device
188570|NCT02412046|Ischemia reperfusion|ischemia reperfusion
188571|NCT02412046|Monitoring|monitoring
188572|NCT02412046|Microvascularization|microvascularization
188573|NCT02412033|vaginal misoprostol|vaginal misoprostol
188574|NCT02412007|spastic diplegia;cerebral palsy;activity based therapy|spastic diplegia;cerebral palsy;activity based therapy
188575|NCT02411981|Lung Clearance Index|lung clearance index
188576|NCT02411981|Non cystic fibrosis Bronchiectasis|non cystic fibrosis bronchiectasis
188577|NCT02411981|Multiple Breath Nitrogen Washout|multiple breath nitrogen washout
188578|NCT02411968|Cryosurgery|cryosurgery
188579|NCT02411968|Carcinoma, renal cell|carcinoma, renal cell
188580|NCT02411968|Diagnostic Imaging|diagnostic imaging
188581|NCT02411968|Diagnostic techniques, urological|diagnostic techniques, urological
188582|NCT02411968|Radionuclide imaging|radionuclide imaging
188583|NCT02411968|Follow up|follow up
188584|NCT02411903|Clopidogrel-drug interactions|clopidogrel-drug interactions
188585|NCT02411890|postoperative pain|postoperative pain
188586|NCT02411890|femoral nerve block|femoral nerve block
188587|NCT02411890|adductor canal block|adductor canal block
188588|NCT02411890|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
188589|NCT02411877|Acute ischemic stroke|acute ischemic stroke
188590|NCT02411877|Mild hypothermia|mild hypothermia
188591|NCT02411877|Stroke|stroke
188592|NCT02411877|Hypothermia|hypothermia
188593|NCT02411877|Cerebral infarction|cerebral infarction
188594|NCT02411877|Ischemia|ischemia
188595|NCT02411877|Cerebrovascular disorder|cerebrovascular disorder
188596|NCT02411877|Brain disease|brain disease
188597|NCT02411877|Central nervous system disease|central nervous system disease
188598|NCT02411877|Nervous system disease|nervous system disease
188599|NCT02411877|Vascular disease|vascular disease
188600|NCT02411877|Cardiovascular disease|cardiovascular disease
188601|NCT02411877|Brain infarction|brain infarction
188602|NCT02411877|Brain ischemia|brain ischemia
188603|NCT02411877|Pathologic process|pathologic process
188604|NCT02411877|Body temperature change|body temperature change
188605|NCT02411877|Signs and symptoms|signs and symptoms
188606|NCT02411864|IVIM|ivim
188607|NCT02411864|brain|brain
188608|NCT02411864|diffusion-weighted imaging|diffusion-weighted imaging
188609|NCT02411851|Actinic Keratoses|actinic keratoses
188610|NCT02411838|Multiple sclerosis|multiple sclerosis
188611|NCT02411838|calorie restriction|calorie restriction
188612|NCT02411838|adipokines|adipokines
188613|NCT02411812|Orthodontic Appliances, Functional|orthodontic appliances, functional
188614|NCT02411812|Herbst Appliance|herbst appliance
188615|NCT02411812|Malocclusion, Angle Class II|malocclusion, angle class ii
188616|NCT02411760|MRI|mri
188617|NCT02411747|Medical|medical
188618|NCT02411747|Urology|urology
188619|NCT02411747|Randomized Controlled Trial|randomized controlled trial
188620|NCT02411747|Endoscopy|endoscopy
188621|NCT02411747|Cystoscopy|cystoscopy
188622|NCT02411721|Anxiety|anxiety
188623|NCT02411721|Dog Intervention|dog intervention
188624|NCT02411721|MRI|mri
188625|NCT02411721|Children|children
188626|NCT02411695|Adolescent|adolescent
188627|NCT02411695|Otsuka,|otsuka,
188628|NCT02411695|Brexpiprazole|brexpiprazole
188629|NCT02411669|Patient centred care|patient centred care
188630|NCT02411656|Breast cancer|breast cancer
188631|NCT02411656|Metastatic inflammatory breast cancer|metastatic inflammatory breast cancer
188632|NCT02411656|MIBC|mibc
188633|NCT02411656|IBC|ibc
188634|NCT02411656|Breast carcinoma|breast carcinoma
188635|NCT02411656|Metastatic|metastatic
188636|NCT02411656|MK-3475|mk-3475
188637|NCT02411656|Keytruda|keytruda
188638|NCT02411656|Pembrolizumab|pembrolizumab
188639|NCT02411656|SCH-900475|sch-900475
188640|NCT02411630|PrEP|prep
188641|NCT02411630|HIV Prevention|hiv prevention
188642|NCT02411578|T1D|t1d
188643|NCT02411578|Type 1 diabetes|type 1 diabetes
188644|NCT02411578|Mini-dose glucagon|mini-dose glucagon
188645|NCT02411578|adults|adults
188646|NCT02411578|non-severe hypoglycemia|non-severe hypoglycemia
188647|NCT02411565|epithelial|epithelial
188648|NCT02411565|ovarian|ovarian
188649|NCT02411565|fallopian tube|fallopian tube
188650|NCT02411565|primary peritoneal carcinoma|primary peritoneal carcinoma
188651|NCT02411565|peritoneal|peritoneal
188652|NCT02411565|ovary|ovary
188653|NCT02411539|HIV|hiv
188654|NCT02411539|VRC01|vrc01
188655|NCT02411500|Healthy|healthy
188656|NCT02411500|Male|male
188657|NCT02411500|Pharmacokinetics|pharmacokinetics
188658|NCT02411474|stem cell transplantation (SCT)|stem cell transplantation (sct)
188659|NCT02411461|Pediatric obesity|pediatric obesity
188660|NCT02411461|pseudohypoparathyroidism|pseudohypoparathyroidism
188661|NCT02411461|Albright Hereditary Osteodystrophy|albright hereditary osteodystrophy
188662|NCT02411435|rifampin|rifampin
188663|NCT02411435|drug interaction|drug interaction
188664|NCT02411435|pharmacokinetics|pharmacokinetics
188665|NCT02411435|cabotegravir|cabotegravir
188666|NCT02411422|intubation|intubation
188667|NCT02411422|cardiopulmonary resuscitation|cardiopulmonary resuscitation
188668|NCT02411422|manikins|manikins
188669|NCT02411409|Health Information Technology (HIT)|health information technology (hit)
188670|NCT02411409|self-care|self-care
188671|NCT02411383|Diaphragm pacing|diaphragm pacing
188672|NCT02411383|Respiratory assistance|respiratory assistance
188673|NCT02411383|Lung transplant|lung transplant
188674|NCT02411357|Contraception|contraception
188675|NCT02411357|Unintended pregnancy|unintended pregnancy
188676|NCT02411357|HIV risk|hiv risk
188677|NCT02411357|Sexually transmitted infections|sexually transmitted infections
188678|NCT02411357|Women|women
188679|NCT02411357|Pregnancy|pregnancy
188680|NCT02411357|Neonatal health|neonatal health
188681|NCT02411357|Drug use|drug use
188682|NCT02411357|Drug treatment|drug treatment
188683|NCT02411357|Opioids|opioids
188684|NCT02411344|HER2+/HR+|her2+/hr+
188685|NCT02411344|breast cancer|breast cancer
188686|NCT02411331|Lock Solution|lock solution
188687|NCT02411331|Catheter related blood stream infections|catheter related blood stream infections
188688|NCT02411331|Central venous catheter infection|central venous catheter infection
188689|NCT02411331|Intravenous Drug Delivery Systems|intravenous drug delivery systems
188690|NCT02411331|Coagulase-negative staphylococci infection|coagulase-negative staphylococci infection
188691|NCT02411331|Ethanol lock solution|ethanol lock solution
188692|NCT02411331|Vancomycin lock solution|vancomycin lock solution
188693|NCT02411279|Heart failure|heart failure
188694|NCT02411279|telemonitoring|telemonitoring
188695|NCT02411279|intrusive sensors|intrusive sensors
188696|NCT02411279|intrusive devices|intrusive devices
188697|NCT02411279|Heart failure stage II|heart failure stage ii
188698|NCT02411279|Heart failure stage III|heart failure stage iii
188699|NCT02411279|heart disease|heart disease
188700|NCT02411253|IL2|il2
188701|NCT02411253|Interleukin 2|interleukin 2
188702|NCT02411253|IL-2|il-2
188703|NCT02411253|Auto-immune disease|auto-immune disease
188704|NCT02411253|Insulin|insulin
188705|NCT02411253|Diabetes|diabetes
188706|NCT02411253|Regulatory T cells|regulatory t cells
188707|NCT02411253|Treg|treg
188708|NCT02411253|Immunoregulation|immunoregulation
188709|NCT02411253|Immune tolerance|immune tolerance
188710|NCT02411253|Immunotherapy|immunotherapy
188711|NCT02411240|Air filtration|air filtration
188712|NCT02411240|cardiovascular health|cardiovascular health
188713|NCT02411240|cognition|cognition
188714|NCT02411240|particulate matter|particulate matter
188715|NCT02411240|mitochondrial DNA|mitochondrial dna
188716|NCT02411227|Neuropsychologic Testing|neuropsychologic testing
188717|NCT02411227|Neurocognitive|neurocognitive
188718|NCT02411227|Virtual Reality|virtual reality
188719|NCT02411227|Rehabilitation|rehabilitation
188720|NCT02411227|Driving|driving
188721|NCT02411175|Constipation|constipation
188722|NCT02411175|Homeopathy|homeopathy
188723|NCT02411162|atopic dermatitis|atopic dermatitis
188724|NCT02411162|FLIM|flim
188725|NCT02411162|chronic plaque psoriasis|chronic plaque psoriasis
188726|NCT02411162|healthy volunteers|healthy volunteers
188727|NCT02411162|GSK2894512|gsk2894512
188728|NCT02411162|Skin residency|skin residency
188729|NCT02411149|Adductor Canal Block|adductor canal block
188730|NCT02411149|Total Knee Arthroplasty|total knee arthroplasty
188731|NCT02411123|PGx|pgx
188732|NCT02411123|pharmacogenetics|pharmacogenetics
188733|NCT02411123|depression|depression
188734|NCT02411123|anxiety|anxiety
188735|NCT02411123|Neuropsychiatric diseases|neuropsychiatric diseases
188736|NCT02411123|IDgenetix|idgenetix
188737|NCT02411123|AltheaDx|altheadx
188738|NCT02411097|Deep venous thromboembolism|deep venous thromboembolism
188739|NCT02411097|Femoral nerve block|femoral nerve block
188740|NCT02411097|Total knee arthroplasty|total knee arthroplasty
188741|NCT02411084|Graft vs Host Disease|graft vs host disease
188742|NCT02411084|Immune System Diseases|immune system diseases
188743|NCT02411084|Dipeptidyl Peptidase 4|dipeptidyl peptidase 4
188744|NCT02411084|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
188745|NCT02411084|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
188746|NCT02411071|HIV-1|hiv-1
188747|NCT02411071|antiretroviral treatment|antiretroviral treatment
188748|NCT02411071|low viral load|low viral load
188749|NCT02411071|low-level viremia|low-level viremia
188750|NCT02411058|information|information
188751|NCT02411058|incentives|incentives
188752|NCT02411045|Indirect incentives|indirect incentives
188753|NCT02411045|Exercise more|exercise more
188754|NCT02411019|Phase 2 follow up|phase 2 follow up
188755|NCT02411019|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
188756|NCT02411019|Adult|adult
188757|NCT02411019|Safety|safety
188758|NCT02411019|Efficacy|efficacy
188759|NCT02410941|Randomized controlled trial|randomized controlled trial
188760|NCT02410941|Practice management|practice management
188761|NCT02410941|tomography, x-ray computed/adverse effects|tomography, x-ray computed/adverse effects
188762|NCT02410941|Clinical decision support|clinical decision support
188763|NCT02410941|Computerized clinical decision support|computerized clinical decision support
188764|NCT02410941|Decision support systems, clinical|decision support systems, clinical
188765|NCT02410941|Health Expenditures|health expenditures
189065|NCT02409264|Homeopathy|homeopathy
188766|NCT02410941|Physician's practice patterns|physician's practice patterns
188767|NCT02410941|Unnecessary Procedures/economics|unnecessary procedures/economics
188768|NCT02410941|Physician's Practice Patterns/economics|physician's practice patterns/economics
188769|NCT02410941|Diffusion of innovation|diffusion of innovation
188770|NCT02410941|Decision Support Models|decision support models
188771|NCT02410941|Clinical Prediction Rules|clinical prediction rules
188772|NCT02410915|Rehabilitation|rehabilitation
188773|NCT02410915|Robotics|robotics
188774|NCT02410902|Autism|autism
188775|NCT02410876|Bladder|bladder
188776|NCT02410876|neurogenic lower urinary tract dysfunction|neurogenic lower urinary tract dysfunction
188777|NCT02410876|benign prostatic obstruction|benign prostatic obstruction
188778|NCT02410863|Stage III or IV with BRAF V600E/K mutation|stage iii or iv with braf v600e/k mutation
188779|NCT02410850|Oral Appliance|oral appliance
188780|NCT02410850|objective adherence|objective adherence
188781|NCT02410850|cardiovascular events|cardiovascular events
188782|NCT02410850|cardiovascular mortality|cardiovascular mortality
188783|NCT02410850|cerebrovascular mortality|cerebrovascular mortality
188784|NCT02410850|cost effectiveness|cost effectiveness
188785|NCT02410837|lung lesion|lung lesion
188786|NCT02410837|biopsy|biopsy
188787|NCT02410837|bronchoscopy|bronchoscopy
188788|NCT02410811|Sickle Cell Disease (SCD)|sickle cell disease (scd)
188789|NCT02410811|Cardiac Magnetic Resonance Imaging (CMR)|cardiac magnetic resonance imaging (cmr)
188790|NCT02410811|Cardiomyopathy|cardiomyopathy
188791|NCT02410811|Pulmonary Hypertension|pulmonary hypertension
188792|NCT02410785|obesity,|obesity,
188793|NCT02410785|body weight,|body weight,
188794|NCT02410785|overweight,|overweight,
188795|NCT02410785|weight loss,|weight loss,
188796|NCT02410785|polyglucosamine,|polyglucosamine,
188797|NCT02410785|L112|l112
188798|NCT02410785|caloric restriction|caloric restriction
188799|NCT02410785|physical activity|physical activity
188800|NCT02410746|pain|pain
188801|NCT02410746|surgery|surgery
188802|NCT02410733|melanoma|melanoma
188803|NCT02410733|Lipo-MERIT|lipo-merit
188804|NCT02410733|cancer vaccine|cancer vaccine
188805|NCT02410733|RB_0003-01|rb_0003-01
188806|NCT02410733|BioNTech|biontech
188807|NCT02410733|BioNTech RNA Pharmaceuticals|biontech rna pharmaceuticals
188808|NCT02410733|BioNTech RNA|biontech rna
188809|NCT02410733|RNA|rna
188810|NCT02410720|Colonoscopy Preparation|colonoscopy preparation
188811|NCT02410720|Polyethylene Glycols|polyethylene glycols
188812|NCT02410720|Mobile application|mobile application
188813|NCT02410720|Software|software
188814|NCT02410720|Compliance|compliance
188815|NCT02410720|Patient Compliance|patient compliance
188816|NCT02410720|Adherence|adherence
188817|NCT02410707|procedural sedation|procedural sedation
188818|NCT02410707|procedural pain|procedural pain
188819|NCT02410707|procedural anxiolysis|procedural anxiolysis
188820|NCT02410655|Uterine atony|uterine atony
188821|NCT02410655|Postpartum hemorrhage|postpartum hemorrhage
188822|NCT02410655|Vaginal delivery|vaginal delivery
188823|NCT02410655|Uterotonic|uterotonic
188824|NCT02410655|Oxytocin|oxytocin
188825|NCT02410655|Bolus|bolus
188826|NCT02410655|Evidence-based|evidence-based
188827|NCT02410655|Protocol|protocol
188828|NCT02410642|cardiopulmonary bypass|cardiopulmonary bypass
188829|NCT02410629|Stroke|stroke
188830|NCT02410616|Psychotherapy|psychotherapy
188831|NCT02410616|Comparative Effectiveness Research|comparative effectiveness research
188832|NCT02410616|Randomized Controlled Trial|randomized controlled trial
188833|NCT02410616|Secondary Care|secondary care
188834|NCT02410603|Chemotherapy|chemotherapy
188835|NCT02410577|89Zr-J591|89zr-j591
188836|NCT02410577|15-002|15-002
188837|NCT02410564|insomnia|insomnia
188838|NCT02410564|Sleep|sleep
188839|NCT02410564|CBT-I intervention|cbt-i intervention
188840|NCT02410564|SHUTi|shuti
188841|NCT02410551|Myeloproliferative Diseases|myeloproliferative diseases
188842|NCT02410551|Myeloproliferative Neoplasms|myeloproliferative neoplasms
188843|NCT02410551|MPN|mpn
188844|NCT02410551|Myelofibrosis|myelofibrosis
188845|NCT02410551|Polycythemia vera|polycythemia vera
188846|NCT02410551|PV|pv
188847|NCT02410551|Essential thrombocythemia|essential thrombocythemia
188848|NCT02410551|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
188849|NCT02410551|Allo TP|allo tp
188850|NCT02410551|Pacritinib|pacritinib
188851|NCT02410551|Busulfan|busulfan
188852|NCT02410551|Busulfex|busulfex
188853|NCT02410551|Myleran|myleran
188854|NCT02410551|Questionnaires|questionnaires
188855|NCT02410551|Surveys|surveys
188856|NCT02410551|Phone calls|phone calls
188857|NCT02410525|hyperlipidemia|hyperlipidemia
188858|NCT02410525|positron emission tomography|positron emission tomography
188859|NCT02410499|Drug therapy|drug therapy
188860|NCT02410473|Congenital Heart Disease|congenital heart disease
188861|NCT02410473|Point-of-care coagulation monitoring|point-of-care coagulation monitoring
188862|NCT02410447|Shock waves|shock waves
188863|NCT02410434|Stigma|stigma
188864|NCT02410434|lesbian|lesbian
188865|NCT02410434|gay|gay
188866|NCT02410434|bisexual|bisexual
188868|NCT02410421|Individualized Medicine|individualized medicine
188869|NCT02410421|Functional Neuroimaging|functional neuroimaging
188870|NCT02410421|Robotic Proceedure|robotic proceedure
188871|NCT02410421|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
188872|NCT02410421|Transcranial Direct Current Stimulation Monocentric|transcranial direct current stimulation monocentric
188873|NCT02410421|Compariative Cross-Over 3 Arms Study Randomized, Single-Blind Method|compariative cross-over 3 arms study randomized, single-blind method
188874|NCT02410408|Patient Safety|patient safety
188875|NCT02410408|App|app
188876|NCT02410408|Root Cause Analysis|root cause analysis
188877|NCT02410408|Patient Safety Certification|patient safety certification
188878|NCT02410382|cancer|cancer
188879|NCT02410382|radiation therapy|radiation therapy
188880|NCT02410382|chemotherapy|chemotherapy
188881|NCT02410382|dexamethasone|dexamethasone
188882|NCT02410382|corticosteroids|corticosteroids
188883|NCT02410330|Therapeutic ultrasound|therapeutic ultrasound
188884|NCT02410330|Angiographic recanalization rate|angiographic recanalization rate
188885|NCT02410330|Salvagability index|salvagability index
188886|NCT02410330|Sonothrombolysis|sonothrombolysis
188887|NCT02410317|Postoperative pain|postoperative pain
188888|NCT02410317|Postoperative morphine consumption|postoperative morphine consumption
188889|NCT02410317|Emergency cesarean delivery|emergency cesarean delivery
188890|NCT02410317|Ropivacaine|ropivacaine
188891|NCT02410317|Local anesthetic wound 48-hours infusion|local anesthetic wound 48-hours infusion
188892|NCT02410317|Emergency cesarean section|emergency cesarean section
188893|NCT02410304|Rheumatoid arthritis / ultrasonography / synovitis|rheumatoid arthritis / ultrasonography / synovitis
188894|NCT02410265|guided self-help|guided self-help
188895|NCT02410265|student mental health|student mental health
188896|NCT02410265|task shifting|task shifting
188897|NCT02410265|prevention|prevention
188898|NCT02410252|continuous temperature monitoring|continuous temperature monitoring
188899|NCT02410252|patient self-management|patient self-management
188900|NCT02410252|iThermonitor|ithermonitor
188901|NCT02410252|Home monitoring|home monitoring
188902|NCT02410239|Cerebral Adrenoleukodystrophy|cerebral adrenoleukodystrophy
188903|NCT02410239|cALD|cald
188904|NCT02410200|Pediatrics|pediatrics
188905|NCT02410187|stereotactic body radiotherapy|stereotactic body radiotherapy
188906|NCT02410174|Renal Cell Carcinoma|renal cell carcinoma
188907|NCT02410174|RCC|rcc
188908|NCT02410174|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
188909|NCT02410174|SBRT|sbrt
188910|NCT02410161|ketone|ketone
188911|NCT02410161|α-linolenic acid|α-linolenic acid
188912|NCT02410161|flaxseed|flaxseed
188913|NCT02410161|aging|aging
188914|NCT02410161|β-hydroxybutyrate|β-hydroxybutyrate
188915|NCT02410161|acetoacetate|acetoacetate
188916|NCT02410161|omega-3 fatty acids|omega-3 fatty acids
188917|NCT02410161|ketogenesis|ketogenesis
188918|NCT02410148|open-angle glaucoma|open-angle glaucoma
188919|NCT02410148|papilledema|papilledema
188920|NCT02410148|non-invasive ICP|non-invasive icp
188921|NCT02410148|Intracranial pressure|intracranial pressure
188922|NCT02410135|Lower Urinary Tract Symptoms|lower urinary tract symptoms
188923|NCT02410135|Sleep Disturbance|sleep disturbance
188924|NCT02410096|exercise-induced asthma|exercise-induced asthma
188925|NCT02410096|cold chamber|cold chamber
188926|NCT02410096|exercise challenge|exercise challenge
188927|NCT02410096|cold air challenge|cold air challenge
188928|NCT02410096|oil supplementation|oil supplementation
188929|NCT02410096|middle-chain and Polyunsaturated Fatty Acids|middle-chain and polyunsaturated fatty acids
188930|NCT02410070|Distal radial fracture|distal radial fracture
188931|NCT02410070|pronator quadratus|pronator quadratus
188932|NCT02410070|mini-approach|mini-approach
188933|NCT02410070|volar plating|volar plating
188934|NCT02410070|open reduction and internal fixation|open reduction and internal fixation
188935|NCT02410057|growth|growth
188936|NCT02410057|formula|formula
188937|NCT02410057|protein|protein
188938|NCT02410057|alpha-lactalbumin|alpha-lactalbumin
188939|NCT02410057|amino acids|amino acids
188940|NCT02410044|Patient Reported Outcomes|patient reported outcomes
188941|NCT02409992|Children with ODD and low prosocial emotions|children with odd and low prosocial emotions
188942|NCT02409979|colonoscopy|colonoscopy
188943|NCT02409979|carbon dioxide|carbon dioxide
188944|NCT02409979|water exchange|water exchange
188945|NCT02409979|discomfort|discomfort
188946|NCT02409979|colonoscopy pain|colonoscopy pain
188947|NCT02409966|periodontitis|periodontitis
188948|NCT02409966|therapeutics|therapeutics
188949|NCT02409966|quality of life|quality of life
188950|NCT02409966|fear|fear
188951|NCT02409966|anxiety|anxiety
188952|NCT02409966|pain|pain
188953|NCT02409953|volunteers|volunteers
188954|NCT02409927|Medium-chain triglycerides|medium-chain triglycerides
188955|NCT02409927|Metabolism|metabolism
188956|NCT02409927|Ketones|ketones
188957|NCT02409927|Lipids|lipids
188958|NCT02409927|Emulsification|emulsification
188959|NCT02409914|Insulin Resistance|insulin resistance
188960|NCT02409914|Brain metabolism|brain metabolism
188961|NCT02409914|PET|pet
188962|NCT02409914|MRI|mri
188963|NCT02409901|Physical Activity|physical activity
188964|NCT02409901|Exercise Rehabilitation|exercise rehabilitation
188965|NCT02409901|Kidney Function|kidney function
188966|NCT02409901|Employment|employment
188967|NCT02409901|Kidney Transplant|kidney transplant
188968|NCT02409875|early intervention|early intervention
188969|NCT02409875|obesity|obesity
188970|NCT02409875|body weight|body weight
188971|NCT02409875|body mass index|body mass index
188972|NCT02409875|overnutrition|overnutrition
188973|NCT02409875|early promoters, genetic|early promoters, genetic
188974|NCT02409862|oxytocin|oxytocin
188975|NCT02409862|socioemotional functioning|socioemotional functioning
188976|NCT02409862|aging|aging
188977|NCT02409849|Octreotide LAR|octreotide lar
188978|NCT02409849|Neuroendocrine carcinomas|neuroendocrine carcinomas
188979|NCT02409849|unresectable or metastatic|unresectable or metastatic
188980|NCT02409849|Disease-free survival|disease-free survival
188981|NCT02409823|adverse drug reactions|adverse drug reactions
188982|NCT02409823|adherence to treatment|adherence to treatment
188983|NCT02409823|quality of life|quality of life
188984|NCT02409823|clinical status|clinical status
188985|NCT02409784|Brain metabolism|brain metabolism
188986|NCT02409784|Ketones|ketones
188987|NCT02409784|Ketogenic diet|ketogenic diet
188988|NCT02409784|TEP scan|tep scan
188989|NCT02409758|Voice disorders|voice disorders
188990|NCT02409758|Hoarseness|hoarseness
188991|NCT02409758|Therapy|therapy
188992|NCT02409745|endometrial scratch|endometrial scratch
188993|NCT02409745|IVF|ivf
188994|NCT02409745|randomized controlled study|randomized controlled study
188995|NCT02409745|Prospective controlled trial|prospective controlled trial
188996|NCT02409745|Different time to perform endometrial scratch|different time to perform endometrial scratch
188997|NCT02409745|In vitro fertilization|in vitro fertilization
188998|NCT02409745|embryo transfer|embryo transfer
188999|NCT02409732|Actinic cheilitis|actinic cheilitis
189000|NCT02409732|Photodynamic therapy|photodynamic therapy
189001|NCT02409732|Levulan|levulan
189002|NCT02409732|Blue light|blue light
189003|NCT02409719|Arthritis, Degenerative|arthritis, degenerative
189004|NCT02409719|Recovery of function|recovery of function
189005|NCT02409706|Paediatric|paediatric
189006|NCT02409706|Critical care|critical care
189007|NCT02409706|Micronutrients|micronutrients
189008|NCT02409680|Preterm birth|preterm birth
189009|NCT02409680|Low dose aspirin|low dose aspirin
189010|NCT02409667|plaque, psoriasis|plaque, psoriasis
189011|NCT02409641|IOL|iol
189012|NCT02409628|Non-melanoma Skin Cancer|non-melanoma skin cancer
189013|NCT02409628|Basal Cell Carcinoma|basal cell carcinoma
189014|NCT02409628|Squamous Cell Carcinoma|squamous cell carcinoma
189015|NCT02409628|Surgical excision|surgical excision
189016|NCT02409628|EktoTherix|ektotherix
189017|NCT02409628|Secondary intention healing|secondary intention healing
189018|NCT02409628|Acute wound repair|acute wound repair
189019|NCT02409628|Tissue repair scaffold|tissue repair scaffold
189020|NCT02409628|Regenerative medicine scaffold|regenerative medicine scaffold
189021|NCT02409628|Electrospun scaffold|electrospun scaffold
189022|NCT02409615|Complementary therapies|complementary therapies
189023|NCT02409615|Hypnosis|hypnosis
189024|NCT02409615|Healing Touch|healing touch
189025|NCT02409602|Ultrasonography, Doppler, Color|ultrasonography, doppler, color
189026|NCT02409602|Postpartum hemorrhage|postpartum hemorrhage
189027|NCT02409602|Bilateral iliac artery ligation|bilateral iliac artery ligation
189028|NCT02409602|Dorsal clitoral artery|dorsal clitoral artery
189029|NCT02409576|EWS|ews
189030|NCT02409576|OS|os
189031|NCT02409576|RMS|rms
189032|NCT02409550|Allergic Rhinitis|allergic rhinitis
189033|NCT02409550|Asthma|asthma
189034|NCT02409550|Children|children
189035|NCT02409550|Control|control
189036|NCT02409537|Asymptomatic hypercholesterolemia,|asymptomatic hypercholesterolemia,
189037|NCT02409537|cardiovascular risk,|cardiovascular risk,
189038|NCT02409537|total antioxidant capacity|total antioxidant capacity
189039|NCT02409537|red wine polyphenol content|red wine polyphenol content
189040|NCT02409537|vitamin E.|vitamin e.
189041|NCT02409537|resveratrol|resveratrol
189042|NCT02409511|Type 1 Diabetic|type 1 diabetic
189043|NCT02409511|Type 2 Diabetic|type 2 diabetic
189044|NCT02409511|Hypertension|hypertension
189045|NCT02409511|Renal Injury|renal injury
189046|NCT02409511|Diabetic retinopathy|diabetic retinopathy
189047|NCT02409498|pudendal nerve block|pudendal nerve block
189048|NCT02409498|vaginal reconstructive surgery|vaginal reconstructive surgery
189049|NCT02409485|self-management|self-management
189050|NCT02409485|head and neck cancer|head and neck cancer
189051|NCT02409485|psychosocial intervention|psychosocial intervention
189052|NCT02409485|couples|couples
189053|NCT02409472|randomized clinical trial|randomized clinical trial
189054|NCT02409433|lacosamide|lacosamide
189055|NCT02409433|phenytoin|phenytoin
189056|NCT02409394|Subjects|subjects
189057|NCT02409303|Autism Spectrum Disorder|autism spectrum disorder
189058|NCT02409303|Screening|screening
189059|NCT02409303|Preventive intervention|preventive intervention
189060|NCT02409303|Risk|risk
189061|NCT02409277|Self-Management|self-management
189062|NCT02409277|Asthma|asthma
189063|NCT02409264|Insomnia|insomnia
189066|NCT02409251|Antinuclear antibody (ANA)|antinuclear antibody (ana)
189067|NCT02409251|Overuse|overuse
189068|NCT02409251|Rheumatologists|rheumatologists
189069|NCT02409251|Quality of care|quality of care
189070|NCT02409238|Mild Cognitive Impairment|mild cognitive impairment
189071|NCT02409238|Insulin Resistance|insulin resistance
189072|NCT02409238|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
189073|NCT02409225|remote monitoring|remote monitoring
189074|NCT02409225|ICD|icd
189075|NCT02409225|CRT-D|crt-d
189076|NCT02409199|Gastric Carcinoma|gastric carcinoma
189077|NCT02409199|apatinib|apatinib
189078|NCT02409173|Metabolic syndrome|metabolic syndrome
189079|NCT02409173|Sleep disorders|sleep disorders
189080|NCT02409173|Bariatric Surgery|bariatric surgery
189081|NCT02409173|Noninvasive ventilation|noninvasive ventilation
189082|NCT02409173|Inflammation|inflammation
189083|NCT02409173|Quality of life|quality of life
189084|NCT02409160|Severe Obesity|severe obesity
189085|NCT02409160|Sleep Disorders|sleep disorders
189086|NCT02409160|Bariatric Surgery|bariatric surgery
189087|NCT02409160|Inflammation|inflammation
189088|NCT02409160|Quality of Life|quality of life
189089|NCT02409134|Bone Marrow Transplantation|bone marrow transplantation
189090|NCT02409134|Hematologic Malignancies|hematologic malignancies
189091|NCT02409134|Adults|adults
189092|NCT02409134|Cognition|cognition
189093|NCT02409121|hematopoietic cell transplantation|hematopoietic cell transplantation
189094|NCT02409121|caregivers|caregivers
189095|NCT02409121|health information technology|health information technology
189096|NCT02409121|patient-centered care|patient-centered care
189097|NCT02409069|Transcutaneous vagus nerve stimulation|transcutaneous vagus nerve stimulation
189098|NCT02409069|P300|p300
189099|NCT02409069|Memory task|memory task
189100|NCT02409056|intervention|intervention
189101|NCT02409056|translation|translation
189102|NCT02409056|workplace|workplace
189103|NCT02409056|CVD|cvd
189104|NCT02409056|CDSMP|cdsmp
189105|NCT02409043|Stroke|stroke
189106|NCT02409043|Ischemic stroke|ischemic stroke
189107|NCT02409043|Hemorrhagic stroke|hemorrhagic stroke
189108|NCT02409043|Biomarkers|biomarkers
189109|NCT02409043|Angiotensins|angiotensins
189110|NCT02409017|insulin drip|insulin drip
189111|NCT02409017|labor|labor
189112|NCT02409004|Drug-drug interaction|drug-drug interaction
189113|NCT02408991|Chronic lower limb ischemia|chronic lower limb ischemia
189114|NCT02408991|Art-Assist Device|art-assist device
189115|NCT02408991|Neupogen|neupogen
189116|NCT02408926|Pertussis|pertussis
189117|NCT02408926|Pregnancy|pregnancy
189118|NCT02408926|Humoral immune response|humoral immune response
189119|NCT02408926|Functionality|functionality
189120|NCT02408926|Vaccination|vaccination
189121|NCT02408913|Immunity|immunity
189122|NCT02408913|Ebola Virus|ebola virus
189123|NCT02408913|Ebola Hemorrhagic Fever|ebola hemorrhagic fever
189124|NCT02408913|Healthy|healthy
189125|NCT02408913|Filovirus|filovirus
189126|NCT02408900|Spasticity|spasticity
189127|NCT02408900|Primary Lateral Sclerosis|primary lateral sclerosis
189128|NCT02408900|Elastography|elastography
189129|NCT02408900|Ultrasound|ultrasound
189130|NCT02408887|Thyroidectomy|thyroidectomy
189131|NCT02408887|Serum Thyroglobulin|serum thyroglobulin
189132|NCT02408887|Quality of Life|quality of life
189133|NCT02408887|Central Neck Lymph Node Metastasis|central neck lymph node metastasis
189134|NCT02408887|Central Neck Lymph Node Dissection|central neck lymph node dissection
189135|NCT02408874|Nanoparticles|nanoparticles
189136|NCT02408874|Inflammatory Response|inflammatory response
189137|NCT02408874|Silver|silver
189138|NCT02408874|Lung Function|lung function
189139|NCT02408874|Lung Microbiome|lung microbiome
189140|NCT02408835|negative pressure wound therapy|negative pressure wound therapy
189141|NCT02408835|lymphadenectomy|lymphadenectomy
189142|NCT02408835|wound healing|wound healing
189143|NCT02408809|Orthopaedic Smoking Cessation Discussion|orthopaedic smoking cessation discussion
189144|NCT02408809|Smoking Cessation|smoking cessation
189145|NCT02408809|Randomized Controlled Trial|randomized controlled trial
189146|NCT02408796|Acute otitis media with tympanostomy tubes|acute otitis media with tympanostomy tubes
189147|NCT02408757|ultrasound|ultrasound
189148|NCT02408757|cerebral perfusion|cerebral perfusion
189149|NCT02408757|cerebrospinal fluid drainage|cerebrospinal fluid drainage
189150|NCT02408744|nephroprotection|nephroprotection
189151|NCT02408744|pirfenidone|pirfenidone
189152|NCT02408744|polymorphisms|polymorphisms
189153|NCT02408718|Mobility|mobility
189154|NCT02408718|walking aids|walking aids
189155|NCT02408718|falls|falls
189156|NCT02408718|gait and balance|gait and balance
189157|NCT02408705|Endogenous Glucose Production|endogenous glucose production
189158|NCT02408705|Hypoglycemic clamp|hypoglycemic clamp
189159|NCT02408705|Tracer to Tracee Technique|tracer to tracee technique
189160|NCT02408705|Type 1 diabetes mellitus|type 1 diabetes mellitus
189161|NCT02408692|Emergency contraception|emergency contraception
189162|NCT02408692|Obese BMI|obese bmi
189163|NCT02408692|Normal BMI|normal bmi
189164|NCT02408679|Vitamin D|vitamin d
189165|NCT02408679|Vitamin D Deficiency|vitamin d deficiency
189166|NCT02408679|Vitamin D Insufficiency|vitamin d insufficiency
189167|NCT02408679|Healthy adults|healthy adults
189168|NCT02408679|Predictive questionnaire|predictive questionnaire
189169|NCT02408640|Internet-Based|internet-based
189170|NCT02408640|Treatment|treatment
189171|NCT02408549|Lacosamide|lacosamide
189172|NCT02408549|Vimpat|vimpat
189173|NCT02408549|Epilepsy|epilepsy
189174|NCT02408549|Children|children
189175|NCT02408549|Primary Generalized Tonic Clonic seizures|primary generalized tonic clonic seizures
189176|NCT02408549|Idiopathic Generalized Epilepsy|idiopathic generalized epilepsy
189177|NCT02408549|Adults|adults
189178|NCT02408536|chemotherapy|chemotherapy
189179|NCT02408536|hormone therapy|hormone therapy
189180|NCT02408536|borderline|borderline
189181|NCT02408536|low-grade|low-grade
189182|NCT02408536|serous ovarian cancer|serous ovarian cancer
189183|NCT02408523|Lacosamide|lacosamide
189184|NCT02408523|Vimpat|vimpat
189185|NCT02408523|Epilepsy|epilepsy
189186|NCT02408523|Children|children
189187|NCT02408523|Primary Generalized Tonic Clonic seizures|primary generalized tonic clonic seizures
189188|NCT02408523|Idiopathic Generalized Epilepsy|idiopathic generalized epilepsy
189189|NCT02408523|Adults|adults
189190|NCT02408510|Volunteers|volunteers
189191|NCT02408471|Arthritis|arthritis
189192|NCT02408471|Rheumatoid Arthritis|rheumatoid arthritis
189193|NCT02408471|Systemic Lupus Erythematosus|systemic lupus erythematosus
189194|NCT02408471|Osteoarthritis|osteoarthritis
189195|NCT02408471|Autoimmune Diseases|autoimmune diseases
189196|NCT02408471|Connective Tissue Diseases|connective tissue diseases
189197|NCT02408471|Immune System Diseases|immune system diseases
189198|NCT02408471|Joint Diseases|joint diseases
189199|NCT02408471|Musculoskeletal Diseases|musculoskeletal diseases
189200|NCT02408471|Rheumatic Diseases|rheumatic diseases
189201|NCT02408445|body composition|body composition
189202|NCT02408445|Klinefelter syndrome|klinefelter syndrome
189203|NCT02408445|XXY|xxy
189204|NCT02408445|sex chromosome variation|sex chromosome variation
189205|NCT02408445|sex chromsome aneuploidy|sex chromsome aneuploidy
189206|NCT02408432|Blood And Marrow Transplantation|blood and marrow transplantation
189207|NCT02408432|Left ventricular dysfunction|left ventricular dysfunction
189208|NCT02408432|LV|lv
189209|NCT02408432|Heart failure secondary to chemotherapy with anthracyclines|heart failure secondary to chemotherapy with anthracyclines
189210|NCT02408432|Allogeneic human mesenchymal stem cells|allogeneic human mesenchymal stem cells
189211|NCT02408432|hMSCs|hmscs
189212|NCT02408432|Standard of care drugs for heart failure|standard of care drugs for heart failure
189213|NCT02408406|TNM Finding v7|tnm finding v7
189214|NCT02408393|Surgery|surgery
189215|NCT02408393|Paravertebral block|paravertebral block
189216|NCT02408393|Chronic pain|chronic pain
189217|NCT02408380|biomarker|biomarker
189218|NCT02408380|disease progression|disease progression
189219|NCT02408367|Training|training
189220|NCT02408367|Cognition|cognition
189221|NCT02408367|Multiple Sclerosis|multiple sclerosis
189222|NCT02408341|Propofol, Induction anesthesia, Doppler tissue imaging|propofol, induction anesthesia, doppler tissue imaging
189223|NCT02408315|induction of labor|induction of labor
189224|NCT02408315|safety|safety
189225|NCT02408315|pharmacokinetic|pharmacokinetic
189226|NCT02408315|misoprostol|misoprostol
189227|NCT02408250|algorithm|algorithm
189228|NCT02408250|critical illness|critical illness
189229|NCT02408250|early exercise|early exercise
189230|NCT02408250|feasibility|feasibility
189231|NCT02408250|intensive care unit|intensive care unit
189232|NCT02408250|physical therapy|physical therapy
189233|NCT02408237|Transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
189234|NCT02408237|tDCS for domiciliary use|tdcs for domiciliary use
189235|NCT02408237|Healthy Participants|healthy participants
189236|NCT02408224|ACS|acs
189237|NCT02408185|infections|infections
189238|NCT02408185|multidrug resistant Gram negative bacteria (MDR-GNB)|multidrug resistant gram negative bacteria (mdr-gnb)
189239|NCT02408185|Skin infections|skin infections
189240|NCT02408185|Pneumonia|pneumonia
189241|NCT02408185|Bacteriemia|bacteriemia
189242|NCT02408185|Nosocomial infections|nosocomial infections
189243|NCT02408172|hypertension|hypertension
189244|NCT02408172|Sleep apnea syndrome|sleep apnea syndrome
189245|NCT02408172|Amlodipine|amlodipine
189246|NCT02408172|metoprolol|metoprolol
189247|NCT02408159|Live, attenuated virus varicella-zoster vaccine|live, attenuated virus varicella-zoster vaccine
189248|NCT02408159|Zostavax|zostavax
189249|NCT02408159|herpes zoster|herpes zoster
189250|NCT02408159|shingles|shingles
189251|NCT02408133|Breast Cancer|breast cancer
189252|NCT02408133|elderly|elderly
189253|NCT02408133|quality of life|quality of life
189254|NCT02408133|exercise|exercise
189255|NCT02408120|Hyperglycemia|hyperglycemia
189256|NCT02408120|Hypoglycemia|hypoglycemia
189257|NCT02408107|Physical activity|physical activity
189258|NCT02408107|Randomized controlled trial|randomized controlled trial
189259|NCT02408094|Rheumatoid Arthritis|rheumatoid arthritis
189260|NCT02408094|Heat-dampness and blood stasis syndrome|heat-dampness and blood stasis syndrome
189261|NCT02408094|Protein markers|protein markers
189262|NCT02408081|Depression|depression
189263|NCT02408081|Family functioning|family functioning
189264|NCT02408081|Family Focused Nursing|family focused nursing
189265|NCT02408081|Quality of life|quality of life
189266|NCT02408068|subjects|subjects
189267|NCT02408029|Focus|focus
189268|NCT02408029|Testing Performance|testing performance
189269|NCT02408029|CORA Hemostasis System|cora hemostasis system
189270|NCT02408003|Transesophageal|transesophageal
189271|NCT02408003|Echocardiography|echocardiography
189272|NCT02408003|Milrinone|milrinone
189273|NCT02408003|Levosimendan|levosimendan
189274|NCT02408003|Strain|strain
189275|NCT02408003|Deformation|deformation
189276|NCT02408003|Diastole|diastole
189277|NCT02408003|Afterload|afterload
189278|NCT02408003|Preload|preload
189279|NCT02408003|Systole|systole
189280|NCT02407964|Drug-Induced Liver Injury|drug-induced liver injury
189281|NCT02407964|DILI|dili
189282|NCT02407938|dysphagia|dysphagia
189283|NCT02407938|reflux symptoms|reflux symptoms
189284|NCT02407938|retrosternal pain|retrosternal pain
189285|NCT02407925|Optical diagnosis|optical diagnosis
189286|NCT02407899|LADA|lada
189287|NCT02407899|saxagliptin|saxagliptin
189288|NCT02407899|vitamin D3|vitamin d3
189289|NCT02407899|C-Peptide|c-peptide
189290|NCT02407873|aged of 75 years or more|aged of 75 years or more
189291|NCT02407860|breast feeding|breast feeding
189292|NCT02407860|sucking|sucking
189293|NCT02407860|dysfunction|dysfunction
189294|NCT02407860|Latch assessment tool|latch assessment tool
189295|NCT02407860|visual analogic scale|visual analogic scale
189296|NCT02407860|infant physiology|infant physiology
189297|NCT02407847|Nurse practitioners|nurse practitioners
189298|NCT02407847|Primary healthcare|primary healthcare
189299|NCT02407847|Emergency Medical Services|emergency medical services
189300|NCT02407847|Substitution of care|substitution of care
189301|NCT02407834|Biofilms|biofilms
189302|NCT02407834|Dentures|dentures
189303|NCT02407834|Denture Cleansers|denture cleansers
189304|NCT02407834|Castor Oil|castor oil
189305|NCT02407834|Stomatitis|stomatitis
189306|NCT02407821|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
189307|NCT02407821|Kidney Failure|kidney failure
189308|NCT02407821|Renal Insufficiency, Chronic|renal insufficiency, chronic
189309|NCT02407821|Dialysis, Renal|dialysis, renal
189310|NCT02407821|Peritoneal Dialysis|peritoneal dialysis
189311|NCT02407821|Hemodialysis|hemodialysis
189312|NCT02407821|Depressive Symptoms|depressive symptoms
189313|NCT02407821|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors
189314|NCT02407821|Antidepressants|antidepressants
189315|NCT02407821|Escitalopram|escitalopram
189316|NCT02407795|stereotactic radiotherapy|stereotactic radiotherapy
189317|NCT02407795|pain reduction|pain reduction
189318|NCT02407795|quality of life|quality of life
189319|NCT02407782|Scabies|scabies
189320|NCT02407782|children|children
189321|NCT02407782|cluster|cluster
189322|NCT02407782|permethrin|permethrin
189323|NCT02407782|Ivermectin|ivermectin
189324|NCT02407769|Liver transplantation|liver transplantation
189325|NCT02407769|Liver cirrhosis|liver cirrhosis
189326|NCT02407769|Branched chain amino acids|branched chain amino acids
189327|NCT02407769|Late evening supplementation|late evening supplementation
189328|NCT02407769|Nutritional status|nutritional status
189329|NCT02407756|Eczema|eczema
189330|NCT02407743|postoperative pain|postoperative pain
189331|NCT02407743|surgery|surgery
189332|NCT02407743|pain resolution|pain resolution
189333|NCT02407743|pain intensity|pain intensity
189334|NCT02407743|persistent postsurgical pain|persistent postsurgical pain
189335|NCT02407743|pain-related genes|pain-related genes
189336|NCT02407743|analgesic|analgesic
189337|NCT02407704|Exercise|exercise
189338|NCT02407704|Physical activity|physical activity
189339|NCT02407704|GABA|gaba
189340|NCT02407704|Venlafaxine|venlafaxine
189341|NCT02407704|fMRI|fmri
189342|NCT02407704|Spectroscopy|spectroscopy
189343|NCT02407704|Reward system|reward system
189344|NCT02407704|BDNF|bdnf
189345|NCT02407704|Sleep|sleep
189346|NCT02407704|Cognitive function|cognitive function
189347|NCT02407704|Biomarkers|biomarkers
189348|NCT02407704|Aerobic exercise|aerobic exercise
189349|NCT02407665|Tai Chi|tai chi
189350|NCT02407665|fMRI|fmri
189351|NCT02407639|insufflation|insufflation
189352|NCT02407639|abdominal pain|abdominal pain
189353|NCT02407626|ischemia|ischemia
189354|NCT02407626|cardiac surgery|cardiac surgery
189355|NCT02407626|volatile anesthetic|volatile anesthetic
189356|NCT02407626|total intravenous anesthesia|total intravenous anesthesia
189357|NCT02407613|breast cancer|breast cancer
189358|NCT02407613|MR-HIFU|mr-hifu
189359|NCT02407613|ablation|ablation
189360|NCT02407613|non-invasive treatment|non-invasive treatment
189361|NCT02407600|EMEND for Injection|emend for injection
189362|NCT02407600|5HT-3|5ht-3
189363|NCT02407600|Fosaprepitant|fosaprepitant
189364|NCT02407561|rectal|rectal
189365|NCT02407561|adenocarcinoma|adenocarcinoma
189366|NCT02407561|DecisionDx|decisiondx
189367|NCT02407548|cholesterol efflux|cholesterol efflux
189368|NCT02407548|dyslipidemia|dyslipidemia
189369|NCT02407522|Metabolic Syndrome|metabolic syndrome
189370|NCT02407522|black rice|black rice
189371|NCT02407483|Laparoscopy|laparoscopy
189372|NCT02407483|Training Programs|training programs
189373|NCT02407470|Severe Aplastic Anemia (SAA), Hematopoietic Stem Cells, HSC Transplantation|severe aplastic anemia (saa), hematopoietic stem cells, hsc transplantation
189374|NCT02407470|ATG, Mesenchymal Stem Cells, Transdifferentiation,|atg, mesenchymal stem cells, transdifferentiation,
189375|NCT02407444|Proximal hip fracture|proximal hip fracture
189376|NCT02407444|Elderly patients|elderly patients
189377|NCT02407444|Physiotherapy|physiotherapy
189378|NCT02407444|Leg cycling ergometer|leg cycling ergometer
189379|NCT02407418|spinal manipulation|spinal manipulation
189380|NCT02407418|muscle strength dynamometer|muscle strength dynamometer
189381|NCT02407418|muscle strength|muscle strength
189382|NCT02407379|Laser|laser
189383|NCT02407379|periodontitis|periodontitis
189384|NCT02407379|scaling root planing|scaling root planing
189385|NCT02407379|bacteria|bacteria
189386|NCT02407379|PMN|pmn
189387|NCT02407366|Inoperable stage III non-small cell lung cancer|inoperable stage iii non-small cell lung cancer
189388|NCT02407366|EGFR mutation|egfr mutation
189389|NCT02407366|Icotinib|icotinib
189390|NCT02407366|Radiotherapy|radiotherapy
189391|NCT02407366|Chemoradiotherapy|chemoradiotherapy
189392|NCT02407353|Phase 1|phase 1
189393|NCT02407353|Double blind|double blind
189394|NCT02407353|Placebo-Controlled|placebo-controlled
189395|NCT02407353|Parallel Design|parallel design
189396|NCT02407353|CSF Aβ Concentrations|csf aβ concentrations
189397|NCT02407353|PF-06648671|pf-06648671
189398|NCT02407340|Alcohol Withdrawal Delirium|alcohol withdrawal delirium
189399|NCT02407327|Circulating tumour cells in Advanced Non Small Cell Lung Cancer|circulating tumour cells in advanced non small cell lung cancer
189400|NCT02407314|Peripheral Arterial Disease|peripheral arterial disease
189401|NCT02407314|Optical Coherence Tomography|optical coherence tomography
189402|NCT02407314|Ticagrelor|ticagrelor
189403|NCT02407314|Aspirin|aspirin
189404|NCT02407314|Claudication|claudication
189405|NCT02407314|Clopidogrel|clopidogrel
189406|NCT02407288|OCD|ocd
189407|NCT02407262|asthma|asthma
189408|NCT02407262|black seed|black seed
189409|NCT02407262|Nigella sativa|nigella sativa
189410|NCT02407262|supplementation|supplementation
189411|NCT02407236|Ustekinumab|ustekinumab
189412|NCT02407236|Inflammatory Bowel Diseases (IBD)|inflammatory bowel diseases (ibd)
189413|NCT02407236|Colitis, Ulcerative|colitis, ulcerative
189414|NCT02407223|Nonradiographic Axial Spondylitis, Ankylosing|nonradiographic axial spondylitis, ankylosing
189415|NCT02407223|Ustekinumab|ustekinumab
189416|NCT02407210|Azilsartan，Olmesartan Medoxomil|azilsartan，olmesartan medoxomil
189417|NCT02407197|T1 mapping|t1 mapping
189418|NCT02407197|CMR|cmr
189419|NCT02407197|Outcome|outcome
189420|NCT02407197|multicenter|multicenter
189421|NCT02407184|Microbiota|microbiota
189422|NCT02407184|Microbiome|microbiome
189423|NCT02407145|retropubic|retropubic
189424|NCT02407145|midurethral sling|midurethral sling
189425|NCT02407145|polyvinylidene fluoride|polyvinylidene fluoride
189426|NCT02407119|H. pylori eradication|h. pylori eradication
189427|NCT02407119|Atrophy|atrophy
189428|NCT02407119|Intestinal metaplasia|intestinal metaplasia
189429|NCT02407119|Endoscopic resection|endoscopic resection
189430|NCT02407119|Stomach neoplasm|stomach neoplasm
189431|NCT02407106|BLIS K12|blis k12
189432|NCT02407106|streptococcus|streptococcus
189433|NCT02407093|Body Composition|body composition
189434|NCT02407093|Military|military
189435|NCT02407093|High-Intensity Functional Training|high-intensity functional training
189436|NCT02407093|Army Physical Fitness|army physical fitness
189437|NCT02407093|CrossFit|crossfit
189438|NCT02407002|Nitroglycerin|nitroglycerin
189439|NCT02407002|Safety|safety
189440|NCT02406976|Exercise|exercise
189441|NCT02406976|Morbidity Obesity|morbidity obesity
189442|NCT02406963|telemedicine|telemedicine
189443|NCT02406950|Sitagliptin|sitagliptin
189444|NCT02406950|Endothelium|endothelium
189445|NCT02406950|Ischemia-Reperfusion Injury|ischemia-reperfusion injury
189446|NCT02406950|human|human
189447|NCT02406924|pin|pin
189448|NCT02406924|particulated graft|particulated graft
189449|NCT02406924|bone augmentation|bone augmentation
189450|NCT02406924|vertical augmentation|vertical augmentation
189451|NCT02406924|horizontal augmentation|horizontal augmentation
189452|NCT02406911|platelet|platelet
189453|NCT02406911|ticagrelor|ticagrelor
189454|NCT02406911|clopidogrel|clopidogrel
189455|NCT02406911|end stage renal disease|end stage renal disease
189456|NCT02406911|hemodialysis|hemodialysis
189457|NCT02406859|Spinal Cord Injury|spinal cord injury
189458|NCT02406859|Constipation|constipation
189459|NCT02406859|Fecal Incontinence|fecal incontinence
189460|NCT02406859|Neurogenic Bowel|neurogenic bowel
189461|NCT02406859|Bowel Biofeedback|bowel biofeedback
189462|NCT02406859|Manometry|manometry
189463|NCT02406846|Pancreatic Neoplasms|pancreatic neoplasms
189464|NCT02406846|Circulating Tumor Cells|circulating tumor cells
189465|NCT02406833|glaucoma|glaucoma
189466|NCT02406833|trabeculectomy|trabeculectomy
189467|NCT02406807|chronic low back pain|chronic low back pain
189468|NCT02406807|HVLA manipulation|hvla manipulation
189469|NCT02406794|Breast cancer|breast cancer
189470|NCT02406794|Hormonal therapy|hormonal therapy
189471|NCT02406794|Aromatase inhibitors|aromatase inhibitors
189472|NCT02406794|Estrogen deprivation|estrogen deprivation
189473|NCT02406794|Myalgia|myalgia
189474|NCT02406794|Arthralgia|arthralgia
189475|NCT02406794|Carpal tunnel syndrome|carpal tunnel syndrome
189476|NCT02406794|Pressure pain threshold|pressure pain threshold
189477|NCT02406794|Neuromuscular taping|neuromuscular taping
189478|NCT02406794|Kinesio taping|kinesio taping
189479|NCT02406781|Efficacy of MK 3475 with Metronomic Cyclophosphamide|efficacy of mk 3475 with metronomic cyclophosphamide
189480|NCT02406781|Advanced Sarcomas|advanced sarcomas
189481|NCT02406781|Leiomyosarcoma|leiomyosarcoma
189482|NCT02406781|Undifferentiated Sarcoma|undifferentiated sarcoma
189483|NCT02406781|Other Sarcoma|other sarcoma
189484|NCT02406781|GIST|gist
189485|NCT02406781|Osteosarcoma|osteosarcoma
189486|NCT02406768|normal controls|normal controls
189487|NCT02406742|CC-122|cc-122
189488|NCT02406742|Pharmacokinetics|pharmacokinetics
189489|NCT02406742|Safety|safety
189490|NCT02406742|Ibrutinib|ibrutinib
189491|NCT02406742|Obinutuzumab|obinutuzumab
189492|NCT02406742|GA101|ga101
189493|NCT02406742|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
189494|NCT02406742|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
189495|NCT02406703|local anesthesia|local anesthesia
189496|NCT02406703|regional anesthetic|regional anesthetic
189497|NCT02406690|Endometrial Insufficiency|endometrial insufficiency
189498|NCT02406690|Endometrial Receptivity|endometrial receptivity
189499|NCT02406677|Acute Coronary Syndromes, ACS, Myocardial Infarction, STEMI, NSTEMI, MI, Co-Payments, Copay, Cost Sharing|acute coronary syndromes, acs, myocardial infarction, stemi, nstemi, mi, co-payments, copay, cost sharing
189500|NCT02406638|3D Pelvic floor USG|3d pelvic floor usg
189501|NCT02406638|Mid-Urethral Sling|mid-urethral sling
189502|NCT02406638|TVT|tvt
189503|NCT02406638|TVT-O|tvt-o
189504|NCT02406638|TVT-S|tvt-s
189505|NCT02406612|Vascular Closure Device|vascular closure device
189506|NCT02406612|Femoral Artery Closure|femoral artery closure
189507|NCT02406573|Sensitivity|sensitivity
189508|NCT02406547|Serrated lesion|serrated lesion
189509|NCT02406547|sessile serrated adenoma|sessile serrated adenoma
189510|NCT02406547|Narrow Band Imaging|narrow band imaging
189511|NCT02406547|Colonoscopy|colonoscopy
189512|NCT02406547|colorectal neoplasms|colorectal neoplasms
189513|NCT02406521|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
189514|NCT02406521|mRCC|mrcc
189515|NCT02406482|sex work, Kazakhstan, microfinance, drug use|sex work, kazakhstan, microfinance, drug use
189516|NCT02406443|Type 2 Diabetes, DPP-4 inhibitors, renal sodium excretion|type 2 diabetes, dpp-4 inhibitors, renal sodium excretion
189517|NCT02406339|Physical Therapy|physical therapy
189518|NCT02406339|Rehabilitation|rehabilitation
189519|NCT02406339|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
189520|NCT02406339|Muscle Strength|muscle strength
189521|NCT02406300|Hip Fracture|hip fracture
189522|NCT02406300|Regional Anesthesia|regional anesthesia
189523|NCT02406300|Peripheral Nerve Blocks|peripheral nerve blocks
189524|NCT02406300|Post-operative Mortality|post-operative mortality
189525|NCT02406300|Cognitive Dysfunction|cognitive dysfunction
189526|NCT02406300|Quality of Life|quality of life
189527|NCT02406274|Mammography|mammography
189528|NCT02406274|Contrast Enhanced Spectral Mammography|contrast enhanced spectral mammography
189529|NCT02406274|Palpable Breast Abnormalities|palpable breast abnormalities
189530|NCT02406274|15-053|15-053
189531|NCT02406248|NSTEMI|nstemi
189532|NCT02406222|Relapsed|relapsed
189533|NCT02406222|Refractory|refractory
189534|NCT02406222|Pomalidomide|pomalidomide
189535|NCT02406222|Dexamethasone|dexamethasone
189536|NCT02406222|Cyclophosphamide|cyclophosphamide
189537|NCT02406209|uveitis|uveitis
189538|NCT02406209|acute uveitis|acute uveitis
189539|NCT02406209|anterior uveitis|anterior uveitis
189540|NCT02406209|NS2|ns2
189541|NCT02406209|Aldeyra|aldeyra
189542|NCT02406209|prednisolone acetate|prednisolone acetate
189543|NCT02406157|diabetic macular edema|diabetic macular edema
189544|NCT02406157|micropulse|micropulse
189545|NCT02406157|laser|laser
189546|NCT02406157|subthreshold|subthreshold
189547|NCT02406144|Multiple Myeloma|multiple myeloma
189548|NCT02406131|Peripheral Vascular Diseases|peripheral vascular diseases
189549|NCT02406131|Ischemic Preconditioning|ischemic preconditioning
189550|NCT02406131|Inflammation|inflammation
189551|NCT02406131|Angioplasty|angioplasty
189552|NCT02406131|Restenosis|restenosis
189553|NCT02406131|RCT|rct
189554|NCT02406118|transanal TME quality|transanal tme quality
189555|NCT02406118|CRM|crm
189556|NCT02406105|tremor|tremor
189557|NCT02406105|Parkinson disease|parkinson disease
189558|NCT02406105|functional radioablation|functional radioablation
189559|NCT02406105|Cyber Knife radiosurgery|cyber knife radiosurgery
189560|NCT02406079|tracheotomy|tracheotomy
189561|NCT02406079|procalcitonin|procalcitonin
189562|NCT02406079|sepsis|sepsis
189563|NCT02406053|lung cancer|lung cancer
189564|NCT02406053|antioxidants|antioxidants
189565|NCT02406053|oxidative damage|oxidative damage
189566|NCT02406040|Protein synthesis|protein synthesis
189567|NCT02406040|Protein breakdown|protein breakdown
189568|NCT02406040|Muscle|muscle
189569|NCT02406040|Energy restriction|energy restriction
189570|NCT02406027|Alzheimer's Disease|alzheimer's disease
189571|NCT02406027|JNJ-54861911|jnj-54861911
189572|NCT02406027|Placebo|placebo
189573|NCT02406001|peri-implantitis|peri-implantitis
189574|NCT02406001|osseous defects|osseous defects
189575|NCT02406001|implant surface decontamination|implant surface decontamination
189576|NCT02406001|bone grafting|bone grafting
189577|NCT02406001|surgical therapy|surgical therapy
189578|NCT02406001|porous titanium granules|porous titanium granules
189579|NCT02406001|reconstruction|reconstruction
189580|NCT02405988|Emergency Treatment|emergency treatment
189581|NCT02405988|Morphine Derivates|morphine derivates
189582|NCT02405988|Heroin|heroin
189583|NCT02405988|Antidotes|antidotes
189584|NCT02405988|Administration, Intravenous|administration, intravenous
189585|NCT02405988|Pharmacology|pharmacology
189586|NCT02405988|Naloxone|naloxone
189587|NCT02405988|Healthy volunteers|healthy volunteers
189588|NCT02405962|Acceptance and Commitment Therapy|acceptance and commitment therapy
189589|NCT02405962|Childhood asthma|childhood asthma
189590|NCT02405962|Randomized controlled trial|randomized controlled trial
189591|NCT02405962|Training parents|training parents
189592|NCT02405910|advanced|advanced
189593|NCT02405910|non-squamous|non-squamous
189594|NCT02405910|first line therapy|first line therapy
189595|NCT02405897|flexible bronchoscopy|flexible bronchoscopy
189596|NCT02405897|transbronchial lung biopsy|transbronchial lung biopsy
189597|NCT02405897|forceps|forceps
189598|NCT02405884|Glaucoma|glaucoma
189599|NCT02405884|Renal Insufficiency, Chronic|renal insufficiency, chronic
189600|NCT02405884|Low Tension Glaucoma|low tension glaucoma
189601|NCT02405884|Ocular Hypertension|ocular hypertension
189602|NCT02405858|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
189603|NCT02405858|Abiraterone Acetate|abiraterone acetate
189604|NCT02405858|ZYTIGA|zytiga
189605|NCT02405858|Prednisolone|prednisolone
189606|NCT02405845|Atherosclerosis|atherosclerosis
189607|NCT02405845|Internal Carotid Artery|internal carotid artery
189608|NCT02405845|Free-floating thrombus|free-floating thrombus
189609|NCT02405845|Ulcerated plaque|ulcerated plaque
189610|NCT02405845|FFT|fft
189611|NCT02405819|Cancer|cancer
189612|NCT02405819|Oncology|oncology
189613|NCT02405819|Survivorship|survivorship
189614|NCT02405819|Care|care
189615|NCT02405819|Plan|plan
189616|NCT02405780|Rheumatoid|rheumatoid
189617|NCT02405780|Arthritis|arthritis
189618|NCT02405767|Diabetic foot ulcer|diabetic foot ulcer
189619|NCT02405754|Corus CAD|corus cad
189620|NCT02405754|Personalized Medicine|personalized medicine
189621|NCT02405754|CAD|cad
189622|NCT02405754|ASGES|asges
189623|NCT02405754|Age/Sex/Gene Expression Score|age/sex/gene expression score
189624|NCT02405754|GES|ges
189625|NCT02405754|CVD|cvd
189626|NCT02405754|CHD|chd
189627|NCT02405754|Precision Medicine|precision medicine
189628|NCT02405754|Clinical Utility|clinical utility
189629|NCT02405754|Gene Expression|gene expression
189630|NCT02405754|Coronary Heart Disease|coronary heart disease
189631|NCT02405754|Cardiovascular Disease|cardiovascular disease
189632|NCT02405754|Chest Pain|chest pain
189633|NCT02405754|Coronary Artery Disease|coronary artery disease
189634|NCT02405754|Angina Pectoris|angina pectoris
189635|NCT02405754|exercise stress testing|exercise stress testing
189636|NCT02405754|CT angiography|ct angiography
189637|NCT02405754|invasive cardiac angiography|invasive cardiac angiography
189638|NCT02405754|African-American patient|african-american patient
189639|NCT02405754|ICA|ica
189640|NCT02405754|CTA|cta
189641|NCT02405728|PICC|picc
189642|NCT02405728|BLOODSTREAM INFECTIONS|bloodstream infections
189643|NCT02405728|VASCULAR ACCESS|vascular access
189644|NCT02405728|DEEP VEIN THROMBOSIS|deep vein thrombosis
189645|NCT02405728|CICC|cicc
189646|NCT02405702|Infection|infection
189647|NCT02405702|Knee|knee
189648|NCT02405702|knee replacement|knee replacement
189649|NCT02405676|Lymphoma|lymphoma
189650|NCT02405676|non-Hodgkin|non-hodgkin
189651|NCT02405676|B-lymphocytes|b-lymphocytes
189652|NCT02405676|Child|child
189653|NCT02405676|Multicenter study|multicenter study
189654|NCT02405663|blood loss|blood loss
189655|NCT02405663|caesarean section|caesarean section
189656|NCT02405663|placental delivery|placental delivery
189657|NCT02405650|CKD, chronic kidney disease, CRIC|ckd, chronic kidney disease, cric
189658|NCT02405637|Feeding intolerance|feeding intolerance
189659|NCT02405637|Simulated amniotic fluid|simulated amniotic fluid
189660|NCT02405637|Necrotizing enterocolitis|necrotizing enterocolitis
189661|NCT02405585|Pancreatic Cancer|pancreatic cancer
189662|NCT02405585|Immunotherapy|immunotherapy
189663|NCT02405585|Vaccine Therapy|vaccine therapy
189664|NCT02405572|formula-fed|formula-fed
189665|NCT02405572|infants|infants
189666|NCT02405546|Nasal intubation|nasal intubation
189667|NCT02405546|Counterclockwise rotation|counterclockwise rotation
189668|NCT02405533|AHCC|ahcc
189669|NCT02405533|nutritional supplement|nutritional supplement
189670|NCT02405533|HPV|hpv
189671|NCT02405520|human papillomavirus vaccine|human papillomavirus vaccine
189672|NCT02405520|condylomata acuminata|condylomata acuminata
189673|NCT02405507|Gastrointestinal Discomfort|gastrointestinal discomfort
189674|NCT02405507|Wheat germ|wheat germ
189675|NCT02405507|Constipation|constipation
189676|NCT02405507|Glycaemic Index|glycaemic index
189677|NCT02405507|Blood Cholesterol Level|blood cholesterol level
189678|NCT02405507|Glycaemic Response|glycaemic response
189679|NCT02405507|Cholesterol|cholesterol
189680|NCT02405507|PAC-SYM|pac-sym
189681|NCT02405507|Gut Microbiota|gut microbiota
189682|NCT02405468|blood microbiota|blood microbiota
189683|NCT02405468|coronary disease|coronary disease
189684|NCT02405468|myocardial infarction|myocardial infarction
189685|NCT02405455|cervical insufficiency|cervical insufficiency
189686|NCT02405455|cervical cerclage|cervical cerclage
189687|NCT02405455|cervical pessary|cervical pessary
189688|NCT02405416|Hepatocellular Carcinoma|hepatocellular carcinoma
189689|NCT02405416|Blood Loss|blood loss
189690|NCT02405416|Haemorrhage|haemorrhage
189691|NCT02405416|Vascular Control|vascular control
189692|NCT02405403|amyotrophic lateral sclerosis disease|amyotrophic lateral sclerosis disease
189693|NCT02405403|PET|pet
189694|NCT02405403|microglial activation|microglial activation
189695|NCT02405390|Storz C-Mac®|storz c-mac®
189696|NCT02405390|Pediatric Airway|pediatric airway
189697|NCT02405390|Cervical Spine Injury|cervical spine injury
189698|NCT02405390|Trauma Airway Management|trauma airway management
189699|NCT02405377|contrast-induced nephropathy|contrast-induced nephropathy
189700|NCT02405377|hydration|hydration
189701|NCT02405377|Percutaneous coronary intervention|percutaneous coronary intervention
189702|NCT02405364|Multiple Myeloma|multiple myeloma
189703|NCT02405364|Carfilzomib|carfilzomib
189704|NCT02405364|Lenalidomide|lenalidomide
189705|NCT02405364|Dexamethasone|dexamethasone
189706|NCT02405364|Patient up to 65 years|patient up to 65 years
189707|NCT02405364|initial management|initial management
189708|NCT02405351|Telemedicine, Stroke, Working Memory, Cognitive Training|telemedicine, stroke, working memory, cognitive training
189709|NCT02405338|AML|aml
189710|NCT02405325|physical activity|physical activity
189711|NCT02405325|multilevel|multilevel
189712|NCT02405325|cost-effectiveness|cost-effectiveness
189713|NCT02405325|older adults|older adults
189714|NCT02405312|communication|communication
189715|NCT02405312|palliative care|palliative care
189716|NCT02405312|death|death
189717|NCT02405299|child|child
189718|NCT02405299|disorders inhibition|disorders inhibition
189719|NCT02405299|neuropsychology|neuropsychology
189720|NCT02405299|rehabilitation|rehabilitation
189721|NCT02405299|ADHD|adhd
189722|NCT02405299|assessment of neurocognitive rehabilitations in ADHD in children|assessment of neurocognitive rehabilitations in adhd in children
189723|NCT02405273|Lung Cancer|lung cancer
189724|NCT02405273|Surgery|surgery
189725|NCT02405273|COPD|copd
189726|NCT02405273|Rehabilitation|rehabilitation
189727|NCT02405247|NSCLC|nsclc
189728|NCT02405247|T790M|t790m
189729|NCT02405247|EGFR|egfr
189730|NCT02405247|TKI|tki
189731|NCT02405247|Resistance|resistance
189732|NCT02405247|Non Small Cell Lung Cancer|non small cell lung cancer
189733|NCT02405247|AZD9291|azd9291
189734|NCT02405234|Radial Head Arthroplasty|radial head arthroplasty
189735|NCT02405221|HPV|hpv
189736|NCT02405221|HPV16|hpv16
189737|NCT02405221|Cervical Cancer|cervical cancer
189738|NCT02405221|TA-CIN|ta-cin
189739|NCT02405221|Vaccine|vaccine
189740|NCT02405221|Adjuvant|adjuvant
189741|NCT02405221|Nickles FaderPI|nickles faderpi
189742|NCT02405182|Magnetic Resonance Imaging|magnetic resonance imaging
189743|NCT02405182|MRI|mri
189744|NCT02405182|Biomarker|biomarker
189745|NCT02405169|Implantology|implantology
189746|NCT02405169|oral surgery|oral surgery
189747|NCT02405169|bone level changes|bone level changes
189748|NCT02405169|marginal bone level|marginal bone level
189749|NCT02405156|Letrozole|letrozole
189750|NCT02405156|misoprostol|misoprostol
189751|NCT02405156|second trimester miscarriage|second trimester miscarriage
189752|NCT02405143|Controlled clinical trial|controlled clinical trial
189753|NCT02405143|Electric Stimulation Therapy|electric stimulation therapy
189754|NCT02405117|Bipolar Disorder|bipolar disorder
189755|NCT02405117|Behavior Therapy|behavior therapy
189756|NCT02405117|Technology Assisted|technology assisted
189757|NCT02405117|Mobile Phone|mobile phone
189758|NCT02405117|Smartphone|smartphone
189759|NCT02405104|osteoarthritis|osteoarthritis
189760|NCT02405104|hip|hip
189761|NCT02405104|knee|knee
189762|NCT02405104|total hip arthroplasty|total hip arthroplasty
189763|NCT02405104|total knee arthroplasty|total knee arthroplasty
189764|NCT02405104|post operative pain management|post operative pain management
189765|NCT02405078|Lymphoma|lymphoma
189766|NCT02405078|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
189767|NCT02405078|DLBCL|dlbcl
189869|NCT02404519|Vitamin K|vitamin k
189768|NCT02405078|Relapsed/Refractory|relapsed/refractory
189769|NCT02405078|Fluorodeoxyglucose-positron emission tomography/computed tomography|fluorodeoxyglucose-positron emission tomography/computed tomography
189770|NCT02405078|FDG-PET/CT|fdg-pet/ct
189771|NCT02405078|18F-Fluorodeoxyglucose|18f-fluorodeoxyglucose
189772|NCT02405078|Blood draws|blood draws
189773|NCT02405078|Chemotherapy|chemotherapy
189774|NCT02405039|DED|ded
189775|NCT02405039|Disease|disease
189776|NCT02405013|Africa|africa
189777|NCT02405013|Hepatitis C|hepatitis c
189778|NCT02405013|HIV|hiv
189779|NCT02405013|Antiviral treatment|antiviral treatment
189780|NCT02405013|Adults|adults
189781|NCT02405013|HCV genotype 1|hcv genotype 1
189782|NCT02405013|HCV genotype 2|hcv genotype 2
189783|NCT02405013|HCV genotype 4|hcv genotype 4
189784|NCT02404974|physical activity|physical activity
189785|NCT02404948|coronary artery disease|coronary artery disease
189786|NCT02404948|diagnosis|diagnosis
189787|NCT02404948|non-invasive|non-invasive
189788|NCT02404935|Metastatic colorectal cancer|metastatic colorectal cancer
189789|NCT02404935|cetuximab|cetuximab
189790|NCT02404935|maintenance|maintenance
189791|NCT02404922|Safety/Efficacy Study|safety/efficacy study
189792|NCT02404922|Randomized|randomized
189793|NCT02404922|Double Blind|double blind
189794|NCT02404883|Cancer|cancer
189795|NCT02404883|decisional conflict|decisional conflict
189796|NCT02404883|online|online
189797|NCT02404883|decision-aid tool|decision-aid tool
189798|NCT02404870|Diabetes|diabetes
189799|NCT02404870|Phosphate|phosphate
189800|NCT02404870|Fibroblast Growth Factor 23 (FGF23)|fibroblast growth factor 23 (fgf23)
189801|NCT02404870|Vitamin D|vitamin d
189802|NCT02404870|PTH|pth
189803|NCT02404857|Post stroke|post stroke
189804|NCT02404857|BCI|bci
189805|NCT02404857|Reeducation|reeducation
189806|NCT02404857|Hand movement|hand movement
189807|NCT02404831|Physiotherapy|physiotherapy
189808|NCT02404831|Pulmonary Rehabilitation|pulmonary rehabilitation
189809|NCT02404831|Exercise|exercise
189810|NCT02404831|Telerehab|telerehab
189811|NCT02404818|Radiation|radiation
189812|NCT02404818|Cardiac|cardiac
189813|NCT02404818|Hodgkin's lymphoma|hodgkin's lymphoma
189814|NCT02404805|dolutegravir|dolutegravir
189815|NCT02404805|simeprevir|simeprevir
189816|NCT02404805|HIV|hiv
189817|NCT02404805|HCV|hcv
189818|NCT02404792|Frail Elderly|frail elderly
189819|NCT02404792|IGF-1|igf-1
189820|NCT02404779|ICU|icu
189821|NCT02404779|Deep sedation|deep sedation
189822|NCT02404779|Mechanical ventilation|mechanical ventilation
189823|NCT02404779|Traumatic brain injury|traumatic brain injury
189824|NCT02404779|Intracranial hypertension|intracranial hypertension
189825|NCT02404779|Cisatracurium|cisatracurium
189826|NCT02404779|Neuromuscular Blocking Agent|neuromuscular blocking agent
189827|NCT02404779|Randomization versus placebo|randomization versus placebo
189828|NCT02404766|manual therapy|manual therapy
189829|NCT02404766|cervical|cervical
189830|NCT02404766|range of movement|range of movement
189831|NCT02404753|Locally advanced gastric cancer|locally advanced gastric cancer
189832|NCT02404753|Laparoscopic distal D2 gastrectomy|laparoscopic distal d2 gastrectomy
189833|NCT02404753|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
189834|NCT02404740|VP shunted|vp shunted
189835|NCT02404740|Normal intracranial pathology|normal intracranial pathology
189836|NCT02404740|patients|patients
189837|NCT02404727|Osteoarthritis, Hip|osteoarthritis, hip
189838|NCT02404727|acetabular fixation|acetabular fixation
189839|NCT02404727|dual mobility cup|dual mobility cup
189840|NCT02404727|Radiostereometric Analysis|radiostereometric analysis
189841|NCT02404727|Dual-Energy Radiographic Absorptiometry|dual-energy radiographic absorptiometry
189842|NCT02404727|Accelerometry|accelerometry
189843|NCT02404727|total hip arthroplasty|total hip arthroplasty
189844|NCT02404727|intra-prosthetic dislocation|intra-prosthetic dislocation
189845|NCT02404662|Alcohol use disorder|alcohol use disorder
189846|NCT02404662|Depression|depression
189847|NCT02404662|Mood disorders|mood disorders
189848|NCT02404662|Bipolar disorder|bipolar disorder
189849|NCT02404662|Supportive text messages|supportive text messages
189850|NCT02404623|Vitamin D|vitamin d
189851|NCT02404623|Respiratory Morbidity|respiratory morbidity
189852|NCT02404623|prematurity|prematurity
189853|NCT02404610|propofol|propofol
189854|NCT02404610|moderate procedural sedation|moderate procedural sedation
189855|NCT02404610|deep procedural sedation|deep procedural sedation
189856|NCT02404610|memory|memory
189857|NCT02404610|emergency department|emergency department
189858|NCT02404597|Cardiac output|cardiac output
189859|NCT02404597|Low blood pressure|low blood pressure
189860|NCT02404597|Total Body Surface Area (TBSA)|total body surface area (tbsa)
189861|NCT02404584|Metastatic kidney cancer|metastatic kidney cancer
189862|NCT02404545|Hernia|hernia
189863|NCT02404545|Mesh|mesh
189864|NCT02404545|Ileal conduit|ileal conduit
189865|NCT02404532|OPC-14597 Digital|opc-14597 digital
189866|NCT02404532|Aripiprazole|aripiprazole
189867|NCT02404532|Medical Information Device #1 System (MIND1)|medical information device #1 system (mind1)
189868|NCT02404532|Ingestible Event Marker|ingestible event marker
189870|NCT02404519|Menaquinone-7|menaquinone-7
189871|NCT02404519|Matrix Gla Protein|matrix gla protein
189872|NCT02404519|Vascular stiffness|vascular stiffness
189873|NCT02404506|Eribulin|eribulin
189874|NCT02404506|Breast Cancer|breast cancer
189875|NCT02404506|Elderly Patient|elderly patient
189876|NCT02404506|Phase II Trial|phase ii trial
189877|NCT02404506|HER2-neg|her2-neg
189878|NCT02404506|adenocarcinoma|adenocarcinoma
189879|NCT02404493|Atopic Dermatitis|atopic dermatitis
189880|NCT02404441|Phase I/II, PDR001, Checkpoint inhibitor, PD-1, PD-L1|phase i/ii, pdr001, checkpoint inhibitor, pd-1, pd-l1
189881|NCT02404428|active surveillance|active surveillance
189882|NCT02404428|MRI|mri
189883|NCT02404428|diet|diet
189884|NCT02404415|catheter ablation|catheter ablation
189885|NCT02404415|genomics|genomics
189886|NCT02404402|Traumatic Brain Injury|traumatic brain injury
189887|NCT02404402|Light Emitting Diodes|light emitting diodes
189888|NCT02404402|Cognition|cognition
189889|NCT02404402|Neuromodulation|neuromodulation
189890|NCT02404402|PTSD|ptsd
189891|NCT02404402|Neurorehabilitation|neurorehabilitation
189892|NCT02404402|Veterans|veterans
189893|NCT02404402|Sleep|sleep
189894|NCT02404389|Actinic keratosis, patients, topical, lesion count, clearance rate|actinic keratosis, patients, topical, lesion count, clearance rate
189895|NCT02404376|STEMI|stemi
189896|NCT02404376|Reperfusion Injury|reperfusion injury
189897|NCT02404376|Myocardial Infarction|myocardial infarction
189898|NCT02404376|Myocardial Ischemia|myocardial ischemia
189899|NCT02404376|Remote Ischemic Conditioning|remote ischemic conditioning
189900|NCT02404376|Exenatide|exenatide
189901|NCT02404376|Glucagon-Like Peptide-1 (GLP-1)|glucagon-like peptide-1 (glp-1)
189902|NCT02404376|Acute Coronary Syndrome|acute coronary syndrome
189903|NCT02404376|Cardioprotection|cardioprotection
189904|NCT02404363|Clopidogrel|clopidogrel
189905|NCT02404363|Pancreatic Cancer|pancreatic cancer
189906|NCT02404363|Efficacy|efficacy
189907|NCT02404363|Chemotherapy|chemotherapy
189908|NCT02404363|Microparticles|microparticles
189909|NCT02404363|Disease free survival|disease free survival
189910|NCT02404363|First line chemotherapy|first line chemotherapy
189911|NCT02404350|Psoriatic Arthritis, Arthritis, Psoriatic, Psoriatic Arthropathy|psoriatic arthritis, arthritis, psoriatic, psoriatic arthropathy
189912|NCT02404311|HIV|hiv
189913|NCT02404311|AIDS|aids
189914|NCT02404311|Vaccine|vaccine
189915|NCT02404298|Transcriptome analysis|transcriptome analysis
189916|NCT02404298|peripheral blood|peripheral blood
189917|NCT02404298|chronic inflammatory demyelinating polyradiculoneuropathy|chronic inflammatory demyelinating polyradiculoneuropathy
189918|NCT02404298|auto immune diseases|auto immune diseases
189919|NCT02404298|IVIg|ivig
189920|NCT02404272|Neonate|neonate
189921|NCT02404272|oral feeding disorder|oral feeding disorder
189922|NCT02404272|full oral feeding|full oral feeding
189923|NCT02404272|training|training
189924|NCT02404272|quality of health care|quality of health care
189925|NCT02404259|pharmacokinetics|pharmacokinetics
189926|NCT02404259|TDF|tdf
189927|NCT02404259|HIV-infected children|hiv-infected children
189928|NCT02404259|Thai|thai
189929|NCT02404259|non-nucleoside reverse transcriptase inhibitor (NNRTI)|non-nucleoside reverse transcriptase inhibitor (nnrti)
189930|NCT02404259|ritonavir-boosted protease inhibitor (bPI)|ritonavir-boosted protease inhibitor (bpi)
189931|NCT02404259|less than eighteen years old|less than eighteen years old
189932|NCT02404246|Bipolar|bipolar
189933|NCT02404246|Peers|peers
189934|NCT02404246|DBSA|dbsa
189935|NCT02404220|Syk inhibitor|syk inhibitor
189936|NCT02404220|Blood malignancy|blood malignancy
189937|NCT02404220|Leukemia|leukemia
189938|NCT02404207|Prevention|prevention
189939|NCT02404194|schizophrenia|schizophrenia
189940|NCT02404194|psychosis|psychosis
189941|NCT02404194|at risk|at risk
189942|NCT02404194|prodrome|prodrome
189943|NCT02404194|attenuated psychosis syndrome|attenuated psychosis syndrome
189944|NCT02404181|Validation Studies|validation studies
189945|NCT02404181|EEG|eeg
189946|NCT02404142|Trachel intubation|trachel intubation
189947|NCT02404142|IDS score|ids score
189948|NCT02404142|Videoaryngoscopy|videoaryngoscopy
189949|NCT02404142|Glidescope® Titanium®|glidescope® titanium®
189950|NCT02404142|NMBA|nmba
189951|NCT02404142|Curare (Atracurium)|curare (atracurium)
189952|NCT02404129|Fall|fall
189953|NCT02404129|Turn 180 test|turn 180 test
189954|NCT02404129|elderly|elderly
189955|NCT02404129|balance|balance
189956|NCT02404090|Obesity|obesity
189957|NCT02404090|Weight Loss|weight loss
189958|NCT02404090|Knee Osteoarthritis|knee osteoarthritis
189959|NCT02404090|Subchondral Mineralization|subchondral mineralization
189960|NCT02404077|Patients|patients
189961|NCT02404077|undergoing|undergoing
189962|NCT02404077|ICU|icu
189963|NCT02404051|Breast cancer|breast cancer
189964|NCT02404051|HER2Negative|her2negative
189965|NCT02404051|hormone receptor positive (HR+)|hormone receptor positive (hr+)
189966|NCT02404051|Metastatic|metastatic
189967|NCT02404051|Locally Advanced|locally advanced
189968|NCT02404051|fulvestrant|fulvestrant
189969|NCT02404051|everolimus|everolimus
189970|NCT02404051|exemestane|exemestane
189971|NCT02404038|choice|choice
189972|NCT02404038|young women|young women
189973|NCT02404038|adolescent girls|adolescent girls
189974|NCT02404038|preference|preference
189975|NCT02404025|Eltrombopag|eltrombopag
189976|NCT02404025|rabbit anti-thymocyte globulin|rabbit anti-thymocyte globulin
189977|NCT02404025|additive effect|additive effect
189978|NCT02404025|cyclosporine A|cyclosporine a
189979|NCT02404012|iron deficiency|iron deficiency
189980|NCT02404012|sleeve gastrectomy|sleeve gastrectomy
189981|NCT02404012|gastric bypass|gastric bypass
189982|NCT02404012|bariatric surgery|bariatric surgery
189983|NCT02403973|Patient hotel|patient hotel
189984|NCT02403973|Patient Satisfaction|patient satisfaction
189985|NCT02403973|Perioperative care|perioperative care
189986|NCT02403973|IN2005E|in2005e
189987|NCT02403947|Multiple Sclerosis|multiple sclerosis
189988|NCT02403947|Bone-marrow|bone-marrow
189989|NCT02403947|Stem cells|stem cells
189990|NCT02403947|Cell therapy|cell therapy
189991|NCT02403934|Airway Management|airway management
189992|NCT02403934|deep sedation|deep sedation
189993|NCT02403934|Jaw elevation device|jaw elevation device
189994|NCT02403921|biomarker|biomarker
189995|NCT02403908|radiofrequency denervation, pulmonary hypertension|radiofrequency denervation, pulmonary hypertension
189996|NCT02403882|behavioral economics|behavioral economics
189997|NCT02403882|food pantry|food pantry
189998|NCT02403882|food choice|food choice
189999|NCT02403869|Metastatic breast cancer|metastatic breast cancer
190000|NCT02403869|Monotherapy|monotherapy
190001|NCT02403869|chemotherapy|chemotherapy
190002|NCT02403869|second line|second line
190003|NCT02403869|treatment|treatment
190004|NCT02403869|Her 2 negative|her 2 negative
190005|NCT02403856|calcifying tendinitis|calcifying tendinitis
190006|NCT02403856|Needle lavage|needle lavage
190007|NCT02403856|Shoulder|shoulder
190008|NCT02403856|Corticosteroid injection|corticosteroid injection
190009|NCT02403856|Ultrasound-guided|ultrasound-guided
190010|NCT02403817|Video Games|video games
190011|NCT02403804|Dietary supplements|dietary supplements
190012|NCT02403804|serum choline|serum choline
190013|NCT02403804|women|women
190014|NCT02403791|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
190015|NCT02403778|Melanoma|melanoma
190016|NCT02403778|Malignant Melanoma|malignant melanoma
190017|NCT02403752|dementia|dementia
190018|NCT02403752|Alzheimer's disease|alzheimer's disease
190019|NCT02403752|exercise|exercise
190020|NCT02403739|Growth|growth
190021|NCT02403700|bone remodeling|bone remodeling
190022|NCT02403700|bone resorption|bone resorption
190023|NCT02403700|three-dimensional imaging|three-dimensional imaging
190024|NCT02403700|clinical trial|clinical trial
190025|NCT02403700|dental implant|dental implant
190026|NCT02403700|maxilla|maxilla
190027|NCT02403700|bone healing|bone healing
190028|NCT02403635|HSV|hsv
190029|NCT02403635|Herpes|herpes
190030|NCT02403635|volunteers|volunteers
190031|NCT02403635|drug-drug interaction|drug-drug interaction
190032|NCT02403609|cognitive assessment|cognitive assessment
190033|NCT02403609|Brain Performance Test|brain performance test
190034|NCT02403609|Lumosity|lumosity
190035|NCT02403609|test-retest reliability|test-retest reliability
190036|NCT02403609|computerized assessment|computerized assessment
190037|NCT02403596|Hip replacement|hip replacement
190038|NCT02403596|rivaroxaban|rivaroxaban
190039|NCT02403596|exacyl|exacyl
190040|NCT02403596|blood loss|blood loss
190041|NCT02403583|HIV Transmission|hiv transmission
190042|NCT02403583|Prevention of Mother to Child Transmission|prevention of mother to child transmission
190043|NCT02403583|Serodiscordancy|serodiscordancy
190044|NCT02403583|Home-based testing|home-based testing
190045|NCT02403583|Home-based counseling|home-based counseling
190046|NCT02403583|Linkage to care|linkage to care
190047|NCT02403583|Couples HIV Testing and Counseling|couples hiv testing and counseling
190048|NCT02403583|Acceptance of repeat HIV testing during pregnancy|acceptance of repeat hiv testing during pregnancy
190049|NCT02403583|Retention in care|retention in care
190050|NCT02403570|Multiple Sclerosis, MRI, rotating frame|multiple sclerosis, mri, rotating frame
190051|NCT02403544|Clinical Trial, Phase I|clinical trial, phase i
190052|NCT02403544|Concurrent Chemoradiation|concurrent chemoradiation
190053|NCT02403544|Oxaliplatin|oxaliplatin
190054|NCT02403544|Capecitabine|capecitabine
190055|NCT02403544|Carcinoma, Hepatocellular|carcinoma, hepatocellular
190056|NCT02403531|Esophageal cancer|esophageal cancer
190057|NCT02403531|Chemoradiotherapy|chemoradiotherapy
190058|NCT02403531|induction chemotherapy|induction chemotherapy
190059|NCT02403505|Prostate Cancer|prostate cancer
190060|NCT02403505|SNP|snp
190061|NCT02403505|Single Nucleotide Polymorphism|single nucleotide polymorphism
190062|NCT02403505|Genetics|genetics
190063|NCT02403505|Pharmacogenomic|pharmacogenomic
190064|NCT02403505|Pharmacogenetic|pharmacogenetic
190065|NCT02403505|gene|gene
190066|NCT02403505|genome|genome
190067|NCT02403505|genotype|genotype
190068|NCT02403505|genotyping|genotyping
190069|NCT02403505|Oncology|oncology
190070|NCT02403505|Chemotherapy|chemotherapy
190071|NCT02403505|Personalize|personalize
190271|NCT02402543|ketamine|ketamine
190072|NCT02403505|Individualize|individualize
190073|NCT02403492|Children|children
190074|NCT02403492|Obesity|obesity
190075|NCT02403492|Cardiovascular|cardiovascular
190076|NCT02403492|Sleep|sleep
190077|NCT02403492|Apnea|apnea
190078|NCT02403492|Obstructive|obstructive
190079|NCT02403466|Medical errors|medical errors
190080|NCT02403466|Communication|communication
190081|NCT02403466|Resident sign-out|resident sign-out
190082|NCT02403453|Radiculopathy|radiculopathy
190083|NCT02403453|Myelopathy|myelopathy
190084|NCT02403453|Spondylosis|spondylosis
190085|NCT02403453|Herniated Nucleus Pulposus|herniated nucleus pulposus
190086|NCT02403453|C3-C7|c3-c7
190087|NCT02403453|Osteophytes|osteophytes
190088|NCT02403453|Neurological deficit|neurological deficit
190089|NCT02403427|Bolus calculator|bolus calculator
190090|NCT02403427|Insulin pump|insulin pump
190091|NCT02403427|basal-bolus insulin therapy|basal-bolus insulin therapy
190092|NCT02403401|Pregnancy prevention|pregnancy prevention
190093|NCT02403388|Patient safety|patient safety
190094|NCT02403388|Primary care|primary care
190095|NCT02403388|Incident reporting|incident reporting
190096|NCT02403388|Pluridisciplinary care offices|pluridisciplinary care offices
190097|NCT02403388|Risk management|risk management
190098|NCT02403388|Assessment|assessment
190099|NCT02403310|adverse-risk AML|adverse-risk aml
190100|NCT02403310|poor-risk karyotype|poor-risk karyotype
190101|NCT02403310|cytogenetic abnormality|cytogenetic abnormality
190102|NCT02403310|poor-risk mutations|poor-risk mutations
190103|NCT02403310|antecedent hematologic disorder|antecedent hematologic disorder
190104|NCT02403310|treatment related AML|treatment related aml
190105|NCT02403297|Bleeding gums|bleeding gums
190106|NCT02403297|Gum inflammation|gum inflammation
190107|NCT02403297|Saliva|saliva
190108|NCT02403284|insulin resistance|insulin resistance
190109|NCT02403284|lipid metabolism|lipid metabolism
190110|NCT02403284|glucose metabolism|glucose metabolism
190111|NCT02403284|high fat diets|high fat diets
190112|NCT02403271|Pharmacyclics|pharmacyclics
190113|NCT02403271|PCYC|pcyc
190114|NCT02403271|Ibrutinib|ibrutinib
190115|NCT02403271|Durvalumab (MEDI4736)|durvalumab (medi4736)
190116|NCT02403271|Relapsed Refractory Solid Tumor|relapsed refractory solid tumor
190117|NCT02403271|Non-Small Cell Lung Cancer|non-small cell lung cancer
190118|NCT02403271|NSCLC|nsclc
190119|NCT02403271|Squamous|squamous
190120|NCT02403271|Squamous NSCLC|squamous nsclc
190121|NCT02403271|Squamous Non-Small Cell Lung Cancer|squamous non-small cell lung cancer
190122|NCT02403271|Immunotherapy|immunotherapy
190123|NCT02403271|IMBRUVICA®|imbruvica®
190124|NCT02403271|Tumor Immunotherapy|tumor immunotherapy
190125|NCT02403271|Anti-PD-L1|anti-pd-l1
190126|NCT02403271|Lung Cancer|lung cancer
190127|NCT02403271|Breast Cancer|breast cancer
190128|NCT02403271|Triple Negative|triple negative
190129|NCT02403271|HER2 Positive|her2 positive
190130|NCT02403271|HER2 + Breast Cancer|her2 + breast cancer
190131|NCT02403271|Pancreatic Cancer|pancreatic cancer
190132|NCT02403258|acupuncture|acupuncture
190133|NCT02403258|plum-blossom needle|plum-blossom needle
190134|NCT02403258|tourette syndrome|tourette syndrome
190135|NCT02403258|randomized controlled trial|randomized controlled trial
190136|NCT02403245|Social interactions|social interactions
190137|NCT02403245|Dementia|dementia
190138|NCT02403245|Social stimulation|social stimulation
190139|NCT02403245|Direct observation|direct observation
190140|NCT02403232|Autologous adipose-derived stem cells|autologous adipose-derived stem cells
190141|NCT02403219|Dry eye|dry eye
190142|NCT02403219|Botulinum toxin A|botulinum toxin a
190143|NCT02403219|Orbicularis muscle of the eye|orbicularis muscle of the eye
190144|NCT02403193|Adenosine A2a receptor antagonist|adenosine a2a receptor antagonist
190145|NCT02403193|NSCLC|nsclc
190146|NCT02403193|PBF-509|pbf-509
190147|NCT02403193|Immunotherapy|immunotherapy
190148|NCT02403193|adenosine|adenosine
190149|NCT02403193|PDR001|pdr001
190150|NCT02403193|immune checkpoint inhibitors|immune checkpoint inhibitors
190151|NCT02403193|Programmed Death-1 (PD-1) receptor|programmed death-1 (pd-1) receptor
190152|NCT02403193|Adenosine A2a receptor (A2AR)|adenosine a2a receptor (a2ar)
190153|NCT02403180|Visual Performance|visual performance
190154|NCT02403154|Anterior pelvic ring|anterior pelvic ring
190155|NCT02403154|Internal fixation|internal fixation
190156|NCT02403154|External fixation|external fixation
190157|NCT02403154|Orthopaedic|orthopaedic
190158|NCT02403154|Orthopedic|orthopedic
190159|NCT02403154|pubic rami|pubic rami
190160|NCT02403128|362.17|362.17
190161|NCT02403102|Magnetic Resonance Imaging|magnetic resonance imaging
190162|NCT02403102|Myeloma|myeloma
190163|NCT02403102|Autograft|autograft
190164|NCT02403089|MAIT (Mucosal-Associated Invariant T) cells|mait (mucosal-associated invariant t) cells
190165|NCT02403089|Gut microbiota|gut microbiota
190166|NCT02403089|Preterm birth|preterm birth
190167|NCT02403089|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
190168|NCT02403089|Microbial infections|microbial infections
190169|NCT02403050|Neoplasm Staging|neoplasm staging
190170|NCT02403050|Radiotherapy|radiotherapy
190171|NCT02403050|Fiducial Markers|fiducial markers
190172|NCT02403037|Breast Neoplasms|breast neoplasms
190173|NCT02403037|Auricular Therapy|auricular therapy
190174|NCT02403037|Acupressure|acupressure
190175|NCT02403037|Chemotherapy|chemotherapy
190176|NCT02403037|Nausea|nausea
190177|NCT02403037|Vomiting|vomiting
190178|NCT02403024|Colon cancer|colon cancer
190179|NCT02403024|rectal cancer|rectal cancer
190180|NCT02403024|exercise|exercise
190181|NCT02403024|physical activity|physical activity
190182|NCT02403024|metabolic health|metabolic health
190183|NCT02403011|Congenital Muscular Torticollis|congenital muscular torticollis
190184|NCT02403011|Manual Therapy|manual therapy
190185|NCT02403011|Infant|infant
190186|NCT02402998|Primacy immune thrombocytopenia|primacy immune thrombocytopenia
190187|NCT02402998|Adults|adults
190188|NCT02402998|Eltrombopag|eltrombopag
190189|NCT02402998|Long-term remission|long-term remission
190190|NCT02402985|nutritional support|nutritional support
190191|NCT02402985|diet therapy|diet therapy
190192|NCT02402985|protein diet|protein diet
190193|NCT02402985|isocaloric diet|isocaloric diet
190194|NCT02402972|adjuvant chemotherapy|adjuvant chemotherapy
190195|NCT02402972|intraportal chemotherapy|intraportal chemotherapy
190196|NCT02402972|prevention|prevention
190197|NCT02402959|Insomnia|insomnia
190198|NCT02402959|Traditional Chinese Medicine|traditional chinese medicine
190199|NCT02402959|herbal medicine|herbal medicine
190200|NCT02402959|cohort study|cohort study
190201|NCT02402959|individualized treatment|individualized treatment
190202|NCT02402959|TCM pattern differentiation|tcm pattern differentiation
190203|NCT02402920|Lung Cancer|lung cancer
190204|NCT02402920|Small Cell Lung Cancer|small cell lung cancer
190205|NCT02402920|SCLC|sclc
190206|NCT02402920|Limited-Stage Small-Cell Lung Cancer|limited-stage small-cell lung cancer
190207|NCT02402920|LS-SCLC|ls-sclc
190208|NCT02402920|Extensive-Stage Small-Cell Lung Cancer|extensive-stage small-cell lung cancer
190209|NCT02402920|ES-SCLC|es-sclc
190210|NCT02402920|MK-3475|mk-3475
190211|NCT02402920|Keytruda|keytruda
190212|NCT02402920|Pembrolizumab|pembrolizumab
190213|NCT02402920|SCH-900475|sch-900475
190214|NCT02402920|Etoposide|etoposide
190215|NCT02402920|VePesid|vepesid
190216|NCT02402920|Cisplatin|cisplatin
190217|NCT02402920|Platinol-AQ|platinol-aq
190218|NCT02402920|Platinol|platinol
190219|NCT02402920|CDDP|cddp
190220|NCT02402920|Carboplatin|carboplatin
190221|NCT02402920|Radiation therapy|radiation therapy
190222|NCT02402920|XRT|xrt
190223|NCT02402907|cesarean section|cesarean section
190224|NCT02402907|chlorhexidine gluconate|chlorhexidine gluconate
190225|NCT02402907|CHG|chg
190226|NCT02402907|surgical site infection|surgical site infection
190227|NCT02402907|obstetrics|obstetrics
190228|NCT02402907|infection prevention|infection prevention
190229|NCT02402907|pregnancy|pregnancy
190230|NCT02402881|venous thromboembolism|venous thromboembolism
190231|NCT02402881|deep venous thrombosis|deep venous thrombosis
190232|NCT02402881|pulmonary embolism|pulmonary embolism
190233|NCT02402881|blood clots|blood clots
190234|NCT02402855|Couverture Maladie Universelle|couverture maladie universelle
190235|NCT02402855|Couverture Maladie Universelle-Complémentaire|couverture maladie universelle-complémentaire
190236|NCT02402855|free health care|free health care
190237|NCT02402842|gastrointestinal oncology|gastrointestinal oncology
190238|NCT02402842|immunology|immunology
190239|NCT02402842|taxane|taxane
190240|NCT02402764|Triple Negative Breast Cancer (TNBC)|triple negative breast cancer (tnbc)
190241|NCT02402764|Breast - Female|breast - female
190242|NCT02402764|Breast - Male|breast - male
190243|NCT02402764|Metastatic Triple Negative Breast Cancer|metastatic triple negative breast cancer
190244|NCT02402764|Receptor Tyrosine-protein Kinase erbB-2 (HER2) Negative|receptor tyrosine-protein kinase erbb-2 (her2) negative
190245|NCT02402764|Erythroblastosis virus oncogene B (erbB)|erythroblastosis virus oncogene b (erbb)
190246|NCT02402751|Volunteers|volunteers
190247|NCT02402725|Relapsed Multiple Myeloma|relapsed multiple myeloma
190248|NCT02402699|HBV|hbv
190249|NCT02402699|HBC|hbc
190250|NCT02402647|Hoarding|hoarding
190251|NCT02402647|Compulsive Hoarding|compulsive hoarding
190252|NCT02402595|Drug-drug interaction|drug-drug interaction
190253|NCT02402595|Healthy Volunteers|healthy volunteers
190254|NCT02402595|Pharmacokinetics|pharmacokinetics
190255|NCT02402595|deuterated dextromethorphan|deuterated dextromethorphan
190256|NCT02402595|dextromethorphan|dextromethorphan
190257|NCT02402595|dextromethorphan with quinidine|dextromethorphan with quinidine
190258|NCT02402595|deuterated dextromethorphan with quinidine|deuterated dextromethorphan with quinidine
190259|NCT02402595|itraconazole|itraconazole
190260|NCT02402582|Family-Centered Empowerment Model|family-centered empowerment model
190261|NCT02402582|Quality of life|quality of life
190262|NCT02402582|Perceived stress|perceived stress
190263|NCT02402582|Anxiety|anxiety
190264|NCT02402582|Myocardial infarction|myocardial infarction
190265|NCT02402582|Clinical trial|clinical trial
190266|NCT02402582|Iran|iran
190267|NCT02402543|preemptive analgesia|preemptive analgesia
190268|NCT02402543|anorectal surgery|anorectal surgery
190269|NCT02402543|gabapentin|gabapentin
190270|NCT02402543|neurontin|neurontin
190272|NCT02402543|acetaminophen|acetaminophen
190273|NCT02402543|tylenol|tylenol
190274|NCT02402543|postoperative pain|postoperative pain
190275|NCT02402543|postoperative narcotic usage|postoperative narcotic usage
190276|NCT02402543|dexamethasone|dexamethasone
190277|NCT02402543|decadron|decadron
190278|NCT02402530|Neridronic Acid|neridronic acid
190279|NCT02402530|Neridronate|neridronate
190280|NCT02402530|CRPS|crps
190281|NCT02402530|RSD|rsd
190282|NCT02402517|Diabetes Prevention|diabetes prevention
190283|NCT02402517|Obesity Prevention|obesity prevention
190284|NCT02402491|Dual Antiplatelet Treatment|dual antiplatelet treatment
190285|NCT02402491|In-Stent Restenosis|in-stent restenosis
190286|NCT02402478|Clinical Cohort|clinical cohort
190287|NCT02402478|Electronic Health Records|electronic health records
190288|NCT02402478|Prognosis|prognosis
190289|NCT02402478|Stable Coronary Artery Disease|stable coronary artery disease
190290|NCT02402439|Type 1 diabetes|type 1 diabetes
190291|NCT02402439|diabetes mellitus|diabetes mellitus
190292|NCT02402439|pancreatic islet transplant|pancreatic islet transplant
190293|NCT02402439|beta cell replacement|beta cell replacement
190294|NCT02402426|Brain Health|brain health
190295|NCT02402426|Brain Research|brain research
190296|NCT02402426|Alzheimer's Disease|alzheimer's disease
190297|NCT02402426|Neurodegenerative Disease|neurodegenerative disease
190298|NCT02402426|Parkinson's Disease|parkinson's disease
190299|NCT02402426|Dementia|dementia
190300|NCT02402426|Stroke|stroke
190301|NCT02402426|PTSD|ptsd
190302|NCT02402426|Multiple Sclerosis|multiple sclerosis
190303|NCT02402400|NSTEMI|nstemi
190304|NCT02402361|Neuropathic pain|neuropathic pain
190305|NCT02402361|Diabetic Neuropathy|diabetic neuropathy
190306|NCT02402348|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
190307|NCT02402309|Sjögren-Larsson Syndrome|sjögren-larsson syndrome
190308|NCT02402309|SLS|sls
190309|NCT02402309|Ichthyosis|ichthyosis
190310|NCT02402309|FALDH Deficiency|faldh deficiency
190311|NCT02402309|Neuro-ichthyosis|neuro-ichthyosis
190312|NCT02402309|Fatty Alcohol:NAD+ Oxidoreductase Deficiency|fatty alcohol:nad+ oxidoreductase deficiency
190313|NCT02402309|Fatty Aldehyde Dehydrogenase Deficiency Disease|fatty aldehyde dehydrogenase deficiency disease
190314|NCT02402309|Congenital Icthyosis Mental Retardation Spasticity Syndrome|congenital icthyosis mental retardation spasticity syndrome
190315|NCT02402309|Spastic Neurologic Disorder|spastic neurologic disorder
190316|NCT02402309|Oligophrenia|oligophrenia
190317|NCT02402283|Bioequivalency|bioequivalency
190318|NCT02402283|two metronidazole-containing products|two metronidazole-containing products
190319|NCT02402270|Colonoscopy|colonoscopy
190320|NCT02402270|Preparation|preparation
190321|NCT02402257|Central Venous Catheter|central venous catheter
190322|NCT02402257|Simulation-based Mastery Learning|simulation-based mastery learning
190323|NCT02402257|Medical Education|medical education
190324|NCT02402257|Patient Outcomes|patient outcomes
190325|NCT02402257|Bloodstream Infection Due to Central Venous Catheter|bloodstream infection due to central venous catheter
190326|NCT02402257|Pneumothorax|pneumothorax
190327|NCT02402257|Inadvertent Arterial Puncture|inadvertent arterial puncture
190328|NCT02402205|Implementation; TF-CBT; adjudicated youth; RTF; trauma|implementation; tf-cbt; adjudicated youth; rtf; trauma
190329|NCT02402192|corifollitropin alfa|corifollitropin alfa
190330|NCT02402192|recombinant FSH|recombinant fsh
190331|NCT02402192|HP-hMG|hp-hmg
190332|NCT02402192|time-lapse|time-lapse
190333|NCT02402192|kinetics of development|kinetics of development
190334|NCT02402179|protein quality|protein quality
190335|NCT02402153|evaluation of subcutaneous EEG recording|evaluation of subcutaneous eeg recording
190336|NCT02402140|tacrolimus blood concentration|tacrolimus blood concentration
190337|NCT02402140|pharmaceutical intervention|pharmaceutical intervention
190338|NCT02402140|intrasubject variability|intrasubject variability
190339|NCT02402127|Contact lenses|contact lenses
190340|NCT02402127|Lubricity|lubricity
190341|NCT02402101|tDCS|tdcs
190342|NCT02402101|Dopamine|dopamine
190343|NCT02402101|PET|pet
190344|NCT02402088|stress|stress
190345|NCT02402088|food cues|food cues
190346|NCT02402088|obesity|obesity
190347|NCT02402075|muscle motor evoked potentials|muscle motor evoked potentials
190348|NCT02402075|spinal motor evoked potentials|spinal motor evoked potentials
190349|NCT02402075|D-wave|d-wave
190350|NCT02402075|brain tumor surgery|brain tumor surgery
190351|NCT02402075|intraoperative neuromonitoring|intraoperative neuromonitoring
190352|NCT02402062|pNET|pnet
190353|NCT02401997|sperm|sperm
190354|NCT02401997|oxidative stress|oxidative stress
190355|NCT02401997|sexual abstinence|sexual abstinence
190356|NCT02401971|Thalidomide|thalidomide
190357|NCT02401971|Irinotecan|irinotecan
190358|NCT02401971|Second Line|second line
190359|NCT02401945|Macular Degeneration|macular degeneration
190360|NCT02401919|Nursing|nursing
190361|NCT02401919|Hospital|hospital
190362|NCT02401919|Communication|communication
190363|NCT02401919|Patient Participation|patient participation
190364|NCT02401919|Individualised Care|individualised care
190365|NCT02401893|aging|aging
190366|NCT02401893|influenza vaccine|influenza vaccine
190367|NCT02401893|immune responses|immune responses
190368|NCT02401867|transgender|transgender
190369|NCT02401867|female-to-male|female-to-male
190370|NCT02401867|cervical cancer|cervical cancer
190371|NCT02401867|HPV|hpv
190372|NCT02401867|sexual health|sexual health
190373|NCT02401854|atrial fibrillation|atrial fibrillation
190374|NCT02401854|hypertension|hypertension
190375|NCT02401854|risk factors|risk factors
190376|NCT02401854|primary care|primary care
190377|NCT02401854|elderly|elderly
190378|NCT02401815|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
190379|NCT02401815|KIT|kit
190380|NCT02401815|Biomarkers|biomarkers
190381|NCT02401815|PLX9486|plx9486
190382|NCT02401815|PLX3397|plx3397
190383|NCT02401815|Sunitinib|sunitinib
190384|NCT02401802|Colonoscopy|colonoscopy
190385|NCT02401802|Diet|diet
190386|NCT02401802|Polyethylene glycols|polyethylene glycols
190387|NCT02401802|Efficacy|efficacy
190388|NCT02401802|Personal satisfaction|personal satisfaction
190389|NCT02401802|Colorectal cancer screening|colorectal cancer screening
190390|NCT02401789|oral surgery|oral surgery
190391|NCT02401789|Implantology|implantology
190392|NCT02401776|heart rate|heart rate
190393|NCT02401776|blood pressure|blood pressure
190394|NCT02401776|caffeine|caffeine
190395|NCT02401776|energy drink|energy drink
190396|NCT02401763|biomarker|biomarker
190397|NCT02401737|Hepatitis B|hepatitis b
190398|NCT02401724|Hemispatial neglect|hemispatial neglect
190399|NCT02401724|Transcranial direct current stimulation|transcranial direct current stimulation
190400|NCT02401724|Rehabilitation|rehabilitation
190401|NCT02401698|Stroke|stroke
190402|NCT02401698|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
190403|NCT02401698|Neuronal Plasticity|neuronal plasticity
190404|NCT02401698|Rehabilitation|rehabilitation
190405|NCT02401685|breast cancer|breast cancer
190406|NCT02401685|sentinel lymph node biopsy|sentinel lymph node biopsy
190407|NCT02401685|axillary lymph node clearance|axillary lymph node clearance
190408|NCT02401685|axillary lymph node dissection|axillary lymph node dissection
190409|NCT02401685|macrometastases|macrometastases
190410|NCT02401685|axillary radiotherapy|axillary radiotherapy
190411|NCT02401685|POSNOC|posnoc
190412|NCT02401672|TMS|tms
190413|NCT02401672|nicotine dependence|nicotine dependence
190414|NCT02401672|smoking cessation|smoking cessation
190415|NCT02401659|remote monitoring|remote monitoring
190416|NCT02401659|satisfaction|satisfaction
190417|NCT02401659|telemonitoring|telemonitoring
190418|NCT02401659|quality of life|quality of life
190419|NCT02401633|Cardio-Pulmonary-Resuscitation|cardio-pulmonary-resuscitation
190420|NCT02401633|Advanced Cardiac Life Support|advanced cardiac life support
190421|NCT02401633|Compression-Only CPR|compression-only cpr
190422|NCT02401633|Chest compression CPR|chest compression cpr
190423|NCT02401620|AR: arthritis rheumatoid|ar: arthritis rheumatoid
190424|NCT02401620|DMARDs: Disease-modifying antirheumatic drugs|dmards: disease-modifying antirheumatic drugs
190425|NCT02401620|ACR. American College of Rheumatology|acr. american college of rheumatology
190426|NCT02401620|EULAR: European League against rheumatology|eular: european league against rheumatology
190427|NCT02401607|stress|stress
190428|NCT02401607|emergency physicians|emergency physicians
190429|NCT02401607|health care workers|health care workers
190430|NCT02401607|biomarkers|biomarkers
190431|NCT02401607|questionnaires|questionnaires
190432|NCT02401607|anxiety|anxiety
190433|NCT02401607|depression|depression
190434|NCT02401607|burn-out|burn-out
190435|NCT02401594|Non-major orthopaedic surgery|non-major orthopaedic surgery
190436|NCT02401594|deep vein thrombosis|deep vein thrombosis
190437|NCT02401542|Urothelial Cell Carcinoma|urothelial cell carcinoma
190438|NCT02401542|UCC|ucc
190439|NCT02401542|bladder cancer|bladder cancer
190440|NCT02401542|B-701|b-701
190441|NCT02401542|FGFR3|fgfr3
190442|NCT02401542|invasive bladder cancer|invasive bladder cancer
190443|NCT02401542|targeted therapy|targeted therapy
190444|NCT02401542|Transitional Cell Carcinoma|transitional cell carcinoma
190445|NCT02401542|TCC|tcc
190446|NCT02401542|Phase 2|phase 2
190447|NCT02401542|second line therapy|second line therapy
190448|NCT02401542|monoclonal antibody|monoclonal antibody
190449|NCT02401542|docetaxel|docetaxel
190450|NCT02401542|combination therapy|combination therapy
190451|NCT02401542|Phase 1|phase 1
190452|NCT02401529|Dexamethasone|dexamethasone
190453|NCT02401529|Prednisolone|prednisolone
190454|NCT02401529|Tonsillectomy Nausea|tonsillectomy nausea
190455|NCT02401529|Pain, Postoperative|pain, postoperative
190456|NCT02401529|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
190457|NCT02401529|Randomized controlled trial|randomized controlled trial
190458|NCT02401529|Post-tonsillectomy pain|post-tonsillectomy pain
190459|NCT02401529|delayed feeding|delayed feeding
190460|NCT02401516|Postural Reprogramming Insole|postural reprogramming insole
190461|NCT02401516|Blood Pressure|blood pressure
190462|NCT02401516|Posture|posture
190463|NCT02401516|Quality Of Life|quality of life
190464|NCT02401516|General Functional Capacity|general functional capacity
190465|NCT02401516|Respiratory Muscles Strength|respiratory muscles strength
190466|NCT02401516|Flexibility|flexibility
190467|NCT02401516|Arterial Systemic Hypertension|arterial systemic hypertension
190468|NCT02401503|CLL|cll
190469|NCT02401477|helicobacter pylori|helicobacter pylori
190470|NCT02401477|ilaprazole|ilaprazole
190471|NCT02401477|eradication|eradication
190472|NCT02401477|dual therapy|dual therapy
190473|NCT02401477|high dose therapy|high dose therapy
190474|NCT02401425|Letrozole|letrozole
190475|NCT02401425|Misoprostol|misoprostol
190476|NCT02401425|First-Trimester|first-trimester
190477|NCT02401425|Pretreatment|pretreatment
190478|NCT02401386|Fibromyalgia; Eight Brocades; Baduanjin; Qigong; Pain severity|fibromyalgia; eight brocades; baduanjin; qigong; pain severity
190479|NCT02401373|Vaccines|vaccines
190480|NCT02401373|Ebola Virus Disease|ebola virus disease
190481|NCT02401347|PALB2 mutation|palb2 mutation
190482|NCT02401347|BRIP1 mutation|brip1 mutation
190483|NCT02401347|BARD1 mutation|bard1 mutation
190484|NCT02401347|Rad51c mutation|rad51c mutation
190485|NCT02401347|PTEN mutation|pten mutation
190486|NCT02401347|CHEK2 mutation|chek2 mutation
190487|NCT02401347|ATM mutation|atm mutation
190488|NCT02401347|NBN mutation|nbn mutation
190489|NCT02401347|Rad51d mutation|rad51d mutation
190490|NCT02401347|Rad50 mutation|rad50 mutation
190491|NCT02401347|MRE11 mutation|mre11 mutation
190492|NCT02401347|FANC mutation|fanc mutation
190493|NCT02401347|HRD assay score|hrd assay score
190494|NCT02401347|ATR mutation|atr mutation
190495|NCT02401295|Relapsed multiple myeloma|relapsed multiple myeloma
190496|NCT02401256|Efavirenz|efavirenz
190497|NCT02401256|metabolism|metabolism
190498|NCT02401256|pharmacokinetics changes|pharmacokinetics changes
190499|NCT02401230|Human Immunodeficiency Virus|human immunodeficiency virus
190500|NCT02401230|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
190501|NCT02401230|Pre-exposure Prophylaxis|pre-exposure prophylaxis
190502|NCT02401204|Bacterial transmission|bacterial transmission
190503|NCT02401204|Surveillance|surveillance
190504|NCT02401204|Neonatal|neonatal
190505|NCT02401204|Drug Resistance|drug resistance
190506|NCT02401178|FLG-FADS genes variations-LCPUFA-atopic dermatitis|flg-fads genes variations-lcpufa-atopic dermatitis
190507|NCT02401165|GADD34|gadd34
190508|NCT02401165|Unfolded Protein Response|unfolded protein response
190509|NCT02401165|Anti-citrullinated protein antibodies|anti-citrullinated protein antibodies
190510|NCT02401100|Rectal Neoplasms|rectal neoplasms
190511|NCT02401061|ITP|itp
190512|NCT02401061|Thrombocytopenia|thrombocytopenia
190513|NCT02401035|candidate for acid suppression therapy|candidate for acid suppression therapy
190514|NCT02401035|presumptive diagnosis of GERD|presumptive diagnosis of gerd
190515|NCT02401035|clinical diagnosis of suspected GERD|clinical diagnosis of suspected gerd
190516|NCT02401035|symptomatic GERD|symptomatic gerd
190517|NCT02401035|endoscopically proven GERD|endoscopically proven gerd
190518|NCT02401022|smoking|smoking
190519|NCT02401022|smoking cessation|smoking cessation
190520|NCT02401022|cigarette|cigarette
190521|NCT02400996|Endocrine Pancreas|endocrine pancreas
190522|NCT02400996|Pancreatic Endocrine Neoplasm|pancreatic endocrine neoplasm
190523|NCT02400983|ACAP, Automatic Algorithm|acap, automatic algorithm
190524|NCT02400970|Polymerase Chain Reaction|polymerase chain reaction
190525|NCT02400970|fertility preservation|fertility preservation
190526|NCT02400957|silver nanoparticles|silver nanoparticles
190527|NCT02400957|demineralization|demineralization
190528|NCT02400957|brackets|brackets
190529|NCT02400944|MSK Tobacco Cessation Program|msk tobacco cessation program
190530|NCT02400944|smoking exposure|smoking exposure
190531|NCT02400944|15-047|15-047
190532|NCT02400905|PAD|pad
190533|NCT02400905|PVD|pvd
190534|NCT02400905|SFA stent|sfa stent
190535|NCT02400879|bispectral index|bispectral index
190536|NCT02400879|cardiac surgery|cardiac surgery
190537|NCT02400879|recovery|recovery
190538|NCT02400879|remifentanil|remifentanil
190539|NCT02400866|cancer patients receiving moderately emetogenic chemotherapy|cancer patients receiving moderately emetogenic chemotherapy
190540|NCT02400827|Polymerase Chain Reaction|polymerase chain reaction
190541|NCT02400827|fertility preservation|fertility preservation
190542|NCT02400801|endometriosis|endometriosis
190543|NCT02400801|infertility|infertility
190544|NCT02400801|assisted reproductive technology|assisted reproductive technology
190545|NCT02400775|Pharmacotherapy|pharmacotherapy
190546|NCT02400749|moderate to severe non-pustular palmo-plantar psoriasis|moderate to severe non-pustular palmo-plantar psoriasis
190547|NCT02400736|Individual Placement and Support|individual placement and support
190548|NCT02400736|Supported Employment|supported employment
190549|NCT02400736|Employment|employment
190550|NCT02400736|Vocational Rehabilitation|vocational rehabilitation
190551|NCT02400736|Veterans|veterans
190552|NCT02400736|Patient Aligned Care Team|patient aligned care team
190553|NCT02400723|behavioral intervention|behavioral intervention
190554|NCT02400723|relaxation|relaxation
190555|NCT02400723|Veterans|veterans
190556|NCT02400723|geriatric|geriatric
190557|NCT02400684|AFSr classification|afsr classification
190558|NCT02400684|laparoscopy|laparoscopy
190559|NCT02400658|breast cancer|breast cancer
190560|NCT02400658|early-stage|early-stage
190561|NCT02400658|IORT|iort
190562|NCT02400658|brachytherapy|brachytherapy
190664|NCT02400190|lumpectomy|lumpectomy
190563|NCT02400645|laparoscopic hysterectomy|laparoscopic hysterectomy
190564|NCT02400645|robotic assisted hysterectomy|robotic assisted hysterectomy
190565|NCT02400632|drug-eluting balloon|drug-eluting balloon
190566|NCT02400632|in-stent restenosis|in-stent restenosis
190567|NCT02400619|shockwaves|shockwaves
190568|NCT02400619|Physiotherapy|physiotherapy
190569|NCT02400619|Botulinum toxin|botulinum toxin
190570|NCT02400606|constructing VPs|constructing vps
190571|NCT02400606|knowledge and skills transfer|knowledge and skills transfer
190572|NCT02400580|Laparoscopic Hysterectomy|laparoscopic hysterectomy
190573|NCT02400580|IV acetaminophen|iv acetaminophen
190574|NCT02400580|Postoperative pain control|postoperative pain control
190575|NCT02400580|Surgery|surgery
190576|NCT02400567|Luminal|luminal
190577|NCT02400567|Post menopausal|post menopausal
190578|NCT02400567|Breast conservation|breast conservation
190579|NCT02400567|Neoadjuvant|neoadjuvant
190580|NCT02400554|Indian, North American|indian, north american
190581|NCT02400554|Oklahoma|oklahoma
190582|NCT02400554|Female|female
190583|NCT02400554|health promotion|health promotion
190584|NCT02400541|Anorexia nervosa|anorexia nervosa
190585|NCT02400541|Cognitive remediation therapy|cognitive remediation therapy
190586|NCT02400515|Exercise|exercise
190587|NCT02400515|Exercise Therapy|exercise therapy
190588|NCT02400515|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
190589|NCT02400502|Schizophrenia|schizophrenia
190590|NCT02400502|Treatment|treatment
190591|NCT02400502|Meditation|meditation
190592|NCT02400502|Mindfulness|mindfulness
190593|NCT02400502|Stress reactivity|stress reactivity
190594|NCT02400502|First Episode Psychosis|first episode psychosis
190595|NCT02400502|Coping|coping
190596|NCT02400489|Heart Valve Replacement Surgery|heart valve replacement surgery
190597|NCT02400489|Perimount|perimount
190598|NCT02400489|Edwards|edwards
190599|NCT02400476|HER2 +|her2 +
190600|NCT02400476|Breast Cancer|breast cancer
190601|NCT02400476|Neratinib|neratinib
190602|NCT02400476|Nerlynx|nerlynx
190603|NCT02400450|Pre-diabetes|pre-diabetes
190604|NCT02400450|prediabetes|prediabetes
190605|NCT02400450|glycated hemoglobin|glycated hemoglobin
190606|NCT02400450|hemoglobin A1c|hemoglobin a1c
190607|NCT02400450|LDL cholesterol|ldl cholesterol
190608|NCT02400450|Cholesterol|cholesterol
190609|NCT02400450|metabolic function|metabolic function
190610|NCT02400450|vascular function|vascular function
190611|NCT02400450|functional food|functional food
190612|NCT02400437|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
190613|NCT02400424|Stereotactic lung radiation therapy|stereotactic lung radiation therapy
190614|NCT02400424|Radiochemotherapy|radiochemotherapy
190615|NCT02400424|Unresectable stage III Non-Small Cell lung Carcinoma|unresectable stage iii non-small cell lung carcinoma
190616|NCT02400424|Peripheral primary tumor|peripheral primary tumor
190617|NCT02400411|Carbohydrate|carbohydrate
190618|NCT02400411|Glycemic response|glycemic response
190619|NCT02400411|insulin|insulin
190620|NCT02400411|whole grain|whole grain
190621|NCT02400411|meal|meal
190622|NCT02400359|fMRI|fmri
190623|NCT02400359|Magnetic Resonance Imaging|magnetic resonance imaging
190624|NCT02400359|endocrinology|endocrinology
190625|NCT02400359|MRI|mri
190626|NCT02400359|obesity|obesity
190627|NCT02400359|weight loss|weight loss
190628|NCT02400359|lorcaserin|lorcaserin
190629|NCT02400333|ticagrelor orodispersible tablet|ticagrelor orodispersible tablet
190630|NCT02400333|ticagrelor immediate-release tablet|ticagrelor immediate-release tablet
190631|NCT02400333|relative bioavailability|relative bioavailability
190632|NCT02400333|Phase I|phase i
190633|NCT02400333|healthy subjects|healthy subjects
190634|NCT02400307|Phase 1|phase 1
190635|NCT02400307|Renally Impaired|renally impaired
190636|NCT02400294|Critical care|critical care
190637|NCT02400294|Mechanical ventilation|mechanical ventilation
190638|NCT02400294|Ventilator associated pneumonia|ventilator associated pneumonia
190639|NCT02400294|Oral care|oral care
190640|NCT02400268|Enterobacteriaceae|enterobacteriaceae
190641|NCT02400268|Bloodstream|bloodstream
190642|NCT02400268|Bacteremia|bacteremia
190643|NCT02400268|Recurrence|recurrence
190644|NCT02400268|Reinfection|reinfection
190645|NCT02400229|coronary artery disease|coronary artery disease
190646|NCT02400229|stable chest pain|stable chest pain
190647|NCT02400229|intermediate pretest probability|intermediate pretest probability
190648|NCT02400229|pragmatic randomised controlled trial|pragmatic randomised controlled trial
190649|NCT02400229|coronary computed tomography|coronary computed tomography
190650|NCT02400229|angiography|angiography
190651|NCT02400229|invasive coronary angiography|invasive coronary angiography
190652|NCT02400216|Chronic Hepatitis C|chronic hepatitis c
190653|NCT02400216|Cirrhosis|cirrhosis
190654|NCT02400216|Liver Biopsy|liver biopsy
190655|NCT02400216|Microbiome|microbiome
190656|NCT02400203|hemp oil,|hemp oil,
190657|NCT02400203|hemp|hemp
190658|NCT02400203|fatty acids|fatty acids
190659|NCT02400203|omega-6|omega-6
190660|NCT02400203|omega-3|omega-3
190661|NCT02400203|blood pressure|blood pressure
190662|NCT02400203|blood lipids|blood lipids
190663|NCT02400190|radiation|radiation
190665|NCT02400190|favorable biology|favorable biology
190666|NCT02400190|omission|omission
190667|NCT02400125|Patient Registry|patient registry
190668|NCT02400125|Coronary Artery Bypass|coronary artery bypass
190669|NCT02400125|Cardiac Valve Annuloplasty|cardiac valve annuloplasty
190670|NCT02400112|Vancomycin|vancomycin
190671|NCT02400086|neuroligical or neuromuscular diseases|neuroligical or neuromuscular diseases
190672|NCT02400086|bacterial respiratory tract flora|bacterial respiratory tract flora
190673|NCT02400086|long term tracheostomy|long term tracheostomy
190674|NCT02400047|Paediatric surgery|paediatric surgery
190675|NCT02400034|midurethral sling|midurethral sling
190676|NCT02400034|Voiding trial|voiding trial
190677|NCT02400034|stress urinary incontinence|stress urinary incontinence
190678|NCT02399995|Quality of Life|quality of life
190679|NCT02399995|Hepatectomy|hepatectomy
190680|NCT02399995|15-057|15-057
190681|NCT02399982|Smartphone Application|smartphone application
190682|NCT02399982|mobile mental health|mobile mental health
190683|NCT02399982|Binge Eating|binge eating
190684|NCT02399982|Cognitive behavioral therapy|cognitive behavioral therapy
190685|NCT02399982|Eating Disorder treatment|eating disorder treatment
190686|NCT02399982|Cognitive behavioral therapy guided self-help|cognitive behavioral therapy guided self-help
190687|NCT02399982|self-monitoring|self-monitoring
190688|NCT02399982|eating disorders|eating disorders
190689|NCT02399982|ecological momentary intervention|ecological momentary intervention
190690|NCT02399969|Low back pain|low back pain
190691|NCT02399969|Acupuncture therapy|acupuncture therapy
190692|NCT02399969|Acupuncture, ear|acupuncture, ear
190693|NCT02399956|Lactation|lactation
190694|NCT02399956|Pediatric malignancies|pediatric malignancies
190695|NCT02399956|Cancer survivor|cancer survivor
190696|NCT02399917|Leukemia|leukemia
190697|NCT02399917|Acute Myeloid Leukemia|acute myeloid leukemia
190698|NCT02399917|Refractory|refractory
190699|NCT02399917|Relapsed|relapsed
190700|NCT02399917|AML|aml
190701|NCT02399917|Myelodysplastic Syndrome (MDS).|myelodysplastic syndrome (mds).
190702|NCT02399917|MDS|mds
190703|NCT02399917|High-risk|high-risk
190704|NCT02399917|5-azacytidine|5-azacytidine
190705|NCT02399917|Azacitidine|azacitidine
190706|NCT02399917|5-aza|5-aza
190707|NCT02399917|Vidaza|vidaza
190708|NCT02399917|5-AZC|5-azc
190709|NCT02399917|AZA-CR|aza-cr
190710|NCT02399917|Ladakamycin|ladakamycin
190711|NCT02399917|NSC-102816|nsc-102816
190712|NCT02399917|Azacytidine|azacytidine
190713|NCT02399917|Lirilumab|lirilumab
190714|NCT02399917|Phone call|phone call
190715|NCT02399891|Remodeling|remodeling
190716|NCT02399891|Prognosis|prognosis
190717|NCT02399891|Incidence|incidence
190718|NCT02399891|Quality Assurance|quality assurance
190719|NCT02399891|Ejection Fraction|ejection fraction
190720|NCT02399891|Sudden Death|sudden death
190721|NCT02399800|pancreatitis, chronic|pancreatitis, chronic
190722|NCT02399800|endosonography|endosonography
190723|NCT02399761|AADC deficiency, newborn screening|aadc deficiency, newborn screening
190724|NCT02399735|NK cells|nk cells
190725|NCT02399735|Liver Transplantation|liver transplantation
190726|NCT02399735|Hepatocellular Carcinoma Recurrence|hepatocellular carcinoma recurrence
190727|NCT02399722|Negative Pressure Wound Therapy, polymeric membrane dressing, wounds|negative pressure wound therapy, polymeric membrane dressing, wounds
190728|NCT02399670|Total hip arthroplasty|total hip arthroplasty
190729|NCT02399670|degenerative joint disease|degenerative joint disease
190730|NCT02399670|Femoral offset|femoral offset
190731|NCT02399670|Patient reported outcome|patient reported outcome
190732|NCT02399657|diabetes mellitus|diabetes mellitus
190733|NCT02399657|macular edema|macular edema
190734|NCT02399657|hard exudate|hard exudate
190735|NCT02399657|intravitreal injections|intravitreal injections
190736|NCT02399657|dexamethasone|dexamethasone
190737|NCT02399657|implant|implant
190738|NCT02399644|pain|pain
190739|NCT02399644|rehabilitation|rehabilitation
190740|NCT02399644|exercise|exercise
190741|NCT02399644|psychological|psychological
190742|NCT02399644|intervention|intervention
190743|NCT02399631|Perioperative treatment|perioperative treatment
190744|NCT02399631|Laparoscopic surgery|laparoscopic surgery
190745|NCT02399618|Clostridium difficile Infection|clostridium difficile infection
190746|NCT02399618|Fecal Microbiota Transplantation|fecal microbiota transplantation
190747|NCT02399618|Freeze-dried|freeze-dried
190748|NCT02399618|Acid-resistant Capsules|acid-resistant capsules
190749|NCT02399592|Platinum resistant|platinum resistant
190750|NCT02399579|cat allergy|cat allergy
190751|NCT02399579|symptom score|symptom score
190752|NCT02399566|erlotinib|erlotinib
190753|NCT02399566|pemetrexed|pemetrexed
190754|NCT02399566|maintenance therapy|maintenance therapy
190755|NCT02399527|Vascular Anomalies|vascular anomalies
190756|NCT02399527|Lymphatic Anomalies|lymphatic anomalies
190757|NCT02399527|Lymphatic Malformation|lymphatic malformation
190758|NCT02399514|Sleep|sleep
190759|NCT02399514|emphysema|emphysema
190760|NCT02399514|coils|coils
190761|NCT02399514|lung volume reduction|lung volume reduction
190762|NCT02399501|2D ultrasound|2d ultrasound
190763|NCT02399501|3D ultrasound|3d ultrasound
190764|NCT02399501|sonohysterography|sonohysterography
190765|NCT02399501|hysteroscopy|hysteroscopy
190766|NCT02399501|Uterine factor of infertility|uterine factor of infertility
190767|NCT02399475|Levothyroxine|levothyroxine
190768|NCT02399475|Liothyronine|liothyronine
190769|NCT02399475|Thyrotropin Releasing Hormone|thyrotropin releasing hormone
190770|NCT02399475|Aging|aging
190771|NCT02399475|Hypothyroidism|hypothyroidism
190772|NCT02399475|Thyroid diseases|thyroid diseases
190773|NCT02399449|iron|iron
190774|NCT02399449|pharmacokinetics|pharmacokinetics
190775|NCT02399436|Community-Based Participatory Research|community-based participatory research
190776|NCT02399436|Community-Institutional Relations|community-institutional relations
190777|NCT02399423|diabetes|diabetes
190778|NCT02399423|metabolism|metabolism
190779|NCT02399423|cardiovascular disease|cardiovascular disease
190780|NCT02399423|weight gain|weight gain
190781|NCT02399423|weight loss|weight loss
190782|NCT02399423|european|european
190783|NCT02399423|south asian|south asian
190784|NCT02399423|obesity|obesity
190785|NCT02399410|cytoreductive surgery|cytoreductive surgery
190786|NCT02399410|hipec|hipec
190787|NCT02399410|perioperative chemotherapy|perioperative chemotherapy
190788|NCT02399410|peritoneal carcinomatosis|peritoneal carcinomatosis
190789|NCT02399410|bevacizumab|bevacizumab
190790|NCT02399410|colorectal surgery|colorectal surgery
190791|NCT02399384|Cardiac Magnetic Resonance (CMR)|cardiac magnetic resonance (cmr)
190792|NCT02399358|Drug induced Hyponatremia|drug induced hyponatremia
190793|NCT02399358|Cyclophosphamide|cyclophosphamide
190794|NCT02399358|Hyponatremia|hyponatremia
190795|NCT02399358|Cyclophosphamide induced Hyponatremia|cyclophosphamide induced hyponatremia
190796|NCT02399345|Treatment naive|treatment naive
190797|NCT02399345|Hepatitis C Genotype 1|hepatitis c genotype 1
190798|NCT02399319|anterior pelvic ring|anterior pelvic ring
190799|NCT02399319|symphysis disruption|symphysis disruption
190800|NCT02399293|Cognitive training|cognitive training
190801|NCT02399293|Cognitive rehabilitation|cognitive rehabilitation
190802|NCT02399293|Acquired brain injury|acquired brain injury
190803|NCT02399293|N-back|n-back
190804|NCT02399293|Visual Search|visual search
190805|NCT02399293|Cognitive transfer|cognitive transfer
190806|NCT02399280|Meal pattern|meal pattern
190807|NCT02399280|weight loss|weight loss
190808|NCT02399280|high caloric intake|high caloric intake
190809|NCT02399280|Dinner|dinner
190810|NCT02399280|Lunch|lunch
190811|NCT02399267|mechanical ventilation|mechanical ventilation
190812|NCT02399267|weaning|weaning
190813|NCT02399267|critically ill|critically ill
190814|NCT02399267|spontaneous breathing trial|spontaneous breathing trial
190815|NCT02399267|screening|screening
190816|NCT02399267|invasive ventilation|invasive ventilation
190817|NCT02399267|SBT technique|sbt technique
190818|NCT02399254|Pulmonary Rehabilitation|pulmonary rehabilitation
190819|NCT02399228|radiation therapy|radiation therapy
190820|NCT02399228|chemotherapy|chemotherapy
190821|NCT02399228|head and neck cancer|head and neck cancer
190822|NCT02399202|Renal impairment, osilodrostat, LCI699|renal impairment, osilodrostat, lci699
190823|NCT02399189|Primary central nervous system lymphoma|primary central nervous system lymphoma
190824|NCT02399189|rituximab|rituximab
190825|NCT02399189|Methotrexate and Temozolomide|methotrexate and temozolomide
190826|NCT02399189|autologous stem cell transplantation|autologous stem cell transplantation
190827|NCT02399189|Carmustine and thiotepa|carmustine and thiotepa
190828|NCT02399176|Osteoporosis|osteoporosis
190829|NCT02399176|Yoga|yoga
190830|NCT02399150|acute abdomen|acute abdomen
190831|NCT02399150|Pain|pain
190832|NCT02399150|stress biomarker|stress biomarker
190833|NCT02399137|Pancreatic Cancer|pancreatic cancer
190834|NCT02399137|Front-line Pancreatic Cancer|front-line pancreatic cancer
190835|NCT02399137|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
190836|NCT02399137|Gemcitabine|gemcitabine
190837|NCT02399137|Nab-paclitaxel|nab-paclitaxel
190838|NCT02399137|Abraxane|abraxane
190839|NCT02399137|Free IGF-1|free igf-1
190840|NCT02399137|Heregulin|heregulin
190842|NCT02399124|Renal Cell Carcinoma|renal cell carcinoma
190843|NCT02399124|Kidney tumors|kidney tumors
190844|NCT02399111|Prevena Incision Management System (PIMS)|prevena incision management system (pims)
190845|NCT02399111|Surgical Site Infection (SSI)|surgical site infection (ssi)
190846|NCT02399085|DLBCL|dlbcl
190847|NCT02399085|CD19|cd19
190848|NCT02399085|monoclonal antibody|monoclonal antibody
190849|NCT02399085|MOR00208|mor00208
190850|NCT02399085|MOR208|mor208
190851|NCT02399085|lenalidomide|lenalidomide
190852|NCT02399059|recurrence|recurrence
190853|NCT02399033|Xihuang Capsules|xihuang capsules
190854|NCT02399033|hepatocellular carcinoma|hepatocellular carcinoma
190855|NCT02399033|Recurrence|recurrence
190856|NCT02399033|hepatectomy|hepatectomy
190857|NCT02398994|Clinical Trials Unit|clinical trials unit
190858|NCT02398994|Pediatric|pediatric
190859|NCT02398968|Iron|iron
190860|NCT02398968|RURTIs|rurtis
190861|NCT02398968|CARIFS|carifs
190862|NCT02398968|children|children
190863|NCT02398955|Drug-Eluting Stents|drug-eluting stents
190864|NCT02398955|Coronary Artery Disease|coronary artery disease
190865|NCT02398955|Sirolimus|sirolimus
190866|NCT02398955|Absorbable Implants|absorbable implants
190867|NCT02398903|Morbid obesity|morbid obesity
190868|NCT02398903|bariatric surgery|bariatric surgery
190869|NCT02398903|sleeve gastrectomy|sleeve gastrectomy
190870|NCT02398903|Roux-en-Y gastric bypass|roux-en-y gastric bypass
190871|NCT02398903|hormonal contraception|hormonal contraception
190872|NCT02398903|combined oral contraceptive|combined oral contraceptive
190873|NCT02398903|progestin contraceptive desogestrel|progestin contraceptive desogestrel
190874|NCT02398903|pharmacokinetics|pharmacokinetics
190875|NCT02398825|Chronic myeloid leukemia|chronic myeloid leukemia
190876|NCT02398825|Chronic phase|chronic phase
190877|NCT02398825|Adults|adults
190878|NCT02398825|Ponatinib|ponatinib
190879|NCT02398825|Imatinib resistant|imatinib resistant
190880|NCT02398760|Low Back Pain|low back pain
190881|NCT02398760|Clinical Instability|clinical instability
190882|NCT02398760|Motor Control Exercises|motor control exercises
190883|NCT02398760|Clinical Tests|clinical tests
190884|NCT02398734|sonolysis|sonolysis
190885|NCT02398734|carotid endarterectomy|carotid endarterectomy
190886|NCT02398734|stroke prevention|stroke prevention
190887|NCT02398734|brain infarction|brain infarction
190888|NCT02398721|FNAC|fnac
190889|NCT02398721|Small Incidental Thyroid Nodules|small incidental thyroid nodules
190890|NCT02398708|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
190891|NCT02398708|Graft versus Host Disease|graft versus host disease
190892|NCT02398695|Plaque|plaque
190893|NCT02398695|Saliva|saliva
190894|NCT02398695|Caries|caries
190895|NCT02398682|electronic alerts|electronic alerts
190896|NCT02398682|acute kidney injury|acute kidney injury
190897|NCT02398682|NHS|nhs
190898|NCT02398682|mortality|mortality
190899|NCT02398669|Obesity|obesity
190900|NCT02398669|Lorcaserin hydrochloride|lorcaserin hydrochloride
190901|NCT02398669|APD356|apd356
190902|NCT02398669|Pediatric|pediatric
190903|NCT02398669|Pharmacokinetics|pharmacokinetics
190904|NCT02398656|Minor Ischemic Stroke|minor ischemic stroke
190905|NCT02398643|Acute Exacerbation of COPD|acute exacerbation of copd
190906|NCT02398643|COPD|copd
190907|NCT02398643|Emphysema|emphysema
190908|NCT02398643|Chronic Bronchitis|chronic bronchitis
190909|NCT02398630|Histerosalpingography|histerosalpingography
190910|NCT02398630|MRI|mri
190911|NCT02398630|Magnetic Resonance Imaging|magnetic resonance imaging
190912|NCT02398630|HSG|hsg
190913|NCT02398630|Diagnostico Maipu|diagnostico maipu
190914|NCT02398630|Imaging|imaging
190915|NCT02398630|Carrascosa Patricia|carrascosa patricia
190916|NCT02398617|Heart Failure|heart failure
190917|NCT02398617|End of Life Care|end of life care
190918|NCT02398617|Decision Making|decision making
190919|NCT02398604|Pediatrics|pediatrics
190920|NCT02398604|HLHS|hlhs
190921|NCT02398591|Healthy|healthy
190922|NCT02398591|JNJ 53718678|jnj 53718678
190923|NCT02398552|metastatic renal cell carcinoma|metastatic renal cell carcinoma
190924|NCT02398552|sunitinib|sunitinib
190925|NCT02398552|schedule 2weeks on/1 week off|schedule 2weeks on/1 week off
190926|NCT02398526|Observational study|observational study
190927|NCT02398526|Bone metastases|bone metastases
190928|NCT02398526|Hormone Refractory Prostatic Cancer|hormone refractory prostatic cancer
190929|NCT02398526|Xofigo|xofigo
190930|NCT02398526|Radium-223|radium-223
190931|NCT02398500|First-in-human|first-in-human
190932|NCT02398500|anti-VEGF|anti-vegf
190933|NCT02398500|neovascular AMD (nvAMD)|neovascular amd (nvamd)
190934|NCT02398435|Auto-inflammatory disease|auto-inflammatory disease
190935|NCT02398435|Still's disease|still's disease
190936|NCT02398435|Arthritis Rheumatoid|arthritis rheumatoid
190937|NCT02398435|IL-18|il-18
190938|NCT02398435|interleukin-18|interleukin-18
190939|NCT02398435|IL-18 binding protein|il-18 binding protein
190940|NCT02398422|Autonomic nervous system|autonomic nervous system
190941|NCT02398422|Auditory processing disorder|auditory processing disorder
190942|NCT02398422|Social behavior|social behavior
190943|NCT02398409|stroke|stroke
190944|NCT02398409|Injury, Brain, Traumatic|injury, brain, traumatic
190945|NCT02398409|Family Caregivers|family caregivers
190946|NCT02398409|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
190947|NCT02398409|Informal Caregivers|informal caregivers
190948|NCT02398370|ED|ed
190949|NCT02398357|anticoagulation|anticoagulation
190950|NCT02398357|Zelen-designed randomized controlled trial|zelen-designed randomized controlled trial
190951|NCT02398331|Spinal cord injuries|spinal cord injuries
190952|NCT02398331|Sexual function|sexual function
190953|NCT02398331|Sexual response|sexual response
190954|NCT02398331|Sexuality|sexuality
190955|NCT02398331|Women|women
190956|NCT02398318|neurosurgery|neurosurgery
190957|NCT02398318|deep brain stimulation|deep brain stimulation
190958|NCT02398318|exposure response prevention|exposure response prevention
190959|NCT02398305|Cardiac catheterisation|cardiac catheterisation
190960|NCT02398305|Radial access|radial access
190961|NCT02398305|Compression|compression
190962|NCT02398305|Terumo TR Band|terumo tr band
190963|NCT02398305|radial artery|radial artery
190964|NCT02398305|diagnostic|diagnostic
190965|NCT02398279|schizophrenia|schizophrenia
190966|NCT02398279|L-Arginine|l-arginine
190967|NCT02398279|nitric oxide|nitric oxide
190968|NCT02398279|drug augmentation|drug augmentation
190969|NCT02398253|weight maintenance|weight maintenance
190970|NCT02398253|cognitive behavior therapy|cognitive behavior therapy
190971|NCT02398253|successful weight loss|successful weight loss
190972|NCT02398227|Battered Women|battered women
190973|NCT02398227|Trauma|trauma
190974|NCT02398227|Domestic Violence|domestic violence
190975|NCT02398214|Sleep|sleep
190976|NCT02398214|Infants|infants
190977|NCT02398214|Toddlers|toddlers
190978|NCT02398214|Behavioral intervention|behavioral intervention
190979|NCT02398175|Pediatric polytrauma|pediatric polytrauma
190980|NCT02398175|thoracic injuries|thoracic injuries
190981|NCT02398162|Scrub Typhus in Pediatric|scrub typhus in pediatric
190982|NCT02398162|Immunology|immunology
190983|NCT02398136|intervention|intervention
190984|NCT02398136|ketamine|ketamine
190985|NCT02398136|PTSD|ptsd
190986|NCT02398136|treatment|treatment
190987|NCT02398136|posttraumatic stress disorder|posttraumatic stress disorder
190988|NCT02398123|Transversus Abdominis Plane|transversus abdominis plane
190989|NCT02398123|caudal block|caudal block
190990|NCT02398123|postoperative pain|postoperative pain
190991|NCT02398123|children|children
190992|NCT02398084|mastication|mastication
190993|NCT02398084|cashews|cashews
190994|NCT02398084|walnuts|walnuts
190995|NCT02398084|participants|participants
190996|NCT02398071|Positive Expiratory Pressure|positive expiratory pressure
190997|NCT02398071|Exercise Recovery|exercise recovery
190998|NCT02398071|COPD|copd
190999|NCT02398058|trabectedin|trabectedin
191000|NCT02398058|olaparib|olaparib
191001|NCT02398058|sarcoma|sarcoma
191002|NCT02398058|bone tumor|bone tumor
191003|NCT02398045|Obsessive-compulsive disorder|obsessive-compulsive disorder
191004|NCT02398045|cognitive behavioural therapy|cognitive behavioural therapy
191005|NCT02398045|computerised|computerised
191006|NCT02398032|sleep apnea|sleep apnea
191007|NCT02398032|hypertension|hypertension
191008|NCT02398032|mechanosensitivity|mechanosensitivity
191009|NCT02398032|chemosensitivity|chemosensitivity
191010|NCT02398032|adhesion factors|adhesion factors
191011|NCT02398019|CPB|cpb
191012|NCT02398019|OXIRIS®|oxiris®
191013|NCT02398019|SIRS|sirs
191014|NCT02398019|AKI|aki
191015|NCT02398019|Cytokines|cytokines
191016|NCT02398019|LPS|lps
191017|NCT02398006|Clavicle [mh]|clavicle [mh]
191018|NCT02398006|Fracture Healing [mh]|fracture healing [mh]
191019|NCT02398006|Fractures, Bone [mh]|fractures, bone [mh]
191020|NCT02398006|Treatment outcome [mh]|treatment outcome [mh]
191021|NCT02398006|Conservative treatment [tw]|conservative treatment [tw]
191022|NCT02397980|Caregivers|caregivers
191023|NCT02397967|NF1|nf1
191024|NCT02397967|children|children
191025|NCT02397967|reading disabilities|reading disabilities
191026|NCT02397954|idiopathic polypoidal choroidal vasculopathy|idiopathic polypoidal choroidal vasculopathy
191027|NCT02397954|IPCV|ipcv
191028|NCT02397954|Zimura®|zimura®
191029|NCT02397954|Avastin®|avastin®
191030|NCT02397954|Eylea®|eylea®
191031|NCT02397954|Lucentis®|lucentis®
191032|NCT02397928|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
191033|NCT02397928|Treatment|treatment
191034|NCT02397928|Minimal toxicity|minimal toxicity
191035|NCT02397928|TTFields|ttfields
191036|NCT02397928|Tumor Treating Fields|tumor treating fields
191037|NCT02397928|Novocure|novocure
191038|NCT02397928|Pemetrexed|pemetrexed
191039|NCT02397928|Carboplatin|carboplatin
191040|NCT02397928|Cisplatin|cisplatin
191041|NCT02397915|Nasal Spray|nasal spray
191042|NCT02397915|Fluticasone Furoate|fluticasone furoate
191043|NCT02397915|Attributes|attributes
191044|NCT02397915|Single Dose|single dose
191045|NCT02397915|Allergic Rhinitis|allergic rhinitis
191046|NCT02397915|Mometasone Furoate|mometasone furoate
191047|NCT02397915|Questionnaire|questionnaire
191048|NCT02397915|Preference|preference
191049|NCT02397889|posttraumatic stress disorder|posttraumatic stress disorder
191050|NCT02397889|PTSD|ptsd
191051|NCT02397889|ketamine|ketamine
191052|NCT02397889|trauma|trauma
191053|NCT02397889|treatment|treatment
191054|NCT02397889|New York|new york
191055|NCT02397889|NYC|nyc
191056|NCT02397876|Food Allergy|food allergy
191057|NCT02397876|Cows Milk Allergy|cows milk allergy
191058|NCT02397850|depression, chronic, psychotherapy, telephone, feasibility|depression, chronic, psychotherapy, telephone, feasibility
191059|NCT02397837|Bipolar Disorder|bipolar disorder
191060|NCT02397837|Cognition|cognition
191061|NCT02397785|chronic pelvic pain|chronic pelvic pain
191062|NCT02397785|electrical stimulation|electrical stimulation
191063|NCT02397785|pelvic floor rehabilitation|pelvic floor rehabilitation
191064|NCT02397785|neuromodulation|neuromodulation
191065|NCT02397772|Soil-transmitted helminths|soil-transmitted helminths
191066|NCT02397772|Intestinal Nematodes|intestinal nematodes
191067|NCT02397772|Hookworm|hookworm
191068|NCT02397772|Ascaris|ascaris
191069|NCT02397772|Mass Treatment|mass treatment
191070|NCT02397772|Kenya|kenya
191071|NCT02397746|osteoarthritis|osteoarthritis
191072|NCT02397746|avascular necrosis|avascular necrosis
191073|NCT02397746|ankylosis|ankylosis
191074|NCT02397746|protrusio acetabuli|protrusio acetabuli
191075|NCT02397746|rheumatoid arthritis|rheumatoid arthritis
191076|NCT02397746|correction of functional deformity|correction of functional deformity
191077|NCT02397746|revision procedures|revision procedures
191078|NCT02397720|Leukemia|leukemia
191079|NCT02397720|Acute myeloid leukemia|acute myeloid leukemia
191080|NCT02397720|AML|aml
191081|NCT02397720|Refractory/ relapsed|refractory/ relapsed
191082|NCT02397720|5-azacytidine|5-azacytidine
191083|NCT02397720|Azacitidine|azacitidine
191084|NCT02397720|5-aza|5-aza
191085|NCT02397720|Vidaza|vidaza
191086|NCT02397720|5-AZC|5-azc
191087|NCT02397720|AZA-CR|aza-cr
191088|NCT02397720|Ladakamycin|ladakamycin
191089|NCT02397720|NSC-102816|nsc-102816
191090|NCT02397720|Azacytidine|azacytidine
191091|NCT02397720|Nivolumab|nivolumab
191092|NCT02397720|BMS-936558|bms-936558
191093|NCT02397720|Phone calls|phone calls
191094|NCT02397694|Adult|adult
191095|NCT02397694|HIV|hiv
191096|NCT02397694|naive|naive
191097|NCT02397655|stroke|stroke
191098|NCT02397655|ischemia|ischemia
191099|NCT02397655|atherosclerosis|atherosclerosis
191100|NCT02397655|ultrasonography|ultrasonography
191101|NCT02397590|Fimasartan|fimasartan
191102|NCT02397564|scar|scar
191103|NCT02397564|ICD-10 CM:L90.5|icd-10 cm:l90.5
191104|NCT02397538|Fimasartan|fimasartan
191105|NCT02397447|Momordica Charantia|momordica charantia
191106|NCT02397447|Insulin secretion|insulin secretion
191107|NCT02397447|Insulin sensitivity|insulin sensitivity
191108|NCT02397434|assessment of QOL (EORTC QLQ-C30)|assessment of qol (eortc qlq-c30)
191109|NCT02397421|Heart failure|heart failure
191110|NCT02397421|Diabetes|diabetes
191111|NCT02397421|Left ventricular remodelling|left ventricular remodelling
191112|NCT02397421|SGLT-2 inhibitors|sglt-2 inhibitors
191113|NCT02397395|Renal Impairment|renal impairment
191114|NCT02397395|End-stage Renal Disease|end-stage renal disease
191115|NCT02397395|Simeprevir|simeprevir
191116|NCT02397395|Daclatasvir|daclatasvir
191117|NCT02397382|Psoriasis|psoriasis
191118|NCT02397382|Guselkumab|guselkumab
191119|NCT02397382|Cytochromes P450|cytochromes p450
191120|NCT02397369|Education and evaluate post intervention KAP|education and evaluate post intervention kap
191121|NCT02397356|ketamine|ketamine
191122|NCT02397343|Reduction of secondary hyperalgesia and/-or local inflammation|reduction of secondary hyperalgesia and/-or local inflammation
191123|NCT02397304|Intra-muscular triglyceride use|intra-muscular triglyceride use
191124|NCT02397291|Pregnancy|pregnancy
191125|NCT02397291|IUGR|iugr
191126|NCT02397265|Type 1 diabetes|type 1 diabetes
191127|NCT02397265|Hypoglycaemia|hypoglycaemia
191128|NCT02397265|Closed loop insulin pump|closed loop insulin pump
191129|NCT02397265|Artificial pancreas|artificial pancreas
191130|NCT02397265|Exercise|exercise
191131|NCT02397265|Mixed meals|mixed meals
191132|NCT02397265|Bihormonal pump|bihormonal pump
191133|NCT02397252|Human Papillomavirus|human papillomavirus
191134|NCT02397252|Screening|screening
191135|NCT02397252|Self-collection test|self-collection test
191136|NCT02397252|Pap test|pap test
191137|NCT02397226|Radiofrequency ablation|radiofrequency ablation
191138|NCT02397226|Plethysmography|plethysmography
191139|NCT02397226|Duplex ultrasound|duplex ultrasound
191140|NCT02397226|High ligation/stripping|high ligation/stripping
191141|NCT02397213|Ciclosporin|ciclosporin
191142|NCT02397213|Acute Kidney injury|acute kidney injury
191143|NCT02397213|Cardiac surgery|cardiac surgery
191144|NCT02397213|Ischemia|ischemia
191145|NCT02397213|Safety|safety
191146|NCT02397213|Cystatin C|cystatin c
191147|NCT02397200|Growth|growth
191148|NCT02397200|low weight|low weight
191149|NCT02397200|low height|low height
191150|NCT02397200|Nutritional Supplementation|nutritional supplementation
191151|NCT02397174|Polycystic Ovary syndrome|polycystic ovary syndrome
191152|NCT02397174|hypocaloric diet|hypocaloric diet
191153|NCT02397174|Ovarian Cysts|ovarian cysts
191154|NCT02397174|Ovarian Diseases|ovarian diseases
191155|NCT02397174|Obesity|obesity
191156|NCT02397174|Mediterranean Diet|mediterranean diet
191157|NCT02397135|genomic markers|genomic markers
191158|NCT02397083|Endometrial Cancer|endometrial cancer
191159|NCT02397083|Endometrial hyperplasia|endometrial hyperplasia
191160|NCT02397083|Intrauterine device|intrauterine device
191161|NCT02397083|IUD|iud
191162|NCT02397083|Levonorgestrel intrauterine device|levonorgestrel intrauterine device
191163|NCT02397083|LIUD|liud
191164|NCT02397083|Mirena|mirena
191165|NCT02397083|Everolimus|everolimus
191166|NCT02397083|Afinitor|afinitor
191167|NCT02397083|Zortress|zortress
191168|NCT02397083|RAD001|rad001
191169|NCT02397083|Questionnaires|questionnaires
191170|NCT02397083|Survey|survey
191171|NCT02397083|Quality of life|quality of life
191172|NCT02397083|QOL|qol
191173|NCT02397070|Jaw exercise|jaw exercise
191174|NCT02397070|Occlusal splint|occlusal splint
191175|NCT02397070|Treatment|treatment
191176|NCT02397070|Muscular pain|muscular pain
191177|NCT02397070|Mandibular movement|mandibular movement
191178|NCT02397044|Implants, stability, loading|implants, stability, loading
191179|NCT02397031|borderline personality disorder|borderline personality disorder
191180|NCT02397031|mindfulness|mindfulness
191181|NCT02397018|stroke|stroke
191182|NCT02397018|cord blood|cord blood
191183|NCT02397018|umbilical cord blood|umbilical cord blood
191184|NCT02397018|hematopoietic stem cells|hematopoietic stem cells
191185|NCT02397018|acute ischemic stroke|acute ischemic stroke
191186|NCT02396992|Oropharyngeal Dysphagia|oropharyngeal dysphagia
191187|NCT02396992|Aspiration pneumonia|aspiration pneumonia
191188|NCT02396992|Malnutrition|malnutrition
191189|NCT02396992|Oral Health|oral health
191190|NCT02396992|Bacterial colonization|bacterial colonization
191191|NCT02396992|Aging|aging
191192|NCT02396940|3D|3d
191193|NCT02396940|Three-dimensional|three-dimensional
191194|NCT02396940|Laparoscopy|laparoscopy
191195|NCT02396940|Inguinal hernia repair|inguinal hernia repair
191196|NCT02396927|3D|3d
191197|NCT02396927|Three-dimensional|three-dimensional
191198|NCT02396927|laparoscopy|laparoscopy
191199|NCT02396927|cholecystectomy|cholecystectomy
191200|NCT02396901|early goal direct therapy|early goal direct therapy
191201|NCT02396901|preventive strategies|preventive strategies
191202|NCT02396901|cardiac surgery|cardiac surgery
191203|NCT02396888|Blood vessel|blood vessel
191204|NCT02396888|Fibroplasia|fibroplasia
191205|NCT02396888|Wound healing|wound healing
191206|NCT02396888|Insulin|insulin
191207|NCT02396836|Hand hygiene|hand hygiene
191208|NCT02396836|Hand decontamination|hand decontamination
191209|NCT02396836|Microbial load|microbial load
191210|NCT02396836|Hand coverage|hand coverage
191211|NCT02396836|Glove juice technique|glove juice technique
191212|NCT02396836|Ayliffe technique|ayliffe technique
191213|NCT02396836|6 step technique|6 step technique
191214|NCT02396823|Blood pressure regulation|blood pressure regulation
191215|NCT02396823|Respiratory Muscle Training|respiratory muscle training
191216|NCT02396797|Sick leave|sick leave
191217|NCT02396797|Mental Health|mental health
191218|NCT02396797|Coping|coping
191219|NCT02396797|Social Support|social support
191220|NCT02396797|Subjective Health Complaints|subjective health complaints
191221|NCT02396784|child overweight|child overweight
191222|NCT02396784|child obesity|child obesity
191223|NCT02396784|prevention|prevention
191224|NCT02396784|targeted intervention|targeted intervention
191225|NCT02396784|development of overweight|development of overweight
191226|NCT02396771|Uterine|uterine
191227|NCT02396771|Massage|massage
191228|NCT02396771|Compression|compression
191229|NCT02396732|Aspirin|aspirin
191230|NCT02396732|Enoxaparin|enoxaparin
191231|NCT02396732|Thromboprophylaxis|thromboprophylaxis
191232|NCT02396732|Trauma|trauma
191233|NCT02396732|Venous thromboembolism|venous thromboembolism
191234|NCT02396693|Newborn|newborn
191235|NCT02396693|non invasive ventilation|non invasive ventilation
191236|NCT02396680|Ragweed Allergy|ragweed allergy
191237|NCT02396680|Rhinoconjunctivitis|rhinoconjunctivitis
191238|NCT02396680|Immunotherapy|immunotherapy
191239|NCT02396680|Ragweed-SPIRE|ragweed-spire
191240|NCT02396641|Best Supportive Care|best supportive care
191241|NCT02396628|Graft-versus-Host Disease (GvHD)|graft-versus-host disease (gvhd)
191242|NCT02396628|resistance to therapy|resistance to therapy
191243|NCT02396628|allogeneic stem cell transplantation|allogeneic stem cell transplantation
191244|NCT02396628|Ruxolitinib|ruxolitinib
191245|NCT02396615|Ad libitum energy intake|ad libitum energy intake
191246|NCT02396615|Appetite|appetite
191247|NCT02396589|stroke rehabilitation|stroke rehabilitation
191248|NCT02396589|barriers to independence|barriers to independence
191249|NCT02396589|environmental support|environmental support
191250|NCT02396550|Expectations|expectations
191251|NCT02396537|Children|children
191252|NCT02396537|Midazolam|midazolam
191253|NCT02396537|Lidocaine|lidocaine
191254|NCT02396537|Intranasal|intranasal
191255|NCT02396524|Chronic Disease|chronic disease
191256|NCT02396524|Lifestyle Intervention|lifestyle intervention
191257|NCT02396524|Health Promotion|health promotion
191258|NCT02396524|Sport Mentorship|sport mentorship
191259|NCT02396524|Men|men
191260|NCT02396524|Health Technology|health technology
191261|NCT02396524|Prevention|prevention
191262|NCT02396524|Exercise|exercise
191263|NCT02396524|Diet|diet
191264|NCT02396472|social support|social support
191265|NCT02396459|Triac|triac
191266|NCT02396459|MCT8|mct8
191267|NCT02396459|Allan-Herndon-Dudley Syndrome|allan-herndon-dudley syndrome
191268|NCT02396433|Halaven|halaven
191269|NCT02396433|BRCA|brca
191270|NCT02396433|E7449|e7449
191271|NCT02396420|BPH|bph
191272|NCT02396420|prostatic hyperplasia|prostatic hyperplasia
191273|NCT02396420|enlarged prostate|enlarged prostate
191274|NCT02396420|benign prostatic hypertrophy|benign prostatic hypertrophy
191275|NCT02396407|Chlorine water treatment|chlorine water treatment
191276|NCT02396407|Point-of-use water treatment|point-of-use water treatment
191277|NCT02396407|Household water treatment with safe storage|household water treatment with safe storage
191278|NCT02396407|Handwashing with soap|handwashing with soap
191279|NCT02396407|Hand hygiene|hand hygiene
191280|NCT02396407|Latrines|latrines
191281|NCT02396407|Child potties|child potties
191282|NCT02396407|Intestinal parasitic infection|intestinal parasitic infection
191283|NCT02396407|Soil-transmitted helminths|soil-transmitted helminths
191284|NCT02396407|Water|water
191285|NCT02396407|Sanitation|sanitation
191286|NCT02396407|Handwashing|handwashing
191287|NCT02396407|Diarrhea|diarrhea
191288|NCT02396407|Herd immunity|herd immunity
191289|NCT02396407|Helminths|helminths
191290|NCT02396394|HIV|hiv
191291|NCT02396394|ART Adherence|art adherence
191292|NCT02396394|Retention in Care|retention in care
191293|NCT02396394|Pregnant Women|pregnant women
191294|NCT02396394|Postpartum Women|postpartum women
191295|NCT02396381|Candidate modified risk tobacco product|candidate modified risk tobacco product
191296|NCT02396381|Conventional cigarette|conventional cigarette
191297|NCT02396381|Exposure response|exposure response
191298|NCT02396381|Smoking|smoking
191299|NCT02396381|Tobacco Heating System|tobacco heating system
191300|NCT02396368|Prostate cancer|prostate cancer
191301|NCT02396368|Bone metastatic Castration-Resistant Prostate Cancer|bone metastatic castration-resistant prostate cancer
191302|NCT02396368|Radium 223|radium 223
191303|NCT02396368|Tasquinimod|tasquinimod
191304|NCT02396355|flow cytometry|flow cytometry
191305|NCT02396342|Hemophilia B, gene therapy|hemophilia b, gene therapy
191306|NCT02396303|General: To compare Carbetocin and Oxytocin for the control of PPH.|general: to compare carbetocin and oxytocin for the control of pph.
191307|NCT02396290|acne scar|acne scar
191308|NCT02396290|fractional carbon dioxide laser|fractional carbon dioxide laser
191309|NCT02396290|platelet rich plasma|platelet rich plasma
191310|NCT02396264|Mediterranean Diet|mediterranean diet
191311|NCT02396264|Ovarian Cysts|ovarian cysts
191312|NCT02396264|Treatment|treatment
191313|NCT02396264|Ovarian Diseases|ovarian diseases
191314|NCT02396264|normocaloric diet|normocaloric diet
191315|NCT02396225|voriconazole|voriconazole
191316|NCT02396225|inhalation|inhalation
191317|NCT02396225|aerosol|aerosol
191318|NCT02396225|epithelial lining fluid|epithelial lining fluid
191319|NCT02396225|concentration|concentration
191320|NCT02396225|pharmacokinetic|pharmacokinetic
191321|NCT02396199|Abdominal aortic aneurysm|abdominal aortic aneurysm
191322|NCT02396199|Endovascular|endovascular
191323|NCT02396199|Juxtarenal|juxtarenal
191324|NCT02396199|Pararenal|pararenal
191325|NCT02396199|Fenestrated|fenestrated
191326|NCT02396173|disability|disability
191327|NCT02396173|vocational|vocational
191328|NCT02396173|rehabilitation|rehabilitation
191329|NCT02396173|prediction|prediction
191330|NCT02396160|overactive bladder|overactive bladder
191331|NCT02396160|urinary incontinence|urinary incontinence
191332|NCT02396160|nocturia|nocturia
191333|NCT02396160|urinary frequency|urinary frequency
191334|NCT02396147|Drug therapy|drug therapy
191335|NCT02396095|female|female
191336|NCT02396095|cancer|cancer
191337|NCT02396082|care coordination|care coordination
191338|NCT02396082|quality of life|quality of life
191339|NCT02396082|community-based|community-based
191340|NCT02396082|care quality|care quality
191341|NCT02396082|Long term care placement|long term care placement
191342|NCT02396082|memory care|memory care
191343|NCT02396082|Neuropsychiatric behaviors|neuropsychiatric behaviors
191344|NCT02396056|Guided Bone Regeneration|guided bone regeneration
191345|NCT02396056|Gingival Mesenchymal Stem Cells|gingival mesenchymal stem cells
191346|NCT02395991|gadoxetic acid|gadoxetic acid
191347|NCT02395991|transient dyspnea|transient dyspnea
191348|NCT02395965|Osteopathic manipulative medicine|osteopathic manipulative medicine
191349|NCT02395965|Osteopathic manipulative treatment|osteopathic manipulative treatment
191350|NCT02395952|cornea|cornea
191351|NCT02395952|epithelial defect|epithelial defect
191352|NCT02395952|amniotic membrane|amniotic membrane
191353|NCT02395939|Cryobiopsy|cryobiopsy
191354|NCT02395939|Radial EBUS|radial ebus
191355|NCT02395939|Guide Sheath|guide sheath
191356|NCT02395939|Peripheral pulmonary lesions|peripheral pulmonary lesions
191357|NCT02395887|Spinal stenosis|spinal stenosis
191358|NCT02395887|Spinal decompression|spinal decompression
191359|NCT02395887|Postural balance|postural balance
191360|NCT02395887|Neurogenic claudication|neurogenic claudication
191361|NCT02395848|recurrent|recurrent
191362|NCT02395848|infection|infection
191363|NCT02395835|body mass index|body mass index
191364|NCT02395835|methylation|methylation
191365|NCT02395835|PPAR gamma|ppar gamma
191366|NCT02395835|pregnancy|pregnancy
191367|NCT02395822|AML|aml
191368|NCT02395822|Relapsed|relapsed
191369|NCT02395822|Refractory|refractory
191370|NCT02395796|epidural|epidural
191371|NCT02395796|labor analgesia|labor analgesia
191372|NCT02395796|pressure monitoring|pressure monitoring
191373|NCT02395783|Preterm infants|preterm infants
191374|NCT02395783|diagnosis of cerebral white matter injury|diagnosis of cerebral white matter injury
191375|NCT02395770|Shoulder|shoulder
191376|NCT02395770|Rotator cuff|rotator cuff
191377|NCT02395770|Rehabilitation|rehabilitation
191378|NCT02395770|Motor control|motor control
191379|NCT02395757|Age Related Macular Degeneration (AMD)|age related macular degeneration (amd)
191380|NCT02395757|Microperimetry|microperimetry
191381|NCT02395757|Diagnostic|diagnostic
191382|NCT02395731|dual eligible|dual eligible
191383|NCT02395731|care coordination|care coordination
191384|NCT02395731|community-based|community-based
191385|NCT02395731|care quality|care quality
191386|NCT02395731|care needs|care needs
191387|NCT02395731|health services|health services
191388|NCT02395731|care management|care management
191389|NCT02395731|low income|low income
191390|NCT02395731|Neuropsychiatric behaviors|neuropsychiatric behaviors
191391|NCT02395718|elderly|elderly
191392|NCT02395718|quick diagnostic unit|quick diagnostic unit
191393|NCT02395718|short stay unit|short stay unit
191394|NCT02395718|randomised controlled trial|randomised controlled trial
191395|NCT02395679|Dendritic cell-based immunotherapy|dendritic cell-based immunotherapy
191642|NCT02394197|14-day treatment (T14)|14-day treatment (t14)
191396|NCT02395666|Neuroblastoma in remission|neuroblastoma in remission
191397|NCT02395666|Relapsed Neuroblastoma|relapsed neuroblastoma
191398|NCT02395666|Refractory Neuroblastoma|refractory neuroblastoma
191399|NCT02395653|Pediatric|pediatric
191400|NCT02395653|Postoperative|postoperative
191401|NCT02395653|Pain Management|pain management
191402|NCT02395627|Hormone Therapy Resistant|hormone therapy resistant
191403|NCT02395627|Estrogen Receptor-Positive|estrogen receptor-positive
191404|NCT02395627|Estrogen Receptor-Negative|estrogen receptor-negative
191405|NCT02395614|tissue expander|tissue expander
191406|NCT02395614|breast reconstruction|breast reconstruction
191407|NCT02395601|B-Cell Lymphoma|b-cell lymphoma
191408|NCT02395601|EZH2 Inhibitor|ezh2 inhibitor
191409|NCT02395601|Phase 1|phase 1
191410|NCT02395497|Penile Transplant|penile transplant
191411|NCT02395497|Vascularized Composite Allotransplantation (VCA)|vascularized composite allotransplantation (vca)
191412|NCT02395497|Composite Tissue Allotransplantation (CTA)|composite tissue allotransplantation (cta)
191413|NCT02395497|Penis|penis
191414|NCT02395497|Amputation|amputation
191415|NCT02395497|Immunosuppression|immunosuppression
191416|NCT02395497|Composite Tissue|composite tissue
191417|NCT02395497|Male|male
191418|NCT02395497|Humans|humans
191419|NCT02395497|Allotransplantation|allotransplantation
191420|NCT02395458|Sequential therapy|sequential therapy
191421|NCT02395458|Triple therapy|triple therapy
191422|NCT02395458|Eradication|eradication
191423|NCT02395393|Acute rejection|acute rejection
191424|NCT02395393|Chronic rejection|chronic rejection
191425|NCT02395393|Confocal microscopy|confocal microscopy
191427|NCT02395380|Postoperative complication|postoperative complication
191428|NCT02395380|Length of stay|length of stay
191429|NCT02395367|Prognosis|prognosis
191430|NCT02395367|Risk Factors|risk factors
191431|NCT02395354|Endoscopic treatment|endoscopic treatment
191432|NCT02395354|Stenosis|stenosis
191433|NCT02395354|Crohn's Disease|crohn's disease
191434|NCT02395354|balloon dilatation|balloon dilatation
191435|NCT02395354|self-expanding metallic stent|self-expanding metallic stent
191436|NCT02395354|chronic transmural inflammation|chronic transmural inflammation
191437|NCT02395354|steady narrowing of the intestinal lumen|steady narrowing of the intestinal lumen
191438|NCT02395341|reproductive hormones|reproductive hormones
191439|NCT02395341|cancer survivors|cancer survivors
191440|NCT02395341|endocrine function|endocrine function
191441|NCT02395341|antral follicle counts|antral follicle counts
191442|NCT02395341|female infertility due to diminished ovarian reserve|female infertility due to diminished ovarian reserve
191443|NCT02395341|perimenopause|perimenopause
191444|NCT02395341|premature menopause|premature menopause
191445|NCT02395328|Orphans and vulnerable children (OVC)|orphans and vulnerable children (ovc)
191446|NCT02395328|Home visiting intervention|home visiting intervention
191447|NCT02395328|South Africa|south africa
191448|NCT02395328|Program evaluation|program evaluation
191449|NCT02395315|Diabetes Mellitus|diabetes mellitus
191450|NCT02395315|Osseointegration|osseointegration
191451|NCT02395315|Bone vascularity|bone vascularity
191452|NCT02395315|Primary implant stability|primary implant stability
191453|NCT02395289|Cognitive-Based Compassion Training (CBCT)|cognitive-based compassion training (cbct)
191454|NCT02395289|HIV-related clinical outcomes|hiv-related clinical outcomes
191455|NCT02395289|Stress and stress-related psychological adjustment|stress and stress-related psychological adjustment
191456|NCT02395289|Stress-related inflammatory biomarkers|stress-related inflammatory biomarkers
191457|NCT02395276|Congenital Heart Defects|congenital heart defects
191458|NCT02395276|Hypoxic Ischemic Brain Injury|hypoxic ischemic brain injury
191459|NCT02395276|Hypothermia Therapy|hypothermia therapy
191460|NCT02395276|Pediatrics|pediatrics
191461|NCT02395237|Fed Conditions|fed conditions
191462|NCT02395224|Follow-up studies|follow-up studies
191463|NCT02395224|Prognosis|prognosis
191464|NCT02395224|Palliative care|palliative care
191465|NCT02395224|Chemotherapy, adjuvant|chemotherapy, adjuvant
191466|NCT02395224|Cost-benefit analysis|cost-benefit analysis
191467|NCT02395224|Population|population
191468|NCT02395224|Antineoplastic agents/Adverse effects|antineoplastic agents/adverse effects
191469|NCT02395224|Terminal care|terminal care
191470|NCT02395224|Medical futility|medical futility
191471|NCT02395224|Survival rate|survival rate
191472|NCT02395224|Norway|norway
191473|NCT02395198|hepatitis c virus|hepatitis c virus
191474|NCT02395198|opioid substitution treatment|opioid substitution treatment
191475|NCT02395172|avelumab|avelumab
191476|NCT02395172|MSB0010718C|msb0010718c
191477|NCT02395172|Non-Small Cell Lung Cancer|non-small cell lung cancer
191478|NCT02395172|Anti-PD-L1|anti-pd-l1
191479|NCT02395159|vascular surgery patients|vascular surgery patients
191480|NCT02395159|wound management|wound management
191481|NCT02395133|Eczema|eczema
191482|NCT02395120|Dental Care|dental care
191483|NCT02395120|Caregiver Illness Perception|caregiver illness perception
191484|NCT02395120|Common Sense Model of Self-Regulation|common sense model of self-regulation
191485|NCT02395120|Dental Access|dental access
191486|NCT02395120|Referral letter|referral letter
191487|NCT02395120|Dental Caries|dental caries
191488|NCT02395107|Aortic Valve Stenosis|aortic valve stenosis
191489|NCT02395107|Functional Capacity|functional capacity
191490|NCT02395107|Cardiomyopathies|cardiomyopathies
191491|NCT02395107|Endomyocardial Fibrosis|endomyocardial fibrosis
191492|NCT02395107|Cardiovascular Diseases|cardiovascular diseases
191493|NCT02395107|Heart Diseases|heart diseases
191494|NCT02395107|Heart Valve Diseases|heart valve diseases
191495|NCT02395107|Atrial Fibrillation|atrial fibrillation
191496|NCT02395107|Hypertrophy|hypertrophy
191497|NCT02395107|Hypertrophy, Left Ventricular|hypertrophy, left ventricular
191498|NCT02395107|Diastology|diastology
191499|NCT02395081|pregnancy|pregnancy
191500|NCT02395081|Mongolia|mongolia
191501|NCT02395081|Vitamin D|vitamin d
191502|NCT02395081|preeclampsia|preeclampsia
191503|NCT02395068|Pharmacokinetics|pharmacokinetics
191504|NCT02395068|Nimotuzumab|nimotuzumab
191505|NCT02395068|Safety|safety
191506|NCT02395068|Effcacy|effcacy
191507|NCT02395068|Irinotecan|irinotecan
191508|NCT02395029|PD|pd
191509|NCT02395003|Obesity|obesity
191510|NCT02395003|Pediatric|pediatric
191511|NCT02394977|CPR|cpr
191512|NCT02394977|Cardio first angle|cardio first angle
191513|NCT02394977|Clinical trial|clinical trial
191514|NCT02394951|chemotherapy|chemotherapy
191515|NCT02394938|Music therapy|music therapy
191516|NCT02394912|vena cava filter|vena cava filter
191517|NCT02394899|SCD|scd
191518|NCT02394899|early childhood intervention|early childhood intervention
191519|NCT02394899|parental stress|parental stress
191520|NCT02394899|neurocognition|neurocognition
191521|NCT02394873|Deep Second-Degree Burn Wound|deep second-degree burn wound
191522|NCT02394847|propofol|propofol
191523|NCT02394847|electroconvulsive therapy|electroconvulsive therapy
191524|NCT02394847|anesthesia|anesthesia
191525|NCT02394834|Metastatic colorectal cancer, Panitumumab, mFOLFOX6, Bevacizumab|metastatic colorectal cancer, panitumumab, mfolfox6, bevacizumab
191526|NCT02394795|Metastatic colorectal cancer, Panitumumab, mFOLFOX6, Bevacizumab|metastatic colorectal cancer, panitumumab, mfolfox6, bevacizumab
191527|NCT02394782|Multiple sclerosis, relapsing-remitting|multiple sclerosis, relapsing-remitting
191528|NCT02394782|Rebif|rebif
191529|NCT02394782|Interferon beta-1a|interferon beta-1a
191530|NCT02394782|RebiSmart®2.0|rebismart®2.0
191531|NCT02394782|MSdialog™|msdialog™
191532|NCT02394769|Colorectal Cancer|colorectal cancer
191533|NCT02394743|Glomerular Filtration Rate|glomerular filtration rate
191534|NCT02394730|HIV, d-dimer, hs-CRP, activated T-lymphocytes|hiv, d-dimer, hs-crp, activated t-lymphocytes
191535|NCT02394704|Rumination|rumination
191536|NCT02394704|Sensory processing|sensory processing
191537|NCT02394704|Non-pharmacological intervention|non-pharmacological intervention
191538|NCT02394704|Depression|depression
191539|NCT02394704|Anxiety|anxiety
191540|NCT02394704|PTSD|ptsd
191541|NCT02394665|Glioblastoma|glioblastoma
191542|NCT02394665|Gliosarcoma|gliosarcoma
191543|NCT02394665|GBM|gbm
191544|NCT02394626|Recurrent glioblastoma|recurrent glioblastoma
191545|NCT02394626|Surgery|surgery
191546|NCT02394626|Complete resection of enhancing tumor|complete resection of enhancing tumor
191547|NCT02394626|Survival|survival
191548|NCT02394626|Quality of life|quality of life
191549|NCT02394613|Glaucoma|glaucoma
191550|NCT02394613|DARC|darc
191551|NCT02394613|Diagnosis|diagnosis
191552|NCT02394600|rhinitis|rhinitis
191553|NCT02394600|allergy|allergy
191554|NCT02394587|mindfulness|mindfulness
191555|NCT02394587|MBSR|mbsr
191556|NCT02394587|SCD|scd
191557|NCT02394587|experimental|experimental
191558|NCT02394548|Locally advanced, inoperable non-small cell lung carcinoma|locally advanced, inoperable non-small cell lung carcinoma
191559|NCT02394548|Limited stage small cell lung carcinoma|limited stage small cell lung carcinoma
191560|NCT02394548|Acute esophagitis|acute esophagitis
191561|NCT02394548|Intensity-modulated radiation therapy|intensity-modulated radiation therapy
191562|NCT02394535|Pancreatic Cancer|pancreatic cancer
191563|NCT02394535|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
191564|NCT02394535|Locally Advanced Pancreatic Cancer|locally advanced pancreatic cancer
191565|NCT02394535|Abraxane|abraxane
191566|NCT02394535|Nab-Paclitaxel|nab-paclitaxel
191567|NCT02394535|Paclitaxel (Protein-Bound)|paclitaxel (protein-bound)
191568|NCT02394535|ABI-007|abi-007
191569|NCT02394535|Radiation therapy|radiation therapy
191570|NCT02394535|XRT|xrt
191571|NCT02394535|Capecitabine|capecitabine
191572|NCT02394535|Xeloda|xeloda
191573|NCT02394535|Questionnaires|questionnaires
191574|NCT02394535|Surveys|surveys
191575|NCT02394522|Malaria|malaria
191576|NCT02394522|Spatial Repellents|spatial repellents
191577|NCT02394522|Plasmodium|plasmodium
191578|NCT02394509|Epilepsy Memory Problems|epilepsy memory problems
191579|NCT02394509|Self-Management|self-management
191580|NCT02394496|Fulvestrant|fulvestrant
191581|NCT02394496|Lapatinib|lapatinib
191582|NCT02394496|Aromatase Inhibitor|aromatase inhibitor
191583|NCT02394496|metastatic breast cancer|metastatic breast cancer
191584|NCT02394483|Single ascending dose|single ascending dose
191585|NCT02394483|double blind|double blind
191586|NCT02394470|congestion|congestion
191587|NCT02394470|total body water|total body water
191588|NCT02394470|bioimpedentiometry|bioimpedentiometry
191589|NCT02394470|lung ultrasound|lung ultrasound
191590|NCT02394470|diuretics|diuretics
191591|NCT02394470|dyspnea|dyspnea
191592|NCT02394470|pulmonary B lines|pulmonary b lines
191593|NCT02394470|deuterium|deuterium
191594|NCT02394457|Postdural puncture headache|postdural puncture headache
191595|NCT02394457|Epidural Blood Patch|epidural blood patch
191596|NCT02394457|Cosyntropin|cosyntropin
191597|NCT02394457|PDPH|pdph
191598|NCT02394457|Regional anesthesia|regional anesthesia
191599|NCT02394457|Lumbar puncture|lumbar puncture
191600|NCT02394457|ACTH|acth
191601|NCT02394457|Tetracosactin|tetracosactin
191602|NCT02394444|Intervention program|intervention program
191603|NCT02394444|Parenting stress|parenting stress
191604|NCT02394444|Parental mental health|parental mental health
191605|NCT02394444|Preterm infant's development|preterm infant's development
191606|NCT02394431|Sickle Cell Disease|sickle cell disease
191607|NCT02394431|Echocardiography|echocardiography
191608|NCT02394431|Speckle tracking|speckle tracking
191609|NCT02394392|Medication satisfaction|medication satisfaction
191610|NCT02394392|Quality of life|quality of life
191611|NCT02394392|Drug compliance|drug compliance
191612|NCT02394366|Skin oxygenation|skin oxygenation
191613|NCT02394366|peripheral perfusion|peripheral perfusion
191614|NCT02394353|bariatrics|bariatrics
191615|NCT02394353|transient elastography|transient elastography
191616|NCT02394314|MEDI0382, diabetes|medi0382, diabetes
191617|NCT02394301|Efficacy of Novel Drug Combinations for Relief of Psoriasis|efficacy of novel drug combinations for relief of psoriasis
191618|NCT02394288|Cardiac Troponin|cardiac troponin
191619|NCT02394288|Perioperative Period|perioperative period
191620|NCT02394288|surgery|surgery
191621|NCT02394262|Biological Markers|biological markers
191622|NCT02394262|Multidetector Computed Tomography|multidetector computed tomography
191623|NCT02394249|Insulin Resistance|insulin resistance
191624|NCT02394249|Cognition|cognition
191625|NCT02394249|Affect|affect
191626|NCT02394249|Insulin|insulin
191627|NCT02394249|Lipids|lipids
191628|NCT02394236|exercise training|exercise training
191629|NCT02394223|Cancer|cancer
191630|NCT02394223|Prostate|prostate
191631|NCT02394223|PSA|psa
191632|NCT02394223|Biopsies|biopsies
191633|NCT02394223|FFOCT procedure|ffoct procedure
191634|NCT02394210|Multiple myeloma asymptomatic relapse symptomatic relapse|multiple myeloma asymptomatic relapse symptomatic relapse
191635|NCT02394210|IMW Consensus Panel|imw consensus panel
191636|NCT02394210|anti-MM therapy|anti-mm therapy
191637|NCT02394197|Plasmodium vivax|plasmodium vivax
191638|NCT02394197|Mexico|mexico
191639|NCT02394197|treatment|treatment
191640|NCT02394197|chloroquine|chloroquine
191641|NCT02394197|primaquine|primaquine
191643|NCT02394197|intermittent single doses (ISD)|intermittent single doses (isd)
191644|NCT02394184|transcatheter aortic valve replacement|transcatheter aortic valve replacement
191645|NCT02394171|Physical Activity|physical activity
191646|NCT02394171|Social Cohesion|social cohesion
191647|NCT02394171|Intervention Development|intervention development
191648|NCT02394171|Ethnic Minorities|ethnic minorities
191649|NCT02394171|Nutrition|nutrition
191650|NCT02394158|Recurrent Gestational Diabetes Mellitus|recurrent gestational diabetes mellitus
191651|NCT02394158|Prevention|prevention
191652|NCT02394158|Metformin|metformin
191653|NCT02394145|platelet|platelet
191654|NCT02394145|ticagrelor|ticagrelor
191655|NCT02394145|clopidogrel|clopidogrel
191656|NCT02394145|end stage renal disease|end stage renal disease
191657|NCT02394145|hemodialysis|hemodialysis
191658|NCT02394145|genetics|genetics
191659|NCT02394132|Lentigo maligna|lentigo maligna
191660|NCT02394132|Imiquimod|imiquimod
191661|NCT02394132|Radiotherapy|radiotherapy
191662|NCT02394054|vasopressin|vasopressin
191663|NCT02394054|intranasal administration|intranasal administration
191664|NCT02394054|healthy sample|healthy sample
191665|NCT02394041|acupuncture|acupuncture
191666|NCT02394041|cervical dystocia|cervical dystocia
191667|NCT02394041|caesarean section|caesarean section
191668|NCT02394041|obstetric labor|obstetric labor
191963|NCT02392208|dialysis|dialysis
191669|NCT02394041|randomized controlled trial|randomized controlled trial
191670|NCT02394015|Platinum-sensitive Recurrent Ovarian Cancer|platinum-sensitive recurrent ovarian cancer
191671|NCT02394002|EEG, burst-suppression, N20, SEP, median nerve, facilitation|eeg, burst-suppression, n20, sep, median nerve, facilitation
191672|NCT02393911|vestibulitis|vestibulitis
191673|NCT02393911|microbiome|microbiome
191674|NCT02393872|Prevention|prevention
191675|NCT02393859|ALL|all
191676|NCT02393859|High-risk first relapse B-precursor ALL|high-risk first relapse b-precursor all
191677|NCT02393859|Precursor Cell Lymphoblastic Leukemia|precursor cell lymphoblastic leukemia
191678|NCT02393859|Neoplasms|neoplasms
191679|NCT02393859|Lymphoproliferative Disorders|lymphoproliferative disorders
191680|NCT02393859|Immunoproliferative Disorders|immunoproliferative disorders
191681|NCT02393859|Antibodies, Bispecific|antibodies, bispecific
191682|NCT02393846|ankle sprain|ankle sprain
191683|NCT02393846|topical ketoprofen|topical ketoprofen
191684|NCT02393846|non-steroidal anti-inflammatory drug|non-steroidal anti-inflammatory drug
191685|NCT02393846|emergency department|emergency department
191686|NCT02393833|Vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
191687|NCT02393833|Vascular cell adhesion molecule-1 (VCAM-1)|vascular cell adhesion molecule-1 (vcam-1)
191688|NCT02393833|HER2-ECD|her2-ecd
191689|NCT02393807|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
191690|NCT02393794|BRCA1|brca1
191691|NCT02393794|BRCA2|brca2
191692|NCT02393794|TNBC|tnbc
191693|NCT02393781|severe sepsis|severe sepsis
191694|NCT02393781|septic shock|septic shock
191695|NCT02393781|adrenomedullin|adrenomedullin
191696|NCT02393781|organ dysfunction|organ dysfunction
191697|NCT02393703|exosomes|exosomes
191698|NCT02393703|15-015|15-015
191699|NCT02393664|Thoracoscopy|thoracoscopy
191700|NCT02393664|Recovery|recovery
191701|NCT02393664|Tracheal intubation|tracheal intubation
191702|NCT02393638|Endoscopic Sphincterotomy|endoscopic sphincterotomy
191703|NCT02393625|NSCLC, ALK-positive|nsclc, alk-positive
191704|NCT02393586|Tuberculosis|tuberculosis
191705|NCT02393586|Whole blood Bactericidal Activity|whole blood bactericidal activity
191706|NCT02393586|WBA|wba
191707|NCT02393586|Faropenem|faropenem
191708|NCT02393573|Insulin Resistance|insulin resistance
191709|NCT02393573|Protein balance|protein balance
191710|NCT02393573|Surgery|surgery
191711|NCT02393573|Post operative complications|post operative complications
191712|NCT02393573|metformin|metformin
191713|NCT02393573|Pre-diabetes|pre-diabetes
191714|NCT02393573|Fasting blood glucose|fasting blood glucose
191715|NCT02393547|obesity|obesity
191716|NCT02393534|Primary Care|primary care
191717|NCT02393534|Health Services Research|health services research
191718|NCT02393534|Telemedicine|telemedicine
191719|NCT02393521|Vibration|vibration
191720|NCT02393521|Pressure Pain Threshold|pressure pain threshold
191721|NCT02393521|Trigger Points|trigger points
191722|NCT02393521|Neck Pain|neck pain
191723|NCT02393508|transfusion, red blood cell|transfusion, red blood cell
191724|NCT02393508|transfusion reaction|transfusion reaction
191725|NCT02393508|quality of life|quality of life
191726|NCT02393443|oxytocin|oxytocin
191727|NCT02393443|healthy sample|healthy sample
191728|NCT02393443|intranasal administration|intranasal administration
191729|NCT02393443|learning|learning
191730|NCT02393417|Verruca vulgaris|verruca vulgaris
191731|NCT02393417|Common Warts|common warts
191732|NCT02393378|Drug Therapy|drug therapy
191733|NCT02393365|Hepatitis C|hepatitis c
191734|NCT02393365|HCV|hcv
191735|NCT02393365|screening|screening
191736|NCT02393352|Body Composition|body composition
191737|NCT02393352|Autonomic Nervous System|autonomic nervous system
191738|NCT02393352|Oxygen|oxygen
191739|NCT02393352|Randomized Controlled Trial|randomized controlled trial
191740|NCT02393300|tranexamic acid|tranexamic acid
191741|NCT02393300|blood loss|blood loss
191742|NCT02393300|topical administration|topical administration
191743|NCT02393300|intravenous administration|intravenous administration
191744|NCT02393248|alterations in FGF or FGFR|alterations in fgf or fgfr
191745|NCT02393248|squamous non-small cell lung cancer|squamous non-small cell lung cancer
191746|NCT02393248|gastric cancer|gastric cancer
191747|NCT02393248|urothelial cancer|urothelial cancer
191748|NCT02393248|endometrial cancer|endometrial cancer
191749|NCT02393248|multiple myeloma|multiple myeloma
191750|NCT02393248|MPN|mpn
191751|NCT02393235|unexplained infertility|unexplained infertility
191752|NCT02393235|tubal infertility|tubal infertility
191753|NCT02393235|pulsatility index|pulsatility index
191754|NCT02393235|resistance index|resistance index
191755|NCT02393235|fertile women|fertile women
191756|NCT02393222|Dialysis|dialysis
191757|NCT02393222|Cerebrovascular disease|cerebrovascular disease
191758|NCT02393222|ESRD|esrd
191759|NCT02393209|Drug therapy|drug therapy
191760|NCT02393196|colloid preloading|colloid preloading
191761|NCT02393196|colloid coloading|colloid coloading
191762|NCT02393183|Antioxidant|antioxidant
191763|NCT02393183|Graves' ophthalmopathy|graves' ophthalmopathy
191764|NCT02393183|Thyroid eye disease|thyroid eye disease
191765|NCT02393183|Severity score|severity score
191766|NCT02393183|Activity score|activity score
191767|NCT02393183|Quality of life|quality of life
191768|NCT02393144|Labor analysis|labor analysis
191769|NCT02393144|Transperineal ultrasound imaging|transperineal ultrasound imaging
191770|NCT02393144|Labor curve|labor curve
191771|NCT02393131|Brain Metastases|brain metastases
191772|NCT02393131|Whole Brain Radiotherapy|whole brain radiotherapy
191773|NCT02393131|Neurocognitive function|neurocognitive function
191774|NCT02393118|Assistive technology|assistive technology
191775|NCT02393118|Non-surgical visual prosthetic|non-surgical visual prosthetic
191776|NCT02393118|sensory substitution|sensory substitution
191777|NCT02393118|BrainPort|brainport
191778|NCT02393118|Blindness|blindness
191779|NCT02393118|Assistive device|assistive device
191780|NCT02393105|Breast Cancer|breast cancer
191781|NCT02393079|Traumatic Brain Injury|traumatic brain injury
191782|NCT02393079|Cognitive|cognitive
191783|NCT02393053|Gingival Recession|gingival recession
191784|NCT02393053|Case-Control Studies|case-control studies
191785|NCT02393053|Adipose Tissue|adipose tissue
191786|NCT02393040|Alopecia|alopecia
191787|NCT02393040|Androgenetic Alopecia|androgenetic alopecia
191788|NCT02393040|Alopecia, Male Pattern|alopecia, male pattern
191789|NCT02393040|Hair loss|hair loss
191790|NCT02393040|Platelet-Rich Plasma|platelet-rich plasma
191791|NCT02393040|Alopecia, Female Pattern|alopecia, female pattern
191792|NCT02393040|placebo|placebo
191793|NCT02393040|double-blind|double-blind
191794|NCT02393014|65 years old or older|65 years old or older
191795|NCT02393014|hospitalized in|hospitalized in
191796|NCT02393014|geriatrics|geriatrics
191797|NCT02393001|skin cancer|skin cancer
191798|NCT02393001|suspicious lesion|suspicious lesion
191799|NCT02393001|skin biopsy|skin biopsy
191800|NCT02393001|noninvasive|noninvasive
191801|NCT02393001|screening|screening
191802|NCT02392962|proprioception|proprioception
191803|NCT02392962|countermovement jump|countermovement jump
191804|NCT02392962|postural balance|postural balance
191805|NCT02392949|Spine|spine
191806|NCT02392949|mobilization|mobilization
191807|NCT02392936|according to the definition of the Comité Technique des Infections Nosocomiales et Liées aux Soins (2007)|according to the definition of the comité technique des infections nosocomiales et liées aux soins (2007)
191808|NCT02392923|health related quality of life|health related quality of life
191809|NCT02392910|Iron Sucrose|iron sucrose
191810|NCT02392910|Mortality|mortality
191811|NCT02392910|Hospitalization|hospitalization
191812|NCT02392897|meal frequency|meal frequency
191813|NCT02392897|eating frequency|eating frequency
191814|NCT02392897|ingestive frequency|ingestive frequency
191815|NCT02392897|Positive energy balance|positive energy balance
191816|NCT02392897|Satiation|satiation
191817|NCT02392884|Human Immunodeficiency Virus|human immunodeficiency virus
191818|NCT02392884|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
191819|NCT02392884|Cognitive Rehabilitation|cognitive rehabilitation
191820|NCT02392884|Minority Health|minority health
191821|NCT02392884|Vulnerable Populations|vulnerable populations
191822|NCT02392884|Underserved, Patients|underserved, patients
191823|NCT02392884|Medication Adherence|medication adherence
191824|NCT02392884|Medication Compliance|medication compliance
191825|NCT02392884|Medication Non-compliance|medication non-compliance
191826|NCT02392884|Medication Persistence|medication persistence
191827|NCT02392884|Medication Non-Adherence|medication non-adherence
191828|NCT02392871|Metastatic melanoma|metastatic melanoma
191829|NCT02392871|Palliative radiotherapy|palliative radiotherapy
191830|NCT02392845|Drug combination|drug combination
191831|NCT02392845|Accelerated chemotherapy|accelerated chemotherapy
191832|NCT02392845|Mathematical model|mathematical model
191833|NCT02392845|Hematotoxicity|hematotoxicity
191834|NCT02392845|Individualized dosage|individualized dosage
191835|NCT02392832|long-lasting microbial larvicide|long-lasting microbial larvicide
191836|NCT02392832|intervention|intervention
191837|NCT02392832|cluster randomised controlled trial|cluster randomised controlled trial
191838|NCT02392832|Anopheles mosquito|anopheles mosquito
191839|NCT02392806|Continuous positive airway pressure|continuous positive airway pressure
191840|NCT02392806|CPAP|cpap
191841|NCT02392806|Bubble CPAP|bubble cpap
191842|NCT02392806|Extubation failure|extubation failure
191843|NCT02392806|Preterm infant|preterm infant
191844|NCT02392767|L-Arginine|l-arginine
191845|NCT02392767|Pycnogenol|pycnogenol
191846|NCT02392767|vitamin K2|vitamin k2
191847|NCT02392767|vitamin B|vitamin b
191848|NCT02392767|endothelial function|endothelial function
191849|NCT02392767|hypertension|hypertension
191850|NCT02392767|Homocystein >10|homocystein >10
191851|NCT02392754|Screening|screening
191852|NCT02392754|Atrial Fibrillation|atrial fibrillation
191853|NCT02392754|ECG|ecg
191854|NCT02392754|Primary care|primary care
191855|NCT02392741|Physical Activity|physical activity
191856|NCT02392741|Microcirculation|microcirculation
191857|NCT02392741|Pregnancy Outcome|pregnancy outcome
191858|NCT02392741|Obesity|obesity
191859|NCT02392741|Pregnancy|pregnancy
191860|NCT02392715|Inspiratory muscle training|inspiratory muscle training
191861|NCT02392715|General exercise training|general exercise training
191862|NCT02392715|pulmonary rehabilitation|pulmonary rehabilitation
191863|NCT02392715|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
191864|NCT02392702|Subjects|subjects
191865|NCT02392702|Safety/Efficacy Study|safety/efficacy study
191866|NCT02392702|Randomized|randomized
191867|NCT02392702|Open Label|open label
191868|NCT02392689|procalcitonin|procalcitonin
191869|NCT02392689|biomarker|biomarker
191870|NCT02392689|antibiotic therapy|antibiotic therapy
191871|NCT02392689|emergency department|emergency department
191872|NCT02392689|cardiology|cardiology
191873|NCT02392689|in vitro diagnostics|in vitro diagnostics
191874|NCT02392676|Ovarian cancer|ovarian cancer
191875|NCT02392676|Platinum|platinum
191876|NCT02392676|Somatic BRCA mutation|somatic brca mutation
191877|NCT02392676|Homologous recombination repair|homologous recombination repair
191878|NCT02392663|Sputum clearance|sputum clearance
191879|NCT02392663|Cough severity|cough severity
191880|NCT02392663|Hypertonic saline|hypertonic saline
191881|NCT02392663|Acid hyaluronic|acid hyaluronic
191882|NCT02392663|Tolerability|tolerability
191883|NCT02392637|Biliary Tract Cancer|biliary tract cancer
191884|NCT02392637|Intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
191885|NCT02392637|Extrahepatic cholangiocarcinoma,|extrahepatic cholangiocarcinoma,
191886|NCT02392637|Gallbladder cancer|gallbladder cancer
191887|NCT02392637|Metastatic|metastatic
191888|NCT02392637|Unresectable|unresectable
191889|NCT02392637|Abraxane|abraxane
191890|NCT02392637|Nab-Paclitaxel|nab-paclitaxel
191891|NCT02392637|Paclitaxel (Protein-Bound)|paclitaxel (protein-bound)
191892|NCT02392637|ABI-007|abi-007
191893|NCT02392637|Cisplatin|cisplatin
191894|NCT02392637|Platinol-AQ|platinol-aq
191895|NCT02392637|Platinol|platinol
191896|NCT02392637|CDDP|cddp
191897|NCT02392637|Gemcitabine|gemcitabine
191898|NCT02392637|Gemcitabine Hydrochloride|gemcitabine hydrochloride
191899|NCT02392637|Gemzar|gemzar
191900|NCT02392637|Phone calls|phone calls
191901|NCT02392611|Estrogen Receptor Positive Breast Cancer|estrogen receptor positive breast cancer
191902|NCT02392585|Leiomyoma of uterus|leiomyoma of uterus
191903|NCT02392585|Hemostasis, Surgical|hemostasis, surgical
191904|NCT02392585|Prevention of Surgical Blood Loss|prevention of surgical blood loss
191905|NCT02392585|mechanical uterine tourniquet|mechanical uterine tourniquet
191906|NCT02392572|Leukemia|leukemia
191907|NCT02392572|Acute myelogenous leukemia|acute myelogenous leukemia
191908|NCT02392572|AML|aml
191909|NCT02392572|Myelodysplastic syndrome|myelodysplastic syndrome
191910|NCT02392572|MDS|mds
191911|NCT02392572|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
191912|NCT02392572|ALL|all
191913|NCT02392572|Relapsed|relapsed
191914|NCT02392572|Refractory|refractory
191915|NCT02392572|ONC201|onc201
191916|NCT02392572|Cytarabine|cytarabine
191917|NCT02392572|Ara-C|ara-c
191918|NCT02392572|Cytosar|cytosar
191919|NCT02392572|DepoCyt|depocyt
191920|NCT02392572|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
191921|NCT02392559|Hypercholesterolemia|hypercholesterolemia
191922|NCT02392559|Elevated Cholesterol|elevated cholesterol
191923|NCT02392559|High Cholesterol|high cholesterol
191924|NCT02392559|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
191925|NCT02392559|PCSK9 mutations|pcsk9 mutations
191926|NCT02392559|Paediatric|paediatric
191927|NCT02392559|pediatric|pediatric
191928|NCT02392559|Childhood Familial Hypercholesterolemia|childhood familial hypercholesterolemia
191929|NCT02392533|ultrasound|ultrasound
191930|NCT02392520|severe OHSS|severe ohss
191931|NCT02392520|antagonist administration|antagonist administration
191932|NCT02392520|conventional treatment|conventional treatment
191933|NCT02392442|Bronchoalveolar Lavage|bronchoalveolar lavage
191934|NCT02392442|Bronchoscopy|bronchoscopy
191935|NCT02392442|Endotoxin Instillation|endotoxin instillation
191936|NCT02392442|Immunophenotype|immunophenotype
191937|NCT02392442|miRNA|mirna
191938|NCT02392390|Topical Dynamic Phototherapy|topical dynamic phototherapy
191939|NCT02392390|Microbiota|microbiota
191940|NCT02392351|Hypertension|hypertension
191941|NCT02392351|Renal Denervation|renal denervation
191942|NCT02392338|Atrial fibrillation|atrial fibrillation
191943|NCT02392338|Ablation|ablation
191944|NCT02392338|Hybrid|hybrid
191945|NCT02392312|kidney transplant|kidney transplant
191946|NCT02392312|ATG-F|atg-f
191947|NCT02392286|Corticosteroid|corticosteroid
191948|NCT02392273|migraine|migraine
191949|NCT02392273|cluster headache|cluster headache
191950|NCT02392273|primary headache|primary headache
191951|NCT02392273|Ausanil|ausanil
191952|NCT02392273|capsicum annuum|capsicum annuum
191953|NCT02392221|Crohn's disease (CD)|crohn's disease (cd)
191954|NCT02392221|Pediatric|pediatric
191955|NCT02392221|Inflammatory Bowel Disease|inflammatory bowel disease
191956|NCT02392208|telavancin|telavancin
191957|NCT02392208|end-stage renal disease|end-stage renal disease
191958|NCT02392208|ESRD|esrd
191959|NCT02392208|pharmacokinetics|pharmacokinetics
191960|NCT02392208|hemodialysis|hemodialysis
191961|NCT02392208|chronic kidney disease|chronic kidney disease
191962|NCT02392208|CKD|ckd
191964|NCT02392208|Vibativ|vibativ
191965|NCT02392195|Plagiocephaly|plagiocephaly
191966|NCT02392182|lung|lung
191967|NCT02392169|neuroendocrine|neuroendocrine
191968|NCT02392169|ADHD|adhd
191969|NCT02392169|heredity|heredity
191970|NCT02392169|cognitive function|cognitive function
191971|NCT02392143|colorectal cancer screening|colorectal cancer screening
191972|NCT02392104|International Normalized Ratio|international normalized ratio
191973|NCT02392104|Warfarin|warfarin
191974|NCT02392078|Procedural Success|procedural success
191975|NCT02392078|Progression|progression
191976|NCT02392078|Quality of Life|quality of life
191977|NCT02392052|caregivers|caregivers
191978|NCT02392039|Lymphoma|lymphoma
191979|NCT02392039|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
191980|NCT02392039|Mantle Cell Lymphoma|mantle cell lymphoma
191981|NCT02392039|Grade 3B Follicular Lymphoma|grade 3b follicular lymphoma
191982|NCT02392039|Burkitt Lymphoma|burkitt lymphoma
191983|NCT02392039|Peripheral T cell Lymphoma NOS|peripheral t cell lymphoma nos
191984|NCT02392039|NK/T cell Lymphoma|nk/t cell lymphoma
191985|NCT02392039|Transformed Lymphoma|transformed lymphoma
191986|NCT02392039|Aggressive lymphoma|aggressive lymphoma
191987|NCT02392039|Bone pain|bone pain
191988|NCT02392039|Pegfilgrastim|pegfilgrastim
191989|NCT02392039|Neulasta|neulasta
191990|NCT02392039|PEG-G-CSF|peg-g-csf
191991|NCT02392039|Loratadine|loratadine
191992|NCT02392039|Placebo|placebo
191993|NCT02392039|Sugar pill|sugar pill
191994|NCT02392039|Questionnaires|questionnaires
191995|NCT02392039|Surveys|surveys
191996|NCT02392013|older adult falls|older adult falls
191997|NCT02392013|home hazards|home hazards
191998|NCT02392013|home barriers|home barriers
191999|NCT02392000|chronic insomnia|chronic insomnia
192000|NCT02392000|Veterans Health|veterans health
192001|NCT02391974|Hyaluronic acid|hyaluronic acid
192002|NCT02391974|Periodontal pockets|periodontal pockets
192003|NCT02391974|Periodontitis|periodontitis
192004|NCT02391948|Cerebral palsy|cerebral palsy
192005|NCT02391948|Gross motor delay|gross motor delay
192006|NCT02391935|Chronic Effect of Ultraviolet Radiation on Normal Skin (Photo-aging)|chronic effect of ultraviolet radiation on normal skin (photo-aging)
192007|NCT02391922|out of hospital cardiac arrest|out of hospital cardiac arrest
192008|NCT02391922|first aid|first aid
192009|NCT02391909|Vaccine|vaccine
192010|NCT02391883|clopidogrel therapy|clopidogrel therapy
192011|NCT02391883|platelet aggregation inhibitor|platelet aggregation inhibitor
192012|NCT02391883|adverse event|adverse event
192013|NCT02391870|depression|depression
192014|NCT02391870|mindfulness|mindfulness
192015|NCT02391870|pregnancy|pregnancy
192016|NCT02391870|prevention|prevention
192017|NCT02391870|cognitive behavioral therapy|cognitive behavioral therapy
192018|NCT02391857|cardiopulmonary resuscitation|cardiopulmonary resuscitation
192019|NCT02391857|Gastric emptying|gastric emptying
192020|NCT02391844|Knee|knee
192021|NCT02391844|Post-Operative Pain|post-operative pain
192022|NCT02391844|Xartemis|xartemis
192023|NCT02391831|SMA|sma
192024|NCT02391831|Spinal Muscular Atrophy|spinal muscular atrophy
192025|NCT02391831|Neuromuscular disease|neuromuscular disease
192026|NCT02391818|balance|balance
192027|NCT02391818|quality of life|quality of life
192028|NCT02391818|chemotherapy|chemotherapy
192029|NCT02391818|neuropathy|neuropathy
192030|NCT02391818|cancer|cancer
192031|NCT02391779|High normal blood pressure|high normal blood pressure
192032|NCT02391779|Stage I|stage i
192033|NCT02391766|Self-management|self-management
192034|NCT02391766|Caregiving|caregiving
192035|NCT02391766|Quality of life|quality of life
192036|NCT02391766|Empowerment|empowerment
192037|NCT02391753|levator avulsion|levator avulsion
192038|NCT02391753|transperineal ultrasound|transperineal ultrasound
192039|NCT02391753|levator hiatus|levator hiatus
192040|NCT02391727|SYN004|syn004
192041|NCT02391727|cetuximab|cetuximab
192042|NCT02391714|pain assessment|pain assessment
192043|NCT02391714|patient satisfaction|patient satisfaction
192044|NCT02391714|Visual Analog Scale|visual analog scale
192045|NCT02391714|contraceptive devices|contraceptive devices
192046|NCT02391714|nulliparity|nulliparity
192047|NCT02391662|Metastatic Pancreatic Adenocarcinoma|metastatic pancreatic adenocarcinoma
192048|NCT02391662|Elderly|elderly
192049|NCT02391662|Nab-paclitaxel|nab-paclitaxel
192050|NCT02391662|Gemcitabine|gemcitabine
192051|NCT02391649|schizophrenia|schizophrenia
192052|NCT02391649|bibliotherapy program|bibliotherapy program
192053|NCT02391649|problem-solving|problem-solving
192054|NCT02391649|family caregivers|family caregivers
192055|NCT02391649|randomized controlled trial|randomized controlled trial
192056|NCT02391636|Postpartum Hemorrhage|postpartum hemorrhage
192057|NCT02391636|carbetocin|carbetocin
192058|NCT02391636|oxytocin|oxytocin
192059|NCT02391623|Multiple Ascending Dose|multiple ascending dose
192060|NCT02391623|Healthy Subjects|healthy subjects
192061|NCT02391623|Hyperlipidemia|hyperlipidemia
192062|NCT02391623|Lipid Metabolism Disorders|lipid metabolism disorders
192063|NCT02391623|Metabolic Diseases|metabolic diseases
192064|NCT02391610|birth cohort study|birth cohort study
192372|NCT02389764|Nintedanib|nintedanib
192065|NCT02391610|environmental exposures|environmental exposures
192066|NCT02391610|birth defects|birth defects
192067|NCT02391610|pregnant outcomes|pregnant outcomes
192068|NCT02391610|children development|children development
192069|NCT02391545|Follicular Lymphoma|follicular lymphoma
192070|NCT02391545|Previously Untreated|previously untreated
192071|NCT02391519|Pregnancy|pregnancy
192072|NCT02391519|High altitude|high altitude
192073|NCT02391519|vasoreactivity|vasoreactivity
192074|NCT02391519|myometrial arteries|myometrial arteries
192075|NCT02391506|First CMC joint|first cmc joint
192076|NCT02391506|Osteoarthritis|osteoarthritis
192077|NCT02391506|Cartilage Replacement|cartilage replacement
192078|NCT02391506|First CMC Joint Osteoarthritis|first cmc joint osteoarthritis
192079|NCT02391506|Damaged Articular Surface|damaged articular surface
192080|NCT02391493|bilinguals|bilinguals
192081|NCT02391493|language control|language control
192082|NCT02391493|executive functions|executive functions
192083|NCT02391493|functional MRI|functional mri
192084|NCT02391493|stimulation mapping|stimulation mapping
192085|NCT02391493|brain tumors|brain tumors
192086|NCT02391480|Cancer|cancer
192087|NCT02391480|Bromodomain Inhibitor|bromodomain inhibitor
192088|NCT02391454|Neoplasms|neoplasms
192089|NCT02391454|Cell Phones|cell phones
192090|NCT02391454|Motor Activity|motor activity
192091|NCT02391454|Feasibility|feasibility
192092|NCT02391441|Pulmonary|pulmonary
192093|NCT02391441|Arterial|arterial
192094|NCT02391441|Hypertension|hypertension
192095|NCT02391441|Lung|lung
192096|NCT02391441|Transplantation|transplantation
192097|NCT02391441|MRI|mri
192098|NCT02391428|ADHD|adhd
192099|NCT02391428|omega3|omega3
192100|NCT02391402|Brain injury|brain injury
192101|NCT02391402|TBI|tbi
192102|NCT02391402|PTSD|ptsd
192103|NCT02391402|Polytrauma|polytrauma
192104|NCT02391389|preterm infant|preterm infant
192105|NCT02391376|superficial heat|superficial heat
192106|NCT02391376|hot pack|hot pack
192107|NCT02391376|thermotherapy|thermotherapy
192108|NCT02391376|physiotherapy|physiotherapy
192109|NCT02391376|Schober Test|schober test
192110|NCT02391363|anxiety|anxiety
192111|NCT02391363|worry|worry
192112|NCT02391337|Atrial fibrillation|atrial fibrillation
192113|NCT02391337|Quality of life|quality of life
192114|NCT02391337|Left ventricular ejection fraction|left ventricular ejection fraction
192115|NCT02391337|Diastolic function|diastolic function
192116|NCT02391337|Echocardiography|echocardiography
192117|NCT02391337|Beta-blockers|beta-blockers
192118|NCT02391337|Digoxin|digoxin
192119|NCT02391311|tDCS|tdcs
192120|NCT02391311|Cognitive remediation therapy|cognitive remediation therapy
192121|NCT02391298|Multiple Sclerosis|multiple sclerosis
192122|NCT02391298|stress|stress
192123|NCT02391298|meditation|meditation
192124|NCT02391298|attention|attention
192125|NCT02391272|recombinant human thrombopoietin|recombinant human thrombopoietin
192126|NCT02391272|immune thrombocytopenia|immune thrombocytopenia
192127|NCT02391272|pregnancy|pregnancy
192128|NCT02391246|central nervous system tumours|central nervous system tumours
192129|NCT02391246|[18F]-fluorodeoxyglucose|[18f]-fluorodeoxyglucose
192130|NCT02391233|Effectiveness intervention|effectiveness intervention
192131|NCT02391233|Cost-effectiveness intervention|cost-effectiveness intervention
192132|NCT02391233|HIV prevention|hiv prevention
192133|NCT02391233|Sexually transmitted infections prevention|sexually transmitted infections prevention
192134|NCT02391233|Multimedia evidence-based intervention|multimedia evidence-based intervention
192135|NCT02391233|Drug-users|drug-users
192136|NCT02391233|Black/African-American women|black/african-american women
192137|NCT02391233|Probation|probation
192138|NCT02391233|HIV testing|hiv testing
192139|NCT02391194|AVB-620|avb-620
192140|NCT02391194|stage I|stage i
192141|NCT02391194|newly diagnosed|newly diagnosed
192142|NCT02391194|breast cancer|breast cancer
192143|NCT02391194|stage II|stage ii
192144|NCT02391194|stage III|stage iii
192145|NCT02391194|ductal carcinoma in situ|ductal carcinoma in situ
192146|NCT02391181|Bioequivalence|bioequivalence
192147|NCT02391181|Iron Status|iron status
192148|NCT02391155|follicular flushing|follicular flushing
192149|NCT02391155|IVF|ivf
192150|NCT02391155|poor responders|poor responders
192151|NCT02391155|oocyte retrival|oocyte retrival
192152|NCT02391142|heart failure|heart failure
192153|NCT02391142|cardiac sympathetic nerve block|cardiac sympathetic nerve block
192154|NCT02391142|sympathetic nervous system|sympathetic nervous system
192155|NCT02391090|asthma|asthma
192156|NCT02391090|hypoxia|hypoxia
192157|NCT02391090|forced exhaled nitric oxide|forced exhaled nitric oxide
192158|NCT02391090|inflammation|inflammation
192159|NCT02391077|PrePex|prepex
192160|NCT02391077|Male Circumcision|male circumcision
192161|NCT02391077|Bacterial Load|bacterial load
192162|NCT02391064|cognition|cognition
192163|NCT02391064|brief computerized cognitive assessment|brief computerized cognitive assessment
192164|NCT02391064|impairment prediction|impairment prediction
192165|NCT02391051|prostate cancer|prostate cancer
192166|NCT02391051|focal brachytherapy|focal brachytherapy
192167|NCT02391051|PSA|psa
192168|NCT02391051|Biological marker|biological marker
192169|NCT02391038|MLN0264|mln0264
192170|NCT02391038|Advanced gastrointestinal carcinoma|advanced gastrointestinal carcinoma
192171|NCT02391025|Metastatic|metastatic
192172|NCT02391025|Prostate Cancer|prostate cancer
192173|NCT02391025|Castrate Resistant|castrate resistant
192174|NCT02391012|Ulcerative colitis|ulcerative colitis
192175|NCT02391012|Crohns disease|crohns disease
192176|NCT02391012|Microbial transplantation|microbial transplantation
192177|NCT02390986|Cancer|cancer
192178|NCT02390986|Malignant Neoplasm|malignant neoplasm
192179|NCT02390986|Anti-cancer drug|anti-cancer drug
192180|NCT02390947|Colorectal Cancer|colorectal cancer
192181|NCT02390947|Famitinib|famitinib
192182|NCT02390934|Radium 223|radium 223
192183|NCT02390934|bone metastases|bone metastases
192184|NCT02390908|alcohol use|alcohol use
192185|NCT02390908|hazardous drinking|hazardous drinking
192186|NCT02390908|behavioral intervention|behavioral intervention
192187|NCT02390908|ART adherence|art adherence
192188|NCT02390908|viral load|viral load
192189|NCT02390908|CD4|cd4
192190|NCT02390895|Minimally-invasive endoscopic repair|minimally-invasive endoscopic repair
192191|NCT02390895|fetal surgery|fetal surgery
192192|NCT02390895|outcome|outcome
192193|NCT02390895|Foetus|foetus
192194|NCT02390869|relapse|relapse
192195|NCT02390869|progression|progression
192196|NCT02390804|postoperative pain|postoperative pain
192197|NCT02390804|hysterectomy|hysterectomy
192198|NCT02390804|single-port access laparoscopy|single-port access laparoscopy
192199|NCT02390804|multi-port access laparoscopy|multi-port access laparoscopy
192200|NCT02390804|TLH|tlh
192201|NCT02390778|secondary traumatic stress|secondary traumatic stress
192202|NCT02390778|vicarious trauma|vicarious trauma
192203|NCT02390778|secondary distress|secondary distress
192204|NCT02390765|Stress Response|stress response
192205|NCT02390765|Binge Eating|binge eating
192206|NCT02390765|Eating Behavior|eating behavior
192207|NCT02390765|Obesity|obesity
192208|NCT02390765|Disordered Eating|disordered eating
192209|NCT02390752|Maximum Tolerated Dose|maximum tolerated dose
192210|NCT02390752|Dose Escalation|dose escalation
192211|NCT02390752|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
192212|NCT02390752|Acute Myelogenous Leukemia|acute myelogenous leukemia
192213|NCT02390739|Immunotherapy|immunotherapy
192214|NCT02390739|Gene Therapy|gene therapy
192215|NCT02390739|Metastatic Cancer|metastatic cancer
192216|NCT02390713|hepatectomy|hepatectomy
192217|NCT02390713|post-operative liver failure|post-operative liver failure
192218|NCT02390713|portal vein|portal vein
192219|NCT02390713|portal flow|portal flow
192220|NCT02390713|portal pressure|portal pressure
192221|NCT02390713|modulation|modulation
192222|NCT02390713|surgical device|surgical device
192223|NCT02390700|Rheumatoid Arthritis|rheumatoid arthritis
192224|NCT02390700|Observational|observational
192225|NCT02390700|Golimumab|golimumab
192226|NCT02390700|SIMPONI|simponi
192227|NCT02390700|Intravenous Infusion|intravenous infusion
192228|NCT02390661|seroma|seroma
192229|NCT02390661|accelerated partial breast irradiation (APBI)|accelerated partial breast irradiation (apbi)
192230|NCT02390661|breast lumpectomy|breast lumpectomy
192231|NCT02390661|breast cancer|breast cancer
192232|NCT02390635|Leukemia|leukemia
192233|NCT02390635|Acute myeloid leukemia|acute myeloid leukemia
192234|NCT02390635|AML|aml
192235|NCT02390635|Acute promyelocytic leukemia|acute promyelocytic leukemia
192236|NCT02390635|APL|apl
192237|NCT02390635|Extramedullary leukemia|extramedullary leukemia
192238|NCT02390635|EML|eml
192239|NCT02390635|Whole body magnetic resonance imaging|whole body magnetic resonance imaging
192240|NCT02390635|MRI|mri
192241|NCT02390635|Positron emission tomography/ computed tomography|positron emission tomography/ computed tomography
192242|NCT02390635|PET/CT|pet/ct
192243|NCT02390635|18F-FDG|18f-fdg
192244|NCT02390635|Gadolinium contrast agent|gadolinium contrast agent
192245|NCT02390609|Healthy|healthy
192246|NCT02390609|Ibrutinib|ibrutinib
192247|NCT02390609|Bioavailability|bioavailability
192248|NCT02390596|Kawasaki disease|kawasaki disease
192249|NCT02390596|anti Interleukin 1 treatment|anti interleukin 1 treatment
192250|NCT02390596|anakinra|anakinra
192251|NCT02390596|resistance to IVIg|resistance to ivig
192252|NCT02390596|coronary aneurysms|coronary aneurysms
192253|NCT02390596|phase II trial|phase ii trial
192254|NCT02390583|Internet dependence|internet dependence
192255|NCT02390583|Sleep disorders|sleep disorders
192256|NCT02390583|pathological gambling|pathological gambling
192257|NCT02390570|Patient Capacity|patient capacity
192258|NCT02390544|children|children
192259|NCT02390544|bone marrow transplant|bone marrow transplant
192260|NCT02390544|pharmacokinetics|pharmacokinetics
192261|NCT02390531|Retinopathy of Prematurity|retinopathy of prematurity
192262|NCT02390531|Bevacizumab|bevacizumab
192263|NCT02390531|ROP|rop
192264|NCT02390505|vitamin C|vitamin c
192265|NCT02390505|CRPS|crps
192266|NCT02390505|Upper limb surgery|upper limb surgery
192267|NCT02390479|Sclerostin|sclerostin
192268|NCT02390479|OPG|opg
192269|NCT02390479|RANKL|rankl
192373|NCT02389764|Phone call|phone call
192270|NCT02390453|mild cognitive impairment|mild cognitive impairment
192271|NCT02390453|randomized controlled trial|randomized controlled trial
192272|NCT02390453|cognitive training|cognitive training
192273|NCT02390453|exercise training|exercise training
192274|NCT02390453|cognition|cognition
192275|NCT02390453|physical performance|physical performance
192276|NCT02390453|disability|disability
192277|NCT02390453|mood|mood
192278|NCT02390440|Pain management|pain management
192279|NCT02390440|Exparel|exparel
192280|NCT02390440|Rib fracture|rib fracture
192281|NCT02390427|Metastatic Breast Cancer|metastatic breast cancer
192282|NCT02390427|Advanced Breast Cancer|advanced breast cancer
192283|NCT02390427|Recurrent Breast Cancer|recurrent breast cancer
192284|NCT02390414|Myelodysplastic syndromes (MDS)|myelodysplastic syndromes (mds)
192285|NCT02390388|pudendal block|pudendal block
192286|NCT02390388|Hypospadias|hypospadias
192287|NCT02390388|caudal block|caudal block
192288|NCT02390388|child|child
192289|NCT02390388|analgesia|analgesia
192290|NCT02390336|Osteoarthritis of the hip|osteoarthritis of the hip
192291|NCT02390336|Pain|pain
192292|NCT02390336|Range of Motion|range of motion
192293|NCT02390336|Physical Function|physical function
192294|NCT02390336|Manual Therapy|manual therapy
192295|NCT02390310|male circumcision|male circumcision
192296|NCT02390310|Shang Ring|shang ring
192297|NCT02390310|male circumcision device|male circumcision device
192298|NCT02390310|prevention|prevention
192299|NCT02390310|voluntary medical male circumcision (VMMC)|voluntary medical male circumcision (vmmc)
192300|NCT02390284|RGCD|rgcd
192301|NCT02390284|Glaucoma Suspect|glaucoma suspect
192302|NCT02390232|gut microbiota|gut microbiota
192303|NCT02390232|Non Alcoholic Steato Hepatitis|non alcoholic steato hepatitis
192304|NCT02390232|Steatohepatitis|steatohepatitis
192305|NCT02390232|Escherichia coli|escherichia coli
192306|NCT02390232|colibactin|colibactin
192307|NCT02390206|Stroke|stroke
192308|NCT02390206|Spasticity|spasticity
192309|NCT02390206|Botulinum Toxin type A|botulinum toxin type a
192310|NCT02390206|Dysport|dysport
192311|NCT02390193|Chronic kidney disease|chronic kidney disease
192312|NCT02390193|Dialysis|dialysis
192313|NCT02390193|Sleep|sleep
192314|NCT02390193|Pulmonary function|pulmonary function
192315|NCT02390193|Polysomnography|polysomnography
192316|NCT02390193|Upper airway|upper airway
192317|NCT02390128|iodine|iodine
192318|NCT02390128|thyroid|thyroid
192319|NCT02390128|TSH|tsh
192320|NCT02390128|pregnancy|pregnancy
192321|NCT02390128|nutrition|nutrition
192322|NCT02390128|diet|diet
192323|NCT02390102|Anemia|anemia
192324|NCT02390102|Severe aortic stenosis|severe aortic stenosis
192325|NCT02390102|Red blood cell transfusion|red blood cell transfusion
192326|NCT02390102|Erythropoietin|erythropoietin
192327|NCT02390089|Dysphagia|dysphagia
192328|NCT02390089|Cough|cough
192329|NCT02390089|Aspiration pneumonia|aspiration pneumonia
192330|NCT02390024|Mechanical Ventilation|mechanical ventilation
192331|NCT02390024|Asynchronies|asynchronies
192332|NCT02390024|Cognition|cognition
192333|NCT02390011|Advanced Solid Tumor|advanced solid tumor
192334|NCT02389998|Functional Pain|functional pain
192335|NCT02389998|Abdominal Pain|abdominal pain
192336|NCT02389998|Irritable Bowel Syndrome|irritable bowel syndrome
192337|NCT02389998|IBS|ibs
192338|NCT02389998|Functional Dyspepsia|functional dyspepsia
192339|NCT02389998|FGID|fgid
192340|NCT02389998|Functional Gastrointestinal Disorders|functional gastrointestinal disorders
192341|NCT02389959|HHT|hht
192342|NCT02389959|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
192343|NCT02389959|epistaxis|epistaxis
192344|NCT02389959|nose bleeds|nose bleeds
192345|NCT02389959|nasal bleeding|nasal bleeding
192346|NCT02389959|Avastin|avastin
192347|NCT02389959|bevacizumab|bevacizumab
192348|NCT02389946|Drug eluting coronary stents|drug eluting coronary stents
192349|NCT02389946|Sirolimus|sirolimus
192350|NCT02389946|Bioabsorbable polymer|bioabsorbable polymer
192351|NCT02389946|DES|des
192352|NCT02389933|Multiple Patient Program, LCZ696, heart failure, heart failure with reduced ejection fraction, HF-rEF|multiple patient program, lcz696, heart failure, heart failure with reduced ejection fraction, hf-ref
192353|NCT02389894|Embolic Protection Device|embolic protection device
192354|NCT02389894|Stroke|stroke
192355|NCT02389894|Brain Infarction|brain infarction
192356|NCT02389894|atheroma|atheroma
192357|NCT02389894|Aortic Valve Replacement|aortic valve replacement
192358|NCT02389881|Drug therapy|drug therapy
192359|NCT02389868|Lovastatin|lovastatin
192360|NCT02389868|Proteome|proteome
192361|NCT02389868|Blood platelets|blood platelets
192362|NCT02389855|Progression|progression
192363|NCT02389855|Quality of Life|quality of life
192364|NCT02389816|Drug therapy|drug therapy
192365|NCT02389790|Crohn's Disease|crohn's disease
192366|NCT02389764|Breast cancer|breast cancer
192367|NCT02389764|Metastatic inflammatory breast cancer|metastatic inflammatory breast cancer
192368|NCT02389764|MIBC|mibc
192369|NCT02389764|HER2-negative|her2-negative
192370|NCT02389764|Breast carcinoma|breast carcinoma
192371|NCT02389764|BIBF 1120|bibf 1120
192374|NCT02389751|Esophageal Cancer|esophageal cancer
192375|NCT02389751|Esophageal carcinoma|esophageal carcinoma
192376|NCT02389751|Adenocarcinoma or squamous cell carcinoma of the gastroesophageal junction|adenocarcinoma or squamous cell carcinoma of the gastroesophageal junction
192377|NCT02389751|Adenocarcinoma or squamous cell carcinoma of the cervical esophagus|adenocarcinoma or squamous cell carcinoma of the cervical esophagus
192378|NCT02389751|Adenocarcinoma or squamous cell carcinoma of thoracic esophagus|adenocarcinoma or squamous cell carcinoma of thoracic esophagus
192379|NCT02389751|Ganetespib|ganetespib
192380|NCT02389751|Carboplatin|carboplatin
192381|NCT02389751|Paraplatin|paraplatin
192382|NCT02389751|Paclitaxel|paclitaxel
192383|NCT02389751|Taxol|taxol
192384|NCT02389725|peripheral intravenous access|peripheral intravenous access
192385|NCT02389725|tourniquet techniques|tourniquet techniques
192386|NCT02389712|Bipolar Disorder|bipolar disorder
192387|NCT02389712|Mayo Clinic|mayo clinic
192388|NCT02389699|Intermediate and high grade ductal carcinoma in situ （DCIS）|intermediate and high grade ductal carcinoma in situ （dcis）
192389|NCT02389686|Ductal carcinoma in situ （DCIS）|ductal carcinoma in situ （dcis）
192390|NCT02389686|Nipple-sparing mastectomy (NSM)|nipple-sparing mastectomy (nsm)
192391|NCT02389686|Intraoperative radiotherapy (IORT)|intraoperative radiotherapy (iort)
192392|NCT02389686|INTRABEAM|intrabeam
192393|NCT02389673|Intermediate and high grade ductal carcinoma in situ （DCIS）|intermediate and high grade ductal carcinoma in situ （dcis）
192394|NCT02389660|Depression, Blended Cognitive Behavioural Therapy, Internet intervention|depression, blended cognitive behavioural therapy, internet intervention
192395|NCT02389621|Elective invasive procedures|elective invasive procedures
192396|NCT02389608|Transcranial direct current stimulation|transcranial direct current stimulation
192397|NCT02389608|functional electrical stimulation|functional electrical stimulation
192398|NCT02389608|hemiparesis|hemiparesis
192399|NCT02389608|electromyography|electromyography
192400|NCT02389608|balance|balance
192401|NCT02389595|HIV|hiv
192402|NCT02389595|vaccine|vaccine
192403|NCT02389595|T cell|t cell
192404|NCT02389582|platelet function; dabigatran;enoxaparin|platelet function; dabigatran;enoxaparin
192405|NCT02389569|Biomaterial|biomaterial
192406|NCT02389569|Dental caries|dental caries
192407|NCT02389569|Composite|composite
192408|NCT02389543|KPT-330|kpt-330
192409|NCT02389543|Selinexor|selinexor
192410|NCT02389543|Multiple Myeloma|multiple myeloma
192411|NCT02389543|Relapsed/refractory|relapsed/refractory
192412|NCT02389543|Lenalidomide|lenalidomide
192413|NCT02389543|Dexamethasone|dexamethasone
192414|NCT02389543|Karyopharm|karyopharm
192415|NCT02389530|glioma|glioma
192416|NCT02389530|neoplasms|neoplasms
192417|NCT02389504|Exertion|exertion
192418|NCT02389504|Efficacy of Treatment|efficacy of treatment
192419|NCT02389491|high density formula|high density formula
192420|NCT02389491|heart defects|heart defects
192421|NCT02389491|infant|infant
192422|NCT02389478|oropharyngeal|oropharyngeal
192423|NCT02389478|breastmilk|breastmilk
192424|NCT02389478|colostrum|colostrum
192425|NCT02389478|human milk|human milk
192426|NCT02389478|premature infant|premature infant
192427|NCT02389465|Depression|depression
192428|NCT02389465|Geriatric|geriatric
192429|NCT02389465|Inflammation|inflammation
192430|NCT02389426|Multiple Sclerosis|multiple sclerosis
192431|NCT02389426|Cerebral hemodynamics|cerebral hemodynamics
192432|NCT02389426|Cerebral hypoperfusion|cerebral hypoperfusion
192433|NCT02389426|Cerebral circulation|cerebral circulation
192434|NCT02389413|PQ912|pq912
192435|NCT02389413|Glutaminy Cyclase (QC)|glutaminy cyclase (qc)
192436|NCT02389413|QC - Inhibitor|qc - inhibitor
192437|NCT02389400|adult with Langerhans cell histiocytosis|adult with langerhans cell histiocytosis
192438|NCT02389400|newly diagnosed|newly diagnosed
192439|NCT02389400|methotrexate|methotrexate
192440|NCT02389400|cytosine arabinoside|cytosine arabinoside
192441|NCT02389387|Dialysis Facilities|dialysis facilities
192442|NCT02389387|African Americans|african americans
192443|NCT02389387|Racial Disparity|racial disparity
192444|NCT02389387|Kidney Transplantation|kidney transplantation
192445|NCT02389387|Community-based Participatory Research|community-based participatory research
192446|NCT02389387|Coalition|coalition
192447|NCT02389348|Induced blood stage malaria|induced blood stage malaria
192448|NCT02389335|type 1diabetes|type 1diabetes
192449|NCT02389335|IFN γ|ifn γ
192450|NCT02389335|IL-2|il-2
192451|NCT02389335|TNF α|tnf α
192452|NCT02389322|ESAT6|esat6
192453|NCT02389322|CFP10|cfp10
192454|NCT02389322|skin test|skin test
192455|NCT02389322|diagnostic test|diagnostic test
192456|NCT02389309|Solid tumors|solid tumors
192457|NCT02389309|Advanced tumors|advanced tumors
192458|NCT02389309|Temsirolimus|temsirolimus
192459|NCT02389309|CCI-779|cci-779
192460|NCT02389309|Torisel|torisel
192461|NCT02389309|Dasatinib|dasatinib
192462|NCT02389309|BMS-354825|bms-354825
192463|NCT02389309|Sprycel|sprycel
192464|NCT02389309|Cyclophosphamide|cyclophosphamide
192465|NCT02389309|Cytoxan|cytoxan
192466|NCT02389309|Neosar|neosar
192467|NCT02389283|Rheumatoid arthritis|rheumatoid arthritis
192468|NCT02389283|ultrasound joint count|ultrasound joint count
192469|NCT02389270|Neurotrophins|neurotrophins
192470|NCT02389270|Nerve Growth Factor|nerve growth factor
192471|NCT02389270|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
192472|NCT02389270|Urinary Biomarkers|urinary biomarkers
192473|NCT02389270|Children|children
192474|NCT02389257|volunteers|volunteers
192475|NCT02389231|interleukine 2|interleukine 2
192476|NCT02389231|warm autoimmune hemolytic anemia|warm autoimmune hemolytic anemia
192477|NCT02389231|CD8 regulatory T cells|cd8 regulatory t cells
192478|NCT02389218|atrial fibrillation|atrial fibrillation
192479|NCT02389218|cryoablation|cryoablation
192480|NCT02389218|catheter ablation|catheter ablation
192481|NCT02389192|Ebola|ebola
192482|NCT02389192|Mono-clonal Antibody|mono-clonal antibody
192483|NCT02389179|Vitamin D Deficiency|vitamin d deficiency
192484|NCT02389153|secondary prevention coronary heart disease|secondary prevention coronary heart disease
192485|NCT02389153|myocardial infarction|myocardial infarction
192486|NCT02389153|cardiovascular risk factors|cardiovascular risk factors
192487|NCT02389153|collaborative care|collaborative care
192488|NCT02389153|quality of life|quality of life
192489|NCT02389153|patients´ satisfaction with treatment|patients´ satisfaction with treatment
192490|NCT02389140|Blood flow|blood flow
192491|NCT02389140|Glucose|glucose
192492|NCT02389140|lactic acid|lactic acid
192493|NCT02389127|Cirrhosis|cirrhosis
192494|NCT02389127|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
192495|NCT02389127|Glycosylated hemoglobin A1c|glycosylated hemoglobin a1c
192496|NCT02389127|Glucose|glucose
192497|NCT02389101|Lymphoma|lymphoma
192498|NCT02389101|68Ga-DOTANOC PET/CT|68ga-dotanoc pet/ct
192499|NCT02389101|Somatostatin receptor|somatostatin receptor
192500|NCT02389101|MRI|mri
192501|NCT02389101|Diffusion weighted imaging|diffusion weighted imaging
192502|NCT02389101|Early treatment response|early treatment response
192503|NCT02389088|Granulosa Cell|granulosa cell
192504|NCT02389088|Androgens|androgens
192505|NCT02389088|FSH|fsh
192506|NCT02389088|Ovary|ovary
192507|NCT02389075|intraepithelial lymphocytes (IEL)|intraepithelial lymphocytes (iel)
192508|NCT02389075|microbiome|microbiome
192509|NCT02389075|colon mucosa|colon mucosa
192510|NCT02389049|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
192511|NCT02389049|Kartagener Syndrome|kartagener syndrome
192512|NCT02389023|surgical site infection|surgical site infection
192513|NCT02389023|infrainguinal bypass|infrainguinal bypass
192514|NCT02389023|incisional wound vacuum assisted closure|incisional wound vacuum assisted closure
192515|NCT02389023|Prevena|prevena
192516|NCT02389010|Umbilical Cord Blood|umbilical cord blood
192517|NCT02389010|Diabetic Foot|diabetic foot
192518|NCT02389010|Ulcer|ulcer
192519|NCT02389010|Cost|cost
192520|NCT02389010|Effectiveness|effectiveness
192521|NCT02389010|Safety|safety
192522|NCT02389010|Platelet Gel|platelet gel
192523|NCT02389010|Cord Blood Platelet Gel|cord blood platelet gel
192524|NCT02389010|Adverse Event|adverse event
192525|NCT02388997|mild asthma|mild asthma
192526|NCT02388997|young adults|young adults
192527|NCT02388997|rhinovirus|rhinovirus
192528|NCT02388971|Drug therapy|drug therapy
192529|NCT02388919|anlotinib|anlotinib
192530|NCT02388919|Cancer|cancer
192531|NCT02388919|NSCLC|nsclc
192532|NCT02388919|Non-small Cell Lung Cancer|non-small cell lung cancer
192533|NCT02388880|ITPR|itpr
192534|NCT02388880|CPP|cpp
192535|NCT02388880|TBI|tbi
192536|NCT02388880|traumatic brain injury|traumatic brain injury
192537|NCT02388880|cerebral perfusion pressure|cerebral perfusion pressure
192538|NCT02388880|intrathoracic pressure regulator|intrathoracic pressure regulator
192539|NCT02388841|Pulmonary embolism, Computed tomographic pulmonary|pulmonary embolism, computed tomographic pulmonary
192540|NCT02388815|Diabetes Mellitus|diabetes mellitus
192541|NCT02388815|Sensing Technology|sensing technology
192542|NCT02388802|Infertility|infertility
192543|NCT02388802|Transplant|transplant
192544|NCT02388802|IVF|ivf
192545|NCT02388802|Hysterectomy|hysterectomy
192546|NCT02388802|Absolute uterine infertility|absolute uterine infertility
192547|NCT02388789|sensory receptors|sensory receptors
192548|NCT02388789|balance control|balance control
192549|NCT02388789|gait|gait
192550|NCT02388789|temperature|temperature
192551|NCT02388776|ROTEM|rotem
192552|NCT02388776|Fibrinogen|fibrinogen
192553|NCT02388763|Contact lenses|contact lenses
192554|NCT02388750|nausea|nausea
192555|NCT02388750|vomiting|vomiting
192556|NCT02388750|radiation|radiation
192557|NCT02388750|anti-emetic drug|anti-emetic drug
192558|NCT02388737|Drug therapy|drug therapy
192559|NCT02388724|Drug therapy|drug therapy
192560|NCT02388711|Dementia|dementia
192561|NCT02388711|Transitional Care|transitional care
192562|NCT02388711|Caregiver|caregiver
192563|NCT02388698|HPV DNA|hpv dna
192564|NCT02388698|PET-CT|pet-ct
192565|NCT02388698|Recurrent cervical cancer|recurrent cervical cancer
192566|NCT02388698|chemoradiation|chemoradiation
192567|NCT02388685|peripheral arterial disease|peripheral arterial disease
192568|NCT02388685|exercise|exercise
192569|NCT02388685|perfusion|perfusion
192570|NCT02388685|energetics|energetics
192571|NCT02388685|magnetic resonance imaging|magnetic resonance imaging
192572|NCT02388685|magnetic resonance spectroscopy|magnetic resonance spectroscopy
192573|NCT02388659|MRS Biomarkers|mrs biomarkers
192574|NCT02388581|Helicobactor pylori, Hp|helicobactor pylori, hp
192575|NCT02388581|mucosa-associated lymphoid tissue-type lymphoma, MALToma|mucosa-associated lymphoid tissue-type lymphoma, maltoma
192576|NCT02388542|cardiovascular disease|cardiovascular disease
192577|NCT02388542|education|education
192578|NCT02388542|peer mentor|peer mentor
192579|NCT02388529|Heart Failure|heart failure
192580|NCT02388529|Bendavia™|bendavia™
192581|NCT02388529|MTP-131|mtp-131
192582|NCT02388516|Bangladesh|bangladesh
192583|NCT02388516|Vitamin D|vitamin d
192584|NCT02388516|Acute Respiratory Infections|acute respiratory infections
192585|NCT02388516|Infancy|infancy
192586|NCT02388516|Pregnancy|pregnancy
192587|NCT02388503|Blood glucose|blood glucose
192588|NCT02388490|Brentuximabvedotin|brentuximabvedotin
192589|NCT02388490|EBV|ebv
192590|NCT02388490|Lymphoma|lymphoma
192591|NCT02388477|rotator cuff repair|rotator cuff repair
192592|NCT02388477|Doxycycline|doxycycline
192593|NCT02388464|Congestive Heart Failure|congestive heart failure
192594|NCT02388464|Bendavia™|bendavia™
192595|NCT02388464|MTP-131|mtp-131
192596|NCT02388451|Mild Cognitive Impairment|mild cognitive impairment
192597|NCT02388438|demineralized bone matrix|demineralized bone matrix
192598|NCT02388412|Positron emission tomography|positron emission tomography
192599|NCT02388412|Tissue background ratio|tissue background ratio
192600|NCT02388412|Optical coherence tomography|optical coherence tomography
192601|NCT02388412|Thin cap fibroous atheroma|thin cap fibroous atheroma
192602|NCT02388412|Vulnerability|vulnerability
192603|NCT02388412|Acute coronary syndrome|acute coronary syndrome
192604|NCT02388399|Optical coherence tomography|optical coherence tomography
192605|NCT02388399|Axial Plaque Stress|axial plaque stress
192606|NCT02388399|Wall Shear Stress|wall shear stress
192607|NCT02388399|Vulnerability|vulnerability
192608|NCT02388386|Telemedicine|telemedicine
192609|NCT02388386|Mobile Health|mobile health
192610|NCT02388360|Prostaglandin analogs|prostaglandin analogs
192611|NCT02388360|Corneal biomechanics|corneal biomechanics
192612|NCT02388360|Corneal Hysteresis|corneal hysteresis
192613|NCT02388360|Glaucoma, Open-Angle|glaucoma, open-angle
192614|NCT02388334|Caregivers|caregivers
192615|NCT02388334|Quality of life|quality of life
192616|NCT02388334|Quality of care|quality of care
192617|NCT02388321|Analgesia|analgesia
192618|NCT02388321|pediatrics|pediatrics
192619|NCT02388321|pain management|pain management
192620|NCT02388308|Prostate cancer|prostate cancer
192621|NCT02388308|Image-guided radiotherapy|image-guided radiotherapy
192622|NCT02388308|Ultrasound guidance|ultrasound guidance
192623|NCT02388295|Multiple System Atrophy (MSA), PET imaging, myeloperoxidase (MPO) inhibitor|multiple system atrophy (msa), pet imaging, myeloperoxidase (mpo) inhibitor
192624|NCT02388282|dynamic intrinsic PEEP|dynamic intrinsic peep
192625|NCT02388282|diaphragm echography|diaphragm echography
192626|NCT02388282|respiratory mechanics|respiratory mechanics
192627|NCT02388256|colon|colon
192628|NCT02388256|colorectal|colorectal
192629|NCT02388256|cancer|cancer
192630|NCT02388256|neoplasm|neoplasm
192631|NCT02388243|Brief intervention|brief intervention
192632|NCT02388243|Low and middle income countries (LMIC)|low and middle income countries (lmic)
192633|NCT02388243|eLearning|elearning
192634|NCT02388243|Screening|screening
192635|NCT02388243|Capacity Building|capacity building
192636|NCT02388243|Primary Health Care|primary health care
192637|NCT02388243|Education, Medical|education, medical
192638|NCT02388243|Education, Nursing|education, nursing
192639|NCT02388243|Education, Professional|education, professional
192640|NCT02388243|Community Health Workers|community health workers
192641|NCT02388230|Breast cancer|breast cancer
192642|NCT02388230|Elastography|elastography
192643|NCT02388230|Ultrasound imaging|ultrasound imaging
192644|NCT02388230|Quantification of toxicity|quantification of toxicity
192645|NCT02388230|Side-effects|side-effects
192646|NCT02388217|chronic pain|chronic pain
192647|NCT02388217|cannabis|cannabis
192776|NCT02387658|pressure gradient|pressure gradient
192648|NCT02388217|Approved for cannabis treatment by Israeli ministry of health|approved for cannabis treatment by israeli ministry of health
192649|NCT02388217|Unrelieved chronic pain|unrelieved chronic pain
192650|NCT02388204|Gait|gait
192651|NCT02388204|Locomotion|locomotion
192652|NCT02388204|Freezing|freezing
192653|NCT02388191|Contraception|contraception
192654|NCT02388191|Naproxen|naproxen
192655|NCT02388191|Intrauterine devices|intrauterine devices
192656|NCT02388191|Pain Control|pain control
192657|NCT02388165|Staphylococcal Vaccine|staphylococcal vaccine
192658|NCT02388165|Post-operative Surgical Site Infection|post-operative surgical site infection
192659|NCT02388165|Spinal Surgery|spinal surgery
192660|NCT02388165|MRSA|mrsa
192661|NCT02388165|Staphylococcus aureus|staphylococcus aureus
192662|NCT02388139|acute myocardial infarction|acute myocardial infarction
192663|NCT02388139|renal artery stenosis|renal artery stenosis
192664|NCT02388113|Exercise therapy|exercise therapy
192665|NCT02388113|Time factors|time factors
192666|NCT02388074|Lung Cancer|lung cancer
192667|NCT02388074|Porphyrin|porphyrin
192668|NCT02388074|Fluorescence|fluorescence
192669|NCT02388074|Diagnostic|diagnostic
192670|NCT02388074|Sputum Cytology|sputum cytology
192671|NCT02388074|Early Detection|early detection
192672|NCT02388048|Leukemia|leukemia
192673|NCT02388048|Chronic|chronic
192674|NCT02388048|High-risk|high-risk
192675|NCT02388048|ofatumumab|ofatumumab
192676|NCT02388048|ibrutinib|ibrutinib
192677|NCT02388048|Lymphoblastic|lymphoblastic
192678|NCT02388035|profiles changes|profiles changes
192679|NCT02388035|microorganisms|microorganisms
192680|NCT02388035|cefotaxime|cefotaxime
192681|NCT02388035|SBP|sbp
192682|NCT02388035|Egyptian|egyptian
192683|NCT02388035|effective antibiotics|effective antibiotics
192684|NCT02388009|bioconjugate vaccine|bioconjugate vaccine
192685|NCT02388009|safety|safety
192686|NCT02388009|immunogenicity|immunogenicity
192687|NCT02388009|shigellosis|shigellosis
192688|NCT02387970|Dental implants|dental implants
192689|NCT02387970|Partial edentulism|partial edentulism
192690|NCT02387970|Immediate/delayed provisionalization|immediate/delayed provisionalization
192691|NCT02387957|Wet AMD|wet amd
192692|NCT02387957|subfoveal choroidal neovascularization|subfoveal choroidal neovascularization
192693|NCT02387957|Fovista®|fovista®
192694|NCT02387957|Avastin®|avastin®
192695|NCT02387957|Lucentis®|lucentis®
192696|NCT02387957|Eylea®|eylea®
192697|NCT02387944|Children|children
192698|NCT02387944|Cyanotic congenital heart defect|cyanotic congenital heart defect
192699|NCT02387944|Cardiopulmonary Bypass|cardiopulmonary bypass
192700|NCT02387944|Thromboelastometry|thromboelastometry
192701|NCT02387944|Platelet Function Tests|platelet function tests
192702|NCT02387931|Adolescent|adolescent
192703|NCT02387931|Endometriosis|endometriosis
192704|NCT02387931|Diet|diet
192705|NCT02387931|Nutrition|nutrition
192706|NCT02387931|Pain|pain
192707|NCT02387918|Tonsillectomy|tonsillectomy
192708|NCT02387918|postoperative vomiting (POV)|postoperative vomiting (pov)
192709|NCT02387918|Dexamethasone|dexamethasone
192710|NCT02387918|Acupuncture|acupuncture
192711|NCT02387905|Stereotactic spinal radiosurgery|stereotactic spinal radiosurgery
192712|NCT02387905|Spinal Cord Diseases|spinal cord diseases
192713|NCT02387905|Vertebral body compression fracture|vertebral body compression fracture
192714|NCT02387905|SSRS|ssrs
192715|NCT02387905|Brief Pain Inventory|brief pain inventory
192716|NCT02387905|MD Anderson Symptom Inventory - Spine Tumor|md anderson symptom inventory - spine tumor
192717|NCT02387905|MDASI-SP|mdasi-sp
192718|NCT02387905|Questionnaires|questionnaires
192719|NCT02387905|Survey|survey
192720|NCT02387879|Multiple Myeloma|multiple myeloma
192721|NCT02387879|PASS|pass
192722|NCT02387879|Observational|observational
192723|NCT02387879|Non-interventional|non-interventional
192724|NCT02387879|Relapse|relapse
192725|NCT02387879|Refractory|refractory
192726|NCT02387879|CC-5013|cc-5013
192727|NCT02387879|Lenalidomide|lenalidomide
192728|NCT02387879|Turkey|turkey
192729|NCT02387866|Pharmacokinetic|pharmacokinetic
192730|NCT02387866|Healthy Volunteers|healthy volunteers
192731|NCT02387866|Male|male
192732|NCT02387866|Japanese|japanese
192733|NCT02387866|Caucasian|caucasian
192734|NCT02387866|AG-221|ag-221
192735|NCT02387840|Brain|brain
192736|NCT02387840|Cancer|cancer
192737|NCT02387840|Neurofibromatosis type 1|neurofibromatosis type 1
192738|NCT02387840|NF1|nf1
192739|NCT02387840|Magnetic resonance fingerprinting|magnetic resonance fingerprinting
192740|NCT02387840|MRF|mrf
192741|NCT02387827|long bout physical activity|long bout physical activity
192742|NCT02387827|short bout physical activity|short bout physical activity
192743|NCT02387827|Caloric Restriction|caloric restriction
192744|NCT02387775|esophageal cooling device|esophageal cooling device
192745|NCT02387775|post cardiac arrest|post cardiac arrest
192746|NCT02387775|targetted temperature management|targetted temperature management
192747|NCT02387775|therapeutic hypothermia|therapeutic hypothermia
192748|NCT02387775|cooling|cooling
192749|NCT02387775|rewarming|rewarming
192750|NCT02387762|Acalabrutinib|acalabrutinib
192751|NCT02387749|diabetic peripheral neuropathy|diabetic peripheral neuropathy
192752|NCT02387749|mesenchymal stem cells|mesenchymal stem cells
192753|NCT02387736|BPD|bpd
192754|NCT02387736|DBT|dbt
192755|NCT02387736|Dialectical Behaviour Therapy|dialectical behaviour therapy
192756|NCT02387736|Borderline Personality Disorder|borderline personality disorder
192757|NCT02387736|Suicide|suicide
192758|NCT02387736|Non-suicidal self injury|non-suicidal self injury
192759|NCT02387736|NSSI|nssi
192760|NCT02387736|Randomized Control trials|randomized control trials
192761|NCT02387736|treatment|treatment
192762|NCT02387710|arousal threshold|arousal threshold
192763|NCT02387710|phenotype|phenotype
192764|NCT02387710|tiagabine|tiagabine
192765|NCT02387710|slow wave sleep|slow wave sleep
192766|NCT02387684|chronic hepatitis B|chronic hepatitis b
192767|NCT02387684|interferon|interferon
192768|NCT02387684|peginterferon|peginterferon
192769|NCT02387684|HBsAg loss|hbsag loss
192770|NCT02387658|peripheral arterial disease|peripheral arterial disease
192771|NCT02387658|claudication|claudication
192772|NCT02387658|translesional pressure gradient|translesional pressure gradient
192773|NCT02387658|pressure wire|pressure wire
192774|NCT02387658|six minute walk|six minute walk
192775|NCT02387658|superficial femoral artery|superficial femoral artery
192777|NCT02387658|endovascular|endovascular
192778|NCT02387645|Endometrium|endometrium
192779|NCT02387645|Endometrial Neoplasms|endometrial neoplasms
192780|NCT02387645|Early detection|early detection
192781|NCT02387645|Carcinoma of Endometrium|carcinoma of endometrium
192782|NCT02387645|Gynaecological Cancer|gynaecological cancer
192783|NCT02387606|Respiratory Syncytial Virus Infections|respiratory syncytial virus infections
192784|NCT02387606|Placebo|placebo
192785|NCT02387606|Antiviral activity|antiviral activity
192786|NCT02387606|JNJ-53718678|jnj-53718678
192787|NCT02387593|Adenoma|adenoma
192788|NCT02387593|Colonoscopy|colonoscopy
192789|NCT02387593|Screening|screening
192790|NCT02387580|Malaria|malaria
192791|NCT02387580|Bioavailability|bioavailability
192792|NCT02387580|Formulation|formulation
192793|NCT02387541|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
192794|NCT02387528|MIndfulness|mindfulness
192795|NCT02387528|Primary Health Care|primary health care
192796|NCT02387463|chronic hepatitis B|chronic hepatitis b
192797|NCT02387463|antiviral therapy|antiviral therapy
192798|NCT02387463|peginterferon|peginterferon
192799|NCT02387463|HBeAg seroconversion|hbeag seroconversion
192800|NCT02387463|HBsAg loss|hbsag loss
192801|NCT02387450|Claudication|claudication
192802|NCT02387450|Maximal walking distance|maximal walking distance
192803|NCT02387450|Morbi-mortality|morbi-mortality
192804|NCT02387437|ARDS|ards
192805|NCT02387437|EIT|eit
192806|NCT02387437|recruitment maneuvers|recruitment maneuvers
192807|NCT02387424|depression|depression
192808|NCT02387424|mindfulness|mindfulness
192809|NCT02387424|pregnancy|pregnancy
192810|NCT02387424|prevention|prevention
192811|NCT02387424|cognitive behavioral therapy|cognitive behavioral therapy
192812|NCT02387411|heart failure|heart failure
192813|NCT02387411|aerobic exercise|aerobic exercise
192814|NCT02387411|strength training|strength training
192815|NCT02387411|cardiopulmonary rehabilitation|cardiopulmonary rehabilitation
192816|NCT02387411|high-intensity exercise training|high-intensity exercise training
192817|NCT02387333|Radical cystectomy|radical cystectomy
192818|NCT02387333|Urinary diversion|urinary diversion
192819|NCT02387333|Ileal conduit|ileal conduit
192820|NCT02387333|Parastomal hernia|parastomal hernia
192821|NCT02387333|Prophylactic mesh|prophylactic mesh
192822|NCT02387333|Mesh stoma reinforcement technique|mesh stoma reinforcement technique
192823|NCT02387320|Anxiety|anxiety
192824|NCT02387320|Pain|pain
192825|NCT02387320|Nausea|nausea
192826|NCT02387320|Fatigue|fatigue
192827|NCT02387320|Sleep Disturbance|sleep disturbance
192828|NCT02387320|Breast Cancer|breast cancer
192829|NCT02387320|Surgery|surgery
192830|NCT02387294|immunogenicity|immunogenicity
192831|NCT02387294|reduced dos|reduced dos
192832|NCT02387294|Phase III|phase iii
192833|NCT02387294|tolerability|tolerability
192834|NCT02387294|safety|safety
192835|NCT02387281|Freezing of gait|freezing of gait
192836|NCT02387242|Tuberculosis|tuberculosis
192837|NCT02387242|Whole blood Bactericidal Activity|whole blood bactericidal activity
192838|NCT02387242|WBA|wba
192839|NCT02387242|Rifampicin|rifampicin
192840|NCT02387229|Atrial Fibrillation|atrial fibrillation
192841|NCT02387229|Stroke|stroke
192842|NCT02387229|Neurocognitive decline|neurocognitive decline
192843|NCT02387229|Rivaroxaban|rivaroxaban
192844|NCT02387229|Acetylsalicylic acid|acetylsalicylic acid
192845|NCT02387229|Anticoagulation|anticoagulation
192846|NCT02387216|NSCLC|nsclc
192847|NCT02387216|Non-Small Cell Lung Cancer|non-small cell lung cancer
192848|NCT02387216|heregulin|heregulin
192849|NCT02387216|ErbB3|erbb3
192850|NCT02387216|docetaxel|docetaxel
192851|NCT02387203|Pseudomyxoma Peritonei|pseudomyxoma peritonei
192852|NCT02387203|Appendiceal cancer|appendiceal cancer
192853|NCT02387203|CRS/HIPEC|crs/hipec
192854|NCT02387203|PMP|pmp
192855|NCT02387190|Heart Failure|heart failure
192856|NCT02387190|Lung function test|lung function test
192857|NCT02387190|Telenursing|telenursing
192858|NCT02387190|Morbidity|morbidity
192859|NCT02387190|Mortality|mortality
192860|NCT02387190|Quality of life|quality of life
192861|NCT02387164|Type 1 diabetes|type 1 diabetes
192862|NCT02387164|Islet autoantibodies|islet autoantibodies
192863|NCT02387164|glutamate decarboxylase autoantibodies (GADA)|glutamate decarboxylase autoantibodies (gada)
192864|NCT02387164|Immune tolerance|immune tolerance
192865|NCT02387164|Prediabetes|prediabetes
192866|NCT02387164|Glucose tolerance|glucose tolerance
192867|NCT02387164|glutamate decarboxylase|glutamate decarboxylase
192868|NCT02387164|Prevention|prevention
192869|NCT02387164|Children|children
192870|NCT02387151|Mesenchymal Stromal Cells|mesenchymal stromal cells
192871|NCT02387151|Rejection|rejection
192872|NCT02387112|End stage heart disease|end stage heart disease
192873|NCT02387112|Ventricular assist device|ventricular assist device
192874|NCT02387099|Stage IIIB|stage iiib
192875|NCT02387099|Stage IV|stage iv
192876|NCT02387099|Recurrent|recurrent
192877|NCT02387099|Metastatic|metastatic
192878|NCT02387086|gefitinib|gefitinib
192879|NCT02387086|thalidomide|thalidomide
192880|NCT02387086|NSCLC|nsclc
192881|NCT02387086|EGFR mutation|egfr mutation
192882|NCT02387073|outcome assessment|outcome assessment
192883|NCT02387073|self-reported|self-reported
192884|NCT02387073|patient|patient
192885|NCT02387073|clinical outcome|clinical outcome
192886|NCT02387060|Anesthesia|anesthesia
192887|NCT02387060|Spinal and Epidural|spinal and epidural
192888|NCT02387060|Adverse Effect|adverse effect
192889|NCT02387060|Complications|complications
192890|NCT02387034|Osteoarthritis|osteoarthritis
192891|NCT02387034|Sedentary|sedentary
192892|NCT02387034|Physical activity|physical activity
192893|NCT02387034|Health related quality of life|health related quality of life
192894|NCT02387021|analgesia|analgesia
192895|NCT02387021|nerve block|nerve block
192896|NCT02387021|Total knee replacement|total knee replacement
192897|NCT02386995|depth of anesthesia monitors|depth of anesthesia monitors
192898|NCT02386995|deep brain stimulation|deep brain stimulation
192899|NCT02386969|Neuropathic Pain|neuropathic pain
192900|NCT02386969|repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
192901|NCT02386956|manual therapy|manual therapy
192902|NCT02386956|muscle chains|muscle chains
192903|NCT02386956|Dynamic stretching|dynamic stretching
192904|NCT02386956|Active stretching|active stretching
192905|NCT02386930|Cognitive behavior therapy|cognitive behavior therapy
192906|NCT02386930|Lifestyle modification|lifestyle modification
192907|NCT02386930|HbA1c|hba1c
192908|NCT02386930|Carbohydrates|carbohydrates
192909|NCT02386891|food intake|food intake
192910|NCT02386891|indoor thermal environment|indoor thermal environment
192911|NCT02386878|Orphans and vulnerable children (OVC)|orphans and vulnerable children (ovc)
192912|NCT02386878|Program Evaluation|program evaluation
192913|NCT02386878|HIV Prevention|hiv prevention
192914|NCT02386878|Psychosocial Wellbeing|psychosocial wellbeing
192915|NCT02386878|Adolescents|adolescents
192916|NCT02386852|Ginseng|ginseng
192917|NCT02386852|Ginkgo Biloba|ginkgo biloba
192918|NCT02386852|cardiovascular reactivity|cardiovascular reactivity
192919|NCT02386852|cognition|cognition
192920|NCT02386826|INC280|inc280
192921|NCT02386826|c-MET Inhibitors|c-met inhibitors
192922|NCT02386826|bevacizumab|bevacizumab
192923|NCT02386826|Avastin|avastin
192924|NCT02386826|C-Met proto-oncogene|c-met proto-oncogene
192925|NCT02386800|primary myelofibrosis|primary myelofibrosis
192926|NCT02386800|chronic idiopathic myelofibrosis,|chronic idiopathic myelofibrosis,
192927|NCT02386800|post polycythemia vera myelofibrosis,|post polycythemia vera myelofibrosis,
192928|NCT02386800|post essential thrombocythaemia myelofibrosis.|post essential thrombocythaemia myelofibrosis.
192929|NCT02386787|Ultrasonography|ultrasonography
192930|NCT02386787|Non-elective surgery|non-elective surgery
192931|NCT02386787|Anesthesia|anesthesia
192932|NCT02386774|In vivo confocal microscopy|in vivo confocal microscopy
192933|NCT02386774|corneal disease|corneal disease
192934|NCT02386774|Blepharitis|blepharitis
192935|NCT02386774|Lacrimal Apparatus Diseases|lacrimal apparatus diseases
192936|NCT02386774|Microscopy, Confocal|microscopy, confocal
192937|NCT02386748|Cesarean section|cesarean section
192938|NCT02386748|Chewing gums|chewing gums
192939|NCT02386748|Intestinal motility|intestinal motility
192940|NCT02386735|Corticosteroid treatment|corticosteroid treatment
192941|NCT02386735|COPD|copd
192942|NCT02386735|Primary Health Care|primary health care
192943|NCT02386735|Randomized controlled trial|randomized controlled trial
192944|NCT02386722|Adherence of inhaled medication|adherence of inhaled medication
192945|NCT02386722|pharmaceutical care intervention|pharmaceutical care intervention
192946|NCT02386683|Protective mechanical ventilation|protective mechanical ventilation
192947|NCT02386683|ventilator-induced lung injury|ventilator-induced lung injury
192948|NCT02386683|neurosurgery|neurosurgery
192949|NCT02386657|Sickle Cell Disease|sickle cell disease
192950|NCT02386657|Vaso-occlusive crisis|vaso-occlusive crisis
192951|NCT02386657|Emergency management|emergency management
192952|NCT02386631|gait|gait
192953|NCT02386631|orthotics|orthotics
192954|NCT02386631|kinetics|kinetics
192955|NCT02386631|hallux valgus|hallux valgus
192956|NCT02386631|bunions|bunions
192957|NCT02386618|colorectal cancer|colorectal cancer
192958|NCT02386618|laterally spreading tumors|laterally spreading tumors
192959|NCT02386618|endoscopic mucosal resestion|endoscopic mucosal resestion
192960|NCT02386618|local residual neoplasia|local residual neoplasia
192961|NCT02386605|recovery|recovery
192962|NCT02386605|rehabilitation|rehabilitation
192963|NCT02386553|NURTURE|nurture
192964|NCT02386540|Community Health Workers|community health workers
192965|NCT02386540|Community Health Workers: utilization|community health workers: utilization
192966|NCT02386540|Emergency Service|emergency service
192967|NCT02386540|Primary Health Care/utilization|primary health care/utilization
192968|NCT02386540|Health Services Accessibility|health services accessibility
192969|NCT02386514|sexually transmitted infection|sexually transmitted infection
192970|NCT02386514|gonorrhea|gonorrhea
192971|NCT02386514|chlamydia|chlamydia
192972|NCT02386514|presumptive therapy|presumptive therapy
192973|NCT02386462|laryngeal mask airway|laryngeal mask airway
192974|NCT02386462|circulatory reflexes|circulatory reflexes
192975|NCT02386436|GSK2330811|gsk2330811
192976|NCT02386436|Dose Escalation|dose escalation
192977|NCT02386436|Safety|safety
192978|NCT02386436|First Time in Human|first time in human
192979|NCT02386436|Pharmacodynamics|pharmacodynamics
192980|NCT02386436|Pharmacokinetics|pharmacokinetics
192981|NCT02386423|RLS|rls
192982|NCT02386423|Willis-Ekbom|willis-ekbom
192983|NCT02386384|pregnancy failure|pregnancy failure
192984|NCT02386358|Chronic Chagas Disease|chronic chagas disease
192985|NCT02386358|Randomized Clinical Trial double blind|randomized clinical trial double blind
192986|NCT02386358|Benznidazole vs Placebo|benznidazole vs placebo
192987|NCT02386358|Adult patients|adult patients
192988|NCT02386345|FIRM procedure|firm procedure
192989|NCT02386319|Melatonin|melatonin
192990|NCT02386319|Analgesic|analgesic
192991|NCT02386319|Surgery|surgery
192992|NCT02386319|Pharmacokinetic|pharmacokinetic
192993|NCT02386280|Primary Prevention|primary prevention
192994|NCT02386280|Substance-Related Disorders|substance-related disorders
192995|NCT02386280|Family|family
192996|NCT02386254|premorbid|premorbid
192997|NCT02386254|scoring system|scoring system
192998|NCT02386254|ECOG|ecog
192999|NCT02386254|ICU|icu
193000|NCT02386254|morbidity|morbidity
193001|NCT02386254|mortality|mortality
193002|NCT02386241|brain tumor|brain tumor
193003|NCT02386228|miRNA|mirna
193004|NCT02386228|posthemorrhagic hydrocephalus (PHH)|posthemorrhagic hydrocephalus (phh)
193005|NCT02386215|HIV self-testing|hiv self-testing
193006|NCT02386215|randomized controlled trial|randomized controlled trial
193007|NCT02386215|Kenya|kenya
193008|NCT02386189|Continuity of Patient Care|continuity of patient care
193009|NCT02386189|Health Records, Personal|health records, personal
193010|NCT02386189|Veterans|veterans
193011|NCT02386189|Patient Participation|patient participation
193012|NCT02386189|Chronic Disease|chronic disease
193013|NCT02386137|MR-HIFU|mr-hifu
193014|NCT02386137|HIFU|hifu
193015|NCT02386137|Fibroid treatment|fibroid treatment
193016|NCT02386137|MR Perfusion|mr perfusion
193017|NCT02386137|CEUS perfusion|ceus perfusion
193018|NCT02386137|Diffusion weighted imaging|diffusion weighted imaging
193019|NCT02386137|ARFI|arfi
193020|NCT02386137|Fibroid stiffness|fibroid stiffness
193021|NCT02386124|frailty|frailty
193022|NCT02386124|elderly|elderly
193023|NCT02386124|acute coronary syndrome|acute coronary syndrome
193024|NCT02386124|acute heart failure|acute heart failure
193025|NCT02386124|arrhythmias|arrhythmias
193026|NCT02386111|Sutent|sutent
193027|NCT02386085|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
193028|NCT02386085|Osteopathic Manipulation|osteopathic manipulation
193029|NCT02386085|adverse effects|adverse effects
193030|NCT02386085|side effects|side effects
193031|NCT02386085|undesirable effects|undesirable effects
193032|NCT02386072|Betanis®|betanis®
193033|NCT02386072|Myrbetriq®|myrbetriq®
193034|NCT02386072|Quality of Life|quality of life
193035|NCT02386072|Antimuscarinics|antimuscarinics
193036|NCT02386072|Betmiga®|betmiga®
193037|NCT02386072|Overactive Bladder|overactive bladder
193038|NCT02386072|Observational|observational
193039|NCT02386059|ondansetron|ondansetron
193040|NCT02386059|dexamethasone|dexamethasone
193041|NCT02386059|vitrectomy|vitrectomy
193042|NCT02386059|local anesthesia|local anesthesia
193043|NCT02386046|Caffeine use|caffeine use
193044|NCT02386046|Normative data|normative data
193045|NCT02385968|Modic|modic
193046|NCT02385968|Microbiology|microbiology
193047|NCT02385968|Immunology|immunology
193048|NCT02385942|u-health|u-health
193049|NCT02385942|chronic wound management|chronic wound management
193050|NCT02385942|pressure ulcer|pressure ulcer
193051|NCT02385929|Head and Neck Cancer|head and neck cancer
193052|NCT02385929|Intervention|intervention
193053|NCT02385929|Rehabilitation|rehabilitation
193054|NCT02385929|Late Effects|late effects
193055|NCT02385929|Dysphagia|dysphagia
193056|NCT02385916|EstroSense|estrosense
193057|NCT02385916|estrogen|estrogen
193058|NCT02385903|Flammacerium|flammacerium
193059|NCT02385903|Ischemic wound|ischemic wound
193060|NCT02385903|Lower limb|lower limb
193061|NCT02385903|Arteriopathy|arteriopathy
193062|NCT02385903|Amputation|amputation
193063|NCT02385903|Dressing|dressing
193064|NCT02385838|Nutrition labelling|nutrition labelling
193065|NCT02385838|Front-of-pack nutrition labels|front-of-pack nutrition labels
193066|NCT02385838|Purchasing intentions|purchasing intentions
193067|NCT02385838|Nutritional quality|nutritional quality
193068|NCT02385838|Randomized controlled trial (RCT)|randomized controlled trial (rct)
193069|NCT02385812|Lung Cancer|lung cancer
193070|NCT02385812|Mesothelioma|mesothelioma
193071|NCT02385812|Asbestos|asbestos
193072|NCT02385812|Screening|screening
193073|NCT02385799|Autism Spectrum Disorder|autism spectrum disorder
193074|NCT02385799|Behavior|behavior
193075|NCT02385799|sertraline|sertraline
193076|NCT02385799|treatment|treatment
193077|NCT02385786|mindfulness-based cognitive therapy|mindfulness-based cognitive therapy
193078|NCT02385786|depression|depression
193079|NCT02385786|treatment|treatment
193080|NCT02385786|mindfulness meditation|mindfulness meditation
193081|NCT02385786|psychotherapy|psychotherapy
193082|NCT02385773|colostrum|colostrum
193083|NCT02385773|Immunoglobulin Y (IgY)|immunoglobulin y (igy)
193084|NCT02385760|Facial Acne|facial acne
193085|NCT02385747|perimenopausal bleeding|perimenopausal bleeding
193086|NCT02385747|postmenopausal bleeding|postmenopausal bleeding
193087|NCT02385747|hysteroscopy|hysteroscopy
193088|NCT02385747|Steroid receptors|steroid receptors
193089|NCT02385734|Multiple gingival recession|multiple gingival recession
193090|NCT02385734|Concentrated growth factor|concentrated growth factor
193091|NCT02385734|Coronally advanced flap|coronally advanced flap
193092|NCT02385695|Disc Degeneration Disease|disc degeneration disease
193093|NCT02385695|DDD|ddd
193094|NCT02385695|multilevel lumbar Disc Degeneration Disease|multilevel lumbar disc degeneration disease
193095|NCT02385669|vaccine|vaccine
193096|NCT02385669|peptide|peptide
193097|NCT02385669|ipilimumab|ipilimumab
193098|NCT02385669|Yervoy|yervoy
193099|NCT02385669|Montanide ISA-51|montanide isa-51
193100|NCT02385643|alcohol dependence|alcohol dependence
193101|NCT02385643|abstinence|abstinence
193102|NCT02385643|relapse prevention|relapse prevention
193103|NCT02385643|mobile support system|mobile support system
193104|NCT02385630|Longitudinal Studies|longitudinal studies
193105|NCT02385630|Esophagectomy|esophagectomy
193106|NCT02385630|Gastrectomy|gastrectomy
193107|NCT02385630|Hunger|hunger
193108|NCT02385630|Appetite|appetite
193109|NCT02385630|Glucagon-like Peptide 1|glucagon-like peptide 1
193110|NCT02385630|Peptide YY|peptide yy
193111|NCT02385630|Ghrelin|ghrelin
193112|NCT02385630|Satiety Response|satiety response
193113|NCT02385630|Feeding Behavior|feeding behavior
193114|NCT02385630|Meals|meals
193115|NCT02385630|Postprandial Period|postprandial period
193116|NCT02385617|Glucagon-Like Peptide 1|glucagon-like peptide 1
193117|NCT02385617|Peptide YY|peptide yy
193118|NCT02385617|Ghrelin|ghrelin
193119|NCT02385617|Satiety Response|satiety response
193120|NCT02385617|Appetite|appetite
193121|NCT02385617|Hunger|hunger
193122|NCT02385617|Somatostatin|somatostatin
193123|NCT02385617|Octreotide|octreotide
193124|NCT02385617|Anastomosis, Roux-en-Y|anastomosis, roux-en-y
193125|NCT02385617|Digestive System Surgical Procedures|digestive system surgical procedures
193126|NCT02385617|Pharmacologic Actions|pharmacologic actions
193127|NCT02385617|Physiological Effects of Drugs|physiological effects of drugs
193128|NCT02385617|Endocrine System Diseases|endocrine system diseases
193129|NCT02385617|Enteroendocrine Cells|enteroendocrine cells
193130|NCT02385617|Gastrointestinal Agents|gastrointestinal agents
193131|NCT02385604|Positron-Emission Tomography|positron-emission tomography
193132|NCT02385604|Neoadjuvant Therapy|neoadjuvant therapy
193133|NCT02385604|Chemoradiotherapy|chemoradiotherapy
193134|NCT02385604|Esophagectomy|esophagectomy
193135|NCT02385604|Response Evaluation Criteria in Solid Tumors|response evaluation criteria in solid tumors
193136|NCT02385604|Treatment Outcome|treatment outcome
193137|NCT02385604|Survival|survival
193138|NCT02385604|Recurrence|recurrence
193139|NCT02385604|Disease-Free Survival|disease-free survival
193140|NCT02385604|Progression-Free Survival|progression-free survival
193141|NCT02385604|Prognosis|prognosis
193142|NCT02385604|Neoplasm Grading|neoplasm grading
193143|NCT02385604|Adenocarcinoma|adenocarcinoma
193144|NCT02385604|Squamous Cell Carcinoma|squamous cell carcinoma
193145|NCT02385604|Neoplasm Metastasis|neoplasm metastasis
193146|NCT02385591|physical activity|physical activity
193147|NCT02385591|Latinos|latinos
193148|NCT02385591|overweight|overweight
193149|NCT02385591|SMS|sms
193150|NCT02385591|mHealth|mhealth
193151|NCT02385578|VS (vessel plus surface) classification system|vs (vessel plus surface) classification system
193152|NCT02385578|Magnified endoscopy with narrow band imaging (ME-NBI)|magnified endoscopy with narrow band imaging (me-nbi)
193153|NCT02385578|the rate of detection|the rate of detection
193154|NCT02385552|colonoscopy|colonoscopy
193155|NCT02385552|quality improvement|quality improvement
193156|NCT02385552|adenoma detection rate|adenoma detection rate
193157|NCT02385526|Vagus Nerve Stimulation|vagus nerve stimulation
193158|NCT02385526|ASCEND|ascend
193159|NCT02385526|VNS Titration to Improve Tolerance and Accelerate Adaptation|vns titration to improve tolerance and accelerate adaptation
193160|NCT02385513|Immunogenicity|immunogenicity
193161|NCT02385487|Myocardial Infarction|myocardial infarction
193162|NCT02385487|Inflammation|inflammation
193163|NCT02385487|Critical Illness|critical illness
193164|NCT02385487|Necrosis|necrosis
193165|NCT02385487|Sepsis|sepsis
193166|NCT02385487|Respiratory Insufficiency|respiratory insufficiency
193167|NCT02385487|Myocardial Ischemia|myocardial ischemia
193168|NCT02385487|Cardiovascular Diseases|cardiovascular diseases
193169|NCT02385487|Heart Diseases|heart diseases
193170|NCT02385487|Vascular Diseases|vascular diseases
193171|NCT02385474|silver diamine fluoride|silver diamine fluoride
193172|NCT02385474|randomized clinical trial|randomized clinical trial
193173|NCT02385474|caries|caries
193174|NCT02385474|children|children
193175|NCT02385474|fluoride|fluoride
193176|NCT02385448|dienogest|dienogest
193177|NCT02385448|combined oral contraceptive pills|combined oral contraceptive pills
193178|NCT02385448|endometriosis|endometriosis
193179|NCT02385435|caudal block|caudal block
193180|NCT02385422|secondary prophylaxis|secondary prophylaxis
193181|NCT02385422|Propranolol|propranolol
193182|NCT02385422|Carvedilol|carvedilol
193183|NCT02385422|comparative effectiveness research|comparative effectiveness research
193184|NCT02385409|Patient Blood Management|patient blood management
193185|NCT02385409|Preoperative anemia|preoperative anemia
193186|NCT02385409|Hip replacement|hip replacement
193187|NCT02385409|Knee replacement|knee replacement
193188|NCT02385396|Polycystic Ovary Syndrome|polycystic ovary syndrome
193189|NCT02385396|Infertility|infertility
193190|NCT02385396|Myo-inositol|myo-inositol
193191|NCT02385396|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
193192|NCT02385383|Patient Blood Management|patient blood management
193193|NCT02385383|Preoperative anemia|preoperative anemia
193194|NCT02385383|IV Iron|iv iron
193195|NCT02385357|Muscle function|muscle function
193196|NCT02385357|Anaerobic power|anaerobic power
193197|NCT02385357|Muscle damage|muscle damage
193198|NCT02385331|Neutrophils|neutrophils
193199|NCT02385331|necroptosis|necroptosis
193200|NCT02385331|apoptosis|apoptosis
193201|NCT02385305|Pressure support ventilation|pressure support ventilation
193202|NCT02385305|respiratory drive|respiratory drive
193203|NCT02385305|Physiology|physiology
193205|NCT02385279|ACS|acs
193206|NCT02385279|All comers|all comers
193207|NCT02385279|PCI|pci
193208|NCT02385266|Interstitial cystitis with Painful Bladder Syndrome|interstitial cystitis with painful bladder syndrome
193209|NCT02385266|Urological Chronic Pelvic Pain Syndrome|urological chronic pelvic pain syndrome
193210|NCT02385253|Training|training
193211|NCT02385253|Primary Health Care|primary health care
193212|NCT02385253|Skin Cancer|skin cancer
193213|NCT02385253|Primary Care Physicians|primary care physicians
193214|NCT02385253|Surveillance|surveillance
193215|NCT02385253|Education|education
193216|NCT02385214|Malignant|malignant
193217|NCT02385214|Melanoma|melanoma
193218|NCT02385214|Cancer|cancer
193219|NCT02385214|Surgery|surgery
193220|NCT02385188|Extramammary Paget's disease|extramammary paget's disease
193221|NCT02385188|Vulva|vulva
193222|NCT02385188|Genital, female|genital, female
193223|NCT02385188|imiquimod|imiquimod
193224|NCT02385175|Eustachian tube|eustachian tube
193225|NCT02385175|test accuracy|test accuracy
193226|NCT02385175|clinical test|clinical test
193227|NCT02385175|questionnaire|questionnaire
193228|NCT02385162|Mucolipidoses|mucolipidoses
193229|NCT02385162|Metabolic Diseases|metabolic diseases
193230|NCT02385162|Lysosomal Storage Diseases|lysosomal storage diseases
193231|NCT02385149|resilience|resilience
193232|NCT02385149|challenge test|challenge test
193233|NCT02385149|whole grain wheat|whole grain wheat
193234|NCT02385149|metabolic flexibility|metabolic flexibility
193235|NCT02385149|cardio-metabolic|cardio-metabolic
193236|NCT02385149|liver and adipose tissue|liver and adipose tissue
193237|NCT02385136|NSCLC|nsclc
193238|NCT02385136|Radiotherpy|radiotherpy
193239|NCT02385136|Temozolomide|temozolomide
193240|NCT02385123|ex-vivo|ex-vivo
193241|NCT02385123|Influenza|influenza
193242|NCT02385123|plasmablasts|plasmablasts
193243|NCT02385110|Leukemia|leukemia
193244|NCT02385110|Hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
193245|NCT02385110|HLH|hlh
193246|NCT02385110|Alemtuzumab|alemtuzumab
193247|NCT02385110|CAMPATH-1H|campath-1h
193248|NCT02385110|Campath|campath
193249|NCT02385110|Etoposide|etoposide
193250|NCT02385110|VePesid|vepesid
193251|NCT02385110|Dexamethasone|dexamethasone
193252|NCT02385110|Decadron|decadron
193253|NCT02385110|Methotrexate|methotrexate
193254|NCT02385110|Phone call|phone call
193255|NCT02385071|Healthy|healthy
193256|NCT02385071|Simeprevir|simeprevir
193257|NCT02385071|Bioavailability|bioavailability
193258|NCT02385058|Helminthiasis|helminthiasis
193259|NCT02385058|Amoebiasis|amoebiasis
193260|NCT02385058|Mebendazole|mebendazole
193261|NCT02385058|Quinfamide|quinfamide
193262|NCT02385058|Mexican population|mexican population
193263|NCT02385019|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
193264|NCT02385019|Graft vs host disease|graft vs host disease
193265|NCT02385019|Regulatory T cells|regulatory t cells
193266|NCT02385006|Thromboelastography|thromboelastography
193267|NCT02385006|simulatneous pancreas-kidney transplantation|simulatneous pancreas-kidney transplantation
193268|NCT02384993|Alzheimer's Disease|alzheimer's disease
193269|NCT02384993|Dementia|dementia
193270|NCT02384993|aerobic exercise|aerobic exercise
193271|NCT02384993|physical activity|physical activity
193272|NCT02384993|exercise|exercise
193273|NCT02384993|neuroimaging|neuroimaging
193274|NCT02384980|Intermittent Claudication|intermittent claudication
193275|NCT02384980|Functional Electrical Stimulation|functional electrical stimulation
193276|NCT02384954|Lymphoma|lymphoma
193277|NCT02384954|indolent B Cell|indolent b cell
193278|NCT02384954|non-Hodgkin Lymphoma|non-hodgkin lymphoma
193279|NCT02384954|Cancer|cancer
193280|NCT02384954|Immunotherapy|immunotherapy
193281|NCT02384954|Relapsed|relapsed
193282|NCT02384954|Refractory|refractory
193283|NCT02384954|Rituximab|rituximab
193284|NCT02384954|Interleukin-15|interleukin-15
193285|NCT02384954|Absolute Lymphocyte Count|absolute lymphocyte count
193286|NCT02384954|White Blood Cell|white blood cell
193287|NCT02384954|Follicular Lymphoma|follicular lymphoma
193288|NCT02384954|Marginal Zone Lymphoma|marginal zone lymphoma
193289|NCT02384954|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
193290|NCT02384954|Lymphoplasmacytic Lymphoma|lymphoplasmacytic lymphoma
193291|NCT02384954|anti-CD20|anti-cd20
193292|NCT02384928|Acupuncture|acupuncture
193293|NCT02384928|Pharmacopuncture|pharmacopuncture
193294|NCT02384928|Usual Care|usual care
193295|NCT02384902|glycemic index|glycemic index
193296|NCT02384902|diabetic nephropathy|diabetic nephropathy
193297|NCT02384902|low glycemic load|low glycemic load
193298|NCT02384902|inflammation|inflammation
193299|NCT02384876|pediatric|pediatric
193300|NCT02384876|intraoperative arterial hypotension|intraoperative arterial hypotension
193301|NCT02384876|ephedrine|ephedrine
193302|NCT02384876|general anesthesia|general anesthesia
193303|NCT02384863|Chest Pain|chest pain
193304|NCT02384863|Acute Coronary Syndrome|acute coronary syndrome
193305|NCT02384863|Cardiac|cardiac
193306|NCT02384863|Emergency Department|emergency department
193307|NCT02384863|Cardiac Testing|cardiac testing
193308|NCT02384863|Healthcare Utilization|healthcare utilization
193309|NCT02384863|Patient Centered Outcomes|patient centered outcomes
193310|NCT02384863|Shared Decision Making|shared decision making
193311|NCT02384863|Unnecessary hospital admissions|unnecessary hospital admissions
193312|NCT02384863|Decision Aid|decision aid
193313|NCT02384850|metastatic|metastatic
193314|NCT02384837|national Cather Lad|national cather lad
193315|NCT02384837|Interventional Imaging Training Base|interventional imaging training base
193316|NCT02384811|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
193317|NCT02384811|postoperative radiotherapy|postoperative radiotherapy
193318|NCT02384759|cancer, colorectal,|cancer, colorectal,
193319|NCT02384746|metastatic breast cancer|metastatic breast cancer
193320|NCT02384746|ER-positive|er-positive
193321|NCT02384746|HER2-negative|her2-negative
193322|NCT02384746|Fulvestrant|fulvestrant
193323|NCT02384746|MLN9708|mln9708
193324|NCT02384733|Radiation induced morbidity, recurrence|radiation induced morbidity, recurrence
193325|NCT02384694|cardiorespiratory fitness|cardiorespiratory fitness
193326|NCT02384694|weight|weight
193327|NCT02384694|quality of life|quality of life
193328|NCT02384694|depression|depression
193329|NCT02384694|menopausal symptoms|menopausal symptoms
193330|NCT02384694|exercise barriers|exercise barriers
193331|NCT02384694|executive functions|executive functions
193332|NCT02384681|Speech intelligibility|speech intelligibility
193333|NCT02384681|Short-term memory|short-term memory
193334|NCT02384681|Working memory|working memory
193335|NCT02384681|Perceived mental task load|perceived mental task load
193336|NCT02384668|Cholecalciferol|cholecalciferol
193337|NCT02384668|Vitamin D3|vitamin d3
193338|NCT02384668|Arterial stiffness|arterial stiffness
193339|NCT02384668|Quality of Life|quality of life
193340|NCT02384668|Bone density and geometry|bone density and geometry
193341|NCT02384668|Muscle strength and balance|muscle strength and balance
193342|NCT02384655|Preterms|preterms
193343|NCT02384655|Breastfeeding|breastfeeding
193344|NCT02384655|Lactation|lactation
193345|NCT02384655|Macronutrients|macronutrients
193346|NCT02384642|Adolescent Health|adolescent health
193347|NCT02384642|Democratic Republic of Congo|democratic republic of congo
193348|NCT02384642|Sexual Violence|sexual violence
193349|NCT02384616|Lung Volume Measurements|lung volume measurements
193350|NCT02384616|airway resistance|airway resistance
193351|NCT02384616|general anesthesia|general anesthesia
193352|NCT02384564|Laryngoscopy|laryngoscopy
193353|NCT02384564|Video Laryngoscopy|video laryngoscopy
193354|NCT02384564|Tracheal intubation|tracheal intubation
193355|NCT02384551|GERD|gerd
193356|NCT02384551|diet|diet
193357|NCT02384551|carbohydrate|carbohydrate
193358|NCT02384551|obesity|obesity
193359|NCT02384538|Osteoarthritis|osteoarthritis
193360|NCT02384538|Joint diseases|joint diseases
193361|NCT02384538|Musculoskeletal diseases|musculoskeletal diseases
193362|NCT02384538|Rheumatic diseases|rheumatic diseases
193363|NCT02384538|Arthritis|arthritis
193364|NCT02384538|Osteoarthritis, Hand|osteoarthritis, hand
193365|NCT02384525|Septic AKI|septic aki
193366|NCT02384525|CRRT|crrt
193367|NCT02384525|BIA|bia
193368|NCT02384512|Parkinson's disease|parkinson's disease
193369|NCT02384512|akinesia|akinesia
193370|NCT02384512|Azilect®|azilect®
193371|NCT02384512|Rasagiline|rasagiline
193372|NCT02384512|Combination therapy with L-dopa|combination therapy with l-dopa
193373|NCT02384512|Wearing-off Questionnaire-32|wearing-off questionnaire-32
193374|NCT02384512|Quality of life|quality of life
193375|NCT02384512|Daily practice|daily practice
193376|NCT02384460|Simplex|simplex
193377|NCT02384460|Recessive Dystrophic|recessive dystrophic
193378|NCT02384460|Junctional non-Herlitz|junctional non-herlitz
193379|NCT02384460|Epidermolysis Bullosa|epidermolysis bullosa
193380|NCT02384447|above knee amputation|above knee amputation
193381|NCT02384447|sciatic nerve|sciatic nerve
193382|NCT02384447|ultrasonography|ultrasonography
193383|NCT02384447|histology|histology
193384|NCT02384408|menopause|menopause
193385|NCT02384408|drospirenone|drospirenone
193386|NCT02384408|tibolone|tibolone
193387|NCT02384408|Bcl-2|bcl-2
193388|NCT02384408|steroid receptors|steroid receptors
193389|NCT02384395|Dolutegravir|dolutegravir
193390|NCT02384395|Abacavir|abacavir
193391|NCT02384395|Lamivudine|lamivudine
193392|NCT02384395|acute HIV infection|acute hiv infection
193393|NCT02384395|human leukocyte antigen|human leukocyte antigen
193394|NCT02384395|latent HIV reservoir|latent hiv reservoir
193395|NCT02384395|integrase-based regimen|integrase-based regimen
193396|NCT02384395|viremia|viremia
193397|NCT02384395|antiretroviral therapy|antiretroviral therapy
193398|NCT02384395|fixed dose combination|fixed dose combination
193399|NCT02384382|Cancer of the Prostate|cancer of the prostate
193400|NCT02384356|Non-communicable diseases|non-communicable diseases
193401|NCT02384356|Chronic disease|chronic disease
193402|NCT02384356|Mobile health|mobile health
193403|NCT02384356|Diabetes Mellitus|diabetes mellitus
193404|NCT02384356|Hypertension|hypertension
193405|NCT02384356|Bolivia|bolivia
193406|NCT02384356|Longitudinal survey|longitudinal survey
193407|NCT02384356|Health indicators|health indicators
193408|NCT02384356|Primary care|primary care
193409|NCT02384356|Ambulatory care|ambulatory care
193410|NCT02384343|Dexmedetomidine|dexmedetomidine
193411|NCT02384343|Cesarean section|cesarean section
193412|NCT02384343|Anesthesia, Spinal|anesthesia, spinal
193413|NCT02384343|Anesthesia, Epidural|anesthesia, epidural
193414|NCT02384304|randomized controlled trial|randomized controlled trial
193415|NCT02384304|alcohol|alcohol
193416|NCT02384304|internet|internet
193417|NCT02384304|internet based therapy|internet based therapy
193418|NCT02384304|cognitive behavior therapy|cognitive behavior therapy
193419|NCT02384278|alcohol use disorder|alcohol use disorder
193420|NCT02384278|internet|internet
193421|NCT02384278|cognitive behavior therapy|cognitive behavior therapy
193422|NCT02384278|relapse prevention|relapse prevention
193423|NCT02384265|Diabetes|diabetes
193424|NCT02384265|Disparities|disparities
193425|NCT02384265|Behavioral|behavioral
193426|NCT02384265|Text messaging|text messaging
193427|NCT02384265|Social networks|social networks
193428|NCT02384265|African American|african american
193429|NCT02384265|Female|female
193430|NCT02384252|obese cardiomyopathy|obese cardiomyopathy
193431|NCT02384252|mitochondria|mitochondria
193432|NCT02384252|contractile dysfunction|contractile dysfunction
193433|NCT02384226|mobile application|mobile application
193434|NCT02384226|postpartum|postpartum
193435|NCT02384226|weight loss|weight loss
193436|NCT02384187|Gabapentin|gabapentin
193437|NCT02384187|PONV|ponv
193438|NCT02384187|Adenotonsillectomy|adenotonsillectomy
193439|NCT02384187|Pediatrics|pediatrics
193440|NCT02384174|Aging|aging
193441|NCT02384174|Resistant starch|resistant starch
193442|NCT02384174|Dietary fibre|dietary fibre
193443|NCT02384174|Immune system|immune system
193444|NCT02384174|Bacteria|bacteria
193445|NCT02384174|older subjects|older subjects
193446|NCT02384122|Angiodysplasias|angiodysplasias
193447|NCT02384122|Sandostatin LAR|sandostatin lar
193448|NCT02384122|Gastrointestinal|gastrointestinal
193449|NCT02384122|Somatostatin|somatostatin
193450|NCT02384122|Octreotide|octreotide
193451|NCT02384096|stimulation|stimulation
193452|NCT02384096|implantable|implantable
193453|NCT02384096|pulse generator|pulse generator
193454|NCT02384096|back pain|back pain
193455|NCT02384096|chronic pain|chronic pain
193456|NCT02384096|leg pain|leg pain
193457|NCT02384083|Multiple Myeloma|multiple myeloma
193458|NCT02384083|Pethema|pethema
193459|NCT02384083|Filanesib|filanesib
193460|NCT02384083|Pomalidomide|pomalidomide
193461|NCT02384044|Sensitivity|sensitivity
193462|NCT02383979|Phantom limb pain|phantom limb pain
193463|NCT02383979|Mirror therapy|mirror therapy
193464|NCT02383979|Elective amputation|elective amputation
193465|NCT02383979|Residual limb pain|residual limb pain
193466|NCT02383979|Functional MRI|functional mri
193467|NCT02383953|twins|twins
193468|NCT02383953|IBD|ibd
193469|NCT02383953|UC|uc
193470|NCT02383953|CD|cd
193471|NCT02383875|nutrition economics|nutrition economics
193472|NCT02383875|food expenditure|food expenditure
193473|NCT02383875|nutritional quality|nutritional quality
193474|NCT02383875|low income|low income
193475|NCT02383862|Sleep|sleep
193476|NCT02383862|Pain|pain
193477|NCT02383862|Anxiety|anxiety
193478|NCT02383862|Depression|depression
193479|NCT02383862|Fatigue|fatigue
193480|NCT02383862|PROMIS|promis
193481|NCT02383862|primary care|primary care
193482|NCT02383836|Patent Foramen Ovale|patent foramen ovale
193483|NCT02383823|glucose, cholesterol, estrogen, gender, age|glucose, cholesterol, estrogen, gender, age
193484|NCT02383810|Chemotherapy Induced Diarrhea (CID)|chemotherapy induced diarrhea (cid)
193485|NCT02383771|Ticagrelor|ticagrelor
193486|NCT02383771|Aspirin|aspirin
193487|NCT02383771|Peri-operative treatment|peri-operative treatment
193488|NCT02383758|Behavioral Symptoms|behavioral symptoms
193489|NCT02383758|Child Development Disorders, Pervasive|child development disorders, pervasive
193490|NCT02383758|Bowel Incontinence|bowel incontinence
193491|NCT02383758|Constipation|constipation
193492|NCT02383745|Acute EEG|acute eeg
193493|NCT02383745|status epilepticus|status epilepticus
193494|NCT02383745|seizure|seizure
193495|NCT02383706|Sleep Apnea, Obstructive|sleep apnea, obstructive
193496|NCT02383706|Pregnancy|pregnancy
193497|NCT02383706|Obesity, Morbid|obesity, morbid
193498|NCT02383706|Complications, pregnancy|complications, pregnancy
193499|NCT02383693|depression|depression
193500|NCT02383693|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
193501|NCT02383693|tolerability|tolerability
193502|NCT02383693|efficiency|efficiency
193503|NCT02383693|TMS|tms
193504|NCT02383693|refractory|refractory
193505|NCT02383680|Methotrexate therapy|methotrexate therapy
193506|NCT02383654|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
193507|NCT02383654|Autologous Adipose-Tissue Derived Stem Cells (ADSCs)|autologous adipose-tissue derived stem cells (adscs)
193508|NCT02383641|Lipid Metabolism|lipid metabolism
193509|NCT02383641|Inborn Errors|inborn errors
193510|NCT02383641|Cholesterol Ester Storage Disease|cholesterol ester storage disease
193511|NCT02383628|ICG Dye|icg dye
193512|NCT02383628|endoscopic neurosurgery|endoscopic neurosurgery
193513|NCT02383628|tissue perfusion|tissue perfusion
193514|NCT02383602|6,000 Thai MSM and TG from study sites in Bangkok, Chiang Mai, Chonburi and Songkhla|6,000 thai msm and tg from study sites in bangkok, chiang mai, chonburi and songkhla
193515|NCT02383550|Multiple Sclerosis|multiple sclerosis
193516|NCT02383550|Cognition|cognition
193517|NCT02383498|Overall Response Rate|overall response rate
193518|NCT02383498|Immune Activation|immune activation
193519|NCT02383498|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
193520|NCT02383498|T Cell Response|t cell response
193521|NCT02383498|Cross-Over|cross-over
193522|NCT02383485|arterial stiffness|arterial stiffness
193523|NCT02383472|Concussion|concussion
193524|NCT02383472|Mild Traumatic Brain Injury|mild traumatic brain injury
193525|NCT02383472|MTBI|mtbi
193526|NCT02383472|LED|led
193527|NCT02383472|Light Emitting Diode|light emitting diode
193528|NCT02383472|Headache|headache
193529|NCT02383472|Brain Concussion|brain concussion
193530|NCT02383446|Echeclon|echeclon
193531|NCT02383446|Elan|elan
193532|NCT02383446|TTA|tta
193533|NCT02383446|Transtibial Amputee|transtibial amputee
193534|NCT02383394|second trimesteric pregnancy loss|second trimesteric pregnancy loss
193535|NCT02383368|Pharmacokinetics|pharmacokinetics
193536|NCT02383368|ASP4132|asp4132
193537|NCT02383368|Lymphoma|lymphoma
193538|NCT02383368|Refractory Solid Tumors|refractory solid tumors
193539|NCT02383355|Persistent immune activation|persistent immune activation
193540|NCT02383355|Platelet hyperreactivity|platelet hyperreactivity
193541|NCT02383342|Pain Processing|pain processing
193542|NCT02383342|Genetic Factors|genetic factors
193543|NCT02383342|Biomarkers|biomarkers
193544|NCT02383329|malnutrition|malnutrition
193545|NCT02383329|Underweight|underweight
193546|NCT02383329|Oral Nutrition Supplements|oral nutrition supplements
193547|NCT02383329|Children|children
193548|NCT02383316|Insulin sensitivity|insulin sensitivity
193549|NCT02383316|Metabolism|metabolism
193550|NCT02383316|Noonan syndrome|noonan syndrome
193551|NCT02383316|Shp2|shp2
193552|NCT02383303|savings|savings
193553|NCT02383303|assets|assets
193554|NCT02383303|material hardship|material hardship
193555|NCT02383303|poverty|poverty
193556|NCT02383303|Individual Development Account|individual development account
193557|NCT02383264|feeding intolerance|feeding intolerance
193558|NCT02383264|preterm infants|preterm infants
193559|NCT02383264|near infrared spectroscopy|near infrared spectroscopy
193560|NCT02383238|Dapagliflozin|dapagliflozin
193561|NCT02383238|diabetes mellitus|diabetes mellitus
193562|NCT02383238|vascular|vascular
193563|NCT02383225|American Indian|american indian
193564|NCT02383225|Adolescent|adolescent
193565|NCT02383225|Prevention|prevention
193566|NCT02383212|Advanced cancerous growth|advanced cancerous growth
193567|NCT02383173|end of life|end of life
193568|NCT02383173|palliative care|palliative care
193569|NCT02383173|implementation|implementation
193570|NCT02383160|low-intensity pulsed ultrasound|low-intensity pulsed ultrasound
193571|NCT02383160|nonunion|nonunion
193572|NCT02383160|scaphoid|scaphoid
193573|NCT02383147|Adult|adult
193574|NCT02383147|Aged|aged
193575|NCT02383147|Alpha Rhythm|alpha rhythm
193576|NCT02383147|Auditory Cortex|auditory cortex
193577|NCT02383147|Chronic|chronic
193578|NCT02383147|Electroencephalography|electroencephalography
193579|NCT02383147|Female|female
193580|NCT02383147|Humans|humans
193581|NCT02383147|Male|male
193682|NCT02382601|Pregnancy|pregnancy
193582|NCT02383147|Neurofeedback|neurofeedback
193583|NCT02383147|Prospective Studies|prospective studies
193584|NCT02383147|Questionnaires|questionnaires
193585|NCT02383147|Tinnitus|tinnitus
193586|NCT02383147|Treatment Outcome|treatment outcome
193587|NCT02383095|Schizophrenia|schizophrenia
193588|NCT02383095|Art-therapy|art-therapy
193589|NCT02383095|Visual organization|visual organization
193590|NCT02383069|Pulmonary rehabilitation|pulmonary rehabilitation
193591|NCT02383069|Asthma|asthma
193592|NCT02383069|Children|children
193593|NCT02383069|Teenager|teenager
193594|NCT02383069|Physical capacity|physical capacity
193595|NCT02383056|wound|wound
193596|NCT02383056|secondary intention healing|secondary intention healing
193597|NCT02383056|lower extremity|lower extremity
193598|NCT02383030|Breast cancer|breast cancer
193599|NCT02383030|Metastatic|metastatic
193600|NCT02383030|HER2 negative|her2 negative
193601|NCT02383030|postmenopausal|postmenopausal
193602|NCT02383030|maintenance therapy|maintenance therapy
193603|NCT02383030|fulvestrant|fulvestrant
193604|NCT02383017|Multi-ingredient performance supplement, High Intensity Interval Training, Concurrent training|multi-ingredient performance supplement, high intensity interval training, concurrent training
193605|NCT02383004|myringotomy tubes|myringotomy tubes
193606|NCT02383004|acupuncture|acupuncture
193607|NCT02383004|emergence delirium|emergence delirium
193608|NCT02383004|pediatrics|pediatrics
193609|NCT02383004|general anesthesia|general anesthesia
193610|NCT02382991|Moderately active amputees|moderately active amputees
193611|NCT02382991|C-leg Compact|c-leg compact
193612|NCT02382991|Knee prosthesis|knee prosthesis
193613|NCT02382991|Kenevo|kenevo
193614|NCT02382991|Microprocessor controlled knee|microprocessor controlled knee
193615|NCT02382991|Amputation|amputation
193616|NCT02382991|3C60|3c60
193617|NCT02382991|TGUG|tgug
193618|NCT02382991|LCI|lci
193619|NCT02382991|QUEST|quest
193620|NCT02382991|SF-36|sf-36
193621|NCT02382952|Abdominal surgery|abdominal surgery
193622|NCT02382952|Pelvic surgery|pelvic surgery
193623|NCT02382952|Stoma takedown|stoma takedown
193624|NCT02382952|Bowel resection|bowel resection
193625|NCT02382952|Lysis of abdominal adhesions|lysis of abdominal adhesions
193626|NCT02382926|capacitive electrocardiography|capacitive electrocardiography
193627|NCT02382926|Eulerian Magnification Method|eulerian magnification method
193628|NCT02382900|quadrivalent|quadrivalent
193629|NCT02382900|vaccine|vaccine
193630|NCT02382887|intubation|intubation
193631|NCT02382887|difficult airway|difficult airway
193632|NCT02382887|fiberscopy|fiberscopy
193633|NCT02382887|Airtraq|airtraq
193634|NCT02382887|general anesthesia|general anesthesia
193635|NCT02382874|Idiopathic nephrotic syndrome|idiopathic nephrotic syndrome
193636|NCT02382874|adipose derived mesenchymal stromal cell|adipose derived mesenchymal stromal cell
193637|NCT02382874|Focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
193638|NCT02382861|Neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
193639|NCT02382861|Weaning|weaning
193640|NCT02382861|Mechanical ventilation|mechanical ventilation
193641|NCT02382861|Extubation|extubation
193642|NCT02382848|Eating Disorders|eating disorders
193643|NCT02382848|Bulimia Nervosa|bulimia nervosa
193644|NCT02382848|Nightmares|nightmares
193645|NCT02382848|Post Traumatic Stress Disorder|post traumatic stress disorder
193646|NCT02382835|metal-on-metal|metal-on-metal
193647|NCT02382809|Alveolar osteitis|alveolar osteitis
193648|NCT02382809|Third molar|third molar
193649|NCT02382809|Dry socket|dry socket
193650|NCT02382809|Mouthwash|mouthwash
193651|NCT02382809|third molar extraction|third molar extraction
193652|NCT02382783|Rheumatoid Arthritis|rheumatoid arthritis
193653|NCT02382783|Disease Activity|disease activity
193654|NCT02382783|Flare|flare
193655|NCT02382783|Management of Flares|management of flares
193656|NCT02382783|Pfizer|pfizer
193657|NCT02382744|Saphenous Nerve|saphenous nerve
193658|NCT02382744|Nerve Block|nerve block
193659|NCT02382744|Ultrasound guided|ultrasound guided
193660|NCT02382744|Neurostimulation|neurostimulation
193661|NCT02382744|Regional Anesthesia|regional anesthesia
193662|NCT02382744|Ropivacaine|ropivacaine
193663|NCT02382744|Foot Surgery|foot surgery
193664|NCT02382744|Nerve Stimulation|nerve stimulation
193665|NCT02382744|Ankle Surgery|ankle surgery
193666|NCT02382718|fish allergy|fish allergy
193667|NCT02382718|parvalbumin|parvalbumin
193668|NCT02382718|immunotherapy|immunotherapy
193669|NCT02382718|mCyp c 1|mcyp c 1
193670|NCT02382705|capsule endoscopy|capsule endoscopy
193671|NCT02382705|battery life|battery life
193672|NCT02382705|completion rate|completion rate
193673|NCT02382705|diagnostic yield|diagnostic yield
193674|NCT02382640|Drug therapy|drug therapy
193675|NCT02382614|Endobronchial Valve|endobronchial valve
193676|NCT02382614|Minimally Invasive|minimally invasive
193677|NCT02382614|Intrabronchial Valves|intrabronchial valves
193678|NCT02382614|Digital Thoracic Drainage System|digital thoracic drainage system
193679|NCT02382614|Spiration Valve System|spiration valve system
193680|NCT02382614|Prolonged Air Leak|prolonged air leak
193681|NCT02382614|Persistent Air Leak|persistent air leak
193683|NCT02382601|IUGR|iugr
193684|NCT02382601|Small for gestational age|small for gestational age
193685|NCT02382562|Depression|depression
193686|NCT02382562|Asthma|asthma
193687|NCT02382562|Urticaria|urticaria
193688|NCT02382549|vaccine|vaccine
193689|NCT02382549|peptide|peptide
193690|NCT02382549|dabrafenib|dabrafenib
193691|NCT02382549|trametinib|trametinib
193692|NCT02382549|Montanide ISA-51|montanide isa-51
193693|NCT02382549|MEKINIST|mekinist
193694|NCT02382549|Tafinlar|tafinlar
193695|NCT02382536|Diabetes|diabetes
193696|NCT02382536|Insulin therapy|insulin therapy
193697|NCT02382536|insulin pump|insulin pump
193698|NCT02382536|Infusion sets|infusion sets
193699|NCT02382523|acthar|acthar
193700|NCT02382523|proteinuria|proteinuria
193701|NCT02382523|IgA nephropathy|iga nephropathy
193702|NCT02382484|Hypertension Resistant to Conventional Therapy|hypertension resistant to conventional therapy
193703|NCT02382471|atherosclerotic|atherosclerotic
193704|NCT02382471|BDNF|bdnf
193705|NCT02382471|Follistatin|follistatin
193706|NCT02382471|Irisin|irisin
193707|NCT02382432|Anesthesia|anesthesia
193708|NCT02382432|dexmedetomidine|dexmedetomidine
193709|NCT02382432|pethidine|pethidine
193710|NCT02382432|shivering|shivering
193711|NCT02382432|spinal|spinal
193712|NCT02382406|MK-3475|mk-3475
193713|NCT02382406|Pembrolizumab|pembrolizumab
193714|NCT02382406|Carboplatin|carboplatin
193715|NCT02382406|Nab-paclitaxel|nab-paclitaxel
193716|NCT02382393|cognitive assessment|cognitive assessment
193717|NCT02382393|Brain Performance Test|brain performance test
193718|NCT02382393|Lumosity|lumosity
193719|NCT02382393|concurrent validity|concurrent validity
193720|NCT02382393|computerized assessment|computerized assessment
193721|NCT02382380|Magnetic Resonance Imaging|magnetic resonance imaging
193722|NCT02382380|Contrast Agent|contrast agent
193723|NCT02382380|Gadoterate|gadoterate
193724|NCT02382341|ACL|acl
193725|NCT02382341|BIOSURE|biosure
193726|NCT02382341|HEALICOIL|healicoil
193727|NCT02382341|PEEK|peek
193728|NCT02382341|In-Growth|in-growth
193729|NCT02382315|fear of cancer recurrence|fear of cancer recurrence
193730|NCT02382315|psychosocial intervention|psychosocial intervention
193731|NCT02382315|randomized controlled clinical trial|randomized controlled clinical trial
193732|NCT02382302|U-health|u-health
193733|NCT02382302|chronic wound management|chronic wound management
193734|NCT02382289|Radiofrequency|radiofrequency
193735|NCT02382289|monopolar|monopolar
193736|NCT02382289|bipolar|bipolar
193737|NCT02382289|Sacroiliac Joint Arthropathy|sacroiliac joint arthropathy
193738|NCT02382289|three different modalities|three different modalities
193739|NCT02382263|Advanced pancreatic cancer|advanced pancreatic cancer
193740|NCT02382263|Fragile|fragile
193741|NCT02382263|Nab-paclitaxel|nab-paclitaxel
193742|NCT02382237|denutrition in Head and Neck cancer or oesophageal cancer|denutrition in head and neck cancer or oesophageal cancer
193743|NCT02382224|generalized anxiety disorder|generalized anxiety disorder
193744|NCT02382224|anxiety|anxiety
193745|NCT02382224|worry exposure|worry exposure
193746|NCT02382224|treatment|treatment
193747|NCT02382211|CMV|cmv
193748|NCT02382198|droooling, sialorrhea, parkinson's disease, parkinsons|droooling, sialorrhea, parkinson's disease, parkinsons
193749|NCT02382185|Cardiac output|cardiac output
193750|NCT02382120|carbon dioxide|carbon dioxide
193751|NCT02382120|cardiac output|cardiac output
193752|NCT02382120|ventilation|ventilation
193753|NCT02382120|thermodilution|thermodilution
193754|NCT02382107|TB|tb
193755|NCT02382107|Tuberculosis|tuberculosis
193756|NCT02382107|Diagnostic study|diagnostic study
193757|NCT02382094|curative intention|curative intention
193758|NCT02382094|radiation Therapy|radiation therapy
193759|NCT02382094|health related quality of life|health related quality of life
193760|NCT02382055|Eating Disorders|eating disorders
193761|NCT02382055|Psychotherapy|psychotherapy
193762|NCT02382055|Anorexia Nervosa|anorexia nervosa
193763|NCT02382055|Treatment|treatment
193764|NCT02382042|Rural Health|rural health
193765|NCT02382042|Veterans|veterans
193766|NCT02382042|Substance Abuse|substance abuse
193767|NCT02382003|Anxiety|anxiety
193768|NCT02382003|Cognitive bias|cognitive bias
193769|NCT02382003|Telemedicine|telemedicine
193770|NCT02381990|Prostate|prostate
193771|NCT02381990|PSA|psa
193772|NCT02381990|FUSION|fusion
193773|NCT02381990|Ultrasound|ultrasound
193774|NCT02381990|MRI|mri
193775|NCT02381990|Cancer|cancer
193776|NCT02381990|Cryotherapy|cryotherapy
193777|NCT02381990|Outcomes|outcomes
193778|NCT02381990|Recurrence|recurrence
193779|NCT02381990|QOL, Quality of Life|qol, quality of life
193780|NCT02381990|Urinary function|urinary function
193781|NCT02381990|Sexual Function|sexual function
193782|NCT02381964|cerebral blood flow|cerebral blood flow
193783|NCT02381964|cognitive function|cognitive function
193784|NCT02381964|vitamins|vitamins
193785|NCT02381964|energy expenditure|energy expenditure
193786|NCT02381964|NIRS|nirs
193787|NCT02381964|Indirect calorimetry|indirect calorimetry
193788|NCT02381938|inactivity|inactivity
193789|NCT02381938|behavior change|behavior change
193790|NCT02381938|worksite wellness|worksite wellness
193791|NCT02381938|child care|child care
193792|NCT02381925|CT|ct
193793|NCT02381925|Scintigraphy|scintigraphy
193794|NCT02381925|Ultrasound|ultrasound
193795|NCT02381899|chronic lymphocytic leukemia|chronic lymphocytic leukemia
193796|NCT02381899|bendamustine|bendamustine
193797|NCT02381899|rituximab|rituximab
193798|NCT02381886|IDHR132 mutations|idhr132 mutations
193799|NCT02381886|IDH305|idh305
193800|NCT02381886|IDH|idh
193801|NCT02381886|IDH1|idh1
193802|NCT02381886|AML|aml
193803|NCT02381886|Acute Myeloid Leukemia|acute myeloid leukemia
193804|NCT02381886|Leukemia|leukemia
193805|NCT02381886|Myeloid|myeloid
193806|NCT02381886|Acute|acute
193807|NCT02381886|MDS|mds
193808|NCT02381886|Myelodysplastic Syndrome|myelodysplastic syndrome
193809|NCT02381886|Glioma|glioma
193810|NCT02381886|Oligodendroglioma|oligodendroglioma
193811|NCT02381886|Astrocytoma|astrocytoma
193812|NCT02381886|Glioblastoma|glioblastoma
193813|NCT02381886|Cholangiocarcinoma|cholangiocarcinoma
193814|NCT02381886|Solid Tumors|solid tumors
193815|NCT02381873|Arthroplasty|arthroplasty
193816|NCT02381873|Replacement|replacement
193817|NCT02381873|Knee|knee
193818|NCT02381873|Osteoarthritis|osteoarthritis
193819|NCT02381847|gastric cancer|gastric cancer
193820|NCT02381847|intraperitoneal chemoperfusion|intraperitoneal chemoperfusion
193821|NCT02381834|Urine Specimen Collection|urine specimen collection
193822|NCT02381834|Infant|infant
193823|NCT02381834|Neonate|neonate
193824|NCT02381834|Bacterial Infection|bacterial infection
193825|NCT02381821|junctional zone|junctional zone
193826|NCT02381821|Implantation|implantation
193827|NCT02381821|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
193828|NCT02381717|ultrasound|ultrasound
193829|NCT02381717|bupivacaine|bupivacaine
193830|NCT02381717|femoral nerve block|femoral nerve block
193831|NCT02381717|pain reduction|pain reduction
193832|NCT02381678|Heart Valve Replacement|heart valve replacement
193833|NCT02381678|Perimount 2900|perimount 2900
193834|NCT02381678|China|china
193835|NCT02381678|Perimount 6900P|perimount 6900p
193836|NCT02381626|HEPA filter|hepa filter
193837|NCT02381626|14-247|14-247
193838|NCT02381613|Fish|fish
193839|NCT02381613|Herring|herring
193840|NCT02381613|Meat|meat
193841|NCT02381613|Beef|beef
193842|NCT02381600|vitamin D|vitamin d
193843|NCT02381600|aging|aging
193844|NCT02381600|cognitive function|cognitive function
193845|NCT02381600|depression|depression
193846|NCT02381600|executive function|executive function
193847|NCT02381574|Lumbar Total Disk Replacement|lumbar total disk replacement
193848|NCT02381522|remote ischemic preconditioning|remote ischemic preconditioning
193849|NCT02381509|inferior vena cava filters|inferior vena cava filters
193850|NCT02381496|ACT-453859|act-453859
193851|NCT02381496|ACT-463036|act-463036
193852|NCT02381496|Setipiprant|setipiprant
193853|NCT02381496|Tolerability|tolerability
193854|NCT02381496|safety|safety
193855|NCT02381496|pharmacodynamics|pharmacodynamics
193856|NCT02381496|pharmacokinetics|pharmacokinetics
193857|NCT02381457|Microdeletion Syndrome|microdeletion syndrome
193858|NCT02381457|Aneuploidy|aneuploidy
193859|NCT02381457|22q|22q
193860|NCT02381457|Non-Invasive Prenatal Screening|non-invasive prenatal screening
193861|NCT02381457|DiGeorge Syndrome|digeorge syndrome
193862|NCT02381444|Advanced Parkinson's Disease|advanced parkinson's disease
193863|NCT02381444|Levodopa Carbidopa Intestinal Gel|levodopa carbidopa intestinal gel
193864|NCT02381444|Observational Study|observational study
193865|NCT02381444|Quality of life|quality of life
193866|NCT02381444|Jejunal Percutaneous Endoscopic Gastrostomy|jejunal percutaneous endoscopic gastrostomy
193867|NCT02381431|imaging|imaging
193868|NCT02381431|diagnostic|diagnostic
193869|NCT02381431|pediatrics|pediatrics
193870|NCT02381418|Influenza|influenza
193871|NCT02381418|Vaccine|vaccine
193872|NCT02381418|Committee for Medicinal Products for Human Use (CHMP) criteria|committee for medicinal products for human use (chmp) criteria
193873|NCT02381392|emergency medicine|emergency medicine
193874|NCT02381392|infrared|infrared
193875|NCT02381392|intravenous|intravenous
193876|NCT02381379|CML|cml
193877|NCT02381379|peginterferon|peginterferon
193878|NCT02381379|stop|stop
193879|NCT02381379|BCR-ABL|bcr-abl
193880|NCT02381366|Mesenchymal Stem Cells|mesenchymal stem cells
193881|NCT02381366|Human Umbilical Cord Blood|human umbilical cord blood
193882|NCT02381366|Premature Infants|premature infants
193883|NCT02381366|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
193884|NCT02381366|Chronic Lung Disease|chronic lung disease
193885|NCT02381366|Cell Therapy|cell therapy
193886|NCT02381353|Enucleation|enucleation
193887|NCT02381353|Evisceration|evisceration
193888|NCT02381353|Exparel|exparel
193889|NCT02381353|bupivacaine|bupivacaine
193890|NCT02381340|Obesity|obesity
193891|NCT02381340|Bariatric surgery|bariatric surgery
193892|NCT02381340|Gastric plication|gastric plication
193893|NCT02381340|Minimal invasive surgery|minimal invasive surgery
194094|NCT02380443|metastatic|metastatic
193894|NCT02381340|gastrointestinal hormones|gastrointestinal hormones
193895|NCT02381340|food-reward|food-reward
193896|NCT02381340|satiety|satiety
193897|NCT02381340|microbiota|microbiota
193898|NCT02381327|Speed of eating|speed of eating
193899|NCT02381327|body weight|body weight
193900|NCT02381327|food intake|food intake
193901|NCT02381314|Other B7-H3 expressing cancers|other b7-h3 expressing cancers
193902|NCT02381301|Biological Markers|biological markers
193903|NCT02381301|Multidetector Computed Tomography|multidetector computed tomography
193904|NCT02381288|Drug therapy|drug therapy
193905|NCT02381262|Fitbit|fitbit
193906|NCT02381249|Esophagectomy|esophagectomy
193907|NCT02381249|Gastrectomy|gastrectomy
193908|NCT02381249|Octreotide|octreotide
193909|NCT02381249|Somatostatin|somatostatin
193910|NCT02381249|Appetite|appetite
193911|NCT02381249|Hunger|hunger
193912|NCT02381249|Glucagon-Like Peptide 1|glucagon-like peptide 1
193913|NCT02381249|Peptide YY|peptide yy
193914|NCT02381249|Reinforcement|reinforcement
193915|NCT02381249|Reward|reward
193916|NCT02381249|Psychological Phenomena and Processes|psychological phenomena and processes
193917|NCT02381249|Gastrointestinal Agents|gastrointestinal agents
193918|NCT02381249|Nutritional Status|nutritional status
193919|NCT02381249|Pancreaticoduodenectomy|pancreaticoduodenectomy
193920|NCT02381249|Whipple Procedure|whipple procedure
193921|NCT02381210|Congo Red Dot Test|congo red dot test
193922|NCT02381197|Congo Red Dot Test|congo red dot test
193923|NCT02381171|myofacial pain|myofacial pain
193924|NCT02381171|neuromodulation|neuromodulation
193925|NCT02381171|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
193926|NCT02381171|electroacupuncture|electroacupuncture
193927|NCT02381158|Wheezing|wheezing
193928|NCT02381158|Children|children
193929|NCT02381145|Polyphenols|polyphenols
193930|NCT02381145|Resveratrol|resveratrol
193931|NCT02381145|Epigallocatechin-gallate|epigallocatechin-gallate
193932|NCT02381145|Insulin sensitivity|insulin sensitivity
193933|NCT02381145|mitochondrial function|mitochondrial function
193934|NCT02381145|lipid oxidation|lipid oxidation
193935|NCT02381145|tissue lipolysis|tissue lipolysis
193936|NCT02381119|dietary services|dietary services
193937|NCT02381119|personalized advice|personalized advice
193938|NCT02381119|biological markers|biological markers
193939|NCT02381106|arterial contractility|arterial contractility
193940|NCT02381106|Uterine contractility|uterine contractility
193941|NCT02381080|B-Cell Chronic Lymphocytic Leukemia|b-cell chronic lymphocytic leukemia
193942|NCT02381080|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
193943|NCT02381080|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
193944|NCT02381080|Marginal Zone Lymphoma|marginal zone lymphoma
193945|NCT02381080|Mantle Cell Lymphoma|mantle cell lymphoma
193946|NCT02381080|Follicular Lymphoma|follicular lymphoma
193947|NCT02381080|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
193948|NCT02381080|Ibrutinib|ibrutinib
193949|NCT02381080|IMBRUVICA|imbruvica
193950|NCT02381080|PCI-32765|pci-32765
193951|NCT02381080|JNJ-54179060|jnj-54179060
193952|NCT02381067|Cervical Fusion|cervical fusion
193953|NCT02381067|NuCel|nucel
193954|NCT02381067|Amniotic Allograft|amniotic allograft
193955|NCT02381067|Prospective|prospective
193956|NCT02381054|Patient reported outcomes|patient reported outcomes
193957|NCT02381041|Rhinoplasty|rhinoplasty
193958|NCT02381041|Topical Vasonconstrictor|topical vasonconstrictor
193959|NCT02381041|Cocaine|cocaine
193960|NCT02381041|Adrenaline|adrenaline
193961|NCT02381028|Atopic eczema|atopic eczema
193962|NCT02381028|Human milk|human milk
193963|NCT02381028|Topical treatment|topical treatment
193964|NCT02381028|Children|children
193965|NCT02381015|Genetic testing|genetic testing
193966|NCT02381015|Genomic testing|genomic testing
193967|NCT02381015|Chemoprevention|chemoprevention
193968|NCT02381015|Prostate Specific Antigen|prostate specific antigen
193969|NCT02381015|Prostate Cancer|prostate cancer
193970|NCT02381015|Predictive Genetic Testing|predictive genetic testing
193971|NCT02381015|Genetic Counseling|genetic counseling
193972|NCT02381015|Prostate-Specific Antigen|prostate-specific antigen
193973|NCT02381002|Serum ferritin, physical exercise, Diet|serum ferritin, physical exercise, diet
193974|NCT02380989|Ayurveda|ayurveda
193975|NCT02380989|Acute pain|acute pain
193976|NCT02380989|Sports Injury|sports injury
193977|NCT02380963|Soy|soy
193978|NCT02380963|Obesity|obesity
193979|NCT02380963|Weight Loss|weight loss
193980|NCT02380963|Muscle|muscle
193981|NCT02380963|Cardiovascular Disease|cardiovascular disease
193982|NCT02380963|Colorado Diet|colorado diet
193983|NCT02380937|real-time MRI|real-time mri
193984|NCT02380937|electrophysiology study|electrophysiology study
193985|NCT02380937|atrial flutter|atrial flutter
193986|NCT02380937|ablation|ablation
193987|NCT02380937|active tracking|active tracking
193988|NCT02380924|subjects|subjects
193989|NCT02380911|Dyslipidemia|dyslipidemia
193990|NCT02380911|Global cardiovascular risk|global cardiovascular risk
193991|NCT02380911|Statins|statins
193992|NCT02380911|Educational interventions|educational interventions
193993|NCT02380885|severe mental illness|severe mental illness
193994|NCT02380885|social cognition|social cognition
193995|NCT02380885|intervention|intervention
193996|NCT02380872|Gingival recession|gingival recession
193997|NCT02380872|fibrin|fibrin
193998|NCT02380872|connective tissue|connective tissue
193999|NCT02380872|gingival crevicular fluid|gingival crevicular fluid
194000|NCT02380872|matrix metalloproteinase|matrix metalloproteinase
194001|NCT02380872|cytokine|cytokine
194002|NCT02380859|problems of gait and balance|problems of gait and balance
194003|NCT02380820|Mattress|mattress
194004|NCT02380820|Preventing bed sores|preventing bed sores
194005|NCT02380820|Skin pressure|skin pressure
194006|NCT02380807|Paraspinal Muscles|paraspinal muscles
194007|NCT02380807|Trigger Points|trigger points
194008|NCT02380807|Randomized Controlled Trial|randomized controlled trial
194009|NCT02380807|Mobility Limitation|mobility limitation
194010|NCT02380794|Danshen Gegen Capsule|danshen gegen capsule
194011|NCT02380768|Supraglottic airway|supraglottic airway
194012|NCT02380768|Laryngeal mask airway|laryngeal mask airway
194013|NCT02380768|Children|children
194014|NCT02380755|Flow-mediated dilatation|flow-mediated dilatation
194015|NCT02380755|Clomiphene citrate|clomiphene citrate
194016|NCT02380755|sICAM-1|sicam-1
194017|NCT02380755|sVCAM-1|svcam-1
194018|NCT02380755|sE- Selectin|se- selectin
194019|NCT02380755|Endothelial function|endothelial function
194020|NCT02380755|Cardiovascular risk|cardiovascular risk
194021|NCT02380755|Endocrine System Diseases|endocrine system diseases
194022|NCT02380755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators
194023|NCT02380755|Estrogen Receptor Modulators|estrogen receptor modulators
194024|NCT02380755|Infertility, Male|infertility, male
194025|NCT02380755|Endothelial Progenitor Cells|endothelial progenitor cells
194026|NCT02380755|Obesity|obesity
194027|NCT02380755|Testosterone|testosterone
194028|NCT02380742|Pessary|pessary
194029|NCT02380742|Pain|pain
194030|NCT02380742|EMLA|emla
194031|NCT02380742|lidocaine|lidocaine
194032|NCT02380742|prilocaine|prilocaine
194033|NCT02380729|Health care delivery|health care delivery
194034|NCT02380729|Human Phenotype Ontology|human phenotype ontology
194035|NCT02380729|Mutation prioritization|mutation prioritization
194036|NCT02380729|Next Generation Sequencing|next generation sequencing
194037|NCT02380729|Mutation detection|mutation detection
194038|NCT02380729|Bioinformatic analysis|bioinformatic analysis
194039|NCT02380729|Quality of life|quality of life
194040|NCT02380703|aggression|aggression
194041|NCT02380703|dementia|dementia
194042|NCT02380703|Alzheimer's disease|alzheimer's disease
194043|NCT02380703|pain|pain
194044|NCT02380703|depression|depression
194045|NCT02380703|caregiver|caregiver
194046|NCT02380703|behavioral health|behavioral health
194047|NCT02380703|counseling|counseling
194048|NCT02380690|self-management|self-management
194049|NCT02380690|peer support|peer support
194050|NCT02380690|social support|social support
194051|NCT02380664|swimmers|swimmers
194052|NCT02380664|adolescent swimmers|adolescent swimmers
194053|NCT02380664|whole-body vibration|whole-body vibration
194054|NCT02380664|bone and bones|bone and bones
194055|NCT02380664|body composition|body composition
194057|NCT02380625|EVD|evd
194058|NCT02380625|Adaptive design|adaptive design
194059|NCT02380625|therapeutics|therapeutics
194060|NCT02380612|Second Degree Burn Injuries|second degree burn injuries
194061|NCT02380599|Spinal Manipulation|spinal manipulation
194062|NCT02380599|Mobilization|mobilization
194063|NCT02380599|Autonomic Nervous System|autonomic nervous system
194064|NCT02380573|methylene blue|methylene blue
194065|NCT02380573|fMRI|fmri
194066|NCT02380560|myometrial thickness|myometrial thickness
194067|NCT02380560|Preterm premature rupture of membranes|preterm premature rupture of membranes
194068|NCT02380560|Preterm Labour|preterm labour
194069|NCT02380547|Sonography|sonography
194070|NCT02380547|Diaphragmatic function|diaphragmatic function
194071|NCT02380547|Non invasive ventilation|non invasive ventilation
194072|NCT02380547|Critical care patients|critical care patients
194073|NCT02380547|Extubation after 24 hours of invasive ventilation|extubation after 24 hours of invasive ventilation
194074|NCT02380534|High level of Lp(a)|high level of lp(a)
194075|NCT02380521|Exenatide once weekly|exenatide once weekly
194076|NCT02380521|T2DM|t2dm
194077|NCT02380521|IMT|imt
194078|NCT02380521|Atherogenic lipoproteins|atherogenic lipoproteins
194079|NCT02380508|BCG study|bcg study
194080|NCT02380495|Adolescents|adolescents
194081|NCT02380495|Respiratory Pathology|respiratory pathology
194082|NCT02380482|Traumatic brain injury|traumatic brain injury
194083|NCT02380482|Myocardial dysfunction|myocardial dysfunction
194084|NCT02380482|Transthoracic echocardiography|transthoracic echocardiography
194085|NCT02380482|Speckle tracking|speckle tracking
194086|NCT02380469|Caregivers|caregivers
194087|NCT02380469|Cancer|cancer
194088|NCT02380469|Information|information
194089|NCT02380469|Intervention|intervention
194090|NCT02380469|Randomised trial|randomised trial
194091|NCT02380443|colorectal cancer|colorectal cancer
194092|NCT02380443|KRAS mutant|kras mutant
194093|NCT02380443|BRAF mutant|braf mutant
194095|NCT02380443|liver metastasis|liver metastasis
194096|NCT02380443|AlloStim®|allostim®
194097|NCT02380443|cryoablation|cryoablation
194098|NCT02380443|cancer vaccine|cancer vaccine
194099|NCT02380443|immunotherapy|immunotherapy
194100|NCT02380430|Ambulatory surgery|ambulatory surgery
194101|NCT02380430|Pain management|pain management
194102|NCT02380430|Nausea and vomiting management|nausea and vomiting management
194103|NCT02380430|Questionnaire|questionnaire
194104|NCT02380430|Survey|survey
194105|NCT02380430|Management|management
194106|NCT02380404|Edentulous maxilla|edentulous maxilla
194107|NCT02380391|Platelet reactivity|platelet reactivity
194108|NCT02380391|Acute coronary syndrome|acute coronary syndrome
194109|NCT02380391|Antiplatelet treatment|antiplatelet treatment
194110|NCT02380391|Antiretroviral treatment|antiretroviral treatment
194111|NCT02380391|HIV|hiv
194112|NCT02380365|lung transplantation|lung transplantation
194113|NCT02380365|electrocardiography|electrocardiography
194114|NCT02380365|macrolides|macrolides
194115|NCT02380365|QTc interval|qtc interval
194116|NCT02380365|arrhythmia|arrhythmia
194117|NCT02380352|antibiotic stewardship|antibiotic stewardship
194118|NCT02380352|non-inferiority|non-inferiority
194119|NCT02380352|randomized controlled trial|randomized controlled trial
194120|NCT02380313|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
194121|NCT02380313|Enzalutamide|enzalutamide
194122|NCT02380313|Abiraterone|abiraterone
194123|NCT02380313|Dose-Finding|dose-finding
194124|NCT02380313|Afuresertib|afuresertib
194125|NCT02380287|interleukin-17|interleukin-17
194126|NCT02380287|maximum tolerated dose|maximum tolerated dose
194127|NCT02380287|novel monoclonal antibody|novel monoclonal antibody
194128|NCT02380274|Prostate Cancer|prostate cancer
194129|NCT02380274|Castration-resistant Prostate Cancer|castration-resistant prostate cancer
194130|NCT02380274|Metastatic Prostate Cancer|metastatic prostate cancer
194131|NCT02380222|Systemic mastocytosis|systemic mastocytosis
194132|NCT02380222|Patient-reported outcome (PRO)|patient-reported outcome (pro)
194133|NCT02380209|breast cancer|breast cancer
194134|NCT02380209|CEST MRI|cest mri
194135|NCT02380183|anesthesia|anesthesia
194136|NCT02380183|nerve block|nerve block
194137|NCT02380183|needle guidance|needle guidance
194138|NCT02380170|sepsis|sepsis
194139|NCT02380170|urinary tract infection|urinary tract infection
194140|NCT02380170|resistance|resistance
194141|NCT02380170|pathogens|pathogens
194142|NCT02380170|mortality|mortality
194143|NCT02380170|health economics|health economics
194144|NCT02380157|Blood pressure|blood pressure
194145|NCT02380157|Potassium, Dietary|potassium, dietary
194146|NCT02380157|Renin-angiotensin-aldosterone system|renin-angiotensin-aldosterone system
194147|NCT02380157|Sympathetic nervous system|sympathetic nervous system
194148|NCT02380144|carotenoid|carotenoid
194149|NCT02380144|bioavailability|bioavailability
194150|NCT02380144|beta-cryptoxanthin|beta-cryptoxanthin
194151|NCT02380144|flavonoid|flavonoid
194152|NCT02380144|hesperidin|hesperidin
194153|NCT02380144|narirutin|narirutin
194154|NCT02380144|randomized cross-over|randomized cross-over
194155|NCT02380144|Pharmacokinetics|pharmacokinetics
194156|NCT02380144|micronutrients|micronutrients
194157|NCT02380144|Oranges/Orange Juice|oranges/orange juice
194158|NCT02380131|XELOX|xelox
194159|NCT02380131|Herceptin|herceptin
194160|NCT02380131|Potentially Resectable Gastric Cancer|potentially resectable gastric cancer
194161|NCT02380118|emergency|emergency
194162|NCT02380118|emergency medicine|emergency medicine
194163|NCT02380118|sedation|sedation
194164|NCT02380118|acute agitation|acute agitation
194165|NCT02380092|Knee|knee
194166|NCT02380092|Post-Market Surveillance|post-market surveillance
194167|NCT02380092|Legion|legion
194168|NCT02380092|Verilast|verilast
194169|NCT02380092|Degenerative Joint Disease|degenerative joint disease
194170|NCT02380079|Homozygous Sickle Cell Disease S/Beta 0 Thalassemia|homozygous sickle cell disease s/beta 0 thalassemia
194171|NCT02380053|Beta-blocker|beta-blocker
194172|NCT02380053|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
194173|NCT02380027|Prostate biopsy|prostate biopsy
194175|NCT02380027|transrectal|transrectal
194176|NCT02380027|Detection|detection
194177|NCT02380001|Postoperative pain|postoperative pain
194178|NCT02380001|Dexketoprofen trometamol|dexketoprofen trometamol
194179|NCT02380001|third molar surgery|third molar surgery
194180|NCT02379962|biobanking|biobanking
194181|NCT02379962|research participation|research participation
194182|NCT02379962|China|china
194183|NCT02379949|virtual reality exposure therapy|virtual reality exposure therapy
194184|NCT02379949|social phobia|social phobia
194185|NCT02379949|social anxiety disorder|social anxiety disorder
194186|NCT02379949|cognitive behavioral therapy|cognitive behavioral therapy
194187|NCT02379936|Classification|classification
194188|NCT02379936|HIE|hie
194189|NCT02379936|Infections|infections
194190|NCT02379936|Lactate dehydrogenase|lactate dehydrogenase
194191|NCT02379936|Intensive Care|intensive care
194192|NCT02379884|Mechanical ventilation|mechanical ventilation
194193|NCT02379884|Elderly|elderly
194194|NCT02379884|Mortality|mortality
194195|NCT02379884|Health services|health services
194196|NCT02379871|Thoracic Spinal Manipulation, Autonomic Nervous System|thoracic spinal manipulation, autonomic nervous system
194197|NCT02379858|GI Tract Recovery|gi tract recovery
194198|NCT02379858|Hospital Discharge|hospital discharge
194199|NCT02379832|preeclampsia|preeclampsia
194200|NCT02379832|preterm birth|preterm birth
194201|NCT02379832|pregnancy|pregnancy
194202|NCT02379832|placenta|placenta
194203|NCT02379832|intra-uterine growth restriction|intra-uterine growth restriction
194204|NCT02379832|fetal growth restriction|fetal growth restriction
194205|NCT02379832|ultrasound|ultrasound
194206|NCT02379832|doppler|doppler
194207|NCT02379832|biomarkers|biomarkers
194208|NCT02379832|serum|serum
194209|NCT02379832|PAPP-A|papp-a
194210|NCT02379832|PlGF|plgf
194211|NCT02379832|sFlt-1|sflt-1
194212|NCT02379832|endoglin|endoglin
194213|NCT02379793|LEO 80185 gel|leo 80185 gel
194214|NCT02379793|calcipotriol|calcipotriol
194215|NCT02379793|betamethasone|betamethasone
194216|NCT02379754|vestibular schwannoma|vestibular schwannoma
194217|NCT02379754|acoustic neuroma|acoustic neuroma
194218|NCT02379754|cerebellopontine angle tumour|cerebellopontine angle tumour
194219|NCT02379754|gentamicin|gentamicin
194220|NCT02379754|rehabilitation|rehabilitation
194221|NCT02379754|postural balance|postural balance
194222|NCT02379741|Antibodies|antibodies
194223|NCT02379741|Antibodies, Monoclonal|antibodies, monoclonal
194224|NCT02379741|Antineoplastic agent|antineoplastic agent
194225|NCT02379741|Physiological effects of drugs|physiological effects of drugs
194226|NCT02379741|Therapeutic uses|therapeutic uses
194227|NCT02379741|Clinical Trial, Phase I|clinical trial, phase i
194228|NCT02379741|Immunotherapy, Active|immunotherapy, active
194229|NCT02379741|CD40 Antigen|cd40 antigen
194230|NCT02379741|Immunologic Factors|immunologic factors
194231|NCT02379741|Injections, Intralesional|injections, intralesional
194232|NCT02379728|positional therapy|positional therapy
194233|NCT02379728|tennis ball technique|tennis ball technique
194234|NCT02379728|sleep pregnancy|sleep pregnancy
194235|NCT02379728|supine position|supine position
194236|NCT02379728|supine|supine
194237|NCT02379728|sleep position|sleep position
194238|NCT02379728|low birth weight|low birth weight
194239|NCT02379728|stillbirth|stillbirth
194240|NCT02379728|intrauterine growth restriction|intrauterine growth restriction
194241|NCT02379715|Remifentanil|remifentanil
194242|NCT02379715|smooth induction|smooth induction
194243|NCT02379715|desflurane|desflurane
194244|NCT02379689|psychosocial state|psychosocial state
194245|NCT02379637|N-acetylcysteine|n-acetylcysteine
194246|NCT02379637|adults|adults
194247|NCT02379637|cough and cold|cough and cold
194248|NCT02379572|5-ALA|5-ala
194249|NCT02379572|Intraoperative MRI|intraoperative mri
194250|NCT02379572|Extent of resection|extent of resection
194251|NCT02379559|prostate cancer|prostate cancer
194252|NCT02379559|African-American|african-american
194253|NCT02379559|Metabolic Syndrome|metabolic syndrome
194254|NCT02379559|Exercise|exercise
194255|NCT02379559|Men's Health|men's health
194256|NCT02379546|reflex, oculocardiac|reflex, oculocardiac
194257|NCT02379546|monitoring, intraoperative|monitoring, intraoperative
194258|NCT02379520|recurrent cancer|recurrent cancer
194259|NCT02379520|refractory cancer|refractory cancer
194260|NCT02379520|virus specific T-cells|virus specific t-cells
194261|NCT02379520|gene therapy|gene therapy
194262|NCT02379520|HPV|hpv
194263|NCT02379507|mild to moderate|mild to moderate
194264|NCT02379468|Diabetic|diabetic
194265|NCT02379468|Foot|foot
194266|NCT02379468|Ulcer|ulcer
194267|NCT02379455|Polypharmacy|polypharmacy
194268|NCT02379455|Geriatrics|geriatrics
194269|NCT02379455|Elderly|elderly
194270|NCT02379455|Drug review|drug review
194271|NCT02379442|Graft-Versus-Host Disease|graft-versus-host disease
194272|NCT02379442|Corticosteroids|corticosteroids
194273|NCT02379442|Mesenchymal Stromal Cell|mesenchymal stromal cell
194274|NCT02379442|Adoptive Cellular Therapy|adoptive cellular therapy
194275|NCT02379429|Specimen Collection|specimen collection
194276|NCT02379429|Urine|urine
194277|NCT02379429|Blood|blood
194278|NCT02379429|Saliva|saliva
194279|NCT02379416|Drug Efflux|drug efflux
194280|NCT02379416|Taxanes|taxanes
194281|NCT02379416|Combination|combination
194282|NCT02379416|Bcr-Abl Kinase Inhibitors|bcr-abl kinase inhibitors
194283|NCT02379416|Neoplasms|neoplasms
194284|NCT02379403|Flavonoid|flavonoid
194285|NCT02379403|Vascular|vascular
194286|NCT02379403|Biomarkers|biomarkers
194287|NCT02379403|Arterial Stiffness|arterial stiffness
194288|NCT02379403|Nutrigenomics|nutrigenomics
194289|NCT02379364|Physiotherapy|physiotherapy
194290|NCT02379364|Patellofemoral Pain Syndrome|patellofemoral pain syndrome
194291|NCT02379364|Manual therapy|manual therapy
194292|NCT02379351|Non-stress Test|non-stress test
194293|NCT02379351|Fetal Monitoring|fetal monitoring
194294|NCT02379351|Telemedicine|telemedicine
194295|NCT02379338|Dopamine D3 receptor|dopamine d3 receptor
194296|NCT02379312|Foams|foams
194297|NCT02379312|Satiety|satiety
194298|NCT02379312|Appetite|appetite
194299|NCT02379247|HER-2 Negative|her-2 negative
194300|NCT02379247|Metastatic Breast Cancer|metastatic breast cancer
194301|NCT02379234|CVVH|cvvh
194302|NCT02379234|Renal replacement therapy|renal replacement therapy
194303|NCT02379234|High fidelity simulation|high fidelity simulation
194304|NCT02379234|Nurse training|nurse training
194305|NCT02379208|Visual Field Tests|visual field tests
194306|NCT02379208|Ocular Hypertension|ocular hypertension
194307|NCT02379208|Glaucoma, Open-Angle|glaucoma, open-angle
194308|NCT02379208|Quality of Life|quality of life
194309|NCT02379208|Glaucoma progression|glaucoma progression
194310|NCT02379208|Early glaucoma|early glaucoma
194311|NCT02379208|Frequency Doubling Technology (FDT)|frequency doubling technology (fdt)
194312|NCT02379208|RareBit|rarebit
194313|NCT02379208|Octopus 900 perimetry|octopus 900 perimetry
194314|NCT02379182|dysphagia|dysphagia
194315|NCT02379182|VitalStim|vitalstim
194316|NCT02379182|electrical stimulation|electrical stimulation
194317|NCT02379169|macular pigment optical density, age related macular degeneration, dry eye, vision|macular pigment optical density, age related macular degeneration, dry eye, vision
194318|NCT02379156|Quadriplegia|quadriplegia
194319|NCT02379156|Spinal Cord Injury|spinal cord injury
194320|NCT02379156|Body Temperature Regulation|body temperature regulation
194321|NCT02379156|Mild Cognitive Impairment|mild cognitive impairment
194322|NCT02379143|SWD, EPA, SAFE PRACTICE|swd, epa, safe practice
194323|NCT02379130|Premature|premature
194324|NCT02379130|Family Nurture Intervention|family nurture intervention
194325|NCT02379091|Drug therapy|drug therapy
194326|NCT02379078|Shared decision-making|shared decision-making
194327|NCT02379078|Priority setting|priority setting
194328|NCT02379078|Patient decision aid|patient decision aid
194329|NCT02379078|Interprofessional care|interprofessional care
194330|NCT02379078|Diabetes mellitus|diabetes mellitus
194331|NCT02379078|Patient education|patient education
194332|NCT02379078|Medical informatics|medical informatics
194333|NCT02379078|Toolkit development|toolkit development
194334|NCT02379078|Study protocol|study protocol
194335|NCT02379078|User-centred design|user-centred design
194336|NCT02379078|Qualitative methods|qualitative methods
194337|NCT02379013|Fatigue|fatigue
194338|NCT02379013|functional MRI|functional mri
194339|NCT02378987|cerebral palsy|cerebral palsy
194340|NCT02378987|language|language
194341|NCT02378987|acoustic|acoustic
194342|NCT02378987|motor speech|motor speech
194343|NCT02378987|follow-up|follow-up
194344|NCT02378974|Cerebral Infarction|cerebral infarction
194345|NCT02378974|Mesenchymal Stem Cells|mesenchymal stem cells
194346|NCT02378974|Stroke|stroke
194347|NCT02378948|Esophagectomy|esophagectomy
194348|NCT02378948|Nutrition|nutrition
194349|NCT02378948|Oral feeding|oral feeding
194350|NCT02378948|Enteral feeding|enteral feeding
194351|NCT02378948|Pulmonary complications|pulmonary complications
194352|NCT02378948|Anastomotic leakage|anastomotic leakage
194353|NCT02378948|Quality of life|quality of life
194354|NCT02378896|Cognitive Behavioral Therapy|cognitive behavioral therapy
194355|NCT02378883|Apollo|apollo
194356|NCT02378883|Onyx|onyx
194357|NCT02378883|arteriovenous malformation|arteriovenous malformation
194358|NCT02378883|AVM|avm
194359|NCT02378883|Onyx™ Liquid Embolic System|onyx™ liquid embolic system
194360|NCT02378883|Apollo™ Onyx™ Delivery Micro Catheter|apollo™ onyx™ delivery micro catheter
194361|NCT02378883|Brain Diseases|brain diseases
194362|NCT02378870|CRPC|crpc
194363|NCT02378857|Univentricular heart defect|univentricular heart defect
194364|NCT02378857|Fontan circulation|fontan circulation
194365|NCT02378831|diagnosing sleep|diagnosing sleep
194366|NCT02378818|Schizophrenia|schizophrenia
194367|NCT02378818|Negative symptoms|negative symptoms
194368|NCT02378818|Lack of motivation|lack of motivation
194369|NCT02378818|Cognitive characterization|cognitive characterization
194370|NCT02378818|Computational psychiatry|computational psychiatry
194371|NCT02378818|Depression|depression
194372|NCT02378805|Alport syndrome|alport syndrome
194373|NCT02378805|thin basement membrane disease|thin basement membrane disease
194374|NCT02378805|familial benign hematuria|familial benign hematuria
194375|NCT02378792|PINS VNS Refractory Epilepsy|pins vns refractory epilepsy
194376|NCT02378779|Premature ejaculation|premature ejaculation
194377|NCT02378779|general practice|general practice
194378|NCT02378779|sexual dysfunction|sexual dysfunction
194379|NCT02378766|tailored web-based intervention|tailored web-based intervention
194380|NCT02378766|health behavior|health behavior
194381|NCT02378766|hiv comorbidities|hiv comorbidities
194382|NCT02378766|online trial|online trial
194383|NCT02378753|Ebola|ebola
194384|NCT02378753|Sierra Leone|sierra leone
194385|NCT02378753|vaccine|vaccine
194386|NCT02378753|rVSVΔG-ZEBOV|rvsvδg-zebov
194387|NCT02378740|Anesthesia|anesthesia
194388|NCT02378740|Cervical Fusion|cervical fusion
194389|NCT02378740|Quality of Recovery|quality of recovery
194390|NCT02378740|Ketamine Infusion|ketamine infusion
194391|NCT02378714|Smoking Cessation|smoking cessation
194392|NCT02378714|Major Depressive Disorder|major depressive disorder
194393|NCT02378714|Nicotine Dependence|nicotine dependence
194394|NCT02378714|Varenicline|varenicline
194395|NCT02378714|Behavioral Activation Therapy|behavioral activation therapy
194396|NCT02378714|Cigarette Smoking|cigarette smoking
194397|NCT02378701|Leukemia|leukemia
194398|NCT02378701|Myelodysplastic syndrome|myelodysplastic syndrome
194399|NCT02378701|MDS|mds
194400|NCT02378701|Low- or intermediate-1-risk|low- or intermediate-1-risk
194401|NCT02378701|Chronic Myelomonocytic Leukemia -1|chronic myelomonocytic leukemia -1
194402|NCT02378701|CMML-1|cmml-1
194403|NCT02378701|Quality of Life in Myelodysplasia Scale|quality of life in myelodysplasia scale
194404|NCT02378701|QUALMS-1|qualms-1
194405|NCT02378701|Anemia Subset of FACT|anemia subset of fact
194406|NCT02378701|FACT-An|fact-an
194407|NCT02378701|Questionnaires|questionnaires
194408|NCT02378701|Surveys|surveys
194409|NCT02378688|Crohn's Disease|crohn's disease
194410|NCT02378675|Adipocytokines|adipocytokines
194411|NCT02378662|Peritoneal Dialysis|peritoneal dialysis
194412|NCT02378662|End Stage Renal Disease|end stage renal disease
194413|NCT02378662|Anemia|anemia
194414|NCT02378649|Pulmonary Hypertension|pulmonary hypertension
194415|NCT02378623|paradoxical embolism|paradoxical embolism
194416|NCT02378623|lead thrombus|lead thrombus
194417|NCT02378623|ICD|icd
194418|NCT02378623|Pacemaker|pacemaker
194419|NCT02378623|Cognitive decline|cognitive decline
194420|NCT02378623|Stroke|stroke
194421|NCT02378623|TIA|tia
194422|NCT02378597|Resiliency burnout stress|resiliency burnout stress
194423|NCT02378571|Medication adherence|medication adherence
194424|NCT02378571|Hospital readmissions|hospital readmissions
194425|NCT02378558|Breast Surgery|breast surgery
194426|NCT02378545|Sepsis|sepsis
194427|NCT02378545|Hyperoxia|hyperoxia
194428|NCT02378545|Sepsis Six|sepsis six
194429|NCT02378545|Oxygen delivery|oxygen delivery
194430|NCT02378532|Glioblastoma|glioblastoma
194431|NCT02378532|Chloroquine|chloroquine
194432|NCT02378532|Autophagy|autophagy
194433|NCT02378532|EGFRvIII|egfrviii
194434|NCT02378532|Radiotherapy|radiotherapy
194435|NCT02378532|Temozolomide|temozolomide
194436|NCT02378519|Low back pain,|low back pain,
194437|NCT02378519|neck pain,|neck pain,
194438|NCT02378519|chronic pain|chronic pain
194439|NCT02378519|SSED|ssed
194440|NCT02378519|Pilot project|pilot project
194441|NCT02378519|interactive web-based self-help programme|interactive web-based self-help programme
194442|NCT02378519|CBT-coaching|cbt-coaching
194443|NCT02378519|physiotherapy|physiotherapy
194444|NCT02378493|Antibiogramme|antibiogramme
194445|NCT02378493|Antibiofilmogramme|antibiofilmogramme
194446|NCT02378467|Cystic Fibrosis|cystic fibrosis
194447|NCT02378467|Hypertonic Saline|hypertonic saline
194448|NCT02378467|Inhaled Saline|inhaled saline
194449|NCT02378467|Digestive System Diseases|digestive system diseases
194450|NCT02378467|Genetic Diseases, Inborn|genetic diseases, inborn
194451|NCT02378467|Lung Diseases|lung diseases
194452|NCT02378467|Pancreatic Diseases|pancreatic diseases
194453|NCT02378467|Pathologic Processes|pathologic processes
194454|NCT02378467|Respiratory Tract Diseases|respiratory tract diseases
194455|NCT02378454|Lung Clearance Index|lung clearance index
194456|NCT02378454|Cystic Fibrosis|cystic fibrosis
194457|NCT02378454|Multiple Breath Nitrogen Washout|multiple breath nitrogen washout
194458|NCT02378441|volunteers|volunteers
194459|NCT02378428|Neuroblastoma|neuroblastoma
194460|NCT02378415|Depression|depression
194461|NCT02378402|Creatine|creatine
194462|NCT02378402|heart failure|heart failure
194463|NCT02378402|lipid|lipid
194464|NCT02378402|MRS|mrs
194465|NCT02378402|myocardium|myocardium
194466|NCT02378324|Attendance|attendance
194467|NCT02378324|Screening without fee|screening without fee
194468|NCT02378311|Bike|bike
194469|NCT02378311|Bicycle|bicycle
194470|NCT02378311|Scooter|scooter
194471|NCT02378311|Handlebar|handlebar
194472|NCT02378285|recent lateral humeral epicondylitis|recent lateral humeral epicondylitis
194473|NCT02378285|platelet-rich plasma|platelet-rich plasma
194474|NCT02378285|infiltration|infiltration
194475|NCT02378285|tennis elbow|tennis elbow
194476|NCT02378285|ultrasonography|ultrasonography
194477|NCT02378272|Care Manager|care manager
194478|NCT02378272|Primary Care|primary care
194479|NCT02378272|Depressive symptoms|depressive symptoms
194480|NCT02378272|quality of life|quality of life
194481|NCT02378272|return to work|return to work
194482|NCT02378246|Iodine|iodine
194483|NCT02378246|Double-Blind Method|double-blind method
194484|NCT02378246|Randomized Controlled Tria|randomized controlled tria
194485|NCT02378246|Cognitive Development|cognitive development
194486|NCT02378233|Iodine|iodine
194487|NCT02378233|Double-Blind Method|double-blind method
194488|NCT02378233|Randomized Controlled Trial|randomized controlled trial
194489|NCT02378220|Home Care Agencies|home care agencies
194490|NCT02378220|Home Health Care Agencies|home health care agencies
194491|NCT02378220|Home Health Care Nursing|home health care nursing
194492|NCT02378220|Home Health Nurses|home health nurses
194493|NCT02378220|CYP 2D6|cyp 2d6
194494|NCT02378220|CYP 2C9|cyp 2c9
194495|NCT02378220|CYP 2C19|cyp 2c19
194496|NCT02378220|CYP 3A4|cyp 3a4
194497|NCT02378220|CYP 3A5|cyp 3a5
194700|NCT02377128|Study|study
194498|NCT02378194|in stage 3 or 4 steps|in stage 3 or 4 steps
194499|NCT02378168|postconditioning|postconditioning
194500|NCT02378168|six month follow up|six month follow up
194501|NCT02378168|cardiac event|cardiac event
194502|NCT02378168|non-cardiac event|non-cardiac event
194503|NCT02378155|cardioversion|cardioversion
194504|NCT02378155|atrial fibrillation|atrial fibrillation
194505|NCT02378129|Dentin Sensitivity|dentin sensitivity
194506|NCT02378129|Dentin Desensitizing Agents|dentin desensitizing agents
194507|NCT02378129|Glass Ionomer Cements|glass ionomer cements
194508|NCT02378129|Randomized Controlled Trial|randomized controlled trial
194509|NCT02378103|Aortic Dissection|aortic dissection
194510|NCT02378103|Chinese XinJiang Province|chinese xinjiang province
194511|NCT02378077|Obesity|obesity
194512|NCT02378077|Insulin Resistance|insulin resistance
194513|NCT02378064|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
194514|NCT02378064|Positron-Emission Tomography and Computed Tomography|positron-emission tomography and computed tomography
194515|NCT02378064|Plaque, Atherosclerotic|plaque, atherosclerotic
194516|NCT02378064|Renin-Angiotensin System|renin-angiotensin system
194517|NCT02378038|PNT2258|pnt2258
194518|NCT02378038|Richter's Transformation|richter's transformation
194519|NCT02378038|NHL|nhl
194520|NCT02378038|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
194521|NCT02378038|Lymphoma|lymphoma
194522|NCT02378038|DLBCL|dlbcl
194523|NCT02378038|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
194524|NCT02378038|Lymphoma, Large B-cell, Diffuse|lymphoma, large b-cell, diffuse
194525|NCT02378038|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
194526|NCT02378038|Lymphoma, B-cell|lymphoma, b-cell
194527|NCT02378025|Chronic Pain|chronic pain
194528|NCT02378025|Veterans|veterans
194529|NCT02378025|Gulf War Illness|gulf war illness
194530|NCT02377973|growth,|growth,
194531|NCT02377973|infancy,|infancy,
194532|NCT02377973|children,|children,
194533|NCT02377973|diet,|diet,
194534|NCT02377973|breastfeeding|breastfeeding
194535|NCT02377973|complementary feeding|complementary feeding
194536|NCT02377973|early life programming|early life programming
194537|NCT02377973|tracking|tracking
194538|NCT02377973|physical activity|physical activity
194539|NCT02377960|SMS|sms
194540|NCT02377960|text message|text message
194541|NCT02377960|mHealth|mhealth
194542|NCT02377960|IMB|imb
194543|NCT02377947|Lactulose Retention Enema|lactulose retention enema
194544|NCT02377947|Hepatic Encephalopathy, Grade 3 or 4 West Haven Criteria|hepatic encephalopathy, grade 3 or 4 west haven criteria
194545|NCT02377947|The Retro Study|the retro study
194546|NCT02377934|Pulmonary Hypertension|pulmonary hypertension
194547|NCT02377934|Cardiac MRT|cardiac mrt
194548|NCT02377934|Radiotherapy|radiotherapy
194549|NCT02377921|GNE Myopathy|gne myopathy
194550|NCT02377921|GNEM|gnem
194551|NCT02377921|HIBM|hibm
194552|NCT02377921|Nonaka|nonaka
194553|NCT02377921|Hereditary Inclusion Body Myopathy|hereditary inclusion body myopathy
194554|NCT02377921|DMRV|dmrv
194555|NCT02377882|Intra-operative neuromonitoring|intra-operative neuromonitoring
194556|NCT02377882|Neuromuscular blocking agent|neuromuscular blocking agent
194557|NCT02377882|Rocuronium|rocuronium
194558|NCT02377882|Thyroid surgery|thyroid surgery
194559|NCT02377856|acute hepatitis C|acute hepatitis c
194560|NCT02377856|treatment|treatment
194561|NCT02377856|SVR|svr
194562|NCT02377843|vaccine|vaccine
194563|NCT02377843|physician training|physician training
194564|NCT02377843|adolescent health|adolescent health
194565|NCT02377817|positional therapy|positional therapy
194566|NCT02377817|tennis ball technique|tennis ball technique
194567|NCT02377817|sleep in pregnancy|sleep in pregnancy
194568|NCT02377817|supine|supine
194569|NCT02377817|polysomnography|polysomnography
194570|NCT02377817|sleep position|sleep position
194571|NCT02377817|supine position|supine position
194572|NCT02377804|dry needling|dry needling
194573|NCT02377804|spasticity|spasticity
194574|NCT02377804|pain|pain
194575|NCT02377791|tacrolimus|tacrolimus
194576|NCT02377791|Cytochrome P-450 CYP3A|cytochrome p-450 cyp3a
194577|NCT02377791|Kidney transplant|kidney transplant
194578|NCT02377791|FK506|fk506
194579|NCT02377791|Prograf|prograf
194580|NCT02377791|Rejection|rejection
194581|NCT02377791|Gene Polymorphism|gene polymorphism
194582|NCT02377765|Neuromodulation|neuromodulation
194583|NCT02377765|Detrusor overactivity|detrusor overactivity
194584|NCT02377765|Urinary urgency|urinary urgency
194585|NCT02377765|Urgency urinary incontinence|urgency urinary incontinence
194586|NCT02377726|Randomized Controlled Trial|randomized controlled trial
194587|NCT02377726|Alcohol|alcohol
194588|NCT02377726|Internet|internet
194589|NCT02377726|Internet based therapy|internet based therapy
194590|NCT02377726|Cognitive behavioral therapy|cognitive behavioral therapy
194591|NCT02377713|KHK6640|khk6640
194592|NCT02377713|Phase 1|phase 1
194593|NCT02377713|Japanese|japanese
194594|NCT02377713|single dose|single dose
194595|NCT02377713|Alzheimer's disease|alzheimer's disease
194596|NCT02377687|Emergency surgery|emergency surgery
194597|NCT02377687|HRQoL|hrqol
194598|NCT02377687|Elderly|elderly
194701|NCT02377128|focus|focus
194599|NCT02377648|Cardiac Allograft Vasculopathy|cardiac allograft vasculopathy
194600|NCT02377648|Heart Transplant|heart transplant
194601|NCT02377648|Bioresorbable Vascular Scaffold|bioresorbable vascular scaffold
194602|NCT02377635|Arsenic|arsenic
194603|NCT02377635|Arsenicosis|arsenicosis
194604|NCT02377609|Dry Blood Spot (DBS)|dry blood spot (dbs)
194605|NCT02377609|Validation|validation
194606|NCT02377609|Tacrolimus|tacrolimus
194607|NCT02377609|Bioanalytical assay method cross-validation|bioanalytical assay method cross-validation
194608|NCT02377596|Feeding|feeding
194609|NCT02377596|difficulties|difficulties
194610|NCT02377596|disorders|disorders
194611|NCT02377596|childhood|childhood
194612|NCT02377596|eating|eating
194613|NCT02377557|Dermatologic Agent|dermatologic agent
194614|NCT02377531|early glucose screen, perinatal outcome|early glucose screen, perinatal outcome
194615|NCT02377505|Treatment-Resistant Schizophrenia|treatment-resistant schizophrenia
194616|NCT02377505|Deep Brain Stimulation|deep brain stimulation
194617|NCT02377466|Spontaneous Preterm Labor|spontaneous preterm labor
194618|NCT02377466|GSK221149|gsk221149
194619|NCT02377466|Retosiban|retosiban
194620|NCT02377453|stroke|stroke
194621|NCT02377453|participation|participation
194622|NCT02377453|brain imaging|brain imaging
194623|NCT02377453|biomechanical|biomechanical
194624|NCT02377440|ACE inhibitor|ace inhibitor
194625|NCT02377427|pharmacokinetics|pharmacokinetics
194626|NCT02377427|pediatric|pediatric
194627|NCT02377427|Mepolizumab|mepolizumab
194628|NCT02377427|subcutaneous|subcutaneous
194629|NCT02377427|eosinophilic asthma|eosinophilic asthma
194630|NCT02377427|pharmacodynamics|pharmacodynamics
194631|NCT02377414|Preterm labor|preterm labor
194632|NCT02377414|Retosiban|retosiban
194633|NCT02377414|Pharmacokinetics|pharmacokinetics
194634|NCT02377414|Safety|safety
194635|NCT02377414|Infusion|infusion
194636|NCT02377414|GSK2847065|gsk2847065
194637|NCT02377401|healthy volunteer|healthy volunteer
194638|NCT02377401|Zanamivir|zanamivir
194639|NCT02377401|pharmacokinetics|pharmacokinetics
194640|NCT02377401|intravenous|intravenous
194641|NCT02377388|diabetes mellitus|diabetes mellitus
194642|NCT02377388|platelet function testing|platelet function testing
194643|NCT02377388|acute coronary syndromes|acute coronary syndromes
194644|NCT02377388|saxagliptin|saxagliptin
194645|NCT02377388|sitagliptin|sitagliptin
194646|NCT02377388|dpp-4 inhibitors|dpp-4 inhibitors
194647|NCT02377375|Deep Brain Stimulation|deep brain stimulation
194648|NCT02377375|OCD|ocd
194649|NCT02377336|GS-6615|gs-6615
194650|NCT02377336|coronary heart disease|coronary heart disease
194651|NCT02377336|angina pectoris|angina pectoris
194652|NCT02377336|late sodium current|late sodium current
194653|NCT02377336|myocardial ischemia|myocardial ischemia
194654|NCT02377336|coronary artery disease|coronary artery disease
194655|NCT02377336|chronic stable angina|chronic stable angina
194656|NCT02377323|Multiple Sclerosis|multiple sclerosis
194657|NCT02377323|Patient-reported outcomes|patient-reported outcomes
194658|NCT02377323|Employment status|employment status
194659|NCT02377323|Quality of Life|quality of life
194660|NCT02377323|Cognition|cognition
194661|NCT02377323|Rebif|rebif
194662|NCT02377297|dental atraumatic restorative treatment|dental atraumatic restorative treatment
194663|NCT02377297|primary tooth|primary tooth
194664|NCT02377297|occlusal restoration|occlusal restoration
194665|NCT02377297|glass-ionomer cement|glass-ionomer cement
194666|NCT02377271|Bosentan|bosentan
194667|NCT02377245|Juvenile|juvenile
194668|NCT02377245|Inflammatory|inflammatory
194669|NCT02377245|Rheumatism|rheumatism
194670|NCT02377245|Pediatric-Onset inflammatory diseases|pediatric-onset inflammatory diseases
194671|NCT02377206|PET|pet
194672|NCT02377206|[18F]DPA-714|[18f]dpa-714
194673|NCT02377206|cognitive decline|cognitive decline
194674|NCT02377193|kidney transplant|kidney transplant
194675|NCT02377193|luminex method|luminex method
194676|NCT02377193|simulect ATG|simulect atg
194677|NCT02377193|immunosuppression|immunosuppression
194678|NCT02377180|musculoskeletal pain|musculoskeletal pain
194679|NCT02377180|regional anesthesia|regional anesthesia
194680|NCT02377180|diagnostic nerve block|diagnostic nerve block
194681|NCT02377180|intramuscular capsaicin|intramuscular capsaicin
194682|NCT02377180|referred pain|referred pain
194683|NCT02377180|hyperalgesia|hyperalgesia
194684|NCT02377180|experimental pain|experimental pain
194685|NCT02377180|central hypersensitivity|central hypersensitivity
194686|NCT02377180|human experimental pain|human experimental pain
194687|NCT02377154|keratometry|keratometry
194688|NCT02377154|verion|verion
194689|NCT02377154|iol|iol
194690|NCT02377154|intraocular lens|intraocular lens
194691|NCT02377154|iolmaster|iolmaster
194692|NCT02377154|lenstar|lenstar
194693|NCT02377154|pentacam|pentacam
194694|NCT02377154|IOL calculation|iol calculation
194695|NCT02377154|VERION Image Guided System|verion image guided system
194696|NCT02377141|Oesophageal Variceal Bleed|oesophageal variceal bleed
194697|NCT02377141|TIPSS|tipss
194698|NCT02377141|Endoscopic Variceal Band Ligation|endoscopic variceal band ligation
194699|NCT02377141|Decompensated Liver Disease|decompensated liver disease
194702|NCT02377128|ovarian|ovarian
194703|NCT02377128|reserve|reserve
194704|NCT02377115|Postoperative delirium|postoperative delirium
194705|NCT02377115|Postoperative cognitive decline|postoperative cognitive decline
194706|NCT02377115|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
194707|NCT02377115|Risk assessment|risk assessment
194708|NCT02377115|Tablet computer|tablet computer
194709|NCT02377115|Clinical screening tool|clinical screening tool
194710|NCT02377089|Trigeminal Nerve Stimulation|trigeminal nerve stimulation
194711|NCT02377089|Post-Traumatic Stress Disorder|post-traumatic stress disorder
194712|NCT02377063|colonic flora|colonic flora
194713|NCT02377063|microbiomes|microbiomes
194714|NCT02377050|Nutritional support|nutritional support
194715|NCT02377037|Sitting|sitting
194716|NCT02377037|Standing|standing
194717|NCT02377037|Transitions|transitions
194718|NCT02376998|Thoracic Aorta|thoracic aorta
194719|NCT02376998|Trauma|trauma
194720|NCT02376998|Endovascular|endovascular
194721|NCT02376959|Anxiety|anxiety
194722|NCT02376959|Complementary Therapies|complementary therapies
194723|NCT02376959|energy therapies|energy therapies
194724|NCT02376933|vertebral bodies|vertebral bodies
194725|NCT02376933|vertebral fracture|vertebral fracture
194726|NCT02376933|vertebral augmentation|vertebral augmentation
194727|NCT02376933|radiotherapy|radiotherapy
194728|NCT02376933|vertebroplasty|vertebroplasty
194729|NCT02376933|kyphoplasty|kyphoplasty
194730|NCT02376920|occular melanoma|occular melanoma
194731|NCT02376920|melanoma of eye|melanoma of eye
194732|NCT02376920|DecisionDx-UM|decisiondx-um
194733|NCT02376907|distal malignant biliary obstruction|distal malignant biliary obstruction
194734|NCT02376907|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
194735|NCT02376907|endoscopic ultrasound|endoscopic ultrasound
194736|NCT02376907|gastric outlet obstruction|gastric outlet obstruction
194737|NCT02376907|stent|stent
194738|NCT02376881|Erythropoietin -Methanol - Optic Neuropathy|erythropoietin -methanol - optic neuropathy
194739|NCT02376855|Health Services Accessibility|health services accessibility
194740|NCT02376842|severe sepsis infection|severe sepsis infection
194741|NCT02376829|Orthodontic|orthodontic
194742|NCT02376829|Orthodontic Treatment|orthodontic treatment
194743|NCT02376829|Clear Aligners|clear aligners
194744|NCT02376829|Malocclusion|malocclusion
194745|NCT02376816|DMD|dmd
194746|NCT02376816|muscular dystrophy|muscular dystrophy
194747|NCT02376816|dystrophin|dystrophin
194748|NCT02376803|Randomized controlled trial|randomized controlled trial
194749|NCT02376803|Warfarin|warfarin
194750|NCT02376803|Time in therapeutic range|time in therapeutic range
194751|NCT02376803|Bleeding|bleeding
194752|NCT02376803|Thromboembolic|thromboembolic
194753|NCT02376803|Hemorrhage|hemorrhage
194754|NCT02376803|Anticoagulant|anticoagulant
194755|NCT02376803|TTR|ttr
194756|NCT02376803|Chronobiology|chronobiology
194757|NCT02376803|Chronotherapeutic|chronotherapeutic
194758|NCT02376803|Coumadin|coumadin
194759|NCT02376803|INR|inr
194760|NCT02376803|International normalized ratio|international normalized ratio
194761|NCT02376803|RCT|rct
194762|NCT02376790|Psoriatic Arthritis|psoriatic arthritis
194763|NCT02376790|Arthritis, Psoriasis|arthritis, psoriasis
194764|NCT02376790|Etanercept|etanercept
194765|NCT02376790|Enbrel|enbrel
194766|NCT02376790|Methotrexate|methotrexate
194767|NCT02376790|Minimal Disease Activity|minimal disease activity
194768|NCT02376777|Anticoagulants|anticoagulants
194769|NCT02376777|Antithrombins|antithrombins
194770|NCT02376777|Atrial Fibrillation|atrial fibrillation
194771|NCT02376777|Intracranial haemorrhage|intracranial haemorrhage
194772|NCT02376777|Gastrointestinal haemorrhage|gastrointestinal haemorrhage
194773|NCT02376777|Myocardial infarction|myocardial infarction
194774|NCT02376777|Stroke|stroke
194775|NCT02376777|Venous thrombosis|venous thrombosis
194776|NCT02376777|Primary care|primary care
194777|NCT02376751|Cholesteryl Ester Storage Disease|cholesteryl ester storage disease
194778|NCT02376751|Acid lipase disease|acid lipase disease
194779|NCT02376751|Cholesterol ester hydrolase deficiency|cholesterol ester hydrolase deficiency
194780|NCT02376751|LIPA Deficiency|lipa deficiency
194781|NCT02376751|Wolman disease|wolman disease
194782|NCT02376751|Lysosomal Storage Disease|lysosomal storage disease
194783|NCT02376725|Goniosynechialysis|goniosynechialysis
194784|NCT02376712|Acute Kidney Injury|acute kidney injury
194785|NCT02376712|Differential diagnosis|differential diagnosis
194786|NCT02376712|Urinary indices|urinary indices
194787|NCT02376712|Renal Blood Flow|renal blood flow
194788|NCT02376712|Transesophageal Echocardiography|transesophageal echocardiography
194789|NCT02376699|CD40 Antigen|cd40 antigen
194790|NCT02376699|Drug Therapy|drug therapy
194791|NCT02376699|Follicular Lymphoma|follicular lymphoma
194792|NCT02376699|Hodgkin Disease|hodgkin disease
194793|NCT02376699|Immunotherapy|immunotherapy
194794|NCT02376699|Indolent Lymphoma|indolent lymphoma
194795|NCT02376699|Lymphoma|lymphoma
194796|NCT02376699|Lymphoma, B-Cell|lymphoma, b-cell
194797|NCT02376699|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
194798|NCT02376699|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
194799|NCT02376699|Monoclonal Antibody|monoclonal antibody
194800|NCT02376699|Neoplasms|neoplasms
194801|NCT02376699|Neoplasm Metastasis|neoplasm metastasis
194802|NCT02376699|Solid tumor|solid tumor
194803|NCT02376686|sleep Quality|sleep quality
194804|NCT02376686|Depression|depression
194805|NCT02376686|Music|music
194806|NCT02376686|quality of life|quality of life
194807|NCT02376673|Pediatric Health Literacy|pediatric health literacy
194808|NCT02376673|Home Literacy Orientation|home literacy orientation
194809|NCT02376673|safe sleep|safe sleep
194810|NCT02376647|Patients|patients
194811|NCT02376647|ARDS diagnosis|ards diagnosis
194812|NCT02376621|omega-3 based dietary supplements|omega-3 based dietary supplements
194813|NCT02376621|Bioavailability|bioavailability
194814|NCT02376595|Rocuronium|rocuronium
194815|NCT02376595|Pharmacokinetics|pharmacokinetics
194816|NCT02376595|Pharmacodynamics|pharmacodynamics
194817|NCT02376582|HIV/AIDS vaccine|hiv/aids vaccine
194818|NCT02376582|helminth infection|helminth infection
194819|NCT02376582|Impact of co-infection|impact of co-infection
194820|NCT02376556|Dry eye syndrome|dry eye syndrome
194821|NCT02376556|Blepharoplasty|blepharoplasty
194822|NCT02376556|Muller muscle resection surgery|muller muscle resection surgery
194823|NCT02376517|Health Behavior|health behavior
194824|NCT02376517|Melanin Index|melanin index
194825|NCT02376517|Spectrophotometry|spectrophotometry
194826|NCT02376517|Sun Protective Clothing|sun protective clothing
194827|NCT02376517|Education|education
194828|NCT02376517|Primary Prevention|primary prevention
194829|NCT02376439|siblings|siblings
194830|NCT02376439|overweight|overweight
194831|NCT02376439|adolescent|adolescent
194832|NCT02376426|Healthy|healthy
194833|NCT02376426|Ebola viruses|ebola viruses
194834|NCT02376426|Ebola Viral Disease (EVD)|ebola viral disease (evd)
194835|NCT02376426|Filoviruses|filoviruses
194836|NCT02376426|Monovalent vaccine|monovalent vaccine
194837|NCT02376426|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
194838|NCT02376426|Modified Vaccinia Virus Ankara - Bavarian Nordic (MVA-BN) Filo-vector|modified vaccinia virus ankara - bavarian nordic (mva-bn) filo-vector
194839|NCT02376426|Safety|safety
194840|NCT02376426|Immunogenicity|immunogenicity
194841|NCT02376413|Morbidity|morbidity
194842|NCT02376413|The Breast Cancer Treatment Outcome Scale|the breast cancer treatment outcome scale
194843|NCT02376413|Disease free survival|disease free survival
194844|NCT02376413|Positivity cavity margin rate|positivity cavity margin rate
194845|NCT02376413|Harvard/NSABP/RTOG breast cosmesis grading scale|harvard/nsabp/rtog breast cosmesis grading scale
194846|NCT02376400|Healthy|healthy
194847|NCT02376400|Ebola viruses|ebola viruses
194848|NCT02376400|Ebola Viral Disease (EVD)|ebola viral disease (evd)
194849|NCT02376400|Filoviruses|filoviruses
194850|NCT02376400|Monovalent vaccine|monovalent vaccine
194851|NCT02376400|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
194852|NCT02376400|Modified Vaccinia Virus Ankara - Bavarian Nordic Filo-vector (MVA-BN Filo)|modified vaccinia virus ankara - bavarian nordic filo-vector (mva-bn filo)
194853|NCT02376400|Safety|safety
194854|NCT02376400|Immunogenicity|immunogenicity
194855|NCT02376374|transmission|transmission
194856|NCT02376374|vaccine|vaccine
194857|NCT02376361|Surveillance|surveillance
194858|NCT02376348|VMMC|vmmc
194859|NCT02376348|Adult males|adult males
194860|NCT02376348|HIV Prevention|hiv prevention
194861|NCT02376348|Africa|africa
194862|NCT02376335|Fatigue|fatigue
194863|NCT02376335|Primary Biliary Cirrhosis|primary biliary cirrhosis
194864|NCT02376335|Rituximab|rituximab
194865|NCT02376335|PBC-40|pbc-40
194866|NCT02376296|metastatic prostate cancer|metastatic prostate cancer
194867|NCT02376296|castrate resistant prostate cancer|castrate resistant prostate cancer
194868|NCT02376296|CRPC|crpc
194869|NCT02376296|hormone sensitive prostate cancer|hormone sensitive prostate cancer
194870|NCT02376283|STEMI|stemi
194871|NCT02376283|NSTEMI|nstemi
194872|NCT02376283|PPCI|ppci
194873|NCT02376244|High intensity Interval Exercise training|high intensity interval exercise training
194874|NCT02376244|Cardiac rehabilitation|cardiac rehabilitation
194875|NCT02376244|cardiac revascularisation|cardiac revascularisation
194876|NCT02376244|Percutaneous coronary interventions|percutaneous coronary interventions
194877|NCT02376244|Cardiac surgery|cardiac surgery
194878|NCT02376231|EOC Epithelial ovarian cancer|eoc epithelial ovarian cancer
194879|NCT02376231|Surgery|surgery
194880|NCT02376231|nil macroscopic residual disease|nil macroscopic residual disease
194881|NCT02376231|Stage 3/4 Epithelial Ovarian Cancer requiring surgery|stage 3/4 epithelial ovarian cancer requiring surgery
194882|NCT02376205|Anterior Cervical Discectomy and Fusion|anterior cervical discectomy and fusion
194883|NCT02376205|Dysphagia|dysphagia
194884|NCT02376192|Microcirculation|microcirculation
194885|NCT02376192|Sidestream Dark Field (SDF) Imaging|sidestream dark field (sdf) imaging
194886|NCT02376192|Spinal Anesthesia|spinal anesthesia
194887|NCT02376192|Phenylephrine|phenylephrine
194888|NCT02376166|Prostate Cancer|prostate cancer
194889|NCT02376140|micronutrient deficiency|micronutrient deficiency
194890|NCT02376140|24-H recall|24-h recall
194891|NCT02376140|West Africa|west africa
194892|NCT02376140|Food consumption|food consumption
194893|NCT02376127|Dynamic Contrast-Enhanced Perfusion|dynamic contrast-enhanced perfusion
194894|NCT02376127|14-203|14-203
194895|NCT02376114|ocular blood flow|ocular blood flow
194896|NCT02376114|ginkgo biloba|ginkgo biloba
194897|NCT02376114|glaucoma|glaucoma
194898|NCT02376114|vasospasm|vasospasm
194899|NCT02376062|Continuing Medical Education|continuing medical education
194900|NCT02376062|Chronic Diseases|chronic diseases
194901|NCT02376062|Nepal|nepal
194902|NCT02376062|Implementation Research|implementation research
194903|NCT02376049|Atopic Dermatitis|atopic dermatitis
194904|NCT02376049|Eczema|eczema
194905|NCT02376049|AD|ad
194906|NCT02376036|Normal healthy volunteer|normal healthy volunteer
194907|NCT02376023|Cervical Cancer|cervical cancer
194908|NCT02376023|Women|women
194909|NCT02376023|Latina|latina
194910|NCT02376023|Chile|chile
194911|NCT02376023|Text Message|text message
194912|NCT02376023|Technology|technology
194913|NCT02376023|Screening|screening
194914|NCT02376023|Cancer Prevention|cancer prevention
194915|NCT02376023|Health Disparities|health disparities
194916|NCT02376023|Mobile Health|mobile health
194917|NCT02376010|atherosclerosis|atherosclerosis
194918|NCT02376010|coronary artery disease|coronary artery disease
194919|NCT02376010|cardiac CT|cardiac ct
194920|NCT02376010|computed tomographic angiography|computed tomographic angiography
194921|NCT02375971|intravitreal ranibizumab|intravitreal ranibizumab
194922|NCT02375971|laser ablation therapy|laser ablation therapy
194923|NCT02375971|retinopathy of prematurity|retinopathy of prematurity
194924|NCT02375971|preterm infants|preterm infants
194925|NCT02375971|RAINBOW|rainbow
194926|NCT02375958|PCA062, Triple Negative Breast Cancer, Head & Neck Cancer, Esophageal Cancer, pCAD, pcadherin, solid-tumors|pca062, triple negative breast cancer, head & neck cancer, esophageal cancer, pcad, pcadherin, solid-tumors
194927|NCT02375945|lymphedema|lymphedema
194928|NCT02375945|post operative compression treatment|post operative compression treatment
194929|NCT02375945|compression therapy|compression therapy
194930|NCT02375945|adjustable fulcro wraps|adjustable fulcro wraps
194931|NCT02375945|edema|edema
194932|NCT02375932|Electronic Medical Records|electronic medical records
194933|NCT02375932|Primary Health Care|primary health care
194934|NCT02375932|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
194935|NCT02375919|PERC rule|perc rule
194936|NCT02375919|emergency department|emergency department
194937|NCT02375919|pulmonary embolism|pulmonary embolism
194938|NCT02375906|HDV, hepatitis delta|hdv, hepatitis delta
194939|NCT02375893|Coronary disease|coronary disease
194940|NCT02375893|Bile acids|bile acids
194941|NCT02375893|Gut microbiota|gut microbiota
194942|NCT02375893|Risk factors|risk factors
194943|NCT02375893|Atherosclerosis|atherosclerosis
194944|NCT02375854|preterm|preterm
194945|NCT02375854|acute kidney injury|acute kidney injury
194946|NCT02375854|biomarkers|biomarkers
194947|NCT02375854|chronic kidney disease|chronic kidney disease
194948|NCT02375841|Communication|communication
194949|NCT02375841|Physicians|physicians
194950|NCT02375841|Patients|patients
194951|NCT02375841|Caregivers|caregivers
194952|NCT02375841|15-034|15-034
194953|NCT02375828|Acceptability|acceptability
194954|NCT02375828|Phase 3|phase 3
194955|NCT02375828|Neonatal diabetes|neonatal diabetes
194956|NCT02375815|statin|statin
194957|NCT02375815|decision aid|decision aid
194958|NCT02375802|Stem cells|stem cells
194959|NCT02375789|Migraine Headache|migraine headache
194960|NCT02375789|Cooling|cooling
194961|NCT02375789|Intranasal|intranasal
194962|NCT02375789|Rhinochill|rhinochill
194963|NCT02375724|COPD|copd
194964|NCT02375711|Chronic renal disease|chronic renal disease
194965|NCT02375711|Hepatitis B vaccine|hepatitis b vaccine
194966|NCT02375711|Biological Aging|biological aging
194967|NCT02375685|Uveitis|uveitis
194968|NCT02375685|Non-infectious Uveitis|non-infectious uveitis
194969|NCT02375685|Intermediate Uveitis|intermediate uveitis
194970|NCT02375685|Posterior Uveitis|posterior uveitis
194971|NCT02375685|Behçet's disease uveitis|behçet's disease uveitis
194972|NCT02375672|Pembrolizumab|pembrolizumab
194973|NCT02375672|MK-3475|mk-3475
194974|NCT02375607|Pain management|pain management
194975|NCT02375581|Radiotherapy|radiotherapy
194976|NCT02375581|Icotinib|icotinib
194977|NCT02375568|mesenchymal stem cells|mesenchymal stem cells
194978|NCT02375555|Multiple Myeloma|multiple myeloma
194979|NCT02375516|Drug abuse|drug abuse
194980|NCT02375503|Calcium|calcium
194981|NCT02375503|Vitamin D|vitamin d
194982|NCT02375503|Parathyroid Hormone|parathyroid hormone
194983|NCT02375503|Bone|bone
194984|NCT02375503|Microarchitecture|microarchitecture
194985|NCT02375490|Exercise|exercise
194986|NCT02375490|Eating Behavior|eating behavior
194987|NCT02375490|Preschool Child|preschool child
194988|NCT02375490|Early Childcare Center|early childcare center
194989|NCT02375490|Obesity|obesity
194990|NCT02375490|Physical Literacy|physical literacy
194991|NCT02375477|Clostridium difficile|clostridium difficile
194992|NCT02375477|C. difficile|c. difficile
194993|NCT02375477|adherence|adherence
194994|NCT02375464|neuroendocrine tumor|neuroendocrine tumor
194995|NCT02375464|carcinoid tumor|carcinoid tumor
194996|NCT02375438|nutrition|nutrition
194997|NCT02375438|mitochondrial cytopathy|mitochondrial cytopathy
194998|NCT02375438|malnutrition|malnutrition
194999|NCT02375438|energy intake|energy intake
195000|NCT02375438|nutritional risk|nutritional risk
195001|NCT02375425|BV, HSV|bv, hsv
195002|NCT02375425|contraceptive|contraceptive
195003|NCT02375425|ex vivo challenge model|ex vivo challenge model
195004|NCT02375412|heart rate variability|heart rate variability
195005|NCT02375412|post-operative outcome|post-operative outcome
195006|NCT02375373|Gut Microbiota|gut microbiota
195007|NCT02375347|Gut Microbiota|gut microbiota
195008|NCT02375321|OSA|osa
195009|NCT02375321|Depression|depression
195010|NCT02375321|Quality of Life|quality of life
195011|NCT02375321|CPAP|cpap
195012|NCT02375308|Hypnotherapy; Cognitive Behavioral Therapy; Efficacy|hypnotherapy; cognitive behavioral therapy; efficacy
195013|NCT02375295|struvite|struvite
195014|NCT02375295|infection|infection
195015|NCT02375295|stones|stones
195016|NCT02375295|calculi|calculi
195017|NCT02375295|antibiotics|antibiotics
195018|NCT02375282|ambulation|ambulation
195019|NCT02375282|cardiac rehabilitation|cardiac rehabilitation
195020|NCT02375269|Visceral Surgery|visceral surgery
195021|NCT02375269|Comprehensive Complication Index|comprehensive complication index
195022|NCT02375269|Patient undergoing abdominal surgery|patient undergoing abdominal surgery
195023|NCT02375230|Neonatal Resuscitation|neonatal resuscitation
195024|NCT02375230|Respiratory Function Tests|respiratory function tests
195025|NCT02375230|Neonatal Simulation|neonatal simulation
195026|NCT02375230|Resuscitation Teaching|resuscitation teaching
195027|NCT02375178|anti-infective agents|anti-infective agents
195028|NCT02375178|local/therapeutic use|local/therapeutic use
195029|NCT02375178|chlorhexidine|chlorhexidine
195030|NCT02375178|dental desinfectants|dental desinfectants
195031|NCT02375178|polyhexamethylene biguanide|polyhexamethylene biguanide
195032|NCT02375178|mouthrinse|mouthrinse
195033|NCT02375152|neurosurgery|neurosurgery
195034|NCT02375152|capsulotomy|capsulotomy
195035|NCT02375113|Obesity prevention|obesity prevention
195036|NCT02375113|Soy supplementation|soy supplementation
195037|NCT02375074|Supported Employment|supported employment
195038|NCT02375074|Vocational Rehabilitation|vocational rehabilitation
195039|NCT02375074|Youth|youth
195040|NCT02375074|Sick leave|sick leave
195041|NCT02375074|Disability|disability
195042|NCT02375074|Coping|coping
195043|NCT02375074|Work|work
195044|NCT02375074|Occupational|occupational
195045|NCT02375074|Labor market participation|labor market participation
195046|NCT02375074|Randomized Controlled Trial|randomized controlled trial
195047|NCT02375061|Best Possible Self|best possible self
195048|NCT02375061|Positive Psychology|positive psychology
195049|NCT02375061|Optimism|optimism
195050|NCT02375061|Positive Technologies|positive technologies
195051|NCT02375061|Future thinking|future thinking
195052|NCT02375061|Pain Catastrophizing|pain catastrophizing
195053|NCT02374983|Gamma Knife Radiosurgery|gamma knife radiosurgery
195054|NCT02374983|Radiation Dosimetry|radiation dosimetry
195055|NCT02374957|leg pain|leg pain
195056|NCT02374957|claudication|claudication
195057|NCT02374931|desmoid|desmoid
195058|NCT02374931|FES-PET|fes-pet
195059|NCT02374931|aggressive fibromatosis|aggressive fibromatosis
195060|NCT02374918|Mild traumatic brain injury|mild traumatic brain injury
195061|NCT02374918|Concussion|concussion
195062|NCT02374918|Sleep problems|sleep problems
195063|NCT02374918|Brain imaging|brain imaging
195064|NCT02374918|fMRI|fmri
195065|NCT02374905|drinksmeter|drinksmeter
195066|NCT02374905|alcohol counselling|alcohol counselling
195067|NCT02374892|Intervention|intervention
195068|NCT02374892|Congenital Heart Disease|congenital heart disease
195069|NCT02374892|Adolescent|adolescent
195070|NCT02374892|Education|education
195071|NCT02374892|Self-management|self-management
195072|NCT02374866|Obesity|obesity
195073|NCT02374866|Morbid Obesity|morbid obesity
195074|NCT02374866|Therapeutic education|therapeutic education
195075|NCT02374840|Pharmacogenomics|pharmacogenomics
195076|NCT02374840|Adverse Drug Reactions|adverse drug reactions
195077|NCT02374840|Pharmacogenetics|pharmacogenetics
195078|NCT02374827|complete salpingectomy|complete salpingectomy
195079|NCT02374827|standard tubal ligation|standard tubal ligation
195080|NCT02374827|cesarean delivery|cesarean delivery
195081|NCT02374827|feasibility|feasibility
195082|NCT02374827|safety|safety
195083|NCT02374827|partial salpingectomy|partial salpingectomy
195084|NCT02374801|CRT-D device|crt-d device
195085|NCT02374801|Severe HF (NYHA Class III or ambulatory IV)|severe hf (nyha class iii or ambulatory iv)
195086|NCT02374801|Stable, optimal drug regimen|stable, optimal drug regimen
195087|NCT02374801|Sinus rhythm|sinus rhythm
195088|NCT02374801|Heart Failure|heart failure
195089|NCT02374775|axial plaque stress|axial plaque stress
195090|NCT02374775|pressure|pressure
195091|NCT02374775|pressure gradient|pressure gradient
195092|NCT02374775|coronary plaque|coronary plaque
195093|NCT02374775|plaque rupture|plaque rupture
195094|NCT02374775|acute coronary syndrome|acute coronary syndrome
195095|NCT02374775|acute myocardial infarction|acute myocardial infarction
195096|NCT02374775|computational fluid dynamics|computational fluid dynamics
195097|NCT02374775|coronary computed tomography angiography|coronary computed tomography angiography
195098|NCT02374775|wall shear stress|wall shear stress
195099|NCT02374762|Arteriovenous Fistula|arteriovenous fistula
195100|NCT02374762|Hemodialysis|hemodialysis
195101|NCT02374762|Vascular Access|vascular access
195102|NCT02374749|Axial Spondyloarthritis|axial spondyloarthritis
195103|NCT02374749|Education|education
195104|NCT02374749|Co-morbidities|co-morbidities
195105|NCT02374749|Nurse|nurse
195106|NCT02374736|recipients|recipients
195107|NCT02374736|Subclinical Antibody-mediated rejection (ABMR)|subclinical antibody-mediated rejection (abmr)
195108|NCT02374736|Intravenous immunoglobulins (IVIg)|intravenous immunoglobulins (ivig)
195109|NCT02374736|Donor-specific antibodies (DSA)|donor-specific antibodies (dsa)
195110|NCT02374723|improve|improve
195111|NCT02374723|vision|vision
195112|NCT02374697|Second opinion|second opinion
195113|NCT02374684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
195114|NCT02374671|Near Vision|near vision
195115|NCT02374671|Reading Vision|reading vision
195116|NCT02374671|Reading Glasses|reading glasses
195117|NCT02374671|Reading|reading
195118|NCT02374671|Readers|readers
195119|NCT02374671|Presbyopic|presbyopic
195120|NCT02374619|eccentric exercise|eccentric exercise
195121|NCT02374619|pro-oxidants|pro-oxidants
195122|NCT02374619|free radicals|free radicals
195123|NCT02374619|adults|adults
195124|NCT02374619|children|children
195125|NCT02374606|outcomes measures|outcomes measures
195126|NCT02374606|strength measurement|strength measurement
195127|NCT02374606|disease progression|disease progression
195128|NCT02374567|geriatric psychiatry|geriatric psychiatry
195129|NCT02374567|pharmacovigilance|pharmacovigilance
195130|NCT02374554|Respiratory Rate|respiratory rate
195131|NCT02374554|Structured Light Plethysmography|structured light plethysmography
195132|NCT02374554|Capnography|capnography
195133|NCT02374541|Patient Navigation|patient navigation
195134|NCT02374541|Health Disparities|health disparities
195135|NCT02374541|Coordination of Services|coordination of services
195136|NCT02374541|Early Intervention (Education)|early intervention (education)
195137|NCT02374541|Health Services Accessibility|health services accessibility
195138|NCT02374541|Patient Advocacy|patient advocacy
195139|NCT02374528|Negative pressure wound therapy|negative pressure wound therapy
195140|NCT02374528|wound|wound
195141|NCT02374528|split-thickness skin grafting|split-thickness skin grafting
195142|NCT02374502|Spondylarthropathies|spondylarthropathies
195143|NCT02374502|Motor Activity|motor activity
195144|NCT02374502|Physical Therapists|physical therapists
195145|NCT02374502|Accelerometry|accelerometry
195146|NCT02374476|VT|vt
195147|NCT02374476|Refractory VT|refractory vt
195148|NCT02374476|VT Storm|vt storm
195149|NCT02374476|Ventricular Fibrillation|ventricular fibrillation
195150|NCT02374476|V Fib|v fib
195151|NCT02374476|VF|vf
195152|NCT02374463|Balance|balance
195153|NCT02374463|Fall Risk|fall risk
195154|NCT02374463|Older Adults|older adults
195155|NCT02374463|Tai Chi|tai chi
195156|NCT02374463|Multimodal Balance Intervention|multimodal balance intervention
195157|NCT02374450|Malaria|malaria
195158|NCT02374450|Surveillance study|surveillance study
195159|NCT02374450|Adverse Events of Specific Interest (AESI)|adverse events of specific interest (aesi)
195160|NCT02374450|Children|children
195161|NCT02374450|Infants|infants
195162|NCT02374450|Adverse events (AE) leading to hospitalisation or death|adverse events (ae) leading to hospitalisation or death
195163|NCT02374450|Meningitis|meningitis
195164|NCT02374450|Epidemiology|epidemiology
195165|NCT02374450|Africa|africa
195166|NCT02374398|Tranexamic Acid|tranexamic acid
195167|NCT02374398|Blood Loss|blood loss
195168|NCT02374398|Aquamantys System|aquamantys system
195169|NCT02374398|TKA|tka
195170|NCT02374372|hemodialysis|hemodialysis
195171|NCT02374372|beta microglobulin|beta microglobulin
195172|NCT02374372|amyloidosis|amyloidosis
195173|NCT02374307|Falls|falls
195174|NCT02374307|home-care services|home-care services
195175|NCT02374307|older people|older people
195176|NCT02374307|falls-prevention|falls-prevention
195177|NCT02374281|Newborn|newborn
195178|NCT02374281|Neonatal Screening|neonatal screening
195179|NCT02374281|Autonomic Nervous System|autonomic nervous system
195180|NCT02374281|Pain|pain
195181|NCT02374281|non-nutritive sucking|non-nutritive sucking
195182|NCT02374281|sucrose administration|sucrose administration
195183|NCT02374281|nociceptive action|nociceptive action
195184|NCT02374281|Electro acoustical characteristics of crying|electro acoustical characteristics of crying
195185|NCT02374255|Advanced cancer|advanced cancer
195186|NCT02374255|goals of care|goals of care
195187|NCT02374255|quality of care|quality of care
195188|NCT02374255|end of life discussions|end of life discussions
195189|NCT02374242|Brain|brain
195190|NCT02374242|Metastases|metastases
195191|NCT02374242|Immunotherapy|immunotherapy
195192|NCT02374242|Intracranial response|intracranial response
195193|NCT02374242|Nivolumab|nivolumab
195194|NCT02374242|Ipilimumab|ipilimumab
195195|NCT02374242|Biomarkers|biomarkers
195196|NCT02374242|Immune related response criteria|immune related response criteria
195197|NCT02374229|pulmonary hypertension|pulmonary hypertension
195198|NCT02374229|pulmonary artery denervation|pulmonary artery denervation
195199|NCT02374229|mitral valve disease|mitral valve disease
195200|NCT02374216|Dental Implants|dental implants
195201|NCT02374216|Periodontal Bone Loss|periodontal bone loss
195202|NCT02374216|Implant-Supported Dental Prosthesis|implant-supported dental prosthesis
195203|NCT02374216|Dental Prosthesis Failure|dental prosthesis failure
195204|NCT02374203|Critical Illness|critical illness
195205|NCT02374203|Mechanical ventilator|mechanical ventilator
195206|NCT02374203|Indirect Calorimetry|indirect calorimetry
195207|NCT02374164|Drug therapy|drug therapy
195208|NCT02374151|intrauterine pressure catheter|intrauterine pressure catheter
195209|NCT02374151|electrohysterography|electrohysterography
195210|NCT02374138|psychosocial stress|psychosocial stress
195211|NCT02374099|Breast Cancer|breast cancer
195212|NCT02374099|Her2 -|her2 -
195213|NCT02374099|ER+|er+
195214|NCT02374099|CC-486 (ORAL AZACITIDINE)|cc-486 (oral azacitidine)
195215|NCT02374099|Metastatic Breast Cancer|metastatic breast cancer
195216|NCT02374099|Oralazacitidine|oralazacitidine
195217|NCT02374099|Fulvestrant|fulvestrant
195218|NCT02374099|Epigenetics|epigenetics
195219|NCT02374021|rheumatoid arthritis|rheumatoid arthritis
195220|NCT02374008|Peripheral nerve block|peripheral nerve block
195221|NCT02374008|Total knee Arthroplasty|total knee arthroplasty
195222|NCT02374008|Dexamethasone|dexamethasone
195223|NCT02373995|Graves|graves
195224|NCT02373995|Orbithopaty|orbithopaty
195225|NCT02373995|euthyroidism|euthyroidism
195226|NCT02373995|microbiome|microbiome
195227|NCT02373943|vitamin A|vitamin a
195228|NCT02373943|human|human
195229|NCT02373943|bioavailability|bioavailability
195230|NCT02373943|fortified maize|fortified maize
195231|NCT02373943|cross-over|cross-over
195232|NCT02373943|beta-carotene|beta-carotene
195233|NCT02373930|Dolutegravir|dolutegravir
195234|NCT02373930|safety|safety
195235|NCT02373930|Rilpivirine|rilpivirine
195236|NCT02373930|fixed dose combination|fixed dose combination
195237|NCT02373930|relative bioavailability|relative bioavailability
195238|NCT02373865|Diabetes mellitus type 2|diabetes mellitus type 2
195239|NCT02373865|nocturnal hypoglycemia|nocturnal hypoglycemia
195240|NCT02373865|metformin monotherapy|metformin monotherapy
195241|NCT02373800|Induced|induced
195242|NCT02373800|pre-term labor|pre-term labor
195243|NCT02373787|Resorbable|resorbable
195244|NCT02373787|Collagen membrane|collagen membrane
195245|NCT02373787|NobelReplace CC|nobelreplace cc
195246|NCT02373774|infant|infant
195247|NCT02373774|lumbar puncture|lumbar puncture
195248|NCT02373774|patient safety|patient safety
195249|NCT02373774|ultrasound|ultrasound
195250|NCT02373735|stroke volume variation|stroke volume variation
195251|NCT02373735|radical cystectomy|radical cystectomy
195252|NCT02373735|blood loss|blood loss
195253|NCT02373735|postoperative complications|postoperative complications
195254|NCT02373696|Pain|pain
195255|NCT02373696|Caesarean section|caesarean section
195256|NCT02373670|Positive deviance|positive deviance
195257|NCT02373670|Peer mentors|peer mentors
195258|NCT02373657|trachoma|trachoma
195259|NCT02373657|soil transmitted helminths|soil transmitted helminths
195260|NCT02373657|water|water
195261|NCT02373657|hand washing|hand washing
195262|NCT02373592|Diabetic Neuropathies|diabetic neuropathies
195263|NCT02373592|Thermometry|thermometry
195264|NCT02373592|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
195265|NCT02373592|Foot Ulcer|foot ulcer
195266|NCT02373592|Telemedicine|telemedicine
195267|NCT02373579|omega-3 fatty acids|omega-3 fatty acids
195268|NCT02373579|methotrexate|methotrexate
195269|NCT02373579|hepatotoxicity|hepatotoxicity
195270|NCT02373566|burns|burns
195271|NCT02373566|dermal substitute|dermal substitute
195272|NCT02373566|scar quality|scar quality
195273|NCT02373566|reconstruction|reconstruction
195274|NCT02373566|wound healing|wound healing
195275|NCT02373566|wound closure|wound closure
195276|NCT02373553|posture|posture
195277|NCT02373553|postural|postural
195278|NCT02373553|kinetics|kinetics
195279|NCT02373540|spinal cord stimulation|spinal cord stimulation
195280|NCT02373540|chronic pain|chronic pain
195281|NCT02373540|failed back surgery syndrome|failed back surgery syndrome
195282|NCT02373501|caesarean delivery|caesarean delivery
195283|NCT02373501|uterine incision repair|uterine incision repair
195284|NCT02373488|Constipation|constipation
195285|NCT02373488|connective tissue manipulation|connective tissue manipulation
195286|NCT02373488|abdominal massage|abdominal massage
195287|NCT02373488|bowel movements|bowel movements
195288|NCT02373488|quality of life|quality of life
195289|NCT02373475|spine surgery|spine surgery
195290|NCT02373475|prone position|prone position
195291|NCT02373475|intraoperative lung protective strategies|intraoperative lung protective strategies
195686|NCT02371252|Alendronate|alendronate
195292|NCT02373475|postoperative pulmonary complications|postoperative pulmonary complications
195293|NCT02373449|Ketamine|ketamine
195294|NCT02373449|fMRI|fmri
195295|NCT02373449|refractory neuropathic pain|refractory neuropathic pain
195296|NCT02373436|Upper Extremity|upper extremity
195297|NCT02373436|Rehabilitation|rehabilitation
195298|NCT02373397|Wound healing|wound healing
195299|NCT02373397|nerve regeneration|nerve regeneration
195300|NCT02373397|re-epithelialization|re-epithelialization
195301|NCT02373397|corneal epithelium|corneal epithelium
195302|NCT02373397|laser corneal surgery|laser corneal surgery
195303|NCT02373384|Radiolucent renal stones|radiolucent renal stones
195304|NCT02373384|Oral dissolution therapy|oral dissolution therapy
195305|NCT02373384|Systemic chemolysis|systemic chemolysis
195306|NCT02373384|Renal uric acid stones|renal uric acid stones
195307|NCT02373384|Alkalinization|alkalinization
195308|NCT02373358|Complex trauma|complex trauma
195309|NCT02373358|Yoga|yoga
195310|NCT02373345|psychological factors|psychological factors
195311|NCT02373345|functional disability|functional disability
195312|NCT02373345|pain thresholds|pain thresholds
195313|NCT02373345|tolerance thresholds|tolerance thresholds
195314|NCT02373345|motor adaptations|motor adaptations
195315|NCT02373345|natural course|natural course
195316|NCT02373332|platelets|platelets
195317|NCT02373332|12-lipoxygenase|12-lipoxygenase
195318|NCT02373332|fatty acids|fatty acids
195319|NCT02373332|DGLA|dgla
195320|NCT02373332|DHA|dha
195321|NCT02373332|EPA|epa
195322|NCT02373332|12-LOX|12-lox
195323|NCT02373319|Cardiovascular risk|cardiovascular risk
195324|NCT02373319|Cholesterol|cholesterol
195325|NCT02373319|Hypertension|hypertension
195326|NCT02373319|Diabetes|diabetes
195327|NCT02373319|Smoking|smoking
195328|NCT02373319|Preventive Medicine|preventive medicine
195329|NCT02373319|Epidemiology|epidemiology
195330|NCT02373319|Public Health|public health
195331|NCT02373319|Diet|diet
195332|NCT02373319|Physical Activity|physical activity
195333|NCT02373306|Risk stratification|risk stratification
195334|NCT02373306|ICD intervention|icd intervention
195335|NCT02373306|occurrence during one-year follow-up after NIPS|occurrence during one-year follow-up after nips
195336|NCT02373293|Acute pancreatitis|acute pancreatitis
195337|NCT02373280|Helicobacter pylori|helicobacter pylori
195338|NCT02373280|tailored therapy|tailored therapy
195339|NCT02373280|eradication|eradication
195340|NCT02373241|Anemia, Sickle Cell|anemia, sickle cell
195341|NCT02373241|Sickle Cell Disease|sickle cell disease
195342|NCT02373241|Kidney Disease|kidney disease
195343|NCT02373241|Hypertension|hypertension
195344|NCT02373241|Proteinuria|proteinuria
195345|NCT02373241|Losartan|losartan
195346|NCT02373241|Antihypertensive Agents|antihypertensive agents
195347|NCT02373241|Blood Pressure|blood pressure
195348|NCT02373111|Anti-aging|anti-aging
195349|NCT02373111|Isoflavones|isoflavones
195350|NCT02373111|Astaxanthine|astaxanthine
195351|NCT02373111|Skin aging|skin aging
195352|NCT02373098|Fingolimod,cytokine,chemokine,RRMS|fingolimod,cytokine,chemokine,rrms
195353|NCT02373085|Asymptomatic Bacteriuria|asymptomatic bacteriuria
195354|NCT02373085|Kidney transplant recipients|kidney transplant recipients
195355|NCT02373085|Pyelonephritis|pyelonephritis
195356|NCT02373072|Pakinson's Disease, Movement Disorders|pakinson's disease, movement disorders
195357|NCT02373033|Folate|folate
195358|NCT02373033|folic acid|folic acid
195359|NCT02373033|intervention trial|intervention trial
195360|NCT02373033|folate status|folate status
195361|NCT02373033|women in childbearing age|women in childbearing age
195362|NCT02373033|food folate|food folate
195363|NCT02372994|chronic disease|chronic disease
195364|NCT02372994|continuity of patient care|continuity of patient care
195365|NCT02372994|patient engagement|patient engagement
195366|NCT02372994|cost effectiveness analysis|cost effectiveness analysis
195367|NCT02372994|user-centred design|user-centred design
195368|NCT02372994|Interdisciplinary Health Team|interdisciplinary health team
195369|NCT02372994|Medical Informatics|medical informatics
195370|NCT02372994|Patient-centred care|patient-centred care
195371|NCT02372942|efficacy|efficacy
195372|NCT02372942|prevention|prevention
195373|NCT02372890|Otorhinolaryngeal Neoplasms|otorhinolaryngeal neoplasms
195374|NCT02372890|Cancer of Head and Neck|cancer of head and neck
195375|NCT02372890|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
195376|NCT02372890|Positron Emission Tomography|positron emission tomography
195377|NCT02372890|PET/CT|pet/ct
195378|NCT02372890|FDG|fdg
195379|NCT02372877|Sickle Cell Disease|sickle cell disease
195380|NCT02372877|Hemoglobin (Hb) S Disease|hemoglobin (hb) s disease
195381|NCT02372877|Hb S Disease|hb s disease
195382|NCT02372877|Congenital Hemolytic Anemia|congenital hemolytic anemia
195383|NCT02372864|Ovariectomy|ovariectomy
195384|NCT02372864|Mindfulness|mindfulness
195385|NCT02372864|Postmenopause|postmenopause
195386|NCT02372864|Hot Flashes|hot flashes
195387|NCT02372851|Arsenic|arsenic
195388|NCT02372851|Household water treatment|household water treatment
195389|NCT02372851|Point of use water treatment|point of use water treatment
195390|NCT02372851|Water Quality|water quality
196292|NCT02367690|Selinexor|selinexor
195391|NCT02372851|Total Urinary Arsenic|total urinary arsenic
195392|NCT02372851|West Bengal|west bengal
195393|NCT02372851|Thermotolerant coliforms|thermotolerant coliforms
195394|NCT02372851|Compliance|compliance
195395|NCT02372851|Diarrhoea|diarrhoea
195396|NCT02372825|Free iliac crest transfer|free iliac crest transfer
195397|NCT02372825|Bone reconstruction|bone reconstruction
195398|NCT02372825|Ankle reconstruction|ankle reconstruction
195399|NCT02372825|Heel reconstruction|heel reconstruction
195400|NCT02372812|effect of dexamethasone|effect of dexamethasone
195401|NCT02372812|general surgery|general surgery
195402|NCT02372812|post operative|post operative
195403|NCT02372786|7% lidocaine / 7% tetracaine cream|7% lidocaine / 7% tetracaine cream
195404|NCT02372786|2,5% lidocaine / 2,5% prilocaine cream|2,5% lidocaine / 2,5% prilocaine cream
195405|NCT02372773|Frontotemporal Dementia|frontotemporal dementia
195406|NCT02372773|MAPT|mapt
195407|NCT02372773|PGRN|pgrn
195408|NCT02372773|C9ORF72|c9orf72
195409|NCT02372760|Bronchoscopic anesthesia lidocaine|bronchoscopic anesthesia lidocaine
195410|NCT02372760|Spray Catheter|spray catheter
195411|NCT02372760|brochoalveolar lavage|brochoalveolar lavage
195412|NCT02372747|Totally laparoscopic gastrectomy|totally laparoscopic gastrectomy
195413|NCT02372747|laparoscopic distal gastrectomy|laparoscopic distal gastrectomy
195414|NCT02372747|Intracorporeal anastomosis|intracorporeal anastomosis
195415|NCT02372747|Delta-Shaped Anastomosis|delta-shaped anastomosis
195416|NCT02372747|Billroth II Anastomosis|billroth ii anastomosis
195417|NCT02372747|Gastric cancer|gastric cancer
195418|NCT02372721|acute kidney injury|acute kidney injury
195419|NCT02372656|Simvastatin, Metformin, Chronic periodontitis|simvastatin, metformin, chronic periodontitis
195420|NCT02372643|clitoris|clitoris
195421|NCT02372643|sexuality|sexuality
195422|NCT02372643|vascularization|vascularization
195423|NCT02372643|doppler|doppler
195424|NCT02372643|ultrasound|ultrasound
195425|NCT02372643|reference|reference
195426|NCT02372643|female|female
195427|NCT02372643|Pilot Projects|pilot projects
195428|NCT02372643|Vagina/ultrasonography|vagina/ultrasonography
195429|NCT02372643|Urethra/ultrasonography|urethra/ultrasonography
195430|NCT02372643|Regional Blood Flow/physiology|regional blood flow/physiology
195431|NCT02372643|Arteries/ultrasonography|arteries/ultrasonography
195432|NCT02372643|Clitoris/ultrasonography|clitoris/ultrasonography
195433|NCT02372643|Reference values|reference values
195434|NCT02372643|Clitoris/blood supply|clitoris/blood supply
195435|NCT02372617|cerebral palsy|cerebral palsy
195436|NCT02372617|hip|hip
195437|NCT02372617|luxation|luxation
195438|NCT02372617|subluxation|subluxation
195439|NCT02372604|Chronic spontaneous urticaria|chronic spontaneous urticaria
195440|NCT02372604|Levocetirizine|levocetirizine
195441|NCT02372604|H1-antihistamine|h1-antihistamine
195442|NCT02372604|Fourfold dosage|fourfold dosage
195443|NCT02372604|Efficacy|efficacy
195444|NCT02372604|Tolerance|tolerance
195445|NCT02372604|UAS7 (Urticaria activity score)|uas7 (urticaria activity score)
195446|NCT02372604|resistant|resistant
195447|NCT02372591|Quantitative Sensory Testing|quantitative sensory testing
195448|NCT02372591|Hydromorphone|hydromorphone
195449|NCT02372591|Buprenorphine|buprenorphine
195450|NCT02372578|Painful diabetic peripheral neuropathy (PDPN)|painful diabetic peripheral neuropathy (pdpn)
195451|NCT02372578|ASP3662|asp3662
195452|NCT02372565|African American|african american
195453|NCT02372565|Women|women
195454|NCT02372565|Physical Activity|physical activity
195455|NCT02372565|Social Media|social media
195456|NCT02372565|Exercise|exercise
195457|NCT02372565|Facebook|facebook
195458|NCT02372565|Text message|text message
195459|NCT02372539|dexamethasone|dexamethasone
195460|NCT02372526|Glucagon-like Peptide-1|glucagon-like peptide-1
195461|NCT02372526|Glucose-dependent insulinotropic peptide|glucose-dependent insulinotropic peptide
195462|NCT02372526|Glucagon|glucagon
195463|NCT02372526|Peptide YY 3-36|peptide yy 3-36
195464|NCT02372526|Ghrelin|ghrelin
195465|NCT02372526|Body Weight|body weight
195466|NCT02372526|Obesity|obesity
195467|NCT02372526|Overnutrition|overnutrition
195468|NCT02372526|Overweight|overweight
195469|NCT02372526|Gastrointestinal Agents|gastrointestinal agents
195470|NCT02372526|GLP-1 secretagogue|glp-1 secretagogue
195471|NCT02372513|Cholesteryl Ester Storage Disease|cholesteryl ester storage disease
195472|NCT02372513|Children|children
195473|NCT02372513|Liver disease|liver disease
195474|NCT02372474|POF|pof
195475|NCT02372474|ESS|ess
195476|NCT02372474|stem cell therapy|stem cell therapy
195477|NCT02372461|Amoxicillin|amoxicillin
195478|NCT02372461|Placebo|placebo
195479|NCT02372435|PJI|pji
195480|NCT02372422|Twins|twins
195481|NCT02372422|Twin gestation|twin gestation
195482|NCT02372422|Preterm birth|preterm birth
195483|NCT02372422|Prevention|prevention
195484|NCT02372396|PTSD|ptsd
195485|NCT02372396|Psychotherapy|psychotherapy
195486|NCT02372396|OEF/OIF|oef/oif
195487|NCT02372396|Veterans|veterans
195488|NCT02372383|Cystic Fibrosis|cystic fibrosis
195489|NCT02372383|Pharmacokinetics|pharmacokinetics
195490|NCT02372383|Pharmacodynamics|pharmacodynamics
196293|NCT02367690|Karyopharm|karyopharm
195491|NCT02372383|Nontuberculous Mycobacteria|nontuberculous mycobacteria
195492|NCT02372383|Treatment|treatment
195493|NCT02372357|chemotherapy|chemotherapy
195494|NCT02372357|stem cell transplantation|stem cell transplantation
195495|NCT02372344|the effect of food timing on PK|the effect of food timing on pk
195496|NCT02372344|the effect of food timing on Safety and Tolerability|the effect of food timing on safety and tolerability
195497|NCT02372344|AZD0585|azd0585
195498|NCT02372344|Japanese|japanese
195499|NCT02372331|pancreaticoduodenectomy|pancreaticoduodenectomy
195500|NCT02372331|ERAS|eras
195501|NCT02372331|Whipple's operation|whipple's operation
195502|NCT02372331|Fast track|fast track
195503|NCT02372318|opiod receptor modulator nalmefene|opiod receptor modulator nalmefene
195504|NCT02372318|cue-reactivity|cue-reactivity
195505|NCT02372318|fMRI|fmri
195506|NCT02372318|resting-state networks|resting-state networks
195507|NCT02372292|cardiorenal syndrome, decompensated heart failure, renal resistivity index, venous impedance index, kidney failure|cardiorenal syndrome, decompensated heart failure, renal resistivity index, venous impedance index, kidney failure
195508|NCT02372279|Embryo development|embryo development
195509|NCT02372279|Implantation|implantation
195510|NCT02372279|In vitro fertilization|in vitro fertilization
195511|NCT02372266|Infant, Newborn|infant, newborn
195512|NCT02372266|hospital discharge|hospital discharge
195513|NCT02372266|Early newborn discharge|early newborn discharge
195514|NCT02372266|Newborn length of stay|newborn length of stay
195515|NCT02372266|Maternity length of stay|maternity length of stay
195516|NCT02372253|verapamil|verapamil
195517|NCT02372253|type 1 diabetes|type 1 diabetes
195518|NCT02372253|diabetes|diabetes
195519|NCT02372253|beta cells|beta cells
195520|NCT02372253|beta cell function|beta cell function
195521|NCT02372253|insulin|insulin
195522|NCT02372214|Endovascular Procedures|endovascular procedures
195523|NCT02372214|3D printing|3d printing
195524|NCT02372214|Simulation|simulation
195525|NCT02372214|Training|training
195526|NCT02372214|Learning curve|learning curve
195527|NCT02372214|Education|education
195528|NCT02372201|irritable bowel disease|irritable bowel disease
195529|NCT02372201|microbiota|microbiota
195530|NCT02372201|hydro colon therapy|hydro colon therapy
195531|NCT02372201|food intolerance|food intolerance
195532|NCT02372175|Dengue|dengue
195533|NCT02372162|Hepatocellular Carcinoma|hepatocellular carcinoma
195534|NCT02372162|Molecular Diagnostics|molecular diagnostics
195535|NCT02372162|Sorafenib|sorafenib
195536|NCT02372162|Therapeutic chemoembolization|therapeutic chemoembolization
195537|NCT02372162|Next-generation sequencing|next-generation sequencing
195538|NCT02372162|Sequence analysis, DNA|sequence analysis, dna
195539|NCT02372162|Sequence analysis, RNA|sequence analysis, rna
195540|NCT02372162|Metabolomics|metabolomics
195541|NCT02372123|Dysmenorrhea|dysmenorrhea
195542|NCT02372123|Primary dysmenorrhea|primary dysmenorrhea
195543|NCT02372123|physiotherapy|physiotherapy
195544|NCT02372123|massage|massage
195545|NCT02372123|connective tissue massage|connective tissue massage
195546|NCT02372123|connective tissue manipulation|connective tissue manipulation
195547|NCT02372084|Hepatic impairment,|hepatic impairment,
195548|NCT02372084|osilodrostat,|osilodrostat,
195549|NCT02372084|LCI699|lci699
195550|NCT02372032|Herniation|herniation
195551|NCT02372032|Discectomy|discectomy
195552|NCT02372032|Ozone|ozone
195553|NCT02372019|Social Anxiety Disorder|social anxiety disorder
195554|NCT02372019|Social Phobia|social phobia
195555|NCT02372019|Reconsolidation|reconsolidation
195556|NCT02372019|Cognitive Bias Modification|cognitive bias modification
195557|NCT02372019|Interpretation Bias|interpretation bias
195558|NCT02371980|Drug therapy|drug therapy
195559|NCT02371928|Shoulder|shoulder
195560|NCT02371928|Instability|instability
195561|NCT02371928|Neuromuscular|neuromuscular
195562|NCT02371928|Physiotherapy|physiotherapy
195563|NCT02371928|Exercise|exercise
195564|NCT02371928|Dislocation|dislocation
195565|NCT02371928|Recurrence|recurrence
195566|NCT02371915|Rural access|rural access
195567|NCT02371915|Telehealth|telehealth
195568|NCT02371902|Elbow pain|elbow pain
195569|NCT02371902|lateral epicondylitis|lateral epicondylitis
195570|NCT02371902|conservative treatment|conservative treatment
195571|NCT02371902|shock wave treatment|shock wave treatment
195572|NCT02371902|therapeutic ultrasound|therapeutic ultrasound
195573|NCT02371850|Bioequivalence|bioequivalence
195574|NCT02371850|Therapeutic Equivalency|therapeutic equivalency
195575|NCT02371824|Magnetic Resonance Imaging|magnetic resonance imaging
195576|NCT02371824|Bone Marrow|bone marrow
195577|NCT02371824|Hip|hip
195578|NCT02371824|Lumbar Vertebrae|lumbar vertebrae
195579|NCT02371785|Peripheral Arterial Disease|peripheral arterial disease
195580|NCT02371785|Critical Limb Ischemia|critical limb ischemia
195581|NCT02371785|Claudication|claudication
195582|NCT02371785|Percutaneous Vascular Intervention|percutaneous vascular intervention
195583|NCT02371785|Peripheral Vascular Intervention|peripheral vascular intervention
195584|NCT02371772|Warfarin|warfarin
195585|NCT02371772|Self Care|self care
195586|NCT02371772|Conventional care|conventional care
195587|NCT02371733|pulmonary arterial hypertension|pulmonary arterial hypertension
195588|NCT02371733|aerobic exercise training|aerobic exercise training
195589|NCT02371733|upper extremity|upper extremity
195590|NCT02371733|exercise capacity|exercise capacity
195591|NCT02371694|Lipid|lipid
195592|NCT02371694|Carbohydrate counting|carbohydrate counting
195593|NCT02371694|Adolescent|adolescent
195594|NCT02371694|Continuous glucose monitoring|continuous glucose monitoring
195595|NCT02371694|Insulin requirements|insulin requirements
195596|NCT02371681|HR2E/RIPE|hr2e/ripe
195597|NCT02371681|South Africa|south africa
195598|NCT02371681|Time to Positivity/TTP|time to positivity/ttp
195599|NCT02371681|FDG-PET/CT|fdg-pet/ct
195600|NCT02371668|Influenza A|influenza a
195601|NCT02371668|H1N1|h1n1
195602|NCT02371668|Challenge Model|challenge model
195603|NCT02371668|Human Immunoglobulin and H1N1|human immunoglobulin and h1n1
195604|NCT02371668|Efficacy and Safety in H1N1|efficacy and safety in h1n1
195605|NCT02371655|Bowel cleansing|bowel cleansing
195606|NCT02371655|CTcolonography|ctcolonography
195607|NCT02371655|Bowel preparation|bowel preparation
195608|NCT02371655|Faecal and fluid tagging|faecal and fluid tagging
195609|NCT02371642|Echocardiography|echocardiography
195610|NCT02371629|Anticholinergic|anticholinergic
195611|NCT02371629|Antimuscarinic|antimuscarinic
195612|NCT02371629|Chronic Obstructive Airway Disease|chronic obstructive airway disease
195613|NCT02371629|Chronic Obstructive Lung Disease|chronic obstructive lung disease
195614|NCT02371629|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
195615|NCT02371629|COPD|copd
195616|NCT02371629|LAMA|lama
195617|NCT02371629|Lung Disease|lung disease
195618|NCT02371629|Lung Diseases, Obstructive|lung diseases, obstructive
195619|NCT02371629|Lung Function|lung function
195620|NCT02371629|Muscarinic receptor antagonist|muscarinic receptor antagonist
195621|NCT02371629|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
195622|NCT02371629|Respiratory Tract Diseases|respiratory tract diseases
195623|NCT02371603|Prolyl hydroxylase inhibitor|prolyl hydroxylase inhibitor
195624|NCT02371603|GSK1278863|gsk1278863
195625|NCT02371603|Anemia|anemia
195626|NCT02371603|Drug interaction|drug interaction
195627|NCT02371590|cancer|cancer
195628|NCT02371590|lenalidomide|lenalidomide
195629|NCT02371590|obinutuzumab|obinutuzumab
195630|NCT02371590|CLL|cll
195631|NCT02371577|Revlimid|revlimid
195632|NCT02371551|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
195633|NCT02371551|Medical Sonography|medical sonography
195634|NCT02371551|Computed Tomography, X-Ray|computed tomography, x-ray
195635|NCT02371538|stem cell transplant|stem cell transplant
195636|NCT02371538|human breastmilk|human breastmilk
195637|NCT02371525|adherence|adherence
195638|NCT02371525|prevention|prevention
195639|NCT02371512|Mitral Valve Insufficiency|mitral valve insufficiency
195640|NCT02371499|Irritable Bowel Syndrome|irritable bowel syndrome
195641|NCT02371499|Lactobacillus casei dg|lactobacillus casei dg
195642|NCT02371499|microbiota|microbiota
195643|NCT02371486|cesarean section defect|cesarean section defect
195644|NCT02371486|implantation|implantation
195645|NCT02371486|ivf|ivf
195646|NCT02371473|Acetazolamide|acetazolamide
195647|NCT02371473|Central Sleep Apnea|central sleep apnea
195648|NCT02371473|Opium Abuse|opium abuse
195649|NCT02371460|Neonatal Prematurity|neonatal prematurity
195650|NCT02371460|Omega-3 Fatty Acids|omega-3 fatty acids
195651|NCT02371460|Breastfeeding|breastfeeding
195652|NCT02371447|bladder cancer|bladder cancer
195653|NCT02371447|recurrent non-muscle invasive bladder cancer|recurrent non-muscle invasive bladder cancer
195654|NCT02371447|VPM1002BC|vpm1002bc
195655|NCT02371447|BCG therapy|bcg therapy
195656|NCT02371369|PLX3397|plx3397
195657|NCT02371369|Pexidartinib|pexidartinib
195658|NCT02371369|Colony Stimulating Factor 1 Receptor (CSF-1R) inhibitor|colony stimulating factor 1 receptor (csf-1r) inhibitor
195659|NCT02371330|Thrombocytopenia|thrombocytopenia
195660|NCT02371330|Neonate|neonate
195661|NCT02371330|PFA-100|pfa-100
195662|NCT02371330|Neo-BAT|neo-bat
195663|NCT02371330|Hemorrhage|hemorrhage
195664|NCT02371317|Randomized clinical trial|randomized clinical trial
195665|NCT02371317|Early medical intervention|early medical intervention
195666|NCT02371317|Intervention studies|intervention studies
195667|NCT02371317|Blood pressure|blood pressure
195668|NCT02371317|Stress Management|stress management
195669|NCT02371304|local therapy|local therapy
195670|NCT02371304|adjuvant chemoradiotherapy|adjuvant chemoradiotherapy
195671|NCT02371304|rectal preserving|rectal preserving
195672|NCT02371291|Memory Flexibility|memory flexibility
195673|NCT02371278|Leucine|leucine
195674|NCT02371278|Protein|protein
195675|NCT02371278|Diet|diet
195676|NCT02371278|Muscle protein synthesis|muscle protein synthesis
195677|NCT02371265|HIV|hiv
195678|NCT02371265|Mozambique|mozambique
195679|NCT02371265|antenatal care|antenatal care
195680|NCT02371265|adherence|adherence
195681|NCT02371265|retention|retention
195682|NCT02371265|pregnancy|pregnancy
195683|NCT02371265|HIV-positive mothers retained in ART after 90 days|hiv-positive mothers retained in art after 90 days
195684|NCT02371252|Osteoporosis|osteoporosis
195685|NCT02371252|Bisphosphonates|bisphosphonates
195687|NCT02371252|Bone mineral density|bone mineral density
195688|NCT02371252|Bone markers|bone markers
195689|NCT02371239|Glucose regulation|glucose regulation
195690|NCT02371239|Glucose|glucose
195691|NCT02371239|Lipids|lipids
195692|NCT02371226|MPS I|mps i
195693|NCT02371213|Social Networking|social networking
195694|NCT02371213|Mobile phone|mobile phone
195695|NCT02371213|Antenatal Care|antenatal care
195696|NCT02371213|Health education|health education
195697|NCT02371213|Maternal outcome|maternal outcome
195698|NCT02371213|Neonatal outcome|neonatal outcome
195699|NCT02371174|HER2-Negative Inoperable or Recurrent Breast Cancer|her2-negative inoperable or recurrent breast cancer
195700|NCT02371174|Japan|japan
195701|NCT02371174|Eribulin Mesylate|eribulin mesylate
195702|NCT02371135|Gut Microbiome|gut microbiome
195703|NCT02371135|15-016|15-016
195704|NCT02371083|Pelvic organ prolapse managed by vaginal pessary|pelvic organ prolapse managed by vaginal pessary
195705|NCT02370979|Dolutegravir|dolutegravir
195706|NCT02370979|Proviral HIV-1 DNA|proviral hiv-1 dna
195707|NCT02370979|Reservoir|reservoir
195708|NCT02370953|Toric IOL alignment|toric iol alignment
195709|NCT02370953|VERION digital marker|verion digital marker
195710|NCT02370953|Manual ink-marking|manual ink-marking
195711|NCT02370953|Randomized controlled trial|randomized controlled trial
195712|NCT02370940|Iron bioavailability|iron bioavailability
195713|NCT02370940|phytate|phytate
195714|NCT02370940|serum iron curve|serum iron curve
195715|NCT02370940|hepcidin|hepcidin
195716|NCT02370940|iron status|iron status
195717|NCT02370914|Concussion|concussion
195718|NCT02370888|Lenalidomide|lenalidomide
195719|NCT02370888|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
195720|NCT02370888|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
195721|NCT02370862|Spinal Cord Injury|spinal cord injury
195722|NCT02370862|Neurogenic Bowel|neurogenic bowel
195723|NCT02370862|Bowel Evacuation|bowel evacuation
195724|NCT02370862|Gut Motility|gut motility
195725|NCT02370849|nimotuzumab|nimotuzumab
195726|NCT02370849|gastric adenocarcinoma|gastric adenocarcinoma
195727|NCT02370849|Cisplatin|cisplatin
195728|NCT02370849|S-1|s-1
195729|NCT02370849|epidermal growth factor receptor|epidermal growth factor receptor
195730|NCT02370836|distress|distress
195731|NCT02370823|Osteoarthritis|osteoarthritis
195732|NCT02370823|Knee|knee
195733|NCT02370810|tinnitus treatment, internet-intervention, CBT|tinnitus treatment, internet-intervention, cbt
195734|NCT02370797|IOERT|ioert
195735|NCT02370797|Radiation|radiation
195736|NCT02370797|Single fraction|single fraction
195737|NCT02370797|Lumpectomy|lumpectomy
195738|NCT02370797|Radiation therapy|radiation therapy
195739|NCT02370797|Avera|avera
195740|NCT02370784|early diffuse scleroderma|early diffuse scleroderma
195741|NCT02370784|Raynaud|raynaud
195742|NCT02370758|Quantiferon-CMV|quantiferon-cmv
195743|NCT02370758|Quantiferon-Monitor|quantiferon-monitor
195744|NCT02370758|Solid Organ Transplants|solid organ transplants
195745|NCT02370758|CMV Disease|cmv disease
195746|NCT02370745|Incretin|incretin
195747|NCT02370745|GLP-1|glp-1
195748|NCT02370745|Skeletal muscle metabolism|skeletal muscle metabolism
195749|NCT02370745|Microvascular recruitment|microvascular recruitment
195750|NCT02370745|Amino Acids|amino acids
195751|NCT02370745|Microvascular blood flow|microvascular blood flow
195752|NCT02370732|Alcohol|alcohol
195753|NCT02370732|Bariatric Surgery|bariatric surgery
195754|NCT02370732|Roux en Y Gastric bypass|roux en y gastric bypass
195755|NCT02370732|Alcohol impairment|alcohol impairment
195756|NCT02370732|Alcohol reinforcement|alcohol reinforcement
195757|NCT02370732|Alcohol pharmacokinetics|alcohol pharmacokinetics
195758|NCT02370719|Diabetes mellitus|diabetes mellitus
195759|NCT02370719|Randomized controlled trial|randomized controlled trial
195760|NCT02370719|Primary care|primary care
195761|NCT02370719|Physical activity|physical activity
195762|NCT02370719|Lifestyle|lifestyle
195763|NCT02370719|Blood glucose|blood glucose
195764|NCT02370719|Mobile health|mobile health
195765|NCT02370719|Hb A1c|hb a1c
195766|NCT02370719|Self-management|self-management
195767|NCT02370706|PIM447|pim447
195768|NCT02370706|LGH447|lgh447
195769|NCT02370706|PIM inhibitor|pim inhibitor
195770|NCT02370706|LEE011|lee011
195771|NCT02370706|CDK 4/6 inhibitor|cdk 4/6 inhibitor
195772|NCT02370706|ruxolitinib|ruxolitinib
195773|NCT02370706|INC424|inc424
195774|NCT02370706|Jakavi®|jakavi®
195775|NCT02370706|Jakafi®|jakafi®
195776|NCT02370706|INCB18424|incb18424
195777|NCT02370706|JAK inhibitor|jak inhibitor
195778|NCT02370706|myelofibrosis|myelofibrosis
195779|NCT02370706|PMF|pmf
195780|NCT02370706|PPV-MF|ppv-mf
195781|NCT02370706|PET-MF|pet-mf
195782|NCT02370693|mycophenolate|mycophenolate
195783|NCT02370693|lung scarring|lung scarring
195784|NCT02370680|Antiplatelet|antiplatelet
195785|NCT02370680|Antiplatelet therapy|antiplatelet therapy
195786|NCT02370680|platelet turnover|platelet turnover
195787|NCT02370680|high platelet turnover|high platelet turnover
195788|NCT02370680|platelet aggregation|platelet aggregation
195789|NCT02370680|cardiovascular disease|cardiovascular disease
195790|NCT02370680|coronary artery disease|coronary artery disease
195791|NCT02370680|diabetes mellitus|diabetes mellitus
195792|NCT02370667|Exercise|exercise
195793|NCT02370667|Magnetic Resonance Imaging|magnetic resonance imaging
195794|NCT02370654|COPD|copd
195795|NCT02370654|Tai chi|tai chi
195796|NCT02370654|Pulmonary rehabilitation|pulmonary rehabilitation
195797|NCT02370641|urolithin A|urolithin a
195798|NCT02370641|microflora|microflora
195799|NCT02370628|percutaneous vertebroplasty|percutaneous vertebroplasty
195800|NCT02370628|facet block|facet block
195801|NCT02370602|Drug therapy|drug therapy
195802|NCT02370589|Ebola|ebola
195803|NCT02370537|omega-3 carboxylic acid|omega-3 carboxylic acid
195804|NCT02370498|Gastric cancer|gastric cancer
195805|NCT02370498|Gastroesophageal junction cancer|gastroesophageal junction cancer
195806|NCT02370498|PD1|pd1
195807|NCT02370498|PD-1|pd-1
195808|NCT02370498|PDL1|pdl1
195809|NCT02370498|PD-L1|pd-l1
195810|NCT02370472|Ultrasound|ultrasound
195811|NCT02370472|Image|image
195812|NCT02370472|Learning Tool|learning tool
195813|NCT02370472|Ultrasound Guide Procedures|ultrasound guide procedures
195814|NCT02370472|Simulated Setting|simulated setting
195815|NCT02370459|Papillomavirus Vaccines|papillomavirus vaccines
195816|NCT02370459|Immunization|immunization
195817|NCT02370459|Quality Improvement|quality improvement
195818|NCT02370459|Adolescent Health Services|adolescent health services
195819|NCT02370446|Medication Log|medication log
195820|NCT02370446|15-008|15-008
195821|NCT02370433|Spinal Cord Injury|spinal cord injury
195822|NCT02370433|Neurogenic Bowel|neurogenic bowel
195823|NCT02370433|Bowel Evacuation|bowel evacuation
195824|NCT02370420|Platelet-rich plasma|platelet-rich plasma
195825|NCT02370420|Osteoarthritis|osteoarthritis
195826|NCT02370407|surgical education|surgical education
195827|NCT02370407|minimally invasive surgical procedures|minimally invasive surgical procedures
195828|NCT02370407|laparoscopic simulation|laparoscopic simulation
195829|NCT02370407|robotic simulation|robotic simulation
195830|NCT02370407|medical education|medical education
195831|NCT02370394|Intimate Partner Violence|intimate partner violence
195832|NCT02370394|Perinatal Women|perinatal women
195833|NCT02370394|Mental Health|mental health
195834|NCT02370316|metacognition|metacognition
195835|NCT02370316|MRI|mri
195836|NCT02370316|Psychotherapy|psychotherapy
195837|NCT02370251|Fat Emulsions, Intravenous|fat emulsions, intravenous
195838|NCT02370251|Parenteral-Nutrition-Associated Liver Disease|parenteral-nutrition-associated liver disease
195839|NCT02370251|Cholestasis|cholestasis
195840|NCT02370251|Omegaven|omegaven
195841|NCT02370251|Fish Oil|fish oil
195842|NCT02370238|Triple negative metastatic breast cancer|triple negative metastatic breast cancer
195843|NCT02370238|Cancer Stem Cells|cancer stem cells
195844|NCT02370225|sjogren's syndrome|sjogren's syndrome
195845|NCT02370225|aerobic exercise|aerobic exercise
195846|NCT02370225|fatigue|fatigue
195847|NCT02370212|Creatine|creatine
195848|NCT02370212|interval training|interval training
195849|NCT02370212|effects on performance|effects on performance
195850|NCT02370173|PTSD|ptsd
195851|NCT02370173|Stress|stress
195852|NCT02370173|Sleep Problems|sleep problems
195853|NCT02370173|Brain imaging|brain imaging
195854|NCT02370173|fMRI|fmri
195855|NCT02370147|smoking reduction intervention|smoking reduction intervention
195856|NCT02370147|no intention to quit|no intention to quit
195857|NCT02370147|randomized controlled trial|randomized controlled trial
195858|NCT02370147|telephone follow-up intervention|telephone follow-up intervention
195859|NCT02370121|Gymnema Sylvestre|gymnema sylvestre
195860|NCT02370121|Insulin Secretion|insulin secretion
195861|NCT02370121|Insulin Sensitivity|insulin sensitivity
195862|NCT02370121|Central Obesity|central obesity
195863|NCT02370108|electrical muscle stimulation|electrical muscle stimulation
195864|NCT02370108|parkinson's disease|parkinson's disease
195865|NCT02370108|rest tremor|rest tremor
195866|NCT02370108|tremor reduction|tremor reduction
195867|NCT02370095|ARDS|ards
195868|NCT02370095|Acute Lung Injury|acute lung injury
195869|NCT02370095|Acute Respiratory Failure|acute respiratory failure
195870|NCT02370082|lumpectomy|lumpectomy
195871|NCT02370082|breast conserving surgery|breast conserving surgery
195872|NCT02370030|sepsis|sepsis
195873|NCT02370030|citrulline|citrulline
195874|NCT02370030|endothelial|endothelial
195875|NCT02370030|toxemia|toxemia
195876|NCT02370030|endothelial determination of progression|endothelial determination of progression
195877|NCT02370030|with vs without citrulline|with vs without citrulline
195878|NCT02370017|Autologous Ex vivo-expanded NK cell enriched lymphocytes|autologous ex vivo-expanded nk cell enriched lymphocytes
195879|NCT02370004|Asthma|asthma
195880|NCT02370004|RFST|rfst
195881|NCT02370004|Bronchial Diseases|bronchial diseases
195882|NCT02370004|Respiratory Tract Diseases|respiratory tract diseases
195883|NCT02370004|Lung Diseases, Obstructive|lung diseases, obstructive
195884|NCT02370004|Lung Diseases|lung diseases
195885|NCT02369991|latissimus dorsi flap|latissimus dorsi flap
195886|NCT02369991|bone transport|bone transport
196294|NCT02367677|Photo|photo
195887|NCT02369991|bone reconstruction|bone reconstruction
195888|NCT02369991|tibia|tibia
195889|NCT02369991|tibial fracture|tibial fracture
195890|NCT02369978|Trypanocidal therapy|trypanocidal therapy
195891|NCT02369978|Benznidazole|benznidazole
195892|NCT02369978|Nifurtimox|nifurtimox
195893|NCT02369978|Polymerase chain reaction|polymerase chain reaction
195894|NCT02369978|Randomized trial|randomized trial
195895|NCT02369965|HIV-1|hiv-1
195896|NCT02369965|AIDS|aids
195897|NCT02369965|Albuvirtide|albuvirtide
195898|NCT02369965|Treatment-experienced|treatment-experienced
195899|NCT02369965|Fusion inhibitor|fusion inhibitor
195900|NCT02369939|anal carcinoma|anal carcinoma
195901|NCT02369939|hyperthermia|hyperthermia
195902|NCT02369939|radiotherapy|radiotherapy
195903|NCT02369939|chemotherapy|chemotherapy
195904|NCT02369939|radiochemotherapy|radiochemotherapy
195905|NCT02369926|multiple sclerosis|multiple sclerosis
195906|NCT02369926|telemedicine|telemedicine
195907|NCT02369926|remote monitoring|remote monitoring
195908|NCT02369926|lisinopril|lisinopril
195909|NCT02369900|Esmolol|esmolol
195910|NCT02369900|Septic Shock|septic shock
195911|NCT02369900|Hypotension|hypotension
195912|NCT02369900|Tachycardia|tachycardia
195913|NCT02369887|MSM/TG who agree to start PrEP|msm/tg who agree to start prep
195914|NCT02369874|Head and Neck cancer; MEDI4736; Tremelimumab|head and neck cancer; medi4736; tremelimumab
195915|NCT02369822|Vitamin C|vitamin c
195916|NCT02369822|convulsions status|convulsions status
195917|NCT02369822|EEG|eeg
195918|NCT02369822|children|children
195919|NCT02369809|Ischemia|ischemia
195920|NCT02369796|Drug therapy|drug therapy
195921|NCT02369770|Acute Stroke|acute stroke
195922|NCT02369770|Robotic therapy|robotic therapy
195923|NCT02369770|Ankle impairment|ankle impairment
195924|NCT02369744|Ureteral calculus|ureteral calculus
195925|NCT02369744|Ureterolithiasis|ureterolithiasis
195926|NCT02369744|Ureteral stone|ureteral stone
195927|NCT02369744|Kidney stone|kidney stone
195928|NCT02369744|Medical expulsive therapy|medical expulsive therapy
195929|NCT02369744|tamsulosin|tamsulosin
195930|NCT02369744|silodosin|silodosin
195931|NCT02369744|rapaflo|rapaflo
195932|NCT02369744|flomax|flomax
195933|NCT02369679|upper limb|upper limb
195934|NCT02369679|lymphedema|lymphedema
195935|NCT02369666|Inflammation|inflammation
195936|NCT02369666|Lycopene|lycopene
195937|NCT02369666|Exercise|exercise
195938|NCT02369653|Anticoagulation|anticoagulation
195939|NCT02369614|rTMS - repetitive transcranial magnetic stimulation|rtms - repetitive transcranial magnetic stimulation
195940|NCT02369614|CAPS - Clinician Administered PTSD Scale|caps - clinician administered ptsd scale
195941|NCT02369601|amniorrhexis|amniorrhexis
195942|NCT02369601|Ruptured membranes|ruptured membranes
195943|NCT02369601|Alfa-fetoprotein|alfa-fetoprotein
195944|NCT02369562|Dental implants|dental implants
195945|NCT02369562|Periodontal Bone Loss|periodontal bone loss
195946|NCT02369549|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
195947|NCT02369549|Micro-particle curcumin|micro-particle curcumin
195948|NCT02369549|Albuminuria|albuminuria
195949|NCT02369536|NAFLD|nafld
195950|NCT02369536|nutraceutical mixture|nutraceutical mixture
195951|NCT02369523|Primary Total Knee Arthroplasty|primary total knee arthroplasty
195952|NCT02369510|spinal anesthesia|spinal anesthesia
195953|NCT02369510|epinephrine|epinephrine
195954|NCT02369510|bupivacaine|bupivacaine
195955|NCT02369510|repeat cesarean|repeat cesarean
195956|NCT02369484|Stage IIIb/ IV NSCLC harbouring HER2 exon 20 mutations|stage iiib/ iv nsclc harbouring her2 exon 20 mutations
195957|NCT02369471|Cannabidivarin|cannabidivarin
195958|NCT02369471|CBDV|cbdv
195959|NCT02369471|GWP42006|gwp42006
195960|NCT02369432|Drug carriers|drug carriers
195961|NCT02369432|Polymeric microparticles|polymeric microparticles
195962|NCT02369432|Preferential accumulation in inflamed skin|preferential accumulation in inflamed skin
195963|NCT02369432|Atopic dermatitis|atopic dermatitis
195964|NCT02369432|Pilosebaceous follicles|pilosebaceous follicles
195965|NCT02369432|Selective drug delivery|selective drug delivery
195966|NCT02369432|Drug reservoir|drug reservoir
195967|NCT02369419|frailty|frailty
195968|NCT02369419|Heart failure|heart failure
195969|NCT02369419|cardiac resynchronization therapy|cardiac resynchronization therapy
195970|NCT02369406|Botswana|botswana
195971|NCT02369406|Immunology|immunology
195972|NCT02369406|Antiretroviral Therapy|antiretroviral therapy
195973|NCT02369393|Internet based treatment|internet based treatment
195974|NCT02369393|Depression|depression
195975|NCT02369393|Efficacy|efficacy
195976|NCT02369393|Cost-effectiveness|cost-effectiveness
195977|NCT02369393|Behavioral Activation|behavioral activation
195978|NCT02369393|Self-applied|self-applied
195979|NCT02369393|Ecological Momentary Assessment|ecological momentary assessment
195980|NCT02369393|Physical Activity|physical activity
195981|NCT02369367|Malignant Gliomas|malignant gliomas
195982|NCT02369367|Glioblastoma Multiforme|glioblastoma multiforme
195983|NCT02369367|Gliosarcoma|gliosarcoma
195984|NCT02369367|Anaplastic Astrocytoma|anaplastic astrocytoma
195985|NCT02369367|Anaplastic Oligodendroglioma|anaplastic oligodendroglioma
195986|NCT02369367|Anaplastic Oligoastrocytoma|anaplastic oligoastrocytoma
195987|NCT02369367|Camptosar|camptosar
195988|NCT02369367|Irinotecan|irinotecan
195989|NCT02369367|CPT-11|cpt-11
195990|NCT02369367|Lenalidomide|lenalidomide
195991|NCT02369367|Revlimid|revlimid
195992|NCT02369367|CC-5013|cc-5013
195993|NCT02369354|Kidney Transplant|kidney transplant
195994|NCT02369354|African Americans|african americans
195995|NCT02369341|Southern Hemisphere influenza vaccine|southern hemisphere influenza vaccine
195996|NCT02369341|Elderly|elderly
195997|NCT02369341|Seasonal flu|seasonal flu
195998|NCT02369341|Fluarix Tetra|fluarix tetra
195999|NCT02369341|Adults|adults
196000|NCT02369341|Immunogenicity|immunogenicity
196001|NCT02369341|Reactogenicity|reactogenicity
196002|NCT02369341|Influenza|influenza
196003|NCT02369315|child development|child development
196004|NCT02369315|music training|music training
196005|NCT02369315|self-regulation|self-regulation
196006|NCT02369315|exposure to violence|exposure to violence
196007|NCT02369276|neck dissection surgery|neck dissection surgery
196008|NCT02369276|shoulder disability|shoulder disability
196009|NCT02369276|musculoskeletal ultrasonography|musculoskeletal ultrasonography
196010|NCT02369263|Deep Vein Thrombosis|deep vein thrombosis
196012|NCT02369263|Leg Swelling|leg swelling
196013|NCT02369263|Leg Pain|leg pain
196014|NCT02369263|Blood Clot|blood clot
196015|NCT02369250|regeneration|regeneration
196016|NCT02369250|surgical therapy|surgical therapy
196017|NCT02369250|furcation defect|furcation defect
196018|NCT02369211|acetaminophen|acetaminophen
196019|NCT02369172|Herpes|herpes
196020|NCT02369172|volunteers|volunteers
196021|NCT02369172|drug-drug interaction|drug-drug interaction
196022|NCT02369120|patient education|patient education
196023|NCT02369120|pain cognitions|pain cognitions
196024|NCT02369107|acupuncture|acupuncture
196025|NCT02369107|chemotherapy-induced nausea and vomiting|chemotherapy-induced nausea and vomiting
196026|NCT02369094|Frailty|frailty
196027|NCT02369094|Frail elderly|frail elderly
196028|NCT02369094|Acupressure|acupressure
196029|NCT02369094|Pragmatic Randomised Controlled Trial|pragmatic randomised controlled trial
196030|NCT02369081|Hypertension|hypertension
196031|NCT02369055|Rehabilitation|rehabilitation
196032|NCT02369029|Phase I|phase i
196033|NCT02369029|Dose escalation|dose escalation
196034|NCT02369029|NUT-midline carcinoma|nut-midline carcinoma
196035|NCT02369029|Acute Leucemia|acute leucemia
196036|NCT02369029|Lymphoma|lymphoma
196037|NCT02369029|Melanoma|melanoma
196038|NCT02369029|Myeloma|myeloma
196039|NCT02369029|HCC|hcc
196040|NCT02369029|NSCLC|nsclc
196041|NCT02369016|indolent Non-Hodgkin lymphoma|indolent non-hodgkin lymphoma
196042|NCT02369016|rituximab-refractory|rituximab-refractory
196043|NCT02369003|Deep Brain Stimulation|deep brain stimulation
196044|NCT02369003|Schwann Cells|schwann cells
196045|NCT02368990|NSCLC|nsclc
196046|NCT02368990|T790M|t790m
196047|NCT02368990|EGFR|egfr
196048|NCT02368990|TKI Resistance|tki resistance
196049|NCT02368990|Non Small Cell Lung Cancer|non small cell lung cancer
196050|NCT02368990|AZD9291|azd9291
196051|NCT02368990|Clovis|clovis
196052|NCT02368977|Colonoscopy|colonoscopy
196053|NCT02368977|Polyps|polyps
196054|NCT02368977|Adenomas|adenomas
196055|NCT02368964|double triggering|double triggering
196056|NCT02368964|Oocyte maturation|oocyte maturation
196057|NCT02368964|GNRH Agonist|gnrh agonist
196058|NCT02368964|hCG|hcg
196059|NCT02368964|IVF treatment|ivf treatment
196060|NCT02368964|immature oocytes|immature oocytes
196061|NCT02368951|Phase 1|phase 1
196062|NCT02368951|Solid Tumors|solid tumors
196063|NCT02368951|FGFR2|fgfr2
196064|NCT02368951|Antibody drug conjugate|antibody drug conjugate
196065|NCT02368938|Cardiovascular risk factors|cardiovascular risk factors
196066|NCT02368938|Prospective study|prospective study
196067|NCT02368938|Mortality|mortality
196068|NCT02368938|Cardiovascular events|cardiovascular events
196069|NCT02368938|Asymptomatic target organ damage|asymptomatic target organ damage
196070|NCT02368938|elderly Chinese|elderly chinese
196071|NCT02368925|Rhytids|rhytids
196072|NCT02368925|Skin Laxity|skin laxity
196073|NCT02368912|Phase 1|phase 1
196074|NCT02368912|ASP1707|asp1707
196075|NCT02368912|Dose escalation|dose escalation
196076|NCT02368912|Food effect|food effect
196077|NCT02368912|Maximum tolerated dose (MTD)|maximum tolerated dose (mtd)
196078|NCT02368912|Healthy subjects|healthy subjects
196079|NCT02368912|Single ascending dose|single ascending dose
196080|NCT02368912|Multiple ascending dose|multiple ascending dose
196081|NCT02368899|technology|technology
196082|NCT02368899|information science|information science
196083|NCT02368899|health care|health care
196084|NCT02368873|prevention|prevention
196085|NCT02368847|Aged|aged
196086|NCT02368847|Psychiatric Hospitals|psychiatric hospitals
196087|NCT02368821|cytotrophoblast|cytotrophoblast
196088|NCT02368821|syncytiotrophoblast|syncytiotrophoblast
196089|NCT02368821|placentas|placentas
196090|NCT02368821|intrauterine growth restriction|intrauterine growth restriction
196091|NCT02368821|preeclampsia|preeclampsia
196092|NCT02368821|placenta accrete|placenta accrete
196093|NCT02368808|orphans and vulnerable children|orphans and vulnerable children
196094|NCT02368808|South Africa|south africa
196095|NCT02368808|peer support group|peer support group
196096|NCT02368795|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
196097|NCT02368795|Pancreatic duct stenting|pancreatic duct stenting
196098|NCT02368795|Post-ERCP pancreatitis|post-ercp pancreatitis
196099|NCT02368782|transient evoked otoacoustic emissions|transient evoked otoacoustic emissions
196100|NCT02368782|distortion product otoacoustic emissions|distortion product otoacoustic emissions
196101|NCT02368782|ketamine|ketamine
196102|NCT02368782|propofol|propofol
196103|NCT02368782|child|child
196104|NCT02368756|dme|dme
196105|NCT02368704|Endoplasmic Reticulum|endoplasmic reticulum
196106|NCT02368678|Halitosis|halitosis
196107|NCT02368678|Sulfur compounds|sulfur compounds
196108|NCT02368678|Periodontitis|periodontitis
196109|NCT02368678|Periodontal treatment|periodontal treatment
196110|NCT02368600|lifestyle intervention|lifestyle intervention
196111|NCT02368600|gestational diabetes mellitus|gestational diabetes mellitus
196112|NCT02368600|Chinese|chinese
196113|NCT02368600|prevention|prevention
196114|NCT02368587|intracoronary infusion|intracoronary infusion
196115|NCT02368587|intravenous infusion|intravenous infusion
196116|NCT02368587|Wharton's jelly-derived mesenchymal stem cells|wharton's jelly-derived mesenchymal stem cells
196117|NCT02368587|ischemic Cardiomyopathy|ischemic cardiomyopathy
196118|NCT02368587|heart function|heart function
196119|NCT02368548|Pharmaceutical care|pharmaceutical care
196120|NCT02368548|Emergency Service|emergency service
196121|NCT02368535|teamwork|teamwork
196122|NCT02368509|sensory test|sensory test
196123|NCT02368509|olfaction|olfaction
196124|NCT02368509|gustation|gustation
196125|NCT02368509|taste|taste
196126|NCT02368509|cancer|cancer
196127|NCT02368496|Long-term parenteral nutrition|long-term parenteral nutrition
196128|NCT02368496|HR-pQCT|hr-pqct
196129|NCT02368496|DXA|dxa
196130|NCT02368496|Bone trophicity|bone trophicity
196131|NCT02368457|Mandibular osteoradionecrosis|mandibular osteoradionecrosis
196132|NCT02368457|Tocopherol|tocopherol
196133|NCT02368457|pentoxifylline|pentoxifylline
196134|NCT02368457|vitamine E|vitamine e
196135|NCT02368457|wounds and injuries|wounds and injuries
196136|NCT02368457|antioxidants|antioxidants
196137|NCT02368457|free radical scavengers|free radical scavengers
196138|NCT02368457|radiation-protective agents|radiation-protective agents
196139|NCT02368457|vasodilatadors agents|vasodilatadors agents
196140|NCT02368457|osteonecrosis|osteonecrosis
196141|NCT02368457|mandible|mandible
196142|NCT02368457|extraoral fistula|extraoral fistula
196143|NCT02368457|exposed bone|exposed bone
196144|NCT02368457|necrotic bone|necrotic bone
196145|NCT02368457|head and neck radiotherapy|head and neck radiotherapy
196146|NCT02368444|Posttraumatic Stress|posttraumatic stress
196147|NCT02368444|Sleep|sleep
196148|NCT02368431|Alcohol Use Disorder|alcohol use disorder
196149|NCT02368431|Alcoholism|alcoholism
196150|NCT02368431|Alcohol Dependence|alcohol dependence
196151|NCT02368431|Zonisamide|zonisamide
196152|NCT02368431|Alcoholic Intoxication|alcoholic intoxication
196153|NCT02368431|Drinking Behaviors|drinking behaviors
196154|NCT02368431|Anticonvulsants|anticonvulsants
196155|NCT02368418|Cardiovascular disease|cardiovascular disease
196156|NCT02368418|Rural health|rural health
196157|NCT02368418|China|china
196158|NCT02368418|Cohort study|cohort study
196159|NCT02368392|in-hospital cardiac arrest|in-hospital cardiac arrest
196160|NCT02368392|quality of life after cardiac arrest|quality of life after cardiac arrest
196161|NCT02368392|survival after cardiac arrest|survival after cardiac arrest
196162|NCT02368392|resources for cardiac arrest|resources for cardiac arrest
196163|NCT02368379|Metyrapone|metyrapone
196164|NCT02368379|ACTH stimulation test|acth stimulation test
196165|NCT02368314|Deep vein thrombosis|deep vein thrombosis
196166|NCT02368314|Prophylaxis|prophylaxis
196167|NCT02368314|Sodium enoxaparin|sodium enoxaparin
196168|NCT02368288|chronic hepatitic B|chronic hepatitic b
196169|NCT02368288|peginterferon|peginterferon
196170|NCT02368288|HBsAg|hbsag
196171|NCT02368288|entecavir|entecavir
196172|NCT02368262|Cerebral Palsy|cerebral palsy
196173|NCT02368262|Risk factors|risk factors
196174|NCT02368262|Child|child
196175|NCT02368262|urinary incontinence|urinary incontinence
196176|NCT02368236|Early Detection of Cancer|early detection of cancer
196177|NCT02368236|Intervention Studies|intervention studies
196178|NCT02368236|Randomized Controlled Trial|randomized controlled trial
196179|NCT02368236|Colorectal Neoplasms|colorectal neoplasms
196180|NCT02368236|Colonic Neoplasms|colonic neoplasms
196181|NCT02368223|Children|children
196182|NCT02368223|Rehabilitation|rehabilitation
196183|NCT02368223|Telerehabilitation|telerehabilitation
196184|NCT02368223|Upper limb therapy|upper limb therapy
196185|NCT02368197|dialysis fistula|dialysis fistula
196186|NCT02368197|cephalic arch stenosis|cephalic arch stenosis
196187|NCT02368197|balloon angioplasty|balloon angioplasty
196188|NCT02368197|drug eluting balloon|drug eluting balloon
196189|NCT02368184|noninvasive physiologic monitoring|noninvasive physiologic monitoring
196190|NCT02368184|acute decompensated heart failure (ADHF)|acute decompensated heart failure (adhf)
196191|NCT02368158|myocard infarction|myocard infarction
196192|NCT02368158|arrhythmia|arrhythmia
196193|NCT02368158|fitness of driving|fitness of driving
196194|NCT02368145|stroke|stroke
196195|NCT02368145|acute stroke|acute stroke
196196|NCT02368145|post stroke depression|post stroke depression
196197|NCT02368132|Caregivers|caregivers
196198|NCT02368132|Dementia|dementia
196199|NCT02368106|patient registry|patient registry
196200|NCT02368106|radiation oncology|radiation oncology
196201|NCT02368106|technology assessment|technology assessment
196202|NCT02368093|Rheumatoid arthritis|rheumatoid arthritis
196203|NCT02368080|Lung Clearance Index|lung clearance index
196204|NCT02368080|Cystic Fibrosis|cystic fibrosis
196205|NCT02368080|Multiple Breath Nitrogen Washout|multiple breath nitrogen washout
196206|NCT02368054|Epinephrine|epinephrine
196207|NCT02368054|Bupivacaine|bupivacaine
196208|NCT02368054|Stroke Volume|stroke volume
196209|NCT02368054|Cardiac Output|cardiac output
196210|NCT02368054|Heart Rate|heart rate
196211|NCT02368054|Hemodynamics|hemodynamics
196212|NCT02368054|Total Peripheral Resistance|total peripheral resistance
196213|NCT02368054|Blood Pressure|blood pressure
196214|NCT02368054|Paracervical block|paracervical block
196215|NCT02368054|LiDCO|lidco
196216|NCT02368054|Adrenaline|adrenaline
196217|NCT02368054|Conization|conization
196218|NCT02368054|PulsCO|pulsco
196219|NCT02368028|Plaque|plaque
196220|NCT02368028|Saliva|saliva
196221|NCT02368028|Dental Caries|dental caries
196222|NCT02368015|Penetration|penetration
196223|NCT02368015|Cefazolin|cefazolin
196224|NCT02368015|Hepatic cyst|hepatic cyst
196225|NCT02368002|obesity|obesity
196226|NCT02368002|diet, reducing|diet, reducing
196227|NCT02367989|Glucose response|glucose response
196228|NCT02367989|Insulin response|insulin response
196229|NCT02367989|Satiety|satiety
196230|NCT02367963|Peer education|peer education
196231|NCT02367963|Comprehensive health intervention|comprehensive health intervention
196232|NCT02367963|Lifestyle|lifestyle
196233|NCT02367963|Adult|adult
196234|NCT02367963|Mid age|mid age
196235|NCT02367963|Male|male
196236|NCT02367963|Female|female
196237|NCT02367963|Human|human
196238|NCT02367963|Clinical trial|clinical trial
196239|NCT02367963|Prevention and control|prevention and control
196240|NCT02367963|Cardiovascular Disease|cardiovascular disease
196241|NCT02367963|Behavior|behavior
196242|NCT02367963|Risk Factors|risk factors
196243|NCT02367963|Healthy lifestyle|healthy lifestyle
196244|NCT02367963|Healthy people program|healthy people program
196245|NCT02367963|Peer-group|peer-group
196246|NCT02367937|Phase I drug-drug interaction|phase i drug-drug interaction
196247|NCT02367898|Cognitive Training|cognitive training
196248|NCT02367898|Lumosity|lumosity
196249|NCT02367898|Crossword Puzzles|crossword puzzles
196250|NCT02367885|Prevention|prevention
196251|NCT02367872|Drug therapy|drug therapy
196252|NCT02367859|ameloblastoma|ameloblastoma
196253|NCT02367859|BRAF|braf
196254|NCT02367859|odontogenic cancer|odontogenic cancer
196255|NCT02367859|adamantinoma|adamantinoma
196256|NCT02367846|Calcium Tracer|calcium tracer
196257|NCT02367846|Oral Contraceptives|oral contraceptives
196258|NCT02367846|Contraceptive Vaginal Ring|contraceptive vaginal ring
196259|NCT02367846|Impact of contraceptives on bone health using 41Ca|impact of contraceptives on bone health using 41ca
196260|NCT02367833|Insulin-like growth factor-1|insulin-like growth factor-1
196261|NCT02367833|Combined oral contraceptive|combined oral contraceptive
196262|NCT02367833|Contraceptive Vaginal Ring|contraceptive vaginal ring
196263|NCT02367833|Transdermal Contraceptive|transdermal contraceptive
196264|NCT02367807|HIV prevention|hiv prevention
196265|NCT02367807|PrEP|prep
196266|NCT02367807|young men who have sex with men|young men who have sex with men
196267|NCT02367807|Truvada|truvada
196268|NCT02367768|trauma blue|trauma blue
196269|NCT02367768|major trauma|major trauma
196270|NCT02367768|cohort study|cohort study
196271|NCT02367768|prognostic factor|prognostic factor
196272|NCT02367768|Healing Time|healing time
196273|NCT02367768|Post Operative|post operative
196274|NCT02367755|cardiopulmonary resuscitation|cardiopulmonary resuscitation
196275|NCT02367755|cardiac arrest|cardiac arrest
196276|NCT02367755|therapeutic hypothermia|therapeutic hypothermia
196277|NCT02367755|propofol|propofol
196278|NCT02367755|lorazepam|lorazepam
196279|NCT02367755|cerebral perfusion|cerebral perfusion
196280|NCT02367755|electroencephalography|electroencephalography
196281|NCT02367742|Diet|diet
196282|NCT02367742|Physical Activity|physical activity
196283|NCT02367742|NAFLD|nafld
196284|NCT02367703|Mini-laparoscopy|mini-laparoscopy
196285|NCT02367703|hysterectomy|hysterectomy
196286|NCT02367703|Benign uterine diseases|benign uterine diseases
196287|NCT02367703|Operative time|operative time
196288|NCT02367690|Diabetes|diabetes
196289|NCT02367690|Foot Ulcers|foot ulcers
196290|NCT02367690|DFU|dfu
196291|NCT02367690|KPT-330|kpt-330
196295|NCT02367664|Japanese encephalitis|japanese encephalitis
196296|NCT02367664|immunogenicity|immunogenicity
196297|NCT02367664|safety|safety
196298|NCT02367664|vaccine|vaccine
196299|NCT02367651|Soft tissue sarcoma|soft tissue sarcoma
196300|NCT02367651|Pazopanib|pazopanib
196301|NCT02367651|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
196302|NCT02367599|PrEP|prep
196303|NCT02367599|Pre exposure Prophylaxis|pre exposure prophylaxis
196304|NCT02367599|Truvada|truvada
196305|NCT02367599|CCTG|cctg
196306|NCT02367599|595|595
196307|NCT02367599|Vitamin D|vitamin d
196308|NCT02367599|Bone mineral density|bone mineral density
196309|NCT02367521|TBI Depression|tbi depression
196310|NCT02367521|co-morbid psychiatric symptoms|co-morbid psychiatric symptoms
196311|NCT02367508|advance care planning|advance care planning
196312|NCT02367508|coping skills|coping skills
196313|NCT02367508|mindfulness|mindfulness
196314|NCT02367508|meditation|meditation
196315|NCT02367508|cancer|cancer
196316|NCT02367508|adult|adult
196317|NCT02367508|caregivers|caregivers
196318|NCT02367508|oncology providers|oncology providers
196319|NCT02367508|advance directives|advance directives
196320|NCT02367508|anxiety|anxiety
196321|NCT02367508|depression|depression
196322|NCT02367508|quality of life|quality of life
196323|NCT02367508|pilot project|pilot project
196324|NCT02367495|Coronary Restenosis|coronary restenosis
196325|NCT02367495|restenosis|restenosis
196326|NCT02367495|paclitaxel-coated balloon|paclitaxel-coated balloon
196327|NCT02367495|drug-eluting stent|drug-eluting stent
196328|NCT02367495|drug-coated balloon|drug-coated balloon
196329|NCT02367495|coronary angiography|coronary angiography
196330|NCT02367482|rGBM|rgbm
196331|NCT02367482|Recurrent GBM|recurrent gbm
196332|NCT02367482|Recurrent Glioblastoma|recurrent glioblastoma
196333|NCT02367469|recurrent brain tumors|recurrent brain tumors
196334|NCT02367469|brain tumors|brain tumors
196335|NCT02367469|Newly diagnosed brain tumors|newly diagnosed brain tumors
196337|NCT02367456|AML|aml
196338|NCT02367443|radiotherapy|radiotherapy
196339|NCT02367443|therapeutic use|therapeutic use
196340|NCT02367443|Radiation|radiation
196341|NCT02367443|non-small cell lung cancer|non-small cell lung cancer
196342|NCT02367443|chemotherapy|chemotherapy
196343|NCT02367417|Revision|revision
196344|NCT02367417|Knee Joint|knee joint
196345|NCT02367417|PMCF|pmcf
196346|NCT02367417|Endo-Modell SL|endo-modell sl
196347|NCT02367378|Minimally invasive surgery|minimally invasive surgery
196348|NCT02367365|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
196349|NCT02367365|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
196350|NCT02367365|neovascular lesion morphology|neovascular lesion morphology
196351|NCT02367365|indocyanine green angiography|indocyanine green angiography
196352|NCT02367365|persistent disease activity|persistent disease activity
196353|NCT02367352|Drug therapy|drug therapy
196354|NCT02367352|dose escalation|dose escalation
196355|NCT02367352|dose expansion|dose expansion
196356|NCT02367339|Critical Care|critical care
196357|NCT02367339|Nursing staff|nursing staff
196358|NCT02367339|Medical staff|medical staff
196359|NCT02367339|Extended-spectrum betalactamase|extended-spectrum betalactamase
196360|NCT02367339|Digestive tract colonization|digestive tract colonization
196361|NCT02367339|Cross-contamination|cross-contamination
196362|NCT02367326|score|score
196363|NCT02367326|inflammatory bowel disease|inflammatory bowel disease
196364|NCT02367326|crohn's disease|crohn's disease
196365|NCT02367326|ulcerative colitis|ulcerative colitis
196366|NCT02367326|clinical response|clinical response
196367|NCT02367326|thiopurines|thiopurines
196368|NCT02367313|Symptomatic Human Rhinovirus Infection|symptomatic human rhinovirus infection
196369|NCT02367313|Moderate to Severe Asthma|moderate to severe asthma
196370|NCT02367313|Antiviral|antiviral
196371|NCT02367313|Cold|cold
196372|NCT02367313|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
196373|NCT02367313|Aviragen Therapeutics|aviragen therapeutics
196374|NCT02367313|Aviragen|aviragen
196375|NCT02367287|Diet|diet
196376|NCT02367287|Phenotype|phenotype
196377|NCT02367287|Immunology|immunology
196378|NCT02367287|Microbiota|microbiota
196379|NCT02367287|Metabolomics|metabolomics
196380|NCT02367287|Physical activity|physical activity
196381|NCT02367287|Neuroendocrine system|neuroendocrine system
196382|NCT02367287|Nutritional Physiological Phenomena|nutritional physiological phenomena
196383|NCT02367248|Brain hemorrhage|brain hemorrhage
196384|NCT02367248|Cerebral Hemorrhage|cerebral hemorrhage
196385|NCT02367248|Deferoxamine|deferoxamine
196386|NCT02367248|Xingnaojing injection|xingnaojing injection
196387|NCT02367248|Hematoma edema|hematoma edema
196388|NCT02367235|robotic|robotic
196389|NCT02367235|sacrocolpopexy|sacrocolpopexy
196390|NCT02367235|Colpassist|colpassist
196391|NCT02367235|vaginal positioning device|vaginal positioning device
196392|NCT02367209|FD MRI|fd mri
196393|NCT02367209|COPD|copd
196394|NCT02367209|SPECT/CT|spect/ct
196395|NCT02367209|DCE MRI|dce mri
196396|NCT02367196|CC-90002|cc-90002
196397|NCT02367196|Monoclonal|monoclonal
196398|NCT02367196|Antibody|antibody
196399|NCT02367196|CD47|cd47
196400|NCT02367196|Advanced|advanced
196401|NCT02367196|Solid Cancers|solid cancers
196402|NCT02367196|Hematologic Cancers|hematologic cancers
196403|NCT02367183|Crohn's Disease|crohn's disease
196404|NCT02367183|Active Crohn's Disease|active crohn's disease
196405|NCT02367183|GED-0301|ged-0301
196406|NCT02367183|Endoscopic|endoscopic
196407|NCT02367183|Double-Blind|double-blind
196408|NCT02367183|IBD|ibd
196409|NCT02367183|Mongersen|mongersen
196410|NCT02367170|respiratory dysfunction|respiratory dysfunction
196411|NCT02367170|chronic critical illness|chronic critical illness
196412|NCT02367170|diaphragm weakness|diaphragm weakness
196413|NCT02367170|sepsis|sepsis
196414|NCT02367170|ventilator dependance|ventilator dependance
196415|NCT02367118|chronic rhinosinusitis without nasal polyps prednisone|chronic rhinosinusitis without nasal polyps prednisone
196416|NCT02367105|Obesity|obesity
196417|NCT02367105|Hypogonadism|hypogonadism
196418|NCT02367105|Frailty|frailty
196419|NCT02367092|Liver Transplantation|liver transplantation
196420|NCT02367066|patients|patients
196421|NCT02367066|glycaemic control on metformin|glycaemic control on metformin
196422|NCT02367040|Clinical trial, Phase III|clinical trial, phase iii
196423|NCT02367040|Phosphatidylinositol-3-kinase|phosphatidylinositol-3-kinase
196424|NCT02367040|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
196425|NCT02367040|Indolent B-cell non-Hodgkin's lymphoma|indolent b-cell non-hodgkin's lymphoma
196426|NCT02367027|Biological Availability|biological availability
196427|NCT02367027|Relative Bioavailability Trial|relative bioavailability trial
196428|NCT02367014|Mitochondrial Myopathy|mitochondrial myopathy
196429|NCT02367014|Primary Mitochondrial Disease|primary mitochondrial disease
196430|NCT02367014|Bendavia™|bendavia™
196431|NCT02367014|elamipretide|elamipretide
196432|NCT02367001|general practitioner|general practitioner
196433|NCT02367001|screening|screening
196434|NCT02367001|participation|participation
196435|NCT02367001|organized screening|organized screening
196436|NCT02366988|Chronic pancreatitis|chronic pancreatitis
196437|NCT02366988|Clinical Trial|clinical trial
196438|NCT02366988|Bile stricture|bile stricture
196439|NCT02366988|Endoscopy|endoscopy
196440|NCT02366988|Surgery|surgery
196441|NCT02366975|BPH/LUTS|bph/luts
196442|NCT02366975|TRT|trt
196443|NCT02366975|Metabolic Syndrome|metabolic syndrome
196444|NCT02366962|Influenza|influenza
196445|NCT02366962|Vaccine|vaccine
196446|NCT02366962|ASP7374|asp7374
196447|NCT02366949|Phase 1|phase 1
196448|NCT02366949|Solid tumors|solid tumors
196449|NCT02366949|Breast cancer|breast cancer
196450|NCT02366949|Paclitaxel|paclitaxel
196451|NCT02366949|MPS-1 inhibitor|mps-1 inhibitor
196452|NCT02366949|Oncology|oncology
196453|NCT02366884|malignant|malignant
196454|NCT02366884|atavistic chemotherapy|atavistic chemotherapy
196455|NCT02366884|cancer|cancer
196456|NCT02366858|19 gauge|19 gauge
196457|NCT02366858|22 gauge|22 gauge
196458|NCT02366858|core tissue|core tissue
196459|NCT02366806|Breast Cancer|breast cancer
196460|NCT02366806|AJCC Stage 1, 2, 3|ajcc stage 1, 2, 3
196461|NCT02366806|Educational Design|educational design
196462|NCT02366806|Radiation Therapy Treatment|radiation therapy treatment
196463|NCT02366793|accessory mobilization, nerve mobilization.|accessory mobilization, nerve mobilization.
196464|NCT02366780|Lactation|lactation
196465|NCT02366780|Breastmilk|breastmilk
196466|NCT02366780|Macronutrients|macronutrients
196467|NCT02366767|Insulin Infusion Systems|insulin infusion systems
196468|NCT02366767|Continuous Glucose Monitors|continuous glucose monitors
196469|NCT02366754|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
196470|NCT02366741|SCLC|sclc
196471|NCT02366741|Neuro-cognitive function|neuro-cognitive function
196472|NCT02366741|PCI|pci
196473|NCT02366741|Hippocampal sparing|hippocampal sparing
196474|NCT02366676|Recurrent cystitis|recurrent cystitis
196475|NCT02366676|hyaluronic acid|hyaluronic acid
196476|NCT02366676|chondroitin sulphate|chondroitin sulphate
196477|NCT02366663|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
196478|NCT02366663|autologous stem cell transplantation|autologous stem cell transplantation
196479|NCT02366663|radioimmunotherapy|radioimmunotherapy
196480|NCT02366663|Zevalin|zevalin
196481|NCT02366663|Lymphoma|lymphoma
196482|NCT02366663|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
196483|NCT02366663|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
196484|NCT02366663|Immune System Diseases|immune system diseases
196485|NCT02366663|Immunoproliferative Disorders|immunoproliferative disorders
196486|NCT02366663|Lymphatic Diseases|lymphatic diseases
196487|NCT02366663|Lymphoma, B-Cell|lymphoma, b-cell
196488|NCT02366663|Lymphoproliferative Disorders|lymphoproliferative disorders
196489|NCT02366663|Neoplasms|neoplasms
196490|NCT02366663|Neoplasms by Histologic Type|neoplasms by histologic type
196491|NCT02366663|Antibodies, Monoclonal|antibodies, monoclonal
196492|NCT02366663|Immunologic Factors|immunologic factors
196493|NCT02366663|Pharmacologic Actions|pharmacologic actions
196494|NCT02366663|Physiological Effects of Drugs|physiological effects of drugs
196495|NCT02366637|COPD|copd
196496|NCT02366637|Sputum|sputum
196497|NCT02366546|Adoptive cell transfer|adoptive cell transfer
196498|NCT02366546|Cell therapy|cell therapy
196499|NCT02366546|Immunotherapy|immunotherapy
196500|NCT02366546|NY-ESO-1|ny-eso-1
196501|NCT02366546|Esophageal cancer|esophageal cancer
196502|NCT02366546|Melanoma|melanoma
196503|NCT02366546|Head and neck cancer|head and neck cancer
196504|NCT02366546|Ovarian cancer|ovarian cancer
196505|NCT02366546|Synovial sarcoma|synovial sarcoma
196506|NCT02366546|TCR gene therapy|tcr gene therapy
196507|NCT02366533|Linkage to care|linkage to care
196508|NCT02366533|HIV|hiv
196509|NCT02366533|Efficacy of linkage to care program|efficacy of linkage to care program
196510|NCT02366520|Child|child
196511|NCT02366520|Child Behavior|child behavior
196512|NCT02366520|Dental Anxiety/prevention & control|dental anxiety/prevention & control
196513|NCT02366520|Dental Anxiety/psychology|dental anxiety/psychology
196514|NCT02366520|Cooperative Behavior|cooperative behavior
196515|NCT02366520|Dental Care/psychology*|dental care/psychology*
196516|NCT02366520|Humans|humans
196517|NCT02366520|Videotape Recording|videotape recording
196518|NCT02366507|hypotension|hypotension
196519|NCT02366507|doppler|doppler
196520|NCT02366507|shock|shock
196521|NCT02366494|prostate cancer|prostate cancer
196522|NCT02366494|treatment response|treatment response
196523|NCT02366494|androgen deprivation therapy|androgen deprivation therapy
196524|NCT02366481|Vitamin K|vitamin k
196525|NCT02366481|Vitamin K2|vitamin k2
196526|NCT02366481|Menaquinone-7|menaquinone-7
196527|NCT02366481|Osteocalcin|osteocalcin
196528|NCT02366481|Adults|adults
196529|NCT02366481|Obesity|obesity
196530|NCT02366481|Insulin resistance|insulin resistance
196531|NCT02366481|Insulin sensitivity|insulin sensitivity
196532|NCT02366481|Beta-cell function|beta-cell function
196533|NCT02366481|Prediabetes|prediabetes
196534|NCT02366468|Diabetic macular edema|diabetic macular edema
196535|NCT02366468|Visual impairment|visual impairment
196536|NCT02366442|dual/multitasking|dual/multitasking
196537|NCT02366442|Executive function|executive function
196538|NCT02366442|Affective function|affective function
196539|NCT02366442|Balance|balance
196540|NCT02366416|Exercise, Physical|exercise, physical
196541|NCT02366403|PTSD|ptsd
196542|NCT02366403|Meditation|meditation
196543|NCT02366403|Yoga|yoga
196544|NCT02366403|Cognitive Therapy|cognitive therapy
196545|NCT02366390|Psychoeducative|psychoeducative
196546|NCT02366390|HADS|hads
196547|NCT02366390|COPD|copd
196548|NCT02366390|dyspnea|dyspnea
196549|NCT02366364|NRX-1074|nrx-1074
196550|NCT02366364|NMDA Receptor Modulator|nmda receptor modulator
196551|NCT02366364|Major Depressive Disorder|major depressive disorder
196552|NCT02366364|Glycine Site Modulator|glycine site modulator
196553|NCT02366312|Keratocystic odontogenic tumor|keratocystic odontogenic tumor
196554|NCT02366312|KCOT|kcot
196555|NCT02366273|Diabetes|diabetes
196556|NCT02366273|Psoriasis|psoriasis
196557|NCT02366273|Inflammation|inflammation
196558|NCT02366273|Insulin-resistance|insulin-resistance
196559|NCT02366247|Polyethylene Glycol Thymosin alpha1|polyethylene glycol thymosin alpha1
196560|NCT02366247|Adefovir|adefovir
196561|NCT02366247|Hepatitis B e Antigens positive|hepatitis b e antigens positive
196562|NCT02366208|Polyethylene Glycol Thymosin alpha1|polyethylene glycol thymosin alpha1
196563|NCT02366208|Adefovir|adefovir
196564|NCT02366208|Hepatitis B e Antigens positive|hepatitis b e antigens positive
196565|NCT02366195|T-VEC|t-vec
196566|NCT02366195|CD8+ cell density|cd8+ cell density
196567|NCT02366195|objective response rate|objective response rate
196568|NCT02366195|unresected|unresected
196569|NCT02366195|Melanoma|melanoma
196570|NCT02366130|Breast cancer|breast cancer
196571|NCT02366130|Hormone-positive bone-dominant metastatic breast cancer|hormone-positive bone-dominant metastatic breast cancer
196572|NCT02366130|Ra-223 dichloride|ra-223 dichloride
196573|NCT02366130|Xofigo|xofigo
196574|NCT02366130|Radium-223 chloride|radium-223 chloride
196575|NCT02366130|Radium-223 dichloride|radium-223 dichloride
196576|NCT02366130|Alpharadin|alpharadin
196577|NCT02366130|Denosumab|denosumab
196578|NCT02366130|AMG 162|amg 162
196579|NCT02366130|Prolia|prolia
196580|NCT02366130|Hormone therapy|hormone therapy
196581|NCT02366117|Quirc|quirc
196582|NCT02366117|Quality Indiciator in Rehabilitative Care|quality indiciator in rehabilitative care
196583|NCT02366104|Cardiovascular Diseases|cardiovascular diseases
196584|NCT02366104|Aged|aged
196585|NCT02366104|Primary Prevention|primary prevention
196586|NCT02366052|Histologically confirmed NASH|histologically confirmed nash
196587|NCT02366052|Hepatocyte Injury determined by M30 antigen|hepatocyte injury determined by m30 antigen
196588|NCT02366026|HIV|hiv
196589|NCT02366013|HIV|hiv
196590|NCT02366013|HIV Prevention|hiv prevention
196591|NCT02366013|HIV Vaccine|hiv vaccine
196592|NCT02366013|Healthy|healthy
196593|NCT02366000|Parent-child communication|parent-child communication
196594|NCT02366000|Health risk behaviors|health risk behaviors
196595|NCT02366000|Randomized controlled trial|randomized controlled trial
196596|NCT02365987|interesterified|interesterified
196597|NCT02365987|postprandial|postprandial
196598|NCT02365974|arterial stiffness|arterial stiffness
196599|NCT02365974|resistant hypertension|resistant hypertension
196600|NCT02365974|sympathetic system|sympathetic system
196601|NCT02365974|blood pressure|blood pressure
196602|NCT02365974|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
196603|NCT02365961|Hip Arthroscopy|hip arthroscopy
196604|NCT02365948|Pharmacokinetics|pharmacokinetics
196605|NCT02365948|Certolizumab Pegol|certolizumab pegol
196606|NCT02365948|Healthy Chinese subjects|healthy chinese subjects
196607|NCT02365935|adjuvant chemotherapy|adjuvant chemotherapy
196608|NCT02365922|FTLD, PSP, CBD, PPA, FTD, FTD-ALS, CBS, ALS, svPPA, nfvPPA, oPSP|ftld, psp, cbd, ppa, ftd, ftd-als, cbs, als, svppa, nfvppa, opsp
196609|NCT02365883|Prostate Cancer|prostate cancer
196610|NCT02365883|Transrectal Imaging|transrectal imaging
196611|NCT02365870|Anxiety Disorders|anxiety disorders
196612|NCT02365870|Parkinson Disease|parkinson disease
196613|NCT02365870|rotigotine|rotigotine
196614|NCT02365857|spinal anesthesia|spinal anesthesia
196615|NCT02365857|caesarian section|caesarian section
196616|NCT02365857|Dexmedetomidine|dexmedetomidine
196617|NCT02365844|Narrow Band Imaging|narrow band imaging
196618|NCT02365844|oropharyngeal carcinoma|oropharyngeal carcinoma
196619|NCT02365831|MBC|mbc
196620|NCT02365831|breast|breast
196621|NCT02365831|metastatic|metastatic
196622|NCT02365831|cancer|cancer
196623|NCT02365831|HER2|her2
196624|NCT02365818|Bladder Cancer|bladder cancer
196625|NCT02365805|BRCA 1 levels|brca 1 levels
196626|NCT02365805|HER2 Negative|her2 negative
196627|NCT02365792|Clinical Decision Support|clinical decision support
196628|NCT02365792|Clinical Practice Guidelines|clinical practice guidelines
196629|NCT02365792|Emergency Medical Services|emergency medical services
196630|NCT02365779|salpingectomy|salpingectomy
196631|NCT02365779|optical biopsy|optical biopsy
196632|NCT02365779|Cellvizio®|cellvizio®
196633|NCT02365766|MK-3475|mk-3475
196634|NCT02365766|Gemcitabine|gemcitabine
196635|NCT02365766|Cisplatin|cisplatin
196636|NCT02365766|Pembrolizumab|pembrolizumab
196637|NCT02365766|Neoadjuvant Bladder Cancer|neoadjuvant bladder cancer
196638|NCT02365753|lower transverse cesarean delivery|lower transverse cesarean delivery
196639|NCT02365753|Pregnant women|pregnant women
196640|NCT02365740|Type 1 Diabetes mellitus|type 1 diabetes mellitus
196641|NCT02365740|Gastric Emptying|gastric emptying
196642|NCT02365740|Insulin Infusion Pump|insulin infusion pump
196643|NCT02365701|Functional Dyspepsia|functional dyspepsia
196644|NCT02365688|Open Abdominal Surgical Procedure|open abdominal surgical procedure
196645|NCT02365675|Pemphigus|pemphigus
196646|NCT02365675|Pemphigoid|pemphigoid
196647|NCT02365675|Wound Healing|wound healing
196648|NCT02365675|Itch|itch
196649|NCT02365675|Pain|pain
196650|NCT02365675|Wound dressing|wound dressing
196651|NCT02365675|Topical treatment|topical treatment
196652|NCT02365662|Oncology|oncology
196653|NCT02365662|Cancer|cancer
196654|NCT02365662|Solid Tumor types likely to exhibit elevated levels of Epidermal Growth Factor Receptor|solid tumor types likely to exhibit elevated levels of epidermal growth factor receptor
196655|NCT02365662|Solid Tumors|solid tumors
196656|NCT02365649|Crohn's Disease|crohn's disease
196657|NCT02365623|Pulmonary Multi-Drug Resistant Tuberculosis (MDR-TB)|pulmonary multi-drug resistant tuberculosis (mdr-tb)
196658|NCT02365623|TMC207|tmc207
196659|NCT02365623|Bedaquiline|bedaquiline
196660|NCT02365610|Cannabidivarin|cannabidivarin
196661|NCT02365610|CBDV|cbdv
196662|NCT02365610|GWP42006|gwp42006
196663|NCT02365597|Urothelial Cancer|urothelial cancer
196664|NCT02365597|JNJ-42756493|jnj-42756493
196665|NCT02365597|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
196666|NCT02365532|drug-induced long QT syndrome|drug-induced long qt syndrome
196667|NCT02365532|DILQTS|dilqts
196668|NCT02365532|prolonged QT|prolonged qt
196669|NCT02365519|LME636|lme636
196670|NCT02365519|dry eye disease|dry eye disease
196671|NCT02365519|efficacy|efficacy
196672|NCT02365519|ocular discomfort|ocular discomfort
196673|NCT02365506|Congenital Long QT Syndrome|congenital long qt syndrome
196674|NCT02365506|LQTS|lqts
196675|NCT02365506|Long QT2 Syndrome|long qt2 syndrome
196676|NCT02365506|LQT2|lqt2
196677|NCT02365506|Sudden Cardiac Death|sudden cardiac death
196678|NCT02365493|Methicillin-Resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
196679|NCT02365467|TEVAR|tevar
196680|NCT02365467|Thoracic Aneurysm|thoracic aneurysm
196681|NCT02365467|Endovascular Aortic Repair|endovascular aortic repair
196682|NCT02365467|Type B Dissection|type b dissection
196683|NCT02365454|TAA|taa
196684|NCT02365441|GIST|gist
196685|NCT02365441|Advanced|advanced
196686|NCT02365428|Maternal welfare|maternal welfare
196687|NCT02365402|chronic hepatitis B|chronic hepatitis b
196688|NCT02365402|peginterferon|peginterferon
196689|NCT02365402|sustained viral response|sustained viral response
196690|NCT02365402|entecavir|entecavir
196691|NCT02365402|HBeAg|hbeag
196692|NCT02365337|Vitamin D|vitamin d
196693|NCT02365337|time lapse monitoring|time lapse monitoring
196694|NCT02365337|embryo|embryo
196695|NCT02365324|culinary skills|culinary skills
196696|NCT02365324|menu planning|menu planning
197294|NCT02361827|IVF outcome|ivf outcome
196697|NCT02365324|grocery shopping|grocery shopping
196698|NCT02365324|children|children
196699|NCT02365324|healthy eating|healthy eating
196700|NCT02365324|physical activity|physical activity
196701|NCT02365272|pharmacokinetics|pharmacokinetics
196702|NCT02365272|aminoglycosides|aminoglycosides
196703|NCT02365246|atopic dermatitis|atopic dermatitis
196704|NCT02365246|immunoadsorption|immunoadsorption
196705|NCT02365233|Type II Diabetes|type ii diabetes
196706|NCT02365233|Nonalcoholic fatty liver|nonalcoholic fatty liver
196707|NCT02365194|Ventral Hernia|ventral hernia
196708|NCT02365194|Prehabilitation|prehabilitation
196709|NCT02365181|Shoulder arthroplasty|shoulder arthroplasty
196710|NCT02365168|Fish allergy|fish allergy
196711|NCT02365155|Frailty|frailty
196712|NCT02365155|Heart failure|heart failure
196713|NCT02365155|Physical activity|physical activity
196714|NCT02365155|Cognitive state|cognitive state
196715|NCT02365142|Knee Osteoarthritis|knee osteoarthritis
196716|NCT02365142|Mesenchimal stem cell|mesenchimal stem cell
196717|NCT02365142|Osteoarthritis|osteoarthritis
196718|NCT02365129|BRITE adipose tissue|brite adipose tissue
196719|NCT02365129|physical activity|physical activity
196720|NCT02365129|Thermogenesis|thermogenesis
196721|NCT02365129|Body Temperature Regulation|body temperature regulation
196722|NCT02365129|Energy Metabolism|energy metabolism
196723|NCT02365116|Peer Mentorship|peer mentorship
196724|NCT02365116|Psychiatric Hospitalization|psychiatric hospitalization
196725|NCT02365116|Suicide Risk|suicide risk
196726|NCT02365103|Anemia, Iron-Deficiency|anemia, iron-deficiency
196727|NCT02365103|Iron, Bioavailability|iron, bioavailability
196728|NCT02365103|Hepcidins|hepcidins
196729|NCT02365103|Intestinal, Absorption|intestinal, absorption
196730|NCT02365103|Isotope Labeling, Stable|isotope labeling, stable
196731|NCT02365077|Adverse Effect of Glucocorticoids|adverse effect of glucocorticoids
196732|NCT02365077|Femur Head Necrosis|femur head necrosis
196733|NCT02365077|Susceptibility|susceptibility
196734|NCT02365077|GWAS|gwas
196735|NCT02365025|Sleep patterns|sleep patterns
196736|NCT02365025|Electronic Media Exposure|electronic media exposure
196737|NCT02365025|Parental Intervention|parental intervention
196738|NCT02364934|rocuronium|rocuronium
196739|NCT02364934|sex|sex
196740|NCT02364934|elderly|elderly
196741|NCT02364934|Close-loop infusion system|close-loop infusion system
196742|NCT02364921|venous ulcer|venous ulcer
196743|NCT02364921|wound healing|wound healing
196744|NCT02364921|compression bandages|compression bandages
196745|NCT02364908|systemic lupus erythematosus|systemic lupus erythematosus
196746|NCT02364908|antimalarials|antimalarials
196747|NCT02364908|therapeutic education|therapeutic education
196748|NCT02364908|Coping questionnaire|coping questionnaire
196749|NCT02364908|MASRI questionnaire|masri questionnaire
196750|NCT02364908|morisky medication adherence scale|morisky medication adherence scale
196751|NCT02364908|lupus Quality Of Life|lupus quality of life
196752|NCT02364908|internal medicine|internal medicine
196753|NCT02364895|Mailed invitation|mailed invitation
196754|NCT02364895|Fecal Occult Blood Test|fecal occult blood test
196755|NCT02364895|Screening|screening
196756|NCT02364869|P-cresyl sulfate|p-cresyl sulfate
196757|NCT02364869|Indoxyl sulfate|indoxyl sulfate
196758|NCT02364869|Intestine|intestine
196759|NCT02364869|Endothelial function|endothelial function
196760|NCT02364856|Autonomic Nervous System|autonomic nervous system
196761|NCT02364856|Cerebral Palsy|cerebral palsy
196762|NCT02364856|Pain|pain
196763|NCT02364856|Children|children
196764|NCT02364843|Threonine|threonine
196765|NCT02364843|enteral feedings|enteral feedings
196766|NCT02364843|infants|infants
196767|NCT02364843|amino acid|amino acid
196768|NCT02364843|requirements|requirements
196769|NCT02364830|Pimpinella anisum L.|pimpinella anisum l.
196770|NCT02364830|Peppermint oil|peppermint oil
196771|NCT02364830|Irritable Bowel Syndrome|irritable bowel syndrome
196772|NCT02364817|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
196773|NCT02364817|Alcohol Dependence|alcohol dependence
196774|NCT02364817|Adults|adults
196775|NCT02364817|Treatment outcome|treatment outcome
196776|NCT02364817|Mental Health|mental health
196777|NCT02364791|pulmonary resection|pulmonary resection
196778|NCT02364791|chest tube|chest tube
196779|NCT02364791|segmentectomy|segmentectomy
196780|NCT02364791|lobectomy|lobectomy
196781|NCT02364778|CAD|cad
196782|NCT02364765|Maxillofacial Orthognathic Surgery|maxillofacial orthognathic surgery
196783|NCT02364765|Hemoglobin|hemoglobin
196784|NCT02364765|Red Blood Cells|red blood cells
196785|NCT02364765|Hematocrit|hematocrit
196786|NCT02364765|Blood Platelets|blood platelets
196787|NCT02364765|Body Weight|body weight
196788|NCT02364765|Operative Time|operative time
196789|NCT02364765|Age Groups|age groups
196790|NCT02364765|Gender|gender
196791|NCT02364726|Acupuncture|acupuncture
196792|NCT02364726|Paclitaxel|paclitaxel
196793|NCT02364726|15-011|15-011
196794|NCT02364700|stroke, robotics, hand rehabilitation|stroke, robotics, hand rehabilitation
196795|NCT02364674|HRCT|hrct
196796|NCT02364674|High Resolution Computed Tomography scans|high resolution computed tomography scans
196797|NCT02364674|Functional Respiratory Imaging|functional respiratory imaging
196798|NCT02364674|FRI|fri
196799|NCT02364674|Computed Tomography|computed tomography
196800|NCT02364674|CT|ct
196801|NCT02364674|Bronchiolitis Obliterans|bronchiolitis obliterans
196802|NCT02364674|BOS|bos
196803|NCT02364674|Lung Transplant|lung transplant
196804|NCT02364661|Hepatitis B virus|hepatitis b virus
196805|NCT02364661|Metabolovirus|metabolovirus
196806|NCT02364648|Endothelium, vascular|endothelium, vascular
196807|NCT02364648|MitoQ|mitoq
196808|NCT02364648|Mitochondria|mitochondria
196809|NCT02364648|Oxidative Stress|oxidative stress
196810|NCT02364648|Chronic Renal Insufficiency|chronic renal insufficiency
196811|NCT02364648|Cardiovascular Disease|cardiovascular disease
196812|NCT02364635|Phase I pharmacokinetics and safety study|phase i pharmacokinetics and safety study
196813|NCT02364622|flexible intubating stylet|flexible intubating stylet
196814|NCT02364622|double-lumen endobronchial tube|double-lumen endobronchial tube
196815|NCT02364596|Staphylococcus aureus vaccine|staphylococcus aureus vaccine
196816|NCT02364596|Staphylococcal infection|staphylococcal infection
196817|NCT02364570|CVD|cvd
196818|NCT02364570|Hyperglycemia|hyperglycemia
196819|NCT02364570|Postprandial|postprandial
196820|NCT02364570|Vascular Function|vascular function
196821|NCT02364531|Prostatic Neoplasms|prostatic neoplasms
196822|NCT02364531|Prostate Cancer|prostate cancer
196823|NCT02364531|Metastatic|metastatic
196824|NCT02364531|Observational|observational
196825|NCT02364531|Abiraterone Acetate|abiraterone acetate
196826|NCT02364531|ZYTIGA|zytiga
196827|NCT02364518|Snoring|snoring
196828|NCT02364518|snoreplasy|snoreplasy
196829|NCT02364518|Tranquill|tranquill
196830|NCT02364518|Sutures|sutures
196831|NCT02364505|caregivers|caregivers
196832|NCT02364492|[C04.588.180]|[c04.588.180]
196833|NCT02364440|skin laxity|skin laxity
196834|NCT02364440|Ultherapy™ System|ultherapy™ system
196835|NCT02364440|rhytids|rhytids
196836|NCT02364427|Pulse wave velocity|pulse wave velocity
196837|NCT02364427|Arterial stiffness|arterial stiffness
196839|NCT02364401|Atrial Fibrillation|atrial fibrillation
196840|NCT02364401|Catheter ablation|catheter ablation
196841|NCT02364388|breast imaging diagnosis|breast imaging diagnosis
196842|NCT02364388|breast ultrasound|breast ultrasound
196843|NCT02364388|Imagio|imagio
196844|NCT02364388|Seno Medical Instruments, Inc.|seno medical instruments, inc.
196845|NCT02364388|Seno|seno
196846|NCT02364388|opto-acoustics|opto-acoustics
196847|NCT02364388|OA|oa
196848|NCT02364336|Chronic Hepatitis B|chronic hepatitis b
196849|NCT02364310|Hypertension|hypertension
196850|NCT02364310|baroreceptor stimulation|baroreceptor stimulation
196851|NCT02364310|Hypertension resistant|hypertension resistant
196852|NCT02364297|Bleeding gastric varices|bleeding gastric varices
196853|NCT02364297|Transjugular intrahepatic portosystemic shunt (TIPS)|transjugular intrahepatic portosystemic shunt (tips)
196854|NCT02364297|Injection of adhesives|injection of adhesives
196855|NCT02364271|High-sensitive troponin|high-sensitive troponin
196856|NCT02364271|Coronary Artery Calcium Score|coronary artery calcium score
196857|NCT02364271|TIMI score|timi score
196858|NCT02364271|Heart-type fatty acid binding protein|heart-type fatty acid binding protein
196859|NCT02364271|Major adverse cardiac event|major adverse cardiac event
196860|NCT02364271|HEART score|heart score
196861|NCT02364245|Cerebral Palsy.|cerebral palsy.
196862|NCT02364245|Upper Extremity|upper extremity
196863|NCT02364245|Kinect|kinect
196864|NCT02364245|Virtual reality|virtual reality
196865|NCT02364219|prewarming|prewarming
196866|NCT02364219|perioperative hypothermia|perioperative hypothermia
196867|NCT02364219|microdialysis|microdialysis
196868|NCT02364219|tissue oxygen saturation|tissue oxygen saturation
196869|NCT02364219|cytoreductive surgery|cytoreductive surgery
196870|NCT02364206|newly diagnosed glioblastoma|newly diagnosed glioblastoma
196871|NCT02364206|p38 MAPK inhibitor|p38 mapk inhibitor
196872|NCT02364206|temozolomide|temozolomide
196873|NCT02364206|radiotherapy|radiotherapy
196874|NCT02364193|Intrathoracic blood volume|intrathoracic blood volume
196875|NCT02364193|Extravascular lung water|extravascular lung water
196876|NCT02364154|biomarker|biomarker
196877|NCT02364154|screening|screening
196878|NCT02364154|coloscopy|coloscopy
196879|NCT02364141|stroke|stroke
196880|NCT02364141|upper extremity|upper extremity
196881|NCT02364141|motor learning|motor learning
196882|NCT02364141|rehabilitation|rehabilitation
196883|NCT02364115|Spinal metastases|spinal metastases
196884|NCT02364115|Spinal metastatic disease|spinal metastatic disease
196885|NCT02364115|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
196886|NCT02364115|Response|response
196887|NCT02364115|Bone metastases|bone metastases
196888|NCT02364089|Adrenal Incidentaloma|adrenal incidentaloma
196889|NCT02364089|Subclinical Cushing's syndrome|subclinical cushing's syndrome
196890|NCT02364089|Hypertension|hypertension
196891|NCT02364089|Cardiovascular Risk Factors|cardiovascular risk factors
196892|NCT02364089|Metabolic Syndrome|metabolic syndrome
196893|NCT02364089|Surgery of adrenal tumor|surgery of adrenal tumor
196894|NCT02364076|Pembrolizumab|pembrolizumab
196895|NCT02364076|Epacadostat|epacadostat
196896|NCT02364063|Urinary incontinence|urinary incontinence
196897|NCT02364063|cerebral palsy|cerebral palsy
196898|NCT02364063|urotherapy|urotherapy
196899|NCT02364063|child|child
196900|NCT02364037|intrauterine device|intrauterine device
196901|NCT02364037|subdermal implant|subdermal implant
196902|NCT02364037|contraceptive counseling|contraceptive counseling
196903|NCT02364024|Colon and rectum carcinoma|colon and rectum carcinoma
196904|NCT02364024|Immune response|immune response
196905|NCT02364024|Biomarker|biomarker
196906|NCT02364024|Prognosis|prognosis
196907|NCT02364011|Biomechanics|biomechanics
196908|NCT02364011|Primary Total Knee Arthroplasty|primary total knee arthroplasty
196909|NCT02364011|TKA Bearings|tka bearings
196910|NCT02364011|Osteoarthritis|osteoarthritis
196911|NCT02364011|Total Knee Replacement|total knee replacement
196912|NCT02363998|detoxification|detoxification
196913|NCT02363998|agonist taper|agonist taper
196914|NCT02363998|methadone step down|methadone step down
196915|NCT02363998|buprenorphine step down|buprenorphine step down
196916|NCT02363998|opioid withdrawal syndrome|opioid withdrawal syndrome
196917|NCT02363959|Hyperbaric Oxygen|hyperbaric oxygen
196918|NCT02363959|Lung Transplantation|lung transplantation
196919|NCT02363959|Central Airway Stenosis|central airway stenosis
196920|NCT02363959|Airway Exudative Plaques|airway exudative plaques
196921|NCT02363959|Hyperbaric Oxygen Therapy|hyperbaric oxygen therapy
196922|NCT02363959|Post-Lung Transplantation|post-lung transplantation
196923|NCT02363959|Airway Ischemia|airway ischemia
196924|NCT02363959|Endobronchial Biopsy|endobronchial biopsy
196925|NCT02363959|Bronchoscopy|bronchoscopy
196926|NCT02363946|alpha-1 antitrypsin|alpha-1 antitrypsin
196927|NCT02363946|AATD|aatd
196928|NCT02363933|Perampanel|perampanel
196929|NCT02363933|Seizures|seizures
196930|NCT02363920|COPD patients|copd patients
196931|NCT02363907|diabetes mellitus|diabetes mellitus
196932|NCT02363907|pediatric|pediatric
196933|NCT02363907|continuous glucose monitoring system|continuous glucose monitoring system
196934|NCT02363907|CGM|cgm
196935|NCT02363855|Neoplasm Metastasis|neoplasm metastasis
196936|NCT02363855|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
196937|NCT02363855|Castration-resistant prostate cancer (CRPC)|castration-resistant prostate cancer (crpc)
196938|NCT02363842|Pressure Ulcer|pressure ulcer
196939|NCT02363842|Skin IQ MCM coverlet|skin iq mcm coverlet
196940|NCT02363842|Pressure redistribution surfaces|pressure redistribution surfaces
196941|NCT02363829|clinical stages IIA, IIB, IIIA, IIIB, IVA|clinical stages iia, iib, iiia, iiib, iva
196942|NCT02363829|invasive carcinoma|invasive carcinoma
196943|NCT02363829|uterine cervix|uterine cervix
196944|NCT02363790|Ventral Hernia|ventral hernia
196945|NCT02363790|Laparoscopic|laparoscopic
196946|NCT02363764|respiratory sampling|respiratory sampling
196947|NCT02363751|Bellini|bellini
196948|NCT02363751|Metastatic|metastatic
196949|NCT02363751|Chemotherapy|chemotherapy
196950|NCT02363751|Bevacizumab|bevacizumab
196951|NCT02363738|Bipolar Disorder|bipolar disorder
196952|NCT02363738|Bipolar Depression|bipolar depression
196953|NCT02363738|Inflammation|inflammation
196954|NCT02363738|Bipolar|bipolar
196955|NCT02363725|Acute myocardial infarction|acute myocardial infarction
196956|NCT02363725|Inflammation|inflammation
196957|NCT02363725|CRP|crp
196958|NCT02363725|Colchicine|colchicine
196959|NCT02363712|Osteoarthritis, knee|osteoarthritis, knee
196960|NCT02363712|therapy|therapy
196961|NCT02363712|shoe|shoe
196962|NCT02363712|Randomized Controlled Trial|randomized controlled trial
196963|NCT02363699|cholelithiasis|cholelithiasis
196964|NCT02363699|Cytokines|cytokines
196965|NCT02363699|under general anesthesia|under general anesthesia
196966|NCT02363673|Autism Spectrum Disorder|autism spectrum disorder
196967|NCT02363673|Children|children
196968|NCT02363673|Homoeopathy|homoeopathy
196969|NCT02363660|HIV-uninfected|hiv-uninfected
196970|NCT02363647|medullary thyroid cancer|medullary thyroid cancer
196971|NCT02363647|thyroid cancer|thyroid cancer
196972|NCT02363647|personalized therapy|personalized therapy
196973|NCT02363647|personalized chemotherapy|personalized chemotherapy
196974|NCT02363647|individualized treatment|individualized treatment
196975|NCT02363647|colon cancer|colon cancer
196976|NCT02363647|colorectal cancer|colorectal cancer
196977|NCT02363634|magnesium status|magnesium status
196978|NCT02363634|sleep quality|sleep quality
196979|NCT02363608|Canine-Assisted|canine-assisted
196980|NCT02363608|15-010|15-010
196981|NCT02363608|post surgery patients|post surgery patients
196982|NCT02363595|Genomic Predictors|genomic predictors
196983|NCT02363595|14-277|14-277
196984|NCT02363569|post coital bleeding|post coital bleeding
196985|NCT02363569|vaginal bleeding|vaginal bleeding
196986|NCT02363556|Cervical Dilation|cervical dilation
196987|NCT02363556|Dilation and Evacuation|dilation and evacuation
196988|NCT02363556|Misoprostol|misoprostol
196989|NCT02363556|Misoprostol-Dilapan|misoprostol-dilapan
196990|NCT02363556|Abortion|abortion
196991|NCT02363530|cataract surgery|cataract surgery
196992|NCT02363530|cornea protect|cornea protect
196993|NCT02363530|xerophthalmia|xerophthalmia
196994|NCT02363530|Corneal clarity|corneal clarity
196995|NCT02363517|Hepatitis|hepatitis
196996|NCT02363517|Viral|viral
196997|NCT02363517|Non-A|non-a
196998|NCT02363517|Non-B|non-b
196999|NCT02363517|Parenterally-Transmitted|parenterally-transmitted
197000|NCT02363504|Magnetic Resonance Imaging|magnetic resonance imaging
197001|NCT02363504|Noradrenaline|noradrenaline
197002|NCT02363504|locus coeruleus|locus coeruleus
197003|NCT02363504|memory|memory
197004|NCT02363465|skin thickness|skin thickness
197005|NCT02363465|high-frequency ultrasound|high-frequency ultrasound
197006|NCT02363452|Aicardi-Goutières syndrome|aicardi-goutières syndrome
197007|NCT02363452|Reverse transcriptase inhibitors|reverse transcriptase inhibitors
197008|NCT02363452|open single study|open single study
197009|NCT02363452|interferon signature|interferon signature
197010|NCT02363426|intravaginal culture|intravaginal culture
197011|NCT02363426|in vitro fertilization|in vitro fertilization
197012|NCT02363426|blastocyst|blastocyst
197013|NCT02363426|pregnancy|pregnancy
197014|NCT02363413|NIV|niv
197015|NCT02363413|Overlap Syndrom|overlap syndrom
197016|NCT02363413|home|home
197017|NCT02363413|hospital|hospital
197018|NCT02363400|Nasopharyngeal carcinoma (NPC)|nasopharyngeal carcinoma (npc)
197019|NCT02363400|Epstein-Barr virus (EBV)|epstein-barr virus (ebv)
197020|NCT02363400|radiotherapy (RT)|radiotherapy (rt)
197021|NCT02363400|Plasma EBV DNA(pEBV DNA)|plasma ebv dna(pebv dna)
197022|NCT02363400|Adjuvant Chemotherapy|adjuvant chemotherapy
197023|NCT02363387|HIV|hiv
197024|NCT02363387|antiretroviral medications|antiretroviral medications
197025|NCT02363387|incentives|incentives
197026|NCT02363374|Rectal cancer stage II|rectal cancer stage ii
197027|NCT02363374|Rectal cancer stage III|rectal cancer stage iii
197028|NCT02363374|Multimodality treatment of locally advanced rectal cancer|multimodality treatment of locally advanced rectal cancer
197029|NCT02363348|L arginine|l arginine
197030|NCT02363348|Preeclampsia|preeclampsia
197031|NCT02363335|GLP-1|glp-1
197032|NCT02363335|Phosphodiesterase Inhibitor|phosphodiesterase inhibitor
197033|NCT02363335|GLP|glp
197034|NCT02363322|Medical Countermeasures|medical countermeasures
197035|NCT02363322|VHF|vhf
197036|NCT02363322|EVD|evd
197037|NCT02363309|13C|13c
197038|NCT02363309|Stable Isotopes|stable isotopes
197039|NCT02363309|Acetate|acetate
197040|NCT02363309|Breath Tests|breath tests
197041|NCT02363309|Palmitate|palmitate
197042|NCT02363296|Brain Cooling - Selected|brain cooling - selected
197043|NCT02363296|Brain Cooling Helmet|brain cooling helmet
197044|NCT02363296|Repetitive TMS (rTMS)|repetitive tms (rtms)
197045|NCT02363270|Analgesia|analgesia
197046|NCT02363270|ketamine|ketamine
197047|NCT02363257|Smoke free bus policy|smoke free bus policy
197048|NCT02363257|BEST commuters|best commuters
197049|NCT02363257|BEST employee|best employee
197050|NCT02363244|Pap,HPVDNA|pap,hpvdna
197051|NCT02363218|Liver Neoplasms|liver neoplasms
197052|NCT02363218|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
197053|NCT02363218|CyberKnife|cyberknife
197054|NCT02363192|Pharmacy|pharmacy
197055|NCT02363179|Emergency Service, Hospital|emergency service, hospital
197056|NCT02363140|Musculoskeletal System|musculoskeletal system
197057|NCT02363127|Reproductive Techniques|reproductive techniques
197058|NCT02363127|Infertility|infertility
197059|NCT02363127|Reproductive Techniques Assisted|reproductive techniques assisted
197060|NCT02363088|cervical screening|cervical screening
197061|NCT02363088|uptake|uptake
197062|NCT02363088|SMS messages|sms messages
197063|NCT02363088|text messages|text messages
197064|NCT02363088|reminder|reminder
197065|NCT02363075|dexamfetamine sulphate|dexamfetamine sulphate
197066|NCT02363075|severe asthenia|severe asthenia
197067|NCT02363075|glioma|glioma
197068|NCT02363075|MFI-20|mfi-20
197069|NCT02363075|double-blind|double-blind
197070|NCT02363075|stabilisation phase|stabilisation phase
197071|NCT02363062|frontotemporal lobar degeneration|frontotemporal lobar degeneration
197072|NCT02363062|genes|genes
197073|NCT02363062|whole exome sequencing|whole exome sequencing
197074|NCT02363049|Colectomy|colectomy
197075|NCT02363049|primary tumor resection|primary tumor resection
197076|NCT02363049|Asymptomatic primary colon cancer|asymptomatic primary colon cancer
197077|NCT02363049|Unresectable synchronous liver metastasis|unresectable synchronous liver metastasis
197078|NCT02363049|TNM Staging Primary Tumor (T)|tnm staging primary tumor (t)
197079|NCT02363049|Unresectable|unresectable
197080|NCT02363023|Ventilator associated pneumonia|ventilator associated pneumonia
197081|NCT02363023|Bronchoalveolar lavage|bronchoalveolar lavage
197082|NCT02363010|Obesity|obesity
197083|NCT02363010|Weight loss|weight loss
197084|NCT02363010|Overweight|overweight
197085|NCT02362997|Classical Hodgkin Lymphoma (cHL)|classical hodgkin lymphoma (chl)
197086|NCT02362997|Diffuse Large B Cell Lymphoma (DLBCL)|diffuse large b cell lymphoma (dlbcl)
197087|NCT02362997|Peripheral T-cell lymphoma (PTCL)|peripheral t-cell lymphoma (ptcl)
197088|NCT02362984|DLBS1033|dlbs1033
197089|NCT02362984|acute ischemic stroke|acute ischemic stroke
197090|NCT02362984|MRS|mrs
197091|NCT02362984|mNIHSS|mnihss
197092|NCT02362919|Influenza vaccination|influenza vaccination
197093|NCT02362919|Elderly individuals|elderly individuals
197094|NCT02362919|Prospective cohort study|prospective cohort study
197095|NCT02362919|response|response
197096|NCT02362906|pneumonia|pneumonia
197097|NCT02362906|pediatrics|pediatrics
197098|NCT02362893|Hypertension|hypertension
197099|NCT02362893|Adherence|adherence
197100|NCT02362893|Direct Observed Therapy (DOT)|direct observed therapy (dot)
197101|NCT02362893|RCT|rct
197102|NCT02362854|dental implant|dental implant
197103|NCT02362854|laser|laser
197104|NCT02362854|diode laser|diode laser
197105|NCT02362854|peri-implantitis|peri-implantitis
197106|NCT02362854|bacterial count|bacterial count
197107|NCT02362828|Post-Dural Puncture Headache|post-dural puncture headache
197108|NCT02362828|Blood Patch, epidural|blood patch, epidural
197109|NCT02362828|Obstetrics|obstetrics
197110|NCT02362828|European Society of Anaesthesiology (ESA)|european society of anaesthesiology (esa)
197111|NCT02362828|epidemiology|epidemiology
197112|NCT02362828|Accidental Dural Puncture (ADP)|accidental dural puncture (adp)
197113|NCT02362828|Anaesthesia|anaesthesia
197114|NCT02362828|childbirth complication|childbirth complication
197115|NCT02362828|epidural analgesia|epidural analgesia
197116|NCT02362828|postdural puncture headache|postdural puncture headache
197117|NCT02362828|prophylactic epidural blood patch|prophylactic epidural blood patch
197118|NCT02362828|epidural|epidural
197119|NCT02362776|NMR spectroscopy|nmr spectroscopy
197120|NCT02362776|metabolic changes|metabolic changes
197121|NCT02362776|blood plasma|blood plasma
197122|NCT02362776|biomarker|biomarker
197123|NCT02362776|cancer|cancer
197124|NCT02362750|comparative effectiveness|comparative effectiveness
197125|NCT02362750|survivorship|survivorship
197126|NCT02362750|Patient-Centered Outcomes Research|patient-centered outcomes research
197127|NCT02362685|Metabolic myopathies|metabolic myopathies
197128|NCT02362685|Exercise testing|exercise testing
197129|NCT02362685|Blood sample|blood sample
197130|NCT02362685|Muscle biopsy|muscle biopsy
197131|NCT02362685|Genetic analysis|genetic analysis
197132|NCT02362685|Cycloergometer|cycloergometer
197133|NCT02362685|Grip-test|grip-test
197134|NCT02362685|Exercise physiology|exercise physiology
197135|NCT02362685|Muscle physiology|muscle physiology
197136|NCT02362659|non-valvular|non-valvular
197137|NCT02362659|atrial fibrillation|atrial fibrillation
197138|NCT02362659|percutaneous coronary intervention|percutaneous coronary intervention
197139|NCT02362646|Heart Failure|heart failure
197140|NCT02362646|Left Ventricular Assist Device|left ventricular assist device
197141|NCT02362646|Heart Transplantation|heart transplantation
197142|NCT02362646|Cardiomyopathy, Destination Therapy|cardiomyopathy, destination therapy
197143|NCT02362646|Cell Therapy|cell therapy
197144|NCT02362646|Bridge to Transplant|bridge to transplant
197145|NCT02362620|Castration Resistant Prostate Cancer, Biomarkers, Taxanes|castration resistant prostate cancer, biomarkers, taxanes
197146|NCT02362594|PD-1|pd-1
197147|NCT02362594|PD1|pd1
197148|NCT02362594|Programmed Cell Death-1|programmed cell death-1
197149|NCT02362594|Programmed Cell Death 1|programmed cell death 1
197150|NCT02362594|Programmed Cell Death-Ligand 1 (PD-L1)|programmed cell death-ligand 1 (pd-l1)
197151|NCT02362594|Programmed Cell Death-Ligand 2 (PD-L2)|programmed cell death-ligand 2 (pd-l2)
197152|NCT02362594|PDL1|pdl1
197153|NCT02362594|PDL2|pdl2
197154|NCT02362581|Prophylaxis treatment|prophylaxis treatment
197155|NCT02362581|On demand treatment|on demand treatment
197156|NCT02362581|Severe hemophilia A|severe hemophilia a
197157|NCT02362581|Moderate hemophilia A|moderate hemophilia a
197158|NCT02362568|Intubation; Difficult|intubation; difficult
197159|NCT02362555|Ossification of nuchal ligament|ossification of nuchal ligament
197160|NCT02362490|chronic hepatitis B|chronic hepatitis b
197161|NCT02362490|interferon|interferon
197162|NCT02362490|Nucleotide analogues|nucleotide analogues
197163|NCT02362490|HBsAg|hbsag
197164|NCT02362464|Multi-epitope|multi-epitope
197165|NCT02362464|Tarp Peptide|tarp peptide
197166|NCT02362464|Dendritic Cell Vaccine|dendritic cell vaccine
197167|NCT02362464|D0 Prostate Cancer|d0 prostate cancer
197168|NCT02362451|Dendritic Cell Vaccine|dendritic cell vaccine
197169|NCT02362451|Multi Epitope Tarp Peptide|multi epitope tarp peptide
197170|NCT02362451|Autolougous Dendritic Cell|autolougous dendritic cell
197171|NCT02362451|D0 Prostate Cancer|d0 prostate cancer
197172|NCT02362451|Vaccine Therapy|vaccine therapy
197173|NCT02362438|Intrathecal|intrathecal
197174|NCT02362438|AAVp Mediated Gene Transfer|aavp mediated gene transfer
197175|NCT02362438|Phase 1|phase 1
197176|NCT02362438|Safety Study|safety study
197177|NCT02362438|Giant Axonal Neuropathy|giant axonal neuropathy
197178|NCT02362425|Neuromuscular Disease|neuromuscular disease
197179|NCT02362425|Clinical Trial|clinical trial
197180|NCT02362425|Ryanodine Receptor Type 1|ryanodine receptor type 1
197181|NCT02362425|Myopathy|myopathy
197182|NCT02362412|major depressive episodes|major depressive episodes
197183|NCT02362412|FK949E|fk949e
197184|NCT02362412|quetiapine|quetiapine
197185|NCT02362412|bipolar depression|bipolar depression
197186|NCT02362412|bipolar disorder|bipolar disorder
197187|NCT02362373|epilepsy|epilepsy
197188|NCT02362373|contraception|contraception
197189|NCT02362373|drug interaction|drug interaction
197190|NCT02362360|Ostomy|ostomy
197191|NCT02362334|dual Sheimpflug analyzer|dual sheimpflug analyzer
197192|NCT02362334|intraocular lens power|intraocular lens power
197193|NCT02362334|optical low-coherence reflectometry|optical low-coherence reflectometry
197194|NCT02362321|[C10.228.140.300.535.450.400.120]|[c10.228.140.300.535.450.400.120]
197195|NCT02362295|palliative care|palliative care
197196|NCT02362295|vulnerable population|vulnerable population
197197|NCT02362295|qualitative research|qualitative research
197198|NCT02362282|stroke|stroke
197199|NCT02362282|walking|walking
197200|NCT02362282|cognition|cognition
197201|NCT02362282|rehabilitation|rehabilitation
197202|NCT02362256|Opioid detoxification|opioid detoxification
197203|NCT02362256|Opioid antagonist induction|opioid antagonist induction
197204|NCT02362256|Conscious sedation|conscious sedation
197205|NCT02362243|low back pain|low back pain
197206|NCT02362243|low back injury|low back injury
197207|NCT02362243|firefighter|firefighter
197208|NCT02362243|prevention|prevention
197209|NCT02362243|physical fitness|physical fitness
197210|NCT02362243|exercise training|exercise training
197211|NCT02362243|worksite|worksite
197212|NCT02362243|web-based|web-based
197213|NCT02362165|multiple myeloma|multiple myeloma
197214|NCT02362165|cyclophosphamide|cyclophosphamide
197215|NCT02362165|bortezomib|bortezomib
197216|NCT02362165|doxorubicin|doxorubicin
197217|NCT02362165|peripheral neuropathy|peripheral neuropathy
197218|NCT02362152|Actinic keratosis|actinic keratosis
197219|NCT02362152|Solar keratosis|solar keratosis
197220|NCT02362152|Field treatment|field treatment
197221|NCT02362152|Ingenol mebutate|ingenol mebutate
197222|NCT02362152|Picato|picato
197223|NCT02362126|Endoscopic full thickness resection|endoscopic full thickness resection
197224|NCT02362126|EFTR|eftr
197225|NCT02362126|FTRD|ftrd
197226|NCT02362126|OTSC|otsc
197227|NCT02362087|pain|pain
197228|NCT02362061|junctional zone|junctional zone
197229|NCT02362061|implantation|implantation
197230|NCT02362061|three D ultraosund|three d ultraosund
197231|NCT02362061|Assisted Reproductive Technology|assisted reproductive technology
197232|NCT02362061|Pregnancy|pregnancy
197233|NCT02362035|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
197234|NCT02362035|Btk|btk
197235|NCT02362035|B-Cell Malignancies|b-cell malignancies
197236|NCT02362035|Mantle Cell|mantle cell
197237|NCT02362035|Multiple Myeloma|multiple myeloma
197238|NCT02362035|CLL|cll
197239|NCT02362035|SLL|sll
197240|NCT02362035|DLBCL|dlbcl
197241|NCT02362035|Follicular|follicular
197242|NCT02362035|Waldenstrom|waldenstrom
197243|NCT02362035|Burkitt lymphoma|burkitt lymphoma
197244|NCT02362035|marginal zone lymphomas|marginal zone lymphomas
197245|NCT02362035|hairy cell leukemia|hairy cell leukemia
197246|NCT02362035|B cell acute lymphoid leukemia|b cell acute lymphoid leukemia
197247|NCT02362035|Acalabrutinib|acalabrutinib
197248|NCT02362035|ACP-196|acp-196
197249|NCT02362009|Myomas|myomas
197250|NCT02362009|Leiomyomas|leiomyomas
197251|NCT02362009|Fibromas|fibromas
197252|NCT02361970|sepsis|sepsis
197253|NCT02361970|gamma delta T cells|gamma delta t cells
197254|NCT02361970|immunosuppression|immunosuppression
197255|NCT02361944|oxygen|oxygen
197256|NCT02361944|hyperoxia|hyperoxia
197257|NCT02361944|reactive oxygen species|reactive oxygen species
197258|NCT02361944|oxidative stress|oxidative stress
197259|NCT02361944|oxidative damage|oxidative damage
197260|NCT02361944|endothelial function|endothelial function
197261|NCT02361944|vascular reactivity|vascular reactivity
197262|NCT02361944|mitochondrial function|mitochondrial function
197263|NCT02361944|surgery|surgery
197264|NCT02361944|anesthesia|anesthesia
197265|NCT02361944|kidney injury|kidney injury
197266|NCT02361944|renal failure|renal failure
197267|NCT02361944|delirium|delirium
197268|NCT02361944|myocardial injury|myocardial injury
197269|NCT02361944|arrythmia|arrythmia
197270|NCT02361931|accelerating healing|accelerating healing
197271|NCT02361931|diabetic chronic wounds|diabetic chronic wounds
197272|NCT02361931|diabetic patients|diabetic patients
197273|NCT02361931|diabetic chronic ulcers|diabetic chronic ulcers
197274|NCT02361931|Wagner grade II|wagner grade ii
197275|NCT02361931|infection|infection
197276|NCT02361931|necrosis|necrosis
197277|NCT02361931|erythema|erythema
197278|NCT02361931|mild drainage|mild drainage
197279|NCT02361905|fibroid|fibroid
197280|NCT02361905|cellular leiomyomas|cellular leiomyomas
197281|NCT02361905|GnRH analogue|gnrh analogue
197282|NCT02361905|ulipristal acetate|ulipristal acetate
197283|NCT02361892|ovarian reserve|ovarian reserve
197284|NCT02361892|infertility|infertility
197285|NCT02361892|leiomyomas|leiomyomas
197286|NCT02361892|ulipristal acetate|ulipristal acetate
197287|NCT02361879|fibroids|fibroids
197288|NCT02361879|gnrh analogue|gnrh analogue
197289|NCT02361879|ulipristal acetate|ulipristal acetate
197290|NCT02361879|hysteroscopy|hysteroscopy
197291|NCT02361840|Troponin I|troponin i
197292|NCT02361840|Pediatric shock|pediatric shock
197293|NCT02361827|Vitamin D|vitamin d
197295|NCT02361814|flexor tendon|flexor tendon
197296|NCT02361814|finger|finger
197297|NCT02361814|amniotic membrane|amniotic membrane
197298|NCT02361814|allograft|allograft
197299|NCT02361814|tendon injury|tendon injury
197300|NCT02361801|cardiac surgery|cardiac surgery
197301|NCT02361801|dobutamine|dobutamine
197302|NCT02361788|neonatal hyperbilirubinemia|neonatal hyperbilirubinemia
197303|NCT02361788|etiology|etiology
197304|NCT02361788|incidence|incidence
197305|NCT02361788|risk factors|risk factors
197306|NCT02361762|Executive Function|executive function
197307|NCT02361762|Theory of Mind|theory of mind
197308|NCT02361762|Individual Differences|individual differences
197309|NCT02361762|Social Skills|social skills
197310|NCT02361762|Executive Control|executive control
197311|NCT02361710|Vitamin D|vitamin d
197312|NCT02361710|pregnancy rate|pregnancy rate
197313|NCT02361710|eFET|efet
197314|NCT02361697|pediatric multiple sclerosis|pediatric multiple sclerosis
197315|NCT02361697|clinically isolated syndrome in children|clinically isolated syndrome in children
197316|NCT02361697|biomarker|biomarker
197317|NCT02361697|magnetic resonance imaging|magnetic resonance imaging
197318|NCT02361697|diffusion weighted imaging|diffusion weighted imaging
197319|NCT02361684|cost-effectiveness|cost-effectiveness
197320|NCT02361684|blended treatment|blended treatment
197448|NCT02360878|DJBS|djbs
197321|NCT02361684|Internet based treatment|internet based treatment
197322|NCT02361684|Efficacy|efficacy
197323|NCT02361684|Depression|depression
197324|NCT02361684|cognitive behavioural therapy|cognitive behavioural therapy
197325|NCT02361645|nonsteroidal antiinflammatory drugs|nonsteroidal antiinflammatory drugs
197326|NCT02361645|prostaglandin E2|prostaglandin e2
197327|NCT02361645|vitrectomy|vitrectomy
197328|NCT02361606|adolescents|adolescents
197329|NCT02361606|cognitive behavioral internet intervention|cognitive behavioral internet intervention
197330|NCT02361593|endoscopic sclerotherapy, esophageal varices, transparent cap|endoscopic sclerotherapy, esophageal varices, transparent cap
197331|NCT02361567|Post Operative Pain|post operative pain
197332|NCT02361567|Addiction|addiction
197333|NCT02361528|Septic shock|septic shock
197334|NCT02361528|Severe sepsis|severe sepsis
197335|NCT02361528|GM-CSF|gm-csf
197336|NCT02361528|Immunosuppression|immunosuppression
197337|NCT02361528|Hospital-acquired infections|hospital-acquired infections
197338|NCT02361528|ICU-acquired infections|icu-acquired infections
197339|NCT02361528|HLA-DR|hla-dr
197340|NCT02361528|Monocytes|monocytes
197341|NCT02361515|Prostate|prostate
197342|NCT02361515|Hypofractionated radiotherapy|hypofractionated radiotherapy
197343|NCT02361515|Stereotactic irradiation|stereotactic irradiation
197344|NCT02361515|Spacer|spacer
197345|NCT02361515|Rectal and bladder toxicities|rectal and bladder toxicities
197346|NCT02361476|Anaesthesia|anaesthesia
197347|NCT02361476|Children|children
197348|NCT02361476|Clonidine|clonidine
197349|NCT02361476|Sevoflurane|sevoflurane
197350|NCT02361476|Postoperative agitation|postoperative agitation
197351|NCT02361476|Prevention|prevention
197352|NCT02361476|Pharmacokinetics|pharmacokinetics
197353|NCT02361476|Safety|safety
197354|NCT02361463|Laparoscopy;|laparoscopy;
197355|NCT02361463|Training;|training;
197356|NCT02361463|Three-Dimensional|three-dimensional
197357|NCT02361450|Faecal incontinence|faecal incontinence
197358|NCT02361450|Spina Bifida|spina bifida
197359|NCT02361450|Enema|enema
197360|NCT02361450|Constipation|constipation
197361|NCT02361450|Myelomeningocele|myelomeningocele
197362|NCT02361450|Human|human
197363|NCT02361437|diabetes type II|diabetes type ii
197364|NCT02361437|diabetic ulcers|diabetic ulcers
197365|NCT02361424|PXT00864|pxt00864
197366|NCT02361424|mild AD|mild ad
197367|NCT02361424|phase 2a|phase 2a
197368|NCT02361359|Arthroplasty|arthroplasty
197369|NCT02361346|CD20|cd20
197370|NCT02361346|immunotoxin|immunotoxin
197371|NCT02361346|NHL|nhl
197372|NCT02361346|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
197373|NCT02361346|lymphoma|lymphoma
197374|NCT02361346|cancer|cancer
197375|NCT02361346|antibodies|antibodies
197376|NCT02361346|immunotherapy|immunotherapy
197377|NCT02361346|safety|safety
197378|NCT02361346|pharmacokinetics|pharmacokinetics
197379|NCT02361346|maximum tolerated dose|maximum tolerated dose
197380|NCT02361346|MT-3724|mt-3724
197381|NCT02361346|relapsed|relapsed
197382|NCT02361346|refractory|refractory
197383|NCT02361346|leukemia|leukemia
197384|NCT02361346|CLL|cll
197385|NCT02361346|SLL|sll
197386|NCT02361320|Pancreatic cancer|pancreatic cancer
197387|NCT02361320|Pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
197388|NCT02361320|PDAC|pdac
197389|NCT02361320|Computed tomography|computed tomography
197390|NCT02361320|CT|ct
197391|NCT02361320|Questionnaire|questionnaire
197392|NCT02361320|Survey|survey
197393|NCT02361268|end-stage renal disease|end-stage renal disease
197394|NCT02361268|hemodialysis|hemodialysis
197395|NCT02361268|yoga|yoga
197396|NCT02361268|mind-body medicine|mind-body medicine
197397|NCT02361268|meditation|meditation
197398|NCT02361242|PXT00864|pxt00864
197399|NCT02361242|mild AD|mild ad
197400|NCT02361242|phase 2a|phase 2a
197401|NCT02361138|SHR3824 Type 2 diabetes mellitus SGLT2|shr3824 type 2 diabetes mellitus sglt2
197402|NCT02361125|Fatigue|fatigue
197403|NCT02361125|Cancer related fatigue|cancer related fatigue
197404|NCT02361125|Methylphenidate|methylphenidate
197405|NCT02361125|Methylphenidate Hydrochloride|methylphenidate hydrochloride
197406|NCT02361125|Ritalin|ritalin
197407|NCT02361125|Concerta|concerta
197408|NCT02361125|Fatigue evaluations|fatigue evaluations
197409|NCT02361086|castration-resistant prostate cancer|castration-resistant prostate cancer
197410|NCT02361086|CYP17|cyp17
197411|NCT02361086|P450c17a|p450c17a
197412|NCT02361086|lyase|lyase
197413|NCT02361073|Stress-induced cardiomyopathy|stress-induced cardiomyopathy
197414|NCT02361073|ERP|erp
197415|NCT02361034|Safety and pharmacokinetics of drug in healthy volunteers|safety and pharmacokinetics of drug in healthy volunteers
197416|NCT02361021|Critical Care|critical care
197417|NCT02361021|Non invasive ventilation|non invasive ventilation
197418|NCT02361021|Electrical impedance tomography|electrical impedance tomography
197419|NCT02361021|End expiratory lung volume|end expiratory lung volume
197420|NCT02361021|Lung ultrasound score|lung ultrasound score
197421|NCT02361008|Infundibular Ventricular Septal Defect|infundibular ventricular septal defect
197422|NCT02361008|occlusion|occlusion
197423|NCT02361008|TEE-guided|tee-guided
197424|NCT02361008|asymmetric occluder|asymmetric occluder
197425|NCT02361008|surgical repair|surgical repair
197426|NCT02360982|Delirium|delirium
197427|NCT02360982|regional anesthesia|regional anesthesia
197428|NCT02360982|general anesthesia|general anesthesia
197429|NCT02360969|strabismus|strabismus
197430|NCT02360969|surgical procedure|surgical procedure
197431|NCT02360969|anesthesia|anesthesia
197432|NCT02360969|squint|squint
197433|NCT02360969|child|child
197434|NCT02360956|Olmesartan medoxomil|olmesartan medoxomil
197435|NCT02360956|Epicardial adipose tissue|epicardial adipose tissue
197436|NCT02360956|Multidetector Computed Tomography|multidetector computed tomography
197437|NCT02360943|elderly patients|elderly patients
197438|NCT02360943|Pulmonary embolism|pulmonary embolism
197439|NCT02360943|Anticoagulant treatments|anticoagulant treatments
197440|NCT02360930|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
197441|NCT02360930|Pharmacokinetics|pharmacokinetics
197442|NCT02360930|Vincristine|vincristine
197443|NCT02360917|Cognitive Dysfunction|cognitive dysfunction
197444|NCT02360917|Cancer Survivorship|cancer survivorship
197445|NCT02360891|multimodal biomarkers|multimodal biomarkers
197446|NCT02360891|prognosis|prognosis
197447|NCT02360891|endophenotypes|endophenotypes
197449|NCT02360878|Duodenal-jejunal bypass sleeve|duodenal-jejunal bypass sleeve
197450|NCT02360878|Duodenal-jejunal bypass liner|duodenal-jejunal bypass liner
197451|NCT02360878|Endobarrier|endobarrier
197452|NCT02360878|Obesity|obesity
197453|NCT02360878|Type 2 diabetes|type 2 diabetes
197454|NCT02360878|Incretin hormones|incretin hormones
197455|NCT02360878|Postprandial glucose metabolism|postprandial glucose metabolism
197456|NCT02360813|Cognitive remediation therapy|cognitive remediation therapy
197457|NCT02360813|Psychiatric rehabilitation|psychiatric rehabilitation
197458|NCT02360813|Forensic mental health|forensic mental health
197459|NCT02360813|Forensic psychiatry|forensic psychiatry
197460|NCT02360813|Clinical psychology|clinical psychology
197461|NCT02360813|Randomized controlled trial|randomized controlled trial
197462|NCT02360813|Principle driven intervention|principle driven intervention
197463|NCT02360813|Psychological Intervention|psychological intervention
197464|NCT02360813|Cognitive enhancement|cognitive enhancement
197465|NCT02360800|Bleeding|bleeding
197466|NCT02360800|Heart Surgery|heart surgery
197467|NCT02360800|Reoperation|reoperation
197468|NCT02360787|Almonds|almonds
197469|NCT02360787|Energy restriction|energy restriction
197470|NCT02360787|Obesity|obesity
197471|NCT02360787|Body weight|body weight
197472|NCT02360787|Body fat|body fat
197473|NCT02360787|Blood pressure|blood pressure
197474|NCT02360787|Cognitive function|cognitive function
197475|NCT02360774|Canagliflozin|canagliflozin
197476|NCT02360774|Obesity|obesity
197477|NCT02360774|Weight Loss|weight loss
197478|NCT02360774|Body Weight|body weight
197479|NCT02360774|Body Weight Changes|body weight changes
197480|NCT02360774|Overweight|overweight
197481|NCT02360774|Sodium-glucose transporter subtype 2 inhibitor|sodium-glucose transporter subtype 2 inhibitor
197482|NCT02360761|Lung cancer;Elderly;Sublobar resection;Lobectomy|lung cancer;elderly;sublobar resection;lobectomy
197483|NCT02360696|Duodenal Eosinophilia|duodenal eosinophilia
197484|NCT02360696|Functional Dyspepsia|functional dyspepsia
197485|NCT02360696|Mucosal Eosinophilia|mucosal eosinophilia
197486|NCT02360683|Subthalamic neurostimulation|subthalamic neurostimulation
197487|NCT02360657|Alzheimer's Disease|alzheimer's disease
197488|NCT02360657|Alzheimer Dementia|alzheimer dementia
197489|NCT02360657|JNJ-54861911|jnj-54861911
197490|NCT02360657|Beta Secretase Inhibitor|beta secretase inhibitor
197491|NCT02360631|smoking|smoking
197492|NCT02360631|quit smoking|quit smoking
197493|NCT02360631|smoking treatment|smoking treatment
197494|NCT02360618|Bladder Cancer|bladder cancer
197495|NCT02360618|Metformin|metformin
197496|NCT02360618|Simvastatin|simvastatin
197497|NCT02360618|Combination Therapy|combination therapy
197498|NCT02360605|colorectal cancer screening|colorectal cancer screening
197499|NCT02360605|low literacy|low literacy
197500|NCT02360605|community clinics|community clinics
197501|NCT02360605|Fecal Immunochemical Test|fecal immunochemical test
197502|NCT02360579|Autologous Adoptive Cell Transfer|autologous adoptive cell transfer
197503|NCT02360579|Autologous Adoptive Cell Therapy|autologous adoptive cell therapy
197504|NCT02360579|Cellular Immuno-therapy|cellular immuno-therapy
197505|NCT02360579|Cell Therapy|cell therapy
197506|NCT02360579|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
197507|NCT02360579|TIL|til
197508|NCT02360579|LN-144|ln-144
197509|NCT02360579|IL-2|il-2
197510|NCT02360579|Melanoma|melanoma
197511|NCT02360566|Psychosis|psychosis
197512|NCT02360566|Schizophrenia|schizophrenia
197513|NCT02360566|Participatory Video|participatory video
197514|NCT02360566|Narrative|narrative
197515|NCT02360540|Pulmonary Embolism|pulmonary embolism
197516|NCT02360540|Diagnostic strategy|diagnostic strategy
197517|NCT02360540|Exclusion|exclusion
197518|NCT02360540|Clinical probability|clinical probability
197519|NCT02360540|Implicit Judgment (Gestalt)|implicit judgment (gestalt)
197520|NCT02360540|PERC|perc
197521|NCT02360501|nasopharyngeal carcinoma|nasopharyngeal carcinoma
197522|NCT02360501|induction chemotherapy|induction chemotherapy
197523|NCT02360501|docetaxel|docetaxel
197524|NCT02360501|xeloda|xeloda
197525|NCT02360475|Vaccine|vaccine
197526|NCT02360475|Immunogenicity|immunogenicity
197527|NCT02360475|Safety|safety
197528|NCT02360475|Respiratory syncytial virus (RSV)|respiratory syncytial virus (rsv)
197529|NCT02360475|Reactogenicity|reactogenicity
197530|NCT02360462|Transcranial Direct Current Stimulation|transcranial direct current stimulation
197531|NCT02360462|tDCS|tdcs
197532|NCT02360462|Hallux Valgus|hallux valgus
197533|NCT02360462|Chronic Pain|chronic pain
197534|NCT02360449|Pivotal Response Treatment|pivotal response treatment
197535|NCT02360449|Applied Behavior Analysis|applied behavior analysis
197536|NCT02360449|Peer Initiation|peer initiation
197537|NCT02360449|Social Skills Group|social skills group
197538|NCT02360436|Rett|rett
197539|NCT02360436|MeCP2|mecp2
197540|NCT02360436|Glutathione|glutathione
197541|NCT02360436|Cysteine|cysteine
197542|NCT02360436|ROS|ros
197543|NCT02360384|wireless motility capsule|wireless motility capsule
197544|NCT02360332|Autism|autism
197545|NCT02360332|transition to adulthood|transition to adulthood
197546|NCT02360332|employment|employment
197547|NCT02360332|High School Seniors|high school seniors
197548|NCT02360319|First episode or recent onset|first episode or recent onset
197549|NCT02360293|Exercise|exercise
197550|NCT02360293|App-mediated|app-mediated
197551|NCT02360293|Veterans|veterans
197552|NCT02360280|Depressive Disorder, Treatment-Resistant|depressive disorder, treatment-resistant
197553|NCT02360267|Bipolar Disorder|bipolar disorder
197554|NCT02360267|Pediatric|pediatric
197555|NCT02360267|Offspring|offspring
197556|NCT02360267|Depression|depression
197557|NCT02360267|Mania|mania
197558|NCT02360267|Children of parents who suffer from Bipolar disorder|children of parents who suffer from bipolar disorder
197559|NCT02360228|tACS|tacs
197560|NCT02360228|tDCS|tdcs
197561|NCT02360228|sham|sham
197562|NCT02360228|auditory hallucinations|auditory hallucinations
197563|NCT02360228|Schizophrenia|schizophrenia
197564|NCT02360228|Schizoaffective Disorder|schizoaffective disorder
197565|NCT02360176|single port surgery|single port surgery
197566|NCT02360176|bariatric surgery|bariatric surgery
197567|NCT02360176|sleeve gastrectomy|sleeve gastrectomy
197568|NCT02360176|randomise prospective study|randomise prospective study
197569|NCT02360176|complication rate|complication rate
197570|NCT02360150|cardiac angiography|cardiac angiography
197571|NCT02360150|cardiac MRI|cardiac mri
197572|NCT02360137|carotids|carotids
197573|NCT02360137|plaque|plaque
197574|NCT02360137|characteristics|characteristics
197575|NCT02360137|stroke|stroke
197576|NCT02360111|GVHD Prophylaxis|gvhd prophylaxis
197577|NCT02360111|Cyclophosphamide|cyclophosphamide
197578|NCT02360111|Renal Insufficiency|renal insufficiency
197579|NCT02360111|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
197580|NCT02360111|14-273|14-273
197581|NCT02360098|Emergence from Anesthesia|emergence from anesthesia
197582|NCT02360098|Anterior temporal lobectomy|anterior temporal lobectomy
197583|NCT02360098|Amygdalohippocampectomy|amygdalohippocampectomy
197584|NCT02360098|Anesthesia|anesthesia
197585|NCT02360085|Cervical Myelopathy|cervical myelopathy
197586|NCT02360085|Hypotension|hypotension
197587|NCT02360072|child|child
197588|NCT02360072|allergic rhinitis|allergic rhinitis
197589|NCT02360072|asthma|asthma
197590|NCT02360072|nitric oxide|nitric oxide
197591|NCT02360072|bronchial hyper-responsiveness|bronchial hyper-responsiveness
197592|NCT02360059|Breast cancer|breast cancer
197593|NCT02360059|Neuropathy|neuropathy
197594|NCT02360059|Paclitaxel|paclitaxel
197595|NCT02360059|Metformin|metformin
197596|NCT02360059|Metformin ER|metformin er
197597|NCT02360059|Placebo|placebo
197598|NCT02360059|Sugar pill|sugar pill
197599|NCT02360059|Questionnaires|questionnaires
197600|NCT02360059|Sensory tests|sensory tests
197601|NCT02360059|Fine-motor tests|fine-motor tests
197602|NCT02360059|Surveys|surveys
197603|NCT02360020|coronary stent|coronary stent
197604|NCT02360020|outcome|outcome
197605|NCT02360007|opioids|opioids
197606|NCT02360007|buprenorphine|buprenorphine
197607|NCT02360007|interim treatment|interim treatment
197608|NCT02360007|opioid dependence|opioid dependence
197609|NCT02359994|hemostasis|hemostasis
197610|NCT02359981|Weight loss, Fitness|weight loss, fitness
197611|NCT02359968|resectable esophageal|resectable esophageal
197612|NCT02359968|junctional cancer|junctional cancer
197613|NCT02359968|FOLFOX|folfox
197614|NCT02359968|paclitaxel-carboplatin|paclitaxel-carboplatin
197615|NCT02359942|Helicobacter pylori infection|helicobacter pylori infection
197616|NCT02359942|Eradication|eradication
197617|NCT02359942|Urea breath test|urea breath test
197618|NCT02359929|graft versus host disease|graft versus host disease
197619|NCT02359929|GVHD|gvhd
197620|NCT02359890|Interventional|interventional
197621|NCT02359890|Radiofrequency ablation|radiofrequency ablation
197622|NCT02359890|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
197623|NCT02359877|pegylated interferon beta|pegylated interferon beta
197624|NCT02359877|Volunteers|volunteers
197625|NCT02359864|radiation treatment|radiation treatment
197626|NCT02359838|Hematologic Malignancy|hematologic malignancy
197627|NCT02359838|Geriatric Assessment|geriatric assessment
197628|NCT02359838|Geriatric Oncology|geriatric oncology
197629|NCT02359838|Frailty|frailty
197630|NCT02359812|Stroke|stroke
197631|NCT02359812|Upper extremity|upper extremity
197632|NCT02359812|Rehabilitation|rehabilitation
197633|NCT02359812|Robot|robot
197634|NCT02359812|Hemiplegia|hemiplegia
197635|NCT02359812|Spasticity|spasticity
197636|NCT02359812|Arm|arm
197637|NCT02359812|Hand|hand
197638|NCT02359799|Cerebral palsy|cerebral palsy
197639|NCT02359799|Ankle|ankle
197640|NCT02359773|Magnetocardiography|magnetocardiography
197641|NCT02359773|Myocardial Infarction|myocardial infarction
197642|NCT02359773|Non-ischaemic chest pain|non-ischaemic chest pain
197643|NCT02359760|Rapid orthodontics|rapid orthodontics
197644|NCT02359760|accelerated orthodontics|accelerated orthodontics
197645|NCT02359760|Piezocision|piezocision
197646|NCT02359760|flapless corticotomies|flapless corticotomies
197647|NCT02359760|minimaly invasive|minimaly invasive
197648|NCT02359747|free gDNA|free gdna
197649|NCT02359747|culture media|culture media
197650|NCT02359734|Patient safety|patient safety
197651|NCT02359734|Medication errors|medication errors
197652|NCT02359734|Smart infusion pump|smart infusion pump
197653|NCT02359721|Colony forming units Antimicrobial agents|colony forming units antimicrobial agents
197654|NCT02359721|Microbial colonization|microbial colonization
197655|NCT02359695|Poor ovarian response|poor ovarian response
197656|NCT02359695|IVF|ivf
197657|NCT02359695|Growth hormone|growth hormone
197658|NCT02359643|Kawasaki disease|kawasaki disease
197659|NCT02359617|continuous glucose sensor|continuous glucose sensor
197660|NCT02359617|subcutaneous insulin infusion|subcutaneous insulin infusion
197661|NCT02359617|closed-loop glucose control|closed-loop glucose control
197662|NCT02359617|type 1 diabetes|type 1 diabetes
197663|NCT02359604|infant|infant
197664|NCT02359604|ppi|ppi
197665|NCT02359604|proton pump inhibitor|proton pump inhibitor
197666|NCT02359604|microbiome|microbiome
197667|NCT02359604|Microbiota|microbiota
197668|NCT02359578|lymphatic system|lymphatic system
197669|NCT02359578|occlusion pressure|occlusion pressure
197670|NCT02359578|Indocyanine Green|indocyanine green
197671|NCT02359526|Chronic Diabetic Macular Edema|chronic diabetic macular edema
197672|NCT02359526|Iluvien|iluvien
197673|NCT02359526|Intra-vitreal injections|intra-vitreal injections
197674|NCT02359526|Pilot study|pilot study
197675|NCT02359513|bulimia|bulimia
197676|NCT02359513|serotoninergic brain activity|serotoninergic brain activity
197677|NCT02359513|fluoxetine|fluoxetine
197678|NCT02359513|serotoninergic antidepressant|serotoninergic antidepressant
197679|NCT02359513|brain serotonin profile|brain serotonin profile
197680|NCT02359513|positon emission tomography|positon emission tomography
197681|NCT02359500|68Ga- DOTATOC|68ga- dotatoc
197682|NCT02359500|Diagnosis|diagnosis
197683|NCT02359500|Somatostatin Receptor-Positive Neuroendocrine Tumors|somatostatin receptor-positive neuroendocrine tumors
197684|NCT02359487|Namibia|namibia
197685|NCT02359487|Alcohol|alcohol
197686|NCT02359487|HIV|hiv
197687|NCT02359487|Sexual risk|sexual risk
197688|NCT02359474|high-risk soft tissue sarcoma|high-risk soft tissue sarcoma
197689|NCT02359474|trabectedin|trabectedin
197690|NCT02359461|Vascular function|vascular function
197691|NCT02359461|Pulsatile cuts|pulsatile cuts
197692|NCT02359461|Type 2 diabetes|type 2 diabetes
197693|NCT02359461|Endothelium|endothelium
197694|NCT02359461|Cardiovascular risk|cardiovascular risk
197695|NCT02359461|Vasomotricity|vasomotricity
197696|NCT02359461|FMD (Flow Mediated Dilatation)|fmd (flow mediated dilatation)
197697|NCT02359435|Helicobacter pylori|helicobacter pylori
197698|NCT02359435|Proton pump inhibitor|proton pump inhibitor
197699|NCT02359435|Eradication|eradication
197700|NCT02359396|Randomized open-label study|randomized open-label study
197701|NCT02359396|Chinese Herbal|chinese herbal
197702|NCT02359396|Constipation/drug therapy|constipation/drug therapy
197703|NCT02359383|pleural disease|pleural disease
197704|NCT02359383|infecTion|infection
197705|NCT02359383|chest physiotherapy|chest physiotherapy
197706|NCT02359370|Laryngoscopy|laryngoscopy
197707|NCT02359370|Tracheal Intubation|tracheal intubation
197708|NCT02359370|Lidocaine|lidocaine
197709|NCT02359370|Magnesium Sulphate|magnesium sulphate
197710|NCT02359370|Cardiovascular Physiological Phenomena|cardiovascular physiological phenomena
197711|NCT02359331|Helicobacter pylori|helicobacter pylori
197712|NCT02359331|resistance|resistance
197713|NCT02359331|rescue therapy|rescue therapy
197714|NCT02359318|White spot lesion|white spot lesion
197715|NCT02359318|Resin Infiltration|resin infiltration
197716|NCT02359318|Icon|icon
197717|NCT02359318|Debonding|debonding
197718|NCT02359318|Enamel damages|enamel damages
197719|NCT02359318|Enamel|enamel
197720|NCT02359318|Orthodontics|orthodontics
197721|NCT02359266|Mood|mood
197722|NCT02359266|Vitamin D deficiency|vitamin d deficiency
197723|NCT02359266|Adjuvant treatment|adjuvant treatment
197724|NCT02359253|Stroke|stroke
197725|NCT02359253|Spasticity|spasticity
197726|NCT02359253|Arm|arm
197727|NCT02359253|Hand|hand
197728|NCT02359253|Robotic therapy|robotic therapy
197729|NCT02359227|Chronic Heart Failure|chronic heart failure
197730|NCT02359227|Natriuretic Peptides|natriuretic peptides
197731|NCT02359227|Cenderitide|cenderitide
197732|NCT02359214|Vitamin D|vitamin d
197733|NCT02359214|Cardiovascular disease|cardiovascular disease
197734|NCT02359214|Diabetes|diabetes
197735|NCT02359214|Obesity|obesity
197736|NCT02359214|Cardiometabolic|cardiometabolic
197737|NCT02359214|Bone disease|bone disease
197738|NCT02359201|Nicotine replacement therapy|nicotine replacement therapy
197739|NCT02359201|craving|craving
197740|NCT02359201|Healthy moderately dependant smokers|healthy moderately dependant smokers
197741|NCT02359188|Vagus Nerve Stimulation|vagus nerve stimulation
197742|NCT02359175|Pain|pain
197743|NCT02359175|Pain Measurement|pain measurement
197744|NCT02359175|VAS|vas
197745|NCT02359175|Visual Analog Pain Scale|visual analog pain scale
197746|NCT02359175|Analgesics|analgesics
197747|NCT02359175|Opioid|opioid
197748|NCT02359175|Epidural analgesia|epidural analgesia
197749|NCT02359175|VATS|vats
197750|NCT02359175|Video-assisted Thoracic Surgery|video-assisted thoracic surgery
197751|NCT02359175|Lobectomy|lobectomy
197752|NCT02359175|Wedge Resection|wedge resection
197753|NCT02359175|Segmental Resection|segmental resection
197754|NCT02359162|NK/T-cell lymphoma|nk/t-cell lymphoma
197755|NCT02359162|induction chemotherapy|induction chemotherapy
197756|NCT02359162|survival|survival
197757|NCT02359149|Intravitreal injections|intravitreal injections
197758|NCT02359149|Nurses|nurses
197759|NCT02359149|Physicians|physicians
197760|NCT02359136|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
197761|NCT02359136|Anesthesia, Local|anesthesia, local
197762|NCT02359136|Ropivacaine|ropivacaine
197763|NCT02359136|Randomized controlled trial|randomized controlled trial
197764|NCT02359110|laparoscopy|laparoscopy
197765|NCT02359110|postoperative pain|postoperative pain
197766|NCT02359110|gynecology|gynecology
197767|NCT02359110|gabapentin|gabapentin
197768|NCT02359071|handoff|handoff
197769|NCT02359071|signoff|signoff
197770|NCT02359071|handover|handover
197771|NCT02359071|sign-out|sign-out
197772|NCT02359071|shift change|shift change
197773|NCT02359071|Emergency Department|emergency department
197774|NCT02359045|Omega-3-carboxylic acids,|omega-3-carboxylic acids,
197775|NCT02359045|Phase I,|phase i,
197776|NCT02359045|Healthy Subjects,|healthy subjects,
197777|NCT02359045|Pharmacokinetics,|pharmacokinetics,
197778|NCT02359045|Relative bioavailability|relative bioavailability
197779|NCT02359032|Healthy subjects|healthy subjects
197780|NCT02359032|Pharmacokinetics of ASP6858|pharmacokinetics of asp6858
197781|NCT02359032|ASP6858|asp6858
197782|NCT02359032|Pharmacodynamics of ASP6858|pharmacodynamics of asp6858
197783|NCT02359006|Analgesia|analgesia
197784|NCT02359006|pain analgesia|pain analgesia
197785|NCT02359006|methadone|methadone
197786|NCT02359006|opiates|opiates
197787|NCT02358993|Urinary Tract Infections|urinary tract infections
197788|NCT02358993|Catheter-Related Infections|catheter-related infections
197789|NCT02358993|Pelvic Reconstructive Surgery|pelvic reconstructive surgery
197790|NCT02358993|Urogynecology|urogynecology
197791|NCT02358993|Urinary catheterization|urinary catheterization
197792|NCT02358993|Post-operative Infections|post-operative infections
197793|NCT02358993|Methenamine hippurate|methenamine hippurate
197794|NCT02358980|Multiple Myeloma|multiple myeloma
197795|NCT02358980|Cast Nephropathy|cast nephropathy
197796|NCT02358980|Acute kidney injury|acute kidney injury
197797|NCT02358980|KIDNEY THERAPY|kidney therapy
197798|NCT02358980|HFR|hfr
197799|NCT02358967|ESRD|esrd
197800|NCT02358967|dyslipidemia|dyslipidemia
197801|NCT02358967|oxidative stress|oxidative stress
197802|NCT02358967|inflammation|inflammation
197803|NCT02358967|Hemodialysis|hemodialysis
197804|NCT02358967|CKD|ckd
197805|NCT02358954|quantitative sensory testing|quantitative sensory testing
197806|NCT02358954|contact heat evoked potentials|contact heat evoked potentials
197807|NCT02358954|vection stimulation|vection stimulation
197808|NCT02358954|3D-turntable|3d-turntable
197809|NCT02358954|Volunteers|volunteers
197810|NCT02358941|ADHD, neurofeedback, computerized cognitive training, school|adhd, neurofeedback, computerized cognitive training, school
197811|NCT02358928|NAFLD|nafld
197812|NCT02358928|Metabolic syndrome|metabolic syndrome
197813|NCT02358928|Hepatic Magnetic Resonance Spectroscopy|hepatic magnetic resonance spectroscopy
197814|NCT02358928|Obesity|obesity
197815|NCT02358902|Transcranial Direct Current Stimulation|transcranial direct current stimulation
197816|NCT02358902|Exercise|exercise
197817|NCT02358902|Fibromyalgia|fibromyalgia
197818|NCT02358876|Parkinson's disease|parkinson's disease
197819|NCT02358876|Deep brain stimulation|deep brain stimulation
197820|NCT02358876|Bradykinesia|bradykinesia
197821|NCT02358850|Tonsillectomy|tonsillectomy
197822|NCT02358850|Adenoidectomy|adenoidectomy
197823|NCT02358837|elastosonography|elastosonography
197824|NCT02358837|comparing conventional sonography with ductosonography|comparing conventional sonography with ductosonography
197825|NCT02358824|Hypertension|hypertension
197826|NCT02358824|CKD-828|ckd-828
197827|NCT02358824|Telmisartan|telmisartan
197828|NCT02358824|S-amlodipine|s-amlodipine
197829|NCT02358824|Pharmacokinetic|pharmacokinetic
197830|NCT02358811|Obstructive Sleep Apnea|obstructive sleep apnea
197831|NCT02358811|Voxel-Based Morphometry|voxel-based morphometry
197832|NCT02358811|Polysomnography|polysomnography
197833|NCT02358811|Magnetic resonance imaging|magnetic resonance imaging
197834|NCT02358798|Time evolution of respiratory function|time evolution of respiratory function
197835|NCT02358798|Longitudinal multicenter monitoring of large cohorts|longitudinal multicenter monitoring of large cohorts
197836|NCT02358798|Preschool aged children|preschool aged children
197837|NCT02358798|Detection of cystic fibrosis in neonatal period|detection of cystic fibrosis in neonatal period
197838|NCT02358772|stroke|stroke
197839|NCT02358772|thrombolysis|thrombolysis
197840|NCT02358772|STEMO|stemo
197841|NCT02358759|Abnormal zygote fertilization|abnormal zygote fertilization
197842|NCT02358759|3PNs correction|3pns correction
197843|NCT02358759|Giant oocyte management|giant oocyte management
197844|NCT02358759|triploidy fertilization|triploidy fertilization
197845|NCT02358759|Maternal nucleus removal|maternal nucleus removal
197846|NCT02358746|epicardial catheter ablation|epicardial catheter ablation
197847|NCT02358733|POR|por
197848|NCT02358733|IMSI|imsi
197849|NCT02358720|bone metastases|bone metastases
197850|NCT02358707|ibuprofen phonophoresis|ibuprofen phonophoresis
197851|NCT02358707|High performance liquid chromatography|high performance liquid chromatography
197852|NCT02358694|IBS|ibs
197853|NCT02358694|IBS-D|ibs-d
197854|NCT02358694|SBI|sbi
197855|NCT02358681|Intranasal|intranasal
197856|NCT02358681|Ketorolac|ketorolac
197857|NCT02358681|Pediatric|pediatric
197858|NCT02358681|Migraine|migraine
197859|NCT02358681|Headache|headache
197860|NCT02358655|Oral anticoagulant|oral anticoagulant
197861|NCT02358655|Knowledge translation|knowledge translation
197862|NCT02358655|Emergency department|emergency department
197863|NCT02358642|Rate of Pneumonia|rate of pneumonia
197864|NCT02358642|Mortality rate|mortality rate
197865|NCT02358603|Chronotropic Incompetence|chronotropic incompetence
197866|NCT02358603|Heart Failure|heart failure
197867|NCT02358564|IBS|ibs
197868|NCT02358564|Irritable Bowel Syndrome|irritable bowel syndrome
197869|NCT02358564|Visceral Hypersensitivity|visceral hypersensitivity
197870|NCT02358564|Permeability|permeability
197871|NCT02358564|Small Bowel|small bowel
197872|NCT02358564|Lactulose|lactulose
197873|NCT02358564|Mannitol|mannitol
197874|NCT02358551|Pacemaker|pacemaker
197875|NCT02358551|Axillary Vein|axillary vein
197876|NCT02358551|Subclavian vein|subclavian vein
197877|NCT02358551|Clinical Study|clinical study
197878|NCT02358551|Cardiovascular implantable electronic devices|cardiovascular implantable electronic devices
197879|NCT02358538|PCDH19|pcdh19
197880|NCT02358538|ganaxolone|ganaxolone
197881|NCT02358538|neurosteroid|neurosteroid
197882|NCT02358538|CDKL5|cdkl5
197883|NCT02358538|LGS|lgs
197884|NCT02358538|CSWS|csws
197885|NCT02358512|Intensive Care|intensive care
197886|NCT02358512|Recovery of Function|recovery of function
197887|NCT02358512|Survivors|survivors
197888|NCT02358512|Outcome Assessment (Health Care)|outcome assessment (health care)
197889|NCT02358512|Medical Economics|medical economics
197890|NCT02358499|triazoles|triazoles
197891|NCT02358499|fungi|fungi
197892|NCT02358499|transplantation, hematopoietic stem cell|transplantation, hematopoietic stem cell
197893|NCT02358499|leukemia|leukemia
197894|NCT02358499|pediatrics|pediatrics
197895|NCT02358499|pharmacokinetics|pharmacokinetics
197896|NCT02358499|bone marrow failure syndrome|bone marrow failure syndrome
197897|NCT02358486|Functional Dyspepsia|functional dyspepsia
197898|NCT02358486|Acupuncture|acupuncture
197899|NCT02358486|Functional MRI|functional mri
197900|NCT02358473|Nonsmall Cell Lung Cancer|nonsmall cell lung cancer
197901|NCT02358473|NSCLC|nsclc
197902|NCT02358473|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
197903|NCT02358473|Carcinoma, Non-Small Cell Lung|carcinoma, non-small cell lung
197904|NCT02358473|KW-0761|kw-0761
197905|NCT02358473|Mogamulizumab|mogamulizumab
197906|NCT02358460|neonatal|neonatal
197907|NCT02358460|respiratory|respiratory
197908|NCT02358460|mechanical ventilation|mechanical ventilation
197909|NCT02358447|total knee arthroplasty|total knee arthroplasty
197910|NCT02358447|total knee prothesis|total knee prothesis
197911|NCT02358447|Spectrometry, X-Ray Emission|spectrometry, x-ray emission
197912|NCT02358447|SPECT/CT|spect/ct
197913|NCT02358447|measurement of TKA component position|measurement of tka component position
197914|NCT02358434|Implant|implant
197915|NCT02358421|Rotterdam's diagnostic criteria of PCOS|rotterdam's diagnostic criteria of pcos
197916|NCT02358421|Risk of OHSS|risk of ohss
197917|NCT02358356|midgut|midgut
197918|NCT02358356|pancreatic|pancreatic
197919|NCT02358356|neuroendocrine|neuroendocrine
197920|NCT02358356|advanced|advanced
197921|NCT02358356|unresectable low|unresectable low
197922|NCT02358356|intermediate grade|intermediate grade
197923|NCT02358356|mNETs|mnets
197924|NCT02358356|pNETs|pnets
197925|NCT02358343|Comorbid Depression|comorbid depression
197926|NCT02358343|Major Depressive Disorder|major depressive disorder
197927|NCT02358343|Dysthymia|dysthymia
197928|NCT02358343|Cognitive Behavioral therapy (CBT)|cognitive behavioral therapy (cbt)
197929|NCT02358343|Sertraline|sertraline
197930|NCT02358343|Engagement Interview|engagement interview
197931|NCT02358343|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
197932|NCT02358343|Hemodialysis|hemodialysis
197933|NCT02358317|Autism|autism
197934|NCT02358317|Postural Stability|postural stability
197935|NCT02358317|Exergaming|exergaming
197936|NCT02358317|White Matter|white matter
197937|NCT02358252|Heart Rate Variability|heart rate variability
197938|NCT02358252|orthostatic hypotension|orthostatic hypotension
197939|NCT02358252|stroke|stroke
197940|NCT02358252|integrated intelligent biosensor system|integrated intelligent biosensor system
197941|NCT02358239|dizziness and vertigo|dizziness and vertigo
197942|NCT02358239|emergency department (ED)|emergency department (ed)
197943|NCT02358239|clinical trial|clinical trial
197944|NCT02358239|acupuncture|acupuncture
197945|NCT02358226|Substance-Related Disorders|substance-related disorders
197946|NCT02358226|Human Immunodeficiency Virus|human immunodeficiency virus
197947|NCT02358226|Alcoholism|alcoholism
197948|NCT02358226|South Africa|south africa
197949|NCT02358226|Men|men
197950|NCT02358226|Soccer|soccer
197951|NCT02358226|Vocational Training|vocational training
197952|NCT02358213|reproductibility|reproductibility
197953|NCT02358174|Hemorrhoids|hemorrhoids
197954|NCT02358174|MMP|mmp
197955|NCT02358174|NGAL|ngal
197956|NCT02358174|Matrix Metalloproteinases|matrix metalloproteinases
197957|NCT02358161|Pancreatic cancer|pancreatic cancer
197958|NCT02358161|LDE225|lde225
197959|NCT02358161|Gemcitabine|gemcitabine
197960|NCT02358161|nab paclitaxel|nab paclitaxel
197961|NCT02358148|Acute Coronary Syndrome|acute coronary syndrome
197962|NCT02358148|Chest Pain|chest pain
197963|NCT02358148|ACS|acs
197964|NCT02358148|Risk Stratification Score|risk stratification score
197965|NCT02358148|HEART Score|heart score
197966|NCT02358148|Modified TIMI|modified timi
197967|NCT02358148|Coronary Artery Disease|coronary artery disease
197968|NCT02358148|Risk Factors|risk factors
197969|NCT02358148|Myocardial Infarction|myocardial infarction
197970|NCT02358135|Pragmatic|pragmatic
197971|NCT02358135|Equivalency|equivalency
197972|NCT02358135|Teledermatology|teledermatology
197973|NCT02358109|Cost-Benefit Analysis, Exercise,Women,Diseases/Prevention|cost-benefit analysis, exercise,women,diseases/prevention
197974|NCT02358096|Chronic Kidney Disease|chronic kidney disease
197975|NCT02358096|Type 2 Diabetes|type 2 diabetes
197976|NCT02358096|ASP8232|asp8232
197977|NCT02358070|Hepatocellular Carcinoma|hepatocellular carcinoma
197978|NCT02358057|Deep sedation|deep sedation
197979|NCT02358057|Dexmedetomidine|dexmedetomidine
197980|NCT02358057|Emergency Service, Hospital|emergency service, hospital
197981|NCT02358031|Programmed Cell Death Receptor 1 (PD-1)|programmed cell death receptor 1 (pd-1)
197982|NCT02358031|Programmed Cell Death Receptor Ligand 1 (PD-L1)|programmed cell death receptor ligand 1 (pd-l1)
197983|NCT02358031|Programmed Cell Death Receptor Ligand 2 (PD-L2)|programmed cell death receptor ligand 2 (pd-l2)
197984|NCT02358031|PD1|pd1
197985|NCT02358031|PD-1|pd-1
197986|NCT02358031|PDL1|pdl1
197987|NCT02358031|PD-L1|pd-l1
197988|NCT02358031|PDL2|pdl2
197989|NCT02358018|68Ga-DOTATOC|68ga-dotatoc
197990|NCT02358018|PET/CT scan|pet/ct scan
197991|NCT02358018|14-226|14-226
197992|NCT02357992|Lung cancer|lung cancer
197993|NCT02357992|Non-small cell lung cancer|non-small cell lung cancer
197994|NCT02357992|NSCLC|nsclc
197995|NCT02357992|Squamous cell carcinoma|squamous cell carcinoma
197996|NCT02357992|Adenocarcinoma with or without BAC features|adenocarcinoma with or without bac features
197997|NCT02357992|Large cell carcinoma with or without neuroendocrine features|large cell carcinoma with or without neuroendocrine features
197998|NCT02357992|Neuroendocrine carcinoma|neuroendocrine carcinoma
197999|NCT02357992|Bronchioloalveolar cell carcinoma|bronchioloalveolar cell carcinoma
198000|NCT02357992|Stereotactic radiotherapy (SRT)|stereotactic radiotherapy (srt)
198001|NCT02357992|SRT|srt
198002|NCT02357992|Stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
198003|NCT02357992|SABR|sabr
198004|NCT02357992|Radiation therapy|radiation therapy
198005|NCT02357992|XRT|xrt
198006|NCT02357979|caries|caries
198007|NCT02357979|prevention|prevention
198008|NCT02357979|laser|laser
198009|NCT02357979|fluoride|fluoride
198010|NCT02357966|Staph|staph
198011|NCT02357966|antibody|antibody
198012|NCT02357940|Eczema|eczema
198013|NCT02357940|Skin Irritation|skin irritation
198014|NCT02357927|fears of recurrence|fears of recurrence
198015|NCT02357927|cancer|cancer
198016|NCT02357927|brief intervention|brief intervention
198017|NCT02357927|telephone counseling|telephone counseling
198018|NCT02357927|following primary cancer treatment|following primary cancer treatment
198019|NCT02357914|Ultrasound|ultrasound
198020|NCT02357914|Shoulder|shoulder
198021|NCT02357914|Spinal Cord Injury|spinal cord injury
198022|NCT02357914|Fluoroscopy|fluoroscopy
198023|NCT02357888|Nicotine replacement therapy|nicotine replacement therapy
198024|NCT02357888|craving|craving
198025|NCT02357862|Cardiovascular Diseases|cardiovascular diseases
198026|NCT02357862|Heart Valve Diseases|heart valve diseases
198027|NCT02357862|Mitral Valve Annuloplasty|mitral valve annuloplasty
198028|NCT02357862|Tricuspid Valve Insufficiency|tricuspid valve insufficiency
198029|NCT02357823|Pneumococcal vaccine|pneumococcal vaccine
198030|NCT02357823|HIV infection|hiv infection
198031|NCT02357823|13-valent Pneumococcal Conjugate Vaccine|13-valent pneumococcal conjugate vaccine
198032|NCT02357823|23-valent Pneumococcal Polysaccharide Vaccine|23-valent pneumococcal polysaccharide vaccine
198033|NCT02357784|Sacral Neuromodulation|sacral neuromodulation
198034|NCT02357784|SNM|snm
198035|NCT02357784|Dual Incontinence|dual incontinence
198036|NCT02357784|Current Perception Threshold Testing|current perception threshold testing
198037|NCT02357784|CPT Testing|cpt testing
198038|NCT02357784|Fecal Incontinence|fecal incontinence
198039|NCT02357784|Urinary Incontinence|urinary incontinence
198040|NCT02357784|Afferent Nerve Sensation|afferent nerve sensation
198041|NCT02357784|InterStim|interstim
198042|NCT02357771|misalignment of the two dental arches|misalignment of the two dental arches
198043|NCT02357771|mal-align teeth|mal-align teeth
198044|NCT02357758|Antibiotic Prophylaxis|antibiotic prophylaxis
198045|NCT02357758|Urinary Microbiota|urinary microbiota
198046|NCT02357745|neopterin|neopterin
198047|NCT02357745|plasma|plasma
198048|NCT02357745|urine|urine
198049|NCT02357745|saliva|saliva
198050|NCT02357745|menopause|menopause
198051|NCT02357745|periodontitis|periodontitis
198052|NCT02357732|Metastatic Melanoma|metastatic melanoma
198053|NCT02357719|Sleep Apnea Syndromes|sleep apnea syndromes
198054|NCT02357719|Polysomnography|polysomnography
198055|NCT02357719|Holter ECG|holter ecg
198056|NCT02357719|Thoracic impedance|thoracic impedance
198057|NCT02357719|Heart rate variability|heart rate variability
198058|NCT02357719|Nasal flow|nasal flow
198059|NCT02357693|nausea, postoperative|nausea, postoperative
198060|NCT02357693|postoperative nausea|postoperative nausea
198061|NCT02357693|postoperative vomiting|postoperative vomiting
198062|NCT02357693|vomiting, postoperative|vomiting, postoperative
198063|NCT02357641|acute coronary disease, echographic strain analysis, cut off|acute coronary disease, echographic strain analysis, cut off
198064|NCT02357602|Participants|participants
198065|NCT02357602|HIV-1 negative|hiv-1 negative
198066|NCT02357589|3D|3d
198067|NCT02357589|laparoscopy|laparoscopy
198068|NCT02357589|cholecystectomy|cholecystectomy
198069|NCT02357563|fibroid|fibroid
198070|NCT02357563|GnRH analogue|gnrh analogue
198071|NCT02357563|ulipristal acetate|ulipristal acetate
198072|NCT02357537|Telemedicine|telemedicine
198073|NCT02357524|Effects on coagulation tests in healthy volunteers|effects on coagulation tests in healthy volunteers
198074|NCT02357511|sensitivity|sensitivity
198075|NCT02357511|specificity|specificity
198076|NCT02357511|novel blood pressure monitor|novel blood pressure monitor
198077|NCT02357511|Saturation|saturation
198078|NCT02357498|pituitary|pituitary
198079|NCT02357498|adenoma|adenoma
198080|NCT02357498|transsphenoidal surgery|transsphenoidal surgery
198081|NCT02357485|ADSC|adsc
198082|NCT02357485|osteoarthritis|osteoarthritis
198083|NCT02357485|knee|knee
198084|NCT02357485|adipose|adipose
198085|NCT02357472|Reproductive aging|reproductive aging
198086|NCT02357472|DHEA|dhea
198087|NCT02357472|poor ovarian responder|poor ovarian responder
198088|NCT02357459|osteoarthritis|osteoarthritis
198089|NCT02357459|knee|knee
198090|NCT02357459|pain|pain
198091|NCT02357459|corticosteroid|corticosteroid
198092|NCT02357459|intra-articular|intra-articular
198093|NCT02357459|injection|injection
198094|NCT02357420|Diabetes Mellitus|diabetes mellitus
198095|NCT02357420|Delayed Gastric Emptying|delayed gastric emptying
198096|NCT02357420|Vomiting|vomiting
198097|NCT02357420|Gastroparesis|gastroparesis
198098|NCT02357420|Gastrointestinal Motility Disorder|gastrointestinal motility disorder
198099|NCT02357407|fluoroquinolones|fluoroquinolones
198100|NCT02357407|pharmacokinetic|pharmacokinetic
198101|NCT02357407|infections|infections
198102|NCT02357368|HIV-negative|hiv-negative
198103|NCT02357329|fat taste|fat taste
198104|NCT02357329|food preference|food preference
198105|NCT02357329|consumption|consumption
198106|NCT02357329|free fatty acids|free fatty acids
198107|NCT02357316|Taste responses of healthy individuals|taste responses of healthy individuals
198108|NCT02357303|Randomized controlled trial|randomized controlled trial
198109|NCT02357303|Endoscopy|endoscopy
198110|NCT02357303|Gastric mucosa|gastric mucosa
198111|NCT02357303|Simethicone|simethicone
198112|NCT02357303|Acetylcysteine|acetylcysteine
198113|NCT02357290|mania|mania
198114|NCT02357290|temper tantrum|temper tantrum
198115|NCT02357290|irritability|irritability
198116|NCT02357290|mood|mood
198117|NCT02357290|bipolar|bipolar
198118|NCT02357277|Osteoporosis|osteoporosis
198119|NCT02357277|Glucocorticoids|glucocorticoids
198120|NCT02357277|Postmenopausal|postmenopausal
198121|NCT02357238|Uveitis|uveitis
198122|NCT02357238|Infectious|infectious
198123|NCT02357225|Pompe disease|pompe disease
198124|NCT02357225|Pyridostigmine|pyridostigmine
198125|NCT02357212|Non-St elevation acute coronary syndrome|non-st elevation acute coronary syndrome
198126|NCT02357199|Mouth Diseases|mouth diseases
198127|NCT02357199|Renal Insufficiency, Chronic|renal insufficiency, chronic
198128|NCT02357199|Intervention Studies|intervention studies
198129|NCT02357186|Mild head injury - clinical decision rule - Child|mild head injury - clinical decision rule - child
198130|NCT02357173|smoking|smoking
198131|NCT02357173|nicotine|nicotine
198132|NCT02357173|tobacco products|tobacco products
198133|NCT02357173|electronic cigarette|electronic cigarette
198134|NCT02357147|Amatuximab|amatuximab
198135|NCT02357147|Pemetrexed|pemetrexed
198136|NCT02357147|Cisplatin|cisplatin
198137|NCT02357147|Unresectable Malignant Pleural Mesothelioma|unresectable malignant pleural mesothelioma
198138|NCT02357147|ARTEMIS|artemis
198139|NCT02357134|Advanced cancers|advanced cancers
198140|NCT02357134|Primary or secondary lung involvement|primary or secondary lung involvement
198141|NCT02357134|Dyspnea|dyspnea
198142|NCT02357134|Difficulty breathing|difficulty breathing
198143|NCT02357134|Stationary cycle test|stationary cycle test
198144|NCT02357134|Questionnaires|questionnaires
198145|NCT02357134|Surveys|surveys
198146|NCT02357134|High flow oxygen|high flow oxygen
198147|NCT02357134|High flow air|high flow air
198148|NCT02357134|Low flow oxygen|low flow oxygen
198149|NCT02357134|Low flow air|low flow air
198150|NCT02357108|Supportive Care|supportive care
198151|NCT02357108|treatment options|treatment options
198152|NCT02357108|doctor's compassion|doctor's compassion
198153|NCT02357095|Caesarean Scar Pregnancy|caesarean scar pregnancy
198154|NCT02357095|uterine artery chemo-embolization|uterine artery chemo-embolization
198155|NCT02357095|treatment|treatment
198156|NCT02357030|Gulf War Illness|gulf war illness
198157|NCT02357030|nutrients|nutrients
198158|NCT02357030|methylphenidate|methylphenidate
198159|NCT02357030|mitochondria|mitochondria
198160|NCT02356991|Famitinib|famitinib
198161|NCT02356991|Phase II|phase ii
198162|NCT02356991|NSCLC|nsclc
198163|NCT02356978|Rare disease|rare disease
198164|NCT02356978|Crigler-Najjar disease|crigler-najjar disease
198165|NCT02356978|Paediatric|paediatric
198166|NCT02356978|Experimental device|experimental device
198167|NCT02356965|Third molar extraction|third molar extraction
198168|NCT02356965|Wisdom tooth extraction|wisdom tooth extraction
198169|NCT02356952|Metabolic Syndrome X|metabolic syndrome x
198170|NCT02356952|Low Glycemic Index Mediterranean Diet|low glycemic index mediterranean diet
198171|NCT02356952|Low Glycemic Index Diet|low glycemic index diet
198172|NCT02356952|Randomized Clinical Trial|randomized clinical trial
198173|NCT02356926|Adverse events|adverse events
198174|NCT02356926|Medical errors|medical errors
198175|NCT02356926|Emergency department|emergency department
198176|NCT02356926|Cross checking|cross checking
198177|NCT02356900|interval training|interval training
198178|NCT02356900|hyperbaric oxygen|hyperbaric oxygen
198179|NCT02356900|VO2 max|vo2 max
198180|NCT02356900|altitude|altitude
198181|NCT02356900|exercise performance|exercise performance
198182|NCT02356900|mitochondrial oxidative capacity|mitochondrial oxidative capacity
198183|NCT02356900|mitochondrial biogenesis|mitochondrial biogenesis
198184|NCT02356861|treatment|treatment
198185|NCT02356861|photobiomodulation|photobiomodulation
198186|NCT02356861|Veterans|veterans
198187|NCT02356861|brain-injury|brain-injury
198188|NCT02356861|TBI|tbi
198189|NCT02356861|PTSD|ptsd
198190|NCT02356848|self-care|self-care
198191|NCT02356848|self-monitoring|self-monitoring
198192|NCT02356848|secondary prevention|secondary prevention
198193|NCT02356848|foot ulcer|foot ulcer
198194|NCT02356809|Gene therapy, plasmid, vegf, systemic scleroderma,secondary raynaud's phenomenon|gene therapy, plasmid, vegf, systemic scleroderma,secondary raynaud's phenomenon
198195|NCT02356757|self-care|self-care
198196|NCT02356757|self-monitoring|self-monitoring
198197|NCT02356757|medication adherence|medication adherence
198198|NCT02356757|diet|diet
198199|NCT02356757|physical activity|physical activity
198200|NCT02356757|primary prevention|primary prevention
198201|NCT02356744|Maternal outcome|maternal outcome
198202|NCT02356744|Fetal outcome|fetal outcome
198203|NCT02356744|bariatric surgery|bariatric surgery
198204|NCT02356744|Third Trimester|third trimester
198205|NCT02356731|seizures,|seizures,
198206|NCT02356731|quality of life|quality of life
198207|NCT02356640|Celiac plexus neurolysis|celiac plexus neurolysis
198208|NCT02356640|Celiac ganglion neurolysis|celiac ganglion neurolysis
198209|NCT02356640|Pancreatic cancer|pancreatic cancer
198210|NCT02356627|Occupational therapy|occupational therapy
198211|NCT02356627|Adaptive intervention|adaptive intervention
198212|NCT02356627|Home-based|home-based
198213|NCT02356627|Assistive Technology|assistive technology
198214|NCT02356627|Home modification|home modification
198215|NCT02356627|Clinical effectiveness|clinical effectiveness
198216|NCT02356627|Cost-effectiveness|cost-effectiveness
198217|NCT02356627|Cost-utility|cost-utility
198218|NCT02356614|Lap Band|lap band
198219|NCT02356601|MRI|mri
198220|NCT02356601|Lumbar spine|lumbar spine
198221|NCT02356601|Ultrasound|ultrasound
198222|NCT02356575|surgery|surgery
198223|NCT02356575|chemotherapy|chemotherapy
198224|NCT02356575|radiation|radiation
198225|NCT02356575|Acupuncture|acupuncture
198226|NCT02356575|16-947|16-947
198227|NCT02356562|Hepatitis C|hepatitis c
198228|NCT02356562|Interferon-Free|interferon-free
198229|NCT02356562|Treatment Experienced|treatment experienced
198230|NCT02356562|Chronic Hepatitis C|chronic hepatitis c
198231|NCT02356562|Hepatitis C Virus|hepatitis c virus
198232|NCT02356510|myocardial infarction|myocardial infarction
198233|NCT02356510|TIMI flow|timi flow
198234|NCT02356510|culprit lesion|culprit lesion
198235|NCT02356510|culprit vessel|culprit vessel
198236|NCT02356497|Bone metastases|bone metastases
198237|NCT02356497|Metastatic bone disease|metastatic bone disease
198238|NCT02356497|Multi-trial facility|multi-trial facility
198239|NCT02356458|Mantle cell lymphoma|mantle cell lymphoma
198240|NCT02356458|Relapsed|relapsed
198241|NCT02356458|Refractory|refractory
198242|NCT02356458|Cancer|cancer
198243|NCT02356458|Lymphoma|lymphoma
198244|NCT02356458|Ibrutinib Imbruvica|ibrutinib imbruvica
198245|NCT02356458|Bortezomib Velcade|bortezomib velcade
198246|NCT02356432|non-valvular atrial fibrillation|non-valvular atrial fibrillation
198247|NCT02356432|cerebral microbleeds|cerebral microbleeds
198248|NCT02356432|warfarin|warfarin
198249|NCT02356432|NOACs|noacs
198250|NCT02356432|acute ischemic stroke|acute ischemic stroke
198251|NCT02356406|Radiosurgery|radiosurgery
198252|NCT02356406|Celiac Plexus|celiac plexus
198253|NCT02356406|Pain|pain
198254|NCT02356406|Quality of Life|quality of life
198255|NCT02356393|Desalinated Sea Water|desalinated sea water
198256|NCT02356393|Magnesium|magnesium
198257|NCT02356393|Drinking Water|drinking water
198258|NCT02356367|telemonitoring|telemonitoring
198259|NCT02356367|Adaptive servo-ventilation|adaptive servo-ventilation
198260|NCT02356354|molecular factors|molecular factors
198261|NCT02356354|cutaneous innervation|cutaneous innervation
198262|NCT02356354|skin biopsy|skin biopsy
198263|NCT02356354|post-burn scar|post-burn scar
198264|NCT02356315|Brain|brain
198265|NCT02356315|Brain Stem|brain stem
198266|NCT02356315|Spinal Cord|spinal cord
198267|NCT02356315|Neurophysiology|neurophysiology
198268|NCT02356315|Magnetic Resonance Imaging|magnetic resonance imaging
198269|NCT02356289|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
198270|NCT02356276|locally advanced gastric cancer|locally advanced gastric cancer
198271|NCT02356276|Hyperthermic Intraperitoneal Chemotherapy|hyperthermic intraperitoneal chemotherapy
198272|NCT02356276|radical gastrectomy with D2 lymphadenectomy|radical gastrectomy with d2 lymphadenectomy
198273|NCT02356263|stressful events|stressful events
198274|NCT02356263|psychological stress|psychological stress
198275|NCT02356263|life experiences|life experiences
198276|NCT02356250|liver biopsy f 4|liver biopsy f 4
198277|NCT02356237|Episiotomy|episiotomy
198278|NCT02356237|Obstetric Anal Sphincter Injury|obstetric anal sphincter injury
198279|NCT02356224|SHR3824 Type 2 diabetes mellitus SGLT2|shr3824 type 2 diabetes mellitus sglt2
198280|NCT02356211|falls|falls
198281|NCT02356185|Alcohol Drinking|alcohol drinking
198282|NCT02356185|Injecting drug|injecting drug
198283|NCT02356185|Antiretroviral therapy|antiretroviral therapy
198284|NCT02356185|sub-Saharan Africa|sub-saharan africa
198285|NCT02356172|Quality of Life|quality of life
198286|NCT02356172|Depression|depression
198287|NCT02356172|Kallmann Syndrome|kallmann syndrome
198288|NCT02356172|Hypogonadotropic Hypogonadism|hypogonadotropic hypogonadism
198289|NCT02356159|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
198290|NCT02356159|Lymphoma|lymphoma
198291|NCT02356159|Leukemia|leukemia
198292|NCT02356159|Unrelated Donors|unrelated donors
198293|NCT02356146|Kidney transplantation|kidney transplantation
198294|NCT02356146|genotype|genotype
198295|NCT02356146|tacrolimus|tacrolimus
198296|NCT02356146|CYP3A5|cyp3a5
198297|NCT02356133|Near-Infrared Spectroscopy|near-infrared spectroscopy
198298|NCT02356094|glaucoma|glaucoma
198299|NCT02356094|primary open angle glaucoma|primary open angle glaucoma
198300|NCT02356094|cornea|cornea
198301|NCT02356068|liver transplantation, rotem, bleeding, transfusion|liver transplantation, rotem, bleeding, transfusion
198302|NCT02356055|activities of daily living|activities of daily living
198303|NCT02356055|massed practice|massed practice
198304|NCT02356055|occupational therapy|occupational therapy
198305|NCT02356029|Cardiopulmonary Arrest|cardiopulmonary arrest
198306|NCT02356029|Emergency Medical Services|emergency medical services
198307|NCT02356029|Medical Futility|medical futility
198308|NCT02356029|Decision Making|decision making
198309|NCT02356029|Emotional Stress|emotional stress
198310|NCT02356029|Burnout, Professional|burnout, professional
198311|NCT02356016|Sarcopenic Obesity|sarcopenic obesity
198312|NCT02356016|community dwelling elderly women|community dwelling elderly women
198313|NCT02356016|electromyostimulation|electromyostimulation
198314|NCT02356016|exercise|exercise
198315|NCT02356016|dietary supplements|dietary supplements
198316|NCT02356003|Tourette Syndrome|tourette syndrome
198317|NCT02356003|Children|children
198318|NCT02356003|Tics|tics
198319|NCT02355977|Chronic periodontitis|chronic periodontitis
198320|NCT02355977|Minocycline|minocycline
198321|NCT02355977|Surface and root planning|surface and root planning
198322|NCT02355977|Pocket depth|pocket depth
198323|NCT02355977|Sulcus bleeding index|sulcus bleeding index
198324|NCT02355977|Prevotella intermedia|prevotella intermedia
198325|NCT02355912|Transfemoral|transfemoral
198326|NCT02355873|heparin-coated|heparin-coated
198327|NCT02355873|surface-treated polyacrylonitrile membrane hemofilter|surface-treated polyacrylonitrile membrane hemofilter
198328|NCT02355873|critical ill|critical ill
198329|NCT02355873|acute kidney injury|acute kidney injury
198330|NCT02355873|chronic kidney disease|chronic kidney disease
198331|NCT02355873|continuous renal replacement therapy|continuous renal replacement therapy
198332|NCT02355834|Fecal Incontinence (FI)|fecal incontinence (fi)
198333|NCT02355834|Inflammatory bowel disease (IBD)|inflammatory bowel disease (ibd)
198334|NCT02355834|bowel control|bowel control
198335|NCT02355834|Chronic diarrhoea|chronic diarrhoea
198336|NCT02355834|rectal inflammation|rectal inflammation
198337|NCT02355821|cellular aging|cellular aging
198338|NCT02355821|vascular aging|vascular aging
198339|NCT02355821|bone metabolism|bone metabolism
198340|NCT02355821|collagen type 1 C-telopeptide|collagen type 1 c-telopeptide
198341|NCT02355821|nuclear factor kappa-B ligand (RANKL)|nuclear factor kappa-b ligand (rankl)
198342|NCT02355821|pulse wave velocity|pulse wave velocity
198343|NCT02355821|telomerase activity|telomerase activity
198344|NCT02355795|weight change|weight change
198345|NCT02355795|diet|diet
198346|NCT02355795|dietary fat|dietary fat
198347|NCT02355795|feeding design|feeding design
198348|NCT02355782|TMA, aHUS, TTP, stem cell transplant-associated TMA|tma, ahus, ttp, stem cell transplant-associated tma
198349|NCT02355769|heart failure|heart failure
198350|NCT02355769|renal failure|renal failure
198351|NCT02355769|prognosis|prognosis
198352|NCT02355769|impedance cardiography|impedance cardiography
198353|NCT02355717|children, bone|children, bone
198354|NCT02355717|Simple obesity|simple obesity
198355|NCT02355717|cardiovascular disease|cardiovascular disease
198356|NCT02355717|osteoporosis|osteoporosis
198357|NCT02355717|diabetes|diabetes
198358|NCT02355704|Kidney Transplantation|kidney transplantation
198359|NCT02355704|Atorvastatin|atorvastatin
198360|NCT02355704|C-Reactive Protein|c-reactive protein
198361|NCT02355704|Biopsy|biopsy
198362|NCT02355704|Interleukin|interleukin
198363|NCT02355652|Total knee arthroplasty|total knee arthroplasty
198364|NCT02355652|IKS Score|iks score
198365|NCT02355652|cemented, uncemented|cemented, uncemented
198366|NCT02355626|Anxiety|anxiety
198367|NCT02355626|level of anxiety|level of anxiety
198368|NCT02355626|delirium|delirium
198369|NCT02355626|agitation|agitation
198370|NCT02355626|tools for measuring anxiety|tools for measuring anxiety
198371|NCT02355626|neuroendocrine system|neuroendocrine system
198372|NCT02355613|Radiosurgery, brain, metastases|radiosurgery, brain, metastases
198373|NCT02355600|Oocyte|oocyte
198374|NCT02355600|Tamoxifen|tamoxifen
198375|NCT02355600|Fertility preservation|fertility preservation
198376|NCT02355587|melanoma|melanoma
198377|NCT02355587|cutaneous melanoma|cutaneous melanoma
198378|NCT02355587|DecisionDx-Melanoma|decisiondx-melanoma
198379|NCT02355574|melanoma|melanoma
198380|NCT02355574|cutaneous melanoma|cutaneous melanoma
198381|NCT02355574|DecisionDx-Melanoma|decisiondx-melanoma
198382|NCT02355561|Bioavailability|bioavailability
198383|NCT02355561|Healthy Participants|healthy participants
198384|NCT02355561|JNJ-54861911|jnj-54861911
198385|NCT02355561|Food Effect|food effect
198386|NCT02355535|refractory|refractory
198387|NCT02355535|intolerant|intolerant
198388|NCT02355535|solid tumors|solid tumors
198389|NCT02355535|lymphoma|lymphoma
198390|NCT02355522|saline infusion sonohysterography|saline infusion sonohysterography
198391|NCT02355509|Acarbose|acarbose
198392|NCT02355509|Postprandial lipemia|postprandial lipemia
198393|NCT02355509|Cardiovascular risk|cardiovascular risk
198394|NCT02355496|Cost Control|cost control
198395|NCT02355496|Data Display|data display
198396|NCT02355496|Diagnostic Tests, Routine|diagnostic tests, routine
198397|NCT02355496|Physician's Practice Patterns|physician's practice patterns
198398|NCT02355470|Sexual assault|sexual assault
198399|NCT02355470|Alcohol consumption|alcohol consumption
198400|NCT02355470|Intimate partner violence|intimate partner violence
198401|NCT02355457|troponin|troponin
198402|NCT02355457|myocardial infarction|myocardial infarction
198403|NCT02355457|acs|acs
198404|NCT02355457|AMI|ami
198405|NCT02355457|biomarker|biomarker
198406|NCT02355457|BACC|bacc
198407|NCT02355457|high-sensitivity|high-sensitivity
198408|NCT02355431|EGFR|egfr
198409|NCT02355431|mutation|mutation
198410|NCT02355405|lung ultrasound|lung ultrasound
198411|NCT02355405|atelectasis|atelectasis
198412|NCT02355405|thoracic computed Tomography|thoracic computed tomography
198413|NCT02355379|Adjuvant chemotherapy in colonic adenocarcinoma in elderly|adjuvant chemotherapy in colonic adenocarcinoma in elderly
198414|NCT02355366|Offspring|offspring
198415|NCT02355366|significant mood symptoms|significant mood symptoms
198416|NCT02355353|DWI-MRI|dwi-mri
198417|NCT02355353|resectable liver metastases|resectable liver metastases
198418|NCT02355340|Bone mineral density|bone mineral density
198419|NCT02355340|Childhood cancer survivors|childhood cancer survivors
198420|NCT02355314|ICU patients|icu patients
198421|NCT02355314|Doppler-based renal|doppler-based renal
198422|NCT02355301|ICF, impairment, activity, satisfaction, quality of care|icf, impairment, activity, satisfaction, quality of care
198423|NCT02355288|Coronary Artery Disease|coronary artery disease
198424|NCT02355288|Diabetes Mellitus|diabetes mellitus
198425|NCT02355288|Minimally Invasive Cardiac Surgery|minimally invasive cardiac surgery
198426|NCT02355288|Percutaneous Coronary Intervention|percutaneous coronary intervention
198427|NCT02355275|Home Exercise|home exercise
198428|NCT02355275|Resistance Exercise|resistance exercise
198429|NCT02355262|Insurance Coverage|insurance coverage
198430|NCT02355262|Insurance Continuity|insurance continuity
198431|NCT02355249|traditional three incisions|traditional three incisions
198432|NCT02355249|minimally invasive thoracol-laparoscopic esophagectomy|minimally invasive thoracol-laparoscopic esophagectomy
198433|NCT02355249|MIE|mie
198434|NCT02355249|esophageal cancer|esophageal cancer
198435|NCT02355236|Naxozol|naxozol
198436|NCT02355236|LDQ|ldq
198437|NCT02355236|GSRS|gsrs
198438|NCT02355236|Osteoarthritis|osteoarthritis
198439|NCT02355236|Gastroprotective|gastroprotective
198440|NCT02355223|Tuberculosis|tuberculosis
198441|NCT02355223|Infection Control|infection control
198442|NCT02355223|Transmission|transmission
198443|NCT02355197|antioxidants|antioxidants
198444|NCT02355197|Gestational diabetes mellitus|gestational diabetes mellitus
198445|NCT02355197|oxidative stress|oxidative stress
198446|NCT02355158|pain|pain
198447|NCT02355158|diabetic neuropathy|diabetic neuropathy
198448|NCT02355158|pain in feet|pain in feet
198449|NCT02355145|type 2 diabetes, add-on diabetes therapy, rationale|type 2 diabetes, add-on diabetes therapy, rationale
198450|NCT02355132|Medicaid|medicaid
198451|NCT02355132|public insurance|public insurance
198452|NCT02355132|cardiovascular disease|cardiovascular disease
198453|NCT02355132|prevention|prevention
198454|NCT02355132|community health centers|community health centers
198455|NCT02355132|electronic health records|electronic health records
198456|NCT02355132|cancer prevention|cancer prevention
198457|NCT02355080|HIV|hiv
198458|NCT02355080|HCV|hcv
198459|NCT02355067|parenting|parenting
198460|NCT02355067|postpartum depression|postpartum depression
198461|NCT02355067|mothers|mothers
198462|NCT02355067|infants|infants
198463|NCT02355067|depression|depression
198464|NCT02355054|Recurrent|recurrent
198465|NCT02355041|diet|diet
198466|NCT02355041|body weight|body weight
198467|NCT02355041|eating|eating
198468|NCT02355041|meal replacement|meal replacement
198469|NCT02355028|LHA510|lha510
198470|NCT02355028|PoC|poc
198471|NCT02355028|Age-related macular degeneration|age-related macular degeneration
198472|NCT02354976|omega-3 carboxylic acid|omega-3 carboxylic acid
198473|NCT02354963|Poor ovarian response|poor ovarian response
198474|NCT02354963|Salvador/Warts/Hippo pathway|salvador/warts/hippo pathway
198475|NCT02354963|Follicular activation|follicular activation
198476|NCT02354963|Poor ovarian reserve|poor ovarian reserve
198477|NCT02354950|GSK1265744|gsk1265744
198478|NCT02354950|healthy controls|healthy controls
198479|NCT02354950|pharmacokinetic|pharmacokinetic
198480|NCT02354950|Hepatic Impairment|hepatic impairment
198481|NCT02354937|Pharmacokinetics|pharmacokinetics
198482|NCT02354937|GSK1265744|gsk1265744
198483|NCT02354937|Severe Renal Impairment|severe renal impairment
198484|NCT02354911|Immunomodulation|immunomodulation
198485|NCT02354872|Nicotine|nicotine
198486|NCT02354859|Cystic Fibrosis|cystic fibrosis
198487|NCT02354859|Gallium Nitrate|gallium nitrate
198488|NCT02354859|IV Gallium|iv gallium
198489|NCT02354859|Pseudomonas aeruginosa|pseudomonas aeruginosa
198490|NCT02354833|Hypotension|hypotension
198491|NCT02354833|Cesarean Delivery|cesarean delivery
198492|NCT02354833|Phenylephrine|phenylephrine
198493|NCT02354833|Spinal Anesthesia|spinal anesthesia
198494|NCT02354833|Norepinephrine|norepinephrine
198495|NCT02354807|BAT activation|bat activation
198496|NCT02354807|quantitative PET imaging|quantitative pet imaging
198497|NCT02354807|Mirabegron effect on BAT|mirabegron effect on bat
198498|NCT02354794|arginine|arginine
198499|NCT02354794|supplementation|supplementation
198500|NCT02354794|metabolic syndrome|metabolic syndrome
198501|NCT02354794|endothelial function|endothelial function
198502|NCT02354781|DMD|dmd
198503|NCT02354781|muscular dystrophy|muscular dystrophy
198504|NCT02354781|Follistatin|follistatin
198505|NCT02354742|Echocardiography|echocardiography
198506|NCT02354742|EGDT|egdt
198507|NCT02354742|Sepsis|sepsis
198508|NCT02354716|esophagus|esophagus
198509|NCT02354716|upper GI|upper gi
198510|NCT02354716|endoscopy|endoscopy
198511|NCT02354716|endoFLIP|endoflip
198512|NCT02354716|functional luminal imaging|functional luminal imaging
198513|NCT02354716|esophageal stricture|esophageal stricture
198514|NCT02354716|narrow esophagus|narrow esophagus
198515|NCT02354716|narrow caliber esophagus|narrow caliber esophagus
198516|NCT02354716|esophageal narrowing|esophageal narrowing
198517|NCT02354716|eosinophilic esophagitis|eosinophilic esophagitis
198518|NCT02354716|Zenkers diverticulum|zenkers diverticulum
198519|NCT02354716|Schatzki ring|schatzki ring
198520|NCT02354703|alcoholism, treatment, serotonin transporter|alcoholism, treatment, serotonin transporter
198521|NCT02354677|Bronchial epithelium|bronchial epithelium
198522|NCT02354677|COPD|copd
198523|NCT02354677|Repair|repair
198524|NCT02354677|Remodelling|remodelling
198525|NCT02354677|Club Cells|club cells
198526|NCT02354664|respiratory test|respiratory test
198527|NCT02354664|respiratory muscle endurance|respiratory muscle endurance
198528|NCT02354664|spirometry|spirometry
198529|NCT02354651|Pompe disease|pompe disease
198530|NCT02354651|mechanical ventilation|mechanical ventilation
198531|NCT02354651|diaphragm pacing|diaphragm pacing
198532|NCT02354638|Perceptions|perceptions
198533|NCT02354638|Education and evaluate post intervention KAP|education and evaluate post intervention kap
198534|NCT02354625|Schwann cells|schwann cells
198535|NCT02354599|Randomized, double-blind, placebo-controlled, single-dose subcutaneous administration study|randomized, double-blind, placebo-controlled, single-dose subcutaneous administration study
198536|NCT02354586|gBRCAmut|gbrcamut
198537|NCT02354586|BRCA|brca
198538|NCT02354586|PARP inhibitor|parp inhibitor
198539|NCT02354586|HRD|hrd
198540|NCT02354586|Ovarian cancer|ovarian cancer
198541|NCT02354586|Serous Epithelial|serous epithelial
198542|NCT02354586|Fallopian Tube|fallopian tube
198543|NCT02354586|Primary Peritoneal|primary peritoneal
198544|NCT02354560|Erythromycin|erythromycin
198545|NCT02354560|Familial Adenomatous Polyposis (FAP)|familial adenomatous polyposis (fap)
198546|NCT02354560|APC gene|apc gene
198547|NCT02354560|nonsense mutations|nonsense mutations
198548|NCT02354534|cervical dysplasia|cervical dysplasia
198549|NCT02354534|HPV|hpv
198550|NCT02354534|Treatment|treatment
198551|NCT02354534|preinvasive|preinvasive
198552|NCT02354534|cervix|cervix
198553|NCT02354534|vaginal suppository|vaginal suppository
198554|NCT02354534|Johns Hopkins|johns hopkins
198555|NCT02354534|Cornelia Trimble|cornelia trimble
198556|NCT02354534|abnormal pap|abnormal pap
198557|NCT02354534|CIN|cin
198558|NCT02354521|Protein|protein
198559|NCT02354521|Mechanical ventilation|mechanical ventilation
198560|NCT02354521|Children|children
198561|NCT02354521|Outcomes|outcomes
198562|NCT02354508|acromegaly|acromegaly
198563|NCT02354508|GH|gh
198564|NCT02354508|IGF-1|igf-1
198565|NCT02354508|pasireotide LAR|pasireotide lar
198566|NCT02354495|Indirect calorimetry|indirect calorimetry
198567|NCT02354495|Protein|protein
198568|NCT02354495|Mechanical ventilation|mechanical ventilation
198569|NCT02354495|Respiratory failure|respiratory failure
198570|NCT02354469|TBI|tbi
198571|NCT02354469|Mild Traumatic Brain Injury|mild traumatic brain injury
198572|NCT02354469|Post-Concussion Syndrome|post-concussion syndrome
198573|NCT02354469|Recovery of Function|recovery of function
198574|NCT02354469|Motor Activity|motor activity
198575|NCT02354469|Diffusion Tensor Imaging|diffusion tensor imaging
198576|NCT02354469|Neural Injury|neural injury
198577|NCT02354469|Biomarkers|biomarkers
198578|NCT02354456|atrial fibrillation|atrial fibrillation
198579|NCT02354456|epidemiology|epidemiology
198580|NCT02354456|antiocaogulation|antiocaogulation
198581|NCT02354430|pregnancy|pregnancy
198582|NCT02354430|low back pain|low back pain
198583|NCT02354430|sick leave,|sick leave,
198584|NCT02354430|motor activity|motor activity
198585|NCT02354404|Ebola virus|ebola virus
198586|NCT02354404|Filoviridae Infections|filoviridae infections
198587|NCT02354404|Hemorrhagic Fever, Ebola|hemorrhagic fever, ebola
198588|NCT02354404|Viral Diseases|viral diseases
198589|NCT02354404|Hemorrhagic Fevers, Viral|hemorrhagic fevers, viral
198590|NCT02354365|PEEP adjustment|peep adjustment
198591|NCT02354365|Tidal Volume|tidal volume
198592|NCT02354365|Driving Pressure|driving pressure
198593|NCT02354365|Compliance|compliance
198594|NCT02354339|Metabolic Syndrome|metabolic syndrome
198595|NCT02354339|Irvingia gabonensis|irvingia gabonensis
198596|NCT02354339|African mango|african mango
198597|NCT02354339|Insulin resistance|insulin resistance
198598|NCT02354313|MANTLE CELL LYMPHOMA (MCL)|mantle cell lymphoma (mcl)
198599|NCT02354313|Lenalidomide (Len)|lenalidomide (len)
198600|NCT02354313|Rituximab|rituximab
198601|NCT02354313|ASCT|asct
198602|NCT02354313|Revlimid|revlimid
198603|NCT02354313|High dose chemotherapy|high dose chemotherapy
198604|NCT02354313|transplant|transplant
198605|NCT02354261|Basal Cell Carcinoma Nevus Syndrome|basal cell carcinoma nevus syndrome
198606|NCT02354261|BCCNS|bccns
198607|NCT02354261|BCC|bcc
198608|NCT02354261|itraconazole|itraconazole
198609|NCT02354261|basal cell carcinoma|basal cell carcinoma
198610|NCT02354261|locally advanced basal cell carcinoma|locally advanced basal cell carcinoma
198611|NCT02354248|TST|tst
198612|NCT02354248|TMS|tms
198613|NCT02354248|Stroke patients|stroke patients
198614|NCT02354248|EMG|emg
198615|NCT02354235|MT-2412|mt-2412
198616|NCT02354235|MP-513|mp-513
198617|NCT02354235|TA-7284|ta-7284
198618|NCT02354235|Teneligliptin|teneligliptin
198619|NCT02354235|Canagliflozin|canagliflozin
198620|NCT02354222|MT-2412|mt-2412
198621|NCT02354222|MP-513|mp-513
198622|NCT02354222|TA-7284|ta-7284
198623|NCT02354222|Teneligliptin|teneligliptin
198624|NCT02354222|Canagliflozin|canagliflozin
198625|NCT02354183|Commitment strategies|commitment strategies
198626|NCT02354183|Motivation|motivation
198627|NCT02354183|DBT skills|dbt skills
198628|NCT02354183|Self-harm|self-harm
198629|NCT02354183|Brief intervention|brief intervention
198630|NCT02354170|Central Serous Chorioretinopathy, CSC|central serous chorioretinopathy, csc
198631|NCT02354157|children dietary pattern|children dietary pattern
198632|NCT02354157|control rules|control rules
198633|NCT02354157|instrumental learning|instrumental learning
198634|NCT02354157|food reinforcement|food reinforcement
198635|NCT02354144|Human papillomavirus|human papillomavirus
198636|NCT02354144|Carrageenan|carrageenan
198637|NCT02354144|Microbicide|microbicide
198638|NCT02354144|Anal HPV infection|anal hpv infection
198639|NCT02354131|Ovarian cancer|ovarian cancer
198640|NCT02354131|Niraparib|niraparib
198641|NCT02354131|Bevacizumab|bevacizumab
198642|NCT02354131|PARP|parp
198643|NCT02354131|Phase 2 randomized|phase 2 randomized
198644|NCT02354105|Axial Spondyloarthritis|axial spondyloarthritis
198645|NCT02354105|Radiographic Axial Spondyloarthritis|radiographic axial spondyloarthritis
198646|NCT02354105|Non-radiographic Axial Spondyloarthritis|non-radiographic axial spondyloarthritis
198647|NCT02354105|Ankylosing spondylitis|ankylosing spondylitis
198648|NCT02354105|Diagnosis|diagnosis
198649|NCT02354105|Cimzia|cimzia
198650|NCT02354105|CZP|czp
198651|NCT02354105|Certolizumab Pegol|certolizumab pegol
198652|NCT02354105|CDP870|cdp870
198653|NCT02354092|cervical dilation|cervical dilation
198654|NCT02354092|pain|pain
198655|NCT02354092|paracervical block|paracervical block
198656|NCT02354092|osmotic dilators|osmotic dilators
198657|NCT02354079|Low LDL-C|low ldl-c
198658|NCT02354079|Target Identification|target identification
198659|NCT02354079|Genetic|genetic
198660|NCT02354079|Endocrinology|endocrinology
198661|NCT02354079|Cardiovascular Disease|cardiovascular disease
198662|NCT02354066|Hallux valgus surgery|hallux valgus surgery
198663|NCT02354066|forefoot surgery|forefoot surgery
198664|NCT02354066|brake response time|brake response time
198665|NCT02354066|foot orthoses|foot orthoses
198666|NCT02354053|HIV|hiv
198667|NCT02354053|Triumeq|triumeq
198668|NCT02354053|vulnerable populations|vulnerable populations
198669|NCT02354040|Stroke, Myocardial Infarction, Adherence, Health Literacy, Implementation, Developing Country|stroke, myocardial infarction, adherence, health literacy, implementation, developing country
198670|NCT02354027|SHR3824 metformin drug-drug interaction|shr3824 metformin drug-drug interaction
198671|NCT02354014|Multidrug-Resistant Tuberculosis|multidrug-resistant tuberculosis
198672|NCT02354014|Bedaquiline|bedaquiline
198673|NCT02354014|TMC207|tmc207
198674|NCT02354001|schizophrenia|schizophrenia
198675|NCT02354001|mental illness|mental illness
198676|NCT02354001|serm|serm
198677|NCT02354001|raloxifene|raloxifene
198678|NCT02354001|clinical trial|clinical trial
198679|NCT02353988|AR-positive|ar-positive
198680|NCT02353988|Androgen Antagonists|androgen antagonists
198681|NCT02353988|Bicalutamide|bicalutamide
198682|NCT02353988|TNBC|tnbc
198683|NCT02353988|metastatic|metastatic
198684|NCT02353975|SHR3824|shr3824
198685|NCT02353975|food effect|food effect
198686|NCT02353975|mass|mass
198687|NCT02353975|balance|balance
198688|NCT02353975|Phase I|phase i
198689|NCT02353962|neglect|neglect
198690|NCT02353962|exergames|exergames
198691|NCT02353949|Mild cognitive impairment|mild cognitive impairment
198692|NCT02353949|Alzheimer|alzheimer
198693|NCT02353949|PET|pet
198694|NCT02353949|Amyloid|amyloid
198695|NCT02353949|Frontotemporal|frontotemporal
198696|NCT02353871|Moderate to Severe|moderate to severe
198697|NCT02353858|Rectal Cancer|rectal cancer
198698|NCT02353858|Hyperthermia|hyperthermia
198699|NCT02353858|Radiochemotherapy|radiochemotherapy
198700|NCT02353858|Chemoradiotherapy|chemoradiotherapy
198701|NCT02353858|Deep regional hyperthermia|deep regional hyperthermia
198702|NCT02353858|pathologic complete response|pathologic complete response
198703|NCT02353858|Regression Grade|regression grade
198704|NCT02353858|Locally advanced rectal cancer|locally advanced rectal cancer
198705|NCT02353858|complete response|complete response
198706|NCT02353806|Amlodipine besylate|amlodipine besylate
198707|NCT02353806|Breast milk|breast milk
198708|NCT02353806|Pharmacokinetics|pharmacokinetics
198709|NCT02353806|Chronic hypertension|chronic hypertension
198710|NCT02353806|Pregnancy|pregnancy
198711|NCT02353793|Hypothermia|hypothermia
198712|NCT02353793|(Poly) Trauma|(poly) trauma
198713|NCT02353793|Emergency Room|emergency room
198714|NCT02353793|Warming Blanket|warming blanket
198715|NCT02353780|Rheumatoid arthritis|rheumatoid arthritis
198716|NCT02353780|TNF inhibitors|tnf inhibitors
198717|NCT02353702|Diaphragmatic function|diaphragmatic function
198718|NCT02353702|sniff-test|sniff-test
198719|NCT02353702|pulmonary complications|pulmonary complications
198720|NCT02353702|upper abdominal surgery|upper abdominal surgery
198721|NCT02353663|Rheumatic heart disease|rheumatic heart disease
198722|NCT02353663|Rheumatic fever|rheumatic fever
198723|NCT02353663|Mitral regurgitation|mitral regurgitation
198724|NCT02353663|Aortic regurgitation|aortic regurgitation
198725|NCT02353663|Mitral stenosis|mitral stenosis
198726|NCT02353650|Q10|q10
198727|NCT02353650|ubiquinol|ubiquinol
198728|NCT02353611|tooth|tooth
198729|NCT02353611|bleaching|bleaching
198730|NCT02353585|vitamin K-antagonist|vitamin k-antagonist
198731|NCT02353585|novel oral anticoagulants|novel oral anticoagulants
198732|NCT02353585|apixaban|apixaban
198733|NCT02353585|dabigatran|dabigatran
198734|NCT02353585|rivaroxaban|rivaroxaban
198735|NCT02353585|edoxaban|edoxaban
198736|NCT02353585|direct oral anticoagulants|direct oral anticoagulants
198737|NCT02353559|acute leukemia|acute leukemia
198738|NCT02353559|traumatic stress|traumatic stress
198739|NCT02353559|quality of life|quality of life
198740|NCT02353559|symptom burden|symptom burden
198741|NCT02353559|psychosocial oncology|psychosocial oncology
198742|NCT02353559|palliative care|palliative care
198743|NCT02353559|intervention|intervention
198744|NCT02353559|hematological malignancies|hematological malignancies
198745|NCT02353559|supportive care|supportive care
198746|NCT02353546|affective symptoms|affective symptoms
198747|NCT02353546|cancer|cancer
198748|NCT02353546|depression|depression
198749|NCT02353546|palliative care|palliative care
198750|NCT02353546|pilot trial|pilot trial
198751|NCT02353546|psychotherapy|psychotherapy
198752|NCT02353533|adenoma|adenoma
198753|NCT02353533|EMR|emr
198754|NCT02353533|FTRD|ftrd
198755|NCT02353533|non- lifting|non- lifting
198756|NCT02353533|colon|colon
198757|NCT02353442|Pain|pain
198758|NCT02353442|Rotator cuff|rotator cuff
198759|NCT02353442|Stretching|stretching
198760|NCT02353442|Mobilization|mobilization
198761|NCT02353442|Scapula|scapula
198762|NCT02353442|Posterior capsule|posterior capsule
198763|NCT02353416|Mediterranean Diet|mediterranean diet
198764|NCT02353416|Low-Glycemic Index|low-glycemic index
198765|NCT02353416|AGEs|ages
198766|NCT02353403|Fructo-oligosaccharides|fructo-oligosaccharides
198767|NCT02353403|Sugar-reduced foods|sugar-reduced foods
198768|NCT02353403|Postprandial glucose response|postprandial glucose response
198769|NCT02353390|presyncope|presyncope
198770|NCT02353390|syncope|syncope
198771|NCT02353390|adolescent|adolescent
198772|NCT02353390|young adult|young adult
198773|NCT02353390|immunization|immunization
198774|NCT02353390|vaccination|vaccination
198775|NCT02353390|water consumption|water consumption
198776|NCT02353364|Advanced maternal age|advanced maternal age
198777|NCT02353364|Aneuploidy|aneuploidy
198778|NCT02353325|Iron deficiency|iron deficiency
198779|NCT02353325|Iron fortification|iron fortification
198780|NCT02353325|Iron encapsulation|iron encapsulation
198781|NCT02353312|Diastolic|diastolic
198782|NCT02353312|Biopterin|biopterin
198783|NCT02353312|Therapeutic Use|therapeutic use
198784|NCT02353312|Drug Therapy|drug therapy
198785|NCT02353312|Quality of Life|quality of life
198786|NCT02353299|Cognition|cognition
198787|NCT02353299|Balance|balance
198788|NCT02353286|Biodegradable stents, ERCP|biodegradable stents, ercp
198789|NCT02353273|WH-1,Diabetic Foot,Ulcer|wh-1,diabetic foot,ulcer
198790|NCT02353234|Phenolics|phenolics
198791|NCT02353234|Aleurone|aleurone
198792|NCT02353234|Bioavailability|bioavailability
198793|NCT02353234|Pharmacokinetics|pharmacokinetics
198794|NCT02353221|Early arthritis|early arthritis
198795|NCT02353221|undiferentiated arthritis|undiferentiated arthritis
198796|NCT02353182|abdominal|abdominal
198797|NCT02353182|lower extremity|lower extremity
198798|NCT02353169|changes in myocardial repolarization in healthy children|changes in myocardial repolarization in healthy children
198799|NCT02353156|Hemorrhoidectomy|hemorrhoidectomy
198800|NCT02353156|postoperative pain|postoperative pain
198801|NCT02353156|Sitz bath|sitz bath
198802|NCT02353156|Electronic bidet|electronic bidet
198803|NCT02353143|Acute Myeloid Leukemia|acute myeloid leukemia
198804|NCT02353143|AML|aml
198805|NCT02353143|Relapsed|relapsed
198806|NCT02353143|Refractory|refractory
198807|NCT02353143|MEN1112|men1112
198808|NCT02353143|Monoclonal antibody|monoclonal antibody
198809|NCT02353130|autism spectrum disorders|autism spectrum disorders
198810|NCT02353130|memantine|memantine
198811|NCT02353130|cortical metrics|cortical metrics
198812|NCT02353130|sensory testing|sensory testing
198813|NCT02353078|Eosinophilic Esophagitis (EOE)|eosinophilic esophagitis (eoe)
198814|NCT02353065|Colles' Fracture|colles' fracture
198815|NCT02353065|ultrasonography|ultrasonography
198816|NCT02353052|morphology standards|morphology standards
198817|NCT02353013|protein intake|protein intake
198818|NCT02353013|body composition|body composition
198819|NCT02352974|Diamyd|diamyd
198820|NCT02352974|Diabetes|diabetes
198821|NCT02352974|Juvenile Diabetes|juvenile diabetes
198822|NCT02352974|Diabetes Type 1|diabetes type 1
198823|NCT02352974|Type 1 Diabetes|type 1 diabetes
198824|NCT02352974|Autoimmune Diabetes|autoimmune diabetes
198825|NCT02352974|Insulin Dependent Diabetes|insulin dependent diabetes
198826|NCT02352974|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
198827|NCT02352974|rhGAD65|rhgad65
198828|NCT02352974|GAD65|gad65
198829|NCT02352974|GAD-Alum|gad-alum
198830|NCT02352974|Diabetes Mellitus|diabetes mellitus
198831|NCT02352974|Diabetes mellitus Type 1|diabetes mellitus type 1
198832|NCT02352974|Glucose Metabolism Disorders|glucose metabolism disorders
198833|NCT02352974|Metabolic Diseases|metabolic diseases
198834|NCT02352974|Vitamin D|vitamin d
198835|NCT02352961|Unrecognised condition|unrecognised condition
198836|NCT02352922|Laparoscopy|laparoscopy
198837|NCT02352922|Robotic Surgical Procedures|robotic surgical procedures
198838|NCT02352922|Hysterectomy|hysterectomy
198839|NCT02352922|Anesthetics, Local|anesthetics, local
198840|NCT02352922|Bupivacaine|bupivacaine
198841|NCT02352922|Pain, Postoperative|pain, postoperative
198842|NCT02352896|Leigh syndrome|leigh syndrome
198843|NCT02352896|Mitochondrial disorders|mitochondrial disorders
198844|NCT02352896|EPI743|epi743
198845|NCT02352896|Vincerinone|vincerinone
198846|NCT02352870|Feasibility study|feasibility study
198847|NCT02352870|Randomised controlled trial|randomised controlled trial
198848|NCT02352870|Cognitive behavioural therapy|cognitive behavioural therapy
198849|NCT02352870|Psychological distress|psychological distress
198850|NCT02352870|Cognitive illness representations|cognitive illness representations
198851|NCT02352870|Common sense model|common sense model
198852|NCT02352857|Fructo-oligosaccharides|fructo-oligosaccharides
198853|NCT02352857|Sugar-reduced foods|sugar-reduced foods
198854|NCT02352857|Postprandial glucose response|postprandial glucose response
198855|NCT02352805|Extracorporeal circulation, ventricular assist device|extracorporeal circulation, ventricular assist device
198856|NCT02352792|Local control|local control
198857|NCT02352779|Cancer Survivor|cancer survivor
198858|NCT02352766|Thyroid cancer|thyroid cancer
198859|NCT02352766|Thyroid nodules|thyroid nodules
198860|NCT02352766|Palpable nodules|palpable nodules
198861|NCT02352766|FNA|fna
198862|NCT02352753|Amgen, OI, Bone|amgen, oi, bone
198863|NCT02352740|arginine|arginine
198864|NCT02352740|supplementation|supplementation
198865|NCT02352740|metabolic syndrome|metabolic syndrome
198866|NCT02352740|nitric oxide|nitric oxide
198867|NCT02352727|Nocturnal hypokinesia|nocturnal hypokinesia
198868|NCT02352727|Accelerometers|accelerometers
198869|NCT02352714|Adolescents|adolescents
198870|NCT02352714|Women's Health|women's health
198871|NCT02352714|Contraception|contraception
198872|NCT02352714|Reproduction|reproduction
198873|NCT02352714|Comparative Effectiveness Research|comparative effectiveness research
198874|NCT02352714|Pregnancy Prevention|pregnancy prevention
198875|NCT02352714|Intrauterine Device|intrauterine device
198876|NCT02352701|helicobacter pylori|helicobacter pylori
198877|NCT02352701|ilaprazole|ilaprazole
198878|NCT02352701|eradication|eradication
198879|NCT02352701|triple therapy|triple therapy
198880|NCT02352688|elderly|elderly
198881|NCT02352688|enhanced recovery after surgery|enhanced recovery after surgery
198882|NCT02352662|Congenital Heart Disease|congenital heart disease
198883|NCT02352662|Point-of-care coagulation monitoring|point-of-care coagulation monitoring
198884|NCT02352662|Rotaional Thromboelastometry|rotaional thromboelastometry
198885|NCT02352649|Peripheral nerve injury|peripheral nerve injury
198886|NCT02352649|Neurotmesis|neurotmesis
198887|NCT02352649|Gene therapy|gene therapy
198888|NCT02352649|Plasmid|plasmid
198889|NCT02352649|Nerve regeneration therapy|nerve regeneration therapy
198890|NCT02352610|carpometacarpal joints|carpometacarpal joints
198891|NCT02352597|PCOS|pcos
198892|NCT02352597|Phytoestrogens|phytoestrogens
198893|NCT02352597|ovulation induction|ovulation induction
198894|NCT02352584|QIV|qiv
198895|NCT02352584|Quadrivalent Influenza Vaccine|quadrivalent influenza vaccine
198896|NCT02352584|Influenza vaccine|influenza vaccine
198897|NCT02352584|Vaccination|vaccination
198898|NCT02352558|Multiple Myeloma|multiple myeloma
198899|NCT02352558|Lymphoma|lymphoma
198900|NCT02352558|Acute Myeloid Leukemia|acute myeloid leukemia
198901|NCT02352558|Myelo-Dysplastic Syndrome|myelo-dysplastic syndrome
198902|NCT02352558|Chronic Myeloid Leukemia|chronic myeloid leukemia
198903|NCT02352558|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
198904|NCT02352532|Dry Needling|dry needling
198905|NCT02352532|Shear Wave Elastography|shear wave elastography
198906|NCT02352532|Ultrasound|ultrasound
198907|NCT02352493|PNH|pnh
198908|NCT02352493|RNAi therapeutic|rnai therapeutic
198909|NCT02352480|Non Healing Wound|non healing wound
198910|NCT02352467|Non Healing Wound|non healing wound
198911|NCT02352454|Non Healing Wound|non healing wound
198912|NCT02352428|Skin Cancer|skin cancer
198913|NCT02352428|Secondary Prevention|secondary prevention
198914|NCT02352428|Population Screening|population screening
198915|NCT02352402|CABG|cabg
198916|NCT02352402|Ticagrelor|ticagrelor
198917|NCT02352402|Graft|graft
198918|NCT02352402|Patency|patency
198919|NCT02352389|Childhood|childhood
198920|NCT02352389|Cancer|cancer
198921|NCT02352389|Genetic mutations|genetic mutations
198922|NCT02352376|Noninvasive ventilation|noninvasive ventilation
198923|NCT02352376|Heart rate variability|heart rate variability
198924|NCT02352376|Thoracic surgery|thoracic surgery
198925|NCT02352363|Parkinson's Disease|parkinson's disease
198926|NCT02352363|Motor fluctuations|motor fluctuations
198927|NCT02352363|levodopa|levodopa
198928|NCT02352363|inhaled drugs|inhaled drugs
198929|NCT02352363|OFF episodes|off episodes
198930|NCT02352350|Pre-Hospital Cardiac Arrest|pre-hospital cardiac arrest
198931|NCT02352350|Blood Lactate Level|blood lactate level
198932|NCT02352350|Neurological Injury|neurological injury
198933|NCT02352337|cancer|cancer
198934|NCT02352337|pancreatic cancer|pancreatic cancer
198935|NCT02352337|metastatic pancreatic cancer|metastatic pancreatic cancer
198936|NCT02352324|cardiac output|cardiac output
198937|NCT02352324|coronary artery bypass grafting|coronary artery bypass grafting
198938|NCT02352324|minimally invasive hemodynamic monitoring|minimally invasive hemodynamic monitoring
198939|NCT02352324|fluid responsiveness|fluid responsiveness
198940|NCT02352272|sleep extension|sleep extension
198941|NCT02352272|attention|attention
198942|NCT02352272|physical performance|physical performance
198943|NCT02352259|Liver metastases of colorectal cancer Electrochemotherapy|liver metastases of colorectal cancer electrochemotherapy
198944|NCT02352259|Bleomycin|bleomycin
198945|NCT02352259|Electrochemotherapy|electrochemotherapy
198946|NCT02352246|intermittent sprinting|intermittent sprinting
198947|NCT02352246|abdominal fat mass|abdominal fat mass
198948|NCT02352246|type 2 diabetes|type 2 diabetes
198949|NCT02352246|postmenopausal women|postmenopausal women
198950|NCT02352233|retroview colonoscope|retroview colonoscope
198951|NCT02352233|retroflexion colonoscopy|retroflexion colonoscopy
198952|NCT02352233|colonoscopy|colonoscopy
198953|NCT02352207|Neonatal respiratory distress|neonatal respiratory distress
198954|NCT02352207|prenatal lung malformation|prenatal lung malformation
198955|NCT02352207|KRAS mutation|kras mutation
198956|NCT02352207|pregnant woman|pregnant woman
198957|NCT02352194|Multiple Sclerosis, Physical therapy, Physical capacity, Fatigue|multiple sclerosis, physical therapy, physical capacity, fatigue
198958|NCT02352181|Cirrhosis, transplantation, transfusion, Rotem®|cirrhosis, transplantation, transfusion, rotem®
198959|NCT02352168|allergic rhinitis；airway inflammation；hyperreactivity|allergic rhinitis；airway inflammation；hyperreactivity
198960|NCT02352155|haemostasis|haemostasis
198961|NCT02352142|Separation stress|separation stress
198962|NCT02352142|Family Nurture|family nurture
198963|NCT02352142|Maternal Confidence|maternal confidence
198964|NCT02352142|Maternal Competence|maternal competence
198965|NCT02352142|Calming Cycle|calming cycle
198966|NCT02352142|Kangaroo Care|kangaroo care
198967|NCT02352142|Infant Neurodevelopment|infant neurodevelopment
198968|NCT02352142|Infant Psychological Development|infant psychological development
198969|NCT02352142|Post-partum depression|post-partum depression
198970|NCT02352142|Mother-infant Co-regulation|mother-infant co-regulation
198971|NCT02352116|Postoperative Experience|postoperative experience
198972|NCT02352116|Postoperative Behavioral Changes|postoperative behavioral changes
198973|NCT02352116|Maladaptive Behavioral Changes|maladaptive behavioral changes
198974|NCT02352103|prostate cancer|prostate cancer
198975|NCT02352103|Urinary continence|urinary continence
198976|NCT02352103|robotic assisted radical prostatectomy|robotic assisted radical prostatectomy
198977|NCT02352103|Vattikuti Urology Institute (VIP) radical prostatectomy|vattikuti urology institute (vip) radical prostatectomy
198978|NCT02352103|Retzius sparing radical prostatectomy|retzius sparing radical prostatectomy
198979|NCT02352090|Contraception, oral|contraception, oral
198980|NCT02352090|Ethinyl Estradiol|ethinyl estradiol
198981|NCT02352090|Estradiol Valerate|estradiol valerate
198982|NCT02352090|Dienogest|dienogest
198983|NCT02352090|Insulin resistance|insulin resistance
198984|NCT02352090|Chronic inflammation|chronic inflammation
198985|NCT02352090|Coagulation|coagulation
198986|NCT02352051|attention deficit-hyperactivity disorder (ADHD).|attention deficit-hyperactivity disorder (adhd).
198987|NCT02352051|executive functions|executive functions
198988|NCT02352038|malocclusion|malocclusion
198989|NCT02352038|low-level laser therapy|low-level laser therapy
198990|NCT02352025|S-equol|s-equol
198991|NCT02352025|breast cancer|breast cancer
198992|NCT02352025|triple negative|triple negative
198993|NCT02352012|Interventional Treatment|interventional treatment
198994|NCT02352012|Refractory Pneumothorax|refractory pneumothorax
198995|NCT02352012|Bronchoscope|bronchoscope
198996|NCT02351999|Atrial fibrillation|atrial fibrillation
198997|NCT02351999|Transseptal puncture|transseptal puncture
198998|NCT02351999|Atrial fibrillation ablation|atrial fibrillation ablation
198999|NCT02351986|subacromial impingement|subacromial impingement
199000|NCT02351986|physical therapy|physical therapy
199001|NCT02351986|cryotherapy|cryotherapy
199002|NCT02351960|Drug therapy|drug therapy
199003|NCT02351960|GERD|gerd
199004|NCT02351960|Dexlansoprazole|dexlansoprazole
199005|NCT02351947|stroke|stroke
199006|NCT02351947|Cerebrovascular accident|cerebrovascular accident
199007|NCT02351947|rehabilitation|rehabilitation
199008|NCT02351947|motor learning|motor learning
199009|NCT02351947|fMRI|fmri
199010|NCT02351947|plasticity|plasticity
199011|NCT02351934|colorectal surgery|colorectal surgery
199012|NCT02351934|volume status|volume status
199013|NCT02351921|transcranial magnetic stimulation|transcranial magnetic stimulation
199014|NCT02351921|spinal cord injury|spinal cord injury
199015|NCT02351921|motor cortex|motor cortex
199016|NCT02351921|somatosensory cortex|somatosensory cortex
199017|NCT02351895|infection control|infection control
199018|NCT02351895|Prevention of hospital acquired infection|prevention of hospital acquired infection
199019|NCT02351856|laminopathy|laminopathy
199020|NCT02351856|ARRY-797|arry-797
199021|NCT02351804|US-guided peripheral nerve block|us-guided peripheral nerve block
199022|NCT02351804|Anesthetics, Local|anesthetics, local
199023|NCT02351804|duration|duration
199024|NCT02351804|Sensation|sensation
199025|NCT02351804|adductor canal block|adductor canal block
199026|NCT02351804|lower limb|lower limb
199027|NCT02351804|Adjuvants, Anesthesia|adjuvants, anesthesia
199028|NCT02351778|Developing Countries|developing countries
199029|NCT02351778|Quality of Life|quality of life
199030|NCT02351778|Mixed Methods|mixed methods
199031|NCT02351778|Validation|validation
199032|NCT02351778|Caregiver Burden|caregiver burden
199033|NCT02351726|aortic valve replacement|aortic valve replacement
199034|NCT02351726|aortic stenosis|aortic stenosis
199035|NCT02351726|aortic steno-insufficiency|aortic steno-insufficiency
199036|NCT02351713|primary prevention|primary prevention
199037|NCT02351687|Moderate Acute Malnutrition|moderate acute malnutrition
199038|NCT02351674|Heart Rate|heart rate
199039|NCT02351674|Percutaneous coronary intervention|percutaneous coronary intervention
199040|NCT02351674|outcome|outcome
199041|NCT02351648|readmission|readmission
199042|NCT02351648|care transition|care transition
199043|NCT02351635|Calprotectin|calprotectin
199044|NCT02351635|Diagnosis|diagnosis
199045|NCT02351609|smoking cessation|smoking cessation
199046|NCT02351609|patient navigation|patient navigation
199047|NCT02351609|financial incentives|financial incentives
199048|NCT02351609|health disparities|health disparities
199049|NCT02351596|Core Stability|core stability
199050|NCT02351596|Balance|balance
199051|NCT02351596|Core Control|core control
199052|NCT02351505|Small Cell Lung Cancer|small cell lung cancer
199053|NCT02351492|Bile duct obstruction|bile duct obstruction
199054|NCT02351492|intraoperative cholangiography|intraoperative cholangiography
199055|NCT02351492|MRCP|mrcp
199056|NCT02351479|hula|hula
199057|NCT02351479|breast cancer|breast cancer
199058|NCT02351479|female|female
199059|NCT02351479|hawaii|hawaii
199060|NCT02351479|physical activity|physical activity
199061|NCT02351479|cervical cancer|cervical cancer
199062|NCT02351479|ovarian cancer|ovarian cancer
199063|NCT02351479|endometrial cancer|endometrial cancer
199064|NCT02351466|Brain Growth and Development|brain growth and development
199065|NCT02351466|Cognition|cognition
199066|NCT02351466|Children|children
199067|NCT02351466|Continuous Glucose Monitoring|continuous glucose monitoring
199068|NCT02351466|MRI|mri
199069|NCT02351466|Functional MRI|functional mri
199070|NCT02351440|duloxetine|duloxetine
199071|NCT02351414|Osteoarthritis|osteoarthritis
199072|NCT02351414|Ankylosis|ankylosis
199073|NCT02351414|Revision procedures|revision procedures
199074|NCT02351414|Correction of functional deformity|correction of functional deformity
199075|NCT02351414|Rheumatoid arthritis|rheumatoid arthritis
199076|NCT02351414|Arthritis|arthritis
199077|NCT02351388|Alzheimer's disease|alzheimer's disease
199078|NCT02351388|Depressive symptoms|depressive symptoms
199079|NCT02351388|Neuropsychiatric symptoms|neuropsychiatric symptoms
199080|NCT02351388|Behavioral and Psychological Symptoms of Dementia|behavioral and psychological symptoms of dementia
199081|NCT02351388|Neuromodulation|neuromodulation
199082|NCT02351388|Transcranial Direct Current Stimulation|transcranial direct current stimulation
199083|NCT02351375|microbiota|microbiota
199084|NCT02351375|small intestine|small intestine
199085|NCT02351375|diet|diet
199086|NCT02351375|feces|feces
199087|NCT02351362|Retention|retention
199088|NCT02351362|Attrition|attrition
199089|NCT02351362|Incentive|incentive
199090|NCT02351362|Pregnant women|pregnant women
199091|NCT02351349|frailty|frailty
199092|NCT02351349|CKD|ckd
199093|NCT02351349|Physical Therapy Modalities|physical therapy modalities
199094|NCT02351349|Elder Nutritional Physiological Phenomena|elder nutritional physiological phenomena
199095|NCT02351336|Threatened preterm birth|threatened preterm birth
199096|NCT02351336|Fetal adrenal gland volume|fetal adrenal gland volume
199097|NCT02351336|Fetal zone enlargement|fetal zone enlargement
199098|NCT02351336|Prediction of preterm birth|prediction of preterm birth
199099|NCT02351297|High protein diet|high protein diet
199100|NCT02351297|Microbiota|microbiota
199101|NCT02351297|Rectal biopsies|rectal biopsies
199102|NCT02351297|Metabolomics|metabolomics
199103|NCT02351297|Bacterial metabolites|bacterial metabolites
199104|NCT02351297|volunteers|volunteers
199105|NCT02351284|HIV, vitamin D, osteoporosis|hiv, vitamin d, osteoporosis
199106|NCT02351258|Pediatrics|pediatrics
199107|NCT02351258|Medical Oncology|medical oncology
199108|NCT02351258|Catheters|catheters
199109|NCT02351258|Infection|infection
199110|NCT02351206|X-Rays|x-rays
199111|NCT02351206|Magnetic Resonance Imaging|magnetic resonance imaging
199112|NCT02351206|Sensitivity and Specificity|sensitivity and specificity
199113|NCT02351180|Chronic lung allograft dysfunction|chronic lung allograft dysfunction
199114|NCT02351180|Community-acquired respiratory viral infection|community-acquired respiratory viral infection
199115|NCT02351167|Smoking cessation|smoking cessation
199116|NCT02351167|Counseling|counseling
199117|NCT02351167|Genetics and Genomics|genetics and genomics
199118|NCT02351141|Noble Gas MRI|noble gas mri
199119|NCT02351141|Pulmonary Function|pulmonary function
199120|NCT02351141|Quality of Life Questionnaires|quality of life questionnaires
199121|NCT02351128|lanreotide|lanreotide
199122|NCT02351102|Congenital CMV|congenital cmv
199123|NCT02351102|Congenital Cytomegalovirus|congenital cytomegalovirus
199124|NCT02351063|Heart failure|heart failure
199125|NCT02351063|BNP|bnp
199126|NCT02351063|home testing|home testing
199127|NCT02351063|remote monitoring|remote monitoring
199128|NCT02351050|sonolysis, brain infarction, coronary angioplasty|sonolysis, brain infarction, coronary angioplasty
199129|NCT02351037|Acute Myeloid Leukemia|acute myeloid leukemia
199130|NCT02351037|AML|aml
199131|NCT02351037|Ibrutinib|ibrutinib
199132|NCT02351037|Cytarabine|cytarabine
199133|NCT02351037|LD-AraC|ld-arac
199134|NCT02351037|Azacitidine|azacitidine
199135|NCT02350985|Migraine|migraine
199136|NCT02350985|Migrainous Vertigo|migrainous vertigo
199137|NCT02350985|Headache Disorders|headache disorders
199138|NCT02350985|Central Nervous System Origin Vertigo|central nervous system origin vertigo
199139|NCT02350985|Paroxysmal Vertigo|paroxysmal vertigo
199140|NCT02350985|Adrenergic beta-Antagonist|adrenergic beta-antagonist
199141|NCT02350985|Vasodilator Agent|vasodilator agent
199142|NCT02350985|Anti Arrhythmia Agent|anti arrhythmia agent
199143|NCT02350985|Serotonin Uptake Inhibitor|serotonin uptake inhibitor
199144|NCT02350985|Antidepressive Agent|antidepressive agent
199145|NCT02350985|Propranolol|propranolol
199146|NCT02350985|Venlafaxine|venlafaxine
199147|NCT02350959|Plaque|plaque
199148|NCT02350959|coronary computed tomography angiography|coronary computed tomography angiography
199149|NCT02350933|tracheal damages|tracheal damages
199150|NCT02350920|IBD|ibd
199151|NCT02350920|Crohn's disease|crohn's disease
199152|NCT02350920|ulcerative colitis|ulcerative colitis
199153|NCT02350920|ACT|act
199154|NCT02350907|antimicrobial resistance|antimicrobial resistance
199155|NCT02350907|point-of-care testing|point-of-care testing
199156|NCT02350907|Neisseria gonorrhoeae|neisseria gonorrhoeae
199157|NCT02350868|without Standard Treatment|without standard treatment
199158|NCT02350855|Nutrition intervention|nutrition intervention
199159|NCT02350855|Palliative care|palliative care
199160|NCT02350855|Public Health|public health
199161|NCT02350855|Quality of life|quality of life
199162|NCT02350855|Tailored food formula|tailored food formula
199163|NCT02350855|Body weight|body weight
199164|NCT02350842|non-Left Bundle Branch Block morphology|non-left bundle branch block morphology
199165|NCT02350842|Triple-site biventricular pacing|triple-site biventricular pacing
199166|NCT02350842|cardiac resynchronization therapy|cardiac resynchronization therapy
199167|NCT02350803|distraction osteogenesis|distraction osteogenesis
199168|NCT02350803|mini plate|mini plate
199169|NCT02350803|Lefort 1 osteotomy|lefort 1 osteotomy
199170|NCT02350790|Robotics|robotics
199171|NCT02350790|Laparoscopy|laparoscopy
199172|NCT02350790|Endometriosis|endometriosis
199173|NCT02350790|Argon|argon
199174|NCT02350790|Gynecology|gynecology
199175|NCT02350777|T-cell Depleted Hematopoietic Stem Cell|t-cell depleted hematopoietic stem cell
199176|NCT02350777|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
199177|NCT02350777|CliniMACS Cell Selection System|clinimacs cell selection system
199178|NCT02350777|14-228|14-228
199179|NCT02350777|HSCT|hsct
199180|NCT02350764|Nivolumab|nivolumab
199181|NCT02350764|Lung|lung
199182|NCT02350764|ipilimumab|ipilimumab
199183|NCT02350764|NSCLC|nsclc
199184|NCT02350764|14-137|14-137
199185|NCT02350751|Influenza, Flu, Flu A, Influenza A|influenza, flu, flu a, influenza a
199186|NCT02350738|Mild cognitive impairment|mild cognitive impairment
199187|NCT02350738|Dementia|dementia
199188|NCT02350738|Cognitive training|cognitive training
199189|NCT02350738|Cognitive rehabilitation|cognitive rehabilitation
199190|NCT02350738|Cognitive therapy|cognitive therapy
199191|NCT02350725|Chronic Fluid Overload|chronic fluid overload
199192|NCT02350712|Recurrent or metastatic squamous cell carcinoma of the head and neck|recurrent or metastatic squamous cell carcinoma of the head and neck
199193|NCT02350712|SCCHN|scchn
199194|NCT02350647|Rotator cuff|rotator cuff
199195|NCT02350647|Ossification|ossification
199196|NCT02350647|Suture anchors|suture anchors
199197|NCT02350621|cervical foraminal stenosis minimal invasive foraminotomy|cervical foraminal stenosis minimal invasive foraminotomy
199198|NCT02350582|breast cancer|breast cancer
199199|NCT02350582|telerehabilitation|telerehabilitation
199200|NCT02350582|strength|strength
199201|NCT02350582|fatigue|fatigue
199202|NCT02350582|quality of life|quality of life
199203|NCT02350569|liver transplant|liver transplant
199204|NCT02350569|hepatitis C|hepatitis c
199205|NCT02350569|Gilead|gilead
199206|NCT02350569|Communicable Diseases|communicable diseases
199207|NCT02350569|Infection|infection
199208|NCT02350569|Liver Diseases|liver diseases
199209|NCT02350569|RNA Virus Infections|rna virus infections
199210|NCT02350543|Aspirin usage|aspirin usage
199211|NCT02350543|Transurethral resection of bladder tumor (TURBT)|transurethral resection of bladder tumor (turbt)
199212|NCT02350530|Colorectal cancer|colorectal cancer
199213|NCT02350530|Metastatic colorectal cancer|metastatic colorectal cancer
199214|NCT02350530|Liver metastases|liver metastases
199215|NCT02350530|Liver resection|liver resection
199216|NCT02350530|Liver ablation|liver ablation
199217|NCT02350530|Conversion therapy|conversion therapy
199218|NCT02350530|FOLFOXIRI|folfoxiri
199219|NCT02350530|Oxaliplatin|oxaliplatin
199220|NCT02350530|Irinotecan|irinotecan
199221|NCT02350530|Fluorouracil|fluorouracil
199222|NCT02350530|Bevacizumab|bevacizumab
199223|NCT02350530|RAS mutation|ras mutation
199224|NCT02350491|Pregnancy|pregnancy
199225|NCT02350491|miRNA|mirna
199226|NCT02350491|Rheumatoid Arthritis (RA)|rheumatoid arthritis (ra)
199227|NCT02350491|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
199228|NCT02350465|sarcopenia|sarcopenia
199229|NCT02350465|aging|aging
199230|NCT02350465|myosteatosis|myosteatosis
199231|NCT02350465|exercise|exercise
199232|NCT02350465|screening|screening
199233|NCT02350452|laparoscopic surgery|laparoscopic surgery
199234|NCT02350452|diode laser|diode laser
199235|NCT02350452|AMH|amh
199236|NCT02350452|AFC|afc
199237|NCT02350439|Coronary artery disease|coronary artery disease
199238|NCT02350439|Fractional floe reserve|fractional floe reserve
199239|NCT02350400|Drug eluting beads|drug eluting beads
199240|NCT02350400|Irinotecan|irinotecan
199241|NCT02350400|Pharmacogenetics|pharmacogenetics
199242|NCT02350400|Pharmacokinetics|pharmacokinetics
199243|NCT02350374|diabetes|diabetes
199244|NCT02350374|children|children
199245|NCT02350361|endostar|endostar
199246|NCT02350361|angiogenesis|angiogenesis
199247|NCT02350361|EGFR-TKI|egfr-tki
199248|NCT02350361|lung caner|lung caner
199249|NCT02350348|neonates|neonates
199250|NCT02350348|infants|infants
199251|NCT02350348|anaesthesia|anaesthesia
199252|NCT02350348|mortality|mortality
199253|NCT02350348|adverse effects|adverse effects
199254|NCT02350348|Epidemiological Study|epidemiological study
199255|NCT02350348|European Society of Anaesthesiology|european society of anaesthesiology
199256|NCT02350335|aneurysm|aneurysm
199257|NCT02350335|nicotine replacement therapy|nicotine replacement therapy
199258|NCT02350335|cerebral vasospasm|cerebral vasospasm
199259|NCT02350335|outcome|outcome
199260|NCT02350322|Diet|diet
199261|NCT02350322|concentration|concentration
199262|NCT02350322|seafood|seafood
199263|NCT02350322|youths|youths
199264|NCT02350322|Norway|norway
199265|NCT02350322|Nutrient status in blood|nutrient status in blood
199266|NCT02350322|Inflammatory markers|inflammatory markers
199267|NCT02350309|Insomnia Disorder|insomnia disorder
199268|NCT02350309|E2006|e2006
199269|NCT02350309|Multiple Sleep Latency Test|multiple sleep latency test
199270|NCT02350296|headache|headache
199271|NCT02350296|dental pain|dental pain
199272|NCT02350296|neuralgia|neuralgia
199273|NCT02350296|dysmenorrhoea|dysmenorrhoea
199274|NCT02350296|muscular and osteoarticular pain|muscular and osteoarticular pain
199275|NCT02350283|Acute Ischemic Stroke|acute ischemic stroke
199276|NCT02350283|Endovascular therapy|endovascular therapy
199277|NCT02350283|Solitaire|solitaire
199278|NCT02350283|Standard Medical Management|standard medical management
199279|NCT02350270|cognitively healthy individuals|cognitively healthy individuals
199280|NCT02350257|cognitive behavior therapy|cognitive behavior therapy
199281|NCT02350257|child|child
199282|NCT02350257|randomized controlled trial|randomized controlled trial
199283|NCT02350257|internet|internet
199284|NCT02350244|musculoskeletal diseases|musculoskeletal diseases
199285|NCT02350244|eyestrain|eyestrain
199286|NCT02350244|occupational diseases|occupational diseases
199287|NCT02350244|computer work|computer work
199288|NCT02350244|muscle stretching exercise|muscle stretching exercise
199289|NCT02350244|computer software application|computer software application
199290|NCT02350244|MSDs|msds
199291|NCT02350231|preterm birth|preterm birth
199292|NCT02350231|Twin pregnancy|twin pregnancy
199293|NCT02350231|progesterone|progesterone
199294|NCT02350218|Transplantation|transplantation
199295|NCT02350218|Living donor|living donor
199296|NCT02350218|Eglandin|eglandin
199297|NCT02350218|Alprostadil|alprostadil
199298|NCT02350205|Burn wounds|burn wounds
199299|NCT02350205|Burns|burns
199300|NCT02350205|Skin substitute|skin substitute
199301|NCT02350192|ehealth|ehealth
199302|NCT02350192|intervention|intervention
199303|NCT02350192|effectiveness|effectiveness
199304|NCT02350192|randomized controlled trial|randomized controlled trial
199305|NCT02350166|colorectal cancer|colorectal cancer
199306|NCT02350166|hepatectomy|hepatectomy
199307|NCT02350166|laparoscopic surgery|laparoscopic surgery
199308|NCT02350166|laparotomy|laparotomy
199309|NCT02350166|complications|complications
199310|NCT02350153|Mortality|mortality
199311|NCT02350153|Morbidity|morbidity
199312|NCT02350153|Incidence|incidence
199313|NCT02350153|Prevalence|prevalence
199314|NCT02350140|HIV|hiv
199315|NCT02350140|Prevention of mother-to-child HIV transmission|prevention of mother-to-child hiv transmission
199316|NCT02350140|PMTCT|pmtct
199317|NCT02350140|mobile health (mHealth)|mobile health (mhealth)
199318|NCT02350140|mobile phone|mobile phone
199319|NCT02350140|text messaging|text messaging
199320|NCT02350140|short message services (SMS)|short message services (sms)
199321|NCT02350127|dementia|dementia
199322|NCT02350127|clinical trial|clinical trial
199323|NCT02350127|behavioral intervention|behavioral intervention
199324|NCT02350127|exercise|exercise
199325|NCT02350127|complementary and alternative medicine|complementary and alternative medicine
199326|NCT02350127|cognition|cognition
199327|NCT02350127|function|function
199328|NCT02350127|quality of life|quality of life
199329|NCT02350114|Heart failure|heart failure
199330|NCT02350114|6 Minute Walk Test|6 minute walk test
199331|NCT02350088|fast-track surgery|fast-track surgery
199332|NCT02350075|short implants|short implants
199333|NCT02350075|sinus floor elevation|sinus floor elevation
199334|NCT02350075|randomized controlled trial|randomized controlled trial
199335|NCT02350036|Preeclampsia|preeclampsia
199336|NCT02350036|placental protein 13|placental protein 13
199337|NCT02350036|Uterine artery doppler|uterine artery doppler
199338|NCT02350023|alopecia areata|alopecia areata
199339|NCT02350023|betamethasone|betamethasone
199340|NCT02350023|latanoprost|latanoprost
199341|NCT02350023|topical steroid|topical steroid
199342|NCT02350023|prostaglandin|prostaglandin
199343|NCT02350010|Etiology|etiology
199344|NCT02350010|Prognostic risk factors|prognostic risk factors
199345|NCT02350010|Intracerebral Hemorrhage|intracerebral hemorrhage
199346|NCT02350010|non-invasive imaging|non-invasive imaging
199347|NCT02350010|CT angiography|ct angiography
199348|NCT02349997|central sleep apnea|central sleep apnea
199349|NCT02349997|Cheyne-Stokes respiration|cheyne-stokes respiration
199350|NCT02349997|obstructive sleep apnea|obstructive sleep apnea
199351|NCT02349997|chronic heart failure|chronic heart failure
199352|NCT02349997|fluid shift|fluid shift
199353|NCT02349919|postinfectious cough, postviral cough|postinfectious cough, postviral cough
199354|NCT02349906|non-malignant diseases, allogeneic stem cell transplantation|non-malignant diseases, allogeneic stem cell transplantation
199355|NCT02349854|pruritus|pruritus
199356|NCT02349854|itch|itch
199357|NCT02349854|skin|skin
199358|NCT02349854|scalp|scalp
199359|NCT02349854|seborrheic dermatitis|seborrheic dermatitis
199360|NCT02349828|antiviral|antiviral
199361|NCT02349828|herpes simplex virus|herpes simplex virus
199362|NCT02349828|herpes|herpes
199363|NCT02349828|burn patients|burn patients
199364|NCT02349828|HSV|hsv
199365|NCT02349828|acyclovir|acyclovir
199366|NCT02349815|Drug Utilization Study|drug utilization study
199367|NCT02349802|Auto-injector Device, device-related injection, Auto-injector|auto-injector device, device-related injection, auto-injector
199368|NCT02349789|Gait|gait
199369|NCT02349789|Cerebellum|cerebellum
199370|NCT02349789|Non invasive electrical stimulation|non invasive electrical stimulation
199371|NCT02349789|tDCS|tdcs
199372|NCT02349789|TMS|tms
199373|NCT02349789|Balance|balance
199374|NCT02349763|Dexamethasone|dexamethasone
199375|NCT02349763|Hypersensitivity reaction|hypersensitivity reaction
199376|NCT02349763|Paclitaxel|paclitaxel
199377|NCT02349750|Endometrial Scratch Injury|endometrial scratch injury
199378|NCT02349750|Unexplained infertility|unexplained infertility
199379|NCT02349750|intrauterine insemenation|intrauterine insemenation
199380|NCT02349750|ovulation induction|ovulation induction
199381|NCT02349737|Bioelectrical Impedance Analysis|bioelectrical impedance analysis
199382|NCT02349737|Body composition|body composition
199383|NCT02349737|ICD|icd
199384|NCT02349724|CEA|cea
199385|NCT02349724|CAR T|car t
199386|NCT02349711|probiotic|probiotic
199387|NCT02349711|allergy|allergy
199388|NCT02349711|immune|immune
199389|NCT02349698|CAR T|car t
199390|NCT02349698|Leukemia|leukemia
199391|NCT02349698|Lymphoma|lymphoma
199392|NCT02349685|Helicobacter pylori|helicobacter pylori
199393|NCT02349685|Personalized therapy|personalized therapy
199394|NCT02349685|antimicrobial susceptibility|antimicrobial susceptibility
199395|NCT02349685|rescue therapy|rescue therapy
199396|NCT02349685|culture|culture
199397|NCT02349672|HIE|hie
199398|NCT02349672|Neonates|neonates
199399|NCT02349633|EGFRm - Epidermal Growth Factor Receptor Mutation|egfrm - epidermal growth factor receptor mutation
199400|NCT02349633|Advanced EGFRm (del19 or L858R +/- T790M NSCLC|advanced egfrm (del19 or l858r +/- t790m nsclc
199401|NCT02349581|Anesthetics, Local|anesthetics, local
199402|NCT02349581|Mastectomy|mastectomy
199403|NCT02349581|Neuralgia|neuralgia
199404|NCT02349581|Nerve block|nerve block
199405|NCT02349542|Liposomal Bupivacaine|liposomal bupivacaine
199406|NCT02349542|Simultaneous Bilateral Total Knee Arthroplasty|simultaneous bilateral total knee arthroplasty
199407|NCT02349542|Safety|safety
199408|NCT02349529|Epilepsy|epilepsy
199409|NCT02349529|psychosocial|psychosocial
199410|NCT02349503|Adrenocortical function|adrenocortical function
199411|NCT02349503|Adrenal hyperplasia, Congenital|adrenal hyperplasia, congenital
199412|NCT02349503|21-hydroxylase deficiency|21-hydroxylase deficiency
199413|NCT02349503|Adrenogenital Syndrome|adrenogenital syndrome
199414|NCT02349503|Adolescents|adolescents
199415|NCT02349503|Female|female
199416|NCT02349503|Hyperplasia|hyperplasia
199417|NCT02349503|Adrenal Gland Diseases|adrenal gland diseases
199418|NCT02349503|Congenital Abnormalities|congenital abnormalities
199419|NCT02349503|Adrenocortical Hyperfunction|adrenocortical hyperfunction
199420|NCT02349503|Disorders of Sex Development|disorders of sex development
199421|NCT02349503|Endocrine System Diseases|endocrine system diseases
199422|NCT02349503|Genetic Diseases, Inborn|genetic diseases, inborn
199423|NCT02349503|Gonadal Disorders|gonadal disorders
199424|NCT02349503|Metabolic Diseases|metabolic diseases
199425|NCT02349503|Metabolism, Inborn Errors|metabolism, inborn errors
199426|NCT02349503|Pathologic Processes|pathologic processes
199427|NCT02349503|Steroid Metabolism, Inborn Errors|steroid metabolism, inborn errors
199428|NCT02349503|Urogenital Abnormalities|urogenital abnormalities
199429|NCT02349503|Corticotropin Releasing Factor|corticotropin releasing factor
199430|NCT02349490|gastrointestinal hemorrhage|gastrointestinal hemorrhage
199431|NCT02349490|endoscopy|endoscopy
199432|NCT02349490|hemostasis|hemostasis
199433|NCT02349451|Safety|safety
199434|NCT02349451|Efficacy|efficacy
199435|NCT02349451|Methotrexate|methotrexate
199436|NCT02349373|Overuse injury|overuse injury
199437|NCT02349373|Running related injury|running related injury
199438|NCT02349373|Running pattern|running pattern
199439|NCT02349360|safety|safety
199440|NCT02349360|tolerability|tolerability
199441|NCT02349321|physical or sexual intimate partner violence|physical or sexual intimate partner violence
199442|NCT02349321|adolescents|adolescents
199443|NCT02349321|primary prevention|primary prevention
199444|NCT02349321|randomised controlled trial|randomised controlled trial
199445|NCT02349321|school|school
199446|NCT02349321|South Africa|south africa
199447|NCT02349321|parenting|parenting
199448|NCT02349282|muscle strength|muscle strength
199449|NCT02349282|physical performance|physical performance
199450|NCT02349282|vitamin D3|vitamin d3
199451|NCT02349282|Cholecalciferol|cholecalciferol
199452|NCT02349282|Calcifediol|calcifediol
199453|NCT02349269|Atrial fibrillation|atrial fibrillation
199454|NCT02349269|CABG|cabg
199455|NCT02349269|Stroke|stroke
199456|NCT02349256|MUS|mus
199457|NCT02349256|British South Asians|british south asians
199458|NCT02349256|Somatic Symptoms|somatic symptoms
199459|NCT02349256|Qualitative interviews|qualitative interviews
199460|NCT02349243|obese|obese
199461|NCT02349243|weight loss|weight loss
199462|NCT02349243|entacapone|entacapone
199463|NCT02349217|Breast cancer|breast cancer
199464|NCT02349217|Breast cancer survivors|breast cancer survivors
199465|NCT02349217|Breast cancer partners|breast cancer partners
199466|NCT02349217|Mindfulness-Based Relationship Enhancement|mindfulness-based relationship enhancement
199467|NCT02349217|MBRE|mbre
199468|NCT02349217|Standard of care|standard of care
199469|NCT02349217|Pain Assessment|pain assessment
199470|NCT02349217|Questionnaires|questionnaires
199471|NCT02349217|Surveys|surveys
199472|NCT02349217|Neurocognitive Tests|neurocognitive tests
199473|NCT02349217|Cortisol Tests|cortisol tests
199474|NCT02349217|Saliva tests|saliva tests
199475|NCT02349217|Interviews|interviews
199476|NCT02349217|Meditation|meditation
199477|NCT02349217|Yoga|yoga
199478|NCT02349217|Self-help materials|self-help materials
199479|NCT02349204|Simulator|simulator
199480|NCT02349204|Music|music
199481|NCT02349204|Mozart Effect|mozart effect
199482|NCT02349191|Alzheimers|alzheimers
199483|NCT02349191|dementia|dementia
199484|NCT02349191|omental transposition|omental transposition
199485|NCT02349191|neurological|neurological
199486|NCT02349152|Cardiopulmonary bypass|cardiopulmonary bypass
199487|NCT02349152|Heart surgery|heart surgery
199488|NCT02349126|Hepatitis B|hepatitis b
199489|NCT02349126|HBV infection|hbv infection
199490|NCT02349126|Hepatitis B Surface Antigen|hepatitis b surface antigen
199491|NCT02349113|estrogen, aging|estrogen, aging
199492|NCT02349087|EEG|eeg
199493|NCT02349087|cardiac arrest|cardiac arrest
199494|NCT02349087|resuscitation|resuscitation
199495|NCT02349087|seizures|seizures
199496|NCT02349061|Systemic Lupus Erythematosus|systemic lupus erythematosus
199497|NCT02349061|Ustekinumab|ustekinumab
199498|NCT02349048|Hepatitis C virus|hepatitis c virus
199499|NCT02349048|Hepatitis C virus genotype 1|hepatitis c virus genotype 1
199500|NCT02349048|Chronic Hepatitis C Virus Genotype 1 Infection|chronic hepatitis c virus genotype 1 infection
199501|NCT02349048|Liver fibrosis|liver fibrosis
199502|NCT02349048|Cirrhosis|cirrhosis
199503|NCT02349048|Simeprevir|simeprevir
199504|NCT02349048|Daclatasvir|daclatasvir
199505|NCT02349048|Sofosbuvir|sofosbuvir
199506|NCT02349035|Transradial amputee|transradial amputee
199507|NCT02349022|[89Zr]Df-IAB2M|[89zr]df-iab2m
199508|NCT02349022|Prostate cancer|prostate cancer
199509|NCT02349022|PET scan|pet scan
199510|NCT02349009|systemic sclerosis|systemic sclerosis
199511|NCT02349009|scleroderma|scleroderma
199512|NCT02348970|mandibular advancement devices ONIRIS®|mandibular advancement devices oniris®
199513|NCT02348970|obstructive sleep apnea and hypopneas|obstructive sleep apnea and hypopneas
199514|NCT02348957|Chronic myeloid leukemia|chronic myeloid leukemia
199515|NCT02348957|Dasatinib|dasatinib
199516|NCT02348957|Any line|any line
199517|NCT02348957|Chronic phase|chronic phase
199518|NCT02348944|Biological markers|biological markers
199519|NCT02348944|Cartilage|cartilage
199520|NCT02348840|Midwives|midwives
199521|NCT02348840|Pregnant Women|pregnant women
199522|NCT02348827|Unipolar depression|unipolar depression
199523|NCT02348827|Family Therapies|family therapies
199524|NCT02348827|Psychoeducation|psychoeducation
199525|NCT02348827|Family psychoeducation|family psychoeducation
199526|NCT02348814|NAFLD, NASH|nafld, nash
199527|NCT02348788|Vivax|vivax
199528|NCT02348788|Malaria|malaria
199529|NCT02348788|artemether-lumefantrine|artemether-lumefantrine
199530|NCT02348788|chloroquine|chloroquine
199531|NCT02348788|RCT|rct
199532|NCT02348749|18F-MFBG Imaging|18f-mfbg imaging
199533|NCT02348749|14-138|14-138
199534|NCT02348749|PET/MR|pet/mr
199535|NCT02348749|PET/CT scan|pet/ct scan
199536|NCT02348736|airway|airway
199537|NCT02348736|videolaryngoscope|videolaryngoscope
199538|NCT02348697|Cartilage Defect in the Knee|cartilage defect in the knee
199539|NCT02348697|MACT|mact
199540|NCT02348684|Breast Cancer|breast cancer
199541|NCT02348658|Pharmacological therapy|pharmacological therapy
199542|NCT02348645|Pilot projects|pilot projects
199543|NCT02348645|Feasibility studies|feasibility studies
199544|NCT02348645|Intervention studies|intervention studies
199545|NCT02348645|Orthopedics|orthopedics
199546|NCT02348645|Orthopedic Procedures|orthopedic procedures
199547|NCT02348645|Neurosurgical Procedures|neurosurgical procedures
199548|NCT02348645|Neurosurgery|neurosurgery
199549|NCT02348645|Spine|spine
199550|NCT02348645|Spinal Fusion|spinal fusion
199551|NCT02348645|Spondylodesis|spondylodesis
199552|NCT02348645|Spondylosyndesis|spondylosyndesis
199553|NCT02348645|Laminectomy|laminectomy
199554|NCT02348645|Foraminotomy|foraminotomy
199555|NCT02348645|Decompression, surgical|decompression, surgical
199556|NCT02348645|Low Back Pain|low back pain
199557|NCT02348645|Quality of Life|quality of life
199558|NCT02348580|teaching|teaching
199559|NCT02348580|education|education
199560|NCT02348580|active learning|active learning
199561|NCT02348580|time on task|time on task
199562|NCT02348580|financial education|financial education
199563|NCT02348580|social education|social education
199564|NCT02348580|rights based education|rights based education
199565|NCT02348580|primary school|primary school
199566|NCT02348580|life-skills|life-skills
199567|NCT02348567|Health care, accreditation, unannounced survey, cluster randomized controlled trial, quality improvement, organisational development|health care, accreditation, unannounced survey, cluster randomized controlled trial, quality improvement, organisational development
199568|NCT02348554|obesity|obesity
199569|NCT02348554|energy expenditure|energy expenditure
199570|NCT02348554|daily living physical activity|daily living physical activity
199571|NCT02348554|smartphone|smartphone
199572|NCT02348554|accelerometry|accelerometry
199573|NCT02348554|prediction algorithm|prediction algorithm
199574|NCT02348528|Multiple Myeloma|multiple myeloma
199575|NCT02348528|Relapsed|relapsed
199576|NCT02348528|Refractory|refractory
199577|NCT02348528|Lenalidomide|lenalidomide
199578|NCT02348528|Dexamethasone|dexamethasone
199579|NCT02348528|open-label|open-label
199580|NCT02348528|CC-5013-MM-021|cc-5013-mm-021
199581|NCT02348502|HBsAg loss|hbsag loss
199582|NCT02348502|interferon|interferon
199583|NCT02348502|HBV reaction|hbv reaction
199584|NCT02348502|Hepatitis B|hepatitis b
199585|NCT02348489|AML|aml
199586|NCT02348489|Acute Myeloid Leukemia|acute myeloid leukemia
199587|NCT02348489|SGI-110|sgi-110
199588|NCT02348489|DNA Hypomethylating Agen|dna hypomethylating agen
199589|NCT02348437|Pronator quadratus|pronator quadratus
199590|NCT02348437|Distal radius fracture|distal radius fracture
199591|NCT02348437|Repair|repair
199592|NCT02348437|Volar plating|volar plating
199593|NCT02348437|PRWE|prwe
199594|NCT02348424|genitourinary|genitourinary
199595|NCT02348424|Neisseriaceae|neisseriaceae
199596|NCT02348424|pharyngeal|pharyngeal
199597|NCT02348424|Solithromycin|solithromycin
199598|NCT02348411|Medication-refractory|medication-refractory
199599|NCT02348398|Cervical Cancer|cervical cancer
199600|NCT02348398|Recurrent cervical cancer|recurrent cervical cancer
199601|NCT02348398|Squamous cervical cancer|squamous cervical cancer
199602|NCT02348398|Adenocarcinoma of the cervix|adenocarcinoma of the cervix
199603|NCT02348398|Adenosquamous cervical cancer|adenosquamous cervical cancer
199604|NCT02348398|Persistent cervical cancer|persistent cervical cancer
199605|NCT02348398|Pazopanib|pazopanib
199606|NCT02348398|GW786034|gw786034
199607|NCT02348398|Topotecan|topotecan
199608|NCT02348398|Hycamtin|hycamtin
199609|NCT02348385|amphetamine|amphetamine
199610|NCT02348385|cigarette smokers|cigarette smokers
199611|NCT02348359|Vascular Endothelial Growth Factor (VEGF)|vascular endothelial growth factor (vegf)
199612|NCT02348359|Platelet Derived Growth Factor (PDGF)|platelet derived growth factor (pdgf)
199613|NCT02348359|AMD|amd
199614|NCT02348346|self-disinfecting surfaces|self-disinfecting surfaces
199615|NCT02348346|titanium dioxide|titanium dioxide
199616|NCT02348281|triple negative breast cancer|triple negative breast cancer
199617|NCT02348281|androgen receptor|androgen receptor
199618|NCT02348281|bicalutamide|bicalutamide
199619|NCT02348268|Neck Pain|neck pain
199620|NCT02348268|Myofascial release|myofascial release
199621|NCT02348268|Manual therapy|manual therapy
199622|NCT02348242|Intensive care|intensive care
199623|NCT02348242|corneal damage|corneal damage
199624|NCT02348242|prevention|prevention
199625|NCT02348242|nursing protocol|nursing protocol
199626|NCT02348229|Enhanced recovery after surgery|enhanced recovery after surgery
199627|NCT02348229|laparoscopic gastrectomy|laparoscopic gastrectomy
199628|NCT02348229|advanced gastric cancer|advanced gastric cancer
199629|NCT02348229|C-reactive,visceral proteins|c-reactive,visceral proteins
199630|NCT02348177|Human immunideficiency virus|human immunideficiency virus
199631|NCT02348177|Tuberculosis|tuberculosis
199632|NCT02348177|superboosting|superboosting
199633|NCT02348177|lopinavir/ritonavir 1:1|lopinavir/ritonavir 1:1
199634|NCT02348177|Pediatric TB/HIV co-infection|pediatric tb/hiv co-infection
199635|NCT02348164|Carotenoids|carotenoids
199636|NCT02348164|absorption|absorption
199637|NCT02348164|citrus|citrus
199638|NCT02348151|COPD|copd
199639|NCT02348151|SWTi|swti
199640|NCT02348151|Treadmill|treadmill
199641|NCT02348138|Isometric Handgrip|isometric handgrip
199642|NCT02348112|stress urinary incontinence|stress urinary incontinence
199643|NCT02348112|Altis 522|altis 522
199644|NCT02348112|urinary incontinence|urinary incontinence
199645|NCT02348099|Diabetes|diabetes
199646|NCT02348099|Lipohypertrophy|lipohypertrophy
199647|NCT02348099|Ultrasound|ultrasound
199648|NCT02348073|Epilepsy|epilepsy
199649|NCT02348073|Attention Deficit Disorders|attention deficit disorders
199650|NCT02348073|VAYARIN|vayarin
199651|NCT02348073|Children|children
199652|NCT02348073|Polyunsaturated n-3 fatty acid supplementation|polyunsaturated n-3 fatty acid supplementation
199653|NCT02348034|Surgical Site Infection (SSI)|surgical site infection (ssi)
199654|NCT02348034|Negative Pressure Wound Therapy (NPWT)|negative pressure wound therapy (npwt)
199655|NCT02348008|MK-3475|mk-3475
199656|NCT02348008|Pembrolizumab|pembrolizumab
199657|NCT02348008|Bevacizumab|bevacizumab
199658|NCT02347995|Exercise|exercise
199659|NCT02347995|Protein|protein
199660|NCT02347995|Nutrition|nutrition
199661|NCT02347995|Stroke|stroke
199662|NCT02347982|Turkey|turkey
199663|NCT02347982|Epidemiologic|epidemiologic
199664|NCT02347969|antioxidant|antioxidant
199665|NCT02347969|skin radiance|skin radiance
199666|NCT02347969|skin elasticity|skin elasticity
199667|NCT02347969|skin firmness|skin firmness
199668|NCT02347969|skin hydration|skin hydration
199669|NCT02347956|robot surgery|robot surgery
199670|NCT02347956|reduced port|reduced port
199671|NCT02347956|single-site|single-site
199672|NCT02347956|safety|safety
199673|NCT02347956|feasibility|feasibility
199674|NCT02347930|acute kidney injury|acute kidney injury
199675|NCT02347930|ultrasound technology|ultrasound technology
199676|NCT02347904|Esophageal cancer|esophageal cancer
199677|NCT02347904|Adjuvant treatment|adjuvant treatment
199678|NCT02347904|S-1|s-1
199679|NCT02347904|Oxaliplatin|oxaliplatin
199680|NCT02347904|Feasibility|feasibility
199681|NCT02347891|Inflammatory Myositis|inflammatory myositis
199682|NCT02347891|Dermatomyositis|dermatomyositis
199683|NCT02347891|Polymyositis|polymyositis
199684|NCT02347891|Muscle Pain|muscle pain
199685|NCT02347891|Myositis|myositis
199686|NCT02347891|Refractory myositis|refractory myositis
199687|NCT02347878|leukemia|leukemia
199688|NCT02347878|lymphoma|lymphoma
199689|NCT02347878|lumbar puncture|lumbar puncture
199690|NCT02347878|intrathecal treatment|intrathecal treatment
199691|NCT02347878|post-lumbar puncture headache|post-lumbar puncture headache
199692|NCT02347865|osteoporosis post menopausal women|osteoporosis post menopausal women
199693|NCT02347826|coned wires, wire lift,|coned wires, wire lift,
199694|NCT02347826|patient|patient
199695|NCT02347826|discomfort|discomfort
199696|NCT02347813|squamous cell carcinoma|squamous cell carcinoma
199697|NCT02347813|pioglitazone|pioglitazone
199698|NCT02347813|PPARgamma|ppargamma
199699|NCT02347813|skin cancer|skin cancer
199700|NCT02347774|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
199701|NCT02347774|COPD|copd
199702|NCT02347761|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
199703|NCT02347748|Pain|pain
199704|NCT02347748|Anesthesia Recovery Period|anesthesia recovery period
199705|NCT02347748|Postoperative Period|postoperative period
199706|NCT02347748|Adaptation, Psychological|adaptation, psychological
199707|NCT02347748|Relaxation|relaxation
199708|NCT02347748|Stress, Psychological|stress, psychological
199709|NCT02347735|Colorectal carcinoma|colorectal carcinoma
199710|NCT02347735|Anastomotic leakage|anastomotic leakage
199711|NCT02347735|Markers|markers
199712|NCT02347735|Diagnosis|diagnosis
199713|NCT02347722|biomarkers|biomarkers
199714|NCT02347722|diagnosis|diagnosis
199715|NCT02347722|etiology of heart failure|etiology of heart failure
199716|NCT02347709|Diabetic Foot Ulcer|diabetic foot ulcer
199717|NCT02347709|DFU|dfu
199718|NCT02347709|Type 2 Diabetes|type 2 diabetes
199719|NCT02347709|Neuropathy|neuropathy
199720|NCT02347696|Diet|diet
199721|NCT02347696|Physical Activity|physical activity
199722|NCT02347696|Trial|trial
199723|NCT02347696|Lipidomics|lipidomics
199724|NCT02347696|Occidental Diseases|occidental diseases
199725|NCT02347657|Homozygous for the F508del CFTR Mutation|homozygous for the f508del cftr mutation
199726|NCT02347566|COPD|copd
199727|NCT02347566|Physical Activity|physical activity
199728|NCT02347566|Accelerometer|accelerometer
199729|NCT02347540|Heart Failure|heart failure
199730|NCT02347540|Diastolic Dysfunction|diastolic dysfunction
199731|NCT02347540|Pre-Eclampsia|pre-eclampsia
199732|NCT02347540|Endothelial dysfunction|endothelial dysfunction
199733|NCT02347540|Biological Markers|biological markers
199734|NCT02347540|MicroRNAs|micrornas
199735|NCT02347540|Circulating cells|circulating cells
199736|NCT02347488|ETT Holder, bite guard, airway, endotracheal tube|ett holder, bite guard, airway, endotracheal tube
199737|NCT02347462|BiPAP|bipap
199738|NCT02347449|Early-stage Breast cancer, node positive|early-stage breast cancer, node positive
199739|NCT02347449|Prognosis|prognosis
199740|NCT02347449|Oncotype Dx|oncotype dx
199741|NCT02347436|Transurethral Resection of Prostate|transurethral resection of prostate
199742|NCT02347423|Poliomyelitis immunization|poliomyelitis immunization
199743|NCT02347423|primary series|primary series
199744|NCT02347371|Heart transplant|heart transplant
199745|NCT02347371|Cardiac allograft vasculopathy|cardiac allograft vasculopathy
199746|NCT02347371|Chronic rejection|chronic rejection
199747|NCT02347371|Immunosuppressant therapy|immunosuppressant therapy
199748|NCT02347345|HCV, injection drug use|hcv, injection drug use
199749|NCT02347280|clostridium difficile|clostridium difficile
199750|NCT02347280|colitis|colitis
199751|NCT02347280|colon|colon
199752|NCT02347267|Beverages sweetened caloric, no caloric|beverages sweetened caloric, no caloric
199753|NCT02347267|Weight|weight
199754|NCT02347267|Fat percentage|fat percentage
199755|NCT02347267|Body Composition|body composition
199756|NCT02347267|Blood pressure|blood pressure
199757|NCT02347267|Sugar|sugar
199758|NCT02347267|Sodium|sodium
199759|NCT02347267|Dietary intake|dietary intake
199760|NCT02347228|OB318|ob318
199761|NCT02347228|Advanced Solid Malignancies|advanced solid malignancies
199762|NCT02347228|Antrodia cinnamomea|antrodia cinnamomea
199763|NCT02347228|Antrodia camphorata|antrodia camphorata
199764|NCT02347202|Counseling|counseling
199765|NCT02347163|triple neg|triple neg
199766|NCT02347163|breast cancer|breast cancer
199767|NCT02347163|zoledronate|zoledronate
199768|NCT02347163|mevalonate pathway|mevalonate pathway
199769|NCT02347124|smoking cessation|smoking cessation
199770|NCT02347124|oral health care|oral health care
199771|NCT02347124|tobacco quitlines|tobacco quitlines
199772|NCT02347098|plaque|plaque
199773|NCT02347098|LDL|ldl
199774|NCT02347098|statin|statin
199775|NCT02347098|endothelial|endothelial
199776|NCT02347098|apheresis|apheresis
199777|NCT02347098|acute coronary artery syndrome|acute coronary artery syndrome
199778|NCT02347033|Sertraline|sertraline
199779|NCT02347033|Selective Serotonin Reuptake Inhibitor (SSRI)|selective serotonin reuptake inhibitor (ssri)
199780|NCT02347033|Cognitive Behavioural Therapy (CBT)|cognitive behavioural therapy (cbt)
199781|NCT02347033|Increasing Access to Psychological Therapies (IAPT)|increasing access to psychological therapies (iapt)
199782|NCT02347020|Obesity|obesity
199783|NCT02347020|Metabolic Disorders|metabolic disorders
199784|NCT02347007|Obesity|obesity
199785|NCT02347007|Overweight|overweight
199786|NCT02347007|Body Weight|body weight
199787|NCT02347007|Cardiovascular Diseases|cardiovascular diseases
199788|NCT02347007|Cholesterol|cholesterol
199789|NCT02347007|Almonds|almonds
199790|NCT02347007|Visceral Adiposity|visceral adiposity
199791|NCT02347007|Quality of Life|quality of life
199792|NCT02347007|Hispanic Americans|hispanic americans
199793|NCT02347007|African Continental Ancestry Group|african continental ancestry group
199794|NCT02347007|Metabolic Syndrome X|metabolic syndrome x
199795|NCT02346994|Body Weight|body weight
199796|NCT02346994|Obesity in Adolescence|obesity in adolescence
199797|NCT02346994|Obesity in Childhood|obesity in childhood
199798|NCT02346994|Childhood Onset Obesity|childhood onset obesity
199799|NCT02346994|Childhood Obesity|childhood obesity
199800|NCT02346994|Child Obesity|child obesity
199801|NCT02346994|Adolescent Obesity|adolescent obesity
199802|NCT02346994|Teenagers|teenagers
199803|NCT02346994|Teens|teens
199804|NCT02346994|Youth|youth
199805|NCT02346994|Adolescents|adolescents
199806|NCT02346994|Adolescence|adolescence
199807|NCT02346968|Kidney Transplantation|kidney transplantation
199808|NCT02346968|Delayed Graft Function|delayed graft function
199809|NCT02346968|C-terminal fragment of agrin|c-terminal fragment of agrin
199810|NCT02346968|Dialysis|dialysis
199811|NCT02346955|Cancer|cancer
199812|NCT02346955|Oncology|oncology
199813|NCT02346955|cCAM Biotherapeutics Ltd|ccam biotherapeutics ltd
199814|NCT02346955|Immunomodulatory therapy|immunomodulatory therapy
199815|NCT02346955|CM-24|cm-24
199816|NCT02346955|Carcinoembryonic Antigen-related Cell Adhesion Molecule 1 (CEACAM1)|carcinoembryonic antigen-related cell adhesion molecule 1 (ceacam1)
199817|NCT02346955|NSCLC (adenocarcinoma)|nsclc (adenocarcinoma)
199818|NCT02346955|Uveal|uveal
199819|NCT02346955|Acral|acral
199820|NCT02346955|Mucosal|mucosal
199821|NCT02346955|Cutaneous|cutaneous
199822|NCT02346955|Colorectal|colorectal
199823|NCT02346955|Gastric|gastric
199824|NCT02346955|Ovarian|ovarian
199825|NCT02346955|Bladder|bladder
199826|NCT02346955|MK-6018-001|mk-6018-001
199827|NCT02346929|Hematoma block|hematoma block
199828|NCT02346929|distal radius fracture reduction|distal radius fracture reduction
199829|NCT02346929|ultrasound|ultrasound
199830|NCT02346929|ultrasound guided hematoma block|ultrasound guided hematoma block
199831|NCT02346929|traditional hematoma block for analgesia|traditional hematoma block for analgesia
199832|NCT02346929|bupivacaine|bupivacaine
199833|NCT02346929|pain reduction|pain reduction
199834|NCT02346929|wrist fracture|wrist fracture
199835|NCT02346890|Volunteer|volunteer
199836|NCT02346877|Enbrel|enbrel
199837|NCT02346877|Rheumatoid Arthritis|rheumatoid arthritis
199838|NCT02346864|head elevated position|head elevated position
199839|NCT02346864|preterm|preterm
199840|NCT02346864|three-stair-position|three-stair-position
199841|NCT02346838|Prediabetes, prebiotics, metabolic endotoxemia|prediabetes, prebiotics, metabolic endotoxemia
199842|NCT02346825|P-CIMT|p-cimt
199843|NCT02346825|Pediatric Constraint Induced Movement Therapy|pediatric constraint induced movement therapy
199844|NCT02346825|Hemiparesis|hemiparesis
199845|NCT02346825|Cerebral Palsy|cerebral palsy
199846|NCT02346825|Infants|infants
199847|NCT02346825|Toddlers|toddlers
199848|NCT02346825|Children|children
199849|NCT02346786|Drinking Water|drinking water
199850|NCT02346786|Mineral water|mineral water
199851|NCT02346786|Sports|sports
199852|NCT02346786|Accident prevention|accident prevention
199853|NCT02346747|Stage III|stage iii
199854|NCT02346747|Stage IV|stage iv
199855|NCT02346747|Ovarian Cancer|ovarian cancer
199856|NCT02346747|Maintenance|maintenance
199857|NCT02346747|Immunotherapy|immunotherapy
199858|NCT02346747|primary peritoneal cancer|primary peritoneal cancer
199859|NCT02346747|fallopian tube cancer|fallopian tube cancer
199860|NCT02346747|endometrioid ovarian cancer|endometrioid ovarian cancer
199861|NCT02346747|high-grade serous ovarian cancer|high-grade serous ovarian cancer
199862|NCT02346734|Multiple Sclerosis|multiple sclerosis
199863|NCT02346734|Telerehablitation|telerehablitation
199864|NCT02346721|Sofosbuvir|sofosbuvir
199865|NCT02346721|SOF/GS-5816|sof/gs-5816
199866|NCT02346721|GS-5816|gs-5816
199867|NCT02346721|Hepatitis C|hepatitis c
199868|NCT02346721|HCV|hcv
199869|NCT02346721|Cirrhosis|cirrhosis
199870|NCT02346721|Velpatasvir|velpatasvir
199871|NCT02346708|Parkinson's|parkinson's
199872|NCT02346708|TMS|tms
199873|NCT02346708|Kluger|kluger
199874|NCT02346695|LV deformation|lv deformation
199875|NCT02346695|Endothelial glycocalyx|endothelial glycocalyx
199876|NCT02346695|Coronary flow reserve|coronary flow reserve
199877|NCT02346682|major depression disorder|major depression disorder
199878|NCT02346682|biochemistry|biochemistry
199879|NCT02346682|TCM diagnosis|tcm diagnosis
199880|NCT02346682|Neurological|neurological
199881|NCT02346682|metabonomics|metabonomics
199882|NCT02346682|neuroimaging|neuroimaging
199883|NCT02346669|Microbiota|microbiota
199884|NCT02346669|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
199885|NCT02346669|Obesity|obesity
199886|NCT02346617|CMV|cmv
199887|NCT02346617|T cell therapy|t cell therapy
199888|NCT02346604|exercise|exercise
199889|NCT02346591|Positive psychology|positive psychology
199890|NCT02346591|Wellbeing|wellbeing
199891|NCT02346591|Stress reduction|stress reduction
199892|NCT02346591|Relaxation|relaxation
199893|NCT02346591|Gratitude|gratitude
199894|NCT02346591|Mobile app|mobile app
199895|NCT02346591|Intervention|intervention
199896|NCT02346591|Altruism|altruism
199897|NCT02346591|Psychological well-being|psychological well-being
199898|NCT02346591|Social well-being|social well-being
199899|NCT02346591|Physical well-being|physical well-being
199900|NCT02346591|Workplace engagement|workplace engagement
199901|NCT02346552|laparoscopic Cholecystectomy|laparoscopic cholecystectomy
199902|NCT02346552|laparoscope holder|laparoscope holder
199903|NCT02346552|Nissen fundoplication|nissen fundoplication
199904|NCT02346552|paraesophageal hernia|paraesophageal hernia
199905|NCT02346552|sleeve surgery|sleeve surgery
199906|NCT02346539|Nicotine|nicotine
199907|NCT02346539|Depression|depression
199908|NCT02346526|Prostate Cancer|prostate cancer
199909|NCT02346526|Castration-resistant prostate cancer|castration-resistant prostate cancer
199910|NCT02346526|Castration-resistant prostate cancer metastatic to bone|castration-resistant prostate cancer metastatic to bone
199911|NCT02346513|Hip Replacement Arthroplasty|hip replacement arthroplasty
199912|NCT02346513|Ceramic on Metal Articulation|ceramic on metal articulation
199913|NCT02346513|Serum level of Cobalt and Chromium|serum level of cobalt and chromium
199914|NCT02346500|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
199915|NCT02346500|Lower urinary tract symptoms|lower urinary tract symptoms
199916|NCT02346500|Photoselective laser vaporization of the prostate|photoselective laser vaporization of the prostate
199917|NCT02346500|Transrectal Ultrasound|transrectal ultrasound
199918|NCT02346487|children|children
199919|NCT02346474|Subcutaneous Fat|subcutaneous fat
199920|NCT02346474|Visceral Fat|visceral fat
199921|NCT02346461|Hereditary Inclusion Body Myopathy (HIBM)|hereditary inclusion body myopathy (hibm)
199922|NCT02346461|Sialic Acid|sialic acid
199923|NCT02346461|GNE Myopathy|gne myopathy
199924|NCT02346461|N-Acetyl-D-mannosamine (ManNAc)|n-acetyl-d-mannosamine (mannac)
199925|NCT02346461|GNE Gene|gne gene
199926|NCT02346448|endoscopic sphincterotomy|endoscopic sphincterotomy
199927|NCT02346448|balloon dilation|balloon dilation
199928|NCT02346448|adverse events|adverse events
199929|NCT02346448|pancreatitis|pancreatitis
199930|NCT02346448|bleeding|bleeding
199931|NCT02346435|small renal mass|small renal mass
199932|NCT02346435|active surveillance|active surveillance
199933|NCT02346422|Heart Failure|heart failure
199934|NCT02346422|Cardiomyopathies|cardiomyopathies
199935|NCT02346422|Heart Diseases|heart diseases
199936|NCT02346422|Cardiovascular Diseases|cardiovascular diseases
199937|NCT02346422|Cardiomegaly|cardiomegaly
199938|NCT02346422|Gene Therapy|gene therapy
199939|NCT02346396|neuropathic pain|neuropathic pain
199940|NCT02346396|neurostimulation|neurostimulation
199941|NCT02346396|ambulatory use|ambulatory use
199942|NCT02346396|tDCS|tdcs
199943|NCT02346383|back pain|back pain
199944|NCT02346383|neuromodulation|neuromodulation
199945|NCT02346383|spinal peripheral neuromodulation|spinal peripheral neuromodulation
199946|NCT02346383|spinal cord stimulation|spinal cord stimulation
199947|NCT02346383|postlaminectomy pain syndrome|postlaminectomy pain syndrome
199948|NCT02346370|Recurrent, previously treated, locally advanced or metastatic NSCLC (non small cell lung cancer)|recurrent, previously treated, locally advanced or metastatic nsclc (non small cell lung cancer)
199949|NCT02346357|hip arthroscopy|hip arthroscopy
199950|NCT02346357|analgesia|analgesia
199951|NCT02346344|type 2 diabetes|type 2 diabetes
199952|NCT02346344|beta cell function|beta cell function
199953|NCT02346344|meal tolerance test|meal tolerance test
199954|NCT02346344|maximum stimulation test|maximum stimulation test
199955|NCT02346344|method standardization|method standardization
199956|NCT02346344|insulin secretion|insulin secretion
199957|NCT02346344|prediabetes|prediabetes
199958|NCT02346344|insulin sensitivity|insulin sensitivity
199959|NCT02346318|Radiotherapy|radiotherapy
199960|NCT02346318|Adverse Effect|adverse effect
199961|NCT02346318|Dermatitis or Eczema|dermatitis or eczema
199962|NCT02346292|COPD|copd
199963|NCT02346292|Spirometry|spirometry
199964|NCT02346292|severe and very severe COPD|severe and very severe copd
199965|NCT02346292|COPD exacerbations|copd exacerbations
199966|NCT02346292|therapy schemes|therapy schemes
199967|NCT02346292|therapy changes|therapy changes
199968|NCT02346279|Multiple Sclerosis|multiple sclerosis
199969|NCT02346279|Rehabilitation|rehabilitation
199970|NCT02346279|Questionnaire|questionnaire
199971|NCT02346279|Patient-Reported Outcome|patient-reported outcome
199972|NCT02346279|Responsiveness|responsiveness
199973|NCT02346279|Minimal Important Clinical Difference|minimal important clinical difference
199974|NCT02346266|Stroke|stroke
199975|NCT02346266|Stroke Prevention|stroke prevention
199976|NCT02346266|Children|children
199977|NCT02346266|Education|education
199978|NCT02346240|Certolizumab Pegol|certolizumab pegol
199979|NCT02346240|Cimzia|cimzia
199980|NCT02346240|Psoriasis|psoriasis
199981|NCT02346227|Human Papillomavirus|human papillomavirus
199982|NCT02346227|Uterine cervix|uterine cervix
199983|NCT02346227|Infection|infection
199984|NCT02346227|Antiviral Drug|antiviral drug
199985|NCT02346227|Therapeutic use|therapeutic use
199986|NCT02346214|Gestational Age|gestational age
199987|NCT02346214|Anterior Lens Capsule Vascularity|anterior lens capsule vascularity
199988|NCT02346214|Preterm|preterm
199989|NCT02346214|Method-comparison|method-comparison
199990|NCT02346188|blood lead, iron, zinc, child, cognition, behavior, Mexico|blood lead, iron, zinc, child, cognition, behavior, mexico
199991|NCT02346175|SHR3824 Type 2 diabetes mellitus SGLT2|shr3824 type 2 diabetes mellitus sglt2
199992|NCT02346162|Pre-pregnancy|pre-pregnancy
199993|NCT02346162|Weight management|weight management
199994|NCT02346136|Tai Chi|tai chi
199995|NCT02346136|Cluster randomized controlled trial|cluster randomized controlled trial
199996|NCT02346136|Intervention|intervention
199997|NCT02346136|Elderly|elderly
199998|NCT02346136|Mobility|mobility
199999|NCT02346136|Health care utilization|health care utilization
200000|NCT02346123|Chagas disease|chagas disease
200001|NCT02346123|Polymorphisms|polymorphisms
200002|NCT02346123|Biomarkers|biomarkers
200003|NCT02346097|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
200004|NCT02346097|Heart Failure|heart failure
200005|NCT02346097|Ejection Fraction|ejection fraction
200006|NCT02346097|Narrow|narrow
200007|NCT02346097|Pacemaker|pacemaker
200008|NCT02346097|Electrophysiology|electrophysiology
200009|NCT02346097|Electrical activation mapping|electrical activation mapping
200010|NCT02346097|Coronary Sinus|coronary sinus
200011|NCT02346097|Mapping|mapping
200012|NCT02346097|QRS|qrs
200013|NCT02346097|QRS width|qrs width
200014|NCT02346097|Pacing Interval|pacing interval
200015|NCT02346097|Left Ventricular Lead|left ventricular lead
200016|NCT02346097|Cardiac CT|cardiac ct
200017|NCT02346097|Echocardiography|echocardiography
200018|NCT02346097|Myocardial Scintigraphy|myocardial scintigraphy
200019|NCT02346097|6 Minutes Walk Test|6 minutes walk test
200020|NCT02346097|Imaging|imaging
200021|NCT02346097|Left ventricular ejection fraction|left ventricular ejection fraction
200022|NCT02346097|Epicardial veins|epicardial veins
200023|NCT02346097|Resynchronization|resynchronization
200024|NCT02346097|ImagingCRT|imagingcrt
200025|NCT02346097|Optimal electrical resynchronization|optimal electrical resynchronization
200026|NCT02346097|Cardiac computed tomography|cardiac computed tomography
200027|NCT02346071|Bodily distress syndrome|bodily distress syndrome
200028|NCT02346071|Medically unexplained symptoms|medically unexplained symptoms
200029|NCT02346071|Functional somatic symptoms|functional somatic symptoms
200030|NCT02346071|Functional somatic syndromes|functional somatic syndromes
200031|NCT02346071|Treatment|treatment
200032|NCT02346071|Acceptance and Commitment Therapy|acceptance and commitment therapy
200033|NCT02346045|hypertension|hypertension
200034|NCT02346032|second line|second line
200035|NCT02346006|Exercise|exercise
200036|NCT02346006|Visual Acuity|visual acuity
200037|NCT02346006|Blood Vessels|blood vessels
200038|NCT02346006|Retina|retina
200039|NCT02346006|Choroid|choroid
200040|NCT02345993|formoterol/beclomethasone in asthmatic crisis|formoterol/beclomethasone in asthmatic crisis
200041|NCT02345993|asthmatic crisis treatment|asthmatic crisis treatment
200042|NCT02345967|diabetes mellitus requiring insulin|diabetes mellitus requiring insulin
200043|NCT02345954|Uterus Prolapse|uterus prolapse
200044|NCT02345954|Laparoscopic Sacropexy|laparoscopic sacropexy
200045|NCT02345954|Laparoscopic Hysteropexy|laparoscopic hysteropexy
200046|NCT02345928|Safety|safety
200047|NCT02345928|Efficacy|efficacy
200048|NCT02345928|CNTO 7160|cnto 7160
200049|NCT02345928|Healthy|healthy
200050|NCT02345928|Asthma|asthma
200051|NCT02345928|Atopic Dermatitis|atopic dermatitis
200052|NCT02345876|Dyslexia, Medial olivocochlear system, Maturation, Auditory Processing|dyslexia, medial olivocochlear system, maturation, auditory processing
200053|NCT02345863|CLL|cll
200054|NCT02345850|Acute Leukemia|acute leukemia
200055|NCT02345850|Myelodysplasia|myelodysplasia
200056|NCT02345850|GVHD Prophylaxis|gvhd prophylaxis
200057|NCT02345850|Chronic GVHD|chronic gvhd
200058|NCT02345824|CDK4/6 Inhibitor|cdk4/6 inhibitor
200059|NCT02345824|LEE011|lee011
200060|NCT02345824|Recurrent Glioblastoma|recurrent glioblastoma
200061|NCT02345824|Anaplastic Glioma|anaplastic glioma
200062|NCT02345824|Ribociclib|ribociclib
200063|NCT02345759|CKD patients|ckd patients
200064|NCT02345759|protein-restricted diets|protein-restricted diets
200065|NCT02345759|compliance|compliance
200066|NCT02345759|psychological aspects|psychological aspects
200067|NCT02345707|Cabotegravir|cabotegravir
200068|NCT02345707|Human Immunodeficiency Virus|human immunodeficiency virus
200069|NCT02345707|Bioavailability|bioavailability
200070|NCT02345707|Pharmacokinetics|pharmacokinetics
200071|NCT02345694|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
200072|NCT02345694|Gait|gait
200073|NCT02345694|Posture|posture
200074|NCT02345694|Continuous Positive Airway Pressure|continuous positive airway pressure
200075|NCT02345681|furosemide|furosemide
200076|NCT02345681|under strict conditions|under strict conditions
200077|NCT02345681|normalize|normalize
200078|NCT02345681|ICU patients|icu patients
200079|NCT02345681|fluid balance|fluid balance
200080|NCT02345668|Transdiagnostic Internet-based Protocol|transdiagnostic internet-based protocol
200081|NCT02345668|Treatment as Usual (TAU)|treatment as usual (tau)
200082|NCT02345655|Substances consumption|substances consumption
200083|NCT02345655|Opiate|opiate
200084|NCT02345655|Family practice|family practice
200085|NCT02345629|Refractory cancer pain|refractory cancer pain
200086|NCT02345629|Cordotomy|cordotomy
200087|NCT02345629|Sharpness pain sensory testing|sharpness pain sensory testing
200088|NCT02345629|Heat pain sensory testing|heat pain sensory testing
200089|NCT02345629|Symptom questionnaire|symptom questionnaire
200090|NCT02345629|Advanced cancers|advanced cancers
200091|NCT02345629|Pain|pain
200092|NCT02345616|Cardiac surgery|cardiac surgery
200093|NCT02345616|Pulmonary hypertension|pulmonary hypertension
200094|NCT02345616|Nitric oxide|nitric oxide
200095|NCT02345616|Induction anesthesia|induction anesthesia
200096|NCT02345577|Kidney transplantation|kidney transplantation
200097|NCT02345577|Stochastic whole body vibration therapy|stochastic whole body vibration therapy
200098|NCT02345577|Muscle strength|muscle strength
200099|NCT02345577|Intramuscular lipid content|intramuscular lipid content
200100|NCT02345577|Intramyocellular lipid content|intramyocellular lipid content
200101|NCT02345577|Short Physical Performance Battery Test|short physical performance battery test
200102|NCT02345577|Prospective, randomised , double blind,placebo-controlled trial|prospective, randomised , double blind,placebo-controlled trial
200103|NCT02345577|Physical Therapy Modalities|physical therapy modalities
200104|NCT02345551|Exercise|exercise
200105|NCT02345551|Sleep|sleep
200106|NCT02345551|Telemedicine|telemedicine
200107|NCT02345551|Behavior|behavior
200108|NCT02345551|Shift work|shift work
200109|NCT02345512|Falls|falls
200110|NCT02345499|Radical cystectomy|radical cystectomy
200111|NCT02345499|Laparoscopy|laparoscopy
200112|NCT02345486|Pilot Projects|pilot projects
200113|NCT02345486|Plasmalyte A|plasmalyte a
200114|NCT02345486|Ringer's lactate|ringer's lactate
200115|NCT02345486|Sodium Chloride|sodium chloride
200116|NCT02345486|Critical Care|critical care
200117|NCT02345486|"Resuscitation"|"resuscitation"
200118|NCT02345473|Bladder cancer|bladder cancer
200119|NCT02345473|Circulating cancer cells|circulating cancer cells
200120|NCT02345421|LAL D|lal d
200121|NCT02345421|CESD|cesd
200122|NCT02345421|NASH|nash
200123|NCT02345421|NAFLD|nafld
200124|NCT02345421|Wilson's|wilson's
200125|NCT02345421|Niemann Pick|niemann pick
200126|NCT02345421|Familial Hypercholesterolemia|familial hypercholesterolemia
200127|NCT02345395|Brain Aneurysm|brain aneurysm
200128|NCT02345395|Pterional Craniotomy|pterional craniotomy
200129|NCT02345395|MiniPterional Craniotomy|minipterional craniotomy
200130|NCT02345395|Transpalpebral Approach|transpalpebral approach
200131|NCT02345395|Unruptured Brain Aneurysm|unruptured brain aneurysm
200132|NCT02345382|Advanced acute leukemia|advanced acute leukemia
200133|NCT02345356|Pharmacogenomics|pharmacogenomics
200134|NCT02345356|Warfarin|warfarin
200135|NCT02345356|Caribbean Hispanics|caribbean hispanics
200136|NCT02345356|Polymorphisms|polymorphisms
200137|NCT02345356|Dosing Algorithm|dosing algorithm
200138|NCT02345278|Immunotherapy|immunotherapy
200139|NCT02345278|Allergic rhinitis/rhinoconjunctivitis|allergic rhinitis/rhinoconjunctivitis
200140|NCT02345252|HIV|hiv
200141|NCT02345226|HIV|hiv
200142|NCT02345213|DLB|dlb
200143|NCT02345213|Dementia with Lewy bodies|dementia with lewy bodies
200144|NCT02345213|Lewy Body Disease|lewy body disease
200145|NCT02345213|Dementia|dementia
200146|NCT02345213|E2020|e2020
200147|NCT02345213|Donepezil|donepezil
200148|NCT02345213|Aricept|aricept
200149|NCT02345200|dystrophy|dystrophy
200150|NCT02345200|body composition|body composition
200151|NCT02345200|malnutrition|malnutrition
200152|NCT02345174|zirconium|zirconium
200153|NCT02345174|oncology|oncology
200154|NCT02345174|mAb|mab
200155|NCT02345174|receptor occupancy|receptor occupancy
200156|NCT02345174|dose|dose
200157|NCT02345174|PET|pet
200158|NCT02345174|HER3|her3
200159|NCT02345174|89-Zr|89-zr
200160|NCT02345174|biodistribution|biodistribution
200161|NCT02345174|tumours|tumours
200162|NCT02345161|Triple Therapy|triple therapy
200163|NCT02345161|Formoterol|formoterol
200164|NCT02345161|Respiratory|respiratory
200165|NCT02345161|COPD|copd
200166|NCT02345161|Budesonide|budesonide
200167|NCT02345161|Vilanterol|vilanterol
200168|NCT02345161|Fluticasone Furoate|fluticasone furoate
200169|NCT02345161|Umeclidinium|umeclidinium
200170|NCT02345161|Lung Function|lung function
200171|NCT02345148|Healthy|healthy
200172|NCT02345148|Esketamine|esketamine
200173|NCT02345148|JNJ-54135419|jnj-54135419
200174|NCT02345122|At-risk Drinking|at-risk drinking
200175|NCT02345122|Depression|depression
200176|NCT02345122|Anxiety|anxiety
200177|NCT02345122|Alcohol Drinking|alcohol drinking
200178|NCT02345109|weight|weight
200179|NCT02345109|total body water|total body water
200180|NCT02345109|body fat|body fat
200181|NCT02345109|muscle mass|muscle mass
200182|NCT02345109|bone mass|bone mass
200183|NCT02345109|BMI|bmi
200184|NCT02345109|visceral fat|visceral fat
200185|NCT02345109|calories|calories
200186|NCT02345083|Frailty|frailty
200187|NCT02345083|Pre-frailty|pre-frailty
200188|NCT02345083|Fit|fit
200189|NCT02345083|Robust|robust
200190|NCT02345083|Elderly|elderly
200191|NCT02345083|Sociodemography status|sociodemography status
200192|NCT02345083|Functional status|functional status
200193|NCT02345083|Cognitive status|cognitive status
200194|NCT02345083|Nutrition status|nutrition status
200195|NCT02345083|Comorbidity|comorbidity
200196|NCT02345083|Polypharmacy|polypharmacy
200197|NCT02345083|Mortality|mortality
200198|NCT02345083|Depression status|depression status
200199|NCT02345083|Health-related quality of life|health-related quality of life
200200|NCT02345083|Fall incidence|fall incidence
200201|NCT02345083|Hospitality|hospitality
200202|NCT02345057|Diabetic Nephropathy|diabetic nephropathy
200203|NCT02345057|mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
200204|NCT02345057|CS-3150|cs-3150
200205|NCT02345057|Japanese|japanese
200206|NCT02345044|Essential hypertension|essential hypertension
200207|NCT02345044|mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
200208|NCT02345044|CS-3150|cs-3150
200209|NCT02345044|Japanese|japanese
200210|NCT02345031|hearing loss|hearing loss
200211|NCT02345031|speech-in-noise|speech-in-noise
200212|NCT02345018|Mechano-chemical ablation|mechano-chemical ablation
200213|NCT02345018|Treatment large varicose veins|treatment large varicose veins
200214|NCT02345018|Below-knee and branches|below-knee and branches
200215|NCT02345018|Endovenous|endovenous
200216|NCT02345005|Vascular diseases|vascular diseases
200217|NCT02345005|Aneurysm|aneurysm
200218|NCT02345005|Treatment Efficacy|treatment efficacy
200219|NCT02345005|Medical device|medical device
200220|NCT02345005|Population Register|population register
200221|NCT02344979|NSCLC|nsclc
200222|NCT02344979|Chemotherapy|chemotherapy
200223|NCT02344979|thrombocytopenia|thrombocytopenia
200224|NCT02344979|rhTPO|rhtpo
200225|NCT02344940|operable|operable
200226|NCT02344940|premenopausal|premenopausal
200227|NCT02344940|endocrine therapy|endocrine therapy
200228|NCT02344940|safety|safety
200229|NCT02344940|tamoxifen|tamoxifen
200230|NCT02344940|toremifene|toremifene
200231|NCT02344927|Cancer|cancer
200232|NCT02344927|End-of-life care|end-of-life care
200233|NCT02344927|Clinically-assisted hydration|clinically-assisted hydration
200234|NCT02344914|dental support|dental support
200235|NCT02344914|second stage of labor|second stage of labor
200236|NCT02344901|non-valvular atrial fibrillation|non-valvular atrial fibrillation
200237|NCT02344901|stroke prevention|stroke prevention
200238|NCT02344901|novel oral anticoagulants|novel oral anticoagulants
200239|NCT02344901|warfarin|warfarin
200240|NCT02344888|PCOS|pcos
200241|NCT02344888|Clomiphene citrate resistant|clomiphene citrate resistant
200242|NCT02344888|Prednisolone|prednisolone
200243|NCT02344823|cirrhosis|cirrhosis
200244|NCT02344823|erectile dysfunction|erectile dysfunction
200245|NCT02344823|portal hypertension|portal hypertension
200246|NCT02344797|Perioperative|perioperative
200247|NCT02344797|Postoperative Complications/prevention & control|postoperative complications/prevention & control
200248|NCT02344784|ADD|add
200249|NCT02344784|ADHD|adhd
200250|NCT02344784|PPI|ppi
200251|NCT02344771|Endothelial dysfunction|endothelial dysfunction
200252|NCT02344771|General Surgery|general surgery
200253|NCT02344771|Perioperative Care|perioperative care
200254|NCT02344745|Lavender|lavender
200255|NCT02344745|Aromatherapy|aromatherapy
200256|NCT02344745|Urodynamics|urodynamics
200257|NCT02344732|epithelium, cornea, diabetes, vitrectomy, oxygen|epithelium, cornea, diabetes, vitrectomy, oxygen
200258|NCT02344719|cirrhosis|cirrhosis
200259|NCT02344719|portal hypertension|portal hypertension
200260|NCT02344719|taurin|taurin
200261|NCT02344706|Emergency Care, Prehospital|emergency care, prehospital
200262|NCT02344706|Coma|coma
200263|NCT02344706|Electroencephalography|electroencephalography
200264|NCT02344693|Electroencephalography|electroencephalography
200265|NCT02344654|Fluorescence|fluorescence
200266|NCT02344654|Cholangiography|cholangiography
200267|NCT02344654|Indocyanine Green|indocyanine green
200268|NCT02344654|Cholecystectomy, Laparoscopic|cholecystectomy, laparoscopic
200269|NCT02344615|nerve stimulator|nerve stimulator
200270|NCT02344615|ultrasound|ultrasound
200271|NCT02344602|Diabetic Nephropathy|diabetic nephropathy
200272|NCT02344602|Diabetes Mellitus|diabetes mellitus
200273|NCT02344602|Diabetes Complications|diabetes complications
200274|NCT02344602|Uric Acid|uric acid
200275|NCT02344602|Febuxostat|febuxostat
200276|NCT02344602|Uloric|uloric
200277|NCT02344602|Glomerular Filtration Rate|glomerular filtration rate
200278|NCT02344602|Kidney Disease|kidney disease
200279|NCT02344602|Vascular Disease|vascular disease
200280|NCT02344602|Cardiovascular Diseases|cardiovascular diseases
200281|NCT02344602|Endothelial Function|endothelial function
200282|NCT02344602|Arterial Stiffness|arterial stiffness
200283|NCT02344602|Pharmacologic Actions|pharmacologic actions
200284|NCT02344602|Gout Suppressants|gout suppressants
200285|NCT02344602|Therapeutic Uses|therapeutic uses
200387|NCT02343965|haematology|haematology
200286|NCT02344602|Free Radical Scavengers|free radical scavengers
200287|NCT02344602|Antioxidants|antioxidants
200288|NCT02344602|Protective Agents|protective agents
200289|NCT02344602|Physiological Effects of Drugs|physiological effects of drugs
200290|NCT02344602|Angiotensin II Infusion|angiotensin ii infusion
200291|NCT02344602|Flow-mediated Dilation|flow-mediated dilation
200292|NCT02344602|Flow-mediated Constriction|flow-mediated constriction
200293|NCT02344602|Nitroglycerin|nitroglycerin
200294|NCT02344602|Hyperglycemia|hyperglycemia
200295|NCT02344602|Renin-angiotensin-aldosterone System|renin-angiotensin-aldosterone system
200296|NCT02344602|Nitric Oxide|nitric oxide
200297|NCT02344602|cGMP|cgmp
200298|NCT02344602|Oxidative Stress|oxidative stress
200299|NCT02344602|Renal Haemodynamic Function|renal haemodynamic function
200300|NCT02344602|Inulin Clearance|inulin clearance
200301|NCT02344602|PAH Clearance|pah clearance
200302|NCT02344602|Skin Biopsy|skin biopsy
200303|NCT02344602|T1R mRNA Expression|t1r mrna expression
200304|NCT02344602|Cytokines|cytokines
200305|NCT02344602|Chemokines|chemokines
200306|NCT02344589|ACB|acb
200307|NCT02344589|Adductor Canal Block|adductor canal block
200308|NCT02344589|Peripheral Nerve Block|peripheral nerve block
200309|NCT02344576|heart failure|heart failure
200310|NCT02344576|heart-assist devices|heart-assist devices
200311|NCT02344576|decision making|decision making
200312|NCT02344576|decision support techniques|decision support techniques
200313|NCT02344576|hospice care|hospice care
200314|NCT02344576|palliative care|palliative care
200315|NCT02344576|caregivers|caregivers
200316|NCT02344563|volunteers|volunteers
200317|NCT02344550|metastatic breast cancer|metastatic breast cancer
200318|NCT02344550|HER2 negative|her2 negative
200319|NCT02344550|hormone-receptor positive|hormone-receptor positive
200320|NCT02344537|Lyme DIsease|lyme disease
200321|NCT02344537|Kundalini Yoga|kundalini yoga
200322|NCT02344498|Liver cirrhosis|liver cirrhosis
200323|NCT02344498|Antiviral agents|antiviral agents
200324|NCT02344498|Liver diseases|liver diseases
200325|NCT02344472|MBC|mbc
200326|NCT02344472|HER2|her2
200327|NCT02344472|CTC|ctc
200328|NCT02344472|endocrine therapy|endocrine therapy
200329|NCT02344472|Pertuzumab|pertuzumab
200330|NCT02344472|Trastuzumab|trastuzumab
200331|NCT02344472|HER2 therapy|her2 therapy
200332|NCT02344446|physical therapy intervention|physical therapy intervention
200333|NCT02344433|Family health history|family health history
200334|NCT02344433|Genetic literacy|genetic literacy
200335|NCT02344433|Health literacy|health literacy
200336|NCT02344433|Relational agent|relational agent
200337|NCT02344433|Common chronic conditions|common chronic conditions
200338|NCT02344420|Heart Failure|heart failure
200340|NCT02344407|Zaire Ebola Virus Disease|zaire ebola virus disease
200341|NCT02344394|Atrial Fibrillation|atrial fibrillation
200342|NCT02344394|Anti-Arrhythmia Agents|anti-arrhythmia agents
200343|NCT02344394|Catheter Ablation|catheter ablation
200344|NCT02344394|surgical hybrid ablation|surgical hybrid ablation
200345|NCT02344368|Sucrose|sucrose
200346|NCT02344368|Anesthesia|anesthesia
200347|NCT02344368|Blood specimen collection|blood specimen collection
200348|NCT02344368|Injections, Intravenous|injections, intravenous
200349|NCT02344355|Ascorbic Acid|ascorbic acid
200350|NCT02344355|temozolomide|temozolomide
200351|NCT02344355|radiation|radiation
200352|NCT02344342|telemonitoring|telemonitoring
200353|NCT02344290|HIV|hiv
200354|NCT02344290|Cardiovascular Disease|cardiovascular disease
200355|NCT02344290|Myocardial Infarction|myocardial infarction
200356|NCT02344290|Inflammation|inflammation
200357|NCT02344290|Statin|statin
200358|NCT02344290|Computerized Tomography|computerized tomography
200359|NCT02344290|Cholesterol|cholesterol
200360|NCT02344277|Subcutaneaous Implantable Cardiac Defibrillator|subcutaneaous implantable cardiac defibrillator
200361|NCT02344277|Brugada syndrome|brugada syndrome
200362|NCT02344277|Effectiveness|effectiveness
200363|NCT02344277|Safety|safety
200364|NCT02344264|US guided nerve block|us guided nerve block
200365|NCT02344264|Total hip Arthroplasty|total hip arthroplasty
200366|NCT02344264|NCFL|ncfl
200367|NCT02344264|nervus cutaneous femoralis lateralis|nervus cutaneous femoralis lateralis
200368|NCT02344251|Drug study|drug study
200369|NCT02344251|Medication compliance|medication compliance
200370|NCT02344238|Medication compliance|medication compliance
200371|NCT02344238|Technology|technology
200372|NCT02344238|Drug study|drug study
200373|NCT02344186|diabetes, endoplasmic reticulum stress, obesity, GLP1 analogs|diabetes, endoplasmic reticulum stress, obesity, glp1 analogs
200374|NCT02344160|Total Hip Arthroplasty|total hip arthroplasty
200375|NCT02344160|THA|tha
200376|NCT02344095|recurrent, persistent|recurrent, persistent
200377|NCT02344069|Fibrinogen|fibrinogen
200378|NCT02344056|Having Lunch|having lunch
200379|NCT02344056|Skipping Lunch|skipping lunch
200380|NCT02344030|airway|airway
200381|NCT02344030|videolaryngoscope|videolaryngoscope
200382|NCT02343978|Chronic Constipation|chronic constipation
200383|NCT02343978|CC|cc
200384|NCT02343965|Touch-massage|touch-massage
200385|NCT02343965|anxiety|anxiety
200386|NCT02343965|leukemia|leukemia
200388|NCT02343965|cancerology|cancerology
200389|NCT02343965|supportive care|supportive care
200390|NCT02343965|complementary therapy|complementary therapy
200391|NCT02343952|Pembrolizumab|pembrolizumab
200392|NCT02343952|MK-3475|mk-3475
200393|NCT02343874|Alcohol consumption|alcohol consumption
200394|NCT02343874|Primary health care|primary health care
200395|NCT02343874|health care costs|health care costs
200396|NCT02343874|health service utilization|health service utilization
200397|NCT02343861|Behavioral Research|behavioral research
200398|NCT02343861|Emollients|emollients
200399|NCT02343822|PRP|prp
200400|NCT02343822|Platelet Rich Plasma|platelet rich plasma
200401|NCT02343822|Lateral Epicondylitis|lateral epicondylitis
200402|NCT02343822|Lateral Epicondylopathy|lateral epicondylopathy
200403|NCT02343822|Lateral Epicondylosis|lateral epicondylosis
200404|NCT02343822|Chronic Lateral Epicondylitis|chronic lateral epicondylitis
200405|NCT02343822|PRPLE|prple
200406|NCT02343822|Multiple PRP Injections|multiple prp injections
200407|NCT02343822|Multiple PRP|multiple prp
200408|NCT02343822|Platelet-Rich Plasma|platelet-rich plasma
200409|NCT02343822|Tennis Elbow|tennis elbow
200410|NCT02343822|Double Blinded Randomized Controlled|double blinded randomized controlled
200411|NCT02343822|Multiple vs Single PRP injections|multiple vs single prp injections
200412|NCT02343822|prp tennis elbow|prp tennis elbow
200413|NCT02343809|Physiotherapy|physiotherapy
200414|NCT02343809|Lateral epicondylitis|lateral epicondylitis
200415|NCT02343809|Manual therapy|manual therapy
200416|NCT02343796|Fiberglass reinforced resins|fiberglass reinforced resins
200417|NCT02343783|Atopic Dermatitis|atopic dermatitis
200418|NCT02343783|Asthma|asthma
200419|NCT02343783|Healthy|healthy
200420|NCT02343783|Skin Blisters|skin blisters
200421|NCT02343783|Adult Participants|adult participants
200422|NCT02343744|Generalized Pustular Psoriasis|generalized pustular psoriasis
200423|NCT02343744|Erythrodermic Psoriasis|erythrodermic psoriasis
200424|NCT02343744|Guselkumab|guselkumab
200425|NCT02343744|CNTO1959|cnto1959
200426|NCT02343731|microbiome|microbiome
200427|NCT02343731|hygiene hypothesis|hygiene hypothesis
200428|NCT02343731|human-animal interaction|human-animal interaction
200429|NCT02343731|microbiota|microbiota
200430|NCT02343731|connections between human-canine microbiome|connections between human-canine microbiome
200431|NCT02343653|Malnutrition|malnutrition
200432|NCT02343653|Muscle mass|muscle mass
200433|NCT02343653|Nutrition|nutrition
200434|NCT02343640|Baseball|baseball
200435|NCT02343640|Ulnar collateral ligament|ulnar collateral ligament
200436|NCT02343614|Intermediate risk|intermediate risk
200437|NCT02343614|Cox-2 inhibitors|cox-2 inhibitors
200438|NCT02343588|Chinese multi-centered school based obesity intervention|chinese multi-centered school based obesity intervention
200439|NCT02343575|Hyperactive delirium|hyperactive delirium
200440|NCT02343575|Mixed delirium|mixed delirium
200441|NCT02343575|Anti-psychotic|anti-psychotic
200442|NCT02343575|Haldol|haldol
200443|NCT02343575|Valproic Acid|valproic acid
200444|NCT02343536|Phase 1|phase 1
200445|NCT02343536|Oral Azacitidine (CC-486)|oral azacitidine (cc-486)
200446|NCT02343536|R-CHOP|r-chop
200447|NCT02343536|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
200448|NCT02343536|Grade 3B Follicular Lymphoma|grade 3b follicular lymphoma
200449|NCT02343536|Follicular Lymphoma|follicular lymphoma
200450|NCT02343536|Transformed Lymphoma|transformed lymphoma
200451|NCT02343523|Wearable device|wearable device
200452|NCT02343523|Wrist-watch|wrist-watch
200453|NCT02343523|Longitudinal monitoring|longitudinal monitoring
200454|NCT02343523|Congestive Heart Failure|congestive heart failure
200455|NCT02343510|Fallopian tubal cancer, high grade serous , ovarian cancer|fallopian tubal cancer, high grade serous , ovarian cancer
200456|NCT02343484|pulsed radiofrequency|pulsed radiofrequency
200457|NCT02343484|gelified ethanol|gelified ethanol
200458|NCT02343471|Whey proteins|whey proteins
200459|NCT02343471|Postprandial lipemia|postprandial lipemia
200460|NCT02343471|Pre-meal|pre-meal
200461|NCT02343471|Type 2 diabetes|type 2 diabetes
200462|NCT02343458|COPD|copd
200463|NCT02343432|Anesthesia|anesthesia
200464|NCT02343432|Adverse Effect|adverse effect
200465|NCT02343432|Spinal|spinal
200466|NCT02343432|Epidural|epidural
200467|NCT02343419|Bronchial Hyperreactivity|bronchial hyperreactivity
200468|NCT02343419|Bronchial Provocation Tests|bronchial provocation tests
200469|NCT02343419|Methacholine Chloride|methacholine chloride
200470|NCT02343419|Respiratory Function Tests|respiratory function tests
200471|NCT02343419|Spirometry|spirometry
200472|NCT02343419|Airway Resistance|airway resistance
200473|NCT02343419|Plethysmography|plethysmography
200474|NCT02343406|Glioblastoma Multiforme|glioblastoma multiforme
200475|NCT02343406|Epithelial Growth Factor vIII mutation|epithelial growth factor viii mutation
200476|NCT02343406|Temozolomide|temozolomide
200477|NCT02343406|Lomustine|lomustine
200478|NCT02343406|ABT-414|abt-414
200479|NCT02343406|European Organization for Research and Treatment of Cancer|european organization for research and treatment of cancer
200480|NCT02343406|recurrent glioblastoma|recurrent glioblastoma
200481|NCT02343406|Epithelial Growth Factor|epithelial growth factor
200482|NCT02343406|Brain Tumor|brain tumor
200483|NCT02343406|Brain Tumor Group|brain tumor group
200484|NCT02343406|Antibody Drug Conjugate|antibody drug conjugate
200485|NCT02343406|EORTC|eortc
200486|NCT02343406|Pediatric High Grade Gliomas|pediatric high grade gliomas
200487|NCT02343406|Pediatric diffuse Intrinsic Pontine Glioma|pediatric diffuse intrinsic pontine glioma
200488|NCT02343406|Pediatric WHO grade III glioma|pediatric who grade iii glioma
200489|NCT02343406|Pediatric WHO grade IV glioma|pediatric who grade iv glioma
200490|NCT02343406|EGFR amplification|egfr amplification
200491|NCT02343406|Children|children
200492|NCT02343393|Endothelial Dysfunction|endothelial dysfunction
200493|NCT02343393|Biomarkers|biomarkers
200494|NCT02343393|Hydralazine-Isosorbide Dinitrate|hydralazine-isosorbide dinitrate
200495|NCT02343380|diet-induced thermogenesis|diet-induced thermogenesis
200496|NCT02343380|glucose|glucose
200497|NCT02343380|respiratory quotient|respiratory quotient
200498|NCT02343367|Hispanic|hispanic
200499|NCT02343367|overweight|overweight
200500|NCT02343367|families|families
200501|NCT02343367|pediatric|pediatric
200502|NCT02343367|primary care|primary care
200503|NCT02343354|behavioural|behavioural
200504|NCT02343354|diabetes prevention|diabetes prevention
200505|NCT02343354|physical activity|physical activity
200506|NCT02343354|healthy eating|healthy eating
200507|NCT02343354|gestational diabetes|gestational diabetes
200508|NCT02343341|early childhood education|early childhood education
200509|NCT02343341|cardiovascular health|cardiovascular health
200510|NCT02343341|behavior change|behavior change
200511|NCT02343341|community-based|community-based
200512|NCT02343341|family-based|family-based
200513|NCT02343341|prevention|prevention
200514|NCT02343315|low back pain|low back pain
200515|NCT02343315|home exercises|home exercises
200516|NCT02343315|chronic pain|chronic pain
200517|NCT02343315|supervised exercise|supervised exercise
200518|NCT02343315|core stability exercises|core stability exercises
200519|NCT02343315|spinal stabilization exercises|spinal stabilization exercises
200520|NCT02343302|Pancreatic Fistula|pancreatic fistula
200521|NCT02343289|Healthy|healthy
200522|NCT02343289|Pharmacokinetics|pharmacokinetics
200523|NCT02343289|Esketamine|esketamine
200524|NCT02343289|JNJ-54135419|jnj-54135419
200525|NCT02343276|Radial Spasm|radial spasm
200526|NCT02343263|Tonsillectomy|tonsillectomy
200527|NCT02343263|Adenotonsillectomy|adenotonsillectomy
200528|NCT02343263|Pain|pain
200529|NCT02343263|Hemorrhage|hemorrhage
200530|NCT02343237|Fibromyalgia syndrome|fibromyalgia syndrome
200531|NCT02343237|pain|pain
200532|NCT02343237|quality of life|quality of life
200533|NCT02343237|osteopathic treatment|osteopathic treatment
200534|NCT02343211|Paraneoplastic Neurological Syndromes|paraneoplastic neurological syndromes
200535|NCT02343211|Onconeural antibodies|onconeural antibodies
200536|NCT02343211|Cancer|cancer
200537|NCT02343185|diaphragm|diaphragm
200538|NCT02343185|osteopathic treatment|osteopathic treatment
200539|NCT02343185|myofascial release|myofascial release
200540|NCT02343172|Liposarcoma,|liposarcoma,
200541|NCT02343172|MDM2 inhibition,|mdm2 inhibition,
200542|NCT02343172|cdk4 inhibition,|cdk4 inhibition,
200543|NCT02343172|HDM201,|hdm201,
200544|NCT02343172|LEE011|lee011
200545|NCT02343133|Radiation countermeasure|radiation countermeasure
200546|NCT02343133|radiomitigation|radiomitigation
200547|NCT02343107|Obesity|obesity
200548|NCT02343107|Type 2 diabetes|type 2 diabetes
200549|NCT02343107|Metabolic syndrome|metabolic syndrome
200550|NCT02343107|e-coaching|e-coaching
200551|NCT02343107|Telehealth|telehealth
200552|NCT02343094|Proteinuria|proteinuria
200553|NCT02343094|Lipocalin 2|lipocalin 2
200554|NCT02343094|Neutrophil gelatinase associated lipocalin|neutrophil gelatinase associated lipocalin
200555|NCT02343094|ELISA|elisa
200556|NCT02343081|brain neoplasm|brain neoplasm
200557|NCT02343081|bioequivalence|bioequivalence
200558|NCT02343081|temozolomide|temozolomide
200559|NCT02343042|Selinexor|selinexor
200560|NCT02343042|KCP-330|kcp-330
200561|NCT02343042|STOMP|stomp
200562|NCT02343042|Multiple Myeloma|multiple myeloma
200563|NCT02343042|Relapsed/Refractory|relapsed/refractory
200564|NCT02343042|Dexamethasone|dexamethasone
200565|NCT02343042|Pomalidomide|pomalidomide
200566|NCT02343042|Bortezomib|bortezomib
200567|NCT02343042|Karyopharm|karyopharm
200568|NCT02343042|Lenalidomide|lenalidomide
200569|NCT02343042|Daratumumab|daratumumab
200570|NCT02343042|Newly Diagnosed|newly diagnosed
200571|NCT02343042|Carfilzomib|carfilzomib
200572|NCT02343029|Aerobic Exercise Training|aerobic exercise training
200573|NCT02343029|prevention|prevention
200574|NCT02343029|magnetic resonance spectroscopic imaging|magnetic resonance spectroscopic imaging
200575|NCT02343029|psychometric tests|psychometric tests
200576|NCT02343029|cognition|cognition
200577|NCT02343029|dementia|dementia
200578|NCT02343029|cognitive impairment|cognitive impairment
200579|NCT02343003|cooled radiofrequency ablation|cooled radiofrequency ablation
200580|NCT02343003|knee pain|knee pain
200581|NCT02343003|osteoarthritis|osteoarthritis
200582|NCT02343003|pain management|pain management
200583|NCT02342990|working memory training|working memory training
200584|NCT02342990|home-based training|home-based training
200585|NCT02342990|periventricular leukomalacia|periventricular leukomalacia
200586|NCT02342990|bilateral cerebral palsy|bilateral cerebral palsy
200587|NCT02342990|neuropsychological profile|neuropsychological profile
200588|NCT02342990|high density EEG|high density eeg
200589|NCT02342990|slow waves activities|slow waves activities
200590|NCT02342977|total hip arthroplasty|total hip arthroplasty
200591|NCT02342964|Cystic fibrosis|cystic fibrosis
200592|NCT02342964|hepatic fibrosis|hepatic fibrosis
200593|NCT02342964|hepatic cirrhosis|hepatic cirrhosis
200594|NCT02342964|non-invasive methods of measurement|non-invasive methods of measurement
200595|NCT02342964|hepatic elasticity|hepatic elasticity
200596|NCT02342951|Cystic fibrosis,|cystic fibrosis,
200597|NCT02342951|lung clearance index,|lung clearance index,
200598|NCT02342951|pulmonary function|pulmonary function
200599|NCT02342938|Epilepsy surgery|epilepsy surgery
200600|NCT02342938|High frequency activity|high frequency activity
200601|NCT02342938|icEEG|iceeg
200602|NCT02342938|fMRI|fmri
200603|NCT02342938|MEG|meg
200604|NCT02342886|Tuberculosis|tuberculosis
200605|NCT02342886|Multi Drug-Resistant Tuberculosis|multi drug-resistant tuberculosis
200606|NCT02342886|Drug-sensitive Tuberculosis|drug-sensitive tuberculosis
200607|NCT02342886|PA-824|pa-824
200608|NCT02342886|Moxifloxacin|moxifloxacin
200609|NCT02342886|Pyrazinamide|pyrazinamide
200610|NCT02342886|Rifampicin|rifampicin
200611|NCT02342886|Isoniazid|isoniazid
200612|NCT02342886|Ethambutol|ethambutol
200613|NCT02342886|HRZE|hrze
200614|NCT02342886|HR|hr
200615|NCT02342886|Pretomanid|pretomanid
200616|NCT02342886|NC-006|nc-006
200617|NCT02342886|STAND|stand
200618|NCT02342873|ultrasound|ultrasound
200619|NCT02342873|nerve stimulator|nerve stimulator
200620|NCT02342860|Water|water
200621|NCT02342860|sanitation|sanitation
200622|NCT02342860|hygiene access in school|hygiene access in school
200623|NCT02342756|ARDS, HFOV|ards, hfov
200624|NCT02342691|Safety and efficacy of BLXA4|safety and efficacy of blxa4
200625|NCT02342665|Non Hodgkin's Lymphomas|non hodgkin's lymphomas
200626|NCT02342626|Prostate|prostate
200627|NCT02342626|Cancer|cancer
200628|NCT02342626|Adenocarcinoma|adenocarcinoma
200629|NCT02342587|Lapatinib|lapatinib
200630|NCT02342561|Infection|infection
200631|NCT02342561|Drape|drape
200632|NCT02342561|Ioban|ioban
200633|NCT02342561|Arthroplasty|arthroplasty
200634|NCT02342561|Knee|knee
200635|NCT02342561|Cylinder Sampling|cylinder sampling
200636|NCT02342561|Bacteria|bacteria
200637|NCT02342548|Huntington; chorea; total motor score; CAG repeat: total functional capacity; motor cognitive and behavioral symptoms|huntington; chorea; total motor score; cag repeat: total functional capacity; motor cognitive and behavioral symptoms
200638|NCT02342522|Cardioprotection|cardioprotection
200639|NCT02342522|STEMI|stemi
200640|NCT02342522|PPCI|ppci
200641|NCT02342522|Myocardial reperfusion injury|myocardial reperfusion injury
200642|NCT02342522|Myocardial infarct size|myocardial infarct size
200643|NCT02342509|et Control|et control
200644|NCT02342509|inhalational sedation|inhalational sedation
200645|NCT02342509|conserve volatile anesthetics|conserve volatile anesthetics
200646|NCT02342470|prevention|prevention
200647|NCT02342470|Recurrent peptic ulcer|recurrent peptic ulcer
200648|NCT02342444|Trauma|trauma
200649|NCT02342444|Surgery|surgery
200650|NCT02342444|Enoxaparin|enoxaparin
200651|NCT02342444|DVTs|dvts
200652|NCT02342444|Thromboembolic events|thromboembolic events
200653|NCT02342431|Thermoregulation|thermoregulation
200654|NCT02342431|Pediatric Anesthesia|pediatric anesthesia
200655|NCT02342431|Cardiac Catheterization|cardiac catheterization
200656|NCT02342405|Oxidative stress|oxidative stress
200657|NCT02342405|Nitrogen oxide|nitrogen oxide
200658|NCT02342405|Reactive oxygen species|reactive oxygen species
200659|NCT02342392|pterygium|pterygium
200660|NCT02342392|ranibizumab|ranibizumab
200661|NCT02342392|anti-VEGF|anti-vegf
200662|NCT02342392|recurrence|recurrence
200663|NCT02342392|vascularity|vascularity
200664|NCT02342392|size|size
200665|NCT02342366|Sodium Oxybate, Altruism, Neurostreroids, Liquid Ecstasy|sodium oxybate, altruism, neurostreroids, liquid ecstasy
200666|NCT02342340|Beans, Lentils, Bioavailability, Phytochemical Absorption|beans, lentils, bioavailability, phytochemical absorption
200667|NCT02342288|Intraoperative ocular pressure|intraoperative ocular pressure
200668|NCT02342275|Infantile hemangioma|infantile hemangioma
200669|NCT02342275|Propranolol|propranolol
200670|NCT02342275|Atenolol|atenolol
200671|NCT02342275|Efficacy|efficacy
200672|NCT02342275|Safety|safety
200673|NCT02342249|Influenza A|influenza a
200674|NCT02342236|Biological Markers|biological markers
200675|NCT02342223|human immunodeficiency virus|human immunodeficiency virus
200676|NCT02342223|facial lipoatrophy|facial lipoatrophy
200677|NCT02342223|facial lipodystrophy|facial lipodystrophy
200678|NCT02342223|hyaluronic acid|hyaluronic acid
200679|NCT02342223|dermal filler|dermal filler
200680|NCT02342223|filler agent|filler agent
200681|NCT02342210|Mindfulness|mindfulness
200682|NCT02342210|Group Therapy|group therapy
200683|NCT02342197|Low responders|low responders
200684|NCT02342197|Minidose long protocol|minidose long protocol
200685|NCT02342197|Microdose flare protocol|microdose flare protocol
200686|NCT02342197|Oocyte yield|oocyte yield
200687|NCT02342171|Ebola Viral Disease|ebola viral disease
200688|NCT02342171|Convalescent Plasma|convalescent plasma
200689|NCT02342171|Developing Countries|developing countries
200690|NCT02342145|beta-Thalassemia major|beta-thalassemia major
200691|NCT02342119|kidney transplantation|kidney transplantation
200692|NCT02342119|race disparities|race disparities
200693|NCT02342119|living donor kidney transplantation|living donor kidney transplantation
200694|NCT02342119|transplant evaluation|transplant evaluation
200695|NCT02342093|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
200696|NCT02342093|Drospirenone|drospirenone
200697|NCT02342093|Oral contraceptive|oral contraceptive
200698|NCT02342080|Rehabilitation|rehabilitation
200699|NCT02342080|Walking|walking
200700|NCT02342080|Robotics|robotics
200701|NCT02342080|Neuronal Plasticity|neuronal plasticity
200702|NCT02342054|Cancer|cancer
200703|NCT02342054|Prostate Cancer|prostate cancer
200704|NCT02342054|Brachytherapy|brachytherapy
200705|NCT02342054|Dose escalation|dose escalation
200706|NCT02342054|High Dose Rate|high dose rate
200707|NCT02342054|MRI-TRUS fusion|mri-trus fusion
200708|NCT02342054|Detection of DILs by MRI|detection of dils by mri
200709|NCT02342054|SINGLE FRACTION|single fraction
200710|NCT02342041|SUVN-G3031|suvn-g3031
200711|NCT02342041|histamine 3 (H3) receptor inverse agonist|histamine 3 (h3) receptor inverse agonist
200712|NCT02342041|first in human|first in human
200713|NCT02342041|safety|safety
200714|NCT02342041|pharmacokinetics|pharmacokinetics
200715|NCT02342041|tolerability|tolerability
200716|NCT02342041|single dose|single dose
200717|NCT02342041|repeat dose|repeat dose
200718|NCT02342028|sleep apnea|sleep apnea
200719|NCT02342028|intermittent hypoxia|intermittent hypoxia
200720|NCT02342028|regulatory T cell|regulatory t cell
200721|NCT02342028|autoimmunity|autoimmunity
200722|NCT02342002|mifepristone|mifepristone
200723|NCT02342002|misoprostol|misoprostol
200724|NCT02342002|obstetrics|obstetrics
200725|NCT02342002|reproductive health|reproductive health
200726|NCT02342002|pregnancy|pregnancy
200727|NCT02342002|abortion|abortion
200728|NCT02342002|missed abortion|missed abortion
200729|NCT02341989|Chemotherapy, adjuvant|chemotherapy, adjuvant
200730|NCT02341989|Recurrence|recurrence
200731|NCT02341989|Carboplatin|carboplatin
200732|NCT02341989|Bleomycin|bleomycin
200733|NCT02341989|Etoposide|etoposide
200734|NCT02341989|Cisplatin|cisplatin
200735|NCT02341976|whole body vibration|whole body vibration
200736|NCT02341976|pelvic floor muscle|pelvic floor muscle
200737|NCT02341976|urinary incontinence|urinary incontinence
200738|NCT02341976|Urinary sphincter|urinary sphincter
200739|NCT02341950|videogame|videogame
200740|NCT02341950|health|health
200741|NCT02341950|behavior|behavior
200742|NCT02341950|mobile|mobile
200743|NCT02341950|spinal|spinal
200744|NCT02341950|cord|cord
200745|NCT02341950|dysfunction|dysfunction
200746|NCT02341911|triple negative breast cancer|triple negative breast cancer
200747|NCT02341911|fine line chemotherapy|fine line chemotherapy
200748|NCT02341898|nursing home care|nursing home care
200749|NCT02341898|physical restraints|physical restraints
200750|NCT02341898|dementia|dementia
200751|NCT02341898|implementation research|implementation research
200752|NCT02341898|cluster-randomized controlled trial|cluster-randomized controlled trial
200753|NCT02341885|Kidney|kidney
200754|NCT02341885|Renal replacement|renal replacement
200755|NCT02341885|Acute kidney injury|acute kidney injury
200756|NCT02341885|chronic kidney disease|chronic kidney disease
200757|NCT02341885|Epidemiology|epidemiology
200758|NCT02341885|Prevalence|prevalence
200759|NCT02341872|White spot lesions|white spot lesions
200760|NCT02341872|remineralization|remineralization
200761|NCT02341872|QLF|qlf
200762|NCT02341872|antibacterial|antibacterial
200763|NCT02341846|cancer pain|cancer pain
200764|NCT02341833|Anesthetic preconditioning|anesthetic preconditioning
200765|NCT02341833|Sevoflurane|sevoflurane
200766|NCT02341833|Liver transplantation|liver transplantation
200767|NCT02341833|brain-death donors|brain-death donors
200768|NCT02341820|breast cancer|breast cancer
200769|NCT02341820|breast conserving surgery|breast conserving surgery
200770|NCT02341820|cosmesis|cosmesis
200771|NCT02341807|Choroideremia|choroideremia
200772|NCT02341807|AAV|aav
200773|NCT02341807|Gene therapy|gene therapy
200774|NCT02341807|CHM|chm
200775|NCT02341807|Adeno-associated virus|adeno-associated virus
200776|NCT02341807|Adeno-associated viral vector|adeno-associated viral vector
200777|NCT02341794|intracranial arterial disease|intracranial arterial disease
200778|NCT02341794|dyslipidemia|dyslipidemia
200779|NCT02341794|rosuvastatin|rosuvastatin
200780|NCT02341781|MANTLE CELL LYMPHOMA|mantle cell lymphoma
200781|NCT02341781|Multicenter|multicenter
200782|NCT02341781|Observational|observational
200783|NCT02341781|Lenalidomide (Revlimid®)|lenalidomide (revlimid®)
200784|NCT02341781|Relapsed or progressed|relapsed or progressed
200785|NCT02341781|Ibrutinib|ibrutinib
200786|NCT02341768|clinical and device functional information|clinical and device functional information
200787|NCT02341768|"real world ICD patient population"|"real world icd patient population"
200788|NCT02341742|Physical activity|physical activity
200789|NCT02341742|Bone health|bone health
200790|NCT02341742|Pediatrics|pediatrics
200791|NCT02341742|Bone|bone
200792|NCT02341729|semi-urgent CABG|semi-urgent cabg
200793|NCT02341729|reanimation|reanimation
200794|NCT02341729|ticagrelor|ticagrelor
200795|NCT02341729|crushed tablet|crushed tablet
200796|NCT02341716|intermittent claudication|intermittent claudication
200797|NCT02341716|exercise therapy|exercise therapy
200798|NCT02341716|physiotherapy|physiotherapy
200799|NCT02341690|Type 2 diabetes|type 2 diabetes
200800|NCT02341690|Interval Walking Training|interval walking training
200801|NCT02341690|Motivation|motivation
200802|NCT02341677|Prostatic Neoplasms|prostatic neoplasms
200803|NCT02341677|Diagnostic Techniques and Procedures|diagnostic techniques and procedures
200804|NCT02341677|Magnetic Resonance Imaging|magnetic resonance imaging
200805|NCT02341677|Ultrasonography|ultrasonography
200806|NCT02341677|Biopsy|biopsy
200807|NCT02341677|Image Fusion|image fusion
200808|NCT02341664|Mobile Tablet Device|mobile tablet device
200809|NCT02341664|Outpatient Clinic|outpatient clinic
200810|NCT02341664|Tobacco|tobacco
200811|NCT02341664|Health|health
200812|NCT02341664|Barriers|barriers
200813|NCT02341664|Prevention|prevention
200814|NCT02341664|Prescribing Practices|prescribing practices
200815|NCT02341664|Informed Consent|informed consent
200816|NCT02341664|Statin|statin
200817|NCT02341664|Lipid Panel|lipid panel
200818|NCT02341664|Low Density Lipoprotein-C|low density lipoprotein-c
200819|NCT02341664|Blood Draw|blood draw
200820|NCT02341664|ACC/AHA Guidelines|acc/aha guidelines
200821|NCT02341664|Adult Treatment Panel Guidelines (ATPIII)|adult treatment panel guidelines (atpiii)
200822|NCT02341664|Atherosclerotic Cardiovascular Disease (ASCVD)|atherosclerotic cardiovascular disease (ascvd)
200823|NCT02341664|Cholesterol-lowering therapies|cholesterol-lowering therapies
200824|NCT02341664|Cholesterol Management|cholesterol management
200825|NCT02341664|Cardiovascular Risk|cardiovascular risk
200826|NCT02341664|10-year CVD Risk|10-year cvd risk
200827|NCT02341664|Labs|labs
200828|NCT02341664|Coronary revascularization|coronary revascularization
200829|NCT02341664|Arterial revascularization|arterial revascularization
200830|NCT02341664|Imaging|imaging
200831|NCT02341651|High blood pressure|high blood pressure
200832|NCT02341651|Cardiovascular diseases|cardiovascular diseases
200833|NCT02341651|Antihypertensive agents|antihypertensive agents
200834|NCT02341651|Pharmacological treatment|pharmacological treatment
200835|NCT02341651|Non-pharmacological treatment|non-pharmacological treatment
200836|NCT02341651|Community health care workers|community health care workers
200837|NCT02341651|Treatment algorithm|treatment algorithm
200838|NCT02341651|Public and private healthcare providers|public and private healthcare providers
200839|NCT02341651|Strategy|strategy
200840|NCT02341651|Referral loops|referral loops
200841|NCT02341651|Intervention|intervention
200842|NCT02341612|exercise-induced muscle damage|exercise-induced muscle damage
200843|NCT02341612|skeletal muscle injury recovery|skeletal muscle injury recovery
200844|NCT02341612|cryotherapy|cryotherapy
200845|NCT02341612|recovery of function|recovery of function
200846|NCT02341612|rehabilitation|rehabilitation
200847|NCT02341586|Malaria|malaria
200848|NCT02341586|Cambodia|cambodia
200849|NCT02341586|Iron|iron
200850|NCT02341586|Childbearing Age|childbearing age
200851|NCT02341586|Women|women
200852|NCT02341586|Home Fortification|home fortification
200853|NCT02341573|Traditional Chinese Medicine|traditional chinese medicine
200854|NCT02341573|Randomized Controlled Trial|randomized controlled trial
200855|NCT02341560|NAION|naion
200856|NCT02341495|Azacitidine|azacitidine
200857|NCT02341495|Vidaza|vidaza
200858|NCT02341495|Deferasirox|deferasirox
200859|NCT02341495|Exjade|exjade
200860|NCT02341495|Cholecalciferol|cholecalciferol
200861|NCT02341495|Vitamin D|vitamin d
200862|NCT02341482|Itraconazole|itraconazole
200863|NCT02341482|Healthy Volunteers|healthy volunteers
200864|NCT02341482|Drug-drug interaction|drug-drug interaction
200865|NCT02341482|PF-04958242|pf-04958242
200866|NCT02341469|Burkina Faso|burkina faso
200867|NCT02341469|cluster randomised|cluster randomised
200868|NCT02341469|stepped-wedge|stepped-wedge
200869|NCT02341469|IMCI|imci
200870|NCT02341443|bilateral double mandibular fractures|bilateral double mandibular fractures
200871|NCT02341443|rigid fixation|rigid fixation
200872|NCT02341443|no-rigid fixation|no-rigid fixation
200873|NCT02341443|jaw|jaw
200874|NCT02341430|hernia|hernia
200875|NCT02341430|synthetic mesh|synthetic mesh
200876|NCT02341417|Chronic Kidney Disease, Dialysis, Secondary Hyperparathyroidism, Pediatric|chronic kidney disease, dialysis, secondary hyperparathyroidism, pediatric
200877|NCT02341391|chondrocyte cells|chondrocyte cells
200878|NCT02341391|Osteoarthritis|osteoarthritis
200879|NCT02341391|gene therapy|gene therapy
200880|NCT02341378|chondrocyte cells|chondrocyte cells
200881|NCT02341378|Osteoarthritis|osteoarthritis
200882|NCT02341378|gene therapy|gene therapy
201190|NCT02339428|Colonoscopy|colonoscopy
200883|NCT02341365|Egg donation|egg donation
200884|NCT02341365|vitaminD|vitamind
200885|NCT02341365|ovarian reserve|ovarian reserve
200886|NCT02341365|ovarian stimulation|ovarian stimulation
200887|NCT02341326|Lung|lung
200888|NCT02341326|COPD|copd
200889|NCT02341326|smoking|smoking
200890|NCT02341326|Non-smoker|non-smoker
200891|NCT02341313|Hypoglycaemia|hypoglycaemia
200892|NCT02341300|Pregnancy|pregnancy
200893|NCT02341300|Cast-Iron pots|cast-iron pots
200894|NCT02341300|Iron-deficiency anemia|iron-deficiency anemia
200895|NCT02341274|Tacrolimus|tacrolimus
200896|NCT02341274|Drug Formulation|drug formulation
200897|NCT02341274|Absorption|absorption
200898|NCT02341274|Bioavailability|bioavailability
200899|NCT02341274|Healthy Volunteer|healthy volunteer
200900|NCT02341248|Enteral Nutrition|enteral nutrition
200901|NCT02341248|Pediatrics|pediatrics
200902|NCT02341248|Microbiota|microbiota
200903|NCT02341248|Metabolomics|metabolomics
200904|NCT02341235|video game|video game
200905|NCT02341235|narrative|narrative
200906|NCT02341235|story|story
200907|NCT02341235|survivorship|survivorship
200908|NCT02341235|cancer survivor|cancer survivor
200909|NCT02341235|mhealth|mhealth
200910|NCT02341235|physical activity|physical activity
200911|NCT02341235|women|women
200912|NCT02341235|women's health|women's health
200913|NCT02341222|hernia prosthetic surgery|hernia prosthetic surgery
200914|NCT02341222|incisional hernia prosthesis|incisional hernia prosthesis
200915|NCT02341222|prosthesis mesh fixation|prosthesis mesh fixation
200916|NCT02341222|prosthesis mesh biocompatibility|prosthesis mesh biocompatibility
200917|NCT02341209|CTCL|ctcl
200918|NCT02341209|Sezary Syndrome (SS)|sezary syndrome (ss)
200919|NCT02341209|Mycosis Fungoides (MF)|mycosis fungoides (mf)
200920|NCT02341209|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
200921|NCT02341209|MF|mf
200922|NCT02341209|SS|ss
200923|NCT02341131|Schizophrenia|schizophrenia
200924|NCT02341131|Cognitive Remediation|cognitive remediation
200925|NCT02341131|BDNF|bdnf
200926|NCT02341118|BRCA1/2 Mutational Status|brca1/2 mutational status
200927|NCT02341092|Traumatic brain injury|traumatic brain injury
200928|NCT02341079|Total Knee Arthroplasty|total knee arthroplasty
200929|NCT02341079|Osteoarthritis|osteoarthritis
200930|NCT02341079|Femoral Nerve Blockade|femoral nerve blockade
200931|NCT02341079|Liposomal Bupivacaine|liposomal bupivacaine
200932|NCT02341066|Cardiovascular risk score|cardiovascular risk score
200933|NCT02341066|Framingham risk score 2-year|framingham risk score 2-year
200934|NCT02341066|Endothelial dysfunction|endothelial dysfunction
200935|NCT02341066|EndoPAT|endopat
200936|NCT02341066|Rheumatoid arthritis|rheumatoid arthritis
200937|NCT02341053|SMA|sma
200938|NCT02341053|Neuromuscular disability|neuromuscular disability
200939|NCT02341040|wheat allergy|wheat allergy
200940|NCT02341040|food allergy|food allergy
200941|NCT02341040|pediatric|pediatric
200942|NCT02341027|Immediate postpartum contraception|immediate postpartum contraception
200943|NCT02341027|Contraceptive implants|contraceptive implants
200944|NCT02341027|Breastfeeding|breastfeeding
200945|NCT02341027|Jadelle|jadelle
200946|NCT02341027|Lactation|lactation
200947|NCT02341027|Levonorgestrel|levonorgestrel
200948|NCT02341014|Carfilzomib|carfilzomib
200949|NCT02341014|Romidepsin|romidepsin
200950|NCT02341014|Lenalidomide|lenalidomide
200951|NCT02341014|Lymphomas|lymphomas
200952|NCT02341014|14-179|14-179
200953|NCT02341001|Bariatric surgery|bariatric surgery
200954|NCT02341001|Sleeve gastrectomy|sleeve gastrectomy
200955|NCT02341001|Text messaging|text messaging
200956|NCT02341001|Weight loss|weight loss
200957|NCT02341001|BAROS|baros
200958|NCT02341001|Follow-up care|follow-up care
200959|NCT02340975|Gastric Adenocarcinoma|gastric adenocarcinoma
200960|NCT02340975|Gastroesophageal Junction Adenocarcinoma|gastroesophageal junction adenocarcinoma
200961|NCT02340975|Immunotherapy|immunotherapy
200962|NCT02340975|Antibodies, Monoclonal|antibodies, monoclonal
200963|NCT02340975|Tremelimumab|tremelimumab
200964|NCT02340975|MEDI4736|medi4736
200965|NCT02340923|DMD|dmd
200966|NCT02340923|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
200967|NCT02340923|EIM|eim
200968|NCT02340910|spasticity|spasticity
200969|NCT02340910|whole body vibration|whole body vibration
200970|NCT02340910|walking|walking
200971|NCT02340871|Neurogenetics|neurogenetics
200972|NCT02340871|genetic testing|genetic testing
200973|NCT02340845|breast,colon, ovary, uterus, cervix, lung|breast,colon, ovary, uterus, cervix, lung
200974|NCT02340845|Treatments|treatments
200975|NCT02340806|epidural bolus|epidural bolus
200976|NCT02340806|pain management|pain management
200977|NCT02340806|labor analgesia|labor analgesia
200978|NCT02340793|Weight loss|weight loss
200979|NCT02340767|Suspicious Occlusal Caries|suspicious occlusal caries
200980|NCT02340754|mindfulness|mindfulness
200981|NCT02340754|meditation|meditation
200982|NCT02340754|stress, psychological|stress, psychological
200983|NCT02340754|quality of life|quality of life
200984|NCT02340754|randomized controlled trial|randomized controlled trial
200985|NCT02340741|carbon dioxide|carbon dioxide
201191|NCT02339428|diagnostic|diagnostic
200986|NCT02340741|postoperative cerebrovascular complications|postoperative cerebrovascular complications
200987|NCT02340741|air embolism|air embolism
200988|NCT02340728|Stent Placement|stent placement
200989|NCT02340728|Biliary Obstruction|biliary obstruction
200990|NCT02340728|14-260|14-260
200991|NCT02340715|Anal canal|anal canal
200992|NCT02340715|Brain|brain
200993|NCT02340715|Breast|breast
200994|NCT02340715|Cervix|cervix
200995|NCT02340715|Esophagus|esophagus
200996|NCT02340715|Gynecology|gynecology
200997|NCT02340715|Head and Neck|head and neck
200998|NCT02340715|Lung|lung
200999|NCT02340715|Pancreas|pancreas
201000|NCT02340715|Primary liver or liver metastases|primary liver or liver metastases
201001|NCT02340715|Prostate cancer|prostate cancer
201002|NCT02340715|Sarcoma|sarcoma
201003|NCT02340702|COPD and heart failure|copd and heart failure
201004|NCT02340689|PH|ph
201005|NCT02340689|PH type 1|ph type 1
201006|NCT02340689|Primary Hyperoxaluria|primary hyperoxaluria
201007|NCT02340689|Hyperoxaluria|hyperoxaluria
201008|NCT02340689|Primary Oxalosis|primary oxalosis
201009|NCT02340689|PH type 2|ph type 2
201010|NCT02340689|PH type 3|ph type 3
201011|NCT02340689|Genetic testing for PH|genetic testing for ph
201012|NCT02340689|Genetic testing for Primary Hyperoxaluria|genetic testing for primary hyperoxaluria
201013|NCT02340689|Hereditary study for PH|hereditary study for ph
201014|NCT02340689|Hereditary study for Primary Hyperoxaluria|hereditary study for primary hyperoxaluria
201015|NCT02340689|AGXT|agxt
201016|NCT02340689|GRHPR|grhpr
201017|NCT02340689|HOGA1|hoga1
201018|NCT02340676|chronic graft-versus-host-disease|chronic graft-versus-host-disease
201019|NCT02340663|dental orthotic|dental orthotic
201020|NCT02340663|bite splint|bite splint
201021|NCT02340663|oral parafunction|oral parafunction
201022|NCT02340663|clenching|clenching
201023|NCT02340663|grinding|grinding
201024|NCT02340650|suspicious bladder lesion, normal bladder tissue|suspicious bladder lesion, normal bladder tissue
201025|NCT02340585|Next Generation Neuroform Stent System|next generation neuroform stent system
201026|NCT02340585|Wide Neck, Intracranial, Saccular Aneurysms|wide neck, intracranial, saccular aneurysms
201027|NCT02340585|Cerebral Aneurysms|cerebral aneurysms
201028|NCT02340572|Healthy Subjects|healthy subjects
201029|NCT02340559|meta-cognition|meta-cognition
201030|NCT02340559|positive symptoms|positive symptoms
201031|NCT02340559|early phases|early phases
201032|NCT02340559|schizophrenia|schizophrenia
201033|NCT02340533|adenomyosis|adenomyosis
201034|NCT02340481|Diarrhea|diarrhea
201035|NCT02340481|Flatulence|flatulence
201036|NCT02340481|Abdominal discomfort|abdominal discomfort
201037|NCT02340481|Loperamide hydrochloride|loperamide hydrochloride
201038|NCT02340481|Simethicone|simethicone
201039|NCT02340481|Placebo|placebo
201040|NCT02340442|arteriovenous ratio|arteriovenous ratio
201041|NCT02340442|retinal flicker stimulation|retinal flicker stimulation
201042|NCT02340442|Dynamic vessel analyzer|dynamic vessel analyzer
201043|NCT02340416|orthopedic surgeries|orthopedic surgeries
201044|NCT02340416|general anesthesia|general anesthesia
201045|NCT02340403|Neuropathy|neuropathy
201046|NCT02340403|Oxaliplatin|oxaliplatin
201047|NCT02340403|Insula|insula
201048|NCT02340403|choline|choline
201049|NCT02340390|G7 Acetabular System|g7 acetabular system
201050|NCT02340377|core body temperature|core body temperature
201051|NCT02340377|whole-body hyperthermia|whole-body hyperthermia
201052|NCT02340377|rectal body temperature|rectal body temperature
201053|NCT02340364|Hospital Readmissions|hospital readmissions
201054|NCT02340364|Patient Navigation|patient navigation
201055|NCT02340351|acupuncture|acupuncture
201056|NCT02340351|auricular acupuncture|auricular acupuncture
201057|NCT02340351|NADA|nada
201058|NCT02340351|anxiety|anxiety
201059|NCT02340351|depression|depression
201060|NCT02340299|High Frequency Oscillation Ventilation|high frequency oscillation ventilation
201061|NCT02340299|Nasal Continuous Positive Airway Pressure|nasal continuous positive airway pressure
201062|NCT02340299|Airway Extubation|airway extubation
201063|NCT02340299|Prematurity|prematurity
201064|NCT02340273|tendinopathy|tendinopathy
201065|NCT02340273|ultrasound|ultrasound
201066|NCT02340273|pain|pain
201067|NCT02340273|heat|heat
201068|NCT02340273|strength|strength
201069|NCT02340273|LITUS|litus
201070|NCT02340273|long duration|long duration
201071|NCT02340273|therapeutic ultrasound|therapeutic ultrasound
201072|NCT02340273|tendonopathy|tendonopathy
201073|NCT02340260|Exercise|exercise
201074|NCT02340260|Risk factors|risk factors
201075|NCT02340260|Exercise therapy|exercise therapy
201076|NCT02340260|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
201077|NCT02340208|Non-Small Cell Lung Cancer|non-small cell lung cancer
201078|NCT02340208|Neoplasms|neoplasms
201079|NCT02340208|Immunoconjugate|immunoconjugate
201080|NCT02340208|Tumor microenvironment alkalinization|tumor microenvironment alkalinization
201081|NCT02340195|Kidney impairment|kidney impairment
201082|NCT02340182|gut flora|gut flora
201083|NCT02340182|antibiotics|antibiotics
201084|NCT02340182|systemic immune response|systemic immune response
201085|NCT02340182|Volunteers|volunteers
201086|NCT02340091|facial nasolabial fold wrinkles|facial nasolabial fold wrinkles
201087|NCT02340078|the facial nasolabial fold|the facial nasolabial fold
201088|NCT02340065|colonoscopy|colonoscopy
201089|NCT02340065|adenoma detection rate|adenoma detection rate
201090|NCT02340065|Endocuff-assisted colonoscopy|endocuff-assisted colonoscopy
201091|NCT02340052|postoperative pain treatment|postoperative pain treatment
201092|NCT02340039|Polyphenol|polyphenol
201093|NCT02340039|Fruit|fruit
201094|NCT02340039|Metabolic|metabolic
201095|NCT02340026|Delay in motor skill development|delay in motor skill development
201096|NCT02340000|acute sinusitis|acute sinusitis
201097|NCT02340000|amoxicillin/clavulanate|amoxicillin/clavulanate
201098|NCT02340000|adults|adults
201099|NCT02340000|outcomes|outcomes
201100|NCT02339961|Systemic Sclerosis|systemic sclerosis
201101|NCT02339961|Pulmonary hypertension|pulmonary hypertension
201102|NCT02339961|Lung Doppler Signals|lung doppler signals
201103|NCT02339948|Locally confined|locally confined
201104|NCT02339935|Autism Spectrum Disorder|autism spectrum disorder
201105|NCT02339935|Autism|autism
201106|NCT02339909|Screening|screening
201107|NCT02339909|Incentives|incentives
201108|NCT02339896|rabies|rabies
201109|NCT02339896|modified TRC intradermal rabies vaccine|modified trc intradermal rabies vaccine
201110|NCT02339896|SPEEDA|speeda
201111|NCT02339883|Physiological Measures|physiological measures
201113|NCT02339883|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
201114|NCT02339883|Cognitive Testing|cognitive testing
201115|NCT02339857|coronary artery bypass grafting|coronary artery bypass grafting
201116|NCT02339857|saphenous vein|saphenous vein
201117|NCT02339857|grafts|grafts
201118|NCT02339844|glutamate|glutamate
201119|NCT02339844|dopamine|dopamine
201120|NCT02339844|cognition|cognition
201121|NCT02339844|cortical thickness|cortical thickness
201122|NCT02339844|ppi|ppi
201123|NCT02339844|p50|p50
201124|NCT02339831|Knee|knee
201125|NCT02339831|Arthroplasty|arthroplasty
201126|NCT02339831|CPM|cpm
201127|NCT02339831|Camoped|camoped
201128|NCT02339831|Active vs Passive Motion Device|active vs passive motion device
201129|NCT02339805|Minimal residual disease, NGS, NHL, DNA sequencing|minimal residual disease, ngs, nhl, dna sequencing
201130|NCT02339792|COMPREHENSIVE GERIATRIC ASSESSMENT (CGA)|comprehensive geriatric assessment (cga)
201131|NCT02339792|MEDICATION APPROPRIATENESS PRESCRIBING|medication appropriateness prescribing
201132|NCT02339792|DRUG INTERACTIONS|drug interactions
201133|NCT02339792|E-LEARNING|e-learning
201134|NCT02339779|fat grafting|fat grafting
201135|NCT02339779|fat injection|fat injection
201136|NCT02339779|lipoaspirate|lipoaspirate
201137|NCT02339779|fat transfer|fat transfer
201138|NCT02339779|lipofilling|lipofilling
201139|NCT02339779|liposculpturing|liposculpturing
201140|NCT02339779|lipoinjection|lipoinjection
201141|NCT02339779|lipotransfer|lipotransfer
201142|NCT02339779|breast reconstruction|breast reconstruction
201143|NCT02339766|Cesarean|cesarean
201144|NCT02339766|Quadratus Lumborum Block|quadratus lumborum block
201145|NCT02339766|Analgesia|analgesia
201146|NCT02339766|Ultrasonography|ultrasonography
201147|NCT02339727|Omega-3|omega-3
201148|NCT02339727|Omega-6|omega-6
201149|NCT02339714|allergic rhinitis|allergic rhinitis
201150|NCT02339714|acupuncture|acupuncture
201151|NCT02339714|moxibustion|moxibustion
201152|NCT02339714|efficacy|efficacy
201153|NCT02339714|safety|safety
201154|NCT02339649|sepsis|sepsis
201155|NCT02339649|septic shock|septic shock
201156|NCT02339649|ICU|icu
201157|NCT02339649|long-term outcome|long-term outcome
201158|NCT02339649|neurocognitive|neurocognitive
201159|NCT02339649|inflammatory|inflammatory
201160|NCT02339649|MRI|mri
201161|NCT02339649|EEG|eeg
201162|NCT02339649|brain imaging|brain imaging
201163|NCT02339649|serum biomarkers|serum biomarkers
201164|NCT02339649|CSF|csf
201165|NCT02339636|subclinical, enthesitis, synovitis|subclinical, enthesitis, synovitis
201166|NCT02339623|Threatened preterm birth - fetal adrenal gland volume|threatened preterm birth - fetal adrenal gland volume
201167|NCT02339610|Osteoarthritis|osteoarthritis
201168|NCT02339610|Post-traumatic Arthritis|post-traumatic arthritis
201169|NCT02339584|OAG|oag
201170|NCT02339584|OHT|oht
201171|NCT02339532|HER2-positive|her2-positive
201172|NCT02339532|non-metastatic|non-metastatic
201173|NCT02339532|TOP2A|top2a
201174|NCT02339519|Laryngeal Masks|laryngeal masks
201175|NCT02339506|stress|stress
201176|NCT02339506|ACTH|acth
201177|NCT02339506|cosyntropin|cosyntropin
201178|NCT02339506|baroreflex sensitivity|baroreflex sensitivity
201179|NCT02339506|cardiovagal|cardiovagal
201180|NCT02339480|Massage therapy|massage therapy
201181|NCT02339480|Simple obesity|simple obesity
201182|NCT02339480|Energy metabolism|energy metabolism
201183|NCT02339480|Mechanism|mechanism
201184|NCT02339467|decreased outdoor walking ability|decreased outdoor walking ability
201185|NCT02339467|Older adult|older adult
201186|NCT02339454|Cardiac Shock wave therapy|cardiac shock wave therapy
201187|NCT02339454|stable angina|stable angina
201188|NCT02339454|exercise tolerance|exercise tolerance
201189|NCT02339441|Systemic sclerosis|systemic sclerosis
201192|NCT02339428|diclophenac|diclophenac
201193|NCT02339428|randomized controlled trial|randomized controlled trial
201194|NCT02339402|Cystic fibrosis, Myotonic dystrophy, Noonan, Huntingtons|cystic fibrosis, myotonic dystrophy, noonan, huntingtons
201195|NCT02339363|mindfulness|mindfulness
201196|NCT02339363|adolescents|adolescents
201197|NCT02339363|working memory|working memory
201198|NCT02339363|stress|stress
201199|NCT02339363|anxiety|anxiety
201200|NCT02339311|The study focus is on lifestyle changes and patient activation in diabetic patients by regular monthly visit by the CHRs|the study focus is on lifestyle changes and patient activation in diabetic patients by regular monthly visit by the chrs
201201|NCT02339298|Music Therapy|music therapy
201202|NCT02339285|tACS|tacs
201203|NCT02339285|Major Depressive Disorder|major depressive disorder
201204|NCT02339285|MDD|mdd
201205|NCT02339285|mood symptoms|mood symptoms
201206|NCT02339285|sham|sham
201207|NCT02339272|meiosis|meiosis
201208|NCT02339272|synapsis|synapsis
201209|NCT02339272|recombination|recombination
201210|NCT02339272|sperm aneuploidy|sperm aneuploidy
201211|NCT02339259|Rickettsial disease|rickettsial disease
201212|NCT02339259|Febrile|febrile
201213|NCT02339259|Murine typhus|murine typhus
201214|NCT02339259|Scrub typhus|scrub typhus
201215|NCT02339259|Diagnostic test|diagnostic test
201216|NCT02339259|Clinical features|clinical features
201217|NCT02339233|Epidural Stimulation|epidural stimulation
201218|NCT02339220|Constraint-Induced Movement Therapy|constraint-induced movement therapy
201219|NCT02339220|Physical Therapy|physical therapy
201220|NCT02339220|Rehabilitation|rehabilitation
201221|NCT02339220|Occupational Therapy|occupational therapy
201222|NCT02339220|Fitness Training|fitness training
201223|NCT02339220|Recovery of Function|recovery of function
201224|NCT02339220|Neuroplasticity|neuroplasticity
201225|NCT02339220|Exercise Therapy|exercise therapy
201226|NCT02339220|Brain Injuries|brain injuries
201227|NCT02339220|Traumatic Brain Injury|traumatic brain injury
201228|NCT02339220|Physical Therapy Modalities|physical therapy modalities
201229|NCT02339220|Neuroimaging|neuroimaging
201230|NCT02339194|complete denture|complete denture
201231|NCT02339194|quality of life|quality of life
201232|NCT02339194|patient satisfaction|patient satisfaction
201233|NCT02339155|Anthrax Vaccine Adsorbed|anthrax vaccine adsorbed
201234|NCT02339155|Raxibacumab|raxibacumab
201235|NCT02339155|Immunogenicity|immunogenicity
201236|NCT02339103|arteriovenous anastomoses|arteriovenous anastomoses
201237|NCT02339103|accidental hypothermia|accidental hypothermia
201238|NCT02339103|rewarming|rewarming
201239|NCT02339090|VRS-317|vrs-317
201240|NCT02339090|Growth Hormone Deficiency|growth hormone deficiency
201241|NCT02339090|Long Acting Recombinant Growth Hormone|long acting recombinant growth hormone
201242|NCT02339090|Long Acting Growth Hormone|long acting growth hormone
201243|NCT02339090|Pediatric Growth Hormone Deficiency|pediatric growth hormone deficiency
201244|NCT02339090|Growth Hormone Replacement Therapy|growth hormone replacement therapy
201245|NCT02339090|Versartis|versartis
201246|NCT02339090|Xten|xten
201247|NCT02339090|Human Growth Hormone|human growth hormone
201248|NCT02339090|somavaratan|somavaratan
201249|NCT02339090|growth failure|growth failure
201250|NCT02339077|Group B Streptococcus, stillborn|group b streptococcus, stillborn
201251|NCT02339064|Parkinson's disease,|parkinson's disease,
201252|NCT02339064|apomorphine|apomorphine
201253|NCT02339064|Apokyn|apokyn
201254|NCT02339064|dopamine agonist|dopamine agonist
201255|NCT02339064|levodopa|levodopa
201256|NCT02339064|advanced|advanced
201257|NCT02339064|PD|pd
201258|NCT02339064|carbidopa|carbidopa
201259|NCT02339064|pramipexole|pramipexole
201260|NCT02339064|ropinirole|ropinirole
201261|NCT02339064|rotigotine|rotigotine
201262|NCT02339064|MAO-B inhibitors|mao-b inhibitors
201263|NCT02339064|COMT inhibitors|comt inhibitors
201264|NCT02339064|off|off
201265|NCT02339064|dyskinesia|dyskinesia
201266|NCT02339051|Basic Science|basic science
201267|NCT02339038|Community Based Research|community based research
201268|NCT02339038|Hepatitis C Virus and Human Immunodeficiency Virus|hepatitis c virus and human immunodeficiency virus
201269|NCT02339038|Ledipasvir/Sofosbuvir|ledipasvir/sofosbuvir
201270|NCT02339038|Fixed Dose Combination|fixed dose combination
201271|NCT02339038|Sustained Viral Response|sustained viral response
201272|NCT02339025|Cohort|cohort
201273|NCT02339025|Participation|participation
201274|NCT02339025|Biobank|biobank
201275|NCT02339012|Genome Wide Association|genome wide association
201276|NCT02339012|Biomarkers|biomarkers
201277|NCT02339012|Methylation|methylation
201278|NCT02339012|Phenotype|phenotype
201279|NCT02339012|Cytometry|cytometry
201280|NCT02338999|Autoimmunity Pathogenesis|autoimmunity pathogenesis
201281|NCT02338999|Arteriosclerosis|arteriosclerosis
201282|NCT02338999|Adult|adult
201283|NCT02338986|High Titer Antibodies|high titer antibodies
201284|NCT02338986|Convalescent Volunteers|convalescent volunteers
201285|NCT02338986|Apheresis|apheresis
201286|NCT02338986|Males|males
201287|NCT02338986|Quantitative IgG|quantitative igg
201288|NCT02338973|Macular Edema|macular edema
201289|NCT02338973|Rod-Cone Dystrophy|rod-cone dystrophy
201290|NCT02338973|Inherited Retinal Degeneration|inherited retinal degeneration
201291|NCT02338973|Enhanced S-Cone Syndrom|enhanced s-cone syndrom
201292|NCT02338973|Interferon Gamma|interferon gamma
201293|NCT02338960|HSDD Female|hsdd female
201294|NCT02338960|Sexual Desire Disorder|sexual desire disorder
201295|NCT02338960|decreased desire|decreased desire
201296|NCT02338960|female sexual dysfunction|female sexual dysfunction
201297|NCT02338947|Frailty|frailty
201298|NCT02338947|Cardiopulmonary Bypass|cardiopulmonary bypass
201299|NCT02338947|Coronary artery bypass surgery|coronary artery bypass surgery
201300|NCT02338947|Mortality|mortality
201301|NCT02338947|Morbidity|morbidity
201302|NCT02338921|triple combination therapy|triple combination therapy
201303|NCT02338921|sitagliptin|sitagliptin
201304|NCT02338921|dapagliflozin|dapagliflozin
201305|NCT02338921|lobeglitazone|lobeglitazone
201306|NCT02338908|dry needling|dry needling
201307|NCT02338908|trigger point|trigger point
201308|NCT02338908|eccentric exercise|eccentric exercise
201309|NCT02338895|acute kidney injury, oliguria,renal ultrasound|acute kidney injury, oliguria,renal ultrasound
201310|NCT02338882|Lenses|lenses
201311|NCT02338882|Intraocular|intraocular
201312|NCT02338856|Obesity|obesity
201313|NCT02338830|Twins|twins
201314|NCT02338830|Preterm labor|preterm labor
201315|NCT02338830|Progesterone|progesterone
201316|NCT02338830|Short cervix|short cervix
201317|NCT02338804|mix vaccine, breast neoplasms, immunotherapy|mix vaccine, breast neoplasms, immunotherapy
201318|NCT02338778|mix vaccine, liver neoplasms, immunotherapy|mix vaccine, liver neoplasms, immunotherapy
201319|NCT02338752|mix vaccine, pancreatic neoplasms, immunotherapy|mix vaccine, pancreatic neoplasms, immunotherapy
201320|NCT02338739|Retention|retention
201321|NCT02338739|Lost to follow up|lost to follow up
201322|NCT02338739|Adaptive strategies|adaptive strategies
201323|NCT02338739|Dynamic regime|dynamic regime
201324|NCT02338739|Sequentially randomized trial|sequentially randomized trial
201325|NCT02338739|Sequential multiple assignment randomized trial|sequential multiple assignment randomized trial
201326|NCT02338739|Engagement in care|engagement in care
201327|NCT02338739|Kenya|kenya
201328|NCT02338726|urinary incontinence|urinary incontinence
201329|NCT02338726|pelvic floor|pelvic floor
201330|NCT02338726|quality of life|quality of life
201331|NCT02338726|elderly women|elderly women
201332|NCT02338713|Drug therapy|drug therapy
201333|NCT02338700|mix vaccine, prostate carcinoma, immunotherapy|mix vaccine, prostate carcinoma, immunotherapy
201334|NCT02338687|Calcium|calcium
201335|NCT02338687|Dietary supplements|dietary supplements
201336|NCT02338687|Hypertension, Pregnancy-Induced|hypertension, pregnancy-induced
201337|NCT02338687|Pre-Eclampsia|pre-eclampsia
201338|NCT02338687|Nutritional education|nutritional education
201339|NCT02338687|Diet therapy|diet therapy
201340|NCT02338687|Diet records|diet records
201341|NCT02338687|Hospitalization|hospitalization
201342|NCT02338687|Maternal mortality|maternal mortality
201343|NCT02338635|ER stress|er stress
201344|NCT02338635|Peritoneal Dialysis|peritoneal dialysis
201345|NCT02338622|olaparib|olaparib
201346|NCT02338622|AZD5363|azd5363
201347|NCT02338622|intrapatient dose escalation|intrapatient dose escalation
201348|NCT02338622|advanced solid tumours|advanced solid tumours
201349|NCT02338609|TSC-associated SEGA,|tsc-associated sega,
201350|NCT02338609|height,|height,
201351|NCT02338609|weight,|weight,
201352|NCT02338609|Tanner Stage,|tanner stage,
201353|NCT02338609|growth development,|growth development,
201354|NCT02338609|everolimus,|everolimus,
201355|NCT02338609|RAD001|rad001
201356|NCT02338557|MRP, MIRROR THERAPY, STROKE|mrp, mirror therapy, stroke
201357|NCT02338518|gastric cancer|gastric cancer
201358|NCT02338518|neoadjuvant chemotherapy|neoadjuvant chemotherapy
201359|NCT02338518|efficacy|efficacy
201360|NCT02338518|safety|safety
201361|NCT02338505|Robotic Surgery|robotic surgery
201362|NCT02338505|Telelap-ALFX|telelap-alfx
201363|NCT02338505|Gynecological disease|gynecological disease
201364|NCT02338453|Social Anxiety|social anxiety
201365|NCT02338453|Attention Modification|attention modification
201366|NCT02338453|Dot-Probe|dot-probe
201367|NCT02338453|GCBT|gcbt
201368|NCT02338362|Corticosteroids|corticosteroids
201369|NCT02338362|Bronchodilator Agents|bronchodilator agents
201370|NCT02338362|Intraocular Pressure|intraocular pressure
201371|NCT02338323|Hyperuricemia|hyperuricemia
201372|NCT02338323|Renal Function|renal function
201373|NCT02338323|Chronic kidney disease|chronic kidney disease
201374|NCT02338323|Febuxostat|febuxostat
201375|NCT02338323|Benzbromarone|benzbromarone
201376|NCT02338297|Hepatocellular Carcinoma|hepatocellular carcinoma
201377|NCT02338297|Arterioportal shunts|arterioportal shunts
201378|NCT02338297|Transarterial Chemoembolization|transarterial chemoembolization
201379|NCT02338297|Ethanol|ethanol
201380|NCT02338297|Gelfoam|gelfoam
201381|NCT02338297|Polyvinyl Alcohol Foam Embolization Particles (PVA)|polyvinyl alcohol foam embolization particles (pva)
201382|NCT02338284|increased intracranial pressure|increased intracranial pressure
201383|NCT02338284|optic nerve sheath diameter|optic nerve sheath diameter
201384|NCT02338271|Low back pain|low back pain
201385|NCT02338271|Mesenchymal stromal stem cell|mesenchymal stromal stem cell
201386|NCT02338271|Hyaluronic acid|hyaluronic acid
201387|NCT02338219|postpartum pelvic floor|postpartum pelvic floor
201388|NCT02338206|infertility|infertility
201390|NCT02338193|T2DM|t2dm
201391|NCT02338193|prediabetes|prediabetes
201392|NCT02338180|dental caries|dental caries
201393|NCT02338180|risk assessment|risk assessment
201394|NCT02338180|approximal sealant|approximal sealant
201395|NCT02338180|permanent molar|permanent molar
201396|NCT02338180|preventive dentistry|preventive dentistry
201397|NCT02338180|adolescent|adolescent
201398|NCT02338154|Aortic Valve Replacement|aortic valve replacement
201399|NCT02338154|Aortic Stenosis|aortic stenosis
201400|NCT02338154|EDWARDS INTUITY|edwards intuity
201401|NCT02338141|cervical cancer|cervical cancer
201402|NCT02338141|colposcopy|colposcopy
201403|NCT02338141|human papillomavirus|human papillomavirus
201404|NCT02338141|human immunodeficiency virus|human immunodeficiency virus
201405|NCT02338128|peritoneal dialysis|peritoneal dialysis
201406|NCT02338128|hyperuricemia|hyperuricemia
201407|NCT02338128|cardiovascular|cardiovascular
201408|NCT02338128|Febuxostat|febuxostat
201409|NCT02338089|Uterine contraction|uterine contraction
201410|NCT02338089|Oxytocin desensitization|oxytocin desensitization
201411|NCT02338063|Adolescent Risk Behavior|adolescent risk behavior
201412|NCT02338063|Emotion Regulation|emotion regulation
201413|NCT02338063|Health Promotion|health promotion
201414|NCT02338063|Intervention|intervention
201415|NCT02338063|Mental Health|mental health
201416|NCT02338050|ALL|all
201417|NCT02338050|Moxetumomab Pasudotox|moxetumomab pasudotox
201418|NCT02338050|Moxe|moxe
201419|NCT02338050|CAT-8015, HA22|cat-8015, ha22
201420|NCT02338024|Enrollment in HIV care|enrollment in hiv care
201421|NCT02338024|Recently detected HIV-positive|recently detected hiv-positive
201422|NCT02338024|specialized health care clinics|specialized health care clinics
201423|NCT02338024|Ukraine|ukraine
201424|NCT02337998|Neurology|neurology
201425|NCT02337998|Sports Medicine|sports medicine
201426|NCT02337972|diabetic macular edema|diabetic macular edema
201427|NCT02337972|Intravitreal injection|intravitreal injection
201428|NCT02337972|conjunctival flora|conjunctival flora
201429|NCT02337959|Healthy Volunteers|healthy volunteers
201430|NCT02337946|Metastatic colorectal cancer, Panitumumab, mFOLFOX6, First-line|metastatic colorectal cancer, panitumumab, mfolfox6, first-line
201431|NCT02337933|Metabolic Syndrome|metabolic syndrome
201432|NCT02337933|Central Obesity|central obesity
201433|NCT02337933|Insulin Sensitivity|insulin sensitivity
201434|NCT02337933|Ursolic Acid|ursolic acid
201435|NCT02337933|Triterpenoid|triterpenoid
201436|NCT02337894|Protein kinetics|protein kinetics
201437|NCT02337894|liver steatosis|liver steatosis
201438|NCT02337868|dose-ranging,double blind,female,healthy,HydroVax,male,Placebo-Controlled,Vaccine,West Nile Virus|dose-ranging,double blind,female,healthy,hydrovax,male,placebo-controlled,vaccine,west nile virus
201439|NCT02337855|Intestinal|intestinal
201440|NCT02337855|Pichia pastoris|pichia pastoris
201441|NCT02337855|S. mansoni|s. mansoni
201442|NCT02337855|Schistosomiasis|schistosomiasis
201443|NCT02337855|Sm-TSP-2/Alhydrogel|sm-tsp-2/alhydrogel
201444|NCT02337855|Sm-TSP-2/Alhydrogel/GLA-AF|sm-tsp-2/alhydrogel/gla-af
201445|NCT02337855|vaccine|vaccine
201446|NCT02337842|NoV, CIN-1, GII4. Norovirus, challenge, FUT-2 gene, HBGA-blocking Ab|nov, cin-1, gii4. norovirus, challenge, fut-2 gene, hbga-blocking ab
201447|NCT02337829|CLL|cll
201448|NCT02337829|SLL|sll
201449|NCT02337829|Btk|btk
201450|NCT02337829|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
201451|NCT02337829|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
201452|NCT02337829|Leukemia|leukemia
201453|NCT02337829|Lymphoma|lymphoma
201454|NCT02337829|Lymphocytic|lymphocytic
201455|NCT02337829|ACP-196|acp-196
201456|NCT02337829|acalabrutinib|acalabrutinib
201457|NCT02337816|Endometriosis|endometriosis
201458|NCT02337816|Metabolomics|metabolomics
201459|NCT02337803|Physical Activity|physical activity
201460|NCT02337790|Hypertension|hypertension
201461|NCT02337790|Heart Failure|heart failure
201462|NCT02337790|Fluids|fluids
201463|NCT02337777|Magnetic Resonance Imaging|magnetic resonance imaging
201464|NCT02337777|Magnetic Resonance Angiography|magnetic resonance angiography
201465|NCT02337777|Diffusion Tensor Imaging|diffusion tensor imaging
201466|NCT02337777|IDEAL|ideal
201467|NCT02337777|T2* mapping|t2* mapping
201468|NCT02337777|Magnetic ResonanceCine|magnetic resonancecine
201469|NCT02337777|BOLD|bold
201470|NCT02337777|phase contrast|phase contrast
201471|NCT02337777|diffusion-weighted imaging|diffusion-weighted imaging
201472|NCT02337777|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
201473|NCT02337712|Small cell lung cancer|small cell lung cancer
201474|NCT02337712|Radiotherapy|radiotherapy
201475|NCT02337712|Dose fractionation|dose fractionation
201476|NCT02337686|Keytruda|keytruda
201477|NCT02337686|pembrolizumab|pembrolizumab
201478|NCT02337686|immune effector function|immune effector function
201479|NCT02337686|pembrolizumab monotherapy|pembrolizumab monotherapy
201480|NCT02337686|ex vivo T-cell-specific cytokines profiling|ex vivo t-cell-specific cytokines profiling
201481|NCT02337686|immune effector Tcell:Treg ratio|immune effector tcell:treg ratio
201482|NCT02337686|immunological changes|immunological changes
201483|NCT02337686|immune response|immune response
201484|NCT02337673|Postoperative Pulmonary Complication|postoperative pulmonary complication
201485|NCT02337673|Electrical Impedance Tomography|electrical impedance tomography
201486|NCT02337673|Splenectomy|splenectomy
201487|NCT02337673|Gastric surgery|gastric surgery
201488|NCT02337673|Gastrectomy|gastrectomy
201489|NCT02337673|Pancreatic surgery|pancreatic surgery
201490|NCT02337673|Pancreatectomy|pancreatectomy
201491|NCT02337673|Liver surgery|liver surgery
201492|NCT02337673|Hemihepatectomy|hemihepatectomy
201493|NCT02337673|Cholecystectomy|cholecystectomy
201494|NCT02337673|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
201495|NCT02337673|Hypoxemia|hypoxemia
201496|NCT02337673|Atelectasis|atelectasis
201497|NCT02337673|Pulmonary obstruction|pulmonary obstruction
201498|NCT02337673|Pneumonia|pneumonia
201499|NCT02337673|Pneumothorax|pneumothorax
201500|NCT02337673|Pleural effusion|pleural effusion
201501|NCT02337673|Pulmonary edema|pulmonary edema
201502|NCT02337621|sunken chest|sunken chest
201503|NCT02337621|caved-in chest|caved-in chest
201504|NCT02337621|chest deformity|chest deformity
201505|NCT02337621|sunken sternum|sunken sternum
201506|NCT02337608|moderate to severe ulcerative colitis|moderate to severe ulcerative colitis
201507|NCT02337608|GLPG1205|glpg1205
201508|NCT02337595|CD45RA-depletion|cd45ra-depletion
201509|NCT02337595|TCR-alpha/beta depletion|tcr-alpha/beta depletion
201510|NCT02337595|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
201511|NCT02337595|immune reconstitution|immune reconstitution
201512|NCT02337595|Graft Enhancement, Immunologic|graft enhancement, immunologic
201513|NCT02337595|Immunocompromized Host|immunocompromized host
201514|NCT02337491|Recurrent|recurrent
201515|NCT02337452|Hereditary cancer-causing mutation|hereditary cancer-causing mutation
201516|NCT02337452|Gene mutation|gene mutation
201517|NCT02337452|Family member with genetic mutation|family member with genetic mutation
201518|NCT02337452|Questionnaire|questionnaire
201519|NCT02337452|Surveys|surveys
201520|NCT02337452|Registry|registry
201521|NCT02337452|Database|database
201522|NCT02337452|Communication|communication
201523|NCT02337413|Constipation|constipation
201524|NCT02337374|Urodynamics|urodynamics
201525|NCT02337374|Midurethral sling|midurethral sling
201526|NCT02337374|Transobturator tape (TOT)|transobturator tape (tot)
201527|NCT02337374|Tension free vaginal tape (TVT)|tension free vaginal tape (tvt)
201528|NCT02337361|risky alcohol use|risky alcohol use
201529|NCT02337361|pregnancy|pregnancy
201530|NCT02337348|coronary stents|coronary stents
201531|NCT02337335|Hemodialyisis|hemodialyisis
201532|NCT02337335|Predictive Model|predictive model
201533|NCT02337335|ESAs|esas
201534|NCT02337335|patients|patients
201535|NCT02337322|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
201536|NCT02337322|HIV|hiv
201537|NCT02337322|HIV-1|hiv-1
201538|NCT02337322|Antiretroviral treatment|antiretroviral treatment
201539|NCT02337322|HIV Advanced Disease|hiv advanced disease
201540|NCT02337322|AIDS|aids
201541|NCT02337322|Dolutegravir|dolutegravir
201542|NCT02337322|Darunavir|darunavir
201543|NCT02337296|Motivational Interviewing|motivational interviewing
201544|NCT02337296|Cognitive Behavioral Therapy|cognitive behavioral therapy
201545|NCT02337296|Cancer|cancer
201546|NCT02337296|Oral Agents|oral agents
201547|NCT02337296|Adherence|adherence
201548|NCT02337270|Tuberculosis|tuberculosis
201549|NCT02337270|Vaccine|vaccine
201550|NCT02337270|Aerosol|aerosol
201551|NCT02337270|Adenovirus|adenovirus
201552|NCT02337270|Immunogenicity|immunogenicity
201553|NCT02337244|Osteoarthritis|osteoarthritis
201554|NCT02337244|Rheumatoid arthritis|rheumatoid arthritis
201555|NCT02337244|Traumatic arthritis|traumatic arthritis
201556|NCT02337244|Polyarthritis|polyarthritis
201557|NCT02337244|Total knee arthroplasty|total knee arthroplasty
201558|NCT02337192|Orthodontic, Photochemoterapy|orthodontic, photochemoterapy
201559|NCT02337166|alveolar bone loss|alveolar bone loss
201560|NCT02337166|periodontal attachment loss|periodontal attachment loss
201561|NCT02337153|Orthodontique Bone Stretching|orthodontique bone stretching
201562|NCT02337140|TAVI|tavi
201563|NCT02337140|complete AV-block|complete av-block
201564|NCT02337140|HV-interval|hv-interval
201565|NCT02337140|permanent pacemaker|permanent pacemaker
201566|NCT02337140|valve implantation|valve implantation
201567|NCT02337140|severe|severe
201568|NCT02337140|conduction|conduction
201569|NCT02337140|disorders|disorders
201570|NCT02337114|Acceptance and Commitment Therapy|acceptance and commitment therapy
201571|NCT02337101|Brain concussion|brain concussion
201572|NCT02337101|Mild Traumatic Brain Injury|mild traumatic brain injury
201573|NCT02337101|Post-concussion symptoms|post-concussion symptoms
201574|NCT02337101|Therapy|therapy
201575|NCT02337101|Randomised controlled trial|randomised controlled trial
201576|NCT02337101|Cognitive assessment|cognitive assessment
201577|NCT02337088|delayed cord clamping|delayed cord clamping
201578|NCT02337075|condition|condition
201579|NCT02337075|preventing|preventing
201580|NCT02337075|physical activity|physical activity
201887|NCT02335034|Education|education
201581|NCT02337049|Preeclampsia. Cardiovascular Disease (CVD) Risk.|preeclampsia. cardiovascular disease (cvd) risk.
201582|NCT02337036|Liver transplantation|liver transplantation
201583|NCT02337036|Child|child
201584|NCT02337036|Tacrolimus|tacrolimus
201585|NCT02337036|Pharmacokinetic|pharmacokinetic
201586|NCT02337023|Brain scintigraphy|brain scintigraphy
201587|NCT02336997|skin regeneration|skin regeneration
201588|NCT02336997|mechanical stretch|mechanical stretch
201589|NCT02336984|Ductal carcinoma in situ (DCIS)|ductal carcinoma in situ (dcis)
201590|NCT02336958|cervical plexus|cervical plexus
201591|NCT02336958|regional anesthesia|regional anesthesia
201592|NCT02336958|ultrasound|ultrasound
201593|NCT02336958|carotid surgery|carotid surgery
201594|NCT02336932|vitamin d|vitamin d
201595|NCT02336932|free hormone|free hormone
201596|NCT02336932|surgical stress|surgical stress
201597|NCT02336919|discharge|discharge
201598|NCT02336919|mHealth|mhealth
201599|NCT02336919|telehealth|telehealth
201600|NCT02336919|text messaging|text messaging
201601|NCT02336906|Lower urinary tract dysfunction|lower urinary tract dysfunction
201602|NCT02336906|constipation|constipation
201603|NCT02336893|Communication Barriers|communication barriers
201604|NCT02336893|Total Communication Methods|total communication methods
201605|NCT02336893|Quality Improvement|quality improvement
201606|NCT02336893|Quality of Health Care|quality of health care
201607|NCT02336893|Critical Care|critical care
201608|NCT02336867|Complex anal fistula, clip,|complex anal fistula, clip,
201609|NCT02336854|pharmacokinetics|pharmacokinetics
201610|NCT02336841|Guided Self-Help|guided self-help
201611|NCT02336841|Peer Mentoring|peer mentoring
201612|NCT02336841|Anorexia Nervosa|anorexia nervosa
201613|NCT02336841|Eating Disorders|eating disorders
201614|NCT02336828|MEWS|mews
201615|NCT02336828|deteriorate|deteriorate
201616|NCT02336828|oncology|oncology
201617|NCT02336828|ICU|icu
201618|NCT02336828|predicting outcomes|predicting outcomes
201619|NCT02336828|MEWS in predicting outcomes in oncology patients|mews in predicting outcomes in oncology patients
201620|NCT02336815|Multiple myeloma|multiple myeloma
201621|NCT02336815|Karyopharm|karyopharm
201622|NCT02336815|KPT-330|kpt-330
201623|NCT02336815|Selinexor|selinexor
201624|NCT02336815|Refractory|refractory
201625|NCT02336815|Bortezomib|bortezomib
201626|NCT02336815|Carfilzomib|carfilzomib
201627|NCT02336815|Lenalidomide|lenalidomide
201628|NCT02336815|Pomalidomide|pomalidomide
201629|NCT02336815|Dexamethasone|dexamethasone
201630|NCT02336815|STORM|storm
201631|NCT02336815|Daratumumab|daratumumab
201632|NCT02336802|Anxiety|anxiety
201633|NCT02336802|Fear|fear
201634|NCT02336802|Avoidance|avoidance
201635|NCT02336776|Chronic Kidney Disease|chronic kidney disease
201636|NCT02336776|Electrical Stimulation|electrical stimulation
201637|NCT02336737|breast cancer|breast cancer
201638|NCT02336737|sentinel lymph node biopsy|sentinel lymph node biopsy
201639|NCT02336724|gastrointestinal stromal tumor|gastrointestinal stromal tumor
201640|NCT02336724|famitinib|famitinib
201641|NCT02336698|Osteoarthritis|osteoarthritis
201642|NCT02336698|Pain|pain
201643|NCT02336698|Fulranumab|fulranumab
201644|NCT02336698|JNJ-42160443|jnj-42160443
201645|NCT02336698|Monotherapy|monotherapy
201646|NCT02336698|Hip|hip
201647|NCT02336698|Knee|knee
201648|NCT02336698|Joint replacement surgery|joint replacement surgery
201649|NCT02336685|Osteoarthritis|osteoarthritis
201650|NCT02336685|Pain|pain
201651|NCT02336685|Fulranumab|fulranumab
201652|NCT02336685|JNJ-42160443|jnj-42160443
201653|NCT02336685|Adjunctive therapy|adjunctive therapy
201654|NCT02336685|Opioid|opioid
201655|NCT02336685|Hip|hip
201656|NCT02336685|Knee|knee
201657|NCT02336685|Joint replacement surgery|joint replacement surgery
201658|NCT02336672|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
201659|NCT02336672|Cryothermoablation|cryothermoablation
201660|NCT02336633|Huntington disease|huntington disease
201661|NCT02336633|Neurodegenerative disease|neurodegenerative disease
201662|NCT02336633|Volumetric MRI|volumetric mri
201663|NCT02336633|31P MR spectroscopy|31p mr spectroscopy
201664|NCT02336633|metabolism|metabolism
201665|NCT02336633|Caudate atrophy|caudate atrophy
201666|NCT02336620|Severe sepsis, Balanced Salt Solution, Normal Saline|severe sepsis, balanced salt solution, normal saline
201667|NCT02336581|Acceptance and Commitment Therapy|acceptance and commitment therapy
201668|NCT02336581|Mindfulness|mindfulness
201669|NCT02336581|Inpatients|inpatients
201670|NCT02336581|Psychiatric Hospitalization|psychiatric hospitalization
201671|NCT02336568|PTSD, Oxytocin|ptsd, oxytocin
201672|NCT02336542|diagnosis of Tuberculosis|diagnosis of tuberculosis
201673|NCT02336542|ESAT6|esat6
201674|NCT02336542|CFP10|cfp10
201675|NCT02336542|skin test|skin test
201676|NCT02336542|diagnostic test|diagnostic test
201677|NCT02336529|postoperative|postoperative
201678|NCT02336477|non-dystrophic myotonias|non-dystrophic myotonias
201679|NCT02336477|paramyotonia congenita|paramyotonia congenita
201680|NCT02336477|myotonia congenita|myotonia congenita
201681|NCT02336477|Mexiletine|mexiletine
201682|NCT02336477|Randomized clinical trial|randomized clinical trial
201683|NCT02336451|ALK-positive|alk-positive
201684|NCT02336451|NSCLC|nsclc
201685|NCT02336451|brain metastasis|brain metastasis
201686|NCT02336451|metastatic to the brain and/or to leptomeninges.|metastatic to the brain and/or to leptomeninges.
201687|NCT02336425|Asthma|asthma
201688|NCT02336412|Medication adherence|medication adherence
201689|NCT02336399|HBsAg loss, interferon, HBV reaction|hbsag loss, interferon, hbv reaction
201690|NCT02336386|Bortezomib|bortezomib
201691|NCT02336373|Hemoglobin SC disease|hemoglobin sc disease
201692|NCT02336373|hydroxyurea|hydroxyurea
201693|NCT02336373|quality of life|quality of life
201694|NCT02336373|viscosity|viscosity
201695|NCT02336373|red cell density|red cell density
201696|NCT02336347|Pharmacokinetics|pharmacokinetics
201697|NCT02336347|Healthy Volunteers|healthy volunteers
201698|NCT02336347|deuterated dextromethorphan|deuterated dextromethorphan
201699|NCT02336347|deuterated dextromethorphan with quinidine|deuterated dextromethorphan with quinidine
201700|NCT02336282|Adult survivor of acute lymphoblastic leukemia|adult survivor of acute lymphoblastic leukemia
201701|NCT02336282|Executive dysfunction|executive dysfunction
201702|NCT02336282|Transcranial direct current stimulation|transcranial direct current stimulation
201703|NCT02336282|Cancer prevention and control|cancer prevention and control
201704|NCT02336269|Pharmacogenomics|pharmacogenomics
201705|NCT02336256|inguinal hernia repair|inguinal hernia repair
201706|NCT02336256|totally extraperitoneal (TEP)|totally extraperitoneal (tep)
201707|NCT02336256|single incision laparoscopic surgery (SILS)|single incision laparoscopic surgery (sils)
201708|NCT02336256|plasma total antioxidant status|plasma total antioxidant status
201709|NCT02336243|docosahexaenoic acid|docosahexaenoic acid
201710|NCT02336243|premature birth|premature birth
201711|NCT02336243|placentation disorders|placentation disorders
201712|NCT02336243|preeclampsia|preeclampsia
201713|NCT02336243|fetal growth|fetal growth
201714|NCT02336230|GVHD|gvhd
201715|NCT02336191|living donor liver transplantation|living donor liver transplantation
201716|NCT02336191|graft function|graft function
201717|NCT02336191|thromboelastometry|thromboelastometry
201718|NCT02336165|Glioblastoma|glioblastoma
201719|NCT02336165|Immunotherapy|immunotherapy
201720|NCT02336165|T Cell|t cell
201721|NCT02336165|PD-L1|pd-l1
201722|NCT02336165|MEDI4736|medi4736
201723|NCT02336165|Radiation|radiation
201724|NCT02336165|Radiotherapy|radiotherapy
201725|NCT02336165|GBM|gbm
201726|NCT02336100|Diagnostic technique and procedure|diagnostic technique and procedure
201727|NCT02336074|HIV|hiv
201728|NCT02336074|Vaccine|vaccine
201729|NCT02336074|Cure|cure
201730|NCT02336074|Early Intervention|early intervention
201731|NCT02336074|Infection|infection
201732|NCT02336074|Primary infection|primary infection
201733|NCT02336074|Reservoir|reservoir
201734|NCT02336074|Vorinostat|vorinostat
201735|NCT02336074|HDAC|hdac
201736|NCT02336022|general anesthesia|general anesthesia
201737|NCT02336009|wrist arthritis|wrist arthritis
201738|NCT02336009|total wrist arthroplasty|total wrist arthroplasty
201739|NCT02335970|Pain|pain
201740|NCT02335970|Range of motion|range of motion
201741|NCT02335970|Quality of life|quality of life
201742|NCT02335944|non small cell lung cancer,|non small cell lung cancer,
201743|NCT02335944|NSCLC,|nsclc,
201744|NCT02335944|EGF816,|egf816,
201745|NCT02335944|INC280,|inc280,
201746|NCT02335944|tyrosine kinase inhibitor,|tyrosine kinase inhibitor,
201747|NCT02335944|c-MET|c-met
201748|NCT02335918|Opdivo®|opdivo®
201749|NCT02335866|Platelet rich fibrin|platelet rich fibrin
201750|NCT02335866|Gingival Recession|gingival recession
201751|NCT02335853|urinary bladder|urinary bladder
201752|NCT02335853|nerve growth factor|nerve growth factor
201753|NCT02335853|overactive bladder|overactive bladder
201754|NCT02335827|irreversible electroporation|irreversible electroporation
201755|NCT02335827|renal tumor|renal tumor
201756|NCT02335801|heart failure|heart failure
201757|NCT02335801|growth hormone|growth hormone
201758|NCT02335801|testosterone|testosterone
201759|NCT02335801|insulin resistance|insulin resistance
201760|NCT02335801|thyroid hormones|thyroid hormones
201761|NCT02335801|survival|survival
201762|NCT02335788|Therapeutic|therapeutic
201763|NCT02335788|Embolization|embolization
201764|NCT02335736|infertility|infertility
201765|NCT02335684|Heart-assist devices|heart-assist devices
201766|NCT02335684|exercise capacity|exercise capacity
201767|NCT02335671|Early Stage Breast Cancer|early stage breast cancer
201768|NCT02335671|Breast Conserving Surgery|breast conserving surgery
201769|NCT02335671|Breast Cancer Stage I|breast cancer stage i
201770|NCT02335671|Breast Cancer Stage II|breast cancer stage ii
201771|NCT02335645|ACL reconstruction|acl reconstruction
201772|NCT02335645|Running Mechanics|running mechanics
201773|NCT02335645|Physical Therapy|physical therapy
201774|NCT02335645|Knee|knee
201775|NCT02335645|Video Analysis|video analysis
201776|NCT02335645|Body Weight Supported Treadmill|body weight supported treadmill
201777|NCT02335632|Hepatitis|hepatitis
201778|NCT02335632|Probiotics|probiotics
201779|NCT02335632|Lipopolysaccharides|lipopolysaccharides
201780|NCT02335632|Cytokines|cytokines
201781|NCT02335632|Alcoholics|alcoholics
201782|NCT02335593|Hemodialysis patients|hemodialysis patients
201783|NCT02335593|Zinc|zinc
201784|NCT02335593|Anemia|anemia
201785|NCT02335593|Oxidative stress|oxidative stress
201786|NCT02335580|Prognosis|prognosis
201787|NCT02335554|Subthreshold|subthreshold
201788|NCT02335554|Employees|employees
201789|NCT02335554|Internet|internet
201790|NCT02335554|Mobile|mobile
201791|NCT02335554|cognitive-behavioral|cognitive-behavioral
201792|NCT02335515|Gastroretentive System|gastroretentive system
201793|NCT02335515|Gastric Retention Time (GRT)|gastric retention time (grt)
201794|NCT02335515|capsule|capsule
201795|NCT02335515|Soctec|soctec
201796|NCT02335515|Gastroenterology|gastroenterology
201797|NCT02335476|optical coherence tomography|optical coherence tomography
201798|NCT02335463|optical coherence tomography|optical coherence tomography
201799|NCT02335450|exercise|exercise
201800|NCT02335450|motivational interviewing|motivational interviewing
201801|NCT02335424|P-D1|p-d1
201802|NCT02335424|PD-1|pd-1
201803|NCT02335424|PD1|pd1
201804|NCT02335424|P-DL1|p-dl1
201805|NCT02335424|PD-L1|pd-l1
201806|NCT02335424|PDL-1|pdl-1
201807|NCT02335424|PDL1|pdl1
201808|NCT02335424|Bladder cancer|bladder cancer
201809|NCT02335411|Gastric cancer|gastric cancer
201810|NCT02335411|Gastroesophageal junction cancer|gastroesophageal junction cancer
201811|NCT02335411|PD1|pd1
201812|NCT02335411|PD-1|pd-1
201813|NCT02335411|PDL1|pdl1
201814|NCT02335411|PD-L1|pd-l1
201815|NCT02335398|methadone|methadone
201816|NCT02335398|chronic pain|chronic pain
201817|NCT02335398|noncancer pain|noncancer pain
201818|NCT02335398|cancer pain|cancer pain
201819|NCT02335398|QTc prolongation|qtc prolongation
201820|NCT02335372|Cervical cancer|cervical cancer
201821|NCT02335372|Cervical neoplasia|cervical neoplasia
201822|NCT02335372|Cervical cancer screening|cervical cancer screening
201823|NCT02335372|Colposcopy|colposcopy
201824|NCT02335372|Wide-field white light imaging|wide-field white light imaging
201825|NCT02335372|Wide-field fluorescence imaging|wide-field fluorescence imaging
201826|NCT02335372|Acetic acid|acetic acid
201827|NCT02335372|Proflavine solution|proflavine solution
201828|NCT02335333|Delayed Graft Function|delayed graft function
201829|NCT02335333|Slow Graft Function|slow graft function
201830|NCT02335333|Renal Transplant|renal transplant
201831|NCT02335333|Extended Criteria Donor|extended criteria donor
201832|NCT02335333|Biomarker of Aging|biomarker of aging
201833|NCT02335333|Kidney Transplant|kidney transplant
201834|NCT02335320|VHC|vhc
201835|NCT02335320|IL28-B|il28-b
201836|NCT02335320|point of care|point of care
201837|NCT02335307|Pain|pain
201838|NCT02335307|CYP2D6|cyp2d6
201839|NCT02335294|Pain|pain
201840|NCT02335294|abdominoplasty|abdominoplasty
201841|NCT02335294|PCA|pca
201842|NCT02335281|Standardized Fecal Microbiota Transplantation|standardized fecal microbiota transplantation
201843|NCT02335281|Inflammatory Bowel Disease|inflammatory bowel disease
201844|NCT02335281|Ulcerative Colitis|ulcerative colitis
201845|NCT02335281|Crohn's Disease|crohn's disease
201846|NCT02335268|MDS classified as IPSS low/int-1|mds classified as ipss low/int-1
201847|NCT02335242|Sildenafil|sildenafil
201848|NCT02335242|Magnetic Resonance Imaging|magnetic resonance imaging
201849|NCT02335242|Dermatology|dermatology
201850|NCT02335242|Pediatrics|pediatrics
201851|NCT02335190|Sacroiliac joint|sacroiliac joint
201852|NCT02335190|Radiofrequency ablation|radiofrequency ablation
201853|NCT02335190|Ultrasound|ultrasound
201854|NCT02335177|Falls|falls
201855|NCT02335177|Elderly|elderly
201856|NCT02335177|Physical activities|physical activities
201857|NCT02335177|Technologies for autonomy|technologies for autonomy
201858|NCT02335177|Impact of intervention|impact of intervention
201859|NCT02335177|autonomy|autonomy
201860|NCT02335177|physical activity program|physical activity program
201861|NCT02335151|Circulating Tumor Cells|circulating tumor cells
201862|NCT02335151|Anesthesia and immunity|anesthesia and immunity
201863|NCT02335151|Cell Search System|cell search system
201864|NCT02335138|HIV|hiv
201865|NCT02335138|MSM|msm
201866|NCT02335138|Couples|couples
201867|NCT02335138|Home Testing|home testing
201868|NCT02335138|Sexual Agreements|sexual agreements
201869|NCT02335112|irreversible electroporation|irreversible electroporation
201870|NCT02335112|Unresectable Head and Neck Neoplasms|unresectable head and neck neoplasms
201871|NCT02335099|hemodialysis|hemodialysis
201872|NCT02335099|vascular access|vascular access
201873|NCT02335099|vascular access patency|vascular access patency
201874|NCT02335099|ticagrelor|ticagrelor
201875|NCT02335099|brilinta|brilinta
201876|NCT02335073|Prognosis|prognosis
201877|NCT02335060|cannabis|cannabis
201878|NCT02335060|Marijuana|marijuana
201879|NCT02335060|THC|thc
201880|NCT02335060|N-acetylcysteine|n-acetylcysteine
201881|NCT02335060|Psychotic Disorders|psychotic disorders
201882|NCT02335047|reliability|reliability
201883|NCT02335047|clinical test|clinical test
201884|NCT02335047|physical therapy|physical therapy
201885|NCT02335034|Osteoarthritis|osteoarthritis
201886|NCT02335034|Knee|knee
201888|NCT02335034|Quality of life|quality of life
201889|NCT02335034|Treatment outcome|treatment outcome
201890|NCT02335034|Musculoskeletal pain|musculoskeletal pain
201891|NCT02334995|solitery rectal ulcer|solitery rectal ulcer
201892|NCT02334995|biofeedback|biofeedback
201893|NCT02334995|dissynergy|dissynergy
201894|NCT02334982|Drug therapy|drug therapy
201895|NCT02334969|ischemic stroke；Naoxintong Capsule|ischemic stroke；naoxintong capsule
201896|NCT02334956|MRI|mri
201897|NCT02334956|Executive Deficits|executive deficits
201898|NCT02334943|Immune Activation|immune activation
201899|NCT02334943|HIV-1 infected subjects|hiv-1 infected subjects
201900|NCT02334943|Undetectable viral load|undetectable viral load
201901|NCT02334943|Causes of Immune Activation in HIV-1 infected patients|causes of immune activation in hiv-1 infected patients
201902|NCT02334943|Forms of Immune Activation|forms of immune activation
201903|NCT02334943|Emergent non-AIDS related comorbidities|emergent non-aids related comorbidities
201904|NCT02334930|propranolol|propranolol
201905|NCT02334930|betablocker|betablocker
201906|NCT02334930|angiogenesis|angiogenesis
201907|NCT02334917|Suture Comparison|suture comparison
201908|NCT02334891|congestive heart failure|congestive heart failure
201909|NCT02334891|heart failure, diastolic|heart failure, diastolic
201910|NCT02334891|heart failure, systolic|heart failure, systolic
201911|NCT02334891|elderly frail|elderly frail
201912|NCT02334891|guideline adherence|guideline adherence
201913|NCT02334878|Stem Cells|stem cells
201914|NCT02334878|Mesenchymal|mesenchymal
201915|NCT02334826|multivessel coronary artery disease|multivessel coronary artery disease
201916|NCT02334826|revascularization|revascularization
201917|NCT02334826|bioresorbable vascular scaffold|bioresorbable vascular scaffold
201918|NCT02334826|percutaneous coronary intervention|percutaneous coronary intervention
201919|NCT02334826|coronary artery bypass grafting|coronary artery bypass grafting
201920|NCT02334800|Palbociclib, PD-0332991, Hepatic Impairment|palbociclib, pd-0332991, hepatic impairment
201921|NCT02334761|Biopsy|biopsy
201922|NCT02334748|Juvenile Rheumatoid arthritis (JRA) chronic|juvenile rheumatoid arthritis (jra) chronic
201923|NCT02334748|systemic inflammatory disorder|systemic inflammatory disorder
201924|NCT02334748|painful joints|painful joints
201925|NCT02334748|inflammation of the synovial membrane|inflammation of the synovial membrane
201926|NCT02334748|auto-immune rheumatoid disease|auto-immune rheumatoid disease
201927|NCT02334748|reactive rheumatoid arthritis|reactive rheumatoid arthritis
201928|NCT02334748|Systemic Juvenile Rheumatoid arthritis (SJRA)|systemic juvenile rheumatoid arthritis (sjra)
201929|NCT02334748|Hereditary Periodic Fevers|hereditary periodic fevers
201930|NCT02334748|Hereditary periodic fever syndrome(HPFS)|hereditary periodic fever syndrome(hpfs)
201931|NCT02334748|Familial Mediterranean fever syndrome(FMFS)|familial mediterranean fever syndrome(fmfs)
201932|NCT02334748|Hyperimmunoglobulinemia D|hyperimmunoglobulinemia d
201933|NCT02334748|Tumor necrosis factor (TNF) receptor-associated periodic syndrome (TRAPS)|tumor necrosis factor (tnf) receptor-associated periodic syndrome (traps)
201934|NCT02334748|Muckle-Wells syndrome (MWS)|muckle-wells syndrome (mws)
201935|NCT02334748|Familial cold auto inflammatory syndrome|familial cold auto inflammatory syndrome
201936|NCT02334735|Melanoma|melanoma
201937|NCT02334735|Immunotherapy|immunotherapy
201938|NCT02334735|DC Vaccine|dc vaccine
201939|NCT02334735|Adjuvant Therapy|adjuvant therapy
201940|NCT02334735|Immunogenicity|immunogenicity
201941|NCT02334696|Vascular Access|vascular access
201942|NCT02334683|Comparison|comparison
201943|NCT02334683|Botulinum toxin treatments|botulinum toxin treatments
201944|NCT02334683|Ultrasound|ultrasound
201945|NCT02334683|Electrophysiologic|electrophysiologic
201946|NCT02334683|Spasticity|spasticity
201947|NCT02334683|Focal dystonia|focal dystonia
201948|NCT02334670|cryptococcal meningitis|cryptococcal meningitis
201949|NCT02334670|HIV|hiv
201950|NCT02334670|AIDS|aids
201951|NCT02334670|Fluconazole|fluconazole
201952|NCT02334657|non-aneurysmal|non-aneurysmal
201953|NCT02334644|Treatment|treatment
201954|NCT02334644|Natural Health Product|natural health product
201955|NCT02334644|Anxiety|anxiety
201956|NCT02334592|the effect of tanning|the effect of tanning
201957|NCT02334592|vitamin D production|vitamin d production
201958|NCT02334579|Radiation|radiation
201959|NCT02334579|Stereotactic Radiosurgery|stereotactic radiosurgery
201960|NCT02334579|Radiotherapy|radiotherapy
201961|NCT02334579|Prostate Tumor|prostate tumor
201962|NCT02334579|Prostate Surgery|prostate surgery
201963|NCT02334579|CyberKnife|cyberknife
201964|NCT02334566|PTSD|ptsd
201965|NCT02334566|Refugee children mental health|refugee children mental health
201966|NCT02334566|community health care|community health care
201967|NCT02334553|COPD|copd
201968|NCT02334553|Chronic bronchitis|chronic bronchitis
201969|NCT02334553|Cystic fibrosis|cystic fibrosis
201970|NCT02334553|Bronchoconstriction|bronchoconstriction
201971|NCT02334553|Perfluorocarbons|perfluorocarbons
201972|NCT02334553|Carbon dioxide|carbon dioxide
201973|NCT02334527|metastatic urothelial carcinoma (UC)|metastatic urothelial carcinoma (uc)
201974|NCT02334527|LCCC 1406|lccc 1406
201975|NCT02334527|Lineberger|lineberger
201976|NCT02334527|palbociclib|palbociclib
201977|NCT02334514|Influenza|influenza
201978|NCT02334514|Viral shedding|viral shedding
201979|NCT02334514|oseltamivir|oseltamivir
201980|NCT02334514|Polymerase Chain Reaction|polymerase chain reaction
201981|NCT02334501|Healthy Volunteers|healthy volunteers
201982|NCT02334462|Assays|assays
201983|NCT02334462|Antibody|antibody
201984|NCT02334462|Reactogenicity|reactogenicity
201985|NCT02334462|Mosquito|mosquito
201986|NCT02334462|Responses|responses
201987|NCT02334449|healthy volunteers|healthy volunteers
201988|NCT02334410|fractures|fractures
201989|NCT02334410|immobilisation|immobilisation
201990|NCT02334410|paraplegia|paraplegia
201991|NCT02334410|tetraplegia|tetraplegia
201992|NCT02334397|Prenatal Exercise|prenatal exercise
201993|NCT02334397|Prenatal Education|prenatal education
201994|NCT02334397|Pregnancy|pregnancy
201995|NCT02334397|Exercise and Birth Outcomes|exercise and birth outcomes
201996|NCT02334397|Education and Birth Outcomes|education and birth outcomes
201997|NCT02334397|Maternal Quality of Life|maternal quality of life
201998|NCT02334397|Birth Satisfaction|birth satisfaction
201999|NCT02334371|Magnetic Resonance Imaging|magnetic resonance imaging
202000|NCT02334371|Positron-Emission Tomography|positron-emission tomography
202001|NCT02334332|Caregiver|caregiver
202002|NCT02334293|Omegaven|omegaven
202003|NCT02334293|parenteral nutrition|parenteral nutrition
202004|NCT02334293|liver disease|liver disease
202005|NCT02334293|liver injury|liver injury
202006|NCT02334280|Community mental health|community mental health
202007|NCT02334280|Health coach|health coach
202008|NCT02334280|Weight loss|weight loss
202009|NCT02334280|Fitness|fitness
202010|NCT02334280|Serious mental illness|serious mental illness
202011|NCT02334280|Health promotion|health promotion
202012|NCT02334254|safety|safety
202013|NCT02334254|rivaroxaban|rivaroxaban
202014|NCT02334254|ticagrel|ticagrel
202015|NCT02334254|triple antithrombotic regimen|triple antithrombotic regimen
202016|NCT02334254|undergoing PCI|undergoing pci
202017|NCT02334241|Sorbact|sorbact
202018|NCT02334241|Best local Cares|best local cares
202019|NCT02334241|DFU|dfu
202020|NCT02334202|Adolescent|adolescent
202021|NCT02334202|Obesity/Psychology|obesity/psychology
202022|NCT02334202|Loss of Control Eating|loss of control eating
202023|NCT02334202|Child|child
202024|NCT02334202|Female|female
202025|NCT02334202|Follow-Up Studies|follow-up studies
202026|NCT02334202|Health Behavior|health behavior
202027|NCT02334202|Health Education|health education
202028|NCT02334202|Humans|humans
202029|NCT02334202|Intervention Studies|intervention studies
202030|NCT02334202|Prospective Studies|prospective studies
202031|NCT02334202|Psychotherapy|psychotherapy
202032|NCT02334202|Risk Factors|risk factors
202033|NCT02334202|Weight Loss|weight loss
202034|NCT02334202|Weight Gain|weight gain
202035|NCT02334202|Military|military
202036|NCT02334163|Hepatic Encephalopathy|hepatic encephalopathy
202037|NCT02334163|Nitazoxanide|nitazoxanide
202038|NCT02334163|Serum ammonia|serum ammonia
202039|NCT02334150|combined spinal-epidural analgesia|combined spinal-epidural analgesia
202040|NCT02334150|pelvic floor muscle|pelvic floor muscle
202041|NCT02334150|postpartum electrophysiological function|postpartum electrophysiological function
202042|NCT02334111|Parenting Support for Mothers in Recovery|parenting support for mothers in recovery
202043|NCT02334111|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
202044|NCT02334111|Social Determinants of Health|social determinants of health
202045|NCT02334111|Child Development|child development
202046|NCT02334111|Child Abuse|child abuse
202047|NCT02334111|Child Neglect|child neglect
202048|NCT02334111|Primary Care|primary care
202049|NCT02334098|Aggression|aggression
202050|NCT02334098|Omega-3 supplementation|omega-3 supplementation
202051|NCT02334098|Neurocognition|neurocognition
202052|NCT02334098|Attention|attention
202053|NCT02334098|Antisocial|antisocial
202054|NCT02334059|opioid sparing|opioid sparing
202055|NCT02334059|ketamine|ketamine
202056|NCT02334059|obese|obese
202057|NCT02334059|magnesium|magnesium
202058|NCT02334046|tracheal extubation|tracheal extubation
202059|NCT02334046|remifentanil|remifentanil
202060|NCT02334033|hypertension|hypertension
202061|NCT02334033|blood pressure|blood pressure
202062|NCT02334033|cystatin C|cystatin c
202063|NCT02334033|real-life|real-life
202064|NCT02334033|kidney|kidney
202065|NCT02334020|Mental illness|mental illness
202066|NCT02334020|training|training
202067|NCT02334020|support|support
202068|NCT02334020|Mental Health|mental health
202069|NCT02334007|venous thromboembolism prophylaxis|venous thromboembolism prophylaxis
202070|NCT02334007|deep vein thrombosis|deep vein thrombosis
202071|NCT02334007|pulmonary embolism|pulmonary embolism
202072|NCT02334007|lung resection|lung resection
202073|NCT02334007|low molecular weight heparin|low molecular weight heparin
202074|NCT02333968|Cancer pain|cancer pain
202075|NCT02333968|Self-management|self-management
202076|NCT02333968|Randomized controlled trial|randomized controlled trial
202077|NCT02333942|Aging|aging
202078|NCT02333942|Diagnostic Equipment|diagnostic equipment
202079|NCT02333929|rivaroxaban|rivaroxaban
202080|NCT02333929|NOAC|noac
202081|NCT02333929|anti-Xa activity|anti-xa activity
202182|NCT02333370|LEE011,|lee011,
202082|NCT02333929|method comparison|method comparison
202083|NCT02333929|LCMS|lcms
202084|NCT02333903|Obesity|obesity
202085|NCT02333903|Sleeve gastrectomy|sleeve gastrectomy
202086|NCT02333903|Personalized physical activity program|personalized physical activity program
202087|NCT02333903|Body Composition|body composition
202088|NCT02333903|Fat mass|fat mass
202089|NCT02333903|Lean mass|lean mass
202090|NCT02333890|breast|breast
202091|NCT02333851|Type 2 diabetes mellitus treatment|type 2 diabetes mellitus treatment
202092|NCT02333851|Hospitalized patients|hospitalized patients
202093|NCT02333838|Cord Cell Transplantation|cord cell transplantation
202094|NCT02333838|High risk myeloid malignancies|high risk myeloid malignancies
202095|NCT02333799|Tuberculosis|tuberculosis
202096|NCT02333799|MDR-TB|mdr-tb
202097|NCT02333799|XDR-TB|xdr-tb
202098|NCT02333799|Multi-drug resistant|multi-drug resistant
202099|NCT02333799|Extensively drug resistant|extensively drug resistant
202100|NCT02333799|Bedaquiline|bedaquiline
202101|NCT02333799|PA-824|pa-824
202102|NCT02333799|Linezolid|linezolid
202103|NCT02333799|TB|tb
202104|NCT02333799|Pretomanid|pretomanid
202105|NCT02333799|TMC-207|tmc-207
202106|NCT02333799|NiX-TB|nix-tb
202107|NCT02333773|irreversible electroporation|irreversible electroporation
202108|NCT02333773|Portal venous tumor emboli|portal venous tumor emboli
202109|NCT02333734|Type 2 diabetes|type 2 diabetes
202110|NCT02333734|Interval training|interval training
202111|NCT02333734|Insulin resistance|insulin resistance
202112|NCT02333734|fat metabolism|fat metabolism
202113|NCT02333721|Stomach Neoplasms|stomach neoplasms
202114|NCT02333721|Laparoscopy|laparoscopy
202115|NCT02333695|SCI, Spinal Cord Injury, Stroke|sci, spinal cord injury, stroke
202116|NCT02333669|Lung fluid absorption disorders|lung fluid absorption disorders
202117|NCT02333669|Neonatal respiratory distress syndrome|neonatal respiratory distress syndrome
202118|NCT02333669|Single nucleotide polymorphism|single nucleotide polymorphism
202119|NCT02333669|SCNN1A|scnn1a
202120|NCT02333630|asthma|asthma
202121|NCT02333617|Manual Therapy|manual therapy
202122|NCT02333617|Physical Therapy|physical therapy
202123|NCT02333617|Dry Needling|dry needling
202124|NCT02333617|Gluteus Medius|gluteus medius
202125|NCT02333604|cancer|cancer
202126|NCT02333604|cancer survivorship|cancer survivorship
202127|NCT02333604|psychosocial needs|psychosocial needs
202128|NCT02333604|cancer experience|cancer experience
202129|NCT02333604|metastatic breast cancer|metastatic breast cancer
202130|NCT02333604|multiple myeloma|multiple myeloma
202131|NCT02333604|chronic myeloid leukemia|chronic myeloid leukemia
202132|NCT02333604|breast cancer|breast cancer
202133|NCT02333604|Prostate|prostate
202134|NCT02333604|Colon|colon
202135|NCT02333604|Kidney|kidney
202136|NCT02333604|Lung|lung
202137|NCT02333604|Melanoma|melanoma
202138|NCT02333604|Caregiver|caregiver
202139|NCT02333604|gastric cancer|gastric cancer
202140|NCT02333604|stomach cancer|stomach cancer
202141|NCT02333604|chronic lymphocytic leukemia|chronic lymphocytic leukemia
202142|NCT02333552|Frailty|frailty
202143|NCT02333552|Pre-frailty|pre-frailty
202144|NCT02333552|Fit|fit
202145|NCT02333552|Robust|robust
202146|NCT02333552|Elderly|elderly
202147|NCT02333552|Sociodemography status|sociodemography status
202148|NCT02333552|Functional status|functional status
202149|NCT02333552|Cognitive status|cognitive status
202150|NCT02333552|Nutrition status|nutrition status
202151|NCT02333552|Comorbidity|comorbidity
202152|NCT02333552|Mortality|mortality
202153|NCT02333552|Depression status|depression status
202154|NCT02333526|ulcerative colitis|ulcerative colitis
202155|NCT02333526|Clostidium difficile-associated colitis|clostidium difficile-associated colitis
202156|NCT02333526|Syndecan-1|syndecan-1
202157|NCT02333526|biomarker|biomarker
202158|NCT02333474|mix vaccine, lung neoplasms, immunotherapy|mix vaccine, lung neoplasms, immunotherapy
202159|NCT02333435|Prostatectomy|prostatectomy
202160|NCT02333435|Omega-3 fatty acids|omega-3 fatty acids
202161|NCT02333435|Quality of life|quality of life
202162|NCT02333435|inflammation|inflammation
202163|NCT02333435|cellular proliferation|cellular proliferation
202164|NCT02333422|NIRS Neurofeedback|nirs neurofeedback
202165|NCT02333422|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
202166|NCT02333422|Near Infrared Spectroscopy|near infrared spectroscopy
202167|NCT02333422|ADHD|adhd
202168|NCT02333409|Cancer of pancreas|cancer of pancreas
202169|NCT02333409|Acupuncture|acupuncture
202170|NCT02333409|Pain|pain
202171|NCT02333396|Navigator|navigator
202172|NCT02333396|Intervention Study|intervention study
202173|NCT02333396|Randomized Controlled Trial|randomized controlled trial
202174|NCT02333396|Pediatric Intensive Care Unit|pediatric intensive care unit
202175|NCT02333396|Decision Making|decision making
202176|NCT02333383|Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) score|bath ankylosing spondylitis disease activity index (basdai) score
202177|NCT02333383|EAMs|eams
202178|NCT02333383|Adalimumab|adalimumab
202179|NCT02333370|Advanced breast cancer|advanced breast cancer
202180|NCT02333370|Hormone receptor positive|hormone receptor positive
202181|NCT02333370|HER2-negative|her2-negative
202183|NCT02333370|Letrozole|letrozole
202184|NCT02333370|Tamoxifen|tamoxifen
202185|NCT02333370|Fulvestrant|fulvestrant
202186|NCT02333370|Postmenopausal Asian women|postmenopausal asian women
202187|NCT02333370|Pre and Postmenopausal Japanese women|pre and postmenopausal japanese women
202188|NCT02333344|prosthetic fixation|prosthetic fixation
202189|NCT02333331|Sarcopenia, muscle wasting, elderly, strength, physical function, muscle, gait speed|sarcopenia, muscle wasting, elderly, strength, physical function, muscle, gait speed
202190|NCT02333305|Ataxia with Oculomotor Apraxia type 1|ataxia with oculomotor apraxia type 1
202191|NCT02333305|CoQ10|coq10
202192|NCT02333305|hypoalbuminemia|hypoalbuminemia
202193|NCT02333266|Candida bloodstream infection|candida bloodstream infection
202194|NCT02333266|Detection fungal cells|detection fungal cells
202195|NCT02333266|Fiber-Optic Surface Plasmon Resonance (FO-SPR)|fiber-optic surface plasmon resonance (fo-spr)
202196|NCT02333253|poor responders|poor responders
202197|NCT02333253|GnRH antagonist|gnrh antagonist
202198|NCT02333253|Conventional protocol|conventional protocol
202199|NCT02333240|Pregnancy|pregnancy
202200|NCT02333240|Postnatal Care|postnatal care
202201|NCT02333240|Blood Pressure Monitoring, Home|blood pressure monitoring, home
202202|NCT02333240|Self Care|self care
202203|NCT02333240|Pregnancy Complications, Cardiovascular|pregnancy complications, cardiovascular
202204|NCT02333240|Qualitative Research|qualitative research
202205|NCT02333240|Antihypertensive Agents|antihypertensive agents
202206|NCT02333214|Virtual Reality Therapy|virtual reality therapy
202207|NCT02333214|Video Game|video game
202208|NCT02333214|Physical Exercise|physical exercise
202209|NCT02333214|Aged|aged
202210|NCT02333214|Frailty|frailty
202211|NCT02333201|Deglutition Disorders|deglutition disorders
202212|NCT02333201|Dysphagia|dysphagia
202213|NCT02333201|Mechanical Ventilation|mechanical ventilation
202214|NCT02333201|Sepsis|sepsis
202215|NCT02333175|Parkinson's disease, Late stage|parkinson's disease, late stage
202216|NCT02333149|Melatonin|melatonin
202217|NCT02333071|HSDD|hsdd
202218|NCT02333071|Female Sexual Desire Disorder|female sexual desire disorder
202219|NCT02333058|ALL|all
202220|NCT02333058|AML|aml
202221|NCT02333058|MDS|mds
202222|NCT02333058|JMML|jmml
202223|NCT02333045|HIV-negative|hiv-negative
202224|NCT02333045|Women|women
202225|NCT02333045|At-risk|at-risk
202226|NCT02333019|risk|risk
202227|NCT02333006|Anosognosia|anosognosia
202228|NCT02332993|FPP (Fermented Papaya Preparation)|fpp (fermented papaya preparation)
202229|NCT02332993|Negative Pressure Therapy|negative pressure therapy
202230|NCT02332993|Wound Vac|wound vac
202231|NCT02332993|Wound|wound
202232|NCT02332993|Type II Diabetic|type ii diabetic
202233|NCT02332954|Depression|depression
202234|NCT02332954|Major Depressive Disorder|major depressive disorder
202235|NCT02332954|Cognition|cognition
202236|NCT02332954|Cognitive symptoms|cognitive symptoms
202237|NCT02332954|vortioxetine|vortioxetine
202238|NCT02332954|real life|real life
202239|NCT02332954|naturalistic|naturalistic
202240|NCT02332915|apraxia|apraxia
202241|NCT02332915|aphasia|aphasia
202242|NCT02332915|rehabilitation|rehabilitation
202243|NCT02332915|efficacy|efficacy
202244|NCT02332915|intensity|intensity
202245|NCT02332902|Neurofibroma|neurofibroma
202246|NCT02332902|NF-1|nf-1
202247|NCT02332902|Everolimus|everolimus
202248|NCT02332902|mTOR inhibitor|mtor inhibitor
202249|NCT02332863|Pancreatic cancer|pancreatic cancer
202250|NCT02332863|Image guided radiation therapy|image guided radiation therapy
202251|NCT02332863|Fiducial marker placement|fiducial marker placement
202252|NCT02332863|Endoscopic ultrasound|endoscopic ultrasound
202253|NCT02332850|Relapsed|relapsed
202254|NCT02332850|Refractory|refractory
202255|NCT02332837|informed consent, public led trials, shared decision making,|informed consent, public led trials, shared decision making,
202256|NCT02332824|Pharmacological therapy|pharmacological therapy
202257|NCT02332798|Multiple ascending doses|multiple ascending doses
202258|NCT02332798|safety|safety
202259|NCT02332798|tolerability|tolerability
202260|NCT02332798|pharmacokinetics|pharmacokinetics
202261|NCT02332798|cognitive impairment associated with schizophrenia (CIAS)|cognitive impairment associated with schizophrenia (cias)
202262|NCT02332785|Colon Serrated Polyps|colon serrated polyps
202263|NCT02332785|Serrated polyp|serrated polyp
202264|NCT02332785|Hyperplastic polyps above sigmoid colon|hyperplastic polyps above sigmoid colon
202265|NCT02332785|Sessile serrated adenoma|sessile serrated adenoma
202266|NCT02332785|Traditional serrated adenoma|traditional serrated adenoma
202267|NCT02332785|Colonoscopy|colonoscopy
202268|NCT02332785|Endoscopy|endoscopy
202269|NCT02332785|Data collection|data collection
202270|NCT02332785|Data review|data review
202271|NCT02332772|Colon Polyps|colon polyps
202272|NCT02332772|Large polyps|large polyps
202273|NCT02332772|Flat lesions|flat lesions
202274|NCT02332772|Endoscopy|endoscopy
202275|NCT02332772|Colonoscopic resection|colonoscopic resection
202276|NCT02332772|Colonoscopy|colonoscopy
202277|NCT02332772|Data review|data review
202278|NCT02332772|Data collection|data collection
202279|NCT02332668|PD1|pd1
202280|NCT02332668|PD-1|pd-1
202281|NCT02332668|PDL1|pdl1
202282|NCT02332668|PD-L1|pd-l1
202283|NCT02332668|cHL|chl
202284|NCT02332668|MSI-H|msi-h
202285|NCT02332655|Sturge-Weber syndrome|sturge-weber syndrome
202286|NCT02332655|SWS|sws
202287|NCT02332655|Drug resistant epilepsy|drug resistant epilepsy
202288|NCT02332629|Glucocorticoid|glucocorticoid
202289|NCT02332629|Endothelial barrier|endothelial barrier
202290|NCT02332629|Glycocalyx|glycocalyx
202291|NCT02332629|Knee arthroplasty, total|knee arthroplasty, total
202292|NCT02332616|Glucocorticoid|glucocorticoid
202293|NCT02332616|Complement activation|complement activation
202294|NCT02332616|Knee arthroplasty, total|knee arthroplasty, total
202295|NCT02332603|Glucocorticoid|glucocorticoid
202296|NCT02332603|Glucose homeostasis|glucose homeostasis
202297|NCT02332603|Knee arthroplasty, total|knee arthroplasty, total
202298|NCT02332603|Hip arthroplasty, total|hip arthroplasty, total
202299|NCT02332564|Circulation, Collateral|circulation, collateral
202300|NCT02332564|Coronary Artery Disease|coronary artery disease
202301|NCT02332564|Internal Mammary-Coronary Artery Anastomosis|internal mammary-coronary artery anastomosis
202302|NCT02332564|Ischemia|ischemia
202303|NCT02332538|LASER|laser
202304|NCT02332538|PROSTATE|prostate
202305|NCT02332538|BIPOLAR|bipolar
202306|NCT02332538|HYPERPLASIA|hyperplasia
202307|NCT02332538|VAPORIZATION|vaporization
202308|NCT02332525|Oral Vibrational Stimulation|oral vibrational stimulation
202309|NCT02332525|Cognitive Function|cognitive function
202310|NCT02332525|Mild Cognitive Impairment|mild cognitive impairment
202311|NCT02332525|cognitive normal elderly|cognitive normal elderly
202312|NCT02332512|Non-squamous non-small cell lung cancer|non-squamous non-small cell lung cancer
202313|NCT02332512|Wild-type EGFR|wild-type egfr
202314|NCT02332512|3rd/4th line treatment|3rd/4th line treatment
202315|NCT02332512|apatinib|apatinib
202316|NCT02332499|Anlotinib|anlotinib
202317|NCT02332499|Metastatic Colorectal Cancer （mCRC）|metastatic colorectal cancer （mcrc）
202318|NCT02332499|ALTER0703|alter0703
202319|NCT02332447|Tonic-clonic seizures|tonic-clonic seizures
202320|NCT02332447|Naloxone|naloxone
202321|NCT02332447|SUDEP|sudep
202322|NCT02332421|canine retraction|canine retraction
202323|NCT02332421|acceleration of tooth movement|acceleration of tooth movement
202324|NCT02332421|dentoalveolar distraction osteogenesis|dentoalveolar distraction osteogenesis
202325|NCT02332408|vertebral hemangioma|vertebral hemangioma
202326|NCT02332408|conventional radiotherapy|conventional radiotherapy
202327|NCT02332408|Cyber Knife radiotherapy|cyber knife radiotherapy
202328|NCT02332408|randomized trial|randomized trial
202329|NCT02332408|radioablation|radioablation
202330|NCT02332395|pain|pain
202331|NCT02332395|pain catastrophizing|pain catastrophizing
202332|NCT02332395|cesarean section|cesarean section
202333|NCT02332369|Cataract|cataract
202334|NCT02332356|Crohn Disease|crohn disease
202335|NCT02332356|Inflammatory Bowel Diseases|inflammatory bowel diseases
202336|NCT02332356|Disease Attributes|disease attributes
202337|NCT02332343|Retina|retina
202338|NCT02332343|Retinal pigment epithelium|retinal pigment epithelium
202339|NCT02332317|Advanced cancer|advanced cancer
202340|NCT02332317|Early integration|early integration
202341|NCT02332317|Palliative rehabilitation|palliative rehabilitation
202342|NCT02332304|Respiratory Distress Syndrome, Newborn|respiratory distress syndrome, newborn
202343|NCT02332291|Depression|depression
202344|NCT02332291|Geriatrics|geriatrics
202345|NCT02332291|Elderly|elderly
202346|NCT02332291|MRI|mri
202347|NCT02332291|Antidepressants|antidepressants
202348|NCT02332278|Cesarean section|cesarean section
202349|NCT02332278|Early feeding|early feeding
202350|NCT02332265|Food Security|food security
202351|NCT02332265|Microfinance|microfinance
202352|NCT02332265|Village Savings and Loans|village savings and loans
202353|NCT02332265|HIV|hiv
202354|NCT02332265|Quasi-experimental design|quasi-experimental design
202355|NCT02332265|Malawi|malawi
202356|NCT02332265|Structural intervention|structural intervention
202357|NCT02332252|Surgical Wound Infection|surgical wound infection
202358|NCT02332252|Electrocautery|electrocautery
202359|NCT02332252|Scalpel|scalpel
202360|NCT02332239|depression|depression
202361|NCT02332239|violence|violence
202362|NCT02332239|emergency department|emergency department
202363|NCT02332239|mhealth|mhealth
202364|NCT02332239|text message|text message
202365|NCT02332213|Volatile organic compounds|volatile organic compounds
202366|NCT02332213|Nanosensor technology|nanosensor technology
202367|NCT02332213|GC-MS|gc-ms
202368|NCT02332213|Breath-testing|breath-testing
202369|NCT02332213|Digestive cancer|digestive cancer
202370|NCT02332213|Precancerous lesions|precancerous lesions
202371|NCT02332213|Colorectal cancer|colorectal cancer
202372|NCT02332213|Adenoma|adenoma
202373|NCT02332213|Gastric cancer|gastric cancer
202374|NCT02332213|Atrophic gastritis|atrophic gastritis
202375|NCT02332213|OLGIM|olgim
202376|NCT02332200|Spondylolysis|spondylolysis
202377|NCT02332200|Spondylolisthesis|spondylolisthesis
202378|NCT02332200|Low Back Pain|low back pain
202379|NCT02332174|pharmacokinetics|pharmacokinetics
202380|NCT02332174|food effect|food effect
202381|NCT02332174|sex effect|sex effect
202382|NCT02332174|tolerability|tolerability
202383|NCT02332135|microwave ablation|microwave ablation
202384|NCT02332135|maintenance hemodialysis|maintenance hemodialysis
202385|NCT02332135|mild-to-moderate Secondary Hyperparathyroidism|mild-to-moderate secondary hyperparathyroidism
202386|NCT02332122|COPD|copd
202387|NCT02332122|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
202388|NCT02332122|Aspergillus fumigatus|aspergillus fumigatus
202389|NCT02332122|Bronchiectasis|bronchiectasis
202390|NCT02332122|Sensitization|sensitization
202391|NCT02332122|Vitamin D|vitamin d
202392|NCT02332109|Fuchs endothelial dystrophy|fuchs endothelial dystrophy
202393|NCT02332109|oedema|oedema
202394|NCT02332109|sodium chloride|sodium chloride
202395|NCT02332109|hyaluronan|hyaluronan
202396|NCT02332109|sodium hyaluronate|sodium hyaluronate
202397|NCT02332070|acute kidney injury|acute kidney injury
202398|NCT02332070|coronary angiography|coronary angiography
202399|NCT02332070|cardiac surgery|cardiac surgery
202400|NCT02332070|adverse events|adverse events
202401|NCT02332070|iodinated contrast|iodinated contrast
202402|NCT02332070|Thoracic Surgery|thoracic surgery
202403|NCT02332057|IUD,Diclofenac , Lidocaine|iud,diclofenac , lidocaine
202404|NCT02332031|Sorafenib, levothyroxine, drug interaction, pharmacokinetics, healthy volunteer|sorafenib, levothyroxine, drug interaction, pharmacokinetics, healthy volunteer
202405|NCT02331992|Continuous Positive Airway Pressure|continuous positive airway pressure
202406|NCT02331966|FGF-23|fgf-23
202407|NCT02331966|GROWTH FACTORS RECEPTORS|growth factors receptors
202408|NCT02331966|RECURRENCES|recurrences
202409|NCT02331953|spine surgery|spine surgery
202410|NCT02331953|cerebral oximetry|cerebral oximetry
202411|NCT02331953|postoperative delirium|postoperative delirium
202412|NCT02331940|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
202413|NCT02331940|sleeping oxygen saturation|sleeping oxygen saturation
202414|NCT02331940|sleep quality|sleep quality
202415|NCT02331927|colorectal cancer|colorectal cancer
202416|NCT02331927|marker-driven|marker-driven
202417|NCT02331927|bevacizumab|bevacizumab
202418|NCT02331927|aflibercept|aflibercept
202419|NCT02331927|cytokines|cytokines
202420|NCT02331927|angiogenic factors|angiogenic factors
202421|NCT02331927|CAF|caf
202422|NCT02331914|GIST|gist
202423|NCT02331914|Bio-databank|bio-databank
202424|NCT02331862|urinary tract infection|urinary tract infection
202425|NCT02331862|methylprednisolone|methylprednisolone
202426|NCT02331849|Eosinophilic esophagitis (EoE)|eosinophilic esophagitis (eoe)
202427|NCT02331849|GERD|gerd
202428|NCT02331849|esophageal motility|esophageal motility
202429|NCT02331836|adenoma detection rate|adenoma detection rate
202430|NCT02331836|polyp detection rate|polyp detection rate
202431|NCT02331836|withdrawal time|withdrawal time
202432|NCT02331836|coecal and ileum intubation rate|coecal and ileum intubation rate
202433|NCT02331797|endoscope|endoscope
202434|NCT02331797|microscope|microscope
202435|NCT02331797|transcanal|transcanal
202436|NCT02331719|intracerebral hemorrhage|intracerebral hemorrhage
202437|NCT02331719|subcortical intracerebral hemorrhage|subcortical intracerebral hemorrhage
202438|NCT02331719|ICH|ich
202439|NCT02331719|parafascicular minimally invasive subcortical access|parafascicular minimally invasive subcortical access
202440|NCT02331693|EGFR|egfr
202441|NCT02331693|CAR T cells|car t cells
202442|NCT02331693|glioma|glioma
202443|NCT02331680|Undergoing Hemodialysis|undergoing hemodialysis
202444|NCT02331680|Undergoing Hemodiafiltration|undergoing hemodiafiltration
202445|NCT02331667|Diet|diet
202446|NCT02331667|Vitamin-D|vitamin-d
202447|NCT02331667|Meat|meat
202448|NCT02331667|Fatty fish|fatty fish
202449|NCT02331667|Iodine|iodine
202450|NCT02331667|fatty acid|fatty acid
202451|NCT02331667|Intervention study|intervention study
202452|NCT02331667|Wechsler Preschool and Primary Scale of Intelligence|wechsler preschool and primary scale of intelligence
202453|NCT02331667|Strengths and Difficulties Questionnaire|strengths and difficulties questionnaire
202454|NCT02331667|Nine hole peg test|nine hole peg test
202455|NCT02331654|Chronic pain|chronic pain
202456|NCT02331654|Direct Current Stimulation|direct current stimulation
202457|NCT02331641|hepatectomy|hepatectomy
202458|NCT02331641|hepatic resection|hepatic resection
202459|NCT02331628|TBI Traumatic Brain Injury|tbi traumatic brain injury
202460|NCT02331628|HO Heterotopic Ossification|ho heterotopic ossification
202461|NCT02331628|NHO Neurogenic Heterotopic Ossification|nho neurogenic heterotopic ossification
202462|NCT02331628|ESWT Extracorporeal Shock Wave Therapy|eswt extracorporeal shock wave therapy
202463|NCT02331615|Traumatic Brain Injury|traumatic brain injury
202464|NCT02331615|Executive function difficulties|executive function difficulties
202465|NCT02331615|Transcranial direct current stimulation|transcranial direct current stimulation
202466|NCT02331602|atrial fibrillation|atrial fibrillation
202467|NCT02331602|anticoagulation|anticoagulation
202468|NCT02331602|inflammation|inflammation
202469|NCT02331589|Fatigue|fatigue
202470|NCT02331589|Panax ginseng|panax ginseng
202471|NCT02331589|Chronic hepatitis|chronic hepatitis
202472|NCT02331589|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
202473|NCT02331589|Adiponectin|adiponectin
202474|NCT02331563|dexmedetomidine|dexmedetomidine
202673|NCT02330354|nutrition|nutrition
202475|NCT02331550|Low-Grade Squamous Intraepithelial Lesions|low-grade squamous intraepithelial lesions
202476|NCT02331524|exercise|exercise
202477|NCT02331524|daily activity|daily activity
202478|NCT02331485|Prevention of wound infection and wound complication|prevention of wound infection and wound complication
202479|NCT02331472|interstitial cystitis|interstitial cystitis
202480|NCT02331472|biomarker|biomarker
202481|NCT02331459|mood|mood
202482|NCT02331459|cognitive state|cognitive state
202483|NCT02331459|physical activity|physical activity
202484|NCT02331459|frailty|frailty
202485|NCT02331394|Chinese herbs|chinese herbs
202486|NCT02331394|lung cancer|lung cancer
202487|NCT02331394|quality of life|quality of life
202488|NCT02331355|amputation, hand, forearm, arm, traumatic, transplantation|amputation, hand, forearm, arm, traumatic, transplantation
202489|NCT02331342|Agreement of NICOM and Innocor|agreement of nicom and innocor
202490|NCT02331329|Accuracy of NICOM|accuracy of nicom
202491|NCT02331329|precision of NICOM|precision of nicom
202492|NCT02331316|obesity|obesity
202493|NCT02331316|diet|diet
202494|NCT02331316|weight|weight
202495|NCT02331316|hunger|hunger
202496|NCT02331316|public led trial|public led trial
202497|NCT02331264|Cardiac Toxicity|cardiac toxicity
202498|NCT02331264|Metal on Metal Hip Implants|metal on metal hip implants
202499|NCT02331186|Obesity|obesity
202500|NCT02331186|Bariatric surgery|bariatric surgery
202501|NCT02331186|Urinary incontinence|urinary incontinence
202502|NCT02331186|Pelvic floor|pelvic floor
202503|NCT02331173|XLRS|xlrs
202504|NCT02331173|RS1|rs1
202505|NCT02331173|maculoschisis|maculoschisis
202506|NCT02331160|Pregnancy|pregnancy
202507|NCT02331160|Breech Presentation|breech presentation
202508|NCT02331160|Version, fetal|version, fetal
202509|NCT02331160|Musculoskeletal Manipulations|musculoskeletal manipulations
202510|NCT02331160|Medicine, Traditional|medicine, traditional
202511|NCT02331134|Tissue|tissue
202512|NCT02331134|Hematopoietic Stem Cell|hematopoietic stem cell
202513|NCT02331134|Melanoma|melanoma
202514|NCT02331134|Squamous Head and Neck Cancer|squamous head and neck cancer
202515|NCT02331121|children|children
202516|NCT02331121|parents|parents
202517|NCT02331121|internet|internet
202518|NCT02331121|video|video
202519|NCT02331121|training|training
202520|NCT02331121|interactive|interactive
202521|NCT02331082|Infant Mortality|infant mortality
202522|NCT02331082|Under-two mortality|under-two mortality
202523|NCT02331082|Maternal Mortality|maternal mortality
202524|NCT02331082|Implementation Research|implementation research
202525|NCT02331082|Health Systems Strengthening|health systems strengthening
202526|NCT02331082|Chronic Disease Management|chronic disease management
202527|NCT02331082|Commuity Health Workers|commuity health workers
202528|NCT02331069|radial neuropathy|radial neuropathy
202529|NCT02331056|Stroke volume variation|stroke volume variation
202530|NCT02331056|fluid responsiveness|fluid responsiveness
202531|NCT02331056|One-lung ventilation|one-lung ventilation
202532|NCT02331056|thoracotomy|thoracotomy
202533|NCT02331030|brachio-axillary|brachio-axillary
202534|NCT02331030|brachio-basilic|brachio-basilic
202535|NCT02331030|interfascial plane block|interfascial plane block
202536|NCT02331030|Pecs II block|pecs ii block
202537|NCT02331030|supraclavicular brachial plexus block|supraclavicular brachial plexus block
202538|NCT02331017|Bimodal|bimodal
202539|NCT02331017|Cochlear Implant|cochlear implant
202540|NCT02331017|Hearing aid|hearing aid
202541|NCT02331017|Auditory Perception|auditory perception
202542|NCT02331004|Frail Elderly|frail elderly
202543|NCT02331004|Motor Skills|motor skills
202544|NCT02331004|Upper Extremity|upper extremity
202545|NCT02330991|glioblastoma|glioblastoma
202546|NCT02330991|relapse|relapse
202547|NCT02330991|Temozolomide|temozolomide
202548|NCT02330991|glioblastoma at first relapse|glioblastoma at first relapse
202549|NCT02330965|clinical research|clinical research
202550|NCT02330965|mechanistic studies|mechanistic studies
202551|NCT02330965|blood draw|blood draw
202552|NCT02330965|CSF by lumbar puncture (optional)|csf by lumbar puncture (optional)
202553|NCT02330952|Double-blind method|double-blind method
202554|NCT02330952|Randomized Controlled trials|randomized controlled trials
202555|NCT02330939|Postprandial glycemia|postprandial glycemia
202556|NCT02330939|Momounsaturated fatty acids|momounsaturated fatty acids
202557|NCT02330939|Saturated fatty acids|saturated fatty acids
202558|NCT02330939|Glycemic index|glycemic index
202559|NCT02330939|Glycemic load|glycemic load
202560|NCT02330939|Sensor augmented pump system|sensor augmented pump system
202561|NCT02330926|Combined modality treatment|combined modality treatment
202562|NCT02330926|Diet therapy|diet therapy
202563|NCT02330926|Exercise therapy|exercise therapy
202564|NCT02330926|Ibuprofen|ibuprofen
202565|NCT02330926|Dietary supplements|dietary supplements
202566|NCT02330913|total gastrectomy|total gastrectomy
202567|NCT02330913|intracorporeal|intracorporeal
202568|NCT02330913|totally laparoscopic|totally laparoscopic
202569|NCT02330913|esophagojejunostomy|esophagojejunostomy
202570|NCT02330913|anastomosis|anastomosis
202571|NCT02330900|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
202877|NCT02328963|Everolimus|everolimus
202572|NCT02330900|Electromagnetic interference|electromagnetic interference
202573|NCT02330900|Cell phone|cell phone
202574|NCT02330887|Maternal Mortality|maternal mortality
202575|NCT02330887|Institutional Birth Rate|institutional birth rate
202576|NCT02330887|Neonatal Mortality Rate|neonatal mortality rate
202577|NCT02330887|Preterm Birth|preterm birth
202578|NCT02330887|Stillbirth|stillbirth
202579|NCT02330887|Infant, Small for Gestational Age|infant, small for gestational age
202580|NCT02330887|Nepal|nepal
202581|NCT02330887|Implementation Research|implementation research
202582|NCT02330887|Global Health|global health
202583|NCT02330874|Risk|risk
202584|NCT02330874|score|score
202585|NCT02330874|readmission|readmission
202586|NCT02330874|ICU|icu
202587|NCT02330861|Coronary Circulation|coronary circulation
202588|NCT02330848|Obesity|obesity
202589|NCT02330848|Walnuts|walnuts
202590|NCT02330848|Endothelial Function|endothelial function
202591|NCT02330848|Adults at risk|adults at risk
202592|NCT02330835|school|school
202593|NCT02330835|bus|bus
202594|NCT02330835|school bus|school bus
202595|NCT02330835|driver|driver
202596|NCT02330835|training|training
202597|NCT02330835|behavior|behavior
202598|NCT02330835|management|management
202599|NCT02330835|interactive|interactive
202600|NCT02330835|computer|computer
202601|NCT02330809|headache|headache
202602|NCT02330809|hunger intensity|hunger intensity
202603|NCT02330809|public led online trial|public led online trial
202604|NCT02330809|water intake|water intake
202605|NCT02330783|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
202606|NCT02330783|Third-line treatment|third-line treatment
202607|NCT02330783|Sorafenib|sorafenib
202608|NCT02330783|Bevacizumab|bevacizumab
202609|NCT02330770|GnRHa trigger|gnrha trigger
202610|NCT02330770|Luteal phase support|luteal phase support
202611|NCT02330770|OHSS|ohss
202612|NCT02330757|Frozen-thawed embryo transfer|frozen-thawed embryo transfer
202613|NCT02330757|FET protocols|fet protocols
202614|NCT02330705|Intrauterine insemination|intrauterine insemination
202615|NCT02330705|IUI|iui
202616|NCT02330705|HCG|hcg
202617|NCT02330679|Major Depression, Neuroimaging, Desvenlafaxine, Machine learning|major depression, neuroimaging, desvenlafaxine, machine learning
202618|NCT02330653|Colitis|colitis
202619|NCT02330653|Fecal Microbiota Transplant|fecal microbiota transplant
202620|NCT02330653|Ulcerative colitis|ulcerative colitis
202621|NCT02330653|inflammatory bowel disease|inflammatory bowel disease
202622|NCT02330640|CABG|cabg
202623|NCT02330640|antiplatelet therapy|antiplatelet therapy
202624|NCT02330640|ticagrelor|ticagrelor
202625|NCT02330614|personality|personality
202626|NCT02330614|bleaching|bleaching
202627|NCT02330588|Obesity|obesity
202628|NCT02330588|Prevention|prevention
202629|NCT02330588|Pediatric|pediatric
202630|NCT02330588|Parents|parents
202631|NCT02330588|Primary Care|primary care
202632|NCT02330588|eHealth|ehealth
202633|NCT02330588|Internet|internet
202634|NCT02330562|Marizomib|marizomib
202635|NCT02330562|Bevacizumab|bevacizumab
202636|NCT02330562|Avastin|avastin
202637|NCT02330562|Grade IV malignant glioma|grade iv malignant glioma
202638|NCT02330562|proteasome inhibitor|proteasome inhibitor
202639|NCT02330562|glioblastoma|glioblastoma
202640|NCT02330562|brain tumor|brain tumor
202641|NCT02330562|malignant glioma|malignant glioma
202642|NCT02330562|brain cancer|brain cancer
202643|NCT02330562|gliosarcoma|gliosarcoma
202644|NCT02330562|BEV|bev
202645|NCT02330536|Circulatory and Respiratory Physiological Phenomena|circulatory and respiratory physiological phenomena
202646|NCT02330536|Thoracoscopy|thoracoscopy
202647|NCT02330510|Alzheimer's Disease|alzheimer's disease
202648|NCT02330510|White Matter Hyperintensities|white matter hyperintensities
202649|NCT02330510|Vascular Cognitive Impairment|vascular cognitive impairment
202650|NCT02330510|Amyloid Imaging|amyloid imaging
202651|NCT02330510|Transient Ischemic Attack|transient ischemic attack
202652|NCT02330484|Community management， incentives, Medication Adherence|community management， incentives, medication adherence
202653|NCT02330471|conization|conization
202654|NCT02330471|LLETZ|lletz
202655|NCT02330471|cervical dysplasia|cervical dysplasia
202656|NCT02330471|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
202657|NCT02330458|Inflammatory Bowel Disease|inflammatory bowel disease
202658|NCT02330458|Crohn's disease|crohn's disease
202659|NCT02330458|Pediatric IBD|pediatric ibd
202660|NCT02330458|small bowel ultrasound|small bowel ultrasound
202661|NCT02330458|infliximab|infliximab
202662|NCT02330419|Naltrexone|naltrexone
202663|NCT02330406|Dipeptidyl-Peptidase 4 Inhibitors|dipeptidyl-peptidase 4 inhibitors
202664|NCT02330406|LDL Cholesterol|ldl cholesterol
202665|NCT02330406|Glycosylated Hemoglobin|glycosylated hemoglobin
202666|NCT02330406|Diabetes Mellitus|diabetes mellitus
202667|NCT02330406|Coronary Disease|coronary disease
202668|NCT02330380|psoriasis, comparative effects, inflammation|psoriasis, comparative effects, inflammation
202669|NCT02330354|preschool|preschool
202670|NCT02330354|behavior change|behavior change
202671|NCT02330354|social marketing|social marketing
202672|NCT02330354|child care providers|child care providers
202674|NCT02330354|child care centers|child care centers
202675|NCT02330354|physical activity|physical activity
202676|NCT02330341|Glucose Intolerance|glucose intolerance
202677|NCT02330341|Artemisia dracunculus|artemisia dracunculus
202678|NCT02330341|Insulin|insulin
202679|NCT02330328|Chest Pain|chest pain
202680|NCT02330328|Telemetry|telemetry
202681|NCT02330315|transcranial direct current stimulation|transcranial direct current stimulation
202682|NCT02330315|transcranial ultrasound|transcranial ultrasound
202683|NCT02330315|non-invasive brain stimulation|non-invasive brain stimulation
202684|NCT02330250|Systemic Lupus Erythematosus|systemic lupus erythematosus
202685|NCT02330250|Pharmaceutical care|pharmaceutical care
202686|NCT02330250|Pharmaceutical services|pharmaceutical services
202687|NCT02330250|Medication adherence|medication adherence
202688|NCT02330224|Blood pressure|blood pressure
202689|NCT02330224|Lipids|lipids
202690|NCT02330224|Cardiovascular|cardiovascular
202691|NCT02330224|Health services|health services
202692|NCT02330224|Hypertension|hypertension
202693|NCT02330211|Colitis|colitis
202694|NCT02330211|Fecal Microbiota Transplant|fecal microbiota transplant
202695|NCT02330211|Crohn's Disease|crohn's disease
202696|NCT02330211|inflammatory bowel disease|inflammatory bowel disease
202697|NCT02330198|self-reported outcome instrument|self-reported outcome instrument
202698|NCT02330185|spinal anesthesia|spinal anesthesia
202699|NCT02330185|ultrasonography|ultrasonography
202700|NCT02330185|anatomical landmark|anatomical landmark
202701|NCT02330159|Pilonidal|pilonidal
202702|NCT02330159|Quality of Life|quality of life
202703|NCT02330133|mid-life women|mid-life women
202704|NCT02330133|unintended pregnancy|unintended pregnancy
202705|NCT02330133|STI/HIV prevention|sti/hiv prevention
202706|NCT02330133|intervention|intervention
202707|NCT02330133|interactive|interactive
202708|NCT02330133|CD-ROM|cd-rom
202709|NCT02330133|multimedia|multimedia
202710|NCT02330133|video|video
202711|NCT02330120|peak airway pressure|peak airway pressure
202712|NCT02330120|airway resistance|airway resistance
202713|NCT02330120|sedation|sedation
202714|NCT02330120|intensive care|intensive care
202715|NCT02330094|aSAH|asah
202716|NCT02330094|SAH|sah
202717|NCT02330081|pathogen reduction technology|pathogen reduction technology
202718|NCT02330081|whole blood|whole blood
202719|NCT02330081|Platelets|platelets
202720|NCT02330081|Mirasol|mirasol
202721|NCT02330042|Diabetes|diabetes
202722|NCT02330042|OCT|oct
202723|NCT02330042|Angiography|angiography
202724|NCT02330042|Diabetic retinopathy|diabetic retinopathy
202725|NCT02330029|Irritable bowel syndrome,|irritable bowel syndrome,
202726|NCT02330029|Pinaverium|pinaverium
202727|NCT02330029|Herbal medication for IBS,|herbal medication for ibs,
202728|NCT02330029|Tong Xie Yao Fang (Formula for pain and diarrhea)|tong xie yao fang (formula for pain and diarrhea)
202729|NCT02330003|Influenza|influenza
202730|NCT02330003|Influenza vaccine|influenza vaccine
202731|NCT02330003|Split influenza vaccine|split influenza vaccine
202732|NCT02330003|Seasonal influenza vaccine|seasonal influenza vaccine
202733|NCT02329990|phosphorus intake|phosphorus intake
202734|NCT02329977|duodenal-biliary reflux|duodenal-biliary reflux
202735|NCT02329964|Rocuronium|rocuronium
202736|NCT02329964|Sugammadex|sugammadex
202737|NCT02329964|Succinylcholine|succinylcholine
202738|NCT02329964|Cisatracurium|cisatracurium
202739|NCT02329964|Neostigmine|neostigmine
202740|NCT02329964|acceleromyography (TOF-Watch®)|acceleromyography (tof-watch®)
202741|NCT02329912|postoperative ileus|postoperative ileus
202742|NCT02329912|SmartPill|smartpill
202743|NCT02329912|gastrointestinal transit|gastrointestinal transit
202744|NCT02329912|prokinetic drugs|prokinetic drugs
202745|NCT02329886|chronic diseases|chronic diseases
202746|NCT02329886|risk factors|risk factors
202747|NCT02329886|health outcomes|health outcomes
202748|NCT02329873|Acute exacerbation of chronic obstructive pulmonary disease|acute exacerbation of chronic obstructive pulmonary disease
202749|NCT02329873|Older adults|older adults
202750|NCT02329873|Respiratory rehabilitation exercise|respiratory rehabilitation exercise
202751|NCT02329847|Hematologic Neoplasms|hematologic neoplasms
202752|NCT02329847|JNJ54179060|jnj54179060
202753|NCT02329847|Ibrutinib|ibrutinib
202754|NCT02329847|Nivolumab|nivolumab
202755|NCT02329821|lactate|lactate
202756|NCT02329821|hartmann solution|hartmann solution
202757|NCT02329821|hepatocellular carcinoma|hepatocellular carcinoma
202758|NCT02329808|TDM|tdm
202759|NCT02329808|dried blood spot|dried blood spot
202760|NCT02329808|immunosuppressive|immunosuppressive
202761|NCT02329808|antifungal|antifungal
202762|NCT02329769|Duchenne muscular dystrophy|duchenne muscular dystrophy
202763|NCT02329769|DMD|dmd
202764|NCT02329769|BioMarin|biomarin
202765|NCT02329769|PRO044|pro044
202766|NCT02329730|diagnosis of Tuberculosis (TB)|diagnosis of tuberculosis (tb)
202767|NCT02329730|ESAT6|esat6
202768|NCT02329730|CFP10|cfp10
202769|NCT02329730|Phase IIa Clinical Trial|phase iia clinical trial
202770|NCT02329704|IUI/AIH|iui/aih
202771|NCT02329704|Semen preparation|semen preparation
202772|NCT02329704|Semen processing|semen processing
202773|NCT02329704|ICSI/IVF|icsi/ivf
202774|NCT02329704|ART|art
202775|NCT02329704|Density Gradient|density gradient
202776|NCT02329704|Swimming down|swimming down
202777|NCT02329704|hyaluronan affinity testing|hyaluronan affinity testing
202778|NCT02329704|Sperm vitality testin|sperm vitality testin
202779|NCT02329691|safety climate|safety climate
202780|NCT02329691|surgery|surgery
202781|NCT02329678|Apicomarginal defects|apicomarginal defects
202782|NCT02329678|clinical study/trial|clinical study/trial
202783|NCT02329678|collagen membrane|collagen membrane
202784|NCT02329678|guided tissue regeneration|guided tissue regeneration
202785|NCT02329678|endodontic microsurgery|endodontic microsurgery
202786|NCT02329652|Neuroprosthesis|neuroprosthesis
202787|NCT02329652|Functional Electrical Stimulation|functional electrical stimulation
202788|NCT02329639|bevacizumab|bevacizumab
202789|NCT02329639|paclitaxel|paclitaxel
202790|NCT02329639|pharmacogenetics|pharmacogenetics
202791|NCT02329639|breast cancer|breast cancer
202792|NCT02329561|Pharmacokinetics|pharmacokinetics
202793|NCT02329561|Opioid|opioid
202794|NCT02329561|Geriatric|geriatric
202795|NCT02329561|Pharmacodynamics|pharmacodynamics
202796|NCT02329548|Alizarin|alizarin
202797|NCT02329548|Orthostatic|orthostatic
202798|NCT02329548|POTS|pots
202799|NCT02329548|Tilt table testing|tilt table testing
202800|NCT02329548|Syncope|syncope
202801|NCT02329548|Anxiety|anxiety
202802|NCT02329522|Haemodynamics|haemodynamics
202803|NCT02329522|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
202804|NCT02329522|Ultrasonic Cardiac Output Monitor|ultrasonic cardiac output monitor
202805|NCT02329522|severity|severity
202806|NCT02329509|operative procedures|operative procedures
202807|NCT02329483|Infertility|infertility
202808|NCT02329483|Ovulation induction|ovulation induction
202809|NCT02329483|Low-dose step-up protocol|low-dose step-up protocol
202810|NCT02329483|Ovarian high responder|ovarian high responder
202811|NCT02329483|Androgens|androgens
202812|NCT02329483|Androstenedione|androstenedione
202813|NCT02329483|Testosterone|testosterone
202814|NCT02329483|rhFSH|rhfsh
202815|NCT02329457|double-blind, randomized, intradermal, VZVv, HSCT|double-blind, randomized, intradermal, vzvv, hsct
202816|NCT02329431|child mental health, mental health services, Latino families|child mental health, mental health services, latino families
202817|NCT02329340|child safety|child safety
202818|NCT02329340|injury|injury
202819|NCT02329340|prevention|prevention
202820|NCT02329340|computer|computer
202821|NCT02329340|internet|internet
202822|NCT02329327|Factor Xa Inhibitors|factor xa inhibitors
202823|NCT02329327|Major|major
202824|NCT02329327|Bleeding|bleeding
202825|NCT02329327|Anticoagulant|anticoagulant
202826|NCT02329301|malaria|malaria
202827|NCT02329301|malaria, falciparum|malaria, falciparum
202828|NCT02329301|antimalarials|antimalarials
202829|NCT02329262|exercise|exercise
202830|NCT02329262|mentors|mentors
202831|NCT02329262|health education|health education
202832|NCT02329262|obesity|obesity
202833|NCT02329249|smoking cessation|smoking cessation
202834|NCT02329249|coach-supported|coach-supported
202835|NCT02329249|tobacco use cessation|tobacco use cessation
202836|NCT02329249|online|online
202837|NCT02329249|internet-based|internet-based
202838|NCT02329249|tailored|tailored
202839|NCT02329223|Chronic spontaneous uriticaria|chronic spontaneous uriticaria
202840|NCT02329223|Omalizumab|omalizumab
202841|NCT02329197|Infertility|infertility
202842|NCT02329197|Invitro fertilization|invitro fertilization
202843|NCT02329145|renal denervation|renal denervation
202844|NCT02329132|diabetic macular edema|diabetic macular edema
202845|NCT02329132|VEGF|vegf
202846|NCT02329132|ranibizumab|ranibizumab
202847|NCT02329132|oxygen consumption|oxygen consumption
202848|NCT02329054|Ebola Virus Disease|ebola virus disease
202849|NCT02329054|Antivirals|antivirals
202850|NCT02329054|Mortality|mortality
202851|NCT02329054|Viral load|viral load
202852|NCT02329054|Proof-of-concept|proof-of-concept
202853|NCT02329054|Phase II trial|phase ii trial
202854|NCT02329054|Guinea|guinea
202855|NCT02329054|Adults|adults
202856|NCT02329054|Children|children
202857|NCT02329041|videolaryngoscope|videolaryngoscope
202858|NCT02329041|double-lumen tube|double-lumen tube
202859|NCT02329041|intubation|intubation
202860|NCT02329028|Emergency Care, Prehospital|emergency care, prehospital
202861|NCT02329028|Electroencephalography|electroencephalography
202862|NCT02329028|Coma|coma
202863|NCT02329015|stress|stress
202864|NCT02329015|alternative|alternative
202865|NCT02329015|complementary|complementary
202866|NCT02329015|self-regulation|self-regulation
202867|NCT02329002|Retinoblastoma|retinoblastoma
202868|NCT02329002|Second primary tumor|second primary tumor
202869|NCT02329002|Screening|screening
202870|NCT02329002|Magnetic resonance imaging|magnetic resonance imaging
202871|NCT02328989|prematurity|prematurity
202872|NCT02328989|short cervix|short cervix
202873|NCT02328989|twin pregnancy|twin pregnancy
202874|NCT02328989|pessary|pessary
202875|NCT02328963|Cytomegalovirus infection and disease|cytomegalovirus infection and disease
202876|NCT02328963|CMV-seropositive recipients|cmv-seropositive recipients
202878|NCT02328963|preemptive strategy|preemptive strategy
202879|NCT02328963|mTOR inhibitor|mtor inhibitor
202880|NCT02328898|Polymer free stent|polymer free stent
202881|NCT02328898|percutaneous coronary intervention|percutaneous coronary intervention
202882|NCT02328885|high-risk acute leukemia|high-risk acute leukemia
202883|NCT02328885|graft versus leukemia|graft versus leukemia
202884|NCT02328885|DLI|dli
202885|NCT02328885|UCBT|ucbt
202886|NCT02328872|screening|screening
202887|NCT02328872|cervical screening|cervical screening
202888|NCT02328872|Human Papillomavirus (HPV)|human papillomavirus (hpv)
202889|NCT02328872|cancer prevention|cancer prevention
202890|NCT02328859|Gait|gait
202891|NCT02328859|Rehabilitation|rehabilitation
202892|NCT02328859|Virtual Reality|virtual reality
202893|NCT02328833|Depression|depression
202894|NCT02328833|Clinical Practice Guideline|clinical practice guideline
202895|NCT02328833|Implementation|implementation
202896|NCT02328833|Primary Care|primary care
202897|NCT02328833|Computerized Guideline|computerized guideline
202898|NCT02328820|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
202899|NCT02328820|Coronary Flow Reserve|coronary flow reserve
202900|NCT02328807|adenocarcinoma|adenocarcinoma
202901|NCT02328807|prostate|prostate
202902|NCT02328807|ENCAGE™|encage™
202903|NCT02328807|focal bipolar radiofrequency ablation|focal bipolar radiofrequency ablation
202904|NCT02328807|radiofrequency ablation (RFA)|radiofrequency ablation (rfa)
202905|NCT02328807|radiotherapy|radiotherapy
202906|NCT02328794|smoking cessation|smoking cessation
202907|NCT02328794|behavioral economics|behavioral economics
202908|NCT02328794|e-cigarettes|e-cigarettes
202909|NCT02328794|NRT|nrt
202910|NCT02328781|vertebral artery stenosis|vertebral artery stenosis
202911|NCT02328781|drug-eluting stent|drug-eluting stent
202912|NCT02328703|Reiki|reiki
202913|NCT02328703|Neuropathic Pain|neuropathic pain
202914|NCT02328703|Military Service Members|military service members
202915|NCT02328703|Extermity Trauma|extermity trauma
202916|NCT02328690|binaural beat technology|binaural beat technology
202917|NCT02328690|sound technology|sound technology
202918|NCT02328690|cardiovascular stress response|cardiovascular stress response
202919|NCT02328690|military|military
202920|NCT02328690|music|music
202921|NCT02328690|anxiety|anxiety
202922|NCT02328690|stress|stress
202923|NCT02328677|Colorectal cancer|colorectal cancer
202924|NCT02328677|rectosigmoid|rectosigmoid
202925|NCT02328677|rectum|rectum
202926|NCT02328677|colon|colon
202927|NCT02328664|Endoscopic resection|endoscopic resection
202928|NCT02328664|Pathology|pathology
202929|NCT02328664|Rescue surgery|rescue surgery
202930|NCT02328651|Mild and Moderate Severe Patients With hand_foot-mouth Disease|mild and moderate severe patients with hand_foot-mouth disease
202931|NCT02328638|ASD|asd
202932|NCT02328625|Scleroderma|scleroderma
202933|NCT02328625|Device|device
202934|NCT02328625|ADRCs|adrcs
202935|NCT02328625|adipose derived regenerative cells|adipose derived regenerative cells
202936|NCT02328625|hand|hand
202937|NCT02328547|fecal microbiota transplantation|fecal microbiota transplantation
202938|NCT02328547|diarrhea-predominant|diarrhea-predominant
202939|NCT02328534|ICSI/IVF|icsi/ivf
202940|NCT02328534|Semen processing|semen processing
202941|NCT02328534|Semen preparation|semen preparation
202942|NCT02328534|Swim down|swim down
202943|NCT02328534|Density gradient|density gradient
202944|NCT02328534|Silica solution|silica solution
202945|NCT02328521|Neointima|neointima
202946|NCT02328521|Tomography, Optical Coherence|tomography, optical coherence
202947|NCT02328521|drug-eluting stents|drug-eluting stents
202948|NCT02328521|Nicorandil|nicorandil
202949|NCT02328508|hyperbaric oxygen therapy|hyperbaric oxygen therapy
202950|NCT02328508|diabetic foot ulcer|diabetic foot ulcer
202951|NCT02328508|wound healing|wound healing
202952|NCT02328508|inflammation|inflammation
202953|NCT02328508|glycemic control|glycemic control
202954|NCT02328508|amputation|amputation
202955|NCT02328508|bacterial infection|bacterial infection
202956|NCT02328508|quality of life|quality of life
202957|NCT02328495|Misoprostol, Office hysteroscopy ,Pain|misoprostol, office hysteroscopy ,pain
202958|NCT02328469|aseptic meningitis|aseptic meningitis
202959|NCT02328469|tick-borne encephalitis|tick-borne encephalitis
202960|NCT02328469|Lyme neuroborreliosis|lyme neuroborreliosis
202961|NCT02328469|inflammation|inflammation
202962|NCT02328469|outcome|outcome
202963|NCT02328443|CYP3A|cyp3a
202964|NCT02328443|Metabolomics|metabolomics
202965|NCT02328404|Vitamin D|vitamin d
202966|NCT02328404|deficiency|deficiency
202967|NCT02328404|hypovitaminosis D|hypovitaminosis d
202968|NCT02328404|Biodal|biodal
202969|NCT02328404|25 hydroxy Vitamin D|25 hydroxy vitamin d
202970|NCT02328404|25hydroxyvitamin D|25hydroxyvitamin d
202971|NCT02328404|25(OH)D|25(oh)d
202972|NCT02328404|PCOS|pcos
202973|NCT02328404|insulin resistance|insulin resistance
202974|NCT02328404|BMI|bmi
202975|NCT02328404|chromium levels|chromium levels
202976|NCT02328404|vitamin D 3|vitamin d 3
202977|NCT02328404|cholecalciferol|cholecalciferol
202978|NCT02328404|50,000 IU|50,000 iu
202979|NCT02328365|Colorectal Cancer|colorectal cancer
202980|NCT02328365|Comorbidity|comorbidity
202981|NCT02328365|Perioperative Care|perioperative care
202982|NCT02328365|Surgery|surgery
202983|NCT02328352|Buckypaper (BP) of Multi-Walled Carbon Nanotubes (MWCNTs)|buckypaper (bp) of multi-walled carbon nanotubes (mwcnts)
202984|NCT02328352|surgical hernia prosthesis|surgical hernia prosthesis
202985|NCT02328352|abdominal wall defects surgery|abdominal wall defects surgery
202986|NCT02328352|prosthesis adhesion|prosthesis adhesion
202987|NCT02328352|disaster preparation and recovery hernia|disaster preparation and recovery hernia
202988|NCT02328352|Abdominal Wall Disaster Surgery|abdominal wall disaster surgery
202989|NCT02328352|Fixation of prosthetic materials in general surgery|fixation of prosthetic materials in general surgery
202990|NCT02328326|Diabetes|diabetes
202991|NCT02328326|diabetes self-management|diabetes self-management
202992|NCT02328326|patient activation|patient activation
202993|NCT02328326|social support|social support
202994|NCT02328313|Cancer|cancer
202995|NCT02328313|Breast Cancer|breast cancer
202996|NCT02328313|Geriatric|geriatric
202997|NCT02328313|Advance Age|advance age
202998|NCT02328313|Exercise|exercise
202999|NCT02328313|Physical Activity|physical activity
203000|NCT02328313|Genetic Marker|genetic marker
203001|NCT02328313|p16|p16
203002|NCT02328313|Chemotherapy|chemotherapy
203003|NCT02328313|Breast Cancer Treatment|breast cancer treatment
203004|NCT02328287|Spinal Fusion|spinal fusion
203005|NCT02328287|Revision Surgery|revision surgery
203006|NCT02328287|Pseudarthrosis|pseudarthrosis
203007|NCT02328287|Cell Therapy|cell therapy
203008|NCT02328287|Bone Graft|bone graft
203009|NCT02328235|skeletal muscle, metabolism, physiology|skeletal muscle, metabolism, physiology
203010|NCT02328222|Early steroid withdrawal|early steroid withdrawal
203011|NCT02328222|Acute allograft rejection|acute allograft rejection
203012|NCT02328222|Mycophenolate|mycophenolate
203013|NCT02328222|Tacrolimus|tacrolimus
203014|NCT02328222|Basiliximab|basiliximab
203015|NCT02328196|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
203016|NCT02328196|Rasch analysis|rasch analysis
203017|NCT02328196|Meal time performance|meal time performance
203018|NCT02328183|polymyxin B|polymyxin b
203019|NCT02328183|carbapenem resistant bacteria|carbapenem resistant bacteria
203020|NCT02328170|immunoglobulin E, food hypersensitivities, child, allergens|immunoglobulin e, food hypersensitivities, child, allergens
203021|NCT02328144|Hemorrhoidectomy|hemorrhoidectomy
203022|NCT02328144|Postoperative pain|postoperative pain
203023|NCT02328144|Metronidazole|metronidazole
203024|NCT02328118|Lucentis|lucentis
203025|NCT02328118|Ranibizumab|ranibizumab
203026|NCT02328118|Triamcinolone Acetonide|triamcinolone acetonide
203027|NCT02328118|Vitrectomy|vitrectomy
203028|NCT02328118|PDR|pdr
203029|NCT02328079|Facial Palsy (acute), Acyclovir, Prednisolone|facial palsy (acute), acyclovir, prednisolone
203030|NCT02328066|NBI|nbi
203031|NCT02328066|NICE classification|nice classification
203032|NCT02328066|deep submucosal invasion|deep submucosal invasion
203033|NCT02328066|Colonic Polyps [C23.300.825.411.235]|colonic polyps [c23.300.825.411.235]
203034|NCT02328066|Colonoscopy [E01.370.372.250.250.200]|colonoscopy [e01.370.372.250.250.200]
203035|NCT02328053|fungal keratitis|fungal keratitis
203036|NCT02328053|collagen cross linking|collagen cross linking
203037|NCT02328040|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
203038|NCT02328040|Closed loop|closed loop
203039|NCT02328040|Artificial Pancreas|artificial pancreas
203040|NCT02328040|Insulin|insulin
203041|NCT02328040|Sitagliptin|sitagliptin
203042|NCT02328040|Januvia|januvia
203043|NCT02328014|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
203044|NCT02328014|Btk|btk
203045|NCT02328014|B-Cell Malignancies|b-cell malignancies
203046|NCT02328014|Mantle Cell|mantle cell
203047|NCT02328014|Multiple Myeloma|multiple myeloma
203048|NCT02328014|CLL|cll
203049|NCT02328014|SLL|sll
203050|NCT02328014|DLBCL|dlbcl
203051|NCT02328014|Folicular|folicular
203052|NCT02328014|Waldenstrom|waldenstrom
203053|NCT02328014|B-All|b-all
203054|NCT02327988|cryotherapy|cryotherapy
203055|NCT02327988|laser therapy|laser therapy
203056|NCT02327988|eccentric exercise|eccentric exercise
203057|NCT02327988|delayed onset muscle soreness|delayed onset muscle soreness
203058|NCT02327988|muscle damage|muscle damage
203059|NCT02327988|dynamometry|dynamometry
203060|NCT02327988|electromyography|electromyography
203061|NCT02327923|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
203062|NCT02327923|lidocaine infusion|lidocaine infusion
203063|NCT02327923|Esmolol infusion|esmolol infusion
203064|NCT02327923|Postoperative opioid consumption|postoperative opioid consumption
203065|NCT02327923|Multimodal analgesia|multimodal analgesia
203066|NCT02327910|Elderly patients，|elderly patients，
203067|NCT02327910|General anesthesia，|general anesthesia，
203068|NCT02327910|Transcutaneous partial pressure of carbon dioxide(TcPCO2)，|transcutaneous partial pressure of carbon dioxide(tcpco2)，
203069|NCT02327910|Train-of-four(TOF)，|train-of-four(tof)，
203070|NCT02327910|Extubation|extubation
203071|NCT02327910|，Respiratory events|，respiratory events
203072|NCT02327897|Atopic Asthma|atopic asthma
203073|NCT02327897|Exposures|exposures
203074|NCT02327897|Disease Progression|disease progression
203075|NCT02327884|Genetics|genetics
203076|NCT02327884|Dry Mouth|dry mouth
203077|NCT02327884|Sjogren's Syndrome|sjogren's syndrome
203078|NCT02327884|Gland Dysfuntion|gland dysfuntion
203079|NCT02327884|Induced Pluripotent Stem Cell (iPS) Cell Lines|induced pluripotent stem cell (ips) cell lines
203080|NCT02327871|Therapeutic hypothermia|therapeutic hypothermia
203081|NCT02327871|patients|patients
203082|NCT02327871|Safety, Efficacy|safety, efficacy
203083|NCT02327845|natural history, biomarkers, phenotype, genotype|natural history, biomarkers, phenotype, genotype
203084|NCT02327832|Confirmation|confirmation
203085|NCT02327832|safety|safety
203086|NCT02327793|Perfusion|perfusion
203087|NCT02327793|Blood pressure|blood pressure
203088|NCT02327767|Active Assistance|active assistance
203089|NCT02327767|Resonance|resonance
203090|NCT02327767|Stroke|stroke
203091|NCT02327767|Arm Rehabilitation|arm rehabilitation
203092|NCT02327741|Dual antiplatelet therapy|dual antiplatelet therapy
203093|NCT02327741|clopidogrel|clopidogrel
203094|NCT02327741|percutaneous coronary intervention|percutaneous coronary intervention
203095|NCT02327728|blepharospasm|blepharospasm
203096|NCT02327728|botulinum A|botulinum a
203097|NCT02327728|injection pattern|injection pattern
203098|NCT02327728|tear|tear
203099|NCT02327715|Hepatitis B virus|hepatitis b virus
203100|NCT02327715|Emtricitabine|emtricitabine
203101|NCT02327715|Pregnancy|pregnancy
203102|NCT02327715|Vertical transmission|vertical transmission
203103|NCT02327702|Hepatitis B, chronic|hepatitis b, chronic
203104|NCT02327702|Emtricitabine|emtricitabine
203105|NCT02327702|Pregnancy|pregnancy
203106|NCT02327689|Hepatitis B virus|hepatitis b virus
203107|NCT02327689|Cirrhosis|cirrhosis
203108|NCT02327689|Emtricitabine|emtricitabine
203109|NCT02327689|Adefovir dipivoxil|adefovir dipivoxil
203110|NCT02327676|Hepatitis B, chronic|hepatitis b, chronic
203111|NCT02327676|Emtricitabine|emtricitabine
203112|NCT02327676|Child|child
203113|NCT02327663|Hepatitis B, chronic|hepatitis b, chronic
203114|NCT02327663|Emtricitabine|emtricitabine
203115|NCT02327663|Adefovir dipivixil|adefovir dipivixil
203116|NCT02327663|HBeAg|hbeag
203117|NCT02327637|Preterm Premature Rupture of the Membranes|preterm premature rupture of the membranes
203118|NCT02327637|Bedrest|bedrest
203119|NCT02327637|Physical Activity|physical activity
203120|NCT02327585|Executive function training|executive function training
203121|NCT02327585|child|child
203122|NCT02327559|childbirth|childbirth
203123|NCT02327559|mindfulness|mindfulness
203124|NCT02327559|fear of labor|fear of labor
203125|NCT02327559|labor pain|labor pain
203126|NCT02327559|coping|coping
203127|NCT02327559|self-efficacy|self-efficacy
203128|NCT02327559|childbirth satisfaction|childbirth satisfaction
203129|NCT02327559|depression|depression
203130|NCT02327546|Pharmacokinetics|pharmacokinetics
203131|NCT02327546|Anemia|anemia
203132|NCT02327546|Chronic kidney disease|chronic kidney disease
203133|NCT02327546|CKD|ckd
203134|NCT02327546|Chronic renal insufficiency|chronic renal insufficiency
203135|NCT02327546|Renal impairment|renal impairment
203136|NCT02327546|Ferrous sulfate|ferrous sulfate
203137|NCT02327546|Iron|iron
203138|NCT02327546|Drug-drug interaction|drug-drug interaction
203139|NCT02327546|End stage renal disease|end stage renal disease
203140|NCT02327546|Dialysis|dialysis
203141|NCT02327546|Erythropoietin|erythropoietin
203142|NCT02327546|Oral anemia treatment|oral anemia treatment
203143|NCT02327546|Hypoxia-induciable factor|hypoxia-induciable factor
203144|NCT02327546|HIF|hif
203145|NCT02327546|Hypoxia-induciable factor prolyl-hydroxylase inhibitor|hypoxia-induciable factor prolyl-hydroxylase inhibitor
203146|NCT02327546|HIF-PHI|hif-phi
203147|NCT02327533|generalized aggressive periodontitis|generalized aggressive periodontitis
203148|NCT02327533|microarray analysis|microarray analysis
203149|NCT02327520|Clostridium difficile infection|clostridium difficile infection
203150|NCT02327520|burden|burden
203151|NCT02327520|nationwide study|nationwide study
203152|NCT02327520|South East Asia|south east asia
203153|NCT02327520|Thailand|thailand
203154|NCT02327520|Epidemiology|epidemiology
203155|NCT02327520|Outcome Assessment (Health Care) [N04.761.559.590]|outcome assessment (health care) [n04.761.559.590]
203156|NCT02327507|children|children
203157|NCT02327507|fluoridated toothpaste|fluoridated toothpaste
203158|NCT02327507|health education|health education
203159|NCT02327507|Medicaid|medicaid
203160|NCT02327494|Neuromuscular blockade|neuromuscular blockade
203161|NCT02327494|Laparoscopy|laparoscopy
203162|NCT02327494|Oxygen measurements|oxygen measurements
203163|NCT02327481|Stomach Neoplasms Laparoscopy|stomach neoplasms laparoscopy
203164|NCT02327442|chemokine receptor|chemokine receptor
203165|NCT02327442|galium|galium
203166|NCT02327442|dosimetry|dosimetry
203167|NCT02327442|glioma|glioma
203168|NCT02327403|Proteinuria|proteinuria
203169|NCT02327403|Kidney transplantation|kidney transplantation
203170|NCT02327403|Allograft dysfunction|allograft dysfunction
203171|NCT02327403|B7-1|b7-1
203172|NCT02327403|Belatacept|belatacept
203173|NCT02327377|Irritable bowel syndrome|irritable bowel syndrome
203174|NCT02327377|Intervention studies|intervention studies
203175|NCT02327377|Visceral pain|visceral pain
203176|NCT02327377|Chronic pain|chronic pain
203177|NCT02327377|Abdominal pain|abdominal pain
203178|NCT02327377|Dyspepsia|dyspepsia
203179|NCT02327377|Nausea|nausea
203180|NCT02327377|Nociception|nociception
203181|NCT02327377|Parents|parents
203182|NCT02327377|Coping behavior|coping behavior
203183|NCT02327377|Anxiety|anxiety
203184|NCT02327377|Depression|depression
203185|NCT02327377|Catastrophization|catastrophization
203186|NCT02327377|Reinforcement (psychology)|reinforcement (psychology)
203187|NCT02327377|Self efficacy|self efficacy
203188|NCT02327377|Health services overutilization|health services overutilization
203189|NCT02327377|Questionnaires|questionnaires
203190|NCT02327377|Self report|self report
203191|NCT02327377|Health surveys|health surveys
203192|NCT02327377|Prospective studies|prospective studies
203193|NCT02327377|Adolescent health|adolescent health
203194|NCT02327377|Mental health services|mental health services
203195|NCT02327377|Health services accessibility|health services accessibility
203196|NCT02327377|Health diaries|health diaries
203197|NCT02327377|National Institute of Child Health & Human Development (US.)|national institute of child health & human development (us.)
203198|NCT02327377|Telemedicine|telemedicine
203199|NCT02327377|E-Health|e-health
203200|NCT02327377|Web-based intervention|web-based intervention
203201|NCT02327377|Parenting education|parenting education
203202|NCT02327325|Low Back Pain|low back pain
203203|NCT02327325|Exercise|exercise
203204|NCT02327325|Cognitive Behavioral Therapy|cognitive behavioral therapy
203205|NCT02327325|Aged|aged
203206|NCT02327299|Iron deficiency|iron deficiency
203207|NCT02327299|Iron fortification|iron fortification
203208|NCT02327286|Diabetes Mellitus|diabetes mellitus
203209|NCT02327286|Gestational diabetes|gestational diabetes
203210|NCT02327273|subjects|subjects
203211|NCT02327221|Crohn Disease|crohn disease
203212|NCT02327221|Cell therapy|cell therapy
203213|NCT02327221|Regulatory T lymphocytes|regulatory t lymphocytes
203214|NCT02327221|Treg|treg
203215|NCT02327221|Autologous|autologous
203216|NCT02327221|Antigen specific T regulatory lymphocytes|antigen specific t regulatory lymphocytes
203217|NCT02327208|Military Training|military training
203218|NCT02327208|Whey Protein|whey protein
203219|NCT02327208|Body Composition|body composition
203220|NCT02327182|MT-4666|mt-4666
203221|NCT02327182|α7 nicotinic acetylcholine receptor agonist|α7 nicotinic acetylcholine receptor agonist
203222|NCT02327182|Alzheimer's Disease|alzheimer's disease
203223|NCT02327182|Cognitive function|cognitive function
203224|NCT02327182|Dementia|dementia
203225|NCT02327182|Central Nervous System Agents|central nervous system agents
203226|NCT02327169|Drug therapy|drug therapy
203227|NCT02327156|Dexmedetomidine|dexmedetomidine
203228|NCT02327104|mindfulness|mindfulness
203229|NCT02327104|tobacco dependence|tobacco dependence
203230|NCT02327104|relapse prevention|relapse prevention
203231|NCT02327091|Alfacalcidol|alfacalcidol
203232|NCT02327091|Falls|falls
203233|NCT02327091|Handgrip|handgrip
203234|NCT02327091|Muscle strength|muscle strength
203235|NCT02327091|Sarcopenia|sarcopenia
203236|NCT02327065|EUS|eus
203237|NCT02327065|FNA|fna
203238|NCT02327065|FNB|fnb
203239|NCT02327052|Chagas disease|chagas disease
203240|NCT02327052|longitudinal global strain|longitudinal global strain
203241|NCT02327052|speckle tracking|speckle tracking
203242|NCT02327026|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
203243|NCT02327026|Bag-valve-mask ventilation|bag-valve-mask ventilation
203244|NCT02327026|Tracheal intubation|tracheal intubation
203245|NCT02326961|osteoarthritis|osteoarthritis
203246|NCT02326961|knee|knee
203247|NCT02326961|adipose derived regenerative cells|adipose derived regenerative cells
203248|NCT02326961|ADRC|adrc
203249|NCT02326961|Celution|celution
203250|NCT02326961|arthritis|arthritis
203251|NCT02326948|Gallbladder cancer|gallbladder cancer
203252|NCT02326948|Case-control study|case-control study
203253|NCT02326948|Risk factor|risk factor
203254|NCT02326948|Alcohol consumption|alcohol consumption
203255|NCT02326948|Polypoid lesions of gallbladder|polypoid lesions of gallbladder
203256|NCT02326948|Biliary stone|biliary stone
203257|NCT02326935|MS|ms
203258|NCT02326935|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
203259|NCT02326935|Multiple Sclerosis, Chronic Progressive|multiple sclerosis, chronic progressive
203260|NCT02326935|Myelitis|myelitis
203261|NCT02326922|Dysfunctional uterine bleeding|dysfunctional uterine bleeding
203262|NCT02326922|Metraplant-E|metraplant-e
203263|NCT02326922|Levonorgestrel-releasing intrauterine device|levonorgestrel-releasing intrauterine device
203264|NCT02326922|Endometrial decidualization|endometrial decidualization
203265|NCT02326909|Upper Urinary Tract|upper urinary tract
203266|NCT02326909|Optical Coherence Tomography|optical coherence tomography
203267|NCT02326909|Transitional Cell Carcinoma|transitional cell carcinoma
203268|NCT02326909|Urothelial Cell Carcinoma|urothelial cell carcinoma
203269|NCT02326909|Diagnostic accuracy|diagnostic accuracy
203270|NCT02326896|intubation|intubation
203271|NCT02326896|intensive care unit|intensive care unit
203272|NCT02326896|MACOCHA Score|macocha score
203273|NCT02326870|laparoscopic Cholecystectomy|laparoscopic cholecystectomy
203274|NCT02326870|laparoscope holder|laparoscope holder
203275|NCT02326870|gynecological laparoscopy procedures|gynecological laparoscopy procedures
203276|NCT02326870|fundoplication surgery|fundoplication surgery
203277|NCT02326870|laparoscopic adnexal surgery|laparoscopic adnexal surgery
203278|NCT02326870|excision of endometriosis lesion|excision of endometriosis lesion
203279|NCT02326870|diagnostic laparoscopy procedures|diagnostic laparoscopy procedures
203280|NCT02326870|right hemicolectomy|right hemicolectomy
203281|NCT02326870|Diaphragmatic hernia|diaphragmatic hernia
203282|NCT02326857|Distribution of Molecular Profiles in Latin American Women|distribution of molecular profiles in latin american women
203283|NCT02326857|AJCC 7 Clinical Stage II to III|ajcc 7 clinical stage ii to iii
203284|NCT02326857|Breast Cancer Observational Study|breast cancer observational study
203285|NCT02326857|Prospective Cohort|prospective cohort
203286|NCT02326857|Epidemiological, Histological, and Clinical Data|epidemiological, histological, and clinical data
203287|NCT02326844|Germline BRCA1/2 Mutations (gBRCAm)|germline brca1/2 mutations (gbrcam)
203288|NCT02326844|DNA Damaging Agents|dna damaging agents
203289|NCT02326844|FOX03a, 53BP1 and RAD51|fox03a, 53bp1 and rad51
203290|NCT02326818|Dystonia|dystonia
203291|NCT02326818|Botulinum Toxin|botulinum toxin
203292|NCT02326818|Musician's Dystonia|musician's dystonia
203293|NCT02326818|Spasticity|spasticity
203294|NCT02326792|Exercise|exercise
203295|NCT02326792|Training|training
203296|NCT02326792|Low back Pain|low back pain
203297|NCT02326792|Physical Therapy|physical therapy
203298|NCT02326779|esophageal cancer|esophageal cancer
203299|NCT02326779|aspirin|aspirin
203300|NCT02326779|survival|survival
203301|NCT02326740|Pyoderma Gangrenosum|pyoderma gangrenosum
203302|NCT02326740|Classic Pyoderma Gangrenosum|classic pyoderma gangrenosum
203303|NCT02326727|Epidural Analgesia|epidural analgesia
203304|NCT02326727|Natural Killer Cells|natural killer cells
203305|NCT02326675|Etoposide|etoposide
203306|NCT02326675|Cryotherapy|cryotherapy
203307|NCT02326662|spinal cord injury|spinal cord injury
203308|NCT02326662|neural stem cells|neural stem cells
203309|NCT02326662|paraplegia|paraplegia
203310|NCT02326662|transplantation|transplantation
203311|NCT02326649|cardiac output|cardiac output
203312|NCT02326610|Small for gestational age (SGA)|small for gestational age (sga)
203313|NCT02326610|Human growth hormone (hGH)|human growth hormone (hgh)
203314|NCT02326597|Hydroxyurea|hydroxyurea
203315|NCT02326597|Bone marrow transplant|bone marrow transplant
203316|NCT02326597|Chronic blood transfusion|chronic blood transfusion
203317|NCT02326597|Treatment options for sickle cell disease|treatment options for sickle cell disease
203318|NCT02326597|Decision making|decision making
203319|NCT02326584|Acute Myeloid Leukemia|acute myeloid leukemia
203320|NCT02326584|Antibody-Drug Conjugate|antibody-drug conjugate
203321|NCT02326584|CD33 Antigen|cd33 antigen
203322|NCT02326584|Drug Therapy|drug therapy
203323|NCT02326584|Acute Myelogenous Leukemia|acute myelogenous leukemia
203324|NCT02326571|EEG|eeg
203325|NCT02326571|Cortical Spreading Depression|cortical spreading depression
203326|NCT02326571|Cerebral Hemorrhage|cerebral hemorrhage
203327|NCT02326571|miRNA|mirna
203328|NCT02326571|Reactivity in EEG|reactivity in eeg
203329|NCT02326571|Multimodal monitoring|multimodal monitoring
203330|NCT02326558|zero ischemia|zero ischemia
203331|NCT02326558|microwave|microwave
203332|NCT02326558|ablation|ablation
203333|NCT02326558|enucleation|enucleation
203334|NCT02326558|renal cell carcinoma|renal cell carcinoma
203335|NCT02326545|Video Games|video games
203336|NCT02326545|Child|child
203337|NCT02326545|Adolescent|adolescent
203338|NCT02326532|Rheumatoid Arthritis|rheumatoid arthritis
203339|NCT02326532|Veterans|veterans
203340|NCT02326506|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
203341|NCT02326506|Cardiopulmonary Bypass|cardiopulmonary bypass
203342|NCT02326493|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
203343|NCT02326493|LV lead position|lv lead position
203344|NCT02326493|Device programming|device programming
203345|NCT02326493|Optimization|optimization
203346|NCT02326493|Vectorcardiography|vectorcardiography
203347|NCT02326480|Childhood Obesity|childhood obesity
203348|NCT02326480|Genetics|genetics
203349|NCT02326467|chlorhexidine|chlorhexidine
203350|NCT02326467|safety|safety
203351|NCT02326467|bath|bath
203352|NCT02326467|rash|rash
203353|NCT02326467|infant|infant
203354|NCT02326441|advanced malignancies|advanced malignancies
203355|NCT02326441|refractory therapies|refractory therapies
203356|NCT02326441|phase 1|phase 1
203357|NCT02326428|Stroke|stroke
203358|NCT02326428|Cerebrovascular Accident|cerebrovascular accident
203359|NCT02326428|Brain ischemia|brain ischemia
203360|NCT02326428|Intravenous thrombolysis|intravenous thrombolysis
203361|NCT02326428|Stroke thrombectomy|stroke thrombectomy
203362|NCT02326428|Stent-retriever|stent-retriever
203363|NCT02326415|Acute Appendicitis|acute appendicitis
203364|NCT02326415|Appendectomy|appendectomy
203365|NCT02326415|Fast-Track|fast-track
203366|NCT02326415|Clinical Pathway|clinical pathway
203367|NCT02326402|Circulatory support|circulatory support
203368|NCT02326402|Extracorporeal circulatory support|extracorporeal circulatory support
203369|NCT02326402|Extracorporeal bypass|extracorporeal bypass
203370|NCT02326389|Cognitive functioning|cognitive functioning
203371|NCT02326363|substance abuse|substance abuse
203372|NCT02326363|Mental Health Disorders|mental health disorders
203373|NCT02326350|Acute Respiratory Distress syndrome|acute respiratory distress syndrome
203374|NCT02326350|Aspirin|aspirin
203375|NCT02326298|Certolizumab Pegol|certolizumab pegol
203376|NCT02326298|Cimzia|cimzia
203377|NCT02326298|Psoriasis|psoriasis
203378|NCT02326285|induction therapy|induction therapy
203379|NCT02326285|NSCLC|nsclc
203380|NCT02326285|Non-small Cell Lung Cancer|non-small cell lung cancer
203381|NCT02326285|curative surgery|curative surgery
203382|NCT02326272|Certolizumab Pegol|certolizumab pegol
203383|NCT02326272|Cimzia|cimzia
203384|NCT02326272|Psoriasis|psoriasis
203385|NCT02326259|Diabetic Retinopathy|diabetic retinopathy
203386|NCT02326259|Disease Progression|disease progression
203387|NCT02326246|MRI|mri
203388|NCT02326246|active surveillance|active surveillance
203389|NCT02326207|Infant, Newborn|infant, newborn
203390|NCT02326207|Neonatal intensive care unit|neonatal intensive care unit
203391|NCT02326207|Ventilator circuit|ventilator circuit
203392|NCT02326194|Safety,immunogenicity,Ebola|safety,immunogenicity,ebola
203393|NCT02326181|respiratory muscle training|respiratory muscle training
203394|NCT02326181|respiratory muscle strength|respiratory muscle strength
203395|NCT02326181|respiratory endurance test|respiratory endurance test
203396|NCT02326181|6-minute walking test|6-minute walking test
203397|NCT02326142|Premature Obstetric Labor|premature obstetric labor
203398|NCT02326142|Premature Birth|premature birth
203399|NCT02326103|alcoholic|alcoholic
203400|NCT02326103|hepatitis|hepatitis
203401|NCT02326103|cirrhosis|cirrhosis
203402|NCT02326103|cholesterol metabolites|cholesterol metabolites
203403|NCT02326103|ciprofloxacin|ciprofloxacin
203404|NCT02326077|sonopartogram|sonopartogram
203405|NCT02326077|transperineal ultrasound|transperineal ultrasound
203406|NCT02326077|intrapartum ultrasound|intrapartum ultrasound
203407|NCT02326077|labor|labor
203408|NCT02326077|delivery|delivery
203409|NCT02326077|partogram|partogram
203410|NCT02326077|ultrasound|ultrasound
203411|NCT02326051|Antiphospholipid syndrome|antiphospholipid syndrome
203412|NCT02326051|APS|aps
203413|NCT02326051|LMWH|lmwh
203414|NCT02326038|Memory|memory
203415|NCT02326038|Attention|attention
203416|NCT02326038|MCI|mci
203417|NCT02326038|Ritalin|ritalin
203418|NCT02325999|Endoscopic Submucosal Dissection|endoscopic submucosal dissection
203419|NCT02325999|Laparoscopic Regional Lymph node Dissection|laparoscopic regional lymph node dissection
203420|NCT02325999|early gastric cancer|early gastric cancer
203421|NCT02325999|Disease-free survival|disease-free survival
203422|NCT02325986|radiotherapy|radiotherapy
203423|NCT02325986|esophageal carcinoma|esophageal carcinoma
203424|NCT02325986|chemotherapy|chemotherapy
203425|NCT02325973|STEMI|stemi
203426|NCT02325973|IMR|imr
203427|NCT02325973|FFR|ffr
203428|NCT02325973|microcirculatory|microcirculatory
203429|NCT02325960|exenatide|exenatide
203430|NCT02325960|insulin glargine|insulin glargine
203431|NCT02325947|Post stroke hand paresis brain injury|post stroke hand paresis brain injury
203432|NCT02325934|Stribild|stribild
203433|NCT02325934|pharmacokinetics|pharmacokinetics
203434|NCT02325934|Crushing|crushing
203435|NCT02325934|Drip feed|drip feed
203436|NCT02325921|Magnetic Resonance Imaging|magnetic resonance imaging
203437|NCT02325921|Diffusion Weighted MRI|diffusion weighted mri
203438|NCT02325921|Diffusion Tensor Imaging|diffusion tensor imaging
203439|NCT02325908|Hemodialysis|hemodialysis
203440|NCT02325908|Estimated Dry Weight|estimated dry weight
203441|NCT02325895|Osteoporosis|osteoporosis
203442|NCT02325895|Dried plum|dried plum
203443|NCT02325895|functional food|functional food
203444|NCT02325869|Acute Coronary Syndrome, Coronary Occlusion, catheter|acute coronary syndrome, coronary occlusion, catheter
203445|NCT02325856|Hemodialysis|hemodialysis
203446|NCT02325856|Body Composition Monitor|body composition monitor
203447|NCT02325830|Functional mitral regurgitation|functional mitral regurgitation
203448|NCT02325830|Secondary mitral regurgitation|secondary mitral regurgitation
203449|NCT02325830|Percutaneous mitral repair|percutaneous mitral repair
203450|NCT02325817|Bifurcation Lesions|bifurcation lesions
203451|NCT02325817|drug eluting balloon|drug eluting balloon
203452|NCT02325817|paclitaxel|paclitaxel
203453|NCT02325817|drug coated balloon|drug coated balloon
203454|NCT02325804|overweight and obesity|overweight and obesity
203455|NCT02325804|adipose tissue|adipose tissue
203456|NCT02325804|weight loss program|weight loss program
203457|NCT02325804|low-calorie diet|low-calorie diet
203458|NCT02325804|circuit-based exercise|circuit-based exercise
203459|NCT02325804|metabolic cardiovascular syndrome|metabolic cardiovascular syndrome
203460|NCT02325765|congential cardiac surgery|congential cardiac surgery
203461|NCT02325765|nuclearsome|nuclearsome
203462|NCT02325765|systemic inflammation response syndrome|systemic inflammation response syndrome
203463|NCT02325752|readmission|readmission
203464|NCT02325752|chronic diseases|chronic diseases
203465|NCT02325739|FGF401, PDR001, PD-1, FGFR4, FGF19, HCC|fgf401, pdr001, pd-1, fgfr4, fgf19, hcc
203466|NCT02325726|Cardiac surgery|cardiac surgery
203467|NCT02325726|Extracorporeal circulation|extracorporeal circulation
203468|NCT02325726|Renal failure|renal failure
203469|NCT02325713|ODT-PZQ|odt-pzq
203470|NCT02325713|Bio-availability|bio-availability
203471|NCT02325713|Praziquantel|praziquantel
203472|NCT02325713|Cysticide|cysticide
203473|NCT02325713|Pharmacokinetics|pharmacokinetics
203474|NCT02325687|Obstructive Sleep Apnea|obstructive sleep apnea
203475|NCT02325687|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
203476|NCT02325687|Cerebrospinal Fluid|cerebrospinal fluid
203477|NCT02325687|Inflammation|inflammation
203478|NCT02325687|TNF-alpha|tnf-alpha
203479|NCT02325687|Interleukin-6 (IL-6)|interleukin-6 (il-6)
203480|NCT02325687|Interleukin-8 (IL-8)|interleukin-8 (il-8)
203481|NCT02325687|Interleukin-10 (IL-10)|interleukin-10 (il-10)
203482|NCT02325687|Cytokines|cytokines
203483|NCT02325687|Neurotrophins|neurotrophins
203484|NCT02325687|BDNF|bdnf
203485|NCT02325687|Beta-NGF|beta-ngf
203486|NCT02325687|Proteomic Analysis|proteomic analysis
203487|NCT02325674|Lipodystrophy|lipodystrophy
203488|NCT02325674|Metreleptin Registry|metreleptin registry
203489|NCT02325635|Adenoma Detection|adenoma detection
203490|NCT02325635|Adenoma Prediction|adenoma prediction
203491|NCT02325596|Chronic rhinosinusitis|chronic rhinosinusitis
203492|NCT02325596|microRNA|microrna
203493|NCT02325596|dendritic cell|dendritic cell
203494|NCT02325596|helper T cell|helper t cell
203495|NCT02325583|Intraoral 30% glucose, newborn, MRI|intraoral 30% glucose, newborn, mri
203496|NCT02325544|dissociative seizures,|dissociative seizures,
203497|NCT02325544|psychogenic nonepileptic seizures|psychogenic nonepileptic seizures
203498|NCT02325531|implementation strategies|implementation strategies
203499|NCT02325531|diabetes mellitus|diabetes mellitus
203500|NCT02325531|cardiovascular disease|cardiovascular disease
203501|NCT02325531|community health centers|community health centers
203502|NCT02325531|quality improvement|quality improvement
203503|NCT02325531|translational medical research|translational medical research
203504|NCT02325518|Open-angle glaucoma (OAG)|open-angle glaucoma (oag)
203505|NCT02325518|Ocular hypertension (OHT)|ocular hypertension (oht)
203506|NCT02325518|AZORGA®|azorga®
203507|NCT02325518|COSOPT®|cosopt®
203508|NCT02325492|bariatric surgery|bariatric surgery
203509|NCT02325492|NASH|nash
203510|NCT02325492|ARAMCHOL|aramchol
203511|NCT02325479|Low Molecular Weight (LMWH) Heparin ICSI Enaoxaprin sodium|low molecular weight (lmwh) heparin icsi enaoxaprin sodium
203512|NCT02325466|Peripheral Artery Disease|peripheral artery disease
203513|NCT02325466|Type 2 Diabetes|type 2 diabetes
203514|NCT02325466|Blood Viscosity|blood viscosity
203515|NCT02325466|Ticagrelor|ticagrelor
203516|NCT02325466|Aspirin|aspirin
203517|NCT02325453|Robotic Surgery|robotic surgery
203518|NCT02325453|Laparoscopic Surgery|laparoscopic surgery
203519|NCT02325453|Minimally Invasive Surgery|minimally invasive surgery
203520|NCT02325453|Robotic Gastrectomy|robotic gastrectomy
203521|NCT02325453|Laparoscopic Gastrectomy|laparoscopic gastrectomy
203522|NCT02325453|Open Gastrectomy|open gastrectomy
203523|NCT02325453|Gastric Surgery|gastric surgery
203524|NCT02325440|RRMS (relapsing remitting multiple sclerosis)|rrms (relapsing remitting multiple sclerosis)
203525|NCT02325440|Cluster of differentiation 49d (CD49d)|cluster of differentiation 49d (cd49d)
203526|NCT02325440|immune function|immune function
203527|NCT02325440|disease activity|disease activity
203528|NCT02325427|stroke|stroke
203529|NCT02325427|rehabilitation|rehabilitation
203530|NCT02325427|upper limb|upper limb
203531|NCT02325427|TMS|tms
203532|NCT02325427|tDCS|tdcs
203533|NCT02325414|Osteoporosis|osteoporosis
203534|NCT02325414|Spinal Cord Injury|spinal cord injury
203535|NCT02325414|Bone Diseases|bone diseases
203536|NCT02325414|Metabolic Bone Diseases|metabolic bone diseases
203537|NCT02325414|Musculoskeletal Diseases|musculoskeletal diseases
203538|NCT02325414|Spinal Cord Diseases|spinal cord diseases
203539|NCT02325414|Central Nervous System Diseases|central nervous system diseases
203540|NCT02325414|Nervous System Diseases|nervous system diseases
203541|NCT02325414|Nervous System|nervous system
203542|NCT02325414|Wounds and Injuries|wounds and injuries
203543|NCT02325414|Bone Density Conservation Agents|bone density conservation agents
203544|NCT02325414|Physiological Effects of Drugs|physiological effects of drugs
203545|NCT02325414|Pharmacologic Actions|pharmacologic actions
203546|NCT02325414|Department of Defense|department of defense
203547|NCT02325388|pressure ulcer|pressure ulcer
203548|NCT02325388|decubitus ulcer|decubitus ulcer
203549|NCT02325388|bed sore|bed sore
203550|NCT02325388|continuous pressure mapping|continuous pressure mapping
203551|NCT02325388|interface pressure imaging|interface pressure imaging
203552|NCT02325375|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
203553|NCT02325375|spinal fluid|spinal fluid
203554|NCT02325375|CD163|cd163
203555|NCT02325362|Cystic fibrosis|cystic fibrosis
203556|NCT02325362|CFTR|cftr
203557|NCT02325362|F508del mutation|f508del mutation
203558|NCT02325362|Miglustat|miglustat
203559|NCT02325362|Total Chloride Secretion|total chloride secretion
203560|NCT02325362|Nasal Potential Difference|nasal potential difference
203561|NCT02325349|Angiogenesis|angiogenesis
203562|NCT02325349|Integrins|integrins
203563|NCT02325349|RGD PET/CT|rgd pet/ct
203564|NCT02325349|FDG PET/CT|fdg pet/ct
203565|NCT02325349|Predictive value|predictive value
203566|NCT02325349|Therapeutic response|therapeutic response
203567|NCT02325349|Efficacy|efficacy
203568|NCT02325349|Tolerability|tolerability
203569|NCT02325336|Medication Errors|medication errors
203570|NCT02325336|nurses|nurses
203571|NCT02325336|hospital|hospital
203572|NCT02325323|stomach cancer|stomach cancer
203573|NCT02325323|gastric intestinal metaplasia|gastric intestinal metaplasia
203574|NCT02325323|prospective cohort|prospective cohort
203575|NCT02325323|low grade dysplasia|low grade dysplasia
203576|NCT02325323|high grade dysplasia|high grade dysplasia
203577|NCT02325323|prognosis factor|prognosis factor
203578|NCT02325323|gastric cancer risks|gastric cancer risks
203579|NCT02325310|Vaccine strain excretion in breast milk|vaccine strain excretion in breast milk
203580|NCT02325310|Postpartum vaccination|postpartum vaccination
203581|NCT02325310|Breastfeeding women|breastfeeding women
203582|NCT02325310|Measles-mumps-rubella vaccine|measles-mumps-rubella vaccine
203583|NCT02325310|Breast milk|breast milk
203584|NCT02325310|Vaccinology|vaccinology
203585|NCT02325297|Intensive care unit|intensive care unit
203586|NCT02325258|Sepsis diagnosis|sepsis diagnosis
203587|NCT02325258|Sepsis drug therapy|sepsis drug therapy
203588|NCT02325258|Sepsis outcome|sepsis outcome
203589|NCT02325245|Frailty|frailty
203590|NCT02325245|Pre-frailty|pre-frailty
203591|NCT02325245|Metformin|metformin
203592|NCT02325245|Elderly|elderly
203593|NCT02325245|Quality of life|quality of life
203594|NCT02325245|Handgrip|handgrip
203595|NCT02325245|Gait speed|gait speed
203596|NCT02325245|Myostatin|myostatin
203597|NCT02325219|Psoriasis|psoriasis
203598|NCT02325219|CNTO 1959|cnto 1959
203599|NCT02325219|Guselkumab|guselkumab
203600|NCT02325219|Placebo|placebo
203601|NCT02325180|ACT|act
203602|NCT02325180|Plasmodium falciparum|plasmodium falciparum
203603|NCT02325180|malaria|malaria
203604|NCT02325180|efficacy|efficacy
203605|NCT02325180|Indonesia|indonesia
203606|NCT02325167|informal caregivers|informal caregivers
203607|NCT02325167|mental stress|mental stress
203608|NCT02325167|quality of life|quality of life
203609|NCT02325167|psychotherapeutic intervention|psychotherapeutic intervention
203610|NCT02325128|social anxiety|social anxiety
203611|NCT02325128|exposure therapy|exposure therapy
203612|NCT02325128|extinction|extinction
203613|NCT02325128|sleep-dependent memory consolidation|sleep-dependent memory consolidation
203614|NCT02325115|well-being, mental health, schizophrenia, quality of life|well-being, mental health, schizophrenia, quality of life
203615|NCT02325089|Elderly|elderly
203616|NCT02325089|Obstructive Sleep Apnea|obstructive sleep apnea
203617|NCT02325089|Mandibular advancement oral appliance|mandibular advancement oral appliance
203618|NCT02325089|Hypertension|hypertension
203619|NCT02325089|Cardiovascular disease|cardiovascular disease
203620|NCT02325089|Quality of life|quality of life
203621|NCT02325076|Airway Management|airway management
203622|NCT02325076|intubation|intubation
203623|NCT02325076|pulmonary function test|pulmonary function test
203624|NCT02325050|Healthy|healthy
203625|NCT02325050|Ebola viruses|ebola viruses
203626|NCT02325050|Ebola Viral Disease (EVD)|ebola viral disease (evd)
203627|NCT02325050|Filoviruses|filoviruses
203628|NCT02325050|monovalent vaccine|monovalent vaccine
203629|NCT02325050|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
203630|NCT02325050|Modified Vaccinia Virus Ankara - Bavarian Nordic (MVA-BN) Filo-vector|modified vaccinia virus ankara - bavarian nordic (mva-bn) filo-vector
203631|NCT02325050|Safety|safety
203632|NCT02325050|Immunogenicity|immunogenicity
203633|NCT02325024|Sativex|sativex
203634|NCT02325024|GW-1000-02|gw-1000-02
203635|NCT02325024|Nabiximols|nabiximols
203636|NCT02325024|Pharmacokinetics|pharmacokinetics
203637|NCT02325024|Renal Insufficiency|renal insufficiency
203638|NCT02325024|Chronic Kidney Failure|chronic kidney failure
203639|NCT02325011|Sativex|sativex
203640|NCT02325011|GW-1000-02|gw-1000-02
203641|NCT02325011|Nabiximols|nabiximols
203642|NCT02325011|Fluconazole|fluconazole
203643|NCT02325011|Pharmacokinetics|pharmacokinetics
203644|NCT02325011|Drug-drug interaction|drug-drug interaction
203645|NCT02324998|Radical Prostatectomy|radical prostatectomy
203646|NCT02324998|Prostate Cancer|prostate cancer
203647|NCT02324998|PARP inhibition|parp inhibition
203648|NCT02324998|Olaparib|olaparib
203649|NCT02324998|Degarelix|degarelix
203650|NCT02324998|Neoadjuvant|neoadjuvant
203651|NCT02324998|Pharmacodynamics|pharmacodynamics
203652|NCT02324998|Pharmacokinetics|pharmacokinetics
203653|NCT02324998|Biomarkers|biomarkers
203654|NCT02324985|muscle soreness|muscle soreness
203655|NCT02324972|Atopic dermatitis|atopic dermatitis
203656|NCT02324972|Eczema|eczema
203657|NCT02324972|AD|ad
203658|NCT02324972|AQX-1125|aqx-1125
203659|NCT02324972|SHIP1|ship1
203660|NCT02324946|Sleep Apnea Syndromes|sleep apnea syndromes
203661|NCT02324946|Perioperative Period|perioperative period
203662|NCT02324946|Mass Screening|mass screening
203663|NCT02324920|Syncope|syncope
203664|NCT02324920|Closed Loop Stimulation|closed loop stimulation
203665|NCT02324920|CLS|cls
203666|NCT02324894|screening|screening
203667|NCT02324894|MRI|mri
203668|NCT02324881|smartphone|smartphone
203669|NCT02324881|application|application
203670|NCT02324881|pain management|pain management
203671|NCT02324868|Bandages|bandages
203672|NCT02324868|Catheter|catheter
203673|NCT02324855|Autogenic drainage|autogenic drainage
203674|NCT02324855|Positive expiratory pressure|positive expiratory pressure
203675|NCT02324855|Airway clearance technique|airway clearance technique
203676|NCT02324855|Quality of life|quality of life
203677|NCT02324855|Exacerbations|exacerbations
203678|NCT02324855|Chest physiotherapy|chest physiotherapy
203679|NCT02324829|Total joint replacement|total joint replacement
203680|NCT02324829|Physiotherapy|physiotherapy
203681|NCT02324829|Kalman filtering|kalman filtering
203682|NCT02324829|Kinematic modeling|kinematic modeling
203683|NCT02324829|Hidden Markov model|hidden markov model
203684|NCT02324829|Motion segmentation|motion segmentation
203685|NCT02324790|OSA, Oral Pressure Therapy (OPT)|osa, oral pressure therapy (opt)
203686|NCT02324764|transradial coronary angiography|transradial coronary angiography
203687|NCT02324764|radial artery occlusion|radial artery occlusion
203688|NCT02324764|coronary heart disease|coronary heart disease
203689|NCT02324764|Glidesheath Slender|glidesheath slender
203690|NCT02324738|Mefloquine/Dihydroartemisinin-piperaquine|mefloquine/dihydroartemisinin-piperaquine
203691|NCT02324738|drug interaction|drug interaction
203692|NCT02324725|naltrexone|naltrexone
203693|NCT02324725|neuroimaging|neuroimaging
203694|NCT02324725|heroin|heroin
203695|NCT02324725|addiction|addiction
203696|NCT02324725|dependence|dependence
203697|NCT02324725|opioid|opioid
203698|NCT02324725|Vivitrol®|vivitrol®
203699|NCT02324725|functional magnetic resonance imaging|functional magnetic resonance imaging
203700|NCT02324699|Vedolizumab|vedolizumab
203701|NCT02324699|Corticosteroids|corticosteroids
203702|NCT02324699|Prednisone|prednisone
203703|NCT02324699|Crohn's disease|crohn's disease
203704|NCT02324686|Warfarin|warfarin
203705|NCT02324686|International Normalized Ratio|international normalized ratio
203706|NCT02324686|Vitamin K|vitamin k
203707|NCT02324673|Treatment-resistant seizures|treatment-resistant seizures
203708|NCT02324660|screening procedure|screening procedure
203709|NCT02324660|peak expiratory flow|peak expiratory flow
203710|NCT02324660|respiratory health screening questionnaire|respiratory health screening questionnaire
203711|NCT02324647|Urinary steroid profiling|urinary steroid profiling
203712|NCT02324647|Adrenal incidentaloma|adrenal incidentaloma
203713|NCT02324647|Adrenocortical carcinoma|adrenocortical carcinoma
203714|NCT02324647|cost-effectiveness|cost-effectiveness
203715|NCT02324621|protocol specific|protocol specific
203716|NCT02324595|Ovarian Cancer|ovarian cancer
203717|NCT02324595|Laparoscopy|laparoscopy
203718|NCT02324595|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
203720|NCT02324595|Interval Debulking Surgery|interval debulking surgery
203721|NCT02324582|Urinary Bladder Neoplasms|urinary bladder neoplasms
203722|NCT02324582|Mycobacterium bovis|mycobacterium bovis
203723|NCT02324582|Programmed Cell Death 1 Receptor|programmed cell death 1 receptor
203724|NCT02324582|pembrolizumab|pembrolizumab
203725|NCT02324569|Pharmacological therapy|pharmacological therapy
203726|NCT02324556|Rectal Cancer|rectal cancer
203727|NCT02324556|Surgery|surgery
203728|NCT02324556|Laparoscopy|laparoscopy
203729|NCT02324517|response to various potential therapies as managed by lab assays|response to various potential therapies as managed by lab assays
203730|NCT02324504|Peripherally Inserted Central Catheter (PICC)|peripherally inserted central catheter (picc)
203731|NCT02324504|Electrocardiographic guidance|electrocardiographic guidance
203732|NCT02324504|Reposition|reposition
203733|NCT02324478|autonomic nervous system|autonomic nervous system
203734|NCT02324478|heart rate variability|heart rate variability
203735|NCT02324478|laparoscopic surgery|laparoscopic surgery
203736|NCT02324478|general anesthesia|general anesthesia
203737|NCT02324478|photoplethysmography|photoplethysmography
203738|NCT02324439|ovarian cancer|ovarian cancer
203739|NCT02324439|flaxseed|flaxseed
203740|NCT02324439|dietary supplement|dietary supplement
203741|NCT02324439|organic dietary supplement|organic dietary supplement
203742|NCT02324439|recurrence|recurrence
203743|NCT02324426|Parkinson's Disease|parkinson's disease
203744|NCT02324426|Reduced Glutathione|reduced glutathione
203745|NCT02324426|CNS|cns
203746|NCT02324426|Glutathione|glutathione
203747|NCT02324426|Uptake|uptake
203748|NCT02324426|Intranasal|intranasal
203749|NCT02324426|(in)GSH|(in)gsh
203750|NCT02324387|Breast Cancer|breast cancer
203751|NCT02324387|Molecular breast imaging|molecular breast imaging
203752|NCT02324387|MBI|mbi
203753|NCT02324387|Tc99m sestamibi|tc99m sestamibi
203754|NCT02324387|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
203755|NCT02324387|NAC|nac
203756|NCT02324374|colon cancer|colon cancer
203757|NCT02324361|Pediatric|pediatric
203758|NCT02324361|Obesity|obesity
203759|NCT02324361|Intervention|intervention
203760|NCT02324361|Information and Communication Technologies|information and communication technologies
203761|NCT02324361|Social Media|social media
203762|NCT02324361|Text Messaging|text messaging
203763|NCT02324361|Mobile Health|mobile health
203764|NCT02324335|Oral Mucositis|oral mucositis
203765|NCT02324335|Brilacidin|brilacidin
203766|NCT02324335|Chemoradiation|chemoradiation
203767|NCT02324322|Device: Robotic Exoskeleton|device: robotic exoskeleton
203768|NCT02324296|small cell lung cancer|small cell lung cancer
203769|NCT02324296|extended disease|extended disease
203770|NCT02324296|limited disease|limited disease
203771|NCT02324296|chemotherapy|chemotherapy
203772|NCT02324296|cisplatin|cisplatin
203773|NCT02324296|etoposide|etoposide
203774|NCT02324296|ifosfamide|ifosfamide
203775|NCT02324283|one-lung ventilation, oxygenation|one-lung ventilation, oxygenation
203776|NCT02324270|Pain due to ankle sprain|pain due to ankle sprain
203777|NCT02324244|Cytomegalovirus|cytomegalovirus
203778|NCT02324244|critical patient|critical patient
203779|NCT02324244|ICU|icu
203780|NCT02324244|immunocompetent|immunocompetent
203781|NCT02324244|clinical suspicion|clinical suspicion
203782|NCT02324244|risk factors|risk factors
203783|NCT02324218|Diabetes mellitus|diabetes mellitus
203784|NCT02324218|Hepatitis B|hepatitis b
203785|NCT02324218|Incidence|incidence
203786|NCT02324192|Ultrasonography|ultrasonography
203787|NCT02324192|clinical|clinical
203788|NCT02324192|hand|hand
203789|NCT02324166|cefazolin|cefazolin
203790|NCT02324166|lidocaine|lidocaine
203791|NCT02324153|Post-operative Delirium|post-operative delirium
203792|NCT02324114|Cancer|cancer
203793|NCT02324075|sanitation, toilet, urban, behavior change|sanitation, toilet, urban, behavior change
203794|NCT02324062|Cancer Genetics|cancer genetics
203795|NCT02324062|Multi-gene cancer panel testing|multi-gene cancer panel testing
203796|NCT02324049|MPS IIIB|mps iiib
203797|NCT02324049|Mucopolysaccharidosis|mucopolysaccharidosis
203798|NCT02324049|Mucopolysaccharidosis type IIIB|mucopolysaccharidosis type iiib
203799|NCT02324049|Sanfilippo Syndrome|sanfilippo syndrome
203800|NCT02324049|Metabolism, Inborn Errors|metabolism, inborn errors
203801|NCT02324049|Metabolic Diseases|metabolic diseases
203802|NCT02324049|Genetic Diseases, Inborn|genetic diseases, inborn
203803|NCT02324049|Carbohydrate Metabolism, Inborn Errors|carbohydrate metabolism, inborn errors
203804|NCT02324049|Connective Tissue Diseases|connective tissue diseases
203805|NCT02324049|Lysosomal Storage Diseases|lysosomal storage diseases
203806|NCT02324049|Mucinoses|mucinoses
203807|NCT02324049|Mucopolysaccharidoses|mucopolysaccharidoses
203808|NCT02324049|Pathologic Processes|pathologic processes
203809|NCT02324023|ultrasound|ultrasound
203810|NCT02324023|perfusion|perfusion
203811|NCT02324023|endoscopic|endoscopic
203812|NCT02324010|gastric emptying|gastric emptying
203813|NCT02324010|glycemia|glycemia
203814|NCT02324010|appetite|appetite
203815|NCT02324010|incretin hormones|incretin hormones
203816|NCT02323997|HPV|hpv
203817|NCT02323997|cervical cancer|cervical cancer
203818|NCT02323997|human papillomavirus|human papillomavirus
203819|NCT02323997|cervical pre-cancer|cervical pre-cancer
203820|NCT02323997|cervical neoplasia|cervical neoplasia
203821|NCT02323945|acute intermittent hypoxia|acute intermittent hypoxia
203822|NCT02323945|incomplete spinal cord injury|incomplete spinal cord injury
203823|NCT02323945|strength|strength
203824|NCT02323945|walking|walking
203825|NCT02323945|breathing|breathing
203826|NCT02323919|myocardial infarction|myocardial infarction
203827|NCT02323919|coronary artery bypass graft (CABG)|coronary artery bypass graft (cabg)
203828|NCT02323919|angioplasty|angioplasty
203829|NCT02323919|exercise|exercise
203830|NCT02323919|cardiac patient|cardiac patient
203831|NCT02323919|physical activity|physical activity
203832|NCT02323906|Hepatocellular|hepatocellular
203833|NCT02323906|Carcinoma|carcinoma
203834|NCT02323906|Phase 1|phase 1
203835|NCT02323906|CC-122|cc-122
203836|NCT02323906|Sorafenib,|sorafenib,
203837|NCT02323906|Nexavar|nexavar
203838|NCT02323906|Unresectable Hepatocellular Carcinoma|unresectable hepatocellular carcinoma
203839|NCT02323906|Unresectable HCCAdvanced,|unresectable hccadvanced,
203840|NCT02323906|Hepatocellular Carcinoma|hepatocellular carcinoma
203841|NCT02323906|liver cancer|liver cancer
203842|NCT02323893|Positron Emission Tomography|positron emission tomography
203843|NCT02323893|Cancer Immunotherapy|cancer immunotherapy
203844|NCT02323867|Transplant|transplant
203845|NCT02323867|Alternative Donor|alternative donor
203846|NCT02323854|primary, recurrent, metastatic lung tumor, ablation|primary, recurrent, metastatic lung tumor, ablation
203847|NCT02323841|cervical cancer|cervical cancer
203848|NCT02323841|neoadjuvant chemotherapy|neoadjuvant chemotherapy
203849|NCT02323841|Adverse Effects|adverse effects
203850|NCT02323815|child acute malnutrition prevention|child acute malnutrition prevention
203851|NCT02323815|behavior change communication|behavior change communication
203852|NCT02323815|lipid-based nutrient supplement|lipid-based nutrient supplement
203853|NCT02323815|screening coverage|screening coverage
204045|NCT02322723|Humira|humira
203854|NCT02323763|Magnetic Resonance Imaging|magnetic resonance imaging
203855|NCT02323763|Bipolar Disorder|bipolar disorder
203856|NCT02323763|Suicidal Ideation|suicidal ideation
203857|NCT02323698|acute intermittent hypoxia|acute intermittent hypoxia
203858|NCT02323698|incomplete spinal cord injury|incomplete spinal cord injury
203859|NCT02323685|DCI|dci
203860|NCT02323685|Delayed Cerebral Ischemia|delayed cerebral ischemia
203861|NCT02323685|SAH|sah
203862|NCT02323685|Subarachnoid Hemorrhage|subarachnoid hemorrhage
203863|NCT02323685|Aneurysmal Subarachnoid Hemorrhage|aneurysmal subarachnoid hemorrhage
203864|NCT02323685|Cerebral Ischemia|cerebral ischemia
203865|NCT02323685|Brain Ischemia|brain ischemia
203866|NCT02323659|Mycosis Fungoides|mycosis fungoides
203867|NCT02323659|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
203868|NCT02323659|Interferon|interferon
203869|NCT02323659|Methotrexate|methotrexate
203870|NCT02323646|uterine fibroids|uterine fibroids
203871|NCT02323646|leiomyoma|leiomyoma
203872|NCT02323646|fibroid tumor|fibroid tumor
203873|NCT02323646|fibroma|fibroma
203874|NCT02323633|Pediatric Attention Deficit Hyperactivity Disorder|pediatric attention deficit hyperactivity disorder
203875|NCT02323620|Acute myocardial Infarction|acute myocardial infarction
203876|NCT02323620|bone marrow|bone marrow
203877|NCT02323620|stem cells|stem cells
203878|NCT02323620|cardiovascular disease|cardiovascular disease
203879|NCT02323620|mortality|mortality
203880|NCT02323581|Thoracoabdominal|thoracoabdominal
203881|NCT02323581|Aneurysm|aneurysm
203882|NCT02323581|Endovascular|endovascular
203883|NCT02323581|Stent-Graft|stent-graft
203884|NCT02323568|ovarian cancer|ovarian cancer
203885|NCT02323568|quality of life|quality of life
203886|NCT02323568|remission more than 3 years|remission more than 3 years
203887|NCT02323555|Cancer|cancer
203888|NCT02323555|chemotherapy|chemotherapy
203889|NCT02323555|Targeted therapy|targeted therapy
203890|NCT02323555|Day Hospital|day hospital
203891|NCT02323542|Starch|starch
203892|NCT02323542|cereal products|cereal products
203893|NCT02323542|glucose kinetics|glucose kinetics
203894|NCT02323542|blood glucose|blood glucose
203895|NCT02323542|blood insulin|blood insulin
203896|NCT02323529|Orfadin|orfadin
203897|NCT02323529|Nitisinone|nitisinone
203898|NCT02323529|NTBC|ntbc
203899|NCT02323503|CRT-D|crt-d
203900|NCT02323503|replacement|replacement
203901|NCT02323503|primary prevention|primary prevention
203902|NCT02323503|ventricular tachyarrhythmias|ventricular tachyarrhythmias
203903|NCT02323490|meniscus repair|meniscus repair
203904|NCT02323490|bone marrow stimulation|bone marrow stimulation
203905|NCT02323477|cellular therapy|cellular therapy
203906|NCT02323477|chronic ischemic heart disease|chronic ischemic heart disease
203907|NCT02323477|phase 1/2 clinical study|phase 1/2 clinical study
203908|NCT02323477|human umbilical cord multipotent stem cell|human umbilical cord multipotent stem cell
203909|NCT02323477|human umbilical cord mesenchymal stem cell|human umbilical cord mesenchymal stem cell
203910|NCT02323477|ischemic heart disease|ischemic heart disease
203911|NCT02323477|bone marrow mononuclear cell|bone marrow mononuclear cell
203912|NCT02323477|allogeneic stem cell transplantation|allogeneic stem cell transplantation
203913|NCT02323438|biomarkers of tobacco exposure|biomarkers of tobacco exposure
203914|NCT02323438|exposure|exposure
203915|NCT02323438|tobacco|tobacco
203916|NCT02323438|nicotine|nicotine
203917|NCT02323438|nicotine gum|nicotine gum
203918|NCT02323438|electronic cigarette|electronic cigarette
203919|NCT02323438|e-cig|e-cig
203920|NCT02323425|stroke|stroke
203921|NCT02323425|Remote ischemic postconditioning|remote ischemic postconditioning
203922|NCT02323425|symptomatic atherosclerotic intracranial arterial stenosis|symptomatic atherosclerotic intracranial arterial stenosis
203923|NCT02323412|Low back pain|low back pain
203924|NCT02323412|Chronic|chronic
203925|NCT02323412|Modic Changes|modic changes
203926|NCT02323412|MRI|mri
203927|NCT02323412|epigenetics|epigenetics
203928|NCT02323412|antibiotics|antibiotics
203929|NCT02323412|randomized placebo controlled trial|randomized placebo controlled trial
203930|NCT02323386|Dynamic RSA|dynamic rsa
203931|NCT02323386|Knee|knee
203932|NCT02323386|Total Knee Arthroplasty|total knee arthroplasty
203933|NCT02323386|Kinematic Analysis|kinematic analysis
203934|NCT02323373|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
203935|NCT02323373|Tranexamic Acid|tranexamic acid
203936|NCT02323373|Drug Administration Routes|drug administration routes
203937|NCT02323360|SBRT|sbrt
203938|NCT02323360|TACE|tace
203939|NCT02323360|TAE|tae
203940|NCT02323321|heart transplant|heart transplant
203941|NCT02323321|heart preservation|heart preservation
203942|NCT02323321|beating heart transplant|beating heart transplant
203943|NCT02323295|Malignant bone tumors|malignant bone tumors
203944|NCT02323282|Dose-response relationship|dose-response relationship
203945|NCT02323282|Drug|drug
203946|NCT02323256|cochlear implant|cochlear implant
203947|NCT02323256|deafness|deafness
203948|NCT02323256|audiometry|audiometry
203949|NCT02323256|speech perception|speech perception
203950|NCT02323256|severe to profound deafness restored with cochlear implantation|severe to profound deafness restored with cochlear implantation
203951|NCT02323243|Detrusor striated sphincter dyssynergia|detrusor striated sphincter dyssynergia
203952|NCT02323243|Temporary urethral stent|temporary urethral stent
203953|NCT02323217|Imidazoline Receptor 2|imidazoline receptor 2
203954|NCT02323217|(4,5-dihydro-1H-imidazol-2-yl)-1-methyl-1H-indole|(4,5-dihydro-1h-imidazol-2-yl)-1-methyl-1h-indole
203955|NCT02323217|BU99008|bu99008
203956|NCT02323217|Radionuclide Imaging|radionuclide imaging
203957|NCT02323217|Molecular Imaging|molecular imaging
203958|NCT02323217|Healthy Volunteers|healthy volunteers
203959|NCT02323217|Alzheimer Disease|alzheimer disease
203960|NCT02323204|posttraumatic stress|posttraumatic stress
203961|NCT02323178|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
203962|NCT02323178|thrombocytopenia|thrombocytopenia
203963|NCT02323178|eltrombopag|eltrombopag
203964|NCT02323152|women|women
203965|NCT02323152|high risk|high risk
203966|NCT02323139|High risk MDS|high risk mds
203967|NCT02323139|Azacitidine|azacitidine
203968|NCT02323139|LDE255|lde255
203969|NCT02323126|Non small cell lung cancer,|non small cell lung cancer,
203970|NCT02323126|NSCLC,|nsclc,
203971|NCT02323126|EGFR-mutated,|egfr-mutated,
203972|NCT02323126|EGF816,|egf816,
203973|NCT02323126|INC280,|inc280,
203974|NCT02323126|Nivolumab,|nivolumab,
203975|NCT02323126|EGFR-T790M NSCLC,|egfr-t790m nsclc,
203976|NCT02323126|EGFR wild-type (wt),|egfr wild-type (wt),
203977|NCT02323126|cMET positive NSCLC,|cmet positive nsclc,
203978|NCT02323126|cMET negative NSCLC|cmet negative nsclc
203979|NCT02323113|Drug therapy|drug therapy
203980|NCT02323100|cystic fibrosis|cystic fibrosis
203981|NCT02323100|corrector|corrector
203982|NCT02323100|glycerol phenylbutyrate|glycerol phenylbutyrate
203983|NCT02323100|nasal potential difference|nasal potential difference
203984|NCT02323087|Antibiotic resistance|antibiotic resistance
203985|NCT02323087|Point of care tests|point of care tests
203986|NCT02323087|Primary Health Care|primary health care
203987|NCT02323022|AML|aml
203988|NCT02323022|cladribine|cladribine
203989|NCT02323022|induction therapy|induction therapy
203990|NCT02323009|Transpulmonary pressure|transpulmonary pressure
203991|NCT02323009|Esophageal balloon|esophageal balloon
203992|NCT02323009|Esophageal pressure monitoring device|esophageal pressure monitoring device
203993|NCT02323009|Cstat|cstat
203994|NCT02323009|Static effective compliance|static effective compliance
203995|NCT02323009|Ventilator weaning|ventilator weaning
203996|NCT02323009|Morbidly Obese Ventilator Dependent Tracheotomized Patients|morbidly obese ventilator dependent tracheotomized patients
203997|NCT02322983|Cerebral Palsy|cerebral palsy
203998|NCT02322983|Dental Care|dental care
203999|NCT02322983|Conscious Sedation|conscious sedation
204000|NCT02322983|Autonomic Nervous System|autonomic nervous system
204001|NCT02322983|Nitrous Oxide|nitrous oxide
204002|NCT02322970|intracranial hypertension|intracranial hypertension
204003|NCT02322970|tcd|tcd
204004|NCT02322970|non invasive|non invasive
204005|NCT02322970|ICP|icp
204006|NCT02322944|acute myocardial infarction|acute myocardial infarction
204007|NCT02322944|quality improvement|quality improvement
204008|NCT02322944|reperfusion therapy|reperfusion therapy
204009|NCT02322905|informal caregivers|informal caregivers
204010|NCT02322905|caregiving|caregiving
204011|NCT02322905|psychotherapy for caregivers|psychotherapy for caregivers
204012|NCT02322905|cancer|cancer
204013|NCT02322905|emotion regulation|emotion regulation
204014|NCT02322905|distress|distress
204015|NCT02322905|inflammation|inflammation
204016|NCT02322892|Thiamine|thiamine
204017|NCT02322892|Vitamin B1|vitamin b1
204018|NCT02322892|Coronary artery bypass grafting|coronary artery bypass grafting
204019|NCT02322892|Cardiac surgery|cardiac surgery
204020|NCT02322892|Lactate|lactate
204021|NCT02322892|Pyruvate dehydrogenase|pyruvate dehydrogenase
204022|NCT02322879|Acetaminophen|acetaminophen
204023|NCT02322879|Propylene glycol|propylene glycol
204024|NCT02322866|acne|acne
204025|NCT02322853|Metastatic breast cancer|metastatic breast cancer
204026|NCT02322853|p38 map kinase|p38 map kinase
204027|NCT02322853|tamoxifen|tamoxifen
204028|NCT02322853|LY2228820|ly2228820
204029|NCT02322853|Postmenopausal woman with advanced or metastatic breast cancer progressing on aromatase inhibitors (AI)|postmenopausal woman with advanced or metastatic breast cancer progressing on aromatase inhibitors (ai)
204030|NCT02322827|hiv/aids|hiv/aids
204031|NCT02322788|Inhalation, Pharmacodynamic, Patients,|inhalation, pharmacodynamic, patients,
204032|NCT02322775|Asthma, Bronchial Diseases, Respiratory Tract Diseases, Lung Diseases, Obstructive Lung Diseases,|asthma, bronchial diseases, respiratory tract diseases, lung diseases, obstructive lung diseases,
204033|NCT02322762|Type 2 diabetes mellitus|type 2 diabetes mellitus
204034|NCT02322762|Anti-diabetic management patterns|anti-diabetic management patterns
204035|NCT02322749|bioequivalence|bioequivalence
204036|NCT02322749|bioavailability|bioavailability
204037|NCT02322749|pharmacokinetics|pharmacokinetics
204038|NCT02322749|Phase I|phase i
204039|NCT02322749|AZD6244|azd6244
204040|NCT02322749|cancer|cancer
204041|NCT02322736|Metastatic Colorectal Cancer, wild type RAS, Panitumumab, Vectibix, Greece|metastatic colorectal cancer, wild type ras, panitumumab, vectibix, greece
204042|NCT02322723|Adalimumab|adalimumab
204043|NCT02322723|real life|real life
204044|NCT02322723|RA|ra
204046|NCT02322723|Rheumatoid Arthritis|rheumatoid arthritis
204047|NCT02322723|effectiveness|effectiveness
204048|NCT02322710|non-inferiority|non-inferiority
204049|NCT02322710|randomized|randomized
204050|NCT02322710|TulleGras|tullegras
204051|NCT02322710|Urgotul|urgotul
204052|NCT02322710|healing|healing
204053|NCT02322710|surgical acute wounds|surgical acute wounds
204054|NCT02322710|pain|pain
204055|NCT02322697|Carnitine|carnitine
204056|NCT02322697|hemodialysis|hemodialysis
204057|NCT02322697|fatty acid|fatty acid
204058|NCT02322697|imaging|imaging
204059|NCT02322697|heart|heart
204060|NCT02322684|Bougie|bougie
204061|NCT02322684|Air-Q|air-q
204062|NCT02322684|Insertion|insertion
204063|NCT02322671|chewable tablet|chewable tablet
204064|NCT02322671|montelukast sodium|montelukast sodium
204065|NCT02322671|healthy adult subjects|healthy adult subjects
204066|NCT02322671|relative bioavailability|relative bioavailability
204067|NCT02322671|GW483100|gw483100
204068|NCT02322593|Gastric Cancer|gastric cancer
204069|NCT02322593|Gastrointestinal Diseases|gastrointestinal diseases
204070|NCT02322593|Gastrointestinal Neoplasms|gastrointestinal neoplasms
204071|NCT02322593|First Line Treatment|first line treatment
204072|NCT02322593|Antineoplastic Agents|antineoplastic agents
204073|NCT02322580|anti-TNF|anti-tnf
204074|NCT02322580|therapeutic drug monitoring|therapeutic drug monitoring
204075|NCT02322580|immunogenicity|immunogenicity
204076|NCT02322554|electronic health records|electronic health records
204077|NCT02322554|Qualified Clinical Data Registry|qualified clinical data registry
204078|NCT02322554|PQRS|pqrs
204079|NCT02322554|quality reporting|quality reporting
204080|NCT02322554|cellular based products|cellular based products
204081|NCT02322554|bioengieered skin|bioengieered skin
204082|NCT02322554|USWR|uswr
204083|NCT02322528|Non-invasive instruments|non-invasive instruments
204084|NCT02322528|Environment|environment
204085|NCT02322528|Wavefront|wavefront
204086|NCT02322528|Placido Disk|placido disk
204087|NCT02322528|Ellipsometer|ellipsometer
204088|NCT02322528|Thermal Imaging|thermal imaging
204089|NCT02322515|Knee|knee
204090|NCT02322515|Proprioception|proprioception
204091|NCT02322515|Electromyography|electromyography
204092|NCT02322515|Taping|taping
204093|NCT02322502|laryngeal mask airway|laryngeal mask airway
204094|NCT02322502|desflurane|desflurane
204095|NCT02322502|sevoflurane|sevoflurane
204096|NCT02322502|propofol|propofol
204097|NCT02322489|microcurent|microcurent
204098|NCT02322489|pain|pain
204099|NCT02322489|flexibility|flexibility
204100|NCT02322463|patients who were admitted to the pediatric ED|patients who were admitted to the pediatric ed
204101|NCT02322411|Stroke|stroke
204102|NCT02322411|Deglutition|deglutition
204103|NCT02322411|Deglutition disorders|deglutition disorders
204104|NCT02322411|Resistance training|resistance training
204105|NCT02322385|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
204106|NCT02322385|PKD 1 gene|pkd 1 gene
204107|NCT02322385|PKD 2 gene|pkd 2 gene
204108|NCT02322385|Truncational mutation|truncational mutation
204109|NCT02322385|Hypomorphic mutation|hypomorphic mutation
204110|NCT02322372|femoral blockade|femoral blockade
204111|NCT02322372|bupivacaine|bupivacaine
204112|NCT02322346|posttonsillectomy pain|posttonsillectomy pain
204113|NCT02322346|levobupivacaine|levobupivacaine
204114|NCT02322320|Multiple Myeloma|multiple myeloma
204115|NCT02322320|Lenalidomide|lenalidomide
204116|NCT02322320|Maintenance Therapy|maintenance therapy
204117|NCT02322320|Progression|progression
204118|NCT02322320|Long-term|long-term
204119|NCT02322320|Anti-Myeloma Agents|anti-myeloma agents
204120|NCT02322320|Hematologic Disorders|hematologic disorders
204121|NCT02322307|Inflammatory Bowel Disease|inflammatory bowel disease
204122|NCT02322307|Crohn's Disease|crohn's disease
204123|NCT02322307|Ulcerative Colitis|ulcerative colitis
204124|NCT02322307|Colitis|colitis
204125|NCT02322307|PRO|pro
204126|NCT02322307|Patient-centric|patient-centric
204127|NCT02322307|HealthPROMISE|healthpromise
204128|NCT02322294|Protein|protein
204129|NCT02322294|mung bean|mung bean
204130|NCT02322294|glucose|glucose
204131|NCT02322294|triglycerides|triglycerides
204132|NCT02322294|insulin|insulin
204133|NCT02322294|body weight,|body weight,
204134|NCT02322294|DXA scan|dxa scan
204135|NCT02322281|cancer|cancer
204136|NCT02322281|metastatic|metastatic
204137|NCT02322281|locally advanced|locally advanced
204138|NCT02322281|lung|lung
204139|NCT02322281|non-small cell lung cancer|non-small cell lung cancer
204140|NCT02322281|NSCLC|nsclc
204141|NCT02322281|epidermal growth factor receptor|epidermal growth factor receptor
204142|NCT02322281|EGFR|egfr
204143|NCT02322281|T790M|t790m
204144|NCT02322281|CO-1686|co-1686
204145|NCT02322281|unresectable|unresectable
204146|NCT02322281|recurrent|recurrent
204147|NCT02322281|EGFR-directed therapy|egfr-directed therapy
204148|NCT02322281|irreversible EGFR inhibitor|irreversible egfr inhibitor
204149|NCT02322281|TIGER|tiger
204150|NCT02322281|Rociletinib|rociletinib
204249|NCT02321800|cefiderocol|cefiderocol
204151|NCT02322268|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
204152|NCT02322268|Cosmos Caudatus|cosmos caudatus
204153|NCT02322268|Ulam Raja|ulam raja
204154|NCT02322268|Metabolomic profiling|metabolomic profiling
204155|NCT02322268|antioxidant|antioxidant
204156|NCT02322255|Natural History Study|natural history study
204157|NCT02322255|Non-interventional Study|non-interventional study
204158|NCT02322255|Observational Study|observational study
204159|NCT02322255|Heterotopic ossification|heterotopic ossification
204160|NCT02322255|Fibrodysplasia Ossificans Progressiva|fibrodysplasia ossificans progressiva
204161|NCT02322255|FOP disease progression|fop disease progression
204162|NCT02322255|FOP flare-up progression|fop flare-up progression
204163|NCT02322255|Clementia|clementia
204164|NCT02322255|Myositosis Ossificans Progressiva|myositosis ossificans progressiva
204165|NCT02322255|Munchmeyer's Disease|munchmeyer's disease
204166|NCT02322255|FOP|fop
204167|NCT02322255|Palovarotene|palovarotene
204168|NCT02322229|VMT|vmt
204169|NCT02322229|sVMA|svma
204170|NCT02322229|vitrectomy|vitrectomy
204171|NCT02322229|ocriplasmin|ocriplasmin
204172|NCT02322216|Allergies|allergies
204173|NCT02322216|Ocular|ocular
204174|NCT02322203|Niacin|niacin
204175|NCT02322203|Cholesterol|cholesterol
204176|NCT02322203|High-Density Lipoprotein|high-density lipoprotein
204177|NCT02322203|Low-Density Lipoprotein|low-density lipoprotein
204178|NCT02322203|Lipoproteins|lipoproteins
204179|NCT02322190|Steroid Failure|steroid failure
204180|NCT02322190|Immunomodulation|immunomodulation
204181|NCT02322190|Corticosteroid Therapy|corticosteroid therapy
204182|NCT02322177|Inborn Error of Metabolism|inborn error of metabolism
204183|NCT02322177|Pregnancy|pregnancy
204184|NCT02322177|Methylmalonic Acidemia|methylmalonic acidemia
204185|NCT02322177|Urea Cycle Disorder|urea cycle disorder
204186|NCT02322164|Skin|skin
204187|NCT02322164|TEMPERATURE|temperature
204188|NCT02322164|Placebo|placebo
204189|NCT02322151|Filgrastim|filgrastim
204190|NCT02322151|Neupogen|neupogen
204191|NCT02322151|Transplant|transplant
204192|NCT02322151|Breast Feeding|breast feeding
204193|NCT02322151|Concentration|concentration
204194|NCT02322125|walking|walking
204195|NCT02322125|locomotion|locomotion
204196|NCT02322125|rehabilitation|rehabilitation
204197|NCT02322112|Dietary Fiber|dietary fiber
204198|NCT02322112|Gastrointestinal Microbiome|gastrointestinal microbiome
204199|NCT02322112|Overweight and Obesity|overweight and obesity
204200|NCT02322112|Personalized Nutrition|personalized nutrition
204201|NCT02322112|Inflammation|inflammation
204202|NCT02322112|Metabolism|metabolism
204203|NCT02322099|human immunodeficiency virus|human immunodeficiency virus
204204|NCT02322099|bone diseases|bone diseases
204205|NCT02322099|osteopenia|osteopenia
204206|NCT02322099|osteoporosis|osteoporosis
204207|NCT02322099|fracture|fracture
204208|NCT02322099|bone turnover|bone turnover
204209|NCT02322099|alendronate|alendronate
204210|NCT02322099|antiretroviral|antiretroviral
204211|NCT02322060|IVA, ovary tissue grafting, POI|iva, ovary tissue grafting, poi
204212|NCT02322034|chronic heart failure|chronic heart failure
204213|NCT02322034|multiple neurohormonal axis disequilibrium|multiple neurohormonal axis disequilibrium
204214|NCT02322034|growth hormone deficiency|growth hormone deficiency
204215|NCT02322034|Insulin-like growth factor-1 (IGF-1)|insulin-like growth factor-1 (igf-1)
204216|NCT02322034|metabolic deficiency syndrome|metabolic deficiency syndrome
204217|NCT02322034|interval training|interval training
204218|NCT02322021|E2609|e2609
204219|NCT02322021|Mild Cognitive Impairment|mild cognitive impairment
204220|NCT02322021|Mild to Moderate Dementia|mild to moderate dementia
204221|NCT02322021|Alzheimer's Disease|alzheimer's disease
204222|NCT02322021|Prodromal Alzheimer's Disease|prodromal alzheimer's disease
204223|NCT02321982|Mohs surgery|mohs surgery
204224|NCT02321982|Preoperative consultation|preoperative consultation
204225|NCT02321969|Chemoprevention|chemoprevention
204226|NCT02321969|Colorectal adenomatous polyp|colorectal adenomatous polyp
204227|NCT02321969|Green tea extract|green tea extract
204228|NCT02321956|ASA class 1,2|asa class 1,2
204229|NCT02321956|age 1-6 years|age 1-6 years
204230|NCT02321956|General anesthesia with ETT|general anesthesia with ett
204231|NCT02321930|Rheumatoid Arthritis|rheumatoid arthritis
204232|NCT02321930|Musculoskeletal Ultrasound|musculoskeletal ultrasound
204233|NCT02321930|Tofacitinib|tofacitinib
204234|NCT02321930|biomarker|biomarker
204235|NCT02321904|Confocal microscopy|confocal microscopy
204236|NCT02321904|Cornea|cornea
204237|NCT02321904|Neuropathy|neuropathy
204238|NCT02321904|Detection|detection
204239|NCT02321904|Diabetes|diabetes
204240|NCT02321839|neovascular age-related macular degeneration|neovascular age-related macular degeneration
204241|NCT02321839|Ranibizumab|ranibizumab
204242|NCT02321839|Treat and extend|treat and extend
204243|NCT02321813|quality of life|quality of life
204244|NCT02321813|colorectal cancer|colorectal cancer
204245|NCT02321813|definitive RCT|definitive rct
204246|NCT02321813|complex intervention|complex intervention
204247|NCT02321800|S-649266|s-649266
204248|NCT02321800|complicated urinary tract infection|complicated urinary tract infection
204250|NCT02321800|acute uncomplicated pyelonephritis|acute uncomplicated pyelonephritis
204251|NCT02321800|Gram-negative pathogens|gram-negative pathogens
204252|NCT02321800|imipenem/cilastatin|imipenem/cilastatin
204253|NCT02321787|Anesthesia, Caudal|anesthesia, caudal
204254|NCT02321787|Ultrasonography|ultrasonography
204255|NCT02321774|Stress|stress
204256|NCT02321774|Virtual Reality|virtual reality
204257|NCT02321774|Wearable Sensor|wearable sensor
204258|NCT02321774|Wellness|wellness
204259|NCT02321761|Amantadine hydrochloride|amantadine hydrochloride
204260|NCT02321761|Rehabilitation|rehabilitation
204261|NCT02321761|Acquired Brain Injury|acquired brain injury
204262|NCT02321761|TBI|tbi
204263|NCT02321748|HSV|hsv
204264|NCT02321748|Herpes|herpes
204265|NCT02321748|volunteers|volunteers
204266|NCT02321748|drug-drug interaction|drug-drug interaction
204267|NCT02321735|Long-Term Survivor|long-term survivor
204268|NCT02321735|Genomic|genomic
204269|NCT02321735|Survivorship|survivorship
204270|NCT02321735|Quality of Life|quality of life
204271|NCT02321722|Colonoscopy|colonoscopy
204272|NCT02321696|physiotherapy|physiotherapy
204273|NCT02321696|manual therapy|manual therapy
204274|NCT02321696|acupuncture|acupuncture
204275|NCT02321696|eccentric exercise|eccentric exercise
204276|NCT02321670|operative technique|operative technique
204277|NCT02321644|CC-90001|cc-90001
204278|NCT02321644|PHARMACOKINETICS|pharmacokinetics
204279|NCT02321644|PHARMACODYNAMICS|pharmacodynamics
204280|NCT02321644|HEALTHY SUBJECTS|healthy subjects
204281|NCT02321644|SINGLE DOSE|single dose
204282|NCT02321644|MULTIPLE DOSE|multiple dose
204283|NCT02321644|PUNCH BIOPSY|punch biopsy
204284|NCT02321631|Malnourished|malnourished
204285|NCT02321631|Head and Neck Cancer|head and neck cancer
204286|NCT02321631|Surgery|surgery
204287|NCT02321618|Hypertension|hypertension
204288|NCT02321618|High Blood Pressure|high blood pressure
204289|NCT02321618|African American men|african american men
204290|NCT02321618|Black men|black men
204291|NCT02321618|barbershop|barbershop
204292|NCT02321605|Best Possible Self|best possible self
204293|NCT02321605|Positive Psychology|positive psychology
204294|NCT02321605|Optimism|optimism
204295|NCT02321605|Positive Technology|positive technology
204296|NCT02321605|Future Thinking|future thinking
204297|NCT02321592|Hodgkin Lymphoma|hodgkin lymphoma
204298|NCT02321592|AFM13|afm13
204299|NCT02321592|Natural Killer Cells|natural killer cells
204300|NCT02321553|metabolic syndrome|metabolic syndrome
204301|NCT02321553|glucose|glucose
204302|NCT02321553|cholesterol|cholesterol
204303|NCT02321553|brown rice|brown rice
204304|NCT02321553|inflammation|inflammation
204305|NCT02321553|oxidative stress|oxidative stress
204306|NCT02321540|Lung Cancer|lung cancer
204307|NCT02321540|Non-small cell lung cancer|non-small cell lung cancer
204308|NCT02321540|NSCLC|nsclc
204309|NCT02321540|Epidermal growth factor receptor mutations|epidermal growth factor receptor mutations
204310|NCT02321540|EGFR|egfr
204311|NCT02321540|Recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
204312|NCT02321540|Ibrutinib|ibrutinib
204313|NCT02321540|PCI-32765|pci-32765
204314|NCT02321540|Imbruvica|imbruvica
204315|NCT02321527|Breast Cancer|breast cancer
204316|NCT02321527|Microbubble contrast-enhanced ultrasound|microbubble contrast-enhanced ultrasound
204317|NCT02321527|CEUS|ceus
204318|NCT02321527|Sentinel lymph nodes|sentinel lymph nodes
204319|NCT02321527|SLN|sln
204320|NCT02321527|Perflutren Protein-Type A Microspheres Injectable Suspension|perflutren protein-type a microspheres injectable suspension
204321|NCT02321527|OPTISON™|optison™
204322|NCT02321527|Ultrasound|ultrasound
204323|NCT02321527|Breast biopsy|breast biopsy
204324|NCT02321527|Radioactive seed|radioactive seed
204325|NCT02321527|Phone call|phone call
204326|NCT02321527|Fine needle aspiration|fine needle aspiration
204327|NCT02321527|FNA|fna
204328|NCT02321501|Head and Neck Cancer|head and neck cancer
204329|NCT02321501|Lung Cancer|lung cancer
204330|NCT02321501|Non small cell lung|non small cell lung
204331|NCT02321501|NSCLC|nsclc
204332|NCT02321501|Metastatic|metastatic
204333|NCT02321501|Locally advanced|locally advanced
204334|NCT02321501|Metastatic solid tumors|metastatic solid tumors
204335|NCT02321501|Anaplastic lymphoma kinase|anaplastic lymphoma kinase
204336|NCT02321501|ALK|alk
204337|NCT02321501|Ceritinib|ceritinib
204338|NCT02321501|LDK378|ldk378
204339|NCT02321501|Zykadia|zykadia
204340|NCT02321501|Everolimus|everolimus
204341|NCT02321501|Afinitor|afinitor
204342|NCT02321501|Zortress|zortress
204343|NCT02321501|RAD001|rad001
204344|NCT02321501|Pharmacokinetic|pharmacokinetic
204345|NCT02321501|PK|pk
204346|NCT02321501|Biomarker testing|biomarker testing
204347|NCT02321475|Psycho-emotional symptoms|psycho-emotional symptoms
204348|NCT02321462|preparation|preparation
204349|NCT02321423|Nail Dystrophy|nail dystrophy
204350|NCT02321423|Plantar Keratoderma|plantar keratoderma
204351|NCT02321423|Palmar Keratoderma|palmar keratoderma
204352|NCT02321423|Leukokeratosis|leukokeratosis
204353|NCT02321423|Cysts|cysts
204354|NCT02321423|Pain|pain
204355|NCT02321423|KRT17|krt17
204356|NCT02321423|KRT16|krt16
204357|NCT02321423|KRT6A|krt6a
204358|NCT02321423|KRT6B|krt6b
204359|NCT02321423|KRT6C|krt6c
204360|NCT02321397|oxycodone naloxone combination|oxycodone naloxone combination
204361|NCT02321397|severe chronic and non-malignant pain|severe chronic and non-malignant pain
204362|NCT02321397|Malignant and non-malignant pain that requires around-the clock opioid therapy|malignant and non-malignant pain that requires around-the clock opioid therapy
204363|NCT02321358|Behavior Change|behavior change
204364|NCT02321358|Objectively Measured Physical Activity|objectively measured physical activity
204365|NCT02321358|Survivorship|survivorship
204366|NCT02321345|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
204367|NCT02321345|Hematological Malignancies|hematological malignancies
204368|NCT02321345|Palliative Care|palliative care
204369|NCT02321345|Supportive care|supportive care
204370|NCT02321332|Palmar hyperhidrosis|palmar hyperhidrosis
204371|NCT02321332|Endoscopic thoracic sympathectomy|endoscopic thoracic sympathectomy
204372|NCT02321319|chronic pain|chronic pain
204373|NCT02321319|pediatric|pediatric
204374|NCT02321293|curcumin|curcumin
204375|NCT02321293|lung cancer|lung cancer
204376|NCT02321293|TKI|tki
204377|NCT02321267|AMD|amd
204378|NCT02321267|PCV|pcv
204379|NCT02321267|RAP|rap
204380|NCT02321267|RVO|rvo
204381|NCT02321267|DME|dme
204382|NCT02321267|ERM|erm
204383|NCT02321267|MH|mh
204384|NCT02321267|mCNV|mcnv
204385|NCT02321254|Stroke|stroke
204386|NCT02321254|Upper limb|upper limb
204387|NCT02321254|Robotics|robotics
204388|NCT02321254|Electromyography|electromyography
204389|NCT02321254|Rehabilitation|rehabilitation
204390|NCT02321241|Wet-AMD|wet-amd
204391|NCT02321241|Refractory patients to ranibizumab|refractory patients to ranibizumab
204392|NCT02321241|Real life|real life
204393|NCT02321241|Switch|switch
204394|NCT02321241|Aflibercept|aflibercept
204395|NCT02321228|Salpingectomy|salpingectomy
204396|NCT02321228|Delayed oophorectomy|delayed oophorectomy
204397|NCT02321228|Salpingo-oophorectomy|salpingo-oophorectomy
204398|NCT02321228|Quality of life|quality of life
204399|NCT02321228|Ovarian cancer|ovarian cancer
204400|NCT02321228|BRCA|brca
204401|NCT02321215|AECOPD|aecopd
204402|NCT02321215|COPD|copd
204403|NCT02321215|education|education
204404|NCT02321202|omega-3|omega-3
204405|NCT02321202|Progression|progression
204406|NCT02321202|parenteral nutrition|parenteral nutrition
204407|NCT02321150|Pterygium|pterygium
204408|NCT02321150|Pterygiums|pterygiums
204409|NCT02321150|Pterygia|pterygia
204410|NCT02321150|Graft|graft
204411|NCT02321150|Autograft|autograft
204412|NCT02321150|Excision|excision
204413|NCT02321150|Surgery|surgery
204414|NCT02321150|Eye|eye
204415|NCT02321150|electrocautery|electrocautery
204416|NCT02321150|polyglactin|polyglactin
204417|NCT02321124|Constipation|constipation
204418|NCT02321124|connective tissue manipulation|connective tissue manipulation
204419|NCT02321124|conservative therapy|conservative therapy
204420|NCT02321124|massage|massage
204421|NCT02321124|randomized controlled trial|randomized controlled trial
204422|NCT02321111|Insulin signaling and glucose disposal in muscle|insulin signaling and glucose disposal in muscle
204423|NCT02321111|Hepatic insulin sensitivity|hepatic insulin sensitivity
204424|NCT02321111|TLR4 signaling and inflammatory gene expression|tlr4 signaling and inflammatory gene expression
204425|NCT02321111|Plasma cytokine concentration|plasma cytokine concentration
204426|NCT02321111|Intramyocellular diacylglycerol and ceramide content|intramyocellular diacylglycerol and ceramide content
204427|NCT02321098|Onychomycosis|onychomycosis
204428|NCT02321098|antifungal|antifungal
204429|NCT02321072|oxygen|oxygen
204430|NCT02321072|hypoxia|hypoxia
204431|NCT02321072|hyperoxia|hyperoxia
204432|NCT02321072|critical care|critical care
204433|NCT02321072|intensive care|intensive care
204434|NCT02321059|incisional hernia|incisional hernia
204435|NCT02321059|hernia|hernia
204436|NCT02321059|abdominal wall strength|abdominal wall strength
204437|NCT02321059|validation|validation
204438|NCT02321059|physical activity|physical activity
204439|NCT02321046|Non-Small Cell Lung Cancer, NSCLC, Epidermal growth factor receptor, EGFR|non-small cell lung cancer, nsclc, epidermal growth factor receptor, egfr
204440|NCT02321033|glycemic index|glycemic index
204441|NCT02321033|inactivity|inactivity
204442|NCT02321033|insulin sensitivity|insulin sensitivity
204443|NCT02321033|metabolic flexibility|metabolic flexibility
204444|NCT02321033|arterial stiffness|arterial stiffness
204445|NCT02321033|young men|young men
204446|NCT02320994|stroke|stroke
204447|NCT02320994|aftercare|aftercare
204448|NCT02320981|GERD|gerd
204449|NCT02320981|EGD|egd
204450|NCT02320981|pH testing|ph testing
204451|NCT02320981|eosinophilic esophagitis|eosinophilic esophagitis
204452|NCT02320981|impedance testing|impedance testing
204453|NCT02320955|autologous bone flap|autologous bone flap
204454|NCT02320955|decompressive craniectomy|decompressive craniectomy
204455|NCT02320955|malignant brain swelling|malignant brain swelling
204456|NCT02320955|patient specific implant|patient specific implant
204457|NCT02320955|bone resorption|bone resorption
204458|NCT02320955|aseptic bone necrosis|aseptic bone necrosis
204459|NCT02320942|Bone Marrow Transplantation|bone marrow transplantation
204460|NCT02320942|Exercise|exercise
204461|NCT02320942|Rehabilitation|rehabilitation
204462|NCT02320942|Cancer|cancer
204463|NCT02320929|irrigation|irrigation
204464|NCT02320929|tenosynovitis|tenosynovitis
204465|NCT02320929|purulent|purulent
204466|NCT02320929|closed-catheter|closed-catheter
204467|NCT02320929|flexor tendon|flexor tendon
204468|NCT02320903|Criminal Justice|criminal justice
204469|NCT02320903|Juvenile Delinquency|juvenile delinquency
204470|NCT02320890|transcranial direct current stimulation|transcranial direct current stimulation
204471|NCT02320890|tDCS|tdcs
204472|NCT02320890|Mild Cognitive Impairment|mild cognitive impairment
204473|NCT02320890|MCI|mci
204474|NCT02320864|muscle strength|muscle strength
204475|NCT02320864|muscle weakness|muscle weakness
204476|NCT02320864|hospitalization|hospitalization
204477|NCT02320864|surgery|surgery
204478|NCT02320864|total knee replacement|total knee replacement
204479|NCT02320851|Somatoform disorder|somatoform disorder
204480|NCT02320851|Functional vertigo/dizziness|functional vertigo/dizziness
204481|NCT02320851|Chronic subjective dizziness|chronic subjective dizziness
204482|NCT02320838|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
204483|NCT02320838|Electric Stimulation Therapy|electric stimulation therapy
204484|NCT02320838|Unmodulated Alternating Currents|unmodulated alternating currents
204485|NCT02320838|Neural Conduction|neural conduction
204486|NCT02320838|Pain Threshold|pain threshold
204487|NCT02320825|Stereotactic Radiosurgery (SRS)|stereotactic radiosurgery (srs)
204488|NCT02320825|Single-Fraction|single-fraction
204489|NCT02320825|Hypofractionated|hypofractionated
204490|NCT02320825|Spinal surgery|spinal surgery
204491|NCT02320825|14-233|14-233
204492|NCT02320799|interpersonal psychotherapy|interpersonal psychotherapy
204493|NCT02320799|HIV|hiv
204494|NCT02320799|women|women
204495|NCT02320799|gender based violence|gender based violence
204496|NCT02320799|mental health|mental health
204497|NCT02320799|africa|africa
204498|NCT02320799|kenya|kenya
204499|NCT02320799|global mental health|global mental health
204500|NCT02320799|HIV treatment adherence|hiv treatment adherence
204501|NCT02320786|Power mobility|power mobility
204502|NCT02320786|Wheelchair skills training|wheelchair skills training
204503|NCT02320786|Spinal Cord Injury|spinal cord injury
204504|NCT02320773|Overactive Bladder|overactive bladder
204505|NCT02320773|Quality of Life|quality of life
204506|NCT02320773|Betanis®|betanis®
204507|NCT02320773|Betmiga®|betmiga®
204508|NCT02320773|Observational|observational
204509|NCT02320773|Myrbetriq®|myrbetriq®
204510|NCT02320747|Volunteers|volunteers
204511|NCT02320734|surgical rating scale|surgical rating scale
204512|NCT02320734|neuromuscular relaxation|neuromuscular relaxation
204513|NCT02320734|Anaesthesia|anaesthesia
204514|NCT02320734|minimally invasive esophagectomy|minimally invasive esophagectomy
204515|NCT02320708|Molar,third; Teeth,wisdom; Pain, Postoperative; Dental Surgery; Third molar extraction|molar,third; teeth,wisdom; pain, postoperative; dental surgery; third molar extraction
204516|NCT02320643|Partially absorbable mesh|partially absorbable mesh
204517|NCT02320617|Lung Neoplasms|lung neoplasms
204518|NCT02320617|diffusion weighted MRI|diffusion weighted mri
204519|NCT02320617|ADC value|adc value
204520|NCT02320617|treatment effect|treatment effect
204521|NCT02320604|Liposomal amphotericin B|liposomal amphotericin b
204522|NCT02320604|AmBisome|ambisome
204523|NCT02320604|Pharmacokinetics|pharmacokinetics
204524|NCT02320604|Obesity|obesity
204525|NCT02320604|Bariatric surgery|bariatric surgery
204526|NCT02320578|Neoadjuvant Chemoptherapy|neoadjuvant chemoptherapy
204527|NCT02320578|Laparoscopy 3D|laparoscopy 3d
204528|NCT02320578|Cervical cancer|cervical cancer
204529|NCT02320565|Endometrial Cancer|endometrial cancer
204530|NCT02320565|Laparoscopy 3D|laparoscopy 3d
204531|NCT02320552|Nutritional assessment|nutritional assessment
204532|NCT02320539|MicroRNA|microrna
204533|NCT02320539|Cerebrospinal fluid|cerebrospinal fluid
204534|NCT02320526|Exercise|exercise
204535|NCT02320526|Training|training
204536|NCT02320526|Interval training|interval training
204537|NCT02320526|Systemic inflammation|systemic inflammation
204538|NCT02320526|Glucose disposal|glucose disposal
204539|NCT02320526|Insulin sensitivity|insulin sensitivity
204540|NCT02320526|Glucose effectiveness|glucose effectiveness
204541|NCT02320513|Exercise|exercise
204542|NCT02320461|diabetes mellitus|diabetes mellitus
204543|NCT02320461|cardiovascular diseases|cardiovascular diseases
204544|NCT02320461|cohort studies|cohort studies
204545|NCT02320461|hypertension|hypertension
204546|NCT02320461|obesity|obesity
204547|NCT02320461|smoking|smoking
204548|NCT02320461|social class|social class
204549|NCT02320422|liver transplant|liver transplant
204550|NCT02320422|medication adherence|medication adherence
204551|NCT02320422|intervention|intervention
204552|NCT02320409|Subjects|subjects
204553|NCT02320383|CLL|cll
204554|NCT02320357|Platelet activation|platelet activation
204555|NCT02320357|CD40 ligand|cd40 ligand
204556|NCT02320357|CD154|cd154
204557|NCT02320357|Interferon alpha|interferon alpha
204558|NCT02320357|clopidogrel|clopidogrel
204559|NCT02320318|Irritable Bowel Syndrome|irritable bowel syndrome
204560|NCT02320318|Colon, irritable|colon, irritable
204561|NCT02320318|Bowel disease|bowel disease
204562|NCT02320318|Diarrhea|diarrhea
204563|NCT02320279|Fetal Heart Rate|fetal heart rate
204564|NCT02320279|Fetal EKG|fetal ekg
204565|NCT02320279|FHR tracing|fhr tracing
204566|NCT02320279|fetal R-waves|fetal r-waves
204567|NCT02320266|Deep Brain Stimulation Surgery|deep brain stimulation surgery
204568|NCT02320253|Diabetes|diabetes
204569|NCT02320253|Obesity|obesity
204570|NCT02320253|Primary Care|primary care
204571|NCT02320253|Lifestyle Intervention|lifestyle intervention
204572|NCT02320240|antidepressants|antidepressants
204573|NCT02320240|acute kidney injury|acute kidney injury
204574|NCT02320240|SNRI|snri
204575|NCT02320240|renal failure|renal failure
204576|NCT02320240|duloxetine|duloxetine
204577|NCT02320240|CNODES|cnodes
204578|NCT02320188|modification of treatment planned|modification of treatment planned
204579|NCT02320188|Exercise|exercise
204580|NCT02320175|family centered rounds|family centered rounds
204581|NCT02320175|patient safety|patient safety
204582|NCT02320175|errors|errors
204583|NCT02320175|adverse events|adverse events
204584|NCT02320175|concordance|concordance
204585|NCT02320175|patient experience|patient experience
204586|NCT02320149|acne|acne
204587|NCT02320123|Terminal Care|terminal care
204588|NCT02320123|Decision Making|decision making
204589|NCT02320123|Communication|communication
204590|NCT02320110|Irisin|irisin
204591|NCT02320110|Adiponectin|adiponectin
204592|NCT02320110|Leptin|leptin
204593|NCT02320110|Insulin resistance|insulin resistance
204594|NCT02320110|Body Mass Index|body mass index
204595|NCT02320110|Obesity|obesity
204596|NCT02320110|Metabolic Syndrome|metabolic syndrome
204597|NCT02320110|Lipid Profile|lipid profile
204598|NCT02320110|Diabetes Mellitus|diabetes mellitus
204599|NCT02320084|HT-1|ht-1
204600|NCT02320084|Hereditary Tyrosinemia, Type I|hereditary tyrosinemia, type i
204601|NCT02320084|hypertyrosinemia type 1|hypertyrosinemia type 1
204602|NCT02320084|Orfadin|orfadin
204603|NCT02320084|Long term safety|long term safety
204604|NCT02320084|Hereditary Tyrosinemia Type 1|hereditary tyrosinemia type 1
204605|NCT02320032|Alkermes|alkermes
204606|NCT02320032|Schizophrenia|schizophrenia
204607|NCT02320032|Aripiprazole|aripiprazole
204608|NCT02320032|Aripiprazole lauroxil|aripiprazole lauroxil
204609|NCT02320032|ALKS 9072|alks 9072
204610|NCT02320006|hydrotubation|hydrotubation
204611|NCT02320006|incomplete fallopian tube obstructive infertility|incomplete fallopian tube obstructive infertility
204612|NCT02320006|Acupuncture|acupuncture
204613|NCT02319993|Suan-Zao-Ren Tang|suan-zao-ren tang
204614|NCT02319993|Tian-wang-bu-xin-dan|tian-wang-bu-xin-dan
204615|NCT02319993|Traditional Chinese Medicine|traditional chinese medicine
204616|NCT02319993|Herbs|herbs
204617|NCT02319993|Quality of life|quality of life
204618|NCT02319967|community health worker|community health worker
204619|NCT02319967|emergency|emergency
204620|NCT02319967|asthma|asthma
204621|NCT02319941|Inhibition of Platelet Reactivity|inhibition of platelet reactivity
204622|NCT02319941|ticagrelor|ticagrelor
204623|NCT02319941|clopidogrel|clopidogrel
204624|NCT02319941|Pharmacodynamics|pharmacodynamics
204625|NCT02319941|Pharmacokinetics|pharmacokinetics
204626|NCT02319915|tranexamic acid|tranexamic acid
204627|NCT02319915|knee prosthesis|knee prosthesis
204628|NCT02319915|pharmacokinetic profile|pharmacokinetic profile
204629|NCT02319863|hepatocellular carcinoma|hepatocellular carcinoma
204630|NCT02319863|prognosis|prognosis
204631|NCT02319850|sarcopenia|sarcopenia
204632|NCT02319850|screening|screening
204633|NCT02319850|geriatrics|geriatrics
204634|NCT02319850|muscle|muscle
204635|NCT02319850|aging|aging
204636|NCT02319850|ultrasound|ultrasound
204637|NCT02319798|Crohn's disease|crohn's disease
204638|NCT02319798|ulcerative colitis|ulcerative colitis
204639|NCT02319798|Inflammatory bowel disease|inflammatory bowel disease
204640|NCT02319798|IBD|ibd
204641|NCT02319772|Healthy volunteers|healthy volunteers
204642|NCT02319772|Ebola virus|ebola virus
204643|NCT02319772|Filovirus|filovirus
204644|NCT02319759|Psoriatic Arthritis|psoriatic arthritis
204645|NCT02319759|Guselkumab|guselkumab
204646|NCT02319759|Ustekinumab|ustekinumab
204647|NCT02319759|Placebo|placebo
204648|NCT02319694|Basal Ganglia|basal ganglia
204649|NCT02319694|Behavior|behavior
204650|NCT02319694|Behavioral|behavioral
204651|NCT02319694|Brain|brain
204652|NCT02319694|Cognitive|cognitive
204653|NCT02319694|Computer Simulation|computer simulation
204654|NCT02319694|Cues|cues
204655|NCT02319694|Data|data
204656|NCT02319694|Deep Brain Stimulation|deep brain stimulation
204657|NCT02319694|Disease|disease
204658|NCT02319681|Caregivers|caregivers
204659|NCT02319681|Anxiety|anxiety
204660|NCT02319681|Depression|depression
204661|NCT02319655|Epiretinal membrane|epiretinal membrane
204662|NCT02319655|Macular pucker|macular pucker
204663|NCT02319655|Membrane peeling|membrane peeling
204664|NCT02319655|pars plana vitrectomy|pars plana vitrectomy
204665|NCT02319655|Air|air
204666|NCT02319655|balanced salt solution|balanced salt solution
204667|NCT02319655|Intraoperative OCT|intraoperative oct
204668|NCT02319655|Hyporeflectivity|hyporeflectivity
204669|NCT02319655|Retina|retina
204670|NCT02319642|Rheumatoid Arthritis|rheumatoid arthritis
204671|NCT02319642|TNFα antagonist|tnfα antagonist
204672|NCT02319642|Certolizumab pegol|certolizumab pegol
204673|NCT02319642|Chinese patients|chinese patients
204674|NCT02319642|Open-label|open-label
204675|NCT02319629|Morbid obesity,|morbid obesity,
204676|NCT02319629|Cholelithiasis|cholelithiasis
204677|NCT02319629|Bariatric surgery|bariatric surgery
204678|NCT02319629|Ursodiol|ursodiol
204679|NCT02319577|NSCLC|nsclc
204680|NCT02319577|EGFR|egfr
204681|NCT02319577|vinorelbine|vinorelbine
204682|NCT02319577|gefitinib|gefitinib
204683|NCT02319564|Wheeze|wheeze
204684|NCT02319564|Asthma|asthma
204685|NCT02319564|Randomized Trial|randomized trial
204686|NCT02319564|Pre-school aged children|pre-school aged children
204687|NCT02319538|Chronic thyroiditis|chronic thyroiditis
204688|NCT02319538|Total thyroidectomy|total thyroidectomy
204689|NCT02319538|Anti-TPO|anti-tpo
204690|NCT02319538|PROMs|proms
204691|NCT02319538|SF36|sf36
204692|NCT02319538|Fatigue questionnaire|fatigue questionnaire
204693|NCT02319538|Fatigue|fatigue
204694|NCT02319538|Autoimmune symptoms|autoimmune symptoms
204695|NCT02319538|HADs|hads
204696|NCT02319538|FSS|fss
204697|NCT02319538|fVAS|fvas
204698|NCT02319525|lupus nephritis|lupus nephritis
204699|NCT02319525|lupus|lupus
204700|NCT02319525|decision-making|decision-making
204701|NCT02319525|minorities|minorities
204702|NCT02319525|immunosuppressive medications|immunosuppressive medications
204703|NCT02319525|decision-aid|decision-aid
204704|NCT02319525|treatment|treatment
204705|NCT02319525|Decision conflict|decision conflict
204706|NCT02319525|SLE|sle
204707|NCT02319486|Retinoblastoma|retinoblastoma
204708|NCT02319486|carboplatin|carboplatin
204709|NCT02319473|system of care|system of care
204710|NCT02319473|acute myocardial infarction|acute myocardial infarction
204711|NCT02319473|registry|registry
204712|NCT02319473|Primary PCI|primary pci
204713|NCT02319473|Fibrinolytic therapy|fibrinolytic therapy
204714|NCT02319460|Vitamin K Reversal Antagonist Therapy of Acute Major Bleeding|vitamin k reversal antagonist therapy of acute major bleeding
204715|NCT02319460|Warfarin Reversal|warfarin reversal
204716|NCT02319447|Living Donation|living donation
204717|NCT02319447|Kidney Transplantation|kidney transplantation
204718|NCT02319421|Alarm fatigue|alarm fatigue
204719|NCT02319395|Parkinson's Disease|parkinson's disease
204720|NCT02319395|Behaviour addiction|behaviour addiction
204721|NCT02319395|Dopamine agonist|dopamine agonist
204722|NCT02319395|Genetic.|genetic.
204723|NCT02319382|Parkinson Disease|parkinson disease
204724|NCT02319382|[18F]DPA-714|[18f]dpa-714
204725|NCT02319382|Positron emission tomography (PET)|positron emission tomography (pet)
204726|NCT02319382|Neuroinflammation|neuroinflammation
204727|NCT02319343|Glucocorticoid|glucocorticoid
204728|NCT02319343|Quadriceps muscle function|quadriceps muscle function
204729|NCT02319343|Knee arthroplasty, total|knee arthroplasty, total
204730|NCT02319330|HIV|hiv
204731|NCT02319330|Adherence|adherence
204732|NCT02319330|Mental health|mental health
204733|NCT02319330|Depression|depression
204734|NCT02319330|Women|women
204735|NCT02319330|Mobile phone technology|mobile phone technology
204736|NCT02319330|eHealth|ehealth
204737|NCT02319330|India|india
204738|NCT02319304|Pelvic Radiotherapy|pelvic radiotherapy
204739|NCT02319304|Rectal Adenocarcinoma|rectal adenocarcinoma
204740|NCT02319265|sepsis|sepsis
204741|NCT02319265|antioxidant|antioxidant
204742|NCT02319265|melatonin|melatonin
204743|NCT02319265|inflammation|inflammation
204744|NCT02319239|Prostate neoplasms|prostate neoplasms
204745|NCT02319239|Urogenital neoplasms|urogenital neoplasms
204746|NCT02319239|Genital neoplasms, male|genital neoplasms, male
204747|NCT02319239|Radiation therapy|radiation therapy
204748|NCT02319239|PSA|psa
204749|NCT02319239|DW-MRI, diffusion weighted MRI|dw-mri, diffusion weighted mri
204750|NCT02319239|Intra-fractional movement|intra-fractional movement
204751|NCT02319239|Hypofractionated radiotherapy|hypofractionated radiotherapy
204752|NCT02319239|Stereotactic|stereotactic
204753|NCT02319239|Toxicity due to radiotherapy|toxicity due to radiotherapy
204754|NCT02319239|Quality of life|quality of life
204755|NCT02319213|Intra-abdominal pressure,|intra-abdominal pressure,
204756|NCT02319213|intraocular pressure,|intraocular pressure,
204757|NCT02319213|abdominal hypertension,|abdominal hypertension,
204758|NCT02319213|laparoscopy,|laparoscopy,
204759|NCT02319213|critical care|critical care
204760|NCT02319200|Chemoprevention|chemoprevention
204761|NCT02319200|Decompensation of cirrhosis|decompensation of cirrhosis
204762|NCT02319200|Hepatocellular Carcinoma|hepatocellular carcinoma
204763|NCT02319200|Death|death
204764|NCT02319200|Efficacy|efficacy
204765|NCT02319200|Safety|safety
204766|NCT02319187|Esophageal Neoplasms|esophageal neoplasms
204767|NCT02319161|intravenous regional anesthesia|intravenous regional anesthesia
204768|NCT02319135|Acute Myeloid Leukemia|acute myeloid leukemia
204769|NCT02319122|Cerebral Palsy|cerebral palsy
204770|NCT02319122|Muscle structure|muscle structure
204771|NCT02319122|Strength training|strength training
204772|NCT02319096|Whole body vibration therapy|whole body vibration therapy
204773|NCT02319096|pelvic floor muscle training|pelvic floor muscle training
204774|NCT02319096|stress urinary incontinence|stress urinary incontinence
204775|NCT02319083|CABG|cabg
204776|NCT02319083|Coronary artery bypass surgery|coronary artery bypass surgery
204777|NCT02319083|Coronary artery bypass grafting|coronary artery bypass grafting
204778|NCT02319083|Coronary surgery|coronary surgery
204779|NCT02319083|Myocardial infarction|myocardial infarction
204780|NCT02319083|Coronary artery disease|coronary artery disease
204781|NCT02319083|Off-pump|off-pump
204782|NCT02319083|EuroSCORE|euroscore
204783|NCT02319070|Cost|cost
204784|NCT02319070|Clinical Outcomes|clinical outcomes
204785|NCT02319070|Quality of Life|quality of life
204786|NCT02319070|On Demand Treatment|on demand treatment
204787|NCT02319070|Secondary Prophylaxis|secondary prophylaxis
204788|NCT02319057|Healthy volunteer study|healthy volunteer study
204789|NCT02319044|Head and neck cancer; SCCHN|head and neck cancer; scchn
204790|NCT02319005|Cardiomyopathy|cardiomyopathy
204791|NCT02319005|Heart Failure|heart failure
204792|NCT02319005|FAC|fac
204793|NCT02319005|Amyloid|amyloid
204794|NCT02319005|Transthyretin|transthyretin
204795|NCT02319005|TTR|ttr
204796|NCT02319005|RNAi therapeutic|rnai therapeutic
204797|NCT02318953|Telemedicine|telemedicine
204798|NCT02318953|Ambulatory Surgical Procedures|ambulatory surgical procedures
204799|NCT02318953|Postoperative Care|postoperative care
204800|NCT02318953|Cost Effectiveness|cost effectiveness
204801|NCT02318953|Mobile Applications|mobile applications
204802|NCT02318953|Health Services Research|health services research
204803|NCT02318953|Breast Reconstruction|breast reconstruction
204804|NCT02318940|ultrasound guided|ultrasound guided
204805|NCT02318940|femoral vein|femoral vein
204806|NCT02318940|central venous catheter|central venous catheter
204807|NCT02318940|pediatric|pediatric
204808|NCT02318927|Deep Brain Stimulation|deep brain stimulation
204809|NCT02318914|Pyoderma Gangrenosum|pyoderma gangrenosum
204810|NCT02318914|Classic Pyoderma Gangrenosum|classic pyoderma gangrenosum
204811|NCT02318888|Small bowel obstruction, Surgery, Colorectal cancer|small bowel obstruction, surgery, colorectal cancer
204812|NCT02318875|Inflammation|inflammation
204813|NCT02318875|swell|swell
204814|NCT02318875|pain|pain
204815|NCT02318875|functional impairment|functional impairment
204816|NCT02318875|stiffness|stiffness
204817|NCT02318862|reflux|reflux
204818|NCT02318862|GERD|gerd
204819|NCT02318862|EGD|egd
204820|NCT02318862|pH testing|ph testing
204821|NCT02318849|designated organ donor, college students|designated organ donor, college students
204822|NCT02318836|hepatic, hepatic impairment, lofexidine|hepatic, hepatic impairment, lofexidine
204823|NCT02318823|social neuroscience|social neuroscience
204824|NCT02318823|emotion|emotion
204825|NCT02318823|face recognition|face recognition
204826|NCT02318823|empathy|empathy
204827|NCT02318823|beer|beer
204828|NCT02318823|alcohol|alcohol
204829|NCT02318823|social cognition|social cognition
204830|NCT02318810|Muscle relaxants|muscle relaxants
204831|NCT02318797|Chronic disease|chronic disease
204832|NCT02318797|Mental Health|mental health
204833|NCT02318797|Behavioral Health|behavioral health
204834|NCT02318797|Community mental health centers|community mental health centers
204835|NCT02318797|Intervention studies|intervention studies
204836|NCT02318797|Mixed methods|mixed methods
204837|NCT02318797|Qualitative research|qualitative research
204838|NCT02318784|neuroendocrine malignancies|neuroendocrine malignancies
204839|NCT02318784|pancreatic neuroendocrine tumors (PNETs)|pancreatic neuroendocrine tumors (pnets)
204840|NCT02318784|gastrointestinal (GI) carcinoids|gastrointestinal (gi) carcinoids
204841|NCT02318784|carfilzomib|carfilzomib
204842|NCT02318784|Kyprolis|kyprolis
204843|NCT02318784|proteasome inhibitors|proteasome inhibitors
204844|NCT02318758|This is a healthy volunteer study.|this is a healthy volunteer study.
204845|NCT02318745|Family Therapy|family therapy
204846|NCT02318745|Substance abuse prevention|substance abuse prevention
204847|NCT02318745|Minority|minority
204848|NCT02318745|randomized trials|randomized trials
204849|NCT02318745|outcome research|outcome research
204850|NCT02318745|adolescent treatment|adolescent treatment
204851|NCT02318732|violence|violence
204852|NCT02318719|Post-Herpetic Neuralgia|post-herpetic neuralgia
204853|NCT02318719|Developmental Phase III|developmental phase iii
204854|NCT02318706|Diabetic Peripheral Neuropathic Pain|diabetic peripheral neuropathic pain
204855|NCT02318641|oxygen consumption|oxygen consumption
204856|NCT02318641|retinal oximetry|retinal oximetry
204857|NCT02318628|Cardio ankle vascular index|cardio ankle vascular index
204858|NCT02318628|CAVI|cavi
204859|NCT02318628|pulse wave velocity|pulse wave velocity
204860|NCT02318628|PWV|pwv
204956|NCT02318056|Mepilex® Transfer Ag|mepilex® transfer ag
204861|NCT02318628|Non invasive arterial structure assessment|non invasive arterial structure assessment
204862|NCT02318615|Breast Neoplasm|breast neoplasm
204863|NCT02318615|Lymphedema|lymphedema
204864|NCT02318615|Autologous flap|autologous flap
204865|NCT02318615|lattismus dorsi flap|lattismus dorsi flap
204866|NCT02318602|Lennox-Gastaut syndrome|lennox-gastaut syndrome
204867|NCT02318602|Dravet syndrome|dravet syndrome
204868|NCT02318602|Treatment-resistant seizures|treatment-resistant seizures
204869|NCT02318576|Multiple Sclerosis|multiple sclerosis
204870|NCT02318563|Treatment-resistant seizures|treatment-resistant seizures
204871|NCT02318537|Treatment-resistant seizures|treatment-resistant seizures
204872|NCT02318472|Microdialysis|microdialysis
204873|NCT02318472|Patient related outcome|patient related outcome
204874|NCT02318472|Heel rise test|heel rise test
204875|NCT02318472|Immobilization|immobilization
204876|NCT02318446|Anti-epileptic drugs|anti-epileptic drugs
204877|NCT02318446|Folic acid|folic acid
204878|NCT02318446|Homocysteine|homocysteine
204879|NCT02318433|DRF|drf
204880|NCT02318433|PTOA|ptoa
204881|NCT02318433|dexamethasone|dexamethasone
204882|NCT02318420|Obstetrics|obstetrics
204883|NCT02318420|Partogram|partogram
204884|NCT02318420|ePartogram|epartogram
204885|NCT02318420|eHealth|ehealth
204886|NCT02318420|Low-income|low-income
204887|NCT02318420|Quality of care|quality of care
204888|NCT02318420|Perinatal death|perinatal death
204889|NCT02318420|Maternal death|maternal death
204890|NCT02318420|Cesarean section|cesarean section
204891|NCT02318420|Health information technology|health information technology
204892|NCT02318394|advanced solid tumors; immunotherapy; OX40; immuno-oncology|advanced solid tumors; immunotherapy; ox40; immuno-oncology
204893|NCT02318381|suprascapular nerve|suprascapular nerve
204894|NCT02318381|rotator cuff tear|rotator cuff tear
204895|NCT02318381|suprascapular neuropathy|suprascapular neuropathy
204896|NCT02318381|superior transverse scapular ligament|superior transverse scapular ligament
204897|NCT02318355|hemodilution|hemodilution
204898|NCT02318355|hemorrhage|hemorrhage
204899|NCT02318355|trauma|trauma
204900|NCT02318355|lactate|lactate
204901|NCT02318355|base deficit|base deficit
204902|NCT02318355|randomized control trial|randomized control trial
204903|NCT02318329|FGFR2b, FGFR2, FGFR, bladder neoplasms, esophageal cancer|fgfr2b, fgfr2, fgfr, bladder neoplasms, esophageal cancer
204904|NCT02318316|Exhaled breath condensate|exhaled breath condensate
204905|NCT02318316|allogeneic stem cell transplantation|allogeneic stem cell transplantation
204906|NCT02318316|pulmonary complications|pulmonary complications
204907|NCT02318290|Analgesia|analgesia
204908|NCT02318290|Critical Care|critical care
204909|NCT02318290|Hypnotics and Sedatives|hypnotics and sedatives
204910|NCT02318251|Power, rate of force development|power, rate of force development
204911|NCT02318251|involuntary|involuntary
204912|NCT02318251|reflexive|reflexive
204913|NCT02318238|evaluation|evaluation
204914|NCT02318238|exercise tolerance|exercise tolerance
204915|NCT02318238|healthy children|healthy children
204916|NCT02318238|6MWT|6mwt
204917|NCT02318225|Misoprostol|misoprostol
204918|NCT02318225|Office hysteroscopy|office hysteroscopy
204919|NCT02318225|Pain|pain
204920|NCT02318212|Cervical dilatation|cervical dilatation
204921|NCT02318199|emergence agitation|emergence agitation
204922|NCT02318199|intracranial surgery|intracranial surgery
204923|NCT02318199|general anesthesia|general anesthesia
204924|NCT02318199|incidence|incidence
204925|NCT02318199|risk factor|risk factor
204926|NCT02318186|pharmacokinetic analysis|pharmacokinetic analysis
204927|NCT02318186|remodulin|remodulin
204928|NCT02318186|trepostinil|trepostinil
204929|NCT02318186|pulmonary arterial hypertension|pulmonary arterial hypertension
204930|NCT02318173|Cervical dilatation|cervical dilatation
204931|NCT02318160|Autoimmune Thyroiditis|autoimmune thyroiditis
204932|NCT02318160|Oxidative Status|oxidative status
204933|NCT02318160|Children|children
204934|NCT02318147|Severe acute pancreatitis|severe acute pancreatitis
204935|NCT02318147|Fecal Microbiota Transplantation|fecal microbiota transplantation
204936|NCT02318147|Bacterial Translocation|bacterial translocation
204937|NCT02318147|Infectious Complications|infectious complications
204938|NCT02318134|Severe acute pancreatitis|severe acute pancreatitis
204939|NCT02318134|Fecal Microbiota Transplantation|fecal microbiota transplantation
204940|NCT02318134|Intestinal barrier dysfunction|intestinal barrier dysfunction
204941|NCT02318134|Intestinal flora|intestinal flora
204942|NCT02318121|Labor, prolonged labor, augmentation of labor|labor, prolonged labor, augmentation of labor
204943|NCT02318108|Organizational Innovation|organizational innovation
204944|NCT02318108|Primary Health Care|primary health care
204945|NCT02318095|Cancer of the pancreas|cancer of the pancreas
204946|NCT02318082|Chronic versus Graft Host Disease|chronic versus graft host disease
204947|NCT02318069|immune response|immune response
204948|NCT02318069|TBE-vaccine|tbe-vaccine
204949|NCT02318069|elderly|elderly
204950|NCT02318069|additional doses|additional doses
204951|NCT02318056|hand|hand
204952|NCT02318056|burns|burns
204953|NCT02318056|thermal|thermal
204954|NCT02318056|dressing|dressing
204955|NCT02318056|Aquacel®|aquacel®
204957|NCT02318056|Xeroform®|xeroform®
204958|NCT02318056|Bacitracin®|bacitracin®
204959|NCT02318056|partial thickness|partial thickness
204960|NCT02318056|epithelialization|epithelialization
204961|NCT02318056|wound healing|wound healing
204962|NCT02318056|scar|scar
204963|NCT02318056|scarring|scarring
204964|NCT02318043|adenosine monophosphate|adenosine monophosphate
204965|NCT02318043|histamine|histamine
204966|NCT02318043|bronchial provocation test|bronchial provocation test
204967|NCT02318043|asthma symptom score|asthma symptom score
204968|NCT02318043|asthma control|asthma control
204969|NCT02318030|Transplant|transplant
204970|NCT02318030|Adaptive Immunity|adaptive immunity
204971|NCT02318030|EBV|ebv
204972|NCT02318030|Medication Adherence|medication adherence
204973|NCT02318030|Tacrolimus|tacrolimus
204974|NCT02318030|PTLD|ptld
204975|NCT02318017|adhd|adhd
204976|NCT02318017|global network|global network
204977|NCT02318017|eeg|eeg
204978|NCT02318004|telemonitoring|telemonitoring
204979|NCT02317991|gastroesophageal adenocarcinoma|gastroesophageal adenocarcinoma
204980|NCT02317991|nab-paclitaxel|nab-paclitaxel
204981|NCT02317991|Abraxane|abraxane
204982|NCT02317991|ramucirumab|ramucirumab
204983|NCT02317991|Cyramza|cyramza
204984|NCT02317991|GE junction|ge junction
204985|NCT02317913|Kawasaki disease|kawasaki disease
204986|NCT02317913|Epidemiology|epidemiology
204987|NCT02317913|Incidence|incidence
204988|NCT02317913|Coronary arterial lesions|coronary arterial lesions
204989|NCT02317913|Shanghai|shanghai
204990|NCT02317887|Gene Transfer|gene transfer
204991|NCT02317887|X-Linked|x-linked
204992|NCT02317887|Retinoschisis|retinoschisis
204993|NCT02317887|AAV Vector|aav vector
204994|NCT02317848|Diagnosis|diagnosis
204995|NCT02317848|prognostic marker|prognostic marker
204996|NCT02317848|polygraphy|polygraphy
204997|NCT02317848|echocardiography|echocardiography
204998|NCT02317848|ECG|ecg
204999|NCT02317809|Healthy|healthy
205000|NCT02317809|Pergoveris|pergoveris
205001|NCT02317809|Bioequivalence|bioequivalence
205002|NCT02317809|Infertility|infertility
205003|NCT02317770|lidocaine, esophago-gastro-duodenoscopy|lidocaine, esophago-gastro-duodenoscopy
205004|NCT02317757|elderly cancer patients, chemotherapy toxicity|elderly cancer patients, chemotherapy toxicity
205005|NCT02317731|bowel preparation|bowel preparation
205006|NCT02317718|serum vitamin D levels|serum vitamin d levels
205007|NCT02317718|IVF|ivf
205008|NCT02317718|ovarian reserve|ovarian reserve
205009|NCT02317718|25 OHD3|25 ohd3
205010|NCT02317718|pregnancy outcome|pregnancy outcome
205011|NCT02317666|polypharmacy|polypharmacy
205012|NCT02317666|drug burden index|drug burden index
205013|NCT02317666|aged|aged
205014|NCT02317666|medication review|medication review
205015|NCT02317666|cholinergic agents|cholinergic agents
205016|NCT02317640|Testosterone|testosterone
205017|NCT02317640|Electrical Stimulation|electrical stimulation
205018|NCT02317640|Stand Training|stand training
205019|NCT02317614|Incentives|incentives
205020|NCT02317614|Smartphone|smartphone
205021|NCT02317614|Mobile intervention|mobile intervention
205022|NCT02317614|eDOT|edot
205023|NCT02317614|Adherence reinforcement|adherence reinforcement
205024|NCT02317614|Drug users|drug users
205025|NCT02317588|Oxylipins|oxylipins
205026|NCT02317588|Flax oil|flax oil
205027|NCT02317588|Fish oil|fish oil
205028|NCT02317562|Peripheral neuropathy|peripheral neuropathy
205029|NCT02317562|Disimmune disease|disimmune disease
205030|NCT02317562|Neurology chronic disease|neurology chronic disease
205031|NCT02317562|Rare disease|rare disease
205032|NCT02317549|sepsis|sepsis
205033|NCT02317549|septic shock|septic shock
205034|NCT02317549|vasodilatory shock|vasodilatory shock
205035|NCT02317549|circulatory shock|circulatory shock
205036|NCT02317549|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
205037|NCT02317549|SIRS|sirs
205038|NCT02317549|infection|infection
205039|NCT02317549|toxemia|toxemia
205040|NCT02317549|gut barrier breakdown|gut barrier breakdown
205041|NCT02317549|autodigestion|autodigestion
205042|NCT02317549|multiorgan failure|multiorgan failure
205043|NCT02317549|MOF|mof
205044|NCT02317549|multiorgain dysfunction syndrome|multiorgain dysfunction syndrome
205045|NCT02317549|MODS|mods
205046|NCT02317549|hyperlactatemia|hyperlactatemia
205047|NCT02317549|tissue hypoxia|tissue hypoxia
205048|NCT02317536|Muscle function|muscle function
205049|NCT02317536|L-Carnitine|l-carnitine
205050|NCT02317536|Carnipure|carnipure
205051|NCT02317536|DXA|dxa
205052|NCT02317536|anabolism|anabolism
205053|NCT02317536|6 minute walk|6 minute walk
205054|NCT02317536|dynamometry|dynamometry
205055|NCT02317536|muscle biopsy|muscle biopsy
205056|NCT02317523|Dementia|dementia
205057|NCT02317523|Caregiver|caregiver
205058|NCT02317523|Cardiovascular Disease|cardiovascular disease
205059|NCT02317523|Stress|stress
205060|NCT02317523|Depression|depression
205061|NCT02317523|Anxiety|anxiety
205062|NCT02317523|Heart Disease|heart disease
205063|NCT02317523|Carer|carer
205064|NCT02317523|Care Giver|care giver
205065|NCT02317523|Caregiving|caregiving
205066|NCT02317523|Psychotherapy|psychotherapy
205067|NCT02317523|Therapy|therapy
205068|NCT02317523|Behavioral Activation|behavioral activation
205069|NCT02317523|Education|education
205070|NCT02317523|Intervention|intervention
205071|NCT02317523|CBT|cbt
205072|NCT02317523|Cognitive-Behavior Therapy|cognitive-behavior therapy
205073|NCT02317510|Combined anesthesia|combined anesthesia
205074|NCT02317510|General anesthesia|general anesthesia
205075|NCT02317510|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
205076|NCT02317497|Neurocritical care|neurocritical care
205077|NCT02317497|Severe Stroke|severe stroke
205078|NCT02317497|Ischemic stroke|ischemic stroke
205079|NCT02317497|Intracerebral hemorrhage|intracerebral hemorrhage
205080|NCT02317497|Subarachnoid hemorrhage|subarachnoid hemorrhage
205081|NCT02317497|Sedation|sedation
205082|NCT02317497|RASS|rass
205083|NCT02317497|BIS|bis
205084|NCT02317445|helicobacter pylori|helicobacter pylori
205085|NCT02317445|eradication therapy|eradication therapy
205086|NCT02317445|major adverse cardiac events|major adverse cardiac events
205087|NCT02317445|long-term outcome|long-term outcome
205088|NCT02317445|To explore the significance of Hp eradication therapy in preventing major adverse cardiac events (MACE) and upper gastrointestinal bleeding (UGIB).|to explore the significance of hp eradication therapy in preventing major adverse cardiac events (mace) and upper gastrointestinal bleeding (ugib).
205089|NCT02317432|Depression|depression
205090|NCT02317432|Anxiety|anxiety
205091|NCT02317432|Disability|disability
205092|NCT02317432|Ethnic Minority|ethnic minority
205093|NCT02317432|Elders|elders
205094|NCT02317419|Solid Cancers|solid cancers
205095|NCT02317393|Nuclear medicine|nuclear medicine
205096|NCT02317393|Positron emission tomography|positron emission tomography
205097|NCT02317393|avb3 integrin expression|avb3 integrin expression
205098|NCT02317380|Self-Affirmation|self-affirmation
205099|NCT02317380|Weight Loss|weight loss
205100|NCT02317380|Self vs. Other|self vs. other
205350|NCT02315885|social drinkers|social drinkers
205101|NCT02317380|Cancer Risk and Prevention|cancer risk and prevention
205102|NCT02317367|Construct Validity|construct validity
205103|NCT02317367|Self-Affirmation|self-affirmation
205104|NCT02317367|Alcohol Consumption|alcohol consumption
205105|NCT02317367|Breast Cancer|breast cancer
205106|NCT02317354|X-Linked|x-linked
205107|NCT02317354|Retinoschisis|retinoschisis
205108|NCT02317341|Fatigue|fatigue
205109|NCT02317341|Ketamine|ketamine
205110|NCT02317341|Cancer|cancer
205111|NCT02317328|Retinal Images|retinal images
205112|NCT02317328|Adaptive Optics|adaptive optics
205113|NCT02317263|MS|ms
205114|NCT02317250|Alzheimer's disease|alzheimer's disease
205115|NCT02317250|Alzheimer disease|alzheimer disease
205116|NCT02317250|MDC|mdc
205117|NCT02317250|Mild Decline in Cognition|mild decline in cognition
205118|NCT02317250|MCI|mci
205119|NCT02317250|Dementia|dementia
205120|NCT02317250|PET|pet
205121|NCT02317250|FDG-PET|fdg-pet
205122|NCT02317250|FDG|fdg
205123|NCT02317250|amyloid|amyloid
205124|NCT02317250|amyloid imaging|amyloid imaging
205125|NCT02317250|CMS|cms
205126|NCT02317250|Coverage with Evidence Development|coverage with evidence development
205127|NCT02317250|CED|ced
205128|NCT02317250|MCI-ID|mci-id
205129|NCT02317224|3-Hole approach|3-hole approach
205130|NCT02317224|extended thymectomy|extended thymectomy
205131|NCT02317224|myasthenia gravis|myasthenia gravis
205132|NCT02317224|safety|safety
205133|NCT02317224|effectiveness|effectiveness
205134|NCT02317198|Elderly|elderly
205135|NCT02317198|P2Y12 inhibitors|p2y12 inhibitors
205136|NCT02317198|clopidogrel|clopidogrel
205137|NCT02317198|ticagrelor|ticagrelor
205138|NCT02317172|Saliva substitute|saliva substitute
205139|NCT02317172|Edible gel|edible gel
205140|NCT02317172|Xerostomia|xerostomia
205141|NCT02317172|Diabetes Mellitus|diabetes mellitus
205142|NCT02317172|Hypertension|hypertension
205143|NCT02317133|Tregs|tregs
205144|NCT02317133|bacterial translocation|bacterial translocation
205145|NCT02317133|cytokines|cytokines
205146|NCT02317107|Gait|gait
205147|NCT02317107|Mild Traumatic Brain Injury|mild traumatic brain injury
205148|NCT02317107|Post-Concussion Syndrome|post-concussion syndrome
205149|NCT02317107|Recovery of Function|recovery of function
205150|NCT02317107|Locomotion|locomotion
205151|NCT02317107|Motor Activity|motor activity
205152|NCT02317068|sick sinus syndrome|sick sinus syndrome
205153|NCT02317068|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
205154|NCT02317068|atrial pacing|atrial pacing
205155|NCT02317068|high atrial base rate pacing|high atrial base rate pacing
205156|NCT02317055|MRI|mri
205157|NCT02317055|Oxygenation|oxygenation
205158|NCT02317055|nirs|nirs
205159|NCT02317029|Cardioversion|cardioversion
205160|NCT02317029|Cardiac Arrythmias|cardiac arrythmias
205161|NCT02317029|Myocardial Injury|myocardial injury
205162|NCT02317029|Defibrillators|defibrillators
205163|NCT02317029|Biomarkers|biomarkers
205164|NCT02317016|oncology|oncology
205165|NCT02317016|cancer|cancer
205166|NCT02317016|non small cell lung cancer|non small cell lung cancer
205167|NCT02317016|anticancer drug|anticancer drug
205168|NCT02317016|pharmacokinetics|pharmacokinetics
205169|NCT02317016|AZD9291|azd9291
205170|NCT02317016|rosuvastatin|rosuvastatin
205171|NCT02317016|EGFR genes|egfr genes
205172|NCT02317003|physical exercise|physical exercise
205173|NCT02317003|sedentarity|sedentarity
205174|NCT02317003|general practice|general practice
205175|NCT02317003|family medicine|family medicine
205176|NCT02317003|pedometer|pedometer
205177|NCT02316977|Reproducibility of Results|reproducibility of results
205178|NCT02316964|AML|aml
205179|NCT02316964|acute myeloid leukemia|acute myeloid leukemia
205180|NCT02316964|decitabine|decitabine
205181|NCT02316951|Postoperative|postoperative
205182|NCT02316951|Pain|pain
205183|NCT02316951|Symptoms|symptoms
205184|NCT02316951|Video recording|video recording
205185|NCT02316951|Orthopedic surgery|orthopedic surgery
205186|NCT02316938|kidney transplant, renal transplant, biopsy, biopsies, donor specific antibodies|kidney transplant, renal transplant, biopsy, biopsies, donor specific antibodies
205187|NCT02316912|allergy|allergy
205188|NCT02316899|ASP0456|asp0456
205189|NCT02316899|constipation|constipation
205190|NCT02316899|linaclotide|linaclotide
205191|NCT02316899|irritable bowel syndrome (IBS)|irritable bowel syndrome (ibs)
205192|NCT02316886|coronary intervention|coronary intervention
205193|NCT02316886|Vulnerable Plaque|vulnerable plaque
205194|NCT02316886|Insignificant Stenosis|insignificant stenosis
205195|NCT02316886|Bioresorbable Vascular Scaffold|bioresorbable vascular scaffold
205196|NCT02316886|Everolimus Eluting stent|everolimus eluting stent
205197|NCT02316873|music training, rhythm|music training, rhythm
205198|NCT02316847|Cluster Seizures|cluster seizures
205199|NCT02316847|Seizures|seizures
205200|NCT02316847|Clusters|clusters
205201|NCT02316847|Acute repetitive seizures|acute repetitive seizures
205202|NCT02316834|Fallopian Tube Cancer|fallopian tube cancer
205203|NCT02316834|Ovarian Cancer|ovarian cancer
205204|NCT02316834|Peritoneal Cancer|peritoneal cancer
205205|NCT02316834|BMN 673|bmn 673
205206|NCT02316834|Talazoparib tosylate|talazoparib tosylate
205207|NCT02316821|Diabetes Mellitus|diabetes mellitus
205208|NCT02316821|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
205209|NCT02316821|Diabetic Nephropathies|diabetic nephropathies
205210|NCT02316821|Kidney Diseases|kidney diseases
205211|NCT02316821|Renal Insufficiency, Chronic|renal insufficiency, chronic
205212|NCT02316821|Diabetes Complications|diabetes complications
205213|NCT02316821|Endocrine System Diseases|endocrine system diseases
205214|NCT02316821|Glucose Metabolism Disorders|glucose metabolism disorders
205215|NCT02316821|Metabolic Diseases|metabolic diseases
205216|NCT02316821|Renal Insufficiency|renal insufficiency
205217|NCT02316821|Urologic Diseases|urologic diseases
205218|NCT02316821|bardoxolone methyl|bardoxolone methyl
205219|NCT02316756|Phase 1, Single-Dose Escalation, Double Blind, Placebo-Controlled, Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, PF-06648671, Plasma Abeta|phase 1, single-dose escalation, double blind, placebo-controlled, safety, tolerability, pharmacokinetics, pharmacodynamics, pf-06648671, plasma abeta
205220|NCT02316691|Graves Disease|graves disease
205221|NCT02316691|Rituximab|rituximab
205222|NCT02316678|Patient Preference|patient preference
205223|NCT02316665|Type 1 diabetes|type 1 diabetes
205224|NCT02316665|Sleep apnea syndrome|sleep apnea syndrome
205225|NCT02316665|Nocturnal glycemia|nocturnal glycemia
205351|NCT02315885|alcohol|alcohol
205226|NCT02316665|Continuous glucose monitoring system|continuous glucose monitoring system
205227|NCT02316665|Continuous positive airway pressure|continuous positive airway pressure
205228|NCT02316665|Sleep habits|sleep habits
205229|NCT02316639|Neuromuscular Training|neuromuscular training
205230|NCT02316639|Skeletally Immature|skeletally immature
205231|NCT02316639|Knee Rehabilitation|knee rehabilitation
205232|NCT02316600|elderly|elderly
205233|NCT02316600|Robust volunteers for the first phase;|robust volunteers for the first phase;
205234|NCT02316600|tele-monitoring|tele-monitoring
205235|NCT02316600|self-management|self-management
205236|NCT02316600|Patient 65 and over|patient 65 and over
205237|NCT02316600|Presenting a frailty syndrome for the second phase|presenting a frailty syndrome for the second phase
205238|NCT02316587|Computerized Tomography|computerized tomography
205239|NCT02316587|Magnetic Resonance Imaging|magnetic resonance imaging
205240|NCT02316587|Echocardiography|echocardiography
205241|NCT02316587|Right Heart Catheterization|right heart catheterization
205242|NCT02316574|Alcohol dependence|alcohol dependence
205243|NCT02316574|Cognitive Behavioral Therapy|cognitive behavioral therapy
205244|NCT02316574|Functional neuroimaging|functional neuroimaging
205245|NCT02316535|colorectal cancer|colorectal cancer
205246|NCT02316535|stage II/III|stage ii/iii
205247|NCT02316535|elderly|elderly
205248|NCT02316535|adjuvant chemotherapy|adjuvant chemotherapy
205249|NCT02316535|capecitabine|capecitabine
205250|NCT02316535|non-inferiority|non-inferiority
205251|NCT02316496|Cancer|cancer
205252|NCT02316496|Colorectal|colorectal
205253|NCT02316496|Metastatic|metastatic
205254|NCT02316496|Thrid-line|thrid-line
205255|NCT02316496|Irinotecan|irinotecan
205256|NCT02316496|Cetuximab|cetuximab
205257|NCT02316470|Clostridium difficile|clostridium difficile
205258|NCT02316470|Valneva|valneva
205259|NCT02316470|Phase 2|phase 2
205260|NCT02316470|Healthy adults|healthy adults
205261|NCT02316457|TNBC|tnbc
205262|NCT02316457|Breast Cancer|breast cancer
205263|NCT02316457|Warehouse|warehouse
205264|NCT02316457|Mutanome|mutanome
205265|NCT02316457|RNA|rna
205266|NCT02316457|Vaccine|vaccine
205267|NCT02316444|Hepatitis B vaccine HIV infection|hepatitis b vaccine hiv infection
205268|NCT02316418|Hairstetics™ anchoring system|hairstetics™ anchoring system
205269|NCT02316418|hair extensions|hair extensions
205270|NCT02316392|Helium|helium
205271|NCT02316392|MRI|mri
205272|NCT02316392|Lung transplantation|lung transplantation
205273|NCT02316379|Respiratory|respiratory
205274|NCT02316314|Friedreich's Ataxia|friedreich's ataxia
205275|NCT02316314|Cardiomyopathy|cardiomyopathy
205276|NCT02316301|Misoprostol, pain, office hysteroscopy|misoprostol, pain, office hysteroscopy
205277|NCT02316249|pelvic organ prolapse|pelvic organ prolapse
205278|NCT02316249|Atrophy of Vagina|atrophy of vagina
205279|NCT02316249|Gellhorn pessary|gellhorn pessary
205280|NCT02316249|Ring with support pessary|ring with support pessary
205281|NCT02316249|Estrace cream|estrace cream
205282|NCT02316249|vaginitis with pessary|vaginitis with pessary
205283|NCT02316249|vaginal ulceration with pessary|vaginal ulceration with pessary
205284|NCT02316249|vaginal erosion with pessary|vaginal erosion with pessary
205285|NCT02316249|pessary complications|pessary complications
205286|NCT02316249|vaginal bleeding with pessary|vaginal bleeding with pessary
205287|NCT02316223|asthma|asthma
205288|NCT02316223|high-risk|high-risk
205289|NCT02316223|adult|adult
205290|NCT02316223|elderly|elderly
205291|NCT02316223|care coordination|care coordination
205292|NCT02316223|community health worker|community health worker
205293|NCT02316223|electronic medical record|electronic medical record
205294|NCT02316197|DNA-PK Inhibitor|dna-pk inhibitor
205295|NCT02316197|Advanced solid tumors|advanced solid tumors
205296|NCT02316197|Chronic lymphocytic Leukemia|chronic lymphocytic leukemia
205297|NCT02316197|Phase I, first-in-human|phase i, first-in-human
205298|NCT02316197|Dose escalation|dose escalation
205299|NCT02316197|Dose expansion|dose expansion
205300|NCT02316197|Safety profile|safety profile
205301|NCT02316197|Tolerability|tolerability
205302|NCT02316197|PK|pk
205303|NCT02316197|Antitumor activity|antitumor activity
205304|NCT02316197|Maximum tolerated dose|maximum tolerated dose
205305|NCT02316197|M3814|m3814
205306|NCT02316184|Alcohol|alcohol
205307|NCT02316158|Burden|burden
205308|NCT02316158|Mental illness|mental illness
205309|NCT02316158|Stress|stress
205310|NCT02316158|Social support|social support
205311|NCT02316145|ADHD|adhd
205312|NCT02316145|Autism spectrum condition|autism spectrum condition
205313|NCT02316145|Tourette's disorder|tourette's disorder
205314|NCT02316145|Internet-based|internet-based
205315|NCT02316145|chat|chat
205316|NCT02316145|coach|coach
205317|NCT02316119|bleeding risk, acute coronary syndrome, platelet agregation,|bleeding risk, acute coronary syndrome, platelet agregation,
205318|NCT02316106|Smoldering multiple myeloma (SMM)|smoldering multiple myeloma (smm)
205319|NCT02316106|Daratumumab|daratumumab
205320|NCT02316080|dental bleaching|dental bleaching
205321|NCT02316080|dentin sensitivity|dentin sensitivity
205322|NCT02316080|biomaterials|biomaterials
205323|NCT02316067|Spinal cord|spinal cord
205324|NCT02316067|Wounds and Injuries|wounds and injuries
205325|NCT02316067|Rehabilitation|rehabilitation
205326|NCT02316054|type 2 diabetes mellitus|type 2 diabetes mellitus
205327|NCT02316054|coronary microvascular disease|coronary microvascular disease
205328|NCT02316054|coronary artery disease|coronary artery disease
205329|NCT02316054|myocardial perfusion imaging|myocardial perfusion imaging
205330|NCT02316054|prognosis|prognosis
205331|NCT02316054|atherosclerosis|atherosclerosis
205332|NCT02316054|myocardial ischemia|myocardial ischemia
205333|NCT02316054|coronary heart disease|coronary heart disease
205334|NCT02316041|Femtosecond laser|femtosecond laser
205335|NCT02316041|Small incision lenticule extraction (SMILE)|small incision lenticule extraction (smile)
205336|NCT02316028|decitabine|decitabine
205337|NCT02316028|colorectal cancer|colorectal cancer
205338|NCT02316028|hepatic arterial infusion|hepatic arterial infusion
205339|NCT02316015|Child, Hospitalized|child, hospitalized
205340|NCT02316015|Nutritional status|nutritional status
205341|NCT02315976|chronic stable angina pectoris|chronic stable angina pectoris
205342|NCT02315976|propatyl nitrate|propatyl nitrate
205343|NCT02315976|Seattle Angina Questionnaire|seattle angina questionnaire
205344|NCT02315911|Tonsillectomy|tonsillectomy
205345|NCT02315911|Adenoidectomy|adenoidectomy
205346|NCT02315911|Adenoidpharyngoplasty|adenoidpharyngoplasty
205347|NCT02315911|OSA|osa
205348|NCT02315898|children, congenital heart disease, metabolomics|children, congenital heart disease, metabolomics
205349|NCT02315885|healthy volunteers|healthy volunteers
205352|NCT02315872|Multiple Sclerosis|multiple sclerosis
205353|NCT02315872|Acthar Gel|acthar gel
205355|NCT02315872|Fatigue|fatigue
205356|NCT02315859|suction work|suction work
205357|NCT02315833|Migraine|migraine
205358|NCT02315833|Aura|aura
205359|NCT02315820|Macrosomia|macrosomia
205360|NCT02315820|Induction of labor|induction of labor
205361|NCT02315820|Expectant management|expectant management
205362|NCT02315820|Shoulder dystocia|shoulder dystocia
205363|NCT02315794|aesthetic outcome|aesthetic outcome
205364|NCT02315794|titanium abutment|titanium abutment
205365|NCT02315794|zirconia abutment|zirconia abutment
205366|NCT02315768|CLL|cll
205367|NCT02315768|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
205368|NCT02315768|Ibrutinib|ibrutinib
205369|NCT02315768|Obinutuzumab|obinutuzumab
205370|NCT02315768|Cancer|cancer
205371|NCT02315755|Metastatic renal cell carcinoma, targeted molecular therapy|metastatic renal cell carcinoma, targeted molecular therapy
205372|NCT02315716|Multiple Myeloma|multiple myeloma
205373|NCT02315716|Carfilzomib|carfilzomib
205374|NCT02315703|Healthy|healthy
205375|NCT02315703|Acquired Immuno-Deficiency Syndrome|acquired immuno-deficiency syndrome
205376|NCT02315703|Acquired Immunodeficiency Syndrome Virus|acquired immunodeficiency syndrome virus
205377|NCT02315703|adenovirus serotype 26|adenovirus serotype 26
205378|NCT02315703|Ad26.Mos.HIV|ad26.mos.hiv
205379|NCT02315703|Modified Vaccinia Ankara|modified vaccinia ankara
205380|NCT02315703|Glycoprotein|glycoprotein
205381|NCT02315703|Adjuvant|adjuvant
205382|NCT02315703|Vaccine|vaccine
205383|NCT02315703|Placebo|placebo
205384|NCT02315690|malaria, Swaziland, reactive case detection, focal mass drug administration|malaria, swaziland, reactive case detection, focal mass drug administration
205385|NCT02315677|Epistaxis|epistaxis
205386|NCT02315677|Nasal Intubation|nasal intubation
205387|NCT02315677|Maxillofacial surgery|maxillofacial surgery
205388|NCT02315664|Physical activity|physical activity
205389|NCT02315664|Exercise|exercise
205390|NCT02315664|Osteoarthritis|osteoarthritis
205391|NCT02315664|Knee|knee
205392|NCT02315664|Arthritis|arthritis
205393|NCT02315638|Adeno-associated viral vectors|adeno-associated viral vectors
205394|NCT02315638|Adeno-associated virus|adeno-associated virus
205395|NCT02315638|AAV|aav
205396|NCT02315638|AAV8|aav8
205397|NCT02315638|ddRNAi|ddrnai
205398|NCT02315638|shRNA|shrna
205399|NCT02315638|RNAi|rnai
205400|NCT02315638|Hepatitis|hepatitis
205401|NCT02315638|Chronic Hepatitis C|chronic hepatitis c
205402|NCT02315638|HCV|hcv
205403|NCT02315638|CHC|chc
205404|NCT02315638|Genotype 1|genotype 1
205405|NCT02315625|MEN1|men1
205406|NCT02315625|VHL|vhl
205407|NCT02315625|Neoplasm|neoplasm
205408|NCT02315625|NF1|nf1
205409|NCT02315625|mTOR|mtor
205410|NCT02315612|CD-22 Expressing Tumor|cd-22 expressing tumor
205411|NCT02315612|Chimeric Antigen Receptor|chimeric antigen receptor
205412|NCT02315612|Adoptive Immunotherapy|adoptive immunotherapy
205413|NCT02315612|ALL|all
205414|NCT02315612|Lymphoma|lymphoma
205415|NCT02315599|Replication Competent Retrovirus (RCR)|replication competent retrovirus (rcr)
205416|NCT02315599|Replication Competent Lentivirus (RCL)|replication competent lentivirus (rcl)
205417|NCT02315599|T Cell Persistence|t cell persistence
205418|NCT02315586|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
205419|NCT02315586|Apoliprotein A-1|apoliprotein a-1
205420|NCT02315573|Carpal Tunnel Syndrome|carpal tunnel syndrome
205421|NCT02315573|Anesthetics, Local|anesthetics, local
205422|NCT02315573|Pain Perception|pain perception
205423|NCT02315573|Pain Measurement|pain measurement
205424|NCT02315573|Analgesia|analgesia
205425|NCT02315573|Lidocaine|lidocaine
205426|NCT02315573|Bupivacaine|bupivacaine
205427|NCT02315560|bedwetting|bedwetting
205428|NCT02315547|Microbiota|microbiota
205429|NCT02315547|Airway infection|airway infection
205430|NCT02315547|Bronchiectasis|bronchiectasis
205431|NCT02315547|Airway inflammation|airway inflammation
205432|NCT02315547|Oxidative stress|oxidative stress
205433|NCT02315547|Matrix metalloproteinase|matrix metalloproteinase
205434|NCT02315534|GBM|gbm
205435|NCT02315534|Malignant Glioma|malignant glioma
205436|NCT02315521|lower urinary tract obstruction|lower urinary tract obstruction
205437|NCT02315521|posterior urethral valves|posterior urethral valves
205438|NCT02315521|urethral atresia|urethral atresia
205439|NCT02315521|Prune Belly Syndrome|prune belly syndrome
205440|NCT02315521|Megalo-urethra|megalo-urethra
205441|NCT02315521|Fetal renal function|fetal renal function
205442|NCT02315521|Prenatal Diagnosis|prenatal diagnosis
205443|NCT02315521|Ultrasound|ultrasound
205444|NCT02315482|autonomic nervous system|autonomic nervous system
205445|NCT02315482|heart rate variability|heart rate variability
205446|NCT02315482|prostatectomy|prostatectomy
205447|NCT02315482|steep trendelenburg|steep trendelenburg
205448|NCT02315482|pneumoperitoneum|pneumoperitoneum
205449|NCT02315482|Intervention Affecting Autonomic Nervous System|intervention affecting autonomic nervous system
205450|NCT02315456|capsulorhexis|capsulorhexis
205451|NCT02315456|IOL centration|iol centration
205452|NCT02315443|Stroke|stroke
205453|NCT02315443|Ischemia|ischemia
205454|NCT02315443|Prehospital|prehospital
205455|NCT02315443|NA-1|na-1
205456|NCT02315443|Modified Rankin Scale|modified rankin scale
205457|NCT02315443|Haemorrhagic stroke|haemorrhagic stroke
205458|NCT02315443|Transient ischemic attack|transient ischemic attack
205459|NCT02315417|Pyoderma Gangrenosum|pyoderma gangrenosum
205460|NCT02315417|Classic Pyoderma Gangrenosum|classic pyoderma gangrenosum
205562|NCT02314910|Jaw Bone|jaw bone
205461|NCT02315404|Obscure gastrointestinal bleeding|obscure gastrointestinal bleeding
205462|NCT02315404|Overt gastrointestinal bleeding|overt gastrointestinal bleeding
205463|NCT02315404|Occult gastrointestinal bleeding|occult gastrointestinal bleeding
205464|NCT02315404|Enteroscopy|enteroscopy
205465|NCT02315378|Anxiety, Acute Trauma|anxiety, acute trauma
205466|NCT02315352|Healthy|healthy
205467|NCT02315352|L-PZQ|l-pzq
205468|NCT02315352|PZQ|pzq
205469|NCT02315352|MSC2499550A|msc2499550a
205470|NCT02315352|Praziquantel|praziquantel
205471|NCT02315326|Ibrutinib,|ibrutinib,
205472|NCT02315326|Imbruvica™|imbruvica™
205473|NCT02315326|Bruton's Tyrosine Kinase (BTK) Inhibitor|bruton's tyrosine kinase (btk) inhibitor
205474|NCT02315326|HD-MTX|hd-mtx
205475|NCT02315326|14-184|14-184
205476|NCT02315300|ECG, CGM, Hypoglycaemia, Sudden Cardiac Death|ecg, cgm, hypoglycaemia, sudden cardiac death
205477|NCT02315287|Triple combination|triple combination
205478|NCT02315287|Metformin|metformin
205479|NCT02315287|Sitagliptin|sitagliptin
205480|NCT02315287|Pioglitazone|pioglitazone
205481|NCT02315287|Lobeglitazone|lobeglitazone
205482|NCT02315274|Type 1 diabetes|type 1 diabetes
205483|NCT02315274|Pregnancy|pregnancy
205484|NCT02315274|Glycemic variability|glycemic variability
205485|NCT02315274|Between visit contact|between visit contact
205486|NCT02315261|Epidural analgesia|epidural analgesia
205487|NCT02315261|Pain score|pain score
205488|NCT02315248|bone density|bone density
205489|NCT02315222|Nutriomics|nutriomics
205490|NCT02315222|Dietary supplements|dietary supplements
205491|NCT02315222|Scaling and root planing|scaling and root planing
205492|NCT02315222|full mouth disinfection|full mouth disinfection
205493|NCT02315209|Inguinal Hernia, Quality of Life, Mesh|inguinal hernia, quality of life, mesh
205494|NCT02315183|Post cardiac surgery|post cardiac surgery
205495|NCT02315170|diabetic retinopathy|diabetic retinopathy
205496|NCT02315170|age-related macular edema|age-related macular edema
205497|NCT02315157|Partial Response|partial response
205498|NCT02315144|COPD|copd
205499|NCT02315144|bronchodilation|bronchodilation
205500|NCT02315092|Diabetic Foot Ulcers|diabetic foot ulcers
205501|NCT02315092|Bacteria|bacteria
205502|NCT02315092|Fluorescence|fluorescence
205503|NCT02315079|Ocular Inflammation|ocular inflammation
205504|NCT02315079|Matrix Metalloproteinase 9|matrix metalloproteinase 9
205505|NCT02315066|Immunotherapy|immunotherapy
205506|NCT02315066|PF-04518600|pf-04518600
205507|NCT02315066|PF-05082566|pf-05082566
205508|NCT02315066|solid tumors|solid tumors
205509|NCT02315066|tumors|tumors
205510|NCT02315066|neoplasm metastasis|neoplasm metastasis
205511|NCT02315066|Phase 1|phase 1
205512|NCT02315066|hepatocellular carcinoma|hepatocellular carcinoma
205513|NCT02315066|HCC|hcc
205514|NCT02315066|liver cancer|liver cancer
205515|NCT02315066|ocular melanoma|ocular melanoma
205516|NCT02315066|melanoma|melanoma
205517|NCT02315066|clear cell renal cell carcinoma|clear cell renal cell carcinoma
205518|NCT02315066|RCC|rcc
205519|NCT02315066|kidney cancer|kidney cancer
205520|NCT02315066|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
205521|NCT02315066|HNSCC|hnscc
205522|NCT02315066|head and neck cancer|head and neck cancer
205523|NCT02315066|cervical cancer|cervical cancer
205524|NCT02315066|cancer of the cervix|cancer of the cervix
205525|NCT02315066|gastric cancer|gastric cancer
205526|NCT02315066|stomach cancer|stomach cancer
205527|NCT02315066|non small cell lung cancer|non small cell lung cancer
205528|NCT02315066|NSCLC|nsclc
205529|NCT02315066|lung cancer|lung cancer
205530|NCT02315066|urothelial bladder carcinoma|urothelial bladder carcinoma
205531|NCT02315066|bladder cancer|bladder cancer
205532|NCT02315066|OX40|ox40
205533|NCT02315066|4-1BB|4-1bb
205534|NCT02315053|NSCLC|nsclc
205535|NCT02315053|CCRT|ccrt
205536|NCT02315053|FDG PET/CT|fdg pet/ct
205537|NCT02315040|Intrauterine insemination (IUI)|intrauterine insemination (iui)
205538|NCT02315040|Insemination method|insemination method
205539|NCT02315040|Slow release insemination (SRI)|slow release insemination (sri)
205540|NCT02315040|EVIE|evie
205541|NCT02315040|Pregnancy rate|pregnancy rate
205542|NCT02315001|Liraglutide|liraglutide
205543|NCT02315001|GLP-1|glp-1
205544|NCT02315001|Ischaemic heart disease|ischaemic heart disease
205545|NCT02315001|Coronary heart disease|coronary heart disease
205546|NCT02315001|Chronic stable angina|chronic stable angina
205547|NCT02314988|Tranexamic acid|tranexamic acid
205548|NCT02314988|Antifibrinolytic|antifibrinolytic
205549|NCT02314988|Perioperative blood loss|perioperative blood loss
205550|NCT02314988|Postoperative drain output|postoperative drain output
205551|NCT02314988|Allogenic transfusion|allogenic transfusion
205552|NCT02314949|T-regulatory cells|t-regulatory cells
205553|NCT02314949|Tolerogenic protocol|tolerogenic protocol
205554|NCT02314949|immunomodulation|immunomodulation
205555|NCT02314936|Constipation|constipation
205556|NCT02314936|Polydextrose|polydextrose
205557|NCT02314936|Dietary Fiber|dietary fiber
205558|NCT02314936|Fiber|fiber
205559|NCT02314936|Colonic Transit Time|colonic transit time
205560|NCT02314936|PAC-SYM|pac-sym
205561|NCT02314910|Innervation|innervation
205563|NCT02314910|Implants|implants
205564|NCT02314910|Stereognostic|stereognostic
205565|NCT02314910|Osseoperception|osseoperception
205566|NCT02314871|perioperative analgesia|perioperative analgesia
205567|NCT02314871|minimal residual disease|minimal residual disease
205568|NCT02314871|cancer recurrence|cancer recurrence
205569|NCT02314871|epidural|epidural
205570|NCT02314871|morphine|morphine
205571|NCT02314871|piritramide|piritramide
205572|NCT02314871|colon|colon
205573|NCT02314871|cancer|cancer
205574|NCT02314871|circulating cancer cells|circulating cancer cells
205575|NCT02314871|colon cancer surgery|colon cancer surgery
205576|NCT02314845|Pulmonary Atelectasis|pulmonary atelectasis
205577|NCT02314845|Pulmonary Ventilation|pulmonary ventilation
205578|NCT02314845|Anesthesia, General|anesthesia, general
205579|NCT02314845|Electric Impedance|electric impedance
205580|NCT02314845|Tomography, Spiral Computed|tomography, spiral computed
205581|NCT02314845|Intraoperative Period|intraoperative period
205582|NCT02314832|femoral nerve block|femoral nerve block
205583|NCT02314832|adductor canal block|adductor canal block
205584|NCT02314832|tinetti score|tinetti score
205585|NCT02314832|2- Results to time to up and go (TUG ) test|2- results to time to up and go (tug ) test
205586|NCT02314832|3- Results to Tinetti test|3- results to tinetti test
205587|NCT02314832|4- Ambulation distance|4- ambulation distance
205588|NCT02314832|5- Pain scores at rest and with movement|5- pain scores at rest and with movement
205589|NCT02314819|colorectal cancer|colorectal cancer
205590|NCT02314793|Pharmacokinetics|pharmacokinetics
205591|NCT02314793|ASP2205|asp2205
205592|NCT02314741|poem|poem
205593|NCT02314741|per oral endoscopic myotomy|per oral endoscopic myotomy
205594|NCT02314741|achalasia|achalasia
205595|NCT02314728|Bishop Score|bishop score
205596|NCT02314728|Induction of Labor|induction of labor
205597|NCT02314728|Cervical Ripening|cervical ripening
205598|NCT02314728|Unfavorable Cervix|unfavorable cervix
205599|NCT02314728|Mode of Delivery|mode of delivery
205600|NCT02314728|C-Section|c-section
205601|NCT02314728|Cesarean Section|cesarean section
205602|NCT02314715|Osteoarthritis Knee|osteoarthritis knee
205603|NCT02314702|Osteoarthritis|osteoarthritis
205604|NCT02314702|Avascular necrosis|avascular necrosis
205605|NCT02314702|Ankylosis|ankylosis
205606|NCT02314702|Protrusio acetabuli|protrusio acetabuli
205607|NCT02314702|Painful hip dysplasia|painful hip dysplasia
205608|NCT02314702|Rheumatoid arthritis|rheumatoid arthritis
205609|NCT02314702|Correction of functional deformity|correction of functional deformity
205610|NCT02314702|Revision procedures|revision procedures
205611|NCT02314663|hypercholesterolaemia|hypercholesterolaemia
205612|NCT02314663|medication adherence|medication adherence
205613|NCT02314663|primary health care|primary health care
205614|NCT02314637|DPP-IV inhibitor|dpp-iv inhibitor
205615|NCT02314611|osteoarthritis|osteoarthritis
205616|NCT02314611|avascular necrosis|avascular necrosis
205617|NCT02314611|ankylosis|ankylosis
205618|NCT02314611|protrusio acetabuli|protrusio acetabuli
205619|NCT02314611|painful hip dysplasia|painful hip dysplasia
205620|NCT02314611|rheumatoid arthritis|rheumatoid arthritis
205621|NCT02314611|correction of functional deformity|correction of functional deformity
205622|NCT02314611|revision procedures|revision procedures
205623|NCT02314572|Multifocal Intraocular Lens|multifocal intraocular lens
205624|NCT02314572|Binocular Trifocality|binocular trifocality
205625|NCT02314572|Cataract Surgery|cataract surgery
205626|NCT02314572|Spectacle Independence|spectacle independence
205627|NCT02314572|Intermediate Vision|intermediate vision
205628|NCT02314572|Photopic Vision|photopic vision
205629|NCT02314572|Mesopic Vision|mesopic vision
205630|NCT02314572|Scotopic Vision|scotopic vision
205631|NCT02314572|Binocular Vision|binocular vision
205632|NCT02314559|propofol|propofol
205633|NCT02314559|colonoscopy|colonoscopy
205634|NCT02314507|Gua sha|gua sha
205635|NCT02314481|NSCLC|nsclc
205636|NCT02314481|Clonal dominance|clonal dominance
205637|NCT02314481|Clonal evolution|clonal evolution
205638|NCT02314481|Intratumour heterogeneity|intratumour heterogeneity
205639|NCT02314481|Genomic instability|genomic instability
205640|NCT02314481|Drug resistance|drug resistance
205641|NCT02314481|Immunotherapy|immunotherapy
205642|NCT02314481|PDL1|pdl1
205643|NCT02314481|BRAF V600|braf v600
205645|NCT02314481|RET|ret
205646|NCT02314481|HER2 amplification|her2 amplification
205647|NCT02314481|MPDL3280A|mpdl3280a
205648|NCT02314481|Vemurafenib|vemurafenib
205649|NCT02314481|Alectinib|alectinib
205650|NCT02314481|T-DM1|t-dm1
205651|NCT02314481|Trastuzumab emtansine|trastuzumab emtansine
205652|NCT02314481|TRACERX|tracerx
205653|NCT02314455|Eosinophilic Esophagitis|eosinophilic esophagitis
205654|NCT02314455|EoE|eoe
205655|NCT02314455|dysphagia|dysphagia
205656|NCT02314442|LDL-C|ldl-c
205657|NCT02314442|RNAi therapeutic|rnai therapeutic
205658|NCT02314416|wounds, stem cells, collagen matrix, maturation|wounds, stem cells, collagen matrix, maturation
205659|NCT02314403|ESRD|esrd
205660|NCT02314390|Depression|depression
205661|NCT02314390|Mindfulness|mindfulness
205662|NCT02314390|MBCT|mbct
206445|NCT02309905|skin lesion|skin lesion
205663|NCT02314364|Non-small cell lung cancer|non-small cell lung cancer
205664|NCT02314364|Metastatic|metastatic
205665|NCT02314364|EGFR|egfr
205666|NCT02314364|ALK|alk
205667|NCT02314364|ROS1|ros1
205668|NCT02314364|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
205669|NCT02314351|migraine disorders|migraine disorders
205670|NCT02314351|migraine with aura|migraine with aura
205671|NCT02314351|migraine without aura|migraine without aura
205672|NCT02314351|pain management|pain management
205673|NCT02314351|emergency department|emergency department
205674|NCT02314325|Factor VIII deficiency|factor viii deficiency
205675|NCT02314325|Arthropathy|arthropathy
205676|NCT02314325|MRI|mri
205677|NCT02314325|XRay|xray
205678|NCT02314325|Joint|joint
205679|NCT02314325|HJHS|hjhs
205680|NCT02314312|Kidney transplantation|kidney transplantation
205681|NCT02314312|ECD|ecd
205682|NCT02314299|Macular edema|macular edema
205683|NCT02314299|Macular degeneration|macular degeneration
205684|NCT02314299|MTP-131|mtp-131
205685|NCT02314299|Ocuvia™|ocuvia™
205686|NCT02314286|Rosuvastatin|rosuvastatin
205687|NCT02314286|severe preeclampsia|severe preeclampsia
205688|NCT02314286|48 hours following delivery|48 hours following delivery
205689|NCT02314260|labour induction|labour induction
205690|NCT02314260|cervical length|cervical length
205691|NCT02314260|trans-vaginal assessment of cervical length|trans-vaginal assessment of cervical length
205692|NCT02314260|Bishop score|bishop score
205693|NCT02314247|PTCL|ptcl
205694|NCT02314247|CTCL|ctcl
205695|NCT02314247|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
205696|NCT02314247|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
205697|NCT02314247|Karyopharm|karyopharm
205698|NCT02314247|KPT-330|kpt-330
205699|NCT02314247|Selinexor|selinexor
205700|NCT02314221|Exoskeletal-assisted walking|exoskeletal-assisted walking
205701|NCT02314208|spastic paraplegia|spastic paraplegia
205702|NCT02314208|metabolism|metabolism
205703|NCT02314208|oxysterols|oxysterols
205704|NCT02314208|neurogenetics|neurogenetics
205705|NCT02314195|Obsessive Compulsive Disorder|obsessive compulsive disorder
205706|NCT02314195|Music Therapy/methods|music therapy/methods
205707|NCT02314195|Combined Modality Therapy|combined modality therapy
205708|NCT02314195|Anxiety Disorders/therapy|anxiety disorders/therapy
205709|NCT02314182|Rectal adenocarcinoma|rectal adenocarcinoma
205710|NCT02314182|unresectable|unresectable
205711|NCT02314182|surgery|surgery
205712|NCT02314182|chemotherapy|chemotherapy
205713|NCT02314143|dabrafenib|dabrafenib
205714|NCT02314143|MEK|mek
205715|NCT02314143|trametinib|trametinib
205716|NCT02314143|BRAF|braf
205717|NCT02314143|melanoma|melanoma
205718|NCT02314143|Oncology|oncology
205719|NCT02314104|Surgical procedures, Minimally invasive|surgical procedures, minimally invasive
205720|NCT02314104|Nerve block|nerve block
205721|NCT02314104|Anesthetics, Local|anesthetics, local
205722|NCT02314078|Caesarean section|caesarean section
205723|NCT02314078|Emergency|emergency
205724|NCT02314078|Anaesthesia|anaesthesia
205725|NCT02314065|Severe health anxiety|severe health anxiety
205726|NCT02314065|Somatic symptom disorder|somatic symptom disorder
205727|NCT02314065|Illness anxiety disorder|illness anxiety disorder
205728|NCT02314065|Cognitive behavioral therapy|cognitive behavioral therapy
205729|NCT02314065|Internet|internet
205730|NCT02314065|Exposure|exposure
205731|NCT02314013|uncomplicated diverticulitis, economic cost, hospital stay|uncomplicated diverticulitis, economic cost, hospital stay
205732|NCT02313974|Lupus Nephritis Treatment|lupus nephritis treatment
205733|NCT02313974|Renal Biopsy in Lupus|renal biopsy in lupus
205734|NCT02313974|Lupus Flare|lupus flare
205735|NCT02313961|ST elevation myocardial infarction|st elevation myocardial infarction
205736|NCT02313961|Reperfusion injury|reperfusion injury
205737|NCT02313961|Remote ischaemic conditioning|remote ischaemic conditioning
205738|NCT02313909|Rivaroxaban|rivaroxaban
205739|NCT02313909|Xarelto|xarelto
205740|NCT02313909|Aspirin|aspirin
205741|NCT02313909|ASA|asa
205742|NCT02313909|Oral Anticoagulant|oral anticoagulant
205743|NCT02313909|Blood Thinner|blood thinner
205744|NCT02313909|Stroke|stroke
205745|NCT02313909|Ischemic Stroke|ischemic stroke
205746|NCT02313909|Cryptogenic Stroke|cryptogenic stroke
205747|NCT02313909|Embolic stroke of undetermined source|embolic stroke of undetermined source
205748|NCT02313909|ESUS|esus
205749|NCT02313909|Transient Ischemic Attack|transient ischemic attack
205750|NCT02313909|Thromboembolism|thromboembolism
205751|NCT02313909|Cerebrovascular Disease|cerebrovascular disease
205752|NCT02313883|periodontitis|periodontitis
205753|NCT02313883|taurolidine (PerioSept(r))|taurolidine (periosept(r))
205754|NCT02313883|scaling and root planing|scaling and root planing
205755|NCT02313870|Bullous pemphigoid|bullous pemphigoid
205756|NCT02313870|superpotent topical steroids|superpotent topical steroids
205757|NCT02313870|methotrexate|methotrexate
205758|NCT02313870|safety|safety
205759|NCT02313857|Viralym-C|viralym-c
205760|NCT02313857|Viral infections post HSCT|viral infections post hsct
205761|NCT02313857|Virus-specific T cells|virus-specific t cells
205762|NCT02313844|BK virus|bk virus
205763|NCT02313844|Virus specific T cells|virus specific t cells
205764|NCT02313844|Viral infections|viral infections
205765|NCT02313831|autonomic nervous system|autonomic nervous system
205766|NCT02313831|ventilatory anaerobic threshold|ventilatory anaerobic threshold
205767|NCT02313831|oxygen consumption|oxygen consumption
205768|NCT02313831|metabolic profile|metabolic profile
205769|NCT02313831|exercise training|exercise training
205770|NCT02313831|expiratory flow limitation|expiratory flow limitation
205771|NCT02313818|Posttraumatic Stress Disorder|posttraumatic stress disorder
205772|NCT02313818|Cognitive Processing Therapy|cognitive processing therapy
205773|NCT02313818|Active Duty Military|active duty military
205774|NCT02313805|Insulin initiation|insulin initiation
205775|NCT02313805|Insulin checklist|insulin checklist
205776|NCT02313792|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
205777|NCT02313792|Palifermin|palifermin
205778|NCT02313740|Influenza|influenza
205779|NCT02313740|Influenza Vaccines|influenza vaccines
205780|NCT02313714|heart failure, heart transplant, electrical stimulation|heart failure, heart transplant, electrical stimulation
205781|NCT02313688|adenocarcinomas of esophagogastric junction|adenocarcinomas of esophagogastric junction
205782|NCT02313688|resection margin|resection margin
205783|NCT02313688|length|length
205784|NCT02313688|prognosis|prognosis
205785|NCT02313675|carpal tunnel syndrome|carpal tunnel syndrome
205786|NCT02313675|opioid analgesics|opioid analgesics
205787|NCT02313675|postoperative pain|postoperative pain
205788|NCT02313675|IV tylenol|iv tylenol
205789|NCT02313675|IV toradol|iv toradol
205790|NCT02313649|liver|liver
205791|NCT02313649|fibrosis|fibrosis
205792|NCT02313649|elastography|elastography
205793|NCT02313649|ShearWave Elastography|shearwave elastography
205794|NCT02313649|ultrasound|ultrasound
205795|NCT02313610|Retreatment Pulmonary Tuberculosis, Qinbudan,|retreatment pulmonary tuberculosis, qinbudan,
205796|NCT02313584|dabigatran|dabigatran
205797|NCT02313571|Epidural Analgesia|epidural analgesia
205798|NCT02313571|Pain|pain
205799|NCT02313558|dentifrice|dentifrice
205800|NCT02313558|gingivitis|gingivitis
205801|NCT02313558|dental plaque|dental plaque
205802|NCT02313519|Infections|infections
205803|NCT02313519|anastomotic leakage|anastomotic leakage
205804|NCT02313506|Physical activity|physical activity
205805|NCT02313506|Exercise|exercise
205806|NCT02313506|Osteoarthritis|osteoarthritis
205807|NCT02313506|Knee|knee
205808|NCT02313506|Arthritis|arthritis
205809|NCT02313441|remote ischemic preconditioning|remote ischemic preconditioning
205810|NCT02313428|Diabetic Foot Ulcer|diabetic foot ulcer
205811|NCT02313428|Topical Oxygen Therapy|topical oxygen therapy
205812|NCT02313428|Medicaid Recipients|medicaid recipients
205813|NCT02313428|Standard of Care|standard of care
205814|NCT02313428|Diabetic Wounds|diabetic wounds
205815|NCT02313363|Health care systems|health care systems
205816|NCT02313363|Mobile applications|mobile applications
205817|NCT02313363|Self-care|self-care
205818|NCT02313363|Diabetes mellitus|diabetes mellitus
205819|NCT02313363|Smartphone|smartphone
205820|NCT02313350|Sciatica,|sciatica,
205821|NCT02313350|herniated disc,|herniated disc,
205822|NCT02313350|chemonucleolysis.|chemonucleolysis.
205823|NCT02313337|Administration route|administration route
205824|NCT02313337|Preanesthetic medication|preanesthetic medication
205825|NCT02313337|Sedation|sedation
205826|NCT02313324|Coccydynia|coccydynia
205827|NCT02313324|Extracorporeal shock wave therapy|extracorporeal shock wave therapy
205828|NCT02313324|Disability|disability
205829|NCT02313311|Cleavage pattern, timing parameter, time-lapse|cleavage pattern, timing parameter, time-lapse
205830|NCT02313272|neoplasms|neoplasms
205831|NCT02313272|high-grade glioma|high-grade glioma
205832|NCT02313272|recurrent glioma|recurrent glioma
205833|NCT02313272|glioma|glioma
205834|NCT02313272|Hypofractionated Stereotactic Irradiation (HFSRT)|hypofractionated stereotactic irradiation (hfsrt)
205835|NCT02313272|Bevacizumab|bevacizumab
205836|NCT02313272|Pembrolizumab|pembrolizumab
205837|NCT02313272|recurrent high-grade glioma|recurrent high-grade glioma
205838|NCT02313272|Grade III malignant glioma|grade iii malignant glioma
205839|NCT02313272|Grade IV malignant glioma|grade iv malignant glioma
205840|NCT02313272|brain and nervous system|brain and nervous system
205841|NCT02313220|Obesity|obesity
205842|NCT02313220|Dapagliflozin|dapagliflozin
205843|NCT02313220|Exenatide|exenatide
205844|NCT02313220|Combination treatment|combination treatment
205845|NCT02313220|Type 2 diabetes|type 2 diabetes
205846|NCT02313181|breastfeeding|breastfeeding
205847|NCT02313181|lactation|lactation
205848|NCT02313181|newborn|newborn
205849|NCT02313168|difficult airway; prediction, FRONT score.|difficult airway; prediction, front score.
205850|NCT02313155|Prevention|prevention
205851|NCT02313129|Infertility|infertility
205852|NCT02313129|Rheumatoid Arthritis|rheumatoid arthritis
205853|NCT02313116|Lumpectomy|lumpectomy
205854|NCT02313116|Breast cancer|breast cancer
205855|NCT02313116|Optical coherence tomography|optical coherence tomography
205856|NCT02313116|Tumor margin|tumor margin
205857|NCT02313116|Imaging|imaging
205858|NCT02313103|ESRD|esrd
205859|NCT02313103|End Stage Renal Disease|end stage renal disease
205860|NCT02313103|Normal Healthy Volunteers|normal healthy volunteers
205861|NCT02313103|Renally Impaired|renally impaired
205862|NCT02313077|Healthy|healthy
205863|NCT02313077|Ebola viruses|ebola viruses
205864|NCT02313077|Ebola Viral Disease (EVD)|ebola viral disease (evd)
205865|NCT02313077|Filoviruses|filoviruses
205866|NCT02313077|monovalent vaccine|monovalent vaccine
205867|NCT02313077|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
205868|NCT02313077|Modified Vaccinia Virus Ankara - Bavarian Nordic (MVA-BN) Filo-vector|modified vaccinia virus ankara - bavarian nordic (mva-bn) filo-vector
205869|NCT02313077|Safety|safety
205870|NCT02313077|Immunogenicity|immunogenicity
205871|NCT02313051|metastatic breast cancer, everolimus|metastatic breast cancer, everolimus
205872|NCT02313038|Coronary heart disease|coronary heart disease
205873|NCT02313038|Percutaneous Coronary Intervention|percutaneous coronary intervention
205874|NCT02313038|Drug Eluting Stents|drug eluting stents
205875|NCT02313012|Maximum Tolerated Dose|maximum tolerated dose
205876|NCT02313012|Solid Tumors|solid tumors
205877|NCT02313012|Locally Advanced Tumors|locally advanced tumors
205878|NCT02313012|Metastatic Solid Tumors|metastatic solid tumors
205879|NCT02313012|Relapsed or refractory, BRAFV600 or RAS-mutated solid tumors|relapsed or refractory, brafv600 or ras-mutated solid tumors
205880|NCT02313012|Melanoma|melanoma
205881|NCT02313012|Colorectal Carcinomas Papillary|colorectal carcinomas papillary
205882|NCT02313012|Thyroid carcinomas|thyroid carcinomas
205883|NCT02313012|Pancreatic ductal Adenocarcinomas|pancreatic ductal adenocarcinomas
205884|NCT02313012|Non -small cell lung cancer [NSCLC]|non -small cell lung cancer [nsclc]
205885|NCT02312999|laparotomy|laparotomy
205886|NCT02312999|plasma-Lyte|plasma-lyte
205887|NCT02312999|volulyte|volulyte
205888|NCT02312999|close loop|close loop
205889|NCT02312999|abdominal surgery|abdominal surgery
205890|NCT02312986|infection|infection
205891|NCT02312986|colonization|colonization
205892|NCT02312986|antibiotic resistance|antibiotic resistance
205893|NCT02312973|Chronic kidney disease|chronic kidney disease
205894|NCT02312973|Pharmacokinetics|pharmacokinetics
205895|NCT02312973|Hemodialysis|hemodialysis
205896|NCT02312973|Peritoneal dialysis|peritoneal dialysis
205897|NCT02312973|Erythropoietin|erythropoietin
205898|NCT02312934|Chemo brain|chemo brain
205899|NCT02312934|Chemotherapy-related cognitive impairment|chemotherapy-related cognitive impairment
205900|NCT02312934|CRCI|crci
205901|NCT02312934|Breast cancer|breast cancer
205902|NCT02312934|Chemo fog|chemo fog
205903|NCT02312934|Nicotine|nicotine
205904|NCT02312934|Transdermal nicotine|transdermal nicotine
205905|NCT02312921|managed healthcare|managed healthcare
205906|NCT02312921|child|child
205907|NCT02312921|dental care|dental care
205908|NCT02312908|REM Sleep Behavior Disorder|rem sleep behavior disorder
205909|NCT02312908|Parkinson Disease|parkinson disease
205910|NCT02312908|Placebos|placebos
205911|NCT02312908|Randomized Controlled Trial|randomized controlled trial
205912|NCT02312908|Double-Blind Method|double-blind method
205913|NCT02312908|Clinical Trial|clinical trial
205914|NCT02312869|Mechanical Ventilation|mechanical ventilation
205915|NCT02312869|Burn patients|burn patients
205916|NCT02312843|Mild Cognitive Impairment|mild cognitive impairment
205917|NCT02312843|Cognitive disorders|cognitive disorders
205918|NCT02312843|Prediabetes|prediabetes
205919|NCT02312843|Exercise|exercise
205920|NCT02312817|Carcinoma, Hepatocellular|carcinoma, hepatocellular
205921|NCT02312817|Liver Neoplasms|liver neoplasms
205922|NCT02312817|Liver Disease|liver disease
205923|NCT02312817|Early Detection of Cancer|early detection of cancer
205924|NCT02312817|Comparative Effectiveness Research|comparative effectiveness research
205925|NCT02312791|Radiation|radiation
205926|NCT02312791|Prognosis|prognosis
205927|NCT02312791|Palliative Care|palliative care
205928|NCT02312778|non-specific low back pain|non-specific low back pain
205929|NCT02312778|center of pressure|center of pressure
205930|NCT02312778|spinal lumbar manipulation|spinal lumbar manipulation
205931|NCT02312778|high velocity and low amplitude manipulation|high velocity and low amplitude manipulation
205932|NCT02312778|postural control|postural control
205933|NCT02312752|Intra-epidermal stimulation in healthy control subjects|intra-epidermal stimulation in healthy control subjects
205934|NCT02312739|pain assessment|pain assessment
205935|NCT02312739|pain measurement|pain measurement
205936|NCT02312739|patient satisfaction|patient satisfaction
205937|NCT02312739|anxiety|anxiety
205938|NCT02312739|analgesia and anesthesia|analgesia and anesthesia
205939|NCT02312739|female sterilization|female sterilization
205940|NCT02312726|mixed methods|mixed methods
205941|NCT02312726|visual analog scale|visual analog scale
205942|NCT02312726|verbal rating score|verbal rating score
205943|NCT02312726|pain assessment|pain assessment
205944|NCT02312726|patient satisfaction|patient satisfaction
205945|NCT02312726|contraceptive devices|contraceptive devices
205946|NCT02312726|postpartum|postpartum
205947|NCT02312713|Osteoarthritis|osteoarthritis
205948|NCT02312713|Knee Osteoarthritis|knee osteoarthritis
205949|NCT02312700|empowerment|empowerment
205950|NCT02312700|communication|communication
206548|NCT02309177|ER+|er+
205951|NCT02312700|shared decision making|shared decision making
205952|NCT02312687|XLH|xlh
205953|NCT02312687|FGF23|fgf23
205954|NCT02312687|KRN23|krn23
205955|NCT02312674|pancreatic carcinoma|pancreatic carcinoma
205956|NCT02312674|hepatocellular carcinoma|hepatocellular carcinoma
205957|NCT02312674|palliative therapy|palliative therapy
205958|NCT02312674|oral nutritional supplements|oral nutritional supplements
205959|NCT02312674|quality of life|quality of life
205960|NCT02312674|nutritional status|nutritional status
205961|NCT02312661|ovarian cancer|ovarian cancer
205962|NCT02312661|metformin|metformin
205963|NCT02312661|carboplatin|carboplatin
205964|NCT02312661|paclitaxel|paclitaxel
205965|NCT02312648|Functional Capacity|functional capacity
205966|NCT02312648|Physical Exertion|physical exertion
205967|NCT02312648|Patient Care|patient care
205968|NCT02312648|Early mobilization|early mobilization
205969|NCT02312635|cognitive rehabilitation, traumatic brain injury|cognitive rehabilitation, traumatic brain injury
205970|NCT02312596|non-healing wound|non-healing wound
205971|NCT02312596|diabetic foot ulcer|diabetic foot ulcer
205972|NCT02312596|platelet rich plasma|platelet rich plasma
205973|NCT02312583|depression|depression
205974|NCT02312583|cognitive-behavior intervention|cognitive-behavior intervention
205975|NCT02312570|non-healing wounds|non-healing wounds
205976|NCT02312570|pressure ulcer|pressure ulcer
205977|NCT02312570|platelet rich plasma|platelet rich plasma
205978|NCT02312531|HBV|hbv
205979|NCT02312531|Intrauterine infection|intrauterine infection
205980|NCT02312531|hepatitis B immunoglobulin|hepatitis b immunoglobulin
205981|NCT02312531|immune barrier|immune barrier
205982|NCT02312531|virus replication|virus replication
205983|NCT02312531|placenta|placenta
205984|NCT02312518|non-healing wounds|non-healing wounds
205985|NCT02312518|venous stasis|venous stasis
205986|NCT02312518|ulcer|ulcer
205987|NCT02312518|platelet rich plasma|platelet rich plasma
205988|NCT02312505|cardiac output monitoring|cardiac output monitoring
205989|NCT02312505|semi-invasive pulse contour analysis|semi-invasive pulse contour analysis
205990|NCT02312505|transpulmonary thermodilution|transpulmonary thermodilution
205991|NCT02312492|fatty acid kinetics|fatty acid kinetics
205992|NCT02312440|tranexamic acid|tranexamic acid
205993|NCT02312440|blood loss|blood loss
205994|NCT02312440|topical administration|topical administration
205995|NCT02312440|intravenous administration|intravenous administration
205996|NCT02312401|MRI|mri
205997|NCT02312401|14-172|14-172
205998|NCT02312388|central venous catheters|central venous catheters
205999|NCT02312362|HFDS|hfds
206000|NCT02312362|ab interno|ab interno
206001|NCT02312362|MIGS|migs
206002|NCT02312362|surgery|surgery
206003|NCT02312349|Celiac Disease|celiac disease
206004|NCT02312349|Gluten free elaborated food|gluten free elaborated food
206005|NCT02312336|ST Elevation Myocardial Infarction|st elevation myocardial infarction
206006|NCT02312336|Transcoronary Cooling|transcoronary cooling
206007|NCT02312258|Ixazomib|ixazomib
206008|NCT02312258|Newly diagnosed|newly diagnosed
206009|NCT02312219|HIV|hiv
206010|NCT02312219|Inflammation|inflammation
206011|NCT02312219|Atherosclerosis|atherosclerosis
206012|NCT02312219|Positron-Emission Tomography|positron-emission tomography
206013|NCT02312219|Imaging|imaging
206014|NCT02312219|fluorodeoxyglucose|fluorodeoxyglucose
206015|NCT02312193|hypertension|hypertension
206016|NCT02312193|myogenic tone|myogenic tone
206017|NCT02312167|endomicroscopy|endomicroscopy
206018|NCT02312167|optical biopsy|optical biopsy
206019|NCT02312167|exploratory surgery|exploratory surgery
206020|NCT02312167|resection surgery|resection surgery
206021|NCT02312167|robot-assisted|robot-assisted
206022|NCT02312167|peritoneum carcinosis|peritoneum carcinosis
206023|NCT02312167|inflammatory|inflammatory
206024|NCT02312167|rectum cancer|rectum cancer
206025|NCT02312167|liver cancer|liver cancer
206026|NCT02312167|ovarian cancer|ovarian cancer
206027|NCT02312167|digestive cancer|digestive cancer
206028|NCT02312167|pancreas cancer|pancreas cancer
206029|NCT02312167|duodenum cancer|duodenum cancer
206030|NCT02312128|distal radius fractures|distal radius fractures
206031|NCT02312128|early mobilization|early mobilization
206032|NCT02312128|postoperative treatment|postoperative treatment
206033|NCT02312128|outcome|outcome
206034|NCT02312115|Renal transplant|renal transplant
206035|NCT02312115|Kidney transplant|kidney transplant
206036|NCT02312115|DGF|dgf
206037|NCT02312102|myelodysplastic syndrome|myelodysplastic syndrome
206038|NCT02312102|acute myeloid leukemia|acute myeloid leukemia
206039|NCT02312102|allogeneic stem cell transplantation|allogeneic stem cell transplantation
206040|NCT02312089|Luteal phase support, ICSI, GnRHa|luteal phase support, icsi, gnrha
206041|NCT02312076|Luteal phase support, ICSI, GnRHa|luteal phase support, icsi, gnrha
206042|NCT02312063|DPP-4 inhibitor|dpp-4 inhibitor
206043|NCT02312063|sulfonylurea|sulfonylurea
206044|NCT02312037|Relapsed CD33 AML|relapsed cd33 aml
206045|NCT02312037|Refractory CD33 AML|refractory cd33 aml
206046|NCT02312037|Relapsed CD33 APL|relapsed cd33 apl
206047|NCT02312037|Refractory CD33 APL|refractory cd33 apl
206048|NCT02312037|Relapsed CD33 MDS|relapsed cd33 mds
206049|NCT02312037|Refractory CD33 MDS|refractory cd33 mds
206050|NCT02312024|CytoSorb adsorber|cytosorb adsorber
206051|NCT02312024|sepsis|sepsis
206052|NCT02312024|cytokines|cytokines
206053|NCT02312024|hemofiltration|hemofiltration
206054|NCT02312024|hemadsorption|hemadsorption
206055|NCT02312024|inflammation|inflammation
206056|NCT02312011|Myotonic Dystrophy|myotonic dystrophy
206057|NCT02312011|DM1|dm1
206058|NCT02312011|Adult onset|adult onset
206059|NCT02312011|Neuromuscular Disease|neuromuscular disease
206060|NCT02312011|DMPKRx|dmpkrx
206061|NCT02311998|Leukemia|leukemia
206062|NCT02311998|CD22-positive Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia|cd22-positive philadelphia-chromosome positive acute lymphoblastic leukemia
206063|NCT02311998|ALL|all
206064|NCT02311998|Chronic Myeloid Leukemia Lymphoid Blast Phase|chronic myeloid leukemia lymphoid blast phase
206065|NCT02311998|CML|cml
206066|NCT02311998|Bosutinib|bosutinib
206067|NCT02311998|SKI-606|ski-606
206068|NCT02311998|Inotuzumab Ozogamicin|inotuzumab ozogamicin
206069|NCT02311998|CMC-544|cmc-544
206070|NCT02311998|Phone Call|phone call
206071|NCT02311985|Liver cirrhosis|liver cirrhosis
206072|NCT02311985|Blood coagulation|blood coagulation
206073|NCT02311985|Thromboelastography|thromboelastography
206074|NCT02311985|Blood transfusion|blood transfusion
206075|NCT02311985|Catheterization, central venous|catheterization, central venous
206076|NCT02311959|Breast|breast
206077|NCT02311959|Invasive carcinoma|invasive carcinoma
206078|NCT02311959|In situ carcinoma|in situ carcinoma
206079|NCT02311959|Mastectomy|mastectomy
206080|NCT02311959|Nipple areola|nipple areola
206081|NCT02311959|Reconstruction|reconstruction
206082|NCT02311959|Local recurrence|local recurrence
206083|NCT02311946|Palbociclib, Rabeprazole, Proton Pump Inhibitor, Drug Interaction Study, DDI|palbociclib, rabeprazole, proton pump inhibitor, drug interaction study, ddi
206084|NCT02311829|Quality of life, PNES, Epilepsy,|quality of life, pnes, epilepsy,
206085|NCT02311816|Bacterial infection, empiric antibiotic therapy|bacterial infection, empiric antibiotic therapy
206086|NCT02311790|cis-C16:1n7 supplement|cis-c16:1n7 supplement
206087|NCT02311790|trans-C16:1n7 supplement|trans-c16:1n7 supplement
206088|NCT02311790|palmitoleic acid supplement|palmitoleic acid supplement
206089|NCT02311751|Autism Spectrum Disorder|autism spectrum disorder
206090|NCT02311751|Executive Function|executive function
206091|NCT02311751|rTMS (Repetitive Transcranial Magnetic Stimulation)|rtms (repetitive transcranial magnetic stimulation)
206092|NCT02311751|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
206093|NCT02311751|Healthy Subjects|healthy subjects
206343|NCT02310282|Telemedicine|telemedicine
206094|NCT02311738|Exercise and Genes in Obese (EGO)|exercise and genes in obese (ego)
206095|NCT02311725|narrative communication|narrative communication
206096|NCT02311725|depression|depression
206097|NCT02311725|antidepressant augmentation|antidepressant augmentation
206098|NCT02311725|primary care|primary care
206099|NCT02311712|Esophageal cancer|esophageal cancer
206100|NCT02311712|Early detection|early detection
206101|NCT02311712|Cytological examination|cytological examination
206102|NCT02311699|Gender|gender
206103|NCT02311699|Physical Violence|physical violence
206104|NCT02311699|Sexual Violence|sexual violence
206105|NCT02311699|HIV|hiv
206106|NCT02311699|AIDS|aids
206107|NCT02311699|Prevention|prevention
206108|NCT02311699|Community Intervention|community intervention
206109|NCT02311699|Ethiopia|ethiopia
206110|NCT02311699|Intimate Partner Violence|intimate partner violence
206111|NCT02311686|Ethanol|ethanol
206112|NCT02311686|Fatty acid ethyl esters|fatty acid ethyl esters
206113|NCT02311686|Ethyl glucoronide|ethyl glucoronide
206114|NCT02311686|Ethyl sulphate|ethyl sulphate
206115|NCT02311686|Pharmacokinetics|pharmacokinetics
206116|NCT02311673|Prader-Willi Syndrome|prader-willi syndrome
206117|NCT02311673|obesity|obesity
206118|NCT02311673|hyperphagia|hyperphagia
206119|NCT02311647|Tamoxifen|tamoxifen
206120|NCT02311647|Uterine cavity|uterine cavity
206121|NCT02311647|endometrium|endometrium
206122|NCT02311634|Electrical pudendal nerve stimulation|electrical pudendal nerve stimulation
206123|NCT02311634|Transvaginal electrical stimulation|transvaginal electrical stimulation
206124|NCT02311634|Urge urinary incontinence|urge urinary incontinence
206125|NCT02311634|Comparative study|comparative study
206126|NCT02311608|acute variceal hemorrhage|acute variceal hemorrhage
206127|NCT02311608|terlipressin|terlipressin
206128|NCT02311608|somatostatin|somatostatin
206129|NCT02311608|octreotide|octreotide
206130|NCT02311608|comparative effectiveness research|comparative effectiveness research
206131|NCT02311595|gastric cancer|gastric cancer
206132|NCT02311595|laparoscope|laparoscope
206133|NCT02311569|JAK2|jak2
206134|NCT02311569|Mirabegron|mirabegron
206135|NCT02311569|Primary myelofibrosis|primary myelofibrosis
206136|NCT02311569|beta-3-mimetic drugs|beta-3-mimetic drugs
206137|NCT02311569|Myeloproliferative neoplasm|myeloproliferative neoplasm
206138|NCT02311569|Essential thrombocythemia|essential thrombocythemia
206139|NCT02311569|Polycythemia vera|polycythemia vera
206140|NCT02311569|Betmiga|betmiga
206141|NCT02311569|JAK2-V617F|jak2-v617f
206142|NCT02311543|Axillary Lymph Node Dissection (ALND)|axillary lymph node dissection (alnd)
206143|NCT02311543|Breast Cancer|breast cancer
206144|NCT02311543|TachoSil®|tachosil®
206145|NCT02311543|Lymphatic Drainage|lymphatic drainage
206146|NCT02311543|Surgical Sealing Patch|surgical sealing patch
206147|NCT02311491|nano crystalline|nano crystalline
206148|NCT02311491|archwire|archwire
206149|NCT02311465|Palliative Care|palliative care
206150|NCT02311439|Locally advanced pancreatic cancer|locally advanced pancreatic cancer
206151|NCT02311439|Chemotherapy|chemotherapy
206152|NCT02311439|Radiotherapy|radiotherapy
206153|NCT02311426|Rehabilitation; Functional outcome|rehabilitation; functional outcome
206154|NCT02311413|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
206155|NCT02311400|Emotion|emotion
206156|NCT02311400|Self-Affirmation|self-affirmation
206157|NCT02311400|Alcohol Consumption|alcohol consumption
206158|NCT02311387|Incidence|incidence
206159|NCT02311387|Prevalence|prevalence
206160|NCT02311387|Human|human
206161|NCT02311387|Mastomys|mastomys
206162|NCT02311387|Serosurvey|serosurvey
206163|NCT02311374|Human Brain|human brain
206164|NCT02311374|Sleep|sleep
206165|NCT02311374|EEG|eeg
206166|NCT02311374|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
206167|NCT02311374|Apparent Diffusion Coefficient|apparent diffusion coefficient
206168|NCT02311361|Anti-PDL1|anti-pdl1
206169|NCT02311361|Anti-CTLA4|anti-ctla4
206170|NCT02311361|Streostatic Body Radiation Therapy (SBRT)|streostatic body radiation therapy (sbrt)
206171|NCT02311361|Monoclonal Antibody|monoclonal antibody
206172|NCT02311361|Antitumor Immunity|antitumor immunity
206173|NCT02311348|Biopsy|biopsy
206174|NCT02311348|Pain|pain
206175|NCT02311335|Hypertriglyceridemia|hypertriglyceridemia
206176|NCT02311335|Atherosclerosis|atherosclerosis
206177|NCT02311335|Genectic Variants|genectic variants
206178|NCT02311335|Hyperalphalipoproteinemia|hyperalphalipoproteinemia
206179|NCT02311335|Dyslipidemia|dyslipidemia
206180|NCT02311322|Growth Disorder|growth disorder
206181|NCT02311322|Growth|growth
206182|NCT02311322|Exome Sequencing|exome sequencing
206183|NCT02311244|All-cause mortality|all-cause mortality
206184|NCT02311244|Cardiovascular mortality|cardiovascular mortality
206185|NCT02311244|Myocardial infarction|myocardial infarction
206186|NCT02311244|Stroke|stroke
206187|NCT02311244|Dialysis|dialysis
206188|NCT02311218|oral, microbiota, lactobacillus reuteri,|oral, microbiota, lactobacillus reuteri,
206189|NCT02311205|Transarterial Chemoembolization (TACE)|transarterial chemoembolization (tace)
206190|NCT02311205|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
206191|NCT02311205|Metastasis|metastasis
206192|NCT02311205|Sorafenib|sorafenib
206193|NCT02311192|Vitreous Haze|vitreous haze
206194|NCT02311192|Ocular ultrasound|ocular ultrasound
206195|NCT02311192|B scan|b scan
206196|NCT02311192|Uveitis|uveitis
206197|NCT02311179|Prosthesis fixation|prosthesis fixation
206198|NCT02311179|hip arthroplasty|hip arthroplasty
206199|NCT02311166|Hip dysplasia|hip dysplasia
206200|NCT02311166|Soft tissue|soft tissue
206201|NCT02311166|Hip|hip
206202|NCT02311166|Self-report|self-report
206203|NCT02311166|Physical activity|physical activity
206204|NCT02311140|cystic fibrosis|cystic fibrosis
206205|NCT02311140|nasal lavage|nasal lavage
206206|NCT02311140|inflammation|inflammation
206207|NCT02311140|Interleukin (IL)-6|interleukin (il)-6
206208|NCT02311140|IL-8|il-8
206209|NCT02311140|pulmonary function|pulmonary function
206210|NCT02311127|Peripherally Inserted Central Catheters|peripherally inserted central catheters
206211|NCT02311127|Securement device|securement device
206212|NCT02311114|Program Evaluation|program evaluation
206213|NCT02311114|Telehomecare|telehomecare
206214|NCT02311114|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
206215|NCT02311114|Heart Failure|heart failure
206216|NCT02311114|LHINs|lhins
206217|NCT02311114|Local Health Integrative Network|local health integrative network
206218|NCT02311114|OTN|otn
206219|NCT02311114|Ontario Telemedicine Network|ontario telemedicine network
206220|NCT02311101|bladder cancer|bladder cancer
206221|NCT02311101|mitomycin|mitomycin
206222|NCT02311101|BCG|bcg
206223|NCT02311101|intravesical|intravesical
206224|NCT02311101|non-muscle invasive|non-muscle invasive
206225|NCT02311062|training, soccer, eccentric, lengthening, unstable, squatting|training, soccer, eccentric, lengthening, unstable, squatting
206226|NCT02311036|Post Acute Care(PAC)|post acute care(pac)
206227|NCT02311036|Cerebrovascular diseases|cerebrovascular diseases
206228|NCT02311010|transplant|transplant
206229|NCT02311010|immunosuppressive drug|immunosuppressive drug
206230|NCT02310984|Early breast cancer|early breast cancer
206231|NCT02310984|Lumpectomy|lumpectomy
206232|NCT02310984|Breast conserving surgery|breast conserving surgery
206233|NCT02310984|Radiotherapy|radiotherapy
206234|NCT02310984|Cosmesis|cosmesis
206235|NCT02310971|Adenocarcinoma, resected|adenocarcinoma, resected
206236|NCT02310958|Lapraroscopic surgical procedure|lapraroscopic surgical procedure
206237|NCT02310958|infant|infant
206238|NCT02310958|complications|complications
206239|NCT02310958|inguinal hernia|inguinal hernia
206240|NCT02310958|hernia recurrence|hernia recurrence
206241|NCT02310945|pain|pain
206242|NCT02310945|central nervous system sensitization|central nervous system sensitization
206549|NCT02309177|PR+|pr+
206243|NCT02310945|physiotherapy|physiotherapy
206244|NCT02310932|mental health|mental health
206245|NCT02310932|cardiovascular disease|cardiovascular disease
206246|NCT02310932|diabetes|diabetes
206247|NCT02310932|hypertension|hypertension
206248|NCT02310932|high blood pressure|high blood pressure
206249|NCT02310919|Infertility|infertility
206250|NCT02310919|In vitro fertilization|in vitro fertilization
206251|NCT02310919|IVF|ivf
206252|NCT02310906|Duchenne muscular dystrophy|duchenne muscular dystrophy
206253|NCT02310906|Exon Skipping|exon skipping
206254|NCT02310906|DMD|dmd
206255|NCT02310906|Exon 53|exon 53
206256|NCT02310906|Ambulatory|ambulatory
206257|NCT02310906|Pediatric|pediatric
206258|NCT02310867|hand transplantation, amputation|hand transplantation, amputation
206259|NCT02310854|anterior cruciate ligament rupture|anterior cruciate ligament rupture
206260|NCT02310854|autograft|autograft
206261|NCT02310854|reconstruction|reconstruction
206262|NCT02310854|orthopedic surgery|orthopedic surgery
206263|NCT02310854|dynamic intraligament stabilization|dynamic intraligament stabilization
206264|NCT02310828|Cluster headache|cluster headache
206265|NCT02310828|Migrainous neuralgia|migrainous neuralgia
206266|NCT02310828|Horton's headache|horton's headache
206267|NCT02310828|Histaminic cephalalgia|histaminic cephalalgia
206268|NCT02310802|IVF|ivf
206269|NCT02310802|ICSI|icsi
206270|NCT02310763|Duchenne Muscular Dystrophy, myostatin|duchenne muscular dystrophy, myostatin
206271|NCT02310737|cesarean section|cesarean section
206272|NCT02310737|facial incision|facial incision
206273|NCT02310737|postoperative pain|postoperative pain
206274|NCT02310724|youth onset type 2 diabetes|youth onset type 2 diabetes
206275|NCT02310724|insulin sensitivity|insulin sensitivity
206276|NCT02310724|beta cell function|beta cell function
206277|NCT02310724|macrovascular comorbidities|macrovascular comorbidities
206278|NCT02310724|microvascular comorbidities|microvascular comorbidities
206279|NCT02310711|Breast|breast
206280|NCT02310711|Mastectomy|mastectomy
206281|NCT02310711|Lumpectomy|lumpectomy
206282|NCT02310711|Breast Therapy|breast therapy
206283|NCT02310698|Ultrasound|ultrasound
206284|NCT02310698|Enhanced Mammography|enhanced mammography
206285|NCT02310698|14-240|14-240
206286|NCT02310685|Cardivascular risks (hypertension, sedentary, overweight)|cardivascular risks (hypertension, sedentary, overweight)
206287|NCT02310685|Cardiovascular age|cardiovascular age
206288|NCT02310685|E-health wellness program|e-health wellness program
206289|NCT02310685|Prevention|prevention
206290|NCT02310685|Community pharmacists|community pharmacists
206291|NCT02310685|Lifestyle change|lifestyle change
206292|NCT02310685|Cardiometabolic age|cardiometabolic age
206293|NCT02310672|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
206294|NCT02310633|TBI|tbi
206295|NCT02310633|memory disorder|memory disorder
206296|NCT02310633|injury, brain, traumatic|injury, brain, traumatic
206297|NCT02310633|rehabilitation|rehabilitation
206298|NCT02310607|Post-partum women|post-partum women
206299|NCT02310581|Bunionectomy|bunionectomy
206300|NCT02310568|PF 06372865|pf 06372865
206301|NCT02310568|generalized anxiety disorder|generalized anxiety disorder
206302|NCT02310568|outpatient|outpatient
206303|NCT02310568|safety|safety
206304|NCT02310568|efficacy|efficacy
206305|NCT02310568|suboptimal response|suboptimal response
206306|NCT02310555|Metabolic surgery|metabolic surgery
206307|NCT02310529|Maternal depression|maternal depression
206308|NCT02310529|Interpersonal Psycotherapy|interpersonal psycotherapy
206309|NCT02310503|Mohs Surgery|mohs surgery
206310|NCT02310490|Nasolabial Folds|nasolabial folds
206311|NCT02310477|regorafenib, cohort, metastatic colorectal cancer|regorafenib, cohort, metastatic colorectal cancer
206312|NCT02310438|Music therapy|music therapy
206313|NCT02310438|stroke|stroke
206314|NCT02310438|hemiparesis|hemiparesis
206315|NCT02310438|neurologic music therapy|neurologic music therapy
206316|NCT02310412|INTERCEPT|intercept
206317|NCT02310412|platelet|platelet
206318|NCT02310412|pathogen inactivation|pathogen inactivation
206319|NCT02310412|platelet components stored|platelet components stored
206320|NCT02310412|therapeutic efficacy|therapeutic efficacy
206321|NCT02310399|Auditory Brainstem Implant|auditory brainstem implant
206322|NCT02310399|Deafness|deafness
206323|NCT02310399|Hearing Loss|hearing loss
206324|NCT02310399|ABI|abi
206325|NCT02310386|Fibromyalgia|fibromyalgia
206326|NCT02310386|Electromagnetic field therapy|electromagnetic field therapy
206327|NCT02310386|Randomized controlled trial|randomized controlled trial
206328|NCT02310373|Nicotine-free hookah|nicotine-free hookah
206329|NCT02310373|Waterpipe|waterpipe
206330|NCT02310373|Smoking|smoking
206331|NCT02310373|Sympathetic|sympathetic
206332|NCT02310321|Acute Myeloid Leukemia|acute myeloid leukemia
206333|NCT02310321|Cytarabine|cytarabine
206334|NCT02310321|Idarubicin|idarubicin
206335|NCT02310321|ASP2215|asp2215
206336|NCT02310308|Xylitol|xylitol
206337|NCT02310308|Magnolia|magnolia
206338|NCT02310308|chewing gum|chewing gum
206339|NCT02310295|Diabetic retinopathy|diabetic retinopathy
206340|NCT02310295|Macular edema|macular edema
206341|NCT02310295|Anti-VEGF|anti-vegf
206342|NCT02310295|Triamcinolone|triamcinolone
206344|NCT02310282|Emergency medicine|emergency medicine
206345|NCT02310282|Stroke|stroke
206346|NCT02310282|Stroke syndromes|stroke syndromes
206347|NCT02310269|Cushing's disease,|cushing's disease,
206348|NCT02310269|pasireotide s.c.|pasireotide s.c.
206349|NCT02310269|Signifor|signifor
206350|NCT02310256|Mitochondria, muscle|mitochondria, muscle
206351|NCT02310256|Exercise|exercise
206352|NCT02310256|Blood Flow Velocity|blood flow velocity
206353|NCT02310243|Acute myeloid leukemia|acute myeloid leukemia
206354|NCT02310243|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
206355|NCT02310243|MLL-rearranged leukemia|mll-rearranged leukemia
206356|NCT02310243|Palbociclib (PD-0332991-00)|palbociclib (pd-0332991-00)
206357|NCT02310230|Endoscopy, Upper|endoscopy, upper
206358|NCT02310230|Minute Ventilation|minute ventilation
206359|NCT02310230|Tidal Volume|tidal volume
206360|NCT02310230|Respiratory Rate|respiratory rate
206361|NCT02310217|Hypertension|hypertension
206362|NCT02310217|Cognitive impairment|cognitive impairment
206363|NCT02310217|Biomarkers|biomarkers
206364|NCT02310191|ischemic stroke|ischemic stroke
206365|NCT02310191|carotid stenting|carotid stenting
206366|NCT02310191|MRI diffusion weighted imaging|mri diffusion weighted imaging
206367|NCT02310191|Laboratory marker|laboratory marker
206368|NCT02310178|weight loss|weight loss
206369|NCT02310178|sleeve gastrectomy|sleeve gastrectomy
206370|NCT02310178|gastric bypass|gastric bypass
206371|NCT02310178|gastric banding|gastric banding
206372|NCT02310178|bariatric procedures|bariatric procedures
206373|NCT02310178|cohort|cohort
206374|NCT02310178|morbid obesity|morbid obesity
206375|NCT02310178|medical and economical impact|medical and economical impact
206376|NCT02310178|severe obesity|severe obesity
206377|NCT02310165|Paracentesis|paracentesis
206378|NCT02310165|Ascites|ascites
206379|NCT02310152|Child|child
206380|NCT02310152|Adolescent|adolescent
206381|NCT02310152|Parents|parents
206382|NCT02310152|Cognitive Therapy|cognitive therapy
206383|NCT02310152|Cognitive Behavior Therapy|cognitive behavior therapy
206384|NCT02310152|Anxiety|anxiety
206385|NCT02310113|NIRS|nirs
206386|NCT02310113|transfusion|transfusion
206387|NCT02310113|RBC|rbc
206388|NCT02310087|male infertility|male infertility
206389|NCT02310087|spermatogenesis|spermatogenesis
206390|NCT02310087|antioxidants|antioxidants
206391|NCT02310087|DNA damage|dna damage
206392|NCT02310087|mitochondrial membrane potential|mitochondrial membrane potential
206393|NCT02310087|apoptosis|apoptosis
206394|NCT02310061|Dialysis|dialysis
206395|NCT02310061|ESRD|esrd
206396|NCT02310061|lung congestion|lung congestion
206397|NCT02310061|heart failure|heart failure
206398|NCT02310061|LW-US|lw-us
206399|NCT02310009|Exercise|exercise
206400|NCT02310009|IL-1RA|il-1ra
206401|NCT02310009|Beta-cell function|beta-cell function
206402|NCT02310009|Type 2 Diabetes|type 2 diabetes
206403|NCT02309996|Randomized Controlled Trial|randomized controlled trial
206404|NCT02309996|Intervention Studies|intervention studies
206405|NCT02309996|Inservice Training|inservice training
206406|NCT02309996|Personnel Management|personnel management
206407|NCT02309996|Work place|work place
206408|NCT02309996|Work accommodation|work accommodation
206409|NCT02309996|Job modification|job modification
206410|NCT02309996|Supervision|supervision
206411|NCT02309996|Administration|administration
206412|NCT02309996|Return to Work|return to work
206413|NCT02309996|Industrial Psychology|industrial psychology
206414|NCT02309996|Human Engineering|human engineering
206415|NCT02309996|Risk Management|risk management
206416|NCT02309996|Organization and Administration|organization and administration
206417|NCT02309996|Work Disability|work disability
206418|NCT02309996|Occupational Diseases|occupational diseases
206419|NCT02309996|Occupational Injury|occupational injury
206420|NCT02309996|Occupational Health|occupational health
206421|NCT02309996|Occupational Exposure|occupational exposure
206422|NCT02309996|Sick Leave|sick leave
206423|NCT02309996|Absenteeism|absenteeism
206424|NCT02309996|Employee Health|employee health
206425|NCT02309983|bone turnover|bone turnover
206426|NCT02309983|muscle atrophy|muscle atrophy
206427|NCT02309983|fiber|fiber
206428|NCT02309957|Knee Cartilage Repair, Osteochondral Defects, BioMatrix CRD|knee cartilage repair, osteochondral defects, biomatrix crd
206429|NCT02309944|Wound Healing|wound healing
206430|NCT02309944|Obesity|obesity
206431|NCT02309944|Gynecologic Surgery|gynecologic surgery
206432|NCT02309944|Gynecologic Neoplasms|gynecologic neoplasms
206433|NCT02309944|Surgical Complications|surgical complications
206434|NCT02309931|Right hemicolectomy|right hemicolectomy
206435|NCT02309931|Side-to-side anastomosis|side-to-side anastomosis
206436|NCT02309931|Orocecal time|orocecal time
206437|NCT02309931|Antipersitaltic|antipersitaltic
206438|NCT02309931|Isoperistaltic|isoperistaltic
206439|NCT02309931|Laparoscopic colectomy|laparoscopic colectomy
206440|NCT02309931|Right laparoscopic hemicolectomy|right laparoscopic hemicolectomy
206441|NCT02309918|acute HCV Genotype 1 Infection|acute hcv genotype 1 infection
206442|NCT02309918|HCV RNA|hcv rna
206443|NCT02309918|LDV/SOF FDC|ldv/sof fdc
206444|NCT02309905|inmates|inmates
206446|NCT02309905|telemedicine|telemedicine
206447|NCT02309892|Non-Small Cell Lung Cancer|non-small cell lung cancer
206448|NCT02309892|Neoplasms|neoplasms
206449|NCT02309892|Immunoconjugate|immunoconjugate
206450|NCT02309892|Tumor microenvironment alkalinization|tumor microenvironment alkalinization
206451|NCT02309879|Intravenous lidocaine|intravenous lidocaine
206452|NCT02309879|Magnesium sulphate|magnesium sulphate
206453|NCT02309879|Mastectomy|mastectomy
206454|NCT02309879|Pain|pain
206455|NCT02309827|Inflammatory bowel disease|inflammatory bowel disease
206456|NCT02309723|Alzheimer's Disease|alzheimer's disease
206457|NCT02309723|Mild Cognitive Impairment|mild cognitive impairment
206458|NCT02309723|Neuroimaging|neuroimaging
206459|NCT02309723|Diagnostic Tool|diagnostic tool
206460|NCT02309697|Development|development
206461|NCT02309697|Assessments|assessments
206462|NCT02309697|Premature birth|premature birth
206463|NCT02309684|Diabetic Foot Ulcer (DFU)|diabetic foot ulcer (dfu)
206464|NCT02309684|Venous Leg Ulcer (VLU)|venous leg ulcer (vlu)
206465|NCT02309658|cervix neoplasm|cervix neoplasm
206466|NCT02309658|hENT1 protein, human|hent1 protein, human
206467|NCT02309658|Chemotherapy|chemotherapy
206468|NCT02309645|fibrin sealant|fibrin sealant
206469|NCT02309645|CSF leak|csf leak
206470|NCT02309619|esophageal cancer|esophageal cancer
206471|NCT02309619|esophagectomy|esophagectomy
206472|NCT02309619|quality of life|quality of life
206473|NCT02309593|osteoarthritis|osteoarthritis
206474|NCT02309593|avascular necrosis|avascular necrosis
206475|NCT02309593|ankylosis|ankylosis
206476|NCT02309593|protrusio acetabuli|protrusio acetabuli
206477|NCT02309593|painful hip dysplasia|painful hip dysplasia
206478|NCT02309593|rheumatoid arthritis|rheumatoid arthritis
206479|NCT02309593|correction of functional deformity|correction of functional deformity
206480|NCT02309593|revision procedures|revision procedures
206481|NCT02309580|Ibrutinib|ibrutinib
206482|NCT02309580|14-227|14-227
206483|NCT02309567|Anti-p53 antibody|anti-p53 antibody
206484|NCT02309567|PET/CT|pet/ct
206485|NCT02309567|Lung Cancer|lung cancer
206486|NCT02309567|FDG|fdg
206487|NCT02309554|Contraception|contraception
206488|NCT02309554|Post coital test|post coital test
206489|NCT02309554|Vaginal|vaginal
206490|NCT02309554|Diaphragm|diaphragm
206491|NCT02309541|middle ear implant|middle ear implant
206492|NCT02309541|feedback manager|feedback manager
206493|NCT02309541|Sound quality|sound quality
206494|NCT02309502|diabetic retinopathy|diabetic retinopathy
206495|NCT02309502|retina|retina
206496|NCT02309502|Laser|laser
206497|NCT02309502|Pascal|pascal
206498|NCT02309489|Family Planning Services|family planning services
206499|NCT02309489|Maternal Health Services|maternal health services
206500|NCT02309489|Breast Feeding|breast feeding
206501|NCT02309489|Contraception|contraception
206502|NCT02309489|Postnatal care|postnatal care
206503|NCT02309489|Postpartum contraception|postpartum contraception
206504|NCT02309489|Exclusive breastfeeding|exclusive breastfeeding
206505|NCT02309489|Postpartum Period|postpartum period
206506|NCT02309476|diffuse diabetic macular oedema|diffuse diabetic macular oedema
206507|NCT02309476|Pascal|pascal
206508|NCT02309476|Laser|laser
206509|NCT02309476|DMO|dmo
206510|NCT02309437|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
206511|NCT02309437|Pain|pain
206512|NCT02309437|Oxycodone|oxycodone
206513|NCT02309437|Opioids|opioids
206514|NCT02309437|Oral Mucositis|oral mucositis
206515|NCT02309411|Pediatric|pediatric
206516|NCT02309385|uveitis|uveitis
206517|NCT02309385|acute uveitis|acute uveitis
206518|NCT02309385|anterior uveitis|anterior uveitis
206519|NCT02309385|dexamethasone sodium phosphate|dexamethasone sodium phosphate
206520|NCT02309385|non-infectious uveitis|non-infectious uveitis
206521|NCT02309385|DSP-Visulex|dsp-visulex
206522|NCT02309385|Aciont|aciont
206523|NCT02309346|clindamycin|clindamycin
206524|NCT02309346|septic abortion|septic abortion
206525|NCT02309307|safety and performance|safety and performance
206526|NCT02309294|Patch Test|patch test
206527|NCT02309281|Eylea|eylea
206528|NCT02309268|left atrial appendage closure|left atrial appendage closure
206529|NCT02309255|Secondary coronary prevention|secondary coronary prevention
206530|NCT02309255|Psychosocial factors|psychosocial factors
206531|NCT02309255|Cardiac rehabilitation|cardiac rehabilitation
206532|NCT02309229|sputum colour|sputum colour
206533|NCT02309229|cystic fibrosis|cystic fibrosis
206534|NCT02309229|pollution|pollution
206535|NCT02309190|Transpulmonary pressure - morbid obesity|transpulmonary pressure - morbid obesity
206536|NCT02309177|Pancreatic Cancer|pancreatic cancer
206537|NCT02309177|Breast Cancer|breast cancer
206538|NCT02309177|Metastatic Breast Cancer|metastatic breast cancer
206539|NCT02309177|nab-Paclitaxel|nab-paclitaxel
206540|NCT02309177|Gemcitabine|gemcitabine
206541|NCT02309177|Carboplatin|carboplatin
206542|NCT02309177|Non-Small Cell Lung Cancer|non-small cell lung cancer
206543|NCT02309177|Lung Cancer|lung cancer
206544|NCT02309177|mBC|mbc
206545|NCT02309177|NSCLC|nsclc
206546|NCT02309177|Triple-negative Breast Cancer|triple-negative breast cancer
206547|NCT02309177|Hormone Receptor Positive|hormone receptor positive
206550|NCT02309177|TNBC|tnbc
206551|NCT02309177|Nivolumab|nivolumab
206552|NCT02309177|PD-1|pd-1
206553|NCT02309177|Check-point Inhibitor/s|check-point inhibitor/s
206554|NCT02309177|Immune Check-point Inhibitor/s|immune check-point inhibitor/s
206555|NCT02309177|Anti-PD-1|anti-pd-1
206556|NCT02309177|BMS-936558|bms-936558
206557|NCT02309125|immediate gradual loading|immediate gradual loading
206558|NCT02309099|Acoustic Neuroma|acoustic neuroma
206559|NCT02309099|Vestibular Schwannoma|vestibular schwannoma
206560|NCT02309099|Meniere's Disease|meniere's disease
206561|NCT02309060|narrative communication|narrative communication
206562|NCT02309060|depression|depression
206563|NCT02309060|primary care|primary care
206564|NCT02309060|treatment development|treatment development
206565|NCT02309034|Overweight|overweight
206566|NCT02309034|Obesity|obesity
206567|NCT02309034|Cardiometabolic risk factors|cardiometabolic risk factors
206568|NCT02309034|Adolescents|adolescents
206569|NCT02309034|Exercise|exercise
206570|NCT02309021|craving|craving
206571|NCT02309008|Pharmacokinetics|pharmacokinetics
206572|NCT02308995|Endometriosis|endometriosis
206573|NCT02308995|Laparoscopy|laparoscopy
206574|NCT02308995|Barbed sutures|barbed sutures
206575|NCT02308982|encephalitis|encephalitis
206576|NCT02308982|meningoencephalitis|meningoencephalitis
206577|NCT02308982|encephalomyelitis|encephalomyelitis
206578|NCT02308982|brain inflammation|brain inflammation
206579|NCT02308982|intravenous immunoglobulin|intravenous immunoglobulin
206580|NCT02308982|randomised controlled trial|randomised controlled trial
206581|NCT02308982|Central Nervous System Diseases|central nervous system diseases
206582|NCT02308982|Central Nervous System Infection|central nervous system infection
206583|NCT02308969|altered state of consciousness|altered state of consciousness
206584|NCT02308969|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
206585|NCT02308969|hallucination|hallucination
206586|NCT02308969|model psychosis|model psychosis
206587|NCT02308969|serotonin receptor|serotonin receptor
206588|NCT02308969|LSD|lsd
206589|NCT02308956|task sharing|task sharing
206590|NCT02308956|task shifting|task shifting
206591|NCT02308956|community mental health care|community mental health care
206592|NCT02308956|primary care|primary care
206593|NCT02308956|Developing country|developing country
206594|NCT02308956|Sub-Saharan Africa|sub-saharan africa
206595|NCT02308956|non-inferiority trial|non-inferiority trial
206596|NCT02308917|IBD|ibd
206597|NCT02308917|Crohn's|crohn's
206598|NCT02308917|Ulcerative|ulcerative
206599|NCT02308917|Colitis|colitis
206600|NCT02308904|Infertility|infertility
206601|NCT02308904|Thalassemia|thalassemia
206602|NCT02308904|Iron overload|iron overload
206603|NCT02308904|Pituitary Iron Load|pituitary iron load
206604|NCT02308904|Oxidative Stress|oxidative stress
206605|NCT02308904|REPRODUCTIVE CAPACITY AND ASSOCIATION TO IRON BURDEN AND CHELATION PATTERNS IN THALASSEMIA MAJOR PATIENTS|reproductive capacity and association to iron burden and chelation patterns in thalassemia major patients
206606|NCT02308891|pancreatitis|pancreatitis
206607|NCT02308891|ERCP|ercp
206608|NCT02308878|Opioid abuse|opioid abuse
206609|NCT02308878|Cognitive Therapy|cognitive therapy
206610|NCT02308878|Executive Function|executive function
206611|NCT02308878|Mobile Health|mobile health
206612|NCT02308878|Rehabilitation|rehabilitation
206613|NCT02308865|Early palliative care|early palliative care
206614|NCT02308865|Lung cancer|lung cancer
206615|NCT02308865|Quality of life|quality of life
206616|NCT02308852|bi-manual , motor skill learning , stroke , chronic patients,neuro-rehabilitative robot|bi-manual , motor skill learning , stroke , chronic patients,neuro-rehabilitative robot
206617|NCT02308839|Aneurysm|aneurysm
206618|NCT02308839|Aorta|aorta
206619|NCT02308839|Abdominal|abdominal
206620|NCT02308800|diabetic foot ulcer|diabetic foot ulcer
206621|NCT02308787|platelet depletion|platelet depletion
206622|NCT02308787|apheresis|apheresis
206623|NCT02308774|osteomyelitis, diabetic foot infection|osteomyelitis, diabetic foot infection
206624|NCT02308735|gestation|gestation
206625|NCT02308735|diabetes|diabetes
206626|NCT02308735|ethanol|ethanol
206627|NCT02308722|Borderline resectable|borderline resectable
206628|NCT02308709|Radiotherapy|radiotherapy
206629|NCT02308709|Pulmonary Functional Imaging|pulmonary functional imaging
206630|NCT02308709|Computed Tomography (CT)|computed tomography (ct)
206631|NCT02308709|Image Registration|image registration
206632|NCT02308709|Functional Image-guided Radiotherapy|functional image-guided radiotherapy
206633|NCT02308696|Older Adults|older adults
206634|NCT02308696|Aging in Place|aging in place
206635|NCT02308683|hscrp|hscrp
206636|NCT02308683|hgba1c|hgba1c
206637|NCT02308683|diabetes mellitus|diabetes mellitus
206638|NCT02308644|Diabetic Retinopathy|diabetic retinopathy
206639|NCT02308644|intravitreal bevacizumab|intravitreal bevacizumab
206640|NCT02308644|Contrast Sensitivity|contrast sensitivity
206641|NCT02308631|Endoscopic, Colostomy, Colopexy|endoscopic, colostomy, colopexy
206642|NCT02308618|Achilles tendon rupture|achilles tendon rupture
206643|NCT02308618|Rehabilitation|rehabilitation
206644|NCT02308618|Immobilization|immobilization
206645|NCT02308618|Muscle architecture|muscle architecture
206646|NCT02308618|Functionality|functionality
206647|NCT02308618|Neuromuscular parameters|neuromuscular parameters
206648|NCT02308618|Weight-Bearing|weight-bearing
206649|NCT02308605|SMARTCap|smartcap
206650|NCT02308592|Pregnancy|pregnancy
206651|NCT02308592|Depression|depression
206652|NCT02308592|Antidepressant Use|antidepressant use
206653|NCT02308592|Decision Aid|decision aid
206654|NCT02308566|Intracranial Embolism|intracranial embolism
206655|NCT02308566|Ultrasonography, Doppler, Transcranial|ultrasonography, doppler, transcranial
206656|NCT02308553|BRAF V600 wildtype|braf v600 wildtype
206657|NCT02308553|cutaneous malignant melanoma|cutaneous malignant melanoma
206658|NCT02308553|nintedanib|nintedanib
206659|NCT02308553|paclitaxel|paclitaxel
206660|NCT02308553|kinase inhibitor|kinase inhibitor
206661|NCT02308527|Children|children
206662|NCT02308527|Young adults|young adults
206663|NCT02308514|cryostimulation|cryostimulation
206664|NCT02308488|prone IMRT to breast, level III & Supraclavicular|prone imrt to breast, level iii & supraclavicular
206665|NCT02308488|acute toxicity of prone IMRT to breast, level III & SCV|acute toxicity of prone imrt to breast, level iii & scv
206666|NCT02308462|children of mentally ill parents|children of mentally ill parents
206667|NCT02308462|family intervention|family intervention
206668|NCT02308462|randomized controlled trial|randomized controlled trial
206669|NCT02308410|Tourniquet|tourniquet
206670|NCT02308410|Postoperative outcome|postoperative outcome
206671|NCT02308410|Total knee arthroplasty|total knee arthroplasty
206672|NCT02308397|non coeliac gluten sensitivity|non coeliac gluten sensitivity
206673|NCT02308397|gluten|gluten
206674|NCT02308397|bread|bread
206675|NCT02308384|iFOBT|ifobt
206676|NCT02308384|FIT|fit
206677|NCT02308384|general practice|general practice
206678|NCT02308384|early diagnosis|early diagnosis
206679|NCT02308371|critically ill pediatric patients|critically ill pediatric patients
206680|NCT02308371|fluid resuscitation|fluid resuscitation
206681|NCT02308358|Osteochondral Defect|osteochondral defect
206682|NCT02308358|Femoral condyle osteochondral defect|femoral condyle osteochondral defect
206683|NCT02308319|Hepatocellular carcinoma, Recurrence|hepatocellular carcinoma, recurrence
206684|NCT02308306|Chronic pain|chronic pain
206685|NCT02308306|Opioid analgesics|opioid analgesics
206686|NCT02308306|Prediction study|prediction study
206687|NCT02308306|Pharmaco-EEG|pharmaco-eeg
206688|NCT02308293|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
206689|NCT02308293|Hypoglycemia unawareness|hypoglycemia unawareness
206690|NCT02308293|Lactate|lactate
206691|NCT02308293|high intensity interval exercise|high intensity interval exercise
206692|NCT02308293|MRS|mrs
206693|NCT02308280|High-risk myeloma|high-risk myeloma
206694|NCT02308280|Non myeloablative allogeneic transplantation|non myeloablative allogeneic transplantation
206695|NCT02308280|Bortezomib|bortezomib
206696|NCT02308267|Cystic Fibrosis|cystic fibrosis
206697|NCT02308267|Mucosal immunity|mucosal immunity
206698|NCT02308254|Blood pressure|blood pressure
206699|NCT02308254|Gastric emptying|gastric emptying
206700|NCT02308254|Glycemia|glycemia
206701|NCT02308254|Appetite|appetite
206702|NCT02308254|Incretin Hormones|incretin hormones
206703|NCT02308254|Superior mesenteric artery blood low|superior mesenteric artery blood low
206704|NCT02308241|Ribavirin|ribavirin
206705|NCT02308241|Human Papillomavirus (HPV)|human papillomavirus (hpv)
206706|NCT02308241|Recurrent/Metastatic (R/M)|recurrent/metastatic (r/m)
206707|NCT02308241|14-211|14-211
206708|NCT02308228|Aging|aging
206709|NCT02308228|Hypertrophy|hypertrophy
206710|NCT02308228|Metformin|metformin
206711|NCT02308228|Strength|strength
206712|NCT02308228|Muscle|muscle
206713|NCT02308215|Retina|retina
206714|NCT02308215|AMD|amd
206715|NCT02308215|OCT|oct
206716|NCT02308202|PTSD|ptsd
206717|NCT02308202|treatment|treatment
206718|NCT02308202|virtual reality|virtual reality
206719|NCT02308202|doxazosin|doxazosin
206720|NCT02308189|Exercise|exercise
206721|NCT02308163|Rheumatoid Arthritis|rheumatoid arthritis
206722|NCT02308163|ASP015K|asp015k
206723|NCT02308150|transcatheter aortic valve replacement|transcatheter aortic valve replacement
206724|NCT02308150|asian pacific|asian pacific
206725|NCT02308150|asian|asian
206726|NCT02308111|Primary Biliary Cirrhosis|primary biliary cirrhosis
206727|NCT02308111|PBC|pbc
206728|NCT02308111|Cirrhosis|cirrhosis
206729|NCT02308111|Liver|liver
206730|NCT02308085|Premenopausal|premenopausal
206731|NCT02308085|endocrine responsive|endocrine responsive
206732|NCT02308085|Breast|breast
206733|NCT02308085|Pregnancy|pregnancy
206734|NCT02308072|Squamous Cell Carcinoma|squamous cell carcinoma
206735|NCT02308072|Head and Neck Cancer|head and neck cancer
206736|NCT02308072|Locally Advanced|locally advanced
206737|NCT02308072|Olaparib|olaparib
206738|NCT02308072|Cisplatin|cisplatin
206739|NCT02308072|IMRT|imrt
206740|NCT02308072|Chemoradiotherapy|chemoradiotherapy
206741|NCT02308072|PARP|parp
206742|NCT02308072|HNSCC|hnscc
206743|NCT02307994|infertility|infertility
206744|NCT02307942|Randomized Clinical Trials|randomized clinical trials
206745|NCT02307942|gastric banding|gastric banding
206746|NCT02307942|calorie restriction|calorie restriction
206747|NCT02307942|SPPB|sppb
206748|NCT02307942|physical performance|physical performance
206749|NCT02307942|elderly|elderly
206750|NCT02307916|tympanic membrane perforation|tympanic membrane perforation
206751|NCT02307916|ear drum|ear drum
206752|NCT02307916|hole|hole
206753|NCT02307903|end-stage renal failure (ESRF)|end-stage renal failure (esrf)
206754|NCT02307890|Liver Transplantation|liver transplantation
206755|NCT02307864|Healthy|healthy
206756|NCT02307864|QT interval|qt interval
206757|NCT02307864|QTc interval|qtc interval
206758|NCT02307864|Electrocardiogram|electrocardiogram
206759|NCT02307864|Tramadol hydrochloride|tramadol hydrochloride
206760|NCT02307864|Moxifloxacin|moxifloxacin
206761|NCT02307864|Placebo|placebo
206762|NCT02307838|Multiple Sclerosis, MS, RRMS, relapsing forms of multiple sclerosis, fingolimod, FTY720, Gilenya|multiple sclerosis, ms, rrms, relapsing forms of multiple sclerosis, fingolimod, fty720, gilenya
206763|NCT02307825|Azithromycin|azithromycin
206764|NCT02307825|Endoscopic sinus surgery|endoscopic sinus surgery
206765|NCT02307799|tobacco|tobacco
206766|NCT02307799|spirometry|spirometry
206767|NCT02307799|cohort study|cohort study
206768|NCT02307799|case-control study|case-control study
206769|NCT02307799|prevalence|prevalence
206770|NCT02307773|Upper Gastrointestinal Endoscopy|upper gastrointestinal endoscopy
206771|NCT02307773|Pharyngeal Anesthesia|pharyngeal anesthesia
206772|NCT02307773|Lidocaine|lidocaine
206773|NCT02307773|Belching|belching
206774|NCT02307773|Retching|retching
206775|NCT02307773|Tolerance|tolerance
206776|NCT02307747|infection in ICU|infection in icu
206777|NCT02307734|Lay Health Workers|lay health workers
206778|NCT02307734|Chinese|chinese
206779|NCT02307734|Vietnamese|vietnamese
206780|NCT02307734|Tobacco Use|tobacco use
206781|NCT02307734|Intervention|intervention
206782|NCT02307734|Behavior Change|behavior change
206783|NCT02307734|Social Networks|social networks
206784|NCT02307734|Asians|asians
206785|NCT02307721|Emergency Treatment|emergency treatment
206786|NCT02307721|Morphine Derivates|morphine derivates
206787|NCT02307721|Heroin|heroin
206788|NCT02307721|Antidotes|antidotes
206789|NCT02307721|Administration, Intranasal|administration, intranasal
206790|NCT02307721|Pharmacology|pharmacology
206791|NCT02307721|Naloxone|naloxone
206792|NCT02307721|Healthy volunteers|healthy volunteers
206793|NCT02307695|Saxagliptin|saxagliptin
206794|NCT02307695|Type 1 Diabetes|type 1 diabetes
206795|NCT02307695|Glycemic variability|glycemic variability
206796|NCT02307695|C-Peptide|c-peptide
206797|NCT02307682|AMD|amd
206798|NCT02307682|CNV|cnv
206799|NCT02307682|IVT|ivt
206800|NCT02307643|Systemic lupus erythematosus|systemic lupus erythematosus
206801|NCT02307630|124I-Humanized 3F8|124i-humanized 3f8
206802|NCT02307630|PET Imaging|pet imaging
206803|NCT02307630|13-147|13-147
206804|NCT02307617|Major depressive disorder|major depressive disorder
206805|NCT02307617|MDD|mdd
206806|NCT02307617|healthy control|healthy control
206807|NCT02307617|selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
206808|NCT02307617|SSRI|ssri
206809|NCT02307617|depression|depression
206810|NCT02307617|transcranial magnetic stimulation|transcranial magnetic stimulation
206811|NCT02307617|TMS|tms
206812|NCT02307617|magnetic resonance spectroscopy|magnetic resonance spectroscopy
206813|NCT02307617|MRS|mrs
206814|NCT02307617|adolescent|adolescent
206815|NCT02307617|mild MDD|mild mdd
206816|NCT02307617|mild depression|mild depression
206817|NCT02307617|cortical excitability|cortical excitability
206818|NCT02307617|cortical inhibition|cortical inhibition
206819|NCT02307617|cortical silent period|cortical silent period
206820|NCT02307617|motor threshold|motor threshold
206821|NCT02307617|intracortical facilitation|intracortical facilitation
206822|NCT02307617|intracortical inhibition|intracortical inhibition
206823|NCT02307617|motor cortex|motor cortex
206824|NCT02307617|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
206825|NCT02307617|DLPFC|dlpfc
206826|NCT02307617|thumb twitch|thumb twitch
206827|NCT02307617|gamma aminobutyric acid|gamma aminobutyric acid
206828|NCT02307617|GABA|gaba
206829|NCT02307617|glutamate|glutamate
206830|NCT02307617|single pulse|single pulse
206831|NCT02307617|paired pulse|paired pulse
206832|NCT02307604|Brain tumor|brain tumor
206833|NCT02307604|Biomarkers|biomarkers
206834|NCT02307604|Screening|screening
206835|NCT02307578|Perampanel|perampanel
206836|NCT02307578|Fycompa|fycompa
206837|NCT02307578|Primary Generalized Tonic-Clonic Seizures|primary generalized tonic-clonic seizures
206838|NCT02307578|E2007-G000-332|e2007-g000-332
206839|NCT02307578|E2007|e2007
206840|NCT02307565|Midodrine|midodrine
206841|NCT02307565|Blood pressure|blood pressure
206842|NCT02307565|Orthostatic hypotension|orthostatic hypotension
206843|NCT02307565|Spinal Cord Injury|spinal cord injury
206844|NCT02307565|Sympathetic vascular control|sympathetic vascular control
206845|NCT02307565|Cerebral blood flow velocity|cerebral blood flow velocity
206846|NCT02307565|Cognition function tasks|cognition function tasks
206847|NCT02307565|Quality of Life|quality of life
206848|NCT02307565|MRI|mri
206849|NCT02307565|fMRI|fmri
206850|NCT02307552|Imaging|imaging
206851|NCT02307552|ultrasound|ultrasound
206852|NCT02307552|prostate|prostate
206853|NCT02307552|cancer|cancer
206854|NCT02307552|diagnostic tool|diagnostic tool
206855|NCT02307552|catheter|catheter
206856|NCT02307552|urethra|urethra
206857|NCT02307552|digital rectal exam|digital rectal exam
206858|NCT02307526|Hypotension, Postural|hypotension, postural
206859|NCT02307513|APREMILAST (CC-10004)|apremilast (cc-10004)
206860|NCT02307513|CC-10004|cc-10004
206861|NCT02307513|Efficacy|efficacy
206862|NCT02307513|Safety|safety
206863|NCT02307513|Phase 3|phase 3
206864|NCT02307513|Behçet's Disease|behçet's disease
206865|NCT02307487|TC-3 Gel|tc-3 gel
206866|NCT02307487|MMC|mmc
206867|NCT02307487|NMIBC|nmibc
206868|NCT02307487|Non Muscle Invasive Bladder Cancer|non muscle invasive bladder cancer
206869|NCT02307487|Hydrogel Reverse thermal gelation|hydrogel reverse thermal gelation
206870|NCT02307487|Drug retention|drug retention
206871|NCT02307487|Urinary Bladder Neoplasms|urinary bladder neoplasms
206872|NCT02307487|Urologic Neoplasms|urologic neoplasms
206873|NCT02307487|Urinary Bladder Diseases|urinary bladder diseases
206874|NCT02307487|Urologic Diseases|urologic diseases
206875|NCT02307474|Kidney|kidney
206876|NCT02307474|Renal Cell Carcinoma|renal cell carcinoma
206877|NCT02307474|Cancer|cancer
206878|NCT02307474|Pilot|pilot
206879|NCT02307474|Pazopanib|pazopanib
206880|NCT02307474|stereotactic body radiation therapy|stereotactic body radiation therapy
206881|NCT02307474|SBRT|sbrt
206882|NCT02307461|Phase 1|phase 1
206883|NCT02307461|Bioequivalence|bioequivalence
206884|NCT02307461|Pharmacokinetics|pharmacokinetics
206885|NCT02307461|Food|food
206886|NCT02307461|Healthy Adult|healthy adult
206887|NCT02307435|non union fracture|non union fracture
206888|NCT02307435|bone defect|bone defect
206889|NCT02307435|mesenchymal stem cell|mesenchymal stem cell
206890|NCT02307435|cryopreservation|cryopreservation
206891|NCT02307383|SDD (Selective Digestive Decolonization)|sdd (selective digestive decolonization)
206892|NCT02307383|OXA 48|oxa 48
206893|NCT02307383|carbapenemase|carbapenemase
206894|NCT02307383|probiotics|probiotics
206895|NCT02307331|Total Hip Replacement|total hip replacement
206896|NCT02307318|Radial Artery|radial artery
206897|NCT02307318|Hemostasis|hemostasis
206898|NCT02307318|Angiography|angiography
206899|NCT02307292|Superficial femoral artery|superficial femoral artery
206900|NCT02307292|Self Expanding Stent System|self expanding stent system
206901|NCT02307253|EUS-guided biopsy, EUS-FNB|eus-guided biopsy, eus-fnb
206902|NCT02307240|TNBC|tnbc
206903|NCT02307240|HGSOC|hgsoc
206904|NCT02307240|NMC|nmc
206905|NCT02307188|Atrial Fibrillation|atrial fibrillation
206906|NCT02307188|Atrial Flutter|atrial flutter
206907|NCT02307188|Multipolar Catheter|multipolar catheter
206908|NCT02307188|Atrial Arrhythmia|atrial arrhythmia
206909|NCT02307162|COPD|copd
206910|NCT02307149|melanoma|melanoma
206911|NCT02307149|ipilimumab|ipilimumab
206912|NCT02307149|coxsackievirus A21|coxsackievirus a21
206913|NCT02307149|CAVATAK|cavatak
206914|NCT02307149|CVA21|cva21
206915|NCT02307149|checkpoint inhibitors|checkpoint inhibitors
206916|NCT02307136|intensive care units|intensive care units
206917|NCT02307136|emergency department|emergency department
206918|NCT02307123|Prehospital emergency care (MeSH)|prehospital emergency care (mesh)
206919|NCT02307123|Emergency medical services (MeSH)|emergency medical services (mesh)
206920|NCT02307123|Helicopter emergency medical service, Critical care (MeSH)|helicopter emergency medical service, critical care (mesh)
206921|NCT02307123|Airway management (MeSH)|airway management (mesh)
206922|NCT02307123|Endotracheal intubation (MeSH)|endotracheal intubation (mesh)
206923|NCT02307123|Patient outcome|patient outcome
206924|NCT02307110|Diabetes Mellitus 1|diabetes mellitus 1
206925|NCT02307110|long-term intensified insulin therapy|long-term intensified insulin therapy
206926|NCT02307110|diabetic retinopathy|diabetic retinopathy
206927|NCT02307110|diabetic macular edema|diabetic macular edema
206928|NCT02307097|Randomised Controlled Trial|randomised controlled trial
206929|NCT02307097|Cognitive-Behavioural Bibliotherapy|cognitive-behavioural bibliotherapy
206930|NCT02307097|Social Anxiety Disorder|social anxiety disorder
206931|NCT02307097|Cognitive-Behavioural Therapy|cognitive-behavioural therapy
206932|NCT02307097|IAPT|iapt
206933|NCT02307084|surgical site infection|surgical site infection
206934|NCT02307084|long saphenous vein|long saphenous vein
206935|NCT02307084|coronary artery bypass grafting|coronary artery bypass grafting
206936|NCT02307058|Prostate Cancer|prostate cancer
206937|NCT02307045|Arterial stiffness|arterial stiffness
206938|NCT02307045|Endothelial Glycocalyx|endothelial glycocalyx
206939|NCT02307032|Atrial Fibrillation Relapses Prediction|atrial fibrillation relapses prediction
206940|NCT02307032|P wave Signal Averaged ECG|p wave signal averaged ecg
206941|NCT02307032|P wave Wavelets|p wave wavelets
206942|NCT02307032|Strain|strain
206943|NCT02307032|Tissue Doppler Imaging|tissue doppler imaging
206944|NCT02307019|Caregivers|caregivers
206945|NCT02307019|Apraxias|apraxias
206946|NCT02307019|Stroke|stroke
206947|NCT02307019|Cerebral Stroke|cerebral stroke
206948|NCT02307019|Rehabilitation|rehabilitation
206949|NCT02307019|Pragmatic Clinical Trials as Topic|pragmatic clinical trials as topic
206950|NCT02306993|Sickle Cell Disease (SCD)|sickle cell disease (scd)
206951|NCT02306993|Sickle Cell Trait (SCT)|sickle cell trait (sct)
206952|NCT02306967|oral cancer|oral cancer
206953|NCT02306967|oral dysplasia|oral dysplasia
206954|NCT02306954|Kidney Cancer|kidney cancer
206955|NCT02306954|High Dose IL-2|high dose il-2
206956|NCT02306954|SBRT|sbrt
206957|NCT02306928|Septic shock|septic shock
206958|NCT02306928|Intensive care unit|intensive care unit
206959|NCT02306928|Therapeutic drug monitoring|therapeutic drug monitoring
206960|NCT02306928|Pharmacokinetics|pharmacokinetics
206961|NCT02306928|Critically ill|critically ill
206962|NCT02306915|Lipegfilgrastim, Lonquex, Japanese Bridging|lipegfilgrastim, lonquex, japanese bridging
206963|NCT02306863|Parkinson's Disease|parkinson's disease
206964|NCT02306863|whole-body vibration|whole-body vibration
206965|NCT02306863|WBV|wbv
206966|NCT02306850|immunotherapy|immunotherapy
206967|NCT02306850|PD-1 inhibitor|pd-1 inhibitor
206968|NCT02306850|programmed death 1 inhibitor|programmed death 1 inhibitor
206969|NCT02306850|neoadjuvant|neoadjuvant
206970|NCT02306850|pembrolizumab|pembrolizumab
206971|NCT02306850|MK-3475|mk-3475
206972|NCT02306837|lymphoma, consolidation chemotherapy, auto-HSCT|lymphoma, consolidation chemotherapy, auto-hsct
206973|NCT02306759|analgesia|analgesia
206974|NCT02306759|ketamine|ketamine
206975|NCT02306759|pain|pain
206976|NCT02306746|Enteral nutrition|enteral nutrition
206977|NCT02306746|randomised control trial|randomised control trial
206978|NCT02306746|Critical care|critical care
206979|NCT02306746|Outcome|outcome
206980|NCT02306733|Post partum hemorrhage|post partum hemorrhage
206981|NCT02306733|Ergometrine|ergometrine
206982|NCT02306733|Oxytocin|oxytocin
206983|NCT02306733|Obstetrics|obstetrics
206984|NCT02306694|hemophilia|hemophilia
206985|NCT02306694|bone disease|bone disease
206986|NCT02306694|clinical study|clinical study
206987|NCT02306694|biomarkers|biomarkers
206988|NCT02306668|Dry eye|dry eye
206989|NCT02306655|Coital incontinence|coital incontinence
206990|NCT02306655|Incidence|incidence
206991|NCT02306655|quality of life|quality of life
206992|NCT02306629|Systemic Lupus Erythematosus|systemic lupus erythematosus
206993|NCT02306590|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
206994|NCT02306590|survival time|survival time
206995|NCT02306590|ALS Functional Rating Scale|als functional rating scale
206996|NCT02306590|quality of life|quality of life
206997|NCT02306590|survival|survival
206998|NCT02306577|STRIBILD|stribild
206999|NCT02306577|HIV|hiv
207000|NCT02306577|Illicit dgug user|illicit dgug user
207001|NCT02306564|ICSI|icsi
207002|NCT02306564|cabergoline|cabergoline
207003|NCT02306564|Subendometrial vascularity|subendometrial vascularity
207004|NCT02306551|Offspring|offspring
207005|NCT02306551|Attachment|attachment
207006|NCT02306551|Risk development|risk development
207007|NCT02306551|Resilience|resilience
207008|NCT02306538|edema|edema
207009|NCT02306538|inflammation|inflammation
207010|NCT02306538|scar|scar
207011|NCT02306538|ejection fraction|ejection fraction
207012|NCT02306538|volumes|volumes
207013|NCT02306512|Melanoma In Situ|melanoma in situ
207014|NCT02306512|Lentigo Maligna|lentigo maligna
207015|NCT02306512|Confocal Microscopy|confocal microscopy
207016|NCT02306512|Direct Immunofluorescence|direct immunofluorescence
207017|NCT02306499|VARICOCELE-AZOOSPERMIA-ICSI|varicocele-azoospermia-icsi
207018|NCT02306460|Neurobehavioral Manifestations|neurobehavioral manifestations
207019|NCT02306460|POCD|pocd
207020|NCT02306460|Atrial Fibrillation|atrial fibrillation
207021|NCT02306460|Anti-Arrhythmia|anti-arrhythmia
207022|NCT02306460|Atrial Appendage Closure|atrial appendage closure
207023|NCT02306434|childbirth fear|childbirth fear
207024|NCT02306434|Internet CBT|internet cbt
207025|NCT02306434|counselling|counselling
207026|NCT02306434|antenatal care|antenatal care
207027|NCT02306434|postnatal care|postnatal care
207028|NCT02306434|childbirth|childbirth
207029|NCT02306434|Cognitive behavioural therapy|cognitive behavioural therapy
207030|NCT02306421|RPH with the simplified Milligan-Morgan surgery|rph with the simplified milligan-morgan surgery
207031|NCT02306421|mixed hemorrhoids|mixed hemorrhoids
207032|NCT02306421|the effectiveness and safety|the effectiveness and safety
207033|NCT02306421|A multi center clinical trial|a multi center clinical trial
207034|NCT02306395|endometrial local injury|endometrial local injury
207035|NCT02306395|repeated implatation failure|repeated implatation failure
207036|NCT02306395|embyo transfer|embyo transfer
207037|NCT02306382|endoanal ultrasonography|endoanal ultrasonography
207038|NCT02306382|drainage|drainage
207039|NCT02306382|perianal abscess|perianal abscess
207040|NCT02306382|fistulas|fistulas
207041|NCT02306382|incontience|incontience
207042|NCT02306369|ICBT|icbt
207043|NCT02306369|IBS|ibs
207044|NCT02306369|FGID|fgid
207045|NCT02306369|functional abdominal pain|functional abdominal pain
207046|NCT02306369|Adolescents|adolescents
207047|NCT02306369|Children|children
207048|NCT02306369|Treatment|treatment
207049|NCT02306369|CBT|cbt
207050|NCT02306369|Exposure|exposure
207051|NCT02306369|Cognitive Behavior Therapy|cognitive behavior therapy
207052|NCT02306369|Internet|internet
207053|NCT02306369|Computerized|computerized
207054|NCT02306369|Abdominal Pain|abdominal pain
207055|NCT02306369|Functional Pain|functional pain
207056|NCT02306369|Functional Disorders|functional disorders
207057|NCT02306343|rapid acting insulin|rapid acting insulin
207058|NCT02306343|insulin injection|insulin injection
207059|NCT02306343|insulin delivery|insulin delivery
207060|NCT02306343|local heating|local heating
207061|NCT02306343|experimental device|experimental device
207062|NCT02306343|pre and post meal glucose level|pre and post meal glucose level
207063|NCT02306330|Malditof|malditof
207064|NCT02306330|Malditof MS|malditof ms
207065|NCT02306330|matrix-assisted laser desorption ionization-time|matrix-assisted laser desorption ionization-time
207066|NCT02306330|identifying pathogens|identifying pathogens
207067|NCT02306330|randomized diagnostic trial|randomized diagnostic trial
207068|NCT02306304|Abdominal aortic aneurysm|abdominal aortic aneurysm
207069|NCT02306304|Abdominal aortic aneurism|abdominal aortic aneurism
207070|NCT02306304|AAA|aaa
207071|NCT02306304|Screening|screening
207072|NCT02306304|duplex ultra sound|duplex ultra sound
207073|NCT02306304|Israeli Arab men|israeli arab men
207074|NCT02306304|family physician|family physician
207075|NCT02306291|AML|aml
207076|NCT02306291|Acute myeloid leukemia|acute myeloid leukemia
207077|NCT02306291|E-selectin|e-selectin
207078|NCT02306291|relapse refractory|relapse refractory
207079|NCT02306291|elderly newly diagnosed|elderly newly diagnosed
207080|NCT02306291|induction|induction
207081|NCT02306278|gabapentin|gabapentin
207082|NCT02306278|postoperative pain|postoperative pain
207083|NCT02306278|vomiting|vomiting
207084|NCT02306278|nausea|nausea
207085|NCT02306252|Cancer|cancer
207086|NCT02306252|Older Adult|older adult
207087|NCT02306252|Geriatric|geriatric
207088|NCT02306252|Function|function
207089|NCT02306252|Functional Deficit|functional deficit
207090|NCT02306252|Occupational Therapy|occupational therapy
207091|NCT02306252|Physical Therapy|physical therapy
207092|NCT02306252|Supportive Care|supportive care
207093|NCT02306252|Oncology|oncology
207094|NCT02306252|physiology|physiology
207095|NCT02306252|Geriatric Assessment|geriatric assessment
207096|NCT02306252|Health Services for the Aged|health services for the aged
207097|NCT02306252|Physical Therapy Specialty|physical therapy specialty
207098|NCT02306226|TAVI|tavi
207099|NCT02306226|Aortic stenosis|aortic stenosis
207100|NCT02306226|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
207101|NCT02306226|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
207102|NCT02306226|Transfemoral access|transfemoral access
207103|NCT02306200|Aorta|aorta
207104|NCT02306200|Aortic Disease|aortic disease
207105|NCT02306200|Abdominal Aortic Aneurysm (AAA)|abdominal aortic aneurysm (aaa)
207106|NCT02306200|Thoracic Aortic Aneurysm (TAA)|thoracic aortic aneurysm (taa)
207107|NCT02306200|Bicuspid Aortic Valve (BAV)|bicuspid aortic valve (bav)
207108|NCT02306200|Aortic Dissection|aortic dissection
207109|NCT02306187|The changes of bone mineral density and bone turnover markers|the changes of bone mineral density and bone turnover markers
207110|NCT02306174|Hoarding|hoarding
207111|NCT02306135|Cancer|cancer
207112|NCT02306135|Tumor|tumor
207113|NCT02306135|Everolimus|everolimus
207114|NCT02306135|mTOR|mtor
207115|NCT02306135|Temsirolimus|temsirolimus
207116|NCT02306135|Sirolimus|sirolimus
207117|NCT02306135|Rapamycin|rapamycin
207118|NCT02306122|medication adherence|medication adherence
207119|NCT02306122|choice architecture|choice architecture
207120|NCT02306122|pharmacy home|pharmacy home
207121|NCT02306109|Motor Rehabilitation Treatment|motor rehabilitation treatment
207122|NCT02306109|Intensive versus standard|intensive versus standard
207123|NCT02306109|Motor Disability|motor disability
207124|NCT02306096|prognostic and predictive biomarkers|prognostic and predictive biomarkers
207125|NCT02306096|RNA-sequencing|rna-sequencing
207126|NCT02306096|pathological complete response|pathological complete response
207127|NCT02306096|minimal residual disease|minimal residual disease
207128|NCT02306096|molecular subtype|molecular subtype
207129|NCT02306096|gene expression profiling|gene expression profiling
207130|NCT02306096|mutation screening|mutation screening
207131|NCT02306096|BRCA|brca
207132|NCT02306096|translational research|translational research
207133|NCT02306096|genomics|genomics
207134|NCT02306096|transcriptomics|transcriptomics
207135|NCT02306096|proteomics|proteomics
207136|NCT02306096|metabolomics|metabolomics
207137|NCT02306096|liquid biopsy|liquid biopsy
207138|NCT02306096|circulating tumor cells|circulating tumor cells
207139|NCT02306096|circulating tumor DNA|circulating tumor dna
207140|NCT02306044|Bleeding|bleeding
207141|NCT02306044|Platelet indices|platelet indices
207142|NCT02306044|Platelet aggregometry|platelet aggregometry
207143|NCT02306044|Bleeding questionnaire|bleeding questionnaire
207144|NCT02306031|diclofenac|diclofenac
207145|NCT02306031|macular thickness|macular thickness
207146|NCT02306031|phacoemulsification|phacoemulsification
207455|NCT02304146|Foam|foam
207147|NCT02306031|OCT(Optical coherence tomography )|oct(optical coherence tomography )
207148|NCT02306031|diabetic|diabetic
207149|NCT02306018|liver transplantation|liver transplantation
207150|NCT02306018|cardiac output|cardiac output
207151|NCT02306005|diabetes mellitus type 1, insulin therapy, lipoproteins, HDL|diabetes mellitus type 1, insulin therapy, lipoproteins, hdl
207152|NCT02305966|advanced arthritis|advanced arthritis
207153|NCT02305966|shoulder|shoulder
207154|NCT02305953|Psoriasis|psoriasis
207155|NCT02305953|Vascular Inflammation|vascular inflammation
207156|NCT02305953|Coronary Atherosclerosis|coronary atherosclerosis
207157|NCT02305953|Ascending aorta|ascending aorta
207158|NCT02305953|PET scan|pet scan
207159|NCT02305953|Cytokine|cytokine
207160|NCT02305953|Chemokine|chemokine
207161|NCT02305927|Vitamin D|vitamin d
207162|NCT02305927|Pregnant women|pregnant women
207163|NCT02305914|acute pancreatitis|acute pancreatitis
207164|NCT02305914|chronic pancreatitis|chronic pancreatitis
207165|NCT02305914|pancreatic cancer|pancreatic cancer
207166|NCT02305914|pancreatic disease-associated portal hypertension|pancreatic disease-associated portal hypertension
207167|NCT02305914|autoimmune pancreatitis|autoimmune pancreatitis
207168|NCT02305914|PaO2/FiO2＜200|pao2/fio2＜200
207169|NCT02305914|diabetes mellitus|diabetes mellitus
207170|NCT02305914|blood lipid|blood lipid
207171|NCT02305914|local complications|local complications
207172|NCT02305914|quality of life|quality of life
207173|NCT02305862|Coronary Arteriosclerosis|coronary arteriosclerosis
207174|NCT02305862|Carotid Atherosclerotic Plaque|carotid atherosclerotic plaque
207175|NCT02305862|Rosuvastatin|rosuvastatin
207176|NCT02305849|ASP015K|asp015k
207177|NCT02305849|Rheumatoid Arthritis|rheumatoid arthritis
207178|NCT02305836|Electroacupuncture|electroacupuncture
207179|NCT02305836|Donepezil|donepezil
207180|NCT02305836|Alzheimer's disease|alzheimer's disease
207181|NCT02305836|Randomized controlled trial|randomized controlled trial
207182|NCT02305823|psychosis|psychosis
207183|NCT02305823|antipsychotic agents|antipsychotic agents
207184|NCT02305823|treatment|treatment
207185|NCT02305823|effectiveness|effectiveness
207186|NCT02305784|Cystic fibrosis|cystic fibrosis
207187|NCT02305784|Pulmonary exacerbation|pulmonary exacerbation
207188|NCT02305784|inflammation|inflammation
207189|NCT02305784|Chitinase|chitinase
207190|NCT02305784|cytokine|cytokine
207191|NCT02305784|Cystic fibrosis related diabetes|cystic fibrosis related diabetes
207192|NCT02305758|PARP inhibitor|parp inhibitor
207193|NCT02305758|veliparib|veliparib
207194|NCT02305758|metastatic colorectal cancer|metastatic colorectal cancer
207195|NCT02305758|ABT-888|abt-888
207196|NCT02305758|first line|first line
207197|NCT02305758|previously untreated|previously untreated
207198|NCT02305758|colorectal cancer|colorectal cancer
207199|NCT02305758|colon cancer|colon cancer
207200|NCT02305758|rectal cancer|rectal cancer
207201|NCT02305758|FOLFIRI|folfiri
207202|NCT02305758|fluorouracil|fluorouracil
207203|NCT02305758|5-FU|5-fu
207204|NCT02305758|leucovorin|leucovorin
207205|NCT02305758|irinotecan|irinotecan
207206|NCT02305732|Chikungunya virus|chikungunya virus
207207|NCT02305732|CHIKV|chikv
207208|NCT02305732|Dengue virus|dengue virus
207209|NCT02305732|DENV|denv
207210|NCT02305732|pathogen inactivation|pathogen inactivation
207211|NCT02305732|platelets|platelets
207212|NCT02305732|Puerto Rico|puerto rico
207213|NCT02305706|insertion|insertion
207214|NCT02305706|patient comfort|patient comfort
207215|NCT02305667|Laryngoscope|laryngoscope
207216|NCT02305667|Macintosh|macintosh
207217|NCT02305667|Glidescope®|glidescope®
207218|NCT02305667|King Vision™|king vision™
207219|NCT02305667|Airtraq®|airtraq®
207220|NCT02305667|intubation|intubation
207221|NCT02305667|double lumen tube|double lumen tube
207222|NCT02305654|Penis cancer|penis cancer
207223|NCT02305654|Chemotherapy|chemotherapy
207224|NCT02305654|Chemoradiotherapy|chemoradiotherapy
207225|NCT02305654|Surgery|surgery
207226|NCT02305654|Phase III|phase iii
207227|NCT02305602|extracellular matrix|extracellular matrix
207228|NCT02305589|postoperative delirium|postoperative delirium
207229|NCT02305589|sugammadex|sugammadex
207230|NCT02305589|cholinesterase inhibitor|cholinesterase inhibitor
207231|NCT02305589|hip fracture surgery|hip fracture surgery
207232|NCT02305550|Nitric Oxide|nitric oxide
207233|NCT02305524|endotracheal intubation|endotracheal intubation
207234|NCT02305511|Catheterization|catheterization
207235|NCT02305511|Peripheral|peripheral
207236|NCT02305498|Yoga|yoga
207237|NCT02305498|14-059|14-059
207238|NCT02305485|NeoVas|neovas
207239|NCT02305485|Bioresorbable Coronary Scaffold|bioresorbable coronary scaffold
207240|NCT02305485|Sirolimus|sirolimus
207241|NCT02305485|Randomized Controlled Trial|randomized controlled trial
207242|NCT02305472|NeoVas|neovas
207243|NCT02305472|Bioresorbable Coronary Scaffold|bioresorbable coronary scaffold
207244|NCT02305472|Sirolimus|sirolimus
207245|NCT02305472|Registry Trial|registry trial
207246|NCT02305459|SIRT|sirt
207247|NCT02305459|microcatheter|microcatheter
207248|NCT02305459|primary liver tumor|primary liver tumor
207249|NCT02305459|secondary liver tumor|secondary liver tumor
207250|NCT02305459|radioembolisation|radioembolisation
207251|NCT02305459|QLQ-C30|qlq-c30
207252|NCT02305459|CIRSE|cirse
207253|NCT02305433|elderly|elderly
207254|NCT02305433|functional-based physiotherapy|functional-based physiotherapy
207255|NCT02305433|frailty syndrome|frailty syndrome
207256|NCT02305433|osteoporotic hip fractures|osteoporotic hip fractures
207257|NCT02305433|home-based physiotherapy|home-based physiotherapy
207258|NCT02305433|home-dwelling|home-dwelling
207259|NCT02305433|intervention|intervention
207260|NCT02305433|randomised controlled trial|randomised controlled trial
207261|NCT02305433|costs of social and health care|costs of social and health care
207262|NCT02305433|quality of life|quality of life
207263|NCT02305433|physical functioning|physical functioning
207264|NCT02305433|mobility|mobility
207265|NCT02305433|nutrition|nutrition
207266|NCT02305394|ketamine|ketamine
207267|NCT02305394|Electroconvulsive Therapy|electroconvulsive therapy
207268|NCT02305394|Cognitive Function|cognitive function
207269|NCT02305342|Uncomplicated UTI|uncomplicated uti
207270|NCT02305342|Enoxacin|enoxacin
207271|NCT02305303|Quality of life|quality of life
207272|NCT02305303|post-traumatic stress disorder|post-traumatic stress disorder
207273|NCT02305303|trauma|trauma
207274|NCT02305238|Eylea,|eylea,
207275|NCT02305238|Aflibercept|aflibercept
207276|NCT02305238|Treat and Extend regimen|treat and extend regimen
207277|NCT02305238|Age-related macular degeneration|age-related macular degeneration
207278|NCT02305212|Working Memory|working memory
207279|NCT02305199|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
207280|NCT02305199|Hartmann's solution|hartmann's solution
207281|NCT02305186|Immunotherapy|immunotherapy
207282|NCT02305186|Neoadjuvant|neoadjuvant
207283|NCT02305186|Resectable|resectable
207284|NCT02305186|Borderline resectable|borderline resectable
207285|NCT02305173|dexamethasone|dexamethasone
207286|NCT02305173|pulmonary function|pulmonary function
207287|NCT02305173|spirometry|spirometry
207288|NCT02305173|mastectomy|mastectomy
207289|NCT02305160|Respiratory distress syndrome|respiratory distress syndrome
207290|NCT02305160|Pulmonary surfactant|pulmonary surfactant
207291|NCT02305160|Mortality|mortality
207292|NCT02305160|Prematurity|prematurity
207293|NCT02305147|Parkinson Disease|parkinson disease
207294|NCT02305147|Biomarkers|biomarkers
207295|NCT02305147|Prognostic factors|prognostic factors
207296|NCT02305147|Prodromal features|prodromal features
207297|NCT02305147|Disease progression|disease progression
207298|NCT02305134|Tipepidine, GIRK|tipepidine, girk
207299|NCT02305121|Trochanteric fracture|trochanteric fracture
207300|NCT02305121|Nail|nail
207301|NCT02305121|Fracture reduction|fracture reduction
207302|NCT02305121|Antirotation|antirotation
207303|NCT02305121|trochanteric area with diaphyseal extension|trochanteric area with diaphyseal extension
207304|NCT02305121|trochanteric area with femoral shaft|trochanteric area with femoral shaft
207305|NCT02305043|non-interventional|non-interventional
207306|NCT02305043|advanced gastric cancer|advanced gastric cancer
207307|NCT02305043|Trastuzumab|trastuzumab
207308|NCT02305043|HER2|her2
207309|NCT02304991|Peanut|peanut
207310|NCT02304991|Food Allergy|food allergy
207311|NCT02304978|colorectal cancer|colorectal cancer
207312|NCT02304978|Tissular factor|tissular factor
207313|NCT02304978|TF|tf
207314|NCT02304965|LVAD|lvad
207315|NCT02304952|Lateral epicondylalgia|lateral epicondylalgia
207316|NCT02304952|Pain|pain
207317|NCT02304952|Function|function
207318|NCT02304952|Physiotherapy|physiotherapy
207319|NCT02304952|Quality of Life|quality of life
207320|NCT02304939|Norepinephrine|norepinephrine
207321|NCT02304939|Intensive Care|intensive care
207322|NCT02304939|Changeovers|changeovers
207323|NCT02304939|Smart pumps|smart pumps
207324|NCT02304939|Quick change|quick change
207325|NCT02304939|Double pumping|double pumping
207326|NCT02304939|Shock|shock
207327|NCT02304926|Dyslipidemia|dyslipidemia
207328|NCT02304926|Simvastatin|simvastatin
207329|NCT02304926|Ezetimibe|ezetimibe
207330|NCT02304926|Lipid profile|lipid profile
207331|NCT02304926|Inflammation|inflammation
207332|NCT02304926|Oxidative stress|oxidative stress
207333|NCT02304926|Endothelial function|endothelial function
207334|NCT02304900|cataract|cataract
207335|NCT02304887|Osteoporosis|osteoporosis
207336|NCT02304887|Bone mineral densisty|bone mineral densisty
207337|NCT02304887|Renal function|renal function
207338|NCT02304887|CKD-MBD|ckd-mbd
207339|NCT02304874|Ferritins|ferritins
207340|NCT02304874|Iron Overload|iron overload
207341|NCT02304874|Metabolic Syndrome|metabolic syndrome
207342|NCT02304874|Venesection therapy|venesection therapy
207343|NCT02304874|Volunteers|volunteers
207344|NCT02304861|cataract|cataract
207345|NCT02304861|viscoelastic (OVD) technology|viscoelastic (ovd) technology
207346|NCT02304861|endothelial cell count|endothelial cell count
207347|NCT02304861|endothelial cell pattern|endothelial cell pattern
207348|NCT02304861|central corneal edema|central corneal edema
207349|NCT02304848|Parkinson's Disease|parkinson's disease
207350|NCT02304848|DBS|dbs
207351|NCT02304848|Deep Brain Stimulation|deep brain stimulation
207352|NCT02304848|Subthalamic Nucleus|subthalamic nucleus
207353|NCT02304822|kidney stones|kidney stones
207354|NCT02304822|retrograde intrarenal surgery|retrograde intrarenal surgery
207355|NCT02304822|ciprofloxacin|ciprofloxacin
207356|NCT02304822|prophylaxis|prophylaxis
207357|NCT02304822|systemic inflammatory response syndrome|systemic inflammatory response syndrome
207358|NCT02304809|metastatic or unresectable locally advanced malignancies.|metastatic or unresectable locally advanced malignancies.
207359|NCT02304809|genomic alterations|genomic alterations
207360|NCT02304809|biological vemurafenib targets BRAF|biological vemurafenib targets braf
207361|NCT02304809|genomic.|genomic.
207362|NCT02304796|Anxiety Disorders|anxiety disorders
207363|NCT02304796|Group Psychotherapy|group psychotherapy
207364|NCT02304796|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
207365|NCT02304796|Dance/Movement Therapy|dance/movement therapy
207367|NCT02304796|DMT|dmt
207368|NCT02304796|Unified Protocol|unified protocol
207369|NCT02304783|Renal colic, Piroxicam|renal colic, piroxicam
207370|NCT02304757|differentiated thyroid cancer|differentiated thyroid cancer
207371|NCT02304757|bone mineral density|bone mineral density
207372|NCT02304757|thyroid stimulating hormone suppression|thyroid stimulating hormone suppression
207373|NCT02304731|Physical Exercise, Atmospheric Pollution, Cognition.|physical exercise, atmospheric pollution, cognition.
207374|NCT02304718|GDM|gdm
207375|NCT02304718|pregnancy outcome|pregnancy outcome
207376|NCT02304718|obesity|obesity
207377|NCT02304718|exercise|exercise
207378|NCT02304718|overweight|overweight
207379|NCT02304640|fatigue|fatigue
207380|NCT02304640|chemotherapy|chemotherapy
207381|NCT02304640|breast cancer|breast cancer
207382|NCT02304640|supportive care|supportive care
207383|NCT02304640|Singapore|singapore
207384|NCT02304523|Colonoscopy preparation|colonoscopy preparation
207385|NCT02304523|Bowel cleansing|bowel cleansing
207386|NCT02304523|Colon cleansing|colon cleansing
207387|NCT02304523|Colonoscopy|colonoscopy
207388|NCT02304523|CDFR0612|cdfr0612
207389|NCT02304523|CDFR0613|cdfr0613
207390|NCT02304510|Prevalence|prevalence
207391|NCT02304510|Menorrhagia|menorrhagia
207392|NCT02304497|Diabetes mellitus|diabetes mellitus
207393|NCT02304497|Platelet rich fibrin|platelet rich fibrin
207394|NCT02304497|growth factor|growth factor
207395|NCT02304445|Radiotherapy|radiotherapy
207396|NCT02304445|Chemoembolization|chemoembolization
207397|NCT02304432|D-cycloserine|d-cycloserine
207398|NCT02304432|Glycine|glycine
207399|NCT02304432|Psychosis|psychosis
207400|NCT02304432|Mutation|mutation
207401|NCT02304432|GABA|gaba
207402|NCT02304406|prevalence of ALK rearrangement, NSCLC, MENA|prevalence of alk rearrangement, nsclc, mena
207403|NCT02304367|TIO|tio
207404|NCT02304367|ENS|ens
207405|NCT02304367|FGF23|fgf23
207406|NCT02304367|KRN23|krn23
207407|NCT02304354|rheumatoid arthritis|rheumatoid arthritis
207408|NCT02304354|T lymphocytes|t lymphocytes
207409|NCT02304354|rituximab|rituximab
207410|NCT02304341|critical illness|critical illness
207411|NCT02304341|disease progression|disease progression
207412|NCT02304341|child|child
207413|NCT02304341|severity of illness index|severity of illness index
207414|NCT02304341|monitoring|monitoring
207415|NCT02304328|SAH|sah
207416|NCT02304328|WFNS|wfns
207417|NCT02304328|hWFNS|hwfns
207418|NCT02304328|grading|grading
207419|NCT02304315|HBV-related liver transplantation|hbv-related liver transplantation
207420|NCT02304315|Hepatitis B Immuno Globulin|hepatitis b immuno globulin
207421|NCT02304302|Memantine|memantine
207422|NCT02304302|Episodic Memory|episodic memory
207423|NCT02304302|CVLT|cvlt
207424|NCT02304302|Hippocampus dependent memory|hippocampus dependent memory
207425|NCT02304302|Short-term memory|short-term memory
207426|NCT02304263|tenofovir|tenofovir
207427|NCT02304263|aging|aging
207428|NCT02304263|renal function|renal function
207429|NCT02304263|HIV|hiv
207430|NCT02304263|frailty|frailty
207431|NCT02304237|Premature Birth|premature birth
207432|NCT02304237|progesterone|progesterone
207433|NCT02304224|sepsis|sepsis
207434|NCT02304224|melatonin|melatonin
207435|NCT02304224|Human Leukocyte Antigen-DR|human leukocyte antigen-dr
207436|NCT02304224|outcome|outcome
207437|NCT02304211|Microdosing|microdosing
207438|NCT02304211|Phase 0|phase 0
207439|NCT02304211|Exploratory Investigational New Drug (IND)|exploratory investigational new drug (ind)
207440|NCT02304211|Intra-Arterial|intra-arterial
207441|NCT02304211|PET Imaging|pet imaging
207442|NCT02304185|Healthy|healthy
207443|NCT02304185|Acquired Immuno-Deficiency Syndrome|acquired immuno-deficiency syndrome
207444|NCT02304185|Acquired Immunodeficiency Syndrome Virus|acquired immunodeficiency syndrome virus
207445|NCT02304185|Glycoprotein|glycoprotein
207446|NCT02304185|Adjuvant|adjuvant
207447|NCT02304185|Vaccine|vaccine
207448|NCT02304185|Placebo|placebo
207449|NCT02304172|Thyroidectomy|thyroidectomy
207450|NCT02304172|Thunderbeat|thunderbeat
207451|NCT02304159|HCV|hcv
207452|NCT02304159|Genotype 3|genotype 3
207453|NCT02304159|Treatment naive|treatment naive
207454|NCT02304159|Treatment experienced|treatment experienced
207456|NCT02304146|UGFS|ugfs
207457|NCT02304146|Stripping|stripping
207458|NCT02304146|Incompetence|incompetence
207459|NCT02304120|proprioception|proprioception
207460|NCT02304120|postural control|postural control
207461|NCT02304120|sensorimotor training|sensorimotor training
207462|NCT02304120|uncontrolled manifold|uncontrolled manifold
207463|NCT02304029|epilepsy|epilepsy
207464|NCT02304029|seizures|seizures
207465|NCT02304003|Shoulder tendinopathy|shoulder tendinopathy
207466|NCT02304003|Subacromial impingement syndrome|subacromial impingement syndrome
207467|NCT02304003|Rotator cuff tendinopathy|rotator cuff tendinopathy
207468|NCT02304003|Supraspinatus tendinopathy|supraspinatus tendinopathy
207469|NCT02303964|Trauma|trauma
207470|NCT02303964|Hemorrhage|hemorrhage
207471|NCT02303964|Plasma|plasma
207472|NCT02303964|Shock|shock
207473|NCT02303964|Polytrauma|polytrauma
207474|NCT02303912|relapsed epithelial ovarian cancer,|relapsed epithelial ovarian cancer,
207475|NCT02303912|relapsed fallopian tube cancer|relapsed fallopian tube cancer
207476|NCT02303912|relapsed primary peritoneal cancer.|relapsed primary peritoneal cancer.
207477|NCT02303860|Healthy volunteer study|healthy volunteer study
207478|NCT02303808|Hyperosmolar agents|hyperosmolar agents
207479|NCT02303808|Hypertonic saline|hypertonic saline
207480|NCT02303808|Airway clearance techniques|airway clearance techniques
207481|NCT02303808|Positive Expiratory Pressure|positive expiratory pressure
207482|NCT02303808|Autogenic drainage|autogenic drainage
207483|NCT02303795|bioprosthetic mitral valve|bioprosthetic mitral valve
207484|NCT02303795|valvular heart disease|valvular heart disease
207485|NCT02303795|anticoagulant agents|anticoagulant agents
207486|NCT02303795|NOACs|noacs
207487|NCT02303795|rivaroxaban|rivaroxaban
207488|NCT02303795|warfarin|warfarin
207489|NCT02303769|Lower Urinary Track Syndrome|lower urinary track syndrome
207490|NCT02303769|Harnal|harnal
207491|NCT02303769|Tamsulosin HCL 0.4mg|tamsulosin hcl 0.4mg
207492|NCT02303743|Bowel preparation; colonoscopy; Smartphone application|bowel preparation; colonoscopy; smartphone application
207493|NCT02303730|Diabetes|diabetes
207494|NCT02303730|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
207495|NCT02303717|Left main|left main
207496|NCT02303717|PCI|pci
207497|NCT02303717|DES|des
207498|NCT02303704|Multiperfusion set|multiperfusion set
207499|NCT02303704|Myocardial protection|myocardial protection
207500|NCT02303704|Coronary Artery Bypass Grafting|coronary artery bypass grafting
207501|NCT02303691|anxiety|anxiety
207502|NCT02303691|attention bias modification|attention bias modification
207503|NCT02303691|computer|computer
207504|NCT02303678|D2C7|d2c7
207505|NCT02303678|Randazzo|randazzo
207506|NCT02303678|Bigner|bigner
207507|NCT02303678|Pro00053325|pro00053325
207508|NCT02303678|recurrent malignant glioma|recurrent malignant glioma
207509|NCT02303665|TCM multi-channel therapy|tcm multi-channel therapy
207510|NCT02303665|ART failure|art failure
207511|NCT02303639|implantable cardioverter defibrillator|implantable cardioverter defibrillator
207512|NCT02303639|antiarrhythmic medication|antiarrhythmic medication
207513|NCT02303639|catheter ablation|catheter ablation
207514|NCT02303626|BCX4161|bcx4161
207515|NCT02303626|Prophylaxis|prophylaxis
207516|NCT02303626|Prevention|prevention
207517|NCT02303626|HAE|hae
207518|NCT02303626|Hereditary Angioedema|hereditary angioedema
207519|NCT02303600|Sub-acute cough|sub-acute cough
207520|NCT02303587|Severe mycoplasma pneumoniae|severe mycoplasma pneumoniae
207521|NCT02303587|pneumonia|pneumonia
207522|NCT02303587|children|children
207523|NCT02303574|AZD7986, Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Food Effect, First-in-human, Single Ascending Dose, Multiple Ascending Dose, Healthy Subjects|azd7986, safety, tolerability, pharmacokinetics, pharmacodynamics, food effect, first-in-human, single ascending dose, multiple ascending dose, healthy subjects
207524|NCT02303548|Sodium Bicarbonate|sodium bicarbonate
207525|NCT02303535|Congenital heart disease|congenital heart disease
207526|NCT02303535|European Paediatric Cardiac Code Short List|european paediatric cardiac code short list
207527|NCT02303535|Specific Procedure Definitions|specific procedure definitions
207528|NCT02303535|OPCS|opcs
207529|NCT02303535|paediatric|paediatric
207530|NCT02303535|pediatric|pediatric
207531|NCT02303522|ALL, pediatric, leukemia, childhood, lymphoblastic, lymphoma, acute, Precursor Cell|all, pediatric, leukemia, childhood, lymphoblastic, lymphoma, acute, precursor cell
207532|NCT02303509|Healthy Subjects|healthy subjects
207533|NCT02303509|Mild to moderate Psoriasis|mild to moderate psoriasis
207534|NCT02303509|Subjects|subjects
207535|NCT02303496|platelet rich plasma|platelet rich plasma
207536|NCT02303470|Exercise|exercise
207537|NCT02303457|CO2 laser surgery|co2 laser surgery
207538|NCT02303457|open surgery|open surgery
207539|NCT02303457|multicenter prospective|multicenter prospective
207540|NCT02303457|randomized|randomized
207541|NCT02303457|controlled clinical studies|controlled clinical studies
207542|NCT02303457|T1N0 squamous cell carcinoma of glottis with anterior commissure involved|t1n0 squamous cell carcinoma of glottis with anterior commissure involved
207543|NCT02303444|Progressive radioactive iodine refractory differentiated thyroid carcinoma|progressive radioactive iodine refractory differentiated thyroid carcinoma
207544|NCT02303431|Pediatric|pediatric
207545|NCT02303431|Pharmacokinetics (PK)|pharmacokinetics (pk)
207546|NCT02303431|Pharmacodynamics (PDy)|pharmacodynamics (pdy)
207547|NCT02303431|Anticoagulant|anticoagulant
207548|NCT02303431|Safety|safety
207549|NCT02303418|Obstetrics|obstetrics
207550|NCT02303405|Glucose Control|glucose control
207551|NCT02303405|Inflammation|inflammation
207552|NCT02303379|Training Protocol|training protocol
207553|NCT02303379|Cardiac Rehabilitation|cardiac rehabilitation
207554|NCT02303379|High-Intensity Interval Training|high-intensity interval training
207555|NCT02303379|Continuous Training|continuous training
207556|NCT02303379|Pyramid Training|pyramid training
207557|NCT02303379|Physical Performance|physical performance
207558|NCT02303353|Breast cancer|breast cancer
207559|NCT02303353|Ovarian cancer|ovarian cancer
207560|NCT02303353|Lung cancer|lung cancer
207561|NCT02303353|Colon cancer|colon cancer
207562|NCT02303353|Gastric cancer|gastric cancer
207563|NCT02303353|Pancreatic cancer|pancreatic cancer
207564|NCT02303353|Rectum cancer|rectum cancer
207565|NCT02303353|Plasmacytoma|plasmacytoma
207566|NCT02303340|Cone Beam Computed Tomography|cone beam computed tomography
207567|NCT02303340|Para Thyroid Hormone|para thyroid hormone
207568|NCT02303340|Dual Energy X-ray Absorptiometry|dual energy x-ray absorptiometry
207569|NCT02303340|Digital Imaging and Communication in Medicine|digital imaging and communication in medicine
207570|NCT02303275|Heart Failure|heart failure
207571|NCT02303275|Congestive Heart Failure|congestive heart failure
207572|NCT02303275|Lifestyle Change|lifestyle change
207573|NCT02303236|Exercise|exercise
207574|NCT02303197|head and neck cancer|head and neck cancer
207575|NCT02303197|chemoradiotherapy|chemoradiotherapy
207576|NCT02303197|radioactive stomatitis|radioactive stomatitis
207577|NCT02303184|RVO|rvo
207578|NCT02303184|ME|me
207579|NCT02303184|Central Subfield Thickness|central subfield thickness
207580|NCT02303184|OCT|oct
207581|NCT02303184|optical coherence tomography|optical coherence tomography
207582|NCT02303184|cystoid macular edema|cystoid macular edema
207583|NCT02303184|subretinal fluid|subretinal fluid
207584|NCT02303184|Eylea|eylea
207585|NCT02303184|aflibercept|aflibercept
207586|NCT02303184|anti-VEGF|anti-vegf
207587|NCT02303171|Antiphospholipid syndrome|antiphospholipid syndrome
207588|NCT02303171|APS|aps
207589|NCT02303171|Warfarin|warfarin
207590|NCT02303158|Alzheimer's Disease|alzheimer's disease
207591|NCT02303158|Biomarkers|biomarkers
207592|NCT02303158|Depression|depression
207593|NCT02303158|dementia|dementia
207594|NCT02303158|cerebrospinal fluid|cerebrospinal fluid
207595|NCT02303158|neuropsychological|neuropsychological
207596|NCT02303145|Breast Cancer, Survivors|breast cancer, survivors
207597|NCT02303119|LNH|lnh
207598|NCT02303119|CD20+|cd20+
207599|NCT02303119|follicular|follicular
207600|NCT02303106|AUC exposure to lamotrigine|auc exposure to lamotrigine
207601|NCT02303080|whey protein microgels|whey protein microgels
207602|NCT02303080|thermogenesis|thermogenesis
207603|NCT02303067|Cardiac|cardiac
207604|NCT02303067|Computed Tomography|computed tomography
207605|NCT02303067|Coronary Artery Disease|coronary artery disease
207606|NCT02303054|Prostate Cancer|prostate cancer
207607|NCT02303054|Focal Ablation|focal ablation
207608|NCT02303054|MRI-US Fusion Biopsy|mri-us fusion biopsy
207609|NCT02303054|Focal Therapy|focal therapy
207610|NCT02303028|Pediatric|pediatric
207611|NCT02303028|CNS Tumor|cns tumor
207612|NCT02303028|Solid Tumour|solid tumour
207613|NCT02303015|Germ cell cancer|germ cell cancer
207614|NCT02303015|Late toxicity|late toxicity
207615|NCT02303015|Renal impairment|renal impairment
207616|NCT02303015|Cardiovascular disease|cardiovascular disease
207617|NCT02302963|Diabetes Mellitus, Type 1 (T1DM)|diabetes mellitus, type 1 (t1dm)
207618|NCT02302963|Diabetes Assistant (DiAs)|diabetes assistant (dias)
207619|NCT02302963|Artificial Pancreas (AP) System|artificial pancreas (ap) system
207620|NCT02302963|Closed-Loop Control (CLC)|closed-loop control (clc)
207621|NCT02302963|Unified Safety System (USS) Virginia|unified safety system (uss) virginia
207622|NCT02302963|Sensor Augmented Pump (SAP)|sensor augmented pump (sap)
207623|NCT02302963|Low Blood Glucose Index (LBGI)|low blood glucose index (lbgi)
207624|NCT02302963|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
207625|NCT02302963|inControl Diabetes Management Platform|incontrol diabetes management platform
207626|NCT02302950|HIV infection|hiv infection
207627|NCT02302950|raltegravir use|raltegravir use
207628|NCT02302950|women|women
207629|NCT02302937|Inguinal Hernia|inguinal hernia
207630|NCT02302937|Primary|primary
207631|NCT02302937|laparoscopic surgery|laparoscopic surgery
207632|NCT02302937|single port surgery|single port surgery
207633|NCT02302911|Early intervention|early intervention
207634|NCT02302898|Roux-en-Y Gastric Bypass Surgery|roux-en-y gastric bypass surgery
207635|NCT02302898|Weight Regain|weight regain
207636|NCT02302885|cancer-free 18-60 year old men and women|cancer-free 18-60 year old men and women
207637|NCT02302859|Cancer Prevention|cancer prevention
207638|NCT02302859|Tobacco Use Cessation|tobacco use cessation
207639|NCT02302859|HIV-positive|hiv-positive
207640|NCT02302859|Nicotine patch|nicotine patch
207641|NCT02302859|NRT|nrt
207642|NCT02302859|Questionnaire|questionnaire
207643|NCT02302859|Survey|survey
207644|NCT02302859|Smartphone|smartphone
207645|NCT02302859|Counseling|counseling
207646|NCT02302859|Saliva test|saliva test
207647|NCT02302859|Saliva cotinine test|saliva cotinine test
207648|NCT02302859|Nicotine replacement therapy|nicotine replacement therapy
207649|NCT02302859|Smoking abstinence|smoking abstinence
207650|NCT02302859|Aids|aids
207651|NCT02302846|Leukemia|leukemia
207652|NCT02302846|Acute myeloid leukemia|acute myeloid leukemia
207653|NCT02302846|AML|aml
207654|NCT02302846|High-risk myelodysplastic syndrome|high-risk myelodysplastic syndrome
207655|NCT02302846|MDS|mds
207656|NCT02302846|Ixazomib|ixazomib
207657|NCT02302846|MLN9708|mln9708
207658|NCT02302833|Neuroendocrine tumors|neuroendocrine tumors
207659|NCT02302833|Pheochromocytomas|pheochromocytomas
207660|NCT02302833|Paragangliomas|paragangliomas
207661|NCT02302833|Unresectable|unresectable
207662|NCT02302833|Metastatic|metastatic
207663|NCT02302833|Cabozantinib|cabozantinib
207664|NCT02302833|XL-184|xl-184
207665|NCT02302833|XL184|xl184
207666|NCT02302833|Questionnaire|questionnaire
207667|NCT02302833|Survey|survey
207668|NCT02302820|Advance Care Planning|advance care planning
207669|NCT02302820|Nurse Care Coordination|nurse care coordination
207670|NCT02302820|Comparative Effectiveness|comparative effectiveness
207671|NCT02302820|Advance Directive|advance directive
207672|NCT02302820|Decision Aides|decision aides
207673|NCT02302781|Reasons for Dropout|reasons for dropout
207674|NCT02302781|Subfertility|subfertility
207675|NCT02302781|IVF|ivf
207676|NCT02302781|NON IVF|non ivf
207677|NCT02302742|Triple Negative Breast Cancer|triple negative breast cancer
207678|NCT02302742|TNBC|tnbc
207679|NCT02302742|Hereditary Breast and Ovarian Cancer|hereditary breast and ovarian cancer
207680|NCT02302742|HBOC|hboc
207681|NCT02302742|Prospective Registry|prospective registry
207682|NCT02302729|Micronutrient intervention|micronutrient intervention
207683|NCT02302729|Responsive feeding intervention|responsive feeding intervention
207684|NCT02302729|School readiness intervention|school readiness intervention
207685|NCT02302677|bile acids|bile acids
207686|NCT02302677|sleeve gastrectomy|sleeve gastrectomy
207687|NCT02302677|obesity|obesity
207688|NCT02302677|GLP-1|glp-1
207689|NCT02302677|FGF-19|fgf-19
207690|NCT02302664|Achilles|achilles
207691|NCT02302664|Platelet Rich Plasma|platelet rich plasma
207692|NCT02302664|Patient reported outcome measure|patient reported outcome measure
207693|NCT02302664|Orthopaedic trauma|orthopaedic trauma
207694|NCT02302664|Musculoskeletal|musculoskeletal
207695|NCT02302664|Tendon|tendon
207696|NCT02302664|Sports Injury|sports injury
207697|NCT02302664|Heel-Rise Endurance Test|heel-rise endurance test
207698|NCT02302651|high intensity focused ultrasound|high intensity focused ultrasound
207699|NCT02302651|osteoid osteoma|osteoid osteoma
207700|NCT02302651|bone tumor|bone tumor
207701|NCT02302638|single-step media|single-step media
207702|NCT02302638|embryo development|embryo development
207703|NCT02302638|blastocyst formation|blastocyst formation
207704|NCT02302638|embryo utilization|embryo utilization
207705|NCT02302625|Cognitive behavior therapy|cognitive behavior therapy
207706|NCT02302612|chronic conditions|chronic conditions
207707|NCT02302612|complex patients|complex patients
207708|NCT02302612|engagement|engagement
207709|NCT02302612|activation|activation
207710|NCT02302586|Thoracic paravertebral block|thoracic paravertebral block
207711|NCT02302586|Patient controlled analgesia|patient controlled analgesia
207712|NCT02302586|Video Assisted Thoracoscopic Surgery|video assisted thoracoscopic surgery
207713|NCT02302586|Postoperative acute pain|postoperative acute pain
207714|NCT02302586|Chronic pain|chronic pain
207715|NCT02302573|placenta accreta|placenta accreta
207716|NCT02302573|contrast-enhanced unltrasound|contrast-enhanced unltrasound
207717|NCT02302573|pregnancy|pregnancy
207718|NCT02302573|MRI|mri
207719|NCT02302573|sonovue|sonovue
207720|NCT02302547|HIV-DNA|hiv-dna
207721|NCT02302547|dual therapy|dual therapy
207722|NCT02302547|NRTI|nrti
207723|NCT02302547|virological control|virological control
207724|NCT02302547|truvada®|truvada®
207725|NCT02302534|scoliosis|scoliosis
207726|NCT02302534|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
207727|NCT02302521|MRI|mri
207728|NCT02302508|pharmacokinetics|pharmacokinetics
207729|NCT02302508|drug metabolism|drug metabolism
207730|NCT02302508|platelet reactivity|platelet reactivity
207731|NCT02302508|carboxylesterase|carboxylesterase
207732|NCT02302508|cytochromes p450|cytochromes p450
207733|NCT02302508|type 2 diabetes|type 2 diabetes
207734|NCT02302508|active metabolite|active metabolite
207735|NCT02302495|Carfilzomib weekly|carfilzomib weekly
207736|NCT02302495|and Melphalan and Prednisone|and melphalan and prednisone
207737|NCT02302482|Alzheimer's disease or related disorders|alzheimer's disease or related disorders
207738|NCT02302482|Functional autonomy level|functional autonomy level
207739|NCT02302482|Cognitive function|cognitive function
207740|NCT02302482|Predictive factors|predictive factors
207741|NCT02302469|Lenalidomide|lenalidomide
207742|NCT02302469|Hematology|hematology
207743|NCT02302469|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
207744|NCT02302456|Immediate postpartum hemorrhage|immediate postpartum hemorrhage
207745|NCT02302456|tranexamic acid|tranexamic acid
207746|NCT02302456|prevention|prevention
207747|NCT02302430|Cohesion|cohesion
207748|NCT02302430|Oxytocin|oxytocin
207749|NCT02302430|ROTC|rotc
207750|NCT02302430|Virtual-reality|virtual-reality
207751|NCT02302417|Asthma|asthma
207752|NCT02302417|Asthma-COPD Overlap Syndrome|asthma-copd overlap syndrome
207753|NCT02302417|Clinical Questionnaire|clinical questionnaire
207754|NCT02302417|COPD|copd
207755|NCT02302417|ACOS|acos
207756|NCT02302404|FTIH|ftih
207757|NCT02302404|pharmacodynamics|pharmacodynamics
207758|NCT02302404|pharmacokinetics|pharmacokinetics
207759|NCT02302404|GSK2982772|gsk2982772
207760|NCT02302404|safety|safety
207761|NCT02302404|Repeat dose|repeat dose
207762|NCT02302404|tolerability|tolerability
207763|NCT02302378|Hypotension|hypotension
207764|NCT02302378|Anesthesia, Spinal [E03.155.086.331]|anesthesia, spinal [e03.155.086.331]
207765|NCT02302365|white blood cell depletion|white blood cell depletion
207766|NCT02302365|apheresis|apheresis
207767|NCT02302352|Probiotics|probiotics
207768|NCT02302352|Immune system|immune system
207769|NCT02302339|Advanced melanoma|advanced melanoma
207770|NCT02302339|Unresectable melanoma|unresectable melanoma
207771|NCT02302339|Metastatic melanoma|metastatic melanoma
207772|NCT02302339|Targeted Treatment for melanoma|targeted treatment for melanoma
207773|NCT02302339|GPNMB|gpnmb
207774|NCT02302339|CDX-011|cdx-011
207775|NCT02302339|Glembatumumab vedotin|glembatumumab vedotin
207776|NCT02302339|Antibody-drug-conjugate|antibody-drug-conjugate
207777|NCT02302339|Skin neoplasm|skin neoplasm
207778|NCT02302339|Varlilumab|varlilumab
207779|NCT02302339|CDX-1127|cdx-1127
207780|NCT02302326|reticulum endoplasmic stress|reticulum endoplasmic stress
207781|NCT02302326|Polycystic Ovary Syndrome|polycystic ovary syndrome
207782|NCT02302326|mitochondrial function|mitochondrial function
207783|NCT02302326|insulin resistance|insulin resistance
207784|NCT02302326|inflammation|inflammation
207785|NCT02302326|myoinositol|myoinositol
207786|NCT02302326|metformin|metformin
207787|NCT02302326|oxidative stress|oxidative stress
207788|NCT02302313|healthy volunteers|healthy volunteers
207789|NCT02302313|critical awareness|critical awareness
207790|NCT02302313|hypnosis|hypnosis
207791|NCT02302313|Analgesia Nociception Index|analgesia nociception index
207792|NCT02302313|numerical verbal scale|numerical verbal scale
207793|NCT02302313|Determine the validity of the index (ANI)|determine the validity of the index (ani)
207794|NCT02302313|nociception in critical awareness|nociception in critical awareness
207795|NCT02302300|Cardiac surgery|cardiac surgery
207796|NCT02302300|Preventive non-invasive ventilation|preventive non-invasive ventilation
207797|NCT02302287|Chronic kidney disease|chronic kidney disease
207798|NCT02302287|mediterranean diet|mediterranean diet
207799|NCT02302287|low-protein diet|low-protein diet
207800|NCT02302287|ketoacids|ketoacids
207801|NCT02302287|intestinal microbiota|intestinal microbiota
207802|NCT02302274|Brugada Syndrome|brugada syndrome
207803|NCT02302274|ARVC|arvc
207804|NCT02302274|flecainide|flecainide
207805|NCT02302274|ST elevation|st elevation
207806|NCT02302261|Pulsus paradoxus|pulsus paradoxus
207807|NCT02302235|Glioblastoma multigorme|glioblastoma multigorme
207808|NCT02302235|Ketogenic Diet|ketogenic diet
207809|NCT02302235|radiotherapy|radiotherapy
207810|NCT02302235|chemotherapy|chemotherapy
207811|NCT02302235|safety|safety
207812|NCT02302235|efficiency|efficiency
207813|NCT02302209|oxytocin|oxytocin
207814|NCT02302209|schizophrenia|schizophrenia
207815|NCT02302209|autism spectrum disorder|autism spectrum disorder
207816|NCT02302183|Hypoxemic, Respiratory distress, infant|hypoxemic, respiratory distress, infant
207817|NCT02302157|Cervical spinal cord injury|cervical spinal cord injury
207818|NCT02302157|AST-OPC1|ast-opc1
207819|NCT02302157|SCiStar|scistar
207820|NCT02302157|OPC1|opc1
207821|NCT02302157|Neural cell|neural cell
207822|NCT02302157|Trauma spinal cord|trauma spinal cord
207823|NCT02302157|stemcell transplant|stemcell transplant
207824|NCT02302157|Cervical spine injury|cervical spine injury
207825|NCT02302157|Paralysis|paralysis
207826|NCT02302157|Quadriplegia|quadriplegia
207827|NCT02302157|Tetraplegia|tetraplegia
207828|NCT02302157|Spine injury|spine injury
207829|NCT02302157|oligodendrocyte progenitor cell|oligodendrocyte progenitor cell
207830|NCT02302157|Subacute spinal cord injury|subacute spinal cord injury
207831|NCT02302144|Postural Instability (falling)|postural instability (falling)
207832|NCT02302144|Gait Disturbances (e.g., freezing)|gait disturbances (e.g., freezing)
207833|NCT02302144|Bradykinesia (slowness of movement), rigidity|bradykinesia (slowness of movement), rigidity
207834|NCT02302118|esophageal carcinoma|esophageal carcinoma
207835|NCT02302118|kardia carcinoma|kardia carcinoma
207836|NCT02302092|Drug Therapy|drug therapy
207837|NCT02302079|ASP8232|asp8232
207838|NCT02302079|Diabetes Mellitus|diabetes mellitus
207839|NCT02302079|ranibizumab|ranibizumab
207840|NCT02302079|Diabetic Macular Edema|diabetic macular edema
207841|NCT02302066|Drug therapy|drug therapy
207943|NCT02301403|tobacco|tobacco
207842|NCT02302053|Hair thinning, hair loss, alopecia, women, oral supplement|hair thinning, hair loss, alopecia, women, oral supplement
207843|NCT02302040|Adolescent|adolescent
207844|NCT02302027|withdrawal therapy|withdrawal therapy
207845|NCT02302027|oxygen therapy|oxygen therapy
207846|NCT02302001|Breast augmentation|breast augmentation
207847|NCT02302001|Breast implants|breast implants
207848|NCT02302001|Silicone implants|silicone implants
207849|NCT02302001|Breast surgery|breast surgery
207850|NCT02301975|Adult|adult
207851|NCT02301975|asthma|asthma
207852|NCT02301975|Fluticasone Propionate|fluticasone propionate
207853|NCT02301975|Adolescents|adolescents
207854|NCT02301975|Salmeterol|salmeterol
207855|NCT02301975|Vilanterol|vilanterol
207856|NCT02301975|ELLIPTA|ellipta
207857|NCT02301975|ACCUHALER/DISKUS|accuhaler/diskus
207858|NCT02301975|Non-inferior|non-inferior
207859|NCT02301975|Fluticasone Furoate|fluticasone furoate
207860|NCT02301962|panitumumab|panitumumab
207861|NCT02301962|previously treated|previously treated
207862|NCT02301962|metastatic colorectal cancer|metastatic colorectal cancer
207863|NCT02301962|fully human antibody|fully human antibody
207864|NCT02301962|wild-type KRAS and wild-type NRAS|wild-type kras and wild-type nras
207865|NCT02301949|gastrointestinal bleeding|gastrointestinal bleeding
207866|NCT02301949|vascular malformation|vascular malformation
207867|NCT02301949|thalidomide retreatment|thalidomide retreatment
207868|NCT02301936|Sickle Cell Disease|sickle cell disease
207869|NCT02301936|Gilead|gilead
207870|NCT02301936|Hepatitis C|hepatitis c
207871|NCT02301923|Continuous Positive Airway Pressure|continuous positive airway pressure
207872|NCT02301910|Myocardial Infarction|myocardial infarction
207873|NCT02301910|Fibrinolysis|fibrinolysis
207874|NCT02301910|Fortelyzin|fortelyzin
207875|NCT02301871|MNP|mnp
207876|NCT02301871|MET|met
207877|NCT02301871|Soft tissue mobilization|soft tissue mobilization
207878|NCT02301871|DNF|dnf
207879|NCT02301871|Static Stretching|static stretching
207880|NCT02301858|molecular pathology|molecular pathology
207881|NCT02301858|functional genomics|functional genomics
207882|NCT02301858|lung cancer|lung cancer
207883|NCT02301858|primary tumor|primary tumor
207884|NCT02301858|metastases|metastases
207885|NCT02301845|Respiration, artificial|respiration, artificial
207886|NCT02301832|acute compartment swelling (ACS)|acute compartment swelling (acs)
207887|NCT02301832|near-infrared spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
207888|NCT02301767|MRI|mri
207889|NCT02301767|Risk Factor|risk factor
207890|NCT02301767|background Parenchymal Enhancement|background parenchymal enhancement
207891|NCT02301767|(IMAGINE) Study|(imagine) study
207892|NCT02301741|chronic low back pain|chronic low back pain
207893|NCT02301728|breast milk|breast milk
207894|NCT02301728|short chain fatty acids|short chain fatty acids
207895|NCT02301728|maternal diet|maternal diet
207896|NCT02301715|Intranasal oxytocin|intranasal oxytocin
207897|NCT02301715|Emotion regulation|emotion regulation
207898|NCT02301715|Attachment|attachment
207899|NCT02301702|Maternal Immunization|maternal immunization
207900|NCT02301702|Tdap|tdap
207901|NCT02301702|Td|td
207902|NCT02301702|Pertussis|pertussis
207903|NCT02301689|Heart failure|heart failure
207904|NCT02301689|Chronic heart failure|chronic heart failure
207905|NCT02301689|Sleep disordered breathing|sleep disordered breathing
207906|NCT02301689|Sleep apnea|sleep apnea
207907|NCT02301689|Positive Airway Pressure|positive airway pressure
207908|NCT02301676|Geriatrics; Cognitive impairment; Interviews, Telephone|geriatrics; cognitive impairment; interviews, telephone
207909|NCT02301650|Hepatitis B virus|hepatitis b virus
207910|NCT02301650|pregnancy|pregnancy
207911|NCT02301650|nucleoside (acid) analogs|nucleoside (acid) analogs
207912|NCT02301650|children|children
207913|NCT02301650|safety|safety
207914|NCT02301624|gMG|gmg
207915|NCT02301624|Myasthenia Gravis|myasthenia gravis
207916|NCT02301624|safety|safety
207917|NCT02301624|efficacy|efficacy
207918|NCT02301598|femtosecond laser|femtosecond laser
207919|NCT02301598|anterior lamellar keratoplasty|anterior lamellar keratoplasty
207920|NCT02301598|atomic-force microscopy|atomic-force microscopy
207921|NCT02301585|shock, septic|shock, septic
207922|NCT02301585|hemodynamics|hemodynamics
207923|NCT02301585|algorithms|algorithms
207924|NCT02301533|HIV infection|hiv infection
207925|NCT02301533|antiretroviral therapy|antiretroviral therapy
207926|NCT02301533|adherence|adherence
207927|NCT02301533|men who have sex with men|men who have sex with men
207928|NCT02301520|Vitamin D|vitamin d
207929|NCT02301520|Iodine|iodine
207930|NCT02301520|Lead|lead
207931|NCT02301520|Thyroid function|thyroid function
207932|NCT02301520|point-of-care test|point-of-care test
207933|NCT02301494|CTCL|ctcl
207934|NCT02301494|Mycosis Fungoides|mycosis fungoides
207935|NCT02301494|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
207936|NCT02301494|MF|mf
207937|NCT02301494|topical therapy|topical therapy
207938|NCT02301494|early stage|early stage
207939|NCT02301455|hypertension treatment|hypertension treatment
207940|NCT02301455|stroke prevention|stroke prevention
207941|NCT02301403|smoking|smoking
207942|NCT02301403|cessation|cessation
207944|NCT02301390|INTERVENE|intervene
207945|NCT02301390|Ventricular tachycardia|ventricular tachycardia
207946|NCT02301390|India|india
207947|NCT02301364|Buparlisib (BKM120)|buparlisib (bkm120)
207948|NCT02301364|14-177|14-177
207949|NCT02301338|Videoconferencing|videoconferencing
207950|NCT02301338|Following Surgery|following surgery
207951|NCT02301338|14-213|14-213
207952|NCT02301299|stroke|stroke
207953|NCT02301299|barriers|barriers
207954|NCT02301299|community|community
207955|NCT02301286|Acetylsalicylic acid|acetylsalicylic acid
207956|NCT02301286|Colon cancer|colon cancer
207957|NCT02301286|Survival|survival
207958|NCT02301273|Intensive care unit|intensive care unit
207959|NCT02301273|Physiotherapy|physiotherapy
207960|NCT02301273|Upright position|upright position
207961|NCT02301273|Exercise|exercise
207962|NCT02301273|Long term follow up of ICU survivors|long term follow up of icu survivors
207963|NCT02301260|Processing Speed|processing speed
207964|NCT02301260|Intervention|intervention
207965|NCT02301260|Multiple Sclerosis|multiple sclerosis
207966|NCT02301260|Cognition|cognition
207967|NCT02301247|Multiple Sclerosis, Progressive|multiple sclerosis, progressive
207968|NCT02301247|cognition|cognition
207969|NCT02301247|memory|memory
207970|NCT02301247|treatment|treatment
207971|NCT02301234|Osteoarthritis|osteoarthritis
207972|NCT02301234|Pain|pain
207973|NCT02301234|Fulranumab|fulranumab
207974|NCT02301234|JNJ-42160443|jnj-42160443
207975|NCT02301234|Adjunctive therapy|adjunctive therapy
207976|NCT02301234|Celecoxib|celecoxib
207977|NCT02301234|Hip|hip
207978|NCT02301234|Knee|knee
207979|NCT02301234|Joint replacement surgery|joint replacement surgery
207980|NCT02301221|Fecal Microbiota Transplantation|fecal microbiota transplantation
207981|NCT02301221|Slow Transit Constipation|slow transit constipation
207982|NCT02301221|Colonic motility|colonic motility
207983|NCT02301195|Therapeutic Horseback Riding|therapeutic horseback riding
207984|NCT02301169|Pain|pain
207985|NCT02301143|Pancreatic Neoplasms|pancreatic neoplasms
207986|NCT02301143|Pancreatic Cancer|pancreatic cancer
207987|NCT02301143|Locally advanced pacriatic cancer|locally advanced pacriatic cancer
207988|NCT02301143|nab-Paclitaxel|nab-paclitaxel
207989|NCT02301143|Abraxane|abraxane
207990|NCT02301143|Gemcitabine|gemcitabine
207991|NCT02301143|ABI-007|abi-007
207992|NCT02301130|advanced solid tumors|advanced solid tumors
207993|NCT02301130|solid tumors|solid tumors
207994|NCT02301130|mogamulizumab|mogamulizumab
207995|NCT02301130|MEDI4736 (Durvalumab)|medi4736 (durvalumab)
207996|NCT02301130|Tremelimumab|tremelimumab
207997|NCT02301130|POTELIGEO®|poteligeo®
207998|NCT02301130|KW-0761|kw-0761
207999|NCT02301117|Renal|renal
208000|NCT02301117|Kidney Diseases|kidney diseases
208001|NCT02301117|Urologic Diseases|urologic diseases
208002|NCT02301117|Renal Insufficiency|renal insufficiency
208003|NCT02301117|Renal Impairment|renal impairment
208004|NCT02301117|Pharmacokinetics|pharmacokinetics
208005|NCT02301117|Advance Solid Tumor|advance solid tumor
208006|NCT02301117|Creatinine Clearance|creatinine clearance
208007|NCT02301117|Kidney Neoplasms|kidney neoplasms
208008|NCT02301117|Renal Tumor|renal tumor
208009|NCT02301117|Kidney|kidney
208010|NCT02301117|Urology|urology
208011|NCT02301117|Pharmacologic Action|pharmacologic action
208012|NCT02301104|Liver Neoplasms|liver neoplasms
208013|NCT02301104|Hepatic|hepatic
208014|NCT02301104|TAS-102|tas-102
208015|NCT02301104|mCRC|mcrc
208016|NCT02301104|Liver Impairment|liver impairment
208017|NCT02301104|Pharmacologic Actions|pharmacologic actions
208018|NCT02301104|Liver Diseases|liver diseases
208019|NCT02301104|Liver|liver
208020|NCT02301104|LFT|lft
208021|NCT02301104|Advanced Solid Tumor|advanced solid tumor
208022|NCT02301104|Pharmacokinetics|pharmacokinetics
208023|NCT02301091|HCC PVTT TACE RFA|hcc pvtt tace rfa
208024|NCT02301078|Dupuytren disease|dupuytren disease
208025|NCT02301078|needle aponeurotomy|needle aponeurotomy
208026|NCT02301078|collagenase|collagenase
208027|NCT02301065|Viral|viral
208028|NCT02301065|Infection|infection
208029|NCT02301065|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
208030|NCT02301052|hemorrhoids|hemorrhoids
208031|NCT02301052|Allium Ampeloprasum|allium ampeloprasum
208032|NCT02301052|herbal medicine|herbal medicine
208033|NCT02301052|traditional persian medicine|traditional persian medicine
208034|NCT02301000|Clostridium difficile|clostridium difficile
208035|NCT02301000|Intestinal microbiota therapy|intestinal microbiota therapy
208036|NCT02300987|Teratoma,|teratoma,
208037|NCT02300987|Germ Cell tumor,|germ cell tumor,
208038|NCT02300987|incurable teratoma,|incurable teratoma,
208039|NCT02300987|CDK4/6,|cdk4/6,
208040|NCT02300987|LEE011|lee011
208041|NCT02300948|Pregnancy|pregnancy
208042|NCT02300948|Perinatal Vitamins|perinatal vitamins
208043|NCT02300948|folate|folate
208044|NCT02300935|trametinib|trametinib
208045|NCT02300935|nab-paclitaxel|nab-paclitaxel
208046|NCT02300935|Mekinist|mekinist
208047|NCT02300935|Abraxane|abraxane
208048|NCT02300935|unresectable|unresectable
208049|NCT02300935|metastatic|metastatic
208050|NCT02300896|exercise|exercise
208051|NCT02300896|physical fitness|physical fitness
208052|NCT02300896|geriatrics|geriatrics
208053|NCT02300870|Acute rejection, myocardial blood flow|acute rejection, myocardial blood flow
208054|NCT02300831|NSCLC|nsclc
208055|NCT02300831|Lung Cancer|lung cancer
208056|NCT02300831|SELECT-1|select-1
208057|NCT02300831|SELECT-2|select-2
208058|NCT02300831|selumetinib|selumetinib
208059|NCT02300831|biomarker|biomarker
208060|NCT02300831|NIS|nis
208061|NCT02300831|Observational study|observational study
208062|NCT02300831|Disease registry|disease registry
208063|NCT02300831|Clinical Outcomes|clinical outcomes
208064|NCT02300818|Hipertension ocular, Glaucoma, Magnetotherapy, seawater|hipertension ocular, glaucoma, magnetotherapy, seawater
208065|NCT02300805|Endometrial volume , VOCAL , Endometrial , Metrorrhagia|endometrial volume , vocal , endometrial , metrorrhagia
208066|NCT02300792|honey, hepatitis A|honey, hepatitis a
208067|NCT02300779|Colonoscopy|colonoscopy
208068|NCT02300779|Diabetes Mellitus|diabetes mellitus
208069|NCT02300779|Diet|diet
208070|NCT02300779|Polyethylene glycols|polyethylene glycols
208071|NCT02300779|Efficacy|efficacy
208072|NCT02300779|Personal satisfaction|personal satisfaction
208073|NCT02300766|Cerebellar Mutism Syndrome|cerebellar mutism syndrome
208074|NCT02300766|Posterior Fossa Tumor|posterior fossa tumor
208075|NCT02300766|Pediatric cancer|pediatric cancer
208076|NCT02300766|Neurosurgical techniques|neurosurgical techniques
208077|NCT02300727|Mucositis|mucositis
208078|NCT02300727|Neoplasms|neoplasms
208079|NCT02300727|CANCER|cancer
208080|NCT02300727|Curcumin|curcumin
208081|NCT02300727|Drug Therapy|drug therapy
208082|NCT02300727|ANTINEOPLASTIC AGENTS|antineoplastic agents
208083|NCT02300675|therapeutic patient education|therapeutic patient education
208084|NCT02300675|patient adherence|patient adherence
208085|NCT02300675|empowerment|empowerment
208086|NCT02300675|breast cancer|breast cancer
208087|NCT02300675|oral adjuvant endocrine therapy|oral adjuvant endocrine therapy
208088|NCT02300675|side effects|side effects
208089|NCT02300636|Knee joint|knee joint
208090|NCT02300636|Muscle strength|muscle strength
208091|NCT02300636|anterior cruciate ligament|anterior cruciate ligament
208092|NCT02300610|Ureteral Diseases|ureteral diseases
208093|NCT02300610|Urinary Bladder Diseases|urinary bladder diseases
208094|NCT02300610|Transitional Cell Carcinoma|transitional cell carcinoma
208095|NCT02300610|Bladder|bladder
208096|NCT02300610|Carcinoma|carcinoma
208097|NCT02300610|Renal|renal
208098|NCT02300610|Pelvis|pelvis
208099|NCT02300610|Ureter|ureter
208100|NCT02300610|Urethra|urethra
208101|NCT02300597|ADHD|adhd
208102|NCT02300597|Autism Spectrum Disorders|autism spectrum disorders
208103|NCT02300597|controlled|controlled
208104|NCT02300597|Internet based|internet based
208105|NCT02300597|coaching|coaching
208106|NCT02300558|Type 3 long QT syndrome (LQT3)|type 3 long qt syndrome (lqt3)
208107|NCT02300558|Long QT syndrome|long qt syndrome
208108|NCT02300558|Congenital long QT|congenital long qt
208109|NCT02300558|Sudden cardiac death|sudden cardiac death
208110|NCT02300532|Malignant Glioma|malignant glioma
208111|NCT02300532|Glioblastoma Multiforme|glioblastoma multiforme
208112|NCT02300519|Haemophilia|haemophilia
208113|NCT02300519|numerical models|numerical models
208114|NCT02300519|thrombin generation|thrombin generation
208115|NCT02300519|volunteers|volunteers
208116|NCT02300519|endogenous thrombin potential|endogenous thrombin potential
208117|NCT02300506|Malignant Glioma|malignant glioma
208118|NCT02300506|Glioblastoma multiforme|glioblastoma multiforme
208119|NCT02300493|among college students|among college students
208120|NCT02300480|pain|pain
208121|NCT02300480|calot's triangle|calot's triangle
208122|NCT02300480|local block|local block
208123|NCT02300480|analgesia|analgesia
208124|NCT02300480|patient controlled intravenous analgesia|patient controlled intravenous analgesia
208125|NCT02300454|in-stent restenosis|in-stent restenosis
208126|NCT02300454|percutaneous coronary intervention|percutaneous coronary intervention
208127|NCT02300454|balloon|balloon
208128|NCT02300428|iron deficiency|iron deficiency
208129|NCT02300389|high risk prostate cancer radiotherapy hypofractionation|high risk prostate cancer radiotherapy hypofractionation
208130|NCT02300376|GFR|gfr
208131|NCT02300376|Bayesian model|bayesian model
208132|NCT02300376|plasma clearance|plasma clearance
208133|NCT02300376|Calcium edetate de sodium|calcium edetate de sodium
208134|NCT02300376|Inulin|inulin
208135|NCT02300337|laryngeal tube|laryngeal tube
208136|NCT02300337|cuff pressure|cuff pressure
208137|NCT02300337|leakage|leakage
208138|NCT02300337|laryngeal mask|laryngeal mask
208139|NCT02300324|bioavailability|bioavailability
208140|NCT02300324|Beneforte|beneforte
208141|NCT02300324|sulforaphane|sulforaphane
208142|NCT02300272|Practice-related learning|practice-related learning
208143|NCT02300272|Sleep|sleep
208144|NCT02300272|Pain|pain
208145|NCT02300272|Circadian Rhythm|circadian rhythm
208146|NCT02300272|Older Adults|older adults
208147|NCT02300246|alveolar socket preservation|alveolar socket preservation
208148|NCT02300246|tooth extraction|tooth extraction
208149|NCT02300246|platelet concentrates|platelet concentrates
208150|NCT02300246|growth factors|growth factors
208151|NCT02300207|Electroacupuncture|electroacupuncture
208152|NCT02300207|Cardiovascular function|cardiovascular function
208153|NCT02300207|Orthostatic tolerance|orthostatic tolerance
208154|NCT02300207|Head-down bed rest|head-down bed rest
208155|NCT02300194|Pain management|pain management
208156|NCT02300168|bariatric surgery; neuromuscular blockade|bariatric surgery; neuromuscular blockade
208157|NCT02300155|Pregnancy|pregnancy
208158|NCT02300155|Morning Sickness|morning sickness
208159|NCT02300155|nausea and vomiting|nausea and vomiting
208160|NCT02300155|hyperemesis gravidarum|hyperemesis gravidarum
208161|NCT02300155|perinatal vitamins|perinatal vitamins
208162|NCT02300142|HSV|hsv
208163|NCT02300142|Herpes|herpes
208164|NCT02300142|genital infection|genital infection
208165|NCT02300142|vaccine|vaccine
208166|NCT02300090|COPD, Exacerbation, respiratory disease, lung disease, breathlessness, dyspnoea, sputum, wheezing, cough|copd, exacerbation, respiratory disease, lung disease, breathlessness, dyspnoea, sputum, wheezing, cough
208167|NCT02300077|fentanyl, morphine|fentanyl, morphine
208168|NCT02300077|methadone|methadone
208169|NCT02300051|Compulsive sexual behavior|compulsive sexual behavior
208170|NCT02300051|Intervention|intervention
208171|NCT02300051|Short term psychodynamic group psychotherapy|short term psychodynamic group psychotherapy
208172|NCT02300051|Sexual addiction|sexual addiction
208173|NCT02300051|Hypersexual behavior|hypersexual behavior
208174|NCT02300012|Anterior cruciate ligament|anterior cruciate ligament
208175|NCT02300012|Performance based investigations|performance based investigations
208176|NCT02299973|irritable bowel syndrome|irritable bowel syndrome
208177|NCT02299973|fecal microbiota transplantation|fecal microbiota transplantation
208178|NCT02299973|bloating|bloating
208179|NCT02299960|EndoPAT|endopat
208180|NCT02299960|NICOM|nicom
208181|NCT02299960|circulating endothelial cells|circulating endothelial cells
208182|NCT02299908|Hernia, Inguinal|hernia, inguinal
208183|NCT02299908|Herniorrhaphy|herniorrhaphy
208184|NCT02299908|Abdominal Wall|abdominal wall
208185|NCT02299908|Analgesia|analgesia
208186|NCT02299908|Pain, Postoperative|pain, postoperative
208187|NCT02299895|setting approach|setting approach
208188|NCT02299895|health promotion|health promotion
208189|NCT02299895|organization|organization
208190|NCT02299895|implementation research|implementation research
208191|NCT02299895|qualitative study|qualitative study
208192|NCT02299895|comparison|comparison
208193|NCT02299882|Posterior spine surgery|posterior spine surgery
208194|NCT02299882|infection|infection
208195|NCT02299882|vancomycin|vancomycin
208196|NCT02299882|surgical wound infection|surgical wound infection
208197|NCT02299856|Magnetic Resonance Imaging|magnetic resonance imaging
208198|NCT02299856|Diagnostic Imaging|diagnostic imaging
208199|NCT02299843|RFA|rfa
208200|NCT02299843|ALPPS|alpps
208201|NCT02299843|hepatectomy|hepatectomy
208202|NCT02299843|morbidity and mortality|morbidity and mortality
208203|NCT02299830|neoplasm|neoplasm
208204|NCT02299830|central airway|central airway
208205|NCT02299830|obstruction|obstruction
208206|NCT02299791|clinic-level interventions|clinic-level interventions
208207|NCT02299791|quality improvement|quality improvement
208208|NCT02299791|translational medical research|translational medical research
208209|NCT02299791|community health centers|community health centers
208210|NCT02299765|Advanced Non-small Cell Lung Cancer (NSCLC)|advanced non-small cell lung cancer (nsclc)
208211|NCT02299765|EGFR Mutation|egfr mutation
208212|NCT02299765|gefitinib|gefitinib
208213|NCT02299765|chemotherapy|chemotherapy
208214|NCT02299739|Herbal Medicine|herbal medicine
208215|NCT02299739|Complementary Therapies|complementary therapies
208216|NCT02299739|Liver Function Tests|liver function tests
208217|NCT02299739|Risk Factors|risk factors
208218|NCT02299726|acute heart failure|acute heart failure
208219|NCT02299726|MRA|mra
208220|NCT02299726|emergency department|emergency department
208221|NCT02299713|acupuncture|acupuncture
208222|NCT02299713|knee pain|knee pain
208223|NCT02299700|Janssen Autism Knowledge Engine|janssen autism knowledge engine
208224|NCT02299700|Autism Spectrum Disorder|autism spectrum disorder
208225|NCT02299661|Hypoxia inducible factor prolyl hydroxylase inhibitor.|hypoxia inducible factor prolyl hydroxylase inhibitor.
208226|NCT02299661|Erythropoietin stimulating agent|erythropoietin stimulating agent
208227|NCT02299661|Chronic renal disease|chronic renal disease
208228|NCT02299661|renal anemia|renal anemia
208229|NCT02299635|PF-03084014|pf-03084014
208230|NCT02299635|Notch Alterations|notch alterations
208231|NCT02299609|C14.280.647.500|c14.280.647.500
208232|NCT02299596|Colorectal neoplasm|colorectal neoplasm
208233|NCT02299596|Physical activity|physical activity
208234|NCT02299583|prevention|prevention
208235|NCT02299583|early intervention|early intervention
208236|NCT02299583|trauma-informed practice|trauma-informed practice
208237|NCT02299570|Clostridium difficile|clostridium difficile
208238|NCT02299570|C diff|c diff
208239|NCT02299570|CDI|cdi
208240|NCT02299570|CDAD|cdad
208241|NCT02299570|Fecal transplant|fecal transplant
208242|NCT02299570|Fecal Microbiota Transplant|fecal microbiota transplant
208243|NCT02299570|Diarrhea|diarrhea
208244|NCT02299570|FMT|fmt
208245|NCT02299570|Microbiota restoration therapy|microbiota restoration therapy
208246|NCT02299570|Microbiota suspension|microbiota suspension
208247|NCT02299570|Fecal bacteriotherapy|fecal bacteriotherapy
208248|NCT02299570|C diff diarrhea|c diff diarrhea
208249|NCT02299505|LDK378|ldk378
208250|NCT02299505|ceritinib|ceritinib
208251|NCT02299505|Alk+|alk+
208252|NCT02299505|Alk positive|alk positive
208253|NCT02299505|NSCLC|nsclc
208254|NCT02299505|lung Cancer|lung cancer
208255|NCT02299492|Mental Health Services|mental health services
208256|NCT02299479|insulin pump|insulin pump
208257|NCT02299479|continuous glucose monitor|continuous glucose monitor
208258|NCT02299479|activity monitor|activity monitor
208259|NCT02299466|parenteral nutrition|parenteral nutrition
208260|NCT02299466|complications|complications
208261|NCT02299466|indications|indications
208262|NCT02299466|long-term administration|long-term administration
208263|NCT02299466|HTPN|htpn
208264|NCT02299453|Telemedicine|telemedicine
208265|NCT02299453|Interpersonal Psychotherapy (IPT)|interpersonal psychotherapy (ipt)
208266|NCT02299440|treatment of acute suicidal ideation|treatment of acute suicidal ideation
208267|NCT02299440|ketamine|ketamine
208268|NCT02299440|low-dose ketamine|low-dose ketamine
208269|NCT02299414|Pregnancy|pregnancy
208270|NCT02299414|Chronic hypertension|chronic hypertension
208271|NCT02299401|Medical abortion|medical abortion
208272|NCT02299401|Induced abortion|induced abortion
208273|NCT02299401|Pregnancy test|pregnancy test
208274|NCT02299401|Semi-quantitative pregnancy test|semi-quantitative pregnancy test
208275|NCT02299388|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
208276|NCT02299388|Hypertension|hypertension
208277|NCT02299388|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
208278|NCT02299388|Endothelial Dysfunction|endothelial dysfunction
208279|NCT02299388|Pulse pressure|pulse pressure
208280|NCT02299388|Renin-angiotensin system|renin-angiotensin system
208281|NCT02299388|heart rate variability|heart rate variability
208282|NCT02299375|Phase II clinical study|phase ii clinical study
208283|NCT02299375|losmapimod|losmapimod
208284|NCT02299375|exacerbations|exacerbations
208285|NCT02299375|COPD|copd
208286|NCT02299375|eosinophil sub-group|eosinophil sub-group
208287|NCT02299362|Early Onset Scoliosis|early onset scoliosis
208288|NCT02299362|EOS|eos
208289|NCT02299362|Pulmonary function|pulmonary function
208290|NCT02299362|Infantile Idiopathic Scoliosis|infantile idiopathic scoliosis
208291|NCT02299362|MCGR|mcgr
208292|NCT02299362|Magnetically controlled growing rods|magnetically controlled growing rods
208293|NCT02299362|Growing rods|growing rods
208294|NCT02299362|Growth friendly spine surgery|growth friendly spine surgery
208295|NCT02299362|Cast|cast
208296|NCT02299310|Chronic kidney disease, Anti-hypertensive drugs|chronic kidney disease, anti-hypertensive drugs
208297|NCT02299297|Alopecia Areata|alopecia areata
208298|NCT02299284|Spastic|spastic
208299|NCT02299284|Hemiplegia|hemiplegia
208300|NCT02299245|telomere|telomere
208301|NCT02299245|telomerase|telomerase
208302|NCT02299245|statin|statin
208303|NCT02299245|percutaneous coronary intervention|percutaneous coronary intervention
208304|NCT02299245|acute coronary syndrome|acute coronary syndrome
208305|NCT02299232|dexmedetomidine|dexmedetomidine
208306|NCT02299232|sedation|sedation
208307|NCT02299232|MRI|mri
208308|NCT02299219|Adolescent|adolescent
208309|NCT02299219|Internet Self-Management|internet self-management
208310|NCT02299219|Managing Cancer|managing cancer
208311|NCT02299193|cognitive behavioral therapy for insomnia|cognitive behavioral therapy for insomnia
208312|NCT02299193|sleep hygiene|sleep hygiene
208313|NCT02299180|Advanced care planning|advanced care planning
208314|NCT02299180|End of life care|end of life care
208315|NCT02299167|Perianal surgery|perianal surgery
208316|NCT02299167|hyperbaric bupivacaine|hyperbaric bupivacaine
208317|NCT02299167|saddle block|saddle block
208318|NCT02299115|Vigabatrin|vigabatrin
208319|NCT02299115|Prednisolone|prednisolone
208320|NCT02299102|Aspiration Procedures|aspiration procedures
208321|NCT02299102|Bone Marrow|bone marrow
208322|NCT02299102|To compare powered ported bone marrow aspiration procedures to manual standard bone marrow aspiration procedures|to compare powered ported bone marrow aspiration procedures to manual standard bone marrow aspiration procedures
208323|NCT02299089|acromegaly|acromegaly
208324|NCT02299089|neuroendocrine tumour (NET)|neuroendocrine tumour (net)
208325|NCT02299089|carcinoid syndrome|carcinoid syndrome
208326|NCT02299089|octreotide|octreotide
208327|NCT02299089|Sandostatin LAR|sandostatin lar
208328|NCT02299076|Tobacco smoking cessation|tobacco smoking cessation
208329|NCT02299076|Motivation|motivation
208330|NCT02299063|Mitochondria|mitochondria
208331|NCT02299063|Dexmedetomidine|dexmedetomidine
208332|NCT02299063|Heart Defects, Congenital|heart defects, congenital
208333|NCT02299050|Type 2 Diabetes|type 2 diabetes
208334|NCT02299050|T2DM|t2dm
208335|NCT02299050|Cycloset|cycloset
208336|NCT02299050|Glycemic Control|glycemic control
208337|NCT02299050|GLP-1|glp-1
208338|NCT02299024|opioids|opioids
208339|NCT02299024|health literacy|health literacy
208433|NCT02298582|elderly|elderly
208340|NCT02299011|Biomatrix drug eluting stent|biomatrix drug eluting stent
208341|NCT02299011|Orsiro drug eluting stent|orsiro drug eluting stent
208342|NCT02299011|Coronary artery disease|coronary artery disease
208343|NCT02298985|curcumin; schizophrenia; neuroprotection|curcumin; schizophrenia; neuroprotection
208344|NCT02298946|Anti-PD1 Therapy|anti-pd1 therapy
208345|NCT02298946|Anti-Tumor Immunity|anti-tumor immunity
208346|NCT02298946|Liver Metastatic|liver metastatic
208347|NCT02298946|B7-DC Fc Fushion Protein|b7-dc fc fushion protein
208348|NCT02298933|Complement Inhibition|complement inhibition
208349|NCT02298933|Platelet Refractoriness|platelet refractoriness
208350|NCT02298933|Eculizumab|eculizumab
208351|NCT02298907|colorectal cancer|colorectal cancer
208352|NCT02298907|surgery|surgery
208353|NCT02298907|cardiopulmonary exercise testing|cardiopulmonary exercise testing
208354|NCT02298907|perioperative|perioperative
208355|NCT02298907|fitness|fitness
208356|NCT02298894|Low Density Lipoprotein (LDL)|low density lipoprotein (ldl)
208357|NCT02298894|Lipoprotein|lipoprotein
208358|NCT02298894|Nuclear Magnetic Resonance (NMR)|nuclear magnetic resonance (nmr)
208359|NCT02298894|Vertical Auto Profile (VAP)|vertical auto profile (vap)
208360|NCT02298894|Ion mobility|ion mobility
208361|NCT02298894|Apoliproprotein B (ApoB)|apoliproprotein b (apob)
208362|NCT02298881|Dry Eye|dry eye
208363|NCT02298881|Microbiome|microbiome
208364|NCT02298855|Gynaecological cancer|gynaecological cancer
208365|NCT02298855|Nurse-led care|nurse-led care
208366|NCT02298855|Aftercare|aftercare
208367|NCT02298855|Patient self-management|patient self-management
208368|NCT02298855|Quality of life|quality of life
208369|NCT02298855|Relapse free interval|relapse free interval
208370|NCT02298855|Watch and wait|watch and wait
208371|NCT02298842|Healthy Adults|healthy adults
208372|NCT02298829|curvature|curvature
208373|NCT02298829|bend|bend
208374|NCT02298816|Monoclonal gammopathy of undetermined significance (MGUS)|monoclonal gammopathy of undetermined significance (mgus)
208375|NCT02298816|Smoldering multiple myeloma (SMM)|smoldering multiple myeloma (smm)
208376|NCT02298816|Multiple myeloma (MM)|multiple myeloma (mm)
208377|NCT02298816|Waldenstroms Macroglobulinemia (WM)|waldenstroms macroglobulinemia (wm)
208378|NCT02298816|Monoclonal B-cell lymphocytosis (MBL)|monoclonal b-cell lymphocytosis (mbl)
208379|NCT02298816|Chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
208380|NCT02298816|B-Cell Non-Hodgkin lymphoma (NHL)|b-cell non-hodgkin lymphoma (nhl)
208381|NCT02298816|B-Cell Hematologic Malignancies|b-cell hematologic malignancies
208382|NCT02298816|immunization|immunization
208383|NCT02298816|Vaccination|vaccination
208384|NCT02298816|Influenza, Human|influenza, human
208385|NCT02298816|Pneumonia|pneumonia
208386|NCT02298790|Dietary Habits|dietary habits
208387|NCT02298790|Circadian|circadian
208388|NCT02298790|Metabolism|metabolism
208389|NCT02298790|Feeding Behavior|feeding behavior
208390|NCT02298738|Atrial fibrillation, hypertension, vitamin D|atrial fibrillation, hypertension, vitamin d
208391|NCT02298725|Insulin Resistance|insulin resistance
208392|NCT02298725|Obesity|obesity
208393|NCT02298725|US Dietary Guidelines|us dietary guidelines
208394|NCT02298712|Iduronidase|iduronidase
208395|NCT02298712|Lysosomal Storage Diseases|lysosomal storage diseases
208396|NCT02298712|Genetic Diseases, Inborn|genetic diseases, inborn
208397|NCT02298712|Metabolism, Inborn Errors|metabolism, inborn errors
208398|NCT02298699|Lysosomal Storage Diseases|lysosomal storage diseases
208399|NCT02298699|Hereditary Diseases|hereditary diseases
208400|NCT02298686|Inborn Errors of Metabolism|inborn errors of metabolism
208401|NCT02298686|Lysosomal Storage Diseases|lysosomal storage diseases
208402|NCT02298686|Metabolism Errors, Inborn|metabolism errors, inborn
208403|NCT02298673|Lipid Metabolism, Inborn Errors|lipid metabolism, inborn errors
208404|NCT02298673|Hereditary Disease|hereditary disease
208405|NCT02298673|Inborn Genetic Diseases|inborn genetic diseases
208406|NCT02298660|Autonomic Dysreflexia|autonomic dysreflexia
208407|NCT02298660|Spinal Cord Injury|spinal cord injury
208408|NCT02298660|OnabotulinumtoxinA|onabotulinumtoxina
208409|NCT02298660|Neurogenic detrusor overactivity|neurogenic detrusor overactivity
208410|NCT02298660|Urodynamics|urodynamics
208411|NCT02298660|Cardiovascular|cardiovascular
208412|NCT02298660|Quality of life|quality of life
208413|NCT02298660|Blood pressure|blood pressure
208414|NCT02298660|Twenty-four hour ambulatory blood pressure monitoring|twenty-four hour ambulatory blood pressure monitoring
208415|NCT02298647|Lysosomal Storage Diseases|lysosomal storage diseases
208416|NCT02298634|Lysosomal Storage Diseases|lysosomal storage diseases
208417|NCT02298634|Lipogranulomatosis|lipogranulomatosis
208418|NCT02298608|Renal mass|renal mass
208419|NCT02298608|Kidney cancer|kidney cancer
208420|NCT02298608|Irreversibel Electroporation|irreversibel electroporation
208421|NCT02298608|Ablation|ablation
208422|NCT02298608|Safety|safety
208423|NCT02298608|Efficacy|efficacy
208424|NCT02298608|IRE|ire
208425|NCT02298595|Carcinoma|carcinoma
208426|NCT02298595|Squamous|squamous
208427|NCT02298595|Oropharyngeal|oropharyngeal
208428|NCT02298595|HPV|hpv
208429|NCT02298595|Resectable|resectable
208430|NCT02298582|safety|safety
208431|NCT02298582|procedural pain|procedural pain
208432|NCT02298582|intranasal fentanyl|intranasal fentanyl
208434|NCT02298569|patient discharge|patient discharge
208435|NCT02298569|hospital readmission|hospital readmission
208436|NCT02298569|postnatal care|postnatal care
208437|NCT02298569|Home Care Services|home care services
208438|NCT02298569|Cost-Benefit Analysis|cost-benefit analysis
208439|NCT02298569|Personal satisfaction|personal satisfaction
208440|NCT02298569|Community Care Networks|community care networks
208441|NCT02298556|Hypertension|hypertension
208442|NCT02298556|Diabetes Mellitus|diabetes mellitus
208443|NCT02298556|ACE Inhibitors|ace inhibitors
208444|NCT02298556|Calcium Channel Blockers|calcium channel blockers
208445|NCT02298517|Morbid obesity|morbid obesity
208446|NCT02298517|bariatric surgery|bariatric surgery
208447|NCT02298517|Respiratory muscle endurance|respiratory muscle endurance
208448|NCT02298517|Respiratory muscle strength|respiratory muscle strength
208449|NCT02298517|spirometry|spirometry
208450|NCT02298517|physiotherapy|physiotherapy
208451|NCT02298478|Self-help|self-help
208452|NCT02298478|Computer-aided Treatment|computer-aided treatment
208453|NCT02298478|Internet|internet
208454|NCT02298478|Flying phobia|flying phobia
208455|NCT02298478|minimal contact therapies|minimal contact therapies
208456|NCT02298478|Cognitive-Behavioural Treatment|cognitive-behavioural treatment
208457|NCT02298478|Waiting list control group|waiting list control group
208458|NCT02298465|ESWL|eswl
208459|NCT02298465|distal ureteric stone|distal ureteric stone
208460|NCT02298465|transgluteal|transgluteal
208461|NCT02298465|supine ESWL|supine eswl
208462|NCT02298439|NAFLD|nafld
208463|NCT02298426|Body Constitution Classification|body constitution classification
208464|NCT02298426|Health Management|health management
208465|NCT02298426|Obese Population|obese population
208466|NCT02298374|Rehabilitation|rehabilitation
208467|NCT02298374|Evaluation studies|evaluation studies
208468|NCT02298374|Home care services|home care services
208469|NCT02298361|Adolescent|adolescent
208470|NCT02298361|Child|child
208471|NCT02298361|Child Health Services/organization & administration*|child health services/organization & administration*
208472|NCT02298361|Child, Preschool|child, preschool
208473|NCT02298361|Cohort Studies|cohort studies
208474|NCT02298361|Community Health Centers/organization & administration|community health centers/organization & administration
208475|NCT02298361|Community Health Centers/standards|community health centers/standards
208476|NCT02298361|Electronic Health Records|electronic health records
208477|NCT02298361|Feasibility Studies|feasibility studies
208478|NCT02298361|Female|female
208479|NCT02298361|Health Services Accessibility/economics|health services accessibility/economics
208480|NCT02298361|Humans|humans
208481|NCT02298361|Infant|infant
208482|NCT02298361|Infant, Newborn|infant, newborn
208483|NCT02298361|Insurance Coverage|insurance coverage
208484|NCT02298361|Insurance Coverage/statistics & numerical data|insurance coverage/statistics & numerical data
208485|NCT02298361|Insurance Coverage/trends|insurance coverage/trends
208486|NCT02298361|Insurance, Health|insurance, health
208487|NCT02298361|Insurance, Health/legislation & jurisprudence|insurance, health/legislation & jurisprudence
208488|NCT02298361|Insurance, Health/statistics & numerical data|insurance, health/statistics & numerical data
208489|NCT02298361|Insurance, Health/trends|insurance, health/trends
208490|NCT02298361|Logistic Models|logistic models
208491|NCT02298361|Longitudinal Studies|longitudinal studies
208492|NCT02298361|Male|male
208493|NCT02298361|Medicaid|medicaid
208494|NCT02298361|Medicaid/statistics & numerical data|medicaid/statistics & numerical data
208495|NCT02298361|Medicaid/trends|medicaid/trends
208496|NCT02298361|Medicaid/utilization|medicaid/utilization
208497|NCT02298361|Medically Uninsured|medically uninsured
208498|NCT02298361|Medicare/statistics & numerical data|medicare/statistics & numerical data
208499|NCT02298361|Medicare/trends|medicare/trends
208500|NCT02298361|Medicare/utilization|medicare/utilization
208501|NCT02298361|Multivariate Analysis|multivariate analysis
208502|NCT02298361|Oregon|oregon
208503|NCT02298361|Patient Protection and Affordable Care Act|patient protection and affordable care act
208504|NCT02298361|Patient-Centered Care|patient-centered care
208505|NCT02298361|Pediatrics/legislation & jurisprudence|pediatrics/legislation & jurisprudence
208506|NCT02298361|Pediatrics/standards|pediatrics/standards
208507|NCT02298361|Population Surveillance/methods|population surveillance/methods
208508|NCT02298361|Primary Health Care/economics|primary health care/economics
208509|NCT02298361|Quality Assurance, Health Care/legislation & jurisprudence|quality assurance, health care/legislation & jurisprudence
208510|NCT02298361|Quality Assurance, Health Care/methods|quality assurance, health care/methods
208511|NCT02298361|Quality Indicators, Health Care|quality indicators, health care
208512|NCT02298361|Retrospective Studies|retrospective studies
208513|NCT02298361|Socioeconomic Factors|socioeconomic factors
208514|NCT02298361|United States|united states
208515|NCT02298361|Young Adult|young adult
208516|NCT02298348|Neuroblastoma|neuroblastoma
208517|NCT02298348|NANT|nant
208518|NCT02298348|Sorafenib|sorafenib
208519|NCT02298348|Relapse|relapse
208520|NCT02298335|Prednisone|prednisone
208521|NCT02298335|idiopathic nephrotic syndrome|idiopathic nephrotic syndrome
208522|NCT02298335|prospective|prospective
208523|NCT02298309|TB|tb
208524|NCT02298309|HIV|hiv
208525|NCT02298309|Test and Treat|test and treat
208526|NCT02298309|Linkage|linkage
208527|NCT02298283|Hodgkin lymphoma|hodgkin lymphoma
208528|NCT02298283|HL|hl
208529|NCT02298283|brentuximab vedotin|brentuximab vedotin
208530|NCT02298270|Neurofibromatosis|neurofibromatosis
208531|NCT02298270|NF I|nf i
208532|NCT02298270|NF 2|nf 2
208533|NCT02298270|Schwannomatosis|schwannomatosis
208534|NCT02298270|Stress Management|stress management
208535|NCT02298270|Resiliency|resiliency
208536|NCT02298270|Skype|skype
208537|NCT02298244|Pulmonary Hypertension|pulmonary hypertension
208538|NCT02298244|Atrial Fibrillation|atrial fibrillation
208539|NCT02298244|Pulmonary Arterial Denervation|pulmonary arterial denervation
208540|NCT02298244|Safety|safety
208541|NCT02298244|Pulmonary Arterial GP Ablation|pulmonary arterial gp ablation
208542|NCT02298231|Traumatic Brain Injury|traumatic brain injury
208543|NCT02298231|Balance|balance
208544|NCT02298231|TBI|tbi
208545|NCT02298231|Veterans|veterans
208546|NCT02298231|Virtual Reality|virtual reality
208547|NCT02298166|Acute myeloid leukemia|acute myeloid leukemia
208548|NCT02298166|FLT3 mutations|flt3 mutations
208549|NCT02298166|Crenolanib|crenolanib
208550|NCT02298166|Relapsed|relapsed
208551|NCT02298166|Refractory|refractory
208552|NCT02298140|SMS reminders|sms reminders
208553|NCT02298140|Provider's compliance|provider's compliance
208554|NCT02298140|malaria|malaria
208555|NCT02298127|smoking cessation|smoking cessation
208556|NCT02298127|auricular acupressure|auricular acupressure
208557|NCT02298127|primary care settings|primary care settings
208558|NCT02298127|randomized controlled trial|randomized controlled trial
208559|NCT02298114|electrical stimulation|electrical stimulation
208560|NCT02298114|intensive care unit|intensive care unit
208561|NCT02298114|muscular atrophy|muscular atrophy
208562|NCT02298101|Aerosol delivery|aerosol delivery
208563|NCT02298101|Lung deposition|lung deposition
208564|NCT02298101|SPECT|spect
208565|NCT02298101|subjects|subjects
208566|NCT02298075|Immune thrombocytopenia|immune thrombocytopenia
208567|NCT02298075|Primary|primary
208568|NCT02298075|Thrombopoietin receptor agonist|thrombopoietin receptor agonist
208569|NCT02298062|Kawasaki disease coronary artery lesion, IVIG- resistant, Infliximab|kawasaki disease coronary artery lesion, ivig- resistant, infliximab
208570|NCT02298049|fMRI|fmri
208571|NCT02298049|reward|reward
208572|NCT02298049|satiation|satiation
208573|NCT02298036|Health Anxiety|health anxiety
208574|NCT02298036|Urgent Care|urgent care
208575|NCT02298036|Medically Unexplained|medically unexplained
208576|NCT02298023|adipose derived mesenchymal stem cell|adipose derived mesenchymal stem cell
208577|NCT02298023|allogeneic stem cell|allogeneic stem cell
208578|NCT02298023|Rotator cuff tear|rotator cuff tear
208579|NCT02297997|sarcopenia|sarcopenia
208580|NCT02297997|cetylpyridinium chloride|cetylpyridinium chloride
208581|NCT02297984|Neuroglobin|neuroglobin
208582|NCT02297984|HIF-α|hif-α
208583|NCT02297984|Acute ischemic stroke|acute ischemic stroke
208584|NCT02297984|Prognosis|prognosis
208585|NCT02297932|Exercise|exercise
208586|NCT02297919|Web-based education, Adolescent, Obesity|web-based education, adolescent, obesity
208587|NCT02297906|Intranasal|intranasal
208588|NCT02297906|Ketorolac|ketorolac
208589|NCT02297906|Pharmacokinetics|pharmacokinetics
208590|NCT02297906|Pediatric|pediatric
208591|NCT02297880|low calorie sweetener satiety, intake, hunger|low calorie sweetener satiety, intake, hunger
208592|NCT02297815|antibiotic use|antibiotic use
208593|NCT02297815|effectiveness|effectiveness
208594|NCT02297815|acute respiratory infections|acute respiratory infections
208595|NCT02297815|pediatrics|pediatrics
208596|NCT02297776|cardiac arrest|cardiac arrest
208597|NCT02297776|biomarker|biomarker
208598|NCT02297776|microRNA|microrna
208599|NCT02297776|circRNA|circrna
208601|NCT02297776|CPC|cpc
208602|NCT02297750|The focus of the study is double-wire technique versus single wire technique in patients undergoing ERCP with biliary cannulation as the primary objective.|the focus of the study is double-wire technique versus single wire technique in patients undergoing ercp with biliary cannulation as the primary objective.
208603|NCT02297737|Tai Chi|tai chi
208604|NCT02297698|Breast cancer, NeuVax|breast cancer, neuvax
208605|NCT02297685|Transcutaneous electrical nerve stimulation (TENS)|transcutaneous electrical nerve stimulation (tens)
208606|NCT02297685|Interferential currents therapy|interferential currents therapy
208607|NCT02297685|Therapeutic exercises|therapeutic exercises
208608|NCT02297685|Low back pain|low back pain
208609|NCT02297685|Rehabilitation|rehabilitation
208610|NCT02297672|breast cancer|breast cancer
208611|NCT02297672|brachytherapy|brachytherapy
208612|NCT02297672|partial breast radiotherapy|partial breast radiotherapy
208613|NCT02297672|palladium 103|palladium 103
208614|NCT02297659|damage control|damage control
208615|NCT02297659|resuscitation|resuscitation
208616|NCT02297659|laparotomy|laparotomy
208617|NCT02297646|Prevention|prevention
208618|NCT02297646|Exercise|exercise
208619|NCT02297646|Health|health
208620|NCT02297646|Endurance|endurance
208621|NCT02297633|COPD|copd
208622|NCT02297633|reactive oxygen metabolites|reactive oxygen metabolites
208623|NCT02297620|SGLT-2 inhibitor|sglt-2 inhibitor
208624|NCT02297620|Elderly patients|elderly patients
208625|NCT02297620|ASP1941|asp1941
208626|NCT02297607|Esophageal Cancer|esophageal cancer
208627|NCT02297607|Esophagectomy|esophagectomy
208628|NCT02297581|Geriatrics [MeSH]|geriatrics [mesh]
208629|NCT02297581|Osteoporotic fractures [MeSH]|osteoporotic fractures [mesh]
208630|NCT02297581|Hip fractures [MeSH]|hip fractures [mesh]
208631|NCT02297581|Cost benefit analysis [MeSH]|cost benefit analysis [mesh]
208632|NCT02297581|Quality of life [MeSH]|quality of life [mesh]
208633|NCT02297581|Mortality [MeSH]|mortality [mesh]
208634|NCT02297581|Complications|complications
208635|NCT02297568|Breast-fed infant|breast-fed infant
208636|NCT02297568|vitamin D supplementation|vitamin d supplementation
208637|NCT02297568|Lactation|lactation
208638|NCT02297555|Obesity|obesity
208639|NCT02297555|Metabolic Syndrome|metabolic syndrome
208640|NCT02297555|ENDOBARRIER®|endobarrier®
208641|NCT02297542|Influenza Vaccine|influenza vaccine
208642|NCT02297529|unresected, Melanoma, expanded access, EU|unresected, melanoma, expanded access, eu
208643|NCT02297490|Environmental Exposure Chamber|environmental exposure chamber
208644|NCT02297490|Specific Immunotherapy|specific immunotherapy
208645|NCT02297490|SIT|sit
208646|NCT02297490|SCIT|scit
208647|NCT02297464|Risk|risk
208648|NCT02297438|breast cancer|breast cancer
208649|NCT02297438|postmenopausal women|postmenopausal women
208650|NCT02297438|estrogen-receptor positive|estrogen-receptor positive
208651|NCT02297438|HER2 negative|her2 negative
208652|NCT02297438|locoregionally recurrent|locoregionally recurrent
208653|NCT02297438|metastatic|metastatic
208654|NCT02297425|NSCLC, Non-Small Cell Lung Cancer, EGFRm, Epidermal Grown Factor Receptor mutation|nsclc, non-small cell lung cancer, egfrm, epidermal grown factor receptor mutation
208655|NCT02297399|Colonoscopy|colonoscopy
208656|NCT02297399|Diabetes Mellitus|diabetes mellitus
208657|NCT02297399|Polyethylene glycols|polyethylene glycols
208658|NCT02297399|Ascorbate|ascorbate
208659|NCT02297399|Personal satisfaction|personal satisfaction
208660|NCT02297386|[18F] Dihydro-testosterone|[18f] dihydro-testosterone
208661|NCT02297386|PET Scan|pet scan
208662|NCT02297386|MRI|mri
208663|NCT02297386|14-185|14-185
208664|NCT02297360|Hair loss, hair thinning, women, marine protein supplement|hair loss, hair thinning, women, marine protein supplement
208665|NCT02297334|CytoSorb(TM)|cytosorb(tm)
208666|NCT02297334|cytokines|cytokines
208667|NCT02297334|inflammation|inflammation
208668|NCT02297334|cardiac surgery|cardiac surgery
208669|NCT02297334|extracorporeal bypass|extracorporeal bypass
208670|NCT02297321|tattoos|tattoos
208671|NCT02297321|laser|laser
208672|NCT02297321|whitening|whitening
208673|NCT02297321|patch|patch
208674|NCT02297295|Sequelae of; Amputation, Traumatic, Limb, Lower|sequelae of; amputation, traumatic, limb, lower
208675|NCT02297282|Depression|depression
208676|NCT02297282|Behavioural Activation|behavioural activation
208677|NCT02297269|Deep vein thrombosis|deep vein thrombosis
208678|NCT02297269|Surgery|surgery
208679|NCT02297269|gastrointestinal malignancy|gastrointestinal malignancy
208680|NCT02297230|Locally Advanced Breast Cancer|locally advanced breast cancer
208681|NCT02297191|volunteer|volunteer
208682|NCT02297191|pilot study|pilot study
208683|NCT02297191|adults|adults
208684|NCT02297165|anorexic|anorexic
208685|NCT02297165|olfactory stimulation|olfactory stimulation
208686|NCT02297165|autobiographical memories recovery|autobiographical memories recovery
208687|NCT02297152|Premature ejaculation treatment|premature ejaculation treatment
208688|NCT02297152|Sexual dysfunction|sexual dysfunction
208689|NCT02297152|Intravaginal Ejaculatory Latency time|intravaginal ejaculatory latency time
208690|NCT02297152|Masturbation aid|masturbation aid
208691|NCT02297152|Ejaculatory disorders|ejaculatory disorders
208692|NCT02297113|patients|patients
208693|NCT02297113|departement|departement
208694|NCT02297113|requiring Rapid Sequence Intubation (RSI)|requiring rapid sequence intubation (rsi)
208695|NCT02297100|women|women
208696|NCT02297100|interstitial cystitis|interstitial cystitis
208697|NCT02297100|bladder pain syndrome|bladder pain syndrome
208698|NCT02297100|botox|botox
208699|NCT02297100|onabotulinum toxin A|onabotulinum toxin a
208700|NCT02297074|Bread|bread
208701|NCT02297074|Glycemic index|glycemic index
208702|NCT02297074|Glycemic load|glycemic load
208703|NCT02297074|Insulinemic index|insulinemic index
208704|NCT02297074|Satiety|satiety
208705|NCT02297074|Gastrointestinal hormones|gastrointestinal hormones
208706|NCT02297061|Hip fracture|hip fracture
208707|NCT02297061|Thrombelastography|thrombelastography
208708|NCT02297061|Blood loss|blood loss
208709|NCT02297048|Potassium intake|potassium intake
208710|NCT02297048|Progesterone|progesterone
208711|NCT02297048|steroidogenesis|steroidogenesis
208712|NCT02297048|RU486|ru486
208713|NCT02297048|Synachtene test|synachtene test
208714|NCT02297022|Deep Brain Stimulation|deep brain stimulation
208715|NCT02297022|obesity|obesity
208716|NCT02297022|Prader-Willi syndrome|prader-willi syndrome
208717|NCT02296996|BRAF V600|braf v600
208718|NCT02296996|Rechallenge|rechallenge
208719|NCT02296996|Combination|combination
208720|NCT02296996|Dabrafenib|dabrafenib
208721|NCT02296996|Trametinib|trametinib
208722|NCT02296944|Childrens|childrens
208723|NCT02296944|tempanoplasty|tempanoplasty
208724|NCT02296944|tympanic membrane perforation|tympanic membrane perforation
208725|NCT02296944|retrospective|retrospective
208726|NCT02296944|cohort|cohort
208727|NCT02296918|CLL|cll
208728|NCT02296918|SLL|sll
208729|NCT02296918|PLL|pll
208730|NCT02296918|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
208731|NCT02296918|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
208732|NCT02296918|Prolymphocytic Leukemia|prolymphocytic leukemia
208733|NCT02296918|ACP-196|acp-196
208734|NCT02296918|acalabrutinib|acalabrutinib
208735|NCT02296918|obinutuzumab|obinutuzumab
208736|NCT02296918|rituximab|rituximab
208737|NCT02296918|venetoclax|venetoclax
208738|NCT02296905|Hepatic Impairment|hepatic impairment
208739|NCT02296905|Hepatitis C Virus Infection|hepatitis c virus infection
208740|NCT02296892|Remimazolam, midazolam, bronchoscopy, procedural sedation|remimazolam, midazolam, bronchoscopy, procedural sedation
208741|NCT02296853|Severe Hepatic Impairment|severe hepatic impairment
208742|NCT02296840|analgesia|analgesia
208743|NCT02296840|non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
208744|NCT02296840|narcotic-containing pain medication|narcotic-containing pain medication
208745|NCT02296788|Gut Microbiota|gut microbiota
208746|NCT02296775|Rheumatoid arthritis|rheumatoid arthritis
208747|NCT02296775|Rituximab|rituximab
208748|NCT02296775|Pharmacokinetics|pharmacokinetics
208749|NCT02296736|computerised tomography (CT) scan|computerised tomography (ct) scan
208750|NCT02296736|diagnostic accuracy|diagnostic accuracy
208751|NCT02296736|Pancreatic head malignancy|pancreatic head malignancy
208752|NCT02296710|mitral valve|mitral valve
208753|NCT02296710|valve surgery|valve surgery
208754|NCT02296710|echocardiography|echocardiography
208755|NCT02296697|Pressure Ulcer|pressure ulcer
208756|NCT02296697|Low Level Laser Therapy|low level laser therapy
208757|NCT02296697|Dressings|dressings
208758|NCT02296632|Telemedicine|telemedicine
208759|NCT02296632|Patient Reported Outcomes|patient reported outcomes
208760|NCT02296593|lactate|lactate
208761|NCT02296593|continuous lactate monitoring|continuous lactate monitoring
208762|NCT02296593|continuous blood glucose monitoring|continuous blood glucose monitoring
208763|NCT02296593|EIRUS|eirus
208764|NCT02296593|blood glucose|blood glucose
208765|NCT02296593|cardiac surgery|cardiac surgery
208766|NCT02296593|central veinous catheter|central veinous catheter
208767|NCT02296593|microdialysis|microdialysis
208768|NCT02296554|SLAP Repair|slap repair
208769|NCT02296554|Biceps Tenodesis|biceps tenodesis
208770|NCT02296528|Feeding Tube Dependent|feeding tube dependent
208771|NCT02296502|DSM Diagnosis|dsm diagnosis
208772|NCT02296450|Quality of Life (QoL)|quality of life (qol)
208773|NCT02296450|Assessment|assessment
208774|NCT02296450|14-236|14-236
208775|NCT02296450|Patients and Survivors|patients and survivors
208776|NCT02296424|Juvenile Rheumatoid arthritis (JRA) chronic|juvenile rheumatoid arthritis (jra) chronic
208777|NCT02296424|systemic inflammatory disorder|systemic inflammatory disorder
208778|NCT02296424|painful joints|painful joints
208779|NCT02296424|inflammation of the synovial membrane|inflammation of the synovial membrane
208780|NCT02296424|auto-immune rheumatoid disease|auto-immune rheumatoid disease
208781|NCT02296424|reactive rheumatoid arthritis|reactive rheumatoid arthritis
208782|NCT02296424|Systemic Juvenile Rheumatoid arthritis (SJRA)|systemic juvenile rheumatoid arthritis (sjra)
208783|NCT02296411|Asthma, Anticholinergics|asthma, anticholinergics
208784|NCT02296385|volunteers|volunteers
208785|NCT02296333|Acetaminophen, ondansetron|acetaminophen, ondansetron
208786|NCT02296307|Aged|aged
208787|NCT02296307|Algorithms|algorithms
208788|NCT02296307|CA-125 Antigen/blood*|ca-125 antigen/blood*
208789|NCT02296307|Chi-Square Distribution|chi-square distribution
208790|NCT02296307|Early Detection of Cancer*|early detection of cancer*
208791|NCT02296307|Feasibility Studies|feasibility studies
208792|NCT02296307|Female|female
208793|NCT02296307|Humans|humans
208794|NCT02296307|Logistic Models|logistic models
208795|NCT02296307|Mass Screening/methods*|mass screening/methods*
208796|NCT02296307|Middle Aged|middle aged
208797|NCT02296307|Neoplasm Grading|neoplasm grading
208798|NCT02296307|Neoplasm Invasiveness|neoplasm invasiveness
208799|NCT02296307|Neoplasm Staging|neoplasm staging
208800|NCT02296307|Ovarian Neoplasms/diagnosis*|ovarian neoplasms/diagnosis*
208801|NCT02296307|Ovarian Neoplasms/epidemiology|ovarian neoplasms/epidemiology
208802|NCT02296307|Ovarian Neoplasms/immunology|ovarian neoplasms/immunology
208803|NCT02296307|Ovarian Neoplasms/ultrasonography|ovarian neoplasms/ultrasonography
208804|NCT02296307|Pilot Projects|pilot projects
208805|NCT02296307|Predictive Value of Tests|predictive value of tests
208806|NCT02296307|Prevalence|prevalence
208807|NCT02296307|Prognosis|prognosis
208808|NCT02296307|Prospective Studies|prospective studies
208809|NCT02296307|Quebec/epidemiology|quebec/epidemiology
208810|NCT02296307|Tumor Burden|tumor burden
208811|NCT02296294|Bioimpedance Spectroscopy, Body Composition Monitor, Fluid Therapy|bioimpedance spectroscopy, body composition monitor, fluid therapy
208812|NCT02296268|stroke|stroke
208813|NCT02296268|aerobic exercise|aerobic exercise
208814|NCT02296268|screening|screening
208815|NCT02296268|prescription|prescription
208816|NCT02296255|cervical cancer screening|cervical cancer screening
208817|NCT02296255|young women vaccination|young women vaccination
208818|NCT02296255|impact of HPV vaccination on screening|impact of hpv vaccination on screening
208819|NCT02296216|have been treated or not treated by Gamma Knife Radiosurgery|have been treated or not treated by gamma knife radiosurgery
208820|NCT02296203|cetuximab rechallenge|cetuximab rechallenge
208821|NCT02296177|evidence-based intervention|evidence-based intervention
208822|NCT02296177|mammography|mammography
208823|NCT02296177|underserved population|underserved population
208824|NCT02296164|PROVe|prove
208825|NCT02296164|CTCL|ctcl
208826|NCT02296164|Mechlorethamine|mechlorethamine
208827|NCT02296164|Cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
208828|NCT02296164|Mycosis fungoides cutaneous T-cell lymphoma|mycosis fungoides cutaneous t-cell lymphoma
208829|NCT02296164|Valchlor|valchlor
208830|NCT02296164|Dermatology|dermatology
208831|NCT02296164|MF-CTCL|mf-ctcl
208832|NCT02296164|Mycosis Fungoides|mycosis fungoides
208833|NCT02296164|Oncology|oncology
208834|NCT02296125|Advanced Non-Small Cell Lung Cancer; EGFRm+; AZD9291; TKI; Phase III|advanced non-small cell lung cancer; egfrm+; azd9291; tki; phase iii
208835|NCT02296099|retropubic suburethral sling|retropubic suburethral sling
208836|NCT02296099|stress urinary incontinence|stress urinary incontinence
208837|NCT02296099|liposomal bupivacaine|liposomal bupivacaine
208838|NCT02296086|Geriatrics [MeSH]|geriatrics [mesh]
208839|NCT02296086|Hip fractures [MeSH]|hip fractures [mesh]
208840|NCT02296086|China [MeSH]|china [mesh]
208841|NCT02296086|Early ambulation [MeSH]|early ambulation [mesh]
208842|NCT02296086|Immobilization [MeSH]|immobilization [mesh]
208843|NCT02296073|Pediatric intensive care unit|pediatric intensive care unit
208844|NCT02296073|Sedation|sedation
208845|NCT02296073|Dexmedetomidine|dexmedetomidine
208846|NCT02296073|mechanical ventilation|mechanical ventilation
208847|NCT02296047|COPD, central drive, bronchodilators|copd, central drive, bronchodilators
208848|NCT02296021|helicobacter pylori|helicobacter pylori
208849|NCT02296021|berberine-containing quadruple therapy|berberine-containing quadruple therapy
208850|NCT02296021|bismuth-containing quadruple therapy|bismuth-containing quadruple therapy
208851|NCT02296008|high resolution manometry|high resolution manometry
208852|NCT02296008|children|children
208853|NCT02296008|congenital anorectal disorder|congenital anorectal disorder
208854|NCT02296008|surgery|surgery
208855|NCT02295995|Aged|aged
208856|NCT02295995|Exercise|exercise
208857|NCT02295995|Veterans|veterans
208858|NCT02295995|Adherence|adherence
208859|NCT02295995|Clinical Trials, Randomized|clinical trials, randomized
208860|NCT02295982|Laparoscopic nephrectomy|laparoscopic nephrectomy
208861|NCT02295982|one day surgery|one day surgery
208862|NCT02295969|Rhinitis|rhinitis
208863|NCT02295969|Conjunctivitis|conjunctivitis
208864|NCT02295969|Grass pollen|grass pollen
208865|NCT02295969|Sublingual tablet|sublingual tablet
208866|NCT02295969|Allergen immunotherapy|allergen immunotherapy
208867|NCT02295969|Safety|safety
208868|NCT02295956|Pancreatic Cancer|pancreatic cancer
208869|NCT02295956|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
208870|NCT02295956|Preoperative therapy|preoperative therapy
208871|NCT02295956|Questionnaires|questionnaires
208872|NCT02295956|Surveys|surveys
208873|NCT02295956|Exercises|exercises
208874|NCT02295956|Stretching|stretching
208875|NCT02295956|Walking|walking
208876|NCT02295956|Nutrition counseling|nutrition counseling
208877|NCT02295956|Resistance exercise bands|resistance exercise bands
208878|NCT02295956|Phone calls|phone calls
208879|NCT02295956|Booklet|booklet
208880|NCT02295956|Pamphlet|pamphlet
208881|NCT02295930|colorectal cancer,|colorectal cancer,
208882|NCT02295930|bevacizumab|bevacizumab
208883|NCT02295930|cetuximab|cetuximab
208884|NCT02295930|folfoxiri|folfoxiri
208885|NCT02295930|kras wild type|kras wild type
208886|NCT02295904|perineum|perineum
208887|NCT02295904|videoanalysis|videoanalysis
208888|NCT02295865|Psoriasis|psoriasis
208889|NCT02295865|Toreforant|toreforant
208890|NCT02295865|JNJ-38518168|jnj-38518168
208891|NCT02295852|Low-sodium calcium enriched diet|low-sodium calcium enriched diet
208892|NCT02295852|Low-sodium diet|low-sodium diet
208893|NCT02295852|Glucose and lipid metabolims|glucose and lipid metabolims
208894|NCT02295839|Sleep|sleep
208895|NCT02295839|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
208896|NCT02295839|Fatigue|fatigue
208897|NCT02295839|Sleep hygiene|sleep hygiene
208898|NCT02295839|Relaxation|relaxation
208899|NCT02295839|RCT|rct
208900|NCT02295800|HIV|hiv
208901|NCT02295800|PMTCT|pmtct
208902|NCT02295800|Antenatal Care|antenatal care
208903|NCT02295787|Depression|depression
208904|NCT02295787|Suicide|suicide
208905|NCT02295787|Suicidal Ideation|suicidal ideation
208906|NCT02295787|Ketamine|ketamine
208907|NCT02295787|Late-Life|late-life
208908|NCT02295761|motor activity|motor activity
208909|NCT02295761|obesity|obesity
208910|NCT02295761|overweight|overweight
208911|NCT02295761|intervention study|intervention study
208912|NCT02295761|health promotion|health promotion
208913|NCT02295761|lifestyle counseling|lifestyle counseling
208914|NCT02295761|adherence|adherence
208915|NCT02295735|Skin, safety, wounds, intensive care|skin, safety, wounds, intensive care
208916|NCT02295722|eligible for high-dose therapy and stem cell transplantation|eligible for high-dose therapy and stem cell transplantation
208917|NCT02295709|ultrasound|ultrasound
208918|NCT02295709|cervical Transformational Epidural Steroid Injection|cervical transformational epidural steroid injection
208919|NCT02295696|Adults, dialogue tools, outpatient clinic visits|adults, dialogue tools, outpatient clinic visits
208920|NCT02295644|Therapeutic ultrasound|therapeutic ultrasound
208921|NCT02295592|hemorrhoids|hemorrhoids
208922|NCT02295592|The recurrence rate|the recurrence rate
208923|NCT02295592|PPH|pph
208924|NCT02295592|TSTstarr+|tststarr+
208925|NCT02295566|Nitric Oxide|nitric oxide
208926|NCT02295566|Pseudomonas Aeruginosa|pseudomonas aeruginosa
208927|NCT02295566|Biofilm|biofilm
208928|NCT02295553|Ketamine|ketamine
208929|NCT02295553|Propofol|propofol
208930|NCT02295553|Children|children
208931|NCT02295553|Pediatrics|pediatrics
208932|NCT02295553|Upper endoscopy|upper endoscopy
208933|NCT02295514|Sepsis|sepsis
208934|NCT02295514|Septic shock|septic shock
208935|NCT02295501|Pathogen inactivation|pathogen inactivation
208936|NCT02295501|ebola|ebola
208937|NCT02295501|convalescent plasma|convalescent plasma
208938|NCT02295501|EBOV|ebov
208939|NCT02295501|amotosalen|amotosalen
208940|NCT02295501|Provide access to the potential therapeutic benefit of EBOV convalescent plasma containing antibodies to EBOV.|provide access to the potential therapeutic benefit of ebov convalescent plasma containing antibodies to ebov.
208941|NCT02295488|hymenoptera puncture|hymenoptera puncture
208942|NCT02295462|nursing homes|nursing homes
208943|NCT02295462|person-centered care|person-centered care
208944|NCT02295462|inappropriate prescriptions|inappropriate prescriptions
208945|NCT02295462|cluster-randomised controlled trial|cluster-randomised controlled trial
208946|NCT02295462|antipsychotic drugs|antipsychotic drugs
208947|NCT02295449|Prostate cancer|prostate cancer
208948|NCT02295449|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
208949|NCT02295436|minodronic acid|minodronic acid
208950|NCT02295436|pharmacokinetics|pharmacokinetics
208951|NCT02295436|tolerability|tolerability
208952|NCT02295436|food|food
208953|NCT02295436|age|age
208954|NCT02295436|Chinese subjects|chinese subjects
208955|NCT02295410|Assessment, PTSD, Veterans|assessment, ptsd, veterans
208956|NCT02295397|Food provocation|food provocation
208957|NCT02295397|Matrix effect|matrix effect
208958|NCT02295397|ED05|ed05
208959|NCT02295397|Allergy|allergy
208960|NCT02295397|Proton Pump Inhibitor|proton pump inhibitor
208961|NCT02295384|Polypharmacy|polypharmacy
208962|NCT02295384|Medication Therapy Management|medication therapy management
208963|NCT02295371|Drug therapy|drug therapy
208964|NCT02295371|Patient safety|patient safety
208965|NCT02295371|Polydrug therapy|polydrug therapy
208966|NCT02295319|Discharge|discharge
208967|NCT02295319|Acute Admission Unit|acute admission unit
208968|NCT02295319|Randomized Controlled Trial|randomized controlled trial
208969|NCT02295306|OSA, polysomnography, ExSpiron monitor|osa, polysomnography, exspiron monitor
208970|NCT02295293|Rhus|rhus
208971|NCT02295293|Cholesterol|cholesterol
208972|NCT02295293|Triglycerides|triglycerides
208973|NCT02295293|Lipids|lipids
208974|NCT02295293|Medicine, Traditional|medicine, traditional
208975|NCT02295293|Herbal medicine|herbal medicine
208976|NCT02295280|headache|headache
208977|NCT02295267|Food allergy|food allergy
208978|NCT02295267|Walnut|walnut
208979|NCT02295267|Components|components
208980|NCT02295267|Allergens|allergens
208981|NCT02295241|Sarcopenia, muscles, aging|sarcopenia, muscles, aging
208982|NCT02295228|Vitamin D, Vitamin D deficiency, Hip Arthroplasty|vitamin d, vitamin d deficiency, hip arthroplasty
208983|NCT02295215|chagas disease|chagas disease
208984|NCT02295215|exercise|exercise
208985|NCT02295215|baroreflex sensitivity|baroreflex sensitivity
208986|NCT02295163|Stellate ganglion block|stellate ganglion block
208987|NCT02295163|hot flushes|hot flushes
208988|NCT02295163|androgen deprivation therapy|androgen deprivation therapy
208989|NCT02295163|prostate cancer|prostate cancer
208990|NCT02295150|Nadroparin|nadroparin
208991|NCT02295150|Anti-Xa activity|anti-xa activity
208992|NCT02295124|Nausea|nausea
208993|NCT02295111|electro-acupuncture|electro-acupuncture
208994|NCT02295111|chronic pelvic pain|chronic pelvic pain
208995|NCT02295111|patient practitioner interactions|patient practitioner interactions
208996|NCT02295111|TCM health consultation|tcm health consultation
208997|NCT02295111|meridian balanced method acupuncture|meridian balanced method acupuncture
208998|NCT02295085|Cohort, Prospective, Biospecimens|cohort, prospective, biospecimens
208999|NCT02295072|Exercise-based Randomized Controlled Trial|exercise-based randomized controlled trial
209000|NCT02295072|Brain structure|brain structure
209001|NCT02295072|Brain function|brain function
209002|NCT02295072|Cognitive function|cognitive function
209003|NCT02295072|Physical fitness|physical fitness
209004|NCT02295072|Body Mass Index|body mass index
209005|NCT02295072|Cardiovascular disease risk factors|cardiovascular disease risk factors
209006|NCT02295072|Mental health|mental health
209007|NCT02295072|Stress|stress
209008|NCT02295072|Neurology|neurology
209009|NCT02295072|Obesity|obesity
209010|NCT02295072|brain|brain
209011|NCT02295072|risk factors|risk factors
209012|NCT02295072|bone|bone
209013|NCT02295072|bones|bones
209014|NCT02295072|body composition|body composition
209015|NCT02295059|Breast cancer|breast cancer
209016|NCT02295059|ERPR negative|erpr negative
209017|NCT02295059|HER-2/neu overexpression positive or negative|her-2/neu overexpression positive or negative
209018|NCT02295033|Boost versus no boost irradiation of early breast cancer|boost versus no boost irradiation of early breast cancer
209019|NCT02294955|catheter ablation|catheter ablation
209020|NCT02294955|atrial fibrillation|atrial fibrillation
209021|NCT02294942|RNTA06|rnta06
209022|NCT02294942|RANCAD|rancad
209023|NCT02294929|catheter ablation|catheter ablation
209024|NCT02294929|cryoballoon|cryoballoon
209025|NCT02294903|Focal radiofrequency ablation|focal radiofrequency ablation
209026|NCT02294903|Prostate cancer|prostate cancer
209027|NCT02294903|Encage|encage
209028|NCT02294864|focus: pulsed radiofrequency (E02.779.468.599)|focus: pulsed radiofrequency (e02.779.468.599)
209029|NCT02294825|deep endometriosis;|deep endometriosis;
209030|NCT02294825|colorectal endometriosis|colorectal endometriosis
209031|NCT02294825|surgery|surgery
209032|NCT02294825|medical treatment|medical treatment
209033|NCT02294825|fertility|fertility
209034|NCT02294812|Hearing Loss|hearing loss
209035|NCT02294812|Speech Perception|speech perception
209036|NCT02294812|Cognitive Training|cognitive training
209037|NCT02294812|Cognitive Fitness|cognitive fitness
209038|NCT02294812|Memory, Short-Term|memory, short-term
209039|NCT02294799|Temporomandibular Joint Disorders|temporomandibular joint disorders
209040|NCT02294799|Magnetic Ressonance Imaging|magnetic ressonance imaging
209041|NCT02294799|Complementary Therapy|complementary therapy
209042|NCT02294799|Physical Therapy Modalities.|physical therapy modalities.
209043|NCT02294786|Randomised|randomised
209044|NCT02294786|Octreotide|octreotide
209045|NCT02294786|Diarrhoea|diarrhoea
209046|NCT02294786|Phase II|phase ii
209047|NCT02294786|Capecitabine|capecitabine
209048|NCT02294786|Quality of life|quality of life
209049|NCT02294786|Metastatic breast cancer|metastatic breast cancer
209050|NCT02294786|HER2|her2
209051|NCT02294786|Lapatinib|lapatinib
209052|NCT02294786|Diarrhoea diary|diarrhoea diary
209053|NCT02294773|Infertility|infertility
209054|NCT02294773|Intrauterine insemination|intrauterine insemination
209055|NCT02294773|Luteinizing hormone surge|luteinizing hormone surge
209056|NCT02294760|Irritable Bowel Syndrome|irritable bowel syndrome
209057|NCT02294760|Sacral Nerve Stimulation|sacral nerve stimulation
209058|NCT02294760|Symptoms|symptoms
209059|NCT02294760|Quality of Life|quality of life
209060|NCT02294734|functional respiratory capacity|functional respiratory capacity
209061|NCT02294734|High-resolution computed tomography|high-resolution computed tomography
209062|NCT02294734|GSK2269557|gsk2269557
209063|NCT02294734|acute exacerbation of COPD|acute exacerbation of copd
209064|NCT02294734|lung capacity|lung capacity
209065|NCT02294708|macula-off retinal detachment|macula-off retinal detachment
209066|NCT02294708|scleral buckle|scleral buckle
209067|NCT02294708|persistent sub-foveal fluid|persistent sub-foveal fluid
209068|NCT02294708|postoperative postures|postoperative postures
209069|NCT02294708|optical coherence tomography (OCT)|optical coherence tomography (oct)
209070|NCT02294695|Empiric antibiotic therapy|empiric antibiotic therapy
209071|NCT02294682|uncomplicated urogenital gonorrhea|uncomplicated urogenital gonorrhea
209072|NCT02294682|Bacterial Type II Topoisomerase Inhibitors (BTI)|bacterial type ii topoisomerase inhibitors (bti)
209073|NCT02294682|antibiotics|antibiotics
209074|NCT02294682|GSK2140944|gsk2140944
209075|NCT02294682|N. gonorrhoeae|n. gonorrhoeae
209076|NCT02294656|CYSTOID MACULAR EDEMA|cystoid macular edema
209077|NCT02294643|sarpogrelate|sarpogrelate
209078|NCT02294591|Bipolar Disorder|bipolar disorder
209079|NCT02294591|Depression|depression
209080|NCT02294591|Acetylcystein|acetylcystein
209081|NCT02294591|Oxidative Stress|oxidative stress
209082|NCT02294591|Urine|urine
209083|NCT02294578|Biomarkers|biomarkers
209084|NCT02294578|saliva|saliva
209085|NCT02294578|mRNA|mrna
209086|NCT02294565|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
209087|NCT02294565|Breast Cancer|breast cancer
209088|NCT02294565|Lymphatic Mapping|lymphatic mapping
209089|NCT02294552|Cyclophosphamide|cyclophosphamide
209090|NCT02294552|Leukemia|leukemia
209091|NCT02294552|Lymphoma|lymphoma
209092|NCT02294552|Myelodysplastic Syndromes|myelodysplastic syndromes
209093|NCT02294552|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
209094|NCT02294552|Immunosuppressive Agents|immunosuppressive agents
209095|NCT02294552|Immune System Diseases|immune system diseases
209096|NCT02294552|Busulfan|busulfan
209097|NCT02294552|Fludarabine|fludarabine
209098|NCT02294552|Tacrolimus|tacrolimus
209099|NCT02294552|Mycophenolate mofetil|mycophenolate mofetil
209100|NCT02294552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
209101|NCT02294552|Myeloablative Agonists|myeloablative agonists
209102|NCT02294552|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
209103|NCT02294552|Allogeneic|allogeneic
209104|NCT02294526|Diet|diet
209105|NCT02294526|Sardine|sardine
209106|NCT02294526|Type 2 diabetes|type 2 diabetes
209107|NCT02294513|Alzheimer disease|alzheimer disease
209108|NCT02294513|Dementia|dementia
209109|NCT02294513|Hearing loss|hearing loss
209110|NCT02294513|Correction of hearing impairment|correction of hearing impairment
209111|NCT02294513|Hearing aids|hearing aids
209112|NCT02294513|Communication|communication
209113|NCT02294513|Family caregivers|family caregivers
209114|NCT02294513|Third-party disability|third-party disability
209115|NCT02294500|ovarian function|ovarian function
209116|NCT02294500|female|female
209117|NCT02294500|Genital Function|genital function
209118|NCT02294487|influenza|influenza
209119|NCT02294487|pneumococcal|pneumococcal
209120|NCT02294487|pneumonia|pneumonia
209121|NCT02294487|vaccine|vaccine
209122|NCT02294487|immunization|immunization
209123|NCT02294487|#CAImmun|#caimmun
209124|NCT02294487|Immuno-oncology|immuno-oncology
209125|NCT02294487|supportive care|supportive care
209126|NCT02294487|vaccination|vaccination
209127|NCT02294487|meningococcal|meningococcal
209128|NCT02294487|HIB|hib
209129|NCT02294461|Enzalutamide|enzalutamide
209130|NCT02294461|Androgen receptor|androgen receptor
209131|NCT02294461|Prostate cancer|prostate cancer
209132|NCT02294461|Xtandi|xtandi
209133|NCT02294448|Cervical radiculopathy|cervical radiculopathy
209134|NCT02294448|Neck pain|neck pain
209135|NCT02294448|Qishe pill|qishe pill
209136|NCT02294448|raditional Chinese medicine|raditional chinese medicine
209137|NCT02294448|healthy Chinese subject|healthy chinese subject
209138|NCT02294448|Population Pharmacokinetics|population pharmacokinetics
209139|NCT02294448|Personalized Medicine|personalized medicine
209140|NCT02294448|Individualized Medicine|individualized medicine
209141|NCT02294435|Thoracoabdominal Aneurysms|thoracoabdominal aneurysms
209142|NCT02294435|Endovascular|endovascular
209143|NCT02294435|Ps-ide|ps-ide
209144|NCT02294435|Early Feasibility|early feasibility
209145|NCT02294435|Aneurysm|aneurysm
209146|NCT02294435|Aortic Aneurysm, Thoracic|aortic aneurysm, thoracic
209147|NCT02294435|Aortic Aneurysm|aortic aneurysm
209148|NCT02294435|Aortic Diseases|aortic diseases
209149|NCT02294435|Cardiovascular Diseases|cardiovascular diseases
209150|NCT02294435|Vascular Diseases|vascular diseases
209151|NCT02294435|Pararenal aneurysm|pararenal aneurysm
209152|NCT02294435|Juxtarenal aneurysm|juxtarenal aneurysm
209153|NCT02294435|Aortic dissection|aortic dissection
209154|NCT02294435|Short neck infrarenal aneurysm|short neck infrarenal aneurysm
209155|NCT02294435|Type 4 thoracoabdominal|type 4 thoracoabdominal
209156|NCT02294435|TAAA|taaa
209157|NCT02294422|Loss of resistance|loss of resistance
209158|NCT02294422|Pilot balloon|pilot balloon
209159|NCT02294422|Cuff pressure|cuff pressure
209160|NCT02294422|Endotracheal tube|endotracheal tube
209161|NCT02294409|social anxiety|social anxiety
209162|NCT02294409|psychosis|psychosis
209163|NCT02294409|CBT|cbt
209164|NCT02294409|randomized|randomized
209165|NCT02294409|CRT|crt
209166|NCT02294396|Anticholinergic|anticholinergic
209167|NCT02294396|Overactive Bladder (OAB)|overactive bladder (oab)
209168|NCT02294396|Mirabegron|mirabegron
209169|NCT02294396|YM178|ym178
209170|NCT02294383|Pelvic Floor Biomechanics|pelvic floor biomechanics
209171|NCT02294383|Tissue Elasticity|tissue elasticity
209172|NCT02294383|Tactile Imaging|tactile imaging
209173|NCT02294370|type 2 diabetes|type 2 diabetes
209174|NCT02294370|continuous glucose monitoring|continuous glucose monitoring
209175|NCT02294357|carfilzomib|carfilzomib
209176|NCT02294357|proteasome inhibitor|proteasome inhibitor
209177|NCT02294357|multiple myeloma|multiple myeloma
209178|NCT02294357|relapsed/refractory|relapsed/refractory
209179|NCT02294344|double filtration plasmapheresis|double filtration plasmapheresis
209180|NCT02294344|ANCA-Associated Vasculitis|anca-associated vasculitis
209181|NCT02294305|Depression|depression
209182|NCT02294305|Social Anxiety|social anxiety
209183|NCT02294305|Social Phobia|social phobia
209184|NCT02294305|Major Depression|major depression
209185|NCT02294305|Vortioxetine|vortioxetine
209186|NCT02294279|cough, wheeze, dyspnoea|cough, wheeze, dyspnoea
209187|NCT02294240|Pregnant, malnourished, energy dense biscuits, low birth weight|pregnant, malnourished, energy dense biscuits, low birth weight
209188|NCT02294227|AIN457, psoriatic arthritis, chronic inflammatory disease, loading regimen, secukinumab, self-injection|ain457, psoriatic arthritis, chronic inflammatory disease, loading regimen, secukinumab, self-injection
209189|NCT02294214|malaria|malaria
209190|NCT02294214|Spatial Repellents|spatial repellents
209191|NCT02294214|Plasmodium|plasmodium
209192|NCT02294201|Malaria|malaria
209193|NCT02294201|Spatial Repellents|spatial repellents
209194|NCT02294201|Plasmodium|plasmodium
209195|NCT02294188|Malaria|malaria
209196|NCT02294188|Spatial Repellents|spatial repellents
209197|NCT02294188|Plasmodium|plasmodium
209198|NCT02294175|larva|larva
209199|NCT02294175|debridement|debridement
209200|NCT02294175|lower extremity or diabetic foot ulcer|lower extremity or diabetic foot ulcer
209201|NCT02294175|biofilm|biofilm
209202|NCT02294175|infection|infection
209203|NCT02294175|chronic wound|chronic wound
209204|NCT02294149|chemotherapy|chemotherapy
209205|NCT02294149|Omega 3|omega 3
209206|NCT02294136|HIV|hiv
209207|NCT02294136|HCV|hcv
209208|NCT02294136|Adherence|adherence
209209|NCT02294136|Psychiatric|psychiatric
209210|NCT02294136|Behavioral|behavioral
209211|NCT02294136|Intervention|intervention
209212|NCT02294110|failure|failure
209213|NCT02294110|spinal anesthesia|spinal anesthesia
209214|NCT02294071|acetaminophen|acetaminophen
209215|NCT02294071|ibuprofen|ibuprofen
209216|NCT02294058|MS|ms
209217|NCT02294058|RMS|rms
209218|NCT02294058|Multiple Sclerosis|multiple sclerosis
209219|NCT02294058|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
209220|NCT02294045|Knee|knee
209221|NCT02294045|Healthy|healthy
209222|NCT02294045|arthroscopy|arthroscopy
209223|NCT02294045|MRI|mri
209224|NCT02294045|amplification|amplification
209225|NCT02294045|sounds|sounds
209226|NCT02294045|pre-operative|pre-operative
209227|NCT02294045|analyzing|analyzing
209228|NCT02294032|Bcells|bcells
209229|NCT02294032|kidney allograft dysfunction|kidney allograft dysfunction
209230|NCT02294032|antibody mediated rejection|antibody mediated rejection
209231|NCT02294019|ibuprofen 400 mg|ibuprofen 400 mg
209232|NCT02294019|actual use|actual use
209233|NCT02294019|compliance|compliance
209234|NCT02294006|pancreatic|pancreatic
209235|NCT02294006|neuroendocrine|neuroendocrine
209236|NCT02294006|everolimus|everolimus
209237|NCT02294006|metformin|metformin
209238|NCT02294006|octreotide|octreotide
209239|NCT02293941|liver inflammation|liver inflammation
209240|NCT02293928|Hybrid coronary revascularization|hybrid coronary revascularization
209241|NCT02293928|Antiplatelet therapy|antiplatelet therapy
209242|NCT02293928|Aspirin|aspirin
209243|NCT02293928|Clopidogrel|clopidogrel
209244|NCT02293889|Knee osteoarthritis|knee osteoarthritis
209245|NCT02293889|Pain|pain
209246|NCT02293889|Vitamin D|vitamin d
209247|NCT02293889|Physical activity|physical activity
209248|NCT02293889|Pilot study|pilot study
209249|NCT02293889|Qualitative Interview|qualitative interview
209250|NCT02293889|Obesity|obesity
209251|NCT02293889|Older adults|older adults
209252|NCT02293876|Corneal Diseases|corneal diseases
209253|NCT02293876|Corneal Ulcer|corneal ulcer
209254|NCT02293876|Nursing Diagnosis|nursing diagnosis
209255|NCT02293876|Intensive Care Units|intensive care units
209256|NCT02293876|Nursing|nursing
209257|NCT02293876|Randomized Clinical Trial|randomized clinical trial
209258|NCT02293837|interleukin-6 (IL-6) receptor inhibitor|interleukin-6 (il-6) receptor inhibitor
209259|NCT02293824|Infant, Premature|infant, premature
209260|NCT02293824|Caffeine|caffeine
209261|NCT02293824|Pharmacokinetics|pharmacokinetics
209262|NCT02293824|Metabolism|metabolism
209263|NCT02293772|Bedrest|bedrest
209264|NCT02293772|Appetite|appetite
209265|NCT02293759|BPH- LASER- PROSTATE- BLEEDING TENDENCY|bph- laser- prostate- bleeding tendency
209266|NCT02293746|Obstructive Sleep Apnea|obstructive sleep apnea
209267|NCT02293746|OSA|osa
209268|NCT02293746|neurostimulation|neurostimulation
209269|NCT02293746|hypoglossal nerve|hypoglossal nerve
209270|NCT02293746|tongue|tongue
209271|NCT02293746|upper airway stimulation|upper airway stimulation
209272|NCT02293746|surgery|surgery
209273|NCT02293733|Retrospective|retrospective
209274|NCT02293733|EGFR|egfr
209275|NCT02293733|mutation|mutation
209276|NCT02293733|TKI|tki
209277|NCT02293733|NSCLC|nsclc
209278|NCT02293707|Castration-resistant prostate cancer|castration-resistant prostate cancer
209279|NCT02293707|Therapeutic vaccine|therapeutic vaccine
209280|NCT02293707|Telomerase vaccine|telomerase vaccine
209281|NCT02293694|DMPA-SC: depo medroxyprogesterone acetate sub-cutaneous|dmpa-sc: depo medroxyprogesterone acetate sub-cutaneous
209282|NCT02293694|DMPA-IM: depo medroxyprogesterone acetate intramuscular|dmpa-im: depo medroxyprogesterone acetate intramuscular
209283|NCT02293681|Spondylitis, Ankylosing|spondylitis, ankylosing
209284|NCT02293681|Infliximab|infliximab
209285|NCT02293681|Non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
209286|NCT02293681|Disease-modifying anti-rheumatic drugs|disease-modifying anti-rheumatic drugs
209287|NCT02293668|poor responders|poor responders
209288|NCT02293655|ADHD|adhd
209289|NCT02293655|inattention|inattention
209290|NCT02293655|hyperactivity|hyperactivity
209291|NCT02293655|methylphenidate|methylphenidate
209292|NCT02293642|primary cancers of the breast|primary cancers of the breast
209293|NCT02293642|primary cancers of the kidney|primary cancers of the kidney
209294|NCT02293642|primary cancers of the lung|primary cancers of the lung
209295|NCT02293642|primary cancers of the prostate|primary cancers of the prostate
209296|NCT02293629|Subjects|subjects
209297|NCT02293616|ICU|icu
209298|NCT02293616|Respiratory Failure|respiratory failure
209299|NCT02293616|Weakness|weakness
209300|NCT02293616|Nitrate supplementation|nitrate supplementation
209301|NCT02293603|cardiomyopathy|cardiomyopathy
209302|NCT02293603|cardiosphere-derived stem cells|cardiosphere-derived stem cells
209303|NCT02293603|intracoronary infusion|intracoronary infusion
209304|NCT02293603|adult stem cells|adult stem cells
209305|NCT02293603|heart disease|heart disease
209407|NCT02293057|Adolescent|adolescent
209306|NCT02293603|ventricular dysfunction|ventricular dysfunction
209307|NCT02293603|pathological processes|pathological processes
209308|NCT02293603|cardiovascular diseases|cardiovascular diseases
209309|NCT02293603|heart failure|heart failure
209310|NCT02293590|Certolizumab pegol|certolizumab pegol
209311|NCT02293590|DMARD|dmard
209312|NCT02293590|Joint injection|joint injection
209313|NCT02293590|Glucocorticoids|glucocorticoids
209314|NCT02293564|Erosive Osteoarthritis|erosive osteoarthritis
209315|NCT02293564|Osteoarthritis|osteoarthritis
209316|NCT02293564|Osteoarthritis of the Hand|osteoarthritis of the hand
209317|NCT02293538|Symptoms of Contact Lens Related Discomfort|symptoms of contact lens related discomfort
209318|NCT02293512|Tinnitus|tinnitus
209319|NCT02293512|Coping|coping
209320|NCT02293512|Psychoeducational intervention|psychoeducational intervention
209321|NCT02293499|asthma|asthma
209322|NCT02293499|adolescent|adolescent
209323|NCT02293499|intervention|intervention
209324|NCT02293486|Antioxidants|antioxidants
209325|NCT02293486|Protein Carbonylation|protein carbonylation
209326|NCT02293486|Malondialdehyde|malondialdehyde
209327|NCT02293486|Punicaceae|punicaceae
209328|NCT02293486|Athletic Performance|athletic performance
209329|NCT02293460|Peripheral neuropathy|peripheral neuropathy
209330|NCT02293460|Disimmune disease|disimmune disease
209331|NCT02293460|Neurology Chronic disease|neurology chronic disease
209332|NCT02293460|Rare disease|rare disease
209333|NCT02293447|Uterine|uterine
209334|NCT02293447|Fibroid|fibroid
209335|NCT02293447|Embolization|embolization
209336|NCT02293447|Leiomyoma|leiomyoma
209337|NCT02293447|Lidocaine|lidocaine
209338|NCT02293447|Pain|pain
209339|NCT02293434|Malnutrition|malnutrition
209340|NCT02293434|Status Nutritional Weight|status nutritional weight
209341|NCT02293434|Pediatric intensive care|pediatric intensive care
209342|NCT02293408|MPS IIIB|mps iiib
209343|NCT02293408|Mucopolysaccharidosis|mucopolysaccharidosis
209344|NCT02293408|Mucopolysaccharidosis type IIIB|mucopolysaccharidosis type iiib
209345|NCT02293408|Sanfilippo Syndrome|sanfilippo syndrome
209346|NCT02293395|Acute Coronary Syndrome|acute coronary syndrome
209347|NCT02293395|Myocardial infarction|myocardial infarction
209348|NCT02293395|Unstable angina|unstable angina
209349|NCT02293395|Acetylsalicylic acid|acetylsalicylic acid
209350|NCT02293395|Rivaroxaban|rivaroxaban
209351|NCT02293395|JNJ-39039039|jnj-39039039
209352|NCT02293395|Bay 59-7939|bay 59-7939
209353|NCT02293395|Xarelto|xarelto
209354|NCT02293395|Clopidogrel|clopidogrel
209355|NCT02293395|Ticagrelor|ticagrelor
209356|NCT02293395|Plavix|plavix
209357|NCT02293395|Brilinta|brilinta
209358|NCT02293395|Effient|effient
209359|NCT02293382|MPS IIIB|mps iiib
209360|NCT02293382|Mucopolysaccharodosis III|mucopolysaccharodosis iii
209361|NCT02293382|Mucopolysaccharidosis type IIIB|mucopolysaccharidosis type iiib
209362|NCT02293382|Sanfilippo Syndrome|sanfilippo syndrome
209363|NCT02293343|histamine profile|histamine profile
209364|NCT02293343|IgE Antibodies|ige antibodies
209365|NCT02293330|continuous versus intermittent bolus sciatic nerve block|continuous versus intermittent bolus sciatic nerve block
209366|NCT02293317|Influenza Prime universal vaccine M-001 Multimeric|influenza prime universal vaccine m-001 multimeric
209367|NCT02293291|Gulf war illness|gulf war illness
209368|NCT02293278|MVPA|mvpa
209369|NCT02293278|sedentary behaviour|sedentary behaviour
209370|NCT02293278|PA intervention|pa intervention
209371|NCT02293278|preschool|preschool
209372|NCT02293278|gross motor|gross motor
209373|NCT02293278|anthropometrics|anthropometrics
209374|NCT02293278|day care|day care
209375|NCT02293265|mepolizumab|mepolizumab
209376|NCT02293265|omalizumab|omalizumab
209377|NCT02293265|SB-240563|sb-240563
209378|NCT02293265|Severe Asthma|severe asthma
209379|NCT02293265|reslizumab|reslizumab
209380|NCT02293252|Home Telemonitoring|home telemonitoring
209381|NCT02293239|whole-body electromyostimulation|whole-body electromyostimulation
209382|NCT02293239|cachexia|cachexia
209383|NCT02293239|cancer|cancer
209384|NCT02293239|skeletal muscle mass|skeletal muscle mass
209385|NCT02293239|nutrition|nutrition
209386|NCT02293213|Category D|category d
209387|NCT02293213|Category X|category x
209388|NCT02293213|Electronic Medical Records|electronic medical records
209389|NCT02293213|Long Acting Reversible Contraception|long acting reversible contraception
209390|NCT02293187|vitamin D|vitamin d
209391|NCT02293187|muscle performance|muscle performance
209392|NCT02293187|falls|falls
209393|NCT02293161|Interleukin-7 Receptor α|interleukin-7 receptor α
209394|NCT02293161|monoclonal antibody|monoclonal antibody
209395|NCT02293148|Prolyl hydroxylase inhibitor|prolyl hydroxylase inhibitor
209396|NCT02293148|GSK1278863|gsk1278863
209397|NCT02293148|Anemia|anemia
209398|NCT02293148|QTc|qtc
209399|NCT02293148|erythropoiesis stimulating agent|erythropoiesis stimulating agent
209400|NCT02293135|Type 2 diabetes ; endothelium stimulation|type 2 diabetes ; endothelium stimulation
209401|NCT02293122|Agreement|agreement
209402|NCT02293122|Repeatability|repeatability
209403|NCT02293122|Reproducibility|reproducibility
209404|NCT02293096|Genotype|genotype
209405|NCT02293096|CYP2D6|cyp2d6
209406|NCT02293096|ADRB1|adrb1
209408|NCT02293057|Juvenile Justice|juvenile justice
209409|NCT02293057|Drug Use|drug use
209410|NCT02293057|Marijuana|marijuana
209411|NCT02293057|Gender Responsive|gender responsive
209412|NCT02293057|Girls|girls
209413|NCT02293057|HIV|hiv
209414|NCT02293057|Sexual Risk|sexual risk
209415|NCT02293044|Sensitivity|sensitivity
209416|NCT02293031|maxillofacial bone defects|maxillofacial bone defects
209417|NCT02293031|alveolar ridge atrophy|alveolar ridge atrophy
209418|NCT02293031|gene-activated matrix|gene-activated matrix
209419|NCT02293031|VEGF gene|vegf gene
209420|NCT02293031|DNA plasmid|dna plasmid
209421|NCT02293031|bone gene therapy|bone gene therapy
209422|NCT02293005|Lung Cancer|lung cancer
209423|NCT02293005|Mesothelioma|mesothelioma
209424|NCT02293005|Unresectable malignant pleural mesothelioma|unresectable malignant pleural mesothelioma
209425|NCT02293005|MPM|mpm
209426|NCT02293005|Alisertib|alisertib
209427|NCT02293005|MLN8237|mln8237
209428|NCT02292992|Electrical impedance tomography|electrical impedance tomography
209429|NCT02292992|Nasal Pillow Continuous Positive Airway Pressure(CPAP)|nasal pillow continuous positive airway pressure(cpap)
209430|NCT02292992|High Flow Nasal Cannula|high flow nasal cannula
209431|NCT02292992|extubation|extubation
209432|NCT02292979|HL|hl
209433|NCT02292966|Hepatitis C|hepatitis c
209434|NCT02292966|Hepatitis|hepatitis
209435|NCT02292966|Asunaprevir|asunaprevir
209436|NCT02292966|Daclatasvir|daclatasvir
209437|NCT02292966|Beclabuvir|beclabuvir
209438|NCT02292966|Neurocognitive function|neurocognitive function
209439|NCT02292966|Brain metabolites|brain metabolites
209440|NCT02292966|Direct acting antiviral therapy|direct acting antiviral therapy
209441|NCT02292953|ICSI|icsi
209442|NCT02292953|Ovum Pickup|ovum pickup
209443|NCT02292953|Embryo Transfer|embryo transfer
209444|NCT02292940|patient outcome assessment|patient outcome assessment
209445|NCT02292940|electronic health records|electronic health records
209446|NCT02292888|Doppler VTI TEE SV volume responsiveness|doppler vti tee sv volume responsiveness
209447|NCT02292875|Grass Allergy|grass allergy
209448|NCT02292875|Rhinoconjunctivitis|rhinoconjunctivitis
209449|NCT02292875|Environmental Exposure Unit|environmental exposure unit
209450|NCT02292875|Immunotherapy|immunotherapy
209451|NCT02292875|ToleroMune Grass|toleromune grass
209452|NCT02292849|Depression|depression
209453|NCT02292823|STEMI|stemi
209454|NCT02292823|heart attack|heart attack
209455|NCT02292823|stent|stent
209456|NCT02292823|Bare Metal Stent|bare metal stent
209457|NCT02292823|myocardial infarction|myocardial infarction
209458|NCT02292823|PCI|pci
209459|NCT02292784|infants|infants
209460|NCT02292784|retosiban|retosiban
209461|NCT02292784|Preterm Labor|preterm labor
209462|NCT02292784|long-term safety follow-up|long-term safety follow-up
209463|NCT02292771|Spontaneous Preterm Labor|spontaneous preterm labor
209464|NCT02292771|retosiban|retosiban
209465|NCT02292771|GSK221149|gsk221149
209466|NCT02292771|atosiban|atosiban
209467|NCT02292745|locally advanced pancreatic cancer|locally advanced pancreatic cancer
209468|NCT02292745|chemotherapy|chemotherapy
209469|NCT02292745|stereotactic radiotherapy|stereotactic radiotherapy
209470|NCT02292732|Pharmacokinetics|pharmacokinetics
209471|NCT02292732|Solid Tumors|solid tumors
209472|NCT02292732|Safety|safety
209473|NCT02292732|Trametinib|trametinib
209474|NCT02292732|MEK Inhibitor|mek inhibitor
209475|NCT02292732|Combined Oral Contraceptive|combined oral contraceptive
209476|NCT02292732|Trametinib's Metabolite M5|trametinib's metabolite m5
209477|NCT02292732|Norethindrone|norethindrone
209478|NCT02292732|Ethinyl Estradiol|ethinyl estradiol
209479|NCT02292719|Hepatitis C Virus|hepatitis c virus
209480|NCT02292719|Genotype 2|genotype 2
209481|NCT02292719|Chronic Hepatitis C|chronic hepatitis c
209482|NCT02292719|Genotype 3|genotype 3
209483|NCT02292719|Non-cirrhotic|non-cirrhotic
209484|NCT02292719|Cirrhotic|cirrhotic
209485|NCT02292706|HCV Cirrhosis registry|hcv cirrhosis registry
209486|NCT02292706|Cirrhosis|cirrhosis
209487|NCT02292706|Hepatitis C|hepatitis c
209488|NCT02292693|intubation|intubation
209489|NCT02292680|dentin|dentin
209490|NCT02292680|environmental exposures|environmental exposures
209491|NCT02292680|neurodevelopmental outcomes|neurodevelopmental outcomes
209492|NCT02292667|Transversus Abdominis Plane Block|transversus abdominis plane block
209493|NCT02292667|Postoperative Pain Management|postoperative pain management
209494|NCT02292667|Open Repair of Aortic Abdominal Aneurysm|open repair of aortic abdominal aneurysm
209495|NCT02292641|Lower Gastrointestinal Tract|lower gastrointestinal tract
209496|NCT02292641|Rectum|rectum
209497|NCT02292641|Diagnostic Imaging|diagnostic imaging
209498|NCT02292641|Magnetic Resonance Imaging|magnetic resonance imaging
209499|NCT02292641|Pelvic Exenteration|pelvic exenteration
209500|NCT02292641|Neoplasms|neoplasms
209501|NCT02292641|Adenocarcinoma|adenocarcinoma
209502|NCT02292641|Carcinoma|carcinoma
209503|NCT02292602|preschool|preschool
209504|NCT02292602|obesity|obesity
209505|NCT02292602|health disparities|health disparities
209506|NCT02292602|intervention|intervention
209507|NCT02292589|Traumatic Brain Injury|traumatic brain injury
209508|NCT02292589|Post concussion syndrome|post concussion syndrome
209509|NCT02292589|Transcranial Direct Current Stimulation|transcranial direct current stimulation
209510|NCT02292589|Neuromodulation|neuromodulation
209511|NCT02292576|volunteers|volunteers
209512|NCT02292563|Nurse; Colonoscopy; Polyp; Adenoma;|nurse; colonoscopy; polyp; adenoma;
209513|NCT02292550|Non-small cell lung cancer,|non-small cell lung cancer,
209514|NCT02292550|ALK translocation,|alk translocation,
209515|NCT02292550|ALK-positive,|alk-positive,
209516|NCT02292550|NSCLC,|nsclc,
209517|NCT02292550|LEE011,|lee011,
209518|NCT02292550|CDK4/6 inhibitor,|cdk4/6 inhibitor,
209519|NCT02292550|EML4-ALK|eml4-alk
209520|NCT02292537|Spinal Muscular Atrophy|spinal muscular atrophy
209521|NCT02292537|SMA|sma
209522|NCT02292537|SMN|smn
209523|NCT02292537|SMNRx|smnrx
209524|NCT02292537|ISIS-SMNRx|isis-smnrx
209525|NCT02292537|ISIS-SMN Rx|isis-smn rx
209526|NCT02292537|ISIS 396443|isis 396443
209527|NCT02292537|CHERISH|cherish
209528|NCT02292537|IONIS-SMNRx|ionis-smnrx
209529|NCT02292537|IONIS-SMN Rx|ionis-smn rx
209530|NCT02292511|subjective cognitive impairment|subjective cognitive impairment
209531|NCT02292511|mind-motor intervention|mind-motor intervention
209532|NCT02292511|square-stepping exercise|square-stepping exercise
209533|NCT02292511|older adults|older adults
209534|NCT02292498|imaging, diagnostic|imaging, diagnostic
209535|NCT02292498|feasibility|feasibility
209536|NCT02292485|Lung Cancer Screening|lung cancer screening
209537|NCT02292485|LCS|lcs
209538|NCT02292485|Survey|survey
209539|NCT02292485|Questionnaire|questionnaire
209540|NCT02292485|Texas Academy of Family Physicians|texas academy of family physicians
209541|NCT02292472|masticatory muscles|masticatory muscles
209542|NCT02292446|Polycythemia Vera|polycythemia vera
209543|NCT02292446|Hematologic Diseases|hematologic diseases
209544|NCT02292446|Myeloproliferative Disorders|myeloproliferative disorders
209545|NCT02292446|INC424|inc424
209546|NCT02292446|Ruxolitinib|ruxolitinib
209547|NCT02292433|Phase 1|phase 1
209548|NCT02292433|type 2 diabetes|type 2 diabetes
209549|NCT02292433|monotherapy|monotherapy
209550|NCT02292433|PF-04937319|pf-04937319
209551|NCT02292420|pulse oximetry plethymographic waveform|pulse oximetry plethymographic waveform
209552|NCT02292420|area under curve|area under curve
209553|NCT02292420|amplitude|amplitude
209554|NCT02292394|Depression|depression
209555|NCT02292394|Depressive symptoms|depressive symptoms
209556|NCT02292394|Prevention|prevention
209557|NCT02292394|Caregivers|caregivers
209558|NCT02292394|Telephone intervention|telephone intervention
209559|NCT02292368|Head and Neck Cancer|head and neck cancer
209560|NCT02292368|Xerostomia|xerostomia
209561|NCT02292368|Radiation-induced Xerostomia|radiation-induced xerostomia
209562|NCT02292368|Acupuncture|acupuncture
209563|NCT02292368|Nasopharyngeal cancer|nasopharyngeal cancer
209564|NCT02292368|Radiation therapy|radiation therapy
209565|NCT02292368|XRT|xrt
209566|NCT02292368|Electroencephalogram|electroencephalogram
209567|NCT02292368|EEG|eeg
209568|NCT02292368|Xerostomia questionnaire|xerostomia questionnaire
209569|NCT02292368|XQ|xq
209570|NCT02292368|MD Anderson Symptom Inventory - Head & Neck|md anderson symptom inventory - head & neck
209571|NCT02292368|MDASI-HN|mdasi-hn
209572|NCT02292368|Questionnaires|questionnaires
209573|NCT02292368|Surveys|surveys
209574|NCT02292355|Temporomandibular Joint Disorders|temporomandibular joint disorders
209575|NCT02292355|posture|posture
209576|NCT02292355|pain|pain
209577|NCT02292355|clinical trial|clinical trial
209578|NCT02292355|Pilates|pilates
209579|NCT02292342|Flow mediated dilatation|flow mediated dilatation
209580|NCT02292329|flow-mediated dilation|flow-mediated dilation
209581|NCT02292329|Acai polyphenols|acai polyphenols
209582|NCT02292316|middle-aged and aged adults|middle-aged and aged adults
209583|NCT02292316|fall in the previous year|fall in the previous year
209584|NCT02292303|Zinc/pharmacokinetics|zinc/pharmacokinetics
209585|NCT02292290|Diabetes|diabetes
209586|NCT02292290|Liraglutide|liraglutide
209587|NCT02292290|Ramadan|ramadan
209588|NCT02292290|fasting|fasting
209589|NCT02292277|Ticagrelor|ticagrelor
209590|NCT02292277|Pharmacokinetics|pharmacokinetics
209591|NCT02292277|Platelet Aggregation|platelet aggregation
209592|NCT02292277|Platelet Function Tests|platelet function tests
209593|NCT02292251|Stroke|stroke
209594|NCT02292251|Transcranial direct current stimulation|transcranial direct current stimulation
209595|NCT02292238|Alzheimer's disease|alzheimer's disease
209596|NCT02292238|benfotiamine|benfotiamine
209597|NCT02292238|glucose|glucose
209598|NCT02292238|Amyloid|amyloid
209599|NCT02292225|Phase 1b, CLL/SLL, PI3K|phase 1b, cll/sll, pi3k
209600|NCT02292199|Hypertension|hypertension
209601|NCT02292199|TENS|tens
209602|NCT02292199|Sympathetic and Parasympathetic nervous system|sympathetic and parasympathetic nervous system
209603|NCT02292186|Cardiomyopathy|cardiomyopathy
209604|NCT02292186|Heart Failure|heart failure
209605|NCT02292186|FAC|fac
209606|NCT02292186|Amyloid|amyloid
209607|NCT02292186|Transthyretin|transthyretin
209608|NCT02292186|TTR|ttr
209609|NCT02292186|RNAi therapeutic|rnai therapeutic
209610|NCT02292173|Liver Neoplasms|liver neoplasms
209611|NCT02292173|Liver Diseases|liver diseases
209612|NCT02292173|Digestive System Diseases|digestive system diseases
209613|NCT02292173|Advanced|advanced
209614|NCT02292173|Mitogen-Activated Protein Kinase (MEK) Inhibitor|mitogen-activated protein kinase (mek) inhibitor
209615|NCT02292173|Kinase Inhibitor|kinase inhibitor
209616|NCT02292147|Cerebral anoxia|cerebral anoxia
209617|NCT02292147|Functional outcome|functional outcome
209618|NCT02292134|Sleep quality|sleep quality
209619|NCT02292134|Sleep architecture|sleep architecture
209620|NCT02292134|Intensive care unit|intensive care unit
209621|NCT02292134|Light|light
209622|NCT02292134|Noise|noise
209623|NCT02292134|Earplug|earplug
209624|NCT02292134|Sleep mask|sleep mask
209625|NCT02292121|Obesity|obesity
209626|NCT02292121|Intestinal permeability|intestinal permeability
209627|NCT02292121|Adipose tissue inflammation|adipose tissue inflammation
209628|NCT02292121|Low grade systemic inflammation|low grade systemic inflammation
209629|NCT02292121|Bariatric surgery|bariatric surgery
209630|NCT02292108|Hypnosis|hypnosis
209631|NCT02292108|self-hypnosis|self-hypnosis
209632|NCT02292108|obesity|obesity
209633|NCT02292108|high food impulsiveness|high food impulsiveness
209634|NCT02292095|anesthesia|anesthesia
209635|NCT02292095|transverse abdominis plane block|transverse abdominis plane block
209636|NCT02292095|patient controlled intravenous analgesia|patient controlled intravenous analgesia
209637|NCT02292082|Nerve Block|nerve block
209638|NCT02292082|Rehabilitation|rehabilitation
209639|NCT02292082|Knee Replacement, Total|knee replacement, total
209640|NCT02291991|Safety|safety
209641|NCT02291991|Tolerability|tolerability
209642|NCT02291991|Pharmacokinetics|pharmacokinetics
209643|NCT02291991|Pharmacodynamics|pharmacodynamics
209644|NCT02291991|Immunogenecity|immunogenecity
209645|NCT02291978|back pain|back pain
209646|NCT02291978|facet joint|facet joint
209647|NCT02291978|spine|spine
209648|NCT02291965|hematopoietic cell transplant|hematopoietic cell transplant
209649|NCT02291952|Circadian Misalignment, Forced Desynchrony, Metabolism, Meal-timing, Circadian|circadian misalignment, forced desynchrony, metabolism, meal-timing, circadian
209650|NCT02291926|Human Umbilical Cord Mesenchymal Stem Cell|human umbilical cord mesenchymal stem cell
209651|NCT02291926|Mesenchymal Stem Cell|mesenchymal stem cell
209652|NCT02291926|Osteoarthritis|osteoarthritis
209653|NCT02291913|ER-Positive Breast Cancer|er-positive breast cancer
209654|NCT02291913|HER2-Negative Breast Cancer|her2-negative breast cancer
209655|NCT02291913|everolimus|everolimus
209656|NCT02291913|anti-estrogen therapy|anti-estrogen therapy
209657|NCT02291913|PR-Positive Breast Cancer|pr-positive breast cancer
209658|NCT02291913|Afinitor|afinitor
209659|NCT02291900|avascular necrosis, talus, medial femoral condyle|avascular necrosis, talus, medial femoral condyle
209660|NCT02291874|Diabetes|diabetes
209661|NCT02291874|Ipragliflozin|ipragliflozin
209662|NCT02291874|GLP-1 receptor agonist|glp-1 receptor agonist
209663|NCT02291861|Dyskinesias|dyskinesias
209664|NCT02291861|Movement Disorders|movement disorders
209665|NCT02291861|Central Nervous System Diseases|central nervous system diseases
209666|NCT02291861|Nervous System Diseases|nervous system diseases
209667|NCT02291861|Neurologic Manifestations|neurologic manifestations
209668|NCT02291861|Signs and Symptoms|signs and symptoms
209669|NCT02291848|Multiple Myeloma|multiple myeloma
209670|NCT02291848|Cytotoxic T-lymphocytes|cytotoxic t-lymphocytes
209671|NCT02291809|HIV/AIDS|hiv/aids
209672|NCT02291809|Pediatric|pediatric
209673|NCT02291809|Vaccine|vaccine
209674|NCT02291809|HIV-1 Immunogen|hiv-1 immunogen
209675|NCT02291796|Bezafibrate|bezafibrate
209676|NCT02291796|Hyperfibrinogenemia|hyperfibrinogenemia
209677|NCT02291796|Inflammatory response|inflammatory response
209678|NCT02291796|Acute myocardial infarction|acute myocardial infarction
209679|NCT02291796|Mayor cardiovascular events|mayor cardiovascular events
209680|NCT02291770|Chronic Graft-Versus-Host Disease|chronic graft-versus-host disease
209681|NCT02291770|Mesenchymal Stromal Cells|mesenchymal stromal cells
209682|NCT02291744|TFS (time to failure of strategy)|tfs (time to failure of strategy)
209683|NCT02291731|Autologous serum eye drops|autologous serum eye drops
209684|NCT02291731|Silicone-hydrogel contact lens|silicone-hydrogel contact lens
209685|NCT02291731|Persistent epithelial defects|persistent epithelial defects
209686|NCT02291731|Corneal epithelial defects|corneal epithelial defects
209687|NCT02291718|Suspected or confirmed|suspected or confirmed
209688|NCT02291718|TAA|taa
209689|NCT02291718|Computed tomography angiography|computed tomography angiography
209690|NCT02291718|CTA|cta
209691|NCT02291718|Contrast agent|contrast agent
209692|NCT02291718|Radiation dose|radiation dose
209693|NCT02291718|Thoracoabdominal aortic aneurysm|thoracoabdominal aortic aneurysm
209694|NCT02291705|Ultrasound, rectus sheath block, children, inguinal hernia|ultrasound, rectus sheath block, children, inguinal hernia
209695|NCT02291666|Cytochromes p450|cytochromes p450
209696|NCT02291666|drug metabolism|drug metabolism
209697|NCT02291666|pharmacokinetics|pharmacokinetics
209698|NCT02291666|diabetes|diabetes
209699|NCT02291666|probe markers|probe markers
209700|NCT02291614|Amgen|amgen
209701|NCT02291614|Phase 1|phase 1
209702|NCT02291614|Clinical Trial|clinical trial
209703|NCT02291614|Oncology|oncology
209704|NCT02291614|GI adenocarcinoma|gi adenocarcinoma
209705|NCT02291614|Immunotherapy|immunotherapy
209706|NCT02291536|THC and CBD|thc and cbd
209707|NCT02291536|Attentional blink|attentional blink
209708|NCT02291523|Fecal transplant|fecal transplant
209709|NCT02291484|Computed tomography|computed tomography
209710|NCT02291484|Coronary angiography|coronary angiography
209711|NCT02291484|Coronary artery disease|coronary artery disease
209712|NCT02291484|Perfusion imaging|perfusion imaging
209713|NCT02291484|Comparative effectiveness|comparative effectiveness
209714|NCT02291484|Randomized controlled trial|randomized controlled trial
209715|NCT02291484|Cost-effectiveness|cost-effectiveness
209716|NCT02291445|Peppermint oil|peppermint oil
209717|NCT02291445|Menthol|menthol
209718|NCT02291445|Volatile oil|volatile oil
209719|NCT02291445|Plant oil|plant oil
209720|NCT02291445|Visceral pain|visceral pain
209721|NCT02291445|Abdominal pain|abdominal pain
209722|NCT02291445|Irritable bowel syndrome (IBS)|irritable bowel syndrome (ibs)
209723|NCT02291445|Colonic disease|colonic disease
209724|NCT02291419|ticagrelor|ticagrelor
209725|NCT02291419|non-cardiac surgery|non-cardiac surgery
209726|NCT02291419|elevated troponin|elevated troponin
209727|NCT02291419|myocardial injury|myocardial injury
209728|NCT02291406|Hysterectomy|hysterectomy
209729|NCT02291406|Insulin resistance|insulin resistance
209730|NCT02291406|Metabolism|metabolism
209731|NCT02291380|Chronic Migraine|chronic migraine
209732|NCT02291380|Botulinum Toxin Type A for Injection|botulinum toxin type a for injection
209733|NCT02291354|Fecal Microbiota Transplantation|fecal microbiota transplantation
209734|NCT02291354|Soluble Dietary Fiber|soluble dietary fiber
209735|NCT02291354|Slow Transit Constipation|slow transit constipation
209736|NCT02291315|Triple Stable Isotope|triple stable isotope
209737|NCT02291263|Polio|polio
209738|NCT02291263|Inactivated polio vaccine|inactivated polio vaccine
209739|NCT02291263|IPV|ipv
209740|NCT02291263|oral polio vaccine|oral polio vaccine
209741|NCT02291250|anthocyanin|anthocyanin
209742|NCT02291250|blackcurrant|blackcurrant
209743|NCT02291250|greencurrant|greencurrant
209744|NCT02291250|glucose|glucose
209745|NCT02291250|polyphenol|polyphenol
209746|NCT02291250|post prandial glucose|post prandial glucose
209747|NCT02291237|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
209748|NCT02291237|hcm|hcm
209749|NCT02291237|hocm|hocm
209750|NCT02291237|hypertrophic myocardiopathy|hypertrophic myocardiopathy
209751|NCT02291237|hypertrophic obstructive cardiomyopathies|hypertrophic obstructive cardiomyopathies
209752|NCT02291237|cardiomyopathy|cardiomyopathy
209753|NCT02291237|hypertrophic|hypertrophic
209754|NCT02291237|familial hypertrophic cardiomyopathy|familial hypertrophic cardiomyopathy
209755|NCT02291237|genetic heart disease|genetic heart disease
209756|NCT02291237|echocardiography|echocardiography
209757|NCT02291237|cardiopulmonary exercise testing|cardiopulmonary exercise testing
209758|NCT02291237|exercise Capacity|exercise capacity
209759|NCT02291237|heart failure|heart failure
209760|NCT02291237|angina|angina
209761|NCT02291237|dyspnea|dyspnea
209762|NCT02291237|diastolic dysfunction|diastolic dysfunction
209763|NCT02291237|microvascular ischemia|microvascular ischemia
209764|NCT02291237|late sodium current inhibitor|late sodium current inhibitor
209765|NCT02291237|GS-6615|gs-6615
209766|NCT02291237|late INA|late ina
209767|NCT02291224|dual protection|dual protection
209768|NCT02291224|pregnancy|pregnancy
209769|NCT02291224|reproductive health|reproductive health
209770|NCT02291224|sexually transmitted diseases|sexually transmitted diseases
209771|NCT02291224|condoms|condoms
209772|NCT02291224|contraception|contraception
209773|NCT02291224|adolescent health services|adolescent health services
209774|NCT02291198|colorectal cancer|colorectal cancer
209775|NCT02291198|natural killer cell activity|natural killer cell activity
209776|NCT02291198|screening|screening
209777|NCT02291198|NK cells|nk cells
209778|NCT02291159|stroke|stroke
209779|NCT02291159|spasticity|spasticity
209780|NCT02291159|dry needling|dry needling
209781|NCT02291159|upper motor neuron syndrome|upper motor neuron syndrome
209782|NCT02291159|motor function|motor function
209783|NCT02291146|gardening|gardening
209784|NCT02291146|cooking|cooking
209785|NCT02291146|nutrition education|nutrition education
209786|NCT02291146|Hispanic Americans|hispanic americans
209787|NCT02291133|Primary liver tumors|primary liver tumors
209788|NCT02291133|Bleomycin|bleomycin
209789|NCT02291133|Electrochemotherapy|electrochemotherapy
209790|NCT02291107|Gait orthosis|gait orthosis
209791|NCT02291107|Lokomat|lokomat
209792|NCT02291107|Robotic Rehabilitation|robotic rehabilitation
209793|NCT02291094|Intravenous lidocaine|intravenous lidocaine
209794|NCT02291094|Mastectomy|mastectomy
209795|NCT02291094|Pain|pain
209796|NCT02291081|HIV, AIDS|hiv, aids
209797|NCT02291081|antiretroviral therapy|antiretroviral therapy
209798|NCT02291081|aging|aging
209799|NCT02291081|heart failure|heart failure
209800|NCT02291081|coronary heart disease|coronary heart disease
209801|NCT02291081|myocardial infarction|myocardial infarction
209802|NCT02291081|HIV-associated neurocognitive disorders|hiv-associated neurocognitive disorders
209803|NCT02291042|Bladder|bladder
209804|NCT02291042|Surgery|surgery
210577|NCT02286648|child|child
209805|NCT02291029|Sjögren's syndrome, CFZ533, ESSDAI|sjögren's syndrome, cfz533, essdai
209806|NCT02291016|COPD|copd
209807|NCT02291016|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
209808|NCT02291003|circadian|circadian
209809|NCT02291003|sleep|sleep
209810|NCT02290977|RT, TACE|rt, tace
209811|NCT02290964|Acute normovolemic hemodilution|acute normovolemic hemodilution
209812|NCT02290964|allogeneic transfusion|allogeneic transfusion
209813|NCT02290938|adolescents|adolescents
209814|NCT02290938|Native American|native american
209815|NCT02290938|alcohol use|alcohol use
209816|NCT02290938|drug use|drug use
209817|NCT02290938|cultural|cultural
209818|NCT02290938|traditional activities|traditional activities
209819|NCT02290938|cultural identification|cultural identification
209820|NCT02290925|biscuit containing Salacia reticulate|biscuit containing salacia reticulate
209821|NCT02290925|randomised controlled trial|randomised controlled trial
209822|NCT02290912|Alzheimer's disease prevention lifestyle intervention|alzheimer's disease prevention lifestyle intervention
209823|NCT02290899|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
209824|NCT02290886|safety evaluation|safety evaluation
209825|NCT02290886|intravenous administration|intravenous administration
209826|NCT02290886|3 doses of autologous MSC|3 doses of autologous msc
209827|NCT02290886|ALS|als
209828|NCT02290834|Chemotherapy related cognitive impairment|chemotherapy related cognitive impairment
209829|NCT02290834|Chemo-brain|chemo-brain
209830|NCT02290808|physical|physical
209831|NCT02290808|activity|activity
209832|NCT02290808|exercise|exercise
209833|NCT02290808|new-parents|new-parents
209834|NCT02290808|intervention|intervention
209835|NCT02290808|theory-based|theory-based
209836|NCT02290795|Vitreopapillary traction|vitreopapillary traction
209837|NCT02290782|toxicity|toxicity
209838|NCT02290782|outcome|outcome
209839|NCT02290782|TARGIT|targit
209840|NCT02290782|quality of life|quality of life
209841|NCT02290782|intraoperative radiotherapy (IORT)|intraoperative radiotherapy (iort)
209842|NCT02290769|Guide wire cannulation ERCP|guide wire cannulation ercp
209843|NCT02290769|Time of cannulation|time of cannulation
209844|NCT02290769|Rapid exchange guide wire|rapid exchange guide wire
209845|NCT02290769|Guide wire|guide wire
209846|NCT02290756|Early child development|early child development
209847|NCT02290756|Link Workers|link workers
209848|NCT02290756|Community Birth attendants|community birth attendants
209849|NCT02290756|Parenting Program|parenting program
209850|NCT02290730|Lower trapezius|lower trapezius
209851|NCT02290730|Kinesio taping|kinesio taping
209852|NCT02290717|ultraviolet therapy|ultraviolet therapy
209853|NCT02290717|non segmental|non segmental
209854|NCT02290717|vitiligo|vitiligo
209855|NCT02290717|topical corticosteroid|topical corticosteroid
209856|NCT02290717|laser|laser
209857|NCT02290717|fractional|fractional
209858|NCT02290717|CO2|co2
209859|NCT02290717|carbon dioxide|carbon dioxide
209860|NCT02290717|UVB|uvb
209861|NCT02290704|oxygen saturation|oxygen saturation
209862|NCT02290704|retinal vessels|retinal vessels
209863|NCT02290704|thyroid associated ophthalmopathy|thyroid associated ophthalmopathy
209864|NCT02290691|Needle Free, Influenza|needle free, influenza
209865|NCT02290678|Pilot Study|pilot study
209866|NCT02290678|Adventure-based Programming|adventure-based programming
209867|NCT02290665|enema|enema
209868|NCT02290652|Sexual function in Orthopaedic patients|sexual function in orthopaedic patients
209869|NCT02290639|Posttraumatic Stress|posttraumatic stress
209870|NCT02290639|Posttraumatic Stress Disorder|posttraumatic stress disorder
209871|NCT02290639|Military|military
209872|NCT02290639|Primary Care|primary care
209873|NCT02290639|Cognitive Behavioral Therapy|cognitive behavioral therapy
209874|NCT02290639|Prolonged Exposure|prolonged exposure
209875|NCT02290639|Cognitive Processing Therapy|cognitive processing therapy
209876|NCT02290639|Behavioral Health Optimization Program|behavioral health optimization program
209877|NCT02290639|Behavioral Health Consultant|behavioral health consultant
209878|NCT02290626|Elemental diet|elemental diet
209879|NCT02290626|semi-solid diet|semi-solid diet
209880|NCT02290626|gastric emptying|gastric emptying
209881|NCT02290626|GER|ger
209882|NCT02290626|PEG|peg
209883|NCT02290613|pulmonary hypertension|pulmonary hypertension
209884|NCT02290613|systemic sclerosis|systemic sclerosis
209885|NCT02290587|social cognitive|social cognitive
209886|NCT02290587|theory of mind|theory of mind
209887|NCT02290587|cognitive impairment|cognitive impairment
209888|NCT02290587|functional MRI|functional mri
209889|NCT02290587|brain activation network|brain activation network
209890|NCT02290561|Prostatic Neoplasms|prostatic neoplasms
209891|NCT02290561|Therapeutics|therapeutics
209892|NCT02290561|Magnetic Resonance Imaging|magnetic resonance imaging
209893|NCT02290561|Ultrasonography|ultrasonography
209894|NCT02290561|High Intensity Focused Ultrasound|high intensity focused ultrasound
209895|NCT02290561|Image Fusion|image fusion
209896|NCT02290548|high flow nasal cannula|high flow nasal cannula
209897|NCT02290548|extubation failure|extubation failure
209898|NCT02290535|obstructive pulmonary disease|obstructive pulmonary disease
209899|NCT02290535|children|children
209900|NCT02290535|teenager|teenager
209901|NCT02290535|EIT (Electrical Impedance Tomography)|eit (electrical impedance tomography)
209902|NCT02290496|Insomnia|insomnia
209903|NCT02290496|Depression|depression
209904|NCT02290496|Teen|teen
209905|NCT02290496|SSRI|ssri
209906|NCT02290496|CBT|cbt
209907|NCT02290496|Youth|youth
209908|NCT02290470|Nausea|nausea
209909|NCT02290470|Vomiting|vomiting
209910|NCT02290457|resistance training|resistance training
209911|NCT02290457|trunk muscle strength|trunk muscle strength
209912|NCT02290457|physical fitness|physical fitness
209913|NCT02290457|adolescent|adolescent
209914|NCT02290444|Acute Relapsing Multiple Sclerosis|acute relapsing multiple sclerosis
209915|NCT02290444|Relapsing-Remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
209916|NCT02290444|Multiple Sclerosis, Chronic Progressive|multiple sclerosis, chronic progressive
209917|NCT02290431|LBH589,|lbh589,
209918|NCT02290431|panobinostat,|panobinostat,
209919|NCT02290431|bortezomib,|bortezomib,
209920|NCT02290431|dexamethasone,|dexamethasone,
209921|NCT02290431|Phase II|phase ii
209922|NCT02290418|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
209923|NCT02290418|Omega-Loop Gastric Bypass|omega-loop gastric bypass
209924|NCT02290418|"Mini-Gastric Bypass"|"mini-gastric bypass"
209925|NCT02290405|insomnia|insomnia
209926|NCT02290405|primary insomnia|primary insomnia
209927|NCT02290405|chronic insomnia|chronic insomnia
209928|NCT02290392|African American|african american
209929|NCT02290392|Environmental Factor|environmental factor
209930|NCT02290392|Transcriptome|transcriptome
209931|NCT02290392|Cardiovascular Disease|cardiovascular disease
209932|NCT02290392|Hypertension|hypertension
209933|NCT02290353|Engagement|engagement
209934|NCT02290353|Motivation|motivation
209935|NCT02290353|Exergaming|exergaming
209936|NCT02290340|Respiratory Syncytial Virus, RSV|respiratory syncytial virus, rsv
209937|NCT02290327|Stress ulcer bleeding|stress ulcer bleeding
209938|NCT02290327|proton pump inhibitors|proton pump inhibitors
209939|NCT02290327|pneumonia|pneumonia
209940|NCT02290327|clostridium difficile infection|clostridium difficile infection
209941|NCT02290262|Heart disease|heart disease
209942|NCT02290262|Phase one rehabilitation|phase one rehabilitation
209943|NCT02290223|Chronic pain|chronic pain
209944|NCT02290223|Analgesics, Opioid|analgesics, opioid
209945|NCT02290223|Cognitive Therapy|cognitive therapy
209946|NCT02290223|Behavior Therapy|behavior therapy
209947|NCT02290223|Mindfulness|mindfulness
209948|NCT02290223|Psychophysiology|psychophysiology
209949|NCT02290223|Biofeedback, Psychology|biofeedback, psychology
209950|NCT02290184|type 2 diabetes|type 2 diabetes
209951|NCT02290184|cardiovascular disease prevention|cardiovascular disease prevention
209952|NCT02290184|lifestyle intervention|lifestyle intervention
209953|NCT02290184|physical activity|physical activity
209954|NCT02290184|weight loss|weight loss
209955|NCT02290184|nutrition|nutrition
209956|NCT02290184|Filipinos|filipinos
209957|NCT02290184|culturally appropriate|culturally appropriate
209958|NCT02290158|treatment outcomes|treatment outcomes
209959|NCT02290158|Malocclusion/therapy|malocclusion/therapy
209960|NCT02290145|docetaxel, cisplatin, 5-FU, cyclinD1|docetaxel, cisplatin, 5-fu, cyclind1
209961|NCT02290132|acute lymphoblastic leukemia|acute lymphoblastic leukemia
209962|NCT02290132|lymphoblastic lymphoma|lymphoblastic lymphoma
209963|NCT02290132|stem-cell transplant|stem-cell transplant
209964|NCT02290132|T-cell lymphoma|t-cell lymphoma
209965|NCT02290119|Primary PCL-retaining Total Knee Arthroplasty|primary pcl-retaining total knee arthroplasty
209966|NCT02290119|Intraoperative Sensors|intraoperative sensors
209967|NCT02290119|Ligament Balancing|ligament balancing
209968|NCT02290119|Clinical Outcomes|clinical outcomes
209969|NCT02290106|obesity|obesity
209970|NCT02290106|insulin sensitivity|insulin sensitivity
209971|NCT02290106|statin (HMG-CoA Reductase Inhibitor)|statin (hmg-coa reductase inhibitor)
209972|NCT02290106|fatty liver|fatty liver
209973|NCT02290093|Cathartics|cathartics
209974|NCT02290093|Colonoscopy|colonoscopy
209975|NCT02290093|Polyethylene Glycols|polyethylene glycols
209976|NCT02290093|Elderly|elderly
209977|NCT02290080|acute myocardial infarction (AMI)|acute myocardial infarction (ami)
209978|NCT02290080|acute coronary syndrome (ACS)|acute coronary syndrome (acs)
209979|NCT02290080|ST-segment elevation myocardial infarction (STEMI)|st-segment elevation myocardial infarction (stemi)
209980|NCT02290080|Non ST-segment elevation myocardial infarction (NSTEMI)|non st-segment elevation myocardial infarction (nstemi)
209981|NCT02290080|Ischemic Reperfusion injury (IR-injury)|ischemic reperfusion injury (ir-injury)
209982|NCT02290080|Biomarkers|biomarkers
209983|NCT02290080|Oxygen|oxygen
209984|NCT02290080|Apoptosis|apoptosis
209985|NCT02290080|Fluorescence-activated cell sorting (FACS)|fluorescence-activated cell sorting (facs)
209986|NCT02290080|Flow cytometry|flow cytometry
209987|NCT02290080|Matrix metalloproteinase (MMP)|matrix metalloproteinase (mmp)
209988|NCT02290067|blood glucose monitoring system|blood glucose monitoring system
209989|NCT02290067|system accuracy|system accuracy
209990|NCT02290054|analgesia, epidural|analgesia, epidural
209991|NCT02290054|urinary retention|urinary retention
209992|NCT02290041|mesenchymal stem cells|mesenchymal stem cells
209993|NCT02290041|HIV Infection|hiv infection
210871|NCT02284815|Remission|remission
209994|NCT02290041|discordant immunological response|discordant immunological response
209995|NCT02290028|CRT-D therapy|crt-d therapy
209996|NCT02290028|quadripolar left ventricular lead|quadripolar left ventricular lead
209997|NCT02290015|Single Photon Emission Computed Tomography; Acupuncture|single photon emission computed tomography; acupuncture
209998|NCT02289989|Atopic dermatitis|atopic dermatitis
209999|NCT02289989|Oregano|oregano
210000|NCT02289989|Atopic Dermatitis Quick (ADQ) score|atopic dermatitis quick (adq) score
210001|NCT02289989|Eczema Area and Severity Index score|eczema area and severity index score
210002|NCT02289989|Reflectance confocal microscopy|reflectance confocal microscopy
210003|NCT02289976|talar avascular necrosis|talar avascular necrosis
210004|NCT02289976|osteochondrosis dissecans|osteochondrosis dissecans
210005|NCT02289976|femoral condyle|femoral condyle
210006|NCT02289950|Ovarian Cancer in in first relapse|ovarian cancer in in first relapse
210007|NCT02289950|Platinum-Sensitive|platinum-sensitive
210008|NCT02289937|Postoperative pain|postoperative pain
210009|NCT02289937|regional anaesthesia|regional anaesthesia
210010|NCT02289937|total hip replacement|total hip replacement
210011|NCT02289937|nervus cutaneous femoral lateralis|nervus cutaneous femoral lateralis
210012|NCT02289924|wet AMD|wet amd
210013|NCT02289911|ultrasound|ultrasound
210014|NCT02289898|1st-line metastatic pancreatic ductal adenocarcinoma|1st-line metastatic pancreatic ductal adenocarcinoma
210015|NCT02289885|trauma|trauma
210016|NCT02289885|examination|examination
210017|NCT02289885|knowledge|knowledge
210018|NCT02289885|paramedic|paramedic
210019|NCT02289820|RSV|rsv
210020|NCT02289820|Older adults|older adults
210021|NCT02289820|MEDI7510|medi7510
210022|NCT02289820|Vaccine|vaccine
210023|NCT02289807|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
210024|NCT02289807|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
210025|NCT02289807|intermediate risk|intermediate risk
210026|NCT02289807|intensity-modulated radiotherapy|intensity-modulated radiotherapy
210027|NCT02289794|Bioconjugate vaccine|bioconjugate vaccine
210028|NCT02289794|Urinary tract infections|urinary tract infections
210029|NCT02289755|Urine Oxalate|urine oxalate
210030|NCT02289755|Nephrolithiasis|nephrolithiasis
210031|NCT02289755|Kidney Stones|kidney stones
210032|NCT02289755|Hyperoxaluria|hyperoxaluria
210033|NCT02289755|Enteric Hyperoxaluria|enteric hyperoxaluria
210034|NCT02289755|Idiopathic Hyperoxaluria|idiopathic hyperoxaluria
210035|NCT02289755|Urological Diseases|urological diseases
210036|NCT02289755|Kidney Diseases|kidney diseases
210037|NCT02289742|Dailies AquaComfort Plus® Multifocal (DACP MF)|dailies aquacomfort plus® multifocal (dacp mf)
210038|NCT02289742|Dailies AquaComfort Plus® Toric (DACP Toric)|dailies aquacomfort plus® toric (dacp toric)
210039|NCT02289742|tear film stability|tear film stability
210040|NCT02289742|Non-Invasive Keratograph Break-Up Time (NIK-BUT)|non-invasive keratograph break-up time (nik-but)
210041|NCT02289729|Duodopa|duodopa
210042|NCT02289729|Advanced Parkinson's Disease|advanced parkinson's disease
210043|NCT02289729|Levodopa/Carbidopa intestinal gel|levodopa/carbidopa intestinal gel
210044|NCT02289716|Osteoarthritis|osteoarthritis
210045|NCT02289716|Pain|pain
210046|NCT02289716|Fulranumab|fulranumab
210047|NCT02289716|JNJ-42160443|jnj-42160443
210048|NCT02289716|Monotherapy|monotherapy
210049|NCT02289716|Hip|hip
210050|NCT02289716|Knee|knee
210051|NCT02289716|Joint replacement surgery|joint replacement surgery
210052|NCT02289703|End-Stage Renal Disease|end-stage renal disease
210053|NCT02289703|Healthy|healthy
210054|NCT02289703|Rivaroxaban|rivaroxaban
210055|NCT02289703|BAY 59-7939|bay 59-7939
210056|NCT02289703|JNJ-39039039|jnj-39039039
210057|NCT02289703|Xarelto|xarelto
210058|NCT02289703|Hemodialysis|hemodialysis
210059|NCT02289703|Blood Coagulation|blood coagulation
210060|NCT02289703|Pharmacokinetics|pharmacokinetics
210061|NCT02289690|Extensive Stage Smal Cell Lung Cancer|extensive stage smal cell lung cancer
210062|NCT02289690|ABT-888|abt-888
210063|NCT02289690|Veliparib|veliparib
210064|NCT02289690|PARP - Poly (ADP) ribose polymerase|parp - poly (adp) ribose polymerase
210065|NCT02289677|intubation|intubation
210066|NCT02289677|child|child
210067|NCT02289677|resuscitation|resuscitation
210068|NCT02289677|simulation|simulation
210069|NCT02289677|Endotracheal|endotracheal
210070|NCT02289664|intubation|intubation
210071|NCT02289651|intubation|intubation
210072|NCT02289638|intubation|intubation
210073|NCT02289625|Obstructive Sleep Apnea|obstructive sleep apnea
210074|NCT02289625|cognition|cognition
210075|NCT02289625|neurovascular function|neurovascular function
210076|NCT02289625|brain metabolism|brain metabolism
210077|NCT02289625|exercise training|exercise training
210078|NCT02289612|Risk for Type 2 Diabetes Mellitus|risk for type 2 diabetes mellitus
210079|NCT02289612|Fibre|fibre
210080|NCT02289612|Postprandial Glucose|postprandial glucose
210081|NCT02289612|Postprandial Insulin|postprandial insulin
210082|NCT02289612|Postprandial Acetaminophen|postprandial acetaminophen
210083|NCT02289612|Satiety|satiety
210084|NCT02289599|Healthy Japanese Subjects|healthy japanese subjects
210085|NCT02289599|E2307|e2307
210086|NCT02289599|Pharmacokinetics|pharmacokinetics
210087|NCT02289547|chemotherapy|chemotherapy
210088|NCT02289547|stomach neoplasms|stomach neoplasms
210089|NCT02289521|Transcranial Direct Current stimulation|transcranial direct current stimulation
210090|NCT02289521|Executive function|executive function
210091|NCT02289521|Bilingualism|bilingualism
210092|NCT02289521|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
210093|NCT02289508|Heart Failure|heart failure
210094|NCT02289508|Hemodynamics|hemodynamics
210095|NCT02289508|Echocardiography|echocardiography
210096|NCT02289508|Diagnostic techniques and procedures|diagnostic techniques and procedures
210097|NCT02289508|Ultrasonography|ultrasonography
210098|NCT02289508|USCOM|uscom
210099|NCT02289495|Single Dose Escalation|single dose escalation
210100|NCT02289495|Repeat Dose Escalation|repeat dose escalation
210101|NCT02289495|GSK2838232|gsk2838232
210102|NCT02289495|Ritonavir|ritonavir
210103|NCT02289482|Ritonavir|ritonavir
210104|NCT02289482|Safety|safety
210105|NCT02289482|Continuation Single Dose Escalation|continuation single dose escalation
210106|NCT02289482|GSK2838232|gsk2838232
210107|NCT02289456|Phase II, LOCALLY ADVANCED OR METASTATIC NON SMALL|phase ii, locally advanced or metastatic non small
210108|NCT02289456|CELL LUNG CANCER (NSCLC) AND AN|cell lung cancer (nsclc) and an
210109|NCT02289456|EASTERN COOPERATIVE ONCOLOGY GROUP|eastern cooperative oncology group
210110|NCT02289456|PERFORMANCE STATUS OF 2|performance status of 2
210111|NCT02289456|(ABOUND.PS2)|(abound.ps2)
210112|NCT02289456|LOCALLY ADVANCED OR METASTATIC NON SMALL|locally advanced or metastatic non small
210113|NCT02289456|CELL LUNG CANCER (NSCLC) SUBJECTS THAT AE NOT CANDIDATES FOR RADIATION OR CURATIVE SURGERY|cell lung cancer (nsclc) subjects that ae not candidates for radiation or curative surgery
210114|NCT02289443|complete dentures|complete dentures
210115|NCT02289443|10-year follow-up|10-year follow-up
210116|NCT02289443|patient report outcomes|patient report outcomes
210117|NCT02289417|Ulcerative Colitis|ulcerative colitis
210118|NCT02289417|Inflammatory Bowel Disease|inflammatory bowel disease
210119|NCT02289391|Dexmedetomidine|dexmedetomidine
210120|NCT02289391|Inflammatory factor|inflammatory factor
210121|NCT02289391|Inflammatory mediator|inflammatory mediator
210122|NCT02289391|Cytokines|cytokines
210123|NCT02289391|Asthma|asthma
210124|NCT02289365|Radiodermatitis|radiodermatitis
210125|NCT02289365|Breast cancer|breast cancer
210126|NCT02289365|Radiotherapy|radiotherapy
210127|NCT02289313|obesity prevention|obesity prevention
210128|NCT02289313|CBPR|cbpr
210129|NCT02289313|high risk youth|high risk youth
210130|NCT02289313|school health|school health
210131|NCT02289287|Self-Management|self-management
210132|NCT02289287|Stroke|stroke
210133|NCT02289287|Intervention|intervention
210134|NCT02289287|Group Processes|group processes
210135|NCT02289261|Chronic pain|chronic pain
210136|NCT02289261|Morphine|morphine
210137|NCT02289261|Dexmedetomidine|dexmedetomidine
210138|NCT02289235|Ginger|ginger
210139|NCT02289235|Medicine, traditional|medicine, traditional
210140|NCT02289235|Herbal medicine|herbal medicine
210141|NCT02289222|Relapsed/Refractory|relapsed/refractory
210142|NCT02289222|MK-3475 & Pomalidomide|mk-3475 & pomalidomide
210143|NCT02289222|Immunotherapy|immunotherapy
210144|NCT02289209|head and neck cancer|head and neck cancer
210145|NCT02289209|reirradiation|reirradiation
210146|NCT02289209|MK-3475|mk-3475
210147|NCT02289209|Anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
210148|NCT02289209|Squamous cell carcinoma|squamous cell carcinoma
210149|NCT02289209|Keytruda|keytruda
210150|NCT02289209|pembrolizumab|pembrolizumab
210151|NCT02289196|Vaccine|vaccine
210152|NCT02289183|Stomach Neoplasms|stomach neoplasms
210153|NCT02289183|Laparoscopy|laparoscopy
210154|NCT02289183|Billroth I Operation|billroth i operation
210155|NCT02289170|Chronic low back pain|chronic low back pain
210156|NCT02289170|Heating and cooling combination therapeutic device|heating and cooling combination therapeutic device
210157|NCT02289170|Heating and cooling combination therapy|heating and cooling combination therapy
210158|NCT02289170|Contrast therapy|contrast therapy
210159|NCT02289131|oral care|oral care
210160|NCT02289105|Advance Directive|advance directive
210161|NCT02289105|Active Choice|active choice
210162|NCT02289105|Decision making|decision making
210163|NCT02289053|Colorectal Cancer|colorectal cancer
210164|NCT02289040|Acute Kidney Injury|acute kidney injury
210165|NCT02289040|Microvesicles|microvesicles
210166|NCT02289040|microRNA|microrna
210167|NCT02289040|Paediatric cardiac surgery|paediatric cardiac surgery
210168|NCT02289027|Ebola, Ebolavirus|ebola, ebolavirus
210169|NCT02289014|online intervention|online intervention
210170|NCT02289014|stress management|stress management
210171|NCT02289014|cognitive behavioral therapy|cognitive behavioral therapy
210172|NCT02289014|acceptance and mindfulness based intervention|acceptance and mindfulness based intervention
210173|NCT02289001|patient simulation|patient simulation
210174|NCT02289001|simulation|simulation
210175|NCT02289001|teamwork|teamwork
210176|NCT02289001|interdisciplinary health team|interdisciplinary health team
210177|NCT02289001|healthcare team|healthcare team
210178|NCT02289001|nursing|nursing
210179|NCT02289001|training programs|training programs
210180|NCT02288988|GERD|gerd
210181|NCT02288988|Short Esophagus|short esophagus
210182|NCT02288988|Minimally Invasive Surgery|minimally invasive surgery
210183|NCT02288988|Collis gastroplasty|collis gastroplasty
210184|NCT02288975|hemoadsorption|hemoadsorption
210185|NCT02288975|extracorporeal blood purification|extracorporeal blood purification
210186|NCT02288975|CytoSorb|cytosorb
210187|NCT02288975|hemofiltration|hemofiltration
210188|NCT02288975|SIRS|sirs
210189|NCT02288975|sepsis|sepsis
210190|NCT02288975|septic shock|septic shock
210191|NCT02288975|membranes|membranes
210192|NCT02288975|ICU|icu
210193|NCT02288975|dialysis|dialysis
210194|NCT02288975|adsorption|adsorption
210195|NCT02288962|dopamine agonists|dopamine agonists
210196|NCT02288962|cabergoline|cabergoline
210197|NCT02288949|mechanical ventilation, stratificacion, lung severity|mechanical ventilation, stratificacion, lung severity
210198|NCT02288936|Hormone-refractory prostate cancer|hormone-refractory prostate cancer
210199|NCT02288936|Enzalutamide|enzalutamide
210200|NCT02288936|TMPRSS2-ETS fusion gene|tmprss2-ets fusion gene
210201|NCT02288923|Total knee arthroplasty|total knee arthroplasty
210202|NCT02288923|Femoral nerve block|femoral nerve block
210203|NCT02288923|Local infiltration analgesia|local infiltration analgesia
210204|NCT02288910|Liver Perfusion|liver perfusion
210205|NCT02288910|DynaCT Perfusion|dynact perfusion
210206|NCT02288910|Radioembolization|radioembolization
210207|NCT02288910|Chemoembolization|chemoembolization
210208|NCT02288897|Stage III|stage iii
210209|NCT02288897|Stage IIIB|stage iiib
210210|NCT02288897|Stage IIIC|stage iiic
210211|NCT02288897|Stage IV (M1a)|stage iv (m1a)
210212|NCT02288897|Stage 3|stage 3
210213|NCT02288897|Stage 4|stage 4
210214|NCT02288897|IVM1a|ivm1a
210215|NCT02288897|IV(M1a)|iv(m1a)
210216|NCT02288897|IV-M1a|iv-m1a
210217|NCT02288897|in-transit|in-transit
210218|NCT02288897|in transit|in transit
210219|NCT02288897|intransit|intransit
210220|NCT02288897|satellite|satellite
210221|NCT02288897|recurrent|recurrent
210222|NCT02288884|Complications|complications
210223|NCT02288884|Cesarean Section|cesarean section
210224|NCT02288884|Wound|wound
210225|NCT02288884|Infection (Following Delivery)|infection (following delivery)
210226|NCT02288871|aortic valve replacement|aortic valve replacement
210227|NCT02288871|aortic valve bioprosthesis|aortic valve bioprosthesis
210228|NCT02288871|hemodynamics|hemodynamics
210229|NCT02288858|Hair thinning|hair thinning
210230|NCT02288819|loop diuretics|loop diuretics
210231|NCT02288819|heart failure|heart failure
210232|NCT02288819|natriuresis|natriuresis
210233|NCT02288819|urinary analysis|urinary analysis
210234|NCT02288793|attitudes|attitudes
210235|NCT02288793|knowledge|knowledge
210236|NCT02288793|examination|examination
210237|NCT02288754|DNA in Tumors|dna in tumors
210238|NCT02288741|high-dose chemotherapy|high-dose chemotherapy
210239|NCT02288741|autologous blood stem-cell transplantation|autologous blood stem-cell transplantation
210240|NCT02288741|induction chemotherapy|induction chemotherapy
210241|NCT02288741|elderly patients|elderly patients
210242|NCT02288728|Proximal gastrectomy|proximal gastrectomy
210243|NCT02288728|quality of life|quality of life
210244|NCT02288728|mortality|mortality
210245|NCT02288728|morbidity|morbidity
210246|NCT02288715|cerebral perfusion pressure|cerebral perfusion pressure
210247|NCT02288715|septic encephalopathy|septic encephalopathy
210248|NCT02288676|genomics|genomics
210249|NCT02288676|molecular markers|molecular markers
210250|NCT02288676|genetic mutations|genetic mutations
210251|NCT02288676|high-grade serous cancer|high-grade serous cancer
210252|NCT02288676|ovarian cancer|ovarian cancer
210253|NCT02288676|endometrial cancer|endometrial cancer
210254|NCT02288676|driver mutations|driver mutations
210255|NCT02288676|passenger mutations|passenger mutations
210256|NCT02288676|molecular screening|molecular screening
210257|NCT02288598|Stammering|stammering
210258|NCT02288598|Brain stimulation|brain stimulation
210259|NCT02288585|plant sterols|plant sterols
210260|NCT02288585|blood lipids|blood lipids
210261|NCT02288572|metabolic syndrome X|metabolic syndrome x
210262|NCT02288572|obesity|obesity
210263|NCT02288572|insulin resistance|insulin resistance
210264|NCT02288572|dyslipidemia|dyslipidemia
210265|NCT02288572|probiotic bacteria|probiotic bacteria
210266|NCT02288546|nutritional status|nutritional status
210267|NCT02288546|pesticides|pesticides
210268|NCT02288546|nitrate|nitrate
210269|NCT02288533|Minimally Conscious State|minimally conscious state
210270|NCT02288533|tDCS|tdcs
210271|NCT02288520|Methotrexate|methotrexate
210272|NCT02288520|Therapeutic strategy|therapeutic strategy
210273|NCT02288507|sorafenib, yttrium-90 radioembolization|sorafenib, yttrium-90 radioembolization
210274|NCT02288494|hypoalbuminemia|hypoalbuminemia
210275|NCT02288494|-acid base balance|-acid base balance
210276|NCT02288494|acid base disorders|acid base disorders
210277|NCT02288494|critical ill|critical ill
210278|NCT02288494|Stewart approach|stewart approach
210279|NCT02288494|human albumin infusion|human albumin infusion
210280|NCT02288481|Tuberculosis|tuberculosis
210281|NCT02288481|TBA-354|tba-354
210282|NCT02288481|Pulmonary Tuberculosis|pulmonary tuberculosis
210283|NCT02288481|TB|tb
210284|NCT02288468|Parkinson's Disease|parkinson's disease
210285|NCT02288455|SUI, incontinence, sphincter|sui, incontinence, sphincter
210286|NCT02288429|pharmacokinetics|pharmacokinetics
210287|NCT02288429|cystic fibrosis|cystic fibrosis
210288|NCT02288429|critical illness|critical illness
210289|NCT02288403|Aerobic Exercise|aerobic exercise
210290|NCT02288403|Oxygen Consumption|oxygen consumption
210291|NCT02288403|Blood Pressure|blood pressure
210292|NCT02288390|VAP|vap
210293|NCT02288390|Oral care|oral care
210294|NCT02288390|Chlorhexidine|chlorhexidine
210295|NCT02288390|Miswak (Sewak)|miswak (sewak)
210296|NCT02288377|Lanreotide|lanreotide
210297|NCT02288377|Duodeno-pancreatic neuroendocrine tumours|duodeno-pancreatic neuroendocrine tumours
210298|NCT02288377|Maintenance treatment|maintenance treatment
210299|NCT02288351|Roux-en-Y gastric bypass|roux-en-y gastric bypass
210300|NCT02288325|Fetzima|fetzima
210301|NCT02288325|Relapse-prevention|relapse-prevention
210302|NCT02288325|Placebo-controlled|placebo-controlled
210303|NCT02288299|Instrumental cough assistance|instrumental cough assistance
210304|NCT02288299|positive pressure insufflation maneuver|positive pressure insufflation maneuver
210305|NCT02288299|home mechanical ventilation|home mechanical ventilation
210306|NCT02288299|prospective evaluation|prospective evaluation
210307|NCT02288260|Acute Coronary Syndrome|acute coronary syndrome
210308|NCT02288260|Russian ACS Registry|russian acs registry
210309|NCT02288260|ticagrelor|ticagrelor
210310|NCT02288247|Metastatic|metastatic
210311|NCT02288247|Castration-resistant|castration-resistant
210312|NCT02288247|Docetaxel|docetaxel
210313|NCT02288247|Chemotherapy- Naïve|chemotherapy- naïve
210314|NCT02288247|Enzalutamide|enzalutamide
210315|NCT02288247|Prostate Cancer|prostate cancer
210316|NCT02288247|Chemotherapy Naïve Metastatic Castration Resistant Prostate Cancer|chemotherapy naïve metastatic castration resistant prostate cancer
210317|NCT02288247|Prednisolone|prednisolone
210318|NCT02288247|Xtandi|xtandi
210319|NCT02288247|Metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
210320|NCT02288234|Registry|registry
210321|NCT02288195|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
210322|NCT02288195|Preoperative radiotherapy|preoperative radiotherapy
210323|NCT02288195|Chemoradiotherapy|chemoradiotherapy
210324|NCT02288195|Capecitabine|capecitabine
210325|NCT02288195|Oxaliplatin|oxaliplatin
210326|NCT02288182|Sinus augmentation procedure|sinus augmentation procedure
210327|NCT02288169|Symptom management|symptom management
210328|NCT02288169|palliative care|palliative care
210329|NCT02288117|PMCF|pmcf
210330|NCT02288117|Post Market Clinical Follow up|post market clinical follow up
210331|NCT02288117|SP-CL|sp-cl
210332|NCT02288117|anatomic stem|anatomic stem
210333|NCT02288104|Interventional Radiology|interventional radiology
210334|NCT02288104|Liver|liver
210335|NCT02288104|Kidney|kidney
210336|NCT02288104|Confocal endomicroscopy|confocal endomicroscopy
210337|NCT02288104|Optical Biopsy|optical biopsy
210338|NCT02288104|Scanner|scanner
210339|NCT02288104|Fluoroscopy|fluoroscopy
210340|NCT02288104|CT|ct
210341|NCT02288104|Computed Tomography|computed tomography
210342|NCT02288104|Radiofrequency Ablation|radiofrequency ablation
210343|NCT02288104|Fluorescein|fluorescein
210344|NCT02288091|ALS|als
210345|NCT02288091|Inosine|inosine
210346|NCT02288091|Uric acid|uric acid
210347|NCT02288091|Urate|urate
210348|NCT02288091|Glutathione|glutathione
210349|NCT02288091|Biomarker|biomarker
210350|NCT02288091|Oxidative stress|oxidative stress
210351|NCT02288091|Oxidative damage|oxidative damage
210352|NCT02288091|proof-of-concept|proof-of-concept
210353|NCT02288078|unresectable colorectal cancer|unresectable colorectal cancer
210354|NCT02288078|regorafenib|regorafenib
210355|NCT02288078|Steroid|steroid
210356|NCT02288078|fatigue and malaise|fatigue and malaise
210357|NCT02288078|Phase 2 randomized, controlled trial (RCT)|phase 2 randomized, controlled trial (rct)
210358|NCT02288052|Handwriting|handwriting
210359|NCT02288052|Motor learning|motor learning
210360|NCT02288039|Pulmonary|pulmonary
210361|NCT02288026|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
210362|NCT02288026|Lung Neoplasms|lung neoplasms
210363|NCT02288026|Carcinoma, Bronchogenic|carcinoma, bronchogenic
210364|NCT02288026|Bronchial Neoplasms|bronchial neoplasms
210365|NCT02288013|Cesarean section|cesarean section
210366|NCT02288013|uterine closure technique|uterine closure technique
210367|NCT02288013|materials used|materials used
210368|NCT02288000|Alzheimer|alzheimer
210369|NCT02288000|Memantine|memantine
210370|NCT02288000|biomarkers|biomarkers
210371|NCT02288000|battery|battery
210372|NCT02288000|cognition|cognition
210373|NCT02288000|imaging|imaging
210374|NCT02288000|neuropsychology|neuropsychology
210375|NCT02287987|Renal function|renal function
210376|NCT02287987|Off-clamp|off-clamp
210377|NCT02287987|Partial nephrectomy|partial nephrectomy
210378|NCT02287987|Robotic|robotic
210379|NCT02287987|Hylar clamping|hylar clamping
210380|NCT02287948|Balance|balance
210381|NCT02287948|Multiple Sclerosis|multiple sclerosis
210382|NCT02287948|Nintendo Wii Fit|nintendo wii fit
210383|NCT02287935|Karydakis procedure|karydakis procedure
210384|NCT02287935|Limberg flap|limberg flap
210385|NCT02287935|recurrent pilonidal sinus|recurrent pilonidal sinus
210872|NCT02284789|Hemophilia|hemophilia
210386|NCT02287896|RhD-negative pregnant woman|rhd-negative pregnant woman
210387|NCT02287896|anti-RhD antibody|anti-rhd antibody
210388|NCT02287883|Patient activation and engagement|patient activation and engagement
210389|NCT02287883|Patient reported outcomes|patient reported outcomes
210390|NCT02287883|Accountable Care Organizations|accountable care organizations
210391|NCT02287883|Chronic illness|chronic illness
210392|NCT02287883|Vulnerable population|vulnerable population
210393|NCT02287883|Comparison of approaches|comparison of approaches
210394|NCT02287870|Epidural anesthesia|epidural anesthesia
210395|NCT02287870|Chloroprocaine|chloroprocaine
210396|NCT02287870|Lidocaine|lidocaine
210397|NCT02287844|Xylo-oligosaccharides|xylo-oligosaccharides
210398|NCT02287844|Immunonutrition|immunonutrition
210399|NCT02287844|Prebiotics|prebiotics
210400|NCT02287844|Lipopolysaccharides|lipopolysaccharides
210401|NCT02287844|Cytokines|cytokines
210402|NCT02287805|craniosynostosis|craniosynostosis
210403|NCT02287805|simple form|simple form
210404|NCT02287805|complex form|complex form
210405|NCT02287805|diagnostic|diagnostic
210406|NCT02287805|announcement|announcement
210407|NCT02287805|impacts|impacts
210408|NCT02287792|Infective endocarditis|infective endocarditis
210409|NCT02287792|18-FDG PET/CT|18-fdg pet/ct
210410|NCT02287792|Impact|impact
210411|NCT02287792|Patient's management|patient's management
210412|NCT02287792|Diagnostic|diagnostic
210413|NCT02287753|vascular occlusion test|vascular occlusion test
210414|NCT02287753|near infrared spectroscopy|near infrared spectroscopy
210415|NCT02287740|Exercise|exercise
210416|NCT02287714|Instep plantar fasciotomy|instep plantar fasciotomy
210417|NCT02287701|bladder cancer|bladder cancer
210418|NCT02287701|MRI|mri
210419|NCT02287701|PET|pet
210420|NCT02287688|safety of Meningococcal quadrivalent CRM-197 conjugate vaccine|safety of meningococcal quadrivalent crm-197 conjugate vaccine
210421|NCT02287688|Children 2-23 months of age|children 2-23 months of age
210422|NCT02287675|Sentinel Node|sentinel node
210423|NCT02287662|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
210424|NCT02287649|Immune thrombocytopenia|immune thrombocytopenia
210425|NCT02287649|Fc gamma RIIIA V/F158 polymorphism|fc gamma riiia v/f158 polymorphism
210426|NCT02287649|Rituximab|rituximab
210427|NCT02287649|autoreactive B and T cells|autoreactive b and t cells
210428|NCT02287649|ITP|itp
210429|NCT02287610|RA|ra
210430|NCT02287610|Delayed-release prednisone|delayed-release prednisone
210431|NCT02287610|Immediate-release prednisone|immediate-release prednisone
210432|NCT02287610|Non-interventional|non-interventional
210433|NCT02287571|comfort|comfort
210434|NCT02287571|satisfaction|satisfaction
210435|NCT02287558|HHT|hht
210436|NCT02287558|CASE4Z14|case4z14
210437|NCT02287558|Pomalidomide|pomalidomide
210438|NCT02287545|open angle glaucoma|open angle glaucoma
210439|NCT02287545|corneal biomechanics|corneal biomechanics
210440|NCT02287545|trabeculectomy|trabeculectomy
210441|NCT02287506|diagnosis, strategy|diagnosis, strategy
210442|NCT02287480|Ebolavirus Vaccines|ebolavirus vaccines
210443|NCT02287467|Antiviral|antiviral
210444|NCT02287467|IVIG|ivig
210445|NCT02287467|Hemagglutination inhibition (HAI)|hemagglutination inhibition (hai)
210446|NCT02287467|Antibody|antibody
210447|NCT02287454|Multiple Sclerosis, cognitive rehabilitation, REHACOP|multiple sclerosis, cognitive rehabilitation, rehacop
210448|NCT02287376|Migraine with and without aura|migraine with and without aura
210449|NCT02287350|pain|pain
210450|NCT02287350|moderate pain|moderate pain
210451|NCT02287350|mild pain|mild pain
210452|NCT02287350|acute pain|acute pain
210453|NCT02287350|mild acute pain|mild acute pain
210454|NCT02287350|moderate acute pain|moderate acute pain
210578|NCT02286648|pulpotomy|pulpotomy
210455|NCT02287350|mild or moderate acute pain|mild or moderate acute pain
210456|NCT02287350|NSAID|nsaid
210457|NCT02287350|nonsteroidal anti-inflammatory drug|nonsteroidal anti-inflammatory drug
210458|NCT02287337|Neck pain|neck pain
210459|NCT02287324|Cervicalgia|cervicalgia
210460|NCT02287311|EBV positive diseases|ebv positive diseases
210461|NCT02287311|cytotoxic T lymphocytes|cytotoxic t lymphocytes
210462|NCT02287285|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
210463|NCT02287285|Gastric Bypass Surgery|gastric bypass surgery
210464|NCT02287285|Exendin9|exendin9
210465|NCT02287272|COPD- cimetidine- drug-drug interaction|copd- cimetidine- drug-drug interaction
210466|NCT02287233|Myelogenous Leukemia|myelogenous leukemia
210467|NCT02287233|Treatment Naive AML|treatment naive aml
210468|NCT02287233|Untreated AML|untreated aml
210469|NCT02287220|Non-Contact Oximetry|non-contact oximetry
210470|NCT02287220|video plethysmography|video plethysmography
210471|NCT02287220|oxygen desaturation|oxygen desaturation
210472|NCT02287168|Peritoneal lavage|peritoneal lavage
210473|NCT02287168|Dissemination|dissemination
210474|NCT02287168|Gastrectomy|gastrectomy
210475|NCT02287168|Cytology|cytology
210476|NCT02287168|Lavage|lavage
210477|NCT02287155|Health Promotion|health promotion
210478|NCT02287155|Intervention Study|intervention study
210479|NCT02287155|Occupational Therapy|occupational therapy
210480|NCT02287155|Rural Population|rural population
210481|NCT02287155|Quality of life|quality of life
211568|NCT02280551|alcohol|alcohol
210482|NCT02287155|Sense of coherence|sense of coherence
210483|NCT02287129|Potentially R0 - resectable AEG and primary tumor category|potentially r0 - resectable aeg and primary tumor category
210484|NCT02287129|Histologically confirmed AEG I-III|histologically confirmed aeg i-iii
210485|NCT02287129|Functional operability|functional operability
210486|NCT02287129|Intense FDG tracer uptake of the tumor|intense fdg tracer uptake of the tumor
210487|NCT02287116|preterm infants|preterm infants
210488|NCT02287116|CPAP|cpap
210489|NCT02287116|BPD|bpd
210490|NCT02287116|invasive mechanical ventilation|invasive mechanical ventilation
210491|NCT02287116|we aimed determine that affect the rate of BPD and death of NCPAP therapy with nasal prongs or nasal mask as the initial treatment for RDS.|we aimed determine that affect the rate of bpd and death of ncpap therapy with nasal prongs or nasal mask as the initial treatment for rds.
210492|NCT02287103|Skipping Breakfast|skipping breakfast
210493|NCT02287038|PTSD|ptsd
210494|NCT02287038|ADHD|adhd
210495|NCT02287038|Comorbidity|comorbidity
210496|NCT02287038|Combat Trauma|combat trauma
210497|NCT02287038|Cognitive Deficit|cognitive deficit
210498|NCT02286986|Epilepsy|epilepsy
210499|NCT02286986|Dravet syndrome|dravet syndrome
210500|NCT02286986|Seizures|seizures
210501|NCT02286986|Intractable Epilepsy|intractable epilepsy
210502|NCT02286986|Medically Refractory Epilepsy|medically refractory epilepsy
210503|NCT02286973|Tranexamic acid|tranexamic acid
210504|NCT02286947|DMD|dmd
210505|NCT02286947|exon 51|exon 51
210506|NCT02286947|dystrophin|dystrophin
210507|NCT02286947|dystrophy|dystrophy
210508|NCT02286947|eteplirsen|eteplirsen
210509|NCT02286947|Duchenne|duchenne
210510|NCT02286934|Carvedilol|carvedilol
210511|NCT02286934|CYP2D6|cyp2d6
210512|NCT02286934|Isoproterenol Sensitivity Test|isoproterenol sensitivity test
210513|NCT02286921|Testosterone|testosterone
210514|NCT02286921|Enzalutamide|enzalutamide
210515|NCT02286921|Abiraterone|abiraterone
210516|NCT02286921|Androgen Ablative Therapies|androgen ablative therapies
210517|NCT02286921|Bipolar Androgen Therapy|bipolar androgen therapy
210518|NCT02286908|Ejection fraction, Global Strain, Mechanical dispersion|ejection fraction, global strain, mechanical dispersion
210519|NCT02286895|rotavirus|rotavirus
210520|NCT02286895|rotavirus vaccine|rotavirus vaccine
210521|NCT02286895|Mali|mali
210522|NCT02286895|EPI vaccines|epi vaccines
210523|NCT02286882|Single Ascending Dose|single ascending dose
210524|NCT02286882|healthy subjects|healthy subjects
210525|NCT02286869|mechanical ventilation|mechanical ventilation
210526|NCT02286869|autonomic nervous system|autonomic nervous system
210527|NCT02286869|heart rate variability|heart rate variability
210528|NCT02286869|cardioventilatory coupling|cardioventilatory coupling
210529|NCT02286856|malnutrition, diet intervention, Nutritional Assessment|malnutrition, diet intervention, nutritional assessment
210530|NCT02286843|89Zr-trastuzumab|89zr-trastuzumab
210531|NCT02286843|PET/CT|pet/ct
210532|NCT02286843|14-156|14-156
210533|NCT02286843|89Zr-pertuzumab|89zr-pertuzumab
210534|NCT02286843|HER2-targeted|her2-targeted
210535|NCT02286830|osteolysis|osteolysis
210536|NCT02286830|zoledronic acid|zoledronic acid
210537|NCT02286830|osteonecrosis|osteonecrosis
210538|NCT02286830|bone markers|bone markers
210539|NCT02286830|low-dose CT|low-dose ct
210540|NCT02286791|Prevention of dementia|prevention of dementia
210541|NCT02286791|Mindful awareness program|mindful awareness program
210542|NCT02286791|Mild cognitive impairment|mild cognitive impairment
210543|NCT02286791|Mindfulness|mindfulness
210544|NCT02286791|Elderly|elderly
210545|NCT02286791|Cognitive decline|cognitive decline
210546|NCT02286765|Ulthera System|ulthera system
210547|NCT02286765|Ultherapy|ultherapy
210548|NCT02286739|Total Knee Arthroplasty|total knee arthroplasty
210549|NCT02286739|Rotational Alignment|rotational alignment
210550|NCT02286739|Intraoperative Sensors|intraoperative sensors
210551|NCT02286739|Patient Outcomes|patient outcomes
210552|NCT02286739|Soft Tissue Balance|soft tissue balance
210553|NCT02286726|Leukemia|leukemia
210554|NCT02286726|Acute myeloid leukemia|acute myeloid leukemia
210555|NCT02286726|AML|aml
210556|NCT02286726|CPX-351|cpx-351
210557|NCT02286726|Phone call|phone call
210558|NCT02286713|Lung Cancer Screening|lung cancer screening
210559|NCT02286713|heavy smokers|heavy smokers
210560|NCT02286713|state-based smoking cessation quitlines|state-based smoking cessation quitlines
210561|NCT02286713|patient decision aid|patient decision aid
210562|NCT02286713|low-dose computed tomography|low-dose computed tomography
210563|NCT02286713|LDCT|ldct
210564|NCT02286713|standard educational information|standard educational information
210565|NCT02286700|dermatitis, eczema, itch, moisturizer, amino acid|dermatitis, eczema, itch, moisturizer, amino acid
210566|NCT02286687|Advanced Cancers|advanced cancers
210567|NCT02286687|Germline mutations|germline mutations
210568|NCT02286687|Metastatic cancer|metastatic cancer
210569|NCT02286687|Talazoparib Tosylate|talazoparib tosylate
210570|NCT02286687|BMN 673|bmn 673
210571|NCT02286687|Phone call|phone call
210572|NCT02286674|mYpas|mypas
210573|NCT02286674|anxiety|anxiety
210574|NCT02286674|distraction|distraction
210575|NCT02286674|inhalation induction|inhalation induction
210576|NCT02286648|clinical signs|clinical signs
210580|NCT02286583|Female breast cancer|female breast cancer
210581|NCT02286557|Methylphenidate|methylphenidate
210582|NCT02286557|Multiple Sclerosis|multiple sclerosis
210583|NCT02286557|Cognitive Fatigue|cognitive fatigue
210584|NCT02286544|Myocardial Infarction|myocardial infarction
210585|NCT02286544|Oxygen|oxygen
210586|NCT02286544|Inflammation|inflammation
210587|NCT02286544|Acute coronary syndrome (ACS)|acute coronary syndrome (acs)
210588|NCT02286544|ST-segment elevation myocardial infarction (STEMI)|st-segment elevation myocardial infarction (stemi)
210589|NCT02286544|Reperfusion injury (IR-injury)|reperfusion injury (ir-injury)
210590|NCT02286544|Biomarkers|biomarkers
210591|NCT02286544|Normoxemia|normoxemia
210592|NCT02286544|Salmonella typhi|salmonella typhi
210593|NCT02286544|Vaccine-induced inflammation|vaccine-induced inflammation
210594|NCT02286544|Soluble markers of apoptosis|soluble markers of apoptosis
210595|NCT02286544|Leukocyte subset distribution|leukocyte subset distribution
210596|NCT02286544|Matrix metalloproteinase (MMP)|matrix metalloproteinase (mmp)
210597|NCT02286544|Biological Markers|biological markers
210598|NCT02286531|: Low grade glioma|: low grade glioma
210599|NCT02286531|PET|pet
210600|NCT02286531|FET|fet
210601|NCT02286531|MRI|mri
210602|NCT02286531|Standardized uptake value|standardized uptake value
210603|NCT02286453|Osteoarthritis of The knee|osteoarthritis of the knee
210604|NCT02286453|Benjakul|benjakul
210605|NCT02286453|Alternative Medicine|alternative medicine
210606|NCT02286440|Depression|depression
210607|NCT02286440|Genotyping|genotyping
210608|NCT02286440|Pharmacokinetic|pharmacokinetic
210609|NCT02286440|Pharmacodynamic|pharmacodynamic
210610|NCT02286414|Oral anticoagulants, Geriatrics, General Practitioner, Safety, Misuse|oral anticoagulants, geriatrics, general practitioner, safety, misuse
210611|NCT02286401|myocardial perfusion|myocardial perfusion
210612|NCT02286401|coronary atherosclerosis|coronary atherosclerosis
210613|NCT02286401|coronary blood flow|coronary blood flow
210614|NCT02286401|fractional flow reserve|fractional flow reserve
210615|NCT02286401|coronary flow reserve|coronary flow reserve
210616|NCT02286388|Deep carious lesion|deep carious lesion
210617|NCT02286388|incomplete caries removal|incomplete caries removal
210618|NCT02286388|antibacterial adhesive system|antibacterial adhesive system
210619|NCT02286388|dental composite resin|dental composite resin
210620|NCT02286388|pulp vitality preservation|pulp vitality preservation
210621|NCT02286388|randomized controlled trial|randomized controlled trial
210622|NCT02286375|health-social partnership|health-social partnership
210623|NCT02286375|self-efficacy|self-efficacy
210624|NCT02286349|Neuromodulation Attention Deficit Hyperactivity Disorder|neuromodulation attention deficit hyperactivity disorder
210625|NCT02286336|minimum effective concentration|minimum effective concentration
210626|NCT02286336|ropivacaine|ropivacaine
210627|NCT02286336|ultrasound-guided supraclavicular block|ultrasound-guided supraclavicular block
210628|NCT02286323|Intubation, Endotracheal|intubation, endotracheal
210629|NCT02286310|Exercise|exercise
210630|NCT02286310|Kinematics|kinematics
210631|NCT02286297|Intubation|intubation
210632|NCT02286284|Early severe preeclampsia|early severe preeclampsia
210633|NCT02286284|Angiogenic factor|angiogenic factor
210634|NCT02286284|Apheresis|apheresis
210635|NCT02286271|Seizure detection|seizure detection
210636|NCT02286258|Inulin|inulin
210637|NCT02286258|Ca-EDTA|ca-edta
210638|NCT02286258|Gd-DOTA|gd-dota
210639|NCT02286258|Chronic kidney disease|chronic kidney disease
210640|NCT02286258|glomerular filtration rate measurement|glomerular filtration rate measurement
210641|NCT02286245|Triage|triage
210642|NCT02286245|Hotline|hotline
210643|NCT02286245|Primary Health Care|primary health care
210644|NCT02286245|Emergency Medical Service Communication Systems|emergency medical service communication systems
210645|NCT02286232|Chronic low back pain|chronic low back pain
210646|NCT02286232|stretching exercises|stretching exercises
210647|NCT02286206|Clozapine|clozapine
210648|NCT02286206|Psychotropic Drugs|psychotropic drugs
210649|NCT02286206|Antipsychotic Agents|antipsychotic agents
210650|NCT02286206|Psychotic Disorders|psychotic disorders
210651|NCT02286206|Schizophrenia|schizophrenia
210652|NCT02286206|Adverse Effects|adverse effects
210653|NCT02286206|Drug Monitoring|drug monitoring
210654|NCT02286180|near infrared spectroscopy|near infrared spectroscopy
210655|NCT02286180|NIRS|nirs
210656|NCT02286180|intern|intern
210657|NCT02286167|modified-Atkins diet|modified-atkins diet
210658|NCT02286167|ketogenic diet|ketogenic diet
210659|NCT02286167|central nervous system malignancy|central nervous system malignancy
210660|NCT02286167|glioma|glioma
210661|NCT02286154|Hydroxyurea|hydroxyurea
210662|NCT02286154|Sickle Cell|sickle cell
210663|NCT02286154|Pharmacokinetics|pharmacokinetics
210664|NCT02286154|dynamics|dynamics
210665|NCT02286154|genomics|genomics
210666|NCT02286128|Type 2 diabetes|type 2 diabetes
210667|NCT02286128|RAGE|rage
210668|NCT02286128|osteoblast|osteoblast
210669|NCT02286115|Chronic Pelvic Pain|chronic pelvic pain
210670|NCT02286115|Interstitial Cystitis|interstitial cystitis
210671|NCT02286115|Vulvodynia|vulvodynia
210672|NCT02286115|Dyspareunia|dyspareunia
210673|NCT02286115|Pelvic Floor Dysfunction|pelvic floor dysfunction
211569|NCT02280551|parent|parent
210674|NCT02286115|Emotional Processing|emotional processing
210675|NCT02286089|dry-AMD|dry-amd
210676|NCT02286089|Geographic Atrophy|geographic atrophy
210677|NCT02286076|endometrioma|endometrioma
210678|NCT02286076|laparoscopy|laparoscopy
210679|NCT02286076|ovarian reserve|ovarian reserve
210680|NCT02286037|Secondary Hyperalgesia|secondary hyperalgesia
210681|NCT02286037|Method|method
210682|NCT02286037|Pin-prick|pin-prick
210683|NCT02286037|Monofilament|monofilament
210684|NCT02285998|Influenza|influenza
210685|NCT02285985|Adipose tissue|adipose tissue
210686|NCT02285985|Inflammation|inflammation
210687|NCT02285985|.Obesity|.obesity
210688|NCT02285933|stroke|stroke
210689|NCT02285933|physical therapy specialty|physical therapy specialty
210690|NCT02285933|exercise therapy|exercise therapy
210691|NCT02285933|virtual reality|virtual reality
210692|NCT02285933|man-machine systems|man-machine systems
210693|NCT02285933|randomized control trial|randomized control trial
210694|NCT02285933|inpatients|inpatients
210695|NCT02285933|rehabilitation|rehabilitation
210696|NCT02285920|hemodialysis|hemodialysis
210697|NCT02285920|spironolactone|spironolactone
210698|NCT02285920|cardiac fibrosis|cardiac fibrosis
210699|NCT02285920|diastolic function|diastolic function
210700|NCT02285881|diabetes treatment|diabetes treatment
210701|NCT02285881|personalized medicine|personalized medicine
210702|NCT02285881|shared decision making|shared decision making
210703|NCT02285881|goal setting|goal setting
210704|NCT02285868|Orthopedic rehabilitation|orthopedic rehabilitation
210705|NCT02285868|Rehabilitation outcomes|rehabilitation outcomes
210706|NCT02285868|Physical therapy|physical therapy
210707|NCT02285868|Physical therapy outcomes|physical therapy outcomes
210708|NCT02285855|Lung Cancer|lung cancer
210709|NCT02285855|Non small cell lung cancer|non small cell lung cancer
210710|NCT02285855|Stereotactic body radiotherapy|stereotactic body radiotherapy
210711|NCT02285855|SBRT|sbrt
210712|NCT02285855|XRT|xrt
210713|NCT02285855|Radiation therapy|radiation therapy
210714|NCT02285855|Metformin|metformin
210715|NCT02285855|Metformin ER|metformin er
210716|NCT02285855|Placebo|placebo
210717|NCT02285855|Sugar pill|sugar pill
210718|NCT02285855|Lung adenocarcinoma|lung adenocarcinoma
210719|NCT02285855|Genotypes|genotypes
210720|NCT02285855|Genetic mutations|genetic mutations
210721|NCT02285842|osteoarthritis|osteoarthritis
210722|NCT02285842|avascular necrosis|avascular necrosis
210723|NCT02285842|ankylosis|ankylosis
210724|NCT02285842|protrusio acetabuli|protrusio acetabuli
210725|NCT02285842|painful hip dysplasia|painful hip dysplasia
210726|NCT02285842|rheumatoid arthritis|rheumatoid arthritis
210727|NCT02285842|correction of functional deformity|correction of functional deformity
210728|NCT02285842|revision procedures|revision procedures
210729|NCT02285751|high on treatment platelet reactivity|high on treatment platelet reactivity
210730|NCT02285751|acetylsalicylic acid|acetylsalicylic acid
210731|NCT02285751|clopidogrel|clopidogrel
210732|NCT02285751|prasugrel|prasugrel
210733|NCT02285751|ticagrelor|ticagrelor
210734|NCT02285751|critically ill|critically ill
210735|NCT02285751|pharmacokinetic|pharmacokinetic
210736|NCT02285751|pharmacodynamics|pharmacodynamics
210737|NCT02285738|solid tumor, cancer, simvastatin, aspirin, blood clot, VTE, venous thromboembolism|solid tumor, cancer, simvastatin, aspirin, blood clot, vte, venous thromboembolism
210738|NCT02285712|Peripheral venous catheter|peripheral venous catheter
210739|NCT02285712|ultrasound|ultrasound
210740|NCT02285712|nurse|nurse
210741|NCT02285712|Intensive Care Units|intensive care units
210742|NCT02285699|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors
210743|NCT02285686|troponin|troponin
210744|NCT02285686|biomarkers|biomarkers
210745|NCT02285686|myocardial infarction|myocardial infarction
210746|NCT02285686|critical illness|critical illness
210747|NCT02285673|umbilical cord, mesenchymal stem cell|umbilical cord, mesenchymal stem cell
210748|NCT02285621|Scoliosis|scoliosis
210749|NCT02285621|Spine deformity|spine deformity
210750|NCT02285621|Brace|brace
210751|NCT02285621|3D|3d
210752|NCT02285608|Medication adherence|medication adherence
210753|NCT02285608|Patient education|patient education
210754|NCT02285608|Mood disorders|mood disorders
210755|NCT02285608|Economic assessment|economic assessment
210756|NCT02285608|Mixed methods|mixed methods
210757|NCT02285556|drug carving changes during rehabilitation|drug carving changes during rehabilitation
210758|NCT02285556|community|community
210759|NCT02285556|DNA|dna
210760|NCT02285543|TPF induction chemotherapy, randomized, trial,OSCC|tpf induction chemotherapy, randomized, trial,oscc
210761|NCT02285530|head and neck squamous cell carcinoma, GDF15, TPF|head and neck squamous cell carcinoma, gdf15, tpf
210762|NCT02285504|Postpartum depression|postpartum depression
210763|NCT02285465|Healthy volunteers|healthy volunteers
210764|NCT02285465|Pharmacokinetics|pharmacokinetics
210765|NCT02285465|Pharmacodynamics|pharmacodynamics
210766|NCT02285465|ASP3700|asp3700
210767|NCT02285452|physiologcal phenomena|physiologcal phenomena
210768|NCT02285452|.HRV Parameters|.hrv parameters
210769|NCT02285452|respiratory activity|respiratory activity
210770|NCT02285452|thorax wraps|thorax wraps
210771|NCT02285439|Pediatric Oncology|pediatric oncology
210772|NCT02285439|Ras/Raf pathway|ras/raf pathway
210773|NCT02285439|Low-Grade Glioma|low-grade glioma
210774|NCT02285439|MEK inhibitor|mek inhibitor
210775|NCT02285426|i-scan|i-scan
210776|NCT02285426|histology|histology
210777|NCT02285413|Melanoma|melanoma
210778|NCT02285413|Dendritic cells|dendritic cells
210779|NCT02285413|Cisplatin|cisplatin
210780|NCT02285413|Vaccine|vaccine
210781|NCT02285413|Immunotherapy|immunotherapy
210782|NCT02285400|COPD|copd
210783|NCT02285400|CPAP|cpap
210784|NCT02285400|Central Drive|central drive
210785|NCT02285348|Ataxia Telangiectasia|ataxia telangiectasia
210786|NCT02285348|cerebrospinal fluid|cerebrospinal fluid
210787|NCT02285348|inflammation|inflammation
210788|NCT02285348|proteomic analysis|proteomic analysis
210789|NCT02285309|Cardiac Surgery|cardiac surgery
210790|NCT02285309|Diastolic Dysfunction|diastolic dysfunction
210791|NCT02285309|Enoximone|enoximone
210792|NCT02285296|geriatric assessment|geriatric assessment
210793|NCT02285296|Caregivers|caregivers
210794|NCT02285296|Needs Assessment|needs assessment
210795|NCT02285296|oncology nursing|oncology nursing
210796|NCT02285296|frail elderly|frail elderly
210797|NCT02285296|Medical, psychologic and sociologic approach|medical, psychologic and sociologic approach
210798|NCT02285270|Circadian rhythm|circadian rhythm
210799|NCT02285270|Adipose tissue, brown|adipose tissue, brown
210800|NCT02285270|Metabolism|metabolism
210801|NCT02285257|Sepsis, Severe sepsis, septic shock, epidemiology, outcome|sepsis, severe sepsis, septic shock, epidemiology, outcome
210802|NCT02285231|Anti-hyperglycemic effect|anti-hyperglycemic effect
210803|NCT02285192|18F-FDG Injection|18f-fdg injection
210804|NCT02285192|Positron Lymphography|positron lymphography
210805|NCT02285192|Lymphatic Mapping|lymphatic mapping
210806|NCT02285192|sentinel lymph nodes|sentinel lymph nodes
210807|NCT02285192|PET/CT|pet/ct
210808|NCT02285192|14-222|14-222
210809|NCT02285179|GDC-0032|gdc-0032
210810|NCT02285179|Pi3K inhibitor|pi3k inhibitor
210811|NCT02285179|tamoxifen|tamoxifen
210812|NCT02285179|hormone receptor positive|hormone receptor positive
210813|NCT02285179|RECIST|recist
210814|NCT02285179|pharmacodynamic|pharmacodynamic
210815|NCT02285166|Pharmaocological therapy|pharmaocological therapy
210816|NCT02285153|acetylsalicylic acid|acetylsalicylic acid
210817|NCT02285153|intensive care unit|intensive care unit
210818|NCT02285153|mortality|mortality
210819|NCT02285153|Post mortem examination|post mortem examination
210820|NCT02285153|bleeding|bleeding
210821|NCT02285114|HIV|hiv
210822|NCT02285114|emtricitabine|emtricitabine
210823|NCT02285114|FTC|ftc
210824|NCT02285114|tenofovir|tenofovir
210825|NCT02285114|TDF|tdf
210827|NCT02285114|antiretroviral|antiretroviral
210828|NCT02285114|pharmacokinetic|pharmacokinetic
210829|NCT02285114|PK|pk
210830|NCT02285114|adolescents|adolescents
210831|NCT02285114|children|children
210832|NCT02285114|pediatric|pediatric
210833|NCT02285114|Gilead|gilead
210834|NCT02285101|arginine auxotrophic tumors|arginine auxotrophic tumors
210835|NCT02285101|PEG-BCT-100|peg-bct-100
210836|NCT02285101|arginase|arginase
210837|NCT02285075|temocillin|temocillin
210838|NCT02285075|PD/PD|pd/pd
210839|NCT02285075|T>MIC|t>mic
210840|NCT02285062|R-CHOP chemotherapy|r-chop chemotherapy
210841|NCT02285062|DLBCL front line therapy|dlbcl front line therapy
210842|NCT02285062|gene expression profiling (GEP) activated B-cell (ABC) type DLBCL biomarkers|gene expression profiling (gep) activated b-cell (abc) type dlbcl biomarkers
210843|NCT02285062|Activated B-Cell (ABC) type|activated b-cell (abc) type
210844|NCT02285062|Diffuse Large B-Cell Lymphoma, not otherwise specified|diffuse large b-cell lymphoma, not otherwise specified
210845|NCT02285062|Diffuse Large B-Cell Lymphoma, associated with chronic inflammation|diffuse large b-cell lymphoma, associated with chronic inflammation
210846|NCT02285062|Diffuse Large B-Cell Lymphoma, Epstein-Barr virus positive (EBS+) of the elderly|diffuse large b-cell lymphoma, epstein-barr virus positive (ebs+) of the elderly
210847|NCT02285062|Diffuse Large B-Cell Lymphoma, T-cell / histiocyte-rich|diffuse large b-cell lymphoma, t-cell / histiocyte-rich
210848|NCT02285049|Chronic urticaria|chronic urticaria
210849|NCT02285049|Urticaria Control Test|urticaria control test
210850|NCT02285023|Chronic urticaria|chronic urticaria
210851|NCT02285023|CU-Q2oL|cu-q2ol
210852|NCT02285010|pregabalin|pregabalin
210853|NCT02285010|postoperative pain|postoperative pain
210854|NCT02285010|abdominal hysterectomy|abdominal hysterectomy
210855|NCT02284984|Antibodies, Monoclonal|antibodies, monoclonal
210856|NCT02284984|mabthera|mabthera
210857|NCT02284984|benlysta|benlysta
210858|NCT02284984|Antinuclear Antibodies|antinuclear antibodies
210859|NCT02284958|walking|walking
210860|NCT02284958|pedometer|pedometer
210861|NCT02284932|COPD|copd
210862|NCT02284932|atrophy|atrophy
210863|NCT02284932|muscle|muscle
210864|NCT02284906|Drug therapy|drug therapy
210865|NCT02284867|uterine natural killer cells|uterine natural killer cells
210866|NCT02284867|CD16|cd16
210867|NCT02284867|CD56|cd56
210868|NCT02284867|Preterm labour|preterm labour
210869|NCT02284815|Gluten|gluten
210870|NCT02284815|T1D|t1d
210873|NCT02284776|Therapeutic education|therapeutic education
210874|NCT02284750|Bifurcation lesion|bifurcation lesion
210875|NCT02284750|Percutaneous coronary intervention|percutaneous coronary intervention
210876|NCT02284737|Pulmonary arterial hypertension|pulmonary arterial hypertension
210877|NCT02284711|salpingectomy, ovarian reserve, coagulation technique|salpingectomy, ovarian reserve, coagulation technique
210878|NCT02284685|Mental Health Services|mental health services
210879|NCT02284646|Ankylosing spondylitis|ankylosing spondylitis
210880|NCT02284646|Physical training program|physical training program
210881|NCT02284633|EGFR mutation|egfr mutation
210882|NCT02284633|Liquid biopsies|liquid biopsies
210883|NCT02284633|Lung cancer|lung cancer
210884|NCT02284633|erlotinib|erlotinib
210885|NCT02284620|anesthesia|anesthesia
210886|NCT02284620|nerve block|nerve block
210887|NCT02284620|infltration|infltration
210888|NCT02284581|MBC|mbc
210889|NCT02284581|metastatic|metastatic
210890|NCT02284581|breast|breast
210891|NCT02284581|observational|observational
210892|NCT02284581|disease management|disease management
210893|NCT02284529|high-risk stage-Ⅱ Colorectal Cancer,Orectalip,oxaliplatin|high-risk stage-ⅱ colorectal cancer,orectalip,oxaliplatin
210894|NCT02284503|MI reduction|mi reduction
210895|NCT02284503|intensive statin treatment|intensive statin treatment
210896|NCT02284503|NSTE-ACS|nste-acs
210897|NCT02284490|Brain Metastases|brain metastases
210898|NCT02284477|Insulin resistance|insulin resistance
210899|NCT02284477|Pulmonary function|pulmonary function
210900|NCT02284477|Phthalates|phthalates
210901|NCT02284464|Kidney transplant|kidney transplant
210902|NCT02284464|Immunosuppression|immunosuppression
210903|NCT02284464|Steroid withdrawal|steroid withdrawal
210904|NCT02284464|Donor specific antibodies|donor specific antibodies
210905|NCT02284451|HIV/AIDS and HIV Testing Knowledge|hiv/aids and hiv testing knowledge
210906|NCT02284438|ETT|ett
210907|NCT02284438|Biofilm|biofilm
210908|NCT02284438|Mechanical ventilation|mechanical ventilation
210909|NCT02284438|Critical illness|critical illness
210910|NCT02284438|Ventilator-associated pneumonia|ventilator-associated pneumonia
210911|NCT02284412|Neostigmine|neostigmine
210912|NCT02284412|Sugammadex|sugammadex
210913|NCT02284399|aneuploidy|aneuploidy
210914|NCT02284399|Trisomy 21|trisomy 21
210915|NCT02284399|NIPT|nipt
210916|NCT02284386|Total knee arthroplasty|total knee arthroplasty
210917|NCT02284360|wound healing|wound healing
210918|NCT02284360|APOSEC™|aposec™
210919|NCT02284360|Safety|safety
210920|NCT02284334|mitochondrial diseases|mitochondrial diseases
210921|NCT02284334|nutrition|nutrition
210922|NCT02284334|glycemic index|glycemic index
210923|NCT02284308|NSCLC|nsclc
210924|NCT02284295|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
210925|NCT02284295|silica dust|silica dust
210926|NCT02284295|aromatic hydrocarbons|aromatic hydrocarbons
210927|NCT02284295|genetic|genetic
210928|NCT02284295|occupational|occupational
210929|NCT02284282|Spinal Morphine|spinal morphine
210930|NCT02284282|Laparoscopic GI-surgery|laparoscopic gi-surgery
210931|NCT02284282|Post-operative pain|post-operative pain
210932|NCT02284243|Bunion|bunion
210933|NCT02284243|Bunionectomy|bunionectomy
210934|NCT02284243|Pain|pain
210935|NCT02284243|Analgesia|analgesia
210936|NCT02284243|dexmedetomidine|dexmedetomidine
210937|NCT02284243|intranasal|intranasal
210938|NCT02284191|Radiology|radiology
210939|NCT02284191|Acute Medicine|acute medicine
210940|NCT02284191|Emergency Medicine|emergency medicine
210941|NCT02284191|Cardiology|cardiology
210942|NCT02284178|mechanical ventilation|mechanical ventilation
210943|NCT02284178|aspiration|aspiration
210944|NCT02284178|suctioning|suctioning
210945|NCT02284178|secretions|secretions
210946|NCT02284178|ventilator-associated events|ventilator-associated events
210947|NCT02284152|bottle feeding|bottle feeding
210948|NCT02284152|feeding behavior|feeding behavior
210949|NCT02284152|infants|infants
210950|NCT02284152|mothers|mothers
210951|NCT02284152|responsive feeding|responsive feeding
210952|NCT02284152|maternal feeding practices|maternal feeding practices
210953|NCT02284152|maternal feeding styles|maternal feeding styles
210954|NCT02284139|EGF ointment|egf ointment
210955|NCT02284139|EGFR inhibitor|egfr inhibitor
210956|NCT02284139|Skin side effect|skin side effect
210957|NCT02284126|Vancomycin|vancomycin
210958|NCT02284126|Anti-Infective Agents, Local|anti-infective agents, local
210959|NCT02284126|Craniotomy|craniotomy
210960|NCT02284126|surgical site infection|surgical site infection
210961|NCT02284126|wound prophylaxis|wound prophylaxis
210962|NCT02284126|Anti-Bacterial Agents|anti-bacterial agents
210963|NCT02284126|Neurosurgical Procedures|neurosurgical procedures
210964|NCT02284126|Administration, Topical|administration, topical
210965|NCT02284126|Antibiotic Prophylaxis|antibiotic prophylaxis
210966|NCT02284126|antibiotics|antibiotics
210967|NCT02284126|prophylaxis|prophylaxis
210968|NCT02284126|neurosurgery|neurosurgery
210969|NCT02284126|Bacterial Infections|bacterial infections
210970|NCT02284126|Central Nervous System Infections|central nervous system infections
210971|NCT02284087|transcranial magnetic stimulation|transcranial magnetic stimulation
211673|NCT02280109|Tenofovir|tenofovir
210972|NCT02284087|movement disorders|movement disorders
210973|NCT02284074|Lipopolysaccharide (LPS)|lipopolysaccharide (lps)
210974|NCT02284074|Biomarkers|biomarkers
210975|NCT02284074|Chemokines|chemokines
210976|NCT02284074|Cytokines|cytokines
210977|NCT02284074|Gene Expression|gene expression
210978|NCT02284074|Nasal Challenge|nasal challenge
210979|NCT02284074|Inflammation|inflammation
210980|NCT02284074|Nasal|nasal
210981|NCT02284074|Nasosorption|nasosorption
210982|NCT02284074|Respiratory|respiratory
210983|NCT02284048|Ticagrelor|ticagrelor
210984|NCT02284048|Coronary Flow Reserve|coronary flow reserve
210985|NCT02284009|New-onset type 1 diabetes mellitus|new-onset type 1 diabetes mellitus
210986|NCT02284009|Albiglutide|albiglutide
210987|NCT02283905|amphotericin-B|amphotericin-b
210988|NCT02283905|continuously infused|continuously infused
210989|NCT02283905|voriconazole|voriconazole
210990|NCT02283892|respiratory complaints|respiratory complaints
210991|NCT02283892|dyspnea|dyspnea
210992|NCT02283892|cough|cough
210993|NCT02283892|checklist|checklist
210994|NCT02283879|Human Umbilical Cord Mesenchymal Stem Cell|human umbilical cord mesenchymal stem cell
210995|NCT02283879|Mesenchymal Stem Cell|mesenchymal stem cell
210996|NCT02283879|Cerebral hemorrhage|cerebral hemorrhage
210997|NCT02283853|Pediatrics|pediatrics
210998|NCT02283749|NCSLC|ncslc
210999|NCT02283749|lung cancer|lung cancer
211000|NCT02283749|non small cell lung cancer|non small cell lung cancer
211001|NCT02283749|bone metastases|bone metastases
211002|NCT02283749|maintenance|maintenance
211003|NCT02283736|Chronic periodontitis|chronic periodontitis
211004|NCT02283736|Probiotics|probiotics
211005|NCT02283736|Non- surgical treatment|non- surgical treatment
211006|NCT02283723|older adults, goal attainment, optimal aging|older adults, goal attainment, optimal aging
211007|NCT02283710|Pentoxifylline|pentoxifylline
211008|NCT02283710|Aminotransferase|aminotransferase
211009|NCT02283710|Steatohepatitis|steatohepatitis
211010|NCT02283697|hypertension|hypertension
211011|NCT02283697|high blood pressure|high blood pressure
211012|NCT02283697|sodium|sodium
211013|NCT02283697|prevention|prevention
211014|NCT02283697|dietary sodium|dietary sodium
211015|NCT02283697|salt|salt
211016|NCT02283684|LASER|laser
211017|NCT02283684|PROSTATE|prostate
211018|NCT02283684|BIPOLAR|bipolar
211019|NCT02283684|HYPERPLASIA|hyperplasia
211020|NCT02283684|VAPORIZATION|vaporization
211021|NCT02283580|COPD|copd
211022|NCT02283580|Healthy adults|healthy adults
211023|NCT02283580|Resistance training|resistance training
211024|NCT02283580|Elastic bands|elastic bands
211025|NCT02283580|Limb muscle function|limb muscle function
211026|NCT02283580|Volunteers|volunteers
211027|NCT02283554|Periodontal Surgery|periodontal surgery
211028|NCT02283554|Periodontal Regeneration|periodontal regeneration
211029|NCT02283554|Growth factors|growth factors
211030|NCT02283554|Clinical trials|clinical trials
211031|NCT02283541|Gait|gait
211032|NCT02283541|late life depression|late life depression
211033|NCT02283541|mind-body therapies|mind-body therapies
211034|NCT02283515|chronic periodontitis|chronic periodontitis
211035|NCT02283515|local drug delivery|local drug delivery
211036|NCT02283515|rosuvastatin|rosuvastatin
211037|NCT02283515|osseo-differentiation|osseo-differentiation
211038|NCT02283502|Uterine fibroid|uterine fibroid
211039|NCT02283502|magnetic resonance imaging|magnetic resonance imaging
211040|NCT02283502|ultrasound|ultrasound
211041|NCT02283502|non-invasive therapy|non-invasive therapy
211042|NCT02283489|Recombinant Human Endostatin Adenovirus|recombinant human endostatin adenovirus
211043|NCT02283489|Head and Neck Malignant Tumor|head and neck malignant tumor
211044|NCT02283489|clinical trial|clinical trial
211045|NCT02283489|randomized|randomized
211046|NCT02283489|Endostatin|endostatin
211047|NCT02283489|gene therapy|gene therapy
211048|NCT02283476|efficacy and safety|efficacy and safety
211049|NCT02283437|Bibliotherapy|bibliotherapy
211050|NCT02283437|Problem-solving|problem-solving
211051|NCT02283437|Randomized Controlled Trial|randomized controlled trial
211052|NCT02283437|Schizophrenia Spectrum Disorders|schizophrenia spectrum disorders
211053|NCT02283437|Family Caregivers|family caregivers
211054|NCT02283385|Elder abuse|elder abuse
211055|NCT02283385|Intervention|intervention
211056|NCT02283385|Treatment|treatment
211057|NCT02283385|Detection|detection
211058|NCT02283359|Distal Esophagus|distal esophagus
211059|NCT02283359|Esophageal|esophageal
211060|NCT02283359|Gastric|gastric
211061|NCT02283359|Carcinoma|carcinoma
211062|NCT02283359|Adenocarcinoma|adenocarcinoma
211063|NCT02283359|Stomach|stomach
211064|NCT02283359|Gastro-esophageal junction|gastro-esophageal junction
211065|NCT02283359|Recurrent|recurrent
211066|NCT02283359|Metastatic|metastatic
211067|NCT02283359|Unresectable|unresectable
211068|NCT02283346|Prostate Cancer|prostate cancer
211069|NCT02283346|HDR brachytherapy|hdr brachytherapy
211070|NCT02283346|hypo fractionated external beam radiotherapy|hypo fractionated external beam radiotherapy
211071|NCT02283346|toxicity|toxicity
211072|NCT02283346|biochemical control|biochemical control
211073|NCT02283333|Behavioral Activation|behavioral activation
211074|NCT02283333|Therapeutic Exposure|therapeutic exposure
211075|NCT02283333|Mental Health|mental health
211076|NCT02283333|Veterans|veterans
211077|NCT02283333|Complicated Grief|complicated grief
211078|NCT02283333|Military|military
211079|NCT02283333|Treatment|treatment
211080|NCT02283333|Cognitive Therapy|cognitive therapy
211081|NCT02283333|Bereavement|bereavement
211082|NCT02283333|Complicated Bereavement|complicated bereavement
211083|NCT02283255|Fontan|fontan
211084|NCT02283255|Exercise|exercise
211085|NCT02283255|Pulmonary Function|pulmonary function
211086|NCT02283255|Aerobic Capacity|aerobic capacity
211087|NCT02283255|Skeletal Muscle|skeletal muscle
211088|NCT02283242|Cholinergic Antagonists|cholinergic antagonists
211089|NCT02283242|Inflammation|inflammation
211090|NCT02283242|Oxidative Stress|oxidative stress
211091|NCT02283229|Plagiocephaly|plagiocephaly
211092|NCT02283229|torticollis|torticollis
211093|NCT02283229|occlusal defect|occlusal defect
211094|NCT02283216|neuromodulation|neuromodulation
211095|NCT02283216|noninvasive|noninvasive
211096|NCT02283216|plasticity|plasticity
211097|NCT02283216|transcranial magnetic stimulation|transcranial magnetic stimulation
211098|NCT02283216|hearing|hearing
211099|NCT02283216|hyperacusis|hyperacusis
211100|NCT02283203|Paracetamol|paracetamol
211101|NCT02283203|Management of fever|management of fever
211102|NCT02283203|Infections|infections
211103|NCT02283190|Asparaginase|asparaginase
211104|NCT02283190|Glutamine|glutamine
211105|NCT02283164|Occupational health|occupational health
211106|NCT02283164|Hazardous material handling|hazardous material handling
211107|NCT02283151|Very Low Carbohydrate Diet|very low carbohydrate diet
211108|NCT02283151|Overweight/obese|overweight/obese
211109|NCT02283138|FLV, VOCAL, PA-RI, preterm fetuses, RDS|flv, vocal, pa-ri, preterm fetuses, rds
211110|NCT02283099|Ebola virus, vaccination, phase I, healthy volunteers|ebola virus, vaccination, phase i, healthy volunteers
211111|NCT02283086|Quality Improvement|quality improvement
211112|NCT02283086|Physician Feedback|physician feedback
211113|NCT02283073|Diagnosis|diagnosis
211114|NCT02283060|Atripla|atripla
211115|NCT02283060|Stribild|stribild
211116|NCT02283060|HIV|hiv
211117|NCT02283060|Sleep architecture|sleep architecture
211118|NCT02283060|Neuropsychological performance|neuropsychological performance
211119|NCT02283047|cardiovascular risk, obesity, interval training, diet|cardiovascular risk, obesity, interval training, diet
211120|NCT02283021|expression of L-type calcium subunits|expression of l-type calcium subunits
211121|NCT02282995|Functional dyspepsia|functional dyspepsia
211122|NCT02282995|symptom response|symptom response
211123|NCT02282982|Immunoprophylaxis|immunoprophylaxis
211124|NCT02282982|Palivizumab|palivizumab
211125|NCT02282969|Cancer Prevention|cancer prevention
211126|NCT02282969|Smokers|smokers
211127|NCT02282969|Quit smoking|quit smoking
211128|NCT02282969|Interviews|interviews
211129|NCT02282969|Questionnaires|questionnaires
211130|NCT02282969|Surveys|surveys
211131|NCT02282969|Lung cancer screening|lung cancer screening
211132|NCT02282969|Patient decision aid|patient decision aid
211133|NCT02282943|endometriosis|endometriosis
211134|NCT02282943|CO2 laser vapourisation|co2 laser vapourisation
211135|NCT02282943|Harmonic scalpel|harmonic scalpel
211136|NCT02282943|AFS stage I-III|afs stage i-iii
211137|NCT02282930|ACTH|acth
211138|NCT02282930|Acthar|acthar
211139|NCT02282930|IgA|iga
211140|NCT02282930|Progressive|progressive
211141|NCT02282930|Nephropathy|nephropathy
211142|NCT02282930|renal function|renal function
211143|NCT02282917|NF2|nf2
211144|NCT02282917|Vestibular Schwannoma|vestibular schwannoma
211145|NCT02282917|Schwannoma|schwannoma
211146|NCT02282917|Meningioma|meningioma
211147|NCT02282904|Bone Marrow Transplant|bone marrow transplant
211148|NCT02282904|Subablative Conditioning|subablative conditioning
211149|NCT02282904|Graft Versus Host Disease|graft versus host disease
211150|NCT02282904|Non-Myeloablative|non-myeloablative
211151|NCT02282904|Reduced Intensity|reduced intensity
211152|NCT02282891|propofol|propofol
211153|NCT02282891|ketofol|ketofol
211154|NCT02282878|High Sodium Diet|high sodium diet
211155|NCT02282878|Low Sodium Diet|low sodium diet
211156|NCT02282878|MS|ms
211157|NCT02282865|Emergence agitation, Heart rate variability (HRV)|emergence agitation, heart rate variability (hrv)
211158|NCT02282839|Head and neck cancer|head and neck cancer
211159|NCT02282839|Glutamine|glutamine
211160|NCT02282839|Oral mucositis|oral mucositis
211161|NCT02282839|Quality of life|quality of life
211162|NCT02282813|Parathyroid Diseases|parathyroid diseases
211163|NCT02282813|Renal Insufficiency|renal insufficiency
211164|NCT02282813|Kidney Failure, Chronic|kidney failure, chronic
211165|NCT02282813|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
211166|NCT02282813|Vitamin D|vitamin d
211167|NCT02282813|Hyperparathyroidism|hyperparathyroidism
211168|NCT02282813|Kidney Diseases|kidney diseases
211169|NCT02282813|Kidney Failure|kidney failure
211170|NCT02282813|Renal Insufficiency, Chronic|renal insufficiency, chronic
211171|NCT02282787|local anesthesia|local anesthesia
211172|NCT02282787|peribulbar anesthesia|peribulbar anesthesia
211173|NCT02282787|DEXMEDETOMIDINE|dexmedetomidine
211174|NCT02282787|vitreoretinal surgery|vitreoretinal surgery
211175|NCT02282774|Vitreoretinal surgery|vitreoretinal surgery
211176|NCT02282735|neuroblastoma|neuroblastoma
211177|NCT02282735|end-of-life|end-of-life
211178|NCT02282735|decision-making|decision-making
211179|NCT02282735|parent|parent
211180|NCT02282735|child|child
211181|NCT02282735|prognosis|prognosis
211182|NCT02282735|preferences|preferences
211183|NCT02282735|childhood cancer|childhood cancer
211184|NCT02282735|oncology|oncology
211185|NCT02282722|cancer|cancer
211186|NCT02282722|palliative|palliative
211187|NCT02282722|chemotherapy|chemotherapy
211188|NCT02282722|metastatic|metastatic
211189|NCT02282722|colorectal|colorectal
211190|NCT02282722|communication|communication
211191|NCT02282722|informed consent|informed consent
211192|NCT02282722|video|video
211193|NCT02282722|education|education
211194|NCT02282722|oncology|oncology
211195|NCT02282722|patient-centered|patient-centered
211196|NCT02282722|outcomes research|outcomes research
211197|NCT02282709|Immunity|immunity
211198|NCT02282657|extracorporreal|extracorporreal
211199|NCT02282657|CO2 removal|co2 removal
211200|NCT02282657|ARDS|ards
211201|NCT02282657|lung|lung
211202|NCT02282657|Protective ventilation|protective ventilation
211203|NCT02282631|active school travel|active school travel
211204|NCT02282631|active travel|active travel
211205|NCT02282631|incentive scheme|incentive scheme
211206|NCT02282631|children|children
211207|NCT02282631|school|school
211208|NCT02282631|behaviour change|behaviour change
211209|NCT02282618|Cardiac Sympathetic Blockade|cardiac sympathetic blockade
211210|NCT02282592|Metabolic syndrome|metabolic syndrome
211211|NCT02282592|case-control study|case-control study
211212|NCT02282592|Breast cancer|breast cancer
211213|NCT02282566|Muscle protein synthesis|muscle protein synthesis
211214|NCT02282514|Autoimmune Diseases|autoimmune diseases
211215|NCT02282514|Autologous Hematopoietic Stem Cell Transplantation|autologous hematopoietic stem cell transplantation
211216|NCT02282501|leptin levels|leptin levels
211217|NCT02282501|ghrelin levels|ghrelin levels
211218|NCT02282462|Chest tube|chest tube
211219|NCT02282449|Venous access device|venous access device
211220|NCT02282449|Port catheters|port catheters
211221|NCT02282449|Chemotherapy|chemotherapy
211222|NCT02282410|severe hemophilia A|severe hemophilia a
211223|NCT02282410|moderately severe hemophilia A|moderately severe hemophilia a
211224|NCT02282410|Recombinant Human Coagulation Factor VIII|recombinant human coagulation factor viii
211225|NCT02282410|standard prophylaxis|standard prophylaxis
211226|NCT02282397|Diabetes Mellitus|diabetes mellitus
211227|NCT02282371|Cetuximab|cetuximab
211228|NCT02282371|BYL719|byl719
211229|NCT02282371|IMRT (Intensity-Modulated Radiation Therapy)|imrt (intensity-modulated radiation therapy)
211230|NCT02282371|14-116|14-116
211231|NCT02282358|Mocetinostat|mocetinostat
211232|NCT02282358|14-106|14-106
211233|NCT02282345|Breast cancer|breast cancer
211234|NCT02282345|BRCA deleterious mutation|brca deleterious mutation
211235|NCT02282345|Invasive adenocarcinoma of the breast|invasive adenocarcinoma of the breast
211236|NCT02282345|BMN 673|bmn 673
211237|NCT02282345|Talazoparib tosylate|talazoparib tosylate
211238|NCT02282319|spinal or intravenous dexmedetomidine|spinal or intravenous dexmedetomidine
211239|NCT02282293|Chemoprevention|chemoprevention
211240|NCT02282293|Malaria|malaria
211241|NCT02282293|Uganda|uganda
211242|NCT02282293|Dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
211243|NCT02282293|Trimethoprim-sulfamethoxazole|trimethoprim-sulfamethoxazole
211244|NCT02282293|Human Immunodeficiency Virus|human immunodeficiency virus
211245|NCT02282267|Epidermal growth factor receptor|epidermal growth factor receptor
211246|NCT02282267|Droplet digital PCR|droplet digital pcr
211247|NCT02282254|Type 1 diabetes|type 1 diabetes
211248|NCT02282254|Hypoglycemia unawareness|hypoglycemia unawareness
211249|NCT02282254|Nocturnal hypoglycemia|nocturnal hypoglycemia
211250|NCT02282254|Closed-loop strategy|closed-loop strategy
211251|NCT02282254|Artificial pancreas|artificial pancreas
211252|NCT02282254|Glucagon|glucagon
211253|NCT02282254|Hypoglycemia|hypoglycemia
211254|NCT02282254|Insulin|insulin
211255|NCT02282241|Melatonin|melatonin
211256|NCT02282241|Sleep|sleep
211257|NCT02282241|Delirium|delirium
211258|NCT02282215|Fever|fever
211259|NCT02282215|Induction chemotherapy|induction chemotherapy
211260|NCT02282215|Infection|infection
211261|NCT02282215|Leukemia|leukemia
211262|NCT02282215|Myeloid progenitor cells|myeloid progenitor cells
211263|NCT02282215|Neutropenia|neutropenia
211264|NCT02282202|Sputum|sputum
211265|NCT02282202|Bronchiectasis|bronchiectasis
211266|NCT02282202|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
211267|NCT02282202|Airway clearance therapy|airway clearance therapy
211268|NCT02282202|Oscillatory Positive Expiratory Pressure|oscillatory positive expiratory pressure
211269|NCT02282189|Sputum|sputum
211270|NCT02282189|Airway clearance therapy|airway clearance therapy
211271|NCT02282189|Oscillatory Positive Expiratory Pressure|oscillatory positive expiratory pressure
211368|NCT02281682|photodynamic therapy|photodynamic therapy
211272|NCT02282189|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
211273|NCT02282176|Neonates|neonates
211274|NCT02282176|Preterm|preterm
211275|NCT02282176|Azithromycin|azithromycin
211276|NCT02282176|Ureaplasma|ureaplasma
211277|NCT02282176|Chronic Lung disease|chronic lung disease
211278|NCT02282176|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
211279|NCT02282150|Fatigue|fatigue
211280|NCT02282150|Quality of Life|quality of life
211281|NCT02282150|Hydrocortisone|hydrocortisone
211282|NCT02282150|Ecological Momentary Assessments|ecological momentary assessments
211283|NCT02282124|weight|weight
211284|NCT02282124|self-management|self-management
211285|NCT02282124|exercise|exercise
211286|NCT02282098|Atrial fibrillation|atrial fibrillation
211287|NCT02282098|Arrhythmias, Cardiac|arrhythmias, cardiac
211288|NCT02282098|Stroke|stroke
211289|NCT02282098|agents, anti inflammatory|agents, anti inflammatory
211290|NCT02282098|D-dimer|d-dimer
211291|NCT02282098|C-reactive protein|c-reactive protein
211292|NCT02282085|Medication Non-Adherence|medication non-adherence
211293|NCT02282085|Antipsychotic|antipsychotic
211294|NCT02282046|type 2 diabetes mellitus|type 2 diabetes mellitus
211295|NCT02282046|dental implant|dental implant
211296|NCT02282020|BRCA, ovarian, platinum, chemotherapy,|brca, ovarian, platinum, chemotherapy,
211297|NCT02282007|Quality of life|quality of life
211298|NCT02281994|PEMF|pemf
211299|NCT02281994|odontoid fracture|odontoid fracture
211300|NCT02281994|IDE|ide
211301|NCT02281994|prospective|prospective
211302|NCT02281955|Human Papillomavirus|human papillomavirus
211303|NCT02281955|Oropharynx|oropharynx
211304|NCT02281955|Oropharyngeal Squamous Cell Carcinoma|oropharyngeal squamous cell carcinoma
211305|NCT02281955|Squamous Cell Carcinoma|squamous cell carcinoma
211306|NCT02281955|Radiation Therapy|radiation therapy
211307|NCT02281955|Chemotherapy|chemotherapy
211308|NCT02281955|p16|p16
211309|NCT02281929|Alcoholic hepatitis|alcoholic hepatitis
211310|NCT02281929|corticotherapy|corticotherapy
211311|NCT02281929|antibiotherapy|antibiotherapy
211312|NCT02281929|survival|survival
211313|NCT02281929|infection|infection
211314|NCT02281929|hepato renal syndrome|hepato renal syndrome
211315|NCT02281916|Crohn disease|crohn disease
211316|NCT02281916|Immunotherapy|immunotherapy
211317|NCT02281916|Helminth antigen|helminth antigen
211318|NCT02281890|neurodevelopmental disability|neurodevelopmental disability
211319|NCT02281877|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
211320|NCT02281877|Gene Expression|gene expression
211321|NCT02281851|Endogenous antioxidants|endogenous antioxidants
211322|NCT02281851|Antioxidant supplements|antioxidant supplements
211323|NCT02281851|Vitamin Supplements|vitamin supplements
211324|NCT02281851|Exercise adaptations|exercise adaptations
211325|NCT02281851|Oxidative stress|oxidative stress
211326|NCT02281851|Redox regulation|redox regulation
211327|NCT02281851|Cycling - exercise|cycling - exercise
211328|NCT02281838|Stroke|stroke
211329|NCT02281838|Hypertension|hypertension
211330|NCT02281825|Attention-Deficit and Hyperactivity Disorder|attention-deficit and hyperactivity disorder
211331|NCT02281825|Anxiety|anxiety
211332|NCT02281825|Impulsivity|impulsivity
211333|NCT02281825|Computer Games|computer games
211334|NCT02281825|Depression|depression
211335|NCT02281812|Ablation Technique|ablation technique
211336|NCT02281812|Breast cancer|breast cancer
211337|NCT02281812|Stage 1|stage 1
211338|NCT02281812|Lumpectomy|lumpectomy
211339|NCT02281799|Azathioprine (AZA)|azathioprine (aza)
211340|NCT02281799|6-mercaptopurine (6-MP)|6-mercaptopurine (6-mp)
211341|NCT02281799|Thiopurine-S-methyltransferase (TPMT)|thiopurine-s-methyltransferase (tpmt)
211342|NCT02281799|Xanthine oxidase (XO)|xanthine oxidase (xo)
211343|NCT02281799|6-thioguanine (6-TGN)|6-thioguanine (6-tgn)
211344|NCT02281799|6-methyl-mercaptopurine (6-MMP)|6-methyl-mercaptopurine (6-mmp)
211345|NCT02281799|inflammatory bowel disease (IBD)|inflammatory bowel disease (ibd)
211346|NCT02281799|acute pancreatitis (AP)|acute pancreatitis (ap)
211347|NCT02281799|inosine triphosphate pyrophosphohydrolase (ITPA)|inosine triphosphate pyrophosphohydrolase (itpa)
211348|NCT02281799|rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
211349|NCT02281799|systemic lupus erythematosis (SLE)|systemic lupus erythematosis (sle)
211350|NCT02281799|Crohn's disease (CD)|crohn's disease (cd)
211351|NCT02281799|ulcerative colitis (UC)|ulcerative colitis (uc)
211352|NCT02281760|Histiocytosis|histiocytosis
211353|NCT02281760|Non Langerhans Cell Histiocytosis|non langerhans cell histiocytosis
211354|NCT02281760|BRAF Inhibitor|braf inhibitor
211355|NCT02281747|Biologic Therapy|biologic therapy
211356|NCT02281747|Rheumatoid Arthritis|rheumatoid arthritis
211357|NCT02281747|Arthroplasty|arthroplasty
211358|NCT02281708|normogram|normogram
211359|NCT02281708|recurrence|recurrence
211360|NCT02281708|adjuvant chemotherapy|adjuvant chemotherapy
211361|NCT02281708|disease free survival|disease free survival
211362|NCT02281708|Quality of life|quality of life
211363|NCT02281682|Keratosis, Actinic|keratosis, actinic
211364|NCT02281682|Treatment Outcome|treatment outcome
211365|NCT02281682|cost-effectiveness|cost-effectiveness
211366|NCT02281682|economic evaluation|economic evaluation
211367|NCT02281682|imiquimod|imiquimod
211369|NCT02281682|topical fluorouracil|topical fluorouracil
211370|NCT02281682|ingenol mebutate|ingenol mebutate
211371|NCT02281643|Coinfection|coinfection
211372|NCT02281643|Buruli ulcer|buruli ulcer
211373|NCT02281643|Tuberculosis|tuberculosis
211374|NCT02281643|Mansonella perstans|mansonella perstans
211375|NCT02281630|Chronic Constipation|chronic constipation
211376|NCT02281630|CC|cc
211377|NCT02281578|Sex Workers|sex workers
211378|NCT02281578|Prevention|prevention
211379|NCT02281565|attitudes|attitudes
211380|NCT02281565|blood donation|blood donation
211381|NCT02281565|blood shortage|blood shortage
211382|NCT02281552|Tofacitinib, CP-690,550, Janis kinase, JAK inhibitor, modified release, Xeljanz|tofacitinib, cp-690,550, janis kinase, jak inhibitor, modified release, xeljanz
211383|NCT02281539|Phantom Limb Pain|phantom limb pain
211384|NCT02281539|Augmented Reality|augmented reality
211385|NCT02281539|Myoelectric control|myoelectric control
211386|NCT02281539|Virtual reality|virtual reality
211387|NCT02281539|electromyography|electromyography
211388|NCT02281539|pattern recognition|pattern recognition
211389|NCT02281539|neurorehabilitation|neurorehabilitation
211390|NCT02281513|Nutrition|nutrition
211391|NCT02281487|tubal carcinoma|tubal carcinoma
211392|NCT02281487|ovarian carcinoma|ovarian carcinoma
211393|NCT02281487|tubectomy|tubectomy
211394|NCT02281487|hysterectomy|hysterectomy
211395|NCT02281487|dysplastic changes|dysplastic changes
211396|NCT02281487|Anti Mullerian Hormone|anti mullerian hormone
211397|NCT02281487|Tubal Intraepithelial Carcinoma|tubal intraepithelial carcinoma
211398|NCT02281487|Salpingectomy|salpingectomy
211399|NCT02281461|PrePex|prepex
211400|NCT02281461|Infants|infants
211401|NCT02281461|Early infants|early infants
211402|NCT02281461|Children|children
211403|NCT02281461|Circumcision|circumcision
211404|NCT02281461|HIV|hiv
211405|NCT02281461|AIDS|aids
211406|NCT02281461|Non surgical|non surgical
211407|NCT02281435|Male Circumcision|male circumcision
211408|NCT02281435|HIV Prevention|hiv prevention
211409|NCT02281435|Screen Failure Subjects|screen failure subjects
211410|NCT02281435|PrePex with Incision|prepex with incision
211411|NCT02281409|Mogamulizumab (KW-0761)|mogamulizumab (kw-0761)
211412|NCT02281409|14-135|14-135
211413|NCT02281396|safety|safety
211414|NCT02281396|rabies vaccine|rabies vaccine
211415|NCT02281396|MRC-5 cell|mrc-5 cell
211416|NCT02281383|Bacillus Calmette-Guérin (BCG)|bacillus calmette-guérin (bcg)
211417|NCT02281383|14-174|14-174
211418|NCT02281370|cyclosporine|cyclosporine
211419|NCT02281370|drug-drug interaction|drug-drug interaction
211420|NCT02281370|pharmacokinetics|pharmacokinetics
211421|NCT02281370|eltrombopag|eltrombopag
211422|NCT02281370|SB-497115|sb-497115
211423|NCT02281357|Asthma|asthma
211424|NCT02281357|Reactive Airways|reactive airways
211425|NCT02281357|Repiratory Tract Disease|repiratory tract disease
211426|NCT02281357|Obstructive Lung Disease|obstructive lung disease
211427|NCT02281357|Lung Diseases|lung diseases
211428|NCT02281344|induced blood stage malaria infection|induced blood stage malaria infection
211429|NCT02281318|Asthma control|asthma control
211430|NCT02281318|Lung function|lung function
211431|NCT02281318|Health-related quality of life|health-related quality of life
211432|NCT02281318|Mepolizumab|mepolizumab
211433|NCT02281318|Severe Eosinophilic asthma|severe eosinophilic asthma
211434|NCT02281292|Diabetic Macular Edema|diabetic macular edema
211435|NCT02281292|Intravitreal|intravitreal
211436|NCT02281292|Retina|retina
211437|NCT02281292|Ophthalmology|ophthalmology
211438|NCT02281292|Lucentis|lucentis
211439|NCT02281292|OCT|oct
211440|NCT02281253|L-carnitine|l-carnitine
211441|NCT02281253|fibre|fibre
211442|NCT02281253|bakery product|bakery product
211443|NCT02281253|insulin resistance|insulin resistance
211444|NCT02281240|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
211445|NCT02281214|lung cancer, mutations|lung cancer, mutations
211446|NCT02281214|patients|patients
211447|NCT02281214|mutations|mutations
211448|NCT02281175|Benzodiazepine withdrawal|benzodiazepine withdrawal
211449|NCT02281175|PASSE-65+ program|passe-65+ program
211450|NCT02281175|Psychosocial (non-pharmacological) intervention|psychosocial (non-pharmacological) intervention
211451|NCT02281175|Cognitive-Behavioral Therapy (CBT)|cognitive-behavioral therapy (cbt)
211452|NCT02281175|Older adults|older adults
211453|NCT02281149|breast cancer|breast cancer
211454|NCT02281149|radiotherapy|radiotherapy
211455|NCT02281149|intensity modulation|intensity modulation
211456|NCT02281149|toxicity|toxicity
211457|NCT02281136|Actinic keratosis|actinic keratosis
211458|NCT02281110|Diagnostic coronary catheterization|diagnostic coronary catheterization
211459|NCT02281110|Multi-vessel coronary disease|multi-vessel coronary disease
211460|NCT02281110|Percutaneous Coronary Intervention|percutaneous coronary intervention
211461|NCT02281110|Instantaneous wave free ratio|instantaneous wave free ratio
211462|NCT02281110|Fractional flow reserve|fractional flow reserve
211463|NCT02281097|Postural Orthostatic Tachycardia Syndrome|postural orthostatic tachycardia syndrome
211464|NCT02281097|POTS|pots
211465|NCT02281097|Vagal Stimulation|vagal stimulation
211466|NCT02281084|Keywords provided by Celgene:|keywords provided by celgene:
211467|NCT02281084|myelodysplastic syndromes|myelodysplastic syndromes
211468|NCT02281084|MDS|mds
211469|NCT02281084|azacitidine|azacitidine
211470|NCT02281084|oral azacitidine (CC-486)|oral azacitidine (cc-486)
211471|NCT02281084|decitabine|decitabine
211472|NCT02281084|intermediate-1|intermediate-1
211473|NCT02281084|intermediate-2 and high risk myelodysplastic syndromes (MDS)|intermediate-2 and high risk myelodysplastic syndromes (mds)
211474|NCT02281084|proliferative chronic myelomonocytic leukemia (CMML)|proliferative chronic myelomonocytic leukemia (cmml)
211475|NCT02281084|Chronic|chronic
211476|NCT02281084|iHMA (injectable hypomethylating agents)|ihma (injectable hypomethylating agents)
211477|NCT02281084|PD-L1|pd-l1
211478|NCT02281032|Palliative Care|palliative care
211479|NCT02281032|Nursing Homes|nursing homes
211480|NCT02281032|interRAI Palliative Care instrument|interrai palliative care instrument
211481|NCT02281032|Older adults|older adults
211482|NCT02280980|Stroke|stroke
211483|NCT02280980|Postural Balance|postural balance
211484|NCT02280980|Oculomotor and Gaze Stability Exercises|oculomotor and gaze stability exercises
211485|NCT02280980|Rehabilitation|rehabilitation
211486|NCT02280980|Physical therapy|physical therapy
211487|NCT02280980|Outpatient|outpatient
211488|NCT02280967|Adolescent|adolescent
211489|NCT02280967|Attitude|attitude
211490|NCT02280967|Condom|condom
211491|NCT02280967|Human Papillomavirus Vaccines|human papillomavirus vaccines
211492|NCT02280967|Primary prevention|primary prevention
211493|NCT02280967|School Health|school health
211494|NCT02280954|Solid Tumor|solid tumor
211495|NCT02280915|female|female
211496|NCT02280915|subjects|subjects
211497|NCT02280902|auto-immune diseases|auto-immune diseases
211498|NCT02280902|inflammatory diseases|inflammatory diseases
211499|NCT02280902|risk factors|risk factors
211500|NCT02280902|infections|infections
211501|NCT02280902|cohort study|cohort study
211502|NCT02280889|quality of life|quality of life
211503|NCT02280889|nevus or scar|nevus or scar
211504|NCT02280889|stigmatization|stigmatization
211505|NCT02280889|scar|scar
211506|NCT02280876|MS|ms
211507|NCT02280876|Demyelinating Autoimmune Diseases|demyelinating autoimmune diseases
211508|NCT02280876|CNS|cns
211509|NCT02280876|Nervous System Diseases|nervous system diseases
211510|NCT02280850|Angina|angina
211511|NCT02280837|GLP-1|glp-1
211512|NCT02280824|Transcaval|transcaval
211513|NCT02280824|TAVR|tavr
211514|NCT02280824|AMPLATZER(R) Occluder|amplatzer(r) occluder
211515|NCT02280811|HPV positive|hpv positive
211516|NCT02280811|Metastatic|metastatic
211517|NCT02280811|Diet|diet
211518|NCT02280811|Screening|screening
211519|NCT02280811|Risk Factors|risk factors
211520|NCT02280811|Colorectal adenoma|colorectal adenoma
211521|NCT02280811|Refractory|refractory
211522|NCT02280811|Immunotherapy|immunotherapy
211523|NCT02280811|Reproductive Cancers|reproductive cancers
211524|NCT02280798|ERA|era
211525|NCT02280772|glucomannan|glucomannan
211526|NCT02280772|obesity|obesity
211527|NCT02280772|children|children
211528|NCT02280772|overweight|overweight
211529|NCT02280772|adolescents|adolescents
211530|NCT02280772|treatment|treatment
211531|NCT02280759|diarrhea, gelatin tannate, acute gastroenteritis|diarrhea, gelatin tannate, acute gastroenteritis
211532|NCT02280733|Qualified Clinical Data Registry|qualified clinical data registry
211533|NCT02280733|Quality Measures|quality measures
211534|NCT02280733|Meaningful Use Stage 2|meaningful use stage 2
211535|NCT02280733|Electronic Health Records|electronic health records
211536|NCT02280733|Clinical Data Research Network|clinical data research network
211537|NCT02280733|Real world data|real world data
211538|NCT02280720|titanium-nitride-oxide-coated stent|titanium-nitride-oxide-coated stent
211539|NCT02280720|everolimus-eluting stent|everolimus-eluting stent
211540|NCT02280720|optical coherence tomography|optical coherence tomography
211541|NCT02280720|strut coverage|strut coverage
211542|NCT02280681|reproductive medicine|reproductive medicine
211543|NCT02280681|artificial gametes|artificial gametes
211544|NCT02280681|patient preference|patient preference
211545|NCT02280681|decision making|decision making
211546|NCT02280668|muscle|muscle
211547|NCT02280668|muscle repair|muscle repair
211548|NCT02280668|tissue repair|tissue repair
211549|NCT02280668|eccentric exercise|eccentric exercise
211550|NCT02280668|force loss|force loss
211551|NCT02280668|icing|icing
211552|NCT02280668|cold therapy|cold therapy
211553|NCT02280668|DOMS|doms
211554|NCT02280668|soreness|soreness
211555|NCT02280668|recovery|recovery
211556|NCT02280655|Blood Transfusions|blood transfusions
211557|NCT02280642|Human papillomavirus|human papillomavirus
211558|NCT02280642|Cervical cancer|cervical cancer
211559|NCT02280642|Genital warts|genital warts
211560|NCT02280642|Vaccine|vaccine
211561|NCT02280642|Immunogenicity|immunogenicity
211562|NCT02280564|motivational interviewing|motivational interviewing
211563|NCT02280564|problem solving skills|problem solving skills
211564|NCT02280564|family communication|family communication
211565|NCT02280564|technology support|technology support
211566|NCT02280564|cell phone system|cell phone system
211567|NCT02280551|adolescent|adolescent
211570|NCT02280551|epidemiology|epidemiology
211571|NCT02280538|Knee Osteoarthritis|knee osteoarthritis
211572|NCT02280538|Intra-Articular Hyaluronic Acid|intra-articular hyaluronic acid
211573|NCT02280538|disease modifying|disease modifying
211574|NCT02280525|Leukemia|leukemia
211575|NCT02280525|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
211576|NCT02280525|CLL|cll
211577|NCT02280525|Natural Killer Cells|natural killer cells
211578|NCT02280525|NK|nk
211579|NCT02280525|Umbilical Cord Blood|umbilical cord blood
211580|NCT02280525|UCB|ucb
211581|NCT02280525|Lenalidomide|lenalidomide
211582|NCT02280525|CC-5013|cc-5013
211583|NCT02280525|Revlimid|revlimid
211584|NCT02280525|Rituximab|rituximab
211585|NCT02280525|Rituxan|rituxan
211586|NCT02280525|Fludarabine|fludarabine
211587|NCT02280525|Fludarabine phosphate|fludarabine phosphate
211588|NCT02280525|Fludara|fludara
211589|NCT02280525|Cyclophosphamide|cyclophosphamide
211590|NCT02280525|Cytoxan|cytoxan
211591|NCT02280525|Neosar|neosar
211592|NCT02280525|Cytarabine|cytarabine
211593|NCT02280525|Ara-C|ara-c
211594|NCT02280525|Cytosar|cytosar
211595|NCT02280525|DepoCyt|depocyt
211596|NCT02280525|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
211597|NCT02280512|noninvasive cardiac output measurement(NICOM)|noninvasive cardiac output measurement(nicom)
211598|NCT02280512|Leg fractures|leg fractures
211599|NCT02280512|Near-Infrared Spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
211600|NCT02280512|Intensive care unit(ICU)|intensive care unit(icu)
211601|NCT02280486|saxagliptin|saxagliptin
211602|NCT02280486|glimepiride|glimepiride
211603|NCT02280486|metformin monotherapy|metformin monotherapy
211604|NCT02280421|HSV|hsv
211605|NCT02280421|Herpes|herpes
211606|NCT02280421|volunteers|volunteers
211607|NCT02280421|drug-drug interaction|drug-drug interaction
211608|NCT02280421|transplant|transplant
211609|NCT02280382|splinting|splinting
211610|NCT02280369|posture detection|posture detection
211611|NCT02280369|healthy subjects|healthy subjects
211612|NCT02280356|Radiation Therapy|radiation therapy
211613|NCT02280356|Brachytherapy|brachytherapy
211614|NCT02280356|14-163|14-163
211615|NCT02280343|forced oscillation tecnique|forced oscillation tecnique
211616|NCT02280343|lung function|lung function
211617|NCT02280343|asbestosis|asbestosis
211618|NCT02280330|Iodine Deficiency|iodine deficiency
211619|NCT02280330|Micronutrient Powder|micronutrient powder
211620|NCT02280330|Hypothyroidism|hypothyroidism
211621|NCT02280304|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
211622|NCT02280304|Concussion, Mild|concussion, mild
211623|NCT02280304|Brain Injuries|brain injuries
211624|NCT02280304|Community Integration|community integration
211625|NCT02280304|Meditation|meditation
211626|NCT02280304|Magnetic Resonance Imaging|magnetic resonance imaging
211627|NCT02280278|colon cancer|colon cancer
211628|NCT02280278|cytokine-induced killer cell immunotherapy|cytokine-induced killer cell immunotherapy
211629|NCT02280265|hemophilia A|hemophilia a
211630|NCT02280265|standard prophylaxis|standard prophylaxis
211631|NCT02280265|Recombinant Human Coagulation Factor VIII for injection|recombinant human coagulation factor viii for injection
211632|NCT02280265|ADVATE|advate
211633|NCT02280265|Pediatric|pediatric
211634|NCT02280252|Locally-advanced Breast Cancer|locally-advanced breast cancer
211635|NCT02280252|LABC|labc
211636|NCT02280252|breast cancer|breast cancer
211637|NCT02280252|breast|breast
211638|NCT02280252|cancer|cancer
211639|NCT02280252|metastasis|metastasis
211640|NCT02280252|metastatic|metastatic
211641|NCT02280252|tumor|tumor
211642|NCT02280252|radiation|radiation
211643|NCT02280252|radiation therapy|radiation therapy
211644|NCT02280252|radiotherapy|radiotherapy
211645|NCT02280252|paclitaxel|paclitaxel
211646|NCT02280239|Fever|fever
211647|NCT02280239|Acetaminophen|acetaminophen
211648|NCT02280239|Body Temperature Regulation|body temperature regulation
211649|NCT02280239|Critical Illness|critical illness
211650|NCT02280239|Hypotension|hypotension
211651|NCT02280200|claudication|claudication
211652|NCT02280200|ankle foot orthoses|ankle foot orthoses
211653|NCT02280200|community walking exercise|community walking exercise
211654|NCT02280187|InductOs|inductos
211655|NCT02280187|rhBMP-2|rhbmp-2
211656|NCT02280187|Retrospective|retrospective
211657|NCT02280187|France|france
211658|NCT02280187|Fusion|fusion
211659|NCT02280187|real world use|real world use
211660|NCT02280174|Apo B-48|apo b-48
211661|NCT02280174|TRL|trl
211662|NCT02280174|Linagliptin|linagliptin
211663|NCT02280148|Propofol|propofol
211664|NCT02280148|gastroscopy and colonoscopy|gastroscopy and colonoscopy
211665|NCT02280148|driving simulator|driving simulator
211666|NCT02280148|driving ability|driving ability
211667|NCT02280148|cognitive function|cognitive function
211668|NCT02280148|patients|patients
211669|NCT02280122|activated matrix metalloproteinase 8|activated matrix metalloproteinase 8
211670|NCT02280122|untreated moderate/severe chronic periodontitis|untreated moderate/severe chronic periodontitis
211671|NCT02280122|saliva|saliva
211672|NCT02280122|sensitivity/specificity|sensitivity/specificity
211674|NCT02280109|Healthy Volunteers|healthy volunteers
211675|NCT02280109|HIV|hiv
211676|NCT02280109|pharmacokinetics of tenofovir gel and film|pharmacokinetics of tenofovir gel and film
211677|NCT02280096|Cognitive function|cognitive function
211678|NCT02280096|Multiple sclerosis|multiple sclerosis
211679|NCT02280096|4-aminopyridine|4-aminopyridine
211680|NCT02280096|Fatigue|fatigue
211681|NCT02280083|Spasticity, Post-Stroke|spasticity, post-stroke
211682|NCT02280083|Botulinum toxin type A for Injection|botulinum toxin type a for injection
211683|NCT02280083|upper limb spasticity|upper limb spasticity
211684|NCT02280070|resectable rectal cancer|resectable rectal cancer
211685|NCT02280070|SOX|sox
211686|NCT02280070|mFOLFOX6|mfolfox6
211687|NCT02280070|neoadjuvant|neoadjuvant
211688|NCT02280057|PCOS|pcos
211689|NCT02280057|metformin|metformin
211690|NCT02280057|obesity|obesity
211691|NCT02280057|randomized controlled trial|randomized controlled trial
211692|NCT02280044|Campylobacter jejuni|campylobacter jejuni
211693|NCT02280044|rifaximin|rifaximin
211694|NCT02280044|antibiotic prophylaxis|antibiotic prophylaxis
211695|NCT02280044|dysentery|dysentery
211696|NCT02280044|diarrhea|diarrhea
211697|NCT02280031|Twin Pregnancy|twin pregnancy
211698|NCT02280031|Pregnancy Complications|pregnancy complications
211699|NCT02280018|Healthy|healthy
211700|NCT02280018|JNJ-49122944|jnj-49122944
211701|NCT02280018|Placebo|placebo
211702|NCT02280005|Dialysis|dialysis
211703|NCT02280005|Renal Failure|renal failure
211704|NCT02280005|Wearable|wearable
211705|NCT02280005|Artificial Kidney|artificial kidney
211706|NCT02280005|Hemodialysis|hemodialysis
211707|NCT02279992|Malignant Glioma|malignant glioma
211708|NCT02279992|Brain Neoplasms, Malignant|brain neoplasms, malignant
211709|NCT02279992|Brain metastasis|brain metastasis
211710|NCT02279979|PHP|php
211711|NCT02279979|Cardiogenic Shock|cardiogenic shock
211712|NCT02279979|Percutaneous|percutaneous
211713|NCT02279979|Ventricular Assist|ventricular assist
211714|NCT02279979|Heart Pump|heart pump
211715|NCT02279979|Catheter|catheter
211716|NCT02279979|Thoratec Corporation|thoratec corporation
211717|NCT02279940|rivaroxaban|rivaroxaban
211718|NCT02279940|stroke|stroke
211719|NCT02279940|transient ischemic attack|transient ischemic attack
211720|NCT02279940|ischemia|ischemia
211721|NCT02279927|Ureteroscopy|ureteroscopy
211722|NCT02279901|Obstructive Sleep Apnea|obstructive sleep apnea
211723|NCT02279901|CPAP|cpap
211724|NCT02279901|Continuous positive airway pressure|continuous positive airway pressure
211725|NCT02279901|CPAP compliance|cpap compliance
211726|NCT02279901|Telemedicine|telemedicine
211727|NCT02279901|Automated response mechanisms|automated response mechanisms
211728|NCT02279901|Patient engagement|patient engagement
211729|NCT02279901|OSA|osa
211730|NCT02279888|Pulmonary Artery Pressure Monitoring|pulmonary artery pressure monitoring
211731|NCT02279888|Implantable Hemodynamic Monitor|implantable hemodynamic monitor
211732|NCT02279875|Tuberculosis|tuberculosis
211733|NCT02279875|Drug-Sensitive Tuberculosis|drug-sensitive tuberculosis
211734|NCT02279875|Linezolid|linezolid
211735|NCT02279875|HRZE (isoniazid, rifampicin, pyrazinamide, ethambutol)|hrze (isoniazid, rifampicin, pyrazinamide, ethambutol)
211736|NCT02279875|Pulmonary Tuberculosis|pulmonary tuberculosis
211737|NCT02279875|TB|tb
211738|NCT02279849|multi-level intervention|multi-level intervention
211739|NCT02279849|price discounts|price discounts
211740|NCT02279849|communication|communication
211741|NCT02279849|low income population|low income population
211742|NCT02279849|dietary intervention|dietary intervention
211743|NCT02279849|obesity prevention|obesity prevention
211744|NCT02279849|store-based intervention|store-based intervention
211745|NCT02279836|Patients with any indication for colonoscopy in the U.S.A.|patients with any indication for colonoscopy in the u.s.a.
211746|NCT02279823|androgen|androgen
211747|NCT02279823|alopecia|alopecia
211748|NCT02279823|CB-03-01|cb-03-01
211749|NCT02279823|solution|solution
211750|NCT02279823|topical|topical
211751|NCT02279810|organ shortage|organ shortage
211752|NCT02279810|attitudes to organ transplantation|attitudes to organ transplantation
211753|NCT02279797|bone marrow|bone marrow
211754|NCT02279797|attitude|attitude
211755|NCT02279771|colorectal anastomosis|colorectal anastomosis
211756|NCT02279771|anastomotic leak|anastomotic leak
211757|NCT02279771|ileostomy|ileostomy
211758|NCT02279771|complications|complications
211759|NCT02279758|Neuroendocrine Tumors|neuroendocrine tumors
211760|NCT02279758|The Mammalian Target of Rapamycin (mTOR)|the mammalian target of rapamycin (mtor)
211761|NCT02279758|metformin|metformin
211762|NCT02279693|Raypilot dosimetry|raypilot dosimetry
211763|NCT02279693|CBCT (cone beam computed tomography)|cbct (cone beam computed tomography)
211764|NCT02279654|Lenalidomide|lenalidomide
211765|NCT02279654|Revlimid|revlimid
211766|NCT02279654|Transfusion-dependent|transfusion-dependent
211767|NCT02279654|international Prognostic Scoring System (IPSS) low|international prognostic scoring system (ipss) low
211768|NCT02279654|Intermediate-1-risk|intermediate-1-risk
211769|NCT02279654|MDS|mds
211770|NCT02279654|Isolated del(5q)|isolated del(5q)
211771|NCT02279654|Prospective|prospective
211772|NCT02279654|Non-interventional|non-interventional
211773|NCT02279654|Post-authorization safety study (PASS)|post-authorization safety study (pass)
211774|NCT02279654|Disease registry|disease registry
211775|NCT02279628|cesarean section|cesarean section
211776|NCT02279628|spinal anesthesia|spinal anesthesia
211777|NCT02279628|continuous wound infiltration|continuous wound infiltration
211778|NCT02279628|intrathecal morphine|intrathecal morphine
211779|NCT02279628|oral morphine|oral morphine
211780|NCT02279615|Overactive Bladder|overactive bladder
211781|NCT02279615|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
211782|NCT02279615|Combination Therapy|combination therapy
211783|NCT02279615|β3-Adrenoceptor Agonist|β3-adrenoceptor agonist
211784|NCT02279615|Mirabegron|mirabegron
211785|NCT02279615|Myrbetriq|myrbetriq
211786|NCT02279615|α-Adrenoceptor Antagonist|α-adrenoceptor antagonist
211787|NCT02279615|Tamsulosin|tamsulosin
211788|NCT02279615|Flomax|flomax
211789|NCT02279602|Pancreatic|pancreatic
211790|NCT02279602|Gastrointestional|gastrointestional
211791|NCT02279589|hyporesponsiveness|hyporesponsiveness
211792|NCT02279589|vaccination|vaccination
211793|NCT02279589|recommendations|recommendations
211794|NCT02279589|improvement|improvement
211795|NCT02279589|schedule|schedule
211796|NCT02279589|fractional dose|fractional dose
211797|NCT02279589|conjugate polysaccharide vaccine|conjugate polysaccharide vaccine
211798|NCT02279576|Penile squamous cell carcinoma|penile squamous cell carcinoma
211799|NCT02279576|Pazopanib|pazopanib
211800|NCT02279576|Weekly paclitaxel|weekly paclitaxel
211801|NCT02279550|hip fracture, elderly|hip fracture, elderly
211802|NCT02279537|Wet age-related macular Degeneration (Wet-AMD)|wet age-related macular degeneration (wet-amd)
211803|NCT02279537|Naïve patients|naïve patients
211804|NCT02279537|Real life|real life
211805|NCT02279537|Aflibercept|aflibercept
211806|NCT02279524|NASH|nash
211807|NCT02279511|Alzheimer|alzheimer
211808|NCT02279485|Healthy Subjects|healthy subjects
211809|NCT02279485|Bioequivalence|bioequivalence
211810|NCT02279485|Fasted|fasted
211811|NCT02279485|Fed|fed
211812|NCT02279433|Neoplasms|neoplasms
211813|NCT02279433|Lung Neoplasms|lung neoplasms
211814|NCT02279433|Colorectal Neoplasms|colorectal neoplasms
211815|NCT02279433|Neuroendocrine Tumors|neuroendocrine tumors
211816|NCT02279433|Pancreatic Neoplasms|pancreatic neoplasms
211817|NCT02279407|omega-3 carboxylic acid|omega-3 carboxylic acid
211818|NCT02279394|Smoldering myeloma|smoldering myeloma
211819|NCT02279394|Smoldering Multiple Myeloma|smoldering multiple myeloma
211820|NCT02279381|Chlorhexidine|chlorhexidine
211821|NCT02279381|Kangaroo mother care|kangaroo mother care
211822|NCT02279381|RCT|rct
211823|NCT02279342|Coronary artery disease|coronary artery disease
211824|NCT02279342|hyperuricemia|hyperuricemia
211825|NCT02279342|coronary plaque volume|coronary plaque volume
211826|NCT02279342|IVUS|ivus
211827|NCT02279316|Dalcroze eurhythmics|dalcroze eurhythmics
211828|NCT02279316|home exercise|home exercise
211829|NCT02279316|vitamin D|vitamin d
211830|NCT02279316|mild cognitive impairment|mild cognitive impairment
211831|NCT02279316|MCI|mci
211832|NCT02279316|mild dementia|mild dementia
211833|NCT02279290|Childhood trauma|childhood trauma
211834|NCT02279264|ph|ph
211835|NCT02279264|RightSpot Infant|rightspot infant
211836|NCT02279264|Feeding Tube|feeding tube
211837|NCT02279264|RightBio Metrics|rightbio metrics
211838|NCT02279264|placement|placement
211839|NCT02279264|Nasogastric Tube|nasogastric tube
211840|NCT02279264|NG|ng
211841|NCT02279264|infant|infant
211842|NCT02279251|Anxiety|anxiety
211843|NCT02279251|adolescents|adolescents
211844|NCT02279251|school-based|school-based
211845|NCT02279251|low-intensity CBT|low-intensity cbt
211846|NCT02279225|Phototherapy|phototherapy
211847|NCT02279225|Laser|laser
211848|NCT02279225|Fibromyalgia|fibromyalgia
211849|NCT02279225|DTM/ TMD|dtm/ tmd
211850|NCT02279225|Pain|pain
211851|NCT02279212|Critical illness|critical illness
211852|NCT02279212|pain|pain
211853|NCT02279212|quality of life|quality of life
211854|NCT02279199|hemophilia|hemophilia
211855|NCT02279199|joint health|joint health
211856|NCT02279199|motor development|motor development
211857|NCT02279199|motor proficiency|motor proficiency
211858|NCT02279173|Pediatric|pediatric
211859|NCT02279173|Immune Thrombocytopenia|immune thrombocytopenia
211860|NCT02279173|Amgen|amgen
211861|NCT02279147|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
211862|NCT02279147|Jaundice, Obstructive|jaundice, obstructive
211863|NCT02279147|anti-inflammatory|anti-inflammatory
211864|NCT02279134|StageⅡB-Ⅲ esophageal cancer|stageⅱb-ⅲ esophageal cancer
211865|NCT02279134|adjuvant radiotherapy|adjuvant radiotherapy
211866|NCT02279134|adjuvant chemoradiotherapy|adjuvant chemoradiotherapy
211867|NCT02279121|central venous catheter|central venous catheter
211868|NCT02279121|Taurolidine|taurolidine
211869|NCT02279121|lock-therapy|lock-therapy
211870|NCT02279108|sentinel lymph node|sentinel lymph node
211871|NCT02279108|indocyanine green|indocyanine green
211872|NCT02279108|fluorescence method|fluorescence method
211975|NCT02278731|Pilates|pilates
211873|NCT02279108|radioisotope conventional method|radioisotope conventional method
211874|NCT02279108|breast cancer|breast cancer
211875|NCT02279095|Open-label extension study|open-label extension study
211876|NCT02279095|Clinical trial Phase 2|clinical trial phase 2
211877|NCT02279095|Efficacy and safety|efficacy and safety
211878|NCT02279095|Heterotopic ossification|heterotopic ossification
211879|NCT02279095|Fibrodysplasia Ossificans Progressiva|fibrodysplasia ossificans progressiva
211880|NCT02279095|Flare-up|flare-up
211881|NCT02279095|Palovarotene|palovarotene
211882|NCT02279095|Retinoic acid receptor agonist|retinoic acid receptor agonist
211883|NCT02279095|Retinoic acid receptor gamma agonist|retinoic acid receptor gamma agonist
211884|NCT02279095|Clementia|clementia
211885|NCT02279095|Myositis Ossificans Progressiva|myositis ossificans progressiva
211886|NCT02279095|Munchmeyer's Disease|munchmeyer's disease
211887|NCT02279095|FOP|fop
211888|NCT02279069|stroke|stroke
211889|NCT02279069|walking|walking
211890|NCT02279069|rehabilitation|rehabilitation
211891|NCT02279043|IUD|iud
211892|NCT02279043|IUC|iuc
211893|NCT02279043|birth control|birth control
211894|NCT02279043|contraception|contraception
211895|NCT02279043|online|online
211896|NCT02279030|ablation|ablation
211897|NCT02279017|Mobile Technology|mobile technology
211898|NCT02279017|Diet and Fitness|diet and fitness
211899|NCT02279004|Plasma Genotyping|plasma genotyping
211900|NCT02279004|NSCLC|nsclc
211901|NCT02279004|Melanoma|melanoma
211902|NCT02278978|urothelial carcinoma|urothelial carcinoma
211903|NCT02278978|BIBF1120|bibf1120
211904|NCT02278965|Breast Cancer|breast cancer
211905|NCT02278965|Early Stage|early stage
211906|NCT02278939|diabetes prevention|diabetes prevention
211907|NCT02278939|Filipinos|filipinos
211908|NCT02278939|lifestyle intervention|lifestyle intervention
211909|NCT02278926|Ultrasound|ultrasound
211910|NCT02278926|Lypo-hypertrophy|lypo-hypertrophy
211911|NCT02278913|inpatient|inpatient
211912|NCT02278913|hospital|hospital
211913|NCT02278913|randomized trial|randomized trial
211914|NCT02278913|diabetes|diabetes
211915|NCT02278913|analogs|analogs
211916|NCT02278913|human insulin|human insulin
211917|NCT02278900|communication|communication
211918|NCT02278900|shared decision-making|shared decision-making
211919|NCT02278887|melanoma|melanoma
211920|NCT02278887|TIL treatment|til treatment
211921|NCT02278887|tumor infiltrating lymphocytes|tumor infiltrating lymphocytes
211922|NCT02278887|ipilimumab|ipilimumab
211923|NCT02278887|interleukin 2|interleukin 2
211924|NCT02278887|non-myeloablative|non-myeloablative
211925|NCT02278887|randomization|randomization
211926|NCT02278874|Trisomy 13|trisomy 13
211927|NCT02278874|Trisomy 18|trisomy 18
211928|NCT02278874|Trisomy 21|trisomy 21
211929|NCT02278874|Sex Chromosome Abnormalities|sex chromosome abnormalities
211930|NCT02278874|Monosomy X|monosomy x
211931|NCT02278874|XXX|xxx
211932|NCT02278874|XXY|xxy
211933|NCT02278874|XYY|xyy
211934|NCT02278861|actinic keratosis|actinic keratosis
211935|NCT02278861|tretinoin|tretinoin
211936|NCT02278861|isotretinoin|isotretinoin
211937|NCT02278861|cryotherapy|cryotherapy
211938|NCT02278861|sun protection factor|sun protection factor
211939|NCT02278861|clinical clearance|clinical clearance
211940|NCT02278848|Computerised gait analysis|computerised gait analysis
211941|NCT02278848|Ultrasound measurement of cerebral pulsatility|ultrasound measurement of cerebral pulsatility
211942|NCT02278848|MRI flow|mri flow
211943|NCT02278848|Urinary incontinence scale|urinary incontinence scale
211944|NCT02278848|Subtractive lumbar puncture|subtractive lumbar puncture
211945|NCT02278835|Cardiac valve|cardiac valve
211946|NCT02278809|physical activity|physical activity
211947|NCT02278809|screen time|screen time
211948|NCT02278809|vegetables|vegetables
211949|NCT02278809|fruit|fruit
211950|NCT02278809|snacks|snacks
211951|NCT02278809|softdrink|softdrink
211952|NCT02278809|water|water
211953|NCT02278809|fruit juice|fruit juice
211954|NCT02278809|parenting practices|parenting practices
211955|NCT02278809|online videos|online videos
211956|NCT02278809|intervention mapping protocol|intervention mapping protocol
211957|NCT02278796|Diffuse large B-cell lymphomas (DLBC)|diffuse large b-cell lymphomas (dlbc)
211958|NCT02278796|Follicular lymphomas (FL)|follicular lymphomas (fl)
211959|NCT02278796|Mantle cell lymphomas (MCL)|mantle cell lymphomas (mcl)
211960|NCT02278770|diverticular disease|diverticular disease
211961|NCT02278770|MRI|mri
211962|NCT02278770|visceral and subcutaneous fat|visceral and subcutaneous fat
211963|NCT02278770|adipokines|adipokines
211964|NCT02278757|Metabolic syndrome|metabolic syndrome
211965|NCT02278757|Weight loss|weight loss
211966|NCT02278757|Obesity|obesity
211967|NCT02278757|Hypertension|hypertension
211968|NCT02278757|Dyslipidemia|dyslipidemia
211969|NCT02278744|Single-Fraction Stereotactic Radiosurgery|single-fraction stereotactic radiosurgery
211970|NCT02278744|Salvage Re-Irradiation|salvage re-irradiation
211971|NCT02278744|14-054|14-054
211972|NCT02278731|Physical activity|physical activity
211973|NCT02278731|Rehabilitation|rehabilitation
211974|NCT02278731|Older adults|older adults
211976|NCT02278731|Proprioceptive neuromuscular facilitation|proprioceptive neuromuscular facilitation
211977|NCT02278705|childhood obesity|childhood obesity
211978|NCT02278705|childhood overweight|childhood overweight
211979|NCT02278705|primary care|primary care
211980|NCT02278705|weight management|weight management
211981|NCT02278692|Vitamin K|vitamin k
211982|NCT02278692|Calciphylaxis|calciphylaxis
211983|NCT02278692|Calcific uremic arteriolopathy|calcific uremic arteriolopathy
211984|NCT02278692|Dialysis|dialysis
211985|NCT02278692|End-stage renal disease|end-stage renal disease
211986|NCT02278653|Restaging|restaging
211987|NCT02278653|Watchful Waiting|watchful waiting
211988|NCT02278653|Quality of Life|quality of life
211989|NCT02278653|Manometry|manometry
211990|NCT02278601|Breakthrough pain|breakthrough pain
211991|NCT02278575|antithrombin, Atenativ, preeclampsia, blood flow.|antithrombin, atenativ, preeclampsia, blood flow.
211992|NCT02278549|Spinal kinematics|spinal kinematics
211993|NCT02278536|Trisomy 13|trisomy 13
211994|NCT02278536|Trisomy 18|trisomy 18
211995|NCT02278536|Trisomy 21|trisomy 21
211996|NCT02278536|Sex Chromosome Abnormalities|sex chromosome abnormalities
211997|NCT02278536|Monosomy X|monosomy x
211998|NCT02278536|XXX|xxx
211999|NCT02278536|XXY|xxy
212000|NCT02278536|XYY|xyy
212001|NCT02278510|topotecan|topotecan
212002|NCT02278510|convection-enhanced delivery|convection-enhanced delivery
212003|NCT02278510|CED|ced
212004|NCT02278510|High Grade Glioma|high grade glioma
212005|NCT02278484|sinus infections|sinus infections
212006|NCT02278484|sinusitis|sinusitis
212007|NCT02278484|chronic sinusitis|chronic sinusitis
212008|NCT02278484|rhinosinusitis|rhinosinusitis
212009|NCT02278484|allergic sinusitis|allergic sinusitis
212010|NCT02278484|allergic rhinitis|allergic rhinitis
212011|NCT02278484|chronic rhinosinusitis|chronic rhinosinusitis
212012|NCT02278484|sinus disease in children|sinus disease in children
212013|NCT02278484|sinus balloon dilation|sinus balloon dilation
212014|NCT02278484|balloon dilatation|balloon dilatation
212015|NCT02278484|sinus disease|sinus disease
212016|NCT02278484|pediatric|pediatric
212017|NCT02278471|combination pill|combination pill
212018|NCT02278471|polypill|polypill
212019|NCT02278471|primary prevention|primary prevention
212020|NCT02278445|Systemic Sclerosis|systemic sclerosis
212021|NCT02278445|Pulmonary hypertension|pulmonary hypertension
212022|NCT02278445|Lung Doppler Signals|lung doppler signals
212023|NCT02278432|risk assessment|risk assessment
212024|NCT02278432|pharmacovigilance|pharmacovigilance
212025|NCT02278432|pharmacoepidemiology|pharmacoepidemiology
212026|NCT02278432|drug toxicity|drug toxicity
212027|NCT02278432|adverse drug reaction reporting system|adverse drug reaction reporting system
212028|NCT02278432|omeprazole|omeprazole
212029|NCT02278419|Hepatitis C|hepatitis c
212030|NCT02278419|Simeprevir|simeprevir
212031|NCT02278419|Sofosbuvir|sofosbuvir
212032|NCT02278419|Healthy|healthy
212033|NCT02278406|Parkinson's Disease|parkinson's disease
212034|NCT02278406|Deep brain stimulator|deep brain stimulator
212035|NCT02278406|dbs|dbs
212036|NCT02278393|Japanese healthy volunteers|japanese healthy volunteers
212037|NCT02278393|High LDL-C|high ldl-c
212038|NCT02278393|dairy drinks|dairy drinks
212039|NCT02278393|phytosterols|phytosterols
212040|NCT02278341|ASP1517|asp1517
212041|NCT02278341|FG-4592|fg-4592
212042|NCT02278341|Anemia|anemia
212043|NCT02278341|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
212044|NCT02278341|Erythropoetin Stimulating Agents (ESAs)|erythropoetin stimulating agents (esas)
212045|NCT02278341|Chronic Kidney Disease|chronic kidney disease
212046|NCT02278341|Hematopoetic Agents|hematopoetic agents
212047|NCT02278341|HIF-PH inhibitor|hif-ph inhibitor
212048|NCT02278341|Hemoglobin|hemoglobin
212049|NCT02278341|Dialysis|dialysis
212050|NCT02278341|roxadustat|roxadustat
212051|NCT02278328|dose titration study|dose titration study
212052|NCT02278328|electrophysiology|electrophysiology
212053|NCT02278315|Multiple Myeloma|multiple myeloma
212054|NCT02278315|Radiopharmaceutical|radiopharmaceutical
212055|NCT02278315|Therapy|therapy
212056|NCT02278315|Phase 1|phase 1
212057|NCT02278263|tranexamic acid|tranexamic acid
212058|NCT02278263|enhanced recovery|enhanced recovery
212059|NCT02278263|arthroplasty|arthroplasty
212060|NCT02278263|perioperative care|perioperative care
212061|NCT02278250|VX14-803-001|vx14-803-001
212062|NCT02278250|VX-803|vx-803
212063|NCT02278250|M4344|m4344
212064|NCT02278250|Advanced Solid Tumor|advanced solid tumor
212065|NCT02278250|Cytotoxic Chemotherapy|cytotoxic chemotherapy
212066|NCT02278250|Gemcitabine|gemcitabine
212067|NCT02278250|Cisplatin|cisplatin
212068|NCT02278250|Carboplatin|carboplatin
212069|NCT02278198|thyroid cancer|thyroid cancer
212070|NCT02278172|vitamin D|vitamin d
212071|NCT02278172|athletes|athletes
212072|NCT02278172|fitness|fitness
212073|NCT02278159|end-stage kidney disease|end-stage kidney disease
212074|NCT02278159|peritoneal dialysis|peritoneal dialysis
212075|NCT02278159|home hemodialysis|home hemodialysis
212076|NCT02278159|technique survival|technique survival
212077|NCT02278159|patient survival|patient survival
212078|NCT02278133|metastatic,|metastatic,
212079|NCT02278133|Colorectal cancer,|colorectal cancer,
212080|NCT02278133|WNT974,|wnt974,
212081|NCT02278133|LGX818,|lgx818,
212082|NCT02278133|cetuximab,|cetuximab,
212083|NCT02278133|BRAF-mutant,|braf-mutant,
212084|NCT02278133|mCRC,|mcrc,
212085|NCT02278133|BRAFV600-mutant,|brafv600-mutant,
212086|NCT02278133|KRAS|kras
212087|NCT02278120|HR-positive|hr-positive
212088|NCT02278120|HER2-negative|her2-negative
212089|NCT02278120|Advanced breast cancer|advanced breast cancer
212090|NCT02278120|Letrozole|letrozole
212091|NCT02278120|Anastrozole|anastrozole
212092|NCT02278120|Tamoxifen|tamoxifen
212093|NCT02278120|Goserelin|goserelin
212094|NCT02278120|CDK|cdk
212095|NCT02278120|CDK4|cdk4
212096|NCT02278120|CDK6|cdk6
212097|NCT02278120|CDK4/6|cdk4/6
212098|NCT02278120|Phase III|phase iii
212099|NCT02278120|ER-positive|er-positive
212100|NCT02278120|PR-positive|pr-positive
212101|NCT02278120|Premenopausal|premenopausal
212102|NCT02278094|OSAS|osas
212103|NCT02278094|Adult|adult
212104|NCT02278094|Home-based|home-based
212105|NCT02278094|Genioglossus|genioglossus
212106|NCT02278094|Inspiratory muscle|inspiratory muscle
212107|NCT02278094|Exercise|exercise
212108|NCT02278081|Rhinitis (nasal obstruction) and GERD|rhinitis (nasal obstruction) and gerd
212109|NCT02278068|Type 2 diabetes|type 2 diabetes
212110|NCT02278055|Radium-223|radium-223
212111|NCT02278055|14-098|14-098
212112|NCT02278055|Prostate Cancer Clinical Trials Consortium|prostate cancer clinical trials consortium
212113|NCT02278016|procalcitonin|procalcitonin
212114|NCT02278016|interleukin-6|interleukin-6
212115|NCT02278016|agiotensininⅡ|agiotensininⅱ
212116|NCT02278003|Amnesic|amnesic
212117|NCT02278003|Propofol|propofol
212118|NCT02278003|12-006|12-006
212119|NCT02277977|sepsis|sepsis
212120|NCT02277977|septic shock|septic shock
212121|NCT02277977|contrast-enhanced ultrasound|contrast-enhanced ultrasound
212122|NCT02277977|microcirculation|microcirculation
212123|NCT02277964|RRMS|rrms
212124|NCT02277964|Natalizumab|natalizumab
212125|NCT02277964|Fingolimod|fingolimod
212126|NCT02277964|Treatment Change|treatment change
212127|NCT02277964|Disease Activity|disease activity
212128|NCT02277925|Pelvic Organ Prolapse|pelvic organ prolapse
212129|NCT02277925|Vaginal mesh exposure rates|vaginal mesh exposure rates
212130|NCT02277925|Vaginal suture exposure rates|vaginal suture exposure rates
212131|NCT02277912|ICH|ich
212132|NCT02277912|Stroke|stroke
212133|NCT02277912|Navigated|navigated
212134|NCT02277912|Placebo|placebo
212135|NCT02277912|TMS|tms
212136|NCT02277899|childhood obesity|childhood obesity
212137|NCT02277899|overweight|overweight
212138|NCT02277899|communication|communication
212139|NCT02277899|primary care|primary care
212140|NCT02277899|weight management|weight management
212141|NCT02277899|communication methods|communication methods
212142|NCT02277899|patient-centered communication|patient-centered communication
212143|NCT02277886|sodium alginate|sodium alginate
212144|NCT02277886|esomeprazole|esomeprazole
212145|NCT02277886|GERD|gerd
212146|NCT02277873|moon|moon
212147|NCT02277873|parturition|parturition
212148|NCT02277873|moon phases|moon phases
212149|NCT02277860|Exercise|exercise
212150|NCT02277847|Idarubicin|idarubicin
212151|NCT02277847|Cytosine arabinoside|cytosine arabinoside
212152|NCT02277847|Efficacy|efficacy
212153|NCT02277847|Safety|safety
212154|NCT02277821|Essential Hypertension|essential hypertension
212155|NCT02277821|Central Blood Pressure|central blood pressure
212156|NCT02277821|Microcirculation|microcirculation
212157|NCT02277821|Endothelium Stimulation|endothelium stimulation
212158|NCT02277808|Pneumocystis|pneumocystis
212159|NCT02277808|Nebulizer|nebulizer
212160|NCT02277808|Pentamidine|pentamidine
212161|NCT02277795|Early infant male circumcision|early infant male circumcision
212162|NCT02277795|HIV|hiv
212163|NCT02277795|Prevention|prevention
212164|NCT02277795|AccuCirc|accucirc
212165|NCT02277795|Kenya|kenya
212166|NCT02277795|Providers|providers
212167|NCT02277795|Parents|parents
212168|NCT02277782|Labor|labor
212169|NCT02277782|Analgesia|analgesia
212170|NCT02277756|high functioning autism|high functioning autism
212171|NCT02277756|endogenous modulation systems|endogenous modulation systems
212172|NCT02277730|Hypotension|hypotension
212173|NCT02277717|cancer|cancer
212174|NCT02277717|metastasis|metastasis
212175|NCT02277717|HER2|her2
212176|NCT02277717|trastuzumab|trastuzumab
212177|NCT02277717|duocarmycin|duocarmycin
212178|NCT02277717|SYD985|syd985
212179|NCT02277717|antibody-drug conjugate|antibody-drug conjugate
212180|NCT02277717|ADC|adc
212181|NCT02277717|trastuzumab vc-seco-DUBA|trastuzumab vc-seco-duba
212182|NCT02277704|PTSD|ptsd
212183|NCT02277704|Military-related PTSD and other related conditions|military-related ptsd and other related conditions
212184|NCT02277691|Pharmacological therapy|pharmacological therapy
212185|NCT02277691|Drug Therapy|drug therapy
212186|NCT02277678|Pruritus|pruritus
212375|NCT02276430|Survivor|survivor
212187|NCT02277665|Cannabis Use Disorder|cannabis use disorder
212188|NCT02277665|Tobacco Use|tobacco use
212189|NCT02277665|Treatment|treatment
212190|NCT02277639|Transplant related mortality|transplant related mortality
212191|NCT02277639|Graft versus host disease|graft versus host disease
212192|NCT02277639|Bone marrow transplant|bone marrow transplant
212193|NCT02277613|stem cells|stem cells
212194|NCT02277587|Plenadren|plenadren
212195|NCT02277587|Addison's disease|addison's disease
212196|NCT02277587|Hydrocortisone|hydrocortisone
212197|NCT02277587|Cortisone Acetate|cortisone acetate
212198|NCT02277587|Monocytes|monocytes
212199|NCT02277587|Natural Killer cells|natural killer cells
212200|NCT02277587|Immunological profile|immunological profile
212201|NCT02277587|Inflammation|inflammation
212202|NCT02277574|Rheumatoid arthritis|rheumatoid arthritis
212203|NCT02277574|Arthritis|arthritis
212204|NCT02277574|Joint diseases|joint diseases
212205|NCT02277574|Musculoskeletal diseases|musculoskeletal diseases
212206|NCT02277548|chemotherapy|chemotherapy
212207|NCT02277548|radiation therapy|radiation therapy
212208|NCT02277535|Malnutrition in the ICU (caloric deficit >4000 kcal or 150 g protein deficit) or >48hrs of admission without receiving nutrition|malnutrition in the icu (caloric deficit >4000 kcal or 150 g protein deficit) or >48hrs of admission without receiving nutrition
212209|NCT02277470|pharmacokinetics, Golimumab, IBD|pharmacokinetics, golimumab, ibd
212210|NCT02277444|Methotrexate|methotrexate
212211|NCT02277444|Anti-TNFα Antibody|anti-tnfα antibody
212212|NCT02277444|Golimumab|golimumab
212213|NCT02277444|Pediatric Participants|pediatric participants
212214|NCT02277379|cardiac surgery ; hemorrhage ; transfusion requirements|cardiac surgery ; hemorrhage ; transfusion requirements
212215|NCT02277366|Lung Neoplasms|lung neoplasms
212216|NCT02277366|Bronchoscopy|bronchoscopy
212217|NCT02277366|Early Detection of Cancer|early detection of cancer
212218|NCT02277353|Fluid responsiveness|fluid responsiveness
212219|NCT02277353|NICOM|nicom
212220|NCT02277353|Prone Position|prone position
212221|NCT02277353|Stroke Volume Variation|stroke volume variation
212222|NCT02277327|Hospitalization|hospitalization
212223|NCT02277327|Readmissions|readmissions
212224|NCT02277327|Medical complexity|medical complexity
212225|NCT02277301|Pilot study|pilot study
212226|NCT02277301|Randomised Controlled Trial|randomised controlled trial
212227|NCT02277301|Parenting|parenting
212228|NCT02277301|Paediatrics|paediatrics
212229|NCT02277301|Mental Health|mental health
212230|NCT02277275|Branched chain amino acid, high protein diet, weight loss|branched chain amino acid, high protein diet, weight loss
212231|NCT02277262|peritonitis patients|peritonitis patients
212232|NCT02277236|sarcopenia|sarcopenia
212233|NCT02277236|aging|aging
212234|NCT02277236|insulin resistance|insulin resistance
212235|NCT02277236|screening|screening
212236|NCT02277184|Intermediate Risk HNSCC|intermediate risk hnscc
212237|NCT02277184|High Risk HNSCC|high risk hnscc
212238|NCT02277184|Previously Untreated, Locally Advanced HNSCC|previously untreated, locally advanced hnscc
212239|NCT02277184|Undifferentiated carcinoma|undifferentiated carcinoma
212240|NCT02277184|Poorly differentiated carcinoma of the oral cavity|poorly differentiated carcinoma of the oral cavity
212241|NCT02277184|Poorly differentiated carcinoma of the oropharynx|poorly differentiated carcinoma of the oropharynx
212242|NCT02277184|Poorly differentiated carcinoma of the larynx|poorly differentiated carcinoma of the larynx
212243|NCT02277184|Poorly differentiated carcinoma of the hypopharynx|poorly differentiated carcinoma of the hypopharynx
212244|NCT02277158|Rectal cancer|rectal cancer
212245|NCT02277158|S-1|s-1
212246|NCT02277158|Chemoradiotherapy|chemoradiotherapy
212247|NCT02277158|Phase I|phase i
212248|NCT02277145|radiation-induced pulmonary fibrosis|radiation-induced pulmonary fibrosis
212249|NCT02277145|MSCs|mscs
212250|NCT02277132|Fetal growth restriction|fetal growth restriction
212251|NCT02277132|Sildenafil|sildenafil
212252|NCT02277080|Pain, opioids, immune system, endocrine system, quality of life|pain, opioids, immune system, endocrine system, quality of life
212253|NCT02277067|PPH|pph
212254|NCT02277041|PPH|pph
212255|NCT02277002|Cabin Air Filtration|cabin air filtration
212256|NCT02277002|Particulate Matter|particulate matter
212257|NCT02277002|Commuter Exposure|commuter exposure
212258|NCT02277002|Traffic Related Air Pollution|traffic related air pollution
212259|NCT02276989|Chronic Pain|chronic pain
212260|NCT02276989|Compliance Marker|compliance marker
212261|NCT02276989|Narcotic Abuse|narcotic abuse
212262|NCT02276989|Opioid related disorders|opioid related disorders
212263|NCT02276989|Opiate substitution treatment|opiate substitution treatment
212264|NCT02276989|Buprenorphrine|buprenorphrine
212265|NCT02276989|Suboxone|suboxone
212266|NCT02276989|Lyrica|lyrica
212267|NCT02276989|Pregabalin|pregabalin
212268|NCT02276989|Acetazolamide|acetazolamide
212269|NCT02276989|Quinine|quinine
212270|NCT02276989|Compliance|compliance
212271|NCT02276976|crebral white matter lesions|crebral white matter lesions
212272|NCT02276976|brain networks|brain networks
212273|NCT02276976|MRI|mri
212274|NCT02276976|DTI|dti
212275|NCT02276976|fMRI|fmri
212276|NCT02276976|cognitive impairment|cognitive impairment
212277|NCT02276976|gene|gene
212376|NCT02276430|Cardiovascular disease|cardiovascular disease
212278|NCT02276963|Transverse myelitis, optic neuritis, neuromyelitis optica|transverse myelitis, optic neuritis, neuromyelitis optica
212279|NCT02276950|Cardiac Surgery|cardiac surgery
212280|NCT02276950|Epidemiologic Methods|epidemiologic methods
212281|NCT02276950|Blood Transfusions|blood transfusions
212282|NCT02276937|Recombinant Sendai virus|recombinant sendai virus
212283|NCT02276937|fibroblast growth factor-2|fibroblast growth factor-2
212284|NCT02276937|treadmill|treadmill
212285|NCT02276924|Laser Confocal Microscopy|laser confocal microscopy
212286|NCT02276924|Superior Urinary Tract Tumors|superior urinary tract tumors
212287|NCT02276898|pediatric|pediatric
212288|NCT02276898|lung clearance index|lung clearance index
212289|NCT02276898|Multiple Breath Washout|multiple breath washout
212290|NCT02276898|Hypertonic Saline|hypertonic saline
212291|NCT02276885|breast|breast
212292|NCT02276885|cancer|cancer
212293|NCT02276885|breast cancer|breast cancer
212294|NCT02276885|prone|prone
212295|NCT02276885|partial breast irradiation|partial breast irradiation
212296|NCT02276885|PBI|pbi
212297|NCT02276872|pediatric|pediatric
212298|NCT02276872|treprostinil|treprostinil
212299|NCT02276872|transition|transition
212300|NCT02276872|Remodulin|remodulin
212301|NCT02276859|dual-wave bolus|dual-wave bolus
212302|NCT02276859|square bolus|square bolus
212303|NCT02276859|normal bolus|normal bolus
212304|NCT02276859|standard bolus|standard bolus
212305|NCT02276859|high-protein meal|high-protein meal
212306|NCT02276859|prandial insulin requirement|prandial insulin requirement
212307|NCT02276846|Palpitate-Eluting Balloon|palpitate-eluting balloon
212308|NCT02276846|Bifurcation|bifurcation
212309|NCT02276846|OCT|oct
212310|NCT02276846|Transluminal|transluminal
212311|NCT02276820|Adenovirus|adenovirus
212312|NCT02276820|Virus specific T cells|virus specific t cells
212313|NCT02276820|Viral infections|viral infections
212314|NCT02276807|Depression|depression
212315|NCT02276807|Behavioral Symptoms|behavioral symptoms
212316|NCT02276807|Mental Disorders|mental disorders
212317|NCT02276807|Depressive Disorder|depressive disorder
212318|NCT02276807|suicidal ideation|suicidal ideation
212319|NCT02276807|primary health care|primary health care
212320|NCT02276807|Veterans|veterans
212321|NCT02276794|Low back pain|low back pain
212322|NCT02276794|Thrust manipulation|thrust manipulation
212323|NCT02276794|Spinal manipulation|spinal manipulation
212324|NCT02276794|Joint mobilization|joint mobilization
212325|NCT02276794|Non-thrust manipulation|non-thrust manipulation
212326|NCT02276794|proprioception|proprioception
212327|NCT02276794|Postural stability|postural stability
212328|NCT02276794|Baropodometry|baropodometry
212329|NCT02276781|PAD|pad
212330|NCT02276781|Peripheral Arterial Disease|peripheral arterial disease
212331|NCT02276781|Biomarkers|biomarkers
212332|NCT02276768|rectal distension|rectal distension
212333|NCT02276768|rectal compliance|rectal compliance
212334|NCT02276768|visceral pain|visceral pain
212335|NCT02276768|pain intensity|pain intensity
212336|NCT02276768|barostat|barostat
212337|NCT02276768|distender|distender
212338|NCT02276768|VAS (Visual Analog Scale)|vas (visual analog scale)
212339|NCT02276768|rectal sensory threshold|rectal sensory threshold
212340|NCT02276768|analgesia|analgesia
212341|NCT02276768|trimebutine|trimebutine
212342|NCT02276768|pain management|pain management
212343|NCT02276768|peripheral|peripheral
212344|NCT02276768|colon cancer|colon cancer
212345|NCT02276768|H2S (hydrogen sulfide)|h2s (hydrogen sulfide)
212346|NCT02276729|Upper limb|upper limb
212347|NCT02276729|Rehabilitation|rehabilitation
212348|NCT02276729|Occupational Therapy|occupational therapy
212349|NCT02276729|Mirror Box Therapy|mirror box therapy
212350|NCT02276690|iron deficiency|iron deficiency
212351|NCT02276690|dosage of hepcidin|dosage of hepcidin
212352|NCT02276690|usual biomarker (ferritin and transferrin saturation)|usual biomarker (ferritin and transferrin saturation)
212353|NCT02276690|mass spectrometry|mass spectrometry
212354|NCT02276690|immuno-detection|immuno-detection
212355|NCT02276690|anaemia in intensive care unit|anaemia in intensive care unit
212356|NCT02276664|lung cancer prevention|lung cancer prevention
212357|NCT02276560|main tumor ranging from less than 3cm (T1 up to 7cm (T3)|main tumor ranging from less than 3cm (t1 up to 7cm (t3)
212358|NCT02276547|Mitral|mitral
212359|NCT02276547|Regurgitation|regurgitation
212360|NCT02276547|Heart valve|heart valve
212361|NCT02276547|Transcatheter|transcatheter
212362|NCT02276547|Transapical|transapical
212363|NCT02276547|Functional|functional
212364|NCT02276547|Degenerative|degenerative
212365|NCT02276547|Symptomatic, severe mitral valve regurgitation, high risk for open mitral valve surgery|symptomatic, severe mitral valve regurgitation, high risk for open mitral valve surgery
212366|NCT02276495|pain management for total knee arthroplasty|pain management for total knee arthroplasty
212367|NCT02276469|severe mental illness|severe mental illness
212368|NCT02276443|Breast Cancer|breast cancer
212369|NCT02276443|Triple-negative breast cancer|triple-negative breast cancer
212370|NCT02276443|TNBC|tnbc
212371|NCT02276443|Molecular testing|molecular testing
212372|NCT02276443|Standard chemotherapy|standard chemotherapy
212373|NCT02276443|Ultrasound|ultrasound
212374|NCT02276430|Testicular cancer|testicular cancer
212377|NCT02276430|Risk factors|risk factors
212378|NCT02276417|Sepsis|sepsis
212379|NCT02276417|Surgical ICU|surgical icu
212380|NCT02276313|Peripheral|peripheral
212381|NCT02276313|Infrainguinal|infrainguinal
212382|NCT02276313|Drug Releasing Balloon|drug releasing balloon
212383|NCT02276313|Drug Eluting Balloon|drug eluting balloon
212384|NCT02276287|Adherence|adherence
212385|NCT02276287|HAART|haart
212386|NCT02276287|HIV|hiv
212387|NCT02276287|Illness Perception|illness perception
212388|NCT02276287|IPQ-R|ipq-r
212389|NCT02276235|catgut embedding|catgut embedding
212390|NCT02276235|obese women|obese women
212391|NCT02276235|obesity-related hormones|obesity-related hormones
212392|NCT02276222|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
212393|NCT02276222|COPD|copd
212394|NCT02276157|cholangioscopy|cholangioscopy
212395|NCT02276105|Carpal Tunnel Syndrome|carpal tunnel syndrome
212396|NCT02276105|Quality of Life|quality of life
212397|NCT02276105|EQ-5D|eq-5d
212398|NCT02276105|SF-12|sf-12
212399|NCT02276105|Michigan Hand Questionnaire|michigan hand questionnaire
212400|NCT02276092|Community-acquired pneumonia|community-acquired pneumonia
212401|NCT02276092|Pragmatic study|pragmatic study
212402|NCT02276092|Multi-center|multi-center
212403|NCT02276092|Time-dependent bias|time-dependent bias
212404|NCT02276092|antimicrobial stewardship|antimicrobial stewardship
212405|NCT02276092|prospective audit and feedback|prospective audit and feedback
212406|NCT02276079|Mild Traumatic Brain Injury|mild traumatic brain injury
212407|NCT02276079|Aerobic Exercise|aerobic exercise
212408|NCT02276079|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
212409|NCT02276066|kidney dysfunction|kidney dysfunction
212410|NCT02276066|chronic critical illness|chronic critical illness
212411|NCT02276066|sepsis|sepsis
212412|NCT02276066|Glomerular filtration rate|glomerular filtration rate
212413|NCT02276053|Epilepsy|epilepsy
212414|NCT02276053|Brain tumor|brain tumor
212415|NCT02276053|lacosamide (LCM)|lacosamide (lcm)
212416|NCT02276053|Anti-Epileptic Drugs (AEDs)|anti-epileptic drugs (aeds)
212417|NCT02276040|Arthroplasty|arthroplasty
212418|NCT02276040|Knee Replacement|knee replacement
212419|NCT02276040|Analgesia|analgesia
212420|NCT02276040|pain|pain
212421|NCT02276027|adenocarcinoma lung cancer,squamous cell lung carcinoma, NSCLC|adenocarcinoma lung cancer,squamous cell lung carcinoma, nsclc
212422|NCT02276014|Beta carotene|beta carotene
212423|NCT02276014|Retinol|retinol
212424|NCT02276001|Adult Volunteers|adult volunteers
212425|NCT02275988|Adult Volunteers|adult volunteers
212426|NCT02275975|Adult Volunteers|adult volunteers
212427|NCT02275962|Adult Volunteers|adult volunteers
212428|NCT02275949|SAH (Subarachnoid Hemorrhage)|sah (subarachnoid hemorrhage)
212429|NCT02275949|Cerebral Vasospasm|cerebral vasospasm
212430|NCT02275949|Acupuncture|acupuncture
212431|NCT02275936|N91115|n91115
212432|NCT02275936|Cavosonstat|cavosonstat
212433|NCT02275910|Solid Tumors|solid tumors
212434|NCT02275910|E7090|e7090
212435|NCT02275897|Lower Segmental Caesarean Section (LSCS)|lower segmental caesarean section (lscs)
212436|NCT02275897|Speed of Injection|speed of injection
212437|NCT02275897|Spinal Anaesthesia|spinal anaesthesia
212438|NCT02275897|Anesthesia|anesthesia
212439|NCT02275884|Parkinson Disease|parkinson disease
212440|NCT02275884|Cacao|cacao
212441|NCT02275884|Biogenic amines|biogenic amines
212442|NCT02275884|Xanthines|xanthines
212443|NCT02275884|Neurodegenerative Diseases|neurodegenerative diseases
212444|NCT02275871|Breast Cancer|breast cancer
212445|NCT02275858|balloon assisted enteroscopy|balloon assisted enteroscopy
212446|NCT02275858|terminal ileum intubation|terminal ileum intubation
212447|NCT02275845|metformin|metformin
212448|NCT02275845|prevention|prevention
212449|NCT02275819|Heart Failure|heart failure
212450|NCT02275819|Exercise|exercise
212451|NCT02275819|Echocardiography|echocardiography
212452|NCT02275741|Vaccine|vaccine
212453|NCT02275741|Antibody response|antibody response
212454|NCT02275741|relaps rate|relaps rate
212455|NCT02275741|expanded disability status scale|expanded disability status scale
212456|NCT02275728|Menopause|menopause
212457|NCT02275728|Stress Urinary Incontinence|stress urinary incontinence
212458|NCT02275728|EMG Biofeedback|emg biofeedback
212459|NCT02275728|Pelvic Floor Muscle Training|pelvic floor muscle training
212460|NCT02275728|Quality of life|quality of life
212461|NCT02275728|Physical Therapie|physical therapie
212462|NCT02275715|autism spectrum disorder (ASD)|autism spectrum disorder (asd)
212463|NCT02275715|feeding problems|feeding problems
212464|NCT02275702|Dexamethasone|dexamethasone
212465|NCT02275702|Quality of recovery questionnaire|quality of recovery questionnaire
212466|NCT02275702|QoR-40|qor-40
212467|NCT02275702|Lung cancer|lung cancer
212468|NCT02275702|Video-assisted thoracoscopic|video-assisted thoracoscopic
212469|NCT02275689|Rotator cuff|rotator cuff
212470|NCT02275689|Tendinosis|tendinosis
212471|NCT02275689|Impingement|impingement
212472|NCT02275689|radiofrequency|radiofrequency
212473|NCT02275676|Inflammatory bowel disease|inflammatory bowel disease
212474|NCT02275676|Nutritional Status|nutritional status
212475|NCT02275676|Malnutrition|malnutrition
212476|NCT02275676|Resting Energy Expenditure|resting energy expenditure
212477|NCT02275663|relapsed AML|relapsed aml
212478|NCT02275663|refractory AML|refractory aml
212479|NCT02275663|azacytidine|azacytidine
212480|NCT02275650|calcidiol|calcidiol
212481|NCT02275650|25(oh)d|25(oh)d
212482|NCT02275650|nbUVB|nbuvb
212483|NCT02275650|cyp27A1|cyp27a1
212484|NCT02275650|cyp27B1|cyp27b1
212485|NCT02275650|vitamin D|vitamin d
212486|NCT02275637|Implantable Cardioverter-Defibrillators|implantable cardioverter-defibrillators
212487|NCT02275637|Ventricular Fibrillation|ventricular fibrillation
212488|NCT02275637|ventricular Tachycardia|ventricular tachycardia
212489|NCT02275611|oxytocin|oxytocin
212490|NCT02275611|alcohol withdrawal|alcohol withdrawal
212491|NCT02275611|alcohol dependence|alcohol dependence
212492|NCT02275611|alcoholism|alcoholism
212493|NCT02275585|Portal vein|portal vein
212494|NCT02275585|Thrombosis|thrombosis
212495|NCT02275585|Cirrhosis|cirrhosis
212496|NCT02275481|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
212497|NCT02275481|COPD|copd
212498|NCT02275481|Emphysema|emphysema
212499|NCT02275481|Chronic bronchitis|chronic bronchitis
212500|NCT02275468|Chronic Kidney Disease|chronic kidney disease
212501|NCT02275468|eGFR slope|egfr slope
212502|NCT02275468|Herbal medicine Fu-zheng-qu-zhuo Oral liquid|herbal medicine fu-zheng-qu-zhuo oral liquid
212503|NCT02275442|EPICES scale|epices scale
212504|NCT02275442|Precarious situation|precarious situation
212505|NCT02275442|Rural parturient women|rural parturient women
212506|NCT02275442|Access to care|access to care
212507|NCT02275442|Global Initiative for Sentinel E-health Network on Grid|global initiative for sentinel e-health network on grid
212508|NCT02275442|General practice|general practice
212509|NCT02275429|Metabolic Diseases|metabolic diseases
212510|NCT02275429|Athletes|athletes
212511|NCT02275429|Running|running
212512|NCT02275429|Selenium|selenium
212513|NCT02275429|Zinc|zinc
212514|NCT02275429|Iron Metabolism Disorders|iron metabolism disorders
212515|NCT02275429|Water-Electrolyte Imbalance|water-electrolyte imbalance
212516|NCT02275429|Hyperkalemia|hyperkalemia
212517|NCT02275429|Hypernatremia|hypernatremia
212518|NCT02275429|Selenium levels before and after the race|selenium levels before and after the race
212519|NCT02275429|Levels of other electrolytes and markers|levels of other electrolytes and markers
212520|NCT02275390|mental illness|mental illness
212521|NCT02275390|psychoeducation|psychoeducation
212522|NCT02275390|nurse-led clinic|nurse-led clinic
212523|NCT02275390|randomized controlled trial|randomized controlled trial
212524|NCT02275377|Breathing Exercises; Autonomic Control; Blood Pressure.|breathing exercises; autonomic control; blood pressure.
212525|NCT02275351|alopecia|alopecia
212526|NCT02275351|topical|topical
212527|NCT02275351|Samumed|samumed
212528|NCT02275325|Posture|posture
212529|NCT02275325|Unilateral vestibular deafferentation|unilateral vestibular deafferentation
212530|NCT02275325|Medical management|medical management
212531|NCT02275325|Preoperative vestibular rehabilitation|preoperative vestibular rehabilitation
212532|NCT02275325|Neural plasticity|neural plasticity
212533|NCT02275286|sarcoma|sarcoma
212534|NCT02275273|Adnexal Masses|adnexal masses
212535|NCT02275273|Magnetic Resonance Imaging|magnetic resonance imaging
212536|NCT02275273|Anatomopathology|anatomopathology
212537|NCT02275247|Stellate ganglion block|stellate ganglion block
212538|NCT02275247|Aneurysm surgery|aneurysm surgery
212539|NCT02275247|Cognitive recovery|cognitive recovery
212540|NCT02275247|Cerebral vasospasm|cerebral vasospasm
212541|NCT02275234|cardiac arrest|cardiac arrest
212542|NCT02275234|psychological intervention|psychological intervention
212543|NCT02275221|Hepatitis B (HBV)|hepatitis b (hbv)
212544|NCT02275221|Hepatitis C (HCV)|hepatitis c (hcv)
212545|NCT02275195|hepatitis|hepatitis
212546|NCT02275195|alcohol|alcohol
212547|NCT02275182|Dexmedetomidine|dexmedetomidine
212548|NCT02275169|follicle stimulating hormone treatment|follicle stimulating hormone treatment
212549|NCT02275169|azoospermia nonobstructive|azoospermia nonobstructive
212550|NCT02275169|male infertility|male infertility
212551|NCT02275169|follicle stimulating hormone|follicle stimulating hormone
212552|NCT02275156|Subjects with normal renal function or severe renal impairment (RI) or end stage renal disease (ESRD) receiving hemodialysis|subjects with normal renal function or severe renal impairment (ri) or end stage renal disease (esrd) receiving hemodialysis
212553|NCT02275143|Computed Tomography of Thorax, Abdomen and Pelvis|computed tomography of thorax, abdomen and pelvis
212554|NCT02275143|cancer patients|cancer patients
212555|NCT02275143|coronary angiogram evaluation|coronary angiogram evaluation
212556|NCT02275130|glottic insufficiency|glottic insufficiency
212557|NCT02275130|calcium hydroxyapatite|calcium hydroxyapatite
212558|NCT02275130|augmentation of vocal cords with injection technique|augmentation of vocal cords with injection technique
212559|NCT02275117|Migraine Disorders|migraine disorders
212560|NCT02275117|ALD403|ald403
212561|NCT02275104|Ventricular arrhythmias|ventricular arrhythmias
212562|NCT02275104|Persistent atrial fibrillation|persistent atrial fibrillation
212563|NCT02275104|Ablation guidance|ablation guidance
212564|NCT02275104|Software|software
212565|NCT02275104|MRI (Magnetic resonance imaging)|mri (magnetic resonance imaging)
212566|NCT02275091|Children|children
212567|NCT02275091|Cholesterol|cholesterol
212568|NCT02275078|COPD|copd
212569|NCT02275078|Action Plan|action plan
212570|NCT02275078|Telesystem|telesystem
212571|NCT02275078|New technology|new technology
212572|NCT02275065|HIV-1 Infected|hiv-1 infected
212573|NCT02275065|Adults|adults
212574|NCT02275065|Treatment Naive|treatment naive
212575|NCT02275052|shuttle walk test|shuttle walk test
212576|NCT02275052|umeclidinium|umeclidinium
212577|NCT02275052|beta2-agonist|beta2-agonist
212578|NCT02275052|exercise endurance time|exercise endurance time
212579|NCT02275052|anticholinergic|anticholinergic
212580|NCT02275052|combination product|combination product
212581|NCT02275052|vilanterol|vilanterol
212582|NCT02275052|exercise|exercise
212583|NCT02275052|COPD|copd
212584|NCT02275026|General Anesthesia, Postoperative Delirium, Recovery|general anesthesia, postoperative delirium, recovery
212585|NCT02274974|incisional|incisional
212586|NCT02274974|infiltration|infiltration
212587|NCT02274974|cs|cs
212588|NCT02274974|lidocaine|lidocaine
212589|NCT02274974|epinephrine|epinephrine
212590|NCT02274974|Adverse Reaction to Topical or Infiltrative Lidocaine|adverse reaction to topical or infiltrative lidocaine
212591|NCT02274922|Campylobacter diagnosis,|campylobacter diagnosis,
212592|NCT02274922|immuno-chromatographic test, ELISA, PCR, culture, stool|immuno-chromatographic test, elisa, pcr, culture, stool
212593|NCT02274922|ELISA,|elisa,
212594|NCT02274922|PCR,|pcr,
212595|NCT02274922|culture, stool|culture, stool
212596|NCT02274909|electromyography|electromyography
212597|NCT02274909|aged|aged
212598|NCT02274909|muscle strength|muscle strength
212599|NCT02274909|wavelet analysis|wavelet analysis
212600|NCT02274909|pilates|pilates
212601|NCT02274909|proprioceptive neuromuscular facilitation|proprioceptive neuromuscular facilitation
212602|NCT02274857|FIRMap|firmap
212603|NCT02274857|Rotor|rotor
212604|NCT02274857|FIRM-guided procedure|firm-guided procedure
212605|NCT02274857|REAFFIRM|reaffirm
212606|NCT02274805|Brown adipose tissue|brown adipose tissue
212607|NCT02274805|Neck surgery|neck surgery
212608|NCT02274779|Prostate Cancer,Oligometastasis,Radiotherapy,Hormonotherapy|prostate cancer,oligometastasis,radiotherapy,hormonotherapy
212609|NCT02274766|Levodopa-Induced Dyskinesia|levodopa-induced dyskinesia
212610|NCT02274766|LID|lid
212611|NCT02274766|Parkinsonism|parkinsonism
212612|NCT02274766|Parkinson's Disease|parkinson's disease
212613|NCT02274727|Biomarker|biomarker
212614|NCT02274727|Stroke|stroke
212615|NCT02274727|Etiology|etiology
212616|NCT02274727|Outcome|outcome
212617|NCT02274675|Stroke|stroke
212618|NCT02274675|Robot-assisted therapy|robot-assisted therapy
212619|NCT02274675|Rehabilitation|rehabilitation
212620|NCT02274623|Bone Neoplasms|bone neoplasms
212621|NCT02274623|Hypocalcemia|hypocalcemia
212622|NCT02274623|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
212623|NCT02274610|docetaxel|docetaxel
212624|NCT02274610|Pharmacokinetic|pharmacokinetic
212625|NCT02274597|hypothermia|hypothermia
212626|NCT02274597|pre-hospital|pre-hospital
212627|NCT02274597|epitympanic|epitympanic
212628|NCT02274597|temperature|temperature
212629|NCT02274584|Hodgkin's lymphoma|hodgkin's lymphoma
212630|NCT02274584|Anaplastic large cell lymphoma|anaplastic large cell lymphoma
212631|NCT02274584|CD30 positive lymphoma|cd30 positive lymphoma
212632|NCT02274584|Peripheral T/Natural Killer (NK) cell lymphoma|peripheral t/natural killer (nk) cell lymphoma
212633|NCT02274519|multiple myeloma|multiple myeloma
212634|NCT02274519|plasma cell disorder|plasma cell disorder
212635|NCT02274519|autologous stem cell transplant|autologous stem cell transplant
212636|NCT02274506|Blood And Marrow Transplantation|blood and marrow transplantation
212637|NCT02274506|Leukemia|leukemia
212638|NCT02274506|Lymphoma|lymphoma
212639|NCT02274506|CD19-specific T cells|cd19-specific t cells
212640|NCT02274506|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
212641|NCT02274506|ALL|all
212642|NCT02274506|Biphenotypic leukemia|biphenotypic leukemia
212643|NCT02274506|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
212644|NCT02274506|NHL|nhl
212645|NCT02274506|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
212646|NCT02274506|Small lymphocytic lymphoma|small lymphocytic lymphoma
212647|NCT02274506|Follicular lymphoma|follicular lymphoma
212648|NCT02274506|Mantle cell lymphoma|mantle cell lymphoma
212649|NCT02274506|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
212650|NCT02274506|CLL|cll
212651|NCT02274493|da Vinci® robotic surgical system|da vinci® robotic surgical system
212652|NCT02274493|latissimus dorsi muscle flap harvest procedures|latissimus dorsi muscle flap harvest procedures
212653|NCT02274493|breast reconstruction|breast reconstruction
212654|NCT02274493|scalp reconstruction|scalp reconstruction
212655|NCT02274493|upper extremity reconstruction|upper extremity reconstruction
212656|NCT02274493|lower extremity reconstruction|lower extremity reconstruction
212657|NCT02274480|MRI|mri
212658|NCT02274480|Diffusion Weighted Imaging|diffusion weighted imaging
212659|NCT02274480|14-191|14-191
212660|NCT02274467|Tsui Test|tsui test
212661|NCT02274467|Labour|labour
212662|NCT02274467|Epidural catheter|epidural catheter
212663|NCT02274454|Uterine contraction|uterine contraction
213265|NCT02271217|Post stroke|post stroke
212664|NCT02274454|Oxytocin desensitization|oxytocin desensitization
212665|NCT02274428|intraventricular hemorrhage|intraventricular hemorrhage
212666|NCT02274415|Streptococcus pneumoniae|streptococcus pneumoniae
212667|NCT02274415|Sickle cell disease|sickle cell disease
212668|NCT02274415|Immunogenicity|immunogenicity
212669|NCT02274415|Antibody response|antibody response
212670|NCT02274402|Prednisone|prednisone
212671|NCT02274402|Glucocorticoids|glucocorticoids
212672|NCT02274402|pharmacokinetics|pharmacokinetics
212673|NCT02274389|Pulmonary Multi-drug Resistant Tuberculosis|pulmonary multi-drug resistant tuberculosis
212674|NCT02274389|Bedaquiline|bedaquiline
212675|NCT02274389|Sirturo|sirturo
212676|NCT02274389|Observational|observational
212677|NCT02274389|Prospective|prospective
212678|NCT02274363|Psoriasis|psoriasis
212679|NCT02274363|Plaque|plaque
212680|NCT02274363|Chronic|chronic
212681|NCT02274350|prostate cancer|prostate cancer
212682|NCT02274350|radiation therapy|radiation therapy
212683|NCT02274350|sexual side effects|sexual side effects
212684|NCT02274337|Epidermal Growth Factor Receptor|epidermal growth factor receptor
212685|NCT02274337|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
212686|NCT02274337|T790M mutation|t790m mutation
212687|NCT02274324|parkinson|parkinson
212688|NCT02274324|duodopa|duodopa
212689|NCT02274324|diet|diet
212690|NCT02274324|proteins|proteins
212691|NCT02274324|amino acids|amino acids
212692|NCT02274311|Acromegaly|acromegaly
212693|NCT02274311|SERM|serm
212694|NCT02274311|Clomiphene|clomiphene
212695|NCT02274285|Tetanus|tetanus
212696|NCT02274285|Diphtheria|diphtheria
212697|NCT02274285|Pertussis|pertussis
212698|NCT02274285|Poliomyelitis|poliomyelitis
212699|NCT02274285|Bacterial meningitis|bacterial meningitis
212700|NCT02274285|DTaP-IPV/Hib Combination vaccine|dtap-ipv/hib combination vaccine
212701|NCT02274272|lactobacillus reuteri|lactobacillus reuteri
212702|NCT02274272|type 2 diabetes|type 2 diabetes
212703|NCT02274246|Segmentation|segmentation
212704|NCT02274246|GIMIAS® program|gimias® program
212705|NCT02274246|Atrial fibrillation|atrial fibrillation
212706|NCT02274246|Left atrial fibrosis|left atrial fibrosis
212707|NCT02274246|Healthy volunteers|healthy volunteers
212708|NCT02274233|Chelation|chelation
212709|NCT02274233|Iron Overload|iron overload
212710|NCT02274233|Thalassemia|thalassemia
212711|NCT02274233|Transfusion|transfusion
212712|NCT02274233|Iron Chelation|iron chelation
212713|NCT02274220|systemic inflammation|systemic inflammation
212714|NCT02274220|glucose metabolism|glucose metabolism
212715|NCT02274220|glucose-insulin ratio|glucose-insulin ratio
212716|NCT02274207|Silver dressing|silver dressing
212717|NCT02274207|NPWT|npwt
212718|NCT02274207|DMF|dmf
212719|NCT02274207|foot|foot
212720|NCT02274194|obstructive sleep apnoea|obstructive sleep apnoea
212721|NCT02274194|nasal mask|nasal mask
212722|NCT02274194|oronasal mask|oronasal mask
212723|NCT02274194|breathing route|breathing route
212724|NCT02274194|CPAP|cpap
212725|NCT02274155|Head and Neck Cancer|head and neck cancer
212726|NCT02274155|anti-OX40 antibody|anti-ox40 antibody
212727|NCT02274155|MEDI6469|medi6469
212728|NCT02274155|Immunotherapy|immunotherapy
212729|NCT02274142|dentinal caries|dentinal caries
212730|NCT02274142|occlusal|occlusal
212731|NCT02274142|occluso-proximal|occluso-proximal
212732|NCT02274116|acute intermittent hypoxia|acute intermittent hypoxia
212733|NCT02274116|walking|walking
212734|NCT02274116|spasticity|spasticity
212735|NCT02274116|incomplete spinal cord injury|incomplete spinal cord injury
212736|NCT02274116|breathing|breathing
212737|NCT02274116|strength|strength
212738|NCT02274090|Metformin|metformin
212739|NCT02274090|Pocket depth|pocket depth
212740|NCT02274090|moderate periodontitis|moderate periodontitis
212741|NCT02274090|severe periodontitis|severe periodontitis
212742|NCT02274077|length of stay|length of stay
212743|NCT02274077|nausea|nausea
212744|NCT02274077|emesis|emesis
212745|NCT02274077|bowel function|bowel function
212746|NCT02274077|pain scores|pain scores
212747|NCT02274077|narcotic pain medication|narcotic pain medication
212748|NCT02274077|post operative period|post operative period
212749|NCT02274064|Retention|retention
212750|NCT02274064|Blood Donor Motivation|blood donor motivation
212751|NCT02274025|Patient diagnosed with lung cancer|patient diagnosed with lung cancer
212752|NCT02274012|Gastric|gastric
212753|NCT02274012|Gastroesophageal Junction|gastroesophageal junction
212754|NCT02274012|Gastroesophageal Cancer|gastroesophageal cancer
212755|NCT02274012|Esophageal Cancer|esophageal cancer
212756|NCT02274012|Metastatic|metastatic
212757|NCT02274012|HER2 amplified|her2 amplified
212758|NCT02274012|Afatinib|afatinib
212759|NCT02273999|pulsed electromagnetic fields|pulsed electromagnetic fields
212760|NCT02273999|post operative morbidity|post operative morbidity
212761|NCT02273999|third molar|third molar
212762|NCT02273999|extraction|extraction
212763|NCT02273999|pain|pain
212764|NCT02273986|Adult Volunteers|adult volunteers
212765|NCT02273934|Home-based rehabilitation|home-based rehabilitation
212766|NCT02273934|Activities of daily living|activities of daily living
212767|NCT02273934|Restorative care|restorative care
212768|NCT02273934|Reablement|reablement
212769|NCT02273934|Everyday rehabilitation|everyday rehabilitation
212770|NCT02273921|Dementia, Diagnosis, Electroencephalography|dementia, diagnosis, electroencephalography
212771|NCT02273908|Low-Back Pain|low-back pain
212772|NCT02273908|Neuropathic Pain|neuropathic pain
212773|NCT02273908|Pregabalin|pregabalin
212774|NCT02273895|Scopolamine, AD, EEG, MCI|scopolamine, ad, eeg, mci
212775|NCT02273882|RSV|rsv
212776|NCT02273882|RSVH|rsvh
212777|NCT02273882|Infant|infant
212778|NCT02273882|Gestational Age|gestational age
212779|NCT02273882|wGA|wga
212780|NCT02273882|PRETERM|preterm
212781|NCT02273856|Chronic Lymphocytic Leukaemia (CLL)|chronic lymphocytic leukaemia (cll)
212782|NCT02273856|Indolent Non Hodgkin's Lymphoma (iNHL)|indolent non hodgkin's lymphoma (inhl)
212783|NCT02273843|Preterm|preterm
212784|NCT02273843|late-onset sepsis|late-onset sepsis
212785|NCT02273843|Vitamin D|vitamin d
212786|NCT02273843|Dose|dose
212787|NCT02273843|Interleukin-6|interleukin-6
212788|NCT02273843|Tumor necrosis factor-alpha|tumor necrosis factor-alpha
212789|NCT02273830|oxygen therapy|oxygen therapy
212790|NCT02273830|COPD|copd
212791|NCT02273830|exercise|exercise
212792|NCT02273804|Topiramate|topiramate
212793|NCT02273804|Obesity|obesity
212794|NCT02273804|Children|children
212795|NCT02273804|Adolescents|adolescents
212796|NCT02273791|Frozen-thawed embryo transfer|frozen-thawed embryo transfer
212797|NCT02273791|FET protocols|fet protocols
212798|NCT02273739|solid tumor|solid tumor
212799|NCT02273739|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
212800|NCT02273739|ICC|icc
212801|NCT02273739|chondrosarcoma|chondrosarcoma
212802|NCT02273739|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
212803|NCT02273739|AITL|aitl
212804|NCT02273739|IDH|idh
212805|NCT02273739|glioma|glioma
212806|NCT02273739|solid tumor, including intrahepatic cholangiocarcinoma and chondrosarcoma|solid tumor, including intrahepatic cholangiocarcinoma and chondrosarcoma
212807|NCT02273726|Anemia|anemia
212808|NCT02273726|Chronic Kidney Disease|chronic kidney disease
212809|NCT02273726|Dialysis|dialysis
212810|NCT02273726|hemodialysis|hemodialysis
212811|NCT02273726|peritoneal dialysis|peritoneal dialysis
212812|NCT02273726|hemoglobin|hemoglobin
212813|NCT02273726|End stage renal disease|end stage renal disease
212814|NCT02273726|Stable Dialysis|stable dialysis
212815|NCT02273726|erythropoietins|erythropoietins
212816|NCT02273726|erythropoiesis stimulating agent|erythropoiesis stimulating agent
212817|NCT02273713|Esophageal cancer|esophageal cancer
212818|NCT02273713|Metastasized|metastasized
212819|NCT02273713|Nab-paclitaxel|nab-paclitaxel
212820|NCT02273713|Toxicity|toxicity
212821|NCT02273713|First line treatment|first line treatment
212822|NCT02273713|Phase Ib/II|phase ib/ii
212823|NCT02273700|Xarelto®|xarelto®
212824|NCT02273700|protein/peptide profiles|protein/peptide profiles
212825|NCT02273687|diaphragm movement|diaphragm movement
212826|NCT02273687|ultrasound|ultrasound
212827|NCT02273687|emergency room|emergency room
212828|NCT02273674|Borderline Personality Disorder|borderline personality disorder
212829|NCT02273674|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
212830|NCT02273648|national|national
212831|NCT02273648|multicenter|multicenter
212832|NCT02273648|observational registry|observational registry
212833|NCT02273648|Orsiro Drug Eluting Stent|orsiro drug eluting stent
212834|NCT02273648|Stenting Treatment of coronary artery disease|stenting treatment of coronary artery disease
212835|NCT02273648|coronary revascularization|coronary revascularization
212836|NCT02273648|PCI|pci
212837|NCT02273648|STEMI|stemi
212838|NCT02273648|NSTEMI|nstemi
212839|NCT02273648|Ischemia|ischemia
212840|NCT02273648|Angina|angina
212841|NCT02273648|Acute Myocardial Infarction|acute myocardial infarction
212842|NCT02273648|Small Vessels|small vessels
212843|NCT02273648|Chronic Total Occlusion|chronic total occlusion
212844|NCT02273622|hydroxytyrosol|hydroxytyrosol
212845|NCT02273622|dietary supplement|dietary supplement
212846|NCT02273622|gene expression regulation|gene expression regulation
212847|NCT02273609|Atrial fibrillation|atrial fibrillation
212848|NCT02273609|Anticoagulation|anticoagulation
212849|NCT02273609|Vitamin K antagonists|vitamin k antagonists
212850|NCT02273609|INR control|inr control
212851|NCT02273583|of the extremity|of the extremity
212852|NCT02273570|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
212853|NCT02273570|Anemia|anemia
212854|NCT02273570|Vascular Stiffness|vascular stiffness
212855|NCT02273570|Vascular Calcification|vascular calcification
212856|NCT02273323|Flow mediated dilation|flow mediated dilation
212857|NCT02273323|tea|tea
212858|NCT02273323|blood pressure|blood pressure
212859|NCT02273297|Body composition|body composition
212860|NCT02273297|Body size|body size
212861|NCT02273284|Pain, Pediatrics, Botulinum Toxin injections, Buzzy|pain, pediatrics, botulinum toxin injections, buzzy
212862|NCT02273271|FLT-PET|flt-pet
212863|NCT02273271|DWI-MRI|dwi-mri
212864|NCT02273232|Peripheral Arterial Disease|peripheral arterial disease
212865|NCT02273232|Peripheral Vascular Disease|peripheral vascular disease
212866|NCT02273232|Claudication|claudication
212867|NCT02273232|Remote Ischemic Preconditioning|remote ischemic preconditioning
212868|NCT02273232|EQ-5D|eq-5d
212869|NCT02273232|Symptoms free distance|symptoms free distance
212870|NCT02273232|ABI|abi
212871|NCT02273232|micro vessel formation|micro vessel formation
212872|NCT02273219|Uveal|uveal
212873|NCT02273219|Melanoma|melanoma
212874|NCT02273219|Advanced uveal melanoma|advanced uveal melanoma
212875|NCT02273206|Depression|depression
212876|NCT02273206|Breast Cancer Screening|breast cancer screening
212877|NCT02273206|Cervical Cancer Screening|cervical cancer screening
212878|NCT02273206|Colorectal Cancer Screening|colorectal cancer screening
212879|NCT02273154|major depressive disorder|major depressive disorder
212880|NCT02273154|Efficacy and safety of buspirone add-one treatment in patients with major depression disorder|efficacy and safety of buspirone add-one treatment in patients with major depression disorder
212881|NCT02273154|buspirone|buspirone
212882|NCT02273154|paroxetine|paroxetine
212883|NCT02273154|anxiety|anxiety
212884|NCT02273128|Osteoporosis|osteoporosis
212885|NCT02273128|Chronic Periodontitis|chronic periodontitis
212886|NCT02273128|Calcitonin gene Polymorphism|calcitonin gene polymorphism
212887|NCT02273115|induction|induction
212888|NCT02273115|Foley catheter|foley catheter
212889|NCT02273115|oxytocin|oxytocin
212890|NCT02273102|Acute Myelogenous Leukemia|acute myelogenous leukemia
212891|NCT02273102|AML|aml
212892|NCT02273102|Myelodysplastic Syndromes|myelodysplastic syndromes
212893|NCT02273102|MDS|mds
212894|NCT02273102|Tranylcypromine|tranylcypromine
212895|NCT02273102|TCP|tcp
212896|NCT02273102|ATRA|atra
212897|NCT02273102|Tretinoin|tretinoin
212898|NCT02273089|Obstructive sleep apnea|obstructive sleep apnea
212899|NCT02273089|arterial stiffness|arterial stiffness
212900|NCT02273089|CPAP|cpap
212901|NCT02273089|excessive daytime sleepiness|excessive daytime sleepiness
212902|NCT02273089|pulse wave velocity|pulse wave velocity
212903|NCT02273063|PTSD|ptsd
212904|NCT02273063|MDD|mdd
212905|NCT02273063|TMS|tms
212906|NCT02273063|5Hz|5hz
212907|NCT02273050|Type 2 Diabetes Mellitus, Dipeptidyl-Peptidase 4 Inhibitors, Saxagliptin, Metformin, Endocrine System Diseases|type 2 diabetes mellitus, dipeptidyl-peptidase 4 inhibitors, saxagliptin, metformin, endocrine system diseases
212908|NCT02273037|Labour|labour
212909|NCT02273037|Birth asphyxia|birth asphyxia
212910|NCT02273037|Fetal Heart Rate Monitor|fetal heart rate monitor
212911|NCT02273037|Doppler Fetal Heart Rate Monitor|doppler fetal heart rate monitor
212912|NCT02273037|Pinard Horn|pinard horn
212913|NCT02273037|Pediatrics|pediatrics
212914|NCT02273037|Uganda|uganda
212915|NCT02273024|Exercise|exercise
212916|NCT02273024|Quality of Life|quality of life
212917|NCT02273024|Fatigue|fatigue
212918|NCT02273024|Symptoms|symptoms
212919|NCT02273024|Prehabilitation|prehabilitation
212920|NCT02273024|Aerobic Capacity|aerobic capacity
212921|NCT02272998|FGFR, RET, KIT|fgfr, ret, kit
212922|NCT02272985|cerebral blood flow|cerebral blood flow
212923|NCT02272985|hemodialysis|hemodialysis
212924|NCT02272972|"fluoroscopy[MeSH], education, medical[MeSH]"|"fluoroscopy[mesh], education, medical[mesh]"
212925|NCT02272959|Anxiety/Anxiety disorders, Clinical trials, treatment, cognition, computer/Internet technology|anxiety/anxiety disorders, clinical trials, treatment, cognition, computer/internet technology
212926|NCT02272907|Bariatric Surgery|bariatric surgery
212927|NCT02272907|Laparoscopy|laparoscopy
212928|NCT02272907|Weight Loss Surgery|weight loss surgery
212929|NCT02272907|Staple Line Reinforcement|staple line reinforcement
212930|NCT02272894|Gastric Cancer|gastric cancer
212931|NCT02272894|D2 Lymphadenectomy|d2 lymphadenectomy
212932|NCT02272894|Superior Mesenteric Vein Lymph Node|superior mesenteric vein lymph node
212933|NCT02272855|HF10|hf10
212934|NCT02272855|HSV-1|hsv-1
212935|NCT02272855|Ipilimumab|ipilimumab
212936|NCT02272855|Oncolytic virus|oncolytic virus
212937|NCT02272855|Phase II|phase ii
212938|NCT02272855|Stage IIIB melanoma|stage iiib melanoma
212939|NCT02272855|Stage IIIC melanoma|stage iiic melanoma
212940|NCT02272855|Stage IV melanoma|stage iv melanoma
212941|NCT02272855|Unresectable malignant melanoma|unresectable malignant melanoma
212942|NCT02272855|Metastatic malignant melanoma|metastatic malignant melanoma
212943|NCT02272855|Combination treatment|combination treatment
212944|NCT02272855|Intratumoral injection|intratumoral injection
212945|NCT02272842|Nepal|nepal
212946|NCT02272842|Cobalamin|cobalamin
212947|NCT02272842|Neurodevelopment|neurodevelopment
212948|NCT02272842|Stunting|stunting
212949|NCT02272842|Growth|growth
212950|NCT02272790|Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|ovarian, fallopian tube, or primary peritoneal cancer
212951|NCT02272777|Myelogenous|myelogenous
212952|NCT02272777|Chronic|chronic
212953|NCT02272777|BCR-ABL Positive|bcr-abl positive
212954|NCT02272751|cancer survivorship|cancer survivorship
212955|NCT02272751|exercise|exercise
212956|NCT02272751|relaxation|relaxation
212957|NCT02272751|mindfulness|mindfulness
212958|NCT02272725|ultramarathon|ultramarathon
212959|NCT02272725|ibuprofen|ibuprofen
212960|NCT02272725|acute kidney injury|acute kidney injury
212961|NCT02272725|exercise-associated hyponatremia|exercise-associated hyponatremia
212962|NCT02272725|exertion|exertion
212963|NCT02272712|cancer survivor|cancer survivor
212964|NCT02272712|computerized treatment|computerized treatment
212965|NCT02272712|symptom management|symptom management
212966|NCT02272699|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
212967|NCT02272699|Nimotuzumab|nimotuzumab
212968|NCT02272699|Neoadjuvant treatment|neoadjuvant treatment
212969|NCT02272686|Lymphoma|lymphoma
212970|NCT02272686|Blood And Marrow Transplantation|blood and marrow transplantation
212971|NCT02272686|Post Autologous Stem Cell Transplantation|post autologous stem cell transplantation
212973|NCT02272686|B-cell lymphoma|b-cell lymphoma
212974|NCT02272686|Ibrutinib|ibrutinib
212975|NCT02272686|PCI-32765|pci-32765
212976|NCT02272686|Imbruvica|imbruvica
212977|NCT02272660|preemptive analgesia|preemptive analgesia
212978|NCT02272660|parecoxib sodium|parecoxib sodium
212979|NCT02272660|total knee arthroplasty|total knee arthroplasty
212980|NCT02272660|total hip arthroplasty|total hip arthroplasty
212981|NCT02272647|Normal Healthy Volunteers|normal healthy volunteers
212982|NCT02272634|COPD|copd
212983|NCT02272595|Biologic Markers|biologic markers
212984|NCT02272595|Molecular testing|molecular testing
212985|NCT02272595|Advanced cancers|advanced cancers
212986|NCT02272595|Molecular information|molecular information
212987|NCT02272595|Molecular profiling|molecular profiling
212988|NCT02272595|Genetic Mutation|genetic mutation
212989|NCT02272569|glaucoma|glaucoma
212990|NCT02272569|glaucoma drainage device|glaucoma drainage device
212991|NCT02272569|glaucoma shunt|glaucoma shunt
212992|NCT02272530|Endothelial NO-synthase|endothelial no-synthase
212993|NCT02272530|red blood cell|red blood cell
212994|NCT02272530|erythrocytes|erythrocytes
212995|NCT02272530|Peripheral Blood Mononuclear Cell|peripheral blood mononuclear cell
212996|NCT02272530|cardiovascular disease|cardiovascular disease
212997|NCT02272517|Vortioxetine|vortioxetine
212998|NCT02272517|Cognition|cognition
212999|NCT02272504|HCC|hcc
213000|NCT02272504|AFP|afp
213001|NCT02272504|AFP-L3|afp-l3
213002|NCT02272504|DCP|dcp
213003|NCT02272504|Surveillance|surveillance
213004|NCT02272504|biomarkers|biomarkers
213005|NCT02272478|AML|aml
213006|NCT02272478|MDS|mds
213007|NCT02272465|pre-hospital resuscitation, helicopter, trauma|pre-hospital resuscitation, helicopter, trauma
213008|NCT02272452|High resolution magic angle spinning Nuclear magnetic resonance|high resolution magic angle spinning nuclear magnetic resonance
213009|NCT02272452|Nuclear magnetic resonance|nuclear magnetic resonance
213010|NCT02272452|Spectroscopy|spectroscopy
213011|NCT02272452|Primary brain tumors|primary brain tumors
213012|NCT02272452|Gliomas|gliomas
213013|NCT02272452|extemporaneous analysis|extemporaneous analysis
213014|NCT02272439|Bisphenol A|bisphenol a
213015|NCT02272439|phthalates|phthalates
213016|NCT02272439|infertility|infertility
213017|NCT02272439|human|human
213018|NCT02272426|Stroke|stroke
213019|NCT02272426|Exercise Training|exercise training
213020|NCT02272426|Cognitive Training|cognitive training
213021|NCT02272426|Quality of Life|quality of life
213022|NCT02272400|image guided radiation therapy|image guided radiation therapy
213023|NCT02272400|partial breast irradiation|partial breast irradiation
213024|NCT02272400|breast cancer|breast cancer
213025|NCT02272400|breast|breast
213026|NCT02272400|cancer|cancer
213027|NCT02272400|breast preservation|breast preservation
213028|NCT02272400|IGRT|igrt
213029|NCT02272400|PBI|pbi
213030|NCT02272374|Hemodialysis|hemodialysis
213031|NCT02272374|Arteriovenous fistula|arteriovenous fistula
213032|NCT02272374|Tunneled cuffed catheter|tunneled cuffed catheter
213033|NCT02272374|Arteriovenous graft|arteriovenous graft
213034|NCT02272374|Elderly|elderly
213035|NCT02272374|Very elderly|very elderly
213036|NCT02272348|Therapeutic education|therapeutic education
213037|NCT02272348|Functional insulin therapy|functional insulin therapy
213038|NCT02272335|Breast Cancer|breast cancer
213039|NCT02272335|Health Disparities|health disparities
213040|NCT02272335|Psychosocial Intervention|psychosocial intervention
213041|NCT02272335|Cancer Survivors|cancer survivors
213042|NCT02272322|Anterior prolapse|anterior prolapse
213043|NCT02272296|Injections, Jet|injections, jet
213044|NCT02272296|pharmacology|pharmacology
213045|NCT02272296|Insulin Aspart|insulin aspart
213046|NCT02272296|Equipment and Supplies|equipment and supplies
213047|NCT02272283|PCI optimization|pci optimization
213048|NCT02272283|Coronary Remodeling|coronary remodeling
213049|NCT02272283|Drug-Eluting Stent|drug-eluting stent
213050|NCT02272283|Optical Coherence Tomography|optical coherence tomography
213051|NCT02272283|Intravascular Ultrasound|intravascular ultrasound
213052|NCT02272283|Strut Coverage|strut coverage
213053|NCT02272283|Strut Apposition|strut apposition
213054|NCT02272283|Vascular Healing Pattern|vascular healing pattern
213055|NCT02272257|Musculoskeletal Pain|musculoskeletal pain
213056|NCT02272257|Physical Therapists|physical therapists
213057|NCT02272257|Drug Prescriptions|drug prescriptions
213058|NCT02272257|Humans|humans
213059|NCT02272257|Physical Therapy Modalities|physical therapy modalities
213060|NCT02272257|Referral and Consultation|referral and consultation
213061|NCT02272257|Workers' Compensation|workers' compensation
213062|NCT02272257|United States|united states
213063|NCT02272257|Primary Care|primary care
213064|NCT02272257|Health Services Research|health services research
213065|NCT02272257|Triage|triage
213066|NCT02272257|Acute|acute
213067|NCT02272257|Cost|cost
213068|NCT02272257|Occupational Health|occupational health
213069|NCT02272244|Colorectal Cancer|colorectal cancer
213070|NCT02272244|Cancer Screening|cancer screening
213071|NCT02272244|Decision Support|decision support
213072|NCT02272244|Navigation|navigation
213073|NCT02272231|women's health|women's health
213074|NCT02272231|vaginosis, bacterial|vaginosis, bacterial
213075|NCT02272231|african americans|african americans
213076|NCT02272205|Hip replacement|hip replacement
213077|NCT02272205|Knee replacement|knee replacement
213078|NCT02272205|Knee infection|knee infection
213079|NCT02272205|Hip infection|hip infection
213080|NCT02272205|Antibiotic prophylaxis|antibiotic prophylaxis
213081|NCT02272192|autism|autism
213082|NCT02272192|autism spectrum disorder|autism spectrum disorder
213083|NCT02272192|intensive intervention|intensive intervention
213084|NCT02272192|early intervention|early intervention
213085|NCT02272192|Early Start Denver Model|early start denver model
213086|NCT02272179|adolescence|adolescence
213087|NCT02272179|suicidality|suicidality
213088|NCT02272179|depression|depression
213089|NCT02272127|EGFR tyrosine kinase inhibitor|egfr tyrosine kinase inhibitor
213090|NCT02272088|physical activity|physical activity
213091|NCT02272088|energy expenditure|energy expenditure
213092|NCT02272088|compensatory mechanisms|compensatory mechanisms
213093|NCT02272088|adolescent|adolescent
213094|NCT02272075|screeening|screeening
213095|NCT02272062|Coronary artery disease|coronary artery disease
213096|NCT02272062|Angina|angina
213097|NCT02272062|Shared decision-making|shared decision-making
213098|NCT02272062|Patient preferences|patient preferences
213099|NCT02272062|Percutaneous coronary intervention|percutaneous coronary intervention
213100|NCT02272062|Coronary artery bypass graft|coronary artery bypass graft
213101|NCT02272049|Respiratory|respiratory
213102|NCT02272036|Colonoscopy|colonoscopy
213103|NCT02272036|Colonoscopy preparation|colonoscopy preparation
213104|NCT02272036|screening|screening
213105|NCT02272036|New media|new media
213106|NCT02272036|SMS|sms
213107|NCT02272036|Short message service|short message service
213108|NCT02272023|alcohol|alcohol
213109|NCT02272023|women|women
213110|NCT02272023|motivational interviewing|motivational interviewing
213111|NCT02271984|Healthy|healthy
213112|NCT02271984|Praziquantel|praziquantel
213113|NCT02271984|L-PZQ|l-pzq
213114|NCT02271984|PZQ|pzq
213115|NCT02271984|MSC2499550A|msc2499550a
213116|NCT02271984|Bioavailability|bioavailability
213117|NCT02271984|Pharmacokinetics|pharmacokinetics
213118|NCT02271971|Psoriasis|psoriasis
213119|NCT02271971|Vitamin D|vitamin d
213120|NCT02271971|Metabolic syndrome|metabolic syndrome
213121|NCT02271971|Insulin resistance|insulin resistance
213122|NCT02271971|Cholesterol|cholesterol
213123|NCT02271971|Methotrexate|methotrexate
213124|NCT02271971|Dyslipidemia|dyslipidemia
213125|NCT02271971|PASI|pasi
213126|NCT02271971|Psoriasis Area Severity Index|psoriasis area severity index
213127|NCT02271958|Mifepristone|mifepristone
213128|NCT02271958|Endometriosis|endometriosis
213129|NCT02271945|aggressive lymphoma, DLBCL, NHL|aggressive lymphoma, dlbcl, nhl
213130|NCT02271932|appendicitis|appendicitis
213131|NCT02271932|non-operative management|non-operative management
213132|NCT02271932|children|children
213133|NCT02271932|pediatric|pediatric
213134|NCT02271919|Cancer Prevention|cancer prevention
213135|NCT02271919|Tobacco Use Cessation|tobacco use cessation
213136|NCT02271919|Nicotine replacement therapy|nicotine replacement therapy
213137|NCT02271919|NRT|nrt
213138|NCT02271919|Varenicline|varenicline
213139|NCT02271919|Chantix|chantix
213140|NCT02271919|Nicotine lozenge|nicotine lozenge
213141|NCT02271919|Placebo tablet|placebo tablet
213142|NCT02271919|Placebo patch|placebo patch
213143|NCT02271919|Questionnaire|questionnaire
213144|NCT02271919|Survey|survey
213145|NCT02271919|Counseling|counseling
213146|NCT02271906|Lung Cancer|lung cancer
213147|NCT02271906|Non small cell lung cancer|non small cell lung cancer
213148|NCT02271906|NSCLC|nsclc
213149|NCT02271906|Adenocarcinoma|adenocarcinoma
213150|NCT02271906|Squamous cell carcinoma|squamous cell carcinoma
213151|NCT02271906|BIBW 2992|bibw 2992
213152|NCT02271906|Afatinib|afatinib
213153|NCT02271893|Chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
213154|NCT02271880|Medication nonadherence|medication nonadherence
213155|NCT02271802|Butyrate|butyrate
213156|NCT02271802|Interorgan metabolism|interorgan metabolism
213157|NCT02271802|Short-chain fatty acids|short-chain fatty acids
213158|NCT02271802|Gut production|gut production
213159|NCT02271776|Insulin Sensitivity|insulin sensitivity
213160|NCT02271763|cricothyroid membrane|cricothyroid membrane
213161|NCT02271763|ultrasound|ultrasound
213162|NCT02271750|IGF, Neurotrophic factors, Dementia, spinal fluid|igf, neurotrophic factors, dementia, spinal fluid
213163|NCT02271737|Newborn|newborn
213164|NCT02271737|infection|infection
213468|NCT02269943|nasopharynx|nasopharynx
213165|NCT02271737|community health|community health
213166|NCT02271724|CIDP|cidp
213167|NCT02271724|MMN|mmn
213168|NCT02271724|Spinal fluid|spinal fluid
213169|NCT02271724|CD163|cd163
213170|NCT02271724|CD19|cd19
213171|NCT02271711|Brain Cancer|brain cancer
213172|NCT02271711|Brain tumor|brain tumor
213173|NCT02271711|Recurrent posterior fossa tumors|recurrent posterior fossa tumors
213174|NCT02271711|Central nervous system|central nervous system
213175|NCT02271711|CNS|cns
213176|NCT02271711|Artificial antigen- presenting cells|artificial antigen- presenting cells
213177|NCT02271711|aAPC|aapc
213178|NCT02271711|Natural killer cells|natural killer cells
213179|NCT02271711|NK|nk
213180|NCT02271711|Ommaya reservoir|ommaya reservoir
213181|NCT02271698|Knee arthroplasty|knee arthroplasty
213182|NCT02271698|Dexamethasone|dexamethasone
213183|NCT02271698|Acute pain|acute pain
213184|NCT02271698|Chronic pain|chronic pain
213185|NCT02271685|Diagnostic Information|diagnostic information
213186|NCT02271685|Risk Perception|risk perception
213187|NCT02271659|Prostate|prostate
213188|NCT02271659|external beam radiotherapy|external beam radiotherapy
213189|NCT02271659|brachytherapy boost|brachytherapy boost
213190|NCT02271659|economical evaluation|economical evaluation
213191|NCT02271646|paravertebral block|paravertebral block
213192|NCT02271646|ultrasound guided|ultrasound guided
213193|NCT02271633|Nitrate|nitrate
213194|NCT02271633|Bioavailability|bioavailability
213195|NCT02271633|Sports|sports
213196|NCT02271620|1 prevalence|1 prevalence
213197|NCT02271620|2 children|2 children
213198|NCT02271620|3 local allergic rhinitis|3 local allergic rhinitis
213199|NCT02271607|moxibustion|moxibustion
213200|NCT02271555|electroconvulsive therapy|electroconvulsive therapy
213201|NCT02271555|sevoflurane|sevoflurane
213202|NCT02271555|remifentanil|remifentanil
213203|NCT02271542|Propofol|propofol
213204|NCT02271542|Polymorphism|polymorphism
213205|NCT02271542|UGT1A9|ugt1a9
213206|NCT02271542|CYP2B6|cyp2b6
213207|NCT02271529|Peripheral Vascular Disease|peripheral vascular disease
213208|NCT02271529|Femoral Artery|femoral artery
213209|NCT02271529|Drug-Eluting Stent|drug-eluting stent
213210|NCT02271490|Assisted Reproductive Technique|assisted reproductive technique
213211|NCT02271490|ICSI|icsi
213212|NCT02271490|Acrosome Reaction|acrosome reaction
213213|NCT02271490|Pregnancy outcome|pregnancy outcome
213214|NCT02271477|Fluid replacement|fluid replacement
213215|NCT02271477|Trans-Thoracic Echocardiography|trans-thoracic echocardiography
213216|NCT02271477|Spinal Anesthesia|spinal anesthesia
213217|NCT02271477|Empirical Volemic Repletion|empirical volemic repletion
213218|NCT02271464|Metastatic colorectal cancer|metastatic colorectal cancer
213219|NCT02271464|Ist line therapy|ist line therapy
213220|NCT02271464|metronimic therapy|metronimic therapy
213221|NCT02271464|bevacizumab|bevacizumab
213222|NCT02271451|concussion|concussion
213223|NCT02271438|Healthy|healthy
213224|NCT02271438|Ibrutinib|ibrutinib
213225|NCT02271438|Moxifloxacin|moxifloxacin
213226|NCT02271438|Cardiac Repolarization|cardiac repolarization
213227|NCT02271438|Electrocardiogram|electrocardiogram
213228|NCT02271438|QTc interval|qtc interval
213229|NCT02271399|venous thromboembolism|venous thromboembolism
213230|NCT02271399|total knee arthroplasty|total knee arthroplasty
213231|NCT02271386|Evidence-Based Practice|evidence-based practice
213232|NCT02271386|Provider Education|provider education
213233|NCT02271373|Vision, Ocular|vision, ocular
213234|NCT02271373|Physical activity|physical activity
213235|NCT02271373|Schoolchildren|schoolchildren
213236|NCT02271373|Intervention Studies|intervention studies
213237|NCT02271360|infertility ICSI OHSS Calcium Dobesilate Cabergoline|infertility icsi ohss calcium dobesilate cabergoline
213238|NCT02271334|Asthma|asthma
213239|NCT02271334|Albuterol|albuterol
213240|NCT02271321|dementia|dementia
213241|NCT02271321|white noise|white noise
213242|NCT02271321|agitation|agitation
213243|NCT02271321|saliva cortisol|saliva cortisol
213244|NCT02271308|elastic band resistance training|elastic band resistance training
213245|NCT02271308|nursing home residents|nursing home residents
213246|NCT02271308|muscle strength|muscle strength
213247|NCT02271308|flexibility|flexibility
213248|NCT02271308|quality of life|quality of life
213249|NCT02271308|ease of care|ease of care
213250|NCT02271295|Cirrhosis|cirrhosis
213251|NCT02271295|Child B|child b
213252|NCT02271295|decompensation|decompensation
213253|NCT02271295|mortality|mortality
213254|NCT02271295|portal thrombosis|portal thrombosis
213255|NCT02271295|anticoagulation|anticoagulation
213256|NCT02271269|glaucoma|glaucoma
213257|NCT02271269|medication adherence|medication adherence
213258|NCT02271269|financial incentives|financial incentives
213259|NCT02271269|behavioral economics|behavioral economics
213260|NCT02271256|Functional intimate apparel|functional intimate apparel
213261|NCT02271256|Adolescent Idiopathic scoliosis|adolescent idiopathic scoliosis
213262|NCT02271243|Central line-associated bloodstream infections|central line-associated bloodstream infections
213263|NCT02271243|mucosal barrier injury|mucosal barrier injury
213264|NCT02271243|laboratory-confirmed bloodstream infection|laboratory-confirmed bloodstream infection
213266|NCT02271217|Ischemic stroke|ischemic stroke
213267|NCT02271126|ECMO|ecmo
213268|NCT02271126|Heparin|heparin
213269|NCT02271126|Thromboelastography|thromboelastography
213270|NCT02271126|Bleeding complications|bleeding complications
213271|NCT02271074|HIV|hiv
213272|NCT02271074|Care|care
213273|NCT02271074|Treatment|treatment
213274|NCT02271074|Retention|retention
213275|NCT02271074|Implementation Science|implementation science
213276|NCT02271048|telemedicine|telemedicine
213277|NCT02271048|ultrasonography|ultrasonography
213278|NCT02271048|echocardiography|echocardiography
213279|NCT02271035|VUR|vur
213280|NCT02271022|ACS, Acute Coronary Syndromes|acs, acute coronary syndromes
213281|NCT02271022|NSTEMI|nstemi
213282|NCT02271022|MI, Myocardial Infarction|mi, myocardial infarction
213283|NCT02270996|antibiotic, antimicrobial, stewardship, child|antibiotic, antimicrobial, stewardship, child
213284|NCT02270983|Opioid-Induced Constipation|opioid-induced constipation
213285|NCT02270983|Linaclotide|linaclotide
213286|NCT02270983|Linzess|linzess
213287|NCT02270944|GBS|gbs
213288|NCT02270944|vaccine comparability|vaccine comparability
213289|NCT02270944|Group B Strep|group b strep
213290|NCT02270918|Xa inhibitor|xa inhibitor
213291|NCT02270918|Prothrombin complex concentrate|prothrombin complex concentrate
213292|NCT02270918|anticoagulation|anticoagulation
213293|NCT02270905|meniscus|meniscus
213294|NCT02270905|meniscectomy|meniscectomy
213295|NCT02270905|decellularised|decellularised
213296|NCT02270905|xenograft|xenograft
213297|NCT02270892|Ulthera, Ulthera System, Ultherapy|ulthera, ulthera system, ultherapy
213298|NCT02270866|aphasia|aphasia
213299|NCT02270866|stroke|stroke
213300|NCT02270853|ApneaLink|apnealink
213301|NCT02270853|bronchial carcinoma|bronchial carcinoma
213302|NCT02270853|sleep apnea screening|sleep apnea screening
213303|NCT02270840|cardiac resynchronization therapy|cardiac resynchronization therapy
213304|NCT02270801|recombinant human thrombopoietin|recombinant human thrombopoietin
213305|NCT02270801|immune thrombocytopenia|immune thrombocytopenia
213306|NCT02270801|pregnancy|pregnancy
213307|NCT02270775|Questionnaire|questionnaire
213308|NCT02270775|Translation|translation
213309|NCT02270762|Early Physical Exercise|early physical exercise
213310|NCT02270762|Early Passive Exercise|early passive exercise
213311|NCT02270762|Alveolar Recruitment|alveolar recruitment
213312|NCT02270762|Electrical Impedance Tomography|electrical impedance tomography
213313|NCT02270762|Oxygenation|oxygenation
213314|NCT02270762|Ventilation|ventilation
213315|NCT02270684|Total Knee Arthroplasty|total knee arthroplasty
213316|NCT02270684|Home monitoring|home monitoring
213317|NCT02270671|Social Anxiety|social anxiety
213318|NCT02270671|Social Phobia|social phobia
213319|NCT02270671|Depression|depression
213320|NCT02270671|Attention Bias Modification Training|attention bias modification training
213321|NCT02270658|continuous positive airway pressure|continuous positive airway pressure
213322|NCT02270658|hypertension|hypertension
213323|NCT02270658|sleep apnea|sleep apnea
213324|NCT02270606|Rectum|rectum
213325|NCT02270541|Telemedicine|telemedicine
213326|NCT02270541|Prehospital|prehospital
213327|NCT02270541|Emergency Medicine|emergency medicine
213328|NCT02270541|Stroke|stroke
213329|NCT02270515|Patient-Centered Care|patient-centered care
213330|NCT02270515|Medical Home|medical home
213331|NCT02270502|critically illness|critically illness
213332|NCT02270502|intensive care unit|intensive care unit
213333|NCT02270502|outcome|outcome
213334|NCT02270502|frailty|frailty
213335|NCT02270476|Cystic Fibrosis|cystic fibrosis
213336|NCT02270476|Infant|infant
213337|NCT02270476|Toddler|toddler
213338|NCT02270476|Children|children
213339|NCT02270476|Newborn screening|newborn screening
213340|NCT02270437|total knee arthroplasty|total knee arthroplasty
213341|NCT02270437|cocktail analgesia|cocktail analgesia
213342|NCT02270437|morphine consumption|morphine consumption
213343|NCT02270424|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
213344|NCT02270424|Medicine, Chinese Traditional|medicine, chinese traditional
213345|NCT02270424|Humans|humans
213346|NCT02270424|Treatment Outcome|treatment outcome
213347|NCT02270398|Exercise|exercise
213348|NCT02270398|Balance|balance
213349|NCT02270398|Gait|gait
213350|NCT02270398|Community|community
213351|NCT02270398|Rehabilitation|rehabilitation
213352|NCT02270398|Dual-task|dual-task
213353|NCT02270385|pressure ulcer|pressure ulcer
213354|NCT02270385|nursing home|nursing home
213355|NCT02270372|Advanced breast carcinoma|advanced breast carcinoma
213356|NCT02270372|Advanced ovarian carcinoma|advanced ovarian carcinoma
213357|NCT02270372|MUC1|muc1
213358|NCT02270372|vaccine|vaccine
213359|NCT02270372|Phase 1b|phase 1b
213360|NCT02270359|Myocardial Infarction|myocardial infarction
213361|NCT02270359|CAD|cad
213362|NCT02270346|Allogeneic HSCT, Inspiratory Muscle Training, Exercise Capacity|allogeneic hsct, inspiratory muscle training, exercise capacity
213363|NCT02270333|sarcoidosis|sarcoidosis
213364|NCT02270333|inspiratory muscle strength|inspiratory muscle strength
213365|NCT02270333|exercise capacity|exercise capacity
213366|NCT02270333|quality of life|quality of life
213367|NCT02270320|Tai Chi Chuan|tai chi chuan
213368|NCT02270320|cognitive function|cognitive function
213369|NCT02270320|motor function|motor function
213370|NCT02270320|MRI|mri
213371|NCT02270294|Ischemic stroke|ischemic stroke
213372|NCT02270294|Thai traditional massage|thai traditional massage
213373|NCT02270294|Vascular function|vascular function
213374|NCT02270294|Cerebral blood flow|cerebral blood flow
213375|NCT02270294|Cerebrovascular reactivity|cerebrovascular reactivity
213376|NCT02270268|Irritable bowel syndrome|irritable bowel syndrome
213377|NCT02270268|Gut microbiota|gut microbiota
213378|NCT02270268|Soluble dietary fiber|soluble dietary fiber
213379|NCT02270255|embolization|embolization
213380|NCT02270255|analgesia|analgesia
213381|NCT02270242|PCI|pci
213382|NCT02270242|DAPT|dapt
213383|NCT02270242|ticagrelor|ticagrelor
213384|NCT02270242|aspirin|aspirin
213385|NCT02270216|isolated systolic hypertension|isolated systolic hypertension
213386|NCT02270216|exercise pressor responses|exercise pressor responses
213387|NCT02270203|si joint|si joint
213388|NCT02270203|si joint injury|si joint injury
213389|NCT02270203|si joint treatment|si joint treatment
213390|NCT02270203|si joint inflammation|si joint inflammation
213391|NCT02270203|si joint problems|si joint problems
213392|NCT02270203|si joint symptoms|si joint symptoms
213393|NCT02270203|hypermobile joint|hypermobile joint
213394|NCT02270203|si joint arthritis|si joint arthritis
213395|NCT02270203|si joint pain treatment|si joint pain treatment
213396|NCT02270203|inflamed si joint|inflamed si joint
213397|NCT02270203|si joint sclerosis|si joint sclerosis
213398|NCT02270203|locked si joint|locked si joint
213399|NCT02270203|si joint injuries|si joint injuries
213400|NCT02270203|si joint disease|si joint disease
213401|NCT02270203|si joint infection|si joint infection
213402|NCT02270203|sacroiliac joint pelvic pain|sacroiliac joint pelvic pain
213403|NCT02270203|sacroiliac joint arthritis treatment|sacroiliac joint arthritis treatment
213404|NCT02270203|si joint pain|si joint pain
213405|NCT02270203|si joint injections|si joint injections
213406|NCT02270177|Headache|headache
213407|NCT02270177|Telemedicine|telemedicine
213408|NCT02270177|Videoconsultation|videoconsultation
213409|NCT02270177|Headache-referrals|headache-referrals
213410|NCT02270164|Lipids|lipids
213411|NCT02270164|Cholesterol|cholesterol
213412|NCT02270164|Dietary Supplements|dietary supplements
213413|NCT02270164|Cynara scolymus|cynara scolymus
213414|NCT02270164|Safety|safety
213415|NCT02270151|Atrial fibrillation|atrial fibrillation
213416|NCT02270151|Screening|screening
213417|NCT02270151|Primary care|primary care
213418|NCT02270151|Diagnostic|diagnostic
213419|NCT02270138|physical activity|physical activity
213420|NCT02270138|music|music
213421|NCT02270138|sedentary lifestyle|sedentary lifestyle
213422|NCT02270125|nasal mucosa|nasal mucosa
213423|NCT02270125|chronic hypertrophic rhinosinusitis|chronic hypertrophic rhinosinusitis
213424|NCT02270125|mucotomy|mucotomy
213425|NCT02270125|nanoparticles|nanoparticles
213426|NCT02270125|scanning electron microscopy|scanning electron microscopy
213427|NCT02270125|Raman microspectroscopy|raman microspectroscopy
213428|NCT02270125|nasal polyposis|nasal polyposis
213429|NCT02270112|atrial fibrillation|atrial fibrillation
213430|NCT02270112|atrial electrophysiology|atrial electrophysiology
213431|NCT02270112|stroke|stroke
213432|NCT02270112|vascular stiffness|vascular stiffness
213433|NCT02270073|Psychotherapy process|psychotherapy process
213434|NCT02270073|Change mechanisms|change mechanisms
213435|NCT02270073|Mindfulness|mindfulness
213436|NCT02270073|Micro-interventions|micro-interventions
213437|NCT02270073|Mindfulness interventions|mindfulness interventions
213438|NCT02270073|Progressive muscle relaxation|progressive muscle relaxation
213439|NCT02270060|Music Therapy|music therapy
213440|NCT02270060|Sickle Cell Disease|sickle cell disease
213441|NCT02270060|Pain|pain
213442|NCT02270047|Ad libitum energy intake|ad libitum energy intake
213443|NCT02270047|Appetite sensation|appetite sensation
213444|NCT02270021|Pap smear|pap smear
213445|NCT02270021|Screening|screening
213446|NCT02270021|Women|women
213447|NCT02270021|Human papillomavirus|human papillomavirus
213448|NCT02270021|Cervical precancer|cervical precancer
213449|NCT02270021|Guideline adherence|guideline adherence
213450|NCT02270008|anal incontinence|anal incontinence
213451|NCT02270008|pregnancy-associated pelvic floor disorders|pregnancy-associated pelvic floor disorders
213452|NCT02269995|Hepatocellular|hepatocellular
213453|NCT02269995|Carcinoma|carcinoma
213454|NCT02269969|Aminoglycoside|aminoglycoside
213455|NCT02269969|Pharmacokinetics|pharmacokinetics
213456|NCT02269969|Once daily dosing|once daily dosing
213457|NCT02269943|Metastatic nasopharyngeal carcinoma|metastatic nasopharyngeal carcinoma
213458|NCT02269943|oral azacitidine|oral azacitidine
213459|NCT02269943|oral AZA|oral aza
213460|NCT02269943|CC-486|cc-486
213461|NCT02269943|metastatic|metastatic
213462|NCT02269943|recurrent|recurrent
213463|NCT02269943|nasopharyngeal carcinoma|nasopharyngeal carcinoma
213464|NCT02269943|nasal|nasal
213465|NCT02269943|solid tumors|solid tumors
213466|NCT02269943|locally advanced|locally advanced
213467|NCT02269943|rare head and neck cancer|rare head and neck cancer
213469|NCT02269943|single chemotherapy agent|single chemotherapy agent
213470|NCT02269943|Epstein-Barr Virus (EBV) + nasopharyngeal carcinoma|epstein-barr virus (ebv) + nasopharyngeal carcinoma
213471|NCT02269943|EBV-DN|ebv-dn
213472|NCT02269943|Celgene|celgene
213473|NCT02269943|Sponsor-study|sponsor-study
213474|NCT02269943|oral chemotherapy|oral chemotherapy
213475|NCT02269943|phase 2|phase 2
213476|NCT02269943|oral Vidaza|oral vidaza
213477|NCT02269943|EBV promoter methylation|ebv promoter methylation
213478|NCT02269943|hypomethylation|hypomethylation
213479|NCT02269943|tumor infiltrating lymphocytes (TILs)|tumor infiltrating lymphocytes (tils)
213480|NCT02269943|EBV gene expression|ebv gene expression
213481|NCT02269943|neoplasms|neoplasms
213482|NCT02269917|Human Immunodeficiency Virus Type 1|human immunodeficiency virus type 1
213483|NCT02269917|Emerald|emerald
213484|NCT02269917|Darunavir|darunavir
213485|NCT02269917|Cobicistat|cobicistat
213486|NCT02269917|Emtricitabine|emtricitabine
213487|NCT02269917|Tenofovir Alafenamide|tenofovir alafenamide
213488|NCT02269891|Menopausal symptoms|menopausal symptoms
213489|NCT02269891|Peri-menopause|peri-menopause
213490|NCT02269891|Nu Femme|nu femme
213491|NCT02269891|Labisia pumila|labisia pumila
213492|NCT02269891|Eurycoma longifolia|eurycoma longifolia
213493|NCT02269891|Hot flash|hot flash
213494|NCT02269891|Joint pain|joint pain
213495|NCT02269852|seasonal trivalent inactivated influenza vaccine|seasonal trivalent inactivated influenza vaccine
213496|NCT02269852|immunogenicity|immunogenicity
213497|NCT02269852|safety|safety
213498|NCT02269852|cross-reactivity|cross-reactivity
213499|NCT02269852|Northern hemisphere 2013-2014 formulation|northern hemisphere 2013-2014 formulation
213500|NCT02269839|Tinnitus|tinnitus
213501|NCT02269839|rTMS|rtms
213502|NCT02269813|MammaPrint|mammaprint
213503|NCT02269813|BluePrint|blueprint
213504|NCT02269813|TargetPrint|targetprint
213505|NCT02269774|Atrial Fibrillation|atrial fibrillation
213506|NCT02269774|Obstructive Sleep Apnea|obstructive sleep apnea
213507|NCT02269774|Atrial Premature Complexes|atrial premature complexes
213508|NCT02269774|Pulmonary Vein Isolation|pulmonary vein isolation
213509|NCT02269774|Mueller Manoeuvre|mueller manoeuvre
213510|NCT02269761|Emergency Departments|emergency departments
213511|NCT02269761|Chest|chest
213512|NCT02269761|Lung|lung
213513|NCT02269761|Cough|cough
213514|NCT02269761|Dyspnea|dyspnea
213515|NCT02269761|Wheezing|wheezing
213516|NCT02269761|Ultrasound|ultrasound
213517|NCT02269761|Ultrasonography|ultrasonography
213518|NCT02269657|Scoliosis|scoliosis
213519|NCT02269657|Postural balance|postural balance
213520|NCT02269657|Lordosis|lordosis
213521|NCT02269657|Kyphosis|kyphosis
213522|NCT02269657|X-rays|x-rays
213523|NCT02269631|Weight loss|weight loss
213524|NCT02269631|Epidemiology|epidemiology
213525|NCT02269631|Nutrition|nutrition
213526|NCT02269618|Telehealth, Home-based, rehabilitation|telehealth, home-based, rehabilitation
213527|NCT02269605|HIV reservoir|hiv reservoir
213528|NCT02269605|Bryostatin|bryostatin
213529|NCT02269592|MGUS|mgus
213530|NCT02269592|Smoldering Myeloma|smoldering myeloma
213531|NCT02269592|Chronic Lymphocytic leukemia|chronic lymphocytic leukemia
213532|NCT02269592|Acute Myeloid Leukemia|acute myeloid leukemia
213533|NCT02269592|Myeloproliferative neoplasms|myeloproliferative neoplasms
213534|NCT02269592|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
213535|NCT02269592|Monoclonal Gammopathy of Undermined Significance|monoclonal gammopathy of undermined significance
213536|NCT02269592|Monoclonal B cell lymphocytosis|monoclonal b cell lymphocytosis
213537|NCT02269592|Smoldering Multiple Myeloma|smoldering multiple myeloma
213538|NCT02269592|Myelodysplastic syndromes|myelodysplastic syndromes
213539|NCT02269579|Newly Diagnosed AML|newly diagnosed aml
213540|NCT02269579|Secondary AML|secondary aml
213541|NCT02269579|Relapsed/Refractory AML|relapsed/refractory aml
213542|NCT02269579|Relapsed/Refractory ALL|relapsed/refractory all
213543|NCT02269566|allergic rhinitis|allergic rhinitis
213544|NCT02269566|immunotherapy|immunotherapy
213545|NCT02269553|Migraine|migraine
213546|NCT02269553|Headache|headache
213547|NCT02269514|adoption|adoption
213548|NCT02269514|electronic cigarettes|electronic cigarettes
213549|NCT02269514|e-cigarettes|e-cigarettes
213550|NCT02269514|combustible cigarettes|combustible cigarettes
213551|NCT02269514|nicotine polacrilex|nicotine polacrilex
213552|NCT02269514|own brand cigarette|own brand cigarette
213553|NCT02269514|subjective measures|subjective measures
213554|NCT02269514|pharmacokinetics|pharmacokinetics
213555|NCT02269514|pharmacodynamics|pharmacodynamics
213556|NCT02269488|Safety|safety
213557|NCT02269488|Tolerability|tolerability
213558|NCT02269488|MEDI3250|medi3250
213559|NCT02269488|Japanese children|japanese children
213560|NCT02269475|Efficacy|efficacy
213561|NCT02269475|Safety|safety
213562|NCT02269475|Tolerability|tolerability
213563|NCT02269475|MEDI3250|medi3250
213564|NCT02269475|Japanese children|japanese children
213565|NCT02269449|transradial intervention|transradial intervention
213566|NCT02269449|radial artery|radial artery
213567|NCT02269410|Bariatric Surgery|bariatric surgery
213568|NCT02269410|Nitrogen Balance|nitrogen balance
213569|NCT02269410|Body composition|body composition
213570|NCT02269410|Protein supplementation|protein supplementation
213571|NCT02269410|Satiety|satiety
213572|NCT02269410|Adherence|adherence
213573|NCT02269397|Epilepsy|epilepsy
213574|NCT02269397|Seizures|seizures
213575|NCT02269397|Diagnosis|diagnosis
213576|NCT02269397|Diagnostic|diagnostic
213577|NCT02269397|Inflammation|inflammation
213578|NCT02269384|Pain|pain
213579|NCT02269384|Memory|memory
213580|NCT02269384|Pressure Pain Threshold|pressure pain threshold
213581|NCT02269384|Electromyography|electromyography
213582|NCT02269384|Heart Rate Variability|heart rate variability
213583|NCT02269319|ABSSSI|absssi
213584|NCT02269319|MRX-I|mrx-i
213585|NCT02269319|Acute Bacterial Skin and Skin Structure Infections|acute bacterial skin and skin structure infections
213586|NCT02269306|PCOS|pcos
213587|NCT02269306|clomiphene citrate|clomiphene citrate
213588|NCT02269306|AMH|amh
213589|NCT02269306|visceral fat area|visceral fat area
213590|NCT02269306|HOMA-IR|homa-ir
213591|NCT02269293|Selinexor (KPT-330)|selinexor (kpt-330)
213592|NCT02269293|Paclitaxel|paclitaxel
213593|NCT02269293|Carboplatin|carboplatin
213594|NCT02269293|14-110|14-110
213595|NCT02269280|Leukemia|leukemia
213596|NCT02269280|Myelodysplastic syndrome|myelodysplastic syndrome
213597|NCT02269280|MDS|mds
213598|NCT02269280|Low or intermediate-1 risk|low or intermediate-1 risk
213599|NCT02269280|Transfusion-dependent|transfusion-dependent
213600|NCT02269280|Transfusion-independent|transfusion-independent
213601|NCT02269280|Best supportive care|best supportive care
213602|NCT02269280|BSC|bsc
213603|NCT02269280|Azacitidine|azacitidine
213604|NCT02269280|5-Azacytidine|5-azacytidine
213605|NCT02269280|5-AZA|5-aza
213606|NCT02269280|Vidaza|vidaza
213607|NCT02269280|5-AZC|5-azc
213608|NCT02269280|AZA-CR|aza-cr
213609|NCT02269280|Ladakamycin|ladakamycin
213610|NCT02269280|NSC-102816|nsc-102816
213611|NCT02269280|Azacytidine|azacytidine
213612|NCT02269280|Decitabine|decitabine
213613|NCT02269280|Dacogen|dacogen
213614|NCT02269254|Comparative Study|comparative study
213615|NCT02269254|Knee Prosthesis|knee prosthesis
213616|NCT02269254|Prosthesis Design|prosthesis design
213617|NCT02269254|Treatment Outcome|treatment outcome
213618|NCT02269254|Follow-Up Studies|follow-up studies
213619|NCT02269254|Arthroplasty, Replacement, Knee/methods|arthroplasty, replacement, knee/methods
213620|NCT02269241|contraception|contraception
213621|NCT02269241|hormonal oral contraceptive agents|hormonal oral contraceptive agents
213622|NCT02269241|hormonal oral contraceptive|hormonal oral contraceptive
213623|NCT02269241|oral contraceptive|oral contraceptive
213624|NCT02269241|drospirenone|drospirenone
213625|NCT02269241|LF111|lf111
213626|NCT02269241|birth control|birth control
213627|NCT02269150|Recipients|recipients
213628|NCT02269150|Transplantation|transplantation
213629|NCT02269137|status epileptics|status epileptics
213630|NCT02269137|prognosis|prognosis
213631|NCT02269137|risk factor|risk factor
213632|NCT02269137|outcome|outcome
213633|NCT02269098|type 2 diabetes|type 2 diabetes
213634|NCT02269098|hyperglycemia|hyperglycemia
213635|NCT02269098|Emergency Department|emergency department
213636|NCT02269098|Patient Education as Topic|patient education as topic
213637|NCT02269098|Drug Therapy|drug therapy
213638|NCT02269085|Lymphoma|lymphoma
213639|NCT02269085|Mantle cell lymphoma|mantle cell lymphoma
213640|NCT02269085|MCL|mcl
213641|NCT02269085|Relapsed or refractory|relapsed or refractory
213642|NCT02269085|Ibrutinib|ibrutinib
213643|NCT02269085|PCI-32765|pci-32765
213644|NCT02269085|Imbruvica|imbruvica
213645|NCT02269085|Carfilzomib|carfilzomib
213646|NCT02269072|Natriuretic Peptide|natriuretic peptide
213647|NCT02269046|acupuncture|acupuncture
213648|NCT02269046|moxibustion|moxibustion
213649|NCT02269046|hyperlipidemias|hyperlipidemias
213650|NCT02269046|effectiveness|effectiveness
213651|NCT02269033|Breast cancer|breast cancer
213652|NCT02269033|Patient Navigation|patient navigation
213653|NCT02269033|Health Disparities|health disparities
213654|NCT02269033|Latinas|latinas
213655|NCT02269033|Breast Imaging Reporting and Data System, BI-RADS|breast imaging reporting and data system, bi-rads
213656|NCT02269033|underserved|underserved
213657|NCT02269020|Squamous Cell Carcinoma of the Epi-larynx|squamous cell carcinoma of the epi-larynx
213658|NCT02269007|safety, tolerance, quadrivalent influenza vaccine|safety, tolerance, quadrivalent influenza vaccine
213659|NCT02268994|ferric citrate|ferric citrate
213660|NCT02268994|Chronic kidney disease|chronic kidney disease
213661|NCT02268994|Anemia|anemia
213662|NCT02268981|Oxymizer|oxymizer
213663|NCT02268981|Oxygen conserving device|oxygen conserving device
213664|NCT02268981|Conventional nasal cannula (CNC)|conventional nasal cannula (cnc)
213665|NCT02268981|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
213666|NCT02268968|Topical Lidocaine|topical lidocaine
213667|NCT02268968|Nasal CPAP|nasal cpap
213668|NCT02268968|Pain|pain
213669|NCT02268968|Preterm Infants|preterm infants
213670|NCT02268968|Salivary cortisol|salivary cortisol
213671|NCT02268955|Biliary Colic|biliary colic
213672|NCT02268955|Abdominal pain|abdominal pain
213673|NCT02268955|Intravenous Ibuprofen|intravenous ibuprofen
213674|NCT02268916|diabetes|diabetes
213675|NCT02268916|physical activity|physical activity
213676|NCT02268916|participation|participation
213677|NCT02268903|Pulmonary Embolism|pulmonary embolism
213678|NCT02268903|Right Ventricle failure|right ventricle failure
213679|NCT02268903|Diuretics|diuretics
213680|NCT02268890|Multiple Myeloma|multiple myeloma
213681|NCT02268890|Bortezomib|bortezomib
213682|NCT02268890|Velcade|velcade
213683|NCT02268877|ultrasonography|ultrasonography
213684|NCT02268877|emergency department|emergency department
213685|NCT02268864|Hepatitis C Chronic|hepatitis c chronic
213686|NCT02268864|Simeprevir|simeprevir
213687|NCT02268864|Daclatasvir|daclatasvir
213688|NCT02268851|Mantle Cell Lymphoma|mantle cell lymphoma
213689|NCT02268851|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma|chronic lymphocytic leukemia/small lymphocytic lymphoma
213690|NCT02268838|E6007|e6007
213691|NCT02268838|Healthy Japanese male subjects|healthy japanese male subjects
213692|NCT02268812|Pain Management|pain management
213693|NCT02268812|Europe|europe
213694|NCT02268812|Intrathecal|intrathecal
213695|NCT02268799|Cardioversion|cardioversion
213696|NCT02268799|High Sensitivity Troponin T (Hs-Trop T)|high sensitivity troponin t (hs-trop t)
213697|NCT02268799|Brain Natriuretic Peptide (BNP)|brain natriuretic peptide (bnp)
213698|NCT02268799|Neutrophil Gelatinase-associated Lipocalin (NGAL)|neutrophil gelatinase-associated lipocalin (ngal)
213699|NCT02268786|Preimplantation Genetic Screening|preimplantation genetic screening
213700|NCT02268786|Blastocyst|blastocyst
213701|NCT02268786|Vitrification|vitrification
213702|NCT02268786|In vitro fertilization|in vitro fertilization
213703|NCT02268786|non-invasive prenatal testing|non-invasive prenatal testing
213704|NCT02268786|next generation sequencing|next generation sequencing
213705|NCT02268747|skin squamous cell cancer panHER inhibitor Dacomitinib|skin squamous cell cancer panher inhibitor dacomitinib
213706|NCT02268734|Sporadic Medullary Thyroid Cancer Vandetanib miRNA|sporadic medullary thyroid cancer vandetanib mirna
213707|NCT02268721|Pilot study|pilot study
213708|NCT02268721|Frail elderly|frail elderly
213709|NCT02268721|Malnutrition|malnutrition
213710|NCT02268721|Functionality|functionality
213711|NCT02268721|Life quality|life quality
213712|NCT02268721|Health care technology|health care technology
213713|NCT02268708|COPD|copd
213714|NCT02268708|Surgery, Thoracic|surgery, thoracic
213715|NCT02268695|Recurrent/Metastatic HNSCC|recurrent/metastatic hnscc
213716|NCT02268695|Taxanes|taxanes
213717|NCT02268682|Educator-Guided|educator-guided
213718|NCT02268682|Patient-Guided|patient-guided
213719|NCT02268682|Standard of Care (Control)|standard of care (control)
213720|NCT02268669|primary angioplasty|primary angioplasty
213721|NCT02268669|post-thrombolysis angioplasty|post-thrombolysis angioplasty
213722|NCT02268669|ST elevation acute myocardial infarction|st elevation acute myocardial infarction
213723|NCT02268643|breast cancer|breast cancer
213724|NCT02268643|screening|screening
213725|NCT02268643|ultrasound|ultrasound
213726|NCT02268643|risk model|risk model
213727|NCT02268630|Post-thrombotic syndrome|post-thrombotic syndrome
213728|NCT02268630|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
213729|NCT02268630|Anticoagulation|anticoagulation
213730|NCT02268630|Rivaroxaban|rivaroxaban
213731|NCT02268617|Treadmill|treadmill
213732|NCT02268617|Walking|walking
213733|NCT02268617|Gait|gait
213734|NCT02268617|Exercise|exercise
213735|NCT02268578|Transcranial Direct Current Stimulation|transcranial direct current stimulation
213736|NCT02268578|TDCS|tdcs
213737|NCT02268578|Memory Dysfunction|memory dysfunction
213738|NCT02268578|Depression|depression
213739|NCT02268565|sleep, insomnia, inflammation, pain|sleep, insomnia, inflammation, pain
213740|NCT02268565|Insomnia symptom induction/placebo|insomnia symptom induction/placebo
213741|NCT02268565|Insomnia symptom induction/aspirin|insomnia symptom induction/aspirin
213742|NCT02268552|Type 1 Spinal Muscular Atrophy|type 1 spinal muscular atrophy
213743|NCT02268539|pilot study|pilot study
213744|NCT02268539|atrial fibrillation|atrial fibrillation
213745|NCT02268539|ablation|ablation
213746|NCT02268539|implanted loop recorder|implanted loop recorder
213747|NCT02268526|Safety, efficacy, pharmacokinetics, CSJ148, HCMV, HCMV viral load,|safety, efficacy, pharmacokinetics, csj148, hcmv, hcmv viral load,
213748|NCT02268526|immunogenicity|immunogenicity
213749|NCT02268513|Cardiovascular Disease|cardiovascular disease
213750|NCT02268513|Social network|social network
213751|NCT02268513|South Asians|south asians
213752|NCT02268487|Early Improvement|early improvement
213753|NCT02268487|Depression|depression
213754|NCT02268487|Antidepressant|antidepressant
213755|NCT02268474|532nm|532nm
213756|NCT02268474|Excel V|excel v
213757|NCT02268474|Cutera|cutera
213758|NCT02268474|Laser|laser
213759|NCT02268474|Laser Light|laser light
213760|NCT02268474|PDL|pdl
213761|NCT02268474|595nm|595nm
213762|NCT02268474|Flash Lamp|flash lamp
213763|NCT02268461|Post-Stroke Spasticity|post-stroke spasticity
213764|NCT02268448|itch atopic dermatitis|itch atopic dermatitis
213765|NCT02268422|Healthy volunteer|healthy volunteer
213766|NCT02268422|crossover|crossover
213767|NCT02268422|open-label|open-label
213768|NCT02268422|randomised|randomised
213769|NCT02268422|bioequivalence|bioequivalence
213770|NCT02268422|pharmacokinetic study|pharmacokinetic study
213771|NCT02268357|Dental Anxiety|dental anxiety
213772|NCT02268357|Tooth Extraction|tooth extraction
213773|NCT02268357|Propranolol|propranolol
213774|NCT02268344|nerve regeneration|nerve regeneration
213775|NCT02268344|spinal accessory nerve|spinal accessory nerve
213776|NCT02268344|shoulder function|shoulder function
213777|NCT02268344|head neck cancer|head neck cancer
213778|NCT02268344|electrical stimulation|electrical stimulation
213779|NCT02268318|Japanese Subjects, High LDL-C, fermented-dairy products, phytosterols|japanese subjects, high ldl-c, fermented-dairy products, phytosterols
213780|NCT02268292|Metabolic syndrome|metabolic syndrome
213781|NCT02268292|Diabetes|diabetes
213782|NCT02268292|Muscle strength|muscle strength
213783|NCT02268292|Aerobic exercise|aerobic exercise
213784|NCT02268292|Bicycle|bicycle
213785|NCT02268292|Brain-derived neurotrophic factor|brain-derived neurotrophic factor
213786|NCT02268266|brain injury, early rehabilitation, tilt table|brain injury, early rehabilitation, tilt table
213787|NCT02268214|Dapagliflozin|dapagliflozin
213788|NCT02268214|Efficacy|efficacy
213789|NCT02268214|Safety|safety
213790|NCT02268214|Add on to insulin|add on to insulin
213791|NCT02268214|Oral Antidiabetic|oral antidiabetic
213792|NCT02268214|Type 1 diabetes|type 1 diabetes
213793|NCT02268201|immunosuppressive therapy|immunosuppressive therapy
213794|NCT02268201|tacrolimus|tacrolimus
213795|NCT02268188|Cancer Survivors|cancer survivors
213796|NCT02268175|prostate adenocarcinoma|prostate adenocarcinoma
213797|NCT02268175|advanced prostate cancer|advanced prostate cancer
213798|NCT02268175|high risk prostate cancer|high risk prostate cancer
213799|NCT02268162|Lung Neoplasms|lung neoplasms
213800|NCT02268162|Bronchoscopy|bronchoscopy
213801|NCT02268162|Virtual Bronchoscopic Navigation(VBN)|virtual bronchoscopic navigation(vbn)
213802|NCT02268162|Fluoroscopy|fluoroscopy
213803|NCT02268162|Endobronchial Ultrasonography with a Guide Sheath(EBUS-GS)|endobronchial ultrasonography with a guide sheath(ebus-gs)
213804|NCT02268162|Diagnosis|diagnosis
213805|NCT02268123|Male Infertility|male infertility
213806|NCT02268123|Sperm DNA Fragmentation|sperm dna fragmentation
213807|NCT02268123|Sperm Abnormality|sperm abnormality
213808|NCT02268110|diastasis recti|diastasis recti
213809|NCT02268110|physiotherapy|physiotherapy
213810|NCT02268110|exercise therapy|exercise therapy
213811|NCT02268110|abdominal binding|abdominal binding
213812|NCT02268097|patella|patella
213813|NCT02268097|total knee arthroplasty|total knee arthroplasty
213814|NCT02268097|resection|resection
213815|NCT02268084|PTSD|ptsd
213816|NCT02268084|TMS|tms
213817|NCT02268084|EEG|eeg
213818|NCT02268071|Hypertension|hypertension
213819|NCT02268071|Stopping antihypertensive treatment|stopping antihypertensive treatment
213820|NCT02268071|Primary care|primary care
213821|NCT02268071|White coat hypertension|white coat hypertension
213822|NCT02268071|Masked Hypertension|masked hypertension
213823|NCT02268045|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
213824|NCT02268045|DLBCL|dlbcl
213825|NCT02268045|Diffuse large b-cell lymphoma|diffuse large b-cell lymphoma
213826|NCT02268032|hormone replacement therapy|hormone replacement therapy
213827|NCT02268019|hypospadias|hypospadias
213828|NCT02268019|dehiscence|dehiscence
213829|NCT02268019|urethral stricture|urethral stricture
213830|NCT02268019|side effects|side effects
213831|NCT02268006|rectal carcinoma|rectal carcinoma
213832|NCT02268006|preoperative radiochemotherapy|preoperative radiochemotherapy
213833|NCT02268006|IMRT|imrt
213834|NCT02268006|SIB|sib
213954|NCT02267278|Ruxolitinib|ruxolitinib
213835|NCT02267980|Electroconvulsive therapy; sevoflurane; ketamine|electroconvulsive therapy; sevoflurane; ketamine
213836|NCT02267954|Calories|calories
213837|NCT02267954|Fast Food Literacy|fast food literacy
213838|NCT02267928|Symptom Assessment|symptom assessment
213839|NCT02267915|Relapsed or refractory patients with mantle-cell lymphoma|relapsed or refractory patients with mantle-cell lymphoma
213840|NCT02267915|Progression after high-dose chemotherapy and autologous HPT|progression after high-dose chemotherapy and autologous hpt
213841|NCT02267902|Volunteers|volunteers
213842|NCT02267889|Ganglionated plexi|ganglionated plexi
213843|NCT02267850|Photobiomodulation|photobiomodulation
213844|NCT02267850|Orthodontic treatment|orthodontic treatment
213845|NCT02267850|Malocclusion|malocclusion
213846|NCT02267850|OrthoPulse™|orthopulse™
213847|NCT02267837|Alignment phase|alignment phase
213848|NCT02267837|Photobiomodulation|photobiomodulation
213849|NCT02267837|Orthodontic treatment|orthodontic treatment
213850|NCT02267837|Malocclusion|malocclusion
213851|NCT02267837|OrthoPulse™|orthopulse™
213852|NCT02267824|Alignment phase|alignment phase
213853|NCT02267824|Photobiomodulation|photobiomodulation
213854|NCT02267824|Orthodontic treatment|orthodontic treatment
213855|NCT02267824|Malocclusion|malocclusion
213856|NCT02267824|OrthoPulse™|orthopulse™
213857|NCT02267811|Photobiomodulation|photobiomodulation
213858|NCT02267811|Orthodontic treatment|orthodontic treatment
213859|NCT02267811|Malocclusion|malocclusion
213860|NCT02267811|OrthoPulse™|orthopulse™
213861|NCT02267798|Stroke|stroke
213862|NCT02267798|Rehabilitation|rehabilitation
213863|NCT02267798|Arm motor recovery|arm motor recovery
213864|NCT02267798|biological biomarkers|biological biomarkers
213865|NCT02267785|exercise|exercise
213866|NCT02267785|mild cognitive impairment|mild cognitive impairment
213867|NCT02267785|Parkinson's Disease|parkinson's disease
213868|NCT02267720|Dental Atraumatic Restorative Treatment|dental atraumatic restorative treatment
213869|NCT02267720|Glass ionomer cement|glass ionomer cement
213870|NCT02267720|Occlusal-proximal leasons|occlusal-proximal leasons
213871|NCT02267720|Primary molars|primary molars
213872|NCT02267707|nab®-paclitaxel|nab®-paclitaxel
213873|NCT02267707|ABI-007|abi-007
213874|NCT02267707|Abraxane|abraxane
213875|NCT02267707|Advanced Pancreatic Cancer|advanced pancreatic cancer
213876|NCT02267707|Cholestatic Hyperbilirubinemia|cholestatic hyperbilirubinemia
213877|NCT02267707|Bile Duct Obstruction|bile duct obstruction
213878|NCT02267707|Pancreatic Cancer|pancreatic cancer
213879|NCT02267668|concussion|concussion
213880|NCT02267668|sports concussion|sports concussion
213881|NCT02267668|exercise therapy|exercise therapy
213882|NCT02267655|Inhaled Nitric Oxide (iNO)|inhaled nitric oxide (ino)
213883|NCT02267655|Pulmonary Hypertension (PH)|pulmonary hypertension (ph)
213884|NCT02267655|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
213885|NCT02267655|Long Term Oxygen Therapy (LTOT)|long term oxygen therapy (ltot)
213886|NCT02267655|Idiopathic Pulmonary Fibrosis (IPF)|idiopathic pulmonary fibrosis (ipf)
213887|NCT02267629|OCD|ocd
213888|NCT02267616|Levonorgestrel intrauterine device (LNG IUD)|levonorgestrel intrauterine device (lng iud)
213889|NCT02267616|Etonogestrel (ENG) Implant|etonogestrel (eng) implant
213890|NCT02267616|Contraception|contraception
213891|NCT02267564|patellar dislocation|patellar dislocation
213892|NCT02267564|medial patellofemoral ligament|medial patellofemoral ligament
213893|NCT02267564|tibial tubercle transfer|tibial tubercle transfer
213894|NCT02267551|robotic surgery|robotic surgery
213895|NCT02267551|simulation|simulation
213896|NCT02267538|Delirium|delirium
213897|NCT02267538|Cardiac Surgical Procedures|cardiac surgical procedures
213898|NCT02267538|Postoperative Complications|postoperative complications
213899|NCT02267538|Dexmedetomidine|dexmedetomidine
213900|NCT02267538|Prevention|prevention
213901|NCT02267525|Gastroparesis|gastroparesis
213902|NCT02267525|Diabetic|diabetic
213903|NCT02267525|Idiopathic|idiopathic
213904|NCT02267512|Kidney Transplant Patients|kidney transplant patients
213905|NCT02267512|ATG-F|atg-f
213906|NCT02267499|cognitive training|cognitive training
213907|NCT02267499|physical training|physical training
213908|NCT02267499|exercise games|exercise games
213909|NCT02267499|novelty serious games|novelty serious games
213910|NCT02267499|computer training|computer training
213911|NCT02267499|mild cognitive impairment|mild cognitive impairment
213912|NCT02267499|mild dementia|mild dementia
213913|NCT02267499|healthy elderly|healthy elderly
213914|NCT02267486|Alzheimer Dementia, AD|alzheimer dementia, ad
213915|NCT02267486|patients|patients
213916|NCT02267486|cognitive|cognitive
213917|NCT02267460|Peyronie's disease|peyronie's disease
213918|NCT02267460|penile plaque|penile plaque
213919|NCT02267460|penile curvature|penile curvature
213920|NCT02267447|Cardiovascular diseases|cardiovascular diseases
213921|NCT02267447|Clinical prediction rule|clinical prediction rule
213922|NCT02267447|Population projection|population projection
213923|NCT02267447|Risk stratification|risk stratification
213924|NCT02267447|Health behavior|health behavior
213925|NCT02267408|Heart valve prosthesis|heart valve prosthesis
213926|NCT02267408|Anticoagulation|anticoagulation
213927|NCT02267408|Warfarin|warfarin
213928|NCT02267395|Musicians, Injuries|musicians, injuries
213929|NCT02267369|online|online
213930|NCT02267369|social media|social media
213931|NCT02267369|online social network|online social network
213932|NCT02267369|physical activity|physical activity
213933|NCT02267369|message|message
213934|NCT02267330|Gonadal Radiation Exposure|gonadal radiation exposure
213935|NCT02267330|Fluoroscopic Imaging|fluoroscopic imaging
213936|NCT02267330|Trauma Surgery|trauma surgery
213937|NCT02267330|Pelvis fractures|pelvis fractures
213938|NCT02267330|Femur fractures|femur fractures
213939|NCT02267317|Insulin signaling and glucose disposal in muscle|insulin signaling and glucose disposal in muscle
213940|NCT02267317|Hepatic insulin sensitivity|hepatic insulin sensitivity
213941|NCT02267317|TLR4 signaling and inflammatory gene expression|tlr4 signaling and inflammatory gene expression
213942|NCT02267317|Plasma cytokine concentration|plasma cytokine concentration
213943|NCT02267317|Intramyocellular diacylglycerol and ceramide content|intramyocellular diacylglycerol and ceramide content
213944|NCT02267304|volunteers|volunteers
213945|NCT02267291|Cardiac Catheterization|cardiac catheterization
213946|NCT02267291|Echocardiography|echocardiography
213947|NCT02267291|Noninvasive Ventilation|noninvasive ventilation
213948|NCT02267291|Positive-Pressure Respiration|positive-pressure respiration
213949|NCT02267291|Ventricular Function|ventricular function
213950|NCT02267278|Myeloproliferative Diseases|myeloproliferative diseases
213951|NCT02267278|Myelofibrosis|myelofibrosis
213952|NCT02267278|MF|mf
213953|NCT02267278|Primary or post essential thrombocythemia/polycythemia vera|primary or post essential thrombocythemia/polycythemia vera
213955|NCT02267278|Jakafi|jakafi
213956|NCT02267278|INCB018424|incb018424
213957|NCT02267278|INC424|inc424
213958|NCT02267278|Pracinostat|pracinostat
213959|NCT02267278|Questionnaire|questionnaire
213960|NCT02267278|Survey|survey
213961|NCT02267265|educational intervention|educational intervention
213962|NCT02267265|language development|language development
213963|NCT02267265|universal newborn hearing screening|universal newborn hearing screening
213964|NCT02267265|postpartum|postpartum
213965|NCT02267265|parental attachment|parental attachment
213966|NCT02267265|loss to follow-up|loss to follow-up
213967|NCT02267265|hearing loss|hearing loss
213968|NCT02267265|achievement gap|achievement gap
213969|NCT02267265|language gap|language gap
213970|NCT02267265|school readiness|school readiness
213971|NCT02267239|essential oils|essential oils
213972|NCT02267239|chlorhexidine|chlorhexidine
213973|NCT02267239|microscopy, confocal|microscopy, confocal
213974|NCT02267239|immersion|immersion
213975|NCT02267239|antiseptic|antiseptic
213976|NCT02267200|biomarkers，pulmonary arterial hypertension|biomarkers，pulmonary arterial hypertension
213977|NCT02267187|Craniomaxillofacial (CMF)|craniomaxillofacial (cmf)
213978|NCT02267187|Battle-injured (BI)|battle-injured (bi)
213979|NCT02267187|Facial Trauma|facial trauma
213980|NCT02267187|Fat Grafts|fat grafts
213981|NCT02267187|Autogenous Fat Transfers (AFT)|autogenous fat transfers (aft)
213982|NCT02267187|Wounded Warriors|wounded warriors
213983|NCT02267174|Implementation|implementation
213984|NCT02267174|quality improvement|quality improvement
213985|NCT02267174|patient safety|patient safety
213986|NCT02267174|handoffs|handoffs
213987|NCT02267174|intensive care unit|intensive care unit
213988|NCT02267174|postoperative care|postoperative care
213989|NCT02267174|simulation|simulation
213990|NCT02267161|agenesis|agenesis
213991|NCT02267161|corpus callosum|corpus callosum
213992|NCT02267161|prenatal diagnosis|prenatal diagnosis
213993|NCT02267148|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
213994|NCT02267148|Fatty liver|fatty liver
213995|NCT02267148|Steatosis|steatosis
213996|NCT02267148|Fibrosis|fibrosis
213997|NCT02267148|Liver Stiffness|liver stiffness
213998|NCT02267148|Cirrhosis|cirrhosis
213999|NCT02267148|Genetics|genetics
214000|NCT02267148|Single Nucleotide Polymorphism|single nucleotide polymorphism
214001|NCT02267135|scalp psoriasis, plaque psoriasis, secukinumab, AIN457, biologic, monoclonal antibody, psoriasis, AIN457A|scalp psoriasis, plaque psoriasis, secukinumab, ain457, biologic, monoclonal antibody, psoriasis, ain457a
214002|NCT02267096|lung cancer screening|lung cancer screening
214003|NCT02267083|soft tissue sarcoma|soft tissue sarcoma
214004|NCT02267070|cognitive training|cognitive training
214005|NCT02267070|aerobic exercise|aerobic exercise
214006|NCT02267070|neurotrophic factors|neurotrophic factors
214007|NCT02267070|randomized controlled trial|randomized controlled trial
214008|NCT02267057|Pain measurement|pain measurement
214009|NCT02267057|Pain assessment|pain assessment
214010|NCT02267057|Pain management|pain management
214011|NCT02267057|Analgesia|analgesia
214012|NCT02267057|Analgesics|analgesics
214013|NCT02267057|Depressive symptoms|depressive symptoms
214014|NCT02267057|Alzheimer disease|alzheimer disease
214015|NCT02267057|Vascular dementia|vascular dementia
214016|NCT02267057|Multi-infarct dementia|multi-infarct dementia
214017|NCT02267057|Frontotemporal lobar degeneration|frontotemporal lobar degeneration
214018|NCT02267057|Lewy body disease|lewy body disease
214019|NCT02267031|cognitive dysfunction|cognitive dysfunction
214020|NCT02267031|mechanical ventilation|mechanical ventilation
214021|NCT02267031|hyperoxia|hyperoxia
214022|NCT02267031|hypocapnia|hypocapnia
214023|NCT02267018|nCPAP|ncpap
214024|NCT02267018|High-Frequency Oscillator Ventilation|high-frequency oscillator ventilation
214025|NCT02267018|Diaphragm Electrical Activity|diaphragm electrical activity
214026|NCT02266979|peritoneal dialysis|peritoneal dialysis
214027|NCT02266979|nursing staff|nursing staff
214028|NCT02266979|nursing activities|nursing activities
214029|NCT02266979|Personnel Downsizing|personnel downsizing
214030|NCT02266953|Dietary services|dietary services
214031|NCT02266953|Public Health Nursing|public health nursing
214032|NCT02266953|Preschool child|preschool child
214033|NCT02266940|pharmacokinetics|pharmacokinetics
214034|NCT02266901|leaks after bariatric surgery|leaks after bariatric surgery
214035|NCT02266901|fistulae after bariatric surgery|fistulae after bariatric surgery
214036|NCT02266901|abdominal abcesses and bariatric surgery|abdominal abcesses and bariatric surgery
214037|NCT02266901|endoscopic drainage of abcesses|endoscopic drainage of abcesses
214038|NCT02266901|percutaneous drainage of abcesses|percutaneous drainage of abcesses
214039|NCT02266901|gastric bypass|gastric bypass
214040|NCT02266901|sleeve gastrectomy|sleeve gastrectomy
214041|NCT02266901|necrotic collection and bariatric surgery|necrotic collection and bariatric surgery
214042|NCT02266888|B cells|b cells
214043|NCT02266888|lung transplant recipient|lung transplant recipient
214044|NCT02266888|rituximab|rituximab
214045|NCT02266888|placebo|placebo
214046|NCT02266888|standard of care|standard of care
214047|NCT02266836|Stroke|stroke
214048|NCT02266836|Cerebrovascular accident|cerebrovascular accident
214049|NCT02266836|Upper Extremity|upper extremity
214050|NCT02266836|Cerebral Infarction|cerebral infarction
214051|NCT02266836|Brain Infarction|brain infarction
214052|NCT02266836|Brain Ischemia|brain ischemia
214053|NCT02266836|Cerebrovascular Disorders|cerebrovascular disorders
214054|NCT02266836|Cardiovascular Diseases|cardiovascular diseases
214055|NCT02266836|Nervous System Diseases|nervous system diseases
214056|NCT02266836|Central Nervous System Diseases|central nervous system diseases
214057|NCT02266784|smoking, smoking cessation, contingency management, ADHD|smoking, smoking cessation, contingency management, adhd
214058|NCT02266771|Negative Pressure Wound Therapy, Wound VAC, Instillation|negative pressure wound therapy, wound vac, instillation
214059|NCT02266758|Gestational Diabetes|gestational diabetes
214060|NCT02266758|Obesity|obesity
214061|NCT02266758|Pregnancy|pregnancy
214062|NCT02266719|Aortic Aneurysm, Abdominal [C14.907.055.239.075]|aortic aneurysm, abdominal [c14.907.055.239.075]
214063|NCT02266693|Cognitive Behavioural Therapy|cognitive behavioural therapy
214064|NCT02266693|Internet Based|internet based
214065|NCT02266693|CBT|cbt
214066|NCT02266693|Transdiagnostic|transdiagnostic
214067|NCT02266693|MDD|mdd
214068|NCT02266693|PD|pd
214069|NCT02266693|SAD|sad
214070|NCT02266693|GAD|gad
214071|NCT02266693|iCBT|icbt
214072|NCT02266680|Social Anxiety|social anxiety
214073|NCT02266680|Yoga|yoga
214074|NCT02266667|NEMOT device|nemot device
214075|NCT02266667|pediatrics|pediatrics
214076|NCT02266667|surgery|surgery
214077|NCT02266667|progressive scoliosis|progressive scoliosis
214078|NCT02266654|Emergency Medical Services|emergency medical services
214079|NCT02266654|Lactic Acid|lactic acid
214080|NCT02266654|Sepsis|sepsis
214081|NCT02266641|one-carbon metabolism|one-carbon metabolism
214082|NCT02266641|folate|folate
214083|NCT02266641|choline|choline
214084|NCT02266641|DNA methylation|dna methylation
214085|NCT02266641|imprint marker|imprint marker
214086|NCT02266641|cancer risks|cancer risks
214087|NCT02266602|IORT|iort
214088|NCT02266602|Breast Cancer|breast cancer
214089|NCT02266589|coagulopathy|coagulopathy
214090|NCT02266589|hydrocortisone|hydrocortisone
214091|NCT02266589|organ failure|organ failure
214092|NCT02266589|hemodynamic improvement induced by hydrocortisone|hemodynamic improvement induced by hydrocortisone
214093|NCT02266563|Traumatic Brain Injury|traumatic brain injury
214094|NCT02266563|Chronic Traumatic Encephalopathy|chronic traumatic encephalopathy
214095|NCT02266563|Mild Cognitive Impairment|mild cognitive impairment
214096|NCT02266563|PET imaging|pet imaging
214097|NCT02266563|tauopathy|tauopathy
214098|NCT02266563|amyloid|amyloid
214099|NCT02266446|anxiety disorders|anxiety disorders
214100|NCT02266446|cognitive bias modification|cognitive bias modification
214101|NCT02266446|primary care|primary care
214102|NCT02266446|attention|attention
214103|NCT02266446|interpretation|interpretation
214104|NCT02266446|computer|computer
214105|NCT02266433|DeQuervains Tenosynovitis|dequervains tenosynovitis
214106|NCT02266433|Lateral Epicondylitis|lateral epicondylitis
214107|NCT02266433|Tennis Elbow|tennis elbow
214108|NCT02266433|Trigger Finger|trigger finger
214109|NCT02266433|Tenosynovitis|tenosynovitis
214110|NCT02266433|Inflammatory Disease|inflammatory disease
214111|NCT02266433|Dexamethasone|dexamethasone
214112|NCT02266433|Ketorolac|ketorolac
214113|NCT02266433|Toradol|toradol
214114|NCT02266420|Triple negative breast cancer|triple negative breast cancer
214115|NCT02266420|immuno-histochemistery|immuno-histochemistery
214116|NCT02266420|genomic profiles|genomic profiles
214117|NCT02266407|Revision TKA|revision tka
214118|NCT02266407|Septic|septic
214119|NCT02266407|Aseptic|aseptic
214120|NCT02266407|Transfusion|transfusion
214121|NCT02266407|Blood Loss|blood loss
214122|NCT02266381|PCNL|pcnl
214123|NCT02266381|MPCNL|mpcnl
214124|NCT02266381|guidance|guidance
214125|NCT02266381|puncture|puncture
214126|NCT02266368|Ureteral stents|ureteral stents
214127|NCT02266368|Double J stent|double j stent
214128|NCT02266368|Antimicoreal coated stent|antimicoreal coated stent
214129|NCT02266368|USSQ|ussq
214130|NCT02266368|UTI|uti
214131|NCT02266355|Oxaliplatin|oxaliplatin
214132|NCT02266355|Omalizumab|omalizumab
214133|NCT02266329|controlled clinical trial|controlled clinical trial
214134|NCT02266329|randomized controlled clinical trial|randomized controlled clinical trial
214135|NCT02266290|ADHESIVE TAPE|adhesive tape
214136|NCT02266290|ANKLE INJURY|ankle injury
214137|NCT02266290|POSTURAL BALANCE|postural balance
214138|NCT02266290|FUNCTIONAL ANKLE INSTABILITY|functional ankle instability
214139|NCT02266277|electronic health record, utilization|electronic health record, utilization
214140|NCT02266277|randomized controlled trial|randomized controlled trial
214141|NCT02266277|pragmatic clinical trial|pragmatic clinical trial
214142|NCT02266277|influenza, prevention and control|influenza, prevention and control
214143|NCT02266277|pneumococcal vaccines|pneumococcal vaccines
214144|NCT02266277|qualitative research|qualitative research
214145|NCT02266225|Chronic disease management|chronic disease management
214146|NCT02266225|Physical activity|physical activity
214147|NCT02266225|Fall prevention|fall prevention
214148|NCT02266225|Strength and balance exercise|strength and balance exercise
214149|NCT02266199|questionnaire|questionnaire
214150|NCT02266199|quality assurance|quality assurance
214151|NCT02266199|qualitative Verification|qualitative verification
214152|NCT02266199|conservative patients|conservative patients
214153|NCT02266199|interview|interview
214154|NCT02266160|tinnitus|tinnitus
214155|NCT02266160|local anaesthetic|local anaesthetic
214156|NCT02266160|EMLA cream 5%|emla cream 5%
214157|NCT02266147|Low Grade B-cell Lymphoma|low grade b-cell lymphoma
214158|NCT02266134|implementation|implementation
214159|NCT02266134|measurement based care|measurement based care
214160|NCT02266134|standardized|standardized
214161|NCT02266134|tailored|tailored
214162|NCT02266121|Multiple Sclerosis|multiple sclerosis
214163|NCT02266121|MS|ms
214164|NCT02266121|Cognitive deficits|cognitive deficits
214165|NCT02266121|Motor deficits|motor deficits
214166|NCT02266121|Fatigue|fatigue
214167|NCT02266121|Nervous System Diseases|nervous system diseases
214168|NCT02266121|Brain Diseases|brain diseases
214169|NCT02266121|Brain stimulation|brain stimulation
214170|NCT02266121|Working memory|working memory
214171|NCT02266121|Motor learning|motor learning
214172|NCT02266121|Central Nervous System Diseases|central nervous system diseases
214173|NCT02266121|Neuropsychological rehabilitation|neuropsychological rehabilitation
214174|NCT02266108|Sexually Transmitted Infections|sexually transmitted infections
214175|NCT02266108|Female Sex Workers|female sex workers
214176|NCT02266095|Osteoarthritis|osteoarthritis
214177|NCT02266095|Thumb spica splint|thumb spica splint
214178|NCT02266095|Oval-8 splint|oval-8 splint
214179|NCT02266095|Tee-Pee splint|tee-pee splint
214180|NCT02266069|implementation|implementation
214181|NCT02266069|anticipatory care planning|anticipatory care planning
214182|NCT02266069|symptom assessment|symptom assessment
214183|NCT02266069|interdisciplinary collaboration|interdisciplinary collaboration
214184|NCT02266056|deep neuromuscular block|deep neuromuscular block
214185|NCT02266056|sugammadex|sugammadex
214186|NCT02266056|laparoscopic colorectal surgery|laparoscopic colorectal surgery
214187|NCT02266056|hemodynamic change|hemodynamic change
214188|NCT02266043|Upper airway obstruction|upper airway obstruction
214189|NCT02266017|pain|pain
214190|NCT02266017|coping|coping
214191|NCT02266017|mhealth|mhealth
214192|NCT02266017|cancer|cancer
214193|NCT02266004|transcranial direct current stimulation|transcranial direct current stimulation
214194|NCT02266004|neuromodulation|neuromodulation
214195|NCT02265978|Emotional Self-Awareness|emotional self-awareness
214196|NCT02265978|Positive Coping|positive coping
214197|NCT02265978|Help-Seeking|help-seeking
214198|NCT02265926|filtering facepiece respirators|filtering facepiece respirators
214199|NCT02265926|N95 masks|n95 masks
214200|NCT02265926|pandemic response|pandemic response
214201|NCT02265926|pregnant healthcare workers|pregnant healthcare workers
214202|NCT02265900|Positron Emission Tomography|positron emission tomography
214203|NCT02265900|Dopamine|dopamine
214204|NCT02265900|Parkinson's Disease|parkinson's disease
214205|NCT02265887|Pulmonary Hypertension|pulmonary hypertension
214206|NCT02265887|Africa|africa
214207|NCT02265887|Heart Disease|heart disease
214208|NCT02265887|Echocardiography|echocardiography
214209|NCT02265861|Polycystic ovary syndrome; Vascular endothelial growth factor; Angiotensin-Ⅱ; Ovarian hyperstimulation syndrome|polycystic ovary syndrome; vascular endothelial growth factor; angiotensin-ⅱ; ovarian hyperstimulation syndrome
214210|NCT02265848|Spinal cord stimulation|spinal cord stimulation
214211|NCT02265848|Chronic pain|chronic pain
214212|NCT02265848|Chronic low back pain|chronic low back pain
214213|NCT02265848|Radiculopathy|radiculopathy
214214|NCT02265848|Complex Regional Pain Syndrome (CRPS)|complex regional pain syndrome (crps)
214215|NCT02265848|High Frequency stimulation|high frequency stimulation
214216|NCT02265822|melatonin|melatonin
214217|NCT02265822|midazolam|midazolam
214218|NCT02265822|children|children
214219|NCT02265809|Interleukin 2|interleukin 2
214220|NCT02265809|Type 1 diabetes|type 1 diabetes
214221|NCT02265809|T regulatory cells|t regulatory cells
214222|NCT02265809|Adaptive trial|adaptive trial
214223|NCT02265796|deferred percutaneous coronary intervention|deferred percutaneous coronary intervention
214224|NCT02265796|fractional flow reserve|fractional flow reserve
214225|NCT02265783|Focus of Study: Healthy Volunteers|focus of study: healthy volunteers
214226|NCT02265757|Behavioral Intervention|behavioral intervention
214227|NCT02265757|Mild Cognitive Impairment|mild cognitive impairment
214228|NCT02265757|HABIT|habit
214229|NCT02265757|Cognitive Rehabilitation|cognitive rehabilitation
214230|NCT02265757|Multi-Component Intervention|multi-component intervention
214231|NCT02265731|relapsed multiple myeloma|relapsed multiple myeloma
214232|NCT02265731|refractory multiple myeloma|refractory multiple myeloma
214233|NCT02265731|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
214234|NCT02265731|Lymphoproliferative Disorders|lymphoproliferative disorders
214235|NCT02265731|Lymphatic Diseases|lymphatic diseases
214236|NCT02265731|relapsed chronic lymphocytic leukemia|relapsed chronic lymphocytic leukemia
214237|NCT02265731|small lymphocytic lymphoma|small lymphocytic lymphoma
214238|NCT02265731|relapsed small lymphocytic lymphoma|relapsed small lymphocytic lymphoma
214239|NCT02265731|refractory small lymphocytic lymphoma|refractory small lymphocytic lymphoma
214430|NCT02264353|Obstructive|obstructive
214240|NCT02265731|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
214241|NCT02265731|acute myeloid leukemia|acute myeloid leukemia
214242|NCT02265718|Healthy|healthy
214243|NCT02265718|elderly volunteers|elderly volunteers
214244|NCT02265614|PGS|pgs
214245|NCT02265614|blastocyst|blastocyst
214246|NCT02265614|human|human
214247|NCT02265614|IVF|ivf
214248|NCT02265614|vitrification|vitrification
214249|NCT02265614|single embryo transfer|single embryo transfer
214250|NCT02265601|advance care planning|advance care planning
214251|NCT02265601|living wills|living wills
214252|NCT02265601|end of life|end of life
214253|NCT02265601|cancer|cancer
214254|NCT02265588|Inflammatory bowel disease (IBD)|inflammatory bowel disease (ibd)
214255|NCT02265588|Ulcerative colitis|ulcerative colitis
214256|NCT02265588|Crohn's disease|crohn's disease
214257|NCT02265588|Children|children
214258|NCT02265588|Adolescents|adolescents
214259|NCT02265588|Anxiety|anxiety
214260|NCT02265588|Depression|depression
214261|NCT02265588|Cognitive behavioral therapy|cognitive behavioral therapy
214262|NCT02265562|Hysterectomy|hysterectomy
214263|NCT02265562|Misoprostol|misoprostol
214264|NCT02265562|Blood loss|blood loss
214265|NCT02265549|Metastases,|metastases,
214266|NCT02265549|Neoplasm|neoplasm
214267|NCT02265549|Cerebral|cerebral
214268|NCT02265523|Arthroplasties, Replacement, Knee|arthroplasties, replacement, knee
214269|NCT02265458|Respiratory failure|respiratory failure
214270|NCT02265458|NIV|niv
214271|NCT02265458|Musical intervention|musical intervention
214272|NCT02265445|Carbapenems therapy/ESBL infections/Deescalation|carbapenems therapy/esbl infections/deescalation
214273|NCT02265445|due to ESBL-PE|due to esbl-pe
214274|NCT02265432|Physical activity|physical activity
214275|NCT02265432|Sedentary behavior|sedentary behavior
214276|NCT02265419|hyperinflammation, Cytosorb|hyperinflammation, cytosorb
214277|NCT02265354|Tobacco Smoking Cessation|tobacco smoking cessation
214278|NCT02265354|Computer tailored health communication|computer tailored health communication
214279|NCT02265354|messaging|messaging
214280|NCT02265354|collective intelligence|collective intelligence
214281|NCT02265354|recommender systems|recommender systems
214282|NCT02265354|machine learning|machine learning
214283|NCT02265328|Severe Alcoholic Hepatitis in 'Extremis'|severe alcoholic hepatitis in 'extremis'
214284|NCT02265328|Bovine Colostrum|bovine colostrum
214285|NCT02265328|Glucocorticoids|glucocorticoids
214286|NCT02265276|NAFLD, Diabetes, Glitazone|nafld, diabetes, glitazone
214287|NCT02265250|magnetic resonance imaging|magnetic resonance imaging
214288|NCT02265250|positron emission tomography|positron emission tomography
214289|NCT02265237|Compensated Cirrhosis|compensated cirrhosis
214290|NCT02265237|Hepatitis C|hepatitis c
214291|NCT02265237|Hepatitis C Genotype 4|hepatitis c genotype 4
214292|NCT02265237|Chronic Hepatitis C|chronic hepatitis c
214293|NCT02265198|Pulmonary Contusion|pulmonary contusion
214294|NCT02265198|ARDS|ards
214295|NCT02265198|Respiratory Failure|respiratory failure
214296|NCT02265172|Physiotherapy|physiotherapy
214297|NCT02265172|Orthopaedic|orthopaedic
214298|NCT02265172|Primary care|primary care
214299|NCT02265146|Lipid Core Plaques (LCPs)|lipid core plaques (lcps)
214300|NCT02265146|Vulnerable Plaque|vulnerable plaque
214301|NCT02265146|Near Infrared Spectroscopy|near infrared spectroscopy
214302|NCT02265107|endothelial function|endothelial function
214303|NCT02265107|physical training|physical training
214304|NCT02265107|exercise|exercise
214305|NCT02265107|coronary artery bypass|coronary artery bypass
214306|NCT02265094|Autism Spectrum Disorder|autism spectrum disorder
214307|NCT02265094|Development|development
214308|NCT02265094|Memory|memory
214309|NCT02265094|ERD|erd
214310|NCT02265068|Acute coronary syndrome (ACS), Ticagrelor|acute coronary syndrome (acs), ticagrelor
214311|NCT02265029|fibromyalgia|fibromyalgia
214312|NCT02265029|rheumatism|rheumatism
214313|NCT02265029|fatigue syndrom|fatigue syndrom
214314|NCT02265029|pain|pain
214315|NCT02265029|spa treatment in rheumatology|spa treatment in rheumatology
214316|NCT02265016|coronary artery disease|coronary artery disease
214317|NCT02265016|acute coronary syndrome|acute coronary syndrome
214318|NCT02265016|angina pectoris|angina pectoris
214319|NCT02265016|non-ST-segment elevation myocardial infarction|non-st-segment elevation myocardial infarction
214320|NCT02265016|red blood cells|red blood cells
214321|NCT02265016|erythrocytes|erythrocytes
214322|NCT02265003|red blood cells|red blood cells
214323|NCT02265003|endothelial function|endothelial function
214324|NCT02265003|nitric oxide pool in red blood cells|nitric oxide pool in red blood cells
214325|NCT02265003|nitric oxide poll in blood plasma|nitric oxide poll in blood plasma
214326|NCT02265003|nitric oxide synthase III - expression|nitric oxide synthase iii - expression
214327|NCT02265003|oxidative status|oxidative status
214328|NCT02265003|nitric oxide signalling|nitric oxide signalling
214329|NCT02264990|veliparib|veliparib
214330|NCT02264990|carboplatin|carboplatin
214331|NCT02264990|paclitaxel|paclitaxel
214332|NCT02264990|cisplatin|cisplatin
214333|NCT02264990|pemetrexed|pemetrexed
214334|NCT02264990|Poly Adenosine diphosphate (ADP)-ribose Polymerase (PARP)|poly adenosine diphosphate (adp)-ribose polymerase (parp)
214335|NCT02264990|Metastatic|metastatic
214336|NCT02264990|Non-squamous|non-squamous
214337|NCT02264990|Non-small cell lung cancer|non-small cell lung cancer
214338|NCT02264964|Hemodialysis|hemodialysis
214339|NCT02264964|End-Stage Kidney Disease|end-stage kidney disease
214340|NCT02264964|Central Venous Catheterization|central venous catheterization
214341|NCT02264964|Digital Subtraction Angiography|digital subtraction angiography
214342|NCT02264951|Short fatty acids|short fatty acids
214343|NCT02264951|2-oleoyl glycerol|2-oleoyl glycerol
214344|NCT02264951|GLP-1 secretion|glp-1 secretion
214345|NCT02264951|C8-diet oil|c8-diet oil
214346|NCT02264951|GIP secretion|gip secretion
214347|NCT02264925|Essential tremor|essential tremor
214348|NCT02264925|Deep brain stimulation (DBS)|deep brain stimulation (dbs)
214349|NCT02264925|Ventral intermediate Thalamus (VIM)|ventral intermediate thalamus (vim)
214350|NCT02264925|Local field potentials (LFPs)|local field potentials (lfps)
214351|NCT02264925|Closed loop therapy|closed loop therapy
214352|NCT02264912|antiplatelets, percutanous coronary intervention, acute coronary syndromes, laboratory efficacy|antiplatelets, percutanous coronary intervention, acute coronary syndromes, laboratory efficacy
214353|NCT02264899|Alzheimer's disease|alzheimer's disease
214354|NCT02264899|Mild Cognitive Impairment|mild cognitive impairment
214355|NCT02264873|Relapse|relapse
214356|NCT02264873|Autologous stem cell transplant|autologous stem cell transplant
214357|NCT02264847|Clomiphene Citrate|clomiphene citrate
214358|NCT02264847|Ovulation trigger|ovulation trigger
214359|NCT02264847|Human chorionic gonadotrophin|human chorionic gonadotrophin
214360|NCT02264834|epidural|epidural
214361|NCT02264834|primiparous patient|primiparous patient
214362|NCT02264834|deambulation|deambulation
214363|NCT02264821|analgesia|analgesia
214364|NCT02264821|caesarean|caesarean
214365|NCT02264821|wound infiltration|wound infiltration
214366|NCT02264821|intrathecal morphine.|intrathecal morphine.
214367|NCT02264795|Cesarean section|cesarean section
214368|NCT02264795|Lidocaine|lidocaine
214369|NCT02264769|pregnancy|pregnancy
214370|NCT02264769|postpartum hemorrhage|postpartum hemorrhage
214371|NCT02264769|Cesarean delivery|cesarean delivery
214372|NCT02264769|carbetocin|carbetocin
214373|NCT02264756|Community-acquired pneumonia|community-acquired pneumonia
214374|NCT02264756|Pragmatic clinical trial|pragmatic clinical trial
214375|NCT02264756|Antimicrobial stewardship|antimicrobial stewardship
214376|NCT02264756|length of stay|length of stay
214377|NCT02264756|stepped-wedge design|stepped-wedge design
214378|NCT02264756|time-dependent bias|time-dependent bias
214379|NCT02264704|MS|ms
214380|NCT02264704|Exercise|exercise
214381|NCT02264704|Training|training
214382|NCT02264704|Multiple sclerosis|multiple sclerosis
214383|NCT02264704|Immune response|immune response
214384|NCT02264704|Neurotrophin|neurotrophin
214385|NCT02264704|Cytokine|cytokine
214386|NCT02264704|Fatigue|fatigue
214387|NCT02264678|ATM deficient, ATM proficient, HER2 negative, Breast, Gastric, Head & Neck, Lung|atm deficient, atm proficient, her2 negative, breast, gastric, head & neck, lung
214388|NCT02264652|Refractory|refractory
214389|NCT02264652|Partial|partial
214390|NCT02264652|Epilepsy|epilepsy
214391|NCT02264626|acute respiratory failure|acute respiratory failure
214392|NCT02264626|noninvasive ventilation|noninvasive ventilation
214393|NCT02264626|sedation|sedation
214394|NCT02264626|patient/ventilator interaction|patient/ventilator interaction
214395|NCT02264600|Restless Legs Syndrome, Apelin, Oxidative Stress|restless legs syndrome, apelin, oxidative stress
214396|NCT02264535|Allergy|allergy
214397|NCT02264535|Skin test|skin test
214398|NCT02264535|Ginkgolides Meglumine Injection|ginkgolides meglumine injection
214399|NCT02264509|Arterial Insufficiency|arterial insufficiency
214400|NCT02264509|Human Immunodeficiency Virus|human immunodeficiency virus
214401|NCT02264509|Atherosclerosis|atherosclerosis
214402|NCT02264509|Ankle-brachial index|ankle-brachial index
214403|NCT02264509|HAART|haart
214404|NCT02264496|Colorectal cancer|colorectal cancer
214405|NCT02264496|Exercise|exercise
214406|NCT02264496|CPEX|cpex
214407|NCT02264496|Exercise, Physical|exercise, physical
214408|NCT02264496|Exercise, Aerobic|exercise, aerobic
214409|NCT02264496|Surgery|surgery
214410|NCT02264483|Pneumonia in COPD exacerbation|pneumonia in copd exacerbation
214411|NCT02264470|Prediction|prediction
214412|NCT02264470|Falls|falls
214413|NCT02264470|Stroke|stroke
214414|NCT02264457|Lenses, Intraocular|lenses, intraocular
214415|NCT02264444|Cholecystectomy, visualization, single incision|cholecystectomy, visualization, single incision
214416|NCT02264431|Obesity|obesity
214417|NCT02264431|Obstructive Sleep Apnea|obstructive sleep apnea
214418|NCT02264431|Sleep Habits|sleep habits
214419|NCT02264431|Bariatric Surgery|bariatric surgery
214420|NCT02264431|Cohort|cohort
214421|NCT02264418|Solid tumours|solid tumours
214422|NCT02264405|Autoimmune diseases|autoimmune diseases
214423|NCT02264405|Systemic sclerosis|systemic sclerosis
214424|NCT02264405|Autologous Hematopoietic stem cell transplant|autologous hematopoietic stem cell transplant
214425|NCT02264379|Oligometastases|oligometastases
214426|NCT02264379|Prostate Cancer|prostate cancer
214427|NCT02264379|Stereotactic Radiotherapy|stereotactic radiotherapy
214428|NCT02264379|Hypo fractionation|hypo fractionation
214429|NCT02264379|Normal fractionation|normal fractionation
214431|NCT02264353|Sleep Apnea|sleep apnea
214432|NCT02264353|Arousal threshold|arousal threshold
214433|NCT02264353|Donepezil|donepezil
214434|NCT02264340|Tension-type headache|tension-type headache
214435|NCT02264340|relaxation techniques|relaxation techniques
214436|NCT02264340|physiotherapy|physiotherapy
214437|NCT02264327|Motivational Interviewing|motivational interviewing
214438|NCT02264327|Evidence Based Practice|evidence based practice
214439|NCT02264327|Online Simulation|online simulation
214440|NCT02264327|Workforce development|workforce development
214441|NCT02264327|Training|training
214442|NCT02264314|Aged|aged
214443|NCT02264314|Hearing Aids|hearing aids
214444|NCT02264314|Rehabilitation|rehabilitation
214445|NCT02264288|Peripheral Arterial Disease|peripheral arterial disease
214446|NCT02264288|Diabetic Foot|diabetic foot
214447|NCT02264275|Aerobic Exercise|aerobic exercise
214448|NCT02264275|Exercise|exercise
214449|NCT02264275|Exergame|exergame
214450|NCT02264275|Behavior|behavior
214451|NCT02264275|Video Game|video game
214452|NCT02264275|Inflammatory Bowel Disease|inflammatory bowel disease
214453|NCT02264275|Children|children
214454|NCT02264275|Adolescents|adolescents
214455|NCT02264275|Pediatric|pediatric
214456|NCT02264275|Physical Fitness|physical fitness
214457|NCT02264223|Bioavailability|bioavailability
214458|NCT02264223|Isoflavones|isoflavones
214459|NCT02264223|Plasma|plasma
214460|NCT02264223|Human|human
214461|NCT02264223|Processing|processing
214462|NCT02264223|Cross-over|cross-over
214463|NCT02263950|Cancer|cancer
214464|NCT02263950|Malignant Neoplasm|malignant neoplasm
214465|NCT02263950|Artemether|artemether
214466|NCT02263950|Sublingual|sublingual
214467|NCT02263950|Neoplastic disease|neoplastic disease
214468|NCT02263950|Solid Tumour|solid tumour
214469|NCT02263950|Anti-cancer drug|anti-cancer drug
214470|NCT02263950|Chemotherapy|chemotherapy
214471|NCT02263950|LON002|lon002
214472|NCT02263885|Parkinson's Disease|parkinson's disease
214473|NCT02263885|ExAblate|exablate
214474|NCT02263885|MRgFUS|mrgfus
214475|NCT02263859|Obstructive Sleep Apnea|obstructive sleep apnea
214476|NCT02263846|Breast cancer|breast cancer
214477|NCT02263846|Menopause|menopause
214478|NCT02263846|Estradiol|estradiol
214479|NCT02263846|Follicle stimulating hormone|follicle stimulating hormone
214480|NCT02263820|Acute Kidney Injury|acute kidney injury
214481|NCT02263820|Acute Renal Failure|acute renal failure
214482|NCT02263807|Patella luxation|patella luxation
214483|NCT02263794|Bronchial Thermoplasty|bronchial thermoplasty
214484|NCT02263755|CHB, cohort, fibroscan|chb, cohort, fibroscan
214485|NCT02263742|Healthcare choice and outcomes|healthcare choice and outcomes
214486|NCT02263742|Peer-led whole health|peer-led whole health
214487|NCT02263742|Mental Illness|mental illness
214488|NCT02263742|Peer Health Navigation|peer health navigation
214489|NCT02263742|Health care Coordination|health care coordination
214490|NCT02263716|Physical Activity|physical activity
214491|NCT02263716|Intensive Care|intensive care
214492|NCT02263716|Activities of Daily Living|activities of daily living
214493|NCT02263716|Delirium|delirium
214494|NCT02263716|Sepsis|sepsis
214495|NCT02263716|Mechanical Ventilation|mechanical ventilation
214496|NCT02263716|Critical Care|critical care
214497|NCT02263716|Critical Illness|critical illness
214498|NCT02263716|Aging|aging
214499|NCT02263716|Accelerometery|accelerometery
214500|NCT02263703|HPV vaccine, children, immunocompromised|hpv vaccine, children, immunocompromised
214501|NCT02263677|diabetes|diabetes
214502|NCT02263677|fatty liver|fatty liver
214503|NCT02263664|microcirculation|microcirculation
214504|NCT02263664|esophagectomy|esophagectomy
214505|NCT02263664|side stream dark field|side stream dark field
214506|NCT02263664|microcirculatory derangements|microcirculatory derangements
214507|NCT02263651|Breast cancer|breast cancer
214508|NCT02263651|Mastectomy|mastectomy
214509|NCT02263651|Seroma|seroma
214510|NCT02263651|Quilting suture|quilting suture
214511|NCT02263638|hereditary haemochromatosis|hereditary haemochromatosis
214512|NCT02263638|rheumatism|rheumatism
214513|NCT02263638|anakinra|anakinra
214514|NCT02263625|Indication|indication
214515|NCT02263625|Differences|differences
214516|NCT02263612|Incisional Hernia|incisional hernia
214517|NCT02263612|Complications|complications
214518|NCT02263612|Long-term|long-term
214519|NCT02263586|Ironman|ironman
214520|NCT02263586|Triathlon|triathlon
214521|NCT02263573|PEP'C-R|pep'c-r
214522|NCT02263573|Endurance parameters|endurance parameters
214523|NCT02263573|Maximal cardio-respiratory function|maximal cardio-respiratory function
214524|NCT02263573|Older seniors|older seniors
214525|NCT02263573|Over 70|over 70
214526|NCT02263547|teriflunomide|teriflunomide
214527|NCT02263547|colestipol hcl|colestipol hcl
214528|NCT02263534|stress urinary incontinence|stress urinary incontinence
214529|NCT02263534|tension free vaginal tape|tension free vaginal tape
214530|NCT02263534|single incision minisling|single incision minisling
214531|NCT02263534|midurethral sling|midurethral sling
214532|NCT02263508|Talimogene Laherparepvec|talimogene laherparepvec
214533|NCT02263508|pembrolizumab|pembrolizumab
214534|NCT02263508|KEYNOTE-034|keynote-034
214535|NCT02263508|MASTERKEY-265|masterkey-265
214536|NCT02263495|HER2-Negative|her2-negative
214537|NCT02263482|muscle training|muscle training
214538|NCT02263482|walking test|walking test
214539|NCT02263482|chronic heart failure|chronic heart failure
214540|NCT02263482|functional capacity|functional capacity
214541|NCT02263443|bowel preparation|bowel preparation
214542|NCT02263443|gynecologic surgery|gynecologic surgery
214543|NCT02263443|laparotomy|laparotomy
214544|NCT02263391|transmission|transmission
214545|NCT02263391|prevention|prevention
214546|NCT02263391|women|women
214547|NCT02263391|childbearing age|childbearing age
214548|NCT02263391|HIV testing|hiv testing
214549|NCT02263391|testing strategy|testing strategy
214550|NCT02263378|HPV, L-SIL|hpv, l-sil
214551|NCT02263352|Diabetes, Periodontitis, Oxidative stress, Antioxidant|diabetes, periodontitis, oxidative stress, antioxidant
214552|NCT02263339|Exercise|exercise
214553|NCT02263339|MRI|mri
214554|NCT02263313|Safety and efficacy|safety and efficacy
214555|NCT02263313|Combo stent|combo stent
214556|NCT02263313|Late loss thrombosis|late loss thrombosis
214557|NCT02263313|Late loss catch up|late loss catch up
214558|NCT02263300|Fiberoptic Intubation|fiberoptic intubation
214559|NCT02263300|Medical student|medical student
214560|NCT02263300|Virtual larynx|virtual larynx
214561|NCT02263300|Didactic Training|didactic training
214562|NCT02263300|Medical Education|medical education
214563|NCT02263287|Alzheimer Disease|alzheimer disease
214564|NCT02263287|Lewy Body Disease|lewy body disease
214565|NCT02263261|dermal matrix|dermal matrix
214566|NCT02263235|Alzheimer disease (AD)|alzheimer disease (ad)
214567|NCT02263235|diagnosis biomarkers|diagnosis biomarkers
214568|NCT02263235|cerebrospinal fluid (CSF)|cerebrospinal fluid (csf)
214569|NCT02263235|targeted quantitative proteomics|targeted quantitative proteomics
214570|NCT02263235|mass spectrometry|mass spectrometry
214571|NCT02263235|stable isotope-labelled leucine|stable isotope-labelled leucine
214572|NCT02263183|Metabolic risk|metabolic risk
214573|NCT02263183|Abdominally overweight|abdominally overweight
214574|NCT02263131|Influenza|influenza
214575|NCT02263131|Influenza vaccine|influenza vaccine
214576|NCT02263131|Split influenza vaccine|split influenza vaccine
214577|NCT02263131|Seasonal influenza vaccine|seasonal influenza vaccine
214578|NCT02263118|breastfeeding|breastfeeding
214579|NCT02263118|rural|rural
214580|NCT02263118|m-health|m-health
214581|NCT02263118|mHealth|mhealth
214582|NCT02263118|Patojitos|patojitos
214583|NCT02263118|Guatemala|guatemala
214584|NCT02263118|exclusive breastfeeding|exclusive breastfeeding
214585|NCT02263118|mobile|mobile
214586|NCT02263118|eHealth|ehealth
214587|NCT02263118|e-health|e-health
214588|NCT02263105|recurrent high-grade gliomas|recurrent high-grade gliomas
214589|NCT02263105|cisplatin (CDDP)|cisplatin (cddp)
214590|NCT02263105|temozolomide (TMZ)|temozolomide (tmz)
214591|NCT02263092|Cortical excitability|cortical excitability
214592|NCT02263092|Plasticity|plasticity
214593|NCT02263092|Healthy subjects|healthy subjects
214594|NCT02263040|influenza vaccine|influenza vaccine
214595|NCT02263040|adult|adult
214596|NCT02263040|immunogenicity|immunogenicity
214597|NCT02263040|reactogenicity|reactogenicity
214598|NCT02263027|influenza vaccine|influenza vaccine
214599|NCT02263027|adult|adult
214600|NCT02263027|safety|safety
214601|NCT02263027|reactogenicity|reactogenicity
214602|NCT02263014|Breast Cancer|breast cancer
214603|NCT02263014|Contralateral Prophylactic Mastectomy|contralateral prophylactic mastectomy
214604|NCT02263014|Questionnaires|questionnaires
214605|NCT02263014|Surveys|surveys
214606|NCT02263014|Psychosocial|psychosocial
214607|NCT02263001|Auricular therapy|auricular therapy
214608|NCT02263001|Acupuncture|acupuncture
214609|NCT02263001|Acute, sub-acute pain|acute, sub-acute pain
214610|NCT02263001|Auricular Acupuncture Needles|auricular acupuncture needles
214611|NCT02262988|knee|knee
214612|NCT02262988|joint replacement|joint replacement
214613|NCT02262988|total knee|total knee
214614|NCT02262988|cell therapy|cell therapy
214615|NCT02262975|Alzheimer's disease|alzheimer's disease
214616|NCT02262936|Aged|aged
214617|NCT02262936|Deamino Arginine Vasopressin|deamino arginine vasopressin
214618|NCT02262936|Fesoterodine|fesoterodine
214619|NCT02262936|Randomized Controlled Trial|randomized controlled trial
214620|NCT02262910|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
214621|NCT02262910|CRPC|crpc
214622|NCT02262897|small cell lung cancer|small cell lung cancer
214623|NCT02262897|chemotherapy|chemotherapy
214624|NCT02262897|Nab-paclitaxel|nab-paclitaxel
214625|NCT02262871|Cystic fibrosis|cystic fibrosis
214626|NCT02262871|High-flow nasal oxygen cannula|high-flow nasal oxygen cannula
214627|NCT02262871|Non-invasive ventilation|non-invasive ventilation
214628|NCT02262871|Respiratory distress|respiratory distress
214629|NCT02262871|Oxygen therapy|oxygen therapy
214630|NCT02262832|Diabetes|diabetes
214631|NCT02262832|Leptin|leptin
214632|NCT02262832|Lipodystrophy|lipodystrophy
214633|NCT02262832|Hypertriglyceridemia|hypertriglyceridemia
214634|NCT02262819|Skin Blister|skin blister
214635|NCT02262819|Immune Response|immune response
214636|NCT02262819|Suction Device|suction device
214637|NCT02262819|Anti-Microbial|anti-microbial
214638|NCT02262819|Killed Microbe|killed microbe
214639|NCT02262806|Lipodystrophy|lipodystrophy
214640|NCT02262806|Leptin|leptin
214641|NCT02262806|Hypertriglyceridemia|hypertriglyceridemia
214642|NCT02262806|Diabetes|diabetes
214643|NCT02262767|Phase 1, Randomized, Double Blind, Placebo-Controlled, Single-Dose Escalation, Safety, Tolerability, Pharmacokinetic, PF-06649751, Trimethobenzamide|phase 1, randomized, double blind, placebo-controlled, single-dose escalation, safety, tolerability, pharmacokinetic, pf-06649751, trimethobenzamide
214644|NCT02262728|Hepatitis C, Chronic|hepatitis c, chronic
214645|NCT02262728|Simeprevir|simeprevir
214646|NCT02262728|Daclatasvir|daclatasvir
214647|NCT02262728|Sofosbuvir|sofosbuvir
214648|NCT02262728|Decompensated Liver Disease|decompensated liver disease
214649|NCT02262715|Oseltamivir|oseltamivir
214650|NCT02262715|VX-787|vx-787
214651|NCT02262689|GSK2256294|gsk2256294
214652|NCT02262689|normoxic|normoxic
214653|NCT02262689|hypoxic|hypoxic
214654|NCT02262689|Pulmonary artery systolic pressure (PASP)|pulmonary artery systolic pressure (pasp)
214655|NCT02262676|Stroke prevention on Atrial Fibrillation|stroke prevention on atrial fibrillation
214656|NCT02262676|Prevention and Control|prevention and control
214657|NCT02262676|Stroke|stroke
214658|NCT02262507|Brain|brain
214659|NCT02262507|Hearing|hearing
214660|NCT02262507|MTBI|mtbi
214661|NCT02262468|retrospective analysis|retrospective analysis
214662|NCT02262455|Serous tumor|serous tumor
214663|NCT02262455|Granulosa tumor|granulosa tumor
214664|NCT02262455|Clear Cell tumor|clear cell tumor
214665|NCT02262455|Endometrial cancer|endometrial cancer
214666|NCT02262455|Advanced solid tumors|advanced solid tumors
214667|NCT02262455|Adenocarcinoma|adenocarcinoma
214668|NCT02262455|Prostate cancer|prostate cancer
214669|NCT02262455|Head and Neck cancer|head and neck cancer
214670|NCT02262455|Lung cancer|lung cancer
214671|NCT02262455|Non-small cell lung cancer|non-small cell lung cancer
214672|NCT02262455|Small cell lung cancer|small cell lung cancer
214673|NCT02262455|Gastric cancer|gastric cancer
214674|NCT02262455|Kidney cancer|kidney cancer
214675|NCT02262455|Pancreatic cancer|pancreatic cancer
214676|NCT02262455|Breast cancer|breast cancer
214677|NCT02262455|Colorectal cancer|colorectal cancer
214678|NCT02262455|Bladder cancer|bladder cancer
214679|NCT02262455|Esophagus cancer|esophagus cancer
214680|NCT02262455|Liver cancer|liver cancer
214681|NCT02262455|Hepatobiliary cancer|hepatobiliary cancer
214682|NCT02262455|Skin cancer|skin cancer
214683|NCT02262442|flexible bronchoscopy|flexible bronchoscopy
214684|NCT02262442|anaesthetics|anaesthetics
214685|NCT02262442|transcutaneous pCO2|transcutaneous pco2
214686|NCT02262442|capillary pCO2|capillary pco2
214687|NCT02262442|special atomizing set|special atomizing set
214688|NCT02262416|GnRH agonist|gnrh agonist
214689|NCT02262416|IVF|ivf
214690|NCT02262403|Hookworm|hookworm
214691|NCT02262403|Helminths|helminths
214692|NCT02262403|Treg|treg
214693|NCT02262403|Immune regulation|immune regulation
214694|NCT02262403|Vietnam|vietnam
214695|NCT02262403|Allergic diseases|allergic diseases
214696|NCT02262377|Group Medical Visits|group medical visits
214697|NCT02262377|Integrative Medicine|integrative medicine
214698|NCT02262377|Chronic Pain|chronic pain
214699|NCT02262377|Depression|depression
214700|NCT02262377|MBSR|mbsr
214701|NCT02262377|Mindfulness Based Stress Reduction|mindfulness based stress reduction
214702|NCT02262377|Web based|web based
214703|NCT02262377|Virtual Patient Advocate|virtual patient advocate
214704|NCT02262377|Internet Based|internet based
214705|NCT02262351|Atrial Fibrillation|atrial fibrillation
214706|NCT02262351|Screening|screening
214707|NCT02262351|Family Practice|family practice
214708|NCT02262351|Novel screening technologies|novel screening technologies
214709|NCT02262338|MPS II|mps ii
214710|NCT02262338|Hunter Syndrome|hunter syndrome
214711|NCT02262325|Non-small cell|non-small cell
214712|NCT02262325|Lung Cancer|lung cancer
214713|NCT02262325|Chemoradiation|chemoradiation
214714|NCT02262286|Brain Injury|brain injury
214715|NCT02262273|women|women
214716|NCT02262273|platinum sensitive|platinum sensitive
214717|NCT02262273|recurrent|recurrent
214718|NCT02262273|serous|serous
214719|NCT02262273|ovarian cancer|ovarian cancer
214720|NCT02262273|BRCA|brca
214721|NCT02262273|PARP|parp
214722|NCT02262273|Olaparib|olaparib
214723|NCT02262260|Diabetic macular edema, DME, ranibizumab, wait and extend|diabetic macular edema, dme, ranibizumab, wait and extend
214724|NCT02262247|Transoral|transoral
214725|NCT02262247|Oropharynx|oropharynx
214726|NCT02262247|Hypopharynx|hypopharynx
214727|NCT02262247|Endoscopic|endoscopic
214728|NCT02262247|TORS|tors
214729|NCT02262247|Endoscopic Transoral|endoscopic transoral
214730|NCT02262247|Larynx|larynx
214731|NCT02262234|Spinal cord injury|spinal cord injury
214732|NCT02262234|Chronic pain|chronic pain
214733|NCT02262234|Education|education
214825|NCT02261792|Blood Patch, Epidural|blood patch, epidural
214734|NCT02262208|Glycemic variability, exercise, diabetes|glycemic variability, exercise, diabetes
214735|NCT02262182|Atelectasis, Respiratory physiotherapy, end expiratory pressure, EzPAP®, cardiac surgery|atelectasis, respiratory physiotherapy, end expiratory pressure, ezpap®, cardiac surgery
214736|NCT02262169|Non-Bleeding Peptic Ulcers, DLBS2411, Ulcer Healing|non-bleeding peptic ulcers, dlbs2411, ulcer healing
214737|NCT02262156|Cognitive Behavioral Therapy|cognitive behavioral therapy
214738|NCT02262156|Selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
214739|NCT02262156|depression|depression
214740|NCT02262156|epilepsy|epilepsy
214741|NCT02262130|Omalizumab|omalizumab
214742|NCT02262130|Efficacy|efficacy
214743|NCT02262130|Safety|safety
214744|NCT02262117|IVF, pregnancy, immune endometrial profile, personalization of treatment|ivf, pregnancy, immune endometrial profile, personalization of treatment
214745|NCT02262104|Exercise|exercise
214746|NCT02262104|dementia|dementia
214747|NCT02262104|nursing home|nursing home
214748|NCT02262078|Preserved Ejection Fraction|preserved ejection fraction
214749|NCT02262065|implant|implant
214750|NCT02262065|allergy|allergy
214751|NCT02262065|particle|particle
214752|NCT02262065|cytokine|cytokine
214753|NCT02262052|Deep vein thrombosis|deep vein thrombosis
214754|NCT02262052|Diagnostic management|diagnostic management
214755|NCT02262052|Recurrent|recurrent
214756|NCT02262052|MRI|mri
214757|NCT02262052|Ipsilateral|ipsilateral
214758|NCT02262039|living|living
214759|NCT02262039|kidney|kidney
214760|NCT02262039|donors|donors
214761|NCT02262013|Pediatric Obesity|pediatric obesity
214762|NCT02262013|Lifestyle Intervention|lifestyle intervention
214763|NCT02262013|Family-based Intervention|family-based intervention
214764|NCT02262013|Motivational Interviewing|motivational interviewing
214765|NCT02262000|Non Small Cell Lung Cancer|non small cell lung cancer
214766|NCT02262000|Surgically inoperable|surgically inoperable
214767|NCT02262000|Radiation Therapy|radiation therapy
214768|NCT02261987|Autogenic drainage|autogenic drainage
214769|NCT02261987|Resistive inspiratory manoeuvre|resistive inspiratory manoeuvre
214770|NCT02261987|Computerized respiratory sounds|computerized respiratory sounds
214771|NCT02261987|Airway clearance techniques|airway clearance techniques
214772|NCT02261987|Mucus clearances|mucus clearances
214773|NCT02261974|Vaginal laxity|vaginal laxity
214774|NCT02261974|Sexual Function|sexual function
214775|NCT02261961|resistance exercise|resistance exercise
214776|NCT02261961|Juven|juven
214777|NCT02261961|exercise training|exercise training
214778|NCT02261961|interleukin-1|interleukin-1
214779|NCT02261961|insulin-like growth factor|insulin-like growth factor
214780|NCT02261948|Cardiac Failure|cardiac failure
214781|NCT02261948|Severe Heart Failure|severe heart failure
214782|NCT02261935|Family caregiver|family caregiver
214783|NCT02261935|Home care nursing practice|home care nursing practice
214784|NCT02261935|Palliative care|palliative care
214785|NCT02261935|End of life care|end of life care
214786|NCT02261935|Family caregiver quality of life|family caregiver quality of life
214787|NCT02261935|Family caregiver grief symptoms|family caregiver grief symptoms
214788|NCT02261935|Family caregiver burden|family caregiver burden
214789|NCT02261935|Family caregiver preparedness for caregiving|family caregiver preparedness for caregiving
214790|NCT02261935|Family caregiver perceived social supports|family caregiver perceived social supports
214791|NCT02261935|Family caregiver health status|family caregiver health status
214792|NCT02261935|Family caregiver satisfaction with healthcare provided|family caregiver satisfaction with healthcare provided
214793|NCT02261909|Emergency Medicine|emergency medicine
214794|NCT02261909|diagnosis|diagnosis
214795|NCT02261896|cyst|cyst
214796|NCT02261896|pancreatic cyst|pancreatic cyst
214797|NCT02261896|EUS-FNA|eus-fna
214798|NCT02261896|antibiotic prophylaxis|antibiotic prophylaxis
214799|NCT02261883|PPHN|pphn
214800|NCT02261870|MRI, T2 quantification|mri, t2 quantification
214801|NCT02261857|Obstructive Sleep Apnea|obstructive sleep apnea
214802|NCT02261857|Craniofacial Abnormalities|craniofacial abnormalities
214803|NCT02261857|Pediatrics|pediatrics
214804|NCT02261857|Computer-Aided Design|computer-aided design
214805|NCT02261857|Continuous Positive Airway Pressure|continuous positive airway pressure
214806|NCT02261857|Three-Dimensional Printing|three-dimensional printing
214807|NCT02261857|Additive Manufacturing|additive manufacturing
214808|NCT02261844|Hepatocellular carcinoma|hepatocellular carcinoma
214809|NCT02261844|Metastatic colorectal cancer|metastatic colorectal cancer
214810|NCT02261844|Metabolism|metabolism
214811|NCT02261844|Hepatic function|hepatic function
214812|NCT02261831|bacterial|bacterial
214813|NCT02261831|gut|gut
214814|NCT02261831|type 2 diabetes.|type 2 diabetes.
214815|NCT02261831|16S rDNA gene|16s rdna gene
214816|NCT02261831|intestinal crypt|intestinal crypt
214817|NCT02261818|depression|depression
214818|NCT02261818|aging|aging
214819|NCT02261818|health services|health services
214820|NCT02261792|Postural headache treatment|postural headache treatment
214821|NCT02261792|Spontaneous intracranial hypotension|spontaneous intracranial hypotension
214822|NCT02261792|Epidural blood patch|epidural blood patch
214823|NCT02261792|Trendelenburg position|trendelenburg position
214824|NCT02261792|Head-Down Tilt|head-down tilt
214826|NCT02261753|epilepsy surgery, outcome, ketogenic diet, ortical dysplasia|epilepsy surgery, outcome, ketogenic diet, ortical dysplasia
214827|NCT02261740|Pelvic Pain|pelvic pain
214828|NCT02261740|Genital Pain|genital pain
214829|NCT02261727|COPD|copd
214830|NCT02261727|Theophylline|theophylline
214831|NCT02261727|Oral corticosteroids|oral corticosteroids
214832|NCT02261727|COPD exacerbations|copd exacerbations
214833|NCT02261714|Pancreatic cancer, resected|pancreatic cancer, resected
214834|NCT02261714|Vaccine|vaccine
214835|NCT02261714|KRAS|kras
214836|NCT02261701|shoulder surgery|shoulder surgery
214837|NCT02261701|rotator cuff injury|rotator cuff injury
214838|NCT02261701|rehabilitation|rehabilitation
214839|NCT02261701|function|function
214840|NCT02261701|pain|pain
214841|NCT02261701|quality of life|quality of life
214842|NCT02261675|dexmedetomidine|dexmedetomidine
214843|NCT02261675|sevoflurane|sevoflurane
214844|NCT02261675|MAC bar|mac bar
214845|NCT02261675|drug interaction|drug interaction
214846|NCT02261675|anesthesia|anesthesia
214847|NCT02261649|Cerebellar tumor|cerebellar tumor
214848|NCT02261649|Non-malignant low-grade cerebellar astrocytomas|non-malignant low-grade cerebellar astrocytomas
214849|NCT02261610|PCT algorithm|pct algorithm
214850|NCT02261610|Antibiotic|antibiotic
214851|NCT02261610|Pulmonary embolism|pulmonary embolism
214852|NCT02261597|insomnia, inflammation, stress|insomnia, inflammation, stress
214853|NCT02261545|n-3 fatty acid|n-3 fatty acid
214854|NCT02261545|Sirt-1|sirt-1
214855|NCT02261545|AdipoR1|adipor1
214856|NCT02261545|AdipoR2|adipor2
214857|NCT02261545|MCP-1|mcp-1
214858|NCT02261545|Adiponectin|adiponectin
214859|NCT02261545|Resistin|resistin
214860|NCT02261545|T2DM|t2dm
214861|NCT02261506|Intensive care|intensive care
214862|NCT02261506|bacteremia|bacteremia
214863|NCT02261506|bloodstream infection|bloodstream infection
214864|NCT02261506|antimicrobial|antimicrobial
214865|NCT02261506|mortality|mortality
214866|NCT02261506|antimicrobial stewardship|antimicrobial stewardship
214867|NCT02261480|Parvovirus B19 Infection|parvovirus b19 infection
214868|NCT02261454|postoperative ileus|postoperative ileus
214869|NCT02261454|gum chewing|gum chewing
214870|NCT02261454|postoperative care|postoperative care
214871|NCT02261454|abdominal surgery|abdominal surgery
214872|NCT02261454|child|child
214873|NCT02261441|Cardiovascular disease|cardiovascular disease
214874|NCT02261441|Hypertension|hypertension
214875|NCT02261441|Diabetes|diabetes
214876|NCT02261441|Smoking|smoking
214877|NCT02261441|Hypercholesterolemia|hypercholesterolemia
214878|NCT02261441|Cardiovascular risk factor|cardiovascular risk factor
214879|NCT02261428|Nasotracheal suction, tracheal access|nasotracheal suction, tracheal access
214880|NCT02261415|blood transfusion|blood transfusion
214881|NCT02261415|blood loss|blood loss
214882|NCT02261415|feasibility|feasibility
214883|NCT02261415|outcome|outcome
214884|NCT02261415|liver resection|liver resection
214885|NCT02261402|Adherence|adherence
214886|NCT02261402|Morisky Medication Adherence Scale|morisky medication adherence scale
214887|NCT02261402|Beliefs about Medicines Questionnaire|beliefs about medicines questionnaire
214888|NCT02261402|Medication Possession Ratio|medication possession ratio
214889|NCT02261402|Medication-Related Problems|medication-related problems
214890|NCT02261402|Pharmacist|pharmacist
214891|NCT02261402|Pharmacist Intervention|pharmacist intervention
214892|NCT02261402|Pharmacy|pharmacy
214893|NCT02261402|Pharmacy Service|pharmacy service
214894|NCT02261402|Pharmacy Practice|pharmacy practice
214895|NCT02261402|Hypertension|hypertension
214896|NCT02261402|Antihypertensive Agents|antihypertensive agents
214897|NCT02261402|Anticoagulants|anticoagulants
214898|NCT02261402|Statins|statins
214899|NCT02261402|Dyslipidemia|dyslipidemia
214900|NCT02261389|breast cancer|breast cancer
214901|NCT02261389|follow-up|follow-up
214902|NCT02261389|tumor markers|tumor markers
214903|NCT02261376|pharmacokinetics|pharmacokinetics
214904|NCT02261337|Sarcopenia|sarcopenia
214905|NCT02261324|Percutaneous coronary intervention|percutaneous coronary intervention
214906|NCT02261311|Breast|breast
214907|NCT02261220|advanced solid tumors|advanced solid tumors
214908|NCT02261220|durvalumab|durvalumab
214909|NCT02261220|tremelimumab|tremelimumab
214910|NCT02261194|depression|depression
214911|NCT02261194|age-related macular degeneration|age-related macular degeneration
214912|NCT02261194|self-care|self-care
214913|NCT02261194|self-help|self-help
214914|NCT02261181|head neck cancer XONRID radiation induced dermatitis|head neck cancer xonrid radiation induced dermatitis
214915|NCT02261168|Circadian Rhythm|circadian rhythm
214916|NCT02261051|Palliative Care|palliative care
214917|NCT02261051|Hospice|hospice
214918|NCT02261051|End of Life|end of life
214919|NCT02261051|Health Service Utilization|health service utilization
214920|NCT02261051|Quality of Life|quality of life
214921|NCT02261038|total knee arthroplasty|total knee arthroplasty
214922|NCT02261038|total knee prothesis|total knee prothesis
214923|NCT02261038|X-Ray|x-ray
214924|NCT02261038|Kanekasu radiographs|kanekasu radiographs
214925|NCT02261038|femoral component rotation|femoral component rotation
214926|NCT02261038|effects|effects
214927|NCT02261025|aspirin|aspirin
214928|NCT02260908|Trauma|trauma
214929|NCT02260908|Thromboprophylaxis|thromboprophylaxis
214930|NCT02260908|Intracranial haemorrhage|intracranial haemorrhage
214931|NCT02260908|Deep vein thrombosis|deep vein thrombosis
214932|NCT02260856|RCT|rct
214933|NCT02260856|Epiphysiodesis|epiphysiodesis
214934|NCT02260856|Tantalum beads|tantalum beads
214935|NCT02260856|Patient centered outcome data|patient centered outcome data
214936|NCT02260856|Cost effective analysis|cost effective analysis
214937|NCT02260843|Insomnia|insomnia
214938|NCT02260843|Sleeping|sleeping
214939|NCT02260843|Quality|quality
214940|NCT02260817|Prostate Cancer|prostate cancer
214941|NCT02260817|11C Choline|11c choline
214942|NCT02260817|PET Imaging|pet imaging
214943|NCT02260791|Rheumatoid|rheumatoid
214944|NCT02260791|Arthritis|arthritis
214945|NCT02260778|Learning Collaborative|learning collaborative
214946|NCT02260778|Treat-to-Target|treat-to-target
214947|NCT02260778|Arthritis, Rheumatoid|arthritis, rheumatoid
214948|NCT02260765|Treatment as Usual = TAU|treatment as usual = tau
214949|NCT02260726|femoroacetabular impingement|femoroacetabular impingement
214950|NCT02260726|morphometry|morphometry
214951|NCT02260726|dynamic|dynamic
214952|NCT02260726|magnetic resonance imaging|magnetic resonance imaging
214953|NCT02260726|ultrasound|ultrasound
214954|NCT02260726|screening|screening
214955|NCT02260726|diagnosis|diagnosis
214956|NCT02260700|Healthy|healthy
214957|NCT02260700|Bioavailability|bioavailability
214958|NCT02260700|Alzheimer's Disease|alzheimer's disease
214959|NCT02260700|JNJ-54861911|jnj-54861911
214960|NCT02260687|Aflibercept|aflibercept
214961|NCT02260687|Anti-VEGF|anti-vegf
214962|NCT02260674|Alzheimer's Disease|alzheimer's disease
214963|NCT02260674|JNJ-54861911|jnj-54861911
214964|NCT02260674|Placebo|placebo
214965|NCT02260661|AZD8835|azd8835
214966|NCT02260661|Fulvestrant|fulvestrant
214967|NCT02260661|Breast Cancer|breast cancer
214968|NCT02260661|PIK3CA Gene Mutation|pik3ca gene mutation
214969|NCT02260622|Restenosis|restenosis
214970|NCT02260622|Critical Limb Ischemia|critical limb ischemia
214971|NCT02260622|Infrainguinal Percutaneous Transluminal Angioplasty|infrainguinal percutaneous transluminal angioplasty
214972|NCT02260622|Rivaroxaban|rivaroxaban
214973|NCT02260622|Clopidogrel|clopidogrel
214974|NCT02260609|Complex Wound|complex wound
214975|NCT02260609|Diabetic Foot Ulcer|diabetic foot ulcer
214976|NCT02260609|DFU|dfu
214977|NCT02260609|GrafixCORE|grafixcore
214978|NCT02260609|Exposed tendon|exposed tendon
214979|NCT02260609|Exposed bone|exposed bone
214980|NCT02260609|Allograft tissue|allograft tissue
214981|NCT02260570|concussion|concussion
214982|NCT02260570|traumatic brain injury|traumatic brain injury
214983|NCT02260570|MRI|mri
214984|NCT02260570|memory|memory
214985|NCT02260570|tolcapone|tolcapone
214986|NCT02260557|Systemic Sclerosis|systemic sclerosis
214987|NCT02260557|Raynaud's Phenomenon|raynaud's phenomenon
214988|NCT02260531|Metastatic breast cancer and brain metastases|metastatic breast cancer and brain metastases
214989|NCT02260531|HER-2 Positive Breast Cancer|her-2 positive breast cancer
214990|NCT02260531|ER-Positive PR-Positive HER-2 Negative Breast Cancer|er-positive pr-positive her-2 negative breast cancer
214991|NCT02260531|ER-Negative PR-Negative HER2-Negative Breast Cancer|er-negative pr-negative her2-negative breast cancer
214992|NCT02260518|Gestational weight gain|gestational weight gain
214993|NCT02260518|Lifestyle intervention|lifestyle intervention
214994|NCT02260518|Pregnancy|pregnancy
214995|NCT02260518|Postpartum|postpartum
214996|NCT02260518|Physical activity|physical activity
214997|NCT02260518|Nutrition|nutrition
214998|NCT02260505|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
214999|NCT02260505|Non-metastatic|non-metastatic
215000|NCT02260505|KIT +|kit +
215001|NCT02260505|Imatinib|imatinib
215002|NCT02260505|Adjuvant treatment|adjuvant treatment
215003|NCT02260505|High risk of recurrence|high risk of recurrence
215004|NCT02260505|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
215005|NCT02260505|Disease Free Survival|disease free survival
215006|NCT02260505|Overall survival|overall survival
215007|NCT02260505|Time To Secondary Resistance|time to secondary resistance
215008|NCT02260505|Safety profile|safety profile
215009|NCT02260505|Quality of Life during treatment|quality of life during treatment
215010|NCT02260479|skin disinfection|skin disinfection
215011|NCT02260479|bacterial colonization|bacterial colonization
215012|NCT02260479|perioperative|perioperative
215013|NCT02260479|chlorehexidine|chlorehexidine
215014|NCT02260466|Amyloidosis|amyloidosis
215015|NCT02260466|echocardiography|echocardiography
215016|NCT02260466|magnetic resonance imaging|magnetic resonance imaging
215017|NCT02260466|radionuclide imaging|radionuclide imaging
215018|NCT02260427|elective surgery|elective surgery
215019|NCT02260427|undergoing general anesthesia|undergoing general anesthesia
215020|NCT02260427|elderly adult patients|elderly adult patients
215021|NCT02260414|Endogenous Thrombin Potential|endogenous thrombin potential
215022|NCT02260414|Lymphoma|lymphoma
215023|NCT02260414|Multiple Myeloma|multiple myeloma
215024|NCT02260414|tinzaparin|tinzaparin
215025|NCT02260414|thrombin generation|thrombin generation
215026|NCT02260414|Thromboplastin generation tests|thromboplastin generation tests
215027|NCT02260388|CSPN|cspn
215028|NCT02260388|neuropathy|neuropathy
215029|NCT02260388|pain|pain
215030|NCT02260388|pain management|pain management
215031|NCT02260375|Mesenchymal stromal cells; liver transplantation; tolerance.|mesenchymal stromal cells; liver transplantation; tolerance.
215032|NCT02260349|Prostatic Neoplasms|prostatic neoplasms
215033|NCT02260349|Prostate cancer|prostate cancer
215034|NCT02260349|surgical margins|surgical margins
215035|NCT02260349|indocyanine green|indocyanine green
215036|NCT02260349|characterization|characterization
215037|NCT02260349|prostatectomy|prostatectomy
215038|NCT02260349|peroperative|peroperative
215039|NCT02260349|detection|detection
215040|NCT02260297|Actigraphy|actigraphy
215041|NCT02260297|overweight and obese adults|overweight and obese adults
215042|NCT02260297|sleep disorders|sleep disorders
215043|NCT02260258|Cardiac Arrest, NMB, Neuromuscular Blockade, Rocuronium|cardiac arrest, nmb, neuromuscular blockade, rocuronium
215044|NCT02260219|Ahmed implant|ahmed implant
215045|NCT02260219|Neovascular Glaucoma|neovascular glaucoma
215046|NCT02260219|Intraocular pressure|intraocular pressure
215047|NCT02260206|Pericardial Effusion|pericardial effusion
215048|NCT02260206|Colchicine|colchicine
215049|NCT02260206|arrhythmia Recurrence|arrhythmia recurrence
215050|NCT02260206|pericardiocentesis|pericardiocentesis
215051|NCT02260193|anemia|anemia
215052|NCT02260193|end stage renal disease|end stage renal disease
215053|NCT02260193|chronic kidney disease|chronic kidney disease
215054|NCT02260193|CKD|ckd
215055|NCT02260193|dialysis|dialysis
215056|NCT02260193|chronic renal insufficiency|chronic renal insufficiency
215057|NCT02260193|renal impairment|renal impairment
215058|NCT02260193|erythropoietin|erythropoietin
215059|NCT02260193|kidney|kidney
215060|NCT02260193|oral anemia treatment|oral anemia treatment
215061|NCT02260193|hemoglobin|hemoglobin
215062|NCT02260193|hypoxia-inducible factor|hypoxia-inducible factor
215063|NCT02260193|HIF|hif
215064|NCT02260193|hypoxia-inducible factor propyl-hydroxylase inhibitor|hypoxia-inducible factor propyl-hydroxylase inhibitor
215065|NCT02260193|HIF-PHI|hif-phi
215066|NCT02260193|pharmacokinetics|pharmacokinetics
215067|NCT02260154|Duspatalin|duspatalin
215068|NCT02260154|mebeverine|mebeverine
215069|NCT02260154|cholecystectomy|cholecystectomy
215070|NCT02260154|gastrointestinal spasm|gastrointestinal spasm
215071|NCT02260154|abdominal pain|abdominal pain
215072|NCT02260154|dyspepsia|dyspepsia
215073|NCT02260154|antispasmodics|antispasmodics
215074|NCT02260128|postoperative ileus|postoperative ileus
215075|NCT02260128|chewing gum|chewing gum
215076|NCT02259712|Women|women
215077|NCT02259712|Pelvic floor disorders|pelvic floor disorders
215078|NCT02259712|Urinary incontinence|urinary incontinence
215079|NCT02259712|Fecal incontinence|fecal incontinence
215080|NCT02259712|Physical Therapy Modalities|physical therapy modalities
215081|NCT02259699|Ovarian Cancer|ovarian cancer
215082|NCT02259699|Intraperitoneal chemotherapy|intraperitoneal chemotherapy
215083|NCT02259699|Intravenous chemotherapy|intravenous chemotherapy
215084|NCT02259699|decision making|decision making
215085|NCT02259686|Apelin|apelin
215086|NCT02259686|volunteers|volunteers
215087|NCT02259660|obstructive sleep apnea|obstructive sleep apnea
215088|NCT02259660|osa|osa
215089|NCT02259660|breathing|breathing
215090|NCT02259660|snoring|snoring
215091|NCT02259660|respiratory|respiratory
215092|NCT02259660|exercise|exercise
215093|NCT02259660|inspiratory muscle strength training|inspiratory muscle strength training
215094|NCT02259660|expiratory muscle strength training|expiratory muscle strength training
215095|NCT02259634|Patient Navigation|patient navigation
215096|NCT02259634|Motivational Interviewing|motivational interviewing
215097|NCT02259634|Formerly Incarcerated|formerly incarcerated
215098|NCT02259634|Health Education|health education
215099|NCT02259634|Quality of Life|quality of life
215100|NCT02259634|Healthcare Utilization|healthcare utilization
215101|NCT02259608|Trained innate immunity|trained innate immunity
215102|NCT02259608|Heterologous effects of BCG on immunity|heterologous effects of bcg on immunity
215103|NCT02259595|Hearing Loss|hearing loss
215104|NCT02259595|Sensorineural Hearing Loss|sensorineural hearing loss
215105|NCT02259595|Noise-Induced Hearing Loss|noise-induced hearing loss
215106|NCT02259595|Antioxidant|antioxidant
215107|NCT02259595|NAC|nac
215108|NCT02259595|N-acetylcysteine|n-acetylcysteine
215109|NCT02259595|HPN-07|hpn-07
215110|NCT02259582|Phase 2|phase 2
215111|NCT02259582|histologically|histologically
215112|NCT02259582|confirmed|confirmed
215113|NCT02259582|malignancy|malignancy
215114|NCT02259582|metastatic|metastatic
215115|NCT02259582|pemetrexed|pemetrexed
215116|NCT02259582|carboplatin|carboplatin
215117|NCT02259582|carcinoma|carcinoma
215118|NCT02259582|non small cell lung|non small cell lung
215119|NCT02259582|lung neoplasms|lung neoplasms
215120|NCT02259582|lung diseases|lung diseases
215121|NCT02259569|Gastric insufflation|gastric insufflation
215122|NCT02259569|I-gel|i-gel
215123|NCT02259569|Peak airway pressure|peak airway pressure
215124|NCT02259569|Pressure-controlled ventilation|pressure-controlled ventilation
215125|NCT02259569|Volume-Controlled Ventilation|volume-controlled ventilation
215126|NCT02259569|pediatric patient|pediatric patient
215127|NCT02259543|gingival recession|gingival recession
215128|NCT02259543|soft tissue|soft tissue
215129|NCT02259543|root biomodification|root biomodification
215130|NCT02259543|root coverage|root coverage
215131|NCT02259543|citric acid|citric acid
215132|NCT02259543|tetracycline|tetracycline
215133|NCT02259517|ADHD|adhd
215134|NCT02259517|Intuniv|intuniv
215135|NCT02259517|Non-stimulant|non-stimulant
215136|NCT02259517|Guanfacine extended-release|guanfacine extended-release
215137|NCT02259517|Vyvanse|vyvanse
215138|NCT02259517|Stimulant|stimulant
215139|NCT02259517|Lisdexamfetamine|lisdexamfetamine
215140|NCT02259504|aneurysms|aneurysms
215141|NCT02259491|Wound Healing|wound healing
215142|NCT02259491|Honey|honey
215143|NCT02259491|Skin Grafts|skin grafts
215144|NCT02259491|Free tissue transfer|free tissue transfer
215145|NCT02259478|Intravenous Immunoglobulin (IVIG)|intravenous immunoglobulin (ivig)
215146|NCT02259478|Hemolysis|hemolysis
215147|NCT02259478|Transfusion Medicine|transfusion medicine
215148|NCT02259478|Pharmacovigilance|pharmacovigilance
215149|NCT02259465|microbiota|microbiota
215150|NCT02259465|FODMAP|fodmap
215151|NCT02259465|oligofructose|oligofructose
215152|NCT02259465|Magnetic Resonance Imaging|magnetic resonance imaging
215153|NCT02259465|Metabolomics|metabolomics
215154|NCT02259465|Diet|diet
215155|NCT02259452|Radiation Therapy|radiation therapy
215156|NCT02259413|Hemodialysis|hemodialysis
215157|NCT02259413|End-stage renal disease|end-stage renal disease
215158|NCT02259413|Exercise|exercise
215159|NCT02259413|Symptom Burden|symptom burden
215160|NCT02259400|NIV|niv
215161|NCT02259400|NSIPPV|nsippv
215162|NCT02259400|BiPAP|bipap
215163|NCT02259348|Hematological malignancies|hematological malignancies
215164|NCT02259348|Allogeneic hematopoietic cell transplant|allogeneic hematopoietic cell transplant
215165|NCT02259348|Refractory hematologic malignancy|refractory hematologic malignancy
215166|NCT02259348|Relapsed hematologic malignancy|relapsed hematologic malignancy
215167|NCT02259335|weaning from mechanical ventilation|weaning from mechanical ventilation
215168|NCT02259335|extracorporeal CO2 removal|extracorporeal co2 removal
215169|NCT02259335|post-extubation failure|post-extubation failure
215170|NCT02259322|Bariatric surgery|bariatric surgery
215171|NCT02259322|Weight loss surgery|weight loss surgery
215172|NCT02259322|Behavioral weight loss treatment|behavioral weight loss treatment
215173|NCT02259322|Cognitive behavioral therapy|cognitive behavioral therapy
215174|NCT02259322|Behavioral treatment|behavioral treatment
215175|NCT02259322|Obesity|obesity
215176|NCT02259322|Morbid obesity|morbid obesity
215177|NCT02259322|Binge eating|binge eating
215178|NCT02259322|Binge eating disorder|binge eating disorder
215179|NCT02259322|Loss of control eating|loss of control eating
215180|NCT02259322|Overeating|overeating
215181|NCT02259309|misoprostol|misoprostol
215182|NCT02259309|mucosal|mucosal
215183|NCT02259309|cervical|cervical
215184|NCT02259309|immune|immune
215185|NCT02259309|buccal|buccal
215186|NCT02259309|vaginal|vaginal
215187|NCT02259283|achalasia|achalasia
215188|NCT02259283|per oral endoscopic myotoymy|per oral endoscopic myotoymy
215189|NCT02259283|endoscopy|endoscopy
215190|NCT02259270|Acid suppressive therapy|acid suppressive therapy
215191|NCT02259270|Appropriateness|appropriateness
215192|NCT02259270|Long term treatment|long term treatment
215193|NCT02259270|Risk factors|risk factors
215194|NCT02259270|Hospitalisation|hospitalisation
215195|NCT02259270|Non-critically ill|non-critically ill
215196|NCT02259270|Adult|adult
215197|NCT02259257|carotid arteriosclerosis|carotid arteriosclerosis
215198|NCT02259257|contrast-enhanced ultrasound|contrast-enhanced ultrasound
215199|NCT02259257|neovascularization|neovascularization
215200|NCT02259257|quantitative analysis|quantitative analysis
215201|NCT02259257|3D/4D imaging|3d/4d imaging
215202|NCT02259257|CEUS|ceus
215203|NCT02259257|Vasa vasorum|vasa vasorum
215204|NCT02259231|RTA 408|rta 408
215205|NCT02259231|RTA 408 Capsules|rta 408 capsules
215206|NCT02259231|Myeloid-derived suppressor cells (MDSDs)|myeloid-derived suppressor cells (mdsds)
215207|NCT02259231|iNOS|inos
215208|NCT02259231|Melanoma|melanoma
215209|NCT02259231|Checkpoint inhibitor|checkpoint inhibitor
215210|NCT02259231|omaveloxolone|omaveloxolone
215211|NCT02259218|Biomarker|biomarker
215212|NCT02259218|Radiation|radiation
215213|NCT02259205|platelet activating factor|platelet activating factor
215214|NCT02259205|inflammatory markers|inflammatory markers
215215|NCT02259205|yogurt|yogurt
215216|NCT02259205|olive oil|olive oil
215217|NCT02259205|platelet aggregation|platelet aggregation
215218|NCT02259205|oxidative stress|oxidative stress
215219|NCT02259205|endothelial damage|endothelial damage
215220|NCT02259205|bioactive lipids|bioactive lipids
215221|NCT02259192|deaf adult|deaf adult
215222|NCT02259192|single-sided|single-sided
215223|NCT02259192|cochlear implant|cochlear implant
215224|NCT02259179|Obesity|obesity
215225|NCT02259179|Overweight|overweight
215226|NCT02259179|Contrave|contrave
215227|NCT02259179|Antiobesity agents|antiobesity agents
215228|NCT02259179|Antiobesity drugs|antiobesity drugs
215229|NCT02259179|Weight loss drug|weight loss drug
215230|NCT02259179|Bioequivalence|bioequivalence
215231|NCT02259179|Pharmacokinetic|pharmacokinetic
215232|NCT02259153|Lipids|lipids
215233|NCT02259153|Non Cholesterol Sterols|non cholesterol sterols
215234|NCT02259153|Oxysterols|oxysterols
215235|NCT02259153|Cholesterol Metabolism|cholesterol metabolism
215236|NCT02259140|cerebral palsy|cerebral palsy
215237|NCT02259140|randomized controlled trial|randomized controlled trial
215238|NCT02259140|hip dislocation|hip dislocation
215239|NCT02259140|hip subluxation|hip subluxation
215240|NCT02259140|patient centered outcomes|patient centered outcomes
215241|NCT02259140|cost effectiveness analysis|cost effectiveness analysis
215242|NCT02259088|DME, macular edema, vision impairment, Chinese, diabetes|dme, macular edema, vision impairment, chinese, diabetes
215243|NCT02259075|Migraine with aura|migraine with aura
215244|NCT02259075|Migraine without aura|migraine without aura
215245|NCT02259075|Headache disorders|headache disorders
215246|NCT02259075|Botulinum Toxin Type A|botulinum toxin type a
215247|NCT02259075|Sphenopalatine Ganglion Block|sphenopalatine ganglion block
215248|NCT02259075|Autonomic Nerve Block|autonomic nerve block
215249|NCT02259036|child anxiety|child anxiety
215250|NCT02259036|worries|worries
215251|NCT02259036|fears|fears
215252|NCT02259036|talk therapy|talk therapy
215253|NCT02259023|Stress Perception|stress perception
215254|NCT02259023|Discretionary Calories|discretionary calories
215255|NCT02259023|Health|health
215256|NCT02258997|sickle cell disease|sickle cell disease
215257|NCT02258958|venous thromboembolism prophylaxis|venous thromboembolism prophylaxis
215258|NCT02258958|deep venous thrombosis|deep venous thrombosis
215259|NCT02258958|pulmonary embolus|pulmonary embolus
215260|NCT02258958|thoracic surgery|thoracic surgery
215261|NCT02258958|lung resection|lung resection
215262|NCT02258958|incidence|incidence
215263|NCT02258945|Type 1 diabetes|type 1 diabetes
215264|NCT02258945|CSII|csii
215265|NCT02258945|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
215266|NCT02258945|Insulin pump|insulin pump
215267|NCT02258945|Nutrition|nutrition
215268|NCT02258945|Eating behaviours|eating behaviours
215269|NCT02258945|Quality of life|quality of life
215270|NCT02258945|Cardiometabolic risks|cardiometabolic risks
215271|NCT02258945|Liverpool|liverpool
215272|NCT02258945|NHS|nhs
215273|NCT02258945|Metabolomics|metabolomics
215274|NCT02258945|Observational|observational
215275|NCT02258945|Lipoproteins|lipoproteins
215276|NCT02258945|Lipids|lipids
215277|NCT02258945|Food|food
215278|NCT02258945|Food diary|food diary
215279|NCT02258945|Cross-Sectional|cross-sectional
215280|NCT02258932|Type 1 diabetes|type 1 diabetes
215281|NCT02258932|CSII|csii
215282|NCT02258932|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
215283|NCT02258932|Insulin pump|insulin pump
215284|NCT02258932|Nutrition|nutrition
215285|NCT02258932|Eating behaviours|eating behaviours
215286|NCT02258932|Quality of life|quality of life
215287|NCT02258932|Cardiometabolic risks|cardiometabolic risks
215288|NCT02258932|Liverpool|liverpool
215289|NCT02258932|NHS|nhs
215290|NCT02258932|Metabolomics|metabolomics
215291|NCT02258932|Observational|observational
215292|NCT02258932|Lipoproteins|lipoproteins
215293|NCT02258932|Lipids|lipids
215294|NCT02258932|Food|food
215295|NCT02258932|Food diary|food diary
215296|NCT02258932|Longitudinal|longitudinal
215297|NCT02258919|Intracerebral hemorrhage|intracerebral hemorrhage
215298|NCT02258919|Decompressive craniectomy|decompressive craniectomy
215299|NCT02258919|Randomized controlled trial|randomized controlled trial
215300|NCT02258919|Acute stroke|acute stroke
215301|NCT02258893|Nitrogen Dioxide|nitrogen dioxide
215302|NCT02258893|Parts per billion|parts per billion
215303|NCT02258880|Acute Stroke|acute stroke
215304|NCT02258880|Outcome Measures|outcome measures
215305|NCT02258880|Physical Performance|physical performance
215306|NCT02258867|Uveitis|uveitis
215307|NCT02258867|Behcet's Disease Uveitis|behcet's disease uveitis
215308|NCT02258867|Behcet's Disease|behcet's disease
215309|NCT02258854|Uveitis|uveitis
215310|NCT02258854|Non-infectious Uveitis|non-infectious uveitis
215311|NCT02258854|Intermediate Uveitis|intermediate uveitis
215312|NCT02258854|Posterior Uveitis|posterior uveitis
215313|NCT02258854|Panuveitis|panuveitis
215314|NCT02258854|Behçet's disease uveitis|behçet's disease uveitis
215315|NCT02258841|domestic violence|domestic violence
215316|NCT02258841|mental health|mental health
215317|NCT02258841|safety planning|safety planning
215318|NCT02258815|pediatric|pediatric
215319|NCT02258815|haploidentical|haploidentical
215320|NCT02258815|stem cell transplantation|stem cell transplantation
215321|NCT02258802|psychoeducational intervention|psychoeducational intervention
215322|NCT02258802|nutrition intervention|nutrition intervention
215323|NCT02258802|malnutrition|malnutrition
215324|NCT02258802|micronutrient deficiency|micronutrient deficiency
215913|NCT02255305|CDI|cdi
215325|NCT02258802|nutrition transition|nutrition transition
215326|NCT02258789|Stroke, rehabilitation, spatial neglect|stroke, rehabilitation, spatial neglect
215327|NCT02258763|Pneumonia|pneumonia
215328|NCT02258763|Child|child
215329|NCT02258763|Outcome|outcome
215330|NCT02258763|Antibiotics|antibiotics
215331|NCT02258763|Etiology|etiology
215332|NCT02258737|Case management|case management
215333|NCT02258737|psychiatric hospitalization|psychiatric hospitalization
215334|NCT02258737|discharge|discharge
215335|NCT02258724|Adult|adult
215336|NCT02258724|Registry|registry
215337|NCT02258724|Grown-up congenital heart disease|grown-up congenital heart disease
215338|NCT02258711|Bipolar disorder|bipolar disorder
215339|NCT02258711|Psychoeducation|psychoeducation
215340|NCT02258711|Smart-phone monitoring|smart-phone monitoring
215341|NCT02258685|Gut microbiota composition|gut microbiota composition
215342|NCT02258672|Preoperative rehabilitation|preoperative rehabilitation
215343|NCT02258672|Minimally invasive surgery|minimally invasive surgery
215344|NCT02258672|Functional capacity|functional capacity
215345|NCT02258646|Exercise|exercise
215346|NCT02258646|Rehabilitation|rehabilitation
215347|NCT02258646|Telemedicine|telemedicine
215348|NCT02258646|Treatment Outcome|treatment outcome
215349|NCT02258646|Costs and Cost Analysis|costs and cost analysis
215350|NCT02258646|Physical Therapists|physical therapists
215351|NCT02258646|Adaptation, Psychological|adaptation, psychological
215352|NCT02258568|Cigarette Smoking|cigarette smoking
215353|NCT02258568|Pregnancy|pregnancy
215354|NCT02258568|Postpartum smoking relapse|postpartum smoking relapse
215355|NCT02258568|Romania|romania
215356|NCT02258555|Chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
215357|NCT02258555|Follicular lymphoma (FL)|follicular lymphoma (fl)
215358|NCT02258555|Small Lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
215359|NCT02258555|Phosphatidylinositol 3 kinase (PI3K)|phosphatidylinositol 3 kinase (pi3k)
215360|NCT02258555|Marginal Zone Lymphoma (MZL)|marginal zone lymphoma (mzl)
215361|NCT02258542|Asthma, Bronchial Diseases, Respiratory Tract Diseases, Lung Diseases, Obstructive Lung Diseases|asthma, bronchial diseases, respiratory tract diseases, lung diseases, obstructive lung diseases
215362|NCT02258529|Cancer|cancer
215363|NCT02258529|Indolent Non-Hodgkin Lymphoma|indolent non-hodgkin lymphoma
215364|NCT02258529|FL|fl
215365|NCT02258529|SLL|sll
215366|NCT02258503|Numerical scale|numerical scale
215367|NCT02258503|Pain in elderly patients admitted in emergency department|pain in elderly patients admitted in emergency department
215368|NCT02258490|chronic myeloid leukemia|chronic myeloid leukemia
215369|NCT02258490|myelodysplastic syndrome|myelodysplastic syndrome
215370|NCT02258490|acute myeloid leukemia|acute myeloid leukemia
215371|NCT02258490|CD34+ cell mobilization therapy|cd34+ cell mobilization therapy
215372|NCT02258490|graft versus host disease|graft versus host disease
215373|NCT02258490|allogeneic hematopoietic stem cell|allogeneic hematopoietic stem cell
215374|NCT02258490|G-CSF|g-csf
215375|NCT02258464|Breast Cancer|breast cancer
215376|NCT02258451|Breast Cancer|breast cancer
215377|NCT02258438|Sedentary Behavior|sedentary behavior
215378|NCT02258425|Homeless Women|homeless women
215379|NCT02258425|Parolees|parolees
215380|NCT02258425|Probationers|probationers
215381|NCT02258425|Community Drug Treatment|community drug treatment
215382|NCT02258425|Recidivism|recidivism
215383|NCT02258412|antimicrobial|antimicrobial
215384|NCT02258412|efficacy|efficacy
215385|NCT02258412|hand|hand
215386|NCT02258412|hygiene|hygiene
215387|NCT02258412|bacteria|bacteria
215388|NCT02258373|Diabetes Mellitus|diabetes mellitus
215389|NCT02258373|Continuous Glucose Monitoring|continuous glucose monitoring
215390|NCT02258360|Thromboelastometry|thromboelastometry
215391|NCT02258360|Haemostasis|haemostasis
215392|NCT02258360|Hypothermia|hypothermia
215393|NCT02258360|Heart Arrest|heart arrest
215394|NCT02258334|Influenza|influenza
215395|NCT02258334|Fluzone® Quadrivalent, Influenza Vaccine|fluzone® quadrivalent, influenza vaccine
215396|NCT02258334|Fluzone® Intradermal, Influenza Vaccine|fluzone® intradermal, influenza vaccine
215397|NCT02258334|Fluzone® High-Dose, Influenza Vaccine|fluzone® high-dose, influenza vaccine
215398|NCT02258295|Lateral Humeral Epicondylitis|lateral humeral epicondylitis
215399|NCT02258295|Tendinitis|tendinitis
215400|NCT02258295|Tendinosis|tendinosis
215401|NCT02258295|Athletic Injuries|athletic injuries
215402|NCT02258295|Elbow Joint|elbow joint
215403|NCT02258295|Sports Medicine|sports medicine
215404|NCT02258204|Cerebral Infarct|cerebral infarct
215405|NCT02258204|Thrombolysis|thrombolysis
215406|NCT02258204|Tissue-type plasminogen activator|tissue-type plasminogen activator
215407|NCT02258204|Neuroprotection|neuroprotection
215408|NCT02258204|Anesthetic agent|anesthetic agent
215409|NCT02258204|Magnetic resonance imaging|magnetic resonance imaging
215410|NCT02258191|NIV|niv
215411|NCT02258191|COPD|copd
215412|NCT02258191|telemonitoring|telemonitoring
215413|NCT02258165|ovarian cancer|ovarian cancer
215414|NCT02258165|imaging|imaging
215415|NCT02258165|gated PET/CT scan|gated pet/ct scan
215416|NCT02258152|PDD|pdd
215417|NCT02258152|Parkinson's Disease Dementia|parkinson's disease dementia
215418|NCT02258152|patients taking a cholinesterase inhibitor.|patients taking a cholinesterase inhibitor.
215419|NCT02258126|overweight children|overweight children
215420|NCT02258126|hepatic fat|hepatic fat
215421|NCT02258126|exercise|exercise
215422|NCT02258126|nutritional education program|nutritional education program
215423|NCT02258126|cardiometabolic risk|cardiometabolic risk
215424|NCT02258087|Prostate, Cancer, Brachytherapy, HDR, LDR, monotherapy|prostate, cancer, brachytherapy, hdr, ldr, monotherapy
215425|NCT02258048|Cirrhosis|cirrhosis
215426|NCT02258035|vitamin D binding protein (DBP)|vitamin d binding protein (dbp)
215427|NCT02258022|Wounds and Injuries|wounds and injuries
215428|NCT02258022|Sepsis|sepsis
215429|NCT02257996|Psychoanalytic Psychotherapy|psychoanalytic psychotherapy
215430|NCT02257996|Telepsychology|telepsychology
215431|NCT02257996|Online Therapy|online therapy
215432|NCT02257996|Web conferencing|web conferencing
215433|NCT02257996|RCT|rct
215434|NCT02257996|HIPAA|hipaa
215435|NCT02257983|hearing|hearing
215436|NCT02257983|noise|noise
215437|NCT02257983|oxidative stress|oxidative stress
215438|NCT02257970|Lymphedema|lymphedema
215439|NCT02257970|edema|edema
215440|NCT02257970|swelling|swelling
215441|NCT02257931|infection|infection
215442|NCT02257931|bacteria|bacteria
215443|NCT02257931|gram-negative|gram-negative
215444|NCT02257931|HSCT|hsct
215445|NCT02257931|allogeneic|allogeneic
215446|NCT02257931|autologous|autologous
215447|NCT02257931|recipients, of all ages, for any indications|recipients, of all ages, for any indications
215448|NCT02257918|antibiotic|antibiotic
215449|NCT02257918|antimicrobial|antimicrobial
215450|NCT02257918|AZD0914|azd0914
215451|NCT02257918|Ceftriaxone|ceftriaxone
215452|NCT02257918|drug-resistant|drug-resistant
215453|NCT02257918|sexually transmitted infection|sexually transmitted infection
215454|NCT02257918|urogenital gonorrhoea|urogenital gonorrhoea
215455|NCT02257905|AL Amyloidosis|al amyloidosis
215456|NCT02257905|Amyloidosis|amyloidosis
215457|NCT02257905|allogeneic|allogeneic
215458|NCT02257905|HSCT|hsct
215459|NCT02257892|CTLA4|ctla4
215460|NCT02257892|PI3KCD|pi3kcd
215461|NCT02257892|MAG T1|mag t1
215462|NCT02257892|Rare Immune Disorders|rare immune disorders
215463|NCT02257892|Genetic Testing|genetic testing
215464|NCT02257879|Midazolam|midazolam
215465|NCT02257879|CYP3A|cyp3a
215466|NCT02257879|Loperamide|loperamide
215467|NCT02257866|Autoimmunity|autoimmunity
215468|NCT02257866|Adult and Pediatric Disease|adult and pediatric disease
215469|NCT02257866|Vasculitis|vasculitis
215470|NCT02257866|Rheumatic Disease|rheumatic disease
215471|NCT02257853|Caregiver Stress|caregiver stress
215472|NCT02257853|Cancer Caregivers|cancer caregivers
215473|NCT02257853|Yoga-Based Stress Reduction Intervention|yoga-based stress reduction intervention
215474|NCT02257853|HSCT Caregivers|hsct caregivers
215475|NCT02257827|Hypofractionated schedule|hypofractionated schedule
215476|NCT02257827|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
215477|NCT02257827|Conformal radiotherapy|conformal radiotherapy
215478|NCT02257801|Memory|memory
215479|NCT02257801|Cognition|cognition
215480|NCT02257801|Execute Function|execute function
215481|NCT02257801|Attention|attention
215482|NCT02257801|Mood|mood
215483|NCT02257762|Ready-to-use supplementary food (RUSF)|ready-to-use supplementary food (rusf)
215484|NCT02257762|Lipid-based nutrient supplement (LNS)|lipid-based nutrient supplement (lns)
215485|NCT02257762|Multiple micronutrients (MMN)|multiple micronutrients (mmn)
215486|NCT02257762|Complementary feeding|complementary feeding
215487|NCT02257762|Home fortification|home fortification
215488|NCT02257762|Efficacy/impact|efficacy/impact
215489|NCT02257762|Infant and young child feeding (IYCF)|infant and young child feeding (iycf)
215490|NCT02257762|Cambodia|cambodia
215491|NCT02257762|Cluster randomised controlled trial|cluster randomised controlled trial
215492|NCT02257749|Concussion|concussion
215493|NCT02257749|Persistent Symptoms|persistent symptoms
215494|NCT02257749|Children|children
215495|NCT02257749|Exercise|exercise
215496|NCT02257749|Adolescents|adolescents
215497|NCT02257749|Active Rehabilitation|active rehabilitation
215498|NCT02257749|Education|education
215499|NCT02257736|Prostatic neoplasms|prostatic neoplasms
215500|NCT02257736|JN56021927|jn56021927
215501|NCT02257736|ZYTIGA|zytiga
215502|NCT02257736|Prednisone|prednisone
215503|NCT02257736|Abiraterone acetate|abiraterone acetate
215504|NCT02257736|Apalutamide|apalutamide
215505|NCT02257723|Inpatient care|inpatient care
215506|NCT02257723|Complementary and alternative medicine|complementary and alternative medicine
215507|NCT02257723|Integrated medicine|integrated medicine
215508|NCT02257710|national|national
215509|NCT02257710|Multicenter|multicenter
215510|NCT02257710|Observational registry|observational registry
215511|NCT02257710|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
215512|NCT02257710|Stenting|stenting
215513|NCT02257710|Treatment of coronary artery disease|treatment of coronary artery disease
215514|NCT02257710|Coronary revascularization|coronary revascularization
215515|NCT02257710|Coronary Intervention|coronary intervention
215516|NCT02257710|STEMI|stemi
215517|NCT02257710|NSTEMI|nstemi
215518|NCT02257710|Ischemia|ischemia
215519|NCT02257710|Angina|angina
215520|NCT02257710|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
215521|NCT02257710|Small Vessels|small vessels
215522|NCT02257710|Chronic Total Occlusion|chronic total occlusion
215523|NCT02257684|ALL|all
215524|NCT02257684|LBL|lbl
215525|NCT02257658|Men who have Sex with Men|men who have sex with men
215526|NCT02257658|HIV-positive|hiv-positive
215527|NCT02257658|Syphilis|syphilis
215528|NCT02257658|Contingency Management|contingency management
215529|NCT02257619|Stage IIIb, IV, or Recurrent Non-Small Cell Lung Cancer|stage iiib, iv, or recurrent non-small cell lung cancer
215530|NCT02257593|macronutrient|macronutrient
215531|NCT02257593|malnutrition|malnutrition
215532|NCT02257593|birth weight|birth weight
215533|NCT02257593|protein leverage|protein leverage
215534|NCT02257580|E-Aminocaproic Acid|e-aminocaproic acid
215535|NCT02257580|Bilateral Varus Rotational Osteotomy|bilateral varus rotational osteotomy
215536|NCT02257580|Blood Loss and Transfusion|blood loss and transfusion
215537|NCT02257580|Complications|complications
215538|NCT02257580|Safety|safety
215539|NCT02257554|expectations|expectations
215540|NCT02257541|BGJ398|bgj398
215541|NCT02257541|Imatinib Mesylate|imatinib mesylate
215542|NCT02257541|14-140|14-140
215543|NCT02257502|aflibercept|aflibercept
215544|NCT02257502|iodiopathic choroidal neovascularization|iodiopathic choroidal neovascularization
215545|NCT02257502|young patient|young patient
215546|NCT02257476|carfilzomib|carfilzomib
215547|NCT02257476|advanced solid malignancies|advanced solid malignancies
215548|NCT02257476|advanced solid cancers|advanced solid cancers
215549|NCT02257476|prostate|prostate
215550|NCT02257476|bladder|bladder
215551|NCT02257476|colon|colon
215552|NCT02257476|breast|breast
215553|NCT02257476|lung|lung
215554|NCT02257463|COPD|copd
215555|NCT02257463|inspiratory muscle training|inspiratory muscle training
215556|NCT02257463|dyspnea|dyspnea
215557|NCT02257463|Quality of Life|quality of life
215558|NCT02257450|Primary Aldosteronism|primary aldosteronism
215559|NCT02257450|Hyperaldosteronism|hyperaldosteronism
215560|NCT02257437|Ready-to-use supplementary food (RUSF)|ready-to-use supplementary food (rusf)
215561|NCT02257437|Lipid-based nutrient supplement (LNS)|lipid-based nutrient supplement (lns)
215562|NCT02257437|Multiple micronutrients (MMN)|multiple micronutrients (mmn)
215563|NCT02257437|Complementary feeding|complementary feeding
215564|NCT02257437|Home fortification|home fortification
215565|NCT02257437|Acceptability|acceptability
215566|NCT02257437|Infant and young child feeding (IYCF)|infant and young child feeding (iycf)
215567|NCT02257437|Cambodia|cambodia
215568|NCT02257437|Cross-over studies|cross-over studies
215569|NCT02257411|child|child
215570|NCT02257411|ear based|ear based
215571|NCT02257411|Proseal LMA|proseal lma
215572|NCT02257398|TQTc|tqtc
215573|NCT02257398|Moxifloxacin|moxifloxacin
215574|NCT02257398|GSK2140944|gsk2140944
215575|NCT02257385|indacaterol|indacaterol
215576|NCT02257385|efficacy|efficacy
215577|NCT02257385|FEV1|fev1
215578|NCT02257385|ELLIPTA|ellipta
215579|NCT02257385|non inferiority|non inferiority
215580|NCT02257385|vilanterol|vilanterol
215581|NCT02257385|COPD|copd
215582|NCT02257385|safety|safety
215583|NCT02257385|tiotropium|tiotropium
215584|NCT02257385|umeclidinium bromide|umeclidinium bromide
215585|NCT02257385|GSK573719|gsk573719
215586|NCT02257372|FEV1|fev1
215587|NCT02257372|DPI|dpi
215588|NCT02257372|ICS/LABA|ics/laba
215589|NCT02257372|UMEC|umec
215590|NCT02257372|COPD|copd
215591|NCT02257359|Epelsiban|epelsiban
215592|NCT02257359|Healthy Female Volunteers|healthy female volunteers
215593|NCT02257359|Safety|safety
215594|NCT02257359|Tolerability|tolerability
215595|NCT02257359|Oxytocin|oxytocin
215596|NCT02257359|Pharmacokinetics|pharmacokinetics
215597|NCT02257346|Pregnancy|pregnancy
215598|NCT02257346|Lidocaine|lidocaine
215599|NCT02257346|Quality|quality
215600|NCT02257346|Recovery|recovery
215601|NCT02257333|Retinal Vein Occlusion|retinal vein occlusion
215602|NCT02257333|Atherosclerosis|atherosclerosis
215603|NCT02257333|Risk Factors|risk factors
215604|NCT02257333|Major Adverse Cardiovascular Events|major adverse cardiovascular events
215605|NCT02257307|ROP|rop
215606|NCT02257307|retinopathy|retinopathy
215607|NCT02257307|Referral warranted retinopathy|referral warranted retinopathy
215608|NCT02257281|Sodium lauryl sulfate|sodium lauryl sulfate
215609|NCT02257281|Skin irritants|skin irritants
215610|NCT02257281|inflammation|inflammation
215611|NCT02257281|therapeutic ultrasound|therapeutic ultrasound
215612|NCT02257268|health behavior; risk factors;|health behavior; risk factors;
215613|NCT02257255|cesarean section|cesarean section
215614|NCT02257255|pain, postoperative/diagnosis|pain, postoperative/diagnosis
215615|NCT02257255|pain measurement/methods|pain measurement/methods
215616|NCT02257242|Bendamustine|bendamustine
215617|NCT02257242|Rituximab|rituximab
215618|NCT02257242|Vincristine sulfate|vincristine sulfate
215619|NCT02257242|Vincristine sulfate liposome injection|vincristine sulfate liposome injection
215620|NCT02257242|Phase I|phase i
215621|NCT02257242|Escalation With Overdose Control|escalation with overdose control
215622|NCT02257229|Feet, deformity, correction, management, gait|feet, deformity, correction, management, gait
215623|NCT02257203|Dietary sucrose|dietary sucrose
215624|NCT02257190|Glycemic control|glycemic control
215625|NCT02257190|Exercise|exercise
215626|NCT02257164|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
215627|NCT02257164|femoral nerve block|femoral nerve block
215628|NCT02257164|articular injection and obturator nerve block|articular injection and obturator nerve block
215629|NCT02257151|Volunteers|volunteers
215630|NCT02257138|Leukemia|leukemia
215631|NCT02257138|Myeloproliferative Diseases|myeloproliferative diseases
215632|NCT02257138|Acute Myeloid Leukemia|acute myeloid leukemia
215633|NCT02257138|AML|aml
215634|NCT02257138|Ruxolitinib|ruxolitinib
215635|NCT02257138|Jakafi|jakafi
215636|NCT02257138|INCB018424|incb018424
215637|NCT02257138|INC424|inc424
215638|NCT02257138|Decitabine|decitabine
215639|NCT02257138|Dacogen|dacogen
215640|NCT02257138|Post myeloproliferative neoplasm|post myeloproliferative neoplasm
215641|NCT02257138|Post MPN-AML|post mpn-aml
215642|NCT02257125|rehabilitation|rehabilitation
215643|NCT02257125|virtual reality|virtual reality
215644|NCT02257125|stroke|stroke
215645|NCT02257125|upper extremity|upper extremity
215646|NCT02257125|arm|arm
215647|NCT02257125|feedback|feedback
215648|NCT02257125|reward|reward
215649|NCT02257060|Endocardial Ablation|endocardial ablation
215650|NCT02257060|Atrial Flutter|atrial flutter
215651|NCT02257060|Cavotricuspid Isthmus|cavotricuspid isthmus
215652|NCT02256995|Pregnancy|pregnancy
215653|NCT02256995|Preeclampsia|preeclampsia
215654|NCT02256995|Eclampsia|eclampsia
215655|NCT02256995|Proteinuria|proteinuria
215656|NCT02256982|unresectable intrahepatic cholangiocarcinoma|unresectable intrahepatic cholangiocarcinoma
215657|NCT02256982|resectable intrahepatic cholangiocarcinoma|resectable intrahepatic cholangiocarcinoma
215658|NCT02256956|Pharmacogenetics of Amitriptyline|pharmacogenetics of amitriptyline
215659|NCT02256943|Pharmacogenetics of Amitriptyline|pharmacogenetics of amitriptyline
215660|NCT02256904|Alignment|alignment
215661|NCT02256904|Kinematic|kinematic
215662|NCT02256904|knee|knee
215663|NCT02256904|satisfaction|satisfaction
215664|NCT02256904|function|function
215665|NCT02256904|survivorship|survivorship
215666|NCT02256891|Rotator cuff tear|rotator cuff tear
215667|NCT02256891|Rotator cuff injury|rotator cuff injury
215668|NCT02256891|Shoulder pain|shoulder pain
215669|NCT02256891|Shoulder injury|shoulder injury
215670|NCT02256865|Sleep Restriction|sleep restriction
215671|NCT02256865|Insulin Resistance|insulin resistance
215672|NCT02256865|Testosterone|testosterone
215673|NCT02256865|Cortisol|cortisol
215674|NCT02256839|Tuberculosis|tuberculosis
215675|NCT02256839|TB|tb
215676|NCT02256683|atrial fibrillation|atrial fibrillation
215677|NCT02256683|atrial flutter|atrial flutter
215678|NCT02256683|Atrial-Appendage Thrombus|atrial-appendage thrombus
215679|NCT02256683|Thrombus resolution|thrombus resolution
215680|NCT02256683|Dabigatran|dabigatran
215681|NCT02256683|Phenprocoumon|phenprocoumon
215682|NCT02256683|Transesophageal Echocardiography|transesophageal echocardiography
215683|NCT02256670|Hormone Receptor Positive|hormone receptor positive
215684|NCT02256618|neonatal encephalopathy|neonatal encephalopathy
215685|NCT02256618|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
215686|NCT02256618|newborn infants|newborn infants
215687|NCT02256618|neonates|neonates
215688|NCT02256618|umbilical cord blood cells|umbilical cord blood cells
215689|NCT02256592|inflammation|inflammation
215690|NCT02256592|microbiome|microbiome
215691|NCT02256592|immune activation|immune activation
215692|NCT02256592|fecal microbiota transplantation|fecal microbiota transplantation
215693|NCT02256592|dysbiosis|dysbiosis
215694|NCT02256579|TDF:Tenofovir, Urine beta2microglobulin|tdf:tenofovir, urine beta2microglobulin
215695|NCT02256566|cognitive training|cognitive training
215696|NCT02256566|depression|depression
215697|NCT02256566|bipolar depression|bipolar depression
215698|NCT02256566|anxiety|anxiety
215699|NCT02256566|ptsd|ptsd
215700|NCT02256566|generalized anxiety|generalized anxiety
215701|NCT02256566|social phobia|social phobia
215702|NCT02256514|therapeutic vaccine|therapeutic vaccine
215703|NCT02256501|Dilated cardiomyopathy pediatric heart failure cell therapy|dilated cardiomyopathy pediatric heart failure cell therapy
215704|NCT02256449|Coronary artery disease; angioplasty; bioresorbable device|coronary artery disease; angioplasty; bioresorbable device
215705|NCT02256436|P-D1|p-d1
215706|NCT02256436|PD-1|pd-1
215707|NCT02256436|PD1|pd1
215708|NCT02256436|P-DL1|p-dl1
215709|NCT02256436|PD-L1|pd-l1
215710|NCT02256436|PDL-1|pdl-1
215711|NCT02256436|PDL1|pdl1
215712|NCT02256436|Bladder cancer|bladder cancer
215713|NCT02256423|Ibuprofen|ibuprofen
215714|NCT02256423|healthy volunteer study|healthy volunteer study
215715|NCT02256423|pharmacokinetics|pharmacokinetics
215716|NCT02256410|low back pain|low back pain
215717|NCT02256410|chronic pain|chronic pain
215718|NCT02256410|sensitization|sensitization
215719|NCT02256410|treatment|treatment
215720|NCT02256410|trigger points|trigger points
215721|NCT02256397|Asthma|asthma
215722|NCT02256384|Respiration Rate|respiration rate
215723|NCT02256384|Respiratory Acoustic Monitor|respiratory acoustic monitor
215724|NCT02256384|postoperative|postoperative
215725|NCT02256371|Neuropathic pain|neuropathic pain
215726|NCT02256371|Hypnosis|hypnosis
215727|NCT02256371|Relaxation|relaxation
215728|NCT02256358|child, ketamine, midazolam|child, ketamine, midazolam
215729|NCT02256319|Deep brain stimulation|deep brain stimulation
215730|NCT02256319|Dexmedetomidine|dexmedetomidine
215731|NCT02256319|Propofol|propofol
215732|NCT02256293|Type 1 Diabetes|type 1 diabetes
215733|NCT02256280|Neuromuscular blockade|neuromuscular blockade
215734|NCT02256280|Thoracic surgery|thoracic surgery
215735|NCT02256254|Oxidative stress|oxidative stress
215736|NCT02256254|Simvastatin|simvastatin
215737|NCT02256228|Analgesia|analgesia
215738|NCT02256228|Local infiltration analgesia|local infiltration analgesia
215739|NCT02256228|Pain, relief|pain, relief
215740|NCT02256228|Pain, Postoperative|pain, postoperative
215741|NCT02256228|Intra-peritoneal analgesia|intra-peritoneal analgesia
215742|NCT02256228|Ropivacaine|ropivacaine
215743|NCT02256228|Saline|saline
215744|NCT02256228|Therapeutic Uses|therapeutic uses
215745|NCT02256228|Analgesics, Non-Narcotic|analgesics, non-narcotic
215746|NCT02256228|Analgesics|analgesics
215747|NCT02256228|Opioids|opioids
215748|NCT02256228|Morphine|morphine
215749|NCT02256228|Pain|pain
215750|NCT02256228|Postoperative Complications|postoperative complications
215751|NCT02256228|Physiological Effects of Drugs|physiological effects of drugs
215752|NCT02256228|Anesthetics, Local|anesthetics, local
215753|NCT02256228|Anesthetic|anesthetic
215754|NCT02256228|Cytoreductive|cytoreductive
215755|NCT02256228|Surgery|surgery
215756|NCT02256228|Cancer|cancer
215757|NCT02256215|Vitamin D|vitamin d
215758|NCT02256163|Thoracic Aortic Aneurysm (TAA)|thoracic aortic aneurysm (taa)
215759|NCT02256163|gene|gene
215760|NCT02256163|familial TAA|familial taa
215761|NCT02256163|blood collection|blood collection
215762|NCT02256137|Frailty phenotype|frailty phenotype
215763|NCT02256137|Physical fitness|physical fitness
215764|NCT02256137|Childhood cancer|childhood cancer
215765|NCT02256137|Late onset of chronic health conditions|late onset of chronic health conditions
215766|NCT02256137|Physical frailty|physical frailty
215767|NCT02256124|Neurofibromatosis type 1|neurofibromatosis type 1
215768|NCT02256124|NF1|nf1
215769|NCT02256124|Cognition|cognition
215770|NCT02256124|Learning problems|learning problems
215771|NCT02256124|Lamotrigine|lamotrigine
215772|NCT02256124|Transcranial magnetic stimulation|transcranial magnetic stimulation
215773|NCT02256124|TMS|tms
215774|NCT02256098|Comparative Study|comparative study
215775|NCT02256098|Knee Prosthesis|knee prosthesis
215776|NCT02256098|Prosthesis Design|prosthesis design
215777|NCT02256098|Treatment Outcome|treatment outcome
215778|NCT02256098|Follow-Up Studies|follow-up studies
215779|NCT02256098|Arthroplasty, Replacement, Knee/methods|arthroplasty, replacement, knee/methods
215780|NCT02256085|Dissociative|dissociative
215781|NCT02256085|Dissociation|dissociation
215782|NCT02256085|Depersonalization|depersonalization
215783|NCT02256085|Depersonalization Disorder|depersonalization disorder
215784|NCT02256085|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
215785|NCT02256085|TMS|tms
215786|NCT02256085|DPD|dpd
215787|NCT02256085|rTMS|rtms
215788|NCT02256085|Behavioral Symptoms|behavioral symptoms
215789|NCT02256072|aging, geriatrics, aging in place, home services|aging, geriatrics, aging in place, home services
215790|NCT02256033|Mild hepatic impairment|mild hepatic impairment
215791|NCT02256033|Healthy volunteer|healthy volunteer
215792|NCT02256033|Istradefylline|istradefylline
215793|NCT02256020|Wheel-chair dependent, music aerobic exercise, depression, insomnia|wheel-chair dependent, music aerobic exercise, depression, insomnia
215794|NCT02256007|Videogames; stroke|videogames; stroke
215795|NCT02255981|macular, degeneration, acupuncture, visual acuity, OCT|macular, degeneration, acupuncture, visual acuity, oct
215796|NCT02255968|Normal Volunteers|normal volunteers
215797|NCT02255968|Safety|safety
215798|NCT02255968|Pharmacokinetics|pharmacokinetics
215799|NCT02255955|naproxen sodium codeine|naproxen sodium codeine
215800|NCT02255955|paracetamol codeine|paracetamol codeine
215801|NCT02255955|disk surgery|disk surgery
215802|NCT02255929|Benign Essential Tremor|benign essential tremor
215803|NCT02255929|Tremor|tremor
215804|NCT02255929|Neurologic Manifestations|neurologic manifestations
215805|NCT02255929|Nervous System Diseases|nervous system diseases
215806|NCT02255929|Movement Disorders|movement disorders
215807|NCT02255929|Central Nervous System Diseases|central nervous system diseases
215808|NCT02255916|oncology|oncology
215809|NCT02255916|psychology|psychology
215810|NCT02255916|cancer|cancer
215811|NCT02255916|music|music
215812|NCT02255916|sound-bed|sound-bed
215813|NCT02255877|Bi lateral knee surgery|bi lateral knee surgery
215814|NCT02255877|uni compartmental|uni compartmental
215815|NCT02255864|Stents|stents
215816|NCT02255864|Angioplasty|angioplasty
215817|NCT02255864|Coronary Vessels|coronary vessels
215818|NCT02255864|Coronary Artery Disease|coronary artery disease
215819|NCT02255864|Angina Pectoris|angina pectoris
215820|NCT02255864|Myocardial Ischemia|myocardial ischemia
215821|NCT02255864|Myocardial Infarction|myocardial infarction
215822|NCT02255864|Myocardial Revascularization|myocardial revascularization
215823|NCT02255851|selected for TAVR by heart team consensus|selected for tavr by heart team consensus
215824|NCT02255851|treated with CE-Marked TAVR devices|treated with ce-marked tavr devices
215825|NCT02255799|traumatic brain injury|traumatic brain injury
215826|NCT02255799|TBI|tbi
215827|NCT02255799|brain injury|brain injury
215828|NCT02255799|memory|memory
215829|NCT02255799|verbal memory deficits|verbal memory deficits
215830|NCT02255799|memory problems|memory problems
215831|NCT02255799|cognition|cognition
215832|NCT02255799|cognitive impairment|cognitive impairment
215833|NCT02255799|neuropsychiatric symptoms|neuropsychiatric symptoms
215834|NCT02255799|donepezil|donepezil
215835|NCT02255799|acetylcholinesterase inhibitor|acetylcholinesterase inhibitor
215836|NCT02255786|Group Therapy|group therapy
215837|NCT02255786|Parents|parents
215838|NCT02255786|Autism|autism
215839|NCT02255786|Quality of Life|quality of life
215840|NCT02255773|Head and Neck Cancer|head and neck cancer
215841|NCT02255773|HNC|hnc
215842|NCT02255773|Moderate to severe fatigue|moderate to severe fatigue
215843|NCT02255773|Computerized tasks|computerized tasks
215844|NCT02255773|Questionnaires|questionnaires
215845|NCT02255773|Surveys|surveys
215846|NCT02255773|Disease-free adult males|disease-free adult males
215847|NCT02255773|Cancer survivors|cancer survivors
215848|NCT02255760|MEDI3902, Safety, Pharmacokinetics|medi3902, safety, pharmacokinetics
215849|NCT02255747|infants and children with constipation|infants and children with constipation
215850|NCT02255734|Volunteers|volunteers
215851|NCT02255695|posture|posture
215852|NCT02255695|child|child
215853|NCT02255695|prevention|prevention
215854|NCT02255695|muscle strength|muscle strength
215855|NCT02255695|muscle stretching exercises|muscle stretching exercises
215856|NCT02255695|exercise therapy|exercise therapy
215857|NCT02255695|disease management|disease management
215858|NCT02255695|musculoskeletal pain|musculoskeletal pain
215859|NCT02255695|adolescent|adolescent
215860|NCT02255695|spinal curvatures|spinal curvatures
215861|NCT02255682|physical activity|physical activity
215862|NCT02255682|statin therapy|statin therapy
215863|NCT02255682|diabetes mellitus|diabetes mellitus
215864|NCT02255682|cardiovascular disease|cardiovascular disease
215865|NCT02255682|Q10-supplementation|q10-supplementation
215866|NCT02255643|motor cortex stimulation|motor cortex stimulation
215867|NCT02255643|chronic neuropathic pain|chronic neuropathic pain
215868|NCT02255630|salbutamol|salbutamol
215869|NCT02255630|exercise-induced bronchoconstriction|exercise-induced bronchoconstriction
215870|NCT02255630|anaerobic power|anaerobic power
215871|NCT02255604|Allergic Rhinitis|allergic rhinitis
215872|NCT02255604|Allergen immunotherapy|allergen immunotherapy
215873|NCT02255591|Hip surgery anesthesia|hip surgery anesthesia
215874|NCT02255591|Perioperative analgesia|perioperative analgesia
215875|NCT02255565|Quillivant|quillivant
215876|NCT02255552|DMD, Duchenne, Eteplirsen, dystrophy, dystrophin, exon 51|dmd, duchenne, eteplirsen, dystrophy, dystrophin, exon 51
215877|NCT02255500|Total knee arthroplasty|total knee arthroplasty
215878|NCT02255487|surgical device|surgical device
215879|NCT02255487|surgical irrigation device|surgical irrigation device
215880|NCT02255487|surgical site infection prophylaxis|surgical site infection prophylaxis
215881|NCT02255474|pediatrics|pediatrics
215882|NCT02255474|refractive error - myopia|refractive error - myopia
215883|NCT02255474|contact lenses|contact lenses
215884|NCT02255474|intervention|intervention
215885|NCT02255435|RTA 408|rta 408
215886|NCT02255435|RTA 408 Capsules|rta 408 capsules
215887|NCT02255435|Oxidative Stress|oxidative stress
215888|NCT02255435|Mitochondrial dysfunction|mitochondrial dysfunction
215889|NCT02255435|omaveloxolone|omaveloxolone
215890|NCT02255422|omaveloxolone|omaveloxolone
215891|NCT02255422|RTA 408 capsules|rta 408 capsules
215892|NCT02255422|mitochondrial myopathies|mitochondrial myopathies
215893|NCT02255383|Osteoarthritis|osteoarthritis
215894|NCT02255383|Rheumatoid Arthritis|rheumatoid arthritis
215895|NCT02255383|Traumatic Arthritis|traumatic arthritis
215896|NCT02255383|Polyarthritis|polyarthritis
215897|NCT02255383|Total Knee Arthroplasty|total knee arthroplasty
215898|NCT02255370|Curcumin. Crohn's disease. Post-operative recurrence. Thiopurines . Rutgeerts endoscopic score|curcumin. crohn's disease. post-operative recurrence. thiopurines . rutgeerts endoscopic score
215899|NCT02255357|Oxytocin|oxytocin
215900|NCT02255357|Vasopressin|vasopressin
215901|NCT02255357|Cocaine|cocaine
215902|NCT02255344|Acute Coronary Syndromes|acute coronary syndromes
215903|NCT02255344|Risk Model|risk model
215904|NCT02255344|National Registry|national registry
215905|NCT02255344|Comprehensive Care Program|comprehensive care program
215906|NCT02255344|Major Cardiovascular Events|major cardiovascular events
215907|NCT02255331|Arthroplasty|arthroplasty
215908|NCT02255331|Replacement|replacement
215909|NCT02255331|Hip|hip
215910|NCT02255318|Taurolock®|taurolock®
215911|NCT02255318|infections related to chambers implantable catheter|infections related to chambers implantable catheter
215912|NCT02255318|patients with cancer receiving parenteral nutrition|patients with cancer receiving parenteral nutrition
215914|NCT02255305|C difficile|c difficile
215915|NCT02255305|C diff|c diff
215916|NCT02255305|Clostridium difficile|clostridium difficile
215917|NCT02255253|Telmisartan|telmisartan
215918|NCT02255253|Hydrochlorothiazide|hydrochlorothiazide
215919|NCT02255253|Efficacy|efficacy
215920|NCT02255253|hypertension|hypertension
215921|NCT02255253|high sodium intake|high sodium intake
215922|NCT02255240|breast cancer|breast cancer
215923|NCT02255240|cancer|cancer
215924|NCT02255240|survivorship|survivorship
215925|NCT02255240|cancer survivor|cancer survivor
215926|NCT02255240|physical activity|physical activity
215927|NCT02255240|video game|video game
215928|NCT02255240|women|women
215929|NCT02255240|women's health|women's health
215930|NCT02255227|vaccination|vaccination
215931|NCT02255227|randomized|randomized
215932|NCT02255227|anti-pneumococcal|anti-pneumococcal
215933|NCT02255227|Pneumo 23|pneumo 23
215934|NCT02255227|Prevenar 13|prevenar 13
215935|NCT02255227|Chronic Inflammatory Bowel Disease|chronic inflammatory bowel disease
215936|NCT02255188|Haemostas, prosthesis|haemostas, prosthesis
215937|NCT02255175|Reproductive Affective Disorder|reproductive affective disorder
215938|NCT02255175|Depression|depression
215939|NCT02255175|Perimenopause|perimenopause
215940|NCT02255175|Estrogen|estrogen
215941|NCT02255175|Estradiol treatment|estradiol treatment
215942|NCT02255175|Mood Disorders|mood disorders
215943|NCT02255175|Estrogen Replacement Therapy|estrogen replacement therapy
215944|NCT02255175|Sex Steroids|sex steroids
215945|NCT02255175|Depressive disorder|depressive disorder
215946|NCT02255175|Mental Disorders|mental disorders
215947|NCT02255175|Estradiol|estradiol
215948|NCT02255175|Hormones|hormones
215949|NCT02255175|Physiological effects of drugs|physiological effects of drugs
215950|NCT02255175|Reproductive Control Agents|reproductive control agents
215951|NCT02255162|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
215952|NCT02255162|Acute Myelocytic Leukemia|acute myelocytic leukemia
215953|NCT02255162|Acute Myelogenous Leukemia|acute myelogenous leukemia
215954|NCT02255162|Acute Granulocytic Leukemia|acute granulocytic leukemia
215955|NCT02255162|Acute Non-Lymphocytic Leukemia|acute non-lymphocytic leukemia
215956|NCT02255136|Interleukin|interleukin
215957|NCT02255136|Immunoglobulin|immunoglobulin
215958|NCT02255136|Homeopathy|homeopathy
215959|NCT02255136|Allergic Rhinitis|allergic rhinitis
215960|NCT02255136|Asthma|asthma
215961|NCT02255110|Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma|locally advanced unresectable or metastatic soft tissue sarcoma
215962|NCT02255110|TH-302|th-302
215963|NCT02255110|Doxorubicin|doxorubicin
215964|NCT02255110|Evofosfamide|evofosfamide
215965|NCT02255097|PD-1|pd-1
215967|NCT02255097|PD-L1|pd-l1
215968|NCT02255097|PDL1|pdl1
215969|NCT02255084|Cervical cancer screening|cervical cancer screening
215970|NCT02255084|High Risk Human papillomavirus Infection|high risk human papillomavirus infection
215971|NCT02255084|vaginal self-sampling|vaginal self-sampling
215972|NCT02255084|pap smear|pap smear
215973|NCT02255084|general practitioner|general practitioner
215974|NCT02255071|GERD|gerd
215975|NCT02255071|Neiguan|neiguan
215976|NCT02255071|Acupressure|acupressure
215977|NCT02255071|P6|p6
215978|NCT02255032|uveitis|uveitis
215979|NCT02255032|macular edema|macular edema
215980|NCT02255032|UME|ume
215981|NCT02255032|posterior uveitis|posterior uveitis
215982|NCT02255032|anterior uveitis|anterior uveitis
215983|NCT02255032|panuveitis|panuveitis
215984|NCT02255032|intermediate uveitis|intermediate uveitis
215985|NCT02255032|noninfectious uveitis|noninfectious uveitis
215986|NCT02255032|triamcinolone acetonide|triamcinolone acetonide
215987|NCT02255032|suprachoroidal space|suprachoroidal space
215988|NCT02255032|injection|injection
215989|NCT02255032|microneedle|microneedle
215990|NCT02255032|intravitreal injection|intravitreal injection
215991|NCT02255032|corticosteroid|corticosteroid
215992|NCT02255032|CME|cme
215993|NCT02255032|choroid|choroid
215994|NCT02255032|retina|retina
215995|NCT02255032|microinjection|microinjection
215996|NCT02255032|SCS|scs
215997|NCT02255006|volunteer|volunteer
215998|NCT02255006|BMI(25 kg/m2)|bmi(25 kg/m2)
215999|NCT02254980|Total hip arthroplasty|total hip arthroplasty
216000|NCT02254980|Cemented acetabular cup|cemented acetabular cup
216001|NCT02254980|Vitamin-E|vitamin-e
216002|NCT02254980|Radiostereometry|radiostereometry
216003|NCT02254980|Fixation of cemented acetabular component in total hip arthroplasty|fixation of cemented acetabular component in total hip arthroplasty
216004|NCT02254967|Aged|aged
216005|NCT02254967|Fidaxomicin|fidaxomicin
216006|NCT02254967|Clostridium Difficile|clostridium difficile
216007|NCT02254967|Vancomycin|vancomycin
216008|NCT02254954|glioblastoma|glioblastoma
216009|NCT02254941|Metastatic Colon Cancer|metastatic colon cancer
216010|NCT02254941|Monoclonal antibodies|monoclonal antibodies
216011|NCT02254941|Chemotherapy|chemotherapy
216012|NCT02254941|First line|first line
216013|NCT02254928|poor ovarian response|poor ovarian response
216014|NCT02254928|controlled ovarian stimulation|controlled ovarian stimulation
216015|NCT02254928|randomised clinical trial|randomised clinical trial
216016|NCT02254928|corifollitropin alfa|corifollitropin alfa
216017|NCT02254928|recombinant follicle-stimulating hormone (rFSH)|recombinant follicle-stimulating hormone (rfsh)
216018|NCT02254928|human menopausal gonadotropin (HMG)|human menopausal gonadotropin (hmg)
216019|NCT02254915|Synergo|synergo
216020|NCT02254915|RITE|rite
216021|NCT02254915|SHTC|shtc
216022|NCT02254915|Non Muscle Invasive Bladder Cancer|non muscle invasive bladder cancer
216023|NCT02254915|NMIBC|nmibc
216024|NCT02254915|Superficial Bladder Cancer|superficial bladder cancer
216025|NCT02254915|Urothelial Cell Cancer|urothelial cell cancer
216026|NCT02254915|Transitional Cell Cancer|transitional cell cancer
216027|NCT02254915|Mitomycin|mitomycin
216028|NCT02254902|sedentary lifestyle|sedentary lifestyle
216029|NCT02254902|physical activity|physical activity
216030|NCT02254902|Somali women|somali women
216031|NCT02254902|prevention|prevention
216032|NCT02254876|Stroke|stroke
216033|NCT02254876|Hemiplegia|hemiplegia
216034|NCT02254876|Painful shoulder Syndrome|painful shoulder syndrome
216035|NCT02254876|NeuroMuscolar Taping|neuromuscolar taping
216036|NCT02254863|Adrenoleukodystrophy|adrenoleukodystrophy
216037|NCT02254863|Batten Disease|batten disease
216038|NCT02254863|Hunter Syndrome|hunter syndrome
216039|NCT02254863|Krabbe|krabbe
216040|NCT02254863|Metachromatic Leukodystrophy|metachromatic leukodystrophy
216041|NCT02254863|ALD|ald
216042|NCT02254863|MLD|mld
216043|NCT02254863|PMD|pmd
216044|NCT02254850|Mesoglycan|mesoglycan
216045|NCT02254850|Metabolic Syndrome|metabolic syndrome
216046|NCT02254850|Flow Mediated Dilation|flow mediated dilation
216047|NCT02254824|Xuezhikang|xuezhikang
216048|NCT02254824|atorvastatin|atorvastatin
216049|NCT02254785|poor prognosis|poor prognosis
216050|NCT02254785|castrate-resistant prostate cancer|castrate-resistant prostate cancer
216051|NCT02254785|cabazitaxel|cabazitaxel
216052|NCT02254785|abiraterone|abiraterone
216053|NCT02254785|enzalutamide|enzalutamide
216054|NCT02254733|CBSST|cbsst
216055|NCT02254733|Schizoaffective Disorder|schizoaffective disorder
216056|NCT02254733|Psychotic Disorder|psychotic disorder
216057|NCT02254733|Cognitive Behavioral Therapy|cognitive behavioral therapy
216058|NCT02254733|Social Skills Training|social skills training
216059|NCT02254733|Assertive Community Treatment|assertive community treatment
216060|NCT02254694|sagittal balance|sagittal balance
216061|NCT02254694|posture|posture
216062|NCT02254694|lumbar lordosis|lumbar lordosis
216063|NCT02254694|high heeled shoes|high heeled shoes
216064|NCT02254681|low-dose radiotherapy|low-dose radiotherapy
216065|NCT02254681|gemcitabine|gemcitabine
216066|NCT02254681|cisplatin|cisplatin
216067|NCT02254681|cholangiocarcinoma|cholangiocarcinoma
216068|NCT02254668|intima|intima
216069|NCT02254668|thickness|thickness
216070|NCT02254668|transplantation|transplantation
216071|NCT02254668|cardiology|cardiology
216072|NCT02254668|immunosuppression|immunosuppression
216073|NCT02254655|puerarin|puerarin
216074|NCT02254655|rheumatoid arthritis|rheumatoid arthritis
216075|NCT02254655|atherosclerosis|atherosclerosis
216076|NCT02254655|carotid intima-media thickness|carotid intima-media thickness
216077|NCT02254629|Fecal microflora|fecal microflora
216078|NCT02254629|IBS|ibs
216079|NCT02254629|Sequential treatment|sequential treatment
216080|NCT02254629|Probiotic|probiotic
216081|NCT02254629|Laxative|laxative
216082|NCT02254616|Stroke Rehabilitation|stroke rehabilitation
216083|NCT02254616|Hybrid therapy|hybrid therapy
216084|NCT02254616|Mirror Therapy|mirror therapy
216085|NCT02254616|Transcranial Direct Current Stimulation|transcranial direct current stimulation
216086|NCT02254603|Obesity, ayuveda yoga exercise, acupuncture.|obesity, ayuveda yoga exercise, acupuncture.
216087|NCT02254590|IEDL|iedl
216088|NCT02254590|irrigation endoscopic decompressive laminotomy|irrigation endoscopic decompressive laminotomy
216089|NCT02254590|irrigation endoscopic decompression|irrigation endoscopic decompression
216090|NCT02254590|minimally invasive spine surgery|minimally invasive spine surgery
216091|NCT02254590|endoscopic decompression|endoscopic decompression
216092|NCT02254590|spinal stenosis|spinal stenosis
216093|NCT02254577|Infertility|infertility
216094|NCT02254577|Progesterone|progesterone
216095|NCT02254577|ART|art
216096|NCT02254577|IVF|ivf
216097|NCT02254577|FET|fet
216098|NCT02254577|FBT|fbt
216099|NCT02254577|Frozen Embryo Transfer|frozen embryo transfer
216100|NCT02254551|relapsed multiple myeloma|relapsed multiple myeloma
216101|NCT02254551|refractory multiple myeloma|refractory multiple myeloma
216102|NCT02254551|LDE225|lde225
216103|NCT02254551|Sonidegib|sonidegib
216104|NCT02254551|bortezomib|bortezomib
216105|NCT02254551|smoothened (SMO) inhibitors|smoothened (smo) inhibitors
216106|NCT02254551|Velcade|velcade
216107|NCT02254473|Knee|knee
216108|NCT02254473|Osteoarthritis|osteoarthritis
216109|NCT02254447|relative bio-availability|relative bio-availability
216110|NCT02254447|fasting|fasting
216111|NCT02254447|GW615775|gw615775
216112|NCT02254447|Candesartan cilexetil|candesartan cilexetil
216113|NCT02254447|ATACAND|atacand
216114|NCT02254434|eltrombopag 50 mg|eltrombopag 50 mg
216115|NCT02254434|healthy volunteers|healthy volunteers
216116|NCT02254434|pharmacokinetic|pharmacokinetic
216117|NCT02254434|single-dose|single-dose
216118|NCT02254434|Open-label|open-label
216119|NCT02254434|fasting|fasting
216120|NCT02254421|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
216121|NCT02254421|Antiviral|antiviral
216122|NCT02254421|Hematopoietic Cell Transplant (HCT)|hematopoietic cell transplant (hct)
216123|NCT02254421|Lower respiratory tract infection|lower respiratory tract infection
216124|NCT02254408|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
216125|NCT02254408|Antiviral|antiviral
216126|NCT02254408|Hematopoietic Cell Transplant (HCT)|hematopoietic cell transplant (hct)
216127|NCT02254408|Upper respiratory tract infection|upper respiratory tract infection
216128|NCT02254382|diastolic heart failure|diastolic heart failure
216129|NCT02254356|drug-eluting stent, paclitaxel-eluting stent, peripheral artery disease, peripheral vascular disease, superficial femoral artery, popliteal artery|drug-eluting stent, paclitaxel-eluting stent, peripheral artery disease, peripheral vascular disease, superficial femoral artery, popliteal artery
216130|NCT02254343|stroke rehabilitation|stroke rehabilitation
216131|NCT02254343|robot-assisted therapy|robot-assisted therapy
216132|NCT02254330|Adenoviral conjunctivitis diagnosed with AdenoPlus™ Test|adenoviral conjunctivitis diagnosed with adenoplus™ test
216133|NCT02254317|Impaired Glucose Tolerance|impaired glucose tolerance
216134|NCT02254317|Oral Glucose Tolerance Test|oral glucose tolerance test
216135|NCT02254317|Grape Seed Extract|grape seed extract
216136|NCT02254304|Relapsing multiple sclerosis|relapsing multiple sclerosis
216137|NCT02254304|Clinically isolated syndrome|clinically isolated syndrome
216138|NCT02254304|RMS|rms
216139|NCT02254304|CIS|cis
216140|NCT02254304|RebiSmart™|rebismart™
216141|NCT02254304|Rebif®|rebif®
216142|NCT02254304|Interferon beta-1a|interferon beta-1a
216143|NCT02254252|Slow coronary flow phenomenon|slow coronary flow phenomenon
216144|NCT02254252|Angina pectoris|angina pectoris
216145|NCT02254252|chest pain|chest pain
216146|NCT02254252|nicroandil|nicroandil
216147|NCT02254213|Intra-individual stability, EEG|intra-individual stability, eeg
216148|NCT02254200|exercise|exercise
216149|NCT02254200|fat oxidation|fat oxidation
216150|NCT02254200|indirect calorimetry|indirect calorimetry
216151|NCT02254200|insulin sensitivity|insulin sensitivity
216152|NCT02254200|weight management|weight management
216153|NCT02253810|Dysplasia, Congenital Hip|dysplasia, congenital hip
216154|NCT02253810|Osteotomy|osteotomy
216155|NCT02253810|Blood Transfusion|blood transfusion
216156|NCT02253810|Tranexamic Acid|tranexamic acid
216157|NCT02253758|Magnetic Resonance Imaging|magnetic resonance imaging
216158|NCT02253758|Electroencephalography|electroencephalography
216159|NCT02253758|Conscious Sedation|conscious sedation
216160|NCT02253758|Deep Sedation|deep sedation
216161|NCT02253758|Arousal|arousal
216162|NCT02253758|Consciousness|consciousness
216163|NCT02253745|ADHD|adhd
216164|NCT02253745|Attention Deficit/ Hyperactivity Disorder|attention deficit/ hyperactivity disorder
216165|NCT02253732|MicroRNAs|micrornas
216166|NCT02253732|exercise|exercise
216167|NCT02253732|skeletal muscle|skeletal muscle
216168|NCT02253732|metabolism|metabolism
216169|NCT02253719|cervical neoplasia|cervical neoplasia
216170|NCT02253719|cervical cancer'|cervical cancer'
216171|NCT02253719|visual inspection acetic acid|visual inspection acetic acid
216172|NCT02253719|cryotherapy|cryotherapy
216173|NCT02253706|bronchoscopy|bronchoscopy
216174|NCT02253706|hypoxia|hypoxia
216175|NCT02253706|oxygen supplementation|oxygen supplementation
216176|NCT02253706|safety|safety
216177|NCT02253693|Hemophilia A|hemophilia a
216178|NCT02253693|Hemophilic arthropathy|hemophilic arthropathy
216179|NCT02253693|Accelerometry|accelerometry
216180|NCT02253680|Osteoarthritis|osteoarthritis
216181|NCT02253680|Total knee replacement|total knee replacement
216182|NCT02253680|Enhanced recovery|enhanced recovery
216183|NCT02253680|Compression bandages|compression bandages
216184|NCT02253667|Palliative care|palliative care
216185|NCT02253667|Lung disease|lung disease
216186|NCT02253667|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
216187|NCT02253667|High-flow oxygen nasal cannula|high-flow oxygen nasal cannula
216188|NCT02253667|Dyspnoea|dyspnoea
216189|NCT02253667|Opioids|opioids
216190|NCT02253654|Chronic Kidney Disease|chronic kidney disease
216191|NCT02253654|Anemia|anemia
216192|NCT02253654|Hemodialysis|hemodialysis
216193|NCT02253654|Red Blood Cell Transfusion|red blood cell transfusion
216194|NCT02253641|African American, Women|african american, women
216195|NCT02253641|Weight Loss|weight loss
216196|NCT02253628|Coffee|coffee
216197|NCT02253628|Gastrin|gastrin
216198|NCT02253628|Alpha-amylase|alpha-amylase
216199|NCT02253628|Cortisol|cortisol
216200|NCT02253628|Self-reported gastrointestinal symptoms|self-reported gastrointestinal symptoms
216201|NCT02253628|Self-reported stress|self-reported stress
216202|NCT02253628|Blood pressure|blood pressure
216203|NCT02253615|Aging|aging
216204|NCT02253615|Resistance training|resistance training
216205|NCT02253615|Muscle strength|muscle strength
216206|NCT02253615|Functional performance|functional performance
216207|NCT02253615|Postural balance|postural balance
216208|NCT02253602|Esophageal Neoplasms|esophageal neoplasms
216209|NCT02253602|Lymph Nodes|lymph nodes
216210|NCT02253602|USPIO|uspio
216211|NCT02253602|Magnetic Resonance Imaging|magnetic resonance imaging
216212|NCT02253576|infant|infant
216213|NCT02253576|bronchiolitis|bronchiolitis
216214|NCT02253576|hypertonic saline|hypertonic saline
216215|NCT02253537|Tuberculosis|tuberculosis
216216|NCT02253537|TB|tb
216217|NCT02253524|Metoclopramide|metoclopramide
216218|NCT02253524|Dimenhydrinate|dimenhydrinate
216219|NCT02253524|emergency medicine|emergency medicine
216220|NCT02253511|Hepatocellular carcinoma|hepatocellular carcinoma
216221|NCT02253511|Hepotectomy|hepotectomy
216222|NCT02253511|Recurrence-free survival|recurrence-free survival
216223|NCT02253511|Overall survival|overall survival
216224|NCT02253485|Mother-to-child transmission|mother-to-child transmission
216225|NCT02253446|Dysmenorrhea|dysmenorrhea
216226|NCT02253446|Piroxicam|piroxicam
216227|NCT02253446|Diclofenac Sodium|diclofenac sodium
216228|NCT02253446|Emergency department|emergency department
216229|NCT02253433|asthma|asthma
216230|NCT02253433|environmental triggers|environmental triggers
216231|NCT02253433|home-based intervention|home-based intervention
216232|NCT02253433|asthma home visits|asthma home visits
216233|NCT02253420|Phase 1|phase 1
216234|NCT02253420|Advanced solid tumor|advanced solid tumor
216235|NCT02253420|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
216236|NCT02253420|PI3 Kinase inhibitor|pi3 kinase inhibitor
216237|NCT02253420|Drug-drug Interaction|drug-drug interaction
216238|NCT02253394|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
216239|NCT02253394|Ambrisentan|ambrisentan
216240|NCT02253394|Spironolactone|spironolactone
216241|NCT02253394|Selective Endothelin A (ETA) inhibition|selective endothelin a (eta) inhibition
216242|NCT02253394|Aldosterone antagonism|aldosterone antagonism
216243|NCT02253394|Cardiac output (CO)|cardiac output (co)
216244|NCT02253394|Right ventricular (RV) function|right ventricular (rv) function
216245|NCT02253394|Heart failure|heart failure
216246|NCT02253394|Quality of life|quality of life
216247|NCT02253394|Pro-inflammatory cytokine|pro-inflammatory cytokine
216248|NCT02253394|Interleukin-6 (IL-6)|interleukin-6 (il-6)
216249|NCT02253394|Troponin-I|troponin-i
216250|NCT02253394|N-terminal pro-brain natriuretic peptide (NT-BNP)|n-terminal pro-brain natriuretic peptide (nt-bnp)
216251|NCT02253394|Collagen metabolism|collagen metabolism
216252|NCT02253394|N-terminal procollagen type I|n-terminal procollagen type i
216253|NCT02253394|Collagen III|collagen iii
216254|NCT02253394|Echocardiography|echocardiography
216255|NCT02253394|WHO Functional Class|who functional class
216256|NCT02253394|Cardiopulmonary Exercise Test with Innocor|cardiopulmonary exercise test with innocor
216257|NCT02253394|Peak oxygen consumption (pVO2)|peak oxygen consumption (pvo2)
216258|NCT02253394|Liver function markers (AST/ALT)|liver function markers (ast/alt)
216259|NCT02253394|Renal function markers (creatinine and potassium)|renal function markers (creatinine and potassium)
216260|NCT02253381|lateral decubitus position|lateral decubitus position
216261|NCT02253381|hypotension|hypotension
216262|NCT02253381|cesarean section|cesarean section
216263|NCT02253329|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
216264|NCT02253329|Ageing|ageing
216265|NCT02253329|Protein ingestion|protein ingestion
216266|NCT02253316|Multiple Myeloma|multiple myeloma
216267|NCT02253316|Autologous Stem Cell Transplantation|autologous stem cell transplantation
216268|NCT02253316|Ixazomib|ixazomib
216269|NCT02253316|Lenalidomide|lenalidomide
216270|NCT02253316|Dexamethasone|dexamethasone
216271|NCT02253277|CML, Ph+ ALL|cml, ph+ all
216272|NCT02253251|Breast Cancer|breast cancer
216273|NCT02253251|Cancer Risk|cancer risk
216274|NCT02253251|Family Breast and Ovarian Cancer|family breast and ovarian cancer
216275|NCT02253251|Genetic Cancer Risk|genetic cancer risk
216276|NCT02253251|Cancer Treatment|cancer treatment
216277|NCT02253251|Familial multiple primary cancer risk|familial multiple primary cancer risk
216278|NCT02253251|Autoimmunity|autoimmunity
216279|NCT02253251|Endometriosis|endometriosis
216280|NCT02253238|Head and Neck Cancer|head and neck cancer
216281|NCT02253238|Dehydration|dehydration
216282|NCT02253238|Sensor-based home monitoring|sensor-based home monitoring
216283|NCT02253238|Radiation therapy|radiation therapy
216284|NCT02253238|RT|rt
216285|NCT02253238|XRT|xrt
216286|NCT02253238|Oropharyngeal cancer|oropharyngeal cancer
216287|NCT02253238|Hypopharyngeal cancer|hypopharyngeal cancer
216288|NCT02253238|Nasopharyngeal cancer|nasopharyngeal cancer
216289|NCT02253238|Salivary gland cancer|salivary gland cancer
216290|NCT02253238|Oral cavity cancer|oral cavity cancer
216291|NCT02253238|Questionnaires|questionnaires
216292|NCT02253238|Surveys|surveys
216293|NCT02253238|Quality of life|quality of life
216294|NCT02253238|QOL|qol
216295|NCT02253238|Phone calls|phone calls
216296|NCT02253238|Self-monitoring devices|self-monitoring devices
216297|NCT02253238|CYberinfrastructure for COmparative effectiveness REsearch|cyberinfrastructure for comparative effectiveness research
216298|NCT02253238|CYCORE|cycore
216299|NCT02253238|Emergency room visits|emergency room visits
216300|NCT02253238|ER|er
216301|NCT02253238|Emergency room visits with hospitalization|emergency room visits with hospitalization
216302|NCT02253238|ERHV|erhv
216303|NCT02253225|Bipolar Disorder|bipolar disorder
216304|NCT02253225|Major Depression|major depression
216305|NCT02253225|Rumination|rumination
216306|NCT02253225|Self Processing|self processing
216307|NCT02253173|VVA|vva
216308|NCT02253173|Painful Sex|painful sex
216309|NCT02253173|Postmenopausal|postmenopausal
216310|NCT02253160|MNCs|mncs
216311|NCT02253160|Mononuclear Cells|mononuclear cells
216312|NCT02253160|Apheresis|apheresis
216313|NCT02253160|Spectra Optia|spectra optia
216314|NCT02253147|Nasolabial folds|nasolabial folds
216315|NCT02253147|Dermal filler|dermal filler
216316|NCT02253147|Hyaluronic acid (HA)|hyaluronic acid (ha)
216317|NCT02253147|Wrinkles|wrinkles
216318|NCT02253134|Syncopal events|syncopal events
216319|NCT02253134|Palpitation events|palpitation events
216320|NCT02253121|COPD|copd
216321|NCT02253121|acute exacerbation|acute exacerbation
216322|NCT02253121|glucocorticoid therapy|glucocorticoid therapy
216323|NCT02253121|hyperglycemia|hyperglycemia
216324|NCT02253108|DES|des
216325|NCT02253108|Angina pectoris|angina pectoris
216326|NCT02253108|Stent|stent
216327|NCT02253108|Optical coherence tomography|optical coherence tomography
216328|NCT02253108|Stent thrombosis|stent thrombosis
216329|NCT02253056|Fasting|fasting
216330|NCT02253056|Caloric Restriction|caloric restriction
216331|NCT02253056|Focus is to observe effects of fasting in healthy volunteers.|focus is to observe effects of fasting in healthy volunteers.
216332|NCT02253043|Alzheimer's Disease|alzheimer's disease
216333|NCT02253030|AMD|amd
216334|NCT02253030|OCT|oct
216335|NCT02253030|Angiography|angiography
216336|NCT02253030|Macular degeneration|macular degeneration
216337|NCT02253017|Therapeutic strategies|therapeutic strategies
216338|NCT02253017|Pediatrics|pediatrics
216339|NCT02253017|Cataract|cataract
216340|NCT02253017|Surgery|surgery
216341|NCT02253017|Intra-ocular lens|intra-ocular lens
216342|NCT02252991|Breast cancer|breast cancer
216343|NCT02252991|Fatigue|fatigue
216344|NCT02252991|Physical activity|physical activity
216345|NCT02252965|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
216346|NCT02252965|Metformin XR|metformin xr
216347|NCT02252965|Metformin IR|metformin ir
216348|NCT02252952|Sugar Sweetened Beverages, Diet Beverages, ectopic fat, Functional MRI|sugar sweetened beverages, diet beverages, ectopic fat, functional mri
216349|NCT02252926|Anesthetics, Local|anesthetics, local
216350|NCT02252926|Bupivacaine|bupivacaine
216351|NCT02252926|Lozenge|lozenge
216352|NCT02252926|Administration, Topical|administration, topical
216353|NCT02252900|Brain damages|brain damages
216354|NCT02252900|MRI|mri
216355|NCT02252900|infectious endocarditis|infectious endocarditis
216356|NCT02252887|Gemcitabine,|gemcitabine,
216357|NCT02252887|Trastuzumab|trastuzumab
216358|NCT02252887|Pertuzumab|pertuzumab
216359|NCT02252887|14-124|14-124
216360|NCT02252874|balance|balance
216361|NCT02252874|visual function|visual function
216362|NCT02252874|community-dwelling older adults|community-dwelling older adults
216363|NCT02252874|action video-game|action video-game
216364|NCT02252822|Eating Disorders|eating disorders
216365|NCT02252822|Self Help|self help
216366|NCT02252822|Anonymous CBT|anonymous cbt
216367|NCT02252809|inflammation endotoxin anti-TNF corticosteroids|inflammation endotoxin anti-tnf corticosteroids
216368|NCT02252796|Non-small Cell Lung Cancer|non-small cell lung cancer
216369|NCT02252796|Radiotherapy Therapy|radiotherapy therapy
216370|NCT02252783|Coronary Artery Disease|coronary artery disease
216371|NCT02252783|Myocardial Ischemia|myocardial ischemia
216372|NCT02252783|Coronary Disease|coronary disease
216373|NCT02252783|Heart Diseases|heart diseases
216374|NCT02252783|Cardiovascular Diseases|cardiovascular diseases
216375|NCT02252783|Arteriosclerosis|arteriosclerosis
216376|NCT02252783|Arterial Occlusive Diseases|arterial occlusive diseases
216377|NCT02252783|Vascular Diseases|vascular diseases
216378|NCT02252770|ASA|asa
216379|NCT02252770|ASLD|asld
216380|NCT02252770|UCD|ucd
216381|NCT02252757|mHealth, hypertension, atherosclerotic disease, diabetes, obesity, metabolic syndrome, cardiotoxins, cardiomyopathy, dsypnea|mhealth, hypertension, atherosclerotic disease, diabetes, obesity, metabolic syndrome, cardiotoxins, cardiomyopathy, dsypnea
216382|NCT02252744|dry eye disease|dry eye disease
216383|NCT02252744|rheumatoid arthritis|rheumatoid arthritis
216384|NCT02252731|Phase I|phase i
216385|NCT02252731|FG-4592|fg-4592
216386|NCT02252731|Warfarin|warfarin
216387|NCT02252731|Pharmacokinetics|pharmacokinetics
216388|NCT02252731|Pharmacodynamics|pharmacodynamics
216389|NCT02252705|Pulmonary arterial hypertension|pulmonary arterial hypertension
216390|NCT02252705|Mortality|mortality
216391|NCT02252705|Survival|survival
216392|NCT02252692|Bioavailability|bioavailability
216393|NCT02252692|pharmacokinetics|pharmacokinetics
216394|NCT02252692|enalapril|enalapril
216395|NCT02252692|enalaprilat|enalaprilat
216396|NCT02252679|Bone Turnover Markers|bone turnover markers
216397|NCT02252679|Calcium Isotopes|calcium isotopes
216398|NCT02252666|MS|ms
216399|NCT02252666|balance|balance
216400|NCT02252666|standing|standing
216401|NCT02252666|control|control
216402|NCT02252666|movement|movement
216403|NCT02252653|Cardiomyopathy|cardiomyopathy
216404|NCT02252653|Heart Failure|heart failure
216405|NCT02252653|FAC|fac
216406|NCT02252653|Amyloid|amyloid
216407|NCT02252653|Transthyretin (TTR)|transthyretin (ttr)
216408|NCT02252640|Plasmodium Falciparum|plasmodium falciparum
216409|NCT02252640|Malaria|malaria
216410|NCT02252640|Vaccine|vaccine
216411|NCT02252640|Plasmodium|plasmodium
216412|NCT02252640|Falciparum|falciparum
216413|NCT02252614|naproxen sodium+codein, paracetamol+codein,lumbar disc surgery|naproxen sodium+codein, paracetamol+codein,lumbar disc surgery
216414|NCT02252601|Cystic Fibrosis|cystic fibrosis
216415|NCT02252601|Hearing Loss|hearing loss
216416|NCT02252601|High Frequency Digit Triplet Test|high frequency digit triplet test
216417|NCT02252588|COPD|copd
216418|NCT02252588|Bacteria|bacteria
216419|NCT02252562|Hand hygiene|hand hygiene
216420|NCT02252562|Hospital acquired infections (HAI)|hospital acquired infections (hai)
216421|NCT02252562|Healthcare acquired infections (HCAI)|healthcare acquired infections (hcai)
216422|NCT02252536|alcohol use disorder|alcohol use disorder
216423|NCT02252536|alcoholism|alcoholism
216424|NCT02252536|alcohol dependence|alcohol dependence
216425|NCT02252536|drinking alcohol|drinking alcohol
216426|NCT02252523|Feasibility study|feasibility study
216427|NCT02252497|hip arthroplasty|hip arthroplasty
216428|NCT02252497|Tranexamic acid|tranexamic acid
216429|NCT02252497|randomized control trial|randomized control trial
216430|NCT02252484|prostate cancer|prostate cancer
216431|NCT02252484|prostatectomy|prostatectomy
216432|NCT02252484|weight loss|weight loss
216433|NCT02252484|prevent weight gain|prevent weight gain
216434|NCT02252471|alcohol-exposed pregnancy|alcohol-exposed pregnancy
216435|NCT02252471|nicotine-exposed pregnancy|nicotine-exposed pregnancy
216436|NCT02252471|tobacco-exposed pregnancy|tobacco-exposed pregnancy
216437|NCT02252471|alcohol|alcohol
216438|NCT02252471|contraception|contraception
216439|NCT02252471|smoking|smoking
216440|NCT02252471|pregnancy|pregnancy
216441|NCT02252471|HIV|hiv
216442|NCT02252471|prevention|prevention
216443|NCT02252458|Opioid induced hyperalgesia|opioid induced hyperalgesia
216444|NCT02252458|Fentanyl|fentanyl
216445|NCT02252432|KETAMINE|ketamine
216446|NCT02252432|METHADONE|methadone
216447|NCT02252432|POSTOPERATIVE PAIN|postoperative pain
216448|NCT02252432|OPIOID REQUIREMENTS|opioid requirements
216449|NCT02252432|Length of hospital stay|length of hospital stay
216450|NCT02252432|Perioperative outcomes|perioperative outcomes
216451|NCT02252419|Postoperative Period|postoperative period
216452|NCT02252419|Anesthesia, General|anesthesia, general
216453|NCT02252419|Intubation, Intratracheal|intubation, intratracheal
216454|NCT02252419|Dexamethasone|dexamethasone
216455|NCT02252419|Acetaminophen|acetaminophen
216456|NCT02252406|Stable Angina|stable angina
216457|NCT02252406|Metabolic Syndrome|metabolic syndrome
216458|NCT02252406|Women|women
216459|NCT02252406|Biomarkers|biomarkers
216460|NCT02252367|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors
216461|NCT02252367|BPH/LUTS|bph/luts
216462|NCT02252354|Drug therapy|drug therapy
216463|NCT02252341|smoking|smoking
216464|NCT02252341|inflammation|inflammation
216465|NCT02252341|oxidative stress|oxidative stress
216466|NCT02252341|NAC|nac
216467|NCT02252341|treatment|treatment
216468|NCT02252328|Uveitis|uveitis
216469|NCT02252328|Simvastatin|simvastatin
216470|NCT02252328|Visual acuity|visual acuity
216471|NCT02252328|Corticosteroids|corticosteroids
216472|NCT02252328|Immunosuppression|immunosuppression
216473|NCT02252302|Exercise-induced bronchoconstriction|exercise-induced bronchoconstriction
216474|NCT02252302|Air pollution|air pollution
216475|NCT02252302|Exercise|exercise
216476|NCT02252302|Inhaled beta-2-agonist|inhaled beta-2-agonist
216477|NCT02252302|Cognitive Function|cognitive function
216478|NCT02252289|Asthma|asthma
216479|NCT02252289|children|children
216480|NCT02252289|fluctuation analysis|fluctuation analysis
216481|NCT02252289|exacerbations|exacerbations
216482|NCT02252276|Manual therapy|manual therapy
216483|NCT02252276|proprioception|proprioception
216484|NCT02252276|exercises|exercises
216485|NCT02252276|ankle sprain|ankle sprain
216486|NCT02252250|rectal cancer|rectal cancer
216487|NCT02252250|laparoscopic|laparoscopic
216488|NCT02252250|NOTES|notes
216489|NCT02252237|Prednisone|prednisone
216490|NCT02252237|Prednisolone|prednisolone
216491|NCT02252237|Methylprednisolone|methylprednisolone
216492|NCT02252237|Glucocorticoids|glucocorticoids
216493|NCT02252237|pharmacokinetics|pharmacokinetics
216494|NCT02252211|EphA2 positive cancer|epha2 positive cancer
216495|NCT02252211|DS-8895a monoclonal antibody|ds-8895a monoclonal antibody
216496|NCT02252172|Multiple Myeloma|multiple myeloma
216497|NCT02252172|Daratumumab|daratumumab
216498|NCT02252172|JNJ-54767414|jnj-54767414
216499|NCT02252172|Lenalidomide|lenalidomide
216500|NCT02252172|Dexamethasone|dexamethasone
216501|NCT02252159|Polycythemia|polycythemia
216502|NCT02252159|Polycythemia Vera|polycythemia vera
216503|NCT02252159|Hematologic Diseases|hematologic diseases
216504|NCT02252159|Myeloproliferative Disorders|myeloproliferative disorders
216505|NCT02252159|Bone Marrow Diseases|bone marrow diseases
216506|NCT02252159|Hydroxyurea|hydroxyurea
216507|NCT02252159|Antineoplastic Agents|antineoplastic agents
216508|NCT02252159|Therapeutic Uses|therapeutic uses
216509|NCT02252159|Pharmacologic Actions|pharmacologic actions
216510|NCT02252159|Antisickling Agents|antisickling agents
216511|NCT02252159|Hematologic Agents|hematologic agents
216512|NCT02252159|Enzyme Inhibitors|enzyme inhibitors
216513|NCT02252159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
216514|NCT02252159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors
216515|NCT02252146|DLBCL|dlbcl
216516|NCT02252146|MYD88 L265P|myd88 l265p
216517|NCT02252146|Lymphoma|lymphoma
216518|NCT02252146|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
216519|NCT02252146|Idera|idera
216520|NCT02252146|IMO 8400|imo 8400
216521|NCT02252133|Contact lenses|contact lenses
216522|NCT02252133|Myopia|myopia
216523|NCT02252107|Decitabine|decitabine
216524|NCT02252107|Hematopoietic stem cell transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
216525|NCT02252107|Conditioning|conditioning
216526|NCT02252107|AML|aml
216527|NCT02252081|metformin|metformin
216528|NCT02252081|cardiovascular disease|cardiovascular disease
216529|NCT02252081|Chronic Kidney Disease|chronic kidney disease
216530|NCT02252081|Metabolic Syndrome|metabolic syndrome
216531|NCT02252042|Squamous cell carcinoma|squamous cell carcinoma
216532|NCT02252042|Head and neck carcinoma|head and neck carcinoma
216533|NCT02252042|PD1|pd1
216534|NCT02252042|PD-1|pd-1
216535|NCT02252042|PDL1|pdl1
216536|NCT02252042|PD-L1|pd-l1
216537|NCT02252029|Rotavirus|rotavirus
216538|NCT02252029|Vaccine|vaccine
216539|NCT02252003|Children|children
216540|NCT02252003|Pain|pain
216541|NCT02252003|Pain scale evaluation|pain scale evaluation
216542|NCT02251964|IMID|imid
216543|NCT02251964|Interstitial Pneumonitis|interstitial pneumonitis
216544|NCT02251964|rituximab|rituximab
216545|NCT02251964|Immuno PET|immuno pet
216546|NCT02251964|PET/CT|pet/ct
216547|NCT02251951|Cancer|cancer
216548|NCT02251951|Stomach|stomach
216549|NCT02251951|Gastro-Esophageal Junction|gastro-esophageal junction
216550|NCT02251951|Salvage treatment|salvage treatment
216551|NCT02251951|Nab-paclitaxel|nab-paclitaxel
216552|NCT02251925|infertility froze emberyo transfer hormone replacement|infertility froze emberyo transfer hormone replacement
216553|NCT02251912|Alcohol dependence|alcohol dependence
216554|NCT02251912|Alcohol|alcohol
216555|NCT02251912|Oxytocin|oxytocin
216556|NCT02251912|Intranasal administration|intranasal administration
216557|NCT02251847|cholesterol|cholesterol
216558|NCT02251834|Healthcare Disparities|healthcare disparities
216559|NCT02251834|stroke|stroke
216560|NCT02251834|Hispanic Americans|hispanic americans
216561|NCT02251834|community health worker|community health worker
216562|NCT02251834|Mobile Health|mobile health
216563|NCT02251834|Transient Ischemic Attack (TIA)|transient ischemic attack (tia)
216564|NCT02251834|hypertension|hypertension
216565|NCT02251834|Randomized Controlled Trial|randomized controlled trial
216566|NCT02251834|high cholesterol|high cholesterol
216567|NCT02251834|behavioral|behavioral
216568|NCT02251834|exercise|exercise
216569|NCT02251834|diabetes|diabetes
216570|NCT02251834|diet|diet
216571|NCT02251808|Parkinson's Disease, Deep brain stimulation|parkinson's disease, deep brain stimulation
216572|NCT02251743|ADHD|adhd
216573|NCT02251743|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
216574|NCT02251743|neurofeedback|neurofeedback
216576|NCT02251730|radiation therapy,Smoking pattern,head and neck cancer|radiation therapy,smoking pattern,head and neck cancer
216577|NCT02251717|renal transplant|renal transplant
216578|NCT02251704|Malaria|malaria
216579|NCT02251704|MTI|mti
216580|NCT02251704|Surveillance study|surveillance study
216581|NCT02251704|Africa|africa
216582|NCT02251704|RTSS, adjuvant|rtss, adjuvant
216583|NCT02251704|Epidemiology|epidemiology
216584|NCT02251691|Compliance|compliance
216585|NCT02251678|Plaque|plaque
216586|NCT02251678|Psoriasis|psoriasis
216587|NCT02251678|Biomarkers|biomarkers
216588|NCT02251678|CRP|crp
216589|NCT02251678|αTNF|αtnf
216590|NCT02251678|Interleuken|interleuken
216591|NCT02251665|Acute ischemic stroke|acute ischemic stroke
216592|NCT02251665|Acute intracerebral hemorrhage|acute intracerebral hemorrhage
216593|NCT02251665|Transient ischemic attack|transient ischemic attack
216594|NCT02251652|Actinic|actinic
216595|NCT02251639|Oral cancer|oral cancer
216596|NCT02251639|Pre-cancer|pre-cancer
216597|NCT02251639|Widefield Fluorescence Imaging|widefield fluorescence imaging
216598|NCT02251639|VELScope|velscope
216599|NCT02251639|Point Spectroscopy System|point spectroscopy system
216600|NCT02251639|Oral brush biopsy|oral brush biopsy
216601|NCT02251639|Questionnaire|questionnaire
216602|NCT02251639|Survey|survey
216603|NCT02251639|Diagnostic aid|diagnostic aid
216604|NCT02251639|Screening|screening
216605|NCT02251626|MGH|mgh
216606|NCT02251626|Burn patient|burn patient
216607|NCT02251626|Adult|adult
216608|NCT02251626|CoQ10|coq10
216609|NCT02251626|Ubiquinol|ubiquinol
216610|NCT02251600|Pediatric|pediatric
216611|NCT02251600|Adolescent|adolescent
216612|NCT02251600|Deflazacort|deflazacort
216613|NCT02251561|contact lenses|contact lenses
216614|NCT02251561|contact lens solution|contact lens solution
216615|NCT02251561|corneal staining|corneal staining
216616|NCT02251561|fluorescein|fluorescein
216617|NCT02251548|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
216618|NCT02251548|Leukemia|leukemia
216619|NCT02251535|kinematic analysis|kinematic analysis
216620|NCT02251535|femoral rollback|femoral rollback
216621|NCT02251535|mobile bearing|mobile bearing
216622|NCT02251535|cruciate retaining Primary Total Knee Arthroplasty|cruciate retaining primary total knee arthroplasty
216623|NCT02251496|Malnutrition|malnutrition
216624|NCT02251496|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
216625|NCT02251496|Nutrition Therapy|nutrition therapy
216626|NCT02251496|Oral Nutrition Supplement|oral nutrition supplement
216627|NCT02251496|Food|food
216628|NCT02251483|DIBS|dibs
216629|NCT02251483|SIBO|sibo
216630|NCT02251470|stroke|stroke
216631|NCT02251470|balance|balance
216632|NCT02251470|exer-gaming|exer-gaming
216633|NCT02251470|home-based exercises|home-based exercises
216634|NCT02251470|Wii|wii
216635|NCT02251470|postural balance|postural balance
216636|NCT02251470|Nintendo|nintendo
216637|NCT02251470|balance board|balance board
216638|NCT02251470|Wii-Fit|wii-fit
216639|NCT02251470|home|home
216640|NCT02251470|feasibility|feasibility
216641|NCT02251457|Myotonia Congenita|myotonia congenita
216642|NCT02251457|ranolazine|ranolazine
216643|NCT02251457|Ohio State|ohio state
216644|NCT02251457|Open Label|open label
216645|NCT02251457|Paramyotonia Congenita|paramyotonia congenita
216646|NCT02251457|Myotonic Dystrophy 1|myotonic dystrophy 1
216647|NCT02251431|diabetes mellitus|diabetes mellitus
216648|NCT02251431|chronic kidney disease|chronic kidney disease
216649|NCT02251431|diastolic function|diastolic function
216650|NCT02251431|cardiac fibrosis|cardiac fibrosis
216651|NCT02251431|cardiac strain|cardiac strain
216652|NCT02251431|cardiac biomarker|cardiac biomarker
216653|NCT02251431|renal biomarker|renal biomarker
216654|NCT02251418|Foot ulcer, diabetic|foot ulcer, diabetic
216655|NCT02251418|ESWT (Extracorporeal Shockwave Therapy)|eswt (extracorporeal shockwave therapy)
216656|NCT02251418|Endocrinology|endocrinology
216657|NCT02251418|Dermatology|dermatology
216658|NCT02251418|Wound healing|wound healing
216659|NCT02251418|Ischemia|ischemia
216660|NCT02251418|Neovascularization, Physiologic|neovascularization, physiologic
216661|NCT02251418|Pain management|pain management
216662|NCT02251405|Melamine|melamine
216663|NCT02251405|Melamine tableware|melamine tableware
216664|NCT02251392|chamomilla|chamomilla
216665|NCT02251392|matricaria|matricaria
216666|NCT02251392|chamomile|chamomile
216667|NCT02251392|chamomila|chamomila
216668|NCT02251392|recutita|recutita
216669|NCT02251392|Breast Neoplasms|breast neoplasms
216670|NCT02251392|head and neck neoplasms|head and neck neoplasms
216671|NCT02251392|radiotherapy|radiotherapy
216672|NCT02251366|Age-Related Macular Degeneration|age-related macular degeneration
216673|NCT02251353|breast cancer, intervention to metastasis|breast cancer, intervention to metastasis
216674|NCT02251314|BRAF mutant melanoma|braf mutant melanoma
216675|NCT02251314|circulation tumour DNA|circulation tumour dna
216676|NCT02251314|tumour heterogeneity|tumour heterogeneity
216677|NCT02251314|liquid biopsy|liquid biopsy
216678|NCT02251288|H7N9 pandemic|h7n9 pandemic
216679|NCT02251288|inactivated influenza vaccine (pIIV)|inactivated influenza vaccine (piiv)
216680|NCT02251288|live attenuated influenza vaccine (pLAIV)|live attenuated influenza vaccine (plaiv)
216681|NCT02251288|MF59 adjuvant|mf59 adjuvant
216682|NCT02251275|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
216683|NCT02251262|Pacemaker|pacemaker
216684|NCT02251262|Endocarditis|endocarditis
216685|NCT02251262|18FDG-PET-CT|18fdg-pet-ct
216686|NCT02251262|Diagnostic accuracy|diagnostic accuracy
216687|NCT02251262|Pacing or defibrillation lead|pacing or defibrillation lead
216688|NCT02251236|Stribild|stribild
216689|NCT02251236|Genvoya|genvoya
216690|NCT02251236|elvitegravir|elvitegravir
216691|NCT02251236|Cerebrospinal Fluid|cerebrospinal fluid
216692|NCT02251236|HIV|hiv
216693|NCT02251093|mycosis|mycosis
216694|NCT02251093|vulvovaginal candidiasis|vulvovaginal candidiasis
216695|NCT02251093|lcr35|lcr35
216696|NCT02251093|Lcr Regenerans®|lcr regenerans®
216697|NCT02251080|adherence|adherence
216698|NCT02251080|internet-based|internet-based
216699|NCT02251054|Overactive Bladder|overactive bladder
216700|NCT02251054|Multimedia|multimedia
216701|NCT02251054|Behavioral Therapy|behavioral therapy
216702|NCT02251041|Liver|liver
216703|NCT02251041|Transplantation|transplantation
216704|NCT02251041|Ischemia-reperfusion|ischemia-reperfusion
216705|NCT02251041|Effectiveness|effectiveness
216706|NCT02251028|whiplash, prevention, pain, cognitive-behavioural therapy|whiplash, prevention, pain, cognitive-behavioural therapy
216707|NCT02251015|Postural balance|postural balance
216708|NCT02251015|Temporomandibular disorders|temporomandibular disorders
216709|NCT02251015|splints|splints
216710|NCT02250989|Endothelial disfunction|endothelial disfunction
216711|NCT02250989|Intercellular Adhesion Molecule-1|intercellular adhesion molecule-1
216712|NCT02250989|Vascular Cell Adhesion Molecule-1|vascular cell adhesion molecule-1
216713|NCT02250989|8-epi-prostaglandin F2alpha|8-epi-prostaglandin f2alpha
216714|NCT02250989|Nitric Oxide|nitric oxide
216715|NCT02250989|Plasminogen Activator Inhibitor 1|plasminogen activator inhibitor 1
216716|NCT02250989|Endothelin-1|endothelin-1
216717|NCT02250989|Tumor Necrosis Factor-alpha|tumor necrosis factor-alpha
216718|NCT02250989|Glucose|glucose
216719|NCT02250989|Insulin|insulin
216720|NCT02250989|C-peptide|c-peptide
216721|NCT02250989|C-reactive protein|c-reactive protein
216722|NCT02250989|3-nitrotyrosine|3-nitrotyrosine
216723|NCT02250963|Dobutamine Stress Echocardiography|dobutamine stress echocardiography
216724|NCT02250963|Computed tomography coronary angiography|computed tomography coronary angiography
216725|NCT02250950|self-determination theory|self-determination theory
216726|NCT02250950|motivational interviewing|motivational interviewing
216727|NCT02250950|exercise|exercise
216728|NCT02250950|physical activity|physical activity
216729|NCT02250937|Acute Myeloid Leukemia|acute myeloid leukemia
216730|NCT02250937|AML|aml
216731|NCT02250937|Myelodysplastic Syndrome|myelodysplastic syndrome
216732|NCT02250937|MDS|mds
216733|NCT02250937|Stem Cell Transplantation|stem cell transplantation
216734|NCT02250937|Busulfan|busulfan
216735|NCT02250937|Busulfex|busulfex
216736|NCT02250937|Myleran|myleran
216737|NCT02250937|Fludarabine|fludarabine
216738|NCT02250937|Fludarabine Phosphate|fludarabine phosphate
216739|NCT02250937|Fludara|fludara
216740|NCT02250937|Cladribine|cladribine
216741|NCT02250937|Leustatin|leustatin
216742|NCT02250937|2-CdA|2-cda
216743|NCT02250937|G-CSF|g-csf
216744|NCT02250937|Filgrastim|filgrastim
216745|NCT02250937|Neupogen|neupogen
216746|NCT02250937|Methotrexate|methotrexate
216747|NCT02250911|Caregivers of patients|caregivers of patients
216748|NCT02250911|CCC = Care for the Cancer Caregivers|ccc = care for the cancer caregivers
216749|NCT02250911|MCP-C = Meaning-Centered Psychotherapy for Cancer Caregivers|mcp-c = meaning-centered psychotherapy for cancer caregivers
216750|NCT02250911|14-208|14-208
216751|NCT02250898|Post Breast Surgery|post breast surgery
216752|NCT02250898|Myofascial Massage|myofascial massage
216753|NCT02250898|Pain|pain
216754|NCT02250898|Mobility Limitations|mobility limitations
216755|NCT02250885|Selinexor|selinexor
216756|NCT02250885|phase 2|phase 2
216757|NCT02250885|Gabrail|gabrail
216758|NCT02250872|Cisplatin|cisplatin
216759|NCT02250872|Nephrotoxicity|nephrotoxicity
216760|NCT02250872|Gemigliptin|gemigliptin
216761|NCT02250872|DPP4 inhibitor|dpp4 inhibitor
216762|NCT02250846|EGFR mutations|egfr mutations
216763|NCT02250846|asymptomatic brain metastases|asymptomatic brain metastases
216764|NCT02250846|EGFR-TKI|egfr-tki
216765|NCT02250846|Erlotinib|erlotinib
216766|NCT02250833|Hypertension|hypertension
216767|NCT02250833|CKD-828|ckd-828
216768|NCT02250833|Telmisartan|telmisartan
216769|NCT02250833|S-amlodipine|s-amlodipine
216770|NCT02250833|Pharmacokinetic|pharmacokinetic
216771|NCT02250820|Pediatric|pediatric
216772|NCT02250820|Sedation|sedation
216773|NCT02250820|Transthoracic echocardiography|transthoracic echocardiography
216774|NCT02250820|TTE|tte
216775|NCT02250820|Dexmedetomidine|dexmedetomidine
216776|NCT02250820|Pentobarbital|pentobarbital
216777|NCT02250807|Chronic hepatitis C|chronic hepatitis c
216778|NCT02250807|Genotype 4 chronic hepatitis C|genotype 4 chronic hepatitis c
216779|NCT02250807|Simeprevir|simeprevir
216780|NCT02250807|Sofosbuvir|sofosbuvir
216781|NCT02250794|diabetes mellitus|diabetes mellitus
216782|NCT02250794|inpatient management|inpatient management
216783|NCT02250794|metformin|metformin
216784|NCT02250794|sitagliptin|sitagliptin
216785|NCT02250768|GM-CSF, repeated implantation failure|gm-csf, repeated implantation failure
216786|NCT02250755|MRI perfusion|mri perfusion
216787|NCT02250755|therapeutic response|therapeutic response
216788|NCT02250755|chemotherapy|chemotherapy
216789|NCT02250755|brain metastases|brain metastases
216790|NCT02250742|ultrasound imaging|ultrasound imaging
216791|NCT02250742|acupuncture|acupuncture
216792|NCT02250742|back muscles|back muscles
216793|NCT02250742|spine|spine
216794|NCT02250742|muscle strength|muscle strength
216795|NCT02250729|anaphylaxis|anaphylaxis
216796|NCT02250729|pholcodine|pholcodine
216797|NCT02250729|neuromuscular blocking agents|neuromuscular blocking agents
216798|NCT02250716|CIN1|cin1
216799|NCT02250716|HIV seropositive women|hiv seropositive women
216800|NCT02250716|Cryotherapy|cryotherapy
216801|NCT02250703|Premedication|premedication
216802|NCT02250690|idiopathic PD|idiopathic pd
216803|NCT02250690|Hoehn and Yahr stage I to III|hoehn and yahr stage i to iii
216804|NCT02250690|stable medication usage|stable medication usage
216805|NCT02250690|age 40 to 80 years|age 40 to 80 years
216806|NCT02250690|absence of cognitive impairment|absence of cognitive impairment
216807|NCT02250677|physical activity|physical activity
216808|NCT02250677|Statin therapy|statin therapy
216809|NCT02250677|cardiovascular disease|cardiovascular disease
216810|NCT02250677|diabetes mellitus|diabetes mellitus
216905|NCT02250209|Stage III|stage iii
216811|NCT02250664|Biomarkers of exposure|biomarkers of exposure
216812|NCT02250664|Compensatory smoking|compensatory smoking
216813|NCT02250664|Nicotine dependence|nicotine dependence
216814|NCT02250664|Reduced nicotine cigarettes|reduced nicotine cigarettes
216815|NCT02250664|Tobacco withdrawal|tobacco withdrawal
216816|NCT02250664|Women|women
216817|NCT02250664|Health disparities|health disparities
216818|NCT02250664|Vulnerable populations|vulnerable populations
216819|NCT02250612|SYL040012|syl040012
216820|NCT02250612|bamosiran|bamosiran
216821|NCT02250612|siRNA|sirna
216822|NCT02250612|RNAi|rnai
216823|NCT02250612|Glaucoma|glaucoma
216824|NCT02250612|Ocular hypertension|ocular hypertension
216825|NCT02250599|Metastatic Nasopharyngeal Carcinoma|metastatic nasopharyngeal carcinoma
216826|NCT02250599|treatment|treatment
216827|NCT02250586|concerned significant other|concerned significant other
216828|NCT02250586|internet-delivered cognitive-behavioral therapy,|internet-delivered cognitive-behavioral therapy,
216829|NCT02250586|treatment-refusing problem gambler|treatment-refusing problem gambler
216830|NCT02250534|Biomarkers of exposure|biomarkers of exposure
216831|NCT02250534|Compensatory smoking|compensatory smoking
216832|NCT02250534|Nicotine dependence|nicotine dependence
216833|NCT02250534|Reduced nicotine cigarettes|reduced nicotine cigarettes
216834|NCT02250534|Tobacco withdrawal|tobacco withdrawal
216835|NCT02250534|Women|women
216836|NCT02250534|Health disparities|health disparities
216837|NCT02250534|Vulnerable populations|vulnerable populations
216838|NCT02250521|BMI < 50 kg/m2|bmi < 50 kg/m2
216839|NCT02250521|Mallampatti class: III-IV|mallampatti class: iii-iv
216840|NCT02250521|Reduced mouth opening < 4 cm|reduced mouth opening < 4 cm
216841|NCT02250521|Neck circumference > 40 cm for females and > 43 cm for males|neck circumference > 40 cm for females and > 43 cm for males
216842|NCT02250521|Thyromental distance < 6 cm|thyromental distance < 6 cm
216843|NCT02250521|Ratio of the patient's height to thyromental distance ≥ 23.5|ratio of the patient's height to thyromental distance ≥ 23.5
216844|NCT02250521|Sternomental distance < 12 cm|sternomental distance < 12 cm
216845|NCT02250443|Inclusion Body Myositis (IBM)|inclusion body myositis (ibm)
216846|NCT02250430|acne|acne
216847|NCT02250365|stroke, acute|stroke, acute
216848|NCT02250365|upper extremity|upper extremity
216849|NCT02250365|rehabilitation|rehabilitation
216850|NCT02250365|electric stimulation therapy|electric stimulation therapy
216851|NCT02250339|Child Mental Health|child mental health
216852|NCT02250339|Parenting|parenting
216853|NCT02250339|Family Issues|family issues
216854|NCT02250326|Cancer of the lung|cancer of the lung
216855|NCT02250326|lung neoplasm|lung neoplasm
216856|NCT02250326|NSCLC - non-small cell lung cancer|nsclc - non-small cell lung cancer
216857|NCT02250326|Nonsquamou|nonsquamou
216858|NCT02250326|squamous|squamous
216859|NCT02250326|squamous NSCLC|squamous nsclc
216860|NCT02250326|Tumor|tumor
216861|NCT02250326|locally advanced NSCLC|locally advanced nsclc
216862|NCT02250326|metastatic NSCLC|metastatic nsclc
216863|NCT02250326|advanced lung cancer|advanced lung cancer
216864|NCT02250326|metastatic lung cancer|metastatic lung cancer
216865|NCT02250326|non-squamous NSCLC|non-squamous nsclc
216866|NCT02250326|lung cancer|lung cancer
216867|NCT02250326|Abraxane|abraxane
216868|NCT02250326|ABI-007|abi-007
216869|NCT02250326|nab-paclitaxel|nab-paclitaxel
216870|NCT02250326|albumin-bound paclitaxel|albumin-bound paclitaxel
216871|NCT02250326|taxanes|taxanes
216872|NCT02250326|CC-486|cc-486
216873|NCT02250326|oral azacitidine|oral azacitidine
216874|NCT02250326|azacitidine|azacitidine
216875|NCT02250326|second line treatment of lung cancer|second line treatment of lung cancer
216876|NCT02250326|second line treatment|second line treatment
216877|NCT02250326|Celgene|celgene
216878|NCT02250326|abound.2L|abound.2l
216879|NCT02250326|third line treatment|third line treatment
216880|NCT02250326|durvalumab|durvalumab
216881|NCT02250326|immunotherapy|immunotherapy
216882|NCT02250326|MEDI4736|medi4736
216883|NCT02250313|prostate cancer|prostate cancer
216884|NCT02250287|autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
216885|NCT02250287|magnetic resonance imaging parameters|magnetic resonance imaging parameters
216886|NCT02250287|magnetic resonance elastography|magnetic resonance elastography
216887|NCT02250287|apparent diffusion coefficient|apparent diffusion coefficient
216888|NCT02250287|blood oxygen level determinations|blood oxygen level determinations
216889|NCT02250287|diffusion weighted imaging|diffusion weighted imaging
216890|NCT02250274|Immune response to influenza vaccine|immune response to influenza vaccine
216891|NCT02250274|PCR confirmed Influenza A virus|pcr confirmed influenza a virus
216892|NCT02250274|PCR confirmed Influenza B virus|pcr confirmed influenza b virus
216893|NCT02250261|walking|walking
216894|NCT02250261|cycling|cycling
216895|NCT02250261|intervention|intervention
216896|NCT02250261|physical activity|physical activity
216897|NCT02250261|environment|environment
216898|NCT02250261|promotion|promotion
216899|NCT02250248|Degenerative disc disease|degenerative disc disease
216900|NCT02250248|Lumbar spine|lumbar spine
216901|NCT02250209|Gastric Cancer|gastric cancer
216902|NCT02250209|HER2-positive|her2-positive
216903|NCT02250209|Trastuzumab|trastuzumab
216904|NCT02250209|XELOX|xelox
216906|NCT02250209|D2 Gastrectomy|d2 gastrectomy
216907|NCT02250196|Bowel preparation|bowel preparation
216908|NCT02250196|Polyethylene glycol with ascorbic acid|polyethylene glycol with ascorbic acid
216909|NCT02250196|Sodium picosulfate with magnesium citrate|sodium picosulfate with magnesium citrate
216910|NCT02250183|Medihoney|medihoney
216911|NCT02250183|Santyl|santyl
216912|NCT02250183|Burns|burns
216913|NCT02250144|Patellofemoral pain syndrome|patellofemoral pain syndrome
216914|NCT02250144|Feet orthoses|feet orthoses
216915|NCT02250144|KOOS|koos
216916|NCT02250131|cardiopulmonary bypass|cardiopulmonary bypass
216917|NCT02250118|pleural|pleural
216918|NCT02250118|effusion|effusion
216919|NCT02250118|breast|breast
216920|NCT02250118|cancer|cancer
216921|NCT02250092|Cerebral Palsy|cerebral palsy
216922|NCT02250092|Hemiparesis|hemiparesis
216923|NCT02250092|Stroke|stroke
216924|NCT02250092|Non-Invasive Brain Stimulation|non-invasive brain stimulation
216925|NCT02250092|Transcranial Direct Current Stimulation|transcranial direct current stimulation
216926|NCT02250092|Constraint-Induced Movement Therapy|constraint-induced movement therapy
216927|NCT02250092|Diffusion Tensor Imaging|diffusion tensor imaging
216928|NCT02250092|Congenital Hemiparesis|congenital hemiparesis
216929|NCT02250092|Bimanual Therapy|bimanual therapy
216930|NCT02250053|stage II and stage III colon cancer survivors, who have completed curative treatment i.e., surgical resection and chemotherapy for their colon cancer|stage ii and stage iii colon cancer survivors, who have completed curative treatment i.e., surgical resection and chemotherapy for their colon cancer
216931|NCT02250040|Stroke|stroke
216932|NCT02250040|Rehabilitation|rehabilitation
216933|NCT02250040|Physiotherapy|physiotherapy
216934|NCT02250040|Functional Recovery|functional recovery
216935|NCT02250027|acute bronchitis|acute bronchitis
216936|NCT02250027|acute exacerbations of chronic bronchitis|acute exacerbations of chronic bronchitis
216937|NCT02250001|HCV|hcv
216938|NCT02249962|prospective|prospective
216939|NCT02249962|cohort|cohort
216940|NCT02249936|Volunteers|volunteers
216941|NCT02249923|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
216942|NCT02249923|Pulmonary Vascular Disease (PVD)|pulmonary vascular disease (pvd)
216943|NCT02249923|Registry|registry
216944|NCT02249923|Pediatric|pediatric
216945|NCT02249884|radiodermatitis|radiodermatitis
216946|NCT02249884|head and neck neoplasms|head and neck neoplasms
216947|NCT02249884|Breast Neoplasms|breast neoplasms
216948|NCT02249884|Urea|urea
216949|NCT02249884|Matricaria|matricaria
216950|NCT02249884|chamomilla|chamomilla
216951|NCT02249884|chamomile|chamomile
216952|NCT02249858|cervical spine|cervical spine
216953|NCT02249858|OMT|omt
216954|NCT02249858|HVLA|hvla
216955|NCT02249858|ultrasound|ultrasound
216956|NCT02249845|dehydration|dehydration
216957|NCT02249845|children|children
216958|NCT02249845|gastroenteritis|gastroenteritis
216959|NCT02249832|stroke|stroke
216960|NCT02249832|CVA|cva
216961|NCT02249832|cerebrovascular accident|cerebrovascular accident
216962|NCT02249832|cerebral stroke|cerebral stroke
216963|NCT02249832|robotic therapy|robotic therapy
216964|NCT02249832|anklebot|anklebot
216965|NCT02249832|physical therapy|physical therapy
216966|NCT02249819|stroke|stroke
216967|NCT02249819|aphasia|aphasia
216968|NCT02249819|CVA|cva
216969|NCT02249819|apraxia|apraxia
216970|NCT02249819|cerebrovascular accident|cerebrovascular accident
216971|NCT02249819|cerebral stroke|cerebral stroke
216972|NCT02249819|speech therapy|speech therapy
216973|NCT02249819|aphasia therapy|aphasia therapy
216974|NCT02249819|non-invasive brain stimulation|non-invasive brain stimulation
216975|NCT02249819|transcranial direct current stimulation|transcranial direct current stimulation
216976|NCT02249819|tDCS|tdcs
216977|NCT02249806|Pulmonary Hypertension|pulmonary hypertension
216978|NCT02249806|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
216979|NCT02249806|Pulmonary arterial hypertension|pulmonary arterial hypertension
216980|NCT02249806|Outcome|outcome
216981|NCT02249793|circadian|circadian
216982|NCT02249793|oscillation|oscillation
216983|NCT02249793|clock|clock
216984|NCT02249793|human|human
216985|NCT02249793|social behavior|social behavior
216986|NCT02249793|cell phone with internet access (so-called smartphone)|cell phone with internet access (so-called smartphone)
216987|NCT02249793|social sensing|social sensing
216988|NCT02249793|behavioral feature|behavioral feature
216989|NCT02249793|Ginger.io|ginger.io
216990|NCT02249793|blood pressure|blood pressure
216991|NCT02249793|metabolism|metabolism
216992|NCT02249793|metabolomics|metabolomics
216993|NCT02249793|gut bacteria|gut bacteria
216994|NCT02249793|microbiome|microbiome
216995|NCT02249780|Parathyroid gland angiography|parathyroid gland angiography
216996|NCT02249780|Parathyroid gland indocyanine green angiography|parathyroid gland indocyanine green angiography
216997|NCT02249780|Parathyroid gland indocyanine green fluoroscopy|parathyroid gland indocyanine green fluoroscopy
216998|NCT02249754|Nutrition education|nutrition education
216999|NCT02249754|Maternal counselling|maternal counselling
217000|NCT02249754|Complementary feeding|complementary feeding
217001|NCT02249754|Infant growth|infant growth
217002|NCT02249754|Micronutrients|micronutrients
217003|NCT02249754|Tanzania|tanzania
217004|NCT02249715|Parkinson|parkinson
217005|NCT02249715|TMS|tms
217006|NCT02249715|BNA|bna
217007|NCT02249702|trabectedin|trabectedin
217008|NCT02249702|uterine leiomyosarcoma|uterine leiomyosarcoma
217009|NCT02249676|Autologous mesenchymal stem cells|autologous mesenchymal stem cells
217010|NCT02249676|neuromyelitis optica|neuromyelitis optica
217011|NCT02249676|treatment|treatment
217012|NCT02249663|Bioequivalence|bioequivalence
217013|NCT02249650|metastatic colorectal cancer|metastatic colorectal cancer
217014|NCT02249650|TSB-9-W1|tsb-9-w1
217015|NCT02249624|Twin to twin transfusion syndrome|twin to twin transfusion syndrome
217016|NCT02249624|Developmental disabilities|developmental disabilities
217017|NCT02249624|Magnetic resonance imaging|magnetic resonance imaging
217018|NCT02249611|Physical activity|physical activity
217019|NCT02249611|mobile activity sensor and feedback system|mobile activity sensor and feedback system
217020|NCT02249611|self-management of health|self-management of health
217021|NCT02249572|Vestibular schwannoma|vestibular schwannoma
217022|NCT02249572|Radiosurgery|radiosurgery
217023|NCT02249572|Neurosurgery|neurosurgery
217024|NCT02249572|Randomized|randomized
217025|NCT02249533|Spot Light|spot light
217026|NCT02249533|High School RIO|high school rio
217027|NCT02249533|Concussion|concussion
217028|NCT02249533|Injury Prevention|injury prevention
217029|NCT02249533|Football|football
217030|NCT02249533|Pop Warner|pop warner
217031|NCT02249533|High School|high school
217032|NCT02249533|Middle School|middle school
217033|NCT02249520|Magnetic Resonance Imaging|magnetic resonance imaging
217034|NCT02249520|MRI|mri
217035|NCT02249520|Positron Emission Tomography|positron emission tomography
217036|NCT02249520|PET|pet
217037|NCT02249520|PET-MR|pet-mr
217038|NCT02249520|mMR|mmr
217039|NCT02249507|Resistant Hypertension|resistant hypertension
217040|NCT02249507|Aerobic Exercise|aerobic exercise
217041|NCT02249494|Nutritional Knowledge|nutritional knowledge
217042|NCT02249494|Nutritional Counseling|nutritional counseling
217043|NCT02249481|Anaesthetic|anaesthetic
217044|NCT02249481|total knee replacement|total knee replacement
217045|NCT02249481|Femoral nerve catheter|femoral nerve catheter
217046|NCT02249481|Adductor canal catheter|adductor canal catheter
217047|NCT02249429|Non Hodgkin Lymphoma|non hodgkin lymphoma
217048|NCT02249377|Baker's Cyst|baker's cyst
217049|NCT02249325|group B Streptococcus colonization|group b streptococcus colonization
217050|NCT02249325|Probiotic|probiotic
217051|NCT02249325|Pregnancy|pregnancy
217052|NCT02249299|ADHD,|adhd,
217053|NCT02249299|Cannabis,|cannabis,
217054|NCT02249299|Sativex,|sativex,
217055|NCT02249299|Endocannabinoid,|endocannabinoid,
217056|NCT02249299|Cognition|cognition
217057|NCT02249286|Child Centered Counseling|child centered counseling
217058|NCT02249286|Home based food production|home based food production
217059|NCT02249286|Nutrition|nutrition
217060|NCT02249286|Health|health
217061|NCT02249286|IYCF|iycf
217062|NCT02249260|Exercise, cardiac rehabilitation, quality of life|exercise, cardiac rehabilitation, quality of life
217063|NCT02249234|Scrotal pain|scrotal pain
217064|NCT02249234|Botox|botox
217065|NCT02249221|Influenza vaccine|influenza vaccine
217066|NCT02249221|Vaccination|vaccination
217067|NCT02249221|cell-culture based influenza vaccine|cell-culture based influenza vaccine
217068|NCT02249221|cell culture derived influenza vaccine|cell culture derived influenza vaccine
217069|NCT02249221|CCIV|cciv
217070|NCT02249208|Breast Cancer|breast cancer
217071|NCT02249208|Sentinel Lymph Node|sentinel lymph node
217072|NCT02249208|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
217073|NCT02249208|Clinically Node-Positive with biopsy-proven cN1|clinically node-positive with biopsy-proven cn1
217074|NCT02249208|False-negative Rate|false-negative rate
217075|NCT02249195|ECG loop recorder, pregnant women, arrhythmias|ecg loop recorder, pregnant women, arrhythmias
217076|NCT02249169|IBS|ibs
217077|NCT02249156|Health economics|health economics
217078|NCT02249156|Financial incentives|financial incentives
217079|NCT02249156|Health care spending|health care spending
217080|NCT02249143|Continuous positive airway pressure|continuous positive airway pressure
217081|NCT02249143|Prematurity|prematurity
217082|NCT02249143|Respiratory distress syndrome|respiratory distress syndrome
217083|NCT02249143|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
217084|NCT02249078|Crohn's Disease|crohn's disease
217085|NCT02249013|Ovarian Cancer|ovarian cancer
217086|NCT02248974|End-Stage Heart Failure|end-stage heart failure
217087|NCT02248974|Left Ventricular Assist Device|left ventricular assist device
217088|NCT02248974|Decision Aid|decision aid
217089|NCT02248974|Medical Decision-Making|medical decision-making
217090|NCT02248948|Omega-3|omega-3
217091|NCT02248948|ADHD|adhd
217092|NCT02248948|Quality of Life|quality of life
217093|NCT02248948|Inattention|inattention
217094|NCT02248948|Hyperactivity|hyperactivity
217095|NCT02248935|Robotic Assisted Laparoscopic Sacrocolpopexy|robotic assisted laparoscopic sacrocolpopexy
217096|NCT02248935|Y Mesh|y mesh
217097|NCT02248935|Pelvic Organ Prolapse|pelvic organ prolapse
217192|NCT02248623|Laryngoscopy|laryngoscopy
217193|NCT02248623|Intubation|intubation
217098|NCT02248922|Cystic Fibrosis, Pseudomonas aeruginosa, Lung Clearance Index, Multiple Breath Washout, Inhaled Tobramycin, Inhaled Antibiotics.|cystic fibrosis, pseudomonas aeruginosa, lung clearance index, multiple breath washout, inhaled tobramycin, inhaled antibiotics.
217099|NCT02248909|COPD, Primary Care, Spirometry, Risk factors|copd, primary care, spirometry, risk factors
217100|NCT02248870|femoral neck|femoral neck
217101|NCT02248857|UMS|ums
217102|NCT02248857|medication schedule|medication schedule
217103|NCT02248857|diabetes|diabetes
217104|NCT02248857|drug labeling|drug labeling
217105|NCT02248831|Dyspnea|dyspnea
217106|NCT02248831|Acute decompensated heart failure|acute decompensated heart failure
217107|NCT02248831|Doppler ultrasound|doppler ultrasound
217108|NCT02248831|Lung Doppler signals|lung doppler signals
217109|NCT02248805|colon cancer|colon cancer
217110|NCT02248805|colorectal carcinoma|colorectal carcinoma
217111|NCT02248805|stage IV colorectal cancer|stage iv colorectal cancer
217112|NCT02248779|Diabetes Risk|diabetes risk
217113|NCT02248779|14-202|14-202
217114|NCT02248753|Atrial fibrillation|atrial fibrillation
217115|NCT02248753|Electrical cardioversion|electrical cardioversion
217116|NCT02248753|Pharmacological cardioversion|pharmacological cardioversion
217117|NCT02248753|Rhythm control|rhythm control
217118|NCT02248753|Rate control|rate control
217119|NCT02248740|chronic venous insufficiency|chronic venous insufficiency
217120|NCT02248740|varicose vein|varicose vein
217121|NCT02248740|small saphenous vein|small saphenous vein
217122|NCT02248701|Testosterone|testosterone
217123|NCT02248701|Testosterone enanthate|testosterone enanthate
217124|NCT02248701|Testosterone undecanoate|testosterone undecanoate
217125|NCT02248701|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate
217126|NCT02248701|Methyltestosterone|methyltestosterone
217127|NCT02248701|Androgens|androgens
217128|NCT02248701|Hormones|hormones
217129|NCT02248701|Hormone Substitutes, and Hormone Antagonists|hormone substitutes, and hormone antagonists
217130|NCT02248701|Physiologic Effects of Drugs|physiologic effects of drugs
217131|NCT02248701|Pharmacologic Actions|pharmacologic actions
217132|NCT02248701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal
217133|NCT02248701|Antineoplastic Agents|antineoplastic agents
217134|NCT02248701|Therapeutic Uses|therapeutic uses
217135|NCT02248701|Anabolic Agents|anabolic agents
217136|NCT02248701|Testosterone Replacement Therapy|testosterone replacement therapy
217137|NCT02248701|Dual Energy X ray Absorptiometry|dual energy x ray absorptiometry
217138|NCT02248701|Lean Tissue Mass|lean tissue mass
217139|NCT02248701|Body Composition|body composition
217140|NCT02248701|Lipid and Glucose profile|lipid and glucose profile
217141|NCT02248701|Muscle Strength|muscle strength
217142|NCT02248701|5-alpha Reductase|5-alpha reductase
217143|NCT02248701|Muscle Mass|muscle mass
217144|NCT02248701|Bone Mineral Density|bone mineral density
217145|NCT02248701|Adipose Tissue|adipose tissue
217146|NCT02248701|Body Fat|body fat
217147|NCT02248701|Density, Bone|density, bone
217148|NCT02248701|Bone Formation|bone formation
217149|NCT02248701|Bone Resorption|bone resorption
217150|NCT02248701|Bone Density Conservation Agents|bone density conservation agents
217151|NCT02248701|Magnetic Resonance Imaging|magnetic resonance imaging
217152|NCT02248701|Muscle, Skeletal|muscle, skeletal
217153|NCT02248701|Bone and Bones|bone and bones
217154|NCT02248701|Gait|gait
217155|NCT02248701|Walking|walking
217156|NCT02248701|Locomotion|locomotion
217157|NCT02248701|Motor Activity|motor activity
217158|NCT02248688|Bariatric Embolization|bariatric embolization
217159|NCT02248688|Gastric Artery Emboliziation|gastric artery emboliziation
217160|NCT02248688|Left Gastric Artery Embolization|left gastric artery embolization
217161|NCT02248688|Morbid Obesity|morbid obesity
217162|NCT02248688|Obesity|obesity
217163|NCT02248688|Weight Loss|weight loss
217164|NCT02248688|Ghrelin|ghrelin
217165|NCT02248688|Embolization|embolization
217166|NCT02248675|sleep disorders|sleep disorders
217167|NCT02248675|insomnia|insomnia
217168|NCT02248675|suicidal ideation|suicidal ideation
217169|NCT02248675|Depression|depression
217170|NCT02248675|Depressive disorders|depressive disorders
217171|NCT02248675|PTSD|ptsd
217172|NCT02248675|anxiety disorders|anxiety disorders
217173|NCT02248675|suicide|suicide
217174|NCT02248675|cognitive behavioral therapy|cognitive behavioral therapy
217175|NCT02248662|DCIS|dcis
217176|NCT02248662|PCORI|pcori
217177|NCT02248662|ductal carcinoma in situ|ductal carcinoma in situ
217178|NCT02248662|radiation|radiation
217179|NCT02248662|oncology|oncology
217180|NCT02248662|patient-centered|patient-centered
217181|NCT02248662|decision aid|decision aid
217182|NCT02248662|decision-making|decision-making
217183|NCT02248649|Parkinson's disease|parkinson's disease
217184|NCT02248649|Exercise therapy|exercise therapy
217185|NCT02248649|Mild cognitive impairment|mild cognitive impairment
217186|NCT02248636|Alzheimer's disease|alzheimer's disease
217187|NCT02248636|Cholinesterase inhibitor|cholinesterase inhibitor
217188|NCT02248636|Discontinuation|discontinuation
217189|NCT02248623|Anaesthesia|anaesthesia
217190|NCT02248623|Isolated forearm test|isolated forearm test
217191|NCT02248623|Responsiveness|responsiveness
217194|NCT02248610|Pulmonary embolism|pulmonary embolism
217195|NCT02248610|PE|pe
217196|NCT02248610|Deep vein thrombosis|deep vein thrombosis
217197|NCT02248610|DVT|dvt
217198|NCT02248610|Rivaroxaban|rivaroxaban
217199|NCT02248610|Venous thromboembolism|venous thromboembolism
217200|NCT02248610|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
217201|NCT02248610|Post thrombotic limb syndrome|post thrombotic limb syndrome
217202|NCT02248610|Root cause analysis|root cause analysis
217203|NCT02248571|breast cancer|breast cancer
217204|NCT02248571|advanced|advanced
217205|NCT02248571|inoperable|inoperable
217206|NCT02248571|metastatic|metastatic
217207|NCT02248571|HER2/neu-negative|her2/neu-negative
217208|NCT02248571|hormone receptor positive|hormone receptor positive
217209|NCT02248571|HR+|hr+
217210|NCT02248571|female|female
217211|NCT02248571|postmenopausal|postmenopausal
217212|NCT02248558|Contest|contest
217213|NCT02248558|Crowdsourcing|crowdsourcing
217214|NCT02248558|Innovation|innovation
217215|NCT02248558|Randomized controlled trial|randomized controlled trial
217216|NCT02248558|China|china
217217|NCT02248558|Social entrepreneurship|social entrepreneurship
217218|NCT02248545|Non-Celiac Wheat Sensitivity|non-celiac wheat sensitivity
217219|NCT02248545|Autoimmune diseases|autoimmune diseases
217220|NCT02248545|Anti-nuclear antibodies|anti-nuclear antibodies
217221|NCT02248545|Celiac disease|celiac disease
217222|NCT02248545|Irritable bowel syndrome|irritable bowel syndrome
217223|NCT02248519|Gastric cancer|gastric cancer
217224|NCT02248519|Gastrectomy|gastrectomy
217225|NCT02248519|Laparoscopy|laparoscopy
217226|NCT02248506|Candidiasis|candidiasis
217227|NCT02248493|Pain, Postoperative|pain, postoperative
217228|NCT02248493|Paracetamol|paracetamol
217229|NCT02248493|Administration, Intravenous|administration, intravenous
217230|NCT02248493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
217231|NCT02248493|Child|child
217232|NCT02248493|Adolescent|adolescent
217233|NCT02248467|Testosterone replacement therapy|testosterone replacement therapy
217234|NCT02248428|multiple myeloma|multiple myeloma
217235|NCT02248428|Clarithromycin|clarithromycin
217236|NCT02248428|CTd|ctd
217237|NCT02248415|Cardioplegic Solutions|cardioplegic solutions
217238|NCT02248415|Myocardial Ischemia|myocardial ischemia
217239|NCT02248389|carcinoma, renal cell|carcinoma, renal cell
217240|NCT02248389|ablation|ablation
217241|NCT02248389|laparoscopic surgery|laparoscopic surgery
217242|NCT02248389|high intensity focused ultrasound|high intensity focused ultrasound
217243|NCT02248376|Uterine synechiae Scraping surgery Natural miscarriage|uterine synechiae scraping surgery natural miscarriage
217244|NCT02248363|Rehabilitation|rehabilitation
217245|NCT02248363|Effectiveness|effectiveness
217246|NCT02248363|Determinants|determinants
217247|NCT02248363|Prediction|prediction
217248|NCT02248350|prostate cancer|prostate cancer
217249|NCT02248350|physical activity|physical activity
217250|NCT02248350|exercise|exercise
217251|NCT02248350|intervention|intervention
217252|NCT02248350|side effects|side effects
217253|NCT02248350|androgen deprivation therapy|androgen deprivation therapy
217254|NCT02248337|Colon preparation; Colonoscopy; Inflammatory bowel disease|colon preparation; colonoscopy; inflammatory bowel disease
217255|NCT02248324|Age-related macular degeneration, genetic polymorphisms|age-related macular degeneration, genetic polymorphisms
217256|NCT02248298|Ablative fractional laser|ablative fractional laser
217257|NCT02248298|Actinic keratosis|actinic keratosis
217258|NCT02248298|Efficacy|efficacy
217259|NCT02248298|Photodynamic therapy|photodynamic therapy
217260|NCT02248298|Short incubation time|short incubation time
217261|NCT02248285|multiplex|multiplex
217262|NCT02248285|polymerase chain reaction|polymerase chain reaction
217263|NCT02248285|PCR|pcr
217264|NCT02248285|BioFire Diagnostics|biofire diagnostics
217265|NCT02248285|Infectious gastroenteritis|infectious gastroenteritis
217266|NCT02248285|Diarrheal disease|diarrheal disease
217267|NCT02248285|Emergency department|emergency department
217268|NCT02248285|rapid diagnostics|rapid diagnostics
217269|NCT02248285|FilmArray|filmarray
217270|NCT02248285|FilmArray GI Panel|filmarray gi panel
217271|NCT02248272|Polycystic ovary syndrome|polycystic ovary syndrome
217272|NCT02248272|Type 2 Diabetes|type 2 diabetes
217273|NCT02248272|Hyperinsulinemia|hyperinsulinemia
217274|NCT02248272|Meal frequency|meal frequency
217275|NCT02248246|Hemostasis|hemostasis
217276|NCT02248246|Harmonic ACE®+7 Shears|harmonic ace®+7 shears
217277|NCT02248246|Laparoscopic|laparoscopic
217278|NCT02248246|Inferior mesenteric artery|inferior mesenteric artery
217279|NCT02248246|Inferior mesenteric vein|inferior mesenteric vein
217280|NCT02248246|Observational|observational
217281|NCT02248233|nimodipine|nimodipine
217282|NCT02248233|acute massive cerebral infarction|acute massive cerebral infarction
217283|NCT02248233|Cerebral Infarction|cerebral infarction
217284|NCT02248233|optimal therapeutic time window|optimal therapeutic time window
217285|NCT02248233|optimal dose|optimal dose
217286|NCT02248233|multi-center|multi-center
217287|NCT02248194|Dysfunction uterine bleeding|dysfunction uterine bleeding
217288|NCT02248194|Hysteroscopic endometrial ablation|hysteroscopic endometrial ablation
217289|NCT02248194|Tactile endometrial ablation|tactile endometrial ablation
217290|NCT02248194|Hysteroscopic difficulties|hysteroscopic difficulties
217291|NCT02248194|Quality of life|quality of life
217292|NCT02248194|Satisfaction|satisfaction
217293|NCT02248090|Phase 1|phase 1
217294|NCT02248090|Safety|safety
217295|NCT02248090|Tolerability|tolerability
217296|NCT02248090|Pharmacokinetics|pharmacokinetics
217297|NCT02248090|Ascending Doses|ascending doses
217298|NCT02248090|Estrogen Receptor Positive|estrogen receptor positive
217299|NCT02248090|Her2 Negative|her2 negative
217300|NCT02248090|Advanced Breast Cancer|advanced breast cancer
217301|NCT02248064|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
217302|NCT02248064|Long term oxygen therapy|long term oxygen therapy
217303|NCT02248064|Auto-titrating oxygen system|auto-titrating oxygen system
217304|NCT02248064|Intelligent oxygen therapy|intelligent oxygen therapy
217305|NCT02248064|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
217306|NCT02248025|Fluid responsiveness|fluid responsiveness
217307|NCT02248025|capillary refill time|capillary refill time
217308|NCT02248025|microcirculation|microcirculation
217309|NCT02248025|circulatory failure|circulatory failure
217310|NCT02248025|passive leg raising|passive leg raising
217311|NCT02248012|Gastroenteropancreatic|gastroenteropancreatic
217312|NCT02248012|Neuroendocrine carcinoma|neuroendocrine carcinoma
217313|NCT02248012|Chemotherapy|chemotherapy
217314|NCT02247999|Cervical Cancer|cervical cancer
217315|NCT02247999|HIV/AIDS|hiv/aids
217316|NCT02247999|HPV|hpv
217317|NCT02247999|Biomarkers|biomarkers
217318|NCT02247999|Screening|screening
217319|NCT02247986|Conduct Disorder|conduct disorder
217320|NCT02247986|Methylphenidate|methylphenidate
217321|NCT02247986|Disruptive Behavior Disorders|disruptive behavior disorders
217322|NCT02247947|CPR|cpr
217323|NCT02247934|Primary sclerosing cholangitis|primary sclerosing cholangitis
217324|NCT02247934|PSC|psc
217325|NCT02247921|caregiver delivered rehabilitation|caregiver delivered rehabilitation
217326|NCT02247921|nurse-organized service|nurse-organized service
217327|NCT02247921|disabled stroke patients|disabled stroke patients
217328|NCT02247908|Cigarette smoking|cigarette smoking
217329|NCT02247908|Smoke|smoke
217330|NCT02247908|Smoking|smoking
217331|NCT02247908|Tobacco Use|tobacco use
217332|NCT02247895|ICU Acquired weakness|icu acquired weakness
217333|NCT02247895|Critical illness|critical illness
217334|NCT02247895|Mechanical ventilation|mechanical ventilation
217335|NCT02247882|Osteoarthritis|osteoarthritis
217336|NCT02247882|Patient Education|patient education
217337|NCT02247882|Aquatic Exercise|aquatic exercise
217338|NCT02247882|kinetic|kinetic
217339|NCT02247869|HL|hl
217340|NCT02247869|Hodgkin Lymphoma|hodgkin lymphoma
217341|NCT02247869|First line therapy|first line therapy
217342|NCT02247856|nebulizers,|nebulizers,
217343|NCT02247856|noninvasive ventilation|noninvasive ventilation
217344|NCT02247856|COPD|copd
217345|NCT02247856|scintigraphy,|scintigraphy,
217346|NCT02247856|aerosol|aerosol
217347|NCT02247843|Sickle Cell Disease (SCD)|sickle cell disease (scd)
217348|NCT02247843|Gene Therapy|gene therapy
217349|NCT02247843|Lentiviral Vector|lentiviral vector
217350|NCT02247843|Beta Globin|beta globin
217351|NCT02247830|Radiodermatitis|radiodermatitis
217352|NCT02247830|Head and neck neoplasms|head and neck neoplasms
217353|NCT02247830|Radiotherapy|radiotherapy
217354|NCT02247830|Urea|urea
217355|NCT02247830|Matricaria|matricaria
217356|NCT02247830|Breast Neoplasms|breast neoplasms
217357|NCT02247830|chamomilla|chamomilla
217358|NCT02247830|chamomile|chamomile
217359|NCT02247778|clavicle|clavicle
217360|NCT02247778|surgical intervention|surgical intervention
217361|NCT02247778|mini-incision|mini-incision
217362|NCT02247778|plate osteosynthesis|plate osteosynthesis
217363|NCT02247752|hepatitis|hepatitis
217364|NCT02247752|HBV|hbv
217365|NCT02247752|chronic hepatitis|chronic hepatitis
217366|NCT02247752|HCC|hcc
217367|NCT02247752|cirrhosis|cirrhosis
217368|NCT02247752|quantitative HBsAg|quantitative hbsag
217369|NCT02247752|HBsAg inactive carriers|hbsag inactive carriers
217370|NCT02247739|HAE|hae
217371|NCT02247739|Hereditary Angioedema|hereditary angioedema
217372|NCT02247739|Prophylaxis|prophylaxis
217373|NCT02247726|RSV|rsv
217374|NCT02247726|Third Trimester|third trimester
217375|NCT02247726|Maternal Immunization|maternal immunization
217376|NCT02247713|PET|pet
217377|NCT02247713|radiotherapy|radiotherapy
217378|NCT02247713|international|international
217379|NCT02247713|NSCLC|nsclc
217380|NCT02247713|overall survival|overall survival
217381|NCT02247713|low and middle income countries|low and middle income countries
217382|NCT02247700|Pediatrics|pediatrics
217383|NCT02247700|ARDS|ards
217384|NCT02247700|ARF|arf
217385|NCT02247700|ALI|ali
217386|NCT02247700|Respiratory|respiratory
217387|NCT02247700|Mechanical ventilation|mechanical ventilation
217388|NCT02247700|Ventilation|ventilation
217389|NCT02247700|Noninvasive monitoring|noninvasive monitoring
217390|NCT02247700|electrical impedance tomography|electrical impedance tomography
217391|NCT02247700|EIT|eit
217392|NCT02247687|HIV-1|hiv-1
217393|NCT02247687|antiretroviral treatment|antiretroviral treatment
217394|NCT02247687|viral load|viral load
217395|NCT02247674|Stroke, Cerebrovascular accident, Rehabilitation, Upper extremity|stroke, cerebrovascular accident, rehabilitation, upper extremity
217396|NCT02247661|Femoral neck fracture,surgical approach, limp, abductor strenght, trochanteric pain|femoral neck fracture,surgical approach, limp, abductor strenght, trochanteric pain
217397|NCT02247648|tramadol|tramadol
217398|NCT02247648|shoulder surgery|shoulder surgery
217399|NCT02247648|pain|pain
217400|NCT02247648|interscalen block|interscalen block
217401|NCT02247648|BUPRENORPHINE/HYDROMORPHONE [VA Drug Interaction]|buprenorphine/hydromorphone [va drug interaction]
217402|NCT02247635|Treatment adherence|treatment adherence
217403|NCT02247635|Behavioral model of health care|behavioral model of health care
217404|NCT02247635|Healthy lifestyle|healthy lifestyle
217405|NCT02247635|Chronic metabolic diseases|chronic metabolic diseases
217406|NCT02247635|Metabolic syndrome|metabolic syndrome
217407|NCT02247635|Obesity|obesity
217408|NCT02247622|telomeres|telomeres
217409|NCT02247622|PSC|psc
217410|NCT02247609|B cell lymphoma|b cell lymphoma
217411|NCT02247609|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
217412|NCT02247609|Burkitt lymphoma|burkitt lymphoma
217413|NCT02247609|diffused large B cell lymphoma|diffused large b cell lymphoma
217414|NCT02247609|B cell malignancy|b cell malignancy
217415|NCT02247596|Resveratrol|resveratrol
217416|NCT02247596|obesity|obesity
217417|NCT02247596|insulin resistance|insulin resistance
217418|NCT02247596|energy expenditure|energy expenditure
217419|NCT02247596|diabetes|diabetes
217420|NCT02247570|Vestibular Rehabilitation|vestibular rehabilitation
217421|NCT02247570|PTSD|ptsd
217422|NCT02247570|DSM-IV|dsm-iv
217423|NCT02247557|IC/PBS|ic/pbs
217424|NCT02247557|VAS|vas
217425|NCT02247557|Botulinum Toxin A|botulinum toxin a
217426|NCT02247557|Lipotoxin|lipotoxin
217427|NCT02247544|STS, leiomyosarcoma, liposarcoma, trabectedin|sts, leiomyosarcoma, liposarcoma, trabectedin
217428|NCT02247518|Male|male
217429|NCT02247518|Volunteers|volunteers
217430|NCT02247492|International|international
217431|NCT02247492|Multicenter|multicenter
217432|NCT02247492|Observational registry|observational registry
217433|NCT02247492|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
217434|NCT02247492|Stenting|stenting
217435|NCT02247492|Treatment of coronary artery disease|treatment of coronary artery disease
217436|NCT02247492|Coronary revascularization|coronary revascularization
217560|NCT02247050|Reminder Systems|reminder systems
217437|NCT02247492|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
217439|NCT02247492|NSTEMI|nstemi
217440|NCT02247492|Ischemia|ischemia
217441|NCT02247492|Angina|angina
217442|NCT02247492|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
217443|NCT02247492|Small Vessels|small vessels
217444|NCT02247492|Chronic Total Occlusion (CTO|chronic total occlusion (cto
217445|NCT02247466|Neuromuscular Blockade|neuromuscular blockade
217446|NCT02247466|Laparoscopy|laparoscopy
217447|NCT02247453|lung cancer|lung cancer
217448|NCT02247453|clinical trial|clinical trial
217449|NCT02247453|screening|screening
217450|NCT02247453|microRNA|microrna
217451|NCT02247453|biomarkers|biomarkers
217452|NCT02247440|HCV|hcv
217453|NCT02247440|HIV|hiv
217454|NCT02247440|Thailand|thailand
217455|NCT02247440|pegylated interferon|pegylated interferon
217456|NCT02247440|ribavirin|ribavirin
217457|NCT02247427|Heart failure|heart failure
217458|NCT02247427|Super responder|super responder
217459|NCT02247414|Cirrhosis|cirrhosis
217460|NCT02247414|Hypertension|hypertension
217461|NCT02247414|venous thrombosis|venous thrombosis
217462|NCT02247414|Warfarin|warfarin
217463|NCT02247414|Splenectomy|splenectomy
217464|NCT02247414|Azygoportal Disconnection|azygoportal disconnection
217465|NCT02247414|Laparoscopy|laparoscopy
217466|NCT02247401|Genotype 4|genotype 4
217467|NCT02247401|non-responder|non-responder
217468|NCT02247401|treatment experienced|treatment experienced
217469|NCT02247401|HCV|hcv
217470|NCT02247401|naive|naive
217471|NCT02247401|relapser|relapser
217472|NCT02247401|hepatitis infection|hepatitis infection
217473|NCT02247401|compensated cirrhosis|compensated cirrhosis
217474|NCT02247401|hepatitis c|hepatitis c
217475|NCT02247401|Cirrhosis|cirrhosis
217476|NCT02247401|Egypt|egypt
217477|NCT02247401|null responder|null responder
217478|NCT02247401|partial responder|partial responder
217479|NCT02247388|Alcohol Dependence|alcohol dependence
217480|NCT02247388|Alcoholism|alcoholism
217481|NCT02247388|AB-CASI|ab-casi
217482|NCT02247388|Emergency Department|emergency department
217483|NCT02247362|Safety|safety
217484|NCT02247362|Immunogenicity|immunogenicity
217485|NCT02247336|colorectal cancer|colorectal cancer
217486|NCT02247336|early detection of cancer|early detection of cancer
217487|NCT02247297|Pancreatic stone protein (PSP)|pancreatic stone protein (psp)
217488|NCT02247297|premature rupture of membranes (PPROM)|premature rupture of membranes (pprom)
217489|NCT02247297|amniotic infection syndrome (AIS)|amniotic infection syndrome (ais)
217583|NCT02247037|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
217490|NCT02247297|hemolysis, elevated liver enzymes, and low platelets (HELLP)|hemolysis, elevated liver enzymes, and low platelets (hellp)
217491|NCT02247297|preeclampsia|preeclampsia
217492|NCT02247297|pregnancy|pregnancy
217493|NCT02247271|peer coaches|peer coaches
217494|NCT02247245|CHF|chf
217495|NCT02247245|AF|af
217496|NCT02247245|SR|sr
217497|NCT02247245|HFREF|hfref
217498|NCT02247245|CRT|crt
217499|NCT02247219|Health education|health education
217500|NCT02247219|Health services research|health services research
217501|NCT02247206|Tourette Syndrome|tourette syndrome
217502|NCT02247206|tic disorders|tic disorders
217503|NCT02247206|behavior therapy|behavior therapy
217504|NCT02247206|web-based videoconferencing|web-based videoconferencing
217505|NCT02247206|VoIP|voip
217506|NCT02247193|Botulinum Toxin|botulinum toxin
217507|NCT02247193|Botox|botox
217508|NCT02247193|Craniofacial deformity|craniofacial deformity
217509|NCT02247167|obstructive sleep apnoea, oxidative stress, FMD|obstructive sleep apnoea, oxidative stress, fmd
217510|NCT02247128|Transcatheter Aortic Valve Implantation (TAVI)|transcatheter aortic valve implantation (tavi)
217511|NCT02247128|Transcatheter Aortic Valve Replacement (TAVR)|transcatheter aortic valve replacement (tavr)
217512|NCT02247128|Aortic Valve Disease|aortic valve disease
217513|NCT02247128|Aortic Stenosis|aortic stenosis
217514|NCT02247128|Myocardial Infarction|myocardial infarction
217515|NCT02247128|Ischemic stroke|ischemic stroke
217516|NCT02247128|Bleeding|bleeding
217517|NCT02247128|Thrombosis|thrombosis
217518|NCT02247128|Myocardial Ischemia|myocardial ischemia
217519|NCT02247128|Heart Diseases|heart diseases
217520|NCT02247128|Cardiovascular Diseases|cardiovascular diseases
217521|NCT02247128|Vascular Diseases|vascular diseases
217522|NCT02247128|Embolism and Thrombosis|embolism and thrombosis
217523|NCT02247128|Aspirin|aspirin
217524|NCT02247128|Clopidogrel|clopidogrel
217525|NCT02247128|Prasugrel|prasugrel
217526|NCT02247128|Ticagrelor|ticagrelor
217527|NCT02247128|Antithrombotic treatment|antithrombotic treatment
217528|NCT02247128|Oral anticoagulation|oral anticoagulation
217529|NCT02247128|Warfarin|warfarin
217530|NCT02247128|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
217531|NCT02247128|Genetic Testing|genetic testing
217532|NCT02247128|Cytochrome P450 2C19 (CYP2C19)|cytochrome p450 2c19 (cyp2c19)
217533|NCT02247128|Prostaglandin-endoperoxide synthase 2(PTGS2)|prostaglandin-endoperoxide synthase 2(ptgs2)
217534|NCT02247115|endoscopic ultrasound|endoscopic ultrasound
217535|NCT02247115|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
217536|NCT02247115|competency|competency
217537|NCT02247089|Night Shift work|night shift work
217538|NCT02247089|Stress|stress
217539|NCT02247089|Autonomic nervous system (ANS)|autonomic nervous system (ans)
217540|NCT02247089|Heart rate variability (HRV)|heart rate variability (hrv)
217541|NCT02247089|Pre-ejection period (PEP)|pre-ejection period (pep)
217542|NCT02247089|Inflammation|inflammation
217543|NCT02247089|Pro-inflammatory cytokines|pro-inflammatory cytokines
217544|NCT02247089|Massage Therapy|massage therapy
217545|NCT02247050|Costs and Cost Analysis|costs and cost analysis
217546|NCT02247050|Professional Practice|professional practice
217547|NCT02247050|Attitude of Health Personnel|attitude of health personnel
217548|NCT02247050|Health Knowledge, Attitudes, and Practice|health knowledge, attitudes, and practice
217549|NCT02247050|Decision Making|decision making
217550|NCT02247050|Practice Guidelines as Topic|practice guidelines as topic
217551|NCT02247050|Physician-Patient Relations|physician-patient relations
217552|NCT02247050|Physician's Role|physician's role
217553|NCT02247050|Health Care|health care
217554|NCT02247050|Quality of Health Care|quality of health care
217555|NCT02247050|Quality Assurance|quality assurance
217556|NCT02247050|Physicians, Primary Care|physicians, primary care
217557|NCT02247050|Evidence-Based Medicine|evidence-based medicine
217558|NCT02247050|Evidence-Based Practice|evidence-based practice
217559|NCT02247050|Decision Support Systems, Clinical|decision support systems, clinical
217561|NCT02247050|Judgment|judgment
217562|NCT02247050|Cognition|cognition
217563|NCT02247050|Patient Care|patient care
217564|NCT02247050|Health Services Misuse|health services misuse
217565|NCT02247050|Unnecessary Procedures|unnecessary procedures
217566|NCT02247050|Prescribing Patterns, Physician|prescribing patterns, physician
217567|NCT02247050|Inappropriate Prescribing|inappropriate prescribing
217568|NCT02247050|Over Prescribing|over prescribing
217569|NCT02247050|Low Back Pain|low back pain
217570|NCT02247050|Sinusitis|sinusitis
217571|NCT02247050|Infections, Upper Respiratory|infections, upper respiratory
217572|NCT02247050|Generalized Headache|generalized headache
217573|NCT02247050|Imaging, Diagnostic|imaging, diagnostic
217574|NCT02247050|Antibiotics|antibiotics
217575|NCT02247050|Humans|humans
217576|NCT02247050|Overuse of Low-Value Services|overuse of low-value services
217577|NCT02247050|Pragmatic Trial|pragmatic trial
217578|NCT02247050|Stepped Wedge Design|stepped wedge design
217579|NCT02247050|Cluster Randomized Trial|cluster randomized trial
217580|NCT02247050|Choosing Wisely|choosing wisely
217581|NCT02247037|Triple Negative Breast Cancer|triple negative breast cancer
217582|NCT02247037|Patient Derived Xenograft|patient derived xenograft
217584|NCT02247037|Therapeutic Resistance|therapeutic resistance
217585|NCT02247011|bone mineral density|bone mineral density
217586|NCT02247011|25(OH)D|25(oh)d
217587|NCT02246985|Processed foods|processed foods
217588|NCT02246985|Carotenoids in plasma, urine and faeces|carotenoids in plasma, urine and faeces
217589|NCT02246985|alpha-carotene|alpha-carotene
217590|NCT02246985|beta-carotene|beta-carotene
217591|NCT02246985|Vitamin A|vitamin a
217592|NCT02246985|Lycopene|lycopene
217593|NCT02246985|Gut absorption|gut absorption
217594|NCT02246985|Bread|bread
217595|NCT02246985|Mayonnaise|mayonnaise
217596|NCT02246985|Bioavailability|bioavailability
217597|NCT02246985|Fruits and Vegetables|fruits and vegetables
217598|NCT02246985|Inflammation|inflammation
217599|NCT02246985|Oxidative Stress|oxidative stress
217600|NCT02246972|PTSD|ptsd
217601|NCT02246972|Military sexual trauma|military sexual trauma
217602|NCT02246972|Veterans|veterans
217603|NCT02246972|Women in the military|women in the military
217604|NCT02246972|Sexual assault|sexual assault
217605|NCT02246946|pleural effusion|pleural effusion
217606|NCT02246946|chest tube|chest tube
217607|NCT02246946|respiratory therapy|respiratory therapy
217608|NCT02246946|intermittent positive-pressure breathing|intermittent positive-pressure breathing
217609|NCT02246946|lung function|lung function
217610|NCT02246946|pulmonary complications|pulmonary complications
217611|NCT02246920|Bioequivalence|bioequivalence
217612|NCT02246920|Allergic Rhinitis|allergic rhinitis
217613|NCT02246907|Health related quality of life|health related quality of life
217614|NCT02246855|Subjects|subjects
217615|NCT02246842|Volunteers|volunteers
217616|NCT02246829|wet AMD, SD-OCT, intravitreal injection, central retinal thickness,|wet amd, sd-oct, intravitreal injection, central retinal thickness,
217617|NCT02246816|Short Bowel Syndrome|short bowel syndrome
217618|NCT02246816|SBS|sbs
217619|NCT02246816|Chronic Diarrhea|chronic diarrhea
217620|NCT02246816|Short Bowel|short bowel
217621|NCT02246816|Short Gut|short gut
217622|NCT02246816|Short Gut Syndrome|short gut syndrome
217623|NCT02246816|Anti-Diarrheal|anti-diarrheal
217624|NCT02246816|Opium Tincture|opium tincture
217625|NCT02246816|loperamide|loperamide
217626|NCT02246816|diphenoxylate|diphenoxylate
217627|NCT02246816|ileostomies|ileostomies
217628|NCT02246816|tincture of opium|tincture of opium
217629|NCT02246816|DTO|dto
217630|NCT02246816|codeine|codeine
217631|NCT02246816|morphine|morphine
217632|NCT02246816|opiate|opiate
217633|NCT02246803|paroxysmal atrial fibrillation, CABG, pulmonary vein isolation|paroxysmal atrial fibrillation, cabg, pulmonary vein isolation
217634|NCT02246790|ablation, CABG|ablation, cabg
217635|NCT02246790|Long-standing persistent Atrial Fibrillation|long-standing persistent atrial fibrillation
217636|NCT02246777|Glaucoma|glaucoma
217637|NCT02246764|Ocular hypertension.|ocular hypertension.
217638|NCT02246764|Glaucoma|glaucoma
217639|NCT02246751|postural control|postural control
217640|NCT02246751|Targeted Training|targeted training
217641|NCT02246751|cerebral palsy|cerebral palsy
217642|NCT02246751|sensorimotor control|sensorimotor control
217643|NCT02246751|trunk segments|trunk segments
217644|NCT02246725|Colorectal Neoplasms|colorectal neoplasms
217645|NCT02246725|Depression|depression
217646|NCT02246725|Intestinal Neoplasms|intestinal neoplasms
217647|NCT02246725|Gastrointestinal Neoplasms|gastrointestinal neoplasms
217648|NCT02246725|Digestive System Neoplasms|digestive system neoplasms
217649|NCT02246725|Digestive System Diseases|digestive system diseases
217650|NCT02246725|Gastrointestinal Diseases|gastrointestinal diseases
217651|NCT02246725|Intestinal Diseases|intestinal diseases
217652|NCT02246725|Palliative chemotherapy|palliative chemotherapy
217653|NCT02246725|Palliative care|palliative care
217654|NCT02246725|Palliative treatment|palliative treatment
217655|NCT02246725|Quality of life|quality of life
217656|NCT02246725|Quality of life for relatives|quality of life for relatives
217657|NCT02246725|Survival|survival
217658|NCT02246712|tramadol|tramadol
217659|NCT02246712|pharmacokinetics|pharmacokinetics
217660|NCT02246712|enantiomers|enantiomers
217661|NCT02246712|metabolism|metabolism
217662|NCT02246712|diabetes|diabetes
217663|NCT02246699|obesity|obesity
217664|NCT02246699|overweight|overweight
217665|NCT02246699|chitosan|chitosan
217666|NCT02246699|fungal chitosan|fungal chitosan
217667|NCT02246699|weight management|weight management
217668|NCT02246686|Iberogast N|iberogast n
217669|NCT02246686|Mild to moderate ulcerative colitis|mild to moderate ulcerative colitis
217670|NCT02246686|add-on therapy|add-on therapy
217671|NCT02246686|efficacy|efficacy
217672|NCT02246660|Peripheral Artery Disease|peripheral artery disease
217673|NCT02246660|Peripheral Arterial Disease|peripheral arterial disease
217674|NCT02246660|PAD|pad
217675|NCT02246634|Colorectal Neoplasms|colorectal neoplasms
217676|NCT02246634|Neoplasm Metastases|neoplasm metastases
217677|NCT02246634|Magnetic Resonance Imaging|magnetic resonance imaging
217678|NCT02246634|Diffusion Weighted MRI|diffusion weighted mri
217679|NCT02246634|Hepatic Neoplasms|hepatic neoplasms
217680|NCT02246634|Tumors|tumors
217681|NCT02246634|Neoplasms, Rectal|neoplasms, rectal
217682|NCT02246621|MONARCH 3|monarch 3
217683|NCT02246595|Sepsis|sepsis
217684|NCT02246595|Severe Sepsis|severe sepsis
217685|NCT02246595|Septic Shock|septic shock
217686|NCT02246595|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
217687|NCT02246595|Organ Dysfunction|organ dysfunction
217688|NCT02246582|Type 1 Diabetes|type 1 diabetes
217689|NCT02246582|Type 2 Diabetes|type 2 diabetes
217690|NCT02246582|Enlite 3|enlite 3
217691|NCT02246569|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
217692|NCT02246569|endoscopic lung volume reduction|endoscopic lung volume reduction
217693|NCT02246569|RePneu®Coils|repneu®coils
217694|NCT02246569|physical capacity|physical capacity
217695|NCT02246569|quality of life|quality of life
217696|NCT02246556|Amblyopia|amblyopia
217697|NCT02246556|Dichoptic|dichoptic
217698|NCT02246556|Virtual reality|virtual reality
217699|NCT02246556|Stereopsis|stereopsis
217700|NCT02246556|Stereo vision|stereo vision
217701|NCT02246556|Visual acuity|visual acuity
217702|NCT02246556|Binocular|binocular
217703|NCT02246543|Appetite|appetite
217704|NCT02246543|Gut Hormones|gut hormones
217705|NCT02246543|Protein|protein
217706|NCT02246543|Energy Density|energy density
217707|NCT02246543|Gastric Emptying|gastric emptying
217708|NCT02246465|Hypertrophic scar|hypertrophic scar
217709|NCT02246465|Cicatrix|cicatrix
217710|NCT02246465|Scar prevention|scar prevention
217711|NCT02246465|Scar revision|scar revision
217712|NCT02246452|Children and adolescents|children and adolescents
217713|NCT02246452|Cancer|cancer
217714|NCT02246452|Malnutrition|malnutrition
217715|NCT02246452|BMI percentile|bmi percentile
217716|NCT02246452|BMI-SDS|bmi-sds
217717|NCT02246439|Gastroenteritis|gastroenteritis
217718|NCT02246439|Gastritis|gastritis
217719|NCT02246439|Vomiting|vomiting
217720|NCT02246439|Nausea|nausea
217721|NCT02246439|Diarrhea|diarrhea
217722|NCT02246413|BMI|bmi
217723|NCT02246413|Depressive symptoms|depressive symptoms
217724|NCT02246413|Integrated therapy|integrated therapy
217725|NCT02246413|Cardiometabolic risk|cardiometabolic risk
217726|NCT02246413|Self-regulation|self-regulation
217727|NCT02246413|Behavior change|behavior change
217728|NCT02246413|Precision medicine|precision medicine
217729|NCT02246413|Lifestyle|lifestyle
217730|NCT02246400|eCMP|ecmp
217731|NCT02246400|eHealth|ehealth
217732|NCT02246400|mHealth|mhealth
217733|NCT02246400|Lifestyle intervention|lifestyle intervention
217734|NCT02246400|Cardiometabolic risk reduction|cardiometabolic risk reduction
217735|NCT02246400|PAMF|pamf
217736|NCT02246387|Pelvic Organ Prolapse|pelvic organ prolapse
217737|NCT02246387|Gynecologic Surgery Procedures|gynecologic surgery procedures
217738|NCT02246387|Treatment Outcome|treatment outcome
217739|NCT02246374|Parkinson's Disease|parkinson's disease
217740|NCT02246374|ExAblate|exablate
217741|NCT02246374|MRgFUS|mrgfus
217742|NCT02246361|Ankle sprain|ankle sprain
217743|NCT02246361|Infectious colitis|infectious colitis
217744|NCT02246361|Diverticulitis|diverticulitis
217745|NCT02246361|Pyelonephritis|pyelonephritis
217746|NCT02246361|Prostatitis|prostatitis
217747|NCT02246361|Pneumonitis|pneumonitis
217748|NCT02246361|Patient Information Leaflet (PIL)|patient information leaflet (pil)
217749|NCT02246361|Doctor Patient Communication|doctor patient communication
217750|NCT02246361|Adherence|adherence
217751|NCT02246361|Satisfaction|satisfaction
217752|NCT02246361|Scale|scale
217753|NCT02246361|Doctor Patient Communication scale|doctor patient communication scale
217754|NCT02246361|Adherence scale|adherence scale
217755|NCT02246361|Satisfaction scale|satisfaction scale
217756|NCT02246348|Systemic Sclerosis|systemic sclerosis
217757|NCT02246348|Pulmonary hypertension|pulmonary hypertension
217758|NCT02246348|Lung Doppler signals|lung doppler signals
217759|NCT02246322|Pancreatic cancer|pancreatic cancer
217760|NCT02246322|Neuroendocrine tumors|neuroendocrine tumors
217761|NCT02246322|Lymphadenopathies|lymphadenopathies
217762|NCT02246322|GIST|gist
217763|NCT02246322|Gastrointestinal wall neoplasia|gastrointestinal wall neoplasia
217764|NCT02246309|Infertility|infertility
217765|NCT02246309|Embryo Culture|embryo culture
217766|NCT02246309|Laboratory Technique|laboratory technique
217767|NCT02246296|severe acute malnutrition|severe acute malnutrition
217768|NCT02246296|wasting|wasting
217769|NCT02246296|kwashiorkor|kwashiorkor
217770|NCT02246296|nutrition|nutrition
217771|NCT02246296|feeding|feeding
217772|NCT02246296|milk|milk
217773|NCT02246283|schizophrenia|schizophrenia
217774|NCT02246283|elderly|elderly
217775|NCT02246283|lifelong|lifelong
217776|NCT02246283|quality of life|quality of life
217777|NCT02246283|register|register
217778|NCT02246283|questionaire|questionaire
217779|NCT02246218|Urea Cycle Disorder|urea cycle disorder
217780|NCT02246218|UCD|ucd
217781|NCT02246218|Buphenyl|buphenyl
217782|NCT02246218|Glycerol Phenylbutyrate|glycerol phenylbutyrate
217783|NCT02246218|Ravicti|ravicti
217784|NCT02246218|Hyperammonemia|hyperammonemia
217785|NCT02246218|Sodium Phenylbutyrate|sodium phenylbutyrate
217786|NCT02246218|GPB|gpb
217787|NCT02246218|HPN-100|hpn-100
217788|NCT02246205|pancreaticoduodenectomy|pancreaticoduodenectomy
217789|NCT02246205|delayed gastric emptying|delayed gastric emptying
217790|NCT02246205|Roux en-Y reconstruction|roux en-y reconstruction
217791|NCT02246179|Fractional laser|fractional laser
217792|NCT02246179|Topical anesthesia|topical anesthesia
217793|NCT02246179|Drug delivery|drug delivery
217794|NCT02246153|Laparoscopic gastrectomy|laparoscopic gastrectomy
217795|NCT02246153|Advanced gastric cancer|advanced gastric cancer
217796|NCT02246153|Elderly patients|elderly patients
217797|NCT02246153|Morbidity|morbidity
217798|NCT02246153|Mortality|mortality
217799|NCT02246127|advanced pNET|advanced pnet
217800|NCT02246127|everolimus|everolimus
217801|NCT02246127|STZ-5FU|stz-5fu
217802|NCT02246127|treatment sequence|treatment sequence
217803|NCT02246114|Pregnancy|pregnancy
217804|NCT02246114|Smoking|smoking
217805|NCT02246114|Smoking cessation|smoking cessation
217806|NCT02246101|cardiac disease|cardiac disease
217807|NCT02246101|cardiopulmonary disease|cardiopulmonary disease
217808|NCT02246101|renal disease|renal disease
217809|NCT02246101|albuminuria|albuminuria
217810|NCT02246101|cardiovascular disease|cardiovascular disease
217811|NCT02246101|CVD|cvd
217812|NCT02246101|particulate matter|particulate matter
217813|NCT02246088|Osteoarthritis, Central Nervous System Sensitization|osteoarthritis, central nervous system sensitization
217814|NCT02246075|Alzheimer's disease|alzheimer's disease
217815|NCT02246075|Cognition|cognition
217816|NCT02246075|Alpha-7 nAChR|alpha-7 nachr
217817|NCT02246062|Anxiety|anxiety
217818|NCT02246062|Anesthesia|anesthesia
217819|NCT02246062|Evaluation|evaluation
217820|NCT02246062|Preoperative care|preoperative care
217821|NCT02246062|Child|child
217822|NCT02246049|Metastatic colorectal cancer, bevacizumab, FOLFOXIRI|metastatic colorectal cancer, bevacizumab, folfoxiri
217823|NCT02246010|diarrhea|diarrhea
217824|NCT02246010|developing world|developing world
217825|NCT02246010|lactose-free diet|lactose-free diet
217826|NCT02246010|Clinical trial|clinical trial
217827|NCT02245997|Reduced-dose Radiotherapy|reduced-dose radiotherapy
217828|NCT02245997|14-186|14-186
217829|NCT02245984|clinical competence, nursing process, nursing student|clinical competence, nursing process, nursing student
217830|NCT02245945|HIV|hiv
217831|NCT02245945|prevention|prevention
217832|NCT02245932|Pulmonary disease, Chronic Obstructive|pulmonary disease, chronic obstructive
217833|NCT02245932|Cardiovascular diseases|cardiovascular diseases
217834|NCT02245932|Metabolism|metabolism
217835|NCT02245932|Resveratrol|resveratrol
217836|NCT02245919|Low Back Pain|low back pain
217837|NCT02245919|Chronic Pain|chronic pain
217838|NCT02245919|Cognitive Behavioral Therapy|cognitive behavioral therapy
217839|NCT02245919|Primary Health Care|primary health care
217840|NCT02245919|Physical Therapy|physical therapy
217841|NCT02245906|Brazilian fruit peel|brazilian fruit peel
217842|NCT02245906|Functional food|functional food
217843|NCT02245906|Cardiometabolic risk|cardiometabolic risk
217844|NCT02245906|Metabolic syndrome|metabolic syndrome
217845|NCT02245906|Inflammation|inflammation
217846|NCT02245906|Appetite|appetite
217847|NCT02245906|Gut hormone|gut hormone
217848|NCT02245880|cervical spine|cervical spine
217849|NCT02245880|intubating laryngeal mask airway|intubating laryngeal mask airway
217850|NCT02245880|Glidescope videolaryngoscope|glidescope videolaryngoscope
217851|NCT02245880|collar|collar
217852|NCT02245867|Amyloidosis|amyloidosis
217853|NCT02245867|Relapse|relapse
217854|NCT02245867|Refractory|refractory
217855|NCT02245854|diminutive polyps|diminutive polyps
217856|NCT02245854|small polyps|small polyps
217857|NCT02245854|cold snare polypectomy|cold snare polypectomy
217858|NCT02245854|complications|complications
217859|NCT02245854|bleeding|bleeding
217860|NCT02245841|dermatomyositis|dermatomyositis
217861|NCT02245841|Acthar gel|acthar gel
217862|NCT02245828|healthy subjects, inhaled|healthy subjects, inhaled
217863|NCT02245815|Necrotizing enterocolitis|necrotizing enterocolitis
217864|NCT02245815|Probiotics|probiotics
217865|NCT02245815|Secreting IgA|secreting iga
217866|NCT02245815|Preterm newborns|preterm newborns
217867|NCT02245802|Bleeding peptic ulcer|bleeding peptic ulcer
217868|NCT02245802|Prediction model|prediction model
217869|NCT02245802|Mortality|mortality
217870|NCT02245802|Prediction of in-hospital mortality for bleeding peptic ulcer|prediction of in-hospital mortality for bleeding peptic ulcer
217871|NCT02245776|Incurable Neurological Disorders|incurable neurological disorders
217872|NCT02245776|Autologous mononuclear cell therapy|autologous mononuclear cell therapy
217873|NCT02245776|Stem cells|stem cells
217874|NCT02245750|hysteroscopy - recurrent implantation failure|hysteroscopy - recurrent implantation failure
217875|NCT02245737|Alzheimer's disease|alzheimer's disease
217876|NCT02245737|Dementia|dementia
217877|NCT02245737|Brain Diseases|brain diseases
217878|NCT02245737|Neurogenerative Diseases|neurogenerative diseases
217879|NCT02245737|Central Nervous System Diseases|central nervous system diseases
217880|NCT02245737|Nervous System Diseases|nervous system diseases
217881|NCT02245737|Mental Disorders|mental disorders
217882|NCT02245737|Delirium, Dementia, Amnestic, Cognitive Disorders|delirium, dementia, amnestic, cognitive disorders
217883|NCT02245737|Tauopathies|tauopathies
217884|NCT02245724|Mental retardation|mental retardation
217885|NCT02245724|Autologous mononuclear cell therapy|autologous mononuclear cell therapy
217886|NCT02245724|Stem cell|stem cell
217887|NCT02245711|Limb Girdle Muscular Dystrophy|limb girdle muscular dystrophy
217888|NCT02245711|Autologous Bone Marrow Mononuclear cell therapy|autologous bone marrow mononuclear cell therapy
217889|NCT02245711|Stem Cell|stem cell
217890|NCT02245698|Chronic Stroke|chronic stroke
217891|NCT02245698|Subacute stroke|subacute stroke
217892|NCT02245698|Autologous Bone Marrow Mononuclear Cell therapy|autologous bone marrow mononuclear cell therapy
217893|NCT02245698|Stem cell|stem cell
217894|NCT02245685|Substitution Therapy|substitution therapy
217895|NCT02245685|Specialized Care Center for Addicts|specialized care center for addicts
217896|NCT02245672|Asthma|asthma
217897|NCT02245672|fluticasone|fluticasone
217898|NCT02245672|salmeterol|salmeterol
217899|NCT02245672|CRC749|crc749
217900|NCT02245672|Diskus|diskus
217901|NCT02245672|Advair|advair
217902|NCT02245672|FEV1|fev1
217903|NCT02245672|MGR001|mgr001
217904|NCT02245620|Skeletal muscle dysfunction, MTP-131, Bendavia™|skeletal muscle dysfunction, mtp-131, bendavia™
217905|NCT02245620|elamipretide|elamipretide
217906|NCT02245607|Psychotic Disorders|psychotic disorders
217907|NCT02245607|Cognitive Training|cognitive training
217908|NCT02245607|Mental Disorders|mental disorders
217909|NCT02245607|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
217910|NCT02245594|Gastrointestinal motility|gastrointestinal motility
217911|NCT02245594|Motility Tracking System (MTS)|motility tracking system (mts)
217912|NCT02245594|Transit time|transit time
217913|NCT02245594|Sleep pattern|sleep pattern
217914|NCT02245568|Dementia|dementia
217915|NCT02245568|Alzheimer Disease|alzheimer disease
217916|NCT02245568|bvFTD|bvftd
217917|NCT02245568|Frontotemporal Dementia|frontotemporal dementia
217918|NCT02245568|Neurodegenerative Diseases|neurodegenerative diseases
217919|NCT02245568|Brain Diseases|brain diseases
217920|NCT02245568|Cognitive Disorders|cognitive disorders
217921|NCT02245516|Intraretinal Fluid|intraretinal fluid
217922|NCT02245516|Subretinal Fluid|subretinal fluid
217923|NCT02245516|Retinal Vein Occlusion|retinal vein occlusion
217924|NCT02245516|Diabetic Macular Edema|diabetic macular edema
217925|NCT02245477|Serum VEGF, FGR|serum vegf, fgr
217926|NCT02245425|Neck pain|neck pain
217927|NCT02245425|Thoracic spine manipulation|thoracic spine manipulation
217928|NCT02245425|Range of Motion|range of motion
217929|NCT02245425|Disability|disability
217930|NCT02245412|GIGVHD|gigvhd
217931|NCT02245399|Weight loss|weight loss
217932|NCT02245399|Diabetes|diabetes
217933|NCT02245399|Cardiovascular disease (CVD) risk|cardiovascular disease (cvd) risk
217934|NCT02245399|Weight loss diet|weight loss diet
217935|NCT02245399|mediterranean type diet|mediterranean type diet
217936|NCT02245399|Canola oil|canola oil
217937|NCT02245399|Low-carbohydrate diet|low-carbohydrate diet
217938|NCT02245399|Glycemic index|glycemic index
217939|NCT02245373|Depression|depression
217940|NCT02245373|Primary Care|primary care
217941|NCT02245373|Cost-effectiveness|cost-effectiveness
217942|NCT02245373|Pharmacological treatment|pharmacological treatment
217943|NCT02245373|Watchful-waiting or Active Monitoring.|watchful-waiting or active monitoring.
217944|NCT02245360|GRAZAX|grazax
217946|NCT02245347|Tuberculosis|tuberculosis
217947|NCT02245347|MDR TB|mdr tb
217948|NCT02245347|Drug resistant TB|drug resistant tb
217949|NCT02245321|hemoglobin recovery|hemoglobin recovery
217950|NCT02245321|iron recovery|iron recovery
217951|NCT02245321|iron supplements|iron supplements
217952|NCT02245308|Tobacco use cessation|tobacco use cessation
217953|NCT02245308|Homelessness|homelessness
217954|NCT02245308|Veterans|veterans
217955|NCT02245295|Bronchial endoscopy|bronchial endoscopy
217956|NCT02245295|ultrasound|ultrasound
217957|NCT02245295|EBUS|ebus
217958|NCT02245295|anesthesia|anesthesia
217959|NCT02245295|lung cancer|lung cancer
217960|NCT02245295|diagnosis including staging|diagnosis including staging
217961|NCT02245256|delirium|delirium
217962|NCT02245256|incidence|incidence
217963|NCT02245256|dexmedetomidine|dexmedetomidine
217964|NCT02245243|Hepatic Impairment, single dose, intravenous|hepatic impairment, single dose, intravenous
217965|NCT02245230|Hypertension|hypertension
217966|NCT02245230|Autonomic Nervous System|autonomic nervous system
217967|NCT02245230|Renin-Angiotensin System|renin-angiotensin system
217968|NCT02245230|Angiotensin (1-7)|angiotensin (1-7)
217969|NCT02245230|Ganglionic Blockers|ganglionic blockers
217970|NCT02245230|Trimethaphan|trimethaphan
217971|NCT02245230|Blood Pressure|blood pressure
217972|NCT02245230|Hemodynamics|hemodynamics
217973|NCT02245191|Vasopressor|vasopressor
217974|NCT02245191|Cesarian delivery|cesarian delivery
217975|NCT02245191|Hypotension|hypotension
217976|NCT02245191|Maternal cardiac output|maternal cardiac output
217977|NCT02245191|Uteroplacental blood flow|uteroplacental blood flow
217978|NCT02245191|Cerebral fetal blood flow|cerebral fetal blood flow
217979|NCT02245191|Preeclampsia|preeclampsia
217980|NCT02245165|Nitric oxide|nitric oxide
217981|NCT02245165|Nitric oxide synthase|nitric oxide synthase
218677|NCT02241655|Delirium|delirium
217982|NCT02245165|Gastrointestinal motility|gastrointestinal motility
217983|NCT02245165|Gut peptide hormones|gut peptide hormones
217984|NCT02245152|child acute malnutrition|child acute malnutrition
217985|NCT02245152|prevention|prevention
217986|NCT02245152|behavior change communication|behavior change communication
217987|NCT02245152|lipid-based nutrient supplement|lipid-based nutrient supplement
217988|NCT02245152|screening coverage|screening coverage
217989|NCT02245139|diarrhea|diarrhea
217990|NCT02245139|vomiting|vomiting
217991|NCT02245139|fever|fever
217992|NCT02245139|abdominal pain|abdominal pain
217993|NCT02245139|oliguria|oliguria
217994|NCT02245126|Pain, Visual analogue scale|pain, visual analogue scale
217995|NCT02245087|atorvastatin|atorvastatin
217996|NCT02245087|coronary artery disease|coronary artery disease
217997|NCT02245087|myocardial infarction|myocardial infarction
217998|NCT02245087|stroke|stroke
217999|NCT02245087|revascularization|revascularization
218000|NCT02245074|Infantile asthma|infantile asthma
218001|NCT02245074|Induced sputum|induced sputum
218002|NCT02245074|Phenotypes|phenotypes
218003|NCT02245074|Eosinophils|eosinophils
218004|NCT02245074|Neutrophils|neutrophils
218005|NCT02245061|pharmacoresistant focal epilepsy|pharmacoresistant focal epilepsy
218006|NCT02245061|cortical excitability|cortical excitability
218007|NCT02245061|paired pulses|paired pulses
218008|NCT02245061|TMS|tms
218009|NCT02245061|SEEG|seeg
218010|NCT02245061|DES|des
218011|NCT02245048|Cardiovascular Risk Stratification|cardiovascular risk stratification
218012|NCT02245048|Carotid intima-media thickness (CIMT)|carotid intima-media thickness (cimt)
218013|NCT02245048|Stress echocardiography (SE)|stress echocardiography (se)
218014|NCT02245035|Glutathione|glutathione
218015|NCT02245035|Dairy consumption|dairy consumption
218016|NCT02245035|Brain|brain
218017|NCT02245035|Humans|humans
218018|NCT02245022|HIV|hiv
218019|NCT02245022|Prevention of mother to child transmission|prevention of mother to child transmission
218020|NCT02245022|Africa|africa
218021|NCT02245022|Uganda|uganda
218022|NCT02245022|Pharmacokinetics|pharmacokinetics
218023|NCT02245022|Pregnancy|pregnancy
218024|NCT02245022|Breastfeeding|breastfeeding
218025|NCT02244996|Retinitis pigmentosa|retinitis pigmentosa
218026|NCT02244996|Lycium barbarum|lycium barbarum
218027|NCT02244996|Antioxidation|antioxidation
218028|NCT02244996|Visual field|visual field
218029|NCT02244996|Electroretinogram|electroretinogram
218030|NCT02244970|Mindfulness|mindfulness
218031|NCT02244970|Depressive mood|depressive mood
218032|NCT02244970|anxiety|anxiety
218033|NCT02244970|early psychosis|early psychosis
218034|NCT02244944|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
218035|NCT02244944|NAFLD|nafld
218036|NCT02244931|Spinal cord injuries, paraplegic, manual wheelchairs, assisting propelling device|spinal cord injuries, paraplegic, manual wheelchairs, assisting propelling device
218037|NCT02244905|Positive Deviance|positive deviance
218038|NCT02244905|Infection Control|infection control
218039|NCT02244905|Healthcare-Associated Infections|healthcare-associated infections
218040|NCT02244905|Staff Engagement|staff engagement
218041|NCT02244905|Cluster Randomized Controlled Trial|cluster randomized controlled trial
218042|NCT02244892|Disability glare|disability glare
218043|NCT02244892|Corneal scar|corneal scar
218044|NCT02244892|Corneal haze|corneal haze
218045|NCT02244892|Scheimpflug densitometry|scheimpflug densitometry
218046|NCT02244892|Contrast sensitivity|contrast sensitivity
218047|NCT02244879|resveratrol|resveratrol
218048|NCT02244879|type 2 diabetes mellitus|type 2 diabetes mellitus
218049|NCT02244879|inflammation|inflammation
218050|NCT02244879|insulin resistance|insulin resistance
218051|NCT02244879|body composition|body composition
218052|NCT02244879|bone mass|bone mass
218053|NCT02244866|IVF|ivf
218054|NCT02244866|LH supplementation|lh supplementation
218055|NCT02244866|ovarian stimulation|ovarian stimulation
218056|NCT02244866|poor responder|poor responder
218057|NCT02244840|Bidet, Sitz bath, Anal resting pressure|bidet, sitz bath, anal resting pressure
218058|NCT02244814|glucose|glucose
218059|NCT02244814|insulin resistance|insulin resistance
218060|NCT02244814|dietary carbohydrate|dietary carbohydrate
218061|NCT02244814|dietary fat|dietary fat
218062|NCT02244814|adiposity|adiposity
218063|NCT02244814|Air displacement plethysmography|air displacement plethysmography
218064|NCT02244814|Dual X-ray Absorptiometry|dual x-ray absorptiometry
218065|NCT02244814|continuous glucose monitoring|continuous glucose monitoring
218066|NCT02244775|osteo-arthritis|osteo-arthritis
218067|NCT02244775|post traumatic arthritis|post traumatic arthritis
218068|NCT02244736|Arterial stiffness|arterial stiffness
218069|NCT02244736|Endothelial glycocalyx|endothelial glycocalyx
218070|NCT02244736|Coronary flow reserve|coronary flow reserve
218071|NCT02244723|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
218072|NCT02244723|diagnosis|diagnosis
218073|NCT02244710|Circulating Endothelial Cells|circulating endothelial cells
218074|NCT02244710|Endothelial Progenitor Cells|endothelial progenitor cells
218075|NCT02244710|Acute coronary syndrome (ACS)|acute coronary syndrome (acs)
218076|NCT02244710|Ticagrelor|ticagrelor
218077|NCT02244697|Stridor|stridor
218078|NCT02244697|Vocal Cord Paralysis (VCP)|vocal cord paralysis (vcp)
218079|NCT02244697|Ultrasound (US)|ultrasound (us)
218080|NCT02244684|Folate|folate
218081|NCT02244684|Folic Acid|folic acid
218082|NCT02244684|One-Carbon Nutrients|one-carbon nutrients
218083|NCT02244684|Epigenetics|epigenetics
218084|NCT02244684|Pregnancy|pregnancy
218085|NCT02244684|Fetal Health|fetal health
218086|NCT02244658|chemotherapy-induced thrombocytopenia|chemotherapy-induced thrombocytopenia
218087|NCT02244658|recombinant human thrombopoietin|recombinant human thrombopoietin
218088|NCT02244658|acute myelocytic leukemia|acute myelocytic leukemia
218089|NCT02244645|Low back pain, physical therapy, yoga.|low back pain, physical therapy, yoga.
218090|NCT02244632|Colorectal cancer|colorectal cancer
218091|NCT02244632|Colorectal carcinoma|colorectal carcinoma
218092|NCT02244632|Colorectal tumors|colorectal tumors
218093|NCT02244632|Intestinal Neoplasm|intestinal neoplasm
218094|NCT02244632|Gastrointestinal Neoplasm|gastrointestinal neoplasm
218095|NCT02244632|Gastrointestinal disease|gastrointestinal disease
218096|NCT02244632|5,10-methylenetetrahydrofolate|5,10-methylenetetrahydrofolate
218097|NCT02244632|Tetrahydrofolates|tetrahydrofolates
218098|NCT02244632|Therapeutic uses|therapeutic uses
218099|NCT02244632|Pharmacokinetics|pharmacokinetics
218100|NCT02244632|Pharmacodynamics|pharmacodynamics
218101|NCT02244632|Safety assessments|safety assessments
218102|NCT02244619|Hip replacement|hip replacement
218103|NCT02244619|Knee replacement|knee replacement
218104|NCT02244619|randomized trial|randomized trial
218105|NCT02244619|acetaminophen|acetaminophen
218106|NCT02244619|post-op pain management|post-op pain management
218107|NCT02244606|Invasive Candidiasis|invasive candidiasis
218108|NCT02244606|Invasive Candida infections|invasive candida infections
218109|NCT02244606|Candidemia|candidemia
218110|NCT02244606|SCY-078|scy-078
218111|NCT02244606|Micafungin|micafungin
218112|NCT02244606|Fluconazole|fluconazole
218113|NCT02244606|Echinocandin|echinocandin
218114|NCT02244593|breast cancer survivors|breast cancer survivors
218115|NCT02244593|FAST MRI|fast mri
218116|NCT02244593|mammography screening|mammography screening
218117|NCT02244580|Subtyping of Invasive breast cancer|subtyping of invasive breast cancer
218118|NCT02244567|PCOS|pcos
218119|NCT02244554|tattoo removal|tattoo removal
218120|NCT02244554|Q-switched laser|q-switched laser
218121|NCT02244554|Nd:YAG laser|nd:yag laser
218122|NCT02244554|nanosecond laser|nanosecond laser
218123|NCT02244554|picosecond laser|picosecond laser
218124|NCT02244554|laser therapy|laser therapy
218125|NCT02244554|tattoo|tattoo
218126|NCT02244554|pulsed-laser|pulsed-laser
218127|NCT02244554|laser treatment|laser treatment
218128|NCT02244554|remove tattoo|remove tattoo
218129|NCT02244554|tattoo clearing|tattoo clearing
218130|NCT02244554|tattoo lightening|tattoo lightening
218131|NCT02244554|tattoo lighten|tattoo lighten
218132|NCT02244554|resistant tattoo|resistant tattoo
218133|NCT02244515|children|children
218134|NCT02244502|Ovarian Carcinoma|ovarian carcinoma
218135|NCT02244502|Treatment|treatment
218136|NCT02244502|Minimal toxicity|minimal toxicity
218137|NCT02244502|TTFields|ttfields
218138|NCT02244502|Tumor Treating Fields|tumor treating fields
218139|NCT02244502|Novocure|novocure
218140|NCT02244502|Paclitaxel|paclitaxel
218141|NCT02244502|Weekly paclitaxel|weekly paclitaxel
218142|NCT02244476|mouth feel|mouth feel
218143|NCT02244476|acoustic tribology|acoustic tribology
218144|NCT02244476|vibration spectrum|vibration spectrum
218145|NCT02244476|sensory perception|sensory perception
218146|NCT02244463|Anaplastic Thyroid Cancer|anaplastic thyroid cancer
218147|NCT02244463|Thyroid Cancer|thyroid cancer
218148|NCT02244450|Neonatal screening|neonatal screening
218149|NCT02244450|severe combined immunodeficiency|severe combined immunodeficiency
218150|NCT02244450|T-cell Receptor Excision Circle|t-cell receptor excision circle
218151|NCT02244437|altitude, altitude illnesses, headache|altitude, altitude illnesses, headache
218152|NCT02244424|Infant|infant
218153|NCT02244424|Obesity|obesity
218154|NCT02244424|Adolescent|adolescent
218155|NCT02244424|Social media|social media
218156|NCT02244424|Prevention|prevention
218157|NCT02244411|EQUAL|equal
218158|NCT02244411|Exercise|exercise
218159|NCT02244411|Diet|diet
218160|NCT02244411|Physical activity|physical activity
218161|NCT02244411|14-164|14-164
218162|NCT02244385|vascular disease|vascular disease
218163|NCT02244385|pregnancy|pregnancy
218164|NCT02244385|chronic hypertension|chronic hypertension
218165|NCT02244385|diabetes|diabetes
218166|NCT02244385|obesity|obesity
218167|NCT02244372|Cordyceps sinensis mycelium culture extract(Paecilomyces hepiali, CBG-CS-2)|cordyceps sinensis mycelium culture extract(paecilomyces hepiali, cbg-cs-2)
218168|NCT02244372|immunity|immunity
218169|NCT02244359|Shared Decision making|shared decision making
218170|NCT02244359|Patient Centred care|patient centred care
218171|NCT02244359|Interprofessionalism|interprofessionalism
218172|NCT02244359|Home care|home care
218173|NCT02244359|Frail elderly|frail elderly
218174|NCT02244164|Type 2 Diabetes|type 2 diabetes
218175|NCT02244164|Incretinomimetics|incretinomimetics
218678|NCT02241655|Falls|falls
218176|NCT02244164|DPP-4 inhibitors|dpp-4 inhibitors
218177|NCT02244164|Pancreas|pancreas
218178|NCT02244164|PanIN|panin
218179|NCT02244164|RMN|rmn
218180|NCT02244164|Lipasemia|lipasemia
218181|NCT02244151|ovulation induction,oocyte maturation timing and collection|ovulation induction,oocyte maturation timing and collection
218182|NCT02244138|Adolescent|adolescent
218183|NCT02244138|Screening|screening
218184|NCT02244138|Primary Care|primary care
218185|NCT02244138|Computer Decision Support Systems|computer decision support systems
218186|NCT02244125|Myeloma|myeloma
218187|NCT02244125|Multiple Myeloma|multiple myeloma
218188|NCT02244125|Relapse|relapse
218189|NCT02244125|Refractory|refractory
218190|NCT02244125|PCD|pcd
218191|NCT02244125|IFM/DFCI 2009|ifm/dfci 2009
218192|NCT02244125|Transplantation|transplantation
218193|NCT02244125|Autologous|autologous
218194|NCT02244125|Pomalidomide|pomalidomide
218195|NCT02244125|Immunoglobulin|immunoglobulin
218196|NCT02244125|Ig|ig
218197|NCT02244125|Free light Chain|free light chain
218198|NCT02244099|Controlled substance prescribing|controlled substance prescribing
218199|NCT02244099|Controlled substance treatment agreements|controlled substance treatment agreements
218200|NCT02244099|Opioid use|opioid use
218201|NCT02244086|obstetric pain, bupivacaine, analgesic efficacy|obstetric pain, bupivacaine, analgesic efficacy
218202|NCT02244073|blood glucose target|blood glucose target
218203|NCT02244073|ICU|icu
218204|NCT02244073|insulin|insulin
218205|NCT02244073|hypoglycemia|hypoglycemia
218206|NCT02244073|hyperglycemia|hyperglycemia
218207|NCT02244073|glycated hemoglobin|glycated hemoglobin
218208|NCT02244060|Vignette|vignette
218209|NCT02244060|Priming effect|priming effect
218210|NCT02244021|HD|hd
218211|NCT02244021|Hodgkin's Lymphoma|hodgkin's lymphoma
218212|NCT02244021|RELAPSED-REFRACTORY|relapsed-refractory
218213|NCT02244008|Mobilization|mobilization
218214|NCT02244008|Joint Range of Motion|joint range of motion
218215|NCT02244008|Ankle|ankle
218216|NCT02244008|Manual Therapy|manual therapy
218217|NCT02243995|Training program|training program
218218|NCT02243995|Resistance training|resistance training
218219|NCT02243995|Endurance training|endurance training
218220|NCT02243995|Muscle strength|muscle strength
218221|NCT02243995|Exercise capacity|exercise capacity
218222|NCT02243995|Fatigue|fatigue
218223|NCT02243995|Quality of life|quality of life
218224|NCT02243982|Parkinson, dementia, FDDNP, tau, beta-amyloid|parkinson, dementia, fddnp, tau, beta-amyloid
218225|NCT02243969|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
218226|NCT02243969|Alpha-linolenic acid|alpha-linolenic acid
218227|NCT02243969|Blood pressure|blood pressure
218228|NCT02243969|Vascular function|vascular function
218229|NCT02243943|Neuromuscular block|neuromuscular block
218230|NCT02243943|neuromuscular reversal|neuromuscular reversal
218231|NCT02243943|postoperative conditions|postoperative conditions
218232|NCT02243943|respiratory failure|respiratory failure
218233|NCT02243930|Sigmoidoscopy with or without cap|sigmoidoscopy with or without cap
218234|NCT02243930|Pain during sigmoidoscopy|pain during sigmoidoscopy
218235|NCT02243930|Sigmoidoscopy and time|sigmoidoscopy and time
218236|NCT02243904|Autonomic nervous function|autonomic nervous function
218237|NCT02243904|Blood pressure|blood pressure
218238|NCT02243904|Cardiovascular regulation|cardiovascular regulation
218239|NCT02243904|Lead|lead
218240|NCT02243904|Occupational exposure|occupational exposure
218241|NCT02243904|Renal function|renal function
218242|NCT02243852|Growth Hormone Deficiency (GHD)|growth hormone deficiency (ghd)
218243|NCT02243852|Growth Hormone Replacement Therapy|growth hormone replacement therapy
218244|NCT02243852|Fibroblast Growth Factor 21 (FGF21)|fibroblast growth factor 21 (fgf21)
218245|NCT02243852|Visceral Fat|visceral fat
218246|NCT02243852|Subcutaneous Fat|subcutaneous fat
218247|NCT02243839|Prosthetic valve|prosthetic valve
218248|NCT02243839|Thrombosis|thrombosis
218249|NCT02243839|Surgery|surgery
218250|NCT02243839|Thrombolytic therapy|thrombolytic therapy
218251|NCT02243839|Transesophageal echocardiography|transesophageal echocardiography
218252|NCT02243826|Lumbar puncture|lumbar puncture
218253|NCT02243826|Adults|adults
218254|NCT02243826|Nitrous oxide|nitrous oxide
218255|NCT02243826|Procedural pain|procedural pain
218256|NCT02243826|Procedural anxiety|procedural anxiety
218257|NCT02243813|Psilocybin|psilocybin
218258|NCT02243813|Pharmacologic Actions|pharmacologic actions
218259|NCT02243813|Psychotropic Drugs|psychotropic drugs
218260|NCT02243800|Vitamin D|vitamin d
218261|NCT02243800|Rheumatoid arthritis|rheumatoid arthritis
218262|NCT02243800|Cholecalciferol|cholecalciferol
218263|NCT02243774|Vaccination|vaccination
218264|NCT02243774|Immunization|immunization
218265|NCT02243774|Randomized Controlled Trial|randomized controlled trial
218266|NCT02243774|Prevention & Control|prevention & control
218267|NCT02243774|Preventive Measures|preventive measures
218268|NCT02243774|Health Promotion|health promotion
218269|NCT02243774|Medicare|medicare
218270|NCT02243774|Intention Prompts|intention prompts
218271|NCT02243774|Letters|letters
218272|NCT02243761|Concurrent Disorders|concurrent disorders
218273|NCT02243761|Mental Health|mental health
218274|NCT02243761|Addictions|addictions
218275|NCT02243761|Caregiver Burden|caregiver burden
218276|NCT02243722|laryngeal electromyography|laryngeal electromyography
218277|NCT02243722|intrinsic laryngeal muscles|intrinsic laryngeal muscles
218278|NCT02243722|recurrent laryngeal nerve|recurrent laryngeal nerve
218279|NCT02243722|superior laryngeal nerve|superior laryngeal nerve
218280|NCT02243722|laryngeal sensation|laryngeal sensation
218281|NCT02243722|tone language|tone language
218282|NCT02243709|Stress, alcohol craving, alcohol use disorders|stress, alcohol craving, alcohol use disorders
218283|NCT02243670|opioid addiction|opioid addiction
218284|NCT02243670|opioid substitution therapy|opioid substitution therapy
218285|NCT02243670|addiction|addiction
218286|NCT02243670|buprenorphine maintenance treatment|buprenorphine maintenance treatment
218287|NCT02243670|opioid dependence|opioid dependence
218288|NCT02243670|substitution treatment|substitution treatment
218289|NCT02243670|noncompliance|noncompliance
218290|NCT02243670|opiate addiction|opiate addiction
218291|NCT02243670|Zubzolv® maintenance|zubzolv® maintenance
218292|NCT02243670|adherence monitoring|adherence monitoring
218293|NCT02243670|directly observed therapy|directly observed therapy
218294|NCT02243670|medication adherence|medication adherence
218295|NCT02243670|adherence|adherence
218296|NCT02243670|mobile|mobile
218297|NCT02243670|electronic monitoring|electronic monitoring
218298|NCT02243670|wireless|wireless
218299|NCT02243670|mobile device|mobile device
218300|NCT02243670|artificial intelligence|artificial intelligence
218301|NCT02243670|facial recognition|facial recognition
218302|NCT02243670|computer vision|computer vision
218303|NCT02243670|visual confirmation|visual confirmation
218304|NCT02243670|sublingual buprenorphine/naloxone|sublingual buprenorphine/naloxone
218305|NCT02243670|nonadherence|nonadherence
218306|NCT02243657|ASP3652|asp3652
218307|NCT02243657|Age|age
218308|NCT02243657|Gender|gender
218309|NCT02243657|Pharmacokinetics|pharmacokinetics
218310|NCT02243657|Pharmacodynamics|pharmacodynamics
218311|NCT02243657|Phase 1|phase 1
218312|NCT02243657|Multiple Ascending Doses (MAD)|multiple ascending doses (mad)
218313|NCT02243644|parenchymal neurocysticercosis upto five lesions|parenchymal neurocysticercosis upto five lesions
218314|NCT02243631|ATP|atp
218315|NCT02243631|Probenecid|probenecid
218316|NCT02243631|Chondrocalcinosis|chondrocalcinosis
218317|NCT02243527|Exercise|exercise
218318|NCT02243514|Hypertension|hypertension
218319|NCT02243514|Heart failure|heart failure
218320|NCT02243514|Sympathetic hyperactivity|sympathetic hyperactivity
218321|NCT02243514|Renal nerve|renal nerve
218322|NCT02243514|Remodeling|remodeling
218323|NCT02243514|Nerve remodeling|nerve remodeling
218324|NCT02243488|Menstruation|menstruation
218325|NCT02243488|MHM|mhm
218326|NCT02243488|Menstrual Hygiene Management|menstrual hygiene management
218327|NCT02243488|Girls Education|girls education
218328|NCT02243488|Absenteeism|absenteeism
218329|NCT02243488|Access to Education|access to education
218330|NCT02243488|Menstrual Health Education|menstrual health education
218331|NCT02243488|Reusable Sanitary Product|reusable sanitary product
218332|NCT02243462|Shivering|shivering
218333|NCT02243462|Hypothermia|hypothermia
218334|NCT02243462|Postoperative|postoperative
218335|NCT02243462|Temperature|temperature
218336|NCT02243462|Forced air warmer|forced air warmer
218337|NCT02243449|mechanical ventilation|mechanical ventilation
218338|NCT02243449|weaning|weaning
218339|NCT02243449|elderly|elderly
218340|NCT02243449|critically ill|critically ill
218341|NCT02243449|screening|screening
218342|NCT02243449|spontaneous breathing trial|spontaneous breathing trial
218343|NCT02243449|invasive ventilation|invasive ventilation
218344|NCT02243436|CLASSICAL HODGKIN LYMPHOMA|classical hodgkin lymphoma
218345|NCT02243436|HODGKIN LYMPHOMA|hodgkin lymphoma
218346|NCT02243436|LYMPHOMA|lymphoma
218347|NCT02243436|HL|hl
218348|NCT02243423|Aortocaval compression|aortocaval compression
218349|NCT02243423|Cesarean Section|cesarean section
218350|NCT02243423|Spinal Anesthesia|spinal anesthesia
218351|NCT02243423|Phenylephrine|phenylephrine
218352|NCT02243384|Early Hepatocellular Carcinoma|early hepatocellular carcinoma
218353|NCT02243384|Laparoscopic Hepatectomy|laparoscopic hepatectomy
218354|NCT02243384|Radiofrequency Ablation|radiofrequency ablation
218355|NCT02243384|Micrometastases|micrometastases
218356|NCT02243358|Pancreatic, cancer|pancreatic, cancer
218357|NCT02243345|decompression|decompression
218358|NCT02243345|recompression|recompression
218359|NCT02243345|delayed|delayed
218360|NCT02243345|late|late
218361|NCT02243332|Knee|knee
218362|NCT02243332|Pain|pain
218363|NCT02243332|Joint|joint
218364|NCT02243332|Rehabilitation|rehabilitation
218365|NCT02243332|Patellofemoral Pain Syndrome|patellofemoral pain syndrome
218366|NCT02243332|Anterior Knee Pain Syndrome|anterior knee pain syndrome
218367|NCT02243332|Knee Pain|knee pain
218368|NCT02243332|Quadriceps|quadriceps
218369|NCT02243306|pharmacokinetics|pharmacokinetics
218370|NCT02243306|Chronic kidney disease|chronic kidney disease
218371|NCT02243306|peritoneal dialysis|peritoneal dialysis
218372|NCT02243306|hemoglobin|hemoglobin
218373|NCT02243306|Anemia|anemia
218374|NCT02243306|GSK1278863|gsk1278863
218375|NCT02243306|Prolyl hydroxylase inhibitor|prolyl hydroxylase inhibitor
218376|NCT02243306|erythropoiesis stimulating agents|erythropoiesis stimulating agents
218377|NCT02243293|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
218378|NCT02243293|Hepatitis C|hepatitis c
218379|NCT02243293|Chronic Hepatitis C|chronic hepatitis c
218380|NCT02243293|interferon free|interferon free
218381|NCT02243293|Hepatitis C Genotype 2|hepatitis c genotype 2
218382|NCT02243293|Hepatitis C Genotype 3|hepatitis c genotype 3
218383|NCT02243293|Hepatitis C Genotype 4|hepatitis c genotype 4
218384|NCT02243293|Hepatitis C Genotype 5|hepatitis c genotype 5
218385|NCT02243293|Hepatitis C Genotype 6|hepatitis c genotype 6
218386|NCT02243280|HCV GT4|hcv gt4
218387|NCT02243280|Hepatitis C virus|hepatitis c virus
218388|NCT02243280|HCV GT1|hcv gt1
218389|NCT02243280|HCV|hcv
218390|NCT02243280|Compensated Cirrhosis|compensated cirrhosis
218391|NCT02243280|HCV GT6|hcv gt6
218392|NCT02243280|Hepatitis C Genotype 4 (GT 4)|hepatitis c genotype 4 (gt 4)
218393|NCT02243280|Hepatitis C Genotype 1 (GT1)|hepatitis c genotype 1 (gt1)
218394|NCT02243280|RBV|rbv
218395|NCT02243280|Cirrhotic|cirrhotic
218396|NCT02243280|Hepatitis C|hepatitis c
218397|NCT02243280|Interferon (IFN) Free|interferon (ifn) free
218398|NCT02243280|IFN free|ifn free
218399|NCT02243280|HCV GT5|hcv gt5
218400|NCT02243280|Chronic Hepatitis C|chronic hepatitis c
218401|NCT02243280|Ribavirin|ribavirin
218402|NCT02243280|Child Pugh A|child pugh a
218403|NCT02243280|Hepatitis C Genotype 5 (GT 5)|hepatitis c genotype 5 (gt 5)
218404|NCT02243280|Hepatitis C Genotype 6 (GT 6)|hepatitis c genotype 6 (gt 6)
218405|NCT02243280|ABT-493|abt-493
218406|NCT02243280|ABT-530|abt-530
218407|NCT02243280|glecaprevir|glecaprevir
218408|NCT02243280|pibrentasvir|pibrentasvir
218409|NCT02243267|Colon Cancer Colon Cancer Prevention|colon cancer colon cancer prevention
218410|NCT02243241|Healthy volunteers|healthy volunteers
218411|NCT02243241|Opioid|opioid
218412|NCT02243241|ECG|ecg
218413|NCT02243241|QTcI|qtci
218414|NCT02243228|granulocyte-macrophage colony stimulating factor(GM-CSF)|granulocyte-macrophage colony stimulating factor(gm-csf)
218415|NCT02243228|Autoimmune pulmonary alveolar proteinosis (PAP)|autoimmune pulmonary alveolar proteinosis (pap)
218416|NCT02243215|Laparoscopy|laparoscopy
218417|NCT02243215|Training|training
218418|NCT02243215|Off-site|off-site
218419|NCT02243215|Box trainer|box trainer
218420|NCT02243215|Virtual Reality Simulator|virtual reality simulator
218421|NCT02243202|Obesity|obesity
218422|NCT02243202|Overweight|overweight
218423|NCT02243202|Canagliflozin|canagliflozin
218424|NCT02243202|Phentermine|phentermine
218425|NCT02243202|INVOKANA®|invokana®
218426|NCT02243189|Healthy|healthy
218427|NCT02243189|Asthma|asthma
218428|NCT02243189|JNJ-43260295|jnj-43260295
218429|NCT02243189|Nasal Allergen Challenge|nasal allergen challenge
218430|NCT02243176|Saxagliptin|saxagliptin
218431|NCT02243176|Acarbose|acarbose
218432|NCT02243176|Type 2 Diabetes|type 2 diabetes
218433|NCT02243176|Metformin|metformin
218434|NCT02243124|Anemia|anemia
218435|NCT02243124|Transfusion|transfusion
218436|NCT02243124|AML|aml
218437|NCT02243124|MDS|mds
218438|NCT02243124|CLL|cll
218439|NCT02243124|p53|p53
218440|NCT02243124|erythropoiesis|erythropoiesis
218441|NCT02243111|Systemic sclerosis, pulmonary hypertension|systemic sclerosis, pulmonary hypertension
218442|NCT02243072|Insulin Dependent Diabetes Mellitus|insulin dependent diabetes mellitus
218443|NCT02243072|family therapy|family therapy
218444|NCT02243072|adolescents|adolescents
218445|NCT02243072|regimen adherence|regimen adherence
218446|NCT02243072|metabolic control|metabolic control
218447|NCT02243059|Magnetic Resonance Imaging|magnetic resonance imaging
218448|NCT02243059|Gadofosveset trisodium|gadofosveset trisodium
218449|NCT02243059|Nodal imaging|nodal imaging
218450|NCT02243033|Prostate cancer|prostate cancer
218451|NCT02243033|Focal therapy|focal therapy
218452|NCT02243033|Laser therapy|laser therapy
218453|NCT02243033|Transrectal|transrectal
218454|NCT02243033|MRI-guided|mri-guided
218455|NCT02243007|Resectable pancreatic cancer|resectable pancreatic cancer
218456|NCT02243007|Pancreatic Ductal Carcinoma|pancreatic ductal carcinoma
218457|NCT02242968|Licensed Vaccines|licensed vaccines
218458|NCT02242968|Blood Draw|blood draw
218459|NCT02242968|Investigational Vaccines|investigational vaccines
218460|NCT02242968|Healthy Volunteers|healthy volunteers
218461|NCT02242968|Eligibility Screening|eligibility screening
218462|NCT02242955|Alcohol-dependence|alcohol-dependence
218463|NCT02242955|Relapse|relapse
218464|NCT02242955|Detoxification|detoxification
218465|NCT02242955|Diazepam|diazepam
218466|NCT02242955|Benzodiazepines|benzodiazepines
218467|NCT02242955|Anxiety|anxiety
218468|NCT02242929|Nodular Basal Cell Carcinoma|nodular basal cell carcinoma
218469|NCT02242929|Treatment|treatment
218470|NCT02242929|Imiquimod|imiquimod
218471|NCT02242929|Curettage|curettage
218472|NCT02242929|Surgery|surgery
218473|NCT02242916|reccurent Head and Neck tumors|reccurent head and neck tumors
218474|NCT02242916|re-irradiation|re-irradiation
218475|NCT02242916|photon|photon
218476|NCT02242916|proton|proton
218477|NCT02242916|carbon-ion|carbon-ion
218478|NCT02242890|intrauterine contraception (IUC)|intrauterine contraception (iuc)
218479|NCT02242890|social networks|social networks
218480|NCT02242890|social influence|social influence
218481|NCT02242890|diffusion of innovation|diffusion of innovation
218482|NCT02242890|intrauterine device (IUD)|intrauterine device (iud)
218483|NCT02242890|LARC|larc
218484|NCT02242799|Malaria|malaria
218485|NCT02242799|HIV|hiv
218486|NCT02242799|Dolutegravir|dolutegravir
218487|NCT02242799|Artemisinin|artemisinin
218488|NCT02242799|Pharmacokinetics|pharmacokinetics
218489|NCT02242799|Interactions|interactions
218490|NCT02242773|Prostate Cancer|prostate cancer
218491|NCT02242773|Active Surveillance|active surveillance
218492|NCT02242773|MRI-Guided Biopsy|mri-guided biopsy
218493|NCT02242773|Multi-parametric MRI|multi-parametric mri
218494|NCT02242773|MP-MRI|mp-mri
218495|NCT02242760|acne|acne
218496|NCT02242747|actinic keratosis|actinic keratosis
218497|NCT02242747|field cancerization|field cancerization
218498|NCT02242747|ingenol mebutate|ingenol mebutate
218499|NCT02242747|5-fluorouracil|5-fluorouracil
218500|NCT02242747|tolerability|tolerability
218501|NCT02242747|safety|safety
218502|NCT02242695|vulvovaginal candidiasis|vulvovaginal candidiasis
218503|NCT02242695|vulvovaginal candidosis|vulvovaginal candidosis
218504|NCT02242695|mycotic vaginal infection|mycotic vaginal infection
218505|NCT02242695|dequalinium chloride|dequalinium chloride
218506|NCT02242695|Fluomizin|fluomizin
218507|NCT02242695|clotrimazole|clotrimazole
218508|NCT02242695|canesten|canesten
218509|NCT02242656|Short Bowel Syndrome|short bowel syndrome
218510|NCT02242656|SBS|sbs
218511|NCT02242656|Chronic Diarrhea|chronic diarrhea
218512|NCT02242656|Short Bowel|short bowel
218513|NCT02242656|Short Gut|short gut
218514|NCT02242656|Short Gut Syndrome|short gut syndrome
218515|NCT02242656|Anti-Diarrheal|anti-diarrheal
218516|NCT02242656|Opium Tincture|opium tincture
218517|NCT02242656|loperamide|loperamide
218518|NCT02242656|diphenoxylate|diphenoxylate
218519|NCT02242656|ileostomies|ileostomies
218520|NCT02242656|tincture of opium|tincture of opium
218521|NCT02242656|DTO|dto
218522|NCT02242656|codeine|codeine
218523|NCT02242656|morphine|morphine
218524|NCT02242656|opiate|opiate
218525|NCT02242643|Fluzone Quadrivalent|fluzone quadrivalent
218526|NCT02242643|Comparator|comparator
218527|NCT02242643|Children|children
218528|NCT02242643|Seasonal influenza|seasonal influenza
218529|NCT02242643|Safety|safety
218530|NCT02242643|Immunogenicity|immunogenicity
218531|NCT02242630|Subacromial bursitis|subacromial bursitis
218532|NCT02242630|Triamcinolone|triamcinolone
218533|NCT02242630|Methylprednisolone|methylprednisolone
218534|NCT02242630|Shoulder pain|shoulder pain
218535|NCT02242617|Adherence|adherence
218536|NCT02242617|CPAP|cpap
218537|NCT02242617|Oral Appliance|oral appliance
218538|NCT02242617|Mandibular Advancement Splints|mandibular advancement splints
218539|NCT02242617|Preference|preference
218540|NCT02242591|Knee surgery|knee surgery
218541|NCT02242591|Saphenous nerve|saphenous nerve
218542|NCT02242591|Perineural block|perineural block
218543|NCT02242591|Adductor Canal Block|adductor canal block
218544|NCT02242591|Postoperative Pain|postoperative pain
218545|NCT02242591|Mobilization|mobilization
218546|NCT02242578|Negative symptoms|negative symptoms
218547|NCT02242565|HIV prevention|hiv prevention
218548|NCT02242565|ShangRing|shangring
218549|NCT02242565|adverse events|adverse events
218550|NCT02242565|wound healing|wound healing
218551|NCT02242565|voluntary medical male circumcision (VMMC)|voluntary medical male circumcision (vmmc)
218552|NCT02242565|medical device|medical device
218553|NCT02242565|Zambia|zambia
218554|NCT02242526|hiatal hernia, recurrence, biologic mesh, synthetic mesh|hiatal hernia, recurrence, biologic mesh, synthetic mesh
218555|NCT02242513|Pulsed mode radiofrequency|pulsed mode radiofrequency
218556|NCT02242513|Plantar Fasciitis|plantar fasciitis
218557|NCT02242513|Ultrasound-guided|ultrasound-guided
218558|NCT02242500|Gingival recession/surgery|gingival recession/surgery
218559|NCT02242500|Collagen/therapeutic use|collagen/therapeutic use
218560|NCT02242500|Root coverage|root coverage
218561|NCT02242500|Treatment outcome|treatment outcome
218562|NCT02242487|Parkinson's Disease|parkinson's disease
218563|NCT02242487|Motor fluctuations|motor fluctuations
218564|NCT02242487|levodopa|levodopa
218565|NCT02242487|inhaled drugs|inhaled drugs
218566|NCT02242487|OFF episodes|off episodes
218567|NCT02242474|Rheumatoid arthritis|rheumatoid arthritis
218568|NCT02242474|Surgical Wound Infection|surgical wound infection
218569|NCT02242474|Surgical Site Infection|surgical site infection
218570|NCT02242474|Antirheumatic Agents|antirheumatic agents
218571|NCT02242474|Perioperative Care|perioperative care
218572|NCT02242474|Anti-TNF|anti-tnf
218573|NCT02242474|Anti-TNF-alpha|anti-tnf-alpha
218574|NCT02242461|COPD, Rhodiola L., clinical trial, biomarkers, spirometry|copd, rhodiola l., clinical trial, biomarkers, spirometry
218575|NCT02242448|Healthy Volunteer|healthy volunteer
218576|NCT02242448|Contrast|contrast
218577|NCT02242409|Metastatic pancreatic cancer|metastatic pancreatic cancer
219665|NCT02237027|prevention|prevention
218578|NCT02242409|Second Line treatment|second line treatment
218579|NCT02242409|Gemcitabine|gemcitabine
218580|NCT02242409|Nab-paclitaxel|nab-paclitaxel
218581|NCT02242188|Breastfeeding|breastfeeding
218582|NCT02242188|Iron supplementation|iron supplementation
218583|NCT02242188|Psychomotor development|psychomotor development
218584|NCT02242188|Safety|safety
218585|NCT02242188|infants|infants
218586|NCT02242162|phrenic nerves magnetic stimulations|phrenic nerves magnetic stimulations
218587|NCT02242149|Fat liver|fat liver
218588|NCT02242149|Diabetes|diabetes
218589|NCT02242149|Diacerein|diacerein
218590|NCT02242149|Transient elastography|transient elastography
218591|NCT02242149|Treatment|treatment
218592|NCT02242136|Posttraumatic Stress Disorder|posttraumatic stress disorder
218593|NCT02242136|Aggressive Behavior|aggressive behavior
218594|NCT02242136|Appetitive Aggression|appetitive aggression
218595|NCT02242136|Treatment|treatment
218596|NCT02242136|FORNET|fornet
218597|NCT02242123|Celiac Disease|celiac disease
218598|NCT02242123|Gluten-free diet|gluten-free diet
218599|NCT02242123|EmA assay|ema assay
218600|NCT02242123|Duodenal culture medium|duodenal culture medium
218601|NCT02242110|Nightmares|nightmares
218602|NCT02242110|Sleep|sleep
218603|NCT02242110|PTSD|ptsd
218604|NCT02242110|Exposure, Relaxation, and Rescripting Therapy|exposure, relaxation, and rescripting therapy
218605|NCT02242071|Motor Neuron Disease|motor neuron disease
218606|NCT02242071|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
218607|NCT02242071|Autologous Mononuclear Cell therapy|autologous mononuclear cell therapy
218608|NCT02242071|Stem cells|stem cells
218609|NCT02242032|dry eye disease|dry eye disease
218610|NCT02241993|glucose sensor|glucose sensor
218611|NCT02241993|Inter-sensor distance|inter-sensor distance
218612|NCT02241967|total knee arthroplasty|total knee arthroplasty
218613|NCT02241967|pain|pain
218614|NCT02241967|post-surgical pain|post-surgical pain
218615|NCT02241967|opioid|opioid
218616|NCT02241967|transcranial direct current stimulation|transcranial direct current stimulation
218617|NCT02241967|tDCS|tdcs
218618|NCT02241967|brain stimulation|brain stimulation
218619|NCT02241967|total hip arthroplasty|total hip arthroplasty
218620|NCT02241967|TKA|tka
218621|NCT02241967|THA|tha
218622|NCT02241928|Muscular Dystrophy|muscular dystrophy
218623|NCT02241928|Autologous Mononuclear cell therapy|autologous mononuclear cell therapy
218624|NCT02241928|Stem Cell|stem cell
218625|NCT02241889|diabetes|diabetes
218626|NCT02241889|closed-loop|closed-loop
218627|NCT02241889|bi-hormonal|bi-hormonal
218628|NCT02241889|exercise|exercise
218629|NCT02241863|bipolar disorders|bipolar disorders
218630|NCT02241863|medication adherence|medication adherence
218631|NCT02241863|psychological intervention|psychological intervention
218632|NCT02241863|multifaceted intervention|multifaceted intervention
218633|NCT02241850|High Intensity Training|high intensity training
218634|NCT02241850|Genetic Polymorphisms|genetic polymorphisms
218635|NCT02241850|Genome Wide association study|genome wide association study
218636|NCT02241850|Single Nucleotide Polymorphism genotype|single nucleotide polymorphism genotype
218637|NCT02241850|Subjects|subjects
218638|NCT02241837|heart failure|heart failure
218639|NCT02241837|percutaneous|percutaneous
218640|NCT02241837|interventional cardiology|interventional cardiology
218641|NCT02241837|apical remodeling|apical remodeling
218642|NCT02241837|LV dilatation|lv dilatation
218643|NCT02241837|akinesis|akinesis
218644|NCT02241837|dyskinesis|dyskinesis
218645|NCT02241837|myocardial infarction|myocardial infarction
218646|NCT02241824|Lumbar Orthosis|lumbar orthosis
218647|NCT02241824|Lumbar brace|lumbar brace
218648|NCT02241811|Diabetic|diabetic
218649|NCT02241811|Foot|foot
218650|NCT02241811|Wound|wound
218651|NCT02241811|Sodium pentaborate pentahydrate|sodium pentaborate pentahydrate
218652|NCT02241811|Hydrogel|hydrogel
218653|NCT02241798|epilepsy|epilepsy
218654|NCT02241798|oxygen saturation|oxygen saturation
218655|NCT02241798|transcutaneous carbon dioxide|transcutaneous carbon dioxide
218656|NCT02241798|sudep|sudep
218657|NCT02241798|pre-oxygenation|pre-oxygenation
218658|NCT02241733|exercise|exercise
218659|NCT02241733|pulmonary rehabilitation|pulmonary rehabilitation
218660|NCT02241733|dynamic hyperinflation|dynamic hyperinflation
218661|NCT02241707|Varicose vein|varicose vein
218662|NCT02241707|Endovenous ablation|endovenous ablation
218663|NCT02241707|Compression|compression
218664|NCT02241681|Medium Chain Triglycerides|medium chain triglycerides
218665|NCT02241681|Medium Chain Triglycerides metabolites|medium chain triglycerides metabolites
218666|NCT02241681|Peptamen 1.5|peptamen 1.5
218667|NCT02241668|Brain tumor|brain tumor
218668|NCT02241668|3'-Deoxy-3'-18f-Fluorothymidine|3'-deoxy-3'-18f-fluorothymidine
218669|NCT02241668|Fluoro-L-Thymidine Positron Emission Tomography|fluoro-l-thymidine positron emission tomography
218670|NCT02241668|FLT PET|flt pet
218671|NCT02241668|Magnetic resonance imaging|magnetic resonance imaging
218672|NCT02241668|MRI|mri
218673|NCT02241655|Anesthesia|anesthesia
218674|NCT02241655|Electroencephalography|electroencephalography
218675|NCT02241655|Burst suppression|burst suppression
218676|NCT02241655|Surgery|surgery
218679|NCT02241655|Health related quality of life|health related quality of life
218680|NCT02241642|Percutaneous vascular closure device|percutaneous vascular closure device
218681|NCT02241642|vascular closure device|vascular closure device
218682|NCT02241642|Large hole closure device|large hole closure device
218683|NCT02241629|motion sickness|motion sickness
218684|NCT02241603|Insulin resistance|insulin resistance
218685|NCT02241603|Consummatory Reward|consummatory reward
218686|NCT02241577|peri-implantitis|peri-implantitis
218687|NCT02241577|dental implants|dental implants
218688|NCT02241577|randomized controlled trial|randomized controlled trial
218689|NCT02241577|non-surgical periodontal treatment|non-surgical periodontal treatment
218690|NCT02241577|will be defined by the presence of alveolar bone loss of at least 3mm, pocket depth of at least 5mm and bleeding on probing.|will be defined by the presence of alveolar bone loss of at least 3mm, pocket depth of at least 5mm and bleeding on probing.
218691|NCT02241564|Immunosuppression|immunosuppression
218692|NCT02241551|Borderline|borderline
218693|NCT02241551|Resectable|resectable
218694|NCT02241551|Pancreatic|pancreatic
218695|NCT02241551|Cancer|cancer
218696|NCT02241551|Neoadjuvant|neoadjuvant
218697|NCT02241551|Chemotheraphy|chemotheraphy
218698|NCT02241551|Gemcitabine|gemcitabine
218699|NCT02241551|Nab-Paclitaxel|nab-paclitaxel
218700|NCT02241551|mFOFIRINOX|mfofirinox
218701|NCT02241551|Sterotatic Body Radiation Therapy|sterotatic body radiation therapy
218702|NCT02241538|Pilates-based exercises|pilates-based exercises
218703|NCT02241525|Pulmonary|pulmonary
218704|NCT02241525|Thromboembolic|thromboembolic
218705|NCT02241525|Lung|lung
218706|NCT02241512|post-ERCP pancreatitis|post-ercp pancreatitis
218707|NCT02241512|pediatric|pediatric
218708|NCT02241512|ibuprofen|ibuprofen
218709|NCT02241499|Digestive System Diseases|digestive system diseases
218710|NCT02241499|Esophageal cancer|esophageal cancer
218711|NCT02241499|Intestinal Neoplasms|intestinal neoplasms
218712|NCT02241499|Gastrointestinal Neoplasms|gastrointestinal neoplasms
218713|NCT02241499|Digestive System Neoplasms|digestive system neoplasms
218714|NCT02241499|Endoscopic response|endoscopic response
218715|NCT02241499|Fluorouracil|fluorouracil
218716|NCT02241499|Metabolic response|metabolic response
218717|NCT02241499|Oxaliplatin|oxaliplatin
218718|NCT02241499|Radiotherapy|radiotherapy
218719|NCT02241486|Burn pain|burn pain
218720|NCT02241486|Procedural pain|procedural pain
218721|NCT02241486|Sublingual fentanyl|sublingual fentanyl
218722|NCT02241486|Morphine|morphine
218723|NCT02241473|gait|gait
218724|NCT02241473|physical activity|physical activity
218725|NCT02241473|energy cost|energy cost
218726|NCT02241473|efficiency|efficiency
218727|NCT02241460|Premature Ejaculation|premature ejaculation
218728|NCT02241460|Lidocaine|lidocaine
218729|NCT02241447|aortic valve Stenosis|aortic valve stenosis
218730|NCT02241447|Echo|echo
218731|NCT02241447|TAVI|tavi
218732|NCT02241447|SAVR|savr
218733|NCT02241447|referral|referral
218734|NCT02241434|Duchenne muscular dystrophy|duchenne muscular dystrophy
218735|NCT02241434|Autologous Bone marrow Mononuclear cell therapy|autologous bone marrow mononuclear cell therapy
218736|NCT02241434|Stem Cells|stem cells
218737|NCT02241421|Impaired glucose tolerance|impaired glucose tolerance
218738|NCT02241421|Glucose Metabolism Disorders|glucose metabolism disorders
218739|NCT02241421|Metabolic Diseases|metabolic diseases
218740|NCT02241421|Endocrine System Diseases|endocrine system diseases
218741|NCT02241421|Hyperinsulinism|hyperinsulinism
218742|NCT02241421|Lipid metabolism|lipid metabolism
218743|NCT02241421|Anti Bacterial Agents|anti bacterial agents
218744|NCT02241421|Gastro Intestinal Tract|gastro intestinal tract
218745|NCT02241395|Cerebral Palsy|cerebral palsy
218746|NCT02241395|autologous bone marrow mononuclear cells|autologous bone marrow mononuclear cells
218747|NCT02241395|stem cell|stem cell
218748|NCT02241369|Aerodigestive Lesions and Malignancies|aerodigestive lesions and malignancies
218749|NCT02241369|Human Papillomavirus|human papillomavirus
218750|NCT02241369|Squamous Cell Carcinoma|squamous cell carcinoma
218751|NCT02241356|Down syndrome|down syndrome
218752|NCT02241356|visual functions|visual functions
218753|NCT02241356|bifocals|bifocals
218754|NCT02241356|children|children
218755|NCT02241356|visual acuity at near|visual acuity at near
218756|NCT02241343|Artificially and reversibly achieved with a blood pressure cuff|artificially and reversibly achieved with a blood pressure cuff
218757|NCT02241330|Zinc|zinc
218758|NCT02241330|deficiency|deficiency
218759|NCT02241330|biofortification|biofortification
218760|NCT02241330|wheat|wheat
218761|NCT02241317|Diabetes mellitus|diabetes mellitus
218762|NCT02241317|Hypoglycaemia|hypoglycaemia
218763|NCT02241317|staff training|staff training
218764|NCT02241317|Education|education
218765|NCT02241317|blood glucose|blood glucose
218766|NCT02241304|electromyography|electromyography
218767|NCT02241304|neuromuscular blockade|neuromuscular blockade
218768|NCT02241291|Percutaneous Coronary Intervention|percutaneous coronary intervention
218769|NCT02241291|Registries|registries
218770|NCT02241278|colon surgery|colon surgery
218771|NCT02241278|ketamine|ketamine
218772|NCT02241278|patient-controlled-analgesia|patient-controlled-analgesia
219666|NCT02237027|feasibility|feasibility
218773|NCT02241278|preemptive analgesia|preemptive analgesia
218774|NCT02241265|asthma|asthma
218775|NCT02241265|thermoplasty|thermoplasty
218776|NCT02241252|ECG|ecg
218777|NCT02241252|QT interval|qt interval
218778|NCT02241252|Sotalol|sotalol
218779|NCT02241252|Dofetilide|dofetilide
218780|NCT02241252|iPhone|iphone
218781|NCT02241226|wellbeing|wellbeing
218782|NCT02241226|meditation|meditation
218783|NCT02241226|Ayurveda|ayurveda
218784|NCT02241226|yoga|yoga
218785|NCT02241226|herbs|herbs
218786|NCT02241226|health|health
218787|NCT02241226|longevity|longevity
218788|NCT02241226|individuals|individuals
218789|NCT02241213|Stroke|stroke
218790|NCT02241213|Aphasia|aphasia
218791|NCT02241213|Broca|broca
218792|NCT02241187|PEGPH20|pegph20
218793|NCT02241187|Cetuximab|cetuximab
218794|NCT02241187|14-039|14-039
218795|NCT02241174|Atopic Dermatitis|atopic dermatitis
218796|NCT02241161|skin eythema|skin eythema
218797|NCT02241161|rejuvenating cream|rejuvenating cream
218798|NCT02241161|rejuvenating serum|rejuvenating serum
218799|NCT02241161|antioxidant serum|antioxidant serum
218800|NCT02241135|Rav G protein|rav g protein
218801|NCT02241135|rabies|rabies
218802|NCT02241135|VNT|vnt
218803|NCT02241135|immunogenicity|immunogenicity
218804|NCT02241135|PrEP vaccination|prep vaccination
218805|NCT02241135|mRNA|mrna
218806|NCT02241135|CV7201|cv7201
218807|NCT02241122|prostate cancer|prostate cancer
218808|NCT02241122|PSA|psa
218809|NCT02241122|MRI|mri
218810|NCT02241122|biopsy|biopsy
218811|NCT02241122|biomarker|biomarker
218812|NCT02241109|aortic stenosis progression|aortic stenosis progression
218813|NCT02241109|aortic valve sclerosis progression|aortic valve sclerosis progression
218814|NCT02241109|calcification propensity|calcification propensity
218815|NCT02241070|mindfulness meditation|mindfulness meditation
218816|NCT02241070|mental health promotion|mental health promotion
218817|NCT02241070|worker|worker
218818|NCT02241057|temperature profile|temperature profile
218819|NCT02241057|air activated 3-cell patch|air activated 3-cell patch
218820|NCT02241057|adhesion|adhesion
218821|NCT02241044|argon plasma coagulation, bleeding peptic ulcer|argon plasma coagulation, bleeding peptic ulcer
218822|NCT02241031|Megakaryocytic Progenitor Products|megakaryocytic progenitor products
218823|NCT02241031|Hematological Diseases|hematological diseases
218824|NCT02241031|Thrombocytopenia|thrombocytopenia
218825|NCT02241018|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
218826|NCT02241018|Mesenchymal Stem Cells|mesenchymal stem cells
218827|NCT02241018|CD25 Monoclonal Antibody|cd25 monoclonal antibody
218828|NCT02241018|Acute Graft-versus-host disease|acute graft-versus-host disease
218829|NCT02241005|Health-care associated infection|health-care associated infection
218830|NCT02241005|Skin integrity|skin integrity
218831|NCT02241005|Antimicrobial resistance|antimicrobial resistance
218832|NCT02240992|Poor Graft Function|poor graft function
218833|NCT02240992|Delayed platelet engraftment|delayed platelet engraftment
218834|NCT02240992|Peripheral Blood Stem Cell|peripheral blood stem cell
218835|NCT02240992|Mesenchymal Stem Cells|mesenchymal stem cells
218836|NCT02240992|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
218837|NCT02240979|arterial waveform|arterial waveform
218838|NCT02240979|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
218839|NCT02240979|echocardiography|echocardiography
218840|NCT02240979|intrinsic frequency measures of cardiac function|intrinsic frequency measures of cardiac function
218841|NCT02240966|Testicular Neoplasms|testicular neoplasms
218842|NCT02240966|Hypogonadism|hypogonadism
218843|NCT02240966|Metabolic Syndrome|metabolic syndrome
218844|NCT02240966|Treatment related late effects|treatment related late effects
218845|NCT02240953|Anticoagulation|anticoagulation
218846|NCT02240953|Prosthetic Heart Valves|prosthetic heart valves
218847|NCT02240953|Acetylsalicylic acid|acetylsalicylic acid
218848|NCT02240953|Warfarin|warfarin
218849|NCT02240953|Thrombosis|thrombosis
218850|NCT02240940|Heart Failure|heart failure
218851|NCT02240940|Volume Reduction|volume reduction
218852|NCT02240940|Pressure Reduction|pressure reduction
218853|NCT02240940|Ischemic Heart Failure|ischemic heart failure
218854|NCT02240940|LAD Infarct|lad infarct
218855|NCT02240927|Anticoagulation|anticoagulation
218856|NCT02240927|Prosthetic Heart Valves|prosthetic heart valves
218857|NCT02240927|Pregnancy|pregnancy
218858|NCT02240927|Warfarin|warfarin
218859|NCT02240927|Thrombosis|thrombosis
218860|NCT02240914|Iliac Vein Obstruction|iliac vein obstruction
218861|NCT02240914|May-Thurner Syndrome|may-thurner syndrome
218862|NCT02240914|Cockett Syndrome|cockett syndrome
218863|NCT02240914|Vascular Ultrasound|vascular ultrasound
218864|NCT02240914|IVUS|ivus
218865|NCT02240901|Laryngeal mask airway|laryngeal mask airway
218866|NCT02240901|endotracheal intubation|endotracheal intubation
218867|NCT02240901|postoperative pulmonary complications|postoperative pulmonary complications
218868|NCT02240901|elderly patients|elderly patients
218869|NCT02240888|pneumococcal|pneumococcal
218870|NCT02240888|vaccination|vaccination
218871|NCT02240888|antibody|antibody
218872|NCT02240888|response|response
218873|NCT02240888|immunosuppressive|immunosuppressive
218874|NCT02240888|treatment|treatment
218875|NCT02240888|inflammatory|inflammatory
218876|NCT02240888|rheumatic|rheumatic
218877|NCT02240888|disease|disease
218878|NCT02240875|Ebola|ebola
218879|NCT02240875|Zaire|zaire
218880|NCT02240849|Neck pain|neck pain
218881|NCT02240849|functional pillow|functional pillow
218882|NCT02240849|sleep|sleep
218883|NCT02240849|cervical lordosis|cervical lordosis
218884|NCT02240823|Erectile Function|erectile function
218885|NCT02240823|Mesenchymal Stromal Cells|mesenchymal stromal cells
218886|NCT02240823|Stem Cell|stem cell
218887|NCT02240797|Anorexia Nervosa|anorexia nervosa
218888|NCT02240797|Neuroimaging|neuroimaging
218889|NCT02240797|Positron emission tomography (PET)|positron emission tomography (pet)
218890|NCT02240797|[11C]PKAB|[11c]pkab
218891|NCT02240784|Porphyria|porphyria
218892|NCT02240784|AIP|aip
218893|NCT02240784|VP|vp
218894|NCT02240784|HCP|hcp
218895|NCT02240784|Variegate|variegate
218896|NCT02240784|Coproporphyria|coproporphyria
218897|NCT02240771|Transarterial chemotherapy|transarterial chemotherapy
218898|NCT02240771|Thalidomide|thalidomide
218899|NCT02240771|Capecitabine|capecitabine
218900|NCT02240758|glioma, confocal laser endomicroscopy|glioma, confocal laser endomicroscopy
218901|NCT02240745|Echocardiography, Stress|echocardiography, stress
218902|NCT02240745|Echocardiography, Three-Dimensional|echocardiography, three-dimensional
218903|NCT02240745|Coronary Artery Disease|coronary artery disease
218904|NCT02240745|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
218905|NCT02240745|Coronary Circulation|coronary circulation
218906|NCT02240615|Epiphora|epiphora
218907|NCT02240615|Lacrimal Stent|lacrimal stent
218908|NCT02240615|Lacrimal System|lacrimal system
218909|NCT02240602|acute pain|acute pain
218910|NCT02240602|postoperative|postoperative
218911|NCT02240602|surgery|surgery
218912|NCT02240589|Traumatic Brain Injury|traumatic brain injury
218913|NCT02240589|Memantine|memantine
218914|NCT02240589|Memory|memory
218915|NCT02240576|surgery for nasal fracture|surgery for nasal fracture
218916|NCT02240563|autoimmune thyroiditis|autoimmune thyroiditis
218917|NCT02240563|LLLT|lllt
218918|NCT02240563|safety|safety
218919|NCT02240563|ultrasound|ultrasound
218920|NCT02240550|Open Inguinal Hernia|open inguinal hernia
218921|NCT02240537|AML|aml
218922|NCT02240537|MM|mm
218923|NCT02240537|MDS|mds
218924|NCT02240537|sMM|smm
218925|NCT02240524|Gastric adenocarcinoma|gastric adenocarcinoma
218926|NCT02240524|HIPEC|hipec
218927|NCT02240524|Paclitaxel|paclitaxel
218928|NCT02240524|Oxaliplatin|oxaliplatin
218929|NCT02240524|Capecitabine|capecitabine
218930|NCT02240511|Body Composition|body composition
218931|NCT02240511|Amino Acids Supplementation|amino acids supplementation
218932|NCT02240511|Resistance Exercise|resistance exercise
218933|NCT02240498|Abscess|abscess
218934|NCT02240498|Drainage|drainage
218935|NCT02240485|Pathological gambling|pathological gambling
218936|NCT02240485|Treatment|treatment
218937|NCT02240485|Marital relationship|marital relationship
218938|NCT02240472|sentinel node biopsy, lymph node metastasis, survival|sentinel node biopsy, lymph node metastasis, survival
218939|NCT02240459|crossover study|crossover study
218940|NCT02240459|placebo controlled|placebo controlled
218941|NCT02240459|double blind|double blind
218942|NCT02240459|overactive bladder|overactive bladder
218943|NCT02240420|Type 2 diabetes prevention in the post-partum|type 2 diabetes prevention in the post-partum
218944|NCT02240420|Behavior change among Latinas,|behavior change among latinas,
218945|NCT02240420|Health Coaching, Motivational interviewing techniques|health coaching, motivational interviewing techniques
218946|NCT02240407|Pompe Disease|pompe disease
218947|NCT02240407|Gene Therapy|gene therapy
218948|NCT02240407|Repeated dosing|repeated dosing
218949|NCT02240407|Immune modulation|immune modulation
218950|NCT02240394|TCD Traumatic brain injury increased intracranial pressure|tcd traumatic brain injury increased intracranial pressure
218951|NCT02240368|Depth anesthesia monitors|depth anesthesia monitors
218952|NCT02240368|Children anesthesia|children anesthesia
218953|NCT02240368|Bispectral monitor|bispectral monitor
218954|NCT02240368|Entropy monitor|entropy monitor
218955|NCT02240342|Ovarian reserve|ovarian reserve
218956|NCT02240342|Poor response|poor response
218957|NCT02240342|Follicle recruitment|follicle recruitment
218958|NCT02240342|Bone marrow transplant|bone marrow transplant
218959|NCT02240329|respiratory|respiratory
218960|NCT02240329|cough|cough
218961|NCT02240303|pain|pain
218962|NCT02240303|mobility|mobility
218963|NCT02240303|brain|brain
218964|NCT02240303|cognition|cognition
218965|NCT02240290|C14|c14
218966|NCT02240290|Dosimetry|dosimetry
218967|NCT02240290|Mass balance|mass balance
218968|NCT02240290|ADME|adme
218969|NCT02240277|Septic Shock|septic shock
218970|NCT02240277|Meropenem|meropenem
218971|NCT02240277|Ciprofloxacin|ciprofloxacin
218972|NCT02240277|Pharmacokinetics|pharmacokinetics
218973|NCT02240264|Omega-3 fatty acids|omega-3 fatty acids
218974|NCT02240264|Cognitive function|cognitive function
218975|NCT02240264|Academic performance|academic performance
218976|NCT02240264|Mental health|mental health
218977|NCT02240264|Eye tracking|eye tracking
218978|NCT02240264|Krill oil|krill oil
218979|NCT02240264|LCPUFA|lcpufa
218980|NCT02240251|Inferior Vena Cava Filter|inferior vena cava filter
218981|NCT02240251|IVC Filter|ivc filter
218982|NCT02240251|IVC filter removal|ivc filter removal
218983|NCT02240251|Excimer Laser|excimer laser
218984|NCT02240225|COPD;SRI;Reliability;validity;|copd;sri;reliability;validity;
218985|NCT02240212|second line treatment|second line treatment
218986|NCT02240212|oncology|oncology
218987|NCT02240212|AKT inhibitor|akt inhibitor
218988|NCT02240212|paclitaxel|paclitaxel
218989|NCT02240212|HER2 (ErbB2) negative advanced gastric cancer|her2 (erbb2) negative advanced gastric cancer
218990|NCT02240212|Afuresertib|afuresertib
218991|NCT02240186|Microprocessor-controlled knee|microprocessor-controlled knee
218992|NCT02240186|prosthesis|prosthesis
218993|NCT02240186|amputation|amputation
218994|NCT02240173|antipsychotic Jobelyn schizophrenia sorghum bicolor|antipsychotic jobelyn schizophrenia sorghum bicolor
218995|NCT02240160|Sativex|sativex
218996|NCT02240160|Pharmacokinetics|pharmacokinetics
218997|NCT02240160|Oral pH|oral ph
218998|NCT02240147|adult congenital heart disease|adult congenital heart disease
218999|NCT02240147|exercise capacity|exercise capacity
219000|NCT02240147|exercise training|exercise training
219001|NCT02240147|physical activity|physical activity
219002|NCT02240121|Crohn's Disease|crohn's disease
219003|NCT02240121|Rifaximin|rifaximin
219004|NCT02240121|Clinical remission with endoscopic response|clinical remission with endoscopic response
219005|NCT02240121|Inflammatory Bowel Disease|inflammatory bowel disease
219006|NCT02240108|Crohn's Disease|crohn's disease
219007|NCT02240108|Rifaximin|rifaximin
219008|NCT02240108|Clinical remission with endoscopic response|clinical remission with endoscopic response
219009|NCT02240108|Inflammatory Bowel Disease|inflammatory bowel disease
219010|NCT02240082|Shiftwork|shiftwork
219011|NCT02240082|Sleep disruption|sleep disruption
219012|NCT02240082|Stress|stress
219013|NCT02240030|Parkinson's Disease|parkinson's disease
219014|NCT02240030|Motor fluctuations|motor fluctuations
219015|NCT02240030|levodopa|levodopa
219016|NCT02240030|inhaled drugs|inhaled drugs
219017|NCT02240030|OFF episodes|off episodes
219018|NCT02240017|Urothelial cancer, renal function impaired.|urothelial cancer, renal function impaired.
219019|NCT02239991|Point of care|point of care
219020|NCT02239991|perioperative hemostasis|perioperative hemostasis
219021|NCT02239991|thromboelastometry|thromboelastometry
219022|NCT02239991|bleeding risk|bleeding risk
219023|NCT02239991|end-stage liver disease|end-stage liver disease
219024|NCT02239991|hepatic coagulopathy|hepatic coagulopathy
219025|NCT02239991|whole blood coagulation|whole blood coagulation
219026|NCT02239978|Parkinson Disease|parkinson disease
219027|NCT02239978|Posture Balance|posture balance
219028|NCT02239978|Learning|learning
219029|NCT02239978|Dopamine|dopamine
219030|NCT02239965|Neuromuscular blockade|neuromuscular blockade
219031|NCT02239965|Neuromuscular monitoring|neuromuscular monitoring
219032|NCT02239965|Focus group interview|focus group interview
219033|NCT02239965|Clinical observation|clinical observation
219034|NCT02239939|older adults, body composition, weight loss, muscle mass|older adults, body composition, weight loss, muscle mass
219035|NCT02239926|IBS-D|ibs-d
219036|NCT02239913|Cocaine|cocaine
219037|NCT02239913|Pharmacotherapy|pharmacotherapy
219038|NCT02239913|Phentermine|phentermine
219039|NCT02239913|Topiramate|topiramate
219040|NCT02239913|Self-Administration|self-administration
219041|NCT02239900|Liver Cancer|liver cancer
219042|NCT02239900|Lung Cancer|lung cancer
219043|NCT02239900|Adrenal Gland|adrenal gland
219044|NCT02239900|Metastasis|metastasis
219045|NCT02239900|Advanced Solid Malignancies|advanced solid malignancies
219046|NCT02239900|Ipilimumab|ipilimumab
219047|NCT02239900|Yervoy|yervoy
219048|NCT02239900|BMS-734016|bms-734016
219049|NCT02239900|MDX010|mdx010
219050|NCT02239900|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
219051|NCT02239900|SBRT|sbrt
219052|NCT02239900|XRT|xrt
219053|NCT02239887|LAA occlusion|laa occlusion
219054|NCT02239887|Non-valvular Atrial Fibrillation|non-valvular atrial fibrillation
219055|NCT02239887|Percutaneous|percutaneous
219056|NCT02239887|Oral Anticoagulation|oral anticoagulation
219057|NCT02239887|Occluder|occluder
219058|NCT02239887|WAVECREST|wavecrest
219059|NCT02239874|mammographic breast density, breast disease, breast tissue|mammographic breast density, breast disease, breast tissue
219060|NCT02239861|Rhabdomyosarcoma|rhabdomyosarcoma
219061|NCT02239861|cytotoxic T lymphocytes|cytotoxic t lymphocytes
219062|NCT02239822|Electrodes, Implanted|electrodes, implanted
219063|NCT02239822|Electric Stimulation Therapy|electric stimulation therapy
219064|NCT02239809|Electrodes, Implanted|electrodes, implanted
219065|NCT02239809|Electric Stimulation Therapy|electric stimulation therapy
219066|NCT02239796|transcutaneous posterior tibial nerve stimulation|transcutaneous posterior tibial nerve stimulation
219067|NCT02239796|Randomised controlled trial|randomised controlled trial
219068|NCT02239796|Feasibility|feasibility
219069|NCT02239783|osteoarthritis|osteoarthritis
219070|NCT02239783|avascular necrosis|avascular necrosis
219071|NCT02239783|ankylosis|ankylosis
219072|NCT02239783|protrusio acetabuli|protrusio acetabuli
219073|NCT02239783|painful hip dysplasia|painful hip dysplasia
219074|NCT02239783|rheumatoid arthritis|rheumatoid arthritis
219075|NCT02239783|correction of functional deformity|correction of functional deformity
219076|NCT02239783|revision procedures|revision procedures
219077|NCT02239770|Nicotine|nicotine
219078|NCT02239770|Random Delivery|random delivery
219079|NCT02239770|Smoking Cessation|smoking cessation
219080|NCT02239770|Plasma Nicotine|plasma nicotine
219081|NCT02239770|Oral Film|oral film
219082|NCT02239757|Transradial Approach, Primary PCI, ST-segment elevation myocardial infarction|transradial approach, primary pci, st-segment elevation myocardial infarction
219083|NCT02239744|air pollution|air pollution
219084|NCT02239744|air purification|air purification
219085|NCT02239744|intervention|intervention
219086|NCT02239744|randomized controlled trial|randomized controlled trial
219087|NCT02239744|cardiovascular health|cardiovascular health
219088|NCT02239744|pulmonary health|pulmonary health
219089|NCT02239731|EGFRI|egfri
219090|NCT02239731|Epidermal Growth Factor Receptor Inhibition|epidermal growth factor receptor inhibition
219091|NCT02239731|Skin toxicity|skin toxicity
219092|NCT02239731|Topical|topical
219093|NCT02239731|Doxycycline|doxycycline
219094|NCT02239731|Foam|foam
219095|NCT02239731|Phase II|phase ii
219096|NCT02239731|Cetuximab|cetuximab
219097|NCT02239731|Panitumumab|panitumumab
219098|NCT02239731|Vectibix|vectibix
219099|NCT02239731|Erbitux|erbitux
219100|NCT02239731|Rash|rash
219101|NCT02239718|Resin bonded bridges|resin bonded bridges
219102|NCT02239718|Clinical trial|clinical trial
219103|NCT02239718|Prospective|prospective
219104|NCT02239718|Survival|survival
219105|NCT02239718|Oral health related quality of life|oral health related quality of life
219106|NCT02239705|Trans pulmonary thermodilution|trans pulmonary thermodilution
219107|NCT02239705|Hemodynamic|hemodynamic
219108|NCT02239679|Actinic Keratosis|actinic keratosis
219109|NCT02239666|Dermatology, plaque psoriasis, biologic treatment, biologic naive|dermatology, plaque psoriasis, biologic treatment, biologic naive
219110|NCT02239614|dengue fever|dengue fever
219111|NCT02239614|dengue|dengue
219112|NCT02239601|Physical Therapy|physical therapy
219113|NCT02239601|Physiotherapy|physiotherapy
219114|NCT02239601|Breast Cancer|breast cancer
219115|NCT02239601|Chemotherapy Induced Peripheral Neuropathy (CIPN)|chemotherapy induced peripheral neuropathy (cipn)
219116|NCT02239601|Nerve gliding exercises|nerve gliding exercises
219117|NCT02239601|Nerve Entrapment|nerve entrapment
219118|NCT02239575|Assorted cancers (oncology)|assorted cancers (oncology)
219119|NCT02239562|sPIF|spif
219120|NCT02239562|synthetic PreImplantation Factor|synthetic preimplantation factor
219121|NCT02239562|Autoimmune|autoimmune
219122|NCT02239562|Liver|liver
219123|NCT02239562|Hepatitis|hepatitis
219124|NCT02239549|Colonic Polyps|colonic polyps
219125|NCT02239549|Polypectomy|polypectomy
219126|NCT02239536|neoplastic colorectal polyp|neoplastic colorectal polyp
219127|NCT02239536|hot snare polypectomy|hot snare polypectomy
219128|NCT02239536|hot snare polypectomy after saline injection|hot snare polypectomy after saline injection
219129|NCT02239523|Pathologic fracture|pathologic fracture
219130|NCT02239523|Insufficiency fracture|insufficiency fracture
219131|NCT02239523|Secondary fracture|secondary fracture
219132|NCT02239523|Fracture with bone fragility|fracture with bone fragility
219133|NCT02239523|Osteoporosis|osteoporosis
219134|NCT02239523|Bone loss|bone loss
219135|NCT02239523|Osteopenia|osteopenia
219136|NCT02239523|Metabolic Bone Disease|metabolic bone disease
219137|NCT02239523|Fragility fracture|fragility fracture
219138|NCT02239510|constipation|constipation
219139|NCT02239510|bowel habits|bowel habits
219140|NCT02239497|postoperatory pain|postoperatory pain
219141|NCT02239497|orthopaedic surgery|orthopaedic surgery
219142|NCT02239497|femoral block|femoral block
219143|NCT02239432|Adenocarcinoma of the Lung|adenocarcinoma of the lung
219144|NCT02239432|Adenocarcinoma, Bronchiolo-Alveolar|adenocarcinoma, bronchiolo-alveolar
219145|NCT02239419|Critical Limb Ischemia|critical limb ischemia
219146|NCT02239419|Limb Ischemia|limb ischemia
219147|NCT02239419|Wound Care|wound care
219148|NCT02239419|Hemodialysis|hemodialysis
219149|NCT02239419|Dialysis|dialysis
219150|NCT02239419|Skin Ulceration|skin ulceration
219151|NCT02239406|metal on metal total hip|metal on metal total hip
219152|NCT02239406|avasuclar necrosis|avasuclar necrosis
219153|NCT02239406|acetabular revision|acetabular revision
219154|NCT02239406|bone vascularity|bone vascularity
219155|NCT02239393|Multiple Sclerosis|multiple sclerosis
219156|NCT02239393|Mesenchymal Stem Cells|mesenchymal stem cells
219157|NCT02239393|MSC|msc
219158|NCT02239380|Lorazepam|lorazepam
219159|NCT02239380|Status Epilepticus|status epilepticus
219160|NCT02239341|hospitalized|hospitalized
219161|NCT02239341|activity restriction|activity restriction
219162|NCT02239341|bed rest|bed rest
219163|NCT02239341|antepartum|antepartum
219164|NCT02239341|pregnant|pregnant
219165|NCT02239341|high risk|high risk
219166|NCT02239328|Lung cancer|lung cancer
219167|NCT02239328|esophageal cancer|esophageal cancer
219168|NCT02239315|Breast cancers|breast cancers
219169|NCT02239315|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
219170|NCT02239315|RNA Disruption Assay™ (RDA) score|rna disruption assay™ (rda) score
219171|NCT02239315|Pathological Complete Response (pCR)|pathological complete response (pcr)
219172|NCT02239315|Fine Needle Aspiration Biopsy|fine needle aspiration biopsy
219173|NCT02239302|Obstructed defaecation syndrome|obstructed defaecation syndrome
219174|NCT02239302|Transperineal Ultrasound|transperineal ultrasound
219175|NCT02239302|Endovaginal Ultrasound|endovaginal ultrasound
219176|NCT02239302|Evacuation Proctography|evacuation proctography
219177|NCT02239289|Low back pain|low back pain
219178|NCT02239289|Rehabilitation|rehabilitation
219179|NCT02239289|Biofeedback|biofeedback
219180|NCT02239289|Electromyography|electromyography
219181|NCT02239289|Kinematic|kinematic
219182|NCT02239276|Stiripentol|stiripentol
219183|NCT02239276|Dravet syndrome|dravet syndrome
219184|NCT02239276|Epilepsy|epilepsy
219185|NCT02239276|Epileptic Encephalopathies|epileptic encephalopathies
219186|NCT02239250|Child health|child health
219187|NCT02239250|Pneumonia|pneumonia
219188|NCT02239250|Diarrhoea|diarrhoea
219189|NCT02239250|Household air pollution|household air pollution
219190|NCT02239250|PM2.5|pm2.5
219191|NCT02239250|Stove intervention|stove intervention
219192|NCT02239250|Biomass fuel|biomass fuel
219193|NCT02239250|Monitoring and evaluation|monitoring and evaluation
219194|NCT02239250|Water filter|water filter
219195|NCT02239250|Compliance|compliance
219196|NCT02239250|Thermotolerant coliforms|thermotolerant coliforms
219197|NCT02239250|Rwanda|rwanda
219198|NCT02239224|FSHD|fshd
219199|NCT02239211|BUTEO|buteo
219200|NCT02239211|Primary sclerosing cholangitis|primary sclerosing cholangitis
219202|NCT02239211|VAP-1|vap-1
219203|NCT02239211|BTT1023|btt1023
219204|NCT02239211|Human monoclonal antibody|human monoclonal antibody
219205|NCT02239198|HDL|hdl
219206|NCT02239198|nutrition bar|nutrition bar
219207|NCT02239185|Laparoscopy|laparoscopy
219208|NCT02239185|purse string|purse string
219209|NCT02239185|hernial sac|hernial sac
219210|NCT02239159|transcutaneous electric acupoint stimulation|transcutaneous electric acupoint stimulation
219211|NCT02239159|elderly patients|elderly patients
219212|NCT02239133|Pelvic Organ Prolapse|pelvic organ prolapse
219213|NCT02239133|POP|pop
219214|NCT02239107|polycystic ovary syndrome|polycystic ovary syndrome
219215|NCT02239107|laparoscopic drilling|laparoscopic drilling
219216|NCT02239107|clomiphene citrate|clomiphene citrate
219217|NCT02239107|n acetyl cysteine|n acetyl cysteine
219218|NCT02239107|insulin resistance|insulin resistance
219219|NCT02239094|Bipolar Disorder|bipolar disorder
219220|NCT02239094|depression|depression
219221|NCT02239094|Bipolar depression|bipolar depression
219222|NCT02239081|Pharmacokinetics|pharmacokinetics
219223|NCT02239081|Safety|safety
219224|NCT02239068|CT, sedation, oral contrast|ct, sedation, oral contrast
219225|NCT02239055|Borderline Personality Disorder|borderline personality disorder
219226|NCT02239055|Mentalization Based Treatment|mentalization based treatment
219227|NCT02239055|MBT Skills Training|mbt skills training
219228|NCT02239055|Staff Nurse Perceptions|staff nurse perceptions
219229|NCT02239055|Acute Mental Health|acute mental health
219230|NCT02239042|Gingival recessions|gingival recessions
219231|NCT02239029|Platelet rich plasma|platelet rich plasma
219232|NCT02239029|Osteoarthritis of knee|osteoarthritis of knee
219233|NCT02239029|Balance|balance
219234|NCT02239029|Strength|strength
219235|NCT02239016|Sickle cell disease|sickle cell disease
219236|NCT02239016|Hgb SS|hgb ss
219237|NCT02239016|Hgb SC|hgb sc
219238|NCT02239016|Sβ-Thalassemia|sβ-thalassemia
219239|NCT02238977|depression|depression
219240|NCT02238977|ESRD|esrd
219241|NCT02238977|hemodialysis|hemodialysis
219242|NCT02238951|care coordination, mobile health, chemotherapy, technology|care coordination, mobile health, chemotherapy, technology
219243|NCT02238938|piecemeal polypectomy|piecemeal polypectomy
219244|NCT02238938|piecemeal endoscopic mucosal resection (EMR)|piecemeal endoscopic mucosal resection (emr)
219245|NCT02238938|endoscopic submucosal dissection (ESD)|endoscopic submucosal dissection (esd)
219246|NCT02238938|endoscopic en-bloc resection|endoscopic en-bloc resection
219247|NCT02238925|Newly Diagnosed AML|newly diagnosed aml
219248|NCT02238925|Secondary AML|secondary aml
219249|NCT02238925|Relapsed/Refractory AML|relapsed/refractory aml
219250|NCT02238925|Relapsed/Refractory ALL|relapsed/refractory all
219251|NCT02238925|MDS|mds
219252|NCT02238912|tinea|tinea
219253|NCT02238886|Quality of Life|quality of life
219254|NCT02238886|Enteral nutrition|enteral nutrition
219255|NCT02238886|Nutrition Therapy|nutrition therapy
219256|NCT02238886|Parenteral nutrition, total|parenteral nutrition, total
219257|NCT02238873|lymphoma|lymphoma
219258|NCT02238873|neutropenia|neutropenia
219259|NCT02238873|pegfilgrastim|pegfilgrastim
219260|NCT02238860|Hepatitis B|hepatitis b
219261|NCT02238860|cirrhosis|cirrhosis
219262|NCT02238860|Entacavir|entacavir
219263|NCT02238860|enofovir|enofovir
219264|NCT02238847|Pancreatic|pancreatic
219265|NCT02238847|Pancreatic Cancer|pancreatic cancer
219266|NCT02238847|Preoperative Biliary Drainage|preoperative biliary drainage
219267|NCT02238847|Neoadjuvant Therapy|neoadjuvant therapy
219268|NCT02238834|Phase I|phase i
219269|NCT02238834|Safety and tolerability|safety and tolerability
219270|NCT02238834|Pharmacokinetic|pharmacokinetic
219271|NCT02238834|Randomized|randomized
219272|NCT02238834|Double Blind|double blind
219273|NCT02238834|Placebo-Controlled|placebo-controlled
219274|NCT02238834|Single- & Multiple Dose Escalation|single- & multiple dose escalation
219275|NCT02238834|FP-025|fp-025
219276|NCT02238834|MMP-12 inhibitor|mmp-12 inhibitor
219277|NCT02238821|resectable colorectal cancer|resectable colorectal cancer
219278|NCT02238808|ER+ breast cancer|er+ breast cancer
219279|NCT02238808|Luminal A|luminal a
219280|NCT02238808|Estradiol|estradiol
219281|NCT02238795|Purpura fulminans, Sepsis, Epidemiology, Morbidity, Therapy|purpura fulminans, sepsis, epidemiology, morbidity, therapy
219282|NCT02238782|bioavailability|bioavailability
219283|NCT02238782|pharmacokinetics|pharmacokinetics
219284|NCT02238782|I phase|i phase
219285|NCT02238782|AZD6244|azd6244
219286|NCT02238782|cancer|cancer
219287|NCT02238769|Hepatocellular Carcinoma, 18F-FluoroethylCholine PET|hepatocellular carcinoma, 18f-fluoroethylcholine pet
219288|NCT02238730|Depression|depression
219289|NCT02238730|Depressive Disorder|depressive disorder
219290|NCT02238730|Treatment Resistant Depressive Disorder|treatment resistant depressive disorder
219291|NCT02238730|Bipolar Disorder|bipolar disorder
219292|NCT02238730|Major Depressive Disorder|major depressive disorder
219293|NCT02238730|Electroconvulsive therapy|electroconvulsive therapy
219294|NCT02238717|Pain|pain
219295|NCT02238717|evoked pain|evoked pain
219296|NCT02238717|healthy volunteer|healthy volunteer
219297|NCT02238717|pharmacodynamics|pharmacodynamics
219298|NCT02238704|Adherence|adherence
219299|NCT02238704|Calcium supplementation|calcium supplementation
219300|NCT02238704|Prevention of preeclampsia|prevention of preeclampsia
219301|NCT02238704|Adherence to calcium supplementation|adherence to calcium supplementation
219302|NCT02238691|PEEP|peep
219303|NCT02238691|Air insufflation|air insufflation
219304|NCT02238691|Mask ventilation|mask ventilation
219305|NCT02238691|Esophageal manometry|esophageal manometry
219306|NCT02238691|Esophageal impedance|esophageal impedance
219307|NCT02238652|Nursing homes|nursing homes
219308|NCT02238652|Dementia|dementia
219309|NCT02238652|Quality of Life|quality of life
219310|NCT02238652|Geriatrics|geriatrics
219311|NCT02238652|Aged|aged
219312|NCT02238652|Activities of Daily Living|activities of daily living
219313|NCT02238652|Pain|pain
219314|NCT02238652|Pain management|pain management
219315|NCT02238652|Advance Care Planning|advance care planning
219316|NCT02238652|Patient Safety|patient safety
219317|NCT02238652|Costs and Cost Analysis|costs and cost analysis
219318|NCT02238652|Medication Errors|medication errors
219319|NCT02238652|Medical Order Entry Systems|medical order entry systems
219320|NCT02238652|Medication Reconciliation|medication reconciliation
219321|NCT02238652|Medication Therapy Management|medication therapy management
219322|NCT02238652|Depression|depression
219323|NCT02238652|Psychotropic Drugs|psychotropic drugs
219324|NCT02238652|Informed Consent|informed consent
219325|NCT02238652|Presumed Consent|presumed consent
219326|NCT02238652|Anxiety|anxiety
219327|NCT02238652|Apathy|apathy
219328|NCT02238652|Hospitalization|hospitalization
219329|NCT02238652|Mortality|mortality
219330|NCT02238639|Venous thromboembolism|venous thromboembolism
219331|NCT02238639|COPD exacerbations|copd exacerbations
219332|NCT02238639|Anticoagulation|anticoagulation
219333|NCT02238639|Mortality|mortality
219334|NCT02238626|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
219335|NCT02238626|pharmacotherapy|pharmacotherapy
219336|NCT02238626|intervention|intervention
219337|NCT02238626|prospective|prospective
219338|NCT02238626|safety endpoint|safety endpoint
219339|NCT02238626|preliminary efficacy|preliminary efficacy
219340|NCT02238626|ibudilast|ibudilast
219341|NCT02238613|Radioactive stents|radioactive stents
219342|NCT02238613|Brachytherapy|brachytherapy
219343|NCT02238613|Biliary obstruction|biliary obstruction
219344|NCT02238613|Intrahepatic Cholangiocarcinoma|intrahepatic cholangiocarcinoma
219345|NCT02238613|Cholangiocarcinoma of the Extrahepatic Bile Duct|cholangiocarcinoma of the extrahepatic bile duct
219346|NCT02238613|ampullary carcinoma|ampullary carcinoma
219347|NCT02238587|Gandoerma Spores Powder Capsules, head-and-neck cancer.|gandoerma spores powder capsules, head-and-neck cancer.
219348|NCT02238561|non-invasive|non-invasive
219349|NCT02238561|measurement of oxygen|measurement of oxygen
219350|NCT02238561|consumption|consumption
219351|NCT02238561|delivery|delivery
219352|NCT02238561|post-operative complications|post-operative complications
219353|NCT02238548|immunity|immunity
219354|NCT02238548|vaccination|vaccination
219355|NCT02238548|milk|milk
219356|NCT02238522|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
219357|NCT02238522|B-prolymphocytic leukemia|b-prolymphocytic leukemia
219358|NCT02238522|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
219359|NCT02238522|follicular lymphoma|follicular lymphoma
219360|NCT02238522|mantle cell lymphoma|mantle cell lymphoma
219361|NCT02238522|marginal zone lymphoma|marginal zone lymphoma
219362|NCT02238522|small lymphocytic lymphoma|small lymphocytic lymphoma
219363|NCT02238522|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
219364|NCT02238522|unclassifiable lymphoma|unclassifiable lymphoma
219365|NCT02238522|T-cell lymphoma|t-cell lymphoma
219366|NCT02238522|Richter's syndrome|richter's syndrome
219367|NCT02238522|Waldenström's macroglobulinemia|waldenström's macroglobulinemia
219368|NCT02238509|Breast cancer|breast cancer
219369|NCT02238509|HER2 Positive|her2 positive
219370|NCT02238509|HER2+|her2+
219371|NCT02238509|MBC|mbc
219372|NCT02238509|Metastatic|metastatic
219373|NCT02238509|Metastatic breast cancer|metastatic breast cancer
219374|NCT02238509|Chemotherapy|chemotherapy
219375|NCT02238509|Lapatinib|lapatinib
219376|NCT02238509|Trastuzumab|trastuzumab
219377|NCT02238509|anti HER2 therapies|anti her2 therapies
219378|NCT02238496|Glioblastoma|glioblastoma
219379|NCT02238496|Anaplastic Astrocytoma|anaplastic astrocytoma
219380|NCT02238496|Anaplastic Oligodendroglioma|anaplastic oligodendroglioma
219381|NCT02238496|Mixed Glioma|mixed glioma
219382|NCT02238496|akt-Oncogene Protein|akt-oncogene protein
219383|NCT02238496|mTOR Protein|mtor protein
219384|NCT02238496|Glioma|glioma
219385|NCT02238496|Brain Neoplasms|brain neoplasms
219386|NCT02238496|Brain Tumor, Recurrent|brain tumor, recurrent
219387|NCT02238483|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
219388|NCT02238483|COPD patients|copd patients
219389|NCT02238483|Exacerbations|exacerbations
219390|NCT02238483|ICS|ics
219391|NCT02238483|LABA|laba
219392|NCT02238470|Ischemic stroke|ischemic stroke
219393|NCT02238470|Intracerebral hemorrhage|intracerebral hemorrhage
219394|NCT02238470|Subdural hemorrhage|subdural hemorrhage
219395|NCT02238470|Microbleed|microbleed
219396|NCT02238470|Leukoaraiosis|leukoaraiosis
219397|NCT02238470|Oral anticoagulants|oral anticoagulants
219398|NCT02238457|Heart failure|heart failure
219399|NCT02238457|Losartan|losartan
219400|NCT02238444|Warfarin|warfarin
219401|NCT02238444|Portal Vein|portal vein
219402|NCT02238444|Anticoagulants|anticoagulants
219403|NCT02238444|Cirrhosis|cirrhosis
219404|NCT02238444|Hypertension|hypertension
219405|NCT02238444|Venous Thrombosis|venous thrombosis
219406|NCT02238444|Splenectomy|splenectomy
219407|NCT02238431|Lucrin depot,|lucrin depot,
219408|NCT02238431|frozen embryo transfer,|frozen embryo transfer,
219409|NCT02238431|artificial cycle,|artificial cycle,
219410|NCT02238431|pregnancy,|pregnancy,
219411|NCT02238431|cancellation|cancellation
219412|NCT02238418|Vitamin D, Calciuria, Paediatrics, Nephrology|vitamin d, calciuria, paediatrics, nephrology
219413|NCT02238392|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
219414|NCT02238392|pulmonary vein isolation|pulmonary vein isolation
219415|NCT02238392|adenosine|adenosine
219416|NCT02238392|AF terminatin|af terminatin
219417|NCT02238379|Intranasal oxytocin|intranasal oxytocin
219418|NCT02238379|Social perception|social perception
219419|NCT02238379|EEG/ERP|eeg/erp
219420|NCT02238340|Postoperatory pain|postoperatory pain
219421|NCT02238340|Oxycodone|oxycodone
219422|NCT02238327|Antiretroviral therapy|antiretroviral therapy
219423|NCT02238327|pulmonary function|pulmonary function
219424|NCT02238327|biomarkers|biomarkers
219425|NCT02238301|Intrauterine growth restriction|intrauterine growth restriction
219426|NCT02238301|BOLD effect|bold effect
219427|NCT02238288|anticoagulation|anticoagulation
219428|NCT02238288|extraction|extraction
219429|NCT02238288|epsilon amino caproic|epsilon amino caproic
219430|NCT02238054|Cardiology|cardiology
219431|NCT02238054|Intracoronary angioplasty|intracoronary angioplasty
219432|NCT02238054|Bioresorbable stent|bioresorbable stent
219433|NCT02238041|Glucose monitoring|glucose monitoring
219434|NCT02238041|Intensive care unit|intensive care unit
219435|NCT02238028|Heart rate variability|heart rate variability
219436|NCT02238028|Blood pressure|blood pressure
219437|NCT02238028|Circulating biomarkers|circulating biomarkers
219438|NCT02238028|Respirator|respirator
219439|NCT02238028|Fine particulate matter|fine particulate matter
219440|NCT02238015|cataract ,tear film,SS-OCT|cataract ,tear film,ss-oct
219441|NCT02238002|shallow anterior chamber|shallow anterior chamber
219442|NCT02238002|narrow angle|narrow angle
219443|NCT02238002|SS-OCT|ss-oct
219444|NCT02237989|knee osteoarthritis, native collagen type 2, paracetamol|knee osteoarthritis, native collagen type 2, paracetamol
219445|NCT02237937|Depression, Affective Disorder|depression, affective disorder
219446|NCT02237924|nasopharyngeal carcinoma|nasopharyngeal carcinoma
219447|NCT02237924|endostar|endostar
219448|NCT02237924|IMRT|imrt
219449|NCT02237924|chemoradiation|chemoradiation
219450|NCT02237911|total knee replacement|total knee replacement
219451|NCT02237911|rehabilitation|rehabilitation
219452|NCT02237911|exercise program|exercise program
219453|NCT02237911|total knee arthroplasty|total knee arthroplasty
219454|NCT02237898|Tobacco cessation|tobacco cessation
219455|NCT02237885|Military Veterans|military veterans
219456|NCT02237872|Brown Adipose Tissue|brown adipose tissue
219457|NCT02237859|cdiff|cdiff
219458|NCT02237859|vancomycin|vancomycin
219459|NCT02237859|infection|infection
219460|NCT02237859|clostridium difficile|clostridium difficile
219461|NCT02237846|osteoarthritis|osteoarthritis
219462|NCT02237846|knee|knee
219463|NCT02237846|stem cells|stem cells
219464|NCT02237846|mesenchymal|mesenchymal
219465|NCT02237846|umbilical cord|umbilical cord
219466|NCT02237833|septic shock|septic shock
219467|NCT02237833|cerebral oximetry|cerebral oximetry
219468|NCT02237833|vasopressor|vasopressor
219469|NCT02237833|norepinephrine|norepinephrine
219470|NCT02237807|Fed Conditions|fed conditions
219471|NCT02237781|AMH|amh
219472|NCT02237781|IVF|ivf
219473|NCT02237781|ovarian stimulation|ovarian stimulation
219474|NCT02237768|Fasting conditions|fasting conditions
219475|NCT02237755|Clomiphene citrate|clomiphene citrate
219476|NCT02237755|IVF|ivf
219477|NCT02237755|Pregnancy Rates|pregnancy rates
219478|NCT02237755|Ovarian Reserve|ovarian reserve
219479|NCT02237729|healthy subjects|healthy subjects
219480|NCT02237729|immunology|immunology
219481|NCT02237729|PK|pk
219482|NCT02237729|Phase 1|phase 1
219483|NCT02237729|bioequivalence|bioequivalence
219484|NCT02237729|biosimilarity|biosimilarity
219485|NCT02237729|adalimumab|adalimumab
219486|NCT02237729|single dose.|single dose.
219487|NCT02237703|Post-traumatic Stress Disorder (PTSD)|post-traumatic stress disorder (ptsd)
219488|NCT02237703|Positron emission tomography (PET)|positron emission tomography (pet)
219489|NCT02237703|Neuroimaging|neuroimaging
219490|NCT02237703|Kappa opioid receptor (KOR)|kappa opioid receptor (kor)
219491|NCT02237677|Post-traumatic stress disorder (PTSD)|post-traumatic stress disorder (ptsd)
219492|NCT02237677|Trauma|trauma
219493|NCT02237677|Neuroimaging|neuroimaging
219494|NCT02237677|Positron emission tomography (PET)|positron emission tomography (pet)
219495|NCT02237677|[11C]OMAR|[11c]omar
219496|NCT02237677|Endocannabinoid|endocannabinoid
219497|NCT02237664|Thoracoscopy|thoracoscopy
219498|NCT02237664|Patient-controlled analgesia|patient-controlled analgesia
219499|NCT02237664|Paravertebral analgesia|paravertebral analgesia
219500|NCT02237651|anesthesia|anesthesia
219501|NCT02237651|bronchosocopy|bronchosocopy
219502|NCT02237651|lung transplantation|lung transplantation
219503|NCT02237638|VEGF|vegf
219504|NCT02237638|Vaccine|vaccine
219505|NCT02237638|Angiogenesis|angiogenesis
219506|NCT02237625|Hypophosphatasia|hypophosphatasia
219507|NCT02237625|HPP|hpp
219508|NCT02237599|SSEP|ssep
219509|NCT02237599|neuropraxia|neuropraxia
219510|NCT02237599|intraoperative|intraoperative
219511|NCT02237599|automated|automated
219512|NCT02237586|Plasmodium falciparum malaria|plasmodium falciparum malaria
219513|NCT02237586|Malaria|malaria
219514|NCT02237586|PfSPZ Challenge|pfspz challenge
219515|NCT02237586|Controlled Human Malaria Infection (CHMI)|controlled human malaria infection (chmi)
219516|NCT02237586|Sickle Cell Trait|sickle cell trait
219517|NCT02237586|Sporozoites|sporozoites
219518|NCT02237573|general practice|general practice
219519|NCT02237573|viral infections|viral infections
219520|NCT02237573|consultation reports|consultation reports
219521|NCT02237573|drug prescription|drug prescription
219522|NCT02237560|MCI|mci
219523|NCT02237560|Exergaming|exergaming
219524|NCT02237560|Cognition|cognition
219525|NCT02237560|Exercise|exercise
219526|NCT02237560|Older Adults|older adults
219527|NCT02237547|spinal cord injury|spinal cord injury
219528|NCT02237547|mesenchymal|mesenchymal
219529|NCT02237547|bone marrow|bone marrow
219530|NCT02237547|mononuclear cells|mononuclear cells
219531|NCT02237547|stem cells|stem cells
219532|NCT02237547|umbilical cord|umbilical cord
219533|NCT02237534|Lanthanum|lanthanum
219534|NCT02237534|Calcium Carbonate|calcium carbonate
219535|NCT02237534|Vascular Calcification|vascular calcification
219536|NCT02237521|Incretin hormones|incretin hormones
219537|NCT02237521|End-stage renal disease|end-stage renal disease
219538|NCT02237521|ESRD|esrd
219539|NCT02237521|GLP-1|glp-1
219540|NCT02237521|GIP|gip
219541|NCT02237521|Insulin|insulin
219542|NCT02237521|Glucagon|glucagon
219543|NCT02237469|Breast cancer|breast cancer
219544|NCT02237469|Breast conserving surgery.|breast conserving surgery.
219545|NCT02237469|Radiotherapy.|radiotherapy.
219546|NCT02237469|Treatment planning.|treatment planning.
219547|NCT02237469|Prone.|prone.
219548|NCT02237456|Myocardial infarction|myocardial infarction
219549|NCT02237456|Atherosclerosis|atherosclerosis
219550|NCT02237456|PCI|pci
219551|NCT02237456|OCT|oct
219552|NCT02237456|Optical coherence tomography|optical coherence tomography
219553|NCT02237456|Stent|stent
219554|NCT02237456|Bioresorbable stents|bioresorbable stents
219555|NCT02237443|Patient Safety|patient safety
219556|NCT02237430|Coronary angiography (CAG)|coronary angiography (cag)
219557|NCT02237417|MRI|mri
219558|NCT02237417|Imaging|imaging
219559|NCT02237417|Antipsychotic|antipsychotic
219560|NCT02237404|Follow-Up studies|follow-up studies
219561|NCT02237404|Biological Pacemakers|biological pacemakers
219562|NCT02237404|Telemedicine|telemedicine
219563|NCT02237404|Efficiency|efficiency
219564|NCT02237391|High Frequency Emergency Department Visits|high frequency emergency department visits
219565|NCT02237391|Healthcare Utilization|healthcare utilization
219566|NCT02237391|Chronic Pain|chronic pain
219567|NCT02237391|Interdisciplinary|interdisciplinary
219568|NCT02237378|FDG lung and RV uptake|fdg lung and rv uptake
219569|NCT02237365|neurological disability|neurological disability
219570|NCT02237365|tuberculous meningitis (TBM)|tuberculous meningitis (tbm)
219571|NCT02237365|safety|safety
219572|NCT02237365|aspirin|aspirin
219573|NCT02237365|efficacy|efficacy
219574|NCT02237352|Diabetes mellitus|diabetes mellitus
219575|NCT02237352|Diabetic nephropathy|diabetic nephropathy
219576|NCT02237352|Social Factors|social factors
219577|NCT02237352|Biological Factors|biological factors
219578|NCT02237352|VEGF-A|vegf-a
219579|NCT02237352|Tenascin C|tenascin c
219580|NCT02237352|Disease characterization|disease characterization
219581|NCT02237352|Mechanisms|mechanisms
219582|NCT02237352|Kidney|kidney
219583|NCT02237352|Chronic kidney disease|chronic kidney disease
219584|NCT02237352|Secondary nephropathy|secondary nephropathy
219585|NCT02237352|South America|south america
219586|NCT02237352|Hispanics|hispanics
219587|NCT02237352|Ecuador|ecuador
219588|NCT02237352|Biomarkers|biomarkers
219589|NCT02237339|Allopurinol|allopurinol
219590|NCT02237339|Cardiac MRI (CMR)|cardiac mri (cmr)
219591|NCT02237339|Flow mediated dilatation (FMD)|flow mediated dilatation (fmd)
219592|NCT02237339|Pulse wave analysis (PWA)|pulse wave analysis (pwa)
219593|NCT02237339|Endothelial function|endothelial function
219594|NCT02237339|Scar|scar
219595|NCT02237339|Hypertrophy|hypertrophy
219596|NCT02237339|Hypertension|hypertension
219597|NCT02237326|Visual Inspection with Acetic Acid|visual inspection with acetic acid
219598|NCT02237326|Visual Inspection with Lugol's Iodine|visual inspection with lugol's iodine
219599|NCT02237326|Cervical Intraepithelial neoplasia|cervical intraepithelial neoplasia
219600|NCT02237326|Cervical Cancer Screening|cervical cancer screening
219601|NCT02237326|HIV infected women|hiv infected women
219602|NCT02237313|psychological support|psychological support
219603|NCT02237313|therapeutic education|therapeutic education
219604|NCT02237313|vulnerability of patients|vulnerability of patients
219605|NCT02237300|Bulimia nervosa|bulimia nervosa
219606|NCT02237300|Binge eating disorder|binge eating disorder
219607|NCT02237300|Food craving|food craving
219608|NCT02237300|Anxiety|anxiety
219609|NCT02237300|Bingeing|bingeing
219610|NCT02237300|Cue Exposure Therapy|cue exposure therapy
219611|NCT02237300|Virtual Reality|virtual reality
219612|NCT02237274|Fontan circulation|fontan circulation
219613|NCT02237274|High altitude exposure|high altitude exposure
219614|NCT02237261|Newly diagnosed symptomatic multiple myeloma|newly diagnosed symptomatic multiple myeloma
219615|NCT02237248|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
219616|NCT02237248|Functional Movement Screen|functional movement screen
219617|NCT02237248|Y Balance Test|y balance test
219618|NCT02237235|Schizophrenia|schizophrenia
219619|NCT02237235|Schizoaffective disorder|schizoaffective disorder
219620|NCT02237235|Cognition|cognition
219621|NCT02237235|Magnesium|magnesium
219622|NCT02237235|Imaging|imaging
219623|NCT02237235|Negative symptoms|negative symptoms
219624|NCT02237222|Outcome Assessment|outcome assessment
219625|NCT02237222|Gait|gait
219626|NCT02237222|Neuromuscular Diseases|neuromuscular diseases
219627|NCT02237222|Psychometrics|psychometrics
219628|NCT02237222|Clinical Assessment Tools|clinical assessment tools
219629|NCT02237196|cat-allergic|cat-allergic
219630|NCT02237196|cat immunotherapy|cat immunotherapy
219631|NCT02237196|anti-thymic stromal lymphopoietin (anti-TSLP)|anti-thymic stromal lymphopoietin (anti-tslp)
219632|NCT02237170|Sipuleucel-T|sipuleucel-t
219633|NCT02237170|Castration Resistant Prostate Cancer|castration resistant prostate cancer
219634|NCT02237170|Provenge|provenge
219635|NCT02237157|pancreatic cancer|pancreatic cancer
219636|NCT02237157|unresectable|unresectable
219637|NCT02237157|gemcitabine|gemcitabine
219638|NCT02237157|device|device
219639|NCT02237157|local delivery|local delivery
219640|NCT02237157|chemoembolization|chemoembolization
219641|NCT02237131|Endometriosis|endometriosis
219642|NCT02237131|Oral contraceptives|oral contraceptives
219643|NCT02237131|Laparoscopy|laparoscopy
219644|NCT02237118|Acute|acute
219645|NCT02237118|wound|wound
219646|NCT02237118|management|management
219647|NCT02237118|measured|measured
219648|NCT02237118|Visual analoge scale|visual analoge scale
219649|NCT02237066|OCT|oct
219650|NCT02237066|PTA|pta
219651|NCT02237066|Balloon|balloon
219652|NCT02237053|Energy expenditure|energy expenditure
219653|NCT02237053|Glucagon|glucagon
219654|NCT02237053|Octreotide|octreotide
219655|NCT02237053|Weight loss|weight loss
219656|NCT02237040|Children|children
219657|NCT02237040|mandible|mandible
219658|NCT02237040|condylar fracture|condylar fracture
219659|NCT02237040|conservative treatment|conservative treatment
219660|NCT02237040|functional treatment|functional treatment
219661|NCT02237027|HIV|hiv
219662|NCT02237027|Early treatment as prevention (TasP)|early treatment as prevention (tasp)
219663|NCT02237027|Pre-exposure prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
219664|NCT02237027|antiretroviral treatment|antiretroviral treatment
219667|NCT02237027|female sex workers|female sex workers
219668|NCT02237027|Benin|benin
219669|NCT02237027|West Africa|west africa
219670|NCT02237001|meniscal|meniscal
219671|NCT02237001|meniscus|meniscus
219672|NCT02237001|repair|repair
219673|NCT02237001|knee|knee
219674|NCT02237001|arthroscopy knee|arthroscopy knee
219675|NCT02237001|horizontal|horizontal
219676|NCT02236988|Apremilast|apremilast
219677|NCT02236988|Healthy male subjects|healthy male subjects
219678|NCT02236988|Pharmacokinetics|pharmacokinetics
219679|NCT02236949|pediatric pain|pediatric pain
219680|NCT02236949|intervention sustainability|intervention sustainability
219681|NCT02236936|Squamous Cell Carcinoma|squamous cell carcinoma
219682|NCT02236936|Head and neck|head and neck
219683|NCT02236936|SCCHN|scchn
219684|NCT02236936|Parenteral nutrition|parenteral nutrition
219685|NCT02236936|Larynx|larynx
219686|NCT02236936|Hypopharynx|hypopharynx
219687|NCT02236936|Cavum oris|cavum oris
219688|NCT02236936|Radiotherapy|radiotherapy
219689|NCT02236936|Cetuximab|cetuximab
219690|NCT02236936|Cisplatin|cisplatin
219691|NCT02236923|cardiovascular|cardiovascular
219692|NCT02236923|surgery|surgery
219693|NCT02236923|ascending aorta|ascending aorta
219694|NCT02236923|aortic dissection|aortic dissection
219695|NCT02236910|somatostatin receptor positive tumour|somatostatin receptor positive tumour
219696|NCT02236884|rectal cancer|rectal cancer
219697|NCT02236884|no scar|no scar
219698|NCT02236884|NOTES|notes
219699|NCT02236884|TaTME|tatme
219700|NCT02236884|feasibility|feasibility
219701|NCT02236884|safety|safety
219702|NCT02236871|Adolescents|adolescents
219703|NCT02236871|Dairy|dairy
219704|NCT02236871|Bone|bone
219705|NCT02236858|COPD|copd
219706|NCT02236845|Insomnia, medical device, sleep latency|insomnia, medical device, sleep latency
219707|NCT02236806|Breast cancer|breast cancer
219708|NCT02236806|Adjuvant chemotherapy|adjuvant chemotherapy
219709|NCT02236806|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
219710|NCT02236806|Cardioprotection|cardioprotection
219711|NCT02236806|Anthracyclines|anthracyclines
219712|NCT02236780|in vitro fertilisation|in vitro fertilisation
219713|NCT02236780|environmental conditions|environmental conditions
219714|NCT02236780|pregnancy|pregnancy
219715|NCT02236780|live birth rate|live birth rate
219716|NCT02236754|dihydrotetrabenazine|dihydrotetrabenazine
219717|NCT02236754|beta cell mass|beta cell mass
219718|NCT02236754|diabetes mellitus|diabetes mellitus
219719|NCT02236702|Major Depressive Disorder|major depressive disorder
219720|NCT02236702|Anhedonia|anhedonia
219721|NCT02236702|Positron Emission Tomography (PET)|positron emission tomography (pet)
219722|NCT02236702|Kappa Opioid Receptor (KOR)|kappa opioid receptor (kor)
219723|NCT02236676|motor learning TBI|motor learning tbi
219724|NCT02236663|Intimate Partner Violence|intimate partner violence
219725|NCT02236663|Dating Violence|dating violence
219726|NCT02236663|Relationships|relationships
219727|NCT02236663|Safety Planning|safety planning
219728|NCT02236663|College|college
219729|NCT02236663|Student|student
219730|NCT02236663|App|app
219731|NCT02236650|Parental Resilience|parental resilience
219732|NCT02236650|Parental Stress|parental stress
219733|NCT02236650|Family Adaptation|family adaptation
219734|NCT02236650|Autistic Disorder|autistic disorder
219735|NCT02236650|Behavior|behavior
219736|NCT02236650|Child Behavior|child behavior
219737|NCT02236650|Child Development Disorders|child development disorders
219738|NCT02236650|Pervasive Developmental Disabilities|pervasive developmental disabilities
219739|NCT02236650|Caregivers|caregivers
219740|NCT02236650|Parents|parents
219741|NCT02236650|Parenting|parenting
219742|NCT02236650|Primary Health Care|primary health care
219743|NCT02236637|Adenocarcinoma of the Prostate|adenocarcinoma of the prostate
219744|NCT02236637|Registry|registry
219745|NCT02236637|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
219746|NCT02236611|COPD|copd
219747|NCT02236611|inhaler ease of use|inhaler ease of use
219748|NCT02236611|glycopyrronium|glycopyrronium
219749|NCT02236611|umeclidinium|umeclidinium
219750|NCT02236611|novel dry powder inhaler|novel dry powder inhaler
219751|NCT02236611|long-acting muscarinic antagonist|long-acting muscarinic antagonist
219752|NCT02236611|inhaler errors|inhaler errors
219753|NCT02236598|borderline hypokalemia|borderline hypokalemia
219754|NCT02236598|glucose tolerance|glucose tolerance
219755|NCT02236598|insulin secretion|insulin secretion
219756|NCT02236598|insulin sensitivity|insulin sensitivity
219757|NCT02236598|fasting glucose|fasting glucose
219758|NCT02236598|African American|african american
219759|NCT02236585|uterine artery embolization, epidural , patient-controlled analgesia|uterine artery embolization, epidural , patient-controlled analgesia
219760|NCT02236572|Postmenopausal|postmenopausal
219761|NCT02236572|ER-positive, PR-positive, HER2-negative|er-positive, pr-positive, her2-negative
219762|NCT02236572|Low and intermediate risk|low and intermediate risk
219763|NCT02236559|high flow therapy|high flow therapy
219764|NCT02236559|high flow nasal cannula|high flow nasal cannula
219765|NCT02236559|acute respiratory failure|acute respiratory failure
219766|NCT02236559|noninvasive ventilation|noninvasive ventilation
219767|NCT02236546|fluorodeoxyglucose|fluorodeoxyglucose
219768|NCT02236546|FDG|fdg
219769|NCT02236546|PET/CT|pet/ct
219770|NCT02236546|melanoma|melanoma
219771|NCT02236546|imaging biomarkers|imaging biomarkers
219772|NCT02236546|cancer imaging|cancer imaging
219773|NCT02236520|Na+ MRI|na+ mri
219774|NCT02236520|salt stores|salt stores
219775|NCT02236494|alcoholism|alcoholism
219776|NCT02236494|dangerous behavior|dangerous behavior
219777|NCT02236494|aged|aged
219778|NCT02236494|emergency medicine|emergency medicine
219779|NCT02236455|complementary medicine|complementary medicine
219780|NCT02236455|state anxiety|state anxiety
219781|NCT02236455|acute pain|acute pain
219782|NCT02236455|self-efficacy|self-efficacy
219783|NCT02236455|surgery|surgery
219784|NCT02236455|medical music intervention|medical music intervention
219785|NCT02236455|nature therapy|nature therapy
219786|NCT02236455|relaxation technique|relaxation technique
219787|NCT02236442|Cephalalgia|cephalalgia
219788|NCT02236442|Headache|headache
219789|NCT02236442|Migraine|migraine
219790|NCT02236442|Pain|pain
219791|NCT02236442|Global|global
219792|NCT02236442|Treatment|treatment
219793|NCT02236442|Oxygen|oxygen
219794|NCT02236442|Emergency|emergency
219795|NCT02236442|Treatment of cephalalgia in emergency department|treatment of cephalalgia in emergency department
219796|NCT02236429|bacterial vaginitis|bacterial vaginitis
219797|NCT02236429|vaginal flora|vaginal flora
219798|NCT02236429|microbiome|microbiome
219799|NCT02236416|Dementia|dementia
219800|NCT02236416|Prevention|prevention
219801|NCT02236416|Physical Activity|physical activity
219802|NCT02236403|Blepharitis , Demodex, Ivermectin, Metronidazole|blepharitis , demodex, ivermectin, metronidazole
219803|NCT02236390|Nightmare|nightmare
219804|NCT02236390|PTSD|ptsd
219805|NCT02236390|Sleep|sleep
219806|NCT02236390|Emotion Regulation|emotion regulation
219807|NCT02236390|Exposure Relaxation and Rescripting Therapy|exposure relaxation and rescripting therapy
219808|NCT02236390|Cognitive Processing Therapy|cognitive processing therapy
219809|NCT02236377|ERRT|errt
219810|NCT02236377|Nightmares|nightmares
219811|NCT02236377|Sleep|sleep
219812|NCT02236377|Trauma|trauma
219813|NCT02236377|PTSD|ptsd
219814|NCT02236351|patching|patching
219815|NCT02236351|pediatric ophthalmology|pediatric ophthalmology
219816|NCT02236338|chronic venous insufficiency|chronic venous insufficiency
219817|NCT02236338|varicose vein|varicose vein
219818|NCT02236338|greater saphenous vein|greater saphenous vein
219819|NCT02236299|Right Coronary Artery|right coronary artery
219820|NCT02236299|Percutaneous Coronary Intervention|percutaneous coronary intervention
219821|NCT02236299|Diastolic Dysfunction|diastolic dysfunction
219822|NCT02236299|Glucagon-like peptide-1|glucagon-like peptide-1
219823|NCT02236299|GLP-1|glp-1
219824|NCT02236299|Stunning|stunning
219825|NCT02236299|Cardioprotection|cardioprotection
219826|NCT02236286|freezing of gait (FOG)|freezing of gait (fog)
219827|NCT02236286|balance|balance
219828|NCT02236286|gait|gait
219829|NCT02236286|exercise|exercise
219830|NCT02236273|Human papillomavirus|human papillomavirus
219831|NCT02236273|vaccination|vaccination
219832|NCT02236273|text message|text message
219833|NCT02236273|reminder|reminder
219834|NCT02236247|ivabradine|ivabradine
219835|NCT02236247|heart rate|heart rate
219836|NCT02236247|heart failure|heart failure
219837|NCT02236234|HIV|hiv
219838|NCT02236234|HPV|hpv
219839|NCT02236234|Clinical trial|clinical trial
219840|NCT02236234|outcome|outcome
219841|NCT02236195|Urothelial|urothelial
219842|NCT02236195|Bladder|bladder
219843|NCT02236195|HDAC|hdac
219844|NCT02236195|MGCD0103|mgcd0103
219845|NCT02236195|Mocetinostat|mocetinostat
219846|NCT02236195|CREBBP|crebbp
219847|NCT02236195|EP300|ep300
219848|NCT02236195|Mirati|mirati
219849|NCT02236195|MethylGene|methylgene
219850|NCT02236143|Healthy|healthy
219851|NCT02236130|pediatric regional|pediatric regional
219852|NCT02236117|heart rate variability|heart rate variability
219853|NCT02236117|children|children
219854|NCT02236117|progressive test|progressive test
219855|NCT02236104|neuromuscular disorders|neuromuscular disorders
219856|NCT02236104|mechanical insufflation-exsufflation|mechanical insufflation-exsufflation
219857|NCT02236104|respiratory parameters|respiratory parameters
219858|NCT02236104|plethysmography opto electronic|plethysmography opto electronic
219859|NCT02236104|Vital capacity|vital capacity
219860|NCT02236091|cerebral palsy|cerebral palsy
219861|NCT02236091|stroke|stroke
219862|NCT02236091|traumatic brain injury|traumatic brain injury
219863|NCT02236065|Umbilical cord blood|umbilical cord blood
219864|NCT02236065|Granulocyte-colony stimulating factor|granulocyte-colony stimulating factor
219865|NCT02236065|Brain injury|brain injury
219866|NCT02236065|Neurodegenerative disorder|neurodegenerative disorder
219867|NCT02236065|Efficacy|efficacy
219868|NCT02236065|Safety|safety
219869|NCT02236052|Influenza|influenza
219870|NCT02236052|Human|human
219871|NCT02236052|RNA Virus Infections|rna virus infections
219872|NCT02236052|Immunologic|immunologic
219873|NCT02236052|Immunogenic Factors|immunogenic factors
219874|NCT02236052|Physiological Effects of Drugs|physiological effects of drugs
219875|NCT02236052|Virus diseases|virus diseases
219876|NCT02236052|Orthomyxoviridae Infections|orthomyxoviridae infections
219877|NCT02236052|Infection|infection
219878|NCT02236039|Diesel exhaust|diesel exhaust
219879|NCT02236039|Air pollution|air pollution
219880|NCT02236039|Airway responsivness|airway responsivness
219881|NCT02236026|Nestorone use as an IV solution on heart rate;|nestorone use as an iv solution on heart rate;
219882|NCT02236026|Abnormality in Heart Rate or Rhythm, Unspecified as to Time of Onset|abnormality in heart rate or rhythm, unspecified as to time of onset
219883|NCT02236013|ASP2215|asp2215
219884|NCT02236013|Daunorubicin|daunorubicin
219885|NCT02236013|Gilteritinib|gilteritinib
219886|NCT02236013|Acute Myeloid Leukemia|acute myeloid leukemia
219887|NCT02236013|Idarubicin|idarubicin
219888|NCT02236013|Cytarabine|cytarabine
219889|NCT02236000|NSABP|nsabp
219890|NCT02236000|Trastuzumab Emtansine|trastuzumab emtansine
219891|NCT02236000|T DM1|t dm1
219892|NCT02236000|Neratinib|neratinib
219893|NCT02236000|Metastatic Breast Cancer|metastatic breast cancer
219894|NCT02236000|HER2 positive|her2 positive
219895|NCT02236000|Dose Escalation|dose escalation
219896|NCT02235974|stroke|stroke
219897|NCT02235974|critical periods|critical periods
219898|NCT02235974|sensitive periods|sensitive periods
219899|NCT02235974|hemiparesis|hemiparesis
219900|NCT02235974|upper extremity|upper extremity
219901|NCT02235974|physical rehabilitation|physical rehabilitation
219902|NCT02235974|arm therapy|arm therapy
219903|NCT02235974|occupational therapy|occupational therapy
219904|NCT02235974|physical therapy|physical therapy
219905|NCT02235974|task oriented training|task oriented training
219906|NCT02235974|patient focused|patient focused
219907|NCT02235974|arm function|arm function
219908|NCT02235974|hand function|hand function
219909|NCT02235974|neurorehabilitation|neurorehabilitation
219910|NCT02235974|motor learning|motor learning
219911|NCT02235974|motor control|motor control
219912|NCT02235974|motor function|motor function
219913|NCT02235974|motor recovery|motor recovery
219914|NCT02235974|skill acquisition|skill acquisition
219915|NCT02235974|skill training|skill training
219916|NCT02235948|arsenic induced health problem|arsenic induced health problem
219917|NCT02235948|modifying effects|modifying effects
219918|NCT02235948|folic acid|folic acid
219919|NCT02235948|oxidative damage|oxidative damage
219920|NCT02235948|clinical trial|clinical trial
219921|NCT02235922|Aged|aged
219922|NCT02235922|Exercise|exercise
219923|NCT02235922|Cognition|cognition
219924|NCT02235922|Functional capacity|functional capacity
219925|NCT02235909|Pediatric Hypertension|pediatric hypertension
219926|NCT02235909|High Blood Pressure|high blood pressure
219927|NCT02235909|Hypertension|hypertension
219928|NCT02235909|Pediatric|pediatric
219929|NCT02235909|Primary Hypertension|primary hypertension
219930|NCT02235909|Secondary Hypertension|secondary hypertension
219931|NCT02235896|risk factors, African American, lipids, blood pressure|risk factors, african american, lipids, blood pressure
219932|NCT02235883|Coronary artery disease|coronary artery disease
219933|NCT02235883|FFR|ffr
219934|NCT02235883|diagnosis|diagnosis
219935|NCT02235883|computational model|computational model
219936|NCT02235883|non-invasive|non-invasive
219937|NCT02235870|Weight Loss|weight loss
219938|NCT02235870|Obesity|obesity
219939|NCT02235870|BMI|bmi
219940|NCT02235857|pediatric, renal transplantation, recurrence, drug-resistant|pediatric, renal transplantation, recurrence, drug-resistant
219941|NCT02235844|Mesenchymal|mesenchymal
219942|NCT02235844|Stem Cells|stem cells
219943|NCT02235844|Umbilical Cord|umbilical cord
219944|NCT02235844|Duchenne's|duchenne's
219945|NCT02235844|Muscular Dystrophy|muscular dystrophy
219946|NCT02235831|DACP MF|dacp mf
219947|NCT02235831|DAILIES AquaComfort Plus® Multifocal|dailies aquacomfort plus® multifocal
219948|NCT02235831|presbyopia|presbyopia
219949|NCT02235831|visual performance|visual performance
219950|NCT02235818|tennis elbow, treatment, lateral epicondylitis, immediate effects|tennis elbow, treatment, lateral epicondylitis, immediate effects
219951|NCT02235805|Metabolic Syndrome|metabolic syndrome
219952|NCT02235805|Obesity|obesity
219953|NCT02235805|Magnesium Supplementation|magnesium supplementation
219954|NCT02235805|Vascular Stiffness|vascular stiffness
219955|NCT02235805|Vascular Function|vascular function
219956|NCT02235779|ILD|ild
219957|NCT02235779|Pulmonary fibrosis|pulmonary fibrosis
219958|NCT02235779|Cryobiopsy|cryobiopsy
219959|NCT02235779|Transbronchial|transbronchial
219960|NCT02235766|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
219961|NCT02235766|Satellite Tele-Echocardiography|satellite tele-echocardiography
219962|NCT02235740|Open label|open label
219963|NCT02235740|carfilzomib|carfilzomib
219964|NCT02235740|Phase I|phase i
219965|NCT02235740|clinical activity|clinical activity
219966|NCT02235740|pharmacokinetics|pharmacokinetics
219967|NCT02235740|afuresertib|afuresertib
219968|NCT02235740|relapsed|relapsed
219969|NCT02235740|refractory|refractory
219970|NCT02235740|safety|safety
219971|NCT02235740|multiple myeloma|multiple myeloma
219972|NCT02235714|Airway inflammation|airway inflammation
219973|NCT02235714|Tetraplegia|tetraplegia
219974|NCT02235714|Asthma|asthma
219975|NCT02235714|Exhaled breath condensate|exhaled breath condensate
219976|NCT02235714|Spirometry|spirometry
219977|NCT02235714|Pulmonary Function Testing|pulmonary function testing
219978|NCT02235701|soft tissue sarcoma|soft tissue sarcoma
219979|NCT02235701|aldoxorubicin|aldoxorubicin
219980|NCT02235701|ifosfamide|ifosfamide
219981|NCT02235701|mesna|mesna
219982|NCT02235701|phase 1|phase 1
219983|NCT02235701|INNO-206|inno-206
219984|NCT02235688|aldoxorubicin|aldoxorubicin
219985|NCT02235688|INNO-206|inno-206
219986|NCT02235688|solid tumors|solid tumors
219987|NCT02235688|gemcitabine|gemcitabine
219988|NCT02235688|phase 1|phase 1
219989|NCT02235675|Angioplasty|angioplasty
219990|NCT02235675|Peripheral Artery Disease|peripheral artery disease
219991|NCT02235675|Critical Limb Ischemia|critical limb ischemia
219992|NCT02235675|CLI|cli
219993|NCT02235675|PAD|pad
219994|NCT02235662|HIV|hiv
219995|NCT02235662|LNG|lng
219996|NCT02235662|IVR|ivr
219997|NCT02235662|Contraception|contraception
219998|NCT02235662|Prevention|prevention
219999|NCT02235623|Laparoscopic Surgery|laparoscopic surgery
220000|NCT02235623|Orchiopexy|orchiopexy
220001|NCT02235610|Lung Transplantation|lung transplantation
220002|NCT02235610|Ex Vivo Lung Perfusion|ex vivo lung perfusion
220003|NCT02235610|EVLP|evlp
220004|NCT02235597|patient access|patient access
220005|NCT02235597|patient centered care|patient centered care
220006|NCT02235597|scheduling|scheduling
220007|NCT02235597|access barriers|access barriers
220008|NCT02235597|improve efficiency|improve efficiency
220009|NCT02235597|decision making tools|decision making tools
220010|NCT02235597|underserved|underserved
220011|NCT02235584|Incretin hormones|incretin hormones
220012|NCT02235584|GLP-1|glp-1
220013|NCT02235584|GIP|gip
220014|NCT02235584|Dexamethasone|dexamethasone
220015|NCT02235558|Acute Ischemic Stoke|acute ischemic stoke
220016|NCT02235558|Thrombectomy|thrombectomy
220017|NCT02235558|Intraarterial Pharmacotherapy|intraarterial pharmacotherapy
220018|NCT02235558|Neuroprotection|neuroprotection
220019|NCT02235545|HV Lead|hv lead
220020|NCT02235545|ICD|icd
220021|NCT02235545|CRT-D System|crt-d system
220022|NCT02235545|Treatment of Heart Failure|treatment of heart failure
220023|NCT02235545|Treamtent of life-threatening ventricular tachyarrhythmia|treamtent of life-threatening ventricular tachyarrhythmia
220024|NCT02235545|Optisure|optisure
220025|NCT02235532|clinical trial|clinical trial
220026|NCT02235532|oral hygiene|oral hygiene
220027|NCT02235532|Gingivitis|gingivitis
220028|NCT02235532|Aloevera|aloevera
220029|NCT02235532|Toothpaste|toothpaste
220030|NCT02235532|anti-inflammatory agents|anti-inflammatory agents
220031|NCT02235493|HPP|hpp
220032|NCT02235493|Soft Bones|soft bones
220033|NCT02235493|low Alkaline Phosphatase|low alkaline phosphatase
220034|NCT02235493|genetic metabolic disorder|genetic metabolic disorder
220035|NCT02235493|alkaline phosphatase|alkaline phosphatase
220036|NCT02235493|tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
220037|NCT02235493|rickets|rickets
220038|NCT02235493|osteomalacia|osteomalacia
220039|NCT02235467|autism|autism
220040|NCT02235467|videomodeling|videomodeling
220041|NCT02235467|behavioral therapy|behavioral therapy
220042|NCT02235467|parental training|parental training
220043|NCT02235454|glaucoma|glaucoma
220044|NCT02235454|OCT|oct
220045|NCT02235454|spectral domain optical coherence tomography|spectral domain optical coherence tomography
220046|NCT02235441|Gastrointestinal malignancy|gastrointestinal malignancy
220047|NCT02235441|Cardiopulmonary fitness|cardiopulmonary fitness
220048|NCT02235441|Chemoradiation therapy|chemoradiation therapy
220049|NCT02235376|Critical Care|critical care
220050|NCT02235376|Brain injured patients|brain injured patients
220051|NCT02235376|Mechanical Ventilation|mechanical ventilation
220052|NCT02235376|Weaning|weaning
220053|NCT02235376|Extubation|extubation
220054|NCT02235376|Prognostic score|prognostic score
220055|NCT02235376|Clinical examination|clinical examination
220056|NCT02235363|face lift|face lift
220057|NCT02235363|thread lift|thread lift
220058|NCT02235363|retaining ligament|retaining ligament
220059|NCT02235363|V-Loc sutures|v-loc sutures
220060|NCT02235363|tensiometer|tensiometer
220061|NCT02235363|FACE-Q|face-q
220062|NCT02235350|Adult|adult
220063|NCT02235350|Male|male
220064|NCT02235350|Female|female
220065|NCT02235350|Neuronal Plasticity|neuronal plasticity
220066|NCT02235350|Imitative Behavior/physiology|imitative behavior/physiology
220194|NCT02234661|Children|children
220067|NCT02235350|Magnetic Resonance Imaging|magnetic resonance imaging
220068|NCT02235350|Psychomotor Disorders/rehabilitation|psychomotor disorders/rehabilitation
220069|NCT02235350|Follow-up Studies|follow-up studies
220070|NCT02235350|Video Recording|video recording
220071|NCT02235350|Physical Therapy Modalities|physical therapy modalities
220072|NCT02235350|Recovery of Function|recovery of function
220073|NCT02235350|Action Observation Treatment|action observation treatment
220074|NCT02235350|Mirror Neuron System|mirror neuron system
220075|NCT02235350|Stroke/rehabilitation|stroke/rehabilitation
220076|NCT02235350|Upper Limb|upper limb
220077|NCT02235337|Concussion|concussion
220078|NCT02235337|Sports related concussion|sports related concussion
220079|NCT02235337|mTBI|mtbi
220080|NCT02235337|Vitamin B|vitamin b
220081|NCT02235337|Riboflavin|riboflavin
220082|NCT02235311|Proton pump inhibitor|proton pump inhibitor
220083|NCT02235311|Upper gastrointestinal bleed|upper gastrointestinal bleed
220084|NCT02235311|Ulcer healing|ulcer healing
220085|NCT02235298|epicardial fat|epicardial fat
220086|NCT02235298|diabetes|diabetes
220087|NCT02235298|dapagliflozin|dapagliflozin
220088|NCT02235285|capsular contracture|capsular contracture
220089|NCT02235285|reoperation|reoperation
220090|NCT02235285|breast augmentation|breast augmentation
220091|NCT02235246|perioperative intravenous magnesium|perioperative intravenous magnesium
220092|NCT02235246|endoscopic submucosal dissection|endoscopic submucosal dissection
220093|NCT02235220|Bruxism|bruxism
220094|NCT02235207|sedentary work|sedentary work
220095|NCT02235207|musculoskeletal pain|musculoskeletal pain
220096|NCT02235207|neuromuscular exercise|neuromuscular exercise
220097|NCT02235207|physical fitness|physical fitness
220098|NCT02235207|quality of life|quality of life
220099|NCT02235207|work ability|work ability
220100|NCT02235181|Twin Pregnancy|twin pregnancy
220101|NCT02235181|Prevention of Preterm birth|prevention of preterm birth
220102|NCT02235181|Short Cervix|short cervix
220103|NCT02235181|Arabin cervical pessary|arabin cervical pessary
220104|NCT02235116|Number of patients|number of patients
220105|NCT02235116|full body skin exam|full body skin exam
220106|NCT02235116|Survey|survey
220107|NCT02235116|preferences|preferences
220108|NCT02235090|Spinal muscular atrophy|spinal muscular atrophy
220109|NCT02235090|Neuromuscular disorders|neuromuscular disorders
220110|NCT02235090|Outcome measures|outcome measures
220111|NCT02235090|Visit-free clinical trial design|visit-free clinical trial design
220112|NCT02235077|Heart Failure|heart failure
220113|NCT02235077|Heart Diseases|heart diseases
220114|NCT02235077|Cardiovascular Diseases|cardiovascular diseases
220115|NCT02235077|Spironolactone|spironolactone
220116|NCT02235077|Aldactone|aldactone
220117|NCT02235025|mild COPD|mild copd
220118|NCT02235025|dyspnea|dyspnea
220119|NCT02235025|exercise|exercise
220120|NCT02235025|respiratory mechanics|respiratory mechanics
220121|NCT02235012|Schizophrenia|schizophrenia
220122|NCT02235012|Ketamine|ketamine
220123|NCT02235012|Cognitive biases|cognitive biases
220124|NCT02235012|Uncertainty|uncertainty
220125|NCT02234999|Pharmacokinetics, Healthy Subjects|pharmacokinetics, healthy subjects
220126|NCT02234986|Advanced Fibrolamellar Carcinoma|advanced fibrolamellar carcinoma
220127|NCT02234947|type 1 diabetes|type 1 diabetes
220128|NCT02234947|pancreas volume|pancreas volume
220129|NCT02234934|Gene Therapy|gene therapy
220130|NCT02234934|X-Linked Chronic Granulomatous Disease (X-CGD)|x-linked chronic granulomatous disease (x-cgd)
220131|NCT02234934|Lentiviral Vector|lentiviral vector
220132|NCT02234921|Prostate|prostate
220133|NCT02234921|Adenocarcinoma|adenocarcinoma
220134|NCT02234921|Metastatic|metastatic
220135|NCT02234921|DRibble|dribble
220136|NCT02234921|Immunotherapy|immunotherapy
220137|NCT02234921|Microbiome|microbiome
220138|NCT02234908|Tuberculosis|tuberculosis
220139|NCT02234908|Drug-resistant tuberculosis|drug-resistant tuberculosis
220140|NCT02234908|Incentives|incentives
220141|NCT02234908|Symptom screening|symptom screening
220142|NCT02234895|osteoarthritis|osteoarthritis
220143|NCT02234895|knee|knee
220144|NCT02234895|biomechanics|biomechanics
220145|NCT02234895|treatment|treatment
220146|NCT02234895|symptoms|symptoms
220147|NCT02234869|Peginterferon Beta-1a|peginterferon beta-1a
220148|NCT02234869|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
220149|NCT02234869|RMS|rms
220150|NCT02234869|flu-like symptoms|flu-like symptoms
220151|NCT02234856|Hysterectomy|hysterectomy
220152|NCT02234856|Laparoscopy|laparoscopy
220153|NCT02234856|Surgical assessment|surgical assessment
220154|NCT02234856|Education|education
220155|NCT02234843|Pediatric|pediatric
220156|NCT02234830|PCI|pci
220157|NCT02234804|Coronary angiography (CAG)|coronary angiography (cag)
220158|NCT02234804|Percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
220159|NCT02234804|OCT|oct
220160|NCT02234804|Stent|stent
220161|NCT02234778|critical limb ischemia|critical limb ischemia
220162|NCT02234778|autologous stromal vascular fraction|autologous stromal vascular fraction
220163|NCT02234765|OSA|osa
220164|NCT02234765|OSAS|osas
220165|NCT02234765|Sleep apnea|sleep apnea
220166|NCT02234765|Management|management
220167|NCT02234765|Primary Care|primary care
220168|NCT02234765|Sleep Unit|sleep unit
220169|NCT02234765|Cost-Effectiveness|cost-effectiveness
220170|NCT02234765|ESS|ess
220171|NCT02234752|Schizophrenia|schizophrenia
220172|NCT02234752|Schizoaffective Disorder|schizoaffective disorder
220173|NCT02234752|Cognition|cognition
220174|NCT02234752|Cognitive Impairment|cognitive impairment
220175|NCT02234752|Galantamine|galantamine
220176|NCT02234752|Memantine|memantine
220177|NCT02234739|voriconazole|voriconazole
220178|NCT02234739|COPD|copd
220179|NCT02234739|invasive pulmonary aspergillosis|invasive pulmonary aspergillosis
220180|NCT02234739|efficacy|efficacy
220181|NCT02234739|safety|safety
220182|NCT02234726|child health|child health
220183|NCT02234726|child development|child development
220184|NCT02234726|malnutrition|malnutrition
220185|NCT02234726|stunting|stunting
220186|NCT02234726|community-based health services|community-based health services
220187|NCT02234687|post-traumatic stress disorder|post-traumatic stress disorder
220188|NCT02234674|Pulsating suit|pulsating suit
220189|NCT02234674|lymphedema|lymphedema
220190|NCT02234674|leg volume|leg volume
220191|NCT02234661|Low income|low income
220192|NCT02234661|Education|education
220193|NCT02234661|Poverty|poverty
220195|NCT02234661|Parents|parents
220196|NCT02234661|Head Start|head start
220197|NCT02234648|Vascular Function|vascular function
220198|NCT02234648|tart Montmorency cherries|tart montmorency cherries
220199|NCT02234648|Arterial Stiffness|arterial stiffness
220200|NCT02234648|Blood Flow|blood flow
220201|NCT02234635|visual acuity|visual acuity
220202|NCT02234635|objective visual quality|objective visual quality
220203|NCT02234635|multifocal intraocular lens|multifocal intraocular lens
220204|NCT02234635|tear-film quality dynamics|tear-film quality dynamics
220205|NCT02234622|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
220206|NCT02234622|Yoga|yoga
220207|NCT02234622|Veterans|veterans
220208|NCT02234609|dentistry|dentistry
220209|NCT02234609|dental caries|dental caries
220210|NCT02234609|atraumatic restorative Treatment|atraumatic restorative treatment
220211|NCT02234609|effectiveness|effectiveness
220212|NCT02234596|Nintedanib|nintedanib
220213|NCT02234596|14-094|14-094
220214|NCT02234583|pain|pain
220215|NCT02234583|fibromyalgia|fibromyalgia
220216|NCT02234570|neurocysticercosis|neurocysticercosis
220217|NCT02234570|pork tapeworm|pork tapeworm
220218|NCT02234570|Taenia solium|taenia solium
220219|NCT02234557|Motor Control|motor control
220220|NCT02234557|Attention|attention
220221|NCT02234557|Cognitive Control|cognitive control
220222|NCT02234544|vitamin D|vitamin d
220223|NCT02234544|absorption|absorption
220224|NCT02234544|ezetimibe|ezetimibe
220225|NCT02234531|Virtual Reality,|virtual reality,
220226|NCT02234531|Enhanced Feedback,|enhanced feedback,
220227|NCT02234531|Stroke,|stroke,
220228|NCT02234531|Rehabilitation,|rehabilitation,
220229|NCT02234531|Motor Learning|motor learning
220230|NCT02234505|prosthetics|prosthetics
220231|NCT02234505|amputation|amputation
220232|NCT02234505|gait stability|gait stability
220233|NCT02234505|step variability|step variability
220234|NCT02234505|load cell|load cell
220235|NCT02234492|Human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
220236|NCT02234492|Statin therapy|statin therapy
220237|NCT02234492|Cardiovascular disease (CVD)|cardiovascular disease (cvd)
220238|NCT02234492|Coronary Flow Reserve (CFR)|coronary flow reserve (cfr)
220239|NCT02234492|Positron Emission Tomography (PET)|positron emission tomography (pet)
220240|NCT02234492|Myocardial contrast echocardiography (MCE)|myocardial contrast echocardiography (mce)
220241|NCT02234479|Breast Cancer|breast cancer
220242|NCT02234479|Radiation Dermatitis|radiation dermatitis
220243|NCT02234466|Quality of Recovery (QOR40)|quality of recovery (qor40)
220244|NCT02234466|Breast Surgery|breast surgery
220245|NCT02234466|Clinically significant Nausea and Vomiting|clinically significant nausea and vomiting
220246|NCT02234466|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
220247|NCT02234453|cancer|cancer
220248|NCT02234453|chemotherapy|chemotherapy
220249|NCT02234453|home|home
220250|NCT02234453|blood count|blood count
220251|NCT02234453|remote|remote
220252|NCT02234427|aspirin, atherosclerosis|aspirin, atherosclerosis
220253|NCT02234414|vertebral fracture assessment (vfa)|vertebral fracture assessment (vfa)
220254|NCT02234414|vitamin D|vitamin d
220255|NCT02234401|Cystic Fibrosis|cystic fibrosis
220256|NCT02234401|Noninvasive ventilation|noninvasive ventilation
220257|NCT02234401|Non invasive ventilation|non invasive ventilation
220258|NCT02234401|Acute respiratory exacerbation|acute respiratory exacerbation
220259|NCT02234401|Bi level pressure support|bi level pressure support
220260|NCT02234388|connective tissue disease|connective tissue disease
220261|NCT02234388|registry|registry
220262|NCT02234388|hospital for special surgery|hospital for special surgery
220263|NCT02234375|Pulmonary embolism|pulmonary embolism
220264|NCT02234375|Contrast|contrast
220265|NCT02234375|Computed tomography|computed tomography
220266|NCT02234375|Gadolinium|gadolinium
220267|NCT02234349|bile acids|bile acids
220268|NCT02234349|pancreas kidney transplantation|pancreas kidney transplantation
220269|NCT02234349|incretins|incretins
220270|NCT02234349|intestinal flora|intestinal flora
220271|NCT02234336|Echocardiography|echocardiography
220272|NCT02234336|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
220273|NCT02234336|cardiomyopathy|cardiomyopathy
220274|NCT02234336|magnetic resonance imaging|magnetic resonance imaging
220275|NCT02234336|contrast|contrast
220276|NCT02234323|prophylaxis treatment|prophylaxis treatment
220277|NCT02234323|Hemophilia A|hemophilia a
220278|NCT02234323|Hemophilia|hemophilia
220279|NCT02234323|episodic treatment|episodic treatment
220280|NCT02234310|prophylaxis treatment|prophylaxis treatment
220281|NCT02234310|episodic treatment|episodic treatment
220282|NCT02234297|Glioma|glioma
220283|NCT02234297|Tumor Paint|tumor paint
220284|NCT02234297|BLZ100|blz100
220285|NCT02234284|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
220286|NCT02234284|Health Coaching|health coaching
220287|NCT02234284|Health Disparities|health disparities
220288|NCT02234284|Self-management|self-management
220289|NCT02234284|Chronic Disease Model|chronic disease model
220290|NCT02234245|Follow-Up studies|follow-up studies
220291|NCT02234245|Biological Pacemakers|biological pacemakers
220292|NCT02234245|Telemedicine|telemedicine
220293|NCT02234245|Efficiency|efficiency
220294|NCT02234232|Hemodialysis|hemodialysis
220295|NCT02234232|Exercise, aerobic|exercise, aerobic
220296|NCT02234232|Exercise, resistance|exercise, resistance
220297|NCT02234232|Intradialytic|intradialytic
220298|NCT02234232|Randomized Controlled Trial|randomized controlled trial
220299|NCT02234232|Safety|safety
220300|NCT02234232|Quality of life|quality of life
220301|NCT02234232|Physical performance|physical performance
220302|NCT02234206|Hypospermatogenesis, Low Sperm Count, Oligozoospermia|hypospermatogenesis, low sperm count, oligozoospermia
220303|NCT02234193|wound healing|wound healing
220304|NCT02234128|Ex Vivo Lung Perfusion|ex vivo lung perfusion
220305|NCT02234128|EVLP|evlp
220306|NCT02234128|Lung Transplant|lung transplant
220307|NCT02234128|Lung Transplantation|lung transplantation
220308|NCT02234128|Toronto EVLP System™|toronto evlp system™
220309|NCT02234128|PERFUSIX|perfusix
220310|NCT02234115|Prostate Neoplasm Cancer Carcinoma|prostate neoplasm cancer carcinoma
220311|NCT02234076|Posttraumatic Stress Disorder|posttraumatic stress disorder
220312|NCT02234076|Depression|depression
220313|NCT02234076|Treatment|treatment
220314|NCT02234076|VRET|vret
220315|NCT02234063|Hypertension|hypertension
220316|NCT02234063|Chronic Kidney Disease|chronic kidney disease
220317|NCT02234063|End Stage Renal Disease|end stage renal disease
220318|NCT02234063|APOL1|apol1
220319|NCT02234063|Genomics|genomics
220320|NCT02234063|Genetics|genetics
220321|NCT02234063|Community-engaged|community-engaged
220322|NCT02234050|Grade 2 Chordoid meningioma|grade 2 chordoid meningioma
220323|NCT02234050|Grade 2 Clear cell meningioma|grade 2 clear cell meningioma
220324|NCT02234050|Grade 2 Atypical meningioma|grade 2 atypical meningioma
220325|NCT02234050|Grade 3 Papillary meningioma|grade 3 papillary meningioma
220326|NCT02234050|Grade 3 Rhabdoid meningioma|grade 3 rhabdoid meningioma
220327|NCT02234050|Grade 3 Anaplastic meningioma|grade 3 anaplastic meningioma
220328|NCT02234050|Grade 3 Malignant meningioma|grade 3 malignant meningioma
220329|NCT02234037|AML|aml
220330|NCT02233998|Plaque|plaque
220331|NCT02233998|Bleeding|bleeding
220332|NCT02233998|Gums|gums
220333|NCT02233998|Gingiva|gingiva
220334|NCT02233998|Gingival Inflammation|gingival inflammation
220335|NCT02233998|Gingival Bleeding|gingival bleeding
220336|NCT02233985|bronchiolitis|bronchiolitis
220337|NCT02233985|hypertonic|hypertonic
220338|NCT02233985|saline|saline
220339|NCT02233985|salbutamol|salbutamol
220340|NCT02233972|Pharmacokinetics|pharmacokinetics
220341|NCT02233972|Ginkgolides Meglumine Injection|ginkgolides meglumine injection
220342|NCT02233946|Substance Abuse|substance abuse
220343|NCT02233946|Prevention|prevention
220344|NCT02233946|Youth|youth
220345|NCT02233946|Alcohol|alcohol
220346|NCT02233946|Drugs|drugs
220347|NCT02233933|radiation proctitis|radiation proctitis
220348|NCT02233933|bleeding|bleeding
220349|NCT02233933|therapy|therapy
220350|NCT02233868|Imaging Studies|imaging studies
220351|NCT02233868|Alcoholism|alcoholism
220352|NCT02233868|Inflammation|inflammation
220353|NCT02233855|Seizures|seizures
220354|NCT02233855|Cestode|cestode
220355|NCT02233855|Hydrocephalus|hydrocephalus
220356|NCT02233855|Taenia Solium|taenia solium
220357|NCT02233855|Helminth|helminth
220358|NCT02233842|Qualitative Data|qualitative data
220359|NCT02233842|Questionnaire|questionnaire
220360|NCT02233829|C-11 Raclopride|c-11 raclopride
220361|NCT02233829|015 PET|015 pet
220362|NCT02233829|Circadian Rhythm|circadian rhythm
220363|NCT02233816|Influenza|influenza
220364|NCT02233816|Human|human
220365|NCT02233816|RNA Virus Infections|rna virus infections
220366|NCT02233816|Immunologic|immunologic
220367|NCT02233816|Immunogenic Factors|immunogenic factors
220368|NCT02233816|Physiological Effects of Drugs|physiological effects of drugs
220369|NCT02233816|Virus diseases|virus diseases
220370|NCT02233816|Orthomyxoviridae Infections|orthomyxoviridae infections
220371|NCT02233816|Infection|infection
220372|NCT02233803|tolerability|tolerability
220373|NCT02233803|NEUMOTEROL|neumoterol
220374|NCT02233803|efficacy|efficacy
220375|NCT02233803|budesonide/formoterol fumarate 400/12 mcg|budesonide/formoterol fumarate 400/12 mcg
220376|NCT02233803|safety|safety
220377|NCT02233803|Asthma|asthma
220378|NCT02233803|pharmacodynamics|pharmacodynamics
220379|NCT02233790|Myocardial infarction|myocardial infarction
220380|NCT02233790|No-Reflow Phenomenon|no-reflow phenomenon
220381|NCT02233790|Ticagrelor|ticagrelor
220382|NCT02233790|Clopidogrel|clopidogrel
220383|NCT02233790|Single-Photon Emission Computerized Tomography|single-photon emission computerized tomography
220384|NCT02233777|Pregabalin|pregabalin
220385|NCT02233777|Bioequivalence|bioequivalence
220386|NCT02233777|Bioavailability|bioavailability
220387|NCT02233777|Pharmacokinetic|pharmacokinetic
220388|NCT02233777|Antiepileptic|antiepileptic
220389|NCT02233764|iron|iron
220390|NCT02233764|zinc|zinc
220391|NCT02233764|pearl millet|pearl millet
220392|NCT02233764|India|india
220393|NCT02233764|children|children
220394|NCT02233764|trial|trial
220395|NCT02233764|randomized|randomized
220396|NCT02233751|Healthy Adult Males|healthy adult males
220397|NCT02233738|Alcoholism|alcoholism
220398|NCT02233738|Substance-related disorders|substance-related disorders
220399|NCT02233738|Dual Diagnosis|dual diagnosis
220400|NCT02233725|Prostatic Neoplasms|prostatic neoplasms
220401|NCT02233725|Magnetic Resonance Imaging|magnetic resonance imaging
220402|NCT02233725|MRI / Ultrasound Fusion|mri / ultrasound fusion
220403|NCT02233725|Contrast-Enhanced Ultrasound (CEUS)|contrast-enhanced ultrasound (ceus)
220404|NCT02233712|gastric cancer, stomach neoplasms,|gastric cancer, stomach neoplasms,
220405|NCT02233673|Obesity|obesity
220406|NCT02233673|Pregnancy|pregnancy
220407|NCT02233647|cocaine|cocaine
220408|NCT02233647|phendimetrazine|phendimetrazine
220409|NCT02233647|pharmacotherapy|pharmacotherapy
220410|NCT02233634|Coronary Angiography|coronary angiography
220411|NCT02233634|Magnetic Resonance Imaging|magnetic resonance imaging
220412|NCT02233634|Oxygen|oxygen
220413|NCT02233634|Hyperoxia|hyperoxia
220414|NCT02233634|Carbon Dioxide|carbon dioxide
220415|NCT02233634|Apnea|apnea
220416|NCT02233634|Hyperventilation|hyperventilation
220417|NCT02233608|Prostate cancer|prostate cancer
220418|NCT02233608|Radical prostatectomy|radical prostatectomy
220419|NCT02233608|Pelvic floor muscle exercises|pelvic floor muscle exercises
220420|NCT02233608|Pfilates|pfilates
220421|NCT02233608|Hypopressives|hypopressives
220422|NCT02233608|Urinary Incontinence|urinary incontinence
220423|NCT02233595|MRI|mri
220424|NCT02233595|PET|pet
220425|NCT02233595|rectal cancer|rectal cancer
220426|NCT02233595|adjuvant chemotherapy|adjuvant chemotherapy
220427|NCT02233582|altitude|altitude
220428|NCT02233582|mountain sickness|mountain sickness
220429|NCT02233582|ibuprofen|ibuprofen
220430|NCT02233582|hypoxia|hypoxia
220431|NCT02233569|Laparoscopic hernia repair|laparoscopic hernia repair
220432|NCT02233569|Ventral hernia|ventral hernia
220433|NCT02233569|Incisional hernia|incisional hernia
220434|NCT02233569|IPOM|ipom
220435|NCT02233556|event-related potential|event-related potential
220436|NCT02233556|mismatch negativity|mismatch negativity
220437|NCT02233556|NMDA|nmda
220438|NCT02233556|Glutamate|glutamate
220439|NCT02233543|COPD|copd
220440|NCT02233543|QVA149|qva149
220441|NCT02233543|nocturnal oxygen levels|nocturnal oxygen levels
220442|NCT02233543|combination bronchodilator|combination bronchodilator
220443|NCT02233530|Dementia|dementia
220444|NCT02233530|Cognitive Stimulation Therapy|cognitive stimulation therapy
220445|NCT02233530|Quality of life|quality of life
220446|NCT02233530|Cognitive impairment|cognitive impairment
220447|NCT02233530|Africa|africa
220448|NCT02233530|Tanzania|tanzania
220450|NCT02233530|Low- and Middle-income countries|low- and middle-income countries
220451|NCT02233530|Non-pharmacological intervention|non-pharmacological intervention
220452|NCT02233530|Task-shifting|task-shifting
220453|NCT02233530|Cognitive screening|cognitive screening
220454|NCT02233517|Veterans|veterans
220455|NCT02233517|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
220456|NCT02233517|Aggression|aggression
220457|NCT02233517|Anger|anger
220458|NCT02233517|Posttraumatic Stress Disorder|posttraumatic stress disorder
220459|NCT02233517|Combat Disorders|combat disorders
220460|NCT02233491|PTDM|ptdm
220461|NCT02233491|kidney transplant|kidney transplant
220462|NCT02233491|lifestyle intervention|lifestyle intervention
220463|NCT02233491|diet|diet
220464|NCT02233491|exercise|exercise
220465|NCT02233478|Pomegranate polyphenols|pomegranate polyphenols
220466|NCT02233478|Soy Protein|soy protein
220467|NCT02233478|Ellagitannins|ellagitannins
220468|NCT02233465|parastomal|parastomal
220469|NCT02233465|hernia|hernia
220470|NCT02233465|mesh|mesh
220471|NCT02233465|parastomal hernia-repair with mesh|parastomal hernia-repair with mesh
220472|NCT02233452|Neuropathic pain|neuropathic pain
220473|NCT02233452|Methadone|methadone
220474|NCT02233452|Ketamine|ketamine
220475|NCT02233452|Multimodal analgesia|multimodal analgesia
220476|NCT02233439|galactagogues|galactagogues
220477|NCT02233439|herbs|herbs
220478|NCT02233439|breastfeeding|breastfeeding
220479|NCT02233439|supplements|supplements
220480|NCT02233439|Silybum marianum|silybum marianum
220481|NCT02233439|Galega officinalis|galega officinalis
220482|NCT02233426|allergic rhinitis|allergic rhinitis
220483|NCT02233426|nasal steroid|nasal steroid
220484|NCT02233426|hypertonic saline|hypertonic saline
220485|NCT02233426|eosinophil|eosinophil
220486|NCT02233426|symptom score|symptom score
220487|NCT02233413|Traumatic brain injury|traumatic brain injury
220488|NCT02233413|TBI|tbi
220489|NCT02233413|Low-level light therapy|low-level light therapy
220490|NCT02233413|LLLT|lllt
220491|NCT02233413|LLLT helmet|lllt helmet
220492|NCT02233400|Acetaminophen|acetaminophen
220493|NCT02233400|Gastric Bypass|gastric bypass
220494|NCT02233400|Sleeve Gastrectomy|sleeve gastrectomy
220495|NCT02233400|Pain|pain
220496|NCT02233400|Cost|cost
220497|NCT02233387|cervix cancer|cervix cancer
220498|NCT02233387|[18F] HX4 PET imaging|[18f] hx4 pet imaging
220499|NCT02233387|hypoxia|hypoxia
220500|NCT02233387|phase II trial|phase ii trial
220501|NCT02233374|Rectal Cancer|rectal cancer
220502|NCT02233374|Magnetic Resonance Imaging|magnetic resonance imaging
220503|NCT02233374|Positron Emission Tomography|positron emission tomography
220504|NCT02233374|pathologic complete response|pathologic complete response
220505|NCT02233374|Diffusion-weighted magnetic resonance imaging|diffusion-weighted magnetic resonance imaging
220506|NCT02233374|Microstructural Imaging|microstructural imaging
220507|NCT02233374|FDG PET|fdg pet
220508|NCT02233361|Hearing rehabilitation|hearing rehabilitation
220509|NCT02233361|Elderly|elderly
220510|NCT02233361|Hearing aid use|hearing aid use
220511|NCT02233322|ADHR|adhr
220512|NCT02233322|Rickets|rickets
220513|NCT02233322|Hypophosphatemia|hypophosphatemia
220514|NCT02233283|LH pulsatility|lh pulsatility
220515|NCT02233283|Insulin sensitivity|insulin sensitivity
220516|NCT02233283|Metabolism|metabolism
220517|NCT02233283|hypercaloric feeding|hypercaloric feeding
220518|NCT02233257|Adrenoleukodystrophy|adrenoleukodystrophy
220519|NCT02233257|Lorenzo's oil|lorenzo's oil
220520|NCT02233257|erucic acid|erucic acid
220521|NCT02233244|Drug Interaction|drug interaction
220522|NCT02233205|microbubble|microbubble
220523|NCT02233205|chemotherapy|chemotherapy
220524|NCT02233205|alimentary|alimentary
220525|NCT02233192|PrEP|prep
220526|NCT02233192|conception|conception
220527|NCT02233192|HIV|hiv
220528|NCT02233192|serodiscordant|serodiscordant
220529|NCT02233179|Diabetic foot ulcer|diabetic foot ulcer
220530|NCT02233153|Senior|senior
220531|NCT02233153|Elderly|elderly
220532|NCT02233153|Acute Care|acute care
220533|NCT02233153|Emergency Surgery|emergency surgery
220534|NCT02233140|Diabetes|diabetes
220535|NCT02233140|Ankle equinus|ankle equinus
220536|NCT02233140|ankle dorsiflexion|ankle dorsiflexion
220537|NCT02233140|dynamic plantar pressure|dynamic plantar pressure
220538|NCT02233140|shockwave therapy|shockwave therapy
220539|NCT02233127|Birth cohort|birth cohort
220540|NCT02233127|Pakistan|pakistan
220541|NCT02233127|Child mortality|child mortality
220542|NCT02233088|Prediabetic State|prediabetic state
220543|NCT02233088|Hypertension|hypertension
220544|NCT02233088|Enlarged Waist Elevated Triglycerides|enlarged waist elevated triglycerides
220545|NCT02233088|HDL Cholesterol, Low Serum|hdl cholesterol, low serum
220546|NCT02233062|Crohn's Disease|crohn's disease
220547|NCT02233062|semen quality|semen quality
220548|NCT02233062|enteral nutrition|enteral nutrition
220549|NCT02233062|CDAI score higher than 150|cdai score higher than 150
220550|NCT02233049|Children|children
220551|NCT02233049|adolescents|adolescents
220552|NCT02233049|young adults|young adults
220553|NCT02233049|newly diagnosed|newly diagnosed
220554|NCT02233036|Young Adults|young adults
220555|NCT02233036|Transfer|transfer
220556|NCT02233036|Chronic Disease|chronic disease
220557|NCT02232997|Chronic kidney disease|chronic kidney disease
220558|NCT02232997|contrast induced nephropathy|contrast induced nephropathy
220559|NCT02232997|diabetes mellitus|diabetes mellitus
220560|NCT02232997|congestive heart failure|congestive heart failure
220561|NCT02232997|hypertension|hypertension
220562|NCT02232984|Heart Failure|heart failure
220563|NCT02232984|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
220564|NCT02232984|CRT-D|crt-d
220565|NCT02232984|Quadripolar pacing|quadripolar pacing
220566|NCT02232971|glucagon|glucagon
220567|NCT02232971|insulin pump|insulin pump
220568|NCT02232971|artificial pancreas|artificial pancreas
220569|NCT02232971|closed-loop|closed-loop
220570|NCT02232958|Hyperbaric Oxygen|hyperbaric oxygen
220571|NCT02232958|Small Vessel Disease of the Brain|small vessel disease of the brain
220572|NCT02232958|Impaired Brain Circuit Connections|impaired brain circuit connections
220573|NCT02232945|influenza A (H1N1,H3N2)|influenza a (h1n1,h3n2)
220574|NCT02232945|influenza B virus|influenza b virus
220575|NCT02232932|Hilar cholangiocarcinoma|hilar cholangiocarcinoma
220576|NCT02232932|Liver transplantation|liver transplantation
220577|NCT02232932|Radiochemotherapy|radiochemotherapy
220578|NCT02232919|Deep Brain Stimulation|deep brain stimulation
220579|NCT02232906|Chronic kidney disease|chronic kidney disease
220581|NCT02232906|non-dialysis-dependent|non-dialysis-dependent
220582|NCT02232906|ND-CKD|nd-ckd
220583|NCT02232906|Erythropoiesis-stimulating agent|erythropoiesis-stimulating agent
220584|NCT02232906|Ferric carboxymaltose|ferric carboxymaltose
220585|NCT02232906|Iron|iron
220586|NCT02232893|Gastrointestinal Quality of Life Index (GIQLI)|gastrointestinal quality of life index (giqli)
220587|NCT02232893|Abdominal Discomfort|abdominal discomfort
220588|NCT02232893|Abdominal Bloating|abdominal bloating
220589|NCT02232893|Laparoscopic colectomy|laparoscopic colectomy
220590|NCT02232893|Postoperative ileus (POI)|postoperative ileus (poi)
220591|NCT02232880|hypertension|hypertension
220592|NCT02232880|inflammation|inflammation
220593|NCT02232867|rehabilitation|rehabilitation
220594|NCT02232867|stroke|stroke
220595|NCT02232867|walking|walking
220596|NCT02232867|interlimb connections|interlimb connections
220597|NCT02232854|Depression|depression
220598|NCT02232841|Electrical impedance tomography|electrical impedance tomography
220599|NCT02232841|lung imaging|lung imaging
220600|NCT02232789|Mephedrone|mephedrone
220601|NCT02232789|3,4-methylenedioxymethamphetamine|3,4-methylenedioxymethamphetamine
220602|NCT02232789|Abuse liability|abuse liability
220603|NCT02232789|Human Pharmacology|human pharmacology
220604|NCT02232776|Losartan|losartan
220605|NCT02232776|Ig A nephropathy|ig a nephropathy
220606|NCT02232776|children|children
220607|NCT02232776|proteinuria|proteinuria
220608|NCT02232763|Losartan|losartan
220609|NCT02232763|children|children
220610|NCT02232763|proteinuria|proteinuria
220611|NCT02232737|Biomarkers of exposure|biomarkers of exposure
220612|NCT02232737|Compensatory smoking|compensatory smoking
220613|NCT02232737|Nicotine dependence|nicotine dependence
220614|NCT02232737|Reduced nicotine cigarettes|reduced nicotine cigarettes
220615|NCT02232737|Tobacco withdrawal|tobacco withdrawal
220616|NCT02232737|Women|women
220617|NCT02232737|Health disparaties|health disparaties
220618|NCT02232737|Vulnerable populations|vulnerable populations
220619|NCT02232724|Prostate Cancer|prostate cancer
220620|NCT02232724|Staging|staging
220621|NCT02232724|PET/CT|pet/ct
220622|NCT02232711|multiplex, polymerase chain reaction, PCR, BioFire, respiratory infection, infectious disease, point of care, CLIA waived, rapid diagnostics|multiplex, polymerase chain reaction, pcr, biofire, respiratory infection, infectious disease, point of care, clia waived, rapid diagnostics
220623|NCT02232698|Sensing Technology|sensing technology
220624|NCT02232698|Type 1 Diabetes,|type 1 diabetes,
220625|NCT02232685|Prostate cancer|prostate cancer
220626|NCT02232685|Staging|staging
220627|NCT02232685|PET/CT|pet/ct
220628|NCT02232672|Prostate Cancer|prostate cancer
220629|NCT02232672|Staging|staging
220630|NCT02232672|PET/CT|pet/ct
220631|NCT02232659|SynCardia|syncardia
220632|NCT02232659|Total Artificial Heart|total artificial heart
220633|NCT02232659|Biventricular heart failure|biventricular heart failure
220634|NCT02232659|Ineligible for cardiac transplant|ineligible for cardiac transplant
220635|NCT02232568|Patient blood management|patient blood management
220636|NCT02232568|RBC transfusion|rbc transfusion
220637|NCT02232568|Restrictive transfusion strategy|restrictive transfusion strategy
220638|NCT02232529|modified release formulation|modified release formulation
220639|NCT02232529|pharmacokinetics|pharmacokinetics
220640|NCT02232490|AFP|afp
220641|NCT02232490|alpha-fetoprotein|alpha-fetoprotein
220642|NCT02232490|cancer vaccine|cancer vaccine
220643|NCT02232490|cirrhosis|cirrhosis
220644|NCT02232490|hepatitis|hepatitis
220645|NCT02232490|HCC|hcc
220646|NCT02232490|hepatocellular carcinoma|hepatocellular carcinoma
220647|NCT02232490|immunotherapy|immunotherapy
220648|NCT02232490|liver tumor|liver tumor
220649|NCT02232490|Cholangiocarcinoma|cholangiocarcinoma
220650|NCT02232464|Adult ADHD|adult adhd
220651|NCT02232464|diffusion spectrum imaging|diffusion spectrum imaging
220652|NCT02232464|resting-state fMRI|resting-state fmri
220653|NCT02232464|frontostriatal circuitries|frontostriatal circuitries
220654|NCT02232464|frontoparietal circuitries|frontoparietal circuitries
220655|NCT02232464|executive function|executive function
220656|NCT02232451|loop|loop
220657|NCT02232451|ERCP|ercp
220658|NCT02232451|cannulation|cannulation
220659|NCT02232451|biliary|biliary
220660|NCT02232451|wire|wire
220661|NCT02232438|Depression|depression
220662|NCT02232438|Psychotherapy|psychotherapy
220663|NCT02232438|Anxiety|anxiety
220664|NCT02232438|Cancer|cancer
220665|NCT02232412|Anemia|anemia
220666|NCT02232412|NIRS|nirs
220667|NCT02232412|Near Infrared Spectroscopy|near infrared spectroscopy
220668|NCT02232412|RBC transfusion|rbc transfusion
220669|NCT02232412|critical ill|critical ill
220670|NCT02232412|regional cerebral oxygen saturation|regional cerebral oxygen saturation
220671|NCT02232412|tissue oxygenation|tissue oxygenation
220672|NCT02232386|Chronic lymphocyte leukemia|chronic lymphocyte leukemia
220673|NCT02232386|Adults|adults
220674|NCT02232386|Ibrutinib|ibrutinib
220675|NCT02232373|FODMAPs|fodmaps
220676|NCT02232373|microbiota|microbiota
220677|NCT02232373|oligofructose|oligofructose
220678|NCT02232373|IBS|ibs
220679|NCT02232373|Irritable bowel syndrome|irritable bowel syndrome
220680|NCT02232360|Atherosclerotic plaque|atherosclerotic plaque
220681|NCT02232360|Virtual histology intravascular ultrasound|virtual histology intravascular ultrasound
220682|NCT02232360|Plaque composition|plaque composition
220683|NCT02232360|Rosuvastatin|rosuvastatin
220684|NCT02232360|Fenofibrate|fenofibrate
220685|NCT02232360|Coronary artery disease|coronary artery disease
220686|NCT02232347|traumatic brain injury|traumatic brain injury
220687|NCT02232347|ketamine|ketamine
220688|NCT02232347|microdialysis|microdialysis
220689|NCT02232347|PtiO2|ptio2
220690|NCT02232347|glutamate|glutamate
220691|NCT02232334|Idiopathic Gastroparesis, Nausea, Vomiting, Abdominal Pain, Gastrectomy, Osteopathy, Gastroparesis Cardinal Symptom Index, GCSI|idiopathic gastroparesis, nausea, vomiting, abdominal pain, gastrectomy, osteopathy, gastroparesis cardinal symptom index, gcsi
220692|NCT02232295|Upper extremity, motor imagery, mirror therapy|upper extremity, motor imagery, mirror therapy
220693|NCT02232282|Painful Bladder Syndrome|painful bladder syndrome
220694|NCT02232282|Interstitial Cystitis|interstitial cystitis
220695|NCT02232282|Suprapubic Pain|suprapubic pain
220696|NCT02232282|Urinary Urgency|urinary urgency
220697|NCT02232269|Coffee|coffee
220698|NCT02232269|Grapefruit Juice|grapefruit juice
220699|NCT02232269|Felodipine|felodipine
220700|NCT02232269|Calcium Channel Blocker|calcium channel blocker
220701|NCT02232269|Hemodynamics|hemodynamics
220703|NCT02232256|Chronic non-cancer pain|chronic non-cancer pain
220704|NCT02232256|Insomnia|insomnia
220705|NCT02232256|California poppy|california poppy
220706|NCT02232256|Eschscholzia californica|eschscholzia californica
220707|NCT02232256|Pain|pain
220708|NCT02232256|Sleep quality|sleep quality
220709|NCT02232243|Cancer|cancer
220710|NCT02232243|Surgery|surgery
220711|NCT02232243|Hydroxychloroquine|hydroxychloroquine
220712|NCT02232217|Children|children
220713|NCT02232217|Sleep|sleep
220714|NCT02232217|Obesity|obesity
220715|NCT02232204|insomnia|insomnia
220716|NCT02232204|implantable cardioverter defibrillator|implantable cardioverter defibrillator
220717|NCT02232204|cardiac arrhythmia|cardiac arrhythmia
220718|NCT02232204|cognitive behavioral treatment|cognitive behavioral treatment
220719|NCT02232178|unilateral inguinal hernioplasty|unilateral inguinal hernioplasty
220720|NCT02232165|acute spinal cord injury|acute spinal cord injury
220721|NCT02232165|hemodynamic therapy|hemodynamic therapy
220722|NCT02232165|functional outcome|functional outcome
220723|NCT02232126|Hospital readmissions|hospital readmissions
220724|NCT02232126|Randomized controlled trial|randomized controlled trial
220725|NCT02232126|Older adults|older adults
220726|NCT02232126|Care transitions|care transitions
220727|NCT02232126|Social work|social work
220728|NCT02232113|malnutrition, inflammation, and anemia (MIA) syndrome,|malnutrition, inflammation, and anemia (mia) syndrome,
220729|NCT02232113|hemodialysis,|hemodialysis,
220730|NCT02232113|erythropoietin stimulating agent (ESA),|erythropoietin stimulating agent (esa),
220731|NCT02232113|cost-effectiveness,|cost-effectiveness,
220732|NCT02232113|pharmacokinetics,|pharmacokinetics,
220733|NCT02232113|endothelial dysfunction|endothelial dysfunction
220734|NCT02232100|Attentional bias modification|attentional bias modification
220735|NCT02232100|Chronic pain|chronic pain
220736|NCT02232100|Visual-probe task|visual-probe task
220737|NCT02232100|Internet-delivered therapy|internet-delivered therapy
220738|NCT02232087|long-acting beta agonist (LABA)|long-acting beta agonist (laba)
220739|NCT02232087|corticosteroid|corticosteroid
220740|NCT02232087|pMDI|pmdi
220741|NCT02232087|inhaler|inhaler
220742|NCT02232074|Patient Navigation|patient navigation
220743|NCT02232074|Medical Legal Partnership|medical legal partnership
220744|NCT02232074|Healthcare Disparities|healthcare disparities
220745|NCT02232061|multiple sclerosis, fingolimod,|multiple sclerosis, fingolimod,
220746|NCT02232035|diazepam|diazepam
220747|NCT02232035|active phase|active phase
220748|NCT02232022|Stroke|stroke
220749|NCT02232022|Ischemic stroke|ischemic stroke
220750|NCT02232022|Atrial fibrillation|atrial fibrillation
220751|NCT02232022|Insertable cardiac monitor|insertable cardiac monitor
220752|NCT02232022|Non-cryptogenic|non-cryptogenic
220753|NCT02232009|Neonate|neonate
220754|NCT02232009|Infant|infant
220755|NCT02231983|Clinical Characteristics|clinical characteristics
220756|NCT02231983|Genetic Profiles|genetic profiles
220757|NCT02231970|Obesity|obesity
220758|NCT02231970|Endoscopic sleeve gastroplasty|endoscopic sleeve gastroplasty
220759|NCT02231970|Weight loss|weight loss
220760|NCT02231892|Repetitive TMS (rTMS)|repetitive tms (rtms)
220761|NCT02231892|Parameter Development|parameter development
220762|NCT02231892|Cognitive Tasks|cognitive tasks
220763|NCT02231892|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
220764|NCT02231879|Infections|infections
220765|NCT02231879|Hypogammaglobulinemia|hypogammaglobulinemia
220766|NCT02231879|CXCR4|cxcr4
220767|NCT02231879|Myelokathexis|myelokathexis
220768|NCT02231879|Warts|warts
220769|NCT02231866|Filovirus|filovirus
220770|NCT02231866|Healthy|healthy
220771|NCT02231866|Ebola Hemorrhagic Fever|ebola hemorrhagic fever
220772|NCT02231866|Immunity|immunity
220773|NCT02231866|Ebola Virus|ebola virus
220774|NCT02231853|BK Virus|bk virus
220775|NCT02231853|Cytotoxic T Cells|cytotoxic t cells
220776|NCT02231853|EBV|ebv
220777|NCT02231853|Adenovirus|adenovirus
220778|NCT02231853|CMV|cmv
220779|NCT02231840|Phenotypes|phenotypes
220780|NCT02231840|Alcohol Use|alcohol use
220781|NCT02231840|Alcohol|alcohol
220782|NCT02231840|Alcohol Dependence|alcohol dependence
220783|NCT02231840|Genetics|genetics
220784|NCT02231827|subjects|subjects
220785|NCT02231814|Crohn's disease|crohn's disease
220786|NCT02231814|Mild to moderate Crohn's Disease|mild to moderate crohn's disease
220787|NCT02231814|Diet|diet
220788|NCT02231814|Enteral Nutrition|enteral nutrition
220789|NCT02231801|Preterm|preterm
220790|NCT02231801|Kangaroo Care|kangaroo care
220791|NCT02231801|Skin-to-Skin|skin-to-skin
220792|NCT02231801|Vital Sign|vital sign
220793|NCT02231801|Heart Rate|heart rate
220794|NCT02231801|Respiratory Rate|respiratory rate
220795|NCT02231801|Oxygen Saturation|oxygen saturation
220796|NCT02231788|Telminuvo|telminuvo
220797|NCT02231788|Telmitrend|telmitrend
220798|NCT02231788|Hypertension|hypertension
220799|NCT02231788|24hr ABPM|24hr abpm
220800|NCT02231788|Telmisartan|telmisartan
220801|NCT02231788|S-amlodipine|s-amlodipine
220802|NCT02231775|Neoadjuvant|neoadjuvant
220803|NCT02231775|Dabrafenib|dabrafenib
220804|NCT02231775|Tafinlar|tafinlar
220805|NCT02231775|GSK2118436|gsk2118436
220806|NCT02231775|Trametinib|trametinib
220807|NCT02231775|GSK1120212|gsk1120212
220808|NCT02231775|Combination therapy|combination therapy
220809|NCT02231775|Surgery|surgery
220810|NCT02231775|Adjuvant therapy|adjuvant therapy
220811|NCT02231775|Melanoma|melanoma
220812|NCT02231736|Type 2 Diabetes|type 2 diabetes
220813|NCT02231736|Chromosomal damage|chromosomal damage
220814|NCT02231736|Micronuclei|micronuclei
220815|NCT02231736|DNA damage|dna damage
220816|NCT02231736|HbA1c|hba1c
220817|NCT02231736|Comet Assay|comet assay
220818|NCT02231736|Glycemic control|glycemic control
220819|NCT02231723|Digestive System Neoplasms|digestive system neoplasms
220820|NCT02231723|Endocrine Gland Neoplasms|endocrine gland neoplasms
220821|NCT02231723|Pancreatic neoplasms|pancreatic neoplasms
220822|NCT02231723|Pancreatic cancer, adult|pancreatic cancer, adult
220823|NCT02231723|Pancreatic cancer|pancreatic cancer
220824|NCT02231723|Pancreas cancer|pancreas cancer
220825|NCT02231723|Pancreatic diseases|pancreatic diseases
220826|NCT02231723|Adenoma, Islet Cell|adenoma, islet cell
220827|NCT02231723|Carcinoma, Islet Cell|carcinoma, islet cell
220828|NCT02231723|Carcinoma, Pancreatic Ductal|carcinoma, pancreatic ductal
220829|NCT02231723|Gemcitabine|gemcitabine
220830|NCT02231723|Gemzar|gemzar
220831|NCT02231723|Nab-paclitaxel|nab-paclitaxel
220832|NCT02231723|Paclitaxel|paclitaxel
220833|NCT02231723|Abraxane|abraxane
220834|NCT02231723|Oxaliplatin|oxaliplatin
220835|NCT02231723|Leucovorin|leucovorin
220836|NCT02231723|Irinotecan|irinotecan
220837|NCT02231723|Fluorouracil|fluorouracil
220838|NCT02231723|5-FU|5-fu
220839|NCT02231723|MM-398|mm-398
220840|NCT02231710|Severe Combined Immune Deficiency|severe combined immune deficiency
220841|NCT02231710|Congenital T-cell Defect|congenital t-cell defect
220842|NCT02231710|Congenital T-cell Deficiency|congenital t-cell deficiency
220843|NCT02231710|Chronic Granulomatous Disease|chronic granulomatous disease
220844|NCT02231710|Shwachman Diamond Syndrome|shwachman diamond syndrome
220845|NCT02231710|Diamond Blackfan Anemia|diamond blackfan anemia
220846|NCT02231710|Dyskeratosis Congenita|dyskeratosis congenita
220847|NCT02231710|Fanconi Anemia|fanconi anemia
220848|NCT02231710|Sickle Cell Disease|sickle cell disease
220849|NCT02231710|Thalassemia|thalassemia
220850|NCT02231710|Mucopolysaccharidosis|mucopolysaccharidosis
220851|NCT02231710|Sphingolipidoses|sphingolipidoses
220852|NCT02231697|XLMTM|xlmtm
220853|NCT02231645|Parkinson's disease|parkinson's disease
220854|NCT02231645|Deep brain stimulation|deep brain stimulation
220855|NCT02231645|Subthalamic nucleus|subthalamic nucleus
220856|NCT02231645|decision-making|decision-making
220857|NCT02231645|cognition|cognition
220858|NCT02231645|behavior|behavior
220859|NCT02231632|Poliomyelitis|poliomyelitis
220860|NCT02231632|Vaccine|vaccine
220861|NCT02231632|Safety|safety
220862|NCT02231632|efficacy|efficacy
220863|NCT02231619|feasibility|feasibility
220864|NCT02231619|self assessment|self assessment
220865|NCT02231619|medical abortion|medical abortion
220866|NCT02231619|low sensitivity urine pregnancy test|low sensitivity urine pregnancy test
220867|NCT02231619|South Africa|south africa
220868|NCT02231606|Myopia Prevalence|myopia prevalence
220869|NCT02231606|Proportion of Purchase of free Spectacles|proportion of purchase of free spectacles
220870|NCT02231606|Proportion of Purchase of update Spectacles|proportion of purchase of update spectacles
220871|NCT02231606|Proportion of Wearing Spectacles|proportion of wearing spectacles
220872|NCT02231580|Neurodegenerative genetic disorder|neurodegenerative genetic disorder
220873|NCT02231567|hip replacement|hip replacement
220874|NCT02231567|neurocognitive rehabilitation|neurocognitive rehabilitation
220875|NCT02231567|WOMAC questionnaire|womac questionnaire
220876|NCT02231554|low back pain|low back pain
220877|NCT02231554|quality of life|quality of life
220878|NCT02231554|rehabilitation|rehabilitation
220879|NCT02231554|exercise|exercise
220880|NCT02231541|Fibromylgia|fibromylgia
220881|NCT02231541|Magnetic Fields|magnetic fields
220882|NCT02231541|Pain|pain
220883|NCT02231541|Visual Analogue scale|visual analogue scale
220884|NCT02231528|anesthesia|anesthesia
220885|NCT02231528|central venous catheter|central venous catheter
220886|NCT02231528|jugular vein|jugular vein
220887|NCT02231528|ultrasound guidance|ultrasound guidance
220888|NCT02231502|Bioavailability in healthy individuals|bioavailability in healthy individuals
220889|NCT02231489|Healthy|healthy
220890|NCT02231489|JNJ-42756493|jnj-42756493
220891|NCT02231489|JNJ-61818549|jnj-61818549
220892|NCT02231463|ultrasound|ultrasound
220893|NCT02231450|AE58054|ae58054
220894|NCT02231450|Hepatic impairment|hepatic impairment
220895|NCT02231411|Delayed Cord Clamping|delayed cord clamping
220896|NCT02231411|Pulmonary Ventilation|pulmonary ventilation
220897|NCT02231398|Cardiovascular disease|cardiovascular disease
220898|NCT02231398|Pregnant women|pregnant women
220899|NCT02231398|Nulliparity|nulliparity
220900|NCT02231398|Pregnancy outcomes|pregnancy outcomes
220901|NCT02231398|Pregnancy complications|pregnancy complications
220902|NCT02231398|Sleep disordered breathing|sleep disordered breathing
220903|NCT02231385|Colorectal cancer|colorectal cancer
220904|NCT02231385|Serrated adenomas|serrated adenomas
220905|NCT02231385|Screening|screening
220906|NCT02231385|Adenoma detection rate|adenoma detection rate
220907|NCT02231385|Polypectomy|polypectomy
220908|NCT02231307|sublingual immunotherapy|sublingual immunotherapy
220909|NCT02231307|birch pollen|birch pollen
220910|NCT02231307|allergic rhinitis / rhinoconjunctivitis|allergic rhinitis / rhinoconjunctivitis
220911|NCT02231307|efficacy|efficacy
220912|NCT02231281|HIV Infections|hiv infections
220913|NCT02231281|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
220914|NCT02231281|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
220915|NCT02231281|Immune System Diseases|immune system diseases
220916|NCT02231281|Lentivirus Infections|lentivirus infections
220917|NCT02231281|Retroviridae Infections|retroviridae infections
220918|NCT02231281|Virus Diseases|virus diseases
220919|NCT02231281|RNA Virus Infections|rna virus infections
220920|NCT02231281|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
220921|NCT02231281|Slow Virus Diseases|slow virus diseases
220922|NCT02231281|Therapeutic Uses|therapeutic uses
220923|NCT02231281|Pharmacologic Actions|pharmacologic actions
220924|NCT02231281|Antiretroviral therapy|antiretroviral therapy
220925|NCT02231281|Early therapy|early therapy
220926|NCT02231242|brain|brain
220927|NCT02231242|children|children
220928|NCT02231242|cerebral palsy|cerebral palsy
220929|NCT02231242|bone marrow stem cells|bone marrow stem cells
220930|NCT02231242|intrathecal autologous total nucleated cells|intrathecal autologous total nucleated cells
220931|NCT02231242|quadriparesis|quadriparesis
220932|NCT02231229|Pulmonary tuberculosis|pulmonary tuberculosis
220933|NCT02231229|Mycobacterium tuberculosis (MTB)|mycobacterium tuberculosis (mtb)
220934|NCT02231229|Drug Resistance (DR)|drug resistance (dr)
220935|NCT02231229|Isoniazid (INH or H)|isoniazid (inh or h)
220936|NCT02231229|Rifampicin (RIF or RMP or R)|rifampicin (rif or rmp or r)
220937|NCT02231229|Pyrazinamide (PZA or Z)|pyrazinamide (pza or z)
220938|NCT02231229|Ethambutol (EMB or E)|ethambutol (emb or e)
220939|NCT02231229|Fast-TB|fast-tb
220940|NCT02231229|Isoniazid, Rifampicin, Pyrazinamide (HRZ)|isoniazid, rifampicin, pyrazinamide (hrz)
220941|NCT02231229|Isoniazid, Rifampicin, Pyrazinamide, Ethambutol (HRZE)|isoniazid, rifampicin, pyrazinamide, ethambutol (hrze)
220942|NCT02231229|drug susceptibility testing (DST)|drug susceptibility testing (dst)
220943|NCT02231229|Acid-Fast Bacilli (AFB+)|acid-fast bacilli (afb+)
220944|NCT02231229|Polymerase Chain Reaction (PCR)|polymerase chain reaction (pcr)
220945|NCT02231216|rhinoseptoplasty|rhinoseptoplasty
220946|NCT02231203|fish oil|fish oil
220947|NCT02231203|omega-3 fatty acids|omega-3 fatty acids
220948|NCT02231203|postoperative inflammatory response|postoperative inflammatory response
220949|NCT02231203|erythrocyte function|erythrocyte function
220950|NCT02231190|muscle soreness|muscle soreness
220951|NCT02231190|Muscle damage and recovery|muscle damage and recovery
220952|NCT02231190|muscle function|muscle function
220953|NCT02231190|eccentric exercise|eccentric exercise
220954|NCT02231151|CPR quality assessment|cpr quality assessment
220955|NCT02231151|Visual CPR assessment|visual cpr assessment
220956|NCT02231151|Position relative to patient|position relative to patient
220957|NCT02231138|Abelmoschus manihot|abelmoschus manihot
220958|NCT02231138|Chronic Kidney Disease|chronic kidney disease
220959|NCT02231138|proteinuria|proteinuria
220960|NCT02231138|efficacy|efficacy
220961|NCT02231138|safety|safety
220962|NCT02231125|Abelmoschus manihot|abelmoschus manihot
220963|NCT02231125|IgA Nephropathy|iga nephropathy
220964|NCT02231125|proteinuria|proteinuria
220965|NCT02231125|efficacy|efficacy
220966|NCT02231125|safety|safety
220967|NCT02231112|Korean|korean
220968|NCT02231112|Left side|left side
220969|NCT02231099|recurrent pelvic organ prolapse|recurrent pelvic organ prolapse
220970|NCT02231099|mesh|mesh
220971|NCT02231086|Chemotherapy, Adjuvant|chemotherapy, adjuvant
220972|NCT02231086|Laparoscopy|laparoscopy
220973|NCT02231086|Peritoneal Lavage|peritoneal lavage
220974|NCT02231086|HIPEC|hipec
220975|NCT02231073|Freezing of gait|freezing of gait
221084|NCT02230709|Soreness|soreness
220976|NCT02231073|Idiopathic Parkinson's disease|idiopathic parkinson's disease
220977|NCT02231073|Exercise|exercise
220978|NCT02231073|parkinsonism|parkinsonism
220979|NCT02231060|Outcome Prediction|outcome prediction
220980|NCT02231060|Anoxic-Ischemic Encephalopathy|anoxic-ischemic encephalopathy
220981|NCT02231060|Coma|coma
220982|NCT02231060|Vegetative State|vegetative state
220983|NCT02231060|Minimally Conscious State|minimally conscious state
220984|NCT02231060|Chronic Disorders of Consciousness|chronic disorders of consciousness
220985|NCT02231047|Diarrhea|diarrhea
220986|NCT02231047|Pneumonia|pneumonia
220987|NCT02231047|Child, Preschool|child, preschool
220988|NCT02231047|Infant|infant
220989|NCT02231047|Dietary Supplements|dietary supplements
220990|NCT02231047|Colostrums|colostrums
220991|NCT02231047|Developing Countries|developing countries
220992|NCT02231021|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
220993|NCT02231021|alogliptin|alogliptin
220994|NCT02231021|pioglitazone|pioglitazone
220995|NCT02231021|DPP4 inhibitor|dpp4 inhibitor
220996|NCT02231021|thiazolidinedione|thiazolidinedione
220997|NCT02231008|SMS|sms
220998|NCT02230969|peginterferon|peginterferon
220999|NCT02230969|relapsing|relapsing
221000|NCT02230969|pegylated|pegylated
221001|NCT02230969|Subcutaneous|subcutaneous
221002|NCT02230969|Injectable|injectable
221003|NCT02230969|Multiple Sclerosis|multiple sclerosis
221004|NCT02230943|rheumatoid|rheumatoid
221005|NCT02230943|arthritis|arthritis
221006|NCT02230943|osteoarthritis|osteoarthritis
221007|NCT02230943|gout|gout
221008|NCT02230930|Parkinson's disease|parkinson's disease
221009|NCT02230930|Apomorphine|apomorphine
221010|NCT02230930|Infusion|infusion
221011|NCT02230930|Skin reactions|skin reactions
221012|NCT02230930|Subcutaneous nodules|subcutaneous nodules
221013|NCT02230930|Hydrocortisone|hydrocortisone
221014|NCT02230930|Massage|massage
221015|NCT02230930|Dilution|dilution
221016|NCT02230904|Rotigotine patch|rotigotine patch
221017|NCT02230904|Neupro|neupro
221018|NCT02230904|Parkinson's Disease|parkinson's disease
221019|NCT02230891|heart failure|heart failure
221020|NCT02230891|biomarkers|biomarkers
221021|NCT02230891|troponin|troponin
221022|NCT02230891|BNP|bnp
221023|NCT02230891|carvedilol|carvedilol
221024|NCT02230891|spironolactone|spironolactone
221025|NCT02230891|prevention|prevention
221026|NCT02230878|JNJ-42847922|jnj-42847922
221027|NCT02230878|Phase 1|phase 1
221028|NCT02230878|Healthy|healthy
221029|NCT02230878|Placebo|placebo
221030|NCT02230865|Funnel chest (Pectus excavatum)|funnel chest (pectus excavatum)
221031|NCT02230852|Telemedicine|telemedicine
221032|NCT02230852|Prehospital|prehospital
221033|NCT02230852|Emergency Medicine|emergency medicine
221034|NCT02230852|Stroke|stroke
221035|NCT02230839|insulin resistance|insulin resistance
221036|NCT02230839|muscle|muscle
221037|NCT02230839|health education|health education
221038|NCT02230839|exercise|exercise
221039|NCT02230826|Arthroplasty|arthroplasty
221040|NCT02230826|Hip Replacement|hip replacement
221041|NCT02230826|Acetabular cup|acetabular cup
221042|NCT02230826|Femoral stem|femoral stem
221043|NCT02230813|Cohort Study,|cohort study,
221044|NCT02230813|Cellulitis,|cellulitis,
221045|NCT02230813|Skin and Soft Tissue Infection,|skin and soft tissue infection,
221046|NCT02230813|Emergency Department,|emergency department,
221047|NCT02230813|Clinical Prediction Rule|clinical prediction rule
221048|NCT02230787|Pilot study|pilot study
221049|NCT02230787|randomized clinical trial|randomized clinical trial
221050|NCT02230787|periodontal disease|periodontal disease
221051|NCT02230787|gingival recession|gingival recession
221052|NCT02230787|Emdogain|emdogain
221053|NCT02230787|connective tissue|connective tissue
221054|NCT02230787|wound healing|wound healing
221055|NCT02230787|inflammation|inflammation
221056|NCT02230774|hydration|hydration
221057|NCT02230774|cognitive function|cognitive function
221058|NCT02230774|doctors|doctors
221059|NCT02230774|nurses|nurses
221060|NCT02230774|Nurses and Doctors oncall|nurses and doctors oncall
221061|NCT02230761|steatoblepharon|steatoblepharon
221062|NCT02230761|blepharoptosis|blepharoptosis
221063|NCT02230761|dermatochalasis|dermatochalasis
221064|NCT02230761|blepharoplasty|blepharoplasty
221065|NCT02230761|periorbital|periorbital
221066|NCT02230761|orbital|orbital
221067|NCT02230761|eyelid|eyelid
221068|NCT02230761|eyebags|eyebags
221069|NCT02230761|eye bags|eye bags
221070|NCT02230748|LAA|laa
221071|NCT02230748|LAA-Occluder|laa-occluder
221072|NCT02230748|Atrial Fibrillation|atrial fibrillation
221073|NCT02230748|AF|af
221074|NCT02230735|Robotic|robotic
221075|NCT02230735|Hysterectomy|hysterectomy
221076|NCT02230735|Uterosacral|uterosacral
221077|NCT02230735|Bupivacaine|bupivacaine
221078|NCT02230735|Robotic hysterectomy pain control|robotic hysterectomy pain control
221079|NCT02230722|opioids|opioids
221080|NCT02230722|chronic pain|chronic pain
221081|NCT02230722|collaborative care|collaborative care
221082|NCT02230709|Neck pain|neck pain
221083|NCT02230709|Myofascial pain syndrome|myofascial pain syndrome
221085|NCT02230683|Liver Cirrhosis|liver cirrhosis
221086|NCT02230683|Hepatic Cirrhosis|hepatic cirrhosis
221087|NCT02230683|Portal Hypertension|portal hypertension
221088|NCT02230670|Liver Cirrhosis|liver cirrhosis
221089|NCT02230670|Hepatic Cirrhosis|hepatic cirrhosis
221090|NCT02230605|Delirium|delirium
221091|NCT02230605|Post Operative Delirium|post operative delirium
221092|NCT02230605|PD|pd
221093|NCT02230605|POD|pod
221094|NCT02230605|Anesthesia|anesthesia
221095|NCT02230605|Anesthesiology|anesthesiology
221096|NCT02230605|Post Operative Recovery|post operative recovery
221097|NCT02230605|Post Anesthesia Care Unit|post anesthesia care unit
221098|NCT02230605|PACU|pacu
221099|NCT02230605|Cognition|cognition
221100|NCT02230605|Cognitive Impairment|cognitive impairment
221101|NCT02230605|Memory|memory
221102|NCT02230605|Thinking|thinking
221103|NCT02230605|Confusion Assessment Method|confusion assessment method
221104|NCT02230605|CAM|cam
221105|NCT02230605|Neurobics|neurobics
221106|NCT02230605|Neuroplasticity|neuroplasticity
221107|NCT02230605|Lumosity|lumosity
221108|NCT02230605|Brain Games|brain games
221109|NCT02230605|Cognitive Exercise|cognitive exercise
221110|NCT02230605|Cognitive Training|cognitive training
221111|NCT02230605|Perioperative Cognitive Protection|perioperative cognitive protection
221112|NCT02230605|Cognitive Reserve|cognitive reserve
221113|NCT02230605|Neurobics Trial|neurobics trial
221114|NCT02230605|Surgery|surgery
221115|NCT02230605|Elderly Patients|elderly patients
221116|NCT02230592|PET|pet
221117|NCT02230592|Metabolic Glutamate Receptors|metabolic glutamate receptors
221118|NCT02230592|Brain Imaging|brain imaging
221119|NCT02230579|safety|safety
221120|NCT02230579|tolerability|tolerability
221121|NCT02230579|malaria|malaria
221122|NCT02230566|MPS 7|mps 7
221123|NCT02230566|Sly Syndrome|sly syndrome
221124|NCT02230566|Mucopolysaccharidosis|mucopolysaccharidosis
221125|NCT02230566|MPS VII|mps vii
221126|NCT02230566|Enzyme Replacement Therapy|enzyme replacement therapy
221127|NCT02230566|Mucopolysaccharidosis type 7|mucopolysaccharidosis type 7
221128|NCT02230566|rare disease|rare disease
221129|NCT02230566|lysosomal storage disease|lysosomal storage disease
221130|NCT02230566|metabolic disorder|metabolic disorder
221131|NCT02230514|Nonunion fracture|nonunion fracture
221132|NCT02230514|Long bones|long bones
221133|NCT02230514|Pseudoarthrosis|pseudoarthrosis
221134|NCT02230514|Cell therapy|cell therapy
221135|NCT02230514|Tissue engineering|tissue engineering
221136|NCT02230514|Mesenchymal stromal cells|mesenchymal stromal cells
221137|NCT02230488|Inpatient Diabetes Management|inpatient diabetes management
221138|NCT02230488|Prevent <31 day readmission in patients with Diabetes|prevent <31 day readmission in patients with diabetes
221139|NCT02230488|CDEs role in transition of care of inpatients with diabetes|cdes role in transition of care of inpatients with diabetes
221140|NCT02230475|Allergic Rhinitis|allergic rhinitis
221141|NCT02230475|NMR|nmr
221142|NCT02230462|patient satisfaction|patient satisfaction
221143|NCT02230462|Mohs surgery|mohs surgery
221144|NCT02230436|Pancreatectomy|pancreatectomy
221145|NCT02230436|Time of drain removal|time of drain removal
221146|NCT02230423|Functional nasal surgery|functional nasal surgery
221147|NCT02230423|Empty Nose Syndrome (ENS)|empty nose syndrome (ens)
221148|NCT02230410|Barrett's|barrett's
221149|NCT02230410|high grade dysplasia|high grade dysplasia
221150|NCT02230410|ablation|ablation
221151|NCT02230410|cyrotherapy|cyrotherapy
221152|NCT02230397|skin aging|skin aging
221153|NCT02230397|anti-aging cream|anti-aging cream
221154|NCT02230397|wrinkles|wrinkles
221155|NCT02230384|Attempt at Smoking Cessation|attempt at smoking cessation
221156|NCT02230384|Schizophrenia or Schizoaffective disorder|schizophrenia or schizoaffective disorder
221157|NCT02230384|Novel nicotinergic drug|novel nicotinergic drug
221158|NCT02230371|Myofascial pain|myofascial pain
221159|NCT02230371|TMD|tmd
221160|NCT02230371|5-HT3|5-ht3
221161|NCT02230371|Granisetron|granisetron
221162|NCT02230371|Placebo-controlled|placebo-controlled
221163|NCT02230371|Patients|patients
221164|NCT02230371|Randomized|randomized
221165|NCT02230371|Double-blind|double-blind
221166|NCT02230358|carotid endarterectomy|carotid endarterectomy
221167|NCT02230358|cardiac output|cardiac output
221168|NCT02230358|trans-cranial Doppler|trans-cranial doppler
221169|NCT02230358|CEA|cea
221170|NCT02230358|regional anesthesia|regional anesthesia
221171|NCT02230358|general anesthesia|general anesthesia
221172|NCT02230345|Probiotic|probiotic
221173|NCT02230345|Yoghourt|yoghourt
221174|NCT02230345|Inflammation|inflammation
221175|NCT02230345|Metabolomics|metabolomics
221176|NCT02230319|Cryotherapy|cryotherapy
221177|NCT02230319|Cold therapy|cold therapy
221178|NCT02230319|Peripheral Neuropathy|peripheral neuropathy
221179|NCT02230319|Paclitaxel|paclitaxel
221180|NCT02230319|Breast Cancer|breast cancer
221181|NCT02230319|Symptom management|symptom management
221182|NCT02230319|Prevention|prevention
221183|NCT02230293|ambulatory care,|ambulatory care,
221184|NCT02230293|hypertension,|hypertension,
221185|NCT02230293|health personnel,|health personnel,
221186|NCT02230293|clinical trial|clinical trial
221187|NCT02230280|Mobile health technology|mobile health technology
221188|NCT02230280|Multiple chronic conditions|multiple chronic conditions
221189|NCT02230280|Older adults|older adults
221190|NCT02230280|Home and community care|home and community care
221191|NCT02230280|Effectiveness|effectiveness
221192|NCT02230280|Cost analysis|cost analysis
221193|NCT02230280|Interprofessional Stroke Rehabilitation|interprofessional stroke rehabilitation
221194|NCT02230267|boot camp|boot camp
221195|NCT02230267|exercise|exercise
221196|NCT02230267|balance training|balance training
221197|NCT02230267|fall prevention|fall prevention
221198|NCT02230267|falling|falling
221199|NCT02230267|strength training|strength training
221200|NCT02230254|Coronary Artery Disease|coronary artery disease
221201|NCT02230241|Dyslipidaemia|dyslipidaemia
221202|NCT02230241|LDL-C goals|ldl-c goals
221203|NCT02230241|Guidelines|guidelines
221204|NCT02230215|Total Knee Replacement|total knee replacement
221205|NCT02230215|Visionaire|visionaire
221206|NCT02230189|Asthma|asthma
221207|NCT02230189|Allergen challenge|allergen challenge
221208|NCT02230163|Chikungunya virus|chikungunya virus
221209|NCT02230163|Human anti-CHIKV hyperimmune intravenous immunoglobulins|human anti-chikv hyperimmune intravenous immunoglobulins
221210|NCT02230163|Neonates|neonates
221211|NCT02230150|Adhesion, Knowledge, Nursing|adhesion, knowledge, nursing
221212|NCT02230137|adolescents|adolescents
221213|NCT02230137|type 1 diabetes|type 1 diabetes
221214|NCT02230137|poorly controlled|poorly controlled
221215|NCT02230137|SMS|sms
221216|NCT02230137|Improve glycaemic control|improve glycaemic control
221217|NCT02230137|HbA1c reduction|hba1c reduction
221218|NCT02230137|poorly controlled type 1 diabetic adolescents|poorly controlled type 1 diabetic adolescents
221219|NCT02230124|Hydrocephalus|hydrocephalus
221220|NCT02230111|Women|women
221221|NCT02230111|Caloric restriction|caloric restriction
221222|NCT02230111|Cognitive dietary restraint|cognitive dietary restraint
221223|NCT02230111|Eating behaviours|eating behaviours
221224|NCT02230111|Food habits|food habits
221225|NCT02230111|Appetite sensations|appetite sensations
221226|NCT02230111|Stress|stress
221227|NCT02230111|Weight management|weight management
221228|NCT02230098|remote ischemic conditioning|remote ischemic conditioning
221229|NCT02230098|ischemic heart disease|ischemic heart disease
221230|NCT02230072|myelomeningocele|myelomeningocele
221231|NCT02230072|MMC|mmc
221232|NCT02230072|NTD|ntd
221233|NCT02230072|neural|neural
221234|NCT02230072|defect|defect
221235|NCT02230072|Spina bifida|spina bifida
221236|NCT02230072|Neural Tube Defect|neural tube defect
221237|NCT02230059|Prostatic Neoplasms|prostatic neoplasms
221238|NCT02230059|observational Study|observational study
221239|NCT02230059|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
221240|NCT02230046|Healthy,|healthy,
221241|NCT02230046|Abiraterone Acetate,|abiraterone acetate,
221242|NCT02230046|Bioequivalence.|bioequivalence.
221243|NCT02230033|JNJ-56021927|jnj-56021927
221244|NCT02230033|Itraconazole|itraconazole
221245|NCT02230033|Gemfibrozil|gemfibrozil
221246|NCT02229994|Dyspnea|dyspnea
221247|NCT02229994|Self-administered questionnaire|self-administered questionnaire
221248|NCT02229994|Chronic respiratory disease|chronic respiratory disease
221249|NCT02229994|COPD|copd
221250|NCT02229994|Diffuse interstitial lung diseases|diffuse interstitial lung diseases
221251|NCT02229994|Pulmonary arterial hypertension|pulmonary arterial hypertension
221252|NCT02229994|Cystic fibrosis|cystic fibrosis
221253|NCT02229981|Lymphoma|lymphoma
221254|NCT02229981|B-cell Lymphomas|b-cell lymphomas
221255|NCT02229981|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
221256|NCT02229981|Lymphosarcoma|lymphosarcoma
221257|NCT02229981|Kaposi's Sarcoma-associated Herpesvirus|kaposi's sarcoma-associated herpesvirus
221258|NCT02229981|KHSV|khsv
221259|NCT02229981|Human Immunodeficiency Virus|human immunodeficiency virus
221260|NCT02229981|HIV|hiv
221261|NCT02229981|Epstein-Barr Virus|epstein-barr virus
221262|NCT02229981|EBV|ebv
221263|NCT02229981|Kaposi sarcoma|kaposi sarcoma
221264|NCT02229968|craniosynostosis|craniosynostosis
221265|NCT02229968|craniofacial|craniofacial
221266|NCT02229968|amicar|amicar
221267|NCT02229968|epsilon aminocaproic acid|epsilon aminocaproic acid
221268|NCT02229968|ε-aminocaproic acid|ε-aminocaproic acid
221269|NCT02229955|Dry Eye Syndromes|dry eye syndromes
221270|NCT02229942|Chronic Fatigue Syndrome (CFS)|chronic fatigue syndrome (cfs)
221271|NCT02229942|Myalgic Encephalitis (ME)|myalgic encephalitis (me)
221272|NCT02229942|Rituximab|rituximab
221273|NCT02229942|B-lymphocyte depletion|b-lymphocyte depletion
221274|NCT02229942|B-cell depletion|b-cell depletion
221275|NCT02229929|Pruritus|pruritus
221276|NCT02229929|uremic pruritus|uremic pruritus
221277|NCT02229929|kappa opioid|kappa opioid
221278|NCT02229929|CR845|cr845
221279|NCT02229916|Testicular Neoplasms|testicular neoplasms
221280|NCT02229916|Testicular Cancer|testicular cancer
221281|NCT02229916|Cohort Study|cohort study
221282|NCT02229903|OCD|ocd
221283|NCT02229864|Absorb™ BVS|absorb™ bvs
221284|NCT02229864|Angioplasty|angioplasty
221285|NCT02229864|Bioabsorbable|bioabsorbable
221286|NCT02229864|BVS|bvs
221287|NCT02229864|Coronary Artery Disease|coronary artery disease
221288|NCT02229864|Coronary Artery Endothelial Responsiveness|coronary artery endothelial responsiveness
221289|NCT02229864|Coronary artery restenosis|coronary artery restenosis
221290|NCT02229864|Coronary artery stenosis|coronary artery stenosis
221291|NCT02229864|Coronary scaffold|coronary scaffold
221292|NCT02229864|Coronary Stent|coronary stent
221293|NCT02229864|Drug eluting stents|drug eluting stents
221294|NCT02229864|Everolimus|everolimus
221295|NCT02229864|Myocardial ischemia|myocardial ischemia
221296|NCT02229864|Stent thrombosis|stent thrombosis
221297|NCT02229864|Stents|stents
221298|NCT02229708|Pregnancy|pregnancy
221299|NCT02229708|Weight control|weight control
221300|NCT02229708|Behavioral|behavioral
221301|NCT02229708|technology-based intervention|technology-based intervention
221302|NCT02229695|Trauma|trauma
221303|NCT02229695|Sepsis|sepsis
221304|NCT02229695|Temporary abdominal closure|temporary abdominal closure
221305|NCT02229695|Bogota bag|bogota bag
221306|NCT02229695|Vacuum assisted closure|vacuum assisted closure
221307|NCT02229682|extranodal NK/T-cell lymphoma,nasal-type,|extranodal nk/t-cell lymphoma,nasal-type,
221308|NCT02229682|radiotherapy,|radiotherapy,
221309|NCT02229682|intensity-modulated radiation treatment,|intensity-modulated radiation treatment,
221310|NCT02229682|asparaginase-based chemotherapy,|asparaginase-based chemotherapy,
221311|NCT02229682|loco-regional control,|loco-regional control,
221312|NCT02229682|survival|survival
221313|NCT02229656|olaparib|olaparib
221314|NCT02229656|radiotherapy|radiotherapy
221315|NCT02229656|Laryngeal SCC|laryngeal scc
221316|NCT02229656|oropharyngeal SCC|oropharyngeal scc
221317|NCT02229643|Traumatic brain injury|traumatic brain injury
221318|NCT02229643|Neuroglobin|neuroglobin
221319|NCT02229643|Nogo-A|nogo-a
221320|NCT02229643|Prognosis|prognosis
221321|NCT02229630|intra-uterine growth restriction|intra-uterine growth restriction
221322|NCT02229630|MRI|mri
221323|NCT02229630|apparent diffusion coefficient|apparent diffusion coefficient
221324|NCT02229617|Intramuscular testosterone|intramuscular testosterone
221325|NCT02229617|Subcutaneous testosterone|subcutaneous testosterone
221326|NCT02229604|electroacupuncture|electroacupuncture
221327|NCT02229604|diminished ovarian reserve|diminished ovarian reserve
221328|NCT02229604|cohort study|cohort study
221329|NCT02229578|Burn pain|burn pain
221330|NCT02229578|lidocaine|lidocaine
221331|NCT02229578|donor site pain|donor site pain
221332|NCT02229578|Narcotic use|narcotic use
221333|NCT02229565|prostate cancer|prostate cancer
221334|NCT02229565|prostate biopsy|prostate biopsy
221335|NCT02229565|prostatectomy|prostatectomy
221336|NCT02229526|Fish oil supplementation|fish oil supplementation
221337|NCT02229526|RCT|rct
221338|NCT02229526|High risk pregnancies|high risk pregnancies
221339|NCT02229526|Twin pregnancy|twin pregnancy
221340|NCT02229526|Preterm birth|preterm birth
221341|NCT02229526|Intrauterine growth retardation|intrauterine growth retardation
221342|NCT02229526|Pregnancy induced hypertension|pregnancy induced hypertension
221343|NCT02229513|postpartum hemorrhage|postpartum hemorrhage
221344|NCT02229513|uterine atony|uterine atony
221345|NCT02229513|cesarean section|cesarean section
221346|NCT02229513|cesarean hysterectomy|cesarean hysterectomy
221347|NCT02229513|acute blood loss anemia|acute blood loss anemia
221348|NCT02229513|uterotonics|uterotonics
221349|NCT02229513|obstetric hemorrhage|obstetric hemorrhage
221350|NCT02229513|severe hemorrhage|severe hemorrhage
221351|NCT02229513|blood transfusion|blood transfusion
221352|NCT02229513|obstetric emergencies|obstetric emergencies
221353|NCT02229513|obstetrics|obstetrics
221354|NCT02229513|massive hemorrhage|massive hemorrhage
221355|NCT02229513|hemorrhage|hemorrhage
221356|NCT02229513|uterine cooling|uterine cooling
221357|NCT02229500|Propionate|propionate
221358|NCT02229500|Microbiome|microbiome
221359|NCT02229500|Dietary Fibre|dietary fibre
221360|NCT02229500|Short chain fatty acids|short chain fatty acids
221361|NCT02229487|Prediabetes|prediabetes
221362|NCT02229487|Short sleepers|short sleepers
221363|NCT02229487|GLP-1|glp-1
221364|NCT02229474|Dementia|dementia
221365|NCT02229474|Cognitive Stimulation Therapy|cognitive stimulation therapy
221366|NCT02229474|Quality of life|quality of life
221367|NCT02229474|Cognitive impairment|cognitive impairment
221368|NCT02229474|Africa|africa
221369|NCT02229474|Tanzania|tanzania
221370|NCT02229474|Nigeria|nigeria
221371|NCT02229474|Low- and Middle-income countries|low- and middle-income countries
221372|NCT02229474|Non-pharmacological intervention|non-pharmacological intervention
221373|NCT02229474|Task-shifting|task-shifting
221374|NCT02229474|Cognitive screening|cognitive screening
221375|NCT02229448|Immunoglobulin G|immunoglobulin g
221376|NCT02229448|focus|focus
221377|NCT02229448|study|study
221378|NCT02229448|detect|detect
221379|NCT02229448|patients|patients
221380|NCT02229435|Chronic kidney disease|chronic kidney disease
221381|NCT02229435|Urological care|urological care
221382|NCT02229435|Nephrological care|nephrological care
221383|NCT02229409|adults|adults
221384|NCT02229396|Diabetes Mellitus|diabetes mellitus
221385|NCT02229396|Exenatide|exenatide
221386|NCT02229396|Dapagliflozin|dapagliflozin
221387|NCT02229396|Diabetes medication|diabetes medication
221388|NCT02229396|Treatment efficacy|treatment efficacy
221389|NCT02229396|Placebo|placebo
221390|NCT02229396|Metabolism|metabolism
221391|NCT02229396|Cardiovascular metabolic|cardiovascular metabolic
221392|NCT02229383|Diabetes Mellitus|diabetes mellitus
221393|NCT02229383|Exenatide|exenatide
221394|NCT02229383|Diabetes drug|diabetes drug
221395|NCT02229383|Treatment efficacy|treatment efficacy
221396|NCT02229383|Placebo|placebo
221397|NCT02229383|Metabolism|metabolism
221398|NCT02229383|Cardiovascilar metabolic|cardiovascilar metabolic
221399|NCT02229370|extracranial|extracranial
221400|NCT02229370|carotid|carotid
221401|NCT02229370|artery|artery
221402|NCT02229370|aneurysm|aneurysm
221403|NCT02229370|registry|registry
221404|NCT02229370|CAR|car
221405|NCT02229357|H5N2 Vaccine|h5n2 vaccine
221406|NCT02229344|colitis, ulcerative|colitis, ulcerative
221407|NCT02229344|MOSAIK|mosaik
221408|NCT02229344|REMICADE|remicade
221409|NCT02229344|Infliximab|infliximab
221410|NCT02229331|haemophilia|haemophilia
221411|NCT02229331|arthropathy|arthropathy
221412|NCT02229331|pediatrics|pediatrics
221413|NCT02229331|ankle|ankle
221414|NCT02229331|biomechanics|biomechanics
221415|NCT02229305|Anxiety|anxiety
221416|NCT02229305|Trauma|trauma
221417|NCT02229305|Depression|depression
221418|NCT02229305|Problem Behavior|problem behavior
221419|NCT02229305|evidence-based treatments|evidence-based treatments
221420|NCT02229279|Surgical Procedures, Operative|surgical procedures, operative
221421|NCT02229266|AML|aml
221422|NCT02229266|high-risk AML|high-risk aml
221423|NCT02229266|acute myeloid leukemia|acute myeloid leukemia
221424|NCT02229266|NK cells|nk cells
221425|NCT02229266|haploidentical natural killer cells|haploidentical natural killer cells
221426|NCT02229266|immunotherapy|immunotherapy
221427|NCT02229240|Albiglutide|albiglutide
221428|NCT02229240|Add-on to basal-bolus insulin therapy|add-on to basal-bolus insulin therapy
221429|NCT02229240|Glucagon-like peptide-1 receptor agonist|glucagon-like peptide-1 receptor agonist
221430|NCT02229240|Type 2 diabetes mellitus|type 2 diabetes mellitus
221431|NCT02229227|switch study|switch study
221432|NCT02229227|albiglutide|albiglutide
221433|NCT02229227|glucagon-like peptide-1 receptor agonist|glucagon-like peptide-1 receptor agonist
221434|NCT02229227|Type 2 diabetes mellitus|type 2 diabetes mellitus
221435|NCT02229227|basal-bolus insulin therapy|basal-bolus insulin therapy
221436|NCT02229214|Renal function|renal function
221437|NCT02229214|Glomerular Filtration Rate|glomerular filtration rate
221438|NCT02229214|Kidney function|kidney function
221439|NCT02229214|Qsymia|qsymia
221440|NCT02229214|Iohexol|iohexol
221441|NCT02229214|Serum Creatinine|serum creatinine
221442|NCT02229214|Creatinine clearance|creatinine clearance
221443|NCT02229214|Renal Clearance|renal clearance
221444|NCT02229214|VI-0521|vi-0521
221445|NCT02229214|Healthy volunteers|healthy volunteers
221446|NCT02229201|propofol|propofol
221447|NCT02229201|sevoflurane|sevoflurane
221448|NCT02229201|Interleukin 6|interleukin 6
221449|NCT02229201|Interleukin 10|interleukin 10
221450|NCT02229188|Depression; mood; cognitive training|depression; mood; cognitive training
221451|NCT02229175|Diabetic Macular Edema|diabetic macular edema
221452|NCT02229175|Diabetic Retinopathy|diabetic retinopathy
221453|NCT02229175|Type 1 Diabetes|type 1 diabetes
221454|NCT02229175|Type 2 Diabetes|type 2 diabetes
221455|NCT02229175|Macular Edema|macular edema
221456|NCT02229175|bevacizumab|bevacizumab
221457|NCT02229175|intravitreal injection|intravitreal injection
221458|NCT02229175|Avastin|avastin
221459|NCT02229175|PASCAL Endpoint Management (EpM) system|pascal endpoint management (epm) system
221460|NCT02229175|Subthreshold focal laser treatments|subthreshold focal laser treatments
221461|NCT02229162|umbilical cord|umbilical cord
221462|NCT02229162|cesarean section|cesarean section
221463|NCT02229162|Blood Loss, Surgical|blood loss, surgical
221464|NCT02229149|breast cancer|breast cancer
221465|NCT02229149|metastatic breast cancer|metastatic breast cancer
221466|NCT02229149|HER2+ breast cancer|her2+ breast cancer
221467|NCT02229136|Mouth sores from chemotherapy|mouth sores from chemotherapy
221468|NCT02229136|mouth sores|mouth sores
221469|NCT02229136|hormone receptor-positive metastatic breast cancer|hormone receptor-positive metastatic breast cancer
221470|NCT02229136|metastatic breast cancer|metastatic breast cancer
221471|NCT02229123|seizures|seizures
221472|NCT02229123|neonates|neonates
221473|NCT02229123|anticonvulsant treatment|anticonvulsant treatment
221474|NCT02229123|levetiracetam|levetiracetam
221475|NCT02229123|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
221476|NCT02229123|electroencephalography|electroencephalography
221477|NCT02229110|type 2 diabetes mellitus|type 2 diabetes mellitus
221478|NCT02229110|e-Health|e-health
221479|NCT02229110|allocation of care|allocation of care
221480|NCT02229110|clinical inertia|clinical inertia
221481|NCT02229110|quality of care|quality of care
221482|NCT02229110|patient satisfaction|patient satisfaction
221483|NCT02229097|type 1 diabetes|type 1 diabetes
221484|NCT02229071|Donafenib|donafenib
221486|NCT02229071|Advanced|advanced
221487|NCT02229071|inoperable|inoperable
221488|NCT02229071|Phase 1B|phase 1b
221489|NCT02229058|Gastric Cancer|gastric cancer
221490|NCT02229058|Albumin Bound Paclitaxel|albumin bound paclitaxel
221491|NCT02229058|S-1|s-1
221492|NCT02229058|First Line|first line
221493|NCT02229045|gastric caner|gastric caner
221494|NCT02229045|Albumin Bound Paclitaxel|albumin bound paclitaxel
221495|NCT02229045|5-FU/CF|5-fu/cf
221496|NCT02229045|taxanes naive|taxanes naive
221497|NCT02229032|Dravet Syndrome|dravet syndrome
221498|NCT02229032|cannabidiol therapy|cannabidiol therapy
221499|NCT02229032|Charlotte's Web|charlotte's web
221500|NCT02229019|Volunteers|volunteers
221501|NCT02229019|Mealtime assistance|mealtime assistance
221502|NCT02229019|Older adults|older adults
221503|NCT02229019|Nutrition|nutrition
221504|NCT02229019|Nursing|nursing
221505|NCT02229006|Aortic aneurysm, abdominal|aortic aneurysm, abdominal
221506|NCT02229006|Sodium Fluoride|sodium fluoride
221507|NCT02229006|Positron Emission Tomography|positron emission tomography
221508|NCT02228980|Influenza|influenza
221509|NCT02228980|Trivalent influenza vaccine|trivalent influenza vaccine
221510|NCT02228980|Sanofi Pasteur Shenzhen trivalent influenza vaccine|sanofi pasteur shenzhen trivalent influenza vaccine
221511|NCT02228967|Alcohol Use|alcohol use
221512|NCT02228967|SBIRT|sbirt
221513|NCT02228967|Military|military
221514|NCT02228967|Health Behavior|health behavior
221515|NCT02228967|Emergency Room|emergency room
221516|NCT02228967|Health Promotion|health promotion
221517|NCT02228967|Formative Research|formative research
221518|NCT02228967|Randomized Trial|randomized trial
221519|NCT02228954|Clear-cell metastatic renal cell carcinoma|clear-cell metastatic renal cell carcinoma
221520|NCT02228954|Positron-Emission Tomography|positron-emission tomography
221521|NCT02228928|Peripheral Nerve Injury|peripheral nerve injury
221522|NCT02228928|Postherpetic Neuralgia|postherpetic neuralgia
221523|NCT02228889|Hernia|hernia
221524|NCT02228889|Abdominal wall reconstruction|abdominal wall reconstruction
221525|NCT02228889|Abdominal wall defect|abdominal wall defect
221526|NCT02228889|Porcine mesh|porcine mesh
221527|NCT02228889|Component separation|component separation
221528|NCT02228889|Abdominal wall tumor|abdominal wall tumor
221529|NCT02228889|Desmoid|desmoid
221530|NCT02228863|Stroke|stroke
221531|NCT02228863|Spasticity|spasticity
221532|NCT02228850|Secondary Raynaud's Phenomenon|secondary raynaud's phenomenon
221533|NCT02228850|Secondary Raynaud's Disease|secondary raynaud's disease
221534|NCT02228850|Scleroderma|scleroderma
221535|NCT02228850|Raynaud's Disease secondary to systemic sclerosis|raynaud's disease secondary to systemic sclerosis
221536|NCT02228850|CREST|crest
221537|NCT02228850|Apricus Biosciences|apricus biosciences
221538|NCT02228850|laser doppler|laser doppler
221539|NCT02228850|thermography|thermography
221540|NCT02228824|Smoking|smoking
221541|NCT02228824|Non-daily smokers|non-daily smokers
221542|NCT02228824|Ecological Momentary Assessment|ecological momentary assessment
221543|NCT02228824|Biomarkers|biomarkers
221544|NCT02228798|anticoagulant|anticoagulant
221545|NCT02228798|atrial fibrillation|atrial fibrillation
221546|NCT02228798|surgery|surgery
221547|NCT02228798|oral anticoagulant|oral anticoagulant
221548|NCT02228798|discontinue|discontinue
221549|NCT02228798|DOAC|doac
221550|NCT02228798|NOAC|noac
221551|NCT02228798|blood thinner|blood thinner
221552|NCT02228798|interruption|interruption
221553|NCT02228772|Acute lymphoblastic Leukemia|acute lymphoblastic leukemia
221554|NCT02228772|Lymphoblastic lymphoma|lymphoblastic lymphoma
221555|NCT02228772|B-cell Adult Acute Lymphoblastic Leukemia|b-cell adult acute lymphoblastic leukemia
221556|NCT02228772|T-cell Adult Acute Lymphoblastic Leukemia|t-cell adult acute lymphoblastic leukemia
221557|NCT02228759|Ambulatory home regional|ambulatory home regional
221558|NCT02228759|adductor canal block|adductor canal block
221559|NCT02228759|Postoperative pain|postoperative pain
221560|NCT02228759|total knee arthroplasty|total knee arthroplasty
221561|NCT02228759|Home regional|home regional
221562|NCT02228759|Fast track arthroplasty|fast track arthroplasty
221563|NCT02228720|Chronic Sinusitis|chronic sinusitis
221564|NCT02228720|Endoscopic Sinus Surgery|endoscopic sinus surgery
221565|NCT02228694|ADC|adc
221566|NCT02228694|Pre installation|pre installation
221567|NCT02228694|Post installation|post installation
221568|NCT02228694|Safety|safety
221569|NCT02228694|Time|time
221570|NCT02228668|AVANT|avant
221571|NCT02228668|GERCOR|gercor
221572|NCT02228668|Follow up|follow up
221573|NCT02228668|Colon cancer|colon cancer
221574|NCT02228668|Bevacizumab|bevacizumab
221575|NCT02228668|Overall survival|overall survival
221576|NCT02228655|Chronic Kidney Disease|chronic kidney disease
221577|NCT02228655|CKD|ckd
221578|NCT02228655|Anemia of Chronic Illness|anemia of chronic illness
221579|NCT02228642|Type 1 diabetes|type 1 diabetes
221580|NCT02228642|Type 2 diabetes|type 2 diabetes
221581|NCT02228642|Hypoglycemia|hypoglycemia
221582|NCT02228642|Cognition disorders|cognition disorders
221583|NCT02228642|Inpatient|inpatient
221584|NCT02228629|Diabetes|diabetes
221585|NCT02228629|Foot complications|foot complications
221586|NCT02228629|plantar keratoma|plantar keratoma
221587|NCT02228629|plantar pressure|plantar pressure
221588|NCT02228616|Constipation|constipation
221589|NCT02228616|Chronic constipation|chronic constipation
221590|NCT02228616|Prucalopride|prucalopride
221591|NCT02228616|Women|women
221592|NCT02228603|exercise therapy|exercise therapy
221593|NCT02228603|rehabilitation|rehabilitation
221594|NCT02228590|Parkinson's Disease|parkinson's disease
221595|NCT02228564|Lack of perfusion in the extremities|lack of perfusion in the extremities
221596|NCT02228564|Atherosclerosis|atherosclerosis
221597|NCT02228564|Intermittent claudication|intermittent claudication
221598|NCT02228564|BOLSTER|bolster
221599|NCT02228551|Augmented renal clearance|augmented renal clearance
221600|NCT02228551|non-critically ill|non-critically ill
221601|NCT02228551|surgery|surgery
221602|NCT02228551|prevalence|prevalence
221603|NCT02228551|risk factors|risk factors
221604|NCT02228538|total knee arthroplasty|total knee arthroplasty
221605|NCT02228538|osteoarthritis|osteoarthritis
221606|NCT02228525|Selinexor (KPT-330)|selinexor (kpt-330)
221607|NCT02228525|Selective Inhibitor of Nuclear Export (SINE)|selective inhibitor of nuclear export (sine)
221608|NCT02228525|14-005|14-005
221609|NCT02228512|HHV8|hhv8
221610|NCT02228512|PEL|pel
221611|NCT02228512|Immune Modulation|immune modulation
221612|NCT02228512|CC-4047|cc-4047
221613|NCT02228512|IMiD|imid
221614|NCT02228499|asthma|asthma
221615|NCT02228499|academics|academics
221616|NCT02228499|GPA|gpa
221617|NCT02228499|attendance|attendance
221618|NCT02228447|Adolescent|adolescent
221619|NCT02228447|Randomized controlled trial|randomized controlled trial
221620|NCT02228447|Eating behavior|eating behavior
221621|NCT02228447|Physical Activity|physical activity
221622|NCT02228447|Sedentary lifestyle|sedentary lifestyle
221623|NCT02228434|Childhood obesity, intervention, effectiveness, comparison|childhood obesity, intervention, effectiveness, comparison
221624|NCT02228408|hemodialysis|hemodialysis
221625|NCT02228408|ESRD|esrd
221626|NCT02228408|Cardiovascular Disease|cardiovascular disease
221627|NCT02228408|Isosorbide Dinitrate|isosorbide dinitrate
221628|NCT02228408|Hydralazine|hydralazine
221629|NCT02228395|Single ascending doses|single ascending doses
221630|NCT02228395|pharmacokinetics|pharmacokinetics
221631|NCT02228395|safety|safety
221632|NCT02228395|tolerability|tolerability
221633|NCT02228395|healthy volunteers|healthy volunteers
221634|NCT02228395|cognitive impairment associated with schizophrenia (CIAS)|cognitive impairment associated with schizophrenia (cias)
221635|NCT02228382|Bosutinib|bosutinib
221636|NCT02228382|Chronic Myeloid Leukemia|chronic myeloid leukemia
221637|NCT02228382|CML|cml
221638|NCT02228382|Leukemia|leukemia
221639|NCT02228382|Myelogenous|myelogenous
221640|NCT02228382|Chronic|chronic
221641|NCT02228382|BC-ABL Positive|bc-abl positive
221642|NCT02228369|Non Small Cell Lung Cancer, EGFR, Tyrosine kinase inhibitor,EGFR mutation positive, Brain Metastasis, Leptomeningeal Metastasis|non small cell lung cancer, egfr, tyrosine kinase inhibitor,egfr mutation positive, brain metastasis, leptomeningeal metastasis
221643|NCT02228356|Neoplasm Metastasis|neoplasm metastasis
221644|NCT02228356|oligometastatic cancer|oligometastatic cancer
221645|NCT02228356|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
221646|NCT02228356|SBRT|sbrt
221647|NCT02228356|Real-time Tumor Tracking (RTTT)|real-time tumor tracking (rttt)
221648|NCT02228356|ITV|itv
221649|NCT02228356|Internal Target Volume|internal target volume
221650|NCT02228356|Respiratory Motion Management|respiratory motion management
221651|NCT02228356|Image-guided Radiotherapy|image-guided radiotherapy
221652|NCT02228356|IGRT|igrt
221653|NCT02228330|Transurethral resection of bladder tumors|transurethral resection of bladder tumors
221654|NCT02228330|Obturator nerve reflex|obturator nerve reflex
221655|NCT02228330|Obturator nerve block|obturator nerve block
221656|NCT02228317|Emergency Medical Dispatch|emergency medical dispatch
221657|NCT02228317|Telemedicine|telemedicine
221658|NCT02228317|Emergency Medical Services|emergency medical services
221659|NCT02228317|Pre-hospital|pre-hospital
221660|NCT02228304|Wet AMD|wet amd
221661|NCT02228304|Wet Age Related Macular Degeneration|wet age related macular degeneration
221662|NCT02228304|Recurrent CNV Secondary to AMD|recurrent cnv secondary to amd
221663|NCT02228304|Active subfoveal CNV|active subfoveal cnv
221664|NCT02228291|Polyphenols|polyphenols
221665|NCT02228291|Endothelial function|endothelial function
221666|NCT02228291|Gut barrier function|gut barrier function
221667|NCT02228278|Pediatric|pediatric
221668|NCT02228278|Obesity|obesity
221669|NCT02228278|Overweight|overweight
221670|NCT02228278|Texting|texting
221671|NCT02228278|Text message|text message
221672|NCT02228278|SMS|sms
221673|NCT02228278|Diet|diet
221674|NCT02228278|Weight Loss|weight loss
221675|NCT02228278|Nutrition|nutrition
221676|NCT02228278|Physical activity|physical activity
221677|NCT02228278|BMI z-score|bmi z-score
221678|NCT02228278|BMI|bmi
221679|NCT02228252|Proteins|proteins
221680|NCT02228252|Postprandial lipemia|postprandial lipemia
221681|NCT02228252|Pre-meal|pre-meal
221682|NCT02228252|Metabolic syndrome|metabolic syndrome
221683|NCT02228239|Healthy|healthy
221684|NCT02228239|Esketamine|esketamine
221685|NCT02228239|Mirtazapine|mirtazapine
221686|NCT02228239|Psychomotor.|psychomotor.
221687|NCT02228226|Arthroscopic Bankart repair|arthroscopic bankart repair
221688|NCT02228226|Bone hole|bone hole
221689|NCT02228226|Ossification|ossification
221690|NCT02228226|Suture anchor|suture anchor
221691|NCT02228226|Shoulder dislocation|shoulder dislocation
221692|NCT02228213|multiple sclerosis|multiple sclerosis
221693|NCT02228213|SPMS|spms
221694|NCT02228200|Oncology Nursing|oncology nursing
221695|NCT02228200|Advanced Practice Nursing|advanced practice nursing
221696|NCT02228200|Nurse-led care|nurse-led care
221697|NCT02228200|Chemotherapy|chemotherapy
221698|NCT02228174|Abnormal Uterine Bleeding associated with fibroids|abnormal uterine bleeding associated with fibroids
221699|NCT02228174|AUB-L|aub-l
221700|NCT02228174|Fibroids|fibroids
221701|NCT02228174|Heavy menstrual bleeding|heavy menstrual bleeding
221702|NCT02228174|HMB|hmb
221703|NCT02228174|Myoma|myoma
221704|NCT02228174|Menorrhagia|menorrhagia
221705|NCT02228161|Yoga|yoga
221706|NCT02228161|Work-related Stress,|work-related stress,
221707|NCT02228161|Stress Adaptation.|stress adaptation.
221708|NCT02228148|Post linguistically deafness, severe to profound deafness|post linguistically deafness, severe to profound deafness
221709|NCT02228122|Chronic wounds|chronic wounds
221710|NCT02228122|Biofilms|biofilms
221711|NCT02228122|Bacteria|bacteria
221712|NCT02228096|relapsed/refractory|relapsed/refractory
221713|NCT02228096|Philadelphia chromosome positive acute lymphoblastic leukemia|philadelphia chromosome positive acute lymphoblastic leukemia
221714|NCT02228096|Pharmaceuticals|pharmaceuticals
221715|NCT02228096|Philadelphia chromosome positive|philadelphia chromosome positive
221716|NCT02228096|Acute Lymphoid Leukemia (ALL)|acute lymphoid leukemia (all)
221717|NCT02228096|Acute Lymphocytic Leukemia (ALL)|acute lymphocytic leukemia (all)
221718|NCT02228083|dental|dental
221719|NCT02228083|epinephrine|epinephrine
221720|NCT02228083|local anesthetic|local anesthetic
221721|NCT02228083|lidocaine|lidocaine
221722|NCT02228083|cardiac arrhythmias|cardiac arrhythmias
221723|NCT02228083|procedure|procedure
221724|NCT02228070|strabismus|strabismus
221725|NCT02228070|oculomotor palsy|oculomotor palsy
221726|NCT02228070|abducens palsy|abducens palsy
221727|NCT02228070|trochlear palsy|trochlear palsy
221728|NCT02228057|arterial patency|arterial patency
221729|NCT02228057|upper extremity|upper extremity
221730|NCT02228057|anastomosis|anastomosis
221731|NCT02228057|sensibility|sensibility
221732|NCT02228057|pain|pain
221733|NCT02228057|cold intolerance|cold intolerance
221734|NCT02228044|suicide|suicide
221735|NCT02228044|alcohol|alcohol
221736|NCT02228044|marijuana|marijuana
221737|NCT02228044|HIV|hiv
221738|NCT02228044|prevention|prevention
221739|NCT02228044|adolescent|adolescent
221740|NCT02228031|Mirror neurons|mirror neurons
221741|NCT02228031|Imitation|imitation
221742|NCT02228031|Oxytocin|oxytocin
221743|NCT02227992|Fibrin Sealant|fibrin sealant
221744|NCT02227992|Hemostatics|hemostatics
221745|NCT02227992|Coagulants|coagulants
221746|NCT02227966|Mild Cognitive Impairment|mild cognitive impairment
221747|NCT02227966|MCI|mci
221748|NCT02227966|tDCS|tdcs
221749|NCT02227966|transcranial Direct Current Stimulation|transcranial direct current stimulation
221750|NCT02227953|Alzheimer's Disease|alzheimer's disease
221751|NCT02227953|AD|ad
221752|NCT02227953|tDCS|tdcs
221753|NCT02227953|transcranial direct current stimulation|transcranial direct current stimulation
221754|NCT02227927|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
221755|NCT02227927|GERD|gerd
221756|NCT02227927|Gastroparesis|gastroparesis
221757|NCT02227927|Domperidone|domperidone
221758|NCT02227888|CF|cf
221759|NCT02227888|F508Del|f508del
221760|NCT02227888|Cavosonstat|cavosonstat
221761|NCT02227888|N91115|n91115
221762|NCT02227849|insulin resistance|insulin resistance
221763|NCT02227836|Allergy Patch testing|allergy patch testing
221764|NCT02227836|Eosinophilic Esophagitis|eosinophilic esophagitis
221765|NCT02227836|EoE|eoe
221766|NCT02227823|spinal muscular atrophy type 3|spinal muscular atrophy type 3
221767|NCT02227823|electromyography|electromyography
221768|NCT02227823|fatigability|fatigability
221769|NCT02227823|decrement|decrement
221770|NCT02227810|Prolong mechanical ventilator,|prolong mechanical ventilator,
221771|NCT02227810|Electrical stimulation,|electrical stimulation,
221772|NCT02227810|Activities of daily life,|activities of daily life,
221773|NCT02227810|Hospitalization outcomes.|hospitalization outcomes.
221774|NCT02227797|stem cell transplant|stem cell transplant
221775|NCT02227797|hematopoietic stem cell transplant|hematopoietic stem cell transplant
221776|NCT02227797|fungal infection|fungal infection
221777|NCT02227797|voriconazole|voriconazole
221778|NCT02227797|pediatric|pediatric
221779|NCT02227719|after augmentation|after augmentation
221780|NCT02227719|procedure|procedure
221781|NCT02227706|Fibrin Sealant|fibrin sealant
221782|NCT02227706|Hemostatics|hemostatics
221783|NCT02227706|Coagulants|coagulants
221784|NCT02227693|Thrombocytopenia|thrombocytopenia
221785|NCT02227693|Chronic Liver Disease|chronic liver disease
222378|NCT02225158|Immunity|immunity
221786|NCT02227680|music therapy|music therapy
221787|NCT02227680|massage therapy|massage therapy
221788|NCT02227667|MEDI4736|medi4736
221789|NCT02227667|14-109|14-109
221790|NCT02227654|Ovary|ovary
221791|NCT02227654|Cancer|cancer
221792|NCT02227654|Morphology|morphology
221793|NCT02227654|Surgery|surgery
221794|NCT02227641|CMV|cmv
221795|NCT02227641|Cytomegalovirus|cytomegalovirus
221796|NCT02227641|EBV|ebv
221797|NCT02227641|Epstein Barr Virus|epstein barr virus
221798|NCT02227641|virus|virus
221799|NCT02227641|T cell|t cell
221800|NCT02227641|adoptive transfer|adoptive transfer
221801|NCT02227641|transplantation|transplantation
221802|NCT02227641|allogeneic|allogeneic
221803|NCT02227589|adolescent,|adolescent,
221804|NCT02227589|alcohol abuse|alcohol abuse
221805|NCT02227589|depression,|depression,
221806|NCT02227589|cognitive behavior therapy|cognitive behavior therapy
221807|NCT02227589|cannabis abuse|cannabis abuse
221808|NCT02227576|glioblastoma, thrombocytopenia, temozolomide, chemotherapy|glioblastoma, thrombocytopenia, temozolomide, chemotherapy
221809|NCT02227563|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
221810|NCT02227563|left superior temporal gyrus|left superior temporal gyrus
221811|NCT02227563|auditory hallucinations|auditory hallucinations
221812|NCT02227563|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
221813|NCT02227550|Atrilal fibrillation|atrilal fibrillation
221814|NCT02227550|anticoagulation|anticoagulation
221815|NCT02227550|prevention of peri-procedural complication|prevention of peri-procedural complication
221816|NCT02227550|catheter ablation|catheter ablation
221817|NCT02227537|Adolescence Idiopathic Scoliosis|adolescence idiopathic scoliosis
221818|NCT02227537|nighttime Bracing|nighttime bracing
221819|NCT02227537|Providence|providence
221820|NCT02227524|Multiple Sclerosis|multiple sclerosis
221821|NCT02227524|Walking|walking
221822|NCT02227524|Gait|gait
221823|NCT02227511|fruit, nuts, liver fat, insulin, glucose|fruit, nuts, liver fat, insulin, glucose
221824|NCT02227511|Focus of the study is to compare the often given advice to eat fruit, containing large amount of glucose and fructose, with nuts that are more rich in fat.|focus of the study is to compare the often given advice to eat fruit, containing large amount of glucose and fructose, with nuts that are more rich in fat.
221825|NCT02227485|Gingivitis|gingivitis
221826|NCT02227485|Diabetes mellitus|diabetes mellitus
221827|NCT02227485|Medicine, Traditional|medicine, traditional
221828|NCT02227485|Herbal medicine|herbal medicine
221829|NCT02227485|Punica granatum|punica granatum
221952|NCT02226887|Eventration|eventration
221830|NCT02227446|Surgical site infection risk prevention|surgical site infection risk prevention
221831|NCT02227446|Bacterial species type and antibacterial sensitives|bacterial species type and antibacterial sensitives
221832|NCT02227433|Hodgkin Lymphoma, Elderly Patients, brentuximab vedotin (BV)|hodgkin lymphoma, elderly patients, brentuximab vedotin (bv)
221833|NCT02227407|SCI|sci
221834|NCT02227407|SMA|sma
221835|NCT02227407|Paralysis|paralysis
221836|NCT02227394|Asthma|asthma
221837|NCT02227394|Functional Respiratory Imaging|functional respiratory imaging
221838|NCT02227394|Computational Fluid Dynamic|computational fluid dynamic
221839|NCT02227368|Myocardial Infarction|myocardial infarction
221840|NCT02227368|Peripheral Arterial disease|peripheral arterial disease
221841|NCT02227368|Mycardial Ischemia|mycardial ischemia
221842|NCT02227368|Heart Diseases|heart diseases
221843|NCT02227368|Cardiovascular Diseases|cardiovascular diseases
221844|NCT02227368|Vascular Diseases|vascular diseases
221845|NCT02227368|Altherosclerosis|altherosclerosis
221846|NCT02227368|Arteriosclerosis|arteriosclerosis
221847|NCT02227368|Arterial Occlusive Diseases|arterial occlusive diseases
221848|NCT02227368|Peripheral Vascular Diseases|peripheral vascular diseases
221849|NCT02227368|Ticagrelor|ticagrelor
221850|NCT02227368|Ticlopidine|ticlopidine
221851|NCT02227368|Platelet Aggregation inhibitors|platelet aggregation inhibitors
221852|NCT02227368|Hematologic Agents|hematologic agents
221853|NCT02227368|Therapeutic Uses|therapeutic uses
221854|NCT02227368|Pharmacologic Actions|pharmacologic actions
221855|NCT02227368|Purinegic P2Y Receptor Antagonists|purinegic p2y receptor antagonists
221856|NCT02227368|Purinegic P2 Receptor Antagonists|purinegic p2 receptor antagonists
221857|NCT02227368|Purinergic Antagonists|purinergic antagonists
221858|NCT02227368|Purinergic Agents|purinergic agents
221859|NCT02227368|Neurotransmitter Agents|neurotransmitter agents
221860|NCT02227368|Molecular Mechanisms of Pharmacological Actions|molecular mechanisms of pharmacological actions
221861|NCT02227368|Physiological Effects of Drugs|physiological effects of drugs
221862|NCT02227368|Fibrinolytic Agents|fibrinolytic agents
221863|NCT02227368|Crardiovascular Agents|crardiovascular agents
221864|NCT02227355|Parkinson's Disease|parkinson's disease
221865|NCT02227355|Neupro®|neupro®
221866|NCT02227355|Rotigotine|rotigotine
221867|NCT02227355|Transdermal patch|transdermal patch
221868|NCT02227355|NEUPART|neupart
221869|NCT02227355|Levodopa|levodopa
221870|NCT02227355|Noninterventional|noninterventional
221871|NCT02227355|Combination therapy|combination therapy
221872|NCT02227329|Home Parenteral Nutrition|home parenteral nutrition
221873|NCT02227329|Infection Prevention|infection prevention
221874|NCT02227329|CRBSI|crbsi
221875|NCT02227329|Ethanol Lock Therapy|ethanol lock therapy
221876|NCT02227316|Uterine Fibroid Embolization|uterine fibroid embolization
221877|NCT02227316|Pain|pain
221878|NCT02227316|UFE|ufe
221879|NCT02227316|Fibroids|fibroids
221880|NCT02227316|Adenomyosis|adenomyosis
221881|NCT02227316|Bleeding|bleeding
221882|NCT02227316|IV Acetaminophen|iv acetaminophen
221883|NCT02227316|IV Ibuprofen|iv ibuprofen
221884|NCT02227316|Menorrhagia|menorrhagia
221885|NCT02227316|Leiomyoma|leiomyoma
221886|NCT02227316|Patient Satisfaction|patient satisfaction
221887|NCT02227290|Tinea Corporis|tinea corporis
221888|NCT02227290|Ringworm|ringworm
221889|NCT02227277|HIV|hiv
221890|NCT02227277|HIV-1|hiv-1
221891|NCT02227277|Pegintron|pegintron
221892|NCT02227277|Peg-IFN-α2b|peg-ifn-α2b
221893|NCT02227277|Viral suppression|viral suppression
221894|NCT02227277|ART cessation|art cessation
221895|NCT02227277|Immune function|immune function
221896|NCT02227277|Innate immunity|innate immunity
221897|NCT02227277|Toxicity|toxicity
221898|NCT02227277|Immune-based therapy|immune-based therapy
221899|NCT02227277|Treatment interruption|treatment interruption
221900|NCT02227277|HIV Cure|hiv cure
221901|NCT02227277|HIV Eradication|hiv eradication
221902|NCT02227277|BEAT-HIV|beat-hiv
221903|NCT02227277|HIV Cure Trial|hiv cure trial
221904|NCT02227277|Cure Trial|cure trial
221905|NCT02227264|Primary hyperparathyroidism|primary hyperparathyroidism
221906|NCT02227264|Calcimimetic Agents|calcimimetic agents
221907|NCT02227264|Parathyroid adenomectomy|parathyroid adenomectomy
221908|NCT02227251|Diffuse large B-cell Lymphoma|diffuse large b-cell lymphoma
221909|NCT02227251|DLBCL|dlbcl
221910|NCT02227251|Karyopharm|karyopharm
221911|NCT02227251|KPT-330|kpt-330
221912|NCT02227251|selinexor|selinexor
221913|NCT02227238|integrase inhibitor|integrase inhibitor
221914|NCT02227238|non-inferiority|non-inferiority
221915|NCT02227238|dolutegravir|dolutegravir
221916|NCT02227238|lopinavir/ritonavir|lopinavir/ritonavir
221917|NCT02227238|second-line treatment|second-line treatment
221918|NCT02227238|HIV-1|hiv-1
221919|NCT02227238|antiretroviral therapy-experienced|antiretroviral therapy-experienced
221920|NCT02227225|Postoperative Delirium|postoperative delirium
221921|NCT02227186|Influenza vaccination rates|influenza vaccination rates
221922|NCT02227147|Neurotrophic Keratitis|neurotrophic keratitis
221923|NCT02227108|pediatric cancer,pediatric acute lymphoblastic leukemia, lymphoblastic lymphoma, B-cell leukemia, ALL, moxetumomab pasudotox, CD22|pediatric cancer,pediatric acute lymphoblastic leukemia, lymphoblastic lymphoma, b-cell leukemia, all, moxetumomab pasudotox, cd22
221924|NCT02227082|radiotherapy|radiotherapy
221925|NCT02227082|olaparib|olaparib
221926|NCT02227082|breast cancer|breast cancer
221927|NCT02227082|locally advanced breast cancer|locally advanced breast cancer
221928|NCT02227056|Acquired pediatric brain injury|acquired pediatric brain injury
221929|NCT02227056|Methylphenidate|methylphenidate
221930|NCT02227056|Traumatic brain injury|traumatic brain injury
221931|NCT02227056|Cerebrovascular event|cerebrovascular event
221932|NCT02227056|Hypoxic ischemic brain injury|hypoxic ischemic brain injury
221933|NCT02227056|Function (ecologic)|function (ecologic)
221934|NCT02227004|MRI|mri
221935|NCT02227004|Magnetic Resonance Imaging|magnetic resonance imaging
221936|NCT02227004|pacemakers|pacemakers
221937|NCT02227004|ICD|icd
221938|NCT02226965|PNT2258|pnt2258
221939|NCT02226965|DLBCL|dlbcl
221940|NCT02226965|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
221941|NCT02226965|NHL|nhl
221942|NCT02226965|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
221943|NCT02226965|Lymphoma|lymphoma
221944|NCT02226913|Buffered|buffered
221945|NCT02226913|inferior alveolar nerve block|inferior alveolar nerve block
221946|NCT02226913|irreversible pulpitis|irreversible pulpitis
221947|NCT02226913|local anesthesia|local anesthesia
221948|NCT02226913|sodium bicarbonate|sodium bicarbonate
221949|NCT02226900|Multivessel Coronary Artery Disease|multivessel coronary artery disease
221950|NCT02226900|Hybrid Revascularization|hybrid revascularization
221951|NCT02226887|Loop ileostomy|loop ileostomy
221953|NCT02226874|Dose Estimation|dose estimation
221954|NCT02226874|Dose Reconstruction|dose reconstruction
221955|NCT02226874|Methods|methods
221956|NCT02226874|Fallout|fallout
221957|NCT02226874|Radiation Exposure|radiation exposure
221958|NCT02226861|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
221959|NCT02226861|MDS|mds
221960|NCT02226861|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
221961|NCT02226861|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
221962|NCT02226861|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
221963|NCT02226848|Endothelial Progenitor Cells|endothelial progenitor cells
221964|NCT02226848|Angiogenesis|angiogenesis
221965|NCT02226848|Traumatic Brain Injury|traumatic brain injury
221966|NCT02226835|OCT|oct
221967|NCT02226835|Alzheimer's Disease|alzheimer's disease
221968|NCT02226835|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
221969|NCT02226822|Type 2 diabetes mellitus|type 2 diabetes mellitus
221970|NCT02226809|Muscle relaxants|muscle relaxants
221971|NCT02226809|Postoperative complications, respiratory|postoperative complications, respiratory
221972|NCT02226809|General anesthesia|general anesthesia
221973|NCT02226809|Postanesthesia care unit|postanesthesia care unit
221974|NCT02226809|Neuromuscular block reversal|neuromuscular block reversal
221975|NCT02226796|Broca's Aphasia|broca's aphasia
221976|NCT02226796|Transcranial Direct Current Stimulation|transcranial direct current stimulation
221977|NCT02226783|Phase I|phase i
221978|NCT02226783|Healthy subjects|healthy subjects
221979|NCT02226783|PK|pk
221980|NCT02226783|PD|pd
221981|NCT02226757|NSCLC|nsclc
221982|NCT02226757|HER2-expression|her2-expression
221983|NCT02226757|EGFR-mutation|egfr-mutation
221984|NCT02226757|Trastuzumab|trastuzumab
221985|NCT02226757|Paclitaxel|paclitaxel
221986|NCT02226744|breathing|breathing
221987|NCT02226744|mind-body practices|mind-body practices
221988|NCT02226744|yoga|yoga
221989|NCT02226744|meditation|meditation
221990|NCT02226731|Immediate postpartum hemorrhage|immediate postpartum hemorrhage
221991|NCT02226731|Intrauterine balloon tamponade|intrauterine balloon tamponade
221992|NCT02226705|Rhinocerebral Mucormycosis|rhinocerebral mucormycosis
221993|NCT02226705|Surgery|surgery
221994|NCT02226705|Fungal Infection|fungal infection
221995|NCT02226705|Survival|survival
221996|NCT02226692|chronic low back pain|chronic low back pain
221997|NCT02226692|prognostic factors|prognostic factors
221998|NCT02226692|disabling low back pain|disabling low back pain
221999|NCT02226692|lumbar muscle activity|lumbar muscle activity
222000|NCT02226692|start back screening tool|start back screening tool
222001|NCT02226692|physical evaluation|physical evaluation
222002|NCT02226679|crossover|crossover
222003|NCT02226679|rollover study|rollover study
222004|NCT02226679|open label|open label
222005|NCT02226666|MRI|mri
222006|NCT02226666|Eovist|eovist
222007|NCT02226666|MultiHance|multihance
222008|NCT02226601|drowsiness|drowsiness
222009|NCT02226601|loopiness|loopiness
222010|NCT02226601|nausea|nausea
222011|NCT02226575|Sense of coherence|sense of coherence
222012|NCT02226549|hepatitis C|hepatitis c
222013|NCT02226549|Gilead|gilead
222014|NCT02226549|GS-9451|gs-9451
222015|NCT02226536|Posture|posture
222016|NCT02226536|Vertigo|vertigo
222017|NCT02226536|glucose metabolism|glucose metabolism
222018|NCT02226536|diet|diet
222019|NCT02226536|scales|scales
222020|NCT02226536|dinamic posturography|dinamic posturography
222021|NCT02226523|immunomagnetic reduction|immunomagnetic reduction
222022|NCT02226523|acute coronary syndrome|acute coronary syndrome
222023|NCT02226523|serum biomarkers|serum biomarkers
222024|NCT02226484|Gastroesophageal reflux disease|gastroesophageal reflux disease
222025|NCT02226484|GERD|gerd
222026|NCT02226484|Acid reflux|acid reflux
222027|NCT02226484|Reflux|reflux
222028|NCT02226484|Quercetin|quercetin
222029|NCT02226458|Autism|autism
222030|NCT02226458|Mitochondrial Disorders|mitochondrial disorders
222031|NCT02226458|EPI-743|epi-743
222032|NCT02226458|EPI743|epi743
222033|NCT02226458|Rett syndrome|rett syndrome
222034|NCT02226458|Angelman syndrome|angelman syndrome
222035|NCT02226445|Adults|adults
222036|NCT02226445|Outpatients|outpatients
222037|NCT02226432|Barthel Scale|barthel scale
222038|NCT02226432|Disability|disability
222039|NCT02226432|Modified Ashworth Scale|modified ashworth scale
222040|NCT02226432|Right Arm|right arm
222041|NCT02226432|Neuromodulation|neuromodulation
222042|NCT02226432|Spasticity|spasticity
222043|NCT02226432|Stroke|stroke
222044|NCT02226419|Fatty acid oxidation disorder|fatty acid oxidation disorder
222045|NCT02226419|Primary carnitine deficiency|primary carnitine deficiency
222046|NCT02226419|Exercise|exercise
222047|NCT02226419|L-carnitine treatment|l-carnitine treatment
222048|NCT02226419|Stable isotopes|stable isotopes
222049|NCT02226419|Carnitine transporter deficiency|carnitine transporter deficiency
222050|NCT02226406|Early Physical Exercise|early physical exercise
222051|NCT02226406|Alveolar Recruitment|alveolar recruitment
222052|NCT02226406|Electrical Impedance Tomography|electrical impedance tomography
222053|NCT02226406|Oxygenation|oxygenation
222054|NCT02226406|Ventilation|ventilation
222055|NCT02226393|Toddlers; Preschoolers; PTSD|toddlers; preschoolers; ptsd
222056|NCT02226367|prazosin|prazosin
222057|NCT02226367|alcohol use disorders|alcohol use disorders
222058|NCT02226367|posttraumatic stress disorder|posttraumatic stress disorder
222059|NCT02226367|PTSD|ptsd
222060|NCT02226367|combat trauma|combat trauma
222061|NCT02226367|military|military
222062|NCT02226367|alpha-1 adrenoreceptor antagonist|alpha-1 adrenoreceptor antagonist
222063|NCT02226354|Dietary vegetable oil|dietary vegetable oil
222064|NCT02226354|Stearidonic acid|stearidonic acid
222065|NCT02226354|Tissue|tissue
222066|NCT02226354|Fatty Acid|fatty acid
222067|NCT02226354|composition|composition
222068|NCT02226341|Lupus|lupus
222069|NCT02226341|Lupus Nephritis|lupus nephritis
222070|NCT02226341|ACTHar|acthar
222071|NCT02226341|Columbia|columbia
222072|NCT02226341|Rheumatology|rheumatology
222073|NCT02226341|CUMC|cumc
222074|NCT02226341|Autoimmune|autoimmune
222075|NCT02226341|SLE|sle
222076|NCT02226341|Proliferative Lupus Nephritis|proliferative lupus nephritis
222077|NCT02226315|noninvasive prenatal testing|noninvasive prenatal testing
222078|NCT02226302|Endometrial cancer|endometrial cancer
222079|NCT02226302|Obesity|obesity
222080|NCT02226289|bevacizumab|bevacizumab
222081|NCT02226289|refractory|refractory
222082|NCT02226289|colorectal cancer|colorectal cancer
222083|NCT02226289|metastatic|metastatic
222084|NCT02226263|Necrotizing enterocolitis|necrotizing enterocolitis
222085|NCT02226263|Probiotics|probiotics
222086|NCT02226263|Preterm newborns|preterm newborns
222087|NCT02226250|sugar-based beverage|sugar-based beverage
222088|NCT02226250|Time Influence|time influence
222089|NCT02226237|urinary incontinence|urinary incontinence
222090|NCT02226237|erectile dysfunction|erectile dysfunction
222091|NCT02226237|Retropubic Prostatectomy|retropubic prostatectomy
222092|NCT02226237|Physiotherapy|physiotherapy
222093|NCT02226224|gastrointestinal neoplasms|gastrointestinal neoplasms
222094|NCT02226224|endosonography|endosonography
222095|NCT02226224|in vitro|in vitro
222096|NCT02226224|Staging|staging
222097|NCT02226198|LDL-C|ldl-c
222098|NCT02226198|HoFH|hofh
222099|NCT02226198|Hyperlipidemia|hyperlipidemia
222100|NCT02226172|Primary myelofibrosis|primary myelofibrosis
222101|NCT02226172|Secondary myelofibrosis|secondary myelofibrosis
222102|NCT02226172|PMF|pmf
222103|NCT02226172|PET-MF|pet-mf
222104|NCT02226172|PPV-MF|ppv-mf
222105|NCT02226172|Ruxolitinib resistant or intolerant|ruxolitinib resistant or intolerant
222106|NCT02226172|previously treated myelofibrosis|previously treated myelofibrosis
222107|NCT02226172|smoothened inhibitor|smoothened inhibitor
222108|NCT02226172|oral|oral
222109|NCT02226172|single agent.|single agent.
222110|NCT02226159|cervical|cervical
222111|NCT02226159|radicular pain|radicular pain
222112|NCT02226159|transforaminal epidural steroid injections|transforaminal epidural steroid injections
222113|NCT02226146|Pemphigoid Bullous|pemphigoid bullous
222114|NCT02226146|Bullous|bullous
222115|NCT02226146|Blisters|blisters
222116|NCT02226146|SKIN DISEASES|skin diseases
222117|NCT02226146|BP|bp
222118|NCT02226120|LCZ696, chronic heart failure, open-label study, ARNI|lcz696, chronic heart failure, open-label study, arni
222119|NCT02226107|Lay health worker|lay health worker
222120|NCT02226107|Patient navigation|patient navigation
222121|NCT02226107|Screening colonoscopy|screening colonoscopy
222122|NCT02226107|Colon cancer|colon cancer
222123|NCT02226107|Training|training
222124|NCT02226107|Hispanic|hispanic
222125|NCT02226107|Latino|latino
222126|NCT02226094|intra-ocular pressure|intra-ocular pressure
222127|NCT02226094|primary open-angle glaucoma|primary open-angle glaucoma
222128|NCT02226094|intra ocular pressure|intra ocular pressure
222129|NCT02226094|primary open angle glaucoma|primary open angle glaucoma
222130|NCT02226094|glaucoma|glaucoma
222131|NCT02226094|deep wave trabeculoplasty|deep wave trabeculoplasty
222132|NCT02226094|ocular hypertension|ocular hypertension
222133|NCT02226081|breast lesion|breast lesion
222134|NCT02226081|ultrasound|ultrasound
222135|NCT02226081|BI-RADS|bi-rads
222136|NCT02226081|women|women
222137|NCT02226081|malignancy|malignancy
222138|NCT02226068|Atopic dermatitis|atopic dermatitis
222139|NCT02226068|Ciclosporine|ciclosporine
222140|NCT02226068|Extracorporal photopheresis|extracorporal photopheresis
222141|NCT02226055|Chronic kidney disease of unknown origin|chronic kidney disease of unknown origin
222142|NCT02226055|Chronic kidney disease of unknown aetiology|chronic kidney disease of unknown aetiology
222143|NCT02226055|Sri Lanka|sri lanka
222144|NCT02226055|CKDu|ckdu
222145|NCT02226055|Arterial stiffness|arterial stiffness
222146|NCT02226055|Cardiovascular risk|cardiovascular risk
222147|NCT02226055|North Central Province|north central province
222148|NCT02226029|MRI, fat fraction, stomach, lipid emulsion|mri, fat fraction, stomach, lipid emulsion
222149|NCT02226016|ptosis|ptosis
222150|NCT02226016|blepharochalasis|blepharochalasis
222151|NCT02226016|dermatochalasis|dermatochalasis
222152|NCT02225990|stroke|stroke
222153|NCT02225990|stroke rehabilitation|stroke rehabilitation
222154|NCT02225990|stroke therapy|stroke therapy
222155|NCT02225964|APOEε4|apoeε4
222156|NCT02225938|Intensive Care|intensive care
222157|NCT02225938|Recovery|recovery
222158|NCT02225938|Long term outcome|long term outcome
222159|NCT02225938|Function|function
222160|NCT02225925|brachytherapy|brachytherapy
222161|NCT02225886|Renal anaemia|renal anaemia
222162|NCT02225886|Intravenous ascorbic acid|intravenous ascorbic acid
222163|NCT02225886|Intravenous iron administration|intravenous iron administration
222164|NCT02225860|ADPKD|adpkd
222165|NCT02225860|Copeptin|copeptin
222166|NCT02225860|Vasopressin|vasopressin
222167|NCT02225860|Diet|diet
222168|NCT02225860|Water|water
222169|NCT02225847|Gardening|gardening
222170|NCT02225847|Therapeutic Horticulture|therapeutic horticulture
222171|NCT02225847|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
222172|NCT02225847|Psychometric Assessment|psychometric assessment
222173|NCT02225847|Stress|stress
222174|NCT02225847|Depression|depression
222175|NCT02225847|Anxiety|anxiety
222176|NCT02225847|Quality of Life|quality of life
222177|NCT02225847|Wellness|wellness
222379|NCT02225158|Co-Infection|co-infection
222178|NCT02225834|Atorvastatin, ischemic stroke, cytokines|atorvastatin, ischemic stroke, cytokines
222179|NCT02225821|Implant Removal|implant removal
222180|NCT02225821|Antibiotic Prophylaxis|antibiotic prophylaxis
222181|NCT02225821|Postoperative wound infection|postoperative wound infection
222182|NCT02225821|Orthopedics|orthopedics
222183|NCT02225808|CBT|cbt
222184|NCT02225808|autism|autism
222185|NCT02225808|anxiety|anxiety
222186|NCT02225808|treatment|treatment
222187|NCT02225808|fMRI|fmri
222188|NCT02225795|Crohn's Disease|crohn's disease
222189|NCT02225795|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
222190|NCT02225795|Children|children
222191|NCT02225795|Young Adults|young adults
222192|NCT02225782|Alteplase; Hemodialysis Catheter; Occlusion; Renal Failure|alteplase; hemodialysis catheter; occlusion; renal failure
222193|NCT02225769|fever|fever
222194|NCT02225769|point-of-care tests|point-of-care tests
222195|NCT02225769|clinical algorithms|clinical algorithms
222196|NCT02225769|electronic support|electronic support
222197|NCT02225769|host biomarkers|host biomarkers
222198|NCT02225756|Drug therapy|drug therapy
222199|NCT02225756|Prevention and control|prevention and control
222200|NCT02225756|Healing|healing
222201|NCT02225756|Tissue regeneration|tissue regeneration
222202|NCT02225756|Therapy|therapy
222203|NCT02225743|Hypothermia|hypothermia
222204|NCT02225743|Total Hip Joint Prosthesis|total hip joint prosthesis
222205|NCT02225743|Total Knee Joint Prosthesis|total knee joint prosthesis
222206|NCT02225717|Preterm labor|preterm labor
222207|NCT02225717|cervicovaginal secretions|cervicovaginal secretions
222208|NCT02225717|markers of fetal membranes remodelling|markers of fetal membranes remodelling
222209|NCT02225717|Multiplex test|multiplex test
222210|NCT02225691|type 1 diabetes|type 1 diabetes
222211|NCT02225691|type 2 diabetes|type 2 diabetes
222212|NCT02225691|paired testing|paired testing
222213|NCT02225678|healthy volunteers|healthy volunteers
222214|NCT02225678|asthma|asthma
222215|NCT02225678|sputum eosinophils|sputum eosinophils
222216|NCT02225639|ADHD|adhd
222217|NCT02225639|Adult|adult
222218|NCT02225613|Cruciate ligament injury|cruciate ligament injury
222219|NCT02225613|Balance control|balance control
222220|NCT02225613|Rehabilitation|rehabilitation
222221|NCT02225613|Spa therapy|spa therapy
222222|NCT02225613|Sport|sport
222223|NCT02225600|Borderline Personality Disorder|borderline personality disorder
222224|NCT02225600|BPD|bpd
222225|NCT02225600|Intranasal oxytocin|intranasal oxytocin
222226|NCT02225574|Leukemia|leukemia
222227|NCT02225574|Advanced phase chronic myeloid leukemia|advanced phase chronic myeloid leukemia
222228|NCT02225574|refractory chronic phase chronic myeloid leukemia|refractory chronic phase chronic myeloid leukemia
222229|NCT02225574|CML|cml
222230|NCT02225574|Accelerated phase|accelerated phase
222231|NCT02225574|(AP)|(ap)
222232|NCT02225574|Blast phase|blast phase
222233|NCT02225574|(BP)|(bp)
222234|NCT02225574|Philadelphia-positive acute leukemia|philadelphia-positive acute leukemia
222235|NCT02225574|MEK-162|mek-162
222236|NCT02225574|Nilotinib|nilotinib
222237|NCT02225574|AMN107|amn107
222238|NCT02225574|Tasigna|tasigna
222239|NCT02225574|Questionnaires|questionnaires
222240|NCT02225574|Surveys|surveys
222241|NCT02225561|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
222242|NCT02225561|Nitroprusside|nitroprusside
222243|NCT02225561|Transthoracic|transthoracic
222244|NCT02225561|Impedances|impedances
222245|NCT02225535|low back pain|low back pain
222246|NCT02225535|telehealth|telehealth
222247|NCT02225535|videoconferencing|videoconferencing
222248|NCT02225535|access to physical therapy|access to physical therapy
222249|NCT02225535|interprofessional care|interprofessional care
222250|NCT02225535|rural health|rural health
222251|NCT02225522|Intensive Care Units, Neonatal|intensive care units, neonatal
222252|NCT02225522|Infant, Newborn|infant, newborn
222253|NCT02225522|Genetic Diseases, Inborn|genetic diseases, inborn
222254|NCT02225509|Thyroid cancer|thyroid cancer
222255|NCT02225509|Thyroid cancer diagnostic|thyroid cancer diagnostic
222256|NCT02225509|Thyroid nodule|thyroid nodule
222257|NCT02225509|Fine needle aspiration biopsy|fine needle aspiration biopsy
222258|NCT02225509|Indeterminate cytological result|indeterminate cytological result
222259|NCT02225509|Molecular diagnostic|molecular diagnostic
222260|NCT02225509|Transcriptomics|transcriptomics
222261|NCT02225509|Molecular signature|molecular signature
222262|NCT02225496|Oropharyngeal cancer|oropharyngeal cancer
222263|NCT02225496|Oropharynx|oropharynx
222264|NCT02225496|Human papilloma virus|human papilloma virus
222265|NCT02225496|HPV positive|hpv positive
222266|NCT02225496|Squamous cell carcinoma|squamous cell carcinoma
222267|NCT02225496|SCC|scc
222268|NCT02225496|Transoral robotic surgery|transoral robotic surgery
222269|NCT02225496|TORS|tors
222270|NCT02225496|Intuitive Surgical da Vinci Surgical System|intuitive surgical da vinci surgical system
222271|NCT02225496|Modified barium swallow|modified barium swallow
222272|NCT02225496|MBS|mbs
222273|NCT02225496|Questionnaires|questionnaires
222274|NCT02225496|Surveys|surveys
222275|NCT02225496|Speech and swallowing function|speech and swallowing function
222380|NCT02225158|Parasite|parasite
222276|NCT02225470|Locally Recurrent or Metastatic Breast Cancer|locally recurrent or metastatic breast cancer
222277|NCT02225457|insulin resistance|insulin resistance
222278|NCT02225457|type 2 diabetes|type 2 diabetes
222279|NCT02225457|obesity|obesity
222280|NCT02225457|polyphenols|polyphenols
222281|NCT02225457|adipose tissue|adipose tissue
222282|NCT02225457|overfeeding|overfeeding
222283|NCT02225444|degenerative lumbosacral spine disease|degenerative lumbosacral spine disease
222284|NCT02225444|posterolateral fusion evaluation|posterolateral fusion evaluation
222285|NCT02225444|OsteoAMP growth factor|osteoamp growth factor
222286|NCT02225444|autograft|autograft
222287|NCT02225431|Contrast-induced nephropathy|contrast-induced nephropathy
222288|NCT02225431|Contrast-Induced acute kidney injury|contrast-induced acute kidney injury
222289|NCT02225431|Contrast media|contrast media
222290|NCT02225431|Angiography|angiography
222291|NCT02225431|Coronary percutaneous intervention|coronary percutaneous intervention
222292|NCT02225418|Laparoscopic|laparoscopic
222293|NCT02225418|Cholecystectomy|cholecystectomy
222294|NCT02225418|Postoperative|postoperative
222295|NCT02225418|Pain|pain
222296|NCT02225418|Quadratus lumborum|quadratus lumborum
222297|NCT02225418|Ultrasound|ultrasound
222298|NCT02225405|Lung Cancer|lung cancer
222299|NCT02225405|Non-small Cell Lung Cancers|non-small cell lung cancers
222300|NCT02225405|NCLC|nclc
222301|NCT02225405|Chemotherapy|chemotherapy
222302|NCT02225405|Nintedanib|nintedanib
222303|NCT02225405|BIBF 1120|bibf 1120
222304|NCT02225405|Cisplatin|cisplatin
222305|NCT02225405|Platinol-AQ|platinol-aq
222306|NCT02225405|Platinol|platinol
222307|NCT02225405|CDDP|cddp
222308|NCT02225405|Docetaxel|docetaxel
222309|NCT02225405|Taxotere|taxotere
222310|NCT02225392|Bronchial thermoplasty|bronchial thermoplasty
222311|NCT02225392|Severe asthma|severe asthma
222312|NCT02225379|Type 1 Diabetes|type 1 diabetes
222313|NCT02225379|Hypoglycemia detection|hypoglycemia detection
222314|NCT02225379|Non-invasive sensor|non-invasive sensor
222315|NCT02225379|Nocturnal hypoglycemia|nocturnal hypoglycemia
222316|NCT02225366|Melanoma|melanoma
222317|NCT02225366|Metastatic|metastatic
222318|NCT02225366|Antimicrobial peptide|antimicrobial peptide
222319|NCT02225366|LL37|ll37
222320|NCT02225366|Photographs|photographs
222321|NCT02225353|Cervical Pessaries|cervical pessaries
222322|NCT02225353|Progesterone|progesterone
222323|NCT02225314|Parkinson's Disease|parkinson's disease
222324|NCT02225314|Mild Cognitive Impairment|mild cognitive impairment
222325|NCT02225301|Child maltreatment|child maltreatment
222326|NCT02225301|Child Care|child care
222327|NCT02225301|Knowledge|knowledge
222328|NCT02225301|Attitude|attitude
222329|NCT02225288|Healthy Subjects|healthy subjects
222330|NCT02225288|Japanese|japanese
222331|NCT02225288|Males|males
222332|NCT02225275|Leukemia|leukemia
222590|NCT02224365|Diabetes|diabetes
222333|NCT02225275|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
222334|NCT02225275|CLL|cll
222335|NCT02225275|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
222336|NCT02225275|SLL|sll
222337|NCT02225275|Recurrent|recurrent
222338|NCT02225275|Lenalidomide|lenalidomide
222339|NCT02225275|CC-5013|cc-5013
222340|NCT02225275|Revlimid|revlimid
222341|NCT02225275|Obinutuzumab|obinutuzumab
222342|NCT02225275|GA101|ga101
222343|NCT02225275|Gazyva|gazyva
222344|NCT02225262|Prostate cancer|prostate cancer
222345|NCT02225262|CyberKnife|cyberknife
222346|NCT02225262|Stereotactic|stereotactic
222347|NCT02225262|Radiation|radiation
222348|NCT02225236|executive functioning|executive functioning
222349|NCT02225236|metacognition|metacognition
222350|NCT02225236|self-regulation|self-regulation
222351|NCT02225236|preschoolers|preschoolers
222352|NCT02225223|metastatic lesions|metastatic lesions
222353|NCT02225223|vertebral body|vertebral body
222354|NCT02225223|ablation|ablation
222355|NCT02225223|radiation|radiation
222356|NCT02225223|targeted radio-frequency ablation|targeted radio-frequency ablation
222357|NCT02225223|radio-frequency targeted vertebral augmentation|radio-frequency targeted vertebral augmentation
222358|NCT02225223|radiofrequency kyphoplasty|radiofrequency kyphoplasty
222359|NCT02225223|spine|spine
222360|NCT02225223|vertebral augmentation|vertebral augmentation
222361|NCT02225223|kyphoplasty|kyphoplasty
222362|NCT02225223|spinal ablation|spinal ablation
222363|NCT02225223|pain|pain
222364|NCT02225223|quality of life|quality of life
222365|NCT02225223|spinal tumors|spinal tumors
222366|NCT02225210|Dexmedetomidine ,Delirium ,Haemodynamic, Mechanical ventilation|dexmedetomidine ,delirium ,haemodynamic, mechanical ventilation
222367|NCT02225197|Perioptic|perioptic
222368|NCT02225197|Stereotactic|stereotactic
222369|NCT02225197|Radiation|radiation
222370|NCT02225197|Benign brain tumor|benign brain tumor
222371|NCT02225197|Optic apparatus|optic apparatus
222372|NCT02225184|Opioid Dependence|opioid dependence
222373|NCT02225184|OPRM1|oprm1
222374|NCT02225184|Outcome|outcome
222375|NCT02225184|Treatment|treatment
222376|NCT02225171|Genetic Knowledge|genetic knowledge
222377|NCT02225171|Genetic Testing|genetic testing
222381|NCT02225158|Mycobacteria|mycobacteria
222382|NCT02225145|Bone Marrow Transplant|bone marrow transplant
222383|NCT02225145|Fertility|fertility
222384|NCT02225145|Ovary|ovary
222385|NCT02225132|Hydroxyurea|hydroxyurea
222386|NCT02225132|Sickle Cell Disease|sickle cell disease
222387|NCT02225132|Fetal Hemoglobin Induction|fetal hemoglobin induction
222388|NCT02225119|Retinal Images|retinal images
222389|NCT02225119|Retinal Pigment Epithelium|retinal pigment epithelium
222390|NCT02225106|Dopamine Receptors|dopamine receptors
222391|NCT02225106|Methylphenidate|methylphenidate
222392|NCT02225106|Traumatic Brain Injury|traumatic brain injury
222393|NCT02225106|C-11 Raclopride|c-11 raclopride
222394|NCT02225106|Dopamine Release|dopamine release
222395|NCT02225093|Safety|safety
222396|NCT02225093|Dextromethorphan|dextromethorphan
222397|NCT02225093|CYP2D6|cyp2d6
222398|NCT02225093|Phase 1|phase 1
222399|NCT02225093|Prostate cancer|prostate cancer
222400|NCT02225093|CYP1A2|cyp1a2
222401|NCT02225093|Pharmacokinetics|pharmacokinetics
222402|NCT02225093|Drug-drug interactions|drug-drug interactions
222403|NCT02225093|Caffeine|caffeine
222404|NCT02225093|Enzalutamide|enzalutamide
222405|NCT02225067|Patients|patients
222406|NCT02225067|Volunteers|volunteers
222407|NCT02225054|duration of analgesia|duration of analgesia
222408|NCT02225041|intensive care|intensive care
222409|NCT02225041|critical care|critical care
222410|NCT02225041|child|child
222411|NCT02225041|family|family
222412|NCT02225041|survivors|survivors
222413|NCT02225028|physical activity|physical activity
222414|NCT02225028|physical fitness|physical fitness
222415|NCT02225028|exercise program|exercise program
222416|NCT02225028|telephone coaching|telephone coaching
222417|NCT02225028|motivational counseling|motivational counseling
222418|NCT02225028|stretching|stretching
222419|NCT02225028|fitness improvement|fitness improvement
222420|NCT02225028|exercise coaching|exercise coaching
222421|NCT02225028|toning|toning
222422|NCT02225028|SCI|sci
222423|NCT02225028|spinal cord injury|spinal cord injury
222424|NCT02225028|home-based|home-based
222425|NCT02225028|home exercise|home exercise
222426|NCT02225015|Cancer|cancer
222427|NCT02225015|Breast cancer|breast cancer
222428|NCT02225015|Ovarian cancer|ovarian cancer
222429|NCT02225015|BRCA Mutation|brca mutation
222430|NCT02225015|BRCA1 Gene Mutation|brca1 gene mutation
222431|NCT02225015|BRCA2 Gene Mutation|brca2 gene mutation
222432|NCT02225015|Telephone genetic counselling|telephone genetic counselling
222433|NCT02225015|Cancer prevention|cancer prevention
222434|NCT02225002|relapsed|relapsed
222435|NCT02225002|refractory to standard therapy|refractory to standard therapy
222436|NCT02225002|no effective therapy exists|no effective therapy exists
222437|NCT02224976|exercise training|exercise training
222438|NCT02224963|Aging,|aging,
222439|NCT02224963|Macular Degeneration,|macular degeneration,
222440|NCT02224963|Preparation for Future Care,|preparation for future care,
222441|NCT02224963|Psychological Well-being,|psychological well-being,
222442|NCT02224963|Problem Solving|problem solving
222443|NCT02224963|Prevention|prevention
222444|NCT02224963|Mental Health Promotion|mental health promotion
222445|NCT02224950|Atopic dermatitis|atopic dermatitis
222446|NCT02224950|eczema|eczema
222447|NCT02224950|alternative therapy|alternative therapy
222448|NCT02224950|complementary therapy|complementary therapy
222449|NCT02224950|moisturizer|moisturizer
222450|NCT02224937|Melatonin|melatonin
222451|NCT02224937|Cognitive parameters|cognitive parameters
222452|NCT02224937|pharmacodynamic|pharmacodynamic
222453|NCT02224937|pharmacokinetics|pharmacokinetics
222454|NCT02224924|Experimental: autologous blood patch injection (ABPI)|experimental: autologous blood patch injection (abpi)
222455|NCT02224924|Experimental: BioSentry (formerly known as Bio-Seal) hydrogel Tract Plug|experimental: biosentry (formerly known as bio-seal) hydrogel tract plug
222456|NCT02224924|14-141|14-141
222457|NCT02224911|focal therapy|focal therapy
222458|NCT02224911|prostate cancer treatment|prostate cancer treatment
222459|NCT02224911|laser treatment|laser treatment
222591|NCT02224365|Arterial Stiffness|arterial stiffness
222460|NCT02224885|Interventional radiology|interventional radiology
222461|NCT02224885|Lung|lung
222462|NCT02224885|Liver|liver
222463|NCT02224885|Confocal endomicroscopy|confocal endomicroscopy
222464|NCT02224885|Optical biopsy|optical biopsy
222465|NCT02224885|Scanner|scanner
222466|NCT02224885|Fluoroscopy|fluoroscopy
222467|NCT02224885|CT|ct
222468|NCT02224885|Computed Tomography|computed tomography
222469|NCT02224885|Radiofrequency Ablation|radiofrequency ablation
222470|NCT02224885|Fluorescein|fluorescein
222471|NCT02224872|bone marrow transplant|bone marrow transplant
222472|NCT02224872|thymoglobulin|thymoglobulin
222473|NCT02224872|cyclophosphamide|cyclophosphamide
222474|NCT02224872|fludarabine|fludarabine
222475|NCT02224872|tacrolimus|tacrolimus
222476|NCT02224872|Mycophenolic Acid Mofetil|mycophenolic acid mofetil
222477|NCT02224872|chemotherapy|chemotherapy
222478|NCT02224872|GVHD|gvhd
222479|NCT02224872|haploidentical|haploidentical
222480|NCT02224833|appropriateness|appropriateness
222481|NCT02224833|elderly|elderly
222482|NCT02224833|polypharmacy|polypharmacy
222483|NCT02224833|primary care|primary care
222484|NCT02224820|transplantation|transplantation
222485|NCT02224820|sensitised patients|sensitised patients
222486|NCT02224820|HLA-antibodies|hla-antibodies
222487|NCT02224807|breast cancer|breast cancer
222488|NCT02224807|diet|diet
222489|NCT02224807|exercise|exercise
222490|NCT02224807|weight loss|weight loss
222491|NCT02224794|abdominal|abdominal
222492|NCT02224794|aortic|aortic
222493|NCT02224794|aneurysm|aneurysm
222494|NCT02224755|Heart Failure|heart failure
222495|NCT02224755|Left Ventricular Assist Device|left ventricular assist device
222496|NCT02224755|Ventricular Dysfunction|ventricular dysfunction
222497|NCT02224755|Cardiomyopathy|cardiomyopathy
222498|NCT02224755|Heart Disease|heart disease
222499|NCT02224755|Cardiovascular Disease|cardiovascular disease
222500|NCT02224755|Heart-assist devices|heart-assist devices
222501|NCT02224755|Thoratec Corporation|thoratec corporation
222502|NCT02224703|Cannabidiol|cannabidiol
222503|NCT02224703|CBD|cbd
222504|NCT02224703|GWP42003-P|gwp42003-p
222505|NCT02224690|Cannabidiol|cannabidiol
222506|NCT02224690|CBD|cbd
222507|NCT02224690|Epidiolex|epidiolex
222508|NCT02224690|GWP42003-P|gwp42003-p
222509|NCT02224677|CFM|cfm
222510|NCT02224677|facial asymmetry|facial asymmetry
222511|NCT02224677|skin tag|skin tag
222512|NCT02224677|facial tag|facial tag
222513|NCT02224677|missing ear|missing ear
222514|NCT02224677|small ear|small ear
222515|NCT02224677|anotia|anotia
222516|NCT02224677|microtia|microtia
222517|NCT02224677|epibulbar dermoid|epibulbar dermoid
222518|NCT02224677|coloboma|coloboma
222519|NCT02224677|macrostomia|macrostomia
222520|NCT02224677|lateral cleft|lateral cleft
222521|NCT02224677|infant|infant
222522|NCT02224677|toddler|toddler
222523|NCT02224677|baby|baby
222524|NCT02224677|neurodevelopment|neurodevelopment
222525|NCT02224677|cognition|cognition
222526|NCT02224677|socialization|socialization
222527|NCT02224638|skin ulcers|skin ulcers
222528|NCT02224612|Pediatric Face Masks|pediatric face masks
222529|NCT02224612|children|children
222530|NCT02224573|Cannabidiol|cannabidiol
222531|NCT02224573|CBD|cbd
222532|NCT02224573|GWP42003-P|gwp42003-p
222533|NCT02224573|GWPCARE5|gwpcare5
222534|NCT02224560|Cannabidiol|cannabidiol
222535|NCT02224560|CBD|cbd
222536|NCT02224560|Epidiolex|epidiolex
222537|NCT02224560|GWP42003-P|gwp42003-p
222538|NCT02224547|non-small cell lung cancer|non-small cell lung cancer
222539|NCT02224547|lung carcinoma|lung carcinoma
222540|NCT02224547|NSCLC|nsclc
222541|NCT02224534|ST elevation myocardial infarction.|st elevation myocardial infarction.
222542|NCT02224534|Ticagrelor|ticagrelor
222543|NCT02224534|Left ventricular remodeling|left ventricular remodeling
222544|NCT02224534|Platelet reactivity|platelet reactivity
222545|NCT02224521|FLAP inhibitor|flap inhibitor
222546|NCT02224521|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
222547|NCT02224521|COPD|copd
222548|NCT02224521|Bioavailability|bioavailability
222549|NCT02224469|Brain-Computer Interface|brain-computer interface
222550|NCT02224469|Motor Cortex|motor cortex
222551|NCT02224469|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
222552|NCT02224469|Quality of Life|quality of life
222553|NCT02224456|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
222554|NCT02224456|hepatocellular carcinoma|hepatocellular carcinoma
222555|NCT02224456|chronic hepatitis B|chronic hepatitis b
222556|NCT02224456|Cirrhosis|cirrhosis
222557|NCT02224443|Dexmedetomidine,postoperative cognitive dysfunction|dexmedetomidine,postoperative cognitive dysfunction
222558|NCT02224430|biomarker of relapse|biomarker of relapse
222559|NCT02224430|schizophrenia|schizophrenia
222560|NCT02224430|schizoaffective disorder|schizoaffective disorder
222561|NCT02224430|on-body sensors|on-body sensors
222562|NCT02224430|smartphone|smartphone
222563|NCT02224430|observational|observational
222564|NCT02224417|Diabetes|diabetes
222565|NCT02224417|Treatment medication adherence|treatment medication adherence
222566|NCT02224417|Physical activity|physical activity
222567|NCT02224417|Financial incentives|financial incentives
222568|NCT02224417|Outcome incentives|outcome incentives
222569|NCT02224417|Process incentives|process incentives
222570|NCT02224417|HbA1c|hba1c
222571|NCT02224391|Smoking Cessation|smoking cessation
222572|NCT02224391|Attentional bias modification|attentional bias modification
222573|NCT02224391|ABM|abm
222574|NCT02224391|Smartphone|smartphone
222575|NCT02224391|Nicotine replacement therapy|nicotine replacement therapy
222576|NCT02224391|Nicotine patch|nicotine patch
222577|NCT02224391|NRT|nrt
222578|NCT02224391|Questionnaires|questionnaires
222579|NCT02224391|Surveys|surveys
222580|NCT02224391|Saliva collection|saliva collection
222581|NCT02224391|Cotinine level|cotinine level
222582|NCT02224391|Counseling sessions|counseling sessions
222583|NCT02224391|Electroencephalography|electroencephalography
222584|NCT02224391|EEG|eeg
222585|NCT02224378|fluid responsiveness|fluid responsiveness
222586|NCT02224378|atrial fibrillation|atrial fibrillation
222587|NCT02224378|passive leg raising|passive leg raising
222588|NCT02224378|central venous pressure|central venous pressure
222589|NCT02224378|valvular heart surgery|valvular heart surgery
222592|NCT02224365|Blood Pressure|blood pressure
222593|NCT02224365|Endothelial Function|endothelial function
222594|NCT02224365|Body Composition|body composition
222595|NCT02224365|Glycemic Control|glycemic control
222596|NCT02224365|Apples|apples
222597|NCT02224365|Functional Foods|functional foods
222598|NCT02224365|Polyphenols|polyphenols
222599|NCT02224365|Fiber|fiber
222600|NCT02224352|Electric Stimulation|electric stimulation
222601|NCT02224352|Respiration|respiration
222602|NCT02224352|Abdominal wall|abdominal wall
222603|NCT02224352|Lung Diseases|lung diseases
222604|NCT02224352|Respiratory Tract Diseases|respiratory tract diseases
222605|NCT02224352|COPD|copd
222606|NCT02224339|Atherosclerosis|atherosclerosis
222607|NCT02224339|carotid plaque|carotid plaque
222608|NCT02224339|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
222609|NCT02224339|Major Adverse Cardiovascular Events|major adverse cardiovascular events
222610|NCT02224326|Alzheimer´s disease|alzheimer´s disease
222611|NCT02224326|early diagnosis|early diagnosis
222612|NCT02224326|evoked potentials|evoked potentials
222613|NCT02224326|near-infrared spectroscopy|near-infrared spectroscopy
222614|NCT02224313|vaginal cytokine|vaginal cytokine
222615|NCT02224287|Urolithiasis|urolithiasis
222616|NCT02224287|Kidney Stones|kidney stones
222617|NCT02224287|Ureteroscopy|ureteroscopy
222618|NCT02224287|Fluoroscopy|fluoroscopy
222619|NCT02224274|Antiplatelet Therapy|antiplatelet therapy
222620|NCT02224274|Cardiac Arrest|cardiac arrest
222621|NCT02224274|Therapeutic hypothermia|therapeutic hypothermia
222622|NCT02224274|Myocardial infarction (STEMI and NSTEMI)|myocardial infarction (stemi and nstemi)
222623|NCT02224261|Axillary web syndrome|axillary web syndrome
222624|NCT02224261|cording|cording
222625|NCT02224261|physical therapy|physical therapy
222626|NCT02224261|breast cancer|breast cancer
222627|NCT02224248|cardiorespiratory fitness|cardiorespiratory fitness
222628|NCT02224248|exercise tolerance|exercise tolerance
222629|NCT02224248|exercise test|exercise test
222630|NCT02224248|health behavior|health behavior
222631|NCT02224248|motor activity|motor activity
222632|NCT02224248|motivation|motivation
222633|NCT02224248|intention|intention
222634|NCT02224248|self-rated health|self-rated health
222635|NCT02224235|Stable angina|stable angina
222636|NCT02224235|PCI|pci
222637|NCT02224235|Percutaneous Coronary Intervention|percutaneous coronary intervention
222638|NCT02224209|Carotid artery stenosis|carotid artery stenosis
222639|NCT02224209|High risk of hyperperfusion|high risk of hyperperfusion
222640|NCT02224209|Staged angioplasty|staged angioplasty
222641|NCT02224209|Routine single-stage stenting|routine single-stage stenting
222642|NCT02224196|manual ventilation|manual ventilation
222643|NCT02224196|pressure-controlled ventilation|pressure-controlled ventilation
222644|NCT02224196|peak airway pressure|peak airway pressure
222645|NCT02224196|antral area|antral area
222646|NCT02224183|low back pain|low back pain
222647|NCT02224183|yoga|yoga
222648|NCT02224183|education|education
222649|NCT02224183|Veterans|veterans
222650|NCT02224183|cost-effectiveness|cost-effectiveness
222651|NCT02224183|military|military
222652|NCT02224183|back pain|back pain
222653|NCT02224170|Dexamethasone|dexamethasone
222654|NCT02224170|Lidocaine|lidocaine
222655|NCT02224170|Quality of Recovery|quality of recovery
222656|NCT02224170|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
222657|NCT02224144|Kidney Transplantation|kidney transplantation
222658|NCT02224144|Calcitriol|calcitriol
222659|NCT02224144|Bone Mineral Density|bone mineral density
222660|NCT02224144|Bone Mass and Strength|bone mass and strength
222661|NCT02224144|Vascular Calcifications|vascular calcifications
222662|NCT02224144|Hyperparathyroidism|hyperparathyroidism
222663|NCT02224144|Parathyroid Hormone|parathyroid hormone
222664|NCT02224131|platelet function test|platelet function test
222665|NCT02224131|stent;|stent;
222666|NCT02224118|Healthy|healthy
222667|NCT02224118|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
222668|NCT02224118|CNTO 3649|cnto 3649
222669|NCT02224092|heart health|heart health
222670|NCT02224092|general well-being|general well-being
222671|NCT02224066|Aortic stenosis|aortic stenosis
222672|NCT02224066|TAVI|tavi
222673|NCT02224066|TAVR|tavr
222674|NCT02224066|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
222675|NCT02224066|Ticagrelor|ticagrelor
222676|NCT02224066|Antiplatelet reactivity|antiplatelet reactivity
222677|NCT02224053|oncology, cancer, non small cell lung cancer, anticancer druge, omeprazole, healthy volunteer|oncology, cancer, non small cell lung cancer, anticancer druge, omeprazole, healthy volunteer
222678|NCT02224001|tip plasty|tip plasty
222679|NCT02224001|septal cartilage|septal cartilage
222680|NCT02223988|Patients|patients
222681|NCT02223988|mechanical|mechanical
222682|NCT02223988|ventilation|ventilation
222683|NCT02223988|tracheostomy|tracheostomy
222684|NCT02223975|Spectrum Analysis, vibrational|spectrum analysis, vibrational
222685|NCT02223975|Spectrum Analysis, infrared|spectrum analysis, infrared
222784|NCT02223520|Neonate|neonate
222686|NCT02223975|Spectrum Analysis, Raman|spectrum analysis, raman
222687|NCT02223975|Spectrum Analysis|spectrum analysis
222688|NCT02223975|Fourier transform infrared spectroscopy|fourier transform infrared spectroscopy
222689|NCT02223975|Raman probe|raman probe
222690|NCT02223975|Optical|optical
222691|NCT02223975|Diagnosis|diagnosis
222692|NCT02223975|Cancer|cancer
222693|NCT02223975|Multivariate analysis|multivariate analysis
222694|NCT02223975|Vulval Intraepithelial Neoplasia|vulval intraepithelial neoplasia
222695|NCT02223975|Vulvar Neoplasm|vulvar neoplasm
222696|NCT02223975|Vulva|vulva
222697|NCT02223975|Vulvar Diseases|vulvar diseases
222698|NCT02223962|physical activity|physical activity
222699|NCT02223962|COPD|copd
222700|NCT02223962|activity monitors|activity monitors
222701|NCT02223949|Obesity|obesity
222702|NCT02223949|Labor complications|labor complications
222703|NCT02223949|Induction of labor|induction of labor
222704|NCT02223949|Mechanical cervical ripening|mechanical cervical ripening
222705|NCT02223936|nuchal translucency, neurological developpment, anxiety, depression, prenatal diagnosis, normal karyotype|nuchal translucency, neurological developpment, anxiety, depression, prenatal diagnosis, normal karyotype
222706|NCT02223923|Phase 1|phase 1
222707|NCT02223923|Maximimum tolerated dose|maximimum tolerated dose
222708|NCT02223923|ATR Inhibitor|atr inhibitor
222709|NCT02223923|Radiotherapy|radiotherapy
222710|NCT02223910|brain computer interface|brain computer interface
222711|NCT02223910|neurofeedback|neurofeedback
222712|NCT02223910|functional connectivity|functional connectivity
222713|NCT02223897|Liver transplantation|liver transplantation
222714|NCT02223897|Biliary complication|biliary complication
222715|NCT02223897|mesenchymal stem cells|mesenchymal stem cells
222716|NCT02223884|Malignant melanoma, second-line treatment, docetaxel, carboplatin|malignant melanoma, second-line treatment, docetaxel, carboplatin
222717|NCT02223871|Malaria|malaria
222718|NCT02223871|ACT-451840|act-451840
222719|NCT02223858|Health Status Disparities|health status disparities
222720|NCT02223858|Arthritis|arthritis
222721|NCT02223858|Psychology|psychology
222722|NCT02223858|Pain Management|pain management
222723|NCT02223858|Affect|affect
222724|NCT02223845|Music, Anxiety, IVF|music, anxiety, ivf
222725|NCT02223832|ACT-128800|act-128800
222726|NCT02223832|Safety|safety
222727|NCT02223832|Tolerability|tolerability
222728|NCT02223832|Pharmacokinetics|pharmacokinetics
222729|NCT02223819|Crizotinib|crizotinib
222730|NCT02223819|14-063|14-063
222731|NCT02223806|Postpartum hemorrhage|postpartum hemorrhage
222732|NCT02223806|Uterine tonus assessment|uterine tonus assessment
222733|NCT02223806|Active management of third stage of labor|active management of third stage of labor
222734|NCT02223793|Vascular screening|vascular screening
222735|NCT02223793|Cardiovascular risk factors|cardiovascular risk factors
222736|NCT02223793|Blood pressure|blood pressure
222737|NCT02223793|Lipids|lipids
222738|NCT02223793|Lifestyle|lifestyle
222739|NCT02223793|Identifying unknown risk|identifying unknown risk
222740|NCT02223793|Low socioeconomic status|low socioeconomic status
222741|NCT02223793|low threshold|low threshold
222742|NCT02223780|COPD|copd
222743|NCT02223780|palliative care|palliative care
222744|NCT02223767|TMS|tms
222745|NCT02223767|VR|vr
222746|NCT02223767|Exposure therapy|exposure therapy
222747|NCT02223767|TMS augmentations of exposure therapy|tms augmentations of exposure therapy
222748|NCT02223741|Cerebral palsy|cerebral palsy
222749|NCT02223741|GMFM-66|gmfm-66
222750|NCT02223741|PEDI|pedi
222751|NCT02223702|Aggressive periodontitis|aggressive periodontitis
222752|NCT02223702|amoxicillin|amoxicillin
222753|NCT02223702|metronidazole|metronidazole
222754|NCT02223702|moxifloxacin|moxifloxacin
222755|NCT02223702|nonsurgical periodontal debridement.|nonsurgical periodontal debridement.
222756|NCT02223689|SkinAffix|skinaffix
222757|NCT02223676|Pharmacy|pharmacy
222758|NCT02223676|Length-of-stay|length-of-stay
222759|NCT02223676|Emergency Department|emergency department
222760|NCT02223650|Intermittent Exotropia|intermittent exotropia
222761|NCT02223650|IXT|ixt
222762|NCT02223650|overminus|overminus
222763|NCT02223624|eccentric|eccentric
222764|NCT02223624|exercise|exercise
222765|NCT02223624|heart disease|heart disease
222766|NCT02223624|chronic heart failure|chronic heart failure
222767|NCT02223624|rehabilitation|rehabilitation
222768|NCT02223611|Stage Ⅱ-ⅢA NSCLC S1 capsule Completely resection|stage ⅱ-ⅲa nsclc s1 capsule completely resection
222769|NCT02223598|Lymphoid Hematological Malignancies|lymphoid hematological malignancies
222770|NCT02223585|Gut microbial|gut microbial
222771|NCT02223585|response|response
222772|NCT02223585|to protein-based|to protein-based
222773|NCT02223585|diet|diet
222774|NCT02223585|challenges|challenges
222775|NCT02223585|population|population
222776|NCT02223533|analgesia|analgesia
222777|NCT02223533|post-operative|post-operative
222778|NCT02223533|wound catheter infusion|wound catheter infusion
222779|NCT02223533|laparoscopic colon surgery|laparoscopic colon surgery
222780|NCT02223520|Staphylococcus aureus|staphylococcus aureus
222781|NCT02223520|Infection|infection
222782|NCT02223520|Colonization|colonization
222783|NCT02223520|Transmission|transmission
222785|NCT02223468|Intestinal Microbiota|intestinal microbiota
222786|NCT02223468|Liver Transplant|liver transplant
222787|NCT02223468|Acute Rejection|acute rejection
222788|NCT02223468|Infection|infection
222789|NCT02223455|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
222790|NCT02223455|Infection Control (IC)|infection control (ic)
222791|NCT02223455|Hospital-associated infections (HAI)|hospital-associated infections (hai)
222792|NCT02223455|Hand Hygiene (HH)|hand hygiene (hh)
222793|NCT02223455|Compliance|compliance
222794|NCT02223455|Health Care Workers (HCWs)|health care workers (hcws)
222795|NCT02223442|chronic pain|chronic pain
222796|NCT02223442|central analgesic drugs|central analgesic drugs
222797|NCT02223442|adherence to therapy|adherence to therapy
222798|NCT02223442|side effects|side effects
222799|NCT02223442|quality of life|quality of life
222800|NCT02223442|MOR-NRI drugs|mor-nri drugs
222801|NCT02223429|Paternal nurturance|paternal nurturance
222802|NCT02223429|Oxytocin|oxytocin
222803|NCT02223429|Vasopressin|vasopressin
222804|NCT02223429|fMRI|fmri
222805|NCT02223429|Neurobiology|neurobiology
222806|NCT02223416|female|female
222807|NCT02223416|volunteers|volunteers
222808|NCT02223403|Nitrate-rich beetroot juice|nitrate-rich beetroot juice
222809|NCT02223403|heart failure|heart failure
222810|NCT02223403|exercise performance|exercise performance
222811|NCT02223403|oxygen consumption|oxygen consumption
222812|NCT02223390|South Africa|south africa
222813|NCT02223390|HIV|hiv
222814|NCT02223390|Mental health|mental health
222815|NCT02223390|Trauma|trauma
222816|NCT02223390|Women|women
222817|NCT02223351|HSV|hsv
222818|NCT02223351|HIV|hiv
222819|NCT02223351|Herpes|herpes
222820|NCT02223351|volunteers|volunteers
222821|NCT02223351|drug-drug interaction|drug-drug interaction
222822|NCT02223325|Elderly|elderly
222823|NCT02223325|Prognosis|prognosis
222824|NCT02223299|Depression|depression
222825|NCT02223299|SSRI|ssri
222826|NCT02223299|Nutritional Supplements|nutritional supplements
222827|NCT02223299|Beck Depression Scale|beck depression scale
222828|NCT02223299|L-tyrosine|l-tyrosine
222829|NCT02223299|L-tryptophan|l-tryptophan
222830|NCT02223286|Corus CAD|corus cad
222831|NCT02223286|ASGES|asges
222832|NCT02223286|Age/Sex/Gene Expression Score|age/sex/gene expression score
222833|NCT02223286|Gene Expression|gene expression
222834|NCT02223286|GES|ges
222835|NCT02223286|CAD|cad
222836|NCT02223286|CVD|cvd
222837|NCT02223286|CHD|chd
222838|NCT02223286|Precision Medicine|precision medicine
222839|NCT02223286|Clinical Utility|clinical utility
222840|NCT02223286|Coronary Artery Disease|coronary artery disease
222841|NCT02223286|Angina Pectoris|angina pectoris
222842|NCT02223286|Chest Pain|chest pain
222843|NCT02223286|Cardiovascular Disease|cardiovascular disease
222844|NCT02223286|Coronary Heart Disease|coronary heart disease
222845|NCT02223286|UCU-CARD|ucu-card
222846|NCT02223273|stroke,|stroke,
222847|NCT02223273|quality improvement|quality improvement
222848|NCT02223247|solid tumors|solid tumors
222849|NCT02223247|cancer|cancer
222850|NCT02223221|In Vitro Fertilization|in vitro fertilization
222851|NCT02223221|Intracytoplasmic Sperm Injections|intracytoplasmic sperm injections
222852|NCT02223221|Infertility, Female|infertility, female
222853|NCT02223221|Abortion, Habitual|abortion, habitual
222854|NCT02223221|recurrent pregnancy loss|recurrent pregnancy loss
222855|NCT02223221|comprehensive chromosome screening|comprehensive chromosome screening
222856|NCT02223221|preimplantation genetic screening|preimplantation genetic screening
222857|NCT02223221|SNP array|snp array
222858|NCT02223208|PTCL|ptcl
222859|NCT02223208|PTCL-NOS|ptcl-nos
222860|NCT02223208|AITL|aitl
222861|NCT02223208|ALCL|alcl
222862|NCT02223195|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
222863|NCT02223195|Saliva|saliva
222864|NCT02223182|Milk Allergy,|milk allergy,
222865|NCT02223182|Viaskin Milk,|viaskin milk,
222866|NCT02223182|Specific Immunotherapy,|specific immunotherapy,
222867|NCT02223182|Epicutaneous ImmunoTherapy (EPIT)|epicutaneous immunotherapy (epit)
222868|NCT02223182|IgE-Mediated Cow's Milk Allergy|ige-mediated cow's milk allergy
222869|NCT02223169|Blood Pressure|blood pressure
222870|NCT02223169|Hypertension|hypertension
222871|NCT02223169|Cardiovascular disease|cardiovascular disease
222872|NCT02223143|Lipid lowering therapy|lipid lowering therapy
222873|NCT02223130|HIV|hiv
222874|NCT02223130|Discrimination|discrimination
222875|NCT02223130|Coping|coping
222876|NCT02223130|Medical Mistrust|medical mistrust
222877|NCT02223130|HIV Outcomes|hiv outcomes
222878|NCT02223130|Cognitive Behavioral Therapy|cognitive behavioral therapy
222879|NCT02223091|complementary therapies|complementary therapies
222880|NCT02223091|consultants|consultants
222881|NCT02223091|medical oncology|medical oncology
222882|NCT02223091|breast-cancer|breast-cancer
222883|NCT02223091|education|education
222884|NCT02223052|CC-486|cc-486
222885|NCT02223052|Oral Azacitidine|oral azacitidine
222886|NCT02223052|Soli Tumor Malignancy|soli tumor malignancy
222887|NCT02223052|Hematological Malignancy|hematological malignancy
222888|NCT02223052|Leukemia|leukemia
222889|NCT02223052|Lymphoma|lymphoma
222890|NCT02223052|Multiple Myeloma|multiple myeloma
222891|NCT02223052|Acute Myeloid Leukemia|acute myeloid leukemia
222892|NCT02223052|Myelodysplastic Syndromes|myelodysplastic syndromes
222893|NCT02223052|Neoplasms|neoplasms
222894|NCT02223052|Melanoma|melanoma
222895|NCT02223052|Breast Cancer|breast cancer
222896|NCT02223052|Metastatic Breast Cancer|metastatic breast cancer
222897|NCT02223052|Non-Small Cell Lung Cancer|non-small cell lung cancer
222898|NCT02223052|Small Cell Lung Cancer|small cell lung cancer
222899|NCT02223052|Renal Cell Carcinoma|renal cell carcinoma
222900|NCT02223052|Glioblastoma Multiforme|glioblastoma multiforme
222901|NCT02223052|Brain Cancer|brain cancer
222902|NCT02223052|Kidney Cancer|kidney cancer
222903|NCT02223052|Lung cancer|lung cancer
222904|NCT02223052|Blood Cancer|blood cancer
222905|NCT02223052|Thyroid Cancer|thyroid cancer
222906|NCT02223052|Bone Cancer|bone cancer
222907|NCT02223052|Bone Metastasis|bone metastasis
222908|NCT02223052|Testicular Cancer|testicular cancer
222909|NCT02223052|Prostate Cancer|prostate cancer
222910|NCT02223052|Bladder Cancer|bladder cancer
222911|NCT02223052|Ovarian Cancer|ovarian cancer
222912|NCT02223052|Skin Cancer|skin cancer
222913|NCT02223052|Cancer general|cancer general
222914|NCT02223052|Survival|survival
222915|NCT02223052|Chemotherapy|chemotherapy
222916|NCT02223052|Targeted Therapy|targeted therapy
222917|NCT02223052|Genitourinary|genitourinary
222918|NCT02223052|MM|mm
222919|NCT02223052|MDS|mds
222920|NCT02223052|AML|aml
222921|NCT02223052|NHL|nhl
222922|NCT02223052|HL|hl
222923|NCT02223052|MBC|mbc
222924|NCT02223052|NSCLC|nsclc
222925|NCT02223052|SCLC|sclc
222926|NCT02223052|GBM|gbm
222927|NCT02223039|Psoriasis|psoriasis
222928|NCT02223039|Dermatology|dermatology
222929|NCT02223039|Monoclonal antibody|monoclonal antibody
222930|NCT02222935|Balance training|balance training
222931|NCT02222935|low back pain|low back pain
222932|NCT02222935|balance test|balance test
222933|NCT02222935|routine back exercise|routine back exercise
222934|NCT02222922|ADC|adc
222935|NCT02222922|PF-06647020|pf-06647020
222936|NCT02222922|solid tumors|solid tumors
222937|NCT02222922|tumors|tumors
222938|NCT02222922|neoplasm metastasis|neoplasm metastasis
222939|NCT02222922|TNBC|tnbc
222940|NCT02222922|triple negative breast cancer|triple negative breast cancer
222941|NCT02222922|NSCLC|nsclc
222942|NCT02222922|non small cell lung cancer|non small cell lung cancer
222943|NCT02222922|advanced metastatic breast cancer|advanced metastatic breast cancer
222944|NCT02222922|ovarian cancer|ovarian cancer
222945|NCT02222922|OVCA|ovca
222946|NCT02222909|Community Based Organization|community based organization
222947|NCT02222909|Reverse Innovation|reverse innovation
222948|NCT02222909|Social Services|social services
222949|NCT02222909|Referral|referral
222950|NCT02222909|Chronic disease|chronic disease
222951|NCT02222870|Influenza|influenza
222952|NCT02222870|Influenza virus vaccine|influenza virus vaccine
222953|NCT02222870|Quadrivalent Influenza Virus Vaccine (No Preservative)|quadrivalent influenza virus vaccine (no preservative)
222954|NCT02222870|Fluzone®|fluzone®
222955|NCT02222857|Acute retinal necrosis|acute retinal necrosis
222956|NCT02222857|Retinal detachment|retinal detachment
222957|NCT02222857|Laser photocoagulation|laser photocoagulation
222958|NCT02222857|Vitrectomy|vitrectomy
222959|NCT02222844|Cancer|cancer
222960|NCT02222844|Colorectal Neoplasms|colorectal neoplasms
222961|NCT02222844|Colon, Sigmoid|colon, sigmoid
222962|NCT02222844|Magnetic Resonance Imaging|magnetic resonance imaging
222963|NCT02222844|General Surgery|general surgery
222964|NCT02222844|Postoperative Complications|postoperative complications
222965|NCT02222831|IVF|ivf
222966|NCT02222831|Embryo Quality|embryo quality
222967|NCT02222831|Time Lapse Culture|time lapse culture
222968|NCT02222831|Preimplantation factor|preimplantation factor
222969|NCT02222805|Cord clamping|cord clamping
222970|NCT02222805|Iron deficiency|iron deficiency
222971|NCT02222805|Anemia|anemia
222972|NCT02222805|Iron|iron
222973|NCT02222805|Hyperbilirubinemia|hyperbilirubinemia
222974|NCT02222805|Jaundice|jaundice
222975|NCT02222805|Neurodevelopment|neurodevelopment
222976|NCT02222792|Staphylococci, Streptococci, P acnes and Gram-negative bacteria|staphylococci, streptococci, p acnes and gram-negative bacteria
222978|NCT02222740|Tolerability|tolerability
222979|NCT02222740|Pharmacokinetics|pharmacokinetics
222980|NCT02222714|ischemic stroke|ischemic stroke
222981|NCT02222714|stroke|stroke
222982|NCT02222714|APC|apc
222983|NCT02222714|3K3A|3k3a
222984|NCT02222714|3K3A-APC|3k3a-apc
222985|NCT02222714|activated protein C|activated protein c
222986|NCT02222714|RHAPSODY|rhapsody
222987|NCT02222701|composite|composite
222988|NCT02222701|dental|dental
222989|NCT02222701|longevity|longevity
222990|NCT02222688|cancer|cancer
222991|NCT02222688|CLL|cll
222992|NCT02222662|Massage|massage
222993|NCT02222662|effectiveness|effectiveness
222994|NCT02222662|autism|autism
222995|NCT02222662|parent stress|parent stress
222996|NCT02222649|Elderly|elderly
222997|NCT02222649|vitamin D insufficiency|vitamin d insufficiency
222998|NCT02222649|High dose vitamin D3 supplementation|high dose vitamin d3 supplementation
222999|NCT02222649|Polymorphism of the VDR gene|polymorphism of the vdr gene
223000|NCT02222636|The efficacy and safety of intranasal dexmedetomidine|the efficacy and safety of intranasal dexmedetomidine
223001|NCT02222623|insulin|insulin
223002|NCT02222623|basal|basal
223003|NCT02222623|diabetes|diabetes
223004|NCT02222623|hospital|hospital
223005|NCT02222623|glucose|glucose
223006|NCT02222623|hypoglycemia|hypoglycemia
223007|NCT02222623|glargine|glargine
223008|NCT02222623|NPH|nph
223009|NCT02222623|neutral protamine hagedorn|neutral protamine hagedorn
223010|NCT02222610|Radiation Retinopathy|radiation retinopathy
223011|NCT02222597|head injury|head injury
223012|NCT02222597|infrascanner|infrascanner
223013|NCT02222597|intracranial hemorrhage|intracranial hemorrhage
223014|NCT02222584|inflammatory bowel disease|inflammatory bowel disease
223015|NCT02222584|physical activity|physical activity
223016|NCT02222584|disease activity|disease activity
223017|NCT02222584|quality of life|quality of life
223018|NCT02222558|hypogonadism|hypogonadism
223019|NCT02222558|Gonadal Disorders|gonadal disorders
223020|NCT02222558|Endocrine System Diseases|endocrine system diseases
223021|NCT02222558|Testosterone|testosterone
223022|NCT02222558|Testosterone enanthate|testosterone enanthate
223023|NCT02222558|Testosterone undecanoate|testosterone undecanoate
223024|NCT02222558|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate
223025|NCT02222558|Methyltestosterone|methyltestosterone
223026|NCT02222558|Androgens|androgens
223027|NCT02222558|Hormones|hormones
223028|NCT02222558|Hormones,|hormones,
223029|NCT02222558|Hormone Substitutes,|hormone substitutes,
223030|NCT02222558|Hormone Antagonists|hormone antagonists
223031|NCT02222558|Physiological Effects of Drugs|physiological effects of drugs
223032|NCT02222558|Pharmacologic Actions|pharmacologic actions
223033|NCT02222558|Therapeutic Uses|therapeutic uses
223034|NCT02222558|Anabolic Agents|anabolic agents
223035|NCT02222558|dihydrotestosterone|dihydrotestosterone
223036|NCT02222545|TMA, aHUS, HSCT-associated TMA, TTP|tma, ahus, hsct-associated tma, ttp
223037|NCT02222532|tetronine|tetronine
223038|NCT02222532|congenital heart disease|congenital heart disease
223039|NCT02222532|cardiopulmonary bypass|cardiopulmonary bypass
223040|NCT02222532|euthyroid sick syndrome|euthyroid sick syndrome
223041|NCT02222519|statins|statins
223042|NCT02222519|nondepolarizing muscle relaxants|nondepolarizing muscle relaxants
223043|NCT02222519|rocuronium|rocuronium
223044|NCT02222519|myalgia|myalgia
223045|NCT02222493|Phase 3|phase 3
223046|NCT02222493|infliximab|infliximab
223047|NCT02222493|rheumatoid arthritis|rheumatoid arthritis
223048|NCT02222480|Patients|patients
223049|NCT02222480|with mild|with mild
223050|NCT02222480|moderate|moderate
223051|NCT02222480|essential|essential
223052|NCT02222441|Palbociclib|palbociclib
223053|NCT02222441|Modafinil|modafinil
223054|NCT02222441|Pioglitazone|pioglitazone
223055|NCT02222441|Pharmacokinetics|pharmacokinetics
223056|NCT02222441|Drug-Drug Interaction Study|drug-drug interaction study
223057|NCT02222441|Healthy Volunteers|healthy volunteers
223058|NCT02222441|CYP3A Inducers|cyp3a inducers
223059|NCT02222415|Muscle mass|muscle mass
223060|NCT02222415|Strength|strength
223061|NCT02222415|Cross-sectional area|cross-sectional area
223062|NCT02222415|Protein|protein
223063|NCT02222402|Quality of Life|quality of life
223064|NCT02222402|Exercise|exercise
223065|NCT02222402|Functional Capacity|functional capacity
223066|NCT02222376|Diabetic ulcer, diabetic foot|diabetic ulcer, diabetic foot
223067|NCT02222363|Phase I|phase i
223068|NCT02222363|Iron chelator|iron chelator
223069|NCT02222363|Refractory advanced solid tumors|refractory advanced solid tumors
223070|NCT02222363|Dose escalation study|dose escalation study
223071|NCT02222363|Safety and tolerability|safety and tolerability
223072|NCT02222363|Tumor response by RECIST 1.1|tumor response by recist 1.1
223073|NCT02222363|Progression-free survival|progression-free survival
223074|NCT02222363|Overall survival Pharmacokinetics|overall survival pharmacokinetics
223075|NCT02222350|type 2 diabetes mellitus|type 2 diabetes mellitus
223076|NCT02222337|behavioral intervention|behavioral intervention
223077|NCT02222337|quality of life|quality of life
223078|NCT02222337|breast cancer|breast cancer
223079|NCT02222337|Latina|latina
223080|NCT02222337|caregiver|caregiver
223081|NCT02222337|PCORI|pcori
223082|NCT02222324|QTc Interval|qtc interval
223083|NCT02222324|Healthy Subjects|healthy subjects
223084|NCT02222272|cml|cml
223085|NCT02222272|chronic myeloid leukemia|chronic myeloid leukemia
223086|NCT02222272|dasatinib|dasatinib
223087|NCT02222272|nilotinib|nilotinib
223088|NCT02222272|tki|tki
223089|NCT02222272|second generation tki|second generation tki
223090|NCT02222272|2nd generation tki|2nd generation tki
223091|NCT02222259|Geriatric Oncology|geriatric oncology
223092|NCT02222259|Quality of Life|quality of life
223093|NCT02222259|Comprehensive Geriatric Assessment|comprehensive geriatric assessment
223094|NCT02222259|Functional Status|functional status
223095|NCT02222259|Chemotherapy|chemotherapy
223096|NCT02222259|Older Adults|older adults
223097|NCT02222246|Sickle Cell Disease|sickle cell disease
223098|NCT02222246|Emergency Department|emergency department
223099|NCT02222246|Vaso-occlusive Crisis|vaso-occlusive crisis
223100|NCT02222246|Pain Management|pain management
223101|NCT02222246|Pilot Project|pilot project
223102|NCT02222207|neovascular Age-related Macular Degeneration|neovascular age-related macular degeneration
223103|NCT02222194|Lung cancer|lung cancer
223104|NCT02222194|Surgery|surgery
223105|NCT02222194|Videomediastinoscopy|videomediastinoscopy
223106|NCT02222181|elderly, medication adherence,pharmaceutical care|elderly, medication adherence,pharmaceutical care
223107|NCT02222155|ANCA-associated vasculitis|anca-associated vasculitis
223108|NCT02222155|complement|complement
223109|NCT02222155|vasculitis|vasculitis
223110|NCT02222155|C5aR|c5ar
223111|NCT02222142|Ischemic heart disease|ischemic heart disease
223112|NCT02222142|Off pump coronary artery bypass graft|off pump coronary artery bypass graft
223113|NCT02222142|Isoflurane|isoflurane
223114|NCT02222142|Propofol|propofol
223115|NCT02222129|Randomized controlled trial|randomized controlled trial
223116|NCT02222129|anesthetics-local|anesthetics-local
223117|NCT02222129|bupivacaine|bupivacaine
223118|NCT02222129|analgesia|analgesia
223119|NCT02222129|Pain, Postoperative|pain, postoperative
223120|NCT02222116|STEMI|stemi
223122|NCT02222116|DES|des
223123|NCT02222116|mesh|mesh
223124|NCT02222090|patients with atrial fibrillation (AF) recommend the use of novel oral anticoagulants (NOACs) in patients with non-valvular AF|patients with atrial fibrillation (af) recommend the use of novel oral anticoagulants (noacs) in patients with non-valvular af
223125|NCT02222077|Central blood pressure|central blood pressure
223126|NCT02222077|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
223127|NCT02222077|Target-organ damage|target-organ damage
223128|NCT02222077|Adolescents and young adults|adolescents and young adults
223129|NCT02222051|neck pain|neck pain
223130|NCT02222051|chronic pain|chronic pain
223131|NCT02221986|Interdisciplinary rehabilitation|interdisciplinary rehabilitation
223132|NCT02221986|Neurooncology|neurooncology
223133|NCT02221986|Physiotherapy|physiotherapy
223134|NCT02221986|Occupational therapy|occupational therapy
223135|NCT02221986|Neurorehabilitation|neurorehabilitation
223136|NCT02221986|Glioma|glioma
223137|NCT02221960|Recurrent or metastatic solid tumors, MEDI6383, OX40|recurrent or metastatic solid tumors, medi6383, ox40
223138|NCT02221947|Alzheimer's|alzheimer's
223139|NCT02221947|bryostatin|bryostatin
223140|NCT02221947|PKC epsilon|pkc epsilon
223141|NCT02221934|Pain|pain
223142|NCT02221934|Chronic|chronic
223143|NCT02221934|Amputation|amputation
223144|NCT02221934|Phantom Pain|phantom pain
223145|NCT02221934|Stump Pain|stump pain
223146|NCT02221908|Systolic Blood pressure < 100 mm Hg|systolic blood pressure < 100 mm hg
223147|NCT02221895|postpartum appointment|postpartum appointment
223148|NCT02221895|breastfeeding|breastfeeding
223149|NCT02221895|postpartum contraception|postpartum contraception
223150|NCT02221895|postpartum cervical cancer screening|postpartum cervical cancer screening
223151|NCT02221895|postpartum depression screening|postpartum depression screening
223152|NCT02221856|Conventional orthodontic treatment|conventional orthodontic treatment
223153|NCT02221856|Motion View|motion view
223154|NCT02221843|sun behavior|sun behavior
223155|NCT02221843|immunosuppression|immunosuppression
223156|NCT02221843|skin neoplasms|skin neoplasms
223157|NCT02221843|sunbit|sunbit
223158|NCT02221843|uv sensor|uv sensor
223159|NCT02221843|uv dosimeter|uv dosimeter
223160|NCT02221843|solar radiation|solar radiation
223161|NCT02221843|uv exposition|uv exposition
223162|NCT02221843|uv index|uv index
223163|NCT02221804|Physical Inactivity|physical inactivity
223164|NCT02221804|Skeletal Muscle|skeletal muscle
223165|NCT02221804|Cachexia|cachexia
223166|NCT02221791|Flavan-3-ol|flavan-3-ol
223167|NCT02221791|Flavonoids|flavonoids
223168|NCT02221791|Epicatechin|epicatechin
223169|NCT02221791|Cocoa|cocoa
223170|NCT02221791|Chocolate|chocolate
223171|NCT02221791|Endothelial function|endothelial function
223172|NCT02221791|Bioavailability|bioavailability
223173|NCT02221778|Carcinoma, Hepatocellular|carcinoma, hepatocellular
223174|NCT02221778|SBRT|sbrt
223175|NCT02221765|Obesity|obesity
223176|NCT02221765|Overnutrition|overnutrition
223177|NCT02221765|Nutrition Disorders|nutrition disorders
223178|NCT02221765|Overweight|overweight
223179|NCT02221765|Body Weight|body weight
223180|NCT02221765|Signs and Symptoms|signs and symptoms
223181|NCT02221752|iron deficiency|iron deficiency
223182|NCT02221752|iron deficiency anemia|iron deficiency anemia
223183|NCT02221752|infant|infant
223184|NCT02221752|pregnancy|pregnancy
223185|NCT02221739|lung cancer|lung cancer
223186|NCT02221739|NSCLC|nsclc
223187|NCT02221739|lung|lung
223188|NCT02221739|cancer|cancer
223189|NCT02221739|radiation|radiation
223190|NCT02221739|immunotherapy|immunotherapy
223191|NCT02221739|metastatic|metastatic
223192|NCT02221726|Healthy|healthy
223193|NCT02221726|JNJ-35685-AAA-G-023|jnj-35685-aaa-g-023
223194|NCT02221726|Placebo|placebo
223401|NCT02220868|DAA|daa
223195|NCT02221726|Transdermal delivery device system|transdermal delivery device system
223196|NCT02221713|diverticulitis|diverticulitis
223197|NCT02221713|diverticulosis|diverticulosis
223198|NCT02221713|diverticular disease|diverticular disease
223199|NCT02221700|Gastrointestinal cancer|gastrointestinal cancer
223200|NCT02221700|Chemotherapy Induced Peripheral Neuropathy|chemotherapy induced peripheral neuropathy
223201|NCT02221700|CIPN|cipn
223202|NCT02221700|Symptom reduction|symptom reduction
223203|NCT02221700|Massage|massage
223204|NCT02221700|Symptom questionnaires|symptom questionnaires
223205|NCT02221700|Surveys|surveys
223206|NCT02221700|Leg function and balance tests|leg function and balance tests
223207|NCT02221687|synbiotic formula|synbiotic formula
223208|NCT02221687|infant formula|infant formula
223209|NCT02221687|diarrhea|diarrhea
223210|NCT02221674|Post-surgical pain|post-surgical pain
223211|NCT02221674|Opioid|opioid
223212|NCT02221661|Alzheimer|alzheimer
223213|NCT02221661|cognitive impairment|cognitive impairment
223214|NCT02221661|blood test|blood test
223215|NCT02221648|Back|back
223216|NCT02221648|Pain|pain
223217|NCT02221648|Muscle|muscle
223218|NCT02221635|Schizoaffective Disorder|schizoaffective disorder
223219|NCT02221635|Repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
223220|NCT02221622|Alzheimer's disease|alzheimer's disease
223221|NCT02221622|Mild Cognitive Impairment|mild cognitive impairment
223222|NCT02221622|Dementia|dementia
223223|NCT02221622|Regenerative therapeutic|regenerative therapeutic
223224|NCT02221609|Low Back Pain, Mechanical Low Back Pain, Low Back Ache, Low Backache, Lower Back Pain, Lumbago|low back pain, mechanical low back pain, low back ache, low backache, lower back pain, lumbago
223225|NCT02221596|Vitamin D|vitamin d
223226|NCT02221596|25(OH)D|25(oh)d
223227|NCT02221596|Aerobic training|aerobic training
223228|NCT02221596|Near-infrared spectroscopy|near-infrared spectroscopy
223229|NCT02221596|Diffuse correlation spectroscopy|diffuse correlation spectroscopy
223230|NCT02221596|MRS|mrs
223231|NCT02221583|End stage renal disease|end stage renal disease
223232|NCT02221583|Renal transplant candidate|renal transplant candidate
223233|NCT02221583|Laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
223234|NCT02221583|Immunosuppressants|immunosuppressants
223235|NCT02221544|Parkinson's disease, rTMS, Freezing of Gait|parkinson's disease, rtms, freezing of gait
223236|NCT02221518|OCD|ocd
223237|NCT02221518|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
223238|NCT02221505|LOP628,|lop628,
223239|NCT02221505|cKit,|ckit,
223240|NCT02221505|ADC,|adc,
223241|NCT02221505|Antibody drug conjugates,|antibody drug conjugates,
223242|NCT02221505|maytansine|maytansine
223243|NCT02221466|diabetes|diabetes
223244|NCT02221466|foot|foot
223245|NCT02221466|wounds|wounds
223246|NCT02221466|nitric oxide|nitric oxide
223247|NCT02221466|endothelium|endothelium
223248|NCT02221466|infection|infection
223249|NCT02221466|biological markers|biological markers
223250|NCT02221466|observational study|observational study
223251|NCT02221466|hyperbaric oxygen|hyperbaric oxygen
223252|NCT02221466|ulcers|ulcers
223253|NCT02221466|cytokines|cytokines
223254|NCT02221466|inflammation|inflammation
223255|NCT02221453|Diabetic Macular Edema|diabetic macular edema
223256|NCT02221453|Ocular Cytokines|ocular cytokines
223257|NCT02221453|Triamcinolone Acetonide|triamcinolone acetonide
223258|NCT02221427|First time mothers|first time mothers
223259|NCT02221427|Labour progression|labour progression
223260|NCT02221427|Prolonged labour|prolonged labour
223261|NCT02221427|Oxytocin|oxytocin
223262|NCT02221427|Mode of delivery|mode of delivery
223263|NCT02221427|Maternal birth outcome|maternal birth outcome
223264|NCT02221427|Neonatal birth outcome|neonatal birth outcome
223265|NCT02221349|Sensitivity|sensitivity
223266|NCT02221336|Bipolar disorder|bipolar disorder
223267|NCT02221336|Daily electronic monitoring|daily electronic monitoring
223268|NCT02221336|Smartphones|smartphones
223269|NCT02221336|Subjective and objective smartphone data|subjective and objective smartphone data
223270|NCT02221336|Feedback loop|feedback loop
223271|NCT02221310|targeted therapy|targeted therapy
223272|NCT02221310|leukemia|leukemia
223273|NCT02221310|MDS|mds
223274|NCT02221310|immune therapy|immune therapy
223275|NCT02221284|Pharmacological therapy|pharmacological therapy
223276|NCT02221258|Rheumatoid Arthritis|rheumatoid arthritis
223277|NCT02221258|Rheumatic Disease|rheumatic disease
223278|NCT02221258|RA|ra
223279|NCT02221258|Stem cell|stem cell
223280|NCT02221258|Cell therapy|cell therapy
223281|NCT02221258|furestem|furestem
223282|NCT02221258|Umbilical cord Blood|umbilical cord blood
223283|NCT02221258|hUCB-MSC|hucb-msc
223284|NCT02221258|UCB-MSC|ucb-msc
223285|NCT02221245|Esophageal cancer|esophageal cancer
223286|NCT02221245|Cancer Stem Cell|cancer stem cell
223287|NCT02221245|CSC|csc
223288|NCT02221245|Wnt|wnt
223289|NCT02221245|Hegdehog|hegdehog
223290|NCT02221245|Notch|notch
223291|NCT02221245|Signaling|signaling
223292|NCT02221245|Pathway|pathway
223293|NCT02221245|Chemo-naive|chemo-naive
223294|NCT02221232|ZuraPrep|zuraprep
223295|NCT02221232|Antimicrobial|antimicrobial
223296|NCT02221232|Bio-Science Laboratories|bio-science laboratories
223297|NCT02221232|Zurex Pharma|zurex pharma
223298|NCT02221232|Surgical/Patient preoperative skin preparation|surgical/patient preoperative skin preparation
223299|NCT02221219|infant|infant
223300|NCT02221219|brain injury|brain injury
223301|NCT02221219|renal|renal
223302|NCT02221219|indomethacin|indomethacin
223303|NCT02221206|Mini-Screw implant anchorage|mini-screw implant anchorage
223304|NCT02221206|retraction of maxillary incisors|retraction of maxillary incisors
223305|NCT02221180|Bioequivalence|bioequivalence
223306|NCT02221180|Metformin|metformin
223307|NCT02221180|Canagliflozin|canagliflozin
223308|NCT02221180|Healthy|healthy
223309|NCT02221167|breastfeeding|breastfeeding
223310|NCT02221167|donor milk|donor milk
223311|NCT02221167|formula|formula
223312|NCT02221167|exclusive breastfeeding|exclusive breastfeeding
223313|NCT02221167|newborn|newborn
223314|NCT02221154|in vitro fertilization|in vitro fertilization
223315|NCT02221154|ovarian hyperstimulation|ovarian hyperstimulation
223316|NCT02221154|pregnancy|pregnancy
223317|NCT02221115|Google Glass device|google glass device
223318|NCT02221115|Evaluation|evaluation
223319|NCT02221115|patient's|patient's
223320|NCT02221115|response|response
223321|NCT02221115|to new technology|to new technology
223322|NCT02221115|clinical setting|clinical setting
223323|NCT02221102|edoxaban|edoxaban
223324|NCT02221102|aspirin|aspirin
223325|NCT02221102|new oral anticoagulant|new oral anticoagulant
223326|NCT02221102|TIA|tia
223327|NCT02221102|acute minor ischemic stroke|acute minor ischemic stroke
223328|NCT02221089|Effect of Retaron on imparied retinal vascular reactivity after LPS administration in healthy subjects|effect of retaron on imparied retinal vascular reactivity after lps administration in healthy subjects
223329|NCT02221076|Cellvizio|cellvizio
223330|NCT02221076|Endomicroscopy|endomicroscopy
223331|NCT02221076|Robot-assisted procedure|robot-assisted procedure
223332|NCT02221076|Cervix cancer|cervix cancer
223333|NCT02221076|Endocervix cancer|endocervix cancer
223334|NCT02221076|Endometrium cancer|endometrium cancer
223335|NCT02221076|Ovarian cancer|ovarian cancer
223336|NCT02221076|Tubal cancer|tubal cancer
223337|NCT02221076|Colposcopy|colposcopy
223338|NCT02221076|Hysteroscopy|hysteroscopy
223339|NCT02221063|thiamin|thiamin
223340|NCT02221063|thiamin diphosphate|thiamin diphosphate
223341|NCT02221063|beriberi|beriberi
223342|NCT02221063|Cambodia|cambodia
223343|NCT02221063|fish sauce|fish sauce
223344|NCT02221063|fortification|fortification
223345|NCT02221063|pregnancy|pregnancy
223346|NCT02221063|breastfeeding|breastfeeding
223347|NCT02221063|childbearing age|childbearing age
223348|NCT02221037|PaO2/FiO2|pao2/fio2
223349|NCT02221037|Peri-operative lung injury|peri-operative lung injury
223350|NCT02221037|EVLWI|evlwi
223351|NCT02221037|ARDS|ards
223352|NCT02221037|PVPI|pvpi
223353|NCT02221037|SOFA scores|sofa scores
223354|NCT02221037|GSK2862277|gsk2862277
223355|NCT02221037|Oesophagectomy|oesophagectomy
223356|NCT02221024|Peripheral intravenous catheter|peripheral intravenous catheter
223357|NCT02221024|Peripheral intravenous lock|peripheral intravenous lock
223358|NCT02221024|Normal saline|normal saline
223359|NCT02221024|Patency|patency
223360|NCT02221024|Management|management
223361|NCT02221024|of peripheral|of peripheral
223362|NCT02221024|intravenous catheter|intravenous catheter
223363|NCT02221011|Shock wave|shock wave
223364|NCT02221011|Spasticity|spasticity
223365|NCT02221011|Effect|effect
223366|NCT02220998|Hepatitis C|hepatitis c
223367|NCT02220998|HCV|hcv
223368|NCT02220998|cirrhosis|cirrhosis
223369|NCT02220998|Sofosbuvir|sofosbuvir
223370|NCT02220998|Sovaldi|sovaldi
223371|NCT02220998|SOF/VEL|sof/vel
223372|NCT02220998|GS-5816|gs-5816
223373|NCT02220998|GS-7977|gs-7977
223374|NCT02220998|liver|liver
223375|NCT02220998|Treatment naive|treatment naive
223376|NCT02220998|Treatment Experience|treatment experience
223377|NCT02220998|genotype 2|genotype 2
223378|NCT02220972|Epilepsy|epilepsy
223379|NCT02220972|Partial Onset Seizures|partial onset seizures
223380|NCT02220972|Insomnia|insomnia
223381|NCT02220959|morbid obesity surgery|morbid obesity surgery
223382|NCT02220959|walk test|walk test
223383|NCT02220959|exercise|exercise
223384|NCT02220946|Vaginal Electrical Stimulation|vaginal electrical stimulation
223385|NCT02220933|Multiple Sclerosis|multiple sclerosis
223386|NCT02220933|MS|ms
223387|NCT02220933|EDSS|edss
223388|NCT02220920|insulin resistance|insulin resistance
223389|NCT02220907|MT-2412|mt-2412
223390|NCT02220907|MP-513|mp-513
223391|NCT02220907|TA-7284|ta-7284
223392|NCT02220907|Teneligliptin|teneligliptin
223393|NCT02220907|Canagliflozin|canagliflozin
223394|NCT02220894|PD-1|pd-1
223395|NCT02220894|PD1|pd1
223396|NCT02220894|PD-L1|pd-l1
223397|NCT02220894|PDL1|pdl1
223398|NCT02220881|Hallux valgus, Mold making silicone toe separator, Toe separator|hallux valgus, mold making silicone toe separator, toe separator
223399|NCT02220868|HIV|hiv
223400|NCT02220868|HCV|hcv
223402|NCT02220829|alpha-blocker|alpha-blocker
223403|NCT02220829|symptomatic urinary problems|symptomatic urinary problems
223404|NCT02220829|radiation therapy|radiation therapy
223405|NCT02220829|prostate cancer|prostate cancer
223406|NCT02220816|Attention|attention
223407|NCT02220816|Competitive|competitive
223408|NCT02220816|Training|training
223409|NCT02220803|Acetazolamide|acetazolamide
223410|NCT02220803|Zonegran|zonegran
223411|NCT02220803|Obstructive Sleep apnea|obstructive sleep apnea
223412|NCT02220803|Apnea|apnea
223413|NCT02220803|Respiration Disorders|respiration disorders
223414|NCT02220803|Sleep Disorders|sleep disorders
223415|NCT02220803|Cardiovascular|cardiovascular
223416|NCT02220803|Hypertension|hypertension
223417|NCT02220803|Carbonic Anhydrase|carbonic anhydrase
223418|NCT02220803|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors
223419|NCT02220803|Enzyme Inhibitors|enzyme inhibitors
223420|NCT02220803|Sulfonamides|sulfonamides
223421|NCT02220803|Therapeutic Uses|therapeutic uses
223422|NCT02220803|Pharmacologic Actions|pharmacologic actions
223423|NCT02220803|Vascular stifness|vascular stifness
223424|NCT02220790|IPFN|ipfn
223425|NCT02220790|Pediatric|pediatric
223426|NCT02220790|Fungal|fungal
223427|NCT02220790|Biomarker Assays|biomarker assays
223428|NCT02220790|Candida|candida
223429|NCT02220790|Pediatric ICU patient|pediatric icu patient
223430|NCT02220777|MTD (Maximum Tolerated Dose)|mtd (maximum tolerated dose)
223431|NCT02220777|Food effect|food effect
223432|NCT02220777|Postmenopausal subjects|postmenopausal subjects
223433|NCT02220777|Vasectomized subjects|vasectomized subjects
223434|NCT02220777|FIH (First In Humans)|fih (first in humans)
223435|NCT02220777|SAD (Single Ascending Dose)|sad (single ascending dose)
223436|NCT02220777|DDI (Drug-Drug Interaction)|ddi (drug-drug interaction)
223437|NCT02220764|prospective study|prospective study
223438|NCT02220764|chipping|chipping
223439|NCT02220764|survival rate|survival rate
223440|NCT02220764|fracture resistance|fracture resistance
223441|NCT02220764|zirconia|zirconia
223442|NCT02220751|Periodontal Attachment Loss|periodontal attachment loss
223443|NCT02220751|Genes|genes
223444|NCT02220751|Saliva|saliva
223445|NCT02220751|Diagnosis|diagnosis
223446|NCT02220738|Alzheimer's Disease|alzheimer's disease
223447|NCT02220725|Andexanet alpha|andexanet alpha
223448|NCT02220725|Anticoagulation|anticoagulation
223449|NCT02220725|Antidote|antidote
223450|NCT02220725|Rivaroxaban|rivaroxaban
223451|NCT02220725|Anti-fXa inhibitor|anti-fxa inhibitor
223452|NCT02220725|PRT4445|prt4445
223453|NCT02220725|Xarelto|xarelto
223454|NCT02220725|Reversal agent|reversal agent
223455|NCT02220712|Aripiprazole|aripiprazole
223456|NCT02220712|Deltoid|deltoid
223457|NCT02220699|Ostoporosis|ostoporosis
223458|NCT02220699|Primary Prevention|primary prevention
223459|NCT02220699|Health Promotion|health promotion
223460|NCT02220699|General Practice|general practice
223461|NCT02220699|Secondary screening|secondary screening
223462|NCT02220699|Patients at increased risk of osteoporosis|patients at increased risk of osteoporosis
223463|NCT02220686|VAPOR|vapor
223464|NCT02220686|smoking cessation|smoking cessation
223465|NCT02220686|PAD|pad
223466|NCT02220621|Intrauterine adhesion|intrauterine adhesion
223467|NCT02220621|crosslinked hyaluronan gel|crosslinked hyaluronan gel
223468|NCT02220621|hysteroscopy|hysteroscopy
223469|NCT02220621|clinical trial|clinical trial
223470|NCT02220608|Multiple Myeloma|multiple myeloma
223471|NCT02220608|G-CSF|g-csf
223472|NCT02220608|Bortezomib|bortezomib
223473|NCT02220595|Stenting|stenting
223474|NCT02220595|Endarterectomy|endarterectomy
223475|NCT02220595|Cognition|cognition
223476|NCT02220582|Cardiac Magnetic Resonance (CMR)|cardiac magnetic resonance (cmr)
223477|NCT02220582|Cardiovascular Diseases|cardiovascular diseases
223478|NCT02220582|socio-environmental factors|socio-environmental factors
223479|NCT02220582|Contextual factors|contextual factors
223480|NCT02220543|Cognitive behavioral therapy|cognitive behavioral therapy
223481|NCT02220543|Primary health care|primary health care
223482|NCT02220543|Physical Therapy|physical therapy
223483|NCT02220530|Sedation.|sedation.
223484|NCT02220530|Colonoscopy quality.|colonoscopy quality.
223485|NCT02220530|Scientific and technical quality.|scientific and technical quality.
223486|NCT02220530|Perceived quality (patient's satisfaction).|perceived quality (patient's satisfaction).
223487|NCT02220530|Safety|safety
223488|NCT02220517|MRI/US fusion-guided prostate biopsy|mri/us fusion-guided prostate biopsy
223489|NCT02220517|MR-guided in-bore prostate biopsy|mr-guided in-bore prostate biopsy
223490|NCT02220517|prostate cancer|prostate cancer
223491|NCT02220504|Treatment|treatment
223492|NCT02220504|Maintenance|maintenance
223493|NCT02220478|hip|hip
223494|NCT02220478|Signature|signature
223495|NCT02220465|sedentary|sedentary
223496|NCT02220465|smoking|smoking
223497|NCT02220465|cue reactivity|cue reactivity
223498|NCT02220465|physical activity|physical activity
223499|NCT02220439|rotavirus|rotavirus
223500|NCT02220439|immunogenicity|immunogenicity
223501|NCT02220439|enteric vaccine|enteric vaccine
223502|NCT02220439|vaccine immunogenicity|vaccine immunogenicity
223503|NCT02220439|rotavirus vaccine|rotavirus vaccine
223504|NCT02220439|gut microbiome|gut microbiome
223505|NCT02220439|microbiome|microbiome
223506|NCT02220426|Brown adipose tissue|brown adipose tissue
223507|NCT02220426|Hyperpolarized xenon gas MRI|hyperpolarized xenon gas mri
223508|NCT02220413|Breastmilk|breastmilk
223509|NCT02220413|Lactogenesis|lactogenesis
223510|NCT02220413|Obesity|obesity
223511|NCT02220400|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
223512|NCT02220400|Ketamine|ketamine
223513|NCT02220400|Surgery|surgery
223514|NCT02220387|occupational COPD|occupational copd
223515|NCT02220387|phenotype|phenotype
223516|NCT02220387|genetic|genetic
223517|NCT02220374|Osteoarthritis|osteoarthritis
223518|NCT02220374|Finger|finger
223519|NCT02220374|Supportive|supportive
223520|NCT02220374|Tape|tape
223521|NCT02220374|Pain|pain
223522|NCT02220374|Function|function
223523|NCT02220374|Trial|trial
223524|NCT02220348|Linzess|linzess
223525|NCT02220335|pulmonary hypertension|pulmonary hypertension
223526|NCT02220335|pulmonary arterial denervation|pulmonary arterial denervation
223527|NCT02220335|left heart failure|left heart failure
223528|NCT02220335|6-min walk distance|6-min walk distance
223529|NCT02220322|cortical thickness|cortical thickness
223530|NCT02220322|age|age
223531|NCT02220309|Anxiety|anxiety
223532|NCT02220309|Depression|depression
223533|NCT02220309|Social Anxiety Disorder|social anxiety disorder
223534|NCT02220309|Bipolar disorder II|bipolar disorder ii
223535|NCT02220309|PTSD|ptsd
223536|NCT02220309|GAD|gad
223537|NCT02220309|Phobia|phobia
223538|NCT02220283|Acute kidney injury,aortic dissection|acute kidney injury,aortic dissection
223539|NCT02220257|diabetes mellitus type 1|diabetes mellitus type 1
223540|NCT02220257|remission, honeymoon|remission, honeymoon
223541|NCT02220257|microangiopathy|microangiopathy
223542|NCT02220244|multiple sclerosis (MS)|multiple sclerosis (ms)
223543|NCT02220244|optic neuritis|optic neuritis
223544|NCT02220244|visual defect|visual defect
223545|NCT02220244|visual loss|visual loss
223546|NCT02220244|relapsing remitting multiple sclerosis (RRMS)|relapsing remitting multiple sclerosis (rrms)
223547|NCT02220244|primary progressive multiple sclerosis (PPMS)|primary progressive multiple sclerosis (ppms)
223548|NCT02220244|secondary progressive multiple sclerosis (SPMS)|secondary progressive multiple sclerosis (spms)
223549|NCT02220231|mediastinal mass, one-lung ventilation, capnothorax, transesophageal echocardiography|mediastinal mass, one-lung ventilation, capnothorax, transesophageal echocardiography
223550|NCT02220218|Healthy|healthy
223551|NCT02220218|Metformin|metformin
223552|NCT02220218|Canagliflozin|canagliflozin
223553|NCT02220218|JNJ-28431754|jnj-28431754
223554|NCT02220205|IUD|iud
223555|NCT02220205|training|training
223556|NCT02220205|simulation|simulation
223557|NCT02220192|cervical neoplasia|cervical neoplasia
223558|NCT02220192|cervix|cervix
223559|NCT02220192|high-grade dysplasia|high-grade dysplasia
223560|NCT02220192|LEEP (loop electrosurgical excision procedure)|leep (loop electrosurgical excision procedure)
223561|NCT02220192|precancerous cells|precancerous cells
223562|NCT02220192|colposcopy|colposcopy
223563|NCT02220166|Celiac Disease|celiac disease
223564|NCT02220166|Gluten|gluten
223565|NCT02220166|Gluten free diet|gluten free diet
223566|NCT02220166|Triticum monococcum|triticum monococcum
223567|NCT02220153|Monoclonal antibody|monoclonal antibody
223568|NCT02220153|subjects|subjects
223569|NCT02220153|First in human|first in human
223570|NCT02220127|Brain|brain
223571|NCT02220127|Neoplasm Micrometastasis|neoplasm micrometastasis
223572|NCT02220127|Gamma Knife Radiosurgery|gamma knife radiosurgery
223573|NCT02220114|Infantile spasms|infantile spasms
223574|NCT02220114|vigabatrin|vigabatrin
223575|NCT02220114|soluble tablets|soluble tablets
223576|NCT02220114|acceptability|acceptability
223577|NCT02220114|adherence|adherence
223578|NCT02220114|pharmacokinetics|pharmacokinetics
223579|NCT02220101|hypothermia|hypothermia
223580|NCT02220101|core temperature|core temperature
223581|NCT02220101|temperature measurement methods|temperature measurement methods
223582|NCT02220088|Hepatocellular Carcinoma|hepatocellular carcinoma
223583|NCT02220088|TACE|tace
223584|NCT02220088|TACE failure|tace failure
223585|NCT02220088|TACE refractoriness|tace refractoriness
223586|NCT02220088|BCLC B|bclc b
223587|NCT02220075|fiberoptic, LMA, caudal block|fiberoptic, lma, caudal block
223588|NCT02220036|Diabetic nephropathy|diabetic nephropathy
223589|NCT02220036|Renal function|renal function
223590|NCT02220036|Insulin resistance|insulin resistance
223591|NCT02220036|Metabolic profile|metabolic profile
223592|NCT02220036|Serum magnesium level|serum magnesium level
223593|NCT02220010|Post operative pancreatic fistulas|post operative pancreatic fistulas
223594|NCT02220010|Pancreatic stenting|pancreatic stenting
223595|NCT02219997|Cataract|cataract
223596|NCT02219997|Intraocular lens (IOL)|intraocular lens (iol)
223597|NCT02219997|AcrySof|acrysof
223598|NCT02219984|Anticoagulation|anticoagulation
223599|NCT02219984|vitamin K antagonists|vitamin k antagonists
223600|NCT02219984|Warfarin|warfarin
223601|NCT02219984|low molecular weight heparin|low molecular weight heparin
223602|NCT02219984|fondaparinux|fondaparinux
223603|NCT02219984|antithrombotics|antithrombotics
223604|NCT02219984|Direct oral anticoagulants|direct oral anticoagulants
223605|NCT02219984|dabigatran|dabigatran
223606|NCT02219984|rivaroxaban|rivaroxaban
223607|NCT02219984|apixaban|apixaban
223608|NCT02219984|edoxaban|edoxaban
223609|NCT02219984|atrial fibrillation|atrial fibrillation
223610|NCT02219984|venous thromboembolism|venous thromboembolism
223611|NCT02219971|Healthy|healthy
223612|NCT02219958|Hypertension|hypertension
223613|NCT02219945|pulmonary tuberculosis; electronic nose; diagnostic accuracy|pulmonary tuberculosis; electronic nose; diagnostic accuracy
223614|NCT02219932|Fampridine|fampridine
223615|NCT02219919|Carpal Tunnel Syndrome|carpal tunnel syndrome
223616|NCT02219919|Pain|pain
223617|NCT02219919|Sensitivity|sensitivity
223618|NCT02219919|Pain Thresholds|pain thresholds
223619|NCT02219919|Sensitization|sensitization
223620|NCT02219919|Physical Therapy|physical therapy
223621|NCT02219893|Peritoneal Carcinomatosis|peritoneal carcinomatosis
223622|NCT02219893|Peritoneal Metastasis|peritoneal metastasis
223623|NCT02219893|Colorectal Cancer|colorectal cancer
223624|NCT02219893|Cytoreductive surgery|cytoreductive surgery
223625|NCT02219893|HIPEC|hipec
223626|NCT02219893|Intraperitoneal treatment|intraperitoneal treatment
223627|NCT02219893|Immunotoxin|immunotoxin
223628|NCT02219893|MOC31PE|moc31pe
223629|NCT02219880|Kava|kava
223630|NCT02219880|Anxiety|anxiety
223631|NCT02219880|Generalized Anxiety Disorder|generalized anxiety disorder
223632|NCT02219880|Psychiatric|psychiatric
223633|NCT02219880|Anxiolytic|anxiolytic
223634|NCT02219880|GABA|gaba
223635|NCT02219880|Kavalactones|kavalactones
223636|NCT02219867|ketamine|ketamine
223637|NCT02219867|MDD|mdd
223638|NCT02219841|Obesity, low-calorie diet, exercise, atrial fibrillation|obesity, low-calorie diet, exercise, atrial fibrillation
223639|NCT02219828|pericarditis|pericarditis
223640|NCT02219828|recurrent pericarditis|recurrent pericarditis
223641|NCT02219828|corticosteroids|corticosteroids
223642|NCT02219828|anakinra|anakinra
223643|NCT02219815|Preoperative Care|preoperative care
223644|NCT02219815|Exercise Therapy|exercise therapy
223645|NCT02219815|Cardiac Surgery|cardiac surgery
223646|NCT02219815|Frailty|frailty
223647|NCT02219802|Coronary artery disease|coronary artery disease
223648|NCT02219802|Acute myocardial infarction|acute myocardial infarction
223649|NCT02219802|Drug-coated balloon|drug-coated balloon
223650|NCT02219802|Drug-eluting stent|drug-eluting stent
223651|NCT02219776|Infection,|infection,
223652|NCT02219776|Proprionbacterium Acne,|proprionbacterium acne,
223653|NCT02219776|Shoulder,|shoulder,
223654|NCT02219776|skin preparation|skin preparation
223655|NCT02219750|premix insuiln, basal-plus insulin|premix insuiln, basal-plus insulin
223656|NCT02219711|MGCD516|mgcd516
223657|NCT02219711|MET|met
223658|NCT02219711|AXL|axl
223659|NCT02219711|RET|ret
223660|NCT02219711|TRK|trk
223661|NCT02219711|NTRK|ntrk
223662|NCT02219711|DDR2|ddr2
223663|NCT02219711|KDR|kdr
223664|NCT02219711|VEGFR|vegfr
223665|NCT02219711|PDGFRA|pdgfra
223666|NCT02219711|KIT|kit
223667|NCT02219711|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
223668|NCT02219711|NSCLC|nsclc
223669|NCT02219711|Non-small cell lung cancer|non-small cell lung cancer
223670|NCT02219711|Head and neck cancer|head and neck cancer
223671|NCT02219711|Renal cell carcinoma|renal cell carcinoma
223672|NCT02219711|Prostate cancer|prostate cancer
223673|NCT02219711|Phase 1|phase 1
223674|NCT02219711|CBL|cbl
223675|NCT02219672|Triptolide wilfordii HIV-1 reservoir acute hiv infection|triptolide wilfordii hiv-1 reservoir acute hiv infection
223676|NCT02219659|sedation strategy|sedation strategy
223677|NCT02219659|mechanical ventilation|mechanical ventilation
223678|NCT02219659|ventilator weaning|ventilator weaning
223679|NCT02219646|T2DM|t2dm
223680|NCT02219646|ED|ed
223681|NCT02219620|creative arts|creative arts
223682|NCT02219620|older adults|older adults
223683|NCT02219620|intervention study|intervention study
223684|NCT02219594|gemstone CT|gemstone ct
223685|NCT02219594|320-detector row spiral CT|320-detector row spiral ct
223686|NCT02219594|optical coherence tomography(OCT)|optical coherence tomography(oct)
223687|NCT02219594|in-stent restenosis|in-stent restenosis
223688|NCT02219594|coronary heart disease|coronary heart disease
223689|NCT02219581|Osteoarthritis|osteoarthritis
223690|NCT02219581|Postoperative pain|postoperative pain
223691|NCT02219581|Total knee arthroplasty|total knee arthroplasty
223692|NCT02219581|Orthopaedics|orthopaedics
223693|NCT02219581|Inflammation|inflammation
223694|NCT02219568|obscure gastrointestinal bleeding, CT enterography|obscure gastrointestinal bleeding, ct enterography
223695|NCT02219555|Carpal tunnel|carpal tunnel
223696|NCT02219542|cytokine Transversus Abdominis Plane Block|cytokine transversus abdominis plane block
223697|NCT02219503|Hepatitis C|hepatitis c
223698|NCT02219503|Chronic Hepatitis C|chronic hepatitis c
223699|NCT02219503|Compensated Cirrhosis|compensated cirrhosis
223700|NCT02219503|Cirrhotic|cirrhotic
223701|NCT02219503|Hepatitis C Genotype 1b|hepatitis c genotype 1b
223702|NCT02219503|Hepatitis C Virus|hepatitis c virus
223797|NCT02219061|Measles|measles
223703|NCT02219503|Interferon-Free|interferon-free
223704|NCT02219503|Child Pugh A|child pugh a
223705|NCT02219503|Ribavirin-Free|ribavirin-free
223706|NCT02219490|Hepatitis C Genotype 1|hepatitis c genotype 1
223707|NCT02219490|Compensated Cirrhosis|compensated cirrhosis
223708|NCT02219490|Cirrhosis|cirrhosis
223709|NCT02219490|Naive|naive
223710|NCT02219490|Treatment-Experienced|treatment-experienced
223711|NCT02219490|Relapser|relapser
223712|NCT02219490|Null responder|null responder
223713|NCT02219490|Non responder|non responder
223714|NCT02219477|Cirrhosis|cirrhosis
223715|NCT02219477|Hepatitis C|hepatitis c
223716|NCT02219477|Child-Pugh B|child-pugh b
223717|NCT02219477|Hepatitis C Genotype 4|hepatitis c genotype 4
223718|NCT02219477|Interferon-Free|interferon-free
223719|NCT02219477|Hepatitis C Genotype 1|hepatitis c genotype 1
223720|NCT02219477|Chronic Hepatitis C|chronic hepatitis c
223721|NCT02219477|Decompensated Cirrhosis|decompensated cirrhosis
223722|NCT02219477|Hepatitis C Virus|hepatitis c virus
223723|NCT02219464|nasopharyngeal catheter|nasopharyngeal catheter
223724|NCT02219464|nasal cannula|nasal cannula
223725|NCT02219451|Chronic heart failure|chronic heart failure
223726|NCT02219451|exercise training|exercise training
223727|NCT02219451|Sympathetic modulation|sympathetic modulation
223728|NCT02219451|arterial baroreflex control|arterial baroreflex control
223729|NCT02219425|Infertility|infertility
223730|NCT02219425|Endometrium|endometrium
223731|NCT02219425|Endometrial biopsy|endometrial biopsy
223732|NCT02219425|Gene expression|gene expression
223733|NCT02219412|ticagrelor|ticagrelor
223734|NCT02219412|platelet aggregation rate|platelet aggregation rate
223735|NCT02219412|ADP antagonist|adp antagonist
223736|NCT02219412|antiplatelet therapy|antiplatelet therapy
223737|NCT02219399|Pregnancy|pregnancy
223738|NCT02219399|DHA|dha
223739|NCT02219399|Gestational Length|gestational length
223740|NCT02219399|Cognitive Development|cognitive development
223741|NCT02219386|Myofascial pain syndromes,physiotherapy,muscle stretching exercises,neck pain,dry needling|myofascial pain syndromes,physiotherapy,muscle stretching exercises,neck pain,dry needling
223742|NCT02219360|acute|acute
223743|NCT02219360|exacerbation|exacerbation
223744|NCT02219360|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
223745|NCT02219347|rheumatoid arthritis|rheumatoid arthritis
223746|NCT02219347|biological markers|biological markers
223747|NCT02219347|remission|remission
223748|NCT02219347|ultrasonography|ultrasonography
223749|NCT02219347|microarray|microarray
223750|NCT02219347|survival analysis|survival analysis
223751|NCT02219347|T cell|t cell
223752|NCT02219334|Children|children
223753|NCT02219334|Nasal suction devices|nasal suction devices
223754|NCT02219334|Suctioning|suctioning
223755|NCT02219321|Pain, Opioid dependence, Lidocaine infusion|pain, opioid dependence, lidocaine infusion
223756|NCT02219308|Contraception|contraception
223757|NCT02219308|Pain|pain
223758|NCT02219308|Intrauterine Device|intrauterine device
223759|NCT02219308|Paracervical Block|paracervical block
223760|NCT02219295|SGLT1 (sodium dependent glucose transporter)|sglt1 (sodium dependent glucose transporter)
223761|NCT02219295|Glut-transporters|glut-transporters
223762|NCT02219295|taste receptors genes|taste receptors genes
223763|NCT02219295|sweet taste receptor T1R2T1R3|sweet taste receptor t1r2t1r3
223764|NCT02219295|bitter taste receptors of the hTAS2gene family|bitter taste receptors of the htas2gene family
223765|NCT02219282|laryngeal mask airway, edentulate geriatric patients|laryngeal mask airway, edentulate geriatric patients
223766|NCT02219269|contraception|contraception
223767|NCT02219269|family planning|family planning
223768|NCT02219269|complex medical conditions|complex medical conditions
223769|NCT02219256|Drug therapy|drug therapy
223770|NCT02219243|Social Anxiety Disorder|social anxiety disorder
223771|NCT02219243|Cognitive Training|cognitive training
223772|NCT02219243|Interpretation Modification Program|interpretation modification program
223773|NCT02219204|Acupuncture|acupuncture
223774|NCT02219204|Herbal treatment|herbal treatment
223775|NCT02219191|Puerarin tablet|puerarin tablet
223776|NCT02219191|rheumatoid arthritis|rheumatoid arthritis
223777|NCT02219191|metabolism syndrome|metabolism syndrome
223778|NCT02219165|Paediatrics|paediatrics
223779|NCT02219165|Toxic Shock Syndrome|toxic shock syndrome
223780|NCT02219165|Intravenous human immunoglobulin|intravenous human immunoglobulin
223781|NCT02219165|feasibility|feasibility
223782|NCT02219139|Edentulous|edentulous
223783|NCT02219139|Roxolid|roxolid
223784|NCT02219139|SLAclive surface|slaclive surface
223785|NCT02219139|Titanium/zirconium|titanium/zirconium
223786|NCT02219113|Damage of articular cartilage|damage of articular cartilage
223787|NCT02219113|Cartilage degeneration|cartilage degeneration
223788|NCT02219113|Intraarticular injection|intraarticular injection
223789|NCT02219113|ADRC|adrc
223790|NCT02219113|Adipose-derived regenerative cells|adipose-derived regenerative cells
223791|NCT02219113|Adipose tissue|adipose tissue
223792|NCT02219113|Stem cells|stem cells
223793|NCT02219087|Total knee arthroplasty|total knee arthroplasty
223794|NCT02219087|Total joint arthroplasty|total joint arthroplasty
223795|NCT02219087|Knee replacement|knee replacement
223796|NCT02219087|Osteoarthritis of the knee|osteoarthritis of the knee
223798|NCT02219061|Meningitis C|meningitis c
223799|NCT02219061|waning|waning
223800|NCT02219061|Geometric Mean Titer|geometric mean titer
223801|NCT02219061|China|china
223802|NCT02219048|Asthma|asthma
223803|NCT02219048|Staged withdrawal of background therapy|staged withdrawal of background therapy
223804|NCT02219035|presentation with|presentation with
223805|NCT02219022|Rheumatoid arthritis|rheumatoid arthritis
223806|NCT02219022|Progressive resistance exercise|progressive resistance exercise
223807|NCT02219022|Pain|pain
223808|NCT02219022|Functional capacity|functional capacity
223809|NCT02219022|Quality of life|quality of life
223810|NCT02219022|Muscle strength|muscle strength
223811|NCT02219009|OPC-14597 Digital|opc-14597 digital
223812|NCT02219009|Aripiprazole|aripiprazole
223813|NCT02219009|Medical Information Device #1 System (MIND1)|medical information device #1 system (mind1)
223814|NCT02219009|Treatment Adherence|treatment adherence
223815|NCT02219009|Ingestible Event Marker|ingestible event marker
223816|NCT02218996|Anxiety|anxiety
223817|NCT02218996|Children|children
223818|NCT02218996|Adolescent|adolescent
223819|NCT02218996|Effectiveness|effectiveness
223820|NCT02218996|Outpatient|outpatient
223821|NCT02218983|trauma|trauma
223822|NCT02218983|echo|echo
223823|NCT02218983|echocardiogram|echocardiogram
223824|NCT02218983|ultrasound|ultrasound
223825|NCT02218983|inferior vena cava collapsibility|inferior vena cava collapsibility
223826|NCT02218970|rehabilitation|rehabilitation
223827|NCT02218970|strength training|strength training
223828|NCT02218970|muscle strength|muscle strength
223829|NCT02218970|physical fitness|physical fitness
223830|NCT02218957|Bariatric surgery|bariatric surgery
223831|NCT02218957|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
223832|NCT02218931|Pre-eclampsia|pre-eclampsia
223833|NCT02218931|Gestational diabetes|gestational diabetes
223834|NCT02218931|Stillbirth|stillbirth
223835|NCT02218931|Small for gestational age|small for gestational age
223836|NCT02218931|Admission to neonatal intensive care unit|admission to neonatal intensive care unit
223837|NCT02218931|Obesity|obesity
223838|NCT02218931|Raised Lipids|raised lipids
223839|NCT02218931|High Blood Pressure|high blood pressure
223840|NCT02218931|Cardiovascular risk|cardiovascular risk
223841|NCT02218931|Insulin resistance|insulin resistance
223842|NCT02218931|Mediterranean dietary pattern|mediterranean dietary pattern
223843|NCT02218931|Dietary interventions|dietary interventions
223844|NCT02218918|Ground walk|ground walk
223845|NCT02218918|treadmill walk|treadmill walk
223846|NCT02218918|Functional walk capacity|functional walk capacity
223847|NCT02218918|COPD|copd
223848|NCT02218918|Quality of Life|quality of life
223849|NCT02218905|Correlation|correlation
223850|NCT02218905|Sit to stand repetitions|sit to stand repetitions
223851|NCT02218905|Anthropometric variables|anthropometric variables
223852|NCT02218905|Age|age
223853|NCT02218905|Height|height
223854|NCT02218905|weight|weight
223855|NCT02218905|Gender|gender
223856|NCT02218905|Regression|regression
223857|NCT02218866|Bariatric surgery|bariatric surgery
223858|NCT02218866|Obesity|obesity
223859|NCT02218866|Neuropathy|neuropathy
223860|NCT02218853|Bipolar disorder|bipolar disorder
223861|NCT02218853|Psychosis|psychosis
223862|NCT02218853|Schizophrenia|schizophrenia
223863|NCT02218840|cigar smoker|cigar smoker
223864|NCT02218840|smoking|smoking
223865|NCT02218840|behavioral pharmacology|behavioral pharmacology
223866|NCT02218840|smoking topography|smoking topography
223867|NCT02218827|Dry Eye|dry eye
223868|NCT02218827|Inflammatory reaction|inflammatory reaction
223869|NCT02218827|steroids|steroids
223870|NCT02218814|Femoral Nerve Block|femoral nerve block
223871|NCT02218814|Adductor Canal Nerve Block|adductor canal nerve block
223872|NCT02218801|Liver metastasis|liver metastasis
223873|NCT02218801|Colorectal carcinoma|colorectal carcinoma
223874|NCT02218801|Unresectable|unresectable
223875|NCT02218801|Borderline resectable|borderline resectable
223876|NCT02218801|Initially unresectable|initially unresectable
223877|NCT02218788|Nasolabial folds|nasolabial folds
223878|NCT02218788|Marionette lines|marionette lines
223879|NCT02218788|Cheek bones|cheek bones
223880|NCT02218788|Jaw lines|jaw lines
223881|NCT02218775|Kappa opioid receptor|kappa opioid receptor
223882|NCT02218775|Mu opioid receptor|mu opioid receptor
223883|NCT02218775|LY2456302|ly2456302
223884|NCT02218775|Anhedonia|anhedonia
223885|NCT02218775|Mood and Anxiety Spectrum Disorders|mood and anxiety spectrum disorders
223886|NCT02218762|Fluticasone propionate/salmeterol in a capsule-based inhaler|fluticasone propionate/salmeterol in a capsule-based inhaler
223887|NCT02218762|replicated cross-over design|replicated cross-over design
223888|NCT02218762|Respiratory|respiratory
223889|NCT02218762|asthma|asthma
223890|NCT02218762|safety|safety
223891|NCT02218762|pharmacokinetics|pharmacokinetics
223892|NCT02218762|Fluticasone propionate/salmeterol|fluticasone propionate/salmeterol
223893|NCT02218762|pharmacodynamics|pharmacodynamics
223894|NCT02218762|Fluticasone propionate/salmeterol in a multi-dose dry powder inhaler|fluticasone propionate/salmeterol in a multi-dose dry powder inhaler
223895|NCT02218736|Anhedonia|anhedonia
224192|NCT02217332|Sinusitis|sinusitis
223896|NCT02218736|Mood and Anxiety Spectrum Disorders|mood and anxiety spectrum disorders
223897|NCT02218736|CERC-501 (investigational product)|cerc-501 (investigational product)
223898|NCT02218736|Kappa Opioid Receptor (KOR)|kappa opioid receptor (kor)
223899|NCT02218723|healthy volunteer|healthy volunteer
223900|NCT02218723|Asthma|asthma
223901|NCT02218723|inhaled corticosteroid|inhaled corticosteroid
223902|NCT02218723|UD-DPI|ud-dpi
223903|NCT02218723|ELLIPTA DPI|ellipta dpi
223904|NCT02218723|Fluticasone furoate|fluticasone furoate
223905|NCT02218697|Immunogenicity|immunogenicity
223906|NCT02218697|Influsplit Tetra (Fluarix Tetra) 2014/2015 season|influsplit tetra (fluarix tetra) 2014/2015 season
223907|NCT02218697|Safety|safety
223908|NCT02218697|Adults|adults
223909|NCT02218697|Pneumovax 23/Pneumovax|pneumovax 23/pneumovax
223910|NCT02218697|Co-administration|co-administration
223911|NCT02218697|Elderly|elderly
223912|NCT02218697|Seasonal influenza|seasonal influenza
223913|NCT02218697|Pneumococcal infection|pneumococcal infection
223914|NCT02218632|Galactosaemia|galactosaemia
223915|NCT02218632|Dysglycosylation|dysglycosylation
223916|NCT02218632|Diet|diet
223917|NCT02218619|type 1 diabetes (T1D)|type 1 diabetes (t1d)
223918|NCT02218619|endoplasmic reticulum (ER) stress|endoplasmic reticulum (er) stress
223919|NCT02218619|induced pluripotential stem (iPS) cells|induced pluripotential stem (ips) cells
223920|NCT02218619|Tauroursodeoxycholic Acid (TUDCA)|tauroursodeoxycholic acid (tudca)
223921|NCT02218606|Abiraterone Acetate|abiraterone acetate
223922|NCT02218606|CABAZITAXEL|cabazitaxel
223923|NCT02218606|CASTRATION RESISTANT|castration resistant
223924|NCT02218606|14-046|14-046
223925|NCT02218606|Prostate Cancer Clinical Trials Consortium|prostate cancer clinical trials consortium
223926|NCT02218580|massage therapy|massage therapy
223927|NCT02218580|juvenile arthritis|juvenile arthritis
223928|NCT02218580|pain|pain
223929|NCT02218554|BRONJ|bronj
223930|NCT02218528|subjects|subjects
223931|NCT02218515|Autogenous bone graft|autogenous bone graft
223932|NCT02218515|Chronic periodontitis|chronic periodontitis
223933|NCT02218515|Enamel matrix derivatives|enamel matrix derivatives
223934|NCT02218515|Gingival crevicular fluid|gingival crevicular fluid
223935|NCT02218515|Periodontal flap surgery|periodontal flap surgery
223936|NCT02218502|Ovarian cancer|ovarian cancer
223937|NCT02218502|Diagnosis|diagnosis
223938|NCT02218502|Risk of Malignancy Index|risk of malignancy index
223939|NCT02218502|RMI|rmi
223940|NCT02218502|Ultrasound|ultrasound
223941|NCT02218502|Simple ultrasound-based rules|simple ultrasound-based rules
223942|NCT02218502|DW-MRI|dw-mri
223943|NCT02218502|Subjective assessment|subjective assessment
223944|NCT02218489|Pain|pain
223945|NCT02218489|Corticosteroid|corticosteroid
223946|NCT02218489|Meibomian Gland Disease|meibomian gland disease
223947|NCT02218489|Blepharitis|blepharitis
223948|NCT02218489|Eyelid|eyelid
223949|NCT02218489|Ocular Discomfort|ocular discomfort
223950|NCT02218463|Vulvar disease, adhesions, topical therapy|vulvar disease, adhesions, topical therapy
223951|NCT02218463|Labial adhesions prepubertal girls|labial adhesions prepubertal girls
223952|NCT02218463|Labial agglutination|labial agglutination
223953|NCT02218463|Labial fusion|labial fusion
223954|NCT02218437|Mesenchymal Stem Cells (MSC)|mesenchymal stem cells (msc)
223955|NCT02218437|Umbilical Cord|umbilical cord
223956|NCT02218437|thymocyte globulin (ATG)|thymocyte globulin (atg)
223957|NCT02218437|Severe Aplastic Anemia (SAA)|severe aplastic anemia (saa)
223958|NCT02218398|airway resistance|airway resistance
223959|NCT02218398|lung compliance|lung compliance
223960|NCT02218398|Duration of mechanical ventilation|duration of mechanical ventilation
223961|NCT02218385|Nipple Aspirate Fluid|nipple aspirate fluid
223962|NCT02218385|Breast Health Screening|breast health screening
223963|NCT02218385|Cytology|cytology
223964|NCT02218372|Clostridium difficile-associated Diarrhea (CDAD)|clostridium difficile-associated diarrhea (cdad)
223965|NCT02218372|vancomycin|vancomycin
223966|NCT02218372|Clostridium difficile infection|clostridium difficile infection
223967|NCT02218372|fidaxomicin|fidaxomicin
223968|NCT02218359|Gram-negative pneumonia|gram-negative pneumonia
223969|NCT02218359|Aerosol antibiotics|aerosol antibiotics
223970|NCT02218359|Mechanical ventilation|mechanical ventilation
223971|NCT02218359|Amikacin|amikacin
223972|NCT02218359|Fosfomycin|fosfomycin
223973|NCT02218359|Pneumonia, Bacterial|pneumonia, bacterial
223974|NCT02218359|Pneumonia|pneumonia
223975|NCT02218359|Bacterial Infections|bacterial infections
223976|NCT02218359|Lung Diseases|lung diseases
223977|NCT02218359|Respiratory Tract Diseases|respiratory tract diseases
223978|NCT02218359|Respiratory Tract Infections|respiratory tract infections
223979|NCT02218359|Anti-Bacterial Agents|anti-bacterial agents
223980|NCT02218359|Anti-Infective Agents|anti-infective agents
223981|NCT02218359|Therapeutic Uses|therapeutic uses
223982|NCT02218359|Pharmacologic Actions|pharmacologic actions
223983|NCT02218359|MRSA|mrsa
223984|NCT02218346|Healthy volunteers|healthy volunteers
223985|NCT02218320|HIV|hiv
223986|NCT02218320|Gut-associated lymphoid tissue|gut-associated lymphoid tissue
223987|NCT02218320|raltegravir|raltegravir
223988|NCT02218320|Isentress|isentress
223989|NCT02218320|dolutegravir|dolutegravir
223990|NCT02218320|Tivicay|tivicay
223991|NCT02218320|pharmacodynamics|pharmacodynamics
223992|NCT02218294|BCX4161|bcx4161
223993|NCT02218294|BioCryst|biocryst
223994|NCT02218294|hereditary angioedema|hereditary angioedema
223995|NCT02218294|mass balance|mass balance
223996|NCT02218294|kallikrein inhibitor|kallikrein inhibitor
223997|NCT02218294|ADME|adme
223998|NCT02218268|type I diabetes|type i diabetes
223999|NCT02218268|healthy|healthy
224000|NCT02218268|children|children
224001|NCT02218268|adolescents|adolescents
224002|NCT02218268|young adults|young adults
224003|NCT02218255|In Vitro Fertilization|in vitro fertilization
224004|NCT02218242|Lung|lung
224005|NCT02218242|Cancer|cancer
224006|NCT02218242|Ultrasound|ultrasound
224007|NCT02218242|Staging|staging
224008|NCT02218229|shock wave|shock wave
224009|NCT02218229|carpal tunnel syndrome|carpal tunnel syndrome
224010|NCT02218216|Mild Traumatic Brain Injury|mild traumatic brain injury
224011|NCT02218203|chronic pain|chronic pain
224012|NCT02218203|central neuropathic pain|central neuropathic pain
224013|NCT02218203|spinal cord injury|spinal cord injury
224014|NCT02218203|dextromethorphan|dextromethorphan
224015|NCT02218203|lidocaine|lidocaine
224016|NCT02218203|combination therapy|combination therapy
224017|NCT02218203|analgesia|analgesia
224018|NCT02218190|Alvimopan|alvimopan
224019|NCT02218190|Ileus|ileus
224020|NCT02218190|Posterior spinal fusion|posterior spinal fusion
224021|NCT02218177|wet Age Related Macular Degeneration|wet age related macular degeneration
224022|NCT02218177|Ranibizumab|ranibizumab
224023|NCT02218177|Aflibercept|aflibercept
224024|NCT02218177|Combination Photodynamic Therapy|combination photodynamic therapy
224025|NCT02218177|Cytokine analysis|cytokine analysis
224026|NCT02218164|metastatic|metastatic
224027|NCT02218164|cutaneous|cutaneous
224028|NCT02218164|skin cancer|skin cancer
224029|NCT02218151|Hematopoietic|hematopoietic
224030|NCT02218151|Stem Cell|stem cell
224031|NCT02218151|Transplant|transplant
224032|NCT02218151|patient-centered|patient-centered
224033|NCT02218151|Microbiota|microbiota
224034|NCT02218151|GVHD|gvhd
224035|NCT02218138|Adolescent|adolescent
224036|NCT02218138|Diabetes|diabetes
224037|NCT02218138|Depression|depression
224038|NCT02218138|Obesity|obesity
224039|NCT02218138|Stress|stress
224040|NCT02218125|Healthy|healthy
224041|NCT02218125|Human immunodeficiency virus type 1 (HIV-1) infection|human immunodeficiency virus type 1 (hiv-1) infection
224042|NCT02218125|Acquired immunodeficiency syndrome (AIDS)|acquired immunodeficiency syndrome (aids)
224043|NCT02218125|recombinant adenovirus (rAd) vector-based vaccines|recombinant adenovirus (rad) vector-based vaccines
224044|NCT02218125|Vaccination|vaccination
224045|NCT02218125|Ad26.ENVA.01|ad26.enva.01
224046|NCT02218125|Recombinant|recombinant
224047|NCT02218125|Modified Vaccinia Ankara (MVA) vector-based vaccines|modified vaccinia ankara (mva) vector-based vaccines
224048|NCT02218112|Blood pressure|blood pressure
224049|NCT02218112|Obesity|obesity
224050|NCT02218112|Glomerular filtration rate|glomerular filtration rate
224051|NCT02218112|Renal Sodium handling|renal sodium handling
224052|NCT02218099|Phase 1|phase 1
224053|NCT02218099|ASP8232|asp8232
224054|NCT02218099|Single dose|single dose
224055|NCT02218099|Multiple doses|multiple doses
224056|NCT02218086|postural control|postural control
224057|NCT02218086|postural balance|postural balance
224058|NCT02218086|slackline|slackline
224059|NCT02218073|Healthy|healthy
224060|NCT02218073|JNJ-42756493|jnj-42756493
224061|NCT02218073|JNJ-61818549|jnj-61818549
224062|NCT02218073|Isotope|isotope
224063|NCT02218047|Pegylated-Proline-interferon alpha-2b (AOP2014)|pegylated-proline-interferon alpha-2b (aop2014)
224064|NCT02218047|Polycythemia Vera|polycythemia vera
224065|NCT02218047|PROUD-PV|proud-pv
224066|NCT02218047|CONTINUATION-PV|continuation-pv
224067|NCT02218047|AOP Orphan|aop orphan
224068|NCT02218047|Polycythemia|polycythemia
224069|NCT02218047|Hematologic Diseases|hematologic diseases
224070|NCT02218047|Myeloproliferative Disorders|myeloproliferative disorders
224071|NCT02218047|Bone Marrow Diseases|bone marrow diseases
224072|NCT02218047|Interferon-alpha|interferon-alpha
224073|NCT02218047|Peginterferon alfa-2b|peginterferon alfa-2b
224074|NCT02218021|Alkermes|alkermes
224075|NCT02218021|ALKS 33|alks 33
224076|NCT02218021|ALKS 5461|alks 5461
224077|NCT02218021|Samidorphan|samidorphan
224078|NCT02218008|Major depressive disorder (MDD)|major depressive disorder (mdd)
224079|NCT02218008|depression|depression
224080|NCT02218008|Alkermes|alkermes
224081|NCT02218008|ALKS 5461|alks 5461
224082|NCT02218008|samidorphan|samidorphan
224083|NCT02217995|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
224084|NCT02217995|Mindfulness|mindfulness
224085|NCT02217969|Anesthesia|anesthesia
224086|NCT02217969|Hypotension|hypotension
224087|NCT02217930|TQT|tqt
224088|NCT02217917|Healthy subjects|healthy subjects
224089|NCT02217917|Randomized|randomized
224090|NCT02217917|Double-blind|double-blind
224091|NCT02217917|Single ascending dose|single ascending dose
224092|NCT02217917|Multiple ascending dose|multiple ascending dose
224191|NCT02217358|direct laryngoscopy|direct laryngoscopy
224093|NCT02217878|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
224094|NCT02217878|non-ST-segment elevation myocardial infarction|non-st-segment elevation myocardial infarction
224095|NCT02217878|ticagrelor|ticagrelor
224096|NCT02217878|morphine|morphine
224097|NCT02217878|pharmacokinetics|pharmacokinetics
224098|NCT02217878|pharmacodynamics|pharmacodynamics
224099|NCT02217878|drug interactions|drug interactions
224100|NCT02217878|VASP assay|vasp assay
224101|NCT02217878|Multiple Electrode Aggregometry|multiple electrode aggregometry
224102|NCT02217878|VerifyNow|verifynow
224103|NCT02217865|Colorectal Cancer|colorectal cancer
224104|NCT02217865|CRC|crc
224105|NCT02217865|Curative resection of colorectal cancer|curative resection of colorectal cancer
224106|NCT02217865|Caregivers|caregivers
224107|NCT02217865|Interviews|interviews
224108|NCT02217865|Focus groups|focus groups
224109|NCT02217865|Questionnaires|questionnaires
224110|NCT02217865|Surveys|surveys
224111|NCT02217852|hypertension|hypertension
224112|NCT02217852|Tibetan|tibetan
224113|NCT02217852|Nitrendipine|nitrendipine
224114|NCT02217852|hydrochlorothiazide|hydrochlorothiazide
224115|NCT02217852|captopril|captopril
224116|NCT02217852|Beijing hypotensive No.0|beijing hypotensive no.0
224117|NCT02217774|Computer-Aided Design/instrumentation|computer-aided design/instrumentation
224118|NCT02217774|Cone-Beam Computed Tomography|cone-beam computed tomography
224119|NCT02217774|Dental Implant|dental implant
224120|NCT02217774|MGuide|mguide
224121|NCT02217761|Pharmacokinetics|pharmacokinetics
224122|NCT02217761|Antifungal Agents|antifungal agents
224123|NCT02217735|Parkinson's Disease|parkinson's disease
224124|NCT02217735|Caregivers|caregivers
224125|NCT02217735|Expressive Writing|expressive writing
224126|NCT02217735|Complementary Medicine|complementary medicine
224127|NCT02217735|Cortisol|cortisol
224128|NCT02217696|Electroencephalography (EEG)|electroencephalography (eeg)
224129|NCT02217696|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
224130|NCT02217696|Multimodal Neuroimaging|multimodal neuroimaging
224131|NCT02217696|Development|development
224132|NCT02217696|Prediction|prediction
224133|NCT02217696|Intervention|intervention
224134|NCT02217683|Catheterization, Swan-Ganz|catheterization, swan-ganz
224135|NCT02217683|Cardiac Surgical Procedures|cardiac surgical procedures
224136|NCT02217683|Blood Transfusion|blood transfusion
224137|NCT02217683|Nitric Oxide|nitric oxide
224138|NCT02217657|Smart-Touch|smart-touch
224139|NCT02217657|Contact force|contact force
224140|NCT02217605|NAFLD|nafld
224141|NCT02217605|Oral Fructose Challenge|oral fructose challenge
224142|NCT02217605|31P MRS|31p mrs
224143|NCT02217605|Liver|liver
224144|NCT02217605|Subjects|subjects
224145|NCT02217579|Weight loss|weight loss
224146|NCT02217579|Appetite|appetite
224147|NCT02217579|Overweight|overweight
224148|NCT02217579|Obesity|obesity
224149|NCT02217579|Dietary fiber|dietary fiber
224150|NCT02217579|Dietary protein|dietary protein
224151|NCT02217566|Prostatic neoplasms|prostatic neoplasms
224152|NCT02217566|Diethylstilbestrol therapy|diethylstilbestrol therapy
224153|NCT02217566|Abiraterone acetate|abiraterone acetate
224154|NCT02217566|Prednisone|prednisone
224155|NCT02217566|Androgen deprivation therapy|androgen deprivation therapy
224156|NCT02217553|platelet|platelet
224157|NCT02217553|P-selectin|p-selectin
224158|NCT02217553|platelet-fibrinogen binding|platelet-fibrinogen binding
224159|NCT02217553|platelet-monocye aggregate formation|platelet-monocye aggregate formation
224160|NCT02217553|vitamin D|vitamin d
224161|NCT02217540|Shoulder, disability evaluation, physiotherapy modalities|shoulder, disability evaluation, physiotherapy modalities
224162|NCT02217527|crossover|crossover
224163|NCT02217501|peripheral arterial disease, antiplatelet therapy|peripheral arterial disease, antiplatelet therapy
224164|NCT02217462|pregnancy|pregnancy
224165|NCT02217462|gestational weight gain|gestational weight gain
224166|NCT02217462|dietary intake|dietary intake
224167|NCT02217462|food reward|food reward
224168|NCT02217423|Physical Therapy Modalities|physical therapy modalities
224169|NCT02217423|Respiration Disorders|respiration disorders
224170|NCT02217423|Respiratory Therapy|respiratory therapy
224171|NCT02217410|renal, de novo,|renal, de novo,
224172|NCT02217397|Apnea-hyponea Index, CPAP, Obstructive Sleep Apnea, Oral Appliance|apnea-hyponea index, cpap, obstructive sleep apnea, oral appliance
224173|NCT02217384|Microbiome|microbiome
224174|NCT02217384|DNA sequencing|dna sequencing
224175|NCT02217384|Leptin|leptin
224176|NCT02217384|Adiponectin|adiponectin
224177|NCT02217384|Insulin|insulin
224178|NCT02217384|IGF-I|igf-i
224179|NCT02217371|ADHD Patient|adhd patient
224180|NCT02217371|Healthy subjects|healthy subjects
224181|NCT02217371|Sleepiness|sleepiness
224182|NCT02217371|PSG|psg
224183|NCT02217371|MWT|mwt
224184|NCT02217371|EEG|eeg
224185|NCT02217371|cognitive tests|cognitive tests
224186|NCT02217358|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
224187|NCT02217358|NBI endoscopy|nbi endoscopy
224188|NCT02217358|videoendoscopy|videoendoscopy
224189|NCT02217358|white light endoscopy|white light endoscopy
224190|NCT02217358|magnifying endoscopy|magnifying endoscopy
224193|NCT02217332|Rhinosinusitis|rhinosinusitis
224194|NCT02217332|CRS|crs
224195|NCT02217332|CRSwNP|crswnp
224196|NCT02217332|CSNP-E|csnp-e
224197|NCT02217332|Nasal polyps|nasal polyps
224198|NCT02217332|Nasal polyposis|nasal polyposis
224199|NCT02217332|Eosinophilia|eosinophilia
224200|NCT02217332|Asthma|asthma
224201|NCT02217319|Volatile Anesthetic|volatile anesthetic
224202|NCT02217319|Cardioprotection|cardioprotection
224203|NCT02217319|Lung surgery|lung surgery
224204|NCT02217319|non cardiac surgery|non cardiac surgery
224205|NCT02217293|Pulsed radiofrequency|pulsed radiofrequency
224206|NCT02217293|Ultrasound-guided|ultrasound-guided
224207|NCT02217293|Carpal tunnel syndrome|carpal tunnel syndrome
224208|NCT02217280|Cervical Radiculopathy|cervical radiculopathy
224209|NCT02217267|Peripheral neuropathy|peripheral neuropathy
224210|NCT02217215|Spectroscopy|spectroscopy
224211|NCT02217215|HPV|hpv
224212|NCT02217202|knee replacement|knee replacement
224213|NCT02217202|knee arthroplasty|knee arthroplasty
224214|NCT02217202|revision|revision
224215|NCT02217202|high risk|high risk
224216|NCT02217189|Zinc supplementation.|zinc supplementation.
224217|NCT02217189|Oxidative stress.|oxidative stress.
224218|NCT02217189|Superoxide radical scavengers.|superoxide radical scavengers.
224219|NCT02217189|Asthenospermia.|asthenospermia.
224220|NCT02217189|Oxido-sensitive index.|oxido-sensitive index.
224221|NCT02217137|Dry Eye|dry eye
224222|NCT02217137|Rheumatoid Arthritis|rheumatoid arthritis
224223|NCT02217137|Systemic Lupus Erythematosus|systemic lupus erythematosus
224224|NCT02217137|Tear cytokines and immune response|tear cytokines and immune response
224225|NCT02217124|apple|apple
224226|NCT02217124|high fiber|high fiber
224227|NCT02217124|body composition|body composition
224228|NCT02217124|children|children
224229|NCT02217111|vocal fold nodules|vocal fold nodules
224230|NCT02217111|pediatric|pediatric
224231|NCT02217111|voice therapy|voice therapy
224232|NCT02217111|acoustic|acoustic
224233|NCT02217111|aerodynamic|aerodynamic
224234|NCT02217111|quality of life|quality of life
224235|NCT02217111|Adventures in Voice|adventures in voice
224236|NCT02217098|ART|art
224237|NCT02217098|Occlusal|occlusal
224238|NCT02217098|Occlusoproximal|occlusoproximal
224239|NCT02217098|Primary teeth|primary teeth
224240|NCT02217085|Colorectal Cancer Screening|colorectal cancer screening
224241|NCT02217085|Colon Cancer Screening|colon cancer screening
224242|NCT02217085|Polyps|polyps
224243|NCT02217085|Colonoscopy|colonoscopy
224244|NCT02217072|academic performance|academic performance
224245|NCT02217072|cognitive development|cognitive development
224246|NCT02217072|children in care|children in care
224247|NCT02217072|prevention of school failure|prevention of school failure
224248|NCT02217059|Emergency Medical Services|emergency medical services
224249|NCT02217059|Emergency Care|emergency care
224250|NCT02217059|Hypertension|hypertension
224251|NCT02217059|BpTRU|bptru
224252|NCT02217059|Blood pressure|blood pressure
224253|NCT02217046|Infection|infection
224254|NCT02217046|prevention|prevention
224255|NCT02217046|cardiac devices|cardiac devices
224256|NCT02217033|Breast Cancer|breast cancer
224257|NCT02217033|Stage I breast cancer|stage i breast cancer
224258|NCT02217033|Stage II breast cancer|stage ii breast cancer
224259|NCT02217033|Water study|water study
224260|NCT02217033|'R'|'r'
224261|NCT02217033|Electro-kinetically altered beverage|electro-kinetically altered beverage
224262|NCT02217033|altered beverage|altered beverage
224263|NCT02217033|Insomnia|insomnia
224264|NCT02217033|Fatigue|fatigue
224265|NCT02217033|Depression|depression
224266|NCT02217033|Adjuvant chemotherapy|adjuvant chemotherapy
224267|NCT02217020|Rectal Cancer|rectal cancer
224268|NCT02217020|Locally advanced rectal cancer|locally advanced rectal cancer
224269|NCT02217020|Neoadjuvant|neoadjuvant
224270|NCT02217020|chemotherapy|chemotherapy
224271|NCT02217020|FOLFOXIRI|folfoxiri
224272|NCT02217007|Tourette|tourette
224273|NCT02217007|Tourette's|tourette's
224274|NCT02217007|tic|tic
224275|NCT02216994|Intestinal dysganglinosis|intestinal dysganglinosis
224276|NCT02216994|Hirschsprung disease|hirschsprung disease
224277|NCT02216994|Hirschsprung disease allied disorders|hirschsprung disease allied disorders
224278|NCT02216994|diagnostic scoring system|diagnostic scoring system
224279|NCT02216994|Prospective study|prospective study
224280|NCT02216981|Obsessive Compulsive Disorder (OCD)|obsessive compulsive disorder (ocd)
224281|NCT02216981|Cognitive Behavioural Therapy (CBT)|cognitive behavioural therapy (cbt)
224282|NCT02216981|Intensive therapy|intensive therapy
224283|NCT02216981|Intensive treatment|intensive treatment
224284|NCT02216981|Treatment Resistant|treatment resistant
224285|NCT02216968|vegetables|vegetables
224286|NCT02216968|Head Start|head start
224287|NCT02216968|preschool|preschool
224288|NCT02216968|children|children
224289|NCT02216968|theater|theater
224290|NCT02216968|puppet|puppet
224291|NCT02216942|Endodontics|endodontics
224292|NCT02216942|Deciduous teeth|deciduous teeth
224293|NCT02216942|Iodoform pastes|iodoform pastes
224294|NCT02216942|Treatment Refusal|treatment refusal
224295|NCT02216929|intubation|intubation
224296|NCT02216929|intensive care|intensive care
224297|NCT02216929|withholding treatment|withholding treatment
224298|NCT02216929|cancer|cancer
224299|NCT02216929|terminal care|terminal care
224300|NCT02216929|APACHE|apache
224301|NCT02216903|Atrial fibrillation, sleep apnea|atrial fibrillation, sleep apnea
224302|NCT02216890|Renal Cell Carcinoma|renal cell carcinoma
224303|NCT02216890|Mantle-Cell Lymphoma|mantle-cell lymphoma
224304|NCT02216890|Diffuse, Large B-Cell, Lymphoma|diffuse, large b-cell, lymphoma
224305|NCT02216890|Follicular Lymphoma, Grade 3|follicular lymphoma, grade 3
224306|NCT02216890|Antibody-Drug Conjugate|antibody-drug conjugate
224307|NCT02216890|CD70 Antigen|cd70 antigen
224308|NCT02216890|Drug Therapy|drug therapy
224309|NCT02216877|Chronic Kidney Disease|chronic kidney disease
224310|NCT02216877|Hypomagnesemia|hypomagnesemia
224311|NCT02216851|hyaluronic acid|hyaluronic acid
224312|NCT02216851|no-treatment control|no-treatment control
224313|NCT02216851|enhancement|enhancement
224314|NCT02216812|Finger stiffness|finger stiffness
224315|NCT02216812|Range of motion|range of motion
224316|NCT02216812|Distal radius fracture|distal radius fracture
224317|NCT02216812|Vitamin C|vitamin c
224318|NCT02216799|Parenteral nutrition|parenteral nutrition
224319|NCT02216799|Hyperglycemia|hyperglycemia
224320|NCT02216799|Glargine insulin|glargine insulin
224321|NCT02216799|Regular insulin|regular insulin
224322|NCT02216773|Liver hypertrophy|liver hypertrophy
224323|NCT02216773|Liver resection|liver resection
224324|NCT02216773|Liver metastases|liver metastases
224325|NCT02216773|Portal vein ligation|portal vein ligation
224326|NCT02216773|Portal vein embolization|portal vein embolization
224327|NCT02216773|Radiofrequency splitting|radiofrequency splitting
224328|NCT02216760|Monomorphic Ventricular Tachycardia|monomorphic ventricular tachycardia
224329|NCT02216760|Myocardial infarction|myocardial infarction
224330|NCT02216760|Dilated cardiomyopathy|dilated cardiomyopathy
224331|NCT02216760|Catheter ablation|catheter ablation
224332|NCT02216760|Substrate mapping|substrate mapping
224333|NCT02216760|Ripple Conduction channels|ripple conduction channels
224334|NCT02216747|Idiopathic Nephrotic syndrome relapse|idiopathic nephrotic syndrome relapse
224335|NCT02216734|HIV/AIDS|hiv/aids
224336|NCT02216734|Prevention of mother-to-child transmission|prevention of mother-to-child transmission
224337|NCT02216734|Mother support groups|mother support groups
224338|NCT02216734|Retention-in-care|retention-in-care
224339|NCT02216734|Male participation|male participation
224340|NCT02216734|Anti-retroviral treatment|anti-retroviral treatment
224341|NCT02216734|Infants|infants
224342|NCT02216721|bone mineral density|bone mineral density
224343|NCT02216721|bone turnover markers|bone turnover markers
224344|NCT02216721|primary aldosteronism treatment|primary aldosteronism treatment
224345|NCT02216708|Severe malnutrition|severe malnutrition
224346|NCT02216708|severe dehydration|severe dehydration
224347|NCT02216708|cholera|cholera
224348|NCT02216695|acute kidney injury|acute kidney injury
224349|NCT02216695|epidemiology|epidemiology
224350|NCT02216695|mortality|mortality
224351|NCT02216682|Acetaminophen|acetaminophen
224352|NCT02216682|Total knee replacement|total knee replacement
224353|NCT02216682|Numeric rating scale|numeric rating scale
224354|NCT02216669|Solid tumors|solid tumors
224355|NCT02216669|Head and Neck Neoplasms|head and neck neoplasms
224356|NCT02216643|Stroke|stroke
224357|NCT02216643|Ischemic Stroke|ischemic stroke
224358|NCT02216643|Thrombectomy|thrombectomy
224359|NCT02216643|Reperfusion Therapy|reperfusion therapy
224360|NCT02216643|Treatment|treatment
224361|NCT02216630|COPD|copd
224362|NCT02216604|Exercise|exercise
224363|NCT02216604|Pediatric oncology|pediatric oncology
224364|NCT02216604|Physical Performance|physical performance
224365|NCT02216604|Quality of Life|quality of life
224366|NCT02216604|Feasibility|feasibility
224367|NCT02216604|during primary|during primary
224368|NCT02216604|anticancer treatment|anticancer treatment
224369|NCT02216591|HIV|hiv
224370|NCT02216591|Medication Adherence|medication adherence
224371|NCT02216591|Working Memory|working memory
224372|NCT02216578|tyrosine kinase inhibitor|tyrosine kinase inhibitor
224373|NCT02216578|progressed|progressed
224374|NCT02216578|(GIST)|(gist)
224375|NCT02216565|Stroke|stroke
224376|NCT02216565|Endovascular treatment|endovascular treatment
224377|NCT02216565|Tandem carotid occlusions|tandem carotid occlusions
224378|NCT02216565|Fibrinolysis|fibrinolysis
224379|NCT02216552|Pediatrics|pediatrics
224380|NCT02216552|Adolescents|adolescents
224381|NCT02216552|NAFLD|nafld
224382|NCT02216552|Spectroscopy|spectroscopy
224383|NCT02216552|Type 2 diabetes|type 2 diabetes
224384|NCT02216539|All terminal|all terminal
224385|NCT02216539|leading|leading
224386|NCT02216539|indication|indication
224387|NCT02216539|lung transplantation|lung transplantation
224388|NCT02216526|Skin health|skin health
224389|NCT02216526|Nursing|nursing
224390|NCT02216526|Long-term care|long-term care
224391|NCT02216513|subarachnoid hemorrhage|subarachnoid hemorrhage
224392|NCT02216513|SAH|sah
224393|NCT02216513|DFO|dfo
224394|NCT02216513|cerebral autoregulation|cerebral autoregulation
225078|NCT02213380|delirium|delirium
224395|NCT02216513|delayed cerebral ischemia|delayed cerebral ischemia
224396|NCT02216500|Ketogenic Therapy|ketogenic therapy
224397|NCT02216500|Ketogenic Diet|ketogenic diet
224398|NCT02216487|mCRC|mcrc
224399|NCT02216487|colorectal cancer|colorectal cancer
224400|NCT02216448|Arthroscopy skills|arthroscopy skills
224401|NCT02216448|Knee|knee
224402|NCT02216448|Virtual reality|virtual reality
224403|NCT02216448|Simulator|simulator
224404|NCT02216422|Chronic Hepatitis C|chronic hepatitis c
224405|NCT02216422|Hepatitis C|hepatitis c
224406|NCT02216422|Hepatitis C Virus|hepatitis c virus
224407|NCT02216422|Hepatitis C Genotype 1b|hepatitis c genotype 1b
224408|NCT02216422|Interferon-Free|interferon-free
224409|NCT02216396|dementia|dementia
224410|NCT02216396|care home|care home
224411|NCT02216396|agitation|agitation
224412|NCT02216396|coping|coping
224413|NCT02216383|Post partum haemorrhage|post partum haemorrhage
224414|NCT02216383|Active Management of Third Stage of Labour|active management of third stage of labour
224415|NCT02216383|Carbetocin|carbetocin
224416|NCT02216383|Syntocinon|syntocinon
224417|NCT02216383|Syntometrine|syntometrine
224418|NCT02216383|Birth experience|birth experience
224419|NCT02216383|Labour|labour
224420|NCT02216370|Cryptogenic stroke /TIA|cryptogenic stroke /tia
224421|NCT02216370|Atrial Fibrillation|atrial fibrillation
224422|NCT02216370|Implantable Loop Recorder|implantable loop recorder
224423|NCT02216370|Genetic Mutation|genetic mutation
224424|NCT02216357|Samster's triad|samster's triad
224425|NCT02216357|Acetylsalicylic acid triad|acetylsalicylic acid triad
224426|NCT02216357|Widal's triad|widal's triad
224427|NCT02216357|Francis' triad|francis' triad
224428|NCT02216357|Aspirin triad|aspirin triad
224429|NCT02216357|Aspirin-induced asthma and rhinitis (AIAR)|aspirin-induced asthma and rhinitis (aiar)
224430|NCT02216344|Patient safety monitors|patient safety monitors
224431|NCT02216331|tuberculosis|tuberculosis
224432|NCT02216331|PK|pk
224433|NCT02216331|TMC207|tmc207
224434|NCT02216331|bedaquiline|bedaquiline
224435|NCT02216331|rifapentine|rifapentine
224436|NCT02216331|rifampicin|rifampicin
224437|NCT02216331|drug drug interaction|drug drug interaction
224438|NCT02216318|sleep|sleep
224439|NCT02216318|circadian|circadian
224440|NCT02216318|melatonine|melatonine
224441|NCT02216318|pupil response|pupil response
224442|NCT02216305|HAL-RAR|hal-rar
224443|NCT02216305|Hemorrhoids|hemorrhoids
224444|NCT02216305|Hemorrhoid artery ligation|hemorrhoid artery ligation
224445|NCT02216305|Anal repair|anal repair
224446|NCT02216305|Quality of Life|quality of life
224447|NCT02216305|Postoperative Complications|postoperative complications
224448|NCT02216292|preterm single donor milk|preterm single donor milk
224449|NCT02216292|human milk|human milk
224450|NCT02216292|very lo birth weight infants|very lo birth weight infants
224451|NCT02216292|enteral feedings|enteral feedings
224452|NCT02216292|NEC|nec
224453|NCT02216279|Pulmonary|pulmonary
224454|NCT02216279|Hypertension|hypertension
224455|NCT02216279|PH|ph
224456|NCT02216279|PulmoBind|pulmobind
224457|NCT02216279|Imaging|imaging
224458|NCT02216266|Delirium|delirium
224459|NCT02216266|CAM-ICU|cam-icu
224460|NCT02216253|Urinary tract infection|urinary tract infection
224461|NCT02216253|Pelvic organ prolapse|pelvic organ prolapse
224462|NCT02216253|Urinary incontinence|urinary incontinence
224463|NCT02216253|Stress urinary incontinence|stress urinary incontinence
224464|NCT02216253|Mixed Urinary incontinence|mixed urinary incontinence
224465|NCT02216253|L-methionine|l-methionine
224466|NCT02216253|Placebo|placebo
224467|NCT02216227|MRSA|mrsa
224468|NCT02216227|surgical site infection|surgical site infection
224469|NCT02216214|Urinary Incontinence|urinary incontinence
224470|NCT02216214|Mirabegron|mirabegron
224471|NCT02216214|Overactive Bladder|overactive bladder
224472|NCT02216175|Cow's milk allergy|cow's milk allergy
224473|NCT02216175|Desensitisation|desensitisation
224474|NCT02216175|Safety|safety
224475|NCT02216162|oncogeriatrics|oncogeriatrics
224476|NCT02216162|adjuvant endocrine therapy|adjuvant endocrine therapy
224477|NCT02216162|compliance|compliance
224478|NCT02216162|elderly|elderly
224479|NCT02216162|Taï Chi|taï chi
224480|NCT02216162|Physical training|physical training
224481|NCT02216149|fluoropyrimidine|fluoropyrimidine
224482|NCT02216149|S-1|s-1
224483|NCT02216149|Teysuno|teysuno
224484|NCT02216149|oxaliplatin|oxaliplatin
224485|NCT02216149|coronary artery flow|coronary artery flow
224609|NCT02215382|changes in IOP|changes in iop
224486|NCT02216149|coronary artery dysfunction|coronary artery dysfunction
224487|NCT02216149|gastrointestinal tract cancer|gastrointestinal tract cancer
224488|NCT02216136|Mastectomy|mastectomy
224489|NCT02216136|Breast Cancer|breast cancer
224490|NCT02216136|Reconstruction|reconstruction
224491|NCT02216136|Lumpectomy|lumpectomy
224492|NCT02216136|Breast Conservation Therapy|breast conservation therapy
224493|NCT02216123|Tafenoquine|tafenoquine
224494|NCT02216123|Plasmodium vivax|plasmodium vivax
224495|NCT02216123|Hemolysis|hemolysis
224496|NCT02216123|Primaquine|primaquine
224497|NCT02216123|Chloroquine|chloroquine
225878|NCT02209285|TIA|tia
224498|NCT02216123|Glucose-6-phosphate dehydrogenase (G6PD)|glucose-6-phosphate dehydrogenase (g6pd)
224499|NCT02216123|Relapse|relapse
224500|NCT02216110|Endoscopic submucosal dissection|endoscopic submucosal dissection
224501|NCT02216110|Gastrectomy|gastrectomy
224502|NCT02216110|Survival|survival
224503|NCT02216110|Outcome|outcome
224504|NCT02216045|Hepatitis C ,Chronic Hepatitis C ,camel milk|hepatitis c ,chronic hepatitis c ,camel milk
224505|NCT02216019|cardiac surgery|cardiac surgery
224506|NCT02216019|infectious complication|infectious complication
224507|NCT02216006|Atelectasis|atelectasis
224508|NCT02216006|Fresh gas flow|fresh gas flow
224509|NCT02216006|Prevention|prevention
224510|NCT02216006|Oxygenation|oxygenation
224511|NCT02216006|Anaesthesia|anaesthesia
224512|NCT02215993|Ticagrelor|ticagrelor
224513|NCT02215993|Prasugrel|prasugrel
224514|NCT02215993|VerifyNow|verifynow
224515|NCT02215993|Acute coronary syndrome|acute coronary syndrome
224516|NCT02215980|Multiple myeloma|multiple myeloma
224517|NCT02215980|Diagnosis|diagnosis
224518|NCT02215980|Elderly and unfit patients|elderly and unfit patients
224519|NCT02215980|Lenalidomide plus steroids|lenalidomide plus steroids
224520|NCT02215967|Immunotherapy|immunotherapy
224521|NCT02215967|Anti-BCMA-CAR|anti-bcma-car
224522|NCT02215967|Gene Therapy|gene therapy
224523|NCT02215967|Adoptive T Cell Therapy|adoptive t cell therapy
224524|NCT02215967|Plasma Cell Malignancy|plasma cell malignancy
224525|NCT02215915|Percutaneous coronary intervention|percutaneous coronary intervention
224526|NCT02215915|Drug-eluting stent|drug-eluting stent
224527|NCT02215915|Intravascular ultrasound|intravascular ultrasound
224528|NCT02215902|ESRD|esrd
224529|NCT02215902|Hepatitis C|hepatitis c
224530|NCT02215889|Liver metastases|liver metastases
224531|NCT02215889|Transplantation|transplantation
224532|NCT02215876|Her 2-negative breast cancer|her 2-negative breast cancer
224533|NCT02215876|neoadjuvant doxorubicin/cyclophosphamide followed by Eribulin chemotherapy|neoadjuvant doxorubicin/cyclophosphamide followed by eribulin chemotherapy
224534|NCT02215863|Immunogenicity, Safety, MF59, Influenza vaccine, Pneumococcal vaccine|immunogenicity, safety, mf59, influenza vaccine, pneumococcal vaccine
224535|NCT02215837|Gastric cancer|gastric cancer
224536|NCT02215837|D-CIK|d-cik
224537|NCT02215837|Autologous tumor lysate|autologous tumor lysate
224538|NCT02215811|Extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
224539|NCT02215785|Funtional constipation|funtional constipation
224540|NCT02215785|Kiwifruit|kiwifruit
224541|NCT02215785|Health promotion|health promotion
224542|NCT02215707|PfSPZ Vaccine|pfspz vaccine
224543|NCT02215707|Plasmodium falciparum|plasmodium falciparum
224544|NCT02215707|Malaria|malaria
224545|NCT02215707|Controlled Human Malaria Infection (CHMI)|controlled human malaria infection (chmi)
224546|NCT02215694|Apolipoprotein A-V|apolipoprotein a-v
224547|NCT02215694|LDL particle size|ldl particle size
224548|NCT02215694|probiotic|probiotic
224549|NCT02215694|triglyceride|triglyceride
224550|NCT02215681|otitis media with effusion|otitis media with effusion
224551|NCT02215681|acupuncture|acupuncture
224552|NCT02215681|inflammatory markers|inflammatory markers
224553|NCT02215655|phosphate binder adherence|phosphate binder adherence
224554|NCT02215655|autonomous motivation|autonomous motivation
224555|NCT02215629|Leukemia|leukemia
224556|NCT02215629|Acute Leukemia|acute leukemia
224557|NCT02215629|Relapsed Leukemia|relapsed leukemia
224558|NCT02215629|Refractory Leukemia|refractory leukemia
224559|NCT02215629|Acute Myeloid Leukemia|acute myeloid leukemia
224560|NCT02215629|B-Cell Acute Lymphoblastic Leukemia|b-cell acute lymphoblastic leukemia
224561|NCT02215590|Postural balance|postural balance
224562|NCT02215590|Motor Learning and Motor Control|motor learning and motor control
224563|NCT02215590|Community integration|community integration
224564|NCT02215590|Quality of life|quality of life
224565|NCT02215590|Functional ambulation|functional ambulation
224566|NCT02215577|cancer, colorectal|cancer, colorectal
224567|NCT02215577|hepatectomy|hepatectomy
224568|NCT02215577|portal vein|portal vein
224569|NCT02215577|embolization|embolization
224570|NCT02215577|two-stage|two-stage
224571|NCT02215564|Bordetella pertussis|bordetella pertussis
224572|NCT02215564|Carriage rates in young adults|carriage rates in young adults
224573|NCT02215551|laminectomy|laminectomy
224574|NCT02215538|ADHD|adhd
224575|NCT02215538|adult|adult
224576|NCT02215538|WRAADDS|wraadds
224577|NCT02215538|OROS MPH|oros mph
224578|NCT02215538|emotional dysregulation|emotional dysregulation
224579|NCT02215525|HCV|hcv
224580|NCT02215525|UVA|uva
224581|NCT02215525|Herbal therapy|herbal therapy
224582|NCT02215499|JZP-386, Xyrem, sodium oxybate|jzp-386, xyrem, sodium oxybate
224583|NCT02215486|Head massage therapy|head massage therapy
224584|NCT02215486|Massage therapy|massage therapy
224585|NCT02215486|Autonomic nervous system (ANS)|autonomic nervous system (ans)
224586|NCT02215486|Heart rate variability (HRV)|heart rate variability (hrv)
224587|NCT02215486|Pre-ejection period (PEP)|pre-ejection period (pep)
224588|NCT02215473|gingivitis|gingivitis
224589|NCT02215473|periodontitis|periodontitis
224590|NCT02215473|mouth rinse|mouth rinse
224591|NCT02215473|bacteremia|bacteremia
224592|NCT02215447|NAB-paclitaxel|nab-paclitaxel
225979|NCT02208895|pleural|pleural
224593|NCT02215447|Gastrointestinal Neuroendocrine Carcinomas|gastrointestinal neuroendocrine carcinomas
224594|NCT02215447|phase II|phase ii
224595|NCT02215447|carboplatin|carboplatin
224596|NCT02215434|Libido; Sexual Dysfunction; testosterone|libido; sexual dysfunction; testosterone
224597|NCT02215421|vegetables|vegetables
224598|NCT02215421|dietary intake|dietary intake
224599|NCT02215421|preschoolers|preschoolers
224600|NCT02215421|parents|parents
224601|NCT02215421|video game|video game
224602|NCT02215408|Diabetes|diabetes
224603|NCT02215408|Hyperlipidemia|hyperlipidemia
224604|NCT02215408|Hypertension|hypertension
224605|NCT02215408|Cardiovascular Disease|cardiovascular disease
224606|NCT02215395|Nestorone|nestorone
224607|NCT02215395|miconazole nitrate|miconazole nitrate
224608|NCT02215382|two reversal methods|two reversal methods
224610|NCT02215382|heart rate|heart rate
224611|NCT02215382|blood pressure|blood pressure
224612|NCT02215382|tracheal extubation|tracheal extubation
224613|NCT02215330|Central serous chorioretinopathy|central serous chorioretinopathy
224614|NCT02215330|Eplerenone|eplerenone
224615|NCT02215330|Photodynamic Therapy|photodynamic therapy
224616|NCT02215330|Macula|macula
224617|NCT02215330|Retina|retina
224618|NCT02215317|Sleep Apnea|sleep apnea
224619|NCT02215317|Stent|stent
224620|NCT02215317|Coronary Artery Disease|coronary artery disease
224621|NCT02215317|Percutaneous Coronary Intervention|percutaneous coronary intervention
224622|NCT02215304|Dietary supplementation|dietary supplementation
224623|NCT02215304|Probiotics|probiotics
224624|NCT02215304|Safety/Efficiency|safety/efficiency
224625|NCT02215304|Healthy infants|healthy infants
224626|NCT02215291|Undergoing Esophagogastroduodenoscopy (EGD) or endoscopy|undergoing esophagogastroduodenoscopy (egd) or endoscopy
224627|NCT02215278|iron biofortification|iron biofortification
224628|NCT02215278|lpa bean|lpa bean
224629|NCT02215278|stable iron isotope study|stable iron isotope study
224630|NCT02215278|phytic acid|phytic acid
224631|NCT02215265|Human papillomavirus HPV positive oropharyngeal cancer|human papillomavirus hpv positive oropharyngeal cancer
224632|NCT02215239|health lifestyle|health lifestyle
224633|NCT02215239|health promotion|health promotion
224634|NCT02215239|occupational health|occupational health
224635|NCT02215239|Work site health promotion|work site health promotion
224636|NCT02215226|Group B Streptococcus, early onset disease, late onset disease, anticapsular antibodies, serotype specific|group b streptococcus, early onset disease, late onset disease, anticapsular antibodies, serotype specific
224637|NCT02215213|Vitamin D|vitamin d
224638|NCT02215213|pregnancy|pregnancy
224639|NCT02215213|Pakistan|pakistan
224640|NCT02215200|Type 1 Diabetes TrialNet|type 1 diabetes trialnet
224641|NCT02215174|Rosuvastatin|rosuvastatin
224642|NCT02215174|PK|pk
224643|NCT02215174|Interethnic|interethnic
224644|NCT02215174|Morbid obese|morbid obese
224645|NCT02215135|Corifollitropin alfa|corifollitropin alfa
224646|NCT02215135|polycystic ovarian syndrome (PCOS)|polycystic ovarian syndrome (pcos)
224647|NCT02215135|controlled ovarian hyperstimulation (COS)|controlled ovarian hyperstimulation (cos)
224648|NCT02215135|GnRH antagonist protocol|gnrh antagonist protocol
224649|NCT02215135|Ovarian hyperstimulation syndrome (OHSS)|ovarian hyperstimulation syndrome (ohss)
224650|NCT02215122|Fluticasone Propionate|fluticasone propionate
224651|NCT02215122|Salmeterol|salmeterol
224652|NCT02215122|Pharmacokinetics|pharmacokinetics
224653|NCT02215122|Healthy Subjects|healthy subjects
224654|NCT02215122|MGR001|mgr001
224655|NCT02215122|CRC749|crc749
224656|NCT02215122|Dry Powder Inhaler|dry powder inhaler
224657|NCT02215122|generic|generic
224658|NCT02215122|Advair Diskus|advair diskus
224659|NCT02215122|Seretide Accuhaler|seretide accuhaler
224660|NCT02215096|enzalutamide|enzalutamide
224661|NCT02215096|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
224662|NCT02215096|GSK2636771|gsk2636771
224663|NCT02215096|PI3K-beta|pi3k-beta
224664|NCT02215096|PTEN deficiency|pten deficiency
224665|NCT02215083|peripheral neuropathy|peripheral neuropathy
224666|NCT02215083|breast cancer|breast cancer
224667|NCT02215083|taxane induced peripheral neuropathy|taxane induced peripheral neuropathy
224668|NCT02215083|chemotherapy induced peripheral neuropathy|chemotherapy induced peripheral neuropathy
224669|NCT02215070|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
224670|NCT02215070|Acute Myeloid Leukemia|acute myeloid leukemia
224671|NCT02215070|Acute Lymphoid Leukemia|acute lymphoid leukemia
224672|NCT02215070|Acute Non-Lymphocytic Leukemia|acute non-lymphocytic leukemia
224673|NCT02215070|Myelodysplastic Syndrome|myelodysplastic syndrome
224674|NCT02215070|Chronic Myeloid Leukemia|chronic myeloid leukemia
224675|NCT02215070|Lymphoma|lymphoma
224676|NCT02215057|topical anesthesia|topical anesthesia
224677|NCT02215057|intracameral lidocaine|intracameral lidocaine
224678|NCT02215057|implantable collamer lens|implantable collamer lens
224679|NCT02214875|Retention|retention
224680|NCT02214862|Unclassifiable Parkinsonism, [F18]-FDDNP-PET, Tauopathy, PSP,MSA|unclassifiable parkinsonism, [f18]-fddnp-pet, tauopathy, psp,msa
224681|NCT02214849|Breastfeeding|breastfeeding
224682|NCT02214849|Breastfeeding peer counseling|breastfeeding peer counseling
224683|NCT02214849|Exclusive breastfeeding|exclusive breastfeeding
225980|NCT02208895|glucose|glucose
224684|NCT02214849|Formula supplementation|formula supplementation
224685|NCT02214849|Mobile health|mobile health
224686|NCT02214849|WIC program|wic program
224687|NCT02214836|kidney stones|kidney stones
224688|NCT02214836|ultrasound imaging|ultrasound imaging
224689|NCT02214836|ureter stones|ureter stones
224690|NCT02214810|Bupivacaine|bupivacaine
224691|NCT02214810|multimodal|multimodal
224692|NCT02214810|exparel|exparel
224693|NCT02214810|open reduction|open reduction
224694|NCT02214810|internal fixation|internal fixation
224695|NCT02214810|post-surgical pain control|post-surgical pain control
224696|NCT02214797|Presbyopia|presbyopia
224697|NCT02214797|Refractive Error|refractive error
224698|NCT02214797|Contact Lenses|contact lenses
224699|NCT02214784|Stress urinary Incontinence|stress urinary incontinence
224700|NCT02214784|SUI|sui
224701|NCT02214784|Continence|continence
224702|NCT02214771|Clostridium difficile infection CDI|clostridium difficile infection cdi
224703|NCT02214771|Observational|observational
224704|NCT02214771|Fidaxomicin recurrence|fidaxomicin recurrence
224705|NCT02214771|France|france
224706|NCT02214758|Home care clients, nutrition, oral health, medication|home care clients, nutrition, oral health, medication
224707|NCT02214745|Israeli Arab population|israeli arab population
224708|NCT02214745|Israeli/ethnology|israeli/ethnology
224709|NCT02214732|Pregnancy|pregnancy
224710|NCT02214732|Postpartum|postpartum
224711|NCT02214732|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
224712|NCT02214732|Depression|depression
224713|NCT02214732|Anxiety|anxiety
224714|NCT02214732|Stress|stress
224715|NCT02214732|MBCT|mbct
224716|NCT02214732|Actigraphy|actigraphy
224717|NCT02214719|type 1 diabetes, insulin therapy, bolus calculator|type 1 diabetes, insulin therapy, bolus calculator
224718|NCT02214693|patients|patients
224719|NCT02214680|Pupil diameter|pupil diameter
224720|NCT02214680|Brimonidine|brimonidine
224721|NCT02214680|Timolol|timolol
224722|NCT02214680|Combigan|combigan
224723|NCT02214667|Jail|jail
224724|NCT02214667|co-occurring disorders|co-occurring disorders
224725|NCT02214667|implementation|implementation
224726|NCT02214667|acceptability|acceptability
224727|NCT02214667|feasibility|feasibility
224728|NCT02214667|fidelity|fidelity
224729|NCT02214628|Wet AMD|wet amd
224982|NCT02213783|Imipenem|imipenem
224730|NCT02214628|Choroidal neovascularization|choroidal neovascularization
224731|NCT02214628|Fovista®|fovista®
224732|NCT02214628|E10030|e10030
224733|NCT02214628|Avastin®|avastin®
224734|NCT02214628|Eylea®|eylea®
224735|NCT02214602|non muscle invasive bladder cancer|non muscle invasive bladder cancer
224736|NCT02214602|intermediate and high risk|intermediate and high risk
224737|NCT02214602|immediate single instillation|immediate single instillation
224738|NCT02214602|Intravesical chemotherapy|intravesical chemotherapy
224739|NCT02214602|Disease prevention|disease prevention
224740|NCT02214576|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
224741|NCT02214576|intubation, intratracheal|intubation, intratracheal
224742|NCT02214576|Oxygen Inhalation Therapy|oxygen inhalation therapy
224743|NCT02214576|Positive-Pressure Respiration|positive-pressure respiration
224744|NCT02214576|laryngoscopy|laryngoscopy
224745|NCT02214563|Vitamin D|vitamin d
224746|NCT02214563|Cholecalciferol|cholecalciferol
224747|NCT02214563|Hepcidins|hepcidins
224748|NCT02214563|Renal Dialysis|renal dialysis
224749|NCT02214550|Cystitis, Interstitial|cystitis, interstitial
224750|NCT02214550|Dysmenorrhea|dysmenorrhea
224751|NCT02214550|Migraine Disorders|migraine disorders
224752|NCT02214550|Cross Organ Sensitization|cross organ sensitization
224753|NCT02214550|Pelvic Pain|pelvic pain
224754|NCT02214550|Endometriosis|endometriosis
224755|NCT02214550|Contraceptives, Oral|contraceptives, oral
224756|NCT02214550|Birth Control Pills|birth control pills
224757|NCT02214550|Painful Bladder Syndrome|painful bladder syndrome
224758|NCT02214550|Visceral Pain|visceral pain
224759|NCT02214550|Chronic Pain|chronic pain
224760|NCT02214524|perioperative hypothermia|perioperative hypothermia
224761|NCT02214524|Tympanic temperature|tympanic temperature
224762|NCT02214524|Blood loss|blood loss
224763|NCT02214524|Blood Coagulation Disorders|blood coagulation disorders
224764|NCT02214524|Major surgery|major surgery
224765|NCT02214511|major depressive disorder|major depressive disorder
224766|NCT02214511|social rejection|social rejection
224767|NCT02214511|rapid facial reaction|rapid facial reaction
224768|NCT02214511|facial mimicry|facial mimicry
224769|NCT02214511|prosocial behavior|prosocial behavior
224770|NCT02214511|inflammation|inflammation
224771|NCT02214511|self esteem|self esteem
224772|NCT02214498|Dipper|dipper
224773|NCT02214498|Non-dipper|non-dipper
224774|NCT02214498|Chronopharmacology|chronopharmacology
224775|NCT02214485|frailty|frailty
224776|NCT02214485|exercise|exercise
224777|NCT02214485|intervention|intervention
224778|NCT02214472|Rumination síndrome|rumination síndrome
224779|NCT02214472|Regurgitation|regurgitation
224780|NCT02214472|Vomiting|vomiting
224781|NCT02214472|Biofeedback|biofeedback
224782|NCT02214472|Electromyography|electromyography
225981|NCT02208895|glucometer|glucometer
224783|NCT02214472|Abdominal accommodation|abdominal accommodation
224784|NCT02214459|mHealth|mhealth
224785|NCT02214459|Hypertension|hypertension
224786|NCT02214459|Mobile|mobile
224787|NCT02214459|smartphone|smartphone
224788|NCT02214459|diet|diet
224789|NCT02214459|lifestyle|lifestyle
224790|NCT02214459|bluetooth|bluetooth
224791|NCT02214459|physical acitvity|physical acitvity
224792|NCT02214459|behavior change|behavior change
224793|NCT02214459|motivational interviewing|motivational interviewing
224794|NCT02214446|truth telling|truth telling
224795|NCT02214446|hope|hope
224796|NCT02214446|quality of life|quality of life
224797|NCT02214446|care burden|care burden
224798|NCT02214446|children with cancer|children with cancer
224799|NCT02214433|Antibiotic|antibiotic
224800|NCT02214433|Antibiotic Resistant Bacterial Infection|antibiotic resistant bacterial infection
224801|NCT02214381|breast cancer|breast cancer
224802|NCT02214381|elderly|elderly
224803|NCT02214329|Postural Balance|postural balance
224804|NCT02214329|Gait|gait
224805|NCT02214329|Fall risk|fall risk
224806|NCT02214303|Allergic asthma|allergic asthma
224807|NCT02214303|Allergic rhinitis|allergic rhinitis
224808|NCT02214303|Healthy subjects|healthy subjects
224809|NCT02214290|Cardiovascular|cardiovascular
224810|NCT02214290|Caffeine|caffeine
224811|NCT02214290|L-citrulline|l-citrulline
224812|NCT02214290|Arterial Function|arterial function
224813|NCT02214290|Hemodynamics|hemodynamics
224814|NCT02214290|Blood Pressure|blood pressure
224815|NCT02214290|Pulse Wave Velocity|pulse wave velocity
224816|NCT02214290|Pulse Wave Analysis|pulse wave analysis
224817|NCT02214277|Embolic Protection|embolic protection
224818|NCT02214277|Edwards SAPIEN THV|edwards sapien thv
224819|NCT02214277|Edwards SAPIEN XT|edwards sapien xt
224820|NCT02214277|TAVR|tavr
224821|NCT02214277|Transfemoral|transfemoral
224822|NCT02214277|Transapical|transapical
224823|NCT02214277|Heart Valve Diseases|heart valve diseases
224824|NCT02214277|Heart Diseases|heart diseases
224825|NCT02214277|TAVI|tavi
224826|NCT02214277|Aortic Stenosis|aortic stenosis
224827|NCT02214277|Aortic Valve|aortic valve
224828|NCT02214277|Transcatheter Heart Valve|transcatheter heart valve
224829|NCT02214251|Parkinson's disease|parkinson's disease
224830|NCT02214251|freezing of gait|freezing of gait
224831|NCT02214251|movement disorders|movement disorders
224832|NCT02214251|neuroscience|neuroscience
224833|NCT02214251|neural|neural
224834|NCT02214251|mechanism|mechanism
224835|NCT02214212|traumatic brain injury|traumatic brain injury
224836|NCT02214212|TBI|tbi
224837|NCT02214212|Sleep|sleep
224838|NCT02214212|Bright White Light Therapy|bright white light therapy
224839|NCT02214212|Red Light Therapy|red light therapy
224840|NCT02214212|Recovery|recovery
224841|NCT02214212|Central Nervous System Diseases|central nervous system diseases
224842|NCT02214212|Brain Diseases|brain diseases
224843|NCT02214212|Nervous System Diseases|nervous system diseases
224844|NCT02214212|Signs and Symptoms|signs and symptoms
224845|NCT02214212|Rehabilitation|rehabilitation
224846|NCT02214212|Actigraphy|actigraphy
224847|NCT02214199|Shoulder Pain|shoulder pain
224848|NCT02214199|Shoulder Impingement Syndrome|shoulder impingement syndrome
224849|NCT02214199|Exercise therapy|exercise therapy
224850|NCT02214199|Randomized Controlled Trial|randomized controlled trial
224851|NCT02214186|Pre-Eclampsia|pre-eclampsia
224852|NCT02214186|Acute Kidney Injury|acute kidney injury
224853|NCT02214186|Fluid Therapy|fluid therapy
224854|NCT02214186|Anesthesia, Spinal|anesthesia, spinal
224855|NCT02214173|HIV, BRM4, hydrolyzed rice bran, metabolic syndrome|hiv, brm4, hydrolyzed rice bran, metabolic syndrome
224856|NCT02214160|Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD)|long-chain fatty acid oxidation disorders (lc-faod)
224857|NCT02214160|carnitine palmitoyltransferase (CPT I or CPT II) deficiency|carnitine palmitoyltransferase (cpt i or cpt ii) deficiency
224858|NCT02214160|very long chain acyl-CoA dehydrogenase (VLCAD) deficiency|very long chain acyl-coa dehydrogenase (vlcad) deficiency
224859|NCT02214160|long-chain 3-hydroxy-acyl-CoA dehydrogenase (LCHAD) deficiency|long-chain 3-hydroxy-acyl-coa dehydrogenase (lchad) deficiency
224860|NCT02214160|trifunctional protein (TFP) deficiency|trifunctional protein (tfp) deficiency
224861|NCT02214160|carnitine-acylcarnitine translocase (CACT) deficiency|carnitine-acylcarnitine translocase (cact) deficiency
224862|NCT02214160|Triheptanoin|triheptanoin
224863|NCT02214160|UX007|ux007
224864|NCT02214160|C7|c7
224865|NCT02214147|Alisertib|alisertib
224866|NCT02214147|MLN8237|mln8237
224867|NCT02214147|Relapsed/refractory lymphoma|relapsed/refractory lymphoma
224868|NCT02214134|Lung cancer|lung cancer
224869|NCT02214134|Malignant pleural mesothelioma|malignant pleural mesothelioma
224870|NCT02214134|Thymic malignancy|thymic malignancy
224871|NCT02214134|Biomarkers|biomarkers
224872|NCT02214134|Screening|screening
224873|NCT02214121|sickle cell anemia|sickle cell anemia
224874|NCT02214121|paediatric|paediatric
224875|NCT02214108|BMI|bmi
224876|NCT02214108|Obesity|obesity
224877|NCT02214108|overweight|overweight
224878|NCT02214108|child|child
224879|NCT02214108|Physical activity|physical activity
224880|NCT02214095|Cytokines|cytokines
224881|NCT02214095|interleukin-1β|interleukin-1β
224882|NCT02214095|chronic periodontitis|chronic periodontitis
224883|NCT02214095|host modulation|host modulation
224884|NCT02214095|glucosamine sulphate.|glucosamine sulphate.
224885|NCT02214056|mobile screening team|mobile screening team
224886|NCT02214056|feasibility|feasibility
224887|NCT02214030|Femoral compression device|femoral compression device
224888|NCT02214030|manual compression|manual compression
224889|NCT02214030|arterial hemostasis|arterial hemostasis
224890|NCT02214030|coronary intervention|coronary intervention
224891|NCT02214030|coronary artery disease|coronary artery disease
224892|NCT02214017|diabetes|diabetes
224893|NCT02214017|telemedicine|telemedicine
224894|NCT02214017|glycemia|glycemia
224895|NCT02214017|lipids|lipids
224896|NCT02214017|blood pressure|blood pressure
224897|NCT02214004|Breast cancer|breast cancer
224898|NCT02214004|HER2|her2
224899|NCT02214004|ER|er
224900|NCT02214004|Postmenopausal|postmenopausal
224901|NCT02214004|Trastuzumab|trastuzumab
224902|NCT02214004|Letrozole|letrozole
224903|NCT02214004|Neoadjuvant endocrine treatment|neoadjuvant endocrine treatment
224904|NCT02213991|Breast Cancer|breast cancer
224905|NCT02213991|Breast Conservative Surgery|breast conservative surgery
224906|NCT02213991|Intraoperative Radiotherapy|intraoperative radiotherapy
224907|NCT02213991|Local Toxicity|local toxicity
224908|NCT02213991|Whole breast radiotherapy|whole breast radiotherapy
224909|NCT02213965|Intravenous Catheter|intravenous catheter
224910|NCT02213965|Vasofix safety|vasofix safety
224911|NCT02213965|Introcan safety|introcan safety
224912|NCT02213952|Ulcer|ulcer
224913|NCT02213952|Platelet-Rich Plasma|platelet-rich plasma
224914|NCT02213939|Myocardial revascularization|myocardial revascularization
224915|NCT02213939|Cytosorb|cytosorb
224916|NCT02213939|Inflammatory response|inflammatory response
224917|NCT02213939|Cardiopulmonary bypass|cardiopulmonary bypass
224918|NCT02213926|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
224919|NCT02213926|Btk|btk
224920|NCT02213926|Mantle Cell Lymphoma|mantle cell lymphoma
224921|NCT02213926|MCL|mcl
224922|NCT02213926|ACP-196|acp-196
224923|NCT02213926|Acalabrutinib|acalabrutinib
224924|NCT02213926|ACE-LY-004|ace-ly-004
224925|NCT02213900|delirium|delirium
224926|NCT02213900|confusion|confusion
224927|NCT02213900|surgery|surgery
224928|NCT02213900|cognitive Impairment|cognitive impairment
224929|NCT02213900|post-traumatic Stress disorder|post-traumatic stress disorder
224930|NCT02213900|depression|depression
224931|NCT02213900|anxiety|anxiety
224932|NCT02213887|Drug Interactions|drug interactions
224933|NCT02213887|Pantoprazole|pantoprazole
224934|NCT02213887|Proton Pump Inhibitors|proton pump inhibitors
224935|NCT02213887|Psychotropic Drugs|psychotropic drugs
224936|NCT02213887|Antipsychotic Agents|antipsychotic agents
224937|NCT02213887|Aripiprazole|aripiprazole
224938|NCT02213887|Asenapine|asenapine
224939|NCT02213887|Clozapine|clozapine
224940|NCT02213887|Lurasidone|lurasidone
224941|NCT02213887|Olanzapine|olanzapine
224942|NCT02213887|9-hydroxy-risperidone|9-hydroxy-risperidone
224943|NCT02213887|Quetiapine|quetiapine
224944|NCT02213887|Risperidone|risperidone
224945|NCT02213887|Ziprasidone|ziprasidone
224946|NCT02213887|Valproic Acid|valproic acid
224947|NCT02213887|Lithium|lithium
224948|NCT02213887|Gastrins|gastrins
224949|NCT02213887|Psychotic Disorders|psychotic disorders
224950|NCT02213887|Gastroesophageal Reflux|gastroesophageal reflux
224951|NCT02213874|Pregnant Women|pregnant women
224952|NCT02213874|Women's Health|women's health
224953|NCT02213874|Contraception|contraception
224954|NCT02213874|Trust in Health Care|trust in health care
224955|NCT02213861|CTCL|ctcl
224956|NCT02213861|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
224957|NCT02213861|Early-stage|early-stage
224958|NCT02213861|SHAPE|shape
224959|NCT02213861|SHP-141|shp-141
224960|NCT02213861|topical|topical
224961|NCT02213861|Histone deacetylase inhibitor|histone deacetylase inhibitor
224962|NCT02213861|CAILS|cails
224963|NCT02213861|mSWAT|mswat
224964|NCT02213861|mycosis fungoides|mycosis fungoides
224965|NCT02213848|Neuromuscular blockade reversal|neuromuscular blockade reversal
224966|NCT02213848|TOF ratio|tof ratio
224967|NCT02213848|Calcium chloride|calcium chloride
224968|NCT02213835|Crohn's disease and Ulcerative colitis|crohn's disease and ulcerative colitis
224969|NCT02213822|genome|genome
224970|NCT02213822|transcriptome|transcriptome
224971|NCT02213822|molecular|molecular
224972|NCT02213822|proteome|proteome
224973|NCT02213822|oncogenic mutations|oncogenic mutations
224974|NCT02213822|sequencing|sequencing
224975|NCT02213822|solid tumor|solid tumor
224976|NCT02213822|hematological malignancy|hematological malignancy
224977|NCT02213822|cancer|cancer
224978|NCT02213822|analysis|analysis
224979|NCT02213822|genetic|genetic
224980|NCT02213822|mutation|mutation
224981|NCT02213796|meropenem, early phase, severe sepsis and septic shock, critically ill, population pharmacokinetics|meropenem, early phase, severe sepsis and septic shock, critically ill, population pharmacokinetics
224983|NCT02213783|Febrile neutropenia|febrile neutropenia
224984|NCT02213783|Gram-negative infection|gram-negative infection
224985|NCT02213783|Pharmacodynamic|pharmacodynamic
224986|NCT02213783|Monte Carlo Simulation|monte carlo simulation
224987|NCT02213757|Hematuria|hematuria
224988|NCT02213757|Menopause|menopause
224989|NCT02213757|Urinalysis|urinalysis
224990|NCT02213744|HER2-positive|her2-positive
224991|NCT02213744|HER2+|her2+
224992|NCT02213744|HER2|her2
224993|NCT02213744|Locally Advanced Breast Cancer|locally advanced breast cancer
224994|NCT02213744|Metastatic Breast Cancer|metastatic breast cancer
224995|NCT02213744|trastuzumab|trastuzumab
224996|NCT02213744|Herceptin|herceptin
224997|NCT02213744|pertuzumab|pertuzumab
224998|NCT02213744|ado-trastuzumab emtansine|ado-trastuzumab emtansine
224999|NCT02213744|TDM-1|tdm-1
225000|NCT02213744|Perjeta|perjeta
225001|NCT02213744|Kadcyla|kadcyla
225002|NCT02213731|Atrial Fibrillation|atrial fibrillation
225003|NCT02213731|Persistent Atrial Fibrillation|persistent atrial fibrillation
225004|NCT02213731|Cryoablation|cryoablation
225005|NCT02213731|Cryoballoon|cryoballoon
225006|NCT02213731|Pulmonary Vein Isolation|pulmonary vein isolation
225007|NCT02213718|Desflurane|desflurane
225008|NCT02213718|myocardial function|myocardial function
225009|NCT02213718|Coronary Artery Bypass Surgery|coronary artery bypass surgery
225010|NCT02213705|SYSTEMIC SCLERODERMA|systemic scleroderma
225011|NCT02213705|TRANSPLANTATION|transplantation
225012|NCT02213705|ALLOGENEIC MESENCHYMAL STEM CELLS|allogeneic mesenchymal stem cells
225013|NCT02213705|ADULT|adult
225014|NCT02213692|Liver Resection|liver resection
225015|NCT02213692|Harmonic Scalpel|harmonic scalpel
225016|NCT02213692|Crush-clamping|crush-clamping
225017|NCT02213692|A Prospective Randomized Study|a prospective randomized study
225018|NCT02213679|Creatine|creatine
225019|NCT02213679|Guanidinoacetic acid|guanidinoacetic acid
225020|NCT02213679|Intervention|intervention
225021|NCT02213679|Fatigue|fatigue
225022|NCT02213679|Muscle strength|muscle strength
225023|NCT02213666|Atrial fibrillation ablation|atrial fibrillation ablation
225024|NCT02213666|Intracardiac echocardiography|intracardiac echocardiography
225025|NCT02213666|Thrombus|thrombus
225026|NCT02213666|Left atrial appendage|left atrial appendage
225027|NCT02213666|Right atrial appendage|right atrial appendage
225028|NCT02213653|Functional iron deficiency|functional iron deficiency
225029|NCT02213653|Metastatic|metastatic
225030|NCT02213640|Neurologic neglect syndrome|neurologic neglect syndrome
225031|NCT02213640|post stroke|post stroke
225032|NCT02213640|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
225033|NCT02213640|prismatic adaptation|prismatic adaptation
225034|NCT02213627|Corifollitropin alfa, recombinant FSH, HP-hMG, apoptosis, oocyte donation|corifollitropin alfa, recombinant fsh, hp-hmg, apoptosis, oocyte donation
225035|NCT02213601|Yoga|yoga
225036|NCT02213601|Complementary and Alternative Medicine Interventions|complementary and alternative medicine interventions
225037|NCT02213601|Treatment|treatment
225038|NCT02213601|Postpartum Depression|postpartum depression
225039|NCT02213588|Antioxidant|antioxidant
225040|NCT02213575|Resistent Hypertension|resistent hypertension
225041|NCT02213536|Metastatic brain cancer|metastatic brain cancer
225042|NCT02213536|Whole brain radiotherapy|whole brain radiotherapy
225043|NCT02213536|Scalp sparing whole brain radiotherapy|scalp sparing whole brain radiotherapy
225044|NCT02213536|Prophylactic whole brain radiotherapy|prophylactic whole brain radiotherapy
225045|NCT02213523|antioxidant|antioxidant
225046|NCT02213510|pacemaker|pacemaker
225047|NCT02213510|implantable cardioverter defibrillator|implantable cardioverter defibrillator
225048|NCT02213510|ICD|icd
225049|NCT02213510|surgical wound closure|surgical wound closure
225050|NCT02213510|sutures|sutures
225051|NCT02213510|Zipline|zipline
225052|NCT02213510|Zips|zips
225053|NCT02213510|CIED|cied
225054|NCT02213510|cardiovascular implantable electronic devices|cardiovascular implantable electronic devices
225055|NCT02213510|arrhythmia|arrhythmia
225056|NCT02213497|Patients with esophageal cancer to be treated with concurrent preoperative chemoradiation with carboplatin and paclitaxel.|patients with esophageal cancer to be treated with concurrent preoperative chemoradiation with carboplatin and paclitaxel.
225057|NCT02213484|aortopathy syndrome|aortopathy syndrome
225058|NCT02213484|aortic aneurysm|aortic aneurysm
225059|NCT02213484|aortic dissection|aortic dissection
225060|NCT02213484|connective tissue disorder|connective tissue disorder
225061|NCT02213458|Pragmatic Clinical Trial|pragmatic clinical trial
225062|NCT02213458|Family Caregivers|family caregivers
225063|NCT02213458|Patient Care Management|patient care management
225064|NCT02213432|influenza vaccine|influenza vaccine
225065|NCT02213432|cancer|cancer
225066|NCT02213419|Cystic Tumors of the Pancreas|cystic tumors of the pancreas
225067|NCT02213419|Endoscopic Ultrasound|endoscopic ultrasound
225068|NCT02213419|Ethanol|ethanol
225069|NCT02213393|undernutrition|undernutrition
225070|NCT02213393|nutritional status|nutritional status
225071|NCT02213393|elderly patients|elderly patients
225072|NCT02213393|protein|protein
225073|NCT02213393|enriched products|enriched products
225074|NCT02213393|recovery|recovery
225075|NCT02213393|physical function|physical function
225076|NCT02213393|quality of life|quality of life
225077|NCT02213393|activities of daily living|activities of daily living
225079|NCT02213380|general anesthesia|general anesthesia
225080|NCT02213380|regional anesthesia|regional anesthesia
225081|NCT02213380|elderly patient|elderly patient
225082|NCT02213380|hip fracture|hip fracture
225083|NCT02213354|Influenza, H7N9, Elderly, Vaccine, MF59 Adjuvant|influenza, h7n9, elderly, vaccine, mf59 adjuvant
225084|NCT02213341|Milk Allergy|milk allergy
225085|NCT02213341|Egg Allergy|egg allergy
225086|NCT02213341|Peanut Allergy|peanut allergy
225087|NCT02213341|Infant Vaccination|infant vaccination
225088|NCT02213315|Healthy Volunteers, Rheumatoid Arthritis, mavrilimumab|healthy volunteers, rheumatoid arthritis, mavrilimumab
225089|NCT02213302|premedication|premedication
225090|NCT02213302|preoperative anxiety|preoperative anxiety
225091|NCT02213302|salivary cortisol level|salivary cortisol level
225092|NCT02213302|anxiety visual analog scale|anxiety visual analog scale
225093|NCT02213289|Gastric|gastric
225094|NCT02213289|Esophagogastric|esophagogastric
225095|NCT02213276|Glucose infusion|glucose infusion
225096|NCT02213276|Bone markers|bone markers
225097|NCT02213276|Inflammatory markers|inflammatory markers
225098|NCT02213263|rituximab|rituximab
225099|NCT02213263|follicular lymphoma|follicular lymphoma
225100|NCT02213263|Non-Hodgkin lymphoma|non-hodgkin lymphoma
225101|NCT02213263|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
225102|NCT02213224|Perindopril,Telmisartan, Efficacy, NAFLD|perindopril,telmisartan, efficacy, nafld
225103|NCT02213211|Malawi|malawi
225104|NCT02213211|Case management|case management
225105|NCT02213211|Rapid diagnostic tests|rapid diagnostic tests
225106|NCT02213211|Artemether lumefantrine|artemether lumefantrine
225107|NCT02213211|School children|school children
225108|NCT02213211|School health services|school health services
225109|NCT02213211|Attendance|attendance
225110|NCT02213211|Anaemia|anaemia
225111|NCT02213211|Parasitic diseases|parasitic diseases
225112|NCT02213198|Serious mental illness transitions shared decision making|serious mental illness transitions shared decision making
225113|NCT02213185|Sterile water injections|sterile water injections
225114|NCT02213185|Pain|pain
225115|NCT02213185|VAS|vas
225116|NCT02213185|Complementary method|complementary method
225117|NCT02213172|IBS|ibs
225118|NCT02213172|Probiotic|probiotic
225119|NCT02213172|Constipation|constipation
225120|NCT02213172|Bifidobacterium longum|bifidobacterium longum
225121|NCT02213172|Lactobacillus paracasei|lactobacillus paracasei
225122|NCT02213172|Lallemand Health Solutions|lallemand health solutions
225123|NCT02213159|Dexmedetomidine|dexmedetomidine
225124|NCT02213159|bariatric surgery|bariatric surgery
225125|NCT02213159|postoperative pain|postoperative pain
225126|NCT02213159|morphine consumption|morphine consumption
225127|NCT02213159|Quality of recovery|quality of recovery
225128|NCT02213133|Squamous|squamous
225129|NCT02213133|SCC|scc
225130|NCT02213133|Carcinoma|carcinoma
225131|NCT02213133|KPT-330|kpt-330
225132|NCT02213133|SINE|sine
225133|NCT02213133|Selinexor|selinexor
225134|NCT02213133|Karyopharm|karyopharm
225135|NCT02213133|Karyopharm Therapeutics|karyopharm therapeutics
225136|NCT02213133|Lung|lung
225137|NCT02213133|Head|head
225138|NCT02213133|Neck|neck
225139|NCT02213133|Esophageal|esophageal
225140|NCT02213120|Vertigo, Dizziness|vertigo, dizziness
225141|NCT02213107|prostate|prostate
225142|NCT02213094|preeclampsia|preeclampsia
225143|NCT02213094|pregnancy-induced hypertension|pregnancy-induced hypertension
225144|NCT02213094|nicotinamide|nicotinamide
225145|NCT02213081|Endometriosis|endometriosis
225146|NCT02213081|chronic pelvic pain|chronic pelvic pain
225147|NCT02213081|dysmenorrhea|dysmenorrhea
225148|NCT02213081|dyschezia|dyschezia
225149|NCT02213081|bleeding|bleeding
225150|NCT02213081|ulipristal|ulipristal
225151|NCT02213081|progesterone|progesterone
225152|NCT02213068|Kidney|kidney
225153|NCT02213068|Renal|renal
225154|NCT02213068|Transplant|transplant
225155|NCT02213068|EBV|ebv
225156|NCT02213068|Immunosuppressants|immunosuppressants
225157|NCT02213068|Belatacept|belatacept
225158|NCT02213055|Lice|lice
225159|NCT02213042|biomarker|biomarker
225160|NCT02213042|Lapatinib|lapatinib
225161|NCT02213042|Prosigna|prosigna
225162|NCT02213042|ErbB2|erbb2
225163|NCT02213042|PAM50|pam50
225164|NCT02213042|HER2|her2
225165|NCT02213042|HER2-overexpressing metastatic breast cancer|her2-overexpressing metastatic breast cancer
225166|NCT02213042|HER2-enriched|her2-enriched
225167|NCT02213042|Trastuzumab|trastuzumab
225168|NCT02213029|epelsiban|epelsiban
225169|NCT02213029|pharmacokinetics|pharmacokinetics
225170|NCT02213029|patient reported pain / discomfort|patient reported pain / discomfort
225171|NCT02213029|pharmacodynamics|pharmacodynamics
225172|NCT02213029|oxytocin infusions|oxytocin infusions
225173|NCT02213029|Uterine contractions|uterine contractions
225174|NCT02213016|Stimulation magnetic transcranial, major depression, cognitive impairment|stimulation magnetic transcranial, major depression, cognitive impairment
225175|NCT02213003|islet transplantation|islet transplantation
225176|NCT02212990|Fever|fever
225177|NCT02212990|Antipyretics|antipyretics
225178|NCT02212990|Acetaminophen|acetaminophen
225179|NCT02212990|Ibuprofen|ibuprofen
225180|NCT02212990|Influenza vaccine|influenza vaccine
225181|NCT02212990|Influenza|influenza
225182|NCT02212990|Body temperature changes|body temperature changes
225183|NCT02212990|Signs and symptoms|signs and symptoms
225184|NCT02212977|Port Catheter|port catheter
225185|NCT02212977|Octyl 2-cyanoacrylate|octyl 2-cyanoacrylate
225186|NCT02212977|2-octylcyanoacrylate|2-octylcyanoacrylate
225187|NCT02212964|Radiation Injury|radiation injury
225188|NCT02212964|Radiation Necrosis|radiation necrosis
225189|NCT02212964|Ultra-high field MRI|ultra-high field mri
225190|NCT02212964|Susceptibility Weighted Imaging|susceptibility weighted imaging
225191|NCT02212964|Post-treatment radiographic imaging change|post-treatment radiographic imaging change
225192|NCT02212912|acute ischemic stroke, performance measure, acute treatment|acute ischemic stroke, performance measure, acute treatment
225193|NCT02212899|Spinal Surgery|spinal surgery
225194|NCT02212899|Spinal Fusion|spinal fusion
225195|NCT02212899|Deformity Correction|deformity correction
225196|NCT02212899|Spinal Instrumentation|spinal instrumentation
225197|NCT02212886|Glatiramer acetate|glatiramer acetate
225198|NCT02212886|Copaxone|copaxone
225199|NCT02212886|Multiple sclerosis|multiple sclerosis
225200|NCT02212886|Relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
225201|NCT02212886|RRMS|rrms
225202|NCT02212886|GA Depot|ga depot
225203|NCT02212886|Monthly injection|monthly injection
225204|NCT02212873|school based intervention|school based intervention
225205|NCT02212873|overweight|overweight
225206|NCT02212873|obese|obese
225207|NCT02212873|BMI z score|bmi z score
225208|NCT02212873|fat mass|fat mass
225209|NCT02212860|neoadjuvant|neoadjuvant
225210|NCT02212860|radiation|radiation
225211|NCT02212860|breast|breast
225212|NCT02212860|cancer|cancer
225213|NCT02212860|hypofractionation|hypofractionation
225214|NCT02212860|stereotactic|stereotactic
225215|NCT02212860|preoperative|preoperative
225216|NCT02212834|Breast|breast
225217|NCT02212834|Cancer|cancer
225218|NCT02212834|Surveillance|surveillance
225219|NCT02212834|Imaging|imaging
225220|NCT02212834|Comparative|comparative
225221|NCT02212834|Effectiveness|effectiveness
225222|NCT02212808|Cluster-randomized crossover trial|cluster-randomized crossover trial
225223|NCT02212808|Antimicrobial stewardship|antimicrobial stewardship
225224|NCT02212808|Community hospitals|community hospitals
225225|NCT02212808|Feasibility|feasibility
225226|NCT02212795|healthy|healthy
225227|NCT02212782|Healthy|healthy
225228|NCT02212769|healthy|healthy
225229|NCT02212756|healthy|healthy
225230|NCT02212717|Acute cholecystitis|acute cholecystitis
225231|NCT02212717|EUS-guided gallbladder drainage|eus-guided gallbladder drainage
225232|NCT02212717|Percutaneous cholecystostomy|percutaneous cholecystostomy
225233|NCT02212704|vestibular|vestibular
225234|NCT02212704|proprioception|proprioception
225235|NCT02212704|spatial orientation|spatial orientation
225236|NCT02212704|bayesian|bayesian
225237|NCT02212691|Sickle Cell|sickle cell
225238|NCT02212652|Bariatric surgery|bariatric surgery
225239|NCT02212652|Vitamin D deficiency|vitamin d deficiency
225240|NCT02212652|Vitamin D insufficiency|vitamin d insufficiency
225241|NCT02212652|Adverse surgical outcomes|adverse surgical outcomes
225242|NCT02212652|Clinical outcomes|clinical outcomes
225243|NCT02212639|Kaposi' s sarcoma|kaposi' s sarcoma
225244|NCT02212639|Digoxin|digoxin
225245|NCT02212613|Major Depressive Disorder|major depressive disorder
225246|NCT02212613|Mental Disorders, nonpsychotic episode, antipsychotic|mental disorders, nonpsychotic episode, antipsychotic
225247|NCT02212613|Mood Disorder, psychotic disorder|mood disorder, psychotic disorder
225248|NCT02212587|inhaled antibiotics|inhaled antibiotics
225249|NCT02212574|Wnt|wnt
225250|NCT02212574|Medulloblastoma|medulloblastoma
225251|NCT02212574|Chemotherapy|chemotherapy
225252|NCT02212548|SpaceOAR Hydrogel Image Guided Modulated Radiotherapy|spaceoar hydrogel image guided modulated radiotherapy
225253|NCT02212535|Sickle cell disease|sickle cell disease
225254|NCT02212535|Open monocenter study|open monocenter study
225255|NCT02212535|Phase I/II|phase i/ii
225256|NCT02212535|hematopoietic stem cells|hematopoietic stem cells
225257|NCT02212535|Plerixafor|plerixafor
225258|NCT02212522|Diabetes Mellitus|diabetes mellitus
225259|NCT02212522|Insulin-Dependent|insulin-dependent
225260|NCT02212522|Genome-Wide Association Study|genome-wide association study
225261|NCT02212522|Environment-Wide Association Study|environment-wide association study
225262|NCT02212522|Predisposition|predisposition
225263|NCT02212522|Complications|complications
225264|NCT02212483|Asthma|asthma
225265|NCT02212483|Medical Indoor Environment Counselors|medical indoor environment counselors
225266|NCT02212483|Pediatric|pediatric
225267|NCT02212483|Environment|environment
225268|NCT02212483|Clinical effectiveness|clinical effectiveness
225269|NCT02212483|Economical impact|economical impact
225270|NCT02212444|plantar fasciitis|plantar fasciitis
225271|NCT02212444|dynamic elastomeric fabric orthoses (DEFO)|dynamic elastomeric fabric orthoses (defo)
225272|NCT02212444|feasibility|feasibility
225273|NCT02212444|Physiotherapy|physiotherapy
225274|NCT02212444|Musculoskeletal|musculoskeletal
225275|NCT02212431|Cystic Fibrosis|cystic fibrosis
225276|NCT02212431|Cysteamine|cysteamine
225277|NCT02212431|Pharmacokinetics|pharmacokinetics
225278|NCT02212405|Deep rTMS|deep rtms
225279|NCT02212405|Insular cortex|insular cortex
225280|NCT02212405|PET|pet
225281|NCT02212405|[11C]-PHNO|[11c]-phno
225282|NCT02212392|acute pancreatitis|acute pancreatitis
225283|NCT02212379|Raltegravir|raltegravir
225284|NCT02212379|Etravirine|etravirine
225285|NCT02212379|aged, 45 and over|aged, 45 and over
225286|NCT02212379|Viral load|viral load
225287|NCT02212379|Efficacy|efficacy
225288|NCT02212379|Safety|safety
225289|NCT02212366|TDCS|tdcs
225290|NCT02212366|Depression|depression
225291|NCT02212366|Brain Stimulation|brain stimulation
225292|NCT02212366|Memory|memory
225293|NCT02212366|Cognition|cognition
225294|NCT02212366|EEG|eeg
225295|NCT02212340|propofol|propofol
225296|NCT02212340|desflurane|desflurane
225297|NCT02212340|quality of recovery|quality of recovery
225298|NCT02212340|vitrectomy|vitrectomy
225299|NCT02212327|Na+ MRI|na+ mri
225300|NCT02212327|salt stores|salt stores
225301|NCT02212314|Response Inhibition, Williams Syndrome|response inhibition, williams syndrome
225302|NCT02212275|ASD|asd
225303|NCT02212275|autism|autism
225304|NCT02212275|typical development|typical development
225305|NCT02212275|sensory testing|sensory testing
225306|NCT02212275|the cortical metric|the cortical metric
225307|NCT02212249|soluble VE-cadherin|soluble ve-cadherin
225308|NCT02212249|antibody|antibody
225309|NCT02212249|systemic slerosis|systemic slerosis
225310|NCT02212236|Distress|distress
225311|NCT02212236|Depression|depression
225312|NCT02212236|Anxiety|anxiety
225313|NCT02212236|Stress|stress
225314|NCT02212236|Coping|coping
225315|NCT02212236|Illness perceptions|illness perceptions
225316|NCT02212236|Stem cell transplantation|stem cell transplantation
225317|NCT02212236|Bone marrow transplantation|bone marrow transplantation
225318|NCT02212223|Vitamin D|vitamin d
225319|NCT02212223|Serum 25-hydroxyvitamin D (25OHD)|serum 25-hydroxyvitamin d (25ohd)
225320|NCT02212223|Dietary supplement|dietary supplement
225321|NCT02212223|Ethnicity|ethnicity
225322|NCT02212223|Immigrant|immigrant
225323|NCT02212197|prostate cancer|prostate cancer
225324|NCT02212197|leuprolide|leuprolide
225325|NCT02212184|Diaphragm|diaphragm
225326|NCT02212184|COPD|copd
225327|NCT02212184|Musculoskeletal Manipulations|musculoskeletal manipulations
225328|NCT02212184|Ultrasonography|ultrasonography
225329|NCT02212184|Optoelectronic Plethysmography.|optoelectronic plethysmography.
225330|NCT02212158|Type 1 diabetes|type 1 diabetes
225331|NCT02212158|adolescents|adolescents
225332|NCT02212158|HA1c|ha1c
225333|NCT02212158|psychological intervention|psychological intervention
225334|NCT02212145|prevention|prevention
225335|NCT02212145|cardiovascular disease|cardiovascular disease
225336|NCT02212145|risk factors|risk factors
225337|NCT02212132|metamemory|metamemory
225338|NCT02212132|memory complaints|memory complaints
225339|NCT02212132|performance mnemonic|performance mnemonic
225340|NCT02212132|cancer|cancer
225341|NCT02212119|Dementia|dementia
225342|NCT02212119|Paratonia|paratonia
225343|NCT02212119|Caregiver Burden|caregiver burden
225344|NCT02212119|Botulinum toxin|botulinum toxin
225345|NCT02212093|Pneumonia, mechanical ventilation, ICU, mortality|pneumonia, mechanical ventilation, icu, mortality
225346|NCT02212041|electronic cigarettes|electronic cigarettes
225347|NCT02212041|smoking|smoking
225348|NCT02212041|schizophrenia|schizophrenia
225349|NCT02212041|serious mental illness|serious mental illness
225350|NCT02212028|ST-elevation myocardial infarction|st-elevation myocardial infarction
225351|NCT02212028|prasugrel|prasugrel
225352|NCT02212028|pharmacodynamic|pharmacodynamic
225353|NCT02212028|pharmacokinetic|pharmacokinetic
225354|NCT02212002|Group B Streptococcus|group b streptococcus
225355|NCT02212002|Intrapartum Antibiotic Prophylaxis|intrapartum antibiotic prophylaxis
225356|NCT02212002|term infants|term infants
225357|NCT02212002|vaginal delivery|vaginal delivery
225358|NCT02212002|gut microbiota|gut microbiota
225359|NCT02212002|feeding|feeding
225360|NCT02212002|molecular analysis|molecular analysis
225361|NCT02212002|real-time PCR|real-time pcr
225362|NCT02211846|Pharmacokinetics|pharmacokinetics
225363|NCT02211846|Mirabegron|mirabegron
225364|NCT02211846|Neurogenic detrusor overactivity (NDO)|neurogenic detrusor overactivity (ndo)
225365|NCT02211846|Overactive bladder (OAB)|overactive bladder (oab)
225366|NCT02211820|Encephalopathy|encephalopathy
225367|NCT02211820|Imaging Studies|imaging studies
225368|NCT02211820|Dementia|dementia
225369|NCT02211820|Cerebellar Cortical Atrophy|cerebellar cortical atrophy
225370|NCT02211794|Total Knee Arthroplasty|total knee arthroplasty
225371|NCT02211794|degenerative joint disease|degenerative joint disease
225372|NCT02211781|Tribal Communities|tribal communities
225373|NCT02211781|Radiation|radiation
225374|NCT02211781|Cancer|cancer
225375|NCT02211768|Genetic Analysis|genetic analysis
225376|NCT02211768|Biopsy|biopsy
225377|NCT02211768|FDG-PET|fdg-pet
225378|NCT02211768|FLT-PET|flt-pet
225379|NCT02211755|Purine Nucleoside Inhibitor|purine nucleoside inhibitor
225380|NCT02211755|Proteasome Inhibitor|proteasome inhibitor
225381|NCT02211755|Combination Treatment|combination treatment
225382|NCT02211755|Solid Tumors|solid tumors
225383|NCT02211755|Hematologic|hematologic
225384|NCT02211742|dapagliflozin|dapagliflozin
225385|NCT02211742|fasting glucose|fasting glucose
225386|NCT02211742|postprandial glucose excursion|postprandial glucose excursion
225387|NCT02211742|euglycemic hyperinsulinemic clamp|euglycemic hyperinsulinemic clamp
225388|NCT02211742|euglycemic oral glucose tolerance test|euglycemic oral glucose tolerance test
225389|NCT02211703|perioperative hypothermia|perioperative hypothermia
225390|NCT02211703|Epidemiology|epidemiology
225391|NCT02211703|Tympanic temperature|tympanic temperature
225392|NCT02211651|adipose tissue|adipose tissue
225393|NCT02211651|placenta|placenta
225394|NCT02211651|pregnancy|pregnancy
225395|NCT02211651|umbilical cord|umbilical cord
225396|NCT02211638|Drug Therapy|drug therapy
225397|NCT02211625|Healthy|healthy
225398|NCT02211625|Pharmacodynamics (PD)|pharmacodynamics (pd)
225399|NCT02211625|Pharmacokinetics (PK)|pharmacokinetics (pk)
225400|NCT02211612|Overfeeding|overfeeding
225401|NCT02211612|Weight gain|weight gain
225402|NCT02211612|Liver fat|liver fat
225403|NCT02211612|Pancreatic fat|pancreatic fat
225404|NCT02211612|Ectopic fat|ectopic fat
225405|NCT02211612|Skeletal muscle|skeletal muscle
225406|NCT02211612|Adipose tissue|adipose tissue
225407|NCT02211612|Gene expression|gene expression
225408|NCT02211612|DNA methylation|dna methylation
225409|NCT02211612|Palmitate|palmitate
225410|NCT02211612|Linoleic acid|linoleic acid
225411|NCT02211612|Saturated fat|saturated fat
225412|NCT02211612|Polyunsaturated fat|polyunsaturated fat
225413|NCT02211612|Metabolism|metabolism
225414|NCT02211612|Insulin sensitivity|insulin sensitivity
225415|NCT02211599|protein|protein
225416|NCT02211599|carbohydrate|carbohydrate
225417|NCT02211599|lipid|lipid
225418|NCT02211599|oxidation|oxidation
225419|NCT02211599|fat|fat
225420|NCT02211599|sugar|sugar
225421|NCT02211599|juice|juice
225422|NCT02211599|obesity|obesity
225423|NCT02211573|Autonomic Nervous System, Body composition, Oxygen Uptake,|autonomic nervous system, body composition, oxygen uptake,
225424|NCT02211573|Water Based Physical Training.|water based physical training.
225425|NCT02211534|Pulsed Electromagnetic Energy Fields|pulsed electromagnetic energy fields
225426|NCT02211534|Total Knee Arthroplasty|total knee arthroplasty
225427|NCT02211534|Pain Intensity|pain intensity
225428|NCT02211521|Osteoarthritis, platelet-rich plasma, hyaluronic acid|osteoarthritis, platelet-rich plasma, hyaluronic acid
225429|NCT02211508|fibromyalgia|fibromyalgia
225430|NCT02211508|pain|pain
225431|NCT02211508|stimulation|stimulation
225432|NCT02211482|HIV-1 infected patients|hiv-1 infected patients
225433|NCT02211482|dual therapy|dual therapy
225434|NCT02211456|Endocardial pacing|endocardial pacing
225435|NCT02211456|Multi site pacing|multi site pacing
225436|NCT02211443|Full human anti-EGFR monoclonal antibody (SCT200) ;|full human anti-egfr monoclonal antibody (sct200) ;
225437|NCT02211443|metastatic colorectal cancer （mCRC）;|metastatic colorectal cancer （mcrc）;
225438|NCT02211443|Escalating doses ;|escalating doses ;
225439|NCT02211443|single dose and multiple doses;|single dose and multiple doses;
225440|NCT02211443|safety, tolerability and pharmacokinetics.|safety, tolerability and pharmacokinetics.
225441|NCT02211430|smoking cessation|smoking cessation
225442|NCT02211430|pregnancy|pregnancy
225443|NCT02211430|postpartum|postpartum
225444|NCT02211430|intervention|intervention
225445|NCT02211391|Nighttime Eating|nighttime eating
225446|NCT02211391|Protein|protein
225447|NCT02211391|Obesity|obesity
225448|NCT02211391|Lipolysis|lipolysis
225449|NCT02211391|Metabolism|metabolism
225450|NCT02211378|stress|stress
225451|NCT02211378|performance|performance
225452|NCT02211378|cortisol|cortisol
225453|NCT02211365|Hypertension|hypertension
225454|NCT02211365|CVD|cvd
225455|NCT02211352|blood pressure, ginseng|blood pressure, ginseng
225456|NCT02211339|Social skills|social skills
225457|NCT02211339|Social communication|social communication
225458|NCT02211339|Cognitive communication|cognitive communication
225459|NCT02211339|Traumatic brain injury|traumatic brain injury
225460|NCT02211339|Acquired brain injury|acquired brain injury
225461|NCT02211339|Communication partner training|communication partner training
225462|NCT02211339|Peer partner training|peer partner training
225463|NCT02211339|Peer mentoring|peer mentoring
225464|NCT02211339|Rating scales|rating scales
225465|NCT02211339|Rehabilitation|rehabilitation
225466|NCT02211326|AF or DVT|af or dvt
225467|NCT02211326|Age Over 18 Years, Acquired|age over 18 years, acquired
225468|NCT02211300|glucose monitoring|glucose monitoring
225469|NCT02211300|OptiScanner|optiscanner
225470|NCT02211287|Dementia|dementia
225471|NCT02211287|Decision-making|decision-making
225472|NCT02211287|Communication|communication
225473|NCT02211287|Advance Care Planning|advance care planning
225474|NCT02211274|Quality of Life|quality of life
225475|NCT02211274|Nursing Homes|nursing homes
225476|NCT02211274|Housing for the Elderly|housing for the elderly
225477|NCT02211274|Homes for the Aged|homes for the aged
225478|NCT02211261|first in human|first in human
225479|NCT02211261|single dose|single dose
225480|NCT02211261|multiple dose|multiple dose
225481|NCT02211261|escalation|escalation
225482|NCT02211261|safety study|safety study
225483|NCT02211261|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
225484|NCT02211248|Cardiac Frequency Variability|cardiac frequency variability
225485|NCT02211248|multidisciplinary care|multidisciplinary care
225486|NCT02211248|clinical trial|clinical trial
225487|NCT02211235|Cystic Fibrosis|cystic fibrosis
225488|NCT02211235|Healthy Controls|healthy controls
225489|NCT02211235|Diabetes|diabetes
225490|NCT02211235|Cystic Fibrosis Related Diabetes (CFRD)|cystic fibrosis related diabetes (cfrd)
225491|NCT02211235|CFRD|cfrd
225492|NCT02211222|Thyroid Cancer|thyroid cancer
225493|NCT02211222|Radioiodine-Refractory|radioiodine-refractory
225494|NCT02211222|Differentiated|differentiated
225495|NCT02211183|Massive Rotator Cuff Tear|massive rotator cuff tear
225496|NCT02211183|Sub-acromial spacer|sub-acromial spacer
225497|NCT02211183|Best repair of rotator cuff|best repair of rotator cuff
225498|NCT02211105|GastroEsophageal Reflux Disease|gastroesophageal reflux disease
225499|NCT02211105|Transoral Incisionless Fundoplication|transoral incisionless fundoplication
225500|NCT02211105|Laparoscopic Nissen Fundoplication|laparoscopic nissen fundoplication
225501|NCT02211092|Family Caregivers|family caregivers
225502|NCT02211092|Advanced Cancer|advanced cancer
225503|NCT02211092|Palliative Care|palliative care
225504|NCT02211092|Support|support
225505|NCT02211092|Self Care|self care
225506|NCT02211092|Physical Activity|physical activity
225507|NCT02211079|Healthy|healthy
225508|NCT02211079|JNJ-54861911|jnj-54861911
225509|NCT02211079|Caffeine|caffeine
225510|NCT02211079|Midazolam|midazolam
225511|NCT02211079|Tolbutamide|tolbutamide
225512|NCT02211079|Cytochrome P450 3A4|cytochrome p450 3a4
225513|NCT02211079|Cytochrome P450 2C9|cytochrome p450 2c9
225514|NCT02211079|Cytochrome P450 1A2|cytochrome p450 1a2
225515|NCT02211079|Alzheimer's disease|alzheimer's disease
225516|NCT02211053|Organ donation|organ donation
225517|NCT02211053|Brain dead|brain dead
225518|NCT02211053|Levothyroxine|levothyroxine
225519|NCT02211040|Intervention Mapping Protocol|intervention mapping protocol
225520|NCT02211040|physical activity|physical activity
225521|NCT02211040|fruit intake|fruit intake
225522|NCT02211040|vegetable intake|vegetable intake
225523|NCT02211040|computer tailoring|computer tailoring
225524|NCT02211040|eHealth|ehealth
225525|NCT02211040|self-regulation|self-regulation
225526|NCT02211040|goal setting|goal setting
225527|NCT02211040|problem solving|problem solving
225528|NCT02211040|general practice|general practice
225529|NCT02211027|Squamous Cell Carcinoma|squamous cell carcinoma
225530|NCT02211027|Head & Neck Cancer|head & neck cancer
225531|NCT02211027|Vaccine|vaccine
225532|NCT02211027|Carcinoma|carcinoma
225533|NCT02211027|Immunization|immunization
225534|NCT02211027|Autologous Tumor|autologous tumor
225535|NCT02211014|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
225537|NCT02211014|Multiple Myeloma|multiple myeloma
225538|NCT02211014|MM|mm
225539|NCT02211014|ACP-196|acp-196
225540|NCT02211014|acalabrutinib|acalabrutinib
225541|NCT02211001|Exercise Movement Techniques|exercise movement techniques
225542|NCT02211001|Exercise Therapy|exercise therapy
225543|NCT02211001|Physical Therapy Modalities.|physical therapy modalities.
225544|NCT02210988|Acupuncture therapy, Acute stroke, Randomized controlled trials|acupuncture therapy, acute stroke, randomized controlled trials
225545|NCT02210975|GERD|gerd
225546|NCT02210975|LES|les
225547|NCT02210975|Sleeve Gastrectomy|sleeve gastrectomy
225548|NCT02210975|Electrical Stimulation Therapy|electrical stimulation therapy
225549|NCT02210962|early psychosis|early psychosis
225550|NCT02210962|chronic schizophrenia|chronic schizophrenia
225551|NCT02210962|first episode psychosis|first episode psychosis
225552|NCT02210962|omega-3 and omega-6 essential fatty acids|omega-3 and omega-6 essential fatty acids
225553|NCT02210962|relapse prevention|relapse prevention
225554|NCT02210962|efficacy|efficacy
225555|NCT02210949|Blood transfusion|blood transfusion
225556|NCT02210949|Erythropoietin|erythropoietin
225557|NCT02210949|Iron suppletion|iron suppletion
225558|NCT02210923|Baroreflex|baroreflex
225559|NCT02210923|Electrical stimulation|electrical stimulation
225560|NCT02210923|Carotid body|carotid body
225561|NCT02210923|Chemoreceptors|chemoreceptors
225562|NCT02210923|Resistant hypertension|resistant hypertension
225563|NCT02210910|Massive Rotator Cuff Tear, Sub-acromial spacer, Best repair of rotator cuff|massive rotator cuff tear, sub-acromial spacer, best repair of rotator cuff
225564|NCT02210884|Vitamin D supplementation|vitamin d supplementation
225565|NCT02210884|Lactation|lactation
225566|NCT02210884|25 hydroxyvitamin D|25 hydroxyvitamin d
225567|NCT02210884|Breast feeding|breast feeding
225568|NCT02210845|Diabetes|diabetes
225569|NCT02210845|Supervised Exercise|supervised exercise
225570|NCT02210845|Weight loss|weight loss
225571|NCT02210832|smoking|smoking
225572|NCT02210832|pregnancy|pregnancy
225573|NCT02210832|cessation|cessation
225574|NCT02210832|incentives|incentives
225575|NCT02210819|Thromboembolism|thromboembolism
225576|NCT02210819|Embolism and Thrombosis|embolism and thrombosis
225577|NCT02210819|Vascular Diseases|vascular diseases
225578|NCT02210819|Cardiovascular Diseases|cardiovascular diseases
225579|NCT02210819|Thrombosis|thrombosis
225580|NCT02210806|Asthma|asthma
225581|NCT02210806|Mild-to-moderate persistent asthma|mild-to-moderate persistent asthma
225582|NCT02210806|Mild asthma|mild asthma
225583|NCT02210806|Moderate asthma|moderate asthma
225584|NCT02210806|Persistent asthma|persistent asthma
225585|NCT02210793|Transepithelial PRK|transepithelial prk
225586|NCT02210793|Dry eye|dry eye
225587|NCT02210793|Schirmer test|schirmer test
225588|NCT02210793|Tear break up time|tear break up time
225589|NCT02210793|Dry eye after advanced surface ablation technique|dry eye after advanced surface ablation technique
225590|NCT02210754|Nicotine|nicotine
225591|NCT02210754|Pharmacokinetics|pharmacokinetics
225592|NCT02210754|Pharmacodynamics|pharmacodynamics
225593|NCT02210754|blu e-cigs|blu e-cigs
225594|NCT02210754|Tolerability|tolerability
225595|NCT02210754|Safety|safety
225596|NCT02210754|Smoke urge|smoke urge
225597|NCT02210741|immune repertoire|immune repertoire
225598|NCT02210741|Graves' disease|graves' disease
225599|NCT02210728|cognitive behavioral therapy|cognitive behavioral therapy
225600|NCT02210728|stimulant medication|stimulant medication
225601|NCT02210728|efficacy|efficacy
225602|NCT02210728|symptoms|symptoms
225603|NCT02210728|functional outcomes|functional outcomes
225604|NCT02210663|Breast cancer|breast cancer
225605|NCT02210663|PARP|parp
225606|NCT02210663|Primary peritoneal cancer|primary peritoneal cancer
225607|NCT02210663|Fallopian tube|fallopian tube
225608|NCT02210663|Ovarian cancer|ovarian cancer
225609|NCT02210663|veliparib|veliparib
225610|NCT02210663|ABT-888|abt-888
225611|NCT02210663|BRCA|brca
225612|NCT02210650|kidney stone|kidney stone
225613|NCT02210637|Appointments and Schedules|appointments and schedules
225614|NCT02210637|Outpatient Clinics, Hospital/Economics|outpatient clinics, hospital/economics
225615|NCT02210637|Emergency Department|emergency department
225616|NCT02210637|Hospitalization|hospitalization
225617|NCT02210637|Mortality|mortality
225618|NCT02210624|Anoxic Brain Injury|anoxic brain injury
225619|NCT02210624|Autologous bone marrow derived stem cell|autologous bone marrow derived stem cell
225620|NCT02210624|stoke|stoke
225621|NCT02210598|labor, induced|labor, induced
225622|NCT02210598|catheter|catheter
225623|NCT02210598|oxytocin|oxytocin
225624|NCT02210598|Cesarean section|cesarean section
225625|NCT02210572|Intestinal microbiota|intestinal microbiota
225626|NCT02210572|Intestinal gas|intestinal gas
225627|NCT02210572|Dietary intervention|dietary intervention
225628|NCT02210572|Low-FODMAPs diet|low-fodmaps diet
225629|NCT02210572|Prebiotics|prebiotics
225630|NCT02210559|locally|locally
225631|NCT02210559|advanced|advanced
225632|NCT02210559|pancreatic|pancreatic
225633|NCT02210559|cancer|cancer
225634|NCT02210559|unresectable|unresectable
225635|NCT02210559|pancreatic cancer|pancreatic cancer
225636|NCT02210546|breast cancer|breast cancer
225637|NCT02210546|intermediate risk|intermediate risk
225638|NCT02210507|vitamin A|vitamin a
225639|NCT02210507|retinol|retinol
225640|NCT02210507|carotenoids|carotenoids
225641|NCT02210481|vitrectomy,|vitrectomy,
225642|NCT02210481|macular thinning,|macular thinning,
225643|NCT02210481|retinal detachment,|retinal detachment,
225644|NCT02210481|epimacular membrane,|epimacular membrane,
225645|NCT02210481|intravitreal glucose,|intravitreal glucose,
225646|NCT02210481|OCT|oct
225647|NCT02210468|Osteoarthritis|osteoarthritis
225648|NCT02210468|Protease Inhibitors|protease inhibitors
225649|NCT02210468|Alpha-2-macroglobulin|alpha-2-macroglobulin
225650|NCT02210468|Autologous treatment|autologous treatment
225651|NCT02210468|APIC-CF|apic-cf
225652|NCT02210468|Pain due to Mild to Moderate osteoarthritis (OA) of the knee|pain due to mild to moderate osteoarthritis (oa) of the knee
225653|NCT02210455|FASD|fasd
225654|NCT02210455|pFAS|pfas
225655|NCT02210455|ARND|arnd
225656|NCT02210455|Fetal Alcohol Syndrome|fetal alcohol syndrome
225657|NCT02210455|Partial Fetal Alcohol Syndrome|partial fetal alcohol syndrome
225658|NCT02210455|Alcohol Related Neurodevelopmental Disorder|alcohol related neurodevelopmental disorder
225659|NCT02210455|Static Encephalopathy (Alcohol Exposed)|static encephalopathy (alcohol exposed)
225660|NCT02210455|Neurobehavioural Disorder (Alcohol Exposed)|neurobehavioural disorder (alcohol exposed)
225661|NCT02210442|educational games|educational games
225662|NCT02210442|clinical practice guideline|clinical practice guideline
225663|NCT02210442|family medicine|family medicine
225664|NCT02210442|primary health care|primary health care
225665|NCT02210442|cluster clinical trial|cluster clinical trial
225666|NCT02210429|Supraclavicular Block|supraclavicular block
225667|NCT02210429|Supraclavicular Catheter|supraclavicular catheter
225668|NCT02210429|Pediatric Anesthesia|pediatric anesthesia
225669|NCT02210429|Regional Anesthesia|regional anesthesia
225670|NCT02210429|Supracondylar Elbow Fracture|supracondylar elbow fracture
225671|NCT02210390|Psycho-education, Bipolar , cultural adaptation, Pakistan|psycho-education, bipolar , cultural adaptation, pakistan
225672|NCT02210377|Auto-moxibusition, intra-dialytic hypotension, hemodialysis|auto-moxibusition, intra-dialytic hypotension, hemodialysis
225673|NCT02210325|gonorrhea|gonorrhea
225674|NCT02210325|chlamydia|chlamydia
225675|NCT02210325|solithromycin|solithromycin
225676|NCT02210299|Healthy young children (2-6 months ; 12-18 months)|healthy young children (2-6 months ; 12-18 months)
225677|NCT02210286|dementia|dementia
225678|NCT02210286|magnesium|magnesium
225679|NCT02210286|learning|learning
225680|NCT02210286|memory|memory
225681|NCT02210286|Alzheimer's disease|alzheimer's disease
225682|NCT02210273|Stress Urinary Incontinence|stress urinary incontinence
225683|NCT02210273|SUI|sui
225684|NCT02210260|Cancer|cancer
225685|NCT02210260|Colorectal|colorectal
225686|NCT02210260|Pain relief|pain relief
225687|NCT02210234|wheat bran|wheat bran
225688|NCT02210234|healthy immunity|healthy immunity
225689|NCT02210234|T cells|t cells
225690|NCT02210221|TBI|tbi
225691|NCT02210195|Cannabis Treatment|cannabis treatment
225692|NCT02210195|Alcohol Treatment|alcohol treatment
225693|NCT02210195|Alcohol-Related Disorders|alcohol-related disorders
225694|NCT02210195|Cannabis-Related Disorders|cannabis-related disorders
225695|NCT02210195|Substance-Related Disorders|substance-related disorders
225696|NCT02210195|Emend|emend
225697|NCT02210195|NK1 receptor antagonist|nk1 receptor antagonist
225698|NCT02210195|Alcohol|alcohol
225699|NCT02210195|Cannabis|cannabis
225700|NCT02210195|aprepitant|aprepitant
225701|NCT02210182|Hepatocellular carcinoma|hepatocellular carcinoma
225702|NCT02210182|Oral Pentamidine|oral pentamidine
225703|NCT02210182|Endo-exonuclease|endo-exonuclease
225704|NCT02210156|Respiratory tract infection|respiratory tract infection
225705|NCT02210156|Incidence|incidence
225706|NCT02210156|Dietary supplements|dietary supplements
225707|NCT02210156|Micronutrients|micronutrients
225708|NCT02210156|Plant extracts|plant extracts
225709|NCT02210117|Kidney Cancer|kidney cancer
225710|NCT02210117|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
225711|NCT02210117|mRCC|mrcc
225712|NCT02210117|Cytoreductive Nephrectomy|cytoreductive nephrectomy
225713|NCT02210117|Presurgical therapy|presurgical therapy
225714|NCT02210117|Nivolumab|nivolumab
225715|NCT02210117|BMS-936558|bms-936558
225716|NCT02210117|Bevacizumab|bevacizumab
225717|NCT02210117|Avastin|avastin
225718|NCT02210117|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
225719|NCT02210117|fhuMab-VEGF|fhumab-vegf
225720|NCT02210117|Ipilimumab|ipilimumab
225721|NCT02210117|Yervoy|yervoy
225722|NCT02210117|BMS-734016|bms-734016
225723|NCT02210117|MDX010|mdx010
225724|NCT02210104|Melanoma|melanoma
225725|NCT02210104|Sarcoma|sarcoma
225726|NCT02210104|Mixed round cell liposarcoma|mixed round cell liposarcoma
225727|NCT02210104|Advanced|advanced
225728|NCT02210104|Metastatic|metastatic
225729|NCT02210104|Immunotherapy|immunotherapy
225730|NCT02210104|Ipilimumab|ipilimumab
225731|NCT02210104|Yervoy|yervoy
225732|NCT02210104|BMS-734016|bms-734016
225733|NCT02210104|MDX010|mdx010
225734|NCT02210104|Cyclophosphamide|cyclophosphamide
225735|NCT02210104|Cytoxan|cytoxan
225736|NCT02210104|Neosar|neosar
225737|NCT02210104|CD4+T Cells|cd4+t cells
225738|NCT02210078|Blood And Marrow Transplantation|blood and marrow transplantation
225739|NCT02210078|Infection|infection
225740|NCT02210078|Cytomegalovirus|cytomegalovirus
225741|NCT02210078|CMV|cmv
225742|NCT02210078|Stem cell transplant|stem cell transplant
225743|NCT02210078|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
225744|NCT02210078|HSCT|hsct
225745|NCT02210078|Human Leukocyte Antigen|human leukocyte antigen
225746|NCT02210078|HLA|hla
225747|NCT02210078|Cytotoxic T-Lymphocytes|cytotoxic t-lymphocytes
225748|NCT02210078|CTL|ctl
225749|NCT02210065|Leukemia|leukemia
225750|NCT02210065|Lymphoma|lymphoma
225751|NCT02210065|Blood And Marrow Transplantation|blood and marrow transplantation
225752|NCT02210065|Hematological malignancies|hematological malignancies
225753|NCT02210065|Cytotoxic T cells|cytotoxic t cells
225754|NCT02210065|CTL|ctl
225755|NCT02210065|Cytomegalovirus|cytomegalovirus
225756|NCT02210065|CMV|cmv
225757|NCT02210065|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
225758|NCT02210065|HSCT|hsct
225759|NCT02210052|radiofrequency ablation|radiofrequency ablation
225760|NCT02210039|SECM|secm
225761|NCT02210039|Esophagus|esophagus
225762|NCT02210039|Imaging|imaging
225763|NCT02210026|bubble nasal continuous positive airway pressure (Bn-CPAP)|bubble nasal continuous positive airway pressure (bn-cpap)
225764|NCT02210026|work of breathing|work of breathing
225765|NCT02210026|pressure-rate products|pressure-rate products
225766|NCT02210013|AMH, AFC, aging, ethnicity|amh, afc, aging, ethnicity
225767|NCT02210000|repeat dose|repeat dose
225768|NCT02210000|phase II|phase ii
225769|NCT02210000|GCSI-DD|gcsi-dd
225770|NCT02210000|pharmacodynamics|pharmacodynamics
225771|NCT02210000|gastroparesis|gastroparesis
225772|NCT02210000|type 1 and type 2 diabetes mellitus|type 1 and type 2 diabetes mellitus
225773|NCT02210000|camicinal|camicinal
225774|NCT02210000|GSK962040|gsk962040
225775|NCT02210000|symptoms|symptoms
225776|NCT02210000|gut motility|gut motility
225777|NCT02209974|emphysema|emphysema
225778|NCT02209974|CRP|crp
225779|NCT02209974|interleukin-8|interleukin-8
225780|NCT02209974|dynamic hyperinflation|dynamic hyperinflation
225781|NCT02209935|pediatric|pediatric
225782|NCT02209935|acute neurologic disease|acute neurologic disease
225783|NCT02209935|critical care|critical care
225784|NCT02209935|rehabilitation|rehabilitation
225785|NCT02209935|outcome|outcome
225786|NCT02209922|tDCS, stroke, postural control|tdcs, stroke, postural control
225787|NCT02209909|preoperative aspirin use|preoperative aspirin use
225788|NCT02209909|platelet activation|platelet activation
225789|NCT02209909|off pump coronary artery bypass|off pump coronary artery bypass
225790|NCT02209896|Peripheral Neuropathic Pain|peripheral neuropathic pain
225791|NCT02209896|PNP|pnp
225792|NCT02209883|sevoflurane, anesthesia, washout time,COPD|sevoflurane, anesthesia, washout time,copd
225793|NCT02209870|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
225794|NCT02209870|Teamwork|teamwork
225795|NCT02209870|electronic checklist|electronic checklist
225796|NCT02209857|Breastcancer|breastcancer
225797|NCT02209857|Adjuvant chemotherapy|adjuvant chemotherapy
225798|NCT02209857|70-gene expression profile|70-gene expression profile
225799|NCT02209857|MammaPrint|mammaprint
225800|NCT02209818|Low level laser therapy|low level laser therapy
225801|NCT02209818|Elastomeric separator|elastomeric separator
225802|NCT02209818|Placebo|placebo
225803|NCT02209818|Visual analog scale|visual analog scale
225804|NCT02209818|Laser irradiation|laser irradiation
225805|NCT02209766|Safety|safety
225806|NCT02209766|Tolerability|tolerability
225807|NCT02209766|Pharmacokinetics|pharmacokinetics
225808|NCT02209766|Pharmacodynamics|pharmacodynamics
225809|NCT02209766|D5884|d5884
225810|NCT02209766|Japanese|japanese
225811|NCT02209766|Caucasian|caucasian
225812|NCT02209740|renal toxicity, HIV, antiretroviral, outcome|renal toxicity, hiv, antiretroviral, outcome
225813|NCT02209675|hepatitis C recurrence|hepatitis c recurrence
225814|NCT02209675|Rejection|rejection
225815|NCT02209675|Liver Transplantation|liver transplantation
225816|NCT02209675|Liver biopsy|liver biopsy
225817|NCT02209662|APIC-PRP|apic-prp
225818|NCT02209662|Chronic Wounds|chronic wounds
225819|NCT02209662|Diabetic foot ulcer|diabetic foot ulcer
225820|NCT02209636|hyperphosphatemia|hyperphosphatemia
225821|NCT02209636|vascular dysfunction|vascular dysfunction
225822|NCT02209636|chronic kidney disease|chronic kidney disease
225823|NCT02209636|cardiovascular disease|cardiovascular disease
225824|NCT02209636|endothelial dysfunction|endothelial dysfunction
225825|NCT02209610|Heart Failure|heart failure
225826|NCT02209597|Major Depressive Disorder|major depressive disorder
225827|NCT02209597|MDD|mdd
225828|NCT02209597|bupropion XL|bupropion xl
225829|NCT02209597|Wellbutrin XL|wellbutrin xl
225830|NCT02209571|Breath Tests|breath tests
225831|NCT02209545|fibroids, leiomyomata, blood loss, misoprostol|fibroids, leiomyomata, blood loss, misoprostol
225832|NCT02209532|Lymph node mapping|lymph node mapping
225833|NCT02209532|Endometrial cancer|endometrial cancer
225834|NCT02209532|Uterine cancer|uterine cancer
225835|NCT02209532|Cervical cancer|cervical cancer
225836|NCT02209519|bacterial vaginosis|bacterial vaginosis
225837|NCT02209519|recurrence|recurrence
225838|NCT02209519|male partner|male partner
225839|NCT02209506|MLN3126|mln3126
225840|NCT02209493|Dietary intervention|dietary intervention
225841|NCT02209493|Hypercholesterolemic adults|hypercholesterolemic adults
225842|NCT02209493|Vegetable intake|vegetable intake
225843|NCT02209493|Functional food|functional food
225844|NCT02209493|Prevention|prevention
225845|NCT02209467|walking|walking
225846|NCT02209467|postural balance|postural balance
225847|NCT02209467|falls|falls
225848|NCT02209454|Dexketoprofen|dexketoprofen
225849|NCT02209454|Bioavailability|bioavailability
225850|NCT02209454|Comparative|comparative
225851|NCT02209454|Pharmacokinetic|pharmacokinetic
225852|NCT02209441|sorafenib, gastric cancer, FOLFOX4|sorafenib, gastric cancer, folfox4
225853|NCT02209428|Temozolomide|temozolomide
225854|NCT02209428|IDH mutation|idh mutation
225855|NCT02209428|Low grade glioma|low grade glioma
225856|NCT02209389|breast cancer|breast cancer
225857|NCT02209389|cancer associated auto antibodies|cancer associated auto antibodies
225858|NCT02209389|breast cancer blood test|breast cancer blood test
225859|NCT02209363|Parkinson's disease|parkinson's disease
225860|NCT02209363|OSA|osa
225861|NCT02209363|CPAP|cpap
225862|NCT02209363|cognition|cognition
225863|NCT02209311|Alveolar Bone Loss|alveolar bone loss
225864|NCT02209311|Alveolar Bone Atrophy|alveolar bone atrophy
225865|NCT02209311|Dental Implantation|dental implantation
225866|NCT02209311|Bone Tissue Reconstruction|bone tissue reconstruction
225867|NCT02209311|Sinus Lift|sinus lift
225868|NCT02209311|Autologous Multipotent Mesenchymal Stem Cell|autologous multipotent mesenchymal stem cell
225869|NCT02209311|Autologous MMSCs|autologous mmscs
225870|NCT02209311|Synthetic Tricalcium Phosphate|synthetic tricalcium phosphate
225871|NCT02209311|Tissue Engineered Construction|tissue engineered construction
225872|NCT02209311|Oral Mucosa|oral mucosa
225873|NCT02209285|Older adults|older adults
225874|NCT02209285|Home and community care|home and community care
225875|NCT02209285|Effectiveness|effectiveness
225876|NCT02209285|Cost analysis|cost analysis
225877|NCT02209285|Stroke|stroke
225879|NCT02209285|Hypertension|hypertension
225880|NCT02209285|Cardiovascular disease|cardiovascular disease
225881|NCT02209220|Obstructive sleep apnea|obstructive sleep apnea
225882|NCT02209220|Treatment compliance|treatment compliance
225883|NCT02209220|Automatic positive airway pressure|automatic positive airway pressure
225884|NCT02209220|Continuous positive airway pressure|continuous positive airway pressure
225885|NCT02209220|Bariatric surgery|bariatric surgery
225886|NCT02209207|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
225887|NCT02209207|endurance training|endurance training
225888|NCT02209207|interval training|interval training
225889|NCT02209207|continuous training|continuous training
225890|NCT02209207|walking training|walking training
225891|NCT02209194|aneurysms|aneurysms
225892|NCT02209194|vascular disease|vascular disease
225893|NCT02209194|E-liac Stent Graft|e-liac stent graft
225894|NCT02209194|E-liac Stent Graft System|e-liac stent graft system
225895|NCT02209194|iliac aneurysm|iliac aneurysm
225896|NCT02209194|branched stent graft|branched stent graft
225897|NCT02209194|self expanding stent graft|self expanding stent graft
225898|NCT02209181|dental pain|dental pain
225899|NCT02209181|post-surgical dental pain|post-surgical dental pain
225900|NCT02209168|AMH, ACF, VIT D, Ethnicity|amh, acf, vit d, ethnicity
225901|NCT02209142|Major depression|major depression
225902|NCT02209129|digital breast tomosynthesis|digital breast tomosynthesis
225903|NCT02209116|ADHD|adhd
225904|NCT02209116|QB Test|qb test
225905|NCT02209116|Activity|activity
225906|NCT02209116|Attention|attention
225907|NCT02209116|Children|children
225908|NCT02209116|Clinical Decision Making|clinical decision making
225909|NCT02209103|Polyphenols|polyphenols
225910|NCT02209103|Orange|orange
225911|NCT02209103|Sleep|sleep
225912|NCT02209103|Fatigue|fatigue
225913|NCT02209090|occiput-posterior|occiput-posterior
225914|NCT02209090|occipitoposterior|occipitoposterior
225915|NCT02209090|labour|labour
225916|NCT02209064|Subxiphoid|subxiphoid
225917|NCT02209064|Access|access
225918|NCT02209051|Diabetic Foot Ulcers|diabetic foot ulcers
225919|NCT02209051|AMNIOEXCEL|amnioexcel
225920|NCT02209051|Wagner Grade 1 or 2 foot ulcers|wagner grade 1 or 2 foot ulcers
225921|NCT02209051|Wound|wound
225922|NCT02209051|Foot health|foot health
225923|NCT02209051|Ulcer|ulcer
225924|NCT02209051|Foot Ulcer|foot ulcer
225925|NCT02209051|Diabetic Foot|diabetic foot
225926|NCT02209051|Foot Diseases|foot diseases
225927|NCT02209051|Skin Diseases|skin diseases
225928|NCT02209051|Leg Ulcer|leg ulcer
225929|NCT02209051|Skin Ulcer|skin ulcer
225930|NCT02209051|Diabetic Angiopathies|diabetic angiopathies
225931|NCT02209051|Vascular Diseases|vascular diseases
225932|NCT02209051|Cardiovascular Diseases|cardiovascular diseases
225933|NCT02209051|Diabetes Complications|diabetes complications
225934|NCT02209051|Diabetes Mellitus|diabetes mellitus
225935|NCT02209051|Endocrine System Diseases|endocrine system diseases
225936|NCT02209051|Diabetic Neuropathies|diabetic neuropathies
225937|NCT02209038|end stage renal disease|end stage renal disease
225938|NCT02209038|hemodialysis|hemodialysis
225939|NCT02209038|dialysis|dialysis
225940|NCT02209025|Atherosclerosis|atherosclerosis
225941|NCT02209025|Cholesterol|cholesterol
225942|NCT02209025|Cholesterol, HDL|cholesterol, hdl
225943|NCT02209025|Apolipoprotein A-I|apolipoprotein a-i
225944|NCT02209025|Theobromine|theobromine
225945|NCT02209012|Actinic Keratosis|actinic keratosis
225946|NCT02208999|medullary neurostimulation|medullary neurostimulation
225947|NCT02208999|pain|pain
225948|NCT02208999|Precision|precision
225949|NCT02208999|rechargeable|rechargeable
225950|NCT02208999|implantable|implantable
225951|NCT02208986|GnRH antagonist|gnrh antagonist
225952|NCT02208986|GnRH agonist trigger|gnrh agonist trigger
225953|NCT02208986|Oocyte donor|oocyte donor
225954|NCT02208973|Adenosine A1 receptor antagonist|adenosine a1 receptor antagonist
225955|NCT02208973|adenosine receptor modulator|adenosine receptor modulator
225956|NCT02208973|Asthma|asthma
225957|NCT02208973|COPD|copd
225958|NCT02208960|Neurodevelopment|neurodevelopment
225959|NCT02208960|Neonatal kit|neonatal kit
225960|NCT02208960|Kenya|kenya
225961|NCT02208960|Cluster Randomized Controlled Trial|cluster randomized controlled trial
225962|NCT02208960|Chlorhexidine|chlorhexidine
225963|NCT02208960|ThermoSpot|thermospot
225964|NCT02208947|advance care planning|advance care planning
225965|NCT02208947|decision making|decision making
225966|NCT02208947|patient engagement|patient engagement
225967|NCT02208947|patient education|patient education
225968|NCT02208947|financial incentives|financial incentives
225969|NCT02208947|behavioral economics|behavioral economics
225970|NCT02208934|PDE10 inhibitor|pde10 inhibitor
225971|NCT02208934|Huntington's disease|huntington's disease
225972|NCT02208934|phosphodiesterase 10 inhibitor|phosphodiesterase 10 inhibitor
225973|NCT02208934|psychiatric disorders|psychiatric disorders
225974|NCT02208921|Type 2 Diabetes|type 2 diabetes
225975|NCT02208908|Oral care|oral care
225976|NCT02208908|cancer|cancer
225977|NCT02208908|palliative|palliative
225978|NCT02208908|training|training
225982|NCT02208895|i-STAT|i-stat
225983|NCT02208869|familial hypercholesterolemia|familial hypercholesterolemia
225984|NCT02208869|cholesterol|cholesterol
225985|NCT02208869|prevention|prevention
225986|NCT02208869|registry|registry
225987|NCT02208869|atherosclerosis|atherosclerosis
225988|NCT02208869|treatment|treatment
225989|NCT02208869|prevalence|prevalence
225990|NCT02208830|bronchiectasis|bronchiectasis
225991|NCT02208830|functional capacity|functional capacity
225992|NCT02208830|lung functional|lung functional
225993|NCT02208817|capillary refill|capillary refill
225994|NCT02208817|paediatric early warning score|paediatric early warning score
225995|NCT02208817|photoplethysmography|photoplethysmography
225996|NCT02208804|Colorectal Cancer Liver Metastases|colorectal cancer liver metastases
225997|NCT02208791|Kidney Transplantation|kidney transplantation
225998|NCT02208791|Graft Rejection|graft rejection
225999|NCT02208791|Immunossupression|immunossupression
226000|NCT02208778|Osteoarthritis|osteoarthritis
226001|NCT02208778|Chronic Pain|chronic pain
226002|NCT02208778|Pain relief|pain relief
226003|NCT02208765|Coronary Circulation|coronary circulation
226004|NCT02208765|Coronary Artery Disease|coronary artery disease
226005|NCT02208765|Myocardial perfusion imaging|myocardial perfusion imaging
226006|NCT02208765|Prognosis|prognosis
226007|NCT02208752|rotator cuff tears|rotator cuff tears
226008|NCT02208752|ultrasound measure|ultrasound measure
226009|NCT02208752|pain|pain
226010|NCT02208752|range of motion|range of motion
226011|NCT02208752|muscle force|muscle force
226012|NCT02208739|Chronic periodontitis|chronic periodontitis
226013|NCT02208739|periodontal pathogens|periodontal pathogens
226014|NCT02208739|inflammatory mediators|inflammatory mediators
226015|NCT02208739|Non surgical periodontal therapy|non surgical periodontal therapy
226016|NCT02208739|Oral hygiene instructions|oral hygiene instructions
226017|NCT02208739|Polymerase chain reaction|polymerase chain reaction
226018|NCT02208739|Elisa|elisa
226019|NCT02208726|anxiety|anxiety
226020|NCT02208726|students|students
226021|NCT02208726|examinations|examinations
226022|NCT02208726|Homeopathy|homeopathy
226023|NCT02208713|FSHD muscle derived stem cell adipose derived mesenchymal stem cell intramuscular injection|fshd muscle derived stem cell adipose derived mesenchymal stem cell intramuscular injection
226024|NCT02208687|Social Participation|social participation
226025|NCT02208687|Fatigue|fatigue
226026|NCT02208687|Self-Management|self-management
226027|NCT02208687|Rehabilitation|rehabilitation
226028|NCT02208687|Physical therapy|physical therapy
226029|NCT02208687|Occupational therapy|occupational therapy
226030|NCT02208687|Group intervention|group intervention
226031|NCT02208687|Exercise|exercise
226032|NCT02208674|chronic kidney disease|chronic kidney disease
226033|NCT02208674|albuminuria|albuminuria
226034|NCT02208674|hypertension|hypertension
226035|NCT02208674|dyslipidemia|dyslipidemia
226036|NCT02208674|cardiovascular disease|cardiovascular disease
226037|NCT02208674|pragmatic trial|pragmatic trial
226038|NCT02208674|cluster randomized trial|cluster randomized trial
226039|NCT02208661|Morquio A syndrome|morquio a syndrome
226040|NCT02208661|Mucopolysaccharidosis IV A|mucopolysaccharidosis iv a
226041|NCT02208661|Psychological health|psychological health
226042|NCT02208648|coronary calcification|coronary calcification
226043|NCT02208648|Computed Tomography|computed tomography
226044|NCT02208648|Coronary artery calcium|coronary artery calcium
226045|NCT02208648|calcium scores|calcium scores
226046|NCT02208648|post-operative mortality|post-operative mortality
226047|NCT02208635|Zinc Absorption|zinc absorption
226048|NCT02208635|Biofortification|biofortification
226049|NCT02208635|Maize|maize
226050|NCT02208635|Zambia|zambia
226051|NCT02208635|Stable isotopes of Zn|stable isotopes of zn
226052|NCT02208622|Zinc absorption|zinc absorption
226053|NCT02208622|Iron Absorption|iron absorption
226054|NCT02208622|Whey Protein|whey protein
226055|NCT02208622|Mexico|mexico
226056|NCT02208622|Stable isotopes|stable isotopes
226057|NCT02208609|Zinc Absorption|zinc absorption
226058|NCT02208609|Maize|maize
226059|NCT02208609|Amaranth|amaranth
226060|NCT02208609|Guatemala|guatemala
226061|NCT02208609|Stable isotopes of Zn|stable isotopes of zn
226062|NCT02208583|Molecular phenotypic；CRPC; personalized treatment|molecular phenotypic；crpc; personalized treatment
226063|NCT02208570|Hypotension during anesthesia induction|hypotension during anesthesia induction
226064|NCT02208557|Incisional hernia|incisional hernia
226065|NCT02208557|prevention|prevention
226066|NCT02208557|laparotomy closure|laparotomy closure
226067|NCT02208557|absorbable mesh|absorbable mesh
226068|NCT02208544|Thyroid Nodule|thyroid nodule
226069|NCT02208544|Indeterminate Cytology|indeterminate cytology
226070|NCT02208544|FDG-PET/CT|fdg-pet/ct
226071|NCT02208544|Diagnostic Thyroid Surgery|diagnostic thyroid surgery
226072|NCT02208544|Efficacy|efficacy
226073|NCT02208544|Cost-Effectiveness|cost-effectiveness
226074|NCT02208544|Quality-of-Life|quality-of-life
226075|NCT02208544|Thyroidectomy|thyroidectomy
226076|NCT02208531|Early Childhood Development (ECD)|early childhood development (ecd)
226077|NCT02208531|Psychosocial stimulation|psychosocial stimulation
226078|NCT02208531|Malnutrition|malnutrition
226079|NCT02208531|Bangladesh|bangladesh
226080|NCT02208531|Scaling up ECD|scaling up ecd
226081|NCT02208518|Endoscopic Ultrasound elastography|endoscopic ultrasound elastography
226082|NCT02208518|Quantitative elastography|quantitative elastography
226083|NCT02208518|Qualitative elastography|qualitative elastography
226084|NCT02208518|Endoscopic Ultrasound|endoscopic ultrasound
226085|NCT02208518|Elastography|elastography
226086|NCT02208492|Levetiracetam, Carabamazepine|levetiracetam, carabamazepine
226087|NCT02208479|cardiac surgery|cardiac surgery
226088|NCT02208479|diaphragm dysfunction|diaphragm dysfunction
226089|NCT02208479|mechanical ventilation weaning|mechanical ventilation weaning
226090|NCT02208479|respiratory paralysis|respiratory paralysis
226091|NCT02208479|muscle weakness|muscle weakness
226092|NCT02208479|cardiac bypass|cardiac bypass
226093|NCT02208479|valvular surgery|valvular surgery
226094|NCT02208479|respiratory insufficiency|respiratory insufficiency
226095|NCT02208466|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
226096|NCT02208466|rTMS|rtms
226097|NCT02208466|TMS|tms
226098|NCT02208466|fluoxetine|fluoxetine
226099|NCT02208453|Massive Rotator Cuff Tear|massive rotator cuff tear
226100|NCT02208453|Local anesthesia|local anesthesia
226101|NCT02208453|Sub-acromial spacer|sub-acromial spacer
226102|NCT02208440|Massive Rotator Cuff Tear, Sub-acromial spacer, Best repair of rotator cuff|massive rotator cuff tear, sub-acromial spacer, best repair of rotator cuff
226103|NCT02208427|isoniazid, LTBI, rifapentine, TST|isoniazid, ltbi, rifapentine, tst
226104|NCT02208414|Food Allergies|food allergies
226105|NCT02208388|Computed tomography perfusion|computed tomography perfusion
226106|NCT02208388|Fractional flow reserve|fractional flow reserve
226107|NCT02208375|Breast Cancer|breast cancer
226108|NCT02208375|Malignant Female Reproductive System Neoplasm|malignant female reproductive system neoplasm
226109|NCT02208375|Recurrent endometrial cancer|recurrent endometrial cancer
226110|NCT02208375|Recurrent endometrial adenocarcinoma|recurrent endometrial adenocarcinoma
226111|NCT02208375|Triple negative breast cancer|triple negative breast cancer
226112|NCT02208375|Ovarian cancer|ovarian cancer
226113|NCT02208375|Primary peritoneal cancer|primary peritoneal cancer
226114|NCT02208375|Fallopian tube cancer|fallopian tube cancer
226115|NCT02208375|Olaparib|olaparib
226116|NCT02208375|AZD2014|azd2014
226117|NCT02208375|AZD5363|azd5363
226118|NCT02208362|chimeric antigen receptor|chimeric antigen receptor
226119|NCT02208362|glioblastoma|glioblastoma
226120|NCT02208349|intubation, video laryngoscopy, direct laryngoscopy, prehospital, emergency medical services|intubation, video laryngoscopy, direct laryngoscopy, prehospital, emergency medical services
226121|NCT02208323|Hypoxia|hypoxia
226122|NCT02208323|Respiratory Distress|respiratory distress
226123|NCT02208310|Crohn's disease|crohn's disease
226124|NCT02208310|Vitamin D deficiency|vitamin d deficiency
226125|NCT02208284|Single Ascending Dose|single ascending dose
226126|NCT02208284|healthy subjects|healthy subjects
226127|NCT02208284|Hyperlipidemia|hyperlipidemia
226128|NCT02208284|Lipid Metabolism Disorders|lipid metabolism disorders
226129|NCT02208284|Metabolic Diseases|metabolic diseases
226130|NCT02208271|tissue necrosis|tissue necrosis
226131|NCT02208271|metal on metal total hip|metal on metal total hip
226132|NCT02208271|biomarker|biomarker
226133|NCT02208258|fecal incontinence, consure medical, semi formed stool, stool management system|fecal incontinence, consure medical, semi formed stool, stool management system
226134|NCT02208232|IOL rotation|iol rotation
226135|NCT02208219|Stroke|stroke
226136|NCT02208219|Paresis|paresis
226137|NCT02208219|Upper extremity|upper extremity
226138|NCT02208219|Motor deficits|motor deficits
226139|NCT02208219|Music Therapy|music therapy
226140|NCT02208219|Neurorehabilitation|neurorehabilitation
226141|NCT02208206|Neuropathic pain|neuropathic pain
226142|NCT02208206|Phenotype|phenotype
226143|NCT02208206|Genotype|genotype
226144|NCT02208206|Biomarkers|biomarkers
226145|NCT02208206|HIV|hiv
226146|NCT02208206|Diabetes mellitus|diabetes mellitus
226147|NCT02208206|Breast cancer|breast cancer
226148|NCT02208206|Genomics|genomics
226149|NCT02208206|Quantitative sensory testing|quantitative sensory testing
226150|NCT02208193|Alzheimer disease Art Healing gardens Discourse analysis|alzheimer disease art healing gardens discourse analysis
226151|NCT02208180|Return of results|return of results
226152|NCT02208180|Genomics|genomics
226153|NCT02208167|Antigen Expanded Specific T Cell Therapy|antigen expanded specific t cell therapy
226154|NCT02208167|HXTC|hxtc
226155|NCT02208167|Antiretroviral Therapy|antiretroviral therapy
226156|NCT02208167|Acute HIV infection|acute hiv infection
226157|NCT02208167|Chronic HIV infection|chronic hiv infection
226158|NCT02208167|Leukapheresis|leukapheresis
226159|NCT02208154|ICU acquired bacteraemia|icu acquired bacteraemia
226160|NCT02208154|colonization|colonization
226161|NCT02208154|decolonization|decolonization
226162|NCT02208154|selective decontamination|selective decontamination
226163|NCT02208154|multidrug resistant bacteria|multidrug resistant bacteria
226164|NCT02208141|children|children
226165|NCT02208141|obesity|obesity
226166|NCT02208141|adipose tissue dysfunction|adipose tissue dysfunction
226167|NCT02208141|inflammation|inflammation
226168|NCT02208141|macrophage infiltration|macrophage infiltration
226169|NCT02208141|insulin resistance|insulin resistance
226170|NCT02208141|dyslipidemia|dyslipidemia
226171|NCT02208128|Renal cell carcinoma|renal cell carcinoma
226172|NCT02208128|Biomarkers|biomarkers
226173|NCT02208128|Molecular modifications|molecular modifications
226174|NCT02208115|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
226175|NCT02208115|Exercise|exercise
226176|NCT02208115|Appetite|appetite
226177|NCT02208102|atrial fibrillation, catheter ablation, blood-biomarkers|atrial fibrillation, catheter ablation, blood-biomarkers
226178|NCT02208089|Keratoconus|keratoconus
226179|NCT02208089|Corneal collagen cross-linking|corneal collagen cross-linking
226180|NCT02208089|Photorefractive keratectomy|photorefractive keratectomy
226181|NCT02208076|Growth disorders|growth disorders
226182|NCT02208076|Saizen|saizen
226183|NCT02208076|Easypod|easypod
226184|NCT02208076|Growth hormone|growth hormone
226185|NCT02208076|Pediatric subject|pediatric subject
226186|NCT02208063|Bacteremia|bacteremia
226187|NCT02208063|Staphylococcus aureus|staphylococcus aureus
226188|NCT02208050|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
226189|NCT02208050|Primary Progressive Multiple Sclerosis|primary progressive multiple sclerosis
226190|NCT02208050|Multiple Sclerosis|multiple sclerosis
226191|NCT02208050|Upper limb function|upper limb function
226192|NCT02208050|Mobility|mobility
226193|NCT02208050|Fampridine|fampridine
226194|NCT02208050|DASH|dash
226195|NCT02208050|AMSQ|amsq
226196|NCT02208050|MSWS-12|msws-12
226197|NCT02208050|MSIS-29|msis-29
226198|NCT02208050|SF-36|sf-36
226199|NCT02208050|9HPT|9hpt
226200|NCT02208050|25FTW|25ftw
226201|NCT02208050|JTT|jtt
226202|NCT02208037|Acute Lymphoblastic Leukemia/Lymphoma|acute lymphoblastic leukemia/lymphoma
226203|NCT02208037|Acute Myelogenous Leukemia|acute myelogenous leukemia
226204|NCT02208037|Mantel-Cell Lymphoma|mantel-cell lymphoma
226205|NCT02208037|Hematopoietic Transplant|hematopoietic transplant
226206|NCT02208037|GVHD Prophylaxis|gvhd prophylaxis
226207|NCT02207998|osteoarthritis, physiotherapy, homeopathy, complex|osteoarthritis, physiotherapy, homeopathy, complex
226208|NCT02207985|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
226209|NCT02207985|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
226210|NCT02207972|Pregnant|pregnant
226211|NCT02207972|labor|labor
226212|NCT02207972|Epidural|epidural
226213|NCT02207959|Gastric cancer|gastric cancer
226214|NCT02207959|Neoplasia|neoplasia
226215|NCT02207959|Endoscopic imaging|endoscopic imaging
226216|NCT02207959|In vivo imaging|in vivo imaging
226217|NCT02207933|anterioposterior|anterioposterior
226218|NCT02207933|weight|weight
226219|NCT02207933|shifting|shifting
226220|NCT02207933|training|training
226221|NCT02207933|patient|patient
226222|NCT02207894|Haemophilia A, factor VIII, development of inhibitor|haemophilia a, factor viii, development of inhibitor
226223|NCT02207881|herpes labialis|herpes labialis
226224|NCT02207881|cold sore|cold sore
226225|NCT02207829|COPD|copd
226226|NCT02207829|inhaler critical errors|inhaler critical errors
226227|NCT02207829|double-dummy|double-dummy
226228|NCT02207829|novel dry powder inhaler|novel dry powder inhaler
226229|NCT02207829|inhaler preference|inhaler preference
226230|NCT02207829|tiotropium|tiotropium
226231|NCT02207829|umeclidinium|umeclidinium
226232|NCT02207829|long-acting muscarinic antagonist|long-acting muscarinic antagonist
226233|NCT02207816|Infants|infants
226234|NCT02207816|Efficacy|efficacy
226235|NCT02207816|Children|children
226236|NCT02207816|Malaria|malaria
226237|NCT02207816|Plasmodium falciparum|plasmodium falciparum
226238|NCT02207816|Safety|safety
226239|NCT02207816|Surveillance|surveillance
226240|NCT02207816|Immunogenicity|immunogenicity
226241|NCT02207816|RTS,S/AS01E|rts,s/as01e
226242|NCT02207816|Africa|africa
226243|NCT02207803|Brain Injuries|brain injuries
226244|NCT02207803|Caregivers|caregivers
226245|NCT02207803|Intervention Studies|intervention studies
226246|NCT02207803|Latin America|latin america
226247|NCT02207790|Clinical Trial, Phase I|clinical trial, phase i
226248|NCT02207790|Healthy Volunteers|healthy volunteers
226249|NCT02207777|Obesity|obesity
226250|NCT02207777|Roux-en-Y gastric bypass (RYGB)|roux-en-y gastric bypass (rygb)
226251|NCT02207777|Type 2 Diabetes|type 2 diabetes
226252|NCT02207777|Sleeve Gastrectomy (SG)|sleeve gastrectomy (sg)
226253|NCT02207777|Weight Loss|weight loss
226254|NCT02207777|Low-Calorie Diet|low-calorie diet
226255|NCT02207751|Chronic Kidney Disease|chronic kidney disease
226256|NCT02207751|Peritoneal Dialysis Access|peritoneal dialysis access
226257|NCT02207751|Peritoneal Dialysis Catheter|peritoneal dialysis catheter
226258|NCT02207751|Catheter Function|catheter function
226259|NCT02207738|acne|acne
226260|NCT02207738|acne scar|acne scar
226261|NCT02207738|microneedling radiofrequency|microneedling radiofrequency
226262|NCT02207738|bipolar radiofrequency|bipolar radiofrequency
226263|NCT02207725|Andexanet alpha|andexanet alpha
226264|NCT02207725|Anticoagulation|anticoagulation
226265|NCT02207725|Antidote|antidote
226266|NCT02207725|Apixaban|apixaban
226267|NCT02207725|Anti-fXa inhibitor|anti-fxa inhibitor
226268|NCT02207725|PRT4445|prt4445
226269|NCT02207725|Eliquis|eliquis
226270|NCT02207725|Reversal agent|reversal agent
226271|NCT02207712|Diabetes|diabetes
226272|NCT02207712|Macular Oedema|macular oedema
226273|NCT02207712|Diabetic retinopathy|diabetic retinopathy
226274|NCT02207712|Noctura|noctura
226275|NCT02207686|CNS hemangioblastoma|cns hemangioblastoma
226276|NCT02207686|Renal Cell Carcinoma|renal cell carcinoma
226277|NCT02207686|VHL germline mutation|vhl germline mutation
226278|NCT02207686|VHL somatic mutation|vhl somatic mutation
226279|NCT02207686|Tumor development|tumor development
226280|NCT02207673|epilepsy surgery|epilepsy surgery
226281|NCT02207673|biomarker|biomarker
226282|NCT02207673|high frequency oscillations (HFOs)|high frequency oscillations (hfos)
226283|NCT02207673|acute electrocorticography (aECoG)|acute electrocorticography (aecog)
226284|NCT02207660|cisplatin|cisplatin
226285|NCT02207660|Cervical cancer|cervical cancer
226286|NCT02207660|metastasis|metastasis
226287|NCT02207660|recurrence|recurrence
226288|NCT02207634|High cholesterol|high cholesterol
226289|NCT02207634|Treatment for high cholesterol|treatment for high cholesterol
226290|NCT02207634|Lowering cholesterol|lowering cholesterol
226291|NCT02207634|Lowering high cholesterol|lowering high cholesterol
226292|NCT02207634|Hypercholesterolemia|hypercholesterolemia
226293|NCT02207621|Glaucoma|glaucoma
226294|NCT02207608|BCG|bcg
226295|NCT02207608|hyaluronic acid|hyaluronic acid
226296|NCT02207608|non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
226297|NCT02207608|non bacterial cystitis|non bacterial cystitis
226298|NCT02207582|depression; trns|depression; trns
226299|NCT02207556|AL amyloidosis|al amyloidosis
226300|NCT02207556|amyloidosis|amyloidosis
226301|NCT02207556|light chain amyloidosis|light chain amyloidosis
226302|NCT02207543|Cancer|cancer
226303|NCT02207543|Palliative care|palliative care
226304|NCT02207543|home|home
226305|NCT02207530|Head and neck cancer; SCCHN|head and neck cancer; scchn
226306|NCT02207517|convergence insufficiency|convergence insufficiency
226307|NCT02207517|vision therapy|vision therapy
226308|NCT02207517|reading|reading
226309|NCT02207517|attention|attention
226310|NCT02207504|Castration-resistant Prostate Cancer|castration-resistant prostate cancer
226311|NCT02207491|Glaucoma|glaucoma
226312|NCT02207478|Electromagnetic navigation bronchoscopy with a guide sheath|electromagnetic navigation bronchoscopy with a guide sheath
226313|NCT02207478|Transbronchial lung biopsy|transbronchial lung biopsy
226314|NCT02207478|Peripheral lung lesions|peripheral lung lesions
226315|NCT02207478|Solitary pulmonary nodule|solitary pulmonary nodule
226316|NCT02207452|Hyperpolarised helium-3|hyperpolarised helium-3
226317|NCT02207452|Lung Imaging|lung imaging
226318|NCT02207452|Magnetic Resonance Imaging|magnetic resonance imaging
226319|NCT02207426|Healthy volunteers|healthy volunteers
226320|NCT02207413|Quadrivalent influenza vaccine|quadrivalent influenza vaccine
226321|NCT02207413|Safety|safety
226322|NCT02207413|Children|children
226323|NCT02207413|Adults|adults
226324|NCT02207413|Immunogenicity|immunogenicity
226325|NCT02207322|Hematopoietic stem cell transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
226326|NCT02207322|autologous stem cell transplant|autologous stem cell transplant
226327|NCT02207322|allogeneic stem cell transplant|allogeneic stem cell transplant
226328|NCT02207309|high-risk soft tissue sarcoma|high-risk soft tissue sarcoma
226329|NCT02207309|pazopanib|pazopanib
226330|NCT02207309|retroperitoneal soft tissue sarcoma|retroperitoneal soft tissue sarcoma
226331|NCT02207309|visceral soft tissue sarcoma|visceral soft tissue sarcoma
226332|NCT02207309|votrient|votrient
226333|NCT02207270|Coronary artery disease|coronary artery disease
226334|NCT02207270|Costs|costs
226335|NCT02207270|Cost minimization|cost minimization
226336|NCT02207270|Percutaneous coronary intervention|percutaneous coronary intervention
226337|NCT02207270|Risk score|risk score
226338|NCT02207270|Same day discharge|same day discharge
226339|NCT02207257|PER977|per977
226340|NCT02207257|anticoagulation reversal|anticoagulation reversal
226341|NCT02207257|pharmacokinetics|pharmacokinetics
226342|NCT02207257|edoxaban|edoxaban
226343|NCT02207257|whole blood clotting time|whole blood clotting time
226344|NCT02207257|D-dimer|d-dimer
226345|NCT02207257|prothrombin fragments 1 and 2|prothrombin fragments 1 and 2
226346|NCT02207257|tissue factor pathway inhibitor|tissue factor pathway inhibitor
226347|NCT02207257|prothrombin time|prothrombin time
226348|NCT02207244|Psoriasis|psoriasis
226349|NCT02207244|Plaque-type psoriasis|plaque-type psoriasis
226350|NCT02207244|Guselkumab|guselkumab
226351|NCT02207244|Adalimumab|adalimumab
226352|NCT02207244|CNTO 1959|cnto 1959
226353|NCT02207244|Monoclonal antibody|monoclonal antibody
226354|NCT02207231|Psoriasis|psoriasis
226355|NCT02207231|Plaque-type psoriasis|plaque-type psoriasis
226356|NCT02207231|Guselkumab|guselkumab
226357|NCT02207231|Adalimumab|adalimumab
226358|NCT02207231|CNTO 1959|cnto 1959
226359|NCT02207231|Monoclonal antibody|monoclonal antibody
226360|NCT02207192|obesity, lung volumes, postural changes|obesity, lung volumes, postural changes
226361|NCT02207179|Intraoperative|intraoperative
226362|NCT02207179|Cancer margin|cancer margin
226363|NCT02207179|Spectroscopy|spectroscopy
226364|NCT02207179|Polarization|polarization
226365|NCT02207166|hypertension|hypertension
226366|NCT02207166|device|device
226367|NCT02207166|errors|errors
226368|NCT02207166|human factor engineering|human factor engineering
226369|NCT02207166|usability engineering|usability engineering
226370|NCT02207153|Chronic Hemodialysis|chronic hemodialysis
226371|NCT02207153|Chronic Peritoneal Dialysis|chronic peritoneal dialysis
226372|NCT02207127|obstructive sleep apnea|obstructive sleep apnea
226373|NCT02207127|sleep apnea|sleep apnea
226374|NCT02207114|Sepsis|sepsis
226375|NCT02207114|Systemic Inflammatory Response Syndrome (SIRS)|systemic inflammatory response syndrome (sirs)
226376|NCT02207114|Antibiotic use|antibiotic use
226377|NCT02207114|Intensive Care Unit|intensive care unit
226378|NCT02207101|Young athletes|young athletes
226379|NCT02207101|Cardiac endurance|cardiac endurance
226380|NCT02207101|Herbal|herbal
226381|NCT02207101|Ejection Fraction|ejection fraction
226382|NCT02207101|Basic Research|basic research
226383|NCT02207101|Cardiovascular Injury|cardiovascular injury
226384|NCT02207088|Chronic Hepatitis C|chronic hepatitis c
226385|NCT02207088|Hepatitis C|hepatitis c
226386|NCT02207088|End-stage renal disease|end-stage renal disease
226387|NCT02207088|Hepatitis C Genotype 1|hepatitis c genotype 1
226388|NCT02207088|Severe Renal Impairment|severe renal impairment
226389|NCT02207088|renal disease|renal disease
226390|NCT02207088|Compensated Cirrhosis|compensated cirrhosis
226391|NCT02207088|Renal impairment|renal impairment
226392|NCT02207088|dialysis|dialysis
226393|NCT02207088|Hepatitis C Virus|hepatitis c virus
226394|NCT02207088|cirrhosis|cirrhosis
226395|NCT02207075|SPMS|spms
226396|NCT02207075|Myelin Water Fraction|myelin water fraction
226397|NCT02207075|activated microglia|activated microglia
226398|NCT02207036|Tobacco|tobacco
226399|NCT02207036|cigarettes|cigarettes
226400|NCT02207036|cessation|cessation
226401|NCT02207036|intervention|intervention
226402|NCT02207036|young adults|young adults
226403|NCT02207036|Internet|internet
226404|NCT02207036|social media|social media
226405|NCT02207036|mobile health|mobile health
226406|NCT02207023|Stroke|stroke
226407|NCT02207023|Telehealth|telehealth
226408|NCT02207023|Rehabilitation|rehabilitation
226409|NCT02207023|Stroke Coach|stroke coach
226410|NCT02207023|Randomized controlled trial|randomized controlled trial
226411|NCT02207023|Lifestyle behaviours|lifestyle behaviours
226412|NCT02207023|Secondary prevention|secondary prevention
226413|NCT02207023|Chronic disease self-management|chronic disease self-management
226414|NCT02207010|Glioblastoma|glioblastoma
226415|NCT02207010|GBM|gbm
226416|NCT02207010|first recurrence|first recurrence
226417|NCT02206997|perioperative hypothermia|perioperative hypothermia
226418|NCT02206997|prewarming|prewarming
226419|NCT02206997|treatment guideline|treatment guideline
226420|NCT02206958|Toileting disability|toileting disability
226421|NCT02206958|Functional urinary incontinence|functional urinary incontinence
226422|NCT02206958|Urinary incontinence|urinary incontinence
226423|NCT02206958|Frailty|frailty
226424|NCT02206958|Physical activity|physical activity
226425|NCT02206932|Hepatitis C|hepatitis c
226426|NCT02206932|HIV|hiv
226427|NCT02206932|Simeprevir|simeprevir
226428|NCT02206932|Sofosbuvir|sofosbuvir
226429|NCT02206919|Flow mediated dilation|flow mediated dilation
226430|NCT02206919|Magnetic Resonance Imaging MRI|magnetic resonance imaging mri
226431|NCT02206919|Diabetes|diabetes
226432|NCT02206919|Endothelial dysfunction|endothelial dysfunction
226433|NCT02206919|Popliteal artery|popliteal artery
226434|NCT02206919|Atherosclerosis|atherosclerosis
226435|NCT02206919|Cardiovascular disease|cardiovascular disease
226436|NCT02206919|Vascular disease|vascular disease
226437|NCT02206906|Medication Adherence|medication adherence
226438|NCT02206906|Incentives|incentives
226439|NCT02206906|Real-time Medication Monitoring|real-time medication monitoring
226440|NCT02206880|Thoracic Surgery|thoracic surgery
226441|NCT02206880|Delirium|delirium
226442|NCT02206880|Cardiopulmonary Bypass|cardiopulmonary bypass
226443|NCT02206880|Intensive Care|intensive care
226444|NCT02206854|Pharmakokinetic|pharmakokinetic
226445|NCT02206854|capsules|capsules
226446|NCT02206854|R-Flurbiprofen|r-flurbiprofen
226447|NCT02206841|fibrosis|fibrosis
226448|NCT02206841|markers|markers
226449|NCT02206828|HERNIA|hernia
226450|NCT02206828|SYMCHRO|symchro
226451|NCT02206828|SOFRADIM|sofradim
226452|NCT02206828|REGISTRY|registry
226453|NCT02206828|SYMBOTEX|symbotex
226454|NCT02206802|Alopecia|alopecia
226455|NCT02206802|Androgenetic Alopecia|androgenetic alopecia
226456|NCT02206802|Female Pattern Hair Loss|female pattern hair loss
226457|NCT02206802|Hair Loss|hair loss
226458|NCT02206802|Minoxidil|minoxidil
226459|NCT02206802|Hair Thinning|hair thinning
226460|NCT02206776|OCD|ocd
226461|NCT02206750|Controlled Human exposure study|controlled human exposure study
226462|NCT02206750|Air Pollution|air pollution
226463|NCT02206750|Cardiovascular|cardiovascular
226464|NCT02206750|Social factors|social factors
226465|NCT02206750|Cognitive function|cognitive function
226466|NCT02206724|Metastatic prostate cancer|metastatic prostate cancer
226467|NCT02206698|Intraabdominal Injury|intraabdominal injury
226468|NCT02206698|CT Abdomen and Pelvis|ct abdomen and pelvis
226469|NCT02206698|Pediatric trauma|pediatric trauma
226470|NCT02206698|blunt abdominal injury|blunt abdominal injury
226471|NCT02206698|blunt trauma|blunt trauma
226472|NCT02206698|clinical prediction model|clinical prediction model
226473|NCT02206633|dehydration|dehydration
226474|NCT02206607|Phase 1|phase 1
226475|NCT02206607|bioavailability|bioavailability
226476|NCT02206607|type 2 diabetes mellitus|type 2 diabetes mellitus
226477|NCT02206607|PF-04937319|pf-04937319
226478|NCT02206581|dehydration|dehydration
226479|NCT02206568|diabetes mellitus|diabetes mellitus
226480|NCT02206568|phase 1|phase 1
226481|NCT02206568|insulin lispro|insulin lispro
226482|NCT02206568|male subjects|male subjects
226483|NCT02206555|HIV|hiv
226484|NCT02206555|prevention|prevention
226485|NCT02206555|prophylaxis|prophylaxis
226486|NCT02206555|antiretroviral|antiretroviral
226487|NCT02206555|biomedical|biomedical
226488|NCT02206555|bio-behavioural|bio-behavioural
226489|NCT02206555|evaluation|evaluation
226490|NCT02206555|demonstration study|demonstration study
226491|NCT02206542|acupuncture,frozen shoulder,robot,sonography,MRI|acupuncture,frozen shoulder,robot,sonography,mri
226492|NCT02206529|obesity|obesity
226493|NCT02206529|child|child
226494|NCT02206529|weight management|weight management
226495|NCT02206529|behavioral|behavioral
226496|NCT02206529|social networks|social networks
226497|NCT02206529|social support|social support
226498|NCT02206503|LENALIDOMIDE|lenalidomide
226499|NCT02206503|BIOCHEMICAL PROGRESSION|biochemical progression
226500|NCT02206503|RELAPSED/REFRACTORY MM|relapsed/refractory mm
226501|NCT02206503|WITHOUT CRAB|without crab
226502|NCT02206490|Gulf War Illness|gulf war illness
226503|NCT02206490|treatment|treatment
226504|NCT02206490|dextromethorphan|dextromethorphan
226505|NCT02206490|naltrexone|naltrexone
226506|NCT02206477|breast capsular contructure|breast capsular contructure
226507|NCT02206477|dimethyl sulfoxide|dimethyl sulfoxide
226508|NCT02206477|radiotherapy|radiotherapy
226509|NCT02206477|breast reconstruction|breast reconstruction
226510|NCT02206464|A/Anhui/1/2013 (H7N9)|a/anhui/1/2013 (h7n9)
226511|NCT02206464|Antibody Response|antibody response
226512|NCT02206464|Avian Influenza|avian influenza
226513|NCT02206464|A/Shanghai/2/2013 (H7N9)|a/shanghai/2/2013 (h7n9)
226514|NCT02206464|Immunogenicity|immunogenicity
226515|NCT02206451|Assay|assay
226516|NCT02206451|Infection|infection
226517|NCT02206451|Direct Skin Feed|direct skin feed
226518|NCT02206451|Midgut|midgut
226519|NCT02206451|Parasite|parasite
226520|NCT02206438|supraglottic airway devices|supraglottic airway devices
226521|NCT02206438|the classic laryngeal mask airway|the classic laryngeal mask airway
226522|NCT02206438|the self-pressurised air-Q intubating laryngeal airway in adult patients|the self-pressurised air-q intubating laryngeal airway in adult patients
226523|NCT02206438|elective surgery of short duration (less than 2 hr) undergoing general anesthesia using supraglottic airway in adult patients|elective surgery of short duration (less than 2 hr) undergoing general anesthesia using supraglottic airway in adult patients
226524|NCT02206425|multiple myeloma|multiple myeloma
226525|NCT02206425|Relapsed/refractory|relapsed/refractory
226526|NCT02206425|Ixazomib|ixazomib
226527|NCT02206425|Proteasome inhibitor|proteasome inhibitor
226528|NCT02206425|Oral|oral
226529|NCT02206412|high mobility group box 1|high mobility group box 1
226530|NCT02206412|prognostic biomarker|prognostic biomarker
226531|NCT02206412|off-pump coronary artery bypass graft|off-pump coronary artery bypass graft
226532|NCT02206412|patients|patients
226533|NCT02206373|creatinine|creatinine
226534|NCT02206373|glomerular filtration rate|glomerular filtration rate
226535|NCT02206373|renal insufficiency, chronic|renal insufficiency, chronic
226536|NCT02206360|Pancreatic Cancer|pancreatic cancer
226537|NCT02206360|Pancreatic Cancer Screening|pancreatic cancer screening
226538|NCT02206360|Pancreas Cancer|pancreas cancer
226539|NCT02206360|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
226540|NCT02206360|Pancreatic Adenocarcinoma screening|pancreatic adenocarcinoma screening
226541|NCT02206360|Familial Pancreatic Cancer|familial pancreatic cancer
226542|NCT02206360|BRCA 1/2|brca 1/2
226543|NCT02206360|HNPCC|hnpcc
226544|NCT02206360|Lynch Syndrome|lynch syndrome
226545|NCT02206360|Hereditary Pancreatitis|hereditary pancreatitis
226546|NCT02206360|FAMMM|fammm
226547|NCT02206360|Familial atypical multiple mole melanoma|familial atypical multiple mole melanoma
226548|NCT02206360|Peutz Jeghers Syndrome|peutz jeghers syndrome
226549|NCT02206360|MRI|mri
226550|NCT02206360|Magnetic Resonance Imaging|magnetic resonance imaging
226551|NCT02206360|EUS|eus
226552|NCT02206360|Endoscopic Ultrasound|endoscopic ultrasound
226553|NCT02206360|Early detection|early detection
226554|NCT02206360|Screening|screening
226555|NCT02206308|Chimeric anti-CD20 monoclonal antibody(SCT400)|chimeric anti-cd20 monoclonal antibody(sct400)
226556|NCT02206308|escalating doses|escalating doses
226557|NCT02206308|safety|safety
226558|NCT02206308|pharmacokinetics and pharmacodynamics|pharmacokinetics and pharmacodynamics
226559|NCT02206295|selexipag|selexipag
226560|NCT02206295|ACT-333679|act-333679
226664|NCT02205684|Exercise|exercise
226561|NCT02206243|Benign prostatic hyperplasia|benign prostatic hyperplasia
226562|NCT02206243|BPH|bph
226563|NCT02206230|glioblastoma|glioblastoma
226564|NCT02206230|radiotherapy|radiotherapy
226565|NCT02206230|hypofractionated radiotherapy|hypofractionated radiotherapy
226566|NCT02206204|Selexipag|selexipag
226567|NCT02206204|ACT-333679|act-333679
226568|NCT02206152|Diabetes|diabetes
226569|NCT02206152|Hypoglycemia|hypoglycemia
226570|NCT02206152|Unawareness|unawareness
226571|NCT02206152|HAAF|haaf
226572|NCT02206126|Obstructive sleep apnea|obstructive sleep apnea
226573|NCT02206126|Weight loss|weight loss
226574|NCT02206126|Obesity|obesity
226575|NCT02206126|Sympathetic activity|sympathetic activity
226576|NCT02206126|Metabolic profile|metabolic profile
226577|NCT02206126|Endothelial function|endothelial function
226578|NCT02206113|Standing workstation|standing workstation
226579|NCT02206100|PER977|per977
226580|NCT02206100|enoxaparin|enoxaparin
226581|NCT02206100|anticoagulation reversal|anticoagulation reversal
226582|NCT02206100|whole blood clotting time|whole blood clotting time
226583|NCT02206087|PER977|per977
226584|NCT02206087|heparin|heparin
226585|NCT02206087|anticoagulation reversal|anticoagulation reversal
226586|NCT02206087|whole blood clotting time|whole blood clotting time
226587|NCT02206048|Cervix Carcinoma|cervix carcinoma
226588|NCT02206048|Cervical adenocarcinoma in situ|cervical adenocarcinoma in situ
226589|NCT02206048|AIS|ais
226590|NCT02206048|Cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
226591|NCT02206048|CIN|cin
226592|NCT02206048|microinvasive carcinoma of the cervix|microinvasive carcinoma of the cervix
226593|NCT02206048|cold knife cone of the cervix|cold knife cone of the cervix
226594|NCT02206048|CKC|ckc
226595|NCT02206048|High-Resolution Microendoscopy|high-resolution microendoscopy
226596|NCT02206048|HRME|hrme
226597|NCT02206048|Proflavine|proflavine
226598|NCT02206022|Central Venous Catheter|central venous catheter
226599|NCT02206022|Remifentanil|remifentanil
226600|NCT02206022|local anesthesia|local anesthesia
226601|NCT02206022|pain|pain
226602|NCT02205996|Type 2 diabetes|type 2 diabetes
226603|NCT02205996|Hypoglycaemia|hypoglycaemia
226604|NCT02205996|Platelets|platelets
226605|NCT02205996|Inflammation|inflammation
226606|NCT02205983|enrolling|enrolling
226607|NCT02205983|adult|adult
226608|NCT02205983|volunteers|volunteers
226609|NCT02205970|TENS|tens
226610|NCT02205970|Dysmenorrhea|dysmenorrhea
226611|NCT02205970|analgesia|analgesia
226612|NCT02205970|interactive|interactive
226613|NCT02205957|anesthesiology and intensive care, quality, training|anesthesiology and intensive care, quality, training
226614|NCT02205944|chronic kidney disease|chronic kidney disease
226615|NCT02205944|hemodialysis|hemodialysis
226616|NCT02205944|vascular access|vascular access
226617|NCT02205944|arteriovenous fistula|arteriovenous fistula
226618|NCT02205944|forearm exercise|forearm exercise
226619|NCT02205931|Epilepsy|epilepsy
226620|NCT02205931|Ketogenic diet|ketogenic diet
226621|NCT02205931|Antiepileptic drugs|antiepileptic drugs
226622|NCT02205931|Randomised controlled trial|randomised controlled trial
226623|NCT02205905|PER977|per977
226624|NCT02205905|metabolic disposition|metabolic disposition
226625|NCT02205905|mass balance|mass balance
226626|NCT02205905|metabolites|metabolites
226627|NCT02205905|radiolabeled|radiolabeled
226628|NCT02205892|natural product|natural product
226629|NCT02205892|clinical trial|clinical trial
226630|NCT02205879|pregabalin|pregabalin
226631|NCT02205879|patients|patients
226632|NCT02205879|treatment|treatment
226633|NCT02205853|Oncology Service Hospital|oncology service hospital
226634|NCT02205853|Patient-centred|patient-centred
226635|NCT02205853|Exercise|exercise
226636|NCT02205853|Neoplasms|neoplasms
226637|NCT02205853|Rehabilitation|rehabilitation
226638|NCT02205853|Qualitative Research|qualitative research
226639|NCT02205853|Health Plan Implementation|health plan implementation
226640|NCT02205853|Quality of Health Care|quality of health care
226641|NCT02205853|Guidelines|guidelines
226642|NCT02205853|Quality of Life|quality of life
226643|NCT02205827|whole blood clotting time|whole blood clotting time
226644|NCT02205814|Osteoarthritis, Knee|osteoarthritis, knee
226645|NCT02205814|Arthritis|arthritis
226646|NCT02205814|WOMAC|womac
226647|NCT02205814|Injections, intra-articular|injections, intra-articular
226648|NCT02205814|Fasitibant|fasitibant
226649|NCT02205814|MEN 16132|men 16132
226650|NCT02205762|Langerhans cell histiocytosis|langerhans cell histiocytosis
226651|NCT02205749|biobanks|biobanks
226652|NCT02205749|informed consent|informed consent
226653|NCT02205749|health literacy|health literacy
226654|NCT02205736|Breast health education|breast health education
226655|NCT02205736|Latino women|latino women
226656|NCT02205736|Group education|group education
226657|NCT02205736|Breast cancer|breast cancer
226658|NCT02205723|Asthma|asthma
226659|NCT02205723|Asthma exacerbations|asthma exacerbations
226660|NCT02205723|Pediatric|pediatric
226661|NCT02205697|Fruit|fruit
226662|NCT02205697|Vegetable|vegetable
226663|NCT02205684|Physical activity|physical activity
226665|NCT02205684|High intensity training|high intensity training
226666|NCT02205684|Schizophrenia|schizophrenia
226667|NCT02205684|Symptoms|symptoms
226668|NCT02205684|Well-being|well-being
226669|NCT02205684|Cognition|cognition
226670|NCT02205684|Hippocampal volume|hippocampal volume
226671|NCT02205684|Neuroplasticity|neuroplasticity
226672|NCT02205684|Smoking|smoking
226673|NCT02205684|Substance use|substance use
226674|NCT02205684|Metabolic indices|metabolic indices
226675|NCT02205671|caregiving|caregiving
226676|NCT02205671|chronic illness|chronic illness
226677|NCT02205671|patient education|patient education
226678|NCT02205671|self management|self management
226679|NCT02205658|Sensory Processing|sensory processing
226680|NCT02205658|Autism|autism
226681|NCT02205645|medial|medial
226682|NCT02205645|meniscus|meniscus
226683|NCT02205645|scaffold|scaffold
226684|NCT02205645|repair|repair
226685|NCT02205645|tear|tear
226686|NCT02205645|injury|injury
226687|NCT02205619|Residual cementum|residual cementum
226688|NCT02205619|root surface instrumentation|root surface instrumentation
226689|NCT02205619|ultrasonic scaling|ultrasonic scaling
226690|NCT02205619|air polishing with glycine|air polishing with glycine
226691|NCT02205593|psoriasis|psoriasis
226692|NCT02205593|atopic dermatitis|atopic dermatitis
226693|NCT02205593|eczema|eczema
226694|NCT02205593|patient education|patient education
226695|NCT02205593|stress reduction|stress reduction
226696|NCT02205593|quality of life|quality of life
226697|NCT02205554|Analgesia|analgesia
226698|NCT02205554|Pharmacokinetics|pharmacokinetics
226699|NCT02205554|Treatment|treatment
226700|NCT02205541|Eculizumab|eculizumab
226701|NCT02205541|Shiga-toxin|shiga-toxin
226702|NCT02205541|hemolytic and uremic syndrome|hemolytic and uremic syndrome
226703|NCT02205541|pediatric|pediatric
226704|NCT02205476|Phase 2|phase 2
226705|NCT02205476|open-label|open-label
226706|NCT02205476|safety|safety
226707|NCT02205476|hypertrophic scar revision surgery|hypertrophic scar revision surgery
226708|NCT02205463|Esophagus|esophagus
226709|NCT02205463|Gastroesophageal Junction|gastroesophageal junction
226710|NCT02205463|Stomach|stomach
226711|NCT02205463|Gastric|gastric
226712|NCT02205463|Cancer|cancer
226713|NCT02205463|HER2|her2
226714|NCT02205463|Metastatic|metastatic
226715|NCT02205463|Adenocarcinoma|adenocarcinoma
226716|NCT02205450|Prader-Willi Syndrome|prader-willi syndrome
226717|NCT02205450|Growth Hormone|growth hormone
226718|NCT02205450|Children|children
226719|NCT02205437|Schizophrenia|schizophrenia
226720|NCT02205437|Psychosis|psychosis
226721|NCT02205437|Antipsychotics|antipsychotics
226722|NCT02205437|Treatment response|treatment response
226723|NCT02205437|Metabolic side effects|metabolic side effects
226724|NCT02205437|Gene expression|gene expression
226725|NCT02205437|RNA|rna
226726|NCT02205437|Genes|genes
226727|NCT02205424|Ischaemic stroke|ischaemic stroke
226728|NCT02205424|Alzheimer's disease|alzheimer's disease
226729|NCT02205424|Brain volume|brain volume
226730|NCT02205424|Cortical thickness|cortical thickness
226731|NCT02205424|Magnetic Resonance Imaging|magnetic resonance imaging
226732|NCT02205411|heart assist device|heart assist device
226733|NCT02205411|ventricular assist device|ventricular assist device
226734|NCT02205398|INC280|inc280
226735|NCT02205398|c-MET inhibitor|c-met inhibitor
226736|NCT02205398|cetuximab|cetuximab
226737|NCT02205398|metastatic colorectal cancer|metastatic colorectal cancer
226738|NCT02205398|head and neck|head and neck
226739|NCT02205398|squamous cell carcinoma|squamous cell carcinoma
226740|NCT02205398|resistance to cetuximab/panitumumab|resistance to cetuximab/panitumumab
226741|NCT02205398|SCCHN,|scchn,
226742|NCT02205398|cancer|cancer
226743|NCT02205398|oral and nasal cavity|oral and nasal cavity
226744|NCT02205398|paranasal sinuses|paranasal sinuses
226745|NCT02205398|pharynx|pharynx
226746|NCT02205398|larynx|larynx
226747|NCT02205398|parotid glands|parotid glands
226748|NCT02205398|lympth nodes of neck|lympth nodes of neck
226749|NCT02205398|mucosal lining|mucosal lining
226750|NCT02205398|epithelium|epithelium
226751|NCT02205398|colon|colon
226752|NCT02205398|large intestine|large intestine
226753|NCT02205398|rectal cancer|rectal cancer
226754|NCT02205385|Neuroma|neuroma
226755|NCT02205385|Amputee|amputee
226756|NCT02205385|Amputation Stump|amputation stump
226757|NCT02205385|Assessment, Pain|assessment, pain
226758|NCT02205372|Diabetic Nephropathy|diabetic nephropathy
226759|NCT02205359|AdaptivCRT|adaptivcrt
226760|NCT02205359|aCRT|acrt
226761|NCT02205346|obstructive sleep apnea|obstructive sleep apnea
226762|NCT02205333|Advanced Solid tumors|advanced solid tumors
226763|NCT02205333|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
226764|NCT02205333|programmed death 1|programmed death 1
226765|NCT02205333|programmed dealth ligand 1|programmed dealth ligand 1
226766|NCT02205333|cytotoxic T-lymphocyte-associated antigen-4|cytotoxic t-lymphocyte-associated antigen-4
226767|NCT02205333|OX40 ligand|ox40 ligand
226768|NCT02205320|Pegfilgrastim|pegfilgrastim
226769|NCT02205320|Pharmacokinetics|pharmacokinetics
226770|NCT02205320|Pharmacodynamics|pharmacodynamics
226771|NCT02205320|Healthy volunteers|healthy volunteers
226772|NCT02205307|Rectal cancer|rectal cancer
226773|NCT02205307|Rectal neoplasm|rectal neoplasm
226774|NCT02205307|Colorectal surgery|colorectal surgery
226775|NCT02205307|Anastomosis|anastomosis
226776|NCT02205294|Osteopathic treatment|osteopathic treatment
226777|NCT02205294|Deep Vein Thrombosis|deep vein thrombosis
226778|NCT02205294|Proximal Leg DVT|proximal leg dvt
226779|NCT02205281|Overweight|overweight
226780|NCT02205281|Obese|obese
226781|NCT02205281|Pregnancy|pregnancy
226782|NCT02205281|Weight Gain|weight gain
226783|NCT02205281|Weight Loss|weight loss
226784|NCT02205268|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
226785|NCT02205268|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
226786|NCT02205268|Biofeedback|biofeedback
226787|NCT02205268|Neurofeedback Training|neurofeedback training
226788|NCT02205268|Prefrontal Cortex|prefrontal cortex
226789|NCT02205268|Near infrared spectroscopy|near infrared spectroscopy
226790|NCT02205255|AECOPD|aecopd
226791|NCT02205255|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
226792|NCT02205255|Acute exacerbation|acute exacerbation
226793|NCT02205255|Hospitalization|hospitalization
226794|NCT02205255|Azithromycin|azithromycin
226795|NCT02205255|Macrolides|macrolides
226796|NCT02205255|Randomized Controlled Trial|randomized controlled trial
226797|NCT02205255|Placebo|placebo
226798|NCT02205255|Economic Impact|economic impact
226799|NCT02205255|Cost-effectiveness|cost-effectiveness
226800|NCT02205255|EQ5D|eq5d
226801|NCT02205242|AECOPD|aecopd
226802|NCT02205242|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
226803|NCT02205242|Acute exacerbation|acute exacerbation
226804|NCT02205242|Hospitalization|hospitalization
226805|NCT02205242|Azithromycin|azithromycin
226806|NCT02205242|Macrolides|macrolides
226807|NCT02205242|Randomized Controlled Trial|randomized controlled trial
226808|NCT02205242|Placebo|placebo
226809|NCT02205242|Physical Activity|physical activity
226810|NCT02205242|PRO-Active|pro-active
226811|NCT02205242|Activity Monitor|activity monitor
226812|NCT02205216|tDCS|tdcs
226813|NCT02205216|FOG|fog
226814|NCT02205216|Freezing of Gait|freezing of gait
226815|NCT02205216|Parkinson|parkinson
226816|NCT02205216|Rehabilitation|rehabilitation
226817|NCT02205203|Anxiety|anxiety
226818|NCT02205203|Social Anxiety|social anxiety
226819|NCT02205203|Social Phobia|social phobia
226820|NCT02205203|Separation Anxiety|separation anxiety
226821|NCT02205203|Generalized Anxiety|generalized anxiety
226822|NCT02205203|GAD|gad
226823|NCT02205203|Phobia|phobia
226824|NCT02205203|Panic|panic
226825|NCT02205203|Agoraphobia|agoraphobia
226826|NCT02205203|Obsessive Compulsive Disorder|obsessive compulsive disorder
226827|NCT02205203|OCD|ocd
226828|NCT02205203|Child|child
226829|NCT02205203|Adolescent|adolescent
226830|NCT02205203|Smartphone|smartphone
226831|NCT02205203|Teen|teen
226832|NCT02205203|Youth|youth
226833|NCT02205190|Fimasartan|fimasartan
226834|NCT02205177|Anxiety|anxiety
226835|NCT02205177|Social Anxiety|social anxiety
226836|NCT02205177|Social Phobia|social phobia
226837|NCT02205177|Separation Anxiety|separation anxiety
226838|NCT02205177|Generalized Anxiety|generalized anxiety
226839|NCT02205177|GAD|gad
226840|NCT02205177|Phobia|phobia
226841|NCT02205177|Panic|panic
226842|NCT02205177|Agoraphobia|agoraphobia
226843|NCT02205177|Obsessive Compulsive Disorder|obsessive compulsive disorder
226844|NCT02205177|OCD|ocd
226845|NCT02205177|Child|child
226846|NCT02205177|Adolescent|adolescent
226847|NCT02205177|Smartphone|smartphone
226848|NCT02205177|Teen|teen
226849|NCT02205177|Youth|youth
226850|NCT02205164|palonosetron|palonosetron
226851|NCT02205164|aprepitant|aprepitant
226852|NCT02205164|CINV|cinv
226853|NCT02205164|AML|aml
226854|NCT02205164|multiple-days|multiple-days
226855|NCT02205151|Fimasartan|fimasartan
226856|NCT02205138|Spinal Fusion|spinal fusion
226857|NCT02205138|Lumbar Interbody Fusion|lumbar interbody fusion
226858|NCT02205138|Degenerative Disc Disease|degenerative disc disease
226859|NCT02205138|Cell Therapy|cell therapy
226860|NCT02205138|Bone Graft|bone graft
226861|NCT02205125|polyp|polyp
226862|NCT02205125|colon|colon
226863|NCT02205125|polypectomy|polypectomy
226864|NCT02205125|snare|snare
226865|NCT02205112|intravenous nemonoxacin|intravenous nemonoxacin
226866|NCT02205112|community-acquired pneumonia|community-acquired pneumonia
226867|NCT02205099|Schizophrenia|schizophrenia
226868|NCT02205047|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
226869|NCT02205034|Prader Willi|prader willi
226870|NCT02205008|advanced gastric cancer|advanced gastric cancer
226871|NCT02205008|serosal invasion|serosal invasion
226872|NCT02205008|peritoneal recurrence|peritoneal recurrence
226873|NCT02205008|intraperitoneal chemotherapy|intraperitoneal chemotherapy
226874|NCT02204995|Osteoarthritis|osteoarthritis
226876|NCT02204995|LRTI|lrti
226877|NCT02204995|Trapeziectomy|trapeziectomy
226878|NCT02204982|Phase 3, Follicular Lymphoma, FL, PI3K|phase 3, follicular lymphoma, fl, pi3k
226879|NCT02204956|Smoking cessation|smoking cessation
226880|NCT02204956|Tobacco use cessation|tobacco use cessation
226881|NCT02204956|Psychiatric comorbidity|psychiatric comorbidity
226882|NCT02204930|Haemostat|haemostat
226883|NCT02204930|Liver surgery|liver surgery
226884|NCT02204930|Primary liver cancer|primary liver cancer
226885|NCT02204930|Metastatic liver cancer|metastatic liver cancer
226886|NCT02204930|Benign liver disease such as adenoma|benign liver disease such as adenoma
226887|NCT02204930|Hepatitis-related or alcoholic-related liver cirrhosis|hepatitis-related or alcoholic-related liver cirrhosis
226888|NCT02204930|Living donation for liver transplant|living donation for liver transplant
226889|NCT02204917|Ultrasound|ultrasound
226890|NCT02204917|Ultrasound Contrast Agents|ultrasound contrast agents
226891|NCT02204917|Optison|optison
226892|NCT02204917|contrast enhanced Voiding Urosonography|contrast enhanced voiding urosonography
226893|NCT02204917|ceVUS|cevus
226894|NCT02204917|Vesicoureteral Reflux|vesicoureteral reflux
226895|NCT02204917|Children|children
226896|NCT02204917|Kidney|kidney
226897|NCT02204917|Bladder|bladder
226898|NCT02204917|Urethra|urethra
226899|NCT02204917|Voiding Cystourethrography|voiding cystourethrography
226900|NCT02204917|VCUG|vcug
226901|NCT02204917|Safety|safety
226902|NCT02204917|Urinary tract|urinary tract
226903|NCT02204904|X-linked Adrenoleukodystrophy|x-linked adrenoleukodystrophy
226904|NCT02204904|Hematopoietic Stem Cells|hematopoietic stem cells
226905|NCT02204891|Abdominal pain|abdominal pain
226906|NCT02204891|Abdominal discomfort|abdominal discomfort
226907|NCT02204891|Flatulence|flatulence
226908|NCT02204891|Diarrhea|diarrhea
226909|NCT02204891|Bacterial overgrowth|bacterial overgrowth
226910|NCT02204891|Cytokines|cytokines
226911|NCT02204865|Sleep-Disordered Breathing|sleep-disordered breathing
226912|NCT02204865|Sleep Apnoea|sleep apnoea
226913|NCT02204865|Heart failure|heart failure
226914|NCT02204839|T1DM, Exercise, Hypoglycaemia|t1dm, exercise, hypoglycaemia
226915|NCT02204826|Effects of Korean Red Ginseng on semen parameters in male infertility patients: a randomized, placebo-controlled, double-blind clinical study|effects of korean red ginseng on semen parameters in male infertility patients: a randomized, placebo-controlled, double-blind clinical study
226916|NCT02204813|Gastric Bypass|gastric bypass
226917|NCT02204813|RYGB|rygb
226918|NCT02204813|GLP-1|glp-1
226919|NCT02204813|Xenin|xenin
226920|NCT02204813|Insulin Secretion|insulin secretion
226921|NCT02204813|Glucose Homeostasis|glucose homeostasis
226922|NCT02204813|Vertical Sleeve|vertical sleeve
226923|NCT02204813|Lap Band|lap band
226924|NCT02204800|Tumor growth rate in maximal dimension, biomarker assessment based on driver gene alterations (specifically CRG)|tumor growth rate in maximal dimension, biomarker assessment based on driver gene alterations (specifically crg)
226925|NCT02204774|aortic aneurysm|aortic aneurysm
226926|NCT02204774|obstructive sleep apnea|obstructive sleep apnea
226927|NCT02204735|Meal Time|meal time
226928|NCT02204735|Weight Loss|weight loss
226929|NCT02204735|Circadian Rhythm|circadian rhythm
226930|NCT02204709|obese|obese
226931|NCT02204709|obesity|obesity
226932|NCT02204709|metabolic syndrome|metabolic syndrome
226933|NCT02204709|omega-3 fatty acids|omega-3 fatty acids
226934|NCT02204709|fish|fish
226935|NCT02204696|sleep apnea|sleep apnea
226936|NCT02204696|obstructive sleep apnea|obstructive sleep apnea
226937|NCT02204696|sleepiness|sleepiness
226938|NCT02204696|quality of life|quality of life
226939|NCT02204683|AMD|amd
226940|NCT02204683|Neovascularization|neovascularization
226941|NCT02204683|macular degeneration|macular degeneration
226942|NCT02204683|wet macular degeneration|wet macular degeneration
226943|NCT02204683|vitrectomy|vitrectomy
226944|NCT02204670|Irisin|irisin
226945|NCT02204670|Obesity|obesity
226946|NCT02204670|Exercise|exercise
226947|NCT02204670|Myokine|myokine
226948|NCT02204670|Impaired Glucose Tolerance|impaired glucose tolerance
226949|NCT02204657|Continuous glucose monitoring in GDM|continuous glucose monitoring in gdm
226950|NCT02204631|Head and Neck Cancer|head and neck cancer
226951|NCT02204618|single sided deafness|single sided deafness
226952|NCT02204618|Asymmetrical hearing loss|asymmetrical hearing loss
226953|NCT02204618|Cost-utility|cost-utility
226954|NCT02204618|Tinnitus|tinnitus
226955|NCT02204618|Cochlear implants|cochlear implants
226956|NCT02204618|Bone conduction device|bone conduction device
226957|NCT02204618|Dichotic hearing|dichotic hearing
226958|NCT02204618|Squelch effect.|squelch effect.
226959|NCT02204605|patients|patients
226960|NCT02204605|puzzling|puzzling
226961|NCT02204605|conditions|conditions
226962|NCT02204579|Autosomal Dominant Hypocalcemia|autosomal dominant hypocalcemia
226963|NCT02204579|Hypocalcemia|hypocalcemia
226964|NCT02204579|ADH|adh
226965|NCT02204579|Hypoparathyroidism|hypoparathyroidism
226966|NCT02204566|OFDI|ofdi
226967|NCT02204566|RF Ablation|rf ablation
226968|NCT02204566|Atrial Fibrillation|atrial fibrillation
226969|NCT02204566|Imaging|imaging
226970|NCT02204566|Esophagus|esophagus
226971|NCT02204553|Multiple Myeloma|multiple myeloma
226972|NCT02204553|Panobinostat|panobinostat
226973|NCT02204553|LBH589|lbh589
226974|NCT02204553|Expanded Access|expanded access
226975|NCT02204553|EAP, ETP|eap, etp
226976|NCT02204553|Expanded Treatment|expanded treatment
226977|NCT02204553|Bortezomib|bortezomib
226978|NCT02204553|HDAC|hdac
226979|NCT02204553|histone deacetylace inhibitor|histone deacetylace inhibitor
226980|NCT02204540|Webcams, video monitoring, compliance, adherence|webcams, video monitoring, compliance, adherence
226981|NCT02204527|hypertension|hypertension
226982|NCT02204527|diabetes mellitus|diabetes mellitus
226983|NCT02204527|vitamin D|vitamin d
226984|NCT02204501|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
226985|NCT02204501|Aviragen Therapeutics|aviragen therapeutics
226986|NCT02204501|Aviragen|aviragen
226987|NCT02204488|Osteoarthritis|osteoarthritis
226988|NCT02204488|Thumb|thumb
226989|NCT02204488|Total joint arthroplasty|total joint arthroplasty
226990|NCT02204488|Trapeziectomy|trapeziectomy
226991|NCT02204462|PET|pet
226992|NCT02204462|Positron Emission Tomography|positron emission tomography
226993|NCT02204462|Breast Cancer|breast cancer
226994|NCT02204462|Imaging|imaging
226995|NCT02204449|cardiac rehabilitation|cardiac rehabilitation
226996|NCT02204449|peer mentorship|peer mentorship
226997|NCT02204449|healthcare utilization|healthcare utilization
226998|NCT02204449|continuity of cardiac care|continuity of cardiac care
226999|NCT02204436|hyperpigmentation|hyperpigmentation
227000|NCT02204436|depigmenting treatment|depigmenting treatment
227001|NCT02204436|hand|hand
227002|NCT02204423|Upper extremity dysfunction|upper extremity dysfunction
227003|NCT02204423|Trans-Radial Percutaneous Coronary Interventions|trans-radial percutaneous coronary interventions
227004|NCT02204410|ADHD|adhd
227005|NCT02204410|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
227006|NCT02204410|DESR|desr
227007|NCT02204410|Deficient Emotional Self-Regulation|deficient emotional self-regulation
227008|NCT02204410|Emotional Dysregulation|emotional dysregulation
227009|NCT02204410|Omega-3 Fatty Acids|omega-3 fatty acids
227010|NCT02204410|Fish Oil|fish oil
227011|NCT02204397|Type 1 Diabetes mellitus|type 1 diabetes mellitus
227012|NCT02204397|INGAP|ingap
227013|NCT02204397|Ustekinumab|ustekinumab
227014|NCT02204384|Dietary fiber|dietary fiber
227015|NCT02204384|Dietary Supplements|dietary supplements
227016|NCT02204384|Type 2 diabetes|type 2 diabetes
227017|NCT02204384|Postprandial Period|postprandial period
227018|NCT02204384|Plasma insulin|plasma insulin
227019|NCT02204384|Plasma glucose|plasma glucose
227020|NCT02204384|Area Under Curve|area under curve
227021|NCT02204384|Soluble fiber|soluble fiber
227022|NCT02204371|Pazopanib|pazopanib
227023|NCT02204371|hereditary haemorrhagic telangiectasia|hereditary haemorrhagic telangiectasia
227024|NCT02204371|bleeding|bleeding
227025|NCT02204319|provoked or non-provoked vulvar vestibulitis|provoked or non-provoked vulvar vestibulitis
227026|NCT02204319|low level laser light device|low level laser light device
227027|NCT02204293|Adult-Onset Still´s Disease|adult-onset still´s disease
227028|NCT02204293|Canakinumab|canakinumab
227029|NCT02204293|Joint involvement|joint involvement
227030|NCT02204293|AOSD|aosd
227031|NCT02204280|UbA52;diabetic nephropathy ;diabetic;ELISA|uba52;diabetic nephropathy ;diabetic;elisa
227032|NCT02204267|Stroke|stroke
227033|NCT02204267|atrial fibrillation|atrial fibrillation
227034|NCT02204267|ECG|ecg
227035|NCT02204241|Multiple myeloma|multiple myeloma
227036|NCT02204241|Diagnosis|diagnosis
227037|NCT02204241|CCyd|ccyd
227038|NCT02204228|osteoarthritis|osteoarthritis
227039|NCT02204228|rheumatoid arthritis|rheumatoid arthritis
227040|NCT02204228|post traumatic arthritis|post traumatic arthritis
227041|NCT02204228|avascular necrosis|avascular necrosis
227042|NCT02204228|severe fractures|severe fractures
227043|NCT02204215|Weakness|weakness
227044|NCT02204215|Mechanical Ventilation|mechanical ventilation
227045|NCT02204215|Acupuncture Therapy|acupuncture therapy
227046|NCT02204202|acute lung transplant rejection|acute lung transplant rejection
227047|NCT02204202|neutrophilic lung inflammation|neutrophilic lung inflammation
227048|NCT02204202|positron emission tomography imaging|positron emission tomography imaging
227049|NCT02204202|[18F] fluorodeoxyglucose|[18f] fluorodeoxyglucose
227050|NCT02204202|[18F] ISO-1|[18f] iso-1
227051|NCT02204189|acute pancreatitis|acute pancreatitis
227052|NCT02204189|gastrointestinal dysfunction|gastrointestinal dysfunction
227053|NCT02204189|TongFuSan|tongfusan
227054|NCT02204189|ShenQue acupoint|shenque acupoint
227055|NCT02204150|Optical Coherence Tomography|optical coherence tomography
227056|NCT02204150|Barrett's Esophagus|barrett's esophagus
227057|NCT02204150|Esophagus|esophagus
227058|NCT02204150|Imaging|imaging
227059|NCT02204124|Whipple procedure|whipple procedure
227060|NCT02204111|Palliative Treatment|palliative treatment
227061|NCT02204111|Trabectedin|trabectedin
227062|NCT02204111|Patient Reported Outcome|patient reported outcome
227063|NCT02204085|Refractory acute myeloid leukemia|refractory acute myeloid leukemia
227064|NCT02204085|Relapsed acute myeloid leukemia|relapsed acute myeloid leukemia
227065|NCT02204020|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
227066|NCT02204020|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
227067|NCT02204020|allogeneic|allogeneic
227170|NCT02203617|baby books|baby books
227068|NCT02204020|5-azacytidine (5-aza)|5-azacytidine (5-aza)
227069|NCT02204020|hematopoietic|hematopoietic
227070|NCT02204020|transplantation|transplantation
227071|NCT02204020|transplant|transplant
227072|NCT02204020|graft-versus-tumor|graft-versus-tumor
227073|NCT02204020|graft-versus-host disease (GVHD)|graft-versus-host disease (gvhd)
227074|NCT02204020|epigenetic|epigenetic
227075|NCT02204020|maintenance|maintenance
227076|NCT02204020|hypomethylation|hypomethylation
227077|NCT02204020|relapse|relapse
227078|NCT02204007|Acetabular Shell|acetabular shell
227079|NCT02204007|Total Hip Arthroplasty|total hip arthroplasty
227080|NCT02204007|3D imaging|3d imaging
227081|NCT02203994|extracorporal shock wave therapy (ESWT)|extracorporal shock wave therapy (eswt)
227082|NCT02203994|spasticity|spasticity
227083|NCT02203994|spinal cord injury|spinal cord injury
227084|NCT02203981|normal Eyes|normal eyes
227085|NCT02203968|Fibrinogen replacement|fibrinogen replacement
227086|NCT02203968|Trauma coagulopathy|trauma coagulopathy
227087|NCT02203968|Hypofibrinogenemia|hypofibrinogenemia
227088|NCT02203968|Early trauma coagulopathy|early trauma coagulopathy
227089|NCT02203968|Haemorrhage|haemorrhage
227090|NCT02203968|Fibrinogen concentrate|fibrinogen concentrate
227091|NCT02203968|Feasibility trial|feasibility trial
227092|NCT02203968|Clinical trials|clinical trials
227093|NCT02203942|Bacterial Vaginosis|bacterial vaginosis
227094|NCT02203942|Vulvovaginal Candidiasis|vulvovaginal candidiasis
227095|NCT02203942|Trichomoniasis|trichomoniasis
227096|NCT02203929|Macular Holes|macular holes
227097|NCT02203929|Progression|progression
227098|NCT02203916|Drug therapy|drug therapy
227099|NCT02203890|Growth|growth
227100|NCT02203890|Hematology|hematology
227101|NCT02203890|Hydration|hydration
227102|NCT02203890|Oxidation|oxidation
227103|NCT02203890|Infection|infection
227104|NCT02203890|Inflammation|inflammation
227105|NCT02203890|Guatemalan children|guatemalan children
227106|NCT02203851|BI 655066|bi 655066
227107|NCT02203851|risankizumab|risankizumab
227108|NCT02203838|Schizophrenia|schizophrenia
227109|NCT02203838|Schizophrenic|schizophrenic
227110|NCT02203838|Schizophrenias|schizophrenias
227111|NCT02203838|Risperidone|risperidone
227112|NCT02203838|Long-acting Risperidone|long-acting risperidone
227113|NCT02203838|Atrigel|atrigel
227114|NCT02203838|Subcutaneous|subcutaneous
227115|NCT02203825|Acute Myeloid Leukemia|acute myeloid leukemia
227116|NCT02203825|NKG2D|nkg2d
227117|NCT02203825|Multiple Myeloma|multiple myeloma
227118|NCT02203825|Cell Therapy|cell therapy
227119|NCT02203799|Peanut Allergy|peanut allergy
227120|NCT02203799|Anaphylaxis|anaphylaxis
227121|NCT02203799|Desensitization|desensitization
227122|NCT02203799|Food Allergy|food allergy
227123|NCT02203799|Oral Immunotherapy|oral immunotherapy
227124|NCT02203786|amphetamine|amphetamine
227125|NCT02203786|d1 and d2 receptors|d1 and d2 receptors
227126|NCT02203786|dopamine antagonists|dopamine antagonists
227127|NCT02203786|pathological gambling|pathological gambling
227128|NCT02203786|priming|priming
227129|NCT02203786|reinforcement|reinforcement
227130|NCT02203773|Acute Myelogenous Leukemia|acute myelogenous leukemia
227131|NCT02203773|AML|aml
227132|NCT02203773|Myelogenous Leukemia|myelogenous leukemia
227133|NCT02203773|ABT-199|abt-199
227134|NCT02203773|GDC-0199|gdc-0199
227135|NCT02203773|Treatment Naive AML|treatment naive aml
227136|NCT02203773|Untreated AML|untreated aml
227137|NCT02203760|Relapsed or metastatic uterine leiomyosarcomas or carcinosarcomas|relapsed or metastatic uterine leiomyosarcomas or carcinosarcomas
227138|NCT02203734|Pregnancy|pregnancy
227139|NCT02203734|Depression|depression
227140|NCT02203734|Massage|massage
227141|NCT02203708|BPD (Borderline Personality Disorder)|bpd (borderline personality disorder)
227142|NCT02203708|Mother/child|mother/child
227143|NCT02203695|Salvage Radiation Therapy (SRT)|salvage radiation therapy (srt)
227144|NCT02203695|Enzalutamide|enzalutamide
227145|NCT02203682|Graves' orbitopathy|graves' orbitopathy
227146|NCT02203682|Graves´ ophthalmopathy|graves´ ophthalmopathy
227147|NCT02203682|Thyroid eye disease|thyroid eye disease
227148|NCT02203682|Thyroid-associated ophthalmopathy|thyroid-associated ophthalmopathy
227149|NCT02203682|Doxycycline|doxycycline
227150|NCT02203682|EUGOGO|eugogo
227151|NCT02203682|CAS|cas
227152|NCT02203669|breast reconstruction|breast reconstruction
227153|NCT02203669|occupational therapy|occupational therapy
227154|NCT02203669|physical therapy|physical therapy
227155|NCT02203669|upper extremity morbidity|upper extremity morbidity
227156|NCT02203656|intervention studies|intervention studies
227157|NCT02203656|nutrition|nutrition
227158|NCT02203656|exercise|exercise
227159|NCT02203656|testosterone|testosterone
227160|NCT02203656|patient readmission|patient readmission
227161|NCT02203630|Septic shock|septic shock
227162|NCT02203630|Vasopressor Agents|vasopressor agents
227163|NCT02203630|Phenylephrine|phenylephrine
227164|NCT02203630|Norepinephrine|norepinephrine
227165|NCT02203630|Tachycardia|tachycardia
227166|NCT02203630|Heart Rate|heart rate
227167|NCT02203630|Arrhythmia|arrhythmia
227168|NCT02203630|Catecholamine|catecholamine
227169|NCT02203617|anticipatory guidance|anticipatory guidance
227171|NCT02203617|safety|safety
227172|NCT02203591|surgical skin prep|surgical skin prep
227173|NCT02203591|CHG|chg
227174|NCT02203591|IPA|ipa
227175|NCT02203552|Breast Cancer|breast cancer
227176|NCT02203539|circadian rhythm|circadian rhythm
227177|NCT02203539|light exposure|light exposure
227178|NCT02203539|exercise capacity|exercise capacity
227179|NCT02203539|endurance|endurance
227180|NCT02203539|strength|strength
227181|NCT02203539|reaction|reaction
227182|NCT02203526|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
227183|NCT02203526|ABC DLBCL|abc dlbcl
227184|NCT02203526|Lymphoma in Brain and CNS|lymphoma in brain and cns
227185|NCT02203526|Diffuse Large B-Cell Lymphomas in CNS|diffuse large b-cell lymphomas in cns
227186|NCT02203513|p53 Dysfunction|p53 dysfunction
227187|NCT02203513|Cell Cycle Arrest|cell cycle arrest
227188|NCT02203513|Checkpoint Kinases|checkpoint kinases
227189|NCT02203513|DNA Damage Repair Pathways|dna damage repair pathways
227190|NCT02203513|Hereditary Breast and Ovarian Cancer Syndrome|hereditary breast and ovarian cancer syndrome
227191|NCT02203461|ART, HIV, insulin resistance|art, hiv, insulin resistance
227192|NCT02203435|code blue|code blue
227193|NCT02203435|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
227194|NCT02203435|APACHE|apache
227195|NCT02203422|Immune Thrombocytopenia|immune thrombocytopenia
227196|NCT02203422|Recombinant Human Thrombopoietin|recombinant human thrombopoietin
227197|NCT02203422|Cyclosporin A|cyclosporin a
227198|NCT02203409|liver tumor|liver tumor
227199|NCT02203409|Two stage hepatectomy|two stage hepatectomy
227200|NCT02203409|Hypertrophy|hypertrophy
227201|NCT02203409|laparoscopy|laparoscopy
227202|NCT02203409|ALPPS|alpps
227203|NCT02203396|SAA|saa
227204|NCT02203396|Immunosuppressive treatment|immunosuppressive treatment
227205|NCT02203396|ATG|atg
227206|NCT02203396|Cyclosporine|cyclosporine
227207|NCT02203396|Levamisole|levamisole
227208|NCT02203383|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
227209|NCT02203383|Central Sleep Apnoea|central sleep apnoea
227210|NCT02203383|Sleep Disordered Breathing|sleep disordered breathing
227211|NCT02203383|Heart Failure|heart failure
227212|NCT02203383|Hypercapnic Ventilatory Response|hypercapnic ventilatory response
227213|NCT02203357|hepatitis B|hepatitis b
227214|NCT02203357|hepatitis B vaccine|hepatitis b vaccine
227215|NCT02203357|immunogenicity|immunogenicity
227216|NCT02203357|adults|adults
227217|NCT02203318|cryptorchidism, undescended testis, hypertrophy of contralateral testis|cryptorchidism, undescended testis, hypertrophy of contralateral testis
227218|NCT02203305|Unilateral hearing loss|unilateral hearing loss
227219|NCT02203305|Single Sided Deafness|single sided deafness
227220|NCT02203305|Asymmetric hearing loss|asymmetric hearing loss
227221|NCT02203292|Traumatic Brain Injury|traumatic brain injury
227222|NCT02203292|Blood Transfusion|blood transfusion
227223|NCT02203279|Chair-side hard relining|chair-side hard relining
227224|NCT02203279|complete denture|complete denture
227225|NCT02203279|patients' satisfaction|patients' satisfaction
227226|NCT02203279|supporting tissues|supporting tissues
227227|NCT02203279|autopolymerized reline resins|autopolymerized reline resins
227228|NCT02203279|heat cured relining material|heat cured relining material
227229|NCT02203266|Medication Adherence|medication adherence
227230|NCT02203266|Patient Compliance|patient compliance
227231|NCT02203253|solid tumor|solid tumor
227232|NCT02203253|chemotherapy-induced delayed nausea and vomiting|chemotherapy-induced delayed nausea and vomiting
227233|NCT02203253|thalidomide|thalidomide
227234|NCT02203253|prevention|prevention
227235|NCT02203240|Cacao|cacao
227236|NCT02203240|Polyphenols|polyphenols
227237|NCT02203240|Prediabetic State|prediabetic state
227238|NCT02203240|Blood Glucose|blood glucose
227239|NCT02203240|Glucose Intolerance|glucose intolerance
227240|NCT02203240|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
227241|NCT02203240|Obesity|obesity
227242|NCT02203240|Muscle, Skeletal|muscle, skeletal
227243|NCT02203240|Endotoxins|endotoxins
227244|NCT02203240|Gut Permeability|gut permeability
227245|NCT02203240|Incretins|incretins
227246|NCT02203240|Metabolic Flexibility|metabolic flexibility
227247|NCT02203227|Dietary supplements|dietary supplements
227248|NCT02203227|Cotinine level|cotinine level
227249|NCT02203227|Malondialdehyde|malondialdehyde
227250|NCT02203227|Chronic smokers|chronic smokers
227251|NCT02203227|Hyperlipidemia|hyperlipidemia
227252|NCT02203214|Ligamys|ligamys
227253|NCT02203214|ACL|acl
227254|NCT02203214|healing|healing
227255|NCT02203201|Not-celiac gluten sensitivity|not-celiac gluten sensitivity
227256|NCT02203201|Celiac Disease|celiac disease
227257|NCT02203201|Gluten-free diet|gluten-free diet
227258|NCT02203201|EMA assay|ema assay
227259|NCT02203201|Duodenal culture medium|duodenal culture medium
227260|NCT02203175|propofol|propofol
227261|NCT02203175|pretreatment|pretreatment
227262|NCT02203175|mixture|mixture
227263|NCT02203162|cough|cough
227264|NCT02203162|cough reflex sensitivity|cough reflex sensitivity
227265|NCT02203162|electronic cigarette|electronic cigarette
227266|NCT02203162|capsaicin|capsaicin
227267|NCT02203136|Bladder cancer|bladder cancer
227268|NCT02203136|Muscle invasive bladder cancer|muscle invasive bladder cancer
227269|NCT02203136|MIBC|mibc
227270|NCT02203136|Biopsy specimen molecular profiling|biopsy specimen molecular profiling
227271|NCT02203136|Bladder surgery|bladder surgery
227272|NCT02203136|Magnetic resonance imaging|magnetic resonance imaging
227273|NCT02203136|MRI|mri
227274|NCT02203136|Trans urethral resection of bladder|trans urethral resection of bladder
227275|NCT02203110|simultaneous bacterial and viral pneumonia|simultaneous bacterial and viral pneumonia
227276|NCT02203097|Target controlled infusion|target controlled infusion
227277|NCT02203097|propofol|propofol
227278|NCT02203097|cerebral vasoreactivity|cerebral vasoreactivity
227279|NCT02203097|arterial stiffness|arterial stiffness
227280|NCT02203097|Transcranial Doppler|transcranial doppler
227281|NCT02203097|SphygmoCor|sphygmocor
227282|NCT02203084|Cystic Fibrosis|cystic fibrosis
227283|NCT02203084|Diabetes Mellitus Type I|diabetes mellitus type i
227284|NCT02203084|Chronic Renal Insufficiency|chronic renal insufficiency
227285|NCT02203084|The influence of socioeconomic variables upon outcome in children with three chronic medical diseases.|the influence of socioeconomic variables upon outcome in children with three chronic medical diseases.
227286|NCT02203071|sports|sports
227287|NCT02203071|injury|injury
227288|NCT02203071|knee|knee
227289|NCT02203071|pain|pain
227290|NCT02203071|cartilage|cartilage
227291|NCT02203058|Inspiratory capacity|inspiratory capacity
227292|NCT02203058|Positive-pressure respiration|positive-pressure respiration
227293|NCT02203058|Exercise|exercise
227294|NCT02203058|Activities of daily living|activities of daily living
227295|NCT02203058|COPD.|copd.
227296|NCT02203045|Total Knee Arthroplasty|total knee arthroplasty
227297|NCT02203032|Psoriasis|psoriasis
227298|NCT02203032|Plaque-type psoriasis|plaque-type psoriasis
227299|NCT02203032|Guselkumab|guselkumab
227300|NCT02203032|Ustekinumab|ustekinumab
227301|NCT02203032|CNTO 1959|cnto 1959
227302|NCT02203032|Monoclonal antibody|monoclonal antibody
227303|NCT02203019|Dexmedetomidine|dexmedetomidine
227304|NCT02203019|Propofol|propofol
227305|NCT02203019|Sepsis|sepsis
227306|NCT02203019|Mechanical Ventilation|mechanical ventilation
227307|NCT02203019|Respiratory Failure|respiratory failure
227308|NCT02203006|HIV,|hiv,
227309|NCT02203006|infection,|infection,
227310|NCT02203006|cohort|cohort
227311|NCT02202967|Aspirin|aspirin
227312|NCT02202967|Intestinal bleeding|intestinal bleeding
227313|NCT02202967|Misoprostol|misoprostol
227314|NCT02202967|NSAIDs|nsaids
227315|NCT02202967|Small intestine|small intestine
227316|NCT02202967|Video capsule endoscopy|video capsule endoscopy
227317|NCT02202954|Stroke|stroke
227318|NCT02202954|Muscle Spasticity|muscle spasticity
227319|NCT02202954|Rehabilitation|rehabilitation
227320|NCT02202928|Colorectal cancer|colorectal cancer
227321|NCT02202928|DC-CIK|dc-cik
227322|NCT02202928|Autologous tumor lysate|autologous tumor lysate
227323|NCT02202902|Cushing's syndrome|cushing's syndrome
227324|NCT02202902|cardiac steatosis|cardiac steatosis
227325|NCT02202902|intramyocardial triglyceride content|intramyocardial triglyceride content
227326|NCT02202902|1H magnetic resonance spectroscopy and cardiac magnetic resonance imaging|1h magnetic resonance spectroscopy and cardiac magnetic resonance imaging
227327|NCT02202902|Left Ventricularly hypertrophy|left ventricularly hypertrophy
227328|NCT02202889|Adolescents|adolescents
227329|NCT02202889|Bone mass|bone mass
227330|NCT02202889|Calcium|calcium
227331|NCT02202889|Perceived milk intolerance|perceived milk intolerance
227332|NCT02202889|lactose maldigestion|lactose maldigestion
227333|NCT02202863|Dietary intervention|dietary intervention
227334|NCT02202863|Wine grape pomace flour|wine grape pomace flour
227335|NCT02202863|Metabolic Syndrome|metabolic syndrome
227336|NCT02202863|Oxidative stress|oxidative stress
227337|NCT02202863|Antioxidants|antioxidants
227338|NCT02202863|Fiber|fiber
227339|NCT02202785|Drug therapy|drug therapy
227340|NCT02202772|Urothelial|urothelial
227341|NCT02202772|Cisplatin|cisplatin
227342|NCT02202772|Gemcitabine|gemcitabine
227343|NCT02202772|Cabazitaxel|cabazitaxel
227344|NCT02202772|Bladder|bladder
227345|NCT02202772|Carcinoma|carcinoma
227346|NCT02202772|Bacillus Calmette-Guerin|bacillus calmette-guerin
227347|NCT02202772|Intravesical|intravesical
227348|NCT02202772|Recurrent|recurrent
227349|NCT02202772|Non-muscle|non-muscle
227350|NCT02202772|Invasive|invasive
227351|NCT02202772|Cancer|cancer
227352|NCT02202759|Drug therapy|drug therapy
227353|NCT02202746|Breast cancer|breast cancer
227354|NCT02202746|Metastatic breast cancer|metastatic breast cancer
227355|NCT02202746|MBC|mbc
227356|NCT02202746|HER2 positive|her2 positive
227357|NCT02202746|HER2+|her2+
227358|NCT02202746|Estrogen receptor positive|estrogen receptor positive
227359|NCT02202746|ER+|er+
227360|NCT02202746|Triple negative|triple negative
227361|NCT02202746|FGFR1|fgfr1
227362|NCT02202746|11q|11q
227363|NCT02202746|FGF aberrant|fgf aberrant
227364|NCT02202746|Biomarker negative|biomarker negative
227365|NCT02202746|FGF non-aberrant|fgf non-aberrant
227366|NCT02202733|cooking skills|cooking skills
227367|NCT02202733|eating out|eating out
227368|NCT02202733|foods prepared away from home|foods prepared away from home
227369|NCT02202720|Sevoflurane|sevoflurane
227370|NCT02202720|RASS score|rass score
227371|NCT02202720|Sedation|sedation
227372|NCT02202720|Minimal alveolar concentration (MAC)|minimal alveolar concentration (mac)
227373|NCT02202694|CBT, Psychosis, cultural adaptation, Pakistan|cbt, psychosis, cultural adaptation, pakistan
227374|NCT02202681|Duodenum|duodenum
227375|NCT02202681|Optical Frequency Domain Imaging (OFDI)|optical frequency domain imaging (ofdi)
227376|NCT02202681|Optical Coherence Tomography|optical coherence tomography
227377|NCT02202681|Imaging|imaging
227378|NCT02202681|Celiac Disease|celiac disease
227379|NCT02202668|Foot ulcer, diabetic|foot ulcer, diabetic
227380|NCT02202668|Spectrum analysis, Raman|spectrum analysis, raman
227381|NCT02202655|non- small cell lung cancer;|non- small cell lung cancer;
227382|NCT02202655|lymphocyte subsets|lymphocyte subsets
227383|NCT02202616|COPD,|copd,
227384|NCT02202616|QVA149,|qva149,
227385|NCT02202616|Tiotropium,|tiotropium,
227386|NCT02202616|FDC,|fdc,
227387|NCT02202616|GlycOpyrronium With IndacatERol,|glycopyrronium with indacaterol,
227388|NCT02202616|POWER|power
227389|NCT02202590|SECM|secm
227390|NCT02202590|Esophagus|esophagus
227391|NCT02202590|Eosinophilic Esophagitis|eosinophilic esophagitis
227392|NCT02202590|Allergy|allergy
227393|NCT02202577|Surgical site infection|surgical site infection
227394|NCT02202577|Surgical site antisepsis|surgical site antisepsis
227395|NCT02202577|Cesarean Delivery|cesarean delivery
227396|NCT02202564|hepatocellular carcinoma|hepatocellular carcinoma
227397|NCT02202564|liver transplantation|liver transplantation
227398|NCT02202564|adenovirus-thymidine kinase|adenovirus-thymidine kinase
227399|NCT02202564|gene therapy|gene therapy
227400|NCT02202551|Levodopa Induced Dyskinesia|levodopa induced dyskinesia
227401|NCT02202551|LID|lid
227402|NCT02202551|Parkinsonism|parkinsonism
227403|NCT02202551|Parkinson's Disease|parkinson's disease
227404|NCT02202538|SCI|sci
227405|NCT02202538|Indego|indego
227406|NCT02202538|Walking|walking
227407|NCT02202499|pharmacotherapy|pharmacotherapy
227408|NCT02202473|Oxymatrine Capsules, lamivudine, chronic Hepatitis B|oxymatrine capsules, lamivudine, chronic hepatitis b
227409|NCT02202447|EC1169|ec1169
227410|NCT02202447|prostate cancer|prostate cancer
227411|NCT02202447|EC0652|ec0652
227412|NCT02202421|Autism|autism
227413|NCT02202421|Applied Behavior Analysis|applied behavior analysis
227414|NCT02202395|Hydroxytriptolide|hydroxytriptolide
227415|NCT02202395|Rheumatoid Arthritis|rheumatoid arthritis
227416|NCT02202395|Methotrexate|methotrexate
227417|NCT02202395|T8|t8
227418|NCT02202395|LTS|lts
227419|NCT02202369|Multimodal Analgesia|multimodal analgesia
227420|NCT02202369|Pain Management|pain management
227421|NCT02202356|RSV|rsv
227422|NCT02202356|Respiratory Syncytial Virus|respiratory syncytial virus
227423|NCT02202343|Nutrition|nutrition
227424|NCT02202343|Food|food
227425|NCT02202343|Security|security
227426|NCT02202343|School|school
227427|NCT02202343|Health|health
227428|NCT02202317|Liver Cancer|liver cancer
227429|NCT02202317|Hepatic Tumors|hepatic tumors
227430|NCT02202317|Primary Liver Tumors|primary liver tumors
227431|NCT02202317|Metastatic Liver Tumors|metastatic liver tumors
227432|NCT02202317|Yttrium-90|yttrium-90
227433|NCT02202317|Y-90|y-90
227434|NCT02202291|Raynaud's phenomenon, Vasospasm, Genetics|raynaud's phenomenon, vasospasm, genetics
227435|NCT02202278|ovarian hyperstimulation|ovarian hyperstimulation
227436|NCT02202278|Oxidative Stress|oxidative stress
227437|NCT02202278|IMA|ima
227438|NCT02202278|OHSS|ohss
227439|NCT02202278|ICSI|icsi
227440|NCT02202278|long agonist protocol|long agonist protocol
227441|NCT02202278|TAC|tac
227442|NCT02202278|TOS|tos
227443|NCT02202278|OSI|osi
227444|NCT02202278|MDA|mda
227445|NCT02202265|Heart Diseases|heart diseases
227446|NCT02202252|Patient comfort|patient comfort
227447|NCT02202252|Drains|drains
227448|NCT02202252|Breast cancer|breast cancer
227449|NCT02202252|Modified radical mastectomy|modified radical mastectomy
227450|NCT02202252|Seroma|seroma
227451|NCT02202200|Melanoma|melanoma
227452|NCT02202200|BRAF mutated|braf mutated
227453|NCT02202174|supraglottic airway|supraglottic airway
227454|NCT02202174|children|children
227455|NCT02202174|safety|safety
227456|NCT02202174|efficacy|efficacy
227457|NCT02202161|pharmacokinetic|pharmacokinetic
227458|NCT02202161|intestinal bile acid transporter inhibitor|intestinal bile acid transporter inhibitor
227459|NCT02202161|metformin|metformin
227460|NCT02202161|sitagliptin|sitagliptin
227461|NCT02202161|GSK2330672|gsk2330672
227462|NCT02202161|pharmacodynamic|pharmacodynamic
227463|NCT02202148|Fibroscan|fibroscan
227464|NCT02202148|alcohol dependence|alcohol dependence
227465|NCT02202148|alcohol withdrawal|alcohol withdrawal
227466|NCT02202148|controlled attenuation parameter|controlled attenuation parameter
227467|NCT02202148|BDNF|bdnf
227468|NCT02202135|complicated skin and soft tissue infections (cSSTI)|complicated skin and soft tissue infections (cssti)
227469|NCT02202135|skin infection|skin infection
227470|NCT02202135|ceftaroline|ceftaroline
227471|NCT02202135|wound infection|wound infection
227472|NCT02202135|cellulitis|cellulitis
227776|NCT02200861|sedation,|sedation,
227473|NCT02202135|burn infection|burn infection
227474|NCT02202135|bacterial infection|bacterial infection
227475|NCT02202135|vancomycin|vancomycin
227476|NCT02202122|Femoral Neck Fractures|femoral neck fractures
227477|NCT02202122|Obstructive Sleep Apnea|obstructive sleep apnea
227478|NCT02202122|Perioperative Complications|perioperative complications
227479|NCT02202109|Screen|screen
227480|NCT02202109|self-sampler|self-sampler
227481|NCT02202109|cervical, cancer|cervical, cancer
227482|NCT02202109|women|women
227483|NCT02202109|community health workers|community health workers
227484|NCT02202109|Hispanic/ Latinas|hispanic/ latinas
227485|NCT02202109|Haitian|haitian
227486|NCT02202109|Focus of study is cervical cancer|focus of study is cervical cancer
227487|NCT02202083|Oxytocin|oxytocin
227488|NCT02202083|Cook Balloon|cook balloon
227489|NCT02202070|onabotulinumtoxinA|onabotulinumtoxina
227490|NCT02202070|Temporomandibular Joint Disorders|temporomandibular joint disorders
227491|NCT02202070|Bruxism|bruxism
227492|NCT02202070|Temporomandibular Joint Dysfunction Syndrome|temporomandibular joint dysfunction syndrome
227493|NCT02202070|Myofascial Pain Dysfunction Syndrome, Temporomandibular Joint|myofascial pain dysfunction syndrome, temporomandibular joint
227494|NCT02202057|respiratory sensation|respiratory sensation
227495|NCT02202057|somatosensation|somatosensation
227496|NCT02202057|resistive load|resistive load
227497|NCT02202057|magnitude estimation|magnitude estimation
227498|NCT02202044|Bladder Cancer|bladder cancer
227499|NCT02202018|Knowledge Translation|knowledge translation
227500|NCT02202018|Chronic Kidney Disease|chronic kidney disease
227501|NCT02202018|Dialysis|dialysis
227502|NCT02202018|Home dialysis|home dialysis
227503|NCT02202018|Cluster randomized trial|cluster randomized trial
227504|NCT02202005|Bioequivalence|bioequivalence
227505|NCT02201979|breast|breast
227506|NCT02201979|ptosis|ptosis
227507|NCT02201979|sagging|sagging
227508|NCT02201979|implant|implant
227509|NCT02201979|lift|lift
227510|NCT02201966|low back pain|low back pain
227511|NCT02201966|pediatric|pediatric
227512|NCT02201966|gymnasts|gymnasts
227513|NCT02201953|Sofosbuvir|sofosbuvir
227514|NCT02201953|Velpatasvir|velpatasvir
227515|NCT02201953|SOF/VEL|sof/vel
227516|NCT02201953|GS-5816|gs-5816
227517|NCT02201953|Hepatitis C|hepatitis c
227519|NCT02201953|Cirrhosis|cirrhosis
227520|NCT02201953|Genotype 3|genotype 3
227521|NCT02201940|Sofosbuvir|sofosbuvir
227522|NCT02201940|SOF/VEL|sof/vel
227523|NCT02201940|Velpatasvir|velpatasvir
227524|NCT02201940|Hepatitis C|hepatitis c
227525|NCT02201940|HCV|hcv
227526|NCT02201940|cirrhosis|cirrhosis
227527|NCT02201927|galvanic vestibular stimulation|galvanic vestibular stimulation
227528|NCT02201927|right parietal lobe lesion|right parietal lobe lesion
227529|NCT02201927|egocentric space|egocentric space
227530|NCT02201901|Sofosbuvir|sofosbuvir
227531|NCT02201901|Velpatasvir|velpatasvir
227532|NCT02201901|SOF/VEL|sof/vel
227533|NCT02201901|GS-5816|gs-5816
227534|NCT02201901|Hepatitis C|hepatitis c
227535|NCT02201901|HCV|hcv
227536|NCT02201901|Cirrhosis|cirrhosis
227537|NCT02201901|CPT-B|cpt-b
227538|NCT02201888|Schizophrenia|schizophrenia
227539|NCT02201888|Rehabilitation|rehabilitation
227540|NCT02201888|Cognition|cognition
227541|NCT02201875|hypoxia|hypoxia
227542|NCT02201875|exercise|exercise
227543|NCT02201875|periodic breathing|periodic breathing
227544|NCT02201875|hypercapnia|hypercapnia
227545|NCT02201875|apneas|apneas
227546|NCT02201875|cardiac failure|cardiac failure
227547|NCT02201862|Aneuploidy|aneuploidy
227548|NCT02201862|Down Syndrome|down syndrome
227549|NCT02201862|amniocentesis|amniocentesis
227550|NCT02201862|chronic villus sampling|chronic villus sampling
227551|NCT02201862|Trisomy|trisomy
227552|NCT02201862|non-invasive prenatal testing|non-invasive prenatal testing
227553|NCT02201862|Chromosome disorders|chromosome disorders
227554|NCT02201849|Alkermes|alkermes
227555|NCT02201849|ALKS 8700|alks 8700
227556|NCT02201810|smoking cessation|smoking cessation
227557|NCT02201810|quit line|quit line
227558|NCT02201810|nicotine replacement therapy|nicotine replacement therapy
227559|NCT02201810|tobacco intervention|tobacco intervention
227560|NCT02201797|Reproducibility of Results|reproducibility of results
227561|NCT02201797|Liver neoplasm|liver neoplasm
227562|NCT02201797|Neoplasm metastasis|neoplasm metastasis
227563|NCT02201797|Regional Perfusion|regional perfusion
227564|NCT02201797|Perfusion Magnetic Resonance Imaging|perfusion magnetic resonance imaging
227565|NCT02201784|Subarachnoid block|subarachnoid block
227566|NCT02201784|intrathecal|intrathecal
227567|NCT02201784|spinal anesthesia|spinal anesthesia
227568|NCT02201784|isobaric|isobaric
227569|NCT02201784|levobupivacaine|levobupivacaine
227570|NCT02201784|ropivacaine|ropivacaine
227571|NCT02201771|CABG|cabg
227572|NCT02201771|Antiplatelet|antiplatelet
227573|NCT02201771|Ticagrelor|ticagrelor
227574|NCT02201758|Inflammatory Bowel Disease (IBD), ulcerative colitis (UC), flaxseed lignan-enriched complex (FLC)|inflammatory bowel disease (ibd), ulcerative colitis (uc), flaxseed lignan-enriched complex (flc)
227575|NCT02201732|Incomplete miscarriage|incomplete miscarriage
227576|NCT02201732|Hysteroscopy|hysteroscopy
227577|NCT02201732|curettage, pregnancy|curettage, pregnancy
227578|NCT02201732|RCT|rct
227579|NCT02201719|Adenomyosis|adenomyosis
227580|NCT02201719|Dysmenorrhea|dysmenorrhea
227581|NCT02201719|Chronic pelvic pain|chronic pelvic pain
227582|NCT02201719|Infertility|infertility
227583|NCT02201719|Sensitivity histology|sensitivity histology
227584|NCT02201719|womens health|womens health
227585|NCT02201719|junction zone|junction zone
227586|NCT02201706|Retinal detachment|retinal detachment
227587|NCT02201706|silicone oil|silicone oil
227588|NCT02201706|retinectomy|retinectomy
227589|NCT02201693|Crohn's disease,|crohn's disease,
227590|NCT02201693|pediatric GETAID (Therapeutic study group of inflammatory bowel diseases of the child),|pediatric getaid (therapeutic study group of inflammatory bowel diseases of the child),
227591|NCT02201693|enteral nutrition,|enteral nutrition,
227592|NCT02201693|randomized multicenter study|randomized multicenter study
227593|NCT02201680|anxiety|anxiety
227594|NCT02201680|preoperative|preoperative
227595|NCT02201667|non-ST elevation acute coronary syndrome|non-st elevation acute coronary syndrome
227596|NCT02201667|myocardial perfusion|myocardial perfusion
227597|NCT02201667|magnetic Resonance Imaging|magnetic resonance imaging
227598|NCT02201667|antiplatelet|antiplatelet
227599|NCT02201641|Indirect pulp capping|indirect pulp capping
227600|NCT02201641|reversible pulpitis|reversible pulpitis
227601|NCT02201641|periapical radiolucency|periapical radiolucency
227602|NCT02201641|periapical radiographs|periapical radiographs
227603|NCT02201641|cone beam computed tomography|cone beam computed tomography
227604|NCT02201641|calcium silicate cements|calcium silicate cements
227605|NCT02201641|glass ionomer cements|glass ionomer cements
227606|NCT02201641|caries|caries
227607|NCT02201628|Oesophageal|oesophageal
227608|NCT02201628|Nasopharyngeal|nasopharyngeal
227609|NCT02201628|temperature|temperature
227610|NCT02201628|Intubation, endotracheal|intubation, endotracheal
227611|NCT02201628|Pediatric|pediatric
227612|NCT02201628|Anesthesia|anesthesia
227613|NCT02201628|Hypothermia|hypothermia
227614|NCT02201615|Perineal Massage; Episiotomy; Perineal Laceration|perineal massage; episiotomy; perineal laceration
227615|NCT02201602|sulphonylureas|sulphonylureas
227616|NCT02201602|gliclazide|gliclazide
227617|NCT02201602|glibenclamide|glibenclamide
227618|NCT02201589|Lesions in the ascending thoracic aorta|lesions in the ascending thoracic aorta
227619|NCT02201576|Chronic antibody-mediated rejection,|chronic antibody-mediated rejection,
227620|NCT02201576|transplant rejection, kidney transplantation,|transplant rejection, kidney transplantation,
227621|NCT02201576|proteasome inhibitor,|proteasome inhibitor,
227622|NCT02201576|anti-HLA antibodies,|anti-hla antibodies,
227623|NCT02201576|immunosuppressive agents|immunosuppressive agents
227624|NCT02201563|Adverse radiation effects (ARE)|adverse radiation effects (are)
227625|NCT02201563|Radiosurgery|radiosurgery
227626|NCT02201563|Brain metastases|brain metastases
227627|NCT02201563|Minocycline|minocycline
227628|NCT02201537|Ultrasound functional imaging|ultrasound functional imaging
227629|NCT02201537|Chronic kidney Nephropathy|chronic kidney nephropathy
227630|NCT02201524|Phase 2|phase 2
227631|NCT02201524|randomized|randomized
227632|NCT02201524|double-blind|double-blind
227633|NCT02201524|placebo|placebo
227634|NCT02201524|plaque|plaque
227635|NCT02201524|psoriasis|psoriasis
227636|NCT02201524|safety|safety
227637|NCT02201524|efficacy|efficacy
227639|NCT02201524|janus kinase|janus kinase
227640|NCT02201524|moderate|moderate
227641|NCT02201524|severe|severe
227642|NCT02201511|relative bioavailbility|relative bioavailbility
227643|NCT02201511|food effect|food effect
227644|NCT02201511|pharmacokinetics|pharmacokinetics
227645|NCT02201511|ALTERATION OF COGNITIVE FUNCTIONS|alteration of cognitive functions
227646|NCT02201485|Budd-Chiari syndrome|budd-chiari syndrome
227647|NCT02201485|percutaneous recanalization|percutaneous recanalization
227648|NCT02201485|treatment|treatment
227649|NCT02201485|reocclusion|reocclusion
227650|NCT02201485|patency|patency
227651|NCT02201472|liver|liver
227652|NCT02201472|mre|mre
227653|NCT02201472|mri|mri
227654|NCT02201472|neonatal|neonatal
227655|NCT02201472|mr touch|mr touch
227656|NCT02201459|Peg-IFN, nilotinib, MR4.5, CML, chronic phase, first-line|peg-ifn, nilotinib, mr4.5, cml, chronic phase, first-line
227657|NCT02201433|breastfeeding|breastfeeding
227658|NCT02201433|fathers|fathers
227659|NCT02201433|preterm newborns|preterm newborns
227660|NCT02201433|partner influence|partner influence
227661|NCT02201394|Antiplatelet|antiplatelet
227662|NCT02201394|Ticagrelor|ticagrelor
227663|NCT02201394|Platelets|platelets
227664|NCT02201394|Thrombosis|thrombosis
227665|NCT02201394|Coronary artery disease|coronary artery disease
227666|NCT02201381|Cancer|cancer
227667|NCT02201381|Cancer Treatments|cancer treatments
227668|NCT02201381|Cancer Palliative Care|cancer palliative care
227669|NCT02201381|Metabolic|metabolic
227670|NCT02201381|Metabolism|metabolism
227671|NCT02201381|Existing Medicines|existing medicines
227672|NCT02201381|Licensed Medicines|licensed medicines
227673|NCT02201381|Real World|real world
227674|NCT02201381|Breast Cancer|breast cancer
227675|NCT02201381|Triple Negative Breast Cancer|triple negative breast cancer
227676|NCT02201381|Colon Cancer|colon cancer
227677|NCT02201381|Prostrate Cancer|prostrate cancer
227678|NCT02201381|Brain Cancer|brain cancer
227679|NCT02201381|Ovarian Cancer|ovarian cancer
227680|NCT02201381|Pancreatic Cancer|pancreatic cancer
227681|NCT02201381|AML|aml
227682|NCT02201381|CML|cml
227683|NCT02201381|Leukemea|leukemea
227684|NCT02201381|Metformin|metformin
227685|NCT02201381|Statins|statins
227686|NCT02201381|Mebendazole|mebendazole
227687|NCT02201381|Doxycycline|doxycycline
227688|NCT02201381|Ibuprofen|ibuprofen
227689|NCT02201381|Metastatic|metastatic
227690|NCT02201368|Triglycerides; Lipid Metabolism; Fatty Acids.|triglycerides; lipid metabolism; fatty acids.
227691|NCT02201355|Head and Neck cancer|head and neck cancer
227692|NCT02201342|Fontan|fontan
227693|NCT02201342|Pharmacokinetics|pharmacokinetics
227694|NCT02201342|Pharmacodynamics|pharmacodynamics
227695|NCT02201342|Exercise capacity|exercise capacity
227696|NCT02201342|Maximal Oxygen Consumption|maximal oxygen consumption
227697|NCT02201342|Vascular function|vascular function
227698|NCT02201342|EndoPAT|endopat
227699|NCT02201342|Myocardial performance|myocardial performance
227700|NCT02201316|Healthy adult human subjects|healthy adult human subjects
227701|NCT02201316|Mosapride citrate anhydrous|mosapride citrate anhydrous
227702|NCT02201316|Bioequivalence|bioequivalence
227703|NCT02201316|Dyspepsia|dyspepsia
227704|NCT02201303|CD11b|cd11b
227705|NCT02201303|Neutrophils|neutrophils
227706|NCT02201303|CXCL1|cxcl1
227707|NCT02201303|Danirixin|danirixin
227708|NCT02201303|Respiratory Syncytial Virus|respiratory syncytial virus
227709|NCT02201303|Children|children
227710|NCT02201303|CXCR2|cxcr2
227711|NCT02201290|Chronic immune thrombocytopenic purpura, ITP, eltrombopag olamine, thrombopoietin receptor agonist, pediatrics|chronic immune thrombocytopenic purpura, itp, eltrombopag olamine, thrombopoietin receptor agonist, pediatrics
227712|NCT02201277|IVC|ivc
227713|NCT02201277|IVC Filter|ivc filter
227714|NCT02201277|Filter|filter
227715|NCT02201277|Option|option
227716|NCT02201277|Denali|denali
227717|NCT02201277|filter tilt|filter tilt
227718|NCT02201277|filter migration|filter migration
227719|NCT02201277|filter fracture|filter fracture
227720|NCT02201277|filter thrombus|filter thrombus
227721|NCT02201277|filter penetration|filter penetration
227722|NCT02201264|myocardial infarction|myocardial infarction
227723|NCT02201264|Angioplasty|angioplasty
227724|NCT02201264|Stent|stent
227725|NCT02201251|Epilepsy|epilepsy
227726|NCT02201251|Topiramate|topiramate
227727|NCT02201251|Levetiracetam|levetiracetam
227728|NCT02201251|Pediatric|pediatric
227729|NCT02201212|TSC1|tsc1
227730|NCT02201212|TSC2|tsc2
227731|NCT02201212|Tuberous Sclerosis Complex|tuberous sclerosis complex
227732|NCT02201212|MTOR|mtor
227733|NCT02201186|honey enema for pouchitis|honey enema for pouchitis
227734|NCT02201160|NAFLD|nafld
227735|NCT02201160|Fatty acid composition|fatty acid composition
227736|NCT02201160|Omega 3 supplementation|omega 3 supplementation
227737|NCT02201160|Metabolism|metabolism
227738|NCT02201134|Cardiac arrest|cardiac arrest
227739|NCT02201134|Therapeutic hypothermia|therapeutic hypothermia
227740|NCT02201134|Sevoflurane|sevoflurane
227741|NCT02201134|Sedation|sedation
227742|NCT02201134|Patient resuscitated from cardiac arrest|patient resuscitated from cardiac arrest
227743|NCT02201134|Requiring sedation|requiring sedation
227744|NCT02201134|Adult patients|adult patients
227745|NCT02201134|Patient covered by french health care system|patient covered by french health care system
227746|NCT02201095|caesarean section|caesarean section
227747|NCT02201095|perioperative hypothermia|perioperative hypothermia
227748|NCT02201095|active warming|active warming
227749|NCT02201095|forced air warming|forced air warming
227750|NCT02201095|conduction mattress warming|conduction mattress warming
227751|NCT02201095|thermal comfort|thermal comfort
227752|NCT02201095|Prevention of|prevention of
227753|NCT02201069|nutrition|nutrition
227754|NCT02201069|physical activity|physical activity
227755|NCT02201069|sleep|sleep
227756|NCT02201069|weight loss|weight loss
227757|NCT02201056|Drug Therapy|drug therapy
227758|NCT02201043|ankylosing spondylitis|ankylosing spondylitis
227759|NCT02201043|thalidomide|thalidomide
227760|NCT02200952|OHSS|ohss
227761|NCT02200952|Oocytes triggering|oocytes triggering
227762|NCT02200952|GnRh agonist triggering|gnrh agonist triggering
227763|NCT02200952|Luteal phase supplementation|luteal phase supplementation
227764|NCT02200952|recombinant LH|recombinant lh
227765|NCT02200900|High flow nasal cannula|high flow nasal cannula
227766|NCT02200900|Continuous Positive Airway Pressure|continuous positive airway pressure
227767|NCT02200900|Respiratory physiology|respiratory physiology
227768|NCT02200887|Dyskinesia|dyskinesia
227769|NCT02200887|Slow Wave Sleep|slow wave sleep
227770|NCT02200874|disease related malnutrition|disease related malnutrition
227771|NCT02200874|influence of Nutrition Support Team|influence of nutrition support team
227772|NCT02200874|length of hospital stay|length of hospital stay
227773|NCT02200874|quality of life|quality of life
227774|NCT02200874|body composition|body composition
227775|NCT02200874|health care costs|health care costs
227777|NCT02200861|tooth extraction,|tooth extraction,
227778|NCT02200848|Lenalidomide|lenalidomide
227779|NCT02200848|Ibrutinib|ibrutinib
227780|NCT02200848|Rituximab|rituximab
227781|NCT02200848|CLL|cll
227782|NCT02200848|SLL|sll
227783|NCT02200835|aortic dissection|aortic dissection
227784|NCT02200835|Chinese patients|chinese patients
227785|NCT02200835|gender differences|gender differences
227786|NCT02200822|neurohumoral blocker therapy|neurohumoral blocker therapy
227787|NCT02200822|renin-angiotensin-aldosterone system (RAAS)|renin-angiotensin-aldosterone system (raas)
227788|NCT02200822|RAAS-blocker|raas-blocker
227789|NCT02200822|beta blocker|beta blocker
227790|NCT02200822|spironolactone|spironolactone
227791|NCT02200822|angiotensin converting enzyme inhibitor (ACE-I)|angiotensin converting enzyme inhibitor (ace-i)
227792|NCT02200822|angiotensin receptor blocker (ARB)|angiotensin receptor blocker (arb)
227793|NCT02200822|cardiac resynchronization therapy (CRT)|cardiac resynchronization therapy (crt)
227794|NCT02200822|heart failure|heart failure
227795|NCT02200822|dyssynchrony|dyssynchrony
227796|NCT02200822|left bundle branch block|left bundle branch block
227797|NCT02200809|MR-guided therapy|mr-guided therapy
227798|NCT02200809|Focal laser ablation|focal laser ablation
227799|NCT02200809|Prostate cancer|prostate cancer
227800|NCT02200796|Dietary Protein|dietary protein
227801|NCT02200796|Satiety|satiety
227802|NCT02200796|Food Intake|food intake
227803|NCT02200796|Thermic Effect of Food|thermic effect of food
227804|NCT02200796|Diet Induced Thermogenesis|diet induced thermogenesis
227805|NCT02200783|Cardiac catheterization|cardiac catheterization
227806|NCT02200783|Radiation Protection|radiation protection
227807|NCT02200783|Radial artery|radial artery
227808|NCT02200783|Femoral artery|femoral artery
227809|NCT02200770|NMO, NMOSD, Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorders, autoimmune, demyelination, MEDI-551, monoclonal antibody, Devic's syndrome, B-cell|nmo, nmosd, neuromyelitis optica, neuromyelitis optica spectrum disorders, autoimmune, demyelination, medi-551, monoclonal antibody, devic's syndrome, b-cell
227810|NCT02200744|Procedural sedation|procedural sedation
227811|NCT02200744|emergency department|emergency department
227812|NCT02200744|adults|adults
227813|NCT02200744|propofol|propofol
227814|NCT02200744|recall assessment|recall assessment
227815|NCT02200731|Childhood cancer|childhood cancer
227816|NCT02200731|Psychosocial intervention|psychosocial intervention
227817|NCT02200731|Family|family
227818|NCT02200731|Siblings|siblings
227819|NCT02200731|Childhood cancer survivors|childhood cancer survivors
227820|NCT02200731|Cogntive Behavioural|cogntive behavioural
227821|NCT02200731|Manualized|manualized
227822|NCT02200718|Multiple Sclerosis Pediatric MS NeuroVax Vaccine Therapeutic|multiple sclerosis pediatric ms neurovax vaccine therapeutic
227823|NCT02200705|cryoablation, cryotherapy, breast cancer|cryoablation, cryotherapy, breast cancer
227824|NCT02200692|plasma transfusion|plasma transfusion
227825|NCT02200692|allergic transfusion reaction|allergic transfusion reaction
227826|NCT02200692|transfusion reaction|transfusion reaction
227827|NCT02200692|blood transfusion|blood transfusion
227828|NCT02200692|Solvent detergent plasma|solvent detergent plasma
227829|NCT02200679|Autism spectrum disorders|autism spectrum disorders
227830|NCT02200679|Prevalence|prevalence
227831|NCT02200679|Diagnosis|diagnosis
227832|NCT02200679|Screen|screen
227833|NCT02200679|Risk Factor|risk factor
227834|NCT02200679|SRS|srs
227835|NCT02200679|ASRS|asrs
227836|NCT02200666|Type 2 diabetes mellitus|type 2 diabetes mellitus
227837|NCT02200666|Diabetes|diabetes
227838|NCT02200666|Forxiga|forxiga
227839|NCT02200666|Long-term use|long-term use
227840|NCT02200627|Type 2 diabetes mellitus|type 2 diabetes mellitus
227841|NCT02200627|Diabetes|diabetes
227842|NCT02200627|Forxiga|forxiga
227843|NCT02200627|Elderly|elderly
227844|NCT02200601|Seipher Wellness|seipher wellness
227845|NCT02200601|algorithm|algorithm
227846|NCT02200601|secure samples of SGC waveform|secure samples of sgc waveform
227847|NCT02200601|volunteers|volunteers
227848|NCT02200601|validation|validation
227849|NCT02200601|heart health algorithm|heart health algorithm
227850|NCT02200588|psychosis|psychosis
227851|NCT02200588|schizophrenia|schizophrenia
227852|NCT02200549|pulmonary rehabilitation|pulmonary rehabilitation
227853|NCT02200549|inspiratory muscle training|inspiratory muscle training
227854|NCT02200549|exercise training|exercise training
227855|NCT02200523|EEG|eeg
227856|NCT02200523|electrode|electrode
227857|NCT02200510|Anemia, Sickle Cell|anemia, sickle cell
227858|NCT02200510|Transition to Adult Care|transition to adult care
227859|NCT02200510|Self Care|self care
227860|NCT02200510|Personal Electronic Health Records|personal electronic health records
227861|NCT02200510|Adolescent|adolescent
227862|NCT02200510|Young Adult|young adult
227863|NCT02200510|Disease Management|disease management
227864|NCT02200510|Physician-Patient Relations|physician-patient relations
227865|NCT02200484|obesity|obesity
227866|NCT02200484|adolescents, females|adolescents, females
227867|NCT02200484|child development|child development
227868|NCT02200484|weight loss programs|weight loss programs
227869|NCT02200484|child rearing|child rearing
227870|NCT02200484|parenting|parenting
227871|NCT02200471|Cosmetic dermatology|cosmetic dermatology
227872|NCT02200471|near-infrared|near-infrared
227873|NCT02200471|patient preference|patient preference
227874|NCT02200471|physician preference|physician preference
227875|NCT02200445|Ulcerative colitis|ulcerative colitis
227876|NCT02200445|Inflammatory bowel disease|inflammatory bowel disease
227877|NCT02200445|Interleukin 2|interleukin 2
227878|NCT02200445|Interleukin-2|interleukin-2
227879|NCT02200445|IL-2|il-2
227880|NCT02200445|Regulatory T Cells|regulatory t cells
227881|NCT02200445|Tregs|tregs
227882|NCT02200445|T-Lymphocytes, Regulatory|t-lymphocytes, regulatory
227883|NCT02200432|Smoking Cessation|smoking cessation
227884|NCT02200432|Persuasive Communication Tailoring|persuasive communication tailoring
227885|NCT02200432|Health Behavior Change|health behavior change
227886|NCT02200432|Patient decision support|patient decision support
227887|NCT02200419|Rotem|rotem
227888|NCT02200419|Point of care coagulation tests|point of care coagulation tests
227889|NCT02200419|Cardiac surgery|cardiac surgery
227890|NCT02200419|Vascular surgery|vascular surgery
227891|NCT02200419|Cardiopulmonary bypass|cardiopulmonary bypass
227892|NCT02200419|Blood products|blood products
227893|NCT02200419|Transfusion|transfusion
227894|NCT02200419|Viscoelastic coagulation|viscoelastic coagulation
227895|NCT02200406|Desvenlafaxine|desvenlafaxine
227896|NCT02200406|Opioid-dependent|opioid-dependent
227897|NCT02200406|Addiction|addiction
227898|NCT02200406|Depression|depression
227899|NCT02200406|Methadone|methadone
227900|NCT02200406|Comorbidity|comorbidity
227901|NCT02200393|Spinal cord injury|spinal cord injury
227902|NCT02200393|Tetraplegia|tetraplegia
227903|NCT02200393|Ventilator|ventilator
227904|NCT02200367|Primary health care|primary health care
227905|NCT02200367|Computer communication network|computer communication network
227906|NCT02200367|Depression|depression
227907|NCT02200328|Clostridium difficile infection|clostridium difficile infection
227908|NCT02200328|Diarrhea|diarrhea
227909|NCT02200328|Flagyl|flagyl
227910|NCT02200328|Metronidazole|metronidazole
227911|NCT02200315|Stomach neoplasms|stomach neoplasms
227912|NCT02200315|Surgical site infection|surgical site infection
227913|NCT02200315|Laparoscopic gastrectomy|laparoscopic gastrectomy
227914|NCT02200315|Antimicrobial prophylaxis|antimicrobial prophylaxis
227915|NCT02200289|Birth cohort|birth cohort
227916|NCT02200289|Ghana|ghana
227917|NCT02200289|Biomass|biomass
227918|NCT02200289|Cook stove|cook stove
227919|NCT02200289|Oxidative stress|oxidative stress
227920|NCT02200289|Lung development|lung development
227921|NCT02200263|ocular albinism (OA)|ocular albinism (oa)
227922|NCT02200263|oculocutaneous albinism (OCA)|oculocutaneous albinism (oca)
227923|NCT02200263|macular pigment|macular pigment
227924|NCT02200263|visual function|visual function
227925|NCT02200237|EV71 Vaccine|ev71 vaccine
227926|NCT02200211|Amblyopia|amblyopia
227927|NCT02200198|undernutrition|undernutrition
227928|NCT02200198|abdominal surgery|abdominal surgery
227929|NCT02200198|respiratory muscles|respiratory muscles
227930|NCT02200198|muscles strength|muscles strength
227931|NCT02200198|pulmonary complication|pulmonary complication
227932|NCT02200198|perioperative care|perioperative care
227933|NCT02200185|post traumatic pain|post traumatic pain
227934|NCT02200185|titrated morphine|titrated morphine
227935|NCT02200185|nebulised morphine|nebulised morphine
227936|NCT02200172|Cancer|cancer
227937|NCT02200172|Melatonin|melatonin
227938|NCT02200172|Delirium|delirium
227939|NCT02200172|Feasibility Studies|feasibility studies
227940|NCT02200172|Palliative Care|palliative care
227941|NCT02200159|Sedation|sedation
227942|NCT02200159|Dexmedetomidine|dexmedetomidine
227943|NCT02200159|ICU|icu
227944|NCT02200159|Delirium|delirium
227945|NCT02200146|sarcoidosis|sarcoidosis
227946|NCT02200146|treatment|treatment
227947|NCT02200146|lung|lung
227948|NCT02200146|glucocorticoids|glucocorticoids
227949|NCT02200146|hydroxychloroquine|hydroxychloroquine
227950|NCT02200133|Hematopoietic cell transplant (HCT) survivors|hematopoietic cell transplant (hct) survivors
227951|NCT02200133|Survivorship Care Plan|survivorship care plan
227952|NCT02200107|Osteoarthritis Knee|osteoarthritis knee
227953|NCT02200107|Self Care|self care
227954|NCT02200107|Treatment Outcome|treatment outcome
227955|NCT02200107|Patient Education as Topic|patient education as topic
227956|NCT02200107|Physical Therapy Modalities|physical therapy modalities
227957|NCT02200081|Extensive disease|extensive disease
227958|NCT02200081|After first line therapy|after first line therapy
227959|NCT02200081|Immuno therapy|immuno therapy
227960|NCT02200068|Perceived Efficacy of Patient Physician Interactions|perceived efficacy of patient physician interactions
227961|NCT02200068|Patient Reported Outcomes|patient reported outcomes
227962|NCT02200068|Personal Health Record|personal health record
227963|NCT02200055|Electrical Bioimpedance|electrical bioimpedance
227964|NCT02200055|Major Intra-abdominal Surgical Procedures|major intra-abdominal surgical procedures
227965|NCT02200055|Total Body Volume|total body volume
227966|NCT02200055|Fluid Resuscitation|fluid resuscitation
227967|NCT02200029|Intrahepatic Cholestasis|intrahepatic cholestasis
227968|NCT02200016|Postoperative pain|postoperative pain
227969|NCT02200016|Regional anesteshia|regional anesteshia
227970|NCT02200016|Nerve catheters|nerve catheters
227971|NCT02200016|Sciatic nerve catheters|sciatic nerve catheters
227972|NCT02200003|attention bias modification, anxiety, event-related potentials|attention bias modification, anxiety, event-related potentials
227973|NCT02199990|cognitive function; propofol; etomidate;|cognitive function; propofol; etomidate;
227974|NCT02199977|Malaria|malaria
227975|NCT02199977|Antimalarial subsidy|antimalarial subsidy
227976|NCT02199977|Malaria rapid diagnostic test (RDT)|malaria rapid diagnostic test (rdt)
227977|NCT02199977|public-private partnership|public-private partnership
227978|NCT02199964|Dry eye|dry eye
227979|NCT02199964|environmental stress|environmental stress
227980|NCT02199964|artificial tears|artificial tears
227981|NCT02199964|cyclosporin|cyclosporin
227982|NCT02199964|Restasis|restasis
227983|NCT02199951|Uncomplicated Malaria|uncomplicated malaria
227984|NCT02199951|dihydroartemisinin|dihydroartemisinin
227985|NCT02199951|piperaquine|piperaquine
227986|NCT02199925|Autism|autism
227987|NCT02199925|Autism spectrum|autism spectrum
227988|NCT02199925|Autism children|autism children
227989|NCT02199912|cachexia|cachexia
227990|NCT02199912|nutrition|nutrition
227991|NCT02199912|cancer|cancer
227992|NCT02199912|colorectal tumor|colorectal tumor
227993|NCT02199834|diabetes|diabetes
227994|NCT02199834|peer support|peer support
227995|NCT02199834|personalized feedback report|personalized feedback report
227996|NCT02199795|stroke|stroke
227997|NCT02199795|hemiplegia|hemiplegia
227998|NCT02199795|footdrop|footdrop
227999|NCT02199795|electrical stimulation|electrical stimulation
228000|NCT02199769|Clinical decision support|clinical decision support
228001|NCT02199769|Diabetes screening|diabetes screening
228002|NCT02199756|Uterine contractions|uterine contractions
228003|NCT02199756|Indomethacin|indomethacin
228004|NCT02199756|Nanovectors|nanovectors
228005|NCT02199743|schizophrenia|schizophrenia
228006|NCT02199743|schizoaffective|schizoaffective
228007|NCT02199743|cognition|cognition
228008|NCT02199743|lurasidone|lurasidone
228009|NCT02199743|Latuda|latuda
228010|NCT02199717|Physical Activity|physical activity
228011|NCT02199717|Accelerometer|accelerometer
228012|NCT02199717|Exercise|exercise
228013|NCT02199717|Obesity|obesity
228014|NCT02199717|BMI|bmi
228015|NCT02199704|Parenting|parenting
228016|NCT02199704|Psychosis|psychosis
228017|NCT02199704|Schizophrenia|schizophrenia
228018|NCT02199704|Delusions|delusions
228019|NCT02199704|Hallucinations|hallucinations
228020|NCT02199691|Meningitis|meningitis
228021|NCT02199691|Meningococcal Meningitis|meningococcal meningitis
228022|NCT02199691|MenACYW conjugate vaccine|menacyw conjugate vaccine
228023|NCT02199691|MENVEO vaccine|menveo vaccine
228024|NCT02199691|Adacel®|adacel®
228025|NCT02199691|GARDASIL®|gardasil®
228026|NCT02199639|Haemophilia|haemophilia
228027|NCT02199639|Arthropathy|arthropathy
228028|NCT02199639|Range of Movement|range of movement
228029|NCT02199639|Strength|strength
228030|NCT02199639|Proprioception|proprioception
228031|NCT02199639|Gait|gait
228032|NCT02199639|Quality of Life|quality of life
228033|NCT02199613|HIV|hiv
228034|NCT02199613|antiretroviral therapy|antiretroviral therapy
228035|NCT02199587|Medical clown|medical clown
228036|NCT02199587|Growth hormone|growth hormone
228037|NCT02199587|Precocious puberty|precocious puberty
228038|NCT02199548|Adolescent|adolescent
228039|NCT02199548|Decision-making|decision-making
228040|NCT02199548|Social network|social network
228041|NCT02199535|operating room,|operating room,
228042|NCT02199535|risk factors|risk factors
228043|NCT02199535|anesthesiologists|anesthesiologists
228044|NCT02199509|Levetiracetam|levetiracetam
228045|NCT02199509|Cranial Dystonia|cranial dystonia
228046|NCT02199509|Oromandibular Dystonia|oromandibular dystonia
228047|NCT02199496|Malabsorption|malabsorption
228048|NCT02199496|Enteropathy|enteropathy
228049|NCT02199496|Diarrhea|diarrhea
228050|NCT02199496|IL-23|il-23
228051|NCT02199496|IL-12|il-12
228052|NCT02199483|Energy Expenditure|energy expenditure
228053|NCT02199483|Behavioral Weight Loss Treatment|behavioral weight loss treatment
228054|NCT02199483|Neurocognitive Function|neurocognitive function
228055|NCT02199483|Weight Loss|weight loss
228056|NCT02199470|β-CELLS,|β-cells,
228057|NCT02199470|MIXED MEAL TEST,|mixed meal test,
228058|NCT02199470|C-PEPTİDE|c-peptide
228059|NCT02199431|Lu AF11167|lu af11167
228060|NCT02199431|Interaction|interaction
228061|NCT02199405|Spondylosis, Massage Therapy, Exercise Therapy ,Treatment Efficacy|spondylosis, massage therapy, exercise therapy ,treatment efficacy
228062|NCT02199392|P-glycoprotein|p-glycoprotein
228063|NCT02199392|Healthy Volunteers|healthy volunteers
228064|NCT02199379|renal impairment|renal impairment
228065|NCT02199379|disease severity|disease severity
228066|NCT02199366|Cardiac MRI|cardiac mri
228067|NCT02199366|Radiation|radiation
228068|NCT02199366|Proton Radiation|proton radiation
228069|NCT02199366|Breast Cancer|breast cancer
228070|NCT02199353|Activities of daily living, Occupational Therapy, Dementia|activities of daily living, occupational therapy, dementia
228071|NCT02199340|Exercise testing|exercise testing
228072|NCT02199340|Children|children
228073|NCT02199340|Exercise capacity|exercise capacity
228074|NCT02199327|Conjunctival-corneal intraepithelial neoplasia|conjunctival-corneal intraepithelial neoplasia
228075|NCT02199327|Mitomycin C|mitomycin c
228076|NCT02199327|Interferon alfa 2b|interferon alfa 2b
228077|NCT02199314|intra|intra
228078|NCT02199314|operative|operative
228079|NCT02199314|neurophysiologic|neurophysiologic
228080|NCT02199314|monitoring|monitoring
228081|NCT02199314|transcranial|transcranial
228082|NCT02199314|motor|motor
228083|NCT02199314|evoked|evoked
228084|NCT02199314|potential|potential
228085|NCT02199314|anesthesia|anesthesia
228086|NCT02199314|pulses|pulses
228087|NCT02199301|Kidney transplantation|kidney transplantation
228088|NCT02199301|Tolerance induction|tolerance induction
228089|NCT02199301|Immunosuppression withdrawal|immunosuppression withdrawal
228090|NCT02199301|Bone marrow transplantation|bone marrow transplantation
228091|NCT02199301|Transplantation conditioning|transplantation conditioning
228092|NCT02199301|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
228093|NCT02199301|Living donor|living donor
228094|NCT02199301|Haplotype|haplotype
228095|NCT02199301|Immune tolerance|immune tolerance
228096|NCT02199275|Non-urgent surgery|non-urgent surgery
228097|NCT02199275|General anesthesia|general anesthesia
228098|NCT02199275|Enterocyte damage|enterocyte damage
228099|NCT02199275|Intestinal fatty acid-binding protein|intestinal fatty acid-binding protein
228100|NCT02199262|Intensive care unit|intensive care unit
228101|NCT02199262|Incidents|incidents
228102|NCT02199262|prevention|prevention
228103|NCT02199262|music|music
228104|NCT02199262|reflexology|reflexology
228105|NCT02199249|open anatomic reduction|open anatomic reduction
228106|NCT02199249|syndesmosis screw fixation, syndesmosis Tightrope fixation|syndesmosis screw fixation, syndesmosis tightrope fixation
228107|NCT02199236|High-Dose-Rate Brachytherapy|high-dose-rate brachytherapy
228108|NCT02199236|oral capecitabine|oral capecitabine
228109|NCT02199236|infusional 5-FU|infusional 5-fu
228110|NCT02199236|Questionnaires|questionnaires
228111|NCT02199236|14-104|14-104
228112|NCT02199210|Massive transfusion protocols|massive transfusion protocols
228113|NCT02199210|Self-regulatory learning|self-regulatory learning
228114|NCT02199210|Forethought|forethought
228115|NCT02199210|Clinical expertise|clinical expertise
228116|NCT02199210|Simulation|simulation
228117|NCT02199210|Education|education
228118|NCT02199184|Leukemia|leukemia
228119|NCT02199184|Burkitt leukemia|burkitt leukemia
228120|NCT02199184|Burkitt-like leukemia/lymphoma|burkitt-like leukemia/lymphoma
228121|NCT02199184|Newly diagnosed|newly diagnosed
228122|NCT02199184|Relapsed/refractory|relapsed/refractory
228123|NCT02199184|Ofatumumab|ofatumumab
228124|NCT02199184|Arzerra|arzerra
228125|NCT02199184|Etoposide|etoposide
228126|NCT02199184|VePesid|vepesid
228127|NCT02199184|Doxorubicin|doxorubicin
228128|NCT02199184|Doxorubicin Hydrochloride|doxorubicin hydrochloride
228129|NCT02199184|Adriamycin PFS|adriamycin pfs
228130|NCT02199184|Adriamycin RDF|adriamycin rdf
228131|NCT02199184|Adriamycin|adriamycin
228132|NCT02199184|Rubex|rubex
228133|NCT02199184|Vincristine|vincristine
228134|NCT02199184|Cyclophosphamide|cyclophosphamide
228135|NCT02199184|Cytoxan|cytoxan
228136|NCT02199184|Neosar|neosar
228137|NCT02199184|Prednisone|prednisone
228138|NCT02199184|Rituximab|rituximab
228139|NCT02199184|Rituxan|rituxan
228140|NCT02199184|DA-EPOCH|da-epoch
228141|NCT02199184|Pegfilgrastim|pegfilgrastim
228142|NCT02199184|Neulasta|neulasta
228143|NCT02199184|PEG-G-CSF|peg-g-csf
228144|NCT02199184|G-CSF|g-csf
228145|NCT02199184|Filgrastim|filgrastim
228146|NCT02199184|Neupogen|neupogen
228147|NCT02199184|Phone calls|phone calls
228148|NCT02199171|hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) carboplatin|hyperthermic intraoperative intraperitoneal chemotherapy (hipec) carboplatin
228149|NCT02199171|intraperitoneal (IP) chemotherapy|intraperitoneal (ip) chemotherapy
228150|NCT02199171|cytoreductive surgery|cytoreductive surgery
228151|NCT02199158|iridoplasty|iridoplasty
228152|NCT02199158|angle|angle
228153|NCT02199158|glaucoma|glaucoma
228154|NCT02199158|anterior chamber|anterior chamber
228155|NCT02199158|laser treatment|laser treatment
228156|NCT02199132|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
228157|NCT02199119|children|children
228158|NCT02199119|television|television
228159|NCT02199119|exercise|exercise
228160|NCT02199119|food intake|food intake
228161|NCT02199119|appetite|appetite
228162|NCT02199119|satiation|satiation
228163|NCT02199093|MeSH terms:|mesh terms:
228164|NCT02199093|Apraxias|apraxias
228165|NCT02199093|Apraxia, Ideomotor|apraxia, ideomotor
228166|NCT02199093|Stroke|stroke
228167|NCT02199093|Cerebral Stroke|cerebral stroke
228168|NCT02199093|Rehabilitation|rehabilitation
228169|NCT02199093|Occupational therapy|occupational therapy
228170|NCT02199093|Treatment Outcome|treatment outcome
228171|NCT02199093|Activities of Daily Living|activities of daily living
228172|NCT02199054|Snack Foods|snack foods
228173|NCT02199054|Safflower Oil|safflower oil
228174|NCT02199054|Soy|soy
228175|NCT02199054|Postmenopausal women|postmenopausal women
228176|NCT02199054|Metabolic Syndrome|metabolic syndrome
228177|NCT02199041|Cord Blood|cord blood
228178|NCT02199041|Haploidentical|haploidentical
228179|NCT02199041|Reduced Intensity Regimen|reduced intensity regimen
228180|NCT02199028|hyaluronidase|hyaluronidase
228181|NCT02199028|infusion sets|infusion sets
228182|NCT02199028|insulin pump|insulin pump
228183|NCT02199028|Continuous glucose monitor|continuous glucose monitor
228184|NCT02199015|Dysarthria|dysarthria
228185|NCT02199015|Electrical Stimulation|electrical stimulation
228186|NCT02199015|Lateral Cord Stimulation|lateral cord stimulation
228187|NCT02199015|Spasticity|spasticity
228188|NCT02199015|Treatment|treatment
228189|NCT02199002|acid pocket|acid pocket
228190|NCT02199002|GERD|gerd
228191|NCT02199002|Barrett|barrett
228192|NCT02198963|Skin irritation potential of RUT058-60.|skin irritation potential of rut058-60.
228193|NCT02198950|sepsis|sepsis
228194|NCT02198950|diagnosis|diagnosis
228195|NCT02198950|biomarker|biomarker
228196|NCT02198937|smokers|smokers
228197|NCT02198937|non-smokers|non-smokers
228198|NCT02198924|sequential administration|sequential administration
228199|NCT02198924|pain control|pain control
228200|NCT02198924|inflammation control|inflammation control
228201|NCT02198924|function recovery|function recovery
228202|NCT02198911|Habituation|habituation
228203|NCT02198911|Orosensory cues|orosensory cues
228204|NCT02198911|Satiation|satiation
228205|NCT02198885|FAST|fast
228206|NCT02198885|Thoracoabdominal Trauma|thoracoabdominal trauma
228207|NCT02198885|Prehospital care|prehospital care
228208|NCT02198885|ultrasound|ultrasound
228209|NCT02198885|NanoMaxx Ultrasound|nanomaxx ultrasound
228210|NCT02198885|RP-Xpress|rp-xpress
228211|NCT02198872|Autonomic Nervous System, Body composition, Oxygen Uptake,|autonomic nervous system, body composition, oxygen uptake,
228212|NCT02198872|Water Based Physical Training, Land Based Physical Training.|water based physical training, land based physical training.
228213|NCT02198859|Prostate Cancer|prostate cancer
228214|NCT02198859|Lithium|lithium
228215|NCT02198859|Androgen|androgen
228216|NCT02198859|PSA|psa
228217|NCT02198833|Urinary Tract Infection|urinary tract infection
228218|NCT02198833|Bacteriuria|bacteriuria
228219|NCT02198833|Transurethral Foley Catheter|transurethral foley catheter
228220|NCT02198833|Suprapubic Foley Catheter|suprapubic foley catheter
228221|NCT02198833|Spinal Cord injury|spinal cord injury
228222|NCT02198820|Femoral Neck Fractures|femoral neck fractures
228223|NCT02198820|Perioperative Care|perioperative care
228224|NCT02198820|Perioperative Period|perioperative period
228225|NCT02198820|Postoperative Complications|postoperative complications
228226|NCT02198794|Dyskinesias|dyskinesias
228227|NCT02198794|Movement Disorders|movement disorders
228228|NCT02198794|Central Nervous System Diseases|central nervous system diseases
228229|NCT02198794|Nervous System Diseases|nervous system diseases
228230|NCT02198794|Neurologic Manifestations|neurologic manifestations
228231|NCT02198794|Signs and Symptoms|signs and symptoms
228232|NCT02198781|atrial fibrilation|atrial fibrilation
228233|NCT02198781|atrial-ventricula|atrial-ventricula
228234|NCT02198781|right ventricle|right ventricle
228235|NCT02198781|left ventricle|left ventricle
228236|NCT02198781|surrogate marker|surrogate marker
228237|NCT02198781|ventricular dysfunction|ventricular dysfunction
228238|NCT02198781|pacing|pacing
228239|NCT02198768|ankle fracture|ankle fracture
228240|NCT02198768|ankle fracture-dislocation|ankle fracture-dislocation
228241|NCT02198768|prospective|prospective
228242|NCT02198768|observational|observational
228243|NCT02198755|high resolution ultrasound|high resolution ultrasound
228244|NCT02198755|osteomyelitis|osteomyelitis
228245|NCT02198716|Percutaneous coronary intervention|percutaneous coronary intervention
228246|NCT02198716|Elderly|elderly
228247|NCT02198716|Angina|angina
228248|NCT02198703|Probiotics|probiotics
228249|NCT02198703|AB-Life|ab-life
228250|NCT02198703|LDL-cholesterol|ldl-cholesterol
228251|NCT02198703|Hypercholesterolemia|hypercholesterolemia
228252|NCT02198690|Mammography, Older women, decision making|mammography, older women, decision making
228253|NCT02198664|Characterized Peanut Allergen|characterized peanut allergen
228254|NCT02198664|Peanut|peanut
228255|NCT02198664|OIT|oit
228256|NCT02198664|Oral Desensitization|oral desensitization
228257|NCT02198664|Peanut Allergen|peanut allergen
228258|NCT02198664|Peanut-Allergic Children|peanut-allergic children
228259|NCT02198664|Children|children
228260|NCT02198664|Peanut-Allergic Adults|peanut-allergic adults
228261|NCT02198651|Rheumatoid Arthritis|rheumatoid arthritis
228262|NCT02198651|Adalimumab|adalimumab
228263|NCT02198651|Taper|taper
228264|NCT02198651|Flare|flare
228265|NCT02198651|Arthritis|arthritis
228266|NCT02198651|Anti-rheumatic drugs|anti-rheumatic drugs
228267|NCT02198651|Remission|remission
228268|NCT02198651|Magnetic Resonance Imaging|magnetic resonance imaging
228269|NCT02198651|Ultrasound|ultrasound
228270|NCT02198651|Biomarker|biomarker
228271|NCT02198651|Drug Level|drug level
228272|NCT02198651|Reduced dose|reduced dose
228273|NCT02198638|Influenza|influenza
228274|NCT02198638|Vaccination rate|vaccination rate
228275|NCT02198638|Hospital acquired infection|hospital acquired infection
228276|NCT02198625|Moderate FiO2|moderate fio2
228277|NCT02198625|Protective lung ventilation|protective lung ventilation
228278|NCT02198625|Postoperative pulmonary complications|postoperative pulmonary complications
228279|NCT02198625|Positive end-expiratory pressure|positive end-expiratory pressure
228280|NCT02198625|recruitment maneuvers|recruitment maneuvers
228281|NCT02198599|Multiple sclerosis|multiple sclerosis
228282|NCT02198599|Stroke|stroke
228283|NCT02198599|Nursing|nursing
228284|NCT02198599|Mobility|mobility
228285|NCT02198599|Rehabilitation|rehabilitation
228286|NCT02198586|Alzheimer's, MRI, APOE|alzheimer's, mri, apoe
228287|NCT02198573|malaria|malaria
228288|NCT02198573|K13|k13
228289|NCT02198573|pfmrp1|pfmrp1
228290|NCT02198573|Myanmar|myanmar
228291|NCT02198560|Normal (Eyes without pathologies)|normal (eyes without pathologies)
228292|NCT02198547|Local anesthetic adjuvant,|local anesthetic adjuvant,
228293|NCT02198547|Magnesium solfatus,|magnesium solfatus,
228294|NCT02198547|Sciatic block|sciatic block
228295|NCT02198534|visual acuity|visual acuity
228296|NCT02198534|Landolt C|landolt c
228297|NCT02198534|ETDRS charts|etdrs charts
228298|NCT02198534|Freiburg Visual Acuity Test|freiburg visual acuity test
228299|NCT02198534|FrACT|fract
228300|NCT02198534|Comparison|comparison
228301|NCT02198534|acceptance|acceptance
228302|NCT02198534|Test retest reliability|test retest reliability
228303|NCT02198534|duration|duration
228304|NCT02198534|questionnaire|questionnaire
228305|NCT02198521|Patients undergoing staged bilateral open Carpal Tunnel Release (CTR) have no difference in overall pain intensity of pain between sides.|patients undergoing staged bilateral open carpal tunnel release (ctr) have no difference in overall pain intensity of pain between sides.
228306|NCT02198482|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
228307|NCT02198482|Volasertib|volasertib
228308|NCT02198482|High-risk Myelodysplastic Syndrome (MDS)|high-risk myelodysplastic syndrome (mds)
228309|NCT02198469|actinic cheilitis|actinic cheilitis
228310|NCT02198469|Er:YAG ablative fractional laser|er:yag ablative fractional laser
228311|NCT02198469|methyl aminolevulinate photodynamic therapy|methyl aminolevulinate photodynamic therapy
228312|NCT02198456|pulmonary arterial hypertension|pulmonary arterial hypertension
228313|NCT02198430|Haemophilia|haemophilia
228314|NCT02198430|Arthropathy|arthropathy
228315|NCT02198430|Range of motion|range of motion
228316|NCT02198430|Strength|strength
228317|NCT02198430|Proprioception|proprioception
228318|NCT02198430|Gait|gait
228319|NCT02198430|Quality of Life.|quality of life.
228320|NCT02198417|Polycystic Ovary Syndrome|polycystic ovary syndrome
228321|NCT02198417|PCOS|pcos
228322|NCT02198417|Acne|acne
228323|NCT02198417|Infertility|infertility
228324|NCT02198417|Irregular menses|irregular menses
228325|NCT02198417|Irregular period|irregular period
228326|NCT02198417|Mitochondria|mitochondria
228327|NCT02198417|Metabolism|metabolism
228328|NCT02198378|premixed nitrous oxide and oxygen|premixed nitrous oxide and oxygen
228329|NCT02198378|pain|pain
228330|NCT02198378|prehospital setting|prehospital setting
228331|NCT02198378|acute coronary syndrome|acute coronary syndrome
228332|NCT02198365|mRNA,|mrna,
228333|NCT02198365|DNA,|dna,
228334|NCT02198365|integrated HPV DNA|integrated hpv dna
228335|NCT02198365|human papillomavirus,|human papillomavirus,
228336|NCT02198365|cervical neoplasia|cervical neoplasia
228337|NCT02198300|dedicated bifurcation stent|dedicated bifurcation stent
228338|NCT02198300|sirolimus eluting stent|sirolimus eluting stent
228339|NCT02198261|alopecia|alopecia
228340|NCT02198261|androgenetic alopecia|androgenetic alopecia
228341|NCT02198261|hair loss|hair loss
228342|NCT02198261|minoxidil|minoxidil
228343|NCT02198261|5% minoxidil foam|5% minoxidil foam
228344|NCT02198261|male pattern hair loss|male pattern hair loss
228345|NCT02198209|liraglutide|liraglutide
228346|NCT02198209|GLP-1|glp-1
228347|NCT02198209|liver glucokinase|liver glucokinase
228348|NCT02198170|Healthy Volunteers|healthy volunteers
228349|NCT02198157|duration of second stage|duration of second stage
228350|NCT02198157|urinary catheterization|urinary catheterization
228351|NCT02198157|epidural anaesthesia|epidural anaesthesia
228352|NCT02198144|Hypertension|hypertension
228353|NCT02198144|High Blood Pressure|high blood pressure
228354|NCT02198144|African American Men|african american men
228355|NCT02198144|Black Men|black men
228356|NCT02198118|breast cancer|breast cancer
228357|NCT02198118|physiotherapy|physiotherapy
228358|NCT02198118|radiotherapy|radiotherapy
228359|NCT02198105|PAD|pad
228360|NCT02198105|femoropoliteal stenosis/occlusion|femoropoliteal stenosis/occlusion
228361|NCT02198105|cutting-balloon|cutting-balloon
228362|NCT02198105|drug-coated-balloon|drug-coated-balloon
228363|NCT02198092|familial adenomatous polyposis|familial adenomatous polyposis
228364|NCT02198092|multiple adenomatous polyposis|multiple adenomatous polyposis
228365|NCT02198092|lynch syndrome|lynch syndrome
228366|NCT02198092|hnpcc|hnpcc
228367|NCT02198092|colorectal cancer|colorectal cancer
228368|NCT02198092|genetic syndrome|genetic syndrome
228369|NCT02198092|epigenomics|epigenomics
228370|NCT02198092|septin9|septin9
228371|NCT02198079|non-tuberculous mycobacteria|non-tuberculous mycobacteria
228372|NCT02198079|Pediatrics|pediatrics
228373|NCT02198079|Cystic Fibrosis|cystic fibrosis
228374|NCT02198066|Sternotomy incision|sternotomy incision
228375|NCT02198066|Silver dressing|silver dressing
228376|NCT02198066|Sternal wound infection|sternal wound infection
228377|NCT02198040|Elbow|elbow
228378|NCT02198040|Joint disease|joint disease
228379|NCT02198040|Hemophilia|hemophilia
228380|NCT02198040|Physiotherapy modalities|physiotherapy modalities
228381|NCT02198027|Percutaneous nephrolithotomy|percutaneous nephrolithotomy
228382|NCT02198027|postoperative analgesia|postoperative analgesia
228383|NCT02198027|peritubal block|peritubal block
228384|NCT02198027|pain|pain
228385|NCT02198027|Visual Analog Pain Scale|visual analog pain scale
228386|NCT02198014|Knee|knee
228387|NCT02198014|Joint disease|joint disease
228388|NCT02198014|Haemophilia|haemophilia
228389|NCT02198014|Physiotherapy modalities|physiotherapy modalities
228390|NCT02198001|Platelets|platelets
228391|NCT02198001|fibrin|fibrin
228392|NCT02198001|growth factors|growth factors
228393|NCT02198001|bisphosphonates|bisphosphonates
228394|NCT02198001|tooth extraction|tooth extraction
228395|NCT02197988|Surgery|surgery
228396|NCT02197988|Abdominal|abdominal
228397|NCT02197988|Epidural Anesthesia|epidural anesthesia
228398|NCT02197988|Transversus Abdominis Plane Block|transversus abdominis plane block
228399|NCT02197988|TAP block|tap block
228400|NCT02197975|Healthy Volunteers|healthy volunteers
228401|NCT02197962|Osteoarthritis|osteoarthritis
228402|NCT02197962|Radial shockwaves|radial shockwaves
228403|NCT02197936|Peristalsis|peristalsis
228404|NCT02197936|ultrasound|ultrasound
228405|NCT02197923|Menorrhagia|menorrhagia
228406|NCT02197923|Dysmenorrhea|dysmenorrhea
228407|NCT02197923|Pelvic pain|pelvic pain
228408|NCT02197923|expression profiling|expression profiling
228409|NCT02197923|uterine biopsies|uterine biopsies
228410|NCT02197923|serum hormones|serum hormones
228411|NCT02197897|Tamoxifen citrate|tamoxifen citrate
228412|NCT02197897|Bladder Cancer|bladder cancer
228413|NCT02197884|Healthy|healthy
228414|NCT02197884|JNJ-54861911|jnj-54861911
228415|NCT02197884|Cytochrome P450 3A4 inhibitor|cytochrome p450 3a4 inhibitor
228416|NCT02197884|Itraconazole|itraconazole
228417|NCT02197884|Clarithromycin|clarithromycin
228418|NCT02197884|Alzheimer's disease|alzheimer's disease
228419|NCT02197871|COPD|copd
228420|NCT02197871|malnutrition|malnutrition
228421|NCT02197871|nutrition supplementation|nutrition supplementation
228422|NCT02197858|invasive arterial pressure|invasive arterial pressure
228423|NCT02197858|extended hemodynamic monitoring|extended hemodynamic monitoring
228424|NCT02197858|propofol|propofol
228425|NCT02197858|remifentanil|remifentanil
228426|NCT02197845|sickle cell disease|sickle cell disease
228427|NCT02197845|hydroxyurea|hydroxyurea
228428|NCT02197845|patient navigator|patient navigator
228429|NCT02197845|community health worker|community health worker
228430|NCT02197845|public health worker|public health worker
228431|NCT02197845|fetal hemoglobin|fetal hemoglobin
228432|NCT02197845|health services research|health services research
228433|NCT02197832|Frozen thawed embryo transfer|frozen thawed embryo transfer
228434|NCT02197832|Endometrial injury|endometrial injury
228435|NCT02197832|Ongoing pregnancy rates|ongoing pregnancy rates
228436|NCT02197780|Diagnostic accuracy|diagnostic accuracy
228437|NCT02197780|Fecal biomarker|fecal biomarker
228438|NCT02197780|Clinical Decision Rule|clinical decision rule
228439|NCT02197780|Cohort Study|cohort study
228440|NCT02197767|fibrillary GN|fibrillary gn
228441|NCT02197767|rituximab|rituximab
228442|NCT02197767|Rituxan|rituxan
228443|NCT02197767|MabThera|mabthera
228444|NCT02197767|Zytux|zytux
228445|NCT02197754|pharmacokinetics|pharmacokinetics
228446|NCT02197754|polyphenol metabolites|polyphenol metabolites
228447|NCT02197754|lean individuals|lean individuals
228448|NCT02197754|obese individuals|obese individuals
228449|NCT02197728|hysterectomy, uterine manipulator, thermal damage, laparoscopy, colpotomy|hysterectomy, uterine manipulator, thermal damage, laparoscopy, colpotomy
228450|NCT02197715|Pregnancy|pregnancy
228451|NCT02197715|Contraceptive Methods|contraceptive methods
228452|NCT02197715|Family Planning Services|family planning services
228453|NCT02197702|RCT|rct
228454|NCT02197702|asthma|asthma
228455|NCT02197702|pediatric|pediatric
228456|NCT02197702|virus|virus
228457|NCT02197702|corticosteroid|corticosteroid
228458|NCT02197689|Personalized Medication Management|personalized medication management
228459|NCT02197689|Medication Adherence|medication adherence
228460|NCT02197689|SMS Medication Reminder|sms medication reminder
228461|NCT02197663|acupuncture|acupuncture
228462|NCT02197663|stroke|stroke
228463|NCT02197663|Randomized Controlled Trial|randomized controlled trial
228464|NCT02197650|ALL L-asparaginase encapsulated erythrocytes|all l-asparaginase encapsulated erythrocytes
228465|NCT02197624|Non-heme iron absorption; HFE|non-heme iron absorption; hfe
228466|NCT02197611|Haemophilia|haemophilia
228467|NCT02197611|Adherence of Treatment|adherence of treatment
228468|NCT02197611|Knowledge of Illness|knowledge of illness
228469|NCT02197611|Medical-patient Relationship|medical-patient relationship
228470|NCT02197611|Illness Behavior|illness behavior
228471|NCT02197611|Treatment Difficulties.|treatment difficulties.
228472|NCT02197598|nalmefene, alcohol consumption, liver effects|nalmefene, alcohol consumption, liver effects
228473|NCT02197585|Male patients|male patients
228474|NCT02197585|Age > 18 year|age > 18 year
228475|NCT02197585|Primary hernia|primary hernia
228476|NCT02197585|glue|glue
228477|NCT02197572|Drug therapy|drug therapy
228478|NCT02197559|Ischemic Stroke, restenosis,bare-metal stents, drug -eluting stents|ischemic stroke, restenosis,bare-metal stents, drug -eluting stents
228479|NCT02197546|Injection pain|injection pain
228480|NCT02197546|local anesthesia|local anesthesia
228481|NCT02197546|acupuncture|acupuncture
228482|NCT02197481|BiClamp forceps hepatectomy|biclamp forceps hepatectomy
228483|NCT02197481|Clamp crushing technique|clamp crushing technique
228484|NCT02197481|Liver parenchyma transection|liver parenchyma transection
228485|NCT02197481|Randomized controlled trial|randomized controlled trial
228486|NCT02197468|Gut microbiome|gut microbiome
228487|NCT02197468|Necrotizing enterocolitis|necrotizing enterocolitis
228488|NCT02197468|Antibiotics|antibiotics
228489|NCT02197429|Vulvodynia|vulvodynia
228490|NCT02197429|Acupuncture|acupuncture
228491|NCT02197429|Provoked Vestibulodynia|provoked vestibulodynia
228492|NCT02197429|Vulvar Vestibulitis|vulvar vestibulitis
228493|NCT02197429|Vulvar Pain|vulvar pain
228494|NCT02197429|Dyspareunia|dyspareunia
228495|NCT02197429|Female Sexual Function|female sexual function
228496|NCT02197403|Dexmedetomidine|dexmedetomidine
228497|NCT02197403|Sedation|sedation
228498|NCT02197403|Paradoxical excitement response|paradoxical excitement response
228499|NCT02197403|Alcohol drinkers|alcohol drinkers
228500|NCT02197390|Childhood obesity|childhood obesity
228501|NCT02197390|Latino|latino
228502|NCT02197390|Hispanic|hispanic
228503|NCT02197377|Laryngeal mask airway, edentulous geriatric patient|laryngeal mask airway, edentulous geriatric patient
228504|NCT02197364|Interstitial Lung Disease|interstitial lung disease
228505|NCT02197364|Diagnosis|diagnosis
228506|NCT02197364|Krebs Von Den Lungen-6|krebs von den lungen-6
228507|NCT02197351|stomach neoplasms|stomach neoplasms
228508|NCT02197351|narrow band imaging|narrow band imaging
228509|NCT02197351|gastroscopy|gastroscopy
228510|NCT02197338|cholangiopancreatography, endoscopic retrograde|cholangiopancreatography, endoscopic retrograde
228511|NCT02197325|NSTEMI and STEMI|nstemi and stemi
228512|NCT02197312|yttrium-oxide|yttrium-oxide
228513|NCT02197312|Y-TZP|y-tzp
228514|NCT02197312|bridge|bridge
228515|NCT02197312|NobelProcera|nobelprocera
228516|NCT02197312|Shaded Zirconia|shaded zirconia
228517|NCT02197273|Total knee arthroplasty|total knee arthroplasty
228518|NCT02197273|Total shoulder arthroplasty|total shoulder arthroplasty
228519|NCT02197273|Total hip arthroplasty|total hip arthroplasty
228520|NCT02197273|Total joint arthroplasty|total joint arthroplasty
228521|NCT02197273|Hip replacement|hip replacement
228522|NCT02197273|Knee replacement|knee replacement
228523|NCT02197273|Shoulder replacement|shoulder replacement
228524|NCT02197260|Periodontitis|periodontitis
228525|NCT02197260|amoxicillin|amoxicillin
228526|NCT02197260|metronidazole|metronidazole
228527|NCT02197260|case management|case management
228528|NCT02197247|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, AZD9291, rifampicin, CYP P450 inducer, EGFR genes|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, azd9291, rifampicin, cyp p450 inducer, egfr genes
228529|NCT02197234|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, AZD9291, simvastatin, EGFR genes|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, azd9291, simvastatin, egfr genes
228530|NCT02197208|Frozen-thawed embryo transfer|frozen-thawed embryo transfer
228531|NCT02197208|natural cycle|natural cycle
228532|NCT02197208|spontaneous ovulation|spontaneous ovulation
228533|NCT02197208|hCG induced natural cycles|hcg induced natural cycles
228534|NCT02197182|Bacterial Vaginosis (BV)|bacterial vaginosis (bv)
228535|NCT02197182|Amsel's criteria|amsel's criteria
228536|NCT02197182|Pap smear|pap smear
228537|NCT02197169|Brain|brain
228538|NCT02197169|Brain Cancer|brain cancer
228539|NCT02197169|Brain Neoplasms|brain neoplasms
228540|NCT02197169|Central Nervous System Diseases|central nervous system diseases
228541|NCT02197169|Central Nervous System Neoplasms|central nervous system neoplasms
228542|NCT02197169|CNS|cns
228543|NCT02197169|Conditionally Replication-Competent Adenovirus|conditionally replication-competent adenovirus
228544|NCT02197169|DNX-2401|dnx-2401
228545|NCT02197169|Delta-24-RGD|delta-24-rgd
228546|NCT02197169|Glioma|glioma
228547|NCT02197169|Glioblastoma|glioblastoma
228548|NCT02197169|Gliosarcoma|gliosarcoma
228549|NCT02197169|Interferon gamma|interferon gamma
228550|NCT02197169|Malignant brain tumor|malignant brain tumor
228551|NCT02197169|Neoplasms, Neuroepithelial|neoplasms, neuroepithelial
228552|NCT02197169|Neuroectodermal Tumors|neuroectodermal tumors
228553|NCT02197169|Neoplasms, Germ Cell and Embryonal|neoplasms, germ cell and embryonal
228554|NCT02197169|Neoplasms by Histologic Type|neoplasms by histologic type
228555|NCT02197169|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
228653|NCT02196779|circulation|circulation
228556|NCT02197169|Neoplasms, Nerve Tissue|neoplasms, nerve tissue
228557|NCT02197169|Nervous System Diseases|nervous system diseases
228558|NCT02197169|Alcyone Lifesciences|alcyone lifesciences
228559|NCT02197169|AMC™|amc™
228560|NCT02197169|Cannula|cannula
228561|NCT02197169|Alcyone MEMS Cannula (AMC™) System|alcyone mems cannula (amc™) system
228562|NCT02197143|esomeprazole|esomeprazole
228563|NCT02197143|ranitidine|ranitidine
228564|NCT02197143|hydrotalcid|hydrotalcid
228565|NCT02197143|treatment of dyspepsia|treatment of dyspepsia
228566|NCT02197143|emergancy medicine|emergancy medicine
228567|NCT02197130|Huntington; chorea; total motor score; CAG repeat: total functional capacity; motor cognitive and behavioral symptoms|huntington; chorea; total motor score; cag repeat: total functional capacity; motor cognitive and behavioral symptoms
228568|NCT02197117|ST-segment elevation myocardial infarction (STEMI); thrombolysis, remote ischemic conditioning, myocardial infarct size, cardioprotection|st-segment elevation myocardial infarction (stemi); thrombolysis, remote ischemic conditioning, myocardial infarct size, cardioprotection
228569|NCT02197065|hip fracture|hip fracture
228570|NCT02197065|myocardial ischemia|myocardial ischemia
228571|NCT02197065|statin|statin
228572|NCT02197065|surgery|surgery
228573|NCT02197065|troponin|troponin
228574|NCT02197065|complication|complication
228575|NCT02197065|arthroplasty|arthroplasty
228576|NCT02197065|hip|hip
228577|NCT02197065|knee|knee
228578|NCT02197065|orthopedic|orthopedic
228579|NCT02197065|atorvastatin|atorvastatin
228580|NCT02197065|cardiovascular|cardiovascular
228581|NCT02197039|Peptic ulcer hemorrhage, second-look endoscopy|peptic ulcer hemorrhage, second-look endoscopy
228582|NCT02197000|BRCA mutation|brca mutation
228583|NCT02197000|Breast cancer|breast cancer
228584|NCT02197000|Estrogen metabolism|estrogen metabolism
228585|NCT02197000|3,3-Diindolylmethane|3,3-diindolylmethane
228586|NCT02197000|Breast density|breast density
228587|NCT02196987|Pain|pain
228588|NCT02196987|Catheter|catheter
228589|NCT02196987|Urethra|urethra
228590|NCT02196987|Urination|urination
228591|NCT02196974|bronchoscopy|bronchoscopy
228592|NCT02196974|lung nodule|lung nodule
228593|NCT02196974|diagnosis|diagnosis
228594|NCT02196974|cryobiopsy|cryobiopsy
228595|NCT02196961|Merkel cell carcinoma|merkel cell carcinoma
228596|NCT02196961|Adjuvant|adjuvant
228597|NCT02196961|Nivolumab|nivolumab
228598|NCT02196961|Ipilimumab|ipilimumab
228599|NCT02196948|Supraspinatus, tendinopathy, pain, disability, EPTE|supraspinatus, tendinopathy, pain, disability, epte
228600|NCT02196935|Cholangitis|cholangitis
228601|NCT02196935|Choledocholithiasis|choledocholithiasis
228602|NCT02196935|Gastrointestinal Neoplasms|gastrointestinal neoplasms
228603|NCT02196935|Medically underserved area|medically underserved area
228604|NCT02196935|Anesthesia|anesthesia
228605|NCT02196922|Chronic Heart Failure|chronic heart failure
228606|NCT02196922|Telehealth|telehealth
228607|NCT02196922|Self Management|self management
228608|NCT02196909|HIBM|hibm
228609|NCT02196909|GNE|gne
228610|NCT02196870|Airway pressure stress index|airway pressure stress index
228611|NCT02196870|Transpulmonary pressure stress index|transpulmonary pressure stress index
228612|NCT02196870|Acute Respiratory Failure|acute respiratory failure
228613|NCT02196870|Chest wall elastance|chest wall elastance
228614|NCT02196870|Lung stress|lung stress
228615|NCT02196857|Leukemia|leukemia
228616|NCT02196857|Acute myeloid leukemia|acute myeloid leukemia
228617|NCT02196857|AML|aml
228618|NCT02196857|High risk myelodysplastic syndrome|high risk myelodysplastic syndrome
228619|NCT02196857|MDS|mds
228620|NCT02196857|FLT3-ITD mutation|flt3-itd mutation
228621|NCT02196857|Azacytidine|azacytidine
228622|NCT02196857|5-Azacytidine|5-azacytidine
228623|NCT02196857|5-AZA|5-aza
228624|NCT02196857|Vidaza|vidaza
228625|NCT02196857|5-AZC|5-azc
228626|NCT02196857|AZA-CR|aza-cr
228627|NCT02196857|Ladakamycin|ladakamycin
228628|NCT02196857|NSC-102816|nsc-102816
228629|NCT02196857|Sorafenib|sorafenib
228630|NCT02196857|Nexavar|nexavar
228631|NCT02196857|BAY 43-9006|bay 43-9006
228632|NCT02196844|Lung cancer|lung cancer
228633|NCT02196844|Hatha Yoga|hatha yoga
228634|NCT02196844|Questionnaires|questionnaires
228635|NCT02196844|Surveys|surveys
228636|NCT02196844|Walk Test|walk test
228637|NCT02196844|Caregiver|caregiver
228638|NCT02196831|Human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
228639|NCT02196831|Nonalcoholic fatty liver disease (NAFLD)|nonalcoholic fatty liver disease (nafld)
228640|NCT02196831|Nonalcoholic steatohepatitis (NASH)|nonalcoholic steatohepatitis (nash)
228641|NCT02196831|Growth hormone releasing hormone|growth hormone releasing hormone
228642|NCT02196831|tesamorelin|tesamorelin
228643|NCT02196805|bioequivalence|bioequivalence
228644|NCT02196805|imported PROBUCOL table|imported probucol table
228645|NCT02196805|Lorelco|lorelco
228646|NCT02196805|marketed PROBUCOL tablet|marketed probucol tablet
228647|NCT02196805|Chang Tai|chang tai
228648|NCT02196792|Joint Diseases|joint diseases
228649|NCT02196792|Musculoskeletal Diseases|musculoskeletal diseases
228650|NCT02196792|radiostereometric analysis|radiostereometric analysis
228651|NCT02196792|Total hip arthroplasty|total hip arthroplasty
228652|NCT02196779|Abdominoplasty|abdominoplasty
228654|NCT02196779|skin|skin
228655|NCT02196779|dissection|dissection
228656|NCT02196779|laser|laser
228657|NCT02196779|fluorescence|fluorescence
228658|NCT02196779|imaging|imaging
228659|NCT02196753|Positron emission tomography combined with computed tomography|positron emission tomography combined with computed tomography
228660|NCT02196753|PET CT|pet ct
228661|NCT02196753|Cardiovascular Implantable Electronic Device|cardiovascular implantable electronic device
228662|NCT02196753|Infective endocarditis|infective endocarditis
228663|NCT02196753|Generator pocket infection|generator pocket infection
228664|NCT02196753|Fever of unknown origin|fever of unknown origin
228665|NCT02196740|periapical periodontitis,primary teeth|periapical periodontitis,primary teeth
228666|NCT02196727|Postoperative pain|postoperative pain
228667|NCT02196727|Multimodal analgesia|multimodal analgesia
228668|NCT02196727|Bascom Cleft Lift|bascom cleft lift
228669|NCT02196727|Day-case.|day-case.
228670|NCT02196714|Japanese Healthy Volunteers|japanese healthy volunteers
228671|NCT02196701|methotrexate|methotrexate
228672|NCT02196701|adalimumab|adalimumab
228673|NCT02196701|biologic|biologic
228674|NCT02196701|psoriasis|psoriasis
228675|NCT02196701|Tumor necrosis factor (TNF)-α inhibitor|tumor necrosis factor (tnf)-α inhibitor
228676|NCT02196688|subjects with mCRC who failed at least 2nd line therapy|subjects with mcrc who failed at least 2nd line therapy
228677|NCT02196610|End-Stage Renal Disease,|end-stage renal disease,
228678|NCT02196610|arterial or vascular stiffness,|arterial or vascular stiffness,
228679|NCT02196610|hemodialysis,|hemodialysis,
228680|NCT02196610|Pulse wave velocity|pulse wave velocity
228681|NCT02196610|Renal insufficiency,|renal insufficiency,
228682|NCT02196610|tonometry|tonometry
228683|NCT02196597|anorectal manometry|anorectal manometry
228684|NCT02196571|GDM|gdm
228685|NCT02196571|Exercise|exercise
228686|NCT02196571|Diabetes|diabetes
228687|NCT02196571|Pregnancy|pregnancy
228688|NCT02196558|Rheumatoid Arthritis|rheumatoid arthritis
228689|NCT02196558|Japanese subjects|japanese subjects
228690|NCT02196532|retinal nerve fiber layer thickness|retinal nerve fiber layer thickness
228691|NCT02196532|optical coherence tomography|optical coherence tomography
228692|NCT02196532|migraine|migraine
228693|NCT02196506|OPC-34712|opc-34712
228694|NCT02196506|brexpiprazole|brexpiprazole
228695|NCT02196506|Major Depressive Disorder|major depressive disorder
228696|NCT02196506|Adjunctive Treatment|adjunctive treatment
228697|NCT02196506|Anxious Distress|anxious distress
228698|NCT02196493|Productive|productive
228699|NCT02196493|Cough|cough
228700|NCT02196493|Bronchitis|bronchitis
228701|NCT02196493|Azithromycin|azithromycin
228702|NCT02196467|myoblast|myoblast
228703|NCT02196467|transplantation|transplantation
228704|NCT02196467|strength|strength
228705|NCT02196467|tacrolimus|tacrolimus
228706|NCT02196467|immunosuppression|immunosuppression
228707|NCT02196454|HPV vaccine|hpv vaccine
228708|NCT02196454|vaccination|vaccination
228709|NCT02196454|immunization|immunization
228710|NCT02196454|video|video
228711|NCT02196454|health education|health education
228712|NCT02196454|communication|communication
228713|NCT02196441|deep topical fornix nerve block|deep topical fornix nerve block
228714|NCT02196441|topical anesthesia|topical anesthesia
228715|NCT02196441|implantable contact lens procedure|implantable contact lens procedure
228716|NCT02196428|Ambient Assisted Living (AAL)|ambient assisted living (aal)
228717|NCT02196428|Telemonitoring|telemonitoring
228718|NCT02196428|Teleconsultation|teleconsultation
228719|NCT02196415|Hindfoot Alignment|hindfoot alignment
228720|NCT02196415|Rearfoot|rearfoot
228721|NCT02196415|Malalignment|malalignment
228722|NCT02196415|biplanar radiography|biplanar radiography
228723|NCT02196415|3D measurement|3d measurement
228724|NCT02196376|Postural orthostatic syndrome|postural orthostatic syndrome
228725|NCT02196376|orthostatic intolerance|orthostatic intolerance
228726|NCT02196376|autonomic dysfunction|autonomic dysfunction
228727|NCT02196350|personalized treatment|personalized treatment
228728|NCT02196350|prevention|prevention
228729|NCT02196350|improved diagnosis|improved diagnosis
228730|NCT02196337|Iodine deficiency|iodine deficiency
228731|NCT02196324|Prurigo Nodularis|prurigo nodularis
228732|NCT02196324|Atopic Dermatitis|atopic dermatitis
228733|NCT02196324|Lichen-simplex chronicus|lichen-simplex chronicus
228734|NCT02196311|Supracondylar humerus fractures, external fixation, open reduction, and internal fixation.|supracondylar humerus fractures, external fixation, open reduction, and internal fixation.
228735|NCT02196298|physical therapy|physical therapy
228736|NCT02196298|gait|gait
228737|NCT02196298|pediatric rehabilitation|pediatric rehabilitation
228738|NCT02196298|gross motor function|gross motor function
228739|NCT02196298|participation|participation
228740|NCT02196285|Double|double
228741|NCT02196285|Viral|viral
228742|NCT02196285|Vaccine|vaccine
228743|NCT02196285|Measles|measles
228744|NCT02196285|Rubella|rubella
228745|NCT02196285|Safety|safety
228746|NCT02196285|Efficacy|efficacy
228747|NCT02196285|Imunogenicity|imunogenicity
228748|NCT02196259|Pre-Post|pre-post
228749|NCT02196233|Trigger Finger|trigger finger
228849|NCT02195856|Incretin|incretin
228750|NCT02196233|Prospective Clinical Research|prospective clinical research
228751|NCT02196233|Randomized|randomized
228752|NCT02196233|Questionnaires|questionnaires
228753|NCT02196233|Transverse|transverse
228754|NCT02196233|Longitudinal|longitudinal
228755|NCT02196207|Severe Hemophilia A|severe hemophilia a
228756|NCT02196207|Previously Untreated Patients|previously untreated patients
228757|NCT02196207|Hemophilia Inhibitor Formation|hemophilia inhibitor formation
228758|NCT02196207|Long-Acting Factor VIII|long-acting factor viii
228759|NCT02196207|Prophylaxis|prophylaxis
228760|NCT02196155|plantar fasciitis|plantar fasciitis
228761|NCT02196155|Botulinum toxin A|botulinum toxin a
228762|NCT02196155|Cortisone|cortisone
228763|NCT02196155|RCT|rct
228764|NCT02196142|Cortisol|cortisol
228765|NCT02196142|Alcohol Craving|alcohol craving
228766|NCT02196142|Alcohol Dependence|alcohol dependence
228767|NCT02196129|low back pain|low back pain
228768|NCT02196129|pharmacoacupuncture|pharmacoacupuncture
228769|NCT02196129|sinbaro-3|sinbaro-3
228770|NCT02196116|Alzheimer disease|alzheimer disease
228771|NCT02196116|amyloid load|amyloid load
228772|NCT02196116|educational level|educational level
228773|NCT02196116|cognitive performances|cognitive performances
228774|NCT02196103|TOLAC|tolac
228775|NCT02196103|PROM|prom
228776|NCT02196103|Previous Cesarian section|previous cesarian section
228777|NCT02196103|Mechanical cervical ripening|mechanical cervical ripening
228778|NCT02196090|OCD, Exposure and Response Prevention, Vagal Stimulation|ocd, exposure and response prevention, vagal stimulation
228779|NCT02196077|Budesonide and formoterol inhalation aerosol|budesonide and formoterol inhalation aerosol
228780|NCT02196064|HIV HCV antiretroviral|hiv hcv antiretroviral
228781|NCT02196051|Insulin resistance|insulin resistance
228782|NCT02196051|Exercise|exercise
228783|NCT02196051|de novo lipogenesis|de novo lipogenesis
228784|NCT02196051|NAFLD|nafld
228785|NCT02196051|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
228786|NCT02196038|heart failure|heart failure
228787|NCT02196025|Insomnia|insomnia
228788|NCT02196012|overweight|overweight
228789|NCT02196012|obesity|obesity
228790|NCT02196012|Technology|technology
228791|NCT02196012|College Students|college students
228792|NCT02195986|vaginal dryness|vaginal dryness
228793|NCT02195986|vaginal and/or vulvar irritation/itching|vaginal and/or vulvar irritation/itching
228794|NCT02195986|dysuria|dysuria
228795|NCT02195986|vaginal pain and bleeding associated with sexual activity|vaginal pain and bleeding associated with sexual activity
228796|NCT02195986|vaginal atrophy|vaginal atrophy
228797|NCT02195973|ovarian cancer|ovarian cancer
228798|NCT02195973|platinum resistant|platinum resistant
228799|NCT02195973|LED225|led225
228800|NCT02195973|Sonidegib|sonidegib
228801|NCT02195973|Paclitaxel|paclitaxel
228802|NCT02195960|skin toxicity, radiotherapy, antioxidants|skin toxicity, radiotherapy, antioxidants
228803|NCT02195947|Growth hormone|growth hormone
228804|NCT02195947|IVF/ICSI|ivf/icsi
228805|NCT02195947|Poor responder|poor responder
228806|NCT02195947|Antagonist protocol|antagonist protocol
228807|NCT02195934|Cardiovascular disease, blood orange juice, anthocyanins|cardiovascular disease, blood orange juice, anthocyanins
228808|NCT02195895|Teriparatide|teriparatide
228809|NCT02195895|Alendronate|alendronate
228810|NCT02195895|Alendronic Acid|alendronic acid
228811|NCT02195895|Osteoporosis|osteoporosis
228812|NCT02195895|Bone Fracture|bone fracture
228813|NCT02195895|Bone Loss|bone loss
228814|NCT02195895|Spinal Cord Injury|spinal cord injury
228815|NCT02195895|Bone Diseases|bone diseases
228816|NCT02195895|Metabolic Bone Diseases|metabolic bone diseases
228817|NCT02195895|Musculoskeletal Diseases|musculoskeletal diseases
228818|NCT02195895|Spinal Cord Diseases|spinal cord diseases
228819|NCT02195895|Central Nervous System Diseases|central nervous system diseases
228820|NCT02195895|Nervous System Diseases|nervous system diseases
228821|NCT02195895|Nervous System|nervous system
228822|NCT02195895|Wounds and Injuries|wounds and injuries
228823|NCT02195895|Bone Density Conservation Agents|bone density conservation agents
228824|NCT02195895|Physiological Effects of Drugs|physiological effects of drugs
228825|NCT02195895|Pharmacologic Actions|pharmacologic actions
228826|NCT02195882|strength training|strength training
228827|NCT02195882|scapular stabilization|scapular stabilization
228828|NCT02195882|kayakers.|kayakers.
228829|NCT02195869|PCYC1129|pcyc1129
228830|NCT02195869|PCYC1129CA|pcyc1129ca
228831|NCT02195869|1129|1129
228832|NCT02195869|Ibrutinib|ibrutinib
228833|NCT02195869|PCI32765|pci32765
228834|NCT02195869|IMBRUVICA|imbruvica
228835|NCT02195869|Pharmacyclics|pharmacyclics
228836|NCT02195869|PCYC|pcyc
228837|NCT02195869|GVHD|gvhd
228838|NCT02195869|Steroid dependent|steroid dependent
228839|NCT02195869|refractory|refractory
228840|NCT02195869|chronic|chronic
228841|NCT02195869|graft versus host disease|graft versus host disease
228842|NCT02195869|chronic graft versus host disease|chronic graft versus host disease
228843|NCT02195869|immunology|immunology
228844|NCT02195856|Diabetes|diabetes
228845|NCT02195856|Nitrate|nitrate
228846|NCT02195856|Nitrite|nitrite
228847|NCT02195856|Hepatic|hepatic
228848|NCT02195856|MRI|mri
228850|NCT02195856|Insulin|insulin
228851|NCT02195856|Glucose|glucose
228852|NCT02195843|CRT-D|crt-d
228853|NCT02195843|Heart Failure|heart failure
228854|NCT02195843|Middle East|middle east
228855|NCT02195843|Quadripolar|quadripolar
228856|NCT02195830|Sepsis|sepsis
228857|NCT02195830|ultrasound|ultrasound
228858|NCT02195830|inferior vena cava collapsibility|inferior vena cava collapsibility
228859|NCT02195778|Health Literacy|health literacy
228860|NCT02195778|Adult|adult
228861|NCT02195778|UAE|uae
228862|NCT02195778|Disease|disease
228863|NCT02195778|Age|age
228864|NCT02195765|Chronic Periodontitis|chronic periodontitis
228865|NCT02195765|Periodontal disease|periodontal disease
228866|NCT02195752|Compounded pain cream|compounded pain cream
228867|NCT02195752|Ordinary care|ordinary care
228868|NCT02195752|Compounding|compounding
228869|NCT02195752|Topical treatment|topical treatment
228870|NCT02195752|Analgesia|analgesia
228871|NCT02195739|smoking|smoking
228872|NCT02195739|smoking cessation|smoking cessation
228873|NCT02195739|cardiovascular disease|cardiovascular disease
228874|NCT02195739|pharmacological intervention|pharmacological intervention
228875|NCT02195739|UK primary care population|uk primary care population
228876|NCT02195739|nicotine replacement therapy|nicotine replacement therapy
228877|NCT02195700|Dyskinesias|dyskinesias
228878|NCT02195700|Movement Disorders|movement disorders
228879|NCT02195700|Central Nervous System Diseases|central nervous system diseases
228880|NCT02195700|Nervous System Diseases|nervous system diseases
228881|NCT02195700|Neurologic Manifestations|neurologic manifestations
228882|NCT02195700|Signs and Symptoms|signs and symptoms
228883|NCT02195661|Epilepsy|epilepsy
228884|NCT02195661|Electroencephalogram|electroencephalogram
228885|NCT02195661|children|children
228886|NCT02195661|sedation|sedation
228887|NCT02195648|Tension-Type Headache|tension-type headache
228888|NCT02195648|Physical Therapy Modalities|physical therapy modalities
228889|NCT02195648|Musculoskeletal Manipulations|musculoskeletal manipulations
228890|NCT02195648|Sub-occipital muscle inhibition technique|sub-occipital muscle inhibition technique
228891|NCT02195609|Vasomotor Symptoms Associated With Menopause|vasomotor symptoms associated with menopause
228892|NCT02195609|Menopause|menopause
228893|NCT02195609|Hot Flashes|hot flashes
228894|NCT02195609|Postmenopausal Women|postmenopausal women
228895|NCT02195596|Alzheimer disease, exercise, cognition|alzheimer disease, exercise, cognition
228896|NCT02195570|contingency management|contingency management
228897|NCT02195570|smoking cessation|smoking cessation
228898|NCT02195570|prenatal tobacco exposure|prenatal tobacco exposure
228899|NCT02195570|maternal smoking|maternal smoking
228900|NCT02195531|Adherence|adherence
228901|NCT02195518|Chronic Hepatitis B|chronic hepatitis b
228902|NCT02195518|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
228903|NCT02195518|Failure of multiple NAs treatment|failure of multiple nas treatment
228904|NCT02195479|Multiple Myeloma|multiple myeloma
228905|NCT02195479|Bortezomib|bortezomib
228906|NCT02195479|Velcade|velcade
228907|NCT02195479|Melphalan|melphalan
228908|NCT02195479|Prednisone|prednisone
228909|NCT02195479|Daratumumab|daratumumab
228910|NCT02195453|Non-small cell lung cancer|non-small cell lung cancer
228911|NCT02195453|FACT-L scale|fact-l scale
228912|NCT02195453|Yangzhengxiaoji|yangzhengxiaoji
228913|NCT02195440|Hepatitis C virus, cirrhosis|hepatitis c virus, cirrhosis
228914|NCT02195427|Nasolabial folds|nasolabial folds
228915|NCT02195427|Dermal filler|dermal filler
228916|NCT02195427|Hyaluronic acid (HA)|hyaluronic acid (ha)
228917|NCT02195427|Wrinkles|wrinkles
228918|NCT02195414|NeoVas|neovas
228919|NCT02195414|Bioresorbable scaffold|bioresorbable scaffold
228920|NCT02195414|Sirolimus|sirolimus
228921|NCT02195414|First-in-Man|first-in-man
228922|NCT02195401|autism, cleanroom, immune dysregulation, toxins|autism, cleanroom, immune dysregulation, toxins
228923|NCT02195388|Arterial stiffness,|arterial stiffness,
228924|NCT02195388|endothelial function,|endothelial function,
228925|NCT02195388|autonomic nervous system,|autonomic nervous system,
228926|NCT02195388|acute coronary syndrome,|acute coronary syndrome,
228927|NCT02195388|arterial hypertension,|arterial hypertension,
228928|NCT02195388|pulse wave velocity,|pulse wave velocity,
228929|NCT02195388|augmentation index,|augmentation index,
228930|NCT02195388|arterial stiffness index,|arterial stiffness index,
228931|NCT02195388|heart rate variability,|heart rate variability,
228932|NCT02195388|heart rate turbulence,|heart rate turbulence,
228933|NCT02195388|vascular endothelial growth factor,|vascular endothelial growth factor,
228934|NCT02195388|asymmetric dimethylarginine|asymmetric dimethylarginine
228935|NCT02195375|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
228936|NCT02195375|FEV1 ≤ 50%|fev1 ≤ 50%
228937|NCT02195349|Tuberculin Purified Protein Derivative|tuberculin purified protein derivative
228938|NCT02195349|Delayed Type Hypersensitivity|delayed type hypersensitivity
228939|NCT02195349|Biopsy|biopsy
228940|NCT02195349|Induration|induration
228941|NCT02195349|First time in human|first time in human
228942|NCT02195349|T-cells|t-cells
228943|NCT02195349|LAG-3|lag-3
228944|NCT02195349|safety|safety
228945|NCT02195349|GSK2831781|gsk2831781
228946|NCT02195349|psoriasis|psoriasis
228947|NCT02195323|autologous bone marrow mesenchymal stem cells chronic kidney disease|autologous bone marrow mesenchymal stem cells chronic kidney disease
228948|NCT02195310|Sternotomy|sternotomy
228949|NCT02195310|Surgical site Occurences|surgical site occurences
228950|NCT02195310|Negative Pressure Wound Therapy|negative pressure wound therapy
228951|NCT02195310|Surgical Site Infection|surgical site infection
228952|NCT02195297|cellulitis|cellulitis
228953|NCT02195297|anticellulitis|anticellulitis
228954|NCT02195284|Inhaler preference|inhaler preference
228955|NCT02195284|Overall inhaler error|overall inhaler error
228956|NCT02195284|DISKUS/ACCUHALER|diskus/accuhaler
228957|NCT02195284|MDI|mdi
228958|NCT02195284|TURBUHALER|turbuhaler
228959|NCT02195284|ELLIPTA|ellipta
228960|NCT02195284|Ease of use|ease of use
228961|NCT02195284|Critical inhaler error|critical inhaler error
228962|NCT02195271|Melatonin|melatonin
228963|NCT02195271|Transcranial Direct Current Stimulation|transcranial direct current stimulation
228964|NCT02195271|Neuroplasticity|neuroplasticity
228965|NCT02195271|Analgesia|analgesia
228966|NCT02195271|Pain|pain
228967|NCT02195245|CO2 filter|co2 filter
228968|NCT02195245|anesthesia|anesthesia
228969|NCT02195245|device|device
228970|NCT02195232|Venous Thromboembolic Events in Cancer Patients|venous thromboembolic events in cancer patients
228971|NCT02195232|Thromboembolism of Vein in Colorectal Cancer|thromboembolism of vein in colorectal cancer
228972|NCT02195232|Thromboembolism of Vein in Pancreatic Cancer|thromboembolism of vein in pancreatic cancer
228973|NCT02195232|Thromboembolism of Vein in Non-small Cell Lung Cancer|thromboembolism of vein in non-small cell lung cancer
228974|NCT02195219|conservative|conservative
228975|NCT02195219|treatment|treatment
228976|NCT02195219|surgical|surgical
228977|NCT02195219|Acromioclavicular|acromioclavicular
228978|NCT02195219|Joint|joint
228979|NCT02195219|dislocation|dislocation
228980|NCT02195206|Hyperpolarized gas magnetic resonance imaging|hyperpolarized gas magnetic resonance imaging
228981|NCT02195206|Hyperpolarized Xenon-129 magnetic resonance imaging|hyperpolarized xenon-129 magnetic resonance imaging
228982|NCT02195206|Lung Imaging|lung imaging
228983|NCT02195206|Healthy Adults|healthy adults
228984|NCT02195193|Health Services Research|health services research
228985|NCT02195193|Acute Coronary Syndromes|acute coronary syndromes
228986|NCT02195193|Depression|depression
228987|NCT02195193|Integrated care|integrated care
228988|NCT02195180|Pancreas|pancreas
228989|NCT02195180|adenocarcinoma|adenocarcinoma
228990|NCT02195180|cancer|cancer
228991|NCT02195180|asparaginase|asparaginase
228992|NCT02195180|erythrocytes|erythrocytes
228993|NCT02195180|red blood cell|red blood cell
228994|NCT02195180|Encapsulation|encapsulation
228995|NCT02195180|folfox|folfox
228996|NCT02195180|gemcitabine|gemcitabine
228997|NCT02195154|18F-DTBZ|18f-dtbz
228998|NCT02195141|Preoperative Chemoradiotherapy|preoperative chemoradiotherapy
228999|NCT02195141|Locally Advanced Rectal Cancer|locally advanced rectal cancer
229000|NCT02195141|boost|boost
229001|NCT02195141|IMRT|imrt
229002|NCT02195102|transcatheter aortic valve Replacement|transcatheter aortic valve replacement
229003|NCT02195089|Treatment of Cervical Intraepithelial Neoplasia(CIN3)|treatment of cervical intraepithelial neoplasia(cin3)
229004|NCT02195076|Lung cancer|lung cancer
229005|NCT02195076|Breast Cancer|breast cancer
229006|NCT02195076|Biosensors|biosensors
229007|NCT02195076|Volatile Organic Compounds|volatile organic compounds
229008|NCT02195076|Odor|odor
229009|NCT02195076|Urine Sample|urine sample
229010|NCT02195076|Exhaled Breath Samples|exhaled breath samples
229011|NCT02195063|Pain management|pain management
229012|NCT02195063|Scar care|scar care
229013|NCT02195063|Wound care|wound care
229014|NCT02195063|UDT|udt
229015|NCT02195063|Urinary drug testing|urinary drug testing
229016|NCT02195037|Delayed Cord Clamping|delayed cord clamping
229017|NCT02195024|pacemaker|pacemaker
229018|NCT02195024|magnetic resonance imaging|magnetic resonance imaging
229019|NCT02195024|MRI conditional|mri conditional
229020|NCT02195024|pacemaker leads|pacemaker leads
229021|NCT02195011|Regorafenib|regorafenib
229022|NCT02195011|90Y|90y
229023|NCT02195011|Radioembolization|radioembolization
229024|NCT02195011|SIR-Spheres Microspheres|sir-spheres microspheres
229025|NCT02195011|Metastatic Colorectal Cancer|metastatic colorectal cancer
229026|NCT02195011|Liver Metastases|liver metastases
229027|NCT02195011|SIRT|sirt
229028|NCT02195011|Refractory|refractory
229029|NCT02194985|Fabry disease|fabry disease
229030|NCT02194985|Lysosomal storage disease|lysosomal storage disease
229031|NCT02194985|migalastat HCl|migalastat hcl
229032|NCT02194985|AT1001|at1001
229033|NCT02194972|constipation|constipation
229034|NCT02194972|colon transit time|colon transit time
229035|NCT02194972|gut microbiota|gut microbiota
229036|NCT02194972|soluble dietary fiber|soluble dietary fiber
229037|NCT02194972|disturbance of gut microbiota in constipation|disturbance of gut microbiota in constipation
229038|NCT02194959|Patient Navigation|patient navigation
229039|NCT02194959|Screening Colonoscopy|screening colonoscopy
229040|NCT02194959|Colorectal Cancer Screening|colorectal cancer screening
229041|NCT02194959|African Americans|african americans
229042|NCT02194946|Chronic Kidney Disease,|chronic kidney disease,
229043|NCT02194946|End-Stage Renal Disease,|end-stage renal disease,
229044|NCT02194946|Traditional Chinese Medicine,|traditional chinese medicine,
229045|NCT02194946|dialysis initiation.|dialysis initiation.
229046|NCT02194933|Schizophrenia|schizophrenia
229047|NCT02194933|Mental Disorders, Antipsychotic,|mental disorders, antipsychotic,
229048|NCT02194933|Psychotic disorder, Impulsivity|psychotic disorder, impulsivity
229049|NCT02194907|Emotional Aging|emotional aging
229050|NCT02194907|Neurofeedback|neurofeedback
229051|NCT02194894|Acetaminophen, Non-alcoholic Fatty Liver Disease (NAFLD)|acetaminophen, non-alcoholic fatty liver disease (nafld)
229052|NCT02194881|Cystic fibrosis|cystic fibrosis
229053|NCT02194881|CFTR|cftr
229054|NCT02194881|G551D mutation|g551d mutation
229055|NCT02194881|Novel treatments|novel treatments
229056|NCT02194881|Potentiator|potentiator
229057|NCT02194881|Ivacaftor|ivacaftor
229058|NCT02194868|Allogeneic hematopoietic stem cell transplantation,|allogeneic hematopoietic stem cell transplantation,
229059|NCT02194868|Immunoregulatory T lymphocytes,|immunoregulatory t lymphocytes,
229060|NCT02194868|acute graft versus host disease|acute graft versus host disease
229061|NCT02194855|rocuronium|rocuronium
229062|NCT02194855|cisatracurium|cisatracurium
229063|NCT02194855|pharmacokinetic|pharmacokinetic
229064|NCT02194842|metastatic|metastatic
229065|NCT02194842|prostate cancer|prostate cancer
229066|NCT02194816|Parkinson's Disease|parkinson's disease
229067|NCT02194816|PD|pd
229068|NCT02194816|Complementary and Alternative|complementary and alternative
229069|NCT02194816|CAM|cam
229070|NCT02194790|Chronic Kidney Disease|chronic kidney disease
229071|NCT02194790|Diabetic Nephropathy|diabetic nephropathy
229072|NCT02194790|Integrated Chronic Kidney Disease Care|integrated chronic kidney disease care
229073|NCT02194725|Stress and Coping Model|stress and coping model
229074|NCT02194725|Coping|coping
229075|NCT02194712|circulating anodic antigen|circulating anodic antigen
229076|NCT02194686|cilostazol|cilostazol
229077|NCT02194686|progenitor cells|progenitor cells
229078|NCT02194686|cardiovascular disease|cardiovascular disease
229079|NCT02194686|risk factors|risk factors
229080|NCT02194686|angiogenesis|angiogenesis
229081|NCT02194686|biological markers|biological markers
229082|NCT02194686|endothelial function|endothelial function
229083|NCT02194660|Fractures Liaison Service|fractures liaison service
229084|NCT02194660|Osteoporosis|osteoporosis
229085|NCT02194660|Fracture|fracture
229086|NCT02194660|Medication adherence|medication adherence
229087|NCT02194647|Osteoporosis|osteoporosis
229088|NCT02194647|Medication Monitoring|medication monitoring
229089|NCT02194647|Education|education
229090|NCT02194647|Adherence|adherence
229091|NCT02194647|Management|management
229092|NCT02194595|type 2 diabetes|type 2 diabetes
229093|NCT02194595|beta-cell function|beta-cell function
229094|NCT02194595|GLP-1|glp-1
229095|NCT02194595|insulin|insulin
229096|NCT02194582|FSGS|fsgs
229097|NCT02194582|NS|ns
229098|NCT02194582|Kidney disease|kidney disease
229099|NCT02194582|Kidney failure|kidney failure
229100|NCT02194582|Renal disease|renal disease
229101|NCT02194582|nephrotic syndrome|nephrotic syndrome
229102|NCT02194582|focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
229103|NCT02194582|familial kidney disease|familial kidney disease
229104|NCT02194582|minimal change disease|minimal change disease
229105|NCT02194582|proteinuria|proteinuria
229106|NCT02194543|Cataract|cataract
229107|NCT02194543|HD 3D|hd 3d
229108|NCT02194543|Microscope|microscope
229109|NCT02194530|Peanut allergic individuals|peanut allergic individuals
229110|NCT02194530|Allergic/atopic individuals (not allergic to peanut)|allergic/atopic individuals (not allergic to peanut)
229111|NCT02194530|Non-allergic individuals|non-allergic individuals
229112|NCT02194517|diabetes|diabetes
229113|NCT02194517|diet control toolset|diet control toolset
229114|NCT02194517|food exchanges|food exchanges
229115|NCT02194517|CHO|cho
229116|NCT02194517|FP|fp
229117|NCT02194504|Metabolic health|metabolic health
229118|NCT02194504|Phenotyping|phenotyping
229119|NCT02194504|Abdominal obesity|abdominal obesity
229120|NCT02194504|Abdominal adiposity|abdominal adiposity
229121|NCT02194504|Liver fat|liver fat
229122|NCT02194504|Belly fat|belly fat
229123|NCT02194491|[11C]AS2471907|[11c]as2471907
229124|NCT02194491|ASP3662|asp3662
229125|NCT02194491|Positron Emission Tomography (PET)|positron emission tomography (pet)
229126|NCT02194491|Brain enzyme occupancy|brain enzyme occupancy
229127|NCT02194478|Stress|stress
229128|NCT02194478|Meditation|meditation
229129|NCT02194478|Mind body|mind body
229130|NCT02194439|Acute Graft Versus Host Disease|acute graft versus host disease
229131|NCT02194439|Affect|affect
229132|NCT02194439|Anti-inflammatory|anti-inflammatory
229133|NCT02194439|Anti-inflammatory Agents|anti-inflammatory agents
229134|NCT02194439|Antigen-Presenting Cells|antigen-presenting cells
229135|NCT02194439|Alloantigen|alloantigen
229136|NCT02194439|Allogeneic|allogeneic
229137|NCT02194439|Allograft rejection|allograft rejection
229138|NCT02194439|Allograft Tolerance|allograft tolerance
229139|NCT02194439|Antigens|antigens
229140|NCT02194439|Autoimmunity|autoimmunity
229141|NCT02194439|Biomarkers|biomarkers
229142|NCT02194439|Biospecimen Repository|biospecimen repository
229143|NCT02194439|BMT|bmt
229144|NCT02194439|Bone Marrow Transplantation|bone marrow transplantation
229145|NCT02194439|Cell Transplantation|cell transplantation
229146|NCT02194439|Cells|cells
229147|NCT02194439|Clonal Expansion|clonal expansion
229148|NCT02194439|Complex|complex
229149|NCT02194439|Cytokine|cytokine
229150|NCT02194439|Data|data
229151|NCT02194439|Development|development
229152|NCT02194439|Environment|environment
229153|NCT02194439|Failure (biologic function)|failure (biologic function)
229154|NCT02194439|Genomics|genomics
229155|NCT02194439|Graft-vs-Host Disease|graft-vs-host disease
229156|NCT02194439|Graft-vs-Leukemia|graft-vs-leukemia
229157|NCT02194439|GVHD|gvhd
229158|NCT02194439|GVL|gvl
229159|NCT02194439|Hematopoietic|hematopoietic
229160|NCT02194439|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
229161|NCT02194439|HCT|hct
229162|NCT02194439|HSCT|hsct
229163|NCT02194439|IL-33 Receptor|il-33 receptor
229164|NCT02194439|Immune Reconstitution|immune reconstitution
229165|NCT02194439|Immune Response|immune response
229166|NCT02194439|Inflammatory|inflammatory
229167|NCT02194439|Modeling|modeling
229168|NCT02194439|Novel|novel
229169|NCT02194439|Novel therapeutics|novel therapeutics
229170|NCT02194439|Outcome|outcome
229171|NCT02194439|Pathway interactions|pathway interactions
229172|NCT02194439|Peptides|peptides
229173|NCT02194439|Prevent|prevent
229174|NCT02194439|Process|process
229175|NCT02194439|Production|production
229176|NCT02194439|Proteomics|proteomics
229177|NCT02194439|Regulatory T-Lymphocyte|regulatory t-lymphocyte
229178|NCT02194439|Response|response
229179|NCT02194439|Role|role
229180|NCT02194439|Signal|signal
229181|NCT02194439|ST2|st2
229182|NCT02194439|Transduction|transduction
229183|NCT02194439|T-cell response|t-cell response
229184|NCT02194439|T-cell Activation|t-cell activation
229185|NCT02194439|T-Lymphocytes|t-lymphocytes
229186|NCT02194439|Tissues|tissues
229187|NCT02194400|RSLV-132|rslv-132
229188|NCT02194400|Systemic Lupus Erythematosus|systemic lupus erythematosus
229189|NCT02194400|Lupus|lupus
229190|NCT02194400|SLE|sle
229191|NCT02194400|Resolve|resolve
229192|NCT02194387|Breast Cancer|breast cancer
229193|NCT02194387|Ovarian Cancer|ovarian cancer
229194|NCT02194387|Triple negative breast cancer|triple negative breast cancer
229195|NCT02194387|TNBC|tnbc
229196|NCT02194387|BRCA-positive survivor|brca-positive survivor
229197|NCT02194387|High-grade serous ovarian cancer|high-grade serous ovarian cancer
229198|NCT02194387|HGSOC|hgsoc
229199|NCT02194387|Female biological relative of a BRCA positive TNBC or HGSOC survivor|female biological relative of a brca positive tnbc or hgsoc survivor
229200|NCT02194387|Cancer survivors|cancer survivors
229201|NCT02194387|Employees at MD Anderson|employees at md anderson
229202|NCT02194387|Multi-phase Optimization Strategy|multi-phase optimization strategy
229203|NCT02194387|MOST|most
229204|NCT02194387|Energy balance interventions|energy balance interventions
229205|NCT02194387|EB|eb
229206|NCT02194387|Telephone Coaching|telephone coaching
229207|NCT02194387|Text Messaging|text messaging
229208|NCT02194387|Resistance Training|resistance training
229209|NCT02194387|Daily Self-Monitoring|daily self-monitoring
229210|NCT02194387|Weekly Self-Monitoring|weekly self-monitoring
229211|NCT02194387|Email Coaching|email coaching
229212|NCT02194387|Questionnaires|questionnaires
229213|NCT02194387|Surveys|surveys
229214|NCT02194374|Leukemia|leukemia
229215|NCT02194374|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
229216|NCT02194374|CLL|cll
229217|NCT02194374|Small lymphocytic lymphoma|small lymphocytic lymphoma
229218|NCT02194374|SLL|sll
229219|NCT02194374|B cell|b cell
229220|NCT02194374|ROR1-specific T cells|ror1-specific t cells
229221|NCT02194374|Fludarabine|fludarabine
229222|NCT02194374|Fludarabine Phosphate|fludarabine phosphate
229223|NCT02194374|Fludara|fludara
229224|NCT02194374|Cyclophosphamide|cyclophosphamide
229225|NCT02194374|Cytoxan|cytoxan
229226|NCT02194374|Neosar|neosar
229227|NCT02194374|Rituximab|rituximab
229228|NCT02194374|Rituxan|rituxan
229229|NCT02194374|Bendamustine|bendamustine
229230|NCT02194374|Bendamustine Hydrochloride|bendamustine hydrochloride
229231|NCT02194374|Bendamustine HCL|bendamustine hcl
229232|NCT02194374|CEP-18083|cep-18083
229233|NCT02194374|SDX-105|sdx-105
229234|NCT02194374|Treanda|treanda
229235|NCT02194231|Mesothelioma|mesothelioma
229236|NCT02194231|MPM|mpm
229237|NCT02194231|Trabectedin|trabectedin
229238|NCT02194192|prevention of hypotension|prevention of hypotension
229239|NCT02194192|spinal anesthesia|spinal anesthesia
229240|NCT02194192|cesarean section|cesarean section
229241|NCT02194192|ephedrine|ephedrine
229242|NCT02194192|ondansetron|ondansetron
229243|NCT02194140|ultrasound|ultrasound
229244|NCT02194140|iodinated contrast material|iodinated contrast material
229245|NCT02194140|computed tomography|computed tomography
229246|NCT02194114|Chronic Renal Failure|chronic renal failure
229247|NCT02194114|End-Stage Renal Disease|end-stage renal disease
229248|NCT02194114|Nitrogen Balance|nitrogen balance
229249|NCT02194114|Dietary Protein Intake|dietary protein intake
229250|NCT02194101|oxygen delivery|oxygen delivery
229251|NCT02194101|proximal femoral fracture|proximal femoral fracture
229252|NCT02194101|goal-directed therapy|goal-directed therapy
229253|NCT02194062|Chronic rhinosinusitis with polyps|chronic rhinosinusitis with polyps
229254|NCT02194062|Nasal steroids|nasal steroids
229255|NCT02194062|Functional endoscopic sinus surgery|functional endoscopic sinus surgery
229256|NCT02194062|SNOT-22|snot-22
229257|NCT02194062|Lund-Kennedy|lund-kennedy
229258|NCT02194036|Ownership of body|ownership of body
229259|NCT02194036|Bodily and mental balance|bodily and mental balance
229260|NCT02194036|Learning|learning
229261|NCT02194036|Body image|body image
229262|NCT02194036|Sensations|sensations
229263|NCT02194036|Expectations|expectations
229264|NCT02194023|chlorhexidine digluconate|chlorhexidine digluconate
229265|NCT02194023|gingivitis|gingivitis
229266|NCT02194023|cetylpyridinium chloride|cetylpyridinium chloride
229267|NCT02194023|mouthrinse|mouthrinse
229268|NCT02194023|dental plaque|dental plaque
229269|NCT02194023|de novo|de novo
229270|NCT02194023|in vivo|in vivo
229271|NCT02194010|Outcome Measure|outcome measure
229272|NCT02194010|Patient Reported Questionnaires|patient reported questionnaires
229273|NCT02193984|Diabetes|diabetes
229274|NCT02193984|Peer support|peer support
229275|NCT02193984|Hispanic|hispanic
229276|NCT02193984|Latino|latino
229277|NCT02193971|Acute coronary syndrome|acute coronary syndrome
229278|NCT02193971|Drug eluting stent|drug eluting stent
229279|NCT02193971|Everolimus|everolimus
229280|NCT02193971|Prasugrel|prasugrel
229281|NCT02193958|Acute Myeloid Leukemia|acute myeloid leukemia
229282|NCT02193958|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
229283|NCT02193958|Myelodysplastic Syndrome|myelodysplastic syndrome
229284|NCT02193932|EEG triggered|eeg triggered
229285|NCT02193932|fMRI|fmri
229286|NCT02193932|epilepsy|epilepsy
229287|NCT02193932|intractable|intractable
229288|NCT02193919|psoriasis|psoriasis
229289|NCT02193906|Cognitive training|cognitive training
229290|NCT02193906|Multiple sclerosis|multiple sclerosis
229291|NCT02193906|Cognitive deficits|cognitive deficits
229292|NCT02193893|cell-based therapy|cell-based therapy
229293|NCT02193893|autologous bone marrow-derived stem/progenitor cells|autologous bone marrow-derived stem/progenitor cells
229294|NCT02193893|stem cell infusion, stem cell transplantation|stem cell infusion, stem cell transplantation
229295|NCT02193893|biological therapy with neurotrophic factors|biological therapy with neurotrophic factors
229296|NCT02193893|bioactive neurotrophic factors|bioactive neurotrophic factors
229297|NCT02193880|stem cell transplant|stem cell transplant
229298|NCT02193867|LIPA|lipa
229299|NCT02193867|Wolman Disease|wolman disease
229300|NCT02193867|Wolman Phenotype|wolman phenotype
229301|NCT02193867|Acid Lipase Deficiency|acid lipase deficiency
229302|NCT02193867|Acid Cholesteryl Hydrolase|acid cholesteryl hydrolase
229303|NCT02193867|Acid Lipase Disease Deficiency, type 2|acid lipase disease deficiency, type 2
229304|NCT02193867|Cholesteryl Ester Storage Disease (CESD)|cholesteryl ester storage disease (cesd)
229305|NCT02193867|Cholesteryl Ester Hydrolase Deficiency|cholesteryl ester hydrolase deficiency
229306|NCT02193867|Early Onset Lysosomal Acid Lipase Deficiency (Wolman Disease)|early onset lysosomal acid lipase deficiency (wolman disease)
229307|NCT02193867|LAL Deficiency|lal deficiency
229308|NCT02193867|Late Onset Lysosomal Acid Lipase Deficiency (CESD)|late onset lysosomal acid lipase deficiency (cesd)
229309|NCT02193867|Wolman Disease (early onset LAL Deficiency)|wolman disease (early onset lal deficiency)
229310|NCT02193867|Related Disorders:|related disorders:
229311|NCT02193867|Non-alcoholic Fatty Liver Disease (NAFLD)|non-alcoholic fatty liver disease (nafld)
229312|NCT02193867|Non-alcoholic Steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
229313|NCT02193867|Alcoholic Liver Disease|alcoholic liver disease
229314|NCT02193867|Cryptogenic Cirrhosis|cryptogenic cirrhosis
229315|NCT02193867|Niemann-Pick Disease (NPD) Type C|niemann-pick disease (npd) type c
229316|NCT02193867|Chanarin Dorfman Syndrome|chanarin dorfman syndrome
229317|NCT02193854|Telemedicine|telemedicine
229318|NCT02193854|Mobile phone|mobile phone
229319|NCT02193854|Rural physicians|rural physicians
229320|NCT02193854|Mongolia|mongolia
229321|NCT02193841|Simple bone cyst|simple bone cyst
229322|NCT02193841|Unicameral bone cyst|unicameral bone cyst
229323|NCT02193828|Dupuytren's nodules|dupuytren's nodules
229324|NCT02193815|psoriasis|psoriasis
229325|NCT02193815|plaque|plaque
229326|NCT02193815|vulgaris|vulgaris
229327|NCT02193815|phase 1|phase 1
229328|NCT02193815|randomized|randomized
229329|NCT02193815|double-blind|double-blind
229330|NCT02193815|topical|topical
229331|NCT02193815|safety|safety
229332|NCT02193802|Crohn's disease|crohn's disease
229333|NCT02193802|small bowel (SB)|small bowel (sb)
229334|NCT02193802|capsule endoscopy|capsule endoscopy
229335|NCT02193802|ileocolonoscopy|ileocolonoscopy
229336|NCT02193802|anti-TNF-alpha antibodies|anti-tnf-alpha antibodies
229337|NCT02193789|Anastomosis site structure|anastomosis site structure
229338|NCT02193789|Stent insertion|stent insertion
229742|NCT02191982|Tiredness|tiredness
229339|NCT02193789|Stent migration|stent migration
229340|NCT02193776|Tuberculosis|tuberculosis
229341|NCT02193776|Multi Drug-Resistant Tuberculosis|multi drug-resistant tuberculosis
229342|NCT02193776|Drug-Sensitive Tuberculosis|drug-sensitive tuberculosis
229343|NCT02193776|Pa-824|pa-824
229344|NCT02193776|Bedaquiline|bedaquiline
229345|NCT02193776|Moxifloxacin|moxifloxacin
229346|NCT02193776|Pyrazinamide|pyrazinamide
229347|NCT02193776|Nitroimidazole|nitroimidazole
229348|NCT02193776|Quinolone|quinolone
229349|NCT02193776|Pretomanid|pretomanid
229350|NCT02193776|NC-005|nc-005
229351|NCT02193763|pediatric|pediatric
229352|NCT02193763|lumbar puncture|lumbar puncture
229353|NCT02193763|ultrasonography|ultrasonography
229354|NCT02193763|efficacy|efficacy
229355|NCT02193750|Crohn's Disease|crohn's disease
229356|NCT02193724|Heritable Retinoblastoma|heritable retinoblastoma
229357|NCT02193724|Familial Retinoblastoma|familial retinoblastoma
229358|NCT02193724|Pluripotent Stem Cells|pluripotent stem cells
229359|NCT02193698|POEMS syndrome|poems syndrome
229360|NCT02193698|lenalidomide|lenalidomide
229361|NCT02193685|(HAEC) Hirschsprung Associated Entrocolistis|(haec) hirschsprung associated entrocolistis
229362|NCT02193685|(HD) Hirschsprung Disease|(hd) hirschsprung disease
229363|NCT02193685|(IBD) Inflammatory Bowel Disease|(ibd) inflammatory bowel disease
229364|NCT02193685|Children|children
229365|NCT02193672|Advanced cancers|advanced cancers
229366|NCT02193672|PET/CT|pet/ct
229367|NCT02193672|Positron emission tomography / computed tomography|positron emission tomography / computed tomography
229368|NCT02193672|[18F]Fluciclatide|[18f]fluciclatide
229369|NCT02193672|Chemotherapy|chemotherapy
229370|NCT02193672|Phone calls|phone calls
229371|NCT02193659|breakfast cereal|breakfast cereal
229372|NCT02193659|omega-3|omega-3
229373|NCT02193659|cholesterol|cholesterol
229374|NCT02193659|lipidic profile|lipidic profile
229375|NCT02193659|consumption|consumption
229376|NCT02193659|acceptability|acceptability
229377|NCT02193646|Colonoscopy|colonoscopy
229378|NCT02193646|Adenoma|adenoma
229380|NCT02193646|Screening Colon Cancer|screening colon cancer
229381|NCT02193620|Analgesic|analgesic
229382|NCT02193620|Narcotics|narcotics
229383|NCT02193620|Opioids|opioids
229384|NCT02193620|Pain relief after surgery|pain relief after surgery
229385|NCT02193607|Occult stress incontinence|occult stress incontinence
229386|NCT02193607|Pelvic Organ Prolapse|pelvic organ prolapse
229387|NCT02193607|Surgical Intervention|surgical intervention
229388|NCT02193607|TVT-O(Tension-free vaginal tape-obturator)|tvt-o(tension-free vaginal tape-obturator)
229389|NCT02193607|Improved Reconstructive Pelvic Surgery|improved reconstructive pelvic surgery
229390|NCT02193607|Combined Surgery|combined surgery
229391|NCT02193607|Two-step Approach|two-step approach
229392|NCT02193607|Prophylactic Incontinence Procedure|prophylactic incontinence procedure
229393|NCT02193607|Randomized Controlled Trial|randomized controlled trial
229394|NCT02193594|Preoperative concurrent chemoradiotherapy|preoperative concurrent chemoradiotherapy
229395|NCT02193594|Neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
229396|NCT02193594|Gastroesophageal junction adenocarcinoma|gastroesophageal junction adenocarcinoma
229397|NCT02193568|Supratentorial Glioma|supratentorial glioma
229398|NCT02193568|Craniotomy|craniotomy
229399|NCT02193555|Presbyopia|presbyopia
229400|NCT02193555|Refractive error correction|refractive error correction
229401|NCT02193555|Contact lenses|contact lenses
229402|NCT02193542|regional anesthesia|regional anesthesia
229403|NCT02193542|general anesthesia|general anesthesia
229404|NCT02193542|obstetric|obstetric
229405|NCT02193529|sleeve gastrectomy, dietary intake, morbid obesity.|sleeve gastrectomy, dietary intake, morbid obesity.
229406|NCT02193503|cancer|cancer
229407|NCT02193503|solid tumors|solid tumors
229408|NCT02193503|gene therapy|gene therapy
229409|NCT02193503|cell therapy|cell therapy
229410|NCT02193503|encapsulation|encapsulation
229411|NCT02193490|DNase, Pulmozyme, dry eye disease, treatment|dnase, pulmozyme, dry eye disease, treatment
229412|NCT02193464|inflammatory bowel disease, registry, incidence, Korea|inflammatory bowel disease, registry, incidence, korea
229413|NCT02193451|Lower urinary tract symptoms|lower urinary tract symptoms
229414|NCT02193451|Male LUTS|male luts
229415|NCT02193451|Voiding dysfunction|voiding dysfunction
229416|NCT02193451|Benign prostate obstruction|benign prostate obstruction
229417|NCT02193451|Detrusor underactivity|detrusor underactivity
229418|NCT02193438|Heart rate variability|heart rate variability
229419|NCT02193438|Resting energy expenditure|resting energy expenditure
229420|NCT02193438|Facial thermography|facial thermography
229421|NCT02193438|Blood pressure|blood pressure
229422|NCT02193438|Spices ingestion|spices ingestion
229423|NCT02193425|Brain|brain
229424|NCT02193425|Connectivity|connectivity
229425|NCT02193425|PET|pet
229426|NCT02193425|fcMRI|fcmri
229427|NCT02193425|18FDG|18fdg
229428|NCT02193412|analgesia nociception index|analgesia nociception index
229429|NCT02193412|heart rate variability|heart rate variability
229430|NCT02193412|autonomic nervous system|autonomic nervous system
229431|NCT02193412|specificity|specificity
229432|NCT02193412|systemic venous return|systemic venous return
229433|NCT02193412|pulse pressure variation|pulse pressure variation
229434|NCT02193412|Intraoperative Monitoring|intraoperative monitoring
229435|NCT02193399|Stem cell transplantation|stem cell transplantation
229436|NCT02193399|Fatigue|fatigue
229437|NCT02193399|Physiotherapy|physiotherapy
229438|NCT02193399|Quality of Life|quality of life
229439|NCT02193399|Cancer|cancer
229440|NCT02193399|Psychosocial aspects|psychosocial aspects
229441|NCT02193386|Cerebral Palsy|cerebral palsy
229442|NCT02193386|Physical Therapy|physical therapy
229443|NCT02193386|gait analysis|gait analysis
229444|NCT02193386|gross motor function|gross motor function
229445|NCT02193373|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
229446|NCT02193373|Autonomic Nervous System|autonomic nervous system
229447|NCT02193373|Heart Rate Variability|heart rate variability
229448|NCT02193373|Sub-Occipital Release|sub-occipital release
229449|NCT02193373|Rib-Raising|rib-raising
229450|NCT02193373|Stellate Ganglion Release|stellate ganglion release
229451|NCT02193360|Inflammation|inflammation
229452|NCT02193360|PBC|pbc
229453|NCT02193347|Immunotherapy|immunotherapy
229454|NCT02193347|Adult|adult
229455|NCT02193334|Hepatocyte Growth Factor|hepatocyte growth factor
229456|NCT02193334|HGF|hgf
229457|NCT02193334|KP-100IT|kp-100it
229458|NCT02193334|Intrathecal injection|intrathecal injection
229459|NCT02193321|Atrial Fibrillation|atrial fibrillation
229460|NCT02193321|Amniotic Membrane|amniotic membrane
229461|NCT02193295|Weight Reduction|weight reduction
229462|NCT02193295|Caloric Restriction|caloric restriction
229463|NCT02193295|Euglycemic Hyperinsulinemic Clamp|euglycemic hyperinsulinemic clamp
229464|NCT02193295|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
229465|NCT02193269|Abstinent cocaine users|abstinent cocaine users
229466|NCT02193269|minocycline|minocycline
229467|NCT02193269|antibiotic|antibiotic
229468|NCT02193256|varenicline|varenicline
229469|NCT02193256|prazosin|prazosin
229470|NCT02193256|cigarette smoking|cigarette smoking
229471|NCT02193256|alcohol drinking|alcohol drinking
229472|NCT02193256|sleep|sleep
229473|NCT02193256|dreams|dreams
229474|NCT02193243|Congenital Heart Disease|congenital heart disease
229475|NCT02193243|Six Minute Walk Test|six minute walk test
229476|NCT02193243|Exercise Testing|exercise testing
229477|NCT02193243|Peak oxygen uptake|peak oxygen uptake
229478|NCT02193230|Atopic dermatitis, Feasibility, Adherence to treatment|atopic dermatitis, feasibility, adherence to treatment
229479|NCT02193204|Alcohol dependence|alcohol dependence
229480|NCT02193204|Stress|stress
229481|NCT02193204|Cytokines|cytokines
229482|NCT02193204|Depressive Symptomatology|depressive symptomatology
229483|NCT02193191|Plerixafor|plerixafor
229484|NCT02193191|13-229|13-229
229485|NCT02193152|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
229486|NCT02193152|NSCLC|nsclc
229487|NCT02193152|Pazopanib|pazopanib
229488|NCT02193126|Long term foster care|long term foster care
229489|NCT02193126|child abuse and neglect|child abuse and neglect
229490|NCT02193126|trauma|trauma
229491|NCT02193113|Diabetic Macular Edema|diabetic macular edema
229492|NCT02193113|DME|dme
229493|NCT02193113|Plasma Kallikrein inhibitor|plasma kallikrein inhibitor
229494|NCT02193113|KVD001|kvd001
229495|NCT02193113|KVD001-001|kvd001-001
229496|NCT02193113|Intravitreal|intravitreal
229497|NCT02193113|IVT|ivt
229498|NCT02193113|Diabetes mellitus|diabetes mellitus
229499|NCT02193087|Drug therapy|drug therapy
229500|NCT02193074|Spinal Muscular Atrophy|spinal muscular atrophy
229501|NCT02193074|SMA|sma
229502|NCT02193074|SMN|smn
229503|NCT02193074|SMNRx|smnrx
229504|NCT02193074|ISIS-SMNRx|isis-smnrx
229505|NCT02193074|ISIS-SMN Rx|isis-smn rx
229506|NCT02193074|ISIS 396443|isis 396443
229507|NCT02193074|IONIS-SMNRx|ionis-smnrx
229508|NCT02193074|IONIS-SMN Rx|ionis-smn rx
229509|NCT02193074|Spinraza|spinraza
229510|NCT02193074|ENDEAR|endear
229511|NCT02193061|Rotavirus|rotavirus
229512|NCT02193061|immunological behavior|immunological behavior
229513|NCT02193061|Rotarix|rotarix
229514|NCT02193061|RotaTeq|rotateq
229515|NCT02193061|vaccine interchangeability|vaccine interchangeability
229516|NCT02193035|Microparticles|microparticles
229517|NCT02193035|Severe aortic stenosis|severe aortic stenosis
229518|NCT02193035|Calcified aortic stenosis|calcified aortic stenosis
229519|NCT02193035|transcatheter aortic valve replacement|transcatheter aortic valve replacement
229520|NCT02193022|Bangladesh, PKDL, Visceral Leishmaniasis, Children, Miltefosine|bangladesh, pkdl, visceral leishmaniasis, children, miltefosine
229521|NCT02192996|VLBW preterm|vlbw preterm
229522|NCT02192996|GUT microbiota|gut microbiota
229523|NCT02192996|probiotics supplementation|probiotics supplementation
229524|NCT02192996|immune compounds|immune compounds
229525|NCT02192970|Retinal detachment|retinal detachment
229526|NCT02192970|Proliferative vitreoretinopathy|proliferative vitreoretinopathy
229527|NCT02192957|cardioversion|cardioversion
229528|NCT02192957|electrical cardioversion|electrical cardioversion
229529|NCT02192957|atrial fibrillation|atrial fibrillation
229530|NCT02192957|cardioversion protocol|cardioversion protocol
229531|NCT02192944|ECG|ecg
229532|NCT02192944|Pharmacokinetic profile|pharmacokinetic profile
229533|NCT02192892|Young children|young children
229534|NCT02192892|Acceptability|acceptability
229535|NCT02192892|Food intake|food intake
229536|NCT02192892|Energy dense porridge|energy dense porridge
229537|NCT02192879|thoracic epidural|thoracic epidural
229538|NCT02192879|continuous paravertebral catheter|continuous paravertebral catheter
229539|NCT02192879|PCA|pca
229540|NCT02192879|liver resection|liver resection
229541|NCT02192879|pain management|pain management
229542|NCT02192853|Diabetes Mellitus|diabetes mellitus
229543|NCT02192853|Glucagon-like peptide 1|glucagon-like peptide 1
229544|NCT02192853|Dipeptidyl peptidase 4|dipeptidyl peptidase 4
229545|NCT02192853|Dipeptidyl peptidase 4 inhibitor|dipeptidyl peptidase 4 inhibitor
229546|NCT02192853|sitagliptin|sitagliptin
229547|NCT02192853|Enzyme activity|enzyme activity
229548|NCT02192840|provisional T stenting|provisional t stenting
229549|NCT02192840|dedicated bifurcation stent|dedicated bifurcation stent
229550|NCT02192827|Pediatric|pediatric
229551|NCT02192827|Asthma|asthma
229552|NCT02192827|Exacerbation|exacerbation
229553|NCT02192827|Dexamethasone|dexamethasone
229554|NCT02192827|Peak flow|peak flow
229555|NCT02192814|Lacosamide|lacosamide
229556|NCT02192814|LCM|lcm
229557|NCT02192814|Epilepsy|epilepsy
229558|NCT02192814|Partial-onset seizures|partial-onset seizures
229559|NCT02192814|iv|iv
229560|NCT02192801|Classic Bladder Exstrophy|classic bladder exstrophy
229561|NCT02192801|Renal function|renal function
229562|NCT02192801|GFR|gfr
229563|NCT02192801|Proteinuria|proteinuria
229564|NCT02192788|SBRT|sbrt
229565|NCT02192788|Oligometastases|oligometastases
229566|NCT02192788|Prostate Cancer|prostate cancer
229567|NCT02192775|Measles virus|measles virus
229568|NCT02192775|Sodium Iodide Symporter|sodium iodide symporter
229569|NCT02192775|Cyclophosphamide|cyclophosphamide
229570|NCT02192775|Refractory multiple myeloma|refractory multiple myeloma
229571|NCT02192749|autism|autism
229572|NCT02192749|umbilical cord|umbilical cord
229573|NCT02192749|mesenchymal|mesenchymal
229574|NCT02192749|stem cells|stem cells
229575|NCT02192736|asthma|asthma
229576|NCT02192736|umbilical cord|umbilical cord
229577|NCT02192736|mesenchymal|mesenchymal
229578|NCT02192736|stem cells|stem cells
229579|NCT02192736|trophic factors|trophic factors
229580|NCT02192710|outpatient surgery|outpatient surgery
229581|NCT02192710|anaesthesia|anaesthesia
229582|NCT02192710|midazolam|midazolam
229583|NCT02192710|electronic tab|electronic tab
229584|NCT02192697|safety|safety
229585|NCT02192697|pharmacokinetics|pharmacokinetics
229586|NCT02192697|tolerability|tolerability
229587|NCT02192697|ASP8273|asp8273
229588|NCT02192697|Non-small Cell Lung Cancer|non-small cell lung cancer
229589|NCT02192697|T790M resistance mutation|t790m resistance mutation
229590|NCT02192697|NSCLC|nsclc
229591|NCT02192697|Epidermal Growth Factor Receptor mutations|epidermal growth factor receptor mutations
229592|NCT02192697|irreversible EGFR inhibitor|irreversible egfr inhibitor
229593|NCT02192697|antitumor activity|antitumor activity
229594|NCT02192697|EGFR|egfr
229595|NCT02192684|obstructive sleep apnea|obstructive sleep apnea
229596|NCT02192684|insulin sensitivity|insulin sensitivity
229597|NCT02192684|cardiovascular risk|cardiovascular risk
229598|NCT02192684|positive airway pressure therapy|positive airway pressure therapy
229599|NCT02192671|hepatocellular carcinoma|hepatocellular carcinoma
229600|NCT02192671|radiofrequency ablation|radiofrequency ablation
229601|NCT02192671|hepatic resection|hepatic resection
229602|NCT02192671|portal hypertension|portal hypertension
229603|NCT02192671|Milan criteria|milan criteria
229604|NCT02192671|randomized critical trial|randomized critical trial
229605|NCT02192619|APL|apl
229606|NCT02192619|acute promyelocytic leukemia|acute promyelocytic leukemia
229607|NCT02192619|AML M3|aml m3
229608|NCT02192606|Laparoscopy|laparoscopy
229609|NCT02192606|3D Visual System|3d visual system
229610|NCT02192606|Total Hysterectomy|total hysterectomy
229611|NCT02192567|Advanced solid malignant tumor|advanced solid malignant tumor
229612|NCT02192567|phase 1|phase 1
229613|NCT02192567|oncology|oncology
229614|NCT02192554|OPC-34712|opc-34712
229615|NCT02192554|brexpiprazole|brexpiprazole
229616|NCT02192554|Dementia|dementia
229617|NCT02192554|Alzheimer's Disease|alzheimer's disease
229618|NCT02192554|Cognitive Disorders|cognitive disorders
229619|NCT02192554|Memory|memory
229620|NCT02192554|Agitation|agitation
229621|NCT02192541|Urothelial Carcinomas|urothelial carcinomas
229622|NCT02192541|Non-Squamous Non-Small Cell Lung Carcinomas|non-squamous non-small cell lung carcinomas
229623|NCT02192541|Refractory Gastrointestinal Carcinomas|refractory gastrointestinal carcinomas
229624|NCT02192541|Hsp90 Inhibitor|hsp90 inhibitor
229625|NCT02192541|Sarcomas|sarcomas
229626|NCT02192528|vitamin D|vitamin d
229627|NCT02192528|25-hydroxyvitamin D|25-hydroxyvitamin d
229628|NCT02192528|1,25-dihydroxyvitamin D|1,25-dihydroxyvitamin d
229629|NCT02192528|MACCE|macce
229630|NCT02192528|mortality|mortality
229631|NCT02192528|cardiac|cardiac
229632|NCT02192528|cerebrovascular|cerebrovascular
229633|NCT02192515|Healthy Subjects|healthy subjects
229634|NCT02192515|Japanese Adult|japanese adult
229635|NCT02192489|Chronic Cutaneous Sarcoidosis|chronic cutaneous sarcoidosis
229636|NCT02192489|Cutaneous Sarcoidosis|cutaneous sarcoidosis
229637|NCT02192489|Skin Sarcoidosis|skin sarcoidosis
229638|NCT02192489|Sarcoidosis|sarcoidosis
229639|NCT02192476|Stroke, subluxation|stroke, subluxation
229640|NCT02192450|Diabetes Mellitus|diabetes mellitus
229641|NCT02192450|Hypoglycaemia|hypoglycaemia
229642|NCT02192450|Glucose Metabolism Disorders|glucose metabolism disorders
229643|NCT02192450|Metabolic Diseases|metabolic diseases
229644|NCT02192450|Endocrine System Diseases|endocrine system diseases
229645|NCT02192450|Autoimmune Diseases|autoimmune diseases
229646|NCT02192450|Insulin|insulin
229647|NCT02192450|Hypoglycaemic Agents|hypoglycaemic agents
229648|NCT02192450|Physiological Effetcs of Drugs|physiological effetcs of drugs
229649|NCT02192437|methionine|methionine
229650|NCT02192437|cysteine|cysteine
229651|NCT02192437|sulfur amino acid restriction|sulfur amino acid restriction
229652|NCT02192424|beta-cell function,|beta-cell function,
229653|NCT02192424|type 2 diabetes,|type 2 diabetes,
229654|NCT02192424|intermittent insulin|intermittent insulin
229655|NCT02192411|lidocaine|lidocaine
229656|NCT02192411|tumescent|tumescent
229657|NCT02192411|endovenous|endovenous
229658|NCT02192411|laser|laser
229659|NCT02192411|pain|pain
229660|NCT02192398|Pain|pain
229661|NCT02192398|Pain management|pain management
229662|NCT02192398|Neck|neck
229663|NCT02192398|Back|back
229664|NCT02192372|creatinine|creatinine
229665|NCT02192372|glomerular filtration rate|glomerular filtration rate
229666|NCT02192372|metabolic syndrome|metabolic syndrome
229667|NCT02192346|metastatic|metastatic
229668|NCT02192346|refractory|refractory
229669|NCT02192346|progressive|progressive
229670|NCT02192320|Atorvastatin|atorvastatin
229671|NCT02192320|Atorvastatin and Dexamethasone|atorvastatin and dexamethasone
229672|NCT02192320|Chronic Subdural Hematoma|chronic subdural hematoma
229673|NCT02192320|conservative treatment|conservative treatment
229674|NCT02192307|Sensitivity|sensitivity
229675|NCT02192294|Bosutinib|bosutinib
229676|NCT02192294|absolute bioavailability|absolute bioavailability
229677|NCT02192281|Physical activity|physical activity
229678|NCT02192281|Recess|recess
229679|NCT02192281|Accelerometer|accelerometer
229680|NCT02192281|Play|play
229681|NCT02192255|diabetes type 2|diabetes type 2
229682|NCT02192255|primary care|primary care
229683|NCT02192255|chronic disease care improvement|chronic disease care improvement
229684|NCT02192255|adherence, randomized trial|adherence, randomized trial
229685|NCT02192255|BP control|bp control
229686|NCT02192255|lipid control|lipid control
229687|NCT02192255|glucose control|glucose control
229688|NCT02192255|natural language processing.|natural language processing.
229689|NCT02192242|acute ischemic pain|acute ischemic pain
229690|NCT02192242|model|model
229691|NCT02192242|S100|s100
229692|NCT02192242|interleukine 6|interleukine 6
229693|NCT02192216|Body composition|body composition
229694|NCT02192216|Chemotherapy|chemotherapy
229695|NCT02192216|Muscle mass|muscle mass
229696|NCT02192216|Muscle function|muscle function
229697|NCT02192216|Exercise|exercise
229698|NCT02192177|Apoptosis|apoptosis
229699|NCT02192177|intrahepatic cholestasis|intrahepatic cholestasis
229700|NCT02192177|obstetric outcomes|obstetric outcomes
229701|NCT02192164|plaque psoriasis|plaque psoriasis
229702|NCT02192164|smoking|smoking
229703|NCT02192164|etanercept|etanercept
229704|NCT02192151|Analgesic|analgesic
229705|NCT02192151|Narcotics|narcotics
229706|NCT02192151|Opioids|opioids
229707|NCT02192151|Non-scheduled substanse|non-scheduled substanse
229708|NCT02192138|Pleural effusion|pleural effusion
229709|NCT02192138|Pleural fluid|pleural fluid
229710|NCT02192138|Thoracentesis|thoracentesis
229711|NCT02192138|Intrapleural pressure|intrapleural pressure
229712|NCT02192138|Pleural manometry|pleural manometry
229713|NCT02192125|stroke|stroke
229714|NCT02192125|rehabilitation|rehabilitation
229715|NCT02192125|balance|balance
229716|NCT02192125|training|training
229717|NCT02192125|posture|posture
229718|NCT02192086|Kidney transplantation|kidney transplantation
229719|NCT02192060|Biofilm|biofilm
229720|NCT02192060|Triclosan|triclosan
229721|NCT02192060|Crossover|crossover
229722|NCT02192060|Clinical trial|clinical trial
229723|NCT02192034|Colonoscopy|colonoscopy
229724|NCT02192034|Colon cancer|colon cancer
229725|NCT02192034|screening|screening
229726|NCT02192034|navigation|navigation
229727|NCT02192021|CTCL|ctcl
229728|NCT02192021|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
229729|NCT02192021|Mycosis Fungoides|mycosis fungoides
229730|NCT02192008|Challenge|challenge
229731|NCT02192008|Re-challenge|re-challenge
229732|NCT02192008|Controlled Infection|controlled infection
229733|NCT02192008|Enteric fever|enteric fever
229734|NCT02191982|Cancer|cancer
229735|NCT02191982|Chemotherapy|chemotherapy
229736|NCT02191982|Fatigue|fatigue
229737|NCT02191982|Elderly|elderly
229738|NCT02191982|Geriatric|geriatric
229739|NCT02191982|Any Cancer|any cancer
229740|NCT02191982|Cancer Treatment|cancer treatment
229741|NCT02191982|Weakness|weakness
229743|NCT02191969|Chemotherapy|chemotherapy
229744|NCT02191969|Adjuvant Chemotherapy|adjuvant chemotherapy
229745|NCT02191969|Cancer Therapy|cancer therapy
229746|NCT02191969|Fatigue|fatigue
229747|NCT02191969|Physical Activity|physical activity
229748|NCT02191969|Physical Function|physical function
229749|NCT02191969|Tiredness|tiredness
229750|NCT02191969|Colon Cancer|colon cancer
229751|NCT02191969|Rectal Cancer|rectal cancer
229752|NCT02191969|Walk With Ease|walk with ease
229753|NCT02191969|Colorectal Cancer|colorectal cancer
229754|NCT02191969|Geriatric Assessment|geriatric assessment
229755|NCT02191969|Geriatric|geriatric
229756|NCT02191969|Elderly|elderly
229757|NCT02191956|Disruptive behavior disorders|disruptive behavior disorders
229758|NCT02191956|Early Onset|early onset
229759|NCT02191956|Young Children|young children
229760|NCT02191956|Parenting|parenting
229761|NCT02191956|Behavioral Parent Training|behavioral parent training
229762|NCT02191943|caries|caries
229763|NCT02191943|proximal|proximal
229764|NCT02191943|non-cavitated|non-cavitated
229765|NCT02191943|fluoridation|fluoridation
229766|NCT02191878|Liver Cancer|liver cancer
229767|NCT02191878|Liver Neoplasms|liver neoplasms
229768|NCT02191878|Liver Epithelial Neoplasms|liver epithelial neoplasms
229769|NCT02191878|Liver Cancer, malignant|liver cancer, malignant
229770|NCT02191839|cardiac surgery|cardiac surgery
229771|NCT02191839|alpha 1 antitrypsin|alpha 1 antitrypsin
229772|NCT02191839|inflammation|inflammation
229773|NCT02191839|post operative bleeding|post operative bleeding
229774|NCT02191839|organ function|organ function
229775|NCT02191826|Transthyretin|transthyretin
229776|NCT02191826|TTR|ttr
229777|NCT02191826|Amyloidosis|amyloidosis
229778|NCT02191826|SOM0226|som0226
229779|NCT02191826|Familiar Amyloid Polyneuropathy|familiar amyloid polyneuropathy
229780|NCT02191774|Medical abortion|medical abortion
229781|NCT02191774|Home abortion|home abortion
229782|NCT02191683|Anaemia|anaemia
229783|NCT02191683|Pregnancy|pregnancy
229784|NCT02191683|Foetal programming|foetal programming
229785|NCT02191683|Epigenetics|epigenetics
229786|NCT02191683|Non-communicable diseases|non-communicable diseases
229787|NCT02191683|Tanzania|tanzania
229788|NCT02191657|HIV|hiv
229789|NCT02191657|deferiprone|deferiprone
229790|NCT02191657|iron chelation|iron chelation
229791|NCT02191631|OCD|ocd
229792|NCT02191631|adolescents|adolescents
229793|NCT02191631|pediatric|pediatric
229794|NCT02191631|internet|internet
229795|NCT02191631|online|online
229796|NCT02191631|CBT|cbt
229797|NCT02191618|Aneurysm|aneurysm
229798|NCT02191618|Intracranial Aneurysm|intracranial aneurysm
229799|NCT02191618|Vascular Diseases|vascular diseases
229800|NCT02191618|Cardiovascular Diseases|cardiovascular diseases
229801|NCT02191618|Intracranial Arterial Diseases|intracranial arterial diseases
229802|NCT02191618|Cerebrovascular Disorders|cerebrovascular disorders
229803|NCT02191618|Brain Diseases|brain diseases
229804|NCT02191618|Central Nervous System Diseases|central nervous system diseases
229805|NCT02191618|Nervous System Diseases|nervous system diseases
229806|NCT02191605|Computerized Brief Intervention|computerized brief intervention
229807|NCT02191592|Tinnitus|tinnitus
229808|NCT02191592|EMA|ema
229809|NCT02191592|Bothersome|bothersome
229810|NCT02191566|Stomach Cancer|stomach cancer
229811|NCT02191553|mindfulness meditation|mindfulness meditation
229812|NCT02191553|alpha rhythm|alpha rhythm
229813|NCT02191553|EEG|eeg
229814|NCT02191553|brain mapping|brain mapping
229815|NCT02191553|emotion|emotion
229816|NCT02191553|attention|attention
229817|NCT02191527|PMTCT|pmtct
229818|NCT02191527|HIV|hiv
229819|NCT02191527|Syphilis|syphilis
229820|NCT02191527|Anemia during pregnancy|anemia during pregnancy
229821|NCT02191527|Point of care diagnostics|point of care diagnostics
229822|NCT02191514|Prehospital|prehospital
229823|NCT02191514|EMS|ems
229824|NCT02191514|EMD|emd
229825|NCT02191514|Stroke|stroke
229826|NCT02191514|Dispatch|dispatch
229827|NCT02191501|Obesity Treatment|obesity treatment
229828|NCT02191501|Endoscopy|endoscopy
229829|NCT02191501|Pyloric Suturing|pyloric suturing
229830|NCT02191501|Pyloric restriction|pyloric restriction
229831|NCT02191488|Fluorescence|fluorescence
229832|NCT02191488|Brain Tumors|brain tumors
229833|NCT02191488|Brain Metastases|brain metastases
229834|NCT02191488|Malignant Glioma|malignant glioma
229835|NCT02191488|Brain Lesions|brain lesions
229836|NCT02191475|sepsis shock|sepsis shock
229837|NCT02191475|Tigecycline|tigecycline
229838|NCT02191475|Piperacillin / tazobactam|piperacillin / tazobactam
229839|NCT02191475|Abdominal infection|abdominal infection
229840|NCT02191462|Pharmacokinetics|pharmacokinetics
229841|NCT02191462|Niagen|niagen
229842|NCT02191462|Nicotinamide riboside|nicotinamide riboside
229843|NCT02191436|Haemophilia|haemophilia
229844|NCT02191436|Adherence|adherence
229845|NCT02191436|Family Functioning|family functioning
229846|NCT02191436|Quality of Life|quality of life
229847|NCT02191436|Anxiety|anxiety
229848|NCT02191436|Illness Behavior|illness behavior
229849|NCT02191436|Coping Strategies|coping strategies
229850|NCT02191423|postpartum Depression|postpartum depression
229851|NCT02191423|Diadic psychotherapy|diadic psychotherapy
229852|NCT02191423|Oxytocin|oxytocin
229853|NCT02191423|fMRI|fmri
229854|NCT02191423|attachment|attachment
229855|NCT02191423|empathy|empathy
229856|NCT02191410|Video-assisted thoracoscopic surgery|video-assisted thoracoscopic surgery
229857|NCT02191410|one-lung ventilation|one-lung ventilation
229858|NCT02191410|continuous positive-airway ventilation|continuous positive-airway ventilation
229859|NCT02191410|high-frequency positive-pressure ventilation|high-frequency positive-pressure ventilation
229860|NCT02191410|stroke volume variation|stroke volume variation
229861|NCT02191410|fluid responsiveness|fluid responsiveness
229862|NCT02191397|Escitalopram|escitalopram
229863|NCT02191397|Major depressive disorder|major depressive disorder
229864|NCT02191397|Non-inferiority|non-inferiority
229865|NCT02191397|Bupropion|bupropion
229866|NCT02191371|oxygenation|oxygenation
229867|NCT02191371|microcirculation|microcirculation
229868|NCT02191371|one-lung ventilation|one-lung ventilation
229869|NCT02191371|thoracic surgery|thoracic surgery
229870|NCT02191358|Cytochrome drug interactions|cytochrome drug interactions
229871|NCT02191358|Drug-drug interaction|drug-drug interaction
229872|NCT02191358|Drug-gene interaction|drug-gene interaction
229873|NCT02191358|Drug-drug-gene interaction|drug-drug-gene interaction
229874|NCT02191358|Drug Metabolism|drug metabolism
229875|NCT02191358|Elderly|elderly
229876|NCT02191358|Geriatric medicine|geriatric medicine
229877|NCT02191358|Geriatrics|geriatrics
229878|NCT02191358|Personalized medicine|personalized medicine
229879|NCT02191358|Pharmacist|pharmacist
229880|NCT02191358|Pharmacogenetics|pharmacogenetics
229881|NCT02191358|Pharmacogenomics|pharmacogenomics
229882|NCT02191358|Pharmacokinetics|pharmacokinetics
229883|NCT02191358|Polymorphism|polymorphism
229884|NCT02191358|Polypharmacy|polypharmacy
229885|NCT02191358|Precision medicine|precision medicine
229886|NCT02191358|Seniors|seniors
229887|NCT02191358|YouScript|youscript
229888|NCT02191358|CYP2C9|cyp2c9
229889|NCT02191358|CYP2C19|cyp2c19
229890|NCT02191358|CYP2D6|cyp2d6
229891|NCT02191358|CYP3A4|cyp3a4
229892|NCT02191358|CYP3A5|cyp3a5
229893|NCT02191358|VKORC1|vkorc1
229894|NCT02191358|Amitriptyline|amitriptyline
229895|NCT02191358|Aripiprazole|aripiprazole
229896|NCT02191358|Atomoxetine|atomoxetine
229897|NCT02191358|Carvedilol|carvedilol
229898|NCT02191358|Celecoxib|celecoxib
229899|NCT02191358|Citalopram|citalopram
229900|NCT02191358|Clobazam|clobazam
229901|NCT02191358|Clomipramine|clomipramine
229902|NCT02191358|Clopidogrel|clopidogrel
229903|NCT02191358|Clozapine|clozapine
229904|NCT02191358|Codeine|codeine
229905|NCT02191358|Desipramine|desipramine
229906|NCT02191358|Dextromethorphan|dextromethorphan
229907|NCT02191358|Diazepam|diazepam
229908|NCT02191358|Doxepin|doxepin
229909|NCT02191358|Escitalopram|escitalopram
229910|NCT02191358|Esomeprazole|esomeprazole
229911|NCT02191358|Fesoterodine|fesoterodine
229912|NCT02191358|Flecainide|flecainide
229913|NCT02191358|Fluoxetine|fluoxetine
229914|NCT02191358|Flurbiprofen|flurbiprofen
229915|NCT02191358|Fluvoxamine|fluvoxamine
229916|NCT02191358|Haloperidol|haloperidol
229917|NCT02191358|Hydrocodone|hydrocodone
229918|NCT02191358|Ibuprofen|ibuprofen
229919|NCT02191358|Iloperidone|iloperidone
229920|NCT02191358|Imipramine|imipramine
229921|NCT02191358|Indomethacin|indomethacin
229922|NCT02191358|Meloxicam|meloxicam
229923|NCT02191358|Metoprolol|metoprolol
229924|NCT02191358|Mexiletine|mexiletine
229925|NCT02191358|Nortriptyline|nortriptyline
229926|NCT02191358|Omeprazole|omeprazole
229927|NCT02191358|Oxycodone|oxycodone
229928|NCT02191358|Paroxetine|paroxetine
229929|NCT02191358|Perphenazine|perphenazine
229930|NCT02191358|Phenobarbital|phenobarbital
229931|NCT02191358|Phenytoin|phenytoin
229932|NCT02191358|Pimozide|pimozide
229933|NCT02191358|Piroxicam|piroxicam
229934|NCT02191358|Proguanil|proguanil
229935|NCT02191358|Propafenone|propafenone
229936|NCT02191358|Propranolol|propranolol
229937|NCT02191358|Risperidone|risperidone
229938|NCT02191358|Sertraline|sertraline
229939|NCT02191358|Tetrabenazine|tetrabenazine
229940|NCT02191358|Thioridazine|thioridazine
229941|NCT02191358|Timolol|timolol
229942|NCT02191358|Tolterodine|tolterodine
229943|NCT02191358|Torsemide|torsemide
229944|NCT02191358|Tramadol|tramadol
229945|NCT02191358|Trimipramine|trimipramine
229946|NCT02191358|Venlafaxine|venlafaxine
229947|NCT02191358|Voriconazole|voriconazole
229948|NCT02191358|Vortioxetine|vortioxetine
229949|NCT02191345|guided imagery|guided imagery
229950|NCT02191345|burnout|burnout
229951|NCT02191345|compassion fatigue|compassion fatigue
229952|NCT02191345|state anxiety|state anxiety
229953|NCT02191267|CTE|cte
229954|NCT02191267|Positron Emission Topography|positron emission topography
229955|NCT02191267|Tau|tau
229956|NCT02191267|Beta-amyloid|beta-amyloid
229957|NCT02191267|Magnetic Resonance Imaging|magnetic resonance imaging
229958|NCT02191267|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
229959|NCT02191267|Diffusion Tensor Imaging|diffusion tensor imaging
229960|NCT02191150|Anaemia, Chronic Kidney Disease, Switching, Aranesp, Darbepoetin Alfa, Epoetin Alfa Biosimilars, Haemodialysis.|anaemia, chronic kidney disease, switching, aranesp, darbepoetin alfa, epoetin alfa biosimilars, haemodialysis.
229961|NCT02191137|Pulmonary Hypertension,Riociguat,Living with Pulmonary Hypertension Questionnaire|pulmonary hypertension,riociguat,living with pulmonary hypertension questionnaire
229962|NCT02191124|Measurement-based care|measurement-based care
229963|NCT02191124|Unipolar depression|unipolar depression
229964|NCT02191124|Outpatients|outpatients
229965|NCT02191111|Pharmacist|pharmacist
229966|NCT02191111|Pharmacy practice|pharmacy practice
229967|NCT02191111|Patient care|patient care
229968|NCT02191111|Community pharmacy|community pharmacy
229969|NCT02191111|Hypertension|hypertension
229970|NCT02191111|Diabetes|diabetes
229971|NCT02191111|Dyslipidemia|dyslipidemia
229972|NCT02191111|Pharmaceutical care|pharmaceutical care
229973|NCT02191098|HIV|hiv
229974|NCT02191098|ART|art
229975|NCT02191072|urticaria,omalizumab|urticaria,omalizumab
229976|NCT02191059|Non Small Cell Lung Cancer|non small cell lung cancer
229977|NCT02191059|Wild Type EGFR|wild type egfr
229978|NCT02191059|Icotinib|icotinib
229979|NCT02191059|Second-line Treatment|second-line treatment
229980|NCT02191046|nasal irrigation|nasal irrigation
229981|NCT02191046|sinusitis|sinusitis
229982|NCT02191046|children|children
229983|NCT02191046|buffered hypertonic saline|buffered hypertonic saline
229984|NCT02191046|nasal irrigation device|nasal irrigation device
229985|NCT02191033|cigarette smoking|cigarette smoking
229986|NCT02191033|tobacco use cessation products|tobacco use cessation products
229987|NCT02191020|Total Glucosides of Paeony(TGP)|total glucosides of paeony(tgp)
229988|NCT02191020|Acitretin Capsules|acitretin capsules
229989|NCT02191020|Psoriasis Vulgaris|psoriasis vulgaris
229990|NCT02190994|Hydrocortisone|hydrocortisone
229991|NCT02190994|Pituitary adenomas|pituitary adenomas
229992|NCT02190994|Replacement therapy|replacement therapy
229993|NCT02190981|Small bowel obstruction|small bowel obstruction
229994|NCT02190981|Ultrasound|ultrasound
229995|NCT02190981|Emergency department|emergency department
229996|NCT02190968|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
229997|NCT02190968|Internet interventions|internet interventions
229998|NCT02190968|Residual depressive symptoms|residual depressive symptoms
229999|NCT02190968|Depressive relapse prevention|depressive relapse prevention
230000|NCT02190903|delirium|delirium
230001|NCT02190903|hip fracture|hip fracture
230002|NCT02190903|general anesthesia|general anesthesia
230003|NCT02190903|spinal anesthesia|spinal anesthesia
230004|NCT02190903|postoperative complications|postoperative complications
230005|NCT02190877|Heart Failure|heart failure
230006|NCT02190877|Impedance|impedance
230007|NCT02190877|Fluids|fluids
230008|NCT02190851|urinary disorders|urinary disorders
230009|NCT02190851|Parkinson's disease|parkinson's disease
230010|NCT02190838|Melanoma|melanoma
230011|NCT02190838|Melatonin|melatonin
230012|NCT02190838|Metformin|metformin
230013|NCT02190838|Dacarbazine|dacarbazine
230014|NCT02190812|wrist muscle strength|wrist muscle strength
230015|NCT02190799|Corona Virus|corona virus
230016|NCT02190799|Convalescent plasma|convalescent plasma
230017|NCT02190799|Serology|serology
230018|NCT02190786|Hyperuricemia|hyperuricemia
230019|NCT02190773|Chronic Periodontitis, Aggressive Periodontitis, RANKL/OPG ratio, Gingival crevicular fluid|chronic periodontitis, aggressive periodontitis, rankl/opg ratio, gingival crevicular fluid
230020|NCT02190747|Intervention study|intervention study
230021|NCT02190747|Clinical trial Phase 2|clinical trial phase 2
230022|NCT02190747|Efficacy and safety|efficacy and safety
230023|NCT02190747|Heterotopic ossification|heterotopic ossification
230024|NCT02190747|Flare-up|flare-up
230025|NCT02190747|Palovarotene|palovarotene
230026|NCT02190747|Retinoic acid receptor agonist|retinoic acid receptor agonist
230027|NCT02190747|Retinoic acid receptor gamma agonist|retinoic acid receptor gamma agonist
230028|NCT02190747|Clementia|clementia
230029|NCT02190747|Myositis Ossificans Progressiva|myositis ossificans progressiva
230030|NCT02190747|Munchmeyer's Disease|munchmeyer's disease
230031|NCT02190747|FOP|fop
230032|NCT02190734|Stroke|stroke
230033|NCT02190734|Pusher Syndrome|pusher syndrome
230034|NCT02190734|Lateropulsion|lateropulsion
230035|NCT02190734|Pushing Behaviors|pushing behaviors
230036|NCT02190734|Burke Lateropulsion Scale|burke lateropulsion scale
230037|NCT02190721|Neutropenia|neutropenia
230038|NCT02190708|PQ912|pq912
230039|NCT02190708|Midazolam|midazolam
230040|NCT02190708|Omeprazole|omeprazole
230041|NCT02190708|Pharmacokinetics|pharmacokinetics
230042|NCT02190708|Drug Interaction|drug interaction
230043|NCT02190682|postoperative|postoperative
230044|NCT02190682|chronic|chronic
230045|NCT02190682|pain|pain
230046|NCT02190682|software|software
230047|NCT02190656|Rectal cancer|rectal cancer
230048|NCT02190656|Anterior Resection Syndrome|anterior resection syndrome
230049|NCT02190656|Functional outcomes|functional outcomes
230050|NCT02190643|Smoking|smoking
230051|NCT02190643|HIV|hiv
230052|NCT02190643|Latino|latino
230053|NCT02190643|Cessation|cessation
230054|NCT02190643|Nicotine patch|nicotine patch
230055|NCT02190617|Asthma|asthma
230056|NCT02190617|Guidelines|guidelines
230057|NCT02190617|Community Health Worker|community health worker
230058|NCT02190604|FEV1- Forced Expiratory volume|fev1- forced expiratory volume
230059|NCT02190604|LCI - Lung Clearance Index|lci - lung clearance index
230060|NCT02190604|CFTR - cystic fibrosis transmembrane conductance regulator|cftr - cystic fibrosis transmembrane conductance regulator
230061|NCT02190604|cystic fibrosis|cystic fibrosis
230062|NCT02190604|allergic bronchopulmonary aspergillosis|allergic bronchopulmonary aspergillosis
230063|NCT02190591|epidural|epidural
230064|NCT02190591|pregnant|pregnant
230065|NCT02190591|Cesarean Section|cesarean section
230066|NCT02190591|forceps|forceps
230067|NCT02190591|vaginal|vaginal
230068|NCT02190565|pregnancy, lactation, food supplement, anaemia|pregnancy, lactation, food supplement, anaemia
230069|NCT02190552|Brain|brain
230070|NCT02190552|Brain Clot|brain clot
230071|NCT02190552|Brain Diseases|brain diseases
230072|NCT02190552|Brain Infarction|brain infarction
230073|NCT02190552|Cerebral Ischemia|cerebral ischemia
230074|NCT02190552|Cerebrovascular Disorders|cerebrovascular disorders
230075|NCT02190552|EmboTrap® Revascularization Device|embotrap® revascularization device
230076|NCT02190552|EmboTrap|embotrap
230077|NCT02190552|Ischemia|ischemia
230078|NCT02190552|Ischemic|ischemic
230079|NCT02190552|Ischemic Stroke|ischemic stroke
230080|NCT02190552|Mechanical Thrombectomy|mechanical thrombectomy
230081|NCT02190552|Neurovascular Intervention|neurovascular intervention
230082|NCT02190552|Revascularization|revascularization
230083|NCT02190552|Stent Retriever|stent retriever
230084|NCT02190552|Stroke|stroke
230085|NCT02190552|Vascular Diseases|vascular diseases
230086|NCT02190539|Breast cancer|breast cancer
230087|NCT02190539|complementary medicine|complementary medicine
230088|NCT02190539|homeopathy|homeopathy
230089|NCT02190539|quality of life|quality of life
230090|NCT02190526|mesalamine|mesalamine
230091|NCT02190526|amitriptyline|amitriptyline
230092|NCT02190526|Severity of Illness Index|severity of illness index
230093|NCT02190500|stroke|stroke
230094|NCT02190500|tpa|tpa
230095|NCT02190500|emergency medical service|emergency medical service
230096|NCT02190500|ems|ems
230097|NCT02190500|mobile|mobile
230098|NCT02190500|ct scan|ct scan
230099|NCT02190474|fibromyalgia|fibromyalgia
230100|NCT02190474|juvenile fibromyalgia|juvenile fibromyalgia
230101|NCT02190474|juvenile primary fibromyalgia syndrome (JPFS)|juvenile primary fibromyalgia syndrome (jpfs)
230102|NCT02190474|adolescent pain|adolescent pain
230103|NCT02190474|mindfulness|mindfulness
230104|NCT02190474|MBSR|mbsr
230105|NCT02190461|Early Respiratory Rehabilitation|early respiratory rehabilitation
230106|NCT02190461|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
230107|NCT02190461|Re-admitted patients|re-admitted patients
230108|NCT02190461|Open clinical trial|open clinical trial
230109|NCT02190461|Exacerbations|exacerbations
230110|NCT02190448|galactogogue|galactogogue
230111|NCT02190448|lactation|lactation
230112|NCT02190448|milk production|milk production
230113|NCT02190448|breastfeeding|breastfeeding
230114|NCT02190435|Computer-assisted navigation|computer-assisted navigation
230115|NCT02190435|ADAPT|adapt
230116|NCT02190435|Intramedullary nail|intramedullary nail
230117|NCT02190435|Intertrochanteric femur fracture|intertrochanteric femur fracture
230118|NCT02190422|reproductive technologies, assisted|reproductive technologies, assisted
230119|NCT02190422|echocardiography|echocardiography
230120|NCT02190422|cardiology|cardiology
230121|NCT02190422|pediatrics|pediatrics
230122|NCT02190409|Dental Implant,|dental implant,
230123|NCT02190396|Calcium|calcium
230124|NCT02190396|Vitamin D|vitamin d
230125|NCT02190396|Placental calcification.|placental calcification.
230126|NCT02190383|Tic-Disorder, Tourette-Disorder, Habit Reversal Training|tic-disorder, tourette-disorder, habit reversal training
230127|NCT02190370|Tic-Disorder, Tourette-Disorder, Resources activation|tic-disorder, tourette-disorder, resources activation
230128|NCT02190357|Cirrhosis|cirrhosis
230129|NCT02190344|Eight|eight
230130|NCT02190344|Channel|channel
230131|NCT02190344|Paddle|paddle
230132|NCT02190344|Coil|coil
230133|NCT02190344|MRI|mri
230134|NCT02190344|Prostate|prostate
230135|NCT02190344|Healthy Male|healthy male
230136|NCT02190331|Detraining|detraining
230137|NCT02190331|Neck|neck
230138|NCT02190331|Exercise|exercise
230139|NCT02190331|Posture|posture
230140|NCT02190331|Rehabilitation|rehabilitation
230141|NCT02190318|peritoneal dialysis；|peritoneal dialysis；
230142|NCT02190318|residual renal function；|residual renal function；
230143|NCT02190318|RAAS|raas
230144|NCT02190279|Prostate Specific Membrane Antigen|prostate specific membrane antigen
230145|NCT02190279|Radiolabeled PET Agent|radiolabeled pet agent
230146|NCT02190279|Imaging|imaging
230147|NCT02190279|NaF|naf
230148|NCT02190266|Extrapulmonary|extrapulmonary
230149|NCT02190266|Immunodeficiency|immunodeficiency
230150|NCT02190266|Genetics|genetics
230151|NCT02190266|Infection|infection
230152|NCT02190266|Fungal|fungal
230153|NCT02190253|Renal Threshold|renal threshold
230154|NCT02190253|Liver Transplant|liver transplant
230155|NCT02190253|Transplantation|transplantation
230156|NCT02190253|Hepatitis E|hepatitis e
230157|NCT02190240|Complementary and Alternative Medicine|complementary and alternative medicine
230158|NCT02190240|Integrative Medicine|integrative medicine
230159|NCT02190240|Pain Management|pain management
230160|NCT02190227|Breast Cancer|breast cancer
230161|NCT02190227|Chemotherapy|chemotherapy
230162|NCT02190227|Neoadjuvant|neoadjuvant
230163|NCT02190227|RNA Disruption Assay|rna disruption assay
230164|NCT02190227|Biopsies|biopsies
230165|NCT02190227|Response|response
230166|NCT02190214|Hyperthyroidism|hyperthyroidism
230167|NCT02190214|Hypothyroidism|hypothyroidism
230168|NCT02190214|Autoimmune thyroid disorders|autoimmune thyroid disorders
230169|NCT02190214|Iodine deficiency|iodine deficiency
230170|NCT02190214|Genetic susceptibility|genetic susceptibility
230171|NCT02190201|videolaryngoscope|videolaryngoscope
230172|NCT02190201|double lumen intubation|double lumen intubation
230173|NCT02190188|wedge insoles,|wedge insoles,
230174|NCT02190188|knee brace,|knee brace,
230175|NCT02190188|orthotic device|orthotic device
230176|NCT02190188|goal|goal
230177|NCT02190162|Patients undergoing tonsillectomy with or without adenoidectomy|patients undergoing tonsillectomy with or without adenoidectomy
230178|NCT02190149|Factor VIII Deficiency|factor viii deficiency
230179|NCT02190149|Factor FIX Deficiency|factor fix deficiency
230180|NCT02190136|obesity|obesity
230181|NCT02190136|protein-rich whole foods diet|protein-rich whole foods diet
230182|NCT02190136|aerobic fitness|aerobic fitness
230183|NCT02190136|resistance training|resistance training
230184|NCT02190136|stretching/yoga training|stretching/yoga training
230185|NCT02190136|glycemia|glycemia
230186|NCT02190136|mood state|mood state
230187|NCT02190123|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
230188|NCT02190123|Oral antiplatelets (ticagrelor, prasugrel, clopidogrel) (OAP)|oral antiplatelets (ticagrelor, prasugrel, clopidogrel) (oap)
230189|NCT02190123|Treatment persistence.|treatment persistence.
230190|NCT02190110|Pulmonary embolism|pulmonary embolism
230191|NCT02190110|diagnosis|diagnosis
230192|NCT02190110|emergency medicine|emergency medicine
230193|NCT02190110|ultrasonography|ultrasonography
230194|NCT02190097|PCOS|pcos
230195|NCT02190097|insulin sensitivity|insulin sensitivity
230196|NCT02190097|paleolithic diet|paleolithic diet
230197|NCT02190084|apathy|apathy
230198|NCT02190084|Alzheimer's|alzheimer's
230199|NCT02190084|executive function|executive function
230200|NCT02190071|EUS-FNA|eus-fna
230201|NCT02190071|cytopathology|cytopathology
230202|NCT02190071|slide smear|slide smear
230203|NCT02190058|safety|safety
230204|NCT02190058|pharmacokinetics|pharmacokinetics
230205|NCT02190058|DS-1971a|ds-1971a
230206|NCT02190045|Balance|balance
230207|NCT02190045|gait|gait
230208|NCT02190045|Wii-Fit|wii-fit
230209|NCT02190019|Mild Cognitive Impairment|mild cognitive impairment
230210|NCT02190019|apathy|apathy
230211|NCT02190019|executive function|executive function
230212|NCT02190006|Polycystic ovarian syndrome|polycystic ovarian syndrome
230213|NCT02190006|Follicle output rate|follicle output rate
230214|NCT02190006|preovulatory count|preovulatory count
230215|NCT02190006|ICSI|icsi
230216|NCT02189993|Mortality|mortality
230217|NCT02189993|Long term follow-up|long term follow-up
230218|NCT02189993|Parenteral Nutrition, Total|parenteral nutrition, total
230219|NCT02189980|Nausea|nausea
230220|NCT02189980|Post-operative|post-operative
230221|NCT02189967|non-small cell lung cancer|non-small cell lung cancer
230222|NCT02189967|radiotherapy|radiotherapy
230223|NCT02189967|accelerated fractionation|accelerated fractionation
230224|NCT02189967|conventional fractionation|conventional fractionation
230225|NCT02189967|postoperative|postoperative
230226|NCT02189954|elderly; laryngeal masks; postoperative complications|elderly; laryngeal masks; postoperative complications
230227|NCT02189941|Deferiprone|deferiprone
230228|NCT02189941|Deferiprone sustained-release tablets|deferiprone sustained-release tablets
230229|NCT02189941|Pharmacokinetics|pharmacokinetics
230230|NCT02189902|Vitamin D|vitamin d
230231|NCT02189889|Active preoperative anemia management|active preoperative anemia management
230232|NCT02189889|Erythrocyte transfusion|erythrocyte transfusion
230233|NCT02189889|RBC transfusion|rbc transfusion
230234|NCT02189889|Red cell transfusion|red cell transfusion
230235|NCT02189889|Transfusion in cardiac surgery|transfusion in cardiac surgery
230236|NCT02189889|Anemia treatment with erythropoietin|anemia treatment with erythropoietin
230237|NCT02189889|Anemic cardiac surgery patients|anemic cardiac surgery patients
230238|NCT02189889|Erythrocyte stimulating agent (ESA)|erythrocyte stimulating agent (esa)
230239|NCT02189889|Iron deficiency anemia|iron deficiency anemia
230240|NCT02189889|EPO|epo
230241|NCT02189889|Feraheme|feraheme
230242|NCT02189876|HIV Prevention|hiv prevention
230243|NCT02189876|Behavioral Intervention|behavioral intervention
230244|NCT02189876|Condom Use|condom use
230245|NCT02189876|African American|african american
230246|NCT02189876|Sexually Transmitted Disease|sexually transmitted disease
230247|NCT02189876|Sexually Transmitted Infection|sexually transmitted infection
230248|NCT02189876|Internet|internet
230249|NCT02189863|Driving Simulator|driving simulator
230250|NCT02189863|Air Optix Aqua|air optix aqua
230251|NCT02189863|AOAMF|aoamf
230252|NCT02189850|colonoscopy|colonoscopy
230253|NCT02189850|pediatric|pediatric
230254|NCT02189837|Raised cholesterol|raised cholesterol
230255|NCT02189837|Cholesterol|cholesterol
230256|NCT02189837|Elevated Cholesterol|elevated cholesterol
230257|NCT02189837|Hyperlipidemias|hyperlipidemias
230258|NCT02189837|Dyslipidemias|dyslipidemias
230259|NCT02189837|Lipid Metabolism Disorders|lipid metabolism disorders
230260|NCT02189837|Metabolic Diseases|metabolic diseases
230261|NCT02189811|IPV|ipv
230262|NCT02189811|OPV|opv
230263|NCT02189811|tOPV|topv
230264|NCT02189811|bOPV|bopv
230265|NCT02189811|Polio|polio
230266|NCT02189811|Endgame|endgame
230267|NCT02189811|Pakistan|pakistan
230268|NCT02189798|Cochlear Implant|cochlear implant
230269|NCT02189798|HiRes™ 90K Advantage implant|hires™ 90k advantage implant
230270|NCT02189798|Cochlear Implantation|cochlear implantation
230271|NCT02189798|HiFocus™ Mid-Scala electrode|hifocus™ mid-scala electrode
230272|NCT02189798|Listening Benefits|listening benefits
230273|NCT02189798|Adults|adults
230274|NCT02189798|Cochlear Implant Benefit|cochlear implant benefit
230275|NCT02189798|Electrical Stimulation|electrical stimulation
230276|NCT02189798|Electro-Acoustic Stimulation (EAS)|electro-acoustic stimulation (eas)
230277|NCT02189785|social|social
230278|NCT02189785|rejection|rejection
230279|NCT02189785|acceptance|acceptance
230280|NCT02189785|PET|pet
230281|NCT02189785|opioid|opioid
230282|NCT02189785|fMRI|fmri
230283|NCT02189785|reward|reward
230284|NCT02189785|exclusion|exclusion
230285|NCT02189772|ADHD|adhd
230286|NCT02189772|Inattention|inattention
230287|NCT02189772|MDX|mdx
230288|NCT02189759|Hypothermia|hypothermia
230289|NCT02189759|Hyperthermia|hyperthermia
230290|NCT02189759|Kangaroo Mother Care|kangaroo mother care
230291|NCT02189759|Newborn|newborn
230292|NCT02189746|Hypothermia|hypothermia
230293|NCT02189746|Newborn|newborn
230294|NCT02189746|Hyperthermia|hyperthermia
230295|NCT02189746|Kangaroo mother care|kangaroo mother care
230296|NCT02189720|Amifampridine Phosphate|amifampridine phosphate
230297|NCT02189720|Amifampridine|amifampridine
230298|NCT02189720|3,4-Diaminopyridine Phosphate|3,4-diaminopyridine phosphate
230299|NCT02189720|3,4-Diaminopyridine|3,4-diaminopyridine
230300|NCT02189720|3,4-DAP|3,4-dap
230301|NCT02189720|LEMS|lems
230302|NCT02189720|CMS|cms
230303|NCT02189720|Lambert-Eaton Myasthenic Syndrome|lambert-eaton myasthenic syndrome
230304|NCT02189720|Congenital Myasthenic Syndrome|congenital myasthenic syndrome
230305|NCT02189720|Neuromuscular disorders|neuromuscular disorders
230306|NCT02189720|Neuromuscular|neuromuscular
230307|NCT02189720|eye movement|eye movement
230308|NCT02189720|electromyography|electromyography
230309|NCT02189720|EMG|emg
230310|NCT02189720|Expanded Access|expanded access
230311|NCT02189720|Firdapse®|firdapse®
230312|NCT02189720|Downbeat Nystagmus|downbeat nystagmus
230313|NCT02189707|Gastrointestinal disorder|gastrointestinal disorder
230314|NCT02189707|Constipation|constipation
230315|NCT02189707|Probiotics|probiotics
230316|NCT02189707|Dietary supplement|dietary supplement
230317|NCT02189694|Type 1 diabetes|type 1 diabetes
230318|NCT02189694|Hypoglycemia|hypoglycemia
230319|NCT02189694|Insulin|insulin
230320|NCT02189694|Glucagon|glucagon
230321|NCT02189694|Closed-loop system|closed-loop system
230322|NCT02189694|Artificial pancreas|artificial pancreas
230323|NCT02189681|spinal anaesthesia|spinal anaesthesia
230324|NCT02189681|ultrasound|ultrasound
230325|NCT02189681|paramedian|paramedian
230326|NCT02189668|Appendicitis|appendicitis
230327|NCT02189668|Non-operative|non-operative
230328|NCT02189668|Children|children
230329|NCT02189668|Appendicolith|appendicolith
230330|NCT02189668|fecalith|fecalith
230331|NCT02189668|Pediatrics|pediatrics
230332|NCT02189655|shivering spinal anesthesia|shivering spinal anesthesia
230333|NCT02189629|Acne vulgaris|acne vulgaris
230334|NCT02189629|Safety|safety
230335|NCT02189629|Face|face
230336|NCT02189629|Trunk|trunk
230337|NCT02189616|asthma management|asthma management
230338|NCT02189616|SMS reminder|sms reminder
230339|NCT02189616|SMS consultation|sms consultation
230340|NCT02189603|hepatitis E|hepatitis e
230341|NCT02189603|Immunogenicity|immunogenicity
230342|NCT02189603|vaccine|vaccine
230343|NCT02189603|safety|safety
230344|NCT02189590|supraglottic airway|supraglottic airway
230345|NCT02189590|children|children
230346|NCT02189590|fiberoptic guided tracheal intubation|fiberoptic guided tracheal intubation
230347|NCT02189590|air-Q|air-q
230348|NCT02189590|i-gel|i-gel
230349|NCT02189577|Chronic Obstructive Pulmonary disease|chronic obstructive pulmonary disease
230350|NCT02189577|COPD|copd
230351|NCT02189538|Infections, Enteral nutrition, SIRS, critically ill|infections, enteral nutrition, sirs, critically ill
230352|NCT02189525|traumatic brain injury|traumatic brain injury
230353|NCT02189525|sports head injury|sports head injury
230354|NCT02189525|sports concussion|sports concussion
230355|NCT02189512|brain-death organ donors|brain-death organ donors
230356|NCT02189512|intestinal manipulation|intestinal manipulation
230357|NCT02189512|monocytes|monocytes
230358|NCT02189499|Stents|stents
230359|NCT02189499|Angioplasty|angioplasty
230360|NCT02189499|Coronary Vessels|coronary vessels
230361|NCT02189499|Coronary Artery Disease|coronary artery disease
230362|NCT02189499|Angina Pectoris|angina pectoris
230363|NCT02189499|Myocardial Ischemia|myocardial ischemia
230364|NCT02189499|Myocardial Infarction|myocardial infarction
230365|NCT02189499|Myocardial Revascularization|myocardial revascularization
230366|NCT02189486|Prostate Cancer|prostate cancer
230367|NCT02189486|Radical Prostatectomy|radical prostatectomy
230368|NCT02189486|Prostate biopsy|prostate biopsy
230369|NCT02189486|Upgrading|upgrading
230370|NCT02189486|Upgrading Reference set|upgrading reference set
230371|NCT02189473|metastatic epidural spinal cord compression|metastatic epidural spinal cord compression
230372|NCT02189473|motor function|motor function
230373|NCT02189473|ambulatory status|ambulatory status
230374|NCT02189473|pain|pain
230375|NCT02189473|quality of life|quality of life
230376|NCT02189473|overall survival|overall survival
230377|NCT02189473|local control|local control
230378|NCT02189473|toxicity|toxicity
230379|NCT02189460|Cognition|cognition
230380|NCT02189447|Keratoconus|keratoconus
230381|NCT02189447|Ectasia|ectasia
230382|NCT02189447|Corneal Cross-linking|corneal cross-linking
230383|NCT02189421|peroral cholangioscopy|peroral cholangioscopy
230384|NCT02189421|ultra-slim upper endoscope|ultra-slim upper endoscope
230385|NCT02189421|multibending endoscope|multibending endoscope
230386|NCT02189408|Platelet rich plasma|platelet rich plasma
230387|NCT02189408|Autologous conditioned plasma|autologous conditioned plasma
230388|NCT02189408|Outerbridge|outerbridge
230389|NCT02189395|Type 2 diabetes|type 2 diabetes
230390|NCT02189395|Uncontrolled blood glucose|uncontrolled blood glucose
230391|NCT02189395|insulin|insulin
230392|NCT02189395|glargine|glargine
230393|NCT02189395|NPH|nph
230394|NCT02189382|Sensitivity|sensitivity
230395|NCT02189356|Pregnancy-related low back and pelvic pain|pregnancy-related low back and pelvic pain
230396|NCT02189356|exercise program|exercise program
230397|NCT02189356|nurse|nurse
230398|NCT02189343|Multiple Myeloma|multiple myeloma
230399|NCT02189343|Relapsed and Refractory|relapsed and refractory
230400|NCT02189343|Refractory Disease|refractory disease
230401|NCT02189343|Progressive Disease|progressive disease
230402|NCT02189343|Pomalidomide|pomalidomide
230403|NCT02189343|Dexamethasone|dexamethasone
230404|NCT02189343|Proteasome Inhibitor|proteasome inhibitor
230405|NCT02189343|Ricolinostat|ricolinostat
230406|NCT02189304|Healthy volunteers|healthy volunteers
230407|NCT02189291|Indwelling catheter|indwelling catheter
230408|NCT02189291|Hospital stay|hospital stay
230409|NCT02189291|Urinary tract infection|urinary tract infection
230410|NCT02189291|Sacrocolpopexy|sacrocolpopexy
230411|NCT02189278|Breast Cancer|breast cancer
230412|NCT02189278|Surveillance|surveillance
230413|NCT02189278|Mammography|mammography
230414|NCT02189278|Adherence|adherence
230415|NCT02189265|Live birth [MeSH]|live birth [mesh]
230416|NCT02189265|Infant [MeSH]|infant [mesh]
230417|NCT02189265|Infant, newborn [MeSH]|infant, newborn [mesh]
230418|NCT02189265|Second-hand smoke|second-hand smoke
230419|NCT02189265|Tobacco smoke pollution [MeSH]|tobacco smoke pollution [mesh]
230420|NCT02189265|Smoke-free|smoke-free
230421|NCT02189265|Smoke-free policy [MeSH]|smoke-free policy [mesh]
230422|NCT02189226|probe-based confocal laser endomicroscopy (pCLE), early gastric cancer (EGC), endoscopic submucosal dissection (ESD), margin|probe-based confocal laser endomicroscopy (pcle), early gastric cancer (egc), endoscopic submucosal dissection (esd), margin
230423|NCT02189213|anxiety|anxiety
230424|NCT02189213|SSRI|ssri
230425|NCT02189213|biomarker|biomarker
230426|NCT02189213|sleep|sleep
230427|NCT02189213|children|children
230428|NCT02189213|adolescents|adolescents
230429|NCT02189213|young adults|young adults
230430|NCT02189200|nutritional counseling|nutritional counseling
230431|NCT02189200|oat bran|oat bran
230432|NCT02189200|dyslipidemia|dyslipidemia
230433|NCT02189200|cardiovascular disease|cardiovascular disease
230434|NCT02189187|Weight Loss|weight loss
230435|NCT02189187|Body Weight Changes|body weight changes
230436|NCT02189187|Body Weight|body weight
230437|NCT02189187|Magnetic Resonance Imaging|magnetic resonance imaging
230438|NCT02189187|Emotions|emotions
230439|NCT02189187|Emotion regulation|emotion regulation
230440|NCT02189187|Health Behavior|health behavior
230441|NCT02189187|Eating behavior|eating behavior
230442|NCT02189174|Solid tumor,|solid tumor,
230443|NCT02189174|breast cancer,|breast cancer,
230444|NCT02189174|lung cancer,|lung cancer,
230445|NCT02189174|endometrial cancer|endometrial cancer
230446|NCT02189161|anal intraepithelial neoplasia|anal intraepithelial neoplasia
230447|NCT02189161|AIN|ain
230448|NCT02189161|Radiofrequency Ablation|radiofrequency ablation
230449|NCT02189161|RFA|rfa
230450|NCT02189148|Prediction|prediction
230451|NCT02189148|Preeclampsia|preeclampsia
230452|NCT02189148|Preterm birth|preterm birth
230453|NCT02189148|Pregnancy|pregnancy
230454|NCT02189148|Placenta|placenta
230455|NCT02189148|Intra-uterine growth restriction|intra-uterine growth restriction
230456|NCT02189148|fetal growth restriction|fetal growth restriction
230457|NCT02189148|Ultrasound|ultrasound
230458|NCT02189148|Doppler|doppler
230459|NCT02189148|Biomarkers|biomarkers
230460|NCT02189148|PAPP-A|papp-a
230461|NCT02189148|Placental growth factor (PlGF)|placental growth factor (plgf)
230462|NCT02189109|glioblastoma|glioblastoma
230463|NCT02189109|multiforme|multiforme
230464|NCT02189109|radiation|radiation
230465|NCT02189109|radiation therapy|radiation therapy
230466|NCT02189096|Sepsis|sepsis
230467|NCT02189096|National Early Warning Score|national early warning score
230468|NCT02189096|Lactate|lactate
230469|NCT02189083|Leiomyoma|leiomyoma
230470|NCT02189083|Medicine, Chinese Traditional|medicine, chinese traditional
230471|NCT02189083|Randomized Controlled Trial|randomized controlled trial
230472|NCT02189070|Follow-up|follow-up
230473|NCT02189070|Percutaneous coronary intervention|percutaneous coronary intervention
230474|NCT02189070|Patient preference|patient preference
230475|NCT02189070|DUTCH PEERS|dutch peers
230476|NCT02189070|TWENTE|twente
230477|NCT02189057|Bipolar|bipolar
230478|NCT02189057|Unipolar|unipolar
230479|NCT02189057|Genotyping|genotyping
230480|NCT02189057|Pharmacokinetic|pharmacokinetic
230481|NCT02189057|Pharmacodynamic|pharmacodynamic
230482|NCT02189044|aged;|aged;
230483|NCT02189044|breathing exercises;|breathing exercises;
230484|NCT02189044|muscle strength.|muscle strength.
230485|NCT02189031|Upper limb Amputee|upper limb amputee
230486|NCT02189031|Targeted Muscle Reinnervation|targeted muscle reinnervation
230487|NCT02189031|Prosthetic|prosthetic
230488|NCT02189018|Peripheral arterial disease|peripheral arterial disease
230489|NCT02189018|Endovascular|endovascular
230490|NCT02189018|Exercise|exercise
230491|NCT02189018|Perfusion|perfusion
230492|NCT02189018|Functional capacity|functional capacity
230493|NCT02189005|High blood sugar|high blood sugar
230494|NCT02189005|High HbA1C|high hba1c
230495|NCT02189005|hyperglycemia|hyperglycemia
230496|NCT02189005|Pre-Diabetes|pre-diabetes
230497|NCT02189005|Natural Supplement for Diabetes|natural supplement for diabetes
230498|NCT02188992|Sepsis|sepsis
230499|NCT02188992|Immune activation|immune activation
230500|NCT02188992|Systemic Inflammation|systemic inflammation
230501|NCT02188992|Emergency Medicine|emergency medicine
230502|NCT02188992|Critical Care|critical care
230503|NCT02188979|airway|airway
230504|NCT02188979|equipment - laryngoscopes|equipment - laryngoscopes
230505|NCT02188979|intubation - tracheal|intubation - tracheal
230506|NCT02188979|obesity.|obesity.
230507|NCT02188966|Geographic Information System|geographic information system
230508|NCT02188966|Emergency Care Information Systems|emergency care information systems
230509|NCT02188966|Telemedicine|telemedicine
230510|NCT02188966|Emergency Hospital Service|emergency hospital service
230511|NCT02188953|aflatoxin|aflatoxin
230512|NCT02188953|Kenya|kenya
230513|NCT02188940|Asthma|asthma
230514|NCT02188940|Obesity|obesity
230515|NCT02188940|Clinical control|clinical control
230516|NCT02188940|Exercise|exercise
230517|NCT02188940|Weight-loss|weight-loss
230518|NCT02188927|Advanced notification letter|advanced notification letter
230519|NCT02188927|Standard invitation|standard invitation
230520|NCT02188927|Participation rate|participation rate
230521|NCT02188927|Colonoscopy|colonoscopy
230522|NCT02188927|Screening|screening
230523|NCT02188927|Colorectal Neoplasms|colorectal neoplasms
230524|NCT02188927|Digestive System Diseases|digestive system diseases
230525|NCT02188914|Inhalant use disorder|inhalant use disorder
230526|NCT02188914|Positron emission tomography|positron emission tomography
230527|NCT02188914|Magnetic Resonance Imaging|magnetic resonance imaging
230528|NCT02188914|Executive functions assessment|executive functions assessment
230529|NCT02188914|Transcriptome|transcriptome
230530|NCT02188901|HCC|hcc
230531|NCT02188901|Sonazoid|sonazoid
230532|NCT02188901|Ultrasonography|ultrasonography
230533|NCT02188901|Screening|screening
230534|NCT02188888|septic shock|septic shock
230535|NCT02188888|esmolol|esmolol
230536|NCT02188888|tachycardia|tachycardia
230537|NCT02188888|betablockers|betablockers
230538|NCT02188875|Fitbit One|fitbit one
230539|NCT02188875|wearable sensor|wearable sensor
230540|NCT02188875|wearable device|wearable device
230541|NCT02188875|web-based intervention|web-based intervention
230542|NCT02188875|SMS text messages|sms text messages
230543|NCT02188875|randomized controlled trial|randomized controlled trial
230544|NCT02188875|physical activity|physical activity
230545|NCT02188875|behavioral intervention|behavioral intervention
230546|NCT02188875|text message prompts|text message prompts
230547|NCT02188875|text messaging|text messaging
230548|NCT02188875|technology|technology
230549|NCT02188875|exercise|exercise
230550|NCT02188862|Rheumatic heart disease|rheumatic heart disease
230551|NCT02188862|Acute rheumatic fever|acute rheumatic fever
230552|NCT02188862|Group A streptococcal disease|group a streptococcal disease
230553|NCT02188862|Streptococcus pyogenes|streptococcus pyogenes
230554|NCT02188862|Genetics|genetics
230555|NCT02188862|Oceania|oceania
230556|NCT02188849|creatine|creatine
230557|NCT02188849|resistance training|resistance training
230558|NCT02188849|older women|older women
230559|NCT02188849|muscle strength|muscle strength
230560|NCT02188823|prediabetes|prediabetes
230561|NCT02188823|obesity|obesity
230562|NCT02188823|mindful eating|mindful eating
230563|NCT02188823|positive affect|positive affect
230564|NCT02188823|low carbohydrate|low carbohydrate
230565|NCT02188823|ketogenic|ketogenic
230566|NCT02188823|diet|diet
230567|NCT02188810|PAL|pal
230568|NCT02188810|fluviral|fluviral
230569|NCT02188810|healthy volunteer|healthy volunteer
230570|NCT02188810|adjuvant|adjuvant
230571|NCT02188810|TH1 immune response|th1 immune response
230572|NCT02188797|homeless|homeless
230573|NCT02188797|young adults|young adults
230574|NCT02188797|substance use|substance use
230575|NCT02188797|HIV risk|hiv risk
230576|NCT02188797|sexual risk behavior|sexual risk behavior
230577|NCT02188797|group motivational interviewing|group motivational interviewing
230578|NCT02188771|Moderate to Severe OA|moderate to severe oa
230579|NCT02188771|VAS score of ≥ 5|vas score of ≥ 5
230580|NCT02188771|grade III-IV Kellgren Lawrence of OA|grade iii-iv kellgren lawrence of oa
230581|NCT02188771|subjects who failed conservative treatment|subjects who failed conservative treatment
230582|NCT02188771|subjects who candidates for total knee replacement (TKR)|subjects who candidates for total knee replacement (tkr)
230583|NCT02188771|subject 45 and 75 years old|subject 45 and 75 years old
230584|NCT02188771|subject is experiencing pain in the intended study knee with a VAS score of ≥ 5|subject is experiencing pain in the intended study knee with a vas score of ≥ 5
230585|NCT02188771|subject has a Body Mass Index (BMI) between 18.5 and 35|subject has a body mass index (bmi) between 18.5 and 35
230586|NCT02188758|iron|iron
230587|NCT02188758|hepcidin-25|hepcidin-25
230588|NCT02188758|pulmonary exacerbation|pulmonary exacerbation
230589|NCT02188758|interleukin-6|interleukin-6
230590|NCT02188745|metastatic|metastatic
230591|NCT02188745|locally advanced|locally advanced
230592|NCT02188745|ER+|er+
230593|NCT02188745|Estrogen therapy|estrogen therapy
230594|NCT02188745|Estradiol therapy|estradiol therapy
230595|NCT02188732|Community Mental Health|community mental health
230596|NCT02188732|Serious Mental Illness|serious mental illness
230597|NCT02188732|Medical Comorbidity|medical comorbidity
230598|NCT02188732|Self-Management|self-management
230599|NCT02188732|Automated Telehealth|automated telehealth
230600|NCT02188732|Early Mortality|early mortality
230601|NCT02188719|Donor-Alloantigen-Reactive Regulatory T Cell Therapy|donor-alloantigen-reactive regulatory t cell therapy
230602|NCT02188719|Tregs|tregs
230603|NCT02188719|Cell- and Tissue-Based Therapy|cell- and tissue-based therapy
230604|NCT02188719|Immunotherapy, Adoptive|immunotherapy, adoptive
230605|NCT02188719|Liver Transplantation|liver transplantation
230606|NCT02188680|fructose test|fructose test
230607|NCT02188667|Chronic Noncancer Pain|chronic noncancer pain
230608|NCT02188667|Musculoskeletal Pain|musculoskeletal pain
230609|NCT02188667|Neuropathic Pain|neuropathic pain
230610|NCT02188667|Headache Pain|headache pain
230611|NCT02188654|psoriatic arthritis|psoriatic arthritis
230612|NCT02188654|inflammation|inflammation
230613|NCT02188654|metabolic syndrome|metabolic syndrome
230614|NCT02188654|metformin|metformin
230615|NCT02188641|Psoriatic arthritis|psoriatic arthritis
230616|NCT02188641|inflammation|inflammation
230617|NCT02188641|obesity|obesity
230618|NCT02188641|diet|diet
230619|NCT02188641|exercise|exercise
230620|NCT02188628|Motor recovery, robotics, stroke rehabilitation|motor recovery, robotics, stroke rehabilitation
230621|NCT02188615|Squamous Cell Esophageal Carcinoma|squamous cell esophageal carcinoma
230622|NCT02188615|minimally invasive esophagectomy|minimally invasive esophagectomy
230623|NCT02188615|laparoscopy|laparoscopy
230624|NCT02188615|thoracoscopy|thoracoscopy
230625|NCT02188576|Craniofacial Surgery|craniofacial surgery
230626|NCT02188576|tranexamic acid|tranexamic acid
230627|NCT02188576|Antifibrinolytic|antifibrinolytic
230628|NCT02188563|Smoking cessation|smoking cessation
230629|NCT02188563|Head and neck neoplasms|head and neck neoplasms
230630|NCT02188563|Lung neoplasms|lung neoplasms
230631|NCT02188563|Thoracic neoplasms|thoracic neoplasms
230632|NCT02188563|Radiation|radiation
230633|NCT02188550|relapse or refractory or persistent epithelial ovarian fallopian tube|relapse or refractory or persistent epithelial ovarian fallopian tube
230634|NCT02188550|primary peritoneal carcinoma or endometrial cancer|primary peritoneal carcinoma or endometrial cancer
230635|NCT02188537|Myeloma|myeloma
230636|NCT02188537|proteasome inhibitor-nonresponsive myeloma|proteasome inhibitor-nonresponsive myeloma
230637|NCT02188537|Nelfinavir|nelfinavir
230638|NCT02188537|bortezomib|bortezomib
230639|NCT02188537|bortezomib-sensitizing drug|bortezomib-sensitizing drug
230640|NCT02188524|balance, exercise, compensatory stepping, tai chi|balance, exercise, compensatory stepping, tai chi
230641|NCT02188511|E-Cigarettes|e-cigarettes
230642|NCT02188511|Lung|lung
230643|NCT02188511|Non-Smokers|non-smokers
230644|NCT02188511|Lung Biology|lung biology
230645|NCT02188472|Oxidative Stress|oxidative stress
230646|NCT02188472|antibiotics|antibiotics
230647|NCT02188446|Radical cystectomy|radical cystectomy
230648|NCT02188446|Bladder cancer|bladder cancer
230649|NCT02188446|Smoking cessation|smoking cessation
230650|NCT02188446|Alcohol cessation|alcohol cessation
230651|NCT02188446|Postoperative complications|postoperative complications
230652|NCT02188433|Effectiveness of quit immediately (QI) and cut down to quit (CDTQ) interventions in achieving smoking abstinence|effectiveness of quit immediately (qi) and cut down to quit (cdtq) interventions in achieving smoking abstinence
230653|NCT02188420|PAS|pas
230654|NCT02188420|TMS|tms
230655|NCT02188420|Stroke|stroke
230656|NCT02188420|Paired Associative Stimulation|paired associative stimulation
230657|NCT02188420|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
230658|NCT02188407|thoracotomy|thoracotomy
230659|NCT02188407|one-lung ventilation (OLV)|one-lung ventilation (olv)
230660|NCT02188407|total intravenous anaesthesia (TIVA)|total intravenous anaesthesia (tiva)
230661|NCT02188407|volatile induced and maintained anaesthesia (VIMA)|volatile induced and maintained anaesthesia (vima)
230662|NCT02188407|cytokines|cytokines
230663|NCT02188407|interleukine (IL)|interleukine (il)
230664|NCT02188394|migraine,|migraine,
230665|NCT02188394|pressure pain,|pressure pain,
230666|NCT02188394|anesthetic blocks|anesthetic blocks
230667|NCT02188394|patients|patients
230668|NCT02188381|Resistant Hypertension|resistant hypertension
230669|NCT02188381|Uncontrolled Hypertension|uncontrolled hypertension
230670|NCT02188368|Pomalidomide|pomalidomide
230671|NCT02188368|Lenalidomide refractory|lenalidomide refractory
230672|NCT02188368|multiple myeloma|multiple myeloma
230673|NCT02188355|Ultimaster|ultimaster
230674|NCT02188355|registry|registry
230675|NCT02188355|DES|des
230676|NCT02188355|DAPT|dapt
230677|NCT02188329|Early care and education|early care and education
230678|NCT02188329|ECE|ece
230679|NCT02188329|workforce|workforce
230680|NCT02188329|child care|child care
230681|NCT02188329|caregivers|caregivers
230682|NCT02188329|home-based providers|home-based providers
230683|NCT02188329|center-based providers|center-based providers
230684|NCT02188316|Cold forceps polypectomy|cold forceps polypectomy
230685|NCT02188316|Diminutive colorectal polyp|diminutive colorectal polyp
230686|NCT02188316|Hot biopsy forceps electrocauterization|hot biopsy forceps electrocauterization
230687|NCT02188316|Jumbo forceps.|jumbo forceps.
230688|NCT02188290|Haploidentical donor|haploidentical donor
230689|NCT02188290|Unrelated donor|unrelated donor
230690|NCT02188290|Umbilical cord blood|umbilical cord blood
230691|NCT02188290|Graft versus host disease|graft versus host disease
230692|NCT02188290|Transplant-related mortality|transplant-related mortality
230693|NCT02188290|Hematologic malignancy|hematologic malignancy
230694|NCT02188290|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
230695|NCT02188251|Activamp|activamp
230696|NCT02188251|Gynostemma pentaphyllum|gynostemma pentaphyllum
230697|NCT02188251|Body weight|body weight
230698|NCT02188251|Fat Loss|fat loss
230699|NCT02188251|Metabolic markers|metabolic markers
230700|NCT02188251|Overweight participants|overweight participants
230701|NCT02188251|DXA|dxa
230702|NCT02188251|AMPK|ampk
230703|NCT02188238|saliva|saliva
230704|NCT02188238|protein|protein
230705|NCT02188238|oral health|oral health
230706|NCT02188238|film|film
230707|NCT02188238|pellicle|pellicle
230708|NCT02188225|Hot flash|hot flash
230709|NCT02188225|Acupuncture|acupuncture
230710|NCT02188225|Fluoxetine|fluoxetine
230711|NCT02188225|Quality of life|quality of life
230712|NCT02188199|Hip|hip
230713|NCT02188199|Knee|knee
230714|NCT02188199|Hip replacement|hip replacement
230715|NCT02188199|Knee replacement|knee replacement
230716|NCT02188199|Total Joint|total joint
230717|NCT02188186|triple combination|triple combination
230718|NCT02188186|metformin|metformin
230719|NCT02188186|sitagliptin|sitagliptin
230720|NCT02188186|thiazolidinedione|thiazolidinedione
230721|NCT02188160|Pain|pain
230722|NCT02188160|Corticosteroid|corticosteroid
230723|NCT02188160|Dry Eye|dry eye
230724|NCT02188160|Hyperemia|hyperemia
230725|NCT02188160|Ocular Discomfort|ocular discomfort
230726|NCT02188147|Syncope|syncope
230727|NCT02188147|Sudden Cardiac Arrest|sudden cardiac arrest
230728|NCT02188147|Sudden Cardiac Death|sudden cardiac death
230729|NCT02188147|Cardiac Arrest|cardiac arrest
230730|NCT02188147|Emergency Service|emergency service
230731|NCT02188147|Emergency Department|emergency department
230732|NCT02188147|Ambulatory Electrocardiography|ambulatory electrocardiography
230733|NCT02188147|Holter|holter
230734|NCT02188147|Holter Electrocardiography|holter electrocardiography
230735|NCT02188147|Holter Monitoring|holter monitoring
230736|NCT02188134|Adverse events,|adverse events,
230737|NCT02188134|adverse drug reactions,|adverse drug reactions,
230738|NCT02188134|medication error,|medication error,
230739|NCT02188134|noncompliance|noncompliance
230740|NCT02188108|quality of life|quality of life
230741|NCT02188108|QOL|qol
230742|NCT02188108|urolithiasis|urolithiasis
230743|NCT02188108|nephrolithiasis|nephrolithiasis
230744|NCT02188108|kidney stones|kidney stones
230745|NCT02188108|patient-reported outcomes|patient-reported outcomes
230746|NCT02188069|Non-atherosclerotic Coronary Artery Disease|non-atherosclerotic coronary artery disease
230747|NCT02188056|Venous|venous
230748|NCT02188056|Thromboembolic|thromboembolic
230749|NCT02188056|Pulmonary embolism|pulmonary embolism
230750|NCT02188043|Alcohol use disorder|alcohol use disorder
230751|NCT02188043|Motivational Intervention|motivational intervention
230752|NCT02188043|Health expenditures|health expenditures
230753|NCT02188043|efficacy study|efficacy study
230754|NCT02188030|musculoskeletal symptom|musculoskeletal symptom
230755|NCT02188030|industrial workers|industrial workers
230756|NCT02188030|physical-activity program|physical-activity program
230757|NCT02188030|resistance training|resistance training
230758|NCT02188030|randomized controlled trial|randomized controlled trial
230759|NCT02188017|prednisone, methotrexate, sarcoidosis, azathioprine|prednisone, methotrexate, sarcoidosis, azathioprine
230760|NCT02188004|HPV|hpv
230761|NCT02188004|genital warts|genital warts
230762|NCT02187991|metastatic breast cancer|metastatic breast cancer
230763|NCT02187991|Human Epidermal Growth Factor Receptor 2-negative (HER2-) breast cancer|human epidermal growth factor receptor 2-negative (her2-) breast cancer
230764|NCT02187991|Estrogen Receptor-positive (ER+) breast cancer|estrogen receptor-positive (er+) breast cancer
230765|NCT02187991|Triple Negative breast cancer|triple negative breast cancer
230766|NCT02187991|alisertib|alisertib
230767|NCT02187991|paclitaxel|paclitaxel
230768|NCT02187978|Early total enteral feeding (ETEF)|early total enteral feeding (etef)
230769|NCT02187978|Conventional enteral feeding (CEF)|conventional enteral feeding (cef)
230770|NCT02187978|VLBW infants|vlbw infants
230771|NCT02187978|NEC|nec
230772|NCT02187978|Preterm infants|preterm infants
230773|NCT02187926|Drug therapy|drug therapy
230774|NCT02187900|Tripterygium Wilfordii HOOK. f.|tripterygium wilfordii hook. f.
230775|NCT02187900|Mycophenolate mofetil|mycophenolate mofetil
230776|NCT02187887|alcohol|alcohol
230777|NCT02187887|young adult veterans|young adult veterans
230778|NCT02187887|brief intervention|brief intervention
230779|NCT02187887|online|online
230780|NCT02187887|perceived norms|perceived norms
230781|NCT02187835|complexity|complexity
230782|NCT02187835|electroencephalogram|electroencephalogram
230783|NCT02187835|entropy|entropy
230784|NCT02187835|negative symptoms|negative symptoms
230785|NCT02187835|schizophrenia.|schizophrenia.
230786|NCT02187822|Brain|brain
230787|NCT02187822|Advanced solid tumors|advanced solid tumors
230788|NCT02187822|Fractionated Stereotactic Radiotherapy (FSRT)|fractionated stereotactic radiotherapy (fsrt)
230789|NCT02187822|Brain lesions|brain lesions
230790|NCT02187822|Primary solid malignancy|primary solid malignancy
230791|NCT02187796|HIV|hiv
230792|NCT02187796|Dementia|dementia
230793|NCT02187796|HAND|hand
230794|NCT02187796|COGNISION System|cognision system
230795|NCT02187796|ERP|erp
230796|NCT02187796|event-related potentials|event-related potentials
230797|NCT02187783|Solid malignancy,|solid malignancy,
230798|NCT02187783|Hematologic malignancy,|hematologic malignancy,
230799|NCT02187783|Mutations,|mutations,
230800|NCT02187783|Amplifications,|amplifications,
230801|NCT02187783|Signature,|signature,
230802|NCT02187783|CDK4,|cdk4,
230803|NCT02187783|CDK6,|cdk6,
230804|NCT02187783|CDK4/6,|cdk4/6,
230805|NCT02187783|Cyclin D1,|cyclin d1,
230806|NCT02187783|CCND1,|ccnd1,
230807|NCT02187783|Cyclin D3,|cyclin d3,
230808|NCT02187783|CCND3,|ccnd3,
230809|NCT02187783|p16 mutation,|p16 mutation,
230810|NCT02187783|CDKN2A,|cdkn2a,
230811|NCT02187783|LEE011,|lee011,
230812|NCT02187783|Breast cancer,|breast cancer,
230813|NCT02187783|Ovarian cancer,|ovarian cancer,
230814|NCT02187783|Lymphoma,|lymphoma,
230815|NCT02187783|Mesothelioma,|mesothelioma,
230816|NCT02187783|Pancreatic neuroendocrine,|pancreatic neuroendocrine,
230817|NCT02187783|Leukemia|leukemia
230818|NCT02187783|Tumor|tumor
230819|NCT02187757|Dyslipidemia|dyslipidemia
230820|NCT02187757|High cholesterol|high cholesterol
230821|NCT02187757|High LDL|high ldl
230822|NCT02187757|Triglycerides|triglycerides
230823|NCT02187744|Biosimilars|biosimilars
230824|NCT02187744|Non-inferiority|non-inferiority
230825|NCT02187744|Neoadjuvant Setting|neoadjuvant setting
230826|NCT02187744|Early Breast Cancer|early breast cancer
230827|NCT02187744|PK|pk
230828|NCT02187744|Phase 3|phase 3
230829|NCT02187744|Trastuzumab|trastuzumab
230830|NCT02187744|Herceptin|herceptin
230831|NCT02187744|HER2 Positive|her2 positive
230832|NCT02187731|Multiple Myeloma|multiple myeloma
230833|NCT02187731|Functional Imaging|functional imaging
230834|NCT02187731|PET/CT|pet/ct
230835|NCT02187731|Diffusion Weighted MRI|diffusion weighted mri
230836|NCT02187718|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
230837|NCT02187718|Local Anaesthesia|local anaesthesia
230838|NCT02187692|schizophrenia;|schizophrenia;
230839|NCT02187692|meta-cognition;|meta-cognition;
230840|NCT02187692|general functioning;|general functioning;
230841|NCT02187692|positive symptoms;|positive symptoms;
230842|NCT02187692|insight;|insight;
230843|NCT02187679|Tourette Syndrome|tourette syndrome
230844|NCT02187679|Tourette's Syndrome|tourette's syndrome
230845|NCT02187679|Chronic Vocal Tic|chronic vocal tic
230846|NCT02187679|Vocal Tic|vocal tic
230847|NCT02187666|Cervical|cervical
230848|NCT02187666|Lumbar|lumbar
230849|NCT02187666|Spine|spine
230850|NCT02187666|Spinal Disease|spinal disease
230851|NCT02187653|IOM|iom
230852|NCT02187653|IONM|ionm
230853|NCT02187653|Intraoperative Monitoring|intraoperative monitoring
230854|NCT02187653|Intraoperative Neuromonitoring|intraoperative neuromonitoring
230855|NCT02187653|Spine|spine
230856|NCT02187653|Lumbar|lumbar
230857|NCT02187653|Cervical|cervical
230858|NCT02187640|Acupressure|acupressure
230859|NCT02187640|Self-administration|self-administration
230860|NCT02187640|Psychiatric in-patients|psychiatric in-patients
230861|NCT02187640|Constipation|constipation
230862|NCT02187640|Self-administered acupressure program|self-administered acupressure program
230863|NCT02187640|Sham control group|sham control group
230864|NCT02187614|Acute Renal colic|acute renal colic
230865|NCT02187614|Acute Ureteric Colic|acute ureteric colic
230866|NCT02187614|Renal or Ureteral Calculi|renal or ureteral calculi
230867|NCT02187614|Urolithiasis|urolithiasis
230868|NCT02187614|Kidney or Ureteral stones|kidney or ureteral stones
230869|NCT02187601|CLD|cld
230870|NCT02187549|Hyaluronic Acid|hyaluronic acid
230871|NCT02187549|Osteoarthritis|osteoarthritis
230872|NCT02187549|Knee|knee
230873|NCT02187549|Hyaluronan|hyaluronan
230874|NCT02187549|Viscoelastic|viscoelastic
230875|NCT02187549|Hydrogel|hydrogel
230876|NCT02187510|Hemodynamics|hemodynamics
230877|NCT02187510|Premature Infant|premature infant
230878|NCT02187510|Umbilical cord|umbilical cord
230879|NCT02187510|Milking|milking
230880|NCT02187510|Delayed clamping|delayed clamping
230881|NCT02187471|pain|pain
230882|NCT02187471|fibromyalgia|fibromyalgia
230883|NCT02187445|Sickle Cell Disease|sickle cell disease
230884|NCT02187445|Budesonide inhalation suspension|budesonide inhalation suspension
230885|NCT02187445|Acute Chest Syndrome|acute chest syndrome
230886|NCT02187419|Sleep|sleep
230887|NCT02187419|Menopause|menopause
230888|NCT02187419|Hypnosis|hypnosis
230889|NCT02187419|Relaxation|relaxation
230890|NCT02187419|Hypnotic Relaxation Therapy|hypnotic relaxation therapy
230891|NCT02187419|Hot Flash|hot flash
230892|NCT02187406|athletic tape|athletic tape
230893|NCT02187406|tennis|tennis
230894|NCT02187406|warm-up exercise|warm-up exercise
230895|NCT02187393|Epithelial cell function of cells from individuals with various genotypes|epithelial cell function of cells from individuals with various genotypes
230896|NCT02187302|nanopharmaceutical,|nanopharmaceutical,
230897|NCT02187289|NCSG|ncsg
230898|NCT02187289|Compression bandages|compression bandages
230899|NCT02187289|devices|devices
230900|NCT02187289|Night time compression|night time compression
230901|NCT02187289|Breast cancer treatment side effects|breast cancer treatment side effects
230902|NCT02187289|Compression therapy|compression therapy
230903|NCT02187289|Reid Sleeve|reid sleeve
230904|NCT02187289|Comprefit|comprefit
230905|NCT02187289|Medassist|medassist
230906|NCT02187289|Tribute|tribute
230907|NCT02187289|Comprilan|comprilan
230908|NCT02187276|Predictive factors of response|predictive factors of response
230909|NCT02187276|mild and moderate|mild and moderate
230910|NCT02187276|Alzheimer disease|alzheimer disease
230911|NCT02187276|mixed dementia|mixed dementia
230912|NCT02187276|APOE|apoe
230913|NCT02187276|polymorphisms of CYP 2D6|polymorphisms of cyp 2d6
230914|NCT02187263|hereditary cardiomyopathy,|hereditary cardiomyopathy,
230915|NCT02187263|inflammatory cardiomyopathy,|inflammatory cardiomyopathy,
230916|NCT02187263|registry,|registry,
230917|NCT02187263|biomaterial,|biomaterial,
230918|NCT02187263|clinical trial|clinical trial
230919|NCT02187263|Patients|patients
230920|NCT02187250|PCOS|pcos
230921|NCT02187250|PDE-4 inhibitor|pde-4 inhibitor
230922|NCT02187250|roflumilast|roflumilast
230923|NCT02187250|liraglutide|liraglutide
230924|NCT02187250|metformin|metformin
230925|NCT02187250|obesity|obesity
230926|NCT02187224|Alcohol Dependence|alcohol dependence
230927|NCT02187224|Post-Traumatic stress disorder (PTSD)|post-traumatic stress disorder (ptsd)
230928|NCT02187224|Progesterone|progesterone
230929|NCT02187211|Alcohol Dependence|alcohol dependence
230930|NCT02187211|Minocycline|minocycline
230931|NCT02187198|Opioid Dependence|opioid dependence
230932|NCT02187198|Buprenorphine|buprenorphine
230933|NCT02187185|Inflammatory biomarkers|inflammatory biomarkers
230934|NCT02187185|Periodontitis|periodontitis
230935|NCT02187172|Psoriasis|psoriasis
230936|NCT02187172|Cardiovascular Disease|cardiovascular disease
230937|NCT02187172|Vascular Inflammation|vascular inflammation
230938|NCT02187172|Lipid Biomarkers|lipid biomarkers
230939|NCT02187172|FDG-PET/CT|fdg-pet/ct
230940|NCT02187159|pain|pain
230941|NCT02187159|fibromyalgia|fibromyalgia
230942|NCT02187146|Vitamin D|vitamin d
230943|NCT02187146|Infertility|infertility
230945|NCT02187146|ART|art
230946|NCT02187133|Relapsed|relapsed
230947|NCT02187133|Refractory|refractory
230948|NCT02187120|Wounds and Injuries|wounds and injuries
230949|NCT02187120|Acute Coagulopathy|acute coagulopathy
230950|NCT02187120|Tranexamic Acid|tranexamic acid
230951|NCT02187120|Emergency Medical Services|emergency medical services
230952|NCT02187107|HIV|hiv
230953|NCT02187107|AIDS|aids
230954|NCT02187107|TMC114|tmc114
230955|NCT02187107|Ritonavir|ritonavir
230956|NCT02187107|Norvir|norvir
230957|NCT02187107|Darunavir|darunavir
230958|NCT02187081|HCC|hcc
230959|NCT02187081|RFA|rfa
230960|NCT02187081|Sorafenib|sorafenib
230961|NCT02187081|Tumor recurrence|tumor recurrence
230962|NCT02187081|Overall survival|overall survival
230963|NCT02187068|Anaesthetics iv|anaesthetics iv
230964|NCT02187068|Dexmedetomidine|dexmedetomidine
230965|NCT02187068|Pharmacokinetic|pharmacokinetic
230966|NCT02187042|sunitinib|sunitinib
230967|NCT02187042|call center|call center
230968|NCT02187042|management of patients|management of patients
230969|NCT02187042|nurses|nurses
230970|NCT02187042|metastatic renal carcinoma|metastatic renal carcinoma
230971|NCT02187029|Hyperuricemia|hyperuricemia
230972|NCT02187029|gout|gout
230973|NCT02187029|serum uric acid|serum uric acid
230974|NCT02187016|Gingivitis|gingivitis
230975|NCT02187016|plaque|plaque
230976|NCT02187016|interproximal cleaning|interproximal cleaning
230977|NCT02187016|dental floss|dental floss
230978|NCT02187003|Sickle Cell Anemia|sickle cell anemia
230979|NCT02187003|Sickle Cell Disease|sickle cell disease
230980|NCT02187003|Sickle Cell Disorders|sickle cell disorders
230981|NCT02187003|pain crisis|pain crisis
230982|NCT02187003|vaso-occlusive crisis|vaso-occlusive crisis
230983|NCT02187003|rivipansel|rivipansel
230984|NCT02187003|GMI-1070|gmi-1070
230985|NCT02187003|selectin inhibitor|selectin inhibitor
230986|NCT02187003|SCD|scd
230987|NCT02187003|VOC|voc
230988|NCT02186977|immunogenicity|immunogenicity
230989|NCT02186977|safety|safety
230990|NCT02186977|proof of concept|proof of concept
230991|NCT02186951|ventilator-associated pneumonia|ventilator-associated pneumonia
230992|NCT02186951|cardiac arrests with shockable rhythm|cardiac arrests with shockable rhythm
230993|NCT02186951|Mild therapeutic hypothermia|mild therapeutic hypothermia
230994|NCT02186951|preventive antibiotics|preventive antibiotics
230995|NCT02186938|head and neck cancer|head and neck cancer
230996|NCT02186938|patients requiring a free flap surgery|patients requiring a free flap surgery
230997|NCT02186925|Kidney Cancer|kidney cancer
230998|NCT02186925|Prostate Cancer|prostate cancer
230999|NCT02186925|Bladder Cancer|bladder cancer
231000|NCT02186912|edentulous|edentulous
231001|NCT02186912|Nobel Active|nobel active
231002|NCT02186912|Nobel Procera|nobel procera
231003|NCT02186912|IBO|ibo
231004|NCT02186912|CAD/CAM|cad/cam
231005|NCT02186886|Ulcerative Colitis|ulcerative colitis
231006|NCT02186886|Golimumab|golimumab
231007|NCT02186886|Physiological Intermolecular Modification Spectroscopy|physiological intermolecular modification spectroscopy
231008|NCT02186886|PIMS|pims
231009|NCT02186873|Ankylosing Spondylitis|ankylosing spondylitis
231010|NCT02186873|Golimumab|golimumab
231011|NCT02186873|SIMPONI|simponi
231012|NCT02186834|Relapsed|relapsed
231013|NCT02186834|Refractory|refractory
231014|NCT02186834|Myeloma|myeloma
231015|NCT02186821|hematological malignancy|hematological malignancy
231016|NCT02186821|solid tumor malignancy|solid tumor malignancy
231017|NCT02186821|mutation|mutation
231018|NCT02186821|translocation|translocation
231019|NCT02186821|rearrangement|rearrangement
231020|NCT02186821|amplification|amplification
231021|NCT02186821|ALK|alk
231022|NCT02186821|ROS1|ros1
231023|NCT02186821|NSCLC|nsclc
231024|NCT02186821|B-cell lymphoma|b-cell lymphoma
231025|NCT02186795|Arthroplasty|arthroplasty
231026|NCT02186795|Replacement, Hip|replacement, hip
231027|NCT02186782|Clomiphene citrate|clomiphene citrate
231028|NCT02186782|Estradiol|estradiol
231029|NCT02186782|Endometrial thickness|endometrial thickness
231030|NCT02186756|Fibromyalgia|fibromyalgia
231031|NCT02186756|Complementary Therapies|complementary therapies
231032|NCT02186756|Biofeedback|biofeedback
231033|NCT02186756|Randomized controlled trial|randomized controlled trial
231034|NCT02186756|Relaxation Therapy|relaxation therapy
231035|NCT02186743|Irritable Bowel Syndrome|irritable bowel syndrome
231036|NCT02186743|IBS|ibs
231037|NCT02186743|Diet|diet
231038|NCT02186743|Food sensitivity|food sensitivity
231039|NCT02186730|Computerised Cognitive Behaviour Therapy|computerised cognitive behaviour therapy
231040|NCT02186730|Adolescents|adolescents
231041|NCT02186730|Depression|depression
231042|NCT02186730|Low Mood|low mood
231043|NCT02186704|Atrial Fibrillation|atrial fibrillation
231044|NCT02186704|Implantable Defibrillators|implantable defibrillators
231045|NCT02186704|Implanted Electrodes|implanted electrodes
231046|NCT02186691|pulmonary valve replacement|pulmonary valve replacement
231047|NCT02186691|tetralogy of Fallot|tetralogy of fallot
231048|NCT02186652|obese|obese
231049|NCT02186652|children|children
231050|NCT02186652|adolescents|adolescents
231051|NCT02186652|GERD|gerd
231052|NCT02186652|pharmacokinetic|pharmacokinetic
231053|NCT02186639|exhaled breath|exhaled breath
231054|NCT02186639|volatile organic compounds (VOCs)|volatile organic compounds (vocs)
231055|NCT02186639|SESI-MS|sesi-ms
231056|NCT02186626|West Nile Virus, vaccine|west nile virus, vaccine
231057|NCT02186613|Breast Feeding|breast feeding
231058|NCT02186613|Telephone|telephone
231059|NCT02186613|Education|education
231060|NCT02186613|Primary Health Care|primary health care
231061|NCT02186600|Low bone mass|low bone mass
231062|NCT02186600|Post-menopausal women|post-menopausal women
231063|NCT02186600|Bone mineral density|bone mineral density
231064|NCT02186600|Bone structure|bone structure
231065|NCT02186600|Bone turnover|bone turnover
231066|NCT02186600|Bone-loading exercises|bone-loading exercises
231067|NCT02186600|calcium and vitamin D|calcium and vitamin d
231068|NCT02186600|risedronate|risedronate
231069|NCT02186574|Non-Hodgkin|non-hodgkin
231070|NCT02186574|Lymphoma|lymphoma
231071|NCT02186574|Hepatitis B|hepatitis b
231072|NCT02186574|Tenofovir|tenofovir
231073|NCT02186574|Viread|viread
231074|NCT02186561|intracranial aneurysm|intracranial aneurysm
231075|NCT02186561|brain aneurysm|brain aneurysm
231076|NCT02186522|Sepsis|sepsis
231077|NCT02186522|Septic shock|septic shock
231078|NCT02186522|Critical care|critical care
231079|NCT02186522|Immune dysfunction|immune dysfunction
231080|NCT02186522|Inflammatory markers|inflammatory markers
231081|NCT02186522|Neutrophil|neutrophil
231082|NCT02186522|Monocyte|monocyte
231083|NCT02186522|Tregs|tregs
231084|NCT02186470|Breast Cancer|breast cancer
231085|NCT02186470|Early Stage Breast Cancer|early stage breast cancer
231086|NCT02186470|Hormone responsive breast cancer|hormone responsive breast cancer
231087|NCT02186457|Pancreatoduodenectomy|pancreatoduodenectomy
231088|NCT02186457|Whipple|whipple
231089|NCT02186444|newly diagnosed prostate cancer|newly diagnosed prostate cancer
231090|NCT02186444|prostate|prostate
231091|NCT02186431|Contact lenses|contact lenses
231092|NCT02186418|sickle cell disease|sickle cell disease
231093|NCT02186418|sickle cell anemia|sickle cell anemia
231094|NCT02186418|hemoglobinopathies|hemoglobinopathies
231095|NCT02186418|hematopoietic stem cell|hematopoietic stem cell
231096|NCT02186418|gene transfer|gene transfer
231097|NCT02186418|gene therapy|gene therapy
231098|NCT02186392|Depression|depression
231099|NCT02186392|Anxiety|anxiety
231100|NCT02186392|Stroke|stroke
231101|NCT02186392|Cerebral Infarction|cerebral infarction
231102|NCT02186392|Sleep disorders|sleep disorders
231103|NCT02186392|Circadian Rhythm disorders|circadian rhythm disorders
231104|NCT02186392|Circadian Light|circadian light
231105|NCT02186392|Light therapy|light therapy
231106|NCT02186392|Melatonin|melatonin
231107|NCT02186392|Sleep|sleep
231108|NCT02186392|Sleep apnea|sleep apnea
231109|NCT02186392|Coagulation disturbances|coagulation disturbances
231110|NCT02186392|Bone metabolism|bone metabolism
231111|NCT02186392|Rehabilitation|rehabilitation
231112|NCT02186392|Mood disorders|mood disorders
231113|NCT02186392|Mental disorders|mental disorders
231114|NCT02186392|Neurologic Manifestations|neurologic manifestations
231115|NCT02186392|Signs and Symptoms Cerebrovascular Disorders|signs and symptoms cerebrovascular disorders
231116|NCT02186392|Brain Diseases|brain diseases
231117|NCT02186392|Vascular Disease|vascular disease
231118|NCT02186392|Brain Infarction|brain infarction
231119|NCT02186392|Brain Ischemia|brain ischemia
231120|NCT02186379|Obesity|obesity
231121|NCT02186379|Obesity Prevention|obesity prevention
231122|NCT02186379|Childhood obesity prevention|childhood obesity prevention
231123|NCT02186379|Rapid Eating Style|rapid eating style
231124|NCT02186366|Anxiety Disorders, Massage Therapy, Treatment Efficacy|anxiety disorders, massage therapy, treatment efficacy
231125|NCT02186353|Whole grains|whole grains
231126|NCT02186353|Food processing|food processing
231127|NCT02186353|Cardiometabolic risk factors|cardiometabolic risk factors
231128|NCT02186327|Integrative Health Coaching|integrative health coaching
231129|NCT02186314|atrial fibrillation, heart failure, pacemaker|atrial fibrillation, heart failure, pacemaker
231130|NCT02186301|cancer|cancer
231131|NCT02186301|metastatic|metastatic
231132|NCT02186301|locally advanced|locally advanced
231133|NCT02186301|lung|lung
231134|NCT02186301|non-small cell lung cancer|non-small cell lung cancer
231135|NCT02186301|NSCLC|nsclc
231136|NCT02186301|epidermal growth factor receptor|epidermal growth factor receptor
231137|NCT02186301|EGFR|egfr
231138|NCT02186301|T790M|t790m
231139|NCT02186301|CO-1686|co-1686
231140|NCT02186301|unresectable|unresectable
231141|NCT02186301|recurrent|recurrent
231142|NCT02186301|EGFR-directed therapy|egfr-directed therapy
231143|NCT02186301|irreversible EGFR inhibitor|irreversible egfr inhibitor
231144|NCT02186301|TIGER|tiger
231145|NCT02186301|rociletinib|rociletinib
231146|NCT02186288|Critical Care|critical care
231147|NCT02186288|High-flow nasal cannula oxygen|high-flow nasal cannula oxygen
231148|NCT02186288|Electrical impedance tomography|electrical impedance tomography
231149|NCT02186288|End expiratory lung volume|end expiratory lung volume
231150|NCT02186288|End expiratory lung impedance|end expiratory lung impedance
231151|NCT02186288|Diaphragmatic ultrasound|diaphragmatic ultrasound
231152|NCT02186275|Crohn|crohn
231153|NCT02186275|vitamin D|vitamin d
231154|NCT02186275|remission|remission
231155|NCT02186275|inflammation|inflammation
231156|NCT02186275|tolerance|tolerance
231157|NCT02186262|Glioma|glioma
231158|NCT02186262|MRI|mri
231159|NCT02186262|Rotating frame relaxation|rotating frame relaxation
231160|NCT02186262|DWI|dwi
231161|NCT02186262|treatment response|treatment response
231162|NCT02186236|Detection of Oncogenic Tumor Mutations|detection of oncogenic tumor mutations
231163|NCT02186236|blood|blood
231164|NCT02186236|urine|urine
231165|NCT02186236|14-114|14-114
231166|NCT02186223|Pulmonary Embolism|pulmonary embolism
231167|NCT02186223|PE|pe
231168|NCT02186223|DVT|dvt
231169|NCT02186223|Deep Vein Thrombosis|deep vein thrombosis
231170|NCT02186223|VTE|vte
231171|NCT02186223|Venous Thromboembolism|venous thromboembolism
231172|NCT02186223|prophylaxis|prophylaxis
231173|NCT02186223|thromboprophylaxis|thromboprophylaxis
231174|NCT02186223|contraindications to thromboprophylaxis|contraindications to thromboprophylaxis
231175|NCT02186223|prophylactic|prophylactic
231176|NCT02186223|prevention|prevention
231177|NCT02186223|Inferior vena cava filter|inferior vena cava filter
231178|NCT02186223|IVC filter|ivc filter
231179|NCT02186223|filter|filter
231180|NCT02186223|prevention of pulmonary embolism|prevention of pulmonary embolism
231181|NCT02186223|trauma|trauma
231182|NCT02186223|critically-ill|critically-ill
231183|NCT02186210|microcirculation|microcirculation
231184|NCT02186210|off-pump coronary artery bypass surgery|off-pump coronary artery bypass surgery
231185|NCT02186210|tissue oxygen saturation|tissue oxygen saturation
231186|NCT02186210|vascular occlusion test|vascular occlusion test
231187|NCT02186210|recovery slope|recovery slope
231188|NCT02186197|Volume Responsiveness|volume responsiveness
231189|NCT02186184|Myopia progression|myopia progression
231190|NCT02186184|Orthokeratology|orthokeratology
231191|NCT02186171|Osteoporosis in men|osteoporosis in men
231192|NCT02186158|Pneumonia|pneumonia
231193|NCT02186158|Elderly|elderly
231194|NCT02186158|Ascorbic acid|ascorbic acid
231195|NCT02186158|Vitamin C|vitamin c
231196|NCT02186158|Hospitalized patient|hospitalized patient
231197|NCT02186132|heart rate|heart rate
231198|NCT02186132|neostigmine|neostigmine
231199|NCT02186132|atropine|atropine
231200|NCT02186132|dosage|dosage
231201|NCT02186093|Coronary Artery Disease|coronary artery disease
231202|NCT02186093|Angina, Stable|angina, stable
231203|NCT02186093|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
231204|NCT02186093|Coronary Angiography|coronary angiography
231205|NCT02186080|diabetes mellitus|diabetes mellitus
231206|NCT02186080|metabolic endotoxemia|metabolic endotoxemia
231207|NCT02186080|gemigliptin|gemigliptin
231208|NCT02186080|DPP-4 inhibitor|dpp-4 inhibitor
231209|NCT02186067|Hypertension|hypertension
231210|NCT02186067|Uncontrolled Hypertension|uncontrolled hypertension
231211|NCT02186054|Abdominal-Pelvic MRI (magnetic resonance image)|abdominal-pelvic mri (magnetic resonance image)
231212|NCT02186054|T2W (T2 weighted)|t2w (t2 weighted)
231213|NCT02186054|FSE Flex (recently developed MRI pulse sequence)|fse flex (recently developed mri pulse sequence)
231214|NCT02186054|Enhanced single shot FSE (fast spin echo).|enhanced single shot fse (fast spin echo).
231215|NCT02186028|oral daily supplementation with vitamin D for 6 months|oral daily supplementation with vitamin d for 6 months
231216|NCT02186015|Metastatic Breast Cancer|metastatic breast cancer
231217|NCT02186015|MBC|mbc
231218|NCT02186015|Vitamin D Supplementation|vitamin d supplementation
231219|NCT02186015|Symptom Management|symptom management
231220|NCT02186002|ACT-451840|act-451840
231221|NCT02186002|Safety|safety
231222|NCT02186002|Tolerability|tolerability
231223|NCT02186002|Pharmacokinetics|pharmacokinetics
231224|NCT02185989|Critical Illness/*rehabilitation|critical illness/*rehabilitation
231225|NCT02185989|Humans|humans
231226|NCT02185989|*Intensive Care Units|*intensive care units
231227|NCT02185989|Muscle Weakness/diagnosis/*etiology/physiopathology/prevention & control|muscle weakness/diagnosis/*etiology/physiopathology/prevention & control
231228|NCT02185989|Polyneuropathies/diagnosis/*etiology/physiopathology|polyneuropathies/diagnosis/*etiology/physiopathology
231229|NCT02185976|preoperative anxiety|preoperative anxiety
231230|NCT02185976|paediatric patients|paediatric patients
231231|NCT02185976|Cartoon|cartoon
231232|NCT02185963|Diabetes|diabetes
231233|NCT02185963|Dyslipidemia|dyslipidemia
231234|NCT02185963|HDL function|hdl function
231235|NCT02185963|Cholesterol efflux|cholesterol efflux
231236|NCT02185963|MCA assay|mca assay
231237|NCT02185963|MCP-1|mcp-1
231238|NCT02185950|Burn|burn
231239|NCT02185950|Skin graft|skin graft
231240|NCT02185950|Elasticity|elasticity
231241|NCT02185950|Skin|skin
231242|NCT02185950|Physical therapy modalities|physical therapy modalities
231243|NCT02185937|imatinib|imatinib
231244|NCT02185937|gastrectomy|gastrectomy
231245|NCT02185937|gastrointestinal stromal tumor|gastrointestinal stromal tumor
231246|NCT02185937|pharmacokinetics|pharmacokinetics
231247|NCT02185924|PARECOXIB|parecoxib
231248|NCT02185924|CONTINUOUS FEMORAL BLOCK|continuous femoral block
231249|NCT02185911|chronic kidney disease,|chronic kidney disease,
231373|NCT02185508|IONM|ionm
231250|NCT02185911|anaemia correction/maintenance,|anaemia correction/maintenance,
231251|NCT02185911|non dialysis,|non dialysis,
231252|NCT02185898|electronic cigarettes|electronic cigarettes
231253|NCT02185898|e-cigarettes|e-cigarettes
231254|NCT02185898|combustible cigarettes|combustible cigarettes
231255|NCT02185898|second-hand smoke|second-hand smoke
231256|NCT02185898|environmental tobacco smoke|environmental tobacco smoke
231257|NCT02185898|tobacco-burning|tobacco-burning
231258|NCT02185885|Ischemic stroke|ischemic stroke
231259|NCT02185885|Embolic stroke|embolic stroke
231260|NCT02185885|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
231261|NCT02185885|Cardiac Bypass Surgery|cardiac bypass surgery
231262|NCT02185885|Cardiac Anaesthesia|cardiac anaesthesia
231263|NCT02185872|Exercise|exercise
231264|NCT02185872|Physical Fitness|physical fitness
231265|NCT02185872|Body Composition, Beneficial|body composition, beneficial
231266|NCT02185859|Lidocaine|lidocaine
231267|NCT02185859|Magnesium|magnesium
231268|NCT02185859|Mastectomy|mastectomy
231269|NCT02185859|Functional Recovery|functional recovery
231270|NCT02185846|Fed condition|fed condition
231271|NCT02185833|Fasting condition|fasting condition
231272|NCT02185820|Multiple myeloma|multiple myeloma
231273|NCT02185820|Relapsed and/or refractory|relapsed and/or refractory
231274|NCT02185820|CPD|cpd
231275|NCT02185807|cataract|cataract
231276|NCT02185807|surgery|surgery
231277|NCT02185807|consent process|consent process
231278|NCT02185807|video-assisted|video-assisted
231279|NCT02185794|HCV genotype 1 (GT-1)|hcv genotype 1 (gt-1)
231280|NCT02185794|HCV genotype 2 (GT-2)|hcv genotype 2 (gt-2)
231281|NCT02185794|HCV genotype 3 (GT-3)|hcv genotype 3 (gt-3)
231282|NCT02185794|HCV genotype 4 (GT-4)|hcv genotype 4 (gt-4)
231283|NCT02185794|HCV|hcv
231284|NCT02185794|Sustained Virologic Response|sustained virologic response
231285|NCT02185794|Direct Acting Antiviral|direct acting antiviral
231286|NCT02185794|Combination Therapy|combination therapy
231287|NCT02185794|Open Label|open label
231288|NCT02185794|Hepatitis|hepatitis
231289|NCT02185794|Hepatitis, Chronic|hepatitis, chronic
231290|NCT02185794|Hepatitis C|hepatitis c
231291|NCT02185794|Hepatitis C, Chronic|hepatitis c, chronic
231292|NCT02185794|Liver Diseases|liver diseases
231293|NCT02185794|Digestive System Diseases|digestive system diseases
231294|NCT02185794|Hepatitis, Viral, Human|hepatitis, viral, human
231295|NCT02185794|Virus Diseases|virus diseases
231296|NCT02185794|Enterovirus Infections|enterovirus infections
231297|NCT02185794|Picornaviridae Infections|picornaviridae infections
231298|NCT02185794|RNA Virus Infections|rna virus infections
231299|NCT02185794|Flaviviridae Infections|flaviviridae infections
231300|NCT02185794|Antiviral Agents|antiviral agents
231301|NCT02185794|Anti-Infective Agents|anti-infective agents
231302|NCT02185794|Therapeutic Uses|therapeutic uses
231303|NCT02185794|Pharmacologic Actions|pharmacologic actions
231304|NCT02185794|Antimetabolites|antimetabolites
231305|NCT02185794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
231306|NCT02185781|Phase I|phase i
231307|NCT02185781|Adoptive immunotherapy|adoptive immunotherapy
231308|NCT02185781|Enriched and expanded autologous natural killer (NK) cells|enriched and expanded autologous natural killer (nk) cells
231309|NCT02185781|Ph+ acute lymphoblastic leukemia|ph+ acute lymphoblastic leukemia
231310|NCT02185781|≥60 years|≥60 years
231311|NCT02185781|Not eligible for other post-CHR treatment modalities|not eligible for other post-chr treatment modalities
231312|NCT02185768|Liver cancer|liver cancer
231313|NCT02185755|Internet-Based Glucose Monitoring System|internet-based glucose monitoring system
231314|NCT02185755|Type 2 Diabetes|type 2 diabetes
231315|NCT02185742|HIV|hiv
231316|NCT02185742|jail|jail
231317|NCT02185742|detainee|detainee
231318|NCT02185742|Linkage and Retention|linkage and retention
231319|NCT02185742|Treatment as Prevention|treatment as prevention
231320|NCT02185742|Strength Based Case Management|strength based case management
231321|NCT02185742|releases|releases
231322|NCT02185729|Intravenous Feeding|intravenous feeding
231323|NCT02185729|Lipid Emulsions, Intravenous|lipid emulsions, intravenous
231324|NCT02185716|Transversus abdominis plane block|transversus abdominis plane block
231325|NCT02185716|levobupivacaine|levobupivacaine
231326|NCT02185690|Lung cancer|lung cancer
231327|NCT02185690|Non small cell lung cancer|non small cell lung cancer
231328|NCT02185690|non squamous|non squamous
231329|NCT02185690|pemetrexed|pemetrexed
231330|NCT02185690|carboplatin|carboplatin
231331|NCT02185690|binimetinib|binimetinib
231332|NCT02185690|chemotherapy|chemotherapy
231333|NCT02185690|combination chemotherapy|combination chemotherapy
231334|NCT02185690|Phase 1|phase 1
231335|NCT02185690|Princess Margaret Cancer Centre|princess margaret cancer centre
231336|NCT02185690|carcinoma|carcinoma
231337|NCT02185677|dysexecutive syndrome|dysexecutive syndrome
231338|NCT02185677|multiple system atrophy|multiple system atrophy
231339|NCT02185677|imaging study|imaging study
231340|NCT02185664|internal jugular vein|internal jugular vein
231341|NCT02185664|landmark|landmark
231342|NCT02185664|ultrasound|ultrasound
231343|NCT02185664|static|static
231344|NCT02185664|cardiac surgery|cardiac surgery
231345|NCT02185651|Pompe Disease|pompe disease
231346|NCT02185651|Enzyme Replacement Therapy|enzyme replacement therapy
231347|NCT02185651|Infusion Associated Reaction|infusion associated reaction
231348|NCT02185638|obesity|obesity
231646|NCT02184390|Education|education
231349|NCT02185638|herbal bioactive compounds|herbal bioactive compounds
231350|NCT02185638|appetite|appetite
231351|NCT02185638|GLP-1|glp-1
231352|NCT02185638|ghrelin|ghrelin
231353|NCT02185638|CCK|cck
231354|NCT02185599|colposcopy|colposcopy
231355|NCT02185599|CIN|cin
231356|NCT02185599|cervical neoplasia|cervical neoplasia
231357|NCT02185599|cervical dysplasia|cervical dysplasia
231358|NCT02185599|cervical cancer|cervical cancer
231359|NCT02185599|CIN2+|cin2+
231360|NCT02185573|Bulk fill|bulk fill
231361|NCT02185573|SonicFill|sonicfill
231362|NCT02185573|resin composite application|resin composite application
231363|NCT02185573|class II restoration|class ii restoration
231364|NCT02185560|Sorafenib|sorafenib
231365|NCT02185560|Differentiated Thyroid Carcinoma,|differentiated thyroid carcinoma,
231366|NCT02185560|Japan|japan
231367|NCT02185560|Post Marketing Surveillance|post marketing surveillance
231368|NCT02185560|Drug Use Investigation|drug use investigation
231369|NCT02185547|women|women
231370|NCT02185534|Clopidogrel, Zyllt, Plavix, Phase I, Healthy Subjects, Pharmacokinetics, Bioequivalence|clopidogrel, zyllt, plavix, phase i, healthy subjects, pharmacokinetics, bioequivalence
231371|NCT02185521|Hemodynamics|hemodynamics
231372|NCT02185521|Medical Informatics|medical informatics
231374|NCT02185508|Lumbar Disk Disease|lumbar disk disease
231375|NCT02185508|Degenerative Spine Disease|degenerative spine disease
231376|NCT02185508|Radiculopathy|radiculopathy
231377|NCT02185508|Intraoperative Neurophysiological Monitoring|intraoperative neurophysiological monitoring
231378|NCT02185508|Somatosensory Evoked Potentials|somatosensory evoked potentials
231379|NCT02185508|Electromyography|electromyography
231380|NCT02185482|Psychological counselling|psychological counselling
231381|NCT02185482|Randomized single blind study|randomized single blind study
231382|NCT02185482|Depression|depression
231383|NCT02185482|Diabetes|diabetes
231384|NCT02185469|Corneal Endothelial Cell Loss|corneal endothelial cell loss
231385|NCT02185469|pneumatic retinopexy|pneumatic retinopexy
231386|NCT02185469|vitrectomy|vitrectomy
231387|NCT02185443|SBRT|sbrt
231388|NCT02185443|radiation|radiation
231389|NCT02185443|Neoplasm Metastasis|neoplasm metastasis
231390|NCT02185443|Colorectal Neoplasms|colorectal neoplasms
231391|NCT02185443|Anal Canal|anal canal
231392|NCT02185443|Neuroendocrine Tumors|neuroendocrine tumors
231393|NCT02185417|Hypertension|hypertension
231394|NCT02185417|Diuretic|diuretic
231395|NCT02185417|Comparative Effectiveness Research|comparative effectiveness research
231396|NCT02185417|Point of Care Research|point of care research
231397|NCT02185391|Coronary Disease|coronary disease
231398|NCT02185391|Audience Response System|audience response system
231399|NCT02185365|T1-rho MRI|t1-rho mri
231400|NCT02185365|dGEMRIC MRI|dgemric mri
231401|NCT02185365|DDH|ddh
231402|NCT02185365|Developmental dysplasia of the hip|developmental dysplasia of the hip
231403|NCT02185352|Bevacizumab|bevacizumab
231404|NCT02185352|Brain Metastases|brain metastases
231405|NCT02185352|Breast Cancer|breast cancer
231406|NCT02185352|Chemotherapy|chemotherapy
231407|NCT02185352|Whole Brain Radiotherapy|whole brain radiotherapy
231408|NCT02185339|Respiratory mechanics|respiratory mechanics
231409|NCT02185339|Respiratory function test|respiratory function test
231410|NCT02185339|Hemodynamics|hemodynamics
231411|NCT02185326|Poor responders|poor responders
231412|NCT02185326|Poor ovarian response|poor ovarian response
231413|NCT02185326|IVF/ICSI|ivf/icsi
231414|NCT02185326|Microflare protocol|microflare protocol
231415|NCT02185326|Growth hormone|growth hormone
231416|NCT02185326|Oral contraceptive pills|oral contraceptive pills
231417|NCT02185300|GSK1349572|gsk1349572
231418|NCT02185300|granule|granule
231419|NCT02185300|pediatric|pediatric
231420|NCT02185300|CONTREX mineral water|contrex mineral water
231421|NCT02185300|free-acid|free-acid
231422|NCT02185300|chelating|chelating
231423|NCT02185300|cations|cations
231424|NCT02185300|divalent|divalent
231425|NCT02185300|dolutegravir|dolutegravir
231426|NCT02185300|dispersible tablet|dispersible tablet
231427|NCT02185300|relative bioavailability|relative bioavailability
231428|NCT02185274|Transsexualism|transsexualism
231429|NCT02185274|Cross-sex hormone treatment|cross-sex hormone treatment
231430|NCT02185274|Sex hormones|sex hormones
231431|NCT02185274|Mood|mood
231432|NCT02185274|Stress|stress
231433|NCT02185274|Cortisol|cortisol
231434|NCT02185274|Cardiovascular|cardiovascular
231435|NCT02185274|Metabolome|metabolome
231436|NCT02185261|Relapse|relapse
231437|NCT02185261|Minimal residual disease|minimal residual disease
231438|NCT02185261|Graft-versus-host disease|graft-versus-host disease
231439|NCT02185261|Acute leukemia|acute leukemia
231440|NCT02185261|Interferon Alfa-2b|interferon alfa-2b
231441|NCT02185248|Pediatric Obesity|pediatric obesity
231442|NCT02185248|Body Mass Index|body mass index
231443|NCT02185248|Weight Perception|weight perception
231444|NCT02185248|Counseling|counseling
231445|NCT02185248|Health Behavior|health behavior
231446|NCT02185235|Electrical stimulation|electrical stimulation
231447|NCT02185235|Biofeedback|biofeedback
231448|NCT02185222|Vitamin D|vitamin d
231449|NCT02185222|Cholecalciferol|cholecalciferol
231450|NCT02185222|25-hydroxyvitamin D|25-hydroxyvitamin d
231451|NCT02185222|Memory complaint|memory complaint
231452|NCT02185222|Subjective memory complaint|subjective memory complaint
231453|NCT02185222|Mild cognitive impairment|mild cognitive impairment
231454|NCT02185222|Preventive therapy|preventive therapy
231455|NCT02185222|Cognitive disorders|cognitive disorders
231456|NCT02185196|Vitamin D,|vitamin d,
231457|NCT02185196|Severe pneumonia,|severe pneumonia,
231458|NCT02185196|Under-five children,|under-five children,
231459|NCT02185196|Randomised|randomised
231460|NCT02185196|Controlled|controlled
231461|NCT02185196|Trial (RCT)|trial (rct)
231462|NCT02185196|Morbidity|morbidity
231463|NCT02185170|Prostate|prostate
231464|NCT02185170|Cancer|cancer
231465|NCT02185170|Medical Device|medical device
231466|NCT02185170|Fluorescence|fluorescence
231467|NCT02185157|elderly|elderly
231468|NCT02185157|dual-task training|dual-task training
231469|NCT02185157|aerobic training|aerobic training
231470|NCT02185157|gait|gait
231471|NCT02185157|cognition|cognition
231472|NCT02185144|HIV, mental health, substance abuse|hiv, mental health, substance abuse
231473|NCT02185131|Major Depressive Disorder|major depressive disorder
231474|NCT02185131|Alcohol Use Disorder|alcohol use disorder
231475|NCT02185092|exacerbations|exacerbations
231476|NCT02185092|COPD|copd
231477|NCT02185092|pneumonia|pneumonia
231478|NCT02185092|probiotic|probiotic
231479|NCT02185079|labor|labor
231480|NCT02185079|epidural|epidural
231481|NCT02185040|Lupus, Systemic Lupus, SLE|lupus, systemic lupus, sle
231482|NCT02185027|Oral anticoagulants|oral anticoagulants
231483|NCT02185027|Surgery|surgery
231484|NCT02185027|Haemorrhage|haemorrhage
231485|NCT02185027|Emergency|emergency
231486|NCT02185014|Crohn's Disease|crohn's disease
231487|NCT02185001|Medial patellofemoral ligament|medial patellofemoral ligament
231488|NCT02185001|MPFL|mpfl
231489|NCT02185001|Repair|repair
231490|NCT02185001|Patellar dislocation|patellar dislocation
231491|NCT02185001|Knee|knee
231492|NCT02184988|Glabellar Lines|glabellar lines
231493|NCT02184988|Botulinum purifies neurotoxin, Type A (DWP-450)|botulinum purifies neurotoxin, type a (dwp-450)
231494|NCT02184975|cold knife conization|cold knife conization
231495|NCT02184975|lateral hemostatic sutures|lateral hemostatic sutures
231496|NCT02184975|cervix|cervix
231497|NCT02184949|PCI|pci
231498|NCT02184949|Coronary angioplasty|coronary angioplasty
231499|NCT02184949|Percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
231500|NCT02184949|PTCA|ptca
231501|NCT02184936|CT Angiography, CT Perfusion, Ischemic Stroke, Collaterals|ct angiography, ct perfusion, ischemic stroke, collaterals
231502|NCT02184910|atrophic gastritis, pepsinogen, Helicobacter pylori|atrophic gastritis, pepsinogen, helicobacter pylori
231503|NCT02184884|off-pump coronary artery bypass surgery, clopidogrel responsiveness, ischemic outcome|off-pump coronary artery bypass surgery, clopidogrel responsiveness, ischemic outcome
231504|NCT02184871|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
231505|NCT02184871|RNAseq|rnaseq
231506|NCT02184871|risk factors|risk factors
231507|NCT02184871|asbestos|asbestos
231508|NCT02184845|single tooth implant|single tooth implant
231509|NCT02184845|supported restoration(s)|supported restoration(s)
231510|NCT02184845|maxillary lateral incisor|maxillary lateral incisor
231511|NCT02184845|mandibular central incisor|mandibular central incisor
231512|NCT02184845|lateral incisor|lateral incisor
231513|NCT02184845|areas of the mouth|areas of the mouth
231514|NCT02184819|coronary artery bypass graft|coronary artery bypass graft
231515|NCT02184819|left ventricular dysfunction|left ventricular dysfunction
231516|NCT02184819|low cardiac output syndrome|low cardiac output syndrome
231517|NCT02184819|levosimendan|levosimendan
231518|NCT02184819|mortality|mortality
231519|NCT02184819|inotropic agents|inotropic agents
231520|NCT02184819|cardiac mechanical assist devices|cardiac mechanical assist devices
231521|NCT02184819|renal replacement therapy|renal replacement therapy
231522|NCT02184819|mechanical ventilation duration|mechanical ventilation duration
231523|NCT02184819|ICU stay|icu stay
231524|NCT02184806|Ovarian tissue transplantation|ovarian tissue transplantation
231525|NCT02184806|Cryopreserved ovarian tissue|cryopreserved ovarian tissue
231526|NCT02184793|mechanical ventilation|mechanical ventilation
231527|NCT02184793|semirecumbent position|semirecumbent position
231528|NCT02184793|electronic monitoring device|electronic monitoring device
231529|NCT02184780|Neurodevelopment|neurodevelopment
231530|NCT02184780|General Anaesthesia|general anaesthesia
231531|NCT02184780|Infants|infants
231532|NCT02184780|Epidural|epidural
231533|NCT02184780|Spinal|spinal
231534|NCT02184780|Anxiety and depression|anxiety and depression
231535|NCT02184754|Magnetic endoscope imaging|magnetic endoscope imaging
231536|NCT02184754|single-balloon-enteroscopy|single-balloon-enteroscopy
231537|NCT02184741|IVIG|ivig
231538|NCT02184741|Unexplained Recurrent miscarriage|unexplained recurrent miscarriage
231539|NCT02184741|Recurrent abortion|recurrent abortion
231540|NCT02184741|Intravenous immunoglobulin|intravenous immunoglobulin
231541|NCT02184728|end-tidal CO2|end-tidal co2
231542|NCT02184728|capnometer|capnometer
231647|NCT02184377|quantitative laryngeal electromyography|quantitative laryngeal electromyography
231543|NCT02184715|virtual reality system, children, developmental delay|virtual reality system, children, developmental delay
231544|NCT02184676|Type 1 diabetes|type 1 diabetes
231545|NCT02184676|risk assessment|risk assessment
231546|NCT02184676|immunological marker|immunological marker
231547|NCT02184676|children|children
231548|NCT02184676|relatives|relatives
231549|NCT02184676|autoantibodies|autoantibodies
231550|NCT02184676|lymphocytes|lymphocytes
231551|NCT02184676|T cells|t cells
231552|NCT02184676|epitopes|epitopes
231553|NCT02184676|Children born to mother/father with type 1 diabetes and their parents|children born to mother/father with type 1 diabetes and their parents
231554|NCT02184663|Unresectable|unresectable
231555|NCT02184663|Pancreatic cancer|pancreatic cancer
231556|NCT02184663|GERCOR|gercor
231557|NCT02184663|Adapted physical activity (APA)|adapted physical activity (apa)
231558|NCT02184663|Quality of life|quality of life
231559|NCT02184663|Fatigue|fatigue
231560|NCT02184650|Premature infants|premature infants
231561|NCT02184650|Nutritional status|nutritional status
231562|NCT02184650|Polyunsaturated fatty acids status|polyunsaturated fatty acids status
231563|NCT02184637|Malaria|malaria
231564|NCT02184637|Artemisinin-based Combination Therapies (ACT)|artemisinin-based combination therapies (act)
231565|NCT02184624|BREEZHALER|breezhaler
231566|NCT02184624|DISKUS/ACCUHALER|diskus/accuhaler
231567|NCT02184624|MDI|mdi
231568|NCT02184624|Inhaler preference|inhaler preference
231569|NCT02184624|Overall inhaler error|overall inhaler error
231570|NCT02184624|HANDIHALER|handihaler
231571|NCT02184624|Ease of use|ease of use
231572|NCT02184624|TURBUHALER|turbuhaler
231573|NCT02184624|ELLIPTA|ellipta
231574|NCT02184624|Critical inhaler error|critical inhaler error
231575|NCT02184611|lung function|lung function
231576|NCT02184611|Umeclidinium|umeclidinium
231577|NCT02184611|GSK573719|gsk573719
231578|NCT02184611|anticholinergic|anticholinergic
231579|NCT02184611|novel dry powder inhaler|novel dry powder inhaler
231580|NCT02184611|long-acting muscarinic receptor antagonist|long-acting muscarinic receptor antagonist
231581|NCT02184611|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
231582|NCT02184598|ADHD|adhd
231583|NCT02184598|Cognitive training|cognitive training
231584|NCT02184598|fMRI|fmri
231585|NCT02184598|Cognitive function|cognitive function
231586|NCT02184585|bioavailability|bioavailability
231587|NCT02184585|crossover design|crossover design
231588|NCT02184585|healthy male volunteers|healthy male volunteers
231589|NCT02184585|tamsulosin hydrochloride|tamsulosin hydrochloride
231590|NCT02184585|Dutasteride|dutasteride
231591|NCT02184572|Rubella|rubella
231592|NCT02184572|Healthy children|healthy children
231593|NCT02184572|Measles|measles
231594|NCT02184572|Safety|safety
231595|NCT02184572|Mumps|mumps
231596|NCT02184572|12 to 15 months|12 to 15 months
231597|NCT02184572|Immunogenicity|immunogenicity
231598|NCT02184507|insulin resistance|insulin resistance
231599|NCT02184507|blood glucose|blood glucose
231600|NCT02184507|CABG|cabg
231601|NCT02184507|oxidative stress|oxidative stress
231602|NCT02184494|Parkinson's Disease|parkinson's disease
231603|NCT02184494|Multiple Sclerosis|multiple sclerosis
231604|NCT02184494|Fatigue|fatigue
231605|NCT02184494|Resting Energy Expenditure|resting energy expenditure
231606|NCT02184494|Whole Body Vibration|whole body vibration
231607|NCT02184494|Exercise|exercise
231608|NCT02184494|Blood Lactate|blood lactate
231609|NCT02184481|Depression|depression
231610|NCT02184481|Anxiety|anxiety
231611|NCT02184481|Working memory|working memory
231612|NCT02184481|Rumination|rumination
231613|NCT02184481|Cognitive training|cognitive training
231614|NCT02184481|Executive functioning|executive functioning
231615|NCT02184468|Cardiac Arrest|cardiac arrest
231616|NCT02184468|Out-of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
231617|NCT02184468|Firefighters|firefighters
231618|NCT02184468|Police|police
231619|NCT02184468|Defibrillators|defibrillators
231620|NCT02184468|Survival|survival
231621|NCT02184455|Diabetic|diabetic
231622|NCT02184455|Chronic Ulcer|chronic ulcer
231623|NCT02184455|Wound Healing|wound healing
231624|NCT02184455|Leg|leg
231625|NCT02184442|SAPIEN|sapien
231626|NCT02184442|TAVR|tavr
231627|NCT02184442|THV|thv
231628|NCT02184442|Aortic Stenosis|aortic stenosis
231629|NCT02184442|Heart Valve Disease|heart valve disease
231630|NCT02184442|Aortic Valve|aortic valve
231631|NCT02184442|Retroflex|retroflex
231632|NCT02184442|Ascendra|ascendra
231633|NCT02184429|First in human|first in human
231634|NCT02184429|single ascending dose study|single ascending dose study
231635|NCT02184429|multiple ascending dose study|multiple ascending dose study
231636|NCT02184429|safety and tolerability|safety and tolerability
231637|NCT02184429|pharmacokinetics|pharmacokinetics
231638|NCT02184429|food effect|food effect
231639|NCT02184429|Parkinson's Disease|parkinson's disease
231640|NCT02184416|Inlyta|inlyta
231641|NCT02184416|axitinib|axitinib
231642|NCT02184416|Sutent|sutent
231643|NCT02184416|sunitinib|sunitinib
231644|NCT02184416|renal|renal
231645|NCT02184390|Internet|internet
231648|NCT02184377|cricothyroid muscle|cricothyroid muscle
231649|NCT02184377|unilateral vocal fold paralysis|unilateral vocal fold paralysis
231650|NCT02184377|superior laryngeal nerve|superior laryngeal nerve
231651|NCT02184377|lexical tone|lexical tone
231652|NCT02184377|Mandarin|mandarin
231653|NCT02184221|Deep-brain magnetic stimulation|deep-brain magnetic stimulation
231654|NCT02184221|Brain derived neurotropic factor|brain derived neurotropic factor
231655|NCT02184221|Effectiveness|effectiveness
231656|NCT02184221|Safety|safety
231657|NCT02184208|ARDS|ards
231658|NCT02184208|ALI|ali
231659|NCT02184208|mechanical ventilation|mechanical ventilation
231660|NCT02184195|BRCA, metastatic adenocarcinoma pancreas, maintenance olaparib monotherapy, first line platinum chemotherapy, pancreatic cancer, PARP inhibitor|brca, metastatic adenocarcinoma pancreas, maintenance olaparib monotherapy, first line platinum chemotherapy, pancreatic cancer, parp inhibitor
231661|NCT02184169|hemodynamics|hemodynamics
231662|NCT02184169|neonatal|neonatal
231663|NCT02184169|cardiac disease|cardiac disease
231664|NCT02184169|congenital heart disease|congenital heart disease
231665|NCT02184169|volumetric oxygen consumption|volumetric oxygen consumption
231666|NCT02184117|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
231667|NCT02184117|Adenosine|adenosine
231668|NCT02184117|Contrast Media|contrast media
231669|NCT02184104|caffeine|caffeine
231670|NCT02184104|pharmacokinetics|pharmacokinetics
231671|NCT02184104|pharmacodynamics|pharmacodynamics
231672|NCT02184026|nightmare|nightmare
231673|NCT02184026|PTSD|ptsd
231674|NCT02184026|trauma|trauma
231675|NCT02184026|children|children
231676|NCT02184026|Children Age 8 to 13|children age 8 to 13
231677|NCT02184013|Atrial fibrillation|atrial fibrillation
231678|NCT02184013|Catheter ablation|catheter ablation
231679|NCT02184013|Delayed gadolinium enhanced MRI|delayed gadolinium enhanced mri
231680|NCT02184013|C-metahydroxyepherdrine (HED) PET scan|c-metahydroxyepherdrine (hed) pet scan
231681|NCT02184013|ECGI mapping|ecgi mapping
231682|NCT02184013|Atrial Fibrosis|atrial fibrosis
231683|NCT02184013|Atrial sympathetic denervation|atrial sympathetic denervation
231684|NCT02184000|strain elastography|strain elastography
231685|NCT02184000|hepatopathy|hepatopathy
231686|NCT02184000|liver fibrosis|liver fibrosis
231687|NCT02183987|Knowledge Translation|knowledge translation
231688|NCT02183987|Chronic Kidney Disease|chronic kidney disease
231689|NCT02183987|Dialysis|dialysis
231690|NCT02183987|Intent-to-defer|intent-to-defer
231691|NCT02183987|Early dialysis|early dialysis
231692|NCT02183987|Cluster randomized trial|cluster randomized trial
231693|NCT02183974|otitis media with effusion|otitis media with effusion
231694|NCT02183974|Laryngopharyngeal Reflux|laryngopharyngeal reflux
231695|NCT02183961|otitis media with effusion|otitis media with effusion
231696|NCT02183961|peptest|peptest
231697|NCT02183961|restech|restech
231698|NCT02183961|oropharyngeal pH monitoring|oropharyngeal ph monitoring
231699|NCT02183961|laryngopharyngeal reflux|laryngopharyngeal reflux
231700|NCT02183948|treatment|treatment
231701|NCT02183948|mask face exoressions|mask face exoressions
231702|NCT02183948|genier|genier
231703|NCT02183935|Obesity|obesity
231704|NCT02183935|Diabetes|diabetes
231705|NCT02183935|Metabolic syndrome|metabolic syndrome
231706|NCT02183935|Gut hormones|gut hormones
231707|NCT02183935|Adipokines|adipokines
231708|NCT02183935|Appetite|appetite
231709|NCT02183935|Adolescent|adolescent
231710|NCT02183896|Femoroacetabular impingement (FAI)|femoroacetabular impingement (fai)
231711|NCT02183896|Chondral lesions|chondral lesions
231712|NCT02183896|Hip|hip
231713|NCT02183896|Microfracture|microfracture
231714|NCT02183896|Platelet-rich plasma (PRP)|platelet-rich plasma (prp)
231715|NCT02183883|Non-small cell lung cancer|non-small cell lung cancer
231716|NCT02183883|NSCLC|nsclc
231717|NCT02183883|Afatinib|afatinib
231718|NCT02183883|Intra-tumour heterogeneity|intra-tumour heterogeneity
231719|NCT02183883|Clonal dominance|clonal dominance
231720|NCT02183883|Drug resistance|drug resistance
231721|NCT02183883|EGFR|egfr
231722|NCT02183883|HER2|her2
231723|NCT02183883|Phase 2|phase 2
231724|NCT02183870|lung cancer|lung cancer
231725|NCT02183870|adenocarcinoma|adenocarcinoma
231726|NCT02183870|NSCLC|nsclc
231727|NCT02183870|ROS1|ros1
231728|NCT02183870|ROS1 translocation|ros1 translocation
231729|NCT02183870|crizotinib|crizotinib
231730|NCT02183870|phase II|phase ii
231731|NCT02183857|children|children
231732|NCT02183857|congenital heart disease|congenital heart disease
231733|NCT02183844|Medical Informatics|medical informatics
231734|NCT02183844|Patient-Centered|patient-centered
231735|NCT02183844|Healthcare Preferences|healthcare preferences
231736|NCT02183844|Health Education|health education
231737|NCT02183844|Quality Improvement|quality improvement
231738|NCT02183844|Weight Loss|weight loss
231739|NCT02183844|Personal Satisfaction|personal satisfaction
231740|NCT02183844|Humans|humans
231741|NCT02183844|Cognition|cognition
231742|NCT02183844|Body Weight|body weight
231743|NCT02183818|Smoking|smoking
231744|NCT02183818|COPD|copd
231745|NCT02183818|Non-Smokers|non-smokers
231746|NCT02183818|Smokers|smokers
231747|NCT02183805|triple negative breast cancer|triple negative breast cancer
231748|NCT02183805|autologous hematopoietic stem-cell transplantation|autologous hematopoietic stem-cell transplantation
231749|NCT02183779|post-occlusive hyperaemia|post-occlusive hyperaemia
231750|NCT02183779|laser-speckle contrast imaging|laser-speckle contrast imaging
231751|NCT02183779|epoxyeicosatrienoic acid|epoxyeicosatrienoic acid
231752|NCT02183779|nitrous oxide|nitrous oxide
231753|NCT02183753|LAIV|laiv
231754|NCT02183753|Flumist|flumist
231755|NCT02183753|wood smoke|wood smoke
231756|NCT02183740|Education|education
231757|NCT02183740|Nurses|nurses
231758|NCT02183740|Nursing homes|nursing homes
231759|NCT02183740|Fecal incontinence|fecal incontinence
231760|NCT02183740|Cluster-randomized controlled trial|cluster-randomized controlled trial
231761|NCT02183727|ACL|acl
231762|NCT02183727|knee injury|knee injury
231763|NCT02183727|anterior cruciate ligament|anterior cruciate ligament
231764|NCT02183597|Magnetic Resonance Imaging|magnetic resonance imaging
231765|NCT02183597|Data Accuracy|data accuracy
231766|NCT02183597|Reproducibility of Results|reproducibility of results
231767|NCT02183597|Diagnosis|diagnosis
231768|NCT02183558|PCOS|pcos
231769|NCT02183558|GDM|gdm
231770|NCT02183558|OGTT|ogtt
231771|NCT02183558|Glucose metabolism|glucose metabolism
231772|NCT02183519|Cough|cough
231773|NCT02183519|Reflex|reflex
231774|NCT02183519|Voluntary|voluntary
231775|NCT02183519|Healthy older adults|healthy older adults
231776|NCT02183519|Parkinson's disease|parkinson's disease
231777|NCT02183519|Respiratory kinematics|respiratory kinematics
231778|NCT02183519|Cueing|cueing
231779|NCT02183454|intracoronary stent|intracoronary stent
231780|NCT02183454|drug eluting stent|drug eluting stent
231781|NCT02183454|sirolimus|sirolimus
231782|NCT02183454|endothelial progenitor cells|endothelial progenitor cells
231783|NCT02183272|Depression|depression
231784|NCT02183272|Suicidal Ideation|suicidal ideation
231785|NCT02183272|Ketamine|ketamine
231786|NCT02183272|Emergency Department|emergency department
231787|NCT02183207|percutaneous endoscopic gastrostomy|percutaneous endoscopic gastrostomy
231788|NCT02183207|Introducer method|introducer method
231789|NCT02182999|Hallux valgus surgery|hallux valgus surgery
231790|NCT02182999|wound infiltration|wound infiltration
231791|NCT02182999|pain|pain
231792|NCT02182986|Biomarkers|biomarkers
231793|NCT02182986|Post-Transplant Lymphoproliferative Disorders (PTLDs)|post-transplant lymphoproliferative disorders (ptlds)
231794|NCT02182973|neonatal abstinence syndrome, infant opiate withdrawal|neonatal abstinence syndrome, infant opiate withdrawal
231795|NCT02182947|Pediatric|pediatric
231796|NCT02182947|Inflammatory Bowel Disease|inflammatory bowel disease
231797|NCT02182947|capsule endoscopy|capsule endoscopy
231798|NCT02182947|MRI|mri
231799|NCT02182947|Crohn's Disease|crohn's disease
231800|NCT02182947|Indeterminant Colitis|indeterminant colitis
231801|NCT02182947|Small bowel Crohn's Disease|small bowel crohn's disease
231802|NCT02182908|Aneurysm of abdominal aorta|aneurysm of abdominal aorta
231803|NCT02182908|18F-fluorodesoxyglucose (FDG-F18)|18f-fluorodesoxyglucose (fdg-f18)
231804|NCT02182843|Cellentra ACDF|cellentra acdf
231805|NCT02182817|General Anaesthesia|general anaesthesia
231806|NCT02182817|Neurocognitive Development|neurocognitive development
231807|NCT02182817|Behaviour|behaviour
231808|NCT02182804|Confocal Laser Endomicroscopy|confocal laser endomicroscopy
231809|NCT02182804|Narrow Band Imaging|narrow band imaging
231810|NCT02182804|Lugol Chromoendoscopy|lugol chromoendoscopy
231811|NCT02182804|Esophageal Neoplasm|esophageal neoplasm
231812|NCT02182804|Head and Neck Cancer|head and neck cancer
231813|NCT02182687|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
231814|NCT02182687|Orthotopic liver transplant|orthotopic liver transplant
231815|NCT02182687|Bridge to transplant|bridge to transplant
231816|NCT02182687|stereotactic body radiation therapy (SBRT)|stereotactic body radiation therapy (sbrt)
231817|NCT02182687|trans-arterial chemoembolization (TACE)|trans-arterial chemoembolization (tace)
231818|NCT02182596|Acute Myeloid Leukemia|acute myeloid leukemia
231819|NCT02182596|First relapsing AML|first relapsing aml
231820|NCT02182466|Colon capsule endoscopy|colon capsule endoscopy
231821|NCT02182466|Colonoscopy|colonoscopy
231822|NCT02182466|Screening colonoscopy|screening colonoscopy
231823|NCT02182440|SA-AKI|sa-aki
231824|NCT02182440|Sepsis|sepsis
231825|NCT02182440|AKI|aki
231826|NCT02182440|Recombinant Alkaline Phosphatase|recombinant alkaline phosphatase
231827|NCT02182440|recAP|recap
231828|NCT02182167|Drug Induced Hepatitis (DIH)|drug induced hepatitis (dih)
231829|NCT02182167|Toxic Liver|toxic liver
231830|NCT02182167|Drug Induced Liver Injury (DILI)|drug induced liver injury (dili)
231831|NCT02182115|Staphylococcus aureus infection|staphylococcus aureus infection
231832|NCT02182115|Decolonization|decolonization
231833|NCT02182115|Surgical site infection|surgical site infection
231834|NCT02181894|Infant|infant
231835|NCT02181894|Newborn|newborn
231836|NCT02181894|Neonate|neonate
231837|NCT02181894|Intubation|intubation
231838|NCT02181894|Neonatal resuscitation|neonatal resuscitation
231839|NCT02181842|Pharmacological therapy|pharmacological therapy
231840|NCT02181829|Whole Lung IMRT|whole lung imrt
231841|NCT02181829|14-075|14-075
232355|NCT02179801|AAA|aaa
231842|NCT02181816|Pharmacological therapy|pharmacological therapy
231843|NCT02181790|psoriasis|psoriasis
231844|NCT02181790|palmoplantar|palmoplantar
231845|NCT02181790|acitretin|acitretin
231846|NCT02181790|retinoids|retinoids
231847|NCT02181790|laser treatment|laser treatment
231848|NCT02181777|Psychosis|psychosis
231849|NCT02181777|Schizophrenia|schizophrenia
231850|NCT02181777|Social Skills|social skills
231851|NCT02181777|Therapy|therapy
231852|NCT02181764|XLH|xlh
231853|NCT02181751|Child Sexual Abuse|child sexual abuse
231854|NCT02181751|CSA|csa
231855|NCT02181751|Treatment|treatment
231856|NCT02181751|Prevention|prevention
231857|NCT02181751|PTSD|ptsd
231858|NCT02181751|Post Traumatic Stress Disorder|post traumatic stress disorder
231859|NCT02181751|Depression|depression
231860|NCT02181751|Anxiety|anxiety
231861|NCT02181751|Quality of Life|quality of life
231862|NCT02181751|Attachment|attachment
231863|NCT02181751|Cognitive Behavioural Therapy|cognitive behavioural therapy
231864|NCT02181751|Group Therapy|group therapy
231865|NCT02181725|Chronic Pain|chronic pain
231866|NCT02181725|Adolescent|adolescent
231867|NCT02181725|Graded Exposure|graded exposure
231868|NCT02181712|Bronchiolitis obliterans|bronchiolitis obliterans
231869|NCT02181712|lung transplant|lung transplant
231870|NCT02181712|mesenchymal stem cell|mesenchymal stem cell
231871|NCT02181712|cell therapy|cell therapy
231872|NCT02181686|Heart Failure|heart failure
231873|NCT02181686|Iperia ICD family|iperia icd family
231874|NCT02181686|Sentus QP left ventricular lead|sentus qp left ventricular lead
231875|NCT02181686|Quadripolar CRT-D system|quadripolar crt-d system
231876|NCT02181673|Psoriatic arthritis|psoriatic arthritis
231877|NCT02181673|Golimumab|golimumab
231878|NCT02181673|Simponi|simponi
231879|NCT02181660|AML|aml
231880|NCT02181660|Acute myeloid leukemia|acute myeloid leukemia
231881|NCT02181660|Gilteritinib|gilteritinib
231882|NCT02181660|ASP2215|asp2215
231883|NCT02181634|Advanced Cholangiocarcinoma|advanced cholangiocarcinoma
231884|NCT02181634|Metastatic Cholangiocarcinoma|metastatic cholangiocarcinoma
231885|NCT02181634|CCA|cca
231886|NCT02181634|Bile Duct Cancer|bile duct cancer
231887|NCT02181634|Nab-Paclitaxel|nab-paclitaxel
231888|NCT02181634|Abraxane®|abraxane®
231889|NCT02181634|Gemcitabine|gemcitabine
231890|NCT02181634|Gemzar®|gemzar®
231891|NCT02181608|Alcohol Dependence|alcohol dependence
231892|NCT02181608|Fear Conditioning|fear conditioning
231893|NCT02181608|Stress|stress
231894|NCT02181608|Alcohol|alcohol
231895|NCT02181595|Reading|reading
231896|NCT02181595|FACIT-SP|facit-sp
231897|NCT02181595|Primary Ovarian Insufficiency|primary ovarian insufficiency
231898|NCT02181582|Health Humans|health humans
231899|NCT02181582|Receptor Occupancy|receptor occupancy
231900|NCT02181569|Addiction Severity Index|addiction severity index
231901|NCT02181569|Addiction|addiction
231902|NCT02181569|Sleep Measures|sleep measures
231903|NCT02181569|Sleep Disorders|sleep disorders
231904|NCT02181556|colorectal cancer|colorectal cancer
231905|NCT02181556|Metastatic|metastatic
231906|NCT02181543|Clonidine|clonidine
231907|NCT02181543|Psychomotor agitation|psychomotor agitation
231908|NCT02181543|Anesthesia recovery period|anesthesia recovery period
231909|NCT02181543|Tonsillectomy|tonsillectomy
231910|NCT02181543|Child, preschool|child, preschool
231911|NCT02181478|Total Body Irradiation|total body irradiation
231912|NCT02181478|Human Mesenchymal Stromal Cells|human mesenchymal stromal cells
231913|NCT02181478|hMSC|hmsc
231914|NCT02181478|Cyclophosphamide|cyclophosphamide
231915|NCT02181478|Fludarabine|fludarabine
231916|NCT02181478|Dimethyl Sulfoxide|dimethyl sulfoxide
231917|NCT02181478|DMSO|dmso
231918|NCT02181478|Cyclosporine|cyclosporine
231919|NCT02181478|Mycophenolate Mofetil|mycophenolate mofetil
231920|NCT02181478|MMF|mmf
231921|NCT02181478|Granulocyte- Colony Stimulating Factor|granulocyte- colony stimulating factor
231922|NCT02181478|G-CSF|g-csf
231923|NCT02181478|GVHD|gvhd
231924|NCT02181478|Cancer|cancer
231925|NCT02181478|feasibility|feasibility
231926|NCT02181452|liver|liver
231927|NCT02181452|fibrosis|fibrosis
231928|NCT02181452|ShearWave Elastography|shearwave elastography
231929|NCT02181452|ultrasound|ultrasound
231930|NCT02181426|Knee Arthroscopy|knee arthroscopy
231931|NCT02181413|Drug therapy|drug therapy
231932|NCT02181413|TOURMALINE|tourmaline
231933|NCT02181413|ixazomib|ixazomib
231934|NCT02181400|diabetic retinopathy|diabetic retinopathy
231935|NCT02181400|diabetic macular edema|diabetic macular edema
231936|NCT02181400|diabetic macular oedema|diabetic macular oedema
231937|NCT02181400|near infrared light therapy|near infrared light therapy
231938|NCT02181387|labor pain|labor pain
231939|NCT02181387|acetaminophen|acetaminophen
231940|NCT02181374|atrial fibrillation|atrial fibrillation
231941|NCT02181374|NT-proBNP|nt-probnp
231942|NCT02181374|Cardioembolic Stroke|cardioembolic stroke
231943|NCT02181361|atrial fibrillation|atrial fibrillation
231944|NCT02181361|cardioembolic stroke|cardioembolic stroke
231945|NCT02181361|Hirudin|hirudin
231946|NCT02181361|aspirin|aspirin
231947|NCT02181361|warfarin|warfarin
231948|NCT02181348|Vitamin E, Hemoglobin, mild anemia|vitamin e, hemoglobin, mild anemia
231949|NCT02181296|Shoulder arthroscopy|shoulder arthroscopy
231950|NCT02181296|Interscalene block|interscalene block
231951|NCT02181296|Drug concentration|drug concentration
231952|NCT02181296|0.1% ropivacaine or 0.2% ropivacaine|0.1% ropivacaine or 0.2% ropivacaine
231953|NCT02181283|alcohol|alcohol
231954|NCT02181283|prescribed drugs|prescribed drugs
231955|NCT02181283|National Guard|national guard
231956|NCT02181270|NAFLD|nafld
231957|NCT02181270|obesity|obesity
231958|NCT02181270|ck18|ck18
231959|NCT02181270|blood lipids|blood lipids
231960|NCT02181270|high intensity exercise training|high intensity exercise training
231961|NCT02181270|individuals|individuals
231962|NCT02181270|>5% liver fat|>5% liver fat
231963|NCT02181257|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
231964|NCT02181257|Lung Transplantation|lung transplantation
231965|NCT02181257|Extracorporeal Photopheresis|extracorporeal photopheresis
231966|NCT02181257|Methoxsalen|methoxsalen
231967|NCT02181244|egg|egg
231968|NCT02181244|oatmeal|oatmeal
231969|NCT02181244|atherogenic dyslipidemia|atherogenic dyslipidemia
231970|NCT02181244|glycosylated hemoglobin|glycosylated hemoglobin
231971|NCT02181244|inflammatory markers|inflammatory markers
231972|NCT02181231|depression|depression
231973|NCT02181231|older adult|older adult
231974|NCT02181231|buprenorphine|buprenorphine
231975|NCT02181231|Effexor XR|effexor xr
231976|NCT02181231|treatment resistant|treatment resistant
231977|NCT02181231|venlafaxine|venlafaxine
231978|NCT02181231|Saint Louis|saint louis
231979|NCT02181231|late life|late life
231980|NCT02181231|major depression|major depression
231981|NCT02181192|biochemical recurrence|biochemical recurrence
231982|NCT02181192|prostate carcinoma|prostate carcinoma
231983|NCT02181192|prostate cancer|prostate cancer
231984|NCT02181192|PSA|psa
231985|NCT02181192|postoperative|postoperative
231986|NCT02181192|radiotherapy|radiotherapy
231987|NCT02181192|imaging diagnostic|imaging diagnostic
231988|NCT02181192|PET/CT|pet/ct
231989|NCT02181192|social economic aspects|social economic aspects
231990|NCT02181192|quality of life|quality of life
231991|NCT02181179|yoga|yoga
231992|NCT02181179|exercise intervention|exercise intervention
231993|NCT02181179|smoking|smoking
231994|NCT02181179|stress|stress
231995|NCT02181179|mind-body|mind-body
231996|NCT02181179|intervention|intervention
231997|NCT02181166|Breast Neoplasms|breast neoplasms
231998|NCT02181166|Mastectomy|mastectomy
231999|NCT02181166|Myofascial pain syndromes|myofascial pain syndromes
232000|NCT02181166|Physical Therapy Modalities|physical therapy modalities
232128|NCT02180906|Bacterial Infections|bacterial infections
232001|NCT02181153|inflammatory bowel disease|inflammatory bowel disease
232002|NCT02181153|siblings|siblings
232003|NCT02181140|fine needle aspiration|fine needle aspiration
232004|NCT02181140|core biopsy|core biopsy
232005|NCT02181140|endoscopic ultrasound|endoscopic ultrasound
232006|NCT02181140|space occupying process mediastinal, perigastral, perihilar|space occupying process mediastinal, perigastral, perihilar
232007|NCT02181140|suspect lymph nodes mediastinal, perigastral or perihilar|suspect lymph nodes mediastinal, perigastral or perihilar
232008|NCT02181140|diagnostic accuracy of EUS guided core biopsy|diagnostic accuracy of eus guided core biopsy
232009|NCT02181127|bionic pancreas|bionic pancreas
232010|NCT02181127|artificial pancreas|artificial pancreas
232011|NCT02181127|insulin|insulin
232012|NCT02181127|glucagon|glucagon
232013|NCT02181127|continuous glucose monitoring (CGM)|continuous glucose monitoring (cgm)
232014|NCT02181127|outpatient|outpatient
232015|NCT02181127|insulin pump|insulin pump
232016|NCT02181127|glucagon pump|glucagon pump
232017|NCT02181114|Coaching|coaching
232018|NCT02181114|Educational Materials|educational materials
232019|NCT02181114|Expert System|expert system
232020|NCT02181114|Living Donor Kidney Transplant|living donor kidney transplant
232021|NCT02181088|Malaria|malaria
232022|NCT02181088|Plasmodium falciparum|plasmodium falciparum
232023|NCT02181088|RH5|rh5
232024|NCT02181075|ThermoDox|thermodox
232025|NCT02181075|High Intensity Focused Ultrasound|high intensity focused ultrasound
232026|NCT02181075|Lyso thermosensitive Liposomal|lyso thermosensitive liposomal
232027|NCT02181075|Non invasive drug delivery|non invasive drug delivery
232028|NCT02181075|Hepatic metastatic disease|hepatic metastatic disease
232029|NCT02181075|Liver tumour(s)|liver tumour(s)
232030|NCT02181075|Targeted Release of Chemotherapy|targeted release of chemotherapy
232031|NCT02181062|Stroke|stroke
232032|NCT02181062|Stroke prevention|stroke prevention
232033|NCT02181062|older adults|older adults
232034|NCT02181062|self efficacy|self efficacy
232035|NCT02181062|walking|walking
232036|NCT02181062|minorities|minorities
232037|NCT02181062|minority older adults|minority older adults
232038|NCT02181062|hypertension|hypertension
232039|NCT02181062|high blood pressure|high blood pressure
232040|NCT02181062|elderly|elderly
232041|NCT02181062|sedentary lifestyle|sedentary lifestyle
232042|NCT02181049|Childhood cancer survivors|childhood cancer survivors
232043|NCT02181049|Cardiac|cardiac
232044|NCT02181049|Vascular|vascular
232045|NCT02181049|Cardiovascular|cardiovascular
232046|NCT02181049|Late-sequelae|late-sequelae
232047|NCT02181036|Family work shop|family work shop
232048|NCT02181036|speech developmental delays|speech developmental delays
232049|NCT02181036|children|children
232050|NCT02181023|COPD|copd
232051|NCT02181023|Hyperinflation|hyperinflation
232052|NCT02181023|Aclidinium|aclidinium
232053|NCT02181023|Glycopyrronium|glycopyrronium
232054|NCT02181023|Volume distribution|volume distribution
232055|NCT02181023|Anticholinergic|anticholinergic
232056|NCT02181023|Pharmacokinetics|pharmacokinetics
232057|NCT02181023|Single Breath Nitrogen Test|single breath nitrogen test
232058|NCT02181023|Phase III|phase iii
232059|NCT02181010|African American|african american
232060|NCT02181010|Adolescents|adolescents
232061|NCT02181010|Urban|urban
232062|NCT02181010|Food Desert|food desert
232063|NCT02181010|Food Insecurity|food insecurity
232064|NCT02181010|Obesity|obesity
232065|NCT02181010|Baltimore City|baltimore city
232066|NCT02181010|Peer mentors|peer mentors
232067|NCT02181010|Multi level|multi level
232068|NCT02181010|Policy|policy
232069|NCT02181010|Caregivers|caregivers
232070|NCT02181010|Systems|systems
232071|NCT02181010|Agent Based Model|agent based model
232072|NCT02181010|Systems Dynamic Model|systems dynamic model
232073|NCT02181010|Corner Store|corner store
232074|NCT02181010|Carryout|carryout
232075|NCT02181010|Recreation Center|recreation center
232076|NCT02181010|Text Messaging|text messaging
232077|NCT02181010|Social Media|social media
232078|NCT02181010|Mapping|mapping
232079|NCT02180997|α1-blockers|α1-blockers
232080|NCT02180997|antimuscarinic agent|antimuscarinic agent
232081|NCT02180984|Binge Eating|binge eating
232082|NCT02180984|Obesity|obesity
232083|NCT02180984|TMS|tms
232084|NCT02180984|Neuroimage|neuroimage
232085|NCT02180984|Neuromodulation|neuromodulation
232086|NCT02180984|Biomarkers|biomarkers
232087|NCT02180984|Eating Disorders|eating disorders
232088|NCT02180984|Cognition|cognition
232089|NCT02180984|Endocrine|endocrine
232090|NCT02180984|Hormones|hormones
232091|NCT02180984|BDNF|bdnf
232092|NCT02180984|Inflammatory biomarkers|inflammatory biomarkers
232093|NCT02180971|Multi-detector computed tomography angiography|multi-detector computed tomography angiography
232094|NCT02180971|Coronary vessel distensibility|coronary vessel distensibility
232095|NCT02180971|Coronary spasm|coronary spasm
232096|NCT02180958|cerebral arteriovenous malformations|cerebral arteriovenous malformations
232097|NCT02180958|cAVM|cavm
232098|NCT02180958|ONYX|onyx
232099|NCT02180945|dAVF|davf
232100|NCT02180945|Arteriovenous fistula|arteriovenous fistula
232101|NCT02180945|ONYX|onyx
232102|NCT02180919|Telemonitoring|telemonitoring
232103|NCT02180919|COPD|copd
232104|NCT02180919|Heart failure|heart failure
232105|NCT02180919|Exacerbation|exacerbation
232106|NCT02180919|Respiratory failure|respiratory failure
232107|NCT02180919|Prevention|prevention
232108|NCT02180919|Self monitoring|self monitoring
232109|NCT02180906|Fasciitis|fasciitis
232110|NCT02180906|Gangrene|gangrene
232111|NCT02180906|Fasciitis, Necrotizing|fasciitis, necrotizing
232112|NCT02180906|Soft Tissue Infections|soft tissue infections
232113|NCT02180906|Fournier's Gangrene|fournier's gangrene
232114|NCT02180906|Streptococcal septic shock syndrome|streptococcal septic shock syndrome
232115|NCT02180906|Flesh eating bacteria|flesh eating bacteria
232116|NCT02180906|Meleneys ulcer|meleneys ulcer
232117|NCT02180906|Wounds and Injuries|wounds and injuries
232118|NCT02180906|Streptococcus pyogenes|streptococcus pyogenes
232119|NCT02180906|Staphylococcus aureus|staphylococcus aureus
232120|NCT02180906|Immunopathogenesis|immunopathogenesis
232121|NCT02180906|Soft Tissue Infections/blood|soft tissue infections/blood
232122|NCT02180906|Necrosis/blood|necrosis/blood
232123|NCT02180906|Necrosis/diagnosis|necrosis/diagnosis
232124|NCT02180906|Necrosis/mortality|necrosis/mortality
232125|NCT02180906|Necrosis/surgery|necrosis/surgery
232126|NCT02180906|Prognosis|prognosis
232127|NCT02180906|Risk Factors|risk factors
232129|NCT02180906|Infection|infection
232130|NCT02180906|Skin Diseases, Bacterial|skin diseases, bacterial
232131|NCT02180906|Observational study|observational study
232132|NCT02180906|Biological markers|biological markers
232133|NCT02180880|Neuralgia|neuralgia
232134|NCT02180880|Spinal cord|spinal cord
232135|NCT02180880|Oxcarbazepine|oxcarbazepine
232136|NCT02180880|Pregabalin|pregabalin
232137|NCT02180880|Drug therapy|drug therapy
232138|NCT02180880|Algorithms|algorithms
232139|NCT02180854|Early warning score|early warning score
232140|NCT02180854|Rapid response systems|rapid response systems
232141|NCT02180854|Medical emergency team|medical emergency team
232142|NCT02180841|soy|soy
232143|NCT02180841|hypertension|hypertension
232144|NCT02180841|HDL-C|hdl-c
232145|NCT02180841|cholesterol efflux|cholesterol efflux
232146|NCT02180841|cardiovascular disease|cardiovascular disease
232147|NCT02180815|Obstructive Sleep Apnea|obstructive sleep apnea
232148|NCT02180815|Obstructive Sleep Apnea due to primary tongue base closure|obstructive sleep apnea due to primary tongue base closure
232149|NCT02180815|Minimally invasive surgery|minimally invasive surgery
232150|NCT02180815|ReVENT Sleep Apnea System|revent sleep apnea system
232151|NCT02180815|Tongue implants|tongue implants
232152|NCT02180802|obese adolescents|obese adolescents
232153|NCT02180802|BMI ≥ 95th percentile for age and gender|bmi ≥ 95th percentile for age and gender
232154|NCT02180789|tamsulosin,|tamsulosin,
232155|NCT02180789|benign prostatic hyperplasia,|benign prostatic hyperplasia,
232156|NCT02180789|α1-adrenoceptor antagonists|α1-adrenoceptor antagonists
232157|NCT02180763|Primary Immunodeficiency, PID|primary immunodeficiency, pid
232158|NCT02180750|Children|children
232159|NCT02180750|HIV|hiv
232160|NCT02180750|orphans|orphans
232161|NCT02180737|dexmedetomedine|dexmedetomedine
232162|NCT02180737|sedation|sedation
232163|NCT02180737|interventional radiology|interventional radiology
232164|NCT02180724|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
232165|NCT02180724|Btk|btk
232166|NCT02180724|Waldenström Macroglobulinemia|waldenström macroglobulinemia
232167|NCT02180724|WM|wm
232168|NCT02180724|Waldenström|waldenström
232169|NCT02180724|Macroglobulinemia|macroglobulinemia
232170|NCT02180711|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
232171|NCT02180711|Btk|btk
232172|NCT02180711|Follicular Lymphoma|follicular lymphoma
232173|NCT02180711|FL|fl
232174|NCT02180711|acalabrutinib|acalabrutinib
232175|NCT02180711|ACP-196|acp-196
232176|NCT02180711|MZL|mzl
232177|NCT02180711|Marginal Zone Lymphoma|marginal zone lymphoma
232178|NCT02180672|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
232179|NCT02180672|OSA|osa
232180|NCT02180672|sleep apnea|sleep apnea
232181|NCT02180672|nasal steroids|nasal steroids
232182|NCT02180672|corticosteroids|corticosteroids
232183|NCT02180646|GLP-1|glp-1
232184|NCT02180646|GIP|gip
232185|NCT02180646|second meal phenomena|second meal phenomena
232186|NCT02180646|type 2 diabetes|type 2 diabetes
232187|NCT02180633|Idiopathic Macular Hole|idiopathic macular hole
232188|NCT02180620|GIP|gip
232189|NCT02180620|GLP-1|glp-1
232190|NCT02180620|exercise timing|exercise timing
232191|NCT02180620|resistance exercise|resistance exercise
232192|NCT02180620|glucose concentrations|glucose concentrations
232193|NCT02180607|depression|depression
232194|NCT02180607|social|social
232195|NCT02180607|rejection|rejection
232196|NCT02180607|acceptance|acceptance
232197|NCT02180607|fMRI|fmri
232198|NCT02180607|reward|reward
232199|NCT02180607|exclusion|exclusion
232200|NCT02180581|Infections|infections
232201|NCT02180581|Allergy|allergy
232202|NCT02180581|Immune function|immune function
232203|NCT02180581|Microbiota|microbiota
232204|NCT02180581|Infant|infant
232205|NCT02180568|Ground-glass-opacity (GGO)|ground-glass-opacity (ggo)
232206|NCT02180568|Lung localization|lung localization
232207|NCT02180568|Lipiodol|lipiodol
232208|NCT02180568|Hook wire|hook wire
232209|NCT02180568|Video assisted thoracic surgery (VATS)|video assisted thoracic surgery (vats)
232210|NCT02180542|stroke|stroke
232211|NCT02180542|Ischemic stroke|ischemic stroke
232212|NCT02180542|Cerebral infarction|cerebral infarction
232213|NCT02180542|recurrent stroke|recurrent stroke
232214|NCT02180542|atrial fibrillation|atrial fibrillation
232215|NCT02180542|premature atrial complexes|premature atrial complexes
232216|NCT02180542|heart rhythm monitoring|heart rhythm monitoring
232217|NCT02180542|left atrial function|left atrial function
232218|NCT02180542|carotid artery|carotid artery
232219|NCT02180542|plaque morphology|plaque morphology
232220|NCT02180529|methylphenidate, elderly, mild cognitive impairment|methylphenidate, elderly, mild cognitive impairment
232221|NCT02180464|psoriasis, topical|psoriasis, topical
232222|NCT02180438|HIV-2|hiv-2
232223|NCT02180425|acne|acne
232224|NCT02180425|lipid|lipid
232225|NCT02180425|tretinoin|tretinoin
232226|NCT02180425|isotretinoin|isotretinoin
232227|NCT02180412|Acute porphyria|acute porphyria
232228|NCT02180412|Hemin|hemin
232229|NCT02180399|Sepsis|sepsis
232230|NCT02180399|Capillary blood lactate|capillary blood lactate
232231|NCT02180399|Serial measurement of capillary|serial measurement of capillary
232232|NCT02180386|Audiovisual distraction|audiovisual distraction
232233|NCT02180386|Pediatric dentistry|pediatric dentistry
232234|NCT02180360|Capoeira training|capoeira training
232235|NCT02180360|Range of motion|range of motion
232236|NCT02180360|Flexibility|flexibility
232237|NCT02180360|beginners|beginners
232238|NCT02180347|Pediatrics|pediatrics
232239|NCT02180347|Contact lenses|contact lenses
232240|NCT02180334|Gastric Emptying|gastric emptying
232241|NCT02180334|Gastrointestinal Motility|gastrointestinal motility
232242|NCT02180334|Incretins|incretins
232243|NCT02180334|Glucagon-Like Peptide 1|glucagon-like peptide 1
232244|NCT02180334|Diabetes Mellitus|diabetes mellitus
232245|NCT02180321|Tranexamic acid|tranexamic acid
232246|NCT02180321|pharmacokinetics|pharmacokinetics
232247|NCT02180321|craniosynostosis|craniosynostosis
232248|NCT02180308|Head cancer|head cancer
232249|NCT02180308|Neck cancer|neck cancer
232250|NCT02180308|MRI|mri
232251|NCT02180308|PET|pet
232252|NCT02180282|Acne Treatment|acne treatment
232253|NCT02180269|Healthy|healthy
232254|NCT02180269|JNJ-54861911|jnj-54861911
232255|NCT02180269|Alzheimer's disease|alzheimer's disease
232256|NCT02180256|IVF|ivf
232257|NCT02180256|ICSI|icsi
232258|NCT02180256|Embryo transfer|embryo transfer
232259|NCT02180256|Assisted reproduction|assisted reproduction
232260|NCT02180256|Endometrial injury|endometrial injury
232261|NCT02180256|Endometrial scratching|endometrial scratching
232262|NCT02180243|meditation|meditation
232263|NCT02180243|acupuncture|acupuncture
232264|NCT02180243|Gulf War Veterans' Illness|gulf war veterans' illness
232265|NCT02180243|Gulf War health education|gulf war health education
232266|NCT02180243|iRest yoga|irest yoga
232267|NCT02180230|Short implants|short implants
232268|NCT02180230|prospective multicenter study|prospective multicenter study
232269|NCT02180230|maxilla & mandible|maxilla & mandible
232270|NCT02180217|LCI699|lci699
232271|NCT02180217|Cushing's disease|cushing's disease
232272|NCT02180204|Cerebral Infarction|cerebral infarction
232273|NCT02180204|Ischemic Stroke|ischemic stroke
232274|NCT02180204|Thrombolysis|thrombolysis
232275|NCT02180191|Gut microbiota|gut microbiota
232276|NCT02180178|microvascular disease|microvascular disease
232277|NCT02180178|coronary artery disease|coronary artery disease
232278|NCT02180178|Coronary artery disease, with or without microvascular dysfuntion|coronary artery disease, with or without microvascular dysfuntion
232279|NCT02180152|Perinatal outcomes|perinatal outcomes
232280|NCT02180113|Cirrhotic patients|cirrhotic patients
232281|NCT02180113|Fibroscan|fibroscan
232282|NCT02180113|Liver Stiffness Measurement|liver stiffness measurement
232283|NCT02180113|Oesophageal Varices|oesophageal varices
232284|NCT02180113|Portal Hypertension|portal hypertension
232285|NCT02180113|Spleen Stiffness Measurement|spleen stiffness measurement
232286|NCT02180087|Cardiac surgery|cardiac surgery
232287|NCT02180087|Post-operative pain|post-operative pain
232288|NCT02180087|Kétoprofène|kétoprofène
232289|NCT02180087|Minimum analgesic dose|minimum analgesic dose
232290|NCT02180087|Morphin consumption|morphin consumption
232291|NCT02180087|Morphin secondary effects|morphin secondary effects
232292|NCT02180087|Patient comfort and satisfaction|patient comfort and satisfaction
232293|NCT02180087|Renal fonction|renal fonction
232294|NCT02180074|Hydrogen Sulfide Pools,|hydrogen sulfide pools,
232296|NCT02180061|PD-1|pd-1
232297|NCT02180061|PDL1|pdl1
232298|NCT02180061|PD-L1|pd-l1
232299|NCT02180035|diet therapy|diet therapy
232300|NCT02180035|symbiotic|symbiotic
232301|NCT02180035|dyslipidemia|dyslipidemia
232302|NCT02180035|gastrointestinal symptoms|gastrointestinal symptoms
232303|NCT02180035|body composition|body composition
232304|NCT02180035|adherence|adherence
232305|NCT02180035|HIV|hiv
232306|NCT02180035|HAART|haart
232307|NCT02180022|Quercetin|quercetin
232308|NCT02180022|Endothelial function|endothelial function
232309|NCT02180022|Onion peel extract|onion peel extract
232310|NCT02180022|volunteers|volunteers
232311|NCT02179996|Vaccination|vaccination
232312|NCT02179996|Very preterm-born infants|very preterm-born infants
232313|NCT02179996|Hib immunisation|hib immunisation
232314|NCT02179996|Pertussis immunisation|pertussis immunisation
232315|NCT02179983|Bronchiectasis|bronchiectasis
232316|NCT02179983|rehabilitation|rehabilitation
232317|NCT02179983|exercise|exercise
232318|NCT02179983|exacerbations|exacerbations
232319|NCT02179970|Advanced pancreatic cancer|advanced pancreatic cancer
232320|NCT02179970|Advanced ovarian cancer|advanced ovarian cancer
232321|NCT02179970|Advanced colorectal cancer|advanced colorectal cancer
232322|NCT02179970|Metastatic pancreatic cancer|metastatic pancreatic cancer
232323|NCT02179970|Metastatic ovarian cancer|metastatic ovarian cancer
232324|NCT02179970|Metastatic colorectal cancer|metastatic colorectal cancer
232325|NCT02179957|Stenoses|stenoses
232326|NCT02179957|Ischaemia|ischaemia
232327|NCT02179957|haemodynamics|haemodynamics
232328|NCT02179957|fractional flow reserve (FFR)|fractional flow reserve (ffr)
232329|NCT02179957|computed tomography (CT)|computed tomography (ct)
232330|NCT02179957|cardiac|cardiac
232331|NCT02179944|medication abortion|medication abortion
232332|NCT02179944|serum hCG|serum hcg
232333|NCT02179918|Advanced Solid Tumors|advanced solid tumors
232334|NCT02179905|MRI|mri
232335|NCT02179905|Heart rate variability|heart rate variability
232336|NCT02179905|Fatty acid|fatty acid
232337|NCT02179892|anesthesia|anesthesia
232338|NCT02179892|surgery|surgery
232339|NCT02179892|pain|pain
232340|NCT02179879|labor,epidural,analgesia|labor,epidural,analgesia
232341|NCT02179853|Kawasaki disease|kawasaki disease
232342|NCT02179853|Anakinra|anakinra
232343|NCT02179853|IL-1|il-1
232344|NCT02179840|Cerebral microvascular circulation|cerebral microvascular circulation
232345|NCT02179840|Cerebral autoregulation|cerebral autoregulation
232346|NCT02179814|bulimia nervosa|bulimia nervosa
232347|NCT02179814|dopamine|dopamine
232348|NCT02179814|reward|reward
232349|NCT02179814|catechol-O-methyltransferase|catechol-o-methyltransferase
232350|NCT02179814|gene|gene
232351|NCT02179814|catecholamines|catecholamines
232352|NCT02179814|alpha-methyl-para-tyrosine|alpha-methyl-para-tyrosine
232353|NCT02179814|magnetic resonance imaging|magnetic resonance imaging
232354|NCT02179801|Abdominal aortic aneurysm|abdominal aortic aneurysm
232356|NCT02179801|Screening|screening
232357|NCT02179788|lactation|lactation
232358|NCT02179788|breastfeeding|breastfeeding
232359|NCT02179788|human milk|human milk
232360|NCT02179788|insulin|insulin
232361|NCT02179788|metformin|metformin
232362|NCT02179788|prediabetes|prediabetes
232363|NCT02179788|pre-diabetes|pre-diabetes
232364|NCT02179788|insulin resistance|insulin resistance
232365|NCT02179762|cancer survivor|cancer survivor
232366|NCT02179762|prostate cancer|prostate cancer
232367|NCT02179762|exercise|exercise
232368|NCT02179762|Active surveillance|active surveillance
232369|NCT02179762|EASE|ease
232370|NCT02179749|Alcohol-Related Disorders|alcohol-related disorders
232371|NCT02179749|Substance-Related Disorders|substance-related disorders
232372|NCT02179749|Mental Disorders|mental disorders
232373|NCT02179749|Mifepristone|mifepristone
232374|NCT02179749|Glucocorticoid Antagonists|glucocorticoid antagonists
232375|NCT02179749|Alcohol Treatment|alcohol treatment
232376|NCT02179749|Alcohol|alcohol
232377|NCT02179736|Correction of moderate to severe nasolabial folds|correction of moderate to severe nasolabial folds
232378|NCT02179723|wound healing|wound healing
232379|NCT02179723|cosmetic results|cosmetic results
232380|NCT02179723|trocar incision|trocar incision
232381|NCT02179710|adherence|adherence
232382|NCT02179710|cystic fibrosis|cystic fibrosis
232383|NCT02179710|adolescents|adolescents
232384|NCT02179710|adults|adults
232385|NCT02179697|Groups:|groups:
232386|NCT02179697|Group 1 (2 Treatment Arms (Randomized between 2 treatments))|group 1 (2 treatment arms (randomized between 2 treatments))
232387|NCT02179697|Treatment 1: Surgery + Bracing|treatment 1: surgery + bracing
232388|NCT02179697|Treatment 2: Bracing Alone|treatment 2: bracing alone
232389|NCT02179697|Group 2|group 2
232390|NCT02179697|The patient will decide which group is best for themselves.|the patient will decide which group is best for themselves.
232391|NCT02179684|Cranial Nerve fascial paresis|cranial nerve fascial paresis
232392|NCT02179671|Lung cancer; NSCLC|lung cancer; nsclc
232393|NCT02179658|Clostridium|clostridium
232394|NCT02179658|Infections|infections
232395|NCT02179658|Difficile|difficile
232396|NCT02179658|Vancomycin|vancomycin
232397|NCT02179658|Fidaxomicin|fidaxomicin
232398|NCT02179632|disclosure|disclosure
232399|NCT02179632|conflicts of interest|conflicts of interest
232400|NCT02179632|trust|trust
232401|NCT02179632|patient doctor relationship|patient doctor relationship
232402|NCT02179593|Maxillary expansion|maxillary expansion
232403|NCT02179593|Orthognathic surgery|orthognathic surgery
232404|NCT02179593|Symmetry|symmetry
232405|NCT02179593|Palatal expansion technique|palatal expansion technique
232406|NCT02179593|Maxilla abnormality|maxilla abnormality
232407|NCT02179580|Traditional Chinese Medicine|traditional chinese medicine
232408|NCT02179580|Clinical trial|clinical trial
232409|NCT02179580|Good Clinical Practice|good clinical practice
232410|NCT02179567|Metastatic NSCLC|metastatic nsclc
232411|NCT02179567|Elderly|elderly
232412|NCT02179567|1st Line|1st line
232413|NCT02179567|Bevacizumab-based treatment|bevacizumab-based treatment
232414|NCT02179541|Otitis media with effusion, viscosity, RGB (red-green-blue).|otitis media with effusion, viscosity, rgb (red-green-blue).
232415|NCT02179515|Immune Response|immune response
232416|NCT02179515|Maximum Tolerated Dose|maximum tolerated dose
232417|NCT02179515|Vaccine Therapy|vaccine therapy
232418|NCT02179515|Increased Expression of Brachyury|increased expression of brachyury
232419|NCT02179515|Immunotherapy|immunotherapy
232420|NCT02179489|Peritoneal carcinomatosis|peritoneal carcinomatosis
232421|NCT02179489|HIPEC|hipec
232422|NCT02179489|controlled clinical trial|controlled clinical trial
232423|NCT02179489|colorectal cancer|colorectal cancer
232424|NCT02179476|Facet joint|facet joint
232425|NCT02179476|facet joint pain|facet joint pain
232426|NCT02179476|facet joint disease|facet joint disease
232427|NCT02179476|lumbar pain|lumbar pain
232428|NCT02179476|back pain|back pain
232429|NCT02179463|Gastric Cancer|gastric cancer
232430|NCT02179463|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
232431|NCT02179463|Response Evaluation|response evaluation
232432|NCT02179437|TIVA|tiva
232433|NCT02179437|Propofol|propofol
232434|NCT02179437|Postoperative pain|postoperative pain
232435|NCT02179437|Liver resection surgery|liver resection surgery
232436|NCT02179437|Retrospective study|retrospective study
232437|NCT02179424|smoking cessation interventions|smoking cessation interventions
232438|NCT02179398|Fever without source|fever without source
232439|NCT02179398|Antibiotic prescription|antibiotic prescription
232440|NCT02179398|Serious bacterial infection|serious bacterial infection
232441|NCT02179385|Type 2 diabetes|type 2 diabetes
232442|NCT02179385|Type II diabetes|type ii diabetes
232443|NCT02179359|Stem Cell Transplant|stem cell transplant
232444|NCT02179346|cartilage defect|cartilage defect
232446|NCT02179346|impingement|impingement
232447|NCT02179320|Myofascial Pain Syndrome|myofascial pain syndrome
232448|NCT02179320|Dry needling|dry needling
232449|NCT02179320|Clinical Trial|clinical trial
232450|NCT02179307|muscle hypertrophy|muscle hypertrophy
232451|NCT02179307|strength|strength
232452|NCT02179307|resistance training|resistance training
232453|NCT02179307|exercise|exercise
232454|NCT02179307|physical fitness|physical fitness
232455|NCT02179307|health|health
232456|NCT02179307|physical conditioning|physical conditioning
232457|NCT02179294|Pain relief|pain relief
232458|NCT02179294|Labour|labour
232459|NCT02179294|Child birth|child birth
232460|NCT02179294|Anaesthetics|anaesthetics
232461|NCT02179268|Antidepressants|antidepressants
232462|NCT02179268|bone mineral density|bone mineral density
232463|NCT02179268|bone turnover markers|bone turnover markers
232464|NCT02179255|DOR|dor
232465|NCT02179255|Premature Ovarian Failure (POF)|premature ovarian failure (pof)
232466|NCT02179255|Ovarian Failure|ovarian failure
232467|NCT02179255|Human Growth Hormone|human growth hormone
232468|NCT02179242|cardiac rehab|cardiac rehab
232469|NCT02179242|heart failure|heart failure
232470|NCT02179242|KCCQ|kccq
232471|NCT02179242|6 minute walk test|6 minute walk test
232472|NCT02179242|readmission|readmission
232473|NCT02179229|Kidney transplantation|kidney transplantation
232474|NCT02179229|pCresol|pcresol
232475|NCT02179229|Immunosuppressant drugs|immunosuppressant drugs
232476|NCT02179216|Orthostatic hypotension in the elderly|orthostatic hypotension in the elderly
232477|NCT02179216|Efficacity of Hydration|efficacity of hydration
232478|NCT02179216|Difference between hydratation and venous contention|difference between hydratation and venous contention
232479|NCT02179177|Vaso-occlusive crisis|vaso-occlusive crisis
232480|NCT02179177|Reduction in hospitalizations|reduction in hospitalizations
232481|NCT02179177|Sickle Cell Disease|sickle cell disease
232482|NCT02179151|Prader-Willi Syndrome|prader-willi syndrome
232483|NCT02179151|Obesity|obesity
232484|NCT02179151|Hyperphagia|hyperphagia
232485|NCT02179125|COPD|copd
232486|NCT02179125|Endobronchial treatment|endobronchial treatment
232487|NCT02179112|Surgery|surgery
232488|NCT02179112|Specialties, Surgical|specialties, surgical
232489|NCT02179112|Geography, Medical|geography, medical
232490|NCT02179112|Developing Countries|developing countries
232491|NCT02179112|Developed Countries|developed countries
232492|NCT02179112|Laparotomy|laparotomy
232493|NCT02179112|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
232494|NCT02179112|Treatment Outcome|treatment outcome
232495|NCT02179112|Quality of Health Care|quality of health care
232496|NCT02179099|overactive bladder|overactive bladder
232497|NCT02179099|OAB|oab
232498|NCT02179099|urgency|urgency
232499|NCT02179099|botulinum toxin|botulinum toxin
232500|NCT02179099|BTX|btx
232501|NCT02179099|botox|botox
232502|NCT02179099|intravesical|intravesical
232503|NCT02179099|TheraCoat|theracoat
232504|NCT02179099|TCGel|tcgel
232505|NCT02179099|TC-3 Gel|tc-3 gel
232506|NCT02179060|Sudden cardiac arrest, RhinoChill -cooling, MRI|sudden cardiac arrest, rhinochill -cooling, mri
232507|NCT02179047|SYNTAX ,NGAL,Cystatin C,Galectin-3,Copeptin.MR-ProANP,sST2.|syntax ,ngal,cystatin c,galectin-3,copeptin.mr-proanp,sst2.
232508|NCT02179034|tobacco|tobacco
232509|NCT02179034|electronic cigarettes|electronic cigarettes
232510|NCT02179034|menthol|menthol
232511|NCT02179034|flavors|flavors
232512|NCT02179021|Thromboelastometry|thromboelastometry
232513|NCT02179021|Haemostasis|haemostasis
232514|NCT02179021|Hypothermia|hypothermia
232515|NCT02179021|Heart arrest|heart arrest
232516|NCT02179008|Santen|santen
232517|NCT02179008|Eye|eye
232518|NCT02179008|Glaucoma|glaucoma
232519|NCT02179008|Ocular hypertension|ocular hypertension
232520|NCT02178982|mechanical ventilation|mechanical ventilation
232521|NCT02178982|ARDS|ards
232522|NCT02178982|Ventilator strategy|ventilator strategy
232523|NCT02178982|outcome|outcome
232524|NCT02178943|Molecular Diagnostics|molecular diagnostics
232525|NCT02178943|Heart Transplantation|heart transplantation
232526|NCT02178943|Risk Factors|risk factors
232527|NCT02178943|Prognosis|prognosis
232528|NCT02178930|HIV|hiv
232529|NCT02178930|cardiovascular disease|cardiovascular disease
232530|NCT02178930|self-management|self-management
232531|NCT02178930|HIV co-morbidities|hiv co-morbidities
232532|NCT02178930|self-efficacy|self-efficacy
232533|NCT02178930|coronary heart disease risk|coronary heart disease risk
232534|NCT02178930|quality of life|quality of life
232535|NCT02178904|Ischemia|ischemia
232536|NCT02178904|Dual Energy Computed Tomography|dual energy computed tomography
232537|NCT02178904|Computed Tomographic Perfusion|computed tomographic perfusion
232538|NCT02178904|Fractional Flow Rate|fractional flow rate
232539|NCT02178904|Invasive Coronary Angiography|invasive coronary angiography
232540|NCT02178904|Coronary Artery Stenosis|coronary artery stenosis
232541|NCT02178891|short implants|short implants
232542|NCT02178891|Nobel Biocare|nobel biocare
232543|NCT02178891|partially edentulous|partially edentulous
232544|NCT02178891|maxilla or mandible|maxilla or mandible
232545|NCT02178878|Labor pain and progress, variation, genetic|labor pain and progress, variation, genetic
232546|NCT02178865|translocation|translocation
232547|NCT02178839|Non Alcoholic Fatty Liver Disease(NAFLD)|non alcoholic fatty liver disease(nafld)
232548|NCT02178839|β- glucan|β- glucan
232549|NCT02178839|Appetite|appetite
232550|NCT02178839|Insulin Resistance|insulin resistance
232551|NCT02178826|Nocturnal Enuresis|nocturnal enuresis
232552|NCT02178826|Rapid Maxillary Expansion|rapid maxillary expansion
232553|NCT02178826|Orthodontics|orthodontics
232554|NCT02178826|Polysomnography|polysomnography
232555|NCT02178826|Quality of life|quality of life
232556|NCT02178813|Minocycline|minocycline
232557|NCT02178813|Neuroprotection|neuroprotection
232558|NCT02178813|Stroke|stroke
232559|NCT02178787|cerebral blood flow|cerebral blood flow
232560|NCT02178787|near infrared spectroscopy|near infrared spectroscopy
232561|NCT02178787|transcranial Doppler|transcranial doppler
232562|NCT02178787|diabetes mellitus|diabetes mellitus
232563|NCT02178787|cerebral autoregulation|cerebral autoregulation
232564|NCT02178774|Near-Infrared Spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
232565|NCT02178774|spinal anesthesia|spinal anesthesia
232566|NCT02178774|cesarean section|cesarean section
232567|NCT02178761|Erectile dysfunction|erectile dysfunction
232568|NCT02178761|Lower Urinary Tract Symptoms|lower urinary tract symptoms
232569|NCT02178761|Peripheral Arterial Disease|peripheral arterial disease
232570|NCT02178761|Angioplasty|angioplasty
232571|NCT02178761|Multidetector Computed Tomography|multidetector computed tomography
232572|NCT02178748|Tuberculosis|tuberculosis
232573|NCT02178748|Phase II|phase ii
232574|NCT02178748|MVA85A|mva85a
232575|NCT02178748|Schistosoma mansoni|schistosoma mansoni
232576|NCT02178735|pelvic organ prolapse, vaginal mesh, urodynamic studies|pelvic organ prolapse, vaginal mesh, urodynamic studies
232577|NCT02178709|Pancreatic|pancreatic
232578|NCT02178709|Cancer|cancer
232579|NCT02178709|Resectable|resectable
232580|NCT02178683|TACROLIMUS|tacrolimus
232581|NCT02178683|MYCOPHENOLATE MOFETIL|mycophenolate mofetil
232582|NCT02178683|FLUDARABINE|fludarabine
232583|NCT02178683|HLA-MATCHED|hla-matched
232584|NCT02178683|MIS-MATCHED|mis-matched
232585|NCT02178657|Stroke|stroke
232586|NCT02178657|Cell therapy|cell therapy
232587|NCT02178657|Bone marrow|bone marrow
232588|NCT02178605|rhBMP-2|rhbmp-2
232589|NCT02178605|arthrodesis|arthrodesis
232590|NCT02178605|cervical|cervical
232591|NCT02178592|integrase inhibitor|integrase inhibitor
232592|NCT02178592|Mycobacterium tuberculosis|mycobacterium tuberculosis
232593|NCT02178592|rifampicin-sensitive|rifampicin-sensitive
232594|NCT02178592|dolutegravir|dolutegravir
232595|NCT02178592|antiretroviral therapy-naïve|antiretroviral therapy-naïve
232596|NCT02178592|HIV-1 infection|hiv-1 infection
232597|NCT02178592|efavirenz|efavirenz
232598|NCT02178592|co-infection|co-infection
232599|NCT02178579|Heart Failure|heart failure
232600|NCT02178579|Cardiac Toxicity|cardiac toxicity
232601|NCT02178579|Multiple Myeloma|multiple myeloma
232602|NCT02178579|Bortezomib|bortezomib
232603|NCT02178579|Carfilzomib|carfilzomib
232604|NCT02178566|COPD|copd
232605|NCT02178566|Trepostinil|trepostinil
232606|NCT02178566|Pulmonary Rehabilitation|pulmonary rehabilitation
232607|NCT02178553|Thoracotomy|thoracotomy
232608|NCT02178553|Pain|pain
232609|NCT02178540|Human factors, TOBI® Podhaler™, Instructions For use, IFU, CF patients|human factors, tobi® podhaler™, instructions for use, ifu, cf patients
232610|NCT02178527|Geriatrics|geriatrics
232611|NCT02178527|Accidental Falls|accidental falls
232612|NCT02178527|Podiatry|podiatry
232613|NCT02178527|Exercise Therapy|exercise therapy
232614|NCT02178527|Orthotic Devices|orthotic devices
232615|NCT02178527|Foot|foot
232616|NCT02178501|OMEGA-3 PUFA|omega-3 pufa
232617|NCT02178501|type 2 diabetes|type 2 diabetes
232618|NCT02178501|cardiovascular diseases|cardiovascular diseases
232619|NCT02178475|NHL|nhl
232620|NCT02178475|Breast Cancer|breast cancer
232621|NCT02178423|children, ultrasound, central catheter|children, ultrasound, central catheter
232622|NCT02178410|Atrial Fibrillation|atrial fibrillation
232623|NCT02178410|Vitamin D3|vitamin d3
232624|NCT02178410|Omega-3 fatty acids|omega-3 fatty acids
232625|NCT02178410|Fish oil|fish oil
232626|NCT02178397|erlotinib|erlotinib
232627|NCT02178397|lung cancer|lung cancer
232628|NCT02178397|EGFR mutation|egfr mutation
232629|NCT02178384|Loading Forces|loading forces
232630|NCT02178384|Removable partial dentures|removable partial dentures
232631|NCT02178384|Bilateral distal extension|bilateral distal extension
232632|NCT02178371|Upper extremity|upper extremity
232633|NCT02178371|Physical therapy modalities|physical therapy modalities
232634|NCT02178358|transforming growth factor beta (TGF-β)|transforming growth factor beta (tgf-β)
232635|NCT02178345|MRI|mri
232636|NCT02178345|14-126|14-126
232637|NCT02178332|Children|children
232638|NCT02178332|socio-emotional|socio-emotional
232639|NCT02178332|socio-emotional skills|socio-emotional skills
232640|NCT02178332|psychiatric symptoms|psychiatric symptoms
232641|NCT02178332|SDQ|sdq
232642|NCT02178332|Finland|finland
232643|NCT02178332|School|school
232644|NCT02178332|School community|school community
232645|NCT02178332|Teacher|teacher
232646|NCT02178332|Whole school approach|whole school approach
232647|NCT02178332|Intervention|intervention
232648|NCT02178332|Effectiveness study|effectiveness study
232649|NCT02178332|Cluster randomised trial|cluster randomised trial
232650|NCT02178319|portal hypertension|portal hypertension
232651|NCT02178319|Randomized clinical trial|randomized clinical trial
232652|NCT02178319|laparoscopic|laparoscopic
232653|NCT02178319|open|open
232654|NCT02178267|Newborn, preterm, probiotic, resistant microorganisms|newborn, preterm, probiotic, resistant microorganisms
232655|NCT02178254|Pseudomonas aeruginosa, ZTI-101, phosphonic acid derivative, Monurol, fosfomycin tromethamine|pseudomonas aeruginosa, zti-101, phosphonic acid derivative, monurol, fosfomycin tromethamine
232656|NCT02178228|Anastomotic Leaks|anastomotic leaks
232657|NCT02178228|Bowel Resection|bowel resection
232658|NCT02178228|Postoperative Complication|postoperative complication
232659|NCT02178215|atopic dermatitis|atopic dermatitis
232660|NCT02178215|skin barrier function|skin barrier function
232661|NCT02178215|transepidermal water loss|transepidermal water loss
232662|NCT02178215|skin pH|skin ph
232663|NCT02178215|stratum corneum hydration|stratum corneum hydration
232664|NCT02178215|sebum|sebum
232665|NCT02178215|wrinkle|wrinkle
232666|NCT02178202|Harmonic technique, Low Back Pain, McKenzie exercise, Pain, Disability|harmonic technique, low back pain, mckenzie exercise, pain, disability
232667|NCT02178189|prenatal opioid exposure|prenatal opioid exposure
232668|NCT02178189|infant|infant
232669|NCT02178189|weight gain|weight gain
232670|NCT02178189|infant formula|infant formula
232671|NCT02178150|Magnesium|magnesium
232672|NCT02178150|Insulin Resistance|insulin resistance
232673|NCT02178150|Lipid profile|lipid profile
232674|NCT02178150|Sex hormones|sex hormones
232675|NCT02178150|Inflammatory factors|inflammatory factors
232676|NCT02178111|episiotomy, vaginal delivery, randomized, perineum|episiotomy, vaginal delivery, randomized, perineum
232677|NCT02178098|LDL|ldl
232678|NCT02178098|Cholesterol|cholesterol
232679|NCT02178085|glaucoma|glaucoma
232680|NCT02178085|phase-contrast MRI|phase-contrast mri
232681|NCT02178085|blood flow|blood flow
232682|NCT02178085|cerebrospinal fluid|cerebrospinal fluid
232683|NCT02178072|HNSCC|hnscc
232684|NCT02178059|Healthy volunteers, pharmacokinetic, inhalation|healthy volunteers, pharmacokinetic, inhalation
232685|NCT02178046|Gingivitis|gingivitis
232686|NCT02178033|adenoma detection rate, screening colonoscopy|adenoma detection rate, screening colonoscopy
232687|NCT02178020|Knee Arthroplasty|knee arthroplasty
232688|NCT02178020|Osteolysis|osteolysis
232689|NCT02178020|Radiolucent Lines|radiolucent lines
232690|NCT02177994|Elective Cesarean Section|elective cesarean section
232691|NCT02177994|Antibiotic prophylaxis|antibiotic prophylaxis
232692|NCT02177994|Timing of Antibiotic prophylaxis|timing of antibiotic prophylaxis
232693|NCT02177994|post cesarean section infection|post cesarean section infection
232694|NCT02177981|Remote Ischemic Preconditioning|remote ischemic preconditioning
232695|NCT02177981|Coronary Artery Bypass Grafting|coronary artery bypass grafting
232696|NCT02177981|Diffusion Weighted Magnetic Resonance Imaging|diffusion weighted magnetic resonance imaging
232697|NCT02177981|Resting State Functional Magnetic Resonance Imaging|resting state functional magnetic resonance imaging
232698|NCT02177981|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
232699|NCT02177968|fall|fall
232700|NCT02177968|elderly|elderly
232701|NCT02177968|characteristics|characteristics
232702|NCT02177955|Third Molar|third molar
232703|NCT02177955|Anty-anxiety drugs|anty-anxiety drugs
232704|NCT02177955|hemodynamic|hemodynamic
232705|NCT02177955|Benzodiazepines|benzodiazepines
232706|NCT02177929|Spinal cord injury,|spinal cord injury,
232707|NCT02177929|adaptive sport,|adaptive sport,
232708|NCT02177929|dynamometry,|dynamometry,
232709|NCT02177929|electromyography,|electromyography,
232710|NCT02177929|force platform.|force platform.
232711|NCT02177916|lung transplantation|lung transplantation
232712|NCT02177903|hypothermia|hypothermia
232713|NCT02177903|surgical site infection|surgical site infection
232714|NCT02177903|opioid usage|opioid usage
232715|NCT02177903|blood loss|blood loss
232716|NCT02177903|pain severity|pain severity
232717|NCT02177903|anxiety|anxiety
232718|NCT02177903|Length of Stay|length of stay
232719|NCT02177877|Epilepsy|epilepsy
232720|NCT02177877|Seizures|seizures
232721|NCT02177877|Wrist accelerometer|wrist accelerometer
232722|NCT02177877|Epilepsy diary|epilepsy diary
232723|NCT02177877|Seizure detection|seizure detection
232724|NCT02177877|Biosensor|biosensor
232725|NCT02177851|Iron bio-availability|iron bio-availability
232726|NCT02177851|Hepcidin|hepcidin
232727|NCT02177851|Iron absorption|iron absorption
232728|NCT02177812|Oncology|oncology
232729|NCT02177812|LSD1|lsd1
232730|NCT02177812|GSK2879552|gsk2879552
232731|NCT02177812|Acute myeloid leukemia|acute myeloid leukemia
232732|NCT02177799|Gastroenteritis|gastroenteritis
232733|NCT02177799|Hospitalized|hospitalized
232734|NCT02177799|Children|children
232735|NCT02177786|Diabetic Kidney Disease|diabetic kidney disease
232736|NCT02177786|Gilead|gilead
232737|NCT02177760|SCID|scid
232738|NCT02177760|severe combined immunodeficiency|severe combined immunodeficiency
232739|NCT02177760|maternal engraftment|maternal engraftment
232740|NCT02177760|aGVHD prophylaxis|agvhd prophylaxis
232741|NCT02177760|sirolimus|sirolimus
232742|NCT02177734|Adjuvant|adjuvant
232743|NCT02177734|Safety|safety
232744|NCT02177734|Influenza|influenza
232745|NCT02177734|H7N9|h7n9
232746|NCT02177734|Immunogenicity|immunogenicity
232747|NCT02177734|Adults|adults
232748|NCT02177721|Raxibacumab|raxibacumab
232749|NCT02177721|anthrax|anthrax
232750|NCT02177721|anti-toxin|anti-toxin
232751|NCT02177695|Bladder Cancer|bladder cancer
232752|NCT02177695|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
232753|NCT02177695|Coexpression Extrapolation|coexpression extrapolation
232754|NCT02177695|COXEN|coxen
232755|NCT02177695|S1314|s1314
232756|NCT02177695|SWOG|swog
232757|NCT02177682|AKT inhibitor|akt inhibitor
232758|NCT02177682|Afuresertib|afuresertib
232759|NCT02177682|multiple myeloma|multiple myeloma
232760|NCT02177669|Normal, healthy individuals without ocular disease|normal, healthy individuals without ocular disease
232761|NCT02177669|Ages 20-89|ages 20-89
232762|NCT02177669|English speaking|english speaking
232763|NCT02177669|Visual acuity better than 20/25|visual acuity better than 20/25
232764|NCT02177656|heart failure|heart failure
232765|NCT02177656|self-care|self-care
232766|NCT02177656|self-care maintenance|self-care maintenance
232767|NCT02177656|self-care management|self-care management
232768|NCT02177656|self-efficacy|self-efficacy
232769|NCT02177656|quality of life|quality of life
232770|NCT02177656|symptoms|symptoms
232771|NCT02177643|Diabetes|diabetes
232772|NCT02177643|Diacerein|diacerein
232773|NCT02177630|myocarditis, myocardial inflammation, imaging, magnetic resonance|myocarditis, myocardial inflammation, imaging, magnetic resonance
232774|NCT02177617|Cervical Dystonia|cervical dystonia
232775|NCT02177617|Botox|botox
232776|NCT02177578|Subventricular Zone|subventricular zone
232777|NCT02177578|progenitor cell|progenitor cell
232778|NCT02177578|radiation therapy|radiation therapy
232779|NCT02177578|temozolomide|temozolomide
232780|NCT02177565|Non-union|non-union
232781|NCT02177565|fracture|fracture
232782|NCT02177565|bone marrow stem cells|bone marrow stem cells
232783|NCT02177552|Esophageal cancer|esophageal cancer
232784|NCT02177552|Gastric cancer|gastric cancer
232785|NCT02177539|cycloplegia|cycloplegia
232786|NCT02177539|refraction in children|refraction in children
232787|NCT02177539|cycloplegic agents|cycloplegic agents
232788|NCT02177539|cycloplegic schemes|cycloplegic schemes
232789|NCT02177539|cyclopentolate|cyclopentolate
232790|NCT02177526|CT|ct
232791|NCT02177526|MRI|mri
232792|NCT02177513|Cannabis|cannabis
232793|NCT02177513|Pharmacodynamics|pharmacodynamics
232794|NCT02177513|Marijuana|marijuana
232795|NCT02177513|Cannabinoids|cannabinoids
232796|NCT02177513|Vaporized|vaporized
232797|NCT02177474|depressive symptoms|depressive symptoms
232798|NCT02177474|perceived social support|perceived social support
232799|NCT02177474|coronary heart disease|coronary heart disease
232800|NCT02177474|peer support|peer support
232801|NCT02177474|women|women
232802|NCT02177279|Wheat bran cereals, bran phytochemicals, phytochemicals bioavailability|wheat bran cereals, bran phytochemicals, phytochemicals bioavailability
232803|NCT02177240|GlideScope®|glidescope®
232804|NCT02177240|GlideRite®|gliderite®
232805|NCT02177240|Flex-it®|flex-it®
232806|NCT02177240|Difficult intubation|difficult intubation
232807|NCT02177227|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
232808|NCT02177227|Attune|attune
232809|NCT02177227|Primary Total Knee Prosthesis|primary total knee prosthesis
232810|NCT02177227|TruMatch|trumatch
232811|NCT02177188|Hypovolaemic shock|hypovolaemic shock
232812|NCT02177188|Monitoring|monitoring
232813|NCT02177188|Haemorrhage|haemorrhage
232814|NCT02177188|Transthoracic Echocardiography|transthoracic echocardiography
232815|NCT02177175|Carvedilol|carvedilol
232816|NCT02177175|Anthracycline|anthracycline
232817|NCT02177175|HER2|her2
232818|NCT02177175|14-099|14-099
232819|NCT02177136|PSC|psc
232820|NCT02177123|glaucoma shunt|glaucoma shunt
232821|NCT02177123|glaucoma drainage device|glaucoma drainage device
232822|NCT02177110|advanced melanoma|advanced melanoma
232823|NCT02177110|metastatic melanoma|metastatic melanoma
232824|NCT02177110|fresh frozen tissue|fresh frozen tissue
232825|NCT02177110|FFPE tissue|ffpe tissue
232826|NCT02177097|Pain|pain
232827|NCT02177097|Infection|infection
232828|NCT02177097|Inflammation|inflammation
232829|NCT02177097|Prosthesis|prosthesis
232830|NCT02177084|PTNS|ptns
232831|NCT02177084|rectal cancer|rectal cancer
232832|NCT02177084|low anterior resection syndrome|low anterior resection syndrome
232833|NCT02177071|CROHN DISEASE|crohn disease
232834|NCT02177071|INFLIXIMAB|infliximab
232835|NCT02177071|COMBINATION THERAPY|combination therapy
232836|NCT02177071|steroid free remission|steroid free remission
232837|NCT02177071|anti-metabolites|anti-metabolites
232838|NCT02177058|Nursing homes|nursing homes
232839|NCT02177058|Hospitalizations|hospitalizations
232840|NCT02177032|Rabies vaccines|rabies vaccines
232841|NCT02177032|intradermal|intradermal
232842|NCT02177032|human rabies immunoglobulins|human rabies immunoglobulins
232843|NCT02177019|frequent headaches|frequent headaches
232844|NCT02177019|personalized health plan|personalized health plan
232845|NCT02176993|Acute stroke|acute stroke
232846|NCT02176993|Therapeutic Hypothermia|therapeutic hypothermia
232847|NCT02176980|HCV|hcv
232848|NCT02176980|hepatitis C|hepatitis c
232849|NCT02176980|alcohol|alcohol
232850|NCT02176980|integrated care|integrated care
232851|NCT02176941|Telomere Length|telomere length
232852|NCT02176941|Arterial Aging|arterial aging
232853|NCT02176941|Endothelial Progenitor Cells|endothelial progenitor cells
232854|NCT02176941|Inflammation|inflammation
232855|NCT02176941|Atherosclerosis|atherosclerosis
232856|NCT02176889|Lactospore|lactospore
232857|NCT02176889|Bacillus coagulans|bacillus coagulans
232858|NCT02176889|Safety|safety
232859|NCT02176889|Probiotic|probiotic
232860|NCT02176889|Healthy Adults|healthy adults
232861|NCT02176889|Tolerability|tolerability
232862|NCT02176876|rheumatoid arthritis|rheumatoid arthritis
232863|NCT02176876|RA|ra
232864|NCT02176876|GS-5745|gs-5745
232865|NCT02176876|MMP9|mmp9
232866|NCT02176876|phase 1|phase 1
232867|NCT02176863|FORCE|force
232868|NCT02176863|post-polio syndrome|post-polio syndrome
232869|NCT02176863|Flebogamma|flebogamma
232870|NCT02176863|Immune Globulin Intravenous|immune globulin intravenous
232871|NCT02176863|IGIV|igiv
232872|NCT02176837|subarachnoid hemorrhage|subarachnoid hemorrhage
232873|NCT02176837|vasospasm|vasospasm
232874|NCT02176837|nitrite|nitrite
232875|NCT02176837|sodium nitrite|sodium nitrite
232876|NCT02176811|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
232877|NCT02176811|Betatrophin|betatrophin
232878|NCT02176785|Sleep|sleep
232879|NCT02176785|Transcranial Electric Stimulation|transcranial electric stimulation
232880|NCT02176720|Glioma|glioma
232881|NCT02176720|Glioblastoma|glioblastoma
232882|NCT02176720|Glioblastoma multiforme|glioblastoma multiforme
232883|NCT02176720|GBM|gbm
232884|NCT02176720|Recurrence|recurrence
232886|NCT02176720|FDOPA|fdopa
232887|NCT02176707|Lung Function|lung function
232888|NCT02176707|Exercise Capacity|exercise capacity
232889|NCT02176694|persistent asthma|persistent asthma
232890|NCT02176694|adherence|adherence
232891|NCT02176694|text message reminders|text message reminders
232892|NCT02176655|Delayed Alcohol Induced Headache|delayed alcohol induced headache
232893|NCT02176642|Urinary Urge Incontinence|urinary urge incontinence
232894|NCT02176642|Posterior Tibial Nerve Stimulation|posterior tibial nerve stimulation
232895|NCT02176642|PTNS|ptns
232896|NCT02176642|Neuromodulation|neuromodulation
232897|NCT02176642|Oxybutynin|oxybutynin
232898|NCT02176642|Anticholinergic Medication|anticholinergic medication
232899|NCT02176629|Virtual Reality|virtual reality
232900|NCT02176629|mild cognitive impairment|mild cognitive impairment
232901|NCT02176629|Alzheimer's disease|alzheimer's disease
232902|NCT02176603|phenylketonuria, endothelial dysfunction, CKD|phenylketonuria, endothelial dysfunction, ckd
232903|NCT02176590|PATHS Social Emotional Learning|paths social emotional learning
232904|NCT02176590|Coping Power|coping power
232905|NCT02176590|Power PATH|power path
232906|NCT02176590|Head Start|head start
232907|NCT02176486|Drug therapy|drug therapy
232908|NCT02176473|Depression|depression
232909|NCT02176460|Knee Osteoarthritis|knee osteoarthritis
232910|NCT02176460|Double-blind|double-blind
232911|NCT02176460|placebo-controlled|placebo-controlled
232912|NCT02176460|randomized|randomized
232913|NCT02176460|colchicine|colchicine
232914|NCT02176434|End stage renal disease|end stage renal disease
232915|NCT02176434|Transplantation|transplantation
232916|NCT02176434|Tolerance|tolerance
232917|NCT02176408|Major Depressive Disorder|major depressive disorder
232918|NCT02176408|Depression|depression
232919|NCT02176408|MDD|mdd
232920|NCT02176408|Exercise|exercise
232921|NCT02176408|Physical Activity|physical activity
232922|NCT02176408|Treatment|treatment
232923|NCT02176408|Behavioral Activation|behavioral activation
232924|NCT02176395|Acute Ischemic Stroke|acute ischemic stroke
232925|NCT02176395|Randomized Controlled Trial|randomized controlled trial
232926|NCT02176395|Traditional Chinese Medicine|traditional chinese medicine
232927|NCT02176395|Proteomics|proteomics
232928|NCT02176369|Non small cell lung cancer (NSCLC)|non small cell lung cancer (nsclc)
232929|NCT02176369|Lung tumor in advanced phase|lung tumor in advanced phase
232930|NCT02176343|Cataract|cataract
232931|NCT02176343|Intraocular lens|intraocular lens
232932|NCT02176343|ACRYSOF IQ ReSTOR + 2.5 D Multifocal Toric IOL|acrysof iq restor + 2.5 d multifocal toric iol
232933|NCT02176330|Randomised Controlled Trial|randomised controlled trial
232934|NCT02176330|Virtual Clinic|virtual clinic
232935|NCT02176330|ePAQ-PF|epaq-pf
232936|NCT02176330|Pelvic Floor Disorders|pelvic floor disorders
232937|NCT02176330|Economic Analysis|economic analysis
232938|NCT02176317|Autism Spectrum Disorder|autism spectrum disorder
232939|NCT02176317|ASD|asd
232940|NCT02176317|Umbilical cord blood|umbilical cord blood
232941|NCT02176317|Autologous cord blood|autologous cord blood
232942|NCT02176317|cord blood|cord blood
232943|NCT02176304|knee|knee
232944|NCT02176304|arthritis|arthritis
232945|NCT02176304|injections|injections
232946|NCT02176304|corticosteroids|corticosteroids
232947|NCT02176291|Buprenorphine|buprenorphine
232948|NCT02176291|Receptors, opioid|receptors, opioid
232949|NCT02176291|Receptors, opioid kappa and mu|receptors, opioid kappa and mu
232950|NCT02176278|Diabetic Kidney Disease|diabetic kidney disease
232951|NCT02176278|Diabetes|diabetes
232952|NCT02176278|Asian|asian
233056|NCT02175680|PRO140|pro140
233057|NCT02175680|CytoDyn|cytodyn
232953|NCT02176278|Joint Asia Diabetes Evaluation (JADE) Program|joint asia diabetes evaluation (jade) program
232954|NCT02176265|CAD|cad
232955|NCT02176265|PCI|pci
232956|NCT02176265|bioactive coronary stent|bioactive coronary stent
232957|NCT02176265|OCT|oct
232958|NCT02176226|Major Depressive Disorder|major depressive disorder
232959|NCT02176226|Anxiety Disorders|anxiety disorders
232960|NCT02176226|Behavior Therapy|behavior therapy
232961|NCT02176226|Technology Assisted|technology assisted
232962|NCT02176226|Mobile Phone|mobile phone
232963|NCT02176226|Cellular Phone|cellular phone
232964|NCT02176226|Smartphone|smartphone
232965|NCT02176226|App|app
232966|NCT02176213|Relapsed|relapsed
232967|NCT02176213|Refractory|refractory
232968|NCT02176213|Multiple Myeloma|multiple myeloma
232969|NCT02176213|Pomalidomide|pomalidomide
232970|NCT02176213|Cyclophosphamide|cyclophosphamide
232971|NCT02176213|Dexamethasone|dexamethasone
232972|NCT02176174|Ethnic group|ethnic group
232973|NCT02176174|Cardiovascular disease|cardiovascular disease
232974|NCT02176174|Atherosclerosis|atherosclerosis
232975|NCT02176161|Prostate Cancer|prostate cancer
232976|NCT02176161|Prostate Cancer Recurrent|prostate cancer recurrent
232977|NCT02176148|cutaneous lupus|cutaneous lupus
232978|NCT02176148|systemic lupus|systemic lupus
232979|NCT02176148|systemic therapy|systemic therapy
232980|NCT02176148|medication|medication
232981|NCT02176135|HIV|hiv
232982|NCT02176135|HAART suppressed|haart suppressed
232983|NCT02176135|Auranofin|auranofin
232984|NCT02176135|HIV latent reservoir|hiv latent reservoir
232985|NCT02176057|trachoma|trachoma
232986|NCT02176044|Nitric Oxide|nitric oxide
232987|NCT02176044|Sodium Nitroprusside|sodium nitroprusside
232988|NCT02176044|Spatial Working Memory|spatial working memory
232989|NCT02176044|Psychosis|psychosis
232990|NCT02176044|Schizophrenia|schizophrenia
232991|NCT02176031|Graft Versus Host Disease|graft versus host disease
232992|NCT02176018|Episodic Migraine|episodic migraine
232993|NCT02176018|Migraine|migraine
232994|NCT02176018|Headache|headache
232995|NCT02175979|postoperative ileus|postoperative ileus
232996|NCT02175979|anastomotic leak|anastomotic leak
232997|NCT02175979|colorectal surgery|colorectal surgery
232998|NCT02175979|inflammation|inflammation
232999|NCT02175953|caregiver burden|caregiver burden
233000|NCT02175953|stress|stress
233001|NCT02175953|depression|depression
233002|NCT02175953|dementia|dementia
233003|NCT02175927|Helicobacter pylori|helicobacter pylori
233004|NCT02175927|Treatment Failure|treatment failure
233005|NCT02175927|second-line therapy|second-line therapy
233006|NCT02175914|Erythromycin|erythromycin
233007|NCT02175914|Familial Adenomatous Polyposis (FAP).|familial adenomatous polyposis (fap).
233008|NCT02175914|APC gene|apc gene
233009|NCT02175914|nonsense mutations|nonsense mutations
233010|NCT02175901|helicobacter pylori eradication|helicobacter pylori eradication
233011|NCT02175901|antibiotic|antibiotic
233012|NCT02175888|Iron bio availability|iron bio availability
233013|NCT02175888|Hepcidin|hepcidin
233014|NCT02175888|Iron absorption|iron absorption
233015|NCT02175875|ticagrelor|ticagrelor
233016|NCT02175875|platelet function test|platelet function test
233017|NCT02175875|comatose|comatose
233018|NCT02175875|PCI|pci
233019|NCT02175875|naso-gastric tube|naso-gastric tube
233020|NCT02175862|Helicopter Emergency Medical Service|helicopter emergency medical service
233021|NCT02175862|Trauma|trauma
233022|NCT02175862|Early retirement|early retirement
233023|NCT02175862|ISS|iss
233024|NCT02175862|Quality of life|quality of life
233025|NCT02175849|Multi-Drug Resistant Tuberculosis|multi-drug resistant tuberculosis
233026|NCT02175849|Social Network Analysis|social network analysis
233027|NCT02175836|Arrhythmic Sudden Cardiac Death|arrhythmic sudden cardiac death
233028|NCT02175836|Heart Failure|heart failure
233029|NCT02175836|Risk Stratification|risk stratification
233030|NCT02175836|Autonomic Nervous System|autonomic nervous system
233031|NCT02175836|Heart Rate|heart rate
233032|NCT02175836|Repolarization|repolarization
233033|NCT02175823|Cancer survivors|cancer survivors
233034|NCT02175823|circadian rhythm|circadian rhythm
233035|NCT02175823|Elderly Patients|elderly patients
233036|NCT02175823|frailty|frailty
233037|NCT02175810|Obesity|obesity
233038|NCT02175810|Bariatric surgery|bariatric surgery
233039|NCT02175810|physical activity|physical activity
233040|NCT02175810|cardiopulmonary exercise test|cardiopulmonary exercise test
233041|NCT02175797|Pacemaker, leads and MRI exam|pacemaker, leads and mri exam
233042|NCT02175784|Blood glucose|blood glucose
233043|NCT02175784|insulin|insulin
233044|NCT02175784|ipragliflozin|ipragliflozin
233045|NCT02175784|SGLT2 inhibitor|sglt2 inhibitor
233046|NCT02175732|Type 1 Diabetes|type 1 diabetes
233047|NCT02175732|Distress|distress
233048|NCT02175719|Torticollis|torticollis
233049|NCT02175719|rimabotulinumtoxinB|rimabotulinumtoxinb
233050|NCT02175693|Torticollis|torticollis
233051|NCT02175693|rimabotulinumtoxinB|rimabotulinumtoxinb
233052|NCT02175680|HIV-1|hiv-1
233053|NCT02175680|HIV|hiv
233054|NCT02175680|Treatment Substitution|treatment substitution
233055|NCT02175680|PRO 140|pro 140
233058|NCT02175680|Amarex|amarex
233059|NCT02175667|Global postural reeducation|global postural reeducation
233060|NCT02175667|Stabilometry|stabilometry
233061|NCT02175667|Postural Sway|postural sway
233062|NCT02175667|Range of motion|range of motion
233063|NCT02175667|Personality traits|personality traits
233064|NCT02175654|metastatic colorectal cancer|metastatic colorectal cancer
233065|NCT02175654|RAS/BRAF mutation|ras/braf mutation
233066|NCT02175654|Regorafenib|regorafenib
233067|NCT02175654|FOLFOXIRI|folfoxiri
233068|NCT02175654|Bevacizumab|bevacizumab
233069|NCT02175641|Healthy lifestyle Intervention|healthy lifestyle intervention
233070|NCT02175641|Serious Mental Illness|serious mental illness
233071|NCT02175641|Effectiveness trial|effectiveness trial
233072|NCT02175641|Supportive housing|supportive housing
233073|NCT02175641|Racial and Ethnic Health Disparities|racial and ethnic health disparities
233074|NCT02175628|Ultrasound|ultrasound
233075|NCT02175628|Breast|breast
233076|NCT02175628|Angiography|angiography
233077|NCT02175615|CYCLOSPORINE|cyclosporine
233078|NCT02175615|ACUTE GRAFT VERSUS HOST DISEASE|acute graft versus host disease
233079|NCT02175615|PROPHYLAXIS|prophylaxis
233080|NCT02175615|CHILDREN|children
233081|NCT02175615|HAEMATOPOIETIC STEM CELL TRANSPLANT|haematopoietic stem cell transplant
233082|NCT02175589|Familial Mediterranean Fever|familial mediterranean fever
233083|NCT02175589|Monozygous|monozygous
233084|NCT02175589|MEFV|mefv
233085|NCT02175589|Colchicine|colchicine
233086|NCT02175589|Serum Amyloid A|serum amyloid a
233087|NCT02175563|Chest|chest
233088|NCT02175563|Compression|compression
233089|NCT02175550|partially edentulous|partially edentulous
233090|NCT02175550|maxilla|maxilla
233091|NCT02175550|implants|implants
233092|NCT02175550|Conical connection|conical connection
233093|NCT02175550|Nobel Biocare|nobel biocare
233094|NCT02175550|NobelReplace|nobelreplace
233095|NCT02175550|Immediate loading|immediate loading
233096|NCT02175550|One- stage surgery|one- stage surgery
233097|NCT02175550|Two- stage surgery|two- stage surgery
233098|NCT02175550|supported restoration|supported restoration
233099|NCT02175550|patients|patients
233100|NCT02175537|Diabetes Mellitus, Type II|diabetes mellitus, type ii
233101|NCT02175537|Disease management|disease management
233102|NCT02175537|Obesity|obesity
233103|NCT02175537|Social Network|social network
233104|NCT02175537|Chronic disease|chronic disease
233105|NCT02175537|Prevention and control|prevention and control
233106|NCT02175537|Education|education
233107|NCT02175524|nut chewing|nut chewing
233108|NCT02175511|Home Blood Pressure|home blood pressure
233109|NCT02175511|Computerized physician order entry (CPOE)|computerized physician order entry (cpoe)
233110|NCT02175511|Telemonitoring|telemonitoring
233111|NCT02175511|Hypertension|hypertension
233112|NCT02175498|Homoeopathy Similimum female infertility|homoeopathy similimum female infertility
233113|NCT02175472|Parkinson's disease|parkinson's disease
233114|NCT02175472|Light therapy|light therapy
233115|NCT02175472|Circadian rhythm|circadian rhythm
233116|NCT02175446|Breast cancer|breast cancer
233117|NCT02175446|HER2Negative|her2negative
233118|NCT02175446|Second line treatment|second line treatment
233119|NCT02175446|HER2-|her2-
233120|NCT02175446|MBC|mbc
233121|NCT02175446|Metastatic|metastatic
233122|NCT02175446|Metastatic breast cancer|metastatic breast cancer
233123|NCT02175446|bevacizumab|bevacizumab
233124|NCT02175446|eribulin|eribulin
233125|NCT02175446|Human Epidermal Growth Factor Receptor 2-Negative|human epidermal growth factor receptor 2-negative
233126|NCT02175433|Refractory or relapsed chronic lymphocytic leukemia (CLL) prolymphocytic leukemia (PLL)|refractory or relapsed chronic lymphocytic leukemia (cll) prolymphocytic leukemia (pll)
233127|NCT02175433|Relapsed lymphoid malignancy|relapsed lymphoid malignancy
233128|NCT02175433|Refractory lymphoid malignancy|refractory lymphoid malignancy
233129|NCT02175433|Pharmacokinetics of AGS67E|pharmacokinetics of ags67e
233130|NCT02175433|hairy cell leukemia (HCL)|hairy cell leukemia (hcl)
233131|NCT02175433|AGS67C|ags67c
233132|NCT02175433|non-Hodgkin lymphoma (NHL)|non-hodgkin lymphoma (nhl)
233133|NCT02175433|AGS67E|ags67e
233135|NCT02175420|Salmonella|salmonella
233136|NCT02175420|Trained immunity|trained immunity
233137|NCT02175420|Non-specific effect vaccines|non-specific effect vaccines
233138|NCT02175407|Healthy subjects|healthy subjects
233139|NCT02175407|ASP1707|asp1707
233140|NCT02175407|Itraconazole|itraconazole
233141|NCT02175381|Metastatic NSCLC|metastatic nsclc
233142|NCT02175381|Elderly|elderly
233143|NCT02175381|1st Line|1st line
233144|NCT02175381|Platinum-based treatment|platinum-based treatment
233145|NCT02175368|total etch protocol|total etch protocol
233146|NCT02175368|direct filling therapy|direct filling therapy
233147|NCT02175329|CAD/CAM, three-unit posterior bridges, zirconia framework|cad/cam, three-unit posterior bridges, zirconia framework
233148|NCT02175277|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
233149|NCT02175277|Darbepoetin alfa|darbepoetin alfa
233150|NCT02175277|low risk MDS|low risk mds
233151|NCT02175277|intermediate-1 risk MDS|intermediate-1 risk mds
233152|NCT02175277|International Prognostic Scoring System (IPSS)|international prognostic scoring system (ipss)
233153|NCT02175264|Isolated non syndromic CDH|isolated non syndromic cdh
233154|NCT02175251|rTMS|rtms
233155|NCT02175251|Schizophrenia|schizophrenia
233156|NCT02175251|high frequency rTMS|high frequency rtms
233157|NCT02175251|low frequency rTMS|low frequency rtms
233158|NCT02175251|AHRS|ahrs
233159|NCT02175251|SAPS SANS PANSS|saps sans panss
233160|NCT02175251|GAF|gaf
233161|NCT02175251|UKU|uku
233162|NCT02175225|Brain hemorrhage|brain hemorrhage
233163|NCT02175225|Cerebral hemorrhage|cerebral hemorrhage
233164|NCT02175225|Bleeding in the brain|bleeding in the brain
233165|NCT02175225|Deferoxamine|deferoxamine
233166|NCT02175225|iDEF trial|idef trial
233167|NCT02175212|Patients with prostate adenocarcinoma|patients with prostate adenocarcinoma
233168|NCT02175199|Contact lens|contact lens
233169|NCT02175199|Vision care|vision care
233170|NCT02175199|Daily wear|daily wear
233171|NCT02175199|Color contact lens|color contact lens
233172|NCT02175186|Gastritis|gastritis
233173|NCT02175186|Gastroduodenal Ulcer|gastroduodenal ulcer
233174|NCT02175186|Percutaneous Coronary Revascularization|percutaneous coronary revascularization
233175|NCT02175186|Dual Antiplatelet Therapy|dual antiplatelet therapy
233176|NCT02175173|Epileptic encephalopathy, Lennox-Gastaut type|epileptic encephalopathy, lennox-gastaut type
233177|NCT02175160|Driver reaction time|driver reaction time
233178|NCT02175134|tuberculosis|tuberculosis
233179|NCT02175134|peritonitis|peritonitis
233180|NCT02175134|laparoscopy|laparoscopy
233181|NCT02175108|Cerebral palsy|cerebral palsy
233182|NCT02175108|Adolescents|adolescents
233183|NCT02175108|Adults|adults
233184|NCT02175108|Diet|diet
233185|NCT02175108|Activity|activity
233186|NCT02175108|Metabolic Syndrome|metabolic syndrome
233187|NCT02175095|regorafenib|regorafenib
233188|NCT02175095|fluorothymidine|fluorothymidine
233189|NCT02175095|positron emission tomography|positron emission tomography
233190|NCT02175095|metastatic colorectal cancer|metastatic colorectal cancer
233191|NCT02175082|Parkinson Disease|parkinson disease
233192|NCT02175082|Exercise|exercise
233193|NCT02175082|Rehabilitation|rehabilitation
233194|NCT02175082|Physical Therapy|physical therapy
233195|NCT02175082|Cycling|cycling
233196|NCT02175069|Shoulder surgery|shoulder surgery
233197|NCT02175056|First In Human|first in human
233198|NCT02175056|CAPS, SoJIA, AOSD, Bechet Disease, Rheumatoid arthritis|caps, sojia, aosd, bechet disease, rheumatoid arthritis
233199|NCT02175043|atrial fibrillation, catheter ablation, recurrence|atrial fibrillation, catheter ablation, recurrence
233200|NCT02175030|Emergency contraception|emergency contraception
233201|NCT02175030|Levonorgestrel IUD|levonorgestrel iud
233202|NCT02175030|Copper IUD|copper iud
233203|NCT02175017|ONO-4538|ono-4538
233204|NCT02175017|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
233205|NCT02175004|FAP|fap
233206|NCT02175004|Familial Amyloid Polyneuropathy|familial amyloid polyneuropathy
233207|NCT02175004|TTR|ttr
233208|NCT02175004|Transthyretin|transthyretin
233209|NCT02175004|Amyloidosis|amyloidosis
233210|NCT02174978|Malaria vaccine|malaria vaccine
233211|NCT02174952|Parenting interventions|parenting interventions
233212|NCT02174952|ADHD|adhd
233213|NCT02174952|Family functioning|family functioning
233214|NCT02174952|Parent Training|parent training
233215|NCT02174939|cilostazol|cilostazol
233216|NCT02174939|progenitor cells|progenitor cells
233217|NCT02174939|coronary artery disease|coronary artery disease
233218|NCT02174939|myocardial infarction|myocardial infarction
233219|NCT02174939|angiogenesis|angiogenesis
233220|NCT02174939|biological markers|biological markers
233221|NCT02174939|endothelial function|endothelial function
233222|NCT02174913|Awakening time|awakening time
233223|NCT02174913|Bispectral index|bispectral index
233224|NCT02174913|clinical signs|clinical signs
233225|NCT02174913|neurophysiologic monitoring|neurophysiologic monitoring
233226|NCT02174913|spine surgery|spine surgery
233227|NCT02174900|G6PD deficiency|g6pd deficiency
233228|NCT02174900|safety|safety
233229|NCT02174900|transmission|transmission
233230|NCT02174887|pancreatic adenocarcinoma|pancreatic adenocarcinoma
233231|NCT02174887|liver metastases|liver metastases
233232|NCT02174861|Chronic Migraine|chronic migraine
233233|NCT02174848|Pantothenate Kinase-Associated Neurodegeneration|pantothenate kinase-associated neurodegeneration
233234|NCT02174848|PKAN|pkan
233235|NCT02174848|Neurodegeneration with Brain Iron Accumulation|neurodegeneration with brain iron accumulation
233236|NCT02174848|NBIA|nbia
233237|NCT02174848|Deferiprone|deferiprone
233238|NCT02174848|Ferriprox|ferriprox
233239|NCT02174835|Pharmacokinetics|pharmacokinetics
233240|NCT02174835|Healthy Volunteers|healthy volunteers
233241|NCT02174835|deuterated dextromethorphan|deuterated dextromethorphan
233242|NCT02174835|deuterated dextromethorphan with quinidine|deuterated dextromethorphan with quinidine
233243|NCT02174822|Drug-drug interaction|drug-drug interaction
233244|NCT02174822|Pharmacokinetics|pharmacokinetics
233245|NCT02174822|Healthy Volunteers|healthy volunteers
233246|NCT02174822|deuterated dextromethorphan|deuterated dextromethorphan
233247|NCT02174822|deuterated dextromethorphan with quinidine|deuterated dextromethorphan with quinidine
233248|NCT02174809|Pregnancy|pregnancy
233249|NCT02174809|Gestational Weight Gain|gestational weight gain
233250|NCT02174809|Primary Care|primary care
233251|NCT02174809|Guidelines|guidelines
233252|NCT02174796|Pectus excavatum|pectus excavatum
233253|NCT02174796|cardiac output|cardiac output
233254|NCT02174796|transthoracic impedancemetry|transthoracic impedancemetry
233255|NCT02174783|Weight Loss|weight loss
233256|NCT02174783|Diet, Mediterranean|diet, mediterranean
233257|NCT02174783|Diet, Reducing|diet, reducing
233258|NCT02174783|protein sparing modified diet|protein sparing modified diet
233259|NCT02174744|Pain in elderly patients having communication disorders|pain in elderly patients having communication disorders
233260|NCT02174744|Numerical scale|numerical scale
233261|NCT02174744|Algoplus® scale|algoplus® scale
233262|NCT02174744|Doloplus® scale|doloplus® scale
233263|NCT02174731|Renal,|renal,
233264|NCT02174731|CKD,|ckd,
233265|NCT02174731|Epoetin alfa,|epoetin alfa,
233266|NCT02174731|Roxadustat,|roxadustat,
233267|NCT02174731|dialysis,|dialysis,
233268|NCT02174731|anemia|anemia
233269|NCT02174718|Cholecalciferol|cholecalciferol
233270|NCT02174718|Transdermal patch|transdermal patch
233271|NCT02174705|vaccination|vaccination
233272|NCT02174705|pain management|pain management
233273|NCT02174705|sucrose|sucrose
233274|NCT02174705|rotavirus|rotavirus
233275|NCT02174666|Aglycones|aglycones
233276|NCT02174666|Isoflavones|isoflavones
233277|NCT02174666|Red clover|red clover
233278|NCT02174666|Osteopenia|osteopenia
233279|NCT02174666|Menopause|menopause
233280|NCT02174666|Bone turnover|bone turnover
233281|NCT02174666|Bone mineral density|bone mineral density
233282|NCT02174640|Coffee|coffee
233283|NCT02174640|Polyphenolics|polyphenolics
233284|NCT02174627|Renal,|renal,
233285|NCT02174627|CKD,|ckd,
233286|NCT02174627|Roxadustat,|roxadustat,
233287|NCT02174627|anemia,|anemia,
233288|NCT02174627|non-dialysis|non-dialysis
233289|NCT02174614|Cocaine use disorder|cocaine use disorder
233290|NCT02174601|bowel preparation|bowel preparation
233291|NCT02174601|coolprep|coolprep
233292|NCT02174601|colonoscopy|colonoscopy
233293|NCT02174601|prediction model|prediction model
233294|NCT02174588|sedation, propofol, midazolam|sedation, propofol, midazolam
233295|NCT02174575|Hepatectomy|hepatectomy
233296|NCT02174562|Type 2 diabetes|type 2 diabetes
233297|NCT02174562|Mild Cognitive Impairment|mild cognitive impairment
233298|NCT02174549|Hypoxia|hypoxia
233299|NCT02174549|Embolization|embolization
233300|NCT02174549|Tirapazamine|tirapazamine
233301|NCT02174523|pharmacokinetic|pharmacokinetic
233302|NCT02174523|lurasidone|lurasidone
233303|NCT02174523|multiple dose|multiple dose
233304|NCT02174510|pharmacokinetic|pharmacokinetic
233305|NCT02174510|lurasidone|lurasidone
233306|NCT02174510|single dose|single dose
233307|NCT02174497|Pediatric Colonoscopy|pediatric colonoscopy
233308|NCT02174497|Bowel Preparation|bowel preparation
233309|NCT02174497|Safety|safety
233310|NCT02174497|Tolerability|tolerability
233311|NCT02174484|Pacemaker|pacemaker
233312|NCT02174484|Remote monitoring|remote monitoring
233313|NCT02174484|Remote follow-up|remote follow-up
233314|NCT02174484|Home monitoring|home monitoring
233315|NCT02174484|Periodic IEGM|periodic iegm
233316|NCT02174484|Intracardiac electrogram|intracardiac electrogram
233317|NCT02174471|Aortic Stenosis|aortic stenosis
233318|NCT02174471|Aortic Valve Replacement|aortic valve replacement
233319|NCT02174471|T1 Mapping|t1 mapping
233320|NCT02174471|Extracellular Volume Fraction|extracellular volume fraction
233321|NCT02174471|Cardiovascular Magnetic Resonance|cardiovascular magnetic resonance
233322|NCT02174471|Diffuse Myocardial Fibrosis|diffuse myocardial fibrosis
233323|NCT02174458|Bariatric surgery; Body contouring; Quality of life|bariatric surgery; body contouring; quality of life
233324|NCT02174445|Patients with CML in chronic phase|patients with cml in chronic phase
233325|NCT02174445|Imatinib|imatinib
233326|NCT02174445|Nilotinib|nilotinib
233327|NCT02174432|Itch|itch
233328|NCT02174432|Chronic Itch|chronic itch
233329|NCT02174432|Nalbupine|nalbupine
233330|NCT02174419|Itch|itch
233331|NCT02174419|Chronic Itch|chronic itch
233332|NCT02174419|nalbuphine|nalbuphine
233333|NCT02174406|Ultrasound|ultrasound
233334|NCT02174406|Digital Breast Tomosynthesis|digital breast tomosynthesis
233335|NCT02174406|14-119|14-119
233336|NCT02174367|Chronic plaque psoriasis|chronic plaque psoriasis
233337|NCT02174367|Liver fibrosis|liver fibrosis
233338|NCT02174367|Fatty liver disease|fatty liver disease
233339|NCT02174367|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
233340|NCT02174367|Transient elastography|transient elastography
233341|NCT02174367|Fibroscan|fibroscan
233342|NCT02174367|Procollagen-3 N-Terminal peptide|procollagen-3 n-terminal peptide
233343|NCT02174367|Alanine aminotransferase|alanine aminotransferase
233344|NCT02174367|Liver function tests|liver function tests
233345|NCT02174354|Psoriasis|psoriasis
233346|NCT02174354|Methotrexate|methotrexate
233347|NCT02174354|Methotrexate Polyglutamates|methotrexate polyglutamates
233348|NCT02174354|Injury of Liver|injury of liver
233349|NCT02174341|Chikungunya fever|chikungunya fever
233350|NCT02174341|Chikungunya Virus|chikungunya virus
233443|NCT02173704|Meningitis|meningitis
233444|NCT02173704|Infants|infants
233351|NCT02174328|See incidence of Pre-Eclampsia in acetylsalicylic acid group|see incidence of pre-eclampsia in acetylsalicylic acid group
233352|NCT02174328|See incidence of Pre-Eclampsia in placebo group|see incidence of pre-eclampsia in placebo group
233353|NCT02174289|Heart Failure|heart failure
233354|NCT02174289|Cardiac Resynchronisation Therapy|cardiac resynchronisation therapy
233355|NCT02174289|Transseptal left ventricular endocardial lead|transseptal left ventricular endocardial lead
233356|NCT02174250|PD|pd
233357|NCT02174237|Phase 1, safety, tolerability, PK, PD|phase 1, safety, tolerability, pk, pd
233358|NCT02174224|Violence|violence
233359|NCT02174224|At-risk youth|at-risk youth
233360|NCT02174224|Intentional Injury|intentional injury
233361|NCT02174224|Violence Intervention|violence intervention
233362|NCT02174224|Youth|youth
233363|NCT02174224|recidivism|recidivism
233364|NCT02174198|Immediate implant|immediate implant
233365|NCT02174198|bone graft|bone graft
233366|NCT02174198|immediate restoration|immediate restoration
233367|NCT02174185|bladder cancer|bladder cancer
233368|NCT02174185|conduit diversion|conduit diversion
233369|NCT02174185|orthotopic neobladder|orthotopic neobladder
233370|NCT02174185|health-related quality of life|health-related quality of life
233371|NCT02174185|validated questionnaire|validated questionnaire
233372|NCT02174146|leptin|leptin
233373|NCT02174146|visfatin|visfatin
233374|NCT02174146|chronic periodontitis|chronic periodontitis
233375|NCT02174146|diabetes mellitus|diabetes mellitus
233376|NCT02174146|non-surgical periodontal therapy|non-surgical periodontal therapy
233377|NCT02174133|left ventricular assist device|left ventricular assist device
233378|NCT02174133|endothelial function|endothelial function
233379|NCT02174133|microvascular perfusion|microvascular perfusion
233380|NCT02174133|microparticles|microparticles
233381|NCT02174107|Health economics|health economics
233382|NCT02174107|Percutaneous vertebroplasty|percutaneous vertebroplasty
233383|NCT02174107|Radiation therapy|radiation therapy
233384|NCT02174107|Painful spine metastases|painful spine metastases
233385|NCT02174081|mechanical ventilation, ARDS, Ventilator strategy, outcome|mechanical ventilation, ards, ventilator strategy, outcome
233386|NCT02174068|Paracetamol|paracetamol
233387|NCT02174068|Nefopam|nefopam
233388|NCT02174068|Pharmacokinetic|pharmacokinetic
233389|NCT02174068|Drug interaction|drug interaction
233390|NCT02174055|Depression|depression
233391|NCT02174055|14-101|14-101
233392|NCT02174029|Atrophy|atrophy
233393|NCT02174029|Ventilator|ventilator
233394|NCT02174029|Induced|induced
233395|NCT02174029|Diaphragm|diaphragm
233396|NCT02174029|Dysfunction|dysfunction
233397|NCT02174016|Intensive Care Units|intensive care units
233398|NCT02174016|Pediatric|pediatric
233399|NCT02174003|whole body hyperthermia|whole body hyperthermia
233400|NCT02174003|depression|depression
233401|NCT02174003|fibromyalgia|fibromyalgia
233402|NCT02174003|rheumatoid arthritis|rheumatoid arthritis
233403|NCT02174003|perimenopausal symptoms|perimenopausal symptoms
233404|NCT02174003|open treatment|open treatment
233405|NCT02173990|adenocarcinoma|adenocarcinoma
233406|NCT02173990|colon and/or rectum|colon and/or rectum
233407|NCT02173977|GnRH Agonist|gnrh agonist
233408|NCT02173977|GnRH Antagonist|gnrh antagonist
233409|NCT02173977|OHSS|ohss
233410|NCT02173964|fluorodeoxyglucose|fluorodeoxyglucose
233411|NCT02173964|positron emission tomography|positron emission tomography
233412|NCT02173964|computed tomography|computed tomography
233413|NCT02173964|bowel|bowel
233414|NCT02173964|pinaverium bromide|pinaverium bromide
233415|NCT02173951|young minimally transfused beta thalassemia major|young minimally transfused beta thalassemia major
233416|NCT02173951|labile plasma iron (LPI)|labile plasma iron (lpi)
233417|NCT02173951|Transferrin saturation (TSAT)|transferrin saturation (tsat)
233418|NCT02173951|Deferiprone|deferiprone
233419|NCT02173951|Transfusional iron loading rate|transfusional iron loading rate
233420|NCT02173951|Transfusion units|transfusion units
233421|NCT02173938|Smokers|smokers
233422|NCT02173938|outpatient|outpatient
233423|NCT02173938|Tobacco Dependence Treatment Program|tobacco dependence treatment program
233424|NCT02173873|Age related macular degeneration|age related macular degeneration
233425|NCT02173873|central retinal vein occlusion|central retinal vein occlusion
233426|NCT02173860|Coronary artery disease|coronary artery disease
233427|NCT02173860|Valvular heart disease|valvular heart disease
233428|NCT02173860|Fractional flow reserve|fractional flow reserve
233429|NCT02173860|Coronary artery bypass surgery|coronary artery bypass surgery
233430|NCT02173860|Coronary graft failure or patency|coronary graft failure or patency
233431|NCT02173847|anvil-shaped corneal graft|anvil-shaped corneal graft
233432|NCT02173847|penetrating keratoplasty|penetrating keratoplasty
233433|NCT02173847|femtosecond laser|femtosecond laser
233434|NCT02173847|laser welding|laser welding
233435|NCT02173834|Brown Adipose Tissue|brown adipose tissue
233436|NCT02173834|Weight|weight
233437|NCT02173834|Sympathetic Nervous System|sympathetic nervous system
233438|NCT02173756|chemotherapy|chemotherapy
233439|NCT02173756|mucositis|mucositis
233440|NCT02173756|systemic opioids|systemic opioids
233441|NCT02173756|morphine|morphine
233442|NCT02173743|plasma, calcific tendinitis, rotator cuff, PRP|plasma, calcific tendinitis, rotator cuff, prp
233445|NCT02173704|Meningococcal B Recombinant Vaccine|meningococcal b recombinant vaccine
233446|NCT02173626|Mindfulness|mindfulness
233447|NCT02173613|infection lung elderly patients|infection lung elderly patients
233448|NCT02173600|Cardiovascular risk|cardiovascular risk
233449|NCT02173600|Primary prevention|primary prevention
233450|NCT02173600|Intensive dietary counselling|intensive dietary counselling
233451|NCT02173600|Physical exercise|physical exercise
233452|NCT02173587|Anti-inflammation, Rheumatoid arthritis, Thick shell mussel lipid extract, Chinese|anti-inflammation, rheumatoid arthritis, thick shell mussel lipid extract, chinese
233453|NCT02173574|Hepatitis C Virus, Viral, Antiviral, Infection, Infectious disease, alisporivir, EDP239, DEB025|hepatitis c virus, viral, antiviral, infection, infectious disease, alisporivir, edp239, deb025
233454|NCT02173561|Posttraumatic Stress Disorder|posttraumatic stress disorder
233455|NCT02173561|Cognitive Processing Therapy|cognitive processing therapy
233456|NCT02173561|combat|combat
233457|NCT02173561|military|military
233458|NCT02173561|CPT|cpt
233459|NCT02173561|group therapy|group therapy
233460|NCT02173548|heart failure|heart failure
233461|NCT02173548|HFpEF|hfpef
233462|NCT02173548|diastole|diastole
233463|NCT02173548|diastolic heart failure|diastolic heart failure
233464|NCT02173548|inflammation|inflammation
233465|NCT02173548|interleukin-1|interleukin-1
233466|NCT02173548|C-reactive protein|c-reactive protein
233467|NCT02173522|Prostate cancer|prostate cancer
233468|NCT02173522|Prostate artery embolization|prostate artery embolization
233469|NCT02173522|Robot-assisted laparoscopic radical prostatectomy|robot-assisted laparoscopic radical prostatectomy
233470|NCT02173496|Wet age-related macular degeneration|wet age-related macular degeneration
233471|NCT02173496|Assessment modalities for preclinical, pre-symptomatic ARMD|assessment modalities for preclinical, pre-symptomatic armd
233472|NCT02173457|Chiglitazar|chiglitazar
233473|NCT02173457|Sitagliptin|sitagliptin
233474|NCT02173457|diabetes|diabetes
233475|NCT02173457|type 2 diabetes|type 2 diabetes
233476|NCT02173444|in-vitro fertilization|in-vitro fertilization
233477|NCT02173444|ovarian stimulation|ovarian stimulation
233478|NCT02173431|BMI|bmi
233479|NCT02173431|Pressure|pressure
233480|NCT02173431|Bedsore|bedsore
233481|NCT02173418|Postoperative pain|postoperative pain
233482|NCT02173418|Acute postoperative pain|acute postoperative pain
233483|NCT02173418|Chronic postoperative pain|chronic postoperative pain
233484|NCT02173418|Shoulder pain|shoulder pain
233485|NCT02173418|Thoracotomy|thoracotomy
233486|NCT02173418|Thoracoscopy|thoracoscopy
233487|NCT02173405|Myofascial Pain Syndromes|myofascial pain syndromes
233488|NCT02173405|Pelvic pain|pelvic pain
233489|NCT02173405|Trigger points + injections|trigger points + injections
233490|NCT02173405|Myofascial Trigger Point Pain|myofascial trigger point pain
233491|NCT02173405|Trigger Point Pain, Myofascial|trigger point pain, myofascial
233492|NCT02173405|Botulinum Toxins, Type A|botulinum toxins, type a
233493|NCT02173405|Botulinum Neurotoxin A|botulinum neurotoxin a
233494|NCT02173405|Botulinum Toxin Type A|botulinum toxin type a
233495|NCT02173405|Clostridium botulinum A Toxin|clostridium botulinum a toxin
233496|NCT02173405|Clostridium Botulinum Toxin Type A|clostridium botulinum toxin type a
233497|NCT02173405|Oculinum|oculinum
233498|NCT02173379|Absorb™ BVS|absorb™ bvs
233499|NCT02173379|Angioplasty|angioplasty
233500|NCT02173379|Bioabsorbable|bioabsorbable
233502|NCT02173379|Coronary Artery Disease|coronary artery disease
233503|NCT02173379|Coronary Artery Endothelial Responsiveness|coronary artery endothelial responsiveness
233504|NCT02173379|Coronary artery restenosis|coronary artery restenosis
233505|NCT02173379|Coronary artery stenosis|coronary artery stenosis
233506|NCT02173379|Coronary scaffold|coronary scaffold
233507|NCT02173379|Coronary Stent|coronary stent
233508|NCT02173379|Drug eluting stents|drug eluting stents
233509|NCT02173379|Everolimus|everolimus
233510|NCT02173379|Myocardial ischemia|myocardial ischemia
233511|NCT02173379|Stent thrombosis|stent thrombosis
233512|NCT02173379|Stents|stents
233513|NCT02173353|Ultrasound use during radiation therapy for Pancreas cancer|ultrasound use during radiation therapy for pancreas cancer
233514|NCT02173314|Long term foster care|long term foster care
233515|NCT02173314|child abuse and neglect|child abuse and neglect
233516|NCT02173262|Breast|breast
233517|NCT02173236|Dental Implant Platform Switching|dental implant platform switching
233518|NCT02173236|Early Dental Implant Loading|early dental implant loading
233519|NCT02173210|Premature birth|premature birth
233520|NCT02173210|Premature delivery|premature delivery
233521|NCT02173210|Metabolomics|metabolomics
233522|NCT02173210|Microbiota|microbiota
233523|NCT02173210|Genetics|genetics
233524|NCT02173210|17 hydroxyprogesterone caproate|17 hydroxyprogesterone caproate
233525|NCT02173197|Occupational Therapy|occupational therapy
233526|NCT02173197|Complex patients|complex patients
233527|NCT02173197|Occupational performance problem|occupational performance problem
233528|NCT02173197|Rehabilitation Complexity Scale|rehabilitation complexity scale
233529|NCT02173184|bacterial vaginosis|bacterial vaginosis
233530|NCT02173184|Gynevac Lactobacillus vaccine|gynevac lactobacillus vaccine
233531|NCT02173171|Melanoma|melanoma
233532|NCT02173171|talimogene laherparepvec|talimogene laherparepvec
233533|NCT02173145|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
233534|NCT02173145|cough|cough
233535|NCT02173145|immunomodulation|immunomodulation
233536|NCT02173145|macrolide|macrolide
233537|NCT02173119|Hepatocellular|hepatocellular
233538|NCT02173119|Carcinoma|carcinoma
233539|NCT02173119|HCC|hcc
233540|NCT02173119|lipiodol|lipiodol
233541|NCT02173093|Neuroblastoma|neuroblastoma
233542|NCT02173093|Osteosarcoma|osteosarcoma
233543|NCT02173093|Solid tumor|solid tumor
233544|NCT02173093|Immunotherapy targeting GD2|immunotherapy targeting gd2
233545|NCT02173093|Bispecific antibodies|bispecific antibodies
233546|NCT02173093|Activated T cells|activated t cells
233547|NCT02173080|autosomal dominant polycystic liver disease|autosomal dominant polycystic liver disease
233548|NCT02173080|autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
233549|NCT02173080|quality of life|quality of life
233550|NCT02173080|patient reported outcome tool|patient reported outcome tool
233551|NCT02173067|Diabetes mellitus|diabetes mellitus
233552|NCT02173067|Epinephrine|epinephrine
233553|NCT02173067|Anesthesia, Dental|anesthesia, dental
233554|NCT02173067|lidocaine|lidocaine
233555|NCT02173067|Ambulatory Surgical Procedures|ambulatory surgical procedures
233556|NCT02173054|Acne|acne
233557|NCT02173054|Moisturizer|moisturizer
233558|NCT02173054|Efficacy|efficacy
233559|NCT02173054|Irritation|irritation
233560|NCT02173041|Prevention and Awareness Groups (PAG),|prevention and awareness groups (pag),
233561|NCT02173041|Substance Use Disorder,|substance use disorder,
233562|NCT02173041|Community based intervention|community based intervention
233563|NCT02173028|Beta Blocker Intolerance;|beta blocker intolerance;
233564|NCT02173028|Remote Patient Management system;|remote patient management system;
233565|NCT02173028|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
233566|NCT02173015|accidental falls|accidental falls
233567|NCT02173015|older adults|older adults
233568|NCT02173015|long-term care|long-term care
233569|NCT02173015|nursing home|nursing home
233570|NCT02173015|postural balance|postural balance
233571|NCT02173002|Telemedicine|telemedicine
233572|NCT02173002|Patient empowerment|patient empowerment
233573|NCT02173002|Integrated care|integrated care
233574|NCT02172989|Near-infrared fluorescence|near-infrared fluorescence
233575|NCT02172989|Indocyanine green, ICG|indocyanine green, icg
233576|NCT02172989|Radio-guided surgery|radio-guided surgery
233577|NCT02172989|breast cancer|breast cancer
233578|NCT02172976|pancreas cancer|pancreas cancer
233579|NCT02172976|neoadjuvant chemotherapy|neoadjuvant chemotherapy
233580|NCT02172976|Folfirinox|folfirinox
233581|NCT02172976|gemcitabine|gemcitabine
233582|NCT02172963|Stem Cell Transplantation|stem cell transplantation
233583|NCT02172963|Decidual Stromal Cells|decidual stromal cells
233584|NCT02172937|Stem Cell Transplantation|stem cell transplantation
233585|NCT02172937|Decidual Stromal Cells|decidual stromal cells
233586|NCT02172924|Stem Cell Transplantation|stem cell transplantation
233587|NCT02172924|Decidual Stromal Cells|decidual stromal cells
233588|NCT02172911|Cervical cancer|cervical cancer
233589|NCT02172911|Papillomavirus|papillomavirus
233590|NCT02172911|Chemoradiation|chemoradiation
233591|NCT02172911|Recurrent cervical cancer|recurrent cervical cancer
233592|NCT02172911|Persistent cervical cancer|persistent cervical cancer
233593|NCT02172885|Mesenchymal stem cell based therapy|mesenchymal stem cell based therapy
233594|NCT02172885|cell infusion|cell infusion
233595|NCT02172872|Newly diagnosed|newly diagnosed
233596|NCT02172872|AML|aml
233597|NCT02172872|Elderly|elderly
233598|NCT02172872|Decitabine|decitabine
233599|NCT02172872|Transplant|transplant
233600|NCT02172859|lumiVida™, cognition, mood, sleep, tryptophane|lumivida™, cognition, mood, sleep, tryptophane
233601|NCT02172820|cardiac rehabilitation|cardiac rehabilitation
233602|NCT02172820|contingency management|contingency management
233603|NCT02172768|pharmacokinetics|pharmacokinetics
233604|NCT02172768|alternate dosing|alternate dosing
233605|NCT02172768|micafungin|micafungin
233606|NCT02172755|Eslicarbazepine acetate|eslicarbazepine acetate
233607|NCT02172755|BIA 2-093|bia 2-093
233608|NCT02172742|Eslicarbazepine acetate|eslicarbazepine acetate
233609|NCT02172742|BIA 2-093|bia 2-093
233610|NCT02172729|adductor canal block|adductor canal block
233611|NCT02172729|healthy volunteers|healthy volunteers
233612|NCT02172729|US-guided peripheral nerve block|us-guided peripheral nerve block
233613|NCT02172729|lower limb|lower limb
233614|NCT02172729|duration|duration
233615|NCT02172729|Muscle Strength|muscle strength
233616|NCT02172729|Anesthetics, Local|anesthetics, local
233617|NCT02172729|Sensation|sensation
233618|NCT02172703|TBI|tbi
233619|NCT02172703|SAH|sah
233620|NCT02172703|ICP|icp
233621|NCT02172703|non invasive measurement|non invasive measurement
233622|NCT02172690|Gastric Cancer|gastric cancer
233623|NCT02172690|Laparoscopic Staging|laparoscopic staging
233624|NCT02172690|Cytology|cytology
233625|NCT02172690|Peritoneal Metastases|peritoneal metastases
233626|NCT02172664|noncarious cervical lesions|noncarious cervical lesions
233627|NCT02172664|dental adhesive|dental adhesive
233628|NCT02172664|retention|retention
233629|NCT02172664|enamel margin discoloration|enamel margin discoloration
233630|NCT02172664|self etch|self etch
233631|NCT02172664|selective etch procedures|selective etch procedures
233632|NCT02172651|Vitamin D|vitamin d
233633|NCT02172651|Stage I-III colon cancer|stage i-iii colon cancer
233634|NCT02172651|Stage IV colon cancer|stage iv colon cancer
233635|NCT02172651|Resectable liver metastases|resectable liver metastases
233636|NCT02172638|Enhanced Recovery After Surgery|enhanced recovery after surgery
233637|NCT02172638|ERAS|eras
233638|NCT02172638|Fast-Track|fast-track
233639|NCT02172638|Ovarian cancer|ovarian cancer
233640|NCT02172638|Gynecologic surgery|gynecologic surgery
233641|NCT02172638|Gynecology oncology|gynecology oncology
233642|NCT02172638|Median length of stay|median length of stay
233643|NCT02172638|Readmission rate|readmission rate
233644|NCT02172638|Surgery related complications|surgery related complications
233645|NCT02172638|Cost|cost
233646|NCT02172625|Athletic performance|athletic performance
233647|NCT02172625|Running|running
233648|NCT02172625|Dietary supplementation|dietary supplementation
233649|NCT02172625|Quality of life|quality of life
233650|NCT02172625|Running performance|running performance
233651|NCT02172625|oxidative damage|oxidative damage
233652|NCT02172612|Anticholinergic drugs|anticholinergic drugs
233653|NCT02172599|sit-stand workstation|sit-stand workstation
233654|NCT02172599|workplace|workplace
233655|NCT02172599|multi-component intervention|multi-component intervention
233656|NCT02172599|randomised control trial design|randomised control trial design
233657|NCT02172599|physical activity|physical activity
233658|NCT02172599|sitting|sitting
233659|NCT02172599|sedentary behaviour|sedentary behaviour
233660|NCT02172599|process evaluation|process evaluation
233661|NCT02172599|health|health
233662|NCT02172365|Chronic myeloid leukemia|chronic myeloid leukemia
233663|NCT02172365|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
233664|NCT02172365|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
233665|NCT02172365|TKI failure|tki failure
233666|NCT02172183|cognitive-behavioral therapy, adolescents, ADHD.|cognitive-behavioral therapy, adolescents, adhd.
233667|NCT02172092|Diabetes|diabetes
233668|NCT02172092|Ketoacidosis|ketoacidosis
233669|NCT02172092|fluid shift|fluid shift
233670|NCT02172079|shoulder impingement, manual therapy, pain, motion.|shoulder impingement, manual therapy, pain, motion.
233671|NCT02172066|Posttraumatic Stress Disorder|posttraumatic stress disorder
233672|NCT02172066|Childhood maltreatment|childhood maltreatment
233673|NCT02172053|Workplace|workplace
233674|NCT02172053|Industrial workers|industrial workers
233675|NCT02172053|Resistance exercise|resistance exercise
233676|NCT02172053|Fatigue|fatigue
233677|NCT02172053|Occupational risk|occupational risk
233678|NCT02172053|Physical therapy|physical therapy
233679|NCT02172040|High blood pressure|high blood pressure
233680|NCT02172040|Systolic blood pressure|systolic blood pressure
233681|NCT02172040|Diastolic blood pressure|diastolic blood pressure
233682|NCT02172040|Antihypertensive|antihypertensive
233683|NCT02172014|Mechanical Ventilation|mechanical ventilation
233684|NCT02172014|Sedation|sedation
233685|NCT02172014|Fentanyl|fentanyl
233686|NCT02172014|Midazolam|midazolam
233687|NCT02172014|Comfort behavior scale|comfort behavior scale
233688|NCT02172001|IDA|ida
233689|NCT02172001|Iron deficiency|iron deficiency
233690|NCT02172001|iron deficiency anemia and who are intolerant or unresponsive to oral iron therapy|iron deficiency anemia and who are intolerant or unresponsive to oral iron therapy
233691|NCT02171988|Postural Orthostatic Tachycardia Syndrome|postural orthostatic tachycardia syndrome
233692|NCT02171988|propranolol|propranolol
233693|NCT02171988|bisoprolol|bisoprolol
233694|NCT02171988|pyridostigmine|pyridostigmine
233695|NCT02171975|Spinal anaesthesia|spinal anaesthesia
233696|NCT02171975|Ultrasound pre-procedure guided|ultrasound pre-procedure guided
233697|NCT02171975|Paramedian spinal|paramedian spinal
233698|NCT02171962|Zilver® PTX® Drug-Eluting Peripheral Stent|zilver® ptx® drug-eluting peripheral stent
233699|NCT02171962|Above-the-Knee Femoropopliteal Artery|above-the-knee femoropopliteal artery
233700|NCT02171962|Chinese patient|chinese patient
233701|NCT02171949|Chronic hepatitis|chronic hepatitis
233702|NCT02171949|Hepatic cirrhosis|hepatic cirrhosis
233703|NCT02171936|Pain|pain
233704|NCT02171936|Precariousness|precariousness
233705|NCT02171936|EPICES Score|epices score
233706|NCT02171936|CETD|cetd
233707|NCT02171923|depression|depression
233708|NCT02171910|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
233709|NCT02171910|Sedation|sedation
233710|NCT02171871|EFFECTS,|effects,
233711|NCT02171871|PASSIVE SMOKING ,|passive smoking ,
233712|NCT02171871|RESPIRATORY SYSTEM MECHANICS,|respiratory system mechanics,
233713|NCT02171871|DIFFERENT BODY POSITIONS.|different body positions.
233714|NCT02171858|Stroke|stroke
233715|NCT02171858|National Institutes of Health Stroke Scale|national institutes of health stroke scale
233716|NCT02171858|Serum high sensitivity C-Reactive Protein|serum high sensitivity c-reactive protein
233717|NCT02171845|Male foetuses of 10 to 37 weeks|male foetuses of 10 to 37 weeks
233718|NCT02171819|Influenza|influenza
233719|NCT02171819|Avian|avian
233720|NCT02171819|H5N1|h5n1
233721|NCT02171819|Vaccine|vaccine
233722|NCT02171390|Hypogonadism|hypogonadism
233723|NCT02171390|Endothelial dysfunction|endothelial dysfunction
233724|NCT02171390|Insulin resistance|insulin resistance
233725|NCT02171390|Inflammation|inflammation
233726|NCT02171390|Testosterone replacement therapy|testosterone replacement therapy
233727|NCT02171377|COPD|copd
233728|NCT02171377|electrical stimulation|electrical stimulation
233729|NCT02171377|Rehabilitation|rehabilitation
233730|NCT02171377|exercise test|exercise test
233731|NCT02171364|Atrial fibrillation, Virtual ablation, electrocardiography, electroanatomical mapping data|atrial fibrillation, virtual ablation, electrocardiography, electroanatomical mapping data
233732|NCT02171351|sympathetic nerve reactivity|sympathetic nerve reactivity
233733|NCT02171351|neuromuscular electrostimulation|neuromuscular electrostimulation
233734|NCT02171338|Procalcitonin|procalcitonin
233735|NCT02171338|Antibiotic therapy|antibiotic therapy
233736|NCT02171338|Lower respiratory tract diseases|lower respiratory tract diseases
233737|NCT02171325|irinotecan|irinotecan
233738|NCT02171325|Small Cell Lung Cancer|small cell lung cancer
233739|NCT02171312|Dizziness|dizziness
233740|NCT02171312|Imbalance|imbalance
233741|NCT02171286|KRAS|kras
233742|NCT02171286|EGFR|egfr
233743|NCT02171286|BRAF|braf
233744|NCT02171286|NRAS and HRAS|nras and hras
233745|NCT02171286|PIK3CA|pik3ca
233746|NCT02171286|RAS-RAF-MEK-MAPK|ras-raf-mek-mapk
233747|NCT02171286|HER2|her2
233748|NCT02171286|IDH1 and IDH2|idh1 and idh2
233749|NCT02171286|ALK|alk
233750|NCT02171286|TP53|tp53
233751|NCT02171286|c-KIT|c-kit
233752|NCT02171286|STAT1&3|stat1&3
233753|NCT02171286|PDGFRA|pdgfra
233754|NCT02171286|Metastatic colorectal cancer|metastatic colorectal cancer
233755|NCT02171286|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
233756|NCT02171286|Advanced melanoma|advanced melanoma
233757|NCT02171286|Gastrointestingal Struma Tumor|gastrointestingal struma tumor
233758|NCT02171286|Candidate genes implicated as potential prognostic and predictive biomarkers in patients with solid tumours|candidate genes implicated as potential prognostic and predictive biomarkers in patients with solid tumours
233759|NCT02171286|Circulating Tumor DNA|circulating tumor dna
233760|NCT02171273|Sleep|sleep
233761|NCT02171273|Aging|aging
233762|NCT02171273|Metabolism|metabolism
233763|NCT02171273|Circadian|circadian
233764|NCT02171273|Genetic|genetic
233765|NCT02171273|Alertness|alertness
233766|NCT02171260|Tumors|tumors
233767|NCT02171260|Lymphomas|lymphomas
233768|NCT02171260|Solid Tumors|solid tumors
233769|NCT02171260|Pediatric|pediatric
233770|NCT02171247|coronary computed tomographic angiography|coronary computed tomographic angiography
233771|NCT02171247|contrast|contrast
233772|NCT02171234|Epilepsy|epilepsy
233773|NCT02171234|BIA 2-093|bia 2-093
233774|NCT02171234|Eslicarbazepine acetate|eslicarbazepine acetate
233775|NCT02171221|Refractory or relapsed tumors|refractory or relapsed tumors
233776|NCT02171221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic
233777|NCT02171221|Fluorouracil|fluorouracil
233778|NCT02171195|Eslicarbazepine acetate|eslicarbazepine acetate
233779|NCT02171195|BIA 2-093|bia 2-093
233780|NCT02171195|Epilepsy|epilepsy
233781|NCT02171182|Qutenza|qutenza
233782|NCT02171182|8% capsaicin patch|8% capsaicin patch
233783|NCT02171182|Non-interventional|non-interventional
233784|NCT02171182|Post-operative peripheral neuropathic pain|post-operative peripheral neuropathic pain
233785|NCT02171182|Observational|observational
233786|NCT02171182|Czech Republic|czech republic
233787|NCT02171143|ASP2409|asp2409
233788|NCT02171143|Rheumatoid Arthritis|rheumatoid arthritis
233789|NCT02171143|methotrexate|methotrexate
233790|NCT02171130|Diabetes Mellitus|diabetes mellitus
233791|NCT02171130|Hypoglycemia|hypoglycemia
233792|NCT02171130|Glucagon|glucagon
233793|NCT02171130|Anti-glucagon Antibody|anti-glucagon antibody
233794|NCT02171130|Immunogenicity|immunogenicity
233795|NCT02171117|Acute Myeloid Leukemia|acute myeloid leukemia
233796|NCT02171117|microtransplantation|microtransplantation
233797|NCT02171117|elderly patients|elderly patients
233798|NCT02171117|HLA-mismatched|hla-mismatched
233799|NCT02171117|donor|donor
233800|NCT02171117|Peripheral|peripheral
233801|NCT02171117|stem cell|stem cell
233802|NCT02171117|infusion|infusion
233803|NCT02171104|allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
233804|NCT02171104|bone marrow transplantation|bone marrow transplantation
233805|NCT02171104|IMD|imd
233806|NCT02171104|AMACRD|amacrd
233807|NCT02171104|MNGIE|mngie
233808|NCT02171104|HDLS|hdls
233809|NCT02171104|OP|op
233810|NCT02171104|ALD|ald
233811|NCT02171091|endotracheal|endotracheal
233812|NCT02171091|intubation|intubation
233813|NCT02171091|airway|airway
233814|NCT02171091|inflammation|inflammation
233815|NCT02171078|Breast Cancer|breast cancer
233816|NCT02171078|Breast Neoplasms|breast neoplasms
233817|NCT02171078|Health Services Research|health services research
233818|NCT02171078|Surveillance|surveillance
233819|NCT02171078|Diagnostic Imaging|diagnostic imaging
233820|NCT02171078|Magnetic Resonance Imaging|magnetic resonance imaging
233821|NCT02171078|Mammography|mammography
233822|NCT02171078|Toxicity|toxicity
233823|NCT02171078|Adverse Effects|adverse effects
233824|NCT02171078|Side Effects|side effects
233825|NCT02171078|Recurrence|recurrence
233826|NCT02171065|NIRS/IVUS|nirs/ivus
233827|NCT02171065|multimodality imaging|multimodality imaging
233828|NCT02171065|PROSPECT|prospect
233829|NCT02170961|Acute heart failure|acute heart failure
233830|NCT02170961|RAAS|raas
233831|NCT02170961|MMP3|mmp3
233832|NCT02170961|MMP12|mmp12
233833|NCT02170961|Polymorphysm|polymorphysm
233834|NCT02170948|ultrasound-guided regional anesthesia|ultrasound-guided regional anesthesia
233835|NCT02170948|nerve block|nerve block
233836|NCT02170948|ankle block|ankle block
233837|NCT02170948|dexmedetomidine|dexmedetomidine
233838|NCT02170948|Precedex|precedex
233839|NCT02170948|ankle surgery|ankle surgery
233840|NCT02170948|forefoot surgery|forefoot surgery
233841|NCT02170948|duration|duration
233842|NCT02170948|anesthetic duration following ankle block for forefoot surgery|anesthetic duration following ankle block for forefoot surgery
233843|NCT02170883|asthma|asthma
233844|NCT02170883|mHealth|mhealth
233845|NCT02170883|cluster randomized controlled trial|cluster randomized controlled trial
233846|NCT02170883|pharmacy practice|pharmacy practice
233847|NCT02170883|pharmacist|pharmacist
233848|NCT02170857|Hyaluronic acid|hyaluronic acid
233849|NCT02170857|infra-bony defects|infra-bony defects
233850|NCT02170857|chronic periodontitis|chronic periodontitis
233851|NCT02170857|experimental|experimental
233852|NCT02170857|radiographic|radiographic
233853|NCT02170857|clinical|clinical
233854|NCT02170857|periodontal surgical treatment|periodontal surgical treatment
233855|NCT02170857|open flap curettage|open flap curettage
233856|NCT02170818|Education|education
233857|NCT02170818|Curriculum|curriculum
233858|NCT02170818|Anesthesiology|anesthesiology
233859|NCT02170818|Operating Rooms|operating rooms
233860|NCT02170779|multiple sclerosis|multiple sclerosis
233861|NCT02170779|spasticity|spasticity
233862|NCT02170779|stretching|stretching
233863|NCT02170779|exercise|exercise
233864|NCT02170779|rehabilitation|rehabilitation
233865|NCT02170714|Acute severe colitis|acute severe colitis
233866|NCT02170714|Children|children
233867|NCT02170714|Infliximab|infliximab
233868|NCT02170714|colectomy|colectomy
233869|NCT02170688|IV contrast|iv contrast
233870|NCT02170688|contrast dosing|contrast dosing
233871|NCT02170662|male pattern hair loss|male pattern hair loss
233872|NCT02170662|androgenetic alopecia|androgenetic alopecia
233873|NCT02170662|bimatoprost|bimatoprost
233874|NCT02170649|BIA 2-093|bia 2-093
233875|NCT02170649|Eslicarbazepine acetate|eslicarbazepine acetate
233876|NCT02170558|Trabecular Metal|trabecular metal
233877|NCT02170558|Metal reduction CT|metal reduction ct
233878|NCT02170558|TM- Ardis|tm- ardis
233879|NCT02170545|avascular necrosis|avascular necrosis
233880|NCT02170545|humeral head fracture|humeral head fracture
233881|NCT02170545|proximal arm fracture|proximal arm fracture
233882|NCT02170545|arthroplasty|arthroplasty
233883|NCT02170532|asthma|asthma
233884|NCT02170519|pulmonary hypertension|pulmonary hypertension
233885|NCT02170493|Insole Sensor|insole sensor
233886|NCT02170493|Optimial Limb Loading|optimial limb loading
233887|NCT02170493|42IIIB|42iiib
233888|NCT02170493|IIIC|iiic
233889|NCT02170493|Lower Extremity Fractures|lower extremity fractures
233890|NCT02170467|Intestinal permeability - Anorexia nervosa- Re feeding - auto-antibodies α-MSH|intestinal permeability - anorexia nervosa- re feeding - auto-antibodies α-msh
233891|NCT02170454|neuromodulation|neuromodulation
233892|NCT02170454|swallowing|swallowing
233893|NCT02170454|magnetic stimulation|magnetic stimulation
233894|NCT02170454|healthy subjects|healthy subjects
233895|NCT02170441|Tuberculosis|tuberculosis
233896|NCT02170441|Multi-drug resistant tuberculosis|multi-drug resistant tuberculosis
233897|NCT02170441|Extensively drug-resistant tuberculosis|extensively drug-resistant tuberculosis
233898|NCT02170441|Drug-resistant tuberculosis|drug-resistant tuberculosis
233899|NCT02170441|Mycobacterial Growth Indicator Tube Drug Susceptibility Test|mycobacterial growth indicator tube drug susceptibility test
233900|NCT02170441|Line Probe Assay|line probe assay
233901|NCT02170441|Microscopic Observation Drug Susceptibility Assay|microscopic observation drug susceptibility assay
233902|NCT02170441|Pyrosequencing|pyrosequencing
233903|NCT02170428|growth,|growth,
233904|NCT02170428|infancy,|infancy,
233905|NCT02170428|children,|children,
233906|NCT02170428|diet,|diet,
233907|NCT02170428|breastfeeding|breastfeeding
233908|NCT02170428|complementary feeding|complementary feeding
233909|NCT02170428|early life programming|early life programming
233910|NCT02170428|tracking|tracking
233911|NCT02170428|physical activity|physical activity
233912|NCT02170415|Persistent post-surgical pain|persistent post-surgical pain
233913|NCT02170415|Breast surgery|breast surgery
233914|NCT02170415|Complex intervention|complex intervention
233915|NCT02170415|Pain treatment|pain treatment
233916|NCT02170376|Parkinson's disease (PD)|parkinson's disease (pd)
233917|NCT02170376|BIA 9-1067|bia 9-1067
233918|NCT02170376|Opicapone|opicapone
233919|NCT02170363|Heart Failure|heart failure
233920|NCT02170363|Ventricular Dysfunction|ventricular dysfunction
233921|NCT02170363|Cardiomyopathies|cardiomyopathies
233922|NCT02170363|Heart Disease|heart disease
233923|NCT02170363|Cardiovascular Disease|cardiovascular disease
233924|NCT02170363|Heart-assist devices|heart-assist devices
233925|NCT02170363|Thoratec Corporation|thoratec corporation
233926|NCT02170311|Z-213, Ferric carboxymaltose, Iron, Iron-deficiency-anemia|z-213, ferric carboxymaltose, iron, iron-deficiency-anemia
233927|NCT02170298|ADHD|adhd
233928|NCT02170298|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
233929|NCT02170298|Vyvanse|vyvanse
233930|NCT02170298|Lisdexamfetamine|lisdexamfetamine
233931|NCT02170285|perinatal stroke|perinatal stroke
233932|NCT02170285|hemiparetic cerebral palsy|hemiparetic cerebral palsy
233933|NCT02170285|brain stimulation|brain stimulation
233934|NCT02170285|tDCS|tdcs
233935|NCT02170285|constraint-induced movement therapy|constraint-induced movement therapy
233936|NCT02170285|hand arm bimanual intensive therapy|hand arm bimanual intensive therapy
233937|NCT02170259|Tension-type headache|tension-type headache
233938|NCT02170259|Depression|depression
233939|NCT02170259|Anxiety|anxiety
233940|NCT02170259|Manual therapy|manual therapy
233941|NCT02170259|Spinal manipulation|spinal manipulation
233942|NCT02170259|Patients diagnosed with tension-type headache|patients diagnosed with tension-type headache
233943|NCT02170246|Acute HIV infection|acute hiv infection
233944|NCT02170246|Central nervous system|central nervous system
233945|NCT02170246|Antiretroviral therapy|antiretroviral therapy
233946|NCT02170246|Telmisartan|telmisartan
233947|NCT02170246|Cerebrospinal fluid|cerebrospinal fluid
233948|NCT02170220|Drug therapy|drug therapy
233949|NCT02170207|Pharmacological therapy|pharmacological therapy
233950|NCT02170194|smart phone apps|smart phone apps
233951|NCT02170194|subthreshold PTSD|subthreshold ptsd
233952|NCT02170194|resilience enhancement|resilience enhancement
233953|NCT02170194|military veterans|military veterans
233954|NCT02170194|natural disasters|natural disasters
233955|NCT02170194|terrorism|terrorism
233956|NCT02170194|shootings|shootings
233957|NCT02170194|fMRI|fmri
233958|NCT02170194|physiology|physiology
233959|NCT02170181|SBRT|sbrt
233960|NCT02170181|prostate cancer|prostate cancer
233961|NCT02170181|lung cancer|lung cancer
233962|NCT02170181|bladder cancer|bladder cancer
233963|NCT02170181|kidney cancer|kidney cancer
233964|NCT02170181|oligometastatic disease|oligometastatic disease
233965|NCT02170168|Community health services|community health services
233966|NCT02170168|Models, organizational|models, organizational
233967|NCT02170168|Referral and consultation|referral and consultation
233968|NCT02170168|Palliative medicine|palliative medicine
233969|NCT02170168|Terminal care|terminal care
233971|NCT02170142|perinatal brain|perinatal brain
233972|NCT02170142|development, neonates|development, neonates
233973|NCT02170103|segment elevation myocardial infarctions (STEMIs),|segment elevation myocardial infarctions (stemis),
233974|NCT02170103|sonothrombolysis|sonothrombolysis
233975|NCT02170103|reperfusion|reperfusion
233976|NCT02170103|percutaneous intervention (PCI),|percutaneous intervention (pci),
233977|NCT02170103|antithrombotic therapy,|antithrombotic therapy,
233978|NCT02170103|antiplatelet therapy,|antiplatelet therapy,
233979|NCT02170090|adjuvant chemotherapy|adjuvant chemotherapy
233980|NCT02170090|cholangiocarcinoma|cholangiocarcinoma
233981|NCT02170090|muscle invasive gall bladder carcinoma|muscle invasive gall bladder carcinoma
233982|NCT02170090|translational research|translational research
233983|NCT02170090|multidisciplinary|multidisciplinary
233984|NCT02170090|AIO, DGAV, DGVS|aio, dgav, dgvs
233985|NCT02170077|Epilepsy|epilepsy
233986|NCT02170077|BIA 2-093|bia 2-093
233987|NCT02170064|Epilepsy|epilepsy
233988|NCT02170064|BIA 2-093|bia 2-093
233989|NCT02170051|negative symptoms|negative symptoms
233990|NCT02170051|cognition|cognition
233991|NCT02170051|functioning|functioning
233992|NCT02170051|defeatist attitudes|defeatist attitudes
233993|NCT02170051|psychosocial treatment|psychosocial treatment
233994|NCT02170038|Drug Kinetics|drug kinetics
233995|NCT02170025|Cystic fibrosis|cystic fibrosis
233996|NCT02170025|delta F508|delta f508
233997|NCT02170025|Safety|safety
233998|NCT02170025|Tolerability|tolerability
233999|NCT02170025|Sweat Chloride|sweat chloride
234000|NCT02170025|Pharmacokinetics|pharmacokinetics
234001|NCT02170012|Multiple dose|multiple dose
234002|NCT02170012|safety|safety
234003|NCT02170012|tolerability|tolerability
234004|NCT02170012|PK|pk
234005|NCT02169973|Healthy|healthy
234006|NCT02169973|Positron Emission Tomography|positron emission tomography
234007|NCT02169973|11C-MK-3168|11c-mk-3168
234008|NCT02169973|JNJ-42165279|jnj-42165279
234009|NCT02169973|Human Brain|human brain
234010|NCT02169895|Parkinson's disease (PD)|parkinson's disease (pd)
234011|NCT02169895|Opicapone|opicapone
234012|NCT02169895|Bia 9-1067|bia 9-1067
234013|NCT02169882|Tuberculous meningitis|tuberculous meningitis
234014|NCT02169882|Rifampicin|rifampicin
234015|NCT02169882|Dose finding study|dose finding study
234016|NCT02169882|Pharmacokinetics|pharmacokinetics
234017|NCT02169869|intrauterine device, postpartum, contraception, Mirena, Paragard, intrauterine system|intrauterine device, postpartum, contraception, mirena, paragard, intrauterine system
234018|NCT02169856|Cholecystectomy|cholecystectomy
234019|NCT02169856|Laparoscopic|laparoscopic
234020|NCT02169856|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
234021|NCT02169843|Dexmedetomidine,|dexmedetomidine,
234022|NCT02169843|agitation,|agitation,
234023|NCT02169843|AFPS,|afps,
234024|NCT02169843|NRS,|nrs,
234025|NCT02169843|mean arterial pressure|mean arterial pressure
234026|NCT02169843|heart rate(HR)|heart rate(hr)
234027|NCT02169830|vestibular migraines, nortriptyline and topiramate|vestibular migraines, nortriptyline and topiramate
234028|NCT02169791|hematologic malignancies|hematologic malignancies
234029|NCT02169778|Weight loss|weight loss
234030|NCT02169778|Intermittent energy restriction|intermittent energy restriction
234031|NCT02169778|Metabolic compensation|metabolic compensation
234032|NCT02169778|Diet therapy|diet therapy
234033|NCT02169765|Hepatocellular Carcinoma|hepatocellular carcinoma
234034|NCT02169765|Liver Cancer|liver cancer
234035|NCT02169752|Pre-Pulmonary Atrial Hypertension|pre-pulmonary atrial hypertension
234036|NCT02169739|ischemic preconditioning|ischemic preconditioning
234037|NCT02169739|remote ischemic preconditioning|remote ischemic preconditioning
234038|NCT02169739|ischemic stroke|ischemic stroke
234039|NCT02169739|white matter disease|white matter disease
234040|NCT02169739|cerebral small vessel disease|cerebral small vessel disease
234041|NCT02169739|cognitive decline|cognitive decline
234042|NCT02169739|leukoaraiosis|leukoaraiosis
234043|NCT02169739|diffusion tensor imaging|diffusion tensor imaging
234044|NCT02169739|white matter hyper intensity score|white matter hyper intensity score
234045|NCT02169739|European scale of age-related white matter change|european scale of age-related white matter change
234046|NCT02169713|Healthy subjects|healthy subjects
234047|NCT02169713|Mirabegron|mirabegron
234048|NCT02169713|Solifenacin|solifenacin
234049|NCT02169713|Tamsulosin HCl|tamsulosin hcl
234050|NCT02169700|Ischemic compression|ischemic compression
234051|NCT02169700|Myofascial trigger points|myofascial trigger points
234052|NCT02169700|Post-needling soreness|post-needling soreness
234053|NCT02169687|Thyroid, HIFU, hyperfunctioning, autonomous|thyroid, hifu, hyperfunctioning, autonomous
234054|NCT02169674|Hepatitis B|hepatitis b
234055|NCT02169674|Vaccine|vaccine
234056|NCT02169674|Immunogenicity|immunogenicity
234057|NCT02169661|Oxidative stress|oxidative stress
234058|NCT02169661|Lipid peroxides|lipid peroxides
234059|NCT02169661|Phytochemicals|phytochemicals
234060|NCT02169661|Ready meals|ready meals
234061|NCT02169661|Beetroot|beetroot
234062|NCT02169661|Blood pressure|blood pressure
234063|NCT02169648|macular edema|macular edema
234064|NCT02169648|branch retinal vein occlusion|branch retinal vein occlusion
234065|NCT02169648|central retinal vein occlusion|central retinal vein occlusion
234066|NCT02169648|ranibizumab|ranibizumab
234067|NCT02169648|cytokines|cytokines
234068|NCT02169648|visual acuity|visual acuity
234069|NCT02169648|central macular thickness|central macular thickness
234070|NCT02169635|macular buckle|macular buckle
234071|NCT02169635|high myopia|high myopia
234072|NCT02169635|posterior staphyloma|posterior staphyloma
234073|NCT02169609|Neuroblastoma|neuroblastoma
234074|NCT02169609|Immunotherapy|immunotherapy
234075|NCT02169609|Dinutuximab|dinutuximab
234076|NCT02169596|Acute Coronary Syndrome|acute coronary syndrome
234077|NCT02169596|Nitric oxide|nitric oxide
234078|NCT02169596|Ticagrelor|ticagrelor
234079|NCT02169596|Antiplatelet agents|antiplatelet agents
234080|NCT02169596|Endothelial function|endothelial function
234081|NCT02169583|GSK1325756|gsk1325756
234082|NCT02169583|Safety|safety
234083|NCT02169583|Bioavailability|bioavailability
234084|NCT02169583|Pharmacokinetics|pharmacokinetics
234085|NCT02169570|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
234086|NCT02169570|Pulmonary Tuberculosis|pulmonary tuberculosis
234087|NCT02169570|Vitamin D|vitamin d
234088|NCT02169570|Calcium|calcium
234089|NCT02169531|Diabetes Mellitus Type 2|diabetes mellitus type 2
234090|NCT02169531|Hyperglycemia|hyperglycemia
234091|NCT02169531|Immunotherapy|immunotherapy
234092|NCT02169531|Autologous|autologous
234093|NCT02169518|PON1 activity|pon1 activity
234094|NCT02169518|HDL functionality|hdl functionality
234095|NCT02169518|LDL oxidation|ldl oxidation
234096|NCT02169518|Diabetes Mellitus Type 1|diabetes mellitus type 1
234097|NCT02169518|Obesity|obesity
234098|NCT02169518|Diabetes Mellitus Type 2|diabetes mellitus type 2
234099|NCT02169518|Bariatric Surgery|bariatric surgery
234100|NCT02169505|Lymphoma|lymphoma
234101|NCT02169505|Hodgkin lymphoma|hodgkin lymphoma
234102|NCT02169505|HL|hl
234103|NCT02169505|CD30 positive Hodgkin Lymphoma|cd30 positive hodgkin lymphoma
234104|NCT02169505|Anaplastic large cell lymphoma|anaplastic large cell lymphoma
234105|NCT02169505|ALCL|alcl
234106|NCT02169505|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
234107|NCT02169505|ASCT|asct
234108|NCT02169505|Graft-versus-host disease|graft-versus-host disease
234109|NCT02169505|GVHD|gvhd
234110|NCT02169505|Brentuximab Vedotin|brentuximab vedotin
234111|NCT02169505|SGN-35|sgn-35
234112|NCT02169505|Adcetris|adcetris
234113|NCT02169492|Thrombectomy|thrombectomy
234114|NCT02169492|Stroke|stroke
234115|NCT02169492|ReVive SE|revive se
234116|NCT02169479|Parkinson's disease (PD)|parkinson's disease (pd)
234117|NCT02169479|Opicapone|opicapone
234118|NCT02169479|BIA 9-1067|bia 9-1067
234119|NCT02169466|Parkinson's disease (PD)|parkinson's disease (pd)
234120|NCT02169466|Opicapone|opicapone
234121|NCT02169466|BIA 9-1067|bia 9-1067
234122|NCT02169453|Parkinson's disease (PD)|parkinson's disease (pd)
234123|NCT02169453|BIA 9-1067|bia 9-1067
234124|NCT02169453|Opicapone|opicapone
234125|NCT02169440|Parkinson's disease (PD)|parkinson's disease (pd)
234126|NCT02169440|BIA 9-1067|bia 9-1067
234127|NCT02169440|Opicapone|opicapone
234128|NCT02169427|Parkinson's disease (PD)|parkinson's disease (pd)
234129|NCT02169427|BIA 9-1067|bia 9-1067
234130|NCT02169427|Opicapone|opicapone
234131|NCT02169414|Parkinson's disease (PD)|parkinson's disease (pd)
234132|NCT02169414|BIA 9-1067|bia 9-1067
234133|NCT02169414|Opicapone|opicapone
234134|NCT02169388|Gut microflora|gut microflora
234135|NCT02169388|colorectal cancer|colorectal cancer
234136|NCT02169388|Chemotherapy|chemotherapy
234137|NCT02169388|Immunity|immunity
234138|NCT02169388|Nutrition|nutrition
234139|NCT02169362|Burns|burns
234140|NCT02169362|Thermal burns|thermal burns
234141|NCT02169362|Second degree burns|second degree burns
234142|NCT02169362|Partial thickness burns|partial thickness burns
234143|NCT02169362|Deep partial thickness burns|deep partial thickness burns
234144|NCT02169362|Acute burns|acute burns
234145|NCT02169362|Burn wounds|burn wounds
234146|NCT02169336|Bunion|bunion
234147|NCT02169336|Bunionectomy|bunionectomy
234148|NCT02169336|Pain|pain
234149|NCT02169336|Analgesia|analgesia
234150|NCT02169336|dexmedetomidine|dexmedetomidine
234151|NCT02169336|intranasal|intranasal
234152|NCT02169323|Non-eosinophilic Asthma|non-eosinophilic asthma
234153|NCT02169323|Inhaled corticosteroids|inhaled corticosteroids
234154|NCT02169323|Step-down|step-down
234155|NCT02169310|Traumatic Brain Injury|traumatic brain injury
234156|NCT02169310|Decision-Making|decision-making
234157|NCT02169310|Dopaminergic Network|dopaminergic network
234158|NCT02169310|Brain Imaging|brain imaging
234159|NCT02169310|Non-Invasive Brain Stimulation|non-invasive brain stimulation
234160|NCT02169297|Pain Management|pain management
234161|NCT02169297|Anesthesia: Nerve Block|anesthesia: nerve block
234162|NCT02169258|coronary artery disease|coronary artery disease
234163|NCT02169258|peripheral artery disease|peripheral artery disease
234164|NCT02169258|percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
234165|NCT02169258|coronary angiography|coronary angiography
234166|NCT02169258|revascularization|revascularization
234167|NCT02169258|gene polymorphisms|gene polymorphisms
234168|NCT02169258|microRNAs|micrornas
234169|NCT02169232|Awake intubation|awake intubation
234170|NCT02169232|Videolaryngoscope|videolaryngoscope
234171|NCT02169232|Fiberoptic|fiberoptic
234172|NCT02169206|Frozen shoulder|frozen shoulder
234173|NCT02169206|scapulothoracic angle|scapulothoracic angle
234174|NCT02169206|scapulohumeral angle|scapulohumeral angle
234175|NCT02169206|acromiohumeral distance|acromiohumeral distance
234176|NCT02169206|center equator distance|center equator distance
234177|NCT02169206|shoulder radiography|shoulder radiography
234178|NCT02169193|microaspiration|microaspiration
234179|NCT02169193|mechanical ventilation|mechanical ventilation
234180|NCT02169193|enteral feeding|enteral feeding
234181|NCT02169193|99m technetium|99m technetium
234182|NCT02169193|pepsin|pepsin
234183|NCT02169180|Ibrutinib|ibrutinib
234184|NCT02169180|IMBRUVICA|imbruvica
234185|NCT02169180|PCI-32765|pci-32765
234186|NCT02169180|JNJ-54179060|jnj-54179060
234187|NCT02169180|Lymphoma, Mantle-cell|lymphoma, mantle-cell
234188|NCT02169167|Diabetes complications|diabetes complications
234189|NCT02169167|Diabetic foot|diabetic foot
234190|NCT02169167|Foot ulcer|foot ulcer
234191|NCT02169167|Wound healing|wound healing
234192|NCT02169167|Wound infection|wound infection
234193|NCT02169141|pharmacokinetics|pharmacokinetics
234194|NCT02169141|pharmacodynamics|pharmacodynamics
234195|NCT02169141|MDR-TB|mdr-tb
234196|NCT02169141|Levofloxacin|levofloxacin
234197|NCT02169141|Capreomycin|capreomycin
234198|NCT02169102|Low power laser|low power laser
234199|NCT02169102|Pulpitis|pulpitis
234200|NCT02169102|Pain|pain
234201|NCT02169076|Ventricular Assist Device, Cardiac Resynchronization Therapy|ventricular assist device, cardiac resynchronization therapy
234202|NCT02169050|Vitamin D deficiency|vitamin d deficiency
234203|NCT02169050|Inflammation|inflammation
234204|NCT02169050|Obesity|obesity
234205|NCT02169037|Rotor|rotor
234206|NCT02169037|FIRM|firm
234207|NCT02169037|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
234208|NCT02169037|Atrial tachyarrhythmia|atrial tachyarrhythmia
234209|NCT02169037|Ablation|ablation
234210|NCT02169037|Contact mapping|contact mapping
234211|NCT02169037|Clinical trial|clinical trial
234212|NCT02169037|Signal processing.|signal processing.
234213|NCT02169024|prenatal care|prenatal care
234214|NCT02169024|group care|group care
234215|NCT02169024|Expect With Me|expect with me
234216|NCT02169024|evaluation studies|evaluation studies
234217|NCT02169024|group prenatal care|group prenatal care
234218|NCT02169011|Breast reconstruction|breast reconstruction
234219|NCT02169011|Breast cancer|breast cancer
234220|NCT02168998|Medical clown|medical clown
234221|NCT02168998|Pediatric emergency medicine|pediatric emergency medicine
234222|NCT02168985|Child violence|child violence
234223|NCT02168985|HIV AIDS conflicted couples|hiv aids conflicted couples
234224|NCT02168985|Intimate partner violence|intimate partner violence
234225|NCT02168985|Tanzania|tanzania
234226|NCT02168985|Marriage counseling|marriage counseling
234227|NCT02168985|Child maltreatment|child maltreatment
234228|NCT02168985|Couples communication|couples communication
234229|NCT02168972|atrial fibrillation|atrial fibrillation
234230|NCT02168972|global|global
234231|NCT02168972|radiofrequency RF ablation|radiofrequency rf ablation
234232|NCT02168972|left atrium anatomical and electrophysiological mapping|left atrium anatomical and electrophysiological mapping
234233|NCT02168959|Femoral Nerve Block|femoral nerve block
234234|NCT02168959|Pain Control|pain control
234235|NCT02168959|Tibial Plateau Fracture|tibial plateau fracture
234236|NCT02168959|Prospective|prospective
234237|NCT02168959|Randomized|randomized
234238|NCT02168933|psoriasis|psoriasis
234239|NCT02168933|nail|nail
234240|NCT02168933|laser|laser
234241|NCT02168933|excimer|excimer
234242|NCT02168933|treatment|treatment
234243|NCT02168920|Alzeheimer|alzeheimer
234244|NCT02168894|Peripheral neuropathy|peripheral neuropathy
234245|NCT02168894|Chemotherapy-Induced Peripheral Neuropathy|chemotherapy-induced peripheral neuropathy
234246|NCT02168894|Cancer Survivors|cancer survivors
234247|NCT02168894|Acupuncture|acupuncture
234248|NCT02168894|Electrical stimulation|electrical stimulation
234249|NCT02168894|Nerve function tests|nerve function tests
234250|NCT02168894|Hand function tests|hand function tests
234251|NCT02168894|Balance tests|balance tests
234252|NCT02168894|Questionnaires|questionnaires
234253|NCT02168894|Surveys|surveys
234254|NCT02168881|labour|labour
234255|NCT02168881|induction|induction
234256|NCT02168881|misoprostol|misoprostol
234257|NCT02168881|dinoprostone|dinoprostone
234258|NCT02168868|Autoimmune Diseases|autoimmune diseases
234259|NCT02168868|Child Development Disorders, Pervasive|child development disorders, pervasive
234260|NCT02168868|Inflammation|inflammation
234261|NCT02168868|Risk Factors|risk factors
234262|NCT02168855|Smoking cessation|smoking cessation
234263|NCT02168855|Non-daily smokers|non-daily smokers
234264|NCT02168855|Ecological Momentary Assessment|ecological momentary assessment
234265|NCT02168855|nicotine replacement therapy|nicotine replacement therapy
234266|NCT02168842|Parkinson|parkinson
234267|NCT02168842|Parkinson Disease|parkinson disease
234268|NCT02168842|Parkinson's Disease|parkinson's disease
234269|NCT02168829|AF ablation|af ablation
234270|NCT02168829|Anticoagulation AF ablation|anticoagulation af ablation
234271|NCT02168829|Stroke prevention|stroke prevention
234272|NCT02168816|Osteomyelitis|osteomyelitis
234273|NCT02168816|Diabetes|diabetes
234274|NCT02168816|Foot Infection|foot infection
234275|NCT02168803|abnormal cholesterol|abnormal cholesterol
234276|NCT02168790|amniotic membrane holder, aminiotic membrane transplantation|amniotic membrane holder, aminiotic membrane transplantation
234277|NCT02168777|Patients with Cancer|patients with cancer
234278|NCT02168751|one lung ventilation|one lung ventilation
234279|NCT02168751|inflammatory response|inflammatory response
234280|NCT02168751|thoracic surgery|thoracic surgery
234281|NCT02168738|nutrition|nutrition
234282|NCT02168725|briciclib|briciclib
234283|NCT02168725|Dose escalation|dose escalation
234284|NCT02168725|Maximum tolerated dose|maximum tolerated dose
234285|NCT02168712|Coronary Heart Disease|coronary heart disease
234286|NCT02168712|Interval exercise training|interval exercise training
234287|NCT02168712|Continuous exercise training|continuous exercise training
234288|NCT02168712|Quality of life|quality of life
234289|NCT02168712|Safety|safety
234290|NCT02168699|children|children
234291|NCT02168699|infants|infants
234292|NCT02168699|musculocutaneous nerve|musculocutaneous nerve
234293|NCT02168699|ultrasonography|ultrasonography
234294|NCT02168686|alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
234295|NCT02168686|alpha1-antitrypsin deficiency|alpha1-antitrypsin deficiency
234296|NCT02168686|alpha-1-antitrypsin deficiency|alpha-1-antitrypsin deficiency
234297|NCT02168686|alpha1AT|alpha1at
234298|NCT02168686|A1AT|a1at
234299|NCT02168686|ADVM-043|advm-043
234300|NCT02168686|AAVrh.10halpha1AT|aavrh.10halpha1at
234301|NCT02168686|AAVrh.10hA1AT|aavrh.10ha1at
234302|NCT02168686|Gene transfer vector|gene transfer vector
234303|NCT02168686|Gene therapy|gene therapy
234304|NCT02168686|Lung disease|lung disease
234305|NCT02168686|Emphysema|emphysema
234306|NCT02168686|ANN001-01|ann001-01
234307|NCT02168686|ADVANCE study|advance study
234308|NCT02168673|COPD|copd
234309|NCT02168673|Cigarette Smoke|cigarette smoke
234310|NCT02168673|Smoker|smoker
234311|NCT02168673|Nonsmoker|nonsmoker
234312|NCT02168673|ODF2|odf2
234313|NCT02168673|Cilia|cilia
234314|NCT02168660|Obesity|obesity
234315|NCT02168660|Insulin Resistance|insulin resistance
234316|NCT02168660|Vitamin D Deficiency|vitamin d deficiency
234317|NCT02168660|Children|children
234318|NCT02168660|Adolescents|adolescents
234319|NCT02168647|Excessive gestational weight gain|excessive gestational weight gain
234320|NCT02168647|Insulin resistance|insulin resistance
234321|NCT02168647|Physical activity|physical activity
234322|NCT02168647|Behavioral prenatal lifestyle intervention|behavioral prenatal lifestyle intervention
234323|NCT02168647|Reduced carbohydrate intake|reduced carbohydrate intake
234324|NCT02168647|Self-determination theory|self-determination theory
234325|NCT02168647|Motivational interviewing|motivational interviewing
234326|NCT02168621|Chronic periodontitis|chronic periodontitis
234327|NCT02168621|Non-surgical therapy|non-surgical therapy
234328|NCT02168621|Ultrasonic debridement|ultrasonic debridement
234329|NCT02168621|Scaling and root planing|scaling and root planing
234330|NCT02168608|hepatic ischemia reperfusion injury|hepatic ischemia reperfusion injury
234331|NCT02168608|ischemia precondition|ischemia precondition
234332|NCT02168608|remote ischemia precondition|remote ischemia precondition
234333|NCT02168608|anti-inflammation|anti-inflammation
234334|NCT02168595|healthy volunteers, GMI-1271|healthy volunteers, gmi-1271
234335|NCT02168582|Physical Therapy Modalities|physical therapy modalities
234336|NCT02168582|Prognosis|prognosis
234337|NCT02168582|Patient Selection|patient selection
234338|NCT02168569|treatment|treatment
234339|NCT02168569|artemisin-based combinations|artemisin-based combinations
234340|NCT02168569|children|children
234341|NCT02168556|Urodynamics, Anxiety|urodynamics, anxiety
234342|NCT02168517|Obesity|obesity
234343|NCT02168517|Pain|pain
234344|NCT02168517|Fertility|fertility
234345|NCT02168478|Neo-Synalar|neo-synalar
234346|NCT02168478|Patch Test|patch test
234347|NCT02168478|Sodium lauryl sulfate|sodium lauryl sulfate
234348|NCT02168478|Saline|saline
234349|NCT02168478|Presensitization|presensitization
234350|NCT02168465|self-efficacy|self-efficacy
234351|NCT02168465|self-management|self-management
234352|NCT02168465|web-based intervention research|web-based intervention research
234353|NCT02168452|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
234354|NCT02168452|Indocyanine green (ICG)|indocyanine green (icg)
234355|NCT02168452|Radioisotope (RI)|radioisotope (ri)
234356|NCT02168452|Near infrared fluorescence camera|near infrared fluorescence camera
234357|NCT02168439|Dexmedetomidine|dexmedetomidine
234358|NCT02168439|Midazolam|midazolam
234359|NCT02168413|cortical excitability|cortical excitability
234360|NCT02168413|robotized TMS|robotized tms
234361|NCT02168413|EEG|eeg
234362|NCT02168413|EMG|emg
234363|NCT02168387|atelectasis|atelectasis
234364|NCT02168387|continuous high frequency oscillator|continuous high frequency oscillator
234365|NCT02168387|acetylcysteine|acetylcysteine
234366|NCT02168387|dornase alfa|dornase alfa
234367|NCT02168374|Glass ionomer cement|glass ionomer cement
234368|NCT02168374|Indirect pulp therapy|indirect pulp therapy
234369|NCT02168361|cirrhosis|cirrhosis
234370|NCT02168322|growth factors|growth factors
234371|NCT02168322|periodontal regeneration|periodontal regeneration
234372|NCT02168322|modefied perforated membranes|modefied perforated membranes
234373|NCT02168296|Pharmacokinetics|pharmacokinetics
234374|NCT02168296|Blood glucose|blood glucose
234375|NCT02168296|subjects|subjects
234376|NCT02168283|cardiovascular disease|cardiovascular disease
234377|NCT02168283|hypertension|hypertension
234378|NCT02168257|Nasal Cannula|nasal cannula
234379|NCT02168244|psoriasis|psoriasis
234380|NCT02168244|biologics|biologics
234381|NCT02168244|subcutaneous|subcutaneous
234382|NCT02168244|pain|pain
234383|NCT02168244|heat|heat
234385|NCT02168231|Complex abdominal wall hernia|complex abdominal wall hernia
234386|NCT02168231|Biologic mesh|biologic mesh
234387|NCT02168231|Strattice|strattice
234388|NCT02168218|protein synthesis|protein synthesis
234389|NCT02168218|intrahepatic fat|intrahepatic fat
234390|NCT02168218|lean body mass|lean body mass
234391|NCT02168218|IGF1|igf1
234392|NCT02168218|energy metabolism|energy metabolism
234393|NCT02168205|Healthy volunteer|healthy volunteer
234394|NCT02168205|Pharmacokinetics|pharmacokinetics
234395|NCT02168205|Pomalyst|pomalyst
234396|NCT02168205|Pomalidomide|pomalidomide
234397|NCT02168205|Food effect|food effect
234398|NCT02168205|smoker|smoker
234399|NCT02168192|Breaking bad news skills|breaking bad news skills
234400|NCT02168192|Communications skills|communications skills
234401|NCT02168192|Medical education|medical education
234402|NCT02168192|Obstetrics|obstetrics
234403|NCT02168192|Simulation|simulation
234404|NCT02168166|Neurological Disorders|neurological disorders
234405|NCT02168166|Neuroscience|neuroscience
234406|NCT02168166|Neuropsychology|neuropsychology
234407|NCT02168166|EEG|eeg
234408|NCT02168166|Cognitive remediation|cognitive remediation
234409|NCT02168166|Cognitive Response|cognitive response
234410|NCT02168153|Chiropractic Manipulative Therapy|chiropractic manipulative therapy
234411|NCT02168153|Reaction Times|reaction times
234412|NCT02168153|Response Times|response times
234413|NCT02168153|Special Forces|special forces
234414|NCT02168153|Biomechanical Assessments|biomechanical assessments
234415|NCT02168114|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
234416|NCT02168114|Exercise|exercise
234417|NCT02168114|Optical Imaging|optical imaging
234418|NCT02168114|Magnetic Resonance|magnetic resonance
234419|NCT02168101|MLN9708|mln9708
234420|NCT02168101|allogeneic stem cell transplant|allogeneic stem cell transplant
234421|NCT02168101|multiple myeloma|multiple myeloma
234422|NCT02168101|ixazomib|ixazomib
234423|NCT02168101|autologous stem cell transplant|autologous stem cell transplant
234424|NCT02168088|Sudden unexplained death|sudden unexplained death
234425|NCT02168049|cardiac, respiratory, monitoring|cardiac, respiratory, monitoring
234426|NCT02168036|lung disease|lung disease
234427|NCT02168036|mediastinal lymph node|mediastinal lymph node
234428|NCT02168036|bronchoscopy|bronchoscopy
234429|NCT02168036|Endobronchial-Guided Transbronchial Needle Aspiration|endobronchial-guided transbronchial needle aspiration
234430|NCT02168023|surgical site infection|surgical site infection
234431|NCT02168023|dialkylcarbamoylchloride impregnated dressing|dialkylcarbamoylchloride impregnated dressing
234432|NCT02168023|caesarean section|caesarean section
234433|NCT02168023|wound dehiscence|wound dehiscence
234434|NCT02167984|esophageal swallow|esophageal swallow
234435|NCT02167984|gastroesophageal reflux|gastroesophageal reflux
234436|NCT02167984|esophageal impedance|esophageal impedance
234437|NCT02167984|newborn|newborn
234438|NCT02167984|preterm|preterm
234439|NCT02167971|traumatic brain injury|traumatic brain injury
234440|NCT02167971|diffuse axonal injury|diffuse axonal injury
234441|NCT02167971|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
234442|NCT02167971|neuromodulation|neuromodulation
234443|NCT02167971|cognitive rehabilitation|cognitive rehabilitation
234444|NCT02167945|Hepatitis C Genotype 1|hepatitis c genotype 1
234445|NCT02167945|Compensated Cirrhosis|compensated cirrhosis
234446|NCT02167945|Cirrhosis|cirrhosis
234447|NCT02167945|Naïve|naïve
234448|NCT02167945|Hepatitis C|hepatitis c
234449|NCT02167945|Hepatitis C Virus|hepatitis c virus
234450|NCT02167945|Treatment-Experienced|treatment-experienced
234451|NCT02167945|Relapser|relapser
234452|NCT02167945|Null responder|null responder
234453|NCT02167945|Non responder|non responder
234454|NCT02167932|Breast Cancer|breast cancer
234455|NCT02167932|Walk With Ease|walk with ease
234456|NCT02167932|Physical Activity|physical activity
234457|NCT02167932|Walking|walking
234458|NCT02167932|Younger Women|younger women
234459|NCT02167932|Cancer|cancer
234460|NCT02167932|p16|p16
234461|NCT02167932|Aging|aging
234462|NCT02167932|Biomarkers|biomarkers
234463|NCT02167932|Biomarkers of Aging|biomarkers of aging
234464|NCT02167932|Chemotherapy|chemotherapy
234465|NCT02167932|Chemotherapy Treatment|chemotherapy treatment
234466|NCT02167932|Adjuvant Chemotherapy|adjuvant chemotherapy
234467|NCT02167932|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
234468|NCT02167919|Prostate|prostate
234469|NCT02167919|Men|men
234470|NCT02167919|Hyperplasia|hyperplasia
234471|NCT02167893|Pharmacological therapy|pharmacological therapy
234472|NCT02167867|body contouring|body contouring
234473|NCT02167867|circumference reduction|circumference reduction
234474|NCT02167867|body shaping|body shaping
234475|NCT02167867|low level laser|low level laser
234476|NCT02167854|LJM716|ljm716
234477|NCT02167854|BYL719 [Alpelisib]|byl719 [alpelisib]
234478|NCT02167854|TRASTUZUMAB|trastuzumab
234479|NCT02167854|HER2+|her2+
234480|NCT02167854|14-057|14-057
234481|NCT02167841|Breech presentation,|breech presentation,
234482|NCT02167841|External cephalic version,|external cephalic version,
234483|NCT02167841|Maternal posture,|maternal posture,
234484|NCT02167841|Pregnancy,|pregnancy,
234485|NCT02167841|Caesarean section.|caesarean section.
234486|NCT02167828|HIV|hiv
234487|NCT02167828|AIDS|aids
234488|NCT02167828|treatment adherence|treatment adherence
234489|NCT02167828|social network|social network
234490|NCT02167802|severe infection, pediatrics, sub-optimal care, term care|severe infection, pediatrics, sub-optimal care, term care
234491|NCT02167789|HF, diagnosis|hf, diagnosis
234492|NCT02167763|contraception|contraception
234494|NCT02167763|copper|copper
234495|NCT02167750|cognitive|cognitive
234496|NCT02167750|phytochmicals|phytochmicals
234497|NCT02167750|caffeine|caffeine
234498|NCT02167750|cognitive performance after ingestion of test beverage|cognitive performance after ingestion of test beverage
234499|NCT02167737|Accident Prevention|accident prevention
234500|NCT02167737|Accidental Falls|accidental falls
234501|NCT02167737|Geriatric Health Services|geriatric health services
234502|NCT02167737|Gender Differences|gender differences
234503|NCT02167698|Pediatric acute respiratory distress syndrome|pediatric acute respiratory distress syndrome
234504|NCT02167698|Mechanical ventilation|mechanical ventilation
234505|NCT02167698|Airway pressure release ventilation|airway pressure release ventilation
234506|NCT02167698|Conventional low-tidal volume ventilation|conventional low-tidal volume ventilation
234507|NCT02167672|total abdominal hysterectomy, total laparoscopic hysterectomy, vaginal hysterectomy|total abdominal hysterectomy, total laparoscopic hysterectomy, vaginal hysterectomy
234508|NCT02167659|Lymphedema|lymphedema
234509|NCT02167659|Breast cancer|breast cancer
234510|NCT02167659|Bioimpedance Spectroscopy|bioimpedance spectroscopy
234511|NCT02167659|L-Dex|l-dex
234512|NCT02167646|Soft tissue defect|soft tissue defect
234606|NCT02167087|near infrared|near infrared
234513|NCT02167646|dorsal branch of the digital nerve|dorsal branch of the digital nerve
234514|NCT02167646|dorsal branch of the digital artery|dorsal branch of the digital artery
234515|NCT02167646|dorsal digital flap|dorsal digital flap
234516|NCT02167633|Radiosurgery|radiosurgery
234517|NCT02167633|Laminectomy|laminectomy
234518|NCT02167633|Radiotherapy|radiotherapy
234519|NCT02167633|Spinal Cord Compression|spinal cord compression
234520|NCT02167633|Neoplasm Metastasis|neoplasm metastasis
234521|NCT02167633|Randomized Controlled Trial|randomized controlled trial
234522|NCT02167607|Purple Potatoes|purple potatoes
234523|NCT02167607|Polyphenolics|polyphenolics
234524|NCT02167581|Maxillofacial surgery|maxillofacial surgery
234525|NCT02167581|Epithelial odontogenic tumours|epithelial odontogenic tumours
234526|NCT02167568|corpus callosum agenesis/dysgenesis|corpus callosum agenesis/dysgenesis
234527|NCT02167568|mental deficiency/ Intellectual deficiency|mental deficiency/ intellectual deficiency
234528|NCT02167568|genetic and phenotypic characterization|genetic and phenotypic characterization
234529|NCT02167555|Wild Blueberries|wild blueberries
234530|NCT02167555|Polyphenolics|polyphenolics
234531|NCT02167542|Severe hypoxemic respiratory failure|severe hypoxemic respiratory failure
234532|NCT02167542|Fiberoptic bronchoscopy|fiberoptic bronchoscopy
234533|NCT02167542|Noninvasive possitive pressure ventilation|noninvasive possitive pressure ventilation
234534|NCT02167542|Continuous positive airway pressure|continuous positive airway pressure
234535|NCT02167529|Quality of life-Thyroidectomy-Morbidity|quality of life-thyroidectomy-morbidity
234536|NCT02167516|Xinfeng capsule|xinfeng capsule
234537|NCT02167516|Knee osteoarthritis|knee osteoarthritis
234538|NCT02167516|Randomized controlled trials|randomized controlled trials
234539|NCT02167516|Double-blind|double-blind
234540|NCT02167490|BC; conservative surgery; SNB; AD; axillary US imaging|bc; conservative surgery; snb; ad; axillary us imaging
234541|NCT02167477|Intubation, Endotracheal|intubation, endotracheal
234542|NCT02167464|Hypertension|hypertension
234543|NCT02167451|stem cell transplant|stem cell transplant
234544|NCT02167451|GVHD prevention|gvhd prevention
234545|NCT02167438|Cesarean|cesarean
234546|NCT02167438|Section|section
234547|NCT02167438|second|second
234548|NCT02167438|stage|stage
234549|NCT02167438|labor|labor
234550|NCT02167425|People who Inject Drugs|people who inject drugs
234551|NCT02167425|HIV|hiv
234552|NCT02167425|Methadone|methadone
234553|NCT02167425|Sub Saharan Africa|sub saharan africa
234554|NCT02167425|Tanzania|tanzania
234555|NCT02167425|Implementation Science|implementation science
234556|NCT02167412|POTS|pots
234557|NCT02167412|Syncope|syncope
234558|NCT02167386|Men who have sex with men (MSM)|men who have sex with men (msm)
234559|NCT02167386|Black/African-American|black/african-american
234560|NCT02167360|adult patients|adult patients
234561|NCT02167360|B-cell ALL|b-cell all
234562|NCT02167360|chemo-refractory|chemo-refractory
234563|NCT02167360|relapsed after allogeneic SCT|relapsed after allogeneic sct
234564|NCT02167360|ineligible for allogeneic SCT|ineligible for allogeneic sct
234565|NCT02167347|CBT, Psychosis, cultural adaptation, Pakistan|cbt, psychosis, cultural adaptation, pakistan
234566|NCT02167334|panendoscopy|panendoscopy
234567|NCT02167334|preoxygenation|preoxygenation
234568|NCT02167334|non invasive ventilation|non invasive ventilation
234569|NCT02167295|betel nut|betel nut
234570|NCT02167295|dependence|dependence
234571|NCT02167295|withdraw|withdraw
234572|NCT02167295|deprivation test|deprivation test
234573|NCT02167269|enclosed afferent reservoir|enclosed afferent reservoir
234574|NCT02167269|Jackson Rees system|jackson rees system
234575|NCT02167269|anesthesia breathing circuit|anesthesia breathing circuit
234576|NCT02167269|spontaneous breathing|spontaneous breathing
234577|NCT02167269|pediatric anesthesia|pediatric anesthesia
234578|NCT02167230|Coronary Artery Disease|coronary artery disease
234579|NCT02167230|Percutaneous Coronary Intervention|percutaneous coronary intervention
234580|NCT02167230|Bifurcation|bifurcation
234581|NCT02167230|Jailed-balloon technique|jailed-balloon technique
234582|NCT02167217|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
234583|NCT02167217|Corticosteroids|corticosteroids
234584|NCT02167217|Infants|infants
234585|NCT02167217|Young Children|young children
234586|NCT02167217|Toddlers|toddlers
234587|NCT02167165|Atrial Fibrillation|atrial fibrillation
234588|NCT02167165|Digoxin|digoxin
234589|NCT02167165|SNP|snp
234590|NCT02167139|Rheumatoid Arthritis, Adalimumab|rheumatoid arthritis, adalimumab
234591|NCT02167126|Athletic Performance;|athletic performance;
234592|NCT02167126|Muscle Strength;|muscle strength;
234593|NCT02167126|Isometric Contraction;|isometric contraction;
234594|NCT02167126|Kinesio Taping|kinesio taping
234595|NCT02167100|HIV|hiv
234596|NCT02167100|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
234597|NCT02167100|Patient Care|patient care
234598|NCT02167100|Patient Care Management|patient care management
234599|NCT02167100|Lost to Follow-Up|lost to follow-up
234600|NCT02167087|Sentinel node mapping|sentinel node mapping
234601|NCT02167087|lymphatic mapping|lymphatic mapping
234602|NCT02167087|lymphatic metastasis|lymphatic metastasis
234603|NCT02167087|Aberrant lymphatic drainage|aberrant lymphatic drainage
234604|NCT02167087|indocyanine green|indocyanine green
234605|NCT02167087|ICG|icg
234607|NCT02167087|colon cancer|colon cancer
234608|NCT02167087|laparoscopic surgery|laparoscopic surgery
234609|NCT02167074|Diagnostic accuracy|diagnostic accuracy
234610|NCT02167074|Endoscopic Ultrasound-Guided Fine Needle Aspiration|endoscopic ultrasound-guided fine needle aspiration
234611|NCT02167074|EUS-FNA|eus-fna
234612|NCT02167074|Endoscopic Ultrasound-Guided Fine Needle Biopsy|endoscopic ultrasound-guided fine needle biopsy
234613|NCT02167074|EUS-FNB|eus-fnb
234614|NCT02167074|Pancreatic mass|pancreatic mass
234615|NCT02167074|Lymph node|lymph node
234616|NCT02167048|Attention Deficit Hyperactivity Disorders|attention deficit hyperactivity disorders
234617|NCT02167048|Executive Function|executive function
234618|NCT02167048|Methylphenidate|methylphenidate
234619|NCT02167048|Psychostimulants|psychostimulants
234620|NCT02167048|Adolescent|adolescent
234621|NCT02167048|Child|child
234622|NCT02167048|Working Memory|working memory
234623|NCT02167048|Prefrontal Cortex|prefrontal cortex
234624|NCT02167048|Attention|attention
234625|NCT02167048|Cognitive Function|cognitive function
234626|NCT02167048|Inhibition|inhibition
234627|NCT02167035|Open-Angle Glaucoma|open-angle glaucoma
234628|NCT02167035|Ocular Hypertension|ocular hypertension
234629|NCT02167022|intense therapy|intense therapy
234630|NCT02167022|brain plasticity|brain plasticity
234631|NCT02167022|Perception-Action approach|perception-action approach
234632|NCT02167009|ARTERY EMBOLIZATION|artery embolization
234633|NCT02167009|BPH|bph
234634|NCT02166970|Hilar tumor|hilar tumor
234635|NCT02166970|Metal stent|metal stent
234636|NCT02166970|Single|single
234637|NCT02166970|Multiple|multiple
234638|NCT02166957|Esophageal disruption|esophageal disruption
234639|NCT02166957|anterograde-retrograde endoscopy|anterograde-retrograde endoscopy
234640|NCT02166957|rendez-vous technique|rendez-vous technique
234641|NCT02166957|NOTES|notes
234642|NCT02166957|recanalization|recanalization
234643|NCT02166957|dilatations|dilatations
234644|NCT02166957|Stenting|stenting
234645|NCT02166957|radiation therapy|radiation therapy
234646|NCT02166957|head and neck carcinoma|head and neck carcinoma
234647|NCT02166944|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
234648|NCT02166944|ALS functional ration scale|als functional ration scale
234649|NCT02166944|TAR-DNA-binding protein-43|tar-dna-binding protein-43
234650|NCT02166944|tamoxifen|tamoxifen
234651|NCT02166944|mTOR|mtor
234652|NCT02166931|Essence of Chicken|essence of chicken
234653|NCT02166931|stress|stress
234654|NCT02166931|cognitive function|cognitive function
234655|NCT02166918|Schizophrenia|schizophrenia
234656|NCT02166918|Real-Life Functioning|real-life functioning
234657|NCT02166918|Schizophrenia Endophenotypes|schizophrenia endophenotypes
234658|NCT02166892|Childhood obesity|childhood obesity
234659|NCT02166892|Plate|plate
234660|NCT02166892|Food consumption|food consumption
234661|NCT02166879|Obstructive Sleep Apnea-Hypopnea Syndrome|obstructive sleep apnea-hypopnea syndrome
234662|NCT02166879|Obstructive sleep apnea|obstructive sleep apnea
234663|NCT02166879|OSA|osa
234664|NCT02166879|Chart review|chart review
234665|NCT02166879|Questionnaire|questionnaire
234666|NCT02166879|Survey|survey
234667|NCT02166853|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
234668|NCT02166853|Sevoflurane|sevoflurane
234669|NCT02166853|Mechanical ventilation|mechanical ventilation
234670|NCT02166853|Intensive Care Unit (ICU)|intensive care unit (icu)
234671|NCT02166853|Prospective study|prospective study
234672|NCT02166853|Lung injury|lung injury
234673|NCT02166853|Gas exchange|gas exchange
234674|NCT02166853|Inflammation|inflammation
234675|NCT02166853|Receptor for advanced glycation end-produts (RAGE)|receptor for advanced glycation end-produts (rage)
234676|NCT02166853|sRAGE|srage
234677|NCT02166827|TMS|tms
234678|NCT02166827|Cognitive Stimulation|cognitive stimulation
234679|NCT02166827|NeuroAD|neuroad
234680|NCT02166801|Cerebral palsy|cerebral palsy
234681|NCT02166801|Children|children
234682|NCT02166801|Early Intervention|early intervention
234683|NCT02166801|Communication|communication
234684|NCT02166801|Gross motor function|gross motor function
234685|NCT02166801|Hand function|hand function
234686|NCT02166788|metastatic melanoma|metastatic melanoma
234687|NCT02166788|groin lymph nodes|groin lymph nodes
234688|NCT02166788|surgery|surgery
234689|NCT02166788|lymphadenectomy|lymphadenectomy
234690|NCT02166762|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
234691|NCT02166762|Biventricular implantable cardioverter defibrillators|biventricular implantable cardioverter defibrillators
234692|NCT02166762|Heart failure|heart failure
234693|NCT02166762|Cardiomyopathy|cardiomyopathy
234694|NCT02166762|QLV|qlv
234695|NCT02166762|LV lead placement|lv lead placement
234696|NCT02166762|Arrhythmia|arrhythmia
234697|NCT02166749|Hysterectomy, long term follow up, subjective outcome|hysterectomy, long term follow up, subjective outcome
234698|NCT02166736|Instantaneous wave Free Ratio|instantaneous wave free ratio
234699|NCT02166736|Fractional Flow Reserve|fractional flow reserve
234700|NCT02166723|persistent atrial fibrillation|persistent atrial fibrillation
234701|NCT02166723|Cryoballoon ablation|cryoballoon ablation
234702|NCT02166710|Knee arthroplasty|knee arthroplasty
234703|NCT02166710|Adductor canal block|adductor canal block
234704|NCT02166710|Quadriceps strength|quadriceps strength
234705|NCT02166697|Pharmacological therapy|pharmacological therapy
234706|NCT02166684|Do-it-yourself devices|do-it-yourself devices
234707|NCT02166684|User-experiences|user-experiences
234708|NCT02166684|Health behavior|health behavior
234709|NCT02166684|Self-measurement|self-measurement
234710|NCT02166684|Methodology, Evaluation|methodology, evaluation
234711|NCT02166684|Personal health records|personal health records
234712|NCT02166684|Blood Glucose Self-Monitoring|blood glucose self-monitoring
234713|NCT02166684|Self Blood Pressure Monitoring|self blood pressure monitoring
234714|NCT02166658|Patients with breast or lung cancer and recurrent or progressive brain|patients with breast or lung cancer and recurrent or progressive brain
234715|NCT02166658|metastases|metastases
234716|NCT02166645|patient positioning|patient positioning
234717|NCT02166645|premature infant|premature infant
234718|NCT02166645|mechanical ventilation|mechanical ventilation
234719|NCT02166645|airway extubation|airway extubation
234720|NCT02166632|Knee arthroplasty|knee arthroplasty
234721|NCT02166632|Exparel|exparel
234722|NCT02166632|Bupivacaine liposome|bupivacaine liposome
234723|NCT02166632|Total knee replacement|total knee replacement
234724|NCT02166632|Pain control|pain control
234725|NCT02166619|Stroke|stroke
234726|NCT02166619|Rehabilitation|rehabilitation
234727|NCT02166619|Electric stimulation therapy|electric stimulation therapy
234728|NCT02166619|Neuroplasticity|neuroplasticity
234729|NCT02166567|intracytoplasmic sperm injection|intracytoplasmic sperm injection
234730|NCT02166567|Male infertility|male infertility
234731|NCT02166567|apoptosis|apoptosis
234732|NCT02166567|flow cytometry and sorting|flow cytometry and sorting
234733|NCT02166567|DNA fragmentation|dna fragmentation
234734|NCT02166554|Adhesions|adhesions
234735|NCT02166554|Hyaluronan|hyaluronan
234736|NCT02166554|Gynaecological surgery|gynaecological surgery
234737|NCT02166554|Clinical outcomes|clinical outcomes
234738|NCT02166541|cerebral palsy, spastic, diplegic,|cerebral palsy, spastic, diplegic,
234739|NCT02166541|children,|children,
234740|NCT02166541|intervention study,|intervention study,
234741|NCT02166541|manipulation, spinal|manipulation, spinal
234742|NCT02166541|randomized controlled trial|randomized controlled trial
234743|NCT02166528|female pelvic floor dysfunction|female pelvic floor dysfunction
234744|NCT02166528|pelvic organ prolaps|pelvic organ prolaps
234745|NCT02166528|urinary incontinence|urinary incontinence
234746|NCT02166528|massively parallel sequencing|massively parallel sequencing
234747|NCT02166515|cervical cancer|cervical cancer
234748|NCT02166515|ovarian cancer|ovarian cancer
234749|NCT02166515|endometrial cancer|endometrial cancer
234750|NCT02166515|high-throughput sequencing|high-throughput sequencing
234751|NCT02166502|pediatric|pediatric
234752|NCT02166502|HIV|hiv
234753|NCT02166502|prevention|prevention
234754|NCT02166502|prophylaxis|prophylaxis
234755|NCT02166502|nevirapine|nevirapine
234756|NCT02166489|autologous mesenchymal stem cells|autologous mesenchymal stem cells
234757|NCT02166489|polycystic kidney disease|polycystic kidney disease
234758|NCT02166489|intravenous injection|intravenous injection
234759|NCT02166489|CRF|crf
234760|NCT02166450|Denture stomatitis|denture stomatitis
234761|NCT02166450|Dentures|dentures
234762|NCT02166450|Denture wearers|denture wearers
234763|NCT02166437|osteoporosis|osteoporosis
234764|NCT02166437|BMD|bmd
234765|NCT02166437|teriparatide|teriparatide
234766|NCT02166437|bisphosphonate|bisphosphonate
234767|NCT02166437|denosmab|denosmab
234768|NCT02166424|Pregnancy|pregnancy
234769|NCT02166424|Depression|depression
234770|NCT02166424|omega-3 fatty acids|omega-3 fatty acids
234771|NCT02166411|Myomectomy ,Laparoscopy , Barbed sutures|myomectomy ,laparoscopy , barbed sutures
234772|NCT02166398|Amlodipine basylate, Losartan potassium|amlodipine basylate, losartan potassium
234773|NCT02166359|Icodextrin|icodextrin
234774|NCT02166359|Triglyceride|triglyceride
234775|NCT02166346|Transverse myelitis|transverse myelitis
234776|NCT02166333|vitamin D|vitamin d
234777|NCT02166333|falls|falls
234778|NCT02166333|high risk of falling|high risk of falling
234779|NCT02166333|insufficient or deficient serum vitamin D levels|insufficient or deficient serum vitamin d levels
234780|NCT02166333|10-29 ng/ml|10-29 ng/ml
234781|NCT02166307|formaldehyde; Maillard Reaction; cross-linkage; human aging|formaldehyde; maillard reaction; cross-linkage; human aging
234782|NCT02166294|Foot|foot
234783|NCT02166294|Ulcer|ulcer
234784|NCT02166294|Diabetes|diabetes
234785|NCT02166294|Amputation|amputation
234786|NCT02166294|Limb salvage|limb salvage
234787|NCT02166281|Insomnia|insomnia
234788|NCT02166281|Anxiety|anxiety
234789|NCT02166281|Depression|depression
234790|NCT02166281|Restless leg syndrome|restless leg syndrome
234791|NCT02166281|Aromatase inhibitor|aromatase inhibitor
234792|NCT02166281|Body composition|body composition
234793|NCT02166268|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
234794|NCT02166268|Allergic rhinitis|allergic rhinitis
234795|NCT02166268|Allergy|allergy
234796|NCT02166268|Grass pollen|grass pollen
234797|NCT02166242|non-small cell lung cancer|non-small cell lung cancer
234798|NCT02166242|thioredoxin reductase|thioredoxin reductase
234897|NCT02165670|Myocardial infarction|myocardial infarction
234799|NCT02166216|Prolonged high intensity exercise|prolonged high intensity exercise
234800|NCT02166216|Healthy subjects|healthy subjects
234801|NCT02166216|Cardiovascular risk markers|cardiovascular risk markers
234802|NCT02166216|Troponin|troponin
234803|NCT02166216|Leisure sports athletes|leisure sports athletes
234804|NCT02166216|Cycling|cycling
234805|NCT02166216|CT coronary angiography|ct coronary angiography
234806|NCT02166216|Outcomes|outcomes
234807|NCT02166190|Pancreatic cancer|pancreatic cancer
234808|NCT02166190|cholangiocarcinoma|cholangiocarcinoma
234809|NCT02166190|radiofrequency ablation|radiofrequency ablation
234810|NCT02166164|Pain|pain
234811|NCT02166164|Secondary hyperalgesia|secondary hyperalgesia
234812|NCT02166164|thermal sensitization|thermal sensitization
234813|NCT02166164|Catastrophization|catastrophization
234814|NCT02166164|Anxiety|anxiety
234815|NCT02166125|gastric bypass|gastric bypass
234816|NCT02166125|sleeve gastrectomy|sleeve gastrectomy
234817|NCT02166125|esophageal stent|esophageal stent
234818|NCT02166125|suturing|suturing
234819|NCT02166112|Hernia of Abdominal Wall|hernia of abdominal wall
234820|NCT02166112|Biologic implant|biologic implant
234821|NCT02166112|Infected Hernioplasty Mesh|infected hernioplasty mesh
234822|NCT02166047|Hepatitis B|hepatitis b
234823|NCT02166047|HBV|hbv
234824|NCT02166047|GS-9620|gs-9620
234825|NCT02166047|TLR-7 Agonist|tlr-7 agonist
234826|NCT02166034|children|children
234827|NCT02166034|fruit|fruit
234828|NCT02166034|vegetable|vegetable
234829|NCT02166034|diet|diet
234830|NCT02166034|school|school
234831|NCT02166034|garden|garden
234832|NCT02166021|Multiple Sclerosis (MS)|multiple sclerosis (ms)
234833|NCT02166021|Stem Cells|stem cells
234834|NCT02166008|Repamipide|repamipide
234835|NCT02166008|Dual antiplatelet|dual antiplatelet
234836|NCT02166008|Peptic ulcer|peptic ulcer
234837|NCT02165995|Brain Tumor|brain tumor
234838|NCT02165995|Glioma|glioma
234839|NCT02165995|Tumor resection|tumor resection
234840|NCT02165995|Navigated Transcranial Magnetic Stimulation|navigated transcranial magnetic stimulation
234841|NCT02165995|nTMS|ntms
234842|NCT02165995|Brain mapping|brain mapping
234843|NCT02165995|Motor function|motor function
234844|NCT02165995|Speech function|speech function
234845|NCT02165995|Speech mapping|speech mapping
234846|NCT02165969|tumor|tumor
234847|NCT02165969|inflammatory process|inflammatory process
234848|NCT02165969|fracture|fracture
234849|NCT02165969|defect|defect
234850|NCT02165956|Cereals|cereals
234851|NCT02165956|Obesity|obesity
234852|NCT02165956|Complementary Feeding|complementary feeding
234853|NCT02165930|Bioavailability|bioavailability
234854|NCT02165930|oxycodone|oxycodone
234855|NCT02165930|ethanol interaction|ethanol interaction
234856|NCT02165930|healthy volunteers|healthy volunteers
234857|NCT02165917|Endometriosis|endometriosis
234858|NCT02165917|Adhesions|adhesions
234859|NCT02165917|Hyalobarrier®|hyalobarrier®
234860|NCT02165917|Hyaluronic acid|hyaluronic acid
234861|NCT02165917|Antiadhesion agent|antiadhesion agent
234862|NCT02165917|Adhesionbarrier|adhesionbarrier
234863|NCT02165917|Pregnancy rate|pregnancy rate
234864|NCT02165904|Analyze clinical efficacy of subarachnoid administration of|analyze clinical efficacy of subarachnoid administration of
234865|NCT02165904|"autologous BMSC expanded in vitro"|"autologous bmsc expanded in vitro"
234866|NCT02165878|Chronic kidney disease(CKD)|chronic kidney disease(ckd)
234867|NCT02165865|hand transplantation|hand transplantation
234868|NCT02165865|hand allotransplantation|hand allotransplantation
234869|NCT02165865|upper extremity transplantation|upper extremity transplantation
234870|NCT02165865|upper extremity amputation|upper extremity amputation
234871|NCT02165865|hand amputation|hand amputation
234872|NCT02165865|vascularized composite allotransplantation|vascularized composite allotransplantation
234873|NCT02165865|composite tissue allotransplantation|composite tissue allotransplantation
234874|NCT02165865|variance component analysis (VCA)|variance component analysis (vca)
234875|NCT02165865|composite tissue allograft (CTA)|composite tissue allograft (cta)
234876|NCT02165852|ampulla of Vater|ampulla of vater
234877|NCT02165852|adenoma|adenoma
234878|NCT02165852|papillectomy|papillectomy
234879|NCT02165852|injection|injection
234880|NCT02165852|non-injection|non-injection
234881|NCT02165826|Drug therapy|drug therapy
234882|NCT02165774|sacral neuromodulation, neurogenic lower urinary tract dysfunction|sacral neuromodulation, neurogenic lower urinary tract dysfunction
234883|NCT02165761|Hemodialysis|hemodialysis
234884|NCT02165761|End Stage Renal Disease|end stage renal disease
234885|NCT02165761|Vascular Graft|vascular graft
234886|NCT02165722|Influenza|influenza
234887|NCT02165722|HPV|hpv
234888|NCT02165722|Tdap|tdap
234889|NCT02165722|MCV|mcv
234890|NCT02165722|vaccination|vaccination
234891|NCT02165722|adolescents|adolescents
234892|NCT02165696|compression bandage, manual lymphatic drainage, lymphedema, breast cancer, qualitative research.|compression bandage, manual lymphatic drainage, lymphedema, breast cancer, qualitative research.
234893|NCT02165683|Cancer|cancer
234894|NCT02165683|Pediatric|pediatric
234895|NCT02165683|PET Scan|pet scan
234896|NCT02165670|Ischemic heart disesase|ischemic heart disesase
235300|NCT02163798|Walking|walking
234898|NCT02165670|Angina pectoris|angina pectoris
234899|NCT02165657|Excimer laser|excimer laser
234900|NCT02165657|UVB|uvb
234901|NCT02165657|Psoriasis|psoriasis
234902|NCT02165644|Subarachnoid Hemorrhage|subarachnoid hemorrhage
234903|NCT02165644|Vasospasm|vasospasm
234904|NCT02165644|Acetazolamide|acetazolamide
234905|NCT02165618|frailty|frailty
234906|NCT02165618|geriatric, elderly|geriatric, elderly
234907|NCT02165618|polypharmacy|polypharmacy
234908|NCT02165605|external beam radiotherapy|external beam radiotherapy
234909|NCT02165605|breast cancer|breast cancer
234910|NCT02165592|Hemophilia|hemophilia
234911|NCT02165592|Arthropathy|arthropathy
234912|NCT02165592|Range of Motion|range of motion
234913|NCT02165592|Strength|strength
234914|NCT02165592|Proprioception|proprioception
234915|NCT02165592|Gait|gait
234916|NCT02165592|Quality of Life|quality of life
234917|NCT02165579|procalcitonin|procalcitonin
234918|NCT02165579|biomarkers|biomarkers
234919|NCT02165579|Osteomyelitis|osteomyelitis
234920|NCT02165579|diabetes|diabetes
234921|NCT02165579|foot ulcer(s)|foot ulcer(s)
234922|NCT02165579|Infectious Disease Society of America stage 3 infection|infectious disease society of america stage 3 infection
234923|NCT02165566|intensive insulin therapy|intensive insulin therapy
234924|NCT02165566|critical care patients|critical care patients
234925|NCT02165566|blood glucose concentration>180 mg/dl|blood glucose concentration>180 mg/dl
234926|NCT02165553|Hibiscus sabdariffa calyces|hibiscus sabdariffa calyces
234927|NCT02165553|Blood Pressure|blood pressure
234928|NCT02165553|Vascular Function|vascular function
234929|NCT02165553|Inflammation|inflammation
234930|NCT02165553|Cardiometabolic risk markers|cardiometabolic risk markers
234931|NCT02165553|Systemic antioxidant capacity|systemic antioxidant capacity
234932|NCT02165540|Doula|doula
234933|NCT02165540|Pain management|pain management
234934|NCT02165540|Miscarriage|miscarriage
234935|NCT02165540|Abortion|abortion
234936|NCT02165514|spinal curvatures|spinal curvatures
234937|NCT02165488|ketamine|ketamine
234938|NCT02165488|abuse|abuse
234939|NCT02165488|abdominal discomfort|abdominal discomfort
234940|NCT02165488|cholangiopathy|cholangiopathy
234941|NCT02165462|Haemophilia|haemophilia
234942|NCT02165462|Arthropathy|arthropathy
234943|NCT02165462|Bilateral deficit phenomenon|bilateral deficit phenomenon
234944|NCT02165462|Proprioception|proprioception
234945|NCT02165449|ketamine|ketamine
234946|NCT02165449|major depression|major depression
234947|NCT02165449|imaging|imaging
234948|NCT02165449|gene expression|gene expression
234949|NCT02165423|pediatric|pediatric
234950|NCT02165423|solid organ transplant|solid organ transplant
234951|NCT02165423|parents|parents
234952|NCT02165423|heart|heart
234953|NCT02165423|kidney|kidney
234954|NCT02165423|liver|liver
234955|NCT02165410|Autism, mental retardation, Magnetic Resonance Imaging|autism, mental retardation, magnetic resonance imaging
234956|NCT02165397|Ibrutinib|ibrutinib
234957|NCT02165397|Pharmacyclics|pharmacyclics
234958|NCT02165397|PCYC|pcyc
234959|NCT02165397|Lymphoma|lymphoma
234960|NCT02165397|Btk inhibitor|btk inhibitor
234961|NCT02165397|WM|wm
234962|NCT02165397|Rituximab|rituximab
234963|NCT02165397|Rituxan|rituxan
234964|NCT02165397|Waldenström's|waldenström's
234965|NCT02165397|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
234966|NCT02165397|non-Hodgkin lymphoma|non-hodgkin lymphoma
234967|NCT02165397|NHL|nhl
234968|NCT02165384|tympanostomy|tympanostomy
234969|NCT02165384|myringotomy|myringotomy
234970|NCT02165384|otitis media|otitis media
234971|NCT02165384|ear tubes|ear tubes
234972|NCT02165384|ear infection|ear infection
234973|NCT02165358|BMD|bmd
234974|NCT02165358|LGMD2I|lgmd2i
234975|NCT02165358|Calf enlargement|calf enlargement
234976|NCT02165358|Muscular dystrophy|muscular dystrophy
234977|NCT02165358|MRI|mri
234978|NCT02165306|epilepsy|epilepsy
234979|NCT02165280|Pelvic Organ Prolapse|pelvic organ prolapse
234980|NCT02165280|Surgery|surgery
234981|NCT02165254|physical activity|physical activity
234982|NCT02165254|coronary heart disease|coronary heart disease
234983|NCT02165254|exercise|exercise
234984|NCT02165254|affect|affect
234985|NCT02165254|mind/body therapies|mind/body therapies
234986|NCT02165254|stress, psychological|stress, psychological
234987|NCT02165241|Hypertension|hypertension
234988|NCT02165241|Cardiac remodeling|cardiac remodeling
234989|NCT02165241|Immune system|immune system
234990|NCT02165202|HIV Pre-exposure Prophylaxis;|hiv pre-exposure prophylaxis;
234991|NCT02165202|long-acting injectable;|long-acting injectable;
234992|NCT02165202|HIV PrEP;|hiv prep;
234993|NCT02165202|biomedical HIV prevention research|biomedical hiv prevention research
234994|NCT02165189|Simeprevir|simeprevir
234995|NCT02165189|Sofosbuvir|sofosbuvir
234996|NCT02165189|Ribavirin|ribavirin
234997|NCT02165189|Hepatitits C|hepatitits c
234998|NCT02165189|Hepatitis C virus ribonucleic acid|hepatitis c virus ribonucleic acid
234999|NCT02165176|cannabis|cannabis
235000|NCT02165176|toxicology|toxicology
235001|NCT02165176|intoxication|intoxication
235002|NCT02165150|Elastic Band|elastic band
235003|NCT02165150|Institutional Elders|institutional elders
235004|NCT02165150|Functional Fitness|functional fitness
235005|NCT02165150|Sleep Quality|sleep quality
235006|NCT02165150|Depression|depression
235007|NCT02165137|trauma|trauma
235008|NCT02165137|major trauma|major trauma
235009|NCT02165137|multiple trauma|multiple trauma
235010|NCT02165137|outcome|outcome
235011|NCT02165137|quality|quality
235012|NCT02165137|process Management|process management
235013|NCT02165137|emergency room|emergency room
235014|NCT02165137|trauma center|trauma center
235015|NCT02165124|Obesity|obesity
235016|NCT02165124|Morbid Obesity|morbid obesity
235017|NCT02165124|Bariatric Surgery|bariatric surgery
235018|NCT02165124|Embolization|embolization
235019|NCT02165124|Minimally Invasive|minimally invasive
235020|NCT02165124|Weight Loss|weight loss
235021|NCT02165111|Scleroderma, Systemic|scleroderma, systemic
235022|NCT02165111|Raynaud Disease|raynaud disease
235023|NCT02165111|Botulinum Toxins, Type A|botulinum toxins, type a
235024|NCT02165085|Biomarkers|biomarkers
235025|NCT02165085|Ehlers-Danlos syndrome, vascular type|ehlers-danlos syndrome, vascular type
235026|NCT02165085|Pathophysiology|pathophysiology
235027|NCT02165072|Inferior vena cava|inferior vena cava
235028|NCT02165072|Kidney injury|kidney injury
235029|NCT02165072|Ultrasound|ultrasound
235030|NCT02165059|Nausea|nausea
235031|NCT02165059|Vomiting|vomiting
235032|NCT02165059|Functional dyspepsia|functional dyspepsia
235033|NCT02165059|Bloating|bloating
235034|NCT02165059|Regurgitation|regurgitation
235035|NCT02165059|Retching|retching
235036|NCT02165020|Prostate|prostate
235037|NCT02165020|Hypofractionated radiotherapy|hypofractionated radiotherapy
235038|NCT02165020|Hyaluronic acid|hyaluronic acid
235039|NCT02165020|Spacer|spacer
235040|NCT02165020|Rectum toxicity|rectum toxicity
235041|NCT02165020|Rectal toxicities after hypofractionated irradiation and injection of hyaluronic acid in patients with low- to intermediate-risk Prostate Cancer|rectal toxicities after hypofractionated irradiation and injection of hyaluronic acid in patients with low- to intermediate-risk prostate cancer
235042|NCT02164994|Astigmatism, arcuate incisions, astigmatic keratotomy|astigmatism, arcuate incisions, astigmatic keratotomy
235043|NCT02164968|Device investigation|device investigation
235044|NCT02164955|Pomalidomide|pomalidomide
235045|NCT02164955|Multiple Myeloma|multiple myeloma
235046|NCT02164955|Relapsed, Refractory|relapsed, refractory
235047|NCT02164955|Observational|observational
235048|NCT02164955|Imnovid|imnovid
235049|NCT02164955|Registry|registry
235050|NCT02164955|Post-approval|post-approval
235051|NCT02164955|Safety|safety
235052|NCT02164929|TAP block|tap block
235053|NCT02164929|Paravertebral block|paravertebral block
235054|NCT02164929|Epidural|epidural
235055|NCT02164929|Laparoscopic colectomy|laparoscopic colectomy
235056|NCT02164916|BRAF Mutant|braf mutant
235057|NCT02164916|Metastatic|metastatic
235058|NCT02164903|Quality of Life|quality of life
235059|NCT02164903|Chronic Myeloid Leukemia|chronic myeloid leukemia
235060|NCT02164903|Imatinib|imatinib
235061|NCT02164903|Dasatinib|dasatinib
235062|NCT02164877|Dietary fiber|dietary fiber
235063|NCT02164851|shock, emergencies, inflammation, infection|shock, emergencies, inflammation, infection
235064|NCT02164851|pathologic process|pathologic process
235065|NCT02164799|Shock|shock
235066|NCT02164799|Predicting diagnosis|predicting diagnosis
235067|NCT02164799|Predicting adverse outcomes|predicting adverse outcomes
235068|NCT02164786|Acute severe disease|acute severe disease
235069|NCT02164786|Intensive care unit|intensive care unit
235070|NCT02164786|adult|adult
235071|NCT02164786|cohort study|cohort study
235072|NCT02164786|metabolomics|metabolomics
235073|NCT02164786|NMR|nmr
235074|NCT02164786|High Performance Liquid Chromatography|high performance liquid chromatography
235075|NCT02164773|sevoflurane|sevoflurane
235076|NCT02164773|pediatric|pediatric
235077|NCT02164773|lower abdominal surgery|lower abdominal surgery
235078|NCT02164773|caudal|caudal
235079|NCT02164773|magnesium sulfate|magnesium sulfate
235080|NCT02164773|Magnesium Sulfate Causing Adverse Effects in Therapeutic Use|magnesium sulfate causing adverse effects in therapeutic use
235081|NCT02164773|Agitation States as Acute Reaction to Exceptional Stress|agitation states as acute reaction to exceptional stress
235082|NCT02164760|burns|burns
235083|NCT02164760|dermal substitute|dermal substitute
235084|NCT02164760|scar quality|scar quality
235085|NCT02164760|reconstruction|reconstruction
235086|NCT02164760|wound healing|wound healing
235087|NCT02164760|wound closure|wound closure
235088|NCT02164734|surfactant|surfactant
235089|NCT02164721|Heart failure|heart failure
235090|NCT02164721|Chemotherapy-induced cardiomyopathy|chemotherapy-induced cardiomyopathy
235091|NCT02164721|Cardiac resynchronization therapy|cardiac resynchronization therapy
235092|NCT02164708|mindfulness meditation, mental health, self-criticism|mindfulness meditation, mental health, self-criticism
235093|NCT02164695|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
235094|NCT02164695|Remote ischemic perconditioning|remote ischemic perconditioning
235095|NCT02164695|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
235096|NCT02164695|Cardiac magnetic resonance|cardiac magnetic resonance
235097|NCT02164682|Hypospadias repair|hypospadias repair
235098|NCT02164682|Caudal block|caudal block
235099|NCT02164682|Postoperative complications|postoperative complications
235100|NCT02164669|Inflammation|inflammation
235101|NCT02164669|Coronary artery bypass graft|coronary artery bypass graft
235102|NCT02164669|Magnetic Resonance Imaging|magnetic resonance imaging
235103|NCT02164643|Alzheimer's disease|alzheimer's disease
235104|NCT02164643|Mild Cognitive Impairment|mild cognitive impairment
235105|NCT02164630|Temporomandibular Joint Disorder|temporomandibular joint disorder
235106|NCT02164630|TMD|tmd
235107|NCT02164630|Hope|hope
235108|NCT02164630|Resilience|resilience
235109|NCT02164630|Cognitive Behavior Therapy|cognitive behavior therapy
235110|NCT02164617|Dementia|dementia
235111|NCT02164617|Wheelchair-bound seniors|wheelchair-bound seniors
235112|NCT02164617|Long-term care facilities|long-term care facilities
235113|NCT02164617|Elastic band exercise|elastic band exercise
235114|NCT02164617|Functional fitness|functional fitness
235115|NCT02164617|Daily life function|daily life function
235116|NCT02164617|Depression|depression
235117|NCT02164617|Problem behaviors|problem behaviors
235118|NCT02164604|ranibizumab|ranibizumab
235119|NCT02164604|intravitreal therapy|intravitreal therapy
235120|NCT02164604|ROP|rop
235121|NCT02164604|Plus disease|plus disease
235122|NCT02164604|stage 3 plus|stage 3 plus
235123|NCT02164591|gastroparesis|gastroparesis
235124|NCT02164591|gastric electrical stimulator|gastric electrical stimulator
235125|NCT02164591|GES|ges
235126|NCT02164591|vomiting|vomiting
235127|NCT02164591|nausea|nausea
235128|NCT02164591|bloating|bloating
235129|NCT02164591|postprandial fullness|postprandial fullness
235130|NCT02164591|epigastric pain|epigastric pain
235131|NCT02164552|PCOS|pcos
235132|NCT02164552|vitamin D|vitamin d
235133|NCT02164552|insulin resistance|insulin resistance
235134|NCT02164552|glycemic control|glycemic control
235135|NCT02164539|GSK573719|gsk573719
235136|NCT02164539|asthma|asthma
235137|NCT02164539|UMEC|umec
235138|NCT02164539|FF|ff
235139|NCT02164539|GSK2829332|gsk2829332
235140|NCT02164539|persistent obstruction|persistent obstruction
235141|NCT02164539|GW685698|gw685698
235142|NCT02164539|Fluticasone Furoate|fluticasone furoate
235143|NCT02164539|COPD|copd
235144|NCT02164539|umeclidinium bromide|umeclidinium bromide
235145|NCT02164526|Pulmonary Hypertension|pulmonary hypertension
235146|NCT02164526|Left Heart Disease|left heart disease
235147|NCT02164526|Heart failure|heart failure
235148|NCT02164526|Registry|registry
235149|NCT02164526|China|china
235150|NCT02164513|COPD|copd
235151|NCT02164513|umeclidinium|umeclidinium
235152|NCT02164513|fluticasone furoate|fluticasone furoate
235153|NCT02164513|vilanterol|vilanterol
235154|NCT02164513|triple therapy|triple therapy
235155|NCT02164513|exacerbation|exacerbation
235156|NCT02164487|B1 adolescents Eating disorders Thaimine|b1 adolescents eating disorders thaimine
235157|NCT02164461|Adenocarcinoma|adenocarcinoma
235158|NCT02164461|Carcinoma|carcinoma
235159|NCT02164461|Carcinoma, Squamous Cell|carcinoma, squamous cell
235160|NCT02164461|Uterine Cervical Neoplasms|uterine cervical neoplasms
235161|NCT02164461|Small Cell Lung Carcinoma|small cell lung carcinoma
235162|NCT02164461|Carcinoma, Small Cell|carcinoma, small cell
235163|NCT02164461|Carcinoma, Adenosquamous|carcinoma, adenosquamous
235164|NCT02164461|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
235165|NCT02164461|Neoplasms by Histologic Type|neoplasms by histologic type
235166|NCT02164461|Neoplasms|neoplasms
235167|NCT02164461|Neoplasms, Squamous Cell|neoplasms, squamous cell
235168|NCT02164461|Uterine Neoplasms|uterine neoplasms
235169|NCT02164461|Genital Neoplasms, Female|genital neoplasms, female
235170|NCT02164461|Urogenital Neoplasms|urogenital neoplasms
235171|NCT02164461|Neoplasms by Site|neoplasms by site
235172|NCT02164461|Uterine Cervical Diseases|uterine cervical diseases
235173|NCT02164461|Uterine Diseases|uterine diseases
235174|NCT02164461|Genital Diseases, Female|genital diseases, female
235175|NCT02164448|dexmedetomidine|dexmedetomidine
235176|NCT02164448|postoperative bowel movement|postoperative bowel movement
235177|NCT02164448|laparoscopic gastrectomy|laparoscopic gastrectomy
235178|NCT02164435|Uncontrolled hypertension|uncontrolled hypertension
235179|NCT02164435|Renal denervation|renal denervation
235180|NCT02164435|Renal artery|renal artery
235181|NCT02164422|Alcohol|alcohol
235182|NCT02164422|Drinkers|drinkers
235183|NCT02164422|Guanfacine|guanfacine
235184|NCT02164383|Smoking Cessation|smoking cessation
235185|NCT02164383|Smoking|smoking
235186|NCT02164383|Nicotine|nicotine
235187|NCT02164357|Ischaemic Stroke|ischaemic stroke
235188|NCT02164357|Main artery occlusion|main artery occlusion
235189|NCT02164357|Endovascular treatment|endovascular treatment
235190|NCT02164357|Intravenous Thrombolytic Therapy|intravenous thrombolytic therapy
235191|NCT02164344|HIV|hiv
235192|NCT02164344|Gut|gut
235193|NCT02164344|probiotics|probiotics
235194|NCT02164344|immune activation|immune activation
235195|NCT02164305|Rotator cuff muscle|rotator cuff muscle
235196|NCT02164305|Excitability|excitability
235197|NCT02164305|Proprioception|proprioception
235198|NCT02164305|Kinematics|kinematics
235199|NCT02164305|Muscle activity|muscle activity
235200|NCT02164305|Electromyography|electromyography
235201|NCT02164292|Liver tumor|liver tumor
235202|NCT02164292|ALPPS|alpps
235203|NCT02164292|Two-stage hepatectomy|two-stage hepatectomy
235204|NCT02164292|Morbidity|morbidity
235205|NCT02164292|Hypertrophy|hypertrophy
235206|NCT02164279|Microalbuminuria|microalbuminuria
235207|NCT02164279|diabetic nephropathy|diabetic nephropathy
235208|NCT02164279|type I diabetes|type i diabetes
235209|NCT02164279|early predictive urinary biomarkers|early predictive urinary biomarkers
235210|NCT02164240|Gastrointestinal Stromal Tumor|gastrointestinal stromal tumor
235211|NCT02164227|anxiety|anxiety
235212|NCT02164227|breathing exercise|breathing exercise
235213|NCT02164227|labour|labour
235214|NCT02164201|Type A Aortic Dissection (where the use of BioFoam is limited to the anastomotic site)|type a aortic dissection (where the use of biofoam is limited to the anastomotic site)
235215|NCT02164188|Stress|stress
235216|NCT02164188|Well-being|well-being
235217|NCT02164188|Functional magnetic resonance imaging|functional magnetic resonance imaging
235218|NCT02164188|Positive psychology|positive psychology
235219|NCT02164175|HeRO Graft|hero graft
235220|NCT02164162|Parkinson's disease, Lokomat, gait training, rehabilitation.|parkinson's disease, lokomat, gait training, rehabilitation.
235221|NCT02164149|Colon cancer|colon cancer
235222|NCT02164149|Quality of surgery|quality of surgery
235223|NCT02164149|Length of tumour feeding artery|length of tumour feeding artery
235224|NCT02164123|Autonomic effects|autonomic effects
235225|NCT02164123|spinal mobilization|spinal mobilization
235226|NCT02164123|clinical trial|clinical trial
235227|NCT02164097|ICE|ice
235228|NCT02164097|ODSH|odsh
235229|NCT02164097|platelet recovery|platelet recovery
235230|NCT02164097|recurrent solid tumor|recurrent solid tumor
235231|NCT02164084|acne|acne
235232|NCT02164071|Haematological malignancy|haematological malignancy
235233|NCT02164071|Elderly|elderly
235234|NCT02164071|Health Status|health status
235235|NCT02164071|Scale validation|scale validation
235236|NCT02164058|Myocardial infarction|myocardial infarction
235237|NCT02164058|STEMI|stemi
235238|NCT02164058|ST elevation MI|st elevation mi
235239|NCT02164058|Acute MI|acute mi
235240|NCT02164019|Pathologic Fractures|pathologic fractures
235241|NCT02164019|hip replacements|hip replacements
235242|NCT02164019|12-287|12-287
235243|NCT02164006|Hodgkin's|hodgkin's
235244|NCT02163980|dexmedetomidine|dexmedetomidine
235245|NCT02163980|caudal block|caudal block
235246|NCT02163980|children|children
235247|NCT02163980|children (1-6 years) undergoing ambulatory orchipexy|children (1-6 years) undergoing ambulatory orchipexy
235248|NCT02163967|cranial electrical stimulation|cranial electrical stimulation
235250|NCT02163967|heart rate variability|heart rate variability
235251|NCT02163967|parasympathetic|parasympathetic
235252|NCT02163967|Vagal|vagal
235253|NCT02163954|platelet|platelet
235254|NCT02163954|ticagrelor|ticagrelor
235255|NCT02163954|clopidogrel|clopidogrel
235256|NCT02163954|end stage renal disease|end stage renal disease
235257|NCT02163954|hemodialysis|hemodialysis
235258|NCT02163941|PTSD|ptsd
235259|NCT02163941|empathy|empathy
235260|NCT02163941|meditation|meditation
235261|NCT02163941|compassion|compassion
235262|NCT02163941|inflammation|inflammation
235263|NCT02163941|oxytocin|oxytocin
235264|NCT02163941|fMRI|fmri
235265|NCT02163928|Antioxidants|antioxidants
235266|NCT02163928|Carotenoids|carotenoids
235267|NCT02163928|Diet|diet
235268|NCT02163915|Drug therapy|drug therapy
235269|NCT02163889|Candida|candida
235270|NCT02163889|Blood culture|blood culture
235271|NCT02163889|Antifungal therapy|antifungal therapy
235272|NCT02163889|Sepsis|sepsis
235273|NCT02163876|spine|spine
235274|NCT02163876|injury|injury
235275|NCT02163876|trauma|trauma
235276|NCT02163876|spine injury|spine injury
235277|NCT02163876|cervical spine injury|cervical spine injury
235278|NCT02163876|cervical spine|cervical spine
235279|NCT02163876|stemcells transplantation|stemcells transplantation
235280|NCT02163863|Peripheral arterial disease (PAD)|peripheral arterial disease (pad)
235281|NCT02163863|Peripheral vascular disease (PVD)|peripheral vascular disease (pvd)
235282|NCT02163863|Biomimetic stent|biomimetic stent
235283|NCT02163863|Helical centerline|helical centerline
235284|NCT02163837|sleep quality|sleep quality
235285|NCT02163837|physical activity|physical activity
235286|NCT02163837|daytime sleepiness|daytime sleepiness
235287|NCT02163837|actigraphy|actigraphy
235288|NCT02163837|quality of life|quality of life
235289|NCT02163824|postsurgical|postsurgical
235290|NCT02163824|postoperative|postoperative
235291|NCT02163824|ocular|ocular
235292|NCT02163824|cataract|cataract
235293|NCT02163824|inflammation|inflammation
235294|NCT02163824|pain|pain
235295|NCT02163824|corticosteroid|corticosteroid
235296|NCT02163811|Self-management|self-management
235297|NCT02163811|Functional status|functional status
235298|NCT02163811|Depression|depression
235299|NCT02163798|Tai Chi|tai chi
235301|NCT02163798|Physical activity|physical activity
235302|NCT02163798|Randomized controlled trial|randomized controlled trial
235303|NCT02163798|Chinese population|chinese population
235304|NCT02163798|Exercise|exercise
235305|NCT02163798|Body composition|body composition
235306|NCT02163798|Cardiovascular risk factor|cardiovascular risk factor
235307|NCT02163798|Energy expenditure|energy expenditure
235308|NCT02163798|Fitness|fitness
235309|NCT02163798|SF-12|sf-12
235310|NCT02163785|Inferior rectal cancer|inferior rectal cancer
235311|NCT02163785|Abdominoperineal resection|abdominoperineal resection
235312|NCT02163785|Miles operation|miles operation
235313|NCT02163785|Supine Miles operation|supine miles operation
235314|NCT02163785|Prone Miles operation|prone miles operation
235315|NCT02163785|Total mesorectal excision|total mesorectal excision
235316|NCT02163785|Circumferential radial margin|circumferential radial margin
235317|NCT02163746|Hidradenitis suppurativa|hidradenitis suppurativa
235318|NCT02163733|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, AZD9291, EGFR sensitivity mutation, food effect|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, azd9291, egfr sensitivity mutation, food effect
235319|NCT02163720|ovarian cancer|ovarian cancer
235320|NCT02163720|fallopian tube or primary peritoneal|fallopian tube or primary peritoneal
235321|NCT02163720|relapse|relapse
235322|NCT02163720|platinum-sensitive|platinum-sensitive
235323|NCT02163720|Yondelis®-Caelyx®|yondelis®-caelyx®
235324|NCT02163707|Psilocybin|psilocybin
235325|NCT02163707|Pharmacokinetics|pharmacokinetics
235326|NCT02163694|PARP Inhibitor|parp inhibitor
235327|NCT02163694|Veliparib|veliparib
235328|NCT02163694|BRCA1|brca1
235329|NCT02163694|BRCA2|brca2
235330|NCT02163694|HER2-negative|her2-negative
235331|NCT02163694|Locally recurrent|locally recurrent
235332|NCT02163694|Breast Cancer|breast cancer
235333|NCT02163694|Metastatic Breast Cancer|metastatic breast cancer
235334|NCT02163694|ABT-888|abt-888
235335|NCT02163694|Genetic breast cancer|genetic breast cancer
235336|NCT02163694|Paclitaxel|paclitaxel
235337|NCT02163694|BRCA Mutation|brca mutation
235338|NCT02163694|PARP|parp
235339|NCT02163694|Carboplatin|carboplatin
235340|NCT02163668|Yoga|yoga
235341|NCT02163668|Bone turnover markers|bone turnover markers
235342|NCT02163668|Bone strength|bone strength
235343|NCT02163668|Bone mineral density|bone mineral density
235344|NCT02163655|preeclampsia, very high blood pressure, diuretics|preeclampsia, very high blood pressure, diuretics
235345|NCT02163642|Bronchiectasis|bronchiectasis
235346|NCT02163642|Immunity|immunity
235347|NCT02163629|Psychotherapeutic intervention|psychotherapeutic intervention
235348|NCT02163629|stress management|stress management
235349|NCT02163629|cardiac transplantation|cardiac transplantation
235350|NCT02163629|quality of life|quality of life
235351|NCT02163616|Primary postpartum hemorrhage|primary postpartum hemorrhage
235352|NCT02163616|PPH|pph
235353|NCT02163616|uterine atony|uterine atony
235354|NCT02163616|high fever|high fever
235355|NCT02163616|hyperpyrexia|hyperpyrexia
235356|NCT02163616|shock index|shock index
235357|NCT02163590|Spinal mobilisation|spinal mobilisation
235358|NCT02163590|Pressure pain threshold|pressure pain threshold
235359|NCT02163590|Thoracic spine|thoracic spine
235360|NCT02163577|X-linked hypophosphatemia|x-linked hypophosphatemia
235361|NCT02163577|XLH|xlh
235362|NCT02163577|FGF23|fgf23
235363|NCT02163577|KRN23|krn23
235364|NCT02163564|Adolescent|adolescent
235365|NCT02163564|Depression|depression
235366|NCT02163564|Insomnia|insomnia
235367|NCT02163551|dyspnea|dyspnea
235368|NCT02163551|respiratory sensation|respiratory sensation
235369|NCT02163551|event-related potentials|event-related potentials
235370|NCT02163551|spinal cord injury|spinal cord injury
235371|NCT02163538|energy device|energy device
235372|NCT02163538|laparoscopic|laparoscopic
235373|NCT02163538|hysterectomy|hysterectomy
235374|NCT02163538|enseal|enseal
235375|NCT02163538|ligasure|ligasure
235376|NCT02163538|raw tlx|raw tlx
235377|NCT02163525|Fibroids|fibroids
235378|NCT02163525|Myomas|myomas
235379|NCT02163525|leiomyomata|leiomyomata
235380|NCT02163525|menorrhagia|menorrhagia
235381|NCT02163525|Acessa Procedure|acessa procedure
235382|NCT02163525|Radiofrequency Ablation (RFA)|radiofrequency ablation (rfa)
235383|NCT02163525|GFA|gfa
235384|NCT02163525|Acessa|acessa
235385|NCT02163512|Hepatic cirrhosis|hepatic cirrhosis
235386|NCT02163512|Ascites|ascites
235387|NCT02163512|Beta blockers treatment|beta blockers treatment
235388|NCT02163486|I-gel|i-gel
235389|NCT02163486|oropharyngeal leak pressure|oropharyngeal leak pressure
235390|NCT02163486|head position|head position
235391|NCT02163460|ventral hernia|ventral hernia
235392|NCT02163460|seroma|seroma
235393|NCT02163460|drainage|drainage
235394|NCT02163460|infection|infection
235395|NCT02163447|Chemoprevention|chemoprevention
235396|NCT02163447|Malaria|malaria
235397|NCT02163447|Uganda|uganda
235398|NCT02163447|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
235399|NCT02163447|Dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
235400|NCT02163434|pregnancy|pregnancy
235401|NCT02163434|nausea|nausea
235402|NCT02163434|vomiting|vomiting
235403|NCT02163434|hyperemesis|hyperemesis
235404|NCT02163434|treatment|treatment
235405|NCT02163434|gabapentin|gabapentin
235406|NCT02163434|metoclopramide|metoclopramide
235407|NCT02163434|safety|safety
235408|NCT02163421|Drug therapy|drug therapy
235409|NCT02163408|MRI|mri
235410|NCT02163408|Plaque Characterization|plaque characterization
235411|NCT02163395|Ceramic implant|ceramic implant
235412|NCT02163382|Nava|nava
235413|NCT02163382|Non Invasive Ventilation|non invasive ventilation
235414|NCT02163356|neuroblastoma|neuroblastoma
235415|NCT02163356|recurrent|recurrent
235416|NCT02163356|resistant|resistant
235417|NCT02163343|Serum metal ion levels|serum metal ion levels
235418|NCT02163343|Cathcart/Corail hemiarthroplasty|cathcart/corail hemiarthroplasty
235419|NCT02163343|Hip replacement|hip replacement
235420|NCT02163291|advanced gastric cancer|advanced gastric cancer
235421|NCT02163291|neoadjuvant chemotherapy|neoadjuvant chemotherapy
235422|NCT02163291|safety|safety
235423|NCT02163291|feasibility|feasibility
235424|NCT02163278|DBPR108|dbpr108
235425|NCT02163278|DPP4|dpp4
235426|NCT02163278|Diabetes|diabetes
235427|NCT02163278|Glucagon-like peptide-1 (GLP-1)|glucagon-like peptide-1 (glp-1)
235428|NCT02163278|Incretins|incretins
235429|NCT02163239|FloShield|floshield
235430|NCT02163239|MID|mid
235431|NCT02163239|Minimally invasive surgery|minimally invasive surgery
235432|NCT02163239|Minimally Invasive devices|minimally invasive devices
235433|NCT02163239|Robot-assisted Laparoscopic Surgery|robot-assisted laparoscopic surgery
235434|NCT02163239|Single-site Laparoscopic Surgery|single-site laparoscopic surgery
235435|NCT02163239|Single Incision Laparoscopic Surgery|single incision laparoscopic surgery
235436|NCT02163239|Cannula|cannula
235437|NCT02163239|Blunt Obturator|blunt obturator
235438|NCT02163239|Cholecystectomy|cholecystectomy
235439|NCT02163239|Benign hysterectomy|benign hysterectomy
235440|NCT02163239|Salpingo-oophorectomy|salpingo-oophorectomy
235441|NCT02163226|Bone metastases|bone metastases
235442|NCT02163226|Hypofractionated Radiation Therapy|hypofractionated radiation therapy
235443|NCT02163226|Standard Radiation Therapy|standard radiation therapy
235444|NCT02163226|XRT|xrt
235445|NCT02163226|Pain control|pain control
235446|NCT02163226|Palliation of symptoms|palliation of symptoms
235447|NCT02163226|Questionnaire|questionnaire
235448|NCT02163226|Survey|survey
235449|NCT02163213|diarrhea|diarrhea
235450|NCT02163213|irritable bowel syndrome|irritable bowel syndrome
235451|NCT02163200|Bedsores|bedsores
235452|NCT02163200|pressure|pressure
235453|NCT02163200|hip|hip
235454|NCT02163187|Neuromodulation (SNM)|neuromodulation (snm)
235455|NCT02163187|sphincter preservation|sphincter preservation
235456|NCT02163187|rectal polyp|rectal polyp
235457|NCT02163187|InterStimTM|interstimtm
235458|NCT02163187|14-100|14-100
235459|NCT02163174|neonatal|neonatal
235460|NCT02163174|pentoxifylline|pentoxifylline
235461|NCT02163174|randomized controlled trial|randomized controlled trial
235462|NCT02163161|Phase I|phase i
235463|NCT02163161|Open Label|open label
235464|NCT02163161|Single dose|single dose
235465|NCT02163161|Crossover|crossover
235466|NCT02163161|Bioavailability|bioavailability
235467|NCT02163161|Fasting|fasting
235468|NCT02163161|Fed|fed
235469|NCT02163161|PF-04965842|pf-04965842
235470|NCT02163161|Healthy|healthy
235471|NCT02163122|Cat Allergy|cat allergy
235472|NCT02163122|Feld1|feld1
235473|NCT02163109|Oxygen consumption|oxygen consumption
235474|NCT02163109|Pulmonary gas exchange|pulmonary gas exchange
235475|NCT02163109|Cardiac output|cardiac output
235476|NCT02163070|whey protein|whey protein
235477|NCT02163070|malnutrition|malnutrition
235478|NCT02163070|oxidative stress|oxidative stress
235479|NCT02163070|hemodialysis|hemodialysis
235480|NCT02163057|Head and neck squamous cell cancer|head and neck squamous cell cancer
235481|NCT02163057|Papillomavirus|papillomavirus
235482|NCT02163031|heart transplant|heart transplant
235483|NCT02163031|radial approach|radial approach
235484|NCT02163031|catheterization|catheterization
235485|NCT02163005|GDL contrast agent|gdl contrast agent
235486|NCT02162992|Antibodies, Antinuclear|antibodies, antinuclear
235487|NCT02162992|SS-A antigen|ss-a antigen
235488|NCT02162992|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
235489|NCT02162992|Atrioventricular Block|atrioventricular block
235490|NCT02162992|Sudden death|sudden death
235491|NCT02162979|Parkinson's disease|parkinson's disease
235492|NCT02162979|PD|pd
235493|NCT02162979|dyskinesia|dyskinesia
235494|NCT02162979|treatment|treatment
235495|NCT02162979|motor complications|motor complications
235496|NCT02162966|colistin|colistin
235497|NCT02162966|ICU|icu
235498|NCT02162966|critical care|critical care
235499|NCT02162953|eye disease|eye disease
235500|NCT02162953|retinal|retinal
235501|NCT02162953|best1|best1
235502|NCT02162940|low back pain|low back pain
235503|NCT02162940|epidural steroid injection|epidural steroid injection
235504|NCT02162940|statin|statin
235505|NCT02162940|quality of life|quality of life
235506|NCT02162927|muscular strength|muscular strength
235507|NCT02162927|muscular endurance|muscular endurance
235508|NCT02162927|muscular power|muscular power
235509|NCT02162927|rowing|rowing
235510|NCT02162927|CrossFit|crossfit
235511|NCT02162927|dietary nitrate|dietary nitrate
235512|NCT02162914|Intra-hepatic|intra-hepatic
235513|NCT02162914|Hilar|hilar
235514|NCT02162914|Locally Advanced|locally advanced
235515|NCT02162914|Non Resectable|non resectable
235516|NCT02162914|Metastatic|metastatic
235517|NCT02162914|Regorafenib|regorafenib
235518|NCT02162914|Placebo|placebo
235519|NCT02162901|Diabetes prevention|diabetes prevention
235520|NCT02162875|Schistosoma mansoni|schistosoma mansoni
235521|NCT02162875|treatment|treatment
235522|NCT02162875|school children|school children
235523|NCT02162875|adults|adults
235524|NCT02162862|Inflammatory Bowel Disease|inflammatory bowel disease
235525|NCT02162862|Physical Illness|physical illness
235526|NCT02162862|Wellbutrin|wellbutrin
235527|NCT02162849|Tobacco Use Cessation|tobacco use cessation
235528|NCT02162849|Smoking Cessation|smoking cessation
235529|NCT02162849|Cancer Prevention|cancer prevention
235530|NCT02162849|Behavioral Counseling|behavioral counseling
235531|NCT02162849|Nicotine Replacement Therapy|nicotine replacement therapy
235532|NCT02162849|NRT|nrt
235533|NCT02162849|Nicotine patch|nicotine patch
235534|NCT02162849|Placebo patch|placebo patch
235535|NCT02162849|Placebo pill|placebo pill
235536|NCT02162849|Sugar pill|sugar pill
235537|NCT02162849|Varenicline|varenicline
235538|NCT02162849|Chantix|chantix
235539|NCT02162849|Questionnaires|questionnaires
235540|NCT02162849|Surveys|surveys
235541|NCT02162849|Saliva test|saliva test
235542|NCT02162836|Prostatic Neoplasms, Castration-Resistant|prostatic neoplasms, castration-resistant
235543|NCT02162836|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
235544|NCT02162836|Prostate Cancer|prostate cancer
235545|NCT02162836|Androgen Receptor|androgen receptor
235546|NCT02162836|JNJ-56021927|jnj-56021927
235547|NCT02162823|The MeSH name is Carcinoma, Pancreatic Ductal|the mesh name is carcinoma, pancreatic ductal
235548|NCT02162810|hypospadias|hypospadias
235549|NCT02162797|HIV|hiv
235550|NCT02162797|AIDS|aids
235551|NCT02162797|zinc|zinc
235552|NCT02162797|zinc supplement|zinc supplement
235553|NCT02162797|immunological deficiency|immunological deficiency
235554|NCT02162771|Advanced Follicular Lymphoma|advanced follicular lymphoma
235555|NCT02162758|Drug therapy|drug therapy
235556|NCT02162745|Bronchiolitis|bronchiolitis
235557|NCT02162745|Normal saline solution|normal saline solution
235558|NCT02162745|Hypertonic solution|hypertonic solution
235559|NCT02162745|Nasal irrigation|nasal irrigation
235560|NCT02162680|local anesthesia|local anesthesia
235561|NCT02162680|intravenous catheter|intravenous catheter
235562|NCT02162654|neuroprotection|neuroprotection
235563|NCT02162654|ischemic preconditioning|ischemic preconditioning
235564|NCT02162654|cerebral aneurysm|cerebral aneurysm
235565|NCT02162628|Pelvic Floor Disorder|pelvic floor disorder
235566|NCT02162628|Pelvic Organ Prolapse|pelvic organ prolapse
235567|NCT02162628|Sexual Dysfunction|sexual dysfunction
235568|NCT02162628|Mesh|mesh
235569|NCT02162628|POP|pop
235570|NCT02162628|Transvaginal|transvaginal
235571|NCT02162628|Total Repair|total repair
235572|NCT02162628|Uterine Prolapse|uterine prolapse
235573|NCT02162628|Cystocele|cystocele
235574|NCT02162628|Rectocele|rectocele
235575|NCT02162628|Enterocele|enterocele
235576|NCT02162628|Vaginal Vault Prolapse|vaginal vault prolapse
235577|NCT02162628|Native Tissue Repair|native tissue repair
235578|NCT02162628|Repair Augmented with Mesh|repair augmented with mesh
235579|NCT02162628|Pathological Conditions, Anatomical|pathological conditions, anatomical
235580|NCT02162628|Exair Prolapse Repair System|exair prolapse repair system
235581|NCT02162628|Vaginal Mesh|vaginal mesh
235582|NCT02162628|Transvaginal Mesh|transvaginal mesh
235583|NCT02162615|Pelvic Floor Disorder|pelvic floor disorder
235584|NCT02162615|Pelvic Organ Prolapse|pelvic organ prolapse
235585|NCT02162615|Sexual Dysfunction|sexual dysfunction
235586|NCT02162615|Mesh|mesh
235587|NCT02162615|POP|pop
235588|NCT02162615|Transvaginal|transvaginal
235589|NCT02162615|Anterior|anterior
235590|NCT02162615|Posterior|posterior
235591|NCT02162615|Apical|apical
235592|NCT02162615|Uterine Prolapse|uterine prolapse
235593|NCT02162615|Cystocele|cystocele
235594|NCT02162615|Rectocele|rectocele
235595|NCT02162615|Enterocele|enterocele
235596|NCT02162615|Vaginal Vault Prolapse|vaginal vault prolapse
235597|NCT02162615|Native Tissue Repair|native tissue repair
235598|NCT02162615|Repair Augmented with Mesh|repair augmented with mesh
235599|NCT02162615|Pathological Conditions, Anatomical|pathological conditions, anatomical
235600|NCT02162615|Restorelle Direct Fix|restorelle direct fix
235601|NCT02162615|Vaginal Mesh|vaginal mesh
235602|NCT02162615|Transvaginal Mesh|transvaginal mesh
235603|NCT02162576|asthma|asthma
235604|NCT02162576|asthma control|asthma control
235605|NCT02162576|healthcare utilization costs|healthcare utilization costs
235606|NCT02162576|community hotspots|community hotspots
235607|NCT02162576|public health research|public health research
235608|NCT02162563|Colorectal cancer|colorectal cancer
235609|NCT02162563|Chemotherapy|chemotherapy
235610|NCT02162563|Anti-EGFR|anti-egfr
235611|NCT02162563|Liver metastases|liver metastases
235612|NCT02162563|R0 R1 liver resection|r0 r1 liver resection
235613|NCT02162563|Resectability of liver|resectability of liver
235614|NCT02162563|Liver expert panel|liver expert panel
235615|NCT02162550|Type 2 Diabetes|type 2 diabetes
235616|NCT02162550|Cardiovascular Disease|cardiovascular disease
235617|NCT02162550|Hyperglycemia|hyperglycemia
235618|NCT02162550|Carotid Plaque|carotid plaque
235619|NCT02162550|Endothelial function|endothelial function
235620|NCT02162550|Incretins|incretins
235621|NCT02162550|Atherosclerosis|atherosclerosis
235622|NCT02162537|Strategy|strategy
235623|NCT02162537|Radiotherapy|radiotherapy
235624|NCT02162537|Chemotherapy|chemotherapy
235625|NCT02162537|Cisplatin|cisplatin
235626|NCT02162524|aerobic exercise|aerobic exercise
235628|NCT02162524|energy balance|energy balance
235629|NCT02162511|Haplocompatible|haplocompatible
235630|NCT02162511|Stem cell transplant|stem cell transplant
235631|NCT02162511|Borderline organ function|borderline organ function
235632|NCT02162511|Alternative donor stem cell transplant|alternative donor stem cell transplant
235633|NCT02162498|Peer support|peer support
235634|NCT02162498|Adherence|adherence
235635|NCT02162498|Exclusive breastfeeding|exclusive breastfeeding
235636|NCT02162498|Early infant diagnosis|early infant diagnosis
235637|NCT02162498|Stigma and disclosure|stigma and disclosure
235638|NCT02162472|videocapillaroscopy, psoriasis, systemic agent|videocapillaroscopy, psoriasis, systemic agent
235639|NCT02162459|Adolescent|adolescent
235640|NCT02162459|supplements|supplements
235641|NCT02162459|strength|strength
235642|NCT02162459|whey protein|whey protein
235643|NCT02162459|bench press strength|bench press strength
235644|NCT02162459|squat strength|squat strength
235645|NCT02162420|severe aplastic anemia|severe aplastic anemia
235646|NCT02162420|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
235647|NCT02162381|Humphrey visual fields|humphrey visual fields
235648|NCT02162381|methylphenidate|methylphenidate
235649|NCT02162381|attention deficit disorder|attention deficit disorder
235650|NCT02162381|MoCa questionnaire|moca questionnaire
235651|NCT02162368|laryngeal mask, prone position, spine surgery|laryngeal mask, prone position, spine surgery
235652|NCT02162342|upper extremity|upper extremity
235653|NCT02162342|muscle activity|muscle activity
235654|NCT02162342|kinematics|kinematics
235655|NCT02162342|motion capture|motion capture
235656|NCT02162342|Electromyography|electromyography
235657|NCT02162329|Breast Cancer|breast cancer
235658|NCT02162329|Cognitive function|cognitive function
235659|NCT02162329|Questionnaires|questionnaires
235660|NCT02162329|Surveys|surveys
235661|NCT02162329|Electroencephalography|electroencephalography
235662|NCT02162329|EEG|eeg
235663|NCT02162329|Magnetic resonance imaging|magnetic resonance imaging
235664|NCT02162329|fMRI|fmri
235665|NCT02162329|Tibetan meditation|tibetan meditation
235666|NCT02162329|Quality of life|quality of life
235667|NCT02162329|QOL|qol
235668|NCT02162303|Atherosclerosis|atherosclerosis
235669|NCT02162303|Vascular|vascular
235670|NCT02162303|Cardiovascular|cardiovascular
235671|NCT02162303|Coronary artery disease|coronary artery disease
235672|NCT02162303|Imaging|imaging
235673|NCT02162303|PET|pet
235674|NCT02162303|Scan|scan
235675|NCT02162303|anti-inflammatory|anti-inflammatory
235676|NCT02162277|To decrease|to decrease
235677|NCT02162277|number|number
235678|NCT02162277|osteoporotic|osteoporotic
235679|NCT02162277|patients in|patients in
235680|NCT02162277|Kami-Ina area|kami-ina area
235681|NCT02162277|Nagano prefecture|nagano prefecture
235682|NCT02162264|Alzheimer's Disease|alzheimer's disease
235683|NCT02162264|donepezil hydrochloride|donepezil hydrochloride
235684|NCT02162251|Alzheimer's Disease|alzheimer's disease
235685|NCT02162251|donepezil hydrochloride|donepezil hydrochloride
235686|NCT02162238|zinc|zinc
235687|NCT02162238|diet|diet
235688|NCT02162238|water|water
235689|NCT02162238|morbidity|morbidity
235690|NCT02162238|growth|growth
235691|NCT02162225|Erythrocyte Deformability|erythrocyte deformability
235692|NCT02162225|Platelet Activation|platelet activation
235693|NCT02162225|Platelet Aggregation|platelet aggregation
235694|NCT02162225|Nitrite|nitrite
235695|NCT02162225|Sickle Cell Anemia|sickle cell anemia
235696|NCT02162225|Diet Therapy|diet therapy
235697|NCT02162199|Antibiotic|antibiotic
235698|NCT02162199|Antibiotic Resistant Bacterial Infection|antibiotic resistant bacterial infection
235699|NCT02162186|Arthroplasty, Replacement, Hip/methods|arthroplasty, replacement, hip/methods
235700|NCT02162186|Hip Joint/physiopathology|hip joint/physiopathology
235701|NCT02162186|Hip Joint/radiography|hip joint/radiography
235702|NCT02162186|Hip Joint/surgery|hip joint/surgery
235703|NCT02162186|Hip Prosthesis|hip prosthesis
235704|NCT02162186|Outcome Assessment (Health Care)|outcome assessment (health care)
235705|NCT02162186|Female|female
235706|NCT02162186|Male|male
235707|NCT02162186|Adult|adult
235708|NCT02162173|Familial adenomatous polyposis syndrome|familial adenomatous polyposis syndrome
235709|NCT02162173|Non-ampullary polyp|non-ampullary polyp
235710|NCT02162173|Ampullary polyp|ampullary polyp
235711|NCT02162173|Narrow band imaging endoscopy|narrow band imaging endoscopy
235712|NCT02162173|Confocal laser endomicroscopy|confocal laser endomicroscopy
235713|NCT02162160|probiotic|probiotic
235714|NCT02162160|post-menopausal|post-menopausal
235715|NCT02162160|atrophic vaginitis|atrophic vaginitis
235716|NCT02162147|patient safety|patient safety
235717|NCT02162147|pediatrics|pediatrics
235718|NCT02162147|emergency medicine|emergency medicine
235719|NCT02162134|cholecystectomy|cholecystectomy
235720|NCT02162134|laparoscopic|laparoscopic
235721|NCT02162134|postoperative|postoperative
235722|NCT02162134|ileus|ileus
235723|NCT02162134|chewing gum|chewing gum
235724|NCT02162095|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
235725|NCT02162095|Coronary artery disease|coronary artery disease
235726|NCT02162095|Coronary calcium score|coronary calcium score
235727|NCT02162043|Glaucoma|glaucoma
235728|NCT02162043|Perimetry|perimetry
235729|NCT02162043|Diagnostic self-evaluation|diagnostic self-evaluation
235730|NCT02162043|Screening|screening
235731|NCT02162043|Visual fields|visual fields
235732|NCT02162017|Acute ischemic stroke|acute ischemic stroke
235733|NCT02162017|Acute intracerebral haemorrhage|acute intracerebral haemorrhage
235734|NCT02162017|Head position|head position
235735|NCT02162017|Lying flat head position|lying flat head position
235736|NCT02162017|Sitting up head position|sitting up head position
235737|NCT02162017|Death|death
235738|NCT02162017|Disability|disability
235739|NCT02162017|Clinical trial|clinical trial
235740|NCT02162004|Type 1 diabetes|type 1 diabetes
235741|NCT02162004|Continuous Glucose Monitoring|continuous glucose monitoring
235742|NCT02162004|Insulin pump|insulin pump
235743|NCT02162004|Sensor-augmented pump|sensor-augmented pump
235744|NCT02162004|Continuous correction of high blood glucose|continuous correction of high blood glucose
235745|NCT02161991|aprepitant|aprepitant
235746|NCT02161991|non-small cell lung cancer|non-small cell lung cancer
235747|NCT02161978|antiangiogenic|antiangiogenic
235748|NCT02161978|cancer|cancer
235749|NCT02161978|vascular|vascular
235750|NCT02161978|biomarker|biomarker
235751|NCT02161978|tyrosine kinase inhibitor|tyrosine kinase inhibitor
235752|NCT02161965|Anticoagulation|anticoagulation
235753|NCT02161965|Coronary and peripheral calcification|coronary and peripheral calcification
235754|NCT02161965|Arterial stiffness|arterial stiffness
235755|NCT02161965|Biomarker|biomarker
235756|NCT02161952|Fibrosis, necroinflammation, hepatitis C chronic|fibrosis, necroinflammation, hepatitis c chronic
235757|NCT02161926|Obesity|obesity
235758|NCT02161926|dietary restrictions|dietary restrictions
235759|NCT02161926|metabolism|metabolism
235760|NCT02161926|nutrition|nutrition
235761|NCT02161926|elderly|elderly
235762|NCT02161874|edentulism|edentulism
235763|NCT02161874|dental implants|dental implants
235764|NCT02161874|clinical study|clinical study
235765|NCT02161874|endosseous|endosseous
235766|NCT02161874|randomized|randomized
235767|NCT02161874|crestal bone level|crestal bone level
235768|NCT02161874|T3|t3
235769|NCT02161874|Nanotite Certain|nanotite certain
235770|NCT02161874|Nanotite Certain Prevail|nanotite certain prevail
235771|NCT02161874|Tapered|tapered
235772|NCT02161861|tripeptide FEE|tripeptide fee
235773|NCT02161861|fertilization rates|fertilization rates
235774|NCT02161861|embryos|embryos
235775|NCT02161861|oocytes|oocytes
235776|NCT02161835|Congenital myotonia|congenital myotonia
235777|NCT02161835|Myotonia congenita|myotonia congenita
235778|NCT02161835|Thomsons disease|thomsons disease
235779|NCT02161835|Becker type|becker type
235780|NCT02161835|Training|training
235781|NCT02161835|Exercise|exercise
235782|NCT02161822|locally advanced rectal cancer, neoadjuvant chemoradiation|locally advanced rectal cancer, neoadjuvant chemoradiation
235783|NCT02161809|MVPA|mvpa
235784|NCT02161809|Healthy Eating|healthy eating
235785|NCT02161809|children|children
235786|NCT02161809|childhood obesity|childhood obesity
235787|NCT02161796|Phase 1|phase 1
235788|NCT02161796|FG-4592|fg-4592
235789|NCT02161796|Age/gender comparison|age/gender comparison
235790|NCT02161783|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
235791|NCT02161770|oncology, cancer, neoplasm, anticancer drug, pharmacokinetics, area under curve, AZD9291, solid tumour, mild hepatic impairment, moderate hepatic impairment|oncology, cancer, neoplasm, anticancer drug, pharmacokinetics, area under curve, azd9291, solid tumour, mild hepatic impairment, moderate hepatic impairment
235792|NCT02161757|Asthma|asthma
235793|NCT02161757|Reactive Airways|reactive airways
235794|NCT02161757|Respiratory Tract Disease|respiratory tract disease
235795|NCT02161757|Obstructive Lung Disease|obstructive lung disease
235796|NCT02161757|Lung Diseases|lung diseases
235797|NCT02161744|Adipose derived stem cells|adipose derived stem cells
235798|NCT02161744|Stromal vascular fraction cells|stromal vascular fraction cells
235799|NCT02161744|Pulmonary Function Tests|pulmonary function tests
235800|NCT02161744|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
235801|NCT02161718|Alkermes|alkermes
235802|NCT02161718|Schizophrenia|schizophrenia
235803|NCT02161718|Alcohol Use Disorder|alcohol use disorder
235804|NCT02161718|ALKS 3831|alks 3831
235805|NCT02161705|Immediate breast reconstruction|immediate breast reconstruction
235806|NCT02161705|pain control|pain control
235807|NCT02161705|post mastectomy pain control|post mastectomy pain control
235808|NCT02161679|Antibody drug conjugate|antibody drug conjugate
235809|NCT02161679|IMMU-132|immu-132
235810|NCT02161679|Triple-negative breast cancer|triple-negative breast cancer
235811|NCT02161679|Safety and tolerability|safety and tolerability
235812|NCT02161679|Progression Free Survival (PFS)|progression free survival (pfs)
235813|NCT02161666|Obesity|obesity
235814|NCT02161666|Gastric Bypass|gastric bypass
235815|NCT02161666|Bariatric Surgery|bariatric surgery
235816|NCT02161666|Incretin Function|incretin function
235817|NCT02161666|Islet Function|islet function
235818|NCT02161653|Severe alcoholic hepatitis|severe alcoholic hepatitis
235819|NCT02161653|survival|survival
235820|NCT02161653|oxidative stress|oxidative stress
235821|NCT02161627|spinal cord stimulation|spinal cord stimulation
235822|NCT02161627|automatic control|automatic control
235823|NCT02161614|hormone replacement therapy|hormone replacement therapy
235824|NCT02161614|Dopplervelocimetry|dopplervelocimetry
235825|NCT02161614|Flow-mediated dilation|flow-mediated dilation
235826|NCT02161614|menopause|menopause
235827|NCT02161614|Estradiol valerate|estradiol valerate
235828|NCT02161601|Cricoid pressure|cricoid pressure
235829|NCT02161601|Rapid Sequence Induction|rapid sequence induction
235830|NCT02161562|chronic spontaneous urticaria, CSU, chronic idiopathic urticaria, CIU, hives, angioedema, itch|chronic spontaneous urticaria, csu, chronic idiopathic urticaria, ciu, hives, angioedema, itch
235831|NCT02161523|mast cells, lung cancer, cancer associated fibroblasts (CAF)|mast cells, lung cancer, cancer associated fibroblasts (caf)
235832|NCT02161497|Medical History Taking|medical history taking
235833|NCT02161497|Electronic Health Records|electronic health records
235834|NCT02161497|Pediatrics|pediatrics
235835|NCT02161497|Parents|parents
235836|NCT02161484|Peripheral Nerve Block|peripheral nerve block
235837|NCT02161484|Total Hip Replacement|total hip replacement
235838|NCT02161471|Atria, Heart|atria, heart
235839|NCT02161471|Function, Atrial|function, atrial
235840|NCT02161471|Heart Defects, Congenital|heart defects, congenital
235841|NCT02161471|Cardiovascular Abnormalities|cardiovascular abnormalities
235842|NCT02161471|Congenital Abnormalities|congenital abnormalities
235843|NCT02161471|Tetralogy, Fallot|tetralogy, fallot
235844|NCT02161471|Transposition of Great Arteries|transposition of great arteries
235845|NCT02161471|Coarctation of the Aorta|coarctation of the aorta
235846|NCT02161458|Escitalopram|escitalopram
235847|NCT02161458|Amyloid Beta|amyloid beta
235848|NCT02161458|Cerebrospinal Fluid|cerebrospinal fluid
235849|NCT02161445|impedance|impedance
235850|NCT02161445|pep|pep
235851|NCT02161445|tevg|tevg
235852|NCT02161445|dyspnea|dyspnea
235853|NCT02161445|AHF|ahf
235854|NCT02161445|BNP|bnp
235855|NCT02161419|Small Cell Lung Carcinoma,|small cell lung carcinoma,
235856|NCT02161419|First line|first line
235857|NCT02161419|Extensive disease|extensive disease
235858|NCT02161419|Small cell lung cancer|small cell lung cancer
235859|NCT02161406|Scleroderma|scleroderma
235860|NCT02161393|Physical Activity|physical activity
235861|NCT02161393|Pulmonary Rehabilitation|pulmonary rehabilitation
235862|NCT02161393|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
235863|NCT02161380|Gene therapy|gene therapy
235864|NCT02161380|Mitochondrial Genes|mitochondrial genes
235865|NCT02161380|Leber's|leber's
235866|NCT02161380|AAV2 Viral vectors|aav2 viral vectors
235867|NCT02161367|colorectal surgery|colorectal surgery
235868|NCT02161367|postoperative ileus|postoperative ileus
235869|NCT02161367|simethicone|simethicone
235870|NCT02161367|randomized controlled trial|randomized controlled trial
235871|NCT02161367|double blind|double blind
235872|NCT02161367|pilot study|pilot study
235873|NCT02161367|anti-foaming agent|anti-foaming agent
235874|NCT02161367|abdominal pain|abdominal pain
235875|NCT02161367|abdominal distention|abdominal distention
235876|NCT02161367|nausea vomiting|nausea vomiting
235877|NCT02161367|flatus|flatus
235878|NCT02161367|bowel movement|bowel movement
235879|NCT02161367|placebo|placebo
235880|NCT02161367|postoperative complications|postoperative complications
235881|NCT02161367|polydimethylsiloxane|polydimethylsiloxane
235882|NCT02161367|hydrated silica gel|hydrated silica gel
235883|NCT02161367|gas bubbles|gas bubbles
235884|NCT02161367|intestinal tract|intestinal tract
235885|NCT02161354|Dental Pain|dental pain
235886|NCT02161354|Acute Pain|acute pain
235887|NCT02161354|Mild Pain|mild pain
235888|NCT02161354|Moderate Pain|moderate pain
235889|NCT02161341|Bacterial microbiome|bacterial microbiome
235890|NCT02161341|Gene expression|gene expression
235891|NCT02161315|SAID, Progestogens, nSAID-resistanced, LSBC|said, progestogens, nsaid-resistanced, lsbc
235892|NCT02161302|Endometriosis|endometriosis
235893|NCT02161302|Transcranial Direct Current Stimulation|transcranial direct current stimulation
235894|NCT02161302|tDCS|tdcs
235895|NCT02161302|Near Infrared Spectroscopy|near infrared spectroscopy
235896|NCT02161302|NIRS|nirs
235897|NCT02161302|Chronic Pelvic Pain|chronic pelvic pain
235898|NCT02161289|100 HIV-negagtve MSM|100 hiv-negagtve msm
235899|NCT02161263|LASIK|lasik
235900|NCT02161263|Satisfaction|satisfaction
235901|NCT02161237|Acute rejection|acute rejection
235902|NCT02161237|Advagraf|advagraf
235903|NCT02161237|Renal function|renal function
235904|NCT02161224|Phase 1|phase 1
235905|NCT02161224|FG-4592|fg-4592
235906|NCT02161224|Single dose|single dose
235907|NCT02161224|Moderate hepatic impairment|moderate hepatic impairment
235908|NCT02161211|alcohol|alcohol
235909|NCT02161211|anxiety|anxiety
235910|NCT02161198|Panax ginseng CA|panax ginseng ca
235911|NCT02161198|ginsan|ginsan
235912|NCT02161198|polysaccharide|polysaccharide
235913|NCT02161198|immunity|immunity
235914|NCT02161198|natural killer cell|natural killer cell
235915|NCT02161185|Epilepsy|epilepsy
235916|NCT02161185|seizure cluster|seizure cluster
235917|NCT02161185|acute repetitive seizures|acute repetitive seizures
235918|NCT02161185|open-label|open-label
235919|NCT02161185|intranasal Midazolam|intranasal midazolam
235920|NCT02161185|USL261|usl261
235921|NCT02161185|Upsher-Smith|upsher-smith
235922|NCT02161172|Mild traumatic brain injury|mild traumatic brain injury
235923|NCT02161172|Cognitive outcome|cognitive outcome
235924|NCT02161172|Psychological outcome|psychological outcome
235925|NCT02161133|Veterans|veterans
235926|NCT02161133|neuropsychology|neuropsychology
235927|NCT02161133|fatigue|fatigue
235928|NCT02161133|Chronic Multisymptom Illness|chronic multisymptom illness
235929|NCT02161133|Gulf War Illness|gulf war illness
235930|NCT02161133|behavioral treatment|behavioral treatment
235931|NCT02161120|IBS, irritable bowel syndrome, functional gastrointestinal disorder, diet, bread, rye, FODMAP, microbiota|ibs, irritable bowel syndrome, functional gastrointestinal disorder, diet, bread, rye, fodmap, microbiota
235932|NCT02161107|Grass|grass
235933|NCT02161107|Allergy|allergy
235934|NCT02161107|rhinoconjunctivitis|rhinoconjunctivitis
235935|NCT02161107|rhinitis|rhinitis
235936|NCT02161107|asthma|asthma
235937|NCT02161094|Community management incentives|community management incentives
235938|NCT02161081|Myocardial ischemia|myocardial ischemia
235939|NCT02161081|Coronary artery disease|coronary artery disease
235940|NCT02161081|Myocardial CT perfusion|myocardial ct perfusion
235941|NCT02161081|Modified scan protocol|modified scan protocol
235942|NCT02161081|Diagnostic performance|diagnostic performance
235943|NCT02161081|Radiation dose|radiation dose
235944|NCT02161068|ADPKD|adpkd
235945|NCT02161068|Chart Review|chart review
235946|NCT02161068|PKD Genotyping|pkd genotyping
235947|NCT02161055|Insulin|insulin
235948|NCT02161055|Hyperglycemia|hyperglycemia
235949|NCT02161055|Postoperative Mortality|postoperative mortality
235950|NCT02161055|Intensive insulin therapy|intensive insulin therapy
235951|NCT02161055|Non-intensive insulin therapy|non-intensive insulin therapy
235952|NCT02161055|Brain Injuries|brain injuries
235953|NCT02161055|Wounds and Injuries|wounds and injuries
235954|NCT02161055|Craniocerebral Trauma|craniocerebral trauma
235955|NCT02161055|Trauma, Nervous System|trauma, nervous system
235956|NCT02161042|Blood transfusion|blood transfusion
235957|NCT02161042|Storage Lesion|storage lesion
235958|NCT02161042|Endothelial dysfunction|endothelial dysfunction
235959|NCT02161042|Nitric Oxide|nitric oxide
235960|NCT02161029|Gastric tumor|gastric tumor
235961|NCT02161003|Fecal Incontinence|fecal incontinence
235962|NCT02161003|Posterior Sagittal Ano-rectoplasty|posterior sagittal ano-rectoplasty
235963|NCT02161003|Mesenchymal Stem Cell|mesenchymal stem cell
235964|NCT02160990|Obesity|obesity
235965|NCT02160977|Surgical procedures|surgical procedures
235966|NCT02160977|Minimally invasive|minimally invasive
235967|NCT02160977|Arthroplasty|arthroplasty
235968|NCT02160977|Knee|knee
235969|NCT02160964|Inferior Vena Cava|inferior vena cava
235970|NCT02160951|Multiple Myeloma,|multiple myeloma,
235971|NCT02160951|Phase I,|phase i,
235972|NCT02160951|PIM,|pim,
235973|NCT02160951|Japanese patients,|japanese patients,
235974|NCT02160951|LGH447|lgh447
235975|NCT02160938|microarray|microarray
235976|NCT02160938|prenatal|prenatal
235977|NCT02160938|copy number variant|copy number variant
235978|NCT02160938|CNV|cnv
235979|NCT02160938|microdeletion|microdeletion
235980|NCT02160938|microduplication|microduplication
235981|NCT02160938|genetic|genetic
235982|NCT02160899|High Lipoprotein(a)|high lipoprotein(a)
235983|NCT02160847|children|children
235984|NCT02160847|pediatric obesity|pediatric obesity
235985|NCT02160847|parent training|parent training
235986|NCT02160847|home-based|home-based
235987|NCT02160847|nutrition|nutrition
235988|NCT02160847|physical activity|physical activity
235989|NCT02160847|parent-child interaction|parent-child interaction
235990|NCT02160847|parenting|parenting
235991|NCT02160834|Sedentary behavior|sedentary behavior
235992|NCT02160834|Physical activity|physical activity
235993|NCT02160834|Obesity|obesity
235994|NCT02160834|Mobile health|mobile health
235995|NCT02160834|Smartphone|smartphone
235996|NCT02160834|Time spent sedentary|time spent sedentary
235997|NCT02160821|Transversus Abdominis Plane Block|transversus abdominis plane block
235998|NCT02160821|Caudal Epidural|caudal epidural
235999|NCT02160821|Pediatric Pain control|pediatric pain control
236101|NCT02160236|tenoxicam|tenoxicam
236000|NCT02160821|Pain control for Lower Abdominal Surgery|pain control for lower abdominal surgery
236001|NCT02160795|Periconceptional|periconceptional
236002|NCT02160795|Folic Acid|folic acid
236003|NCT02160795|Leukemia|leukemia
236004|NCT02160795|Childhood Cancer|childhood cancer
236005|NCT02160769|Tear Lipid Thickness|tear lipid thickness
236006|NCT02160769|Pterygium surgery|pterygium surgery
236007|NCT02160756|Healthy|healthy
236008|NCT02160756|JNJ-56021927|jnj-56021927
236009|NCT02160756|JNJ-56142060|jnj-56142060
236010|NCT02160756|ARN-509|arn-509
236011|NCT02160730|Cushings disease|cushings disease
236012|NCT02160730|R-roscovitine|r-roscovitine
236013|NCT02160717|Turner Syndrome|turner syndrome
236014|NCT02160717|Diabetes|diabetes
236015|NCT02160704|Sperm density|sperm density
236016|NCT02160704|Testosterone|testosterone
236017|NCT02160704|Hypogonadism|hypogonadism
236018|NCT02160652|Ureteral Obstruction|ureteral obstruction
236019|NCT02160652|HYDRONEPHROSIS|hydronephrosis
236020|NCT02160652|nephrostomy tube|nephrostomy tube
236021|NCT02160639|diabetes self management education|diabetes self management education
236022|NCT02160639|diabetes self management support|diabetes self management support
236023|NCT02160639|type 2 diabetes|type 2 diabetes
236024|NCT02160626|Seborrheic keratosis|seborrheic keratosis
236025|NCT02160626|A101|a101
236026|NCT02160613|Osteoprotegerin|osteoprotegerin
236027|NCT02160613|Biomarker|biomarker
236028|NCT02160613|Chronic periodontitis|chronic periodontitis
236029|NCT02160613|Open flap debridement|open flap debridement
236030|NCT02160561|mechanical|mechanical
236031|NCT02160561|ventilation|ventilation
236032|NCT02160561|acute|acute
236033|NCT02160561|respiratory|respiratory
236034|NCT02160561|failure|failure
236035|NCT02160548|Organophosphate, insectiside, Salbutamol, Atropine|organophosphate, insectiside, salbutamol, atropine
236036|NCT02160535|Mild Traumatic Brain Injury|mild traumatic brain injury
236037|NCT02160535|Concussion|concussion
236038|NCT02160535|Post Concussive Headache|post concussive headache
236039|NCT02160522|Intubation|intubation
236040|NCT02160522|cuff|cuff
236041|NCT02160522|cuffed|cuffed
236042|NCT02160522|endotracheal|endotracheal
236043|NCT02160522|tube|tube
236044|NCT02160522|pressure|pressure
236045|NCT02160522|pediatric|pediatric
236046|NCT02160522|child|child
236047|NCT02160522|children|children
236048|NCT02160522|emergency|emergency
236049|NCT02160509|real time, ultrasonography, handheld|real time, ultrasonography, handheld
236050|NCT02160496|Weight Loss|weight loss
236051|NCT02160496|Obesity|obesity
236052|NCT02160496|Overweight|overweight
236053|NCT02160496|Diet, Reducing|diet, reducing
236054|NCT02160496|Lipids|lipids
236055|NCT02160483|Chronic pelvic pain|chronic pelvic pain
236056|NCT02160483|Endometriosis|endometriosis
236057|NCT02160457|Cerebral palsy|cerebral palsy
236058|NCT02160457|Instrumented gait analysis|instrumented gait analysis
236059|NCT02160457|Gait Deviation Index|gait deviation index
236061|NCT02160444|Parent Training|parent training
236062|NCT02160444|Anxiety Disorders in Children|anxiety disorders in children
236063|NCT02160431|Children|children
236064|NCT02160431|OCD|ocd
236065|NCT02160431|CBT|cbt
236066|NCT02160431|Neuropsychological profiles|neuropsychological profiles
236067|NCT02160405|Iron levels|iron levels
236068|NCT02160392|HIV|hiv
236069|NCT02160392|female|female
236070|NCT02160392|genital tract|genital tract
236071|NCT02160379|roux-en-Y-gastric bypass|roux-en-y-gastric bypass
236072|NCT02160379|brain responses to food|brain responses to food
236073|NCT02160379|gastrointestinal hormones|gastrointestinal hormones
236074|NCT02160379|bile acids|bile acids
236075|NCT02160366|Advanced Cancers|advanced cancers
236076|NCT02160366|Molecular profiling|molecular profiling
236077|NCT02160366|Biomarker data|biomarker data
236078|NCT02160366|Data analysis|data analysis
236079|NCT02160366|Tumor marker|tumor marker
236080|NCT02160340|Posterior Vitreous Detachment|posterior vitreous detachment
236081|NCT02160340|Vitreomacular Traction|vitreomacular traction
236082|NCT02160340|Vitreous|vitreous
236083|NCT02160314|stress urinary incontinence, SUI, pessary|stress urinary incontinence, sui, pessary
236084|NCT02160301|pain|pain
236085|NCT02160301|postoperative|postoperative
236086|NCT02160301|multimodal|multimodal
236087|NCT02160301|satisfaction|satisfaction
236088|NCT02160301|narcotic|narcotic
236089|NCT02160288|Botox|botox
236090|NCT02160288|Obstructed Defecation Syndrome|obstructed defecation syndrome
236091|NCT02160288|ODS|ods
236092|NCT02160288|Outlet-Type Constipation|outlet-type constipation
236093|NCT02160288|injection|injection
236094|NCT02160275|Artificial pancreas|artificial pancreas
236095|NCT02160275|Bi-hormonal closed loop|bi-hormonal closed loop
236096|NCT02160275|Diabetes Type 1|diabetes type 1
236097|NCT02160249|Schizophrenia|schizophrenia
236098|NCT02160249|Psychotic disorders|psychotic disorders
236099|NCT02160249|Schizophrenia spectrum disorder (schizophrenia, schizoaffective disorder or schizophreniform disorder) using DSM-IV criteria|schizophrenia spectrum disorder (schizophrenia, schizoaffective disorder or schizophreniform disorder) using dsm-iv criteria
236100|NCT02160236|dexketoprofen trometamol|dexketoprofen trometamol
236102|NCT02160236|postoperative pain|postoperative pain
236103|NCT02160223|sugammadex|sugammadex
236104|NCT02160223|neostigmine|neostigmine
236105|NCT02160223|obstructive sleep apnea|obstructive sleep apnea
236106|NCT02160197|Ankle Fractures|ankle fractures
236107|NCT02160197|Fracture Fixation|fracture fixation
236108|NCT02160197|Early Ambulation|early ambulation
236109|NCT02160197|Fracture Healing|fracture healing
236110|NCT02160197|Return to Work|return to work
236111|NCT02160171|Decision Support Algorithm|decision support algorithm
236112|NCT02160171|Neonatal Seizures|neonatal seizures
236113|NCT02160171|EEG|eeg
236114|NCT02160158|Fesoterodine|fesoterodine
236115|NCT02160158|SR3|sr3
236116|NCT02160158|SR4|sr4
236117|NCT02160158|bioavailability|bioavailability
236118|NCT02160158|pharmacokinetics|pharmacokinetics
236119|NCT02160158|sprinkle|sprinkle
236120|NCT02160158|applesauce|applesauce
236121|NCT02160145|Chronic Kidney Disease|chronic kidney disease
236122|NCT02160145|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
236123|NCT02160119|Autism Spectrum Disorders|autism spectrum disorders
236124|NCT02160119|Emotion|emotion
236125|NCT02160119|Attention|attention
236126|NCT02160119|Event-related potential|event-related potential
236127|NCT02160119|Functional neuroimaging|functional neuroimaging
236128|NCT02160119|Diffusion Tensor Imaging|diffusion tensor imaging
236129|NCT02160119|Development|development
236130|NCT02160106|Cancer|cancer
236131|NCT02160106|advanced solid tumors|advanced solid tumors
236132|NCT02160106|metastatic|metastatic
236133|NCT02160106|phase I|phase i
236134|NCT02160106|transforming growth factor beta|transforming growth factor beta
236135|NCT02160106|TGF-β|tgf-β
236136|NCT02160106|first-in-human|first-in-human
236137|NCT02160106|TEW-7197|tew-7197
236138|NCT02160106|activin receptor-like kinase 5|activin receptor-like kinase 5
236139|NCT02160106|ALK5|alk5
236140|NCT02160106|Smad2|smad2
236141|NCT02160106|Smad3|smad3
236142|NCT02160106|phospho-Smad|phospho-smad
236143|NCT02160106|phospho Smad|phospho smad
236144|NCT02160106|psmad|psmad
236145|NCT02160106|serine / threonine kinase inhibitor|serine / threonine kinase inhibitor
236146|NCT02160106|pharmacokinetics|pharmacokinetics
236147|NCT02160106|MedPacto|medpacto
236148|NCT02160106|National OncoVenture|national oncoventure
236149|NCT02160093|sarcopenia|sarcopenia
236150|NCT02160093|frailty|frailty
236151|NCT02160093|chronic disease control|chronic disease control
236152|NCT02160093|aging psychology|aging psychology
236153|NCT02160080|Boceprevir;|boceprevir;
236154|NCT02160080|Liver pre-transplant|liver pre-transplant
236155|NCT02160067|Healthy Volunteers|healthy volunteers
236156|NCT02160067|Pharmacokinetics|pharmacokinetics
236157|NCT02160054|tacrolimus|tacrolimus
236158|NCT02160054|cyclosporine|cyclosporine
236159|NCT02160054|Graceptor®|graceptor®
236160|NCT02160054|kidney transplantation|kidney transplantation
236161|NCT02160041|Solid tumor malignancy|solid tumor malignancy
236162|NCT02160041|hematologic malignancy|hematologic malignancy
236163|NCT02160041|mutation|mutation
236164|NCT02160041|translocations|translocations
236165|NCT02160041|amplifications,|amplifications,
236166|NCT02160041|fusions|fusions
236167|NCT02160041|signature|signature
236168|NCT02160041|FGFR|fgfr
236169|NCT02160041|ligand|ligand
236170|NCT02160041|BGJ398|bgj398
236171|NCT02160028|Information|information
236172|NCT02160028|Pain|pain
236173|NCT02160028|Stress|stress
236174|NCT02160028|Fear|fear
236175|NCT02160028|Placebo analgesia|placebo analgesia
236176|NCT02160002|Incubator Weaning|incubator weaning
236177|NCT02160002|Moderately Preterm Infants|moderately preterm infants
236178|NCT02160002|Growth Velocity|growth velocity
236179|NCT02159976|Helicobacter pylori|helicobacter pylori
236180|NCT02159963|FSHD|fshd
236181|NCT02159963|HIT|hit
236182|NCT02159963|Training|training
236183|NCT02159963|Exercise|exercise
236184|NCT02159963|10-20-30 interval training|10-20-30 interval training
236185|NCT02159937|cancer|cancer
236186|NCT02159937|in vitro|in vitro
236187|NCT02159937|peptides|peptides
236188|NCT02159937|dendritic cells|dendritic cells
236189|NCT02159924|Smartphone measurements|smartphone measurements
236190|NCT02159924|Orientation|orientation
236191|NCT02159924|Range of motion|range of motion
236192|NCT02159924|Median nerve neurodynamic test|median nerve neurodynamic test
236193|NCT02159924|Posture|posture
236194|NCT02159924|Thoracic spine|thoracic spine
236195|NCT02159924|Shoulder girdle|shoulder girdle
236196|NCT02159911|Cervical|cervical
236197|NCT02159911|Hysteroscopy|hysteroscopy
236198|NCT02159911|Misoprostol|misoprostol
236199|NCT02159911|Oral|oral
236200|NCT02159898|Esophageal Cancer|esophageal cancer
236201|NCT02159898|Dysphagia|dysphagia
236202|NCT02159898|Regurgitation|regurgitation
236203|NCT02159885|obstructive sleep apnea|obstructive sleep apnea
236204|NCT02159885|adherence|adherence
236205|NCT02159885|telemedicine|telemedicine
236206|NCT02159885|auto-titrating continuous positive airway pressure|auto-titrating continuous positive airway pressure
236207|NCT02159872|Leukemia|leukemia
236208|NCT02159872|Myelodysplastic Syndrome|myelodysplastic syndrome
236209|NCT02159872|MDS|mds
236210|NCT02159872|Omacetaxine|omacetaxine
236211|NCT02159872|Synribo|synribo
236212|NCT02159872|Homoharringtonine|homoharringtonine
236213|NCT02159859|ertapenem|ertapenem
236214|NCT02159859|pharmacokinetic|pharmacokinetic
236215|NCT02159859|pharmacodynamics|pharmacodynamics
236216|NCT02159859|hemodialysis|hemodialysis
236217|NCT02159859|requires hemodialysis three times a week|requires hemodialysis three times a week
236218|NCT02159846|Herbs|herbs
236219|NCT02159846|Diabetes Mellitus|diabetes mellitus
236220|NCT02159846|HbA1c|hba1c
236221|NCT02159846|Lipid Profile|lipid profile
236222|NCT02159833|Food allergy|food allergy
236223|NCT02159833|Diagnosis|diagnosis
236224|NCT02159807|Pain control|pain control
236225|NCT02159807|labor|labor
236226|NCT02159807|epidural|epidural
236227|NCT02159807|pregnant|pregnant
236228|NCT02159794|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
236229|NCT02159794|Aortic valve stenosis|aortic valve stenosis
236230|NCT02159794|Severe aortic stenosis|severe aortic stenosis
236231|NCT02159768|tracheal intubation|tracheal intubation
236232|NCT02159742|Adult subjects|adult subjects
236233|NCT02159742|history|history
236234|NCT02159742|treatment|treatment
236235|NCT02159742|photodynamic therapy|photodynamic therapy
236236|NCT02159716|Subjects|subjects
236237|NCT02159703|T1-2 N2 M0,|t1-2 n2 m0,
236238|NCT02159703|stage IVa SCCA|stage iva scca
236239|NCT02159703|oropharynx|oropharynx
236240|NCT02159703|negative for PNI,|negative for pni,
236241|NCT02159703|negative surgical margins|negative surgical margins
236242|NCT02159690|prostate cancer|prostate cancer
236243|NCT02159690|prostatectomy|prostatectomy
236244|NCT02159690|localized prostate cancer|localized prostate cancer
236245|NCT02159677|EIM|eim
236246|NCT02159664|didgeridoo|didgeridoo
236247|NCT02159664|sleep apnea|sleep apnea
236248|NCT02159664|drug induced sleep endoscopy|drug induced sleep endoscopy
236249|NCT02159651|tacrolimus|tacrolimus
236250|NCT02159651|interstitial pneumonia|interstitial pneumonia
236251|NCT02159651|prograf|prograf
236252|NCT02159638|Diabetes Mellitus|diabetes mellitus
236253|NCT02159638|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
236254|NCT02159638|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
236255|NCT02159638|Endocrine System Diseases|endocrine system diseases
236256|NCT02159638|Blood glucose|blood glucose
236257|NCT02159638|Blood Glucose, Self-Monitoring|blood glucose, self-monitoring
236258|NCT02159625|Abdominal Compression Elastic Support|abdominal compression elastic support
236259|NCT02159625|Hemodialysis|hemodialysis
236260|NCT02159625|hypotension|hypotension
236261|NCT02159625|occurrence rate|occurrence rate
236262|NCT02159612|FSHD|fshd
236263|NCT02159612|MRI|mri
236264|NCT02159612|Disease progression|disease progression
236265|NCT02159586|gastroparesis|gastroparesis
236266|NCT02159586|gastric electrical stimulator|gastric electrical stimulator
236267|NCT02159586|GES|ges
236268|NCT02159586|vomiting|vomiting
236269|NCT02159586|nausea|nausea
236270|NCT02159586|bloating|bloating
236271|NCT02159586|postprandial fullness|postprandial fullness
236272|NCT02159586|epigastric pain|epigastric pain
236273|NCT02159547|migraine, emergency department, dexketoprofen, placebo|migraine, emergency department, dexketoprofen, placebo
236274|NCT02159521|deep vein thrombosis|deep vein thrombosis
236275|NCT02159521|post-thrombotic syndrome|post-thrombotic syndrome
236276|NCT02159521|chronic deep vein thrombosis|chronic deep vein thrombosis
236277|NCT02159508|nutritional status|nutritional status
236278|NCT02159508|nutritional intervention|nutritional intervention
236279|NCT02159508|handgrip strength|handgrip strength
236280|NCT02159508|patient-generated subjective global assessment|patient-generated subjective global assessment
236281|NCT02159508|chemoradiotherapy|chemoradiotherapy
236282|NCT02159508|survival|survival
236283|NCT02159469|Hypogonadism|hypogonadism
236284|NCT02159469|Testosterone enanthate|testosterone enanthate
236285|NCT02159443|Hu14.18K322A|hu14.18k322a
236286|NCT02159443|Human anti-human antibodies (HAHA)|human anti-human antibodies (haha)
236287|NCT02159443|Pretreatment anti-therapeutic antibodies (PATA)|pretreatment anti-therapeutic antibodies (pata)
236288|NCT02159417|Evolution of the sport, HbA1C, IMC|evolution of the sport, hba1c, imc
236289|NCT02159391|Accident Prevention|accident prevention
236290|NCT02159391|Alcohol Drinking|alcohol drinking
236291|NCT02159391|Substance-Related Disorders|substance-related disorders
236292|NCT02159391|Motivational Interviewing|motivational interviewing
236293|NCT02159391|Adult|adult
236294|NCT02159391|Humans|humans
236295|NCT02159391|Intervention Studies|intervention studies
236296|NCT02159391|Recurrence|recurrence
236297|NCT02159391|Risk Factors|risk factors
236298|NCT02159391|Trauma Centers|trauma centers
236299|NCT02159391|Wounds and Injuries/epidemiology|wounds and injuries/epidemiology
236300|NCT02159391|Wounds and Injuries/etiology*|wounds and injuries/etiology*
236301|NCT02159391|Wounds and Injuries/prevention & control*|wounds and injuries/prevention & control*
236302|NCT02159378|Gestational Diabetes|gestational diabetes
236303|NCT02159378|Fructosamines|fructosamines
236304|NCT02159378|Insulin treatment|insulin treatment
236305|NCT02159339|DNA methylation|dna methylation
236306|NCT02159313|Biological Availability|biological availability
236307|NCT02159300|Fibromyalgia|fibromyalgia
236308|NCT02159300|Pain|pain
236309|NCT02159287|ischemic stroke|ischemic stroke
236310|NCT02159287|atrial fibrillation|atrial fibrillation
236311|NCT02159287|bridging therapy|bridging therapy
236312|NCT02159274|Late symptoms|late symptoms
236313|NCT02159274|Shoulder function|shoulder function
236314|NCT02159274|Cosmetic results|cosmetic results
236315|NCT02159274|EORTC|eortc
236316|NCT02159274|Lymphoedema|lymphoedema
236317|NCT02159261|Personal Satisfaction|personal satisfaction
236318|NCT02159248|pancreatic, gemcitabine, radiation, tolfenamic acid|pancreatic, gemcitabine, radiation, tolfenamic acid
236319|NCT02159235|cadmium|cadmium
236320|NCT02159235|lead|lead
236321|NCT02159235|mercury|mercury
236322|NCT02159235|zinc|zinc
236323|NCT02159235|endostatin|endostatin
236324|NCT02159235|angiostatin|angiostatin
236325|NCT02159235|VEGF|vegf
236326|NCT02159235|CAD|cad
236327|NCT02159235|osteopontin|osteopontin
236328|NCT02159209|Acute Kidney Injury|acute kidney injury
236329|NCT02159209|Adverse Drug Reaction|adverse drug reaction
236330|NCT02159209|Acute Kidney Failure|acute kidney failure
236331|NCT02159209|Kidney|kidney
236332|NCT02159209|Kidneys|kidneys
236333|NCT02159196|mechanical ventilation|mechanical ventilation
236334|NCT02159196|nebulisation|nebulisation
236335|NCT02159196|respiratory failure|respiratory failure
236336|NCT02159170|Use of NGF injection as a model of non-inflammatory neuropathic pain in healthy subjects|use of ngf injection as a model of non-inflammatory neuropathic pain in healthy subjects
236337|NCT02159157|breast cancer, exercise|breast cancer, exercise
236338|NCT02159144|Brown adipose tissue|brown adipose tissue
236339|NCT02159144|Subcutaneous white adipose tissue|subcutaneous white adipose tissue
236340|NCT02159144|White adipose tissue|white adipose tissue
236341|NCT02159131|ethinyl estradiol|ethinyl estradiol
236342|NCT02159131|GSK1265744|gsk1265744
236343|NCT02159131|pharmacokinetics|pharmacokinetics
236344|NCT02159131|oral contraceptive|oral contraceptive
236345|NCT02159131|oral contraceptive containing levonorgestrel and ethinyl estradiol|oral contraceptive containing levonorgestrel and ethinyl estradiol
236346|NCT02159131|levonorgestrel|levonorgestrel
236347|NCT02159118|bone marrow aspiration|bone marrow aspiration
236348|NCT02159118|bone marrow biopsy|bone marrow biopsy
236349|NCT02159118|OnControl|oncontrol
236350|NCT02159118|powered bone marrow aspiration and biopsy device|powered bone marrow aspiration and biopsy device
236351|NCT02159118|standard manual bone marrow aspiration and biopsy device|standard manual bone marrow aspiration and biopsy device
236352|NCT02159105|postpartum hemorrhage|postpartum hemorrhage
236353|NCT02159105|postsurgical bleeding|postsurgical bleeding
236354|NCT02159105|abdominal ultrasound|abdominal ultrasound
236355|NCT02159105|FAST scan|fast scan
236356|NCT02159105|non-invasive hemoglobin measurement|non-invasive hemoglobin measurement
236357|NCT02159092|Waterpipe|waterpipe
236358|NCT02159092|Smoking cessation|smoking cessation
236359|NCT02159092|Contingency management|contingency management
236360|NCT02159092|Dependence|dependence
236361|NCT02159079|Sepsis|sepsis
236362|NCT02159079|Severe Sepsis|severe sepsis
236363|NCT02159079|Septic Shock|septic shock
236364|NCT02159079|Conservative Fluid Management|conservative fluid management
236365|NCT02159079|Fluid Balance|fluid balance
236366|NCT02159079|Fluid Restriction|fluid restriction
236367|NCT02159066|Melanoma|melanoma
236368|NCT02159053|AIN457, ankylosing spondylitis, chronic inflammatory disease, inflammatory back pain, secukinumab, self-injection|ain457, ankylosing spondylitis, chronic inflammatory disease, inflammatory back pain, secukinumab, self-injection
236369|NCT02159040|Int-2 MDS|int-2 mds
236370|NCT02159027|Human Immunodeficiency Virus|human immunodeficiency virus
236371|NCT02159027|AIDS Dementia Complex|aids dementia complex
236372|NCT02159014|Physical activity intervention|physical activity intervention
236373|NCT02159014|Aerobic dance|aerobic dance
236374|NCT02159014|Nutritional intervention|nutritional intervention
236375|NCT02159014|Online participation|online participation
236376|NCT02159014|Primary Care settings|primary care settings
236377|NCT02159014|General Practice Physical Activity Questionnaire GPPAQ|general practice physical activity questionnaire gppaq
236378|NCT02159014|Qrisk2|qrisk2
236379|NCT02159014|QDS Diabetes|qds diabetes
236380|NCT02159001|clozapine|clozapine
236381|NCT02159001|ECT|ect
236382|NCT02159001|PANSS|panss
236383|NCT02159001|schizoaffective disorder|schizoaffective disorder
236384|NCT02159001|schizophrenia|schizophrenia
236385|NCT02159001|treatment|treatment
236386|NCT02158988|Gastric cancer|gastric cancer
236387|NCT02158988|cancer of the esophagogastric junction|cancer of the esophagogastric junction
236388|NCT02158988|peritoneal carcinomatosis|peritoneal carcinomatosis
236389|NCT02158988|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
236390|NCT02158988|HIPEC|hipec
236391|NCT02158962|Partner abuse|partner abuse
236392|NCT02158962|Abuse African Caribbean women|abuse african caribbean women
236393|NCT02158962|Intimate Partner Violence|intimate partner violence
236394|NCT02158949|alcohol|alcohol
236395|NCT02158949|mHealth|mhealth
236396|NCT02158949|SBIRT|sbirt
236397|NCT02158936|thrombocytopenia|thrombocytopenia
236398|NCT02158936|myelodysplastic syndromes|myelodysplastic syndromes
236399|NCT02158936|MDS|mds
236400|NCT02158936|thrombopoietin|thrombopoietin
236401|NCT02158936|azacitidine|azacitidine
236402|NCT02158936|Eltrombopag|eltrombopag
236403|NCT02158936|myelodysplastic syndromes (MDS)|myelodysplastic syndromes (mds)
236404|NCT02158923|ventilation|ventilation
236405|NCT02158923|lung|lung
236406|NCT02158923|lung complications|lung complications
236407|NCT02158923|postoperative complications|postoperative complications
236408|NCT02158923|perioperative lung protective ventilation|perioperative lung protective ventilation
236409|NCT02158910|Alzheimer's disease|alzheimer's disease
236410|NCT02158884|Major extremity trauma|major extremity trauma
236411|NCT02158884|wounded warriors|wounded warriors
236412|NCT02158884|IDEO|ideo
236413|NCT02158884|return to run|return to run
236414|NCT02158871|Education|education
236415|NCT02158871|Early intervention|early intervention
236416|NCT02158871|Workplace|workplace
236417|NCT02158871|Stigma|stigma
236418|NCT02158871|Mental Health Literacy|mental health literacy
236419|NCT02158858|Phase 1/2|phase 1/2
236420|NCT02158858|Oncology|oncology
236421|NCT02158858|BET Inhibitor|bet inhibitor
236422|NCT02158858|Ruxolitinib|ruxolitinib
236423|NCT02158845|endometriosis|endometriosis
236424|NCT02158845|blood coagulation|blood coagulation
236425|NCT02158845|levonorgestrel|levonorgestrel
236426|NCT02158845|GnRH agonist|gnrh agonist
236427|NCT02158845|progesterone-releasing intrauterine device|progesterone-releasing intrauterine device
236428|NCT02158832|Lymphoedema|lymphoedema
236429|NCT02158832|Edema|edema
236430|NCT02158832|Oedema|oedema
236431|NCT02158832|Cancer|cancer
236432|NCT02158832|Breast Cancer|breast cancer
236433|NCT02158819|Visionaire|visionaire
236434|NCT02158819|Health Economics|health economics
236435|NCT02158819|Degenerative arthritis|degenerative arthritis
236436|NCT02158819|total knee arthroplasty|total knee arthroplasty
236437|NCT02158806|Venous ulcer, varicose ulcer, gravitational ulcer, aspirin|venous ulcer, varicose ulcer, gravitational ulcer, aspirin
236438|NCT02158793|face transplant|face transplant
236439|NCT02158793|Craniomaxillofacial Allotransplantation|craniomaxillofacial allotransplantation
236440|NCT02158793|facial disfigurement|facial disfigurement
236441|NCT02158793|facial trauma|facial trauma
236442|NCT02158754|Corus CAD|corus cad
236443|NCT02158754|ASGES|asges
236444|NCT02158754|Coronary Artery Disease|coronary artery disease
236445|NCT02158754|Gene Expression|gene expression
236446|NCT02158754|Age/Sex/Gene Expression Score|age/sex/gene expression score
236447|NCT02158754|GES|ges
236448|NCT02158754|Angina Pectoris|angina pectoris
236449|NCT02158754|Chest Pain|chest pain
236450|NCT02158754|Cardiovascular Disease|cardiovascular disease
236451|NCT02158754|CAD|cad
236452|NCT02158754|CVD|cvd
236453|NCT02158754|CHD|chd
236454|NCT02158754|Coronary Heart Disease|coronary heart disease
236455|NCT02158754|Precision Medicine|precision medicine
236456|NCT02158754|Clinical Utility|clinical utility
236457|NCT02158741|Self-Management|self-management
236458|NCT02158741|Home Visits|home visits
236459|NCT02158702|Relapsed Myeloma Patients|relapsed myeloma patients
236460|NCT02158702|Relapsed after use of Bortezomib and Lenalidomide|relapsed after use of bortezomib and lenalidomide
236461|NCT02158702|Pomalidomide and Dexamethasone|pomalidomide and dexamethasone
236462|NCT02158702|Efficacy and Safety|efficacy and safety
236463|NCT02158689|Poor responders|poor responders
236464|NCT02158689|letrozole|letrozole
236465|NCT02158689|human menopausal gonadotropin|human menopausal gonadotropin
236466|NCT02158676|Roux-en-y gastric bypass|roux-en-y gastric bypass
236467|NCT02158676|Inflammatory markers|inflammatory markers
236468|NCT02158676|Nutritional status|nutritional status
236469|NCT02158676|Fatty acids|fatty acids
236470|NCT02158676|Glucose|glucose
236471|NCT02158676|Prebiotic|prebiotic
236472|NCT02158676|Synbiotic|synbiotic
236473|NCT02158663|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
236474|NCT02158663|TMS|tms
236475|NCT02158663|PTSD|ptsd
236476|NCT02158650|informed consent|informed consent
236477|NCT02158650|video-based|video-based
236478|NCT02158637|PRO-CTCAE|pro-ctcae
236479|NCT02158637|Patient-Reported Outcomes|patient-reported outcomes
236480|NCT02158637|Common Terminology Criteria for Adverse Events|common terminology criteria for adverse events
236481|NCT02158637|Questionnaire|questionnaire
236482|NCT02158637|Adverse Events|adverse events
236483|NCT02158637|Symptoms|symptoms
236484|NCT02158611|Individual Counseling service|individual counseling service
236485|NCT02158611|Group Counseling service|group counseling service
236486|NCT02158585|Lamotrigine|lamotrigine
236487|NCT02158585|Lamictal|lamictal
236488|NCT02158585|Anticonvulsant|anticonvulsant
236489|NCT02158585|Ménière's disease|ménière's disease
236490|NCT02158585|Vertigo attack|vertigo attack
236491|NCT02158585|Dizziness|dizziness
236492|NCT02158585|Vestibular disorder|vestibular disorder
236493|NCT02158572|prevention of pregnancy|prevention of pregnancy
236494|NCT02158546|Major Depressive Disorder|major depressive disorder
236495|NCT02158546|Depression|depression
236496|NCT02158546|Alkermes|alkermes
236497|NCT02158546|ALKS 5461|alks 5461
236498|NCT02158546|Samidorphan|samidorphan
236499|NCT02158533|Major Depressive Disorder|major depressive disorder
236500|NCT02158533|Depression|depression
236501|NCT02158533|Alkermes|alkermes
236502|NCT02158533|ALKS 5461|alks 5461
236503|NCT02158533|Samidorphan|samidorphan
236504|NCT02158507|metastatic|metastatic
236505|NCT02158507|triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
236506|NCT02158507|Veliparib|veliparib
236507|NCT02158507|Lapatinib|lapatinib
236508|NCT02158507|estrogen receptor (ER) negative|estrogen receptor (er) negative
236509|NCT02158507|progesterone receptor (PR) negative|progesterone receptor (pr) negative
236510|NCT02158507|human epidermal growth factor receptor 2 (HER-2-Neu) negative|human epidermal growth factor receptor 2 (her-2-neu) negative
236511|NCT02158494|Cranial Nerve Noninvasive Neuromodulation|cranial nerve noninvasive neuromodulation
236512|NCT02158494|Portable Neuromodulation Stimulator (PoNS)|portable neuromodulation stimulator (pons)
236513|NCT02158494|Balance and Gait Training|balance and gait training
236514|NCT02158494|Breathing Awareness Training|breathing awareness training
236515|NCT02158481|Vascular function|vascular function
236516|NCT02158481|Dietary ingredients|dietary ingredients
236517|NCT02158481|Acute glucose load|acute glucose load
236518|NCT02158481|Oxidative stress|oxidative stress
236519|NCT02158468|STEMI, reperfusion, preconditioning, postconditioning, reperfusion injury, myocardial salvage|stemi, reperfusion, preconditioning, postconditioning, reperfusion injury, myocardial salvage
236520|NCT02158455|CABG|cabg
236521|NCT02158455|Saphenous vein|saphenous vein
236522|NCT02158455|Radial artery|radial artery
236523|NCT02158442|Diabetes|diabetes
236524|NCT02158442|Lower limb infection|lower limb infection
236525|NCT02158442|Significant wound infections|significant wound infections
236526|NCT02158442|Intravenous antibiotics|intravenous antibiotics
236527|NCT02158442|Timentin|timentin
236528|NCT02158429|substance use disorders|substance use disorders
236529|NCT02158429|pregnancy|pregnancy
236530|NCT02158429|maternal attachment|maternal attachment
236531|NCT02158429|paternal attachment|paternal attachment
236532|NCT02158429|three dimensional ultrasound|three dimensional ultrasound
236533|NCT02158416|platelet|platelet
236534|NCT02158416|transfusion|transfusion
236535|NCT02158416|ThromboLUX|thrombolux
236536|NCT02158416|corrected count increment|corrected count increment
236537|NCT02158416|thrombocytopenic|thrombocytopenic
236538|NCT02158403|HeartMate II|heartmate ii
236539|NCT02158403|heart assist device|heart assist device
236540|NCT02158403|pump thrombosis|pump thrombosis
236541|NCT02158403|hypercoagulable disorder|hypercoagulable disorder
236542|NCT02158403|thrombus|thrombus
236543|NCT02158403|Thoratec Corporation|thoratec corporation
236544|NCT02158390|Down syndrome|down syndrome
236545|NCT02158390|Language intervention|language intervention
236546|NCT02158390|Communication intervention|communication intervention
236547|NCT02158377|Dental implants|dental implants
236548|NCT02158377|Trabecular Metal dental implants|trabecular metal dental implants
236549|NCT02158377|TSV dental implants|tsv dental implants
236550|NCT02158377|Zimmer Dental|zimmer dental
236551|NCT02158377|Implant stability|implant stability
236552|NCT02158377|Implant stability quotient (ISQ)|implant stability quotient (isq)
236553|NCT02158377|Resonance Frequency Analysis (RFA)|resonance frequency analysis (rfa)
236554|NCT02158364|Pharmacological therapy|pharmacological therapy
236555|NCT02158351|Simple steatosis (SS)|simple steatosis (ss)
236556|NCT02158351|Non-alcoholic steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
236557|NCT02158351|Gut microbiota (GM)|gut microbiota (gm)
236558|NCT02158351|Non alcoholic fatty liver disease (NAFLD)|non alcoholic fatty liver disease (nafld)
236559|NCT02158338|asthma|asthma
236560|NCT02158338|maternal bonding|maternal bonding
236561|NCT02158338|maternal bonding disruptions|maternal bonding disruptions
236562|NCT02158338|mother-infant interaction|mother-infant interaction
236563|NCT02158312|neuroplasticity|neuroplasticity
236564|NCT02158273|Alcohol|alcohol
236565|NCT02158273|Relapse|relapse
236566|NCT02158260|Capsule endoscopy|capsule endoscopy
236567|NCT02158260|Patient position changing|patient position changing
236568|NCT02158234|squamous cell carcinoma|squamous cell carcinoma
236569|NCT02158234|head and neck cancer|head and neck cancer
236570|NCT02158234|paranasal sinuses|paranasal sinuses
236571|NCT02158234|nasal cavity|nasal cavity
236572|NCT02158234|nasopharynx|nasopharynx
236573|NCT02158234|oropharynx|oropharynx
236574|NCT02158234|oral cavity|oral cavity
236575|NCT02158234|larynx|larynx
236576|NCT02158234|hypopharynx|hypopharynx
236577|NCT02158234|salivary glands|salivary glands
236578|NCT02158234|cervical lymph nodes|cervical lymph nodes
236579|NCT02158208|before any treatment|before any treatment
236580|NCT02158208|at the diagnosis|at the diagnosis
236581|NCT02158182|Hepatic Encephalopathy|hepatic encephalopathy
236582|NCT02158182|Acute Variceal Bleeding|acute variceal bleeding
236583|NCT02158182|Cirrhosis|cirrhosis
236584|NCT02158130|Physical Inactivity|physical inactivity
236585|NCT02158130|Aerobic Exercise Detraining|aerobic exercise detraining
236586|NCT02158130|Body Weight|body weight
236587|NCT02158130|Energy Expenditure|energy expenditure
236588|NCT02158130|Metabolic Syndrome|metabolic syndrome
236589|NCT02158117|Emergency Treatment|emergency treatment
236590|NCT02158117|Morphine Derivates|morphine derivates
236591|NCT02158117|Heroin|heroin
236592|NCT02158117|Antidotes|antidotes
236593|NCT02158117|Administration, Intranasal|administration, intranasal
236594|NCT02158091|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
236595|NCT02158078|Diabetes Mellitus|diabetes mellitus
236596|NCT02158078|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
236597|NCT02158078|Glucose Metabolism Disorders|glucose metabolism disorders
236598|NCT02158078|Metabolic Diseases|metabolic diseases
236599|NCT02158078|Endocrine System Diseases|endocrine system diseases
236600|NCT02158078|Insulin|insulin
236601|NCT02158078|Continuous subcutaneous insulin infusion (CSII)|continuous subcutaneous insulin infusion (csii)
236602|NCT02158078|Insulin pumps|insulin pumps
236603|NCT02158065|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
236604|NCT02158065|physical activity|physical activity
236605|NCT02158065|PROactive|proactive
236606|NCT02158065|telecoaching|telecoaching
236607|NCT02158052|HLA matched|hla matched
236608|NCT02158052|bone marrow transplantation|bone marrow transplantation
236609|NCT02158052|kidney transplantation|kidney transplantation
236610|NCT02158039|Intraductal Papillary Mucinous Neoplasm|intraductal papillary mucinous neoplasm
236611|NCT02158039|Mucinous Cystic Neoplasm|mucinous cystic neoplasm
236612|NCT02158039|Endoscopic Ultrasound|endoscopic ultrasound
236613|NCT02158039|Ethanol|ethanol
236614|NCT02158026|Follicular sensitivity index|follicular sensitivity index
236615|NCT02158026|ICSI|icsi
236617|NCT02157987|telangietasia hereditary hemorragic|telangietasia hereditary hemorragic
236618|NCT02157987|epistaxis|epistaxis
236619|NCT02157987|safety|safety
236620|NCT02157987|quality of life|quality of life
236621|NCT02157987|bevacizumab|bevacizumab
236622|NCT02157987|spray|spray
236623|NCT02157948|postmenopausal osteoporosis|postmenopausal osteoporosis
236624|NCT02157948|osteoporosis|osteoporosis
236625|NCT02157948|postmenopausal|postmenopausal
236626|NCT02157948|denosumab|denosumab
236627|NCT02157948|women|women
236628|NCT02157935|COPD, turbuhaler, pMDI|copd, turbuhaler, pmdi
236629|NCT02157922|Cystic fibrosis|cystic fibrosis
236630|NCT02157922|mucolytic|mucolytic
236631|NCT02157922|mucociliary clearance|mucociliary clearance
236632|NCT02157922|lung clearance|lung clearance
236633|NCT02157909|Lens fit|lens fit
236634|NCT02157909|contact lenses|contact lenses
236635|NCT02157909|myopia|myopia
236636|NCT02157896|Acute ischemic stroke|acute ischemic stroke
236637|NCT02157896|Vascular endothelial growth factor|vascular endothelial growth factor
236638|NCT02157896|Endostatin|endostatin
236639|NCT02157883|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, AZD9291, intraconazole, EGFR sensitivity mutation|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, azd9291, intraconazole, egfr sensitivity mutation
236640|NCT02157870|Ovary|ovary
236641|NCT02157870|ovarian cancer|ovarian cancer
236642|NCT02157870|biologic therapy|biologic therapy
236643|NCT02157870|platinum-resistant|platinum-resistant
236644|NCT02157870|platinum-refractory ovarian cancer|platinum-refractory ovarian cancer
236645|NCT02157870|platinum-resistant ovarian cancer|platinum-resistant ovarian cancer
236646|NCT02157870|paclitaxel|paclitaxel
236647|NCT02157870|tgDCC-E1A|tgdcc-e1a
236648|NCT02157870|E1A|e1a
236649|NCT02157870|Taxol|taxol
236650|NCT02157857|NSCLC, SCLC, lung cancer, EBUS-TBNA|nsclc, sclc, lung cancer, ebus-tbna
236651|NCT02157844|Obstructive Sleep Apnea|obstructive sleep apnea
236652|NCT02157844|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
236653|NCT02157844|Obesity|obesity
236654|NCT02157844|Hepatic fat metabolism|hepatic fat metabolism
236655|NCT02157844|fat digestion|fat digestion
236656|NCT02157844|whole body protein synthesis|whole body protein synthesis
236657|NCT02157844|protein digestion|protein digestion
236658|NCT02157844|amino acid metabolism|amino acid metabolism
236659|NCT02157844|adipose tissue fat metabolism|adipose tissue fat metabolism
236660|NCT02157844|lipolysis|lipolysis
236661|NCT02157831|Subjects with Clinical Benefit After a Single Infusion of CP - 870, 893|subjects with clinical benefit after a single infusion of cp - 870, 893
236662|NCT02157805|Meat processes|meat processes
236663|NCT02157805|Amino acids bioavailability|amino acids bioavailability
236664|NCT02157805|Digestion rate|digestion rate
236665|NCT02157805|Protein synthesis|protein synthesis
236666|NCT02157805|Aging|aging
236667|NCT02157805|Sarcopenia|sarcopenia
236668|NCT02157792|Solid Tumor|solid tumor
236669|NCT02157792|Advanced Solid Tumor|advanced solid tumor
236670|NCT02157792|VX12-970-001|vx12-970-001
236671|NCT02157792|M6620|m6620
236672|NCT02157792|VX-970|vx-970
236673|NCT02157792|Gemcitabine|gemcitabine
236674|NCT02157792|Cisplatin|cisplatin
236675|NCT02157792|Etoposide|etoposide
236676|NCT02157792|Carboplatin|carboplatin
236677|NCT02157792|Irinotecan|irinotecan
236678|NCT02157779|Veterans|veterans
236679|NCT02157779|Anger|anger
236680|NCT02157779|Cognitive Behavioral Therapy|cognitive behavioral therapy
236681|NCT02157779|Treatment|treatment
236682|NCT02157766|Mental Health|mental health
236683|NCT02157766|Asthma|asthma
236684|NCT02157766|Mindfulness|mindfulness
236685|NCT02157766|Compassion|compassion
236686|NCT02157766|Meditation|meditation
236687|NCT02157753|Osteoporotic fracture|osteoporotic fracture
236688|NCT02157753|treatment for osteoporosis|treatment for osteoporosis
236689|NCT02157753|adherence and compliance|adherence and compliance
236690|NCT02157701|Dietary herbs|dietary herbs
236691|NCT02157701|Polyherbal capsule|polyherbal capsule
236692|NCT02157701|Functional exercise capacity|functional exercise capacity
236693|NCT02157701|Joint health|joint health
236694|NCT02157688|folliculitis decalvans|folliculitis decalvans
236695|NCT02157688|Staphylococcus Aureus|staphylococcus aureus
236696|NCT02157688|antibiotics|antibiotics
236697|NCT02157675|Delayed onset muscle soreness|delayed onset muscle soreness
236698|NCT02157675|Muscle damage|muscle damage
236699|NCT02157675|Eccentric exercise|eccentric exercise
236700|NCT02157636|Phase 1|phase 1
236701|NCT02157636|Oncology|oncology
236702|NCT02157636|BET Inhibitor|bet inhibitor
236703|NCT02157623|Basal Cell Nevus Syndrome|basal cell nevus syndrome
236704|NCT02157623|Gorlin's Syndrome|gorlin's syndrome
236705|NCT02157610|Cervical Cancer|cervical cancer
236706|NCT02157610|Cervical Cancer Survivors|cervical cancer survivors
236707|NCT02157610|Smoking Cessation|smoking cessation
236708|NCT02157610|Motivation And Problem-Solving|motivation and problem-solving
236709|NCT02157610|MAPS|maps
236710|NCT02157610|Saliva test|saliva test
236711|NCT02157610|Self help materials|self help materials
236712|NCT02157610|Pamphlets|pamphlets
236713|NCT02157610|Texas Quitline|texas quitline
236714|NCT02157610|Nicotine patch|nicotine patch
236715|NCT02157610|Questionnaires|questionnaires
236716|NCT02157610|Surveys|surveys
236717|NCT02157610|Telephone counseling sessions|telephone counseling sessions
236718|NCT02157571|prulifloxacin|prulifloxacin
236719|NCT02157571|AECB|aecb
236720|NCT02157571|Levofloxacin|levofloxacin
236721|NCT02157545|muscle relaxants|muscle relaxants
236722|NCT02157545|pyridostigmine|pyridostigmine
236723|NCT02157545|pharmacodynamics|pharmacodynamics
236724|NCT02157545|potency|potency
236725|NCT02157532|Severe stroke|severe stroke
236726|NCT02157532|IV tPA|iv tpa
236727|NCT02157532|mechanical thrombectomy|mechanical thrombectomy
236728|NCT02157519|Oral Chemotherapy|oral chemotherapy
236729|NCT02157519|Cancer|cancer
236730|NCT02157506|Acute Heart failure|acute heart failure
236731|NCT02157506|Hemodynamics|hemodynamics
236732|NCT02157506|Pharmacokinetics|pharmacokinetics
236733|NCT02157506|Renal Function|renal function
236734|NCT02157493|American Indian|american indian
236735|NCT02157493|Adolescents|adolescents
236736|NCT02157493|Entrepreneurship|entrepreneurship
236737|NCT02157493|Paraprofessional|paraprofessional
236738|NCT02157493|Life skills|life skills
236739|NCT02157480|glucose profile|glucose profile
236740|NCT02157480|continuous glucose monitoring|continuous glucose monitoring
236741|NCT02157480|electrostimulation|electrostimulation
236742|NCT02157441|Postpartum Hemorrhage|postpartum hemorrhage
236743|NCT02157441|Placenta Previa|placenta previa
236744|NCT02157441|uterine cavity|uterine cavity
236745|NCT02157402|Adolescent|adolescent
236746|NCT02157376|SUP|sup
236747|NCT02157376|Upper GI bleeding|upper gi bleeding
236748|NCT02157376|Seriously ill patients|seriously ill patients
236749|NCT02157350|Eye Diseases|eye diseases
236750|NCT02157350|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
236751|NCT02157350|Retinal Vessel Geometry|retinal vessel geometry
236752|NCT02157350|Retinal Oxymetry|retinal oxymetry
236753|NCT02157350|Retina Ischemia|retina ischemia
236754|NCT02157350|Panretinal Photocoagulation|panretinal photocoagulation
236755|NCT02157350|Lasers, Semiconductor|lasers, semiconductor
236756|NCT02157350|Fluorescein Angiography|fluorescein angiography
236757|NCT02157337|aortic surgery|aortic surgery
236758|NCT02157337|postoperative acute kidney injury|postoperative acute kidney injury
236759|NCT02157337|statin|statin
236760|NCT02157337|the patient undergoing aortic surgery|the patient undergoing aortic surgery
236761|NCT02157324|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
236762|NCT02157324|Btk|btk
236763|NCT02157311|HIV-1|hiv-1
236764|NCT02157311|simplification,|simplification,
236765|NCT02157311|treatment discontinuation|treatment discontinuation
236766|NCT02157311|virological success|virological success
236767|NCT02157311|four days a week|four days a week
236768|NCT02157298|Japanese patients with type 2 diabetes with inadequate glycemic control on insulin|japanese patients with type 2 diabetes with inadequate glycemic control on insulin
236769|NCT02157285|Unintended pregnancy in adolescence|unintended pregnancy in adolescence
236770|NCT02157285|LARC|larc
236771|NCT02157285|contraception|contraception
236772|NCT02157272|Antiphospholipid|antiphospholipid
236773|NCT02157272|Syndrome|syndrome
236774|NCT02157272|Rivaroxaban|rivaroxaban
236775|NCT02157272|Warfarin|warfarin
236776|NCT02157272|Thrombosis|thrombosis
236777|NCT02157272|Treatment|treatment
236778|NCT02157246|hypoxia|hypoxia
236779|NCT02157246|rectal cancer|rectal cancer
236780|NCT02157207|antioxidants|antioxidants
236781|NCT02157207|Caucasians|caucasians
236782|NCT02157207|healthy|healthy
237075|NCT02155816|omega 3|omega 3
236783|NCT02157207|African Americans|african americans
236784|NCT02157207|vascular|vascular
236785|NCT02157207|aging|aging
236786|NCT02157207|racial differences|racial differences
236787|NCT02157181|HCL variant|hcl variant
236788|NCT02157181|HCL relapse|hcl relapse
236789|NCT02157181|Risk stratified|risk stratified
236790|NCT02157168|Affordable Care Act|affordable care act
236791|NCT02157168|Medically underserved minorities|medically underserved minorities
236792|NCT02157168|Community health workers|community health workers
236793|NCT02157168|Health disparities among Mexican origin|health disparities among mexican origin
236794|NCT02157142|Severe aortic stenosis|severe aortic stenosis
236795|NCT02157142|Aortic valve stenosis|aortic valve stenosis
236796|NCT02157142|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
236797|NCT02157129|Tracheostomy|tracheostomy
236798|NCT02157129|inflammation|inflammation
236799|NCT02157129|mucous congestion|mucous congestion
236800|NCT02157129|inhalation therapy|inhalation therapy
236801|NCT02157129|phospholipids|phospholipids
236802|NCT02157116|Dose-Dense Chemotherapy|dose-dense chemotherapy
236803|NCT02157103|GBM|gbm
236804|NCT02157103|Glioblastoma|glioblastoma
236805|NCT02157103|Bevacizumab|bevacizumab
236806|NCT02157103|Avastin|avastin
236807|NCT02157103|Subcutaneous|subcutaneous
236808|NCT02157090|HSL of lips|hsl of lips
236809|NCT02157090|perioral skin|perioral skin
236810|NCT02157090|duration of HSL symptoms not more than three days|duration of hsl symptoms not more than three days
236811|NCT02157090|not acyclovir or other cold sore therapies|not acyclovir or other cold sore therapies
236812|NCT02157077|Eye diseases|eye diseases
236813|NCT02157077|Vision Impairment and Blindness|vision impairment and blindness
236814|NCT02157077|Eyes and Vision|eyes and vision
236815|NCT02157077|Seniors|seniors
236816|NCT02157077|Neovascular Age-Related Macular Degeneration (AMD)|neovascular age-related macular degeneration (amd)
236817|NCT02157077|Retinal Disease|retinal disease
236818|NCT02157038|whiplash|whiplash
236819|NCT02157038|neck pain|neck pain
236820|NCT02157038|chronic pain|chronic pain
236821|NCT02157038|motor vehicle accident|motor vehicle accident
236822|NCT02157038|car accident|car accident
236823|NCT02157038|MRI|mri
236824|NCT02157038|DNA|dna
236825|NCT02157038|RNA|rna
236826|NCT02157025|Humphrey visual fields|humphrey visual fields
236827|NCT02157025|perimetry|perimetry
236828|NCT02157025|pediatrics|pediatrics
236829|NCT02156973|cardiac computed tomography|cardiac computed tomography
236830|NCT02156973|Image quality|image quality
236831|NCT02156947|Power Doppler sonography|power doppler sonography
236832|NCT02156947|cholecystitis, adhesion|cholecystitis, adhesion
236833|NCT02156934|autologous stress urinary incontinence muscle derived cells|autologous stress urinary incontinence muscle derived cells
236834|NCT02156908|cognitive remediation|cognitive remediation
236835|NCT02156895|Korean PMS of Axitinib|korean pms of axitinib
236836|NCT02156895|Metastatic RCC ; 2nd line only|metastatic rcc ; 2nd line only
236837|NCT02156882|TB|tb
236838|NCT02156882|Tuberculosis|tuberculosis
236839|NCT02156882|MaTuTU - Maputo Tuberculosis Trial Unit|matutu - maputo tuberculosis trial unit
236840|NCT02156882|Clinical Trial Capacity Development|clinical trial capacity development
236841|NCT02156869|Prostate cancer|prostate cancer
236842|NCT02156869|Screening|screening
236843|NCT02156869|Decision aids|decision aids
236844|NCT02156856|hemodynamic monitoring|hemodynamic monitoring
236845|NCT02156856|cardiac output|cardiac output
236846|NCT02156856|cardiac surgery|cardiac surgery
236847|NCT02156843|Diabetic Kidney Disease|diabetic kidney disease
236848|NCT02156843|Nephropathy|nephropathy
236849|NCT02156843|Diabetic Nephropathy|diabetic nephropathy
236850|NCT02156843|Kidney Disease|kidney disease
236851|NCT02156843|Type 2 Diabetes|type 2 diabetes
236852|NCT02156817|Amplitude integrated electroencephalogram|amplitude integrated electroencephalogram
236853|NCT02156817|Heart rate variability|heart rate variability
236854|NCT02156817|Respiratory rate variability|respiratory rate variability
236855|NCT02156817|Preterm Infants|preterm infants
236856|NCT02156817|Length of Hospital Stay|length of hospital stay
236857|NCT02156791|Seasonal allergic rhinoconjunctivitis|seasonal allergic rhinoconjunctivitis
236858|NCT02156791|Grass pollen|grass pollen
236859|NCT02156791|Allergen specific immunotherapy|allergen specific immunotherapy
236860|NCT02156778|Post-Stroke Disease Management|post-stroke disease management
236861|NCT02156778|Post-Stroke Complication|post-stroke complication
236862|NCT02156778|Risk Factor Control|risk factor control
236863|NCT02156778|Quality-of-Life|quality-of-life
236864|NCT02156765|Atrial Fibrillation|atrial fibrillation
236865|NCT02156765|Screening|screening
236866|NCT02156765|Stroke patients|stroke patients
236867|NCT02156739|Liver Neoplasms|liver neoplasms
236868|NCT02156739|Liver lesions|liver lesions
236869|NCT02156739|Benign liver lesions|benign liver lesions
236870|NCT02156739|Malignant liver lesions|malignant liver lesions
236871|NCT02156739|Contrast-Enhanced Magnetic Resonance Imaging|contrast-enhanced magnetic resonance imaging
236872|NCT02156739|MRI|mri
236873|NCT02156739|Gadoxetate|gadoxetate
236874|NCT02156739|Eovist|eovist
236875|NCT02156739|Gadopentetate Dimeglumine|gadopentetate dimeglumine
236876|NCT02156739|Magnevist|magnevist
237076|NCT02155816|omega 7|omega 7
236877|NCT02156726|chronic lymphocytic leukemia|chronic lymphocytic leukemia
236878|NCT02156726|fludarabine|fludarabine
236879|NCT02156726|rituximab|rituximab
236880|NCT02156726|elderly|elderly
236881|NCT02156726|comorbid|comorbid
236882|NCT02156726|FCR|fcr
236883|NCT02156726|CIRS|cirs
236884|NCT02156713|Hemiparesis|hemiparesis
236885|NCT02156713|Occupational Therapy|occupational therapy
236886|NCT02156700|shear wave elastography|shear wave elastography
236887|NCT02156700|haemangiomas|haemangiomas
236888|NCT02156700|metastases|metastases
236889|NCT02156700|hepatocellular carcinoma|hepatocellular carcinoma
236890|NCT02156700|focal nodular hyperplasia|focal nodular hyperplasia
236891|NCT02156700|cholangiocellular carcinoma|cholangiocellular carcinoma
236892|NCT02156674|Maroteaux-Lamy Syndrome|maroteaux-lamy syndrome
236893|NCT02156674|mucopolysaccharide VI|mucopolysaccharide vi
236894|NCT02156674|MPS VI|mps vi
236895|NCT02156648|Invasive ductal|invasive ductal
236896|NCT02156648|HER2-neu positive|her2-neu positive
236897|NCT02156635|Rehabilitation|rehabilitation
236898|NCT02156635|Direct Current Stimulation|direct current stimulation
236899|NCT02156635|Acute Stroke|acute stroke
236900|NCT02156622|HIV|hiv
236901|NCT02156622|Depression|depression
236902|NCT02156622|Measurement-based care|measurement-based care
236903|NCT02156622|Outcomes|outcomes
236904|NCT02156622|Viral load|viral load
236905|NCT02156609|HeartMate PHP|heartmate php
236906|NCT02156609|HeartMate PHP CE Mark|heartmate php ce mark
236907|NCT02156609|Percutaneous coronary intervention|percutaneous coronary intervention
236908|NCT02156609|PCI|pci
236909|NCT02156609|Percutaneous ventricular assist|percutaneous ventricular assist
236910|NCT02156609|Thoratec Corporation|thoratec corporation
236911|NCT02156596|renal colic|renal colic
236912|NCT02156596|nebulised morphine|nebulised morphine
236913|NCT02156596|Intravenous NSAID|intravenous nsaid
236914|NCT02156583|Ventricular Assist Device|ventricular assist device
236915|NCT02156583|Skeletal Muscle|skeletal muscle
236916|NCT02156583|Frailty|frailty
236917|NCT02156583|Older adults|older adults
236918|NCT02156570|Hepatitis C|hepatitis c
236919|NCT02156570|Acute/early chronic|acute/early chronic
236920|NCT02156570|Recently acquired|recently acquired
236921|NCT02156570|Directly acting antiviral therapy|directly acting antiviral therapy
236922|NCT02156570|Sofosbuvir|sofosbuvir
236923|NCT02156570|Ribavirin|ribavirin
236924|NCT02156531|Anxiety|anxiety
236925|NCT02156531|Youth Anxiety|youth anxiety
236926|NCT02156531|CBM|cbm
236927|NCT02156531|Cognitive Bias Modification|cognitive bias modification
236928|NCT02156531|Adolescents|adolescents
236929|NCT02156518|radiation therapy, laryngeal cancer, voice therapy, vocal function exercises|radiation therapy, laryngeal cancer, voice therapy, vocal function exercises
236930|NCT02156505|stent|stent
236931|NCT02156505|gastric outlet obstruction|gastric outlet obstruction
236932|NCT02156505|restenosis|restenosis
236933|NCT02156479|CMV|cmv
236934|NCT02156479|T-Track CMV|t-track cmv
236935|NCT02156479|allo-HSCT|allo-hsct
236936|NCT02156479|CMI|cmi
236937|NCT02156466|Psoriasis|psoriasis
236938|NCT02156466|MSB0010841|msb0010841
236939|NCT02156466|Anti-IL17A/F Nanobody|anti-il17a/f nanobody
236940|NCT02156466|M1095|m1095
236941|NCT02156453|Functional recovery|functional recovery
236942|NCT02156453|Total knee arthroplasty|total knee arthroplasty
236943|NCT02156440|Ostearthritis|ostearthritis
236944|NCT02156440|Knee|knee
236945|NCT02156440|SierraSil|sierrasil
236946|NCT02156414|Prostatectomy|prostatectomy
236947|NCT02156414|Extended Lymphadenectomy|extended lymphadenectomy
236948|NCT02156414|Pelvic lymph node dissection|pelvic lymph node dissection
236949|NCT02156414|Prostatic Neoplasm|prostatic neoplasm
236950|NCT02156414|Prospective Studies|prospective studies
236951|NCT02156401|Venous thromboembolism|venous thromboembolism
236952|NCT02156401|Deep vein thrombosis|deep vein thrombosis
236953|NCT02156401|Pulmonary embolism|pulmonary embolism
236954|NCT02156401|Cohort study/epidemiology|cohort study/epidemiology
236955|NCT02156401|Outcome|outcome
236956|NCT02156401|Prognosis|prognosis
236957|NCT02156375|Healthy|healthy
236958|NCT02156375|Ustekinumab|ustekinumab
236959|NCT02156375|STELARA®|stelara®
236960|NCT02156362|Thyroid carcinoma|thyroid carcinoma
236961|NCT02156362|predictive factors|predictive factors
236962|NCT02156362|refractory|refractory
236963|NCT02156362|Differentiated|differentiated
236964|NCT02156362|follicular origin|follicular origin
236965|NCT02156349|Diabetes|diabetes
236966|NCT02156336|Diabetic Peripheral Neuropathic Pain|diabetic peripheral neuropathic pain
236967|NCT02156336|Ranexa|ranexa
236968|NCT02156336|Ranolazine|ranolazine
236969|NCT02156336|Neurology|neurology
236970|NCT02156284|Fear; Thoracic Surgery; Nursing Care; Preoperative Care|fear; thoracic surgery; nursing care; preoperative care
236971|NCT02156271|Insomnia|insomnia
236972|NCT02156258|Imaging|imaging
236973|NCT02156258|Mammography|mammography
236974|NCT02156232|hepatic encephalopathy (HE)|hepatic encephalopathy (he)
236975|NCT02156232|vericeal bleeding|vericeal bleeding
236976|NCT02156232|spontaneous portosystemic shunts (SPSS)|spontaneous portosystemic shunts (spss)
237074|NCT02155816|lipoproteins|lipoproteins
236977|NCT02156232|transjugular intrahepatic portosystemic shunt (TIPS)|transjugular intrahepatic portosystemic shunt (tips)
236978|NCT02156232|embolization|embolization
236979|NCT02156180|exhaled breath|exhaled breath
236980|NCT02156180|volatile organic compounds|volatile organic compounds
236981|NCT02156180|surgery|surgery
236982|NCT02156180|chemotherapy|chemotherapy
236983|NCT02156180|radiotherapy|radiotherapy
236984|NCT02156167|Otosclerosis, cochlear implant, acoustic stimulation|otosclerosis, cochlear implant, acoustic stimulation
236985|NCT02156141|Kennedy's disease|kennedy's disease
236986|NCT02156141|Spinal and bulbar muscular atrophy|spinal and bulbar muscular atrophy
236987|NCT02156141|High Intensity Training|high intensity training
236988|NCT02156141|High Intensity Interval Training|high intensity interval training
236989|NCT02156141|HIT|hit
236990|NCT02156141|HIIT|hiit
236991|NCT02156141|Training|training
236992|NCT02156141|Exercise|exercise
236993|NCT02156141|10-20-30|10-20-30
236994|NCT02156128|Cognitive therapy|cognitive therapy
236995|NCT02156115|Lymphangiomatosis|lymphangiomatosis
236996|NCT02156115|Lymphangiogenesis|lymphangiogenesis
236997|NCT02156115|Smooth Muscle Cell|smooth muscle cell
236998|NCT02156115|Vascular Anomalies|vascular anomalies
236999|NCT02156102|Genetic Disorders|genetic disorders
237000|NCT02156102|Sickle Cell Disease|sickle cell disease
237001|NCT02156102|African American|african american
237002|NCT02156102|Leg Ulcers|leg ulcers
237003|NCT02156102|Skin|skin
237004|NCT02156089|fMRI|fmri
237005|NCT02156089|Reward Processing|reward processing
237006|NCT02156089|Nutrition|nutrition
237007|NCT02156089|Omega-3 Fatty Acids|omega-3 fatty acids
237008|NCT02156089|ADHD|adhd
237009|NCT02156063|Recurrent Pregnancy Loss|recurrent pregnancy loss
237010|NCT02156063|Recurrent Miscarriage|recurrent miscarriage
237011|NCT02156063|Miscarriage|miscarriage
237012|NCT02156063|Pregnancy Loss|pregnancy loss
237013|NCT02156063|Repeated Pregnancy Loss|repeated pregnancy loss
237014|NCT02156037|Hispanic|hispanic
237015|NCT02156037|clinical decision support|clinical decision support
237016|NCT02156037|diabetes|diabetes
237017|NCT02156037|Hba1c|hba1c
237018|NCT02156037|psychosocial|psychosocial
237019|NCT02156024|clinical trials|clinical trials
237020|NCT02156024|Gastrodia and Uncaria Drink|gastrodia and uncaria drink
237021|NCT02156011|In vivo knee joint kinematics|in vivo knee joint kinematics
237022|NCT02156011|In vivo knee joint loading|in vivo knee joint loading
237023|NCT02156011|Video-fluoroscopy|video-fluoroscopy
237024|NCT02156011|Instrumented implants|instrumented implants
237025|NCT02156011|Optical motion capture|optical motion capture
237026|NCT02156011|Ground reaction forces|ground reaction forces
237027|NCT02156011|Electromyography|electromyography
237028|NCT02155998|prostate adenocarcinoma, locally advanced prostate cancer with high and very high risk of recurrence, adjuvant endocrine treatment, prostate specific antigen|prostate adenocarcinoma, locally advanced prostate cancer with high and very high risk of recurrence, adjuvant endocrine treatment, prostate specific antigen
237029|NCT02155972|Bipolar|bipolar
237030|NCT02155972|Depression|depression
237031|NCT02155972|Probiotic|probiotic
237032|NCT02155972|ALIGN|align
237033|NCT02155972|HAMD|hamd
237034|NCT02155972|STAI|stai
237035|NCT02155972|YMRS|ymrs
237036|NCT02155972|CGI|cgi
237037|NCT02155972|SDS|sds
237038|NCT02155972|WHOQOL-BREF|whoqol-bref
237039|NCT02155972|C-SSRS|c-ssrs
237040|NCT02155972|TSES|tses
237041|NCT02155959|astigmatism|astigmatism
237042|NCT02155959|cataract|cataract
237043|NCT02155959|toric|toric
237044|NCT02155959|lens|lens
237045|NCT02155946|Aging|aging
237046|NCT02155946|Alzheimer's Disease/Dementia|alzheimer's disease/dementia
237047|NCT02155946|Cognitive Disorders|cognitive disorders
237048|NCT02155946|Imaging|imaging
237049|NCT02155946|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
237050|NCT02155946|Neurology|neurology
237051|NCT02155946|Physical Medicine & Rehabilitation|physical medicine & rehabilitation
237052|NCT02155946|transcranial direct current stimulation|transcranial direct current stimulation
237053|NCT02155920|Ependymoma|ependymoma
237054|NCT02155920|Anaplastic Ependymoma|anaplastic ependymoma
237055|NCT02155894|Rheumatoid arthritis, treat to target, telemedicine|rheumatoid arthritis, treat to target, telemedicine
237056|NCT02155881|Drug therapy|drug therapy
237057|NCT02155868|Cerebral near-infrared spectroscopy monitoring|cerebral near-infrared spectroscopy monitoring
237058|NCT02155868|Postoperative complications|postoperative complications
237059|NCT02155868|Cardiac surgery|cardiac surgery
237060|NCT02155855|type 1 diabetes, home glucose monitor, upload, cloud|type 1 diabetes, home glucose monitor, upload, cloud
237061|NCT02155842|exercise therapy|exercise therapy
237062|NCT02155829|PTSD|ptsd
237063|NCT02155829|TBI|tbi
237064|NCT02155829|Riluzole|riluzole
237065|NCT02155829|Rilutek|rilutek
237066|NCT02155829|augmentation|augmentation
237067|NCT02155829|supplement|supplement
237068|NCT02155829|double blinded|double blinded
237069|NCT02155829|clinical trial|clinical trial
237070|NCT02155829|placebo|placebo
237071|NCT02155829|RCT|rct
237072|NCT02155829|Randomized Control Trial|randomized control trial
237073|NCT02155816|inflammation|inflammation
237077|NCT02155803|Sarcoidosis-Associated Calcium Dysregulation|sarcoidosis-associated calcium dysregulation
237078|NCT02155803|Sarcoidosis-Associated hypercalciuria|sarcoidosis-associated hypercalciuria
237079|NCT02155803|hypercalcemia|hypercalcemia
237080|NCT02155803|hypercalciuria|hypercalciuria
237081|NCT02155803|nephrocalcinosis|nephrocalcinosis
237082|NCT02155803|nephrolithiasis|nephrolithiasis
237083|NCT02155803|interstitial nephritis|interstitial nephritis
237084|NCT02155803|glomerulonephritis|glomerulonephritis
237085|NCT02155803|acute kidney disease|acute kidney disease
237086|NCT02155803|chronic kidney disease|chronic kidney disease
237087|NCT02155790|safety, performance, hypertension, renal denervation|safety, performance, hypertension, renal denervation
237088|NCT02155777|BRCA1|brca1
237089|NCT02155777|BRCA2|brca2
237090|NCT02155777|Risk-reducing surgery|risk-reducing surgery
237091|NCT02155777|Oral Contraceptives|oral contraceptives
237092|NCT02155764|tooth|tooth
237093|NCT02155764|extraction|extraction
237094|NCT02155764|alveolar socket|alveolar socket
237095|NCT02155764|socket preservation|socket preservation
237096|NCT02155764|ridge preservation|ridge preservation
237097|NCT02155764|bone graft|bone graft
237098|NCT02155764|tricalcium phosphate|tricalcium phosphate
237099|NCT02155764|octacalcium phosphate|octacalcium phosphate
237100|NCT02155764|xenograft|xenograft
237101|NCT02155764|bio oss|bio oss
237102|NCT02155751|Obesity prevention|obesity prevention
237103|NCT02155751|Nutrition and exercise in pregnancy|nutrition and exercise in pregnancy
237104|NCT02155751|Postpartum|postpartum
237105|NCT02155751|Maternal obesity risk|maternal obesity risk
237106|NCT02155738|IV acetaminophen|iv acetaminophen
237107|NCT02155738|Postoperative pain|postoperative pain
237108|NCT02155738|Pelvic organ prolapse surgery|pelvic organ prolapse surgery
237109|NCT02155738|Pelvic organ prolapse repair|pelvic organ prolapse repair
237110|NCT02155725|PPH|pph
237111|NCT02155725|fibrinogen|fibrinogen
237112|NCT02155725|vaginal delivery|vaginal delivery
237113|NCT02155699|UHR, Remediation, Exercise, Intervention, Psychosis|uhr, remediation, exercise, intervention, psychosis
237114|NCT02155686|Elderly|elderly
237115|NCT02155686|Prevention|prevention
237116|NCT02155686|Multiple chronic disease|multiple chronic disease
237117|NCT02155686|Telemonitoring|telemonitoring
237118|NCT02155686|Geriatric teleexpertise|geriatric teleexpertise
237119|NCT02155686|Home heath care|home heath care
237120|NCT02155686|Medico-economics|medico-economics
237121|NCT02155660|Obstructive Lung Diseases|obstructive lung diseases
237122|NCT02155660|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
237123|NCT02155660|Lung Disease|lung disease
237124|NCT02155660|Bronchial Diseases|bronchial diseases
237125|NCT02155660|COPD Exacerbation|copd exacerbation
237126|NCT02155660|Respiratory Tract Diseases|respiratory tract diseases
237127|NCT02155647|Carcinoma, Merkel Cell|carcinoma, merkel cell
237128|NCT02155647|MSB0010718C|msb0010718c
237129|NCT02155647|avelumab|avelumab
237130|NCT02155647|Bavencio|bavencio
237131|NCT02155647|anti PD-L1|anti pd-l1
237132|NCT02155647|JAVELIN Merkel 200|javelin merkel 200
237133|NCT02155634|Newly Diagnosed Multiple Myeloma|newly diagnosed multiple myeloma
237134|NCT02155634|Multiple Myeloma|multiple myeloma
237135|NCT02155634|Lenalidomide|lenalidomide
237136|NCT02155634|Revlimid|revlimid
237137|NCT02155634|Phase III|phase iii
237138|NCT02155634|Phase IIIb|phase iiib
237139|NCT02155634|Plasma Cell Dyscrasia|plasma cell dyscrasia
237140|NCT02155621|cancer genomics|cancer genomics
237141|NCT02155621|precision medicine|precision medicine
237142|NCT02155621|metastatic cancer|metastatic cancer
237143|NCT02155621|clinical decision-making|clinical decision-making
237144|NCT02155608|ADHD|adhd
237145|NCT02155608|neuromodulation|neuromodulation
237146|NCT02155608|trigeminal nerve stimulation|trigeminal nerve stimulation
237147|NCT02155608|cognition|cognition
237148|NCT02155582|Solid tumors|solid tumors
237149|NCT02155569|Cesarean, extraperitoneal|cesarean, extraperitoneal
237150|NCT02155569|Cesarean|cesarean
237151|NCT02155569|Pain|pain
237152|NCT02155517|TCI,Schnider Model, Cortinez Model, BIS, Cardiac Output.|tci,schnider model, cortinez model, bis, cardiac output.
237153|NCT02155504|Healthy volunteers|healthy volunteers
237154|NCT02155504|Pharmacokinetics|pharmacokinetics
237155|NCT02155504|ASP3700|asp3700
237156|NCT02155504|Itraconazole|itraconazole
237157|NCT02155504|Drug-drug interaction|drug-drug interaction
237158|NCT02155491|venous, thromboembolism, embolism, DVT, Pulmonary Embolism, thrombosis|venous, thromboembolism, embolism, dvt, pulmonary embolism, thrombosis
237159|NCT02155465|Ruxolitinib|ruxolitinib
237160|NCT02155465|Erlotinib|erlotinib
237161|NCT02155465|EGFR-mutant|egfr-mutant
237162|NCT02155465|14-043|14-043
237163|NCT02155452|ALA|ala
237164|NCT02155452|Malignant gliomas|malignant gliomas
237165|NCT02155439|Prospective, randomized controlled trial - pilot study|prospective, randomized controlled trial - pilot study
237166|NCT02155413|Acute pain|acute pain
237167|NCT02155413|Audit|audit
237168|NCT02155413|Safety|safety
237169|NCT02155413|Tolerability|tolerability
237170|NCT02155400|perioperative hypothermia|perioperative hypothermia
237171|NCT02155400|thermal compression|thermal compression
237382|NCT02154334|Healthy|healthy
237172|NCT02155400|forced air warming|forced air warming
237173|NCT02155387|EVLW|evlw
237174|NCT02155387|EVLWI|evlwi
237175|NCT02155387|PVPI|pvpi
237176|NCT02155387|MICS|mics
237177|NCT02155374|Glucocorticoid induced hyperglycemia, insulin, chemotherapy|glucocorticoid induced hyperglycemia, insulin, chemotherapy
237178|NCT02155361|Diabetes mellitus|diabetes mellitus
237179|NCT02155361|Diabetes complications|diabetes complications
237180|NCT02155361|Pain|pain
237181|NCT02155309|scopolamine|scopolamine
237182|NCT02155309|motion|motion
237183|NCT02155309|sickness|sickness
237184|NCT02155296|positive youth development|positive youth development
237185|NCT02155296|restorative practices|restorative practices
237186|NCT02155296|school climate|school climate
237187|NCT02155296|social competency|social competency
237188|NCT02155283|Chronic Low Back Pain|chronic low back pain
237189|NCT02155283|Mild-to-Moderate Chronic Low Back Pain|mild-to-moderate chronic low back pain
237190|NCT02155283|Continuous Passive Motion Devices|continuous passive motion devices
237191|NCT02155270|Cataract|cataract
237192|NCT02155270|Incision|incision
237193|NCT02155270|Precut|precut
237194|NCT02155270|Corneal|corneal
237195|NCT02155270|OCT|oct
237196|NCT02155270|Intraoperative OCT|intraoperative oct
237197|NCT02155270|Imaging|imaging
237198|NCT02155270|Astigmatism|astigmatism
237199|NCT02155270|Clear corneal incision|clear corneal incision
237200|NCT02155257|Osteoarthritis|osteoarthritis
237201|NCT02155244|CBDS|cbds
237202|NCT02155244|ERCP|ercp
237203|NCT02155244|Dindo-Clavien classification|dindo-clavien classification
237204|NCT02155231|Male with history of anal sex with men or previous participants of the MSM VCT study|male with history of anal sex with men or previous participants of the msm vct study
237205|NCT02155218|Magnetic Resonance Angiography|magnetic resonance angiography
237206|NCT02155218|Contrast Media|contrast media
237207|NCT02155192|CNTO1959PSO2001|cnto1959pso2001
237208|NCT02155192|C0743T08|c0743t08
237209|NCT02155192|C0743T09|c0743t09
237210|NCT02155192|C0743T12|c0743t12
237211|NCT02155192|Psoriasis|psoriasis
237212|NCT02155192|Pharmacogenomics|pharmacogenomics
237213|NCT02155166|Levonorgestrel-releasing intrauterine system|levonorgestrel-releasing intrauterine system
237214|NCT02155166|anesthesia|anesthesia
237215|NCT02155166|pain|pain
237216|NCT02155166|nulliparous|nulliparous
237217|NCT02155140|enteral feeding|enteral feeding
237218|NCT02155140|Discharged|discharged
237219|NCT02155140|surgical resection of an upper gastrointestinal malignancy|surgical resection of an upper gastrointestinal malignancy
237220|NCT02155140|Nutritional supplementation via a jejunostomy|nutritional supplementation via a jejunostomy
237221|NCT02155127|chronic kidney disease|chronic kidney disease
237222|NCT02155127|physical function|physical function
237223|NCT02155114|Hepcidins|hepcidins
237224|NCT02155114|Homeostasis|homeostasis
237225|NCT02155114|Iron/administration & dosage|iron/administration & dosage
237226|NCT02155114|Biological Markers/blood|biological markers/blood
237227|NCT02155101|Efficacy|efficacy
237228|NCT02155101|Safety|safety
237229|NCT02155101|Darunavir|darunavir
237230|NCT02155101|HIV-1 RNA level|hiv-1 rna level
237231|NCT02155101|Cameroon|cameroon
237232|NCT02155088|Locally Advanced|locally advanced
237233|NCT02155088|Metastatic|metastatic
237234|NCT02155088|Recurrent|recurrent
237235|NCT02155088|Pancreas|pancreas
237236|NCT02155075|Breast neoplasm|breast neoplasm
237237|NCT02155075|Breast implants|breast implants
237238|NCT02155075|Mammography|mammography
237239|NCT02155075|Breast imaging|breast imaging
237240|NCT02155075|Imaging augmented breast|imaging augmented breast
237241|NCT02155062|Nutritional biomarker|nutritional biomarker
237242|NCT02155062|Dietary assessment|dietary assessment
237243|NCT02155062|Whole grain|whole grain
237244|NCT02155062|Wheat|wheat
237245|NCT02155062|Rye|rye
237246|NCT02155062|Alkylresorcinol|alkylresorcinol
237247|NCT02155062|Urine|urine
237248|NCT02155049|TED|ted
237249|NCT02155049|Prostaglandin Analogues|prostaglandin analogues
237250|NCT02155036|exercise|exercise
237251|NCT02155036|rehabilitation|rehabilitation
237252|NCT02155036|kidney function|kidney function
237253|NCT02155036|cardiovascular disease risk|cardiovascular disease risk
237254|NCT02155010|Dexmedetomidine|dexmedetomidine
237255|NCT02155010|Spinal anesthesia|spinal anesthesia
237256|NCT02154971|HIV Seropositivity|hiv seropositivity
237257|NCT02154971|Audiometry|audiometry
237258|NCT02154971|Hearing Loss|hearing loss
237259|NCT02154958|Follicular output rate|follicular output rate
237260|NCT02154958|IVF|ivf
237261|NCT02154958|ICSI|icsi
237262|NCT02154932|Myomectomy, Misoprostol|myomectomy, misoprostol
237263|NCT02154906|periodontal disease|periodontal disease
237264|NCT02154906|periodontitis|periodontitis
237265|NCT02154893|Ultrasound|ultrasound
237266|NCT02154893|Laser|laser
237267|NCT02154893|Therapeutic exercise|therapeutic exercise
237268|NCT02154893|Rehabilitation|rehabilitation
237269|NCT02154893|Osteoarthritis|osteoarthritis
237270|NCT02154880|HIV|hiv
237271|NCT02154880|lung|lung
237272|NCT02154880|aging|aging
237273|NCT02154867|IBS-D|ibs-d
237274|NCT02154867|FMT|fmt
237275|NCT02154867|metagenomics|metagenomics
237276|NCT02154867|gut microbiome|gut microbiome
237277|NCT02154854|Renal|renal
237278|NCT02154854|Transplantation|transplantation
237279|NCT02154854|Tacrolimus|tacrolimus
237280|NCT02154854|Arterial stiffness|arterial stiffness
237281|NCT02154854|Vascular fibrose plasma markers|vascular fibrose plasma markers
237282|NCT02154841|Postoperative|postoperative
237283|NCT02154841|nutrition|nutrition
237284|NCT02154841|taste|taste
237285|NCT02154841|perception|perception
237286|NCT02154841|preference|preference
237287|NCT02154841|choice|choice
237288|NCT02154828|Children|children
237289|NCT02154828|aged|aged
237290|NCT02154828|3 to 6 years|3 to 6 years
237291|NCT02154815|End Stage Renal Disease|end stage renal disease
237292|NCT02154815|Renal transplantation|renal transplantation
237293|NCT02154815|Dialysis|dialysis
237294|NCT02154815|Pre-emptive transplantation|pre-emptive transplantation
237295|NCT02154815|Psychological adjustment|psychological adjustment
237296|NCT02154815|Quality of life.|quality of life.
237297|NCT02154776|LEE011,|lee011,
237298|NCT02154776|buparlisib,|buparlisib,
237299|NCT02154776|letrozole,|letrozole,
237300|NCT02154776|HR +,|hr +,
237301|NCT02154776|HER2 - negative,|her2 - negative,
237302|NCT02154776|post-menopausal,|post-menopausal,
237303|NCT02154776|breast cancer,|breast cancer,
237304|NCT02154776|CDK 4/6,|cdk 4/6,
237305|NCT02154776|PI3K,|pi3k,
237306|NCT02154776|MTD|mtd
237307|NCT02154763|Bariatric surgery|bariatric surgery
237308|NCT02154763|Bariatrics|bariatrics
237309|NCT02154763|Local anesthetic|local anesthetic
237310|NCT02154763|Ropivacaine|ropivacaine
237311|NCT02154763|Intraperitoneal|intraperitoneal
237312|NCT02154750|Atrioventricular delay|atrioventricular delay
237313|NCT02154750|AV delay|av delay
237314|NCT02154750|Pacemaker|pacemaker
237315|NCT02154750|Sick Sinus Syndrome|sick sinus syndrome
237316|NCT02154750|Bradycardia|bradycardia
237317|NCT02154750|PR interval|pr interval
237318|NCT02154750|Atrioventricular block|atrioventricular block
237319|NCT02154750|AV block|av block
237320|NCT02154750|Echocardiography|echocardiography
237321|NCT02154750|Arrhythmia|arrhythmia
237322|NCT02154750|AV optimization|av optimization
237323|NCT02154737|Pancreatic|pancreatic
237324|NCT02154737|Gemcitabine|gemcitabine
237325|NCT02154737|Gemzar|gemzar
237326|NCT02154737|erlotinib|erlotinib
237327|NCT02154737|Tarceva|tarceva
237328|NCT02154711|mitochondrial disease|mitochondrial disease
237329|NCT02154711|magnetic resonance imaging|magnetic resonance imaging
237330|NCT02154711|magnetic resonance spectroscopy|magnetic resonance spectroscopy
237331|NCT02154711|creatine|creatine
237332|NCT02154711|phosphocreatine|phosphocreatine
237333|NCT02154685|Smoking|smoking
237334|NCT02154685|Nicotine|nicotine
237335|NCT02154685|Addiction|addiction
237336|NCT02154685|Cessation|cessation
237337|NCT02154620|Distal radius fracture|distal radius fracture
237338|NCT02154620|wrist fracture|wrist fracture
237339|NCT02154620|volar plate|volar plate
237340|NCT02154620|surgical treatment|surgical treatment
237341|NCT02154620|plaster immobilisation|plaster immobilisation
237342|NCT02154607|oral lichen planus|oral lichen planus
237343|NCT02154607|recurrence|recurrence
237344|NCT02154607|Treatment|treatment
237345|NCT02154607|cancer|cancer
237346|NCT02154607|Primary disease Management|primary disease management
237347|NCT02154594|Acacia|acacia
237348|NCT02154594|Chlorhexidine|chlorhexidine
237349|NCT02154594|Gingivitis|gingivitis
237350|NCT02154594|Orthodontic appliances.|orthodontic appliances.
237351|NCT02154581|Dental implants|dental implants
237352|NCT02154581|Esthetic score|esthetic score
237353|NCT02154581|Immediate implants|immediate implants
237354|NCT02154581|Gingival biotype|gingival biotype
237355|NCT02154568|Hyperpolarized gas MRI|hyperpolarized gas mri
237356|NCT02154542|Nava|nava
237357|NCT02154542|Mechanical ventilation|mechanical ventilation
237358|NCT02154477|hypogonadotropic hypogonadism|hypogonadotropic hypogonadism
237359|NCT02154464|Morphine-sparing|morphine-sparing
237360|NCT02154464|Paracetamol|paracetamol
237361|NCT02154464|Obesity|obesity
237362|NCT02154464|Gastric banding|gastric banding
237363|NCT02154425|Cimzia®|cimzia®
237364|NCT02154425|CZP|czp
237365|NCT02154425|Breastfeeding|breastfeeding
237366|NCT02154425|Nursing|nursing
237367|NCT02154425|Autoimmune diseases and pregnancy|autoimmune diseases and pregnancy
237368|NCT02154412|Respiration|respiration
237369|NCT02154412|Motor control|motor control
237370|NCT02154412|Blood Pressure|blood pressure
237371|NCT02154412|Orthostatic Hypotension|orthostatic hypotension
237372|NCT02154386|bone augmentation|bone augmentation
237373|NCT02154386|tooth extraction|tooth extraction
237374|NCT02154386|dental implant|dental implant
237375|NCT02154360|HIV infection|hiv infection
237376|NCT02154360|NK-1R antagonists|nk-1r antagonists
237377|NCT02154360|aprepitant|aprepitant
237378|NCT02154360|ritonavir boosting|ritonavir boosting
237379|NCT02154347|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
237380|NCT02154347|HbA1c|hba1c
237381|NCT02154334|Allergic Rhinitis|allergic rhinitis
237383|NCT02154334|Esketamine|esketamine
237384|NCT02154334|Mometasone|mometasone
237385|NCT02154334|Oxymetazoline|oxymetazoline
237386|NCT02154334|Phase 1|phase 1
237387|NCT02154308|Influenza|influenza
237388|NCT02154308|Influenza vaccine|influenza vaccine
237389|NCT02154308|Split influenza vaccine|split influenza vaccine
237390|NCT02154308|Seasonal influenza vaccine|seasonal influenza vaccine
237391|NCT02154282|hepatic encephalopathy|hepatic encephalopathy
237392|NCT02154282|covert hepatic encephalopathy|covert hepatic encephalopathy
237393|NCT02154282|cirrhosis|cirrhosis
237394|NCT02154269|Chagas disease|chagas disease
237395|NCT02154269|G-CSF|g-csf
237396|NCT02154269|Cell therapy|cell therapy
237397|NCT02154256|walking|walking
237398|NCT02154256|incentives|incentives
237399|NCT02154256|exercise|exercise
237400|NCT02154256|habits|habits
237401|NCT02154230|weight loss|weight loss
237402|NCT02154230|sulphate-bicarbonate-calcium water|sulphate-bicarbonate-calcium water
237403|NCT02154230|gut microbiota|gut microbiota
237404|NCT02154230|body composition|body composition
237405|NCT02154230|bile salts|bile salts
237406|NCT02154191|Lumbosacral Region|lumbosacral region
237407|NCT02154191|Sedentary Lifestyle|sedentary lifestyle
237408|NCT02154191|Surgical Procedure, Operative|surgical procedure, operative
237409|NCT02154178|empiric antifungal therapy|empiric antifungal therapy
237410|NCT02154178|biomarkers|biomarkers
237411|NCT02154178|invasive fungal infection|invasive fungal infection
237412|NCT02154178|Candida|candida
237413|NCT02154165|Neonatal hyperbilirubinemia|neonatal hyperbilirubinemia
237414|NCT02154165|Phototherapy|phototherapy
237415|NCT02154165|Light emitting diodes|light emitting diodes
237416|NCT02154165|Blue light|blue light
237417|NCT02154165|Turquoise light|turquoise light
237418|NCT02154152|Bed wetting|bed wetting
237419|NCT02154152|Primary Enuresis|primary enuresis
237420|NCT02154152|Frequency|frequency
237421|NCT02154152|Efficacy|efficacy
237422|NCT02154152|Homoeopathic Medicine|homoeopathic medicine
237423|NCT02154152|Causticum 200c|causticum 200c
237424|NCT02154139|Pharmacological therapy|pharmacological therapy
237425|NCT02154113|Syneron|syneron
237426|NCT02154113|Velashape|velashape
237427|NCT02154113|ELOS|elos
237428|NCT02154113|Ultrashape|ultrashape
237429|NCT02154100|Metabolic Syndrome|metabolic syndrome
237430|NCT02154100|Arterial Stiffness|arterial stiffness
237431|NCT02154100|Blood Pressure|blood pressure
237432|NCT02154100|Endothelial Function|endothelial function
237433|NCT02154100|Tart Cherries|tart cherries
237434|NCT02154087|Venous leg ulcer|venous leg ulcer
237435|NCT02154087|Ulcer|ulcer
237436|NCT02154087|Venous stasis|venous stasis
237437|NCT02154087|Compression|compression
237438|NCT02154074|Dexmedetomidine perioperative blood glucose and insulin|dexmedetomidine perioperative blood glucose and insulin
237439|NCT02154061|Flu Vaccine, Intestinal Microbiome, Antibiotics|flu vaccine, intestinal microbiome, antibiotics
237440|NCT02154035|Viral Suppression|viral suppression
237441|NCT02154035|Functional Cure|functional cure
237442|NCT02154022|PK|pk
237443|NCT02154009|Autonomic Nervous System|autonomic nervous system
237444|NCT02154009|Catecholamines|catecholamines
237445|NCT02154009|Dysautonomia|dysautonomia
237446|NCT02154009|Parasympathetic Cholinergic System|parasympathetic cholinergic system
237447|NCT02154009|Sympathetic Adrenergic System|sympathetic adrenergic system
237448|NCT02153996|Malaria Immunity Longevity|malaria immunity longevity
237449|NCT02153983|Obesity|obesity
237450|NCT02153983|Colchicine|colchicine
237451|NCT02153983|Inflammation|inflammation
237452|NCT02153983|Metabolic Syndrome|metabolic syndrome
237453|NCT02153983|Dyslipidemia|dyslipidemia
237454|NCT02153970|Clinical Outcomes Measures|clinical outcomes measures
237455|NCT02153970|Proxy Reported Outcome|proxy reported outcome
237456|NCT02153970|Pediatric|pediatric
237457|NCT02153970|Neuromuscular Disease|neuromuscular disease
237458|NCT02153970|Cerebral Palsy|cerebral palsy
237459|NCT02153957|Exercise|exercise
237460|NCT02153957|Memory|memory
237461|NCT02153957|BDNF|bdnf
237462|NCT02153957|Zamzee|zamzee
237463|NCT02153957|QOL|qol
237464|NCT02153944|Startle|startle
237465|NCT02153944|Induced-Threat|induced-threat
237466|NCT02153944|Memory|memory
237467|NCT02153944|Stimulant|stimulant
237468|NCT02153944|Cognitive Interference|cognitive interference
237469|NCT02153931|Children's Tumor Foundation|children's tumor foundation
237470|NCT02153931|Social Support|social support
237471|NCT02153931|Online|online
237472|NCT02153931|Anxiety|anxiety
237473|NCT02153931|Depression|depression
237474|NCT02153918|Surgery|surgery
237475|NCT02153918|Neoadjuvant|neoadjuvant
237476|NCT02153918|CD8 Cell Infiltrate Response|cd8 cell infiltrate response
237477|NCT02153918|CD4 Cell Infiltrate Response|cd4 cell infiltrate response
237478|NCT02153918|Vaccine|vaccine
237479|NCT02153905|Tumor Regression|tumor regression
237480|NCT02153905|Immunotherapy|immunotherapy
237481|NCT02153905|Metastatic Cancer|metastatic cancer
237482|NCT02153905|Gene Therapy|gene therapy
237483|NCT02153905|T Cells|t cells
237484|NCT02153892|Functional Mitral Regurgitation|functional mitral regurgitation
237485|NCT02153892|Heart Failure|heart failure
237486|NCT02153892|Ventricular Reshaping|ventricular reshaping
237487|NCT02153879|HDL|hdl
237488|NCT02153879|Niacin|niacin
237489|NCT02153879|Fenofibrate|fenofibrate
237490|NCT02153879|Diabetes|diabetes
237491|NCT02153879|Metabolomics|metabolomics
237492|NCT02153866|rotavirus vaccine|rotavirus vaccine
237493|NCT02153840|Stable Plaque Psoriasis|stable plaque psoriasis
237494|NCT02153827|Shoulder|shoulder
237495|NCT02153827|Eccentric Training|eccentric training
237496|NCT02153827|Subacromial Impingement Syndrome|subacromial impingement syndrome
237497|NCT02153814|Infertility|infertility
237498|NCT02153814|In vitro fertilization|in vitro fertilization
237499|NCT02153814|Endometrial injury|endometrial injury
237500|NCT02153801|High Ligation, Low ligation, Genito-urinary function, laparoscopy, rectal cancer, aterior resection, Total mesorectal Excision, anastomotic leak.|high ligation, low ligation, genito-urinary function, laparoscopy, rectal cancer, aterior resection, total mesorectal excision, anastomotic leak.
237501|NCT02153788|Insomnia|insomnia
237502|NCT02153788|HIV|hiv
237503|NCT02153775|Progressive muscle relaxation|progressive muscle relaxation
237504|NCT02153775|Cigarette|cigarette
237505|NCT02153775|Smoking|smoking
237506|NCT02153775|Craving|craving
237507|NCT02153762|Atopic Dermatitis|atopic dermatitis
237508|NCT02153762|AD|ad
237509|NCT02153723|Treatment trial|treatment trial
237510|NCT02153710|Aphasia|aphasia
237511|NCT02153710|Anomia|anomia
237512|NCT02153697|solar lentigines|solar lentigines
237513|NCT02153697|Q-switches Laser|q-switches laser
237514|NCT02153697|bleaching cream|bleaching cream
237515|NCT02153684|smoking|smoking
237516|NCT02153684|small airway dysfunction|small airway dysfunction
237517|NCT02153684|mild COPD|mild copd
237518|NCT02153684|dyspnea|dyspnea
237519|NCT02153684|exercise|exercise
237520|NCT02153684|clinical outcomes|clinical outcomes
237521|NCT02153671|LAIV H5N2|laiv h5n2
237522|NCT02153671|Influenza vaccine|influenza vaccine
237523|NCT02153671|Russia|russia
237524|NCT02153658|PrePex|prepex
237525|NCT02153658|Odor|odor
237526|NCT02153658|Cleaning technique|cleaning technique
237527|NCT02153658|Male Circumcision|male circumcision
237528|NCT02153658|HIV|hiv
237529|NCT02153658|AIDS|aids
237530|NCT02153658|Chlorhexidine|chlorhexidine
237531|NCT02153658|Soap|soap
237532|NCT02153645|Parkinson's Disease|parkinson's disease
237533|NCT02153645|Levodopa Induced Dyskinesias (LID)|levodopa induced dyskinesias (lid)
237534|NCT02153645|Dyskinesias|dyskinesias
237535|NCT02153645|Parkinsonism|parkinsonism
237536|NCT02153632|Parkinson's Disease|parkinson's disease
237537|NCT02153632|Levodopa Induced Dyskinesia (LID)|levodopa induced dyskinesia (lid)
237538|NCT02153632|LID|lid
237539|NCT02153632|Parkinsonism|parkinsonism
237540|NCT02153632|Dyskinesia|dyskinesia
237541|NCT02153619|Grief|grief
237542|NCT02153619|bereavement|bereavement
237543|NCT02153619|questionnaires|questionnaires
237544|NCT02153619|therapy sessions|therapy sessions
237545|NCT02153619|14-102|14-102
237546|NCT02153606|Glycerin Suppositories|glycerin suppositories
237547|NCT02153606|Enteral Nutrition|enteral nutrition
237548|NCT02153606|Enterocolitis, Necrotizing|enterocolitis, necrotizing
237549|NCT02153606|Infant, Premature|infant, premature
237550|NCT02153606|Meconium|meconium
237551|NCT02153593|Clinical trial|clinical trial
237552|NCT02153593|Randomized|randomized
237553|NCT02153593|Fibrin glue|fibrin glue
237554|NCT02153593|Tranexamic acid|tranexamic acid
237555|NCT02153593|Blood loss|blood loss
237556|NCT02153567|Functional dyspepsia|functional dyspepsia
237557|NCT02153567|symptom response|symptom response
237558|NCT02153567|postprandial fullness|postprandial fullness
237559|NCT02153567|Anxiety|anxiety
237560|NCT02153567|Depression|depression
237561|NCT02153528|Bangladesh|bangladesh
237562|NCT02153528|Rimfapicin|rimfapicin
237563|NCT02153515|Finger prick with diabetic lancet|finger prick with diabetic lancet
237564|NCT02153515|Fingerprick|fingerprick
237565|NCT02153515|Fresh|fresh
237566|NCT02153515|Your own blood|your own blood
237567|NCT02153515|autologous blood|autologous blood
237568|NCT02153515|Dry eyes|dry eyes
237569|NCT02153515|Sjogren's disease with dry eyes|sjogren's disease with dry eyes
237570|NCT02153515|Persistent corneal epithelial defects|persistent corneal epithelial defects
237571|NCT02153515|Chronic corneal ulcers|chronic corneal ulcers
237572|NCT02153463|Tourette Syndrome|tourette syndrome
237573|NCT02153463|Persistent Tic Disorder|persistent tic disorder
237574|NCT02153463|Physical Activity|physical activity
237575|NCT02153463|Quality of Life|quality of life
237576|NCT02153450|pancreatic cancer|pancreatic cancer
237577|NCT02153450|Radiation|radiation
237578|NCT02153450|Metformin|metformin
237579|NCT02153450|Pancreatic Adenocarcinomas|pancreatic adenocarcinomas
237580|NCT02153411|Asthma control|asthma control
237581|NCT02153398|Gastric ulcer (GU)|gastric ulcer (gu)
237582|NCT02153398|Duodenal ulcer (DU)|duodenal ulcer (du)
237583|NCT02153398|Anastomotic ulcer (AU)|anastomotic ulcer (au)
237584|NCT02153398|Non-erosive reflux esophagitis disease (NERD)|non-erosive reflux esophagitis disease (nerd)
237585|NCT02153398|Reflux esophagitis (RE)|reflux esophagitis (re)
237586|NCT02153398|Zollinger-Ellison syndrome|zollinger-ellison syndrome
237587|NCT02153385|Yoga, heart rate variability, stress, mood, women|yoga, heart rate variability, stress, mood, women
237588|NCT02153372|large bone defect, bone marrow-derived mononuclear cells|large bone defect, bone marrow-derived mononuclear cells
237589|NCT02153359|asthma|asthma
237590|NCT02153359|HEPA|hepa
237591|NCT02153359|air pollutants|air pollutants
237592|NCT02153359|lung function|lung function
237593|NCT02153359|home environment|home environment
237594|NCT02153359|respiratory symptoms|respiratory symptoms
237595|NCT02153359|diet|diet
237596|NCT02153346|indirect cost|indirect cost
237597|NCT02153346|asthma|asthma
237598|NCT02153333|Human rotavirus (HRV) vaccine|human rotavirus (hrv) vaccine
237599|NCT02153333|Serologic response|serologic response
237600|NCT02153333|Porcine circovirus type 1 (PCV-1)|porcine circovirus type 1 (pcv-1)
237601|NCT02153333|Laboratory evaluations|laboratory evaluations
237602|NCT02153320|HBsAg|hbsag
237603|NCT02153320|Persistence of the immune response|persistence of the immune response
237604|NCT02153320|Adjuvants|adjuvants
237605|NCT02153294|low tidal volume|low tidal volume
237606|NCT02153294|high tidal volume|high tidal volume
237607|NCT02153294|protective ventilation|protective ventilation
237608|NCT02153294|ARDS|ards
237609|NCT02153281|Depression|depression
237610|NCT02153281|Positron Emission Tomography (PET)|positron emission tomography (pet)
237611|NCT02153281|MAO-B|mao-b
237612|NCT02153268|Safety|safety
237613|NCT02153268|efficacy|efficacy
237614|NCT02153268|BonoFill|bonofill
237615|NCT02153268|bone filler|bone filler
237616|NCT02153268|autologous adipose tissue derived cells (HATDCs)|autologous adipose tissue derived cells (hatdcs)
237617|NCT02153268|Bone augmentation|bone augmentation
237618|NCT02153268|sinus augmentation|sinus augmentation
237619|NCT02153268|Bone grafting after removal of cysts from jaws|bone grafting after removal of cysts from jaws
237621|NCT02153255|Mucopolysaccharidosis|mucopolysaccharidosis
237622|NCT02153255|Galactosamine-6-Sulfatase|galactosamine-6-sulfatase
237623|NCT02153255|GALNS|galns
237624|NCT02153242|Pacing|pacing
237625|NCT02153242|Haemodynamics|haemodynamics
237626|NCT02153242|Pilot|pilot
237627|NCT02153229|Histological diagnosis of MPM|histological diagnosis of mpm
237628|NCT02153229|epitheliod subtype|epitheliod subtype
237629|NCT02153229|limited to the hemithorax|limited to the hemithorax
237630|NCT02153229|macroscopically complete resection of the tumor|macroscopically complete resection of the tumor
237631|NCT02153203|Autism spectrum disorder|autism spectrum disorder
237632|NCT02153203|Problem behavior|problem behavior
237633|NCT02153190|Type 1 Diabetes,|type 1 diabetes,
237634|NCT02153190|T1DM,|t1dm,
237635|NCT02153190|Artificial Pancreas|artificial pancreas
237636|NCT02153177|Randomized Controlled Trial (RCT)|randomized controlled trial (rct)
237637|NCT02153177|RCT|rct
237638|NCT02153177|rotator cuff tear|rotator cuff tear
237639|NCT02153177|NSAIDs|nsaids
237640|NCT02153177|non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
237641|NCT02153177|rotator cuff repair|rotator cuff repair
237642|NCT02153164|Enthalpy|enthalpy
237643|NCT02153164|Trendelenberg position|trendelenberg position
237644|NCT02153164|Mechanical ventilation|mechanical ventilation
237645|NCT02153138|vegetarian diet|vegetarian diet
237646|NCT02153138|vegan|vegan
237647|NCT02153138|cardiovascular diseases|cardiovascular diseases
237648|NCT02153138|endothelial function|endothelial function
237649|NCT02153138|carotid intima-media thickness|carotid intima-media thickness
237650|NCT02153112|Drug therapy|drug therapy
237651|NCT02153099|Drug therapy|drug therapy
237652|NCT02153086|Pharmacological therapy|pharmacological therapy
237653|NCT02153073|Pharmacological therapy|pharmacological therapy
237654|NCT02153060|immune thrombocytopenia|immune thrombocytopenia
237655|NCT02153060|dexamethasone|dexamethasone
237656|NCT02153060|efficacy|efficacy
237657|NCT02153060|safety|safety
237658|NCT02153047|Smoking cessation|smoking cessation
237659|NCT02153047|Spirometry|spirometry
237660|NCT02153047|Primary health care|primary health care
237661|NCT02153034|Buruli ulcer|buruli ulcer
237662|NCT02153034|Mycobacterium ulcerans disease|mycobacterium ulcerans disease
237663|NCT02153034|M. ulcerans disease|m. ulcerans disease
237664|NCT02153021|anthropometric parameters;|anthropometric parameters;
237665|NCT02153021|biochemical parameters;|biochemical parameters;
237666|NCT02153021|inflammatory markers|inflammatory markers
237667|NCT02153021|neuropeptide markers|neuropeptide markers
237668|NCT02153021|phototherapy|phototherapy
237669|NCT02153008|Strep throat|strep throat
237670|NCT02152956|AML|aml
237671|NCT02152956|leukemia|leukemia
237672|NCT02152956|myelogenous|myelogenous
237673|NCT02152956|myeloid|myeloid
237674|NCT02152956|refractory|refractory
237675|NCT02152956|MDS|mds
237676|NCT02152956|Myelodysplastic|myelodysplastic
237677|NCT02152943|Breast Cancer|breast cancer
237678|NCT02152943|Advanced Metastatic Breast Cancer|advanced metastatic breast cancer
237679|NCT02152943|Solid Tumors|solid tumors
237680|NCT02152943|Advanced Solid Tumors|advanced solid tumors
237681|NCT02152943|Everolimus|everolimus
237682|NCT02152943|Afinitor|afinitor
237683|NCT02152943|Zortress|zortress
237684|NCT02152943|RAD001|rad001
237685|NCT02152943|Trastuzumab|trastuzumab
237686|NCT02152943|Herceptin|herceptin
237687|NCT02152943|Letrozole|letrozole
237688|NCT02152943|Femara|femara
237689|NCT02152930|Fish oil supplements|fish oil supplements
237690|NCT02152930|Supervised Exercise Training|supervised exercise training
237691|NCT02152930|Walking distance|walking distance
237692|NCT02152930|Hemorheological factors|hemorheological factors
237693|NCT02152930|Cardiovascular risk|cardiovascular risk
237694|NCT02152904|Peptic ulcer bleeding|peptic ulcer bleeding
237695|NCT02152904|rebleeding|rebleeding
237696|NCT02152904|mortality|mortality
237697|NCT02152904|nationwide|nationwide
237698|NCT02152891|Emergency Medical Services|emergency medical services
237699|NCT02152891|Elderly|elderly
237700|NCT02152878|transcranial direct current stimulation|transcranial direct current stimulation
237701|NCT02152878|non invasive brain stimulation|non invasive brain stimulation
237702|NCT02152878|bipolar disorder|bipolar disorder
237703|NCT02152878|depression|depression
237704|NCT02152865|medication|medication
237705|NCT02152852|Type 2 Diabetes|type 2 diabetes
237706|NCT02152826|Sensitivity|sensitivity
237707|NCT02152813|Electrical stimulation, exercise, stroke , rehabilitation|electrical stimulation, exercise, stroke , rehabilitation
237708|NCT02152787|emergence agitation|emergence agitation
237709|NCT02152787|propofol|propofol
237710|NCT02152787|strabismus surgery|strabismus surgery
237711|NCT02152787|children|children
237712|NCT02152787|elective strabismus surgery|elective strabismus surgery
237713|NCT02152761|bimagrumab,|bimagrumab,
237714|NCT02152761|BYM338,|bym338,
237715|NCT02152761|hip fracture,|hip fracture,
237716|NCT02152761|elderly,|elderly,
237717|NCT02152761|controlled clinical trial,|controlled clinical trial,
237718|NCT02152761|randomized,|randomized,
237719|NCT02152761|muscle wasting (atrophy)|muscle wasting (atrophy)
237720|NCT02152748|glioblastoma|glioblastoma
237721|NCT02152748|morphological and molecular changes|morphological and molecular changes
237722|NCT02152748|progression|progression
237723|NCT02152748|therapy-resistance|therapy-resistance
237724|NCT02152722|Breath test|breath test
237725|NCT02152722|Volatile Organic Compounds|volatile organic compounds
237726|NCT02152722|VOC|voc
237727|NCT02152722|oxidative stress|oxidative stress
237728|NCT02152722|radiation biodosimetry|radiation biodosimetry
237729|NCT02152722|metabolomics|metabolomics
237730|NCT02152722|GCxGC TOF-MS|gcxgc tof-ms
237731|NCT02152709|Safety|safety
237732|NCT02152709|Immunogenicity|immunogenicity
237733|NCT02152709|Vaccine|vaccine
237734|NCT02152709|Hepatitis B|hepatitis b
237735|NCT02152657|Spinal cord injury|spinal cord injury
237736|NCT02152657|Stem cell transplantation|stem cell transplantation
237737|NCT02152657|Mesenchymal stem cell|mesenchymal stem cell
237738|NCT02152644|amyloidosis-carpal tunnel|amyloidosis-carpal tunnel
237739|NCT02152631|Therapy, Platinum, Kras +|therapy, platinum, kras +
237740|NCT02152618|Serious emotional disturbance|serious emotional disturbance
237741|NCT02152618|foster care|foster care
237742|NCT02152618|child protective services|child protective services
237743|NCT02152605|SGRQ|sgrq
237744|NCT02152605|vilanterol|vilanterol
237745|NCT02152605|long-acting beta2-agonist|long-acting beta2-agonist
237746|NCT02152605|long-acting muscarinic antagonist|long-acting muscarinic antagonist
237747|NCT02152605|COPD|copd
237748|NCT02152605|umeclidinium|umeclidinium
237749|NCT02152592|Postoperative pain|postoperative pain
237750|NCT02152592|Ambulatory surgery|ambulatory surgery
237751|NCT02152592|NSAIDS|nsaids
237752|NCT02152592|CR Oxycodone|cr oxycodone
237753|NCT02152592|Compliance to study medication|compliance to study medication
237754|NCT02152579|Stable Angina|stable angina
237755|NCT02152553|Biomarker|biomarker
237756|NCT02152553|Glucocorticoids|glucocorticoids
237757|NCT02152553|Metabolism|metabolism
237758|NCT02152553|Pharmacology|pharmacology
237759|NCT02152553|Metabolomics|metabolomics
237760|NCT02152540|TBI|tbi
237761|NCT02152540|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
237762|NCT02152540|magnetic resonance imaging functional|magnetic resonance imaging functional
237763|NCT02152540|Quality of life|quality of life
237764|NCT02152540|Executive Function|executive function
237765|NCT02152540|Veterans|veterans
237766|NCT02152501|obese|obese
237767|NCT02152501|overweight|overweight
237768|NCT02152501|exercise|exercise
237769|NCT02152501|energy expenditure differences|energy expenditure differences
237770|NCT02152501|relative reinforcing values (RRV)|relative reinforcing values (rrv)
237771|NCT02152501|food|food
237772|NCT02152501|physical activity|physical activity
237773|NCT02152501|biological|biological
237774|NCT02152501|neurobehavioral|neurobehavioral
237775|NCT02152501|behavioral|behavioral
237776|NCT02152488|cerebral blood flow|cerebral blood flow
237777|NCT02152488|position|position
237778|NCT02152488|cervical spine|cervical spine
237779|NCT02152475|Blue-LED|blue-led
237780|NCT02152475|Curcumin|curcumin
237781|NCT02152475|PDT|pdt
237782|NCT02152475|Oral disinfection|oral disinfection
237783|NCT02152462|exergaming|exergaming
237784|NCT02152462|breast cancer|breast cancer
237987|NCT02151422|age 18-65|age 18-65
237785|NCT02152462|African American women|african american women
237786|NCT02152462|obesity|obesity
237787|NCT02152423|enoxaparin|enoxaparin
237788|NCT02152423|Enoxamed|enoxamed
237789|NCT02152423|lovenox|lovenox
237790|NCT02152423|anti Xa|anti xa
237791|NCT02152423|acute coronary syndrome|acute coronary syndrome
237792|NCT02152410|acupuncture|acupuncture
237793|NCT02152410|renal colic|renal colic
237794|NCT02152358|Cytomegalovirus|cytomegalovirus
237795|NCT02152358|Herpes simplex virus|herpes simplex virus
237796|NCT02152358|ICU|icu
237797|NCT02152358|mechanical ventilation|mechanical ventilation
237798|NCT02152358|mortality|mortality
237799|NCT02152358|ventilator-free days|ventilator-free days
237800|NCT02152358|PCR|pcr
237801|NCT02152345|kidney|kidney
237802|NCT02152345|renal|renal
237803|NCT02152345|transplant|transplant
237804|NCT02152345|belatacept|belatacept
237805|NCT02152345|delayed graft function|delayed graft function
237806|NCT02152345|thymoglobulin|thymoglobulin
237807|NCT02152345|tacrolimus|tacrolimus
237808|NCT02152345|kidney function|kidney function
237809|NCT02152345|immunosuppression|immunosuppression
237810|NCT02152345|NGAL|ngal
237811|NCT02152332|JNJ-54861912|jnj-54861912
237812|NCT02152332|RSC-385896|rsc-385896
237813|NCT02152332|MTS-0385896A|mts-0385896a
237814|NCT02152332|Phase 1|phase 1
237815|NCT02152332|Moxifloxacin|moxifloxacin
237816|NCT02152332|Placebo|placebo
237817|NCT02152332|Healthy|healthy
237818|NCT02152319|Parkinson's disease|parkinson's disease
237819|NCT02152319|Telemedicine|telemedicine
237820|NCT02152319|Telehealth|telehealth
237821|NCT02152319|Kinesia|kinesia
237822|NCT02152319|Tremor|tremor
237823|NCT02152319|Bradykinesia|bradykinesia
237824|NCT02152319|Dyskinesia|dyskinesia
237825|NCT02152306|Fimasartan|fimasartan
237826|NCT02152306|Fimasartan and Amlodipine|fimasartan and amlodipine
237827|NCT02152306|Antihypertension|antihypertension
237828|NCT02152267|Temporomandibular|temporomandibular
237829|NCT02152267|Musculoskeletal Diseases|musculoskeletal diseases
237830|NCT02152267|Electrical Stimulation of the Brain|electrical stimulation of the brain
237831|NCT02152267|Prefrontal Cortex|prefrontal cortex
237832|NCT02152254|Metastatic Cancer|metastatic cancer
237833|NCT02152254|Molecular Profiling|molecular profiling
237834|NCT02152254|Genomic alteration analysis of the tumor|genomic alteration analysis of the tumor
237835|NCT02152254|Advanced Cancer Therapy|advanced cancer therapy
237836|NCT02152254|Gene mutations|gene mutations
237837|NCT02152254|Tumor biopsy|tumor biopsy
237838|NCT02152254|Personalized medicine|personalized medicine
237839|NCT02152241|IBD|ibd
237840|NCT02152241|Crohn|crohn
237841|NCT02152241|Colitis|colitis
237842|NCT02152241|Function|function
237843|NCT02152176|pain|pain
237844|NCT02152176|analgesia|analgesia
237845|NCT02152176|morphine|morphine
237846|NCT02152176|PCA|pca
237847|NCT02152176|Nurse|nurse
237848|NCT02152163|Assessing the efficacy of IV Ibuprofen for Treatment of Pain in Orthopedic Trauma Patients|assessing the efficacy of iv ibuprofen for treatment of pain in orthopedic trauma patients
237849|NCT02152150|iron|iron
237850|NCT02152150|anemia|anemia
237851|NCT02152150|bio-fortification|bio-fortification
237852|NCT02152150|children|children
237853|NCT02152150|India|india
237854|NCT02152124|Acromegaly|acromegaly
237855|NCT02152124|Acromegaly treatment|acromegaly treatment
237856|NCT02152124|Long-acting somatostatin analogs|long-acting somatostatin analogs
237857|NCT02152124|Pegvisomant|pegvisomant
237858|NCT02152124|Insulin sensitivity|insulin sensitivity
237859|NCT02152124|Gut hormones|gut hormones
237860|NCT02152124|Lipid metabolism|lipid metabolism
237861|NCT02152124|Adipokines|adipokines
237862|NCT02152111|Obesity|obesity
237863|NCT02152111|Coconut flour|coconut flour
237864|NCT02152111|Diet quality|diet quality
237865|NCT02152111|Cardiovascular risk factor|cardiovascular risk factor
237866|NCT02152085|Walking|walking
237867|NCT02152085|Mobility|mobility
238241|NCT02150148|Hodgkin lymphoma|hodgkin lymphoma
237868|NCT02152085|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
237869|NCT02152085|Multiple sclerosis|multiple sclerosis
237870|NCT02152059|Small cell lung cancer|small cell lung cancer
237871|NCT02152059|BIBF1120|bibf1120
237872|NCT02152059|nintedanib|nintedanib
237873|NCT02152059|platinum-sensitive|platinum-sensitive
237874|NCT02152033|Substance Abuse|substance abuse
237875|NCT02152033|Continuing Care|continuing care
237876|NCT02152033|Recovery|recovery
237877|NCT02152033|Substance Abuse Treatment|substance abuse treatment
237878|NCT02152033|Parent|parent
237879|NCT02152033|Family|family
237880|NCT02152033|Young Adult|young adult
237881|NCT02152007|pachyonychia congenita|pachyonychia congenita
237882|NCT02151994|BIA 5-1058|bia 5-1058
237883|NCT02151994|hypertension|hypertension
237884|NCT02151994|chronic heart failure|chronic heart failure
237885|NCT02151994|cardiovascular disorders|cardiovascular disorders
237886|NCT02151981|Advanced Non-Small Cell Lung Cancer; T790M Mutation Positive|advanced non-small cell lung cancer; t790m mutation positive
237887|NCT02151942|elective endovascular AAA repair|elective endovascular aaa repair
237888|NCT02151929|myocardial infarction|myocardial infarction
237889|NCT02151929|primary PCI|primary pci
237890|NCT02151929|stent|stent
237891|NCT02151916|dental caries|dental caries
237892|NCT02151916|early childhood caries|early childhood caries
237893|NCT02151916|topical fluorides|topical fluorides
237894|NCT02151916|fluoride varnish|fluoride varnish
237895|NCT02151903|NHL|nhl
237896|NCT02151903|Immunocytokine|immunocytokine
237897|NCT02151903|Lymphoma|lymphoma
237898|NCT02151903|Non-Hodgkin|non-hodgkin
237899|NCT02151903|B-cell|b-cell
237900|NCT02151903|IL (interleukin)|il (interleukin)
237901|NCT02151890|POF|pof
237902|NCT02151890|ESS|ess
237903|NCT02151890|stem cell|stem cell
237904|NCT02151877|Ischemia/reperfusion injury|ischemia/reperfusion injury
237905|NCT02151864|liver cancer|liver cancer
237906|NCT02151864|cirrhosis|cirrhosis
237907|NCT02151864|Child-Pugh A|child-pugh a
237908|NCT02151864|Hedgehog|hedgehog
237909|NCT02151851|Rheumatoid Arthritis|rheumatoid arthritis
237910|NCT02151851|TNFα antagonist|tnfα antagonist
237911|NCT02151851|Certolizumab Pegol|certolizumab pegol
237912|NCT02151851|Chinese patients|chinese patients
237913|NCT02151838|HIV-infected pregnant women who request HAART from the TRCSPMTCT|hiv-infected pregnant women who request haart from the trcspmtct
237914|NCT02151825|Gut microbiota|gut microbiota
237915|NCT02151825|Probiotics|probiotics
237916|NCT02151825|Prebiotics|prebiotics
237917|NCT02151825|Synbiotic|synbiotic
237918|NCT02151825|Bifidobacterium lactis BB-12|bifidobacterium lactis bb-12
237919|NCT02151825|Lactobacillus acidophilus LA-5|lactobacillus acidophilus la-5
237920|NCT02151825|Lactobacillus casei 431|lactobacillus casei 431
237921|NCT02151825|Inulin|inulin
237922|NCT02151825|GOS|gos
237923|NCT02151825|Body Weight|body weight
237924|NCT02151825|Overweight|overweight
237925|NCT02151825|Adiposity|adiposity
237926|NCT02151825|Obesity|obesity
237927|NCT02151825|ANGPTL4|angptl4
237928|NCT02151786|Pharmacological therapy|pharmacological therapy
237929|NCT02151773|Pharmacological therapy|pharmacological therapy
237930|NCT02151760|Metastatic Prostate Cancer|metastatic prostate cancer
237931|NCT02151747|breast neoplasms, BRCA1, Sanger, NGS, Next generation sequencing|breast neoplasms, brca1, sanger, ngs, next generation sequencing
237932|NCT02151721|Vorinostat|vorinostat
237933|NCT02151721|Gefitinib|gefitinib
237934|NCT02151721|BIM polymorphism|bim polymorphism
237935|NCT02151721|EGFR-TKI resistance|egfr-tki resistance
237936|NCT02151708|accommodation, emptying,motilitone|accommodation, emptying,motilitone
237937|NCT02151682|chronic pain|chronic pain
237938|NCT02151682|opioid|opioid
237939|NCT02151669|Mediterranean diet|mediterranean diet
237940|NCT02151669|Smoking/tobacco|smoking/tobacco
237941|NCT02151669|Spirometry|spirometry
237942|NCT02151656|Schizophrenia|schizophrenia
237943|NCT02151656|Mental disorders|mental disorders
237944|NCT02151656|Antipsychotic Drugs|antipsychotic drugs
237945|NCT02151643|Dialysis Dependent Chronic Kidney Disease|dialysis dependent chronic kidney disease
237946|NCT02151630|wart|wart
237947|NCT02151630|verruca vulgaris|verruca vulgaris
237948|NCT02151630|topical therapy|topical therapy
237949|NCT02151630|pyruvic acid|pyruvic acid
237950|NCT02151630|salicylic acid|salicylic acid
237951|NCT02151617|Multiple dose|multiple dose
237952|NCT02151617|safety|safety
237953|NCT02151617|tolerability|tolerability
237954|NCT02151617|PK|pk
237955|NCT02151591|Quit smoking|quit smoking
237956|NCT02151591|Quit drinking|quit drinking
237957|NCT02151578|Impact of home management of malaria and pneumonia on child mortality|impact of home management of malaria and pneumonia on child mortality
237958|NCT02151578|home management of malaria and pneumonia|home management of malaria and pneumonia
237959|NCT02151565|back pain|back pain
237960|NCT02151565|sciatica|sciatica
237961|NCT02151565|electrotherapy|electrotherapy
237962|NCT02151565|HTEMS|htems
237963|NCT02151565|TENS|tens
237964|NCT02151552|lung inflammation|lung inflammation
237965|NCT02151552|positron emission tomography|positron emission tomography
237966|NCT02151552|inducible nitric oxide synthase|inducible nitric oxide synthase
237967|NCT02151513|Cancer-associated pain|cancer-associated pain
237968|NCT02151513|Immune function|immune function
237969|NCT02151500|Medically Unexplained Symptoms (MUPS)|medically unexplained symptoms (mups)
237970|NCT02151500|Somatoform disorders|somatoform disorders
237971|NCT02151500|Chronic pain|chronic pain
237972|NCT02151500|Somatic symptoms|somatic symptoms
237973|NCT02151500|Emotional processing|emotional processing
237974|NCT02151500|Primary Care|primary care
237975|NCT02151487|Supraclavicular block|supraclavicular block
237976|NCT02151487|Ropivacaine|ropivacaine
237977|NCT02151487|Dexamethasone|dexamethasone
237978|NCT02151487|Clonidine|clonidine
237979|NCT02151461|Diabetes|diabetes
237980|NCT02151461|Type 2 Diabetes|type 2 diabetes
237981|NCT02151435|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
237982|NCT02151435|Biomarkers|biomarkers
237983|NCT02151435|Forced Vital Capacity|forced vital capacity
237984|NCT02151435|Diffusion Capacity for Carbon Monoxide|diffusion capacity for carbon monoxide
237985|NCT02151435|Prognosis|prognosis
237986|NCT02151422|Adults|adults
237988|NCT02151422|physician-diagnosed|physician-diagnosed
237989|NCT02151422|persistent asthma|persistent asthma
237990|NCT02151396|ADHD, hyperactivity, inattention, working memory|adhd, hyperactivity, inattention, working memory
237991|NCT02151383|Acute heart failure,|acute heart failure,
237992|NCT02151383|RELAX−AHF−PEDIATRIC PK|relax−ahf−pediatric pk
237993|NCT02151357|first in man|first in man
237994|NCT02151357|dose escalating|dose escalating
237995|NCT02151357|MTD|mtd
237996|NCT02151357|DLT|dlt
237997|NCT02151331|Chronic care model|chronic care model
237998|NCT02151331|Mood disorders|mood disorders
237999|NCT02151331|Adaptive implementation|adaptive implementation
238000|NCT02151279|Shrimp allergy|shrimp allergy
238001|NCT02151279|Chitosan|chitosan
238002|NCT02151279|fining agent|fining agent
238003|NCT02151266|Heart failure|heart failure
238004|NCT02151266|Exercise|exercise
238005|NCT02151266|Cognitive training|cognitive training
238006|NCT02151253|Nocturia|nocturia
238007|NCT02151253|Daytime sleepiness|daytime sleepiness
238008|NCT02151240|herpes zoster, Foscarnet Sodium, Acyclovir, Postherpetic neuralgia|herpes zoster, foscarnet sodium, acyclovir, postherpetic neuralgia
238009|NCT02151227|Meta-Analysis|meta-analysis
238010|NCT02151227|Metabolic Syndrome|metabolic syndrome
238011|NCT02151227|Magnesium|magnesium
238012|NCT02151227|Dose Response Effect|dose response effect
238013|NCT02151227|Systematic Review|systematic review
238014|NCT02151214|Palliative Phase of Cancer|palliative phase of cancer
238015|NCT02151214|Quality of life|quality of life
238016|NCT02151214|Parenteral nutrition|parenteral nutrition
238017|NCT02151214|Undernutrition|undernutrition
238018|NCT02151201|pregnancy vaccination influenza education|pregnancy vaccination influenza education
238019|NCT02151149|NSCLC advanced non-small cell lung cancer squamous adenocarcinoma large cell carcinoma lung cancer elderly first line treatment abraxane carbo nab-paclitaxel|nsclc advanced non-small cell lung cancer squamous adenocarcinoma large cell carcinoma lung cancer elderly first line treatment abraxane carbo nab-paclitaxel
238020|NCT02151136|Sucrose|sucrose
238021|NCT02151136|Pain|pain
238022|NCT02151123|Colonic Neoplasms|colonic neoplasms
238023|NCT02151123|Colon Cancer|colon cancer
238024|NCT02151123|Microbiome|microbiome
238025|NCT02151110|Healthy Male|healthy male
238026|NCT02151110|Healthy Female of non child bearing potential|healthy female of non child bearing potential
238027|NCT02151097|Prostatectomy|prostatectomy
238028|NCT02151097|Prostate cancer|prostate cancer
238029|NCT02151097|Cerenkov Luminescence Imaging|cerenkov luminescence imaging
238030|NCT02151084|randomized|randomized
238031|NCT02151084|selumetinib|selumetinib
238032|NCT02151084|tablets|tablets
238033|NCT02151084|cisplatin|cisplatin
238034|NCT02151084|gemcitabine|gemcitabine
238035|NCT02151084|non-resectable|non-resectable
238036|NCT02151084|recurrent|recurrent
238037|NCT02151084|metstatic|metstatic
238038|NCT02151071|Breast Cancer|breast cancer
238039|NCT02151071|Mastectomy, Segmental|mastectomy, segmental
238040|NCT02151071|Breast Conserving Surgery|breast conserving surgery
238041|NCT02151071|Cerenkov Luminescence Imaging|cerenkov luminescence imaging
238042|NCT02151071|Beta particle detection|beta particle detection
238043|NCT02151058|Staining|staining
238044|NCT02151058|Intensity|intensity
238045|NCT02151058|Area|area
238046|NCT02151045|Epidural infiltration of Corticoids|epidural infiltration of corticoids
238047|NCT02151045|L3-L4 stage|l3-l4 stage
238048|NCT02151045|On contact of disco radicular conflict|on contact of disco radicular conflict
238049|NCT02151045|Scan control|scan control
238050|NCT02151032|Colorectal Cancer|colorectal cancer
238051|NCT02151032|Colorectal cancer screening|colorectal cancer screening
238052|NCT02151032|Multimedia|multimedia
238053|NCT02151032|Booklet|booklet
238054|NCT02151032|Pamphlet|pamphlet
238055|NCT02151032|Audio CD|audio cd
238056|NCT02151032|Video with animated images|video with animated images
238057|NCT02151032|Video with non-moving images|video with non-moving images
238058|NCT02151032|Questionnaires|questionnaires
238059|NCT02151032|Surveys|surveys
238060|NCT02151006|DHEA|dhea
238061|NCT02151006|IVF|ivf
238062|NCT02151006|ICSI|icsi
238063|NCT02150993|Africa|africa
238064|NCT02150993|Antiretroviral Treatment|antiretroviral treatment
238065|NCT02150993|HIV-2|hiv-2
238066|NCT02150993|firsts line ART|firsts line art
238067|NCT02150993|Adults|adults
238068|NCT02150980|Fractures|fractures
238069|NCT02150980|burden of fractures|burden of fractures
238070|NCT02150980|orthopaedic fractures|orthopaedic fractures
238071|NCT02150980|orthopaedic injuries|orthopaedic injuries
238072|NCT02150980|orthopaedic trauma|orthopaedic trauma
238073|NCT02150980|observational study|observational study
238074|NCT02150980|outcomes of fracture care|outcomes of fracture care
238075|NCT02150980|epidemiology|epidemiology
238076|NCT02150967|cholangiocarcinoma,|cholangiocarcinoma,
238077|NCT02150967|FGFR2 gene fusion,|fgfr2 gene fusion,
238078|NCT02150967|FGFR genetic alteration|fgfr genetic alteration
238079|NCT02150954|induction of labor|induction of labor
238080|NCT02150954|pitocin|pitocin
238081|NCT02150954|foley bulb|foley bulb
238082|NCT02150941|Upper gastrointestinal tract|upper gastrointestinal tract
238083|NCT02150941|Endoscopy|endoscopy
238084|NCT02150941|Endoscopic Hemostasis|endoscopic hemostasis
238085|NCT02150915|Acupoints|acupoints
238086|NCT02150915|Acupuncture therapy|acupuncture therapy
238087|NCT02150915|Median nerve|median nerve
238088|NCT02150915|Biomechanics|biomechanics
238089|NCT02150902|Catheter ablation for atrial fibrillation|catheter ablation for atrial fibrillation
238090|NCT02150902|treatment for atrial fibrillation|treatment for atrial fibrillation
238091|NCT02150902|comparison of catheter ablation techniques for atrial fibrillation|comparison of catheter ablation techniques for atrial fibrillation
238092|NCT02150889|insulin resistance|insulin resistance
238093|NCT02150889|lipid metabolism|lipid metabolism
238094|NCT02150889|diabetes|diabetes
238095|NCT02150876|DES|des
238096|NCT02150876|SDF|sdf
238097|NCT02150876|MACE|mace
238098|NCT02150876|SYNERGY|synergy
238099|NCT02150863|actinic keratosis|actinic keratosis
238100|NCT02150863|field cancerization|field cancerization
238101|NCT02150863|organ transplant patients|organ transplant patients
238102|NCT02150850|Femoral Fractures|femoral fractures
238103|NCT02150850|Subtrochanteric Fractures|subtrochanteric fractures
238104|NCT02150850|Osteoporotic Fractures|osteoporotic fractures
238105|NCT02150850|Fractures, Spontaneous|fractures, spontaneous
238106|NCT02150850|Stress Fractures|stress fractures
238107|NCT02150850|Bone Fractures|bone fractures
238108|NCT02150850|Hip Fractures|hip fractures
238109|NCT02150850|Osteoporosis|osteoporosis
238110|NCT02150837|Obesity|obesity
238111|NCT02150837|Weight Loss|weight loss
238112|NCT02150837|Meal replacements|meal replacements
238113|NCT02150837|Weight maintenance|weight maintenance
238114|NCT02150798|Diet Therapy|diet therapy
238115|NCT02150798|Diet, Carbohydrate Restricted|diet, carbohydrate restricted
238116|NCT02150798|Fatty Acids, Omega 3|fatty acids, omega 3
238117|NCT02150798|Oximetry|oximetry
238118|NCT02150798|phase angle|phase angle
238119|NCT02150798|Triglycerides, blood|triglycerides, blood
238120|NCT02150798|Lipids, blood|lipids, blood
238121|NCT02150798|Hand Strength|hand strength
238122|NCT02150798|Body Composition|body composition
238123|NCT02150798|Electric Impedance|electric impedance
238124|NCT02150785|Thrombolysis|thrombolysis
238125|NCT02150785|Safety of Streptokinase|safety of streptokinase
238126|NCT02150785|tissue plasminogen activator tPA|tissue plasminogen activator tpa
238127|NCT02150785|Stroke treatment|stroke treatment
238128|NCT02150759|Dexmedetomidine|dexmedetomidine
238129|NCT02150759|Ketamine|ketamine
238130|NCT02150759|Pain|pain
238131|NCT02150746|Pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
238132|NCT02150746|Pancreatic cancer|pancreatic cancer
238133|NCT02150746|PDAC|pdac
238134|NCT02150746|Circulating tumor cells|circulating tumor cells
238135|NCT02150720|Hip fractures|hip fractures
238136|NCT02150720|Clinical Trial|clinical trial
238137|NCT02150720|Randomized|randomized
238138|NCT02150720|Fibrin glue|fibrin glue
238139|NCT02150720|Tranexamic acid|tranexamic acid
238140|NCT02150720|Blood loss|blood loss
238141|NCT02150681|preconception|preconception
238142|NCT02150681|pregnancy|pregnancy
238143|NCT02150681|postpartum|postpartum
238144|NCT02150681|women|women
238145|NCT02150668|ADHD|adhd
238146|NCT02150668|Homework|homework
238147|NCT02150668|School|school
238148|NCT02150668|Organization|organization
238149|NCT02150668|Time-management|time-management
238150|NCT02150616|Pulmonary hypertension|pulmonary hypertension
238151|NCT02150616|Interstitial lung disease|interstitial lung disease
238152|NCT02150616|Pulmonary fibrosis|pulmonary fibrosis
238153|NCT02150603|Heart defects, congenital|heart defects, congenital
238154|NCT02150603|Patient-reported outcomes|patient-reported outcomes
238155|NCT02150603|Health status|health status
238156|NCT02150603|Factors, psychosocial|factors, psychosocial
238157|NCT02150603|Health behavior|health behavior
238158|NCT02150603|Quality of life|quality of life
238159|NCT02150603|Sense of coherence|sense of coherence
238160|NCT02150603|Illness perceptions|illness perceptions
238161|NCT02150603|Depression|depression
238162|NCT02150603|Anxiety|anxiety
238163|NCT02150590|airway disease|airway disease
238164|NCT02150590|bronchitis|bronchitis
238165|NCT02150590|emphysema|emphysema
238166|NCT02150590|lung|lung
238167|NCT02150577|Screening|screening
238168|NCT02150577|Mood Stabilizers|mood stabilizers
238169|NCT02150577|Computer delivered psychotherapy|computer delivered psychotherapy
238170|NCT02150577|Peer Support|peer support
238171|NCT02150577|Telepsychiatry|telepsychiatry
238172|NCT02150577|Implementation|implementation
238173|NCT02150577|Rural|rural
238174|NCT02150564|Malignant gliomas|malignant gliomas
238175|NCT02150564|Sono RCT|sono rct
238176|NCT02150551|Crohn disease|crohn disease
238177|NCT02150551|ulcerative colitis|ulcerative colitis
238178|NCT02150551|mesenchymal stromal cells|mesenchymal stromal cells
238179|NCT02150551|inflammatory bowel diseases|inflammatory bowel diseases
238180|NCT02150538|Cardiac Resynchronization therapy|cardiac resynchronization therapy
238181|NCT02150538|Minimized Right ventricular pacing|minimized right ventricular pacing
238182|NCT02150538|Prolonged AV conduction|prolonged av conduction
238183|NCT02150525|breast cancer|breast cancer
238184|NCT02150525|vaginal dryness|vaginal dryness
238185|NCT02150525|dyspareunia|dyspareunia
238186|NCT02150525|genital irritation|genital irritation
238187|NCT02150512|Septic shock|septic shock
238188|NCT02150512|Critically ill patients|critically ill patients
238189|NCT02150512|Transpulmonary thermodilution|transpulmonary thermodilution
238190|NCT02150512|Fluid resuscitation|fluid resuscitation
238191|NCT02150499|Acute Asthma exacerbation|acute asthma exacerbation
238192|NCT02150473|rheumatoid Arthritis|rheumatoid arthritis
238193|NCT02150460|ophthalmic surgery, peribulbar local anaesthesia|ophthalmic surgery, peribulbar local anaesthesia
238194|NCT02150447|Gastric cancer bleeding|gastric cancer bleeding
238195|NCT02150447|Proton pump inhibitor|proton pump inhibitor
238196|NCT02150434|Oxygen therapy|oxygen therapy
238197|NCT02150434|Hypoxemia|hypoxemia
238198|NCT02150434|COPD|copd
238199|NCT02150434|Closed-loop|closed-loop
238200|NCT02150434|Automated titration,|automated titration,
238201|NCT02150382|hypertension|hypertension
238202|NCT02150382|rural|rural
238203|NCT02150382|China|china
238204|NCT02150382|protocol-based treatment|protocol-based treatment
238205|NCT02150343|Cat allergy|cat allergy
238206|NCT02150343|Rhinoconjunctivitis|rhinoconjunctivitis
238207|NCT02150330|Dehydroepiandrosterone|dehydroepiandrosterone
238208|NCT02150330|DHEAS|dheas
238209|NCT02150330|Gene expression of cumulus cells.|gene expression of cumulus cells.
238210|NCT02150330|Folliculogenesis.|folliculogenesis.
238211|NCT02150330|Oocyte maturation.|oocyte maturation.
238212|NCT02150330|Ovarian hyper-stimulation protocol.|ovarian hyper-stimulation protocol.
238213|NCT02150330|Artificial reproduction technology.|artificial reproduction technology.
238214|NCT02150317|Carcinoma, Hepatocellular|carcinoma, hepatocellular
238215|NCT02150317|Chemoembolization, Therapeutic|chemoembolization, therapeutic
238216|NCT02150317|Sorafenib|sorafenib
238217|NCT02150278|Driving|driving
238218|NCT02150278|Alcohol consumption|alcohol consumption
238219|NCT02150278|Risk perception|risk perception
238220|NCT02150252|Clinical trial|clinical trial
238221|NCT02150252|Ischemic stroke|ischemic stroke
238222|NCT02150252|Bu-Yang-Huan-Wu Tang (BYHWT）|bu-yang-huan-wu tang (byhwt）
238223|NCT02150252|Gait parameter|gait parameter
238224|NCT02150252|Quality of life|quality of life
238225|NCT02150239|pain|pain
238226|NCT02150239|postoperative|postoperative
238227|NCT02150213|Adrenocortical Adenoma,|adrenocortical adenoma,
238228|NCT02150213|Endometrial Stromal sarcomas|endometrial stromal sarcomas
238229|NCT02150213|BGG492|bgg492
238230|NCT02150187|Androgenetic Alopecia|androgenetic alopecia
238231|NCT02150187|Male|male
238232|NCT02150187|Baldness|baldness
238233|NCT02150187|hair loss pattern|hair loss pattern
238234|NCT02150174|Schizophrenia|schizophrenia
238235|NCT02150174|Episodic memory deficits|episodic memory deficits
238236|NCT02150148|breast cancer|breast cancer
238237|NCT02150148|prostate cancer|prostate cancer
238238|NCT02150148|colorectal cancer|colorectal cancer
238239|NCT02150148|small intestine cancer|small intestine cancer
238240|NCT02150148|thyroid cancer|thyroid cancer
238242|NCT02150148|non-Hodgkin lymphoma|non-hodgkin lymphoma
238243|NCT02150148|endometrial cancer|endometrial cancer
238244|NCT02150148|kidney cancer|kidney cancer
238245|NCT02150148|cervical cancer|cervical cancer
238246|NCT02150148|diet|diet
238247|NCT02150148|exercise|exercise
238248|NCT02150148|physical activity|physical activity
238249|NCT02150148|garden|garden
238250|NCT02150135|Pancreatic cancer|pancreatic cancer
238251|NCT02150135|Quality of life|quality of life
238252|NCT02150135|Pain|pain
238253|NCT02150122|Vitamin D|vitamin d
238254|NCT02150122|Serum 25-hydroxyvitamin D (25OHD)|serum 25-hydroxyvitamin d (25ohd)
238255|NCT02150122|Adolescents|adolescents
238256|NCT02150096|chronic non-specific low back pain|chronic non-specific low back pain
238257|NCT02150096|clinical trial|clinical trial
238258|NCT02150096|disability|disability
238259|NCT02150096|women|women
238260|NCT02150083|midurethral sling|midurethral sling
238261|NCT02150083|voiding study|voiding study
238262|NCT02150083|voiding trial|voiding trial
238263|NCT02150083|retrograde voiding trial|retrograde voiding trial
238264|NCT02150070|Healthy subjects|healthy subjects
238265|NCT02150070|ASP2408|asp2408
238266|NCT02150070|Rheumatoid arthritis|rheumatoid arthritis
238267|NCT02150070|Safety and Tolerability|safety and tolerability
238268|NCT02150070|Pharmacokinetics|pharmacokinetics
238269|NCT02150057|knee osteoarthritis unicompartmental unloading brace|knee osteoarthritis unicompartmental unloading brace
238270|NCT02150031|prevention and control|prevention and control
238271|NCT02150031|chlorhexidine|chlorhexidine
238272|NCT02150031|therapeutic irrigation|therapeutic irrigation
238273|NCT02150031|mouthwashes|mouthwashes
238274|NCT02150031|culture|culture
238275|NCT02150018|- Critical Care|- critical care
238276|NCT02150018|Non invasive ventilation|non invasive ventilation
238277|NCT02150018|Electrical impedance tomography|electrical impedance tomography
238278|NCT02150018|End expiratory lung volume|end expiratory lung volume
238279|NCT02150018|End expiratory lung impedance|end expiratory lung impedance
238280|NCT02150005|periodontal diseases|periodontal diseases
238281|NCT02150005|cardiovascular diseases|cardiovascular diseases
238282|NCT02150005|periodontitis treatment|periodontitis treatment
238283|NCT02149992|gestational diabetes|gestational diabetes
238284|NCT02149992|myoinositol|myoinositol
238285|NCT02149979|Incision|incision
238286|NCT02149979|Wound Closure|wound closure
238287|NCT02149979|Laser Tissue Soldering|laser tissue soldering
238288|NCT02149966|safety and tolerability|safety and tolerability
238289|NCT02149966|pharmacokinetic study|pharmacokinetic study
238290|NCT02149953|Pregnancy|pregnancy
238291|NCT02149953|Glycine requirements|glycine requirements
238292|NCT02149953|Indicator Amino Acid Oxidation (IAAO) method|indicator amino acid oxidation (iaao) method
238293|NCT02149953|Stable isotopes|stable isotopes
238294|NCT02149940|Elderly|elderly
238295|NCT02149940|Frailty|frailty
238296|NCT02149940|Polypharmacy|polypharmacy
238297|NCT02149940|Medication review|medication review
238298|NCT02149940|Clinical pharmacy services|clinical pharmacy services
238299|NCT02149927|EEG|eeg
238300|NCT02149927|fMRI|fmri
238301|NCT02149927|connectivity|connectivity
238302|NCT02149927|sevoflurane|sevoflurane
238303|NCT02149914|Ryodoraku|ryodoraku
238304|NCT02149914|Meridian energy|meridian energy
238305|NCT02149914|Heart rate variability|heart rate variability
238306|NCT02149914|Autonomic Nervous System|autonomic nervous system
238307|NCT02149914|GERD|gerd
238308|NCT02149901|Pure Autonomic Failure|pure autonomic failure
238309|NCT02149901|Multiple System Atrophy|multiple system atrophy
238310|NCT02149901|Pseudoephedrine|pseudoephedrine
238311|NCT02149901|Water|water
238312|NCT02149901|Osmopressor|osmopressor
238313|NCT02149888|HIV|hiv
238314|NCT02149888|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
238315|NCT02149888|PrEP|prep
238316|NCT02149888|Human Immunodeficiency Virus|human immunodeficiency virus
238317|NCT02149875|Acute ischemic stroke|acute ischemic stroke
238318|NCT02149875|Dl-3-n-butylphthalide|dl-3-n-butylphthalide
238319|NCT02149875|Cerebrolysin|cerebrolysin
238320|NCT02149862|Bladder cancer|bladder cancer
238321|NCT02149862|Diagnostic|diagnostic
238322|NCT02149862|Infrared|infrared
238323|NCT02149862|Spectrum|spectrum
238324|NCT02149862|Urina|urina
238325|NCT02149862|Patients with an indication of partial or total bladder resection|patients with an indication of partial or total bladder resection
238326|NCT02149862|or|or
238327|NCT02149862|"Lithiasic patients should be operated a urinary calculation, without catheter double J"|"lithiasic patients should be operated a urinary calculation, without catheter double j"
238328|NCT02149849|Ipsilateral shoulder pain|ipsilateral shoulder pain
238329|NCT02149849|Surgical positioning|surgical positioning
238330|NCT02149849|Lung cancer|lung cancer
238331|NCT02149849|Thoracotomy|thoracotomy
238332|NCT02149849|Video assisted thoracic surgery|video assisted thoracic surgery
238333|NCT02149836|major depressive disorder|major depressive disorder
238334|NCT02149836|depression|depression
238335|NCT02149836|treatment resistent depression|treatment resistent depression
238336|NCT02149823|Oxytocin, Social Cognition|oxytocin, social cognition
238337|NCT02149823|Borderline Personality Disorder|borderline personality disorder
238338|NCT02149823|Schizotypal Personality Disorder|schizotypal personality disorder
238339|NCT02149823|Social Cognition|social cognition
238340|NCT02149823|BPD|bpd
238341|NCT02149823|SPD|spd
238342|NCT02149823|MASC|masc
238343|NCT02149823|Autism Spectrum Disorder|autism spectrum disorder
238344|NCT02149823|Schizophrenia|schizophrenia
238345|NCT02149823|Schizoaffective Disorder|schizoaffective disorder
238346|NCT02149823|Bipolar Disorder|bipolar disorder
238347|NCT02149810|MDD|mdd
238348|NCT02149784|Metastasis colorectal cancer|metastasis colorectal cancer
238349|NCT02149784|Chemotherapy|chemotherapy
238350|NCT02149784|Resection of primary tumor|resection of primary tumor
238351|NCT02149771|hepatocellular carcinoma|hepatocellular carcinoma
238352|NCT02149771|portal vein tumor thrombosis|portal vein tumor thrombosis
238353|NCT02149771|stents|stents
238354|NCT02149771|chemoembolization|chemoembolization
238355|NCT02149758|Cyclooxygenase two inhibitors|cyclooxygenase two inhibitors
238356|NCT02149758|Etoricoxib|etoricoxib
238357|NCT02149758|Periodontitis|periodontitis
238358|NCT02149758|Superoxide dismutase|superoxide dismutase
238359|NCT02149758|Saliva|saliva
238360|NCT02149732|Limbal stem cell deficiency|limbal stem cell deficiency
238361|NCT02149732|Cultivated oral mucosal cell sheet transplantation|cultivated oral mucosal cell sheet transplantation
238362|NCT02149732|Ocular surface reconstruction|ocular surface reconstruction
238363|NCT02149719|Peanut allergy|peanut allergy
238364|NCT02149719|Desensitisation|desensitisation
238365|NCT02149719|Safety|safety
238366|NCT02149706|Secondary Progress Multiple Sclerosis|secondary progress multiple sclerosis
238367|NCT02149706|SPMS|spms
238368|NCT02149706|Multiple Sclerosis|multiple sclerosis
238369|NCT02149706|NeuroVax|neurovax
238370|NCT02149693|Flipped classroom|flipped classroom
238371|NCT02149693|High-fidelity simulation|high-fidelity simulation
238372|NCT02149693|Medical education reform|medical education reform
238373|NCT02149693|Medical teamwork|medical teamwork
238374|NCT02149693|Resuscitation training|resuscitation training
238375|NCT02149680|Post-dural puncture headache|post-dural puncture headache
238376|NCT02149680|epidural blood patch|epidural blood patch
238377|NCT02149680|labour analgesia|labour analgesia
238378|NCT02149680|epidural analgesia|epidural analgesia
238379|NCT02149667|osteoarthritis|osteoarthritis
238380|NCT02149667|avascular necrosis|avascular necrosis
238381|NCT02149667|ankylosis|ankylosis
238382|NCT02149667|protrusio acetabuli|protrusio acetabuli
238383|NCT02149667|painful hip dysplasia|painful hip dysplasia
238384|NCT02149667|rheumatoid arthritis|rheumatoid arthritis
238385|NCT02149667|correction of functional deformity|correction of functional deformity
238386|NCT02149667|revision procedures|revision procedures
238387|NCT02149654|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
238388|NCT02149654|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
238389|NCT02149654|Engager transcatheter aortic valve implantation system|engager transcatheter aortic valve implantation system
238390|NCT02149654|Engager bioprosthesis|engager bioprosthesis
238391|NCT02149615|idiopathic intracranial hypertension|idiopathic intracranial hypertension
238392|NCT02149615|optic disc swelling|optic disc swelling
238393|NCT02149615|antiacne medication|antiacne medication
238394|NCT02149615|isotretinoin|isotretinoin
238395|NCT02149602|involvement of bilateral parapharyngeal spaces|involvement of bilateral parapharyngeal spaces
238396|NCT02149589|ARDS|ards
238397|NCT02149589|PEEP|peep
238398|NCT02149589|Recruitment manoeuvres|recruitment manoeuvres
238399|NCT02149589|Lung Morphology|lung morphology
238400|NCT02149576|Retrospective Review|retrospective review
238401|NCT02149576|Pilot Study|pilot study
238402|NCT02149576|Early Stage NSCLC|early stage nsclc
238403|NCT02149576|Post-Surgical Surveillance|post-surgical surveillance
238404|NCT02149576|Re-intervention Rates|re-intervention rates
238405|NCT02149550|Plasmodium falciparum|plasmodium falciparum
238406|NCT02149550|malaria|malaria
238407|NCT02149537|sickle cell disease|sickle cell disease
238408|NCT02149537|sickle cell anemia|sickle cell anemia
238409|NCT02149537|hydroxyurea|hydroxyurea
238410|NCT02149537|Nigeria|nigeria
238411|NCT02149537|low income country|low income country
238412|NCT02149537|middle income country|middle income country
238413|NCT02149537|developing country|developing country
238414|NCT02149524|HER2 Positive Breast Cancer|her2 positive breast cancer
238415|NCT02149524|Trastuzumab|trastuzumab
238416|NCT02149524|Biosimilar|biosimilar
238417|NCT02149498|Parkinson|parkinson
238418|NCT02149498|EEG|eeg
238419|NCT02149498|BNA|bna
238420|NCT02149485|PGD,|pgd,
238421|NCT02149485|follow up|follow up
238422|NCT02149459|Radiotherapy|radiotherapy
238423|NCT02149459|Ketosis|ketosis
238424|NCT02149459|Metformin|metformin
238425|NCT02149459|Magnetic Resonance Imaging|magnetic resonance imaging
238426|NCT02149459|Metabolome|metabolome
238427|NCT02149459|Insulin|insulin
238428|NCT02149459|recurrent brain tumors|recurrent brain tumors
238429|NCT02149459|gliomas|gliomas
238430|NCT02149459|glioblastomas|glioblastomas
238431|NCT02149459|astrocytomas|astrocytomas
238432|NCT02149446|Left sided pancreatic resections|left sided pancreatic resections
238433|NCT02149446|Distal pancreatic resections|distal pancreatic resections
238434|NCT02149446|Reinforced staple line|reinforced staple line
238435|NCT02149446|Post operative pancreatic fistula|post operative pancreatic fistula
238436|NCT02149433|Pneumocystis Jiroveci|pneumocystis jiroveci
238437|NCT02149433|Steroids|steroids
238438|NCT02149433|Infants|infants
238439|NCT02149420|primary Sjögren's syndrome, pharmacodynamics|primary sjögren's syndrome, pharmacodynamics
238440|NCT02149394|Thirst|thirst
238441|NCT02149394|Ice|ice
238442|NCT02149394|Water|water
238443|NCT02149394|Perioperative Nursing|perioperative nursing
238444|NCT02149394|Recovery Room|recovery room
238445|NCT02149381|Depression|depression
238446|NCT02149381|treatment as usual|treatment as usual
238447|NCT02149381|CBASP|cbasp
238448|NCT02149381|befriending|befriending
238449|NCT02149355|teeth position|teeth position
238450|NCT02149355|jaw alignment|jaw alignment
238451|NCT02149342|Actinic keratoses|actinic keratoses
238452|NCT02149342|Daylight-PDT|daylight-pdt
238453|NCT02149342|Hexylaminolaevulinate|hexylaminolaevulinate
238454|NCT02149342|HAL|hal
238455|NCT02149342|Methylaminolaevulinate|methylaminolaevulinate
238456|NCT02149342|MAL|mal
238457|NCT02149342|Hyperspectral imaging|hyperspectral imaging
238458|NCT02149329|fever|fever
238459|NCT02149329|neutropenia|neutropenia
238460|NCT02149329|febrile neutropenia|febrile neutropenia
238461|NCT02149329|carbapenem|carbapenem
238462|NCT02149329|imipenem|imipenem
238463|NCT02149329|meropenem|meropenem
238464|NCT02149329|antibiotic stewardship|antibiotic stewardship
238465|NCT02149329|hematology|hematology
238466|NCT02149329|oncology|oncology
238467|NCT02149290|Heart Failure|heart failure
238468|NCT02149290|Six minute walk test|six minute walk test
238469|NCT02149277|Infertility|infertility
238470|NCT02149277|IVF|ivf
238471|NCT02149277|Embryo transfer|embryo transfer
238472|NCT02149251|Pre-genetic diagnosis|pre-genetic diagnosis
238473|NCT02149251|ICSI|icsi
238474|NCT02149238|flavanols|flavanols
238475|NCT02149238|cardiovascular effects|cardiovascular effects
238476|NCT02149238|nutrition-nutrition interaction|nutrition-nutrition interaction
238477|NCT02149225|Actively personalized peptide vaccinations|actively personalized peptide vaccinations
238478|NCT02149225|Newly diagnosed Glioblastoma|newly diagnosed glioblastoma
238479|NCT02149225|Concurrent to first line temozolomide maintenance therapy|concurrent to first line temozolomide maintenance therapy
238480|NCT02149212|Iliac|iliac
238481|NCT02149212|Vein|vein
238482|NCT02149212|Stent|stent
238483|NCT02149160|Histone deacetylase inhibitor|histone deacetylase inhibitor
238484|NCT02149160|Frontotemporal dementia|frontotemporal dementia
238485|NCT02149160|Granulin|granulin
238486|NCT02149147|physical activity|physical activity
238487|NCT02149147|environmental factors|environmental factors
238488|NCT02149147|variety|variety
238489|NCT02149147|MVPA|mvpa
238490|NCT02149095|treprostinil|treprostinil
238491|NCT02149082|Intracranial hematoma|intracranial hematoma
238492|NCT02149082|traumatic brain injury|traumatic brain injury
238493|NCT02149082|Near infrared spectroscopy|near infrared spectroscopy
238494|NCT02149082|NIRS|nirs
238495|NCT02149056|Platelets/Lymphocytes Rate;Serological Index;|platelets/lymphocytes rate;serological index;
238496|NCT02149043|inflammatory bowel disease|inflammatory bowel disease
238497|NCT02149043|ulcerative colitis|ulcerative colitis
238498|NCT02149043|thermography|thermography
238499|NCT02149043|endoscopy|endoscopy
238500|NCT02149043|CRP|crp
238501|NCT02149017|amyloid plaque|amyloid plaque
238502|NCT02149017|Positron-Emission Tomography|positron-emission tomography
238503|NCT02149017|radiopharmaceuticals|radiopharmaceuticals
238504|NCT02149004|Human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
238505|NCT02149004|Prevention|prevention
238506|NCT02149004|Long-term life|long-term life
238507|NCT02149004|Cure|cure
238508|NCT02149004|Cohort|cohort
238509|NCT02148965|motor activity|motor activity
238510|NCT02148965|clinical trials|clinical trials
238511|NCT02148965|pregnancy|pregnancy
238512|NCT02148965|hypertension|hypertension
238513|NCT02148965|cohort studies|cohort studies
238514|NCT02148952|Maternal Health|maternal health
238515|NCT02148952|Maternal Death|maternal death
238516|NCT02148952|Maternal Morbidity|maternal morbidity
238517|NCT02148952|Stillbirth|stillbirth
238518|NCT02148952|Neonatal Mortality|neonatal mortality
238519|NCT02148952|Quality Improvement|quality improvement
238520|NCT02148952|Resource Limited Settings|resource limited settings
238521|NCT02148952|Checklist|checklist
238522|NCT02148952|Safe Childbirth|safe childbirth
238523|NCT02148939|ischemic stroke|ischemic stroke
238524|NCT02148939|Antiplatelet Effects|antiplatelet effects
238525|NCT02148939|aspirin|aspirin
238526|NCT02148939|metamizole|metamizole
238527|NCT02148939|dipyrone|dipyrone
238528|NCT02148900|Marfan syndrome|marfan syndrome
238529|NCT02148900|blood test|blood test
238530|NCT02148900|aortic root size|aortic root size
238531|NCT02148900|Marfan related disorders|marfan related disorders
238532|NCT02148874|pregnant|pregnant
238533|NCT02148874|flu shot|flu shot
238534|NCT02148874|influenza|influenza
238535|NCT02148874|vaccine|vaccine
238536|NCT02148848|Osteoporosis|osteoporosis
238537|NCT02148848|Femoral neck fracture|femoral neck fracture
238538|NCT02148848|hemiarthroplasty|hemiarthroplasty
238539|NCT02148835|Omega-3 Index|omega-3 index
238540|NCT02148835|Bioavailability|bioavailability
238541|NCT02148835|Eicosapentaenoic acid|eicosapentaenoic acid
238542|NCT02148835|Docosahexaenoic acid|docosahexaenoic acid
238543|NCT02148835|Fortified food|fortified food
238544|NCT02148822|Visceral leishmaniasis|visceral leishmaniasis
238545|NCT02148822|kala azar|kala azar
238546|NCT02148822|malnutrition|malnutrition
238547|NCT02148822|stunting|stunting
238548|NCT02148822|thinness|thinness
238549|NCT02148822|Leishmania donovani|leishmania donovani
238550|NCT02148796|Wheezing|wheezing
238551|NCT02148796|Lower respiratory tract illness|lower respiratory tract illness
238552|NCT02148796|Asthma|asthma
238553|NCT02148796|Atopy|atopy
238554|NCT02148783|Traumatic brain injury|traumatic brain injury
238555|NCT02148783|Attention deficit and memory problems|attention deficit and memory problems
238556|NCT02148783|Methylphenidate|methylphenidate
238557|NCT02148783|Dopamine receptor imaging|dopamine receptor imaging
238558|NCT02148783|Motivation and reward|motivation and reward
238559|NCT02148783|Positron emission tomography|positron emission tomography
238560|NCT02148783|Transcranial magnetic stimulation|transcranial magnetic stimulation
238561|NCT02148770|rt-fmri|rt-fmri
238562|NCT02148770|self-control|self-control
238563|NCT02148770|eating behaviour|eating behaviour
238564|NCT02148770|overweight|overweight
238565|NCT02148770|neurofeedback|neurofeedback
238566|NCT02148757|DVT|dvt
238567|NCT02148731|Colon cancer|colon cancer
238568|NCT02148731|Elderly patients|elderly patients
238569|NCT02148718|Crohn's Disease|crohn's disease
238570|NCT02148705|fire/flame|fire/flame
238571|NCT02148705|scalds|scalds
238572|NCT02148705|contact|contact
238573|NCT02148679|Heart Failure|heart failure
238574|NCT02148679|Diet|diet
238575|NCT02148653|Cardiometabolic risk|cardiometabolic risk
238576|NCT02148653|Diet|diet
238577|NCT02148653|Dietary prevention|dietary prevention
238578|NCT02148653|Functional diet|functional diet
238579|NCT02148653|Functional foods|functional foods
238580|NCT02148653|Metabolic Syndrome|metabolic syndrome
238581|NCT02148653|Overweight|overweight
238582|NCT02148627|antibody|antibody
238583|NCT02148627|autoimmune|autoimmune
238584|NCT02148601|Fecal microbiota transplantation|fecal microbiota transplantation
238585|NCT02148601|Recurrent C. difficile infection|recurrent c. difficile infection
238586|NCT02148601|Colonoscopy|colonoscopy
238587|NCT02148601|Randomized clinical trial|randomized clinical trial
238588|NCT02148588|Central Post Stroke Pain|central post stroke pain
238589|NCT02148588|Nerve block|nerve block
238590|NCT02148575|Palliative Care|palliative care
238591|NCT02148575|Self-management|self-management
238592|NCT02148575|Breast Cancer|breast cancer
238593|NCT02148549|Borderline resectable pancreatic cancer|borderline resectable pancreatic cancer
238594|NCT02148549|R0 resection|r0 resection
238595|NCT02148549|Resection rate|resection rate
238596|NCT02148549|Optimal schedule|optimal schedule
238597|NCT02148523|Medication Adherence|medication adherence
238598|NCT02148523|High Blood Pressure|high blood pressure
238599|NCT02148523|Diabetes|diabetes
238600|NCT02148523|Statins|statins
238601|NCT02148510|human|human
238602|NCT02148510|sleep apnea|sleep apnea
238603|NCT02148510|adults|adults
238604|NCT02148510|oral appliance|oral appliance
238605|NCT02148510|efficacy|efficacy
238606|NCT02148510|safety|safety
238607|NCT02148510|polygraphy|polygraphy
238608|NCT02148510|bruxism|bruxism
238609|NCT02148510|cost|cost
238610|NCT02148497|volunteers|volunteers
238611|NCT02148484|PTSD|ptsd
238612|NCT02148484|Cognitive Behavioral Treatment|cognitive behavioral treatment
238613|NCT02148484|Child Sexual Abuse|child sexual abuse
238614|NCT02148471|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
238615|NCT02148471|Steatosis|steatosis
238616|NCT02148471|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
238617|NCT02148458|Intermittent fasting|intermittent fasting
238618|NCT02148458|Mediterranean diet|mediterranean diet
238619|NCT02148458|overweight|overweight
238620|NCT02148458|Calorie restriction|calorie restriction
238621|NCT02148445|smoking cessation|smoking cessation
238622|NCT02148445|tobacco use cessation products|tobacco use cessation products
238623|NCT02148445|nicotine|nicotine
238624|NCT02148432|sleep apnea syndrome, fiberoptic bronchoscopy, IV sedation|sleep apnea syndrome, fiberoptic bronchoscopy, iv sedation
238625|NCT02148419|quality of life|quality of life
238626|NCT02148419|maltreatment|maltreatment
238627|NCT02148419|neglect|neglect
238628|NCT02148419|childhood|childhood
238629|NCT02148406|Yoga|yoga
238630|NCT02148406|Mind-body therapies|mind-body therapies
238631|NCT02148406|Fatigue|fatigue
238632|NCT02148406|Colorectal cancer|colorectal cancer
238633|NCT02148406|Depressive symptoms|depressive symptoms
238634|NCT02148380|Lung adenocarcinoma,EGFR mutation, chemotherapy, gefitinib|lung adenocarcinoma,egfr mutation, chemotherapy, gefitinib
238635|NCT02148367|Traumatic brain injury|traumatic brain injury
238636|NCT02148367|Endothelial progenitor cells|endothelial progenitor cells
238637|NCT02148367|Cerebrovascular reactivity|cerebrovascular reactivity
238638|NCT02148367|Angiogenesis|angiogenesis
238639|NCT02148354|Depression|depression
238640|NCT02148354|Self-applied treatment|self-applied treatment
238641|NCT02148354|Internet|internet
238642|NCT02148354|Support by the therapist|support by the therapist
238643|NCT02148354|Cognitive-Behavioural Treatment|cognitive-behavioural treatment
238644|NCT02148354|Positive Psychology|positive psychology
238645|NCT02148354|Behavioral Activation|behavioral activation
238646|NCT02148328|Healthy participants|healthy participants
238647|NCT02148328|Immunogenicity|immunogenicity
238648|NCT02148328|Influenza|influenza
238649|NCT02148328|Prevention|prevention
238650|NCT02148328|Safety|safety
238651|NCT02148315|physical activity|physical activity
238652|NCT02148315|children|children
238653|NCT02148315|school|school
238654|NCT02148315|garden|garden
238655|NCT02148302|Venous Leg Ulcerations|venous leg ulcerations
238656|NCT02148302|Epidermal Grafts|epidermal grafts
238657|NCT02148302|Chronic wounds|chronic wounds
238658|NCT02148302|Clinical trial|clinical trial
238659|NCT02148302|Protease levels in chronic wounds|protease levels in chronic wounds
238660|NCT02148289|COPD, beetroot, dietary nitrate, nitric oxide|copd, beetroot, dietary nitrate, nitric oxide
238661|NCT02148276|Social harm detection|social harm detection
238662|NCT02148276|Instrument development|instrument development
238663|NCT02148276|HIV-related clinical trials|hiv-related clinical trials
238664|NCT02148276|Substance abuse|substance abuse
238665|NCT02148276|Research participation|research participation
238666|NCT02148263|Contact Lenses|contact lenses
238667|NCT02148263|Neophytes|neophytes
238668|NCT02148263|Contact Lens Adaptation|contact lens adaptation
238669|NCT02148263|Randomized|randomized
238670|NCT02148250|Type 2 diabetes|type 2 diabetes
238671|NCT02148250|Insulin resistance|insulin resistance
238672|NCT02148250|High insulin requirements|high insulin requirements
238673|NCT02148250|U 500|u 500
238674|NCT02148237|Breastfeeding duration|breastfeeding duration
238675|NCT02148237|Puerto Rican mothers|puerto rican mothers
238676|NCT02148237|WIC program|wic program
238677|NCT02148237|Home-based individual breastfeeding consultation|home-based individual breastfeeding consultation
238678|NCT02148224|glycemic index|glycemic index
238679|NCT02148224|body composition|body composition
238680|NCT02148211|Fluarix Quadrivalent|fluarix quadrivalent
238681|NCT02148211|Fluarix|fluarix
238682|NCT02148211|FluLaval|flulaval
238683|NCT02148211|FluLaval Quadrivalent|flulaval quadrivalent
238684|NCT02148211|Pregnancy Registry|pregnancy registry
238685|NCT02148211|Pregnancy outcome|pregnancy outcome
238686|NCT02148185|Crohn's disease|crohn's disease
238687|NCT02148172|Knee|knee
238688|NCT02148172|plyometrics|plyometrics
238689|NCT02148172|motor learning|motor learning
238690|NCT02148172|psychological factors|psychological factors
238691|NCT02148159|anorexia|anorexia
238692|NCT02148159|cachexia|cachexia
238693|NCT02148159|cancer|cancer
238694|NCT02148159|unintentional weigh loss|unintentional weigh loss
238695|NCT02148159|gastrointestinal tract|gastrointestinal tract
238696|NCT02148159|adults|adults
238697|NCT02148146|short bowel syndrome|short bowel syndrome
238698|NCT02148146|intestinal failure|intestinal failure
238699|NCT02148146|total parenteral nutrition associated cholestasis|total parenteral nutrition associated cholestasis
238700|NCT02148133|Thrombocytopenia|thrombocytopenia
238701|NCT02148133|Eltrombopag|eltrombopag
238702|NCT02148133|Aplastic Anemia (AA)|aplastic anemia (aa)
238703|NCT02148133|Thrombopoietin|thrombopoietin
238704|NCT02148094|HIV|hiv
238705|NCT02148094|AIDS|aids
238706|NCT02148094|India|india
238707|NCT02148094|Prevention|prevention
238708|NCT02148094|Female sex workers|female sex workers
238709|NCT02148094|PrEP|prep
238710|NCT02148094|Pre-exposure prophylaxis|pre-exposure prophylaxis
238711|NCT02148094|Truvada|truvada
238712|NCT02148094|Tenofovir|tenofovir
238713|NCT02148081|pediatrics, critical illness, recovery, function, health|pediatrics, critical illness, recovery, function, health
238714|NCT02148068|Obesity|obesity
238715|NCT02148068|Bariatric Surgery|bariatric surgery
238716|NCT02148068|Roux-en-y Gastric Bypass|roux-en-y gastric bypass
238717|NCT02148068|Sleeve Gastrectomy|sleeve gastrectomy
238718|NCT02148055|spontaneous intrauterine death|spontaneous intrauterine death
238719|NCT02148055|fetal MRI|fetal mri
238720|NCT02148055|autopsy|autopsy
238721|NCT02148042|Anorexia|anorexia
238722|NCT02148042|Generalized anxiety|generalized anxiety
238723|NCT02148042|Fear|fear
238724|NCT02148029|Deep vein thrombosis|deep vein thrombosis
238725|NCT02148029|Post thrombotic syndrome|post thrombotic syndrome
238726|NCT02148029|Thrombus resolution|thrombus resolution
238727|NCT02148016|Corneal disorders|corneal disorders
238728|NCT02148016|Chemical injury|chemical injury
238729|NCT02148016|Pterygium|pterygium
238730|NCT02148016|Refractive error|refractive error
238731|NCT02148016|Myopia|myopia
238732|NCT02148016|Hyperopia|hyperopia
238733|NCT02148016|Cornea|cornea
238734|NCT02148016|Monocular|monocular
238735|NCT02148016|Transparent|transparent
238736|NCT02148016|Transplantation|transplantation
238737|NCT02148016|Visual function|visual function
238738|NCT02147990|cancer|cancer
238739|NCT02147990|metastatic|metastatic
238740|NCT02147990|locally advanced|locally advanced
238741|NCT02147990|lung|lung
238742|NCT02147990|non-small cell lung cancer|non-small cell lung cancer
238743|NCT02147990|NSCLC|nsclc
238744|NCT02147990|epidermal growth factor receptor|epidermal growth factor receptor
238745|NCT02147990|EGFR|egfr
238746|NCT02147990|T790M|t790m
238747|NCT02147990|CO-1686|co-1686
238748|NCT02147990|unresectable|unresectable
238749|NCT02147990|recurrent|recurrent
238750|NCT02147990|EGFR-directed therapy|egfr-directed therapy
238751|NCT02147990|irreversible EGFR inhibitor|irreversible egfr inhibitor
238752|NCT02147990|TIGER|tiger
238753|NCT02147990|Rociletinib|rociletinib
238754|NCT02147977|Renal Dialysis|renal dialysis
238755|NCT02147977|Arrhythmias Cardiac|arrhythmias cardiac
238756|NCT02147977|Death Sudden Cardiac|death sudden cardiac
238757|NCT02147977|Fatty Acids Omega 3|fatty acids omega 3
238758|NCT02147964|intratesticular androgens|intratesticular androgens
238759|NCT02147964|testosterone|testosterone
238760|NCT02147964|dutasteride|dutasteride
238761|NCT02147964|gonadotropin suppression|gonadotropin suppression
238762|NCT02147964|male contraception|male contraception
238763|NCT02147964|spermatogenesis|spermatogenesis
238764|NCT02147951|Melanoma|melanoma
238765|NCT02147938|France|france
238766|NCT02147938|Tacrolimus|tacrolimus
238767|NCT02147938|Prograf|prograf
238768|NCT02147938|Observational|observational
238769|NCT02147938|Advagraf|advagraf
238770|NCT02147925|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
238771|NCT02147925|Glucagon-like peptide-1 receptor agonists|glucagon-like peptide-1 receptor agonists
238772|NCT02147925|Diabetes mellitus, type 2|diabetes mellitus, type 2
238773|NCT02147912|Depression|depression
238774|NCT02147912|COPD|copd
238775|NCT02147912|Aerobic Exercise|aerobic exercise
238776|NCT02147912|Anxiety|anxiety
238777|NCT02147912|Quality of life|quality of life
238778|NCT02147912|neurocognitive functioning|neurocognitive functioning
238779|NCT02147886|Bioblast, Randomized, parallel-group, and dose-controlled|bioblast, randomized, parallel-group, and dose-controlled
238780|NCT02147873|MDS|mds
238781|NCT02147873|CMML|cmml
238782|NCT02147873|myelodysplastic syndrome|myelodysplastic syndrome
238783|NCT02147873|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
238784|NCT02147873|TL32711|tl32711
238785|NCT02147873|TL32711-0094|tl32711-0094
238786|NCT02147873|azacitidine|azacitidine
238787|NCT02147873|birinapant|birinapant
238788|NCT02147873|higher risk|higher risk
238789|NCT02147873|naive|naive
238790|NCT02147873|double blind|double blind
238791|NCT02147873|placebo|placebo
238792|NCT02147873|placebo controlled|placebo controlled
238793|NCT02147873|randomized|randomized
238794|NCT02147860|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
238795|NCT02147860|Artificial Pancreas Project (APP)|artificial pancreas project (app)
238796|NCT02147860|Diabetes Assistant (DiAs)|diabetes assistant (dias)
238797|NCT02147860|Closed-Loop Control (CLC)|closed-loop control (clc)
238798|NCT02147860|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
238799|NCT02147860|Insulin Pump|insulin pump
238800|NCT02147847|Presbycusis|presbycusis
238801|NCT02147847|Hearing In Noise|hearing in noise
238802|NCT02147847|Hearing Impairment|hearing impairment
238803|NCT02147847|Hearing Loss|hearing loss
238804|NCT02147847|Aging|aging
238805|NCT02147847|Plasticity|plasticity
238806|NCT02147847|Video Games|video games
238807|NCT02147847|Perceptual Learning|perceptual learning
238808|NCT02147834|deferred percutaneous coronary intervention|deferred percutaneous coronary intervention
238809|NCT02147834|fractional flow reserve|fractional flow reserve
238810|NCT02147795|Patient Blood Management|patient blood management
238811|NCT02147795|Red Blood Cell Transfusion Practice|red blood cell transfusion practice
238812|NCT02147795|Patient Safety|patient safety
238813|NCT02147795|Anemia|anemia
238814|NCT02147795|Clinical Outcome|clinical outcome
238815|NCT02147795|perioperative care|perioperative care
238816|NCT02147782|chronic renal insufficient, renal osteodystrophy, bone mineral density, bone turnover, kidney function|chronic renal insufficient, renal osteodystrophy, bone mineral density, bone turnover, kidney function
238817|NCT02147769|cerebral autoregulation|cerebral autoregulation
238818|NCT02147769|preterm|preterm
238819|NCT02147769|near-infrared spectroscopy|near-infrared spectroscopy
238820|NCT02147756|Skin pigmentation, skin texture disorders, fractional laser, CO2, fractional CO2, Syneron, Solta.|skin pigmentation, skin texture disorders, fractional laser, co2, fractional co2, syneron, solta.
238821|NCT02147743|Adolescents|adolescents
238822|NCT02147743|Family-Based treatment|family-based treatment
238823|NCT02147743|Multidimensional Family Therapy|multidimensional family therapy
238824|NCT02147730|chronic pain|chronic pain
238825|NCT02147717|preterm newborns|preterm newborns
238826|NCT02147717|Transfontanellar ultrafast doppler|transfontanellar ultrafast doppler
238827|NCT02147717|Acupuncture|acupuncture
238828|NCT02147717|perioperative pain|perioperative pain
238829|NCT02147717|surgery of the ductus arteriosus|surgery of the ductus arteriosus
238830|NCT02147665|Hookah|hookah
238831|NCT02147665|waterpipe|waterpipe
238832|NCT02147665|smoking|smoking
238833|NCT02147665|sympathetic|sympathetic
238834|NCT02147652|moderate dementia|moderate dementia
238835|NCT02147652|severe dementia|severe dementia
238836|NCT02147652|Alzheimer's disease|alzheimer's disease
238837|NCT02147652|Vascular dementia|vascular dementia
238838|NCT02147652|agitation|agitation
238839|NCT02147652|personalized music therapy|personalized music therapy
238840|NCT02147626|preeclampsia|preeclampsia
238841|NCT02147626|cardiovascular disease|cardiovascular disease
238842|NCT02147626|health behaviors|health behaviors
238843|NCT02147626|behavioral intervention|behavioral intervention
238844|NCT02147626|web-based|web-based
238845|NCT02147626|Hypertension|hypertension
238846|NCT02147626|Post-partum Weight Retention|post-partum weight retention
238847|NCT02147600|adalimumab|adalimumab
238848|NCT02147600|biologicals|biologicals
238849|NCT02147600|immunogenicity|immunogenicity
238850|NCT02147574|slow-transit constipation|slow-transit constipation
238851|NCT02147574|laparoscope Sub-total Colectomy|laparoscope sub-total colectomy
238852|NCT02147574|anti-peristaltic anastomosis|anti-peristaltic anastomosis
238853|NCT02147522|community health worker|community health worker
238854|NCT02147522|promotoras|promotoras
238855|NCT02147522|self-care behaviors activation|self-care behaviors activation
238856|NCT02147522|depression|depression
238857|NCT02147522|low-income patients|low-income patients
238858|NCT02147522|safety-net care|safety-net care
238859|NCT02147509|Dry eye|dry eye
238860|NCT02147509|Therapeutic bandage contact lenses|therapeutic bandage contact lenses
238861|NCT02147509|The quality of life|the quality of life
238862|NCT02147496|Food intake|food intake
238863|NCT02147496|Appetite|appetite
238864|NCT02147496|Blood glucose|blood glucose
238865|NCT02147496|Insulin|insulin
238866|NCT02147496|Dairy|dairy
238867|NCT02147496|Milk|milk
238868|NCT02147483|Mindfulness|mindfulness
238869|NCT02147483|Alcohol use disorders|alcohol use disorders
238870|NCT02147470|cirrhosis of the liver|cirrhosis of the liver
238871|NCT02147470|Acute kidney injury|acute kidney injury
238872|NCT02147457|Prematurity|prematurity
238873|NCT02147457|Extremely low birth weight|extremely low birth weight
238874|NCT02147457|Phenotyping|phenotyping
238875|NCT02147444|Rivaroxaban|rivaroxaban
238876|NCT02147444|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
238877|NCT02147444|NOAC|noac
238878|NCT02147444|Xa inhibitor|xa inhibitor
238879|NCT02147418|Head and neck cancer|head and neck cancer
238880|NCT02147418|Throat cancer|throat cancer
238881|NCT02147418|Human papillomavirus|human papillomavirus
238882|NCT02147418|HPV|hpv
238883|NCT02147418|Exosome|exosome
238884|NCT02147418|Diagnostic|diagnostic
238885|NCT02147418|Early Detection|early detection
238886|NCT02147405|FDG PET/CT Scan|fdg pet/ct scan
238887|NCT02147405|Lymph Node Biopsy|lymph node biopsy
238888|NCT02147405|Apheresis|apheresis
238889|NCT02147392|PET Imaging|pet imaging
238890|NCT02147379|Bipolar Disorder|bipolar disorder
238891|NCT02147379|Cognition|cognition
238892|NCT02147379|Euthymic|euthymic
238893|NCT02147379|Lurasidone|lurasidone
238894|NCT02147366|Hypertension,ambulatory pressure,autonomic function,music|hypertension,ambulatory pressure,autonomic function,music
238895|NCT02147353|External Genital Warts|external genital warts
238896|NCT02147353|Sinecatechins|sinecatechins
238897|NCT02147353|Cryotherapy|cryotherapy
238898|NCT02147340|Heart Failure patients|heart failure patients
238899|NCT02147340|Remote Patient Management|remote patient management
238900|NCT02147340|External Sensors|external sensors
238901|NCT02147327|vitamin D|vitamin d
238902|NCT02147327|cord blood|cord blood
238903|NCT02147327|neonatal sepsis|neonatal sepsis
238904|NCT02147327|neonatal morbidity|neonatal morbidity
238905|NCT02147314|diabetes|diabetes
238906|NCT02147314|glucometer|glucometer
238907|NCT02147314|Yofimeter|yofimeter
238908|NCT02147314|diabetes monitoring|diabetes monitoring
238909|NCT02147275|hypertension|hypertension
238910|NCT02147275|cerebral oxygen saturation|cerebral oxygen saturation
238911|NCT02147275|near-infrared spectroscopy|near-infrared spectroscopy
238912|NCT02147275|cognitive function|cognitive function
238913|NCT02147262|chronic atrophic acrodermatitis|chronic atrophic acrodermatitis
238914|NCT02147262|Lyme borreliosis|lyme borreliosis
238915|NCT02147262|molecular characteristics|molecular characteristics
238916|NCT02147262|outcome|outcome
238917|NCT02147249|erythema migrans|erythema migrans
238918|NCT02147249|Lyme borreliosis|lyme borreliosis
238919|NCT02147249|inflammation|inflammation
238920|NCT02147249|outcome|outcome
238921|NCT02147236|autism|autism
238922|NCT02147236|pervasive developmental disorders|pervasive developmental disorders
238923|NCT02147236|social skills intervention|social skills intervention
238924|NCT02147223|flavanols|flavanols
238925|NCT02147223|sex-related cardiovascular effects|sex-related cardiovascular effects
238926|NCT02147210|Chronic transplant glomerulopathy|chronic transplant glomerulopathy
238927|NCT02147210|antibody mediated rejection|antibody mediated rejection
238928|NCT02147210|Ephrin-B1|ephrin-b1
238929|NCT02147184|SSRI|ssri
238930|NCT02147184|serotonin transporter|serotonin transporter
238931|NCT02147184|DXA|dxa
238932|NCT02147184|pQCT|pqct
238933|NCT02147184|bone mass|bone mass
238934|NCT02147184|adolescents|adolescents
238935|NCT02147171|Retinal ageing, macular pigment, visual function|retinal ageing, macular pigment, visual function
238936|NCT02147145|GIST|gist
238937|NCT02147145|endoscopy|endoscopy
238938|NCT02147145|endoscopic ultrasound|endoscopic ultrasound
238939|NCT02147132|Cigarette|cigarette
238940|NCT02147132|Methadone|methadone
238941|NCT02147132|Smoking|smoking
238942|NCT02147132|Cessation|cessation
238943|NCT02147132|Varenicline|varenicline
238944|NCT02147132|Nicotine|nicotine
238945|NCT02147106|Neuroendocrine tumor|neuroendocrine tumor
238946|NCT02147106|Videoconsultation|videoconsultation
238947|NCT02147106|Feasibility|feasibility
238948|NCT02147080|prevention or control|prevention or control
238949|NCT02147067|microvascular angina|microvascular angina
238950|NCT02147067|coronary microvascular disease|coronary microvascular disease
238951|NCT02147067|coronary physiology|coronary physiology
238952|NCT02147067|ranolazine|ranolazine
238953|NCT02147054|Organophosphate poisoning|organophosphate poisoning
238954|NCT02147054|Intermediate syndrome|intermediate syndrome
238955|NCT02147054|Rocuronium|rocuronium
238956|NCT02147041|diabetes mellitus|diabetes mellitus
238957|NCT02147041|hyperlipidemia|hyperlipidemia
238958|NCT02147041|green tea|green tea
238959|NCT02147041|epigallocatechin gallate|epigallocatechin gallate
238960|NCT02147028|whole brain RT|whole brain rt
238961|NCT02147028|hippocampal sparing|hippocampal sparing
238962|NCT02147028|neurocognitive function|neurocognitive function
238963|NCT02147015|Acute Exacerbations|acute exacerbations
238964|NCT02147015|Corticosteroids|corticosteroids
238965|NCT02147015|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
238966|NCT02147015|Doses|doses
238967|NCT02147002|Chronic Kidney Disease|chronic kidney disease
238968|NCT02147002|Cardiovascular Complications|cardiovascular complications
238969|NCT02146989|Cerebral Palsy|cerebral palsy
238970|NCT02146989|child|child
238971|NCT02146989|upper extremity|upper extremity
238972|NCT02146989|strength, reproducibility|strength, reproducibility
238973|NCT02146976|postoperative|postoperative
238974|NCT02146976|sleep quality|sleep quality
238975|NCT02146976|propofol|propofol
238976|NCT02146976|sevoflurane|sevoflurane
238977|NCT02146950|LCS-12|lcs-12
238978|NCT02146950|Intrauterine Device (IUD)|intrauterine device (iud)
238979|NCT02146950|Intrauterine System (IUS)|intrauterine system (ius)
238980|NCT02146950|Levonorgestrel|levonorgestrel
238981|NCT02146950|Pearl Index|pearl index
238982|NCT02146950|Hormonal Contraception|hormonal contraception
238983|NCT02146937|active surveillance|active surveillance
238984|NCT02146937|MRI/transrectal ultrasound fusion guided biopsy|mri/transrectal ultrasound fusion guided biopsy
238985|NCT02146937|biopsy|biopsy
238986|NCT02146911|Smoking Cessation Medication|smoking cessation medication
238987|NCT02146911|Smoking Treatment|smoking treatment
238988|NCT02146911|Tobacco Treatment|tobacco treatment
238989|NCT02146911|Quitting Smoking|quitting smoking
238990|NCT02146911|Bupropion|bupropion
238991|NCT02146911|Varenicline|varenicline
238992|NCT02146911|Efficacy|efficacy
238993|NCT02146911|Pharmacogenetics of Smoking Treatment|pharmacogenetics of smoking treatment
238994|NCT02146911|Genetics analysis|genetics analysis
238995|NCT02146911|Smoking Personality|smoking personality
238996|NCT02146911|Dependence|dependence
238997|NCT02146911|Addiction|addiction
238998|NCT02146911|Cigarettes|cigarettes
238999|NCT02146911|Primary Care Physicians|primary care physicians
239000|NCT02146911|Biochemical Confirmation|biochemical confirmation
239001|NCT02146898|spinal anesthesia|spinal anesthesia
239002|NCT02146898|hypotension|hypotension
239003|NCT02146898|pregnancy|pregnancy
239004|NCT02146872|Coronary Artery Disease|coronary artery disease
239005|NCT02146872|Myocardial Infarction|myocardial infarction
239006|NCT02146872|Atherosclerosis|atherosclerosis
239007|NCT02146872|High-Throughput Nucleotide Sequencing|high-throughput nucleotide sequencing
239008|NCT02146872|Sequence Analysis, DNA|sequence analysis, dna
239009|NCT02146872|Genetic Testing|genetic testing
239010|NCT02146872|Genetic Linkage|genetic linkage
239011|NCT02146859|residual neuromuscular blockade|residual neuromuscular blockade
239012|NCT02146846|cml|cml
239013|NCT02146833|castrate-resistant prostate cancer|castrate-resistant prostate cancer
239014|NCT02146833|prostate cancer|prostate cancer
239015|NCT02146833|Karyopharm|karyopharm
239016|NCT02146833|KPT-330|kpt-330
239017|NCT02146833|selinexor|selinexor
239018|NCT02146820|Pigmented Lesions, Skin Pigment, Picosecond Laser, Syneron|pigmented lesions, skin pigment, picosecond laser, syneron
239019|NCT02146807|Tattoos, Picosecond Laser, Syneron|tattoos, picosecond laser, syneron
239020|NCT02146742|ASP1707|asp1707
239021|NCT02146742|Japanese subjects|japanese subjects
239022|NCT02146742|Safety|safety
239023|NCT02146742|Pharmacokinetics|pharmacokinetics
239024|NCT02146742|Pharmacodynamics|pharmacodynamics
239025|NCT02146729|Randomized|randomized
239026|NCT02146729|Thoracolumbar fractures|thoracolumbar fractures
239027|NCT02146729|Spine Trauma|spine trauma
239028|NCT02146729|Percutaneous Pedicle Screw Fixation|percutaneous pedicle screw fixation
239029|NCT02146729|Functional Outcome|functional outcome
239030|NCT02146716|RESC, alcohol withdrawal syndrome|resc, alcohol withdrawal syndrome
239031|NCT02146703|biliary tract neoplasm|biliary tract neoplasm
239032|NCT02146703|gemcitabine|gemcitabine
239033|NCT02146703|S-1|s-1
239034|NCT02146690|pathology|pathology
239035|NCT02146690|newborn|newborn
239036|NCT02146690|osteopathic manipulative treatment|osteopathic manipulative treatment
239037|NCT02146690|pain|pain
239038|NCT02146677|prematurity|prematurity
239039|NCT02146677|newborns|newborns
239040|NCT02146677|pain|pain
239041|NCT02146677|cost|cost
239042|NCT02146664|Acute NSTEMI|acute nstemi
239043|NCT02146664|DLBS1033|dlbs1033
239044|NCT02146664|SPECT|spect
239045|NCT02146664|Infarct size|infarct size
239046|NCT02146664|Left ventricular function|left ventricular function
239047|NCT02146638|post operative analgesia, morphine, fentanyl|post operative analgesia, morphine, fentanyl
239048|NCT02146573|Intensive Care Units, Pediatric|intensive care units, pediatric
239049|NCT02146573|Communication|communication
239050|NCT02146573|Health personnel|health personnel
239051|NCT02146573|Decision making|decision making
239052|NCT02146573|Critical Care|critical care
239053|NCT02146573|Length of Stay|length of stay
239054|NCT02146573|Iatrogenic Disease|iatrogenic disease
239055|NCT02146560|Surgery|surgery
239056|NCT02146560|Non-cardiac|non-cardiac
239057|NCT02146560|Elective|elective
239058|NCT02146560|Adult|adult
239059|NCT02146560|Patients|patients
239060|NCT02146560|Troponin|troponin
239061|NCT02146560|Myocardial|myocardial
239062|NCT02146560|Injury|injury
239063|NCT02146560|Postoperative|postoperative
239064|NCT02146560|Recovery|recovery
239065|NCT02146560|Outcome|outcome
239066|NCT02146547|depot, oral, antipsychotics, paliperidone, aripiprazole|depot, oral, antipsychotics, paliperidone, aripiprazole
239067|NCT02146521|z-axis limited CT|z-axis limited ct
239068|NCT02146521|computed tomography|computed tomography
239069|NCT02146521|CT|ct
239070|NCT02146521|abdominal non-traumatic pain and tenderness|abdominal non-traumatic pain and tenderness
239071|NCT02146521|emergency patients|emergency patients
239072|NCT02146508|Esophageal cancer|esophageal cancer
239073|NCT02146508|Radiofrequency, catheter ablation|radiofrequency, catheter ablation
239074|NCT02146508|Endoscopic mucosal resection|endoscopic mucosal resection
239075|NCT02146508|Esophageal squamous dysplasia|esophageal squamous dysplasia
239076|NCT02146508|Cancer prevention|cancer prevention
239077|NCT02146482|back pain|back pain
239078|NCT02146482|low back pain|low back pain
239079|NCT02146482|sit-stand workstation|sit-stand workstation
239080|NCT02146482|standing desk|standing desk
239081|NCT02146469|varicella vaccination|varicella vaccination
239082|NCT02146443|Manual dexterity|manual dexterity
239083|NCT02146443|hand to eye coordination|hand to eye coordination
239084|NCT02146443|stress|stress
239085|NCT02146443|fatigue|fatigue
239086|NCT02146430|pain|pain
239087|NCT02146430|fibromyalgia|fibromyalgia
239088|NCT02146417|Low pressure pneumoperitoneum|low pressure pneumoperitoneum
239089|NCT02146417|Deep neuromuscular block|deep neuromuscular block
239090|NCT02146404|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
239091|NCT02146404|Hypoglycemia unawareness|hypoglycemia unawareness
239092|NCT02146404|1H MRS|1h mrs
239093|NCT02146404|Lactate|lactate
239094|NCT02146352|Pancreatic pseudocyst|pancreatic pseudocyst
239095|NCT02146339|nutrition|nutrition
239096|NCT02146339|milk|milk
239097|NCT02146339|polar lipids|polar lipids
239098|NCT02146339|cardiometabolic risk|cardiometabolic risk
239099|NCT02146300|birch pollen|birch pollen
239100|NCT02146300|allergy|allergy
239101|NCT02146300|breathing|breathing
239102|NCT02146300|pattern|pattern
239103|NCT02146300|exposure|exposure
239104|NCT02146287|cycled light|cycled light
239105|NCT02146287|preterm infants|preterm infants
239106|NCT02146287|infant neurodevelopment|infant neurodevelopment
239107|NCT02146287|infant sleep|infant sleep
239108|NCT02146274|PROSPER|prosper
239109|NCT02146274|Stroke|stroke
239110|NCT02146274|Ischemic Stroke|ischemic stroke
239111|NCT02146261|Volunteers|volunteers
239112|NCT02146261|Japanese|japanese
239113|NCT02146261|Males|males
239114|NCT02146248|hysterosalpingography, DMPA, combined oral contraceptive, tubal patency|hysterosalpingography, dmpa, combined oral contraceptive, tubal patency
239115|NCT02146235|Music Therapy|music therapy
239116|NCT02146235|Pulmonary Disease|pulmonary disease
239117|NCT02146235|COPD|copd
239118|NCT02146235|Music Visualization|music visualization
239119|NCT02146235|Therapeutic Singing|therapeutic singing
239120|NCT02146235|Wind-playing|wind-playing
239121|NCT02146235|Lung Condition|lung condition
239122|NCT02146196|Heart failure|heart failure
239123|NCT02146196|robotic assisted gait therapy|robotic assisted gait therapy
239124|NCT02146183|Stevio glycosides|stevio glycosides
239125|NCT02146183|sport|sport
239126|NCT02146183|glycogen|glycogen
239127|NCT02146170|Sample Acquisition|sample acquisition
239128|NCT02146170|Generic and Epigenetic Alterations|generic and epigenetic alterations
239129|NCT02146170|Mig6 Expression|mig6 expression
239130|NCT02146170|Proteomic Analysis|proteomic analysis
239131|NCT02146170|Genomic Analysis|genomic analysis
239132|NCT02146144|Idiopathic epimacular membrane|idiopathic epimacular membrane
239133|NCT02146144|internal limiting membrane peeling|internal limiting membrane peeling
239134|NCT02146144|microscotomas|microscotomas
239135|NCT02146131|Peripheral pulmonary lesions|peripheral pulmonary lesions
239136|NCT02146131|Solitary pulmonary lesions|solitary pulmonary lesions
239137|NCT02146131|Multiple pulmonary lesions|multiple pulmonary lesions
239138|NCT02146118|Erlotinib|erlotinib
239139|NCT02146118|Silybin-phytosome|silybin-phytosome
239140|NCT02146118|EGFR mutant lung adenocarcinoma|egfr mutant lung adenocarcinoma
239141|NCT02146092|lung resection|lung resection
239142|NCT02146092|incentive spirometry|incentive spirometry
239143|NCT02146092|physiotherapy|physiotherapy
239144|NCT02146092|quality improvement|quality improvement
239145|NCT02146092|outcomes|outcomes
239146|NCT02146092|post operative complications|post operative complications
239147|NCT02146066|GBM|gbm
239148|NCT02146066|Brain tumor|brain tumor
239149|NCT02146066|glioblastoma|glioblastoma
239150|NCT02146066|Brain tumor WHO grade IV|brain tumor who grade iv
239151|NCT02146053|healthy participants|healthy participants
239152|NCT02146053|gastrointestinal side-effects associated with oral iron|gastrointestinal side-effects associated with oral iron
239153|NCT02146040|anticoagulation|anticoagulation
239154|NCT02146040|atrial fibrillation|atrial fibrillation
239155|NCT02146040|cardioversion|cardioversion
239156|NCT02146040|complications|complications
239157|NCT02146040|hemorrhage|hemorrhage
239158|NCT02146040|medications|medications
239159|NCT02146040|thromboembolism|thromboembolism
239160|NCT02146040|TIA|tia
239161|NCT02146040|stroke|stroke
239162|NCT02146040|treatment|treatment
239163|NCT02146027|HIV|hiv
239164|NCT02146027|Lactobacillus casei Shirota|lactobacillus casei shirota
239165|NCT02146027|NK cell|nk cell
239166|NCT02146027|CD4|cd4
239167|NCT02146027|Lymphocyte|lymphocyte
239168|NCT02146027|Cell activation|cell activation
239169|NCT02146027|Antiretroviral therapy|antiretroviral therapy
239170|NCT02146027|Immune discordants|immune discordants
239265|NCT02145546|Propafenone|propafenone
239171|NCT02146014|cigarette smoking, smoking|cigarette smoking, smoking
239172|NCT02146001|sedentary behavior|sedentary behavior
239173|NCT02146001|physical activity|physical activity
239174|NCT02146001|older adults|older adults
239175|NCT02145988|DLBS1033|dlbs1033
239176|NCT02145988|Peripheral arterial disease|peripheral arterial disease
239177|NCT02145988|Ankle-brachial index|ankle-brachial index
239178|NCT02145975|Severe postoperative pain|severe postoperative pain
239179|NCT02145975|Morphine|morphine
239180|NCT02145975|Fentanyl|fentanyl
239181|NCT02145975|Time to titration of pain|time to titration of pain
239182|NCT02145975|Pain and PACU|pain and pacu
239183|NCT02145975|Anesthesiology|anesthesiology
239184|NCT02145962|diabetic foot ulcer healing|diabetic foot ulcer healing
239185|NCT02145962|magnetic therapy|magnetic therapy
239186|NCT02145962|safety and efficacy|safety and efficacy
239187|NCT02145962|wound care|wound care
239188|NCT02145949|aging|aging
239189|NCT02145949|clinical|clinical
239190|NCT02145949|translational|translational
239191|NCT02145949|functional mobility|functional mobility
239192|NCT02145949|total knee arthroplasty|total knee arthroplasty
239193|NCT02145936|fatty acid|fatty acid
239194|NCT02145923|Hodgkin Lymphoma|hodgkin lymphoma
239195|NCT02145923|Non-Hodgkin's Lymphomas|non-hodgkin's lymphomas
239196|NCT02145923|Allogeneic Mesenchymal Stem Cell Transplantation|allogeneic mesenchymal stem cell transplantation
239197|NCT02145923|Autologous Peripheral Blood Stem Cell Transplantation|autologous peripheral blood stem cell transplantation
239198|NCT02145923|Neutropenic Enterocolitis|neutropenic enterocolitis
239199|NCT02145923|Myeloablative Chemotherapy|myeloablative chemotherapy
239200|NCT02145923|Bone Marrow Aplasia|bone marrow aplasia
239201|NCT02145897|CLI|cli
239202|NCT02145884|hemangioma|hemangioma
239203|NCT02145884|birthmark|birthmark
239204|NCT02145884|strawberry hemangioma|strawberry hemangioma
239205|NCT02145884|timolol|timolol
239206|NCT02145871|Radical Cystectomy|radical cystectomy
239207|NCT02145871|Perioperative Fluid Management|perioperative fluid management
239208|NCT02145871|EV1000|ev1000
239209|NCT02145871|14-069|14-069
239210|NCT02145858|atrial fibrillation, pericardial effusion, pleural effusion|atrial fibrillation, pericardial effusion, pleural effusion
239211|NCT02145845|critical limb ischemia|critical limb ischemia
239212|NCT02145845|wound healing|wound healing
239213|NCT02145845|amputation|amputation
239214|NCT02145832|TINN|tinn
239215|NCT02145832|Pharmacokinetic|pharmacokinetic
239216|NCT02145832|Neonates|neonates
239217|NCT02145832|Antifungal|antifungal
239218|NCT02145832|Fluconazole|fluconazole
239219|NCT02145832|Micafungin|micafungin
239220|NCT02145806|Urinary incontinence|urinary incontinence
239221|NCT02145806|Validation study|validation study
239222|NCT02145806|Pregnant women|pregnant women
239223|NCT02145806|Postpartum period|postpartum period
239224|NCT02145793|primary care|primary care
239225|NCT02145793|pediatrics|pediatrics
239226|NCT02145793|parenting|parenting
239227|NCT02145793|education|education
239228|NCT02145780|Overfeeding|overfeeding
239229|NCT02145780|Fat distribution|fat distribution
239230|NCT02145780|Subcutaneous and visceral adipose tissue|subcutaneous and visceral adipose tissue
239231|NCT02145780|Insulin sensitivity|insulin sensitivity
239232|NCT02145780|Insulin resistance|insulin resistance
239233|NCT02145780|Peripheral and hepatic insulin sensitivity|peripheral and hepatic insulin sensitivity
239234|NCT02145780|Stable isotopes|stable isotopes
239235|NCT02145780|Lipid oxidation|lipid oxidation
239236|NCT02145780|Energy expenditure|energy expenditure
239237|NCT02145780|Muscle and subcutaneous adipose tissue gene expression|muscle and subcutaneous adipose tissue gene expression
239238|NCT02145754|erythema migrans|erythema migrans
239239|NCT02145754|Lyme borreliosis|lyme borreliosis
239240|NCT02145754|Borrelia burgdorferi|borrelia burgdorferi
239241|NCT02145754|skin culture|skin culture
239242|NCT02145754|culture media|culture media
239243|NCT02145728|Non-specific chronic low back pain|non-specific chronic low back pain
239244|NCT02145728|Cognitive functional therapy|cognitive functional therapy
239245|NCT02145728|Exercise classes|exercise classes
239246|NCT02145702|ESRD|esrd
239247|NCT02145702|Kidney Failure|kidney failure
239248|NCT02145702|Exercise|exercise
239249|NCT02145702|Cognitive impairment|cognitive impairment
239250|NCT02145637|Cancer, Lung cancer, Head and neck squamous cell carcinoma, Afatinib, Ruxolitinib, EGFR, JAK, STAT|cancer, lung cancer, head and neck squamous cell carcinoma, afatinib, ruxolitinib, egfr, jak, stat
239251|NCT02145624|pertussis|pertussis
239252|NCT02145624|maternal vaccination|maternal vaccination
239253|NCT02145624|maternal immunisation|maternal immunisation
239254|NCT02145624|immune response|immune response
239255|NCT02145611|hypertension, diabetes, endothelial function|hypertension, diabetes, endothelial function
239256|NCT02145598|Multiple Myeloma|multiple myeloma
239257|NCT02145598|Revlimid|revlimid
239258|NCT02145598|Lenalidomide maintenance|lenalidomide maintenance
239259|NCT02145585|Cardiac surgery|cardiac surgery
239260|NCT02145585|Robotic pharmacological anesthesia|robotic pharmacological anesthesia
239261|NCT02145585|Anesthesia|anesthesia
239262|NCT02145546|Pacing dependent|pacing dependent
239263|NCT02145546|Atrial Fibrillation|atrial fibrillation
239264|NCT02145546|Amiodarone|amiodarone
239266|NCT02145546|Sotalol|sotalol
239267|NCT02145546|AF burden|af burden
239268|NCT02145533|MMP|mmp
239269|NCT02145533|NGAL|ngal
239270|NCT02145533|Arterial Aneurysms|arterial aneurysms
239271|NCT02145520|bronchiolitis|bronchiolitis
239272|NCT02145507|Leukoreduction|leukoreduction
239273|NCT02145507|Red Blood Cell post-leukoreduction recovery|red blood cell post-leukoreduction recovery
239274|NCT02145507|Packed red blood cell post storage hemolysis|packed red blood cell post storage hemolysis
239275|NCT02145507|Red blood cell recovery|red blood cell recovery
239276|NCT02145507|Plasma clotting factors|plasma clotting factors
239277|NCT02145507|2,3-DPG rejuvenation|2,3-dpg rejuvenation
239278|NCT02145494|SBRT (stereotactic body radiotherapy)|sbrt (stereotactic body radiotherapy)
239279|NCT02145494|Focal boost|focal boost
239280|NCT02145494|Prostate|prostate
239281|NCT02145481|coronary artery disease|coronary artery disease
239282|NCT02145481|decision quality|decision quality
239283|NCT02145481|decision making|decision making
239284|NCT02145481|survey|survey
239285|NCT02145481|measure development|measure development
239286|NCT02145481|patient-centered care|patient-centered care
239287|NCT02145481|cardiology|cardiology
239288|NCT02145481|heart disease|heart disease
239289|NCT02145468|Myocardial infarction|myocardial infarction
239290|NCT02145468|Acute coronary syndrome|acute coronary syndrome
239291|NCT02145468|Cardiovascular disease|cardiovascular disease
239292|NCT02145468|p38 mitogen-activated protein kinase (MAPK) inhibitor|p38 mitogen-activated protein kinase (mapk) inhibitor
239293|NCT02145468|NSTEMI|nstemi
239294|NCT02145468|Losmapimod|losmapimod
239295|NCT02145468|STEMI|stemi
239296|NCT02145455|Arthroplasty, Replacement, Knee/methods|arthroplasty, replacement, knee/methods
239297|NCT02145455|Knee Joint/physiopathology|knee joint/physiopathology
239298|NCT02145455|Knee Joint/radiography|knee joint/radiography
239299|NCT02145455|Knee Joint/surgery|knee joint/surgery
239300|NCT02145455|Knee Prosthesis|knee prosthesis
239301|NCT02145455|Outcome Assessment (Health Care)|outcome assessment (health care)
239302|NCT02145455|Female|female
239303|NCT02145455|Male|male
239304|NCT02145455|Adult|adult
239305|NCT02145442|Impaired fasting glucose|impaired fasting glucose
239306|NCT02145442|Prediabetes|prediabetes
239307|NCT02145442|Obesity|obesity
239308|NCT02145442|Overweight|overweight
239309|NCT02145442|Insulin sensitivity|insulin sensitivity
239310|NCT02145442|Weight loss|weight loss
239311|NCT02145442|Nutritional supplement|nutritional supplement
239312|NCT02145442|Waist|waist
239313|NCT02145442|Body composition|body composition
239314|NCT02145429|Prevention of depression and anxiety disorder|prevention of depression and anxiety disorder
239315|NCT02145429|Depression Prevention|depression prevention
239316|NCT02145416|Imaging|imaging
239317|NCT02145416|Chemoradiotherapy|chemoradiotherapy
239318|NCT02145403|Allogeneic Transplantation|allogeneic transplantation
239319|NCT02145403|Carfilzomib|carfilzomib
239320|NCT02145403|Relapse|relapse
239321|NCT02145403|Graft-Versus-Host Disease|graft-versus-host disease
239322|NCT02145403|Multiple Myeloma|multiple myeloma
239323|NCT02145403|Lymphoma|lymphoma
239324|NCT02145403|Leukemia|leukemia
239325|NCT02145390|Bladder Cancer|bladder cancer
239326|NCT02145390|Bladder Carcinoma|bladder carcinoma
239327|NCT02145390|Transition Cell Cancer|transition cell cancer
239328|NCT02145390|TCC|tcc
239329|NCT02145390|Muscle Invasive Bladder Carcinoma|muscle invasive bladder carcinoma
239330|NCT02145377|Cholera|cholera
239331|NCT02145377|Vaccine|vaccine
239332|NCT02145377|Mali|mali
239333|NCT02145364|Ulthera System®|ulthera system®
239334|NCT02145364|Ultherapy®|ultherapy®
239335|NCT02145364|Ulthera, Inc.|ulthera, inc.
239336|NCT02145351|HFpEF|hfpef
239337|NCT02145351|Heart failure|heart failure
239338|NCT02145351|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
239339|NCT02145351|Chronotropic incompetence|chronotropic incompetence
239340|NCT02145338|Urinary tract infection|urinary tract infection
239341|NCT02145338|Clean intermittent self-catheterisation|clean intermittent self-catheterisation
239342|NCT02145338|Antibiotic prophylaxis|antibiotic prophylaxis
239343|NCT02145325|Kidney transplant|kidney transplant
239344|NCT02145325|Regulatory T cells|regulatory t cells
239345|NCT02145325|Leukopheresis|leukopheresis
239346|NCT02145325|Immune cells|immune cells
239347|NCT02145325|Stem Cells|stem cells
239348|NCT02145325|Tolerance|tolerance
239349|NCT02145273|Maternal Depression|maternal depression
239350|NCT02145273|Interpersonal Psychotherapy|interpersonal psychotherapy
239351|NCT02145273|School Readiness|school readiness
239352|NCT02145260|Hemodialysis|hemodialysis
239353|NCT02145260|Hypotension|hypotension
239354|NCT02145260|Hospitalization|hospitalization
239355|NCT02145208|BPH|bph
239356|NCT02145195|Vitamin D|vitamin d
239357|NCT02145195|Children|children
239358|NCT02145195|Supplements|supplements
239359|NCT02145195|Cardiometabolic markers|cardiometabolic markers
239360|NCT02145195|Immune defense|immune defense
239361|NCT02145195|Bone turnover|bone turnover
239362|NCT02145195|Muscle strength|muscle strength
239363|NCT02145182|DGF|dgf
239364|NCT02145182|Dialysis|dialysis
239365|NCT02145182|Kidney|kidney
239366|NCT02145182|Kidney Transplantation|kidney transplantation
239367|NCT02145182|eGFR|egfr
239368|NCT02145182|Complement|complement
239369|NCT02145182|Eculizumab|eculizumab
239370|NCT02145169|procedural sedation|procedural sedation
239371|NCT02145169|emergence reaction|emergence reaction
239372|NCT02145169|nitrous oxide|nitrous oxide
239373|NCT02145169|ketamine|ketamine
239374|NCT02145156|HPV vaccination|hpv vaccination
239375|NCT02145156|Tailored health messaging|tailored health messaging
239376|NCT02145143|Radioiodine (RAI) Incorporation|radioiodine (rai) incorporation
239377|NCT02145143|Vemurafenib|vemurafenib
239378|NCT02145143|14-031|14-031
239379|NCT02145130|Skin|skin
239380|NCT02145130|Tissue-engineering|tissue-engineering
239381|NCT02145130|Autologous|autologous
239382|NCT02145130|Dermis|dermis
239383|NCT02145130|Epidermis|epidermis
239384|NCT02145117|MBSR|mbsr
239385|NCT02145117|fMRI|fmri
239386|NCT02145117|PTH|pth
239387|NCT02145091|Psilocybin|psilocybin
239388|NCT02145091|Hallucinogens|hallucinogens
239389|NCT02145091|Pharmacologic Actions|pharmacologic actions
239390|NCT02145091|Central Nervous System Agents|central nervous system agents
239391|NCT02145091|Therapeutic Uses|therapeutic uses
239392|NCT02145091|Psychotropic Drugs|psychotropic drugs
239393|NCT02145065|paclitaxel coated balloon|paclitaxel coated balloon
239394|NCT02145065|restenosis|restenosis
239395|NCT02145065|Femoropopliteal artery disease|femoropopliteal artery disease
239396|NCT02145052|Fascial closure|fascial closure
239397|NCT02145052|Interrupted suture|interrupted suture
239398|NCT02145052|Running suture|running suture
239399|NCT02145052|Continuous suture|continuous suture
239400|NCT02145039|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
239401|NCT02145039|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
239402|NCT02145039|Burkitt's lymphoma|burkitt's lymphoma
239403|NCT02145039|Natural killer cell malignancies|natural killer cell malignancies
239404|NCT02145039|Chronic myelogenous leukemia|chronic myelogenous leukemia
239405|NCT02145039|Myelodysplastic syndrome|myelodysplastic syndrome
239406|NCT02145039|Large-cell lymphoma|large-cell lymphoma
239407|NCT02145039|Hodgkin lymphoma|hodgkin lymphoma
239408|NCT02145039|Multiple myeloma|multiple myeloma
239409|NCT02145039|Chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
239410|NCT02145039|Small lymphocytic lymphoma (SLL)|small lymphocytic lymphoma (sll)
239411|NCT02145039|Marginal zone B-cell lymphoma|marginal zone b-cell lymphoma
239412|NCT02145039|Follicular lymphoma|follicular lymphoma
239413|NCT02145039|Lymphoplasmacytic lymphoma|lymphoplasmacytic lymphoma
239414|NCT02145039|Mantle-cell lymphoma|mantle-cell lymphoma
239415|NCT02145039|Prolymphocytic leukemia|prolymphocytic leukemia
239416|NCT02145039|Refractory leukemia|refractory leukemia
239417|NCT02145039|MDS|mds
239418|NCT02145039|Bone marrow failure syndromes|bone marrow failure syndromes
239419|NCT02145039|Myeloproliferative syndromes|myeloproliferative syndromes
239420|NCT02145013|portal hypertension, hepatocellular carcinoma, resection|portal hypertension, hepatocellular carcinoma, resection
239421|NCT02145000|Rotavirus|rotavirus
239422|NCT02145000|Gastroenteritis|gastroenteritis
239423|NCT02145000|Diarrhea|diarrhea
239424|NCT02145000|Vaccine|vaccine
239425|NCT02145000|Niger|niger
239426|NCT02144974|Total pelvic exenteration.|total pelvic exenteration.
239427|NCT02144961|breast reconstruction|breast reconstruction
239428|NCT02144961|Deep Inferior Epigastric Artery Perforator (DIEP)|deep inferior epigastric artery perforator (diep)
239429|NCT02144961|Indocyanine Green Angiography (IGA)|indocyanine green angiography (iga)
239430|NCT02144961|autologous tissue transfer|autologous tissue transfer
239431|NCT02144948|diabetes|diabetes
239432|NCT02144935|pediatrics|pediatrics
239433|NCT02144922|Hypertension|hypertension
239434|NCT02144922|Statin|statin
239435|NCT02144909|Diabetes self management|diabetes self management
239436|NCT02144909|support group|support group
239437|NCT02144909|semi structured support group|semi structured support group
239438|NCT02144883|telephone counseling|telephone counseling
239439|NCT02144870|Tic-Disorder, Tourette-Disorder, Habit Reversal Training, Resources activation|tic-disorder, tourette-disorder, habit reversal training, resources activation
239440|NCT02144844|Antepartum depressive symptoms|antepartum depressive symptoms
239441|NCT02144844|Antepartum depression|antepartum depression
239442|NCT02144844|Cognitive behavioral intervention|cognitive behavioral intervention
239443|NCT02144844|Feasibility|feasibility
239444|NCT02144844|randomized clinical trial|randomized clinical trial
239445|NCT02144831|TIA|tia
239446|NCT02144831|stroke prevention|stroke prevention
239447|NCT02144831|ASA|asa
239448|NCT02144831|clopidogrel|clopidogrel
239449|NCT02144831|dual antiplatelet treatment|dual antiplatelet treatment
239450|NCT02144753|IBS-C|ibs-c
239451|NCT02144753|Constipation|constipation
239452|NCT02144753|IBS|ibs
239453|NCT02144740|Flow-mediated dilation|flow-mediated dilation
239454|NCT02144688|Human Immunodeficiency Virus|human immunodeficiency virus
239455|NCT02144688|HIV|hiv
239456|NCT02144688|Cognitive symptoms|cognitive symptoms
239457|NCT02144688|Cognitive evaluation|cognitive evaluation
239458|NCT02144688|Neuropsychological testing|neuropsychological testing
239459|NCT02144688|Quality of life|quality of life
239460|NCT02144688|Anxiety|anxiety
239461|NCT02144688|Viral load|viral load
239462|NCT02144688|Antiretroviral|antiretroviral
239463|NCT02144688|Cerebrospinal fluid|cerebrospinal fluid
239464|NCT02144688|Lumbar puncture|lumbar puncture
239465|NCT02144688|Magnetic resonance imaging|magnetic resonance imaging
239466|NCT02144688|MRI|mri
239467|NCT02144649|Prostate Cancer|prostate cancer
239468|NCT02144649|Tangerine Juice|tangerine juice
239469|NCT02144649|Tomato Juice|tomato juice
239470|NCT02144623|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
239471|NCT02144623|Valproate|valproate
239472|NCT02144623|Cluster of differentiation antigen 20|cluster of differentiation antigen 20
239473|NCT02144623|Lymphomas|lymphomas
239474|NCT02144623|B-cell lymphomas|b-cell lymphomas
239475|NCT02144623|Translational research|translational research
239476|NCT02144623|Monoclonal antibodies|monoclonal antibodies
239477|NCT02144610|CLI|cli
239478|NCT02144597|morbid obesity|morbid obesity
239479|NCT02144597|gastric bypass|gastric bypass
239480|NCT02144597|bariatrics|bariatrics
239481|NCT02144597|diet|diet
239482|NCT02144597|caloric restriction|caloric restriction
239483|NCT02144597|liver fat|liver fat
239484|NCT02144597|appetite|appetite
239485|NCT02144584|ischemic stroke|ischemic stroke
239486|NCT02144584|memantine|memantine
239487|NCT02144584|upper extremity weakness|upper extremity weakness
239488|NCT02144584|motor recovery|motor recovery
239489|NCT02144558|Sperm parameters|sperm parameters
239490|NCT02144558|Spinal cord injuries|spinal cord injuries
239491|NCT02144558|Oxidative stress|oxidative stress
239492|NCT02144558|Inflammatory syndrome|inflammatory syndrome
239493|NCT02144545|Surgery|surgery
239494|NCT02144545|Morbid Obesity|morbid obesity
239495|NCT02144545|Bariatric surgery|bariatric surgery
239496|NCT02144545|Sleeve gastrectomy|sleeve gastrectomy
239497|NCT02144545|Bougie Size|bougie size
239498|NCT02144545|Distance from pylorus|distance from pylorus
239499|NCT02144545|Hormones|hormones
239500|NCT02144545|Gastric remanent|gastric remanent
239501|NCT02144532|Ehlers-Danlos syndrome|ehlers-danlos syndrome
239502|NCT02144532|hypermobility|hypermobility
239503|NCT02144532|Compression garment|compression garment
239504|NCT02144532|pain|pain
239505|NCT02144532|isokinetic evaluation|isokinetic evaluation
239506|NCT02144506|Elderly, home-based exercises programm|elderly, home-based exercises programm
239507|NCT02144493|common bile duct stones|common bile duct stones
239508|NCT02144493|diverticulum|diverticulum
239509|NCT02144480|coronary bypass surgery|coronary bypass surgery
239510|NCT02144480|rehabilitation|rehabilitation
239511|NCT02144480|exercise training|exercise training
239512|NCT02144480|platelet activation|platelet activation
239513|NCT02144480|cardiopulmonary fitness|cardiopulmonary fitness
239514|NCT02144467|Multiple-MRI, Gene, Cognition|multiple-mri, gene, cognition
239515|NCT02144454|Cardiovascular disease|cardiovascular disease
239516|NCT02144454|Fatty acids|fatty acids
239517|NCT02144454|Vascular function|vascular function
239518|NCT02144454|Blood pressure|blood pressure
239519|NCT02144454|Plasma lipids|plasma lipids
239520|NCT02144454|Insulin resistance|insulin resistance
239521|NCT02144454|Endothelial activation|endothelial activation
239522|NCT02144441|Diabetes Mellitus|diabetes mellitus
239523|NCT02144441|Insulin|insulin
239524|NCT02144441|Self Administration|self administration
239525|NCT02144441|Patient Satisfaction|patient satisfaction
239526|NCT02144441|Glucose|glucose
239527|NCT02144441|Hypoglycemia|hypoglycemia
239528|NCT02144441|Hyperglycemia|hyperglycemia
239529|NCT02144415|abuse liability|abuse liability
239530|NCT02144415|recreational drug user|recreational drug user
239531|NCT02144415|stimulant|stimulant
239532|NCT02144415|d-amphetamine|d-amphetamine
239533|NCT02144415|ADHD|adhd
239534|NCT02144389|Arachidonic acid|arachidonic acid
239535|NCT02144389|Bilharzia|bilharzia
239536|NCT02144389|Mansoni|mansoni
239537|NCT02144389|Schistosomiasis|schistosomiasis
239538|NCT02144389|Polyunsaturated fatty acid|polyunsaturated fatty acid
239539|NCT02144376|Constipation|constipation
239540|NCT02144376|psyllium|psyllium
239541|NCT02144376|ispaghula|ispaghula
239542|NCT02144376|Magnetic Resonance Imaging|magnetic resonance imaging
239543|NCT02144376|MRI|mri
239544|NCT02144376|microbiota|microbiota
239545|NCT02144363|Preterm|preterm
239546|NCT02144363|RDS|rds
239547|NCT02144363|Mechanical Ventilation|mechanical ventilation
239548|NCT02144363|Extubation failure|extubation failure
239549|NCT02144350|hyperbaric oxygen|hyperbaric oxygen
239550|NCT02144337|Physical activity|physical activity
239551|NCT02144337|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
239552|NCT02144337|Children|children
239553|NCT02144337|Intervention|intervention
239554|NCT02144324|Maxillary protraction|maxillary protraction
239555|NCT02144324|Modified Tandem Appliance|modified tandem appliance
239556|NCT02144324|Face mask therapy|face mask therapy
239557|NCT02144324|Class III malocclusion|class iii malocclusion
239558|NCT02144324|Maxillary deficiency|maxillary deficiency
239559|NCT02144311|MRI|mri
239560|NCT02144311|FDG PET/CT|fdg pet/ct
239561|NCT02144311|histologic heterogeneity|histologic heterogeneity
239562|NCT02144311|14-061|14-061
239563|NCT02144298|microcirculation|microcirculation
239564|NCT02144298|coronary artery bypass grafting|coronary artery bypass grafting
239565|NCT02144298|cold blood cardioplegia|cold blood cardioplegia
239566|NCT02144298|cristalloid cardioplegia|cristalloid cardioplegia
239567|NCT02144285|Renal dialysis|renal dialysis
239568|NCT02144272|Antibody|antibody
239569|NCT02144272|Tumor Necrosis Factor alpha|tumor necrosis factor alpha
239570|NCT02144272|Interleukin-17|interleukin-17
239571|NCT02144233|Pain|pain
239572|NCT02144233|Temporomandibular joint disorders|temporomandibular joint disorders
239573|NCT02144233|Occlusal adjustment|occlusal adjustment
239574|NCT02144233|Therapy|therapy
239575|NCT02144233|Randomized clinical trial|randomized clinical trial
239576|NCT02144233|Mastication|mastication
239577|NCT02144233|Habitual chewing side|habitual chewing side
239578|NCT02144233|Handedness preference|handedness preference
239579|NCT02144233|Hemimandibular retrognathia|hemimandibular retrognathia
239580|NCT02144220|Telemedicine|telemedicine
239581|NCT02144220|Virtual care visit|virtual care visit
239582|NCT02144220|Remote visit|remote visit
239583|NCT02144220|Video-conferencing|video-conferencing
239584|NCT02144194|Oral Vinorelbine|oral vinorelbine
239585|NCT02144194|Oral Chemotherapy|oral chemotherapy
239586|NCT02144194|Metastatic Breast Cancer|metastatic breast cancer
239587|NCT02144194|Advanced Breast Cancer|advanced breast cancer
239588|NCT02144194|Maintenance treatment|maintenance treatment
239589|NCT02144181|Ulthera® System|ulthera® system
239590|NCT02144181|Ultherapy® Treatment|ultherapy® treatment
239591|NCT02144181|Ulthera, Inc.|ulthera, inc.
239592|NCT02144168|Prebiotics|prebiotics
239593|NCT02144168|diarrhoea|diarrhoea
239594|NCT02144168|Enteral nutrition|enteral nutrition
239595|NCT02144168|Fibre|fibre
239596|NCT02144168|Bifidobacteria|bifidobacteria
239597|NCT02144168|SCFA|scfa
239598|NCT02144155|Oxytocin|oxytocin
239599|NCT02144142|Microbiome|microbiome
239600|NCT02144142|Atopic dermatitis|atopic dermatitis
239601|NCT02144142|Eczema|eczema
239602|NCT02144142|Bacteriotherapy|bacteriotherapy
239603|NCT02144129|Whole Body Electromyostimulation|whole body electromyostimulation
239604|NCT02144129|Inflammatory Bowel Disease|inflammatory bowel disease
239605|NCT02144129|Lean Body Mass|lean body mass
239606|NCT02144129|Muscle Strength|muscle strength
239607|NCT02144116|dance-movement therapy|dance-movement therapy
239608|NCT02144116|balance|balance
239609|NCT02144116|Fibromyalgia|fibromyalgia
239610|NCT02144103|Glaucomatous Neurodegeneration|glaucomatous neurodegeneration
239611|NCT02144103|Retinal Degeneration|retinal degeneration
239612|NCT02144103|Primary Open-Angle Glaucoma|primary open-angle glaucoma
239613|NCT02144103|Optic Neuropathy|optic neuropathy
239614|NCT02144103|Intraocular pressure|intraocular pressure
239615|NCT02144103|Retinal ganglion cell degeneration|retinal ganglion cell degeneration
239616|NCT02144103|Optic nerve atrophy|optic nerve atrophy
239617|NCT02144103|Subtenon injection|subtenon injection
239618|NCT02144103|Glaucomatous damage|glaucomatous damage
239619|NCT02144103|ADRC|adrc
239620|NCT02144103|Adipose-derived regenerative cells|adipose-derived regenerative cells
239621|NCT02144103|Fat tissue|fat tissue
239622|NCT02144103|Stem cells|stem cells
239623|NCT02144090|Angiography|angiography
239624|NCT02144090|Angioplasty|angioplasty
239625|NCT02144090|Coronary artery disease|coronary artery disease
239626|NCT02144090|Diagnostic|diagnostic
239627|NCT02144090|Fractional flow reserve|fractional flow reserve
239628|NCT02144077|Photodynamic Therapy|photodynamic therapy
239630|NCT02144077|non-aggressive BCC|non-aggressive bcc
239631|NCT02144064|Aspirin, heparin, pregnancy, recurrent pregnancy loss|aspirin, heparin, pregnancy, recurrent pregnancy loss
239632|NCT02144051|solid tumor, prostate cancer, breast cancer, bladder cancer, ovarian cancer, gastric cancer, salivary duct cancer|solid tumor, prostate cancer, breast cancer, bladder cancer, ovarian cancer, gastric cancer, salivary duct cancer
239633|NCT02144038|multiple myeloma,|multiple myeloma,
239634|NCT02144038|relapsed and refractory,|relapsed and refractory,
239635|NCT02144038|LGH447,|lgh447,
239636|NCT02144038|pan-PIM inhibitor,|pan-pim inhibitor,
239637|NCT02144038|PIM Kinase,|pim kinase,
239638|NCT02144038|BYL719,|byl719,
239639|NCT02144038|PI3K inhibitor|pi3k inhibitor
239640|NCT02144025|Ocular Graft-Versus-Host-Disease|ocular graft-versus-host-disease
239641|NCT02144025|Topical Cyclosporine|topical cyclosporine
239642|NCT02143986|sepsis|sepsis
239643|NCT02143986|Macrophagic activation syndrome|macrophagic activation syndrome
239644|NCT02143986|Ferritin|ferritin
239645|NCT02143986|Still's disease|still's disease
239646|NCT02143973|Uremic|uremic
239647|NCT02143973|Pruritus|pruritus
239648|NCT02143973|Itch|itch
239649|NCT02143973|Chronic Itch|chronic itch
239650|NCT02143973|Nalbuphine|nalbuphine
239651|NCT02143960|Syneron|syneron
239652|NCT02143960|Velashape|velashape
239653|NCT02143960|ELOS|elos
239654|NCT02143960|Zeltiq|zeltiq
239655|NCT02143960|Cryolipolysis|cryolipolysis
239656|NCT02143947|Orthoses|orthoses
239657|NCT02143947|Foot|foot
239658|NCT02143947|Kinematics|kinematics
239659|NCT02143947|EMG|emg
239660|NCT02143947|Biomechanics|biomechanics
239661|NCT02143934|Plasmodium vivax|plasmodium vivax
239662|NCT02143934|Hypnozoites|hypnozoites
239663|NCT02143934|Primaquine|primaquine
239664|NCT02143934|Liver-stage|liver-stage
239665|NCT02143934|Blood-stage|blood-stage
239666|NCT02143934|Plasmodium falciparum|plasmodium falciparum
239667|NCT02143921|NGO zinc scale|ngo zinc scale
239668|NCT02143921|compliance with WHO zinc treatment recommendations|compliance with who zinc treatment recommendations
239669|NCT02143908|Diarrhea|diarrhea
239670|NCT02143908|L-lysine supplementation|l-lysine supplementation
239671|NCT02143908|immune status|immune status
239672|NCT02143908|adults|adults
239673|NCT02143908|Bangladesh|bangladesh
239674|NCT02143908|aged 18-45 years|aged 18-45 years
239675|NCT02143908|urban community|urban community
239676|NCT02143882|Live attenuated influenza vaccine|live attenuated influenza vaccine
239677|NCT02143882|fluenz|fluenz
239678|NCT02143882|pandemrix|pandemrix
239679|NCT02143882|pandemic influenza vaccine|pandemic influenza vaccine
239680|NCT02143882|immunogenicity|immunogenicity
239681|NCT02143869|Gastrointestinal cancer|gastrointestinal cancer
239682|NCT02143869|Lung cancer|lung cancer
239683|NCT02143869|Bioelectrical Impedance analysis|bioelectrical impedance analysis
239684|NCT02143869|Body composition|body composition
239685|NCT02143869|Perioperative|perioperative
239686|NCT02143830|marrow aplasia|marrow aplasia
239687|NCT02143830|cytopenia|cytopenia
239688|NCT02143830|myelodysplasia|myelodysplasia
239689|NCT02143830|AML|aml
239690|NCT02143830|bone marrow transplant|bone marrow transplant
239691|NCT02143830|cytoreductive regimen|cytoreductive regimen
239692|NCT02143830|T-cell reduction|t-cell reduction
239693|NCT02143817|whole body vibration training|whole body vibration training
239694|NCT02143817|L-citrulline|l-citrulline
239695|NCT02143817|hypertension|hypertension
239696|NCT02143817|obesity|obesity
239697|NCT02143817|arterial function|arterial function
239698|NCT02143817|arterial stiffness|arterial stiffness
239699|NCT02143817|autonomic function|autonomic function
239700|NCT02143817|endothelial function|endothelial function
239701|NCT02143804|Oncolytic virus|oncolytic virus
239702|NCT02143804|GMCSF|gmcsf
239703|NCT02143804|pRb|prb
239704|NCT02143804|PDL1|pdl1
239705|NCT02143804|Immunotherapy|immunotherapy
239706|NCT02143804|Adenovirus|adenovirus
239707|NCT02143791|SCS|scs
239708|NCT02143791|Burst stimulation|burst stimulation
239709|NCT02143778|MBT|mbt
239710|NCT02143778|CSPH|csph
239711|NCT02143778|HVPG|hvpg
239712|NCT02143765|Mitiglinide|mitiglinide
239713|NCT02143765|Acarbose|acarbose
239714|NCT02143765|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
239715|NCT02143752|Smoking|smoking
239716|NCT02143752|Tobacco|tobacco
239717|NCT02143752|Addiction|addiction
239718|NCT02143752|Mindfulness|mindfulness
239719|NCT02143752|Meditation|meditation
239720|NCT02143739|asthma|asthma
239721|NCT02143713|Dyspareunia|dyspareunia
239722|NCT02143713|Endometriosis-associated pain|endometriosis-associated pain
239723|NCT02143713|Dysmenorrhea (DYS)|dysmenorrhea (dys)
239724|NCT02143713|Elagolix|elagolix
239725|NCT02143713|Gonadotropin-releasing Hormone Antagonist|gonadotropin-releasing hormone antagonist
239726|NCT02143713|Non-menstrual Pelvic Pain (NMPP)|non-menstrual pelvic pain (nmpp)
239727|NCT02143700|exacerbation|exacerbation
239728|NCT02143700|cognitive|cognitive
239729|NCT02143700|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
239730|NCT02143687|Pulmonary hypertension|pulmonary hypertension
239731|NCT02143687|Interstitial lung disease|interstitial lung disease
239732|NCT02143687|Pulmonary fibrosis|pulmonary fibrosis
239733|NCT02143674|Stretching exercise muscle|stretching exercise muscle
239734|NCT02143674|Elderly|elderly
239735|NCT02143674|Techniques and exercise|techniques and exercise
239736|NCT02143674|Physiotherapy|physiotherapy
239737|NCT02143648|uremic|uremic
239738|NCT02143648|pruritus|pruritus
239739|NCT02143648|itch|itch
239740|NCT02143648|chronic itch|chronic itch
239741|NCT02143648|nalbuphine|nalbuphine
239742|NCT02143635|HDM201,TP53wt, p53, MDM2, HDM2, advanced tumors, BLRM (Bayesian logistic regression model)|hdm201,tp53wt, p53, mdm2, hdm2, advanced tumors, blrm (bayesian logistic regression model)
239743|NCT02143622|Head and neck cancer|head and neck cancer
239744|NCT02143609|airway disease|airway disease
239745|NCT02143609|bronchitis|bronchitis
239746|NCT02143609|emphysema|emphysema
239747|NCT02143609|lung|lung
239748|NCT02143596|stroke|stroke
239749|NCT02143596|dehydration|dehydration
239750|NCT02143596|prognosis|prognosis
239751|NCT02143583|rhinoconjunctivitis|rhinoconjunctivitis
239752|NCT02143583|birch pollen|birch pollen
239753|NCT02143583|desensitization|desensitization
239754|NCT02143583|allergen immunotherapy|allergen immunotherapy
239755|NCT02143570|Urinary Bladder, Overactive|urinary bladder, overactive
239756|NCT02143570|Darifenacin|darifenacin
239757|NCT02143570|Physiotherapy|physiotherapy
239758|NCT02143570|Quality of Life|quality of life
239759|NCT02143557|breast milk|breast milk
239760|NCT02143557|infants|infants
239761|NCT02143557|chylothorax|chylothorax
239762|NCT02143557|cardiac surgery|cardiac surgery
239763|NCT02143557|modified breast milk|modified breast milk
239764|NCT02143544|Intra-aortic balloon counterpulsation|intra-aortic balloon counterpulsation
239765|NCT02143544|Cardiac surgery|cardiac surgery
239766|NCT02143544|High-risk patients|high-risk patients
239767|NCT02143518|Human Hookworm|human hookworm
239768|NCT02143518|Necator americanus|necator americanus
239769|NCT02143518|Hookworm|hookworm
239770|NCT02143518|Hookworm Disease|hookworm disease
239771|NCT02143518|Iron-deficiency anemia|iron-deficiency anemia
239772|NCT02143518|Soil-transmitted helminth infection|soil-transmitted helminth infection
239773|NCT02143518|Neglected Tropical Disease|neglected tropical disease
239774|NCT02143518|Na-GST-1|na-gst-1
239775|NCT02143518|CpG|cpg
239776|NCT02143479|France|france
239777|NCT02143479|Prograf|prograf
239778|NCT02143479|Pharmaco-epidemiology|pharmaco-epidemiology
239779|NCT02143479|Tacrolimus|tacrolimus
239780|NCT02143479|Observational|observational
239781|NCT02143466|Phase I|phase i
239782|NCT02143466|Safety|safety
239783|NCT02143466|Tolerability|tolerability
239784|NCT02143466|Efficacy|efficacy
239785|NCT02143466|Anti-tumour|anti-tumour
239786|NCT02143466|AZD9291|azd9291
239787|NCT02143466|AZD6094|azd6094
239788|NCT02143466|MEDI4736|medi4736
239789|NCT02143466|Osimertinib|osimertinib
239790|NCT02143466|Savolitinib|savolitinib
239791|NCT02143466|Selumetinib|selumetinib
239792|NCT02143466|Durvalumab|durvalumab
239793|NCT02143466|Ascending Doses|ascending doses
239794|NCT02143466|Expansion cohorts|expansion cohorts
239795|NCT02143466|EGFR|egfr
239796|NCT02143466|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
239797|NCT02143466|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors
239798|NCT02143453|exercise|exercise
239799|NCT02143453|overweight|overweight
239800|NCT02143453|children|children
239801|NCT02143427|social skills training,|social skills training,
239802|NCT02143427|computer based,|computer based,
239803|NCT02143427|social competence training,|social competence training,
239804|NCT02143427|Oppositional Defiant Disorder|oppositional defiant disorder
239805|NCT02143427|peer related aggressive behavior|peer related aggressive behavior
239806|NCT02143427|randomized controlled trial|randomized controlled trial
239807|NCT02143388|Local advanced|local advanced
239808|NCT02143388|high risk|high risk
239809|NCT02143388|nasopharyngeal carcinoma|nasopharyngeal carcinoma
239810|NCT02143362|Intraoperative wake up|intraoperative wake up
239811|NCT02143362|Closed loop of target controlled infusion|closed loop of target controlled infusion
239812|NCT02143362|Dexmedetomidine|dexmedetomidine
239813|NCT02143362|Propofol|propofol
239814|NCT02143349|obesity|obesity
239815|NCT02143349|herbal remedies|herbal remedies
239816|NCT02143349|metabolic disorders|metabolic disorders
239817|NCT02143336|Surgical site infections|surgical site infections
239818|NCT02143336|Skin closure techniques|skin closure techniques
239819|NCT02143336|Colorectal surgery|colorectal surgery
239820|NCT02143323|GST, DILI, biomarker|gst, dili, biomarker
239821|NCT02143297|Sleep Apnea/Hypopnea Syndrome|sleep apnea/hypopnea syndrome
239822|NCT02143297|Pulse Oximetry|pulse oximetry
239823|NCT02143297|Nonlinear Dynamics|nonlinear dynamics
239824|NCT02143297|Fourier Analysis|fourier analysis
239825|NCT02143297|Neural Networks (Computer)|neural networks (computer)
239826|NCT02143271|Secondary Hyperparathyroidism in Patients Receiving Peritoneal Dialysis|secondary hyperparathyroidism in patients receiving peritoneal dialysis
239827|NCT02143258|stenting venous sinus|stenting venous sinus
239828|NCT02143258|intracranial hypertension|intracranial hypertension
239829|NCT02143258|quality of life|quality of life
239830|NCT02143258|headache|headache
239831|NCT02143258|visual impairment|visual impairment
239832|NCT02143232|knee replacement|knee replacement
239833|NCT02143232|hip replacement|hip replacement
239834|NCT02143232|patient monitor|patient monitor
239835|NCT02143219|Pancreatic metastatic cancer|pancreatic metastatic cancer
239836|NCT02143219|FOLFIRINOX|folfirinox
239837|NCT02143219|toxicity|toxicity
239838|NCT02143219|efficacy|efficacy
239839|NCT02143206|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
239840|NCT02143206|Pain|pain
239841|NCT02143206|Arthritis|arthritis
239842|NCT02143206|Dyspnea|dyspnea
239843|NCT02143206|Exercise|exercise
239844|NCT02143206|Aerobic|aerobic
239845|NCT02143193|Breastfeeding|breastfeeding
239846|NCT02143193|Newborn|newborn
239847|NCT02143193|Formula|formula
239848|NCT02143193|Temperature|temperature
239849|NCT02143193|Initial Bath|initial bath
239850|NCT02143180|real-time tissue elastography|real-time tissue elastography
239851|NCT02143180|hepatic fibrosis|hepatic fibrosis
239852|NCT02143154|vancomycin, GBS|vancomycin, gbs
239853|NCT02143141|postoperative pain|postoperative pain
239854|NCT02143141|narcotic side effects|narcotic side effects
239855|NCT02143128|score|score
239856|NCT02143128|postoperative|postoperative
239857|NCT02143128|pain|pain
239858|NCT02143128|nausea|nausea
239859|NCT02143128|mental status|mental status
239860|NCT02143128|tool|tool
239861|NCT02143115|Colorectal cancer surveillance|colorectal cancer surveillance
239862|NCT02143089|CCSWI|ccswi
239863|NCT02143076|Medication Adherence|medication adherence
239864|NCT02143076|Hydroxyurea|hydroxyurea
239865|NCT02143050|Unresectable melanoma Stage IIIC and Stage IV BRAF V600E+|unresectable melanoma stage iiic and stage iv braf v600e+
239866|NCT02143024|depression|depression
239867|NCT02143024|family|family
239868|NCT02143024|primary health care|primary health care
239869|NCT02143011|sugar|sugar
239870|NCT02143011|sucrose|sucrose
239871|NCT02143011|fruit juice|fruit juice
239872|NCT02143011|orange juice|orange juice
239873|NCT02143011|metabolism|metabolism
239874|NCT02143011|immune cell aging|immune cell aging
239875|NCT02143011|lipids|lipids
239876|NCT02142998|GERD|gerd
239877|NCT02142998|Laparoscopic|laparoscopic
239878|NCT02142998|sleeve|sleeve
239879|NCT02142998|gastrectomy|gastrectomy
239880|NCT02142972|Low back pain|low back pain
239881|NCT02142972|Oswestry questionnaire|oswestry questionnaire
239882|NCT02142972|Post-partum Depression|post-partum depression
239883|NCT02142972|Pelvic pain|pelvic pain
239884|NCT02142959|RTA 408|rta 408
239885|NCT02142959|RTA 408 Lotion|rta 408 lotion
239886|NCT02142959|Breast cancer|breast cancer
239887|NCT02142959|Radiation therapy|radiation therapy
239888|NCT02142959|Radiation dermatitis|radiation dermatitis
239889|NCT02142959|Oxidative stress|oxidative stress
239890|NCT02142959|Inflammation|inflammation
239891|NCT02142959|omaveloxolone|omaveloxolone
239892|NCT02142933|colonization|colonization
239893|NCT02142933|screening|screening
239894|NCT02142933|group B streptococci|group b streptococci
239895|NCT02142933|extended-spectrum beta-lactamase|extended-spectrum beta-lactamase
239896|NCT02142933|enterobacteriaceae|enterobacteriaceae
239897|NCT02142920|Healthy Volunteers|healthy volunteers
239898|NCT02142907|Breast conservative surgery|breast conservative surgery
239899|NCT02142907|boost radiation|boost radiation
239900|NCT02142907|acute toxicity|acute toxicity
239901|NCT02142907|cosmesis|cosmesis
239902|NCT02142907|local control|local control
239903|NCT02142894|Tuberculosis|tuberculosis
239904|NCT02142894|TB|tb
239905|NCT02142868|Expanded Access|expanded access
239906|NCT02142868|Advanced Breast Cancer|advanced breast cancer
239907|NCT02142855|volunteers|volunteers
239908|NCT02142855|young (18-30 y)|young (18-30 y)
239909|NCT02142855|older (65-75 y)|older (65-75 y)
239910|NCT02142855|age groups|age groups
239911|NCT02142842|Adipose stem cell|adipose stem cell
239912|NCT02142842|Platelet rich plasma|platelet rich plasma
239913|NCT02142842|Knee Osteoarthritis|knee osteoarthritis
239914|NCT02142842|Injured cartilage|injured cartilage
239915|NCT02142829|bariatric surgery, postoperative pain|bariatric surgery, postoperative pain
239916|NCT02142777|S-equol|s-equol
239917|NCT02142777|COX activity|cox activity
239918|NCT02142764|Multiple Sclerosis|multiple sclerosis
239919|NCT02142764|CD8+ T-cells|cd8+ t-cells
239920|NCT02142764|Class I Major Histocompatibility Complex (MHC)|class i major histocompatibility complex (mhc)
239921|NCT02142764|pentamers|pentamers
239922|NCT02142751|Escherichia coli|escherichia coli
239923|NCT02142751|Extended-spectrum β-lactamases (ESBLs)|extended-spectrum β-lactamases (esbls)
239924|NCT02142751|Bacteremia|bacteremia
239925|NCT02142751|Urinary tract infection|urinary tract infection
239926|NCT02142751|Bloodstream infection|bloodstream infection
239927|NCT02142751|Fosfomycin|fosfomycin
239928|NCT02142751|Meropenem|meropenem
239929|NCT02142751|Pharmacokinetics|pharmacokinetics
239930|NCT02142751|intestinal colonization|intestinal colonization
239931|NCT02142751|Recurrence|recurrence
239932|NCT02142751|multidrug resistance E.coli|multidrug resistance e.coli
239933|NCT02142751|Ceftriaxone|ceftriaxone
239934|NCT02142738|PD-1|pd-1
239935|NCT02142738|PD1|pd1
239936|NCT02142738|PD-L1|pd-l1
239937|NCT02142738|PDL1|pdl1
239938|NCT02142712|Ischemic Stroke|ischemic stroke
239939|NCT02142712|Brain Edema|brain edema
239940|NCT02142712|Diphenhydramine|diphenhydramine
239941|NCT02142712|Dextromethorphan|dextromethorphan
239942|NCT02142712|Famotidine|famotidine
239943|NCT02142699|Acute kidney injury|acute kidney injury
239944|NCT02142699|Cardiac surgery|cardiac surgery
239945|NCT02142699|Ischaemia reperfusion injury|ischaemia reperfusion injury
239946|NCT02142699|hemearginate|hemearginate
239947|NCT02142686|Hysteroscopy|hysteroscopy
239948|NCT02142686|Filling pressures|filling pressures
239949|NCT02142673|Operative hysteroscopy|operative hysteroscopy
239950|NCT02142673|Filling pressure|filling pressure
239951|NCT02142660|Adhesion barrier system|adhesion barrier system
239952|NCT02142660|Bariatric surgery|bariatric surgery
239953|NCT02142647|infant growth|infant growth
239954|NCT02142647|dietary protein|dietary protein
239955|NCT02142647|body composition|body composition
239956|NCT02142647|gut microbiome|gut microbiome
239957|NCT02142608|Prostate cancer|prostate cancer
239958|NCT02142608|Ultrasound Imaging|ultrasound imaging
239959|NCT02142595|dexmedetomidine|dexmedetomidine
239960|NCT02142595|midazolam|midazolam
239961|NCT02142595|sleep quality|sleep quality
239962|NCT02142595|delirium|delirium
239963|NCT02142582|Home Parenteral Nutrition|home parenteral nutrition
239964|NCT02142582|Compliance|compliance
239965|NCT02142582|Short Bowel Syndrome|short bowel syndrome
239966|NCT02142582|Oral Rehydration Solution|oral rehydration solution
239967|NCT02142569|Monacolin K|monacolin k
239968|NCT02142569|Cholesterol|cholesterol
239969|NCT02142569|Tocotrienol-enriched fraction of palm oil (TRF)|tocotrienol-enriched fraction of palm oil (trf)
239970|NCT02142569|Chinese Red Yeast Rice (CRYR|chinese red yeast rice (cryr
239971|NCT02142530|NHL|nhl
239972|NCT02142530|DLBCL|dlbcl
239973|NCT02142530|PTCL|ptcl
239974|NCT02142530|Marginal zone lymphoma|marginal zone lymphoma
239975|NCT02142530|lymphoplasmacytic lymphoma|lymphoplasmacytic lymphoma
239976|NCT02142530|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
239977|NCT02142517|pancreaticoduodenectomy, pancreatic fistula|pancreaticoduodenectomy, pancreatic fistula
239978|NCT02142504|Drug therapy|drug therapy
239979|NCT02142491|Egg allergy|egg allergy
239980|NCT02142491|live attenuated influenza vaccine|live attenuated influenza vaccine
239981|NCT02142478|physical activity|physical activity
239982|NCT02142478|behaviour change|behaviour change
239983|NCT02142478|exercise referral|exercise referral
239984|NCT02142478|self-determination theory|self-determination theory
239985|NCT02142478|mixed-method|mixed-method
239986|NCT02142478|evaluation|evaluation
239987|NCT02142478|qualitative|qualitative
239988|NCT02142452|Pregnancy|pregnancy
239989|NCT02142452|Obesity/Overweight|obesity/overweight
239990|NCT02142452|postpartum|postpartum
239991|NCT02142452|mobile health|mobile health
239992|NCT02142452|cardiovascular disease|cardiovascular disease
239993|NCT02142439|Anorexia|anorexia
239994|NCT02142439|Bulimia|bulimia
239995|NCT02142439|Physical activity|physical activity
239996|NCT02142439|Treatment|treatment
239997|NCT02142426|wound chronic|wound chronic
239998|NCT02142413|Stroke|stroke
239999|NCT02142413|Atrial fibrillation|atrial fibrillation
240000|NCT02142413|Holter ECG|holter ecg
240001|NCT02142413|cardiac MRI|cardiac mri
240002|NCT02142335|B-Raf, inoperable stage III melanoma, metastatic stage IV melanoma,|b-raf, inoperable stage iii melanoma, metastatic stage iv melanoma,
240003|NCT02142296|Pigment Epithelial Detachment|pigment epithelial detachment
240004|NCT02142296|Age-related Macular degeneration|age-related macular degeneration
240005|NCT02142283|Mechanical thrombectomy|mechanical thrombectomy
240006|NCT02142283|Acute ischemic stroke|acute ischemic stroke
240007|NCT02142283|Wake up stroke|wake up stroke
240008|NCT02142283|Late presenting stroke|late presenting stroke
240009|NCT02142257|Obesity|obesity
240010|NCT02142257|Gastric Bypass|gastric bypass
240011|NCT02142257|Aspiration Therapy|aspiration therapy
240012|NCT02142257|AspireAssist|aspireassist
240013|NCT02142244|Sentinel node biopsy|sentinel node biopsy
240014|NCT02142244|Near infra red light|near infra red light
240015|NCT02142244|Indocyanine green|indocyanine green
240016|NCT02142244|micrometastasis|micrometastasis
240017|NCT02142231|acupuncture|acupuncture
240018|NCT02142231|test anxiety|test anxiety
240019|NCT02142231|neuroenhancer|neuroenhancer
240020|NCT02142231|placebo|placebo
240021|NCT02142179|Asthma|asthma
240022|NCT02142179|Knowledge|knowledge
240023|NCT02142179|School-Based Service|school-based service
240024|NCT02142179|Adolescents|adolescents
240025|NCT02142166|aneurysmal subarachnoid hemorrhage (ASH)|aneurysmal subarachnoid hemorrhage (ash)
240026|NCT02142166|biomarker|biomarker
240027|NCT02142153|First in man|first in man
240028|NCT02142153|Antifungal|antifungal
240029|NCT02142153|Intravenous infusion|intravenous infusion
240030|NCT02142153|Healthy volunteers|healthy volunteers
240031|NCT02142140|Treatment of ADHD|treatment of adhd
240032|NCT02142140|Long-term treatment follow-up|long-term treatment follow-up
240033|NCT02142127|GFT505|gft505
240034|NCT02142127|Mass balance|mass balance
240035|NCT02142127|Pharmacokinetics|pharmacokinetics
240036|NCT02142127|Metabolites|metabolites
240037|NCT02142127|Healthy subjects|healthy subjects
240038|NCT02142127|Healthy male volunteers|healthy male volunteers
240039|NCT02142114|Intravitreal injection|intravitreal injection
240040|NCT02142114|Needle size|needle size
240041|NCT02142114|Pain|pain
240042|NCT02142114|Intraocular pressure|intraocular pressure
240043|NCT02142114|Pain following an Intravitreal injection|pain following an intravitreal injection
240044|NCT02142101|Gut Microbiota|gut microbiota
240045|NCT02142101|Polycystic kidney disease|polycystic kidney disease
240046|NCT02142101|Chronic kidney disease|chronic kidney disease
240047|NCT02142101|Uremic metabolites|uremic metabolites
240048|NCT02142088|Glycaemic Control|glycaemic control
240049|NCT02142088|Glucose Monitoring|glucose monitoring
240050|NCT02142088|Intravascular Glucose Monitoring|intravascular glucose monitoring
240051|NCT02142075|Pharmacokinetics|pharmacokinetics
240052|NCT02142062|Venous outflow obstruction|venous outflow obstruction
240053|NCT02142062|Iliac Vein|iliac vein
240054|NCT02142062|Common Femoral Vein|common femoral vein
240055|NCT02142062|Iliac Compression|iliac compression
240056|NCT02142049|DLBCL|dlbcl
240057|NCT02142049|ABC|abc
240058|NCT02142049|GCB|gcb
240059|NCT02142049|Primary Mediastinal B-cell lymphoma|primary mediastinal b-cell lymphoma
240060|NCT02142049|Pharmacyclics|pharmacyclics
240061|NCT02142049|Lenalidomide|lenalidomide
240062|NCT02142049|lymphoma|lymphoma
240063|NCT02142049|Rituximab|rituximab
240064|NCT02142049|EPOCH|epoch
240065|NCT02142036|Metastatic disease|metastatic disease
240066|NCT02142036|Metastasis|metastasis
240067|NCT02142036|Targeted therapy|targeted therapy
240068|NCT02142036|Solid tumor|solid tumor
240069|NCT02142036|Personalized medicine|personalized medicine
240070|NCT02142036|N-of-1 trial|n-of-1 trial
240071|NCT02141997|efficacy|efficacy
240072|NCT02141997|Methotrexate|methotrexate
240073|NCT02141997|safety|safety
240074|NCT02141984|Korean regulatory required Postmarketing Surveillance|korean regulatory required postmarketing surveillance
240075|NCT02141971|Down syndrome|down syndrome
240076|NCT02141971|Alzheimer's disease|alzheimer's disease
240077|NCT02141971|biomarkers|biomarkers
240078|NCT02141971|amyloid|amyloid
240079|NCT02141971|tau|tau
240080|NCT02141945|Cancer|cancer
240081|NCT02141945|Colon Cancer|colon cancer
240082|NCT02141945|Colorectal Cancer|colorectal cancer
240083|NCT02141945|Neoplasm|neoplasm
240084|NCT02141945|Colorectal Neoplasm|colorectal neoplasm
240085|NCT02141945|Intestinal Neoplasms|intestinal neoplasms
240086|NCT02141945|Gastrointestinal Neoplasms|gastrointestinal neoplasms
240087|NCT02141945|Digestive System Neoplasms|digestive system neoplasms
240088|NCT02141945|Neoplasms by Site|neoplasms by site
240089|NCT02141945|Neoplasms|neoplasms
240090|NCT02141945|Colonic Diseases|colonic diseases
240091|NCT02141945|Digestive System Diseases|digestive system diseases
240092|NCT02141945|Gastrointestinal Diseases|gastrointestinal diseases
240093|NCT02141945|Intestinal Diseases|intestinal diseases
240094|NCT02141945|Rectal Diseases|rectal diseases
240095|NCT02141932|Hand-held|hand-held
240096|NCT02141932|Ultrasound|ultrasound
240097|NCT02141932|Diagnosis|diagnosis
240098|NCT02141932|Cardiovascular|cardiovascular
240099|NCT02141932|Carotid artery stenosis|carotid artery stenosis
240100|NCT02141919|renal cancer|renal cancer
240101|NCT02141880|Obesity|obesity
240102|NCT02141867|Surgery|surgery
240103|NCT02141867|Mortality|mortality
240104|NCT02141841|intrathecal;|intrathecal;
240105|NCT02141841|bupivacaine;|bupivacaine;
240106|NCT02141841|concentration;|concentration;
240107|NCT02141828|Leukemia|leukemia
240108|NCT02141828|Advanced hematologic malignancies|advanced hematologic malignancies
240109|NCT02141828|Epizyme|epizyme
240110|NCT02141828|Phase 1b|phase 1b
240111|NCT02141828|MLL gene|mll gene
240112|NCT02141828|11q23|11q23
240113|NCT02141828|Ambiguous lineage|ambiguous lineage
240114|NCT02141828|ALL|all
240115|NCT02141828|AML|aml
240116|NCT02141828|Acute leukemias|acute leukemias
240117|NCT02141828|MLL-r|mll-r
240118|NCT02141763|Psoriatic Arthritis|psoriatic arthritis
240119|NCT02141724|Neuromuscular|neuromuscular
240120|NCT02141724|Wheelchair|wheelchair
240121|NCT02141724|Pain|pain
240122|NCT02141724|Bedsore|bedsore
240123|NCT02141724|Trouble postural|trouble postural
240124|NCT02141711|Drug therapy|drug therapy
240125|NCT02141698|Drug therapy|drug therapy
240126|NCT02141685|in vitro fertilization|in vitro fertilization
240127|NCT02141685|assisted reproduction techniques|assisted reproduction techniques
240128|NCT02141685|noninvasive imaging of embryos|noninvasive imaging of embryos
240129|NCT02141685|time lapse imaging of embryos|time lapse imaging of embryos
240130|NCT02141685|traditional morphological grading of embryos|traditional morphological grading of embryos
240131|NCT02141685|prediction of blastocysts|prediction of blastocysts
240132|NCT02141685|infertility|infertility
240133|NCT02141685|preimplantation genetic diagnosis|preimplantation genetic diagnosis
240134|NCT02141685|array-Comparative Genomic Hybridization|array-comparative genomic hybridization
240135|NCT02141672|lupus nephritis|lupus nephritis
240136|NCT02141672|calcineurin inhibitors|calcineurin inhibitors
240137|NCT02141672|voclosporin|voclosporin
240138|NCT02141646|HIV/AIDS, motivational interviewing, behavioral skills training, MRI|hiv/aids, motivational interviewing, behavioral skills training, mri
240139|NCT02141633|smokers|smokers
240140|NCT02141633|airway blood flow|airway blood flow
240141|NCT02141633|fluticasone|fluticasone
240142|NCT02141633|echocardiogram|echocardiogram
240143|NCT02141607|shock|shock
240144|NCT02141607|heart failure|heart failure
240145|NCT02141607|inflammation|inflammation
240146|NCT02141607|biomarkers|biomarkers
240147|NCT02141607|cardiovascular instability|cardiovascular instability
240148|NCT02141607|metabolic pathways|metabolic pathways
240149|NCT02141607|proteolysis|proteolysis
240150|NCT02141581|Intramuscular inactivated trivalent influenza vaccine|intramuscular inactivated trivalent influenza vaccine
240151|NCT02141581|Intradermal inactivated trivalent influenza vaccine|intradermal inactivated trivalent influenza vaccine
240152|NCT02141581|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
240153|NCT02141581|Young adults|young adults
240154|NCT02141568|Cost-effective|cost-effective
240155|NCT02141568|Unexplained Medical Symptoms|unexplained medical symptoms
240156|NCT02141568|Frequent Attenders|frequent attenders
240157|NCT02141555|misoprostol, early pregnancy loss, missed abortion|misoprostol, early pregnancy loss, missed abortion
240158|NCT02141542|Metastatic Melanoma|metastatic melanoma
240159|NCT02141529|Intraarticular|intraarticular
240160|NCT02141529|pulsed radiofrequency|pulsed radiofrequency
240161|NCT02141529|osteoarthritis|osteoarthritis
240162|NCT02141516|Meningitis|meningitis
240163|NCT02141516|vaccination|vaccination
240164|NCT02141516|complement deficiency|complement deficiency
240165|NCT02141516|asplenia|asplenia
240166|NCT02141516|splenic dysfunction|splenic dysfunction
240167|NCT02141503|Biomarkers|biomarkers
240168|NCT02141503|Alpha-Manosidosis|alpha-manosidosis
240169|NCT02141490|Lymph Node|lymph node
240170|NCT02141490|Biopsy|biopsy
240171|NCT02141490|Metastatic Nodes|metastatic nodes
240172|NCT02141490|Imaging Agent|imaging agent
240173|NCT02141477|Leukemia|leukemia
240174|NCT02141477|Acute Myelogenous Leukemia|acute myelogenous leukemia
240175|NCT02141477|AML|aml
240176|NCT02141477|High Risk Myelodysplastic Syndrome|high risk myelodysplastic syndrome
240177|NCT02141477|MDS|mds
240178|NCT02141477|Omacetaxine|omacetaxine
240179|NCT02141477|Synribo|synribo
240180|NCT02141477|Homoharringtonine|homoharringtonine
240181|NCT02141477|Decitabine|decitabine
240182|NCT02141477|Dacogen|dacogen
240183|NCT02141451|DLBCL|dlbcl
240184|NCT02141438|Radium-223|radium-223
240185|NCT02141438|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
240186|NCT02141438|CRPC|crpc
240187|NCT02141438|Phase IV|phase iv
240188|NCT02141438|Safety study|safety study
240189|NCT02141425|Healthy volunteers|healthy volunteers
240190|NCT02141425|ASP015K|asp015k
240191|NCT02141412|optimal dose of dexmedetomidine|optimal dose of dexmedetomidine
240192|NCT02141412|prevent shivering|prevent shivering
240193|NCT02141412|improve quality of emergence|improve quality of emergence
240194|NCT02141412|anesthesia|anesthesia
240195|NCT02141412|without delay|without delay
240196|NCT02141412|recovery|recovery
240197|NCT02141386|Multiple Sclerosis|multiple sclerosis
240198|NCT02141386|Cognitive remediation|cognitive remediation
240199|NCT02141386|Plasticity-based, adaptive, computerized cognitive remediation|plasticity-based, adaptive, computerized cognitive remediation
240200|NCT02141386|Cognitive impairment|cognitive impairment
240201|NCT02141373|seroma|seroma
240202|NCT02141373|axillary|axillary
240203|NCT02141373|dissection|dissection
240204|NCT02141360|Mild Traumatic Brain Injury|mild traumatic brain injury
240205|NCT02141321|IUD|iud
240206|NCT02141321|Misoprostol|misoprostol
240207|NCT02141321|Rectal administration|rectal administration
240208|NCT02141308|Retina|retina
240209|NCT02141308|Optical coherence tomography|optical coherence tomography
240210|NCT02141308|Imaging|imaging
240211|NCT02141282|Oncology|oncology
240212|NCT02141282|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
240213|NCT02141282|Cancer of the blood and bone marrow|cancer of the blood and bone marrow
240214|NCT02141269|Transthoracic echocardiogram|transthoracic echocardiogram
240215|NCT02141269|Hand-held Echocardiography|hand-held echocardiography
240216|NCT02141256|elderly|elderly
240217|NCT02141256|protein enrichment|protein enrichment
240218|NCT02141256|undernutrition|undernutrition
240219|NCT02141217|Odontogenic (Dental) Infections|odontogenic (dental) infections
240220|NCT02141217|Dental infections, periapical abscess|dental infections, periapical abscess
240221|NCT02141217|Bacterial infection|bacterial infection
240222|NCT02141204|HRV|hrv
240223|NCT02141204|Liquid vaccine|liquid vaccine
240224|NCT02141204|Human rotavirus vaccine|human rotavirus vaccine
240225|NCT02141191|cystic fibrosis|cystic fibrosis
240226|NCT02141191|hypertonic saline|hypertonic saline
240227|NCT02141191|nebulizer|nebulizer
240228|NCT02141191|nasal cannula|nasal cannula
240229|NCT02141165|sleep apnea|sleep apnea
240230|NCT02141165|portable monitor|portable monitor
240231|NCT02141165|primary care|primary care
240232|NCT02141165|cost-effectiveness|cost-effectiveness
240233|NCT02141165|OSAS|osas
240234|NCT02141139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
240235|NCT02141139|Inflammation|inflammation
240236|NCT02141139|Perioperative Period|perioperative period
240237|NCT02141126|Older adults|older adults
240238|NCT02141126|Strength training|strength training
240239|NCT02141126|Muscle mass|muscle mass
240240|NCT02141126|Function|function
240241|NCT02141126|Inpatients|inpatients
240242|NCT02141100|thioguanine|thioguanine
240243|NCT02141100|mercaptopurine|mercaptopurine
240244|NCT02141100|methotrexate|methotrexate
240245|NCT02141048|Parenting programme|parenting programme
240246|NCT02141048|Randomised controlled trial|randomised controlled trial
240247|NCT02141048|South Africa|south africa
240248|NCT02141048|Positive parenting|positive parenting
240249|NCT02141048|Child behaviour problems|child behaviour problems
240250|NCT02141048|Implementation fidelity|implementation fidelity
240251|NCT02141048|Low- and middle-income country|low- and middle-income country
240252|NCT02141035|Acetyl-l-carnitine|acetyl-l-carnitine
240253|NCT02141035|Carpal tunnel syndrome|carpal tunnel syndrome
240254|NCT02141035|Motor unit number estimation|motor unit number estimation
240255|NCT02141035|Compression neuropathy|compression neuropathy
240256|NCT02141022|Multiple Sclerosis|multiple sclerosis
240257|NCT02141022|Cognition|cognition
240258|NCT02141022|Cognitive Remediation|cognitive remediation
240259|NCT02141022|Gilenya|gilenya
240260|NCT02141022|Computerized Cognitive Exercise|computerized cognitive exercise
240261|NCT02141009|Vaccination, prevnar, PCV13|vaccination, prevnar, pcv13
240262|NCT02140996|MUC-1 vector vaccine; epithelial cancers; immunotherapy; safety; antigen specific vaccine, dendritic cell activation|muc-1 vector vaccine; epithelial cancers; immunotherapy; safety; antigen specific vaccine, dendritic cell activation
240263|NCT02140983|Insulin Resistance|insulin resistance
240264|NCT02140983|Family History of Dementia|family history of dementia
240265|NCT02140983|Cognition|cognition
240266|NCT02140970|ureteral stent|ureteral stent
240267|NCT02140970|stent pain|stent pain
240268|NCT02140970|ureteral spasm|ureteral spasm
240269|NCT02140970|NSAID|nsaid
240270|NCT02140970|ibuprofen|ibuprofen
240271|NCT02140970|placebo|placebo
240272|NCT02140970|ureteropelvic junction obstruction|ureteropelvic junction obstruction
240273|NCT02140970|urolithiasis|urolithiasis
240274|NCT02140957|Toddler Bottle Use|toddler bottle use
240275|NCT02140957|Educational Intervention|educational intervention
240276|NCT02140957|Pediatrics|pediatrics
240277|NCT02140957|Iron Deficiency|iron deficiency
240278|NCT02140944|Cord blood transplantation|cord blood transplantation
240279|NCT02140944|CCR5Δ32|ccr5δ32
240280|NCT02140944|HIV cure|hiv cure
240281|NCT02140931|Cell therapy|cell therapy
240282|NCT02140931|Autologous|autologous
240283|NCT02140918|Fludrocortisone|fludrocortisone
240284|NCT02140918|Mineralocorticoids|mineralocorticoids
240285|NCT02140918|Hemodynamics|hemodynamics
240286|NCT02140918|Pharmacokinetics|pharmacokinetics
240287|NCT02140905|Hemodialysis|hemodialysis
240288|NCT02140905|Heart failure|heart failure
240289|NCT02140905|Impedance|impedance
240290|NCT02140905|Fluids|fluids
240291|NCT02140879|pregnancy|pregnancy
240292|NCT02140879|inflammation|inflammation
240293|NCT02140879|infant assessment|infant assessment
240294|NCT02140853|MDR gram-negative bacilli|mdr gram-negative bacilli
240295|NCT02140853|Mortality|mortality
240296|NCT02140853|Therapy|therapy
240297|NCT02140840|TMTB|tmtb
240298|NCT02140840|Mekinist|mekinist
240299|NCT02140840|Trametinib|trametinib
240300|NCT02140840|relapse|relapse
240301|NCT02140840|refractory|refractory
240302|NCT02140840|response rate|response rate
240303|NCT02140827|bowel preparation|bowel preparation
240304|NCT02140827|instant messaging program|instant messaging program
240305|NCT02140814|PKD|pkd
240306|NCT02140814|niacinamide|niacinamide
240307|NCT02140814|Vitamin B3|vitamin b3
240308|NCT02140814|Vitamin B|vitamin b
240309|NCT02140801|Percutaneous coronary intervention|percutaneous coronary intervention
240310|NCT02140801|Drug-eluting stent|drug-eluting stent
240311|NCT02140801|Thrombosis|thrombosis
240312|NCT02140788|schizophrenia|schizophrenia
240313|NCT02140788|schizo-affective disorder|schizo-affective disorder
240314|NCT02140775|HIV|hiv
240315|NCT02140775|AIDS|aids
240316|NCT02140775|Fatigue|fatigue
240317|NCT02140775|armodafinil|armodafinil
240318|NCT02140775|Unemployment|unemployment
240319|NCT02140762|Meningitis ABCWY|meningitis abcwy
240320|NCT02140762|adolescents|adolescents
240321|NCT02140762|accination|accination
240322|NCT02140762|meningococcal disease|meningococcal disease
240323|NCT02140749|Bifidobacteria|bifidobacteria
240324|NCT02140749|Bristol Stool Scale|bristol stool scale
240325|NCT02140749|Constipation|constipation
240326|NCT02140749|Diet|diet
240327|NCT02140749|Fructooligosacchardes|fructooligosacchardes
240328|NCT02140749|Microbiota|microbiota
240329|NCT02140749|Oligofructose|oligofructose
240330|NCT02140736|Chemotherapy-induced anemia|chemotherapy-induced anemia
240331|NCT02140736|Epoetin biosimilar|epoetin biosimilar
240332|NCT02140723|preoperative short course radiotherapy|preoperative short course radiotherapy
240333|NCT02140723|delay of surgery|delay of surgery
240334|NCT02140723|rectal cancer|rectal cancer
240335|NCT02140723|TP53|tp53
240336|NCT02140723|predictive marker|predictive marker
240337|NCT02140723|MRT imaging|mrt imaging
240338|NCT02140710|premature infant|premature infant
240339|NCT02140710|visceral osteopathy|visceral osteopathy
240340|NCT02140710|alternative medicine|alternative medicine
240341|NCT02140710|meconium passage|meconium passage
240342|NCT02140710|enteral feedings|enteral feedings
240343|NCT02140710|hospital stay|hospital stay
240344|NCT02140684|Real-world|real-world
240345|NCT02140684|observational|observational
240346|NCT02140684|Nitric oxide|nitric oxide
240347|NCT02140684|Inhaled corticosteroid|inhaled corticosteroid
240348|NCT02140684|UK|uk
240349|NCT02140671|asthma management|asthma management
240350|NCT02140671|anti-inflammatory therapy|anti-inflammatory therapy
240351|NCT02140671|compliance|compliance
240352|NCT02140671|hospital admission|hospital admission
240353|NCT02140671|educations|educations
240354|NCT02140671|self-management|self-management
240355|NCT02140671|guidelines|guidelines
240356|NCT02140671|exacerbations|exacerbations
240357|NCT02140671|diagnostic accuracy|diagnostic accuracy
240358|NCT02140671|symptom control|symptom control
240359|NCT02140658|ischemic stroke|ischemic stroke
240360|NCT02140658|Statins Medication Compliance|statins medication compliance
240361|NCT02140658|outcome|outcome
240362|NCT02140632|Carpal tunnel syndrome|carpal tunnel syndrome
240363|NCT02140632|Local steroid injection|local steroid injection
240364|NCT02140632|Wrist splinting|wrist splinting
240365|NCT02140619|ischemic stroke|ischemic stroke
240366|NCT02140619|Medication Compliance|medication compliance
240367|NCT02140619|outcome|outcome
240368|NCT02140606|AML|aml
240369|NCT02140606|phase1|phase1
240370|NCT02140606|MTD|mtd
240371|NCT02140606|Cafusertib|cafusertib
240372|NCT02140580|Minimally-invasive surfactant therapy|minimally-invasive surfactant therapy
240373|NCT02140541|Asthma|asthma
240374|NCT02140541|Blood eosinophils|blood eosinophils
240375|NCT02140541|Sputum eosinophils|sputum eosinophils
240376|NCT02140541|Clinical predictor|clinical predictor
240377|NCT02140541|UK primary care|uk primary care
240378|NCT02140541|Global Initiative for Asthma (GINA)|global initiative for asthma (gina)
240379|NCT02140528|Allogenic adipose derived mesenchymal stem cell tibial fracture|allogenic adipose derived mesenchymal stem cell tibial fracture
240380|NCT02140515|Gonal-F Luveris Assisted Reproductive Technology Hypogonadotropic Hypogonadism|gonal-f luveris assisted reproductive technology hypogonadotropic hypogonadism
240381|NCT02140502|Enterobacterial Infections|enterobacterial infections
240382|NCT02140502|Prostate cancer|prostate cancer
240383|NCT02140502|Biopsy|biopsy
240384|NCT02140502|Incidence of fluoroquinolone resistant enteric bacteria|incidence of fluoroquinolone resistant enteric bacteria
240385|NCT02140476|Thyroid goiter|thyroid goiter
240386|NCT02140476|Papillary thyroid cancer|papillary thyroid cancer
240387|NCT02140476|Bipolar device|bipolar device
240388|NCT02140476|Sealing and cutting device|sealing and cutting device
240389|NCT02140476|Thyroidectomy|thyroidectomy
240390|NCT02140450|intraocular pressure, intravitreal injection, short term|intraocular pressure, intravitreal injection, short term
240391|NCT02140437|Fulvestrant|fulvestrant
240392|NCT02140437|Anastrozole|anastrozole
240393|NCT02140437|Luminal A-like|luminal a-like
240394|NCT02140437|Postmenopausal|postmenopausal
240395|NCT02140437|Advanced breast cancer|advanced breast cancer
240396|NCT02140424|type 1 diabetes|type 1 diabetes
240397|NCT02140424|osteoporosis|osteoporosis
240398|NCT02140424|children|children
240399|NCT02140398|infertility|infertility
240400|NCT02140398|PCOS|pcos
240401|NCT02140398|scratching|scratching
240402|NCT02140398|endometrial receptivity|endometrial receptivity
240403|NCT02140372|colchicine|colchicine
240404|NCT02140372|platelet activity|platelet activity
240405|NCT02140372|neutrophil|neutrophil
240406|NCT02140359|homelessness|homelessness
240407|NCT02140359|housing first|housing first
240408|NCT02140359|social networks|social networks
240409|NCT02140359|drug abuse|drug abuse
240410|NCT02140359|alcohol use|alcohol use
240411|NCT02140359|HIV|hiv
240412|NCT02140333|erlotinib|erlotinib
240413|NCT02140333|EGFR mutation|egfr mutation
240414|NCT02140307|Health Promotion|health promotion
240415|NCT02140307|Prevention|prevention
240416|NCT02140307|Relaxation Response|relaxation response
240417|NCT02140307|Meditation|meditation
240418|NCT02140307|Cortisol|cortisol
240419|NCT02140281|Phase I, Healthy Volunteers|phase i, healthy volunteers
240420|NCT02140268|Phase I|phase i
240421|NCT02140268|Healthy|healthy
240422|NCT02140268|Pharmacokinetics|pharmacokinetics
240423|NCT02140255|HIV Remission|hiv remission
240424|NCT02140242|AML|aml
240425|NCT02140242|leukemia|leukemia
240426|NCT02140242|induction treatment|induction treatment
240427|NCT02140242|daunorubicin|daunorubicin
240428|NCT02140242|7+3|7+3
240429|NCT02140229|Rheumatoid Arthritis|rheumatoid arthritis
240430|NCT02140229|Remission,|remission,
240431|NCT02140229|DAS28,|das28,
240432|NCT02140229|ACR/EULAR,|acr/eular,
240433|NCT02140229|RAPID, Randomized study,|rapid, randomized study,
240434|NCT02140229|Longitudinal follow-up|longitudinal follow-up
240435|NCT02140216|Blood transfusion|blood transfusion
240436|NCT02140216|Immune|immune
240437|NCT02140216|Surgery|surgery
240438|NCT02140203|Metabolic Syndrome|metabolic syndrome
240439|NCT02140203|Waist circumference|waist circumference
240440|NCT02140203|blood pressure|blood pressure
240441|NCT02140203|triglyceride|triglyceride
240442|NCT02140203|HDL|hdl
240443|NCT02140177|Screening|screening
240444|NCT02140177|Adults|adults
240445|NCT02140177|Medical Inpatients|medical inpatients
240446|NCT02140177|Suicide|suicide
240447|NCT02140164|Cystoid Macular Edema|cystoid macular edema
240448|NCT02140164|Minocycline|minocycline
240449|NCT02140164|Microglia|microglia
240450|NCT02140164|Retinitis Pigmentosa|retinitis pigmentosa
240451|NCT02140151|amd|amd
240452|NCT02140151|non-exudative macular degeneration|non-exudative macular degeneration
240453|NCT02140151|exudative macular degeneration|exudative macular degeneration
240454|NCT02140151|age-related macular degeneration|age-related macular degeneration
240455|NCT02140151|ranibizumab|ranibizumab
240456|NCT02140151|anti-VEGF|anti-vegf
240457|NCT02140125|ASP2408|asp2408
240458|NCT02140112|T. suis ova|t. suis ova
240459|NCT02140112|Trichuris suis ova|trichuris suis ova
240460|NCT02140112|Autism Spectrum Disorder|autism spectrum disorder
240461|NCT02140112|ASD|asd
240462|NCT02140099|Mental health|mental health
240463|NCT02140099|Violence|violence
240464|NCT02140099|Substance use|substance use
240465|NCT02140099|Adolescent|adolescent
240466|NCT02140099|Prevention|prevention
240467|NCT02140086|asthma|asthma
240468|NCT02140086|Buteyko|buteyko
240469|NCT02140086|remedial breathing|remedial breathing
240470|NCT02140086|children|children
240471|NCT02140073|GERD|gerd
240472|NCT02140073|Omez|omez
240473|NCT02140073|Omez DSR|omez dsr
240474|NCT02140073|heartburn|heartburn
240475|NCT02140073|esophagitis|esophagitis
240476|NCT02140073|omeprazole|omeprazole
240477|NCT02140073|omeprazole+domperidone|omeprazole+domperidone
240478|NCT02140060|Glaucoma|glaucoma
240479|NCT02140060|Ocular|ocular
240480|NCT02140060|Hypertension|hypertension
240481|NCT02140060|OAG|oag
240482|NCT02140060|POAG|poag
240483|NCT02140060|OHT|oht
240484|NCT02140047|Haemophilus influenza type b|haemophilus influenza type b
240485|NCT02140047|Hib|hib
240486|NCT02140034|Extensive Peritoneal Lavage|extensive peritoneal lavage
240487|NCT02140034|Overall Survival|overall survival
240488|NCT02140034|Disease Free Survival|disease free survival
240489|NCT02140034|Peritoneal Recurrence Rate|peritoneal recurrence rate
240490|NCT02140034|T3 and T4 Gastric Cancer|t3 and t4 gastric cancer
240491|NCT02140021|Malignant Female Reproductive System Neoplasm|malignant female reproductive system neoplasm
240492|NCT02140021|Gynecological Cancer|gynecological cancer
240493|NCT02140021|High-grade dysplasia|high-grade dysplasia
240494|NCT02140021|Carcinoma of the cervix|carcinoma of the cervix
240495|NCT02140021|Carcinoma of the vagina|carcinoma of the vagina
240496|NCT02140021|Carcinoma of the vulva|carcinoma of the vulva
240497|NCT02140021|Invasive squamous cell carcinoma|invasive squamous cell carcinoma
240498|NCT02140021|Anal pap test|anal pap test
240499|NCT02140021|Anoscopy|anoscopy
240500|NCT02140008|supraglottic airway devices|supraglottic airway devices
240501|NCT02140008|the i-gel|the i-gel
240502|NCT02140008|the self-pressurised air-Q intubating laryngeal airway,|the self-pressurised air-q intubating laryngeal airway,
240503|NCT02140008|children|children
240504|NCT02139995|transfusion|transfusion
240505|NCT02139995|trigger|trigger
240506|NCT02139995|critically-ill|critically-ill
240507|NCT02139982|hemodynamics|hemodynamics
240508|NCT02139982|anaesthetics|anaesthetics
240509|NCT02139982|brachial plexus|brachial plexus
240510|NCT02139982|peripheral nerves|peripheral nerves
240511|NCT02139982|skin temperature|skin temperature
240512|NCT02139982|sympathetic nervous system|sympathetic nervous system
240513|NCT02139982|dose-response relationship|dose-response relationship
240514|NCT02139943|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
240515|NCT02139943|Canagliflozin|canagliflozin
240516|NCT02139943|Continuous Glucose Monitoring|continuous glucose monitoring
240517|NCT02139930|smoking|smoking
240518|NCT02139930|nicotine reduction|nicotine reduction
240519|NCT02139917|transitional palliative care|transitional palliative care
240520|NCT02139917|end stage renal failure|end stage renal failure
240521|NCT02139904|Mesothelioma|mesothelioma
240522|NCT02139904|Vinorelbine|vinorelbine
240523|NCT02139904|BRCA1|brca1
240524|NCT02139891|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
240525|NCT02139891|non responders|non responders
240526|NCT02139891|MultiPoint Pacing (MPP)|multipoint pacing (mpp)
240527|NCT02139813|Obesity -|obesity -
240528|NCT02139813|Bariatric surgery|bariatric surgery
240529|NCT02139813|Gastric bypass|gastric bypass
240530|NCT02139800|Neonatal resuscitation|neonatal resuscitation
240531|NCT02139800|Extreme Low Gestational Age Newborn (ELGAN)|extreme low gestational age newborn (elgan)
240532|NCT02139800|Delivery Room|delivery room
240533|NCT02139800|Continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
240534|NCT02139800|Positive pressure ventilation (PPV)|positive pressure ventilation (ppv)
240535|NCT02139800|Sustained inflation|sustained inflation
240536|NCT02139787|Hypertension, obesity|hypertension, obesity
240537|NCT02139787|Dietary behaviors|dietary behaviors
240538|NCT02139787|Physical activity behaviors|physical activity behaviors
240539|NCT02139787|Radio story, entertainment health education|radio story, entertainment health education
240540|NCT02139787|Immigrants|immigrants
240541|NCT02139787|Somali, Latino, Hmong|somali, latino, hmong
240542|NCT02139787|Families with 3-18 year old children|families with 3-18 year old children
240543|NCT02139774|Prostate Cancer|prostate cancer
240544|NCT02139774|Elderly|elderly
240545|NCT02139774|Geriatric|geriatric
240546|NCT02139774|Radiation|radiation
240547|NCT02139774|Arthritis|arthritis
240548|NCT02139774|Exercise|exercise
240549|NCT02139774|Walking|walking
240550|NCT02139774|Endocrine Therapy|endocrine therapy
240551|NCT02139774|Androgen Deprivation Therapy|androgen deprivation therapy
240552|NCT02139774|Active Surveillance|active surveillance
240554|NCT02139761|Cocaine|cocaine
240555|NCT02139761|Treatment|treatment
240556|NCT02139748|Dental Implants|dental implants
240557|NCT02139748|Alveolar Bone Grafting|alveolar bone grafting
240558|NCT02139748|Acellular Dermis|acellular dermis
240559|NCT02139735|Temporomandibular Joint Disorders,|temporomandibular joint disorders,
240560|NCT02139735|Ultrasonics,|ultrasonics,
240561|NCT02139735|Electromyography,|electromyography,
240562|NCT02139735|Pain Measurement,|pain measurement,
240563|NCT02139735|Muscle Stretching Exercise|muscle stretching exercise
240564|NCT02139722|hepatitis B|hepatitis b
240565|NCT02139722|hepatitis C|hepatitis c
240566|NCT02139722|screening|screening
240567|NCT02139722|Asian Americans|asian americans
240568|NCT02139722|mobile technology|mobile technology
240569|NCT02139657|Rabies|rabies
240570|NCT02139657|Rabies virus|rabies virus
240571|NCT02139657|Rhabdoviridae|rhabdoviridae
240572|NCT02139657|Rabies immune globulin|rabies immune globulin
240573|NCT02139657|Rabies antibodies|rabies antibodies
240574|NCT02139657|Passive rabies immunization|passive rabies immunization
240575|NCT02139644|fluticasone propionate|fluticasone propionate
240576|NCT02139644|multidose dry powder inhaler|multidose dry powder inhaler
240577|NCT02139631|hemodynamic|hemodynamic
240578|NCT02139631|mechanical ventilation|mechanical ventilation
240579|NCT02139631|respiration with positive pressure|respiration with positive pressure
240580|NCT02139618|Randomized-controlled-trial|randomized-controlled-trial
240581|NCT02139618|Methyl-Aminolevulinate|methyl-aminolevulinate
240582|NCT02139618|Daylight|daylight
240583|NCT02139618|Photodynamic-therapy|photodynamic-therapy
240584|NCT02139605|D2 versus D3 Lymphadenectomy|d2 versus d3 lymphadenectomy
240585|NCT02139592|Pharmacological therapy|pharmacological therapy
240586|NCT02139579|chemotherapy|chemotherapy
240587|NCT02139579|EGFR-TKI resistance|egfr-tki resistance
240588|NCT02139579|Bevacizumab|bevacizumab
240589|NCT02139553|Rhythmic versus discrete movements|rhythmic versus discrete movements
240590|NCT02139553|Rehabilitation|rehabilitation
240591|NCT02139540|Treatment|treatment
240592|NCT02139527|arthroplasty|arthroplasty
240593|NCT02139527|spinal|spinal
240594|NCT02139527|CHARITE|charite
240595|NCT02139527|PRODISC-L|prodisc-l
240596|NCT02139527|PRODISC|prodisc
240597|NCT02139527|disc|disc
240598|NCT02139527|replacement|replacement
240599|NCT02139527|lumbar|lumbar
240600|NCT02139514|Social Skills|social skills
240601|NCT02139514|Adults|adults
240602|NCT02139501|Recombinant Human Thrombopoietin|recombinant human thrombopoietin
240603|NCT02139501|Dose and frequency|dose and frequency
240604|NCT02139501|Immune Thrombocytopenia|immune thrombocytopenia
240605|NCT02139488|Esophageal cancer|esophageal cancer
240606|NCT02139488|Chemoradiation|chemoradiation
240607|NCT02139475|bowel cleansing, colorectal cancer surgery|bowel cleansing, colorectal cancer surgery
240608|NCT02139462|FBT, fidelity, training|fbt, fidelity, training
240609|NCT02139449|CRT, heart failure, ICD|crt, heart failure, icd
240610|NCT02139423|Congenital cytomegalovirus infection|congenital cytomegalovirus infection
240611|NCT02139423|newborn universal hearing screening|newborn universal hearing screening
240612|NCT02139410|sarcopenia|sarcopenia
240613|NCT02139410|mortality|mortality
240614|NCT02139384|procalcitonin|procalcitonin
240615|NCT02139384|community acquired pneumonia|community acquired pneumonia
240616|NCT02139384|pneumonia score|pneumonia score
240617|NCT02139371|Positron Emission Tomography|positron emission tomography
240618|NCT02139371|Uroplasminogen Plasminogen Activator Receptor|uroplasminogen plasminogen activator receptor
240619|NCT02139371|Breast cancer|breast cancer
240620|NCT02139371|Prostate cancer|prostate cancer
240621|NCT02139371|Urinary bladder cancer|urinary bladder cancer
240622|NCT02139371|Biodistribution|biodistribution
240623|NCT02139371|Radiation exposure|radiation exposure
240624|NCT02139358|Breast - Female|breast - female
240625|NCT02139358|Metastatic|metastatic
240626|NCT02139358|HER2+|her2+
240627|NCT02139345|Osteoarthritis|osteoarthritis
240628|NCT02139345|Rheumatoid arthritis|rheumatoid arthritis
240629|NCT02139345|Post-traumatic arthritis|post-traumatic arthritis
240630|NCT02139345|Avascular necrosis|avascular necrosis
240631|NCT02139345|AVN|avn
240632|NCT02139332|Attachment theory|attachment theory
240633|NCT02139332|Parent- child relationship|parent- child relationship
240634|NCT02139332|Child mental health|child mental health
240635|NCT02139332|Behavioral health|behavioral health
240636|NCT02139293|vagus nerve stimulation effects on heart rate variability and peripheral blood perfusion|vagus nerve stimulation effects on heart rate variability and peripheral blood perfusion
240637|NCT02139280|Cyclophosphamide|cyclophosphamide
240638|NCT02139280|Hematopoietic|hematopoietic
240639|NCT02139280|Stem Cell|stem cell
240640|NCT02139280|Mobilization|mobilization
240641|NCT02139280|Hematologic Malignancy|hematologic malignancy
240642|NCT02139267|CIN3|cin3
240643|NCT02139267|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
240644|NCT02139267|High-Risk HPV|high-risk hpv
240645|NCT02139267|HPV Infection|hpv infection
240646|NCT02139267|Neoplasm|neoplasm
240647|NCT02139267|Precancerous Diseases|precancerous diseases
240648|NCT02139267|Uterine Diseases|uterine diseases
240649|NCT02139267|Genital Diseases, Female|genital diseases, female
240650|NCT02139254|Gestational Diabetes|gestational diabetes
240651|NCT02139254|HbA1c|hba1c
240652|NCT02139254|Glucose|glucose
240653|NCT02139254|First Trimenon|first trimenon
240654|NCT02139228|Haemophilus influenzae type b|haemophilus influenzae type b
240655|NCT02139228|persistency|persistency
240656|NCT02139228|children|children
240657|NCT02139228|CRM197|crm197
240658|NCT02139228|anti-PRP antibody|anti-prp antibody
240659|NCT02139202|Acute|acute
240660|NCT02139202|Myocardial|myocardial
240661|NCT02139202|Infarction|infarction
240662|NCT02139202|AMI|ami
240663|NCT02139176|couple HIV testing and counseling|couple hiv testing and counseling
240664|NCT02139176|disclosure|disclosure
240665|NCT02139176|discordant|discordant
240666|NCT02139176|HIV|hiv
240667|NCT02139176|Malawi|malawi
240668|NCT02139163|Community acquired pneumonia|community acquired pneumonia
240669|NCT02139163|CAP|cap
240670|NCT02139163|CAPNETZ|capnetz
240671|NCT02139163|age ≥18|age ≥18
240672|NCT02139163|infiltrate on chest X-ray|infiltrate on chest x-ray
240673|NCT02139163|cough or production of purulent sputum|cough or production of purulent sputum
240674|NCT02139163|pathologic lung auscultation|pathologic lung auscultation
240675|NCT02139163|fever|fever
240676|NCT02139150|FLT PET Imaging|flt pet imaging
240677|NCT02139150|3'deoxy-3' [18F] fluorothymidine ([18F] FLT)|3'deoxy-3' [18f] fluorothymidine ([18f] flt)
240678|NCT02139150|CT|ct
240679|NCT02139150|scans|scans
240680|NCT02139150|14-050|14-050
240681|NCT02139098|sleep architecture|sleep architecture
240682|NCT02139098|conditioning of pharmacological responses|conditioning of pharmacological responses
240683|NCT02139098|insomnia|insomnia
240684|NCT02139085|varicose veins|varicose veins
240685|NCT02139085|catheter ablation|catheter ablation
240686|NCT02139085|Catheter Ablation, Electrical|catheter ablation, electrical
240687|NCT02139085|Catheter Ablation, Radiofrequency|catheter ablation, radiofrequency
240688|NCT02139072|Anticoagulation|anticoagulation
240689|NCT02139072|International normalized ratio|international normalized ratio
240690|NCT02139072|Warfarin|warfarin
240691|NCT02139059|anuria|anuria
240692|NCT02139059|children|children
240693|NCT02139059|ureteroscopy|ureteroscopy
240694|NCT02139059|initial urinary drainage|initial urinary drainage
240695|NCT02139059|ureteric stones|ureteric stones
240696|NCT02139046|Drug therapy|drug therapy
240697|NCT02139033|Dry Eye, Dry Eye Syndrome, Retaine, KCS, Keratoconjunctivitis sicca|dry eye, dry eye syndrome, retaine, kcs, keratoconjunctivitis sicca
240698|NCT02139020|Targeted therapies|targeted therapies
240699|NCT02139020|Plasma samples|plasma samples
240700|NCT02138981|Hepatocellular Carcinoma|hepatocellular carcinoma
240701|NCT02138981|Milan Criteria|milan criteria
240702|NCT02138968|Pre-frailty|pre-frailty
240703|NCT02138968|Frail|frail
240704|NCT02138968|Exercise|exercise
240705|NCT02138968|Nutritional assessment|nutritional assessment
240706|NCT02138968|Functional capacity|functional capacity
240707|NCT02138942|automated vascular filling|automated vascular filling
240708|NCT02138942|Learning Intravenous Resuscitator (LIR)|learning intravenous resuscitator (lir)
240709|NCT02138942|General Surgery|general surgery
240710|NCT02138942|Fluid Therapy|fluid therapy
240711|NCT02138929|Esophageal Cancer|esophageal cancer
240712|NCT02138929|Advanced adenocarcinoma of the esophagus|advanced adenocarcinoma of the esophagus
240713|NCT02138929|Advanced adenocarcinoma of the gastroesophageal junction|advanced adenocarcinoma of the gastroesophageal junction
240714|NCT02138929|GEJ|gej
240715|NCT02138929|Metastatic|metastatic
240716|NCT02138929|Everolimus|everolimus
240717|NCT02138929|Afinitor|afinitor
240718|NCT02138929|Zortress|zortress
240719|NCT02138929|RAD001|rad001
240720|NCT02138929|LDE 225|lde 225
240721|NCT02138916|Obstructive Lung Diseases|obstructive lung diseases
240722|NCT02138916|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
240723|NCT02138916|Lung Disease|lung disease
240724|NCT02138916|Bronchial Diseases|bronchial diseases
240725|NCT02138916|COPD Exacerbation|copd exacerbation
240726|NCT02138916|Respiratory Tract Diseases|respiratory tract diseases
240727|NCT02138903|weaning|weaning
240728|NCT02138903|Cardiac|cardiac
240729|NCT02138903|Echocardiography|echocardiography
240730|NCT02138903|Mechanical Ventilation|mechanical ventilation
240731|NCT02138890|Autologous Protein Solution|autologous protein solution
240732|NCT02138890|APS|aps
240733|NCT02138890|Osteoarthritis|osteoarthritis
240734|NCT02138890|Intra Articular Injection|intra articular injection
240735|NCT02138877|Pelviureteric junction obstruction|pelviureteric junction obstruction
240736|NCT02138877|pyeloplasty|pyeloplasty
240737|NCT02138877|Neonate affected by hydronephrosis|neonate affected by hydronephrosis
240738|NCT02138877|obstructive uropathy|obstructive uropathy
240739|NCT02138877|urinary stent|urinary stent
240740|NCT02138864|carbon monoxide intoxication|carbon monoxide intoxication
240741|NCT02138864|Parkinsonism|parkinsonism
240742|NCT02138864|18F-DTBZ AV-133|18f-dtbz av-133
240743|NCT02138838|Chronic Kidney Disease, Secondary Hyperparathyroidism, Dialysis, Pediatric|chronic kidney disease, secondary hyperparathyroidism, dialysis, pediatric
240744|NCT02138812|Phase 1|phase 1
240745|NCT02138812|Solid tumors|solid tumors
240746|NCT02138812|Breast cancer|breast cancer
240747|NCT02138812|Paclitaxel|paclitaxel
240748|NCT02138812|MPS-1 inhibitor|mps-1 inhibitor
240749|NCT02138812|Taxanes|taxanes
240750|NCT02138799|Phase I|phase i
240751|NCT02138799|Pharmacokinetics|pharmacokinetics
240752|NCT02138799|Safety|safety
240753|NCT02138799|Drug-drug interactions|drug-drug interactions
240754|NCT02138799|Enzalutamide|enzalutamide
240755|NCT02138799|Rifampin|rifampin
240756|NCT02138799|CYP3A4|cyp3a4
240757|NCT02138799|CYP2D8|cyp2d8
240758|NCT02138799|Enzyme induction|enzyme induction
240759|NCT02138786|Richter's Transformation|richter's transformation
240760|NCT02138786|Richter's Syndrome|richter's syndrome
240761|NCT02138786|Karyopharm|karyopharm
240762|NCT02138786|selinexor|selinexor
240763|NCT02138786|KPT-330|kpt-330
240764|NCT02138786|SIRRT|sirrt
240765|NCT02138786|CLL|cll
240766|NCT02138773|prolonged release formulation|prolonged release formulation
240767|NCT02138773|adrenergic blocker|adrenergic blocker
240768|NCT02138773|Bioequivalence|bioequivalence
240769|NCT02138760|prostate cancer|prostate cancer
240770|NCT02138760|prostate biopsy|prostate biopsy
240771|NCT02138760|magnetic resonance imaging guidance|magnetic resonance imaging guidance
240772|NCT02138760|detection rates|detection rates
240773|NCT02138760|performance|performance
240774|NCT02138747|Overactive bladder (OAB)|overactive bladder (oab)
240775|NCT02138747|tolterodine ER|tolterodine er
240776|NCT02138747|mirabegron|mirabegron
240777|NCT02138734|antitumor|antitumor
240778|NCT02138734|BCG|bcg
240779|NCT02138734|bladder cancer|bladder cancer
240780|NCT02138734|cancer|cancer
240781|NCT02138734|immunotherapy|immunotherapy
240782|NCT02138734|instillation|instillation
240783|NCT02138734|interleukin-15|interleukin-15
240784|NCT02138734|intravesical|intravesical
240785|NCT02138734|naive|naive
240786|NCT02138734|non-muscle invasive|non-muscle invasive
240787|NCT02138734|transitional cell carcinoma|transitional cell carcinoma
240788|NCT02138721|Metastatic Prostate Cancer|metastatic prostate cancer
240789|NCT02138721|Prostatectomy|prostatectomy
240790|NCT02138708|Pulmonary arterial hypertension,|pulmonary arterial hypertension,
240791|NCT02138708|congenital heart disease,|congenital heart disease,
240792|NCT02138708|heart shunt,|heart shunt,
240793|NCT02138708|acetylcholine|acetylcholine
240794|NCT02138708|Pharmacological test of pulmonary vascular reactivity (acetylcholine) in|pharmacological test of pulmonary vascular reactivity (acetylcholine) in
240795|NCT02138695|atrial fibrillation|atrial fibrillation
240796|NCT02138695|catheter ablation|catheter ablation
240797|NCT02138695|recurrence|recurrence
240798|NCT02138682|DaT-SPECT scan|dat-spect scan
240799|NCT02138682|Parkinson's|parkinson's
240800|NCT02138682|Diagnostic|diagnostic
240801|NCT02138669|Cornea|cornea
240802|NCT02138669|Keratoconus|keratoconus
240803|NCT02138669|Steep cornea|steep cornea
240804|NCT02138656|Crying|crying
240805|NCT02138656|Chiropractic|chiropractic
240806|NCT02138656|Infant|infant
240807|NCT02138656|pediatric|pediatric
240808|NCT02138656|Infantile colic|infantile colic
240809|NCT02138656|Clinical Trial|clinical trial
240810|NCT02138643|Achalasia|achalasia
240811|NCT02138643|Megaesophagus|megaesophagus
240812|NCT02138643|Peropal endoscopic myotomy(POEM)|peropal endoscopic myotomy(poem)
240813|NCT02138643|Laparoscopic Heller myotomy|laparoscopic heller myotomy
240814|NCT02138630|Exercise|exercise
240815|NCT02138617|Colon Cancer|colon cancer
240816|NCT02138617|Irinotecan|irinotecan
240817|NCT02138617|FOLFIRI|folfiri
240818|NCT02138617|Genotyping|genotyping
240819|NCT02138617|UGT1A1|ugt1a1
240820|NCT02138604|chest pain|chest pain
240821|NCT02138604|myocardial ischemia|myocardial ischemia
240822|NCT02138604|acute myocardial dysfunction|acute myocardial dysfunction
240823|NCT02138604|plethesmography|plethesmography
240824|NCT02138604|non invasive dP/dt|non invasive dp/dt
240825|NCT02138591|vitamin d deficiency|vitamin d deficiency
240826|NCT02138591|cathelicidin antimicrobial peptide|cathelicidin antimicrobial peptide
240827|NCT02138591|resistin, human|resistin, human
240828|NCT02138591|protein, human|protein, human
240829|NCT02138591|1,25-dihydroxy-16,23-diene vitamin D3|1,25-dihydroxy-16,23-diene vitamin d3
240830|NCT02138591|Cholecalciferol|cholecalciferol
240831|NCT02138591|Nutritional Status|nutritional status
240832|NCT02138591|length of stay|length of stay
240833|NCT02138539|hyperpigmentation|hyperpigmentation
240834|NCT02138539|melasma|melasma
240835|NCT02138539|sun spots|sun spots
240836|NCT02138539|dark spots|dark spots
240837|NCT02138526|cancer|cancer
240838|NCT02138526|pazopanib|pazopanib
240839|NCT02138526|food|food
240840|NCT02138526|pharmacokinetics|pharmacokinetics
240841|NCT02138513|Mindfulness|mindfulness
240842|NCT02138513|MBCT|mbct
240843|NCT02138513|Cancer|cancer
240844|NCT02138513|Oncology|oncology
240845|NCT02138513|E-health|e-health
240846|NCT02138513|Cost-effectiveness|cost-effectiveness
240847|NCT02138500|PF-06372865|pf-06372865
240848|NCT02138500|phase 1|phase 1
240849|NCT02138500|open-label|open-label
240850|NCT02138500|GABA-A receptor occupancy|gaba-a receptor occupancy
240851|NCT02138500|positron emission tomography|positron emission tomography
240852|NCT02138500|healthy subjects|healthy subjects
240853|NCT02138487|pelvic organ prolapse|pelvic organ prolapse
240854|NCT02138487|reconstructive pelvic surgery|reconstructive pelvic surgery
240855|NCT02138487|postoperative restrictions|postoperative restrictions
240856|NCT02138487|patient satisfaction|patient satisfaction
240857|NCT02138474|Lacticum acidum homaccord|lacticum acidum homaccord
240858|NCT02138474|homeopathy|homeopathy
240859|NCT02138474|chronic tension-type headaches|chronic tension-type headaches
240860|NCT02138461|glaucoma|glaucoma
240861|NCT02138461|bimatoprost|bimatoprost
240862|NCT02138461|latanoprost|latanoprost
240863|NCT02138461|tolerability|tolerability
240864|NCT02138448|Cancer Screenings|cancer screenings
240865|NCT02138448|Health Information Technology|health information technology
240866|NCT02138448|Patient Health Record|patient health record
240867|NCT02138448|Preventive Services|preventive services
240868|NCT02138422|colorectal cancer|colorectal cancer
240869|NCT02138383|advanced pancreatic cancer|advanced pancreatic cancer
240870|NCT02138383|pancreas|pancreas
240871|NCT02138383|malignant neoplasm|malignant neoplasm
240872|NCT02138383|endocrine system|endocrine system
240873|NCT02138357|Restless Legs Syndrome|restless legs syndrome
240874|NCT02138357|Willis Ekbom Disease|willis ekbom disease
240875|NCT02138357|Twitchy Legs|twitchy legs
240876|NCT02138357|Periodic Limb Movements|periodic limb movements
240877|NCT02138357|Leg Movements|leg movements
240878|NCT02138357|Augmentation|augmentation
240879|NCT02138357|Requip|requip
240880|NCT02138357|ropinirole|ropinirole
240881|NCT02138357|Mirapex|mirapex
240882|NCT02138357|pramipexole|pramipexole
240883|NCT02138357|gabapentin|gabapentin
240884|NCT02138357|Horizant|horizant
240885|NCT02138357|Neupro|neupro
240886|NCT02138357|rotigotine|rotigotine
240887|NCT02138331|Diabetes Mellitus Type 1|diabetes mellitus type 1
240888|NCT02138331|Microvesicles|microvesicles
240889|NCT02138331|Exosomes|exosomes
240890|NCT02138331|Cord Blood|cord blood
240891|NCT02138331|Mesenchymal Stem Cells|mesenchymal stem cells
240892|NCT02138305|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
240893|NCT02138305|Instantaneous Wave Free Ratio (iFR)|instantaneous wave free ratio (ifr)
240894|NCT02138305|Coronary Flow Reserve (CFR)|coronary flow reserve (cfr)
240895|NCT02138305|Hyperemic Stenosis Resistance Index (HSR)|hyperemic stenosis resistance index (hsr)
240896|NCT02138305|Hyperemic microvascular resistance (HMR)|hyperemic microvascular resistance (hmr)
240897|NCT02138305|Wave intensity analysis (WIA)|wave intensity analysis (wia)
240898|NCT02138305|Myocardial Perfusion|myocardial perfusion
240899|NCT02138305|SPY NIRF Regional Myocardial Perfusion Analysis|spy nirf regional myocardial perfusion analysis
240900|NCT02138253|liver transplant|liver transplant
240901|NCT02138253|hepatitis C|hepatitis c
240902|NCT02138253|liver fibrosis|liver fibrosis
240903|NCT02138253|hepatic fibrosis|hepatic fibrosis
240904|NCT02138253|liver cirrhosis|liver cirrhosis
240905|NCT02138253|hepatic cirrhosis|hepatic cirrhosis
240906|NCT02138227|Organ donation request|organ donation request
240907|NCT02138227|Effective Communication|effective communication
240908|NCT02138201|diffusion tensor imaging fiber tracking|diffusion tensor imaging fiber tracking
240909|NCT02138201|magnetic resonance Imaging|magnetic resonance imaging
240910|NCT02138201|spinal cord injury|spinal cord injury
240911|NCT02138201|neurogenic lower urinary tract dysfunction|neurogenic lower urinary tract dysfunction
240912|NCT02138175|bleeding|bleeding
240913|NCT02138175|blood loss|blood loss
240914|NCT02138175|hemoglobin|hemoglobin
240915|NCT02138175|hemoglobin monitoring|hemoglobin monitoring
240916|NCT02138175|noninvasive monitoring|noninvasive monitoring
240917|NCT02138162|Phase 1|phase 1
240918|NCT02138162|Pharmacokinetics|pharmacokinetics
240919|NCT02138162|Safety|safety
240920|NCT02138162|Severe hepatic impairment|severe hepatic impairment
240921|NCT02138162|Enzalutamide|enzalutamide
240922|NCT02138149|spinal cord injury|spinal cord injury
240923|NCT02138149|neurogenic lower urinary tract dysfunction|neurogenic lower urinary tract dysfunction
240924|NCT02138149|nerve growth factor|nerve growth factor
240925|NCT02138149|neurogenic detrusor overactivity|neurogenic detrusor overactivity
240926|NCT02138149|urodynamics|urodynamics
240927|NCT02138123|dense cataract|dense cataract
240928|NCT02138123|phacoemulsification|phacoemulsification
240929|NCT02138123|lens-shell technique|lens-shell technique
240930|NCT02138123|intraocular lens|intraocular lens
240931|NCT02138110|Spinal Cord Injury (SCI)|spinal cord injury (sci)
240932|NCT02138110|Complete (AIS A) Traumatic Acute Spinal Cord Injury|complete (ais a) traumatic acute spinal cord injury
240933|NCT02138071|low back pain|low back pain
240934|NCT02138071|lumbar pain|lumbar pain
240935|NCT02138058|compulsive buying, compulsive shopping, topiramate|compulsive buying, compulsive shopping, topiramate
240936|NCT02138045|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
240937|NCT02138045|Diabetic Neuropathy|diabetic neuropathy
240938|NCT02138045|Liraglutide|liraglutide
240939|NCT02138032|message framing|message framing
240940|NCT02138032|smoking cessation|smoking cessation
240941|NCT02138032|peripheral artery disease|peripheral artery disease
240942|NCT02138019|corneal ulcers|corneal ulcers
240943|NCT02138019|conjunctival closure in strabismus surgery|conjunctival closure in strabismus surgery
240944|NCT02138019|surgery for retinal detachment|surgery for retinal detachment
240945|NCT02138019|cataract surgery|cataract surgery
240946|NCT02138019|mucous membrane grafting|mucous membrane grafting
240947|NCT02137954|cancer|cancer
240948|NCT02137954|pain|pain
240949|NCT02137941|Stress|stress
240950|NCT02137941|occupations|occupations
240951|NCT02137941|biomarkers|biomarkers
240952|NCT02137941|firefighters|firefighters
240953|NCT02137928|Retinoblastoma|retinoblastoma
240954|NCT02137928|carboplatin|carboplatin
240955|NCT02137915|AMD|amd
240956|NCT02137902|Tobacco dependence|tobacco dependence
240957|NCT02137902|Cardiovascular disease|cardiovascular disease
240958|NCT02137902|Risk behaviors|risk behaviors
240959|NCT02137902|Smoking|smoking
240960|NCT02137902|Physical activity|physical activity
240961|NCT02137902|Alaska Native people|alaska native people
240962|NCT02137889|CLL|cll
240963|NCT02137876|B cells|b cells
240964|NCT02137876|Thymoglubulin|thymoglubulin
240965|NCT02137876|humoral rejections|humoral rejections
240966|NCT02137876|transplant|transplant
240967|NCT02137876|rATG|ratg
240968|NCT02137863|Contrast induced nephropathy|contrast induced nephropathy
240969|NCT02137863|Diabetes Mellitus|diabetes mellitus
240970|NCT02137863|Dexmedetomidine|dexmedetomidine
240971|NCT02137837|Metastatic breast cancer|metastatic breast cancer
240972|NCT02137837|Invasive breast carcinoma|invasive breast carcinoma
240973|NCT02137837|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
240974|NCT02137837|HER2-negative breast cancer|her2-negative breast cancer
240975|NCT02137837|Stage IV breast cancer|stage iv breast cancer
240976|NCT02137837|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
240977|NCT02137811|cancer|cancer
240978|NCT02137811|CorrectChemo|correctchemo
240979|NCT02137811|assay|assay
240980|NCT02137811|lab test|lab test
240981|NCT02137811|MICK assay|mick assay
240982|NCT02137811|apoptosis|apoptosis
240983|NCT02137811|increase survival|increase survival
240984|NCT02137811|increase response rates|increase response rates
240985|NCT02137811|decrease time to progression|decrease time to progression
240986|NCT02137811|chemotherapy|chemotherapy
240987|NCT02137811|cancer treatment|cancer treatment
240988|NCT02137798|fluoroscopy exposure|fluoroscopy exposure
240989|NCT02137798|paroxysmal atrial fibrillation Ablation|paroxysmal atrial fibrillation ablation
240990|NCT02137798|fluoroscopy|fluoroscopy
240991|NCT02137798|Atrial Fibrillation Ablation|atrial fibrillation ablation
240992|NCT02137785|Actinic Keratosis|actinic keratosis
240993|NCT02137759|Glioblastoma|glioblastoma
240994|NCT02137746|Prostate Cancer|prostate cancer
240995|NCT02137746|Radical Prostatectomy|radical prostatectomy
240996|NCT02137720|Diabetes|diabetes
240997|NCT02137720|Treatment Adherence|treatment adherence
240998|NCT02137720|Self-management|self-management
240999|NCT02137720|Emotional Distress|emotional distress
241000|NCT02137720|Diabetes-related Distress|diabetes-related distress
241001|NCT02137707|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
241002|NCT02137707|Gilenya|gilenya
241003|NCT02137707|Fingolimod|fingolimod
241004|NCT02137694|Papillomavirus|papillomavirus
241005|NCT02137694|Vaginal auto-takings|vaginal auto-takings
241006|NCT02137694|Urinary test|urinary test
241007|NCT02137681|immune thrombocytopenia|immune thrombocytopenia
241008|NCT02137681|rituximab|rituximab
241009|NCT02137681|efficacy|efficacy
241010|NCT02137681|safety|safety
241011|NCT02137642|constipation|constipation
241012|NCT02137629|Myelodysplastic syndromes|myelodysplastic syndromes
241013|NCT02137629|Vidaza|vidaza
241014|NCT02137629|Observational study|observational study
241015|NCT02137629|Korea|korea
241016|NCT02137616|psychosis|psychosis
241017|NCT02137616|syndrome|syndrome
241018|NCT02137616|risk|risk
241019|NCT02137616|antipsychotic|antipsychotic
241020|NCT02137603|Suppurative appendicitis, appendicitis, pediatric|suppurative appendicitis, appendicitis, pediatric
241021|NCT02137590|Spanish Black Radish|spanish black radish
241022|NCT02137590|Phase I detoxification enzymes|phase i detoxification enzymes
241023|NCT02137590|Phase II detoxification enzymes|phase ii detoxification enzymes
241024|NCT02137590|Acetaminophen|acetaminophen
241025|NCT02137577|drug eluting balloon catheter|drug eluting balloon catheter
241026|NCT02137551|adherence|adherence
241027|NCT02137551|healthcare costs|healthcare costs
241028|NCT02137551|appointment based model|appointment based model
241029|NCT02137551|accountable care organization|accountable care organization
241030|NCT02137512|Artificial Pancreas|artificial pancreas
241031|NCT02137486|stable angina|stable angina
241032|NCT02137486|high angulated bifurcation|high angulated bifurcation
241033|NCT02137486|SYNTAX|syntax
241034|NCT02137486|DES|des
241035|NCT02137486|BMS|bms
241036|NCT02137460|Alzheimer's disease|alzheimer's disease
241037|NCT02137460|Early diagnosis|early diagnosis
241038|NCT02137460|Prediction|prediction
241039|NCT02137460|Biomarker|biomarker
241040|NCT02137460|Imaging|imaging
241041|NCT02137447|Prevena|prevena
241042|NCT02137447|faster healing time|faster healing time
241043|NCT02137447|surgical site infection|surgical site infection
241044|NCT02137434|Acute calcium|acute calcium
241045|NCT02137434|Dietary calcium|dietary calcium
241046|NCT02137434|Supplementary calcium|supplementary calcium
241047|NCT02137434|Postprandial metabolism|postprandial metabolism
241048|NCT02137421|Coronary artery disease|coronary artery disease
241049|NCT02137421|Metabolic syndrome|metabolic syndrome
241050|NCT02137421|Resveratrol|resveratrol
241051|NCT02137421|β-catenin|β-catenin
241052|NCT02137421|Wnt signaling|wnt signaling
241053|NCT02137421|FOXO|foxo
241054|NCT02137421|MnSOD|mnsod
241055|NCT02137408|Chronic hypertension in pregnancy|chronic hypertension in pregnancy
241056|NCT02137408|Pre-term delivery|pre-term delivery
241057|NCT02137408|Preeclampsia|preeclampsia
241058|NCT02137408|Endothelial Health|endothelial health
241059|NCT02137408|Docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
241060|NCT02137395|Children, Dexamethasone, Sugammadex,|children, dexamethasone, sugammadex,
241061|NCT02137382|maldigestion of dietary macronutrients (pancreas not producing enough enzymes for digestion of fat, sugars and proteins) in Cystic Fibrosis|maldigestion of dietary macronutrients (pancreas not producing enough enzymes for digestion of fat, sugars and proteins) in cystic fibrosis
241062|NCT02137369|MDD|mdd
241063|NCT02137369|Major Depressive Disorder|major depressive disorder
241064|NCT02137369|Treatment|treatment
241065|NCT02137369|Antidepressants|antidepressants
241066|NCT02137369|Lexapro|lexapro
241067|NCT02137369|Talk therapy|talk therapy
241068|NCT02137356|rectal cancer|rectal cancer
241069|NCT02137356|rectal adenocarcinoma|rectal adenocarcinoma
241070|NCT02137356|Selinexor|selinexor
241071|NCT02137356|capecitabine|capecitabine
241072|NCT02137356|chemoradiation|chemoradiation
241073|NCT02137356|radiation|radiation
241074|NCT02137356|radiotherapy|radiotherapy
241075|NCT02137356|neoadjuvant|neoadjuvant
241076|NCT02137356|locally advanced rectal cancer|locally advanced rectal cancer
241077|NCT02137343|Gastric Cancer|gastric cancer
241078|NCT02137343|First Line Treatment Gastroesophageal Junction (GEJ)|first line treatment gastroesophageal junction (gej)
241079|NCT02137343|Gastroesophageal Junction Cancer (GEJ)|gastroesophageal junction cancer (gej)
241080|NCT02137343|GEJ Cancer|gej cancer
241081|NCT02137330|Obalon swallowable intragastric balloons|obalon swallowable intragastric balloons
241082|NCT02137330|Severe obesity|severe obesity
241083|NCT02137330|Children|children
241084|NCT02137317|Pesticides|pesticides
241085|NCT02137317|Personal protective equipment|personal protective equipment
241086|NCT02137317|Developing countries|developing countries
241087|NCT02137317|Tropical Climate|tropical climate
241088|NCT02137304|cough help|cough help
241089|NCT02137304|in-exsufflation|in-exsufflation
241090|NCT02137304|neuromuscular disease|neuromuscular disease
241091|NCT02137304|cough assistance optimization|cough assistance optimization
241092|NCT02137304|efficient cough flow|efficient cough flow
241093|NCT02137291|Video-assisted thoracoscopic surgery (VATS)|video-assisted thoracoscopic surgery (vats)
241094|NCT02137291|Lung isolation device|lung isolation device
241095|NCT02137291|One-lung ventilation|one-lung ventilation
241096|NCT02137291|Double lumen endotracheal tube|double lumen endotracheal tube
241097|NCT02137291|Bronchial blocker|bronchial blocker
241098|NCT02137278|Syncope|syncope
241099|NCT02137278|Presyncope|presyncope
241100|NCT02137278|Vasoactive drugs|vasoactive drugs
241101|NCT02137278|Hypotension|hypotension
241102|NCT02137278|Carotid sinus massage|carotid sinus massage
241103|NCT02137278|Tilt table test|tilt table test
241104|NCT02137265|Azoospermia|azoospermia
241105|NCT02137265|Hypogonadism|hypogonadism
241106|NCT02137265|Clomiphene|clomiphene
241107|NCT02137252|Invasive Breast Cancer (Stage I-III)|invasive breast cancer (stage i-iii)
241108|NCT02137252|Ductal Carcinoma in Situ|ductal carcinoma in situ
241109|NCT02137252|Lobular Carcinoma in Situ|lobular carcinoma in situ
241110|NCT02137252|Lobular Carcinoma|lobular carcinoma
241111|NCT02137252|Fatigue Related to Cancer Treatment|fatigue related to cancer treatment
241112|NCT02137213|Opioid-induced constipation|opioid-induced constipation
241113|NCT02137213|Methadone|methadone
241114|NCT02137213|Naloxone|naloxone
241115|NCT02137187|Atrial fibrillation|atrial fibrillation
241116|NCT02137187|Heart failure|heart failure
241117|NCT02137187|Catheter ablation|catheter ablation
241118|NCT02137187|Cardiac resynchronization therapy|cardiac resynchronization therapy
241119|NCT02137187|Implantable defibrillator|implantable defibrillator
241120|NCT02137148|Vascular Access|vascular access
241121|NCT02137148|Sonic Window|sonic window
241122|NCT02137148|Ultrasound|ultrasound
241123|NCT02137135|chronic postoperative pain|chronic postoperative pain
241124|NCT02137135|menstrual cycle|menstrual cycle
241125|NCT02137122|Volunteers|volunteers
241126|NCT02137109|Pediatric|pediatric
241127|NCT02137096|Recurrent nasopharynx carcinoma|recurrent nasopharynx carcinoma
241128|NCT02137083|Chemotherapy|chemotherapy
241129|NCT02137083|Endocrine therapy|endocrine therapy
241130|NCT02137083|Docetaxel|docetaxel
241131|NCT02137083|Fulvestrant|fulvestrant
241132|NCT02137070|Weightloss and brain function|weightloss and brain function
241133|NCT02137070|Effects of bariatric surgery on brain function|effects of bariatric surgery on brain function
241134|NCT02137070|Reduced glucose insulin changes and brain function|reduced glucose insulin changes and brain function
241135|NCT02137057|Heart Rate Variability|heart rate variability
241136|NCT02137057|spinal anesthesia|spinal anesthesia
241137|NCT02137057|DM|dm
241138|NCT02137057|cardiac autonomic dysfunction|cardiac autonomic dysfunction
241139|NCT02137044|multiple sclerosis|multiple sclerosis
241140|NCT02137044|pain|pain
241141|NCT02137044|depression|depression
241142|NCT02137018|hernia|hernia
241143|NCT02137018|incisional hernia|incisional hernia
241144|NCT02137018|device|device
241145|NCT02137018|pig|pig
241146|NCT02137005|walking|walking
241147|NCT02137005|gait disorders, neurologic|gait disorders, neurologic
241148|NCT02137005|health status|health status
241149|NCT02137005|cognition|cognition
241150|NCT02137005|quality of life|quality of life
241151|NCT02137005|Transition to Adult Care|transition to adult care
241152|NCT02136953|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
241153|NCT02136953|Exercise|exercise
241154|NCT02136953|Cognitive Behavior Therapy|cognitive behavior therapy
241155|NCT02136953|Cognitive Behavioral Therapy|cognitive behavioral therapy
241156|NCT02136953|Treatment Efficacy|treatment efficacy
241157|NCT02136953|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
241158|NCT02136914|Levodopa Induced Dyskinesia|levodopa induced dyskinesia
241159|NCT02136914|LID|lid
241160|NCT02136914|Parkinsonism|parkinsonism
241161|NCT02136901|NuSurface|nusurface
241162|NCT02136901|Meniscus|meniscus
241163|NCT02136901|Prosthesis|prosthesis
241164|NCT02136901|KOOS|koos
241165|NCT02136888|Ponesimod|ponesimod
241166|NCT02136888|Safety|safety
241167|NCT02136875|COPD|copd
241168|NCT02136875|COPD exacerbation|copd exacerbation
241169|NCT02136862|Alport syndrome|alport syndrome
241170|NCT02136862|kidney disease|kidney disease
241171|NCT02136849|severe intellectual disability, genetic, de novo exome|severe intellectual disability, genetic, de novo exome
241172|NCT02136836|Genes, erbB-2|genes, erbb-2
241173|NCT02136836|Prognosis|prognosis
241174|NCT02136823|Spinal Cord Injury|spinal cord injury
241175|NCT02136810|Hypertension|hypertension
241176|NCT02136810|Perioperative Care|perioperative care
241177|NCT02136797|CMVpp65 Specific T-cells|cmvpp65 specific t-cells
241178|NCT02136797|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
241179|NCT02136797|14-070|14-070
241180|NCT02136784|pain|pain
241181|NCT02136784|cold presser test|cold presser test
241182|NCT02136784|buprenorphine|buprenorphine
241183|NCT02136784|opioids|opioids
241184|NCT02136758|lifestyle modification|lifestyle modification
241185|NCT02136758|diet|diet
241186|NCT02136758|exercise|exercise
241187|NCT02136758|cardiovascular disease|cardiovascular disease
241188|NCT02136758|gene expression|gene expression
241189|NCT02136758|obesity|obesity
241190|NCT02136745|Irritable Bowel Syndrome|irritable bowel syndrome
241191|NCT02136745|Inflammatory Bowel Disease|inflammatory bowel disease
241192|NCT02136745|mind body|mind body
241193|NCT02136745|intervention|intervention
241194|NCT02136745|group|group
241195|NCT02136745|Relaxation Response|relaxation response
241196|NCT02136745|genomic effects|genomic effects
241197|NCT02136732|chronic conditions|chronic conditions
241198|NCT02136732|multimorbid|multimorbid
241199|NCT02136719|Uterine massage|uterine massage
241200|NCT02136719|vaginal birth|vaginal birth
241201|NCT02136719|postpartum haemorrhage|postpartum haemorrhage
241202|NCT02136706|Stable coronary artery disease|stable coronary artery disease
241203|NCT02136693|obstructed defecation|obstructed defecation
241204|NCT02136693|STARR|starr
241205|NCT02136693|constipation|constipation
241206|NCT02136693|incontinence|incontinence
241207|NCT02136693|psyllium|psyllium
241208|NCT02136680|HIV disease|hiv disease
241209|NCT02136680|palliative care|palliative care
241210|NCT02136680|educational intervention|educational intervention
241211|NCT02136667|Preeclampsia|preeclampsia
241212|NCT02136667|Cardiovascular disease (CVD) risk|cardiovascular disease (cvd) risk
241213|NCT02136654|diabetes|diabetes
241214|NCT02136654|ethnicity|ethnicity
241215|NCT02136654|South Asian|south asian
241216|NCT02136654|diabetes management|diabetes management
241217|NCT02136641|Anesthesia|anesthesia
241218|NCT02136641|Spinal Anesthesia|spinal anesthesia
241219|NCT02136641|Conscious Sedation|conscious sedation
241220|NCT02136641|Operating Rooms.|operating rooms.
241221|NCT02136628|RTL Technique|rtl technique
241222|NCT02136615|hyperbaric oxygenation|hyperbaric oxygenation
241223|NCT02136615|insulin sensitivity|insulin sensitivity
241224|NCT02136615|human|human
241225|NCT02136615|inflammation|inflammation
241226|NCT02136615|adipose tissue|adipose tissue
241227|NCT02136563|Chronic kidney disease|chronic kidney disease
241228|NCT02136563|Erythropoiesis stimulating agent response index|erythropoiesis stimulating agent response index
241229|NCT02136563|Hyporesponsive anemia to erythropoiesis stimulating agent|hyporesponsive anemia to erythropoiesis stimulating agent
241230|NCT02136563|Observational study|observational study
241231|NCT02136550|smoking|smoking
241232|NCT02136550|smoking cessation|smoking cessation
241233|NCT02136550|mucociliary clearance|mucociliary clearance
241234|NCT02136550|proteomics|proteomics
241235|NCT02136550|miRNA|mirna
241236|NCT02136498|smoking cessation|smoking cessation
241237|NCT02136498|varenicline|varenicline
241238|NCT02136498|adherence|adherence
241239|NCT02136472|Subfertility|subfertility
241240|NCT02136472|Metabolic syndrome|metabolic syndrome
241241|NCT02136472|Plasma volume|plasma volume
241242|NCT02136472|Intima media thickness|intima media thickness
241243|NCT02136472|Flow mediated dilatation|flow mediated dilatation
241244|NCT02136459|Thyroidectomy|thyroidectomy
241245|NCT02136459|Endotracheal tube|endotracheal tube
241246|NCT02136459|Voice|voice
241247|NCT02136459|Complications|complications
241248|NCT02136459|Patients undergoing elective thyroidectomy|patients undergoing elective thyroidectomy
241249|NCT02136446|Paravertebral block|paravertebral block
241250|NCT02136446|Mastectomy|mastectomy
241251|NCT02136446|Post-operative pain|post-operative pain
241252|NCT02136446|Echogenic|echogenic
241253|NCT02136446|Peripheral nerve block catheter|peripheral nerve block catheter
241254|NCT02136433|Hand|hand
241255|NCT02136433|Rehabilitation|rehabilitation
241256|NCT02136433|Stroke|stroke
241257|NCT02136433|Brain-injury|brain-injury
241258|NCT02136433|Tablet|tablet
241259|NCT02136407|Vitamin D|vitamin d
241260|NCT02136407|vitamin D deficiency|vitamin d deficiency
241261|NCT02136407|parathyroid hormone|parathyroid hormone
241262|NCT02136381|Lifestyle, interventions, retirement|lifestyle, interventions, retirement
241263|NCT02136368|older adults|older adults
241264|NCT02136368|multiple-modality exercise|multiple-modality exercise
241265|NCT02136368|mind-motor exercise|mind-motor exercise
241266|NCT02136368|self-reported cognitive complaints|self-reported cognitive complaints
241267|NCT02136368|global cognitive functioning|global cognitive functioning
241268|NCT02136368|mobility|mobility
241269|NCT02136368|vascular function|vascular function
241270|NCT02136368|sensorimotor function|sensorimotor function
241271|NCT02136368|brain imaging|brain imaging
241272|NCT02136368|community-based research|community-based research
241273|NCT02136368|subjective cognitive complaints|subjective cognitive complaints
241274|NCT02136342|no available effective treatment|no available effective treatment
241275|NCT02136316|Healthy volunteers|healthy volunteers
241276|NCT02136316|ASP7962|asp7962
241277|NCT02136316|pharmacokinetics|pharmacokinetics
241278|NCT02136290|Weight loss|weight loss
241279|NCT02136277|colorectal surgery|colorectal surgery
241280|NCT02136277|cardiac output|cardiac output
241281|NCT02136264|hypertension|hypertension
241282|NCT02136264|dietary intervention|dietary intervention
241283|NCT02136264|personalized nutrition|personalized nutrition
241284|NCT02136264|randomized controlled trial|randomized controlled trial
241285|NCT02136251|Total Shoulder Arthroplasty|total shoulder arthroplasty
241286|NCT02136251|Glenoid anchor peg component fixation|glenoid anchor peg component fixation
241287|NCT02136251|Autologous bone grafting|autologous bone grafting
241288|NCT02136238|amputation|amputation
241289|NCT02136238|transradial|transradial
241290|NCT02136238|prosthesis|prosthesis
241291|NCT02136238|terminal device|terminal device
241292|NCT02136225|youth|youth
241293|NCT02136225|gun|gun
241294|NCT02136225|access|access
241295|NCT02136225|home|home
241296|NCT02136186|home telemonitoring|home telemonitoring
241297|NCT02136186|readmission|readmission
241298|NCT02136186|high risk|high risk
241299|NCT02136160|elementary school|elementary school
241300|NCT02136160|children|children
241301|NCT02136160|health promotion|health promotion
241302|NCT02136160|teachers|teachers
241303|NCT02136160|prevention|prevention
241304|NCT02136147|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
241305|NCT02136147|Neuropsychiatry|neuropsychiatry
241306|NCT02136147|Drug therapy|drug therapy
241307|NCT02136147|Pharmacogenetics|pharmacogenetics
241308|NCT02136147|Child Psychiatry|child psychiatry
241309|NCT02136134|Multiple Myeloma|multiple myeloma
241310|NCT02136134|Plasmacytoma|plasmacytoma
241311|NCT02136134|Refractory Multiple Myeloma|refractory multiple myeloma
241312|NCT02136134|Relapsed Multiple Myeloma|relapsed multiple myeloma
241313|NCT02136134|Daratumumab|daratumumab
241314|NCT02136134|VELCADE|velcade
241315|NCT02136108|Chronic pain|chronic pain
241316|NCT02136108|Complementary and alternative therapies|complementary and alternative therapies
241317|NCT02136108|Mobile health|mobile health
241318|NCT02136108|Medicaid|medicaid
241319|NCT02136108|Patient navigation|patient navigation
241320|NCT02136095|Fluorescent cholangiography|fluorescent cholangiography
241321|NCT02136095|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
241322|NCT02136082|HIV|hiv
241323|NCT02136082|Women|women
241324|NCT02136082|Children|children
241325|NCT02136082|Nutrition|nutrition
241326|NCT02136056|Sick-leave|sick-leave
241327|NCT02136056|Return to work|return to work
241328|NCT02136056|Self-management|self-management
241329|NCT02136056|Self-efficacy|self-efficacy
241330|NCT02136056|Quality of Life and Well-being|quality of life and well-being
241331|NCT02136056|Motivation|motivation
241332|NCT02136030|Cryptococcal meningitis|cryptococcal meningitis
241333|NCT02136017|AEFI|aefi
241334|NCT02136017|influenza vaccine|influenza vaccine
241335|NCT02136004|arteriotomy|arteriotomy
241336|NCT02136004|vessel closure|vessel closure
241337|NCT02136004|femoral access site|femoral access site
241338|NCT02135978|Spinal Cord Injury|spinal cord injury
241339|NCT02135978|Shoulder Pain|shoulder pain
241340|NCT02135978|Exercise|exercise
241341|NCT02135952|Periodontitis|periodontitis
241342|NCT02135952|Diabetes|diabetes
241343|NCT02135926|Cerebral Stroke, Stroke, Acute, Brain Infarction|cerebral stroke, stroke, acute, brain infarction
241344|NCT02135913|Obese|obese
241345|NCT02135913|Children|children
241346|NCT02135913|Vitamin D deficiency|vitamin d deficiency
241347|NCT02135913|Low HDL|low hdl
241348|NCT02135900|Heliox|heliox
241349|NCT02135900|Obstructive Sleep Apnea|obstructive sleep apnea
241350|NCT02135887|Stage III Colorectal Cancer|stage iii colorectal cancer
241351|NCT02135887|Grade 4 Neutropenia|grade 4 neutropenia
241352|NCT02135887|MB-6|mb-6
241353|NCT02135874|Leukemia|leukemia
241354|NCT02135874|Mixed Phenotype Acute Leukemia|mixed phenotype acute leukemia
241355|NCT02135874|MPAL|mpal
241356|NCT02135874|Newly Diagnosed|newly diagnosed
241357|NCT02135874|Relapsed|relapsed
241358|NCT02135874|Clofarabine|clofarabine
241359|NCT02135874|Clofarex|clofarex
241360|NCT02135874|Clolar|clolar
241361|NCT02135874|Idarubicin|idarubicin
241362|NCT02135874|Idamycin|idamycin
241363|NCT02135874|Cytarabine|cytarabine
241364|NCT02135874|Ara-C|ara-c
241365|NCT02135874|Cytosar|cytosar
241366|NCT02135874|DepoCyt|depocyt
241367|NCT02135874|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
241368|NCT02135874|Vincristine|vincristine
241369|NCT02135874|Rituximab|rituximab
241370|NCT02135874|Rituxan|rituxan
241371|NCT02135874|Dexamethasone|dexamethasone
241372|NCT02135874|Decadron|decadron
241373|NCT02135861|Acute decompensated heart failure|acute decompensated heart failure
241374|NCT02135861|heart failure|heart failure
241375|NCT02135861|MRI|mri
241376|NCT02135861|trpV4 channel inhibitors|trpv4 channel inhibitors
241377|NCT02135861|pulmonary oedema|pulmonary oedema
241378|NCT02135822|nanoparticle albumin-bound paclitaxel|nanoparticle albumin-bound paclitaxel
241379|NCT02135822|gemcitabine|gemcitabine
241380|NCT02135822|advanced pancreatic cancer|advanced pancreatic cancer
241381|NCT02135796|Septic Shock|septic shock
241382|NCT02135796|Severe Sepsis|severe sepsis
241383|NCT02135796|ICU|icu
241384|NCT02135770|heparin|heparin
241385|NCT02135770|sepsis|sepsis
241386|NCT02135770|inflammation|inflammation
241387|NCT02135744|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
241388|NCT02135744|COPD|copd
241389|NCT02135744|Readmissions|readmissions
241390|NCT02135718|ELLIPTA|ellipta
241391|NCT02135718|Asthma|asthma
241392|NCT02135718|Inhaler preference|inhaler preference
241393|NCT02135718|Fluticasone furoate|fluticasone furoate
241394|NCT02135718|ELLIPTA inhaler|ellipta inhaler
241395|NCT02135718|Dry Powder Inhaler|dry powder inhaler
241396|NCT02135692|Severe eosinophilic asthma|severe eosinophilic asthma
241397|NCT02135692|Extension study|extension study
241398|NCT02135692|Expanded access|expanded access
241399|NCT02135692|Safety|safety
241400|NCT02135692|Mepolizumab|mepolizumab
241401|NCT02135692|Eosinophils|eosinophils
241402|NCT02135666|Twinrix|twinrix
241403|NCT02135666|Long-term follow-up|long-term follow-up
241404|NCT02135666|Persistence|persistence
241405|NCT02135666|Hepatitis A|hepatitis a
241406|NCT02135666|Antibody|antibody
241407|NCT02135666|Immunity|immunity
241408|NCT02135666|Hepatitis B|hepatitis b
241409|NCT02135666|Combination vaccine|combination vaccine
241410|NCT02135666|Adult|adult
241411|NCT02135601|colonoscopy|colonoscopy
241412|NCT02135601|water|water
241413|NCT02135601|adenoma|adenoma
241414|NCT02135601|pain|pain
241415|NCT02135575|premenopausal|premenopausal
241416|NCT02135575|postmenopausal|postmenopausal
241417|NCT02135575|cardiovascular|cardiovascular
241418|NCT02135575|exercise training|exercise training
241419|NCT02135575|vascular function|vascular function
241420|NCT02135575|cardiac function|cardiac function
241421|NCT02135575|cardiac morphology|cardiac morphology
241422|NCT02135575|health|health
241423|NCT02135562|endometrial cancer|endometrial cancer
241424|NCT02135562|survivor|survivor
241425|NCT02135562|obesity|obesity
241426|NCT02135562|diet|diet
241427|NCT02135562|high protein|high protein
241428|NCT02135562|protein-sparing modified fast intervention|protein-sparing modified fast intervention
241429|NCT02135562|PSMF|psmf
241430|NCT02135523|ovarian cancer|ovarian cancer
241431|NCT02135523|involved-field radiation therapy|involved-field radiation therapy
241432|NCT02135523|progression free survival|progression free survival
241433|NCT02135484|Prostate Cancer|prostate cancer
241434|NCT02135484|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
241435|NCT02135484|Castrate resistant prostate cancer|castrate resistant prostate cancer
241436|NCT02135484|CRPC|crpc
241437|NCT02135484|Skeletal metastases|skeletal metastases
241438|NCT02135484|Alpharadin|alpharadin
241439|NCT02135484|Xofigo|xofigo
241440|NCT02135484|Radium-223 chloride|radium-223 chloride
241441|NCT02135484|Radium-223 dichloride|radium-223 dichloride
241442|NCT02135471|gingival recession|gingival recession
241443|NCT02135471|dental enamel proteins|dental enamel proteins
241444|NCT02135471|acellular dermal matrix graft|acellular dermal matrix graft
241445|NCT02135471|tobacco|tobacco
241446|NCT02135458|Heart failure|heart failure
241447|NCT02135458|Telemonitoring|telemonitoring
241448|NCT02135458|therapeutic education|therapeutic education
241449|NCT02135458|care network|care network
241450|NCT02135458|hospitalization|hospitalization
241451|NCT02135445|Drug therapy|drug therapy
241452|NCT02135432|Chronic Obstructive pulmonary disease, Ivacaftor|chronic obstructive pulmonary disease, ivacaftor
241453|NCT02135406|Adult|adult
241454|NCT02135406|18 years or older|18 years or older
241455|NCT02135406|multiple myeloma|multiple myeloma
241456|NCT02135406|poor prognosis|poor prognosis
241457|NCT02135406|relapsed/progressive disease|relapsed/progressive disease
241458|NCT02135406|within one year of first autologous stem cell transplantation|within one year of first autologous stem cell transplantation
241459|NCT02135367|PRP|prp
241460|NCT02135367|growth factors|growth factors
241461|NCT02135367|Viscosupplementation|viscosupplementation
241462|NCT02135367|injections|injections
241463|NCT02135367|chondropathy|chondropathy
241464|NCT02135367|randomized controlled trial|randomized controlled trial
241465|NCT02135354|AECOPD|aecopd
241466|NCT02135354|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
241467|NCT02135354|Acute exacerbation|acute exacerbation
241468|NCT02135354|Hospitalization|hospitalization
241469|NCT02135354|Azithromycin|azithromycin
241470|NCT02135354|Macrolides|macrolides
241471|NCT02135354|Randomized Controlled Trial|randomized controlled trial
241472|NCT02135354|Placebo|placebo
241473|NCT02135341|Detrusor Overactivity|detrusor overactivity
241474|NCT02135341|Impaired Contractility|impaired contractility
241475|NCT02135341|Botulinum Toxin A (BoNT-A)|botulinum toxin a (bont-a)
241476|NCT02135328|Type 2 diabetes|type 2 diabetes
241477|NCT02135328|Dietary behaviors|dietary behaviors
241478|NCT02135328|Physical activity behaviors|physical activity behaviors
241479|NCT02135328|Radio story, entertainment health education|radio story, entertainment health education
241480|NCT02135328|Immigrants|immigrants
241481|NCT02135328|Somali, Latino, Hmong|somali, latino, hmong
241482|NCT02135328|Families with 3-18 year old children|families with 3-18 year old children
241483|NCT02135315|Acute Coronary Syndrome, arterial pressure|acute coronary syndrome, arterial pressure
241484|NCT02135302|hepatic|hepatic
241485|NCT02135250|Traditional Chinese Medicine|traditional chinese medicine
241486|NCT02135211|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
241487|NCT02135211|multiple risk factor|multiple risk factor
241488|NCT02135211|lifestyle intervention|lifestyle intervention
241489|NCT02135211|health behavior|health behavior
241490|NCT02135211|lifestyle risk reduction|lifestyle risk reduction
241491|NCT02135211|health related quality of life|health related quality of life
241492|NCT02135198|GABA modulator|gaba modulator
241493|NCT02135198|AZD7325|azd7325
241494|NCT02135198|Short interval intracortical inhibition|short interval intracortical inhibition
241495|NCT02135198|volunteers|volunteers
241496|NCT02135146|Hypotension|hypotension
241497|NCT02135146|Kidney injury|kidney injury
241498|NCT02135133|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
241499|NCT02135133|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
241500|NCT02135107|Gastroesophageal reflux disease|gastroesophageal reflux disease
241501|NCT02135094|trapezius|trapezius
241502|NCT02135094|upper back|upper back
241503|NCT02135094|muscle pain|muscle pain
241504|NCT02135094|pain relief|pain relief
241505|NCT02135094|ultrasound|ultrasound
241506|NCT02135094|double blind|double blind
241507|NCT02135094|Sam|sam
241508|NCT02135094|ZetrOZ|zetroz
241509|NCT02135094|muscle|muscle
241510|NCT02135094|LITUS|litus
241511|NCT02135094|low intensity therapeutic ultrasound|low intensity therapeutic ultrasound
241512|NCT02135081|Single ventricle|single ventricle
241513|NCT02135081|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
241514|NCT02135081|Congenital heart lesion|congenital heart lesion
241515|NCT02135081|Right or left ventricle|right or left ventricle
241516|NCT02135081|Cerebral blood flow|cerebral blood flow
241517|NCT02135081|Pulmonary blood flow|pulmonary blood flow
241518|NCT02135081|Staged Fontan reconstruction|staged fontan reconstruction
241519|NCT02135081|hemi Fontan/bidirectional Glenn stages|hemi fontan/bidirectional glenn stages
241520|NCT02135068|type 1 diabetes|type 1 diabetes
241521|NCT02135068|closed loop insulin delivery systems|closed loop insulin delivery systems
241522|NCT02135068|exercise|exercise
241523|NCT02135068|hypoglycemia|hypoglycemia
241524|NCT02135055|organ function|organ function
241525|NCT02135055|sedation|sedation
241526|NCT02135029|Hyperlipidemia|hyperlipidemia
241527|NCT02135029|statin intolerance|statin intolerance
241528|NCT02135016|effect-site concentration|effect-site concentration
241529|NCT02135016|propofol|propofol
241530|NCT02135016|thoracic epidural anesthesia|thoracic epidural anesthesia
241531|NCT02134990|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
241532|NCT02134990|Docetaxel|docetaxel
241533|NCT02134977|Pharmacological therapy|pharmacological therapy
241534|NCT02134964|Safety|safety
241535|NCT02134964|Tolerability|tolerability
241536|NCT02134964|Pharmacokinetics|pharmacokinetics
241537|NCT02134964|Dose escalation|dose escalation
241538|NCT02134964|Randomized|randomized
241539|NCT02134964|Healthy volunteers|healthy volunteers
241540|NCT02134964|OLT1177|olt1177
241541|NCT02134964|Olatec|olatec
241542|NCT02134899|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
241543|NCT02134899|cyst|cyst
241544|NCT02134899|kidney|kidney
241545|NCT02134899|liver|liver
241546|NCT02134899|kidney transplantation|kidney transplantation
241547|NCT02134899|IF/TA|if/ta
241548|NCT02134899|fibrosis|fibrosis
241549|NCT02134899|DSA|dsa
241550|NCT02134899|mTOR inhibitors|mtor inhibitors
241551|NCT02134899|calcineurin inhibitors|calcineurin inhibitors
241552|NCT02134873|Pain|pain
241553|NCT02134873|Pain management|pain management
241554|NCT02134873|Hospitalized|hospitalized
241555|NCT02134873|Infants|infants
241556|NCT02134873|Sucrose|sucrose
241557|NCT02134847|Resident|resident
241558|NCT02134847|Fatigue|fatigue
241559|NCT02134847|Sleep deprivation|sleep deprivation
241560|NCT02134847|medical errors|medical errors
241561|NCT02134808|Major Depressive Disorder|major depressive disorder
241562|NCT02134808|Creatine|creatine
241563|NCT02134808|Brain Chemistry|brain chemistry
241564|NCT02134808|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
241565|NCT02134808|Treatment Resistance|treatment resistance
241566|NCT02134808|Selective Serotonin Reuptake Inhibitor (SSRI) Resistance|selective serotonin reuptake inhibitor (ssri) resistance
241567|NCT02134795|Parkinson's disease|parkinson's disease
241568|NCT02134782|Randomized Controlled Trial, yoga, children, chemotherapy, haematopoietic stem cell transplantation, fatigue, quality of life|randomized controlled trial, yoga, children, chemotherapy, haematopoietic stem cell transplantation, fatigue, quality of life
241569|NCT02134769|catheter-related bloodstream infections|catheter-related bloodstream infections
241570|NCT02134756|Supplement impact|supplement impact
241571|NCT02134756|Performance|performance
241572|NCT02134756|Fatigue|fatigue
241573|NCT02134743|dental implant|dental implant
241574|NCT02134743|Surface energy|surface energy
241575|NCT02134743|Hydrophilicity|hydrophilicity
241576|NCT02134743|Contact angle|contact angle
241577|NCT02134743|Titanium implant roughness|titanium implant roughness
241578|NCT02134743|Surface conditioning|surface conditioning
241579|NCT02134730|FRIENDS for life|friends for life
241580|NCT02134730|universal prevention|universal prevention
241581|NCT02134730|school children|school children
241582|NCT02134730|anxiety|anxiety
241583|NCT02134717|sarcoidosis|sarcoidosis
241584|NCT02134717|CCR5 inhibition|ccr5 inhibition
241585|NCT02134717|maraviroc|maraviroc
241586|NCT02134691|Posttraumatic Stress Disorder (PTSD)|posttraumatic stress disorder (ptsd)
241587|NCT02134691|Prolonged Exposure (PE)|prolonged exposure (pe)
241588|NCT02134678|self-system therapy|self-system therapy
241589|NCT02134678|cognitive therapy|cognitive therapy
241590|NCT02134678|depression|depression
241591|NCT02134678|psychotherapy|psychotherapy
241592|NCT02134678|mechanisms of action|mechanisms of action
241593|NCT02134665|Vancomycin|vancomycin
241594|NCT02134665|severe acute pancreatitis|severe acute pancreatitis
241595|NCT02134665|Creatinine clearance|creatinine clearance
241596|NCT02134652|Ultrasonography|ultrasonography
241597|NCT02134652|World Health|world health
241598|NCT02134626|Portal Hypertension|portal hypertension
241599|NCT02134626|Hepatic Venous Pressure Gradient|hepatic venous pressure gradient
241600|NCT02134626|Esophageal Varices|esophageal varices
241601|NCT02134626|Liver Cirrhosis|liver cirrhosis
241602|NCT02134626|Simvastatin|simvastatin
241603|NCT02134626|Nitric oxide|nitric oxide
241604|NCT02134626|HVPG|hvpg
241605|NCT02134613|99mTc-anti-TNF|99mtc-anti-tnf
241606|NCT02134613|Inflammation|inflammation
241607|NCT02134613|Psoriatic arthritis|psoriatic arthritis
241608|NCT02134613|Rheumatoid arthritis|rheumatoid arthritis
241609|NCT02134600|Omega-3 fatty acids|omega-3 fatty acids
241610|NCT02134600|DHA|dha
241611|NCT02134600|EPA|epa
241612|NCT02134600|Docosahexaenoic acid|docosahexaenoic acid
241613|NCT02134600|Eicosapentaenoic acid|eicosapentaenoic acid
241614|NCT02134600|Childhood cancer|childhood cancer
241615|NCT02134600|Body composition|body composition
241616|NCT02134600|Inflammation|inflammation
241617|NCT02134600|Neuropsychiatric symptoms|neuropsychiatric symptoms
241618|NCT02134587|Health knowledge, attitudes, practices.|health knowledge, attitudes, practices.
241619|NCT02134587|Adverse drug reaction reporting systems.|adverse drug reaction reporting systems.
241620|NCT02134587|Pharmacovigilance. Product Surveillance, Postmarketing.|pharmacovigilance. product surveillance, postmarketing.
241621|NCT02134587|Drug-related side effects and adverse reactions.|drug-related side effects and adverse reactions.
241622|NCT02134574|Lymphoma,|lymphoma,
241623|NCT02134574|leukemia,|leukemia,
241624|NCT02134574|multiple myeloma,|multiple myeloma,
241625|NCT02134574|hodgkin disease|hodgkin disease
241626|NCT02134522|non alcoholic fatty liver|non alcoholic fatty liver
241627|NCT02134522|childhood obesity|childhood obesity
241628|NCT02134522|Sleep Apnea|sleep apnea
241629|NCT02134509|Cigarette smoking|cigarette smoking
241630|NCT02134496|hip|hip
241631|NCT02134496|knee|knee
241632|NCT02134496|arthroplasty|arthroplasty
241633|NCT02134496|spinal|spinal
241634|NCT02134496|anesthesia|anesthesia
241635|NCT02134483|Parathyroid|parathyroid
241636|NCT02134483|Permanent hypocalcemia|permanent hypocalcemia
241637|NCT02134483|Transplantation|transplantation
241638|NCT02134470|saliva|saliva
241639|NCT02134470|blood|blood
241640|NCT02134470|urine|urine
241641|NCT02134444|Dizziness|dizziness
241642|NCT02134444|Vertigo|vertigo
241937|NCT02133378|Bleeding|bleeding
241643|NCT02134444|Vestibular Diseases|vestibular diseases
241644|NCT02134444|Vestibular Neuritis|vestibular neuritis
241645|NCT02134444|Labyrinth Diseases|labyrinth diseases
241646|NCT02134444|Ear Diseases|ear diseases
241647|NCT02134444|Vestibular rehabilitation|vestibular rehabilitation
241648|NCT02134444|Telerehabilitation|telerehabilitation
241649|NCT02134444|Gaze control|gaze control
241650|NCT02134444|Balance|balance
241651|NCT02134431|HIV|hiv
241652|NCT02134431|tenofovir|tenofovir
241653|NCT02134431|miocrobicide|miocrobicide
241654|NCT02134431|endoscopy (colonoscopy, sigmoidoscopy)|endoscopy (colonoscopy, sigmoidoscopy)
241655|NCT02134431|adolescents|adolescents
241656|NCT02134431|pediatrics|pediatrics
241657|NCT02134418|Schizophrenia|schizophrenia
241658|NCT02134418|Irony|irony
241659|NCT02134418|Hemispheric processing|hemispheric processing
241660|NCT02134418|Theory of mind|theory of mind
241661|NCT02134405|functional dyspepsia|functional dyspepsia
241662|NCT02134405|symptoms|symptoms
241663|NCT02134405|proton pump inhibitor|proton pump inhibitor
241664|NCT02134405|gastritis|gastritis
241665|NCT02134392|C-diff|c-diff
241666|NCT02134392|Clostridium difficile|clostridium difficile
241667|NCT02134392|Fecal Transplant|fecal transplant
241668|NCT02134392|FMT|fmt
241669|NCT02134392|Fecal Microbiota Transplant|fecal microbiota transplant
241670|NCT02134379|Thoracic Impedance|thoracic impedance
241671|NCT02134379|Diagnostic Marker|diagnostic marker
241672|NCT02134379|Bed Rest Test|bed rest test
241673|NCT02134379|Transthoracic Impedance|transthoracic impedance
241674|NCT02134379|Heart Failure|heart failure
241675|NCT02134379|HF|hf
241676|NCT02134366|Epilepsia Partialis Continua|epilepsia partialis continua
241677|NCT02134366|Kojewnikov's Epilepsy|kojewnikov's epilepsy
241678|NCT02134366|Epilepsy|epilepsy
241679|NCT02134366|Clobazam|clobazam
241680|NCT02134366|Focal Motor Epilepsy|focal motor epilepsy
241681|NCT02134366|Partial Motor Seizure|partial motor seizure
241682|NCT02134340|IGF1R|igf1r
241683|NCT02134314|ESRD|esrd
241684|NCT02134314|CKD|ckd
241685|NCT02134314|Kidney Transplant|kidney transplant
241686|NCT02134314|ECD|ecd
241687|NCT02134314|delayed graft function|delayed graft function
241688|NCT02134301|oritavancin|oritavancin
241689|NCT02134301|pediatrics|pediatrics
241690|NCT02134301|gram positive|gram positive
241691|NCT02134301|bacterial infection|bacterial infection
241692|NCT02134301|Confirmed|confirmed
241693|NCT02134301|Suspected|suspected
241694|NCT02134288|Dialysis|dialysis
241695|NCT02134288|Kidney Transplant|kidney transplant
241696|NCT02134288|immunosuppressive therapy|immunosuppressive therapy
241697|NCT02134288|Delayed Graft Function|delayed graft function
241698|NCT02134288|Belatacept|belatacept
241699|NCT02134275|whole body vibration training|whole body vibration training
241700|NCT02134275|young adult|young adult
241701|NCT02134275|weight gain|weight gain
241702|NCT02134275|obesity|obesity
241703|NCT02134275|randomized clinical trial|randomized clinical trial
241704|NCT02134262|Anti-CD19 CAR Expressing T cells Therapy|anti-cd19 car expressing t cells therapy
241705|NCT02134262|CD19 CAR Gene-Transduced Lymphocyte|cd19 car gene-transduced lymphocyte
241706|NCT02134262|Adoptive Immunotherapy|adoptive immunotherapy
241707|NCT02134262|Genetically Engineered Lymphocyte Therapy|genetically engineered lymphocyte therapy
241708|NCT02134262|Retroviral Vector|retroviral vector
241709|NCT02134262|Burkitt Lymphoma|burkitt lymphoma
241710|NCT02134262|Lymphoma|lymphoma
241711|NCT02134262|Lymphoma, Follicular|lymphoma, follicular
241712|NCT02134262|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
241713|NCT02134262|Lymphomatoid Granulomatosis|lymphomatoid granulomatosis
241714|NCT02134262|Lymphoma, B-Cell|lymphoma, b-cell
241715|NCT02134262|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
241716|NCT02134262|Lymphoma, Large-Cell, Immunoblastic|lymphoma, large-cell, immunoblastic
241717|NCT02134262|Lymphoma, B-Cell, Marginal Zone|lymphoma, b-cell, marginal zone
241718|NCT02134262|Lymphoma, Extranodal NK-T-Cell|lymphoma, extranodal nk-t-cell
241719|NCT02134262|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
241720|NCT02134262|Neoplasms by Histologic Type|neoplasms by histologic type
241721|NCT02134262|Neoplasms|neoplasms
241722|NCT02134262|Neoplasms, Experimental|neoplasms, experimental
241723|NCT02134262|Immune System Diseases|immune system diseases
241724|NCT02134249|infertility|infertility
241725|NCT02134249|ICSI|icsi
241726|NCT02134249|OHSS|ohss
241727|NCT02134249|Diosmin|diosmin
241728|NCT02134249|Cabergoline|cabergoline
241729|NCT02134210|PsO|pso
241730|NCT02134197|Oncology|oncology
241731|NCT02134197|Solid tumors|solid tumors
241732|NCT02134197|Antibody drug conjugate|antibody drug conjugate
241733|NCT02134197|Maximum tolerated dose|maximum tolerated dose
241734|NCT02134171|Thrombotic microangiopathy,|thrombotic microangiopathy,
241735|NCT02134171|haemolytic uremic syndrome,|haemolytic uremic syndrome,
241736|NCT02134171|thrombotic thrombocytopenic purpura,|thrombotic thrombocytopenic purpura,
241737|NCT02134171|ADAMTS13,|adamts13,
241738|NCT02134171|troponin,|troponin,
241739|NCT02134171|plasma exchange.|plasma exchange.
241740|NCT02134158|tDCS, gait disorders, equilibrium, hemiplegic, stroke|tdcs, gait disorders, equilibrium, hemiplegic, stroke
241741|NCT02134145|Mobile Health|mobile health
241743|NCT02134145|Technology|technology
241744|NCT02134132|Platelet gel|platelet gel
241745|NCT02134132|diabetic foot ulcer|diabetic foot ulcer
241746|NCT02134132|umbilical cord blood|umbilical cord blood
241747|NCT02134119|dietary supplement|dietary supplement
241748|NCT02134119|endurance athletes|endurance athletes
241749|NCT02134119|VO2max|vo2max
241750|NCT02134119|red blood cells|red blood cells
241751|NCT02134106|Multicenter|multicenter
241752|NCT02134106|Open-label|open-label
241753|NCT02134106|Randomized|randomized
241754|NCT02134106|Controlled|controlled
241755|NCT02134106|RCT|rct
241756|NCT02134106|antibiotic|antibiotic
241757|NCT02134106|drug-resistant|drug-resistant
241758|NCT02134106|Gram-negative|gram-negative
241759|NCT02134106|bacteria|bacteria
241760|NCT02134080|Tourette Syndrome|tourette syndrome
241761|NCT02134080|FAAH-Inhibitor|faah-inhibitor
241762|NCT02134080|Tics|tics
241763|NCT02134080|Tic Disorders|tic disorders
241764|NCT02134067|advanced solid tumors|advanced solid tumors
241765|NCT02134067|tumor|tumor
241766|NCT02134067|Dose Escalation|dose escalation
241767|NCT02134067|TAS-119|tas-119
241768|NCT02134067|Taxane|taxane
241769|NCT02134067|Paclitaxel|paclitaxel
241770|NCT02134067|Aurora A kinase inhibitor|aurora a kinase inhibitor
241771|NCT02134067|AurA|aura
241772|NCT02134054|Therapeutic drug monitoring|therapeutic drug monitoring
241773|NCT02134054|Biological treatment|biological treatment
241774|NCT02134054|IBD|ibd
241775|NCT02134041|traumatic brain injury|traumatic brain injury
241776|NCT02134041|Alzheimer disease|alzheimer disease
241777|NCT02134015|Carcinoma|carcinoma
241778|NCT02134015|Non-Small-Cell Lung|non-small-cell lung
241779|NCT02134015|Lung Neoplasms|lung neoplasms
241780|NCT02134015|Bronchogenic|bronchogenic
241781|NCT02134015|Bronchial Neoplasms|bronchial neoplasms
241782|NCT02134015|Respiratory Tract Neoplasms|respiratory tract neoplasms
241783|NCT02134015|Thoracic Neoplasms|thoracic neoplasms
241784|NCT02134015|Neoplasms by Site|neoplasms by site
241785|NCT02134015|Neoplasms|neoplasms
241786|NCT02134015|Lung Diseases|lung diseases
241787|NCT02134015|Respiratory Tract Diseases|respiratory tract diseases
241788|NCT02134015|Erlotinib|erlotinib
241789|NCT02134015|Therapeutic Uses|therapeutic uses
241790|NCT02134015|Pharmacologic Actions|pharmacologic actions
241791|NCT02134015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
241792|NCT02134002|cocaine|cocaine
241793|NCT02134002|disulfiram|disulfiram
241794|NCT02134002|beta-dopamine hydroxylase|beta-dopamine hydroxylase
241795|NCT02133989|Carotid stenosis|carotid stenosis
241796|NCT02133989|Stenting|stenting
241797|NCT02133989|Clopidogrel resistance|clopidogrel resistance
241798|NCT02133989|Stroke, ischemic|stroke, ischemic
241799|NCT02133976|chronic low back pain|chronic low back pain
241800|NCT02133976|psychosocial interventions|psychosocial interventions
241801|NCT02133976|mechanisms|mechanisms
241802|NCT02133963|depression|depression
241803|NCT02133963|postpartum depression|postpartum depression
241804|NCT02133963|pregnancy|pregnancy
241805|NCT02133963|perinatal depression|perinatal depression
241806|NCT02133963|sleep|sleep
241807|NCT02133963|life stress|life stress
241808|NCT02133950|preimplantation genetic diagnosis|preimplantation genetic diagnosis
241809|NCT02133950|cryopreservation|cryopreservation
241810|NCT02133950|pregnancy|pregnancy
241811|NCT02133924|Graft vs Host Disease|graft vs host disease
241812|NCT02133924|Graft vs Host Reaction|graft vs host reaction
241813|NCT02133924|allogeneic bone marrow transplantation|allogeneic bone marrow transplantation
241814|NCT02133924|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
241815|NCT02133924|adverse effects|adverse effects
241816|NCT02133898|Depression|depression
241817|NCT02133898|MTHFR|mthfr
241818|NCT02133898|L-methylfolate|l-methylfolate
241819|NCT02133885|Resistent Hypertension|resistent hypertension
241820|NCT02133885|Systolic Blood Pressure|systolic blood pressure
241821|NCT02133872|Resistent Hypertension|resistent hypertension
241822|NCT02133846|4RT, CBS, PSP, CBD, TPI-287|4rt, cbs, psp, cbd, tpi-287
241823|NCT02133820|Healthy Volunteer|healthy volunteer
241824|NCT02133820|Pharmacokinetics|pharmacokinetics
241825|NCT02133807|Lipoprotein(a);|lipoprotein(a);
241826|NCT02133807|Lp(a) immunoadsorption;|lp(a) immunoadsorption;
241827|NCT02133807|Apheresis;|apheresis;
241828|NCT02133807|Coronary atherosclerosis;|coronary atherosclerosis;
241829|NCT02133807|Carotid Atherosclerosis;|carotid atherosclerosis;
241830|NCT02133807|Intima-media thickness;|intima-media thickness;
241831|NCT02133807|Regression;|regression;
241832|NCT02133807|Quantitative Coronary Angiography;|quantitative coronary angiography;
241833|NCT02133807|Intravascular Ultrasound;|intravascular ultrasound;
241834|NCT02133807|Virtual Histology;|virtual histology;
241835|NCT02133807|Plaque;|plaque;
241836|NCT02133807|Atorvastatin;|atorvastatin;
241837|NCT02133794|Hip fracture|hip fracture
241838|NCT02133794|Tomosynthesis|tomosynthesis
241839|NCT02133794|X-ray|x-ray
241840|NCT02133794|Emergency room|emergency room
241841|NCT02133781|Inactivated influenza vaccine|inactivated influenza vaccine
241842|NCT02133781|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
241843|NCT02133781|Child identical twins|child identical twins
241844|NCT02133781|Young and elderly adults|young and elderly adults
241845|NCT02133742|Axitinib and MK-3475|axitinib and mk-3475
241846|NCT02133742|patients with advanced Renal Cell Cancer.|patients with advanced renal cell cancer.
241847|NCT02133716|pain|pain
241848|NCT02133716|premature infant|premature infant
241849|NCT02133716|sucrose|sucrose
241850|NCT02133716|breastfeeding|breastfeeding
241851|NCT02133716|expressed breast milk|expressed breast milk
241852|NCT02133716|PIPP|pipp
241853|NCT02133703|Genetic counseling|genetic counseling
241854|NCT02133703|genetic testing|genetic testing
241855|NCT02133703|BRCA1|brca1
241856|NCT02133703|BRCA2|brca2
241857|NCT02133703|Hereditary breast cancer|hereditary breast cancer
241858|NCT02133703|Hereditary ovarian cancer|hereditary ovarian cancer
241859|NCT02133690|rotavirus|rotavirus
241860|NCT02133690|rotavirus vaccine|rotavirus vaccine
241861|NCT02133690|BRV-PV|brv-pv
241862|NCT02133677|lung cancer and breast cancer patients with brain metastases|lung cancer and breast cancer patients with brain metastases
241863|NCT02133664|multiple sclerosis|multiple sclerosis
241864|NCT02133664|cognition|cognition
241865|NCT02133664|clinical trial|clinical trial
241866|NCT02133664|thiotic acid|thiotic acid
241867|NCT02133664|Omega-3 fatty acids|omega-3 fatty acids
241868|NCT02133651|Clostridium difficile|clostridium difficile
241869|NCT02133651|Intestinal Microbiota Transplantation|intestinal microbiota transplantation
241870|NCT02133651|Diarrhea|diarrhea
241871|NCT02133651|Fecal Microbiota Transplant|fecal microbiota transplant
241872|NCT02133638|Delirium|delirium
241873|NCT02133638|Hypoxic Brain Damage|hypoxic brain damage
241874|NCT02133638|Propofol|propofol
241875|NCT02133638|S100b protein|s100b protein
241876|NCT02133638|Sevoflurane|sevoflurane
241877|NCT02133625|Advanced solid tumor|advanced solid tumor
241878|NCT02133625|Metastatic solid tumor|metastatic solid tumor
241879|NCT02133612|esophageal cancer|esophageal cancer
241880|NCT02133612|adjuvant chemotherapy|adjuvant chemotherapy
241881|NCT02133612|esophageal surgery|esophageal surgery
241882|NCT02133612|paclitaxel|paclitaxel
241883|NCT02133612|cisplatin|cisplatin
241884|NCT02133586|Air pollution|air pollution
241885|NCT02133586|Ozone|ozone
241886|NCT02133586|Nitrogen dioxide|nitrogen dioxide
241887|NCT02133586|Lung function|lung function
241888|NCT02133586|Cytokines|cytokines
241889|NCT02133573|progesterone|progesterone
241890|NCT02133573|congenital heart disease|congenital heart disease
241891|NCT02133573|periventricular leucomalacia|periventricular leucomalacia
241892|NCT02133573|brain development|brain development
241893|NCT02133573|cardiac surgery|cardiac surgery
241894|NCT02133573|neurodevelopmental disability|neurodevelopmental disability
241895|NCT02133573|fetus|fetus
241896|NCT02133573|fetal neuroprotection|fetal neuroprotection
241897|NCT02133560|Sickle cell|sickle cell
241898|NCT02133560|Thalassemia|thalassemia
241899|NCT02133560|Adherence|adherence
241900|NCT02133547|Nitric Oxide|nitric oxide
241901|NCT02133547|Nose|nose
241902|NCT02133547|Healthy Volunteers|healthy volunteers
241903|NCT02133547|Kartagener Syndrome|kartagener syndrome
241904|NCT02133547|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
241905|NCT02133534|Chronic kidney disease|chronic kidney disease
241906|NCT02133534|High cholesterol|high cholesterol
241907|NCT02133521|DLBS1033|dlbs1033
241908|NCT02133521|Acute ischemic stroke|acute ischemic stroke
241909|NCT02133521|NIHSS|nihss
241910|NCT02133521|Barthel Index|barthel index
241911|NCT02133495|lower eyelid|lower eyelid
241912|NCT02133495|retraction|retraction
241913|NCT02133469|Effectiveness|effectiveness
241914|NCT02133469|Prevenar|prevenar
241915|NCT02133469|nasopharyngeal carriage|nasopharyngeal carriage
241916|NCT02133469|vaccine serotype|vaccine serotype
241917|NCT02133456|safety|safety
241918|NCT02133456|influenza vaccine|influenza vaccine
241919|NCT02133456|post-marketing|post-marketing
241920|NCT02133443|Mechanical ventilation|mechanical ventilation
241921|NCT02133443|Acute respiratory failure|acute respiratory failure
241922|NCT02133443|Weaning|weaning
241923|NCT02133443|Pressure support ventilation|pressure support ventilation
241924|NCT02133443|Neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
241925|NCT02133430|Postoperative delirium|postoperative delirium
241926|NCT02133417|Quantitative Transmission Ultrasound|quantitative transmission ultrasound
241927|NCT02133417|QTUS|qtus
241928|NCT02133404|secondary hyperparathyroidism(SHPT)|secondary hyperparathyroidism(shpt)
241929|NCT02133404|Chronic kidney disease(CKD)|chronic kidney disease(ckd)
241930|NCT02133404|Mineral bone disease(MBD)|mineral bone disease(mbd)
241931|NCT02133391|Accountable Care Organization|accountable care organization
241932|NCT02133391|Comparative Effectiveness Research|comparative effectiveness research
241933|NCT02133391|Immunization/statistics & numerical data|immunization/statistics & numerical data
241934|NCT02133391|Medicaid|medicaid
241935|NCT02133391|Reminder Systems/economics|reminder systems/economics
241936|NCT02133391|Reminder Systems/statistics & numerical data|reminder systems/statistics & numerical data
241938|NCT02133378|Hemostatic|hemostatic
241939|NCT02133352|pulmonary hypertension|pulmonary hypertension
241940|NCT02133352|diastolic dyfunction|diastolic dyfunction
241941|NCT02133326|Analgesia|analgesia
241942|NCT02133326|Third Molar Extraction|third molar extraction
241943|NCT02133326|Ibuprofen|ibuprofen
241944|NCT02133326|Acetaminophen|acetaminophen
241945|NCT02133326|Pain Medicine|pain medicine
241946|NCT02133326|Nonsteroidal|nonsteroidal
241947|NCT02133326|Anti-inflammatory|anti-inflammatory
241948|NCT02133313|Peritoneal Dialysis|peritoneal dialysis
241949|NCT02133313|Peritoneal Fibrosis|peritoneal fibrosis
241950|NCT02133313|Glucose Transporters|glucose transporters
241951|NCT02133274|Neoplasms|neoplasms
241952|NCT02133274|Early Palliative Care|early palliative care
241953|NCT02133274|Psychosocial Intervention|psychosocial intervention
241954|NCT02133274|Symptoms|symptoms
241955|NCT02133274|Quality of life|quality of life
241956|NCT02133274|Depression|depression
241957|NCT02133248|donor specific antibodies|donor specific antibodies
241958|NCT02133248|B cells|b cells
241959|NCT02133248|antibody mediated rejection|antibody mediated rejection
241960|NCT02133248|kidney transplant|kidney transplant
241961|NCT02133248|desensitization|desensitization
241962|NCT02133235|endobronchial blocker|endobronchial blocker
241963|NCT02133235|lung separation|lung separation
241964|NCT02133235|vedio-assisted thoracic operation|vedio-assisted thoracic operation
241965|NCT02133209|migraine|migraine
241966|NCT02133209|headache|headache
241967|NCT02133209|meditation|meditation
241968|NCT02133209|mindfulness based stress reduction|mindfulness based stress reduction
241969|NCT02133209|MBSR|mbsr
241970|NCT02133196|Metastatic|metastatic
241971|NCT02133196|Non-Small Cell Lung Cancer|non-small cell lung cancer
241972|NCT02133196|NSCLC|nsclc
241973|NCT02133196|Lung Cancer|lung cancer
241974|NCT02133170|BIPOLAR DISORDER|bipolar disorder
241975|NCT02133170|DEPRESSIVE SYMPTOMS|depressive symptoms
241976|NCT02133170|MINDFULNESS|mindfulness
241977|NCT02133170|PSYCHOEDUCATION|psychoeducation
241978|NCT02133170|BIPOLAR PATIENTS WITH DEPRESSIVE SYMPTOMS|bipolar patients with depressive symptoms
241979|NCT02133157|tumor|tumor
241980|NCT02133144|NAFLD|nafld
241981|NCT02133144|insulin resistance|insulin resistance
241982|NCT02133144|metabolic syndrome|metabolic syndrome
241983|NCT02133144|de novo lipogenesis|de novo lipogenesis
241984|NCT02133144|overfeeding|overfeeding
241985|NCT02133118|Type 2 diabetes|type 2 diabetes
241986|NCT02133118|New-user design|new-user design
241987|NCT02133118|Weight trajectory|weight trajectory
241988|NCT02133118|Add-on therapy|add-on therapy
241989|NCT02133118|Sulphonylureas.|sulphonylureas.
241990|NCT02133105|Heart failure|heart failure
241991|NCT02133105|Renal failure|renal failure
241992|NCT02133105|Inotropic drugs|inotropic drugs
241993|NCT02133105|Levosimendan|levosimendan
241994|NCT02133105|Dobutamine|dobutamine
241995|NCT02133092|Respiratory syncytial virus|respiratory syncytial virus
241996|NCT02133092|RSV|rsv
241997|NCT02133092|Lower respiratory tract infection|lower respiratory tract infection
241998|NCT02133092|LRTI|lrti
241999|NCT02133092|Acute respiratory infection|acute respiratory infection
242000|NCT02133092|Belgian children|belgian children
242001|NCT02133066|Ultrasound|ultrasound
242002|NCT02133066|Lumbar Puncture|lumbar puncture
242003|NCT02133066|Spinal Tap|spinal tap
242004|NCT02133066|Pediatric|pediatric
242005|NCT02133066|Infant|infant
242006|NCT02133066|Bedside Ultrasonography|bedside ultrasonography
242007|NCT02133053|Allergic Rhinitis|allergic rhinitis
242008|NCT02133053|Ectoine|ectoine
242009|NCT02133053|bitop|bitop
242010|NCT02133053|Ectoin|ectoin
242011|NCT02133040|Brown Adipose Tissue|brown adipose tissue
242012|NCT02133027|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
242013|NCT02133014|pancreatitis|pancreatitis
242014|NCT02133014|laparoscopic|laparoscopic
242015|NCT02133014|drainage|drainage
242016|NCT02133014|surgery|surgery
242017|NCT02133001|Major Depressive Disorder|major depressive disorder
242018|NCT02133001|Esketamine|esketamine
242019|NCT02133001|Intranasal esketamine|intranasal esketamine
242020|NCT02133001|Placebo|placebo
242021|NCT02132975|prostate|prostate
242022|NCT02132975|cancer|cancer
242023|NCT02132923|Respiratory syncytial virus|respiratory syncytial virus
242024|NCT02132923|RSV|rsv
242025|NCT02132923|Lower respiratory tract infection|lower respiratory tract infection
242026|NCT02132923|LRTI|lrti
242027|NCT02132923|Acute respiratory infection|acute respiratory infection
242028|NCT02132923|Japanese children|japanese children
242029|NCT02132897|Antiepileptic|antiepileptic
242030|NCT02132897|Carbamazepine|carbamazepine
242031|NCT02132897|Bio-equivalence|bio-equivalence
242032|NCT02132897|Fed|fed
242033|NCT02132897|Crossover|crossover
242034|NCT02132832|marijuana|marijuana
242035|NCT02132832|attentional bias|attentional bias
242036|NCT02132832|stress|stress
242037|NCT02132832|buspirone|buspirone
242038|NCT02132819|transfusion|transfusion
242039|NCT02132819|feeding|feeding
242040|NCT02132819|TRAGI|tragi
242041|NCT02132819|NEC|nec
242142|NCT02132312|Cataract|cataract
242042|NCT02132806|class II furcation involvement|class ii furcation involvement
242043|NCT02132806|piezoelectric surgery|piezoelectric surgery
242044|NCT02132806|regeneration|regeneration
242045|NCT02132806|biomaterial|biomaterial
242046|NCT02132793|technology|technology
242047|NCT02132793|mobile|mobile
242048|NCT02132793|anger management|anger management
242049|NCT02132793|anger|anger
242050|NCT02132793|PTSD|ptsd
242051|NCT02132793|veterans|veterans
242052|NCT02132767|Heart surgery|heart surgery
242053|NCT02132767|Cardiac surgery|cardiac surgery
242054|NCT02132767|Coronary artery bypass|coronary artery bypass
242055|NCT02132767|Mitral valve surgery|mitral valve surgery
242056|NCT02132767|Aortic valve surgery|aortic valve surgery
242057|NCT02132767|Atrial fibrillation|atrial fibrillation
242058|NCT02132767|Atrial flutter|atrial flutter
242059|NCT02132767|Cardiac arrhythmia|cardiac arrhythmia
242060|NCT02132767|Valve surgery|valve surgery
242061|NCT02132741|OCT; hypertension; CKD|oct; hypertension; ckd
242062|NCT02132728|flaxseed|flaxseed
242063|NCT02132728|lignans|lignans
242064|NCT02132728|inflammation|inflammation
242065|NCT02132728|Nutrition|nutrition
242066|NCT02132728|enterolactone|enterolactone
242067|NCT02132728|enterodiol|enterodiol
242068|NCT02132689|Moderate Risk Acute Pulmonary Embolism|moderate risk acute pulmonary embolism
242069|NCT02132676|Self-Management|self-management
242070|NCT02132676|Patient Care Management|patient care management
242071|NCT02132676|Peer Group|peer group
242072|NCT02132676|Disease Management|disease management
242073|NCT02132676|Health Plan Implementation|health plan implementation
242074|NCT02132676|Diabetes Mellitus|diabetes mellitus
242075|NCT02132650|Rehabilitation|rehabilitation
242076|NCT02132650|Walking|walking
242077|NCT02132650|Motor skills disorders|motor skills disorders
242078|NCT02132650|Electromyography|electromyography
242079|NCT02132598|Lung Cancer|lung cancer
242080|NCT02132598|Non Small Cell|non small cell
242081|NCT02132598|Brain metastases|brain metastases
242082|NCT02132598|c-MET|c-met
242083|NCT02132520|Hemiparesis|hemiparesis
242084|NCT02132520|Stroke|stroke
242085|NCT02132520|Rehabilitation|rehabilitation
242086|NCT02132520|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
242087|NCT02132520|Electroencephalography|electroencephalography
242088|NCT02132520|Functional Neuroimaging|functional neuroimaging
242089|NCT02132520|Brain-Computer Interface|brain-computer interface
242090|NCT02132507|epilepsy|epilepsy
242091|NCT02132507|fMRI|fmri
242092|NCT02132507|EEG|eeg
242093|NCT02132507|ICA|ica
242094|NCT02132481|Smartphones|smartphones
242095|NCT02132481|Mobile phones|mobile phones
242096|NCT02132481|Substance use disorder|substance use disorder
242097|NCT02132481|Recovery Support Services|recovery support services
242098|NCT02132481|Ecological Momentary Assessment (EMA)|ecological momentary assessment (ema)
242099|NCT02132481|Ecological Momentary Intervention (EMI)|ecological momentary intervention (emi)
242100|NCT02132481|Randomized field experiment|randomized field experiment
242101|NCT02132481|Effectiveness|effectiveness
242102|NCT02132481|Post-Discharge|post-discharge
242103|NCT02132468|PNET|pnet
242104|NCT02132468|GI-NET|gi-net
242105|NCT02132468|neuroendocrine|neuroendocrine
242106|NCT02132468|carcinoid|carcinoid
242107|NCT02132455|Screening colonoscopy|screening colonoscopy
242108|NCT02132455|Surveillance colonoscopy|surveillance colonoscopy
242109|NCT02132442|Children|children
242110|NCT02132442|Adolescents|adolescents
242111|NCT02132442|Adults|adults
242112|NCT02132442|Type 2 diabetes|type 2 diabetes
242113|NCT02132442|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
242114|NCT02132442|Vitamin D deficiency|vitamin d deficiency
242115|NCT02132429|Migraine|migraine
242116|NCT02132416|Prospective study|prospective study
242117|NCT02132416|Surgical management|surgical management
242118|NCT02132416|Unstable thoracic cage injuries|unstable thoracic cage injuries
242119|NCT02132416|Trauma|trauma
242120|NCT02132416|Ventilator support|ventilator support
242121|NCT02132403|pancreatic cancer|pancreatic cancer
242122|NCT02132403|adenocarcinoma of the pancreas (PDAC)|adenocarcinoma of the pancreas (pdac)
242123|NCT02132403|mixed adenocarcinoma of the pancreas|mixed adenocarcinoma of the pancreas
242124|NCT02132403|locally advanced|locally advanced
242125|NCT02132403|recurrent|recurrent
242126|NCT02132403|metastatic|metastatic
242127|NCT02132390|Breast cancer|breast cancer
242128|NCT02132390|Chemotherapy induced amenorrhea|chemotherapy induced amenorrhea
242129|NCT02132390|Goserelin|goserelin
242130|NCT02132364|stroke|stroke
242131|NCT02132364|hypertension|hypertension
242132|NCT02132364|secondary prevention|secondary prevention
242133|NCT02132364|educational program|educational program
242134|NCT02132338|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
242135|NCT02132338|Prevention|prevention
242136|NCT02132338|Health Education|health education
242137|NCT02132325|Pancreatic Cancer|pancreatic cancer
242138|NCT02132325|Dignity Therapy|dignity therapy
242139|NCT02132325|Palliative Care|palliative care
242140|NCT02132325|Advanced Lung Cancer|advanced lung cancer
242141|NCT02132325|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
242143|NCT02132312|Lens replacement|lens replacement
242144|NCT02132312|pediatric|pediatric
242145|NCT02132299|Malaria|malaria
242146|NCT02132299|Plasmodium falciparum malaria|plasmodium falciparum malaria
242147|NCT02132299|PfSPZ Vaccine|pfspz vaccine
242148|NCT02132299|PfSPZ Challenge|pfspz challenge
242149|NCT02132299|Controlled human malaria infection (CHMI)|controlled human malaria infection (chmi)
242150|NCT02132286|Functional magnetic resonance neuroimaging|functional magnetic resonance neuroimaging
242151|NCT02132286|Serotonin transporter gene polymorphism|serotonin transporter gene polymorphism
242152|NCT02132286|Amygdala|amygdala
242153|NCT02132286|Antidepressant|antidepressant
242154|NCT02132286|Quetiapine|quetiapine
242155|NCT02132286|Citalopram|citalopram
242156|NCT02132286|imaging biomarker|imaging biomarker
242157|NCT02132260|Naftifine|naftifine
242158|NCT02132260|Naftin®|naftin®
242159|NCT02132260|Tinea pedis|tinea pedis
242160|NCT02132247|Minor athletic injuries|minor athletic injuries
242161|NCT02132247|Pain|pain
242162|NCT02132247|Diclofenac|diclofenac
242163|NCT02132247|Topical|topical
242164|NCT02132221|Chronic non cancer pain|chronic non cancer pain
242165|NCT02132221|Long term opioid therapy|long term opioid therapy
242166|NCT02132221|Side effects|side effects
242167|NCT02132221|risks|risks
242168|NCT02132221|function|function
242169|NCT02132221|negative benefit/risk ratio|negative benefit/risk ratio
242170|NCT02132143|Lung adenocarcinoma|lung adenocarcinoma
242171|NCT02132143|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
242172|NCT02132143|Sequential chemoradiotherapy|sequential chemoradiotherapy
242173|NCT02132143|Progression-free survival|progression-free survival
242174|NCT02132130|gene therapy|gene therapy
242175|NCT02132130|unilateral hearing loss|unilateral hearing loss
242176|NCT02132130|bilateral hearing loss|bilateral hearing loss
242177|NCT02132130|balance|balance
242178|NCT02132130|vestibular|vestibular
242179|NCT02132130|cochlear implant|cochlear implant
242180|NCT02132130|hearing restoration|hearing restoration
242181|NCT02132104|Intrauterine adhesions|intrauterine adhesions
242182|NCT02132104|Asherman Syndrome|asherman syndrome
242183|NCT02132104|Amnion graft|amnion graft
242184|NCT02132091|Sirtuins|sirtuins
242185|NCT02132091|Calorie Restriction|calorie restriction
242186|NCT02132091|Intermittent Fasting|intermittent fasting
242187|NCT02132091|Antioxidant|antioxidant
242188|NCT02132091|Aging|aging
242189|NCT02132091|Metabolism|metabolism
242190|NCT02132091|Mitochondria|mitochondria
242191|NCT02132091|Oxidative Stress|oxidative stress
242192|NCT02132078|Lung transplant recipients|lung transplant recipients
242193|NCT02132078|diverticulitis|diverticulitis
242194|NCT02132078|immunosuppression|immunosuppression
242195|NCT02132052|Essential Tremor|essential tremor
242196|NCT02132052|Multiple System Atrophy|multiple system atrophy
242197|NCT02132052|Corticobasal Degeneration|corticobasal degeneration
242198|NCT02132052|Supranuclear Palsy, Progressive|supranuclear palsy, progressive
242199|NCT02132052|Parkinson's Disease|parkinson's disease
242200|NCT02132052|PD|pd
242201|NCT02132039|Tai Chi, dementia, caregivers|tai chi, dementia, caregivers
242202|NCT02132026|Aortic Stenosis|aortic stenosis
242203|NCT02132026|Denosumab|denosumab
242204|NCT02132026|Alendronic Acid|alendronic acid
242205|NCT02132026|Osteoporosis|osteoporosis
242206|NCT02131987|Dislocation|dislocation
242207|NCT02131987|Hemiarthroplasty|hemiarthroplasty
242208|NCT02131987|Femoral neck fracture|femoral neck fracture
242209|NCT02131987|Femoral offset|femoral offset
242210|NCT02131987|Leg length difference|leg length difference
242211|NCT02131987|Wiberg angle|wiberg angle
242212|NCT02131974|intubation, pediatric, endotracheal, cuffed ETT|intubation, pediatric, endotracheal, cuffed ett
242213|NCT02131961|diabetic foot|diabetic foot
242214|NCT02131961|foot ulcer|foot ulcer
242215|NCT02131961|foot wound|foot wound
242216|NCT02131961|plantar ulcer|plantar ulcer
242217|NCT02131961|plantar wound|plantar wound
242218|NCT02131961|contact cast|contact cast
242219|NCT02131961|collagenase|collagenase
242220|NCT02131948|Insulin resistance|insulin resistance
242221|NCT02131948|Brain insulin action|brain insulin action
242222|NCT02131948|Type 2 Diabetes|type 2 diabetes
242223|NCT02131909|unilateral cerebral palsy|unilateral cerebral palsy
242224|NCT02131909|children|children
242225|NCT02131909|upper-limb|upper-limb
242226|NCT02131909|mirror therapy|mirror therapy
242227|NCT02131909|bimanual coordination|bimanual coordination
242228|NCT02131909|kinematics analysis|kinematics analysis
242229|NCT02131896|Type 1 Diabetes|type 1 diabetes
242230|NCT02131896|Newly diagnosed|newly diagnosed
242231|NCT02131896|Lipid profile|lipid profile
242232|NCT02131896|Mediterranean diet|mediterranean diet
242233|NCT02131883|Health Anxiety|health anxiety
242234|NCT02131883|Hypochondriasis|hypochondriasis
242235|NCT02131883|Illness Anxiety Disorder|illness anxiety disorder
242236|NCT02131883|Somatic Symptom Disorder|somatic symptom disorder
242237|NCT02131883|Personality Disorders|personality disorders
242238|NCT02131883|Cognitive Behavioral Therapy|cognitive behavioral therapy
242239|NCT02131883|Group-CBT|group-cbt
242240|NCT02131883|Illness Perception|illness perception
242446|NCT02130947|Exercise|exercise
242241|NCT02131883|Cost-effectiveness|cost-effectiveness
242242|NCT02131870|iron absorption|iron absorption
242243|NCT02131870|healthy females|healthy females
242244|NCT02131870|child bearing age|child bearing age
242245|NCT02131857|Mindfulness|mindfulness
242246|NCT02131857|stress reduction|stress reduction
242247|NCT02131844|colorectal surgery|colorectal surgery
242248|NCT02131844|postoperative recovery|postoperative recovery
242249|NCT02131844|early mobilization|early mobilization
242250|NCT02131831|telomere|telomere
242251|NCT02131831|telomerase|telomerase
242252|NCT02131831|cirrhosis|cirrhosis
242253|NCT02131818|amoxicillin|amoxicillin
242254|NCT02131818|postpartum infections|postpartum infections
242255|NCT02131818|puerperal infection|puerperal infection
242256|NCT02131805|skin|skin
242257|NCT02131805|Brachytherapy|brachytherapy
242258|NCT02131805|14-001|14-001
242259|NCT02131779|prostate cancer disparities|prostate cancer disparities
242260|NCT02131779|African American|african american
242261|NCT02131779|Spiritually based intervention|spiritually based intervention
242262|NCT02131779|Men's Health|men's health
242263|NCT02131779|Informed Decision Making|informed decision making
242264|NCT02131779|Community Based Participatory Research|community based participatory research
242265|NCT02131779|Health Communication|health communication
242266|NCT02131779|Health Information Technology|health information technology
242267|NCT02131779|Community Health Advisors|community health advisors
242268|NCT02131766|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
242269|NCT02131766|Artificial Pancreas Project (APP)|artificial pancreas project (app)
242270|NCT02131766|Diabetes Assistant (DiAs)|diabetes assistant (dias)
242271|NCT02131766|Closed-Loop Control (CLC)|closed-loop control (clc)
242272|NCT02131753|hairy cell leukemia|hairy cell leukemia
242273|NCT02131753|untreated|untreated
242274|NCT02131753|cladribine subcutaneous|cladribine subcutaneous
242275|NCT02131740|corneal|corneal
242276|NCT02131740|eye rubbing|eye rubbing
242277|NCT02131727|hand hygiene|hand hygiene
242278|NCT02131727|communicable diseases|communicable diseases
242279|NCT02131727|respiratory tract infections|respiratory tract infections
242280|NCT02131727|primary prevention|primary prevention
242281|NCT02131727|employees|employees
242282|NCT02131714|pressure pain threshold|pressure pain threshold
242283|NCT02131714|temporomandibular disorder syndrome|temporomandibular disorder syndrome
242284|NCT02131714|therapeutic exercise|therapeutic exercise
242285|NCT02131714|conservative treatment|conservative treatment
242286|NCT02131714|facial pain|facial pain
242287|NCT02131701|Physical fitness|physical fitness
242288|NCT02131701|Family history of type 2 diabetes|family history of type 2 diabetes
242289|NCT02131701|Prescription of exercise|prescription of exercise
242290|NCT02131688|safety;malignant lymphoma;|safety;malignant lymphoma;
242291|NCT02131675|C-peptide|c-peptide
242292|NCT02131675|type 1 diabetes|type 1 diabetes
242293|NCT02131662|Uterine fibroids|uterine fibroids
242294|NCT02131649|Prostate Cancer|prostate cancer
242295|NCT02131649|PET|pet
242296|NCT02131649|MRI|mri
242297|NCT02131649|Fluorocholine|fluorocholine
242298|NCT02131649|Radiotherapy|radiotherapy
242299|NCT02131649|Prostatectomy|prostatectomy
242300|NCT02131610|Sleep apnea|sleep apnea
242301|NCT02131610|Obstructive sleep apnea|obstructive sleep apnea
242302|NCT02131610|Subclinical atherosclerosis|subclinical atherosclerosis
242303|NCT02131610|Epigenetics|epigenetics
242304|NCT02131610|T cells|t cells
242305|NCT02131597|Leukemia|leukemia
242306|NCT02131597|Myelodysplastic syndrome|myelodysplastic syndrome
242307|NCT02131597|MDS|mds
242308|NCT02131597|Higher risk|higher risk
242309|NCT02131597|SGI-110|sgi-110
242310|NCT02131584|Leukemia|leukemia
242311|NCT02131584|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
242312|NCT02131584|CLL|cll
242313|NCT02131584|Fatigue|fatigue
242314|NCT02131584|Brief Fatigue Inventory|brief fatigue inventory
242315|NCT02131584|BFI|bfi
242316|NCT02131584|Questionnaires|questionnaires
242317|NCT02131584|Surveys|surveys
242318|NCT02131584|Ruxolitinib|ruxolitinib
242319|NCT02131584|Jakafi|jakafi
242320|NCT02131584|INCB018424|incb018424
242321|NCT02131584|INC424|inc424
242322|NCT02131571|HIV|hiv
242323|NCT02131571|bone|bone
242324|NCT02131571|fractures|fractures
242325|NCT02131571|vitamin D|vitamin d
242326|NCT02131571|biomarkers|biomarkers
242327|NCT02131558|Endometrial cancer|endometrial cancer
242328|NCT02131558|Sentinel lymph node|sentinel lymph node
242329|NCT02131558|Indocyanine green|indocyanine green
242330|NCT02131558|Near infrared imaging|near infrared imaging
242331|NCT02131545|quetiapine|quetiapine
242332|NCT02131545|pharmacokinetics|pharmacokinetics
242333|NCT02131545|dementia|dementia
242334|NCT02131545|delirium|delirium
242335|NCT02131545|palliative care|palliative care
242336|NCT02131532|Post-stroke fatigue|post-stroke fatigue
242337|NCT02131532|Psychological intervention|psychological intervention
242338|NCT02131532|Feasibility|feasibility
242339|NCT02131506|Advanced HER2 positive Breast Cancer|advanced her2 positive breast cancer
242340|NCT02131506|pretreated breast cancer|pretreated breast cancer
242341|NCT02131506|advanced disease|advanced disease
242342|NCT02131454|asthma and COPD treatment|asthma and copd treatment
242343|NCT02131454|inhalation techniques|inhalation techniques
242344|NCT02131454|training of inhalation|training of inhalation
242345|NCT02131428|Heart Failure|heart failure
242346|NCT02131428|Depression|depression
242347|NCT02131428|BNP|bnp
242348|NCT02131415|schizophrenia|schizophrenia
242349|NCT02131415|real-life|real-life
242350|NCT02131415|long-acting injectable|long-acting injectable
242351|NCT02131415|Reliam|reliam
242352|NCT02131389|Hip|hip
242353|NCT02131389|Arthroplasty|arthroplasty
242354|NCT02131389|Arthroplasties|arthroplasties
242355|NCT02131389|Prosthesis|prosthesis
242356|NCT02131389|Iconacy|iconacy
242357|NCT02131389|Osteoarthritis|osteoarthritis
242358|NCT02131389|Arthritis|arthritis
242359|NCT02131389|THA|tha
242360|NCT02131389|THR|thr
242361|NCT02131389|DJD|djd
242362|NCT02131376|carcinoma, renal cell|carcinoma, renal cell
242363|NCT02131376|partial nephrectomy|partial nephrectomy
242364|NCT02131376|kidney function test|kidney function test
242365|NCT02131376|robotics|robotics
242366|NCT02131324|Psoriasis|psoriasis
242367|NCT02131311|single use|single use
242368|NCT02131311|disposable|disposable
242369|NCT02131311|pessary|pessary
242370|NCT02131311|stress urinary incontinence|stress urinary incontinence
242371|NCT02131311|sui|sui
242372|NCT02131298|Palbociclib|palbociclib
242373|NCT02131298|Itraconazole|itraconazole
242374|NCT02131298|Pharmacokinetics|pharmacokinetics
242375|NCT02131298|Drug-Drug Interaction Study|drug-drug interaction study
242376|NCT02131298|Healthy Volunteers|healthy volunteers
242377|NCT02131285|Rehabilitation,|rehabilitation,
242378|NCT02131285|Balance,|balance,
242379|NCT02131285|Sensory strategies,|sensory strategies,
242380|NCT02131285|Multiple Sclerosis,|multiple sclerosis,
242381|NCT02131285|Postural control|postural control
242382|NCT02131220|No-Reflow Phenomenon|no-reflow phenomenon
242383|NCT02131194|Cataract|cataract
242384|NCT02131194|Nutritional Supplement|nutritional supplement
242385|NCT02131181|Delirium, postoperative delirium, elderly|delirium, postoperative delirium, elderly
242386|NCT02131142|ischemic heart disease|ischemic heart disease
242387|NCT02131142|CAD|cad
242388|NCT02131129|schizophrenia|schizophrenia
242389|NCT02131129|schizophreniform disorder|schizophreniform disorder
242390|NCT02131129|schizoaffective disorder|schizoaffective disorder
242391|NCT02131129|first episode|first episode
242392|NCT02131129|psychosis|psychosis
242393|NCT02131129|cognition|cognition
242394|NCT02131116|schizophrenia|schizophrenia
242395|NCT02131116|schizophreniform disorder|schizophreniform disorder
242396|NCT02131116|schizoaffective disorder|schizoaffective disorder
242397|NCT02131116|cognition|cognition
242398|NCT02131116|metacognition|metacognition
242399|NCT02131116|insight|insight
242400|NCT02131116|first episode psychosis|first episode psychosis
242401|NCT02131116|psychosis|psychosis
242402|NCT02131103|Pharmacoinvasive strategy|pharmacoinvasive strategy
242403|NCT02131090|Epidural|epidural
242404|NCT02131090|Catheter|catheter
242405|NCT02131090|Fixation|fixation
242406|NCT02131090|Device|device
242407|NCT02131090|Intrapartum|intrapartum
242408|NCT02131077|Lateral Epicondylitis|lateral epicondylitis
242409|NCT02131051|ectoine|ectoine
242410|NCT02131051|allergic rhinitis|allergic rhinitis
242411|NCT02131051|bitop|bitop
242412|NCT02131038|Ectoine|ectoine
242413|NCT02131038|bitop|bitop
242414|NCT02131038|Allergic Rhinitis|allergic rhinitis
242415|NCT02131012|Macular edema|macular edema
242416|NCT02130999|Non-24|non-24
242417|NCT02130999|absolute bioavailability|absolute bioavailability
242418|NCT02130999|tasimelteon|tasimelteon
242419|NCT02130999|Hetlioz™|hetlioz™
242420|NCT02130986|procalcitonin (PCT)|procalcitonin (pct)
242421|NCT02130986|lower respiratory tract infection (LRTI)|lower respiratory tract infection (lrti)
242422|NCT02130986|antibiotic exposure|antibiotic exposure
242423|NCT02130986|antibiotic decision making|antibiotic decision making
242424|NCT02130986|community acquired pneumonia (CAP)|community acquired pneumonia (cap)
242425|NCT02130986|chronic obstructive pulmonary disease (COPD) exacerbation|chronic obstructive pulmonary disease (copd) exacerbation
242426|NCT02130986|acute asthma exacerbation|acute asthma exacerbation
242427|NCT02130986|acute bronchitis|acute bronchitis
242428|NCT02130986|procalcitonin guideline|procalcitonin guideline
242429|NCT02130973|teriparatide|teriparatide
242430|NCT02130973|Forteo|forteo
242431|NCT02130973|Denosumab|denosumab
242432|NCT02130973|Prolia|prolia
242433|NCT02130973|bone density|bone density
242434|NCT02130973|treatment|treatment
242435|NCT02130960|RMR|rmr
242436|NCT02130960|Reliability|reliability
242437|NCT02130960|Obese|obese
242438|NCT02130960|Energy Expenditure|energy expenditure
242439|NCT02130960|Resting Energy Expenditure|resting energy expenditure
242440|NCT02130960|Resting Metabolic Rate|resting metabolic rate
242441|NCT02130947|Metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
242442|NCT02130947|Prostate Cancer|prostate cancer
242443|NCT02130947|mCRPC|mcrpc
242444|NCT02130947|Pilot Study|pilot study
242445|NCT02130947|UNC Lineberger|unc lineberger
242447|NCT02130934|Childhood cancer|childhood cancer
242448|NCT02130934|anthracyclines|anthracyclines
242449|NCT02130934|cardiotoxicity|cardiotoxicity
242450|NCT02130934|cardiac MRI|cardiac mri
242451|NCT02130934|cumulative does of at least 150 mg/m2 of anthracyclines|cumulative does of at least 150 mg/m2 of anthracyclines
242452|NCT02130934|Ventricular function|ventricular function
242453|NCT02130921|Stigma|stigma
242454|NCT02130921|HIV|hiv
242455|NCT02130921|CHWs|chws
242456|NCT02130921|PLH|plh
242457|NCT02130921|Injecting Drug Users|injecting drug users
242458|NCT02130921|FM|fm
242459|NCT02130895|prescribing|prescribing
242460|NCT02130895|STOPP Criteria|stopp criteria
242461|NCT02130895|potentially inappropriate prescribing|potentially inappropriate prescribing
242462|NCT02130895|clinical decision support|clinical decision support
242463|NCT02130895|Electronic Medical Records|electronic medical records
242464|NCT02130895|primary care|primary care
242465|NCT02130882|Interleukin-5|interleukin-5
242466|NCT02130882|Monoclonal Antibody|monoclonal antibody
242467|NCT02130882|Treatment|treatment
242468|NCT02130869|Autologous stem cell transplantation|autologous stem cell transplantation
242469|NCT02130869|Natural killer cells|natural killer cells
242470|NCT02130856|Neonatal mortality|neonatal mortality
242471|NCT02130856|Neonatal kit|neonatal kit
242472|NCT02130856|Pakistan|pakistan
242473|NCT02130856|Randomized Control Trial|randomized control trial
242474|NCT02130856|Chlorhexidine|chlorhexidine
242475|NCT02130856|ThermoSpot|thermospot
242476|NCT02130856|Birth|birth
242477|NCT02130843|URINARY INCONTINENCE|urinary incontinence
242478|NCT02130843|URODYNAMICS|urodynamics
242479|NCT02130843|URINARY RETENTION|urinary retention
242480|NCT02130843|URINARY CATHETERIZATION|urinary catheterization
242481|NCT02130830|hemorrhoids|hemorrhoids
242482|NCT02130830|Rubber band ligation|rubber band ligation
242483|NCT02130830|pain|pain
242484|NCT02130817|Renal Transplant|renal transplant
242485|NCT02130817|Kidney Transplant|kidney transplant
242486|NCT02130817|Mean flourescent Intensity|mean flourescent intensity
242487|NCT02130817|Delayed Graft Function|delayed graft function
242488|NCT02130817|Antagonist of Thymocyte Cell Activation|antagonist of thymocyte cell activation
242489|NCT02130804|Obesity|obesity
242490|NCT02130804|Adipose tissue inflammation|adipose tissue inflammation
242491|NCT02130804|Salsalate|salsalate
242492|NCT02130804|Hispanics|hispanics
242493|NCT02130765|Monomorphic Ventricular Tachycardia|monomorphic ventricular tachycardia
242494|NCT02130765|Ischemic|ischemic
242495|NCT02130765|Non-ischemic|non-ischemic
242496|NCT02130765|Catheter Ablation|catheter ablation
242497|NCT02130752|Stomach Neoplasms|stomach neoplasms
242498|NCT02130752|Operative Time|operative time
242499|NCT02130752|Gastrectomy|gastrectomy
242500|NCT02130752|Surgical Hemorrhage|surgical hemorrhage
242501|NCT02130752|Mortality|mortality
242502|NCT02130752|Morbidity|morbidity
242503|NCT02130739|Anesthesia|anesthesia
242504|NCT02130739|Epidural|epidural
242505|NCT02130739|Thoracic Nerves|thoracic nerves
242506|NCT02130739|Horner syndrome|horner syndrome
242507|NCT02130726|Gastric cancer|gastric cancer
242508|NCT02130726|Minimally-invasive|minimally-invasive
242509|NCT02130726|Oncological quality of resection|oncological quality of resection
242510|NCT02130700|mCRPC|mcrpc
242511|NCT02130700|metastatic|metastatic
242512|NCT02130700|castration-resistant prostate cancer|castration-resistant prostate cancer
242513|NCT02130687|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
242514|NCT02130687|Hypertension|hypertension
242515|NCT02130687|Angiotensin Converting Enzyme Inhibitors|angiotensin converting enzyme inhibitors
242516|NCT02130687|Dipeptidyl Peptidase IV Inhibitors|dipeptidyl peptidase iv inhibitors
242517|NCT02130687|Sitagliptin|sitagliptin
242518|NCT02130687|Aprepitant|aprepitant
242519|NCT02130687|Ramipril|ramipril
242520|NCT02130674|traumatic brain injury|traumatic brain injury
242521|NCT02130674|glutamine|glutamine
242522|NCT02130674|microdialysis|microdialysis
242523|NCT02130674|metabolism|metabolism
242524|NCT02130661|drug interaction|drug interaction
242525|NCT02130661|healthy volunteer|healthy volunteer
242526|NCT02130661|rilapladib|rilapladib
242527|NCT02130661|SB-659032|sb-659032
242528|NCT02130661|Alzheimer's disease|alzheimer's disease
242529|NCT02130661|itraconazole|itraconazole
242530|NCT02130648|Non-invasive Prenatal Diagnosis (NIPD)|non-invasive prenatal diagnosis (nipd)
242531|NCT02130648|Cystic Fibrosis|cystic fibrosis
242532|NCT02130648|Quantitative real time MEMO-PCR|quantitative real time memo-pcr
242533|NCT02130635|PI3Kd|pi3kd
242534|NCT02130635|Pharmacodynamics|pharmacodynamics
242535|NCT02130635|dry powder inhaler|dry powder inhaler
242536|NCT02130635|GSK2269557|gsk2269557
242537|NCT02130635|safety|safety
242538|NCT02130635|COPD subjects|copd subjects
242539|NCT02130622|Diabetic Gastroparesis|diabetic gastroparesis
242540|NCT02130622|Promethazine|promethazine
242541|NCT02130570|Adverse events|adverse events
242542|NCT02130570|Readmissions|readmissions
242543|NCT02130570|Patient Centered Medical Home (PCMH)|patient centered medical home (pcmh)
242544|NCT02130570|Accountable Care Organizations (ACO)|accountable care organizations (aco)
242648|NCT02130193|EXACT-RS|exact-rs
242545|NCT02130570|Medication reconciliation|medication reconciliation
242546|NCT02130570|Discharge Advocate|discharge advocate
242547|NCT02130570|Patient engagement|patient engagement
242548|NCT02130570|Transitions of care|transitions of care
242549|NCT02130570|Transitions coach|transitions coach
242550|NCT02130570|Pharmacist intervention|pharmacist intervention
242551|NCT02130557|Leukemia|leukemia
242552|NCT02130557|Myelogenous|myelogenous
242553|NCT02130557|Chronic|chronic
242554|NCT02130557|BCR-ABL Positive|bcr-abl positive
242555|NCT02130557|Bosutinib|bosutinib
242556|NCT02130557|Leukemia, Myeloid|leukemia, myeloid
242557|NCT02130557|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
242558|NCT02130557|Philadelphia Chromosome|philadelphia chromosome
242559|NCT02130557|Neoplasms by Histologic Type|neoplasms by histologic type
242560|NCT02130557|Bone Marrow Diseases|bone marrow diseases
242561|NCT02130557|Hematologic Diseases|hematologic diseases
242562|NCT02130557|Translocation, Genetic|translocation, genetic
242563|NCT02130557|Pathologic Processes|pathologic processes
242564|NCT02130557|Imatinib|imatinib
242565|NCT02130557|Therapeutic Uses|therapeutic uses
242566|NCT02130557|Pharmacologic Actions|pharmacologic actions
242567|NCT02130557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
242569|NCT02130466|PD-1|pd-1
242570|NCT02130466|PDL1|pdl1
242571|NCT02130466|PD-L1|pd-l1
242572|NCT02130453|Ischemia|ischemia
242573|NCT02130453|Coronary artery disease|coronary artery disease
242574|NCT02130453|Nuclear stress test|nuclear stress test
242575|NCT02130453|Stress Echocardiogram|stress echocardiogram
242576|NCT02130453|Echocardiography strain measurement|echocardiography strain measurement
242577|NCT02130453|Ultrasound cardiac imaging|ultrasound cardiac imaging
242578|NCT02130453|ReSTE|reste
242579|NCT02130453|SPECT|spect
242580|NCT02130453|Regadenoson|regadenoson
242581|NCT02130440|nasal obstruction|nasal obstruction
242582|NCT02130440|sneezing|sneezing
242583|NCT02130440|itching|itching
242584|NCT02130440|rhinorrhea|rhinorrhea
242585|NCT02130440|respiratory infections|respiratory infections
242586|NCT02130440|wheezing|wheezing
242587|NCT02130427|Adult subjects|adult subjects
242588|NCT02130427|NSCLC|nsclc
242589|NCT02130414|Cyclosporine|cyclosporine
242590|NCT02130414|Healthy Volunteers|healthy volunteers
242591|NCT02130414|Immunosuppressive Agents|immunosuppressive agents
242592|NCT02130414|CyCol|cycol
242593|NCT02130414|Pharmacokinetics|pharmacokinetics
242594|NCT02130401|neuromodulation|neuromodulation
242595|NCT02130401|caloric vestibular stimulation|caloric vestibular stimulation
242596|NCT02130401|Type 2 Diabetes|type 2 diabetes
242597|NCT02130362|Adalimumab|adalimumab
242598|NCT02130362|Crohn's|crohn's
242599|NCT02130362|Crohn's Disease|crohn's disease
242600|NCT02130362|Registry|registry
242601|NCT02130362|Gastrointestinal Diseases|gastrointestinal diseases
242602|NCT02130362|Inflammatory Bowel Diseases|inflammatory bowel diseases
242603|NCT02130349|IBD|ibd
242604|NCT02130349|Crohns Disease|crohns disease
242605|NCT02130349|Ulcerative Colitis|ulcerative colitis
242606|NCT02130349|Cohort|cohort
242607|NCT02130349|Biobank|biobank
242608|NCT02130349|Population based|population based
242609|NCT02130349|IBDSL|ibdsl
242610|NCT02130336|Metabolic syndrome|metabolic syndrome
242611|NCT02130336|Metabolic risk factors|metabolic risk factors
242612|NCT02130336|High-intensity interval training|high-intensity interval training
242613|NCT02130336|Moderate-intensity exercise|moderate-intensity exercise
242614|NCT02130323|Cervical intraepithelial neoplasia, Imiquimod|cervical intraepithelial neoplasia, imiquimod
242615|NCT02130310|Chronic ulcers|chronic ulcers
242616|NCT02130310|Venous ulcers|venous ulcers
242617|NCT02130297|Mohs|mohs
242618|NCT02130297|scar|scar
242619|NCT02130297|post excision|post excision
242620|NCT02130297|CO2 laser|co2 laser
242621|NCT02130297|laser|laser
242622|NCT02130297|skin cancer|skin cancer
242623|NCT02130297|resurfacing|resurfacing
242624|NCT02130271|Sciatica|sciatica
242625|NCT02130271|PET scan|pet scan
242626|NCT02130271|MRI|mri
242627|NCT02130271|Inflammation|inflammation
242628|NCT02130271|Epidural Steroid Injection (ESI)|epidural steroid injection (esi)
242629|NCT02130258|Radicular|radicular
242630|NCT02130258|Pain|pain
242631|NCT02130258|Epidural Steroid Injection|epidural steroid injection
242632|NCT02130245|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
242633|NCT02130245|Acute cholecystitis|acute cholecystitis
242634|NCT02130245|Early|early
242635|NCT02130245|Delayed|delayed
242636|NCT02130232|Gestational weight gain|gestational weight gain
242637|NCT02130232|Lifestyle|lifestyle
242638|NCT02130232|Intervention|intervention
242639|NCT02130219|ICP, intracranial hypertension, Vittamed 205|icp, intracranial hypertension, vittamed 205
242640|NCT02130206|Plaque, Saliva, Cavities|plaque, saliva, cavities
242641|NCT02130193|Efficacy|efficacy
242642|NCT02130193|Danirixin|danirixin
242643|NCT02130193|EXACT-PRO|exact-pro
242644|NCT02130193|COPD|copd
242645|NCT02130193|Safety|safety
242646|NCT02130193|RD|rd
242647|NCT02130193|CXCR2 inhibitor|cxcr2 inhibitor
242649|NCT02130193|PK|pk
242650|NCT02130193|HCRU exacerbations|hcru exacerbations
242651|NCT02130193|PD|pd
242652|NCT02130167|Myopia progression|myopia progression
242653|NCT02130167|Low concentration atropine|low concentration atropine
242654|NCT02130154|Brown adipose Tissue|brown adipose tissue
242655|NCT02130154|Ageing|ageing
242656|NCT02130154|Sympathetic Nervous Stimulation|sympathetic nervous stimulation
242657|NCT02130154|Obesity|obesity
242658|NCT02130141|cocoa|cocoa
242659|NCT02130141|dark chocolate|dark chocolate
242660|NCT02130141|hypertension|hypertension
242661|NCT02130141|blood pressure monitoring, ambulatory|blood pressure monitoring, ambulatory
242662|NCT02130141|flavanols|flavanols
242663|NCT02130102|technology acceptance|technology acceptance
242664|NCT02130102|ambient assisted living|ambient assisted living
242665|NCT02130102|independent living|independent living
242666|NCT02130102|quality of life|quality of life
242667|NCT02130102|socioeconomic impact|socioeconomic impact
242668|NCT02130102|usability of information and communication technologies|usability of information and communication technologies
242669|NCT02130063|IDA|ida
242670|NCT02130063|Iron deficiency|iron deficiency
242671|NCT02130063|iron deficiency anaemia and who are intolerant or unresponsive to oral iron therapy|iron deficiency anaemia and who are intolerant or unresponsive to oral iron therapy
242672|NCT02130050|Obstructive Sleep Apnea|obstructive sleep apnea
242673|NCT02130050|Continuous Positive Airway Pressure|continuous positive airway pressure
242674|NCT02130050|Cardiovascular disease|cardiovascular disease
242675|NCT02130050|Polysomnography|polysomnography
242676|NCT02130050|Metabolomic|metabolomic
242677|NCT02130037|APPLICATION|application
242678|NCT02130037|SMARTPHONE|smartphone
242679|NCT02130037|BULIMIA|bulimia
242680|NCT02130037|B.E.D|b.e.d
242681|NCT02130037|BINGE EATING DISORDER|binge eating disorder
242682|NCT02130024|Age-related macular degeneration, ranibizumab, aflibercept, geographic atrophy, inject and extend|age-related macular degeneration, ranibizumab, aflibercept, geographic atrophy, inject and extend
242683|NCT02129998|Infertility|infertility
242684|NCT02129998|IVF/ICSI|ivf/icsi
242685|NCT02129998|Progesterone|progesterone
242686|NCT02129998|Preimplantation Factor (PIF)|preimplantation factor (pif)
242687|NCT02129985|the newly onset type 2 diabetes|the newly onset type 2 diabetes
242688|NCT02129985|short-term insulin treatment|short-term insulin treatment
242689|NCT02129985|exenatide sequential therapy|exenatide sequential therapy
242690|NCT02129985|beta cell function|beta cell function
242691|NCT02129985|glycaemic remission|glycaemic remission
242692|NCT02129972|Inflammatory Bowel Disease, colon lesions, colon capsule endoscopy|inflammatory bowel disease, colon lesions, colon capsule endoscopy
242693|NCT02129959|laparoscopic cholecystectomy, laparoscopic gastrectomy, laparoscopic colectomy, laparoscopic appendectomy, laparoscopic|laparoscopic cholecystectomy, laparoscopic gastrectomy, laparoscopic colectomy, laparoscopic appendectomy, laparoscopic
242694|NCT02129959|assisted vaginal hysterectomy, robot-assisted laparoscopic radical prostatectomy|assisted vaginal hysterectomy, robot-assisted laparoscopic radical prostatectomy
242695|NCT02129946|Type 2 Diabetes|type 2 diabetes
242696|NCT02129946|Resistant Starch|resistant starch
242697|NCT02129946|Postprandial Glucose|postprandial glucose
242698|NCT02129946|Postprandial Insulin|postprandial insulin
242699|NCT02129946|Satiety|satiety
242700|NCT02129933|EAC|eac
242701|NCT02129933|HGD|hgd
242702|NCT02129933|Esophagus|esophagus
242703|NCT02129920|Stroke|stroke
242704|NCT02129920|Cerebral Infarction|cerebral infarction
242705|NCT02129920|Atrial Fibrillation|atrial fibrillation
242706|NCT02129920|Arrhythmias, Cardiac|arrhythmias, cardiac
242707|NCT02129920|Heart Diseases|heart diseases
242708|NCT02129920|Cardiovascular Diseases|cardiovascular diseases
242709|NCT02129920|Cerebrovascular Disorders|cerebrovascular disorders
242710|NCT02129920|Brain Diseases|brain diseases
242711|NCT02129920|Central Nervous System Diseases|central nervous system diseases
242712|NCT02129920|Nervous System Diseases|nervous system diseases
242713|NCT02129920|Vascular Diseases|vascular diseases
242714|NCT02129920|Brain Infarction|brain infarction
242715|NCT02129920|Brain Ischemia|brain ischemia
242716|NCT02129920|Anticoagulants|anticoagulants
242717|NCT02129920|Hematologic Agents|hematologic agents
242718|NCT02129920|Therapeutic Uses|therapeutic uses
242719|NCT02129907|Anemias|anemias
242720|NCT02129907|Iron-Deficiency|iron-deficiency
242721|NCT02129907|thrombin|thrombin
242722|NCT02129894|cesarean section|cesarean section
242723|NCT02129894|postoperative pain|postoperative pain
242724|NCT02129894|pregnancy|pregnancy
242725|NCT02129894|abdominal binder|abdominal binder
242726|NCT02129868|Type 1 diabetes|type 1 diabetes
242727|NCT02129868|Closed-loop glucose control|closed-loop glucose control
242728|NCT02129868|Artificial Pancreas|artificial pancreas
242729|NCT02129868|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
242730|NCT02129868|Continuous glucose monitoring|continuous glucose monitoring
242731|NCT02129842|AFib|afib
242732|NCT02129842|AF|af
242733|NCT02129842|ablation|ablation
242734|NCT02129842|EndoPAT|endopat
242735|NCT02129842|Endothelial dysfunction|endothelial dysfunction
242736|NCT02129842|PAT|pat
242737|NCT02129829|Cirrhosis|cirrhosis
242738|NCT02129829|HBV|hbv
242739|NCT02129829|HIV|hiv
242740|NCT02129829|HCV|hcv
242741|NCT02129816|Female|female
242742|NCT02129816|Postmenopause|postmenopause
242743|NCT02129803|Cystic Fibrosis, high flow 20 liters per minute (LPM) humidification therapy|cystic fibrosis, high flow 20 liters per minute (lpm) humidification therapy
242744|NCT02129790|Bipolar Disorder|bipolar disorder
242745|NCT02129790|Suicidal|suicidal
242746|NCT02129790|Depression|depression
242747|NCT02129790|Self-harm|self-harm
242748|NCT02129790|Psychosocial intervention|psychosocial intervention
242749|NCT02129777|Drug therapy|drug therapy
242750|NCT02129751|able to swallow medications without difficulty|able to swallow medications without difficulty
242751|NCT02129751|bupropion hydrobromide|bupropion hydrobromide
242752|NCT02129699|NSCLC|nsclc
242753|NCT02129699|stage IV|stage iv
242754|NCT02129686|Chemotherapy-induced peripheral neuropathy (CIPN)|chemotherapy-induced peripheral neuropathy (cipn)
242755|NCT02129686|Acupuncture|acupuncture
242756|NCT02129686|Early-Stage Breast Carcinoma|early-stage breast carcinoma
242757|NCT02129686|Stage I Breast Cancer|stage i breast cancer
242758|NCT02129686|Stage II Breast Cancer|stage ii breast cancer
242759|NCT02129686|Stage III Breast Cancer|stage iii breast cancer
242760|NCT02129673|Glaucoma|glaucoma
242761|NCT02129673|Intra-ocular pressure|intra-ocular pressure
242762|NCT02129673|Slow Release|slow release
242763|NCT02129673|Controlled release|controlled release
242764|NCT02129647|Neurofibromatosis Type 2|neurofibromatosis type 2
242765|NCT02129647|Vestibular Schwannomas|vestibular schwannomas
242766|NCT02129647|Axitinib|axitinib
242767|NCT02129634|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
242768|NCT02129634|Limb-salvage|limb-salvage
242769|NCT02129634|Randomized Controlled Trial|randomized controlled trial
242770|NCT02129634|Paclitaxel|paclitaxel
242771|NCT02129621|Lipocalin|lipocalin
242772|NCT02129621|mineralocorticoid receptor|mineralocorticoid receptor
242773|NCT02129608|overweight|overweight
242774|NCT02129608|obese|obese
242775|NCT02129608|central adiposity|central adiposity
242776|NCT02129608|Laser|laser
242777|NCT02129608|lorcaserin|lorcaserin
242778|NCT02129608|low level laser therapy|low level laser therapy
242779|NCT02129608|belviq|belviq
242780|NCT02129595|Resveratrol|resveratrol
242781|NCT02129595|Diabetes Mellitus|diabetes mellitus
242782|NCT02129595|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
242783|NCT02129595|Insulin Resistance|insulin resistance
242784|NCT02129595|Glucose Metabolism Disorders|glucose metabolism disorders
242785|NCT02129595|Metabolic Diseases|metabolic diseases
242786|NCT02129595|Endocrine System Diseases|endocrine system diseases
242787|NCT02129595|Hyperinsulinism|hyperinsulinism
242788|NCT02129595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
242789|NCT02129595|Analgesics, Non-Narcotic|analgesics, non-narcotic
242790|NCT02129595|Analgesics|analgesics
242791|NCT02129595|Sensory System Agents|sensory system agents
242792|NCT02129595|Peripheral Nervous System Agents|peripheral nervous system agents
242793|NCT02129595|Physiological Effects of Drugs|physiological effects of drugs
242794|NCT02129595|Pharmacologic Actions|pharmacologic actions
242795|NCT02129595|Anti-Inflammatory Agents|anti-inflammatory agents
242796|NCT02129595|Therapeutic Uses|therapeutic uses
242797|NCT02129595|Antirheumatic Agents|antirheumatic agents
242798|NCT02129595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic
242799|NCT02129595|Antineoplastic Agents|antineoplastic agents
242800|NCT02129595|Antioxidants|antioxidants
242801|NCT02129595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
242802|NCT02129595|Protective Agents|protective agents
242803|NCT02129595|Enzyme Inhibitors|enzyme inhibitors
242804|NCT02129595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
242805|NCT02129595|Hematologic Agents|hematologic agents
242806|NCT02129595|Antimutagenic Agents|antimutagenic agents
242807|NCT02129595|Anticarcinogenic Agents|anticarcinogenic agents
242808|NCT02129595|Central Nervous System Agents|central nervous system agents
242809|NCT02129595|Brown Adipose Tissue|brown adipose tissue
242810|NCT02129556|Metastatic|metastatic
242811|NCT02129556|Breast|breast
242812|NCT02129556|trastuzumab-resistant|trastuzumab-resistant
242813|NCT02129556|PD-L1 expressing|pd-l1 expressing
242814|NCT02129556|HER2-positive|her2-positive
242815|NCT02129543|SCT|sct
242816|NCT02129543|Stem Cell Transplantation|stem cell transplantation
242817|NCT02129543|Stem Cell Transplant|stem cell transplant
242818|NCT02129530|Community Mobilization|community mobilization
242819|NCT02129530|HIV|hiv
242820|NCT02129530|Intimate Partner Violence|intimate partner violence
242821|NCT02129530|Gender Norms|gender norms
242822|NCT02129504|root coverage|root coverage
242823|NCT02129504|gingival recession|gingival recession
242824|NCT02129504|periodontal surgery|periodontal surgery
242825|NCT02129491|stroke|stroke
242826|NCT02129491|Congenital stroke|congenital stroke
242827|NCT02129491|neonatal|neonatal
242828|NCT02129491|hemiplegia|hemiplegia
242829|NCT02129478|olanzapine|olanzapine
242830|NCT02129478|pediatrics|pediatrics
242831|NCT02129478|chemotherapy-induced nausea|chemotherapy-induced nausea
242832|NCT02129478|chemotherapy-induced vomiting|chemotherapy-induced vomiting
242833|NCT02129465|Cytomegalovirus|cytomegalovirus
242834|NCT02129465|CMV|cmv
242835|NCT02129465|pregnancy|pregnancy
242836|NCT02129465|transmission|transmission
242837|NCT02129452|Alzheimer disease|alzheimer disease
242838|NCT02129452|Dementia|dementia
242839|NCT02129452|Neurodegenerative Diseases|neurodegenerative diseases
242840|NCT02129452|Tauopathies|tauopathies
242841|NCT02129452|Amyloid beta Peptides|amyloid beta peptides
242842|NCT02129452|Amyloid Plaque|amyloid plaque
242843|NCT02129452|MicroRNAs|micrornas
242844|NCT02129452|Early Diagnosis|early diagnosis
242845|NCT02129439|Antisense oligonucleotide|antisense oligonucleotide
242846|NCT02129439|Colitis Ulcerosa|colitis ulcerosa
242847|NCT02129439|Ulcerative colitis|ulcerative colitis
242848|NCT02129439|Phase II|phase ii
242849|NCT02129439|Transcription factor GATA-3|transcription factor gata-3
242850|NCT02129439|intrarectal application|intrarectal application
242851|NCT02129439|proof-of-concept|proof-of-concept
242852|NCT02129426|Sedation|sedation
242853|NCT02129426|MRI|mri
242854|NCT02129413|Aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
242855|NCT02129413|Subarachnoid hemorrhage|subarachnoid hemorrhage
242856|NCT02129413|Cerebral vasospasm|cerebral vasospasm
242857|NCT02129413|Ruptured aneurysm|ruptured aneurysm
242858|NCT02129413|Delayed Cerebral Ischemia|delayed cerebral ischemia
242859|NCT02129413|Delayed Ischemic Deficit|delayed ischemic deficit
242860|NCT02129413|Delayed ischemic neurological deficit|delayed ischemic neurological deficit
242861|NCT02129413|Neurostimulation|neurostimulation
242862|NCT02129413|Carotid body|carotid body
242863|NCT02129400|Xenon-inhalation|xenon-inhalation
242864|NCT02129400|Erythropoetin|erythropoetin
242865|NCT02129400|Pharmakokinetic|pharmakokinetic
242866|NCT02129400|Pharmacodynamic|pharmacodynamic
242867|NCT02129400|Hemodynamic parameters|hemodynamic parameters
242868|NCT02129400|Inflammatory parameters|inflammatory parameters
242869|NCT02129400|Growth factors|growth factors
242870|NCT02129400|Oxidative stress parameters|oxidative stress parameters
242871|NCT02129387|Nicotine|nicotine
242872|NCT02129387|Smoking Progression|smoking progression
242873|NCT02129387|EEG|eeg
242874|NCT02129387|Young adults|young adults
242875|NCT02129387|Light smokers|light smokers
242876|NCT02129387|rs1051730 genotype|rs1051730 genotype
242877|NCT02129374|Spondylolysis|spondylolysis
242878|NCT02129374|Lumbar spine|lumbar spine
242879|NCT02129374|Young population|young population
242880|NCT02129374|Direct repair|direct repair
242881|NCT02129374|Union rate|union rate
242882|NCT02129374|Functional outcome|functional outcome
242883|NCT02129361|traumatic brain injury|traumatic brain injury
242884|NCT02129348|Alzheimer's disease|alzheimer's disease
242885|NCT02129348|psychosis|psychosis
242886|NCT02129348|agitation|agitation
242887|NCT02129348|aggression|aggression
242888|NCT02129348|Lithium|lithium
242889|NCT02129348|delusions|delusions
242890|NCT02129348|hallucinations|hallucinations
242891|NCT02129335|glioblastoma|glioblastoma
242892|NCT02129335|partner|partner
242893|NCT02129335|stress|stress
242894|NCT02129335|exercise|exercise
242895|NCT02129335|outcome|outcome
242896|NCT02129309|COPD|copd
242897|NCT02129309|Apelin|apelin
242898|NCT02129309|agonist|agonist
242899|NCT02129309|antagonist|antagonist
242900|NCT02129296|Morbid obesity|morbid obesity
242901|NCT02129296|Gastric balloon|gastric balloon
242902|NCT02129296|Weight loss|weight loss
242903|NCT02129296|Tolerance|tolerance
242904|NCT02129296|Safety|safety
242905|NCT02129283|physicians, nurses, ICU, end-of-life, simulation training|physicians, nurses, icu, end-of-life, simulation training
242906|NCT02129270|Fractures of the distal radius|fractures of the distal radius
242907|NCT02129270|Hematoma block|hematoma block
242908|NCT02129270|Lidocaine|lidocaine
242909|NCT02129244|MDR-TB|mdr-tb
242910|NCT02129244|HIV|hiv
242911|NCT02129244|Nurse Case Management (NCM)|nurse case management (ncm)
242912|NCT02129231|ezetimibe/simvastatin|ezetimibe/simvastatin
242913|NCT02129231|rosuvastatin|rosuvastatin
242914|NCT02129231|diabetic polyneuropathy|diabetic polyneuropathy
242915|NCT02129231|oxidative stress|oxidative stress
242916|NCT02129231|mitochondrial dysfunction|mitochondrial dysfunction
242917|NCT02129205|solid tumors|solid tumors
242918|NCT02129205|triple negative breast cancer|triple negative breast cancer
242919|NCT02129205|PF-06650808|pf-06650808
242920|NCT02129205|Phase 1|phase 1
242921|NCT02129153|Randomized controlled trial|randomized controlled trial
242922|NCT02129153|Population, School Age|population, school age
242923|NCT02129140|hernia repair|hernia repair
242924|NCT02129140|ventral incisional hernia|ventral incisional hernia
242925|NCT02129140|biologic mesh|biologic mesh
242926|NCT02129140|hernia graft|hernia graft
242927|NCT02129088|Healthy|healthy
242928|NCT02129088|Esketamine|esketamine
242929|NCT02129088|Phase 1|phase 1
242930|NCT02129088|Placebo|placebo
242931|NCT02129088|Elderly|elderly
242932|NCT02129088|Adult|adult
242933|NCT02129036|Ovarian cancer|ovarian cancer
242934|NCT02129036|Clear cell carcinoma|clear cell carcinoma
242935|NCT02129036|Paclitaxel-platinum|paclitaxel-platinum
242936|NCT02129036|Chemotherapy|chemotherapy
242937|NCT02129036|response to chemotherapy|response to chemotherapy
242938|NCT02129036|survival of clear cell ovarian carcinoma|survival of clear cell ovarian carcinoma
242939|NCT02129036|Prognostic factors|prognostic factors
242940|NCT02129023|Exergame|exergame
242941|NCT02129023|user health|user health
242942|NCT02129023|exercise|exercise
242943|NCT02129010|subarachnoid hemorrhage|subarachnoid hemorrhage
242944|NCT02129010|terson syndrome|terson syndrome
242945|NCT02129010|CSF-proteines|csf-proteines
242946|NCT02129010|phospho-tau|phospho-tau
242947|NCT02129010|beta-amyloid|beta-amyloid
242948|NCT02128997|obesity, cesarean section, wound complication|obesity, cesarean section, wound complication
242949|NCT02128984|Malnutrition|malnutrition
242950|NCT02128984|Dietary supplement|dietary supplement
242951|NCT02128984|Nutritional supplement|nutritional supplement
242952|NCT02128984|Symbiotic formula|symbiotic formula
242953|NCT02128984|DHA|dha
242954|NCT02128984|Cystic Fibrosis|cystic fibrosis
242955|NCT02128984|Failure to Thrive|failure to thrive
242956|NCT02128971|Iron supplement study|iron supplement study
242957|NCT02128958|Hepatocellular Carcinoma|hepatocellular carcinoma
242958|NCT02128958|Child-Pugh Class B Cirrhosis|child-pugh class b cirrhosis
242959|NCT02128945|PET|pet
242960|NCT02128945|Chronic lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
242961|NCT02128945|Diffuse Large B Cells Lymphoma (DLBCL)|diffuse large b cells lymphoma (dlbcl)
242962|NCT02128945|Fludarabine|fludarabine
242963|NCT02128919|Schizophrenia|schizophrenia
242964|NCT02128919|Cigarette smoking|cigarette smoking
242965|NCT02128919|Cognition|cognition
242966|NCT02128919|Craving|craving
242967|NCT02128919|MATRICS|matrics
242968|NCT02128906|ERCC1|ercc1
242969|NCT02128906|squamous cell carcinoma|squamous cell carcinoma
242970|NCT02128906|oropharynx|oropharynx
242971|NCT02128906|larynx|larynx
242972|NCT02128906|hypopharynx|hypopharynx
242973|NCT02128906|p16|p16
242974|NCT02128906|radiotherapy|radiotherapy
242975|NCT02128906|docetaxel|docetaxel
242976|NCT02128906|cetuximab|cetuximab
242977|NCT02128906|cisplatin|cisplatin
242978|NCT02128906|EGFR|egfr
242979|NCT02128906|Biomarker|biomarker
242980|NCT02128906|efficacy|efficacy
242981|NCT02128906|head and neck|head and neck
242982|NCT02128906|tongue|tongue
242983|NCT02128906|throat|throat
242984|NCT02128893|Isavuconazole|isavuconazole
242985|NCT02128893|Esomeprazole|esomeprazole
242986|NCT02128893|BAL4815|bal4815
242987|NCT02128893|BAL8728|bal8728
242988|NCT02128893|Healthy Subjects|healthy subjects
242989|NCT02128880|AEP, drinking, contraception, FASD, Internet interventions|aep, drinking, contraception, fasd, internet interventions
242990|NCT02128867|gastro-esophageal reflux|gastro-esophageal reflux
242991|NCT02128867|GOR|gor
242993|NCT02128867|airway clearance techniques|airway clearance techniques
242994|NCT02128854|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
242995|NCT02128854|Diabetes Mellitus, Adult-Onset|diabetes mellitus, adult-onset
242996|NCT02128854|Diabetes Mellitus, Non-Insulin-Dependent|diabetes mellitus, non-insulin-dependent
242997|NCT02128854|Diabetes Mellitus, Noninsulin Dependent|diabetes mellitus, noninsulin dependent
242998|NCT02128854|Diabetes Mellitus, Type II|diabetes mellitus, type ii
242999|NCT02128854|African Americans|african americans
243000|NCT02128854|Blacks|blacks
243001|NCT02128854|Non-Hispanic Blacks|non-hispanic blacks
243002|NCT02128854|Randomized Control Trial|randomized control trial
243003|NCT02128854|Controlled Clinical Trial|controlled clinical trial
243004|NCT02128854|Behavioral Research|behavioral research
243005|NCT02128854|Behavioral Medicine|behavioral medicine
243006|NCT02128841|rivaroxaban|rivaroxaban
243007|NCT02128841|Heart Valve Prosthesis Implantation|heart valve prosthesis implantation
243008|NCT02128841|anticoagulants|anticoagulants
243009|NCT02128841|Factor Xa/antagonists & inhibitors|factor xa/antagonists & inhibitors
243010|NCT02128828|AIDS Dementia Complex|aids dementia complex
243011|NCT02128828|HIV-1-Associated Cognitive Motor Complex|hiv-1-associated cognitive motor complex
243012|NCT02128828|Human Immunodeficiency Virus|human immunodeficiency virus
243013|NCT02128815|adults|adults
243014|NCT02128815|coaching|coaching
243015|NCT02128815|type 2 diabetes|type 2 diabetes
243016|NCT02128802|Obesity|obesity
243017|NCT02128802|Renal failure|renal failure
243018|NCT02128802|Gastric bypass|gastric bypass
243019|NCT02128789|Older Adults|older adults
243020|NCT02128789|Caregivers|caregivers
243021|NCT02128789|Aging|aging
243022|NCT02128789|Support|support
243023|NCT02128776|Children|children
243024|NCT02128776|Chronic illnesses|chronic illnesses
243025|NCT02128724|Lung cancer|lung cancer
243026|NCT02128724|BKM120|bkm120
243027|NCT02128724|Hypoxia|hypoxia
243028|NCT02128724|Misonidazole|misonidazole
243029|NCT02128724|Radiotherapy|radiotherapy
243030|NCT02128711|lung|lung
243031|NCT02128711|cystic fibrosis|cystic fibrosis
243032|NCT02128711|bacteria|bacteria
243033|NCT02128711|positive diagnosis of CF,|positive diagnosis of cf,
243034|NCT02128698|Bariatric surgery|bariatric surgery
243035|NCT02128698|Protein supplementation|protein supplementation
243036|NCT02128698|Physical activity|physical activity
243037|NCT02128698|Muscle mass|muscle mass
243038|NCT02128698|Weight loss|weight loss
243231|NCT02127788|Micafungin|micafungin
243039|NCT02128698|Physical fitness|physical fitness
243040|NCT02128698|Muscle strength|muscle strength
243041|NCT02128685|Threatened miscarriage|threatened miscarriage
243042|NCT02128685|Dydrogesterone|dydrogesterone
243043|NCT02128685|Randomized controlled trial|randomized controlled trial
243044|NCT02128646|Pain Management|pain management
243045|NCT02128646|Exparel|exparel
243046|NCT02128646|Abdominal Hernia Repair|abdominal hernia repair
243047|NCT02128646|Laparoscopic Surgery|laparoscopic surgery
243048|NCT02128633|Dentin hypersensitivity|dentin hypersensitivity
243049|NCT02128633|Dentin Sensitivities|dentin sensitivities
243050|NCT02128620|Sexually transmitted diseases|sexually transmitted diseases
243051|NCT02128620|Internet|internet
243052|NCT02128620|Education|education
243053|NCT02128620|Appointments and Schedules|appointments and schedules
243054|NCT02128607|low back pain|low back pain
243055|NCT02128607|manual therapy|manual therapy
243056|NCT02128607|Mulligan|mulligan
243057|NCT02128607|sustained natural apophyseal glide (SNAG)|sustained natural apophyseal glide (snag)
243058|NCT02128607|Kinematic spine model|kinematic spine model
243059|NCT02128568|Depression/therapy;|depression/therapy;
243060|NCT02128568|Developing Countries;|developing countries;
243061|NCT02128568|Interpersonal Relations;|interpersonal relations;
243062|NCT02128568|Life Change Events;|life change events;
243063|NCT02128568|Psychotherapy, Group;|psychotherapy, group;
243064|NCT02128568|Resilience, Psychological;|resilience, psychological;
243065|NCT02128568|Sierra Leone;|sierra leone;
243066|NCT02128568|Survivors/psychology;|survivors/psychology;
243067|NCT02128568|Social Adjustment;|social adjustment;
243068|NCT02128568|Social Behavior;|social behavior;
243069|NCT02128568|War|war
243070|NCT02128555|ankle arthritis|ankle arthritis
243071|NCT02128555|osteoarthritis|osteoarthritis
243072|NCT02128555|total ankle replacement|total ankle replacement
243073|NCT02128555|arthrodesis|arthrodesis
243074|NCT02128555|quality of life|quality of life
243075|NCT02128555|musculoskeletal|musculoskeletal
243076|NCT02128542|Veterans HCV|veterans hcv
243077|NCT02128529|COPD|copd
243078|NCT02128490|Drug therapy|drug therapy
243079|NCT02128477|Myocardial infarction|myocardial infarction
243080|NCT02128477|Repolarization instability|repolarization instability
243081|NCT02128477|Ventricular fibrillation|ventricular fibrillation
243082|NCT02128464|Knee Osteoarthritis|knee osteoarthritis
243083|NCT02128464|Total Knee Arthroplasty|total knee arthroplasty
243084|NCT02128464|Customized Cutting Block|customized cutting block
243085|NCT02128464|Conventional Intramedullary Cutting Guide|conventional intramedullary cutting guide
243086|NCT02128451|meperdine ,fentanyl, clonidine, orthopedic surgery .|meperdine ,fentanyl, clonidine, orthopedic surgery .
243087|NCT02128425|Colorectal cancer|colorectal cancer
243088|NCT02128425|Metastatic colorectal cancer|metastatic colorectal cancer
243089|NCT02128425|FOLFOXIRI|folfoxiri
243090|NCT02128425|FOLFOX|folfox
243091|NCT02128425|Oxaliplatin|oxaliplatin
243092|NCT02128425|irinotecan|irinotecan
243093|NCT02128425|Leucovorin|leucovorin
243094|NCT02128425|5-FU|5-fu
243095|NCT02128412|Patients scheduled to undergo coronary angioplasty and stenting because of symptoms related to a single de novo coronary artery stenoses|patients scheduled to undergo coronary angioplasty and stenting because of symptoms related to a single de novo coronary artery stenoses
243096|NCT02128399|antimicrobial stewardship|antimicrobial stewardship
243097|NCT02128360|Low ovarian reserve|low ovarian reserve
243098|NCT02128360|Poor responder|poor responder
243099|NCT02128360|Infertility|infertility
243100|NCT02128347|Hemodialysis, Home|hemodialysis, home
243101|NCT02128347|Peritoneal Dialysis|peritoneal dialysis
243102|NCT02128347|Telemedicine|telemedicine
243103|NCT02128334|Uro-Oncologists|uro-oncologists
243104|NCT02128334|PSA|psa
243105|NCT02128334|Eligard|eligard
243106|NCT02128334|prostate carcinoma|prostate carcinoma
243107|NCT02128321|Isavuconazole|isavuconazole
243108|NCT02128321|Repaglinide|repaglinide
243109|NCT02128321|Caffeine|caffeine
243110|NCT02128321|BAL4815|bal4815
243111|NCT02128321|BAL8728|bal8728
243112|NCT02128321|Healthy Subjects|healthy subjects
243113|NCT02128308|Antituberculosis agents|antituberculosis agents
243114|NCT02128308|Pharmacokinetics|pharmacokinetics
243115|NCT02128295|Breast pumps, breast milk, expression, term infants|breast pumps, breast milk, expression, term infants
243116|NCT02128282|Cholangiocarcinoma|cholangiocarcinoma
243117|NCT02128282|Bile duct cancer|bile duct cancer
243118|NCT02128282|Biliary tract cancer|biliary tract cancer
243119|NCT02128269|Antiphospholipid (aPL)-positive|antiphospholipid (apl)-positive
243120|NCT02128269|Antiphospholid syndrome (APS)|antiphospholid syndrome (aps)
243121|NCT02128256|Osteomyelitis|osteomyelitis
243122|NCT02128256|Bone substitute|bone substitute
243123|NCT02128256|Ceramic|ceramic
243124|NCT02128256|Gentamicin|gentamicin
243125|NCT02128230|High risk|high risk
243126|NCT02128230|Carfilzomib|carfilzomib
243127|NCT02128191|Patent ductus arteriosus|patent ductus arteriosus
243128|NCT02128191|Ibuprofen|ibuprofen
243129|NCT02128191|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
243130|NCT02128178|Morbid obesity|morbid obesity
243131|NCT02128178|Laparoscopic surgery|laparoscopic surgery
243132|NCT02128178|Compression ultrasonography|compression ultrasonography
243133|NCT02128178|Pulmonary embolism|pulmonary embolism
243134|NCT02128178|Bleeding|bleeding
243135|NCT02128165|gastric balloon|gastric balloon
243136|NCT02128165|morbid obesity|morbid obesity
243137|NCT02128152|stroke|stroke
243138|NCT02128152|exoskeleton|exoskeleton
243139|NCT02128152|Ekso|ekso
243140|NCT02128152|ambulation|ambulation
243141|NCT02128152|robotics|robotics
243142|NCT02128139|Infective endocarditis|infective endocarditis
243143|NCT02128139|Developing country|developing country
243144|NCT02128139|Global health|global health
243145|NCT02128139|Cardiac surgery|cardiac surgery
243146|NCT02128139|Heart valve disease|heart valve disease
243147|NCT02128139|Bacteremia|bacteremia
243148|NCT02128126|Advanced or recurrent cervical cancer|advanced or recurrent cervical cancer
243149|NCT02128126|HPV16 positive|hpv16 positive
243150|NCT02128126|No curative treatment options|no curative treatment options
243151|NCT02128113|RTA 408|rta 408
243152|NCT02128113|Cataract surgery|cataract surgery
243153|NCT02128113|Corneal Endothelial Cells|corneal endothelial cells
243154|NCT02128113|omaveloxolone|omaveloxolone
243155|NCT02128100|Pancreatic Cancer|pancreatic cancer
243156|NCT02128087|HIV|hiv
243157|NCT02128087|Antiretroviral (ARV)|antiretroviral (arv)
243158|NCT02128087|co-trimoxazole|co-trimoxazole
243159|NCT02128087|SMS|sms
243160|NCT02128087|mobile Health (mHealth)|mobile health (mhealth)
243161|NCT02128087|Adolescents|adolescents
243162|NCT02128087|Uganda|uganda
243163|NCT02128087|Adherence|adherence
243164|NCT02128035|radiation protection|radiation protection
243165|NCT02128035|interventional cardiologist|interventional cardiologist
243166|NCT02128035|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
243167|NCT02128035|angiography|angiography
243168|NCT02128035|lead shield|lead shield
243169|NCT02128022|Glucagon-Like Peptide 1|glucagon-like peptide 1
243170|NCT02128022|Angina Pectoris|angina pectoris
243171|NCT02128022|Percutaneous Coronary Intervention|percutaneous coronary intervention
243172|NCT02128022|Ischemic Preconditioning|ischemic preconditioning
243173|NCT02128022|Myocardial Reperfusion Injury|myocardial reperfusion injury
243174|NCT02127996|Angina Pectoris|angina pectoris
243175|NCT02127996|Percutaneous Coronary Intervention|percutaneous coronary intervention
243176|NCT02127996|Myocardial Infarction|myocardial infarction
243177|NCT02127996|Glucagon-Like Peptide 1|glucagon-like peptide 1
243178|NCT02127996|Reperfusion Injury|reperfusion injury
243179|NCT02127983|TB, HIV, case finding, access, informal providers|tb, hiv, case finding, access, informal providers
243180|NCT02127957|cystic fibrosis|cystic fibrosis
243181|NCT02127957|exercise|exercise
243182|NCT02127957|Cystic fibrosis related diabetes|cystic fibrosis related diabetes
243183|NCT02127918|Electrical status epilepticus in sleep|electrical status epilepticus in sleep
243184|NCT02127918|Continuous spikes and waves during sleep|continuous spikes and waves during sleep
243185|NCT02127918|Children|children
243186|NCT02127918|Electroencephalogram|electroencephalogram
243187|NCT02127918|Neuropsychology|neuropsychology
243188|NCT02127918|Development|development
243189|NCT02127918|Antiepileptic drugs|antiepileptic drugs
243190|NCT02127918|Clobazam|clobazam
243191|NCT02127918|Seizures|seizures
243192|NCT02127905|Fanconi Anemia|fanconi anemia
243193|NCT02127905|compassionate treatment|compassionate treatment
243194|NCT02127905|BMT|bmt
243195|NCT02127905|HSCT|hsct
243196|NCT02127905|unrelated|unrelated
243197|NCT02127905|bone marrow transplantation|bone marrow transplantation
243198|NCT02127905|PBSC|pbsc
243199|NCT02127905|peripheral blood|peripheral blood
243200|NCT02127905|CD34+|cd34+
243201|NCT02127892|Severe Combined Immune Deficiency|severe combined immune deficiency
243202|NCT02127892|SCID|scid
243203|NCT02127892|HLA-matched unrelated donor|hla-matched unrelated donor
243204|NCT02127892|unrelated|unrelated
243205|NCT02127892|MUD|mud
243206|NCT02127892|bone marrow|bone marrow
243207|NCT02127892|cord blood|cord blood
243208|NCT02127892|haplo-identical|haplo-identical
243209|NCT02127892|peripheral blood|peripheral blood
243210|NCT02127892|CD34+ selection|cd34+ selection
243211|NCT02127892|T cell depletion|t cell depletion
243212|NCT02127892|HSCT|hsct
243213|NCT02127892|BMT|bmt
243214|NCT02127892|CliniMACS|clinimacs
243215|NCT02127879|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
243216|NCT02127879|Schizophrenia|schizophrenia
243217|NCT02127879|Negative symptoms|negative symptoms
243218|NCT02127879|Intensive|intensive
243219|NCT02127879|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
243220|NCT02127866|Asthma, anticholinergics|asthma, anticholinergics
243221|NCT02127853|serial cataract surgery|serial cataract surgery
243222|NCT02127853|hyperalgesia|hyperalgesia
243223|NCT02127853|gabapentin|gabapentin
243224|NCT02127853|central sensitization|central sensitization
243225|NCT02127840|primary aldosteronism|primary aldosteronism
243226|NCT02127840|adrenal adenoma|adrenal adenoma
243227|NCT02127840|arterial hypertension|arterial hypertension
243228|NCT02127814|induced diarrhea|induced diarrhea
243229|NCT02127814|Clostridium difficile toxicity|clostridium difficile toxicity
243230|NCT02127788|Haematology|haematology
243232|NCT02127788|Observational study|observational study
243233|NCT02127788|Prophylaxis|prophylaxis
243234|NCT02127788|Invasive Fungal Infection|invasive fungal infection
243235|NCT02127788|France|france
243236|NCT02127762|Pain|pain
243237|NCT02127762|Quality of Life|quality of life
243238|NCT02127762|Glycemic Control|glycemic control
243239|NCT02127762|diabetic neuropathy|diabetic neuropathy
243240|NCT02127762|mindfulness|mindfulness
243241|NCT02127762|stress reduction|stress reduction
243242|NCT02127762|adult|adult
243243|NCT02127762|chronic pain|chronic pain
243244|NCT02127762|depression|depression
243245|NCT02127762|cortisol|cortisol
243246|NCT02127749|antibiotics|antibiotics
243247|NCT02127749|gut microbiota|gut microbiota
243248|NCT02127749|endotoxemia|endotoxemia
243249|NCT02127749|innate immunity|innate immunity
243250|NCT02127723|cellulite|cellulite
243251|NCT02127710|AZD6094|azd6094
243252|NCT02127710|Savolitinib|savolitinib
243253|NCT02127710|Papillary Renal Cell Cancer|papillary renal cell cancer
243254|NCT02127697|Asthma, poorly controlled asthma, LAMA, Long-Acting Muscarinic Antagonist, Glycopyrronium, Glycopyrronium bromide, Anticholinergic|asthma, poorly controlled asthma, lama, long-acting muscarinic antagonist, glycopyrronium, glycopyrronium bromide, anticholinergic
243255|NCT02127684|diabetic macular edema|diabetic macular edema
243256|NCT02127645|RADIOTHERAPY|radiotherapy
243257|NCT02127645|TRANSANAL ENDOSCOPIC MICROSURGERY|transanal endoscopic microsurgery
243258|NCT02127645|LOCAL EXCISION|local excision
243259|NCT02127632|laryngeal mask Supreme|laryngeal mask supreme
243260|NCT02127632|laparoscopic gynecologic surgery|laparoscopic gynecologic surgery
243261|NCT02127632|Laryngeal mask during surgery|laryngeal mask during surgery
243262|NCT02127619|knee prosthesis|knee prosthesis
243263|NCT02127619|total knee replacement|total knee replacement
243264|NCT02127619|total knee arthroplasty|total knee arthroplasty
243265|NCT02127619|prospective study|prospective study
243266|NCT02127619|Therapeutic level IV|therapeutic level iv
243267|NCT02127593|Norgestimate|norgestimate
243268|NCT02127593|Ethinyl estradiol|ethinyl estradiol
243269|NCT02127593|Norgestrel|norgestrel
243270|NCT02127593|Norelgestromin|norelgestromin
243271|NCT02127593|Ortho cyclen|ortho cyclen
243272|NCT02127593|Phase 1|phase 1
243273|NCT02127593|Healthy Women|healthy women
243274|NCT02127580|THV|thv
243275|NCT02127580|BAV|bav
243276|NCT02127580|pre-dilation|pre-dilation
243277|NCT02127580|Aortic valve stenosis|aortic valve stenosis
243278|NCT02127567|medical writing, reporting, randomized controlled trial|medical writing, reporting, randomized controlled trial
243279|NCT02127541|Localisation of Insulinoma|localisation of insulinoma
243280|NCT02127541|beta-cell imaging|beta-cell imaging
243281|NCT02127541|exendin-4|exendin-4
243282|NCT02127541|68Ga-DOTA-exendin-4 PET/CT|68ga-dota-exendin-4 pet/ct
243283|NCT02127541|111In-DOTA-exendin-4 SPECT/CT|111in-dota-exendin-4 spect/ct
243284|NCT02127515|Down, trisomy 21|down, trisomy 21
243285|NCT02127515|NIPT|nipt
243286|NCT02127515|Amniocentesis|amniocentesis
243287|NCT02127515|miscarriage|miscarriage
243288|NCT02127515|invasive|invasive
243289|NCT02127515|prenatal|prenatal
243290|NCT02127515|screening.|screening.
243291|NCT02127489|Bupivacaine, caudal, rectal midazolam, children|bupivacaine, caudal, rectal midazolam, children
243292|NCT02127463|AMD|amd
243293|NCT02127463|Dry AMD|dry amd
243294|NCT02127463|Non-Exudative AMD|non-exudative amd
243295|NCT02127463|MC-1101|mc-1101
243296|NCT02127450|Enterobacteriaceae|enterobacteriaceae
243297|NCT02127450|non-susceptible to carbapenem|non-susceptible to carbapenem
243298|NCT02127450|carbapenemases|carbapenemases
243299|NCT02127450|prevalence|prevalence
243300|NCT02127450|screening algorithm|screening algorithm
243301|NCT02127437|Autosomal dominant polycystic kidney disease,|autosomal dominant polycystic kidney disease,
243302|NCT02127437|Glomerular filtration rate,|glomerular filtration rate,
243303|NCT02127437|Somatostatin,|somatostatin,
243304|NCT02127437|lanreotide|lanreotide
243305|NCT02127424|Nurse|nurse
243306|NCT02127424|Nursing|nursing
243307|NCT02127424|Screening|screening
243308|NCT02127424|HIV|hiv
243309|NCT02127424|Emergency Service Hospital|emergency service hospital
243310|NCT02127411|Mindfulness|mindfulness
243311|NCT02127411|Benzodiazepines|benzodiazepines
243312|NCT02127411|Sleep|sleep
243313|NCT02127411|Dependence|dependence
243314|NCT02127411|Relapse Prevention|relapse prevention
243315|NCT02127398|C. difficile colitis|c. difficile colitis
243316|NCT02127398|fecal microbiota transplantation|fecal microbiota transplantation
243317|NCT02127372|non-small cell|non-small cell
243318|NCT02127372|lung cancer|lung cancer
243319|NCT02127359|Metastatic|metastatic
243320|NCT02127346|Chronic Periodontitis|chronic periodontitis
243321|NCT02127346|Vitamin D concentration|vitamin d concentration
243322|NCT02127346|Calcium concentration|calcium concentration
243323|NCT02127333|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
243324|NCT02127333|Coronary artery disease|coronary artery disease
243325|NCT02127333|Endothelial function|endothelial function
243326|NCT02127307|Myocardial sympathetic innervation|myocardial sympathetic innervation
243327|NCT02127307|Heart failure (HF)|heart failure (hf)
243328|NCT02127307|Nuclear imaging|nuclear imaging
243329|NCT02127307|Radiopharmaceutical|radiopharmaceutical
243330|NCT02127294|Foramen Ovale, Patent|foramen ovale, patent
243331|NCT02127294|migraine|migraine
243332|NCT02127294|transcatheter patent foramen ovale closure|transcatheter patent foramen ovale closure
243333|NCT02127294|contrast-enhanced transcranial Doppler|contrast-enhanced transcranial doppler
243334|NCT02127294|Transthoracic Echocardiography|transthoracic echocardiography
243335|NCT02127281|Revision total knee arthroplasty|revision total knee arthroplasty
243336|NCT02127281|Revision total hip arthroplasty|revision total hip arthroplasty
243337|NCT02127281|Negative pressure wound therapy system (NPWT)|negative pressure wound therapy system (npwt)
243338|NCT02127281|Drainage|drainage
243339|NCT02127255|chemotherapy|chemotherapy
243340|NCT02127255|nausea|nausea
243341|NCT02127255|vomiting|vomiting
243342|NCT02127255|cancer|cancer
243343|NCT02127242|hepatolithiasis|hepatolithiasis
243344|NCT02127242|ureteroscope|ureteroscope
243345|NCT02127242|air-pressure ballistic lithotripsy|air-pressure ballistic lithotripsy
243346|NCT02127242|hepatectomy|hepatectomy
243347|NCT02127229|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
243348|NCT02127229|disposable accessory cost|disposable accessory cost
243349|NCT02127229|endoscopy cost analysis|endoscopy cost analysis
243350|NCT02127216|Mobile Health|mobile health
243351|NCT02127216|Diabetes|diabetes
243352|NCT02127216|Self-Care of Diabetes|self-care of diabetes
243353|NCT02127203|oxidative stress|oxidative stress
243354|NCT02127203|periodontal disease|periodontal disease
243355|NCT02127203|nitric oxide|nitric oxide
243356|NCT02127190|nitro-fatty acids|nitro-fatty acids
243357|NCT02127190|anti-inflammatory|anti-inflammatory
243358|NCT02127190|Nrf2 activation|nrf2 activation
243359|NCT02127190|contrast induced AKI|contrast induced aki
243360|NCT02127177|obstructive sleep apnea|obstructive sleep apnea
243361|NCT02127177|coronary heart disease|coronary heart disease
243362|NCT02127177|continuous positive airway pressure|continuous positive airway pressure
243363|NCT02127177|lipid profiles|lipid profiles
243364|NCT02127177|high-sensitivity C-reactive protein|high-sensitivity c-reactive protein
243365|NCT02127138|unprotected distal left main bifurcation lesion|unprotected distal left main bifurcation lesion
243366|NCT02127138|Percutaneous coronary intervention|percutaneous coronary intervention
243367|NCT02127138|clinical study|clinical study
243368|NCT02127138|Active Transfer of Plaque （ATP）|active transfer of plaque （atp）
243369|NCT02127138|Provisional T Stenting|provisional t stenting
243370|NCT02127112|Ridge Augmentation|ridge augmentation
243371|NCT02127112|Bone regeneration|bone regeneration
243372|NCT02127112|Guided Bone Regeneration|guided bone regeneration
243373|NCT02127112|Partially Edentulous|partially edentulous
243374|NCT02127099|OSA|osa
243375|NCT02127099|obstructive|obstructive
243376|NCT02127099|sleep|sleep
243377|NCT02127099|apnea|apnea
243378|NCT02127099|operation|operation
243379|NCT02127086|Acute pain severity|acute pain severity
243380|NCT02127086|Non-communicative patients|non-communicative patients
243381|NCT02127086|PAIN algorithm|pain algorithm
243382|NCT02127086|Multi-dimensional Pain Assessment Tool (MOPAT)|multi-dimensional pain assessment tool (mopat)
243383|NCT02127073|Breast cancer|breast cancer
243384|NCT02127073|Ductal carcinoma in situ (DCIS)|ductal carcinoma in situ (dcis)
243385|NCT02127073|Oxytocin|oxytocin
243386|NCT02127060|vitamin C|vitamin c
243387|NCT02127060|effectiveness|effectiveness
243388|NCT02127060|pain management|pain management
243389|NCT02127060|posterior lumbar interbody fusion|posterior lumbar interbody fusion
243390|NCT02127034|Healthy subjects|healthy subjects
243391|NCT02127034|Mirabegron|mirabegron
243392|NCT02127034|Solifenacin|solifenacin
243393|NCT02127034|Digoxin|digoxin
243394|NCT02127021|Pancreaticoduodenectomy|pancreaticoduodenectomy
243395|NCT02127021|Nutritional Status|nutritional status
243396|NCT02127021|Quality of Life|quality of life
243397|NCT02127021|Biochemical Marker|biochemical marker
243398|NCT02127008|epidural fat|epidural fat
243399|NCT02127008|resection|resection
243400|NCT02127008|spinal stenosis|spinal stenosis
243401|NCT02127008|lumbar spine|lumbar spine
243402|NCT02126995|Fragile X Syndrome, Fra(X) Syndrome, FRAXA Syndrome|fragile x syndrome, fra(x) syndrome, fraxa syndrome
243403|NCT02126982|clopidogrel besylate|clopidogrel besylate
243404|NCT02126982|clopidogrel hydrogen sulfate|clopidogrel hydrogen sulfate
243405|NCT02126982|Generic clopidogrel|generic clopidogrel
243406|NCT02126982|Coronary Artery Disease|coronary artery disease
243407|NCT02126969|Cancer|cancer
243408|NCT02126969|Low dose radiation|low dose radiation
243409|NCT02126956|ACT-128800|act-128800
243410|NCT02126943|PAH|pah
243411|NCT02126943|pulmonary arterial hypertension|pulmonary arterial hypertension
243412|NCT02126930|anti-infectious treatment|anti-infectious treatment
243413|NCT02126930|observance|observance
243414|NCT02126930|pharmaceutical consultation|pharmaceutical consultation
243415|NCT02126917|Phase 1|phase 1
243416|NCT02126917|Alcohol|alcohol
243417|NCT02126917|Hydrocodone Bitartrate|hydrocodone bitartrate
243418|NCT02126917|Pharmacokinetics|pharmacokinetics
243419|NCT02126891|Cardiac functions|cardiac functions
243420|NCT02126891|Endurance training|endurance training
243421|NCT02126891|Senior athletes|senior athletes
243617|NCT02125955|Prebiotic|prebiotic
243422|NCT02126852|residual paralysis,neuromuscular blockade,acceleromyography,electromyography|residual paralysis,neuromuscular blockade,acceleromyography,electromyography
243423|NCT02126813|Postoperative urinary retention|postoperative urinary retention
243424|NCT02126813|Fast-track total hip (THA) and knee arthroplasty (TKA)|fast-track total hip (tha) and knee arthroplasty (tka)
243425|NCT02126813|Urinary bladder volume|urinary bladder volume
243426|NCT02126800|breast cancer|breast cancer
243427|NCT02126787|Anxiety disorders|anxiety disorders
243428|NCT02126787|Depressive disorders|depressive disorders
243429|NCT02126787|Personality disorders|personality disorders
243430|NCT02126787|Psychodynamic psychotherapy|psychodynamic psychotherapy
243431|NCT02126787|Cognitive-behavioral psychotherapy|cognitive-behavioral psychotherapy
243432|NCT02126787|Group psychotherapy|group psychotherapy
243433|NCT02126787|Day treatment|day treatment
243434|NCT02126774|epilepsy|epilepsy
243435|NCT02126774|focal epilepsy|focal epilepsy
243436|NCT02126761|Influenza|influenza
243437|NCT02126761|elderly|elderly
243438|NCT02126761|adjuvant|adjuvant
243439|NCT02126748|bronchiolitis|bronchiolitis
243440|NCT02126748|Wang score|wang score
243441|NCT02126748|Sa02|sa02
243442|NCT02126748|airway clearance techniques|airway clearance techniques
243443|NCT02126748|intrapulmonary percussive ventilation|intrapulmonary percussive ventilation
243444|NCT02126748|assisted autogenic drainage|assisted autogenic drainage
243445|NCT02126722|Helicobacter pylori|helicobacter pylori
243446|NCT02126722|Gastritis|gastritis
243447|NCT02126709|Povidone Iodine|povidone iodine
243448|NCT02126709|Safety|safety
243449|NCT02126709|Efficacy|efficacy
243450|NCT02126709|Acne treatment|acne treatment
243451|NCT02126696|Anti-retroviral Therapy|anti-retroviral therapy
243452|NCT02126696|Lesotho|lesotho
243453|NCT02126696|Southern Africa|southern africa
243454|NCT02126696|Comorbidity|comorbidity
243455|NCT02126696|Virologic failure|virologic failure
243456|NCT02126683|Hashimoto's thyroiditis|hashimoto's thyroiditis
243457|NCT02126683|Plaquenil|plaquenil
243458|NCT02126657|Acne scars|acne scars
243459|NCT02126657|70% Glycolic acid peel|70% glycolic acid peel
243460|NCT02126644|Photoaging|photoaging
243461|NCT02126644|70% glycolic acid peel|70% glycolic acid peel
243462|NCT02126618|Lower urinary tract symptoms|lower urinary tract symptoms
243463|NCT02126618|urodynamic studies|urodynamic studies
243464|NCT02126618|diuresis|diuresis
243465|NCT02126605|diabetes alert dogs|diabetes alert dogs
243466|NCT02126605|hypoglycemia|hypoglycemia
243467|NCT02126579|melanoma|melanoma
243468|NCT02126579|neoplasms|neoplasms
243469|NCT02126579|Poly ICLC|poly iclc
243470|NCT02126579|Freund's Adjuvant|freund's adjuvant
243471|NCT02126579|Metastatic melanoma|metastatic melanoma
243472|NCT02126579|resiquimod|resiquimod
243473|NCT02126579|adjuvants|adjuvants
243474|NCT02126579|peptide vaccine|peptide vaccine
243475|NCT02126566|striae distensiae|striae distensiae
243476|NCT02126553|Leukemia|leukemia
243477|NCT02126553|Acute myeloid leukemia|acute myeloid leukemia
243478|NCT02126553|AML|aml
243479|NCT02126553|Remission|remission
243480|NCT02126553|Lenalidomide|lenalidomide
243481|NCT02126553|CC-5013|cc-5013
243482|NCT02126553|Revlimid|revlimid
243483|NCT02126540|Peripheral Arterial Disease|peripheral arterial disease
243484|NCT02126540|Atherectomy|atherectomy
243485|NCT02126540|Optical Coherence Tomography|optical coherence tomography
243486|NCT02126514|Beta secretase inhibitor|beta secretase inhibitor
243487|NCT02126514|Alzheimer disease|alzheimer disease
243488|NCT02126501|weaning|weaning
243489|NCT02126501|NCPAP|ncpap
243490|NCT02126501|Preterm|preterm
243491|NCT02126501|sudden wean|sudden wean
243492|NCT02126501|gradual pressure off wean|gradual pressure off wean
243493|NCT02126488|treadmill training|treadmill training
243494|NCT02126488|generalization|generalization
243495|NCT02126488|retention|retention
243496|NCT02126475|"parkinson patients ON"|"parkinson patients on"
243497|NCT02126475|"parkinson patients OFF"|"parkinson patients off"
243498|NCT02126475|time estimation|time estimation
243499|NCT02126475|anticipation|anticipation
243500|NCT02126462|Human Hookworm|human hookworm
243501|NCT02126462|Necator americanus|necator americanus
243502|NCT02126462|Hookworm|hookworm
243503|NCT02126462|Hookworm Disease|hookworm disease
243504|NCT02126462|Iron-deficiency anemia|iron-deficiency anemia
243505|NCT02126462|Soil-transmitted helminth infection|soil-transmitted helminth infection
243506|NCT02126462|Neglected Tropical Disease|neglected tropical disease
243507|NCT02126462|Na-APR-1|na-apr-1
243508|NCT02126462|Na-GST-1|na-gst-1
243509|NCT02126436|phantom limb pain|phantom limb pain
243510|NCT02126436|phantom limb sensation|phantom limb sensation
243511|NCT02126436|acupuncture|acupuncture
243512|NCT02126436|randomised controlled trial|randomised controlled trial
243513|NCT02126423|Drug Resistance, Microbial|drug resistance, microbial
243514|NCT02126410|sarcopenia|sarcopenia
243515|NCT02126410|sleep duration|sleep duration
243516|NCT02126410|body composition|body composition
243517|NCT02126410|skeletal muscle|skeletal muscle
243518|NCT02126397|endometrial polyp|endometrial polyp
243519|NCT02126397|resection of endometrial polyps|resection of endometrial polyps
243520|NCT02126397|hysteroscopy|hysteroscopy
243521|NCT02126397|bipolar electrode Versapoint|bipolar electrode versapoint
243522|NCT02126397|Laser Diode|laser diode
243523|NCT02126384|Immunology|immunology
243524|NCT02126384|human|human
243525|NCT02126384|B-lymphocytes subsets|b-lymphocytes subsets
243526|NCT02126384|Antibody-Producing Cells|antibody-producing cells
243527|NCT02126384|23 valent pneumococcal capsular polysaccharide vaccine|23 valent pneumococcal capsular polysaccharide vaccine
243528|NCT02126332|Severe acute pancreatitis|severe acute pancreatitis
243529|NCT02126332|Epidural analgesia|epidural analgesia
243530|NCT02126332|Acute respiratory failure|acute respiratory failure
243531|NCT02126332|Mechanical ventilation|mechanical ventilation
243532|NCT02126332|Intensive Care Unit (ICU)|intensive care unit (icu)
243533|NCT02126319|Cognitive-affective preparation|cognitive-affective preparation
243534|NCT02126319|prostate cancer counseling|prostate cancer counseling
243535|NCT02126280|proinflammatory cytokines|proinflammatory cytokines
243536|NCT02126280|anti-inflammatory cytokines|anti-inflammatory cytokines
243537|NCT02126280|human monocytes|human monocytes
243538|NCT02126280|activation|activation
243539|NCT02126280|biomarkers|biomarkers
243540|NCT02126280|asymptomatic atherosclerosis|asymptomatic atherosclerosis
243541|NCT02126267|periodontal disease|periodontal disease
243542|NCT02126267|therapy|therapy
243543|NCT02126267|anti-bacterial agents|anti-bacterial agents
243544|NCT02126267|Randomized Controlled Trials|randomized controlled trials
243545|NCT02126241|Heart Failure|heart failure
243546|NCT02126241|Cardiac Resyncronization Therapy|cardiac resyncronization therapy
243547|NCT02126241|Optimization|optimization
243548|NCT02126241|Non-invasive cardiac system|non-invasive cardiac system
243549|NCT02126241|Impedance measured cardiac output|impedance measured cardiac output
243550|NCT02126228|antibiotics, cesarean|antibiotics, cesarean
243551|NCT02126215|magnetic resonance imaging|magnetic resonance imaging
243552|NCT02126215|carbon dioxide|carbon dioxide
243553|NCT02126215|abdominal aortic aneurysm|abdominal aortic aneurysm
243554|NCT02126215|post-op delirium|post-op delirium
243555|NCT02126202|Elderly|elderly
243556|NCT02126202|Octogenarians|octogenarians
243557|NCT02126202|PCI|pci
243558|NCT02126202|Myocardial infarction|myocardial infarction
243559|NCT02126202|NSTEMI|nstemi
243560|NCT02126202|Unstable angina pectoris|unstable angina pectoris
243561|NCT02126189|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
243562|NCT02126189|Human Papillomavirus|human papillomavirus
243563|NCT02126189|Aetiology|aetiology
243564|NCT02126189|prevalence|prevalence
243565|NCT02126189|risk factors|risk factors
243566|NCT02126189|clinical outcome|clinical outcome
243567|NCT02126163|Excessive Drinking|excessive drinking
243568|NCT02126163|Hazardous Drinking|hazardous drinking
243569|NCT02126137|HCV|hcv
243570|NCT02126137|Ezetimibe|ezetimibe
243571|NCT02126137|Cholesterol|cholesterol
243572|NCT02126137|Host|host
243573|NCT02126124|Brainsway, dTMS, Deep Transcranial Magnetic Stimulation, Smoking Cessation|brainsway, dtms, deep transcranial magnetic stimulation, smoking cessation
243574|NCT02126098|ANCA-associated vasculitis|anca-associated vasculitis
243575|NCT02126098|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
243576|NCT02126098|Microscopic polyangiitis|microscopic polyangiitis
243577|NCT02126098|Wegner's granulomatosis|wegner's granulomatosis
243578|NCT02126098|Eosinphilic granulomatosis with polyangiitis|eosinphilic granulomatosis with polyangiitis
243579|NCT02126085|ischemic stroke|ischemic stroke
243580|NCT02126085|recanalisation|recanalisation
243581|NCT02126085|sedation|sedation
243582|NCT02126072|Ethanol|ethanol
243583|NCT02126072|Alcohol|alcohol
243584|NCT02126072|Consumption|consumption
243585|NCT02126072|Gut wall integrity|gut wall integrity
243586|NCT02126072|Endotoxemia|endotoxemia
243587|NCT02126059|dementia|dementia
243588|NCT02126059|behavioral and psychological symptoms|behavioral and psychological symptoms
243589|NCT02126059|quality of life|quality of life
243590|NCT02126046|Cord Blood Transplant|cord blood transplant
243591|NCT02126046|Haploidentical HSCT|haploidentical hsct
243592|NCT02126046|Thalassemia major|thalassemia major
243593|NCT02126033|celiac|celiac
243594|NCT02126033|telomere|telomere
243595|NCT02126033|telomerase|telomerase
243596|NCT02126020|Keratoprosthesis|keratoprosthesis
243597|NCT02126020|corneal melt|corneal melt
243598|NCT02126020|keratolysis|keratolysis
243599|NCT02126020|Tumor necrosis factor alpha|tumor necrosis factor alpha
243600|NCT02126020|infliximab|infliximab
243601|NCT02126020|matrix metalloproteinase|matrix metalloproteinase
243602|NCT02126007|fatigue|fatigue
243603|NCT02126007|HIV|hiv
243604|NCT02126007|behavioral intervention|behavioral intervention
243605|NCT02126007|sleep|sleep
243606|NCT02125981|limaprost alfadex|limaprost alfadex
243607|NCT02125981|cervical myelopathy|cervical myelopathy
243608|NCT02125981|surgery|surgery
243609|NCT02125968|chronic low back pain|chronic low back pain
243610|NCT02125968|video game|video game
243611|NCT02125968|therapeutic effects|therapeutic effects
243612|NCT02125955|Pediatric|pediatric
243613|NCT02125955|Overweight|overweight
243614|NCT02125955|Obesity|obesity
243615|NCT02125955|Gut microbiota|gut microbiota
243616|NCT02125955|Adiposity|adiposity
243618|NCT02125955|Dietary fiber|dietary fiber
243619|NCT02125942|Borderline Personality Disorder|borderline personality disorder
243620|NCT02125877|Iron overload|iron overload
243621|NCT02125877|Chelation|chelation
243622|NCT02125877|Thalassemia|thalassemia
243623|NCT02125877|Myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
243624|NCT02125877|Transfusional hemisiderosis|transfusional hemisiderosis
243625|NCT02125877|Deferasirox|deferasirox
243626|NCT02125877|ICL670|icl670
243627|NCT02125877|Dispersible tablet|dispersible tablet
243628|NCT02125877|Film-coated tablet|film-coated tablet
243629|NCT02125864|AMD|amd
243630|NCT02125864|VEGF|vegf
243631|NCT02125864|Aflibercept|aflibercept
243632|NCT02125851|slurry|slurry
243633|NCT02125851|splenda|splenda
243634|NCT02125851|sucralose|sucralose
243635|NCT02125851|budesonide|budesonide
243636|NCT02125851|mucosal contact time|mucosal contact time
243637|NCT02125838|laryngeal mask Supreme|laryngeal mask supreme
243638|NCT02125838|laparoscopic gynecologic surgery|laparoscopic gynecologic surgery
243639|NCT02125838|Laryngeal mask during surgery|laryngeal mask during surgery
243640|NCT02125812|Aggressive Periodontitis|aggressive periodontitis
243641|NCT02125812|antimicrobial(s)|antimicrobial(s)
243642|NCT02125812|microbiology|microbiology
243643|NCT02125773|PrEP|prep
243644|NCT02125773|Risk score|risk score
243645|NCT02125773|Self-perception|self-perception
243646|NCT02125760|Respiratory muscle training|respiratory muscle training
243647|NCT02125760|stroke|stroke
243648|NCT02125760|rehabilitation|rehabilitation
243649|NCT02125747|Respiratory muscle training; high-intensity training|respiratory muscle training; high-intensity training
243650|NCT02125721|cystinuria|cystinuria
243651|NCT02125721|D-penicillamine (Cuprimine®)|d-penicillamine (cuprimine®)
243652|NCT02125721|tiopronin (Thiola®)|tiopronin (thiola®)
243653|NCT02125708|preterm prelabor rupture of membranes|preterm prelabor rupture of membranes
243654|NCT02125708|Ovula Ring|ovula ring
243655|NCT02125708|body-core-temperature|body-core-temperature
243656|NCT02125708|biomarkers|biomarkers
243657|NCT02125708|Single pregnancies|single pregnancies
243658|NCT02125708|PPROM|pprom
243659|NCT02125708|gestation week 22 and 27|gestation week 22 and 27
243660|NCT02125682|HDL|hdl
243661|NCT02125682|Hyperlipidemia|hyperlipidemia
243662|NCT02125682|Diabetes|diabetes
243663|NCT02125682|Inflammation|inflammation
243664|NCT02125669|basal cell carcinoma|basal cell carcinoma
243665|NCT02125669|laser surgery|laser surgery
243666|NCT02125669|pulsed dye laser|pulsed dye laser
243667|NCT02125669|randomized controlled trial|randomized controlled trial
243668|NCT02125643|Exercise-induced muscle damage|exercise-induced muscle damage
243669|NCT02125643|Caffeine|caffeine
243670|NCT02125643|Maximal voluntary strength|maximal voluntary strength
243671|NCT02125630|Metastatic breast carcer|metastatic breast carcer
243672|NCT02125630|Bone metastasis|bone metastasis
243673|NCT02125630|surgery|surgery
243674|NCT02125617|Castration-resistant prostate cancer|castration-resistant prostate cancer
243675|NCT02125617|Abiraterone|abiraterone
243676|NCT02125617|Biomarker|biomarker
243677|NCT02125617|Urokinase Plasminogen Activator Receptor|urokinase plasminogen activator receptor
243678|NCT02125617|Plasma|plasma
243679|NCT02125617|Predictive markers|predictive markers
243680|NCT02125604|Gastrointestinal event|gastrointestinal event
243681|NCT02125591|Mild Traumatic Brain Injury|mild traumatic brain injury
243682|NCT02125565|Arterial|arterial
243683|NCT02125565|Blood|blood
243684|NCT02125565|Gas|gas
243685|NCT02125565|Needle|needle
243686|NCT02125565|Pain|pain
243687|NCT02125565|Local|local
243688|NCT02125565|Anaesthesia|anaesthesia
243689|NCT02125565|Anaesthetic|anaesthetic
243690|NCT02125552|vascular access device|vascular access device
243691|NCT02125552|ultrasonography|ultrasonography
243692|NCT02125539|Online adolescent substance abuse relapse prevention program|online adolescent substance abuse relapse prevention program
243693|NCT02125526|Acute myocardial infarction|acute myocardial infarction
243694|NCT02125526|Persisting ischemia|persisting ischemia
243695|NCT02125526|No reflow|no reflow
243696|NCT02125526|Intra-aortic balloon pump|intra-aortic balloon pump
243697|NCT02125526|Exhausted autoregulation|exhausted autoregulation
243698|NCT02125513|neoadjuvant chemotherapy|neoadjuvant chemotherapy
243699|NCT02125513|ovarian cancer|ovarian cancer
243700|NCT02125513|fallopian tube carcinoma|fallopian tube carcinoma
243701|NCT02125513|peritoneal carcinoma|peritoneal carcinoma
243702|NCT02125513|randomized study|randomized study
243703|NCT02125500|HCV/HIV coinfection|hcv/hiv coinfection
243704|NCT02125500|HCV genotype 1|hcv genotype 1
243705|NCT02125487|Clinical Breast Examination|clinical breast examination
243706|NCT02125487|Breast Cancer detection|breast cancer detection
243707|NCT02125487|Breast Simulator|breast simulator
243708|NCT02125487|Hybrid Simulation|hybrid simulation
243709|NCT02125487|Patient Simulation|patient simulation
243710|NCT02125487|Standardized Patient|standardized patient
243711|NCT02125487|Medical student education|medical student education
243712|NCT02125487|Health Communication|health communication
243713|NCT02125487|Communication Barriers|communication barriers
243714|NCT02125487|Cultural competency|cultural competency
243715|NCT02125487|Cultural|cultural
243716|NCT02125487|Middle East|middle east
243717|NCT02125487|Lebanon|lebanon
243718|NCT02125474|Neuroendocrine Tumors|neuroendocrine tumors
243719|NCT02125474|Lutetium|lutetium
243720|NCT02125474|Treatment Outcome|treatment outcome
243721|NCT02125461|Locally advanced|locally advanced
243722|NCT02125461|Unresectable Non-Small Cell Lung Cancer|unresectable non-small cell lung cancer
243723|NCT02125461|MEDI4736|medi4736
243724|NCT02125461|PD-L1|pd-l1
243725|NCT02125461|Stage III Non-Small Cell Lung Cancer|stage iii non-small cell lung cancer
243726|NCT02125461|Chemoradiation|chemoradiation
243727|NCT02125461|Immune-mediated cancer therapy|immune-mediated cancer therapy
243728|NCT02125448|Esophageal cancer|esophageal cancer
243729|NCT02125448|MRI|mri
243730|NCT02125448|PET-CT|pet-ct
243731|NCT02125448|Response assessment|response assessment
243732|NCT02125435|Healthy subjects|healthy subjects
243733|NCT02125435|ASP2408|asp2408
243734|NCT02125435|pharmacokinetics|pharmacokinetics
243735|NCT02125396|hepatocellular carcinoma|hepatocellular carcinoma
243736|NCT02125396|liver cancer|liver cancer
243737|NCT02125396|transarterial chemoembolization|transarterial chemoembolization
243738|NCT02125396|radiotherapy|radiotherapy
243739|NCT02125396|adjuvant therapy|adjuvant therapy
243740|NCT02125383|Parkinson's disease|parkinson's disease
243741|NCT02125383|Transcranial direct current stimulation|transcranial direct current stimulation
243742|NCT02125357|sequencing|sequencing
243743|NCT02125357|abiraterone|abiraterone
243744|NCT02125357|enzalutamide|enzalutamide
243745|NCT02125357|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
243746|NCT02125357|randomized|randomized
243747|NCT02125331|Blood Pressure|blood pressure
243748|NCT02125318|myeloproliferative neoplasm|myeloproliferative neoplasm
243749|NCT02125318|chronic myelogenous leukemia|chronic myelogenous leukemia
243750|NCT02125318|polycythemia vera|polycythemia vera
243751|NCT02125318|primary myelofibrosis|primary myelofibrosis
243752|NCT02125318|essential thrombocythemia|essential thrombocythemia
243753|NCT02125318|anagrelide|anagrelide
243754|NCT02125318|thrombocytosis|thrombocytosis
243755|NCT02125318|GALE-401|gale-401
243756|NCT02125305|Metformin|metformin
243757|NCT02125305|Pharmacokinetics/ Pharmacodynamics|pharmacokinetics/ pharmacodynamics
243758|NCT02125214|consciousness, anesthesia, electroencephalogram, microstate, long-range dependency|consciousness, anesthesia, electroencephalogram, microstate, long-range dependency
243759|NCT02125201|intranasal fentanyl|intranasal fentanyl
243760|NCT02125201|newborn|newborn
243761|NCT02125162|BCX4161|bcx4161
243762|NCT02125162|BioCryst|biocryst
243763|NCT02125162|hereditary angioedema|hereditary angioedema
243764|NCT02125162|relative bioavailability|relative bioavailability
243765|NCT02125162|kallikrein inhibitor|kallikrein inhibitor
243766|NCT02125149|pregnancy|pregnancy
243767|NCT02125149|obese|obese
243768|NCT02125136|unresectable|unresectable
243769|NCT02125136|borderline resectable|borderline resectable
243770|NCT02125110|neurotoxicants|neurotoxicants
243771|NCT02125110|MRI|mri
243772|NCT02125110|developing brain|developing brain
243773|NCT02125097|Intracranial Aneurysm Treatment|intracranial aneurysm treatment
243774|NCT02125097|Endovascular Therapy|endovascular therapy
243775|NCT02125084|Metastatic Prostate Cancer|metastatic prostate cancer
243776|NCT02125084|Castrate-resistant|castrate-resistant
243777|NCT02125084|Enzalutamide|enzalutamide
243778|NCT02125084|Everolimus|everolimus
243779|NCT02125058|intracutaneous sutures|intracutaneous sutures
243780|NCT02125058|transcutaneous sutures|transcutaneous sutures
243781|NCT02125058|dermatological surgery|dermatological surgery
243782|NCT02125058|facial area|facial area
243783|NCT02125045|GSH|gsh
243784|NCT02125045|cardiovascular risk factors|cardiovascular risk factors
243785|NCT02125045|endothelial dysfunction|endothelial dysfunction
243786|NCT02125045|oxidative stress|oxidative stress
243787|NCT02125019|Breast Cancer|breast cancer
243788|NCT02125019|Taxane|taxane
243789|NCT02125019|Gait|gait
243790|NCT02125019|Men|men
243791|NCT02125019|Women|women
243792|NCT02125006|Mindfulness|mindfulness
243793|NCT02125006|Breast Cancer|breast cancer
243794|NCT02125006|Painful Neuropathy|painful neuropathy
243795|NCT02125006|Chronic Pain|chronic pain
243796|NCT02125006|fMRI|fmri
243797|NCT02125006|Disability|disability
243798|NCT02125006|Quality of Life|quality of life
243799|NCT02125006|Cytokines|cytokines
243800|NCT02125006|Cortisol|cortisol
243801|NCT02124993|Gastrectomy|gastrectomy
243802|NCT02124980|Opioid Substitution Treatment|opioid substitution treatment
243803|NCT02124980|Cognitive Behavioral Therapy|cognitive behavioral therapy
243804|NCT02124980|Mobile Health|mobile health
243805|NCT02124928|stroke|stroke
243806|NCT02124928|biomarkers|biomarkers
243807|NCT02124928|vulnerable plaque|vulnerable plaque
243808|NCT02124928|carotid endarterectomy|carotid endarterectomy
243809|NCT02124928|carotid artery disease|carotid artery disease
243810|NCT02124915|prosthetic socket|prosthetic socket
243811|NCT02124915|amputee|amputee
243812|NCT02124889|bariatric surgery|bariatric surgery
243813|NCT02124889|multivitamin|multivitamin
243814|NCT02124889|weight loss|weight loss
243815|NCT02124889|adherence|adherence
243816|NCT02124876|amputee|amputee
243817|NCT02124876|prosthetics|prosthetics
243818|NCT02124837|lunch breaks, recovery, nature, park walking, relaxation|lunch breaks, recovery, nature, park walking, relaxation
243819|NCT02124811|Schizophrenia|schizophrenia
243820|NCT02124811|Clozapine|clozapine
243821|NCT02124811|Minocycline|minocycline
243822|NCT02124798|Subcutaneous|subcutaneous
243823|NCT02124798|Autoinjector|autoinjector
243824|NCT02124798|Belimumab|belimumab
243825|NCT02124798|Real-Life Use Study|real-life use study
243826|NCT02124798|Reliability|reliability
243827|NCT02124785|Long-term persistence|long-term persistence
243828|NCT02124785|Havrix|havrix
243829|NCT02124785|Hepatitis A|hepatitis a
243830|NCT02124772|v600-mutation|v600-mutation
243831|NCT02124772|neuroblastoma|neuroblastoma
243832|NCT02124772|Trametinib|trametinib
243833|NCT02124772|pediatrics|pediatrics
243834|NCT02124772|Langerhans Cell Histiocytosis|langerhans cell histiocytosis
243835|NCT02124772|low grade glioma plexiform neurofibromas|low grade glioma plexiform neurofibromas
243836|NCT02124746|Primary Myelofibrosis|primary myelofibrosis
243837|NCT02124746|Post Polycythemia Vera Myelofibrosis|post polycythemia vera myelofibrosis
243838|NCT02124746|Post Essential Thrombocythemia Myelofibrosis|post essential thrombocythemia myelofibrosis
243839|NCT02124746|Polycythemia Vera|polycythemia vera
243840|NCT02124746|Essential Thrombocythemia|essential thrombocythemia
243841|NCT02124746|blood disorders|blood disorders
243842|NCT02124733|Actinic Keratosis|actinic keratosis
243843|NCT02124733|Actinic Keratoses|actinic keratoses
243844|NCT02124733|AK|ak
243845|NCT02124733|PDT|pdt
243846|NCT02124733|Photodynamic Therapy|photodynamic therapy
243847|NCT02124733|Blue Light Therapy|blue light therapy
243848|NCT02124733|ALA|ala
243849|NCT02124733|aminolevulinic acid|aminolevulinic acid
243850|NCT02124733|Levulan|levulan
243851|NCT02124720|Autism spectrum disorders|autism spectrum disorders
243852|NCT02124720|Stereotypy|stereotypy
243853|NCT02124720|Repetitive behavior|repetitive behavior
243854|NCT02124707|Head and neck cancer|head and neck cancer
243855|NCT02124707|Squamous cell carcinoma|squamous cell carcinoma
243856|NCT02124707|Metastatic|metastatic
243857|NCT02124707|Recurrent|recurrent
243858|NCT02124707|Phase II|phase ii
243859|NCT02124707|Carboplatin|carboplatin
243860|NCT02124707|Paclitaxel|paclitaxel
243861|NCT02124707|Cetuximab|cetuximab
243862|NCT02124694|historical trauma and unresolved grief|historical trauma and unresolved grief
243863|NCT02124694|complicated grief|complicated grief
243864|NCT02124694|prolonged grief|prolonged grief
243865|NCT02124694|interpersonal conflicts|interpersonal conflicts
243866|NCT02124694|depression|depression
243867|NCT02124694|American Indians|american indians
243868|NCT02124694|interpersonal psychotherapy|interpersonal psychotherapy
243869|NCT02124694|traumatic grief|traumatic grief
243870|NCT02124694|posttraumatic stress disorder|posttraumatic stress disorder
243871|NCT02124668|Xtandi|xtandi
243872|NCT02124668|MDV3100|mdv3100
243873|NCT02124668|Progressive Castration-Resistant Prostate Cancer|progressive castration-resistant prostate cancer
243874|NCT02124668|Enzalutamide|enzalutamide
243875|NCT02124655|Biofilms|biofilms
243876|NCT02124655|Chlorhexidine|chlorhexidine
243877|NCT02124655|Microscopy, confocal|microscopy, confocal
243878|NCT02124655|Dental plaque|dental plaque
243879|NCT02124655|Mouthwashes|mouthwashes
243880|NCT02124642|Folate requirements|folate requirements
243881|NCT02124642|Pregnancy|pregnancy
243882|NCT02124642|Folic acid|folic acid
243883|NCT02124642|DNA methylation|dna methylation
243884|NCT02124642|Folate biomarkers|folate biomarkers
243885|NCT02124616|spinal muscular atrophy|spinal muscular atrophy
243886|NCT02124616|Muscular dystrophy|muscular dystrophy
243887|NCT02124616|Muscle diseases|muscle diseases
243888|NCT02124616|myasthenic syndromes|myasthenic syndromes
243889|NCT02124616|Polyneuropathies|polyneuropathies
243890|NCT02124616|Myopathies|myopathies
243891|NCT02124603|cataract|cataract
243892|NCT02124603|prophylaxis|prophylaxis
243893|NCT02124603|susceptibility|susceptibility
243894|NCT02124590|Carnitine|carnitine
243895|NCT02124590|Acylcarnitine|acylcarnitine
243896|NCT02124590|Exercise|exercise
243897|NCT02124590|Exercise Intensity|exercise intensity
243898|NCT02124590|Insulin Sensitivity|insulin sensitivity
243899|NCT02124564|Lacosamide|lacosamide
243900|NCT02124564|Epilepsy|epilepsy
243901|NCT02124564|Focal, Partial-Onset Seizures with or without secondary generalization|focal, partial-onset seizures with or without secondary generalization
243902|NCT02124564|Monotherapy|monotherapy
243903|NCT02124551|Goal-directed fluid therapy|goal-directed fluid therapy
243904|NCT02124512|obese|obese
243905|NCT02124512|insulin resistance|insulin resistance
243906|NCT02124512|metabolic syndrome|metabolic syndrome
243907|NCT02124499|anesthesia recovery period|anesthesia recovery period
243908|NCT02124499|postoperative complications|postoperative complications
243909|NCT02124499|pain|pain
243910|NCT02124499|pain measurement|pain measurement
243911|NCT02124499|postoperative nausea and vomiting|postoperative nausea and vomiting
243912|NCT02124499|quality of life|quality of life
243913|NCT02124499|genetic association study|genetic association study
243914|NCT02124486|IIH|iih
243915|NCT02124486|Weight loss|weight loss
243916|NCT02124486|Bariatric surgery|bariatric surgery
243917|NCT02124473|Resistant hypertension|resistant hypertension
243918|NCT02124473|Homeopathy|homeopathy
243919|NCT02124473|Blood pressure|blood pressure
243920|NCT02124473|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
243921|NCT02124460|Pediatric|pediatric
243922|NCT02124460|Obesity|obesity
243923|NCT02124460|Overweight|overweight
243924|NCT02124460|Intervention|intervention
243925|NCT02124434|Laparoscopic Sleeve Gastrectomy surgery|laparoscopic sleeve gastrectomy surgery
243926|NCT02124421|Ovarian cancer|ovarian cancer
243927|NCT02124421|Cytoreductive surgery|cytoreductive surgery
243928|NCT02124421|Hyperthermic Intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
243929|NCT02124421|Systemic chemotherapy|systemic chemotherapy
243930|NCT02124421|Primary peritoneal carcinoma|primary peritoneal carcinoma
243931|NCT02124421|Fallopian Tube cancer|fallopian tube cancer
243932|NCT02124421|Intraperitoneal chemotherapy|intraperitoneal chemotherapy
243933|NCT02124421|IV/IP chemotherapy|iv/ip chemotherapy
243934|NCT02124421|IV chemotherapy|iv chemotherapy
243935|NCT02124382|liver failure|liver failure
243936|NCT02124382|liver malignancy|liver malignancy
243937|NCT02124382|metabolic diseases|metabolic diseases
243938|NCT02124382|Pediatric liver transplanted recipients and their healthy donors|pediatric liver transplanted recipients and their healthy donors
243939|NCT02124369|Pancreatic cancer|pancreatic cancer
243940|NCT02124369|locally advanced|locally advanced
243941|NCT02124369|unresectable|unresectable
243942|NCT02124343|Neutrophil|neutrophil
243943|NCT02124343|Exercise|exercise
243944|NCT02124343|COPD|copd
243945|NCT02124343|Pulmonary Rehabilitation|pulmonary rehabilitation
243946|NCT02124330|Montmorillonite, proteic diet, in vitro and in vivo models|montmorillonite, proteic diet, in vitro and in vivo models
243947|NCT02124317|nanoparticle albumin-bound paclitaxel|nanoparticle albumin-bound paclitaxel
243948|NCT02124317|S-1|s-1
243949|NCT02124317|advanced pancreatic cancer|advanced pancreatic cancer
243950|NCT02124317|objective response rate|objective response rate
243951|NCT02124304|Sternocleidomastoid|sternocleidomastoid
243952|NCT02124304|Neck pain|neck pain
243953|NCT02124304|EMG|emg
243954|NCT02124304|Perceived Exertion|perceived exertion
243955|NCT02124304|Thera-Band|thera-band
243956|NCT02124304|Cervical Paraspinals|cervical paraspinals
243957|NCT02124291|In Vitro Fertilization|in vitro fertilization
243958|NCT02124291|Vitrification|vitrification
243959|NCT02124291|Frozen Embryo|frozen embryo
243960|NCT02124291|Assisted Hatching|assisted hatching
243961|NCT02124291|Pregnancy Rate|pregnancy rate
243962|NCT02124278|Single ascending dose|single ascending dose
243963|NCT02124278|Safety and tolerability in healthy subjects|safety and tolerability in healthy subjects
243964|NCT02124265|Oral Rehydration Therapy|oral rehydration therapy
243965|NCT02124252|cervical cancer screening|cervical cancer screening
243966|NCT02124252|human papillomavirus testing|human papillomavirus testing
243967|NCT02124252|Kenya|kenya
243968|NCT02124252|implementation science|implementation science
243969|NCT02124226|Chronic severe asthma, immunomodulation, methotrexate, steroids, omalizumab|chronic severe asthma, immunomodulation, methotrexate, steroids, omalizumab
243970|NCT02124213|Receptor Occupancy|receptor occupancy
243971|NCT02124213|PET|pet
243972|NCT02124213|D1 Receptor Agonist|d1 receptor agonist
243973|NCT02124174|acute myelogenous leukemia (AML)|acute myelogenous leukemia (aml)
243974|NCT02124174|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
244347|NCT02122471|Chronic Constipation|chronic constipation
243975|NCT02124161|Pneumococcal polysaccharide vaccine|pneumococcal polysaccharide vaccine
243976|NCT02124161|13-valent pneumococcal conjugate vaccine|13-valent pneumococcal conjugate vaccine
243977|NCT02124161|invasive pneumococcal disease|invasive pneumococcal disease
243978|NCT02124161|flu vaccine|flu vaccine
243979|NCT02124148|cancer|cancer
243980|NCT02124135|Nutrition|nutrition
243981|NCT02124122|Focus|focus
243982|NCT02124122|safety|safety
243983|NCT02124109|Rheumatic Fever|rheumatic fever
243984|NCT02124109|Acquired Heart Disease|acquired heart disease
243985|NCT02124109|Rheumatic Heart Disease|rheumatic heart disease
243986|NCT02124109|Endomyocardial Fibrosis|endomyocardial fibrosis
243987|NCT02124096|Zoonotic|zoonotic
243988|NCT02124096|Influenza|influenza
243989|NCT02124096|Infections|infections
243990|NCT02124096|Ohio|ohio
243991|NCT02124096|Fairs|fairs
243992|NCT02124083|Niemann Pick Disease, Type C1|niemann pick disease, type c1
243993|NCT02124083|Phase I, Phase 2|phase i, phase 2
243994|NCT02124083|Vorinostat|vorinostat
243995|NCT02124070|Cystinosis|cystinosis
243996|NCT02124070|Myopathy|myopathy
243997|NCT02124070|Recombiant Growth Hormone|recombiant growth hormone
243998|NCT02124057|Liver|liver
243999|NCT02124057|Motor Neuron Disease|motor neuron disease
244000|NCT02124044|Coinfection|coinfection
244001|NCT02124044|HCV Genotype 1b|hcv genotype 1b
244002|NCT02124044|Interferon Free therapy|interferon free therapy
244003|NCT02124044|Liver Biopsy|liver biopsy
244004|NCT02124044|Virological Response|virological response
244005|NCT02124031|Osteoarthritis|osteoarthritis
244006|NCT02124031|Rheumatoid Arthritis|rheumatoid arthritis
244007|NCT02124031|Disability|disability
244008|NCT02124031|Joint function|joint function
244009|NCT02124018|Myocardial infarction|myocardial infarction
244010|NCT02124018|Risk stratification|risk stratification
244011|NCT02124018|Sudden cardiac death|sudden cardiac death
244012|NCT02124018|Preserved ejection fraction|preserved ejection fraction
244013|NCT02124018|Programmed ventricular stimulation|programmed ventricular stimulation
244014|NCT02124005|Knee surgery|knee surgery
244015|NCT02124005|Femoral block|femoral block
244016|NCT02124005|Bupivacaine|bupivacaine
244017|NCT02124005|Ultrasound|ultrasound
244018|NCT02123966|Chronic Graft-versus-Host-Disease|chronic graft-versus-host-disease
244019|NCT02123966|Oral mucosal disease|oral mucosal disease
244020|NCT02123953|Drug therapy|drug therapy
244021|NCT02123940|Weaning from mechanical ventilation|weaning from mechanical ventilation
244022|NCT02123940|Lung ultrasound|lung ultrasound
244023|NCT02123940|Nasal humidified high flow therapy|nasal humidified high flow therapy
244024|NCT02123940|Weaning failure|weaning failure
244025|NCT02123940|Postextubation distress|postextubation distress
244026|NCT02123927|Drug therapy|drug therapy
244027|NCT02123914|Exercise training|exercise training
244028|NCT02123914|Allergic rhinitis|allergic rhinitis
244029|NCT02123914|Vitamin C|vitamin c
244030|NCT02123914|Cytokine|cytokine
244031|NCT02123914|Rhinitis symptoms|rhinitis symptoms
244032|NCT02123901|Mind and body Exercise|mind and body exercise
244033|NCT02123901|Flow mediated dilation|flow mediated dilation
244034|NCT02123901|Diabetes|diabetes
244035|NCT02123888|Prostate|prostate
244036|NCT02123888|Lung|lung
244037|NCT02123862|Prostate Cancer|prostate cancer
244038|NCT02123862|Breast Cancer|breast cancer
244039|NCT02123862|Colorectal Cancer|colorectal cancer
244040|NCT02123862|Colon Cancer|colon cancer
244041|NCT02123862|Rectal Cancer|rectal cancer
244042|NCT02123862|Cancer|cancer
244043|NCT02123862|Solid Tumor|solid tumor
244044|NCT02123862|Metastatic|metastatic
244045|NCT02123862|Circulating Tumor Cells|circulating tumor cells
244046|NCT02123810|fatigue|fatigue
244047|NCT02123810|motor skills|motor skills
244048|NCT02123810|cardiopulmonary resuscitation|cardiopulmonary resuscitation
244049|NCT02123784|Rotator Cuff Tear|rotator cuff tear
244050|NCT02123784|Rotator Cuff Repair|rotator cuff repair
244051|NCT02123784|Biomarker|biomarker
244052|NCT02123784|Predictive factors|predictive factors
244053|NCT02123784|Skeletal Muscle|skeletal muscle
244054|NCT02123784|Tendon|tendon
244055|NCT02123784|Subacromial Bursa|subacromial bursa
244056|NCT02123771|Focus of Study : HELICOBACTER PYLORI INFECTIONS|focus of study : helicobacter pylori infections
244057|NCT02123758|Prostatic Neoplasms|prostatic neoplasms
244058|NCT02123758|Metastatic Castration-Resistant Prostate Cancer (mCRPC)|metastatic castration-resistant prostate cancer (mcrpc)
244059|NCT02123758|Prostate cancer|prostate cancer
244060|NCT02123758|Abiraterone Acetate (ZYTIGA)|abiraterone acetate (zytiga)
244061|NCT02123758|Prednisone|prednisone
244062|NCT02123758|JNJ-56021927|jnj-56021927
244063|NCT02123745|infiltration|infiltration
244064|NCT02123745|extravasation|extravasation
244065|NCT02123745|peripheral intravenous therapy|peripheral intravenous therapy
244066|NCT02123732|Diabetes|diabetes
244067|NCT02123732|Diabetes Mellitus|diabetes mellitus
244068|NCT02123732|Herbal|herbal
244069|NCT02123732|food supplement|food supplement
244070|NCT02123693|Osteopathic manipulative treatment|osteopathic manipulative treatment
244071|NCT02123693|Low back pain|low back pain
244072|NCT02123693|Dynamic MRI|dynamic mri
244073|NCT02123680|expectation|expectation
244074|NCT02123680|chronic illness|chronic illness
244075|NCT02123680|trajectory|trajectory
244076|NCT02123628|diabetic foot osteomyelitis, antibiotic treatment duration|diabetic foot osteomyelitis, antibiotic treatment duration
244077|NCT02123615|Primary Immunodeficiency|primary immunodeficiency
244078|NCT02123615|Subdermal bloodless space|subdermal bloodless space
244079|NCT02123615|Subdermal injection|subdermal injection
244080|NCT02123615|Subcutaneous injection|subcutaneous injection
244081|NCT02123615|Injectable electromyography needle|injectable electromyography needle
244082|NCT02123615|Electrical stimulation|electrical stimulation
244083|NCT02123615|MRI with Gadolinium|mri with gadolinium
244084|NCT02123602|patellofemoral pain syndrome|patellofemoral pain syndrome
244085|NCT02123602|abdominal muscles|abdominal muscles
244086|NCT02123576|Hepatorenal syndrome|hepatorenal syndrome
244087|NCT02123576|Renal failure|renal failure
244088|NCT02123576|Pentoxyfylline|pentoxyfylline
244089|NCT02123576|Liver transplantation|liver transplantation
244090|NCT02123576|Cirrhosis|cirrhosis
244091|NCT02123550|deep|deep
244092|NCT02123550|venous|venous
244093|NCT02123550|thrombosis|thrombosis
244094|NCT02123550|Doppler|doppler
244095|NCT02123550|ultrasound|ultrasound
244096|NCT02123550|plastic|plastic
244097|NCT02123550|surgery|surgery
244098|NCT02123550|thromboembolism|thromboembolism
244099|NCT02123550|prevention|prevention
244100|NCT02123537|Bioness L300 Foot Drop System|bioness l300 foot drop system
244101|NCT02123537|Functional electrical stimulation|functional electrical stimulation
244102|NCT02123524|Superficial Vein Thrombosis|superficial vein thrombosis
244103|NCT02123498|ear pressure|ear pressure
244104|NCT02123498|ear fullness|ear fullness
244105|NCT02123498|ear pain|ear pain
244106|NCT02123498|ETD|etd
244107|NCT02123498|laryngopharyngeal reflux|laryngopharyngeal reflux
244108|NCT02123498|LPR|lpr
244109|NCT02123498|gastroesophageal reflux disease|gastroesophageal reflux disease
244110|NCT02123498|GERD|gerd
244111|NCT02123498|nasopharyngeal reflux|nasopharyngeal reflux
244112|NCT02123498|acid reflux|acid reflux
244113|NCT02123485|Depression,|depression,
244114|NCT02123485|ECT,|ect,
244115|NCT02123485|rTMS,|rtms,
244116|NCT02123485|Right prefrontal,|right prefrontal,
244117|NCT02123485|antidepressive efficacy|antidepressive efficacy
244118|NCT02123485|Inflammation markers|inflammation markers
244119|NCT02123433|HIV|hiv
244120|NCT02123433|Streptococcus pneumoniae|streptococcus pneumoniae
244121|NCT02123433|13-valent conjugate pneumococcal vaccine|13-valent conjugate pneumococcal vaccine
244122|NCT02123433|Vaccine|vaccine
244123|NCT02123433|Immunological Response|immunological response
244124|NCT02123433|Pneumococcal Carriage|pneumococcal carriage
244125|NCT02123420|Platform Switching vs Regular Platform|platform switching vs regular platform
244126|NCT02123407|Advanced Gastric Cancer|advanced gastric cancer
244127|NCT02123407|Carbon Nanoparticles|carbon nanoparticles
244128|NCT02123407|Lymph Nodes|lymph nodes
244129|NCT02123394|Low Back Pain|low back pain
244130|NCT02123394|Mechanical Low Back Pain|mechanical low back pain
244131|NCT02123394|Low Back Ache|low back ache
244132|NCT02123394|Low Backache|low backache
244133|NCT02123394|Lower Back Pain|lower back pain
244134|NCT02123394|Lumbago|lumbago
244135|NCT02123381|tumor tissue and serum biomarkers|tumor tissue and serum biomarkers
244136|NCT02123381|cetuximab|cetuximab
244137|NCT02123381|preoperative radiotherapy|preoperative radiotherapy
244138|NCT02123381|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
244139|NCT02123368|Osteoarthritis|osteoarthritis
244140|NCT02123368|Mesenchimal stem cell|mesenchimal stem cell
244141|NCT02123368|Knee|knee
244142|NCT02123342|health|health
244143|NCT02123342|older adults|older adults
244144|NCT02123342|mobile phone|mobile phone
244145|NCT02123329|Qatar|qatar
244146|NCT02123329|Pharmacy|pharmacy
244147|NCT02123329|Pharmacist|pharmacist
244148|NCT02123329|Smoking cessation|smoking cessation
244149|NCT02123316|local allergic rhinitis|local allergic rhinitis
244150|NCT02123316|subcutaneous immunotherapy|subcutaneous immunotherapy
244151|NCT02123316|house dust mite allergy|house dust mite allergy
244152|NCT02123316|Dermatophagoides pteronyssinus allergy|dermatophagoides pteronyssinus allergy
244153|NCT02123303|Hypotension, Orthostatic Hypotension|hypotension, orthostatic hypotension
244154|NCT02123290|Plasmodium|plasmodium
244155|NCT02123290|falciparum|falciparum
244156|NCT02123290|malaria|malaria
244157|NCT02123290|vivax|vivax
244158|NCT02123290|DSM265|dsm265
244159|NCT02123290|pharmacokinetics|pharmacokinetics
244160|NCT02123290|adult|adult
244161|NCT02123251|Incentives,|incentives,
244162|NCT02123251|Diabetes,|diabetes,
244163|NCT02123251|Medicaid,|medicaid,
244164|NCT02123251|Health behavior,|health behavior,
244165|NCT02123251|Cost effectiveness|cost effectiveness
244166|NCT02123225|STOP-BANG|stop-bang
244167|NCT02123225|Obstructive sleep apnea (OSA)|obstructive sleep apnea (osa)
244168|NCT02123225|total knee arthroplasty (TKA)|total knee arthroplasty (tka)
244169|NCT02123225|portable monitoring|portable monitoring
244170|NCT02123225|sleep medicine|sleep medicine
244171|NCT02123225|unattended sleep study|unattended sleep study
244172|NCT02123225|postoperative sleep study|postoperative sleep study
244173|NCT02123212|Hepatitis C|hepatitis c
244174|NCT02123212|Chronic Hepatitis C|chronic hepatitis c
244175|NCT02123212|Screening|screening
244176|NCT02123199|COPD|copd
244177|NCT02123186|Newborn Screening , spinal muscular atrophy|newborn screening , spinal muscular atrophy
244178|NCT02123173|one lung ventilation,|one lung ventilation,
244179|NCT02123173|cardiac output|cardiac output
244180|NCT02123173|fluid responsiveness|fluid responsiveness
244181|NCT02123160|Depression|depression
244182|NCT02123160|Dyadic therapy|dyadic therapy
244183|NCT02123160|Behavioral Problems|behavioral problems
244184|NCT02123160|Child parent therapy|child parent therapy
244185|NCT02123160|Affect regulation|affect regulation
244186|NCT02123160|Immune markers|immune markers
244187|NCT02123160|Cortisol|cortisol
244188|NCT02123121|Aging|aging
244189|NCT02123121|Biogenesis|biogenesis
244190|NCT02123121|Cell Respiration|cell respiration
244191|NCT02123121|Elderly|elderly
244192|NCT02123121|Enzymes|enzymes
244193|NCT02123121|Mitochondria|mitochondria
244194|NCT02123121|Mitochondrial DNA|mitochondrial dna
244195|NCT02123121|Muscle Fatigue|muscle fatigue
244196|NCT02123121|Physical Function|physical function
244197|NCT02123121|Resveratrol|resveratrol
244198|NCT02123108|Simulect, Myfortic, OLT, Renal Dysfunction, Liver Transplant, Orthotopic Liver Transplantation|simulect, myfortic, olt, renal dysfunction, liver transplant, orthotopic liver transplantation
244199|NCT02123082|Urolithiasis|urolithiasis
244200|NCT02123082|Kidney stones|kidney stones
244201|NCT02123082|Ureteral Obstruction|ureteral obstruction
244202|NCT02123082|Ureteroscopes|ureteroscopes
244203|NCT02123082|Ureteroscopies|ureteroscopies
244204|NCT02123069|Autonomic nervous system|autonomic nervous system
244205|NCT02123069|Blood pressure|blood pressure
244206|NCT02123069|Blood vessels|blood vessels
244207|NCT02123069|Physiological effects of drugs|physiological effects of drugs
244208|NCT02123069|Vascular stiffness|vascular stiffness
244209|NCT02123056|reflex fainting|reflex fainting
244210|NCT02123056|vasovagal syncope|vasovagal syncope
244211|NCT02123056|metoprolol|metoprolol
244212|NCT02123056|randomized clinical trial|randomized clinical trial
244213|NCT02123056|quality of life|quality of life
244214|NCT02123043|rehabilitation|rehabilitation
244215|NCT02123043|wheelchair|wheelchair
244216|NCT02123043|older adults|older adults
244217|NCT02123043|manual wheelchair|manual wheelchair
244218|NCT02123043|motor learning|motor learning
244219|NCT02123043|biomechanics|biomechanics
244220|NCT02123043|gross mechanical efficiency|gross mechanical efficiency
244221|NCT02123030|Lung cancer|lung cancer
244222|NCT02123030|pulmonary disease|pulmonary disease
244223|NCT02123017|Bowel Evacuation|bowel evacuation
244224|NCT02123017|Colonoscopy Preparation|colonoscopy preparation
244225|NCT02123004|ST-Segment Elevation Myocardial Infarction|st-segment elevation myocardial infarction
244226|NCT02123004|Percutaneous Coronary Intervention|percutaneous coronary intervention
244227|NCT02122991|spinal cord injury|spinal cord injury
244228|NCT02122991|autonomic dysreflexia|autonomic dysreflexia
244229|NCT02122991|baroreceptor integrity|baroreceptor integrity
244230|NCT02122991|sympathetic integrity|sympathetic integrity
244231|NCT02122991|vagal integrity|vagal integrity
244232|NCT02122991|autonomic integrity|autonomic integrity
244233|NCT02122991|arterial stiffness|arterial stiffness
244234|NCT02122991|cognitive function|cognitive function
244235|NCT02122991|traumatic brain injury|traumatic brain injury
244236|NCT02122991|cerebral blood flow|cerebral blood flow
244237|NCT02122978|psoriasis|psoriasis
244238|NCT02122978|dermatology|dermatology
244239|NCT02122978|mindfulness|mindfulness
244240|NCT02122978|self-compassion|self-compassion
244241|NCT02122952|Gene Transfer|gene transfer
244242|NCT02122952|Gene Therapy|gene therapy
244243|NCT02122952|Adeno-associated virus|adeno-associated virus
244244|NCT02122952|Survival Motor Neuron|survival motor neuron
244245|NCT02122952|SMN|smn
244246|NCT02122952|AAV9|aav9
244247|NCT02122926|Transitions in care|transitions in care
244248|NCT02122926|discharge intervention|discharge intervention
244249|NCT02122926|RCT|rct
244250|NCT02122926|readmission rates|readmission rates
244251|NCT02122926|medication adherence|medication adherence
244252|NCT02122926|glycemic control|glycemic control
244253|NCT02122926|ED visits|ed visits
244254|NCT02122926|medication reconciliation|medication reconciliation
244255|NCT02122926|Coleman Transitions Coach|coleman transitions coach
244256|NCT02122926|telemonitoring; hypoglycemic events|telemonitoring; hypoglycemic events
244257|NCT02122913|TRK|trk
244258|NCT02122913|TRKA|trka
244259|NCT02122913|TRKB|trkb
244260|NCT02122913|TRKC|trkc
244261|NCT02122913|NTRK1|ntrk1
244262|NCT02122913|NTRK2|ntrk2
244263|NCT02122913|NTRK3|ntrk3
244264|NCT02122913|larotrectinib|larotrectinib
244265|NCT02122913|NTRK fusion positive|ntrk fusion positive
244266|NCT02122913|NTRK gene rearrangements|ntrk gene rearrangements
244267|NCT02122913|NTRK1 fusion|ntrk1 fusion
244268|NCT02122913|NTRK2 fusion|ntrk2 fusion
244269|NCT02122913|NTRK3 fusion|ntrk3 fusion
244270|NCT02122913|NTRK1 gene rearrangement|ntrk1 gene rearrangement
244271|NCT02122913|NTRK2 gene rearrangement|ntrk2 gene rearrangement
244272|NCT02122913|NTRK3 gene rearrangement|ntrk3 gene rearrangement
244273|NCT02122913|ETV6-NTRK3|etv6-ntrk3
244274|NCT02122913|fusion|fusion
244275|NCT02122913|tumors|tumors
244276|NCT02122913|solid tumors|solid tumors
244277|NCT02122913|CNS tumors|cns tumors
244278|NCT02122913|central nervous system tumors|central nervous system tumors
244279|NCT02122913|TRK fusion|trk fusion
244280|NCT02122913|ETV6|etv6
244281|NCT02122913|ETV6 fusion|etv6 fusion
244282|NCT02122913|ETV6 gene rearrangement|etv6 gene rearrangement
244283|NCT02122913|solid CNS tumor|solid cns tumor
244284|NCT02122913|Advanced CNS tumor|advanced cns tumor
244285|NCT02122913|Primary CNS tumor|primary cns tumor
244286|NCT02122913|Metastatic CNS tumor|metastatic cns tumor
244287|NCT02122913|LOXO-101|loxo-101
244288|NCT02122887|jewish, arab, israel, teenagers|jewish, arab, israel, teenagers
244289|NCT02122874|Percutaneous neurostimulation; dermatome T7, type 2 diabetes|percutaneous neurostimulation; dermatome t7, type 2 diabetes
244290|NCT02122861|Melanoma|melanoma
244291|NCT02122848|Heart failure|heart failure
244292|NCT02122848|Exercise tolerance|exercise tolerance
244293|NCT02122848|Noninvasive ventilation|noninvasive ventilation
244294|NCT02122835|exercise|exercise
244295|NCT02122835|aerobic exercise|aerobic exercise
244296|NCT02122822|supratentoria glioma|supratentoria glioma
244297|NCT02122809|Chiauranib, advanced solid tumors, phase 1 study|chiauranib, advanced solid tumors, phase 1 study
244298|NCT02122796|Breast Cancer|breast cancer
244299|NCT02122796|Mastectomy|mastectomy
244300|NCT02122796|Acupuncture|acupuncture
244301|NCT02122770|Drug Therapy|drug therapy
244302|NCT02122731|antihypertensive therapy|antihypertensive therapy
244303|NCT02122731|amiloride|amiloride
244304|NCT02122731|add-on|add-on
244305|NCT02122731|resistant hypertension|resistant hypertension
244306|NCT02122731|blood pressure control|blood pressure control
244307|NCT02122731|type 2 diabetes mellitus,|type 2 diabetes mellitus,
244308|NCT02122731|microalbuminuria.|microalbuminuria.
244309|NCT02122705|Remifentanil|remifentanil
244310|NCT02122705|Labour analgesia|labour analgesia
244311|NCT02122666|Metabolic Syndrome|metabolic syndrome
244312|NCT02122666|Pre-diabetes|pre-diabetes
244313|NCT02122666|impaired glucose tolerance|impaired glucose tolerance
244314|NCT02122666|Phospholipids|phospholipids
244315|NCT02122653|Fatigue|fatigue
244316|NCT02122653|aging|aging
244317|NCT02122653|transcranial magnetic stimulation|transcranial magnetic stimulation
244318|NCT02122653|interpolated|interpolated
244319|NCT02122653|twitch technique|twitch technique
244320|NCT02122627|Vitamin D, COPD, immunomodulation, pulmonary function|vitamin d, copd, immunomodulation, pulmonary function
244321|NCT02122614|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
244322|NCT02122614|COPD|copd
244323|NCT02122614|Pulmonary rehabilitation|pulmonary rehabilitation
244324|NCT02122614|Physical activity|physical activity
244325|NCT02122614|Exercise|exercise
244326|NCT02122588|serous and endometrioid ovarian, peritoneal, fallopian tube cancer, hereditary ovarian cancer, BRCA (breast cancer gene) mutation, genetic testing|serous and endometrioid ovarian, peritoneal, fallopian tube cancer, hereditary ovarian cancer, brca (breast cancer gene) mutation, genetic testing
244327|NCT02122575|Inflammasome|inflammasome
244328|NCT02122575|Fasting|fasting
244329|NCT02122575|Sirt3|sirt3
244330|NCT02122562|Ketamine|ketamine
244331|NCT02122562|Major Depression|major depression
244332|NCT02122562|Alcohol|alcohol
244333|NCT02122562|Alcohol Clamp|alcohol clamp
244334|NCT02122562|NMDA Antagonist|nmda antagonist
244335|NCT02122549|In-Hospital Cardiac Arrest|in-hospital cardiac arrest
244336|NCT02122549|Telemetry|telemetry
244337|NCT02122523|Image guided surgery|image guided surgery
244338|NCT02122510|Analgesia, casarean section, TAP block|analgesia, casarean section, tap block
244339|NCT02122497|abdominal aortic aneurysm|abdominal aortic aneurysm
244340|NCT02122497|aortic occlusive disease|aortic occlusive disease
244341|NCT02122497|cardiovascular biomarkers|cardiovascular biomarkers
244342|NCT02122497|open surgical repair|open surgical repair
244343|NCT02122497|endovascular aortic repair|endovascular aortic repair
244344|NCT02122484|reperfusion damage|reperfusion damage
244345|NCT02122471|CIC|cic
244346|NCT02122471|Constipation|constipation
244348|NCT02122471|Synergy|synergy
244349|NCT02122471|Plecanatide|plecanatide
244350|NCT02122458|hearing impairment|hearing impairment
244351|NCT02122458|post-traumatic stress disorder|post-traumatic stress disorder
244352|NCT02122458|traumatic brain injury|traumatic brain injury
244353|NCT02122458|auditory processing disorder|auditory processing disorder
244354|NCT02122445|Gluteus Maximum|gluteus maximum
244355|NCT02122445|Gluteus Medius|gluteus medius
244356|NCT02122445|TFL|tfl
244357|NCT02122445|EMG|emg
244358|NCT02122445|Flexion-Response Phenomenon|flexion-response phenomenon
244359|NCT02122445|Thera-Band|thera-band
244360|NCT02122445|kinesiology tape|kinesiology tape
244361|NCT02122432|teledermatology|teledermatology
244362|NCT02122432|dermatology|dermatology
244363|NCT02122432|general practice|general practice
244364|NCT02122432|organization of care|organization of care
244365|NCT02122406|Rheumatoid Arthritis|rheumatoid arthritis
244366|NCT02122406|Depression|depression
244367|NCT02122406|Anxiety|anxiety
244368|NCT02122406|DAS28|das28
244369|NCT02122406|HADS|hads
244370|NCT02122380|Growth Hormone|growth hormone
244371|NCT02122380|Dipeptidyl Peptidase 4|dipeptidyl peptidase 4
244372|NCT02122380|Polycystic Ovary Syndrome|polycystic ovary syndrome
244373|NCT02122328|Twin twin transfusion syndrome|twin twin transfusion syndrome
244374|NCT02122328|Sequential laser photocoagulation of communicating vessels|sequential laser photocoagulation of communicating vessels
244375|NCT02122302|Altered gastrointestinal anatomy|altered gastrointestinal anatomy
244376|NCT02122302|Chronic pancreatic disease|chronic pancreatic disease
244377|NCT02122302|Chronic pancreatic pain|chronic pancreatic pain
244378|NCT02122302|Patient self-assessment|patient self-assessment
244379|NCT02122302|Online assessment|online assessment
244380|NCT02122289|Exacerbation, QoL|exacerbation, qol
244381|NCT02122276|Spinal cord injury|spinal cord injury
244382|NCT02122276|Passive motion|passive motion
244383|NCT02122276|Fatigue index|fatigue index
244384|NCT02122276|Hypertonia|hypertonia
244385|NCT02122250|Diabetes|diabetes
244386|NCT02122250|Health literacy|health literacy
244387|NCT02122250|web intervention|web intervention
244388|NCT02122224|satiety|satiety
244389|NCT02122224|satiation|satiation
244390|NCT02122224|diet quality|diet quality
244391|NCT02122224|memory|memory
244392|NCT02122224|obesity|obesity
244393|NCT02122224|protein|protein
244394|NCT02122224|fiber|fiber
244395|NCT02122211|Sperm motility|sperm motility
244396|NCT02122198|Cognitive impairment|cognitive impairment
244497|NCT02121743|colostomy|colostomy
244397|NCT02122198|Executive function|executive function
244398|NCT02122198|Arterial stiffness|arterial stiffness
244399|NCT02122198|Endothelial function|endothelial function
244400|NCT02122198|Menopause|menopause
244401|NCT02122198|Women's health|women's health
244402|NCT02122198|Hormone therapy|hormone therapy
244403|NCT02122198|functional MRI|functional mri
244404|NCT02122159|safety|safety
244405|NCT02122159|tolerability|tolerability
244406|NCT02122159|RPE cellular therapy|rpe cellular therapy
244407|NCT02122159|MMD|mmd
244408|NCT02122146|ADC|adc
244409|NCT02122146|PF-06664178|pf-06664178
244410|NCT02122146|solid tumors|solid tumors
244411|NCT02122146|tumors|tumors
244412|NCT02122146|neoplasm metastasis|neoplasm metastasis
244413|NCT02122146|NSCLC|nsclc
244414|NCT02122146|non small cell lung cancer|non small cell lung cancer
244415|NCT02122146|OVCA|ovca
244416|NCT02122146|ovarian cancer|ovarian cancer
244417|NCT02122146|Phase 1|phase 1
244418|NCT02122146|breast cancer|breast cancer
244419|NCT02122133|IC aneurysms, coil embolization, PC 400, radiation exposure,|ic aneurysms, coil embolization, pc 400, radiation exposure,
244420|NCT02122120|enteral nutrition, tube feeding, nutritional support|enteral nutrition, tube feeding, nutritional support
244421|NCT02122107|Treatment Exposure|treatment exposure
244422|NCT02122107|Smoking History|smoking history
244423|NCT02122107|14-071|14-071
244424|NCT02122068|Meditation|meditation
244425|NCT02122068|Mindfulness|mindfulness
244426|NCT02122068|Caregiver|caregiver
244427|NCT02122068|Dementia|dementia
244428|NCT02122068|Depression|depression
244429|NCT02122055|combined sedation|combined sedation
244430|NCT02122029|Lifestyle intervention|lifestyle intervention
244431|NCT02122029|Bariatric surgery|bariatric surgery
244432|NCT02122029|Weight management|weight management
244433|NCT02122029|Physical activity|physical activity
244434|NCT02122016|Ventilator weaning|ventilator weaning
244435|NCT02122016|Protocols|protocols
244436|NCT02122016|Computer driven weaning|computer driven weaning
244437|NCT02122016|Decision Making, Computer-Assisted|decision making, computer-assisted
244438|NCT02122016|Therapy, Computer-Assisted|therapy, computer-assisted
244439|NCT02122016|Respiration, Artificial|respiration, artificial
244440|NCT02122003|sorafenib|sorafenib
244441|NCT02122003|pazopanib|pazopanib
244442|NCT02122003|cross-resistance|cross-resistance
244443|NCT02122003|TKI|tki
244444|NCT02122003|mRCC|mrcc
244445|NCT02121990|(IP) Cisplatin|(ip) cisplatin
244446|NCT02121990|IV/IP Paclitaxel|iv/ip paclitaxel
244447|NCT02121990|IV Bevacizumab|iv bevacizumab
244448|NCT02121990|Oral Olaparib (AZD2281)|oral olaparib (azd2281)
244449|NCT02121990|Optimally Debulked|optimally debulked
244450|NCT02121990|Stage II/III|stage ii/iii
244451|NCT02121990|Ovary|ovary
244452|NCT02121990|Pertoneum|pertoneum
244453|NCT02121990|10-220|10-220
244454|NCT02121964|unilateral primary total hip arthroplasty|unilateral primary total hip arthroplasty
244455|NCT02121964|bilateral primary total hip arthroplasty|bilateral primary total hip arthroplasty
244456|NCT02121964|Arthritis|arthritis
244457|NCT02121964|Orthopedic Disorders|orthopedic disorders
244458|NCT02121964|Orthopedics|orthopedics
244459|NCT02121964|Surgery,|surgery,
244460|NCT02121964|Orthopedic|orthopedic
244461|NCT02121964|arthroplasty|arthroplasty
244462|NCT02121964|hip|hip
244463|NCT02121964|osteoarthritis|osteoarthritis
244464|NCT02121964|capsulectomy|capsulectomy
244465|NCT02121964|capsulotomy|capsulotomy
244466|NCT02121951|Percutaneous Nephrostomy|percutaneous nephrostomy
244467|NCT02121951|Quadtatus Lumborum Block|quadtatus lumborum block
244468|NCT02121951|Cancer|cancer
244469|NCT02121951|Monitored Anaesthesia Care|monitored anaesthesia care
244470|NCT02121938|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
244471|NCT02121938|Microbiome|microbiome
244472|NCT02121925|Registry|registry
244473|NCT02121899|Registry|registry
244603|NCT02121340|Geriatric|geriatric
244474|NCT02121873|breast cancer, nipple aspirate, ductal lavage, hyperplasia|breast cancer, nipple aspirate, ductal lavage, hyperplasia
244475|NCT02121860|Hepatic Impairment|hepatic impairment
244476|NCT02121860|Pharmacokinetics|pharmacokinetics
244477|NCT02121860|Pharmacodynamics|pharmacodynamics
244478|NCT02121808|Morbid Obesity|morbid obesity
244479|NCT02121808|Bariatric Surgery Candidate|bariatric surgery candidate
244480|NCT02121808|Pre-Oxygenation|pre-oxygenation
244481|NCT02121808|Functional Residual Capacity|functional residual capacity
244482|NCT02121795|HIV|hiv
244483|NCT02121795|HIV-1 Positive|hiv-1 positive
244484|NCT02121795|Virologically-suppressed|virologically-suppressed
244485|NCT02121782|QIV|qiv
244486|NCT02121782|Quadrivalent Influenza Vaccine|quadrivalent influenza vaccine
244487|NCT02121782|Influenza vaccine|influenza vaccine
244488|NCT02121782|Vaccination|vaccination
244489|NCT02121769|cholestasis|cholestasis
244490|NCT02121769|short bowel syndrome|short bowel syndrome
244491|NCT02121756|Dipyridamole|dipyridamole
244492|NCT02121756|HIV|hiv
244493|NCT02121756|Immune Markers|immune markers
244494|NCT02121756|Immune Activation|immune activation
244495|NCT02121756|Inflammation|inflammation
244496|NCT02121743|strattice|strattice
244498|NCT02121743|parastomal hernia|parastomal hernia
244499|NCT02121730|grafting kidney|grafting kidney
244500|NCT02121730|Cancer|cancer
244501|NCT02121717|Chiglitazar,diabetes,type 2 diabetes|chiglitazar,diabetes,type 2 diabetes
244502|NCT02121704|Sedation|sedation
244503|NCT02121704|Colonoscopy|colonoscopy
244504|NCT02121704|Propofol|propofol
244505|NCT02121704|Scope guide|scope guide
244506|NCT02121691|Cancer|cancer
244507|NCT02121691|Obesity|obesity
244508|NCT02121691|Body Mass Index|body mass index
244509|NCT02121678|Resistance training|resistance training
244510|NCT02121678|Aerobic exercise|aerobic exercise
244511|NCT02121678|Isokinetic muscle strength|isokinetic muscle strength
244512|NCT02121678|Bicycle ergometry test|bicycle ergometry test
244513|NCT02121678|Subcutaneous immunoglobulin|subcutaneous immunoglobulin
244514|NCT02121652|lung cancer survivors|lung cancer survivors
244515|NCT02121652|insomnia treatment|insomnia treatment
244516|NCT02121652|cognitive behavioral therapy|cognitive behavioral therapy
244517|NCT02121639|Metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
244518|NCT02121639|AZD5363|azd5363
244519|NCT02121639|Docetaxel|docetaxel
244520|NCT02121639|Prednisolone|prednisolone
244521|NCT02121626|Cancer|cancer
244522|NCT02121626|Chemotheraphy|chemotheraphy
244523|NCT02121626|Small Bowel Bacterial Overgrowth|small bowel bacterial overgrowth
244524|NCT02121626|Bile Acid Malabsorption|bile acid malabsorption
244525|NCT02121626|Pancreatic Insufficiency|pancreatic insufficiency
244526|NCT02121626|Carbohydrate Malabsorption|carbohydrate malabsorption
244527|NCT02121626|Anorexia|anorexia
244528|NCT02121626|Borborygmi|borborygmi
244529|NCT02121626|Bloating|bloating
244530|NCT02121626|Constipation|constipation
244531|NCT02121626|Diarrhoea|diarrhoea
244532|NCT02121626|Mucositis|mucositis
244533|NCT02121626|Dysphagia|dysphagia
244534|NCT02121626|Early satiety|early satiety
244535|NCT02121626|Frequency of defaecation|frequency of defaecation
244536|NCT02121626|Incontinence|incontinence
244537|NCT02121626|Mucus discharge|mucus discharge
244538|NCT02121626|Nausea|nausea
244539|NCT02121626|Nocturnal defaecation|nocturnal defaecation
244540|NCT02121626|Pain|pain
244541|NCT02121626|Reflux|reflux
244542|NCT02121626|Regurgitation|regurgitation
244543|NCT02121626|Steatorrhoea|steatorrhoea
244544|NCT02121626|Tenesmus|tenesmus
244545|NCT02121626|Urgency of defaecation|urgency of defaecation
244546|NCT02121626|Vomiting|vomiting
244547|NCT02121626|Weight loss|weight loss
244548|NCT02121626|Wind.|wind.
244549|NCT02121600|Fluorocholine (FCH)|fluorocholine (fch)
244550|NCT02121600|Positron Emission Tomography (PET)|positron emission tomography (pet)
244551|NCT02121600|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
244552|NCT02121587|Musculoskeletal Pain, Osteopathy, Mindfulness|musculoskeletal pain, osteopathy, mindfulness
244553|NCT02121574|Surgery|surgery
244554|NCT02121574|thermometers|thermometers
244555|NCT02121574|Hypothermia|hypothermia
244556|NCT02121574|anesthesia|anesthesia
244557|NCT02121574|temperature|temperature
244558|NCT02121561|Shame|shame
244559|NCT02121548|Screen|screen
244560|NCT02121548|cervical, cancer|cervical, cancer
244561|NCT02121548|HPV|hpv
244562|NCT02121548|women|women
244563|NCT02121548|community health workers|community health workers
244564|NCT02121548|Hispanic/ Latinas|hispanic/ latinas
244565|NCT02121548|Haitian|haitian
244566|NCT02121496|Depression|depression
244567|NCT02121496|Development|development
244568|NCT02121496|Infant sleep|infant sleep
244569|NCT02121470|AKI|aki
244570|NCT02121470|Acute Kidney Injury|acute kidney injury
244571|NCT02121470|Renal failure|renal failure
244572|NCT02121470|NGAL|ngal
244573|NCT02121470|neutrophil gelatinase-associated lipocalin|neutrophil gelatinase-associated lipocalin
244574|NCT02121470|lipocalin-2|lipocalin-2
244575|NCT02121470|siderocalin|siderocalin
244576|NCT02121470|Intensive care|intensive care
244577|NCT02121470|ICU|icu
244578|NCT02121470|Critical care|critical care
244579|NCT02121457|cognitive performance|cognitive performance
244580|NCT02121457|selenium|selenium
244581|NCT02121457|brazil nuts|brazil nuts
244582|NCT02121457|oxidative stress|oxidative stress
244583|NCT02121444|RRMS|rrms
244584|NCT02121444|CIS|cis
244585|NCT02121366|Endoscopic Ultrasound-Guided Fine Needle Aspiration|endoscopic ultrasound-guided fine needle aspiration
244586|NCT02121366|Insulinoma|insulinoma
244587|NCT02121366|Ethanol|ethanol
244588|NCT02121366|Ablation Techniques|ablation techniques
244589|NCT02121353|Age related macular degeneration|age related macular degeneration
244590|NCT02121353|AMD|amd
244591|NCT02121353|Wet AMD|wet amd
244592|NCT02121353|Eye conditions|eye conditions
244593|NCT02121353|CFT|cft
244594|NCT02121353|OCT|oct
244595|NCT02121353|CNV|cnv
244596|NCT02121353|FA|fa
244597|NCT02121353|Ocular|ocular
244598|NCT02121353|Eye|eye
244599|NCT02121353|Disorder of the eye|disorder of the eye
244600|NCT02121340|Depression|depression
244601|NCT02121340|Health disparities|health disparities
244602|NCT02121340|African American|african american
244706|NCT02120937|adolescence|adolescence
244604|NCT02121327|stroke, disease management programs, self-management|stroke, disease management programs, self-management
244605|NCT02121314|TB|tb
244606|NCT02121314|bioavailability|bioavailability
244607|NCT02121314|HRZE|hrze
244608|NCT02121314|fasting|fasting
244609|NCT02121314|fed|fed
244610|NCT02121301|Dry Eye|dry eye
244611|NCT02121301|Dry Eye Syndrome|dry eye syndrome
244612|NCT02121301|SkQ1|skq1
244613|NCT02121301|KCS|kcs
244614|NCT02121301|Keratoconjunctivitis|keratoconjunctivitis
244615|NCT02121288|Peripheral Artery Disease|peripheral artery disease
244616|NCT02121288|Myocardial Blood Flow|myocardial blood flow
244617|NCT02121288|Cardiac Blood Flow|cardiac blood flow
244618|NCT02121236|CBCT|cbct
244619|NCT02121236|Ultrasonic diagnosis|ultrasonic diagnosis
244620|NCT02121236|Benign radiolucent lesions|benign radiolucent lesions
244621|NCT02121236|Histopathology|histopathology
244622|NCT02121223|acute ST segment elevated myocardial infarction|acute st segment elevated myocardial infarction
244623|NCT02121223|primary percutaneous intervention|primary percutaneous intervention
244624|NCT02121223|Stent Incomplete Apposition|stent incomplete apposition
244625|NCT02121197|Macular Diabetic Edema|macular diabetic edema
244626|NCT02121197|Ozurdex|ozurdex
244627|NCT02121197|Retrospective|retrospective
244628|NCT02121197|European|european
244629|NCT02121197|Intra-vitreal injections|intra-vitreal injections
244630|NCT02121184|Oxytocin|oxytocin
244631|NCT02121184|Labor, Obstetric|labor, obstetric
244632|NCT02121184|Non-reassuring fetal heart rate|non-reassuring fetal heart rate
244633|NCT02121184|Epidural|epidural
244634|NCT02121158|CSP 592|csp 592
244635|NCT02121158|ICD|icd
244636|NCT02121158|cardiovascular|cardiovascular
244637|NCT02121158|heart|heart
244638|NCT02121158|aging|aging
244639|NCT02121158|chronic diseases|chronic diseases
244640|NCT02121158|multi-site trial|multi-site trial
244641|NCT02121158|investigational device|investigational device
244642|NCT02121158|cardiomyopathy|cardiomyopathy
244643|NCT02121158|coronary artery disease|coronary artery disease
244644|NCT02121158|congestive heart failure|congestive heart failure
244645|NCT02121158|myocardial infarction|myocardial infarction
244646|NCT02121158|I-70|i-70
244647|NCT02121158|I70|i70
244648|NCT02121158|elderly|elderly
244649|NCT02121158|defibrillator|defibrillator
244650|NCT02121145|Vivotif|vivotif
244651|NCT02121145|Typherix|typherix
244652|NCT02121145|Salmonella Typhi|salmonella typhi
244653|NCT02121145|non-typhoid Salmonella|non-typhoid salmonella
244654|NCT02121145|Salmonella Paratyphi|salmonella paratyphi
244655|NCT02121145|enzyme-linked immunospot assay|enzyme-linked immunospot assay
244656|NCT02121145|Plasmablast|plasmablast
244657|NCT02121132|Overweight|overweight
244658|NCT02121132|Obesity|obesity
244659|NCT02121119|Peripheral nerve block|peripheral nerve block
244660|NCT02121119|Lidocaine|lidocaine
244661|NCT02121119|Bupivacaine|bupivacaine
244662|NCT02121093|vibration|vibration
244663|NCT02121093|physiotherapy|physiotherapy
244664|NCT02121093|cortex|cortex
244665|NCT02121093|muscles|muscles
244666|NCT02121067|postpartum|postpartum
244667|NCT02121067|contraception|contraception
244668|NCT02121067|intrauterine device|intrauterine device
244669|NCT02121067|intrauterine system|intrauterine system
244670|NCT02121067|mirena|mirena
244671|NCT02121067|uterine involution|uterine involution
244672|NCT02121054|Antiplatelet Agents|antiplatelet agents
244673|NCT02121054|Drug Resistance|drug resistance
244674|NCT02121041|Hypertension|hypertension
244675|NCT02121041|Blood Pressure|blood pressure
244676|NCT02121041|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
244677|NCT02121028|Intracranial Atherosclerotic Disease|intracranial atherosclerotic disease
244678|NCT02121028|Stroke|stroke
244679|NCT02121028|Transient Ischemic Attack|transient ischemic attack
244680|NCT02121028|Imaging|imaging
244681|NCT02121015|Postpartum Depression|postpartum depression
244682|NCT02121015|Depression Prevention|depression prevention
244683|NCT02121015|Supportive Accountability|supportive accountability
244684|NCT02121015|Individual Internet Interventions (IIIs)|individual internet interventions (iiis)
244685|NCT02121015|Internet Support Groups (ISGs)|internet support groups (isgs)
244686|NCT02121002|Knee|knee
244687|NCT02120989|insomnia|insomnia
244688|NCT02120989|cognitive behavioral therapy for insomnia (CBT-I)|cognitive behavioral therapy for insomnia (cbt-i)
244689|NCT02120989|partner-assisted|partner-assisted
244690|NCT02120976|Safety|safety
244691|NCT02120976|Tolerability|tolerability
244692|NCT02120976|Pharmacokinetics|pharmacokinetics
244693|NCT02120976|Food-effect|food-effect
244694|NCT02120976|Diabetes|diabetes
244695|NCT02120963|Fatigue|fatigue
244696|NCT02120963|Rheumatoid Arthritis|rheumatoid arthritis
244697|NCT02120963|Physical Therapy|physical therapy
244698|NCT02120963|Person-Centred Care|person-centred care
244699|NCT02120950|PCV|pcv
244700|NCT02120937|amygdala|amygdala
244701|NCT02120937|mindfulness|mindfulness
244702|NCT02120937|mood|mood
244703|NCT02120937|emotion|emotion
244704|NCT02120937|bipolar disorder|bipolar disorder
244705|NCT02120937|parental bipolar disorder|parental bipolar disorder
244707|NCT02120924|Moderate facial rosacea|moderate facial rosacea
244708|NCT02120924|Azelaic acid|azelaic acid
244709|NCT02120924|Rosacea|rosacea
244710|NCT02120911|Her2+|her2+
244711|NCT02120911|Resectable esophageal carcinoma|resectable esophageal carcinoma
244712|NCT02120911|Pertuzumab|pertuzumab
244713|NCT02120911|Trastuzumab|trastuzumab
244714|NCT02120898|Actinic Keratosis|actinic keratosis
244715|NCT02120898|Imiquimod|imiquimod
244716|NCT02120898|Zyclara|zyclara
244717|NCT02120885|Gastric cancer|gastric cancer
244718|NCT02120885|minimally invasive gastrectomy|minimally invasive gastrectomy
244719|NCT02120885|Physical activity intervention|physical activity intervention
244720|NCT02120859|PCI|pci
244721|NCT02120859|Drug-eluting balloon (DEB)|drug-eluting balloon (deb)
244722|NCT02120859|Fractional flow reserve (FFR)|fractional flow reserve (ffr)
244723|NCT02120846|Stroke|stroke
244724|NCT02120846|Flywheel resistance exercise|flywheel resistance exercise
244725|NCT02120846|Muscle function|muscle function
244726|NCT02120846|Cognitive function|cognitive function
244727|NCT02120833|Atopic Dermatitis|atopic dermatitis
244728|NCT02120820|massage|massage
244729|NCT02120820|multisensory environment|multisensory environment
244730|NCT02120820|challenging behaviours|challenging behaviours
244731|NCT02120820|relaxation|relaxation
244732|NCT02120807|Certolizumab|certolizumab
244733|NCT02120807|Cisplatin|cisplatin
244734|NCT02120807|Pemetrexed|pemetrexed
244735|NCT02120807|thoracic|thoracic
244736|NCT02120807|13-063|13-063
244737|NCT02120794|Type 1 diabetes|type 1 diabetes
244738|NCT02120794|Pediatric|pediatric
244739|NCT02120794|Threshold Suspend|threshold suspend
244740|NCT02120794|Sensor augmented pump|sensor augmented pump
244741|NCT02120768|Barrier resection|barrier resection
244742|NCT02120768|Local recurrence|local recurrence
244743|NCT02120768|Complication|complication
244744|NCT02120742|Road traffic injury prevention|road traffic injury prevention
244745|NCT02120742|Helmet use|helmet use
244746|NCT02120742|mHealth intervention|mhealth intervention
244747|NCT02120729|Pharmacogenetics|pharmacogenetics
244748|NCT02120729|CYP2D6 Mutations|cyp2d6 mutations
244749|NCT02120729|Major Depressive Disorder|major depressive disorder
244750|NCT02120729|Psychiatric Inpatients|psychiatric inpatients
244751|NCT02120729|Length of Stay|length of stay
244752|NCT02120729|30 Day Readmission Rate|30 day readmission rate
244753|NCT02120729|Psychiatric hospital inpatients|psychiatric hospital inpatients
244754|NCT02120716|HIV|hiv
244755|NCT02120716|STIs|stis
244756|NCT02120716|Health Check Up|health check up
244757|NCT02120716|Intervention|intervention
244758|NCT02120703|Pregabalin|pregabalin
244759|NCT02120703|gabapentin|gabapentin
244760|NCT02120703|microdiscectomy|microdiscectomy
244761|NCT02120703|pain|pain
244762|NCT02120690|pain|pain
244763|NCT02120690|fibromyagia|fibromyagia
244764|NCT02120690|TNS|tns
244765|NCT02120677|skin cancer|skin cancer
244766|NCT02120677|basal cell carcinoma|basal cell carcinoma
244767|NCT02120651|Fibrin monomer|fibrin monomer
244768|NCT02120651|Tympanoplasty|tympanoplasty
244769|NCT02120651|Hemostatic sponge|hemostatic sponge
244770|NCT02120638|Multidrug Resistant Tuberculosis|multidrug resistant tuberculosis
244771|NCT02120638|Pyrazinamide|pyrazinamide
244772|NCT02120625|radiofrequency ablation|radiofrequency ablation
244773|NCT02120625|neurotomy|neurotomy
244774|NCT02120625|facet joint|facet joint
244775|NCT02120625|medial branch|medial branch
244776|NCT02120625|low back pain|low back pain
244777|NCT02120612|Opioid Dependence|opioid dependence
244778|NCT02120612|Addiction|addiction
244779|NCT02120612|Naloxone|naloxone
244780|NCT02120612|Naloxone Education|naloxone education
244781|NCT02120612|Opiate Overdose Knowledge Scale|opiate overdose knowledge scale
244782|NCT02120612|OOKS|ooks
244783|NCT02120586|Elderly|elderly
244784|NCT02120586|Institutionalization|institutionalization
244785|NCT02120586|Sarcopenia|sarcopenia
244786|NCT02120586|Strength training|strength training
244787|NCT02120586|Muscle mass|muscle mass
244788|NCT02120586|Muscle strength|muscle strength
244789|NCT02120586|Physical performance|physical performance
244790|NCT02120573|Cardiac Arrest|cardiac arrest
244791|NCT02120573|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
244792|NCT02120573|Training|training
244793|NCT02120560|Atrial Fibrillation Ablation|atrial fibrillation ablation
244794|NCT02120560|Cerebrothromboemboli|cerebrothromboemboli
244795|NCT02120560|Neurocognitive Function|neurocognitive function
244796|NCT02120547|Liver Insufficiency|liver insufficiency
244797|NCT02120547|Hepatic impairment|hepatic impairment
244798|NCT02120534|soluble CD14 ,serum CD88,sepsis , SIRS.|soluble cd14 ,serum cd88,sepsis , sirs.
244799|NCT02120521|Sepsis and SIRS, ICU|sepsis and sirs, icu
244800|NCT02120508|stroke|stroke
244801|NCT02120508|aphasia|aphasia
244802|NCT02120508|rTMS|rtms
244803|NCT02120508|Functional MRI|functional mri
244804|NCT02120508|Speech training|speech training
244805|NCT02120495|condylectomy|condylectomy
244806|NCT02120495|TMJ function|tmj function
244807|NCT02120495|intraoral approach|intraoral approach
244808|NCT02120482|ABO isoagglutinins|abo isoagglutinins
244809|NCT02120482|ABO incompatible transplantation|abo incompatible transplantation
244810|NCT02120482|immunoadsorption|immunoadsorption
244811|NCT02120482|membrane filtration|membrane filtration
244812|NCT02120482|plasmapheresis|plasmapheresis
244813|NCT02120443|infiltration|infiltration
244814|NCT02120443|extravasation|extravasation
244815|NCT02120443|peripheral intravenous therapy|peripheral intravenous therapy
244816|NCT02120430|Early childhood|early childhood
244817|NCT02120430|Audiovisual materials|audiovisual materials
244818|NCT02120430|Parent-child interaction|parent-child interaction
244819|NCT02120430|Parenting programs|parenting programs
244820|NCT02120430|Timing|timing
244821|NCT02120417|Breast Cancer|breast cancer
244822|NCT02120404|septic shock, hemodynamic tolerance, esmolol|septic shock, hemodynamic tolerance, esmolol
244823|NCT02120378|miscarriage|miscarriage
244824|NCT02120378|fetal viability|fetal viability
244825|NCT02120378|prematurity|prematurity
244826|NCT02120365|Alcoholism|alcoholism
244827|NCT02120365|Heavy Drinking|heavy drinking
244828|NCT02120365|Perampanel|perampanel
244829|NCT02120352|bi-monthly|bi-monthly
244830|NCT02120352|GSK744|gsk744
244831|NCT02120352|injectable|injectable
244832|NCT02120352|long acting|long acting
244833|NCT02120352|maintenance|maintenance
244834|NCT02120352|abacavir|abacavir
244835|NCT02120352|every other month|every other month
244836|NCT02120352|rilpivirine|rilpivirine
244837|NCT02120352|HIV-1 infection|hiv-1 infection
244838|NCT02120352|integrase inhibitor|integrase inhibitor
244839|NCT02120352|TMC278 LA|tmc278 la
244840|NCT02120352|RPV|rpv
244841|NCT02120352|non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
244842|NCT02120352|LA|la
244843|NCT02120352|once monthly|once monthly
244844|NCT02120352|GSK1265744|gsk1265744
244845|NCT02120352|induction|induction
244846|NCT02120352|treatment satisfication|treatment satisfication
244847|NCT02120352|once daily|once daily
244848|NCT02120352|lamivudine|lamivudine
244849|NCT02120352|adherence|adherence
244850|NCT02120352|TMC278|tmc278
244851|NCT02120352|therapy-naive|therapy-naive
244852|NCT02120339|Hypertension|hypertension
244853|NCT02120339|PAH|pah
244854|NCT02120326|Chronic migraine, tDCS, Transcranial direct current stimulation|chronic migraine, tdcs, transcranial direct current stimulation
244855|NCT02120313|rehabilitation|rehabilitation
244856|NCT02120313|total knee arthroplasty|total knee arthroplasty
244857|NCT02120287|Border Zone Stereotactic Radiosurgery|border zone stereotactic radiosurgery
244858|NCT02120287|Bevacizumab|bevacizumab
244859|NCT02120287|Recurrent Glioblastoma Multiforme|recurrent glioblastoma multiforme
244860|NCT02120287|Progressive Glioblastoma Multiforme|progressive glioblastoma multiforme
244861|NCT02120287|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
244862|NCT02120287|Glioblastoma|glioblastoma
244863|NCT02120287|Brain Cancer|brain cancer
244864|NCT02120287|Brain Tumor|brain tumor
244865|NCT02120287|Radiosurgery|radiosurgery
244866|NCT02120274|RNA Virus Infections|rna virus infections
244867|NCT02120274|Flaviviridae Infections|flaviviridae infections
244868|NCT02120274|Hepatitis C|hepatitis c
244869|NCT02120274|Hepatitis C, Chronic|hepatitis c, chronic
244870|NCT02120274|Vitamin D|vitamin d
244871|NCT02120274|Cholecalciferol|cholecalciferol
244872|NCT02120274|Vitamin B 12|vitamin b 12
244873|NCT02120261|Myofascial Pain Syndrome|myofascial pain syndrome
244874|NCT02120261|trigger point injection|trigger point injection
244875|NCT02120248|WIC|wic
244876|NCT02120248|Oregon|oregon
244877|NCT02120248|Breastfeeding|breastfeeding
244878|NCT02120248|Peer Counseling|peer counseling
244879|NCT02120248|Exclusive Breastfeeding|exclusive breastfeeding
244880|NCT02120235|Lysosomal storage disorders|lysosomal storage disorders
244881|NCT02120235|LSD|lsd
244882|NCT02120235|Gaucher disease|gaucher disease
244883|NCT02120235|Fabry disease|fabry disease
244884|NCT02120235|Pompe disease|pompe disease
244885|NCT02120235|Niemann-Pick disease|niemann-pick disease
244886|NCT02120222|melanoma|melanoma
244887|NCT02120209|assessment; falls; older adults; prediction scale; standardized declaration|assessment; falls; older adults; prediction scale; standardized declaration
244888|NCT02120183|Caregivers|caregivers
244889|NCT02120183|Quality of life|quality of life
244890|NCT02120183|Neoplasms|neoplasms
244891|NCT02120183|Psychotherapy, group|psychotherapy, group
244892|NCT02120183|Family|family
244893|NCT02120183|Adaptation, psychological|adaptation, psychological
244894|NCT02120183|Psycho-educational support group therapy|psycho-educational support group therapy
244895|NCT02120183|Cancer patients|cancer patients
244896|NCT02120170|Hemoclip, Heparin bridging therapy, colon polypectomy, warfarin|hemoclip, heparin bridging therapy, colon polypectomy, warfarin
244897|NCT02120157|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
244898|NCT02120157|Acute myeloid leukemia|acute myeloid leukemia
244899|NCT02120157|Juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
244900|NCT02120157|Treatment related leukemia|treatment related leukemia
244901|NCT02120157|Biphenotypic leukemia|biphenotypic leukemia
244902|NCT02120131|third molar surgery, periodontal probing depth , flap design|third molar surgery, periodontal probing depth , flap design
244903|NCT02120118|Treatment failure|treatment failure
245101|NCT02119338|5-ala|5-ala
244904|NCT02120105|Renal aminoaciduria|renal aminoaciduria
244905|NCT02120105|cystinuria|cystinuria
244906|NCT02120105|D-penicillamine|d-penicillamine
244907|NCT02120105|renal tubular transport|renal tubular transport
244908|NCT02120105|inborn errors|inborn errors
244909|NCT02120105|tiopronin|tiopronin
244910|NCT02120105|urolithiasis|urolithiasis
244911|NCT02120092|ACS, Acute coronary syndrome|acs, acute coronary syndrome
244912|NCT02120079|Dry Eye|dry eye
244913|NCT02120066|Submacular hemorrhage|submacular hemorrhage
244914|NCT02120066|Vitrectomy|vitrectomy
244915|NCT02120066|tissue- plasminogen activator|tissue- plasminogen activator
244916|NCT02120053|Immediate complete denture|immediate complete denture
244917|NCT02120053|Alveolar ridge resorption|alveolar ridge resorption
244918|NCT02120053|Alveolar bone loss|alveolar bone loss
244919|NCT02120053|Bone substitute material|bone substitute material
244920|NCT02120053|Edentulism|edentulism
244921|NCT02120027|Irritable Bowel Syndrome|irritable bowel syndrome
244922|NCT02120027|Colon, irritable|colon, irritable
244923|NCT02120027|Bowel disease|bowel disease
244924|NCT02120027|Diarrhea|diarrhea
244925|NCT02120014|Heart Failure|heart failure
244926|NCT02120014|Heart Failure Reduced Ejection Fraction|heart failure reduced ejection fraction
244927|NCT02120014|Heart Failure Preserved Ejection Fraction|heart failure preserved ejection fraction
244928|NCT02120014|Venous Plethysmography|venous plethysmography
244929|NCT02120014|Blood Volume Study|blood volume study
244930|NCT02120001|Medical Devices|medical devices
244931|NCT02120001|Ventilator-Associated Pneumonia (VAP)|ventilator-associated pneumonia (vap)
244932|NCT02120001|Ventilator-Associated Events (VAE)|ventilator-associated events (vae)
244933|NCT02120001|Endotracheal Tube|endotracheal tube
244934|NCT02120001|Microbial Diversity|microbial diversity
244935|NCT02120001|Drug-Resistance|drug-resistance
244936|NCT02120001|biofilms|biofilms
244937|NCT02120001|endotracheal intubation|endotracheal intubation
244938|NCT02120001|mechanical ventilation|mechanical ventilation
244939|NCT02119988|TIPS|tips
244940|NCT02119988|Embolization|embolization
244941|NCT02119988|Variceal rebleeding|variceal rebleeding
244942|NCT02119975|Rumination|rumination
244943|NCT02119975|Working memory|working memory
244944|NCT02119975|Depression|depression
244945|NCT02119975|Anxiety|anxiety
244946|NCT02119975|Working memory training|working memory training
244947|NCT02119975|Overgeneral memories|overgeneral memories
244948|NCT02119962|burnout|burnout
244949|NCT02119962|working memory|working memory
244950|NCT02119962|working memory training|working memory training
244951|NCT02119962|cognitive behavioral therapy|cognitive behavioral therapy
244952|NCT02119962|executive control|executive control
244953|NCT02119949|Substance abuse|substance abuse
244954|NCT02119949|Addiction|addiction
244955|NCT02119949|Working memory|working memory
244956|NCT02119949|Craving|craving
244957|NCT02119949|Impulsivity|impulsivity
244958|NCT02119949|Attention control|attention control
244959|NCT02119936|Stress|stress
244960|NCT02119936|Anxiety|anxiety
244961|NCT02119936|Mental Health|mental health
244962|NCT02119936|Mental Health Services|mental health services
244963|NCT02119936|Maternal Mental Health|maternal mental health
244964|NCT02119923|Depression|depression
244965|NCT02119923|Anxiety|anxiety
244966|NCT02119923|Working memory|working memory
244967|NCT02119923|Rumination|rumination
244968|NCT02119923|Cognitive training|cognitive training
244969|NCT02119923|Executive functioning|executive functioning
244970|NCT02119910|pediatric feeding disorders|pediatric feeding disorders
244971|NCT02119910|behavioral intervention|behavioral intervention
244972|NCT02119910|treatment manual|treatment manual
244973|NCT02119910|feeding|feeding
244974|NCT02119910|food refusal|food refusal
244975|NCT02119910|diet|diet
244976|NCT02119897|Oropharyngeal Mucositis|oropharyngeal mucositis
244977|NCT02119897|Myeloablative Hematopoietic Cell Transplantation|myeloablative hematopoietic cell transplantation
244978|NCT02119897|Low Level Light Therapy|low level light therapy
244979|NCT02119884|Gastric and Esophageal Varices|gastric and esophageal varices
244980|NCT02119884|Hepatic Venous Pressure Gradient|hepatic venous pressure gradient
244981|NCT02119884|Terlipressin|terlipressin
244982|NCT02119884|Octreotide|octreotide
244983|NCT02119871|Cerebral air emboli, heart surgery|cerebral air emboli, heart surgery
244984|NCT02119845|Chronic kidney disease|chronic kidney disease
244985|NCT02119845|Arteriovenous fistula (AVF)|arteriovenous fistula (avf)
244986|NCT02119845|Hemodialysis|hemodialysis
244987|NCT02119845|Vascular access|vascular access
244988|NCT02119845|Endovascular AVF (EndoAVF)|endovascular avf (endoavf)
244989|NCT02119832|Chronic kidney disease|chronic kidney disease
244990|NCT02119832|Arteriovenous fistula|arteriovenous fistula
244991|NCT02119832|Hemodialysis|hemodialysis
244992|NCT02119832|Vascular access|vascular access
244993|NCT02119819|Weight loss|weight loss
244994|NCT02119806|cardiac surgery, benzodiazepines, delirium|cardiac surgery, benzodiazepines, delirium
244995|NCT02119767|Atherosclerosis|atherosclerosis
244996|NCT02119754|Wound|wound
244997|NCT02119754|Ulcer|ulcer
244998|NCT02119754|Infected|infected
244999|NCT02119754|Infection|infection
245000|NCT02119741|Interdental papilla|interdental papilla
245001|NCT02119741|hyaluronic acid|hyaluronic acid
245002|NCT02119741|esthetic zone|esthetic zone
245003|NCT02119741|black triangles|black triangles
245004|NCT02119715|Breast Cancer|breast cancer
245005|NCT02119715|Neutropenia|neutropenia
245006|NCT02119715|Febrile Neutropenia|febrile neutropenia
245007|NCT02119702|HIV/AIDS, perinatal HIV infection|hiv/aids, perinatal hiv infection
245008|NCT02119689|Diabetes|diabetes
245009|NCT02119689|Retinopathy|retinopathy
245010|NCT02119676|Metastatic Colorectal Cancer|metastatic colorectal cancer
245011|NCT02119676|Colon Cancer|colon cancer
245012|NCT02119676|Ruxolitinib|ruxolitinib
245013|NCT02119676|adenocarcinoma|adenocarcinoma
245014|NCT02119676|regorafenib|regorafenib
245015|NCT02119676|Jakavi ®|jakavi ®
245016|NCT02119676|Jakafi ®|jakafi ®
245017|NCT02119676|Stivarga ®|stivarga ®
245018|NCT02119663|Metastatic pancreatic cancer|metastatic pancreatic cancer
245019|NCT02119650|Non small cell lung cancer|non small cell lung cancer
245020|NCT02119637|Emotion|emotion
245021|NCT02119637|Tactile Discrimination|tactile discrimination
245022|NCT02119637|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
245023|NCT02119637|Somatosensory|somatosensory
245024|NCT02119637|Somatosensory Cortex|somatosensory cortex
245025|NCT02119624|Neural Networks|neural networks
245026|NCT02119624|Alcoholism|alcoholism
245027|NCT02119624|fMRI|fmri
245028|NCT02119624|Reward|reward
245029|NCT02119624|Addiction|addiction
245030|NCT02119611|Deep Brain Stimulation|deep brain stimulation
245031|NCT02119611|Movement Disorders|movement disorders
245032|NCT02119611|Parkinson's Disease|parkinson's disease
245033|NCT02119611|Dystonia|dystonia
245034|NCT02119611|Essential Tremor|essential tremor
245035|NCT02119598|Prehospital care|prehospital care
245036|NCT02119598|Telemedicine|telemedicine
245037|NCT02119598|Ambulance-based telemedicine|ambulance-based telemedicine
245038|NCT02119585|orthotopic liver transplantation|orthotopic liver transplantation
245039|NCT02119585|ischemia reperfusion syndrome|ischemia reperfusion syndrome
245040|NCT02119585|cytokines|cytokines
245041|NCT02119585|respiratory system elastance|respiratory system elastance
245042|NCT02119585|lung elastance|lung elastance
245043|NCT02119585|chest wall elastance|chest wall elastance
245044|NCT02119585|shunt|shunt
245045|NCT02119585|dead space|dead space
245046|NCT02119585|acute respiratory failure|acute respiratory failure
245047|NCT02119585|atelectasis|atelectasis
245048|NCT02119585|pleural effusion|pleural effusion
245049|NCT02119572|diabetes,peer support|diabetes,peer support
245050|NCT02119559|Circulating Tumor Cells|circulating tumor cells
245051|NCT02119559|Treatment Efficiency|treatment efficiency
245052|NCT02119559|Biomarker|biomarker
245053|NCT02119546|Mild CognitIve impairment|mild cognitive impairment
245054|NCT02119546|Alzheimer's disease|alzheimer's disease
245055|NCT02119546|Cognitive function|cognitive function
245056|NCT02119546|Exercise training|exercise training
245057|NCT02119533|brain injury|brain injury
245058|NCT02119533|concussion|concussion
245059|NCT02119533|post traumatic stress|post traumatic stress
245060|NCT02119520|Periodontitis|periodontitis
245061|NCT02119520|Surgery|surgery
245062|NCT02119520|Growth Factors|growth factors
245063|NCT02119520|Statins|statins
245064|NCT02119507|Dental caries|dental caries
245065|NCT02119507|Curodont Repair|curodont repair
245066|NCT02119507|P11-4|p11-4
245067|NCT02119494|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
245068|NCT02119494|phenotypes|phenotypes
245069|NCT02119494|categories|categories
245070|NCT02119494|stage|stage
245071|NCT02119494|GOLD|gold
245072|NCT02119494|treatment|treatment
245073|NCT02119481|Mindfulness stress reduction training|mindfulness stress reduction training
245074|NCT02119481|Expressive writing condition|expressive writing condition
245075|NCT02119481|Waiting list control condition|waiting list control condition
245076|NCT02119442|Eisenmenger Syndrome, Pulmonary Arterial Hyptertension|eisenmenger syndrome, pulmonary arterial hyptertension
245077|NCT02119429|Blood pressure|blood pressure
245078|NCT02119429|Pre-menopausal|pre-menopausal
245079|NCT02119429|Supplementation|supplementation
245080|NCT02119416|Cardiovascular influences|cardiovascular influences
245081|NCT02119416|caffeine|caffeine
245082|NCT02119416|healthy children|healthy children
245083|NCT02119403|Minimal Sedation nitrous oxide|minimal sedation nitrous oxide
245084|NCT02119390|adolescents|adolescents
245085|NCT02119390|young adults|young adults
245086|NCT02119390|medication adherence|medication adherence
245087|NCT02119377|trans|trans
245088|NCT02119377|transsexual|transsexual
245089|NCT02119377|transgender|transgender
245090|NCT02119377|sistergirl|sistergirl
245091|NCT02119377|brotherboy|brotherboy
245092|NCT02119377|androgynous|androgynous
245093|NCT02119377|genderqueer|genderqueer
245094|NCT02119364|cerebral palsy|cerebral palsy
245095|NCT02119364|working memory|working memory
245096|NCT02119364|cognitive training|cognitive training
245097|NCT02119351|peripheral intravenous catheters|peripheral intravenous catheters
245098|NCT02119351|blood exposure|blood exposure
245099|NCT02119351|blood control|blood control
245100|NCT02119351|IV catheter insertion|iv catheter insertion
245102|NCT02119338|5-aminolevulinic acid|5-aminolevulinic acid
245103|NCT02119338|fluorescence-guided surgery|fluorescence-guided surgery
245104|NCT02119338|glioma|glioma
245105|NCT02119338|astrocytoma|astrocytoma
245106|NCT02119338|glioblastoma|glioblastoma
245107|NCT02119338|oligodendroglioma|oligodendroglioma
245108|NCT02119338|recurrence of glioma|recurrence of glioma
245109|NCT02119325|fibre|fibre
245110|NCT02119325|overweight|overweight
245111|NCT02119325|impaired fasting glucose|impaired fasting glucose
245112|NCT02119312|Malaria|malaria
245113|NCT02119312|Plasmodium|plasmodium
245114|NCT02119312|Plasmodium falciparum|plasmodium falciparum
245115|NCT02119312|Clinical Trials|clinical trials
245116|NCT02119312|Vaccine Study|vaccine study
245117|NCT02119312|Drug Study|drug study
245118|NCT02119312|Malaria Clinical Trials Center|malaria clinical trials center
245119|NCT02119312|Seattle BioMed|seattle biomed
245120|NCT02119312|Center for Infectious Disease Research|center for infectious disease research
245121|NCT02119286|long acting beta2- receptor agonist|long acting beta2- receptor agonist
245122|NCT02119286|long acting muscarininc receptor antagonist|long acting muscarininc receptor antagonist
245123|NCT02119286|dry powder inhaler|dry powder inhaler
245124|NCT02119286|safety|safety
245125|NCT02119286|COPD|copd
245126|NCT02119286|inhaled corticosteroid|inhaled corticosteroid
245127|NCT02119286|efficacy|efficacy
245128|NCT02119286|fluticasone furoate/vilanterol|fluticasone furoate/vilanterol
245129|NCT02119286|umeclidinium bromide|umeclidinium bromide
245130|NCT02119273|CRSsNP|crssnp
245131|NCT02119273|Steroids|steroids
245132|NCT02119273|Corticosteroids|corticosteroids
245133|NCT02119273|Endoscopic|endoscopic
245134|NCT02119273|Surgery|surgery
245135|NCT02119273|Perioperative|perioperative
245136|NCT02119260|First Time in Human|first time in human
245137|NCT02119260|TRPV4 inhibitor|trpv4 inhibitor
245138|NCT02119260|Heart failure|heart failure
245139|NCT02119247|systemic availability , pharmacokinetics, COPD|systemic availability , pharmacokinetics, copd
245140|NCT02119195|composite|composite
245141|NCT02119195|sealant|sealant
245142|NCT02119195|longevity|longevity
245143|NCT02119182|Traumatic Brain Injury|traumatic brain injury
245144|NCT02119182|Biomarkers|biomarkers
245145|NCT02119182|Neuroimaging|neuroimaging
245146|NCT02119182|Psychological Health|psychological health
245147|NCT02119182|Comparative Effectiveness Research|comparative effectiveness research
245148|NCT02119156|treatment holiday|treatment holiday
245149|NCT02119156|PGA|pga
245150|NCT02119156|belimumab|belimumab
245151|NCT02119156|Lymphostat-B|lymphostat-b
245152|NCT02119156|rebound|rebound
245153|NCT02119156|SELENA SLEDAI|selena sledai
245154|NCT02119156|Systemic Lupus Erythematosus|systemic lupus erythematosus
245155|NCT02119156|immunogenicity|immunogenicity
245156|NCT02119143|common cold, immunity, oxidative stress|common cold, immunity, oxidative stress
245157|NCT02119130|cluster randomized trial|cluster randomized trial
245158|NCT02119130|interferon-gamma|interferon-gamma
245159|NCT02119130|tuberculin test|tuberculin test
245160|NCT02119130|operational comparison|operational comparison
245161|NCT02119130|cost effectiveness|cost effectiveness
245162|NCT02119130|qualitative evaluation|qualitative evaluation
245163|NCT02119117|mtDNA|mtdna
245164|NCT02119117|aneuploidy|aneuploidy
245165|NCT02119117|IVF|ivf
245166|NCT02119117|blastocyst|blastocyst
245167|NCT02119117|COQ10|coq10
245168|NCT02119091|QT prolongation|qt prolongation
245169|NCT02119091|Chinese|chinese
245170|NCT02119091|Caucasian|caucasian
245171|NCT02119091|Moxifloxacin|moxifloxacin
245172|NCT02119078|Geriatrics|geriatrics
245173|NCT02119078|Acute Care for Elders|acute care for elders
245174|NCT02119078|Geriatric syndromes|geriatric syndromes
245175|NCT02119078|Delirium|delirium
245176|NCT02119078|Falls|falls
245177|NCT02119078|Polypharmacy|polypharmacy
245178|NCT02119065|Yttrium-90 Radioembolization|yttrium-90 radioembolization
245179|NCT02119065|hepatic malignancy|hepatic malignancy
245180|NCT02119065|hepatic metastatic disease|hepatic metastatic disease
245181|NCT02119039|Cross-linking|cross-linking
245182|NCT02119039|RGTA OTR4120 (CACICOL20)|rgta otr4120 (cacicol20)
245183|NCT02119026|metastatic colorectal cancer|metastatic colorectal cancer
245184|NCT02119026|Patients with metastatic colorectal cancer who did not receive|patients with metastatic colorectal cancer who did not receive
245185|NCT02119026|systemic treatment for their metastatic disease|systemic treatment for their metastatic disease
245186|NCT02118987|Drug Desensitization|drug desensitization
245187|NCT02118987|Hypersensitivity reactions to chemotherapeutic agents|hypersensitivity reactions to chemotherapeutic agents
245188|NCT02118974|Hysterectomy|hysterectomy
245189|NCT02118974|Robot-assisted|robot-assisted
245190|NCT02118974|Laparoscopy|laparoscopy
245191|NCT02118961|Diphtheria|diphtheria
245192|NCT02118961|Tetanus|tetanus
245193|NCT02118961|Pertussis|pertussis
245194|NCT02118961|DTaP vaccine|dtap vaccine
245195|NCT02118961|Adolescents|adolescents
245196|NCT02118948|abuse|abuse
245197|NCT02118948|sexual behavior|sexual behavior
245198|NCT02118948|sexual risk reduction|sexual risk reduction
245199|NCT02118948|behavioral intervention|behavioral intervention
245200|NCT02118896|Tacrolimus|tacrolimus
245201|NCT02118896|FK506E|fk506e
245202|NCT02118896|MR4|mr4
245203|NCT02118896|Advagraf|advagraf
245204|NCT02118896|Kidney Transplantation|kidney transplantation
245205|NCT02118896|Renal Transplantation|renal transplantation
245206|NCT02118896|Heart Transplantation|heart transplantation
245207|NCT02118883|exercise|exercise
245208|NCT02118883|hydration|hydration
245209|NCT02118883|dehydration|dehydration
245210|NCT02118883|rehydration|rehydration
245211|NCT02118883|alkaline water|alkaline water
245212|NCT02118883|blood viscosity|blood viscosity
245213|NCT02118883|plasma osmolality|plasma osmolality
245214|NCT02118883|bioimpedance|bioimpedance
245215|NCT02118870|ACS patients|acs patients
245216|NCT02118870|Older than 18 years|older than 18 years
245217|NCT02118870|PCI|pci
245218|NCT02118870|Combo stent|combo stent
245219|NCT02118857|Microorganisms and foods|microorganisms and foods
245220|NCT02118857|Fecal microbiota|fecal microbiota
245221|NCT02118857|Salivary microbiota|salivary microbiota
245222|NCT02118844|bariatric surgery|bariatric surgery
245223|NCT02118844|surgical conditions|surgical conditions
245224|NCT02118844|deep neuromuscular blockade|deep neuromuscular blockade
245225|NCT02118831|macular degeneration|macular degeneration
245226|NCT02118831|diabetic macular edema|diabetic macular edema
245227|NCT02118831|vein occlusion|vein occlusion
245228|NCT02118831|vascular endothelial growth factor|vascular endothelial growth factor
245229|NCT02118805|ALS|als
245230|NCT02118805|Myasthenia Gravis|myasthenia gravis
245231|NCT02118805|Myopathy|myopathy
245232|NCT02118805|Stroke|stroke
245233|NCT02118805|Parkinson's Disease|parkinson's disease
245234|NCT02118805|Bulbar|bulbar
245235|NCT02118805|Orofacial|orofacial
245236|NCT02118805|Ultrasound|ultrasound
245237|NCT02118805|Electrical Impedance Myography|electrical impedance myography
245238|NCT02118792|atopic dermatitis|atopic dermatitis
245239|NCT02118779|Myotonic Dystrophy Type 1|myotonic dystrophy type 1
245240|NCT02118779|DM1|dm1
245241|NCT02118779|Physical Exercise|physical exercise
245242|NCT02118779|Cognitive Behavioural Therapy|cognitive behavioural therapy
245243|NCT02118779|Biomarkers|biomarkers
245244|NCT02118766|atopic dermatitis|atopic dermatitis
245245|NCT02118753|ischemia-reperfusion injury|ischemia-reperfusion injury
245246|NCT02118740|Autologous Stem Cells|autologous stem cells
245247|NCT02118740|Spinal Cord Injury|spinal cord injury
245248|NCT02118740|Preclinical|preclinical
245249|NCT02118727|ALS|als
245250|NCT02118727|FTD|ftd
245251|NCT02118727|Tau|tau
245252|NCT02118727|pNF-H/C3|pnf-h/c3
245253|NCT02118714|Diabetic Nephropathies|diabetic nephropathies
245254|NCT02118714|Kidney Diseases|kidney diseases
245255|NCT02118714|Urologic Diseases|urologic diseases
245256|NCT02118714|Diabetes Complications|diabetes complications
245257|NCT02118714|Diabetes Mellitus|diabetes mellitus
245258|NCT02118714|Endocrine System Diseases|endocrine system diseases
245259|NCT02118701|Shared decision making|shared decision making
245260|NCT02118701|Dementia|dementia
245261|NCT02118701|Long-term care|long-term care
245262|NCT02118701|Nursing home|nursing home
245263|NCT02118701|Care plan|care plan
245264|NCT02118636|Joint pain|joint pain
245265|NCT02118636|Hormone receptor positive breast cancer|hormone receptor positive breast cancer
245266|NCT02118636|Estrogen|estrogen
245267|NCT02118636|Androgen|androgen
245268|NCT02118623|Bipolar Disorder|bipolar disorder
245269|NCT02118623|Bipolar|bipolar
245270|NCT02118623|Online intervention|online intervention
245271|NCT02118623|Internet intervention|internet intervention
245272|NCT02118623|Self help|self help
245273|NCT02118545|vWF|vwf
245274|NCT02118545|Liver Resection|liver resection
245275|NCT02118545|Liver Dysfunction|liver dysfunction
245276|NCT02118545|Liver Regeneration|liver regeneration
245277|NCT02118545|Postoperative Outcome|postoperative outcome
245278|NCT02118532|Atherosclerosis|atherosclerosis
245279|NCT02118532|Superficial Femoral Artery|superficial femoral artery
245280|NCT02118532|Proximal Popliteal Artery|proximal popliteal artery
245281|NCT02118519|Bone marrow derived Mesenchymal Stem Cells|bone marrow derived mesenchymal stem cells
245282|NCT02118519|Knee articular cartilage injury|knee articular cartilage injury
245283|NCT02118519|Chondrogenesis|chondrogenesis
245284|NCT02118519|orthopedics|orthopedics
245285|NCT02118506|Primary Parkinsonism.|primary parkinsonism.
245286|NCT02118506|Rehabilitation.|rehabilitation.
245287|NCT02118506|Biomechanics.|biomechanics.
245288|NCT02118506|Neurological gait disorders.|neurological gait disorders.
245289|NCT02118493|Benign Biliary Stenosis|benign biliary stenosis
245290|NCT02118493|Laser Excision|laser excision
245291|NCT02118480|Parkinson disease, cognitive rehabilitation, REHACOP|parkinson disease, cognitive rehabilitation, rehacop
245292|NCT02118467|Shock|shock
245293|NCT02118467|Vasopressor agents|vasopressor agents
245294|NCT02118467|Norepinephrine|norepinephrine
245295|NCT02118467|Epinephrine|epinephrine
245296|NCT02118467|Phenylephrine|phenylephrine
245297|NCT02118467|Vasopressin|vasopressin
245298|NCT02118467|Atrial fibrillation|atrial fibrillation
245299|NCT02118467|Tachyarrhythmia|tachyarrhythmia
245300|NCT02118454|Medication adherence|medication adherence
245301|NCT02118454|Self-management|self-management
245302|NCT02118454|Depression|depression
245303|NCT02118454|Coping|coping
245304|NCT02118454|Social support|social support
245305|NCT02118454|Mobile health|mobile health
245306|NCT02118454|Antiretroviral treatment|antiretroviral treatment
245307|NCT02118428|whole blood|whole blood
245308|NCT02118428|transfusion|transfusion
245309|NCT02118428|Plasmodium|plasmodium
245310|NCT02118428|Malaria|malaria
245311|NCT02118428|Pathogen Reduction Technology|pathogen reduction technology
245312|NCT02118428|Whole blood transfusion|whole blood transfusion
245313|NCT02118415|not eligible for surgery|not eligible for surgery
245314|NCT02118415|efficacy of immunotherapy following RCTx|efficacy of immunotherapy following rctx
245315|NCT02118376|obesity; fat distribution; inflammation|obesity; fat distribution; inflammation
245316|NCT02118363|upper limb|upper limb
245317|NCT02118363|lower limb|lower limb
245318|NCT02118363|monitoring|monitoring
245319|NCT02118363|assessment|assessment
245320|NCT02118363|sensor|sensor
245321|NCT02118337|select advanced malignancies,|select advanced malignancies,
245322|NCT02118337|kidney cancer,|kidney cancer,
245323|NCT02118337|clear cell renal cell carcinoma|clear cell renal cell carcinoma
245324|NCT02118324|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
245325|NCT02118324|ALL|all
245326|NCT02118324|fitness intervention|fitness intervention
245327|NCT02118311|Acute Leukemias|acute leukemias
245328|NCT02118311|Burkitt's Lymphoma|burkitt's lymphoma
245329|NCT02118311|Natural Killer Cell Malignancies|natural killer cell malignancies
245330|NCT02118311|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
245331|NCT02118311|Myelodysplastic Syndrome|myelodysplastic syndrome
245332|NCT02118311|Large-Cell Lymphoma|large-cell lymphoma
245333|NCT02118311|Hodgkin Lymphoma|hodgkin lymphoma
245334|NCT02118311|Multiple Myeloma|multiple myeloma
245335|NCT02118311|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
245336|NCT02118311|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
245337|NCT02118311|Marginal Zone B-Cell Lymphoma|marginal zone b-cell lymphoma
245338|NCT02118311|Follicular Lymphoma:|follicular lymphoma:
245339|NCT02118311|Lymphoplasmacytic Lymphoma|lymphoplasmacytic lymphoma
245340|NCT02118311|Mantle-Cell Lymphoma|mantle-cell lymphoma
245341|NCT02118311|Prolymphocytic Leukemia|prolymphocytic leukemia
245342|NCT02118285|Ovarian cancer|ovarian cancer
245343|NCT02118285|Fallopian cancer|fallopian cancer
245344|NCT02118285|Primary peritoneal cancer|primary peritoneal cancer
245345|NCT02118259|Multidisciplinary review of drug prescriptions|multidisciplinary review of drug prescriptions
245346|NCT02118259|Adverse drug events geriatric risk score|adverse drug events geriatric risk score
245347|NCT02118259|Residence for dependent elderly|residence for dependent elderly
245348|NCT02118246|Knee pain,Dry Needling, kinesioTape,Trigger point|knee pain,dry needling, kinesiotape,trigger point
245349|NCT02118233|carotid|carotid
245350|NCT02118233|stenosis|stenosis
245351|NCT02118233|surgery|surgery
245352|NCT02118233|cognitive|cognitive
245353|NCT02118233|unilateral|unilateral
245354|NCT02118207|SCUBA diving|scuba diving
245355|NCT02118207|Exercise|exercise
245356|NCT02118207|Microparticles|microparticles
245357|NCT02118207|Repetitive diving|repetitive diving
245358|NCT02118207|Endothelial function|endothelial function
245359|NCT02118194|paraplegia|paraplegia
245360|NCT02118194|paralysis|paralysis
245361|NCT02118194|robotics|robotics
245362|NCT02118194|walking|walking
245363|NCT02118194|immobilization|immobilization
245364|NCT02118168|HIV|hiv
245365|NCT02118168|HAART|haart
245366|NCT02118168|Tat Protein|tat protein
245367|NCT02118129|Vitamin D|vitamin d
245368|NCT02118129|Intervention|intervention
245369|NCT02118129|Behaviour|behaviour
245370|NCT02118129|Mobile app|mobile app
245371|NCT02118116|ASIST, gatekeeper, suicide, intervention, First Nations, Aboriginal, educational, prevention, safety|asist, gatekeeper, suicide, intervention, first nations, aboriginal, educational, prevention, safety
245372|NCT02118103|Lumbosacral Region|lumbosacral region
245373|NCT02118103|Psychomotor Performance|psychomotor performance
245374|NCT02118103|Manipulation, Spinal|manipulation, spinal
245375|NCT02118090|malaria|malaria
245376|NCT02118090|Plasmodium vivax|plasmodium vivax
245377|NCT02118090|drug resistance|drug resistance
245378|NCT02118090|chloroquine|chloroquine
245379|NCT02118090|Cambodia|cambodia
245380|NCT02118064|G17DT|g17dt
245381|NCT02118064|irinotecan|irinotecan
245382|NCT02118064|Colorectal Cancer|colorectal cancer
245383|NCT02118051|Infertility|infertility
245384|NCT02118051|IVF|ivf
245385|NCT02118051|Corifollitropin Alfa treatment|corifollitropin alfa treatment
245386|NCT02118051|Ovarian stimulation|ovarian stimulation
245387|NCT02118038|Postpartum haemorrhage|postpartum haemorrhage
245388|NCT02118038|Sulprostone|sulprostone
245389|NCT02118038|Cardiac impact|cardiac impact
245390|NCT02118038|Emotional impact|emotional impact
245391|NCT02118038|Cardiac magnetic imaging resonance|cardiac magnetic imaging resonance
245392|NCT02118025|Off-pump bypass graft surgery|off-pump bypass graft surgery
245393|NCT02118025|Mini extracorporeal circulation bypass surgery|mini extracorporeal circulation bypass surgery
245394|NCT02118012|Chlorcyclizine HCL|chlorcyclizine hcl
245395|NCT02118012|Direct Acting Antivirals|direct acting antivirals
245396|NCT02118012|Ribavirin|ribavirin
245397|NCT02118012|Hepatitis C|hepatitis c
245398|NCT02117999|corneal cross-linking|corneal cross-linking
245399|NCT02117999|transepithelial corneal cross-linking|transepithelial corneal cross-linking
245400|NCT02117999|iontophoresis|iontophoresis
245401|NCT02117999|progressive keratoconus|progressive keratoconus
245402|NCT02117986|critically ill patients|critically ill patients
245403|NCT02117986|colistin dosing|colistin dosing
245404|NCT02117986|multidrug resistant bacteria|multidrug resistant bacteria
245405|NCT02117960|atherosclerotic|atherosclerotic
245406|NCT02117960|BMP-4|bmp-4
245407|NCT02117960|YKL40|ykl40
245408|NCT02117960|HSP70|hsp70
245409|NCT02117960|HSP27|hsp27
245410|NCT02117947|child secondhand smoke|child secondhand smoke
245411|NCT02117947|maternal smoking|maternal smoking
245412|NCT02117947|tobacco|tobacco
245413|NCT02117947|nicotine|nicotine
245414|NCT02117947|behavioral counseling|behavioral counseling
245415|NCT02117947|low-income|low-income
245416|NCT02117947|underserved|underserved
245417|NCT02117934|HBV vaccine|hbv vaccine
245418|NCT02117934|HEPLISAV-B|heplisav-b
245419|NCT02117934|Hepatitis B vaccine|hepatitis b vaccine
245420|NCT02117934|Hepatitis B|hepatitis b
245421|NCT02117934|Hepatitis|hepatitis
245422|NCT02117934|Hepatitis B virus (HBV)|hepatitis b virus (hbv)
245423|NCT02117934|Prevention and Control|prevention and control
245424|NCT02117934|Healthy|healthy
245425|NCT02117934|Healthy volunteers|healthy volunteers
245426|NCT02117921|Mind Body Syndrome|mind body syndrome
245427|NCT02117921|MBS|mbs
245428|NCT02117921|Chronic Pain|chronic pain
245429|NCT02117908|prevention|prevention
245430|NCT02117908|radiofrequency treatment|radiofrequency treatment
245431|NCT02117908|lung cancer ablation|lung cancer ablation
245432|NCT02117895|Distal Pancreatectomy|distal pancreatectomy
245433|NCT02117895|Celiac Plexus|celiac plexus
245434|NCT02117895|Resection|resection
245435|NCT02117895|Pancreatic Cancer|pancreatic cancer
245436|NCT02117895|Body and Tail|body and tail
245437|NCT02117882|lateral approach, bone augmentation , sinus floor elevation|lateral approach, bone augmentation , sinus floor elevation
245438|NCT02117869|Grapefruit juice|grapefruit juice
245439|NCT02117856|Implant-Supported Denture|implant-supported denture
245440|NCT02117856|Single-Implant Denture|single-implant denture
245441|NCT02117856|Patient Satisfaction|patient satisfaction
245442|NCT02117856|Edentulous Mandible|edentulous mandible
245443|NCT02117856|Dental Implants|dental implants
245444|NCT02117856|Standard of Care|standard of care
245445|NCT02117856|Randomized Clinical Trial|randomized clinical trial
245446|NCT02117830|To determine|to determine
245447|NCT02117830|effects|effects
245448|NCT02117830|once|once
245449|NCT02117830|daily|daily
245450|NCT02117830|oral doses|oral doses
245451|NCT02117830|Androxal|androxal
245452|NCT02117804|Discharge Planning|discharge planning
245453|NCT02117804|Decision Support|decision support
245454|NCT02117791|Riociguat, Adempas, sGC stimulator, CTEPH, Japan, PMS|riociguat, adempas, sgc stimulator, cteph, japan, pms
245455|NCT02117765|T1D|t1d
245456|NCT02117765|ustekinumab|ustekinumab
245457|NCT02117765|new-onset|new-onset
245458|NCT02117765|diabetes|diabetes
245459|NCT02117726|Sedation;|sedation;
245460|NCT02117726|ARDS;|ards;
245461|NCT02117726|Mechanical ventilation|mechanical ventilation
245462|NCT02117726|Hypnotics|hypnotics
245463|NCT02117726|Antianxiety Drugs|antianxiety drugs
245464|NCT02117726|Causing|causing
245465|NCT02117726|Adverse Effects|adverse effects
245466|NCT02117726|Therapeutic Use|therapeutic use
245467|NCT02117700|fatty liver|fatty liver
245468|NCT02117700|obesity|obesity
245469|NCT02117700|children|children
245470|NCT02117700|oxidative stress|oxidative stress
245471|NCT02117700|antioxidants|antioxidants
245472|NCT02117674|colonoscopy|colonoscopy
245473|NCT02117674|adenoma detection rate|adenoma detection rate
245474|NCT02117674|full spectrum colonoscopy|full spectrum colonoscopy
245475|NCT02117674|right colon retroflexion|right colon retroflexion
245476|NCT02117674|feasibility|feasibility
245477|NCT02117661|L-carnitine|l-carnitine
245478|NCT02117661|Metabolic syndrome|metabolic syndrome
245479|NCT02117661|Atherosclerosis|atherosclerosis
245480|NCT02117661|Coronary artery disease|coronary artery disease
245481|NCT02117661|Carotid|carotid
245482|NCT02117661|Plaque|plaque
245483|NCT02117661|Cardiovascular disease|cardiovascular disease
245484|NCT02117661|Heart disease|heart disease
245485|NCT02117661|Vascular disease|vascular disease
245486|NCT02117648|advanced cancer|advanced cancer
245487|NCT02117648|metastatic cancer|metastatic cancer
245488|NCT02117635|Efficacy|efficacy
245489|NCT02117635|Non comparative|non comparative
245490|NCT02117635|Neural stem cells|neural stem cells
245491|NCT02117635|Intracranial administration|intracranial administration
245492|NCT02117609|Elderly|elderly
245493|NCT02117609|Nursing home|nursing home
245494|NCT02117609|Functional impairment|functional impairment
245495|NCT02117609|High-protein oral supplement|high-protein oral supplement
245496|NCT02117596|Pediatric|pediatric
245497|NCT02117596|Renal|renal
245498|NCT02117596|Transplant|transplant
245499|NCT02117583|pharmacokinetics|pharmacokinetics
245500|NCT02117583|relative bioavailability|relative bioavailability
245501|NCT02117583|food effects|food effects
245502|NCT02117583|oxycodone|oxycodone
245503|NCT02117570|Clostridium difficile|clostridium difficile
245504|NCT02117570|vaccine|vaccine
245505|NCT02117557|Single-incision|single-incision
245506|NCT02117557|Laparoscopy|laparoscopy
245507|NCT02117557|Colorectal Cancer|colorectal cancer
245508|NCT02117544|Contact lens|contact lens
245509|NCT02117544|Presbyopia|presbyopia
245510|NCT02117544|Multifocal|multifocal
245511|NCT02117518|type 1 diabetes|type 1 diabetes
245512|NCT02117518|autoreactive T cells|autoreactive t cells
245513|NCT02117518|beta cell peptides|beta cell peptides
245514|NCT02117518|genetically modified T cells|genetically modified t cells
245515|NCT02117518|mRNA electroporation|mrna electroporation
245516|NCT02117505|Biological Availability|biological availability
245517|NCT02117505|JNJ-39220675|jnj-39220675
245518|NCT02117505|Healthy|healthy
245519|NCT02117505|Phase 1|phase 1
245520|NCT02117492|hysterectomy|hysterectomy
245521|NCT02117492|vaginal cuff|vaginal cuff
245522|NCT02117479|Metastatic pancreatic cancer|metastatic pancreatic cancer
245523|NCT02117479|Metastatic pancreatic adenocarcinoma that is recurrent|metastatic pancreatic adenocarcinoma that is recurrent
245524|NCT02117466|cetuximab|cetuximab
245525|NCT02117466|PET-imaging|pet-imaging
245526|NCT02117453|ANCA vasculitis|anca vasculitis
245527|NCT02117453|Statin|statin
245528|NCT02117453|Subclinical markers of atherosclerosis|subclinical markers of atherosclerosis
245529|NCT02117453|Cardiovascular events|cardiovascular events
245530|NCT02117453|Myocardial infarction|myocardial infarction
245531|NCT02117453|Stroke|stroke
245532|NCT02117453|Arterial revascularization|arterial revascularization
245533|NCT02117453|Unstable angina|unstable angina
245534|NCT02117453|Death|death
245535|NCT02117440|Lung Cancer|lung cancer
245536|NCT02117440|Lung Neoplasms|lung neoplasms
245537|NCT02117414|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
245538|NCT02117388|Older adults|older adults
245539|NCT02117388|insomnia|insomnia
245540|NCT02117388|CBT-I (cognitive behavioral therapy-insomnia)|cbt-i (cognitive behavioral therapy-insomnia)
245541|NCT02117388|Behavioral Therapy|behavioral therapy
245542|NCT02117388|SRT (sleep restriction therapy)|srt (sleep restriction therapy)
245543|NCT02117388|Cognitive Therapy|cognitive therapy
245544|NCT02117375|multiple sclerosis|multiple sclerosis
245545|NCT02117375|spinal cord|spinal cord
245546|NCT02117375|MRI|mri
245547|NCT02117375|longitudinal study|longitudinal study
245548|NCT02117375|disability|disability
245549|NCT02117362|Melanoma|melanoma
245550|NCT02117362|Ipilimumab|ipilimumab
245551|NCT02117362|Yervoy|yervoy
245552|NCT02117362|Galectin|galectin
245553|NCT02117362|GR-MD-02|gr-md-02
245554|NCT02117362|galactoarabino-rhamnogalacturonate|galactoarabino-rhamnogalacturonate
245555|NCT02117362|galectin-3 inhibitor|galectin-3 inhibitor
245556|NCT02117362|Providence Health & Services|providence health & services
245557|NCT02117362|Earle A. Chiles Research Institute|earle a. chiles research institute
245558|NCT02117362|Robert W. Franz Cancer Center|robert w. franz cancer center
245559|NCT02117362|Immunotherapy|immunotherapy
245560|NCT02117349|surgical hemostasis|surgical hemostasis
245561|NCT02117349|bleeding|bleeding
245562|NCT02117349|fibrin sealant|fibrin sealant
245563|NCT02117349|fibrinogen|fibrinogen
245564|NCT02117349|thrombin|thrombin
245565|NCT02117349|spray dried|spray dried
245566|NCT02117323|corneal opacities|corneal opacities
245567|NCT02117323|Optical coherence tomography|optical coherence tomography
245568|NCT02117284|positron emission tomography (PET)|positron emission tomography (pet)
245569|NCT02117284|Rubidium-82|rubidium-82
245570|NCT02117284|myocardial perfusion imaging|myocardial perfusion imaging
245571|NCT02117284|automated elution system|automated elution system
245572|NCT02117284|controlled radioactivity delivery|controlled radioactivity delivery
245573|NCT02117271|obstructive sleep apnea|obstructive sleep apnea
245574|NCT02117271|treatment|treatment
245575|NCT02117271|placebo|placebo
245576|NCT02117271|appearance|appearance
245577|NCT02117271|skin quality|skin quality
245578|NCT02117258|Z-360, Pancreatic cancer, Pancreatic Adenocarcinoma|z-360, pancreatic cancer, pancreatic adenocarcinoma
245579|NCT02117245|Food effect on MGCD265 bioavailability in healthy volunteers|food effect on mgcd265 bioavailability in healthy volunteers
245580|NCT02117232|colonoscopy|colonoscopy
245581|NCT02117232|cecal intubation|cecal intubation
245582|NCT02117232|carbon dioxide insufflation|carbon dioxide insufflation
245583|NCT02117219|Myelodysplastic syndrome|myelodysplastic syndrome
245584|NCT02117219|MDS|mds
245585|NCT02117206|L-arginine|l-arginine
245586|NCT02117180|functional gastrointestinal disorders|functional gastrointestinal disorders
245587|NCT02117180|FGID|fgid
245588|NCT02117180|children|children
245589|NCT02117180|FODMAP|fodmap
245590|NCT02117154|Continuous Glucose Monitoring System|continuous glucose monitoring system
245591|NCT02117154|HbA1c|hba1c
245592|NCT02117154|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
245593|NCT02117141|Food Effect|food effect
245594|NCT02117141|Pharmacokinetics|pharmacokinetics
245595|NCT02117128|Tranexamic Acid|tranexamic acid
245596|NCT02117128|Antifibrinolytic|antifibrinolytic
245597|NCT02117128|Blood transfusion|blood transfusion
245598|NCT02117128|Total knee arthroplasty|total knee arthroplasty
245599|NCT02117076|Restless leg syndrome|restless leg syndrome
245600|NCT02117076|RLS|rls
245601|NCT02117076|gabapentin|gabapentin
245602|NCT02117076|gabapentin enacarbil|gabapentin enacarbil
245603|NCT02117076|Neurontin|neurontin
245604|NCT02117076|Horizant|horizant
245605|NCT02117050|Multiple Sclerosis|multiple sclerosis
245606|NCT02117050|Rebif ®|rebif ®
245607|NCT02117050|Tecfidera ™|tecfidera ™
245608|NCT02117050|treatment change|treatment change
245609|NCT02117024|lung|lung
245610|NCT02117024|cancer|cancer
245611|NCT02117024|gp96|gp96
245612|NCT02117024|vaccine|vaccine
245613|NCT02117024|immunotherapy|immunotherapy
245614|NCT02117024|Heat Biologics|heat biologics
245615|NCT02117024|cyclophosphamide|cyclophosphamide
245616|NCT02117024|vinorelbine|vinorelbine
245617|NCT02117024|erlotinib|erlotinib
245618|NCT02117024|gemcitabine|gemcitabine
245619|NCT02117024|paclitaxel|paclitaxel
245620|NCT02117024|docetaxel|docetaxel
245621|NCT02117024|pemetrexed|pemetrexed
245622|NCT02116998|GEN-004|gen-004
245623|NCT02116998|Aluminum hydroxide|aluminum hydroxide
245624|NCT02116998|Vaccine|vaccine
245625|NCT02116998|Streptococcus pneumoniae|streptococcus pneumoniae
245626|NCT02116998|Pneumococcal Infections|pneumococcal infections
245627|NCT02116998|Strep pneumoniae|strep pneumoniae
245628|NCT02116998|Pneumonia|pneumonia
245629|NCT02116985|Dual-Loop TCI|dual-loop tci
245630|NCT02116985|NI|ni
245631|NCT02116985|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
245632|NCT02116972|osteoarthritis|osteoarthritis
245633|NCT02116972|knee|knee
245634|NCT02116972|pain|pain
245635|NCT02116972|corticosteroid|corticosteroid
245636|NCT02116972|intra-articular|intra-articular
245637|NCT02116972|injection|injection
245638|NCT02116959|Systemic|systemic
245639|NCT02116959|Chemotherapy|chemotherapy
245640|NCT02116959|Melphalan|melphalan
245641|NCT02116933|Autologous Fat Grafting|autologous fat grafting
245642|NCT02116933|Breast Augmentation|breast augmentation
245643|NCT02116933|Stromal Vascular Fraction|stromal vascular fraction
245644|NCT02116933|Adipose Derived Stem Cell|adipose derived stem cell
245645|NCT02116920|CIN|cin
245646|NCT02116920|HPV DNA|hpv dna
245647|NCT02116920|mRNA E6/E7|mrna e6/e7
245648|NCT02116920|CIN triage|cin triage
245649|NCT02116920|Cervix Biopsy|cervix biopsy
245650|NCT02116920|VIA|via
245651|NCT02116920|Cervix Cancer|cervix cancer
245652|NCT02116907|Healthy|healthy
245653|NCT02116907|Male Subjects|male subjects
245654|NCT02116894|Colorectal cancer|colorectal cancer
245655|NCT02116894|PF-03446962|pf-03446962
245656|NCT02116894|regorafenib|regorafenib
245657|NCT02116881|Incisional hernia|incisional hernia
245658|NCT02116881|colorectal surgery|colorectal surgery
245659|NCT02116881|bowel obstruction|bowel obstruction
245660|NCT02116868|Pupillometry|pupillometry
245661|NCT02116868|Pupillary reflex|pupillary reflex
245662|NCT02116868|Analgesia|analgesia
245663|NCT02116868|Laparoscopic surgery|laparoscopic surgery
245664|NCT02116868|Total intravenous anesthesia|total intravenous anesthesia
245665|NCT02116868|Target controlled infusion|target controlled infusion
245666|NCT02116803|solid tumors|solid tumors
245667|NCT02116803|TKI258|tki258
245668|NCT02116803|Dovitinib|dovitinib
245669|NCT02116803|fulvestrant|fulvestrant
245670|NCT02116803|cancers with a mass|cancers with a mass
245671|NCT02116803|bulky tumor|bulky tumor
245672|NCT02116803|nodule|nodule
245673|NCT02116803|lump|lump
245674|NCT02116803|cancer|cancer
245675|NCT02116803|solid malignancies|solid malignancies
245676|NCT02116790|acute|acute
245677|NCT02116790|pain|pain
245678|NCT02116764|Hematopoietic (Stem) Cell Transplantation|hematopoietic (stem) cell transplantation
245679|NCT02116764|Primary Immune Deficiency Consortium|primary immune deficiency consortium
245680|NCT02116751|HIV, antiretroviral, toxicity, eGFR, tubular disease, BMD|hiv, antiretroviral, toxicity, egfr, tubular disease, bmd
245681|NCT02116738|flap|flap
245682|NCT02116738|pilonidal sinus|pilonidal sinus
245683|NCT02116738|vas|vas
245684|NCT02116738|recurrence|recurrence
245685|NCT02116712|LAM|lam
245686|NCT02116712|saracatinib|saracatinib
245687|NCT02116712|Lymphangioleiomyomatosis|lymphangioleiomyomatosis
245688|NCT02116699|oropharyngeal|oropharyngeal
245689|NCT02116699|colostrum|colostrum
245690|NCT02116699|mother's milk|mother's milk
245691|NCT02116699|premature|premature
245692|NCT02116699|neonate|neonate
245693|NCT02116699|infection|infection
245694|NCT02116699|necrotizing enterocolitis|necrotizing enterocolitis
245695|NCT02116699|ventilator-associated pneumonia|ventilator-associated pneumonia
245696|NCT02116699|breastmilk|breastmilk
245697|NCT02116699|human milk|human milk
245698|NCT02116699|late-onset sepsis|late-onset sepsis
245699|NCT02116699|microbiome|microbiome
245700|NCT02116699|antioxidant|antioxidant
245701|NCT02116699|enteral feeds|enteral feeds
245702|NCT02116686|chronic heart failure|chronic heart failure
245703|NCT02116686|Polysomnography|polysomnography
245704|NCT02116686|Sleep Apnea Syndromes|sleep apnea syndromes
245705|NCT02116686|Electrocardiogram|electrocardiogram
245706|NCT02116673|Head injury|head injury
245707|NCT02116673|Concussion|concussion
245708|NCT02116673|Cognitive rest|cognitive rest
245709|NCT02116673|Emergency department|emergency department
245710|NCT02116647|Gender discrimination|gender discrimination
245711|NCT02116647|Psychoanalysis|psychoanalysis
245712|NCT02116647|Randomized controlled trial|randomized controlled trial
245713|NCT02116621|Musculoskeletal pain|musculoskeletal pain
245714|NCT02116621|Chronic pain|chronic pain
245715|NCT02116621|Patient centered outcomes research|patient centered outcomes research
245716|NCT02116621|Physician patient relationship|physician patient relationship
245717|NCT02116621|Mobile applications|mobile applications
245718|NCT02116595|volunteers|volunteers
245719|NCT02116582|MDV3100|mdv3100
245720|NCT02116582|Xtandi|xtandi
245721|NCT02116582|Abiraterone|abiraterone
245722|NCT02116582|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
245723|NCT02116582|Enzalutamide|enzalutamide
245724|NCT02116569|Multiple Myeloma|multiple myeloma
245725|NCT02116569|Daratumumab|daratumumab
245726|NCT02116569|JNJ-54767414|jnj-54767414
245727|NCT02116569|Phase 1|phase 1
245728|NCT02116569|Relapse|relapse
245729|NCT02116569|Refractory|refractory
245730|NCT02116556|Alcoholic Hepatitis|alcoholic hepatitis
245731|NCT02116556|Bacterial Infections|bacterial infections
245732|NCT02116556|Acute-on-Chronic Liver Failure|acute-on-chronic liver failure
245733|NCT02116543|Hepatitis C|hepatitis c
245734|NCT02116543|HCV|hcv
245735|NCT02116517|obese women|obese women
245736|NCT02116517|high LDL-C|high ldl-c
245737|NCT02116504|Rheumatoid arthritis|rheumatoid arthritis
245738|NCT02116504|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
245739|NCT02116504|Biopharmaceutical|biopharmaceutical
245740|NCT02116504|Immunogenicity|immunogenicity
245741|NCT02116504|Anti-Drug Antibody|anti-drug antibody
245742|NCT02116504|Prediction|prediction
245743|NCT02116478|plantar fasciitis|plantar fasciitis
245744|NCT02116478|gastrocnemius recession|gastrocnemius recession
245745|NCT02116439|Violence|violence
245746|NCT02116426|copeptin|copeptin
245747|NCT02116426|troponin HS|troponin hs
245748|NCT02116413|fluid challenge|fluid challenge
245749|NCT02116413|fluid resuscitation|fluid resuscitation
245750|NCT02116400|Suicidal ideation|suicidal ideation
245751|NCT02116387|Proprioception|proprioception
245752|NCT02116348|Cerebral palsy children|cerebral palsy children
245753|NCT02116348|Cerebrolysin|cerebrolysin
245754|NCT02116348|Sleep questionnaire|sleep questionnaire
245755|NCT02116348|Quality of life|quality of life
245756|NCT02116348|Bayley III scale|bayley iii scale
245757|NCT02116335|arterial stiffness|arterial stiffness
245758|NCT02116335|flow-mediated dilation|flow-mediated dilation
245759|NCT02116335|endothelial function|endothelial function
245760|NCT02116335|pulse wave velocity|pulse wave velocity
245761|NCT02116335|inflammation|inflammation
245762|NCT02116335|oxidative stress|oxidative stress
245763|NCT02116335|Nitric Oxide|nitric oxide
245764|NCT02116335|Cold Pressor Test|cold pressor test
245765|NCT02116335|physio flow|physio flow
245766|NCT02116335|Bosentan|bosentan
245767|NCT02116335|Endothelin Receptor|endothelin receptor
245768|NCT02116335|Endothelin-1|endothelin-1
245769|NCT02116335|BMI|bmi
245770|NCT02116335|stress|stress
245771|NCT02116335|blood pressure|blood pressure
245772|NCT02116283|smoking|smoking
245773|NCT02116283|healthy|healthy
245774|NCT02116283|smartphone|smartphone
245775|NCT02116270|Renal Failure|renal failure
245776|NCT02116270|Dialysis|dialysis
245777|NCT02116270|Biological Aging|biological aging
245778|NCT02116257|Nausea|nausea
245779|NCT02116257|Vomiting|vomiting
245780|NCT02116244|Dry Eye|dry eye
245781|NCT02116244|Civamide|civamide
245782|NCT02116244|Zucapsaicin|zucapsaicin
245783|NCT02116244|Neuropeptides|neuropeptides
245784|NCT02116244|TRPV-1|trpv-1
245785|NCT02116231|Nasopharyngeal neoplasm;IMRT; Concurrent chemotherapy|nasopharyngeal neoplasm;imrt; concurrent chemotherapy
245786|NCT02116218|Traditional Chinese Medicine|traditional chinese medicine
245787|NCT02116218|acupuncture|acupuncture
245788|NCT02116218|complementary alternative medicine|complementary alternative medicine
245789|NCT02116218|cancer pain|cancer pain
245790|NCT02116218|emergency department|emergency department
245791|NCT02116205|Hantaan virus|hantaan virus
245792|NCT02116205|Puumala virus|puumala virus
245793|NCT02116205|HFRS|hfrs
245794|NCT02116192|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
245795|NCT02116192|Adolescent|adolescent
245796|NCT02116179|Human Immunodeficiency Virus|human immunodeficiency virus
245797|NCT02116179|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
245798|NCT02116179|Hepatitis C|hepatitis c
245799|NCT02116179|Hispanic|hispanic
245800|NCT02116179|Criminal Justice|criminal justice
245801|NCT02116166|aging|aging
245802|NCT02116166|sarcopenia|sarcopenia
245803|NCT02116166|mitochondria|mitochondria
245804|NCT02116166|skeletal muscle|skeletal muscle
245805|NCT02116166|inflammation|inflammation
245806|NCT02116153|Cardiac Troponin T|cardiac troponin t
245807|NCT02116153|Micro-RNA|micro-rna
245808|NCT02116153|Sensitivity|sensitivity
245809|NCT02116153|Specificity|specificity
245810|NCT02116140|positron emission tomography|positron emission tomography
245811|NCT02116140|[11C]hydroxyephedrine (HED)|[11c]hydroxyephedrine (hed)
245812|NCT02116140|[11C]acetate|[11c]acetate
245813|NCT02116140|Adaptive Servoventilation (ASV)|adaptive servoventilation (asv)
245814|NCT02116140|Myocardial Energetics|myocardial energetics
245815|NCT02116140|work-metabolic index (WMI)|work-metabolic index (wmi)
245816|NCT02116140|Myocardial sympathetic neuron (SN) presynaptic function continuous positive airway pressure|myocardial sympathetic neuron (sn) presynaptic function continuous positive airway pressure
245817|NCT02116140|heart rate variability|heart rate variability
245818|NCT02116140|overnight polysomnogram|overnight polysomnogram
245819|NCT02116140|Plasma Norepinephrine|plasma norepinephrine
245820|NCT02116140|Urine Normetanephrine|urine normetanephrine
245821|NCT02116140|Quality of Life|quality of life
245822|NCT02116127|Depression|depression
245823|NCT02116127|Pregnancy|pregnancy
245824|NCT02116127|Transcranial Direct Current Stimulation|transcranial direct current stimulation
245825|NCT02116114|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
245826|NCT02116101|Intestinal Health|intestinal health
245827|NCT02116101|Prebiotics|prebiotics
245828|NCT02116101|Blood Lipid|blood lipid
245829|NCT02116088|Externalizing problem behavior, teacher training, teacher coaching, primary school, elementary school, continuing professional development, advanced training|externalizing problem behavior, teacher training, teacher coaching, primary school, elementary school, continuing professional development, advanced training
245830|NCT02116049|Disclosure, intervention|disclosure, intervention
245831|NCT02116049|HIV|hiv
245832|NCT02116049|prevention|prevention
245833|NCT02116049|Disclosure Intervention|disclosure intervention
245834|NCT02116049|Attention Control Case Management|attention control case management
245835|NCT02116036|Antiphospholipid Antibody Syndrome|antiphospholipid antibody syndrome
245836|NCT02116036|Rivaroxaban|rivaroxaban
245837|NCT02116036|Thromboembolism|thromboembolism
245838|NCT02116036|Bleeding|bleeding
245839|NCT02116036|Feasibility|feasibility
245840|NCT02116023|Satiety, beverage, crossover|satiety, beverage, crossover
245841|NCT02116010|Wound Infection in burned patient|wound infection in burned patient
245842|NCT02115971|chronic|chronic
245843|NCT02115971|functional|functional
245844|NCT02115971|instability|instability
245845|NCT02115971|ankle|ankle
245846|NCT02115945|chronic postoperative pain|chronic postoperative pain
245847|NCT02115945|total knee arthroplasty|total knee arthroplasty
245848|NCT02115945|femoral block|femoral block
245849|NCT02115945|We aimed to compare the effects of epidural and femoral block on acute and chronic postoperative pain.|we aimed to compare the effects of epidural and femoral block on acute and chronic postoperative pain.
245850|NCT02115932|Diabetes Mellitus|diabetes mellitus
245851|NCT02115932|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
245852|NCT02115932|Diabetes Complications|diabetes complications
245853|NCT02115932|Diabetic Foot|diabetic foot
245854|NCT02115932|Diabetic Neuropathies|diabetic neuropathies
245855|NCT02115932|Gait|gait
245856|NCT02115932|Balance, Postural|balance, postural
245857|NCT02115932|Muscle Strength|muscle strength
245858|NCT02115932|Exercise Therapy|exercise therapy
245859|NCT02115932|Physical Therapy Modalities|physical therapy modalities
245860|NCT02115932|Endocrine System Diseases|endocrine system diseases
245861|NCT02115932|Peripheral Nervous System Diseases|peripheral nervous system diseases
245862|NCT02115932|Metabolic Diseases|metabolic diseases
245863|NCT02115932|Glucose Metabolism Diseases|glucose metabolism diseases
245864|NCT02115932|Quality of Life|quality of life
245865|NCT02115932|Training|training
245866|NCT02115919|condyloma|condyloma
245867|NCT02115919|HIV|hiv
245868|NCT02115893|Nitrate|nitrate
245869|NCT02115893|Performance|performance
245870|NCT02115893|Sports|sports
245871|NCT02115880|Depression|depression
245872|NCT02115880|Prevention|prevention
245873|NCT02115880|Adolescent|adolescent
245874|NCT02115880|Child|child
245875|NCT02115880|Randomised Controlled Trial|randomised controlled trial
245876|NCT02115880|Risk|risk
245877|NCT02115880|Cognitive behavioural therapy|cognitive behavioural therapy
245878|NCT02115880|Group-based therapy|group-based therapy
245879|NCT02115867|diverticular disease|diverticular disease
245880|NCT02115867|diverticulitis|diverticulitis
245881|NCT02115867|diverticulosis|diverticulosis
245882|NCT02115854|usefullness of labial biopsy to distinguish between tuberculosis and sarcoidosis|usefullness of labial biopsy to distinguish between tuberculosis and sarcoidosis
245883|NCT02115841|Transcutaneous Nerve Stimulation|transcutaneous nerve stimulation
245884|NCT02115841|serial reaction time task|serial reaction time task
245885|NCT02115841|functional near infrared spectroscopy|functional near infrared spectroscopy
245886|NCT02115841|transcranial magnetic stimulation|transcranial magnetic stimulation
245887|NCT02115828|Vismodegib|vismodegib
245888|NCT02115828|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
245889|NCT02115828|Accessible Metastatic Lesions for Tumor Biopsy|accessible metastatic lesions for tumor biopsy
245890|NCT02115815|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
245891|NCT02115815|MEDI7510|medi7510
245892|NCT02115789|cicatrix|cicatrix
245893|NCT02115789|Demonstrate|demonstrate
245894|NCT02115789|that there|that there
245895|NCT02115789|is no perception of superiority|is no perception of superiority
245896|NCT02115776|bacteremia|bacteremia
245897|NCT02115776|prophylaxis|prophylaxis
245898|NCT02115776|antibiotics|antibiotics
245899|NCT02115776|dentistry|dentistry
245900|NCT02115763|physically active,|physically active,
245901|NCT02115763|18-35 year old men|18-35 year old men
245902|NCT02115750|CHS-0214|chs-0214
245903|NCT02115750|Enbrel|enbrel
245904|NCT02115750|RA|ra
245905|NCT02115750|Biosimilar|biosimilar
245906|NCT02115750|Etanercept|etanercept
245907|NCT02115724|Low childhood SES|low childhood ses
245908|NCT02115724|Early Life Stress|early life stress
245909|NCT02115724|Endothelial function|endothelial function
245910|NCT02115724|Flow mediated dilation|flow mediated dilation
245911|NCT02115724|Cardiovascular disease|cardiovascular disease
245912|NCT02115724|Subcutaneous adipose arterioles|subcutaneous adipose arterioles
245913|NCT02115711|India|india
245914|NCT02115711|Cardiovascular risk factors|cardiovascular risk factors
245915|NCT02115711|Community health workers|community health workers
245916|NCT02115711|Hypertension|hypertension
245917|NCT02115711|Diabetes|diabetes
245918|NCT02115711|Smoking|smoking
245919|NCT02115698|Sarcopenia|sarcopenia
245920|NCT02115698|Frailty|frailty
245921|NCT02115698|Ageing|ageing
245922|NCT02115698|Protein supplementation|protein supplementation
245923|NCT02115698|Protein quality|protein quality
245924|NCT02115698|Exercise training|exercise training
245925|NCT02115698|Muscle protein turnover|muscle protein turnover
245926|NCT02115685|spinal cord injury|spinal cord injury
245927|NCT02115685|sympathetic nervous system|sympathetic nervous system
245928|NCT02115685|locomotor training|locomotor training
245929|NCT02115685|exercise|exercise
245930|NCT02115672|Chronic myeloid leukemia|chronic myeloid leukemia
245931|NCT02115672|imatinib|imatinib
245932|NCT02115672|CXCR4 antagonist|cxcr4 antagonist
245933|NCT02115672|BL-8040|bl-8040
245934|NCT02115659|ADPKD|adpkd
245935|NCT02115659|triptolide|triptolide
245936|NCT02115646|burn|burn
245937|NCT02115646|scar|scar
245938|NCT02115620|Heart failure|heart failure
245939|NCT02115620|Cardiac failure|cardiac failure
245940|NCT02115620|Congestive Heart Failure|congestive heart failure
245941|NCT02115620|Cardiomyopathy|cardiomyopathy
245942|NCT02115620|Myocardial Failure|myocardial failure
245943|NCT02115620|Telemedicine|telemedicine
245944|NCT02115620|Telehealth|telehealth
245945|NCT02115620|Remote Consultation|remote consultation
245946|NCT02115607|Breast cancer|breast cancer
245947|NCT02115607|Interstitial fluid pressure|interstitial fluid pressure
245948|NCT02115607|Angiogenesis|angiogenesis
245949|NCT02115607|Contrast enhanced ultrasound imaging|contrast enhanced ultrasound imaging
245950|NCT02115607|Subharmonic imaging|subharmonic imaging
245951|NCT02115607|Subharmonic pressure estimation|subharmonic pressure estimation
245952|NCT02115594|metastatic breast cancer|metastatic breast cancer
245953|NCT02115594|estrogen receptor|estrogen receptor
245954|NCT02115594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors
245955|NCT02115594|Histone Deacetylases|histone deacetylases
245956|NCT02115594|HDAC inhibitors|hdac inhibitors
245957|NCT02115594|selective estrogen receptor modulator|selective estrogen receptor modulator
245958|NCT02115594|estrogen receptor modulator, selective|estrogen receptor modulator, selective
245959|NCT02115594|Estrogen receptor modulators, selective|estrogen receptor modulators, selective
245960|NCT02115581|Coenzyme O10|coenzyme o10
245961|NCT02115581|Children|children
245962|NCT02115581|Idiopathic Dilated Cardiomyopathy|idiopathic dilated cardiomyopathy
245963|NCT02115555|type 1|type 1
245964|NCT02115555|diabetes|diabetes
245965|NCT02115555|adolescents|adolescents
245966|NCT02115555|heath information technology|heath information technology
245967|NCT02115542|biliary|biliary
245968|NCT02115542|liver|liver
245969|NCT02115542|Refractory Advanced Biliary Cancers|refractory advanced biliary cancers
245970|NCT02115542|gallbladder cancer|gallbladder cancer
245971|NCT02115542|carcinoma|carcinoma
245972|NCT02115542|intra-hepatic biliary system|intra-hepatic biliary system
245973|NCT02115542|extra-hepatic biliary system|extra-hepatic biliary system
245974|NCT02115542|gall bladder|gall bladder
245975|NCT02115542|unresectable|unresectable
245976|NCT02115542|locally advanced|locally advanced
245977|NCT02115542|metastatic disease|metastatic disease
245978|NCT02115542|Bile Duct Diseases|bile duct diseases
245979|NCT02115542|Gallbladder Diseases|gallbladder diseases
245980|NCT02115542|regorafenib|regorafenib
245981|NCT02115542|stivarga|stivarga
245982|NCT02115542|Bay 73-4506|bay 73-4506
245983|NCT02115542|multikinase inhibitor|multikinase inhibitor
245984|NCT02115516|Malaria|malaria
245985|NCT02115516|Plasmodium falciparum malaria|plasmodium falciparum malaria
245986|NCT02115516|Antimalarial chemoprophylaxis|antimalarial chemoprophylaxis
245987|NCT02115516|PfSPZ Challenge|pfspz challenge
245988|NCT02115516|Cryopreserved Plasmodium Falciparum Sporozoites|cryopreserved plasmodium falciparum sporozoites
245989|NCT02115516|PfSPZ-CVac|pfspz-cvac
245990|NCT02115490|Alveolar bone|alveolar bone
245991|NCT02115490|Bisphosphonates|bisphosphonates
245992|NCT02115490|Cone-beam CT|cone-beam ct
245993|NCT02115490|Osteoporosis|osteoporosis
245994|NCT02115477|Uterus cancer|uterus cancer
245995|NCT02115477|Hysterectomy|hysterectomy
245996|NCT02115477|Lymphadenectomy|lymphadenectomy
245997|NCT02115477|Lymphedema|lymphedema
245998|NCT02115464|Metformin|metformin
245999|NCT02115464|Non-small cell lung cancer|non-small cell lung cancer
246000|NCT02115464|Locally advanced|locally advanced
246001|NCT02115464|Chemo-radiotherapy|chemo-radiotherapy
246002|NCT02115464|Lung cancer treatment|lung cancer treatment
246003|NCT02115399|Dermatitis|dermatitis
246004|NCT02115399|Staphylococcus|staphylococcus
246005|NCT02115399|Staphylococcus aureus|staphylococcus aureus
246006|NCT02115399|Dermatitis, Atopic|dermatitis, atopic
246007|NCT02115399|Non-atopic controls|non-atopic controls
246008|NCT02115386|Ph+ CML, chronic myeloid leukemia|ph+ cml, chronic myeloid leukemia
246009|NCT02115373|Hepatocellular Carcinoma|hepatocellular carcinoma
246010|NCT02115373|c-Met inhibitor|c-met inhibitor
246011|NCT02115373|Phase 1b|phase 1b
246012|NCT02115373|Sorafenib|sorafenib
246013|NCT02115373|MSC2156119J|msc2156119j
246014|NCT02115360|epidural calcitonin|epidural calcitonin
246015|NCT02115360|amputation|amputation
246016|NCT02115360|postoperative pain|postoperative pain
246017|NCT02115360|Later Complication|later complication
246018|NCT02115334|Developmental delay|developmental delay
246019|NCT02115334|Early Intervention|early intervention
246020|NCT02115334|Home programs|home programs
246021|NCT02115334|Preschool activities|preschool activities
246022|NCT02115295|Leukemia|leukemia
246023|NCT02115295|Acute Myeloid Leukemia|acute myeloid leukemia
246024|NCT02115295|AML|aml
246025|NCT02115295|High Risk Myelodysplastic Syndrome|high risk myelodysplastic syndrome
246026|NCT02115295|HR MDS|hr mds
246027|NCT02115295|Myeloid Blast Phase of Chronic Myeloid Leukemia|myeloid blast phase of chronic myeloid leukemia
246028|NCT02115295|CML|cml
246029|NCT02115295|Acute Biphenotypic Leukemia|acute biphenotypic leukemia
246030|NCT02115295|Cladribine|cladribine
246031|NCT02115295|Leustatin|leustatin
246032|NCT02115295|2-CdA|2-cda
246033|NCT02115295|Cytarabine|cytarabine
246034|NCT02115295|Ara-C|ara-c
246035|NCT02115295|Cytosar|cytosar
246036|NCT02115295|DepoCyt|depocyt
246037|NCT02115295|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
246038|NCT02115295|Idarubicin|idarubicin
246039|NCT02115295|Idamycin|idamycin
246040|NCT02115295|Phone calls|phone calls
246041|NCT02115269|Indoprocaf|indoprocaf
246042|NCT02115269|Indomethacin|indomethacin
246043|NCT02115269|Caffeine|caffeine
246044|NCT02115269|Prochlorperazine|prochlorperazine
246045|NCT02115269|Migraine with Aura|migraine with aura
246046|NCT02115269|Migraine without Aura|migraine without aura
246047|NCT02115269|Tension-Type Headache|tension-type headache
246048|NCT02115256|External Cephalic Version|external cephalic version
246049|NCT02115256|breech|breech
246050|NCT02115230|Heart Failure|heart failure
246051|NCT02115230|Heart Failure, Diastolic|heart failure, diastolic
246052|NCT02115230|Hypertension|hypertension
246053|NCT02115230|Renal Denervation|renal denervation
246054|NCT02115230|Irrigated Radiofrequency Catheter|irrigated radiofrequency catheter
246055|NCT02115217|Kinestiotaping|kinestiotaping
246056|NCT02115217|Basketball players|basketball players
246057|NCT02115217|Effect of kinesiotaping|effect of kinesiotaping
246058|NCT02115217|on postural stability|on postural stability
246059|NCT02115191|2-octylcyanoacrylate|2-octylcyanoacrylate
246060|NCT02115191|Urethrocutaneous fistulas.|urethrocutaneous fistulas.
246061|NCT02115191|Closure.|closure.
246062|NCT02115191|Recurrence.|recurrence.
246063|NCT02115178|Hemodynamic changes|hemodynamic changes
246064|NCT02115178|Spinal anesthesia|spinal anesthesia
246065|NCT02115178|Patient position|patient position
246066|NCT02115178|Impedance cardiography|impedance cardiography
246067|NCT02115152|Capecitabine|capecitabine
246068|NCT02115152|Neoadjuvant therapy|neoadjuvant therapy
246069|NCT02115152|Early Breast Cancer|early breast cancer
246070|NCT02115139|melanoma|melanoma
246071|NCT02115139|brain|brain
246072|NCT02115139|metastases|metastases
246073|NCT02115139|Patients with melanoma and brain metastases|patients with melanoma and brain metastases
246074|NCT02115113|Liver transplantation, everolimus, CNI-minimization, CNI-elimination, renal function|liver transplantation, everolimus, cni-minimization, cni-elimination, renal function
246075|NCT02115100|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
246076|NCT02115100|Persistent atrial fibrillation|persistent atrial fibrillation
246077|NCT02115100|Out of range hypertension|out of range hypertension
246078|NCT02115100|Signs of sympathetic overdrive|signs of sympathetic overdrive
246079|NCT02115087|laparotomy|laparotomy
246080|NCT02115087|levobupivacaine|levobupivacaine
246081|NCT02115087|patient controlled analgesia|patient controlled analgesia
246082|NCT02115074|Low-grade gliomas|low-grade gliomas
246083|NCT02115074|high-grade gliomas|high-grade gliomas
246084|NCT02115074|optico-chiasmatic|optico-chiasmatic
246085|NCT02115074|relapsed|relapsed
246086|NCT02115074|refractory|refractory
247667|NCT02108626|Nicotine|nicotine
246087|NCT02115061|Gastric varices,coil,cyanoacrylate,treating gastric varices.|gastric varices,coil,cyanoacrylate,treating gastric varices.
246088|NCT02115035|Multiple Myeloma|multiple myeloma
246089|NCT02115022|pancreatic cancer|pancreatic cancer
246090|NCT02115022|resectability|resectability
246091|NCT02115022|endosonography (EUS)|endosonography (eus)
246092|NCT02115022|multidetection computer tomography (MDCT)|multidetection computer tomography (mdct)
246093|NCT02115022|staging|staging
246094|NCT02115009|sacroiliac joint lumbopelvic ,chronic low back pain|sacroiliac joint lumbopelvic ,chronic low back pain
246095|NCT02114996|mechanical ventilation|mechanical ventilation
246096|NCT02114996|ischemic stroke|ischemic stroke
246097|NCT02114983|deep vein thrombosis|deep vein thrombosis
246098|NCT02114983|diagnostic accuracy|diagnostic accuracy
246099|NCT02114983|general practitioner|general practitioner
246100|NCT02114983|test|test
246101|NCT02114983|compression ultrasonography|compression ultrasonography
246102|NCT02114983|ultrasound|ultrasound
246103|NCT02114970|Older Adults|older adults
246104|NCT02114970|Informed Consent|informed consent
246105|NCT02114970|Technology|technology
246106|NCT02114970|Tablet-delivered|tablet-delivered
246107|NCT02114957|bio-availability|bio-availability
246108|NCT02114957|decursin|decursin
246109|NCT02114957|decursinol angelate|decursinol angelate
246110|NCT02114957|decursinol|decursinol
246111|NCT02114957|subjects|subjects
246112|NCT02114944|Do-not-intubate|do-not-intubate
246113|NCT02114944|DNI|dni
246114|NCT02114944|Palliative treatment|palliative treatment
246115|NCT02114944|Acute respiratory failure|acute respiratory failure
246116|NCT02114944|Acute on chronic respiratory failure|acute on chronic respiratory failure
246117|NCT02114944|Hypoxia|hypoxia
246118|NCT02114944|Respiratory acidosis|respiratory acidosis
246119|NCT02114944|Hypercarbia|hypercarbia
246120|NCT02114944|Non invasive ventilation|non invasive ventilation
246121|NCT02114944|NIV|niv
246122|NCT02114944|CPAP|cpap
246123|NCT02114944|Oxygen-therapy|oxygen-therapy
246124|NCT02114944|High-flow oxygen therapy|high-flow oxygen therapy
246125|NCT02114931|arthritis|arthritis
246126|NCT02114931|rheumatoid|rheumatoid
246127|NCT02114918|obsessive compulsive disorder|obsessive compulsive disorder
246128|NCT02114918|children|children
246129|NCT02114918|adolescents|adolescents
246130|NCT02114918|attention bias modification|attention bias modification
246131|NCT02114905|Tourette's|tourette's
246132|NCT02114905|Tic Disorder|tic disorder
246133|NCT02114905|CBIT|cbit
246134|NCT02114905|Dissemination|dissemination
246135|NCT02114905|Occupational Therapist|occupational therapist
246136|NCT02114892|metabolic syndrome|metabolic syndrome
246137|NCT02114892|central obesity|central obesity
246138|NCT02114892|resveratrol|resveratrol
246139|NCT02114892|insulin secretion|insulin secretion
246140|NCT02114892|insulin sensitivity|insulin sensitivity
246141|NCT02114879|Physical Therapy|physical therapy
246142|NCT02114879|Occupational Therapy|occupational therapy
246143|NCT02114879|Rehabilitation|rehabilitation
246144|NCT02114879|Older adults|older adults
246145|NCT02114879|Depression|depression
246146|NCT02114879|Physical Functioning|physical functioning
246147|NCT02114827|Multiple Myeloma|multiple myeloma
246148|NCT02114814|Diabetes|diabetes
246149|NCT02114814|Hispanic|hispanic
246150|NCT02114814|Adult|adult
246151|NCT02114814|Family Member|family member
246152|NCT02114801|Cerebral Palsy;|cerebral palsy;
246153|NCT02114801|Toothbrushing;|toothbrushing;
246154|NCT02114801|Dental Plaque|dental plaque
246155|NCT02114775|mild traumatic brain injury|mild traumatic brain injury
246156|NCT02114775|growth hormone|growth hormone
246157|NCT02114775|fatigue|fatigue
246158|NCT02114775|sildenafil|sildenafil
246159|NCT02114775|neurology|neurology
246160|NCT02114762|otitis media|otitis media
246161|NCT02114762|eustachian tube|eustachian tube
246162|NCT02114762|eustachian tube dysfunction|eustachian tube dysfunction
246163|NCT02114762|eustachian tube function testing|eustachian tube function testing
246164|NCT02114749|Healthy volunteers|healthy volunteers
246165|NCT02114749|Physiological variables : respiration and circulation|physiological variables : respiration and circulation
246166|NCT02114736|Stroke|stroke
246167|NCT02114736|Muscle spasticity|muscle spasticity
246168|NCT02114736|Stiff knee gait|stiff knee gait
246169|NCT02114736|Botulinum toxin|botulinum toxin
246170|NCT02114736|Tenotomy|tenotomy
246171|NCT02114723|Mediacal Taping concept|mediacal taping concept
246172|NCT02114723|Neuromuscular bandage|neuromuscular bandage
246173|NCT02114723|Physiotherapy techniques|physiotherapy techniques
246174|NCT02114723|Kinesio Tape|kinesio tape
246175|NCT02114710|coagulopathy|coagulopathy
246176|NCT02114710|hydrocortisone|hydrocortisone
246177|NCT02114710|organ failure|organ failure
246178|NCT02114697|Cancer survivorship, cardiovascular disease, stroke, TIA|cancer survivorship, cardiovascular disease, stroke, tia
246179|NCT02114658|Anaplastic and medullary thyroid carcinoma|anaplastic and medullary thyroid carcinoma
246180|NCT02114658|Thyroid Neoplasms|thyroid neoplasms
246181|NCT02114645|Luteal phase support,GnRH agonist,ART cycles|luteal phase support,gnrh agonist,art cycles
246282|NCT02114333|Shingles vaccine|shingles vaccine
246182|NCT02114632|ADHD, attention deficit/hyperactivity disorder, attention deficit disorder, inattention, cognitive skills, children, polyunsaturated fatty acids, PUFA|adhd, attention deficit/hyperactivity disorder, attention deficit disorder, inattention, cognitive skills, children, polyunsaturated fatty acids, pufa
246183|NCT02114619|radioiodine therapy|radioiodine therapy
246184|NCT02114619|Graves' disease|graves' disease
246185|NCT02114619|Hyperthyroidism|hyperthyroidism
246186|NCT02114619|calculated dose|calculated dose
246187|NCT02114606|Eosinophilic Esophagitis|eosinophilic esophagitis
246188|NCT02114606|EoE|eoe
246189|NCT02114606|Cytosponge|cytosponge
246190|NCT02114593|Mental Health|mental health
246191|NCT02114593|Children|children
246192|NCT02114593|Parent support program|parent support program
246193|NCT02114593|Somali families|somali families
246194|NCT02114593|Sweden|sweden
246195|NCT02114580|mild cognitive impairment|mild cognitive impairment
246196|NCT02114580|exercise|exercise
246197|NCT02114580|brain plasticity|brain plasticity
246198|NCT02114580|FMRI|fmri
246199|NCT02114567|AECOPD|aecopd
246200|NCT02114567|work of breathing|work of breathing
246201|NCT02114567|patient-ventilator synchrony|patient-ventilator synchrony
246202|NCT02114554|MELAS|melas
246203|NCT02114554|MIDD|midd
246204|NCT02114554|Heteroplasmy|heteroplasmy
246205|NCT02114528|Ventricular Tachycardia|ventricular tachycardia
246206|NCT02114528|Ventricular Arrhythmia|ventricular arrhythmia
246207|NCT02114528|Anti-arrhythmic drugs|anti-arrhythmic drugs
246208|NCT02114528|Catheter Ablation|catheter ablation
246209|NCT02114528|ICD Shocks|icd shocks
246210|NCT02114515|Patient Navigators|patient navigators
246211|NCT02114515|Readmissions|readmissions
246212|NCT02114515|Peer Coaching|peer coaching
246213|NCT02114502|Myeloma|myeloma
246214|NCT02114502|Multiple myeloma|multiple myeloma
246215|NCT02114502|MM|mm
246216|NCT02114502|Refractory|refractory
246217|NCT02114502|Relapsed|relapsed
246218|NCT02114502|Stem Cell Transplant|stem cell transplant
246219|NCT02114502|SCT|sct
246220|NCT02114502|Carfilzomib|carfilzomib
246221|NCT02114502|SAHA|saha
246222|NCT02114502|Vorinostat|vorinostat
246223|NCT02114502|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
246224|NCT02114502|MSK-390|msk-390
246225|NCT02114502|Zolinza|zolinza
246226|NCT02114502|Gemcitabine|gemcitabine
246227|NCT02114502|Gemcitabine Hydrochloride|gemcitabine hydrochloride
246228|NCT02114502|Gemzar|gemzar
246229|NCT02114502|Busulfan|busulfan
246230|NCT02114502|Busulfex|busulfex
246231|NCT02114502|Myleran|myleran
246232|NCT02114502|Palifermin|palifermin
246233|NCT02114502|Kepivance|kepivance
246234|NCT02114502|Dexamethasone|dexamethasone
246235|NCT02114502|Decadron|decadron
246236|NCT02114502|Melphalan|melphalan
246237|NCT02114502|Alkeran|alkeran
246238|NCT02114502|Caphosol|caphosol
246239|NCT02114502|Glutamine|glutamine
246240|NCT02114502|Enterex|enterex
246241|NCT02114502|Glutapak-10|glutapak-10
246242|NCT02114502|NutreStore|nutrestore
246243|NCT02114502|Resource|resource
246244|NCT02114502|GlutaSolve|glutasolve
246245|NCT02114502|Sympt-X G.I.|sympt-x g.i.
246246|NCT02114502|Sympt-X|sympt-x
246247|NCT02114502|Pyridoxine|pyridoxine
246248|NCT02114489|AOH|aoh
246249|NCT02114489|ibandronate|ibandronate
246250|NCT02114476|GDM|gdm
246251|NCT02114476|implant|implant
246252|NCT02114476|diabetes mellitus|diabetes mellitus
246253|NCT02114476|metabolic syndrome|metabolic syndrome
246254|NCT02114463|Local analgesia system|local analgesia system
246255|NCT02114463|Ropivacaine|ropivacaine
246256|NCT02114463|Analgesic efficacy after operation|analgesic efficacy after operation
246257|NCT02114463|Postoperative|postoperative
246258|NCT02114450|Stroke|stroke
246259|NCT02114450|Paresis|paresis
246260|NCT02114450|Gait rehabilitation|gait rehabilitation
246261|NCT02114450|Human-Machine Interaction|human-machine interaction
246262|NCT02114450|Wearable Robotic Devices|wearable robotic devices
246263|NCT02114437|Closed-Loop TCI|closed-loop tci
246264|NCT02114437|NI|ni
246265|NCT02114437|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
246266|NCT02114424|Positional Obstructive sleep apnea syndrome (POSAS)|positional obstructive sleep apnea syndrome (posas)
246267|NCT02114424|Obstructive sleep apnea syndrome (OSAS)|obstructive sleep apnea syndrome (osas)
246268|NCT02114424|Apnea-Hypnea Index (AHI)|apnea-hypnea index (ahi)
246269|NCT02114424|Sleep questionnaire|sleep questionnaire
246270|NCT02114424|Positional sleep apnea belt|positional sleep apnea belt
246271|NCT02114424|Adverse events|adverse events
246272|NCT02114424|Compliance|compliance
246273|NCT02114385|Prevention|prevention
246274|NCT02114372|Alzheimer's disease|alzheimer's disease
246275|NCT02114372|Asymptomatic at risk for Alzheimer's disease|asymptomatic at risk for alzheimer's disease
246276|NCT02114372|Retinal diagnosis for Alzheimer's disease|retinal diagnosis for alzheimer's disease
246277|NCT02114359|gastric cancer, elderly, chemotherapy|gastric cancer, elderly, chemotherapy
246278|NCT02114346|Computed Tomography Angiogram|computed tomography angiogram
246279|NCT02114346|Side Effects|side effects
246280|NCT02114346|Contrast-Induced Nephropathy|contrast-induced nephropathy
246281|NCT02114346|Prevention|prevention
246967|NCT02111720|Family|family
246283|NCT02114333|Immune response|immune response
246284|NCT02114333|Zoster vaccine|zoster vaccine
246285|NCT02114320|Endoscopic ultrasonography|endoscopic ultrasonography
246286|NCT02114320|Biliary drainage|biliary drainage
246287|NCT02114320|Metal stent|metal stent
246288|NCT02114307|electrical stimulation|electrical stimulation
246289|NCT02114307|venous insufficiency|venous insufficiency
246290|NCT02114307|post thrombotic syndrome|post thrombotic syndrome
246291|NCT02114307|varicose veins|varicose veins
246292|NCT02114294|Patellofemoral pain syndrome|patellofemoral pain syndrome
246293|NCT02114294|Anterior knee pain|anterior knee pain
246294|NCT02114294|Randomised controlled trial|randomised controlled trial
246295|NCT02114294|Exercise intervention|exercise intervention
246296|NCT02114294|Hip strengthening|hip strengthening
246297|NCT02114294|Quadriceps based training|quadriceps based training
246298|NCT02114294|Anterior knee pain score|anterior knee pain score
246299|NCT02114281|Oral Health|oral health
246300|NCT02114281|Periodontitis|periodontitis
246301|NCT02114281|Tooth cavities|tooth cavities
246302|NCT02114281|Saliva|saliva
246303|NCT02114281|Halitosis|halitosis
246304|NCT02114281|Mucosa|mucosa
246305|NCT02114281|Chronic kidney disease|chronic kidney disease
246306|NCT02114281|Inflammation|inflammation
246307|NCT02114281|Nutrition|nutrition
246308|NCT02114268|Respiratory Syncytial Virus, RSV|respiratory syncytial virus, rsv
246309|NCT02114255|Influenza|influenza
246310|NCT02114255|Trained immunity|trained immunity
246311|NCT02114255|BCG|bcg
246312|NCT02114242|Parkinson's disease|parkinson's disease
246313|NCT02114242|multiple system atrophy|multiple system atrophy
246314|NCT02114242|progressive supranuclear palsy|progressive supranuclear palsy
246315|NCT02114242|alpha-synuclein|alpha-synuclein
246316|NCT02114229|Alisertib|alisertib
246317|NCT02114229|MLN8237|mln8237
246318|NCT02114229|AT/RT|at/rt
246319|NCT02114229|MRT|mrt
246320|NCT02114190|Overweight Adolescents|overweight adolescents
246321|NCT02114190|Mindful Eating and Living|mindful eating and living
246322|NCT02114190|Family Systems|family systems
246323|NCT02114190|Body-Mass Index|body-mass index
246324|NCT02114190|Mindfulness|mindfulness
246325|NCT02114177|Hepatitis C Virus Infection|hepatitis c virus infection
246326|NCT02114177|Simeprevir|simeprevir
246327|NCT02114177|Sofosbuvir|sofosbuvir
246328|NCT02114177|HCV|hcv
246329|NCT02114177|Cirrhosis|cirrhosis
246330|NCT02114164|AirSeal|airseal
246331|NCT02114164|Trocar|trocar
246332|NCT02114164|Carbon Dioxide Exchange and Absorption|carbon dioxide exchange and absorption
246333|NCT02114151|Hepatitis C Virus Infection|hepatitis c virus infection
246334|NCT02114151|Simeprevir|simeprevir
246335|NCT02114151|Sofosbuvir|sofosbuvir
246336|NCT02114151|HCV|hcv
246337|NCT02114151|Cirrhosis|cirrhosis
246338|NCT02114138|postoperative acute kidney injury|postoperative acute kidney injury
246339|NCT02114138|pAKI|paki
246340|NCT02114138|stress injury on the kidney|stress injury on the kidney
246341|NCT02114138|chronic kidney disease|chronic kidney disease
246342|NCT02114138|CKD|ckd
246343|NCT02114125|Physical activity|physical activity
246344|NCT02114125|Cognitive training|cognitive training
246345|NCT02114112|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
246346|NCT02114112|Continuous positive airway pressure pressure|continuous positive airway pressure pressure
246347|NCT02114112|Preterms|preterms
246348|NCT02114099|Kawasaki Disease|kawasaki disease
246349|NCT02114099|Aneurysm, Coronary|aneurysm, coronary
246350|NCT02114086|Observational Study|observational study
246351|NCT02114086|intraoperative Radiation of Breast Cancer|intraoperative radiation of breast cancer
246352|NCT02114086|early and late effects of radiation|early and late effects of radiation
246477|NCT02113631|Effectiveness|effectiveness
246353|NCT02114086|cosmesis and quality of life|cosmesis and quality of life
246354|NCT02114073|glaucoma|glaucoma
246355|NCT02114073|trabeculectomy|trabeculectomy
246356|NCT02114073|cyclosporine|cyclosporine
246357|NCT02114073|betamethasone|betamethasone
246358|NCT02114060|HSV|hsv
246359|NCT02114060|Herpes|herpes
246360|NCT02114060|genital infection|genital infection
246361|NCT02114060|vaccine|vaccine
246362|NCT02114034|Severe asthma,|severe asthma,
246363|NCT02114034|child,|child,
246364|NCT02114034|outcome,|outcome,
246365|NCT02114021|Syndrome incidence after intubation|syndrome incidence after intubation
246366|NCT02114021|Betamethasone gel|betamethasone gel
246367|NCT02114021|lidocaine jelly|lidocaine jelly
246368|NCT02114021|sore throat|sore throat
246369|NCT02114021|cough|cough
246370|NCT02114021|hoarseness of voice|hoarseness of voice
246371|NCT02114008|Gastric emptying.|gastric emptying.
246372|NCT02114008|Residual gastric volume.|residual gastric volume.
246373|NCT02114008|Preoperative fasting.|preoperative fasting.
246374|NCT02114008|Morbid Obesity.|morbid obesity.
246375|NCT02114008|Diabetes.|diabetes.
246376|NCT02113995|Obesity, Morbid|obesity, morbid
246377|NCT02113995|Insulin Resistance|insulin resistance
246378|NCT02113995|Acute-Phase Reaction|acute-phase reaction
246379|NCT02113995|Gastroplasty|gastroplasty
246380|NCT02113995|Length of Stay|length of stay
246381|NCT02113995|Protocols|protocols
247170|NCT02110797|MECP2|mecp2
246382|NCT02113995|Randomized Controlled Trial.|randomized controlled trial.
246383|NCT02113969|Pelvic Organ Prolapse|pelvic organ prolapse
246384|NCT02113969|Quality of Life|quality of life
246385|NCT02113969|Symptoms|symptoms
246386|NCT02113969|Pessary|pessary
246387|NCT02113969|Treatment|treatment
246388|NCT02113956|HIV Prevention|hiv prevention
246389|NCT02113956|Adolescent Men who Have Sex with Men (AMSM)|adolescent men who have sex with men (amsm)
246390|NCT02113956|Text-Messaging|text-messaging
246391|NCT02113956|Information-Motivation-Behavioral Skills(IMB)Model|information-motivation-behavioral skills(imb)model
246392|NCT02113917|infant, adolescent and adult Hemophagocytic Syndrome|infant, adolescent and adult hemophagocytic syndrome
246393|NCT02113917|Hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
246394|NCT02113904|Netherton syndrome|netherton syndrome
246395|NCT02113904|Adalimumab|adalimumab
246396|NCT02113904|TNF-alpha|tnf-alpha
246397|NCT02113904|Orphan genetic syndrome|orphan genetic syndrome
246398|NCT02113891|Antibody-mediated rejection|antibody-mediated rejection
246399|NCT02113891|Complement blockade|complement blockade
246400|NCT02113891|Eculizumab|eculizumab
246401|NCT02113891|Kidney transplantation|kidney transplantation
246402|NCT02113878|Carcinoma, Squamous Cell of Head and Neck|carcinoma, squamous cell of head and neck
246403|NCT02113878|Human Papillomavirus Positive Oropharyngeal Carcinoma|human papillomavirus positive oropharyngeal carcinoma
246404|NCT02113878|Hypopharyngeal Cancer|hypopharyngeal cancer
246405|NCT02113878|Early Invasive Cervical Squamous Cell Carcinoma|early invasive cervical squamous cell carcinoma
246406|NCT02113878|Carcinoma of Larynx|carcinoma of larynx
246407|NCT02113878|Cancer of Nasopharynx|cancer of nasopharynx
246408|NCT02113852|Non small cell Lung Cancer|non small cell lung cancer
246409|NCT02113852|Heavy smokers|heavy smokers
246410|NCT02113852|Treatment naive patients|treatment naive patients
246411|NCT02113839|Dyspnea perception|dyspnea perception
246412|NCT02113839|COPD|copd
246413|NCT02113839|Exacerbations|exacerbations
246414|NCT02113839|CO2 rebreathing test|co2 rebreathing test
246415|NCT02113826|Pazopanib|pazopanib
246416|NCT02113826|Alveolar soft part sarcoma|alveolar soft part sarcoma
246417|NCT02113813|irreversible EGFR inhibitor|irreversible egfr inhibitor
246418|NCT02113813|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
246419|NCT02113813|Midazolam|midazolam
246420|NCT02113813|T790M resistance mutation|t790m resistance mutation
246421|NCT02113813|EGFR|egfr
246422|NCT02113813|NSCLC|nsclc
246423|NCT02113813|naquotinib|naquotinib
246424|NCT02113813|Epidermal Growth Factor Receptor mutations|epidermal growth factor receptor mutations
246425|NCT02113813|ASP8273|asp8273
246426|NCT02113787|epilepsy|epilepsy
246427|NCT02113787|anticonvulsants|anticonvulsants
246428|NCT02113787|generic drugs|generic drugs
246429|NCT02113748|Pulmonary disease, chronic obstructive|pulmonary disease, chronic obstructive
246430|NCT02113748|Downhill walking|downhill walking
246431|NCT02113748|exercise|exercise
246432|NCT02113735|ARDS|ards
246433|NCT02113735|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
246434|NCT02113735|Acthar|acthar
246435|NCT02113735|ACTH|acth
246436|NCT02113735|H.P. Acthar Gel|h.p. acthar gel
246437|NCT02113722|Sudden cardiac death|sudden cardiac death
246438|NCT02113722|Ganglionectomy|ganglionectomy
246439|NCT02113722|Ventricular arrhythmia|ventricular arrhythmia
246440|NCT02113722|Cardiac surgery|cardiac surgery
246441|NCT02113722|Implanted cardiac defibrillator|implanted cardiac defibrillator
246442|NCT02113709|Amblyopia|amblyopia
246443|NCT02113709|Strabismus|strabismus
246444|NCT02113709|Occlusion therapy|occlusion therapy
246445|NCT02113709|Visual improvement|visual improvement
246446|NCT02113696|morbid obesity|morbid obesity
246447|NCT02113696|BMI at or above 4O kg/m2|bmi at or above 4o kg/m2
246448|NCT02113696|ingestion of omega 3|ingestion of omega 3
246449|NCT02113696|inflammatory cytokines|inflammatory cytokines
246450|NCT02113696|biochemical factors|biochemical factors
246451|NCT02113696|anthropometric factors|anthropometric factors
246452|NCT02113683|colo-rectal cancer|colo-rectal cancer
246453|NCT02113683|stomach cancer|stomach cancer
246454|NCT02113683|melanoma|melanoma
246455|NCT02113683|MMS test|mms test
246456|NCT02113683|therapy monitoring|therapy monitoring
246457|NCT02113683|Sarcoma|sarcoma
246458|NCT02113670|stress urinary incontinence|stress urinary incontinence
246459|NCT02113670|abdominal leak point pressure|abdominal leak point pressure
246460|NCT02113670|urodynamic study|urodynamic study
246461|NCT02113657|Prostate cancer|prostate cancer
246462|NCT02113657|Castration-resistant prostate cancer|castration-resistant prostate cancer
246463|NCT02113657|CRPC|crpc
246464|NCT02113657|Metastatic|metastatic
246465|NCT02113657|Hormone therapy treatment|hormone therapy treatment
246466|NCT02113657|Androgen deprivation therapy|androgen deprivation therapy
246467|NCT02113657|gonadotropin-releasing hormone|gonadotropin-releasing hormone
246468|NCT02113657|GnRH|gnrh
246469|NCT02113657|Ipilimumab|ipilimumab
246470|NCT02113657|Yervoy|yervoy
246471|NCT02113657|BMS-734016|bms-734016
246472|NCT02113657|MDX010|mdx010
246473|NCT02113631|Hepatitis C treatment,|hepatitis c treatment,
246474|NCT02113631|Boceprevir,|boceprevir,
246475|NCT02113631|Telaprevir,|telaprevir,
246476|NCT02113631|Safety|safety
246478|NCT02113631|Head-to-head trial|head-to-head trial
246479|NCT02113618|Cognitive function, alcohol dependence, working memory|cognitive function, alcohol dependence, working memory
246480|NCT02113605|Functional gastrointestinal disorders|functional gastrointestinal disorders
246481|NCT02113605|FGID|fgid
246482|NCT02113605|Recurrent abdominal pain|recurrent abdominal pain
246483|NCT02113605|Abdominal pain|abdominal pain
246484|NCT02113605|pain-predominant functional gastrointestinal disorders|pain-predominant functional gastrointestinal disorders
246485|NCT02113605|Pediatric pain|pediatric pain
246486|NCT02113592|Pain management|pain management
246487|NCT02113592|Opioid use|opioid use
246488|NCT02113592|Pragmatic|pragmatic
246489|NCT02113592|Collaborative care|collaborative care
246490|NCT02113592|Primary care|primary care
246491|NCT02113579|Tooth Sensitivity|tooth sensitivity
246492|NCT02113566|Delayed onset muscle soreness|delayed onset muscle soreness
246493|NCT02113566|DOMS|doms
246494|NCT02113540|coronary angiography|coronary angiography
246495|NCT02113540|chronic stable angina|chronic stable angina
246496|NCT02113540|CIN|cin
246497|NCT02113527|Electrogastrography|electrogastrography
246498|NCT02113527|Functional dyspepsia|functional dyspepsia
246499|NCT02113527|Gastric emptying|gastric emptying
246500|NCT02113527|Gastrointestinal peptides|gastrointestinal peptides
246501|NCT02113527|Rome III criteria|rome iii criteria
246502|NCT02113514|Appalachian|appalachian
246503|NCT02113514|abnormal pap test|abnormal pap test
246504|NCT02113501|HGT1|hgt1
246505|NCT02113501|high risk bladder cancer|high risk bladder cancer
246506|NCT02113501|substaging|substaging
246507|NCT02113501|repeat transurethral resection (reTUR)|repeat transurethral resection (retur)
246508|NCT02113501|lamina propria|lamina propria
246509|NCT02113475|CDT|cdt
246510|NCT02113475|PCDT|pcdt
246511|NCT02113475|DVT|dvt
246512|NCT02113475|PTS|pts
246513|NCT02113475|Quality of Life|quality of life
246514|NCT02113462|Chronic kidney disease|chronic kidney disease
246515|NCT02113462|Endothelial dysfunction|endothelial dysfunction
246516|NCT02113462|Inflammation|inflammation
246517|NCT02113462|Insulin resistance|insulin resistance
246518|NCT02113462|Tg/hdl ratio|tg/hdl ratio
246519|NCT02113449|Carbon Dioxide, Allergy symptoms|carbon dioxide, allergy symptoms
246520|NCT02113436|FP/SLM|fp/slm
246521|NCT02113436|Asthma|asthma
246522|NCT02113436|Infant|infant
246523|NCT02113436|Efficacy|efficacy
246524|NCT02113436|Safety|safety
246525|NCT02113423|superiority, re-irradiation, IMRT, recurrent T1-2 NPC|superiority, re-irradiation, imrt, recurrent t1-2 npc
246526|NCT02113410|osteoarthritis|osteoarthritis
246527|NCT02113410|Older adults|older adults
246528|NCT02113410|Sit 'N' Chair Yoga|sit 'n' chair yoga
246529|NCT02113410|Pain|pain
246530|NCT02113410|Physical Function|physical function
246531|NCT02113410|Balance|balance
246532|NCT02113410|Fatigue|fatigue
246533|NCT02113410|Depression|depression
246534|NCT02113410|Life Satisfaction|life satisfaction
246535|NCT02113397|Cystic fibrosis|cystic fibrosis
246536|NCT02113397|Microbiome|microbiome
246537|NCT02113397|Sputum|sputum
246538|NCT02113397|Tobramycin|tobramycin
246539|NCT02113397|Colistimethate|colistimethate
246540|NCT02113384|Rectal cancer|rectal cancer
246541|NCT02113384|Locally advanced rectal cancer|locally advanced rectal cancer
246542|NCT02113384|Peritoneal carcinomatosis|peritoneal carcinomatosis
246543|NCT02113384|Exfoliated peritoneal cells|exfoliated peritoneal cells
246544|NCT02113384|Peritoneal lavage|peritoneal lavage
246545|NCT02113371|Injury Prevention|injury prevention
246546|NCT02113371|Health Promotion|health promotion
246547|NCT02113371|Well being|well being
246548|NCT02113371|Safety|safety
246549|NCT02113371|Nutrition|nutrition
246550|NCT02113371|Physical Activity|physical activity
246551|NCT02113371|Sleep|sleep
246552|NCT02113371|Stress|stress
246553|NCT02113358|fluid therapy|fluid therapy
246554|NCT02113358|neurosurgery|neurosurgery
246555|NCT02113345|metamemory|metamemory
246556|NCT02113345|memory|memory
246557|NCT02113345|mild cognitive impairment|mild cognitive impairment
246558|NCT02113332|Insulin injections|insulin injections
246559|NCT02113332|Overweight|overweight
246560|NCT02113332|Inadequate glycaemic control|inadequate glycaemic control
246561|NCT02113319|Core Binding Factors|core binding factors
246562|NCT02113319|Acute Myelogenous Leukemia refractory to conventional chemotherapy|acute myelogenous leukemia refractory to conventional chemotherapy
246563|NCT02113319|molecular relapse|molecular relapse
246564|NCT02113293|phase I study|phase i study
246565|NCT02113293|tolerability|tolerability
246566|NCT02113293|safety|safety
246567|NCT02113293|CyclASol®|cyclasol®
246568|NCT02113293|eye drops|eye drops
246569|NCT02113267|esophagitis|esophagitis
246570|NCT02113267|eosinophils|eosinophils
246571|NCT02113267|allergy|allergy
246572|NCT02113267|inflammation|inflammation
246573|NCT02113267|corticosteroids|corticosteroids
246574|NCT02113254|corn|corn
246575|NCT02113254|macular pigment|macular pigment
246576|NCT02113254|lutein|lutein
246577|NCT02113254|zeaxanthin|zeaxanthin
246578|NCT02113254|Age Macular Degeneration|age macular degeneration
246579|NCT02113254|AMD|amd
246580|NCT02113241|metabolic syndrome|metabolic syndrome
246581|NCT02113241|forxiga|forxiga
246582|NCT02113241|dapagliflozin|dapagliflozin
246583|NCT02113241|insulin secretion|insulin secretion
246584|NCT02113241|insulin sensitivity|insulin sensitivity
246585|NCT02113228|Energy metabolism|energy metabolism
246586|NCT02113228|Stable isotopes|stable isotopes
246587|NCT02113228|Short bowel syndrome|short bowel syndrome
246588|NCT02113228|Doubly labeled water|doubly labeled water
246589|NCT02113215|aging|aging
246590|NCT02113215|lipid metabolism|lipid metabolism
246591|NCT02113215|very low density lipoproteins|very low density lipoproteins
246592|NCT02113202|Optical imaging|optical imaging
246593|NCT02113202|Fluorescence endoscopy|fluorescence endoscopy
246594|NCT02113202|Near infrared fluorescence|near infrared fluorescence
246595|NCT02113202|Familial Adenomatous Polyposis|familial adenomatous polyposis
246596|NCT02113202|IRDye800CW|irdye800cw
246597|NCT02113202|Vascular Endothelial Growth Factor A|vascular endothelial growth factor a
246598|NCT02113202|Gastrointestinal endoscopy|gastrointestinal endoscopy
246599|NCT02113189|gait|gait
246600|NCT02113189|Parkinson's disease|parkinson's disease
246601|NCT02113176|SAH|sah
246602|NCT02113163|Type 2 diabetes|type 2 diabetes
246603|NCT02113163|T2DM|t2dm
246604|NCT02113163|hypertriglyceridemia|hypertriglyceridemia
246605|NCT02113163|severe hypertriglyceridemia|severe hypertriglyceridemia
246606|NCT02113163|dyslipidemia|dyslipidemia
246607|NCT02113163|triglycerides|triglycerides
246608|NCT02113163|lipids|lipids
246609|NCT02113163|omega-3 fatty acids|omega-3 fatty acids
246610|NCT02113163|EPA|epa
246611|NCT02113163|ethyl-EPA|ethyl-epa
246612|NCT02113163|Metformin|metformin
246613|NCT02113163|Glucophage|glucophage
246614|NCT02113163|Lovaza|lovaza
246615|NCT02113163|Vascepa|vascepa
246616|NCT02113163|Epanova|epanova
246617|NCT02113163|Astra Zeneca|astra zeneca
246618|NCT02113163|Amarin|amarin
246619|NCT02113163|GSK|gsk
246620|NCT02113150|troponin t,cystatin-c,ketamine,remifentanil|troponin t,cystatin-c,ketamine,remifentanil
246621|NCT02113137|halitosis|halitosis
246622|NCT02113137|chlorine dioxide|chlorine dioxide
246623|NCT02113137|tongue cleaning|tongue cleaning
246624|NCT02113124|Chronic Brain Injury|chronic brain injury
246625|NCT02113124|Traumatic brain injury (TBI)|traumatic brain injury (tbi)
246626|NCT02113124|Amino Acids|amino acids
246627|NCT02113124|Microbiome|microbiome
246628|NCT02113098|Stroke|stroke
246629|NCT02113098|Gait|gait
246630|NCT02113098|Rehabilitation|rehabilitation
246631|NCT02113085|Adolescents, foster care, self-determination|adolescents, foster care, self-determination
246632|NCT02113072|wheezing, immune system, cytokines, probiotics, infants.|wheezing, immune system, cytokines, probiotics, infants.
246633|NCT02113059|Liver regeneration|liver regeneration
246634|NCT02113059|liver dysfunction|liver dysfunction
246635|NCT02113059|platelets|platelets
246636|NCT02113059|plasma|plasma
246637|NCT02113059|serum|serum
246638|NCT02113059|platelet activation|platelet activation
246639|NCT02113059|morbidity|morbidity
246640|NCT02113059|mortality|mortality
246641|NCT02113059|Growth factors|growth factors
246642|NCT02113059|Postoperative clinical outcome|postoperative clinical outcome
246643|NCT02113046|pancreas|pancreas
246644|NCT02113046|pancreatico-jejunal anastomosis|pancreatico-jejunal anastomosis
246645|NCT02113046|postoperative pancreatic fistulae|postoperative pancreatic fistulae
246646|NCT02113007|Lymphoma; CNS; rituximab; temozolomide|lymphoma; cns; rituximab; temozolomide
246647|NCT02112994|Enzyme Replacement Therapy (ERT)|enzyme replacement therapy (ert)
246648|NCT02112994|Lysosomal Storage Disease|lysosomal storage disease
246649|NCT02112994|Late Onset Lysosomal Acid Lipase (LAL) Deficiency|late onset lysosomal acid lipase (lal) deficiency
246650|NCT02112994|Acid cholesteryl ester hydrolase deficiency, type 2|acid cholesteryl ester hydrolase deficiency, type 2
246651|NCT02112994|Acid lipase disease|acid lipase disease
246652|NCT02112994|Cholesterol ester hydrolase deficiency|cholesterol ester hydrolase deficiency
246653|NCT02112994|LAL Deficiency|lal deficiency
246654|NCT02112994|LIPA Deficiency|lipa deficiency
246655|NCT02112994|Wolman disease|wolman disease
246656|NCT02112994|Additional relevant MeSH terms:|additional relevant mesh terms:
246657|NCT02112994|Cholesterol Ester Storage Disease|cholesterol ester storage disease
246658|NCT02112994|Metabolic Diseases|metabolic diseases
246659|NCT02112994|Lipidoses|lipidoses
246660|NCT02112994|Lipid Metabolism, Inborn Errors|lipid metabolism, inborn errors
246661|NCT02112994|Metabolism, Inborn Errors|metabolism, inborn errors
246662|NCT02112994|Genetic Diseases, Inborn|genetic diseases, inborn
246663|NCT02112994|Lysosomal Storage Diseases|lysosomal storage diseases
246664|NCT02112994|Lipid Metabolism Disorders|lipid metabolism disorders
246665|NCT02112994|Infant, Newborn, Diseases|infant, newborn, diseases
246666|NCT02112981|Coronary Arteriosclerosis|coronary arteriosclerosis
246667|NCT02112968|Myopia|myopia
246668|NCT02112968|Hyperopia|hyperopia
246669|NCT02112968|Presbyopia|presbyopia
246670|NCT02112968|Supracor|supracor
246671|NCT02112968|Zyoptix|zyoptix
246672|NCT02112968|Proscan|proscan
246673|NCT02112968|LASIK|lasik
246674|NCT02112955|Stroke|stroke
246675|NCT02112955|Disease management|disease management
246676|NCT02112955|Self efficacy|self efficacy
246677|NCT02112955|Quality of life|quality of life
246678|NCT02112955|Community integration|community integration
246679|NCT02112942|Hepatitis C virus|hepatitis c virus
246680|NCT02112942|HCV|hcv
246681|NCT02112929|Magnetic Resonance Imaging|magnetic resonance imaging
246682|NCT02112929|Lung Diseases|lung diseases
246683|NCT02112890|Mexico|mexico
246684|NCT02112890|Adolescents|adolescents
246685|NCT02112890|Hepatitis|hepatitis
246686|NCT02112890|Seroprevalence|seroprevalence
246687|NCT02112890|Pertussis|pertussis
246688|NCT02112890|Young adults|young adults
246689|NCT02112877|iliofemoral vein|iliofemoral vein
246690|NCT02112877|venous|venous
246691|NCT02112877|venous obstruction|venous obstruction
246692|NCT02112838|IGA Glomerulonephritis|iga glomerulonephritis
246693|NCT02112838|Nephritis, IGA Type|nephritis, iga type
246694|NCT02112825|Exercise|exercise
246695|NCT02112825|blood pressure|blood pressure
246696|NCT02112825|chronic kidney disease|chronic kidney disease
246697|NCT02112812|Parkinsons disease|parkinsons disease
246698|NCT02112812|Helicobacter pylori|helicobacter pylori
246699|NCT02112812|Eradication|eradication
246700|NCT02112812|Levodopa response|levodopa response
246701|NCT02112812|Motor outcomes|motor outcomes
246702|NCT02112812|Quality of Life|quality of life
246703|NCT02112812|Open label|open label
246704|NCT02112799|Hepatitis B|hepatitis b
246705|NCT02112786|Overactive Bladder|overactive bladder
246706|NCT02112773|Adenoviral conjunctivitis diagnosed with AdenoPlus™ Test|adenoviral conjunctivitis diagnosed with adenoplus™ test
246707|NCT02112760|specific stabilization exercise|specific stabilization exercise
246708|NCT02112760|ultrasound|ultrasound
246709|NCT02112760|low back pain|low back pain
246710|NCT02112747|Colorectal Cancer Prevention|colorectal cancer prevention
246711|NCT02112747|Colorectal Cancer Screening|colorectal cancer screening
246712|NCT02112747|ACCS|accs
246713|NCT02112747|Lynch Syndrome|lynch syndrome
246714|NCT02112747|LS|ls
246715|NCT02112734|vitamin D|vitamin d
246716|NCT02112734|food allergy|food allergy
246717|NCT02112734|eczema|eczema
246718|NCT02112708|Psychotherapy, Rational-Emotive|psychotherapy, rational-emotive
246719|NCT02112708|Depression|depression
246720|NCT02112708|Social Work|social work
246721|NCT02112708|Primary Health Care|primary health care
246722|NCT02112695|endurance sportswomen|endurance sportswomen
246723|NCT02112695|addiction|addiction
246724|NCT02112695|undernutrition|undernutrition
246725|NCT02112695|[11C]diprenorphine Pet|[11c]diprenorphine pet
246726|NCT02112695|pituitary region|pituitary region
246727|NCT02112682|Sentinel lymph node metastasis|sentinel lymph node metastasis
246728|NCT02112682|Completion axillary lymph node dissection|completion axillary lymph node dissection
246729|NCT02112682|Axillary radiotherapy|axillary radiotherapy
246730|NCT02112656|Carcinoma|carcinoma
246731|NCT02112656|Carcinoma, Hepatocellular|carcinoma, hepatocellular
246732|NCT02112656|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
246733|NCT02112656|Neoplasms by Histologic Type|neoplasms by histologic type
246734|NCT02112656|Neoplasms|neoplasms
246735|NCT02112656|Adenocarcinoma|adenocarcinoma
246736|NCT02112656|Liver Neoplasms|liver neoplasms
246737|NCT02112656|Digestive System Neoplasms|digestive system neoplasms
246738|NCT02112656|Neoplasms by Site|neoplasms by site
246739|NCT02112656|Digestive System Diseases|digestive system diseases
246740|NCT02112656|Liver Diseases|liver diseases
246741|NCT02112656|Doxorubicin|doxorubicin
246742|NCT02112656|Antibiotics, Antineoplastic|antibiotics, antineoplastic
246743|NCT02112656|Antineoplastic Agents|antineoplastic agents
246744|NCT02112656|Therapeutic Uses|therapeutic uses
246745|NCT02112656|Pharmacologic Actions|pharmacologic actions
246746|NCT02112643|Thyroid eye disease|thyroid eye disease
246747|NCT02112643|Thyroid orbitopathy|thyroid orbitopathy
246748|NCT02112643|Graves' orbitopathy|graves' orbitopathy
246749|NCT02112643|Graves' ophthalmopathy|graves' ophthalmopathy
246750|NCT02112630|Hepatitis C Infection|hepatitis c infection
246751|NCT02112630|HCV, genotype 1|hcv, genotype 1
246752|NCT02112630|End Stage Renal Disease|end stage renal disease
246753|NCT02112630|ESRD|esrd
246754|NCT02112630|Boceprevir|boceprevir
246755|NCT02112630|Pegylated Interferon|pegylated interferon
246756|NCT02112630|Ribavirin|ribavirin
246757|NCT02112617|Neuroblastoma|neuroblastoma
246758|NCT02112617|Childhood neuroblastoma|childhood neuroblastoma
246759|NCT02112617|Ganglioneuroblastoma|ganglioneuroblastoma
246760|NCT02112617|Pediatric neuroblastoma|pediatric neuroblastoma
246761|NCT02112604|critically ill, OSA, mechanical ventilation|critically ill, osa, mechanical ventilation
246762|NCT02112591|Stress urinary incontinence|stress urinary incontinence
246763|NCT02112591|mesh|mesh
246764|NCT02112591|tape|tape
246765|NCT02112591|micturition dysfunction|micturition dysfunction
246766|NCT02112591|urinary obstruction|urinary obstruction
246767|NCT02112591|TOT|tot
246768|NCT02112578|Vertigo, Meclizine, dimenhydrinate, Peripheral Origin|vertigo, meclizine, dimenhydrinate, peripheral origin
246769|NCT02112526|de Novo Activated B-cell (ABC) Subtype of Diffuse Large B-Cell Lymphoma|de novo activated b-cell (abc) subtype of diffuse large b-cell lymphoma
246770|NCT02112526|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
246771|NCT02112526|Novo Activated B-cell (ABC)|novo activated b-cell (abc)
247572|NCT02108964|NSCLC|nsclc
246772|NCT02112526|Novo Activated B-cell|novo activated b-cell
246773|NCT02112526|ABC DLBCL|abc dlbcl
246774|NCT02112526|DLBCL|dlbcl
246775|NCT02112526|Lymphoma|lymphoma
246776|NCT02112526|B-Cell|b-cell
246777|NCT02112526|Immunoproliferative Disorders|immunoproliferative disorders
246778|NCT02112526|Immune System Diseases|immune system diseases
246779|NCT02112487|pulmonary arterial hypertension|pulmonary arterial hypertension
246780|NCT02112487|PAH-SYMPACT|pah-sympact
246781|NCT02112487|PAH|pah
246782|NCT02112487|psychometric instrument|psychometric instrument
246783|NCT02112474|Failed Back Surgery Syndrome|failed back surgery syndrome
246784|NCT02112474|Neuropathic pain|neuropathic pain
246785|NCT02112474|Leg Pain|leg pain
246786|NCT02112474|Chronic Pain|chronic pain
246787|NCT02112474|Spinal Cord Stimulation|spinal cord stimulation
246788|NCT02112474|Neurostimulation|neurostimulation
246789|NCT02112461|end of life care|end of life care
246790|NCT02112448|congenital heart disease, pediatric cardiothoracic surgery|congenital heart disease, pediatric cardiothoracic surgery
246791|NCT02112435|obstructive sleep apnea|obstructive sleep apnea
246792|NCT02112435|mandibular advancement splint|mandibular advancement splint
246793|NCT02112435|active mandibular advancement splint|active mandibular advancement splint
246794|NCT02112435|oral appliance|oral appliance
246795|NCT02112422|Parturients|parturients
246796|NCT02112409|Adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
246797|NCT02112409|scoliosis corrective surgery|scoliosis corrective surgery
246798|NCT02112409|autologous blood transfusion|autologous blood transfusion
246799|NCT02112409|cell salvage|cell salvage
246800|NCT02112409|acute normovolemic hemodilution|acute normovolemic hemodilution
246801|NCT02112409|hemoglobin level|hemoglobin level
246802|NCT02112396|CRAFT|craft
246803|NCT02112396|Concerned Significant Others|concerned significant others
246804|NCT02112396|Contingency management|contingency management
246805|NCT02112396|Reinforcement|reinforcement
246806|NCT02112396|Family Intervention|family intervention
246807|NCT02112383|Procrastination|procrastination
246808|NCT02112383|Cognitive behavior therapy|cognitive behavior therapy
246809|NCT02112383|Internet interventions|internet interventions
246810|NCT02112383|Group intervention|group intervention
246811|NCT02112383|Students|students
246812|NCT02112383|Randomized controlled trial|randomized controlled trial
246813|NCT02112370|Ropivacaine|ropivacaine
246814|NCT02112370|Epinephrine|epinephrine
246815|NCT02112370|Endoscopy|endoscopy
246816|NCT02112370|Robotics|robotics
246817|NCT02112370|Thyroidectomy|thyroidectomy
246818|NCT02112357|molecular profiling|molecular profiling
246819|NCT02112357|genetic sequencing|genetic sequencing
246820|NCT02112357|personalised medicine|personalised medicine
246821|NCT02112357|gastrointestinal cancer|gastrointestinal cancer
246822|NCT02112331|Preterm newborns|preterm newborns
246823|NCT02112331|Gastric lipolysis|gastric lipolysis
246824|NCT02112331|Physical treatments|physical treatments
246825|NCT02112331|Human milk|human milk
246826|NCT02112305|Magnesium sulphate nebulized|magnesium sulphate nebulized
246827|NCT02112279|Microbiota|microbiota
246828|NCT02112279|c-difficile|c-difficile
246829|NCT02112279|colonoscopy|colonoscopy
246830|NCT02112279|stool transplant|stool transplant
246831|NCT02112266|depression|depression
246832|NCT02112266|online therapy|online therapy
246833|NCT02112266|cognitive behavioural therapy|cognitive behavioural therapy
246834|NCT02112266|quality of life|quality of life
246835|NCT02112266|alexithymia|alexithymia
246836|NCT02112266|therapy expectation and satisfaction|therapy expectation and satisfaction
246837|NCT02112253|Tourette's syndrome|tourette's syndrome
246838|NCT02112253|Deep brain stimulation|deep brain stimulation
246839|NCT02112253|Stereotactic surgery|stereotactic surgery
246840|NCT02112253|Globus pallidus interna|globus pallidus interna
246841|NCT02112253|Tics|tics
246842|NCT02112240|sentinel lymph node|sentinel lymph node
246843|NCT02112240|lymphatic mapping|lymphatic mapping
246844|NCT02112240|rectal tumor|rectal tumor
246845|NCT02112227|Heart Failure|heart failure
246846|NCT02112227|Transitional Care|transitional care
246847|NCT02112227|Knowledge Translation|knowledge translation
246848|NCT02112227|Outcomes|outcomes
246849|NCT02112214|Helicobacter pylori treatment|helicobacter pylori treatment
246850|NCT02112214|Gastric cancer|gastric cancer
246851|NCT02112214|Screening|screening
246852|NCT02112175|Multiple Myeloma|multiple myeloma
246853|NCT02112175|Lenalidomide|lenalidomide
246854|NCT02112175|Revlimid|revlimid
246855|NCT02112175|MPV|mpv
246856|NCT02112175|Melphalan|melphalan
246857|NCT02112175|Prednisone|prednisone
246858|NCT02112175|Velcade|velcade
246859|NCT02112175|Placebo|placebo
246860|NCT02112149|Body Composition|body composition
246861|NCT02112149|Exercise|exercise
246862|NCT02112149|Survivorship|survivorship
246863|NCT02112136|Autosomal Dominant Polycystic Kidney Disease (ADPKD)|autosomal dominant polycystic kidney disease (adpkd)
246864|NCT02112136|Renal cysts|renal cysts
246865|NCT02112136|Chronic Kidney Diseases|chronic kidney diseases
246866|NCT02112136|Genetic|genetic
246867|NCT02112123|icariin|icariin
246868|NCT02112123|pharmacokinetics|pharmacokinetics
247666|NCT02108626|Lozenge|lozenge
246869|NCT02112123|healthy participants|healthy participants
246870|NCT02112097|Plaque Psoriasis.|plaque psoriasis.
246871|NCT02112097|Subdermal bloodless space|subdermal bloodless space
246872|NCT02112097|Subdermal injection|subdermal injection
246873|NCT02112097|Subcutaneous injection|subcutaneous injection
246874|NCT02112097|Injectable electromyography needle|injectable electromyography needle
246875|NCT02112097|Electrical stimulation|electrical stimulation
246876|NCT02112097|MRI with Gadolinium|mri with gadolinium
246877|NCT02112071|Exercise|exercise
246878|NCT02112071|Diabetic kidney disease|diabetic kidney disease
246879|NCT02112071|vascular function|vascular function
246880|NCT02112071|physical function|physical function
246881|NCT02112032|melanoma|melanoma
246882|NCT02112032|advanced|advanced
246883|NCT02112019|Sjögren's Syndrome|sjögren's syndrome
246884|NCT02112019|Sialoendoscopy|sialoendoscopy
246885|NCT02112019|Saliva|saliva
246886|NCT02112019|Dry Mouth|dry mouth
246887|NCT02112006|hand surgery|hand surgery
246888|NCT02112006|wrist surgery|wrist surgery
246889|NCT02112006|finger surgery|finger surgery
246890|NCT02112006|anesthesia|anesthesia
246891|NCT02112006|regional anesthesia|regional anesthesia
246892|NCT02112006|postoperative pain|postoperative pain
246893|NCT02111993|Defibrillation testing|defibrillation testing
246894|NCT02111993|Upper Limit of Vulnerability|upper limit of vulnerability
246895|NCT02111993|ULV|ulv
246896|NCT02111993|DFT|dft
246897|NCT02111993|ICD|icd
246898|NCT02111993|implantable cardioverter defibrillator|implantable cardioverter defibrillator
246899|NCT02111993|cardiomyopathy|cardiomyopathy
246900|NCT02111993|cardiac arrhythmia|cardiac arrhythmia
246901|NCT02111993|cardiac device testing|cardiac device testing
246902|NCT02111980|CIED|cied
246903|NCT02111980|pacemaker|pacemaker
246904|NCT02111980|implantable cardioverter defibrillator|implantable cardioverter defibrillator
246905|NCT02111980|ICD|icd
246906|NCT02111980|radiofrequency|radiofrequency
246907|NCT02111980|cardiac device programming|cardiac device programming
246908|NCT02111980|RF sponge detection|rf sponge detection
246909|NCT02111980|RF assure|rf assure
246910|NCT02111980|cardiac internal electronic devices|cardiac internal electronic devices
246911|NCT02111980|temporary pacing|temporary pacing
246912|NCT02111980|pulmonary thromboendarterectomy|pulmonary thromboendarterectomy
246913|NCT02111980|pacing interference|pacing interference
246914|NCT02111980|Arrhythmia|arrhythmia
246915|NCT02111954|prostate cancer|prostate cancer
246916|NCT02111954|primary|primary
246917|NCT02111954|recurrence|recurrence
246918|NCT02111954|F-18-FCH PET/CT|f-18-fch pet/ct
246919|NCT02111954|Ga-68-NODAGA-MJ9 PET/CT|ga-68-nodaga-mj9 pet/ct
246920|NCT02111915|Maternal depression|maternal depression
246921|NCT02111902|Cardiovascular Disease|cardiovascular disease
246922|NCT02111902|Obesity|obesity
246923|NCT02111902|Physical Activity|physical activity
246924|NCT02111902|Vitamin D deficiency|vitamin d deficiency
246925|NCT02111902|African Americans|african americans
246926|NCT02111876|ICU, COPD, OHS, OSA, heart failure|icu, copd, ohs, osa, heart failure
246927|NCT02111863|Skin Cancer|skin cancer
246928|NCT02111863|Metastatic Melanoma|metastatic melanoma
246929|NCT02111863|Adoptive Cell Therapy|adoptive cell therapy
246930|NCT02111863|Immunotherapy|immunotherapy
246931|NCT02111863|Clinical Response|clinical response
246932|NCT02111850|Gene Therapy|gene therapy
246933|NCT02111850|Tumor Regression|tumor regression
246934|NCT02111850|Immunotherapy|immunotherapy
246935|NCT02111850|Adoptive Cell Therapy|adoptive cell therapy
246936|NCT02111824|Lung Cancer|lung cancer
246937|NCT02111824|Peripheral lung lesions|peripheral lung lesions
246938|NCT02111824|Lung biopsy|lung biopsy
246939|NCT02111824|Minimally invasive|minimally invasive
246940|NCT02111824|multimodality image-guided intervention system|multimodality image-guided intervention system
246941|NCT02111824|MIMIG|mimig
246942|NCT02111824|Indocyanine green|indocyanine green
246943|NCT02111824|ICG|icg
246944|NCT02111811|Depression|depression
246945|NCT02111811|Treatment Outcome|treatment outcome
246946|NCT02111811|Delivery of Healthcare, Integrated|delivery of healthcare, integrated
246947|NCT02111811|Employment|employment
246948|NCT02111811|Rehabilitation|rehabilitation
246949|NCT02111798|substance abuse treatment|substance abuse treatment
246950|NCT02111798|cocaine dependence|cocaine dependence
246951|NCT02111798|contingency management; abstinence incentives|contingency management; abstinence incentives
246952|NCT02111798|medication-enhanced behavioral therapy|medication-enhanced behavioral therapy
246953|NCT02111785|Dexamethasone|dexamethasone
246954|NCT02111785|Burr hole craniostomy|burr hole craniostomy
246955|NCT02111785|Chronic subdural hematoma|chronic subdural hematoma
246956|NCT02111772|mild asthma, rhinovirus, young adults|mild asthma, rhinovirus, young adults
246957|NCT02111746|Postoperative pain|postoperative pain
246958|NCT02111746|sternotomy|sternotomy
246959|NCT02111746|laparotomy|laparotomy
246960|NCT02111746|thoracotomy|thoracotomy
246961|NCT02111746|mini-thoracotomy|mini-thoracotomy
246962|NCT02111746|truncal surgical incisions|truncal surgical incisions
246963|NCT02111746|local anaesthetics|local anaesthetics
246964|NCT02111746|bupivacaine|bupivacaine
246965|NCT02111720|HIV|hiv
246966|NCT02111720|Disclosure|disclosure
246968|NCT02111720|Intervention|intervention
246969|NCT02111694|infant|infant
246970|NCT02111694|intake|intake
246971|NCT02111694|satiation|satiation
246972|NCT02111694|mother|mother
246973|NCT02111694|feeding practices|feeding practices
246974|NCT02111694|bottle feeding|bottle feeding
246975|NCT02111694|formula feeding|formula feeding
246976|NCT02111694|maternal responsiveness|maternal responsiveness
246977|NCT02111694|infant cues|infant cues
246978|NCT02111681|Calypso-based Deep Inspiration Breath Hold (DIBH)|calypso-based deep inspiration breath hold (dibh)
246979|NCT02111681|radiation treatments|radiation treatments
246980|NCT02111681|13-174|13-174
246981|NCT02111668|Aorta|aorta
246982|NCT02111668|Dilatation|dilatation
246983|NCT02111668|Marfan syndrome|marfan syndrome
246984|NCT02111668|Genetic|genetic
246985|NCT02111668|Fbn1|fbn1
246986|NCT02111655|Thrombosis|thrombosis
246987|NCT02111655|Arteriovenous fistulae|arteriovenous fistulae
246988|NCT02111655|Hemodialysis|hemodialysis
246989|NCT02111655|Doppler ultrasound|doppler ultrasound
246990|NCT02111655|Vascular access blood flow|vascular access blood flow
246991|NCT02111655|Surveillance|surveillance
246992|NCT02111642|Pelvic organ prolapse|pelvic organ prolapse
246993|NCT02111642|Stress urinary incontinence|stress urinary incontinence
246994|NCT02111642|Midurethral sling|midurethral sling
246995|NCT02111642|Patient satisfaction|patient satisfaction
246996|NCT02111629|Vaginosis, bacterial; Candidiasis, vulvovaginal|vaginosis, bacterial; candidiasis, vulvovaginal
246997|NCT02111616|cancer survivorship care|cancer survivorship care
246998|NCT02111616|provider communication|provider communication
246999|NCT02111616|provider care coordination|provider care coordination
247000|NCT02111590|Immunoglobulins, Intravenous|immunoglobulins, intravenous
247001|NCT02111590|Immunoglobulins, Subcutaneous|immunoglobulins, subcutaneous
247002|NCT02111577|Immunotherapy|immunotherapy
247003|NCT02111577|Metastatic|metastatic
247004|NCT02111577|Castrate Resistant|castrate resistant
247005|NCT02111577|Prostate Cancer|prostate cancer
247006|NCT02111577|Biological|biological
247007|NCT02111577|Vaccine|vaccine
247008|NCT02111564|Heart Failure|heart failure
247009|NCT02111564|Respiratory Insufficiency|respiratory insufficiency
247010|NCT02111564|Stroke Acute|stroke acute
247011|NCT02111564|Infectious Diseases|infectious diseases
247012|NCT02111564|Rheumatic Diseases|rheumatic diseases
247013|NCT02111564|Medically ill Patient|medically ill patient
247014|NCT02111564|Rivaroxaban|rivaroxaban
247015|NCT02111564|Thromboembolism|thromboembolism
247016|NCT02111564|Prophylactic Anti-Coagulation|prophylactic anti-coagulation
247017|NCT02111551|Autism|autism
247018|NCT02111551|Nicotinic agonist|nicotinic agonist
247019|NCT02111551|Cognition|cognition
247021|NCT02111551|Alpha 7|alpha 7
247022|NCT02111499|psoriasis plaque test|psoriasis plaque test
247023|NCT02111499|topical application|topical application
247024|NCT02111499|atrophy measure|atrophy measure
247025|NCT02111486|Breakfast|breakfast
247026|NCT02111486|Satiety|satiety
247027|NCT02111486|Fibre|fibre
247028|NCT02111486|Glucose|glucose
247029|NCT02111486|Gastric emptying|gastric emptying
247030|NCT02111473|endothelial dysfunction|endothelial dysfunction
247031|NCT02111473|bone mineral metabolism|bone mineral metabolism
247032|NCT02111473|testosteron replacement treatment|testosteron replacement treatment
247033|NCT02111460|Initially|initially
247034|NCT02111460|Untreated|untreated
247035|NCT02111460|Distant metastatic|distant metastatic
247036|NCT02111447|children|children
247037|NCT02111447|sevoflurane|sevoflurane
247038|NCT02111447|isoflurane|isoflurane
247039|NCT02111447|propofol|propofol
247040|NCT02111447|anesthesia|anesthesia
247041|NCT02111447|MRI|mri
247042|NCT02111447|delirium|delirium
247043|NCT02111434|visceral adiposity index|visceral adiposity index
247044|NCT02111434|triglycerides / hdl cholesterol ratio|triglycerides / hdl cholesterol ratio
247045|NCT02111434|testosterone|testosterone
247046|NCT02111421|dexmedetomidine|dexmedetomidine
247047|NCT02111421|parturient|parturient
247048|NCT02111421|nonpregnant women|nonpregnant women
247049|NCT02111421|sedation|sedation
247050|NCT02111408|Sleep apnea syndromes|sleep apnea syndromes
247051|NCT02111408|Autonomic nervous system +/- disease|autonomic nervous system +/- disease
247052|NCT02111408|Depression|depression
247053|NCT02111408|Peripheral arterial disease|peripheral arterial disease
247054|NCT02111382|Low back pain|low back pain
247055|NCT02111382|osteopathic manipulations|osteopathic manipulations
247056|NCT02111382|electroencephalography|electroencephalography
247057|NCT02111369|Essential Tremor|essential tremor
247058|NCT02111369|Essential Vocal Tremor|essential vocal tremor
247059|NCT02111369|Essential Voice Tremor|essential voice tremor
247060|NCT02111343|auditory processing disorder|auditory processing disorder
247061|NCT02111343|central auditory processing disorder|central auditory processing disorder
247062|NCT02111343|auditory processing|auditory processing
247063|NCT02111343|auditory training|auditory training
247064|NCT02111330|Adenosine A2a receptor antagonist|adenosine a2a receptor antagonist
247065|NCT02111330|adenosine receptor modulator|adenosine receptor modulator
247066|NCT02111330|Cancer|cancer
247067|NCT02111317|ASP015K|asp015k
247068|NCT02111317|Pharmacokinetics|pharmacokinetics
247069|NCT02111317|Healthy Subjects|healthy subjects
247070|NCT02111304|cholera|cholera
247071|NCT02111304|diarrhea|diarrhea
247072|NCT02111304|secretory diarrhea|secretory diarrhea
247073|NCT02111304|ORS|ors
247074|NCT02111304|V. cholerae O1|v. cholerae o1
247075|NCT02111304|iOWH032|iowh032
247076|NCT02111304|children|children
247077|NCT02111304|pharmacokinetic|pharmacokinetic
247078|NCT02111304|Bangladesh|bangladesh
247079|NCT02111291|Diabetic Foot Ulcers|diabetic foot ulcers
247080|NCT02111278|Manipulation|manipulation
247081|NCT02111278|Lumbar|lumbar
247082|NCT02111278|Low Back Pain|low back pain
247083|NCT02111278|Manual Therapy|manual therapy
247084|NCT02111278|Adolescents|adolescents
247085|NCT02111252|Drug Therapy|drug therapy
247086|NCT02111239|DIEP|diep
247087|NCT02111239|DIEP flap|diep flap
247088|NCT02111239|Breast reconstruction|breast reconstruction
247089|NCT02111239|Breast Cancer|breast cancer
247090|NCT02111239|CTA|cta
247091|NCT02111239|MRA|mra
247092|NCT02111226|hypertension|hypertension
247093|NCT02111226|cardiovascular disease|cardiovascular disease
247094|NCT02111226|diabetes|diabetes
247095|NCT02111226|chronic disease management|chronic disease management
247096|NCT02111213|physical activity|physical activity
247097|NCT02111213|Intervention|intervention
247098|NCT02111213|Attitude to Computers|attitude to computers
247099|NCT02111200|urea cycle disorders|urea cycle disorders
247100|NCT02111187|LDE225|lde225
247101|NCT02111187|High risk localized prostate cancer|high risk localized prostate cancer
247102|NCT02111187|Pre-surgical|pre-surgical
247103|NCT02111174|Neuropathy|neuropathy
247104|NCT02111174|Peripheral neuropathy|peripheral neuropathy
247105|NCT02111174|Chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
247106|NCT02111161|Randomised controlled trial (RCT)|randomised controlled trial (rct)
247107|NCT02111161|Immunoglobulin|immunoglobulin
247108|NCT02111161|Patient Reported Outcome|patient reported outcome
247109|NCT02111161|Health-Related Quality of Life|health-related quality of life
247110|NCT02111161|Short Form-36 (SF-36)|short form-36 (sf-36)
247111|NCT02111148|rupture of membranes, nitrazine, urea, creatinine|rupture of membranes, nitrazine, urea, creatinine
247112|NCT02111122|excessive daytime sleepiness|excessive daytime sleepiness
247113|NCT02111122|Parkinson`s Disease|parkinson`s disease
247114|NCT02111122|sleep-wake disturbances|sleep-wake disturbances
247115|NCT02111122|Sodium Oxybate|sodium oxybate
247116|NCT02111109|Microcirculation|microcirculation
247117|NCT02111109|Trauma|trauma
247118|NCT02111109|Haemorrhage|haemorrhage
247119|NCT02111109|Shock|shock
247120|NCT02111070|Influenza|influenza
247121|NCT02111070|Influenza vaccine|influenza vaccine
247122|NCT02111070|Split influenza vaccine|split influenza vaccine
247123|NCT02111057|Rheumatoid Arthritis|rheumatoid arthritis
247124|NCT02111057|Total Hip Replacement|total hip replacement
247125|NCT02111057|Flare|flare
247126|NCT02111057|Perioperative Outcomes|perioperative outcomes
247127|NCT02111044|de novo or partial responder to somatostatin analogues|de novo or partial responder to somatostatin analogues
247128|NCT02111031|CELLSEARCH|cellsearch
247129|NCT02111031|CTC|ctc
247130|NCT02111031|metastatic breast cancer|metastatic breast cancer
247131|NCT02111031|Registry|registry
247132|NCT02111031|mBC|mbc
247133|NCT02111005|apoptosis|apoptosis
247134|NCT02111005|periodontal disease|periodontal disease
247135|NCT02111005|smoking|smoking
247136|NCT02110979|Patient Decision Aid|patient decision aid
247137|NCT02110979|Shared Decision Making|shared decision making
247138|NCT02110966|Anaesthetic effect|anaesthetic effect
247139|NCT02110966|Inferior alveolar nerve block|inferior alveolar nerve block
247140|NCT02110966|Local tramadol|local tramadol
247141|NCT02110966|Mepivacaine|mepivacaine
247142|NCT02110966|Symptomatic irreversible pulpitis.|symptomatic irreversible pulpitis.
247143|NCT02110927|Abdominal fat|abdominal fat
247144|NCT02110927|Metabolic syndrome|metabolic syndrome
247145|NCT02110927|Microcurrent|microcurrent
247146|NCT02110927|Aerobic exercise|aerobic exercise
247147|NCT02110927|Lipolysis|lipolysis
247148|NCT02110914|Feasibility study|feasibility study
247149|NCT02110914|Coaching|coaching
247150|NCT02110914|Health related quality of life|health related quality of life
247151|NCT02110914|Adherence|adherence
247152|NCT02110901|radiocephalic|radiocephalic
247153|NCT02110901|arteriovenous fistula|arteriovenous fistula
247154|NCT02110901|AVF|avf
247155|NCT02110901|hemodialysis|hemodialysis
247156|NCT02110901|PRT-201|prt-201
247157|NCT02110901|vascular access|vascular access
247158|NCT02110901|kidney|kidney
247159|NCT02110901|renal|renal
247160|NCT02110901|vonapanitase|vonapanitase
247161|NCT02110901|PATENCY-1|patency-1
247162|NCT02110875|Healthy Volunteers|healthy volunteers
247163|NCT02110849|Prostate|prostate
247164|NCT02110849|Proton Therapy|proton therapy
247165|NCT02110849|Cancer|cancer
247166|NCT02110810|post-ERCP Acute Pancreatitis|post-ercp acute pancreatitis
247167|NCT02110810|Indomethacin|indomethacin
247168|NCT02110810|NSAIDs|nsaids
247169|NCT02110797|RETT syndrome|rett syndrome
247171|NCT02110797|Osteoporosis|osteoporosis
247172|NCT02110797|RANK-ligand|rank-ligand
247173|NCT02110797|osteoprotegerin|osteoprotegerin
247174|NCT02110784|Artemisinin based Combination Therapies|artemisinin based combination therapies
247175|NCT02110784|eurartesim|eurartesim
247176|NCT02110784|Dihydroartemisinin/Piperaquine|dihydroartemisinin/piperaquine
247177|NCT02110771|schizophrenia|schizophrenia
247178|NCT02110771|social cognition|social cognition
247179|NCT02110771|facial affects recognition|facial affects recognition
247180|NCT02110771|cognitive remediation|cognitive remediation
247181|NCT02110758|Patient Care Management|patient care management
247182|NCT02110758|Patient Care Planning|patient care planning
247183|NCT02110758|Patient-Centered Care|patient-centered care
247184|NCT02110758|Patient Care Team|patient care team
247185|NCT02110758|Advance Care Planning|advance care planning
247186|NCT02110758|Delivery of Health Care|delivery of health care
247187|NCT02110758|Evidence-based Practice|evidence-based practice
247188|NCT02110758|Health Care Costs|health care costs
247189|NCT02110758|Health Care Quality, Access, and Evaluation|health care quality, access, and evaluation
247190|NCT02110758|Quality of Health Care|quality of health care
247191|NCT02110758|Neoplasms|neoplasms
247192|NCT02110758|Medical Oncology|medical oncology
247193|NCT02110719|narcotic use|narcotic use
247194|NCT02110719|pain|pain
247195|NCT02110719|constipation|constipation
247196|NCT02110719|nausea|nausea
247197|NCT02110706|Myasthenia Gravis|myasthenia gravis
247198|NCT02110706|Rituximab|rituximab
247199|NCT02110693|Substance Use|substance use
247200|NCT02110693|Substance Use Disorder|substance use disorder
247201|NCT02110693|Screening|screening
247202|NCT02110693|Brief Assessment|brief assessment
247203|NCT02110680|overactive bladder|overactive bladder
247204|NCT02110680|transcutaneous electric stimulation|transcutaneous electric stimulation
247205|NCT02110680|posterior tibial nerve stimulation|posterior tibial nerve stimulation
247206|NCT02110667|Prostate cancer|prostate cancer
247207|NCT02110667|Prostatectomy|prostatectomy
247208|NCT02110667|Ultrasound|ultrasound
247209|NCT02110667|TPUS|tpus
247210|NCT02110654|chronic rhinosinusitis|chronic rhinosinusitis
247211|NCT02110654|asthma|asthma
247212|NCT02110654|montelukast|montelukast
247213|NCT02110654|surgery|surgery
247214|NCT02110654|treatment outcomes|treatment outcomes
247215|NCT02110641|Breast Cancer|breast cancer
247216|NCT02110641|Survivorship|survivorship
247217|NCT02110641|Weight Loss|weight loss
247218|NCT02110628|total gastrectomy|total gastrectomy
247219|NCT02110628|pouch|pouch
247220|NCT02110628|roux-en-y|roux-en-y
247221|NCT02110628|quality of life|quality of life
247222|NCT02110602|Nutrition|nutrition
247223|NCT02110589|seizures|seizures
247224|NCT02110550|endocrown|endocrown
247225|NCT02110550|marginal adaptation|marginal adaptation
247226|NCT02110550|anatomic form|anatomic form
247227|NCT02110550|retention loss|retention loss
247228|NCT02110550|IPS.emmax crowns|ips.emmax crowns
247229|NCT02110537|Atrial fibrillation|atrial fibrillation
247230|NCT02110537|Acupuncture|acupuncture
247231|NCT02110537|Recurrence|recurrence
247232|NCT02110537|Electrical cardioversion|electrical cardioversion
247233|NCT02110524|Peripheral Arterial Disease|peripheral arterial disease
247234|NCT02110498|Pancreatic cyst|pancreatic cyst
247235|NCT02110498|IPMN|ipmn
247236|NCT02110498|SCA|sca
247237|NCT02110498|SPN|spn
247238|NCT02110498|MCN|mcn
247239|NCT02110498|pancreatic cystic neoplasm|pancreatic cystic neoplasm
247240|NCT02110485|Appendicitis|appendicitis
247241|NCT02110485|Pediatric|pediatric
247242|NCT02110485|Children|children
247243|NCT02110485|Non-operative|non-operative
247244|NCT02110485|Antibiotics alone|antibiotics alone
247245|NCT02110472|Emmetropic presbyopes|emmetropic presbyopes
247246|NCT02110472|Presbyopic|presbyopic
247247|NCT02110459|POL7080|pol7080
247248|NCT02110459|Pharmacokinetics|pharmacokinetics
247249|NCT02110446|Sjögren's syndrome|sjögren's syndrome
247250|NCT02110446|SS-1|ss-1
247251|NCT02110446|Gan-Lu-Yin|gan-lu-yin
247252|NCT02110446|Sang-Ju-Yin|sang-ju-yin
247253|NCT02110446|Xuefu-Zhuyu-Decoction|xuefu-zhuyu-decoction
247254|NCT02110433|chronic heart failure|chronic heart failure
247255|NCT02110433|BNP|bnp
247256|NCT02110433|telemedicine|telemedicine
247257|NCT02110433|telemonitoring|telemonitoring
247258|NCT02110433|weight|weight
247259|NCT02110433|education|education
247260|NCT02110433|self management|self management
247261|NCT02110433|cost effectiveness|cost effectiveness
247262|NCT02110420|Safety|safety
247263|NCT02110420|Pharmacokinetics|pharmacokinetics
247264|NCT02110420|Healthy Subjects|healthy subjects
247265|NCT02110420|First-in-Human|first-in-human
247266|NCT02110407|healthy young adults|healthy young adults
247267|NCT02110407|tDCS|tdcs
247268|NCT02110407|LOCATO task|locato task
247269|NCT02110407|visual-spatial learning|visual-spatial learning
247270|NCT02110394|observational|observational
247271|NCT02110394|chronic lymphocytic leukemia|chronic lymphocytic leukemia
247272|NCT02110394|bendamustine|bendamustine
247273|NCT02110381|High blood pressure|high blood pressure
247274|NCT02110355|Metastatic melanoma|metastatic melanoma
247275|NCT02110342|PF-04449913|pf-04449913
247276|NCT02110342|[14C]PF-04449913|[14c]pf-04449913
247277|NCT02110342|Human ADME|human adme
247278|NCT02110342|Radiolabel|radiolabel
247279|NCT02110342|Mass Balance|mass balance
247280|NCT02110342|Pharmacokinetics|pharmacokinetics
247281|NCT02110329|colorectal cancer|colorectal cancer
247282|NCT02110329|stage II and III|stage ii and iii
247283|NCT02110329|somatic quantitative molecular alterations|somatic quantitative molecular alterations
247284|NCT02110329|Qantitative Multiplex Pcr of Short fluorescent Fragments method (QMPSF)|qantitative multiplex pcr of short fluorescent fragments method (qmpsf)
247285|NCT02110290|quality of life|quality of life
247286|NCT02110290|adaptive sports|adaptive sports
247287|NCT02110290|therapeutic recreation|therapeutic recreation
247288|NCT02110290|mental health|mental health
247289|NCT02110277|Ovarian Cancer|ovarian cancer
247290|NCT02110277|Epithelial ovarian cancer|epithelial ovarian cancer
247291|NCT02110264|Opioid Use|opioid use
247292|NCT02110264|Incarceration|incarceration
247293|NCT02110264|Vivitrol|vivitrol
247294|NCT02110264|Patient Navigator|patient navigator
247295|NCT02110264|Drug Education|drug education
247296|NCT02110238|osteoarthritis|osteoarthritis
247297|NCT02110238|knee pain|knee pain
247298|NCT02110238|Supartz|supartz
247299|NCT02110238|Euflexxa|euflexxa
247300|NCT02110238|HA|ha
247301|NCT02110238|hyaluronic acid|hyaluronic acid
247302|NCT02110225|Cone-Rod Degenerations|cone-rod degenerations
247303|NCT02110225|Cone-Rod Dystrophy|cone-rod dystrophy
247304|NCT02110225|Cone-Rod Dystrophy 2|cone-rod dystrophy 2
247305|NCT02110225|Cone-Rod Retinal Dystrophy|cone-rod retinal dystrophy
247306|NCT02110225|Pigmentary Retinopathy|pigmentary retinopathy
247307|NCT02110225|Retinal Cone-Rod Dystrophy|retinal cone-rod dystrophy
247308|NCT02110225|Rod Cone Dystrophies|rod cone dystrophies
247309|NCT02110225|Rod-Cone Dystrophy|rod-cone dystrophy
247310|NCT02110225|Tapetoretinal Degeneration|tapetoretinal degeneration
247311|NCT02110212|Cataract|cataract
247312|NCT02110212|Surgery, cataract extraction|surgery, cataract extraction
247313|NCT02110212|Optical devices, laser|optical devices, laser
247314|NCT02110186|lumbar disc herniation|lumbar disc herniation
247315|NCT02110186|dynamic stabilization|dynamic stabilization
247316|NCT02110186|discectomy with posterior dynamic stabilization|discectomy with posterior dynamic stabilization
247317|NCT02110186|discectomy alone|discectomy alone
247318|NCT02110186|discectomy with internal fixation and fusion|discectomy with internal fixation and fusion
247319|NCT02110069|KHE|khe
247320|NCT02110069|Vascular anomaly|vascular anomaly
247321|NCT02110069|Kasabach-Merritt Syndrome|kasabach-merritt syndrome
247322|NCT02110069|Tufted angioma|tufted angioma
247323|NCT02110069|hemangioendothelioma|hemangioendothelioma
247324|NCT02110056|healthy older adults|healthy older adults
247325|NCT02110056|tDCS|tdcs
247326|NCT02110056|LOCATO task|locato task
247327|NCT02110056|visual-spatial learning|visual-spatial learning
247328|NCT02110043|mild cognitive impairment (MCI)|mild cognitive impairment (mci)
247329|NCT02110043|tDCS|tdcs
247330|NCT02110043|LOCATO task|locato task
247331|NCT02110043|visual-spatial learning|visual-spatial learning
247332|NCT02110030|Transcutaneous electrical nerve stimulation (TENS)|transcutaneous electrical nerve stimulation (tens)
247333|NCT02110030|Ultrasound|ultrasound
247334|NCT02110030|Interferential current therapy|interferential current therapy
247335|NCT02110030|Rehabilitation|rehabilitation
247336|NCT02110030|Shoulder pain|shoulder pain
247337|NCT02110017|Ecological task|ecological task
247338|NCT02110017|fMRI|fmri
247339|NCT02110017|Schizophrenia|schizophrenia
247340|NCT02110017|Social Cognition|social cognition
247341|NCT02109978|Diabetes|diabetes
247342|NCT02109978|Type 2 diabetes|type 2 diabetes
247343|NCT02109978|Diabetes therapy response|diabetes therapy response
247344|NCT02109978|Diabetes progression|diabetes progression
247345|NCT02109939|MDD|mdd
247346|NCT02109939|Pharmacogenomic|pharmacogenomic
247347|NCT02109939|Pharmacogenomic Testing|pharmacogenomic testing
247348|NCT02109939|Pharmacogenomics|pharmacogenomics
247349|NCT02109939|Genetic Testing|genetic testing
247350|NCT02109939|Genetics|genetics
247351|NCT02109939|Major Depressive Disorder|major depressive disorder
247352|NCT02109939|GeneSight|genesight
247353|NCT02109939|Assurex|assurex
247354|NCT02109939|AssureRx|assurerx
247355|NCT02109939|Psychotropic|psychotropic
247356|NCT02109939|Randomized|randomized
247357|NCT02109939|Double Blind|double blind
247358|NCT02109939|Placebo Controlled|placebo controlled
247359|NCT02109913|Breast Cancer|breast cancer
247360|NCT02109913|metastatic|metastatic
247361|NCT02109913|hormone receptor positive|hormone receptor positive
247362|NCT02109913|everolimus|everolimus
247363|NCT02109913|biomarker|biomarker
247364|NCT02109887|Pneumocystis jiroveci, cytomegalovirus, co-infection|pneumocystis jiroveci, cytomegalovirus, co-infection
247365|NCT02109861|Multiple Myeloma|multiple myeloma
247366|NCT02109861|Phase 0 study|phase 0 study
247367|NCT02109861|Microdose study|microdose study
247368|NCT02109861|Micro array|micro array
247369|NCT02109861|Gene expression profiling|gene expression profiling
247370|NCT02109848|keratoconus|keratoconus
247371|NCT02109848|post-keratoplasty|post-keratoplasty
247372|NCT02109835|Diabetes|diabetes
247373|NCT02109835|coronary artery disease|coronary artery disease
247374|NCT02109835|Cardiac computed tomography|cardiac computed tomography
247375|NCT02109835|Computed tomographics coronary angiography|computed tomographics coronary angiography
247376|NCT02109835|Plaque progression|plaque progression
247377|NCT02109822|Cystic Fibrosis|cystic fibrosis
247378|NCT02109822|Pulmonary Exacerbation|pulmonary exacerbation
247379|NCT02109822|Lung Infection|lung infection
247380|NCT02109822|Cystic Fibrosis Foundation|cystic fibrosis foundation
247381|NCT02109822|Cystic Fibrosis Foundation National Patient Registry|cystic fibrosis foundation national patient registry
247382|NCT02109796|tDCS|tdcs
247383|NCT02109796|Stroke|stroke
247384|NCT02109796|Force|force
247385|NCT02109796|Spasticity|spasticity
247386|NCT02109796|Gait|gait
247388|NCT02109796|Isokinetic|isokinetic
247389|NCT02109783|Athletes|athletes
247390|NCT02109783|Ergogenic aids|ergogenic aids
247391|NCT02109783|Caffeine|caffeine
247392|NCT02109783|Nutrigenomics|nutrigenomics
247393|NCT02109783|Genotype|genotype
247394|NCT02109770|22q|22q
247395|NCT02109770|DiGeorge|digeorge
247396|NCT02109770|Angelman|angelman
247397|NCT02109770|Cri du chat|cri du chat
247398|NCT02109770|Miller Dieker|miller dieker
247399|NCT02109770|1p36|1p36
247400|NCT02109770|Phelan McDermid|phelan mcdermid
247401|NCT02109770|Prader Willi|prader willi
247402|NCT02109770|Wolf Hirschorn|wolf hirschorn
247403|NCT02109770|Smith Magenis|smith magenis
247404|NCT02109770|Trisomy 21|trisomy 21
247405|NCT02109770|Down syndrome|down syndrome
247406|NCT02109770|Trisomy 18|trisomy 18
247407|NCT02109770|Edwards syndrome|edwards syndrome
247408|NCT02109770|Trisomy 13|trisomy 13
247409|NCT02109770|Patau syndrome|patau syndrome
247410|NCT02109770|Monosomy X|monosomy x
247411|NCT02109770|Turner syndrome|turner syndrome
247412|NCT02109770|XXY|xxy
247413|NCT02109770|Klinefelter syndrome|klinefelter syndrome
247414|NCT02109770|XXX|xxx
247415|NCT02109770|XYY|xyy
247416|NCT02109757|Hearing conservation|hearing conservation
247417|NCT02109757|Personal attenuation rating|personal attenuation rating
247418|NCT02109757|earplug|earplug
247419|NCT02109731|Obstructive Sleep Apnea Syndrome (OSAS)|obstructive sleep apnea syndrome (osas)
247420|NCT02109731|Sleep Apnea|sleep apnea
247421|NCT02109718|Burns|burns
247422|NCT02109718|Dressings|dressings
247423|NCT02109718|Outpatient Management|outpatient management
247424|NCT02109718|Petrolatum Jelly|petrolatum jelly
247425|NCT02109718|Superficial Partial Thickness Burns|superficial partial thickness burns
247426|NCT02109718|Less than or equal to 10% Total Body Surface Area|less than or equal to 10% total body surface area
247427|NCT02109692|muscle dystrophies|muscle dystrophies
247428|NCT02109692|dystromirs|dystromirs
247429|NCT02109692|longitudinal study|longitudinal study
247430|NCT02109692|miRNA|mirna
247431|NCT02109653|NSCLC,|nsclc,
247432|NCT02109653|Non-Small Cell Lung Cancer,|non-small cell lung cancer,
247433|NCT02109653|BRAF V600,|braf v600,
247434|NCT02109653|LGX818|lgx818
247435|NCT02109640|Colorectal|colorectal
247436|NCT02109640|Surgery|surgery
247437|NCT02109640|Laparoscopic|laparoscopic
247438|NCT02109640|Analgesia|analgesia
247439|NCT02109640|Enhanced Recovery|enhanced recovery
247440|NCT02109640|Targinact|targinact
247441|NCT02109627|Acute Myeloid Leukemia|acute myeloid leukemia
247442|NCT02109627|Ficlatuzumab|ficlatuzumab
247443|NCT02109627|High Dose Cytarabine|high dose cytarabine
247444|NCT02109627|antibody|antibody
247445|NCT02109614|lipoprotein(a)|lipoprotein(a)
247446|NCT02109614|aortic stenosis|aortic stenosis
247447|NCT02109601|Patient Portals|patient portals
247448|NCT02109601|Personal Health Records|personal health records
247449|NCT02109601|Patient Engagement|patient engagement
247450|NCT02109601|Mobile Health|mobile health
247451|NCT02109601|Tablet Computers|tablet computers
247452|NCT02109575|Acute Rejection|acute rejection
247453|NCT02109575|Cardiac Biomarkers|cardiac biomarkers
247454|NCT02109575|Cardiac Catheterization|cardiac catheterization
247455|NCT02109575|Cardiomyopathy|cardiomyopathy
247456|NCT02109575|Cell-Free DNA|cell-free dna
247457|NCT02109575|Congenital Heart Defect|congenital heart defect
247458|NCT02109575|Congenital Heart Disease|congenital heart disease
247459|NCT02109575|Coronary Angiogram|coronary angiogram
247460|NCT02109575|Donor Specific DNA|donor specific dna
247461|NCT02109575|Donor Specific Cell-Free DNA|donor specific cell-free dna
247462|NCT02109575|Endomyocardial Biopsy|endomyocardial biopsy
247463|NCT02109575|Heart Failure|heart failure
247464|NCT02109575|Heart Transplant Failure|heart transplant failure
247465|NCT02109575|Heart Transplant|heart transplant
247466|NCT02109575|Heart Transplant Rejection|heart transplant rejection
247467|NCT02109562|Schizophrenia|schizophrenia
247468|NCT02109562|Schizophrenic|schizophrenic
247469|NCT02109562|Schizophrenias|schizophrenias
247470|NCT02109562|Risperidone|risperidone
247471|NCT02109536|Colonoscopy|colonoscopy
247472|NCT02109536|Looping|looping
247473|NCT02109536|Loop recognition|loop recognition
247474|NCT02109536|magnetic endoscopic imager|magnetic endoscopic imager
247475|NCT02109471|corneal opacities|corneal opacities
247476|NCT02109471|Optical coherence tomography|optical coherence tomography
247477|NCT02109458|Lung nodule biopsy|lung nodule biopsy
247478|NCT02109432|Pedal Desk|pedal desk
247479|NCT02109432|Physical Activity|physical activity
247480|NCT02109432|Workplace|workplace
247481|NCT02109432|Energy Expenditure|energy expenditure
247482|NCT02109419|computerized assessments|computerized assessments
247483|NCT02109419|mood|mood
247484|NCT02109419|life space|life space
247485|NCT02109419|cognition|cognition
247486|NCT02109393|Rehabilitation|rehabilitation
247487|NCT02109393|Robot-assisted walking training|robot-assisted walking training
247488|NCT02109393|Treadmill|treadmill
247489|NCT02109393|Lokomat|lokomat
247490|NCT02109367|ovarian cancer|ovarian cancer
247491|NCT02109367|ovarian mass|ovarian mass
247492|NCT02109367|CA-125|ca-125
247493|NCT02109367|HE4|he4
247494|NCT02109367|culdocentesis|culdocentesis
247495|NCT02109367|biomarker(s)|biomarker(s)
247496|NCT02109354|HIV infection|hiv infection
247497|NCT02109354|Vaccine|vaccine
247498|NCT02109341|mPC|mpc
247499|NCT02109328|Bladder cancer|bladder cancer
247500|NCT02109328|Urothelial cancer|urothelial cancer
247501|NCT02109328|Alisertib|alisertib
247502|NCT02109328|Phase 2|phase 2
247503|NCT02109328|Advanced disease|advanced disease
247504|NCT02109289|Anti-Tumor necrosis factor alpha|anti-tumor necrosis factor alpha
247505|NCT02109289|18-FluoroDeoxyGlucose Positron Emission Tomography|18-fluorodeoxyglucose positron emission tomography
247506|NCT02109289|High-sensitivity C- Reactive protein|high-sensitivity c- reactive protein
247507|NCT02109276|Fuch's endothelial dystrophy|fuch's endothelial dystrophy
247508|NCT02109276|Aspheric intraocular lens|aspheric intraocular lens
247509|NCT02109276|Higher Order Aberrations|higher order aberrations
247510|NCT02109276|Contrast Sensitivity|contrast sensitivity
247511|NCT02109263|Breast-feeding|breast-feeding
247512|NCT02109263|Saccharose|saccharose
247513|NCT02109263|Breast-feeding newborn|breast-feeding newborn
247514|NCT02109263|cortical pain responses|cortical pain responses
247515|NCT02109263|near infrared spectroscopy (NIRS)|near infrared spectroscopy (nirs)
247516|NCT02109263|Salivary rate cortisol|salivary rate cortisol
247517|NCT02109263|heel lance|heel lance
247518|NCT02109250|Medullary Thyroid Cancer (MTC) vandetanib caprelsa|medullary thyroid cancer (mtc) vandetanib caprelsa
247519|NCT02109237|Lung transplantation|lung transplantation
247520|NCT02109237|Bronchiolitis obliterans|bronchiolitis obliterans
247521|NCT02109198|Mild Traumatic Brain Injury|mild traumatic brain injury
247522|NCT02109185|seasonal allergic rhinitis|seasonal allergic rhinitis
247523|NCT02109185|grass/tree/ragweed allergies|grass/tree/ragweed allergies
247524|NCT02109185|nasal congestion/stuffiness|nasal congestion/stuffiness
247525|NCT02109185|rhinnorea|rhinnorea
247526|NCT02109185|nasal itching|nasal itching
247527|NCT02109185|sneezing|sneezing
247528|NCT02109172|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
247529|NCT02109172|COPD|copd
247530|NCT02109146|TACE|tace
247531|NCT02109146|Postoperation|postoperation
247532|NCT02109133|deep neuromuscular blockade|deep neuromuscular blockade
247533|NCT02109133|intraocular pressure|intraocular pressure
247534|NCT02109107|body contouring|body contouring
247535|NCT02109107|body shaping|body shaping
247536|NCT02109107|circumference reduction|circumference reduction
247537|NCT02109094|insulin|insulin
247538|NCT02109094|metabolomics|metabolomics
247539|NCT02109081|dexamethasone|dexamethasone
247540|NCT02109081|delirium|delirium
247541|NCT02109081|postoperative cognitive dysfunction|postoperative cognitive dysfunction
247542|NCT02109081|postoperative|postoperative
247543|NCT02109081|elderly|elderly
247544|NCT02109068|Breast Cancer|breast cancer
247545|NCT02109068|Survivorship|survivorship
247546|NCT02109068|Weight Loss|weight loss
247547|NCT02109055|Cardiovascular Diseases|cardiovascular diseases
247548|NCT02109055|Thoracic Surgery|thoracic surgery
247549|NCT02109055|Exercise Therapy|exercise therapy
247550|NCT02109016|FGFR1 amplification|fgfr1 amplification
247551|NCT02109016|FGF alteration|fgf alteration
247552|NCT02109016|VEGF alteration|vegf alteration
247553|NCT02109016|PDGF alteration|pdgf alteration
247554|NCT02109016|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
247555|NCT02109016|VEGFR inhibitor|vegfr inhibitor
247556|NCT02109016|FGFR inhibitor|fgfr inhibitor
247557|NCT02109016|PDGFR inhibitor|pdgfr inhibitor
247558|NCT02109016|VEGFR-FGFR inhibitor|vegfr-fgfr inhibitor
247559|NCT02109003|tracheal cuff|tracheal cuff
247560|NCT02109003|cuff overinflation|cuff overinflation
247561|NCT02109003|cuff underinflation|cuff underinflation
247562|NCT02108990|borderline personality disorder|borderline personality disorder
247563|NCT02108990|rejection|rejection
247564|NCT02108990|social pain|social pain
247565|NCT02108977|Remote Consultation|remote consultation
247566|NCT02108977|Teleconsultation|teleconsultation
247567|NCT02108977|Videoconferencing|videoconferencing
247568|NCT02108977|Genetic Counseling|genetic counseling
247569|NCT02108977|Costs and Cost Analysis|costs and cost analysis
247570|NCT02108977|Comparative Effectiveness Research|comparative effectiveness research
247571|NCT02108977|Telehealth|telehealth
247573|NCT02108964|Non-small Cell Lung Cancer EGFRmut|non-small cell lung cancer egfrmut
247574|NCT02108964|EGFR TKIs (EGF816)|egfr tkis (egf816)
247575|NCT02108964|acquired T790M mutation|acquired t790m mutation
247576|NCT02108964|de novo T790M mutation|de novo t790m mutation
247577|NCT02108964|EGFR TKI activating mutation (i.e. L858R or ex19del)|egfr tki activating mutation (i.e. l858r or ex19del)
247578|NCT02108964|Treatment naive advanced NSCLC with EGFR activating mutations|treatment naive advanced nsclc with egfr activating mutations
247579|NCT02108964|Locally advanced NSCLC (Stage IIIB NSCLC not amenable to definitive multi-modality therapy including surgery)|locally advanced nsclc (stage iiib nsclc not amenable to definitive multi-modality therapy including surgery)
247580|NCT02108964|Metastatic NSCLC refers to Stage IV NSCLC|metastatic nsclc refers to stage iv nsclc
247581|NCT02108964|1st line|1st line
247582|NCT02108951|CML|cml
247583|NCT02108951|Ph-CML|ph-cml
247584|NCT02108951|leukaemia|leukaemia
247585|NCT02108951|leukemia|leukemia
247586|NCT02108951|chronic myeloid leukemia|chronic myeloid leukemia
247587|NCT02108951|chronic myeloid leukaemia|chronic myeloid leukaemia
247588|NCT02108951|TKI intolerance|tki intolerance
247589|NCT02108951|tyrosine kinase inhibitor|tyrosine kinase inhibitor
247590|NCT02108951|tyrosine kinase inhibitor intolerance|tyrosine kinase inhibitor intolerance
247591|NCT02108912|stroke|stroke
247592|NCT02108912|gait|gait
247593|NCT02108912|cardiovascular|cardiovascular
247594|NCT02108899|Schizophrenia|schizophrenia
247595|NCT02108899|Episodic memory deficits|episodic memory deficits
247596|NCT02108886|preterm labor|preterm labor
247597|NCT02108886|montelukast|montelukast
247598|NCT02108886|uterine contractions|uterine contractions
247599|NCT02108873|Appointments and Schedules|appointments and schedules
247600|NCT02108873|Outpatient Clinics, Hospital/economics|outpatient clinics, hospital/economics
247726|NCT02108353|Type 2 Diabetes|type 2 diabetes
247601|NCT02108860|Granulomatosis with polyangiitis (Wegener's)|granulomatosis with polyangiitis (wegener's)
247602|NCT02108860|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
247604|NCT02108860|Wegener's granulomatosis|wegener's granulomatosis
247605|NCT02108860|Wegener granulomatosis|wegener granulomatosis
247606|NCT02108860|Anti Neutrophil Cytoplasmic Antibody Associated Vasculitis|anti neutrophil cytoplasmic antibody associated vasculitis
247607|NCT02108860|ANCA Associated Vasculitis|anca associated vasculitis
247608|NCT02108860|AAV|aav
247609|NCT02108860|Vasculitis|vasculitis
247610|NCT02108860|Systemic vasculitis|systemic vasculitis
247611|NCT02108860|Systemic inflammatory disease|systemic inflammatory disease
247612|NCT02108860|Lung Diseases|lung diseases
247613|NCT02108860|Respiratory Tract Diseases|respiratory tract diseases
247614|NCT02108860|Vascular Diseases|vascular diseases
247615|NCT02108860|Abatacept|abatacept
247616|NCT02108860|CTLA4-Ig|ctla4-ig
247617|NCT02108860|Immunosuppressive agent|immunosuppressive agent
247618|NCT02108860|Prednisone|prednisone
247619|NCT02108860|Glucocorticoids|glucocorticoids
247620|NCT02108860|Glucocorticoid|glucocorticoid
247621|NCT02108860|Corticosteroid|corticosteroid
247622|NCT02108860|Corticosteroids|corticosteroids
247623|NCT02108860|Treatment|treatment
247624|NCT02108860|Pharmacologic Actions|pharmacologic actions
247625|NCT02108860|Therapeutic Uses|therapeutic uses
247626|NCT02108860|Anti Inflammatory Agents|anti inflammatory agents
247627|NCT02108847|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
247628|NCT02108847|Pain, Postoperative|pain, postoperative
247629|NCT02108847|Nerve Block|nerve block
247630|NCT02108847|Anesthesia, Regional|anesthesia, regional
247631|NCT02108847|Fascia Iliaca Block|fascia iliaca block
247632|NCT02108847|Ultrasound Guided|ultrasound guided
247633|NCT02108834|chronic postsurgery pain|chronic postsurgery pain
247634|NCT02108834|acute pain|acute pain
247635|NCT02108821|Inflammatory Bowel Diseases (IBD)|inflammatory bowel diseases (ibd)
247636|NCT02108821|Crohn's Disease (CD)|crohn's disease (cd)
247637|NCT02108821|Ulcerative Colitis (UC)|ulcerative colitis (uc)
247638|NCT02108808|FFR|ffr
247639|NCT02108808|adenosine|adenosine
247640|NCT02108808|Ticagrelor|ticagrelor
247641|NCT02108769|Yoga|yoga
247642|NCT02108769|Yogic breathing|yogic breathing
247643|NCT02108769|Saliva|saliva
247644|NCT02108769|Proteomics|proteomics
247645|NCT02108769|Lipdomics|lipdomics
247646|NCT02108769|Nerve growth factor|nerve growth factor
247647|NCT02108769|Thirumanthiram|thirumanthiram
247648|NCT02108717|Telemedicine|telemedicine
247649|NCT02108717|appendicitis|appendicitis
247650|NCT02108717|remote consultation|remote consultation
247651|NCT02108704|Parkinson's Disease|parkinson's disease
247652|NCT02108704|Helicobacter pylori infection|helicobacter pylori infection
247653|NCT02108678|Acceptance and Commitment Therapy (ACT)|acceptance and commitment therapy (act)
247654|NCT02108678|Depression|depression
247655|NCT02108678|Illness Management|illness management
247656|NCT02108678|Behavioral Treatment|behavioral treatment
247657|NCT02108678|Impairment|impairment
247658|NCT02108652|anti-PD-L1|anti-pd-l1
247659|NCT02108652|PD-L1|pd-l1
247660|NCT02108652|MPDL3280A|mpdl3280a
247661|NCT02108652|PD-1|pd-1
247662|NCT02108652|bladder cancer|bladder cancer
247663|NCT02108652|atezolizumab|atezolizumab
247664|NCT02108652|Tecentriq|tecentriq
247665|NCT02108626|Electronic Cigarettes|electronic cigarettes
247668|NCT02108626|Tobacco|tobacco
247669|NCT02108626|Dependence|dependence
247670|NCT02108626|Withdrawal|withdrawal
247671|NCT02108613|Androgen deprivation therapy|androgen deprivation therapy
247672|NCT02108613|Supportive care|supportive care
247673|NCT02108613|Quality of life|quality of life
247674|NCT02108600|Kidney transplantation|kidney transplantation
247675|NCT02108600|Inflammation|inflammation
247676|NCT02108561|Breast Cancer Heterogeneity Her2|breast cancer heterogeneity her2
247677|NCT02108548|ASP7657|asp7657
247678|NCT02108548|Pharmacokinetics|pharmacokinetics
247679|NCT02108548|Pharmacodynamics|pharmacodynamics
247680|NCT02108548|Healthy Subjects|healthy subjects
247681|NCT02108548|First in man|first in man
247682|NCT02108548|Safety|safety
247683|NCT02108535|burns|burns
247684|NCT02108535|dressings|dressings
247685|NCT02108535|silver sulfadiazine|silver sulfadiazine
247686|NCT02108535|silver compounds|silver compounds
247687|NCT02108535|cost|cost
247688|NCT02108522|CMV infection|cmv infection
247689|NCT02108522|EBV infection|ebv infection
247690|NCT02108522|HHV6 virus infection|hhv6 virus infection
247691|NCT02108522|BK virus infection|bk virus infection
247692|NCT02108522|Adenovirus infection|adenovirus infection
247693|NCT02108522|JC virus infection|jc virus infection
247694|NCT02108522|allogeneic stem cell transplant|allogeneic stem cell transplant
247695|NCT02108522|Virus Specific T cells|virus specific t cells
247696|NCT02108509|Chronic Pancreatitis|chronic pancreatitis
247697|NCT02108509|Osteopenia|osteopenia
247698|NCT02108509|Osteoporosis|osteoporosis
247699|NCT02108509|Hypogonadism|hypogonadism
247700|NCT02108509|Opioid medications|opioid medications
247701|NCT02108470|Oral Health Related Quality of Life (OHRQoL)|oral health related quality of life (ohrqol)
247702|NCT02108470|Oral Health Impact Profile (OHIP)|oral health impact profile (ohip)
247703|NCT02108470|Dentist-Patient Relations|dentist-patient relations
247704|NCT02108470|patients' participation.|patients' participation.
247705|NCT02108470|patients' satisfaction with the consultation.|patients' satisfaction with the consultation.
247706|NCT02108457|concurrent chemotherapy|concurrent chemotherapy
247707|NCT02108444|hepatitis|hepatitis
247708|NCT02108444|hepatitis B|hepatitis b
247709|NCT02108444|lymphoma|lymphoma
247710|NCT02108444|Hematologic Diseases|hematologic diseases
247711|NCT02108431|urinary diversion|urinary diversion
247712|NCT02108431|urethral catheter|urethral catheter
247713|NCT02108431|suprapubic tube|suprapubic tube
247714|NCT02108431|radical prostatectomy|radical prostatectomy
247715|NCT02108431|robotic surgery|robotic surgery
247716|NCT02108431|discomfort|discomfort
247717|NCT02108431|pain|pain
247718|NCT02108405|critically ill patient.|critically ill patient.
247719|NCT02108392|PXE|pxe
247720|NCT02108392|phenotype|phenotype
247721|NCT02108392|eye|eye
247722|NCT02108392|biomarkers|biomarkers
247723|NCT02108366|severe|severe
247724|NCT02108366|influenza A|influenza a
247725|NCT02108366|celecoxib|celecoxib
247727|NCT02108353|metabolic control|metabolic control
247728|NCT02108353|Metabolomics|metabolomics
247729|NCT02108353|Circadian Rhythm|circadian rhythm
247730|NCT02108353|Melatonin|melatonin
247731|NCT02108353|Biomarker|biomarker
247732|NCT02108353|Clock Gene|clock gene
247733|NCT02108353|PBMC|pbmc
247734|NCT02108353|Cardiovascular function|cardiovascular function
247735|NCT02108353|Epigenetic modification|epigenetic modification
247736|NCT02108353|Lifestyle Intervention|lifestyle intervention
247737|NCT02108340|Appendicitis|appendicitis
247738|NCT02108340|Diagnosis|diagnosis
247739|NCT02108340|Microwave radiometry|microwave radiometry
247740|NCT02108340|Ultrasonography|ultrasonography
247741|NCT02108327|Blood loss|blood loss
247742|NCT02108327|total knee arthroplasty|total knee arthroplasty
247743|NCT02108327|hot knife|hot knife
247744|NCT02108327|cold knife|cold knife
247745|NCT02108327|unipolar electrocautery|unipolar electrocautery
247746|NCT02108327|surgical blade|surgical blade
247747|NCT02108301|chronic hepatitis C-virus infection|chronic hepatitis c-virus infection
247748|NCT02108301|renal transplantation|renal transplantation
247749|NCT02108301|glucose tolerance|glucose tolerance
247750|NCT02108301|immunosuppression|immunosuppression
247751|NCT02108236|acupuncture|acupuncture
247752|NCT02108236|chinese traditional medicine|chinese traditional medicine
247753|NCT02108223|ICSI|icsi
247754|NCT02108223|Suboptimal Ovarian Response|suboptimal ovarian response
247755|NCT02108223|rLH|rlh
247756|NCT02108210|Chronic fatigue syndrome|chronic fatigue syndrome
247757|NCT02108210|Cytokines|cytokines
247758|NCT02108210|Interleukin-1|interleukin-1
247759|NCT02108210|Fatigue|fatigue
247760|NCT02108210|Anakinra|anakinra
247761|NCT02108184|helicobacter eradication rates|helicobacter eradication rates
247762|NCT02108171|intranasal|intranasal
247763|NCT02108171|dexmedetomidine|dexmedetomidine
247764|NCT02108171|early recovery|early recovery
247765|NCT02108171|suspension laryngoscopy|suspension laryngoscopy
247766|NCT02108145|cholangiocarcinoma|cholangiocarcinoma
247767|NCT02108145|jaundice|jaundice
247768|NCT02108145|metal stent|metal stent
247769|NCT02108145|PTBS|ptbs
247770|NCT02108132|hemophilia|hemophilia
247771|NCT02108132|mesenchymal stem cells|mesenchymal stem cells
247772|NCT02108132|in-vitro transdifferentiation|in-vitro transdifferentiation
247773|NCT02108106|safety and tolerability|safety and tolerability
247774|NCT02108106|pharmacokinetic study|pharmacokinetic study
247775|NCT02108080|Alcohol|alcohol
247776|NCT02108080|Adolescents|adolescents
247777|NCT02108080|Adults|adults
247778|NCT02108054|fMRI|fmri
247779|NCT02108054|Alcoholism|alcoholism
247780|NCT02108054|Phenotype|phenotype
247781|NCT02108054|Imaging|imaging
247782|NCT02108041|Physicians|physicians
247783|NCT02108041|Pharmacogenetic Testing|pharmacogenetic testing
247784|NCT02108041|Decision-Making|decision-making
247785|NCT02108041|Communicative Behaviors|communicative behaviors
247786|NCT02108028|Advance Care Planning Guide|advance care planning guide
247787|NCT02108028|End-of-Life|end-of-life
247788|NCT02108015|Transmembrane AMPA Receptor Regulatory Protein|transmembrane ampa receptor regulatory protein
247789|NCT02108015|Glutamate Receptors|glutamate receptors
247790|NCT02108015|Healthy Volunteers|healthy volunteers
247791|NCT02108002|Missense Mutations|missense mutations
247792|NCT02108002|Hemangioblastoma|hemangioblastoma
247793|NCT02108002|Histone Deacytelase Inhibitors|histone deacytelase inhibitors
247794|NCT02108002|Von Hippel-Lindau Disease|von hippel-lindau disease
247795|NCT02107989|Epilepsy|epilepsy
247796|NCT02107989|MRI|mri
247797|NCT02107989|fMRI|fmri
247798|NCT02107989|MEG|meg
247799|NCT02107976|Diabetes|diabetes
247800|NCT02107976|Red Blood Cells|red blood cells
247801|NCT02107976|Vitamin C|vitamin c
247802|NCT02107976|Plasma Vitamin C Levels|plasma vitamin c levels
247803|NCT02107963|GD2-Expressing Tumors|gd2-expressing tumors
247804|NCT02107963|Anti-GD2 Chimeric Antigen Receptor|anti-gd2 chimeric antigen receptor
247805|NCT02107963|Osteosarcoma|osteosarcoma
247806|NCT02107963|Adoptive Immunotherapy|adoptive immunotherapy
247807|NCT02107963|Sarcomas|sarcomas
247808|NCT02107950|Ovarian|ovarian
247809|NCT02107950|Platinum Sensitive|platinum sensitive
247810|NCT02107950|Epithelial|epithelial
247811|NCT02107937|serous|serous
247812|NCT02107937|endometrioid|endometrioid
247813|NCT02107937|mucinous|mucinous
247814|NCT02107937|epithelial ovarian cancer|epithelial ovarian cancer
247815|NCT02107924|Total|total
247816|NCT02107924|Knee|knee
247817|NCT02107924|Replacment|replacment
247818|NCT02107924|Infection|infection
247819|NCT02107924|Stimulan|stimulan
247820|NCT02107911|men who have sex with men|men who have sex with men
247821|NCT02107911|non-occupational post exposure prophylaxis|non-occupational post exposure prophylaxis
247822|NCT02107911|HIV infection|hiv infection
247823|NCT02107859|Cystic fibrosis|cystic fibrosis
247824|NCT02107859|Nonsense mutation|nonsense mutation
247825|NCT02107859|Premature stop codon|premature stop codon
247826|NCT02107859|PTC124|ptc124
247827|NCT02107859|Ataluren|ataluren
247828|NCT02107820|Bladder training|bladder training
247829|NCT02107820|Percutaneous Tibial nerve stimulation|percutaneous tibial nerve stimulation
247830|NCT02107820|Overactive bladder|overactive bladder
247831|NCT02107820|Randomised controlled study|randomised controlled study
247832|NCT02107807|Influenza,|influenza,
247833|NCT02107807|H5N1|h5n1
247834|NCT02107807|aH5N1|ah5n1
247835|NCT02107807|H5N1 vaccine|h5n1 vaccine
247836|NCT02107807|Pandemic Influenza vaccine|pandemic influenza vaccine
247837|NCT02107807|MF59|mf59
247838|NCT02107807|Adjuvant|adjuvant
247839|NCT02107807|Avian flu|avian flu
247840|NCT02107807|Underlying Immunosuppressive|underlying immunosuppressive
247841|NCT02107807|immunosuppressive conditions|immunosuppressive conditions
247842|NCT02107807|Pandemic vaccine|pandemic vaccine
247843|NCT02107807|Adjuvanted vaccine|adjuvanted vaccine
247844|NCT02107794|Grave's|grave's
247845|NCT02107794|Disease|disease
247846|NCT02107794|Thyroid|thyroid
247847|NCT02107794|Hyperthyroidism|hyperthyroidism
247848|NCT02107794|Thyroidectomy|thyroidectomy
247849|NCT02107794|Radioactive|radioactive
247850|NCT02107794|Iodine|iodine
247851|NCT02107794|Antithyroid|antithyroid
247852|NCT02107794|Shared|shared
247853|NCT02107794|Decision|decision
247854|NCT02107794|Making|making
247855|NCT02107794|Aid|aid
247856|NCT02107794|Evidence|evidence
247857|NCT02107794|Based|based
247858|NCT02107794|Endocrinology|endocrinology
247859|NCT02107794|Mayo|mayo
247860|NCT02107794|Clinic|clinic
247861|NCT02107781|Open abdomen|open abdomen
247862|NCT02107781|abdominal compartment pressure|abdominal compartment pressure
247863|NCT02107768|Stroke|stroke
247864|NCT02107768|Exercise|exercise
247865|NCT02107768|Randomized trial|randomized trial
247866|NCT02107768|Quality of Life|quality of life
247867|NCT02107755|oligometastatic melanoma|oligometastatic melanoma
247868|NCT02107755|melanoma|melanoma
247869|NCT02107742|Injections|injections
247870|NCT02107742|Time factors|time factors
247871|NCT02107742|Pain|pain
247872|NCT02107742|Healthy volunteers|healthy volunteers
247873|NCT02107742|Lidocaine|lidocaine
247874|NCT02107729|Injections|injections
247875|NCT02107729|Pain|pain
247876|NCT02107729|Healthy volunteers|healthy volunteers
247877|NCT02107729|Lidocaine|lidocaine
247878|NCT02107716|Pain|pain
247879|NCT02107716|Injections|injections
247880|NCT02107716|Lidocaine|lidocaine
247881|NCT02107716|Healthy volunteers|healthy volunteers
247882|NCT02107703|MONARCH 2|monarch 2
247883|NCT02107690|Injections|injections
247884|NCT02107690|Temperature|temperature
247885|NCT02107690|Pain|pain
247886|NCT02107690|Healthy volunteers|healthy volunteers
247887|NCT02107690|Lidocaine|lidocaine
247888|NCT02107664|Radiotherapy|radiotherapy
247889|NCT02107664|Cachexia|cachexia
247890|NCT02107664|Inflammation|inflammation
247891|NCT02107664|Depression|depression
247892|NCT02107651|Bleeding|bleeding
247893|NCT02107651|Anticoagulation|anticoagulation
247894|NCT02107638|Parkinson's Disease|parkinson's disease
247895|NCT02107638|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
247896|NCT02107638|Falls|falls
247897|NCT02107638|Balance|balance
247898|NCT02107638|Motor function|motor function
247899|NCT02107625|Defecation|defecation
247900|NCT02107625|Abdominal pain|abdominal pain
247901|NCT02107612|Mini-Dental Implant|mini-dental implant
247902|NCT02107612|Implant-Supported Dental Prosthesis|implant-supported dental prosthesis
247903|NCT02107612|Minimally Invasive Surgical procedures|minimally invasive surgical procedures
247904|NCT02107612|Overdentures|overdentures
247905|NCT02107612|Aged|aged
247906|NCT02107586|biceps tenodesis|biceps tenodesis
247907|NCT02107586|biceps tenotomy|biceps tenotomy
247908|NCT02107586|biceps tendonitis|biceps tendonitis
247909|NCT02107586|biceps inflammation|biceps inflammation
247910|NCT02107586|shoulder surgery|shoulder surgery
247911|NCT02107573|Randomized Controlled Trial|randomized controlled trial
247912|NCT02107573|Rotator Cuff Tear|rotator cuff tear
247913|NCT02107573|Suprascapular Nerve|suprascapular nerve
247914|NCT02107573|Decompression|decompression
247915|NCT02107573|Shoulder Surgery|shoulder surgery
247916|NCT02107560|Cholangitis|cholangitis
247917|NCT02107560|Bacteremia|bacteremia
247918|NCT02107560|Endotoxemia|endotoxemia
247919|NCT02107560|Blood|blood
247920|NCT02107560|Bile|bile
247921|NCT02107547|Randomized Controlled Trial (RCT)|randomized controlled trial (rct)
247922|NCT02107547|Type 2 SLAP lesions|type 2 slap lesions
247923|NCT02107547|labral tear|labral tear
247924|NCT02107547|biceps tenodesis|biceps tenodesis
247925|NCT02107547|shoulder surgery|shoulder surgery
247926|NCT02107547|RCT|rct
247927|NCT02107547|Comparison between two alternative surgical procedures|comparison between two alternative surgical procedures
247928|NCT02107534|parent training|parent training
247929|NCT02107534|homework|homework
247930|NCT02107534|parenting stress|parenting stress
247931|NCT02107521|sperm morphology|sperm morphology
247932|NCT02107521|ICSI|icsi
247933|NCT02107521|IMSI|imsi
247934|NCT02107521|implantation|implantation
247935|NCT02107521|pregnancy|pregnancy
247936|NCT02107508|activity energy expenditure|activity energy expenditure
247937|NCT02107508|body composition|body composition
247938|NCT02107495|CHF|chf
247939|NCT02107469|Diabetic Polyneuropathy|diabetic polyneuropathy
247940|NCT02107469|Diabetic|diabetic
247941|NCT02107469|Polyneuropathy|polyneuropathy
247942|NCT02107469|Ayurvedic|ayurvedic
247943|NCT02107469|Ayurveda|ayurveda
247944|NCT02107469|Neuralgia|neuralgia
247945|NCT02107469|Diabetic Neuralgia|diabetic neuralgia
247946|NCT02107469|Sida cordifolia|sida cordifolia
247947|NCT02107469|Phyllanthus Niruri|phyllanthus niruri
247948|NCT02107469|Phyllanthus Amarus|phyllanthus amarus
247949|NCT02107469|Extracts|extracts
247950|NCT02107469|Extract|extract
247951|NCT02107469|Crude Herb|crude herb
247952|NCT02107469|Crude|crude
247953|NCT02107469|Herb|herb
247954|NCT02107469|Herbal|herbal
247955|NCT02107469|Herbal Extract|herbal extract
247956|NCT02107469|Decoction|decoction
247957|NCT02107469|Churna|churna
247958|NCT02107469|Powder|powder
247959|NCT02107469|Bala|bala
247960|NCT02107469|Bhumyamalaki|bhumyamalaki
247961|NCT02107469|Tamalaki|tamalaki
247962|NCT02107456|Dry Needling, Myofascial trigger point, Upper trapezius|dry needling, myofascial trigger point, upper trapezius
247963|NCT02107430|Immunotherapy|immunotherapy
247964|NCT02107430|Prostate Cancer|prostate cancer
247965|NCT02107430|Biological, Vaccine|biological, vaccine
247966|NCT02107417|chemotherapy|chemotherapy
247967|NCT02107417|pain|pain
247968|NCT02107417|paresthesia|paresthesia
247969|NCT02107417|Physiotherapy|physiotherapy
247970|NCT02107417|Transcutaneous Electrical Nerve Stimulation|transcutaneous electrical nerve stimulation
247971|NCT02107404|Immunotherapy|immunotherapy
247972|NCT02107404|Prostate Cancer|prostate cancer
247973|NCT02107404|Biological|biological
247974|NCT02107404|Vaccine|vaccine
247975|NCT02107391|Immunotherapy|immunotherapy
247976|NCT02107391|Prostate Cancer|prostate cancer
247977|NCT02107391|Biological|biological
247978|NCT02107391|Vaccine|vaccine
247979|NCT02107391|Androgen Deprivation Therapy|androgen deprivation therapy
247980|NCT02107378|Immunotherapy|immunotherapy
247981|NCT02107378|Serous|serous
247982|NCT02107378|Relapsed|relapsed
247983|NCT02107378|Platinum resistant (pt)|platinum resistant (pt)
247984|NCT02107378|Ovarian Cancer (OvCa)|ovarian cancer (ovca)
247985|NCT02107378|Biological|biological
247986|NCT02107378|Vaccine|vaccine
247987|NCT02107365|Hepatitis C|hepatitis c
247988|NCT02107365|HCV infection|hcv infection
247989|NCT02107365|HCV genotype 4|hcv genotype 4
247990|NCT02107365|Non-responders HCV infected patients|non-responders hcv infected patients
247991|NCT02107365|Asunaprevir|asunaprevir
247992|NCT02107365|Daclatasvir|daclatasvir
247993|NCT02107365|Pegylated Interferon|pegylated interferon
247994|NCT02107365|Ribavirin|ribavirin
247995|NCT02107352|Anti-craving medication|anti-craving medication
247996|NCT02107352|Inhibition|inhibition
247997|NCT02107352|Attentional Bias|attentional bias
247998|NCT02107352|Event-Related Potentials|event-related potentials
247999|NCT02107352|Relapse|relapse
248000|NCT02107339|methadone|methadone
248001|NCT02107339|hydromorphone|hydromorphone
248002|NCT02107339|acute postoperative pain|acute postoperative pain
248003|NCT02107339|chronic persistent surgical pain|chronic persistent surgical pain
248004|NCT02107326|Type 1 diabetes|type 1 diabetes
248005|NCT02107326|HbA1C|hba1c
248006|NCT02107326|Quality of Life|quality of life
248007|NCT02107326|Hypoglycaemia|hypoglycaemia
248008|NCT02107326|Self-management|self-management
248009|NCT02107326|Telemedicine|telemedicine
248010|NCT02107300|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
248011|NCT02107274|Azithromycin|azithromycin
248012|NCT02107274|Bronchiectasis|bronchiectasis
248013|NCT02107274|Macrolide|macrolide
248014|NCT02107274|Inflammation|inflammation
248015|NCT02107274|Pulmonary|pulmonary
248016|NCT02107261|Musician's Dystonia|musician's dystonia
248017|NCT02107248|Arthroplasty|arthroplasty
248018|NCT02107248|Replacement|replacement
248019|NCT02107248|Hip|hip
248020|NCT02107248|Posterolateral surgery|posterolateral surgery
248021|NCT02107248|Precautions|precautions
248022|NCT02107235|Chemoradiotherapy|chemoradiotherapy
248023|NCT02107235|cisplatin|cisplatin
248024|NCT02107222|COPD|copd
248025|NCT02107222|Exacerbation|exacerbation
248026|NCT02107222|invasive ventilation|invasive ventilation
248027|NCT02107222|CO2-Removal|co2-removal
248028|NCT02107196|Irritable Bowel Syndrome|irritable bowel syndrome
248029|NCT02107196|Colon, irritable|colon, irritable
248030|NCT02107196|Bowel disease|bowel disease
248031|NCT02107196|Diarrhea|diarrhea
248032|NCT02107183|Oxygen therapy|oxygen therapy
248033|NCT02107183|Extubation|extubation
248034|NCT02107183|Weaning|weaning
248035|NCT02107183|Reintubation|reintubation
248036|NCT02107183|Acute respiratory failure|acute respiratory failure
248037|NCT02107144|trimetazidine|trimetazidine
248038|NCT02107144|microcirculation|microcirculation
248039|NCT02107144|stenting|stenting
248040|NCT02107144|pressure wire|pressure wire
248041|NCT02107118|Stem cells|stem cells
248042|NCT02107118|cardiovascular disease|cardiovascular disease
248043|NCT02107118|erectile dysfunction|erectile dysfunction
248044|NCT02107105|Rectal cancer|rectal cancer
248045|NCT02107105|Adenocarcinoma of the rectum|adenocarcinoma of the rectum
248046|NCT02107105|Quality of Life|quality of life
248047|NCT02107105|QOL|qol
248048|NCT02107105|Post surgery|post surgery
248049|NCT02107105|Pre-surgery|pre-surgery
248050|NCT02107105|Questionnaires|questionnaires
248051|NCT02107105|Surveys|surveys
248052|NCT02107079|melatonin|melatonin
248053|NCT02107079|bioavailability|bioavailability
248054|NCT02107079|pharmacokinetics|pharmacokinetics
248055|NCT02107066|exercise|exercise
248056|NCT02107066|physical activity|physical activity
248057|NCT02107066|ovarian cancer|ovarian cancer
248058|NCT02107066|quality of life|quality of life
248059|NCT02107066|fatigue|fatigue
248060|NCT02107066|weight|weight
248061|NCT02107053|Oxidative stress,|oxidative stress,
248062|NCT02107053|hemodialysis,|hemodialysis,
248063|NCT02107053|pomegranate juice,|pomegranate juice,
248064|NCT02107053|dietary supplement|dietary supplement
248065|NCT02107053|patients|patients
248066|NCT02107001|Lung ultrasound|lung ultrasound
248067|NCT02107001|Community acquired p neumonia (CAP)|community acquired p neumonia (cap)
248068|NCT02107001|Pleuritis|pleuritis
248069|NCT02107001|Pulmonary embolism|pulmonary embolism
248070|NCT02107001|Lung Cancer|lung cancer
248071|NCT02106988|Lymphoma|lymphoma
248072|NCT02106988|NK cell lymphoma-nasal type|nk cell lymphoma-nasal type
248073|NCT02106988|Radiation therapy|radiation therapy
248074|NCT02106988|XRT|xrt
248075|NCT02106988|Dexamethasone|dexamethasone
248076|NCT02106988|Decadron|decadron
248077|NCT02106988|Etoposide|etoposide
248078|NCT02106988|VePesid|vepesid
248079|NCT02106988|Ifosfamide|ifosfamide
248080|NCT02106988|Ifex|ifex
248081|NCT02106988|Mesna|mesna
248082|NCT02106988|Mesnex|mesnex
248083|NCT02106988|Carboplatin|carboplatin
248084|NCT02106988|Paraplatin|paraplatin
248085|NCT02106962|hemodialysis|hemodialysis
248086|NCT02106962|fistula|fistula
248087|NCT02106962|clotting|clotting
248088|NCT02106962|tranexamic acid|tranexamic acid
248089|NCT02106962|bacitracin|bacitracin
248090|NCT02106949|suicide attempt, SMS monitoring, recurrence, phone, prevention control, tertiary healthcare|suicide attempt, sms monitoring, recurrence, phone, prevention control, tertiary healthcare
248091|NCT02106936|Focal Hand Dystonia|focal hand dystonia
248092|NCT02106936|Depotentiation|depotentiation
248093|NCT02106936|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
248094|NCT02106936|Rapid Paired Associative Stimulation|rapid paired associative stimulation
248095|NCT02106936|Healthy Volunteer|healthy volunteer
248096|NCT02106910|Barrett's Esophagus|barrett's esophagus
248097|NCT02106910|Radiofrequency Ablation|radiofrequency ablation
248098|NCT02106884|Pancreatic cancer|pancreatic cancer
248099|NCT02106884|Locally advanced|locally advanced
248100|NCT02106884|Metastatic|metastatic
248101|NCT02106871|cancer|cancer
248102|NCT02106871|pancreas|pancreas
248103|NCT02106871|cholangiocarcinoma|cholangiocarcinoma
248104|NCT02106871|fatigue|fatigue
248105|NCT02106871|sildenafil|sildenafil
248106|NCT02106871|lean mass|lean mass
248107|NCT02106871|muscle|muscle
248108|NCT02106858|Stivarga / Regorafenib / Metastatic Colorectal Cancer / Metastatic or unresectable locally advanced GIST (Gastrointestinal stromal tumors)|stivarga / regorafenib / metastatic colorectal cancer / metastatic or unresectable locally advanced gist (gastrointestinal stromal tumors)
248109|NCT02106845|Regorafenib|regorafenib
248110|NCT02106845|Probe substrates|probe substrates
248111|NCT02106845|Pharmacokinetics|pharmacokinetics
248112|NCT02106845|Cancer|cancer
248113|NCT02106845|Safety|safety
248114|NCT02106845|Advanced solid malignant tumors|advanced solid malignant tumors
248115|NCT02106832|Ciprofloxacin|ciprofloxacin
248116|NCT02106832|Dry Powder for Inhalation|dry powder for inhalation
248117|NCT02106832|Exacerbation|exacerbation
248118|NCT02106832|Bronchiectasis|bronchiectasis
248119|NCT02106819|Cerebellar Ataxia|cerebellar ataxia
248120|NCT02106819|Emotions|emotions
248121|NCT02106819|Affective Prosody|affective prosody
248122|NCT02106819|Facial Expression|facial expression
248123|NCT02106819|Magnetic Resonance Imaging|magnetic resonance imaging
248124|NCT02106806|Oxidative stress|oxidative stress
248125|NCT02106806|Zinc|zinc
248126|NCT02106806|Chemotherapy|chemotherapy
248127|NCT02106806|Colorectal cancer|colorectal cancer
248128|NCT02106793|Chronic Rhinosinusitis|chronic rhinosinusitis
248129|NCT02106793|Mitomicin C|mitomicin c
248130|NCT02106793|Postoperative nasal synerchia|postoperative nasal synerchia
248131|NCT02106780|Phase 1|phase 1
248132|NCT02106780|Healthy subjects|healthy subjects
248133|NCT02106780|Excretion|excretion
248134|NCT02106780|14C-labeled ASP1707|14c-labeled asp1707
248135|NCT02106767|rosuvastatin|rosuvastatin
248136|NCT02106767|rifampin|rifampin
248137|NCT02106767|pharmacokinetics|pharmacokinetics
248138|NCT02106767|drug interaction|drug interaction
248139|NCT02106767|healthy volunteer|healthy volunteer
248140|NCT02106767|drug transporter|drug transporter
248141|NCT02106767|Asian|asian
248142|NCT02106767|White|white
248143|NCT02106741|Pain|pain
248144|NCT02106741|Acupressure|acupressure
248145|NCT02106741|Symptoms|symptoms
248146|NCT02106741|Fatigue|fatigue
248147|NCT02106741|Self-administered|self-administered
248148|NCT02106728|Eating Disorders|eating disorders
248149|NCT02106728|Family Therapy|family therapy
248150|NCT02106728|Multi-Family Therapy|multi-family therapy
248151|NCT02106728|Bulimia Nervosa|bulimia nervosa
248152|NCT02106728|Eating Disorder Not Otherwise Specified|eating disorder not otherwise specified
248153|NCT02106702|HIV|hiv
248154|NCT02106702|detention|detention
248155|NCT02106702|substance abuse|substance abuse
248156|NCT02106689|infertility, superovulation, gonadotropins, needle free injection system|infertility, superovulation, gonadotropins, needle free injection system
248157|NCT02106676|polycystic ovary Syndrome|polycystic ovary syndrome
248158|NCT02106676|hyperandrogenism|hyperandrogenism
248159|NCT02106676|cordblood|cordblood
248160|NCT02106676|androgens|androgens
248161|NCT02106663|atrial fibrillation|atrial fibrillation
248162|NCT02106663|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
248163|NCT02106663|PAF|paf
248164|NCT02106663|arrhythmia|arrhythmia
248165|NCT02106663|atrial fibrillation ablation|atrial fibrillation ablation
248166|NCT02106663|circumferential ablation|circumferential ablation
248167|NCT02106663|CPVA|cpva
248168|NCT02106663|segmental ablation|segmental ablation
248169|NCT02106663|PVI|pvi
248170|NCT02106663|pulmonary vein isolation|pulmonary vein isolation
248171|NCT02106650|Relapsed PTCL|relapsed ptcl
248172|NCT02106650|Refractory PTCL|refractory ptcl
248173|NCT02106637|ACS|acs
248174|NCT02106637|Cessation|cessation
248175|NCT02106624|mechanical ventilation|mechanical ventilation
248176|NCT02106611|MRI|mri
248177|NCT02106611|stress echo|stress echo
248178|NCT02106611|Clinical Assessment|clinical assessment
248179|NCT02106611|14-017|14-017
248180|NCT02106598|Sentinel Lymph Node Mapping|sentinel lymph node mapping
248181|NCT02106598|Intraoperative Sentinel|intraoperative sentinel
248182|NCT02106598|Head and Neck Melanoma|head and neck melanoma
248183|NCT02106598|Targeted Silica Nanoparticles|targeted silica nanoparticles
248184|NCT02106598|cRGDY-PEG-Cy5.5-C dots|crgdy-peg-cy5.5-c dots
248185|NCT02106598|13-249|13-249
248186|NCT02106585|Safety|safety
248187|NCT02106585|Tolerability|tolerability
248188|NCT02106585|Pharmacokinetics|pharmacokinetics
248189|NCT02106585|Food-effect|food-effect
248190|NCT02106585|Diabetes|diabetes
248191|NCT02106572|superficial bladder cancer|superficial bladder cancer
248192|NCT02106572|viscum album extract|viscum album extract
248193|NCT02106572|mistletoe extract|mistletoe extract
248194|NCT02106572|abnobaVISCUM|abnobaviscum
248195|NCT02106572|recurrence rate|recurrence rate
248196|NCT02106559|Pleural Photodynamic Therapy|pleural photodynamic therapy
248197|NCT02106559|Pleural Malignancy|pleural malignancy
248198|NCT02106559|PDT|pdt
248199|NCT02106546|veliparib|veliparib
248200|NCT02106546|carboplatin|carboplatin
248201|NCT02106546|paclitaxel|paclitaxel
248202|NCT02106546|Poly Adenosine diphosphate (ADP)-ribose Polymerase (PARP)|poly adenosine diphosphate (adp)-ribose polymerase (parp)
248203|NCT02106546|Overall Survival|overall survival
248204|NCT02106546|Advanced|advanced
248205|NCT02106546|Metastatic|metastatic
248206|NCT02106546|ABT-888|abt-888
248207|NCT02106546|Squamous|squamous
248208|NCT02106546|Randomized|randomized
248209|NCT02106546|non-small cell lung cancer|non-small cell lung cancer
248210|NCT02106546|placebo controlled|placebo controlled
248211|NCT02106533|Coronary artery disease|coronary artery disease
248212|NCT02106533|Exercise|exercise
248213|NCT02106533|Ventilatory efficiency|ventilatory efficiency
248214|NCT02106520|Epistaxis|epistaxis
248215|NCT02106520|Bevacizumab|bevacizumab
248216|NCT02106507|Apalutamide|apalutamide
248217|NCT02106507|RAD001|rad001
248218|NCT02106507|Everolimus|everolimus
248219|NCT02106507|Castration-resistant|castration-resistant
248220|NCT02106507|13-025|13-025
248221|NCT02106507|ARN-509|arn-509
248222|NCT02106494|Highly emetogenic chemotherapy (HEC)|highly emetogenic chemotherapy (hec)
248223|NCT02106494|Chemotherapy-Induced Nausea and Vomiting (CINV)|chemotherapy-induced nausea and vomiting (cinv)
248224|NCT02106481|TKA|tka
248225|NCT02106481|TKR|tkr
248226|NCT02106481|Knee OA|knee oa
248227|NCT02106481|pain management|pain management
248228|NCT02106481|Femoral Nerve Catheter|femoral nerve catheter
248229|NCT02106481|Single Shot Femoral Nerve Blocks|single shot femoral nerve blocks
248230|NCT02106468|Oral Lichen Planus|oral lichen planus
248231|NCT02106468|Corticosteroid|corticosteroid
248232|NCT02106468|Omega -3|omega -3
248233|NCT02106455|Pharmacological theapy|pharmacological theapy
248234|NCT02106442|Pharmacological therapy|pharmacological therapy
248235|NCT02106429|Vascular Surgery|vascular surgery
248236|NCT02106416|prostate cancer|prostate cancer
248237|NCT02106416|bladder cancer|bladder cancer
248238|NCT02106416|MRI|mri
248239|NCT02106416|PET|pet
248240|NCT02106416|perfusion|perfusion
248241|NCT02106390|Central Nervous System Diseases|central nervous system diseases
248242|NCT02106390|Nervous System Diseases|nervous system diseases
248243|NCT02106390|Meningitis|meningitis
248244|NCT02106338|follow-up to 10-0008, Clostridium difficile, dose-escalating, CRS3123|follow-up to 10-0008, clostridium difficile, dose-escalating, crs3123
248245|NCT02106325|Ketamine|ketamine
248246|NCT02106325|Ketlar|ketlar
248247|NCT02106325|Depression|depression
248248|NCT02106325|Antidepressants|antidepressants
248249|NCT02106325|Treatment|treatment
248250|NCT02106325|Acute|acute
248251|NCT02106312|Radiotherapy|radiotherapy
248252|NCT02106312|Myxoid liposarcoma|myxoid liposarcoma
248253|NCT02106312|Soft tissue sarcoma|soft tissue sarcoma
248254|NCT02106286|Cardiopulmonary exercise test|cardiopulmonary exercise test
248255|NCT02106286|surgery|surgery
248256|NCT02106286|abdominal aortic aneurysm|abdominal aortic aneurysm
248257|NCT02106286|anaerobic threshold|anaerobic threshold
248258|NCT02106286|fitness|fitness
248259|NCT02106286|beta-blockers|beta-blockers
248260|NCT02106273|LMA|lma
248261|NCT02106273|Bronchial blocker|bronchial blocker
248262|NCT02106260|safety|safety
248263|NCT02106260|pharmacokinetics (PK)|pharmacokinetics (pk)
248264|NCT02106260|pharmacodynamics (PD)|pharmacodynamics (pd)
248265|NCT02106260|CLS003|cls003
248266|NCT02106234|contrast induced nephropathy|contrast induced nephropathy
248267|NCT02106234|prophylactic intravenous hydration|prophylactic intravenous hydration
248268|NCT02106234|intravenous normal saline|intravenous normal saline
248269|NCT02106234|acute kidney injury|acute kidney injury
248270|NCT02106221|Care coordination|care coordination
248271|NCT02106221|nurse care management|nurse care management
248272|NCT02106221|practice facilitation|practice facilitation
248273|NCT02106221|health information technology|health information technology
248274|NCT02106182|Benign prostatic hyperplasia|benign prostatic hyperplasia
248275|NCT02106182|Nocturia|nocturia
248276|NCT02106182|Silodosin|silodosin
248277|NCT02106182|Thrupas|thrupas
248278|NCT02106169|Food allergy|food allergy
248279|NCT02106169|Children and families|children and families
248280|NCT02106169|Therapeutic education|therapeutic education
248281|NCT02106169|Quality of life|quality of life
248282|NCT02106130|Mosapride citrate|mosapride citrate
248283|NCT02106130|Rebamipide|rebamipide
248284|NCT02106130|pharmacokinetic drug drug interaction|pharmacokinetic drug drug interaction
248285|NCT02106130|oral administration|oral administration
248286|NCT02106130|healthy male subjects|healthy male subjects
248287|NCT02106104|Type 2 diabetes mellitus|type 2 diabetes mellitus
248288|NCT02106104|Diabetic kidney disease|diabetic kidney disease
248289|NCT02106104|Diabetic nephropathy|diabetic nephropathy
248290|NCT02106104|Renoprotection|renoprotection
248291|NCT02106104|DPP-4 inhibitors|dpp-4 inhibitors
248292|NCT02106104|Linagliptin|linagliptin
248293|NCT02106104|SU derivatives|su derivatives
248294|NCT02106104|Glimepiride|glimepiride
248295|NCT02106078|Bipolar Disorder|bipolar disorder
248296|NCT02106078|Bipolar|bipolar
248297|NCT02106078|Online Intervention|online intervention
248298|NCT02106078|Internet intervention|internet intervention
248299|NCT02106078|Self-Help|self-help
248300|NCT02106065|Dementia|dementia
248301|NCT02106065|Caregivers|caregivers
248302|NCT02106065|Neurodegenerative Diseases|neurodegenerative diseases
248303|NCT02106065|Brain Diseases|brain diseases
248304|NCT02106065|Cost of Illness|cost of illness
248305|NCT02106065|Stress, Psychological|stress, psychological
248306|NCT02106065|Depression|depression
248307|NCT02106065|Vital Statistics|vital statistics
248308|NCT02106065|Mortality|mortality
248309|NCT02106065|Behavioral Symptoms|behavioral symptoms
248310|NCT02106065|Residential Facilities|residential facilities
248311|NCT02106065|Emergency Medical Services|emergency medical services
248312|NCT02106065|Long-Term Care|long-term care
248313|NCT02106052|cognitive function|cognitive function
248314|NCT02106052|cognitive impairment|cognitive impairment
248315|NCT02106052|cognitive intervention|cognitive intervention
248316|NCT02106052|cognitive improvement|cognitive improvement
248317|NCT02106052|information processing speed|information processing speed
248318|NCT02106052|exercise training program|exercise training program
248319|NCT02106052|aerobic exercise|aerobic exercise
248320|NCT02106052|stretching and toning|stretching and toning
248321|NCT02106052|Multiple sclerosis|multiple sclerosis
248322|NCT02106052|executive function|executive function
248323|NCT02106039|diabetes mellitus|diabetes mellitus
248324|NCT02106039|tuberculosis|tuberculosis
248325|NCT02106039|management|management
248326|NCT02106039|randomized controlled trial|randomized controlled trial
248327|NCT02106026|Breastfeeding|breastfeeding
248328|NCT02106026|Nursing|nursing
248329|NCT02106026|Patient Education as Topic|patient education as topic
248330|NCT02106026|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
248331|NCT02106026|Hispanic Americans.|hispanic americans.
248332|NCT02106013|HDL|hdl
248333|NCT02106013|Carotid artery intima-media thickness|carotid artery intima-media thickness
248334|NCT02106013|Cholesterol efflux capacity|cholesterol efflux capacity
248335|NCT02106013|Antioxidant effect of HDL|antioxidant effect of hdl
248336|NCT02106013|Susceptibility to oxidation of HDL|susceptibility to oxidation of hdl
248337|NCT02106013|Anti-inflammatory effect of HDL|anti-inflammatory effect of hdl
248338|NCT02106013|Platelet aggregation inhibition by HDL|platelet aggregation inhibition by hdl
248339|NCT02106000|Post Partum|post partum
248340|NCT02106000|Inhaled Oxytocin|inhaled oxytocin
248341|NCT02106000|Inhalation Profiles|inhalation profiles
248342|NCT02105987|Abacavir/dolutegravir/lamivudine|abacavir/dolutegravir/lamivudine
248343|NCT02105987|Fixed-dose combination|fixed-dose combination
248344|NCT02105987|Once daily|once daily
248345|NCT02105987|Trii|trii
248346|NCT02105987|Single-tablet regimen|single-tablet regimen
248347|NCT02105974|COPD|copd
248348|NCT02105974|Fluticasone Furoate (FF)|fluticasone furoate (ff)
248349|NCT02105974|Vilanterol (VI)|vilanterol (vi)
248350|NCT02105974|Dry Powder Inhaler|dry powder inhaler
248351|NCT02105961|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
248352|NCT02105961|exacerbations|exacerbations
248353|NCT02105961|SB240563|sb240563
248354|NCT02105961|mepolizumab|mepolizumab
248355|NCT02105961|eosinophils|eosinophils
248356|NCT02105948|eosinophils|eosinophils
248357|NCT02105948|SB240563|sb240563
248358|NCT02105948|exacerbations|exacerbations
248359|NCT02105948|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
248360|NCT02105948|mepolizumab|mepolizumab
248361|NCT02105922|Frailty|frailty
248362|NCT02105922|Ageing|ageing
248363|NCT02105922|Protein supplementation|protein supplementation
248364|NCT02105922|Protein quality|protein quality
248365|NCT02105922|Exercise training|exercise training
248366|NCT02105922|Sarcopenia|sarcopenia
248367|NCT02105896|dental bonding|dental bonding
248368|NCT02105857|knee mobilazation|knee mobilazation
248369|NCT02105857|TKA|tka
248370|NCT02105857|joint replacement|joint replacement
248371|NCT02105857|rehabilitation|rehabilitation
248372|NCT02105844|atrial fibrillation|atrial fibrillation
248373|NCT02105844|dementia|dementia
248374|NCT02105844|cognitive dysfunction|cognitive dysfunction
248375|NCT02105844|stroke|stroke
248376|NCT02105844|Magnetic resonance imaging|magnetic resonance imaging
248377|NCT02105831|left ventricular assist device|left ventricular assist device
248378|NCT02105831|contrast ultrasound|contrast ultrasound
248379|NCT02105831|perfusion imaging|perfusion imaging
248380|NCT02105818|Self-reported questionnaire|self-reported questionnaire
248381|NCT02105818|Swallowing disorders|swallowing disorders
248382|NCT02105818|Systemic sclerosis|systemic sclerosis
248383|NCT02105818|Drug therapy|drug therapy
248384|NCT02105818|Adherence to medication regime|adherence to medication regime
248385|NCT02105818|Coping strategy|coping strategy
248386|NCT02105818|Pharmaceutical care|pharmaceutical care
248387|NCT02105818|Patient safety|patient safety
248388|NCT02105818|Patient oriented care|patient oriented care
248389|NCT02105805|intention weight loss|intention weight loss
248390|NCT02105805|heart failure|heart failure
248391|NCT02105805|6-minute walk test|6-minute walk test
248392|NCT02105792|Diabetes|diabetes
248393|NCT02105792|Type 2 diabetes|type 2 diabetes
248394|NCT02105792|Diabetes therapy response|diabetes therapy response
248395|NCT02105792|Diabetes progression|diabetes progression
248396|NCT02105766|Sickle Cell Disease|sickle cell disease
248397|NCT02105766|Allogeneic Hematopoietic Stem Cell Transplant|allogeneic hematopoietic stem cell transplant
248398|NCT02105766|Pentostatin (Nipent)|pentostatin (nipent)
248399|NCT02105766|Cyclophosphamide|cyclophosphamide
248400|NCT02105766|Alemtuzumab (Campath)|alemtuzumab (campath)
248401|NCT02105740|BEHAVIORAL|behavioral
248402|NCT02105740|HYPNOSIS|hypnosis
248403|NCT02105740|ANXIETY|anxiety
248404|NCT02105740|DEPRESSION|depression
248405|NCT02105727|Dietary sodium|dietary sodium
248406|NCT02105727|Urinary sodium excretion|urinary sodium excretion
248407|NCT02105727|Urinary iodine excretion|urinary iodine excretion
248408|NCT02105714|Diarrhoea|diarrhoea
248409|NCT02105714|Abdominal pain|abdominal pain
248410|NCT02105714|Bacterial|bacterial
248411|NCT02105714|Protozoal|protozoal
248412|NCT02105714|Helminth|helminth
248413|NCT02105675|Immunotherapy|immunotherapy
248414|NCT02105675|Metastatic|metastatic
248415|NCT02105675|Castrate Resistant|castrate resistant
248416|NCT02105675|Prostate Cancer|prostate cancer
248417|NCT02105675|Biological|biological
248418|NCT02105675|Vaccine|vaccine
248419|NCT02105649|cerebral palsy|cerebral palsy
248420|NCT02105649|standing|standing
248421|NCT02105649|strengthening|strengthening
248422|NCT02105623|Coronary Arteriosclerosis|coronary arteriosclerosis
248423|NCT02105623|rosuvastatin|rosuvastatin
248424|NCT02105610|volatile anesthetics|volatile anesthetics
248425|NCT02105610|desflurane|desflurane
248426|NCT02105610|isoflurane|isoflurane
248427|NCT02105610|sevoflurane|sevoflurane
248428|NCT02105610|TIVA|tiva
248429|NCT02105610|cardiac surgery|cardiac surgery
248430|NCT02105610|mortality|mortality
248431|NCT02105610|anesthesia|anesthesia
248432|NCT02105610|intensive care|intensive care
248433|NCT02105597|Diabetes mellitus|diabetes mellitus
248434|NCT02105597|Medication adherence|medication adherence
248435|NCT02105597|Compliance|compliance
248436|NCT02105597|Mobile health|mobile health
248437|NCT02105571|Body Weight|body weight
248438|NCT02105571|Nutrition|nutrition
248439|NCT02105571|Physical Activity|physical activity
248440|NCT02105571|Sleep|sleep
248441|NCT02105571|Health Promotion|health promotion
248442|NCT02105571|Stress|stress
248443|NCT02105571|Safety|safety
248444|NCT02105558|trial of labor after cesarean|trial of labor after cesarean
248445|NCT02105558|vaginal birth after cesarean|vaginal birth after cesarean
248446|NCT02105558|epidural vs combined spinal epidural|epidural vs combined spinal epidural
248447|NCT02105545|cancer|cancer
248448|NCT02105545|oncology|oncology
248449|NCT02105545|malignant|malignant
248450|NCT02105545|malignancy|malignancy
248451|NCT02105545|genetics|genetics
248452|NCT02105545|genomics|genomics
248453|NCT02105545|exome|exome
248454|NCT02105545|DNA|dna
248455|NCT02105545|RNA|rna
248456|NCT02105545|sequencing|sequencing
248457|NCT02105545|epigenetic|epigenetic
248458|NCT02105545|clinically actionable findings|clinically actionable findings
248459|NCT02105545|CAF|caf
248460|NCT02105545|secondary findings|secondary findings
248461|NCT02105545|SF|sf
248462|NCT02105545|single nucleotide variants|single nucleotide variants
248463|NCT02105545|SNV|snv
248464|NCT02105545|bioinformatics|bioinformatics
248465|NCT02105545|genotype|genotype
248466|NCT02105545|The American College of Medical Genetics and Genomics|the american college of medical genetics and genomics
248467|NCT02105545|ACMG|acmg
248468|NCT02105532|Transfusion in gastrointestinal bleeding|transfusion in gastrointestinal bleeding
248469|NCT02105519|trivalent influenza vaccine, chronic kidney disease|trivalent influenza vaccine, chronic kidney disease
248470|NCT02105506|Esophagus|esophagus
248471|NCT02105506|Stomach|stomach
248472|NCT02105506|Resection|resection
248473|NCT02105506|Esophageal disease requiring surgery|esophageal disease requiring surgery
248474|NCT02105506|Gastric disease requiring surgery|gastric disease requiring surgery
248475|NCT02105493|Nitroglycerin|nitroglycerin
248476|NCT02105493|Radial Artery Occlusion|radial artery occlusion
248477|NCT02105493|Transradial Catheterization|transradial catheterization
248478|NCT02105480|Computer aided auscultation (CAA)|computer aided auscultation (caa)
248479|NCT02105480|Phonocardiogram analysis|phonocardiogram analysis
248480|NCT02105480|Murmur detection|murmur detection
248481|NCT02105480|Heart auscultation|heart auscultation
248482|NCT02105441|cochlear implant|cochlear implant
248483|NCT02105428|Polycystic Ovarian Syndrome (PCOS)|polycystic ovarian syndrome (pcos)
248582|NCT02105077|doping|doping
248484|NCT02105428|Insulin Resistance|insulin resistance
248485|NCT02105428|Overweight, Obese Women|overweight, obese women
248486|NCT02105428|Protein Metabolism|protein metabolism
248487|NCT02105428|Post Translational Modifications|post translational modifications
248488|NCT02105415|Critical care|critical care
248489|NCT02105415|Emergent|emergent
248490|NCT02105415|Etomidate|etomidate
248491|NCT02105415|Hemodynamics|hemodynamics
248492|NCT02105415|Intensive care unit|intensive care unit
248493|NCT02105415|Intubation|intubation
248494|NCT02105415|Ketamine-Propofol admixture|ketamine-propofol admixture
248495|NCT02105402|Speech sound disorders|speech sound disorders
248496|NCT02105402|Randomized Controlled Trial|randomized controlled trial
248497|NCT02105402|Speech intelligibility|speech intelligibility
248498|NCT02105402|PROMPT treatment|prompt treatment
248499|NCT02105402|Developmental motor speech disorders|developmental motor speech disorders
248500|NCT02105402|Children|children
248501|NCT02105402|Functional outcomes|functional outcomes
248502|NCT02105402|Treatment efficacy|treatment efficacy
248503|NCT02105389|fatigue|fatigue
248504|NCT02105389|quality of life|quality of life
248505|NCT02105389|chemotherapy|chemotherapy
248506|NCT02105389|haematopoietic stem cell transplantation|haematopoietic stem cell transplantation
248507|NCT02105389|children|children
248508|NCT02105389|pilot|pilot
248509|NCT02105389|yoga|yoga
248510|NCT02105376|depression|depression
248511|NCT02105376|cranial nerve stimulation|cranial nerve stimulation
248512|NCT02105376|trigeminal stimulation|trigeminal stimulation
248513|NCT02105350|MEK162|mek162
248514|NCT02105350|Gemcitabine|gemcitabine
248515|NCT02105350|Oxaliplatin|oxaliplatin
248516|NCT02105350|Non-resectable|non-resectable
248517|NCT02105350|Recurrent or metastatic|recurrent or metastatic
248518|NCT02105324|bionic pancreas|bionic pancreas
248519|NCT02105324|artificial pancreas|artificial pancreas
248520|NCT02105324|insulin|insulin
248521|NCT02105324|glucagon|glucagon
248522|NCT02105324|continuous glucose monitoring (CGM)|continuous glucose monitoring (cgm)
248523|NCT02105324|outpatient|outpatient
248524|NCT02105324|insulin pump|insulin pump
248525|NCT02105324|pediatrics|pediatrics
248526|NCT02105324|children|children
248527|NCT02105324|camp|camp
248528|NCT02105324|summer camp|summer camp
248529|NCT02105311|Intraocular pressure|intraocular pressure
248530|NCT02105311|Selective laser trabeculoplasty|selective laser trabeculoplasty
248531|NCT02105311|Travoprost|travoprost
248532|NCT02105311|Ocular surface disease|ocular surface disease
248533|NCT02105311|Glaucoma symptom scale|glaucoma symptom scale
248534|NCT02105298|Fluids|fluids
248535|NCT02105298|Intraoperative|intraoperative
248536|NCT02105298|Respiratory|respiratory
248537|NCT02105298|Outcomes|outcomes
248538|NCT02105298|Surgery|surgery
248539|NCT02105298|Anesthesia|anesthesia
248540|NCT02105259|Test|test
248541|NCT02105259|psychodynamic|psychodynamic
248542|NCT02105259|Internet-delivered psychodynamic treatment|internet-delivered psychodynamic treatment
248543|NCT02105259|patients with social anxiety disorder|patients with social anxiety disorder
248544|NCT02105246|cardiovascular disease|cardiovascular disease
248545|NCT02105246|cardiac rehabilitation|cardiac rehabilitation
248546|NCT02105246|secondary prevention|secondary prevention
248547|NCT02105246|comparative effectiveness|comparative effectiveness
248548|NCT02105246|6 minute walk test|6 minute walk test
248549|NCT02105233|ultrasonography|ultrasonography
248550|NCT02105233|ultrasonics|ultrasonics
248551|NCT02105233|brain|brain
248552|NCT02105233|surgery|surgery
248553|NCT02105220|Respiratory mechanics|respiratory mechanics
248554|NCT02105220|Esophageal pressure|esophageal pressure
248555|NCT02105220|Functional residual capacity|functional residual capacity
248556|NCT02105220|positive end-expiratory pressure|positive end-expiratory pressure
248557|NCT02105194|cerebral decompression illness|cerebral decompression illness
248558|NCT02105181|benign biliary stricture|benign biliary stricture
248559|NCT02105181|anastomotic biliary stricture after liver transplantation|anastomotic biliary stricture after liver transplantation
248560|NCT02105181|chronic pancreatitis|chronic pancreatitis
248561|NCT02105181|biliary surgical procedure|biliary surgical procedure
248562|NCT02105181|fully covered metal stent|fully covered metal stent
248563|NCT02105155|Liver transplantation,|liver transplantation,
248564|NCT02105155|Conversion (Prograf® to Advagraf®),|conversion (prograf® to advagraf®),
248565|NCT02105155|Prograf® ,|prograf® ,
248566|NCT02105155|Advagraf® ,|advagraf® ,
248567|NCT02105155|acute rejection,|acute rejection,
248568|NCT02105155|GFR|gfr
248569|NCT02105142|Attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
248570|NCT02105142|Interventions|interventions
248571|NCT02105142|Primary care|primary care
248572|NCT02105142|Pediatric|pediatric
248573|NCT02105090|Upper gastrointestinal tract|upper gastrointestinal tract
248574|NCT02105090|Endoscopy|endoscopy
248575|NCT02105090|Lozenge|lozenge
248576|NCT02105090|Articaine|articaine
248577|NCT02105090|Dyspepsia|dyspepsia
248578|NCT02105090|Hematemesis|hematemesis
248579|NCT02105090|Abdominal pain|abdominal pain
248580|NCT02105090|Heartburn|heartburn
248581|NCT02105077|xenon|xenon
248583|NCT02105077|anesthesia|anesthesia
248584|NCT02105077|mass spectrometry|mass spectrometry
248585|NCT02105077|surgery|surgery
248586|NCT02105038|distal radius fracture|distal radius fracture
248587|NCT02105038|steering|steering
248588|NCT02105038|steering wheel spinner knob|steering wheel spinner knob
248589|NCT02105025|insertion time|insertion time
248590|NCT02105012|Mild|mild
248591|NCT02105012|moderate persistent|moderate persistent
248592|NCT02105012|Adult|adult
248593|NCT02104986|non seminomateous malignant germ cell tumour (NSMGCT)|non seminomateous malignant germ cell tumour (nsmgct)
248594|NCT02104986|Dose De-escalation|dose de-escalation
248595|NCT02104986|Chemotherapy|chemotherapy
248596|NCT02104960|Skin Surface Microscopy|skin surface microscopy
248597|NCT02104960|Skin Aging|skin aging
248598|NCT02104960|PROOF|proof
248599|NCT02104895|Breast cancer|breast cancer
248600|NCT02104895|Early breast cancer|early breast cancer
248601|NCT02104895|Adjuvant breast cancer|adjuvant breast cancer
248602|NCT02104895|Accelerated partial breast irradiation|accelerated partial breast irradiation
248603|NCT02104895|Intensity modulated radiotherapy|intensity modulated radiotherapy
248604|NCT02104882|Glioblastoma Multiforme|glioblastoma multiforme
248605|NCT02104882|High-Grade Glioma|high-grade glioma
248606|NCT02104882|Malignant Glioma|malignant glioma
248607|NCT02104882|IORT|iort
248608|NCT02104869|Influenza vaccine|influenza vaccine
248609|NCT02104856|Asthma|asthma
248610|NCT02104856|Bronchial Thermoplasty|bronchial thermoplasty
248611|NCT02104856|Registry|registry
248612|NCT02104856|Device|device
248613|NCT02104856|Alair|alair
248614|NCT02104830|empegfilgrastim|empegfilgrastim
248615|NCT02104830|pegylated filgrastim|pegylated filgrastim
248616|NCT02104830|neutropenia|neutropenia
248617|NCT02104830|febrile neutropenia|febrile neutropenia
248618|NCT02104830|chemotherapy-associated neutropenia|chemotherapy-associated neutropenia
248619|NCT02104830|breast cancer|breast cancer
248620|NCT02104830|docetaxel|docetaxel
248621|NCT02104830|doxorubicin|doxorubicin
248622|NCT02104817|omega-3 carboxylic acid|omega-3 carboxylic acid
248623|NCT02104804|Type 2 Diabetes Mellitus, Insulin, Dipeptidyl-Peptidase 4 Inhibitors, Metformin,saxagliptin,Endocrine System Diseases|type 2 diabetes mellitus, insulin, dipeptidyl-peptidase 4 inhibitors, metformin,saxagliptin,endocrine system diseases
248624|NCT02104791|Procalcitonin|procalcitonin
248625|NCT02104791|intra-amniotic subclinical infection.|intra-amniotic subclinical infection.
248626|NCT02104752|Curcumin|curcumin
248627|NCT02104752|Turmeric|turmeric
248628|NCT02104752|Schizophrenia|schizophrenia
248629|NCT02104752|Cognition|cognition
248630|NCT02104752|Psychosis|psychosis
248631|NCT02104739|prediabetes|prediabetes
248632|NCT02104739|diabetes mellitus type 2|diabetes mellitus type 2
248633|NCT02104739|exenatide|exenatide
248634|NCT02104739|saxagliptin|saxagliptin
248635|NCT02104739|exenatide ER|exenatide er
248636|NCT02104713|Skin Burn Degree Second|skin burn degree second
248637|NCT02104713|Second degree Burn|second degree burn
248638|NCT02104713|Burn wound|burn wound
248639|NCT02104700|HIV|hiv
248640|NCT02104687|GTD, goal-directed haemodynamic therapy|gtd, goal-directed haemodynamic therapy
248641|NCT02104687|CI, cardiac index|ci, cardiac index
248642|NCT02104687|MAP, mean arterial pressure|map, mean arterial pressure
248643|NCT02104687|CVP, central venous pressure|cvp, central venous pressure
248644|NCT02104622|spinal cord injury|spinal cord injury
248645|NCT02104622|exoskeleton|exoskeleton
248646|NCT02104622|ambulation|ambulation
248647|NCT02104622|walking|walking
248648|NCT02104622|robotics|robotics
248649|NCT02104609|Obesity|obesity
248650|NCT02104609|Emergency contraception|emergency contraception
248651|NCT02104609|Levonorgestrel emergency contraception|levonorgestrel emergency contraception
248652|NCT02104583|VT|vt
248653|NCT02104583|VF|vf
248654|NCT02104583|Ventricular Tachycardia|ventricular tachycardia
248655|NCT02104583|Ventricular Fibrillation|ventricular fibrillation
248656|NCT02104583|shock|shock
248657|NCT02104583|ATP|atp
248658|NCT02104570|Fatigue|fatigue
248659|NCT02104570|Proprioception|proprioception
248660|NCT02104570|Shoulder|shoulder
248661|NCT02104557|Sayana|sayana
248662|NCT02104557|Pregnancy|pregnancy
248663|NCT02104557|Contraception|contraception
248664|NCT02104557|Endometriosis-associated pain|endometriosis-associated pain
248665|NCT02104557|PMS|pms
248666|NCT02104557|Post Marketing Surveillance|post marketing surveillance
248667|NCT02104544|DHA intake;|dha intake;
248668|NCT02104544|Plasma;|plasma;
248669|NCT02104544|Erythrocyte;|erythrocyte;
248670|NCT02104544|Breast milk.|breast milk.
248671|NCT02104518|glucose-6-phosphate dehydrogenase|glucose-6-phosphate dehydrogenase
248672|NCT02104518|point-of-care diagnostic testing|point-of-care diagnostic testing
248673|NCT02104492|multiple sclerosis|multiple sclerosis
248674|NCT02104492|respiratory muscle strength|respiratory muscle strength
248675|NCT02104492|maximal inspiratory pressure (MIP)|maximal inspiratory pressure (mip)
248676|NCT02104492|maximal expiratory pressure (MEP)|maximal expiratory pressure (mep)
248677|NCT02104492|respiratory muscle endurance|respiratory muscle endurance
248678|NCT02104492|quality of life|quality of life
248679|NCT02104492|qualitative research|qualitative research
248680|NCT02104466|acupuncture|acupuncture
248681|NCT02104466|pain|pain
248682|NCT02104466|neuropathy|neuropathy
248683|NCT02104453|airway maneuver|airway maneuver
248684|NCT02104440|Cytopenia|cytopenia
248685|NCT02104414|Liposomal Bupivacaine|liposomal bupivacaine
248686|NCT02104414|Exparel|exparel
248687|NCT02104375|wave reflection|wave reflection
248688|NCT02104375|augmentation Index|augmentation index
248689|NCT02104375|heart rate variability|heart rate variability
248690|NCT02104375|arterial stiffness|arterial stiffness
248691|NCT02104349|spine surgery|spine surgery
248692|NCT02104349|post op pain management|post op pain management
248693|NCT02104336|Pearson|pearson
248694|NCT02104336|EPI743|epi743
248695|NCT02104336|EPI-743|epi-743
248696|NCT02104336|Vincerinone|vincerinone
248697|NCT02104336|Mitochondrial disorder|mitochondrial disorder
248698|NCT02104336|Mitochondrial disease|mitochondrial disease
248699|NCT02104323|Neurofibromatosis Type 2|neurofibromatosis type 2
248700|NCT02104323|Vestibular Schwannoma|vestibular schwannoma
248701|NCT02104323|Other NF2-related tumors|other nf2-related tumors
248702|NCT02104310|malignant glioma|malignant glioma
248703|NCT02104310|FDOPA|fdopa
248704|NCT02104310|PET CT|pet ct
248705|NCT02104310|radiation therapy|radiation therapy
248706|NCT02104297|Nasal septum operation|nasal septum operation
248707|NCT02104297|agitation|agitation
248708|NCT02104284|Bronchial provocation test|bronchial provocation test
248709|NCT02104284|Mannitol|mannitol
248710|NCT02104284|Methacholine|methacholine
248711|NCT02104284|Bronchial hyperreactivity|bronchial hyperreactivity
248712|NCT02104284|Sensitivity and specificity|sensitivity and specificity
248713|NCT02104271|chronic radiation proctitis|chronic radiation proctitis
248714|NCT02104271|argon plasma coagulation|argon plasma coagulation
248715|NCT02104271|rectal bleeding|rectal bleeding
248716|NCT02104258|Hamstring|hamstring
248717|NCT02104258|Muscle|muscle
248718|NCT02104258|Injury|injury
248719|NCT02104258|Treatment|treatment
248720|NCT02104258|Rehabilitation|rehabilitation
248721|NCT02104245|Non Cystic Fibrosis Bronchiectasis, Pulmaquin, Ciprofloxacin, Pseudomonas aeruginosa|non cystic fibrosis bronchiectasis, pulmaquin, ciprofloxacin, pseudomonas aeruginosa
248722|NCT02104232|Maternal depression|maternal depression
248723|NCT02104219|Hypophosphatasia|hypophosphatasia
248724|NCT02104219|HPP|hpp
248725|NCT02104219|bone disease|bone disease
248726|NCT02104219|Soft Bones|soft bones
248727|NCT02104219|low Alkaline Phosphatase|low alkaline phosphatase
248728|NCT02104219|genetic metabolic disorder|genetic metabolic disorder
248729|NCT02104219|alkaline phosphatase|alkaline phosphatase
248730|NCT02104219|tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
248731|NCT02104219|rickets|rickets
248732|NCT02104219|osteomalacia|osteomalacia
248733|NCT02104193|brain metastases|brain metastases
248734|NCT02104193|simvastatin|simvastatin
248735|NCT02104193|radiation therapy|radiation therapy
248736|NCT02104180|non-inferiority|non-inferiority
248737|NCT02104180|randomized|randomized
248738|NCT02104180|TulleGras|tullegras
248739|NCT02104180|Urgotul|urgotul
248740|NCT02104180|pain|pain
248741|NCT02104180|venous leg ulcer|venous leg ulcer
248742|NCT02104180|healing|healing
248743|NCT02104167|DDD|ddd
248744|NCT02104167|degenerative disc disease|degenerative disc disease
248745|NCT02104167|cervical spine|cervical spine
248746|NCT02104167|fusion rate|fusion rate
248747|NCT02104141|DDD|ddd
248748|NCT02104141|lumbar spine|lumbar spine
248749|NCT02104141|fusion rate|fusion rate
248750|NCT02104141|degenerative disc disease|degenerative disc disease
248751|NCT02104128|Anhedonia|anhedonia
248752|NCT02104128|Dopamine|dopamine
248753|NCT02104128|Bupropion|bupropion
248754|NCT02104128|fMRI|fmri
248755|NCT02104128|emotional processing|emotional processing
248756|NCT02104128|reward|reward
248757|NCT02104115|Stomach|stomach
248758|NCT02104115|Small bowel|small bowel
248759|NCT02104115|Colon|colon
248760|NCT02104115|MRI|mri
248761|NCT02104115|Function|function
248762|NCT02104115|Gastrointestinal volumes|gastrointestinal volumes
248763|NCT02104102|Elderly|elderly
248764|NCT02104102|mirror therapy|mirror therapy
248765|NCT02104102|hands|hands
248766|NCT02104089|Thoracoabdominal aortic aneurysm|thoracoabdominal aortic aneurysm
248767|NCT02104089|Endovascular|endovascular
248768|NCT02104089|Fenestration|fenestration
248769|NCT02104089|Branch|branch
248770|NCT02104089|Off-the-shelf|off-the-shelf
248771|NCT02104076|Bile Duct Obstructions|bile duct obstructions
248772|NCT02104076|Biliary Stases|biliary stases
248773|NCT02104076|Biliary Tract|biliary tract
248774|NCT02104076|Stents|stents
248775|NCT02104024|Kidney|kidney
248776|NCT02104024|Pancreas|pancreas
248777|NCT02104024|Transplant|transplant
248778|NCT02104024|Contrast Enhanced Ultrasound|contrast enhanced ultrasound
248779|NCT02104011|Angiomyolipomas in tuberous sclerosis|angiomyolipomas in tuberous sclerosis
248780|NCT02104011|Beta-blockers|beta-blockers
248781|NCT02104011|Anti-angiogenic therapies|anti-angiogenic therapies
248782|NCT02103998|extremely low gestational age neonate|extremely low gestational age neonate
248783|NCT02103998|hypothyroxinemia of prematurity|hypothyroxinemia of prematurity
248784|NCT02103998|brain development|brain development
248785|NCT02103998|cerebral palsy|cerebral palsy
248786|NCT02103998|cognitive dealy|cognitive dealy
248787|NCT02103985|Healthy|healthy
248788|NCT02103985|JNJ-39823277|jnj-39823277
248789|NCT02103985|JNJ-40917006|jnj-40917006
248790|NCT02103985|Pharmacokinetics|pharmacokinetics
248791|NCT02103972|All subjects of any ethnicity aged from 4 to 30 months with atopic dermatitis skin symptoms with a SCORAD equal or above 20|all subjects of any ethnicity aged from 4 to 30 months with atopic dermatitis skin symptoms with a scorad equal or above 20
248792|NCT02103946|serratus|serratus
248793|NCT02103946|paravertebral|paravertebral
248794|NCT02103946|breast|breast
248795|NCT02103946|cancer|cancer
248796|NCT02103946|axilla|axilla
248797|NCT02103907|balance|balance
248798|NCT02103907|knee|knee
248799|NCT02103907|osteoarthritis|osteoarthritis
248800|NCT02103907|physical function|physical function
248801|NCT02103894|Alzheimer's disease (AD)|alzheimer's disease (ad)
248802|NCT02103894|Parkinson's disease (PD)|parkinson's disease (pd)
248803|NCT02103894|Progressive supranuclear palsy (PSP)|progressive supranuclear palsy (psp)
248804|NCT02103894|Chronic traumatic encephalopathy (CTE)|chronic traumatic encephalopathy (cte)
248805|NCT02103894|Frontal temporal dementia (FTD)|frontal temporal dementia (ftd)
248806|NCT02103894|Pick's disease|pick's disease
248807|NCT02103894|tauopathies|tauopathies
248808|NCT02103881|Agitation|agitation
248809|NCT02103881|Ketamine|ketamine
248810|NCT02103881|Haloperidol|haloperidol
248811|NCT02103881|Emergency Medical Services|emergency medical services
248812|NCT02103881|Feeling of restlessness|feeling of restlessness
248813|NCT02103881|Increased motor activity|increased motor activity
248814|NCT02103868|Tobacco cessation|tobacco cessation
248815|NCT02103868|Zari worker|zari worker
248816|NCT02103868|Behavior therapy|behavior therapy
248817|NCT02103868|Qualitative Research|qualitative research
248818|NCT02103868|Mumbai|mumbai
248819|NCT02103855|pancreas transplantation|pancreas transplantation
248820|NCT02103855|immunosuppression|immunosuppression
248821|NCT02103855|belatacept|belatacept
248822|NCT02103829|Cigarette smoking|cigarette smoking
248823|NCT02103829|Tobacco smoking|tobacco smoking
248824|NCT02103829|Smoking, Tobacco|smoking, tobacco
248825|NCT02103803|concussion|concussion
248826|NCT02103803|sports-related concussion|sports-related concussion
248827|NCT02103803|mild traumatic brain injury (mTBI)|mild traumatic brain injury (mtbi)
248828|NCT02103803|eye tracking|eye tracking
248829|NCT02103803|oculometrics|oculometrics
248830|NCT02103777|high dose of caffeine|high dose of caffeine
248831|NCT02103777|low dose of caffeine|low dose of caffeine
248832|NCT02103777|prevention|prevention
248833|NCT02103764|Anovulatory Dysfunctional Uterine Bleeding|anovulatory dysfunctional uterine bleeding
248834|NCT02103764|cyclic desogestrel|cyclic desogestrel
248835|NCT02103764|cyclic medroxyprogesterone acetate|cyclic medroxyprogesterone acetate
248836|NCT02103764|lipid metabolism|lipid metabolism
248837|NCT02103764|glucose metabolism|glucose metabolism
248838|NCT02103764|endometrial histology changing|endometrial histology changing
248839|NCT02103751|biomarkers|biomarkers
248840|NCT02103751|HPHCs|hphcs
248841|NCT02103751|CVD|cvd
248842|NCT02103751|smoking|smoking
248843|NCT02103751|Smokers|smokers
248844|NCT02103751|non-smokers|non-smokers
248845|NCT02103738|Lucentis|lucentis
248846|NCT02103738|Ranibizumab|ranibizumab
248847|NCT02103738|Treat and Extend|treat and extend
248848|NCT02103738|wetAMD|wetamd
248849|NCT02103738|Age related macular degeneration|age related macular degeneration
248850|NCT02103699|Hepatitis C virus|hepatitis c virus
248851|NCT02103699|Simeprevir|simeprevir
248852|NCT02103699|Ribonucleic acid|ribonucleic acid
248853|NCT02103699|Sustained virologic response|sustained virologic response
248854|NCT02103686|Neuropathic pain|neuropathic pain
248855|NCT02103686|pregabalin|pregabalin
248856|NCT02103660|contraceptive implant|contraceptive implant
248857|NCT02103660|Depo-Medroxyprogesterone Acetate|depo-medroxyprogesterone acetate
248858|NCT02103660|Hormonal Contraception|hormonal contraception
248859|NCT02103660|progestin|progestin
248860|NCT02103647|Neuropathic pain|neuropathic pain
248861|NCT02103647|pregabalin|pregabalin
248862|NCT02103634|breast cancer|breast cancer
248863|NCT02103634|FDG PET/CT|fdg pet/ct
248864|NCT02103634|MRI|mri
248865|NCT02103634|NaF PET/MRI|naf pet/mri
248866|NCT02103634|NaF PET/CT|naf pet/ct
248867|NCT02103608|at Home Photo depilation device, Silk'n.|at home photo depilation device, silk'n.
248868|NCT02103556|Constipation|constipation
248869|NCT02103556|Rome III criteria|rome iii criteria
248870|NCT02103556|Hemodialysis|hemodialysis
248871|NCT02103491|Half-ironman|half-ironman
248872|NCT02103491|Triathlon|triathlon
248873|NCT02103491|Salt|salt
248874|NCT02103491|Exercise|exercise
248875|NCT02103491|Performance|performance
248876|NCT02103478|Myelodysplastic Syndrome|myelodysplastic syndrome
248877|NCT02103478|MDS|mds
248878|NCT02103465|Parkinson's Disease|parkinson's disease
248879|NCT02103465|treatment|treatment
248880|NCT02103465|old patients|old patients
248881|NCT02103465|Rotigotine|rotigotine
248882|NCT02103439|Hepatitis C|hepatitis c
248883|NCT02103439|Cepeginterferon alfa|cepeginterferon alfa
248884|NCT02103439|Peginterferon|peginterferon
248885|NCT02103439|Treatment|treatment
248886|NCT02103426|Cytomegalovirus|cytomegalovirus
248887|NCT02103426|ASP0113|asp0113
248888|NCT02103426|CMV-seropositive|cmv-seropositive
248889|NCT02103426|Healthy subjects|healthy subjects
248890|NCT02103426|CMV-seronegative|cmv-seronegative
248891|NCT02103426|Dialysis|dialysis
248892|NCT02103374|weaned tobacco|weaned tobacco
248893|NCT02103374|Has not submitted an exacerbation in the past 3 months|has not submitted an exacerbation in the past 3 months
248894|NCT02103361|autoimmune disease|autoimmune disease
248895|NCT02103361|pregnancy|pregnancy
248896|NCT02103361|psoriasis|psoriasis
248897|NCT02103361|Stelara|stelara
248898|NCT02103361|ustekinumab|ustekinumab
248899|NCT02103361|birth outcome|birth outcome
248900|NCT02103361|malformation|malformation
248901|NCT02103361|birth defect|birth defect
248902|NCT02103361|psoriatic arthritis|psoriatic arthritis
248903|NCT02103361|Crohn's Disease|crohn's disease
248904|NCT02103348|Severe asthma|severe asthma
248905|NCT02103348|Sputum|sputum
248906|NCT02103348|Mucolysis|mucolysis
248907|NCT02103335|Myeloma|myeloma
248908|NCT02103335|Multiple Myeloma|multiple myeloma
248909|NCT02103335|Pomalidomide|pomalidomide
248910|NCT02103335|Marizomib|marizomib
248911|NCT02103335|Low dose Dexamethasone|low dose dexamethasone
248912|NCT02103335|Relapsed|relapsed
248913|NCT02103335|Refractory|refractory
248914|NCT02103309|Soft contact lenses|soft contact lenses
248915|NCT02103309|DACP|dacp
248916|NCT02103283|Diabetic Macular Edema|diabetic macular edema
248917|NCT02103244|pharmacokinetics|pharmacokinetics
248918|NCT02103244|safety|safety
248919|NCT02103231|Preterm birth|preterm birth
248920|NCT02103231|Hypertension|hypertension
248921|NCT02103231|Exercise capacity|exercise capacity
248922|NCT02103231|Cardiovascular risk|cardiovascular risk
248923|NCT02103218|HIV|hiv
248924|NCT02103218|risky sex prevention|risky sex prevention
248925|NCT02103218|intervention|intervention
248926|NCT02103205|Lactoferrin|lactoferrin
248927|NCT02103205|Infant formula|infant formula
248928|NCT02103205|Iron|iron
248929|NCT02103179|Extrahepatic cholangiocarcinoma|extrahepatic cholangiocarcinoma
248930|NCT02103179|ECC|ecc
248931|NCT02103179|VEGF signaling|vegf signaling
248932|NCT02103140|Breast Cancer|breast cancer
248933|NCT02103140|Obesity|obesity
248934|NCT02103140|African American female|african american female
248935|NCT02103140|exergaming|exergaming
248936|NCT02103101|polymorphism|polymorphism
248937|NCT02103101|ABCB1|abcb1
248938|NCT02103101|P-glycoprotein|p-glycoprotein
248939|NCT02103101|oral anticoagulant|oral anticoagulant
248940|NCT02103101|dabigatran|dabigatran
248941|NCT02103101|apixaban|apixaban
248942|NCT02103101|rivaroxaban|rivaroxaban
248943|NCT02103101|hemorrhagic complication|hemorrhagic complication
248944|NCT02103101|thrombo-embolism|thrombo-embolism
248945|NCT02103101|serious adverse event|serious adverse event
248946|NCT02103088|Prostate cancer|prostate cancer
248947|NCT02103088|Intervention|intervention
248948|NCT02103088|Rehabilitation|rehabilitation
248949|NCT02103088|Couple|couple
248950|NCT02103088|Sexology|sexology
248951|NCT02103088|Urology|urology
248952|NCT02103088|Late effects|late effects
248953|NCT02103075|spinocerebellar ataxia (SCA)|spinocerebellar ataxia (sca)
248954|NCT02103075|motor evoked potential (MEP)|motor evoked potential (mep)
248955|NCT02103075|Neuromuscular electrical stimulation (NMES)|neuromuscular electrical stimulation (nmes)
248956|NCT02103075|silent period|silent period
248957|NCT02103075|cerebellum|cerebellum
248958|NCT02103062|Metastatic Colorectal Cancer|metastatic colorectal cancer
248959|NCT02103062|nab®Paclitaxel|nab®paclitaxel
248960|NCT02103062|Response Evaluation in Solid Tumors|response evaluation in solid tumors
248961|NCT02103062|Progression Free Survival|progression free survival
248962|NCT02103062|Overall Survival|overall survival
248963|NCT02103062|Duration of Response|duration of response
248964|NCT02103062|RAS|ras
248965|NCT02103036|Low Back Pain|low back pain
248966|NCT02103036|Core stability exercise|core stability exercise
248967|NCT02103036|Back school|back school
248968|NCT02103036|TENS|tens
248969|NCT02103036|Infra- red light|infra- red light
248970|NCT02102997|DTS|dts
248971|NCT02102997|Stents|stents
248972|NCT02102997|Stent|stent
248973|NCT02102997|DES|des
248974|NCT02102997|Drug eluting|drug eluting
248975|NCT02102997|Drug Eluting Stent (DES)|drug eluting stent (des)
248976|NCT02102997|Drug eluting stents|drug eluting stents
248977|NCT02102997|Endothelial Progenitor Cell (EPC)|endothelial progenitor cell (epc)
248978|NCT02102997|Endothelial progenitor cell capturing|endothelial progenitor cell capturing
248979|NCT02102997|Sirolimus|sirolimus
248980|NCT02102997|Sirolimus eluting|sirolimus eluting
248981|NCT02102997|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
248982|NCT02102997|PCI|pci
248983|NCT02102997|Registry|registry
248984|NCT02102997|Registries|registries
248985|NCT02102997|Multi center|multi center
248986|NCT02102997|Multi centre|multi centre
248987|NCT02102984|distal malignancy of the extra-hepatic biliary tract|distal malignancy of the extra-hepatic biliary tract
248988|NCT02102984|metallic biliary stents|metallic biliary stents
248989|NCT02102984|covered biliary stents|covered biliary stents
248990|NCT02102984|uncovered biliary stents|uncovered biliary stents
248991|NCT02102971|liver|liver
248992|NCT02102971|ischemia|ischemia
248993|NCT02102971|reperfusion|reperfusion
248994|NCT02102958|diabetes|diabetes
248995|NCT02102958|visual impairment|visual impairment
248996|NCT02102958|foot care|foot care
248997|NCT02102958|diabetes self-management education|diabetes self-management education
248998|NCT02102945|Computed tomography|computed tomography
248999|NCT02102945|Perfusion imaging|perfusion imaging
249000|NCT02102945|Coma|coma
249001|NCT02102945|Heart arrest|heart arrest
249002|NCT02102945|Brain death|brain death
249003|NCT02102906|Adult|adult
249004|NCT02102906|Humans|humans
249005|NCT02102906|Conversion disorder|conversion disorder
249006|NCT02102906|Somatoform Disorders/therapy|somatoform disorders/therapy
249007|NCT02102906|Nervous System Disorders/therapy|nervous system disorders/therapy
249008|NCT02102893|for Gastroentero-Pancreatic Neuroendocrine Tumors in Taiwan|for gastroentero-pancreatic neuroendocrine tumors in taiwan
249009|NCT02102880|Genetic Association Studies|genetic association studies
249010|NCT02102867|HIV|hiv
249011|NCT02102867|STI|sti
249012|NCT02102867|Primary Prevention|primary prevention
249013|NCT02102867|Topical Microbicides|topical microbicides
249014|NCT02102867|User Experience|user experience
249015|NCT02102867|Drug Delivery Systems|drug delivery systems
249016|NCT02102854|kidney transplantation|kidney transplantation
249017|NCT02102854|acute rejection|acute rejection
249018|NCT02102854|rabbit antithymocyte globulin|rabbit antithymocyte globulin
249019|NCT02102828|DVT|dvt
249020|NCT02102828|Total Knee Arthroplasty|total knee arthroplasty
249021|NCT02102815|total knee arthroplasty|total knee arthroplasty
249022|NCT02102815|pain control|pain control
249023|NCT02102815|dexamethasone|dexamethasone
249024|NCT02102815|steroids|steroids
249025|NCT02102802|PTSD|ptsd
249026|NCT02102802|MDMA|mdma
249027|NCT02102802|Brain activity|brain activity
249028|NCT02102802|fMRI|fmri
249029|NCT02102802|Heart rate variability|heart rate variability
249030|NCT02102802|Physiological correlate|physiological correlate
249031|NCT02102776|Primary Pterygium|primary pterygium
249032|NCT02102776|Mitomycin C|mitomycin c
249033|NCT02102776|Amniotic membrane transplantation|amniotic membrane transplantation
249034|NCT02102776|Conjunctival autograft|conjunctival autograft
249035|NCT02102776|Multi-center randomized clinical trial|multi-center randomized clinical trial
249036|NCT02102763|Overweight|overweight
249037|NCT02102763|Obesity|obesity
249038|NCT02102763|Dietary intake|dietary intake
249039|NCT02102763|Physical activity levels|physical activity levels
249040|NCT02102763|Blood pressure levels|blood pressure levels
249041|NCT02102763|Family perceptions|family perceptions
249042|NCT02102737|insulin resistance|insulin resistance
249043|NCT02102737|Scintigraphy|scintigraphy
249044|NCT02102737|Hyperinsulinemic euglycemic clamp|hyperinsulinemic euglycemic clamp
249045|NCT02102724|African Americans|african americans
249046|NCT02102724|Older Adults|older adults
249047|NCT02102711|VITAMIN A|vitamin a
249048|NCT02102711|BLOOD CONCENTRATION|blood concentration
249049|NCT02102711|retinopathy of prematurity|retinopathy of prematurity
249050|NCT02102698|Tourette's Syndrome|tourette's syndrome
249051|NCT02102698|Ecopipam|ecopipam
249052|NCT02102698|D1 Receptor|d1 receptor
249053|NCT02102698|Phase 2|phase 2
249054|NCT02102685|VAC Therapy|vac therapy
249055|NCT02102685|Neck Abscess|neck abscess
249056|NCT02102685|Traditional Therapy|traditional therapy
249057|NCT02102685|Wound Healing|wound healing
249058|NCT02102659|Nutritional Assessment|nutritional assessment
249059|NCT02102659|Oral Epithelial Cell|oral epithelial cell
249060|NCT02102659|Apoptosis|apoptosis
249061|NCT02102633|bosutinib|bosutinib
249062|NCT02102633|dabigatran|dabigatran
249063|NCT02102633|drug interaction|drug interaction
249064|NCT02102633|p-glycoprotein|p-glycoprotein
249065|NCT02102633|pharmacokinetics|pharmacokinetics
249066|NCT02102620|intra-articular injection|intra-articular injection
249067|NCT02102620|corticosteroid|corticosteroid
249068|NCT02102620|osteoarthritis|osteoarthritis
249069|NCT02102620|Interphalangeal joint|interphalangeal joint
249070|NCT02102607|intrathecal; ropivacaine; motor blockade; local anesthetics|intrathecal; ropivacaine; motor blockade; local anesthetics
249071|NCT02102594|Myasthenia Gravis|myasthenia gravis
249072|NCT02102594|Systemic Lupus Erythematosus|systemic lupus erythematosus
249073|NCT02102594|Rheumatoid Arthritis|rheumatoid arthritis
249074|NCT02102594|proteasome inhibitor|proteasome inhibitor
249075|NCT02102594|Bortezomib|bortezomib
249076|NCT02102594|Velcade|velcade
249077|NCT02102594|antibody-mediated autoimmune disease|antibody-mediated autoimmune disease
249078|NCT02102581|Tourniquet|tourniquet
249079|NCT02102581|Total knee arthroplasty|total knee arthroplasty
249080|NCT02102581|Blood loss|blood loss
249081|NCT02102581|Limb swelling|limb swelling
249082|NCT02102581|Limb circumference|limb circumference
249083|NCT02102542|glycopyrrolate|glycopyrrolate
249084|NCT02102542|efficacy|efficacy
249085|NCT02102542|antisialagogue|antisialagogue
249086|NCT02102529|pain|pain
249087|NCT02102529|quality of life|quality of life
249088|NCT02102516|Post operative pain management|post operative pain management
249089|NCT02102490|Endocrine Therapy, Taxane, MONARCH 1|endocrine therapy, taxane, monarch 1
249090|NCT02102477|Prostatic neoplasms|prostatic neoplasms
249091|NCT02102477|Locally advanced|locally advanced
249092|NCT02102477|Radiotherapy|radiotherapy
249093|NCT02102477|Surgery|surgery
249094|NCT02102477|Mortality|mortality
249095|NCT02102451|Interferon-free|interferon-free
249096|NCT02102451|Direct acting antiviral (DAA)|direct acting antiviral (daa)
249097|NCT02102451|Treatment as prevention|treatment as prevention
249098|NCT02102451|Surveillance|surveillance
249099|NCT02102451|Feasibility|feasibility
249100|NCT02102438|Elderly patients|elderly patients
249101|NCT02102438|Localized HER2+ Breast Cancer|localized her2+ breast cancer
249102|NCT02102438|Omission of anthracyclines|omission of anthracyclines
249103|NCT02102438|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
249104|NCT02102438|Adjuvant chemotherapy|adjuvant chemotherapy
249105|NCT02102438|Safety information|safety information
249106|NCT02102425|Peritoneal Dialysis|peritoneal dialysis
249107|NCT02102425|Exit site infection|exit site infection
249108|NCT02102425|Exit site care|exit site care
249109|NCT02102425|Bandage|bandage
249110|NCT02102425|Prevention|prevention
249111|NCT02102425|Guidelines|guidelines
249112|NCT02102412|crc|crc
249113|NCT02102412|colonoscopy|colonoscopy
249114|NCT02102412|colon cancer|colon cancer
249115|NCT02102399|Voice training|voice training
249116|NCT02102399|Education|education
249117|NCT02102399|Voice|voice
249118|NCT02102399|Faculty|faculty
249119|NCT02102386|elective|elective
249120|NCT02102386|carotid endarterectomy surgery|carotid endarterectomy surgery
249121|NCT02102373|colonoscopy, pediatric, preparation, diet|colonoscopy, pediatric, preparation, diet
249122|NCT02102360|microsurgery, furcation defects, periodontal disease, enamel matrix proteins, bone substitutes|microsurgery, furcation defects, periodontal disease, enamel matrix proteins, bone substitutes
249123|NCT02102347|Physical Therapy Modalities|physical therapy modalities
249124|NCT02102347|osteoarthritis|osteoarthritis
249125|NCT02102334|Osteoarthritis, hip,|osteoarthritis, hip,
249126|NCT02102334|radiograpghic measurements|radiograpghic measurements
249127|NCT02102334|femoral offset|femoral offset
249128|NCT02102334|leg length discrepancy|leg length discrepancy
249129|NCT02102334|cup anteversion|cup anteversion
249130|NCT02102334|cup inclination|cup inclination
249131|NCT02102321|hookworm|hookworm
249132|NCT02102321|albendazole|albendazole
249133|NCT02102321|iron supplementation|iron supplementation
249134|NCT02102321|democratic republic of congo|democratic republic of congo
249135|NCT02102321|subsistence farmers|subsistence farmers
249136|NCT02102321|randomized control trial|randomized control trial
249137|NCT02102321|neglected tropical disease|neglected tropical disease
249138|NCT02102321|helminths|helminths
249139|NCT02102295|Gingivitis|gingivitis
249140|NCT02102295|antioxidant|antioxidant
249141|NCT02102295|dentifrice|dentifrice
249142|NCT02102295|Ascorbic Acid Derivative|ascorbic acid derivative
249143|NCT02102295|L ascorbic acid 2 phosphate magnesium salt|l ascorbic acid 2 phosphate magnesium salt
249144|NCT02102282|Pregnancy|pregnancy
249145|NCT02102282|Breast Cancer|breast cancer
249146|NCT02102282|Chemotherapy|chemotherapy
249147|NCT02102282|Surgery|surgery
249148|NCT02102282|Obstetric managment|obstetric managment
249149|NCT02102256|deafness|deafness
249150|NCT02102256|congenital|congenital
249151|NCT02102256|pediatric|pediatric
249152|NCT02102256|device|device
249153|NCT02102243|hypertension|hypertension
249154|NCT02102243|blood pressure|blood pressure
249155|NCT02102243|sympathetic nerve activity|sympathetic nerve activity
249156|NCT02102243|vascular oxidative stress|vascular oxidative stress
249157|NCT02102243|nitric oxide|nitric oxide
249158|NCT02102243|nitric oxide synthase (eNOS)|nitric oxide synthase (enos)
249159|NCT02102243|endothelium|endothelium
249160|NCT02102243|endothelial dysfunction|endothelial dysfunction
249161|NCT02102243|endothelial cell protein expression|endothelial cell protein expression
249162|NCT02102243|microvascular blood flow|microvascular blood flow
249163|NCT02102243|flow mediated dilation|flow mediated dilation
249164|NCT02102243|endothelial cell collection|endothelial cell collection
249165|NCT02102243|microbubbles|microbubbles
249166|NCT02102243|Definity|definity
249167|NCT02102230|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
249168|NCT02102230|marijuana abuse|marijuana abuse
249169|NCT02102230|Veterans|veterans
249170|NCT02102217|Major Abdominal Surgery|major abdominal surgery
249171|NCT02102217|C-reactive protein|c-reactive protein
249172|NCT02102217|Computed Tomography|computed tomography
249173|NCT02102217|Quality Control|quality control
249174|NCT02102217|Postoperative complications|postoperative complications
249175|NCT02102204|Secondary Hyperparathyroidism (SHPT), chrominc kidney disease (CKD), hemodialysis|secondary hyperparathyroidism (shpt), chrominc kidney disease (ckd), hemodialysis
249176|NCT02102178|oncological pain|oncological pain
249177|NCT02102178|therapeutic activities|therapeutic activities
249178|NCT02102178|occupational therapy.|occupational therapy.
249179|NCT02102165|Aurora|aurora
249180|NCT02102165|breast cancer|breast cancer
249181|NCT02102165|metastatic|metastatic
249182|NCT02102165|molecular screening|molecular screening
249183|NCT02102165|targeted gene sequencing|targeted gene sequencing
249184|NCT02102165|molecular aberrations|molecular aberrations
249185|NCT02102165|exploratory|exploratory
249186|NCT02102165|biomarker|biomarker
249187|NCT02102152|Tobramycin Podhaler|tobramycin podhaler
249188|NCT02102152|bronchiectasis|bronchiectasis
249189|NCT02102152|chronic infection|chronic infection
249190|NCT02102152|Pseudomonas Aeruginosa|pseudomonas aeruginosa
249191|NCT02102126|Renal denervation therapy|renal denervation therapy
249192|NCT02102126|Aortic blood pressure|aortic blood pressure
249193|NCT02102126|Blood pressure variability|blood pressure variability
249194|NCT02102126|Arterial stiffness|arterial stiffness
249195|NCT02102126|Target organ damage|target organ damage
249196|NCT02102126|Biomarker|biomarker
249197|NCT02102100|menthol, electronic cigarette, nicotine, smoking, tobacco|menthol, electronic cigarette, nicotine, smoking, tobacco
249198|NCT02102074|colon and rectal tumors|colon and rectal tumors
249199|NCT02102074|colon cancer markers|colon cancer markers
249200|NCT02102061|overweight|overweight
249201|NCT02102061|exercise|exercise
249202|NCT02102061|nutrition|nutrition
249203|NCT02102061|philosophy|philosophy
249204|NCT02102048|HIV|hiv
249205|NCT02102048|diabetes|diabetes
249206|NCT02102048|glucose metabolism|glucose metabolism
249207|NCT02102048|antiretroviral therapy|antiretroviral therapy
249208|NCT02102048|ritonavir|ritonavir
249209|NCT02102048|atazanavir|atazanavir
249210|NCT02102035|defect|defect
249211|NCT02102035|dorsal branch of the proper digital nerve|dorsal branch of the proper digital nerve
249212|NCT02102035|dorsal digital island flap|dorsal digital island flap
249213|NCT02102035|sensory reconstruction.|sensory reconstruction.
249214|NCT02102022|argininosuccinate synthetase|argininosuccinate synthetase
249215|NCT02102022|arginine|arginine
249216|NCT02102022|arginine deiminase|arginine deiminase
249217|NCT02102009|Malnutrition|malnutrition
249218|NCT02102009|Dietary supplement|dietary supplement
249219|NCT02102009|Nutritional supplement|nutritional supplement
249220|NCT02102009|Complete enteral formula|complete enteral formula
249221|NCT02102009|COPD|copd
249222|NCT02101996|stable isotopes|stable isotopes
249223|NCT02101996|triacylglycerol|triacylglycerol
249224|NCT02101983|Acute myeloid leukemia|acute myeloid leukemia
249225|NCT02101983|outpatient consolidation treatment|outpatient consolidation treatment
249226|NCT02101970|Breast cancer risk|breast cancer risk
249227|NCT02101970|DHA|dha
249228|NCT02101970|Omega-3 Fatty Acids|omega-3 fatty acids
249229|NCT02101970|EPA|epa
249230|NCT02101970|Weight Loss|weight loss
249231|NCT02101931|Bladder Cancer|bladder cancer
249232|NCT02101931|Laser Diagnosis|laser diagnosis
249233|NCT02101931|Amino levulinic Acid|amino levulinic acid
249234|NCT02101931|Photodynamic Detection|photodynamic detection
249235|NCT02101931|spectra of urine|spectra of urine
249236|NCT02101892|migraine|migraine
249237|NCT02101892|Amitriptyline|amitriptyline
249238|NCT02101892|pain modulation|pain modulation
249239|NCT02101892|pain psychophysics|pain psychophysics
249240|NCT02101892|pain neurophysiology|pain neurophysiology
249241|NCT02101892|preventive treatment|preventive treatment
249242|NCT02101866|Bioavailability Study|bioavailability study
249243|NCT02101866|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
249244|NCT02101866|Aviragen Therapeutics|aviragen therapeutics
249245|NCT02101866|Aviragen|aviragen
249246|NCT02101840|Substance-Related Disorders|substance-related disorders
249247|NCT02101840|Prescription Drug Misuse|prescription drug misuse
249248|NCT02101840|Analgesics, Opioid|analgesics, opioid
249249|NCT02101840|Oxycodone|oxycodone
249250|NCT02101840|Randomized Controlled Trial|randomized controlled trial
249251|NCT02101840|Cross-Over Studies|cross-over studies
249252|NCT02101840|Placebo|placebo
249253|NCT02101840|Healthy Volunteers|healthy volunteers
249254|NCT02101801|environment, recycled wastewater, carbamazepine|environment, recycled wastewater, carbamazepine
249255|NCT02101762|Foley|foley
249256|NCT02101762|Catheters|catheters
249257|NCT02101762|CAUTI|cauti
249258|NCT02101762|ERASE CAUTI|erase cauti
249259|NCT02101749|trivalent inactivated influenza vaccine|trivalent inactivated influenza vaccine
249260|NCT02101736|Ages 16 or greater|ages 16 or greater
249261|NCT02101736|Cabozantinib|cabozantinib
249262|NCT02101736|XL184|xl184
249263|NCT02101736|Plexiform Neurofibromas|plexiform neurofibromas
249264|NCT02101736|Neurofibromatosis|neurofibromatosis
249265|NCT02101736|Pathogenetic NF1 Mutations|pathogenetic nf1 mutations
249266|NCT02101736|Cometriq|cometriq
249267|NCT02101736|NF1|nf1
249268|NCT02101723|Zinc absorption|zinc absorption
249269|NCT02101723|Micronutrient supplement|micronutrient supplement
249270|NCT02101723|Microbiome|microbiome
249271|NCT02101723|Kenya|kenya
249272|NCT02101723|Complementary foods|complementary foods
249273|NCT02101723|Home fortification|home fortification
249274|NCT02101710|Bioequivalence|bioequivalence
249275|NCT02101710|Isosorbide 5-mononitrate|isosorbide 5-mononitrate
249276|NCT02101710|Elantan|elantan
249277|NCT02101710|Imdur|imdur
249278|NCT02101710|Korean|korean
249279|NCT02101710|Healthy|healthy
249280|NCT02101697|reduce|reduce
249281|NCT02101697|Indian health providers|indian health providers
249282|NCT02101684|Orteronel, Granulosa Cell Tumour|orteronel, granulosa cell tumour
249283|NCT02101671|agitation|agitation
249284|NCT02101671|anaesthesia|anaesthesia
249285|NCT02101671|laparoscopy|laparoscopy
249286|NCT02101671|surgery|surgery
249287|NCT02101671|delirium|delirium
249288|NCT02101671|sedation|sedation
249289|NCT02101671|emergence|emergence
249290|NCT02101671|steep|steep
249291|NCT02101671|trendelemburg|trendelemburg
249292|NCT02101671|position|position
249293|NCT02101671|delayed|delayed
249294|NCT02101671|Confusion|confusion
249295|NCT02101671|Disorientation|disorientation
249296|NCT02101645|Bioimpedance|bioimpedance
249297|NCT02101645|Venous ulcer|venous ulcer
249298|NCT02101645|Edema|edema
249299|NCT02101645|LIDC|lidc
249300|NCT02101645|Electrical stimulation|electrical stimulation
249301|NCT02101632|TMD|tmd
249302|NCT02101632|bee venom|bee venom
249303|NCT02101632|muscle tension|muscle tension
249304|NCT02101632|muscle pain|muscle pain
249305|NCT02101619|aortic stenosis|aortic stenosis
249306|NCT02101619|myocardial tissue|myocardial tissue
249307|NCT02101619|echocardiography|echocardiography
249308|NCT02101619|MRI|mri
249309|NCT02101606|Acute Stroke|acute stroke
249310|NCT02101606|Cerebral Stroke|cerebral stroke
249311|NCT02101606|Brain Ischemia|brain ischemia
249312|NCT02101606|Perfusion Imaging|perfusion imaging
249313|NCT02101606|MRI, Diffusion Weighted|mri, diffusion weighted
249314|NCT02101606|MRI, Perfusion Weighted|mri, perfusion weighted
249315|NCT02101593|argininosuccinate synthetase|argininosuccinate synthetase
249316|NCT02101593|arginine|arginine
249317|NCT02101593|arginine deiminase|arginine deiminase
249318|NCT02101580|argininosuccinate synthetase|argininosuccinate synthetase
249319|NCT02101580|arginine|arginine
249320|NCT02101580|arginine deiminase|arginine deiminase
249321|NCT02101567|Postpartum hemorrhage, Cesarean section, Uterotonics|postpartum hemorrhage, cesarean section, uterotonics
249322|NCT02101554|Pediatric|pediatric
249323|NCT02101554|pain indication|pain indication
249324|NCT02101554|controlled release morphine|controlled release morphine
249325|NCT02101541|Atrial fibrillation|atrial fibrillation
249326|NCT02101541|Arrhythmias, Cardiac|arrhythmias, cardiac
249327|NCT02101541|Heart diseases|heart diseases
249328|NCT02101541|Cardiovascular diseases|cardiovascular diseases
249329|NCT02101541|Pathological processes|pathological processes
249330|NCT02101528|Strength in PD patients|strength in pd patients
249331|NCT02101528|Isokinetic muscle strength|isokinetic muscle strength
249332|NCT02101515|randomized controlled trial|randomized controlled trial
249333|NCT02101515|labor complications|labor complications
249334|NCT02101515|cesarean section|cesarean section
249335|NCT02101515|second stage|second stage
249336|NCT02101502|Healthcare,educational effectiveness, institutional capacity|healthcare,educational effectiveness, institutional capacity
249337|NCT02101489|TVT|tvt
249338|NCT02101489|Stress urinary incontinence|stress urinary incontinence
249339|NCT02101476|Pain|pain
249340|NCT02101463|aortic|aortic
249341|NCT02101463|sm-FBSG|sm-fbsg
249342|NCT02101463|aneurysms|aneurysms
249343|NCT02101463|fenestrated|fenestrated
249344|NCT02101463|stent-grafts|stent-grafts
249345|NCT02101463|Vascular|vascular
249346|NCT02101463|Endovascular|endovascular
249347|NCT02101450|extra-abdominal|extra-abdominal
249348|NCT02101450|intra-abdominal|intra-abdominal
249349|NCT02101450|removal of placenta|removal of placenta
249350|NCT02101450|cesarean section|cesarean section
249351|NCT02101450|bleeding|bleeding
249352|NCT02101424|Overdose|overdose
249353|NCT02101424|Emergency Department|emergency department
249354|NCT02101424|Supplemental Oxygen|supplemental oxygen
249355|NCT02101424|Pulse Oximeter|pulse oximeter
249356|NCT02101424|Capnography|capnography
249357|NCT02101398|tDCS|tdcs
249358|NCT02101398|Stroke|stroke
249359|NCT02101398|Aphasia|aphasia
249360|NCT02101398|Naming|naming
249361|NCT02101385|Genomically-Directed Therapy|genomically-directed therapy
249362|NCT02101385|DNA Sequencing|dna sequencing
249363|NCT02101385|RNA Sequencing|rna sequencing
249364|NCT02101372|first episode psychosis|first episode psychosis
249365|NCT02101372|psychoeducation|psychoeducation
249366|NCT02101372|group therapy|group therapy
249367|NCT02101333|TAKAYASU ARTERITIS|takayasu arteritis
249368|NCT02101333|STEROID SPARING|steroid sparing
249369|NCT02101333|TOCILIZUMAB|tocilizumab
249370|NCT02101333|EFFICACY|efficacy
249371|NCT02101333|SAFETY|safety
249372|NCT02101320|surgery|surgery
249373|NCT02101320|nuclear medicine|nuclear medicine
249374|NCT02101320|Lymphoscintigraphy|lymphoscintigraphy
249375|NCT02101320|Gamma Camera|gamma camera
249376|NCT02101320|SNOLL|snoll
249377|NCT02101320|breast cancer|breast cancer
249378|NCT02101294|carpal tunnel syndrome|carpal tunnel syndrome
249379|NCT02101294|repetitive stress disorder|repetitive stress disorder
249380|NCT02101281|Dry Eye|dry eye
249381|NCT02101255|Dental caries|dental caries
249382|NCT02101255|Curodont Repair|curodont repair
249383|NCT02101255|P11-4|p11-4
249384|NCT02101242|Near-infrared-Spectroscopy|near-infrared-spectroscopy
249385|NCT02101229|Glycemic control algorithm|glycemic control algorithm
249386|NCT02101229|closed loop|closed loop
249387|NCT02101229|artificial pancreas|artificial pancreas
249388|NCT02101216|bioequivalence|bioequivalence
249389|NCT02101216|pharmacokinetics|pharmacokinetics
249390|NCT02101216|psoriasis|psoriasis
249391|NCT02101203|HSDD|hsdd
249392|NCT02101190|BIA 9-1067|bia 9-1067
249393|NCT02101190|Opicapone|opicapone
249394|NCT02101190|catechol-O-methyltransferase (COMT)|catechol-o-methyltransferase (comt)
249395|NCT02101177|Viral Hepatitis C|viral hepatitis c
249396|NCT02101177|Genotype 4|genotype 4
249397|NCT02101177|SVR|svr
249398|NCT02101177|Egyptian National Program|egyptian national program
249399|NCT02101151|Type 2 diabetes mellitus|type 2 diabetes mellitus
249400|NCT02101151|vitamin D|vitamin d
249401|NCT02101151|cholecalciferol|cholecalciferol
249402|NCT02101151|obesity|obesity
249403|NCT02101138|Corticosteroids|corticosteroids
249404|NCT02101138|Eosinophilia|eosinophilia
249405|NCT02101099|Colonoscopy|colonoscopy
249406|NCT02101099|Force|force
249407|NCT02101099|Monitor|monitor
249408|NCT02101099|Endoscopist|endoscopist
249409|NCT02101099|Conscious|conscious
249410|NCT02101099|Sedation|sedation
249411|NCT02101099|Propofol|propofol
249412|NCT02101086|umbilical cord blood|umbilical cord blood
249413|NCT02101086|premature|premature
249414|NCT02101086|autologous transfusion|autologous transfusion
249415|NCT02101086|allogeneic transfusion|allogeneic transfusion
249416|NCT02101060|exercise|exercise
249417|NCT02101060|aging|aging
249418|NCT02101060|aerobic capacity|aerobic capacity
249419|NCT02101060|cardiac function|cardiac function
249420|NCT02101060|inflammation|inflammation
249421|NCT02101047|cesarean section|cesarean section
249422|NCT02101047|hypotension|hypotension
249423|NCT02101047|phenylephrine|phenylephrine
249424|NCT02100982|Multimorbidity|multimorbidity
249425|NCT02100982|Communication|communication
249426|NCT02100982|Primary Care|primary care
249427|NCT02100982|Mental Health|mental health
249428|NCT02100969|MG|mg
249429|NCT02100969|Hizentra|hizentra
249430|NCT02100969|autoimmune neuromuscular disorder|autoimmune neuromuscular disorder
249431|NCT02100956|chronic pain|chronic pain
249432|NCT02100956|neuropathic pain|neuropathic pain
249433|NCT02100943|Obstructive Sleep Apnea|obstructive sleep apnea
249434|NCT02100930|Anti-GD2 3F8 Monoclonal Antibody|anti-gd2 3f8 monoclonal antibody
249435|NCT02100930|oral isotretinoin|oral isotretinoin
249436|NCT02100930|GM-CSF|gm-csf
249437|NCT02100930|Sargramostim|sargramostim
249438|NCT02100930|13-260|13-260
249439|NCT02100917|Bioequivalence|bioequivalence
249440|NCT02100917|Biosimilarity|biosimilarity
249441|NCT02100917|Similarity|similarity
249442|NCT02100917|Pharmacokinetics|pharmacokinetics
249443|NCT02100917|Phase I|phase i
249444|NCT02100917|Trastuzumab|trastuzumab
249445|NCT02100917|Healthy Male Volunteers|healthy male volunteers
249446|NCT02100917|Single-dose|single-dose
249447|NCT02100917|HER-2|her-2
249448|NCT02100917|Oncology|oncology
249449|NCT02100904|Fibroids|fibroids
249450|NCT02100904|Radiofrequency ablation|radiofrequency ablation
249451|NCT02100891|Ewing Sarcoma|ewing sarcoma
249452|NCT02100891|Neuroblastoma|neuroblastoma
249453|NCT02100891|Rhabdomyosarcoma|rhabdomyosarcoma
249454|NCT02100891|Osteosarcoma|osteosarcoma
249455|NCT02100891|CNS tumors|cns tumors
249456|NCT02100891|Brain Tumors|brain tumors
249457|NCT02100839|hypercholesterolemia|hypercholesterolemia
249458|NCT02100839|apolipoprotein E|apolipoprotein e
249459|NCT02100839|First in Human|first in human
249460|NCT02100839|Apolipoprotein E (ApoE)|apolipoprotein e (apoe)
249461|NCT02100839|Apolipoprotein E Mimetic (AEM)|apolipoprotein e mimetic (aem)
249462|NCT02100800|COPD|copd
249463|NCT02100800|Emphysema|emphysema
249464|NCT02100800|MRI|mri
249465|NCT02100800|UTE|ute
249466|NCT02100800|Quantification|quantification
249467|NCT02100800|CT|ct
249468|NCT02100787|tear osmolarity|tear osmolarity
249469|NCT02100787|keratitis sicca|keratitis sicca
249470|NCT02100787|ocular surface disease|ocular surface disease
249471|NCT02100787|TheraTears|theratears
249472|NCT02100774|bioavailability|bioavailability
249473|NCT02100774|postprandial period|postprandial period
249474|NCT02100774|genetic variants|genetic variants
249475|NCT02100774|single nucleotide polymorphisms|single nucleotide polymorphisms
249476|NCT02100774|vitamin|vitamin
249477|NCT02100774|carotenoid|carotenoid
249478|NCT02100774|lutein|lutein
249479|NCT02100774|lycopene|lycopene
249480|NCT02100774|tocopherol|tocopherol
249481|NCT02100774|cholecalciferol|cholecalciferol
249482|NCT02100761|Voriconazole|voriconazole
249483|NCT02100761|Invasive pulmonary aspergillosis|invasive pulmonary aspergillosis
249484|NCT02100761|Therapeutic drug monitoring|therapeutic drug monitoring
249485|NCT02100761|CYP genetic polymorphism|cyp genetic polymorphism
249486|NCT02100761|Efficacy|efficacy
249487|NCT02100761|Safety|safety
249488|NCT02100748|moderate to severe acute pain|moderate to severe acute pain
249489|NCT02100748|bunionectomy|bunionectomy
249490|NCT02100735|sedatives|sedatives
249491|NCT02100735|analgesics|analgesics
249492|NCT02100735|protocol|protocol
249493|NCT02100735|mechanical ventilation|mechanical ventilation
249494|NCT02100735|analgosedation|analgosedation
249495|NCT02100683|Occluder|occluder
249496|NCT02100657|multiple myeloma|multiple myeloma
249497|NCT02100657|plitidepsin|plitidepsin
249498|NCT02100657|APLIDIN|aplidin
249499|NCT02100618|Adolescents|adolescents
249500|NCT02100618|Adults|adults
249501|NCT02100618|Immunogenicity|immunogenicity
249502|NCT02100618|6.5 years|6.5 years
249503|NCT02100618|Safety|safety
249504|NCT02100618|Antibody persistence|antibody persistence
249505|NCT02100618|Human Papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
249506|NCT02100605|Nasal|nasal
249507|NCT02100605|Congestion|congestion
249508|NCT02100605|Decongestion|decongestion
249509|NCT02100605|Hypertonic|hypertonic
249510|NCT02100605|Saline solution|saline solution
249511|NCT02100592|brain injury|brain injury
249512|NCT02100592|coma|coma
249513|NCT02100592|intensive care|intensive care
249514|NCT02100592|early rehabilitation|early rehabilitation
249515|NCT02100566|Advance Directive|advance directive
249516|NCT02100553|Postmenopausal Women|postmenopausal women
249517|NCT02100553|Obese|obese
249518|NCT02100553|Non-obese|non-obese
249519|NCT02100553|Drug Interaction with Itraconazole|drug interaction with itraconazole
249520|NCT02100553|Pharmacokinetic|pharmacokinetic
249521|NCT02100540|PMS|pms
249522|NCT02100540|hot flashes|hot flashes
249523|NCT02100527|safety|safety
249524|NCT02100527|tolerability|tolerability
249525|NCT02100527|pharmacokinetics|pharmacokinetics
249526|NCT02100527|oral dosing|oral dosing
249527|NCT02100527|moderate to severe acne vulgaris|moderate to severe acne vulgaris
249528|NCT02100514|Primary hyperlipidemia or mixed dyslipidemia|primary hyperlipidemia or mixed dyslipidemia
249529|NCT02100514|high risk of cardiovascular events|high risk of cardiovascular events
249530|NCT02100514|multiple cardiovascular disease risk factors.|multiple cardiovascular disease risk factors.
249531|NCT02100501|Seizure control through dietary therapy in pediatric intractable epilepsy patients.|seizure control through dietary therapy in pediatric intractable epilepsy patients.
249532|NCT02100488|Closed-loop insulin infusion|closed-loop insulin infusion
249533|NCT02100488|Postprandial glucose control|postprandial glucose control
249534|NCT02100488|Glucose variability|glucose variability
249535|NCT02100462|Hypertension|hypertension
249536|NCT02100462|Platelet activation|platelet activation
249537|NCT02100462|Platelet aggregation|platelet aggregation
249538|NCT02100462|Chlorthalidone|chlorthalidone
249539|NCT02100449|Atelectasis|atelectasis
249540|NCT02100449|Pneumonia|pneumonia
249541|NCT02100449|Lung ultrasound|lung ultrasound
249542|NCT02100449|Doppler|doppler
249543|NCT02100436|children|children
249544|NCT02100436|H3N2|h3n2
249545|NCT02100436|H3N2v|h3n2v
249546|NCT02100436|influenza|influenza
249547|NCT02100436|pediatric|pediatric
249548|NCT02100436|unadjuvanted|unadjuvanted
249549|NCT02100436|vaccine|vaccine
249550|NCT02100410|Contact Lens|contact lens
249551|NCT02100410|Toric|toric
249552|NCT02100397|Enteric fever|enteric fever
249553|NCT02100397|Paratyphoid|paratyphoid
249554|NCT02100397|Salmonella Paratyphi|salmonella paratyphi
249555|NCT02100397|Challenge study|challenge study
249556|NCT02100397|Human model of infection|human model of infection
249557|NCT02100384|peri implant|peri implant
249558|NCT02100384|Maintenance|maintenance
249559|NCT02100384|Ultrasonic|ultrasonic
249560|NCT02100384|Scalers|scalers
249561|NCT02100371|BMS-833923|bms-833923
249562|NCT02100371|CA194002|ca194002
249563|NCT02100358|acute cholecystitis|acute cholecystitis
249564|NCT02100332|Drug Therapy|drug therapy
249565|NCT02100319|Pharmacological therapy|pharmacological therapy
249566|NCT02100293|magnesium sulfate, rocuronium|magnesium sulfate, rocuronium
249567|NCT02100280|Neuromuscular blockade|neuromuscular blockade
249568|NCT02100280|Sugammadex|sugammadex
249569|NCT02100280|Laparoscopic surgery|laparoscopic surgery
249570|NCT02100280|IL-6|il-6
249571|NCT02100241|Young adult|young adult
249572|NCT02100241|Muscle Stretching Exercises|muscle stretching exercises
249573|NCT02100241|Range of Motion, Articular|range of motion, articular
249574|NCT02100228|apixaban|apixaban
249575|NCT02100228|oral anticoagulant|oral anticoagulant
249576|NCT02100228|non-valvular atrial fibrillation|non-valvular atrial fibrillation
249577|NCT02100228|cardioversion|cardioversion
249578|NCT02100215|simulation|simulation
249579|NCT02100215|competence|competence
249580|NCT02100215|self-efficacy|self-efficacy
249581|NCT02100215|novice nurses|novice nurses
249582|NCT02100202|Dietary supplements|dietary supplements
249583|NCT02100202|Cotinine level|cotinine level
249584|NCT02100202|Malondialdehyde|malondialdehyde
249585|NCT02100202|Chronic smokers|chronic smokers
249586|NCT02100202|Hyperlipidemia|hyperlipidemia
249587|NCT02100176|Rehabilitation treatment|rehabilitation treatment
249588|NCT02100163|Ortho trauma|ortho trauma
249589|NCT02100150|Concussion|concussion
249590|NCT02100124|reproductive life planning|reproductive life planning
249591|NCT02100124|action planning|action planning
249592|NCT02100124|contraceptive use|contraceptive use
249593|NCT02100124|unintended pregnancy|unintended pregnancy
249594|NCT02100098|Ankle fracture|ankle fracture
249595|NCT02100098|Nerve block|nerve block
249596|NCT02100098|Postoperative pain|postoperative pain
249597|NCT02100098|Pain profile|pain profile
249598|NCT02100098|Rebound pain|rebound pain
249599|NCT02100085|Phase 1 follow up|phase 1 follow up
249600|NCT02100085|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
249601|NCT02100085|Adult|adult
249602|NCT02100085|Safety|safety
249603|NCT02100085|Efficacy|efficacy
249604|NCT02100059|meniscectomy|meniscectomy
249605|NCT02100059|arthroscopic partial meniscectomy|arthroscopic partial meniscectomy
249606|NCT02100059|meniscus|meniscus
249607|NCT02100046|Ethosuximide|ethosuximide
249608|NCT02100046|Neuropathic pain|neuropathic pain
249609|NCT02100046|Pain|pain
249610|NCT02100046|Quality of life|quality of life
249611|NCT02100046|Neuropathic Pain diagnostic questionnaire ≥ 4|neuropathic pain diagnostic questionnaire ≥ 4
249612|NCT02100046|Analgesic treatment failure for at least 3 months|analgesic treatment failure for at least 3 months
249613|NCT02100020|physical activity|physical activity
249614|NCT02100020|exercise guidelines|exercise guidelines
249615|NCT02100020|multiple sclerosis|multiple sclerosis
249616|NCT02100007|solid tumors|solid tumors
249617|NCT02100007|relapsed|relapsed
249618|NCT02100007|advanced|advanced
249619|NCT02100007|metastatic|metastatic
249620|NCT02100007|small cell lung cancer|small cell lung cancer
249621|NCT02100007|ovarian cancer|ovarian cancer
249622|NCT02100007|refractory|refractory
249623|NCT02099994|HIV|hiv
249624|NCT02099994|vaccine|vaccine
249625|NCT02099981|Diabetes|diabetes
249626|NCT02099981|Diabetic|diabetic
249627|NCT02099981|Retinopathy|retinopathy
249628|NCT02099981|Ophthalmology|ophthalmology
249629|NCT02099981|Eye|eye
249630|NCT02099981|Eyes|eyes
249631|NCT02099955|spinal cord injury|spinal cord injury
249632|NCT02099955|vitamin D deficiency|vitamin d deficiency
249633|NCT02099955|pulmonary function|pulmonary function
249634|NCT02099955|metabolic diseases|metabolic diseases
249635|NCT02099942|Balloon Aortic Valvuloplasty|balloon aortic valvuloplasty
249636|NCT02099942|Valvuloplasty|valvuloplasty
249637|NCT02099942|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
249638|NCT02099942|Surgical Aortic Valve Replacement|surgical aortic valve replacement
249639|NCT02099929|Coffee|coffee
249640|NCT02099929|Glucose|glucose
249641|NCT02099929|Insulin|insulin
249642|NCT02099929|Diabetes|diabetes
249643|NCT02099929|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
249644|NCT02099916|DHEA, pregnancy, ovarian reserve, AMH|dhea, pregnancy, ovarian reserve, amh
249645|NCT02099903|Heart Failure|heart failure
249646|NCT02099903|Heart Failure, Systolic|heart failure, systolic
249647|NCT02099903|Chagas Disease|chagas disease
249648|NCT02099903|Chagas Cardiomyopathy|chagas cardiomyopathy
249649|NCT02099903|Renal Denervation|renal denervation
249650|NCT02099903|Irrigated Radiofrequency Catheter|irrigated radiofrequency catheter
249651|NCT02099890|Chronic Inflammation|chronic inflammation
249652|NCT02099890|Spinal Cord Injury|spinal cord injury
249653|NCT02099890|Anti-inflammatory Diet|anti-inflammatory diet
249654|NCT02099890|Neuropathic Pain|neuropathic pain
249655|NCT02099890|Depression|depression
249656|NCT02099890|Cognitive Impairment|cognitive impairment
249657|NCT02099890|Somatic Nerve Function|somatic nerve function
249658|NCT02099890|Autonomic Nerve Function|autonomic nerve function
249659|NCT02099877|µ-opioid receptor polymorphism|µ-opioid receptor polymorphism
249660|NCT02099877|Opioids|opioids
249661|NCT02099877|Opioid analgesia|opioid analgesia
249662|NCT02099877|Labor analgesia|labor analgesia
249663|NCT02099838|Pioglitazone|pioglitazone
249664|NCT02099838|Metformin|metformin
249665|NCT02099838|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
249666|NCT02099825|adult male|adult male
249667|NCT02099825|anxiety|anxiety
249668|NCT02099825|public speaking|public speaking
249669|NCT02099825|healthy controls|healthy controls
249670|NCT02099825|exposure therapy|exposure therapy
249671|NCT02099825|social anxiety|social anxiety
249672|NCT02099825|mifepristone|mifepristone
249673|NCT02099825|d-cycloserine|d-cycloserine
249674|NCT02099799|Physical Activity|physical activity
249675|NCT02099799|COPD Self-Management|copd self-management
249676|NCT02099799|Internet|internet
249677|NCT02099799|6-Minute Walk Test|6-minute walk test
249678|NCT02099799|COPD Exacerbation|copd exacerbation
249679|NCT02099799|Health-related Quality of Life|health-related quality of life
249680|NCT02099786|hearing|hearing
249681|NCT02099786|cisplatin|cisplatin
249682|NCT02099786|Ototoxicity|ototoxicity
249683|NCT02099786|Veterans|veterans
249684|NCT02099773|AAC|aac
249685|NCT02099773|support worker|support worker
249686|NCT02099773|direct care staff|direct care staff
249687|NCT02099773|intellectual disability|intellectual disability
249688|NCT02099773|learning disability|learning disability
249689|NCT02099773|communication|communication
249690|NCT02099773|adults|adults
249691|NCT02099760|gonorrhea|gonorrhea
249692|NCT02099760|chlamydia|chlamydia
249693|NCT02099760|trichomonas|trichomonas
249694|NCT02099747|Aplastic Anaemia|aplastic anaemia
249695|NCT02099747|Eltrombopag|eltrombopag
249696|NCT02099747|HATG|hatg
249697|NCT02099747|ATGAM|atgam
249698|NCT02099734|14-016|14-016
249699|NCT02099721|Sudden Cardiac Arrest (SCA)|sudden cardiac arrest (sca)
249700|NCT02099721|Syncope|syncope
249701|NCT02099721|NSVT|nsvt
249702|NCT02099721|PVC|pvc
249703|NCT02099721|LVEF|lvef
249704|NCT02099721|Primary Prevention|primary prevention
249705|NCT02099721|Secondary Prevention|secondary prevention
249706|NCT02099721|ATP|atp
249707|NCT02099721|shock|shock
249708|NCT02099721|appropriate therapy|appropriate therapy
249709|NCT02099708|Pharmacological therapy|pharmacological therapy
249710|NCT02099695|Hyperhidrosis|hyperhidrosis
249711|NCT02099695|Oxybutynin|oxybutynin
249712|NCT02099682|Pharmacological therapy|pharmacological therapy
249713|NCT02099604|Hepatitis C - Genotype 4|hepatitis c - genotype 4
249714|NCT02099604|SVR (Sustained Virological Response)|svr (sustained virological response)
249715|NCT02099604|Vitamin D|vitamin d
249716|NCT02099604|Treatment Naïve|treatment naïve
249717|NCT02099591|Constipation|constipation
249718|NCT02099591|Colonic Inertia|colonic inertia
249719|NCT02099591|Dyschezia|dyschezia
249720|NCT02099591|Pharmacokinetics|pharmacokinetics
249721|NCT02099591|Naloxegol|naloxegol
249722|NCT02099591|Paediatric|paediatric
249723|NCT02099591|Opioids|opioids
249724|NCT02099591|Opioid induced constipation|opioid induced constipation
249725|NCT02099591|OIC|oic
249726|NCT02099591|Phase 1|phase 1
249727|NCT02099578|Blood pressure|blood pressure
249728|NCT02099578|Arterial stiffness|arterial stiffness
249729|NCT02099578|Pulse wave velocity|pulse wave velocity
249730|NCT02099578|Strawberries|strawberries
249731|NCT02099578|Endothelial function|endothelial function
249732|NCT02099578|Oxidative stress|oxidative stress
249733|NCT02099578|Postmenopausal women|postmenopausal women
249734|NCT02099565|Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)|major adverse cardiovascular and cerebrovascular events (macce)
249735|NCT02099565|Statins|statins
249736|NCT02099565|LDL-cholesterol|ldl-cholesterol
249737|NCT02099565|Inflammatory markers|inflammatory markers
249738|NCT02099565|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
249739|NCT02099552|X-Linked hypohidrotic ectodermal dysplasia|x-linked hypohidrotic ectodermal dysplasia
249740|NCT02099552|XLHED|xlhed
249741|NCT02099552|Hypohidrotic ectodermal dysplasia|hypohidrotic ectodermal dysplasia
249742|NCT02099552|HED|hed
249743|NCT02099552|Christ-Siemens-Touraine syndrome|christ-siemens-touraine syndrome
249744|NCT02099539|absolute lymphocyte count|absolute lymphocyte count
249745|NCT02099539|antitumor|antitumor
249746|NCT02099539|cancer|cancer
249747|NCT02099539|immunotherapy|immunotherapy
249748|NCT02099539|immunochemotherapy|immunochemotherapy
249749|NCT02099539|interleukin-15|interleukin-15
249750|NCT02099539|multiple myeloma|multiple myeloma
249751|NCT02099539|NK cell|nk cell
249752|NCT02099539|refractory|refractory
249753|NCT02099539|relapsed|relapsed
249754|NCT02099539|T cell|t cell
249755|NCT02099539|white blood cell count|white blood cell count
249756|NCT02099526|cancer|cancer
249757|NCT02099526|caregiver|caregiver
249758|NCT02099526|caregiving|caregiving
249759|NCT02099526|care give|care give
249760|NCT02099526|elderly|elderly
249761|NCT02099526|older adults|older adults
249762|NCT02099526|unmet needs|unmet needs
249763|NCT02099526|post-discharge|post-discharge
249764|NCT02099526|cancer symptoms|cancer symptoms
249765|NCT02099513|Mobile Technology|mobile technology
249766|NCT02099513|Chronic illness|chronic illness
249767|NCT02099513|Wireless blood pressure device|wireless blood pressure device
249768|NCT02099513|Wireless scale|wireless scale
249769|NCT02099513|Pedometer|pedometer
249770|NCT02099500|Critical Limb Ischemia|critical limb ischemia
249771|NCT02099500|Peripheral Vascular Disease|peripheral vascular disease
249772|NCT02099500|Lower Limb Ulcer|lower limb ulcer
249773|NCT02099500|Gangrene|gangrene
249774|NCT02099500|Amputation|amputation
249775|NCT02099500|Lower Limb Wound|lower limb wound
249776|NCT02099487|HGG|hgg
249777|NCT02099474|HIV-1|hiv-1
249778|NCT02099474|HIV mother to child prevention|hiv mother to child prevention
249779|NCT02099474|Raltegravir|raltegravir
249780|NCT02099474|Pharmacokinetic|pharmacokinetic
249781|NCT02099435|Gastriointestinal|gastriointestinal
249782|NCT02099435|Lower gastriointestinal|lower gastriointestinal
249783|NCT02099435|Digestive|digestive
249784|NCT02099435|Hemostasis|hemostasis
249785|NCT02099435|Recurrent bleeding|recurrent bleeding
249786|NCT02099435|Hemospray|hemospray
249787|NCT02099409|Type 1 diabetes mellitus|type 1 diabetes mellitus
249788|NCT02099409|children|children
249789|NCT02099409|closed loop|closed loop
249790|NCT02099409|cross over|cross over
249791|NCT02099409|overnight|overnight
249792|NCT02099409|FLORENCED2|florenced2
249891|NCT02098902|Obesity|obesity
249793|NCT02099409|DANA Diabecare R pump|dana diabecare r pump
249794|NCT02099409|FreeStyle Navigator II|freestyle navigator ii
249795|NCT02099409|Dexcom G4|dexcom g4
249796|NCT02099396|PFS,efficacy and safety,lobaplatin and gemcitabine in combination, second-line treatments on advanced osteosarcoma|pfs,efficacy and safety,lobaplatin and gemcitabine in combination, second-line treatments on advanced osteosarcoma
249797|NCT02099383|Stroke|stroke
249798|NCT02099383|Dehydration|dehydration
249799|NCT02099383|Fluid Therapy|fluid therapy
249800|NCT02099370|Multiple Sclerosis|multiple sclerosis
249801|NCT02099370|Tecfidera(R)|tecfidera(r)
249802|NCT02099370|Oral medication|oral medication
249803|NCT02099370|Adherence|adherence
249804|NCT02099331|Atrial Fibrillation|atrial fibrillation
249805|NCT02099331|Reactive Oxygen Species|reactive oxygen species
249806|NCT02099331|Cardiac Surgery|cardiac surgery
249807|NCT02099318|Rehearsal Platform|rehearsal platform
249808|NCT02099305|Adolescent; Depression|adolescent; depression
249809|NCT02099305|Early intervention (education)|early intervention (education)
249810|NCT02099305|Randomized Controlled Trial|randomized controlled trial
249811|NCT02099305|Primary Prevention|primary prevention
249812|NCT02099305|schools|schools
249813|NCT02099305|Health Literacy|health literacy
249814|NCT02099305|Discrimination (Psychology)|discrimination (psychology)
249815|NCT02099305|Mental Health Services|mental health services
249816|NCT02099292|lymphoma|lymphoma
249817|NCT02099292|high dose therapy|high dose therapy
249818|NCT02099292|DexaBEAM|dexabeam
249819|NCT02099292|Rituximab|rituximab
249820|NCT02099292|role of alternative salvage treatment - dexaBEAM|role of alternative salvage treatment - dexabeam
249821|NCT02099266|Umbilical Cord Blood (UCB) Stem Cell Transplant|umbilical cord blood (ucb) stem cell transplant
249822|NCT02099266|Hyperbaric oxygen|hyperbaric oxygen
249823|NCT02099266|Leukemia|leukemia
249824|NCT02099266|Lymphoma|lymphoma
249825|NCT02099266|MDS|mds
249826|NCT02099253|Age|age
249827|NCT02099253|Pharmacodynamics|pharmacodynamics
249828|NCT02099253|dexmedetomidine|dexmedetomidine
249829|NCT02099240|Osteomyelitis|osteomyelitis
249830|NCT02099240|IV Antibiotics|iv antibiotics
249831|NCT02099240|Oral Antibiotics|oral antibiotics
249832|NCT02099227|pediatric|pediatric
249833|NCT02099227|soft tissue infections|soft tissue infections
249834|NCT02099227|ultrasonography|ultrasonography
249835|NCT02099227|effectiveness|effectiveness
249836|NCT02099214|myocardial iron overload|myocardial iron overload
249837|NCT02099214|HFE-Associated Hereditary Hemochromatosis|hfe-associated hereditary hemochromatosis
249838|NCT02099214|3 Tesla MRI|3 tesla mri
249839|NCT02099214|cardiological strategy in haemochromatosis|cardiological strategy in haemochromatosis
249840|NCT02099214|congestive heart failure|congestive heart failure
249841|NCT02099201|ACT-389949|act-389949
249842|NCT02099162|OCT|oct
249843|NCT02099162|Coronary|coronary
249844|NCT02099162|Stenting|stenting
249845|NCT02099149|Group B Streptococcus|group b streptococcus
249846|NCT02099149|early onset disease|early onset disease
249847|NCT02099149|late onset disease|late onset disease
249848|NCT02099149|anticapsular antibodies|anticapsular antibodies
249849|NCT02099149|serotype specific|serotype specific
249850|NCT02099123|Survival|survival
249851|NCT02099123|Functional Disability|functional disability
249852|NCT02099123|Cardiovascular Disease|cardiovascular disease
249853|NCT02099123|Diabetes|diabetes
249854|NCT02099123|Dementia|dementia
249855|NCT02099123|Cancer|cancer
249856|NCT02099097|3D Coping Skills Game|3d coping skills game
249857|NCT02099097|Quit smoking|quit smoking
249858|NCT02099097|14-062|14-062
249859|NCT02099071|ACT-389949|act-389949
249860|NCT02099058|Cancer|cancer
249861|NCT02099058|Advanced Solid Tumor|advanced solid tumor
249862|NCT02099058|Neoplasm|neoplasm
249863|NCT02099032|nutrition|nutrition
249864|NCT02099032|milk|milk
249865|NCT02099032|polar lipids|polar lipids
249866|NCT02099032|cardiometabolic risk|cardiometabolic risk
249867|NCT02099019|Coronary CT angiography; Revascularization; Decision-making|coronary ct angiography; revascularization; decision-making
249868|NCT02098993|Sickle cell disease|sickle cell disease
249869|NCT02098993|Acute chest syndrome|acute chest syndrome
249870|NCT02098993|Hemoglobinopathy|hemoglobinopathy
249871|NCT02098993|Hemolytic anemia|hemolytic anemia
249872|NCT02098993|Heparin|heparin
249873|NCT02098993|Anticoagulant|anticoagulant
249874|NCT02098954|TKI|tki
249875|NCT02098954|resistance|resistance
249876|NCT02098954|erlotinib|erlotinib
249877|NCT02098954|combined chemotherapy|combined chemotherapy
249878|NCT02098941|topiramate|topiramate
249879|NCT02098941|oxcarbazepine|oxcarbazepine
249880|NCT02098941|levetiracetam|levetiracetam
249881|NCT02098941|retention rate|retention rate
249882|NCT02098928|Acupuncture|acupuncture
249883|NCT02098928|Electro acupuncture|electro acupuncture
249884|NCT02098928|Menopause|menopause
249885|NCT02098915|gastroschisis|gastroschisis
249886|NCT02098915|intestinal motility|intestinal motility
249887|NCT02098915|prokinetic agents|prokinetic agents
249888|NCT02098915|intravenous metoclopramide|intravenous metoclopramide
249889|NCT02098915|time to full enteral feeding|time to full enteral feeding
249890|NCT02098902|Overweight|overweight
249892|NCT02098902|Overnutrition|overnutrition
249893|NCT02098902|Weight Loss|weight loss
249894|NCT02098902|Body Weight|body weight
249895|NCT02098902|Nutrition Disorders|nutrition disorders
249896|NCT02098889|Cervix, active phase of labor, Hyoscine-N-Butylbromide (HBB)|cervix, active phase of labor, hyoscine-n-butylbromide (hbb)
249897|NCT02098876|neointimal tissue area|neointimal tissue area
249898|NCT02098876|angulated coronary vessels|angulated coronary vessels
249899|NCT02098876|wall shear stress|wall shear stress
249900|NCT02098876|zotarolimus eluting stent|zotarolimus eluting stent
249901|NCT02098876|everolimus eluting stent|everolimus eluting stent
249902|NCT02098863|Sickle Cell Anemia|sickle cell anemia
249903|NCT02098863|Sickle Cell Disease|sickle cell disease
249904|NCT02098863|Survival|survival
249905|NCT02098863|Mortality|mortality
249906|NCT02098863|End-Order Dysfunction|end-order dysfunction
249907|NCT02098850|Staphylococcus aureus|staphylococcus aureus
249908|NCT02098850|bloodstream infection|bloodstream infection
249909|NCT02098850|bacteremia|bacteremia
249910|NCT02098837|HIV|hiv
249911|NCT02098824|vascular cognitive impairment|vascular cognitive impairment
249912|NCT02098824|treatment|treatment
249913|NCT02098824|cerebrovascular lesions|cerebrovascular lesions
249914|NCT02098824|memory impairment|memory impairment
249915|NCT02098824|executive dysfunction|executive dysfunction
249916|NCT02098824|neuronal networks|neuronal networks
249917|NCT02098824|white matter tracts|white matter tracts
249918|NCT02098824|monoaminergic systems|monoaminergic systems
249919|NCT02098824|cholinergic systems|cholinergic systems
249920|NCT02098824|DTI|dti
249921|NCT02098824|rs-fMRI|rs-fmri
249922|NCT02098798|Dysplasia, Inflammatory Bowel Disease|dysplasia, inflammatory bowel disease
249923|NCT02098785|VAP|vap
249924|NCT02098785|liver|liver
249925|NCT02098785|hepatology|hepatology
249926|NCT02098785|caffeine|caffeine
249927|NCT02098772|aortic valve disease|aortic valve disease
249928|NCT02098772|coronary bypass surgery|coronary bypass surgery
249929|NCT02098772|cardioplegic solutions|cardioplegic solutions
249930|NCT02098759|TSC|tsc
249931|NCT02098759|tuberous sclerosis complex|tuberous sclerosis complex
249932|NCT02098759|epilepsy|epilepsy
249933|NCT02098746|Pharmacological therapy|pharmacological therapy
249934|NCT02098733|Pharmacological therapy|pharmacological therapy
249935|NCT02098707|Stabilometric Platform|stabilometric platform
249936|NCT02098707|Rehabilitation|rehabilitation
249937|NCT02098707|Balance Disorders|balance disorders
249938|NCT02098707|Falls|falls
249939|NCT02098694|Physiotherapy|physiotherapy
249940|NCT02098694|Outpatient clinic|outpatient clinic
249941|NCT02098681|Pectus Excavatum|pectus excavatum
249942|NCT02098668|menstrual cycle dynamics|menstrual cycle dynamics
249943|NCT02098668|PCOS|pcos
249944|NCT02098668|hyperprolactinemia|hyperprolactinemia
249945|NCT02098668|endometriosis|endometriosis
249946|NCT02098668|infertility|infertility
249947|NCT02098655|Stabilometric Platform|stabilometric platform
249948|NCT02098655|Postural instability|postural instability
249949|NCT02098642|Gait Disturbances|gait disturbances
249950|NCT02098642|Metatarsophalangeal joint|metatarsophalangeal joint
249951|NCT02098629|Myocardial infarction|myocardial infarction
249952|NCT02098629|myocardial ischemia|myocardial ischemia
249953|NCT02098629|reperfusion injury|reperfusion injury
249954|NCT02098616|Hepatitis|hepatitis
249955|NCT02098616|Hepatitis, Chronic|hepatitis, chronic
249956|NCT02098616|Hepatitis C|hepatitis c
249957|NCT02098616|Hepatitis C, Chronic|hepatitis c, chronic
249958|NCT02098616|Liver Diseases|liver diseases
249959|NCT02098616|Digestive System Diseases|digestive system diseases
249960|NCT02098616|Hepatitis, Viral, Human|hepatitis, viral, human
249961|NCT02098616|RNA Virus Infections|rna virus infections
249962|NCT02098616|Antiviral Agents|antiviral agents
249963|NCT02098616|Drug Resistance, Viral|drug resistance, viral
249964|NCT02098590|Malaria|malaria
249965|NCT02098590|Plasmodium falciparum|plasmodium falciparum
249966|NCT02098577|Balance|balance
249967|NCT02098564|hand therapy|hand therapy
249968|NCT02098564|activity-based training|activity-based training
249969|NCT02098564|hand related injuries|hand related injuries
249970|NCT02098564|sense of coherence|sense of coherence
249971|NCT02098551|atopic dermatitis|atopic dermatitis
249972|NCT02098551|bet v 1|bet v 1
249973|NCT02098551|bet v 1 fragments|bet v 1 fragments
249974|NCT02098551|allergy|allergy
249975|NCT02098538|Regorafenib|regorafenib
249976|NCT02098538|13-244|13-244
249977|NCT02098525|Cryptococcal meningitis|cryptococcal meningitis
249978|NCT02098525|HIV/AIDS|hiv/aids
249979|NCT02098525|Antiretroviral therapy|antiretroviral therapy
249980|NCT02098525|Prognosis|prognosis
249981|NCT02098525|Thailand|thailand
249982|NCT02098512|Brentuximab Vedotin|brentuximab vedotin
249983|NCT02098512|Immunotherapy|immunotherapy
249984|NCT02098512|Relapsed Hodgkin Lymphoma|relapsed hodgkin lymphoma
249985|NCT02098512|Refractory Hodgkin Lymphoma|refractory hodgkin lymphoma
249986|NCT02098512|Reduced Intensity Conditioning|reduced intensity conditioning
249987|NCT02098512|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
249988|NCT02098486|Bile duct obstruction|bile duct obstruction
249989|NCT02098486|Cholangitis|cholangitis
249990|NCT02098486|Moxifloxacin|moxifloxacin
249991|NCT02098486|Ceftriaxone|ceftriaxone
249992|NCT02098486|Sepsis|sepsis
249993|NCT02098460|the Achilles tendon|the achilles tendon
249994|NCT02098460|intima-media thickness|intima-media thickness
249995|NCT02098447|vagus nerve stimulation effects on heart rate variability and peripheral blood perfusion|vagus nerve stimulation effects on heart rate variability and peripheral blood perfusion
249996|NCT02098421|Induction of Labor|induction of labor
249997|NCT02098421|Pitocin|pitocin
249998|NCT02098421|Oxytocin|oxytocin
249999|NCT02098421|Foley bulb|foley bulb
250000|NCT02098408|Ultra-high risk psychosis|ultra-high risk psychosis
250001|NCT02098408|Schizophrenia prodrome|schizophrenia prodrome
250002|NCT02098408|Cognitive remediation|cognitive remediation
250003|NCT02098382|Cervical ripening|cervical ripening
250004|NCT02098369|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
250005|NCT02098369|Supplemental oxygen|supplemental oxygen
250006|NCT02098369|Adherence|adherence
250007|NCT02098369|Telephonic education|telephonic education
250008|NCT02098369|Peer coaching|peer coaching
250009|NCT02098356|hemodialysis|hemodialysis
250010|NCT02098356|dialysis|dialysis
250011|NCT02098356|acidosis|acidosis
250012|NCT02098356|bicarbonate|bicarbonate
250013|NCT02098343|Ovarian cancer|ovarian cancer
250014|NCT02098343|Ovarian carcinoma|ovarian carcinoma
250015|NCT02098343|High Grade Serous Ovarian Cancer|high grade serous ovarian cancer
250016|NCT02098343|Recurrent Cancer|recurrent cancer
250017|NCT02098343|Resistant Cancer|resistant cancer
250018|NCT02098330|Vestibular neuritis|vestibular neuritis
250019|NCT02098330|Vertigo|vertigo
250020|NCT02098330|Head impulse test|head impulse test
250021|NCT02098330|Steroid|steroid
250022|NCT02098317|NAFLD|nafld
250023|NCT02098317|NASH|nash
250024|NCT02098317|DHA|dha
250025|NCT02098317|VITAMIN D|vitamin d
250026|NCT02098317|OBESITY|obesity
250027|NCT02098317|CHILDREN|children
250028|NCT02098304|Caries|caries
250029|NCT02098304|ICDAS|icdas
250030|NCT02098304|Lesion activity|lesion activity
250031|NCT02098304|Demineralisation|demineralisation
250032|NCT02098304|Imaging|imaging
250033|NCT02098265|aneurysm|aneurysm
250034|NCT02098265|transient ischemic attack|transient ischemic attack
250035|NCT02098252|brain arteriovenous malformation|brain arteriovenous malformation
250036|NCT02098252|Arteriovenous Malformations|arteriovenous malformations
250037|NCT02098252|AVM|avm
250038|NCT02098252|BAVM|bavm
250039|NCT02098252|Stroke|stroke
250040|NCT02098252|Intracranial Hemorrhage|intracranial hemorrhage
250041|NCT02098252|Congenital Abnormalities|congenital abnormalities
250042|NCT02098252|Aneurysm|aneurysm
250043|NCT02098252|Vascular Malformations|vascular malformations
250044|NCT02098252|Cardiovascular Abnormalities|cardiovascular abnormalities
250045|NCT02098252|Cardiovascular Diseases|cardiovascular diseases
250046|NCT02098252|Vascular Diseases|vascular diseases
250047|NCT02098213|plaque psoriasis|plaque psoriasis
250048|NCT02098213|DLQI|dlqi
250049|NCT02098213|VQ Dermato|vq dermato
250050|NCT02098213|PASI|pasi
250051|NCT02098213|PASI change|pasi change
250052|NCT02098213|phototherapy|phototherapy
250053|NCT02098213|balneotherapy|balneotherapy
250054|NCT02098213|hydrotherapy|hydrotherapy
250055|NCT02098213|Euroquol EQ 5d scale|euroquol eq 5d scale
250056|NCT02098213|Visual analogic scale|visual analogic scale
250057|NCT02098213|SPA treatment Scale|spa treatment scale
250058|NCT02098213|PSS|pss
250059|NCT02098200|tricuspid|tricuspid
250060|NCT02098200|regurgitation|regurgitation
250061|NCT02098200|repair|repair
250062|NCT02098200|outcomes|outcomes
250063|NCT02098187|Glomerular Filtration Rate|glomerular filtration rate
250064|NCT02098187|Acute Kidney Injury|acute kidney injury
250065|NCT02098174|Glomerular Filtration Rate|glomerular filtration rate
250066|NCT02098174|Acute kidney injury|acute kidney injury
250067|NCT02098161|Leukemia|leukemia
250068|NCT02098161|Primary Myelofibrosis|primary myelofibrosis
250069|NCT02098161|PMF|pmf
250070|NCT02098161|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
250071|NCT02098161|Post-PV MF|post-pv mf
250072|NCT02098161|Post-Essential Thrombocytosis Myelofibrosis|post-essential thrombocytosis myelofibrosis
250073|NCT02098161|Post-ET MF|post-et mf
250074|NCT02098161|LCL-161|lcl-161
250075|NCT02098161|Questionnaire|questionnaire
250076|NCT02098161|Survey|survey
250077|NCT02098161|Phone Call|phone call
250078|NCT02098096|knee|knee
250079|NCT02098096|arthritis|arthritis
250080|NCT02098096|Veterans|veterans
250081|NCT02098096|strength|strength
250082|NCT02098096|exercise|exercise
250083|NCT02098096|muscle|muscle
250084|NCT02098083|acute|acute
250085|NCT02098083|stroke|stroke
250086|NCT02098083|gait|gait
250087|NCT02098070|Knee Pain|knee pain
250088|NCT02098070|Community Study|community study
250089|NCT02098070|Knee Osteoarthritis|knee osteoarthritis
250090|NCT02098070|Risk Factors|risk factors
250091|NCT02098057|IBS-diarrhea|ibs-diarrhea
250092|NCT02098044|knee osteoarthritis|knee osteoarthritis
250093|NCT02098044|epidemiology|epidemiology
250094|NCT02098044|risk factors|risk factors
250095|NCT02098044|prevalence|prevalence
250096|NCT02098044|professional football|professional football
250097|NCT02098031|Child Nutrition Sciences|child nutrition sciences
250098|NCT02098031|Growth and Development|growth and development
250099|NCT02098031|Developing Countries|developing countries
250100|NCT02097992|COPD|copd
250101|NCT02097992|airway blood flow|airway blood flow
250102|NCT02097979|glaucoma|glaucoma
250103|NCT02097979|adherence|adherence
250104|NCT02097979|medication possession ratio|medication possession ratio
250105|NCT02097979|intervention|intervention
250106|NCT02097953|Daptomycin|daptomycin
250107|NCT02097953|Rifampin|rifampin
250108|NCT02097953|P-glycoprotein|p-glycoprotein
250109|NCT02097953|Pharmacokinetic|pharmacokinetic
250110|NCT02097940|Postural balance|postural balance
250111|NCT02097940|Athletes|athletes
250112|NCT02097940|Sports|sports
250113|NCT02097940|Soccer|soccer
250114|NCT02097940|Physiotherapy|physiotherapy
250115|NCT02097927|Appetite|appetite
250116|NCT02097927|Satiety|satiety
250117|NCT02097927|Energy intake|energy intake
250118|NCT02097927|Saliva|saliva
250119|NCT02097927|Biomarkers|biomarkers
250120|NCT02097914|Secondhand smoke exposure|secondhand smoke exposure
250121|NCT02097914|Secondhand smoke|secondhand smoke
250122|NCT02097914|Environmental Tobacco Smoke|environmental tobacco smoke
250123|NCT02097914|Smoke-free homes|smoke-free homes
250124|NCT02097914|Smoke-free homes ban|smoke-free homes ban
250125|NCT02097901|Rotator Cuff|rotator cuff
250126|NCT02097901|Injury|injury
250127|NCT02097901|Repair|repair
250128|NCT02097901|Microfracture|microfracture
250129|NCT02097901|Healing|healing
250130|NCT02097875|Skin cancer|skin cancer
250131|NCT02097875|Basal cell carcinoma|basal cell carcinoma
250132|NCT02097875|Squamous cell carcinoma|squamous cell carcinoma
250133|NCT02097875|Melanoma|melanoma
250134|NCT02097862|Degenerative Disc Disease|degenerative disc disease
250135|NCT02097862|Disc Disease|disc disease
250136|NCT02097862|Back pain|back pain
250137|NCT02097862|stem cells|stem cells
250138|NCT02097862|adipose stem cells|adipose stem cells
250139|NCT02097862|ADSCs|adscs
250140|NCT02097849|vaccine|vaccine
250141|NCT02097849|pneumococcal|pneumococcal
250142|NCT02097849|meningococcal|meningococcal
250143|NCT02097849|tetanus diphtheria|tetanus diphtheria
250144|NCT02097849|immune response|immune response
250145|NCT02097836|postural control|postural control
250146|NCT02097836|Targeted Training|targeted training
250147|NCT02097836|cerebral palsy|cerebral palsy
250148|NCT02097836|trunk segments|trunk segments
250149|NCT02097823|olanzapine|olanzapine
250150|NCT02097823|Nausea and vomiting|nausea and vomiting
250151|NCT02097823|aprepitant|aprepitant
250152|NCT02097823|pediatrics|pediatrics
250153|NCT02097797|Inflammatory bowel disease|inflammatory bowel disease
250154|NCT02097797|Crohn's disease|crohn's disease
250155|NCT02097797|microbiota|microbiota
250156|NCT02097797|fecal transplantation|fecal transplantation
250157|NCT02097784|cirrhosis|cirrhosis
250158|NCT02097784|hepatorenal syndrome|hepatorenal syndrome
250159|NCT02097784|acute kidney injury|acute kidney injury
250160|NCT02097784|diastolic function|diastolic function
250161|NCT02097771|laryngeal mask airway ventilation|laryngeal mask airway ventilation
250162|NCT02097732|Metastatic melanoma|metastatic melanoma
250163|NCT02097732|Brain metastases|brain metastases
250164|NCT02097732|Radiation therapy|radiation therapy
250165|NCT02097732|Immune therapy|immune therapy
250166|NCT02097706|Boderline Personality Disorder|boderline personality disorder
250167|NCT02097706|Mental Illness|mental illness
250168|NCT02097706|Cognition|cognition
250169|NCT02097693|DBS|dbs
250170|NCT02097693|quality of life|quality of life
250171|NCT02097693|dystonia|dystonia
250172|NCT02097693|dyskinetic cerebral palsy|dyskinetic cerebral palsy
250173|NCT02097680|with disturbed glucose metabolism|with disturbed glucose metabolism
250174|NCT02097680|without disturbed glucose metabolism|without disturbed glucose metabolism
250175|NCT02097667|Severe early onset Fetal Growth Restrictions|severe early onset fetal growth restrictions
250176|NCT02097654|Hospital acquired|hospital acquired
250177|NCT02097654|Elderly|elderly
250178|NCT02097641|Allogeneic Bone Marrow-derived Human Mesenchymal Stem Cells|allogeneic bone marrow-derived human mesenchymal stem cells
250179|NCT02097641|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
250180|NCT02097628|volume controlled ventilation|volume controlled ventilation
250181|NCT02097628|pressure controlled ventilation|pressure controlled ventilation
250182|NCT02097615|soft|soft
250183|NCT02097615|tissue|tissue
250184|NCT02097615|infections|infections
250185|NCT02097602|Reticulated platelets|reticulated platelets
250186|NCT02097602|noncardiac surgery|noncardiac surgery
250187|NCT02097602|MACCEs|macces
250188|NCT02097602|major adverse cardiac and cerebrovascular events|major adverse cardiac and cerebrovascular events
250189|NCT02097602|outcome|outcome
250190|NCT02097602|High-risk or intermediate-risk noncardiac surgery|high-risk or intermediate-risk noncardiac surgery
250191|NCT02097589|Health Controls|health controls
250192|NCT02097576|Chronic Rhinosinusitis|chronic rhinosinusitis
250193|NCT02097563|Mood Disorders|mood disorders
250194|NCT02097563|Psychosis|psychosis
250195|NCT02097563|Subthreshold|subthreshold
250196|NCT02097563|Bipolar Disorder|bipolar disorder
250197|NCT02097550|Renal Insufficiency, Chronic|renal insufficiency, chronic
250198|NCT02097550|Kidney Failure, Chronic|kidney failure, chronic
250199|NCT02097550|Self Care|self care
250200|NCT02097550|Consumer Participation|consumer participation
250201|NCT02097550|Patient Participation|patient participation
250202|NCT02097550|Marketing|marketing
250203|NCT02097550|Consumer Health Information|consumer health information
250204|NCT02097511|Drug-drug interaction|drug-drug interaction
250205|NCT02097511|Pharmacokinetics|pharmacokinetics
250206|NCT02097511|Pharmacodynamics|pharmacodynamics
250207|NCT02097498|Simulation|simulation
250208|NCT02097498|Enhance|enhance
250209|NCT02097498|Safety|safety
250210|NCT02097498|Proficiency|proficiency
250211|NCT02097498|Paramedics.|paramedics.
250212|NCT02097498|Airway Management|airway management
250213|NCT02097498|Intubation|intubation
250214|NCT02097459|Breast cancer|breast cancer
250215|NCT02097459|Endocrine therapy|endocrine therapy
250216|NCT02097459|Perimenopausal and recently postmenopausal patients|perimenopausal and recently postmenopausal patients
250217|NCT02097459|Early-stage hormone receptor-positive|early-stage hormone receptor-positive
250218|NCT02097446|cystectomy|cystectomy
250219|NCT02097433|Dacomitinib|dacomitinib
250220|NCT02097433|PF299804|pf299804
250221|NCT02097433|pharmacokinetics|pharmacokinetics
250222|NCT02097433|healthy|healthy
250223|NCT02097433|Chinese|chinese
250224|NCT02097420|Mitral valve|mitral valve
250225|NCT02097381|HIV infection|hiv infection
250226|NCT02097381|GUT|gut
250227|NCT02097381|microbial translocation|microbial translocation
250228|NCT02097381|chronic inflammation|chronic inflammation
250229|NCT02097381|antiretroviral therapy|antiretroviral therapy
250230|NCT02097381|cART|cart
250231|NCT02097381|HAART|haart
250232|NCT02097381|Th17|th17
250233|NCT02097381|Th1|th1
250234|NCT02097381|CD4+|cd4+
250235|NCT02097368|Tongue strength|tongue strength
250236|NCT02097368|neuromuscular|neuromuscular
250237|NCT02097368|swallowing|swallowing
250238|NCT02097355|chronic disease|chronic disease
250239|NCT02097355|patient portal|patient portal
250240|NCT02097355|health information technology|health information technology
250241|NCT02097355|patient provider communication|patient provider communication
250242|NCT02097355|quality improvement|quality improvement
250243|NCT02097342|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
250244|NCT02097342|Insulin sensitivity- hyperinsulinemic euglycemic clamp|insulin sensitivity- hyperinsulinemic euglycemic clamp
250245|NCT02097342|Pancreatic beta cell function|pancreatic beta cell function
250246|NCT02097342|Linagliptin|linagliptin
250247|NCT02097342|Voglibose|voglibose
250248|NCT02097342|Mixed meal test|mixed meal test
250249|NCT02097342|GLP-1 response|glp-1 response
250250|NCT02097329|bioavailability|bioavailability
250251|NCT02097329|antacid|antacid
250252|NCT02097329|rabeprazole|rabeprazole
250253|NCT02097329|famotidine|famotidine
250254|NCT02097329|palbociclib|palbociclib
250255|NCT02097316|Glycemic control|glycemic control
250256|NCT02097316|JewelPump accuracy|jewelpump accuracy
250257|NCT02097303|Prostate Cancer|prostate cancer
250258|NCT02097303|Bone Metastasis|bone metastasis
250259|NCT02097303|Symptomatic|symptomatic
250260|NCT02097303|Androgen Independent|androgen independent
250261|NCT02097303|Hormone Refractory|hormone refractory
250262|NCT02097303|Castrate Resistant|castrate resistant
250263|NCT02097303|AIPC|aipc
250264|NCT02097303|pre-chemotherapy|pre-chemotherapy
250265|NCT02097303|Post-chemotherapy|post-chemotherapy
250266|NCT02097290|Threshold algorithms|threshold algorithms
250267|NCT02097290|CRT-D|crt-d
250268|NCT02097251|Mucopolysaccharidosis Type 7|mucopolysaccharidosis type 7
250269|NCT02097251|Sly syndrome|sly syndrome
250270|NCT02097251|UX003|ux003
250271|NCT02097251|Enzyme Replacement Therapy|enzyme replacement therapy
250272|NCT02097251|rare disease|rare disease
250273|NCT02097251|Lysosomal Storage Disease|lysosomal storage disease
250274|NCT02097251|metabolic disorder|metabolic disorder
250275|NCT02097212|Tracheobronchomalacia|tracheobronchomalacia
250276|NCT02097212|TBM|tbm
250277|NCT02097212|HyperDynamic Airway Collapse|hyperdynamic airway collapse
250278|NCT02097212|HDAC|hdac
250279|NCT02097212|Obstructive Sleep Apnea|obstructive sleep apnea
250280|NCT02097212|OSA|osa
250281|NCT02097199|activity, osteoprotegerin, endocan, atherosclerosis, biomarker|activity, osteoprotegerin, endocan, atherosclerosis, biomarker
250282|NCT02097186|Vascular disease|vascular disease
250283|NCT02097186|Open aortic aneurysm repair|open aortic aneurysm repair
250284|NCT02097186|Endovascular aneurysm repair|endovascular aneurysm repair
250285|NCT02097186|Carotid endartrectomy|carotid endartrectomy
250286|NCT02097186|Lower limb surgical revascularisation|lower limb surgical revascularisation
250287|NCT02097186|Major lower limb amputation|major lower limb amputation
250288|NCT02097160|childhood|childhood
250289|NCT02097160|healthy|healthy
250290|NCT02097160|vitamin D|vitamin d
250291|NCT02097160|bone|bone
250292|NCT02097160|dairy products|dairy products
250293|NCT02097147|Viibryd|viibryd
250294|NCT02097108|HIV infection|hiv infection
250295|NCT02097108|Raltegravir|raltegravir
250296|NCT02097108|Switch|switch
250297|NCT02097108|Hyperlipidemia|hyperlipidemia
250298|NCT02097108|Women|women
250299|NCT02097095|Correlates of risk|correlates of risk
250300|NCT02097095|TB|tb
250301|NCT02097095|Tuberculosis|tuberculosis
250302|NCT02097095|Sub-study|sub-study
250303|NCT02097095|TB-018|tb-018
250304|NCT02097082|Peripheral Arterial Disease|peripheral arterial disease
250305|NCT02097082|Intermittent Claudication|intermittent claudication
250306|NCT02097082|Vascular Diseases|vascular diseases
250307|NCT02097082|Cardiovascular Diseases|cardiovascular diseases
250308|NCT02097082|Superficial Femoral Artery|superficial femoral artery
250309|NCT02097069|Gestational diabetes mellitus|gestational diabetes mellitus
250310|NCT02097069|Myo-inositol|myo-inositol
250311|NCT02097069|D-chiro-inositol|d-chiro-inositol
250312|NCT02097069|Insulin resistance|insulin resistance
250313|NCT02097056|Alzheimer's disease|alzheimer's disease
250314|NCT02097017|lidocaine|lidocaine
250315|NCT02097017|laminaria|laminaria
250316|NCT02097017|dilatation and evacuation|dilatation and evacuation
250317|NCT02097017|pain|pain
250318|NCT02097004|chronic hepatitis B|chronic hepatitis b
250319|NCT02097004|Pegasys|pegasys
250320|NCT02097004|Euvax B|euvax b
250321|NCT02097004|Baracrude|baracrude
250322|NCT02096978|Implant|implant
250323|NCT02096978|Stability|stability
250324|NCT02096978|placement|placement
250325|NCT02096978|Osteotome|osteotome
250326|NCT02096965|Calcium oxalate|calcium oxalate
250327|NCT02096965|Calcium phosphate|calcium phosphate
250328|NCT02096965|Kidney stone|kidney stone
250329|NCT02096952|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
250330|NCT02096952|ADHD|adhd
250331|NCT02096952|Autism spectrum disorder|autism spectrum disorder
250332|NCT02096952|ASD|asd
250333|NCT02096952|High-functioning ASD|high-functioning asd
250334|NCT02096952|Asperger's disorder|asperger's disorder
250335|NCT02096952|Asperger's|asperger's
250336|NCT02096926|Third Molar Extraction|third molar extraction
250337|NCT02096913|Rho-Inhibition|rho-inhibition
250338|NCT02096913|Plasticity|plasticity
250339|NCT02096913|Neurological Function|neurological function
250340|NCT02096913|RhoA|rhoa
250341|NCT02096913|Ibuprofen|ibuprofen
250342|NCT02096913|NSAIDs|nsaids
250343|NCT02096900|Pre-medication|pre-medication
250344|NCT02096900|Pre-operative anxiety|pre-operative anxiety
250345|NCT02096887|education|education
250346|NCT02096887|compliance|compliance
250347|NCT02096887|risk factors|risk factors
250348|NCT02096874|Peripheral retinal ischemia|peripheral retinal ischemia
250349|NCT02096874|ultra wide field fluorescein angiography|ultra wide field fluorescein angiography
250350|NCT02096874|Bevacizumab|bevacizumab
250351|NCT02096848|otitis media|otitis media
250352|NCT02096848|microbiology|microbiology
250353|NCT02096848|vaccines|vaccines
250354|NCT02096835|Postoperative nausea and vomiting|postoperative nausea and vomiting
250355|NCT02096835|Transcutaneous electrical acupoint stimulation|transcutaneous electrical acupoint stimulation
250356|NCT02096835|Gynecological laparoscopic surgery|gynecological laparoscopic surgery
250357|NCT02096835|Tropisetron|tropisetron
250358|NCT02096835|Dexamethasone|dexamethasone
250359|NCT02096822|Facilitated tucking|facilitated tucking
250360|NCT02096822|Non nutritive sucking|non nutritive sucking
250361|NCT02096822|Preterm|preterm
250362|NCT02096822|Pain relief|pain relief
250363|NCT02096809|Bone Conduction|bone conduction
250364|NCT02096809|Hearing loss - conductive|hearing loss - conductive
250365|NCT02096809|Osseointegration|osseointegration
250366|NCT02096809|Prostheses and Implants|prostheses and implants
250367|NCT02096757|Claudication|claudication
250368|NCT02096757|Critical Limb Ischemia|critical limb ischemia
250369|NCT02096757|Endovascular procedure|endovascular procedure
250370|NCT02096757|Atherosclerosis|atherosclerosis
250371|NCT02096679|Phase I, healthy, pharmacokinetics, Mass balance|phase i, healthy, pharmacokinetics, mass balance
250372|NCT02096666|MET Amplified Gastric/ Gastroesophageal Junction/ Esophageal Adenocarcinomas, or other solid tumors|met amplified gastric/ gastroesophageal junction/ esophageal adenocarcinomas, or other solid tumors
250373|NCT02096653|sacroiliac joint|sacroiliac joint
250374|NCT02096653|low back pain|low back pain
250375|NCT02096653|steroid injection|steroid injection
250376|NCT02096627|Cataract, femtosecond laser, FLACS|cataract, femtosecond laser, flacs
250377|NCT02096614|Adoptive cell transfer|adoptive cell transfer
250378|NCT02096614|Cell therapy|cell therapy
250379|NCT02096614|Immunotherapy|immunotherapy
250380|NCT02096614|MAGE-A4|mage-a4
250381|NCT02096614|Esophageal cancer|esophageal cancer
250382|NCT02096614|Melanoma|melanoma
250383|NCT02096614|Head and neck cancer|head and neck cancer
250384|NCT02096614|Ovarian cancer|ovarian cancer
250385|NCT02096614|TCR gene therapy|tcr gene therapy
250386|NCT02096601|Motor fluctuations|motor fluctuations
250387|NCT02096601|levodopa pharmacokinetics|levodopa pharmacokinetics
250388|NCT02096601|levodopa and carbidopa solution|levodopa and carbidopa solution
250389|NCT02096601|continuous subcutaneous delivery|continuous subcutaneous delivery
250590|NCT02095834|Refractory|refractory
250390|NCT02096588|Breast cancer|breast cancer
250391|NCT02096588|Adriamycin|adriamycin
250392|NCT02096588|Simvastatin|simvastatin
250393|NCT02096588|Statin|statin
250394|NCT02096588|Echocardiogram|echocardiogram
250395|NCT02096575|nitrous oxide|nitrous oxide
250396|NCT02096575|pain|pain
250397|NCT02096562|knee welling outpatient compression stockings|knee welling outpatient compression stockings
250398|NCT02096549|cerebral palsy|cerebral palsy
250399|NCT02096549|Botulinum toxin|botulinum toxin
250400|NCT02096549|Propofol|propofol
250401|NCT02096549|Deep sedation|deep sedation
250402|NCT02096549|Bispectral index monitor|bispectral index monitor
250403|NCT02096536|Neonate|neonate
250404|NCT02096536|Vancomycin|vancomycin
250405|NCT02096536|LC/MS-MS|lc/ms-ms
250406|NCT02096536|protein binding|protein binding
250407|NCT02096523|inherited platelet disorders|inherited platelet disorders
250408|NCT02096523|proteome|proteome
250409|NCT02096510|Addison Disease|addison disease
250410|NCT02096510|Adrenal Hyperplasia Congenital|adrenal hyperplasia congenital
250411|NCT02096484|Metacognitive therapy|metacognitive therapy
250412|NCT02096484|mindfulness meditation therapy|mindfulness meditation therapy
250413|NCT02096484|group therapy|group therapy
250414|NCT02096484|generalized anxiety disorder|generalized anxiety disorder
250415|NCT02096484|Group Based Metacognitive Therapy|group based metacognitive therapy
250416|NCT02096484|Group Based Mindfulness Meditation Therapy|group based mindfulness meditation therapy
250417|NCT02096471|Neurofibromatosis Type 1 (Neurofibromas)|neurofibromatosis type 1 (neurofibromas)
250418|NCT02096471|PD-0325901|pd-0325901
250419|NCT02096471|Radiographic Response|radiographic response
250420|NCT02096471|Inoperable Plexiform Neurofibromas|inoperable plexiform neurofibromas
250421|NCT02096458|Drug therapy|drug therapy
250422|NCT02096445|stroke|stroke
250423|NCT02096445|acute|acute
250424|NCT02096445|rehabilitation|rehabilitation
250425|NCT02096445|robot therapy|robot therapy
250426|NCT02096445|hand function|hand function
250427|NCT02096445|fine motor skills|fine motor skills
250428|NCT02096445|neurocognitive|neurocognitive
250429|NCT02096445|sensory|sensory
250430|NCT02096445|Perfetti|perfetti
250431|NCT02096445|haptics|haptics
250432|NCT02096419|clopidogrel|clopidogrel
250433|NCT02096419|platelet reactivity|platelet reactivity
250434|NCT02096419|acute coronary syndrome|acute coronary syndrome
250435|NCT02096419|tailoring therapy|tailoring therapy
250436|NCT02096419|outcome|outcome
250437|NCT02096406|Coronary artery disease|coronary artery disease
250438|NCT02096406|Coronary artery bypass grafting|coronary artery bypass grafting
250439|NCT02096406|angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
250440|NCT02096406|angiotensin receptor blocker|angiotensin receptor blocker
250441|NCT02096406|Surgical valve repair|surgical valve repair
250442|NCT02096406|Valve Replacement|valve replacement
250443|NCT02096380|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
250444|NCT02096380|cycle|cycle
250445|NCT02096380|induction chemotherapy|induction chemotherapy
250446|NCT02096380|docetaxel|docetaxel
250447|NCT02096367|vibrations|vibrations
250448|NCT02096367|stroke|stroke
250449|NCT02096367|posture|posture
250450|NCT02096367|gait|gait
250451|NCT02096367|readaptation|readaptation
250452|NCT02096328|Ventilator Associated Pneumonia (VAP)|ventilator associated pneumonia (vap)
250453|NCT02096328|Lower respiratory infection|lower respiratory infection
250454|NCT02096328|POL7080|pol7080
250455|NCT02096328|Pseudomonas aeruginosa|pseudomonas aeruginosa
250456|NCT02096328|Nosocomial pneumonia|nosocomial pneumonia
250457|NCT02096315|POL7080|pol7080
250458|NCT02096315|Pseudomonas aeruginosa|pseudomonas aeruginosa
250459|NCT02096315|Non cystic fibrosis bronchiectasis|non cystic fibrosis bronchiectasis
250460|NCT02096315|Exacerbation|exacerbation
250461|NCT02096302|Probiotics|probiotics
250462|NCT02096302|Infant Formula|infant formula
250463|NCT02096302|Microbiota|microbiota
250464|NCT02096302|Bifidobacterium longum biovar infantis CECT7210|bifidobacterium longum biovar infantis cect7210
250465|NCT02096302|Growth|growth
250466|NCT02096289|Relapsed Acute Myeloid Leukemia|relapsed acute myeloid leukemia
250467|NCT02096289|Refractory Acute Myeloid Leukemia|refractory acute myeloid leukemia
250468|NCT02096289|Thioridazine|thioridazine
250469|NCT02096289|Phase I|phase i
250470|NCT02096289|Clinical Trial|clinical trial
250471|NCT02096276|Pregnancy Registry|pregnancy registry
250472|NCT02096276|Boostrix|boostrix
250473|NCT02096276|Women|women
250474|NCT02096276|Cohort|cohort
250475|NCT02096276|Prospective|prospective
250476|NCT02096276|Pregnancy outcome|pregnancy outcome
250477|NCT02096276|Exploratory|exploratory
250478|NCT02096263|Infants|infants
250479|NCT02096263|Safety|safety
250480|NCT02096263|Healthy|healthy
250481|NCT02096263|Infanrix Hexa|infanrix hexa
250482|NCT02096263|Immunogenicity|immunogenicity
250483|NCT02096237|asthma, bronchial|asthma, bronchial
250484|NCT02096237|immunoadsorbents|immunoadsorbents
250485|NCT02096237|apheresis|apheresis
250486|NCT02096237|immunoglobulin E|immunoglobulin e
250487|NCT02096211|Total hip replacement|total hip replacement
250488|NCT02096211|Total hip arthroplasty|total hip arthroplasty
250591|NCT02095834|Carfilzomib|carfilzomib
250489|NCT02096211|Hip joint replacement|hip joint replacement
250490|NCT02096211|Hip prosthesis replacement|hip prosthesis replacement
250491|NCT02096198|Total Hip Replacement|total hip replacement
250492|NCT02096198|Total Hip Arthroplasty|total hip arthroplasty
250493|NCT02096198|Hip Joint Replacement|hip joint replacement
250494|NCT02096198|Hip Prosthesis Replacement|hip prosthesis replacement
250495|NCT02096185|Breast cancer|breast cancer
250496|NCT02096185|Surgery|surgery
250497|NCT02096185|Specimen imaging|specimen imaging
250498|NCT02096159|Hypospadias|hypospadias
250499|NCT02096159|Anti-Bacterial Agents|anti-bacterial agents
250500|NCT02096146|Plate|plate
250501|NCT02096146|Hallux valgus|hallux valgus
250502|NCT02096146|Foot deformity|foot deformity
250503|NCT02096146|Screw|screw
250504|NCT02096146|Tarsometatarsal angle|tarsometatarsal angle
250505|NCT02096146|Cost effectiveness|cost effectiveness
250506|NCT02096133|Multiple sclerosis, vitamin D, HPA-axis, cortisol|multiple sclerosis, vitamin d, hpa-axis, cortisol
250507|NCT02096120|Periodontitis|periodontitis
250508|NCT02096107|Everolimus|everolimus
250509|NCT02096107|Graft dysfunction|graft dysfunction
250510|NCT02096107|Interstitial fibrosis|interstitial fibrosis
250511|NCT02096094|Antiseptics|antiseptics
250512|NCT02096094|Administration cutaneously|administration cutaneously
250513|NCT02096094|Chlorine compounds|chlorine compounds
250514|NCT02096094|Infection control|infection control
250515|NCT02096094|Anti-infecting agents, local|anti-infecting agents, local
250516|NCT02096081|Glabellar Frown Lines|glabellar frown lines
250517|NCT02096081|Frown Lines|frown lines
250518|NCT02096081|Facial Wrinkles|facial wrinkles
250519|NCT02096068|Neuroprotection|neuroprotection
250520|NCT02096055|Leukemia|leukemia
250521|NCT02096055|Acute Myeloid Leukemia|acute myeloid leukemia
250522|NCT02096055|AML|aml
250523|NCT02096055|Elderly|elderly
250524|NCT02096055|SGI-110|sgi-110
250525|NCT02096055|Idarubicin|idarubicin
250526|NCT02096055|Idamycin|idamycin
250527|NCT02096055|Leustatin|leustatin
250528|NCT02096055|2-CdA|2-cda
250529|NCT02096042|Leukemia|leukemia
250530|NCT02096042|Acute Myeloid Leukemia|acute myeloid leukemia
250531|NCT02096042|AML|aml
250532|NCT02096042|CD30-Positive|cd30-positive
250533|NCT02096042|Relapsed|relapsed
250534|NCT02096042|Refractory|refractory
250535|NCT02096042|Brentuximab Vedotin|brentuximab vedotin
250536|NCT02096042|SGN-35|sgn-35
250537|NCT02096042|Adcetris|adcetris
250538|NCT02096042|5-Azacytidine|5-azacytidine
250539|NCT02096042|Azacytidine|azacytidine
250540|NCT02096042|Azacitidine|azacitidine
250541|NCT02096042|5-aza|5-aza
250542|NCT02096042|Vidaza|vidaza
250543|NCT02096042|5-AZC|5-azc
250544|NCT02096042|AZA-CR|aza-cr
250545|NCT02096042|Ladakamycin|ladakamycin
250546|NCT02096042|NSC-102816|nsc-102816
250547|NCT02096029|smoking|smoking
250548|NCT02096029|smoking cessation|smoking cessation
250549|NCT02096029|nicotine replacement therapy|nicotine replacement therapy
250550|NCT02096029|primary care|primary care
250551|NCT02096029|comparative effectiveness|comparative effectiveness
250552|NCT02096016|Surveillance|surveillance
250553|NCT02096016|Follow up|follow up
250554|NCT02096003|Intrathecal hydromorphone|intrathecal hydromorphone
250555|NCT02096003|Intrathecal morphine|intrathecal morphine
250556|NCT02096003|Primary cesarean section|primary cesarean section
250557|NCT02096003|Analgesia|analgesia
250558|NCT02095990|Facial Melasma|facial melasma
250559|NCT02095977|St. Jude Riata lead failure|st. jude riata lead failure
250560|NCT02095977|implantable cardioverter-defibrillator (ICD)|implantable cardioverter-defibrillator (icd)
250561|NCT02095977|externalized conductors|externalized conductors
250562|NCT02095977|ventricular tachyarrythmia|ventricular tachyarrythmia
250563|NCT02095977|electrophysiology|electrophysiology
250564|NCT02095964|cardiac syndrome X|cardiac syndrome x
250565|NCT02095964|inflammation|inflammation
250566|NCT02095964|dyslipidemia|dyslipidemia
250567|NCT02095938|schizophrenia|schizophrenia
250568|NCT02095938|brain structure|brain structure
250569|NCT02095938|treatment response|treatment response
250570|NCT02095938|solian|solian
250571|NCT02095938|gene|gene
250572|NCT02095938|mri|mri
250573|NCT02095912|Squamous Cell Carcinoma|squamous cell carcinoma
250574|NCT02095899|Thoracic Surgical Procedures|thoracic surgical procedures
250575|NCT02095873|Oral glucose tolerance test|oral glucose tolerance test
250576|NCT02095873|Flow mediated dilatation|flow mediated dilatation
250577|NCT02095873|Aortal pulse wave velocity|aortal pulse wave velocity
250578|NCT02095873|Finger-fold capillary density by capillaroscopy|finger-fold capillary density by capillaroscopy
250579|NCT02095847|Uterine Cancer|uterine cancer
250580|NCT02095847|Endometrial cancer|endometrial cancer
250581|NCT02095847|Hysterectomy|hysterectomy
250582|NCT02095847|Hysteroscopy|hysteroscopy
250583|NCT02095847|High-resolution microendoscopy|high-resolution microendoscopy
250584|NCT02095847|HRME|hrme
250585|NCT02095847|Hysteroscopic-guided resection|hysteroscopic-guided resection
250586|NCT02095847|Proflavine|proflavine
250587|NCT02095834|Myeloma|myeloma
250588|NCT02095834|Multiple Myeloma|multiple myeloma
250589|NCT02095834|Relapsed|relapsed
250592|NCT02095834|Bendamustine|bendamustine
250593|NCT02095834|Bendamustine Hydrochloride|bendamustine hydrochloride
250594|NCT02095834|Bendamustine HCL|bendamustine hcl
250595|NCT02095834|CEP-18083|cep-18083
250596|NCT02095834|SDX-105|sdx-105
250597|NCT02095834|Treanda|treanda
250598|NCT02095834|Dexamethasone|dexamethasone
250599|NCT02095834|Decadron|decadron
250600|NCT02095795|Exercise Therapy|exercise therapy
250601|NCT02095782|non-small cell lung cancer|non-small cell lung cancer
250602|NCT02095782|erlotinib|erlotinib
250603|NCT02095782|chemotherapy|chemotherapy
250604|NCT02095769|Pharmacogenomics|pharmacogenomics
250605|NCT02095769|Adverse Drug Reactions|adverse drug reactions
250606|NCT02095743|Early breast cancer|early breast cancer
250607|NCT02095743|Chemotherapy|chemotherapy
250608|NCT02095743|PICC line|picc line
250609|NCT02095743|Implanted port|implanted port
250610|NCT02095730|crosslinking|crosslinking
250611|NCT02095730|cornea|cornea
250612|NCT02095730|keratoconus|keratoconus
250613|NCT02095730|ectasia|ectasia
250614|NCT02095730|irradiance|irradiance
250615|NCT02095730|riboflavin|riboflavin
250616|NCT02095691|Renal Sympathetic Denervation|renal sympathetic denervation
250617|NCT02095678|Hepatocellular Carcinoma|hepatocellular carcinoma
250618|NCT02095678|Hepatoma|hepatoma
250619|NCT02095678|Liver Cancer, Adult|liver cancer, adult
250620|NCT02095678|Liver Cell Carcinoma|liver cell carcinoma
250621|NCT02095678|Liver Cell Carcinoma, Adult|liver cell carcinoma, adult
250622|NCT02095678|HCC|hcc
250623|NCT02095665|ureteric stents|ureteric stents
250624|NCT02095665|LUTS|luts
250625|NCT02095665|lower urinary tract symptoms|lower urinary tract symptoms
250626|NCT02095587|Phase 1|phase 1
250627|NCT02095587|hepatic impairment|hepatic impairment
250628|NCT02095574|GDC-0199|gdc-0199
250629|NCT02095574|ADME|adme
250630|NCT02095574|Relapsed|relapsed
250631|NCT02095574|Refractory|refractory
250632|NCT02095574|ABT-199|abt-199
250633|NCT02095574|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
250634|NCT02095561|HPV self testing|hpv self testing
250635|NCT02095561|screening uptake|screening uptake
250636|NCT02095561|cervical cáncer|cervical cáncer
250637|NCT02095561|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
250638|NCT02095535|obstetric patients|obstetric patients
250639|NCT02095535|chloraprep|chloraprep
250640|NCT02095535|chlorhexidine|chlorhexidine
250641|NCT02095535|drying time|drying time
250642|NCT02095522|colchicine NSTEMI endothelial function inflammation|colchicine nstemi endothelial function inflammation
250643|NCT02095496|sleep|sleep
250644|NCT02095496|intensive care|intensive care
250645|NCT02095496|mechanical ventilation|mechanical ventilation
250646|NCT02095470|Laryngoscopy|laryngoscopy
250647|NCT02095470|Equipment|equipment
250648|NCT02095470|Video Laryngoscope|video laryngoscope
250649|NCT02095457|Routine Outcome Monitoring|routine outcome monitoring
250650|NCT02095457|Psychotherapy|psychotherapy
250651|NCT02095457|Alliance|alliance
250652|NCT02095457|Feedback Informed Treatment|feedback informed treatment
250653|NCT02095457|Mental Health Outpatients|mental health outpatients
250654|NCT02095431|patients undergoing the liver transplantation|patients undergoing the liver transplantation
250655|NCT02095431|acute kidney injury|acute kidney injury
250656|NCT02095418|New-onset diabetes after transplantation (NODAT)|new-onset diabetes after transplantation (nodat)
250657|NCT02095418|Liver transplantation|liver transplantation
250658|NCT02095405|Supraventricular Tachycardia|supraventricular tachycardia
250659|NCT02095405|Atrial Fibrillation|atrial fibrillation
250660|NCT02095405|Electrophysiology Study|electrophysiology study
250661|NCT02095405|Programmed Electrical Stimulation|programmed electrical stimulation
250662|NCT02095392|soluble phosphate|soluble phosphate
250663|NCT02095392|phosphorus metabolism|phosphorus metabolism
250664|NCT02095392|calcium metabolism|calcium metabolism
250665|NCT02095392|bone metabolism|bone metabolism
250666|NCT02095392|human study|human study
250667|NCT02095379|oligosecretary multiple myeloma|oligosecretary multiple myeloma
250668|NCT02095366|Acute Pain|acute pain
250669|NCT02095366|Traumatic Pain|traumatic pain
250670|NCT02095366|Emergency setting|emergency setting
250671|NCT02095366|Prehospital setting|prehospital setting
250672|NCT02095366|Analgesia|analgesia
250673|NCT02095366|Intranasal device|intranasal device
250674|NCT02095366|Intra veinous injection|intra veinous injection
250675|NCT02095366|Sufentanil citrate|sufentanil citrate
250676|NCT02095366|Morphine Sulfate|morphine sulfate
250677|NCT02095353|Brain tumor|brain tumor
250678|NCT02095353|extraaxial|extraaxial
250679|NCT02095353|metastasis|metastasis
250680|NCT02095353|glioma|glioma
250681|NCT02095353|primary brain tumor|primary brain tumor
250682|NCT02095353|secondary brain tumor|secondary brain tumor
250683|NCT02095353|MRI|mri
250684|NCT02095353|perfusion|perfusion
250685|NCT02095353|dynamic contrast enhancement|dynamic contrast enhancement
250686|NCT02095353|CBV|cbv
250687|NCT02095353|CBF|cbf
250688|NCT02095353|ktrans|ktrans
250689|NCT02095314|DTP-HB-Hib|dtp-hb-hib
250690|NCT02095314|Pentavalen|pentavalen
250691|NCT02095314|Pentabio|pentabio
250692|NCT02095314|Booster|booster
250693|NCT02095288|lipidomics|lipidomics
250694|NCT02095288|in vitro human whole blood assay|in vitro human whole blood assay
250695|NCT02095288|anti-inflammatory drugs|anti-inflammatory drugs
250696|NCT02095288|Lipidomics screening of anti-inflammatory drugs|lipidomics screening of anti-inflammatory drugs
250697|NCT02095275|BNP, acute kidney injury, fluid status|bnp, acute kidney injury, fluid status
250698|NCT02095249|prostate cancer|prostate cancer
250699|NCT02095249|radical prostatectomy|radical prostatectomy
250700|NCT02095223|Knee injury|knee injury
250701|NCT02095223|Meniscus injury|meniscus injury
250702|NCT02095223|Anterior cruciate ligament injury|anterior cruciate ligament injury
250703|NCT02095223|Knee ligament injury|knee ligament injury
250704|NCT02095210|PET scan|pet scan
250705|NCT02095210|HER2|her2
250706|NCT02095210|breast cancer|breast cancer
250707|NCT02095184|Breast Cancer|breast cancer
250708|NCT02095184|Postmenopausal|postmenopausal
250709|NCT02095184|Hormone-Receptor Positive|hormone-receptor positive
250710|NCT02095119|Uterine cervical cancer|uterine cervical cancer
250711|NCT02095119|Palliative|palliative
250712|NCT02095119|Treatment|treatment
250713|NCT02095119|Monoclonal antibody|monoclonal antibody
250714|NCT02095119|Nimotuzumab|nimotuzumab
250715|NCT02095106|forearm fractures|forearm fractures
250716|NCT02095106|pediatric fractures|pediatric fractures
250717|NCT02095106|distal radius|distal radius
250718|NCT02095093|Total Hip Arthroplasty|total hip arthroplasty
250719|NCT02095093|Navigation|navigation
250720|NCT02095093|Imageless|imageless
250721|NCT02095093|THA|tha
250722|NCT02095093|Computer navigated|computer navigated
250723|NCT02095080|Leucine|leucine
250724|NCT02095080|Upper Intake Level (UL)|upper intake level (ul)
250725|NCT02095080|Elderly|elderly
250726|NCT02095080|Amino acids|amino acids
250727|NCT02095080|Protein|protein
250728|NCT02095067|Telemedicine|telemedicine
250729|NCT02095067|Emergency medical dispatch|emergency medical dispatch
250730|NCT02095067|Prehospital care|prehospital care
250731|NCT02095067|Video conference|video conference
250732|NCT02095054|Advanced Cancers|advanced cancers
250733|NCT02095054|Advanced malignancy|advanced malignancy
250734|NCT02095054|Metastatic cancer|metastatic cancer
250735|NCT02095054|Advanced solid tumor|advanced solid tumor
250736|NCT02095054|Regorafenib|regorafenib
250737|NCT02095054|Stivarga|stivarga
250738|NCT02095054|Cetuximab|cetuximab
250739|NCT02095054|C225|c225
250740|NCT02095054|Erbitux|erbitux
250741|NCT02095054|IMC-C225|imc-c225
250742|NCT02095054|MOAB C225|moab c225
250743|NCT02095054|Questionnaire|questionnaire
250744|NCT02095054|Survey|survey
250745|NCT02095041|Oxygen saturation.|oxygen saturation.
250746|NCT02095041|Term infants.|term infants.
250747|NCT02095041|Saturation trend.|saturation trend.
250748|NCT02095041|Histogram.|histogram.
250749|NCT02095041|Public health nurse.|public health nurse.
250750|NCT02095041|congenital heart disease screening.|congenital heart disease screening.
250751|NCT02095015|MPS|mps
250752|NCT02095015|Mucopolysaccharidosis|mucopolysaccharidosis
250753|NCT02095015|MPS I|mps i
250754|NCT02095015|Mucopolysaccharidosis I|mucopolysaccharidosis i
250755|NCT02095015|Hurler, Hurler-Scheie, or Scheie syndrome|hurler, hurler-scheie, or scheie syndrome
250756|NCT02095015|MPS II|mps ii
250757|NCT02095015|Mucopolysaccharidosis II|mucopolysaccharidosis ii
250758|NCT02095015|Hunter syndrome|hunter syndrome
250759|NCT02095015|MPS VI|mps vi
250760|NCT02095015|Mucopolysaccharidosis VI|mucopolysaccharidosis vi
250761|NCT02095015|Maroteaux-Lamy syndrome|maroteaux-lamy syndrome
250762|NCT02095015|iduronate-2-sulfatase|iduronate-2-sulfatase
250763|NCT02095015|ENT|ent
250764|NCT02095015|ear, nose and throat|ear, nose and throat
250765|NCT02095002|modified valsalva maneuver, internal jugular vein|modified valsalva maneuver, internal jugular vein
250766|NCT02094989|electrocardiogram|electrocardiogram
250767|NCT02094989|vectorcardiogram|vectorcardiogram
250768|NCT02094989|telecardiology|telecardiology
250769|NCT02094989|linear regression|linear regression
250770|NCT02094989|individual transformation matrix|individual transformation matrix
250771|NCT02094989|posture|posture
250772|NCT02094976|Prone position|prone position
250773|NCT02094976|Intra-abdominal pressure|intra-abdominal pressure
250774|NCT02094976|Respiratory system compliance|respiratory system compliance
250775|NCT02094976|Jackson table|jackson table
250776|NCT02094976|Wilson frame|wilson frame
250777|NCT02094976|Chest roll|chest roll
250778|NCT02094963|acute coronary syndrome|acute coronary syndrome
250779|NCT02094963|coronary disease|coronary disease
250780|NCT02094963|coronary artery disease|coronary artery disease
250781|NCT02094950|concurrent chemotherapy|concurrent chemotherapy
250782|NCT02094950|concurrent radiation|concurrent radiation
250783|NCT02094937|fluticasone propionate|fluticasone propionate
250784|NCT02094937|step-down regimen|step-down regimen
250785|NCT02094937|well-controlled subjects|well-controlled subjects
250786|NCT02094937|adults|adults
250787|NCT02094937|switching regimen|switching regimen
250788|NCT02094937|asthma|asthma
250789|NCT02094937|fluticasone furoate|fluticasone furoate
250790|NCT02094937|fluticasone furoate/Vilanterol|fluticasone furoate/vilanterol
251475|NCT02091752|Ruxolitinib|ruxolitinib
250791|NCT02094924|Candesartan cilexetil|candesartan cilexetil
250792|NCT02094924|Hypertension|hypertension
250793|NCT02094924|Hydrochlorothiazide|hydrochlorothiazide
250794|NCT02094924|Healthy adult human subjects|healthy adult human subjects
250795|NCT02094924|Bioequivalence|bioequivalence
250796|NCT02094911|Prevention|prevention
250797|NCT02094911|Combined lifestyle intervention|combined lifestyle intervention
250798|NCT02094911|Primary health care|primary health care
250799|NCT02094898|Depression|depression
250800|NCT02094898|Unipolar|unipolar
250801|NCT02094898|Bipolar|bipolar
250802|NCT02094898|Suicidal|suicidal
250803|NCT02094859|Glucose Monitoring|glucose monitoring
250804|NCT02094846|Cellular phones|cellular phones
250805|NCT02094846|Type 2 diabetes|type 2 diabetes
250806|NCT02094846|Glycated hemoglobin|glycated hemoglobin
250807|NCT02094846|glycemic control|glycemic control
250808|NCT02094833|Diphtheria|diphtheria
250809|NCT02094833|Tetanus|tetanus
250810|NCT02094833|Pertussis|pertussis
250811|NCT02094833|Haemophilus influenzae type b infection|haemophilus influenzae type b infection
250812|NCT02094833|Hepatitis B|hepatitis b
250813|NCT02094833|DTaP-IPV-Hep - PRP-T vaccine|dtap-ipv-hep - prp-t vaccine
250814|NCT02094807|prospective study|prospective study
250815|NCT02094807|surgical management|surgical management
250816|NCT02094807|rib fractures|rib fractures
250817|NCT02094807|trauma|trauma
250818|NCT02094755|critical limb ischemia, High on-treatment platelet reactivity, HPR, aspirin, clopidogrel|critical limb ischemia, high on-treatment platelet reactivity, hpr, aspirin, clopidogrel
250819|NCT02094742|screening program|screening program
250820|NCT02094742|metastatic breast cancer|metastatic breast cancer
250821|NCT02094742|molecular profile|molecular profile
250822|NCT02094742|gene sequencing|gene sequencing
250823|NCT02094729|mild cognitive impairment|mild cognitive impairment
250824|NCT02094729|Alzheimer's disease|alzheimer's disease
250825|NCT02094716|Sarcoptes|sarcoptes
250826|NCT02094716|Scabiei|scabiei
250827|NCT02094716|Scabies|scabies
250828|NCT02094716|ectoparasite|ectoparasite
250829|NCT02094716|parasite|parasite
250830|NCT02094716|infestation|infestation
250831|NCT02094716|Renaissance|renaissance
250832|NCT02094703|female|female
250833|NCT02094703|age 18-65 years|age 18-65 years
250834|NCT02094703|storage symptoms|storage symptoms
250835|NCT02094703|clinical urinary tract infection|clinical urinary tract infection
250836|NCT02094703|non complicated|non complicated
250837|NCT02094690|head and neck neoplasms|head and neck neoplasms
250838|NCT02094690|radiotherapy|radiotherapy
250839|NCT02094690|physical therapy|physical therapy
250840|NCT02094690|trismus|trismus
250841|NCT02094664|Heat|heat
250842|NCT02094664|Humidification|humidification
250843|NCT02094664|Oxygen|oxygen
250844|NCT02094651|Abnormal EEGs|abnormal eegs
250845|NCT02094638|Traditional Chinese Medicine Injection|traditional chinese medicine injection
250846|NCT02094625|Cisplatin|cisplatin
250847|NCT02094625|N-acetylcysteine|n-acetylcysteine
250848|NCT02094625|Hearing Loss|hearing loss
250849|NCT02094625|Otoprotection|otoprotection
250850|NCT02094612|Attention Deficit and Disruptive Behavior Disorders|attention deficit and disruptive behavior disorders
250851|NCT02094612|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
250852|NCT02094612|Pediatrics|pediatrics
250853|NCT02094612|Patient Outcome Assessment|patient outcome assessment
250854|NCT02094573|Drug Therapy|drug therapy
250855|NCT02094560|therapy refractory|therapy refractory
250856|NCT02094560|endstage|endstage
250857|NCT02094560|solid tumours|solid tumours
250858|NCT02094547|Infant Formula|infant formula
250859|NCT02094547|Cognition|cognition
250860|NCT02094547|Neurodevelopment|neurodevelopment
250861|NCT02094547|Immunity|immunity
250862|NCT02094547|Microbiota|microbiota
250863|NCT02094534|Diabetes type 1|diabetes type 1
250864|NCT02094534|Oral Insulin|oral insulin
250865|NCT02094534|Safety|safety
250866|NCT02094534|Tolerability|tolerability
250867|NCT02094534|Phase 2a|phase 2a
250868|NCT02094534|Randomized|randomized
250869|NCT02094534|Blinded|blinded
250870|NCT02094534|Parallel|parallel
250871|NCT02094508|Parasitemia|parasitemia
250872|NCT02094508|HIV-Exposed|hiv-exposed
250873|NCT02094508|HIV-Unexposed|hiv-unexposed
250874|NCT02094508|Liver Stage|liver stage
250875|NCT02094508|Randomized|randomized
250876|NCT02094495|Tamoxifen|tamoxifen
250877|NCT02094495|Breast cancer|breast cancer
250878|NCT02094495|Knowkedge|knowkedge
250879|NCT02094469|Treatment for vasospastic angina|treatment for vasospastic angina
250880|NCT02094456|diverticular disease|diverticular disease
250881|NCT02094456|diverticular bleeding|diverticular bleeding
250882|NCT02094456|endoscopic clipping|endoscopic clipping
250883|NCT02094456|endoscopy|endoscopy
250884|NCT02094456|lower gastrointestinal bleeding|lower gastrointestinal bleeding
250885|NCT02094443|Chronic hepatitis C genotype 2|chronic hepatitis c genotype 2
250886|NCT02094443|Chronic hepatitis C genotype 3|chronic hepatitis c genotype 3
250887|NCT02094443|Cyclophilin inhibitor|cyclophilin inhibitor
250888|NCT02094443|Interferon intolerant|interferon intolerant
250889|NCT02094417|Anemia, Aplastic|anemia, aplastic
250890|NCT02094417|Thrombopoietin|thrombopoietin
250891|NCT02094417|Thrombocytopenia|thrombocytopenia
250892|NCT02094404|Emergency Department|emergency department
250893|NCT02094404|Pediatric Early Warning Score|pediatric early warning score
250894|NCT02094404|Manchester Triage System|manchester triage system
250896|NCT02094378|Esketamine|esketamine
250897|NCT02094378|Cognitive functioning|cognitive functioning
250898|NCT02094352|Complex Regional Pain Syndrome|complex regional pain syndrome
250899|NCT02094352|Pain management|pain management
250900|NCT02094352|Ketamine infusion|ketamine infusion
250901|NCT02094339|Local analgesia system|local analgesia system
250902|NCT02094339|Ropivacaine|ropivacaine
250903|NCT02094339|Analgesic efficacy after operation|analgesic efficacy after operation
250904|NCT02094339|Postoperative|postoperative
250905|NCT02094313|Atorvastatin|atorvastatin
250906|NCT02094313|Human Spermatozoa|human spermatozoa
250907|NCT02094313|Seminal fluid|seminal fluid
250908|NCT02094313|Accessory Glands|accessory glands
250909|NCT02094313|Cholesterol|cholesterol
250910|NCT02094313|Gonadotropins,|gonadotropins,
250911|NCT02094313|Testosterone|testosterone
250912|NCT02094300|Aorta|aorta
250913|NCT02094300|Thoracic|thoracic
250914|NCT02094300|Aortic dissection|aortic dissection
250915|NCT02094300|Rupture|rupture
250916|NCT02094300|Type B|type b
250917|NCT02094300|DeBakey type III|debakey type iii
250918|NCT02094300|Endovascular|endovascular
250919|NCT02094261|Phase II, open label study; safety and efficacy of AZD9291; diagnosis of Epidermal Growth Factor Receptor mutation positive and T790M mutation positive NSCLC|phase ii, open label study; safety and efficacy of azd9291; diagnosis of epidermal growth factor receptor mutation positive and t790m mutation positive nsclc
250920|NCT02094235|Dermatitis|dermatitis
250921|NCT02094235|Atopic|atopic
250922|NCT02094235|Pediatric|pediatric
250923|NCT02094235|Adolescent|adolescent
250924|NCT02094235|Child|child
250925|NCT02094209|External Fixation|external fixation
250926|NCT02094209|Tibial fracture|tibial fracture
250927|NCT02094209|Fracture healing|fracture healing
250928|NCT02094196|Reward- based learning|reward- based learning
250929|NCT02094196|Pavlovian-to-instrumental transfer|pavlovian-to-instrumental transfer
250930|NCT02094196|Relapse Risk|relapse risk
250931|NCT02094196|Positron emission tomography (PET)|positron emission tomography (pet)
250932|NCT02094196|Magnetic resonance spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
250933|NCT02094196|Dopamine receptor availability|dopamine receptor availability
250934|NCT02094196|Glutamate|glutamate
250935|NCT02094157|Atrial fibrillation|atrial fibrillation
250936|NCT02094157|Mechanical heart valve|mechanical heart valve
250937|NCT02094157|Stroke|stroke
250938|NCT02094157|Venous thromboembolism|venous thromboembolism
250939|NCT02094157|Hemorrhage|hemorrhage
250940|NCT02094144|Sedentary|sedentary
250941|NCT02094144|Physical activity|physical activity
250942|NCT02094144|Brisk walking|brisk walking
250943|NCT02094144|Postmenopausal women|postmenopausal women
250944|NCT02094144|Body composition|body composition
250945|NCT02094144|Balance|balance
250946|NCT02094144|Muscle strength|muscle strength
250947|NCT02094144|Depression, bone density|depression, bone density
250948|NCT02094144|Nutrition|nutrition
250949|NCT02094144|Biological effects|biological effects
250950|NCT02094131|incentive spirometry|incentive spirometry
250951|NCT02094131|flow-oriented spirometer|flow-oriented spirometer
250952|NCT02094131|volume-oriented spirometer|volume-oriented spirometer
250953|NCT02094131|physical therapy|physical therapy
250954|NCT02094131|respiratory muscle training|respiratory muscle training
250955|NCT02094118|Transfusion|transfusion
250956|NCT02094118|RBC|rbc
250957|NCT02094118|cardiac|cardiac
250958|NCT02094118|surgery|surgery
250959|NCT02094118|transfusion related acute lung injury (TRALI)|transfusion related acute lung injury (trali)
250960|NCT02094118|transfusion associated circulatory overload (TACO)|transfusion associated circulatory overload (taco)
250961|NCT02094105|esophageal cancer|esophageal cancer
250962|NCT02094105|screening|screening
250963|NCT02094105|endoscopy|endoscopy
250964|NCT02094105|prevention|prevention
250965|NCT02094092|L.reuteri ProTectis DSM 17938|l.reuteri protectis dsm 17938
250966|NCT02094092|Infantile colic|infantile colic
250967|NCT02094092|Maternal mental health.|maternal mental health.
250968|NCT02094092|Infant crying/fussing|infant crying/fussing
250969|NCT02094092|Edinburgh Postnatal Depression Scale (EPDS)|edinburgh postnatal depression scale (epds)
250970|NCT02094079|hypothyroidism|hypothyroidism
250971|NCT02094079|pregnancy|pregnancy
250972|NCT02094066|tranexamic acid|tranexamic acid
250973|NCT02094066|total hip arthroplasty|total hip arthroplasty
250974|NCT02094053|Down syndrome|down syndrome
250975|NCT02094053|regression symptoms|regression symptoms
250976|NCT02094053|disabled activities of daily living|disabled activities of daily living
250977|NCT02094040|frailty|frailty
250978|NCT02094040|readmission|readmission
250979|NCT02094040|transition|transition
250980|NCT02094040|discharge|discharge
250981|NCT02094040|primary care|primary care
250982|NCT02094027|Obesity|obesity
250983|NCT02094027|Bariatric surgery|bariatric surgery
250984|NCT02094027|Binge eating|binge eating
250985|NCT02094027|Self help|self help
250986|NCT02094014|Perceptual masking|perceptual masking
250987|NCT02094014|Auditory stimulation|auditory stimulation
250988|NCT02094014|Speech|speech
250989|NCT02094014|Language|language
250990|NCT02094014|Verbal Fluency Disorders|verbal fluency disorders
250991|NCT02093962|TH-302|th-302
250992|NCT02093962|TH-CR-415|th-cr-415
250993|NCT02093962|Pemetrexed|pemetrexed
250994|NCT02093962|Non-small cell lung cancer|non-small cell lung cancer
250995|NCT02093962|Lung cancer|lung cancer
250996|NCT02093962|Evofosfamide|evofosfamide
250997|NCT02093936|airway inflammation|airway inflammation
250998|NCT02093936|induced sputum|induced sputum
250999|NCT02093936|normal values|normal values
251000|NCT02093936|lymphocyte|lymphocyte
251001|NCT02093936|eosinophil|eosinophil
251002|NCT02093936|neutrophil|neutrophil
251003|NCT02093923|HAE|hae
251004|NCT02093910|multiple myeloma|multiple myeloma
251005|NCT02093910|peripheral neuropathy|peripheral neuropathy
251006|NCT02093910|prophylaxis|prophylaxis
251007|NCT02093884|Pregnancy|pregnancy
251008|NCT02093884|Pregnancy, unplanned|pregnancy, unplanned
251009|NCT02093884|Reproductive behavior|reproductive behavior
251010|NCT02093884|Pregnancy in Adolescence|pregnancy in adolescence
251011|NCT02093884|Text messaging|text messaging
251012|NCT02093871|Ovarian cancer|ovarian cancer
251013|NCT02093871|Therapeutic hyperthermia|therapeutic hyperthermia
251014|NCT02093871|HEATT|heatt
251015|NCT02093871|whole body hyperthermia|whole body hyperthermia
251016|NCT02093871|hyperthermia|hyperthermia
251017|NCT02093871|PISH|pish
251018|NCT02093871|Verthermia|verthermia
251019|NCT02093871|Phase 1 clinical trial|phase 1 clinical trial
251020|NCT02093871|stage 3 ovarian cancer|stage 3 ovarian cancer
251021|NCT02093871|stage 4 ovarian cancer|stage 4 ovarian cancer
251022|NCT02093871|stage III ovarian cancer|stage iii ovarian cancer
251023|NCT02093871|stage IV ovarian cancer|stage iv ovarian cancer
251024|NCT02093871|late stage ovarian cancer|late stage ovarian cancer
251025|NCT02093871|Core HFC|core hfc
251026|NCT02093871|Lilja|lilja
251027|NCT02093871|Vertrees|vertrees
251028|NCT02093871|Bastidas|bastidas
251029|NCT02093871|total body hyperthermia|total body hyperthermia
251030|NCT02093858|Metabolic Syndrome|metabolic syndrome
251031|NCT02093845|Percutaneous coronary intervention|percutaneous coronary intervention
251032|NCT02093845|DES|des
251033|NCT02093845|Angina pectoris|angina pectoris
251034|NCT02093845|Stent|stent
251035|NCT02093832|femoral head size|femoral head size
251036|NCT02093832|cup size|cup size
251037|NCT02093832|Total hip arthroplasty|total hip arthroplasty
251038|NCT02093767|prebiotics|prebiotics
251039|NCT02093767|Synergy1|synergy1
251040|NCT02093728|Phase I, healthy, pharmacokinetics|phase i, healthy, pharmacokinetics
251041|NCT02093715|Bronchiolitis|bronchiolitis
251042|NCT02093715|FeNO|feno
251043|NCT02093715|Asthma|asthma
251044|NCT02093715|wheezing, RSV|wheezing, rsv
251045|NCT02093676|diabetes|diabetes
251046|NCT02093676|type 1|type 1
251047|NCT02093676|adolescents|adolescents
251048|NCT02093676|parents counselling|parents counselling
251049|NCT02093663|Mild|mild
251050|NCT02093663|Moderate|moderate
251051|NCT02093650|Menopausal symptoms|menopausal symptoms
251052|NCT02093650|menopause related quality of life|menopause related quality of life
251053|NCT02093650|black cohosh|black cohosh
251054|NCT02093650|cimicifuga racemosa|cimicifuga racemosa
251055|NCT02093650|MENQOL|menqol
251056|NCT02093650|Kupperman index|kupperman index
251057|NCT02093650|KI|ki
251058|NCT02093650|liver function tests|liver function tests
251059|NCT02093598|pharmacokinetic|pharmacokinetic
251060|NCT02093598|pharmacodynamic|pharmacodynamic
251061|NCT02093598|Carcinoma, Endometrioid|carcinoma, endometrioid
251062|NCT02093598|mTOR protein|mtor protein
251063|NCT02093598|temsirolimus|temsirolimus
251064|NCT02093598|torisel|torisel
251065|NCT02093598|biological marker|biological marker
251066|NCT02093598|phase II|phase ii
251067|NCT02093585|HIV-1|hiv-1
251068|NCT02093585|Abacavir|abacavir
251069|NCT02093585|Platelet activation|platelet activation
251070|NCT02093585|Thromboelastography|thromboelastography
251071|NCT02093585|Coagulation|coagulation
251072|NCT02093572|Clock genes|clock genes
251073|NCT02093572|Metabolism|metabolism
251074|NCT02093572|Insulin sensitivity|insulin sensitivity
251075|NCT02093559|Clinical Trial|clinical trial
251076|NCT02093559|Naloxone|naloxone
251077|NCT02093559|Motivational Interviewing|motivational interviewing
251078|NCT02093546|Endometrial cancer|endometrial cancer
251079|NCT02093546|Endometrioid adenocarcinoma|endometrioid adenocarcinoma
251080|NCT02093546|Serous adenocarcinoma|serous adenocarcinoma
251081|NCT02093546|Undifferentiated carcinoma|undifferentiated carcinoma
251082|NCT02093546|Mixed epithelial carcinoma|mixed epithelial carcinoma
251083|NCT02093546|Adenocarcinoma not otherwise specified|adenocarcinoma not otherwise specified
251084|NCT02093546|NOS|nos
251085|NCT02093546|Companion Protocol to GOG229O|companion protocol to gog229o
251086|NCT02093546|Biomarkers|biomarkers
251087|NCT02093546|Circulating tumor cells|circulating tumor cells
251088|NCT02093546|CTCs|ctcs
251089|NCT02093546|Blood draw|blood draw
251090|NCT02093546|Biopsy|biopsy
251091|NCT02093533|Membranoproliferative glomerulonephritis|membranoproliferative glomerulonephritis
251092|NCT02093533|Nephrotic syndrome|nephrotic syndrome
251093|NCT02093533|Proteinuria|proteinuria
251094|NCT02093533|Alternative complement pathway|alternative complement pathway
251095|NCT02093533|Complement inhibition|complement inhibition
251096|NCT02093533|Eculizumab|eculizumab
251097|NCT02093520|Lumbar Spinal Stenosis|lumbar spinal stenosis
251098|NCT02093520|Spinal Stenosis|spinal stenosis
251099|NCT02093520|Neurogenic Claudication|neurogenic claudication
251100|NCT02093507|newborn|newborn
251101|NCT02093507|foot deformity congenital|foot deformity congenital
251102|NCT02093494|Septicemia|septicemia
251103|NCT02093494|Blood culture|blood culture
251104|NCT02093494|Contamination|contamination
251105|NCT02093468|Acute limb ischemia|acute limb ischemia
251106|NCT02093468|ALI|ali
251107|NCT02093468|Acute lower extremity arterial occlusion|acute lower extremity arterial occlusion
251108|NCT02093455|Endothelial function|endothelial function
251109|NCT02093416|Obesity|obesity
251110|NCT02093416|Leptin|leptin
251111|NCT02093403|AML|aml
251112|NCT02093403|Acute Myeloid Leukemia|acute myeloid leukemia
251113|NCT02093403|Adult Acute Myeloid Leukemia with T(8;21)(Q22;Q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
251114|NCT02093403|adult Acute Myeloid Leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
251115|NCT02093403|adult Acute Myeloid Leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
251116|NCT02093403|adult Acute Myeloid Leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
251117|NCT02093377|acute myocardial infarction|acute myocardial infarction
251118|NCT02093377|sleep apnea|sleep apnea
251119|NCT02093377|adaptive servo-ventilation|adaptive servo-ventilation
251120|NCT02093351|oncology, cancer, tumour, neoplasm, anticancer drug, pharmacokinetics, olaparib, anastrozole, tamoxifen, letrozole,|oncology, cancer, tumour, neoplasm, anticancer drug, pharmacokinetics, olaparib, anastrozole, tamoxifen, letrozole,
251121|NCT02093338|breast pain|breast pain
251122|NCT02093338|probiotic|probiotic
251123|NCT02093338|mastitis|mastitis
251124|NCT02093338|lactobacillus fermentun|lactobacillus fermentun
251125|NCT02093338|Staphylococcus|staphylococcus
251126|NCT02093325|eltrombopag , thrombocytopenia, solid tumor|eltrombopag , thrombocytopenia, solid tumor
251127|NCT02093312|Cancer|cancer
251128|NCT02093312|Food-delivery|food-delivery
251129|NCT02093312|Nutritional Intervention|nutritional intervention
251130|NCT02093312|Quality of life|quality of life
251131|NCT02093312|Outpatients|outpatients
251132|NCT02093286|Pentabio Vaccine|pentabio vaccine
251133|NCT02093286|Safety|safety
251134|NCT02093286|Infants|infants
251135|NCT02093286|Booster Dose|booster dose
251136|NCT02093286|DTwP/HepB/Hib|dtwp/hepb/hib
251137|NCT02093273|tOPV|topv
251138|NCT02093273|Antibody response|antibody response
251139|NCT02093273|Safety|safety
251140|NCT02093260|Flubio Vaccine (Influenza HA)|flubio vaccine (influenza ha)
251141|NCT02093260|Infants|infants
251142|NCT02093260|Children|children
251143|NCT02093260|Safety|safety
251144|NCT02093260|Immunogenicity|immunogenicity
251145|NCT02093234|self care of diabetes type 2 patients|self care of diabetes type 2 patients
251146|NCT02093234|mobile health cell phone application impact on health|mobile health cell phone application impact on health
251147|NCT02093234|community health workers impact on health|community health workers impact on health
251148|NCT02093221|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
251149|NCT02093221|Alpha1-Proteinase Inhibitor|alpha1-proteinase inhibitor
251150|NCT02093221|Beta Cell|beta cell
251151|NCT02093221|Alpha1-Antitrypsin|alpha1-antitrypsin
251152|NCT02093195|Treatment, COPD, bosentan|treatment, copd, bosentan
251153|NCT02093156|bowel preparation|bowel preparation
251154|NCT02093156|Ottawa Score|ottawa score
251155|NCT02093143|Diagnostic panendoscopy of the upper airway|diagnostic panendoscopy of the upper airway
251156|NCT02093143|Total intravenous general anesthesia|total intravenous general anesthesia
251157|NCT02093143|Remifentanil|remifentanil
251158|NCT02093143|Propofol|propofol
251159|NCT02093143|Target controlled infusion|target controlled infusion
251160|NCT02093143|Direct laryngoscopy|direct laryngoscopy
251161|NCT02093143|Tracheoscopy|tracheoscopy
251162|NCT02093143|Oesophagoscopy|oesophagoscopy
251163|NCT02093143|Ear Nose and Throat (ENT) tumor|ear nose and throat (ent) tumor
251164|NCT02093143|Ear Nose and Throat (ENT) cancer|ear nose and throat (ent) cancer
251165|NCT02093130|Double-blind Trial|double-blind trial
251166|NCT02093130|Placebo-controlled|placebo-controlled
251167|NCT02093130|Pomegranate|pomegranate
251168|NCT02093130|Memory|memory
251169|NCT02093130|Memory Impairment|memory impairment
251170|NCT02093130|Cognition|cognition
251171|NCT02093130|Ages 50-75|ages 50-75
251172|NCT02093117|Supratentorial neurosurgery|supratentorial neurosurgery
251173|NCT02093117|Recruitment maneuver|recruitment maneuver
251174|NCT02093117|Subdural pressure|subdural pressure
251175|NCT02093117|Brain relaxation|brain relaxation
251176|NCT02093117|Cerebral perfusion pressure|cerebral perfusion pressure
251177|NCT02093104|unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
251178|NCT02093104|(undergoing chemoembolization and radioembolization)|(undergoing chemoembolization and radioembolization)
251179|NCT02093091|nano-filled resin modified glass ionomer|nano-filled resin modified glass ionomer
251180|NCT02093091|clinical performance|clinical performance
251181|NCT02093091|class I|class i
251182|NCT02093091|primary teeth|primary teeth
251183|NCT02093091|dentin bond strength|dentin bond strength
251184|NCT02093091|Filling of class I|filling of class i
251185|NCT02093065|severe hemophilia A|severe hemophilia a
251186|NCT02093065|coated platelets|coated platelets
251187|NCT02093065|bleeding|bleeding
251188|NCT02093052|Parenting|parenting
251189|NCT02093052|Parent child relations|parent child relations
251190|NCT02093052|Middle childhood outcomes|middle childhood outcomes
251191|NCT02093039|breast cancer screening|breast cancer screening
251192|NCT02093039|patient decision aids|patient decision aids
251193|NCT02093039|informed decision|informed decision
251194|NCT02093039|empowerment|empowerment
251195|NCT02093039|randomized control trial|randomized control trial
251196|NCT02093039|From 50 to 74 years old|from 50 to 74 years old
251197|NCT02093039|invited to national breast cancer screening|invited to national breast cancer screening
251198|NCT02093013|asthma|asthma
251199|NCT02093013|intervention|intervention
251200|NCT02093013|medication adherence|medication adherence
251201|NCT02093013|inhaled corticosteroids|inhaled corticosteroids
251202|NCT02093013|asthma control|asthma control
251203|NCT02093013|integrated care|integrated care
251204|NCT02092987|Hispanic|hispanic
251205|NCT02092987|Dementia|dementia
251206|NCT02092987|Caregivers|caregivers
251207|NCT02092987|Depressive symptoms|depressive symptoms
251208|NCT02092987|Burden|burden
251209|NCT02092987|Pragmatic randomized trial|pragmatic randomized trial
251210|NCT02092974|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
251211|NCT02092974|selective serotonin reuptake inhibitor (SSRI)|selective serotonin reuptake inhibitor (ssri)
251212|NCT02092974|young|young
251213|NCT02092974|older adults|older adults
251214|NCT02092961|Rheumatoid Arthritis|rheumatoid arthritis
251215|NCT02092961|OSKIRA|oskira
251216|NCT02092961|fostamatinib|fostamatinib
251217|NCT02092961|CE-MRI|ce-mri
251218|NCT02092961|DCE-MRI|dce-mri
251219|NCT02092948|metastatic|metastatic
251220|NCT02092948|PSCA|psca
251221|NCT02092948|minibody|minibody
251222|NCT02092948|PET/CT|pet/ct
251223|NCT02092935|CDAD|cdad
251224|NCT02092935|Clostridium Difficile|clostridium difficile
251225|NCT02092896|Diabetes Mellitus|diabetes mellitus
251226|NCT02092896|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
251227|NCT02092896|Glucose Metabolism Disorders|glucose metabolism disorders
251228|NCT02092896|Metabolic Diseases|metabolic diseases
251229|NCT02092896|Cognitive performance|cognitive performance
251230|NCT02092896|Hypoglycemia|hypoglycemia
251231|NCT02092896|Insulin|insulin
251232|NCT02092896|Glucagon-Like Peptide 1|glucagon-like peptide 1
251233|NCT02092896|Hypoglycemic Agents|hypoglycemic agents
251234|NCT02092896|Physiological Effects of Drugs|physiological effects of drugs
251235|NCT02092896|Pharmacologic Actions|pharmacologic actions
251236|NCT02092896|Incretins|incretins
251237|NCT02092896|Hormones|hormones
251238|NCT02092883|Infantile Spasms|infantile spasms
251239|NCT02092883|Neuroinflammation|neuroinflammation
251240|NCT02092883|PK11195|pk11195
251241|NCT02092883|PET|pet
251242|NCT02092883|ACTH|acth
251243|NCT02092870|Chronic Wounds|chronic wounds
251244|NCT02092870|Diabetes|diabetes
251245|NCT02092870|Adipose Derived Stem Cells|adipose derived stem cells
251246|NCT02092870|Diabetic Foot|diabetic foot
251247|NCT02092857|nutrient|nutrient
251248|NCT02092857|nutrition|nutrition
251249|NCT02092857|arachidonic acid|arachidonic acid
251250|NCT02092857|essential fatty acids|essential fatty acids
251251|NCT02092844|Menopause|menopause
251252|NCT02092844|Insomnia|insomnia
251253|NCT02092844|Hot Flashes|hot flashes
251254|NCT02092805|VAS|vas
251255|NCT02092805|VDS|vds
251256|NCT02092805|HAM-D|ham-d
251257|NCT02092805|Visceral pain|visceral pain
251258|NCT02092805|Malignancy|malignancy
251259|NCT02092805|rTMS|rtms
251260|NCT02092805|Motor cortex|motor cortex
251261|NCT02092805|Analgesia|analgesia
251262|NCT02092805|Dynorphin|dynorphin
251263|NCT02092766|malaria|malaria
251264|NCT02092766|anaemia|anaemia
251265|NCT02092766|artesunate|artesunate
251266|NCT02092753|Ketogenic diet, logi diet, breast cancer, rehabilitation|ketogenic diet, logi diet, breast cancer, rehabilitation
251267|NCT02092740|Testicular cancer|testicular cancer
251268|NCT02092727|Dialysis facilities|dialysis facilities
251269|NCT02092727|African Americans|african americans
251270|NCT02092727|Racial disparity|racial disparity
251271|NCT02092727|Kidney Transplantation|kidney transplantation
251272|NCT02092727|Community-based Participatory Research|community-based participatory research
251273|NCT02092727|Coalition|coalition
251274|NCT02092727|Georgia|georgia
251275|NCT02092688|time to delivery|time to delivery
251276|NCT02092688|PROM|prom
251277|NCT02092688|PTL|ptl
251278|NCT02092688|positive predictive value|positive predictive value
251279|NCT02092675|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
251280|NCT02092675|frequent exacerbator|frequent exacerbator
251281|NCT02092675|endothelial dysfunction|endothelial dysfunction
251282|NCT02092675|Flow mediated dilatation|flow mediated dilatation
251283|NCT02092675|Systemic inflammation|systemic inflammation
251284|NCT02092649|Omega-3|omega-3
251285|NCT02092649|Resting metabolic rate|resting metabolic rate
251286|NCT02092649|Eicosapentaenoic acid|eicosapentaenoic acid
251287|NCT02092649|Docosahexaenoic acid|docosahexaenoic acid
251288|NCT02092636|Hybrid NIR/US imaging technique|hybrid nir/us imaging technique
251289|NCT02092636|NIR/US imaging|nir/us imaging
251290|NCT02092636|US imaging|us imaging
251291|NCT02092636|US imaging technique|us imaging technique
251292|NCT02092623|Female|female
251293|NCT02092623|Prolapse surgery with transvaginal mesh|prolapse surgery with transvaginal mesh
251294|NCT02092623|Subjective outcome|subjective outcome
251295|NCT02092584|atherosclerotic|atherosclerotic
251296|NCT02092584|IGF-1|igf-1
251297|NCT02092584|IGFBP-3|igfbp-3
251298|NCT02092558|metaplasia, dysfunction, urinary bladder, children|metaplasia, dysfunction, urinary bladder, children
251299|NCT02092545|Obesity|obesity
251300|NCT02092519|EUSFNA|eusfna
251301|NCT02092519|endoscopic ultrasound|endoscopic ultrasound
251302|NCT02092519|pancreatic masses|pancreatic masses
251303|NCT02092506|H pylori|h pylori
251304|NCT02092506|therapy|therapy
251305|NCT02092493|ScopeGuide|scopeguide
251306|NCT02092493|Colonoscopy|colonoscopy
251307|NCT02092493|Mental workload|mental workload
251308|NCT02092480|Feasibility Trial|feasibility trial
251309|NCT02092480|Educational Intervention|educational intervention
251310|NCT02092480|Teenage Pregnancy|teenage pregnancy
251311|NCT02092480|Boys|boys
251312|NCT02092480|Gender sensitive interventions|gender sensitive interventions
251313|NCT02092480|Unintended pregnancy|unintended pregnancy
251314|NCT02092480|Parents|parents
251315|NCT02092480|Process evaluation|process evaluation
251316|NCT02092480|Economic costing|economic costing
251317|NCT02092467|Post-marketing|post-marketing
251318|NCT02092467|Phase 4|phase 4
251319|NCT02092467|Open-label|open-label
251320|NCT02092467|Safety Surveillance|safety surveillance
251321|NCT02092467|CP690550|cp690550
251322|NCT02092467|Xeljanz|xeljanz
251323|NCT02092467|oral treatment|oral treatment
251324|NCT02092441|Nausea|nausea
251325|NCT02092441|Vomiting|vomiting
251326|NCT02092441|Antiemetic|antiemetic
251327|NCT02092428|Coronary Magnetic Resonance Imaging|coronary magnetic resonance imaging
251328|NCT02092428|CAD|cad
251329|NCT02092428|Coronary Magnetic Resonance Angiography|coronary magnetic resonance angiography
251330|NCT02092428|MRA|mra
251331|NCT02092428|3 Tesla MRI|3 tesla mri
251332|NCT02092415|Tourniquet|tourniquet
251333|NCT02092415|Muscle perfusion|muscle perfusion
251334|NCT02092415|Contrast ultrasound|contrast ultrasound
251335|NCT02092402|Fecal transplantation|fecal transplantation
251336|NCT02092402|microbiota transplantation|microbiota transplantation
251337|NCT02092402|irritable bowel syndrome|irritable bowel syndrome
251338|NCT02092402|IBS|ibs
251339|NCT02092389|Ulcerative Colitis|ulcerative colitis
251340|NCT02092389|Inflammatory Bowel Syndrome|inflammatory bowel syndrome
251341|NCT02092389|Adalimumab|adalimumab
251342|NCT02092389|Tumor necrosis factor (TNF) alpha Antibody|tumor necrosis factor (tnf) alpha antibody
251343|NCT02092389|Calprotectin|calprotectin
251344|NCT02092376|Bariatric surgery|bariatric surgery
251345|NCT02092376|vitamin D|vitamin d
251346|NCT02092376|supplementation|supplementation
251347|NCT02092363|Platinum-Sensitive Ovarian Cancer|platinum-sensitive ovarian cancer
251348|NCT02092337|CAST, Hearing aids, Speech recognition, Cochlear implants|cast, hearing aids, speech recognition, cochlear implants
251349|NCT02092311|varicocele|varicocele
251350|NCT02092311|varicocelectomy|varicocelectomy
251351|NCT02092311|complications of varicocelectomy|complications of varicocelectomy
251352|NCT02092311|Recurrence of varicocele|recurrence of varicocele
251353|NCT02092311|Post-varicocelectomy testicular atrophy|post-varicocelectomy testicular atrophy
251354|NCT02092311|Post-varicocelectomy hydrocele|post-varicocelectomy hydrocele
251355|NCT02092298|Gastrointestinal cancer|gastrointestinal cancer
251356|NCT02092298|Hyperthermic Intraperitoneal Chemoperfusion|hyperthermic intraperitoneal chemoperfusion
251357|NCT02092298|HIPEC|hipec
251358|NCT02092298|Gastric carcinomatosis|gastric carcinomatosis
251359|NCT02092298|Gastroesophageal cancer|gastroesophageal cancer
251360|NCT02092298|Mitomycin C|mitomycin c
251361|NCT02092298|Mitomycin|mitomycin
251362|NCT02092298|Cisplatin|cisplatin
251363|NCT02092298|Platinol-AQ|platinol-aq
251364|NCT02092298|Platinol|platinol
251365|NCT02092298|CDDP|cddp
251366|NCT02092298|Sodium Thiosulfate|sodium thiosulfate
251367|NCT02092298|Tinver|tinver
251368|NCT02092233|ARIES HSV 1&2|aries hsv 1&2
251369|NCT02092220|Bionic Pancreas|bionic pancreas
251370|NCT02092220|Insulin|insulin
251371|NCT02092220|Glucagon|glucagon
251372|NCT02092220|Continuous Glucose Monitor|continuous glucose monitor
251373|NCT02092194|beta 2-Microglobulin|beta 2-microglobulin
251374|NCT02092194|Hemodiafiltration|hemodiafiltration
251375|NCT02092194|convective volume|convective volume
251376|NCT02092168|Opicapone|opicapone
251377|NCT02092168|BIAL|bial
251378|NCT02092142|Q fever|q fever
251379|NCT02092142|Coxiella burnetii|coxiella burnetii
251503|NCT02091596|Wound|wound
251504|NCT02091596|Ulcer|ulcer
251380|NCT02092129|Acromegaly, surgery, histopathology, hyperprolactinaemia,|acromegaly, surgery, histopathology, hyperprolactinaemia,
251381|NCT02092103|Premature Birth|premature birth
251382|NCT02092103|Umbilical Cord Clamping|umbilical cord clamping
251383|NCT02092090|salt substitute|salt substitute
251384|NCT02092090|sodium reduction|sodium reduction
251385|NCT02092090|stroke|stroke
251386|NCT02092090|cluster randomized trial|cluster randomized trial
251387|NCT02092090|China|china
251388|NCT02092077|Growth Hormone-Deficient|growth hormone-deficient
251389|NCT02092077|recombinant human growth hormone|recombinant human growth hormone
251390|NCT02092064|basal proteinuria|basal proteinuria
251391|NCT02092064|FMF|fmf
251392|NCT02092064|pregnancy|pregnancy
251393|NCT02092051|Continuous glucose monitoring|continuous glucose monitoring
251394|NCT02092051|Type 1 diabetes|type 1 diabetes
251395|NCT02092051|Insulin injections|insulin injections
251396|NCT02092051|Cross-over|cross-over
251397|NCT02092038|glioblastoma|glioblastoma
251398|NCT02092038|temozolomide|temozolomide
251399|NCT02092038|radiation therapy|radiation therapy
251400|NCT02092038|radiotherapy|radiotherapy
251401|NCT02092038|surgery|surgery
251402|NCT02092038|pre-operative|pre-operative
251403|NCT02092038|neoadjuvant|neoadjuvant
251404|NCT02092025|Pharmacological therapy|pharmacological therapy
251405|NCT02092012|postoperative pain|postoperative pain
251406|NCT02092012|dexketoprofen trometamol|dexketoprofen trometamol
251407|NCT02092012|dexmedetomidine|dexmedetomidine
251408|NCT02091999|enfortumab vedotin|enfortumab vedotin
251409|NCT02091999|Metastatic Urothelial Cancer|metastatic urothelial cancer
251410|NCT02091999|Safety|safety
251411|NCT02091999|AGS-22C3E|ags-22c3e
251412|NCT02091999|EV-101|ev-101
251413|NCT02091999|Nectin 4 protein, humans|nectin 4 protein, humans
251414|NCT02091999|Clinical Trial, Phase 1|clinical trial, phase 1
251415|NCT02091999|ASG-22CE|asg-22ce
251416|NCT02091999|ASG-22ME|asg-22me
251417|NCT02091999|Pharmacokinetics of ASG-22CE|pharmacokinetics of asg-22ce
251418|NCT02091986|asthma, children, budesonide pMDI|asthma, children, budesonide pmdi
251419|NCT02091973|everolimus|everolimus
251420|NCT02091973|tacrolimus|tacrolimus
251421|NCT02091973|kidney transplantation|kidney transplantation
251422|NCT02091973|microRNA|microrna
251423|NCT02091960|Enzalutamide|enzalutamide
251424|NCT02091960|Trastuzumab|trastuzumab
251425|NCT02091960|Breast cancer|breast cancer
251426|NCT02091960|HER2|her2
251427|NCT02091960|Androgen receptor positive|androgen receptor positive
251428|NCT02091960|Xtandi|xtandi
251429|NCT02091947|FMS|fms
251430|NCT02091947|Urine incontinence|urine incontinence
251431|NCT02091934|Alcon|alcon
251432|NCT02091934|Wavelight|wavelight
251433|NCT02091934|PRK|prk
251434|NCT02091934|Wavefront-guided|wavefront-guided
251435|NCT02091934|Wavefront-optimized|wavefront-optimized
251436|NCT02091934|Myopia|myopia
251437|NCT02091934|Astigmatism|astigmatism
251438|NCT02091921|Critical Limb Ischemia, ticagrelor, Brilinta|critical limb ischemia, ticagrelor, brilinta
251439|NCT02091908|Influenza|influenza
251440|NCT02091908|H5N1|h5n1
251441|NCT02091908|aH5N1|ah5n1
251442|NCT02091908|H5N1 vaccine|h5n1 vaccine
251443|NCT02091908|Pandemic Influenza vaccine|pandemic influenza vaccine
251444|NCT02091908|MF59, Adjuvant, Avian flu|mf59, adjuvant, avian flu
251445|NCT02091908|Underlying medical conditions|underlying medical conditions
251446|NCT02091908|Underlying cardiovascular medical condition|underlying cardiovascular medical condition
251447|NCT02091908|Pandemic vaccine|pandemic vaccine
251448|NCT02091908|Charlson Comorbidity Index (CCI)|charlson comorbidity index (cci)
251449|NCT02091908|Adjuvanted vaccine|adjuvanted vaccine
251450|NCT02091895|probe-based confocal laser endomicroscopy, lower gastrointestinal disorders|probe-based confocal laser endomicroscopy, lower gastrointestinal disorders
251451|NCT02091882|OPC-14597 Digital|opc-14597 digital
251452|NCT02091882|Aripiprazole|aripiprazole
251453|NCT02091882|Medical Information Device #1 System (MIND1)|medical information device #1 system (mind1)
251454|NCT02091882|Ingestible Event Marker|ingestible event marker
251455|NCT02091869|Adolescents|adolescents
251456|NCT02091869|Asthma|asthma
251457|NCT02091869|Asthma Symptoms|asthma symptoms
251458|NCT02091817|oxytocin|oxytocin
251459|NCT02091817|face|face
251460|NCT02091817|memory|memory
251461|NCT02091804|Attachment theory|attachment theory
251462|NCT02091804|Parent- child relationship|parent- child relationship
251463|NCT02091804|Child mental health|child mental health
251464|NCT02091804|Behavioral health|behavioral health
251465|NCT02091791|acute lumbar sciatica, lumbar traction, traction force, radicular pain, lumbar functional parameters, disc herniation|acute lumbar sciatica, lumbar traction, traction force, radicular pain, lumbar functional parameters, disc herniation
251466|NCT02091765|Sexual dysfunction|sexual dysfunction
251467|NCT02091765|Intimacy problems|intimacy problems
251468|NCT02091765|Breast cancer survivors|breast cancer survivors
251469|NCT02091765|Internet-based|internet-based
251470|NCT02091765|Cognitive behavioral therapy|cognitive behavioral therapy
251471|NCT02091752|Primary Myelofibrosis|primary myelofibrosis
251472|NCT02091752|Hematologic Diseases|hematologic diseases
251473|NCT02091752|Myeloproliferative Disorders|myeloproliferative disorders
251474|NCT02091752|INC424|inc424
251476|NCT02091726|Circumcision|circumcision
251477|NCT02091726|HIV prevention|hiv prevention
251478|NCT02091726|Surgical device|surgical device
251479|NCT02091726|Cyanoacrylate|cyanoacrylate
251480|NCT02091726|Tissue Adhesive|tissue adhesive
251481|NCT02091726|voluntary|voluntary
251482|NCT02091713|FMS|fms
251483|NCT02091713|functional movement screen|functional movement screen
251484|NCT02091700|Normal|normal
251485|NCT02091700|Healthy|healthy
251486|NCT02091700|Normal healthy patient|normal healthy patient
251487|NCT02091674|ankle sprain|ankle sprain
251488|NCT02091674|hyaluronic acid|hyaluronic acid
251489|NCT02091661|Clinically localized prostate cancer|clinically localized prostate cancer
251490|NCT02091661|Radical retropubic prostatectomy|radical retropubic prostatectomy
251491|NCT02091661|External beam radiotherapy|external beam radiotherapy
251492|NCT02091661|Efficacy|efficacy
251493|NCT02091661|Quality of life|quality of life
251494|NCT02091661|adverse events|adverse events
251495|NCT02091648|Asthma|asthma
251496|NCT02091648|Stress|stress
251497|NCT02091648|Children|children
251498|NCT02091648|Psychosocial Factors|psychosocial factors
251499|NCT02091648|Relaxation|relaxation
251500|NCT02091648|Stress management|stress management
251501|NCT02091635|accommodation, emptying, motilitone|accommodation, emptying, motilitone
251502|NCT02091609|plaque removal around dental implants|plaque removal around dental implants
251505|NCT02091596|Infected|infected
251506|NCT02091596|Infection|infection
251507|NCT02091583|Metabolic syndrome|metabolic syndrome
251508|NCT02091583|Cardiovascular disease|cardiovascular disease
251509|NCT02091583|High Oleic Canola Oil|high oleic canola oil
251510|NCT02091583|DHA|dha
251511|NCT02091583|β-glucan|β-glucan
251512|NCT02091583|Barley|barley
251513|NCT02091583|Cholesterol|cholesterol
251514|NCT02091583|Lipoproteins|lipoproteins
251515|NCT02091583|Lipids|lipids
251516|NCT02091583|Inflammation|inflammation
251517|NCT02091583|Glucose|glucose
251518|NCT02091583|Insulin|insulin
251519|NCT02091583|Satiety|satiety
251520|NCT02091583|Body composition|body composition
251521|NCT02091583|Blood pressure|blood pressure
251522|NCT02091570|Hunger|hunger
251523|NCT02091570|Fullness|fullness
251524|NCT02091570|Satiety|satiety
251525|NCT02091570|Nutrition bar|nutrition bar
251526|NCT02091570|Crossover|crossover
251527|NCT02091557|GnRH-a|gnrh-a
251528|NCT02091557|endometriosis|endometriosis
251529|NCT02091557|chronic pelvic pain|chronic pelvic pain
251530|NCT02091557|VAS score|vas score
251531|NCT02091557|diagnostic accuracy|diagnostic accuracy
251532|NCT02091544|overweight|overweight
251533|NCT02091544|obesity|obesity
251534|NCT02091544|children|children
251535|NCT02091544|lifestyle intervention|lifestyle intervention
251536|NCT02091531|mTOR Inhibitor MLN0128|mtor inhibitor mln0128
251537|NCT02091531|PSA|psa
251538|NCT02091531|13-143|13-143
251539|NCT02091518|MRI|mri
251540|NCT02091518|13-239|13-239
251541|NCT02091518|volunteers|volunteers
251542|NCT02091518|patients|patients
251543|NCT02091492|Proximal humerus fracture, teriparatide|proximal humerus fracture, teriparatide
251544|NCT02091479|hæmorrhage, thrombosis|hæmorrhage, thrombosis
251545|NCT02091466|Hypothermia|hypothermia
251546|NCT02091466|Perioperative Care|perioperative care
251547|NCT02091466|Anesthesia|anesthesia
251548|NCT02091466|Spinal|spinal
251549|NCT02091466|Rewarming|rewarming
251550|NCT02091453|Brain injury|brain injury
251551|NCT02091453|stroke|stroke
251552|NCT02091453|cognitive rehabilitation|cognitive rehabilitation
251553|NCT02091440|Medical Device|medical device
251554|NCT02091440|Thoracic Surgical Procedure|thoracic surgical procedure
251555|NCT02091440|Pumps Heart Assist|pumps heart assist
251556|NCT02091440|Ventricular Assist Device|ventricular assist device
251557|NCT02091401|magnesium sulfate|magnesium sulfate
251558|NCT02091375|cannabidiol|cannabidiol
251559|NCT02091336|gestational diabetes|gestational diabetes
251560|NCT02091336|metformin|metformin
251561|NCT02091336|glyburide|glyburide
251562|NCT02091336|fetal growth|fetal growth
251563|NCT02091336|capillar glucose|capillar glucose
251564|NCT02091323|T2DM, gastric bypass surgery, BMI<35, obesity|t2dm, gastric bypass surgery, bmi<35, obesity
251565|NCT02091310|GFT505|gft505
251566|NCT02091310|TQT|tqt
251567|NCT02091310|QT/QTc|qt/qtc
251568|NCT02091310|Pharmacokinetic|pharmacokinetic
251569|NCT02091310|Healthy subjects|healthy subjects
251570|NCT02091310|Moxifloxacin|moxifloxacin
251571|NCT02091297|Buprenorphine|buprenorphine
251572|NCT02091297|Suboxone|suboxone
251573|NCT02091297|Subutex|subutex
251574|NCT02091297|Buprenex|buprenex
251575|NCT02091297|Caesarean Delivery|caesarean delivery
251576|NCT02091284|alcoholism|alcoholism
251577|NCT02091284|tDCS|tdcs
251578|NCT02091284|dlPFC|dlpfc
251579|NCT02091284|craving|craving
251580|NCT02091284|cognition|cognition
251581|NCT02091271|Evaluation|evaluation
251582|NCT02091271|Research|research
251583|NCT02091271|Healthy Volunteers|healthy volunteers
251584|NCT02091245|Relapsed acute lymphoblastic leukemia (ALL)|relapsed acute lymphoblastic leukemia (all)
251585|NCT02091245|Refractory acute lymphoblastic leukemia (ALL)|refractory acute lymphoblastic leukemia (all)
251586|NCT02091245|Relapsed acute myelogenous leukemia (AML)|relapsed acute myelogenous leukemia (aml)
251587|NCT02091245|Refractory acute myelogenous leukemia (AML)|refractory acute myelogenous leukemia (aml)
251588|NCT02091245|Relapsed childhood leukemia|relapsed childhood leukemia
251589|NCT02091245|Relapsed mixed lineage leukemia|relapsed mixed lineage leukemia
251590|NCT02091245|Refractory mixed lineage leukemia|refractory mixed lineage leukemia
251591|NCT02091245|Relapsed biphenotypic leukemia|relapsed biphenotypic leukemia
251592|NCT02091245|Refractory biphenotypic leukemia|refractory biphenotypic leukemia
251593|NCT02091245|Chronic myelogenous leukemia (CML) in blast crisis|chronic myelogenous leukemia (cml) in blast crisis
251594|NCT02091219|Hypovitaminosis D|hypovitaminosis d
251595|NCT02091219|Free 25-hydroxyvitamin D|free 25-hydroxyvitamin d
251596|NCT02091219|Total 25-hydroxyvitamin D|total 25-hydroxyvitamin d
251597|NCT02091206|Cannabidiol|cannabidiol
251598|NCT02091193|Krill Oil|krill oil
251599|NCT02091193|Endothelial Function|endothelial function
251600|NCT02091193|Type II Diabetes Mellitus|type ii diabetes mellitus
251601|NCT02091180|Anesthesia|anesthesia
251602|NCT02091180|Recovery|recovery
251603|NCT02091180|laparoscopy|laparoscopy
251604|NCT02091180|cholecystectomy|cholecystectomy
251605|NCT02091167|crack-cocaine addiction|crack-cocaine addiction
251606|NCT02091167|tDCS|tdcs
251607|NCT02091167|dlPFC|dlpfc
251608|NCT02091167|craving|craving
251609|NCT02091167|cognition|cognition
251610|NCT02091154|Food Intake Regulation|food intake regulation
251611|NCT02091154|Fruit|fruit
251612|NCT02091154|Vegetable|vegetable
251613|NCT02091115|Constipation|constipation
251614|NCT02091115|ROMA III criteria|roma iii criteria
251615|NCT02091115|Scale Bristol|scale bristol
251616|NCT02091076|Silk fibroin with bioactive coating layer dressing|silk fibroin with bioactive coating layer dressing
251617|NCT02091076|Wound healing|wound healing
251618|NCT02091076|Skin graft donor|skin graft donor
251619|NCT02091063|hematologic malignancies|hematologic malignancies
251620|NCT02091063|hodgkin|hodgkin
251621|NCT02091063|hodgkins|hodgkins
251622|NCT02091063|non-hodgkin|non-hodgkin
251623|NCT02091063|non-hodgkins|non-hodgkins
251624|NCT02091063|mantle cell lymphoma|mantle cell lymphoma
251625|NCT02091063|follicular|follicular
251626|NCT02091063|lymphoma|lymphoma
251627|NCT02091063|lymphoid malignancies|lymphoid malignancies
251628|NCT02091050|3D Brachytherapy|3d brachytherapy
251629|NCT02091050|cervical cancer|cervical cancer
251630|NCT02091050|endometrial cancer|endometrial cancer
251631|NCT02091050|vaginal vault brachytherapy|vaginal vault brachytherapy
251632|NCT02091037|Atopic dermatitis|atopic dermatitis
251633|NCT02091037|Bacterial colonization|bacterial colonization
251634|NCT02091011|This study is designed to efficiently provide device and battery longevity data on market released|this study is designed to efficiently provide device and battery longevity data on market released
251635|NCT02091011|Boston Scientific ICD and CRT-D (Cardiac Resynchronization Therapy Defibrillator) devices. In addition, the data collected will allow for|boston scientific icd and crt-d (cardiac resynchronization therapy defibrillator) devices. in addition, the data collected will allow for
251636|NCT02091011|comparisons of device survival probability estimated in the Product Performance Report versus|comparisons of device survival probability estimated in the product performance report versus
251637|NCT02091011|those collected in the study. The data collected will also provide a better understanding on the|those collected in the study. the data collected will also provide a better understanding on the
251638|NCT02091011|potential predictors of pulse generator battery longevity.|potential predictors of pulse generator battery longevity.
251639|NCT02090998|Migraine Headache|migraine headache
251640|NCT02090998|Menstrual Migraine|menstrual migraine
251641|NCT02090998|Vascular Headache|vascular headache
251642|NCT02090998|Temporal Lobe Seizure|temporal lobe seizure
251643|NCT02090985|Stoma|stoma
251644|NCT02090985|Peri-stomal|peri-stomal
251645|NCT02090985|Lipomodelling|lipomodelling
251646|NCT02090959|Duchenne muscular dystrophy|duchenne muscular dystrophy
251647|NCT02090959|Dystrophinopathy|dystrophinopathy
251648|NCT02090959|Nonsense mutation|nonsense mutation
251649|NCT02090959|Premature stop codon|premature stop codon
251650|NCT02090959|Becker muscular dystrophy|becker muscular dystrophy
251651|NCT02090959|DMD/BMD|dmd/bmd
251652|NCT02090959|PTC124|ptc124
251653|NCT02090959|Ataluren|ataluren
251654|NCT02090946|children with physical disabilities|children with physical disabilities
251655|NCT02090946|home activity programs|home activity programs
251656|NCT02090946|home programmes|home programmes
251657|NCT02090946|learning|learning
251658|NCT02090946|therapeutic relationship|therapeutic relationship
251659|NCT02090946|phenomenology|phenomenology
251660|NCT02090946|physiotherapy|physiotherapy
251661|NCT02090946|clinicians who teach|clinicians who teach
251662|NCT02090946|parent perspective|parent perspective
251663|NCT02090946|parent-professional relationships|parent-professional relationships
251664|NCT02090946|Parents/carers|parents/carers
251665|NCT02090946|long term physiotherapy needs|long term physiotherapy needs
251666|NCT02090907|Subclinical hypothyroidism|subclinical hypothyroidism
251667|NCT02090907|Atherosclerosis|atherosclerosis
251668|NCT02090907|Cardiovascular disease|cardiovascular disease
251669|NCT02090907|Endothelial function|endothelial function
251670|NCT02090907|Prevention|prevention
251671|NCT02090868|Non-Invasive Ventilation|non-invasive ventilation
251672|NCT02090868|Bi-Level Positive Airway Pressure|bi-level positive airway pressure
251673|NCT02090868|Continuous Positive Airway Pressure|continuous positive airway pressure
251674|NCT02090868|Critical Care|critical care
251675|NCT02090868|Nutrition|nutrition
251676|NCT02090868|Malnutrition|malnutrition
251677|NCT02090868|Staff attitudes, knowledge and beliefs|staff attitudes, knowledge and beliefs
251678|NCT02090842|Milk proteins|milk proteins
251679|NCT02090842|Blood pressure|blood pressure
251680|NCT02090842|Vascular function|vascular function
251681|NCT02090829|Autism|autism
251682|NCT02090829|Oxytocin|oxytocin
251683|NCT02090829|Syntocinon|syntocinon
251684|NCT02090790|dexamethasone|dexamethasone
251685|NCT02090790|femoral block|femoral block
251686|NCT02090790|total knee arthroplasty|total knee arthroplasty
251687|NCT02090751|Retinal Rod Photoreceptor Cells|retinal rod photoreceptor cells
251688|NCT02090751|Dark Adaptation|dark adaptation
251689|NCT02090725|fluctuating muscle weakness|fluctuating muscle weakness
251690|NCT02090725|hyporeflexia|hyporeflexia
251691|NCT02090725|autonomic Dysfunction|autonomic dysfunction
251692|NCT02090712|myocardial infarction|myocardial infarction
251693|NCT02090712|acute coronary syndrome|acute coronary syndrome
251694|NCT02090712|coronary disease|coronary disease
251695|NCT02090699|thalassemia major|thalassemia major
251696|NCT02090699|chronic blood transfusion related iron overload|chronic blood transfusion related iron overload
251697|NCT02090699|magnetic resonance imaging|magnetic resonance imaging
251698|NCT02090699|myocardium|myocardium
251699|NCT02090699|fibrosis|fibrosis
251700|NCT02090647|dental implant, aesthetic, implant abutment|dental implant, aesthetic, implant abutment
251701|NCT02090634|HIV|hiv
251702|NCT02090634|Bipolar Disorder|bipolar disorder
251703|NCT02090634|Medication Adherence|medication adherence
251704|NCT02090621|Liver|liver
251705|NCT02090621|transplantation|transplantation
251706|NCT02090621|Immunosuppression|immunosuppression
251707|NCT02090621|photopheresis|photopheresis
251708|NCT02090621|extracorporeal|extracorporeal
251709|NCT02090595|bipolar disorder|bipolar disorder
251710|NCT02090595|anxiety|anxiety
251711|NCT02090595|mindfulness|mindfulness
251712|NCT02090595|high risk|high risk
251713|NCT02090595|cognitive behavioral|cognitive behavioral
251714|NCT02090569|Functional micro-Doppler Sonography, fmDS, dysplasia, epilepsy, neurosurgery, cerebral blood volume, echography, hemodynamics|functional micro-doppler sonography, fmds, dysplasia, epilepsy, neurosurgery, cerebral blood volume, echography, hemodynamics
251715|NCT02090530|Cancer Genomics|cancer genomics
251716|NCT02090530|Tumor Sequencing|tumor sequencing
251717|NCT02090517|Nasal telangiectasis|nasal telangiectasis
251718|NCT02090504|alcohol withdrawal syndrome|alcohol withdrawal syndrome
251719|NCT02090504|treatment|treatment
251720|NCT02090504|sodium oxybate|sodium oxybate
251721|NCT02090504|oxazepam|oxazepam
251722|NCT02090491|autism|autism
251723|NCT02090465|Actinic Keratosis|actinic keratosis
251724|NCT02090452|Telemedicine|telemedicine
251725|NCT02090452|Mobile|mobile
251726|NCT02090452|Vital signs|vital signs
251727|NCT02090452|Prehospital care|prehospital care
251728|NCT02090452|Emergency medicine|emergency medicine
251729|NCT02090413|multiple sclerosis|multiple sclerosis
251730|NCT02090413|flushing|flushing
251731|NCT02090413|aspirin|aspirin
251732|NCT02090400|Women|women
251733|NCT02090400|Osteoporosis, Postmenopausal|osteoporosis, postmenopausal
251734|NCT02090400|Bazedoxifene|bazedoxifene
251735|NCT02090400|BMD|bmd
251736|NCT02090374|Allergy|allergy
251737|NCT02090374|Asthma|asthma
251738|NCT02090374|Biomarkers|biomarkers
251739|NCT02090374|Chemokines|chemokines
251740|NCT02090374|Cytokines|cytokines
251741|NCT02090374|Eosinophil|eosinophil
251742|NCT02090374|Gene Expression|gene expression
251743|NCT02090374|Grass pollen|grass pollen
251744|NCT02090374|Hay Fever|hay fever
251745|NCT02090374|Human Challenge Study|human challenge study
251746|NCT02090374|Inflammation|inflammation
251747|NCT02090374|Innate Immune Response|innate immune response
251748|NCT02090374|Lipopolysaccharide|lipopolysaccharide
251749|NCT02090374|Mucosal Lining Fluid|mucosal lining fluid
251750|NCT02090374|Nasal|nasal
251751|NCT02090374|Nasorption|nasorption
251752|NCT02090374|Respiratory|respiratory
251753|NCT02090374|Respiratory Tract Infection|respiratory tract infection
251754|NCT02090374|T cells|t cells
251755|NCT02090374|Tuberculosis|tuberculosis
251756|NCT02090374|Virus|virus
251757|NCT02090361|collagen -elastin matrix|collagen -elastin matrix
251758|NCT02090361|skin graft|skin graft
251759|NCT02090361|loss of cutaneous substance|loss of cutaneous substance
251760|NCT02090335|community mental health|community mental health
251761|NCT02090335|health coach|health coach
251762|NCT02090335|weight loss|weight loss
251763|NCT02090335|fitness|fitness
251764|NCT02090335|serious mental illness|serious mental illness
251765|NCT02090335|health promotion|health promotion
251766|NCT02090322|ROP|rop
251767|NCT02090322|Bevacizumab|bevacizumab
251768|NCT02090322|No inferiority|no inferiority
251769|NCT02090283|Epidermolysis Bullosa|epidermolysis bullosa
251770|NCT02090283|Simplex|simplex
251771|NCT02090283|Recessive Dystrophic|recessive dystrophic
251772|NCT02090283|Junctional non-Herlitz|junctional non-herlitz
251773|NCT02090270|hair cortisol|hair cortisol
251774|NCT02090270|stroke|stroke
251775|NCT02090257|Heart transplant recipients who are entering into adult care.|heart transplant recipients who are entering into adult care.
251776|NCT02090244|PTH|pth
251777|NCT02090244|Spinal stenosis|spinal stenosis
251778|NCT02090244|Teriparatide|teriparatide
251779|NCT02090231|stroke|stroke
251780|NCT02090231|dysphagia|dysphagia
251781|NCT02090231|rTMS|rtms
251782|NCT02090205|cardio-pulmonary bypass|cardio-pulmonary bypass
251783|NCT02090205|cardiac surgery|cardiac surgery
251784|NCT02090205|lung injury prevention|lung injury prevention
251785|NCT02090205|mechanical ventilation|mechanical ventilation
251786|NCT02090205|pulmonary insufficiency|pulmonary insufficiency
251787|NCT02090192|Whole-body vibration;|whole-body vibration;
251788|NCT02090192|Frail Elderly;|frail elderly;
251789|NCT02090192|Blood flow;|blood flow;
251790|NCT02090192|Bone density|bone density
251791|NCT02090192|Mobility;|mobility;
251792|NCT02090192|Balance;|balance;
251793|NCT02090192|Muscle strength;|muscle strength;
251794|NCT02090192|Lower Extremity;|lower extremity;
251795|NCT02090192|Musculoskeletal System;|musculoskeletal system;
251796|NCT02090192|Health Status;|health status;
251797|NCT02090192|Exercise;|exercise;
251798|NCT02090192|Mechanical Oscillation|mechanical oscillation
251799|NCT02090179|MPS IIIB|mps iiib
251800|NCT02090179|Mucopolysaccharidosis|mucopolysaccharidosis
251801|NCT02090179|Mucopolysaccharidosis type IIIB|mucopolysaccharidosis type iiib
251802|NCT02090179|Sanfilippo Syndrome|sanfilippo syndrome
251803|NCT02090179|Metabolism, Inborn Errors|metabolism, inborn errors
251804|NCT02090179|Metabolic Diseases|metabolic diseases
251805|NCT02090179|Genetic Diseases, Inborn|genetic diseases, inborn
251806|NCT02090153|Advance Gastric Cancer,|advance gastric cancer,
251807|NCT02090153|S-1 plus leucovorin,|s-1 plus leucovorin,
251808|NCT02090153|ORR,|orr,
251809|NCT02090153|OS,|os,
251810|NCT02090153|TTP,|ttp,
251811|NCT02090153|TTF,|ttf,
251812|NCT02090153|Adverse events,|adverse events,
251813|NCT02090153|Pharmacokinetics|pharmacokinetics
251814|NCT02090140|cartilage/transplantation|cartilage/transplantation
251815|NCT02090140|cartilage, articular/injuries|cartilage, articular/injuries
251816|NCT02090140|cartilage, articular/surgery|cartilage, articular/surgery
251817|NCT02090140|chondrocytes/cytology|chondrocytes/cytology
251818|NCT02090140|knee injuries/surgery|knee injuries/surgery
251819|NCT02090140|knee joint/surgery|knee joint/surgery
251820|NCT02090140|orthopedic procedures/methods|orthopedic procedures/methods
251821|NCT02090140|tissue engineering|tissue engineering
251822|NCT02090140|tissue scaffolds|tissue scaffolds
251823|NCT02090140|arthroscopy/methods|arthroscopy/methods
251824|NCT02090140|chondrocytes/transplantation|chondrocytes/transplantation
251825|NCT02090140|adipose tissue/cytology|adipose tissue/cytology
251826|NCT02090140|cartilage, articular/cytology|cartilage, articular/cytology
251827|NCT02090140|chondrogenesis/physiology|chondrogenesis/physiology
251828|NCT02090140|osteogenesis/physiology|osteogenesis/physiology
251829|NCT02090140|stem cell transplantation/methods|stem cell transplantation/methods
251830|NCT02090140|stem cells|stem cells
251831|NCT02090140|tissue engineering/methods|tissue engineering/methods
251832|NCT02090140|cartilage, articular/pathology|cartilage, articular/pathology
251833|NCT02090140|chondrocytes/pathology|chondrocytes/pathology
251834|NCT02090140|knee joint/pathology|knee joint/pathology
251835|NCT02090140|platelet-rich plasma|platelet-rich plasma
251836|NCT02090114|Bipolar Androgen Therapy|bipolar androgen therapy
251837|NCT02090114|Testosterone|testosterone
251838|NCT02090114|Enzalutamide|enzalutamide
251839|NCT02090114|Abiraterone|abiraterone
251840|NCT02090114|Androgen Ablative Therapies|androgen ablative therapies
251841|NCT02090075|cardiac Computed tomography|cardiac computed tomography
251842|NCT02090075|coronary calcification|coronary calcification
251843|NCT02090075|intervention|intervention
251844|NCT02090075|warfarin|warfarin
251845|NCT02090075|apixaban|apixaban
251846|NCT02090062|endoscopic resection|endoscopic resection
251847|NCT02090062|H. pylori infection|h. pylori infection
251848|NCT02090049|Appetite|appetite
251849|NCT02090049|Satiety|satiety
251850|NCT02090049|Bread|bread
251851|NCT02090049|Dietary fiber|dietary fiber
251852|NCT02090049|Gastrointestinal hormones|gastrointestinal hormones
251853|NCT02090049|Glycemia|glycemia
251854|NCT02090049|Insulinemia|insulinemia
251855|NCT02090036|Efficacy|efficacy
251856|NCT02090036|Safety|safety
251857|NCT02090036|Primaquine|primaquine
251858|NCT02090036|Artemether-lumefantrine|artemether-lumefantrine
251859|NCT02090036|Gametocytes|gametocytes
251860|NCT02090023|Obstructive sleep apnea|obstructive sleep apnea
251861|NCT02090023|National Health Insurance Research Database in Taiwan|national health insurance research database in taiwan
251862|NCT02090023|Survival Analysis|survival analysis
251863|NCT02090023|Validation Studies|validation studies
251864|NCT02090023|Cohort Studies|cohort studies
251865|NCT02089997|Pharmacological therapy|pharmacological therapy
252839|NCT02084940|IVF|ivf
251866|NCT02089984|Cognitive Behavior Therapy|cognitive behavior therapy
251867|NCT02089984|On-line training|on-line training
251868|NCT02089958|Lapraoscopy, incisional hernia repair, mesh|lapraoscopy, incisional hernia repair, mesh
251869|NCT02089945|transcatheter aortic valve implantation|transcatheter aortic valve implantation
251870|NCT02089945|severe aortic stenosis|severe aortic stenosis
251871|NCT02089945|cognition|cognition
251872|NCT02089945|functional capacity|functional capacity
251873|NCT02089945|quality of life|quality of life
251874|NCT02089932|femoral nerve block|femoral nerve block
251875|NCT02089932|peri-neural dexmedetomidine|peri-neural dexmedetomidine
251876|NCT02089867|Ezetimibe|ezetimibe
251877|NCT02089867|Plant sterol|plant sterol
251878|NCT02089867|Hydroxymethylglutaryl coenzyme A Reductase Inhibitors|hydroxymethylglutaryl coenzyme a reductase inhibitors
251879|NCT02089867|Coronary artery disease|coronary artery disease
251880|NCT02089867|LDL-cholesterol|ldl-cholesterol
251881|NCT02089854|triple negative breast cancer|triple negative breast cancer
251882|NCT02089854|estrogen receptor-beta|estrogen receptor-beta
251883|NCT02089854|endocrine therapy|endocrine therapy
251884|NCT02089841|Efficacy|efficacy
251885|NCT02089841|Artemether/lumefantrine|artemether/lumefantrine
251886|NCT02089841|Malaria|malaria
251887|NCT02089841|Children|children
251888|NCT02089802|RCC|rcc
251889|NCT02089789|Natural History|natural history
251890|NCT02089789|Glycosylation|glycosylation
251891|NCT02089789|Genetic Disorders|genetic disorders
251892|NCT02089776|Stroke|stroke
251893|NCT02089776|fMRI|fmri
251894|NCT02089776|Real Time fMRI Feedback|real time fmri feedback
251895|NCT02089763|Hepatocellular carcinoma|hepatocellular carcinoma
251896|NCT02089763|HCC|hcc
251897|NCT02089763|Pegylated recombinant human arginase|pegylated recombinant human arginase
251898|NCT02089763|PEG-BCT-100|peg-bct-100
251899|NCT02089763|ASS|ass
251900|NCT02089763|OTC|otc
251901|NCT02089750|Low Back Pain|low back pain
251902|NCT02089750|Chiropractic|chiropractic
251903|NCT02089750|Shoe Orthotics|shoe orthotics
251904|NCT02089711|Normal subjects|normal subjects
251905|NCT02089698|Kelman tip|kelman tip
251906|NCT02089698|Mini-flared|mini-flared
251907|NCT02089698|phacoemulsification|phacoemulsification
251908|NCT02089698|cataract|cataract
251909|NCT02089633|hepatocellular carcinoma|hepatocellular carcinoma
251910|NCT02089633|HCC|hcc
251911|NCT02089633|pegylated recombinant human arginase|pegylated recombinant human arginase
251912|NCT02089633|PEG-BCT-100|peg-bct-100
251913|NCT02089633|oxaliplatin|oxaliplatin
251914|NCT02089633|capecitabine|capecitabine
251915|NCT02089620|Premenstrual syndrome|premenstrual syndrome
251916|NCT02089620|Oral contraceptive pills|oral contraceptive pills
251917|NCT02089620|Calcium Supplements|calcium supplements
251918|NCT02089594|Hyperbaric Oxygen Treatment|hyperbaric oxygen treatment
251919|NCT02089594|Mild Traumatic Brain Injury|mild traumatic brain injury
251920|NCT02089594|Persistent Post-Concussion Syndrome|persistent post-concussion syndrome
251921|NCT02089581|Healthy Volunteer|healthy volunteer
251922|NCT02089581|Pharmacokinetics|pharmacokinetics
251923|NCT02089581|Bioequivalence|bioequivalence
251924|NCT02089568|Living donation|living donation
251925|NCT02089568|Antibiotics|antibiotics
251926|NCT02089568|Laparoscopic surgery|laparoscopic surgery
251927|NCT02089542|thyroidectomy|thyroidectomy
251928|NCT02089542|parathyroid surgery|parathyroid surgery
251929|NCT02089542|parathyroid identification|parathyroid identification
251930|NCT02089542|methylene blue|methylene blue
251931|NCT02089542|near infrared fluorescence|near infrared fluorescence
251932|NCT02089542|intraoperative imaging|intraoperative imaging
251933|NCT02089529|Axial Spondyloarthritis|axial spondyloarthritis
251934|NCT02089529|Pain|pain
251935|NCT02089529|NSAIDs|nsaids
251936|NCT02089529|Placebo|placebo
251937|NCT02089529|Placebo intervention|placebo intervention
251938|NCT02089529|Stress|stress
251939|NCT02089529|Conditioning|conditioning
251940|NCT02089516|Frailty|frailty
251941|NCT02089516|Accelerometry|accelerometry
251942|NCT02089516|Physical activity|physical activity
251943|NCT02089516|validity|validity
251944|NCT02089477|Type 2 diabetes, InterWalk, Individual Support, Motivation|type 2 diabetes, interwalk, individual support, motivation
251945|NCT02089412|Healthy Subjects|healthy subjects
251946|NCT02089412|Absorption|absorption
251947|NCT02089412|High-Fat Meal|high-fat meal
251948|NCT02089360|Advanced glycation end product|advanced glycation end product
251949|NCT02089360|coronary|coronary
251950|NCT02089360|atherosclerosis|atherosclerosis
251951|NCT02089360|inflammation|inflammation
251952|NCT02089360|outcome|outcome
251953|NCT02089347|Tetanus|tetanus
251954|NCT02089347|Diphtheria|diphtheria
251955|NCT02089347|Pertussis|pertussis
251956|NCT02089347|TdaP vaccine|tdap vaccine
251957|NCT02089347|DT vaccine|dt vaccine
251958|NCT02089334|renal cell carcinoma|renal cell carcinoma
251959|NCT02089334|clear cell|clear cell
251960|NCT02089334|renal cancer|renal cancer
251961|NCT02089334|metastatic renal cancer|metastatic renal cancer
251962|NCT02089334|Carcinoma, Renal Cell*/therapy|carcinoma, renal cell*/therapy
251963|NCT02089334|Humans|humans
251964|NCT02089334|Kidney Neoplasms*/therapy|kidney neoplasms*/therapy
251965|NCT02089321|low back pain|low back pain
251966|NCT02089321|lumbopelvic assessment|lumbopelvic assessment
251967|NCT02089321|active straight leg raise|active straight leg raise
251968|NCT02089321|active hip abduction|active hip abduction
251969|NCT02089308|Smoking cessation|smoking cessation
251970|NCT02089308|Nicotine|nicotine
251971|NCT02089308|Tobacco Use Disorder|tobacco use disorder
251972|NCT02089308|Central Nervous System Agents|central nervous system agents
251973|NCT02089295|dose proportionality|dose proportionality
251974|NCT02089295|oxycodone|oxycodone
251975|NCT02089269|pancreatic neoplasms|pancreatic neoplasms
251976|NCT02089269|neoplasms|neoplasms
251977|NCT02089269|registry|registry
251978|NCT02089269|advanced pancreatic cancer|advanced pancreatic cancer
251979|NCT02089269|health services research|health services research
251980|NCT02089269|epidemiology|epidemiology
251981|NCT02089269|Germany|germany
251982|NCT02089269|palliative treatment|palliative treatment
251983|NCT02089269|palliative care|palliative care
251984|NCT02089269|localized, resectable pancreatic cancer|localized, resectable pancreatic cancer
251985|NCT02089269|adjuvant treatment|adjuvant treatment
251986|NCT02089243|Epilepsy,Temporal Lobe|epilepsy,temporal lobe
251987|NCT02089243|Brain Diseases|brain diseases
251988|NCT02089230|Leukemia|leukemia
251989|NCT02089230|Acute Myeloid Leukemia|acute myeloid leukemia
251990|NCT02089230|AML|aml
251991|NCT02089230|Advanced leukemias|advanced leukemias
251992|NCT02089230|Myelodysplastic syndrome|myelodysplastic syndrome
251993|NCT02089230|MDS|mds
251994|NCT02089230|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
251995|NCT02089230|ALL|all
251996|NCT02089230|Relapsed|relapsed
251997|NCT02089230|Refractory|refractory
251998|NCT02089230|MEK 162|mek 162
251999|NCT02089217|asymptomatic|asymptomatic
252000|NCT02089217|carotid|carotid
252001|NCT02089217|stent|stent
252002|NCT02089217|endarterectomy|endarterectomy
252003|NCT02089217|embolic protection|embolic protection
252004|NCT02089217|medical management|medical management
252005|NCT02089217|hypertension|hypertension
252006|NCT02089217|hyperlipidemia|hyperlipidemia
252007|NCT02089217|cognition|cognition
252008|NCT02089217|risk factor control|risk factor control
252009|NCT02089204|Hypoxia Imaging -Guided Radiotherapy|hypoxia imaging -guided radiotherapy
252010|NCT02089204|PET/CT|pet/ct
252011|NCT02089204|simultaneous modulated accelerated radiation therapy (SMART)|simultaneous modulated accelerated radiation therapy (smart)
252012|NCT02089191|DACP|dacp
252013|NCT02089191|DAILIES® AquaComfort Plus|dailies® aquacomfort plus
252014|NCT02089191|Tear film stability|tear film stability
252015|NCT02089191|NIK-BUT|nik-but
252016|NCT02089178|total intravenous anesthesia, inhalation anesthesia, cancer cell cytotoxicity, breast tumor|total intravenous anesthesia, inhalation anesthesia, cancer cell cytotoxicity, breast tumor
252017|NCT02089152|Diabetes|diabetes
252018|NCT02089152|Melioidosis|melioidosis
252019|NCT02089152|stepped wedge trial|stepped wedge trial
252020|NCT02089152|behaviour change|behaviour change
252021|NCT02089152|Education program|education program
252022|NCT02089139|Back pain|back pain
252023|NCT02089139|Discogel|discogel
252024|NCT02089087|Rheumatoid arthritis, RA, first-in-human, single ascending dose, safety, tolerability|rheumatoid arthritis, ra, first-in-human, single ascending dose, safety, tolerability
252025|NCT02089074|Secondary Prevention|secondary prevention
252026|NCT02089074|Pharmacists|pharmacists
252027|NCT02089074|Directive Counseling|directive counseling
252028|NCT02089074|Medication Adherence|medication adherence
252029|NCT02089074|Patient Compliance|patient compliance
252030|NCT02089048|Amebiasis|amebiasis
252031|NCT02089048|auranofin|auranofin
252032|NCT02089048|pharmacodynamics|pharmacodynamics
252033|NCT02089048|pharmokinetics|pharmokinetics
252034|NCT02089035|Milk fatty acids|milk fatty acids
252035|NCT02089035|Total cholesterol|total cholesterol
252036|NCT02089035|Vascular function|vascular function
252037|NCT02089035|Blood pressure|blood pressure
252038|NCT02089022|Ice|ice
252039|NCT02089022|Heat|heat
252040|NCT02089022|Ground reaction forces|ground reaction forces
252041|NCT02089022|Electromyography|electromyography
252042|NCT02089022|Lower Limb|lower limb
252043|NCT02089022|Center of pressure|center of pressure
252044|NCT02088970|Infectious keratitis|infectious keratitis
252045|NCT02088970|Corneal cross linking|corneal cross linking
252046|NCT02088970|Topical antibiotics|topical antibiotics
252047|NCT02088957|Brivaracetam|brivaracetam
252048|NCT02088957|Phenytoin|phenytoin
252049|NCT02088957|Nonconvulsive electrographic seizures|nonconvulsive electrographic seizures
252050|NCT02088931|Tregs|tregs
252051|NCT02088931|Kidney transplantation|kidney transplantation
252052|NCT02088905|PCIT, autism, parent training, noncompliance|pcit, autism, parent training, noncompliance
252053|NCT02088892|BCG challenge study|bcg challenge study
252054|NCT02088866|Tinnitus|tinnitus
252055|NCT02088866|Otolaryngology|otolaryngology
252056|NCT02088853|intestinal|intestinal
252057|NCT02088853|metabolic control|metabolic control
252058|NCT02088853|mucosa|mucosa
252059|NCT02088853|human|human
252060|NCT02088853|diet|diet
252061|NCT02088840|SIGNB|signb
252840|NCT02084940|COH|coh
252062|NCT02088840|severe infections gram negative bacteria|severe infections gram negative bacteria
252063|NCT02088840|stem cell transplant|stem cell transplant
252064|NCT02088827|Exercise|exercise
252065|NCT02088827|Sedentary Behaviour|sedentary behaviour
252066|NCT02088827|Type 2 Diabetes|type 2 diabetes
252067|NCT02088827|Older Adults|older adults
252068|NCT02088814|posttraumatic stress|posttraumatic stress
252069|NCT02088814|burns|burns
252070|NCT02088814|injuries|injuries
252071|NCT02088814|children|children
252072|NCT02088801|Intubation; Difficult|intubation; difficult
252073|NCT02088788|radiation|radiation
252074|NCT02088788|radiation injury|radiation injury
252075|NCT02088788|occupational risk|occupational risk
252076|NCT02088762|margin of safety|margin of safety
252077|NCT02088749|obesity|obesity
252078|NCT02088749|weight loss|weight loss
252079|NCT02088749|treatment|treatment
252080|NCT02088749|lifestyle|lifestyle
252081|NCT02088723|Sleep Apnea, Obstructive|sleep apnea, obstructive
252082|NCT02088723|Sleep Apnea Syndromes|sleep apnea syndromes
252083|NCT02088723|Polysomnography|polysomnography
252084|NCT02088723|Sleep|sleep
252085|NCT02088723|Patient Positioning|patient positioning
252086|NCT02088710|Patients´ Expectations|patients´ expectations
252087|NCT02088710|Breast Cancer|breast cancer
252088|NCT02088710|Adjuvant Endocrine Treatment|adjuvant endocrine treatment
252089|NCT02088710|Nocebo|nocebo
252090|NCT02088710|Psycho-oncology|psycho-oncology
252091|NCT02088710|Satisfaction with information|satisfaction with information
252092|NCT02088684|Hormone receptor positive, HER2 negative|hormone receptor positive, her2 negative
252093|NCT02088671|NeuroSENSE|neurosense
252094|NCT02088671|Anesthesia|anesthesia
252095|NCT02088671|Hypnosis|hypnosis
252096|NCT02088671|Desflurane|desflurane
252097|NCT02088671|Propofol|propofol
252098|NCT02088658|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
252099|NCT02088658|Diabetes Mellitus, Adult-Onset|diabetes mellitus, adult-onset
252100|NCT02088658|Diabetes Mellitus, Non-Insulin-Dependent|diabetes mellitus, non-insulin-dependent
252101|NCT02088658|Diabetes Mellitus, Noninsulin Dependent|diabetes mellitus, noninsulin dependent
252102|NCT02088658|Diabetes Mellitus, Type II|diabetes mellitus, type ii
252103|NCT02088658|African Americans|african americans
252104|NCT02088658|Blacks|blacks
252105|NCT02088658|non-Hispanic Blacks|non-hispanic blacks
252106|NCT02088658|Randomized Control Trial|randomized control trial
252107|NCT02088658|Controlled Clinical Trial|controlled clinical trial
252108|NCT02088658|Behavioral Research|behavioral research
252109|NCT02088658|Behavioral Medicine|behavioral medicine
252110|NCT02088645|Calcitonin|calcitonin
252111|NCT02088645|Medullary thyroid carcinoma|medullary thyroid carcinoma
252112|NCT02088645|Peptide receptor radionuclide therapy|peptide receptor radionuclide therapy
252113|NCT02088645|Gastrin|gastrin
252114|NCT02088645|Cholecystokinin-2 receptor|cholecystokinin-2 receptor
252115|NCT02088619|psychological wellbeing|psychological wellbeing
252116|NCT02088619|anxiety|anxiety
252117|NCT02088619|depression|depression
252118|NCT02088619|autonomic functioning|autonomic functioning
252119|NCT02088606|Atrial fibrillation|atrial fibrillation
252120|NCT02088593|Medical Students|medical students
252121|NCT02088541|Relapsed/Refractory Acute Myeloid Leukemia|relapsed/refractory acute myeloid leukemia
252122|NCT02088541|Acute Myeloid Leukemia|acute myeloid leukemia
252123|NCT02088541|AML|aml
252124|NCT02088541|Karyopharm|karyopharm
252125|NCT02088541|Selinexor|selinexor
252126|NCT02088541|KPT-330|kpt-330
252127|NCT02088515|Nedaplatin|nedaplatin
252128|NCT02088515|lung squamous cell carcinoma|lung squamous cell carcinoma
252129|NCT02088502|Coronary Angiography|coronary angiography
252130|NCT02088502|Side Effects|side effects
252131|NCT02088502|Contrast-Induced Nephropathy|contrast-induced nephropathy
252132|NCT02088502|Prevention|prevention
252133|NCT02088489|Atrial flutter|atrial flutter
252134|NCT02088489|Thermocool catheter|thermocool catheter
252135|NCT02088489|Thermocool SF catheter|thermocool sf catheter
252136|NCT02088476|candidemia|candidemia
252137|NCT02088476|children|children
252138|NCT02088476|mortality|mortality
252139|NCT02088476|risk factors|risk factors
252140|NCT02088463|Mechanical LBP|mechanical lbp
252141|NCT02088463|Mobilization|mobilization
252142|NCT02088463|Postpartum|postpartum
252143|NCT02088450|Cardiovascular complications|cardiovascular complications
252144|NCT02088450|Clinical trial|clinical trial
252145|NCT02088450|Elderly|elderly
252146|NCT02088450|Isolated systolic hypertension|isolated systolic hypertension
252147|NCT02088450|Stroke|stroke
252148|NCT02088398|relative bioavailability|relative bioavailability
252149|NCT02088398|food-effect|food-effect
252150|NCT02088359|cycled light, near darkness, growth|cycled light, near darkness, growth
252151|NCT02088346|Stroke|stroke
252152|NCT02088346|Thrombolysis|thrombolysis
252153|NCT02088346|Tissue plasminogen activator|tissue plasminogen activator
252154|NCT02088346|Urokinase|urokinase
252155|NCT02088346|Telemedicine|telemedicine
252156|NCT02088333|colorectal cancer screening|colorectal cancer screening
252157|NCT02088333|computer-assisted instruction|computer-assisted instruction
252158|NCT02088333|mHealth|mhealth
252159|NCT02088333|text message|text message
252160|NCT02088307|cardiovascular supplement|cardiovascular supplement
252161|NCT02088307|cardiovascular disease|cardiovascular disease
252162|NCT02088307|coronary artery disease|coronary artery disease
252163|NCT02088294|obesity|obesity
252164|NCT02088294|stress|stress
252165|NCT02088294|intuitive eating|intuitive eating
252166|NCT02088294|guided imagery|guided imagery
252167|NCT02088294|adolescents|adolescents
252168|NCT02088294|insulin resistance|insulin resistance
252169|NCT02088294|latinos|latinos
252170|NCT02088294|minorities|minorities
252171|NCT02088281|Indigo naturalis, indirubin, Th1 cells, Th17 cells|indigo naturalis, indirubin, th1 cells, th17 cells
252172|NCT02088255|Rehabilitation|rehabilitation
252173|NCT02088255|Gait|gait
252174|NCT02088255|Stroke|stroke
252175|NCT02088255|Biomechanics|biomechanics
252176|NCT02088229|Diabetic Macular Edema|diabetic macular edema
252177|NCT02088216|N-acetylcysteine；|n-acetylcysteine；
252178|NCT02088216|Bronchiectasis；|bronchiectasis；
252179|NCT02088216|Acute exacerbations；|acute exacerbations；
252180|NCT02088216|Antioxidant；|antioxidant；
252181|NCT02088216|Anti-inflammatory|anti-inflammatory
252182|NCT02088177|Cannabis|cannabis
252183|NCT02088177|Cannabis Dependence|cannabis dependence
252184|NCT02088177|Cannabis Use Disorder|cannabis use disorder
252185|NCT02088177|Marijuana|marijuana
252186|NCT02088177|Naltrexone|naltrexone
252187|NCT02088177|Long Acting Injectable Naltrexone|long acting injectable naltrexone
252188|NCT02088177|Treatment|treatment
252189|NCT02088164|PSA,|psa,
252190|NCT02088164|asian men,|asian men,
252191|NCT02088164|survival|survival
252192|NCT02088151|selective laser therapy|selective laser therapy
252193|NCT02088151|retinal pigment epithelium|retinal pigment epithelium
252194|NCT02088151|macular edema|macular edema
252195|NCT02088151|diabetic retinopathy|diabetic retinopathy
252196|NCT02088151|central serous chorioretinopathy|central serous chorioretinopathy
252197|NCT02088151|age-related macular degeneration|age-related macular degeneration
252198|NCT02088151|retinal vein occlusion|retinal vein occlusion
252199|NCT02088138|Thoracic Surgery|thoracic surgery
252200|NCT02088138|Electrical Stimulation|electrical stimulation
252201|NCT02088138|Rehabilitation|rehabilitation
252202|NCT02088138|Quality of Life|quality of life
252203|NCT02088125|Stroke|stroke
252204|NCT02088125|Incentive Spirometry|incentive spirometry
252205|NCT02088125|Breath Stacking|breath stacking
252206|NCT02088125|Optoelectronic Plethysmography|optoelectronic plethysmography
252207|NCT02088112|NSCLC|nsclc
252208|NCT02088099|Traumatic brain injury|traumatic brain injury
252209|NCT02088099|Telehealth|telehealth
252210|NCT02088099|ehealth|ehealth
252211|NCT02088099|Mobile Health|mobile health
252212|NCT02088099|social participation|social participation
252213|NCT02088099|patient participation|patient participation
252214|NCT02088099|consumer participation|consumer participation
252215|NCT02088099|Patient Outcome Assessment|patient outcome assessment
252216|NCT02088086|Pediatric obesity|pediatric obesity
252217|NCT02088086|Overweight|overweight
252218|NCT02088086|Body mass index|body mass index
252219|NCT02088086|Primary schools|primary schools
252220|NCT02088086|Secondary schools|secondary schools
252221|NCT02088047|Autism|autism
252222|NCT02088047|Self-Stimulating behaviors|self-stimulating behaviors
252223|NCT02088047|Autism Spectrum Disorders|autism spectrum disorders
252224|NCT02087995|Diabetes Mellitus|diabetes mellitus
252225|NCT02087956|Women|women
252226|NCT02087956|Depression|depression
252227|NCT02087956|Socioeconomically Disadvantaged|socioeconomically disadvantaged
252228|NCT02087956|Navigation|navigation
252229|NCT02087943|Atopic Dermatitis|atopic dermatitis
252230|NCT02087943|Atopic Eczema|atopic eczema
252231|NCT02087917|hypercholesterolemia|hypercholesterolemia
252232|NCT02087917|cholesterol absorption inhibitor|cholesterol absorption inhibitor
252233|NCT02087917|placebo-controlled trial|placebo-controlled trial
252234|NCT02087904|Pain|pain
252235|NCT02087904|Osteoarthritis|osteoarthritis
252236|NCT02087904|Synovitis|synovitis
252237|NCT02087904|Knee|knee
252238|NCT02087878|Hepatosplenic T-Cell Lymphoma|hepatosplenic t-cell lymphoma
252239|NCT02087852|Questionnaire|questionnaire
252241|NCT02087852|saliva|saliva
252242|NCT02087852|kidney cancer|kidney cancer
252243|NCT02087852|13-218|13-218
252244|NCT02087839|Non-Small Cell Lung Cancer|non-small cell lung cancer
252245|NCT02087839|Lung Cancer|lung cancer
252246|NCT02087839|NSCLC|nsclc
252247|NCT02087839|ZD6474|zd6474
252248|NCT02087839|ZACTIMA|zactima
252249|NCT02087839|Vandetanib|vandetanib
252250|NCT02087839|Inoperable NSCLC|inoperable nsclc
252251|NCT02087839|Unresectable NSCLC|unresectable nsclc
252252|NCT02087839|Radiation Therapy|radiation therapy
252253|NCT02087839|Palliative radiation therapy|palliative radiation therapy
252254|NCT02087839|Angiogenesis|angiogenesis
252255|NCT02087813|neuromyelitis optica|neuromyelitis optica
252256|NCT02087813|optic neuritis|optic neuritis
252257|NCT02087813|longitudinally extensive transverse myelitis|longitudinally extensive transverse myelitis
252258|NCT02087800|smoking cessation|smoking cessation
252259|NCT02087800|smoking abstinence|smoking abstinence
252941|NCT02084446|Tacrolimus|tacrolimus
252260|NCT02087800|allopregnanolone|allopregnanolone
252261|NCT02087787|bone marrow transplant|bone marrow transplant
252262|NCT02087787|hematologic malignancies|hematologic malignancies
252263|NCT02087761|ARIES Flu|aries flu
252264|NCT02087748|DOMS|doms
252265|NCT02087735|Cranberry|cranberry
252266|NCT02087735|Proanthocyanidins|proanthocyanidins
252267|NCT02087735|Urinary catabolites|urinary catabolites
252268|NCT02087722|Primary Insomnia|primary insomnia
252269|NCT02087696|Arthritis, Rheumatoid|arthritis, rheumatoid
252270|NCT02087696|methotrexate|methotrexate
252271|NCT02087696|intolerance|intolerance
252272|NCT02087696|poor compliance|poor compliance
252273|NCT02087696|contraindication|contraindication
252274|NCT02087696|Tocilizumab|tocilizumab
252275|NCT02087696|monotherapy|monotherapy
252276|NCT02087683|heart failure|heart failure
252277|NCT02087683|vitamin D deficiency|vitamin d deficiency
252278|NCT02087683|ventricular function|ventricular function
252279|NCT02087683|cytokines|cytokines
252280|NCT02087670|chronic heart failure|chronic heart failure
252281|NCT02087670|cardiac rehabilitation|cardiac rehabilitation
252282|NCT02087670|exercise|exercise
252283|NCT02087670|Natriuretic Brain Pro-peptid|natriuretic brain pro-peptid
252284|NCT02087657|Peripheral Blood Stem Cell (PBSC) Transplant|peripheral blood stem cell (pbsc) transplant
252285|NCT02087657|Hyperbaric oxygen|hyperbaric oxygen
252286|NCT02087657|Lymphoma|lymphoma
252287|NCT02087657|Myeloma|myeloma
252288|NCT02087631|multiple sclerosis|multiple sclerosis
252289|NCT02087631|quetiapine|quetiapine
252290|NCT02087631|remyelination|remyelination
252291|NCT02087618|MCI|mci
252292|NCT02087618|Alzheimer's|alzheimer's
252293|NCT02087618|Dementia|dementia
252294|NCT02087618|Tablet|tablet
252295|NCT02087618|Non-Pharmacological Intervention|non-pharmacological intervention
252296|NCT02087618|Cognition|cognition
252297|NCT02087605|Vascular stiffness, retinal vessels, target organ damage|vascular stiffness, retinal vessels, target organ damage
252298|NCT02087592|hereditary breast and ovarian cancer (HBOC)|hereditary breast and ovarian cancer (hboc)
252299|NCT02087592|BRCA1/2 mutation carriers|brca1/2 mutation carriers
252300|NCT02087592|Mediterranean diet|mediterranean diet
252301|NCT02087592|Structured exercise training|structured exercise training
252302|NCT02087592|prevention|prevention
252303|NCT02087579|Psychotic Disorders|psychotic disorders
252304|NCT02087579|Schizophrenia|schizophrenia
252305|NCT02087579|Bipolar Disorder|bipolar disorder
252306|NCT02087579|Depressive Disorder|depressive disorder
252307|NCT02087579|Antipsychotics|antipsychotics
252308|NCT02087579|Aripiprazole|aripiprazole
252309|NCT02087579|Olanzapine|olanzapine
252310|NCT02087579|Paliperidone|paliperidone
252311|NCT02087579|Quetiapine|quetiapine
252312|NCT02087579|Risperidone|risperidone
252313|NCT02087579|Capillary Concentration|capillary concentration
252314|NCT02087566|Linezolid|linezolid
252315|NCT02087566|Pharmacokinetics|pharmacokinetics
252316|NCT02087566|Haemodialysis|haemodialysis
252317|NCT02087566|Dosing adjustment|dosing adjustment
252318|NCT02087566|Eligible subjects were classified into three groups depending on their 24-h urinary creatinine clearance (CLcr) values or HD status.|eligible subjects were classified into three groups depending on their 24-h urinary creatinine clearance (clcr) values or hd status.
252319|NCT02087566|Group 1, included 6 healthy subjects with normal renal function (CLcr ˃80 ml/min);|group 1, included 6 healthy subjects with normal renal function (clcr ˃80 ml/min);
252320|NCT02087566|Group 2, included 6 patients with acute renal failure (RF) (30˂CLcr˂80 ml/mine);|group 2, included 6 patients with acute renal failure (rf) (30˂clcr˂80 ml/mine);
252321|NCT02087566|Group 3, included 6 patients on long term haemodialysis (minimum period of dialysis was 40 month while maximum period were 130 month)|group 3, included 6 patients on long term haemodialysis (minimum period of dialysis was 40 month while maximum period were 130 month)
252322|NCT02087553|Blood Transfusion|blood transfusion
252323|NCT02087553|Iron|iron
252324|NCT02087553|Packed Red Blood Cells|packed red blood cells
252325|NCT02087553|PRBC|prbc
252326|NCT02087553|NTBI|ntbi
252327|NCT02087527|Cellulitis|cellulitis
252328|NCT02087527|Soft Tissue Infections|soft tissue infections
252329|NCT02087527|Skin Diseases, Infectious|skin diseases, infectious
252330|NCT02087527|Corticosteroids|corticosteroids
252331|NCT02087527|Glucocorticoids|glucocorticoids
252332|NCT02087527|Dexamethasone|dexamethasone
252333|NCT02087514|Blood Transfusion|blood transfusion
252334|NCT02087514|Iron|iron
252335|NCT02087514|Red Blood Cells|red blood cells
252336|NCT02087501|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
252337|NCT02087501|AAA|aaa
252338|NCT02087501|Abdominal Aortoiliac Aneurysm|abdominal aortoiliac aneurysm
252339|NCT02087501|Endovascular Aortic Repair|endovascular aortic repair
252340|NCT02087501|EVAR|evar
252341|NCT02087488|primary insomnia|primary insomnia
252342|NCT02087488|auricular acupuncture|auricular acupuncture
252343|NCT02087462|Sciatica|sciatica
252344|NCT02087462|Electroacupuncture|electroacupuncture
252345|NCT02087462|Intervertebral disc displacement|intervertebral disc displacement
252346|NCT02087423|Locally advanced, metastatic, Non-Small Cell Lung Cancer, MEDI4736, Durvalumab, PD-L1|locally advanced, metastatic, non-small cell lung cancer, medi4736, durvalumab, pd-l1
252347|NCT02087397|Stem Cell|stem cell
252348|NCT02087397|Erectile Dysfunction|erectile dysfunction
252349|NCT02087384|Anal intraepithelial neoplasia|anal intraepithelial neoplasia
252350|NCT02087384|HIV|hiv
252351|NCT02087384|HPV|hpv
252352|NCT02087384|Vaccination|vaccination
252353|NCT02087384|Gardasil|gardasil
252354|NCT02087384|Prophylactic|prophylactic
252355|NCT02087358|alcohol dependence|alcohol dependence
252356|NCT02087358|Stress- correlation|stress- correlation
252357|NCT02087358|genetic|genetic
252358|NCT02087358|CRHR1|crhr1
252359|NCT02087332|Kidney damage hypertension cardiovascular diseases, congestive heart failure renal function natriuresis natriuresis monitoring|kidney damage hypertension cardiovascular diseases, congestive heart failure renal function natriuresis natriuresis monitoring
252360|NCT02087306|Adenovirus Infection|adenovirus infection
252361|NCT02087241|Stage IV Lung Cancer|stage iv lung cancer
252362|NCT02087228|Endometrial ablation, menorrhagia|endometrial ablation, menorrhagia
252363|NCT02087215|diabetes mellitus|diabetes mellitus
252364|NCT02087215|foot ulcer|foot ulcer
252365|NCT02087215|boron|boron
252366|NCT02087215|wound care|wound care
252367|NCT02087202|pain|pain
252368|NCT02087189|ICD, CRT-D, lead|icd, crt-d, lead
252369|NCT02087176|NSCLC|nsclc
252370|NCT02087137|aging|aging
252371|NCT02087137|memory|memory
252372|NCT02087137|memory training|memory training
252373|NCT02087124|Whey protein|whey protein
252374|NCT02087124|Postprandial lipaemia|postprandial lipaemia
252375|NCT02087124|Pre-meal|pre-meal
252376|NCT02087124|Metabolic syndrome|metabolic syndrome
252377|NCT02087111|Telaprevir|telaprevir
252378|NCT02087111|Genotype 3 HCV|genotype 3 hcv
252379|NCT02087098|overactive bladder|overactive bladder
252380|NCT02087098|solifenacin|solifenacin
252381|NCT02087098|quality of life|quality of life
252382|NCT02087072|home visits|home visits
252383|NCT02087072|transitions of care|transitions of care
252384|NCT02087072|pharmacist|pharmacist
252385|NCT02087059|Post-Polycythemia Vera (PV) MF|post-polycythemia vera (pv) mf
252386|NCT02087059|Post-Essential Thrombocythemia (ET) MF|post-essential thrombocythemia (et) mf
252387|NCT02087033|supraventricular ectopic beats|supraventricular ectopic beats
252388|NCT02087020|Joint Prosthesis|joint prosthesis
252389|NCT02087020|Prosthesis-Related Infections|prosthesis-related infections
252390|NCT02087020|Joint Diseases|joint diseases
252391|NCT02087020|Therapeutic Irrigation|therapeutic irrigation
252392|NCT02087020|Prostheses and Implants|prostheses and implants
252393|NCT02087020|Arthroplasty Replacement|arthroplasty replacement
252394|NCT02087007|Treatment for vasospastic angina|treatment for vasospastic angina
252395|NCT02086994|carbetocin, misoprostol, pre-eclampsia, pph|carbetocin, misoprostol, pre-eclampsia, pph
252396|NCT02086955|Diabetes|diabetes
252397|NCT02086955|Nursing counseling|nursing counseling
252398|NCT02086955|Foot ulceration|foot ulceration
252399|NCT02086955|Outpatient|outpatient
252400|NCT02086955|Advanced Practice Nurse|advanced practice nurse
252401|NCT02086929|Trazodone|trazodone
252402|NCT02086929|Venlafaxine|venlafaxine
252403|NCT02086929|Major depressive disorder|major depressive disorder
252404|NCT02086916|Clostridium difficile|clostridium difficile
252405|NCT02086916|Prediction|prediction
252406|NCT02086916|Treatment|treatment
252407|NCT02086916|Failure|failure
252408|NCT02086903|Ticagrelor|ticagrelor
252409|NCT02086903|Clopidogrel|clopidogrel
252410|NCT02086903|Platelet function test|platelet function test
252411|NCT02086890|retinitis pigmentosa|retinitis pigmentosa
252412|NCT02086890|acupuncture|acupuncture
252413|NCT02086890|electroacupuncture|electroacupuncture
252414|NCT02086890|transcorneal electrical stimulation|transcorneal electrical stimulation
252415|NCT02086890|microcurrent|microcurrent
252416|NCT02086864|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
252417|NCT02086864|ADHD|adhd
252418|NCT02086864|Homeopathy|homeopathy
252419|NCT02086851|pediatric obesity|pediatric obesity
252420|NCT02086851|motivational interviewing|motivational interviewing
252421|NCT02086851|lifestyle intervention|lifestyle intervention
252422|NCT02086838|Iron deficiency anemia|iron deficiency anemia
252423|NCT02086838|Pregnancy|pregnancy
252424|NCT02086838|Iron therapy|iron therapy
252425|NCT02086799|asthma|asthma
252426|NCT02086799|thyroid hormones|thyroid hormones
252427|NCT02086799|treatment|treatment
252428|NCT02086799|asthma exacerbation|asthma exacerbation
252429|NCT02086773|Acute Leukemia|acute leukemia
252430|NCT02086773|Red Cell Transfusion|red cell transfusion
252431|NCT02086760|hydronephrosis|hydronephrosis
252432|NCT02086747|Abdominal Hysterectomy, Acetaminophen, chronic pain|abdominal hysterectomy, acetaminophen, chronic pain
252433|NCT02086734|Perfusion-CT|perfusion-ct
252434|NCT02086734|mRCC|mrcc
252435|NCT02086734|antiangiogenic therapy|antiangiogenic therapy
252436|NCT02086734|response assessment|response assessment
252437|NCT02086708|Sonoelastography,|sonoelastography,
252438|NCT02086708|Diffuse liver disease,|diffuse liver disease,
252439|NCT02086708|chronic liver disease,|chronic liver disease,
252440|NCT02086708|NASH,|nash,
252441|NCT02086708|NAFLD,|nafld,
252442|NCT02086708|Elevated Transaminases,|elevated transaminases,
252443|NCT02086708|Liver Biopsy,|liver biopsy,
252444|NCT02086708|Fibrosis,|fibrosis,
252445|NCT02086708|METAVIR|metavir
252446|NCT02086695|Chemotherapy|chemotherapy
252447|NCT02086695|Cardiotoxicity|cardiotoxicity
252448|NCT02086682|hemodialysis|hemodialysis
252449|NCT02086682|dialysis|dialysis
252450|NCT02086682|renal dialysis|renal dialysis
252451|NCT02086682|clotting|clotting
252452|NCT02086682|coagulation|coagulation
252453|NCT02086682|blood lines|blood lines
252454|NCT02086656|liver metastases|liver metastases
252455|NCT02086656|colorectal cancer|colorectal cancer
252456|NCT02086656|perioperative treatment|perioperative treatment
252457|NCT02086643|Infraclavicular block|infraclavicular block
252458|NCT02086643|Brachial Plexus|brachial plexus
252459|NCT02086643|Retroclavicular Approach|retroclavicular approach
252460|NCT02086643|Complications of retroclavicular approach|complications of retroclavicular approach
252461|NCT02086643|Success of retroclavicular approach|success of retroclavicular approach
252462|NCT02086643|Obese Patients|obese patients
252463|NCT02086643|Obesity and Anesthesia|obesity and anesthesia
252464|NCT02086630|disparities|disparities
252465|NCT02086630|antiretroviral|antiretroviral
252466|NCT02086630|HIV|hiv
252467|NCT02086630|barriers|barriers
252468|NCT02086630|access|access
252469|NCT02086630|delay|delay
252470|NCT02086630|decline|decline
252471|NCT02086630|discontinue|discontinue
252472|NCT02086630|African American|african american
252473|NCT02086630|Black|black
252474|NCT02086630|Latino|latino
252475|NCT02086630|Hispanic|hispanic
252476|NCT02086630|care continuum|care continuum
252477|NCT02086630|Heart to Heart Behavioral intervention|heart to heart behavioral intervention
252478|NCT02086630|Treatment as Usual|treatment as usual
252479|NCT02086591|Non Hodgkin Lymphoma|non hodgkin lymphoma
252480|NCT02086591|Doxycycline|doxycycline
252481|NCT02086578|multi-beam Intensity-Modulated Radiation Therapy (IMRT)|multi-beam intensity-modulated radiation therapy (imrt)
252482|NCT02086578|14-028|14-028
252483|NCT02086565|asthma,|asthma,
252484|NCT02086565|asthma control,|asthma control,
252485|NCT02086565|asthma-related quality of life|asthma-related quality of life
252486|NCT02086565|electronic health record,|electronic health record,
252487|NCT02086565|portal,|portal,
252488|NCT02086565|health literacy|health literacy
252489|NCT02086513|Graft versus Host Disease|graft versus host disease
252490|NCT02086513|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
252491|NCT02086500|Tranexamic acid|tranexamic acid
252492|NCT02086500|randomized|randomized
252493|NCT02086500|hemorrhage|hemorrhage
252494|NCT02086500|blinded|blinded
252495|NCT02086487|NIlotinib , Suboptimal Response , Imatinib|nilotinib , suboptimal response , imatinib
252496|NCT02086435|Myomectomy|myomectomy
252497|NCT02086435|Laparoscopic myomectomy|laparoscopic myomectomy
252498|NCT02086435|Morcellation|morcellation
252499|NCT02086435|Risk of dissemination|risk of dissemination
252500|NCT02086435|Uterine Sarcoma|uterine sarcoma
252501|NCT02086435|Parasitic myoma|parasitic myoma
252502|NCT02086396|obesity|obesity
252503|NCT02086396|cardiovascular risk factors|cardiovascular risk factors
252504|NCT02086396|pumpkin seed|pumpkin seed
252505|NCT02086396|diet quality|diet quality
252506|NCT02086383|Pulmonary Rehabilitation|pulmonary rehabilitation
252507|NCT02086383|Self-Efficacy|self-efficacy
252508|NCT02086383|Physical Activity|physical activity
252509|NCT02086370|PBS|pbs
252510|NCT02086370|Prophylactic bilateral salpingectomy|prophylactic bilateral salpingectomy
252511|NCT02086370|Ovarian cancer prevention|ovarian cancer prevention
252512|NCT02086370|Ovarian reserve|ovarian reserve
252513|NCT02086370|Permanent contraception|permanent contraception
252514|NCT02086370|Surgical sterilization|surgical sterilization
252515|NCT02086344|Total Laparoscopic Hysterectomy|total laparoscopic hysterectomy
252516|NCT02086344|TLH|tlh
252517|NCT02086344|Ovarian reserve|ovarian reserve
252518|NCT02086344|Prophylactic bilateral salpingectomy|prophylactic bilateral salpingectomy
252519|NCT02086344|Ovarian cancer prevention|ovarian cancer prevention
252520|NCT02086344|Ovarian cancer|ovarian cancer
252521|NCT02086344|Fallopian Tubes|fallopian tubes
252522|NCT02086318|Ovarian reserve|ovarian reserve
252523|NCT02086318|Ovarian age|ovarian age
252524|NCT02086318|Fertility|fertility
252525|NCT02086318|Reproductive prognosis|reproductive prognosis
252526|NCT02086318|Distance to menopause|distance to menopause
252527|NCT02086305|Transitional care|transitional care
252528|NCT02086305|Supportive and palliative care|supportive and palliative care
252529|NCT02086292|Injections|injections
252530|NCT02086292|Lidocaine|lidocaine
252531|NCT02086292|Pain|pain
252532|NCT02086292|Healthy volunteers|healthy volunteers
252533|NCT02086279|AMH levels|amh levels
252534|NCT02086279|Ovarian reserve|ovarian reserve
252535|NCT02086279|GnRH analogue|gnrh analogue
252536|NCT02086279|Ovarian reserve after GnRH analogue|ovarian reserve after gnrh analogue
252537|NCT02086279|Ovarian reserve modification|ovarian reserve modification
252538|NCT02086279|Antral follicle count|antral follicle count
252539|NCT02086279|Antral follicle count after GnRH analogue|antral follicle count after gnrh analogue
252540|NCT02086266|Prostatectomy|prostatectomy
252541|NCT02086266|Urinary Continence|urinary continence
252542|NCT02086266|Physical Therapy Modalities|physical therapy modalities
252543|NCT02086266|Pelvic Floor|pelvic floor
252544|NCT02086266|Randomized Trial.|randomized trial.
252545|NCT02086253|Endothelin, endothelium, flow-mediated dilatation|endothelin, endothelium, flow-mediated dilatation
252546|NCT02086227|Bioequivalence|bioequivalence
252547|NCT02086214|Upper limb|upper limb
252548|NCT02086214|Proprioceptive pressure therapy|proprioceptive pressure therapy
252549|NCT02086214|Children|children
252550|NCT02086214|Assisting Hand Assessment performance|assisting hand assessment performance
252551|NCT02086201|major depression|major depression
252552|NCT02086201|depression|depression
252553|NCT02086201|depressive disorder|depressive disorder
252554|NCT02086201|mental health|mental health
252555|NCT02086201|mental disorder|mental disorder
252556|NCT02086188|Multiple Sclerosis|multiple sclerosis
252557|NCT02086188|Overactive Bladder|overactive bladder
252558|NCT02086188|Incontinence|incontinence
252559|NCT02086188|Voiding|voiding
252560|NCT02086188|Bladder Urgency|bladder urgency
252561|NCT02086188|Pelvic Floor Exercises|pelvic floor exercises
252562|NCT02086175|relapsed/refractory indolent B cell non-Hodgkin lymphomas|relapsed/refractory indolent b cell non-hodgkin lymphomas
252563|NCT02086162|Schizophrenia|schizophrenia
252564|NCT02086162|Smoking|smoking
252565|NCT02086162|Tobacco|tobacco
252566|NCT02086162|Motivation|motivation
252567|NCT02086162|Cessation Treatment|cessation treatment
252568|NCT02086149|Quit smoking|quit smoking
252569|NCT02086149|Exercise|exercise
252570|NCT02086149|Tobacco|tobacco
252571|NCT02086149|Smoking|smoking
252572|NCT02086136|aortic dissection|aortic dissection
252573|NCT02086136|diagnosis|diagnosis
252574|NCT02086136|emergency medicine|emergency medicine
252575|NCT02086136|d-dimer|d-dimer
252576|NCT02086123|Analgesia|analgesia
252577|NCT02086123|Epidural Analgesia|epidural analgesia
252578|NCT02086123|Narcotic Analgesia|narcotic analgesia
252579|NCT02086123|Patient Controlled Analgesia|patient controlled analgesia
252580|NCT02086123|Anesthesia and Analgesia|anesthesia and analgesia
252581|NCT02086123|Anti inflammatory Analgesics|anti inflammatory analgesics
252582|NCT02086123|NSAIDS|nsaids
252583|NCT02086110|probiotic|probiotic
252584|NCT02086110|prebiotic|prebiotic
252585|NCT02086110|autism|autism
252586|NCT02086110|oligosaccharides|oligosaccharides
252587|NCT02086110|Bifidobacterium infantis|bifidobacterium infantis
252588|NCT02086097|pain|pain
252589|NCT02086097|symptomatic irreversible pulpitis|symptomatic irreversible pulpitis
252590|NCT02086097|postoperative dental pain|postoperative dental pain
252591|NCT02086084|Acute Exacerbation Chronic Obstructive Pulmonary Disease|acute exacerbation chronic obstructive pulmonary disease
252592|NCT02086084|AECOPD|aecopd
252593|NCT02086084|Non invasive ventilation|non invasive ventilation
252594|NCT02086084|NIV|niv
252595|NCT02086084|Extracorporeal carbon dioxide removal|extracorporeal carbon dioxide removal
252596|NCT02086084|ECCO2R|ecco2r
252597|NCT02086071|REBIOP re-biopsies advanced or metastatic NSCLC|rebiop re-biopsies advanced or metastatic nsclc
252598|NCT02086058|overactive bladder|overactive bladder
252599|NCT02086058|daytime urinary incontinence|daytime urinary incontinence
252600|NCT02086058|children|children
252601|NCT02086058|gene expression|gene expression
252602|NCT02086045|Coronary artery disease|coronary artery disease
252603|NCT02086032|Sleeping quality|sleeping quality
252604|NCT02086032|menopause|menopause
252605|NCT02086032|climacteric|climacteric
252606|NCT02086032|progestin|progestin
252607|NCT02086032|dydrogesterone|dydrogesterone
252608|NCT02086032|micronized progesterone|micronized progesterone
252609|NCT02086019|Revascularisation, octogenarian,acute coronary syndromes|revascularisation, octogenarian,acute coronary syndromes
252610|NCT02086006|Coronary artery disease|coronary artery disease
252611|NCT02085993|romiplostim,|romiplostim,
252612|NCT02085993|Nplate,|nplate,
252613|NCT02085993|immune thrombocytopenic purpura|immune thrombocytopenic purpura
252614|NCT02085967|Healthy|healthy
252615|NCT02085967|Metabolism|metabolism
252616|NCT02085967|Drug-Drug Interactions|drug-drug interactions
252617|NCT02085941|Head and Neck Neoplasms|head and neck neoplasms
252618|NCT02085941|Malignant Neoplasm of Vertebral Column|malignant neoplasm of vertebral column
252619|NCT02085928|Tennis elbow|tennis elbow
252620|NCT02085928|Lateral epicondylitis|lateral epicondylitis
252621|NCT02085928|Intratissue percutaneous electrolysis|intratissue percutaneous electrolysis
252622|NCT02085928|Eccentric exercise|eccentric exercise
252623|NCT02085928|Ultrasonography|ultrasonography
252624|NCT02085876|patients|patients
252625|NCT02085876|present|present
252626|NCT02085876|undergo bariatric surgery|undergo bariatric surgery
252627|NCT02085811|Kyphoplasty|kyphoplasty
252628|NCT02085811|at a single level|at a single level
252629|NCT02085811|(between T11 and L5)|(between t11 and l5)
252630|NCT02085811|associated surgery|associated surgery
252631|NCT02085798|Leukemia, Myelomonocytic, Chronic, myelodysplastic syndrome, Prospective, Treatment strategy, epidemiologic data|leukemia, myelomonocytic, chronic, myelodysplastic syndrome, prospective, treatment strategy, epidemiologic data
252632|NCT02085785|weight loss|weight loss
252633|NCT02085785|exercise|exercise
252634|NCT02085785|home-based|home-based
252635|NCT02085785|lower extremity amputation|lower extremity amputation
252636|NCT02085785|pilot study|pilot study
252637|NCT02085759|Healthy|healthy
252638|NCT02085733|Arthritis, Septic|arthritis, septic
252639|NCT02085681|Diabetic Retinopathy|diabetic retinopathy
252640|NCT02085681|Screening|screening
252641|NCT02085681|Tele-medicine|tele-medicine
252642|NCT02085681|Retinal Imaging|retinal imaging
252643|NCT02085681|Remote diagnosis|remote diagnosis
252644|NCT02085668|Chronic Heart Failure|chronic heart failure
252645|NCT02085668|Cardio-Renal Syndrome|cardio-renal syndrome
252646|NCT02085668|Renal Denervation|renal denervation
252647|NCT02085668|Symplicity|symplicity
252648|NCT02085668|Sympathetic activation|sympathetic activation
252649|NCT02085655|Extranodal NK/T-cell lymphoma|extranodal nk/t-cell lymphoma
252650|NCT02085655|PA-Gemox regimen|pa-gemox regimen
252651|NCT02085655|thalidomide|thalidomide
252652|NCT02085642|Stroke|stroke
252653|NCT02085642|Acupuncture|acupuncture
252654|NCT02085642|Gait|gait
252655|NCT02085642|Spasticity|spasticity
252656|NCT02085629|renal failure, end stage|renal failure, end stage
252657|NCT02085629|renal transplantation|renal transplantation
252658|NCT02085629|cell therapy|cell therapy
252659|NCT02085629|macrophages, monocyte derived|macrophages, monocyte derived
252660|NCT02085629|immune tolerance|immune tolerance
252661|NCT02085629|ONE Study|one study
252662|NCT02085629|immunotherapy|immunotherapy
252663|NCT02085616|Smoking cessation|smoking cessation
252664|NCT02085616|Tobacco cessation|tobacco cessation
252665|NCT02085616|Quitline|quitline
252666|NCT02085616|Telephone counselling|telephone counselling
252667|NCT02085616|Intensity|intensity
252668|NCT02085603|advanced solid malignancies|advanced solid malignancies
252669|NCT02085590|BCG vaccine|bcg vaccine
252670|NCT02085590|Sepsis|sepsis
252671|NCT02085590|Immunity|immunity
252672|NCT02085577|Morphine consumption|morphine consumption
252673|NCT02085577|Postoperative pain|postoperative pain
252674|NCT02085577|Ketamine|ketamine
252675|NCT02085577|Side effects|side effects
252676|NCT02085577|Spine surgery|spine surgery
252677|NCT02085577|Chronic pain|chronic pain
252678|NCT02085564|Gastroesophageal-junction cancer|gastroesophageal-junction cancer
252679|NCT02085564|neoadjuvant chemotherapy|neoadjuvant chemotherapy
252680|NCT02085551|peripheral arterial occlusion|peripheral arterial occlusion
252681|NCT02085551|visceral emboli|visceral emboli
252682|NCT02085551|limb ischemia|limb ischemia
252683|NCT02085551|adverse events|adverse events
252684|NCT02085551|Indigo System|indigo system
252685|NCT02085551|aspiration|aspiration
252686|NCT02085551|mechanical thrombectomy|mechanical thrombectomy
252687|NCT02085538|renal impairment|renal impairment
252688|NCT02085538|AUC|auc
252689|NCT02085538|Cmax|cmax
252690|NCT02085538|palbociclib|palbociclib
252691|NCT02085538|normal matched subjects|normal matched subjects
252692|NCT02085512|Post Traumatic Stress Disorder (PTSD)|post traumatic stress disorder (ptsd)
252693|NCT02085512|Major Depression|major depression
252694|NCT02085512|Secondary Prevention|secondary prevention
252695|NCT02085512|Neurocognitive Retraining|neurocognitive retraining
252696|NCT02085512|Randomized Controlled Trial|randomized controlled trial
252697|NCT02085499|nasal ventilation|nasal ventilation
252698|NCT02085499|premature infants|premature infants
252699|NCT02085499|synchronized ventilation|synchronized ventilation
252700|NCT02085486|dialysis|dialysis
252701|NCT02085486|av shunt|av shunt
252702|NCT02085486|cannulation|cannulation
252703|NCT02085486|ultrasound|ultrasound
252704|NCT02085486|outcome|outcome
252705|NCT02085447|Homelessness|homelessness
252706|NCT02085447|Antipsychotic Drugs|antipsychotic drugs
252707|NCT02085447|Antipsychotics|antipsychotics
252708|NCT02085447|Injectables|injectables
252709|NCT02085447|Long Acting Injectable Antipsychotic|long acting injectable antipsychotic
252710|NCT02085447|Psychotic Disorders|psychotic disorders
252711|NCT02085447|Schizophrenia|schizophrenia
252712|NCT02085447|Schizoaffective Disorder|schizoaffective disorder
252713|NCT02085447|Medication Adherence|medication adherence
252714|NCT02085447|Medication Non-Adherence|medication non-adherence
252715|NCT02085447|Community Mental Health Centers|community mental health centers
252716|NCT02085421|tdcs, neuromodulation, CRT, psychosis, schizophrenia|tdcs, neuromodulation, crt, psychosis, schizophrenia
252717|NCT02085395|Actinic Keratosis, AK, Bowen's Disease, Bowen|actinic keratosis, ak, bowen's disease, bowen
252718|NCT02085382|Kangaroo Mother Care(KMC), Low-birth weight, neonates|kangaroo mother care(kmc), low-birth weight, neonates
252719|NCT02085369|bariatric surgery|bariatric surgery
252720|NCT02085369|cognitive function|cognitive function
252721|NCT02085369|gene expression|gene expression
252722|NCT02085356|HIV|hiv
252723|NCT02085356|PMTCT|pmtct
252724|NCT02085356|South Africa|south africa
252725|NCT02085356|Couples|couples
252726|NCT02085356|Male involvement|male involvement
252727|NCT02085343|Exposure therapy|exposure therapy
252728|NCT02085343|Specific phobia|specific phobia
252729|NCT02085343|Fear of heights|fear of heights
252730|NCT02085343|Acrophobia|acrophobia
252731|NCT02085343|Safety behavior fading|safety behavior fading
252732|NCT02085343|Anti-phobic Actions|anti-phobic actions
252733|NCT02085317|Microcirculation|microcirculation
252734|NCT02085317|Leprosy|leprosy
252735|NCT02085317|Nervous system|nervous system
252838|NCT02084940|GnRH antagonist|gnrh antagonist
252736|NCT02085317|Orthogonal polarization spectral (OPS) imaging|orthogonal polarization spectral (ops) imaging
252737|NCT02085317|Laser Doppler flowmetry|laser doppler flowmetry
252738|NCT02085317|Iontophoresis.|iontophoresis.
252739|NCT02085304|Glioblastoma|glioblastoma
252740|NCT02085304|GBM|gbm
252741|NCT02085304|Radiation|radiation
252742|NCT02085304|GammaKnife(R)|gammaknife(r)
252743|NCT02085304|Radiosurgery|radiosurgery
252744|NCT02085304|Gliadel(R)|gliadel(r)
252745|NCT02085304|Temozolomide|temozolomide
252746|NCT02085304|Temodar(R)|temodar(r)
252747|NCT02085291|septic shock; microcirculation; norepinephrine|septic shock; microcirculation; norepinephrine
252748|NCT02085278|arteriovenous malformation|arteriovenous malformation
252749|NCT02085278|Brain|brain
252750|NCT02085278|AVM|avm
252751|NCT02085278|Onyx|onyx
252752|NCT02085278|Micro catheter|micro catheter
252753|NCT02085278|catheter entrapment,|catheter entrapment,
252754|NCT02085278|Embolization|embolization
252755|NCT02085278|Vein Of Galen|vein of galen
252756|NCT02085265|Alzheimer's Disease|alzheimer's disease
252757|NCT02085265|Hypertension|hypertension
252758|NCT02085265|Perindopril|perindopril
252759|NCT02085265|Telmisartan|telmisartan
252760|NCT02085265|Brain atrophy|brain atrophy
252761|NCT02085252|Drug Therapy|drug therapy
252762|NCT02085239|Breast Biopsy|breast biopsy
252763|NCT02085239|Ultrasound|ultrasound
252764|NCT02085239|Lidocaine|lidocaine
252765|NCT02085239|Ropivacaine|ropivacaine
252766|NCT02085239|Breast Lesion|breast lesion
252767|NCT02085226|Stroke|stroke
252768|NCT02085226|Rehabilitation|rehabilitation
252769|NCT02085226|Creative Engagement|creative engagement
252770|NCT02085226|Psychosocial|psychosocial
252771|NCT02085226|Art|art
252772|NCT02085213|Retained placenta|retained placenta
252773|NCT02085213|Manual Removal of Placenta|manual removal of placenta
252774|NCT02085213|Glyceryl Trinitrate|glyceryl trinitrate
252775|NCT02085200|glenohumeral internal rotation deficit|glenohumeral internal rotation deficit
252776|NCT02085200|overhead athlete|overhead athlete
252777|NCT02085200|shoulder exercise|shoulder exercise
252778|NCT02085200|posterior glenohumeral capsule|posterior glenohumeral capsule
252779|NCT02085200|posteroinferior glenohumeral ligament|posteroinferior glenohumeral ligament
252780|NCT02085200|posterior rotator cuff|posterior rotator cuff
252781|NCT02085187|Pulmonary rehabilitation|pulmonary rehabilitation
252782|NCT02085187|Training|training
252783|NCT02085187|Counselling|counselling
252784|NCT02085187|Telemedicine|telemedicine
252785|NCT02085187|Videoconference|videoconference
252786|NCT02085187|COPD|copd
252787|NCT02085187|Chronic disease|chronic disease
252788|NCT02085187|Internet.|internet.
252789|NCT02085148|Pediatric cancer|pediatric cancer
252790|NCT02085148|Rhabdomyosarcoma,|rhabdomyosarcoma,
252791|NCT02085148|Ewing sarcoma|ewing sarcoma
252792|NCT02085148|Hepatoblastoma|hepatoblastoma
252793|NCT02085148|Neuroblastoma|neuroblastoma
252794|NCT02085148|Wilm's tumor|wilm's tumor
252795|NCT02085135|depression|depression
252796|NCT02085135|major depressive disorder|major depressive disorder
252797|NCT02085135|Alkermes|alkermes
252798|NCT02085135|ALKS 5461|alks 5461
252799|NCT02085135|samidorphan|samidorphan
252800|NCT02085135|buprenorphine|buprenorphine
252801|NCT02085109|Cardiovascular Diseases|cardiovascular diseases
252802|NCT02085109|HDL metabolism|hdl metabolism
252803|NCT02085109|ApoA-I|apoa-i
252804|NCT02085109|High fat|high fat
252805|NCT02085109|Theobromine|theobromine
252806|NCT02085096|Caregivers|caregivers
252807|NCT02085096|Coping Skills|coping skills
252808|NCT02085083|Inflammatory Bowel Disease|inflammatory bowel disease
252809|NCT02085083|Transition|transition
252810|NCT02085083|Adolescent|adolescent
252811|NCT02085083|Chronic Disease|chronic disease
252812|NCT02085083|Colitis, Ulcerative|colitis, ulcerative
252813|NCT02085044|malnutrition|malnutrition
252814|NCT02085044|children's health|children's health
252815|NCT02085044|prevention|prevention
252816|NCT02085044|ready-to-use supplementary food|ready-to-use supplementary food
252817|NCT02085044|lipid based nutrient supplement|lipid based nutrient supplement
252818|NCT02085044|chad|chad
252819|NCT02085044|children|children
252820|NCT02085031|Roux-en-Y Anastomosis|roux-en-y anastomosis
252821|NCT02085031|laparoscopic surgery|laparoscopic surgery
252822|NCT02085031|minilaparotomy|minilaparotomy
252823|NCT02085031|stomach neoplasms|stomach neoplasms
252824|NCT02085018|omeprazole, idiopathic pulmonary fibrosis|omeprazole, idiopathic pulmonary fibrosis
252825|NCT02084992|Congestive Heart Failure|congestive heart failure
252826|NCT02084992|Disease management|disease management
252827|NCT02084992|Hospitalization|hospitalization
252828|NCT02084979|Primary care mental health consultation|primary care mental health consultation
252829|NCT02084979|Telepsychiatry|telepsychiatry
252830|NCT02084979|Asynchronous telepsychiatry|asynchronous telepsychiatry
252831|NCT02084966|Kidney|kidney
252832|NCT02084966|Transplantation|transplantation
252833|NCT02084966|Imaging|imaging
252834|NCT02084966|Renal function|renal function
252835|NCT02084966|Optical Coherence Tomography|optical coherence tomography
252836|NCT02084940|PCOS|pcos
252837|NCT02084940|OHSS|ohss
252841|NCT02084914|endometrial scratching|endometrial scratching
252842|NCT02084914|pipelle|pipelle
252843|NCT02084914|pregnancy rate|pregnancy rate
252844|NCT02084914|unexplained infertility|unexplained infertility
252845|NCT02084901|Biodegradable stents|biodegradable stents
252846|NCT02084901|converage|converage
252847|NCT02084901|OCT|oct
252848|NCT02084875|Food effect|food effect
252849|NCT02084875|pharmacokinetic|pharmacokinetic
252850|NCT02084875|healthy volunteer|healthy volunteer
252851|NCT02084862|Tracheostomy|tracheostomy
252852|NCT02084862|Ultrasound|ultrasound
252853|NCT02084836|fMRI obesity adolescents|fmri obesity adolescents
252854|NCT02084797|arginine vasopressin|arginine vasopressin
252855|NCT02084797|sweat sodium|sweat sodium
252856|NCT02084797|V2 antagonist|v2 antagonist
252857|NCT02084797|running|running
252858|NCT02084784|Near-infrared fluorescence|near-infrared fluorescence
252859|NCT02084784|Image guided surgery|image guided surgery
252860|NCT02084784|Breast cancer;|breast cancer;
252861|NCT02084784|Sentinel lymph node biopsy|sentinel lymph node biopsy
252862|NCT02084784|Indocyanine green|indocyanine green
252863|NCT02084784|Methylene blue|methylene blue
252864|NCT02084771|contrast nephropathy|contrast nephropathy
252865|NCT02084771|contrast induced acute kidney injury|contrast induced acute kidney injury
252866|NCT02084771|acute kidney injury|acute kidney injury
252867|NCT02084771|prophylaxis|prophylaxis
252868|NCT02084771|randomized trial|randomized trial
252869|NCT02084758|COPD|copd
252870|NCT02084758|nitrate supplementation|nitrate supplementation
252871|NCT02084758|metabolic efficiency|metabolic efficiency
252872|NCT02084745|Boston keratoprosthesis|boston keratoprosthesis
252873|NCT02084745|Glaucoma drainage device|glaucoma drainage device
252874|NCT02084745|Ahmed tube shunt|ahmed tube shunt
252875|NCT02084732|Sorafenib, thyroid neoplasms, salicylic acid|sorafenib, thyroid neoplasms, salicylic acid
252876|NCT02084680|Prenatal|prenatal
252877|NCT02084680|Newborn care|newborn care
252878|NCT02084680|mobile phones|mobile phones
252879|NCT02084654|prediabetes|prediabetes
252880|NCT02084654|exenatide|exenatide
252881|NCT02084654|weight loss|weight loss
252882|NCT02084654|insulin resistance|insulin resistance
252883|NCT02084654|acute insulin response|acute insulin response
252884|NCT02084654|insulin secretion|insulin secretion
252885|NCT02084641|ectopic fat|ectopic fat
252886|NCT02084641|obesity|obesity
252887|NCT02084641|triglyceride storage|triglyceride storage
252888|NCT02084641|adipocyte|adipocyte
252889|NCT02084641|overfeeding|overfeeding
252890|NCT02084641|intrahepatic fat|intrahepatic fat
252891|NCT02084641|adipocyte proliferation|adipocyte proliferation
252892|NCT02084641|inflammation|inflammation
252893|NCT02084641|macrophage|macrophage
252894|NCT02084615|Aspirin|aspirin
252895|NCT02084615|Postoperative hemorrhage|postoperative hemorrhage
252896|NCT02084615|Inguinal hernia|inguinal hernia
252897|NCT02084602|artesunate|artesunate
252898|NCT02084602|mefloquine|mefloquine
252899|NCT02084602|falciparum|falciparum
252900|NCT02084602|peruvian amazon|peruvian amazon
252901|NCT02084589|PCEA, labor analgesia, background infusion, ropivacaine|pcea, labor analgesia, background infusion, ropivacaine
252902|NCT02084576|Cystoid macular edema|cystoid macular edema
252903|NCT02084576|nonsteroidal anti-inflammatory drug|nonsteroidal anti-inflammatory drug
252904|NCT02084576|OCT|oct
252905|NCT02084576|phacoemulsification.|phacoemulsification.
252906|NCT02084563|Acute Myeloid Leukemia|acute myeloid leukemia
252907|NCT02084563|Myeloproliferative Neoplasms|myeloproliferative neoplasms
252908|NCT02084563|Myelodysplastic Syndromes|myelodysplastic syndromes
252909|NCT02084563|Myeloproliferative/Myelodysplastic Neoplasm|myeloproliferative/myelodysplastic neoplasm
252910|NCT02084563|Leukemia|leukemia
252911|NCT02084563|MDS|mds
252912|NCT02084563|MPN|mpn
252913|NCT02084563|AML|aml
252914|NCT02084563|Chronic myelomonocytic leukemia (CMML)|chronic myelomonocytic leukemia (cmml)
252915|NCT02084563|Polycythemia Vera (PV)|polycythemia vera (pv)
252916|NCT02084563|Essential Thrombocythemia (ET)|essential thrombocythemia (et)
252917|NCT02084563|Myelofibrosis (MF)|myelofibrosis (mf)
252918|NCT02084537|symptomatic|symptomatic
252919|NCT02084537|infected|infected
252920|NCT02084537|necrotic collection|necrotic collection
252921|NCT02084524|vulnerable|vulnerable
252922|NCT02084524|nutrition|nutrition
252923|NCT02084524|cancer|cancer
252924|NCT02084524|colorectal|colorectal
252925|NCT02084524|tumor|tumor
252926|NCT02084498|Automated bolus calculator (ABC)|automated bolus calculator (abc)
252927|NCT02084498|Advanced carbohydrate counting (ACC)|advanced carbohydrate counting (acc)
252928|NCT02084498|Patient empowerment|patient empowerment
252929|NCT02084485|COPD|copd
252930|NCT02084485|LPS|lps
252931|NCT02084472|atopic eczema|atopic eczema
252932|NCT02084472|moisturisers|moisturisers
252933|NCT02084472|alternatives|alternatives
252934|NCT02084472|affordable|affordable
252935|NCT02084459|Chronic pain|chronic pain
252936|NCT02084459|Supportive care|supportive care
252937|NCT02084459|Psychosocial Circumstances|psychosocial circumstances
252938|NCT02084459|Autonomy support|autonomy support
252939|NCT02084459|Nursing intervention|nursing intervention
252940|NCT02084446|Everolimus|everolimus
252942|NCT02084446|Sodium Mycophenolate|sodium mycophenolate
252943|NCT02084446|CMV|cmv
252944|NCT02084446|Graft function|graft function
252945|NCT02084446|Acute rejection|acute rejection
252946|NCT02084433|MIH of the first permanent molar|mih of the first permanent molar
252947|NCT02084407|DM1|dm1
252948|NCT02084407|Cardiopathy|cardiopathy
252949|NCT02084407|Adult|adult
252950|NCT02084394|CBF autoregulation, rSO2,doppler, TCD, delirium,|cbf autoregulation, rso2,doppler, tcd, delirium,
252951|NCT02084381|CKD5, dialysis, high porous membranes|ckd5, dialysis, high porous membranes
252952|NCT02084368|combined lumbar plexus and sciatic nerve block，|combined lumbar plexus and sciatic nerve block，
252953|NCT02084368|combined spinal and epidural anesthesia|combined spinal and epidural anesthesia
252954|NCT02084355|Significant cancer pain|significant cancer pain
252955|NCT02084355|at least numeric rating scale 4|at least numeric rating scale 4
252956|NCT02084342|desmopressin|desmopressin
252957|NCT02084342|tranexamic acid|tranexamic acid
252958|NCT02084342|blood loss|blood loss
252959|NCT02084342|transfusion need|transfusion need
252960|NCT02084342|posterior scoliosis orthopedics|posterior scoliosis orthopedics
252961|NCT02084329|Physiotherapy|physiotherapy
252962|NCT02084329|Physical therapy|physical therapy
252963|NCT02084329|neurotrauma rehabilitation|neurotrauma rehabilitation
252964|NCT02084329|Rehabilitation|rehabilitation
252965|NCT02084329|Balance|balance
252966|NCT02084329|Balance Confidence|balance confidence
252967|NCT02084329|concussion|concussion
252968|NCT02084329|Post-Concussion|post-concussion
252969|NCT02084329|Mild Traumatic Brain Injury|mild traumatic brain injury
252970|NCT02084316|China CDC|china cdc
252971|NCT02084316|One4All testing algorithm|one4all testing algorithm
252972|NCT02084316|Guangxi Autonomous Region|guangxi autonomous region
252973|NCT02084316|Testing and Linkage to HIV Care in China|testing and linkage to hiv care in china
252974|NCT02084290|Crohn's disease|crohn's disease
252975|NCT02084290|Shared Decision Making|shared decision making
252976|NCT02084290|Decision Aid|decision aid
252977|NCT02084277|Oral health-related quality of life (OHRQoL)|oral health-related quality of life (ohrqol)
252978|NCT02084277|Self-ligating brackets (SLB)|self-ligating brackets (slb)
252979|NCT02084277|Conventional brackets (CB)|conventional brackets (cb)
252980|NCT02084277|Oral Health Impact Profile-14 (OHIP-14)|oral health impact profile-14 (ohip-14)
252981|NCT02084277|Short Form-36 (SF-36)|short form-36 (sf-36)
252982|NCT02084264|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
252983|NCT02084264|Pediatric Scoliosis|pediatric scoliosis
252984|NCT02084251|safety,|safety,
252985|NCT02084251|pharmacokinetics,|pharmacokinetics,
252986|NCT02084251|Long acting GLP-1 analogue|long acting glp-1 analogue
252987|NCT02084238|SLE, IL-2|sle, il-2
252988|NCT02084225|low resource|low resource
252989|NCT02084225|conflict setting|conflict setting
252990|NCT02084225|ultrasound guided regional anesthesia|ultrasound guided regional anesthesia
252991|NCT02084225|acute injuries|acute injuries
252992|NCT02084225|pain management|pain management
252993|NCT02084225|education|education
252994|NCT02084225|ultrasound|ultrasound
252995|NCT02084225|trauma|trauma
252996|NCT02084225|emergency department|emergency department
252997|NCT02084173|alcohol|alcohol
252998|NCT02084173|60+ years|60+ years
252999|NCT02084173|treatment|treatment
253000|NCT02084173|met|met
253001|NCT02084173|cra|cra
253002|NCT02084173|multi site|multi site
253003|NCT02084173|multi country|multi country
253004|NCT02084173|questionnaire|questionnaire
253005|NCT02084173|random|random
253006|NCT02084134|pituitary adenoma|pituitary adenoma
253007|NCT02084134|Pituitary Tumor|pituitary tumor
253008|NCT02084134|transsphenoidal resection|transsphenoidal resection
253009|NCT02084134|pituitary cyst|pituitary cyst
253010|NCT02084121|metachromatic leukodystrophy|metachromatic leukodystrophy
253011|NCT02084108|Frail and dependent older adults|frail and dependent older adults
253012|NCT02084108|Integrated care|integrated care
253013|NCT02084108|Home care|home care
253014|NCT02084108|Multidimensional geriatric assessment|multidimensional geriatric assessment
253015|NCT02084108|RAI-HC (resident assessment instrument- Home care)|rai-hc (resident assessment instrument- home care)
253016|NCT02084108|Palliative care.|palliative care.
253017|NCT02084043|aerosol delivery|aerosol delivery
253018|NCT02084043|vibrating mesh nebulizer|vibrating mesh nebulizer
253019|NCT02084043|breath-actuated nebulizer|breath-actuated nebulizer
253020|NCT02084043|non invasive ventilation|non invasive ventilation
253021|NCT02084043|bilevel ventilator|bilevel ventilator
253022|NCT02084043|single limb circuit ventilator|single limb circuit ventilator
253023|NCT02084043|Amikacin|amikacin
253024|NCT02084030|cardiac surgery|cardiac surgery
253025|NCT02084030|POCD|pocd
253026|NCT02084030|GWAS|gwas
253027|NCT02084030|Susceptibility gene|susceptibility gene
253028|NCT02084017|Surgical Site Infection|surgical site infection
253029|NCT02084017|Vascular Surgery|vascular surgery
253030|NCT02084017|Negative Pressure Wound Therapy|negative pressure wound therapy
253031|NCT02084004|Type 2 diabetes mellitus|type 2 diabetes mellitus
253032|NCT02084004|Berberine Hydrochloride|berberine hydrochloride
253033|NCT02084004|Bifidobacterium|bifidobacterium
253034|NCT02083991|NODAT|nodat
253335|NCT02082795|Qualitative|qualitative
253035|NCT02083991|Renal transplantation|renal transplantation
253036|NCT02083991|Corticosteroids avoidance|corticosteroids avoidance
253037|NCT02083991|CNI minimization|cni minimization
253038|NCT02083978|Bipolar Disorder|bipolar disorder
253039|NCT02083978|Magnetic Resonance Imaging (MRI) scanning|magnetic resonance imaging (mri) scanning
253040|NCT02083939|Inguinal hernia|inguinal hernia
253041|NCT02083939|Mesh repair|mesh repair
253042|NCT02083939|Prophylactic Antibiotics|prophylactic antibiotics
253043|NCT02083939|Herniorrhaphy|herniorrhaphy
253044|NCT02083939|Laparoscopic Inguinal Hernia Repair|laparoscopic inguinal hernia repair
253045|NCT02083926|Social Anxiety Disorder|social anxiety disorder
253046|NCT02083926|SAD|sad
253047|NCT02083926|Ketamine|ketamine
253048|NCT02083913|Severely obese|severely obese
253049|NCT02083913|Bariatric surgery|bariatric surgery
253050|NCT02083913|Physical activity|physical activity
253051|NCT02083913|Physical fitness|physical fitness
253052|NCT02083913|Telehealth|telehealth
253053|NCT02083913|Quality of life|quality of life
253054|NCT02083887|Immune response|immune response
253055|NCT02083887|Vaccine|vaccine
253056|NCT02083887|Malaria|malaria
253057|NCT02083874|cannabidiol|cannabidiol
253058|NCT02083874|CBD|cbd
253059|NCT02083874|marijuana|marijuana
253060|NCT02083874|withdrawal|withdrawal
253061|NCT02083874|treatment|treatment
253062|NCT02083861|osteoarthritis|osteoarthritis
253063|NCT02083861|arthritis|arthritis
253064|NCT02083861|musculoskeletal|musculoskeletal
253065|NCT02083861|connective tissue disease|connective tissue disease
253066|NCT02083861|ultrasound|ultrasound
253067|NCT02083861|pain|pain
253068|NCT02083861|mobility|mobility
253069|NCT02083861|heat|heat
253070|NCT02083861|strength|strength
253071|NCT02083861|ZetrOZ|zetroz
253072|NCT02083861|LITUS|litus
253073|NCT02083861|Sam|sam
253074|NCT02083861|grade 1|grade 1
253075|NCT02083861|grade 2|grade 2
253076|NCT02083848|Locoregional invasion|locoregional invasion
253077|NCT02083848|Stage IB1, IB2, IIA or IIB|stage ib1, ib2, iia or iib
253078|NCT02083835|post-operative pain|post-operative pain
253079|NCT02083835|paitent reported outcomes|paitent reported outcomes
253080|NCT02083835|quality improvement|quality improvement
253081|NCT02083822|premature baby|premature baby
253082|NCT02083822|MRI : conventional and advanced images|mri : conventional and advanced images
253083|NCT02083822|Executive function testing at 5 years of age|executive function testing at 5 years of age
253084|NCT02083796|manual therapy|manual therapy
253085|NCT02083796|rehabilitation|rehabilitation
253086|NCT02083796|shoulder|shoulder
253087|NCT02083796|spine|spine
253088|NCT02083770|Hispanics|hispanics
253089|NCT02083770|Patient Participation|patient participation
253090|NCT02083770|Refusal to Participate|refusal to participate
253091|NCT02083770|Education|education
253092|NCT02083770|Clinical Trials|clinical trials
253093|NCT02083757|Fluid responsiveness; Passive leg raising|fluid responsiveness; passive leg raising
253094|NCT02083744|Congestive Heart Failure|congestive heart failure
253095|NCT02083744|Self-care|self-care
253096|NCT02083744|Spanish|spanish
253097|NCT02083731|CMV infection|cmv infection
253098|NCT02083731|Mesenchymal Stem Cells|mesenchymal stem cells
253099|NCT02083731|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
253100|NCT02083718|Poor Graft Function|poor graft function
253101|NCT02083718|Peripheral Blood Stem Cell|peripheral blood stem cell
253102|NCT02083718|Mesenchymal Stem Cells|mesenchymal stem cells
253103|NCT02083718|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
253104|NCT02083705|Chest compression, Delivery Room, NICU,|chest compression, delivery room, nicu,
253105|NCT02083679|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
253106|NCT02083679|Sym004|sym004
253107|NCT02083666|Phase I|phase i
253108|NCT02083666|Dose cohorts|dose cohorts
253109|NCT02083666|Escalating dose|escalating dose
253110|NCT02083666|Single dose|single dose
253111|NCT02083666|Multiple dose|multiple dose
253112|NCT02083666|Safety|safety
253113|NCT02083666|Tolerability|tolerability
253114|NCT02083666|Pharmacokinetics|pharmacokinetics
253115|NCT02083666|Pharmacodynamics|pharmacodynamics
253116|NCT02083666|volunteers|volunteers
253117|NCT02083653|Metastatic Colorectal Cancer|metastatic colorectal cancer
253118|NCT02083653|Sym004|sym004
253119|NCT02083653|Best Supportive Care|best supportive care
253120|NCT02083653|Capecitabine|capecitabine
253121|NCT02083653|Fluorouracil (5-FU)|fluorouracil (5-fu)
253122|NCT02083640|healthy volunteer|healthy volunteer
253123|NCT02083640|bioavailability|bioavailability
253124|NCT02083640|palbociclib|palbociclib
253125|NCT02083640|formulation|formulation
253126|NCT02083627|Pharmacokinetics|pharmacokinetics
253127|NCT02083627|Drug-Drug Interaction|drug-drug interaction
253128|NCT02083627|Intestinal Absorption|intestinal absorption
253129|NCT02083627|Fidaxomicin|fidaxomicin
253130|NCT02083627|Rosuvastatin|rosuvastatin
253131|NCT02083627|Multiple Doses|multiple doses
253132|NCT02083627|Single Doses|single doses
253133|NCT02083601|Caregivers|caregivers
253134|NCT02083601|Spinal Cord Injuries|spinal cord injuries
253135|NCT02083601|Psychology, Educational|psychology, educational
253136|NCT02083601|Counseling|counseling
253137|NCT02083601|Outcome Assessment (Health Care)|outcome assessment (health care)
253138|NCT02083588|Fibromyalgia|fibromyalgia
253139|NCT02083588|dTMS|dtms
253140|NCT02083588|pain|pain
253141|NCT02083588|PFC|pfc
253142|NCT02083588|Subjects with Fibromyalgia|subjects with fibromyalgia
253143|NCT02083575|vitamin c|vitamin c
253144|NCT02083575|thalassemia major|thalassemia major
253145|NCT02083575|iron chelation|iron chelation
253146|NCT02083562|Bronchopulmonary dysplasia, preterm infant|bronchopulmonary dysplasia, preterm infant
253147|NCT02083549|Massive Transfusion Protocol|massive transfusion protocol
253148|NCT02083536|Low Dose Fractionated Whole Abdominal Radiation Therapy|low dose fractionated whole abdominal radiation therapy
253149|NCT02083536|LDFWART|ldfwart
253150|NCT02083536|Docetaxel|docetaxel
253151|NCT02083536|Ovarian Cancer|ovarian cancer
253152|NCT02083536|Ovarian Carcinoma|ovarian carcinoma
253153|NCT02083536|Platinum-Resistant|platinum-resistant
253154|NCT02083523|Motivational Interview, normative feedback, adolescents|motivational interview, normative feedback, adolescents
253155|NCT02083510|Colchicine|colchicine
253156|NCT02083510|Hypertriglyceridemia|hypertriglyceridemia
253157|NCT02083510|Apolipoprotein CIII|apolipoprotein ciii
253158|NCT02083497|kick|kick
253159|NCT02083497|taping|taping
253160|NCT02083497|dynamic equilibrium|dynamic equilibrium
253161|NCT02083458|critical care|critical care
253162|NCT02083458|catheterization|catheterization
253163|NCT02083458|axillary vein|axillary vein
253164|NCT02083445|Traumatic brain injury|traumatic brain injury
253165|NCT02083445|Exercise|exercise
253166|NCT02083445|Psychology|psychology
253167|NCT02083445|Physiology|physiology
253168|NCT02083445|Progenitor cells|progenitor cells
253169|NCT02083445|Hypoxia|hypoxia
253170|NCT02083432|intra-oral injections|intra-oral injections
253171|NCT02083432|CBT|cbt
253172|NCT02083432|Blood-Injury-Injection-phobia|blood-injury-injection-phobia
253173|NCT02083432|DSM-IV. 300.29|dsm-iv. 300.29
253174|NCT02083419|Left Ventricular Assist Devices (LVAD)|left ventricular assist devices (lvad)
253175|NCT02083419|Cardiac Resynchronization Devices (CRT)|cardiac resynchronization devices (crt)
253176|NCT02083406|Malaria|malaria
253177|NCT02083406|Bio-availability|bio-availability
253178|NCT02083393|dendritic cell|dendritic cell
253179|NCT02083380|Plasmodium falciparum malaria|plasmodium falciparum malaria
253180|NCT02083380|malaria|malaria
253181|NCT02083380|OZ439|oz439
253182|NCT02083380|piperaquine|piperaquine
253183|NCT02083380|PQP|pqp
253184|NCT02083354|melanoma|melanoma
253185|NCT02083354|dabrafenib|dabrafenib
253186|NCT02083354|trametinib|trametinib
253187|NCT02083328|heart rate variability|heart rate variability
253188|NCT02083328|exercise performance|exercise performance
253189|NCT02083315|acute pain, analgesia, respiratory drive, ventilator response to hypercapnia, pupillometry|acute pain, analgesia, respiratory drive, ventilator response to hypercapnia, pupillometry
253190|NCT02083302|campus sexual assault|campus sexual assault
253191|NCT02083302|bystander intervention|bystander intervention
253192|NCT02083289|ONO-9054|ono-9054
253193|NCT02083289|ocular hypertension (OHT)|ocular hypertension (oht)
253194|NCT02083289|Open angle-glaucoma (OAG)|open angle-glaucoma (oag)
253195|NCT02083289|Glaucoma|glaucoma
253196|NCT02083289|Eye Diseases|eye diseases
253197|NCT02083289|Mild to moderate|mild to moderate
253198|NCT02083276|Chlamydia trachomatis|chlamydia trachomatis
253199|NCT02083276|Urethritis|urethritis
253200|NCT02083276|Genital Diseases, Male|genital diseases, male
253201|NCT02083263|Lung function|lung function
253202|NCT02083250|Leukemia|leukemia
253203|NCT02083250|Blood And Marrow Transplantation|blood and marrow transplantation
253204|NCT02083250|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
253205|NCT02083250|ALL|all
253206|NCT02083250|Acute myeloid leukemia|acute myeloid leukemia
253207|NCT02083250|AML|aml
253208|NCT02083250|Myelodysplastic syndrome|myelodysplastic syndrome
253209|NCT02083250|MDS|mds
253210|NCT02083250|Allogeneic stem cell transplant|allogeneic stem cell transplant
253211|NCT02083250|SCT|sct
253212|NCT02083250|Thymoglobulin|thymoglobulin
253213|NCT02083250|ATG|atg
253214|NCT02083250|Antithymocyte Globulin|antithymocyte globulin
253215|NCT02083250|Fludarabine|fludarabine
253216|NCT02083250|Fludarabine Phosphate|fludarabine phosphate
253217|NCT02083250|Fludara|fludara
253218|NCT02083250|Clofarabine|clofarabine
253219|NCT02083250|Clofarex|clofarex
253220|NCT02083250|Clolar|clolar
253221|NCT02083250|Busulfan|busulfan
253222|NCT02083250|Busulfex|busulfex
253223|NCT02083250|Myleran|myleran
253224|NCT02083250|SAHA|saha
253225|NCT02083250|Vorinostat|vorinostat
253226|NCT02083250|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
253227|NCT02083250|MSK-390|msk-390
253228|NCT02083250|Zolinza|zolinza
253229|NCT02083237|mild cognitive impairment|mild cognitive impairment
253230|NCT02083237|memory training|memory training
253231|NCT02083237|healthy lifestyle|healthy lifestyle
253232|NCT02083237|psychosocial support|psychosocial support
253233|NCT02083211|Cervical cancer|cervical cancer
253336|NCT02082795|Pregnancy|pregnancy
253234|NCT02083211|Recurrent or persistent tumor|recurrent or persistent tumor
253235|NCT02083211|Monoclonal antibody|monoclonal antibody
253236|NCT02083198|hyperchloremic acidosis|hyperchloremic acidosis
253237|NCT02083198|balanced fluids|balanced fluids
253238|NCT02083198|plasmalyte|plasmalyte
253239|NCT02083185|Drug therapy|drug therapy
253240|NCT02083172|USCOM (UltraSound Cardiac Output Monitor)|uscom (ultrasound cardiac output monitor)
253241|NCT02083172|2D echocardiography|2d echocardiography
253242|NCT02083172|agreement|agreement
253243|NCT02083172|pediatrics|pediatrics
253244|NCT02083133|Diabetes|diabetes
253245|NCT02083133|Renal Failure|renal failure
253246|NCT02083133|Dialysis|dialysis
253247|NCT02083133|End Stage Renal Disease|end stage renal disease
253248|NCT02083133|Hypoglycemia|hypoglycemia
253249|NCT02083120|high flow|high flow
253250|NCT02083120|COPD|copd
253251|NCT02083120|AIRVO|airvo
253252|NCT02083107|Postpartum hemorrhage|postpartum hemorrhage
253253|NCT02083107|Intrapartum blood loss|intrapartum blood loss
253254|NCT02083107|Misoprostol|misoprostol
253255|NCT02083081|tobacco|tobacco
253256|NCT02083081|smoking|smoking
253257|NCT02083068|Malaria, vaccine, P. vivax|malaria, vaccine, p. vivax
253258|NCT02083055|dexmedetomidine|dexmedetomidine
253259|NCT02083055|controlled hypotensive anesthesia|controlled hypotensive anesthesia
253260|NCT02083042|CMV|cmv
253261|NCT02083042|T-Track CMV|t-track cmv
253262|NCT02083042|kidney transplantation|kidney transplantation
253263|NCT02083029|Asthma|asthma
253264|NCT02083029|Death|death
253265|NCT02083029|Mechanism|mechanism
253266|NCT02083029|Syncope|syncope
253267|NCT02083029|Dive reflex|dive reflex
253268|NCT02083003|Pain|pain
253269|NCT02083003|Polyamine|polyamine
253270|NCT02083003|Cholecystectomy|cholecystectomy
253271|NCT02082990|Alcohol-related disorders|alcohol-related disorders
253272|NCT02082990|Alcohol Drinking|alcohol drinking
253273|NCT02082990|e-health|e-health
253274|NCT02082990|Alcohol Use Disorder Test|alcohol use disorder test
253275|NCT02082990|Quality of Life|quality of life
253276|NCT02082977|Refractory|refractory
253277|NCT02082977|Phase I study, dose escalation study|phase i study, dose escalation study
253278|NCT02082977|diffuse large B cell lymphoma|diffuse large b cell lymphoma
253279|NCT02082977|Relapsed|relapsed
253280|NCT02082977|Solid tumors|solid tumors
253281|NCT02082977|transformed follicular lymphoma|transformed follicular lymphoma
253282|NCT02082977|Multiple myeloma|multiple myeloma
253283|NCT02082977|GSK2816126|gsk2816126
253284|NCT02082977|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
253285|NCT02082938|stroke,|stroke,
253286|NCT02082938|rehabilitation,|rehabilitation,
253287|NCT02082938|hemiparesis,|hemiparesis,
253288|NCT02082938|gait training|gait training
253289|NCT02082925|Exercise training|exercise training
253290|NCT02082925|Dyspnea threshold|dyspnea threshold
253291|NCT02082925|6MWT|6mwt
253292|NCT02082899|Allergic Conjunctivitis|allergic conjunctivitis
253293|NCT02082899|Interleukin 1 Receptor Inhibitor|interleukin 1 receptor inhibitor
253294|NCT02082899|Environmental Exposure Chamber|environmental exposure chamber
253295|NCT02082899|Conjunctival Allergen Provocation Test|conjunctival allergen provocation test
253296|NCT02082886|Metastasis|metastasis
253297|NCT02082886|Carcinomatosis|carcinomatosis
253298|NCT02082886|Carcinosis|carcinosis
253299|NCT02082886|Sarcomatosis|sarcomatosis
253300|NCT02082886|CRS|crs
253301|NCT02082886|Cytoreductive surgery|cytoreductive surgery
253302|NCT02082886|HIPEC|hipec
253303|NCT02082886|Heated Intraperitoneal Chemotherapy|heated intraperitoneal chemotherapy
253304|NCT02082886|Intra-abdominal|intra-abdominal
253305|NCT02082886|Sugarbaker technique|sugarbaker technique
253306|NCT02082886|Mitomycin C|mitomycin c
253307|NCT02082886|Cisplatin|cisplatin
253308|NCT02082886|Doxorubicin|doxorubicin
253309|NCT02082886|Oxaliplatin|oxaliplatin
253310|NCT02082886|Melphalan|melphalan
253311|NCT02082873|Quantitative EEG|quantitative eeg
253312|NCT02082873|Nonconvulsive seizures|nonconvulsive seizures
253313|NCT02082873|ICU EEG monitoring|icu eeg monitoring
253314|NCT02082860|Porphyria|porphyria
253315|NCT02082860|Gene therapy|gene therapy
253316|NCT02082860|AAV|aav
253317|NCT02082860|Liver gene transfer|liver gene transfer
253318|NCT02082834|Endovascular aneurysm repair EVAR|endovascular aneurysm repair evar
253319|NCT02082834|Endoleak/diagnosis|endoleak/diagnosis
253320|NCT02082834|VEOTM|veotm
253321|NCT02082834|Model-based iterative reconstruction (MBIR)|model-based iterative reconstruction (mbir)
253322|NCT02082834|Adaptive statistical iterative reconstruction (ASIR)|adaptive statistical iterative reconstruction (asir)
253323|NCT02082834|Aortic Aneurysm|aortic aneurysm
253324|NCT02082834|Low dose|low dose
253325|NCT02082834|Prospective|prospective
253326|NCT02082834|CTA|cta
253327|NCT02082808|Dolutegravir|dolutegravir
253328|NCT02082808|healthy volunteer|healthy volunteer
253329|NCT02082808|pharmacokinetics|pharmacokinetics
253330|NCT02082808|daclatasvir|daclatasvir
253331|NCT02082808|drug interaction|drug interaction
253332|NCT02082795|Breech presentation|breech presentation
253333|NCT02082795|External cephalic version|external cephalic version
253334|NCT02082795|Anaesthesia|anaesthesia
253337|NCT02082782|Colorectal liver metastases (CRLM)|colorectal liver metastases (crlm)
253338|NCT02082782|Tumor ablation|tumor ablation
253339|NCT02082782|Irreversible electroporation (IRE)|irreversible electroporation (ire)
253340|NCT02082782|Interventional oncology|interventional oncology
253341|NCT02082782|NanoKnife|nanoknife
253342|NCT02082782|Colorectal liver metastasis, unresectable and not-thermally ablative due to location near vulnerable structures like vessels or bile ducts|colorectal liver metastasis, unresectable and not-thermally ablative due to location near vulnerable structures like vessels or bile ducts
253343|NCT02082769|Gout|gout
253344|NCT02082769|Uric Acid|uric acid
253345|NCT02082769|Xanthine oxidase|xanthine oxidase
253346|NCT02082769|Febuxostat|febuxostat
253347|NCT02082756|Prediabetes|prediabetes
253348|NCT02082756|Berberine Hydrochloride|berberine hydrochloride
253349|NCT02082756|Bifidobacterium|bifidobacterium
253350|NCT02082743|Myopia|myopia
253351|NCT02082743|Outdoor activity|outdoor activity
253352|NCT02082743|Recess outside classroom|recess outside classroom
253353|NCT02082730|CFS/ME, Chronic fatigue syndrome, Pediatric, remote mobile technology|cfs/me, chronic fatigue syndrome, pediatric, remote mobile technology
253354|NCT02082704|Diabetes|diabetes
253355|NCT02082704|Education, Patient|education, patient
253356|NCT02082704|Educational Technology|educational technology
253357|NCT02082691|G-202|g-202
253358|NCT02082691|Hepatocellular|hepatocellular
253359|NCT02082678|Bipolar Disorder|bipolar disorder
253360|NCT02082678|BPD|bpd
253361|NCT02082678|Alcohol Use Disorder|alcohol use disorder
253362|NCT02082678|Alcohol Abuse|alcohol abuse
253363|NCT02082678|Alcohol Dependence|alcohol dependence
253364|NCT02082678|Ondansetron|ondansetron
253365|NCT02082678|Cognition|cognition
253366|NCT02082678|Mood|mood
253367|NCT02082665|rosuvastatin|rosuvastatin
253368|NCT02082665|BRAF V600|braf v600
253369|NCT02082665|Melanoma|melanoma
253370|NCT02082665|dabrafenib|dabrafenib
253371|NCT02082665|midazolam|midazolam
253372|NCT02082652|Etonogestrel|etonogestrel
253373|NCT02082652|Efavirenz|efavirenz
253374|NCT02082652|Nevirapine|nevirapine
253375|NCT02082652|Pharmacokinetics|pharmacokinetics
253376|NCT02082639|Adolescents|adolescents
253377|NCT02082639|Havrix|havrix
253378|NCT02082639|Immunogenicity|immunogenicity
253379|NCT02082639|Cervarix|cervarix
253380|NCT02082639|Safety|safety
253381|NCT02082626|Phase I|phase i
253382|NCT02082626|Pediatric|pediatric
253383|NCT02082626|Cancer|cancer
253384|NCT02082626|Lymphoma|lymphoma
253385|NCT02082626|Eribulin|eribulin
253386|NCT02082613|Testicular hydrocele|testicular hydrocele
253387|NCT02082613|Hydrocele|hydrocele
253388|NCT02082613|Sclerotherapy|sclerotherapy
253389|NCT02082613|Surgery|surgery
253390|NCT02082613|Complications|complications
253391|NCT02082587|brain metastases|brain metastases
253392|NCT02082587|brain mets|brain mets
253393|NCT02082587|WBRT|wbrt
253394|NCT02082561|transdiagnostic treatment|transdiagnostic treatment
253395|NCT02082561|cognitive behavior therapy|cognitive behavior therapy
253396|NCT02082561|anxiety|anxiety
253397|NCT02082561|panic disorder|panic disorder
253398|NCT02082561|generalized anxiety disorder|generalized anxiety disorder
253399|NCT02082561|social anxiety disorder|social anxiety disorder
253400|NCT02082548|atrial fibrillation|atrial fibrillation
253401|NCT02082548|anticoagulation|anticoagulation
253402|NCT02082548|education|education
253403|NCT02082548|educational intervention|educational intervention
253404|NCT02082535|Premature Birth|premature birth
253405|NCT02082535|Brain Injuries|brain injuries
253406|NCT02082535|Leukomalacia Periventricular|leukomalacia periventricular
253407|NCT02082535|S100B protein human|s100b protein human
253408|NCT02082535|Glial Fibrillary Acidic Protein|glial fibrillary acidic protein
253409|NCT02082535|Magnetic Resonance Imaging|magnetic resonance imaging
253410|NCT02082535|Developmental Disabilities|developmental disabilities
253411|NCT02082522|Cholangiocarcinoma|cholangiocarcinoma
253412|NCT02082522|Unresectable perihilar cholangiocarcinoma|unresectable perihilar cholangiocarcinoma
253413|NCT02082522|Klatskin tumor|klatskin tumor
253414|NCT02082522|Photodynamic therapy|photodynamic therapy
253415|NCT02082522|Porfimer sodium|porfimer sodium
253416|NCT02082522|Photofrin|photofrin
253417|NCT02082522|Gemcitabine|gemcitabine
253418|NCT02082522|Cisplatin|cisplatin
253419|NCT02082522|Stents|stents
253420|NCT02082522|CCA|cca
253421|NCT02082522|PDT|pdt
253422|NCT02082522|Bile duct cancer|bile duct cancer
253423|NCT02082522|Bile duct tumor|bile duct tumor
253424|NCT02082522|Bile duct adenocarcinoma|bile duct adenocarcinoma
253425|NCT02082522|Chemotherapy|chemotherapy
253426|NCT02082509|Traumatic Brain Injury|traumatic brain injury
253427|NCT02082509|Post-Concussive Symptoms|post-concussive symptoms
253428|NCT02082509|Brain Imaging|brain imaging
253429|NCT02082509|Cognition|cognition
253430|NCT02082496|Obesity|obesity
253431|NCT02082496|Obesity Genetics|obesity genetics
253432|NCT02082496|GLP-1|glp-1
253433|NCT02082496|GLP-1 Receptor Agonists|glp-1 receptor agonists
253434|NCT02082483|Kidney Transplant|kidney transplant
253435|NCT02082483|Screening|screening
253436|NCT02082457|Irritable Bowel Syndrome|irritable bowel syndrome
253437|NCT02082457|Constipation|constipation
253438|NCT02082457|C-IBS|c-ibs
253439|NCT02082431|Sensorineural hearing loss|sensorineural hearing loss
253440|NCT02082431|Long QT Syndrome|long qt syndrome
253441|NCT02082418|Mild cognitive impairment|mild cognitive impairment
253442|NCT02082418|Protein digestion|protein digestion
253443|NCT02082418|Tryptophan digestion|tryptophan digestion
253444|NCT02082418|Cognitive function|cognitive function
253445|NCT02082418|Mood|mood
253446|NCT02082418|Muscle function|muscle function
253447|NCT02082418|Alpha-lactalbumin|alpha-lactalbumin
253448|NCT02082379|Interface, aerosol, child, acceptance|interface, aerosol, child, acceptance
253449|NCT02082366|Atrial fibrillation|atrial fibrillation
253450|NCT02082366|CPVI|cpvi
253451|NCT02082366|TCD|tcd
253452|NCT02082366|nMARQ|nmarq
253453|NCT02082366|MES|mes
253454|NCT02082366|microembolic signals|microembolic signals
253455|NCT02082353|Granulomatous Disease, Chronic|granulomatous disease, chronic
253456|NCT02082353|Hematopoietic Stem Cell Transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
253457|NCT02082353|bone marrow transplant (BMT)|bone marrow transplant (bmt)
253458|NCT02082353|non-transplant|non-transplant
253459|NCT02082353|factors associated with best outcomes of transplant in CGD|factors associated with best outcomes of transplant in cgd
253460|NCT02082340|Tuberculosis|tuberculosis
253461|NCT02082340|Armenia|armenia
253462|NCT02082340|Clinical trial|clinical trial
253463|NCT02082340|Directly Observed Therapy (DOT)|directly observed therapy (dot)
253464|NCT02082340|Self-administered drug intake|self-administered drug intake
253465|NCT02082327|Fabry Disease|fabry disease
253466|NCT02082327|Fabry|fabry
253467|NCT02082327|Lysosomal storage disorders|lysosomal storage disorders
253468|NCT02082327|LSD|lsd
253469|NCT02082327|Amicus|amicus
253470|NCT02082327|migalastat HCl|migalastat hcl
253471|NCT02082327|migalastat|migalastat
253472|NCT02082327|AT1001|at1001
253473|NCT02082314|radiofrequency ablation|radiofrequency ablation
253474|NCT02082314|bone metastases|bone metastases
253475|NCT02082288|ICSI outcome|icsi outcome
253476|NCT02082275|Prenatal Care|prenatal care
253477|NCT02082275|Obstetrics|obstetrics
253478|NCT02082249|Safety|safety
253479|NCT02082249|Tolerability|tolerability
253480|NCT02082249|Efficacy|efficacy
253481|NCT02082249|levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
253482|NCT02082249|levodopa|levodopa
253483|NCT02082249|carbidopa|carbidopa
253484|NCT02082249|Advanced Parkinson's Disease|advanced parkinson's disease
253485|NCT02082236|Plasma concentrations|plasma concentrations
253486|NCT02082223|Quality of life|quality of life
253487|NCT02082223|Deficits|deficits
253488|NCT02082223|Complex gastrointestinal surgery|complex gastrointestinal surgery
253489|NCT02082197|low testosterone|low testosterone
253490|NCT02082184|Sensing Technology|sensing technology
253491|NCT02082184|Type 2 Diabetes,|type 2 diabetes,
253492|NCT02082171|older adults|older adults
253493|NCT02082171|physical disability|physical disability
253494|NCT02082171|multidomain intervention|multidomain intervention
253495|NCT02082171|prevention|prevention
253496|NCT02082171|pilot study|pilot study
253497|NCT02082171|frailty|frailty
253498|NCT02082171|mobility|mobility
253499|NCT02082171|comprehensive geriatric assessment|comprehensive geriatric assessment
253500|NCT02082106|alpine skiing|alpine skiing
253501|NCT02082106|cross country skiing|cross country skiing
253502|NCT02082106|indoor cycling|indoor cycling
253503|NCT02082106|physical fitness|physical fitness
253504|NCT02082106|training status|training status
253505|NCT02082106|metabolic equivalent|metabolic equivalent
253506|NCT02082093|Chronic Kidney Disease|chronic kidney disease
253507|NCT02082093|telemedicine|telemedicine
253508|NCT02082054|rhinitis|rhinitis
253509|NCT02082054|seasonal|seasonal
253510|NCT02082054|allergic|allergic
253511|NCT02082015|Neuronal plasticity|neuronal plasticity
253512|NCT02082015|Transcranial magnetic stimulation|transcranial magnetic stimulation
253513|NCT02082015|Stroke|stroke
253514|NCT02082015|Upper extremity|upper extremity
253515|NCT02082015|Function|function
253516|NCT02082015|Recovery|recovery
253517|NCT02082002|Multiple scerlosis|multiple scerlosis
253518|NCT02082002|Fatigue|fatigue
253519|NCT02082002|Sleep|sleep
253520|NCT02082002|Somnolence|somnolence
253521|NCT02082002|Depression|depression
253522|NCT02082002|Cognitive disorders|cognitive disorders
253523|NCT02081989|Diabetes|diabetes
253524|NCT02081989|Renal denervation|renal denervation
253525|NCT02081963|Nebulized amikacin;|nebulized amikacin;
253526|NCT02081963|Non-Cystic Fibrosis Bronchiectasis;|non-cystic fibrosis bronchiectasis;
253527|NCT02081963|Bacterial clearance rate of sputum；|bacterial clearance rate of sputum；
253528|NCT02081963|Acute exacerbation.|acute exacerbation.
253529|NCT02081937|chimeric antigen receptor|chimeric antigen receptor
253530|NCT02081937|immunotherapy|immunotherapy
253531|NCT02081937|T lymphocyte|t lymphocyte
253532|NCT02081937|mantle cell lymphoma|mantle cell lymphoma
253533|NCT02081924|Infertility|infertility
253534|NCT02081924|Kisspeptin|kisspeptin
253535|NCT02081924|Reproductive hormones|reproductive hormones
253536|NCT02081911|adductor canal|adductor canal
253537|NCT02081911|femoral|femoral
253538|NCT02081911|quadriceps|quadriceps
253539|NCT02081898|low calorie diet|low calorie diet
253540|NCT02081898|BMI|bmi
253541|NCT02081898|sphingomyelin|sphingomyelin
253542|NCT02081898|L-leucine|l-leucine
253543|NCT02081898|L-phenylalanine|l-phenylalanine
253544|NCT02081885|Tricalcium phosphate|tricalcium phosphate
253545|NCT02081885|Chitosan|chitosan
253546|NCT02081885|Grafting, Bone|grafting, bone
253547|NCT02081885|Mandibular Fractures|mandibular fractures
253548|NCT02081872|Pharmacogenomics|pharmacogenomics
253549|NCT02081872|Target Drug Related Adverse Events (TDAE)|target drug related adverse events (tdae)
253550|NCT02081846|transitions of care|transitions of care
253551|NCT02081846|reutilization|reutilization
253552|NCT02081846|home nurse visit|home nurse visit
253553|NCT02081846|focus groups|focus groups
253554|NCT02081846|quality improvement|quality improvement
253555|NCT02081833|acute respiratory infections|acute respiratory infections
253556|NCT02081833|acute gastrointestinal infections|acute gastrointestinal infections
253557|NCT02081833|children|children
253558|NCT02081833|child|child
253559|NCT02081833|symptom diary|symptom diary
253560|NCT02081833|nasal swabs|nasal swabs
253561|NCT02081833|stool samples|stool samples
253562|NCT02081820|hyperglycemia|hyperglycemia
253563|NCT02081820|aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
253564|NCT02081820|glycated hemoglobin|glycated hemoglobin
253565|NCT02081820|outcome|outcome
253566|NCT02081820|DCI|dci
253567|NCT02081768|Rathke's cleft cyst|rathke's cleft cyst
253568|NCT02081768|cystic craniopharyngiomas|cystic craniopharyngiomas
253569|NCT02081755|Immunosuppressive Agents|immunosuppressive agents
253570|NCT02081755|Liver Transplantation|liver transplantation
253571|NCT02081742|Colonoscopy, CT colonography, Colon capsule|colonoscopy, ct colonography, colon capsule
253572|NCT02081703|Postsurgical pain|postsurgical pain
253573|NCT02081703|Total knee arthroplasty|total knee arthroplasty
253574|NCT02081703|Total knee replacement|total knee replacement
253575|NCT02081690|PAH-SYMPACT|pah-sympact
253576|NCT02081690|psychometric instrument|psychometric instrument
253577|NCT02081664|Amalgam attributed health complaints|amalgam attributed health complaints
253578|NCT02081664|feasibility pilot study|feasibility pilot study
253579|NCT02081664|integrated medical care program|integrated medical care program
253580|NCT02081664|lifestyle|lifestyle
253581|NCT02081638|Immune Activation|immune activation
253582|NCT02081625|Duchenne muscular dystrophy|duchenne muscular dystrophy
253583|NCT02081625|NS-065/NCNP-01|ns-065/ncnp-01
253584|NCT02081625|exon 53 skipping|exon 53 skipping
253585|NCT02081625|morpholino|morpholino
253586|NCT02081599|insulin resistance|insulin resistance
253587|NCT02081586|CBT|cbt
253588|NCT02081586|Type 2 Diabetes|type 2 diabetes
253589|NCT02081586|Diabetes Distress|diabetes distress
253590|NCT02081586|Adherence|adherence
253591|NCT02081586|Smartphone App|smartphone app
253592|NCT02081586|Self-management|self-management
253593|NCT02081573|Brief CBT|brief cbt
253594|NCT02081573|smartphone app|smartphone app
253595|NCT02081573|mHealth|mhealth
253596|NCT02081573|diabetes distress|diabetes distress
253597|NCT02081573|adherence|adherence
253598|NCT02081573|cognitive behavioral therapy|cognitive behavioral therapy
253599|NCT02081560|pharmacokinetics|pharmacokinetics
253600|NCT02081560|antibiotic|antibiotic
253601|NCT02081560|Gram negative|gram negative
253602|NCT02081560|continuous renal replacement therapy|continuous renal replacement therapy
253603|NCT02081547|rectal carcinoma|rectal carcinoma
253604|NCT02081547|recurrence|recurrence
253605|NCT02081547|pathology|pathology
253606|NCT02081547|cytology|cytology
253607|NCT02081547|free cancer cells|free cancer cells
253608|NCT02081547|survival|survival
253609|NCT02081534|S-phosphate, hyperphosphatemia, hemodialysis, ESRD|s-phosphate, hyperphosphatemia, hemodialysis, esrd
253610|NCT02081521|behaviour change|behaviour change
253611|NCT02081521|diarrhoeal disease|diarrhoeal disease
253612|NCT02081521|handwashing|handwashing
253613|NCT02081521|breastfeeding|breastfeeding
253614|NCT02081521|diarrhoea management|diarrhoea management
253615|NCT02081508|Memory|memory
253616|NCT02081495|Neoplasms|neoplasms
253617|NCT02081495|Neoplasms, Ovarian|neoplasms, ovarian
253618|NCT02081495|Ovarian Cancer|ovarian cancer
253619|NCT02081495|Advanced or Refractory Solid Malignancies|advanced or refractory solid malignancies
253620|NCT02081495|Doxorubicin|doxorubicin
253621|NCT02081495|DOXIL|doxil
253622|NCT02081495|CAELYX|caelyx
253623|NCT02081469|Chronic hepatitis B|chronic hepatitis b
253624|NCT02081469|HBV|hbv
253625|NCT02081469|Chemotherapy|chemotherapy
253626|NCT02081469|Reactivation|reactivation
253627|NCT02081469|Prophylaxis|prophylaxis
253628|NCT02081443|coronary artery disease|coronary artery disease
253629|NCT02081443|platelet function|platelet function
253630|NCT02081443|ticagrelor|ticagrelor
253631|NCT02081443|cangrelor|cangrelor
253632|NCT02081417|Trauma|trauma
253633|NCT02081417|Post traumatic stress disorder|post traumatic stress disorder
253634|NCT02081417|substance use disorders|substance use disorders
253635|NCT02081417|peer-delivered trauma treatment|peer-delivered trauma treatment
253938|NCT02080117|creatinine|creatinine
253636|NCT02081404|Non-erosive Reflux Disease|non-erosive reflux disease
253637|NCT02081391|Acute Pain|acute pain
253638|NCT02081391|Post-operative|post-operative
253639|NCT02081391|Tapentadol|tapentadol
253640|NCT02081391|Opioid Treatment|opioid treatment
253641|NCT02081391|Pediatric Participants|pediatric participants
253642|NCT02081378|CML|cml
253643|NCT02081378|Ph+ ALL|ph+ all
253644|NCT02081352|Dermis|dermis
253645|NCT02081352|Diabetic foot ulcers|diabetic foot ulcers
253646|NCT02081352|Skin substitutes|skin substitutes
253647|NCT02081352|Decellularized|decellularized
253648|NCT02081326|Diabetes Mellitus, Type One|diabetes mellitus, type one
253649|NCT02081326|Diabetes Mellitus, Type I|diabetes mellitus, type i
253650|NCT02081326|Autoimmune Diabetes|autoimmune diabetes
253651|NCT02081326|Insulin Dependent Diabetes Mellitus 1|insulin dependent diabetes mellitus 1
253652|NCT02081326|IDDM|iddm
253653|NCT02081313|Netherton syndrome|netherton syndrome
253654|NCT02081313|Immune system|immune system
253655|NCT02081313|Skin barrier|skin barrier
253656|NCT02081300|Testosterone|testosterone
253657|NCT02081300|Male hypogonadism|male hypogonadism
253658|NCT02081300|Low testosterone|low testosterone
253659|NCT02081300|LPCN 1021|lpcn 1021
253660|NCT02081300|Androgel|androgel
253661|NCT02081300|Testim|testim
253662|NCT02081300|Testopel|testopel
253663|NCT02081300|Fortesta|fortesta
253664|NCT02081300|Axiron.|axiron.
253665|NCT02081300|Hypogonadism|hypogonadism
253666|NCT02081300|Eunuchism|eunuchism
253667|NCT02081300|Gonadal Disorders|gonadal disorders
253668|NCT02081300|Endocrine System Diseases|endocrine system diseases
253669|NCT02081300|Testosterone enanthate|testosterone enanthate
253670|NCT02081300|Testosterone undecanoate|testosterone undecanoate
253671|NCT02081300|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate
253672|NCT02081300|Methyltestosterone|methyltestosterone
253673|NCT02081300|Androgens|androgens
253674|NCT02081300|Hormones|hormones
253675|NCT02081300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
253676|NCT02081300|Physiological Effects of Drugs|physiological effects of drugs
253677|NCT02081300|Pharmacologic Actions|pharmacologic actions
253678|NCT02081300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal
253679|NCT02081300|Antineoplastic Agents|antineoplastic agents
253680|NCT02081300|Anabolic Agents|anabolic agents
253681|NCT02081287|Bipolar Disorder|bipolar disorder
253682|NCT02081287|Depression|depression
253683|NCT02081287|Inositol|inositol
253684|NCT02081287|Inositol Hexaphosphate|inositol hexaphosphate
253685|NCT02081287|Phytic Acid|phytic acid
253686|NCT02081287|IP6|ip6
253687|NCT02081287|Lithium|lithium
253688|NCT02081287|Lamotrigine|lamotrigine
253689|NCT02081274|tidal volume|tidal volume
253690|NCT02081274|congenital heart disease|congenital heart disease
253691|NCT02081274|mortality|mortality
253692|NCT02081261|coronary artery bypass surgery|coronary artery bypass surgery
253693|NCT02081261|acute kidney injury|acute kidney injury
253694|NCT02081261|creatinine|creatinine
253695|NCT02081261|mortality|mortality
253696|NCT02081235|congenital heart disease|congenital heart disease
253697|NCT02081235|acute kidney injury|acute kidney injury
253698|NCT02081235|risk factor|risk factor
253699|NCT02081235|anesthesia|anesthesia
253700|NCT02081222|congenital heart disease|congenital heart disease
253701|NCT02081222|rotational thromboelastometry|rotational thromboelastometry
253702|NCT02081222|blood loss|blood loss
253703|NCT02081222|transfusion requirements|transfusion requirements
253704|NCT02081209|Lipolysis|lipolysis
253705|NCT02081209|Cryolipolysis|cryolipolysis
253706|NCT02081209|Fat Reduction|fat reduction
253707|NCT02081196|Lipolysis|lipolysis
253708|NCT02081196|Cryolipolysis|cryolipolysis
253709|NCT02081196|Fat Reduction|fat reduction
253710|NCT02081144|Standard Care Condition|standard care condition
253711|NCT02081144|Texting + NRT Condition|texting + nrt condition
253712|NCT02081131|periampullary cancer|periampullary cancer
253713|NCT02081131|pancreatic cancer|pancreatic cancer
253714|NCT02081131|randomized controlled trial|randomized controlled trial
253715|NCT02081131|Whipple's operation|whipple's operation
253716|NCT02081131|laparoscopy|laparoscopy
253717|NCT02081105|ARDS,|ards,
253718|NCT02081105|PEEP,|peep,
253719|NCT02081105|lung recruitment,|lung recruitment,
253720|NCT02081105|lung recruitability,|lung recruitability,
253721|NCT02081105|Chest-X-Ray,|chest-x-ray,
253722|NCT02081105|lung imaging,|lung imaging,
253723|NCT02081105|Pressure/Volume (PV) curve,|pressure/volume (pv) curve,
253724|NCT02081105|compliance,|compliance,
253725|NCT02081105|respiratory mechanics|respiratory mechanics
253726|NCT02081092|PAP|pap
253727|NCT02081092|Pulmonary Alveolar Proteinosis|pulmonary alveolar proteinosis
253728|NCT02081092|Pulmonary|pulmonary
253729|NCT02081092|Patients|patients
253730|NCT02081079|HCV GT 4|hcv gt 4
253731|NCT02081079|HCV GT 5|hcv gt 5
253732|NCT02081053|metastatic lesions|metastatic lesions
253733|NCT02081053|vertebral body|vertebral body
253734|NCT02081053|ablation|ablation
253735|NCT02081053|targeted radio-frequency ablation|targeted radio-frequency ablation
254238|NCT02078752|tumors|tumors
253736|NCT02081053|radio-frequency targeted vertebral augmentation|radio-frequency targeted vertebral augmentation
253737|NCT02081053|radiofrequency kyphoplasty|radiofrequency kyphoplasty
253738|NCT02081053|spine|spine
253739|NCT02081053|vertebral augmentation|vertebral augmentation
253740|NCT02081053|kyphoplasty|kyphoplasty
253741|NCT02081053|spinal ablation|spinal ablation
253742|NCT02081053|pain|pain
253743|NCT02081053|quality of life|quality of life
253744|NCT02081040|brainstem|brainstem
253745|NCT02081040|diaphragm|diaphragm
253746|NCT02081040|deglutition disorder|deglutition disorder
253747|NCT02081040|sonography|sonography
253748|NCT02081014|Hypoglycemia|hypoglycemia
253749|NCT02081014|Glucagon|glucagon
253750|NCT02081014|Diabetes|diabetes
253751|NCT02081001|Hypoglycemia|hypoglycemia
253752|NCT02081001|Glucagon|glucagon
253753|NCT02081001|Artificial Pancreas|artificial pancreas
253754|NCT02080988|stroke|stroke
253755|NCT02080988|deglutition disorders|deglutition disorders
253756|NCT02080988|cough|cough
253757|NCT02080988|aspiration pneumonia|aspiration pneumonia
253758|NCT02080988|diaphragm|diaphragm
253759|NCT02080988|respiratory function|respiratory function
253760|NCT02080962|non-melanoma skin cancer, radiotherapy, orthovoltage|non-melanoma skin cancer, radiotherapy, orthovoltage
253761|NCT02080949|brain metastases, hypofractionated stereotactic radiotherapy|brain metastases, hypofractionated stereotactic radiotherapy
253762|NCT02080936|Experimental approaches|experimental approaches
253763|NCT02080936|Peripheral muscle Keyword|peripheral muscle keyword
253764|NCT02080936|Rehabilitation|rehabilitation
253765|NCT02080923|Adolescent|adolescent
253766|NCT02080923|Adolescent Behavior|adolescent behavior
253767|NCT02080923|Age Factors|age factors
253768|NCT02080923|Courtship|courtship
253769|NCT02080923|Randomized Control Trial|randomized control trial
253770|NCT02080923|Female|female
253771|NCT02080923|Male|male
253772|NCT02080923|Minority Groups/statistics & numerical data|minority groups/statistics & numerical data
253773|NCT02080923|Risk-Taking|risk-taking
253774|NCT02080923|Sex Factors|sex factors
253775|NCT02080923|Sexual Behavior/statistics & numerical data|sexual behavior/statistics & numerical data
253776|NCT02080923|Substance-Related Disorders/epidemiology|substance-related disorders/epidemiology
253777|NCT02080923|Urban Population/statistics & numerical data|urban population/statistics & numerical data
253778|NCT02080923|Violence/statistics & numerical data|violence/statistics & numerical data
253779|NCT02080923|Dating Violence|dating violence
253780|NCT02080923|Dating Aggression|dating aggression
253781|NCT02080923|Perpetration|perpetration
253782|NCT02080910|Caregiver|caregiver
253783|NCT02080910|stroke|stroke
253784|NCT02080910|psychoeducation|psychoeducation
253785|NCT02080910|problem-solving|problem-solving
253786|NCT02080897|non-surgical|non-surgical
253787|NCT02080897|palliative surgery|palliative surgery
253788|NCT02080871|PAD|pad
253789|NCT02080871|Stent|stent
253790|NCT02080871|Claudication|claudication
253791|NCT02080871|Viabahn|viabahn
253792|NCT02080871|Gore|gore
253793|NCT02080871|Endoprosthesis|endoprosthesis
253794|NCT02080871|Vascular Diseases|vascular diseases
253795|NCT02080871|Cardiovascular Diseases|cardiovascular diseases
253796|NCT02080871|Iliac Occlusive Disease|iliac occlusive disease
253797|NCT02080871|Balloon Expandable|balloon expandable
253798|NCT02080871|Stent-graft|stent-graft
253799|NCT02080871|VBX|vbx
253800|NCT02080858|Apixaban|apixaban
253801|NCT02080858|Ticagrelor|ticagrelor
253802|NCT02080858|ASA|asa
253803|NCT02080858|shed blood|shed blood
253804|NCT02080858|perfusion chamber|perfusion chamber
253805|NCT02080845|Caffeine|caffeine
253806|NCT02080845|MRI|mri
253807|NCT02080845|Brain blood flow|brain blood flow
253808|NCT02080845|Cognition|cognition
253809|NCT02080845|Perfusion|perfusion
253810|NCT02080845|Resting functional magnetic resonance imaging (fMRI)|resting functional magnetic resonance imaging (fmri)
253811|NCT02080832|substance abuse|substance abuse
253812|NCT02080832|cocaine|cocaine
253813|NCT02080832|impulsivity|impulsivity
253814|NCT02080832|serotonin|serotonin
253815|NCT02080832|MRI|mri
253816|NCT02080819|drug abuse|drug abuse
253817|NCT02080819|cocaine|cocaine
253818|NCT02080819|impulsivity|impulsivity
253819|NCT02080819|dopamine|dopamine
253820|NCT02080806|stroke, dysphagia, cough, mechanical insufflation exsufflation|stroke, dysphagia, cough, mechanical insufflation exsufflation
253821|NCT02080754|Crush induction|crush induction
253822|NCT02080754|Cricoid pressure|cricoid pressure
253823|NCT02080754|Sellick maneuver|sellick maneuver
253824|NCT02080754|Lung aspiration|lung aspiration
253825|NCT02080754|Aspiration pneumonia|aspiration pneumonia
253826|NCT02080715|Sleep-wake|sleep-wake
253827|NCT02080715|regulation|regulation
253828|NCT02080715|volunteers|volunteers
253829|NCT02080702|GIT, Monosyn, anastomoses leakage|git, monosyn, anastomoses leakage
253830|NCT02080676|Cannabis|cannabis
253831|NCT02080676|Intra ocular pressure|intra ocular pressure
253832|NCT02080676|Ocular perfusion|ocular perfusion
253833|NCT02080676|Blood pressure|blood pressure
253834|NCT02080663|carpectomy, proximal row, long-term, wrist, arthritis|carpectomy, proximal row, long-term, wrist, arthritis
253835|NCT02080637|Single ventricle|single ventricle
253836|NCT02080585|Inactivity|inactivity
253837|NCT02080546|Vaginal cuff dehiscence|vaginal cuff dehiscence
253838|NCT02080546|Thermal Injury|thermal injury
253839|NCT02080546|Total laparoscopic hysterectomy|total laparoscopic hysterectomy
253840|NCT02080533|pulmonary arterial hypertension|pulmonary arterial hypertension
253841|NCT02080533|symptoms|symptoms
253842|NCT02080533|dyspnea|dyspnea
253843|NCT02080533|fatigue|fatigue
253844|NCT02080533|sleep|sleep
253845|NCT02080520|Prevention|prevention
253846|NCT02080520|Soy|soy
253847|NCT02080520|Fermented soy|fermented soy
253848|NCT02080520|Nattokinase|nattokinase
253849|NCT02080520|Randomized controlled trial|randomized controlled trial
253850|NCT02080520|Carotid artery|carotid artery
253851|NCT02080520|Cognition|cognition
253852|NCT02080520|Atherothrombosis|atherothrombosis
253853|NCT02080507|rTMS|rtms
253854|NCT02080507|depression|depression
253855|NCT02080507|ECT|ect
253856|NCT02080494|tranexamic acid|tranexamic acid
253857|NCT02080494|orthopaedic trauma|orthopaedic trauma
253858|NCT02080494|pelvic fracture|pelvic fracture
253859|NCT02080494|hip fracture|hip fracture
253860|NCT02080494|femur fracture|femur fracture
253861|NCT02080494|blood loss|blood loss
253862|NCT02080468|Effect|effect
253863|NCT02080468|Ethinyl Estradiol/Norgestimate|ethinyl estradiol/norgestimate
253864|NCT02080468|Pharmacokinetics|pharmacokinetics
253865|NCT02080468|Lomitapide.|lomitapide.
253866|NCT02080442|COPD|copd
253867|NCT02080442|Balance|balance
253868|NCT02080442|Pulmonary Rehabilitation|pulmonary rehabilitation
253869|NCT02080416|EBV|ebv
253870|NCT02080416|KSHV|kshv
253871|NCT02080416|malignancy|malignancy
253872|NCT02080416|lymphoma|lymphoma
253873|NCT02080416|sarcoma|sarcoma
253874|NCT02080416|virus-associated|virus-associated
253875|NCT02080403|Peri-Implantitis|peri-implantitis
253876|NCT02080403|Periodontal Diseases|periodontal diseases
253877|NCT02080403|Chlorhexidine gluconate|chlorhexidine gluconate
253878|NCT02080403|PerioChip|periochip
253879|NCT02080403|Anti-Infective Agents|anti-infective agents
253880|NCT02080403|Mouth Diseases|mouth diseases
253881|NCT02080403|Antiseptics|antiseptics
253882|NCT02080390|Her 2 Positive Breast Cancer|her 2 positive breast cancer
253883|NCT02080390|Trastuzumab|trastuzumab
253884|NCT02080390|Herceptin|herceptin
253885|NCT02080390|Heart Failure|heart failure
253886|NCT02080390|Echocardiography|echocardiography
253887|NCT02080377|Pregnancy|pregnancy
253888|NCT02080377|Gestational diabetes|gestational diabetes
253889|NCT02080377|Glycaemic control|glycaemic control
253890|NCT02080377|Metformin|metformin
253891|NCT02080364|Alzheimer's disease|alzheimer's disease
253892|NCT02080364|RAGE|rage
253893|NCT02080364|ADAS-cog|adas-cog
253894|NCT02080364|CDR-sb|cdr-sb
253895|NCT02080338|Orthodontic, Bracket slot, Effective, Randomized, Duration|orthodontic, bracket slot, effective, randomized, duration
253896|NCT02080325|weight loss|weight loss
253897|NCT02080325|high protein diet|high protein diet
253898|NCT02080325|plant protein|plant protein
253899|NCT02080325|satiety|satiety
253900|NCT02080325|soy|soy
253901|NCT02080312|Meniere's disease|meniere's disease
253902|NCT02080312|endolymphatic hydrops|endolymphatic hydrops
253903|NCT02080286|spatial neglect|spatial neglect
253904|NCT02080286|rehabilitation|rehabilitation
253905|NCT02080286|brain stimulation|brain stimulation
253906|NCT02080286|tDCS|tdcs
253907|NCT02080286|prism adaptation|prism adaptation
253908|NCT02080234|Lymphoma, Extranodal NK-T-Cell|lymphoma, extranodal nk-t-cell
253909|NCT02080234|asparaginase|asparaginase
253910|NCT02080234|GELOX|gelox
253911|NCT02080234|concurrent chemoradiotherapy|concurrent chemoradiotherapy
253912|NCT02080234|sIL-2R|sil-2r
253913|NCT02080221|metastatic pancreatic cancer|metastatic pancreatic cancer
253914|NCT02080221|pancreatic cancer|pancreatic cancer
253915|NCT02080221|metastatic|metastatic
253916|NCT02080208|hypoxemia|hypoxemia
253917|NCT02080208|high flow oxygen therapy|high flow oxygen therapy
253918|NCT02080208|respiratory failure|respiratory failure
253919|NCT02080182|Acute Pyelonephritis|acute pyelonephritis
253920|NCT02080182|Acetylcysteine|acetylcysteine
253921|NCT02080182|Pediatric|pediatric
253922|NCT02080169|Intensive care unit|intensive care unit
253923|NCT02080169|Mechanical ventilation|mechanical ventilation
253924|NCT02080169|Combined sedation|combined sedation
253925|NCT02080156|Obstructive Sleep Apnea|obstructive sleep apnea
253926|NCT02080156|Percutaneous Coronary Intervention|percutaneous coronary intervention
253927|NCT02080156|Coronary Artery Bypass Graft|coronary artery bypass graft
253928|NCT02080156|Mortality|mortality
253929|NCT02080156|Questionnaire|questionnaire
253930|NCT02080156|Biomarker|biomarker
253931|NCT02080143|Skin temperature measurements|skin temperature measurements
253932|NCT02080143|Heat patch adhesion|heat patch adhesion
253933|NCT02080143|Dermal irritation|dermal irritation
253934|NCT02080130|Gastroenteritis|gastroenteritis
253935|NCT02080130|diarrhea|diarrhea
253936|NCT02080117|kidney transplantation|kidney transplantation
253937|NCT02080117|delayed graft function|delayed graft function
253939|NCT02080117|graft survival|graft survival
253940|NCT02080104|postpartum hemorrhage|postpartum hemorrhage
253941|NCT02080104|oxytocin|oxytocin
253942|NCT02080104|vaginal delivery|vaginal delivery
253943|NCT02080104|prophylactic|prophylactic
253944|NCT02080078|Erlotinib|erlotinib
253945|NCT02080078|Theophylline|theophylline
253946|NCT02080078|Diarrhea|diarrhea
253947|NCT02080065|risk factor|risk factor
253948|NCT02080065|acute kidney injury|acute kidney injury
253949|NCT02080065|liver transplantation|liver transplantation
253950|NCT02080065|postoperative renal function|postoperative renal function
253951|NCT02080039|Spinal Cord Injury|spinal cord injury
253952|NCT02080039|Denervation|denervation
253953|NCT02080039|Electrical Stimulation|electrical stimulation
253954|NCT02080026|malaria|malaria
253955|NCT02080026|Plasmodium falciparum|plasmodium falciparum
253956|NCT02080000|Heart Failure|heart failure
253957|NCT02080000|Cardiac Resynchronisation Therapy|cardiac resynchronisation therapy
253958|NCT02080000|Biventricular Pacemaker|biventricular pacemaker
253959|NCT02080000|Optimisation|optimisation
253960|NCT02079987|Health Literacy|health literacy
253961|NCT02079987|Care Transition Intervention|care transition intervention
253962|NCT02079987|Emergency Department Population|emergency department population
253963|NCT02079987|Access to Care|access to care
253964|NCT02079974|endometriosis|endometriosis
253965|NCT02079974|pain|pain
253966|NCT02079974|fertility|fertility
253967|NCT02079961|anemia|anemia
253968|NCT02079961|children|children
253969|NCT02079961|iron-fortified product|iron-fortified product
253970|NCT02079961|value chain|value chain
253971|NCT02079948|Aging|aging
253972|NCT02079948|Cognitive Function|cognitive function
253973|NCT02079948|Physical Function|physical function
253974|NCT02079948|Systematic Inflammation|systematic inflammation
253975|NCT02079948|Methotrexate|methotrexate
253976|NCT02079948|Pain Symptoms|pain symptoms
253977|NCT02079935|BN|bn
253978|NCT02079935|Binge|binge
253979|NCT02079935|overconsumption of food|overconsumption of food
253980|NCT02079935|purging|purging
253981|NCT02079935|purge|purge
253982|NCT02079922|Multiple Ascending Dose|multiple ascending dose
253983|NCT02079922|healthy subjects|healthy subjects
253984|NCT02079922|Hypercholesterolemia|hypercholesterolemia
253985|NCT02079922|Hyperlipidemias|hyperlipidemias
253986|NCT02079922|Dyslipidemias|dyslipidemias
253987|NCT02079922|Lipid Metabolism Disorders|lipid metabolism disorders
253988|NCT02079922|Metabolic Diseases|metabolic diseases
253989|NCT02079909|Alzheimer's Disease|alzheimer's disease
253990|NCT02079909|Alzheimer's|alzheimer's
253991|NCT02079896|Dialysis|dialysis
253992|NCT02079844|Drug therapy|drug therapy
253993|NCT02079831|Adolescent obesity|adolescent obesity
253994|NCT02079831|childhood obesity|childhood obesity
253995|NCT02079831|anthropometry|anthropometry
253996|NCT02079831|body weights and measures|body weights and measures
253997|NCT02079818|visceral artery aneurysms|visceral artery aneurysms
253998|NCT02079818|arteriovenous malformations|arteriovenous malformations
253999|NCT02079818|Penumbra Ruby Coil System|penumbra ruby coil system
254000|NCT02079792|Budesonide|budesonide
254001|NCT02079792|Mucosal Atomization Device|mucosal atomization device
254002|NCT02079792|Head Position|head position
254003|NCT02079779|Robotic-assisted therapy|robotic-assisted therapy
254004|NCT02079779|Acute Stroke|acute stroke
254005|NCT02079779|International Classification of Functioning, Disability and Health|international classification of functioning, disability and health
254006|NCT02079753|COPD, portable concentrator, oxygen sources|copd, portable concentrator, oxygen sources
254007|NCT02079727|Condrosulf|condrosulf
254008|NCT02079727|Chondroitin sulfate|chondroitin sulfate
254009|NCT02079727|Celebrex|celebrex
254010|NCT02079727|Knee OA|knee oa
254011|NCT02079727|Knee osteoarthritis|knee osteoarthritis
254012|NCT02079714|Orthopaedic Trauma|orthopaedic trauma
254013|NCT02079714|Injury|injury
254014|NCT02079701|pneumonia|pneumonia
254015|NCT02079701|pneumococcus|pneumococcus
254016|NCT02079701|vaccine|vaccine
254017|NCT02079701|23-valent pneumococcal vaccine|23-valent pneumococcal vaccine
254018|NCT02079701|military recruits|military recruits
254019|NCT02079688|Antisense oligonucleotide|antisense oligonucleotide
254020|NCT02079688|atopic eczema|atopic eczema
254021|NCT02079688|atopic dermatitis|atopic dermatitis
254022|NCT02079688|Phase II|phase ii
254023|NCT02079688|Transcription factor GATA-3|transcription factor gata-3
254024|NCT02079688|dermal application|dermal application
254025|NCT02079688|Proof-of-Concept|proof-of-concept
254026|NCT02079662|Breast Cancer|breast cancer
254027|NCT02079662|Radiation Therapy|radiation therapy
254028|NCT02079662|Radiotherapy|radiotherapy
254029|NCT02079662|XRT|xrt
254030|NCT02079662|Aerobic Activity|aerobic activity
254031|NCT02079662|Dietician Counseling|dietician counseling
254032|NCT02079662|Dietary Assessment|dietary assessment
254033|NCT02079662|Yoga|yoga
254034|NCT02079662|Cognitive Behavior Therapy|cognitive behavior therapy
254035|NCT02079662|Smoking Cessation Counseling|smoking cessation counseling
254036|NCT02079662|Questionnaires|questionnaires
254037|NCT02079662|Surveys|surveys
254827|NCT02076178|GSK1265744|gsk1265744
254038|NCT02079662|Saliva Samples|saliva samples
254039|NCT02079662|Blood Samples|blood samples
254040|NCT02079649|Allergic conjunctivitis|allergic conjunctivitis
254041|NCT02079649|Red eyes|red eyes
254042|NCT02079649|Eyelid swelling|eyelid swelling
254043|NCT02079649|Ragweed|ragweed
254044|NCT02079649|Allergies|allergies
254045|NCT02079649|Itchy eyes|itchy eyes
254046|NCT02079649|Ocular redness|ocular redness
254047|NCT02079649|Chemosis|chemosis
254048|NCT02079649|Tearing|tearing
254049|NCT02079649|Watery eyes|watery eyes
254050|NCT02079623|Pancreatic cancer|pancreatic cancer
254051|NCT02079623|Electroporation|electroporation
254052|NCT02079623|Nano knife treatment|nano knife treatment
254053|NCT02079610|Depression|depression
254054|NCT02079610|Neurofeedback|neurofeedback
254055|NCT02079610|Amygdala|amygdala
254056|NCT02079597|SIRS|sirs
254057|NCT02079597|Ninj1|ninj1
254058|NCT02079597|Sepsis|sepsis
254059|NCT02079597|Healthy|healthy
254060|NCT02079584|Patient Compliance|patient compliance
254061|NCT02079584|Target Specific Anticoagulant|target specific anticoagulant
254062|NCT02079584|Quality of Life|quality of life
254063|NCT02079558|prevention|prevention
254064|NCT02079558|cesarean section|cesarean section
254065|NCT02079545|Healthy|healthy
254066|NCT02079545|Bioavailability|bioavailability
254067|NCT02079545|Pharmacokinetics|pharmacokinetics
254068|NCT02079545|Sirukumab|sirukumab
254069|NCT02079545|Subcutaneous|subcutaneous
254070|NCT02079545|Male|male
254071|NCT02079493|osteoarthritis|osteoarthritis
254072|NCT02079493|knee replacement|knee replacement
254073|NCT02079493|functional testing|functional testing
254074|NCT02079467|Arthroplasty, Hip|arthroplasty, hip
254075|NCT02079467|Replacement, Hip|replacement, hip
254076|NCT02079467|Postoperative Care|postoperative care
254077|NCT02079467|Rehabilitation|rehabilitation
254078|NCT02079441|Anti- TNF|anti- tnf
254079|NCT02079441|inflammatory bowel disease|inflammatory bowel disease
254080|NCT02079441|pregnancy|pregnancy
254081|NCT02079441|infant|infant
254082|NCT02079441|immunity|immunity
254083|NCT02079441|Immune function|immune function
254084|NCT02079428|Heart Failure|heart failure
254085|NCT02079428|Registry|registry
254086|NCT02079428|China|china
254087|NCT02079415|NICU|nicu
254088|NCT02079402|sepsis|sepsis
254089|NCT02079402|septic|septic
254090|NCT02079402|shock|shock
254091|NCT02079402|ICU|icu
254092|NCT02079402|intensive|intensive
254093|NCT02079402|critical|critical
254094|NCT02079402|resuscitation|resuscitation
254095|NCT02079402|fluid|fluid
254096|NCT02079402|IV|iv
254097|NCT02079402|crystalloid|crystalloid
254098|NCT02079402|balance|balance
254099|NCT02079389|colon cancer|colon cancer
254100|NCT02079389|rectum cancer|rectum cancer
254101|NCT02079389|laparoscopic ultrasound|laparoscopic ultrasound
254102|NCT02079389|LUS|lus
254103|NCT02079389|Contrast enhanced ultrasound|contrast enhanced ultrasound
254104|NCT02079389|CEUS|ceus
254105|NCT02079389|Peroperative TNM staging|peroperative tnm staging
254106|NCT02079389|screening for liver metastases|screening for liver metastases
254107|NCT02079376|diabetes|diabetes
254108|NCT02079363|Pancreatic Diseases|pancreatic diseases
254109|NCT02079363|Pancreatic Neoplasms|pancreatic neoplasms
254110|NCT02079363|Pancreatitis|pancreatitis
254111|NCT02079363|DNA promoter hypermethylation|dna promoter hypermethylation
254112|NCT02079363|DNA methylation|dna methylation
254113|NCT02079363|Cell-free DNA|cell-free dna
254114|NCT02079363|Plasma|plasma
254115|NCT02079324|head and neck cancer|head and neck cancer
254116|NCT02079324|gene therapy|gene therapy
254117|NCT02079324|stem cell therapy|stem cell therapy
254118|NCT02079324|immunotherappy|immunotherappy
254119|NCT02079311|Patient warming|patient warming
254120|NCT02079311|Active warming|active warming
254121|NCT02079311|Forced Air Warming|forced air warming
254122|NCT02079311|Warming blanket|warming blanket
254123|NCT02079272|Tomotherapy|tomotherapy
254124|NCT02079272|Breast Cancer|breast cancer
254125|NCT02079272|Heart|heart
254126|NCT02079272|Subclinical cardiac lesions|subclinical cardiac lesions
254127|NCT02079272|Myocardial lesions|myocardial lesions
254128|NCT02079272|Coronary lesions|coronary lesions
254129|NCT02079272|Circulating biomarkers|circulating biomarkers
254130|NCT02079272|Ionizing radiation|ionizing radiation
254131|NCT02079272|Heart absorbed doses|heart absorbed doses
254132|NCT02079233|Basic Science|basic science
254133|NCT02079233|Safety|safety
254134|NCT02079233|Tolerability|tolerability
254135|NCT02079233|Efficacy of CLP|efficacy of clp
254136|NCT02079220|Colorectal Cancer|colorectal cancer
254137|NCT02079220|Metastatic Colorectal Cancer|metastatic colorectal cancer
254138|NCT02079194|Drug-eluting stents|drug-eluting stents
254139|NCT02079194|aspirin|aspirin
254140|NCT02079194|P2Y12 antagonist monotherapy|p2y12 antagonist monotherapy
254141|NCT02079168|Keloid|keloid
254142|NCT02079168|Cicatrix|cicatrix
254143|NCT02079168|Keloid prevention|keloid prevention
254144|NCT02079168|Keloid revision/excision|keloid revision/excision
254828|NCT02076165|insomnia|insomnia
254145|NCT02079168|Keloidectomy|keloidectomy
254146|NCT02079129|agreement between cMRI PVL grading and TTE PVL grading|agreement between cmri pvl grading and tte pvl grading
254147|NCT02079129|Edwards Sapien TAVR|edwards sapien tavr
254148|NCT02079116|Obesity|obesity
254149|NCT02079116|Lipids|lipids
254150|NCT02079116|Single Photon Emission Computed Tomography|single photon emission computed tomography
254151|NCT02079116|Functional Neuroimaging|functional neuroimaging
254152|NCT02079103|Virtual reality|virtual reality
254153|NCT02079103|Stroke|stroke
254154|NCT02079103|Arm motor function|arm motor function
254155|NCT02079103|Neurorehabilitation|neurorehabilitation
254156|NCT02079090|Propofol|propofol
254157|NCT02079090|Ketamine|ketamine
254158|NCT02079090|Fentanyl|fentanyl
254159|NCT02079090|Procedural sedation|procedural sedation
254160|NCT02079090|children|children
254161|NCT02079090|Emergency Department|emergency department
254162|NCT02079077|HIV, Immune quiescence, ASA, Hydroxychloroquin|hiv, immune quiescence, asa, hydroxychloroquin
254163|NCT02079064|Splenectomy|splenectomy
254164|NCT02079064|Desflurane|desflurane
254165|NCT02079064|Propofol|propofol
254166|NCT02079064|TCI|tci
254167|NCT02079064|ROTEM|rotem
254168|NCT02079051|Obesity Physical Performance Weight loss Optifast|obesity physical performance weight loss optifast
254169|NCT02079025|Prostate Biopsy|prostate biopsy
254170|NCT02079025|Ultrasound guided biopsy of the prostate|ultrasound guided biopsy of the prostate
254171|NCT02079025|High-resolution ultrasound|high-resolution ultrasound
254172|NCT02079012|Walking Program|walking program
254173|NCT02079012|Mental Disorders|mental disorders
254174|NCT02079012|Physical Activity|physical activity
254175|NCT02079012|Physical Fitness|physical fitness
254176|NCT02079012|Anxiety|anxiety
254177|NCT02079012|Depression|depression
254178|NCT02079012|Self Determination|self determination
254179|NCT02078999|Mechanical ventilation, procalcitonin, c-reactive protein|mechanical ventilation, procalcitonin, c-reactive protein
254180|NCT02078986|Whole-Body-Electromyostimulation|whole-body-electromyostimulation
254181|NCT02078986|High Intensity Resistance Exercise Training (HIT)|high intensity resistance exercise training (hit)
254182|NCT02078986|Lean Body Mass|lean body mass
254183|NCT02078986|Muscle Strength|muscle strength
254184|NCT02078973|Tolvaptan|tolvaptan
254185|NCT02078973|L-NMMA|l-nmma
254186|NCT02078973|Healthy subjects|healthy subjects
254187|NCT02078973|Nephrology|nephrology
254188|NCT02078960|Chronic Phase|chronic phase
254189|NCT02078960|Accelerated Phase|accelerated phase
254190|NCT02078960|CML|cml
254191|NCT02078960|Chronic Myeloid Leukemia|chronic myeloid leukemia
254192|NCT02078947|Diastolic heart failure, Heart failure with preserved ejection fraction, exercise|diastolic heart failure, heart failure with preserved ejection fraction, exercise
254193|NCT02078934|Surgical Endoscopy|surgical endoscopy
254194|NCT02078934|Morbid Obesity|morbid obesity
254195|NCT02078934|Weight Loss|weight loss
254196|NCT02078934|Bariatrics|bariatrics
254197|NCT02078934|Complex incisional hernia with mesh|complex incisional hernia with mesh
254198|NCT02078908|Central blood pressure|central blood pressure
254199|NCT02078908|Peripheral (brachial) blood pressure|peripheral (brachial) blood pressure
254200|NCT02078908|Renal variables|renal variables
254201|NCT02078908|Vasoactive hormones|vasoactive hormones
254202|NCT02078908|Pharmacology|pharmacology
254203|NCT02078908|Pharmacokinetics|pharmacokinetics
254204|NCT02078895|Lower Urinary tract discomfort , ureteral stent pain|lower urinary tract discomfort , ureteral stent pain
254205|NCT02078882|Primary Biliary Cirrhosis|primary biliary cirrhosis
254206|NCT02078882|Ursodeoxycholic acid|ursodeoxycholic acid
254207|NCT02078882|Abatacept|abatacept
254208|NCT02078882|Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4)|cytotoxic t-lymphocyte antigen 4 (ctla-4)
254209|NCT02078843|NET|net
254210|NCT02078843|Gallium-68-DOTATATE|gallium-68-dotatate
254211|NCT02078843|PET/CT|pet/ct
254212|NCT02078843|Indium-111-pentetreotide scintigraphy|indium-111-pentetreotide scintigraphy
254213|NCT02078843|octreoscan|octreoscan
254214|NCT02078843|GEP-NET|gep-net
254215|NCT02078843|gastroenteropancreatic neuroendocrine tumors|gastroenteropancreatic neuroendocrine tumors
254216|NCT02078830|Wound Contamination|wound contamination
254217|NCT02078817|Treatment-resistant|treatment-resistant
254218|NCT02078804|Colorectal cancer|colorectal cancer
254219|NCT02078804|Mortality|mortality
254220|NCT02078804|Incidence|incidence
254221|NCT02078804|Screening|screening
254222|NCT02078804|Health-economy|health-economy
254223|NCT02078791|Fibromyalgia|fibromyalgia
254224|NCT02078791|Group Problem Solving Technique|group problem solving technique
254225|NCT02078791|infiltration|infiltration
254226|NCT02078778|Continuous airway pressure|continuous airway pressure
254227|NCT02078778|Hypertension|hypertension
254228|NCT02078778|Obstructive sleep apnea|obstructive sleep apnea
254229|NCT02078765|hypertension|hypertension
254230|NCT02078765|chronic kidneys disease|chronic kidneys disease
254231|NCT02078765|obstructive sleep apnea|obstructive sleep apnea
254232|NCT02078765|24-h blood pressure|24-h blood pressure
254233|NCT02078765|central blood pressure|central blood pressure
254234|NCT02078765|peripheral blood pressure|peripheral blood pressure
254235|NCT02078752|ADC|adc
254236|NCT02078752|PF-06647263|pf-06647263
254237|NCT02078752|solid tumors|solid tumors
254239|NCT02078752|neoplasm metastasis|neoplasm metastasis
254240|NCT02078752|TNBC|tnbc
254241|NCT02078752|Triple negative breast cancer|triple negative breast cancer
254242|NCT02078739|Yoga|yoga
254243|NCT02078739|COPD|copd
254244|NCT02078739|Congestive Heart Failure|congestive heart failure
254245|NCT02078726|glucagon, screening colonoscopy|glucagon, screening colonoscopy
254246|NCT02078713|contraception|contraception
254247|NCT02078713|patient decision support|patient decision support
254248|NCT02078713|patient decision aid|patient decision aid
254249|NCT02078713|shared decision making|shared decision making
254250|NCT02078713|Decision Making, Shared|decision making, shared
254251|NCT02078713|Patient-Centered Outcomes Research|patient-centered outcomes research
254252|NCT02078700|cancer|cancer
254253|NCT02078700|early palliative care|early palliative care
254254|NCT02078700|feasibility|feasibility
254255|NCT02078687|very preterm|very preterm
254256|NCT02078687|nutrition|nutrition
254257|NCT02078687|6 year follow-up|6 year follow-up
254258|NCT02078687|growth|growth
254259|NCT02078687|metabolic syndrome|metabolic syndrome
254260|NCT02078687|allergy|allergy
254261|NCT02078687|dexa|dexa
254262|NCT02078674|H7N9|h7n9
254263|NCT02078661|Keratoconjunctivitis sicca|keratoconjunctivitis sicca
254264|NCT02078661|Dry eye|dry eye
254265|NCT02078648|Glioma Associated Antigen|glioma associated antigen
254266|NCT02078648|Vaccine|vaccine
254267|NCT02078648|Adult|adult
254268|NCT02078648|Recurrent Glioblastoma|recurrent glioblastoma
254269|NCT02078648|Immunotherapy|immunotherapy
254270|NCT02078635|Arterial plaque|arterial plaque
254271|NCT02078635|portfolio diet|portfolio diet
254272|NCT02078635|dietary modification|dietary modification
254273|NCT02078635|dietary trials|dietary trials
254274|NCT02078635|Canadian Network|canadian network
254275|NCT02078635|knowledge synthesis and translation|knowledge synthesis and translation
254276|NCT02078635|Magnetic resonance imaging|magnetic resonance imaging
254277|NCT02078622|COPD|copd
254278|NCT02078622|Respiratory Therapist|respiratory therapist
254279|NCT02078622|Case Management|case management
254280|NCT02078622|Education|education
254281|NCT02078609|AML,|aml,
254282|NCT02078609|MDS,|mds,
254283|NCT02078609|PIM,|pim,
254284|NCT02078609|LGH447,|lgh447,
254285|NCT02078609|acute myelod leukemia,|acute myelod leukemia,
254286|NCT02078609|myelodysplastic syndrome,|myelodysplastic syndrome,
254287|NCT02078609|midostaurin,|midostaurin,
254288|NCT02078609|PKC412|pkc412
254289|NCT02078596|temper outbursts|temper outbursts
254290|NCT02078596|pediatric aggression|pediatric aggression
254291|NCT02078596|irritability|irritability
254292|NCT02078544|Cancer in Gynaecologic Oncology|cancer in gynaecologic oncology
254293|NCT02078505|Change in gut microbial population|change in gut microbial population
254294|NCT02078505|polycystic ovary syndrome|polycystic ovary syndrome
254295|NCT02078505|gut microbiome|gut microbiome
254296|NCT02078505|diet|diet
254297|NCT02078479|Malignancy|malignancy
254298|NCT02078479|VAS|vas
254299|NCT02078479|LANSS|lanss
254300|NCT02078479|VDS|vds
254301|NCT02078479|Neuropathic pain|neuropathic pain
254302|NCT02078479|rTMS|rtms
254303|NCT02078479|motor cortex|motor cortex
254304|NCT02078479|analgesia|analgesia
254305|NCT02078466|Functional assessment|functional assessment
254306|NCT02078466|readmission|readmission
254307|NCT02078466|acute care|acute care
254308|NCT02078466|older medical patients|older medical patients
254309|NCT02078453|Dental caries|dental caries
254310|NCT02078453|Diagnosis|diagnosis
254311|NCT02078453|Visual inspection|visual inspection
254312|NCT02078453|Radiographic examination|radiographic examination
254313|NCT02078440|Type 2 Diabetes|type 2 diabetes
254314|NCT02078440|Children|children
254315|NCT02078440|Adolescents|adolescents
254316|NCT02078440|Bioavailability|bioavailability
254317|NCT02078440|Cycloset|cycloset
254318|NCT02078440|Bromocriptine Mesylate|bromocriptine mesylate
254319|NCT02078401|Optic pathway glioma|optic pathway glioma
254320|NCT02078401|Ophthalmological screening|ophthalmological screening
254321|NCT02078375|Rheumatoid Arthritis|rheumatoid arthritis
254322|NCT02078323|Irritable Bowel Syndrome with Constipation (IBS-C)|irritable bowel syndrome with constipation (ibs-c)
254323|NCT02078323|Linaclotide|linaclotide
254324|NCT02078310|Dementia,|dementia,
254325|NCT02078310|Healthy|healthy
254326|NCT02078310|geriatric|geriatric
254327|NCT02078310|volunteers|volunteers
254328|NCT02078310|patients|patients
254329|NCT02078297|IL-23|il-23
254330|NCT02078297|IL-17A|il-17a
254331|NCT02078297|Skin biopsies|skin biopsies
254332|NCT02078284|platelet transfusion|platelet transfusion
254333|NCT02078258|depression，adolescent，attention bias，modification|depression，adolescent，attention bias，modification
254334|NCT02078245|Familial pancreatic cancer|familial pancreatic cancer
254335|NCT02078245|Surveillance|surveillance
254336|NCT02078245|Screening|screening
254337|NCT02078232|fine needle aspiration under ultrasound endoscopy|fine needle aspiration under ultrasound endoscopy
254338|NCT02078232|solid pancreatic tumors|solid pancreatic tumors
254339|NCT02078232|head of pancreas|head of pancreas
254340|NCT02078232|19G Flex needle|19g flex needle
254341|NCT02078232|22G standard needle|22g standard needle
254342|NCT02078206|Critical illness|critical illness
254343|NCT02078206|Neurocognition|neurocognition
254344|NCT02078206|Neurocognitive stimulation|neurocognitive stimulation
254345|NCT02078206|Delirium|delirium
254346|NCT02078206|Virtual Reality|virtual reality
254347|NCT02078206|cognitive|cognitive
254348|NCT02078206|rehabilitation|rehabilitation
254349|NCT02078206|ICU|icu
254350|NCT02078167|ipercholesterolemia not familiarity|ipercholesterolemia not familiarity
254351|NCT02078154|D-Dimer|d-dimer
254352|NCT02078154|DVT|dvt
254353|NCT02078154|Wells score|wells score
254354|NCT02078141|18F-deoxyglucose (FDG) PET, idiopathic Dilated Cardiomyopathy|18f-deoxyglucose (fdg) pet, idiopathic dilated cardiomyopathy
254355|NCT02078128|burn, wound healing, skin graft|burn, wound healing, skin graft
254356|NCT02078089|Refractory cancer pain|refractory cancer pain
254357|NCT02078076|MRI|mri
254358|NCT02078076|free-breathing acquisitions|free-breathing acquisitions
254359|NCT02078076|myopathy|myopathy
254360|NCT02078076|fibrosis assessment|fibrosis assessment
254361|NCT02078076|function|function
254362|NCT02078037|Intracerebral hemorrhage|intracerebral hemorrhage
254363|NCT02078037|Perihematomal edema|perihematomal edema
254364|NCT02078037|hemorrhage|hemorrhage
254365|NCT02078037|normothermia|normothermia
254366|NCT02078024|Onchocerciasis|onchocerciasis
254367|NCT02077985|autism|autism
254368|NCT02077985|electrodermal activity|electrodermal activity
254369|NCT02077985|cooperation|cooperation
254370|NCT02077985|anxiety|anxiety
254371|NCT02077985|distress|distress
254372|NCT02077985|stress|stress
254373|NCT02077985|oral care|oral care
254374|NCT02077985|sensory processing|sensory processing
254375|NCT02077985|behavior|behavior
254376|NCT02077985|occupational therapy|occupational therapy
254377|NCT02077972|PTSD|ptsd
254378|NCT02077972|Military service|military service
254379|NCT02077972|depression|depression
254380|NCT02077972|Whole Body Hyperthermia (WBH)|whole body hyperthermia (wbh)
254381|NCT02077959|Relapsed Multiple Myeloma|relapsed multiple myeloma
254382|NCT02077959|Refractory Multiple Myeloma|refractory multiple myeloma
254383|NCT02077933|Solid tumors|solid tumors
254384|NCT02077933|renal cell carcinoma|renal cell carcinoma
254385|NCT02077933|pancreatic neuroendocrine tumors|pancreatic neuroendocrine tumors
254386|NCT02077933|breast cancer|breast cancer
254387|NCT02077933|PI3K inhibitor|pi3k inhibitor
254388|NCT02077933|BYL719|byl719
254389|NCT02077933|alpelisib|alpelisib
254390|NCT02077933|everolimus|everolimus
254391|NCT02077933|exemestane|exemestane
254392|NCT02077920|Ventilator-associated pneumonia VAP|ventilator-associated pneumonia vap
254393|NCT02077920|Chlorhexidine|chlorhexidine
254394|NCT02077920|Oropharyngeal decontamination|oropharyngeal decontamination
254395|NCT02077920|Subglottic secretion drainage|subglottic secretion drainage
254396|NCT02077894|Whole Genome Sequencing|whole genome sequencing
254397|NCT02077894|Genetic Eye Disease|genetic eye disease
254398|NCT02077881|metastatic|metastatic
254399|NCT02077881|metastasis|metastasis
254400|NCT02077881|Pancreatic|pancreatic
254401|NCT02077881|Pancreas|pancreas
254402|NCT02077881|Cancer|cancer
254403|NCT02077881|adenocarcinoma|adenocarcinoma
254404|NCT02077868|CRC|crc
254405|NCT02077868|mCRC|mcrc
254406|NCT02077868|maintenance treatment|maintenance treatment
254407|NCT02077868|immune modulation|immune modulation
254408|NCT02077868|colorectal cancer|colorectal cancer
254409|NCT02077868|immunotherapy|immunotherapy
254410|NCT02077868|metastatic|metastatic
254411|NCT02077855|Sensitivity and Sensitivity|sensitivity and sensitivity
254412|NCT02077829|Implementation process|implementation process
254413|NCT02077829|implementation strategy|implementation strategy
254414|NCT02077829|Implementation research|implementation research
254415|NCT02077829|evidence based practice|evidence based practice
254416|NCT02077829|recovery|recovery
254417|NCT02077829|Illness management and recovery|illness management and recovery
254418|NCT02077816|body temperature|body temperature
254419|NCT02077816|Thermometry|thermometry
254420|NCT02077816|Infrared Rays|infrared rays
254421|NCT02077816|catheter related infection|catheter related infection
254422|NCT02077803|Healthy|healthy
254423|NCT02077803|Canagliflozin|canagliflozin
254424|NCT02077803|Metformin|metformin
254425|NCT02077803|Type 2 diabetes mellitus|type 2 diabetes mellitus
254426|NCT02077803|Bioequivalence|bioequivalence
254427|NCT02077803|GLUMETZA®|glumetza®
254428|NCT02077777|mesalazine|mesalazine
254429|NCT02077777|colon|colon
254430|NCT02077777|cancer|cancer
254431|NCT02077764|heart transplantation,|heart transplantation,
254432|NCT02077764|rejection|rejection
254433|NCT02077764|cardiac vasculopathy|cardiac vasculopathy
254434|NCT02077764|optical coherence tomography|optical coherence tomography
254435|NCT02077764|speckle tracking|speckle tracking
254436|NCT02077764|Positron Emission Tomography .|positron emission tomography .
254437|NCT02077764|exercise capacity|exercise capacity
254438|NCT02077738|effectiveness|effectiveness
254439|NCT02077738|elderly|elderly
254440|NCT02077738|high frequency chest wall oscillation|high frequency chest wall oscillation
254441|NCT02077738|mechanical ventilation|mechanical ventilation
254442|NCT02077738|pneumonia|pneumonia
254443|NCT02077738|randomized controlled trial|randomized controlled trial
254444|NCT02077725|drug related problems|drug related problems
254445|NCT02077725|comprehensive medication review|comprehensive medication review
254446|NCT02077725|quality of life|quality of life
254447|NCT02077699|Lactobacillus casei DG|lactobacillus casei dg
254448|NCT02077699|Irritable Bowel Syndrome|irritable bowel syndrome
254449|NCT02077686|diabetes|diabetes
254450|NCT02077686|education|education
254451|NCT02077686|randomized|randomized
254452|NCT02077686|prospective|prospective
254453|NCT02077673|GEJ-cancer|gej-cancer
254454|NCT02077673|surgery|surgery
254455|NCT02077673|gastroesophageal resection|gastroesophageal resection
254456|NCT02077673|gastroesophageal anastomosis|gastroesophageal anastomosis
254457|NCT02077673|anastomotic leakage|anastomotic leakage
254458|NCT02077660|Green tea, aging, oxidation, anthropometrics.|green tea, aging, oxidation, anthropometrics.
254459|NCT02077647|Knee osteoarthritis|knee osteoarthritis
254460|NCT02077647|knee osteonecrosis|knee osteonecrosis
254461|NCT02077647|osteotomy|osteotomy
254462|NCT02077621|cancer-related fatigue|cancer-related fatigue
254463|NCT02077621|Palliative Abdominal Surgery|palliative abdominal surgery
254464|NCT02077621|HRQL|hrql
254465|NCT02077608|In vitro fertilization|in vitro fertilization
254466|NCT02077608|Embryotransfer|embryotransfer
254467|NCT02077608|Hyaluronan|hyaluronan
254468|NCT02077608|Pregnancy rate|pregnancy rate
254469|NCT02077608|Implantation rate|implantation rate
254470|NCT02077595|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
254471|NCT02077595|transcranial magnetic stimulation|transcranial magnetic stimulation
254472|NCT02077582|acute ischemic stroke|acute ischemic stroke
254473|NCT02077569|AKT inhibitor|akt inhibitor
254474|NCT02077569|AZD5363|azd5363
254475|NCT02077569|Anti-tumour activity|anti-tumour activity
254476|NCT02077569|Breast cancer|breast cancer
254477|NCT02077569|ER positive|er positive
254478|NCT02077569|Oestrogen positive|oestrogen positive
254479|NCT02077569|post menopausal|post menopausal
254480|NCT02077569|chemotherapy required|chemotherapy required
254481|NCT02077569|no prior cancer treatment|no prior cancer treatment
254482|NCT02077556|tacrolimus, everolimus, pharmacokinetics, drug interaction|tacrolimus, everolimus, pharmacokinetics, drug interaction
254483|NCT02077530|Patients with metabolic syndrome age between 30 to 64: Central obesity (Men ≥ 90 cm Women ≥ 85 cm), Plasma triglycerides ≥ 150 mg/dL|patients with metabolic syndrome age between 30 to 64: central obesity (men ≥ 90 cm women ≥ 85 cm), plasma triglycerides ≥ 150 mg/dl
254484|NCT02077530|HDL cholesterol Men < 40 mg/dL, Women < 50 mg/dL, Blood pressure ≥130/85 mm Hg (or treatment for hypertension),|hdl cholesterol men < 40 mg/dl, women < 50 mg/dl, blood pressure ≥130/85 mm hg (or treatment for hypertension),
254485|NCT02077530|Fasting plasma glucose ≥ 100 mg/dL|fasting plasma glucose ≥ 100 mg/dl
254486|NCT02077517|Roux en Y Gastric Bypass|roux en y gastric bypass
254487|NCT02077517|Postoperative complications|postoperative complications
254488|NCT02077517|Hand sewn anastomosis|hand sewn anastomosis
254489|NCT02077517|Stapled anastomosis|stapled anastomosis
254490|NCT02077491|Aged|aged
254491|NCT02077491|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
254492|NCT02077491|Body Composition|body composition
254493|NCT02077491|Dietary Protein|dietary protein
254620|NCT02076919|First in human|first in human
254621|NCT02076919|Safety|safety
254494|NCT02077465|COPD, chronic obstructive pulmonary disease; Phase 1b, Safety, Pharmacokinetics|copd, chronic obstructive pulmonary disease; phase 1b, safety, pharmacokinetics
254495|NCT02077452|Glucokinase activator|glucokinase activator
254496|NCT02077452|Phase I|phase i
254497|NCT02077452|Type 2 diabetes mellitus|type 2 diabetes mellitus
254498|NCT02077439|Stroke|stroke
254499|NCT02077439|Hand|hand
254500|NCT02077439|Upper Extremity|upper extremity
254501|NCT02077439|Robotics|robotics
254502|NCT02077426|Functional Capacity|functional capacity
254503|NCT02077426|Exercise Independence|exercise independence
254504|NCT02077426|Peripheral|peripheral
254505|NCT02077426|Strength|strength
254506|NCT02077413|muscle|muscle
254507|NCT02077413|eccentric exercise|eccentric exercise
254508|NCT02077413|T2 MRI|t2 mri
254509|NCT02077387|Inhibitory control|inhibitory control
254510|NCT02077387|executive functioning|executive functioning
254511|NCT02077387|childhood obesity|childhood obesity
254512|NCT02077387|preschool|preschool
254513|NCT02077387|snack foods|snack foods
254514|NCT02077387|caloric intake|caloric intake
254515|NCT02077374|NAFLD|nafld
254516|NCT02077374|NASH|nash
254517|NCT02077361|choroideremia|choroideremia
254518|NCT02077361|gene therapy|gene therapy
254519|NCT02077361|gene transfer|gene transfer
254520|NCT02077348|Diabetes Mellitus type I|diabetes mellitus type i
254521|NCT02077348|Ketoacidosis|ketoacidosis
254522|NCT02077348|Insulin withdrawal|insulin withdrawal
254523|NCT02077348|Growth hormone injection|growth hormone injection
254524|NCT02077348|Lipolysis and ATGL|lipolysis and atgl
254525|NCT02077335|Brachytherapy|brachytherapy
254526|NCT02077335|Monotherapy|monotherapy
254527|NCT02077335|HDR|hdr
254528|NCT02077322|Merocel Middle Meatus Spacers|merocel middle meatus spacers
254829|NCT02076165|women|women
254529|NCT02077322|Silastic Middle Meatus Spacers|silastic middle meatus spacers
254530|NCT02077322|Functional Endoscopic Sinus Surgery|functional endoscopic sinus surgery
254531|NCT02077309|T2DM,|t2dm,
254532|NCT02077309|vascular inflammation,|vascular inflammation,
254533|NCT02077309|18-FDG-PET,|18-fdg-pet,
254534|NCT02077309|plaque morphology,|plaque morphology,
254535|NCT02077309|MRI,|mri,
254536|NCT02077309|DPP-4 Inhibition|dpp-4 inhibition
254537|NCT02077296|cytokines|cytokines
254538|NCT02077296|predictive value|predictive value
254539|NCT02077296|preoperative chemoradiotherapy|preoperative chemoradiotherapy
254540|NCT02077296|rectal cancer|rectal cancer
254541|NCT02077283|NAFLD (non-alcoholic fatty liver disease, NAFLD)|nafld (non-alcoholic fatty liver disease, nafld)
254542|NCT02077283|urinary metabonomics|urinary metabonomics
254543|NCT02077283|TCM pattern|tcm pattern
254544|NCT02077283|"liver depression and spleen deficiency pattern,"|"liver depression and spleen deficiency pattern,"
254545|NCT02077283|"damp-heat in the interior pattern"|"damp-heat in the interior pattern"
254546|NCT02077270|colonoscopy|colonoscopy
254547|NCT02077270|acupuncture|acupuncture
254548|NCT02077270|pain|pain
254549|NCT02077244|patient|patient
254550|NCT02077244|intensive care|intensive care
254551|NCT02077244|follow up|follow up
254552|NCT02077244|post traumatic stress symptoms|post traumatic stress symptoms
254553|NCT02077244|randomized controlled trial|randomized controlled trial
254554|NCT02077205|Diagnostic and Statistical Manual of Mental Disorders-IV/-5: Anxiety Disorders in children|diagnostic and statistical manual of mental disorders-iv/-5: anxiety disorders in children
254555|NCT02077179|Postpartum|postpartum
254556|NCT02077179|Preeclampsia|preeclampsia
254557|NCT02077179|Gestational Hypertension|gestational hypertension
254558|NCT02077179|Gestational Diabetes|gestational diabetes
254559|NCT02077179|Exercise Intervention|exercise intervention
254560|NCT02077179|Dietary Intervention|dietary intervention
254561|NCT02077179|Behavioral Intervention|behavioral intervention
254562|NCT02077179|Mobile Website|mobile website
254563|NCT02077179|Mobile Application|mobile application
254564|NCT02077166|DLBCL|dlbcl
254565|NCT02077101|HIV|hiv
254566|NCT02077101|Therapeutic vaccine|therapeutic vaccine
254567|NCT02077101|acceptability|acceptability
254568|NCT02077101|representations|representations
254569|NCT02077088|interventional|interventional
254570|NCT02077088|doubleblind|doubleblind
254571|NCT02077088|randomised|randomised
254572|NCT02077088|pediatric|pediatric
254573|NCT02077088|prebiotic|prebiotic
254574|NCT02077088|atopic|atopic
254575|NCT02077088|dermatitis|dermatitis
254576|NCT02077088|infant|infant
254577|NCT02077075|weight loss|weight loss
254578|NCT02077075|healthy weight|healthy weight
254579|NCT02077075|overweight|overweight
254580|NCT02077075|body mass index greater that 25 kg/m2|body mass index greater that 25 kg/m2
254581|NCT02077062|hepatectomy,|hepatectomy,
254582|NCT02077062|liver regeneration|liver regeneration
254583|NCT02077062|mediators|mediators
254584|NCT02077049|elderly|elderly
254585|NCT02077049|exercise program|exercise program
254586|NCT02077049|self-training|self-training
254587|NCT02077049|mobility|mobility
254588|NCT02077049|computer-based learning games|computer-based learning games
254589|NCT02077049|serious game|serious game
254590|NCT02077049|balance|balance
254591|NCT02077049|training adherence|training adherence
254592|NCT02077049|training compliance|training compliance
254593|NCT02077049|Kinect ®|kinect ®
254594|NCT02077049|Fit Bit ®|fit bit ®
254595|NCT02077023|Stroke|stroke
254596|NCT02077023|Heart Attack|heart attack
254597|NCT02077023|Asymptomatic Carotid Artery Disease|asymptomatic carotid artery disease
254598|NCT02077023|Atrial Fibrillation|atrial fibrillation
254599|NCT02077010|milrinone|milrinone
254600|NCT02077010|heart failure|heart failure
254601|NCT02077010|cardiomyopathy|cardiomyopathy
254602|NCT02077010|inhaled|inhaled
254603|NCT02076997|Cancer|cancer
254604|NCT02076997|High Dose Methotrexate|high dose methotrexate
254605|NCT02076984|Ventral hernia|ventral hernia
254606|NCT02076984|Incisional hernia|incisional hernia
254607|NCT02076984|Patient affected by ventral or incisional hernias|patient affected by ventral or incisional hernias
254608|NCT02076971|Lung transplant|lung transplant
254609|NCT02076971|Quantiferon|quantiferon
254610|NCT02076971|Immuknow|immuknow
254611|NCT02076958|Implementation|implementation
254612|NCT02076958|Cancer|cancer
254613|NCT02076958|Early detection|early detection
254614|NCT02076958|Faith-based|faith-based
254615|NCT02076958|Community health advisor|community health advisor
254616|NCT02076945|Regional anesthesia|regional anesthesia
254617|NCT02076945|Diabetic neuropathy|diabetic neuropathy
254618|NCT02076945|Ultrasound|ultrasound
254619|NCT02076919|LHA510|lha510
254622|NCT02076919|Tolerability|tolerability
254623|NCT02076919|Pharmacokinetics|pharmacokinetics
254624|NCT02076919|Elderly|elderly
254625|NCT02076919|Age-Related Macular Degeneration|age-related macular degeneration
254626|NCT02076919|AMD|amd
254627|NCT02076919|Ocular|ocular
254628|NCT02076919|Eye drop|eye drop
254629|NCT02076906|relapsed pediatric solid tumors|relapsed pediatric solid tumors
254730|NCT02076633|metastatic melanoma|metastatic melanoma
254630|NCT02076906|refractory pediatric solid tumors|refractory pediatric solid tumors
254631|NCT02076906|high intensity focused ultrasound|high intensity focused ultrasound
254632|NCT02076906|rhabdomyosarcoma|rhabdomyosarcoma
254633|NCT02076906|Ewing's sarcoma|ewing's sarcoma
254634|NCT02076906|osteosarcoma|osteosarcoma
254635|NCT02076906|neuroblastoma|neuroblastoma
254636|NCT02076906|Wilms' tumor|wilms' tumor
254637|NCT02076906|hepatic tumors|hepatic tumors
254638|NCT02076906|germ cell tumors|germ cell tumors
254639|NCT02076906|desmoid tumor|desmoid tumor
254640|NCT02076893|Tonsillectomy|tonsillectomy
254641|NCT02076893|Pain management|pain management
254642|NCT02076893|Pediatrics|pediatrics
254643|NCT02076880|Type 2 diabetes|type 2 diabetes
254644|NCT02076880|Obesity|obesity
254645|NCT02076880|Sleeve gastrectomy|sleeve gastrectomy
254646|NCT02076880|Insulin|insulin
254647|NCT02076880|GLP-1|glp-1
254648|NCT02076867|somatic symptoms and related disorders|somatic symptoms and related disorders
254649|NCT02076867|somatic symptoms|somatic symptoms
254650|NCT02076867|psychodynamic psychotherapy|psychodynamic psychotherapy
254651|NCT02076854|eating disorders|eating disorders
254652|NCT02076854|anorexia nervosa|anorexia nervosa
254653|NCT02076854|treatment|treatment
254654|NCT02076854|technology|technology
254655|NCT02076828|anemia|anemia
254656|NCT02076828|iron polymaltose complexes|iron polymaltose complexes
254657|NCT02076828|iron zinc|iron zinc
254658|NCT02076815|myeloproliferative neoplasm|myeloproliferative neoplasm
254659|NCT02076815|essential thrombocythemia|essential thrombocythemia
254660|NCT02076815|high risk patients|high risk patients
254661|NCT02076815|anagrelide|anagrelide
254662|NCT02076802|prehypertension|prehypertension
254663|NCT02076802|coronary atherosclerosis|coronary atherosclerosis
254664|NCT02076802|cardiovascular disease|cardiovascular disease
254665|NCT02076789|Device Replacement|device replacement
254666|NCT02076789|Device Upgrade|device upgrade
254667|NCT02076789|Long-term Postoperative Complications|long-term postoperative complications
254668|NCT02076789|Resource consumption and associated costs after device replacement/upgrade|resource consumption and associated costs after device replacement/upgrade
254669|NCT02076776|Stroke|stroke
254670|NCT02076776|Exercise|exercise
254671|NCT02076776|Rehabilitation|rehabilitation
254672|NCT02076776|Neuroplasticity|neuroplasticity
254673|NCT02076776|Task Practice|task practice
254674|NCT02076763|Observational|observational
254675|NCT02076763|Porphyria|porphyria
254676|NCT02076750|Inflammatory Bowel Diseases|inflammatory bowel diseases
254677|NCT02076750|Vitamin D|vitamin d
254678|NCT02076750|Cholecalciferol|cholecalciferol
254679|NCT02076750|Skin Pigmentation|skin pigmentation
254680|NCT02076737|Model-based iterative reconstruction MB-IR|model-based iterative reconstruction mb-ir
254681|NCT02076737|VEOTM|veotm
254682|NCT02076737|Ultra low-dose|ultra low-dose
254683|NCT02076737|Abdominal CT|abdominal ct
254684|NCT02076737|Dose reduction|dose reduction
254685|NCT02076737|Adaptative statistical iterative reconstruction ASIR|adaptative statistical iterative reconstruction asir
254686|NCT02076737|Acute renal colic|acute renal colic
254687|NCT02076724|Abdominal donor-site|abdominal donor-site
254688|NCT02076724|Breast reconstruction|breast reconstruction
254689|NCT02076724|Synthetic mesh|synthetic mesh
254690|NCT02076724|Biological mesh|biological mesh
254691|NCT02076711|Aortic Stenosis|aortic stenosis
254692|NCT02076711|Myocardial efficiency|myocardial efficiency
254693|NCT02076698|Deep Brain Stimulation|deep brain stimulation
254694|NCT02076698|Anterior Nucleus of thalamus|anterior nucleus of thalamus
254695|NCT02076698|Treatment refractory|treatment refractory
254696|NCT02076698|Pharmacoresistant partial epilepsy|pharmacoresistant partial epilepsy
254697|NCT02076698|vagus nerve stimulation therapy|vagus nerve stimulation therapy
254698|NCT02076685|pharmacogenetics|pharmacogenetics
254699|NCT02076685|anti-tuberculosis drug|anti-tuberculosis drug
254700|NCT02076685|genetic polymorphism|genetic polymorphism
254701|NCT02076685|isoniazid|isoniazid
254702|NCT02076672|prevention|prevention
254703|NCT02076672|non-malignant asbestos-related disease|non-malignant asbestos-related disease
254704|NCT02076672|benign pleural disease|benign pleural disease
254705|NCT02076672|asbestosis|asbestosis
254706|NCT02076659|F8|f8
254707|NCT02076659|IL10|il10
254708|NCT02076659|Interleukin|interleukin
254709|NCT02076659|monoclonal|monoclonal
254710|NCT02076659|antibody|antibody
254711|NCT02076659|Rheumatoid Arthritis|rheumatoid arthritis
254712|NCT02076646|Interleukin|interleukin
254713|NCT02076646|IL2|il2
254714|NCT02076646|monoclonal|monoclonal
254715|NCT02076646|antibody|antibody
254716|NCT02076646|cytokine|cytokine
254717|NCT02076646|Dacarbazine|dacarbazine
254718|NCT02076646|metastatic|metastatic
254719|NCT02076646|melanoma|melanoma
254720|NCT02076646|tumor targeting|tumor targeting
254721|NCT02076646|Dose definition|dose definition
254722|NCT02076646|L19|l19
254723|NCT02076633|L19|l19
254724|NCT02076633|monoclonal|monoclonal
254725|NCT02076633|antibody|antibody
254726|NCT02076633|IL-2|il-2
254727|NCT02076633|TNFα|tnfα
254728|NCT02076633|Interleukin|interleukin
254729|NCT02076633|Phase II|phase ii
254731|NCT02076633|clinical stage III|clinical stage iii
254732|NCT02076633|Clinical stage IV M1a|clinical stage iv m1a
254733|NCT02076620|L19|l19
254734|NCT02076620|monoclonal|monoclonal
254735|NCT02076620|antibody|antibody
254736|NCT02076620|doxorubicin|doxorubicin
254737|NCT02076620|TNFα|tnfα
254738|NCT02076620|solid tumour|solid tumour
254739|NCT02076620|sarcoma, breast cancer, lung carcinomas, gynecological cancer|sarcoma, breast cancer, lung carcinomas, gynecological cancer
254740|NCT02076620|anthracycline|anthracycline
254741|NCT02076607|vertebra|vertebra
254742|NCT02076607|column|column
254743|NCT02076607|lumbar|lumbar
254744|NCT02076607|toracica|toracica
254745|NCT02076607|fracture|fracture
254746|NCT02076607|burst|burst
254747|NCT02076568|diabetes|diabetes
254748|NCT02076568|education|education
254749|NCT02076568|randomized|randomized
254750|NCT02076568|prospective|prospective
254751|NCT02076555|diabetes|diabetes
254752|NCT02076555|education|education
254753|NCT02076555|randomized|randomized
254754|NCT02076555|prospective|prospective
254755|NCT02076542|diabetes|diabetes
254756|NCT02076542|education|education
254757|NCT02076542|randomized|randomized
254758|NCT02076542|prospective|prospective
254759|NCT02076529|chemotherapy induced nausea vomiting|chemotherapy induced nausea vomiting
254760|NCT02076516|Drug-eluting Stent,Coronary Artery Disease|drug-eluting stent,coronary artery disease
254761|NCT02076503|Neoplasm Staging|neoplasm staging
254762|NCT02076503|Positron-Emission Tomography|positron-emission tomography
254763|NCT02076503|Magnetic Resonance Imaging|magnetic resonance imaging
254764|NCT02076503|1-amino-3-fluorocyclobutane-1-carboxylic acid|1-amino-3-fluorocyclobutane-1-carboxylic acid
254765|NCT02076490|Telerehabilitation, mirror therapy, phantom limb pain|telerehabilitation, mirror therapy, phantom limb pain
254766|NCT02076477|intervention time|intervention time
254767|NCT02076477|radiotherapy|radiotherapy
254768|NCT02076477|oligometastatic|oligometastatic
254769|NCT02076477|non-small cell lung cancer|non-small cell lung cancer
254770|NCT02076438|antibiotics|antibiotics
254771|NCT02076438|diarrhea|diarrhea
254773|NCT02076438|Hospitalized patients|hospitalized patients
254774|NCT02076425|Depressive Disorder, Major|depressive disorder, major
254775|NCT02076425|Child Psychiatry|child psychiatry
254776|NCT02076425|Parent-Child Relationship|parent-child relationship
254777|NCT02076425|Therapy|therapy
254778|NCT02076399|Persistent Immune Thrombocytopenic Purpura|persistent immune thrombocytopenic purpura
254779|NCT02076399|Chronic Immune Thrombocytopenic Purpura|chronic immune thrombocytopenic purpura
254780|NCT02076360|Preoperative counseling|preoperative counseling
254781|NCT02076360|Patient satisfaction|patient satisfaction
254782|NCT02076360|Prolapse|prolapse
254783|NCT02076360|Sacrocolpopexy|sacrocolpopexy
254784|NCT02076347|Metformin|metformin
254785|NCT02076347|Vitamin B12 Deficiency|vitamin b12 deficiency
254786|NCT02076347|Population Management|population management
254787|NCT02076347|Pharmacist|pharmacist
254788|NCT02076334|compression, isokinetic, far-infrared|compression, isokinetic, far-infrared
254789|NCT02076308|Acupuncture, ultrasound|acupuncture, ultrasound
254790|NCT02076295|Cognition|cognition
254791|NCT02076295|Cholinergic nicotinic receptors|cholinergic nicotinic receptors
254792|NCT02076295|Positron Emission Tomography|positron emission tomography
254793|NCT02076282|Stage III non-small cell lung cancer|stage iii non-small cell lung cancer
254794|NCT02076282|Optimization|optimization
254795|NCT02076282|MRI|mri
254796|NCT02076282|Radiotherapy|radiotherapy
254797|NCT02076269|HRCT|hrct
254798|NCT02076269|Dry Powder Inhaler|dry powder inhaler
254799|NCT02076269|COPD|copd
254800|NCT02076269|Pharyngometry|pharyngometry
254801|NCT02076269|Inhalation Profiles|inhalation profiles
254802|NCT02076256|helping relationships, healthy lifestyle, quality of life|helping relationships, healthy lifestyle, quality of life
254803|NCT02076243|cutaneous squamous cell carcinoma|cutaneous squamous cell carcinoma
254804|NCT02076243|SCC|scc
254805|NCT02076243|abraxane|abraxane
254806|NCT02076243|nab-paclitaxel|nab-paclitaxel
254807|NCT02076243|unresectable|unresectable
254808|NCT02076243|metastatic|metastatic
254809|NCT02076230|14C-TH-302|14c-th-302
254810|NCT02076230|Advanced or Metastatic Solid Tumors|advanced or metastatic solid tumors
254811|NCT02076230|Evofosfamide|evofosfamide
254812|NCT02076217|Highly Effective Contraception|highly effective contraception
254813|NCT02076217|Emergency Contraception|emergency contraception
254814|NCT02076217|Birth Control|birth control
254815|NCT02076217|LARC (Long Acting Reversible Contraception)|larc (long acting reversible contraception)
254816|NCT02076217|HERC (Highly Effective Contraception)|herc (highly effective contraception)
254817|NCT02076204|Pregnancy|pregnancy
254818|NCT02076204|Postpartum programs|postpartum programs
254819|NCT02076204|Infant health services|infant health services
254820|NCT02076191|Ruxolitinib|ruxolitinib
254821|NCT02076191|Decitabine|decitabine
254822|NCT02076191|Myeloproliferative Neoplasms|myeloproliferative neoplasms
254823|NCT02076191|Combination Therapy|combination therapy
254824|NCT02076178|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
254825|NCT02076178|HIV integrase|hiv integrase
254826|NCT02076178|Intramuscular Injection|intramuscular injection
254830|NCT02076152|Recurrent Glioblastoma|recurrent glioblastoma
254831|NCT02076139|tuberculosis|tuberculosis
254832|NCT02076139|treg|treg
254833|NCT02076139|tolerance|tolerance
254834|NCT02076139|probiotic|probiotic
254835|NCT02076139|mycobacteria|mycobacteria
254836|NCT02076126|Lung maturity|lung maturity
254837|NCT02076126|RDS|rds
254838|NCT02076126|Prematurity|prematurity
254839|NCT02076126|Lecithin-sphingomyelin ratio|lecithin-sphingomyelin ratio
254840|NCT02076126|Spectroscopy|spectroscopy
254841|NCT02076126|Chemometrics|chemometrics
254842|NCT02076113|cervical spondylotic myelopathy|cervical spondylotic myelopathy
254843|NCT02076113|degenerative cervical spondylosis|degenerative cervical spondylosis
254844|NCT02076113|spinal fusion|spinal fusion
254845|NCT02076087|Subcutaneous adipose tissue|subcutaneous adipose tissue
254846|NCT02076087|Lipectomy|lipectomy
254847|NCT02076061|COPD|copd
254848|NCT02076061|Primary Care|primary care
254849|NCT02076061|Smoking|smoking
254850|NCT02076061|Smokers|smokers
254851|NCT02076061|ex-Smokers|ex-smokers
254852|NCT02076061|Lung Cancer|lung cancer
254853|NCT02076061|Cardiovascular Disease|cardiovascular disease
254854|NCT02076061|Proteomics|proteomics
254855|NCT02076061|Biomarkers|biomarkers
254856|NCT02076061|Biobank|biobank
254857|NCT02076061|Disease Staging|disease staging
254858|NCT02076061|Gold Stage|gold stage
254859|NCT02076048|LCPUFA supplementation|lcpufa supplementation
254860|NCT02076048|Brain Imaging|brain imaging
254861|NCT02076048|MRI|mri
254862|NCT02076048|MEG|meg
254863|NCT02076035|low back pain|low back pain
254864|NCT02076035|periduroscopy|periduroscopy
254865|NCT02076035|genetic|genetic
254866|NCT02076035|genomic|genomic
254867|NCT02076035|inflammation|inflammation
254868|NCT02076022|Fat Grafting|fat grafting
254869|NCT02076022|Pain at amputation site|pain at amputation site
254870|NCT02076022|prosthetic|prosthetic
254871|NCT02076009|Multiple Myeloma|multiple myeloma
254872|NCT02076009|Relapsed Multiple Myeloma|relapsed multiple myeloma
254873|NCT02076009|Refractory Multiple Myeloma|refractory multiple myeloma
254874|NCT02076009|Daratumumab|daratumumab
254875|NCT02076009|Lenalidomide|lenalidomide
254876|NCT02076009|Dexamethasone|dexamethasone
254877|NCT02075996|pomalidomide, Imnovid, dexamethasone, Poseidon, multiple myeloma, daily routine, secondary malignancies, Germany, non-interventional study, safety,|pomalidomide, imnovid, dexamethasone, poseidon, multiple myeloma, daily routine, secondary malignancies, germany, non-interventional study, safety,
254878|NCT02075983|HIV|hiv
254879|NCT02075983|Vaccine|vaccine
254880|NCT02075983|Immunisation|immunisation
254881|NCT02075983|DNA|dna
254882|NCT02075983|Adverse events|adverse events
254883|NCT02075983|Electroporation|electroporation
254884|NCT02075983|Transcutaneous|transcutaneous
254885|NCT02075983|GTU MultiHIV B Clade|gtu multihiv b clade
254886|NCT02075983|Antibody|antibody
254887|NCT02075983|Intramuscular|intramuscular
254888|NCT02075983|Immunogenicity|immunogenicity
254889|NCT02075970|Neonatal|neonatal
254890|NCT02075970|Anemia|anemia
254891|NCT02075970|Transfusion|transfusion
254892|NCT02075970|Erythropoetin|erythropoetin
254893|NCT02075970|Epoetin Alpha|epoetin alpha
254894|NCT02075970|Red Blood Cell|red blood cell
254895|NCT02075970|Survival|survival
254896|NCT02075970|Pharmacodynamics|pharmacodynamics
254897|NCT02075970|Model|model
254898|NCT02075957|Non-small cell lung cancer, adjuvant chemo-therapy, DNA chip|non-small cell lung cancer, adjuvant chemo-therapy, dna chip
254899|NCT02075944|Aerobic exercise|aerobic exercise
254900|NCT02075944|Cognitive function|cognitive function
254901|NCT02075944|Executive function|executive function
254902|NCT02075944|Brain-derived neurotrophic factor|brain-derived neurotrophic factor
254903|NCT02075905|Barrett's Esophagus|barrett's esophagus
254904|NCT02075905|Esophageal Adenocarcinoma|esophageal adenocarcinoma
254905|NCT02075892|cordyceps, aerobic capacity, exercise performance, fatigue|cordyceps, aerobic capacity, exercise performance, fatigue
254906|NCT02075853|Cerebral palsy|cerebral palsy
254907|NCT02075853|Pes planus|pes planus
254908|NCT02075853|Calcaneal lengthening|calcaneal lengthening
254909|NCT02075827|Appetite, metabolism, sedentary behaviour, stress response|appetite, metabolism, sedentary behaviour, stress response
254910|NCT02075801|Sealant, Margins Defect, Amalgam|sealant, margins defect, amalgam
254911|NCT02075775|instability|instability
254912|NCT02075749|irradiation|irradiation
254913|NCT02075749|mucositis|mucositis
254914|NCT02075749|triamcinolone acetonide|triamcinolone acetonide
254915|NCT02075749|licorice|licorice
254916|NCT02075749|mucoadhesive film|mucoadhesive film
254917|NCT02075710|Diet|diet
254918|NCT02075710|Sugar|sugar
254919|NCT02075710|Cardiovascular|cardiovascular
254920|NCT02075710|Lipid|lipid
254921|NCT02075697|psoriasis|psoriasis
254922|NCT02075697|biologic therapy|biologic therapy
254923|NCT02075697|infliximab|infliximab
254924|NCT02075697|etanercept|etanercept
254925|NCT02075697|efalizumab|efalizumab
254926|NCT02075697|adalimumab|adalimumab
254927|NCT02075697|ustekinumab|ustekinumab
254928|NCT02075697|methotrexate|methotrexate
254929|NCT02075697|cyclosporine|cyclosporine
254930|NCT02075697|acitretin|acitretin
254931|NCT02075671|Rosacea|rosacea
254932|NCT02075671|Photodynamic Therapy|photodynamic therapy
254933|NCT02075671|Aminolevulinic Acid|aminolevulinic acid
254934|NCT02075671|Papulopustular Rosacea|papulopustular rosacea
254935|NCT02075671|Blue Light|blue light
254936|NCT02075658|renal cell carcinoma|renal cell carcinoma
254937|NCT02075658|minimally invasive procedures|minimally invasive procedures
254938|NCT02075658|robotic nephrectomy|robotic nephrectomy
254939|NCT02075658|laparoscopic nephrectomy|laparoscopic nephrectomy
254940|NCT02075658|pneumoperitoneum|pneumoperitoneum
254941|NCT02075658|trocars|trocars
254942|NCT02075658|AirSeal® IFS|airseal® ifs
254943|NCT02075632|Alclometasone dipropionate|alclometasone dipropionate
254944|NCT02075632|Eczema|eczema
254945|NCT02075632|Psoriasis|psoriasis
254946|NCT02075632|Itch|itch
254947|NCT02075619|Amlodipine|amlodipine
254948|NCT02075619|Healthy volunteers|healthy volunteers
254949|NCT02075619|Rosuvastatin|rosuvastatin
254950|NCT02075619|Dyslipidaemia|dyslipidaemia
254951|NCT02075619|Pharmacokinetics|pharmacokinetics
254952|NCT02075619|Hypertension|hypertension
254953|NCT02075606|NET|net
254954|NCT02075606|Symptomatic response|symptomatic response
254955|NCT02075606|Functioning NeuroEndocrine Tumours|functioning neuroendocrine tumours
254956|NCT02075606|midgut region|midgut region
254957|NCT02075593|dolutegravir/abacavir/lamivudine fixed dose combination|dolutegravir/abacavir/lamivudine fixed dose combination
254958|NCT02075593|pregnant women|pregnant women
254959|NCT02075593|once daily|once daily
254960|NCT02075593|antiretroviral therapy-naive|antiretroviral therapy-naive
254961|NCT02075593|HIV-1 Infection|hiv-1 infection
254962|NCT02075593|integrase inhibitor|integrase inhibitor
254963|NCT02075580|cancer, quality of life, body-image, subcutaneous-implant|cancer, quality of life, body-image, subcutaneous-implant
254964|NCT02075567|Diabetes Mellitus Type 1|diabetes mellitus type 1
254965|NCT02075567|Exercise|exercise
254966|NCT02075567|Insulin Reduction|insulin reduction
254967|NCT02075567|Glucose|glucose
254968|NCT02075567|Hypoglycemia|hypoglycemia
254969|NCT02075567|Continuous Glucose Monitoring System|continuous glucose monitoring system
254970|NCT02075541|Immunogenicity|immunogenicity
254971|NCT02075541|Observer-blind|observer-blind
254972|NCT02075541|Reactogenicity|reactogenicity
254973|NCT02075541|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
254974|NCT02075541|Safety|safety
254975|NCT02075528|Paliperidone|paliperidone
254976|NCT02075528|Treatment response|treatment response
254977|NCT02075528|Schizophrenia|schizophrenia
254978|NCT02075528|Early prediction|early prediction
254979|NCT02075528|Pharmacokinetics|pharmacokinetics
254980|NCT02075515|Safety|safety
254981|NCT02075515|Zoster|zoster
254982|NCT02075515|Immunogenicity|immunogenicity
254983|NCT02075515|Adults|adults
254984|NCT02075515|Consistency|consistency
254985|NCT02075502|claudication|claudication
254986|NCT02075502|community walking exercise|community walking exercise
254987|NCT02075502|community-based participatory research|community-based participatory research
254988|NCT02075502|exercise adherence|exercise adherence
254989|NCT02075502|endovascular therapy|endovascular therapy
254990|NCT02075489|Acupressure|acupressure
254991|NCT02075489|Reiki|reiki
254992|NCT02075489|EEG|eeg
254993|NCT02075489|EMG|emg
254994|NCT02075489|fatigue relief|fatigue relief
254995|NCT02075489|veterans|veterans
254996|NCT02075476|Fracture-luxation|fracture-luxation
254997|NCT02075476|humeral proximal extremity|humeral proximal extremity
254998|NCT02075476|Hemiarthroplasty|hemiarthroplasty
254999|NCT02075476|reverse Arthroplasty|reverse arthroplasty
255000|NCT02075463|recombinant human erythropoietin|recombinant human erythropoietin
255001|NCT02075463|GSK1278863|gsk1278863
255002|NCT02075463|hemodialysis|hemodialysis
255003|NCT02075463|anemia|anemia
255004|NCT02075463|Hemoglobin|hemoglobin
255005|NCT02075463|chronic rhEPO hyporesponsiveness|chronic rhepo hyporesponsiveness
255006|NCT02075463|chronic kidney disease|chronic kidney disease
255007|NCT02075463|erythropoiesis stimulating agents|erythropoiesis stimulating agents
255008|NCT02075463|pharmacokinetics|pharmacokinetics
255009|NCT02075450|Cardiac|cardiac
255010|NCT02075450|Arrest|arrest
255011|NCT02075450|Simulation|simulation
255012|NCT02075450|Feedback|feedback
255013|NCT02075437|Functional Abdominal Pain, Children|functional abdominal pain, children
255014|NCT02075437|Finding a treatment or intervention for children|finding a treatment or intervention for children
255015|NCT02075424|stress|stress
255016|NCT02075424|cortisol|cortisol
255017|NCT02075424|emergency call center|emergency call center
255018|NCT02075424|hospital staff|hospital staff
255019|NCT02075411|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
255020|NCT02075411|transplantation allografts|transplantation allografts
255021|NCT02075411|adolescent|adolescent
255022|NCT02075411|nerve block|nerve block
255023|NCT02075411|pain|pain
255024|NCT02075398|Portable pulse oximeter|portable pulse oximeter
255025|NCT02075385|Dysphagia|dysphagia
255026|NCT02075385|speech language therapy|speech language therapy
255027|NCT02075385|quality of life|quality of life
255028|NCT02075385|induction chemotherapy|induction chemotherapy
255029|NCT02075385|concurrent chemoradiotherapy|concurrent chemoradiotherapy
255030|NCT02075372|Chronic Total Occlusion of Coronary Artery|chronic total occlusion of coronary artery
255031|NCT02075372|Percutaneous Coronary Intervention|percutaneous coronary intervention
255032|NCT02075372|Hybrid|hybrid
255033|NCT02075372|Angioplasty|angioplasty
255034|NCT02075359|Total Energy Expenditure|total energy expenditure
255035|NCT02075359|Physical Activity Levels|physical activity levels
255036|NCT02075359|Body Mass Index|body mass index
255037|NCT02075359|Children|children
255038|NCT02075346|Patient safety monitors|patient safety monitors
255039|NCT02075320|CT|ct
255040|NCT02075320|Chest|chest
255041|NCT02075320|Lung|lung
255042|NCT02075307|insulin|insulin
255043|NCT02075307|diabetes|diabetes
255044|NCT02075307|obesity|obesity
255045|NCT02075307|DNA damage|dna damage
255046|NCT02075307|metabolic syndrome|metabolic syndrome
255047|NCT02075294|Aged|aged
255048|NCT02075294|Hepatitis B, Chronic|hepatitis b, chronic
255049|NCT02075294|Antiviral Agents|antiviral agents
255050|NCT02075268|Korean|korean
255051|NCT02075268|Healthy|healthy
255052|NCT02075268|Male|male
255053|NCT02075255|Asthma, Bronchial Diseases, Respiratory Tract Diseases, Lung Diseases, Obstructive Lung Diseases, OCS, Oral Corticosteroids|asthma, bronchial diseases, respiratory tract diseases, lung diseases, obstructive lung diseases, ocs, oral corticosteroids
255054|NCT02075242|HBV|hbv
255055|NCT02075229|Cochlear Implant|cochlear implant
255056|NCT02075229|Post-lingual onset hearing loss|post-lingual onset hearing loss
255057|NCT02075229|Profound hearing loss|profound hearing loss
255058|NCT02075229|Low Frequency hearing loss|low frequency hearing loss
255059|NCT02075229|Profound sensorineural hearing loss|profound sensorineural hearing loss
255060|NCT02075229|High frequency hearing loss|high frequency hearing loss
255061|NCT02075229|CMS-eligible patients|cms-eligible patients
255062|NCT02075216|Urinary Incontinence|urinary incontinence
255063|NCT02075216|Children|children
255064|NCT02075216|Bladder Exstrophy|bladder exstrophy
255065|NCT02075216|Extrophy -Epispadias complex,|extrophy -epispadias complex,
255066|NCT02075216|Modern staged repair,|modern staged repair,
255067|NCT02075216|Bladder neck reconstruction|bladder neck reconstruction
255068|NCT02075203|BCG Vaccinated|bcg vaccinated
255069|NCT02075177|neuroblastoma|neuroblastoma
255070|NCT02075164|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
255071|NCT02075164|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
255072|NCT02075164|NAFLD|nafld
255073|NCT02075164|NASH|nash
255074|NCT02075151|Bronchial Thermoplasty|bronchial thermoplasty
255075|NCT02075125|Korea|korea
255076|NCT02075125|Platelet inhibition|platelet inhibition
255077|NCT02075125|Prasugrel|prasugrel
255078|NCT02075125|Ticagrelor|ticagrelor
255079|NCT02075125|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
255080|NCT02075112|Soy|soy
255081|NCT02075112|Isoflavone|isoflavone
255082|NCT02075112|Radiation Therapy|radiation therapy
255083|NCT02075112|Cisplatin|cisplatin
255084|NCT02075099|whole blood donation|whole blood donation
255085|NCT02075099|donation water drink|donation water drink
255086|NCT02075099|isotonic drink|isotonic drink
255087|NCT02075099|presyncopal and syncopal reactions|presyncopal and syncopal reactions
255088|NCT02075086|angiogenic switch|angiogenic switch
255089|NCT02075086|plasma cytokines|plasma cytokines
255090|NCT02075086|Colon cancer|colon cancer
255091|NCT02075073|Pharmacokinetics|pharmacokinetics
255092|NCT02075060|low-grade|low-grade
255093|NCT02075060|NMIBC|nmibc
255094|NCT02075047|Bipolar I Disorder (current or most recent episode manic). Children and adolescents aged 10 to 17 years.|bipolar i disorder (current or most recent episode manic). children and adolescents aged 10 to 17 years.
255095|NCT02075034|Myelodysplastic syndrome|myelodysplastic syndrome
255096|NCT02075034|MDS|mds
255097|NCT02075034|Low risk|low risk
255098|NCT02075034|Intermediate-1 risk|intermediate-1 risk
255099|NCT02075034|Intermediate-2 risk|intermediate-2 risk
255100|NCT02075034|International Prognostic Scoring System|international prognostic scoring system
255101|NCT02075034|IPSS|ipss
255102|NCT02075021|relapsed|relapsed
255103|NCT02075021|refractory|refractory
255104|NCT02075021|multiple myeloma|multiple myeloma
255105|NCT02075021|revlimid|revlimid
255106|NCT02075021|lenalidomide|lenalidomide
255107|NCT02075021|abraxane|abraxane
255108|NCT02075021|n-paclitaxel|n-paclitaxel
255109|NCT02075008|asthma|asthma
255110|NCT02075008|allergic asthma|allergic asthma
255111|NCT02075008|QGE031|qge031
255112|NCT02075008|open-label|open-label
255113|NCT02075008|IgE|ige
255114|NCT02075008|long-term safety|long-term safety
255115|NCT02074995|Burn, Severe burn, Lean body mass, Cachexia, Hypermetabolism, Catabolism, Wound healing|burn, severe burn, lean body mass, cachexia, hypermetabolism, catabolism, wound healing
255116|NCT02074982|chronic plaque type psoriasis, secukinumab, ustekinumab, inflammatory skin disease, scaling|chronic plaque type psoriasis, secukinumab, ustekinumab, inflammatory skin disease, scaling
255117|NCT02074969|re-operation rate|re-operation rate
255118|NCT02074969|pertrochanteric fractures|pertrochanteric fractures
255119|NCT02074969|GammaNail|gammanail
255120|NCT02074969|PFNA|pfna
255121|NCT02074969|Tip-Apex-Distance|tip-apex-distance
255122|NCT02074969|Parkers-Ratio|parkers-ratio
255123|NCT02074956|BCG Vaccinated|bcg vaccinated
255124|NCT02074956|HIV Negative|hiv negative
255125|NCT02074943|Androgenetic Alopecia|androgenetic alopecia
255126|NCT02074917|anterior cruciate ligament|anterior cruciate ligament
255127|NCT02074917|ACL|acl
255128|NCT02074917|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
255129|NCT02074917|outcome assessment|outcome assessment
255130|NCT02074917|outcome assessment, patient|outcome assessment, patient
255131|NCT02074917|treatment outcome|treatment outcome
255132|NCT02074917|exercise test|exercise test
255133|NCT02074917|anatomic|anatomic
255134|NCT02074917|anatomical|anatomical
255135|NCT02074917|single-bundle|single-bundle
255136|NCT02074917|force platform|force platform
255137|NCT02074917|postural balance|postural balance
255138|NCT02074917|biomechanics|biomechanics
255139|NCT02074917|CT scan|ct scan
255140|NCT02074917|X-ray computed tomography|x-ray computed tomography
255141|NCT02074917|tomography|tomography
255142|NCT02074917|diagnostic imaging|diagnostic imaging
255143|NCT02074917|knee|knee
255144|NCT02074917|knee injuries|knee injuries
255145|NCT02074917|joint instability|joint instability
255146|NCT02074917|reconstructive surgical procedures|reconstructive surgical procedures
255147|NCT02074917|knee surgery|knee surgery
255148|NCT02074917|arthroscopy|arthroscopy
255149|NCT02074917|athletes|athletes
255150|NCT02074917|sports medicine|sports medicine
255151|NCT02074917|humans|humans
255152|NCT02074917|prospective studies|prospective studies
255153|NCT02074917|Randomized Controlled Trial|randomized controlled trial
255154|NCT02074891|preexposure prophylaxis|preexposure prophylaxis
255155|NCT02074891|PrEP|prep
255156|NCT02074891|HIV|hiv
255157|NCT02074878|Breast Cancer|breast cancer
255158|NCT02074878|Metastatic|metastatic
255159|NCT02074878|Crizotinib|crizotinib
255160|NCT02074878|Sunitinib|sunitinib
255161|NCT02074878|Xalcori|xalcori
255162|NCT02074878|Sutent|sutent
255163|NCT02074839|acute myeloid leukemia|acute myeloid leukemia
255164|NCT02074839|AML|aml
255165|NCT02074839|myelodysplastic syndrome|myelodysplastic syndrome
255166|NCT02074839|MDS|mds
255167|NCT02074839|hematologic malignancies|hematologic malignancies
255168|NCT02074839|IDH|idh
255169|NCT02074839|Untreated AML|untreated aml
255170|NCT02074839|IDH1|idh1
255171|NCT02074839|relapsed AML|relapsed aml
255172|NCT02074839|refractory AML|refractory aml
255173|NCT02074813|Inspiratory muscle training|inspiratory muscle training
255174|NCT02074813|COPD|copd
255175|NCT02074813|dyspnea|dyspnea
255176|NCT02074813|Multidimensional Dyspnea Profile questionnaire (MDP).|multidimensional dyspnea profile questionnaire (mdp).
255177|NCT02074813|pulmonary rehabilitation|pulmonary rehabilitation
255178|NCT02074800|Healthy|healthy
255179|NCT02074800|CNTO 328|cnto 328
255180|NCT02074800|Sp2/0-derived CNTO 328|sp2/0-derived cnto 328
255181|NCT02074800|CHO-derived CNTO 328|cho-derived cnto 328
255182|NCT02074800|Safety|safety
255183|NCT02074800|Pharmacokinetics|pharmacokinetics
255184|NCT02074774|nasal cannula, high flow oxygen therapy, pulse oximetry|nasal cannula, high flow oxygen therapy, pulse oximetry
255185|NCT02074761|sacroiliac joint fusion|sacroiliac joint fusion
255186|NCT02074761|SIJ fusion|sij fusion
255187|NCT02074761|SI joint|si joint
255188|NCT02074761|SIJ|sij
255189|NCT02074748|Bunion|bunion
255190|NCT02074748|Foot Arch|foot arch
255191|NCT02074748|Instability|instability
255192|NCT02074735|alcohol dependence|alcohol dependence
255193|NCT02074735|alcohol abuse|alcohol abuse
255194|NCT02074709|Pain, Liposomal bupivacaine, Wound infiltration|pain, liposomal bupivacaine, wound infiltration
255195|NCT02074696|brain derived neurotrophic factor|brain derived neurotrophic factor
255196|NCT02074657|Immunotherapy|immunotherapy
255197|NCT02074657|NKAEs|nkaes
255198|NCT02074657|Expanded haploidentical natural killer cells|expanded haploidentical natural killer cells
255199|NCT02074657|Activated natural killer cells|activated natural killer cells
255200|NCT02074644|Prostatism|prostatism
255201|NCT02074644|Randomized Controlled Trial|randomized controlled trial
255202|NCT02074644|Embolization, Therapeutic|embolization, therapeutic
255203|NCT02074644|Hyperplasia|hyperplasia
255204|NCT02074644|Prostatic Diseases|prostatic diseases
255205|NCT02074644|Genital Diseases, Male|genital diseases, male
255206|NCT02074631|bone mineral content|bone mineral content
255207|NCT02074631|bone mineral density|bone mineral density
255208|NCT02074631|bone formation|bone formation
255209|NCT02074631|bone resorption|bone resorption
255210|NCT02074631|pamidronate|pamidronate
255211|NCT02074631|children|children
255212|NCT02074631|DXA|dxa
255213|NCT02074631|bone marrow transplant|bone marrow transplant
255214|NCT02074618|Physical Therapy.|physical therapy.
255215|NCT02074618|Exercise.|exercise.
255216|NCT02074618|Rehabilitation.|rehabilitation.
255217|NCT02074618|Renal Insufficiency.|renal insufficiency.
255218|NCT02074618|Quality of life.|quality of life.
255219|NCT02074605|Melanoma|melanoma
255220|NCT02074605|Interferon|interferon
255221|NCT02074605|Cognition|cognition
255222|NCT02074592|Self assessment|self assessment
255223|NCT02074592|Audit|audit
255224|NCT02074592|Feedback|feedback
255225|NCT02074592|Quality|quality
255226|NCT02074592|Ultrasound|ultrasound
255227|NCT02074592|Fetal|fetal
255228|NCT02074592|Biometry|biometry
255229|NCT02074579|Irritable Bowel Syndrome|irritable bowel syndrome
255230|NCT02074579|Rome III criteria|rome iii criteria
255231|NCT02074579|abdominal bloating|abdominal bloating
255232|NCT02074579|natural|natural
255233|NCT02074579|herbal|herbal
255234|NCT02074579|Kampo|kampo
255235|NCT02074579|Adult ages 18 to 65|adult ages 18 to 65
255236|NCT02074579|Female subjects|female subjects
255237|NCT02074566|Pulmonary Vein Isolation|pulmonary vein isolation
255238|NCT02074566|Atrial fibrillation|atrial fibrillation
255239|NCT02074566|Cryoballoon therapy|cryoballoon therapy
255240|NCT02074566|Duration|duration
255241|NCT02074527|congenital heart disease|congenital heart disease
255242|NCT02074527|cardiac catheterization|cardiac catheterization
255243|NCT02074527|brazilian electronic registration|brazilian electronic registration
255244|NCT02074501|stroke|stroke
255245|NCT02074501|elderly|elderly
255246|NCT02074501|caregivers|caregivers
255247|NCT02074501|empowerment|empowerment
255248|NCT02074501|self-care|self-care
255249|NCT02074501|pilot study|pilot study
255250|NCT02074488|balance|balance
255251|NCT02074488|gait|gait
255252|NCT02074462|Voriconazole|voriconazole
255253|NCT02074462|CRP|crp
255254|NCT02074462|Inflammation|inflammation
255255|NCT02074462|Pharmacokinetics|pharmacokinetics
255256|NCT02074449|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
255257|NCT02074449|Right Ventricular Performance|right ventricular performance
255258|NCT02074449|Treprostinil|treprostinil
255259|NCT02074449|Remodulin|remodulin
255260|NCT02074436|hematological malignancies|hematological malignancies
255261|NCT02074436|thrombocytopenia|thrombocytopenia
255262|NCT02074436|aminocaproic acid|aminocaproic acid
255263|NCT02074423|Cinnamon extract|cinnamon extract
255264|NCT02074423|Postprandial glycemia|postprandial glycemia
255265|NCT02074423|Glycemic index|glycemic index
255266|NCT02074423|Pre-diabetes|pre-diabetes
255267|NCT02074423|Metabolic syndrome|metabolic syndrome
255268|NCT02074371|coronary artery bypass surgery|coronary artery bypass surgery
255269|NCT02074371|cardiopulmonary bypass|cardiopulmonary bypass
255270|NCT02074371|ICU|icu
255271|NCT02074371|postoperative respiratory depression|postoperative respiratory depression
255272|NCT02074345|Drug therapy|drug therapy
255273|NCT02074345|Safety and immunogenicity of Hib vaccine|safety and immunogenicity of hib vaccine
255274|NCT02074332|Obesity|obesity
255275|NCT02074332|Physical activity|physical activity
255276|NCT02074332|Schoolchildren|schoolchildren
255277|NCT02074332|Intervention Studies|intervention studies
255278|NCT02074319|Schizophrenia|schizophrenia
255279|NCT02074319|Anti-Inflammatory|anti-inflammatory
255280|NCT02074319|Methotrexate|methotrexate
255281|NCT02074319|Psychosis Not Otherwise Specified|psychosis not otherwise specified
255282|NCT02074306|endotracheal intubation|endotracheal intubation
255283|NCT02074306|low energy ultrasound|low energy ultrasound
255284|NCT02074306|sputum culture|sputum culture
255285|NCT02074293|Subdermal bloodless space|subdermal bloodless space
255286|NCT02074293|Subdermal injection|subdermal injection
255287|NCT02074293|injectable EMG needle|injectable emg needle
255288|NCT02074293|electrical stimulation|electrical stimulation
255289|NCT02074293|MRI with Gadolinium|mri with gadolinium
255290|NCT02074293|Cervical Dystonia|cervical dystonia
255291|NCT02074293|intramuscular injection|intramuscular injection
255292|NCT02074293|cervical dystonia,|cervical dystonia,
255293|NCT02074280|rifaximin|rifaximin
255294|NCT02074280|endotoxemia|endotoxemia
255295|NCT02074280|cirrhosis|cirrhosis
255296|NCT02074280|advanced cirrhosis|advanced cirrhosis
255297|NCT02074228|Attention-deficit/hyperactivity disorder,|attention-deficit/hyperactivity disorder,
255298|NCT02074228|symptomatology,|symptomatology,
255299|NCT02074228|neurocognitive endophenotype,|neurocognitive endophenotype,
255300|NCT02074228|medication response|medication response
255301|NCT02074215|Mild Cognitive Impairment|mild cognitive impairment
255302|NCT02074215|Alzheimer's disease|alzheimer's disease
255303|NCT02074215|Aerobic exercise|aerobic exercise
255304|NCT02074202|18F fluorocholine|18f fluorocholine
255305|NCT02074202|18F fluorodeoxyglucose|18f fluorodeoxyglucose
255306|NCT02074202|hepatocellular carcinoma|hepatocellular carcinoma
255307|NCT02074202|PET CT scan|pet ct scan
255308|NCT02074176|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
255309|NCT02074176|orexin A|orexin a
255310|NCT02074176|mRNA|mrna
255311|NCT02074163|Subdermal bloodless space|subdermal bloodless space
255312|NCT02074163|Subdermal injection|subdermal injection
255313|NCT02074163|injectable EMG needle|injectable emg needle
255314|NCT02074163|electrical stimulation|electrical stimulation
255315|NCT02074163|MRI with Gadolinium|mri with gadolinium
255316|NCT02074163|Chronic Migraine|chronic migraine
255317|NCT02074163|intramuscular injection|intramuscular injection
255318|NCT02074150|Subdermal bloodless space|subdermal bloodless space
255319|NCT02074150|Subdermal injection|subdermal injection
255320|NCT02074150|injectable EMG needle|injectable emg needle
255712|NCT02072252|Adolescents|adolescents
255321|NCT02074150|electrical stimulation|electrical stimulation
255322|NCT02074150|MRI with Gadolinium|mri with gadolinium
255323|NCT02074150|Upper Limb Spasticity|upper limb spasticity
255324|NCT02074150|intramuscular injection|intramuscular injection
255325|NCT02074111|Moyamoya disease|moyamoya disease
255326|NCT02074111|Intracranial atherosclerotic stroke|intracranial atherosclerotic stroke
255327|NCT02074111|Intracranial steno-occlusive disease|intracranial steno-occlusive disease
255328|NCT02074111|ring finger 213 (RNF213) gene mutation|ring finger 213 (rnf213) gene mutation
255329|NCT02074111|high-resolution MRI|high-resolution mri
255330|NCT02074098|intubation|intubation
255331|NCT02074098|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
255332|NCT02074098|Manikin study|manikin study
255333|NCT02074072|Endotracheal intubation|endotracheal intubation
255334|NCT02074072|Left lateral tilt wedge|left lateral tilt wedge
255335|NCT02074072|Maternal Cardiopulmonary Resuscitation|maternal cardiopulmonary resuscitation
255336|NCT02074072|Manikin Study|manikin study
255337|NCT02074020|SLE|sle
255338|NCT02074020|Lupus|lupus
255339|NCT02074020|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
255340|NCT02074020|Autoimmune Diseases|autoimmune diseases
255341|NCT02074020|A-623|a-623
255342|NCT02074020|Blisibimod|blisibimod
255343|NCT02074020|Nephritis|nephritis
255344|NCT02074007|Acute Otitis Media|acute otitis media
255345|NCT02074007|Pain|pain
255346|NCT02074007|Ear Pain|ear pain
255347|NCT02074007|Ear Ache|ear ache
255348|NCT02074007|Ear infection|ear infection
255349|NCT02074007|middle ear infection|middle ear infection
255350|NCT02073994|chondrosarcoma|chondrosarcoma
255351|NCT02073994|cholangiocarcinoma|cholangiocarcinoma
255352|NCT02073994|glioma|glioma
255353|NCT02073994|advanced solid tumors|advanced solid tumors
255354|NCT02073994|IDH1|idh1
255355|NCT02073994|AG-120|ag-120
255356|NCT02073981|Parkinson Disease|parkinson disease
255357|NCT02073955|Stroke|stroke
255358|NCT02073955|Validation|validation
255359|NCT02073955|Community Health workers|community health workers
255360|NCT02073955|stroke symptom questionnaire|stroke symptom questionnaire
255361|NCT02073916|Breast Cancer|breast cancer
255362|NCT02073916|HER2 positive Breast Cancer|her2 positive breast cancer
255363|NCT02073903|dual handset interpreter phones|dual handset interpreter phones
255364|NCT02073903|communication|communication
255365|NCT02073903|14-042|14-042
255366|NCT02073890|traumatic Subarachnoid Haemorrhage|traumatic subarachnoid haemorrhage
255367|NCT02073890|Head Trauma|head trauma
255368|NCT02073890|Computed Tomography|computed tomography
255369|NCT02073877|Peri-implant dermatitis|peri-implant dermatitis
255370|NCT02073864|Aortic valve stenosis, stenosis, intervention|aortic valve stenosis, stenosis, intervention
255371|NCT02073851|TAVR|tavr
255372|NCT02073825|Computer-assisted interventions|computer-assisted interventions
255373|NCT02073825|Alcohol use disorders|alcohol use disorders
255374|NCT02073825|At-risk drinking|at-risk drinking
255375|NCT02073825|Spouses|spouses
255376|NCT02073825|Military|military
255377|NCT02073825|Brief Intervention|brief intervention
255378|NCT02073773|stroke, virtual reality based therapy|stroke, virtual reality based therapy
255379|NCT02073760|Healthcare acquired infections|healthcare acquired infections
255380|NCT02073760|Cardiac Surgery|cardiac surgery
255381|NCT02073760|Sternal Superficial Wound Infection|sternal superficial wound infection
255382|NCT02073760|Deep Sternal Infection|deep sternal infection
255383|NCT02073760|Mediastinitis|mediastinitis
255384|NCT02073760|Thoracotomy|thoracotomy
255385|NCT02073760|Conduit harvest or cannulation site|conduit harvest or cannulation site
255386|NCT02073760|Sepsis|sepsis
255387|NCT02073760|Pneumonia|pneumonia
255388|NCT02073747|Albuterol|albuterol
255389|NCT02073747|Serum Lactate|serum lactate
255390|NCT02073747|Lactic Acidosis|lactic acidosis
255391|NCT02073747|Asthma|asthma
255392|NCT02073734|pelvic organ prolapse surgery|pelvic organ prolapse surgery
255393|NCT02073734|dexamethasone|dexamethasone
255394|NCT02073734|postoperative nausea and vomiting|postoperative nausea and vomiting
255395|NCT02073734|peroperative administration|peroperative administration
255396|NCT02073695|Proximal humeral fracture|proximal humeral fracture
255397|NCT02073695|Shoulder|shoulder
255398|NCT02073695|Orthopaedics|orthopaedics
255399|NCT02073695|Neutral rotation brace|neutral rotation brace
255400|NCT02073695|Polysling|polysling
255401|NCT02073669|latent tuberculosis|latent tuberculosis
255402|NCT02073669|tuberculin skin test|tuberculin skin test
255403|NCT02073669|Interferon gamma release assay|interferon gamma release assay
255404|NCT02073669|immigration|immigration
255405|NCT02073656|genotype 1|genotype 1
255406|NCT02073656|genotype 4|genotype 4
255407|NCT02073656|HIV|hiv
255408|NCT02073630|magnetoencephalography|magnetoencephalography
255409|NCT02073630|non invasive brain stimulation|non invasive brain stimulation
255410|NCT02073630|cerebellum|cerebellum
255411|NCT02073630|gamma rhythms|gamma rhythms
255412|NCT02073617|DynaCT|dynact
255413|NCT02073617|Aortic valve and root measurements|aortic valve and root measurements
255414|NCT02073617|TAVR|tavr
255415|NCT02073604|Congenital mirror movements|congenital mirror movements
255416|NCT02073604|SMA|sma
255417|NCT02073604|Movement preparation|movement preparation
255418|NCT02073604|Movement lateralization|movement lateralization
255419|NCT02073604|MRI|mri
255420|NCT02073604|Transcranial magnetic stimulation|transcranial magnetic stimulation
255421|NCT02073591|Children|children
255422|NCT02073591|Atopic Dermatitis|atopic dermatitis
255423|NCT02073591|Ceradan|ceradan
255424|NCT02073591|PEST|pest
255425|NCT02073591|SCORAD|scorad
255426|NCT02073578|achalasia|achalasia
255427|NCT02073578|POEM|poem
255428|NCT02073578|peroral endoscopic myotomy|peroral endoscopic myotomy
255429|NCT02073578|myotomy|myotomy
255430|NCT02073578|Heller myotomy|heller myotomy
255431|NCT02073565|intracoronary stent|intracoronary stent
255432|NCT02073565|drug eluting stent|drug eluting stent
255433|NCT02073565|sirolimus|sirolimus
255434|NCT02073565|endothelial progenitor cells|endothelial progenitor cells
255435|NCT02073552|colon cleansing, bowel preparations; polyethyleneglycol|colon cleansing, bowel preparations; polyethyleneglycol
255436|NCT02073539|Chest compression|chest compression
255437|NCT02073539|One accelerometer|one accelerometer
255438|NCT02073539|Manikin Study|manikin study
255439|NCT02073526|Antibodies, Monoclonal|antibodies, monoclonal
255440|NCT02073526|Anti-TNF|anti-tnf
255441|NCT02073526|TNF-alpha|tnf-alpha
255442|NCT02073526|Trough level|trough level
255443|NCT02073526|Drug concentration|drug concentration
255444|NCT02073526|ELISA|elisa
255445|NCT02073513|Spasticity, Hand Function, Cerebral Palsy, Kinesiotape|spasticity, hand function, cerebral palsy, kinesiotape
255446|NCT02073500|Peritoneal carcinomatosis|peritoneal carcinomatosis
255447|NCT02073500|Peritoneal surface malignancy|peritoneal surface malignancy
255448|NCT02073500|Cytoreductive surgery|cytoreductive surgery
255449|NCT02073500|Hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
255450|NCT02073500|CRS|crs
255451|NCT02073500|HIPEC|hipec
255452|NCT02073500|Prognostic biomarker|prognostic biomarker
255453|NCT02073500|Predictive biomarker|predictive biomarker
255454|NCT02073487|Neoadjuvant Breast Cancer|neoadjuvant breast cancer
255455|NCT02073487|HER2 positive Breast Cancer|her2 positive breast cancer
255456|NCT02073474|cannabinoids|cannabinoids
255457|NCT02073474|Sativex|sativex
255458|NCT02073474|THC|thc
255459|NCT02073474|delta-9-tetrahydrocannabinol|delta-9-tetrahydrocannabinol
255460|NCT02073474|cannabidiol|cannabidiol
255461|NCT02073474|CBD|cbd
255462|NCT02073474|Registry|registry
255463|NCT02073474|Safety|safety
255464|NCT02073474|MS|ms
255465|NCT02073461|Acne Vulgaris|acne vulgaris
255466|NCT02073448|Acne Vulgaris|acne vulgaris
255467|NCT02073435|liver transplantation|liver transplantation
255468|NCT02073435|living donor|living donor
255469|NCT02073435|Safety|safety
255470|NCT02073422|Magnetic resonance imaging|magnetic resonance imaging
255471|NCT02073422|Myocardial stress perfusion magnetic resonance imaging|myocardial stress perfusion magnetic resonance imaging
255472|NCT02073422|Fractional flow reserve|fractional flow reserve
255473|NCT02073422|Relaxometry|relaxometry
255474|NCT02073422|Coronary artery disease|coronary artery disease
255475|NCT02073409|Nontuberculous Mycobacteria|nontuberculous mycobacteria
255476|NCT02073383|Axillary brachial plexus block|axillary brachial plexus block
255477|NCT02073383|Ultrasound|ultrasound
255478|NCT02073383|Bupivacaine|bupivacaine
255479|NCT02073344|obstructive sleep apnea|obstructive sleep apnea
255480|NCT02073344|overhydration|overhydration
255481|NCT02073344|end stage renal disease|end stage renal disease
255482|NCT02073344|renal transplantation|renal transplantation
255483|NCT02073344|polysomnography|polysomnography
255484|NCT02073344|bioimpedance|bioimpedance
255485|NCT02073344|leg fluid shift|leg fluid shift
255486|NCT02073344|neck circumference|neck circumference
255487|NCT02073331|Open heart surgery, cardiac repair|open heart surgery, cardiac repair
255488|NCT02073305|obstructive sleep apnea|obstructive sleep apnea
255489|NCT02073305|end stage renal disease|end stage renal disease
255490|NCT02073305|cardiovascular events|cardiovascular events
255491|NCT02073240|Tuberculosis|tuberculosis
255492|NCT02073240|Infection Control|infection control
255493|NCT02073227|Healthy Volunteers|healthy volunteers
255494|NCT02073227|Canagliflozin|canagliflozin
255495|NCT02073227|Metformin|metformin
255496|NCT02073227|Type 2 diabetes mellitus|type 2 diabetes mellitus
255497|NCT02073175|Postpartum|postpartum
255498|NCT02073175|Dietary Supplements|dietary supplements
255499|NCT02073175|Mood Symptoms|mood symptoms
255500|NCT02073149|Iron|iron
255501|NCT02073149|Anemia|anemia
255502|NCT02073149|Sodium Fe(III)-ethylenediaminetetraacetic acid (NaFeEDTA)|sodium fe(iii)-ethylenediaminetetraacetic acid (nafeedta)
255503|NCT02073149|Ferrous compounds|ferrous compounds
255504|NCT02073149|Child, preschool|child, preschool
255505|NCT02073149|Kenya|kenya
255506|NCT02073123|Metastatic melanoma|metastatic melanoma
255507|NCT02073123|Stage III melanoma|stage iii melanoma
255508|NCT02073123|Stage IV melanoma|stage iv melanoma
255509|NCT02073123|unresectable|unresectable
255510|NCT02073110|Kidney cancer|kidney cancer
255511|NCT02073110|Renal mass|renal mass
255512|NCT02073110|Small renal mass|small renal mass
255513|NCT02073110|Optical Coherence Tomography|optical coherence tomography
255514|NCT02073110|OCT|oct
255609|NCT02072694|Functional Neuroimaging|functional neuroimaging
255515|NCT02073110|Diffuse Reflectance Spectroscopy|diffuse reflectance spectroscopy
255516|NCT02073110|DRS|drs
255517|NCT02073110|Optical Biopsy|optical biopsy
255518|NCT02073110|OB|ob
255519|NCT02073058|Subjects with Type 1 or Type 2 Diabetes Requiring Multiple daily Insulin Injection (MDI) or Continuous Subcutaneous Insulin Infusion (CSII)|subjects with type 1 or type 2 diabetes requiring multiple daily insulin injection (mdi) or continuous subcutaneous insulin infusion (csii)
255520|NCT02073032|Refeeding syndrome, risk factors, head and neck cancer|refeeding syndrome, risk factors, head and neck cancer
255521|NCT02073006|Chronic|chronic
255522|NCT02073006|Functional|functional
255523|NCT02073006|Constipation|constipation
255524|NCT02073006|less than 3 bowel movements per week|less than 3 bowel movements per week
255525|NCT02072993|Phase I, healthy, pharmacokinetics|phase i, healthy, pharmacokinetics
255526|NCT02072980|DT1|dt1
255527|NCT02072980|DAILIES TOTAL1®|dailies total1®
255528|NCT02072980|Lubricity|lubricity
255529|NCT02072967|Relapsed|relapsed
255530|NCT02072967|Refractory|refractory
255531|NCT02072967|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
255532|NCT02072967|Bendamustine|bendamustine
255533|NCT02072941|Advance care planning|advance care planning
255534|NCT02072941|Latino Health|latino health
255535|NCT02072941|Medical decision making|medical decision making
255536|NCT02072941|Health Literacy|health literacy
255537|NCT02072941|Limited English proficiency|limited english proficiency
255538|NCT02072941|Aging|aging
255539|NCT02072902|Cohort|cohort
255540|NCT02072902|Historical|historical
255541|NCT02072902|Prospective|prospective
255542|NCT02072902|Medications|medications
255543|NCT02072902|Observational|observational
255544|NCT02072902|Glucose|glucose
255545|NCT02072902|Control|control
255546|NCT02072889|Cardiac Surgery|cardiac surgery
255547|NCT02072889|Internal Jugular Cannulation|internal jugular cannulation
255548|NCT02072889|Optimal Neck Angle|optimal neck angle
255549|NCT02072876|Stroke|stroke
255550|NCT02072876|Asymptomatic Intracranial Atherosclerotic Disease|asymptomatic intracranial atherosclerotic disease
255551|NCT02072876|Lifestyle and socio-economic risk factors|lifestyle and socio-economic risk factors
255552|NCT02072876|Clinical predictors|clinical predictors
255553|NCT02072850|Myocardial infarction|myocardial infarction
255554|NCT02072850|Primary percutaneous coronary intervention (PCI)|primary percutaneous coronary intervention (pci)
255555|NCT02072850|Thrombolysis|thrombolysis
255556|NCT02072850|Rescue PCI|rescue pci
255557|NCT02072850|Electrocardiogram|electrocardiogram
255558|NCT02072850|Magnetic resonance imaging|magnetic resonance imaging
255559|NCT02072850|Area-at-risk|area-at-risk
255560|NCT02072850|Myocardial salvage|myocardial salvage
255561|NCT02072850|Infarct size|infarct size
255562|NCT02072850|Pressure wire|pressure wire
255563|NCT02072850|Coronary thermodilution|coronary thermodilution
255564|NCT02072850|Coronary microvascular function|coronary microvascular function
255565|NCT02072850|Index of microvascular resistance|index of microvascular resistance
255566|NCT02072850|Heart failure|heart failure
255567|NCT02072850|Prognosis|prognosis
255568|NCT02072837|hemodialysis, dyslipidemia, cardiovascular disease|hemodialysis, dyslipidemia, cardiovascular disease
255569|NCT02072824|Partial Onset Seizures|partial onset seizures
255570|NCT02072824|Epilepsy|epilepsy
255571|NCT02072824|Safety|safety
255572|NCT02072824|Efficacy|efficacy
255573|NCT02072824|Tolerability|tolerability
255574|NCT02072824|Pregabalin|pregabalin
255575|NCT02072824|Lyrica|lyrica
255576|NCT02072824|Adjunctive treatment|adjunctive treatment
255577|NCT02072824|Placebo controlled|placebo controlled
255578|NCT02072824|blinded|blinded
255579|NCT02072824|Eligibility Criteria|eligibility criteria
255580|NCT02072811|AML|aml
255581|NCT02072798|Randomized Controlled Trial|randomized controlled trial
255582|NCT02072798|Caesarean Section|caesarean section
255583|NCT02072798|Surgical Site Infections|surgical site infections
255584|NCT02072798|Wound Infections|wound infections
255585|NCT02072798|Infectious Morbidity|infectious morbidity
255586|NCT02072785|Adult Acute Lymphoblastic Leukemia|adult acute lymphoblastic leukemia
255587|NCT02072785|Vincristine Sulfate Liposome|vincristine sulfate liposome
255588|NCT02072785|Vincristine Sulfate|vincristine sulfate
255589|NCT02072759|Insulin sensitivity|insulin sensitivity
255590|NCT02072759|Metabolic flexibility|metabolic flexibility
255591|NCT02072746|cirrhosis|cirrhosis
255592|NCT02072746|alcohol|alcohol
255593|NCT02072733|frailty|frailty
255594|NCT02072733|oncogeriatrics|oncogeriatrics
255595|NCT02072733|Multidisciplinary intervention|multidisciplinary intervention
255596|NCT02072733|multimorbidity|multimorbidity
255597|NCT02072733|Comprehensive geriatric assessment|comprehensive geriatric assessment
255598|NCT02072733|patients|patients
255599|NCT02072720|Radiotherapy|radiotherapy
255600|NCT02072720|VEGF|vegf
255601|NCT02072720|esophagus carcinoma|esophagus carcinoma
255602|NCT02072720|bevacizumab|bevacizumab
255603|NCT02072707|Ventricular Tachycardia|ventricular tachycardia
255604|NCT02072707|RF ablation|rf ablation
255605|NCT02072707|Epicardial Access|epicardial access
255606|NCT02072707|Contact Sensor Irrigated tip catheter|contact sensor irrigated tip catheter
255607|NCT02072694|Obesity|obesity
255608|NCT02072694|Single Photon Emission Computed Tomography|single photon emission computed tomography
255610|NCT02072668|sickle cell anemia|sickle cell anemia
255611|NCT02072668|sickle cell disease|sickle cell disease
255612|NCT02072668|rivaroxaban|rivaroxaban
255613|NCT02072668|direct Xa inhibition|direct xa inhibition
255614|NCT02072668|coagulation|coagulation
255615|NCT02072668|anticoagulation|anticoagulation
255616|NCT02072629|Antimalarials|antimalarials
255617|NCT02072629|Antibiotics|antibiotics
255618|NCT02072629|ORS Zn|ors zn
255619|NCT02072629|Village Health Volunteers|village health volunteers
255620|NCT02072629|Integrated Community Case Management|integrated community case management
255621|NCT02072616|Circulating Tumor Cells|circulating tumor cells
255622|NCT02072616|pancreatic adenocarcinoma|pancreatic adenocarcinoma
255623|NCT02072616|circulating tumor DNA (KRAS)|circulating tumor dna (kras)
255624|NCT02072616|CA 19.9|ca 19.9
255625|NCT02072603|Infant HIV|infant hiv
255626|NCT02072603|Kenya|kenya
255627|NCT02072603|HITSystem|hitsystem
255628|NCT02072603|EID care|eid care
255629|NCT02072603|Early Infant Diagnosis|early infant diagnosis
255630|NCT02072590|Celiac disease|celiac disease
255631|NCT02072590|Eosinophilic esophagitis|eosinophilic esophagitis
255632|NCT02072590|Endomysial antibodies|endomysial antibodies
255633|NCT02072590|Transglutaminase antibodies|transglutaminase antibodies
255634|NCT02072590|Small-bowel|small-bowel
255635|NCT02072577|Nursing care, oral health, educational video, oral hygiene.|nursing care, oral health, educational video, oral hygiene.
255636|NCT02072538|Stress testing|stress testing
255637|NCT02072538|Troponin T|troponin t
255638|NCT02072538|GRACE score|grace score
255639|NCT02072538|Outcome|outcome
255640|NCT02072525|Pertussis|pertussis
255641|NCT02072525|Healthy adults|healthy adults
255642|NCT02072525|Tetanus|tetanus
255643|NCT02072525|Human serum samples|human serum samples
255644|NCT02072525|Streptococcus|streptococcus
255645|NCT02072525|Diphtheria|diphtheria
255646|NCT02072525|Plasma|plasma
255647|NCT02072525|Meningococcus|meningococcus
255648|NCT02072512|pre- and perimenopausal HR+ advanced breast cancer|pre- and perimenopausal hr+ advanced breast cancer
255649|NCT02072473|Re-entrant Atrioventricular Node Tachycardia|re-entrant atrioventricular node tachycardia
255650|NCT02072473|Unsuccessful right-sided slow pathway ablation|unsuccessful right-sided slow pathway ablation
255651|NCT02072473|Coronary sinus / left-sided slow pathway ablation|coronary sinus / left-sided slow pathway ablation
255652|NCT02072447|absolute bioavailability,|absolute bioavailability,
255653|NCT02072447|microdose,|microdose,
255654|NCT02072447|AMS|ams
255655|NCT02072434|Atrial fibrillation|atrial fibrillation
255656|NCT02072434|anti-coagulant|anti-coagulant
255657|NCT02072434|warfarin|warfarin
255658|NCT02072434|edoxaban|edoxaban
255659|NCT02072434|electrical cardioversion|electrical cardioversion
255660|NCT02072395|morbid obesity|morbid obesity
255661|NCT02072395|bariatric surgery|bariatric surgery
255662|NCT02072395|gastric banding|gastric banding
255663|NCT02072395|gastric plication|gastric plication
255664|NCT02072382|Hypertension|hypertension
255665|NCT02072382|Metformin|metformin
255666|NCT02072382|Ambulatory blood pressure monitor|ambulatory blood pressure monitor
255667|NCT02072369|stroke|stroke
255668|NCT02072369|hand|hand
255669|NCT02072369|fingers|fingers
255670|NCT02072369|rehabilitation|rehabilitation
255671|NCT02072369|training|training
255672|NCT02072356|Humanitarian Device|humanitarian device
255673|NCT02072356|Carcinoma|carcinoma
255674|NCT02072356|Hepatocellular Carcinoma|hepatocellular carcinoma
255675|NCT02072356|TheraSphere®|therasphere®
255676|NCT02072356|HUD|hud
255677|NCT02072343|Capnography|capnography
255678|NCT02072343|Catheters|catheters
255679|NCT02072343|Intubation|intubation
255680|NCT02072330|Hypertension, Drug therapy|hypertension, drug therapy
255681|NCT02072317|PFS|pfs
255682|NCT02072304|mood disorder|mood disorder
255683|NCT02072304|depressive disorder|depressive disorder
255684|NCT02072304|mental disorders|mental disorders
255685|NCT02072304|program acceptability|program acceptability
255686|NCT02072304|behavioral symptoms|behavioral symptoms
255687|NCT02072304|suicidal ideation|suicidal ideation
255688|NCT02072304|patient adherence|patient adherence
255689|NCT02072265|infrared thermal image|infrared thermal image
255690|NCT02072265|wound healing|wound healing
255691|NCT02072265|wound infection|wound infection
255692|NCT02072252|Depression|depression
255693|NCT02072252|Anxiety|anxiety
255694|NCT02072252|Mobile Phone|mobile phone
255695|NCT02072252|Cellular Phone|cellular phone
255696|NCT02072252|Mobile Application|mobile application
255697|NCT02072252|Mobile Intervention|mobile intervention
255698|NCT02072252|App|app
255699|NCT02072252|mHealth|mhealth
255700|NCT02072252|eHealth|ehealth
255701|NCT02072252|Technology Assisted|technology assisted
255702|NCT02072252|Internet|internet
255703|NCT02072252|Cognitive Behavioral Therapy|cognitive behavioral therapy
255704|NCT02072252|LGBT|lgbt
255705|NCT02072252|Sexual Minorities|sexual minorities
255706|NCT02072252|Gay|gay
255707|NCT02072252|Bisexual|bisexual
255708|NCT02072252|Same Sex Attraction|same sex attraction
255709|NCT02072252|Males|males
255710|NCT02072252|Men|men
255711|NCT02072252|Youth|youth
255713|NCT02072252|Young Adults|young adults
255714|NCT02072239|CABG|cabg
255715|NCT02072239|Intimal Hyperplasia|intimal hyperplasia
255716|NCT02072239|Atherosclerosis|atherosclerosis
255717|NCT02072239|Myocardial Infarction|myocardial infarction
255718|NCT02072213|Tamsulosin,controlled release formulation|tamsulosin,controlled release formulation
255719|NCT02072200|RA, MS, Safety, Efficacy, MR prednisone|ra, ms, safety, efficacy, mr prednisone
255720|NCT02072187|Depression|depression
255721|NCT02072187|Vitamin D|vitamin d
255722|NCT02072187|Complementary and Alternative Medicine|complementary and alternative medicine
255723|NCT02072187|Supplements|supplements
255724|NCT02072187|Non Remitted Depression|non remitted depression
255725|NCT02072161|Statin|statin
255726|NCT02072161|LDL|ldl
255727|NCT02072161|Cholesterol|cholesterol
255728|NCT02072148|Human Papilloma Virus|human papilloma virus
255729|NCT02072148|Oropharyngeal Squamous Cell Carcinoma|oropharyngeal squamous cell carcinoma
255730|NCT02072148|Transoral Robotic Surgery|transoral robotic surgery
255731|NCT02072122|dry eye|dry eye
255732|NCT02072122|fertility treatment|fertility treatment
255733|NCT02072122|Meibomian gland dysfunction|meibomian gland dysfunction
255734|NCT02072122|supra physiologic estrogen level|supra physiologic estrogen level
255735|NCT02072109|Near infrared spectroscopy|near infrared spectroscopy
255736|NCT02072109|Bolus nutrition|bolus nutrition
255737|NCT02072109|Continuous nutrition|continuous nutrition
255738|NCT02072109|Mesenteric circulation|mesenteric circulation
255739|NCT02072083|dexmedetomidine|dexmedetomidine
255740|NCT02072083|intranasal|intranasal
255741|NCT02072083|strabismus surgery|strabismus surgery
255742|NCT02072083|premedication|premedication
255743|NCT02072083|oculocardiac reflex|oculocardiac reflex
255744|NCT02072070|chondrocyte cells, Osteoarthritis, gene therapy|chondrocyte cells, osteoarthritis, gene therapy
255745|NCT02072044|Renal Cell Carcinoma（RCC）|renal cell carcinoma（rcc）
255746|NCT02072044|Anlotinib|anlotinib
255747|NCT02072031|Anlotinib|anlotinib
255748|NCT02072031|Sunitinib|sunitinib
255749|NCT02072031|Renal Cell Carcinoma（RCC）|renal cell carcinoma（rcc）
255750|NCT02072018|Peyronie's|peyronie's
255751|NCT02072018|Peyronie's disease|peyronie's disease
255752|NCT02072018|Treatment|treatment
255753|NCT02072018|Clinical Study|clinical study
255754|NCT02071979|Chronic|chronic
255755|NCT02071979|Non-healing|non-healing
255756|NCT02071979|Wounds|wounds
255757|NCT02071966|Micro-RNA, Microparticles, Ticagrelor, NSTE-ACS|micro-rna, microparticles, ticagrelor, nste-acs
255758|NCT02071940|Acral Melanoma subtypes|acral melanoma subtypes
255759|NCT02071940|Mucosal Melanoma subtypes|mucosal melanoma subtypes
255760|NCT02071927|leukemia|leukemia
255761|NCT02071927|glutaminase|glutaminase
255762|NCT02071927|glutamine|glutamine
255763|NCT02071888|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
255764|NCT02071888|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
255765|NCT02071888|Multiple myeloma|multiple myeloma
255766|NCT02071888|glutaminase|glutaminase
255767|NCT02071888|glutamine|glutamine
255768|NCT02071875|Vasospasm|vasospasm
255769|NCT02071875|Aneurysm|aneurysm
255771|NCT02071875|Nautilus NeuroWave|nautilus neurowave
255772|NCT02071862|Tumor metabolism|tumor metabolism
255773|NCT02071862|Glutaminase|glutaminase
255774|NCT02071862|Glutamine|glutamine
255775|NCT02071862|Tricarboxylic acid (TCA) cycle|tricarboxylic acid (tca) cycle
255776|NCT02071849|Aortic Insufficiency|aortic insufficiency
255777|NCT02071849|Aortic Regurgitation|aortic regurgitation
255778|NCT02071836|web application|web application
255779|NCT02071836|DWI intervention|dwi intervention
255780|NCT02071836|DUI intervention|dui intervention
255781|NCT02071836|Experimental group: Right Turns + treatment as usual|experimental group: right turns + treatment as usual
255782|NCT02071836|Control group: Treatment as usual|control group: treatment as usual
255783|NCT02071823|Opicapone,|opicapone,
255784|NCT02071823|Parkinson,|parkinson,
255785|NCT02071823|Bial,|bial,
255786|NCT02071823|BIA 9-1067|bia 9-1067
255787|NCT02071810|Parkinson's disease (PD)|parkinson's disease (pd)
255788|NCT02071810|Opicapone|opicapone
255789|NCT02071810|Bial|bial
255790|NCT02071810|BIA 9-1067|bia 9-1067
255791|NCT02071797|Therapeutic Hypothermia|therapeutic hypothermia
255792|NCT02071797|Cardiac Arrest|cardiac arrest
255793|NCT02071797|Randomised Controlled trial|randomised controlled trial
255794|NCT02071797|Pilot study|pilot study
255795|NCT02071771|DACP Toric|dacp toric
255796|NCT02071771|DAILIES® AquaComfort Plus®|dailies® aquacomfort plus®
255797|NCT02071771|Astigmatism|astigmatism
255798|NCT02071771|Toric|toric
255799|NCT02071758|Leishmaniasis|leishmaniasis
255800|NCT02071758|Visceral leishmaniasis|visceral leishmaniasis
255801|NCT02071758|Vaccine|vaccine
255802|NCT02071758|Adjuvant|adjuvant
255803|NCT02071758|GLA|gla
255804|NCT02071758|SLA|sla
255805|NCT02071693|subthalamic nucleus|subthalamic nucleus
255806|NCT02071693|deep brain stimulation|deep brain stimulation
255807|NCT02071693|cognition|cognition
255808|NCT02071693|white matter hyperintensities|white matter hyperintensities
255809|NCT02071680|atrial fibrillation|atrial fibrillation
255810|NCT02071680|atrial cardiac innervation|atrial cardiac innervation
255914|NCT02071160|HIE|hie
255811|NCT02071680|catheter ablation of atrial fibrillation|catheter ablation of atrial fibrillation
255812|NCT02071680|High Frequency Stimulation|high frequency stimulation
255813|NCT02071680|ganglionated plexuses|ganglionated plexuses
255814|NCT02071680|123I-mIBG|123i-mibg
255815|NCT02071680|nuclear imaging|nuclear imaging
255816|NCT02071667|Chronic sinusitis|chronic sinusitis
255817|NCT02071667|Nasal Polyps|nasal polyps
255818|NCT02071654|Venus P-valve|venus p-valve
255819|NCT02071615|Brain Activity|brain activity
255820|NCT02071602|Heart attack|heart attack
255821|NCT02071602|Myocardial Infarction|myocardial infarction
255822|NCT02071602|STEMI|stemi
255823|NCT02071576|Myopia|myopia
255824|NCT02071576|Hyperopia|hyperopia
255825|NCT02071576|Proscan|proscan
255826|NCT02071576|LASIK|lasik
255827|NCT02071576|TENEO|teneo
255828|NCT02071576|Excimer|excimer
255829|NCT02071550|laparoscopic cholecystectomy, near infrared spectroscopy, positive end expiratory pressure|laparoscopic cholecystectomy, near infrared spectroscopy, positive end expiratory pressure
255830|NCT02071498|Pillbox|pillbox
255831|NCT02071498|Non-adherence|non-adherence
255832|NCT02071498|Applications|applications
255833|NCT02071498|Patient safety|patient safety
255834|NCT02071498|Elderly|elderly
255835|NCT02071459|L-threo DOPS (DroxiDopa)|l-threo dops (droxidopa)
255836|NCT02071459|Orthostatic Hypotension|orthostatic hypotension
255837|NCT02071459|Multiple system atrophy|multiple system atrophy
255838|NCT02071446|Deep Brain Stimulation|deep brain stimulation
255839|NCT02071446|Local Field Potential|local field potential
255840|NCT02071446|Subthalamic Nucleus|subthalamic nucleus
255841|NCT02071433|Saphenous nerve block|saphenous nerve block
255842|NCT02071433|Adductor canal block|adductor canal block
255843|NCT02071433|Anterior cruciate ligament|anterior cruciate ligament
255844|NCT02071433|Pain management|pain management
255845|NCT02071433|Day care|day care
255846|NCT02071407|traumatic brain injury|traumatic brain injury
255847|NCT02071407|sedation|sedation
255848|NCT02071407|midazolam|midazolam
255849|NCT02071394|Xenon|xenon
255850|NCT02071394|Hypothermia|hypothermia
255851|NCT02071394|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
255852|NCT02071394|Newborn|newborn
255853|NCT02071394|Neonate|neonate
255854|NCT02071394|Term|term
255855|NCT02071394|Neuroprotection|neuroprotection
255856|NCT02071394|Cooling|cooling
255857|NCT02071394|HIE|hie
255858|NCT02071368|Healthy|healthy
255859|NCT02071368|Canagliflozin|canagliflozin
255860|NCT02071368|Metformin|metformin
255861|NCT02071368|JNJ-28431754|jnj-28431754
255862|NCT02071368|GLUMETZA®|glumetza®
255863|NCT02071368|Bioequivalence|bioequivalence
255864|NCT02071368|Fixed Dose Combination|fixed dose combination
255865|NCT02071355|Healthy|healthy
255866|NCT02071355|Chinese participants|chinese participants
255867|NCT02071355|TMC435|tmc435
255868|NCT02071355|Multiple oral doses|multiple oral doses
255869|NCT02071355|Pharmacokinetics|pharmacokinetics
255870|NCT02071355|Safety|safety
255871|NCT02071355|Tolerability|tolerability
255872|NCT02071342|acute myocardial infarction|acute myocardial infarction
255873|NCT02071342|bioresorbable vascular scaffold|bioresorbable vascular scaffold
255874|NCT02071342|percutaneous coronary intervention|percutaneous coronary intervention
255875|NCT02071329|FP-01.1|fp-01.1
255876|NCT02071329|Influenza A|influenza a
255878|NCT02071329|Vaccine|vaccine
255879|NCT02071329|Virus|virus
255880|NCT02071329|H1N1|h1n1
255881|NCT02071329|Challenge|challenge
255882|NCT02071316|upper gastrointestinal bleeding|upper gastrointestinal bleeding
255883|NCT02071316|Hexacapron|hexacapron
255884|NCT02071316|hemostasis|hemostasis
255885|NCT02071303|Pain|pain
255886|NCT02071303|Hysteroscopy|hysteroscopy
255887|NCT02071303|Tramadol|tramadol
255888|NCT02071303|Celecoxib|celecoxib
255889|NCT02071290|Hemorrhagic Shock|hemorrhagic shock
255890|NCT02071290|Remote Ischemic Conditioning|remote ischemic conditioning
255891|NCT02071277|Mechanical ventilation|mechanical ventilation
255892|NCT02071277|Airway pressure release ventilation|airway pressure release ventilation
255893|NCT02071277|Biphasic intermittent positive airway pressure|biphasic intermittent positive airway pressure
255894|NCT02071277|Pressure-controlled ventilation|pressure-controlled ventilation
255895|NCT02071277|Lung protective ventilation|lung protective ventilation
255896|NCT02071277|Spontaneous breathing|spontaneous breathing
255897|NCT02071264|HIV/AIDS|hiv/aids
255898|NCT02071264|sex work|sex work
255899|NCT02071264|reproductive health|reproductive health
255900|NCT02071264|human rights|human rights
255901|NCT02071264|ethics|ethics
255902|NCT02071251|Wound complications|wound complications
255903|NCT02071251|Wound infection|wound infection
255904|NCT02071251|Wound separation|wound separation
255905|NCT02071238|Carpal tunnel|carpal tunnel
255906|NCT02071238|Carpal tunnel release|carpal tunnel release
255907|NCT02071238|Risk Recall|risk recall
255908|NCT02071238|Patient satisfaction|patient satisfaction
255909|NCT02071238|Pamphlet|pamphlet
255910|NCT02071238|Brochure|brochure
255911|NCT02071199|Gingivitis|gingivitis
255912|NCT02071199|Periodontitis|periodontitis
255913|NCT02071199|ACCS|accs
255915|NCT02071160|hypothermia|hypothermia
255916|NCT02071160|encephalopathy|encephalopathy
255917|NCT02071160|anti oxidants|anti oxidants
255918|NCT02071160|MRI|mri
255919|NCT02071147|Follow-up|follow-up
255920|NCT02071147|No follow-up|no follow-up
255921|NCT02071147|removal|removal
255922|NCT02071147|Randomised Controlled Trial|randomised controlled trial
255923|NCT02071147|6 Weeks|6 weeks
255924|NCT02071134|Deep brain stimulation|deep brain stimulation
255925|NCT02071134|Parkinson's disease|parkinson's disease
255926|NCT02071134|Vercise|vercise
255927|NCT02071121|BIIB061|biib061
255928|NCT02071121|Healthy|healthy
255929|NCT02071095|Human immunodeficiency virus 1|human immunodeficiency virus 1
255930|NCT02071095|Combined Antiretroviral Therapy|combined antiretroviral therapy
255931|NCT02071095|Poly-ICLC|poly-iclc
255932|NCT02071095|Adjuvant|adjuvant
255933|NCT02071082|HIV|hiv
255934|NCT02071082|HBV|hbv
255935|NCT02071082|Coinfection|coinfection
255936|NCT02071069|Incurable colorectal cancer|incurable colorectal cancer
255937|NCT02071069|maintenance therapy|maintenance therapy
255938|NCT02071069|Cetuximab|cetuximab
255939|NCT02071043|neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
255940|NCT02071043|advanced gastric cancer patients|advanced gastric cancer patients
255941|NCT02071043|para-aortic lymph node metastasis|para-aortic lymph node metastasis
255942|NCT02071030|CBCT|cbct
255943|NCT02071030|Third molar removal|third molar removal
255944|NCT02071030|Inferior alveolar nerve injury|inferior alveolar nerve injury
255945|NCT02071004|acute ischemic stroke|acute ischemic stroke
255946|NCT02070991|pre- and post-capillary pulmonary hypertension|pre- and post-capillary pulmonary hypertension
255947|NCT02070991|CpcPH|cpcph
255948|NCT02070978|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
255949|NCT02070978|Atacicept 75 and 150 mg|atacicept 75 and 150 mg
255950|NCT02070978|LTE|lte
255951|NCT02070952|CyberKnife|cyberknife
255952|NCT02070952|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
255953|NCT02070952|Low and Intermediate Risk Prostate Cancer|low and intermediate risk prostate cancer
255954|NCT02070939|Phase 1|phase 1
255955|NCT02070939|Randomized|randomized
255956|NCT02070939|Double Blind|double blind
255957|NCT02070939|Placebo-Controlled|placebo-controlled
255958|NCT02070939|Single and Multiple Dose Escalation|single and multiple dose escalation
255959|NCT02070939|Safety Tolerability|safety tolerability
255960|NCT02070939|PK|pk
255961|NCT02070939|PD|pd
255962|NCT02070939|PF-06460414|pf-06460414
255963|NCT02070913|Hypothermia|hypothermia
255964|NCT02070913|Acute Myocardial Infarction|acute myocardial infarction
255965|NCT02070913|Percutaneous Coronary Intervention|percutaneous coronary intervention
255966|NCT02070913|AMI|ami
255967|NCT02070913|PCI|pci
255968|NCT02070913|Therapeutic Hypothermia|therapeutic hypothermia
255969|NCT02070900|Prevention of Mother to Child Transmission|prevention of mother to child transmission
255970|NCT02070900|PMTCT|pmtct
255971|NCT02070900|Option B+|option b+
255972|NCT02070900|ART|art
255973|NCT02070900|Retention|retention
255974|NCT02070900|Loss to Follow Up|loss to follow up
255975|NCT02070900|Time to initiation|time to initiation
255976|NCT02070900|POC CD4|poc cd4
255977|NCT02070900|Clinical mentoring|clinical mentoring
255978|NCT02070900|Costing|costing
255979|NCT02070900|HIV|hiv
255980|NCT02070900|AIDS|aids
255981|NCT02070900|Zimbabwe|zimbabwe
255982|NCT02070874|pain and symptom management|pain and symptom management
255983|NCT02070861|Cardiac output|cardiac output
255984|NCT02070861|Exhaled CO2|exhaled co2
255985|NCT02070861|Nexfin|nexfin
255986|NCT02070861|Esophageal Doppler|esophageal doppler
255987|NCT02070848|red blood cell|red blood cell
255988|NCT02070848|knee extension exercise|knee extension exercise
255989|NCT02070835|Diabetic Foot Ulcer|diabetic foot ulcer
255990|NCT02070835|ReCell|recell
255991|NCT02070822|Hepatocellular carcinoma|hepatocellular carcinoma
255992|NCT02070822|Transarterial chemoembolization|transarterial chemoembolization
255993|NCT02070822|Magnetic resonance imaging|magnetic resonance imaging
255995|NCT02070809|tissue-engineered skin|tissue-engineered skin
255996|NCT02070796|Rotigotine|rotigotine
255997|NCT02070796|Transdermal Patch|transdermal patch
255998|NCT02070796|Bioequivalence|bioequivalence
255999|NCT02070783|depression|depression
256000|NCT02070783|cognition|cognition
256001|NCT02070783|emotion perception|emotion perception
256002|NCT02070783|information processing|information processing
256003|NCT02070757|Ventilator-associated bacterial pneumonia|ventilator-associated bacterial pneumonia
256004|NCT02070757|Hospital-acquired bacterial pneumonia|hospital-acquired bacterial pneumonia
256005|NCT02070757|Pneumonia|pneumonia
256006|NCT02070757|Lung Diseases|lung diseases
256007|NCT02070757|Respiratory Tract Diseases|respiratory tract diseases
256008|NCT02070757|Respiratory Tract Infections|respiratory tract infections
256009|NCT02070757|Infection|infection
256010|NCT02070757|Ventilator-Induced Lung Injury|ventilator-induced lung injury
256011|NCT02070757|Lung Injury|lung injury
256012|NCT02070744|CF|cf
256013|NCT02070731|TAVR|tavr
256014|NCT02070731|TAVI|tavi
256015|NCT02070731|Aortic Valve Stenosis|aortic valve stenosis
256016|NCT02070718|hot flashes|hot flashes
256017|NCT02070718|menopause|menopause
256018|NCT02070718|kappa agonist|kappa agonist
256019|NCT02070692|Contraceptive implant|contraceptive implant
256020|NCT02070692|Irregular vaginal bleeding|irregular vaginal bleeding
256021|NCT02070692|Etonogestrel implant|etonogestrel implant
256022|NCT02070679|Alpha-tocopherol|alpha-tocopherol
256023|NCT02070679|Vitamin E|vitamin e
256024|NCT02070679|Contrast-Induced Acute Kidney Injury|contrast-induced acute kidney injury
256025|NCT02070679|Coronary angiography|coronary angiography
256026|NCT02070666|ARDS|ards
256027|NCT02070666|Prevention|prevention
256028|NCT02070666|Protective mechanical ventilation|protective mechanical ventilation
256029|NCT02070666|low tidal volumes|low tidal volumes
256030|NCT02070653|Aorta|aorta
256031|NCT02070653|Aneurysm|aneurysm
256032|NCT02070653|Antiplatelet|antiplatelet
256033|NCT02070640|cholecystectomy|cholecystectomy
256034|NCT02070640|cholecystitis|cholecystitis
256035|NCT02070627|acute cholecystitis|acute cholecystitis
256036|NCT02070627|acute cholangitis|acute cholangitis
256037|NCT02070627|cholecystectomy|cholecystectomy
256038|NCT02070614|sufentanil|sufentanil
256039|NCT02070614|metabolism|metabolism
256040|NCT02070614|cytochrome P450 3A4|cytochrome p450 3a4
256041|NCT02070614|gene polymorphism|gene polymorphism
256042|NCT02070588|TBI|tbi
256043|NCT02070588|mTBI|mtbi
256044|NCT02070588|MR|mr
256045|NCT02070588|MRI|mri
256046|NCT02070588|Pulse Sequences|pulse sequences
256047|NCT02070588|NFL|nfl
256048|NCT02070575|PSA|psa
256049|NCT02070575|Human Kallikrein 2|human kallikrein 2
256050|NCT02070575|locally resected prostate cancer|locally resected prostate cancer
256051|NCT02070575|biochemical recurrence|biochemical recurrence
256052|NCT02070575|14-041|14-041
256053|NCT02070562|breast milk, dietary survey|breast milk, dietary survey
256054|NCT02070536|Acute Respiratory Distress Syndrome (ARDS)|acute respiratory distress syndrome (ards)
256055|NCT02070536|Receptor for advanced glycation end products (RAGE)|receptor for advanced glycation end products (rage)
256056|NCT02070536|Soluble RAGE (sRAGE)|soluble rage (srage)
256057|NCT02070536|Gene polymorphisms|gene polymorphisms
256058|NCT02070536|Biomarker|biomarker
256059|NCT02070484|NuCel|nucel
256060|NCT02070484|Lumbar Spine|lumbar spine
256061|NCT02070484|Degenerative Disease|degenerative disease
256062|NCT02070484|Efficacy|efficacy
256063|NCT02070484|Fusion|fusion
256064|NCT02070445|CABG|cabg
256065|NCT02070445|pilot|pilot
256066|NCT02070445|ultrasound|ultrasound
256067|NCT02070445|perioperative|perioperative
256068|NCT02070445|low tidal volume ventilation|low tidal volume ventilation
256069|NCT02070432|LUZ11|luz11
256070|NCT02070432|head and neck cancer|head and neck cancer
256071|NCT02070432|photodynamic therapy|photodynamic therapy
256072|NCT02070432|Redaporfin|redaporfin
256073|NCT02070393|Hodgkins Disease in Young Females|hodgkins disease in young females
256074|NCT02070393|Breast Sparing Radiation Treatments|breast sparing radiation treatments
256075|NCT02070380|confirmed brain disease|confirmed brain disease
256076|NCT02070380|highly suspected brain disease|highly suspected brain disease
256077|NCT02070367|allodynia|allodynia
256078|NCT02070367|complex regional pain syndrome|complex regional pain syndrome
256079|NCT02070367|peripheral nerve injuries|peripheral nerve injuries
256080|NCT02070367|clinical measurement properties|clinical measurement properties
256081|NCT02070354|Obesity|obesity
256082|NCT02070354|Bariatric surgery|bariatric surgery
256083|NCT02070354|Physical Activity|physical activity
256084|NCT02070354|Nutrition|nutrition
256085|NCT02070354|Weight Loss|weight loss
256086|NCT02070341|patient tolerability|patient tolerability
256087|NCT02070341|quality|quality
256088|NCT02070328|Proton Therapy|proton therapy
256089|NCT02070328|Registry|registry
256090|NCT02070315|heart failure|heart failure
256091|NCT02070315|liver failure|liver failure
256092|NCT02070315|post liver transplant|post liver transplant
256093|NCT02070289|Multiple dose|multiple dose
256094|NCT02070289|safety|safety
256095|NCT02070289|tolerability|tolerability
256096|NCT02070289|PK|pk
256097|NCT02070276|Spinal anesthesia|spinal anesthesia
256098|NCT02070276|Systemic hypotension|systemic hypotension
256099|NCT02070276|Total fluid amount|total fluid amount
256100|NCT02070276|Non-invasive fluid responsiveness|non-invasive fluid responsiveness
256101|NCT02070276|Passive Leg Raising Test|passive leg raising test
256102|NCT02070263|Food allergy|food allergy
256103|NCT02070263|Tree nuts|tree nuts
256104|NCT02070250|Stress management|stress management
256105|NCT02070250|Coping skills|coping skills
256106|NCT02070250|Recently diagnosed cancer patients|recently diagnosed cancer patients
256107|NCT02070250|Intervention, Psychological|intervention, psychological
256108|NCT02070237|Obesity|obesity
256109|NCT02070237|Obesity, Morbid|obesity, morbid
256110|NCT02070237|Pregnancy|pregnancy
256111|NCT02070237|Cesarean|cesarean
256112|NCT02070237|Venous thromboembolism|venous thromboembolism
256113|NCT02070237|Deep venous thrombosis|deep venous thrombosis
256114|NCT02070237|Pulmonary embolism|pulmonary embolism
256115|NCT02070211|Psychotic Disorder|psychotic disorder
256116|NCT02070211|22q11 Deletion Syndrome|22q11 deletion syndrome
256117|NCT02070211|Fatty Acids, Omega-3|fatty acids, omega-3
256118|NCT02070198|Poor responders, IVF, GnRH agonist, GnRH antagonist, recombinant FSH|poor responders, ivf, gnrh agonist, gnrh antagonist, recombinant fsh
256119|NCT02070185|caloric adjustment,liking, flavour nutrient learning, children|caloric adjustment,liking, flavour nutrient learning, children
256120|NCT02070172|headache diagnosis|headache diagnosis
256121|NCT02070172|flexion rotation test|flexion rotation test
256122|NCT02070172|range of motion|range of motion
256123|NCT02070172|upper cervical|upper cervical
256124|NCT02070159|coronary artery disease|coronary artery disease
256125|NCT02070159|prasugrel|prasugrel
256126|NCT02070159|platelet function tests|platelet function tests
256127|NCT02070133|Chronic Bronchitis|chronic bronchitis
256128|NCT02070133|Statins|statins
256129|NCT02070133|Endothelial dysfunction|endothelial dysfunction
256130|NCT02070133|Systemic inflammation|systemic inflammation
256131|NCT02070133|BODE index|bode index
256132|NCT02070133|Uric acid|uric acid
256133|NCT02070133|Vascular growth factors|vascular growth factors
256134|NCT02070120|Nonmuscle invasive bladder cancer (NMIBC)|nonmuscle invasive bladder cancer (nmibc)
256135|NCT02070120|Mitomycin C|mitomycin c
256136|NCT02070120|Chemoresection|chemoresection
256137|NCT02070081|Obesity|obesity
256138|NCT02070081|Bariatric surgery|bariatric surgery
256139|NCT02070055|Maximal Rate of Fat Oxidation|maximal rate of fat oxidation
256140|NCT02070055|Substrate Oxidation|substrate oxidation
256141|NCT02070055|Fat oxidation|fat oxidation
256142|NCT02070055|Respiratory Exchange Ratio (RER)|respiratory exchange ratio (rer)
256143|NCT02070055|Exercise|exercise
256144|NCT02070055|indirect calorimetry|indirect calorimetry
256145|NCT02070055|substrate crossover|substrate crossover
256146|NCT02070042|Overactive Bladder|overactive bladder
256147|NCT02070042|Oxybutynin|oxybutynin
256148|NCT02070042|Omega -3 Fatty Acid|omega -3 fatty acid
256149|NCT02070029|Female Sexual Dysfunction (FSD)|female sexual dysfunction (fsd)
256150|NCT02070029|Hypoactive Sexual Desire Disorder (HSDD)|hypoactive sexual desire disorder (hsdd)
256151|NCT02070029|Low libido|low libido
256152|NCT02070029|Acupuncture|acupuncture
256153|NCT02069977|Autism|autism
256154|NCT02069977|Aripiprazole|aripiprazole
256155|NCT02069977|Abilify|abilify
256156|NCT02069951|Laparoscopy|laparoscopy
256157|NCT02069951|Training|training
256158|NCT02069951|Simulator|simulator
256159|NCT02069938|Subjects|subjects
256160|NCT02069912|Major Depression|major depression
256161|NCT02069912|Heart Disease|heart disease
256162|NCT02069912|Hispanics|hispanics
256163|NCT02069912|Collaborative Depression Care Management|collaborative depression care management
256164|NCT02069899|Hemophagocytic lymphohistiocytosis (HLH) previously treated with NI-0501|hemophagocytic lymphohistiocytosis (hlh) previously treated with ni-0501
256165|NCT02069899|Emapalumab|emapalumab
256166|NCT02069886|Endocrine complications|endocrine complications
256167|NCT02069886|transfusion dependent thalassemia|transfusion dependent thalassemia
256168|NCT02069873|Post Traumatic Stress Disorder|post traumatic stress disorder
256169|NCT02069873|Group|group
256170|NCT02069873|Treatment|treatment
256171|NCT02069873|Cognitive, Exposure, Skills|cognitive, exposure, skills
256172|NCT02069873|Women|women
256173|NCT02069873|Veterans|veterans
256174|NCT02069860|bona anchored|bona anchored
256175|NCT02069860|haemodialysis|haemodialysis
256176|NCT02069860|Mastoid bone|mastoid bone
256177|NCT02069860|nephrology|nephrology
256178|NCT02069860|retroauricular anchored devices|retroauricular anchored devices
256179|NCT02069860|permanent central venous access devices.|permanent central venous access devices.
256180|NCT02069847|Esophageal stricture formation|esophageal stricture formation
256181|NCT02069847|Endoscopic mucosal resection|endoscopic mucosal resection
256182|NCT02069847|Endoscopic submucosal dissection|endoscopic submucosal dissection
256183|NCT02069847|Budesonide|budesonide
256184|NCT02069847|Radical endoscopic mucosal resection|radical endoscopic mucosal resection
256185|NCT02069847|EMR|emr
256186|NCT02069847|ESD|esd
256187|NCT02069834|Dolutegravir|dolutegravir
256188|NCT02069834|Rilpivirine|rilpivirine
256189|NCT02069834|PI- and NRTI- sparing ART regimen|pi- and nrti- sparing art regimen
256190|NCT02069834|switch study|switch study
256191|NCT02069795|concussion, athlete, speech analysis|concussion, athlete, speech analysis
256192|NCT02069782|Pregnancy|pregnancy
256193|NCT02069782|postpartum programs|postpartum programs
256194|NCT02069782|infant health services|infant health services
256195|NCT02069769|Hospice Care|hospice care
256196|NCT02069769|Head and Neck cancer|head and neck cancer
256197|NCT02069769|Gynecological Oncology|gynecological oncology
256198|NCT02069769|Sarcoma|sarcoma
256199|NCT02069769|Melanoma|melanoma
256200|NCT02069756|Duchenne|duchenne
256201|NCT02069756|Becker|becker
256202|NCT02069756|Muscular Dystrophy|muscular dystrophy
256203|NCT02069743|cancer pain|cancer pain
256204|NCT02069730|molecular profiling|molecular profiling
256205|NCT02069730|selinexor|selinexor
256206|NCT02069730|tumor tissue|tumor tissue
256207|NCT02069704|colorectal cancer|colorectal cancer
256208|NCT02069704|metastatic|metastatic
256209|NCT02069704|first-line treatment|first-line treatment
256210|NCT02069704|comparability|comparability
256211|NCT02069691|stroke,|stroke,
256212|NCT02069691|rehabilitation,|rehabilitation,
256213|NCT02069691|leg cycling,|leg cycling,
256214|NCT02069691|feedback,|feedback,
256215|NCT02069691|virtual reality|virtual reality
256216|NCT02069665|pneumonia|pneumonia
256217|NCT02069665|pediatrics|pediatrics
256218|NCT02069665|viral|viral
256219|NCT02069613|Mild traumatic injury to extremity (for controls)|mild traumatic injury to extremity (for controls)
256220|NCT02069613|mTBI|mtbi
256221|NCT02069613|concussion|concussion
256222|NCT02069613|MEG|meg
256223|NCT02069613|EEG|eeg
256224|NCT02069613|Blood|blood
256225|NCT02069613|MRI|mri
256226|NCT02069613|DTI|dti
256227|NCT02069613|biomarkers|biomarkers
256228|NCT02069600|Elderly|elderly
256229|NCT02069600|CPAP|cpap
256230|NCT02069600|clinical trial|clinical trial
256231|NCT02069600|obstructive sleep apnea|obstructive sleep apnea
256232|NCT02069587|PPROM|pprom
256233|NCT02069587|PREGNANCY|pregnancy
256234|NCT02069587|POMEGRANATE|pomegranate
256235|NCT02069587|OXIDATIVE STRESS|oxidative stress
256236|NCT02069535|Cupressus arizonica|cupressus arizonica
256237|NCT02069509|Friedreich's Ataxia|friedreich's ataxia
256238|NCT02069509|EFACTS|efacts
256239|NCT02069509|FRDA|frda
256240|NCT02069483|smoking|smoking
256241|NCT02069483|smoker|smoker
256242|NCT02069483|text|text
256243|NCT02069483|smartphone|smartphone
256244|NCT02069483|motivation|motivation
256245|NCT02069483|quitting|quitting
256246|NCT02069483|cessation|cessation
256247|NCT02069483|feedback|feedback
256248|NCT02069483|messages|messages
256249|NCT02069470|Stepped wedged design|stepped wedged design
256250|NCT02069470|Early cancer diagnosis|early cancer diagnosis
256251|NCT02069470|Continuing medical education|continuing medical education
256252|NCT02069431|inflammation|inflammation
256253|NCT02069431|physical function|physical function
256254|NCT02069431|cognitive function|cognitive function
256255|NCT02069392|schizophrenia|schizophrenia
256256|NCT02069392|cognition|cognition
256257|NCT02069392|cognitive remediation|cognitive remediation
256258|NCT02069392|nicotine|nicotine
256259|NCT02069379|Metabolic syndrome|metabolic syndrome
256260|NCT02069379|Insulin resistance|insulin resistance
256261|NCT02069379|Mu-opioid system|mu-opioid system
256262|NCT02069379|Depression|depression
256263|NCT02069379|Emotion regulation|emotion regulation
256264|NCT02069366|Post-Traumatic Stress Disorders|post-traumatic stress disorders
256265|NCT02069366|Dronabinol|dronabinol
256266|NCT02069366|Extinction|extinction
256267|NCT02069366|fMRI|fmri
256268|NCT02069353|Cardiac arrest|cardiac arrest
256269|NCT02069353|Neurological injury|neurological injury
256270|NCT02069353|Seizures|seizures
256271|NCT02069353|Spreading depolarizations|spreading depolarizations
256272|NCT02069353|Cerebral hypoperfusion|cerebral hypoperfusion
256273|NCT02069353|Brain tissue hypoxia|brain tissue hypoxia
256274|NCT02069327|Femur|femur
256275|NCT02069327|Fat|fat
256276|NCT02069327|Emboli|emboli
256277|NCT02069327|Bone|bone
256278|NCT02069327|Marrow|marrow
256279|NCT02069327|proteomic|proteomic
256280|NCT02069327|proteomics|proteomics
256281|NCT02069327|metabolomics|metabolomics
256282|NCT02069327|metabolomic|metabolomic
256283|NCT02069327|inflammatory|inflammatory
256284|NCT02069327|cytokine|cytokine
256285|NCT02069327|chemokine|chemokine
256286|NCT02069327|anaphlylatoxin|anaphlylatoxin
256287|NCT02069327|Thromboelastography|thromboelastography
256288|NCT02069327|Medical Center of the Rockies|medical center of the rockies
256289|NCT02069327|Fat Embolism Syndrome|fat embolism syndrome
256290|NCT02069327|Injury|injury
256291|NCT02069327|Fracture|fracture
256292|NCT02069327|Metabolite|metabolite
256293|NCT02069327|MCR|mcr
256294|NCT02069327|TEG|teg
256295|NCT02069327|FES|fes
256296|NCT02069301|Behavior Activation|behavior activation
256297|NCT02069301|Problem solving therapy|problem solving therapy
256298|NCT02069301|Depression Treatment|depression treatment
256299|NCT02069301|depression care integration|depression care integration
256300|NCT02069301|microfinance|microfinance
256301|NCT02069301|livelihood|livelihood
256302|NCT02069288|fludrocortisone|fludrocortisone
256303|NCT02069288|pharmacology|pharmacology
256304|NCT02069288|septic shock|septic shock
256305|NCT02069275|Immediate mobilization|immediate mobilization
256306|NCT02069275|Bedrest|bedrest
256307|NCT02069275|Coronary angiography|coronary angiography
256308|NCT02069275|Coronary percutaneous intervention|coronary percutaneous intervention
256309|NCT02069275|Vascular access complications|vascular access complications
256310|NCT02069275|Patients comfort|patients comfort
256311|NCT02069262|obscure gastrointestinal bleeding|obscure gastrointestinal bleeding
256312|NCT02069262|laparoscopy|laparoscopy
256313|NCT02069262|angiography|angiography
256314|NCT02069249|Preschool children|preschool children
256315|NCT02069249|Sleep problems|sleep problems
256316|NCT02069249|Nutrition problems|nutrition problems
256317|NCT02069249|Online intervention|online intervention
256318|NCT02069249|Psychological functioning|psychological functioning
256613|NCT02067897|Children|children
256319|NCT02069236|Glucose-6 phosphate dehydrogenase deficiency|glucose-6 phosphate dehydrogenase deficiency
256320|NCT02069236|capillary|capillary
256321|NCT02069236|venous|venous
256322|NCT02069236|genotype phenotype correlation|genotype phenotype correlation
256323|NCT02069223|Biliopancreatic Diversion with Duodenal Switch|biliopancreatic diversion with duodenal switch
256324|NCT02069223|Gastrectomy|gastrectomy
256325|NCT02069197|ketogenic diet|ketogenic diet
256326|NCT02069197|obesity|obesity
256327|NCT02069197|diabetes|diabetes
256328|NCT02069197|obstructive sleep apnea|obstructive sleep apnea
256329|NCT02069184|opioid usage requirements|opioid usage requirements
256330|NCT02069184|pain|pain
256331|NCT02069184|IV acetaminophen|iv acetaminophen
256332|NCT02069184|opioid usage|opioid usage
256333|NCT02069184|c-section|c-section
256334|NCT02069171|Lower extremity edema|lower extremity edema
256335|NCT02069171|Lower leg lymphedema|lower leg lymphedema
256336|NCT02069171|Lower leg edema|lower leg edema
256337|NCT02069171|Lymphedema|lymphedema
256338|NCT02069171|Pelvic lymph node dissection|pelvic lymph node dissection
256339|NCT02069171|Gynecologic Cancer Lymphedema Questionnaire|gynecologic cancer lymphedema questionnaire
256340|NCT02069158|Advanced solid tumor|advanced solid tumor
256341|NCT02069145|Hepatocellular Cancer|hepatocellular cancer
256342|NCT02069145|Liver Cancer|liver cancer
256343|NCT02069132|Warfarin|warfarin
256344|NCT02069132|International Warfarin Pharmacogenetics Consortium algorithm|international warfarin pharmacogenetics consortium algorithm
256345|NCT02069132|Atrial Fibrillation|atrial fibrillation
256346|NCT02069132|Heart Valve Prosthesis Implantation|heart valve prosthesis implantation
256347|NCT02069132|elderly|elderly
256348|NCT02069132|comorbidity|comorbidity
256349|NCT02069106|low density lipoprotein cholesterol|low density lipoprotein cholesterol
256350|NCT02069106|triglycerides|triglycerides
256351|NCT02069106|mixed hyperlipoproteinemia|mixed hyperlipoproteinemia
256352|NCT02069106|Dehydroascorbic Acid|dehydroascorbic acid
256353|NCT02069106|Eicosapentaenoic Acid|eicosapentaenoic acid
256354|NCT02069106|Fish oil|fish oil
256355|NCT02069080|Positron Emission Tomograhy|positron emission tomograhy
256356|NCT02069080|Metastasis|metastasis
256357|NCT02069067|breakthrough cancer pain|breakthrough cancer pain
256358|NCT02069067|pain|pain
256359|NCT02069067|neuropathic pain|neuropathic pain
256360|NCT02069067|intractable pain|intractable pain
256361|NCT02069067|cancer|cancer
256362|NCT02069054|asthma|asthma
256363|NCT02069054|COPD|copd
256364|NCT02069054|airway inflammation|airway inflammation
256365|NCT02069054|remodeling|remodeling
256366|NCT02069054|cytokines|cytokines
256367|NCT02069054|airway wall thickness|airway wall thickness
256368|NCT02069028|surviving sepsis campaign|surviving sepsis campaign
256369|NCT02069028|sepsis|sepsis
256370|NCT02069028|septic|septic
256371|NCT02069028|septicemia|septicemia
256372|NCT02069028|mortality|mortality
256373|NCT02069028|compliance|compliance
256374|NCT02069015|Patient education|patient education
256375|NCT02069015|Hypertension|hypertension
256376|NCT02069015|Patient activation|patient activation
256377|NCT02069002|Indoor Air|indoor air
256378|NCT02069002|Medically unexplained symptoms|medically unexplained symptoms
256379|NCT02069002|Randomized controlled trial|randomized controlled trial
256380|NCT02069002|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
256381|NCT02069002|Applied relaxation|applied relaxation
256382|NCT02068950|Head and neck cancer|head and neck cancer
256383|NCT02068950|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
256384|NCT02068950|Progressive resistance training|progressive resistance training
256385|NCT02068950|Exercise|exercise
256386|NCT02068950|Feasibility|feasibility
256387|NCT02068950|Weight loss|weight loss
256388|NCT02068950|LBM|lbm
256389|NCT02068950|Body composition|body composition
256390|NCT02068937|Heart Failure|heart failure
256391|NCT02068937|Therapy|therapy
256392|NCT02068937|Diuretics|diuretics
256393|NCT02068937|Algorithms|algorithms
256394|NCT02068924|Slow freezing|slow freezing
256395|NCT02068924|Vitrification|vitrification
256396|NCT02068924|Single embryo transfer|single embryo transfer
256397|NCT02068911|Neuromuscular disease|neuromuscular disease
256398|NCT02068911|Home ventilation|home ventilation
256399|NCT02068911|End tidal CO2|end tidal co2
256400|NCT02068911|Transcutaneous CO2|transcutaneous co2
256401|NCT02068911|Monitoring|monitoring
256402|NCT02068885|Low carbohydrate diet|low carbohydrate diet
256403|NCT02068885|Low fat diet|low fat diet
256404|NCT02068885|Glycemic index|glycemic index
256405|NCT02068885|Weight loss maintenance|weight loss maintenance
256406|NCT02068872|Obesity|obesity
256407|NCT02068872|Transplant|transplant
256408|NCT02068872|Sleeve Gastrectomy|sleeve gastrectomy
256409|NCT02068872|Liver Transplantation|liver transplantation
256410|NCT02068872|Weight Loss|weight loss
256411|NCT02068846|HIV|hiv
256412|NCT02068846|Salivary Gland Disease|salivary gland disease
256413|NCT02068846|Benign Lymphoepithelial Lesion|benign lymphoepithelial lesion
256414|NCT02068846|BK Polyomavirus|bk polyomavirus
256415|NCT02068833|Microalbuminuria|microalbuminuria
256416|NCT02068833|Gastrectomy|gastrectomy
256904|NCT02066441|Vitamin D|vitamin d
256417|NCT02068833|Biliopancreatic Diversion With Duodenal Switch|biliopancreatic diversion with duodenal switch
256418|NCT02068820|Sentinel lymph nodes|sentinel lymph nodes
256419|NCT02068820|da Vinci|da vinci
256420|NCT02068820|Firefly|firefly
256421|NCT02068820|Sentinel lymph node mapping|sentinel lymph node mapping
256422|NCT02068820|Fluorescence Imaging|fluorescence imaging
256423|NCT02068820|SLN|sln
256424|NCT02068820|SLN mapping|sln mapping
256425|NCT02068768|fusion|fusion
256426|NCT02068768|lateral interbody fusion system|lateral interbody fusion system
256427|NCT02068768|lumbar spine|lumbar spine
256428|NCT02068768|degenerative disc disease|degenerative disc disease
256429|NCT02068755|anemia|anemia
256430|NCT02068755|renal impairment|renal impairment
256431|NCT02068755|thrombocytopenia|thrombocytopenia
256432|NCT02068755|anticoagulation|anticoagulation
256433|NCT02068755|Coronary bypass|coronary bypass
256434|NCT02068755|Aortic valve surgery|aortic valve surgery
256435|NCT02068755|Mitral valve surgery|mitral valve surgery
256436|NCT02068755|red blood cell|red blood cell
256437|NCT02068755|platelet|platelet
256438|NCT02068755|fresh frozen plasma|fresh frozen plasma
256439|NCT02068755|octaplas|octaplas
256440|NCT02068742|post-operative cognitive dysfunction|post-operative cognitive dysfunction
256441|NCT02068742|elderly|elderly
256442|NCT02068742|Mini Mental State Examination|mini mental state examination
256443|NCT02068742|Geriatric Index of Comorbidity|geriatric index of comorbidity
256444|NCT02068742|Geriatric Depression Scale|geriatric depression scale
256445|NCT02068742|Trail Making Test B-A|trail making test b-a
256446|NCT02068742|Digit Span|digit span
256447|NCT02068742|Digit Symbol Substitution Test|digit symbol substitution test
256448|NCT02068729|degenerative disc disease|degenerative disc disease
256449|NCT02068729|DDD|ddd
256450|NCT02068729|Grade 1 spondylolisthesis|grade 1 spondylolisthesis
256451|NCT02068729|spondylolisthesis|spondylolisthesis
256452|NCT02068729|L2-S1|l2-s1
256453|NCT02068716|Healthcare acquired infections|healthcare acquired infections
256454|NCT02068716|Cardiovascular Surgery|cardiovascular surgery
256455|NCT02068716|Mediastinitis|mediastinitis
256456|NCT02068716|Thoracotomy|thoracotomy
256457|NCT02068716|Conduit harvest or cannulation site|conduit harvest or cannulation site
256458|NCT02068703|survey|survey
256459|NCT02068664|spatial neglect|spatial neglect
256460|NCT02068664|aphasia|aphasia
256461|NCT02068651|End-of-life care|end-of-life care
256462|NCT02068651|Treatment decision making|treatment decision making
256463|NCT02068651|Advance care planning|advance care planning
256464|NCT02068638|exercise|exercise
256465|NCT02068638|isotope labeling, stable|isotope labeling, stable
256466|NCT02068638|spectroscopy, magnetic resonance|spectroscopy, magnetic resonance
256467|NCT02068638|monitoring, home blood glucose|monitoring, home blood glucose
256468|NCT02068638|hormones|hormones
256469|NCT02068625|retinal detachment|retinal detachment
256470|NCT02068625|rasagiline|rasagiline
256471|NCT02068625|optical coherence tomography|optical coherence tomography
256472|NCT02068625|visual acuity|visual acuity
256473|NCT02068625|neuroprotection|neuroprotection
256474|NCT02068625|azilect|azilect
256475|NCT02068612|Executive function,|executive function,
256476|NCT02068612|cardiovascular fitness,|cardiovascular fitness,
256477|NCT02068612|cognitive function|cognitive function
256478|NCT02068599|Osteoarthritis|osteoarthritis
256479|NCT02068599|OA|oa
256480|NCT02068599|Arthritis pain|arthritis pain
256481|NCT02068573|Childhood Asthma|childhood asthma
256482|NCT02068573|Allergy|allergy
256483|NCT02068573|House dust mites|house dust mites
256484|NCT02068573|Indoor air quality|indoor air quality
256485|NCT02068547|posterior cervical fusion|posterior cervical fusion
256486|NCT02068547|posterior cervical decompression|posterior cervical decompression
256487|NCT02068534|in-depth individual interview|in-depth individual interview
256488|NCT02068534|charcoal-burning suicide|charcoal-burning suicide
256489|NCT02068521|Growth Hormone Deficiency|growth hormone deficiency
256490|NCT02068521|Pediatric Growth Hormone Deficiency|pediatric growth hormone deficiency
256491|NCT02068521|GHD|ghd
256492|NCT02068521|PGHD|pghd
256493|NCT02068521|VRS-317|vrs-317
256494|NCT02068521|Versartis|versartis
256495|NCT02068521|Growth disorder|growth disorder
256496|NCT02068521|Long acting growth hormone|long acting growth hormone
256497|NCT02068521|Growth hormone|growth hormone
256498|NCT02068521|Weekly growth hormone dosing|weekly growth hormone dosing
256499|NCT02068521|Semi-monthly growth hormone dosing|semi-monthly growth hormone dosing
256500|NCT02068521|Monthly growth hormone dosing|monthly growth hormone dosing
256501|NCT02068521|IGF-I|igf-i
256502|NCT02068521|Short stature|short stature
256503|NCT02068521|Height velocity|height velocity
256504|NCT02068521|Annual height velocity|annual height velocity
256505|NCT02068521|Growth rate|growth rate
256506|NCT02068521|Somavaratan|somavaratan
256507|NCT02068508|Drug therapy|drug therapy
256508|NCT02068495|Drug therapy|drug therapy
256509|NCT02068482|Uncomplicated|uncomplicated
256510|NCT02068482|Symptomatic|symptomatic
256511|NCT02068456|Drug therapy|drug therapy
256512|NCT02068443|Drug therapy|drug therapy
256513|NCT02068430|Corneal Ulcers|corneal ulcers
256514|NCT02068430|cross-linking|cross-linking
256515|NCT02068430|UVA|uva
256516|NCT02068430|Riboflavin|riboflavin
256517|NCT02068417|IIEF score|iief score
256518|NCT02068417|ED|ed
256519|NCT02068404|Tocolysis|tocolysis
256520|NCT02068404|Preterm labor|preterm labor
256521|NCT02068404|Nifedipine|nifedipine
256522|NCT02068404|Pharmacokinetics|pharmacokinetics
256523|NCT02068391|covert stroke|covert stroke
256524|NCT02068391|cerebral blood flow|cerebral blood flow
256525|NCT02068391|grey matter|grey matter
256526|NCT02068391|attention|attention
256527|NCT02068391|executive function|executive function
256528|NCT02068391|aerobic exercise|aerobic exercise
256529|NCT02068352|Atopic Dermatitis, Eczema|atopic dermatitis, eczema
256530|NCT02068326|Mentalization-based Treatment|mentalization-based treatment
256531|NCT02068326|Adolescence|adolescence
256532|NCT02068326|Borderline Personality Disorder|borderline personality disorder
256533|NCT02068300|1,5-anhydro-D-glucitol, hypoglycemia, surrogate marker|1,5-anhydro-d-glucitol, hypoglycemia, surrogate marker
256534|NCT02068287|Septic Shock|septic shock
256535|NCT02068287|Hemodynamic|hemodynamic
256536|NCT02068287|Inflammatory status|inflammatory status
256537|NCT02068287|Beta adrenergic modulation|beta adrenergic modulation
256538|NCT02068287|Esmolol|esmolol
256539|NCT02068235|Ponesimod|ponesimod
256540|NCT02068235|Bioavailability|bioavailability
256541|NCT02068235|Pharmacokinetics|pharmacokinetics
256542|NCT02068235|Safety|safety
256543|NCT02068222|Hepatitis C|hepatitis c
256544|NCT02068222|HCV|hcv
256545|NCT02068222|Interferon Free|interferon free
256546|NCT02068222|Chronic Hepatitis C|chronic hepatitis c
256547|NCT02068222|Hepatitis C virus|hepatitis c virus
256548|NCT02068222|Hepatitis C Genotype 3|hepatitis c genotype 3
256549|NCT02068209|Outpatient hysteroscopy|outpatient hysteroscopy
256550|NCT02068209|Tramadol|tramadol
256551|NCT02068196|Cancer|cancer
256552|NCT02068196|Malignant Melanoma|malignant melanoma
256553|NCT02068196|Ipilimumab|ipilimumab
256554|NCT02068183|World Trade Center exposure|world trade center exposure
256555|NCT02068183|cardiovascular risk|cardiovascular risk
256556|NCT02068183|insulin resistance|insulin resistance
256557|NCT02068183|post-traumatic stress|post-traumatic stress
256558|NCT02068183|pulmonary disease|pulmonary disease
256559|NCT02068170|QT-prolongation|qt-prolongation
256560|NCT02068170|Torsade de Pointes|torsade de pointes
256561|NCT02068170|QT-prolonging drugs|qt-prolonging drugs
256562|NCT02068144|Cranberry Extract|cranberry extract
256563|NCT02068131|Metastatic Colorectal Cancer|metastatic colorectal cancer
256564|NCT02068131|Novaferon|novaferon
256565|NCT02068131|Recombinant anti-tumor and anti-virus protein for injection|recombinant anti-tumor and anti-virus protein for injection
256566|NCT02068131|xeloda|xeloda
256567|NCT02068118|E health|e health
256568|NCT02068118|Telecardiology program|telecardiology program
256569|NCT02068118|Heart failure|heart failure
256570|NCT02068105|ALKS 5461|alks 5461
256571|NCT02068105|samidorphan|samidorphan
256572|NCT02068066|Physical work requirements|physical work requirements
256573|NCT02068066|Energy expenditure|energy expenditure
256574|NCT02068066|Physical activity|physical activity
256575|NCT02068066|Different occupational categories|different occupational categories
256576|NCT02068066|Aerobic capacity|aerobic capacity
256577|NCT02068040|with preserved ejection fraction of >55%|with preserved ejection fraction of >55%
256578|NCT02068027|Diabetes Mellitus|diabetes mellitus
256579|NCT02068027|Pain|pain
256580|NCT02068027|Foot pain|foot pain
256581|NCT02068027|Neuropathy|neuropathy
256582|NCT02068014|stapplers- obesity- stomach|stapplers- obesity- stomach
256583|NCT02067988|Radioembolization|radioembolization
256584|NCT02067988|Somatostatin receptor treatment|somatostatin receptor treatment
256585|NCT02067988|Neuroendocrine tumors|neuroendocrine tumors
256586|NCT02067988|Liver metastases|liver metastases
256587|NCT02067975|tryptophan|tryptophan
256588|NCT02067975|kynurenic acid|kynurenic acid
256589|NCT02067975|schizophrenia|schizophrenia
256590|NCT02067962|Juvenile idiopathic arhtritis|juvenile idiopathic arhtritis
256591|NCT02067962|JIA|jia
256592|NCT02067962|Gene identification|gene identification
256593|NCT02067962|Whole exome sequencing|whole exome sequencing
256594|NCT02067962|Next generation sequencing|next generation sequencing
256595|NCT02067962|Identification of molecular basis|identification of molecular basis
256596|NCT02067962|Acceptation of both parents to participate to the study|acceptation of both parents to participate to the study
256597|NCT02067923|T1D|t1d
256598|NCT02067923|type 1 diabetes|type 1 diabetes
256599|NCT02067923|type 1 diabetes mellitus|type 1 diabetes mellitus
256600|NCT02067923|juvenile diabetes|juvenile diabetes
256601|NCT02067923|autoimmune diabetes|autoimmune diabetes
256602|NCT02067923|autoimmune|autoimmune
256603|NCT02067923|anti-CD3 mAb|anti-cd3 mab
256604|NCT02067923|mAb hOKT3g1(Ala-Ala)|mab hokt3g1(ala-ala)
256605|NCT02067923|teplizumab|teplizumab
256606|NCT02067910|Abatacept|abatacept
256607|NCT02067910|Subcutaneous|subcutaneous
256608|NCT02067910|Sjögren's syndrome|sjögren's syndrome
256609|NCT02067910|Treatment|treatment
256610|NCT02067910|Safety|safety
256611|NCT02067910|Efficacy|efficacy
256612|NCT02067897|Nails, Ingrown|nails, ingrown
256614|NCT02067897|Ambulatory Surgical Procedures|ambulatory surgical procedures
256615|NCT02067871|neuromuscular electrical stimulation|neuromuscular electrical stimulation
256616|NCT02067871|low-level laser therapy|low-level laser therapy
256617|NCT02067871|knee osteoarthritis|knee osteoarthritis
256618|NCT02067871|muscle architecture|muscle architecture
256619|NCT02067871|functionality|functionality
256620|NCT02067871|neuromuscular parameters|neuromuscular parameters
256621|NCT02067845|Lesbian, queer, bisexual women|lesbian, queer, bisexual women
256622|NCT02067845|HIV and STI prevention|hiv and sti prevention
256623|NCT02067845|Resilient coping|resilient coping
256624|NCT02067845|Sexual stigma|sexual stigma
256625|NCT02067845|Depression|depression
256626|NCT02067845|Safer-sex practices|safer-sex practices
256627|NCT02067845|Safer sex self-efficacy|safer sex self-efficacy
256628|NCT02067845|HIV/STI knowledge and testing|hiv/sti knowledge and testing
256629|NCT02067845|Pilot-testing|pilot-testing
256630|NCT02067819|Tourette's|tourette's
256631|NCT02067819|Tic Disorder|tic disorder
256632|NCT02067819|Dental Appliance|dental appliance
256633|NCT02067819|Oral Orthotic|oral orthotic
256634|NCT02067819|Mouthguard|mouthguard
256635|NCT02067806|PASS|pass
256636|NCT02067806|TNS|tns
256637|NCT02067806|CES|ces
256638|NCT02067806|CHLOROPROCAINE|chloroprocaine
256639|NCT02067793|NRX-1074|nrx-1074
256640|NCT02067793|NMDA Receptor Modulator|nmda receptor modulator
256641|NCT02067793|Major Depressive Disorder|major depressive disorder
256642|NCT02067793|Glycine site modulator|glycine site modulator
256643|NCT02067767|HIV-1 infection|hiv-1 infection
256644|NCT02067767|Nevirapine|nevirapine
256645|NCT02067767|Dolutegravir|dolutegravir
256646|NCT02067767|Anti-retroviral agents|anti-retroviral agents
256647|NCT02067754|The mutation profiling of circulating free DNA|the mutation profiling of circulating free dna
256648|NCT02067741|Post-menopausal women|post-menopausal women
256649|NCT02067741|topical application CR1447|topical application cr1447
256650|NCT02067741|endocrine responsive-HER2neg breast cancer|endocrine responsive-her2neg breast cancer
256651|NCT02067741|triple negative-androgen receptor positive breast cancer|triple negative-androgen receptor positive breast cancer
256652|NCT02067728|obesity prevention|obesity prevention
256653|NCT02067715|Tooth Discoloration|tooth discoloration
256654|NCT02067715|Bleaching Agents|bleaching agents
256655|NCT02067715|Tooth Bleaching|tooth bleaching
256656|NCT02067689|Normal cognition in healthy adults|normal cognition in healthy adults
256657|NCT02067689|Cognitive function|cognitive function
256658|NCT02067689|Transcranial direct current stimulation|transcranial direct current stimulation
256659|NCT02067689|Structural Magnetic Resonance Imaging|structural magnetic resonance imaging
256660|NCT02067689|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
256661|NCT02067676|Campylobacter jejuni|campylobacter jejuni
256662|NCT02067663|Postplacental IUD placement|postplacental iud placement
256663|NCT02067663|LNG-IUS|lng-ius
256664|NCT02067637|cancer therapy, cancer treatment|cancer therapy, cancer treatment
256665|NCT02067611|Phase 2, Efficacy, Safety, Osteoarthritis|phase 2, efficacy, safety, osteoarthritis
256666|NCT02067598|Scapular exercises|scapular exercises
256667|NCT02067572|oral health|oral health
256668|NCT02067572|mouthwash|mouthwash
256669|NCT02067572|salvia|salvia
256670|NCT02067572|hospice|hospice
256671|NCT02067572|xerostomia|xerostomia
256672|NCT02067572|mouth sores|mouth sores
256673|NCT02067559|Post Traumatic Stress Disorder|post traumatic stress disorder
256674|NCT02067559|PTSD|ptsd
256675|NCT02067559|Intensive Care Unit|intensive care unit
256676|NCT02067559|ICU|icu
256677|NCT02067546|constipation|constipation
256678|NCT02067520|Post C/S pain relief|post c/s pain relief
256679|NCT02067507|Human Papillomavirus|human papillomavirus
256680|NCT02067507|Immunization|immunization
256681|NCT02067507|Oncogenic viruses|oncogenic viruses
256682|NCT02067507|Cervical Cancer|cervical cancer
256683|NCT02067507|Health Disparities|health disparities
256684|NCT02067494|Low Back Pain|low back pain
256685|NCT02067494|Chronic Pain|chronic pain
256686|NCT02067494|Manual Therapy|manual therapy
256687|NCT02067494|Randomized Clinical Trial|randomized clinical trial
256688|NCT02067494|Bandages|bandages
256689|NCT02067481|Breast cancer|breast cancer
256690|NCT02067481|Survivors|survivors
256691|NCT02067481|Weight loss|weight loss
256692|NCT02067481|Diet|diet
256693|NCT02067481|Physical activity|physical activity
256694|NCT02067468|Human Papillomavirus|human papillomavirus
256695|NCT02067468|cervical cancer|cervical cancer
256696|NCT02067468|health services research|health services research
256697|NCT02067468|Colombia|colombia
256698|NCT02067468|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
256699|NCT02067455|Right ventricular function|right ventricular function
256700|NCT02067455|echocardiography|echocardiography
256701|NCT02067455|left ventricular assist device|left ventricular assist device
256702|NCT02067455|exercise|exercise
256703|NCT02067442|acetaminophen intravenous oral pain scores opioids|acetaminophen intravenous oral pain scores opioids
256704|NCT02067416|neoadjuvant|neoadjuvant
256705|NCT02067416|mammostrat|mammostrat
256706|NCT02067416|TLE3|tle3
256707|NCT02067416|DDR|ddr
256708|NCT02067416|breast cancer|breast cancer
256709|NCT02067403|Pressure-support|pressure-support
256710|NCT02067403|Asynchrony|asynchrony
256711|NCT02067377|GOLD, COPD, cachexia, BMI|gold, copd, cachexia, bmi
256712|NCT02067364|hydrocephalus|hydrocephalus
256713|NCT02067364|CSF shunt|csf shunt
256714|NCT02067299|Depressive Disorder, Major|depressive disorder, major
256715|NCT02067299|Major Depressive Disorder|major depressive disorder
256716|NCT02067299|Insomnia|insomnia
256717|NCT02067299|JNJ-42847922|jnj-42847922
256718|NCT02067299|Placebo|placebo
256719|NCT02067221|percutaneous nephrolithotomy|percutaneous nephrolithotomy
256720|NCT02067221|renal calculi|renal calculi
256721|NCT02067221|ureteroscopy|ureteroscopy
256722|NCT02067208|Osteoarthritis|osteoarthritis
256723|NCT02067208|Cartilage|cartilage
256724|NCT02067208|Musculoskeletal|musculoskeletal
256725|NCT02067208|Biomechanics|biomechanics
256726|NCT02067208|Subtype|subtype
256727|NCT02067208|Footwear|footwear
256728|NCT02067208|Orthotics|orthotics
256729|NCT02067208|Joint Loading|joint loading
256730|NCT02067195|acute myocardial infarction,contrast,coronary intervention|acute myocardial infarction,contrast,coronary intervention
256731|NCT02067169|Transplantation|transplantation
256732|NCT02067169|CMV infection|cmv infection
256733|NCT02067169|antiviral resistance|antiviral resistance
256734|NCT02067156|glioblastoma|glioblastoma
256735|NCT02067143|Untreated philadelphia positive acute lymphoblastic leukemia|untreated philadelphia positive acute lymphoblastic leukemia
256736|NCT02067143|De novo|de novo
256737|NCT02067143|Secondary|secondary
256738|NCT02067143|Low-dose corticosteroids pretreatment|low-dose corticosteroids pretreatment
256739|NCT02067143|Pegylated asparaginase|pegylated asparaginase
256740|NCT02067143|Lineage-targeted risk and minimal residual disease|lineage-targeted risk and minimal residual disease
256741|NCT02067130|Beta Thalassemia Major|beta thalassemia major
256742|NCT02067117|influenza|influenza
256743|NCT02067091|STEMI|stemi
256744|NCT02067091|Coronary|coronary
256745|NCT02067091|Bioresorbable scaffold|bioresorbable scaffold
256746|NCT02067091|Drug eluting stent|drug eluting stent
256747|NCT02067091|Optical coherence tomography|optical coherence tomography
256748|NCT02067091|Multislice computed tomography|multislice computed tomography
256749|NCT02067078|nerve block|nerve block
256750|NCT02067078|total knee arthroplasty|total knee arthroplasty
256751|NCT02067078|saphenous nerve block|saphenous nerve block
256752|NCT02067078|obturator nerve block|obturator nerve block
256753|NCT02067078|pain|pain
256754|NCT02067078|opioid consumption|opioid consumption
256755|NCT02067065|Colonoscopy|colonoscopy
256756|NCT02067065|Sedation|sedation
256757|NCT02067065|Propofol|propofol
256758|NCT02067065|Non-anesthesiologist propofol administration|non-anesthesiologist propofol administration
256759|NCT02067052|Vulvar neoplasm|vulvar neoplasm
256760|NCT02067052|sentinel nodes|sentinel nodes
256761|NCT02067052|chemotherapy|chemotherapy
256762|NCT02067052|radiotherapy|radiotherapy
256763|NCT02067039|HIV testing|hiv testing
256764|NCT02067039|Rapid HIV test|rapid hiv test
256765|NCT02067039|HIV self-testing|hiv self-testing
256766|NCT02067039|Men who have sex with men (MSM)|men who have sex with men (msm)
256767|NCT02067039|HIV diagnosis|hiv diagnosis
256768|NCT02067039|Sexual behavior|sexual behavior
256769|NCT02067026|overweight|overweight
256770|NCT02067013|Tractional retinal detachment|tractional retinal detachment
256771|NCT02067013|Exudative retinal detachment|exudative retinal detachment
256772|NCT02067013|Macular hole|macular hole
256773|NCT02067013|Neovascular glaucoma|neovascular glaucoma
256774|NCT02066987|Action planning, Implementation intention|action planning, implementation intention
256775|NCT02066974|hepatocellular carcinoma|hepatocellular carcinoma
256776|NCT02066974|genomic expression|genomic expression
256777|NCT02066974|radiotherapy|radiotherapy
256778|NCT02066961|metastatic prostate cancer|metastatic prostate cancer
256779|NCT02066961|castration-resistant prostate cancer|castration-resistant prostate cancer
256780|NCT02066961|prostate cancer|prostate cancer
256781|NCT02066948|DXA|dxa
256782|NCT02066948|MRI|mri
256783|NCT02066948|Fitness assessment|fitness assessment
256784|NCT02066948|Meal tolerance test|meal tolerance test
256785|NCT02066935|immunosuppression|immunosuppression
256786|NCT02066935|medication nonadherence|medication nonadherence
256787|NCT02066935|kidney transplantation|kidney transplantation
256788|NCT02066922|Contact lenses|contact lenses
256789|NCT02066922|Nearsightedness|nearsightedness
256790|NCT02066922|Corneal curvature|corneal curvature
256791|NCT02066922|K-reading|k-reading
256792|NCT02066922|High minus|high minus
256793|NCT02066922|Spectacle refraction|spectacle refraction
256794|NCT02066909|pharmacokinetics|pharmacokinetics
256795|NCT02066909|safety|safety
256796|NCT02066909|tolerability|tolerability
256797|NCT02066909|healthy volunteers|healthy volunteers
256798|NCT02066909|steady state|steady state
256799|NCT02066909|multiple doses|multiple doses
256800|NCT02066909|Japanese subjects|japanese subjects
256801|NCT02066896|Sjogrens Syndrome|sjogrens syndrome
256802|NCT02066896|Syndrome, Sjogren's|syndrome, sjogren's
256803|NCT02066896|Sjogren Syndrome|sjogren syndrome
256804|NCT02066896|Sicca Syndrome|sicca syndrome
257214|NCT02065063|palbociclib|palbociclib
256805|NCT02066896|Syndrome, Sicca|syndrome, sicca
256806|NCT02066870|Icotinib|icotinib
256807|NCT02066870|Arsenic Trioxide|arsenic trioxide
256808|NCT02066870|Resistance|resistance
256809|NCT02066870|Non-small cell lung cancer|non-small cell lung cancer
256810|NCT02066857|Wrist fracture|wrist fracture
256811|NCT02066857|Radius fracture|radius fracture
256812|NCT02066857|Elderly|elderly
256813|NCT02066857|Splint|splint
256814|NCT02066857|Cast|cast
256815|NCT02066844|Hip Pain|hip pain
256816|NCT02066844|Hip Injection|hip injection
256817|NCT02066844|Hip Fracture|hip fracture
256818|NCT02066844|Hip Bursitis|hip bursitis
256819|NCT02066844|Hip Arthritis|hip arthritis
256820|NCT02066844|Hip Sciatica|hip sciatica
256821|NCT02066818|local anesthetic|local anesthetic
256822|NCT02066818|incision and drainage|incision and drainage
256823|NCT02066818|pain|pain
256824|NCT02066818|cutaneous abscess|cutaneous abscess
256825|NCT02066792|Social Phobia|social phobia
256826|NCT02066753|Cardiac arrest|cardiac arrest
256827|NCT02066753|Therapeutic Hypothermia|therapeutic hypothermia
256828|NCT02066753|Cardioprotectiveness|cardioprotectiveness
256829|NCT02066753|Hemodynamics|hemodynamics
256830|NCT02066740|Superficial Femoral Artery|superficial femoral artery
256831|NCT02066740|Proximal Popliteal Artery|proximal popliteal artery
256832|NCT02066740|Everflex|everflex
256833|NCT02066740|Entrust|entrust
256834|NCT02066740|stent|stent
256835|NCT02066727|Dexmedetomidine|dexmedetomidine
256836|NCT02066727|obturator nerve block|obturator nerve block
256837|NCT02066727|lidocaine|lidocaine
256838|NCT02066727|EC50|ec50
256839|NCT02066714|Enterovirus Infections|enterovirus infections
256840|NCT02066714|Hand, Foot and Mouth Disease|hand, foot and mouth disease
256841|NCT02066714|Coxsackievirus Infections|coxsackievirus infections
256842|NCT02066714|Herpangina|herpangina
256843|NCT02066714|Cognition|cognition
256844|NCT02066714|Neurocognitive|neurocognitive
256845|NCT02066714|Sequelae|sequelae
256846|NCT02066714|Outcomes|outcomes
256847|NCT02066701|Barrett's esophagus|barrett's esophagus
256848|NCT02066675|Metastatic|metastatic
256849|NCT02066675|Locally advanced|locally advanced
256850|NCT02066675|Soft tissue tumors|soft tissue tumors
256851|NCT02066662|Coronary or Valvular Calcification|coronary or valvular calcification
256852|NCT02066662|Agatston Score|agatston score
256853|NCT02066662|Rivaroxaban|rivaroxaban
256854|NCT02066662|Coumarin|coumarin
256855|NCT02066662|Oral Anticoagulation Therapy (OAT)|oral anticoagulation therapy (oat)
256856|NCT02066662|Atrial Fibrillation|atrial fibrillation
256857|NCT02066662|Pulmonary Embolism|pulmonary embolism
256858|NCT02066649|portal hypertension|portal hypertension
256859|NCT02066649|esophageal varices|esophageal varices
256860|NCT02066649|variceal bleed|variceal bleed
256861|NCT02066649|carvedilol|carvedilol
256862|NCT02066649|variceal band ligation|variceal band ligation
256863|NCT02066623|coronary artery stenosis, vascular scaffold, ABSORB|coronary artery stenosis, vascular scaffold, absorb
256864|NCT02066597|Deep vein thrombosis|deep vein thrombosis
256865|NCT02066597|thrombectomy|thrombectomy
256866|NCT02066597|percutaneuos|percutaneuos
256867|NCT02066584|sibling oocytes|sibling oocytes
256868|NCT02066584|glucose|glucose
256869|NCT02066584|culture media|culture media
256870|NCT02066571|Parkinson's disease|parkinson's disease
256871|NCT02066571|Freezing of gait|freezing of gait
256872|NCT02066571|Gait|gait
256873|NCT02066558|Carbon monoxide|carbon monoxide
256874|NCT02066558|Headache|headache
256875|NCT02066558|Migraine|migraine
256876|NCT02066532|Breast Neoplasms|breast neoplasms
256877|NCT02066532|Breast Cancer|breast cancer
256878|NCT02066532|Breast Carcinoma|breast carcinoma
256879|NCT02066532|Breast tumors|breast tumors
256880|NCT02066532|Cancer of the Breast|cancer of the breast
256881|NCT02066532|Malignant tumor of the breast|malignant tumor of the breast
256882|NCT02066532|HER2 positive|her2 positive
256883|NCT02066532|erythroblastosis virus oncogene B-2 (erbB-2)|erythroblastosis virus oncogene b-2 (erbb-2)
256884|NCT02066532|Metastatic Breast Cancer|metastatic breast cancer
256885|NCT02066532|Secondary Breast Cancer|secondary breast cancer
256886|NCT02066519|Myasthenia gravis|myasthenia gravis
256887|NCT02066519|physical exercise|physical exercise
256888|NCT02066519|quality of life|quality of life
256889|NCT02066519|muscular performance|muscular performance
256890|NCT02066519|fatigability|fatigability
256891|NCT02066506|systemic right ventricle|systemic right ventricle
256892|NCT02066506|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
256893|NCT02066506|congenital heart disease|congenital heart disease
256894|NCT02066493|giant intracranial aneurysm|giant intracranial aneurysm
256895|NCT02066467|Phrenic Nerve Stimulation|phrenic nerve stimulation
256896|NCT02066467|Heartfailure treatment|heartfailure treatment
256897|NCT02066467|CRT-D therapy|crt-d therapy
256898|NCT02066467|Quadripolar lead|quadripolar lead
256899|NCT02066467|Lead related complication free rate|lead related complication free rate
256900|NCT02066454|myeloma|myeloma
256901|NCT02066454|antiXa anticoagulant|antixa anticoagulant
256902|NCT02066454|venous thromboembolic disease|venous thromboembolic disease
256903|NCT02066454|iMiDs|imids
256905|NCT02066441|bone formation|bone formation
256906|NCT02066441|resorption|resorption
256907|NCT02066441|mineral density|mineral density
256908|NCT02066441|inflammation|inflammation
256909|NCT02066441|flexibility|flexibility
256910|NCT02066441|balance|balance
256911|NCT02066441|elderly|elderly
256912|NCT02066428|BCG Vaccinated|bcg vaccinated
256913|NCT02066428|HIV Negative|hiv negative
256914|NCT02066415|Chronic Migraine|chronic migraine
256915|NCT02066389|anti-inflammatory agents|anti-inflammatory agents
256916|NCT02066389|Joint Diseases|joint diseases
256917|NCT02066389|Arthritis|arthritis
256918|NCT02066389|Musculoskeletal Disease|musculoskeletal disease
256919|NCT02066389|antirheumatic agents|antirheumatic agents
256920|NCT02066363|Bioelectrical impedance|bioelectrical impedance
256921|NCT02066363|Parenteral nutrition|parenteral nutrition
256922|NCT02066363|Malnutrition|malnutrition
256923|NCT02066363|Quality of life.|quality of life.
256924|NCT02066363|Cancer cachexia|cancer cachexia
256925|NCT02066363|Body composition|body composition
256926|NCT02066350|Diabetes type 1|diabetes type 1
256927|NCT02066350|Endothelial dysfunction|endothelial dysfunction
256928|NCT02066350|Pancreas transplantation|pancreas transplantation
256929|NCT02066337|Ozone gel|ozone gel
256930|NCT02066337|Antioxidants|antioxidants
256931|NCT02066337|Chronic periodontitis|chronic periodontitis
256932|NCT02066337|Superoxide dismutase|superoxide dismutase
256933|NCT02066311|lupus|lupus
256935|NCT02066298|Asthma|asthma
256936|NCT02066298|Mometasone|mometasone
256937|NCT02066298|Tiotropium|tiotropium
256938|NCT02066285|Solitary fibrous tumor|solitary fibrous tumor
256939|NCT02066285|Extraskeletal myxoid chondrosarcoma|extraskeletal myxoid chondrosarcoma
256940|NCT02066285|Unresectable|unresectable
256941|NCT02066285|Locally advanced|locally advanced
256942|NCT02066285|Metastatic disease|metastatic disease
256943|NCT02066272|IBD|ibd
256944|NCT02066272|anti-TNF|anti-tnf
256945|NCT02066272|biosimilars|biosimilars
256946|NCT02066272|safety|safety
256947|NCT02066259|colon cancer|colon cancer
256948|NCT02066259|cancer associated auto antibodies|cancer associated auto antibodies
256949|NCT02066259|colon cancer blood test|colon cancer blood test
256950|NCT02066246|laparoscopic robot-assisted surgery|laparoscopic robot-assisted surgery
256951|NCT02066246|in steep trendelenburg position|in steep trendelenburg position
256952|NCT02066233|Barrett's|barrett's
256953|NCT02066233|esophagus|esophagus
256954|NCT02066233|reflux|reflux
256955|NCT02066233|heartburn|heartburn
256956|NCT02066233|screening|screening
256957|NCT02066220|pediatric brain tumor|pediatric brain tumor
256958|NCT02066220|medulloblastoma|medulloblastoma
256959|NCT02066220|event-free survival (EFS)|event-free survival (efs)
256960|NCT02066220|progression-free survival (PFS)|progression-free survival (pfs)
256961|NCT02066220|overall survival (OS)|overall survival (os)
256962|NCT02066220|PNET|pnet
256963|NCT02066220|posterior fossa|posterior fossa
256964|NCT02066220|chemotherapy|chemotherapy
256965|NCT02066220|radiotherapy|radiotherapy
256966|NCT02066220|biological profile|biological profile
256967|NCT02066220|ß-catenin|ß-catenin
256968|NCT02066155|diabetes self-management support|diabetes self-management support
256969|NCT02066155|diabetes-related distress|diabetes-related distress
256970|NCT02066155|parish nurses|parish nurses
256971|NCT02066155|peer support|peer support
256972|NCT02066129|Asthma|asthma
256973|NCT02066129|Fluticasone|fluticasone
256974|NCT02066090|acupuncture|acupuncture
256975|NCT02066090|obesity|obesity
256976|NCT02066090|metabolomics|metabolomics
256977|NCT02066077|Major Depressive Disorder|major depressive disorder
256978|NCT02066077|Modified Electroconvulsive Therapy|modified electroconvulsive therapy
256979|NCT02066077|Cognition|cognition
256980|NCT02066077|Memory|memory
256981|NCT02066064|Colorectal Cancer|colorectal cancer
256982|NCT02066064|Adenoma|adenoma
256983|NCT02066064|Standard Colonoscopy|standard colonoscopy
256984|NCT02066064|G-EYE(TM) Colonoscopy|g-eye(tm) colonoscopy
256985|NCT02066038|chemotherapy|chemotherapy
256986|NCT02066038|maintenance therapy|maintenance therapy
256987|NCT02066038|erlotinib|erlotinib
256988|NCT02066025|breast cancer|breast cancer
256989|NCT02066025|cancer associated auto antibodies|cancer associated auto antibodies
256990|NCT02066025|breast cancer blood test|breast cancer blood test
256991|NCT02066012|Dysmetabolic Iron Overload Syndrome|dysmetabolic iron overload syndrome
256992|NCT02066012|Metabolic Syndrome X|metabolic syndrome x
256993|NCT02066012|Iron|iron
256994|NCT02066012|Monocyte|monocyte
256995|NCT02066012|Macrophage|macrophage
256996|NCT02066012|Polarization|polarization
256997|NCT02065999|Hepatitis C, chronic|hepatitis c, chronic
256999|NCT02065986|Prevention|prevention
257000|NCT02065986|Truvada|truvada
257001|NCT02065960|Feasibility study|feasibility study
257002|NCT02065960|Early breast cancer|early breast cancer
257003|NCT02065960|Stereotactic body radiotherapy|stereotactic body radiotherapy
257004|NCT02065960|Cyberknife|cyberknife
257005|NCT02065960|Pre-operative radiotherapy|pre-operative radiotherapy
257006|NCT02065947|paravertebral block, mastectomy, efficiency|paravertebral block, mastectomy, efficiency
257007|NCT02065934|in hospital cardiac arrest|in hospital cardiac arrest
257008|NCT02065934|in situ simulation|in situ simulation
257009|NCT02065934|clinical audit|clinical audit
257010|NCT02065934|education|education
257011|NCT02065921|COPD cohort|copd cohort
257012|NCT02065921|COPD management|copd management
257013|NCT02065921|exacerbation|exacerbation
257014|NCT02065908|breast cancer|breast cancer
257015|NCT02065908|anthracyclines|anthracyclines
257016|NCT02065908|cardiotoxicity|cardiotoxicity
257017|NCT02065908|circulating microRNA|circulating microrna
257018|NCT02065908|biomarker|biomarker
257019|NCT02065908|serum|serum
257020|NCT02065908|anthracyclines based chemotherapy|anthracyclines based chemotherapy
257021|NCT02065895|Physiologic Insulin Delivery (PID)|physiologic insulin delivery (pid)
257022|NCT02065895|Closed Loop|closed loop
257023|NCT02065895|Sensor|sensor
257024|NCT02065895|Insulin sensitivity|insulin sensitivity
257025|NCT02065882|fibrinogen, bleeding,|fibrinogen, bleeding,
257026|NCT02065869|ALL|all
257027|NCT02065869|AML|aml
257028|NCT02065869|hematologic neoplasms|hematologic neoplasms
257029|NCT02065869|hematologic malignancies|hematologic malignancies
257030|NCT02065869|primary immune deficiences|primary immune deficiences
257031|NCT02065843|Anxiety|anxiety
257032|NCT02065843|Third molar surgery|third molar surgery
257033|NCT02065843|Blood pressure|blood pressure
257034|NCT02065843|Heart rate|heart rate
257035|NCT02065843|Oxygen saturation|oxygen saturation
257036|NCT02065830|Robot|robot
257037|NCT02065830|Spinal Cord Injury|spinal cord injury
257038|NCT02065830|Gait|gait
257039|NCT02065830|Quality of life|quality of life
257040|NCT02065830|Rehabilitation|rehabilitation
257041|NCT02065830|Lower Limb|lower limb
257042|NCT02065817|Lipid|lipid
257043|NCT02065817|Apolipoproteins|apolipoproteins
257044|NCT02065817|Cardiovascular disease risks|cardiovascular disease risks
257045|NCT02065804|Herniorrhaphy|herniorrhaphy
257046|NCT02065804|Surgical Equipment|surgical equipment
257047|NCT02065804|Chronic Pain|chronic pain
257048|NCT02065804|Inguinal Herniorrhaphy|inguinal herniorrhaphy
257049|NCT02065804|Laparoscopy|laparoscopy
257050|NCT02065804|Surgical Outcome|surgical outcome
257051|NCT02065791|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
257052|NCT02065791|Diabetic Nephropathies|diabetic nephropathies
257053|NCT02065791|Canagliflozin|canagliflozin
257054|NCT02065791|JNJ-28431754|jnj-28431754
257055|NCT02065791|End-Stage Kidney Disease|end-stage kidney disease
257056|NCT02065791|Chronic Kidney Disease|chronic kidney disease
257057|NCT02065791|Macroalbuminuria|macroalbuminuria
257058|NCT02065752|Healthy Volunteers|healthy volunteers
257059|NCT02065752|Canagliflozin|canagliflozin
257060|NCT02065752|Metformin|metformin
257061|NCT02065752|Type 2 diabetes mellitus|type 2 diabetes mellitus
257062|NCT02065739|Healthy|healthy
257063|NCT02065739|JNJ-42165279|jnj-42165279
257064|NCT02065739|Itraconazole|itraconazole
257065|NCT02065739|Pharmacokinetics|pharmacokinetics
257066|NCT02065713|Psoriatic arthritis, dactylitis, enthesitis|psoriatic arthritis, dactylitis, enthesitis
257067|NCT02065700|Methotrexate|methotrexate
257068|NCT02065700|insufficient responders|insufficient responders
257069|NCT02065674|type II Diabetes mellitus|type ii diabetes mellitus
257070|NCT02065674|FBS|fbs
257071|NCT02065674|PPBS|ppbs
257072|NCT02065674|HbA1c%|hba1c%
257073|NCT02065648|MRA|mra
257074|NCT02065648|Syngo Native|syngo native
257075|NCT02065648|Gadolinium|gadolinium
257076|NCT02065648|Non contrast|non contrast
257077|NCT02065622|Ulcerative Colitis|ulcerative colitis
257078|NCT02065609|Trastuzumab|trastuzumab
257079|NCT02065596|Sickle Cell Disease|sickle cell disease
257080|NCT02065596|Sickle Cell Anemia|sickle cell anemia
257081|NCT02065596|GvHD|gvhd
257082|NCT02065596|fludarabine|fludarabine
257083|NCT02065583|Ileus|ileus
257084|NCT02065583|Equipment and Supplies|equipment and supplies
257085|NCT02065583|Technology|technology
257086|NCT02065583|Acoustics|acoustics
257087|NCT02065570|Crohn's Disease|crohn's disease
257088|NCT02065557|Ulcerative Colitis|ulcerative colitis
257089|NCT02065557|adalimumab|adalimumab
257090|NCT02065544|Type 2 diabetes mellitus|type 2 diabetes mellitus
257091|NCT02065544|behavioral weight loss|behavioral weight loss
257092|NCT02065544|exercise training|exercise training
257093|NCT02065544|hemoglobin A1c|hemoglobin a1c
257094|NCT02065531|Low Back Pain|low back pain
257095|NCT02065531|Chronic Pain|chronic pain
257096|NCT02065531|Manipulation|manipulation
257097|NCT02065531|Manual Therapy|manual therapy
257098|NCT02065531|Randomized Controlled Trial|randomized controlled trial
257099|NCT02065518|Muscle strength|muscle strength
257100|NCT02065518|Electrical muscle stimulation|electrical muscle stimulation
257101|NCT02065518|Strength training|strength training
257102|NCT02065505|Spastic hemiparesis|spastic hemiparesis
257103|NCT02065505|Posture|posture
257104|NCT02065505|Pilates|pilates
257105|NCT02065505|Respiratory Capacity|respiratory capacity
257106|NCT02065492|Thalassemia|thalassemia
257107|NCT02065492|Amlodipine|amlodipine
257108|NCT02065492|Chelation|chelation
257109|NCT02065492|T2*|t2*
257110|NCT02065492|MRI|mri
257111|NCT02065492|Myocardial Iron|myocardial iron
257112|NCT02065479|Coronary Artery Disease|coronary artery disease
257113|NCT02065479|Percutaneous Coronary Intervention|percutaneous coronary intervention
257114|NCT02065479|Genetic Polymorphism|genetic polymorphism
257115|NCT02065479|Pharmacodynamic|pharmacodynamic
257116|NCT02065453|lap hysterectomy|lap hysterectomy
257117|NCT02065453|Women in need of a lap hysterectomy for benign disease.|women in need of a lap hysterectomy for benign disease.
257118|NCT02065440|Ebastine/Pseudoephedrine|ebastine/pseudoephedrine
257119|NCT02065440|subacute cough|subacute cough
257120|NCT02065440|upper airway cough syndrome|upper airway cough syndrome
257121|NCT02065427|Caregiver|caregiver
257122|NCT02065427|Burden|burden
257123|NCT02065427|Social support|social support
257124|NCT02065427|Primary health Care|primary health care
257125|NCT02065427|Home Care|home care
257126|NCT02065427|Intervention|intervention
257127|NCT02065414|Gums|gums
257128|NCT02065414|Gingiva|gingiva
257129|NCT02065414|Gingival Inflammation|gingival inflammation
257130|NCT02065414|Gingival Bleeding|gingival bleeding
257131|NCT02065375|RTA 408|rta 408
257132|NCT02065375|Ocular surgery|ocular surgery
257133|NCT02065375|Cataract surgery|cataract surgery
257134|NCT02065375|Ocular inflammation|ocular inflammation
257135|NCT02065375|Ocular pain|ocular pain
257136|NCT02065375|Eye inflammation|eye inflammation
257137|NCT02065362|EBV positive|ebv positive
257138|NCT02065362|TGFbeta|tgfbeta
257139|NCT02065362|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
257140|NCT02065362|cytotoxic T lymphocytes|cytotoxic t lymphocytes
257141|NCT02065349|peripheral neuropathy|peripheral neuropathy
257143|NCT02065349|pain|pain
257144|NCT02065349|PDPN|pdpn
257145|NCT02065336|HBV|hbv
257146|NCT02065336|Hepatitis|hepatitis
257147|NCT02065323|Prostate Cancer|prostate cancer
257148|NCT02065323|Metastatic|metastatic
257149|NCT02065323|Hormone-sensitive|hormone-sensitive
257150|NCT02065323|Androgen Deprivation Therapy (ADT)|androgen deprivation therapy (adt)
257151|NCT02065323|Castration-Resistant Prostate Cancer (CRPC)|castration-resistant prostate cancer (crpc)
257152|NCT02065323|Dovitinib|dovitinib
257153|NCT02065323|TKI258|tki258
257154|NCT02065323|Circulating Tumor Cells|circulating tumor cells
257155|NCT02065310|AGE|age
257156|NCT02065310|Diabetes Biomarkers|diabetes biomarkers
257157|NCT02065310|CEdG|cedg
257158|NCT02065284|MS|ms
257159|NCT02065284|Ambulation|ambulation
257160|NCT02065258|Asthma, Clinical control, Exercise|asthma, clinical control, exercise
257161|NCT02065245|Aging Frailty, Frailty, Cardiovascular, stem cells|aging frailty, frailty, cardiovascular, stem cells
257162|NCT02065219|Chronic Pain|chronic pain
257163|NCT02065219|Inguinal Hernia|inguinal hernia
257164|NCT02065219|Outcome|outcome
257165|NCT02065219|Surgical Procedure, Operative|surgical procedure, operative
257166|NCT02065206|Focus groups|focus groups
257167|NCT02065206|Underrepresented Minorities|underrepresented minorities
257168|NCT02065206|Social Media|social media
257169|NCT02065206|Clinical Research Careers|clinical research careers
257170|NCT02065167|avascular necrosis of femoral head|avascular necrosis of femoral head
257171|NCT02065167|cell therapy|cell therapy
257172|NCT02065167|Mesenchymal stem cells|mesenchymal stem cells
257173|NCT02065154|acute myeloid leukemia|acute myeloid leukemia
257174|NCT02065154|AML|aml
257175|NCT02065154|acute lymphoblastic leukemia|acute lymphoblastic leukemia
257176|NCT02065154|ALL|all
257177|NCT02065154|chronic myeloid leukemia|chronic myeloid leukemia
257178|NCT02065154|CML|cml
257179|NCT02065154|chronic lymphocytic leukemia|chronic lymphocytic leukemia
257180|NCT02065154|CLL|cll
257181|NCT02065154|non-Hodgkin lymphoma|non-hodgkin lymphoma
257182|NCT02065154|NHL|nhl
257183|NCT02065154|Hodgkin lymphoma|hodgkin lymphoma
257184|NCT02065154|HL|hl
257185|NCT02065154|myelodysplastic syndrome|myelodysplastic syndrome
257186|NCT02065154|MDS|mds
257187|NCT02065154|myelofibrosis|myelofibrosis
257188|NCT02065154|severe aplastic anemia|severe aplastic anemia
257189|NCT02065141|digestion|digestion
257190|NCT02065141|absorption|absorption
257191|NCT02065141|protein|protein
257192|NCT02065141|amino acids|amino acids
257193|NCT02065141|heart failure|heart failure
257194|NCT02065141|COPD|copd
257195|NCT02065115|ice|ice
257196|NCT02065115|cryotherapy|cryotherapy
257197|NCT02065115|puncture|puncture
257198|NCT02065115|pain|pain
257199|NCT02065102|Rotational atherectomy|rotational atherectomy
257200|NCT02065102|Angina|angina
257201|NCT02065102|Optical coherence tomography|optical coherence tomography
257202|NCT02065102|Intravascular ultrasound|intravascular ultrasound
257203|NCT02065102|Coronary stent|coronary stent
257204|NCT02065076|Sodium Polystyrene Sulfonate|sodium polystyrene sulfonate
257205|NCT02065076|Kayexalate|kayexalate
257206|NCT02065076|Pre-dialysis|pre-dialysis
257207|NCT02065076|Outpatients|outpatients
257208|NCT02065076|Hyperkalemia|hyperkalemia
257209|NCT02065076|Chronic kidney failure|chronic kidney failure
257210|NCT02065076|Potassium|potassium
257211|NCT02065063|MEK inhibitor|mek inhibitor
257212|NCT02065063|PD-0332991|pd-0332991
257213|NCT02065063|CDK4/6 inhibitor|cdk4/6 inhibitor
257215|NCT02065063|NRAS wild type|nras wild type
257216|NCT02065063|cutaneous melanoma|cutaneous melanoma
257217|NCT02065063|GSK1120212|gsk1120212
257218|NCT02065063|trametinib|trametinib
257219|NCT02065063|NRAS mutant|nras mutant
257220|NCT02065063|BRAFV600 wild type|brafv600 wild type
257221|NCT02065050|Diabetes mellitus|diabetes mellitus
257222|NCT02065050|Team approach|team approach
257223|NCT02065037|Insufflation|insufflation
257224|NCT02065037|Carbon Dioxide|carbon dioxide
257225|NCT02065037|Colonic Polyps|colonic polyps
257226|NCT02065037|Colonoscopy|colonoscopy
257227|NCT02065037|Randomized Controlled Trial|randomized controlled trial
257228|NCT02065024|b-cryptoxanthin|b-cryptoxanthin
257229|NCT02065024|plant sterols|plant sterols
257230|NCT02065024|serum Cholesterol|serum cholesterol
257231|NCT02065024|bone turnover markers|bone turnover markers
257232|NCT02064998|Randomized Controlled Trial|randomized controlled trial
257233|NCT02064998|Alcohol|alcohol
257234|NCT02064998|Internet|internet
257235|NCT02064998|Mobile phone|mobile phone
257236|NCT02064998|Screening|screening
257237|NCT02064998|Brief intervention|brief intervention
257238|NCT02064972|Graft vs Host Disease|graft vs host disease
257239|NCT02064972|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
257240|NCT02064972|Biological Marker|biological marker
257241|NCT02064972|Circulating Endothelial Cells|circulating endothelial cells
257242|NCT02064972|Endothelial Dysfunction|endothelial dysfunction
257243|NCT02064959|Subdural Hematoma|subdural hematoma
257244|NCT02064959|Traumatic Brain Injury|traumatic brain injury
257245|NCT02064959|Hypothermia|hypothermia
257246|NCT02064946|prostate cancer|prostate cancer
257247|NCT02064946|bone density|bone density
257248|NCT02064946|vitamin D|vitamin d
257249|NCT02064946|micronutrients|micronutrients
257250|NCT02064946|pharmacologic actions|pharmacologic actions
257251|NCT02064933|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
257252|NCT02064933|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
257253|NCT02064933|Genetic Therapy|genetic therapy
257254|NCT02064907|Drug therapy|drug therapy
257255|NCT02064894|children|children
257256|NCT02064894|analgesia|analgesia
257257|NCT02064894|musculoskeletal injury|musculoskeletal injury
257258|NCT02064894|emergency|emergency
257260|NCT02064881|Postprandial lipemia|postprandial lipemia
257261|NCT02064881|Diabetes|diabetes
257262|NCT02064881|Metformin glycinate|metformin glycinate
257263|NCT02064881|oxidized LDL|oxidized ldl
257264|NCT02064868|AHF,|ahf,
257265|NCT02064868|RLX030,|rlx030,
257266|NCT02064868|SOC,|soc,
257267|NCT02064868|WHF,|whf,
257268|NCT02064868|RELAX-AHF-EU|relax-ahf-eu
257269|NCT02064868|Renal Impairment|renal impairment
257270|NCT02064855|Spinal stenosis|spinal stenosis
257271|NCT02064855|Spondylolisthesis|spondylolisthesis
257272|NCT02064855|Degenerative disc disease|degenerative disc disease
257273|NCT02064855|Spinal fusion|spinal fusion
257274|NCT02064855|Allograft|allograft
257275|NCT02064855|Interbody fusion|interbody fusion
257276|NCT02064842|Healthy|healthy
257277|NCT02064842|TMC647055|tmc647055
257278|NCT02064842|TMC435|tmc435
257279|NCT02064842|Simeprevir|simeprevir
257280|NCT02064842|Sovriad|sovriad
257281|NCT02064842|Ritonavir (RTV)|ritonavir (rtv)
257282|NCT02064829|Metastatic breast cancer|metastatic breast cancer
257283|NCT02064829|Locally recurrent breast cancer|locally recurrent breast cancer
257284|NCT02064829|Bioequivalence|bioequivalence
257285|NCT02064829|IG-001|ig-001
257286|NCT02064829|nab-paclitaxel|nab-paclitaxel
257287|NCT02064829|Paclitaxel|paclitaxel
257288|NCT02064829|Pharmacokinetics|pharmacokinetics
257289|NCT02064816|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
257290|NCT02064816|Interferon beta 1a|interferon beta 1a
257291|NCT02064816|Rebif®|rebif®
257292|NCT02064790|Gabapentin|gabapentin
257293|NCT02064790|Pregabalin|pregabalin
257294|NCT02064790|Lyrica|lyrica
257295|NCT02064790|Neurontin|neurontin
257296|NCT02064790|lumbar|lumbar
257297|NCT02064790|cervical|cervical
257298|NCT02064738|Omega-3 fatty acids|omega-3 fatty acids
257299|NCT02064738|Omega-6 fatty acids|omega-6 fatty acids
257300|NCT02064738|aspirin exacerbated respiratory disease|aspirin exacerbated respiratory disease
257301|NCT02064738|AERD|aerd
257302|NCT02064738|Samter's Triad|samter's triad
257303|NCT02064738|nasal polyp|nasal polyp
257304|NCT02064738|aspirin|aspirin
257305|NCT02064738|diet|diet
257306|NCT02064738|leukotriene|leukotriene
257307|NCT02064725|Endometrial cancer|endometrial cancer
257308|NCT02064725|Recurrent or persistent endometrial carcinoma|recurrent or persistent endometrial carcinoma
257309|NCT02064725|Progesterone Receptor Negative|progesterone receptor negative
257310|NCT02064725|Sodium cridanimod|sodium cridanimod
257311|NCT02064725|Virexxa|virexxa
257312|NCT02064712|Continuous Positive Airway Pressure|continuous positive airway pressure
257313|NCT02064699|Renal transplant|renal transplant
257314|NCT02064699|CMV|cmv
257315|NCT02064699|Test QuantiFERON-CMV|test quantiferon-cmv
257316|NCT02064673|prostate cancer|prostate cancer
257317|NCT02064673|radical prostatectomy|radical prostatectomy
257318|NCT02064660|Myopia|myopia
257319|NCT02064660|Children|children
257320|NCT02064660|Acupressure|acupressure
257321|NCT02064660|Refractive error|refractive error
257322|NCT02064660|Axial length|axial length
257323|NCT02064660|Korean medicine|korean medicine
257324|NCT02064647|Insulin Infusion Systems|insulin infusion systems
257325|NCT02064647|Blood Glucose|blood glucose
257326|NCT02064634|Shinbaro Capsule|shinbaro capsule
257327|NCT02064634|Celecoxib|celecoxib
257328|NCT02064634|Osteoarthritis|osteoarthritis
257329|NCT02064634|GCSB-5|gcsb-5
257330|NCT02064634|Discontinuation rate|discontinuation rate
257331|NCT02064634|Gastrointestinal adverse event|gastrointestinal adverse event
257332|NCT02064634|NSAIDs|nsaids
257333|NCT02064634|OASIS|oasis
257334|NCT02064608|Prostate|prostate
257335|NCT02064608|Cancer|cancer
257336|NCT02064608|Prostate Cancer|prostate cancer
257337|NCT02064608|High Risk|high risk
257338|NCT02064608|Intermediate Risk|intermediate risk
257339|NCT02064608|Early disease|early disease
257340|NCT02064608|Neoadjuvant treatment|neoadjuvant treatment
257341|NCT02064608|Radical Prostatectomy|radical prostatectomy
257342|NCT02064595|Tibial fractures.|tibial fractures.
257343|NCT02064595|Fracture fixation.|fracture fixation.
257344|NCT02064595|External fixators.|external fixators.
257345|NCT02064595|Intramedullary.|intramedullary.
257346|NCT02064595|Quality of life.|quality of life.
257347|NCT02064582|prostate cancer, enzalutamide, radiation, hormone therapy|prostate cancer, enzalutamide, radiation, hormone therapy
257348|NCT02064543|Parkinson's disease|parkinson's disease
257349|NCT02064543|gait|gait
257350|NCT02064530|TAP block|tap block
257351|NCT02064530|dexmedetomidine|dexmedetomidine
257352|NCT02064530|bupivacaine|bupivacaine
257353|NCT02064530|postoperative analgesia|postoperative analgesia
257354|NCT02064517|Necrosed Immature monoradicular Teeth , Revascularisation pulpar, MTA apical barrier, Clinical and radiographic success|necrosed immature monoradicular teeth , revascularisation pulpar, mta apical barrier, clinical and radiographic success
257355|NCT02064504|Respiratory|respiratory
257356|NCT02064504|GSK961081 (MABA)|gsk961081 (maba)
257357|NCT02064504|healthy subjects|healthy subjects
257358|NCT02064504|pharmacokinetics|pharmacokinetics
257359|NCT02064504|GW685698 (fluticasone furoate)|gw685698 (fluticasone furoate)
257360|NCT02064491|Non-small cell lung cancer|non-small cell lung cancer
257361|NCT02064491|EGFR mutant|egfr mutant
257362|NCT02064491|Erlotinib|erlotinib
257363|NCT02064491|Treatment Beyond Progression|treatment beyond progression
257364|NCT02064478|Bone anchored hearing implant|bone anchored hearing implant
257365|NCT02064478|Bone anchored hearing device|bone anchored hearing device
257366|NCT02064452|behavior problems|behavior problems
257367|NCT02064452|children|children
257368|NCT02064452|prevention|prevention
257369|NCT02064452|parenting|parenting
257370|NCT02064452|online|online
257371|NCT02064452|pediatric|pediatric
257372|NCT02064439|deep vein thrombosis|deep vein thrombosis
257373|NCT02064439|pulmonary embolism|pulmonary embolism
257374|NCT02064439|long-term prevention of recurrent symptomatic VTE|long-term prevention of recurrent symptomatic vte
257375|NCT02064426|Anemia of CKD on dialysis|anemia of ckd on dialysis
257376|NCT02064413|Birth control|birth control
257377|NCT02064400|Rheumatoid arthritis|rheumatoid arthritis
257378|NCT02064400|Ultrasound|ultrasound
257379|NCT02064400|Remission|remission
257380|NCT02064400|Qualitative|qualitative
257381|NCT02064387|Multiple Myeloma|multiple myeloma
257382|NCT02064387|BCMA expressing Lymphomas|bcma expressing lymphomas
257383|NCT02064374|Dolutegravir|dolutegravir
257384|NCT02064374|drug interaction|drug interaction
257385|NCT02064374|metformin|metformin
257386|NCT02064374|pharmacokinetics|pharmacokinetics
257387|NCT02064374|healthy volunteers|healthy volunteers
257388|NCT02064361|SCUBA diving|scuba diving
257389|NCT02064361|exercise,|exercise,
257390|NCT02064361|microparticles|microparticles
257391|NCT02064361|neutrophil activation,|neutrophil activation,
257392|NCT02064361|high intensity exercise|high intensity exercise
257393|NCT02064335|physical activity coach, diabetic persons, health, behaviour|physical activity coach, diabetic persons, health, behaviour
257394|NCT02064322|sacroiliac joint fusion|sacroiliac joint fusion
257395|NCT02064322|SIJ fusion|sij fusion
257396|NCT02064322|SI joint|si joint
257397|NCT02064296|Fibromyalgia Chronic Pain|fibromyalgia chronic pain
257398|NCT02064270|incision care|incision care
257399|NCT02064270|Total Hip Arthroplasty|total hip arthroplasty
257400|NCT02064270|Total Knee Arthroplasty|total knee arthroplasty
257401|NCT02064270|Knee surgery|knee surgery
257402|NCT02064270|Hip surgery|hip surgery
257403|NCT02064257|autonomic nervous system|autonomic nervous system
257404|NCT02064257|auditory processing disorder|auditory processing disorder
257405|NCT02064257|social behavior|social behavior
257406|NCT02064244|renal|renal
257407|NCT02064244|kidney|kidney
257408|NCT02064244|creatinine|creatinine
257409|NCT02064244|Inferior Vena Cava (IVC)|inferior vena cava (ivc)
257410|NCT02064244|Acute Renal Failure (ARF)|acute renal failure (arf)
257411|NCT02064244|Acute Kidney Injury (AKI)|acute kidney injury (aki)
257412|NCT02064205|pre-load|pre-load
257413|NCT02064205|satiety|satiety
257414|NCT02064205|energy intake|energy intake
257415|NCT02064205|appetite|appetite
257416|NCT02064192|defibrillator, implantable cardioverter|defibrillator, implantable cardioverter
257417|NCT02064192|sudden cardiac death|sudden cardiac death
257418|NCT02064192|primary prophylaxis|primary prophylaxis
257419|NCT02064192|risk stratification|risk stratification
257420|NCT02064179|Congenital heart disease|congenital heart disease
257421|NCT02064179|Antiplatelet therapy|antiplatelet therapy
257422|NCT02064179|Aspirin|aspirin
257423|NCT02064166|Parkinson disease|parkinson disease
257424|NCT02064166|Multiple system atrophy|multiple system atrophy
257425|NCT02064166|Intranasal|intranasal
257426|NCT02064166|Insulin|insulin
257427|NCT02064153|Dialysate temperature|dialysate temperature
257428|NCT02064153|Spent dialysate|spent dialysate
257429|NCT02064153|Toxin removal|toxin removal
257430|NCT02064153|Intra-dialytic hypotension|intra-dialytic hypotension
257431|NCT02064153|Inter-compartmental resistance|inter-compartmental resistance
257432|NCT02064140|ARDS|ards
257433|NCT02064140|Mechanical Ventilation|mechanical ventilation
257434|NCT02064140|Tidal volume|tidal volume
257435|NCT02064140|NMBA|nmba
257436|NCT02064114|BMI >40|bmi >40
257437|NCT02064101|Scoliosis|scoliosis
257438|NCT02064101|EMG|emg
257439|NCT02064101|Pedicle screw|pedicle screw
257440|NCT02064101|Neuromonitoring|neuromonitoring
257441|NCT02064088|Regional anesthesia|regional anesthesia
257442|NCT02064088|TAP block|tap block
257443|NCT02064088|Pediatric anesthesia|pediatric anesthesia
257444|NCT02064088|analgesic effects|analgesic effects
257445|NCT02064088|pharmacokinetics|pharmacokinetics
257446|NCT02064075|Subarachnoid hemorrhage|subarachnoid hemorrhage
257447|NCT02064075|vasospasm|vasospasm
257448|NCT02064075|Lactated Ringer's solution|lactated ringer's solution
257449|NCT02064075|Hydroxyethyl starch solution|hydroxyethyl starch solution
257450|NCT02064062|Achilles Tendinopathy|achilles tendinopathy
257451|NCT02064062|Autologous Stem Cells|autologous stem cells
257452|NCT02064062|Musculoskeletal|musculoskeletal
257453|NCT02064049|Hepatitis C virus|hepatitis c virus
257454|NCT02064049|People who inject drugs|people who inject drugs
257455|NCT02064049|Drug users|drug users
257456|NCT02064049|Direct acting antiviral (DAA)|direct acting antiviral (daa)
257457|NCT02064049|Infectious diseases|infectious diseases
257458|NCT02064049|Prisoners|prisoners
257459|NCT02064036|Prostate Cancer|prostate cancer
257460|NCT02064036|Radiotherapy|radiotherapy
257461|NCT02064036|Androgen Deprivation|androgen deprivation
257462|NCT02064023|insulin pump|insulin pump
257463|NCT02064023|CSII|csii
257464|NCT02064023|multiple daily injections|multiple daily injections
257465|NCT02064023|MDI|mdi
257466|NCT02064023|type 1 diabetes|type 1 diabetes
257467|NCT02064023|type 2 diabetes|type 2 diabetes
257468|NCT02064023|pregnancy|pregnancy
257469|NCT02063971|Skin aging|skin aging
257470|NCT02063971|Soothing activity|soothing activity
257471|NCT02063971|Hyaluronic acid injections|hyaluronic acid injections
257472|NCT02063958|Neuroendocrine tumor|neuroendocrine tumor
257473|NCT02063958|Hsp90|hsp90
257474|NCT02063945|ADHA|adha
257475|NCT02063945|ODD|odd
257476|NCT02063945|Conduct disorder|conduct disorder
257477|NCT02063945|Aggression|aggression
257478|NCT02063945|Treatment|treatment
257479|NCT02063945|Methylphenidate|methylphenidate
257480|NCT02063945|Risperidone|risperidone
257481|NCT02063932|mucosal microbiome|mucosal microbiome
257482|NCT02063932|H.pylori|h.pylori
257483|NCT02063932|intestinal metaplasia|intestinal metaplasia
257484|NCT02063932|gastric neoplasia|gastric neoplasia
257485|NCT02063932|endomicroscopy|endomicroscopy
257486|NCT02063880|HIV-1|hiv-1
257487|NCT02063880|IRIS|iris
257488|NCT02063867|HAI|hai
257489|NCT02063867|MRSA|mrsa
257490|NCT02063867|VRE|vre
257491|NCT02063854|Drug Therapy|drug therapy
257492|NCT02063802|pediatric obesity|pediatric obesity
257493|NCT02063802|conjugated linoleic acid|conjugated linoleic acid
257494|NCT02063802|CLA|cla
257495|NCT02063802|metformin|metformin
257496|NCT02063789|Immune Thrombocytopenia|immune thrombocytopenia
257497|NCT02063789|Immune Thrombocytopenic Purpura|immune thrombocytopenic purpura
257498|NCT02063789|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
257499|NCT02063789|Human Immunoglobulin|human immunoglobulin
257500|NCT02063789|ITP|itp
257501|NCT02063789|IVIg|ivig
257502|NCT02063789|IgIV|igiv
257503|NCT02063789|IV-Globulin SN Inj.|iv-globulin sn inj.
257504|NCT02063776|Haemodiafiltration (HDF)|haemodiafiltration (hdf)
257505|NCT02063776|Haemodialysis (HD)|haemodialysis (hd)
257506|NCT02063776|Children|children
257507|NCT02063776|Carotid intima media thickness|carotid intima media thickness
257508|NCT02063776|Pulse wave velocity|pulse wave velocity
257509|NCT02063776|Height standard deviation score|height standard deviation score
257510|NCT02063763|Adult patients|adult patients
257511|NCT02063763|Immune primary thrombocytopenia|immune primary thrombocytopenia
257512|NCT02063763|Splenectomy|splenectomy
257513|NCT02063763|TPO-mimetics|tpo-mimetics
257514|NCT02063763|Eltrombopag|eltrombopag
257515|NCT02063763|Romiplostim|romiplostim
257516|NCT02063750|Fibromyalgia|fibromyalgia
258208|NCT02060617|exercise|exercise
257517|NCT02063750|Muscle strength exercises|muscle strength exercises
257518|NCT02063750|Pain|pain
257519|NCT02063750|Quality of life|quality of life
257520|NCT02063737|Shift work|shift work
257521|NCT02063737|Fatigue|fatigue
257522|NCT02063737|Sleepiness|sleepiness
257523|NCT02063737|Injury|injury
257524|NCT02063724|Invasive Breast Cancer|invasive breast cancer
257525|NCT02063724|Breast Cancer|breast cancer
257526|NCT02063724|Immunotherapy|immunotherapy
257527|NCT02063724|Vaccine|vaccine
257528|NCT02063724|Dendritic Cell|dendritic cell
257529|NCT02063711|Prenatal Yoga|prenatal yoga
257530|NCT02063711|Yoga, Pregnancy|yoga, pregnancy
257531|NCT02063711|Yoga, Fetal Response|yoga, fetal response
257532|NCT02063646|polyphenols|polyphenols
257533|NCT02063646|memory|memory
257534|NCT02063646|elderly|elderly
257535|NCT02063633|Thoracic malignancy, irradiation, respiratory gating system PET|thoracic malignancy, irradiation, respiratory gating system pet
257536|NCT02063620|IVRA, ketamine, lidocaine, ECG|ivra, ketamine, lidocaine, ecg
257537|NCT02063607|Hepatitis C naive|hepatitis c naive
257538|NCT02063594|Iodixanol|iodixanol
257539|NCT02063594|Iodinated Contrast|iodinated contrast
257540|NCT02063594|Liposome|liposome
257541|NCT02063594|Computed Tomography|computed tomography
257542|NCT02063594|X-ray Imaging|x-ray imaging
257543|NCT02063594|Blood pool agent|blood pool agent
257544|NCT02063594|Biomarker|biomarker
257545|NCT02063555|Tuberculosis|tuberculosis
257546|NCT02063555|BCG|bcg
257547|NCT02063555|HIV|hiv
257548|NCT02063555|TB Vaccines|tb vaccines
257549|NCT02063542|Postoperative cognitive changes|postoperative cognitive changes
257550|NCT02063542|Acetylcholine in CSF|acetylcholine in csf
257551|NCT02063542|Surgery|surgery
257552|NCT02063529|Colorectal cancer|colorectal cancer
257553|NCT02063529|Metastatic colorectal cancer|metastatic colorectal cancer
257554|NCT02063529|Liver metastases|liver metastases
257555|NCT02063529|Liver resection|liver resection
257556|NCT02063529|Liver ablation|liver ablation
257557|NCT02063529|Conversion therapy|conversion therapy
257558|NCT02063529|FOLFOXIRI|folfoxiri
257559|NCT02063529|Cetuximab|cetuximab
257560|NCT02063529|Oxaliplatin|oxaliplatin
257561|NCT02063529|Irinotecan|irinotecan
257562|NCT02063529|Leucovorin|leucovorin
257563|NCT02063516|Airway Cuff|airway cuff
257564|NCT02063516|Guardian|guardian
257565|NCT02063516|Proseal|proseal
257566|NCT02063516|Cuff Pressure|cuff pressure
257567|NCT02063516|laryngeal Mask Airway|laryngeal mask airway
257568|NCT02063503|prognostic indicator|prognostic indicator
257569|NCT02063503|nonspecific|nonspecific
257570|NCT02063503|chronic|chronic
257571|NCT02063503|low back pain|low back pain
257572|NCT02063503|Non specific chronic low back pain|non specific chronic low back pain
257573|NCT02063490|Adherence|adherence
257574|NCT02063490|dialysis|dialysis
257575|NCT02063490|intervention|intervention
257576|NCT02063490|nurse-led|nurse-led
257577|NCT02063490|phosphate binders|phosphate binders
257578|NCT02063490|trial|trial
257579|NCT02063464|Tumorcidal|tumorcidal
257580|NCT02063464|Monocytes|monocytes
257581|NCT02063464|Interferons Alpha and Gamma|interferons alpha and gamma
257582|NCT02063451|Obesity [C18.654.726.500]|obesity [c18.654.726.500]
257583|NCT02063451|Receptor, Opioid, mu [D12.776.543.750.100.620.550]|receptor, opioid, mu [d12.776.543.750.100.620.550]
257584|NCT02063451|Brain [A08.186.211]|brain [a08.186.211]
257585|NCT02063451|Affect [F01.470.047]|affect [f01.470.047]
257586|NCT02063438|Thoracotomy|thoracotomy
257587|NCT02063438|Pain|pain
257588|NCT02063438|Intracostal Suture|intracostal suture
257589|NCT02063438|Pericostal Suture|pericostal suture
257590|NCT02063425|Motor recovery|motor recovery
257591|NCT02063425|Fluoxetine|fluoxetine
257592|NCT02063425|Transcranial magnetic stimulation|transcranial magnetic stimulation
257593|NCT02063425|stroke|stroke
257594|NCT02063399|NPC|npc
257595|NCT02063399|Cancer screening|cancer screening
257596|NCT02063399|Plasma EBV DNA|plasma ebv dna
257597|NCT02063347|innate collateral supply|innate collateral supply
257598|NCT02063347|collateral|collateral
257599|NCT02063347|coronary collateral|coronary collateral
257600|NCT02063347|renal collateral|renal collateral
257601|NCT02063347|peripheral collateral|peripheral collateral
257602|NCT02063347|coronary artery disease|coronary artery disease
257603|NCT02063334|vitamin D3|vitamin d3
257604|NCT02063334|cholecalciferol|cholecalciferol
257605|NCT02063334|calcidiol|calcidiol
257606|NCT02063334|25-hydroxyvitamin D|25-hydroxyvitamin d
257607|NCT02063334|gene expression|gene expression
257608|NCT02063334|vitamin D receptor|vitamin d receptor
257609|NCT02063334|randomized controlled trial|randomized controlled trial
257610|NCT02063334|men|men
257611|NCT02063334|adults|adults
257612|NCT02063321|DME, diabetic retinopathy, diabetes mellitus, epidemiology|dme, diabetic retinopathy, diabetes mellitus, epidemiology
257613|NCT02063308|Oxaloacetate|oxaloacetate
257614|NCT02063308|OAA|oaa
257615|NCT02063308|AD|ad
257616|NCT02063308|Alzheimer's Disease|alzheimer's disease
257617|NCT02063295|Beloranib|beloranib
257618|NCT02063295|ZGN-440|zgn-440
257619|NCT02063295|ZGN-440 for injectable suspension|zgn-440 for injectable suspension
257620|NCT02063295|ZGN-433|zgn-433
257621|NCT02063282|Asymptomatic|asymptomatic
257622|NCT02063282|Carriage|carriage
257623|NCT02063282|Colonization|colonization
257624|NCT02063282|Clostridium difficile|clostridium difficile
257625|NCT02063282|Colitis|colitis
257626|NCT02063282|Rectal swab|rectal swab
257627|NCT02063269|rivastigmine, butyrylcholinesterase, MRI, PET|rivastigmine, butyrylcholinesterase, mri, pet
257628|NCT02063256|sperm count|sperm count
257629|NCT02063256|sperm concentration|sperm concentration
257630|NCT02063256|mobility|mobility
257631|NCT02063256|diet|diet
257632|NCT02063256|PUFA (polyunsaturated fatty acids)|pufa (polyunsaturated fatty acids)
257633|NCT02063243|Keloid, hypertrophic scar|keloid, hypertrophic scar
257634|NCT02063230|Phase I, healthy, pharmacokinetic, hepatic impairment|phase i, healthy, pharmacokinetic, hepatic impairment
257635|NCT02063204|Phase I, healthy, pharmacokinetics, renal impairment|phase i, healthy, pharmacokinetics, renal impairment
257636|NCT02063191|Atrial Fibrillation|atrial fibrillation
257637|NCT02063191|Bundle Branch Block|bundle branch block
257638|NCT02063165|Safflower Oil|safflower oil
257639|NCT02063165|Linoleic Acid|linoleic acid
257640|NCT02063165|Dyslipidemia|dyslipidemia
257641|NCT02063165|Hypertension|hypertension
257642|NCT02063139|Knemometry|knemometry
257643|NCT02063126|Coenzyme Q10 plus NADH|coenzyme q10 plus nadh
257644|NCT02063126|maximum Heart Rate|maximum heart rate
257645|NCT02063126|Fatigue|fatigue
257646|NCT02063126|Pain|pain
257647|NCT02063126|Sleep|sleep
257648|NCT02063113|Multiple myeloma,|multiple myeloma,
257649|NCT02063113|Older patient,|older patient,
257650|NCT02063113|Treatment,|treatment,
257651|NCT02063113|Geriatric assessment|geriatric assessment
257652|NCT02063100|Glomerulonephritis|glomerulonephritis
257653|NCT02063100|proteinuria|proteinuria
257654|NCT02063100|shenyankangfu tablets|shenyankangfu tablets
257655|NCT02063100|Losartan Potassium|losartan potassium
257656|NCT02063100|efficacy|efficacy
257657|NCT02063100|safety|safety
257658|NCT02063087|Head CT|head ct
257659|NCT02063087|Head Injury|head injury
257660|NCT02063087|Pediatric|pediatric
257661|NCT02063087|Emergency Department|emergency department
257662|NCT02063087|Decision Aids|decision aids
257663|NCT02063087|Shared Decision Making|shared decision making
257664|NCT02063061|extracorporeal shock wave therapy ESWT|extracorporeal shock wave therapy eswt
257665|NCT02063061|erectile dysfunction|erectile dysfunction
257666|NCT02063048|weight loss|weight loss
257667|NCT02063048|Text Messaging|text messaging
257668|NCT02063048|Short Message Service|short message service
257669|NCT02063048|Text Messages|text messages
257670|NCT02063035|lumbar spine surgery|lumbar spine surgery
257671|NCT02063035|thoracic spine surgery|thoracic spine surgery
257672|NCT02063022|Non metastatic Ewing's Sarcoma|non metastatic ewing's sarcoma
257673|NCT02062944|Liver Transplant|liver transplant
257674|NCT02062944|Sirolimus|sirolimus
257675|NCT02062944|Rapamune|rapamune
257676|NCT02062944|Immunosuppressant Therapy|immunosuppressant therapy
257677|NCT02062944|Withdrawal|withdrawal
257678|NCT02062931|Primary Infertility|primary infertility
257679|NCT02062931|Primary Amenorrhea|primary amenorrhea
257680|NCT02062931|Sex Steroid Deficiency|sex steroid deficiency
257681|NCT02062931|Premature Ovarian Failure (POF)|premature ovarian failure (pof)
257682|NCT02062918|Abdominal belt|abdominal belt
257683|NCT02062918|Chronic low back pain|chronic low back pain
257684|NCT02062918|Pain|pain
257685|NCT02062918|Functional capacity|functional capacity
257686|NCT02062892|everolimus|everolimus
257687|NCT02062892|sirolimus|sirolimus
257688|NCT02062892|tacrolimus|tacrolimus
257689|NCT02062892|vascular endothelial function|vascular endothelial function
257690|NCT02062892|kidney|kidney
257691|NCT02062892|Transplantation|transplantation
257692|NCT02062892|biomarkers|biomarkers
257693|NCT02062879|pain|pain
257694|NCT02062879|trauma|trauma
257695|NCT02062840|Whole Body Hyperthermia|whole body hyperthermia
257696|NCT02062840|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
257697|NCT02062840|EEG|eeg
257698|NCT02062827|Glioma|glioma
257699|NCT02062801|Combined spinal epidural analgesia, labor, fetal bradycardia|combined spinal epidural analgesia, labor, fetal bradycardia
257700|NCT02062788|Early Recovery After Surgery|early recovery after surgery
257701|NCT02062788|Oral rehydration solution|oral rehydration solution
257702|NCT02062788|Insulin resistance|insulin resistance
257703|NCT02062788|Postoperative complication|postoperative complication
257704|NCT02062749|Colorectal cancer|colorectal cancer
257705|NCT02062749|Colon Cancer|colon cancer
257706|NCT02062749|Pediatric|pediatric
257707|NCT02062749|Adolescent|adolescent
257708|NCT02062749|Hyperthermic Intraperitoneal Chemotherapy|hyperthermic intraperitoneal chemotherapy
257709|NCT02062749|HIPEC|hipec
257710|NCT02062749|Oxaliplatin|oxaliplatin
257711|NCT02062749|Eloxatin|eloxatin
257712|NCT02062736|methadone|methadone
257713|NCT02062736|heroin addiction|heroin addiction
257714|NCT02062736|methadone maintenance treatment|methadone maintenance treatment
257715|NCT02062736|adequate dosage of methadone|adequate dosage of methadone
257716|NCT02062723|methadone|methadone
257717|NCT02062723|heroin addiction|heroin addiction
258505|NCT02059356|Demented|demented
257718|NCT02062723|methadone maintenance treatment|methadone maintenance treatment
257719|NCT02062723|adequate dosage of methadone|adequate dosage of methadone
257720|NCT02062710|cough|cough
257721|NCT02062710|cough reflex|cough reflex
257722|NCT02062710|capsaicin|capsaicin
257723|NCT02062710|diphenhydramine|diphenhydramine
257724|NCT02062710|phenylephrine|phenylephrine
257725|NCT02062710|dextromethorphan|dextromethorphan
257726|NCT02062710|placebo|placebo
257727|NCT02062697|Neoplasms|neoplasms
257728|NCT02062697|Glandular and Epithelial|glandular and epithelial
257729|NCT02062697|Ovarian Neoplasms|ovarian neoplasms
257730|NCT02062697|Ovarian cancer|ovarian cancer
257731|NCT02062684|IgAN|igan
257732|NCT02062684|IgA Nephropathy|iga nephropathy
257733|NCT02062684|A-623|a-623
257734|NCT02062684|Blisibimod|blisibimod
257735|NCT02062684|Kidney Disease|kidney disease
257736|NCT02062684|Persistent proteinuria|persistent proteinuria
257737|NCT02062671|ADPKD|adpkd
257738|NCT02062671|denervation|denervation
257739|NCT02062671|renal denervation|renal denervation
257740|NCT02062658|OCD|ocd
257741|NCT02062645|essential hypertension|essential hypertension
257742|NCT02062619|Stroke|stroke
257743|NCT02062619|Aphasia|aphasia
257744|NCT02062619|Acquired reading disorders|acquired reading disorders
257745|NCT02062619|Central alexia|central alexia
257746|NCT02062619|Computer based rehabilitation|computer based rehabilitation
257747|NCT02062619|Transcranial direct current stimulation|transcranial direct current stimulation
257748|NCT02062619|tDCS|tdcs
257749|NCT02062619|Magnetoencephalography|magnetoencephalography
257750|NCT02062619|MEG|meg
257751|NCT02062619|Magnetic Resonance Imaging|magnetic resonance imaging
257752|NCT02062619|MRI|mri
257753|NCT02062606|Scoliosis|scoliosis
257754|NCT02062606|Spinal Curvatures|spinal curvatures
257755|NCT02062606|Spinal Diseases|spinal diseases
257756|NCT02062606|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
257757|NCT02062606|Spinal Deformity|spinal deformity
257758|NCT02062593|Stable angina|stable angina
257759|NCT02062593|Percutaneous coronary intervention|percutaneous coronary intervention
257760|NCT02062593|Optimal medical therapy|optimal medical therapy
257761|NCT02062593|Sham-control|sham-control
257762|NCT02062580|Vaccine immunogenicity|vaccine immunogenicity
257763|NCT02062580|Immune activation|immune activation
257764|NCT02062554|Myocardial infarction|myocardial infarction
257765|NCT02062554|Clinical outcome|clinical outcome
257766|NCT02062554|Flow-mediated dilation|flow-mediated dilation
257767|NCT02062554|Inflammation|inflammation
257768|NCT02062541|functional assessment|functional assessment
257769|NCT02062541|rehabilitation|rehabilitation
257770|NCT02062541|cross-sectorial cooperation|cross-sectorial cooperation
257771|NCT02062528|EPA|epa
257772|NCT02062489|breast cancer,|breast cancer,
257773|NCT02062489|tamoxifen,|tamoxifen,
257774|NCT02062489|ER/PR negative, ER-beta positive|er/pr negative, er-beta positive
257775|NCT02062463|Asthma|asthma
257776|NCT02062450|Arthroplasty|arthroplasty
257777|NCT02062450|Hip Replacement|hip replacement
257778|NCT02062450|Acetabular cup|acetabular cup
257779|NCT02062450|Dual mobility|dual mobility
257780|NCT02062450|Hip revision surgery|hip revision surgery
257781|NCT02062437|Arthroplasty|arthroplasty
257782|NCT02062437|Hip Replacement|hip replacement
257783|NCT02062437|Ceramic|ceramic
257784|NCT02062437|Acetabular cup|acetabular cup
257785|NCT02062437|Femoral stem|femoral stem
257786|NCT02062424|ischemic heart disease, dietary guidelines|ischemic heart disease, dietary guidelines
257787|NCT02062411|attention deficit disorder (ADHD)|attention deficit disorder (adhd)
257788|NCT02062411|cognitive behavioral therapy (CBT)|cognitive behavioral therapy (cbt)
257789|NCT02062411|adult|adult
257790|NCT02062398|PNP|pnp
257791|NCT02062398|Stimulation|stimulation
257792|NCT02062398|Peripheral neurostimulation|peripheral neurostimulation
257793|NCT02062372|7 T MRI|7 t mri
257794|NCT02062372|Radiotherapy|radiotherapy
257795|NCT02062372|Glioblastoma|glioblastoma
257796|NCT02062372|Biopsy|biopsy
257797|NCT02062359|Malignant Melanoma|malignant melanoma
257798|NCT02062359|Metastatic Cancer|metastatic cancer
257799|NCT02062359|Gene Therapy|gene therapy
257800|NCT02062359|Immunotherapy|immunotherapy
257801|NCT02062359|Tumor Regression|tumor regression
257802|NCT02062346|endothelin;|endothelin;
257803|NCT02062346|blood pressure;|blood pressure;
257804|NCT02062346|vasculitis|vasculitis
257805|NCT02062333|dexmedetomidine|dexmedetomidine
257806|NCT02062333|esmolol|esmolol
257807|NCT02062333|stapes reflex|stapes reflex
257808|NCT02062320|Acute Pain Service|acute pain service
257809|NCT02062320|postoperative analgesia|postoperative analgesia
257810|NCT02062320|Caesarean Section|caesarean section
257811|NCT02062320|non-opioid analgesia|non-opioid analgesia
257812|NCT02062320|opioid analgesia|opioid analgesia
257813|NCT02062320|epidural analgesia|epidural analgesia
257814|NCT02062307|Hypogonadism|hypogonadism
257815|NCT02062307|Asymmetric Dimethyl Arginine|asymmetric dimethyl arginine
257816|NCT02062307|Osteoprotegerin|osteoprotegerin
257817|NCT02062307|Fibroblast Growth Factor|fibroblast growth factor
257818|NCT02062307|Vitamin D|vitamin d
257819|NCT02062281|Safety|safety
257820|NCT02062281|Immunogenicity|immunogenicity
257821|NCT02062281|vaccine|vaccine
257822|NCT02062281|pneumococcal|pneumococcal
257823|NCT02062281|influenza|influenza
257824|NCT02062268|KAP|kap
257825|NCT02062268|drink driving|drink driving
257826|NCT02062268|public|public
257827|NCT02062268|Jiangsu province|jiangsu province
257828|NCT02062268|China|china
257829|NCT02062255|Asprin|asprin
257830|NCT02062255|Omega-3 Free Fatty Acids|omega-3 free fatty acids
257831|NCT02062255|Obesity|obesity
257832|NCT02062255|COX-2 inhibitor|cox-2 inhibitor
257833|NCT02062242|Pelvic Floor|pelvic floor
257834|NCT02062242|Physical Therapy Specialty|physical therapy specialty
257835|NCT02062242|Awareness|awareness
257836|NCT02062242|Electric Stimulation|electric stimulation
257837|NCT02062242|Palpation|palpation
257838|NCT02062229|oxidative stress|oxidative stress
257839|NCT02062229|oxysterols|oxysterols
257840|NCT02062229|fatty acids|fatty acids
257841|NCT02062229|seminal fluid|seminal fluid
257842|NCT02062216|Coronary artery disease|coronary artery disease
257843|NCT02062216|Percutaneous coronary intervention|percutaneous coronary intervention
257844|NCT02062216|Inflammatory receptors|inflammatory receptors
257845|NCT02062203|Akebia|akebia
257846|NCT02062203|QT interval|qt interval
257847|NCT02062203|TQT|tqt
257848|NCT02062203|pharmacokinetic|pharmacokinetic
257849|NCT02062203|anemia|anemia
257850|NCT02062203|chronic kidney disease|chronic kidney disease
257851|NCT02062203|CKD|ckd
257852|NCT02062203|chronic renal insufficiency|chronic renal insufficiency
257853|NCT02062203|renal impairment|renal impairment
257854|NCT02062203|safety|safety
257855|NCT02062164|psychosocial, healthcare, co-morbidities, extremely obese adolescents|psychosocial, healthcare, co-morbidities, extremely obese adolescents
257856|NCT02062138|rehabilitation|rehabilitation
257857|NCT02062138|total knee arthroplasty|total knee arthroplasty
257858|NCT02062138|range of motion|range of motion
257859|NCT02062138|continuous passive motion|continuous passive motion
257860|NCT02062138|controlled active motion|controlled active motion
257861|NCT02062138|postoperative physical therapy|postoperative physical therapy
257862|NCT02062125|scleroderma|scleroderma
257863|NCT02062125|calcinosis|calcinosis
257864|NCT02062112|Bowel preparation solutions|bowel preparation solutions
257865|NCT02062112|Colonoscopy|colonoscopy
257866|NCT02062112|Polyethylene glycol|polyethylene glycol
257867|NCT02062086|Sarcopenia|sarcopenia
257868|NCT02062086|Mass muscle|mass muscle
257869|NCT02062086|Quality of life|quality of life
257870|NCT02062073|head lice|head lice
257871|NCT02062073|Hatchtech|hatchtech
257872|NCT02062060|Head Lice|head lice
257873|NCT02062060|Hatchtech|hatchtech
257874|NCT02062047|Diabetes Mellitus|diabetes mellitus
257875|NCT02062047|Chronic Periodontitis|chronic periodontitis
257876|NCT02062047|Root Planing|root planing
257877|NCT02062047|Cytokines|cytokines
257878|NCT02062047|microbiology|microbiology
257879|NCT02062047|Glycated hemoglobin|glycated hemoglobin
257880|NCT02062047|diabetic subjects|diabetic subjects
257881|NCT02062034|Oxidative stress|oxidative stress
257882|NCT02062034|Mitochondrial dysfunction|mitochondrial dysfunction
257883|NCT02062034|Ubiquinone|ubiquinone
257884|NCT02062034|Antioxidant combined therapy|antioxidant combined therapy
257885|NCT02062034|Diabetic retinopathy|diabetic retinopathy
257886|NCT02062008|Positron Emission Tomography-Magnetic Resonance Imaging|positron emission tomography-magnetic resonance imaging
257887|NCT02062008|Cardiac Disease|cardiac disease
257888|NCT02061995|Bone Diseases|bone diseases
257889|NCT02061995|Metabolic Bone Diseases|metabolic bone diseases
257890|NCT02061995|Osteoporosis|osteoporosis
257891|NCT02061995|Bone Fractures|bone fractures
257892|NCT02061995|Osteoporotic Fractures|osteoporotic fractures
257893|NCT02061995|Musculoskeletal Diseases|musculoskeletal diseases
257894|NCT02061982|Do It Yourself (DIY)|do it yourself (diy)
257895|NCT02061982|Caffeine|caffeine
257896|NCT02061982|Cognition|cognition
257897|NCT02061969|nursing home facility|nursing home facility
257898|NCT02061969|long-term care facility|long-term care facility
257899|NCT02061969|older patients|older patients
257900|NCT02061969|elderly patients|elderly patients
257901|NCT02061969|hyperglycemia|hyperglycemia
257902|NCT02061969|type 2 diabetes|type 2 diabetes
257903|NCT02061943|Spasmodic dysphonia|spasmodic dysphonia
257904|NCT02061943|Laryngeal dystonia|laryngeal dystonia
257905|NCT02061943|Dystonia|dystonia
257906|NCT02061943|Severity|severity
257907|NCT02061930|single tooth|single tooth
257908|NCT02061930|dental implant|dental implant
257909|NCT02061930|aesthetics outcome|aesthetics outcome
257910|NCT02061930|long term|long term
257911|NCT02061930|soft tissue recession|soft tissue recession
257912|NCT02061930|pink esthetic score|pink esthetic score
257913|NCT02061930|white esthetic score|white esthetic score
257914|NCT02061917|Biomarkers|biomarkers
257915|NCT02061917|Tobacco|tobacco
257916|NCT02061917|Tobacco-heating|tobacco-heating
257917|NCT02061917|Smokeless Tobacco|smokeless tobacco
257918|NCT02061917|Snus|snus
257919|NCT02061917|Smoking|smoking
257920|NCT02061917|Exposure|exposure
257921|NCT02061917|Quality of Life|quality of life
257922|NCT02061891|Coronary Stenosis|coronary stenosis
257923|NCT02061891|Coronary Artery Disease|coronary artery disease
257924|NCT02061891|Acute coronary syndrome|acute coronary syndrome
257925|NCT02061891|Percutaneous Coronary Intervention|percutaneous coronary intervention
257926|NCT02061891|Multidetector Computed Tomography|multidetector computed tomography
257927|NCT02061878|ApoE|apoe
257928|NCT02061878|beta-amyloid|beta-amyloid
257929|NCT02061813|Hatchtech|hatchtech
257930|NCT02061800|Unrelated donor transplant|unrelated donor transplant
257931|NCT02061800|Allogenic Stem Cell Transplant|allogenic stem cell transplant
257932|NCT02061800|Adult Bone Marrow Transplant|adult bone marrow transplant
257933|NCT02061800|Pediatric Bone Marrow Transplant|pediatric bone marrow transplant
257934|NCT02061800|Related donor transplant|related donor transplant
257935|NCT02061800|Haploidentical donor transplant|haploidentical donor transplant
257936|NCT02061800|Peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
257937|NCT02061800|Non-malignant disease|non-malignant disease
257938|NCT02061800|Malignant disease|malignant disease
257939|NCT02061800|Bone marrow failure syndrome|bone marrow failure syndrome
257940|NCT02061800|Severe Aplastic Anemia|severe aplastic anemia
257941|NCT02061800|Severe Congenital Neutropenia|severe congenital neutropenia
257942|NCT02061800|Amegakaryocytic Thrombocytopenia|amegakaryocytic thrombocytopenia
257943|NCT02061800|Diamond-Blackfan Anemia|diamond-blackfan anemia
257944|NCT02061800|Schwachman Diamond Syndrome|schwachman diamond syndrome
257945|NCT02061800|Primary Immunodeficiency Syndrome|primary immunodeficiency syndrome
257946|NCT02061800|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
257947|NCT02061800|Histiocytic Syndrome|histiocytic syndrome
257948|NCT02061800|Familial Hemophagocytic Lymphocytosis|familial hemophagocytic lymphocytosis
257949|NCT02061800|Lymphohistiocytosis|lymphohistiocytosis
257950|NCT02061800|Macrophage Activation Syndrome|macrophage activation syndrome
257951|NCT02061800|Langerhans Cell Histiocytosis (LCH)|langerhans cell histiocytosis (lch)
257952|NCT02061800|Hemoglobinopathies|hemoglobinopathies
257953|NCT02061800|Reduced-Intensity Conditioning|reduced-intensity conditioning
257954|NCT02061800|Sickle Cell Disease|sickle cell disease
257955|NCT02061800|Sickle Cell-beta-thalassemia|sickle cell-beta-thalassemia
257956|NCT02061774|acetaminophen in transforaminal lumbar interbody fusion|acetaminophen in transforaminal lumbar interbody fusion
257957|NCT02061735|skin imaging|skin imaging
257958|NCT02061735|image analysis|image analysis
257959|NCT02061735|infrared thermography|infrared thermography
257960|NCT02061735|infantile hemangioma|infantile hemangioma
257961|NCT02061735|three dimensional imaging|three dimensional imaging
257962|NCT02061735|color imaging and analysis|color imaging and analysis
257963|NCT02061735|propranolol|propranolol
257964|NCT02061735|timolol|timolol
257965|NCT02061735|ontogeny|ontogeny
257966|NCT02061709|Rhinoconjunctivitis|rhinoconjunctivitis
257967|NCT02061709|Rhinitis|rhinitis
257968|NCT02061709|Seasonal|seasonal
257969|NCT02061709|Ragweed|ragweed
257970|NCT02061709|Allergy|allergy
257971|NCT02061696|Coronary Artery Disease|coronary artery disease
257972|NCT02061696|Coronary Disease|coronary disease
257973|NCT02061696|Heart disease|heart disease
257974|NCT02061696|Cardiovascular Diseases|cardiovascular diseases
257975|NCT02061696|Arteriosclerosis|arteriosclerosis
257976|NCT02061696|Atherosclerosis|atherosclerosis
257977|NCT02061696|Manual Compression|manual compression
257978|NCT02061670|Ragweed|ragweed
257979|NCT02061670|Allergy|allergy
257980|NCT02061670|rhinoconjunctivitis|rhinoconjunctivitis
257981|NCT02061670|rhinitis|rhinitis
257982|NCT02061670|asthma|asthma
257983|NCT02061618|South Asian|south asian
257984|NCT02061605|Laparoscopic partial nephrectomy|laparoscopic partial nephrectomy
257985|NCT02061605|Surgical hemostasis|surgical hemostasis
257986|NCT02061605|Laser tissue welding|laser tissue welding
257987|NCT02061605|Tissue sealant|tissue sealant
257988|NCT02061579|Physical Activity|physical activity
257989|NCT02061566|Acute kidney injury|acute kidney injury
257990|NCT02061553|traumatic brain injury|traumatic brain injury
257991|NCT02061553|TBI|tbi
257992|NCT02061553|head injury|head injury
257993|NCT02061553|brain injury|brain injury
257994|NCT02061553|depression|depression
257995|NCT02061553|anxiety|anxiety
257996|NCT02061527|ADM|adm
257997|NCT02061527|Strattice|strattice
257998|NCT02061527|Breast reconstruction|breast reconstruction
257999|NCT02061527|Immediate breast reconstruction|immediate breast reconstruction
258000|NCT02061527|IBR|ibr
258001|NCT02061527|Acellular dermal matrix|acellular dermal matrix
258002|NCT02061527|Biological mesh|biological mesh
258003|NCT02061527|Randomized controlled trial|randomized controlled trial
258004|NCT02061527|RCT|rct
258005|NCT02061527|Breast cancer|breast cancer
258006|NCT02061527|Implants|implants
258007|NCT02061527|Mastectomy|mastectomy
258008|NCT02061527|Direct-to-implant|direct-to-implant
258009|NCT02061501|visual cognitive deficits|visual cognitive deficits
258010|NCT02061488|Artificial pancreas, closed loop glucose control, model predictive control|artificial pancreas, closed loop glucose control, model predictive control
258011|NCT02061475|Lidocaine patches|lidocaine patches
258012|NCT02061475|Pain|pain
258013|NCT02061475|Intravenous cannulation|intravenous cannulation
258701|NCT02058407|FTIH|ftih
258014|NCT02061449|Toll-like receptor agonist|toll-like receptor agonist
258015|NCT02061449|immunostimulation|immunostimulation
258016|NCT02061436|chronic total occlusion, percutaneous coronary intervention|chronic total occlusion, percutaneous coronary intervention
258017|NCT02061423|Invasive Breast Cancer|invasive breast cancer
258018|NCT02061423|Breast Cancer|breast cancer
258019|NCT02061423|Immunotherapy|immunotherapy
258020|NCT02061423|Vaccine|vaccine
258021|NCT02061423|Dendritic Cell|dendritic cell
258022|NCT02061423|Neoadjuvant|neoadjuvant
258023|NCT02061410|Elderly|elderly
258024|NCT02061397|lymphangioleiomyomatosis (LAM)|lymphangioleiomyomatosis (lam)
258025|NCT02061397|tuberous sclerosis complex (TSC)|tuberous sclerosis complex (tsc)
258026|NCT02061397|simvastatin|simvastatin
258027|NCT02061397|sirolimus|sirolimus
258028|NCT02061397|everolimus|everolimus
258029|NCT02061384|Infertility|infertility
258030|NCT02061371|stroke|stroke
258031|NCT02061371|spasticity|spasticity
258032|NCT02061371|physiotherapy|physiotherapy
258033|NCT02061371|virtual reality|virtual reality
258034|NCT02061358|Dengue|dengue
258035|NCT02061358|Arbovirus Infections|arbovirus infections
258036|NCT02061358|Flaviviridae Infections|flaviviridae infections
258037|NCT02061358|Flavivirus Infections|flavivirus infections
258038|NCT02061358|Hemorrhagic Fevers, Viral|hemorrhagic fevers, viral
258039|NCT02061358|RNA Virus Infections|rna virus infections
258040|NCT02061358|Virus Diseases|virus diseases
258041|NCT02061358|Pharmaceutical Solutions|pharmaceutical solutions
258042|NCT02061358|Pharmacologic Actions|pharmacologic actions
258043|NCT02061358|Therapeutic Uses|therapeutic uses
258044|NCT02061345|Prostate cancer|prostate cancer
258045|NCT02061345|Androgen Deprivation Therapy|androgen deprivation therapy
258046|NCT02061345|Mild Cognitive Impairment|mild cognitive impairment
258047|NCT02061332|Breast Cancer|breast cancer
258048|NCT02061332|DCIS|dcis
258049|NCT02061332|Immunotherapy|immunotherapy
258050|NCT02061332|Vaccine|vaccine
258051|NCT02061332|Dendritic Cell|dendritic cell
258052|NCT02061306|Celiac disease|celiac disease
258053|NCT02061306|coeliac disease|coeliac disease
258054|NCT02061306|microbiome|microbiome
258055|NCT02061306|gluten|gluten
258056|NCT02061306|infants|infants
258057|NCT02061306|pregnancy|pregnancy
258058|NCT02061306|genetic|genetic
258059|NCT02061280|Asthma|asthma
258060|NCT02061280|Clinical Trial Design|clinical trial design
258061|NCT02061280|Electronic Data Entry|electronic data entry
258062|NCT02061280|Mobile Devices|mobile devices
258063|NCT02061280|Home Spirometry|home spirometry
258064|NCT02061267|Metabolic Syndrome|metabolic syndrome
258065|NCT02061267|Olive Oil|olive oil
258066|NCT02061267|Niacin|niacin
258067|NCT02061254|Venous insufficiency|venous insufficiency
258068|NCT02061254|Lymphedema|lymphedema
258069|NCT02061254|Elastograph|elastograph
258070|NCT02061254|Ultrasonography|ultrasonography
258071|NCT02061254|Fibrosis|fibrosis
258072|NCT02061254|Dermis|dermis
258073|NCT02061254|Hypodermis|hypodermis
258074|NCT02061254|Skin|skin
258075|NCT02061241|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
258076|NCT02061241|Pacing|pacing
258077|NCT02061215|CYTOF|cytof
258078|NCT02061215|CMV|cmv
258079|NCT02061215|PCR|pcr
258080|NCT02061215|HLA|hla
258081|NCT02061202|Sickle Cell Disease|sickle cell disease
258082|NCT02061202|Pain Crisis|pain crisis
258083|NCT02061202|Painful Crisis|painful crisis
258084|NCT02061202|Sickle Pain|sickle pain
258085|NCT02061189|neuromuscular disease, Spinal Muscular Atrophy, Infantile,|neuromuscular disease, spinal muscular atrophy, infantile,
258086|NCT02061189|motor function measure, Hammersmith scale,|motor function measure, hammersmith scale,
258087|NCT02061189|rehabilitation program, physical exercise|rehabilitation program, physical exercise
258088|NCT02061176|Hemorrhoids|hemorrhoids
258089|NCT02061176|Haemorrhoids|haemorrhoids
258090|NCT02061176|Transanal Haemorrhoidal Dearterialization|transanal haemorrhoidal dearterialization
258091|NCT02061176|Transanal Hemorrhoidal Dearterialisation|transanal hemorrhoidal dearterialisation
258092|NCT02061176|Open Haemorrhoidectomy|open haemorrhoidectomy
258093|NCT02061176|Open Hemorrhoidectomy|open hemorrhoidectomy
258094|NCT02061150|Early onset GBS sepsis|early onset gbs sepsis
258095|NCT02061150|Prevention|prevention
258096|NCT02061150|Maternal risk factors|maternal risk factors
258097|NCT02061137|Rett Syndrome (Mecp2 positive)|rett syndrome (mecp2 positive)
258098|NCT02061137|Fingolimod (FTY 720)|fingolimod (fty 720)
258099|NCT02061137|BDNF|bdnf
258100|NCT02061137|Brain Atrophy|brain atrophy
258101|NCT02061111|Mitochondria Function|mitochondria function
258102|NCT02061111|TPO-antibodies|tpo-antibodies
258103|NCT02061111|Subclinical Thyroid Disease|subclinical thyroid disease
258104|NCT02061111|Thyroid Disease In Pregnancy|thyroid disease in pregnancy
258105|NCT02061111|Children´s Development|children´s development
258106|NCT02061098|Pomegranate|pomegranate
258107|NCT02061098|Cardiovascular|cardiovascular
258108|NCT02061098|Urolithins|urolithins
258109|NCT02061098|Microbiota|microbiota
258110|NCT02061098|Polyphenols|polyphenols
258111|NCT02061098|Nutraceutical|nutraceutical
258112|NCT02061098|Dietary supplement|dietary supplement
258113|NCT02061085|Breast Neoplasm Metastasis|breast neoplasm metastasis
258114|NCT02061085|Receptor,HER-2|receptor,her-2
258115|NCT02061085|Eribulin|eribulin
258116|NCT02061085|Furans, quetones|furans, quetones
258117|NCT02061085|Antimitotic agent|antimitotic agent
258118|NCT02061072|pharmacokinetics|pharmacokinetics
258119|NCT02061072|population pharmacokinetics|population pharmacokinetics
258120|NCT02061072|hemophilia|hemophilia
258121|NCT02061072|factor VIII|factor viii
258122|NCT02061072|factor IX|factor ix
258123|NCT02061046|Gait|gait
258124|NCT02061046|Dual task|dual task
258125|NCT02061033|Hemophilia A|hemophilia a
258126|NCT02061033|Hemophilia B|hemophilia b
258127|NCT02061033|Von Willebrand's Disease|von willebrand's disease
258128|NCT02061033|Endogen thrombin potential|endogen thrombin potential
258129|NCT02061033|Overall hemostatic potential|overall hemostatic potential
258130|NCT02061033|Microparticles|microparticles
258131|NCT02061033|Fibrin clot|fibrin clot
258132|NCT02061020|delta-9-tetrahydrocannabinol, volunteers, cannabis users|delta-9-tetrahydrocannabinol, volunteers, cannabis users
258133|NCT02061007|skin cancer|skin cancer
258134|NCT02060981|Randomized controlled trial|randomized controlled trial
258135|NCT02060981|Primary medication adherence|primary medication adherence
258136|NCT02060981|Decision-support tool|decision-support tool
258137|NCT02060981|Patient-centered outcomes research|patient-centered outcomes research
258138|NCT02060981|Antihypertensive medications|antihypertensive medications
258139|NCT02060981|One-on-one patient interviews|one-on-one patient interviews
258140|NCT02060968|Promus PREMIER|promus premier
258141|NCT02060968|Routine Clinical Practice|routine clinical practice
258142|NCT02060955|Glioblastoma multiforme|glioblastoma multiforme
258143|NCT02060955|Immunotherapy|immunotherapy
258144|NCT02060955|Bevacizumab/Irinotecan|bevacizumab/irinotecan
258145|NCT02060955|ALECSAT|alecsat
258146|NCT02060955|recurrent|recurrent
258147|NCT02060942|Volume responsiveness mean systemic filling pressure|volume responsiveness mean systemic filling pressure
258148|NCT02060929|Healthy|healthy
258149|NCT02060929|Esketamine|esketamine
258150|NCT02060929|Intranasal|intranasal
258151|NCT02060929|Nasal Guide|nasal guide
258152|NCT02060929|Pharmacokinetics|pharmacokinetics
258153|NCT02060903|Head Lice|head lice
258154|NCT02060903|Hatchtech|hatchtech
258155|NCT02060890|Glioblastoma|glioblastoma
258156|NCT02060877|suspected lung cancer|suspected lung cancer
258157|NCT02060877|diagnostic work-up|diagnostic work-up
258158|NCT02060864|enzyme|enzyme
258159|NCT02060864|gluten|gluten
258160|NCT02060864|food intolerance|food intolerance
258161|NCT02060851|EPO|epo
258162|NCT02060851|Intravenous iron|intravenous iron
258163|NCT02060851|iron storage|iron storage
258164|NCT02060851|preterm anemia|preterm anemia
258165|NCT02060812|ultrasound guided axillary nerve block|ultrasound guided axillary nerve block
258166|NCT02060812|arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
258167|NCT02060812|ultrasound guided suprascapular nerve block|ultrasound guided suprascapular nerve block
258168|NCT02060812|rebound phenomenon of pain|rebound phenomenon of pain
258169|NCT02060799|Dyspnea|dyspnea
258170|NCT02060799|Emergency Service, Hospital|emergency service, hospital
258171|NCT02060799|prognosis|prognosis
258172|NCT02060799|Fatal Outcome|fatal outcome
258173|NCT02060799|Epidemiology|epidemiology
258174|NCT02060786|Antiplatelet; clopidogrel; acute coronary syndrome|antiplatelet; clopidogrel; acute coronary syndrome
258175|NCT02060773|Septic shock|septic shock
258176|NCT02060773|Early goal directed therapy|early goal directed therapy
258177|NCT02060773|Fluid resuscitation|fluid resuscitation
258178|NCT02060773|Hepatic perfusion|hepatic perfusion
258179|NCT02060773|Indocyanine Green|indocyanine green
258180|NCT02060760|Prospective cohort study|prospective cohort study
258181|NCT02060760|Diagnostic accuracy|diagnostic accuracy
258182|NCT02060760|High sensitivity versus contemporary troponin I assay|high sensitivity versus contemporary troponin i assay
258183|NCT02060760|Gender|gender
258184|NCT02060760|Renal Function|renal function
258185|NCT02060734|Whiplash,|whiplash,
258186|NCT02060734|injection,|injection,
258187|NCT02060734|lidocaine,|lidocaine,
258188|NCT02060734|sham needling|sham needling
258189|NCT02060721|Chronic thromboembolic pulmonary hypertension (CTEPH)|chronic thromboembolic pulmonary hypertension (cteph)
258190|NCT02060695|Parkinson disease|parkinson disease
258191|NCT02060682|Fractional Flow Reserve|fractional flow reserve
258192|NCT02060682|Rapid Exchange|rapid exchange
258193|NCT02060682|Catheter|catheter
258194|NCT02060656|Relapsed or refractory Diffuse Large B-Cell Lymphoma after R-CHOP chemotherapy|relapsed or refractory diffuse large b-cell lymphoma after r-chop chemotherapy
258195|NCT02060630|Surgical revascularization|surgical revascularization
258196|NCT02060630|Endovascular revascularization|endovascular revascularization
258197|NCT02060630|Amputation|amputation
258198|NCT02060630|Peripheral artery disease|peripheral artery disease
258199|NCT02060630|Critical limb ischemia|critical limb ischemia
258200|NCT02060630|claudication|claudication
258201|NCT02060630|leg pain|leg pain
258202|NCT02060630|leg ulcer|leg ulcer
258203|NCT02060630|gangrene|gangrene
258204|NCT02060617|low back pain|low back pain
258205|NCT02060617|physical therapy|physical therapy
258206|NCT02060617|manual therapy|manual therapy
258207|NCT02060617|manipulation|manipulation
258209|NCT02060617|motor control|motor control
258210|NCT02060617|regional interdependence|regional interdependence
258211|NCT02060604|ketorolac|ketorolac
258212|NCT02060604|NSAIDs|nsaids
258213|NCT02060604|wet macular degeneration|wet macular degeneration
258214|NCT02060604|choroidal neovascularization|choroidal neovascularization
258215|NCT02060578|Cancer palliative care|cancer palliative care
258216|NCT02060578|Dead child|dead child
258217|NCT02060565|diagnosis|diagnosis
258218|NCT02060565|survival|survival
258219|NCT02060565|non-invasive method|non-invasive method
258220|NCT02060565|cirrhosis|cirrhosis
258221|NCT02060565|FibroScan|fibroscan
258222|NCT02060526|sulfoglucosamine sulfohydrolase (SGSH)|sulfoglucosamine sulfohydrolase (sgsh)
258223|NCT02060526|recombinant human heparan N-sulfatase (rhHNS)|recombinant human heparan n-sulfatase (rhhns)
258224|NCT02060526|Hunter's Syndrome|hunter's syndrome
258225|NCT02060526|Shire HGT|shire hgt
258226|NCT02060526|Lysosomal Storage Disease (LSD)|lysosomal storage disease (lsd)
258227|NCT02060526|Sanfilippo Syndrome Type A (Sanfilippo A)|sanfilippo syndrome type a (sanfilippo a)
258228|NCT02060526|enzyme replacement therapy (ERT)|enzyme replacement therapy (ert)
258229|NCT02060513|Wounded warriors|wounded warriors
258230|NCT02060513|Battlefield infection|battlefield infection
258231|NCT02060513|Acinetobacter|acinetobacter
258232|NCT02060513|ESBL|esbl
258233|NCT02060513|MRSA|mrsa
258234|NCT02060513|KPC|kpc
258235|NCT02060500|GERD|gerd
258236|NCT02060500|fundoplication|fundoplication
258237|NCT02060500|cardiaplication|cardiaplication
258238|NCT02060500|reflux|reflux
258239|NCT02060487|pulmonary arterial hypertension|pulmonary arterial hypertension
258240|NCT02060487|pulmonary hypertension|pulmonary hypertension
258241|NCT02060487|PAH|pah
258242|NCT02060487|sildenafil|sildenafil
258243|NCT02060487|revatio|revatio
258244|NCT02060474|Allan-Herndon-Dudley Syndrome|allan-herndon-dudley syndrome
258245|NCT02060474|MCT8|mct8
258246|NCT02060474|Triac|triac
258247|NCT02060474|Therapeutic Trial|therapeutic trial
258248|NCT02060448|Non-suicidal self-injury|non-suicidal self-injury
258249|NCT02060448|Self-injurious behavior|self-injurious behavior
258251|NCT02060448|Anxiety|anxiety
258252|NCT02060448|Depression|depression
258253|NCT02060448|Transdiagnostic|transdiagnostic
258254|NCT02060448|CBT|cbt
258255|NCT02060448|Unified Protocol|unified protocol
258256|NCT02060435|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
258257|NCT02060435|Ebstein-Barr Virus|ebstein-barr virus
258258|NCT02060422|Epilepsy|epilepsy
258259|NCT02060422|Drug-resistant epilepsy|drug-resistant epilepsy
258260|NCT02060422|Seizure|seizure
258261|NCT02060422|Mindfulness|mindfulness
258262|NCT02060422|Stress|stress
258263|NCT02060422|Psychotherapy|psychotherapy
258264|NCT02060409|myelodysplastic syndrome|myelodysplastic syndrome
258265|NCT02060409|decitabine|decitabine
258266|NCT02060409|spliceosome mutation|spliceosome mutation
258267|NCT02060383|Cushing's disease|cushing's disease
258268|NCT02060383|acromegaly|acromegaly
258269|NCT02060383|pasireotide|pasireotide
258270|NCT02060383|hyperglycemia|hyperglycemia
258271|NCT02060370|Genitourinary Cancer|genitourinary cancer
258272|NCT02060370|Kidney Cancer|kidney cancer
258273|NCT02060370|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
258274|NCT02060370|mRCC|mrcc
258275|NCT02060370|Sunitinib|sunitinib
258276|NCT02060370|Sunitinib malate|sunitinib malate
258277|NCT02060370|SUO11248|suo11248
258278|NCT02060370|Sutent|sutent
258279|NCT02060370|Questionnaire|questionnaire
258280|NCT02060370|Survey|survey
258281|NCT02060357|Diabetes Mellitus|diabetes mellitus
258282|NCT02060357|PCI|pci
258283|NCT02060357|Drug eluting stent|drug eluting stent
258284|NCT02060357|OCT|oct
258285|NCT02060344|Cardiovascular Disease|cardiovascular disease
258286|NCT02060344|Hispanic|hispanic
258287|NCT02060344|Latinos|latinos
258288|NCT02060331|Nocturia|nocturia
258289|NCT02060331|Pelvic Organ Prolapse|pelvic organ prolapse
258290|NCT02060331|Nocturnal Polyuria|nocturnal polyuria
258291|NCT02060331|Post-obstructive Diuresis|post-obstructive diuresis
258292|NCT02060318|Crohn Disease|crohn disease
258293|NCT02060318|Regulatory T-cells|regulatory t-cells
258294|NCT02060318|Infliximab|infliximab
258295|NCT02060292|COPD|copd
258296|NCT02060292|Cognitive Function|cognitive function
258297|NCT02060292|MRI Brain|mri brain
258298|NCT02060292|Aortic Stiffness|aortic stiffness
258299|NCT02060292|Cerebrovascular disease|cerebrovascular disease
258300|NCT02060279|Obesity|obesity
258301|NCT02060279|Diabetes Mellitus|diabetes mellitus
258302|NCT02060279|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
258303|NCT02060279|Prevention|prevention
258304|NCT02060279|Behavioral research|behavioral research
258305|NCT02060279|Metabolic Syndrome|metabolic syndrome
258306|NCT02060279|Metabolic Disease|metabolic disease
258307|NCT02060279|Overnutrition|overnutrition
258308|NCT02060279|Nutrition Disorders|nutrition disorders
258309|NCT02060279|Overweight|overweight
258310|NCT02060279|Body weight|body weight
258311|NCT02060279|Insulin resistance|insulin resistance
258312|NCT02060279|Carotenoids|carotenoids
258313|NCT02060279|Dietary Supplement|dietary supplement
258314|NCT02060279|Physical fitness|physical fitness
258315|NCT02060279|Sedentary lifestyle|sedentary lifestyle
258316|NCT02060240|Obesity|obesity
258317|NCT02060240|Prediabetic State|prediabetic state
258318|NCT02060240|Sedentary Lifestyle|sedentary lifestyle
258319|NCT02060240|Insulin Resistance|insulin resistance
258320|NCT02060240|Endothelium|endothelium
258321|NCT02060240|Eicosanoids|eicosanoids
258322|NCT02060240|Nitric Oxide|nitric oxide
258323|NCT02060240|Regional Blood Flow|regional blood flow
258324|NCT02060175|Optical coherence tomography, Drug-eluting stent, Strut coverage|optical coherence tomography, drug-eluting stent, strut coverage
258325|NCT02060162|antiretroviral therapy|antiretroviral therapy
258326|NCT02060162|Hepatitis C virus|hepatitis c virus
258327|NCT02060149|Extensively Drug Resistant A. Baumannii|extensively drug resistant a. baumannii
258328|NCT02060136|Electronic micturition chart, validation|electronic micturition chart, validation
258329|NCT02060123|Qigong|qigong
258330|NCT02060123|Telomerase|telomerase
258331|NCT02060123|Perceived stress|perceived stress
258332|NCT02060123|RCT|rct
258333|NCT02060123|Chinese|chinese
258334|NCT02060123|Abused women|abused women
258335|NCT02060123|intervention|intervention
258336|NCT02060123|Depression|depression
258337|NCT02060110|CRT|crt
258338|NCT02060110|HEART FAILURE|heart failure
258339|NCT02060097|Anti-aging|anti-aging
258340|NCT02060097|High-flavanol cocoa|high-flavanol cocoa
258341|NCT02060084|preterm;|preterm;
258342|NCT02060084|Intestinal flora;|intestinal flora;
258343|NCT02060084|early Micro-feeding|early micro-feeding
258344|NCT02060084|Feeding intolerance|feeding intolerance
258345|NCT02060071|aortic stenosis|aortic stenosis
258346|NCT02060058|hepatitis C virus|hepatitis c virus
258347|NCT02060058|hepatitis B virus|hepatitis b virus
258348|NCT02060058|boceprevir|boceprevir
258349|NCT02060058|null responder|null responder
258350|NCT02060058|partial responder|partial responder
258351|NCT02060058|relapser|relapser
258352|NCT02060045|bundle|bundle
258353|NCT02060045|prevention|prevention
258354|NCT02060045|Disturbance; Heart, Functional, Postoperative, Cardiac Surgery|disturbance; heart, functional, postoperative, cardiac surgery
258355|NCT02060032|Chronic periodontitis, Local drug delivery,|chronic periodontitis, local drug delivery,
258356|NCT02060019|Pharmacokinetics|pharmacokinetics
258357|NCT02060019|Pharmacodynamics|pharmacodynamics
258358|NCT02060019|Safety|safety
258359|NCT02060019|Tolerability|tolerability
258360|NCT02060006|TB|tb
258361|NCT02060006|IRIS|iris
258362|NCT02059993|continuous positive airway pressure|continuous positive airway pressure
258363|NCT02059993|hypertension|hypertension
258364|NCT02059993|coronary heart disease|coronary heart disease
258365|NCT02059993|metabolic disorder|metabolic disorder
258366|NCT02059993|obstructive sleep apnea|obstructive sleep apnea
258367|NCT02059980|OCD|ocd
258368|NCT02059980|Trichotillomania|trichotillomania
258369|NCT02059980|Response inhibition|response inhibition
258370|NCT02059980|Cognitive training|cognitive training
258371|NCT02059967|Lung|lung
258372|NCT02059954|Hysterectomy|hysterectomy
258373|NCT02059941|Severe traumatic brain injury, ICP, Latin America, outcomes|severe traumatic brain injury, icp, latin america, outcomes
258374|NCT02059928|fluid resuscitation|fluid resuscitation
258375|NCT02059928|invasive pressure monitoring|invasive pressure monitoring
258376|NCT02059915|pharmacokinetics|pharmacokinetics
258377|NCT02059915|bioequivalence|bioequivalence
258378|NCT02059915|bioavailability|bioavailability
258379|NCT02059915|oxycodone|oxycodone
258380|NCT02059902|Pain management|pain management
258381|NCT02059902|Narcotic consumption|narcotic consumption
258382|NCT02059902|Skin graft|skin graft
258383|NCT02059889|Lung|lung
258384|NCT02059876|breast cancer|breast cancer
258385|NCT02059876|dose dense|dose dense
258386|NCT02059876|neoadjuvant treatment|neoadjuvant treatment
258387|NCT02059876|pathologic complete response|pathologic complete response
258388|NCT02059863|cluster randomised trial|cluster randomised trial
258389|NCT02059863|low and middle income countries|low and middle income countries
258390|NCT02059863|community based intervention|community based intervention
258391|NCT02059863|complex intervention|complex intervention
258392|NCT02059824|Eyelid sensation, aesthesiometer|eyelid sensation, aesthesiometer
258393|NCT02059811|Kidney Diseases|kidney diseases
258394|NCT02059811|Renal Insufficiency, Chronic|renal insufficiency, chronic
258395|NCT02059811|Diet|diet
258396|NCT02059811|DASH diet|dash diet
258397|NCT02059811|Hypertension|hypertension
258398|NCT02059811|Vascular diseases|vascular diseases
258399|NCT02059811|Cardiovascular Diseases|cardiovascular diseases
258400|NCT02059811|Blood pressure|blood pressure
258401|NCT02059798|Myelopathy|myelopathy
258402|NCT02059785|Pinocembrin for Injection|pinocembrin for injection
258403|NCT02059785|Placebo|placebo
258404|NCT02059785|mRS|mrs
258405|NCT02059759|low-dose interleukin 2|low-dose interleukin 2
258406|NCT02059746|cesarean section|cesarean section
258407|NCT02059746|vaginal birth|vaginal birth
258408|NCT02059746|twins|twins
258409|NCT02059746|urinary incontinence|urinary incontinence
258410|NCT02059746|sexuality|sexuality
258411|NCT02059746|quality of life|quality of life
258412|NCT02059733|18F-DTBZ|18f-dtbz
258413|NCT02059720|acute myeloid leukemia|acute myeloid leukemia
258414|NCT02059720|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
258415|NCT02059720|autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
258416|NCT02059720|maintenance treatment|maintenance treatment
258417|NCT02059720|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
258418|NCT02059694|Eyelid surgery|eyelid surgery
258419|NCT02059694|local block/anesthesia|local block/anesthesia
258420|NCT02059694|hyaluronidase|hyaluronidase
258421|NCT02059694|Bilateral upper eyelid surgery|bilateral upper eyelid surgery
258422|NCT02059694|Duke Eye Centre|duke eye centre
258423|NCT02059694|Duke Aesthetic Center|duke aesthetic center
258424|NCT02059668|locally advanced head and neck cancer|locally advanced head and neck cancer
258425|NCT02059668|biomarkers|biomarkers
258426|NCT02059668|definitive treatment|definitive treatment
258427|NCT02059668|adjuvant treatment|adjuvant treatment
258428|NCT02059668|radiochemotherapy|radiochemotherapy
258429|NCT02059655|Graves' disease|graves' disease
258430|NCT02059629|Heart failure|heart failure
258431|NCT02059629|Eluna pacemaker family|eluna pacemaker family
258432|NCT02059629|Sentus OTW BP L left ventricular lead|sentus otw bp l left ventricular lead
258433|NCT02059629|Bradycardia|bradycardia
258434|NCT02059629|SADE-free rate|sade-free rate
258435|NCT02059603|Electroacupuncture|electroacupuncture
258436|NCT02059603|Fast track program|fast track program
258437|NCT02059603|Postoperative ileus|postoperative ileus
258438|NCT02059603|Laparoscopic surgery|laparoscopic surgery
258439|NCT02059603|Colorectal surgery|colorectal surgery
258440|NCT02059603|Randomized controlled trial|randomized controlled trial
258441|NCT02059603|Hospital stay|hospital stay
258442|NCT02059590|14C-labeled isavuconazonium sulfate|14c-labeled isavuconazonium sulfate
258443|NCT02059590|Pyridinylmethyl-14C-labeled isavuconazonium sulfate|pyridinylmethyl-14c-labeled isavuconazonium sulfate
258444|NCT02059590|Healthy Subjects|healthy subjects
258445|NCT02059590|BAL8728|bal8728
258446|NCT02059590|BAL4815|bal4815
258447|NCT02059577|vitamins|vitamins
258448|NCT02059577|minerals|minerals
258449|NCT02059577|essential fatty acids|essential fatty acids
258450|NCT02059577|Epsom salts|epsom salts
258451|NCT02059577|carnitine|carnitine
258452|NCT02059577|digestive enzymes|digestive enzymes
258453|NCT02059577|gluten-free casein-free diet|gluten-free casein-free diet
258454|NCT02059564|Diabetes Mellitus|diabetes mellitus
258455|NCT02059564|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
258456|NCT02059564|Glucose Metabolism Disorders|glucose metabolism disorders
258457|NCT02059564|Metabolic Diseases|metabolic diseases
258458|NCT02059564|Endocrine System Diseases|endocrine system diseases
258459|NCT02059564|Exendin-4|exendin-4
258460|NCT02059551|pulmonary embolism|pulmonary embolism
258461|NCT02059551|magnetic resonance imaging|magnetic resonance imaging
258462|NCT02059551|venous ultrasonography of the legs|venous ultrasonography of the legs
258463|NCT02059551|diagnostic performances|diagnostic performances
258464|NCT02059538|Obesity|obesity
258465|NCT02059538|Type 2 diabetes|type 2 diabetes
258466|NCT02059538|Coronary artery diseases|coronary artery diseases
258467|NCT02059538|Microbiota|microbiota
258468|NCT02059538|Omics (ie transcriptomics, metabolomics, metagenomics, lipidomics)|omics (ie transcriptomics, metabolomics, metagenomics, lipidomics)
258469|NCT02059525|observational|observational
258470|NCT02059525|Belgium|belgium
258471|NCT02059512|ischemic heart disease,|ischemic heart disease,
258472|NCT02059512|autologous bone marrow mononuclear cells|autologous bone marrow mononuclear cells
258473|NCT02059512|coronary artery bypass grafting|coronary artery bypass grafting
258474|NCT02059460|Terlipressin|terlipressin
258475|NCT02059460|Acute kidney injury|acute kidney injury
258476|NCT02059460|Liver transplantation|liver transplantation
258477|NCT02059460|NGAL|ngal
258478|NCT02059447|Controlled trial|controlled trial
258479|NCT02059447|Active control|active control
258480|NCT02059447|Waiting, non treatment, period|waiting, non treatment, period
258481|NCT02059447|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
258482|NCT02059447|Relaxation Therapy|relaxation therapy
258483|NCT02059421|Johrei therapy|johrei therapy
258484|NCT02059421|Sleep|sleep
258485|NCT02059421|CBT-I|cbt-i
258486|NCT02059421|Critical illness|critical illness
258487|NCT02059382|daily physical activity|daily physical activity
258488|NCT02059382|exercise|exercise
258489|NCT02059382|social support|social support
258490|NCT02059382|online social network|online social network
258491|NCT02059369|Atrial fibrillation|atrial fibrillation
258492|NCT02059369|Recurrence|recurrence
258493|NCT02059369|CFAE|cfae
258494|NCT02059369|linear ablation|linear ablation
258495|NCT02059356|Dementia|dementia
258496|NCT02059356|Alzheimer's|alzheimer's
258497|NCT02059356|Alzheimers|alzheimers
258498|NCT02059356|Cognitive decline|cognitive decline
258499|NCT02059356|Cognitive impairment|cognitive impairment
258500|NCT02059356|Memory loss|memory loss
258501|NCT02059356|Memory disorder|memory disorder
258502|NCT02059356|Forgetfulness|forgetfulness
258503|NCT02059356|Confusion|confusion
258504|NCT02059356|Senile|senile
258506|NCT02059356|Developmental delay|developmental delay
258507|NCT02059356|Portal systemic shunting|portal systemic shunting
258508|NCT02059356|High ammonia level|high ammonia level
258509|NCT02059356|Elevated ammonia level|elevated ammonia level
258510|NCT02059343|pharmacokinetics|pharmacokinetics
258511|NCT02059343|pharmacodynamics|pharmacodynamics
258512|NCT02059343|safety|safety
258513|NCT02059343|dexmedetomidine|dexmedetomidine
258514|NCT02059343|cardiopulmonary bypass|cardiopulmonary bypass
258515|NCT02059343|children|children
258516|NCT02059330|Japanese PK-Bridging Study|japanese pk-bridging study
258517|NCT02059330|dose-proportionality study|dose-proportionality study
258518|NCT02059330|Palbociclib|palbociclib
258519|NCT02059330|PD-0332991|pd-0332991
258520|NCT02059330|healthy volunteers|healthy volunteers
258521|NCT02059304|cervical length|cervical length
258522|NCT02059304|prediction of preterm delivery|prediction of preterm delivery
258523|NCT02059291|Canakinumab, interleukin-1, Hereditary Periodic Fevers, auto-inflammatory diseases|canakinumab, interleukin-1, hereditary periodic fevers, auto-inflammatory diseases
258524|NCT02059278|Primary open angle glaucoma|primary open angle glaucoma
258525|NCT02059278|Ocular hypertension|ocular hypertension
258526|NCT02059239|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
258527|NCT02059239|Hodgkin's Lymphoma|hodgkin's lymphoma
258528|NCT02059239|Lymphoma|lymphoma
258529|NCT02059239|Transplant|transplant
258530|NCT02059200|Randomised controlled trial|randomised controlled trial
258531|NCT02059200|Recurrent depression|recurrent depression
258532|NCT02059200|Mindfulness training|mindfulness training
258533|NCT02059200|Compassion training (MBCL)|compassion training (mbcl)
258534|NCT02059200|Fear of Compassion|fear of compassion
258535|NCT02059200|Added value Compassion|added value compassion
258536|NCT02059135|Preeclampsia|preeclampsia
258537|NCT02059135|Preterm preeclampsia|preterm preeclampsia
258538|NCT02059135|Pregnancy|pregnancy
258539|NCT02059109|Belmont|belmont
258540|NCT02059109|Rapid|rapid
258541|NCT02059109|Infuser|infuser
258542|NCT02059109|proficiency|proficiency
258543|NCT02059109|proficient|proficient
258544|NCT02059109|training|training
258545|NCT02059096|Multiple Sclerosis|multiple sclerosis
258546|NCT02059096|Repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
258547|NCT02059096|Chronic neuropathic pain|chronic neuropathic pain
258548|NCT02059096|Cortical excitability|cortical excitability
258549|NCT02059083|adolescent|adolescent
258550|NCT02059083|cannabis|cannabis
258551|NCT02059083|biofeedback|biofeedback
258552|NCT02059070|Nerve Block/adverse effects|nerve block/adverse effects
258553|NCT02059070|Phrenic Nerve|phrenic nerve
258554|NCT02059070|Respiratory function|respiratory function
258555|NCT02059070|Pain measurement|pain measurement
258556|NCT02059044|patient safety|patient safety
258557|NCT02059044|pharmacoepidemiology|pharmacoepidemiology
258558|NCT02059044|health services research|health services research
258559|NCT02059044|adherence|adherence
258560|NCT02059044|information technology|information technology
258561|NCT02059031|integrase inhibitor|integrase inhibitor
258562|NCT02059031|pharmacokinetics|pharmacokinetics
258563|NCT02059031|HIV|hiv
258564|NCT02059031|relative bioavailability|relative bioavailability
258565|NCT02059031|food|food
258566|NCT02059031|GSK1265744|gsk1265744
258567|NCT02059005|Addiction|addiction
258568|NCT02059005|Substance Use Disorder|substance use disorder
258569|NCT02059005|Rehospitalization|rehospitalization
258570|NCT02059005|Community Disease Management|community disease management
258571|NCT02059005|Behavioral Health|behavioral health
258572|NCT02059005|Community Health Worker|community health worker
258573|NCT02058992|Drug therapy|drug therapy
258574|NCT02058966|Entacapone|entacapone
258575|NCT02058966|COMT val158met|comt val158met
258576|NCT02058966|Methamphetamine|methamphetamine
258577|NCT02058953|Melanoma|melanoma
258578|NCT02058953|skin cancer|skin cancer
258579|NCT02058953|brain metastases|brain metastases
258580|NCT02058953|craniotomy|craniotomy
258581|NCT02058927|HIV|hiv
258582|NCT02058927|ART|art
258583|NCT02058927|children|children
258584|NCT02058914|Sugar sweetened beverages|sugar sweetened beverages
258585|NCT02058914|metabolism|metabolism
258586|NCT02058914|endocrine|endocrine
258587|NCT02058914|lipids|lipids
258588|NCT02058914|blood glucose|blood glucose
258589|NCT02058901|sunitinib|sunitinib
258590|NCT02058901|solid tumors|solid tumors
258591|NCT02058888|metagenomics|metagenomics
258592|NCT02058888|antimicrobial resistance|antimicrobial resistance
258593|NCT02058888|multidrug resistance|multidrug resistance
258594|NCT02058849|Mucositis|mucositis
258595|NCT02058849|Beetroot|beetroot
258596|NCT02058849|Head and neck cancer|head and neck cancer
258597|NCT02058836|Chronic testicular pain|chronic testicular pain
258598|NCT02058836|Orchialgia|orchialgia
258599|NCT02058836|Botulinum toxin|botulinum toxin
258600|NCT02058836|Botox|botox
258601|NCT02058836|Urology|urology
258602|NCT02058823|Hypoxia|hypoxia
258603|NCT02058823|Sleep apnea|sleep apnea
258604|NCT02058823|Valsartan|valsartan
258605|NCT02058823|Amlodipine|amlodipine
259093|NCT02056691|cancer|cancer
258606|NCT02058823|Healthy subjects|healthy subjects
258607|NCT02058823|Randomized|randomized
258608|NCT02058823|Cross-over|cross-over
258609|NCT02058823|International|international
258610|NCT02058823|Sympathetic nervous system|sympathetic nervous system
258611|NCT02058810|nasal high flow oxygen|nasal high flow oxygen
258612|NCT02058810|cardio-renal syndrom|cardio-renal syndrom
258613|NCT02058810|heartfailure|heartfailure
258614|NCT02058797|Procrastination|procrastination
258615|NCT02058797|Coherence Therapy|coherence therapy
258616|NCT02058797|Cognitive Behavioral Therapy|cognitive behavioral therapy
258617|NCT02058797|Repertory Grid Technique|repertory grid technique
258618|NCT02058797|Cognitive Conflicts|cognitive conflicts
258619|NCT02058797|Personal Dilemmas|personal dilemmas
258620|NCT02058771|Action potential duration restitution|action potential duration restitution
258621|NCT02058771|Ventricular arrhythmia|ventricular arrhythmia
258622|NCT02058771|Sudden cardiac death|sudden cardiac death
258623|NCT02058771|Body-surface potential mapping|body-surface potential mapping
258624|NCT02058771|Electrocardiogram|electrocardiogram
258625|NCT02058758|Breast cancer|breast cancer
258626|NCT02058758|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
258627|NCT02058758|Diffusion weighted imaging|diffusion weighted imaging
258628|NCT02058745|Neuro-oncology|neuro-oncology
258629|NCT02058745|Caregivers|caregivers
258630|NCT02058745|Intervention Research|intervention research
258631|NCT02058745|Representational Approach|representational approach
258632|NCT02058745|Cognitive Behavioral Therapy|cognitive behavioral therapy
258634|NCT02058745|Internet|internet
258635|NCT02058680|prostate specific antigen (PSA)|prostate specific antigen (psa)
258636|NCT02058667|Breast Cancer|breast cancer
258637|NCT02058667|Paclitaxel|paclitaxel
258638|NCT02058667|Helical Tomotherapy|helical tomotherapy
258639|NCT02058667|Chest wall|chest wall
258640|NCT02058654|Creatine|creatine
258641|NCT02058654|Functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
258642|NCT02058654|Phosphorus-31 magnetic resonance spectroscopy (31P-MRS)|phosphorus-31 magnetic resonance spectroscopy (31p-mrs)
258643|NCT02058641|cellular accumulation|cellular accumulation
258644|NCT02058641|macrophage phenotype|macrophage phenotype
258645|NCT02058641|cantharidin blister|cantharidin blister
258646|NCT02058641|M1/M2|m1/m2
258647|NCT02058641|inflammatory mediators|inflammatory mediators
258648|NCT02058641|Type 2 diabetes mellitus|type 2 diabetes mellitus
258649|NCT02058641|darapladib|darapladib
258650|NCT02058641|cytokines|cytokines
258651|NCT02058628|azelaic acid|azelaic acid
258652|NCT02058628|Clindamycin|clindamycin
258653|NCT02058628|Benzoyl peroxide|benzoyl peroxide
258654|NCT02058628|Acne vulgaris|acne vulgaris
258655|NCT02058615|Male caregivers|male caregivers
258656|NCT02058615|Breast cancer|breast cancer
258657|NCT02058615|Intervention|intervention
258658|NCT02058615|Online toolkit|online toolkit
258659|NCT02058602|HRCT|hrct
258660|NCT02058602|Airway morphometry|airway morphometry
258661|NCT02058602|Resistivity|resistivity
258662|NCT02058602|Inhalation Profiles|inhalation profiles
258663|NCT02058602|Inhaler|inhaler
258664|NCT02058602|Pharyngometry|pharyngometry
258665|NCT02058602|Idiopathic Pulmonary Fibrosis (IPF)|idiopathic pulmonary fibrosis (ipf)
258666|NCT02058589|Immunocompromised|immunocompromised
258667|NCT02058589|Safety|safety
258668|NCT02058589|≥ 18 years of age|≥ 18 years of age
258669|NCT02058589|Renal transplant|renal transplant
258670|NCT02058589|Adults|adults
258671|NCT02058589|Immunosuppressed|immunosuppressed
258672|NCT02058589|Immunogenicity|immunogenicity
258673|NCT02058589|Herpes zoster|herpes zoster
258674|NCT02058576|combination of dutasteride 0.5 mg and tamsulosin HCL 0.4 mg|combination of dutasteride 0.5 mg and tamsulosin hcl 0.4 mg
258675|NCT02058576|Tamsulosin|tamsulosin
258676|NCT02058576|healthy subject|healthy subject
258677|NCT02058576|bioequivalence|bioequivalence
258678|NCT02058576|GI198745|gi198745
258679|NCT02058576|dutasteride|dutasteride
258680|NCT02058576|tamsulosin hydrochloride|tamsulosin hydrochloride
258681|NCT02058563|Measles, mumps and rubella diseases|measles, mumps and rubella diseases
258682|NCT02058563|Safety|safety
258683|NCT02058563|Immunogenicity|immunogenicity
258684|NCT02058524|Ulcerative Colitis|ulcerative colitis
258685|NCT02058524|Fecal Microbiota Transplantation|fecal microbiota transplantation
258686|NCT02058498|Liver transplant|liver transplant
258687|NCT02058498|Physical Activity|physical activity
258688|NCT02058498|Quality of Life|quality of life
258689|NCT02058485|hypertension|hypertension
258690|NCT02058485|dexmedetomidine|dexmedetomidine
258691|NCT02058485|midazolam|midazolam
258692|NCT02058485|premedication|premedication
258693|NCT02058459|Chronic obstructive pulmonary disease, targeted lung denervation, intervention, device, safety, lung function, Holaira|chronic obstructive pulmonary disease, targeted lung denervation, intervention, device, safety, lung function, holaira
258694|NCT02058433|Chemotherapy|chemotherapy
258695|NCT02058433|Individual Paclitaxel dose|individual paclitaxel dose
258696|NCT02058433|pharmacokinetics|pharmacokinetics
258697|NCT02058420|bone health|bone health
258698|NCT02058407|food effect|food effect
258699|NCT02058407|pharmacokinetics|pharmacokinetics
258700|NCT02058407|GSK2793660|gsk2793660
258702|NCT02058407|pharmacodynamics|pharmacodynamics
258703|NCT02058407|safety|safety
258704|NCT02058394|Retained nuclear lens fragments|retained nuclear lens fragments
258705|NCT02058394|Phacoemulsification|phacoemulsification
258706|NCT02058394|Cataract Surgery|cataract surgery
258707|NCT02058368|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
258708|NCT02058368|Quality of Life|quality of life
258709|NCT02058342|Prader Willi syndrome|prader willi syndrome
258710|NCT02058342|Obesity|obesity
258711|NCT02058342|Childhood|childhood
258712|NCT02058342|Family|family
258713|NCT02058342|Interactive games|interactive games
258714|NCT02058342|Playground games|playground games
258715|NCT02058342|Exercise routine|exercise routine
258716|NCT02058329|Hip fracture|hip fracture
258717|NCT02058329|postoperative complications|postoperative complications
258718|NCT02058329|Depression|depression
258719|NCT02058329|Environmental Hazards|environmental hazards
258720|NCT02058329|FIM scores|fim scores
258721|NCT02058329|Falls|falls
258722|NCT02058303|hand surgery|hand surgery
258723|NCT02058303|wrist surgery|wrist surgery
258724|NCT02058303|finger surgery|finger surgery
258725|NCT02058303|anesthesia|anesthesia
258726|NCT02058303|regional anesthesia|regional anesthesia
258727|NCT02058303|postoperative pain|postoperative pain
258728|NCT02058290|laparoscopic colectomy|laparoscopic colectomy
258729|NCT02058277|bosutinib|bosutinib
258730|NCT02058277|aprepitant|aprepitant
258731|NCT02058277|drug interaction|drug interaction
258732|NCT02058277|healthy volunteers|healthy volunteers
258733|NCT02058277|pharmacokinetics|pharmacokinetics
258734|NCT02058277|chronic myelogenous leukemia|chronic myelogenous leukemia
258735|NCT02058251|Alcohol|alcohol
258736|NCT02058251|Oxytocin|oxytocin
258737|NCT02058251|Stress reactivity|stress reactivity
258738|NCT02058238|Robotic-guided spinal fusions|robotic-guided spinal fusions
258739|NCT02058238|Scoliosis|scoliosis
258740|NCT02058238|Kyphoscoliosis|kyphoscoliosis
258741|NCT02058238|Spinal deformity|spinal deformity
258742|NCT02058238|Spondylosis|spondylosis
258743|NCT02058225|Infant Nutrition|infant nutrition
258744|NCT02058225|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
258745|NCT02058225|Infant Brain Development|infant brain development
258746|NCT02058225|Diffusion weighted Imaging|diffusion weighted imaging
258747|NCT02058225|Diffusion tensor tractography|diffusion tensor tractography
258749|NCT02058212|antioxidants|antioxidants
258750|NCT02058212|ROS|ros
258751|NCT02058212|endometriosis|endometriosis
258752|NCT02058199|gastric bypass|gastric bypass
258753|NCT02058199|rivaroxaban|rivaroxaban
258754|NCT02058199|pharmacodynamics|pharmacodynamics
258755|NCT02058186|Atopic dermatitis, vitamin D supplementation, cathelicidin, Staphylococcus aureus colonization, SCORAD score|atopic dermatitis, vitamin d supplementation, cathelicidin, staphylococcus aureus colonization, scorad score
258756|NCT02058121|Eating disorders|eating disorders
258757|NCT02058121|Acceptance and Commitment Therapy|acceptance and commitment therapy
258758|NCT02058121|Body image|body image
258759|NCT02058108|Chronic hepatitis B, pediatrics, antiviral treatment, telbivudine|chronic hepatitis b, pediatrics, antiviral treatment, telbivudine
258760|NCT02058082|Failure to Conceive Due to Infertility of Male Partner|failure to conceive due to infertility of male partner
258761|NCT02058082|DNA Damage|dna damage
258762|NCT02058056|Early prophylactic|early prophylactic
258763|NCT02058056|cranial irradiation|cranial irradiation
258764|NCT02058056|hippocampal avoidance|hippocampal avoidance
258765|NCT02058056|limited disease small-cell lung cancer|limited disease small-cell lung cancer
258766|NCT02058030|ProSeal laryngeal mask airway|proseal laryngeal mask airway
258767|NCT02058030|Insertion success|insertion success
258768|NCT02058030|complication|complication
258769|NCT02058004|Microaspiration|microaspiration
258770|NCT02058004|ARDS|ards
258771|NCT02058004|Hospital acquired pneumonia|hospital acquired pneumonia
258772|NCT02058004|Cricoid pressure|cricoid pressure
258773|NCT02057978|Late Lumen Loss|late lumen loss
258774|NCT02057978|MACE|mace
258775|NCT02057978|Death|death
258776|NCT02057978|TLF|tlf
258777|NCT02057978|Thrombosis(definite or probable )|thrombosis(definite or probable )
258778|NCT02057965|Mesenchymal Stromal Cells|mesenchymal stromal cells
258779|NCT02057965|Allograft rejection|allograft rejection
258780|NCT02057965|Fibrosis|fibrosis
258781|NCT02057952|Weight Management|weight management
258782|NCT02057952|Diabetes|diabetes
258783|NCT02057952|Exercise|exercise
258784|NCT02057952|Portion Control|portion control
258785|NCT02057952|Multiple Chronic Conditions|multiple chronic conditions
258786|NCT02057939|Prostate cancer|prostate cancer
258787|NCT02057939|enzalutamide|enzalutamide
258788|NCT02057939|ADT|adt
258789|NCT02057939|radiation|radiation
258790|NCT02057926|Membrane degradation|membrane degradation
258791|NCT02057926|Collagen membrane bio-durability|collagen membrane bio-durability
258792|NCT02057913|Penile neoplasms|penile neoplasms
258793|NCT02057913|Chemotherapy|chemotherapy
258794|NCT02057913|Vinflunine|vinflunine
258795|NCT02057913|Phase II|phase ii
258796|NCT02057900|Postinfarction heart failure|postinfarction heart failure
258895|NCT02057419|user experience|user experience
258896|NCT02057419|adherence|adherence
258797|NCT02057900|Transplantation of human embryonic stem cell-derived cardiac progenitors|transplantation of human embryonic stem cell-derived cardiac progenitors
258798|NCT02057900|Tissue-engineered cellular graft|tissue-engineered cellular graft
258799|NCT02057900|Fibrin hydrogel|fibrin hydrogel
258800|NCT02057861|diabetes mellitus|diabetes mellitus
258801|NCT02057861|neuromuscular blockade|neuromuscular blockade
258802|NCT02057861|sugammadex|sugammadex
258803|NCT02057848|carbohydrate, hypoglycemia|carbohydrate, hypoglycemia
258804|NCT02057822|Vernal keratoconjunctivitis|vernal keratoconjunctivitis
258805|NCT02057822|Cytokines|cytokines
258806|NCT02057822|Mediators|mediators
258807|NCT02057822|Tears|tears
258808|NCT02057809|Developmental Disabilities|developmental disabilities
258809|NCT02057809|Family-centered services|family-centered services
258810|NCT02057809|Pediatric rehabilitation|pediatric rehabilitation
258811|NCT02057796|HIV-1|hiv-1
258812|NCT02057796|Tuberculosis|tuberculosis
258813|NCT02057796|Systematic empiric TB treatment|systematic empiric tb treatment
258814|NCT02057796|ART|art
258815|NCT02057796|TB diagnosis|tb diagnosis
258816|NCT02057796|Xpert MTB/RIF®|xpert mtb/rif®
258817|NCT02057796|Urine LAM|urine lam
258818|NCT02057744|Robotic-guided surgery|robotic-guided surgery
258819|NCT02057744|Minimally invasive spinal surgery|minimally invasive spinal surgery
258820|NCT02057744|Spinal fusion|spinal fusion
258821|NCT02057744|Pedicle screws|pedicle screws
258822|NCT02057718|Bile duct diseases|bile duct diseases
258823|NCT02057718|Intrahepatic Cholestasis|intrahepatic cholestasis
258824|NCT02057718|Cholestasis|cholestasis
258825|NCT02057718|PFIC|pfic
258826|NCT02057718|Pruritus|pruritus
258827|NCT02057718|Cholestatic Liver Disease|cholestatic liver disease
258828|NCT02057705|MTM|mtm
258829|NCT02057705|myotubular myopathy|myotubular myopathy
258830|NCT02057705|X-linked centronuclear myopathy|x-linked centronuclear myopathy
258831|NCT02057705|inherited myopathies|inherited myopathies
258832|NCT02057705|neuromuscular diseases|neuromuscular diseases
258833|NCT02057705|hypotonia|hypotonia
258834|NCT02057705|genetic mutation|genetic mutation
258835|NCT02057679|Acute cholecystitis.|acute cholecystitis.
258836|NCT02057679|Amoxicillin clavulanic|amoxicillin clavulanic
258837|NCT02057653|Goal-directed fluid management|goal-directed fluid management
258838|NCT02057601|Local anaesthetic infiltration|local anaesthetic infiltration
258839|NCT02057601|Fractured neck of femur|fractured neck of femur
258840|NCT02057601|Postoperative pain|postoperative pain
258841|NCT02057588|ablation|ablation
258842|NCT02057575|Open Angle Glaucoma|open angle glaucoma
258843|NCT02057575|Ocular Hypertension|ocular hypertension
258844|NCT02057575|Intraocular Pressure|intraocular pressure
258845|NCT02057575|AR13324|ar13324
258846|NCT02057575|PG324|pg324
258847|NCT02057562|Adenoma|adenoma
258848|NCT02057562|Diverticular disease|diverticular disease
258849|NCT02057562|Diverticulosis|diverticulosis
258850|NCT02057562|Colorectal carcinoma|colorectal carcinoma
258851|NCT02057562|Polyp|polyp
258852|NCT02057536|estrogen receptor positive, aromatase inhibitors, exercise,|estrogen receptor positive, aromatase inhibitors, exercise,
258853|NCT02057510|Head and Neck Cancer|head and neck cancer
258854|NCT02057510|Radiation Therapy|radiation therapy
258855|NCT02057484|long-term follow-up|long-term follow-up
258856|NCT02057484|liver transplant|liver transplant
258857|NCT02057484|kidney transplant|kidney transplant
258858|NCT02057484|Advagraf|advagraf
258859|NCT02057484|Tacrolimus|tacrolimus
258860|NCT02057471|Adenocarcinoma|adenocarcinoma
258861|NCT02057471|Anemia|anemia
258862|NCT02057471|Blood Transfusion|blood transfusion
258863|NCT02057471|Colorectal surgery|colorectal surgery
258864|NCT02057471|Preoperative care|preoperative care
258865|NCT02057471|Perioperative care|perioperative care
258866|NCT02057471|Postoperative care|postoperative care
258867|NCT02057471|Iron|iron
258868|NCT02057471|Hematinics|hematinics
258869|NCT02057471|Hepcidin|hepcidin
258870|NCT02057471|Quality of life|quality of life
258871|NCT02057471|Postoperative complications|postoperative complications
258872|NCT02057458|arterial stiffness|arterial stiffness
258873|NCT02057458|flow-mediated dilation|flow-mediated dilation
258874|NCT02057458|endothelial function|endothelial function
258875|NCT02057458|pulse wave velocity|pulse wave velocity
258876|NCT02057458|inflammation|inflammation
258877|NCT02057458|oxidative stress|oxidative stress
258878|NCT02057458|pulmonary function test|pulmonary function test
258879|NCT02057458|Cystic Fibrosis|cystic fibrosis
258880|NCT02057458|Lung Disease|lung disease
258881|NCT02057458|Nitric Oxide|nitric oxide
258882|NCT02057458|Exercise Capacity|exercise capacity
258883|NCT02057458|CF|cf
258884|NCT02057458|Muscle Function|muscle function
258885|NCT02057458|Sildenafil|sildenafil
258886|NCT02057458|Viagra|viagra
258887|NCT02057458|Revatio|revatio
258888|NCT02057445|cellular therapy|cellular therapy
258889|NCT02057445|lymphoma|lymphoma
258890|NCT02057445|lymphoproliferative disorder|lymphoproliferative disorder
258891|NCT02057432|I-II Breast Cancer|i-ii breast cancer
258892|NCT02057419|contraception|contraception
258893|NCT02057419|contraceptive methods|contraceptive methods
258894|NCT02057419|sexual lubricant|sexual lubricant
258897|NCT02057419|User experience: impact on use of contraceptive methods|user experience: impact on use of contraceptive methods
258898|NCT02057419|User experience: impact on use of sexual lubricants|user experience: impact on use of sexual lubricants
258899|NCT02057393|Melanoma|melanoma
258900|NCT02057393|Sentinel node biopsy|sentinel node biopsy
258901|NCT02057393|Indocyanine green|indocyanine green
258902|NCT02057393|Real time lymphangiography|real time lymphangiography
258903|NCT02057380|Paclitaxel|paclitaxel
258904|NCT02057380|Linsitinib|linsitinib
258905|NCT02057380|OSI-774|osi-774
258906|NCT02057380|Advanced Solid Tumor|advanced solid tumor
258907|NCT02057380|Tarceva|tarceva
258908|NCT02057380|Erlotinib|erlotinib
258909|NCT02057380|OSI-906|osi-906
258910|NCT02057367|supratentorial brain tumour|supratentorial brain tumour
258911|NCT02057367|craniotomy|craniotomy
258912|NCT02057354|Brain|brain
258913|NCT02057354|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
258914|NCT02057354|Brain Mapping|brain mapping
258915|NCT02057354|Cognition|cognition
258916|NCT02057354|Exercise|exercise
258917|NCT02057354|Hippocampus|hippocampus
258918|NCT02057354|Hydrocortisone|hydrocortisone
258919|NCT02057354|Learning|learning
258920|NCT02057354|Memory|memory
258921|NCT02057354|Magnetic Resonance Imaging|magnetic resonance imaging
258922|NCT02057354|Nerve Growth Factors|nerve growth factors
258923|NCT02057354|Neuroimaging|neuroimaging
258924|NCT02057354|Physical Endurance|physical endurance
258925|NCT02057354|Physical Fitness|physical fitness
258926|NCT02057354|Resistance Training|resistance training
258927|NCT02057354|Walking|walking
258928|NCT02057341|laminopathy|laminopathy
258929|NCT02057315|Migraine headache|migraine headache
258930|NCT02057315|Photophobia|photophobia
258931|NCT02057315|Phonophobia|phonophobia
258932|NCT02057315|Aura|aura
258933|NCT02057315|Topical treatment|topical treatment
258934|NCT02057302|Xuezhikang Dyslipidemia chinese medicine RCT|xuezhikang dyslipidemia chinese medicine rct
258935|NCT02057289|pediatric|pediatric
258936|NCT02057289|antifungal|antifungal
258937|NCT02057289|bone marrow|bone marrow
258938|NCT02057289|AML or relapsed ALL|aml or relapsed all
258939|NCT02057263|Vaccine|vaccine
258940|NCT02057263|Adjuvant|adjuvant
258941|NCT02057263|Bisphosphonates|bisphosphonates
258942|NCT02057263|Alendronate|alendronate
258943|NCT02057263|Hepatitis B vaccine|hepatitis b vaccine
258944|NCT02057224|Renal denervation|renal denervation
258945|NCT02057224|Hypertension|hypertension
258946|NCT02057224|Insulin resistance|insulin resistance
258947|NCT02057224|Adipose tissue function|adipose tissue function
258948|NCT02057185|Chronic Hematological Diseases|chronic hematological diseases
258949|NCT02057185|work|work
258950|NCT02057185|job|job
258951|NCT02057172|glycaemic control|glycaemic control
258952|NCT02057172|HM11260C|hm11260c
258953|NCT02057172|placebo|placebo
258954|NCT02057172|safety|safety
258955|NCT02057172|tolerability|tolerability
258956|NCT02057172|type 2 diabetes mellitus|type 2 diabetes mellitus
258957|NCT02057172|efficacy|efficacy
258958|NCT02057172|T2DM|t2dm
258959|NCT02057172|glycated haemoglobin (HbA1c)|glycated haemoglobin (hba1c)
258960|NCT02057172|glycosylated haemoglobin (HbA1c)|glycosylated haemoglobin (hba1c)
258961|NCT02057172|Glucagon-Like Peptide-1 (GLP-1) agonists|glucagon-like peptide-1 (glp-1) agonists
258962|NCT02057172|blood sugar levels|blood sugar levels
258963|NCT02057172|fasting plasma glucose (FPG)|fasting plasma glucose (fpg)
258964|NCT02057159|Secondary Progress Multiple Sclerosis|secondary progress multiple sclerosis
258965|NCT02057159|SPMS|spms
258966|NCT02057159|Multiple Sclerosis|multiple sclerosis
258967|NCT02057159|NeuroVax|neurovax
258968|NCT02057146|PSC|psc
258969|NCT02057146|mother-baby endoscopy|mother-baby endoscopy
258970|NCT02057146|ERCP|ercp
258971|NCT02057146|IPMN|ipmn
258972|NCT02057120|Kinesio Taping, Soccer, Hop Test, Electromyography, Athletic Performance, Muscle Strength Dynamometer|kinesio taping, soccer, hop test, electromyography, athletic performance, muscle strength dynamometer
258973|NCT02057081|Stress Disorders, Post-traumatic|stress disorders, post-traumatic
258974|NCT02057081|Mild Traumatic Brain Injury|mild traumatic brain injury
258975|NCT02057081|Veterans Health|veterans health
258976|NCT02057081|Veterans|veterans
258977|NCT02057081|Spouses|spouses
258978|NCT02057081|Couples|couples
258979|NCT02057081|Psychotherapy, Group|psychotherapy, group
258980|NCT02057081|Depression|depression
258981|NCT02057081|Couples Therapy|couples therapy
258982|NCT02057081|Family Therapy|family therapy
258983|NCT02057081|PTSD|ptsd
258984|NCT02057081|posttraumatic stress disorder|posttraumatic stress disorder
258985|NCT02057068|Caregivers|caregivers
258986|NCT02057068|Telemedicine|telemedicine
258987|NCT02057068|Sleep Disorders|sleep disorders
258988|NCT02057068|Meditation|meditation
258989|NCT02057068|Cognitive Behavioral Therapy|cognitive behavioral therapy
258990|NCT02057068|Activity Enhancement|activity enhancement
258991|NCT02057068|Technology|technology
258992|NCT02057068|Non-pharmacological sleep intervention|non-pharmacological sleep intervention
258993|NCT02057055|Antibacterial soaps|antibacterial soaps
258994|NCT02057055|Microbiome|microbiome
258995|NCT02057055|Commensal bacteria|commensal bacteria
258996|NCT02057055|Pyrosequencing|pyrosequencing
258997|NCT02057055|Innate immunity|innate immunity
258998|NCT02057042|Peer Support|peer support
258999|NCT02057042|cCBT|ccbt
259000|NCT02057042|primary care|primary care
259001|NCT02057029|Estrogen Receptor (ER) Positive|estrogen receptor (er) positive
259002|NCT02057029|Early Stage Breast Cancer|early stage breast cancer
259003|NCT02057029|Breast Cancer Index|breast cancer index
259004|NCT02057003|HIV|hiv
259005|NCT02057003|hepatitis C virus|hepatitis c virus
259006|NCT02057003|sustained virologic response|sustained virologic response
259007|NCT02057003|telaprevir|telaprevir
259008|NCT02057003|boceprevir|boceprevir
259009|NCT02057003|simeprevir|simeprevir
259010|NCT02057003|sofosbuvir|sofosbuvir
259011|NCT02057003|daclatasvir|daclatasvir
259012|NCT02057003|paritaprevir|paritaprevir
259013|NCT02057003|pegylated interferon|pegylated interferon
259014|NCT02057003|ribavirin|ribavirin
259015|NCT02057003|direct-acting antivirals|direct-acting antivirals
259016|NCT02057003|dasabuvir|dasabuvir
259017|NCT02057003|ombitasvir|ombitasvir
259018|NCT02057003|ledipasvir|ledipasvir
259019|NCT02057003|velpatasvir|velpatasvir
259020|NCT02057003|grazoprevir|grazoprevir
259021|NCT02057003|elbasvir|elbasvir
259022|NCT02056990|Athletes|athletes
259023|NCT02056977|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
259024|NCT02056977|Cardiac Surgical Procedure|cardiac surgical procedure
259025|NCT02056977|Mechanical Ventilation|mechanical ventilation
259026|NCT02056977|Postoperative Complications|postoperative complications
259027|NCT02056977|Positive End-Expiratory Pressure|positive end-expiratory pressure
259028|NCT02056977|Lung Collapse|lung collapse
259029|NCT02056977|Respiratory Failure|respiratory failure
259030|NCT02056977|Electrical Impedance Tomography|electrical impedance tomography
259031|NCT02056964|Acute Coronary Syndrome|acute coronary syndrome
259032|NCT02056964|Chest Pain|chest pain
259033|NCT02056964|Risk Stratification|risk stratification
259034|NCT02056964|Clinical Decision Aid|clinical decision aid
259035|NCT02056964|Emergency Department|emergency department
259036|NCT02056964|Low Risk Chest Pain|low risk chest pain
259037|NCT02056964|Non Cardiac Chest Pain|non cardiac chest pain
259038|NCT02056951|Rehabilitation|rehabilitation
259039|NCT02056951|Treatment Outcome|treatment outcome
259040|NCT02056951|Interprofessional Relations|interprofessional relations
259041|NCT02056951|Interdisciplinary Communication|interdisciplinary communication
259042|NCT02056951|Behavioural Exercise Therapy|behavioural exercise therapy
259043|NCT02056951|Cognitive Therapy|cognitive therapy
259044|NCT02056951|Health Education|health education
259045|NCT02056951|Workplace related information|workplace related information
259046|NCT02056951|Multicenter Study|multicenter study
259047|NCT02056938|Transplantation|transplantation
259048|NCT02056938|kidney|kidney
259049|NCT02056938|delayed graft function|delayed graft function
259050|NCT02056938|induction therapy|induction therapy
259051|NCT02056938|personalized medicine|personalized medicine
259052|NCT02056938|First kidney transplantation|first kidney transplantation
259053|NCT02056938|No anti HLA immunization prior transplantation|no anti hla immunization prior transplantation
259054|NCT02056938|Risk of DGF higher than 40% calculated byt he score DGFS|risk of dgf higher than 40% calculated byt he score dgfs
259055|NCT02056912|lipodystrophy|lipodystrophy
259056|NCT02056912|gene|gene
259057|NCT02056912|inborn error of metabolism|inborn error of metabolism
259058|NCT02056899|Preterm labor, premature birth, gabapentin|preterm labor, premature birth, gabapentin
259059|NCT02056886|breast cancer, sentinel lymph node, extemporaneous, OSNA|breast cancer, sentinel lymph node, extemporaneous, osna
259060|NCT02056873|deep brain stimulation|deep brain stimulation
259061|NCT02056873|DBS|dbs
259062|NCT02056873|tourette|tourette
259063|NCT02056873|tourette's|tourette's
259064|NCT02056873|tourette syndrome|tourette syndrome
259065|NCT02056873|TS|ts
259066|NCT02056860|cystic fibrosis|cystic fibrosis
259067|NCT02056847|Livalo, pitavastatin, hyperlipidemia, IFG|livalo, pitavastatin, hyperlipidemia, ifg
259068|NCT02056821|stroke|stroke
259069|NCT02056821|transcranial doppler|transcranial doppler
259070|NCT02056821|cerebral blood flow|cerebral blood flow
259071|NCT02056821|cardiac output|cardiac output
259072|NCT02056821|non-invasive hemodynamic monitoring|non-invasive hemodynamic monitoring
259073|NCT02056782|Acute Myeloid Leukemia|acute myeloid leukemia
259074|NCT02056782|AML|aml
259075|NCT02056782|ODSH|odsh
259076|NCT02056782|ODSH-AML|odsh-aml
259077|NCT02056782|Cantex|cantex
259078|NCT02056756|REFRACTORY OR RELAPSED|refractory or relapsed
259079|NCT02056756|CBD|cbd
259080|NCT02056730|chronic hemodialysis patients|chronic hemodialysis patients
259081|NCT02056730|Hyperparathyroidism|hyperparathyroidism
259082|NCT02056730|Regpara|regpara
259083|NCT02056730|FGF 23|fgf 23
259084|NCT02056704|Dialysis Fistula|dialysis fistula
259085|NCT02056704|Dialysis Graft|dialysis graft
259086|NCT02056704|Stenosis|stenosis
259087|NCT02056704|Intravascular Ultrasound|intravascular ultrasound
259088|NCT02056704|Angiography|angiography
259089|NCT02056691|Resectable|resectable
259090|NCT02056691|non-metastatic|non-metastatic
259091|NCT02056691|colorectal|colorectal
259092|NCT02056691|carcinoma|carcinoma
259094|NCT02056691|neoplasm|neoplasm
259095|NCT02056691|exercise|exercise
259096|NCT02056691|effects|effects
259097|NCT02056691|program|program
259098|NCT02056691|pre-operative|pre-operative
259099|NCT02056691|proliferation|proliferation
259100|NCT02056691|diagnosed|diagnosed
259101|NCT02056691|surgery|surgery
259102|NCT02056691|biopsy|biopsy
259103|NCT02056691|muscle|muscle
259104|NCT02056691|signalling|signalling
259105|NCT02056691|IGF1|igf1
259106|NCT02056691|ki67|ki67
259107|NCT02056691|p53|p53
259108|NCT02056691|response|response
259109|NCT02056691|training|training
259110|NCT02056691|biochemical|biochemical
259111|NCT02056691|pathways|pathways
259112|NCT02056691|glucose|glucose
259113|NCT02056678|cholecystitis|cholecystitis
259114|NCT02056678|cholelithiasis|cholelithiasis
259115|NCT02056678|obstructive sleep apnea|obstructive sleep apnea
259116|NCT02056678|acetaminophen|acetaminophen
259117|NCT02056665|Angelman Syndrome|angelman syndrome
259118|NCT02056665|EFFICACY|efficacy
259119|NCT02056665|SAFETY|safety
259120|NCT02056665|MINOCYCLINE|minocycline
259121|NCT02056665|Pediatrics population|pediatrics population
259122|NCT02056665|Rare diseases|rare diseases
259123|NCT02056652|Preterm birth|preterm birth
259124|NCT02056652|Preterm delivery|preterm delivery
259125|NCT02056652|short cervix|short cervix
259126|NCT02056652|pessary|pessary
259127|NCT02056639|Premature birth|premature birth
259128|NCT02056639|Premature delivery|premature delivery
259129|NCT02056639|Short cervix|short cervix
259130|NCT02056639|Pessary|pessary
259131|NCT02056626|hypertension|hypertension
259132|NCT02056613|Blood Donation|blood donation
259133|NCT02056613|Tissue Procurement|tissue procurement
259134|NCT02056613|Cellular Therapies|cellular therapies
259135|NCT02056587|renal cell carcinoma|renal cell carcinoma
259136|NCT02056587|kidney cancer|kidney cancer
259137|NCT02056587|bevacizumab failure|bevacizumab failure
259138|NCT02056587|everolimus|everolimus
259139|NCT02056574|Endovascular repair|endovascular repair
259140|NCT02056574|Subarachnoid hemorrhage|subarachnoid hemorrhage
259141|NCT02056574|Ruptured intracranial aneurysm|ruptured intracranial aneurysm
259142|NCT02056574|Stroke|stroke
259143|NCT02056574|Coiling|coiling
259144|NCT02056574|NA-1|na-1
259145|NCT02056561|Anesthesia|anesthesia
259146|NCT02056561|Oxidants|oxidants
259147|NCT02056561|Antioxidants|antioxidants
259148|NCT02056548|preemptive antiviral treatment|preemptive antiviral treatment
259149|NCT02056548|lymphoma|lymphoma
259150|NCT02056548|chronic hepatitis B|chronic hepatitis b
259151|NCT02056535|Alcohol|alcohol
259152|NCT02056535|SBIRT (Screening, Brief Intervention, Referral to Treatment)|sbirt (screening, brief intervention, referral to treatment)
259153|NCT02056522|Melanoma|melanoma
259154|NCT02056522|Skin Cancer|skin cancer
259155|NCT02056509|cardiopulmonary resuscitation,Ventilation|cardiopulmonary resuscitation,ventilation
259156|NCT02056496|Pomegranate|pomegranate
259157|NCT02056496|Ellagic acid|ellagic acid
259158|NCT02056496|Pharmacokinetics|pharmacokinetics
259159|NCT02056496|Urolithins|urolithins
259160|NCT02056496|Bioavailability|bioavailability
259161|NCT02056483|neoplasms|neoplasms
259162|NCT02056483|rehabilitation|rehabilitation
259163|NCT02056483|anxiety|anxiety
259164|NCT02056483|depression|depression
259165|NCT02056483|adverse effects|adverse effects
259166|NCT02056483|health behavior|health behavior
259167|NCT02056457|Responsible fatherhood|responsible fatherhood
259168|NCT02056457|Healthy marriage|healthy marriage
259169|NCT02056457|Healthy relationships|healthy relationships
259170|NCT02056457|Parenting|parenting
259171|NCT02056457|Economic self-sufficiency|economic self-sufficiency
259172|NCT02056444|Blood conservation|blood conservation
259173|NCT02056444|Tranexamic acid|tranexamic acid
259174|NCT02056444|Total hip arthroplasty|total hip arthroplasty
259175|NCT02056431|Diabetes|diabetes
259176|NCT02056431|Neuropathy|neuropathy
259177|NCT02056431|Patient-Reported Outcomes|patient-reported outcomes
259178|NCT02056405|Postoperative Ileus|postoperative ileus
259179|NCT02056405|Mosapride|mosapride
259180|NCT02056405|Colorectal laparoscopic surgery|colorectal laparoscopic surgery
259181|NCT02056405|Prolonged postoperative ileus|prolonged postoperative ileus
259182|NCT02056392|Phase I, healthy, pharmacokinetics|phase i, healthy, pharmacokinetics
259183|NCT02056379|stridor|stridor
259184|NCT02056379|laryngitis|laryngitis
259185|NCT02056379|budesonide|budesonide
259186|NCT02056379|dexamethasone|dexamethasone
259187|NCT02056379|children|children
259188|NCT02056366|Cardiac Autonomic Neuropathy|cardiac autonomic neuropathy
259189|NCT02056353|Software|software
259190|NCT02056353|Algorithm|algorithm
259191|NCT02056353|Cardiac surgery|cardiac surgery
259192|NCT02056327|Oral Appliance|oral appliance
259193|NCT02056262|Bacteria|bacteria
259194|NCT02056262|microbial community|microbial community
259195|NCT02056262|hygiene|hygiene
259196|NCT02056249|hypoglycemia|hypoglycemia
259197|NCT02056249|Positron Emission Tomography|positron emission tomography
259198|NCT02056249|norepinephrine transporter|norepinephrine transporter
259401|NCT02055378|myopia|myopia
259199|NCT02056236|Cardiac arrest|cardiac arrest
259200|NCT02056236|Postanoxic encephalopathy|postanoxic encephalopathy
259201|NCT02056236|Electroencephalographic status epilepticus|electroencephalographic status epilepticus
259202|NCT02056236|EEG monitoring|eeg monitoring
259203|NCT02056236|Anti-epileptic drugs|anti-epileptic drugs
259204|NCT02056223|Patent ductus arteriosus|patent ductus arteriosus
259205|NCT02056223|Preterm infant|preterm infant
259206|NCT02056223|Paracetamol|paracetamol
259207|NCT02056223|Ibuprofen|ibuprofen
259208|NCT02056210|Stem cells|stem cells
259209|NCT02056210|Bone marrow|bone marrow
259210|NCT02056171|delirium|delirium
259211|NCT02056171|pediatrics|pediatrics
259212|NCT02056171|critical care|critical care
259213|NCT02056171|quetiapine|quetiapine
259214|NCT02056158|HIV|hiv
259215|NCT02056158|COPD|copd
259216|NCT02056158|Emphysema|emphysema
259217|NCT02056158|Smoking|smoking
259218|NCT02056119|Ventilators, mechanical|ventilators, mechanical
259219|NCT02056119|Aerosol Drug Therapy|aerosol drug therapy
259220|NCT02056119|Nebulizers|nebulizers
259221|NCT02056119|Equipment Contamination|equipment contamination
259222|NCT02056119|vibrating mesh nebulizer|vibrating mesh nebulizer
259223|NCT02056119|jet nebulizer|jet nebulizer
259224|NCT02056119|mechanical ventilation|mechanical ventilation
259225|NCT02056119|ventilator associated event|ventilator associated event
259226|NCT02056119|ventilator associated tracheobronchitis|ventilator associated tracheobronchitis
259227|NCT02056106|depression, Uganda, HIV, task-shifting, condom use, adherence|depression, uganda, hiv, task-shifting, condom use, adherence
259228|NCT02056093|NAVA - PAV- Breathing Variability - Asynchrony|nava - pav- breathing variability - asynchrony
259229|NCT02056080|Breast Neoplasm|breast neoplasm
259230|NCT02056080|Receptor,HER2|receptor,her2
259231|NCT02056080|Antineoplastic agent|antineoplastic agent
259232|NCT02056080|Antibodies, monoclonal|antibodies, monoclonal
259233|NCT02056080|Trastuzumab, Lapatinib|trastuzumab, lapatinib
259234|NCT02056080|Protein kinase inhibitors|protein kinase inhibitors
259235|NCT02056080|quinazolines|quinazolines
259236|NCT02056054|Autoimmune hepatitis|autoimmune hepatitis
259237|NCT02056054|Liver transplantation|liver transplantation
259238|NCT02056054|Hepatitis C|hepatitis c
259239|NCT02056002|Peer-driven intervention|peer-driven intervention
259240|NCT02056002|Interactive voice response system|interactive voice response system
259370|NCT02055495|Planovagus feet|planovagus feet
259241|NCT02056002|Continuous Positive Airway Pressure therapy and adherence|continuous positive airway pressure therapy and adherence
259242|NCT02055976|PF-04950615|pf-04950615
259243|NCT02055976|Japan|japan
259244|NCT02055963|Head And Neck Cancer|head and neck cancer
259245|NCT02055963|Postsurgical symptom reduction|postsurgical symptom reduction
259246|NCT02055963|Minocycline|minocycline
259247|NCT02055963|Dynacin|dynacin
259248|NCT02055963|Minocin|minocin
259249|NCT02055963|Minocin PAC|minocin pac
259250|NCT02055963|Myrac|myrac
259251|NCT02055963|Solodyn|solodyn
259252|NCT02055963|Placebo|placebo
259253|NCT02055963|Sugar pill|sugar pill
259254|NCT02055963|Questionnaires|questionnaires
259255|NCT02055963|Surveys|surveys
259256|NCT02055950|Kidney transplant|kidney transplant
259257|NCT02055950|Marginal donors|marginal donors
259258|NCT02055950|Pulse perfusion|pulse perfusion
259259|NCT02055950|Graft function|graft function
259260|NCT02055937|mastectomy, reconstruction|mastectomy, reconstruction
259261|NCT02055924|Bruton's tyrosine kinase (BTK) Inhibition in B-cell Lymphomas|bruton's tyrosine kinase (btk) inhibition in b-cell lymphomas
259262|NCT02055911|diabetic macular edema|diabetic macular edema
259263|NCT02055911|intravitreal ranibizumab|intravitreal ranibizumab
259264|NCT02055911|f retinal ganglion cell|f retinal ganglion cell
259265|NCT02055872|Edema|edema
259266|NCT02055872|Hypoproteinemia|hypoproteinemia
259267|NCT02055872|Albumin|albumin
259268|NCT02055872|Diuresis|diuresis
259269|NCT02055872|Critical illness|critical illness
259270|NCT02055859|acoustic neuromas|acoustic neuromas
259271|NCT02055859|radiosurgery|radiosurgery
259272|NCT02055859|hearing preservation|hearing preservation
259273|NCT02055846|Androgen-independent prostate cancer|androgen-independent prostate cancer
259274|NCT02055807|Atelectasis|atelectasis
259275|NCT02055807|Ultrasound|ultrasound
259276|NCT02055807|Recruitment maneuver|recruitment maneuver
259277|NCT02055807|Positive end-expiratory pressure|positive end-expiratory pressure
259278|NCT02055794|perineal wound|perineal wound
259279|NCT02055794|perineal tear|perineal tear
259280|NCT02055794|perineum|perineum
259281|NCT02055794|pain|pain
259282|NCT02055794|childbirth|childbirth
259283|NCT02055781|Myelofibrosis|myelofibrosis
259284|NCT02055781|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
259285|NCT02055781|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
259286|NCT02055781|Primary Myelofibrosis|primary myelofibrosis
259287|NCT02055781|Polycythemia|polycythemia
259288|NCT02055781|Polycythemia Vera|polycythemia vera
259289|NCT02055781|Thrombocythemia, Essential|thrombocythemia, essential
259290|NCT02055781|Thrombocythemia|thrombocythemia
259291|NCT02055781|Myeloproliferative Disorders|myeloproliferative disorders
259292|NCT02055781|Bone Marrow Disease|bone marrow disease
259293|NCT02055781|Hematologic Diseases|hematologic diseases
259294|NCT02055781|Blood Platelet Disorders|blood platelet disorders
259295|NCT02055781|Hemorrhagic Disorders|hemorrhagic disorders
259296|NCT02055781|Splenomegaly|splenomegaly
259297|NCT02055781|Pacritinib|pacritinib
259298|NCT02055781|MPN-SAF|mpn-saf
259299|NCT02055781|MPN-SAF TSS|mpn-saf tss
259300|NCT02055781|Anemia|anemia
259301|NCT02055781|Myeloproliferative|myeloproliferative
259302|NCT02055781|Myeloproliferative Neoplasm|myeloproliferative neoplasm
259303|NCT02055781|Spleen|spleen
259304|NCT02055781|Spleen volume|spleen volume
259305|NCT02055781|Thrombocytopenia|thrombocytopenia
259306|NCT02055781|SB1518|sb1518
259307|NCT02055755|Diabetes|diabetes
259308|NCT02055755|Wounds|wounds
259309|NCT02055755|Wound Healing|wound healing
259310|NCT02055755|Diabetic Foot Ulcer|diabetic foot ulcer
259311|NCT02055755|DFU|dfu
259312|NCT02055755|Clinical Decision Support|clinical decision support
259313|NCT02055729|bedsore|bedsore
259314|NCT02055729|bacteria|bacteria
259315|NCT02055729|colonization|colonization
259316|NCT02055729|ecology|ecology
259317|NCT02055703|Healthy Subjects|healthy subjects
259318|NCT02055690|Advanced Recurrent Ovarian Cancer|advanced recurrent ovarian cancer
259319|NCT02055690|Pazopanib|pazopanib
259320|NCT02055690|Votrient|votrient
259321|NCT02055690|Fosbretabulin|fosbretabulin
259322|NCT02055677|personality profiles|personality profiles
259323|NCT02055677|values|values
259324|NCT02055677|empathy|empathy
259325|NCT02055677|quality of life|quality of life
259326|NCT02055677|vegetarians|vegetarians
259327|NCT02055677|vegans|vegans
259328|NCT02055651|Worksite|worksite
259329|NCT02055651|Cardiovascular|cardiovascular
259330|NCT02055651|Epidemiology|epidemiology
259331|NCT02055651|Risk factors|risk factors
259332|NCT02055638|Intermittent Explosive Disorder|intermittent explosive disorder
259333|NCT02055638|IED|ied
259334|NCT02055638|Aggression|aggression
259335|NCT02055638|SRX246|srx246
259336|NCT02055638|Vasopressin 1a Receptor Antagonist|vasopressin 1a receptor antagonist
259337|NCT02055638|V1a|v1a
259338|NCT02055625|Graft-versus-host-disease|graft-versus-host-disease
259339|NCT02055625|Immune system diseases|immune system diseases
259340|NCT02055625|Oral|oral
259341|NCT02055612|wet AMD|wet amd
259342|NCT02055612|epidemiology|epidemiology
259343|NCT02055599|Wound|wound
259344|NCT02055599|Wound Healing|wound healing
259345|NCT02055599|Pressure Ulcers|pressure ulcers
259346|NCT02055599|Chronic Wounds|chronic wounds
259347|NCT02055599|Clinical Decision Support|clinical decision support
259348|NCT02055573|Abusive Head Trauma|abusive head trauma
259349|NCT02055573|Early Literacy|early literacy
259350|NCT02055573|Parental Education|parental education
259351|NCT02055573|Low Income|low income
259352|NCT02055560|colorectal|colorectal
259353|NCT02055560|OnDose|ondose
259354|NCT02055560|MyCare|mycare
259355|NCT02055560|5-FU|5-fu
259356|NCT02055560|pharmacokinetics|pharmacokinetics
259357|NCT02055560|exposure|exposure
259358|NCT02055560|optimization|optimization
259359|NCT02055560|dose adjustment|dose adjustment
259360|NCT02055521|Composite tissue allograft|composite tissue allograft
259361|NCT02055521|operational tolerance|operational tolerance
259362|NCT02055521|skin rejection|skin rejection
259363|NCT02055521|Hand and Face allotransplantation|hand and face allotransplantation
259364|NCT02055508|Exercise|exercise
259365|NCT02055508|Physical Activity|physical activity
259366|NCT02055508|Palliative Care|palliative care
259367|NCT02055508|Lung Cancer|lung cancer
259368|NCT02055508|NSCLC|nsclc
259369|NCT02055495|Painful flatfeet|painful flatfeet
259371|NCT02055495|Subtalar arthroeresis|subtalar arthroeresis
259372|NCT02055495|Lateral column lengthening|lateral column lengthening
259373|NCT02055495|Kinematic motion analysis|kinematic motion analysis
259374|NCT02055482|Anemia on CKD|anemia on ckd
259375|NCT02055469|Achalasia|achalasia
259376|NCT02055456|Hormones|hormones
259377|NCT02055456|Androgens|androgens
259378|NCT02055456|Aplastic Anemia|aplastic anemia
259379|NCT02055456|Bone Marrow Failure Syndromes|bone marrow failure syndromes
259380|NCT02055456|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
259381|NCT02055456|Telomere|telomere
259382|NCT02055456|Telomere Shortening|telomere shortening
259383|NCT02055443|nuclear cardiology|nuclear cardiology
259384|NCT02055443|chest pain|chest pain
259385|NCT02055443|cardiac ischemia|cardiac ischemia
259386|NCT02055443|shortness of breath|shortness of breath
259387|NCT02055443|ECG|ecg
259388|NCT02055443|EKG|ekg
259389|NCT02055443|electrocardiogram|electrocardiogram
259390|NCT02055430|anuria|anuria
259391|NCT02055430|children|children
259392|NCT02055430|nephrostomy|nephrostomy
259393|NCT02055430|stents|stents
259394|NCT02055430|urinary calculi|urinary calculi
259395|NCT02055404|astigmatism|astigmatism
259396|NCT02055404|toric|toric
259397|NCT02055404|contact lenses|contact lenses
259398|NCT02055404|daily disposable contact lenses|daily disposable contact lenses
259399|NCT02055404|molded mark|molded mark
259400|NCT02055404|rotation mark|rotation mark
259402|NCT02055378|atropine|atropine
259403|NCT02055378|anterior chamber depth|anterior chamber depth
259404|NCT02055378|auricular acupoint|auricular acupoint
259405|NCT02055378|axial length|axial length
259406|NCT02055365|Hepatitis B vaccine|hepatitis b vaccine
259407|NCT02055326|Smoking|smoking
259408|NCT02055326|yoga|yoga
259409|NCT02055326|men|men
259410|NCT02055326|intervention|intervention
259411|NCT02055313|Exceptional patient|exceptional patient
259412|NCT02055313|Cancer care|cancer care
259413|NCT02055313|Lung cancer|lung cancer
259414|NCT02055313|Pancreatic cancer|pancreatic cancer
259415|NCT02055313|Stomach cancer|stomach cancer
259416|NCT02055313|Unexplained survival|unexplained survival
259417|NCT02055313|still alive from 2001-2008|still alive from 2001-2008
259418|NCT02055287|schizophrenia|schizophrenia
259419|NCT02055287|schizoaffective disorder|schizoaffective disorder
259420|NCT02055274|Parkinsons|parkinsons
259421|NCT02055248|Genetic Counseling|genetic counseling
259422|NCT02055248|Mobius Syndrome|mobius syndrome
259423|NCT02055248|Birth Defects|birth defects
259424|NCT02055248|Congenital Malformations|congenital malformations
259425|NCT02055248|Gene Identification|gene identification
259426|NCT02055235|Brain|brain
259427|NCT02055235|Pain|pain
259428|NCT02055235|Yoga|yoga
259429|NCT02055222|COPD|copd
259430|NCT02055222|Smoking|smoking
259431|NCT02055222|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
259432|NCT02055209|Coronary Artery Calcification|coronary artery calcification
259433|NCT02055209|African American|african american
259434|NCT02055209|African-American Families|african-american families
259435|NCT02055183|Registry|registry
259436|NCT02055183|Botulinum toxin|botulinum toxin
259437|NCT02055183|Botulism Antitoxin Heptavalent- (Equine)|botulism antitoxin heptavalent- (equine)
259438|NCT02055183|BAT®|bat®
259439|NCT02055157|Achondroplasia|achondroplasia
259440|NCT02055157|Dwarfism|dwarfism
259441|NCT02055157|Bone Diseases, Developmental|bone diseases, developmental
259442|NCT02055157|Bone Diseases|bone diseases
259443|NCT02055144|NSCLC|nsclc
259444|NCT02055144|VeriStrat|veristrat
259445|NCT02055144|chemotherapy|chemotherapy
259446|NCT02055144|circulating tumor cells|circulating tumor cells
259447|NCT02055131|vascular access|vascular access
259448|NCT02055131|hemodialysis|hemodialysis
259449|NCT02055131|aspirin resistance|aspirin resistance
259450|NCT02055131|PFA-100|pfa-100
259451|NCT02055118|hunters disease|hunters disease
259452|NCT02055118|MPS II|mps ii
259453|NCT02055118|lysosomal storage disorder|lysosomal storage disorder
259454|NCT02055118|hunters syndrome|hunters syndrome
259455|NCT02055118|ert treatment|ert treatment
259456|NCT02055118|hunter's disease|hunter's disease
259457|NCT02055118|iduronate sulfatase|iduronate sulfatase
259458|NCT02055118|MPS society|mps society
259459|NCT02055118|mps 2|mps 2
259460|NCT02055118|enlarged adenoids|enlarged adenoids
259461|NCT02055118|hunter's syndrome|hunter's syndrome
259462|NCT02055118|iduronate 2 sulfatase|iduronate 2 sulfatase
259463|NCT02055118|chronic ear infection|chronic ear infection
259464|NCT02055118|mucopolysaccharides|mucopolysaccharides
259465|NCT02055118|hunter syndrome therapy|hunter syndrome therapy
259466|NCT02055118|hunter's syndrome treatment|hunter's syndrome treatment
259467|NCT02055118|enzyme replacement therapy|enzyme replacement therapy
259468|NCT02055118|hunter syndrome treatment|hunter syndrome treatment
259469|NCT02055118|elaprase|elaprase
259470|NCT02055118|MPSII|mpsii
259471|NCT02055118|lysosomal storage disease|lysosomal storage disease
259472|NCT02055118|mps diagnosis|mps diagnosis
259473|NCT02055118|mps symptoms|mps symptoms
259474|NCT02055118|idursulfase|idursulfase
259475|NCT02055118|hunter disease|hunter disease
259476|NCT02055118|hunter's disease treatment|hunter's disease treatment
259477|NCT02055118|MPS2|mps2
259478|NCT02055105|Pediatric Sepsis|pediatric sepsis
259479|NCT02055092|Young onset dementia|young onset dementia
259480|NCT02055092|Quality of life|quality of life
259481|NCT02055092|Specific needs|specific needs
259482|NCT02055092|Healthcare resources in dementia|healthcare resources in dementia
259483|NCT02055092|Frontotemporal dementia|frontotemporal dementia
259484|NCT02055092|Alzheimer's disease|alzheimer's disease
259485|NCT02055092|Healthcare services|healthcare services
259486|NCT02055079|ADPKD|adpkd
259487|NCT02055079|PKD|pkd
259488|NCT02055079|Polycystic kidney disease|polycystic kidney disease
259489|NCT02055079|Mammalian target of rapamycin|mammalian target of rapamycin
259490|NCT02055079|mTOR-I|mtor-i
259491|NCT02055079|Sirolimus|sirolimus
259492|NCT02055066|cancer|cancer
259493|NCT02055066|c-MET|c-met
259494|NCT02055053|Post Operative Pain|post operative pain
259495|NCT02055053|hernia repair|hernia repair
259496|NCT02055027|Sleep Apnea, Obstructive|sleep apnea, obstructive
259497|NCT02055027|Continuous Positive Airway Pressure|continuous positive airway pressure
259498|NCT02055027|Perioperative Period|perioperative period
259499|NCT02055014|Endobarrier|endobarrier
259500|NCT02055014|Duodenal-jejunal bypass liner|duodenal-jejunal bypass liner
259501|NCT02055014|Glucagon-like peptide-1 receptor agonist|glucagon-like peptide-1 receptor agonist
259502|NCT02055014|Liraglutide|liraglutide
259503|NCT02055014|Diabesity|diabesity
259504|NCT02055014|Type 2 diabetes|type 2 diabetes
259505|NCT02055014|Obesity|obesity
259506|NCT02055001|gender medicine|gender medicine
259507|NCT02055001|platelet function|platelet function
259508|NCT02055001|sex hormones|sex hormones
259509|NCT02055001|antiplatelet drugs|antiplatelet drugs
259510|NCT02055001|haemostasis|haemostasis
259511|NCT02054975|asthma, children, vitamin D deficiency, clinical trial|asthma, children, vitamin d deficiency, clinical trial
259512|NCT02054962|Pain|pain
259513|NCT02054949|N-acetyl cysteine|n-acetyl cysteine
259514|NCT02054949|Refractory Seizures|refractory seizures
259515|NCT02054923|colonoscopy|colonoscopy
259516|NCT02054923|videorecording|videorecording
259517|NCT02054923|quality indicators|quality indicators
259518|NCT02054923|screening|screening
259519|NCT02054923|colorectal cancer|colorectal cancer
259520|NCT02054884|Interleukin, IL2, F16, monoclonal, antibody, cytokine Paclitaxel, Merkel cell carcinoma|interleukin, il2, f16, monoclonal, antibody, cytokine paclitaxel, merkel cell carcinoma
259521|NCT02054871|Peripheral Angioplasty|peripheral angioplasty
259522|NCT02054871|Remote Ischaemic Preconditioning|remote ischaemic preconditioning
259523|NCT02054871|Contrast Induced Nephropathy|contrast induced nephropathy
259524|NCT02054858|Computerized Tomography|computerized tomography
259525|NCT02054858|Contrast enhanced|contrast enhanced
259526|NCT02054858|Acute Kidney Injury|acute kidney injury
259527|NCT02054858|Remote ischaemic preconditioning|remote ischaemic preconditioning
259528|NCT02054858|RIPC|ripc
259529|NCT02054845|Body awareness therapy|body awareness therapy
259530|NCT02054845|Physical therapy|physical therapy
259531|NCT02054819|lung cancer|lung cancer
259532|NCT02054819|NSCLC|nsclc
259533|NCT02054806|PD1|pd1
259534|NCT02054806|PD-1|pd-1
259535|NCT02054806|PDL1|pdl1
259536|NCT02054806|PD-L1|pd-l1
259537|NCT02054793|metastatic disease|metastatic disease
259538|NCT02054793|non-metastatic disease|non-metastatic disease
259539|NCT02054793|prostate cancer|prostate cancer
259540|NCT02054793|castration-resistant prostate cancer|castration-resistant prostate cancer
259541|NCT02054767|articaine|articaine
259542|NCT02054767|lidocaine|lidocaine
259543|NCT02054767|mepivacaine|mepivacaine
259544|NCT02054767|inferior alveolar nerve block|inferior alveolar nerve block
259545|NCT02054767|irreversible pulpitis|irreversible pulpitis
259546|NCT02054754|Dexanabinol|dexanabinol
259547|NCT02054754|Oral|oral
259548|NCT02054754|Safety|safety
259549|NCT02054754|Tolerability|tolerability
259550|NCT02054754|Pharmacokinetics|pharmacokinetics
259551|NCT02054728|right-heart catheterization|right-heart catheterization
259552|NCT02054728|respiratory muscle training|respiratory muscle training
259553|NCT02054728|inspiratory resistance|inspiratory resistance
259554|NCT02054728|hemodynamics|hemodynamics
259555|NCT02054702|Schizophrenia|schizophrenia
259556|NCT02054702|Mental Disorders|mental disorders
259557|NCT02054702|Psychotic Disorders|psychotic disorders
259558|NCT02054702|Antipsychotic|antipsychotic
259559|NCT02054702|Cognitive testing|cognitive testing
259560|NCT02054676|mandible|mandible
259561|NCT02054676|alveolar nerve inferior|alveolar nerve inferior
259562|NCT02054676|anatomy|anatomy
259563|NCT02054676|cross-sectional|cross-sectional
259564|NCT02054676|dental implants|dental implants
259565|NCT02054676|classification|classification
259566|NCT02054676|reliability|reliability
259567|NCT02054676|validity|validity
259568|NCT02054663|Acute coronary syndrome|acute coronary syndrome
259569|NCT02054663|Coronary artery disease|coronary artery disease
259570|NCT02054663|Antiplatelet therapy|antiplatelet therapy
259571|NCT02054663|Ticagrelor|ticagrelor
259572|NCT02054663|Clopidogrel|clopidogrel
259573|NCT02054650|Chronic low back pain|chronic low back pain
259574|NCT02054650|Type 2 diabetes mellitus|type 2 diabetes mellitus
259575|NCT02054650|Back pain|back pain
259576|NCT02054650|Diabetes|diabetes
259577|NCT02054650|Osteopathic manual treatment|osteopathic manual treatment
259578|NCT02054650|Osteopathic manipulative treatment|osteopathic manipulative treatment
259579|NCT02054650|OMT|omt
259580|NCT02054650|Biomarkers|biomarkers
259581|NCT02054650|Glycemic control|glycemic control
259582|NCT02054650|Kidney function|kidney function
259583|NCT02054637|Bile reflux|bile reflux
259584|NCT02054637|Reflux esophagitis|reflux esophagitis
259585|NCT02054637|Lanreotide autogel|lanreotide autogel
259586|NCT02054637|Somatuline|somatuline
259587|NCT02054637|Endoscopy|endoscopy
259588|NCT02054637|Impedancemetry|impedancemetry
259589|NCT02054624|Obesity|obesity
259590|NCT02054624|Rural Health|rural health
259591|NCT02054624|Exercise|exercise
259592|NCT02054624|Weight loss|weight loss
259593|NCT02054624|Behavior change|behavior change
259594|NCT02054611|ARDS|ards
259595|NCT02054611|Chest radiographs|chest radiographs
259596|NCT02054611|Vignettes|vignettes
259597|NCT02054611|Online educational video|online educational video
259598|NCT02054585|dehydration|dehydration
259599|NCT02054585|pediatric|pediatric
259600|NCT02054585|glucose|glucose
259601|NCT02054585|IV fluid|iv fluid
259602|NCT02054572|AMG 416, ESRD, hemodialysis|amg 416, esrd, hemodialysis
259603|NCT02054559|localized|localized
259604|NCT02054559|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
259605|NCT02054559|R-CHOP chemotherapy|r-chop chemotherapy
259606|NCT02054559|radiotherapy|radiotherapy
259607|NCT02054533|Crohn's disease|crohn's disease
259608|NCT02054533|Ulcerative colitis|ulcerative colitis
259609|NCT02054533|Inflammatory bowel disease|inflammatory bowel disease
259610|NCT02054533|Surgery|surgery
259611|NCT02054533|Anti-Tumor Necrosis Factor|anti-tumor necrosis factor
259612|NCT02054533|Infection|infection
259613|NCT02054520|Stage IV|stage iv
259614|NCT02054520|metastatic melanoma|metastatic melanoma
259615|NCT02054507|Children|children
259616|NCT02054507|Cognitive outcome|cognitive outcome
259617|NCT02054507|Prematurity|prematurity
259618|NCT02054507|Care Network|care network
259619|NCT02054507|Outpatient follow-up of cognitive development|outpatient follow-up of cognitive development
259620|NCT02054507|Care resources|care resources
259621|NCT02054468|Muscle relaxant, Rocuronium, TIVA, Propofol|muscle relaxant, rocuronium, tiva, propofol
259622|NCT02054455|PPI|ppi
259623|NCT02054455|SIBO|sibo
259624|NCT02054455|LP-F19|lp-f19
259625|NCT02054442|cetuximab|cetuximab
259626|NCT02054442|methotrexate|methotrexate
259627|NCT02054442|squamous cell carcinoma head neck|squamous cell carcinoma head neck
259628|NCT02054442|palliative chemotherapy|palliative chemotherapy
259629|NCT02054416|non-traumatic lower limb amputation|non-traumatic lower limb amputation
259631|NCT02054416|BKA|bka
259632|NCT02054390|Angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
259633|NCT02054390|inflammation|inflammation
259634|NCT02054390|metabolic syndrome|metabolic syndrome
259635|NCT02054390|myonecrosis|myonecrosis
259636|NCT02054390|percutaneous coronary intervention|percutaneous coronary intervention
259637|NCT02054390|periprocedural myocardial injury|periprocedural myocardial injury
259638|NCT02054377|cystic fibrosis|cystic fibrosis
259639|NCT02054377|tai chi|tai chi
259640|NCT02054364|Eating Disorder|eating disorder
259641|NCT02054364|Anorexia Nervosa|anorexia nervosa
259642|NCT02054364|Eating Disorder Not Otherwise Specified|eating disorder not otherwise specified
259643|NCT02054364|Maudsley|maudsley
259644|NCT02054364|Family-Based Therapy|family-based therapy
259645|NCT02054364|FBT|fbt
259646|NCT02054364|Family Therapy|family therapy
259647|NCT02054364|Cognitive Remediation Therapy|cognitive remediation therapy
259648|NCT02054364|CRT|crt
259649|NCT02054351|Advanced ovarian cancer|advanced ovarian cancer
259650|NCT02054351|CLDN6 positive|cldn6 positive
259651|NCT02054325|Sclerotherapy|sclerotherapy
259652|NCT02054325|varicose veins|varicose veins
259653|NCT02054325|veins|veins
259654|NCT02054273|Adenoviral conjunctivitis diagnosed with AdenoPlus™ Test|adenoviral conjunctivitis diagnosed with adenoplus™ test
259655|NCT02054247|Carpal tunnel syndrome,ultrasound,pulsed ultrasound|carpal tunnel syndrome,ultrasound,pulsed ultrasound
259656|NCT02054234|Adenoviral conjunctivitis diagnosed with AdenoPlus™ Test|adenoviral conjunctivitis diagnosed with adenoplus™ test
259657|NCT02054221|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
259658|NCT02054221|mitral valve|mitral valve
259659|NCT02054208|human umbilical cord blood derived mesenchymal stem cells|human umbilical cord blood derived mesenchymal stem cells
259660|NCT02054208|stem cells|stem cells
259661|NCT02054208|alzheimer's disease|alzheimer's disease
259662|NCT02054208|cognitive ability|cognitive ability
259663|NCT02054208|mesenchymal stem cells|mesenchymal stem cells
259664|NCT02054208|cord blood|cord blood
259665|NCT02054182|vitamin D supplementation, pneumonia, bronchiolitis|vitamin d supplementation, pneumonia, bronchiolitis
259666|NCT02054156|Cystic fibrosis (CF)|cystic fibrosis (cf)
259667|NCT02054156|Azithromycin|azithromycin
259668|NCT02054156|Tobramycin solution for inhalation (TIS)|tobramycin solution for inhalation (tis)
259669|NCT02054156|Pseudomonas aeruginosa (Pa)|pseudomonas aeruginosa (pa)
259670|NCT02054156|Early Pseudomonas aeruginosa infection|early pseudomonas aeruginosa infection
259671|NCT02054156|Pulmonary exacerbation|pulmonary exacerbation
259672|NCT02054156|Standardized anti-pseudomonal therapy|standardized anti-pseudomonal therapy
259673|NCT02054143|sevoflurane|sevoflurane
259674|NCT02054143|cerebral vasoreactivity|cerebral vasoreactivity
259675|NCT02054143|arterial stiffness|arterial stiffness
259676|NCT02054143|Transcranial Doppler|transcranial doppler
259677|NCT02054143|SphygmoCor|sphygmocor
259678|NCT02054130|Asthma|asthma
259679|NCT02054117|Hemorrhage|hemorrhage
259680|NCT02054117|Intracerebral hemorrhage (ICH)|intracerebral hemorrhage (ich)
259681|NCT02054104|Lung Cancer|lung cancer
259682|NCT02054104|Cancer Vaccine|cancer vaccine
259683|NCT02054104|Immunotherapy|immunotherapy
259684|NCT02054104|Adjuvant Therapy|adjuvant therapy
259685|NCT02054104|Surgical Intervention|surgical intervention
259686|NCT02054091|Preterm infants|preterm infants
259687|NCT02054091|Bovine colostrum|bovine colostrum
259688|NCT02054091|Feeding intolerance|feeding intolerance
259689|NCT02054091|Postnatal growth|postnatal growth
259690|NCT02054091|Intestinal maturation|intestinal maturation
259691|NCT02054091|Necrotizing enterocolitis|necrotizing enterocolitis
259692|NCT02054065|Urinary Catheter|urinary catheter
259693|NCT02054065|urinary tract infection|urinary tract infection
259694|NCT02054052|non-small cell lung cancer|non-small cell lung cancer
259695|NCT02054052|malignant pleural effusion|malignant pleural effusion
259696|NCT02054052|bevacizumab|bevacizumab
259697|NCT02054052|intrapleural injection|intrapleural injection
259698|NCT02054052|pericardial effusion|pericardial effusion
259699|NCT02054039|Cardiac surgery|cardiac surgery
259700|NCT02054039|Spirometry|spirometry
259701|NCT02054039|Physical Therapy Modalities|physical therapy modalities
259702|NCT02054039|Postoperative Complications|postoperative complications
259703|NCT02054000|No-reflow phenomenon, tirofiban, intracoronary|no-reflow phenomenon, tirofiban, intracoronary
259704|NCT02053974|Anthracycline|anthracycline
259705|NCT02053974|spironolactone|spironolactone
259706|NCT02053974|cardiotoxicity|cardiotoxicity
259707|NCT02053948|Reversal|reversal
259708|NCT02053948|Surgical technique|surgical technique
259709|NCT02053948|Pursestring Wound Closure|pursestring wound closure
259710|NCT02053948|Gunsight Skin Incision and Closure Technique|gunsight skin incision and closure technique
259711|NCT02053935|Dopamine|dopamine
259712|NCT02053935|hyperglycemic clamp|hyperglycemic clamp
259713|NCT02053935|sepsis|sepsis
259714|NCT02053935|hyperglycemia|hyperglycemia
259715|NCT02053935|insulin secretion|insulin secretion
259716|NCT02053922|caesarean section, ecbolics, postpartum hemorrhage|caesarean section, ecbolics, postpartum hemorrhage
259717|NCT02053909|Saphenous vein graft disease|saphenous vein graft disease
259718|NCT02053909|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
259719|NCT02053909|Antiplatelet therapy|antiplatelet therapy
259720|NCT02053909|Coronary artery disease|coronary artery disease
259721|NCT02053909|Secondary prevention|secondary prevention
259722|NCT02053909|Graft patency|graft patency
259723|NCT02053896|Type I Gaucher|type i gaucher
259724|NCT02053896|ISU302|isu302
259725|NCT02053896|Imiglucerase|imiglucerase
259726|NCT02053883|SCI|sci
259727|NCT02053883|spinal cord injury|spinal cord injury
259728|NCT02053883|biologic drug|biologic drug
259729|NCT02053883|rho|rho
259730|NCT02053883|paralysis|paralysis
259731|NCT02053883|paraplegia|paraplegia
259732|NCT02053883|tetraplegia|tetraplegia
259733|NCT02053883|quadriplegia|quadriplegia
259734|NCT02053883|trauma|trauma
259735|NCT02053883|central nervous system|central nervous system
259736|NCT02053883|fibrin sealant|fibrin sealant
259737|NCT02053883|neurosurgery|neurosurgery
259738|NCT02053883|cervical|cervical
259739|NCT02053883|regeneration|regeneration
259740|NCT02053883|neurotrauma|neurotrauma
259741|NCT02053870|Adventitious lung sounds|adventitious lung sounds
259742|NCT02053870|Crackles|crackles
259743|NCT02053870|Wheezes|wheezes
259744|NCT02053870|Sputum location|sputum location
259745|NCT02053857|severe acute malnutrition|severe acute malnutrition
259746|NCT02053857|polyunsaturated fatty acids|polyunsaturated fatty acids
259747|NCT02053857|ready-to-use therapeutic food|ready-to-use therapeutic food
259748|NCT02053844|health care costs|health care costs
259749|NCT02053844|quality of health care|quality of health care
259750|NCT02053831|plastic surgery|plastic surgery
259751|NCT02053818|Cognitive dysfunction|cognitive dysfunction
259752|NCT02053818|Cardioprotection|cardioprotection
259753|NCT02053818|Recovery|recovery
259754|NCT02053818|Renal function|renal function
259755|NCT02053818|ICU discharge|icu discharge
259756|NCT02053805|prostate cancer|prostate cancer
259757|NCT02053805|BRCA1 Syndrome|brca1 syndrome
259758|NCT02053805|BRCA germ-line mutation|brca germ-line mutation
259759|NCT02053805|Lynch syndrome|lynch syndrome
259760|NCT02053805|BRCA2 Syndrome|brca2 syndrome
259761|NCT02053779|GnRH agonist|gnrh agonist
259762|NCT02053779|GnRH antagonist|gnrh antagonist
259763|NCT02053779|Luteal phase|luteal phase
259764|NCT02053766|Mitochondrial Diseases|mitochondrial diseases
259765|NCT02053766|Sevoflurane|sevoflurane
259766|NCT02053766|Dexmedetomidine (Precedex®)|dexmedetomidine (precedex®)
259767|NCT02053766|Propofol|propofol
259768|NCT02053753|denosumab, bioequivalence|denosumab, bioequivalence
259769|NCT02053727|Rheumatoid Arthritis|rheumatoid arthritis
259770|NCT02053727|Hepatitis B|hepatitis b
259771|NCT02053727|Abatacept|abatacept
259772|NCT02053727|Orencia|orencia
259773|NCT02053727|entecavir|entecavir
259774|NCT02053701|magnetic resonance spectroscopy|magnetic resonance spectroscopy
259775|NCT02053701|quantification precision|quantification precision
259776|NCT02053701|brain|brain
259777|NCT02053701|brain metabolites|brain metabolites
259778|NCT02053675|septic shock|septic shock
259779|NCT02053675|vasopressin|vasopressin
259780|NCT02053675|microcirculation|microcirculation
259781|NCT02053675|tissue oxygenation|tissue oxygenation
259782|NCT02053675|vasopressors|vasopressors
259783|NCT02053675|hemodynamics|hemodynamics
259784|NCT02053662|Bladder Cancer|bladder cancer
259785|NCT02053649|depression|depression
259786|NCT02053649|major depressive disorder|major depressive disorder
259787|NCT02053649|postpartum depression|postpartum depression
259788|NCT02053649|antenatal depression|antenatal depression
259789|NCT02053649|sleep|sleep
259790|NCT02053649|circadian|circadian
259791|NCT02053649|bright light|bright light
259792|NCT02053597|Primary breast cancer|primary breast cancer
259793|NCT02053597|Young women|young women
259794|NCT02053597|Ovarian function|ovarian function
260090|NCT02052271|cerebellum|cerebellum
259795|NCT02053597|Sexual function|sexual function
259796|NCT02053597|Eligible for adjuvant or neoadjuvant chemotherapy|eligible for adjuvant or neoadjuvant chemotherapy
259797|NCT02053597|Negative hormone-receptor status|negative hormone-receptor status
259798|NCT02053558|Anesthesiology|anesthesiology
259799|NCT02053558|Pain|pain
259800|NCT02053558|TAP block|tap block
259801|NCT02053558|Gynecology|gynecology
259802|NCT02053558|Postoperative|postoperative
259803|NCT02053558|Analgesia|analgesia
259804|NCT02053532|Trauma|trauma
259805|NCT02053532|Post-traumatic stress disorder (PTSD)|post-traumatic stress disorder (ptsd)
259806|NCT02053532|Imaging|imaging
259807|NCT02053532|Neuroimaging|neuroimaging
259808|NCT02053532|F-18-fluorodeoxyglucose (FDG)|f-18-fluorodeoxyglucose (fdg)
259809|NCT02053493|Heart Failure|heart failure
259810|NCT02053493|Preserved Ejection Fraction|preserved ejection fraction
259811|NCT02053480|pyruvate kinase deficiency|pyruvate kinase deficiency
259812|NCT02053480|hemolytic anemia|hemolytic anemia
259813|NCT02053480|anemia|anemia
259814|NCT02053480|enzymopathy|enzymopathy
259815|NCT02053480|jaundice|jaundice
259816|NCT02053480|splenectomy|splenectomy
259817|NCT02053480|health-related quality of life|health-related quality of life
259818|NCT02053480|Hematologic diseases|hematologic diseases
259819|NCT02053467|eConsultation|econsultation
259820|NCT02053467|Specialist care|specialist care
259821|NCT02053467|Primary health care|primary health care
259822|NCT02053467|Reducing wait times for specialist care|reducing wait times for specialist care
259823|NCT02053467|Reducing referral rates|reducing referral rates
259824|NCT02053454|RNAi therapeutic|rnai therapeutic
259825|NCT02053441|Muscle Protein Synthesis|muscle protein synthesis
259826|NCT02053441|Muscle Protein Breakdown|muscle protein breakdown
259827|NCT02053428|Head and neck cancer|head and neck cancer
259828|NCT02053428|Percutaneous image-guided gastrostomy|percutaneous image-guided gastrostomy
259829|NCT02053428|Pain|pain
259830|NCT02053428|Quality of life|quality of life
259831|NCT02053428|Complication|complication
259832|NCT02053415|krill oil|krill oil
259833|NCT02053415|omega-3 index|omega-3 index
259834|NCT02053415|plasma lipid profile|plasma lipid profile
259835|NCT02053415|tolerance|tolerance
259836|NCT02053415|young adults|young adults
259837|NCT02053402|vitamin D supplementation, persistent asthma, control|vitamin d supplementation, persistent asthma, control
259838|NCT02053389|Patient-Physician communication|patient-physician communication
259839|NCT02053389|Decision Support Techniques|decision support techniques
259840|NCT02053389|Health Communication|health communication
259841|NCT02053389|Physician-Patient Relationship|physician-patient relationship
259842|NCT02053389|Decision Making|decision making
259843|NCT02053376|gallbladder cancer, biliary cancer, bile duct cancer, hepatobiliary cancer, Biliary Tract Carcinoma|gallbladder cancer, biliary cancer, bile duct cancer, hepatobiliary cancer, biliary tract carcinoma
259844|NCT02053376|Cholangiocarcinoma|cholangiocarcinoma
259845|NCT02053363|tranexamic acid, reconstructive spine surgery|tranexamic acid, reconstructive spine surgery
259846|NCT02053350|Clostridium difficile|clostridium difficile
259847|NCT02053350|glutamine|glutamine
259848|NCT02053350|diarrhea|diarrhea
259849|NCT02053350|alanyl-glutamine|alanyl-glutamine
259850|NCT02053324|AvidinOX|avidinox
259851|NCT02053311|adenocarcinoma of the prostate|adenocarcinoma of the prostate
259852|NCT02053311|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
259853|NCT02053311|maintenance therapy|maintenance therapy
259854|NCT02053311|orteronel|orteronel
259855|NCT02053311|TAK-700|tak-700
259856|NCT02053298|Glaucoma|glaucoma
259857|NCT02053272|Diabetes|diabetes
259858|NCT02053272|Glycaemic control|glycaemic control
259859|NCT02053272|Delta-9-tetrahydrocannabivarin|delta-9-tetrahydrocannabivarin
259860|NCT02053272|Cannabinoids|cannabinoids
259861|NCT02053233|stroke|stroke
259862|NCT02053233|robot-assisted therapy|robot-assisted therapy
259863|NCT02053233|conventional therapy|conventional therapy
259864|NCT02053233|motor function|motor function
259865|NCT02053207|Cognitive training|cognitive training
259866|NCT02053207|Brain training|brain training
259867|NCT02053207|Plasticity-based training|plasticity-based training
259868|NCT02053207|Cardiac surgery|cardiac surgery
259869|NCT02053207|Preoperative|preoperative
259870|NCT02053207|Cognitive function|cognitive function
259871|NCT02053194|Inappropriate prescribing|inappropriate prescribing
259872|NCT02053194|Health Education|health education
259873|NCT02053194|Community Pharmacy Services|community pharmacy services
259874|NCT02053194|Medication Therapy Management|medication therapy management
259875|NCT02053194|Preventive Health Services|preventive health services
259876|NCT02053194|Polypharmacy|polypharmacy
259877|NCT02053194|Inappropriate prescriptions|inappropriate prescriptions
259879|NCT02053181|Cadazolid|cadazolid
259880|NCT02053181|ACT-179811|act-179811
259881|NCT02053181|Pharmacokinetics|pharmacokinetics
259882|NCT02053181|Safety|safety
259883|NCT02053181|Tolerability|tolerability
259884|NCT02053155|Smoking cessation|smoking cessation
259885|NCT02053155|perioperative complication|perioperative complication
259886|NCT02053155|Smokerlyzer|smokerlyzer
259887|NCT02053155|smokers help line|smokers help line
259888|NCT02053142|Pharmacokinetics|pharmacokinetics
259889|NCT02053142|Herpes simplex virus|herpes simplex virus
259890|NCT02053142|Genital herpes ulcers|genital herpes ulcers
259891|NCT02053129|tuberculosis|tuberculosis
259892|NCT02053129|HIV|hiv
259893|NCT02053129|pregnancy|pregnancy
259894|NCT02053090|Fibromyalgia|fibromyalgia
259895|NCT02053090|Group Acupuncture|group acupuncture
259896|NCT02053090|Group Education with Stretching|group education with stretching
259897|NCT02053090|Nociceptive Reflex Testing|nociceptive reflex testing
259898|NCT02053090|Pain|pain
259899|NCT02053090|Sleep|sleep
259900|NCT02053090|Fatigue|fatigue
259901|NCT02053064|Neurodegenerative diseases|neurodegenerative diseases
259902|NCT02053064|Nervous systems diseases|nervous systems diseases
259903|NCT02053064|Genetic diseases, Inborn|genetic diseases, inborn
259904|NCT02053064|Metabolic diseases|metabolic diseases
259905|NCT02053064|Gene therapy|gene therapy
259906|NCT02053064|Adeno Associated Virus (AAV)|adeno associated virus (aav)
259907|NCT02053025|appetite|appetite
259908|NCT02053025|overweight|overweight
259909|NCT02053025|energy intake|energy intake
259910|NCT02053025|obesity|obesity
259911|NCT02053025|gut hormones|gut hormones
259912|NCT02052986|Fatty Acids, Omega-3|fatty acids, omega-3
259913|NCT02052986|Omega-3 fatty acids|omega-3 fatty acids
259914|NCT02052986|Docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
259915|NCT02052986|Eicosapentaenoic acid (EPA)|eicosapentaenoic acid (epa)
259916|NCT02052986|Docosapentaenoic acid (DPA)|docosapentaenoic acid (dpa)
259917|NCT02052986|Omega Index|omega index
259918|NCT02052986|Omega Score|omega score
259919|NCT02052986|Cardiac Rehab|cardiac rehab
259920|NCT02052973|Streptococcus mutans|streptococcus mutans
259921|NCT02052973|Natural products|natural products
259922|NCT02052947|Alzheimer's disease|alzheimer's disease
259923|NCT02052947|cerebrovascular disease|cerebrovascular disease
259924|NCT02052947|Lewy body disease|lewy body disease
259925|NCT02052947|MRI|mri
259926|NCT02052947|SPECT|spect
259927|NCT02052947|CSF|csf
259928|NCT02052947|biomarkers|biomarkers
259929|NCT02052947|disability|disability
259930|NCT02052947|Multicenter and prospective cohort study|multicenter and prospective cohort study
259931|NCT02052934|Escherichia coli Infections|escherichia coli infections
259932|NCT02052934|ETEC Candidate Vaccine|etec candidate vaccine
259933|NCT02052934|Immunogenicity|immunogenicity
259934|NCT02052921|Observation|observation
259935|NCT02052921|Rectal Resection|rectal resection
259936|NCT02052921|complete clinical response|complete clinical response
259937|NCT02052921|neoadjuvant chemoradiotherapy.|neoadjuvant chemoradiotherapy.
259938|NCT02052895|Presepsin|presepsin
259939|NCT02052895|Sepsis|sepsis
259940|NCT02052895|SIRS|sirs
259941|NCT02052882|Romiplostim|romiplostim
259942|NCT02052882|Thrombocytopenia|thrombocytopenia
259943|NCT02052882|13-132|13-132
259944|NCT02052869|endotracheal intubation|endotracheal intubation
259945|NCT02052869|esophageal intubation|esophageal intubation
259946|NCT02052856|Tunnel Widening|tunnel widening
259947|NCT02052856|All-Inside Suspensory Method|all-inside suspensory method
259948|NCT02052856|Biointerference Screw Fixation|biointerference screw fixation
259949|NCT02052791|Spinal Muscular Atrophy|spinal muscular atrophy
259950|NCT02052791|SMA|sma
259951|NCT02052791|SMN|smn
259952|NCT02052791|SMNRx|smnrx
259953|NCT02052791|ISIS-SMNRx|isis-smnrx
259954|NCT02052791|ISIS 396443|isis 396443
259955|NCT02052791|IONIS-SMNRx|ionis-smnrx
259956|NCT02052791|IONIS-SMN Rx|ionis-smn rx
259957|NCT02052791|Spinraza|spinraza
259958|NCT02052778|Breast Cancer|breast cancer
259959|NCT02052778|Non Small Cell Lung Cancer|non small cell lung cancer
259960|NCT02052778|Gastric Cancer|gastric cancer
259961|NCT02052778|FGF|fgf
259962|NCT02052778|FGFR|fgfr
259963|NCT02052778|FGFR abnormality|fgfr abnormality
259964|NCT02052778|TAS-120|tas-120
259965|NCT02052778|Dose Escalation|dose escalation
259966|NCT02052739|Status Epilepticus|status epilepticus
259967|NCT02052739|Refractory status epilepticus|refractory status epilepticus
259968|NCT02052739|Super-refractory status epilepticus|super-refractory status epilepticus
259969|NCT02052739|SAGE-547|sage-547
259970|NCT02052739|SAGE|sage
259971|NCT02052739|Sage Therapeutics|sage therapeutics
259972|NCT02052713|dutasteride|dutasteride
259973|NCT02052713|tamsulosin|tamsulosin
259974|NCT02052713|healthy subject|healthy subject
259975|NCT02052713|dutasteride and tamsulosin combination|dutasteride and tamsulosin combination
259976|NCT02052713|combination capsule of dutasteride 0.5 mg and tamsulosin HCL 0.4 mg|combination capsule of dutasteride 0.5 mg and tamsulosin hcl 0.4 mg
259977|NCT02052687|Healthy volunteer|healthy volunteer
259978|NCT02052674|Precursor to CAUTI|precursor to cauti
259979|NCT02052661|Infanrix™ hexa|infanrix™ hexa
259980|NCT02052661|Hepatitis B antibodies|hepatitis b antibodies
259981|NCT02052661|Immunogenicity|immunogenicity
259982|NCT02052661|Hepatitis B|hepatitis b
259983|NCT02052661|Adolescents|adolescents
259984|NCT02052661|Infancy|infancy
259985|NCT02052661|Engerix™-B Kinder|engerix™-b kinder
259986|NCT02052661|Safety|safety
259987|NCT02052648|glioblastoma multiforme|glioblastoma multiforme
259988|NCT02052648|glioma|glioma
259989|NCT02052648|gliosarcoma|gliosarcoma
259990|NCT02052648|malignant brain tumor|malignant brain tumor
259991|NCT02052635|Percutaneous Coronary Intervention|percutaneous coronary intervention
259992|NCT02052622|submental fat reduction|submental fat reduction
259993|NCT02052596|Boostrix|boostrix
259994|NCT02052596|Herpes zoster|herpes zoster
259995|NCT02052596|Immunogenicity|immunogenicity
259996|NCT02052596|Co-administration|co-administration
259997|NCT02052596|Adults|adults
259998|NCT02052596|Safety|safety
259999|NCT02052583|Cardiac arrest|cardiac arrest
260000|NCT02052583|Oxymetry|oxymetry
260001|NCT02052583|Hypothermia|hypothermia
260002|NCT02052570|School Reentry after pediatric HSCT|school reentry after pediatric hsct
260003|NCT02052557|Exparel|exparel
260004|NCT02052557|liposomal bupivicaine|liposomal bupivicaine
260005|NCT02052557|post operative pain control|post operative pain control
260006|NCT02052557|local anesthetic after surgery|local anesthetic after surgery
260007|NCT02052557|colorectal surgery|colorectal surgery
260008|NCT02052557|marcaine|marcaine
260009|NCT02052557|long acting local anesthetic|long acting local anesthetic
260010|NCT02052557|pain medication use after surgery|pain medication use after surgery
260011|NCT02052544|determination of heparin levels|determination of heparin levels
260012|NCT02052544|Patients|patients
260013|NCT02052544|requiring|requiring
260014|NCT02052544|unfractionated|unfractionated
260015|NCT02052518|Childhood obesity|childhood obesity
260016|NCT02052518|Breastfeeding|breastfeeding
260017|NCT02052518|Introduction of solids|introduction of solids
260018|NCT02052518|Introduction of juice|introduction of juice
260019|NCT02052505|inappropriate prescribing|inappropriate prescribing
260020|NCT02052505|psychiatry|psychiatry
260021|NCT02052505|medication quality|medication quality
260022|NCT02052505|patient safety|patient safety
260023|NCT02052505|medication errors|medication errors
260024|NCT02052479|Polycystic Ovary Syndrome|polycystic ovary syndrome
260025|NCT02052479|PCOS|pcos
260026|NCT02052479|Secondary Amenorrhea|secondary amenorrhea
260027|NCT02052479|Hirsutism|hirsutism
260028|NCT02052479|Hyperandrogenism|hyperandrogenism
260029|NCT02052479|Insulin Resistance|insulin resistance
260030|NCT02052466|Shoulder Joint|shoulder joint
260031|NCT02052466|Computed tomography|computed tomography
260032|NCT02052453|Pacemaker|pacemaker
260034|NCT02052453|Surgery|surgery
260035|NCT02052453|Electrocautery|electrocautery
260036|NCT02052453|Electromagnetic interference|electromagnetic interference
260037|NCT02052427|Ischemic heart disease|ischemic heart disease
260038|NCT02052427|Coronary artery disease|coronary artery disease
260039|NCT02052427|Chronic Heart Failure|chronic heart failure
260040|NCT02052427|Cardiovascular disease|cardiovascular disease
260041|NCT02052427|adult stem cells|adult stem cells
260042|NCT02052427|adipose derived regenerative cells|adipose derived regenerative cells
260043|NCT02052414|side effects|side effects
260044|NCT02052414|safety|safety
260045|NCT02052414|efficacy|efficacy
260046|NCT02052414|Gralise|gralise
260047|NCT02052414|Fibromyalgia|fibromyalgia
260048|NCT02052414|gabapentin|gabapentin
260049|NCT02052401|OLD AGE|old age
260050|NCT02052401|Elderly|elderly
260051|NCT02052401|Domiciliary Intervention|domiciliary intervention
260052|NCT02052401|Occupational Therapy|occupational therapy
260053|NCT02052401|Rehospitalization|rehospitalization
260054|NCT02052388|Skin Infection|skin infection
260055|NCT02052388|Staph aureus|staph aureus
260056|NCT02052388|MRSA|mrsa
260057|NCT02052388|MSSA|mssa
260058|NCT02052388|Cellulitis/Erysipelas|cellulitis/erysipelas
260059|NCT02052388|Wound Infection|wound infection
260060|NCT02052388|Abscess|abscess
260061|NCT02052375|Rheumatoid Arthritis|rheumatoid arthritis
260062|NCT02052375|ASP2408|asp2408
260063|NCT02052375|methotrexate|methotrexate
260064|NCT02052362|absolute bioavailability|absolute bioavailability
260065|NCT02052362|healthy volunteers|healthy volunteers
260066|NCT02052349|relative bioavailability|relative bioavailability
260067|NCT02052349|healthy volunteers|healthy volunteers
260068|NCT02052336|Drug-Drug interaction|drug-drug interaction
260069|NCT02052336|Pharmacokinetics|pharmacokinetics
260070|NCT02052323|P.f Malaria, Artemisinin resistance, ACT treatment failure|p.f malaria, artemisinin resistance, act treatment failure
260071|NCT02052310|Anemia|anemia
260072|NCT02052310|Chronic Kidney Disease|chronic kidney disease
260073|NCT02052310|Hemoglobin|hemoglobin
260074|NCT02052310|End-Stage Renal Disease|end-stage renal disease
260075|NCT02052310|Incident-Dialysis|incident-dialysis
260076|NCT02052310|Erythropoieitin|erythropoieitin
260077|NCT02052310|Erythropoieisis stimulating-agent|erythropoieisis stimulating-agent
260078|NCT02052310|Roxadustat|roxadustat
260079|NCT02052310|AZD9941|azd9941
260080|NCT02052310|ASP1517|asp1517
260081|NCT02052297|Idiopathic Pulmonary Fibrosis (IPF)|idiopathic pulmonary fibrosis (ipf)
260082|NCT02052297|dosimetry|dosimetry
260083|NCT02052297|Positron Emission Tomograph (PET)|positron emission tomograph (pet)
260084|NCT02052284|ELBW|elbw
260085|NCT02052284|premature|premature
260086|NCT02052284|neonate|neonate
260087|NCT02052284|skin|skin
260088|NCT02052284|water loss|water loss
260089|NCT02052271|essential tremor|essential tremor
260091|NCT02052271|transcranial direct current stimulation|transcranial direct current stimulation
260092|NCT02052271|electrophysiology|electrophysiology
260093|NCT02052258|oxytocin|oxytocin
260094|NCT02052219|Blisibimod|blisibimod
260095|NCT02052219|IgA nephropathy|iga nephropathy
260096|NCT02052219|BAFF|baff
260097|NCT02052219|BLyS|blys
260098|NCT02052206|osteoarthritis|osteoarthritis
260099|NCT02052206|complexe proximal humeral fracture|complexe proximal humeral fracture
260100|NCT02052206|shoulder|shoulder
260101|NCT02052206|shoulder replacement|shoulder replacement
260102|NCT02052206|accuracy|accuracy
260103|NCT02052206|computer-assisted|computer-assisted
260104|NCT02052206|3D|3d
260105|NCT02052180|Carpalmetacarpal arthroplasty|carpalmetacarpal arthroplasty
260106|NCT02052180|Proximal row carpectomy|proximal row carpectomy
260107|NCT02052180|Post-operative pain control|post-operative pain control
260108|NCT02052180|Exparel|exparel
260109|NCT02052180|Marcaine|marcaine
260110|NCT02052154|Pneumococcal infection|pneumococcal infection
260111|NCT02052154|Splenectomized|splenectomized
260112|NCT02052154|vaccination|vaccination
260113|NCT02052141|Pediatric|pediatric
260114|NCT02052141|C1 inhibitor|c1 inhibitor
260115|NCT02052141|HAE|hae
260116|NCT02052141|Cinryze|cinryze
260117|NCT02052141|C1 INH|c1 inh
260118|NCT02052141|Prevention|prevention
260119|NCT02052128|endometrial cancer|endometrial cancer
260120|NCT02052128|ovarian cancer|ovarian cancer
260121|NCT02052128|breast cancer|breast cancer
260122|NCT02052128|uterine sarcoma|uterine sarcoma
260123|NCT02052128|uterine endometrioid adenocarcinoma|uterine endometrioid adenocarcinoma
260124|NCT02052115|breast cancer|breast cancer
260125|NCT02052115|exercise|exercise
260126|NCT02052115|weight loss|weight loss
260127|NCT02052115|executive function|executive function
260128|NCT02052115|breast cancer survivor|breast cancer survivor
260129|NCT02052102|Deep inspiration breath hold|deep inspiration breath hold
260130|NCT02052102|radiation therapy|radiation therapy
260131|NCT02052102|Cardiac toxicity|cardiac toxicity
260132|NCT02052102|Left-sided breast cancer|left-sided breast cancer
260133|NCT02052089|Tennis Elbow|tennis elbow
260134|NCT02052089|lateral epicondylosis|lateral epicondylosis
260135|NCT02052089|lateral epicondylitis|lateral epicondylitis
260136|NCT02052089|Platelet-Rich Plasma|platelet-rich plasma
260137|NCT02052089|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
260138|NCT02052089|Prolotherapy|prolotherapy
260139|NCT02052089|Physiotherapy|physiotherapy
260140|NCT02052076|Energy balance|energy balance
260141|NCT02052076|meal pattern|meal pattern
260142|NCT02052076|metabolic syndrome|metabolic syndrome
260143|NCT02052063|rectocele|rectocele
260144|NCT02052063|intussusception|intussusception
260145|NCT02052063|surgery|surgery
260146|NCT02052050|colorectal-neoplasms,deep-muscles of the back,rehabilitation|colorectal-neoplasms,deep-muscles of the back,rehabilitation
260147|NCT02052037|Type 2 Diabetes|type 2 diabetes
260148|NCT02052037|Egg|egg
260149|NCT02052037|Glycemic Control|glycemic control
260150|NCT02052037|Insulin sensitivity|insulin sensitivity
260151|NCT02052037|Diet quality|diet quality
260152|NCT02052024|Spasticity|spasticity
260153|NCT02052024|Modified Ashworth Scale|modified ashworth scale
260154|NCT02052024|MYOBLOC|myobloc
260155|NCT02052024|Botox|botox
260156|NCT02052024|Muscle Atrophy|muscle atrophy
260157|NCT02052011|Chest Pain|chest pain
260158|NCT02052011|Microvascular Angina|microvascular angina
260159|NCT02052011|Ranolazine|ranolazine
260160|NCT02052011|Emergency department|emergency department
260161|NCT02052011|PET|pet
260162|NCT02051998|Geographic atrophy|geographic atrophy
260163|NCT02051998|Age-related macular degeneration|age-related macular degeneration
260164|NCT02051998|Retina|retina
260165|NCT02051998|Retinal pigment epithelium|retinal pigment epithelium
260166|NCT02051998|Optical coherence tomography|optical coherence tomography
260167|NCT02051998|Scanning laser ophthalmoscopy|scanning laser ophthalmoscopy
260168|NCT02051985|Chronic heart failure|chronic heart failure
260169|NCT02051985|Heart decompensation|heart decompensation
260170|NCT02051985|Aerobic exercise training|aerobic exercise training
260171|NCT02051985|Functional capacity|functional capacity
260172|NCT02051985|Dyspnea|dyspnea
260173|NCT02051985|Beta-adrenergic receptor signaling|beta-adrenergic receptor signaling
260174|NCT02051959|Phantom Limb Pain|phantom limb pain
260175|NCT02051959|Transcranial Direct Current Stimulation|transcranial direct current stimulation
260176|NCT02051959|Amputation|amputation
260177|NCT02051959|Diabetes Mellitus|diabetes mellitus
260178|NCT02051946|novel drug delivery technique for glaucoma patients|novel drug delivery technique for glaucoma patients
260179|NCT02051933|pilon|pilon
260180|NCT02051933|tibial plafond|tibial plafond
260181|NCT02051933|botox|botox
260182|NCT02051933|ankle dorsiflexion|ankle dorsiflexion
260183|NCT02051933|ankle functionality|ankle functionality
260184|NCT02051933|ankle range of motion|ankle range of motion
260185|NCT02051920|Elastography|elastography
260186|NCT02051894|Neonates|neonates
260187|NCT02051894|Dobutamine|dobutamine
260188|NCT02051894|Superior Vena Cana Flow|superior vena cana flow
260189|NCT02051894|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
260190|NCT02051894|Pleth Variability Index|pleth variability index
260191|NCT02051868|Squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
260192|NCT02051868|Anal cancer|anal cancer
260193|NCT02051868|Cancer of the anus|cancer of the anus
260194|NCT02051868|SCCA|scca
260195|NCT02051868|Cisplatin-5FU|cisplatin-5fu
260196|NCT02051868|Carboplatin-Paclitaxel|carboplatin-paclitaxel
260197|NCT02051868|inoperable|inoperable
260198|NCT02051868|locally recurrent|locally recurrent
260199|NCT02051868|metastatic|metastatic
260200|NCT02051855|Neonates|neonates
260201|NCT02051855|Superior Vena Cava Flow|superior vena cava flow
260202|NCT02051855|Pleth Variability Index|pleth variability index
260203|NCT02051855|Dobutamine|dobutamine
260204|NCT02051855|Intensive Care|intensive care
260205|NCT02051842|NAFLD|nafld
260206|NCT02051842|oxidative stress|oxidative stress
260207|NCT02051842|malondialdehyde|malondialdehyde
260208|NCT02051816|Endotracheal Intubation|endotracheal intubation
260209|NCT02051816|Apneic Oxygenation|apneic oxygenation
260210|NCT02051816|Respiratory failure|respiratory failure
260211|NCT02051803|smoking cessation|smoking cessation
260212|NCT02051803|women|women
260213|NCT02051751|Solid tumors, Head and neck non squamous cell carcinoma, breast cancer, PI3K inhibitor, BYL719, paclitaxel|solid tumors, head and neck non squamous cell carcinoma, breast cancer, pi3k inhibitor, byl719, paclitaxel
260214|NCT02051738|Healthy|healthy
260215|NCT02051738|Mebendazole|mebendazole
260216|NCT02051738|Fast-Disintegrating Chewable Formulation|fast-disintegrating chewable formulation
260217|NCT02051738|Bioavailability|bioavailability
260218|NCT02051712|chronic heart failure|chronic heart failure
260219|NCT02051712|exercise training|exercise training
260220|NCT02051712|preferred training|preferred training
260221|NCT02051712|prevention|prevention
260222|NCT02051699|Osteoarthritis of the knee|osteoarthritis of the knee
260223|NCT02051699|Weight bearing radiograph|weight bearing radiograph
260224|NCT02051699|Kellgren-Lawrence classification|kellgren-lawrence classification
260225|NCT02051699|Joint space width|joint space width
260226|NCT02051699|One-leg standing view|one-leg standing view
260227|NCT02051686|Acetabulum Fractures|acetabulum fractures
260228|NCT02051686|Pelvic Ring Injuries|pelvic ring injuries
260229|NCT02051686|Tranexamic Acid|tranexamic acid
260230|NCT02051673|Kidney Transplantation|kidney transplantation
260231|NCT02051647|medical students|medical students
260232|NCT02051647|Basel University|basel university
260233|NCT02051634|Aging|aging
260234|NCT02051634|Papaya|papaya
260235|NCT02051634|Fermented Papaya|fermented papaya
260236|NCT02051634|Inflammation|inflammation
260237|NCT02051634|Phytochemicals|phytochemicals
260238|NCT02051634|Physical function|physical function
260239|NCT02051634|Quality of life|quality of life
260240|NCT02051634|Fatigue|fatigue
260241|NCT02051634|Health|health
260242|NCT02051621|pulmonary vein isolation|pulmonary vein isolation
260243|NCT02051621|isthmus ablation|isthmus ablation
260244|NCT02051621|recurrence|recurrence
260245|NCT02051595|heart lung machine|heart lung machine
260246|NCT02051595|blood pump|blood pump
260247|NCT02051595|cardiac surgery|cardiac surgery
260248|NCT02051595|cardiopulmonary bypass|cardiopulmonary bypass
260249|NCT02051595|circulation|circulation
260250|NCT02051556|Parkinson's disease|parkinson's disease
260251|NCT02051556|Freezing of gait|freezing of gait
260252|NCT02051556|Asymmetry|asymmetry
260253|NCT02051556|Rehabilitation|rehabilitation
260254|NCT02051556|Physical therapy|physical therapy
260256|NCT02051530|empathy|empathy
260257|NCT02051530|mimicry|mimicry
260258|NCT02051530|emotional reactivity|emotional reactivity
260259|NCT02051530|prosody|prosody
260260|NCT02051517|Virectomy|virectomy
260261|NCT02051504|Type 1 diabetes|type 1 diabetes
260262|NCT02051504|Glycated hemoglobin|glycated hemoglobin
260263|NCT02051504|Muscle Oxygenation|muscle oxygenation
260264|NCT02051504|Exercise|exercise
260265|NCT02051504|Maximal Oxygen uptake|maximal oxygen uptake
260266|NCT02051504|Mitochondrial respiration|mitochondrial respiration
260267|NCT02051504|Endocannabinoid system|endocannabinoid system
260268|NCT02051504|Oxidative stress|oxidative stress
260269|NCT02051478|manipulation|manipulation
260270|NCT02051478|mobilization|mobilization
260271|NCT02051478|spine|spine
260272|NCT02051478|pressure pain|pressure pain
260273|NCT02051439|Varicose Veins|varicose veins
260274|NCT02051439|Venous Insufficiency|venous insufficiency
260275|NCT02051439|Doppler|doppler
260276|NCT02051439|Duplex|duplex
260277|NCT02051439|Valsava|valsava
260278|NCT02051426|neuropsychiatric effects|neuropsychiatric effects
260279|NCT02051413|Major depression|major depression
260280|NCT02051413|Antidepressant drug|antidepressant drug
260281|NCT02051413|Beta-arrestin|beta-arrestin
260282|NCT02051413|Biomarker|biomarker
260283|NCT02051413|Predictive factor|predictive factor
260284|NCT02051400|Intubation|intubation
260285|NCT02051400|Laryngoscopes|laryngoscopes
260286|NCT02051361|DAT = Dual Antiplatelet Treatment|dat = dual antiplatelet treatment
260287|NCT02051361|Major Cardiac Adverse Events|major cardiac adverse events
260288|NCT02051348|Helicobacter pylori|helicobacter pylori
260289|NCT02051348|Mild Indigestion|mild indigestion
260290|NCT02051335|Drug therapy|drug therapy
260291|NCT02051309|Smokers|smokers
260292|NCT02051309|Quit Smoking|quit smoking
260293|NCT02051309|Treatment|treatment
260294|NCT02051309|Guanfacine|guanfacine
260295|NCT02051283|Hepatocellular carcinoma|hepatocellular carcinoma
260296|NCT02051283|RFA|rfa
260297|NCT02051283|MRI|mri
260298|NCT02051270|Elderly|elderly
260299|NCT02051270|Nursing homes|nursing homes
260300|NCT02051270|Mild cognitive impairment|mild cognitive impairment
260301|NCT02051244|Alzheimer's Disease|alzheimer's disease
260302|NCT02051244|Retinal Nerve Fiber Layer|retinal nerve fiber layer
260303|NCT02051244|Ocular Computerized Tomography|ocular computerized tomography
260304|NCT02051244|Minimal Cognitive Impairment|minimal cognitive impairment
260305|NCT02051244|Subjective Memory Loss|subjective memory loss
260306|NCT02051244|Asymptomatic Preclinical Alzheimer's Disease|asymptomatic preclinical alzheimer's disease
260307|NCT02051231|Uterine contraction|uterine contraction
260308|NCT02051231|Oxytocin receptors|oxytocin receptors
260309|NCT02051231|Oxytocin desensitization|oxytocin desensitization
260310|NCT02051218|metastatic breast cancer|metastatic breast cancer
260311|NCT02051218|castration resistant metastatic prostate cancer|castration resistant metastatic prostate cancer
260312|NCT02051218|bone metastases|bone metastases
260313|NCT02051218|Denosumab|denosumab
260314|NCT02051218|XGEVA|xgeva
260315|NCT02051218|de-escalation|de-escalation
260316|NCT02051205|Parkinson's disease, risk factors, epidemiology|parkinson's disease, risk factors, epidemiology
260317|NCT02051192|obsessive-compulsive disorder|obsessive-compulsive disorder
260318|NCT02051192|Social phobia|social phobia
260319|NCT02051192|Generalized anxiety disorder|generalized anxiety disorder
260320|NCT02051192|Specific phobia|specific phobia
260321|NCT02051192|Separation anxiety disorder|separation anxiety disorder
260322|NCT02051192|Selective Mutism|selective mutism
260323|NCT02051192|Anxiety Disorder, Not Otherwise Specified|anxiety disorder, not otherwise specified
260324|NCT02051192|Counseling|counseling
260325|NCT02051192|Behavioral therapy|behavioral therapy
260326|NCT02051192|Psychotherapy|psychotherapy
260327|NCT02051192|Exposure|exposure
260328|NCT02051192|Young Children|young children
260329|NCT02051179|Repair|repair
260330|NCT02051179|Replacement|replacement
260331|NCT02051179|Dental Amalgam|dental amalgam
260332|NCT02051153|Modafinil|modafinil
260333|NCT02051153|Cognitive|cognitive
260334|NCT02051153|Performance|performance
260335|NCT02051140|Postural Balance|postural balance
260336|NCT02051140|Walking|walking
260337|NCT02051140|Giat|giat
260338|NCT02051140|Cognition|cognition
260339|NCT02051140|Learning|learning
260340|NCT02051140|Memory|memory
260341|NCT02051140|Antioxidants|antioxidants
260342|NCT02051140|Anti-Inflammatory Agents|anti-inflammatory agents
260343|NCT02051140|Brain|brain
260344|NCT02051140|Strawberry|strawberry
260345|NCT02051127|Exercise|exercise
260346|NCT02051127|Physical Fitness|physical fitness
260347|NCT02051127|Stress, Psychological|stress, psychological
260348|NCT02051127|Cognition|cognition
260349|NCT02051127|Psychophysiology|psychophysiology
260350|NCT02051127|Ergometry|ergometry
260351|NCT02051127|Exercise Test|exercise test
260352|NCT02051127|Sedentary Lifestyle|sedentary lifestyle
260353|NCT02051114|Rheumatoid arthritis|rheumatoid arthritis
260354|NCT02051088|Critical limb ischemia|critical limb ischemia
260355|NCT02051088|Intermittent claudication|intermittent claudication
260356|NCT02051088|endovascular treatment|endovascular treatment
260357|NCT02051088|drug-elution|drug-elution
260358|NCT02051075|IVF|ivf
260359|NCT02051075|ICSI|icsi
260360|NCT02051075|Asthenospermia|asthenospermia
260361|NCT02051075|pentoxyphylline|pentoxyphylline
260362|NCT02051075|Spermatozoa|spermatozoa
260363|NCT02051062|Pharmacokinetics|pharmacokinetics
260364|NCT02051062|BAT|bat
260365|NCT02051062|Pediatric|pediatric
260366|NCT02051049|CN|cn
260367|NCT02051049|UCD|ucd
260368|NCT02051036|moxibustion|moxibustion
260369|NCT02051023|keratoconjunctivitis sicca|keratoconjunctivitis sicca
260371|NCT02051023|dry eye syndrome|dry eye syndrome
260372|NCT02051023|dry eye disease|dry eye disease
260373|NCT02051023|steroids|steroids
260374|NCT02050984|Obesity|obesity
260375|NCT02050984|Hypertension|hypertension
260376|NCT02050984|Bariatric Surgery|bariatric surgery
260377|NCT02050984|Diabetes|diabetes
260378|NCT02050971|Umbilical Cord Blood|umbilical cord blood
260379|NCT02050971|Autologous Umbilical Cord Blood Transfusion|autologous umbilical cord blood transfusion
260380|NCT02050971|Prematurity Complications|prematurity complications
260381|NCT02050971|Infant, Premature, Diseases|infant, premature, diseases
260382|NCT02050971|Infant, Newborn, Diseases|infant, newborn, diseases
260383|NCT02050971|Hematologic Diseases|hematologic diseases
260384|NCT02050971|Lung Diseases|lung diseases
260385|NCT02050971|Central Nervous System Diseases|central nervous system diseases
260386|NCT02050971|Gastrointestinal Tract Diseases|gastrointestinal tract diseases
260387|NCT02050971|Vascular Diseases|vascular diseases
260388|NCT02050971|Retinopathies, Neonates|retinopathies, neonates
260389|NCT02050971|Prevention,Treatment|prevention,treatment
260390|NCT02050932|hepcidin|hepcidin
260391|NCT02050932|iron bioavailability|iron bioavailability
260392|NCT02050932|iron supplementation|iron supplementation
260393|NCT02050906|IDEA-P|idea-p
260394|NCT02050906|Androgen Deprivation Therapy|androgen deprivation therapy
260395|NCT02050893|septic shock|septic shock
260396|NCT02050893|sepsis|sepsis
260397|NCT02050893|fluid responsiveness|fluid responsiveness
260398|NCT02050893|Midazolam|midazolam
260399|NCT02050893|Propofol|propofol
260400|NCT02050893|haemodynamics|haemodynamics
260401|NCT02050880|Normal Eyes|normal eyes
260402|NCT02050880|Eye; Disorder with Glaucoma|eye; disorder with glaucoma
260403|NCT02050880|Eye; Disorder with Retinal Disease|eye; disorder with retinal disease
260404|NCT02050880|Eye; Disorder Corneal Disease incl kerato-refractive group|eye; disorder corneal disease incl kerato-refractive group
260405|NCT02050867|Youth Suicide|youth suicide
260406|NCT02050867|Suicide|suicide
260407|NCT02050854|Aripiprazole|aripiprazole
260408|NCT02050854|Treatment Adherence|treatment adherence
260409|NCT02050841|Pediatric|pediatric
260410|NCT02050841|patients|patients
260411|NCT02050841|replacement|replacement
260412|NCT02050841|coagulation factors|coagulation factors
260413|NCT02050841|plasma|plasma
260414|NCT02050841|s/d plasma|s/d plasma
260415|NCT02050841|Octaplas|octaplas
260416|NCT02050841|plasma replacement|plasma replacement
260417|NCT02050815|MEK162|mek162
260418|NCT02050815|Hepatic impairment|hepatic impairment
260419|NCT02050815|Healthy subjects|healthy subjects
260420|NCT02050802|Macitentan|macitentan
260421|NCT02050802|Pharmacokinetics|pharmacokinetics
260422|NCT02050802|Pharmacodynamics|pharmacodynamics
260423|NCT02050763|HIV|hiv
260424|NCT02050763|Intimate partner violence|intimate partner violence
260425|NCT02050763|Community based prevention intervention|community based prevention intervention
260426|NCT02050763|Uganda|uganda
260427|NCT02050763|Cluster randomized trial|cluster randomized trial
260428|NCT02050750|Must have registered with the ICORG 06-31 TAILORx trial|must have registered with the icorg 06-31 tailorx trial
260429|NCT02050737|Curative resection|curative resection
260430|NCT02050737|Adjuvant chemotherapy|adjuvant chemotherapy
260431|NCT02050724|Solitary Pulmonary Nodule|solitary pulmonary nodule
260432|NCT02050724|Thoracoscopy|thoracoscopy
260433|NCT02050724|Thoracic Surgery|thoracic surgery
260434|NCT02050724|Video-Assisted|video-assisted
260435|NCT02050724|Radioactive Tracers|radioactive tracers
260436|NCT02050724|Radioguided surgery|radioguided surgery
260437|NCT02050724|Handheld-SPECT|handheld-spect
260438|NCT02050711|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
260439|NCT02050711|Pulmonary rehabilitation|pulmonary rehabilitation
260440|NCT02050711|Computerized respiratory sounds|computerized respiratory sounds
260441|NCT02050698|fift metatarsal avulsion fracture|fift metatarsal avulsion fracture
260442|NCT02050698|hard-soled shoe|hard-soled shoe
260443|NCT02050698|short leg walking cast|short leg walking cast
260444|NCT02050698|protected weightbearing|protected weightbearing
260445|NCT02050672|Myoinositol|myoinositol
260446|NCT02050672|ART|art
260447|NCT02050672|EMBRYO QUALITY|embryo quality
260448|NCT02050646|Autoimmune hepatitis|autoimmune hepatitis
260449|NCT02050646|Liver dysfunction|liver dysfunction
260450|NCT02050646|Elevated serum auto antibodies|elevated serum auto antibodies
260451|NCT02050633|Craniocerebral Trauma|craniocerebral trauma
260452|NCT02050633|Long term outcome|long term outcome
260453|NCT02050633|Activities of Daily Living|activities of daily living
260454|NCT02050633|Cognitive Deficiency|cognitive deficiency
260455|NCT02050633|Health Care Quality, Access, and Evaluation|health care quality, access, and evaluation
260456|NCT02050633|Burden of care|burden of care
260457|NCT02050620|Breast cancer, exercise and quality of life|breast cancer, exercise and quality of life
260458|NCT02050581|Platelets are a part of the blood hat helps with clotting|platelets are a part of the blood hat helps with clotting
260459|NCT02050581|ITP idiopathic thrombocytopenia purpura low platelet count|itp idiopathic thrombocytopenia purpura low platelet count
260460|NCT02050568|Genital prolapse|genital prolapse
260461|NCT02050568|Genital prolapse surgery|genital prolapse surgery
260462|NCT02050568|Stress urinary incontinence|stress urinary incontinence
260463|NCT02050568|Urethral Pressure Reflectometry|urethral pressure reflectometry
260464|NCT02050542|cancer|cancer
260465|NCT02050542|prostate|prostate
260466|NCT02050542|PSA|psa
260467|NCT02050542|biopsies|biopsies
260468|NCT02050542|ultrasound|ultrasound
260469|NCT02050542|MRI|mri
260470|NCT02050542|fusion of images|fusion of images
260471|NCT02050529|Hypertension, Pregnancy induced|hypertension, pregnancy induced
260472|NCT02050529|Pre-eclampsia|pre-eclampsia
260473|NCT02050529|Eclampsia|eclampsia
260474|NCT02050529|Labetalol|labetalol
260475|NCT02050529|Hydralazine|hydralazine
260476|NCT02050516|Blastocyst, micro-well group culture dish|blastocyst, micro-well group culture dish
260477|NCT02050503|Mucositis|mucositis
260478|NCT02050503|Breakthrough pain|breakthrough pain
260479|NCT02050503|Head Nad neck cancer|head nad neck cancer
260480|NCT02050503|Intranasal transmucosal fentanyl in pectin|intranasal transmucosal fentanyl in pectin
260481|NCT02050477|Obesity|obesity
260482|NCT02050477|Bariatric|bariatric
260483|NCT02050477|Surgery|surgery
260484|NCT02050477|Sleeve|sleeve
260485|NCT02050477|Gastroplasty|gastroplasty
260486|NCT02050477|Laparoscopy|laparoscopy
260487|NCT02050464|Alzheimer Disease|alzheimer disease
260488|NCT02050464|Frontotemporal Dementia|frontotemporal dementia
260489|NCT02050464|Dementia, Vascular|dementia, vascular
260490|NCT02050464|Mild Cognitive Impairment|mild cognitive impairment
260491|NCT02050464|Diagnosis|diagnosis
260492|NCT02050464|Risk factors|risk factors
260493|NCT02050464|Biomarkers|biomarkers
260494|NCT02050464|AD|ad
260495|NCT02050464|FTD|ftd
260496|NCT02050464|VAD|vad
260497|NCT02050464|MCI|mci
260498|NCT02050451|radical cystectomy|radical cystectomy
260499|NCT02050451|urinary diversion|urinary diversion
260500|NCT02050451|nutrition|nutrition
260501|NCT02050451|oral supplementation|oral supplementation
260502|NCT02050451|enteral nutrition|enteral nutrition
260503|NCT02050438|Osteoarthritis Knee|osteoarthritis knee
260504|NCT02050438|Total Knee Arthroplasty|total knee arthroplasty
260505|NCT02050438|Quality of Life|quality of life
260506|NCT02050425|OSA|osa
260507|NCT02050425|CPAP|cpap
260508|NCT02050425|exhaled breath|exhaled breath
260509|NCT02050399|Isometric Exercise|isometric exercise
260510|NCT02050399|Arterial Pressure|arterial pressure
260511|NCT02050399|Autonomic Nervous System|autonomic nervous system
260512|NCT02050399|Cardiovascular system|cardiovascular system
260513|NCT02050399|Posture|posture
260514|NCT02050386|Brain arousal systems|brain arousal systems
260515|NCT02050386|Aging|aging
260516|NCT02050386|MRI|mri
260517|NCT02050386|fMRI|fmri
260518|NCT02050386|Cognition|cognition
260519|NCT02050373|Mucositis|mucositis
260520|NCT02050373|Stomatitis|stomatitis
260521|NCT02050373|Chemotherapy|chemotherapy
260522|NCT02050373|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
260523|NCT02050373|Laser therapy|laser therapy
260524|NCT02050373|Inflammatory cytokines|inflammatory cytokines
260525|NCT02050360|Raynaud's phenomenon|raynaud's phenomenon
260526|NCT02050360|Sildenafil|sildenafil
260527|NCT02050360|Systemic Sclerosis|systemic sclerosis
260528|NCT02050360|Local cooling|local cooling
260529|NCT02050360|Microcirculation|microcirculation
260530|NCT02050347|CD19.CAR-CD28zeta|cd19.car-cd28zeta
260531|NCT02050347|chimeric antigen receptor|chimeric antigen receptor
260532|NCT02050347|hematopoietic stem cell transplant|hematopoietic stem cell transplant
260533|NCT02050334|Phase 1|phase 1
260534|NCT02050334|Healthy Volunteer|healthy volunteer
260535|NCT02050334|Safety|safety
260536|NCT02050334|Healthy Volunteer Safety Study|healthy volunteer safety study
260537|NCT02050282|Dyspnea|dyspnea
260538|NCT02050282|Prehospital|prehospital
260539|NCT02050282|Biomarker|biomarker
260540|NCT02050282|Heart failure|heart failure
260541|NCT02050282|Triage|triage
260542|NCT02050282|Randomized, controlled study|randomized, controlled study
260543|NCT02050256|Palliative care|palliative care
260544|NCT02050256|Continuing medical education|continuing medical education
260545|NCT02050256|General practitioner|general practitioner
260546|NCT02050256|Electronic decision support|electronic decision support
260547|NCT02050243|pediatrics|pediatrics
260548|NCT02050243|brain tumor|brain tumor
260549|NCT02050243|CNS|cns
260550|NCT02050243|fluorescence|fluorescence
260551|NCT02050243|5ALA|5ala
260552|NCT02050230|transfusion|transfusion
260553|NCT02050230|pulmonary hypertension|pulmonary hypertension
260554|NCT02050230|intensive care medicine|intensive care medicine
260555|NCT02050217|Helmet|helmet
260556|NCT02050217|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
260557|NCT02050217|Children|children
260558|NCT02050217|Respiratory Failure|respiratory failure
260559|NCT02050204|work to family conflict|work to family conflict
260560|NCT02050204|supervisor support|supervisor support
260561|NCT02050204|long work hours|long work hours
260562|NCT02050204|cardiometabolic risk|cardiometabolic risk
260563|NCT02050204|sleep duration|sleep duration
260564|NCT02050204|insomnia symptoms|insomnia symptoms
260565|NCT02050178|Pancreatic Cancer|pancreatic cancer
260566|NCT02050178|Stage IV Pancreatic Cancer|stage iv pancreatic cancer
260567|NCT02050165|obesity|obesity
260568|NCT02050165|snacks|snacks
260569|NCT02050165|satiety|satiety
260570|NCT02050165|hunger|hunger
260571|NCT02050152|Amnesia|amnesia
260572|NCT02050152|Memory|memory
260573|NCT02050152|Implicit|implicit
260574|NCT02050152|Explicit|explicit
260575|NCT02050152|Nitrous Oxide|nitrous oxide
260576|NCT02050139|L-Cysteine|l-cysteine
260577|NCT02050139|Peritoneal dialysis|peritoneal dialysis
260578|NCT02050139|Diuresis|diuresis
260579|NCT02050139|Glomerular filtration rate|glomerular filtration rate
260580|NCT02050139|Peritoneal function|peritoneal function
260581|NCT02050139|Inflammation|inflammation
260582|NCT02050113|Complex Aortic Aneurysms|complex aortic aneurysms
260583|NCT02050113|Thoracoabdominal Aneurysms|thoracoabdominal aneurysms
260584|NCT02050113|Pararenal Aortic Aneurysms|pararenal aortic aneurysms
260585|NCT02050113|Juxtarenal Renal Aneurysms|juxtarenal renal aneurysms
260586|NCT02050113|Endovascular Branch Graft|endovascular branch graft
260587|NCT02050113|Fenestrated Stent Graft|fenestrated stent graft
261084|NCT02048007|Microbiome|microbiome
260588|NCT02050113|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
260589|NCT02050113|Endovascular|endovascular
260590|NCT02050100|primary lung adenocarcinoma Stages I, II, IIIA, IIIB|primary lung adenocarcinoma stages i, ii, iiia, iiib
260591|NCT02050100|squamous cell carcinoma Stages I, II, IIIA, IIIB|squamous cell carcinoma stages i, ii, iiia, iiib
260592|NCT02050100|benign non-calcified pulmonary nodules|benign non-calcified pulmonary nodules
260593|NCT02050100|early detection|early detection
260594|NCT02050087|Rotator cuff|rotator cuff
260595|NCT02050087|Rehabilitation|rehabilitation
260596|NCT02050048|Pancreatitis|pancreatitis
260597|NCT02050048|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
260598|NCT02050048|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
260599|NCT02050048|ERCP|ercp
260600|NCT02050048|High Volume|high volume
260601|NCT02050048|Lactated Ringer|lactated ringer
260602|NCT02050048|Intravenous Administration|intravenous administration
260603|NCT02050048|Sphincterotomy, Endoscopic|sphincterotomy, endoscopic
260604|NCT02050048|Pancreas|pancreas
260605|NCT02050035|Exercise Therapy|exercise therapy
260606|NCT02050035|Endothelium, vascular|endothelium, vascular
260607|NCT02050035|Blood Vessels|blood vessels
260608|NCT02050022|Biomarkers|biomarkers
260609|NCT02050022|Genomics|genomics
260610|NCT02050022|Proteomics|proteomics
260611|NCT02050022|Diagnostics|diagnostics
260612|NCT02050022|Prognostics|prognostics
260613|NCT02049996|Quality of life|quality of life
260614|NCT02049996|Robotic surgery|robotic surgery
260615|NCT02049996|Vaginal surgery|vaginal surgery
260616|NCT02049996|Prolapse repair|prolapse repair
260617|NCT02049996|Vaginal hysterectomy|vaginal hysterectomy
260618|NCT02049970|Supraclavicular block|supraclavicular block
260619|NCT02049957|MLN0128|mln0128
260620|NCT02049944|Antibiotic Prophylaxis|antibiotic prophylaxis
260621|NCT02049944|Obesity|obesity
260622|NCT02049944|Obesity, Morbid|obesity, morbid
260623|NCT02049944|Pregnancy|pregnancy
260624|NCT02049944|Infection; Cesarean Section|infection; cesarean section
260625|NCT02049931|osteoporosis, compression fracture, brace|osteoporosis, compression fracture, brace
260626|NCT02049918|Respiratory viruses|respiratory viruses
260627|NCT02049905|soft tissue sarcoma|soft tissue sarcoma
260628|NCT02049905|unresectable|unresectable
260629|NCT02049905|metastatic|metastatic
260630|NCT02049905|locally advanced|locally advanced
260631|NCT02049905|sarcoma|sarcoma
260632|NCT02049892|Total Hip Replacement|total hip replacement
260633|NCT02049892|Metal Ion|metal ion
260634|NCT02049892|2-5 years after surgery|2-5 years after surgery
260635|NCT02049892|Asymptomatic|asymptomatic
260636|NCT02049866|osteoporosis|osteoporosis
260637|NCT02049866|premenopausal|premenopausal
260638|NCT02049866|denosumab|denosumab
260639|NCT02049866|idiopathic|idiopathic
260640|NCT02049866|Idiopathic Osteoporosis in Premenopausal Women|idiopathic osteoporosis in premenopausal women
260641|NCT02049853|acute dyspnea|acute dyspnea
260642|NCT02049853|heart failure|heart failure
260643|NCT02049853|diagnostics|diagnostics
260644|NCT02049853|POCT analysis|poct analysis
260645|NCT02049853|preclinical area|preclinical area
260646|NCT02049840|Female sling|female sling
260647|NCT02049840|Stress Urinary Incontinence|stress urinary incontinence
260648|NCT02049840|Urination Disorders|urination disorders
260649|NCT02049840|Urologic Diseases|urologic diseases
260650|NCT02049827|Renal transplant, BK virus|renal transplant, bk virus
260651|NCT02049814|Drug therapy|drug therapy
260652|NCT02049762|novel P2Y12 inhibitors|novel p2y12 inhibitors
260653|NCT02049762|aspirin|aspirin
260654|NCT02049762|platelet reactivity|platelet reactivity
260655|NCT02049762|acute coronary syndrome|acute coronary syndrome
260656|NCT02049749|Child Behavior Problems|child behavior problems
260657|NCT02049749|Parent Training Program|parent training program
260658|NCT02049723|Gastroesophageal reflux disease|gastroesophageal reflux disease
260659|NCT02049723|Knowledge|knowledge
260660|NCT02049697|Healthy|healthy
260661|NCT02049697|Healthy male participants|healthy male participants
260662|NCT02049697|14C-JNJ -39823277|14c-jnj -39823277
260663|NCT02049697|TPI 1062|tpi 1062
260664|NCT02049697|Tianeptine|tianeptine
260665|NCT02049697|Absorption|absorption
260666|NCT02049697|Metabolism|metabolism
260667|NCT02049697|Excretion|excretion
260668|NCT02049697|Pharmacokinetics|pharmacokinetics
260669|NCT02049658|tumor|tumor
260670|NCT02049658|cancer|cancer
260671|NCT02049645|lung cancer|lung cancer
260672|NCT02049645|breast cancer|breast cancer
260673|NCT02049632|Breast cancer|breast cancer
260674|NCT02049632|Sentinel Node Biopsy|sentinel node biopsy
260675|NCT02049632|Micrometastasis|micrometastasis
260676|NCT02049632|Axillary lymph node dissection|axillary lymph node dissection
260677|NCT02049619|Pharyngeal pack|pharyngeal pack
260678|NCT02049619|Nausea|nausea
260679|NCT02049619|Vomiting|vomiting
260680|NCT02049619|orthognathic surgery|orthognathic surgery
260681|NCT02049619|maxillary osteotomy|maxillary osteotomy
260682|NCT02049606|LAYLA|layla
260683|NCT02049606|Non-inferiority|non-inferiority
260684|NCT02049606|100mm pain VAS|100mm pain vas
260685|NCT02049593|protocol specific|protocol specific
260686|NCT02049580|lymphoma|lymphoma
260687|NCT02049567|cataract, presbyopia|cataract, presbyopia
260688|NCT02049554|preconception care|preconception care
260689|NCT02049554|women's health|women's health
260690|NCT02049541|BKM120|bkm120
260691|NCT02049541|B-Cell Lymphoma|b-cell lymphoma
260692|NCT02049541|PI3K inhibitor|pi3k inhibitor
260693|NCT02049528|Food Effect|food effect
260694|NCT02049528|Pharmacokinetic|pharmacokinetic
260695|NCT02049528|Healthy|healthy
260696|NCT02049528|Male|male
260697|NCT02049515|Phase 3|phase 3
260698|NCT02049515|CLL/SLL|cll/sll
260699|NCT02049515|PI3K|pi3k
260700|NCT02049502|ulcerative colitis|ulcerative colitis
260701|NCT02049502|fecal microbiota transplantation|fecal microbiota transplantation
260702|NCT02049489|ICT-121|ict-121
260703|NCT02049489|glioblastoma|glioblastoma
260704|NCT02049489|immunotherapy|immunotherapy
260705|NCT02049489|dendritic cell vaccine|dendritic cell vaccine
260706|NCT02049489|CD133|cd133
260707|NCT02049476|Uveitis, Intermediate|uveitis, intermediate
260708|NCT02049476|Uveitis, Posterior|uveitis, posterior
260709|NCT02049476|Dexamethasone|dexamethasone
260710|NCT02049476|Immunosuppressive Agents|immunosuppressive agents
260711|NCT02049476|Eye Abnormalities|eye abnormalities
260712|NCT02049476|Eye Diseases|eye diseases
260713|NCT02049476|Ophthalmology|ophthalmology
260714|NCT02049476|Ophthalmologic Surgical Procedures|ophthalmologic surgical procedures
260715|NCT02049476|Vision Disorders|vision disorders
260716|NCT02049476|Inflammation|inflammation
260717|NCT02049463|carotid artery|carotid artery
260718|NCT02049463|sound|sound
260719|NCT02049463|stenosis|stenosis
260720|NCT02049463|wall|wall
260721|NCT02049463|stroke|stroke
260722|NCT02049450|thalassemia|thalassemia
260723|NCT02049450|thalassemia major|thalassemia major
260724|NCT02049450|spleen enlargement|spleen enlargement
260725|NCT02049450|INC424|inc424
260726|NCT02049450|ruxolitinib|ruxolitinib
260728|NCT02049437|Immune failure|immune failure
260729|NCT02049437|Tocilizumab|tocilizumab
260730|NCT02049437|ACTEMRA|actemra
260731|NCT02049437|Antiretroviral therapy|antiretroviral therapy
260732|NCT02049437|HAART|haart
260733|NCT02049411|Ketamine|ketamine
260734|NCT02049411|acute cognitive dysfunction|acute cognitive dysfunction
260735|NCT02049411|geriatric patients|geriatric patients
260736|NCT02049398|Microbiome|microbiome
260737|NCT02049398|Saliva|saliva
260738|NCT02049398|Reliability|reliability
260739|NCT02049398|Oral Cavity|oral cavity
260740|NCT02049385|Glutamate|glutamate
260741|NCT02049385|Pathophysiology|pathophysiology
260742|NCT02049385|Depression|depression
260743|NCT02049385|Treatment|treatment
260744|NCT02049372|complications|complications
260745|NCT02049372|tonsillectomy|tonsillectomy
260746|NCT02049372|tonsillotomy|tonsillotomy
260747|NCT02049359|Diabetes|diabetes
260748|NCT02049346|Anemia|anemia
260749|NCT02049346|Hemodialysis|hemodialysis
260750|NCT02049346|Erythropoetin Stimulating Agents|erythropoetin stimulating agents
260751|NCT02049346|Comparison|comparison
260752|NCT02049294|Prednisone|prednisone
260753|NCT02049294|Eosinophils|eosinophils
260754|NCT02049294|Immunoglobin E (IgE)|immunoglobin e (ige)
260755|NCT02049294|Asthma|asthma
260756|NCT02049294|Bronchitis|bronchitis
260757|NCT02049294|Inflammation|inflammation
260758|NCT02049294|Allergy|allergy
260759|NCT02049268|alcohol|alcohol
260760|NCT02049268|nicotine|nicotine
260761|NCT02049268|addiction|addiction
260762|NCT02049268|functional MRI|functional mri
260763|NCT02049268|functional connectivity|functional connectivity
260764|NCT02049268|brain circuits|brain circuits
260765|NCT02049255|All|all
260766|NCT02049242|Hemorrhage|hemorrhage
260767|NCT02049242|Leiomyoma|leiomyoma
260768|NCT02049242|Myofibroma|myofibroma
260769|NCT02049242|Uterine Myomectomy|uterine myomectomy
260770|NCT02049242|Tourniquet|tourniquet
260771|NCT02049229|Stent|stent
260772|NCT02049229|Titanium|titanium
260773|NCT02049229|drug eluting stent|drug eluting stent
260774|NCT02049229|myocardial infarction|myocardial infarction
260775|NCT02049229|stent thrombosis|stent thrombosis
260776|NCT02049216|knee|knee
260777|NCT02049216|osteoarthritis|osteoarthritis
260778|NCT02049216|tape|tape
260779|NCT02049216|exercise|exercise
260780|NCT02049216|rocktape|rocktape
260781|NCT02049190|Advanced Prostate Cancer|advanced prostate cancer
260782|NCT02049190|Castration-resistant Prostate Cancer|castration-resistant prostate cancer
260783|NCT02049190|Prostatic Neoplasms|prostatic neoplasms
260784|NCT02049190|Genital Neoplasms, Male|genital neoplasms, male
260785|NCT02049190|Urogenital Neoplasms|urogenital neoplasms
260786|NCT02049190|Neoplasms by Site|neoplasms by site
260787|NCT02049190|Neoplasms|neoplasms
260788|NCT02049190|Genital Diseases, Male|genital diseases, male
260789|NCT02049190|Prostatic Diseases|prostatic diseases
260790|NCT02049190|onapristone|onapristone
260791|NCT02049177|Cancer|cancer
260792|NCT02049177|Epidemiology|epidemiology
260793|NCT02049177|Head and Neck|head and neck
260794|NCT02049177|HPV|hpv
260795|NCT02049164|AR08, Vasomotor Symptoms|ar08, vasomotor symptoms
260796|NCT02049151|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
260797|NCT02049151|Tecemotide|tecemotide
260798|NCT02049151|Placebo|placebo
260799|NCT02049151|NSCLC|nsclc
260800|NCT02049151|L-BLP25|l-blp25
260801|NCT02049138|Musculoskeletal Disease|musculoskeletal disease
260802|NCT02049138|Arthritis|arthritis
260803|NCT02049138|Joint Diseases|joint diseases
260804|NCT02049138|Anti-inflammatory Agents|anti-inflammatory agents
260805|NCT02049138|Antirheumatic agents|antirheumatic agents
260806|NCT02049125|NGAL|ngal
260807|NCT02049125|Acute kidney injury|acute kidney injury
260808|NCT02049125|Cirrhosis|cirrhosis
260809|NCT02049125|Hepatorenal syndrome|hepatorenal syndrome
260810|NCT02049112|Cross-over|cross-over
260811|NCT02049112|Salivary equivalent|salivary equivalent
260812|NCT02049112|Dry mouth|dry mouth
260813|NCT02049112|Medical device|medical device
260814|NCT02049086|SBIRT|sbirt
260815|NCT02049086|Screening|screening
260816|NCT02049086|Brief Intervention|brief intervention
260817|NCT02049086|Referral to Treatment|referral to treatment
260818|NCT02049086|Pain-Management|pain-management
260819|NCT02049086|Veterans|veterans
260820|NCT02049073|hearing loss|hearing loss
260821|NCT02049073|noise induced hearing loss|noise induced hearing loss
260822|NCT02049073|zonisamide|zonisamide
260823|NCT02049060|MPM|mpm
260824|NCT02049060|NSCLC|nsclc
260825|NCT02049047|thymoma thymic carcinoma|thymoma thymic carcinoma
260826|NCT02049034|GLP-1 agonist|glp-1 agonist
260827|NCT02049034|Lixisenatide|lixisenatide
260828|NCT02049034|Postprandial glucose metabolism|postprandial glucose metabolism
260829|NCT02049034|Postprandial lipid metabolism|postprandial lipid metabolism
260830|NCT02049034|Gastric emptying|gastric emptying
260831|NCT02049034|Lipoprotein lipase activity|lipoprotein lipase activity
260832|NCT02049021|schizophrenia|schizophrenia
260833|NCT02049021|electroconvulsive therapy|electroconvulsive therapy
260834|NCT02049021|refractory Schizophrenia|refractory schizophrenia
260835|NCT02049021|super refractory schizophrenia|super refractory schizophrenia
260836|NCT02049021|clozapine|clozapine
260837|NCT02048995|Bipolar Disorder|bipolar disorder
260838|NCT02048995|Depression|depression
260839|NCT02048995|Light Therapy|light therapy
260840|NCT02048995|Contrast Sensitivity|contrast sensitivity
260841|NCT02048995|Visual Evoked Potential|visual evoked potential
260842|NCT02048995|Visual or Neural Responses|visual or neural responses
260843|NCT02048995|Biomarker|biomarker
260844|NCT02048982|physician prescribing|physician prescribing
260845|NCT02048982|behavioral economics|behavioral economics
260846|NCT02048982|primary care practice|primary care practice
260847|NCT02048969|hepatic encephalopathy|hepatic encephalopathy
260848|NCT02048969|flumazenil|flumazenil
260849|NCT02048969|liver cirrhosis|liver cirrhosis
260850|NCT02048956|knee osteoarthritis|knee osteoarthritis
260851|NCT02048956|hydrotherapy|hydrotherapy
260852|NCT02048930|GPRD|gprd
260853|NCT02048930|effectiveness|effectiveness
260854|NCT02048930|cost-effectiveness|cost-effectiveness
260855|NCT02048930|Easyhaler|easyhaler
260856|NCT02048930|Primary care|primary care
260857|NCT02048930|DPI|dpi
260858|NCT02048917|Smoking|smoking
260859|NCT02048917|Cessation|cessation
260860|NCT02048917|Bupropion|bupropion
260861|NCT02048917|Varenicline|varenicline
260862|NCT02048917|Nicotine|nicotine
260863|NCT02048917|Counseling|counseling
260864|NCT02048917|Tobacco|tobacco
260865|NCT02048904|microalbuminuria|microalbuminuria
260866|NCT02048904|type 2 diabetes|type 2 diabetes
260867|NCT02048878|Insomnia|insomnia
260868|NCT02048865|VTE Cancer|vte cancer
260869|NCT02048852|menthol|menthol
260870|NCT02048852|nicotine|nicotine
260871|NCT02048826|stroke|stroke
260872|NCT02048800|Treosulfan pharmacokinetics|treosulfan pharmacokinetics
260873|NCT02048800|Children|children
260874|NCT02048800|Any condition that requires an allogeneic HSCT|any condition that requires an allogeneic hsct
260875|NCT02048787|Renal impairment|renal impairment
260876|NCT02048787|Healthy volunteers|healthy volunteers
260877|NCT02048787|Clinical pharmacology study|clinical pharmacology study
260878|NCT02048748|Home Care Services|home care services
260879|NCT02048748|Telemedicine|telemedicine
260880|NCT02048696|Exercise training|exercise training
260881|NCT02048696|High intensity interval training|high intensity interval training
260882|NCT02048696|left ventricular systolic function|left ventricular systolic function
260883|NCT02048696|G-protein related kinase 2|g-protein related kinase 2
260884|NCT02048696|heart failure|heart failure
260885|NCT02048696|myocardial infarction|myocardial infarction
260886|NCT02048696|coronary artery disease|coronary artery disease
260887|NCT02048696|beta adrenergic receptor|beta adrenergic receptor
260888|NCT02048683|Pharmacokinetics|pharmacokinetics
260889|NCT02048683|Sevoflurane|sevoflurane
260890|NCT02048683|Burn|burn
260891|NCT02048683|Sedation|sedation
260892|NCT02048670|Pilot study|pilot study
260893|NCT02048670|Assessment of sway phase|assessment of sway phase
260894|NCT02048670|Therapy trial phase|therapy trial phase
260895|NCT02048657|LMA, Foley Airway Stylet Tool (FAST), introducer-tool (I-Tool)|lma, foley airway stylet tool (fast), introducer-tool (i-tool)
260896|NCT02048644|Platelets adhesion|platelets adhesion
260897|NCT02048631|oral cancer,Quality of life,Sensory|oral cancer,quality of life,sensory
260898|NCT02048618|Active Crohn's Disease|active crohn's disease
260899|NCT02048618|GLPG0634|glpg0634
260900|NCT02048592|cystic fibrosis, immunonutrition, oxidative stress|cystic fibrosis, immunonutrition, oxidative stress
260901|NCT02048566|Echocardiography, Transesophageal|echocardiography, transesophageal
260902|NCT02048566|Monitoring, Physiologic|monitoring, physiologic
260903|NCT02048566|Shock|shock
260904|NCT02048553|ventriculostomy; complications in neurosurgery;catheter accuracy;|ventriculostomy; complications in neurosurgery;catheter accuracy;
260905|NCT02048514|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
260906|NCT02048514|Endovascular Procedures|endovascular procedures
260907|NCT02048501|Weight regain|weight regain
260908|NCT02048501|Sustain weight loss|sustain weight loss
260909|NCT02048501|Weight loss|weight loss
260910|NCT02048501|Gut hormones|gut hormones
260911|NCT02048488|non small cell lung cancer|non small cell lung cancer
260912|NCT02048488|NSCLC|nsclc
260913|NCT02048488|Anaplastic lymphoma kinase|anaplastic lymphoma kinase
260914|NCT02048488|ALK tyrosine kinase receptor|alk tyrosine kinase receptor
260915|NCT02048488|ALK+|alk+
260916|NCT02048488|TRK+|trk+
260917|NCT02048488|ALK inhibitor|alk inhibitor
260918|NCT02048488|TRK inhibitor|trk inhibitor
260919|NCT02048488|tropomyosin receptor kinase|tropomyosin receptor kinase
260920|NCT02048488|TRKA|trka
260921|NCT02048488|TRKB|trkb
260922|NCT02048488|TRKC|trkc
260923|NCT02048488|advanced malignancy|advanced malignancy
260924|NCT02048475|desflurane|desflurane
260925|NCT02048475|electroencephalogram|electroencephalogram
260926|NCT02048449|Reflux finding score, interrater reliability|reflux finding score, interrater reliability
260927|NCT02048436|Respiratory Rate|respiratory rate
260928|NCT02048423|suicidal|suicidal
260929|NCT02048397|Bronchiectasis.|bronchiectasis.
260930|NCT02048384|rapamycin|rapamycin
260931|NCT02048384|metformin|metformin
260932|NCT02048384|pancreatic cancer|pancreatic cancer
260933|NCT02048384|adenocarcinoma|adenocarcinoma
260934|NCT02048384|metastatic|metastatic
260935|NCT02048358|Healthy volunteers|healthy volunteers
260936|NCT02048358|first in human|first in human
260937|NCT02048358|2B3-201|2b3-201
260938|NCT02048358|methylprednisolone|methylprednisolone
260939|NCT02048358|CNS-targeting|cns-targeting
260940|NCT02048358|liposomal|liposomal
260941|NCT02048358|crossover|crossover
260942|NCT02048358|placebo controlled|placebo controlled
260943|NCT02048358|active controlled|active controlled
260944|NCT02048358|multiple sclerosis|multiple sclerosis
260945|NCT02048358|multiple sclerosis relapse|multiple sclerosis relapse
260946|NCT02048345|ten mL suspension of posaconazol (Noxafil) together with 240mL water will be taken by the volunteer in a fasted state|ten ml suspension of posaconazol (noxafil) together with 240ml water will be taken by the volunteer in a fasted state
260947|NCT02048345|ten mL suspension of posaconazol (Noxafil) together with 240mL water will be taken by the volunteer in a fed state|ten ml suspension of posaconazol (noxafil) together with 240ml water will be taken by the volunteer in a fed state
260948|NCT02048345|two point six mL of suspension that is dissolved in 247mL water will be administered to the volunteer by the stomach catheter in a fasted state|two point six ml of suspension that is dissolved in 247ml water will be administered to the volunteer by the stomach catheter in a fasted state
260949|NCT02048345|two point six mL of suspension that is dissolved in 247mL water will be administered to the volunteer by the stomach catheter in a fed state|two point six ml of suspension that is dissolved in 247ml water will be administered to the volunteer by the stomach catheter in a fed state
260950|NCT02048332|Epstein-Barr Virus (EBV)|epstein-barr virus (ebv)
260951|NCT02048332|Adenovirus (ADV)|adenovirus (adv)
260952|NCT02048332|t-cells|t-cells
260953|NCT02048332|donor|donor
260954|NCT02048332|transplant|transplant
260955|NCT02048332|children|children
260956|NCT02048332|cytomegalovirus (CMV)|cytomegalovirus (cmv)
260957|NCT02048332|BK virus (BKV)|bk virus (bkv)
260958|NCT02048319|Liver cyst|liver cyst
260959|NCT02048319|Hepatic cyst|hepatic cyst
260960|NCT02048319|Symptomatic|symptomatic
260961|NCT02048319|Aspiration sclerotherapy|aspiration sclerotherapy
260962|NCT02048306|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
260963|NCT02048306|Pulmonary rehabilitation|pulmonary rehabilitation
260964|NCT02048306|Family|family
260965|NCT02048306|Integrated care|integrated care
260966|NCT02048306|Mixed methods|mixed methods
260967|NCT02048293|remifentanil|remifentanil
260968|NCT02048293|propofol|propofol
260969|NCT02048293|pharmacodynamic|pharmacodynamic
260970|NCT02048293|total intravenous anesthesia|total intravenous anesthesia
260971|NCT02048293|orotracheal intubation|orotracheal intubation
260972|NCT02048293|heart rate|heart rate
260973|NCT02048293|mean arterial pressure|mean arterial pressure
260974|NCT02048293|Cooper intubation condition score|cooper intubation condition score
260975|NCT02048267|Alcoholic|alcoholic
260976|NCT02048267|Non alcoholic|non alcoholic
260977|NCT02048267|Idiopathic|idiopathic
260978|NCT02048267|Tropical|tropical
260979|NCT02048267|Exocrine dysfunction|exocrine dysfunction
260980|NCT02048267|Endocrine dysfunction|endocrine dysfunction
260981|NCT02048267|Pain control|pain control
260982|NCT02048267|Frey's procedure|frey's procedure
260983|NCT02048267|Duodenum preserving pancreatic head resection|duodenum preserving pancreatic head resection
260984|NCT02048254|inoperable salivary gland cancer|inoperable salivary gland cancer
260985|NCT02048254|brachytherapy|brachytherapy
260986|NCT02048254|intensity-modulated radiation therapy|intensity-modulated radiation therapy
260987|NCT02048241|childhood|childhood
260988|NCT02048241|temper|temper
260989|NCT02048241|explosive|explosive
260990|NCT02048241|aggression|aggression
260991|NCT02048241|tantrums|tantrums
260992|NCT02048241|oppositional|oppositional
260993|NCT02048241|defiant|defiant
260994|NCT02048241|conduct|conduct
260995|NCT02048241|disruptive|disruptive
260996|NCT02048241|emotional dysregulation|emotional dysregulation
260997|NCT02048241|special education|special education
260998|NCT02048228|Clopidogrel,|clopidogrel,
260999|NCT02048228|Pharmacogenetics,|pharmacogenetics,
261000|NCT02048228|Platelet reactivity,|platelet reactivity,
261001|NCT02048228|CYP2C19,|cyp2c19,
261002|NCT02048228|point-of-care|point-of-care
261003|NCT02048215|thermogenesis|thermogenesis
261004|NCT02048215|low-calorie diet|low-calorie diet
261005|NCT02048215|uncoupling-protein 3|uncoupling-protein 3
261006|NCT02048215|beta-3 adrenoceptors|beta-3 adrenoceptors
261007|NCT02048215|thermogenic drugs|thermogenic drugs
261008|NCT02048202|clown|clown
261009|NCT02048202|neonate|neonate
261010|NCT02048202|premature|premature
261011|NCT02048176|Mutism|mutism
261012|NCT02048163|Meropenem|meropenem
261013|NCT02048163|Nausea|nausea
261014|NCT02048163|Pharmacokinetics|pharmacokinetics
261015|NCT02048124|25d ProCor needle|25d procor needle
261016|NCT02048124|22 gauge|22 gauge
261017|NCT02048124|endoscopic ultrasonography|endoscopic ultrasonography
261018|NCT02048124|fine needle biopsies|fine needle biopsies
261019|NCT02048124|Patients|patients
261020|NCT02048124|presenting|presenting
261021|NCT02048111|Hemophilia B|hemophilia b
261022|NCT02048111|Hemophilia A|hemophilia a
261023|NCT02048111|Blood Coagulation Disorders, Inherited|blood coagulation disorders, inherited
261024|NCT02048111|Blood Coagulation Disorders|blood coagulation disorders
261025|NCT02048111|Hematologic Diseases|hematologic diseases
261026|NCT02048111|Coagulation Protein Disorders|coagulation protein disorders
261027|NCT02048111|Hemorrhagic Disorders|hemorrhagic disorders
261028|NCT02048111|Genetic Diseases, Inborn|genetic diseases, inborn
261029|NCT02048111|Genetic Diseases, X-Linked|genetic diseases, x-linked
261030|NCT02048098|misoprostol|misoprostol
261031|NCT02048098|Labor, Induced|labor, induced
261032|NCT02048098|Pregnancy Trimester, Second|pregnancy trimester, second
261033|NCT02048098|Abortion, Induced|abortion, induced
261034|NCT02048085|ACS|acs
261035|NCT02048085|STEMI|stemi
261036|NCT02048085|Fibrinolysis|fibrinolysis
261037|NCT02048085|Pharmacodynamics|pharmacodynamics
261038|NCT02048085|Pharmacokinetics|pharmacokinetics
261039|NCT02048085|Plavix|plavix
261040|NCT02048085|Brilinta|brilinta
261041|NCT02048085|Ticagrelor|ticagrelor
261042|NCT02048085|Clopidogrel|clopidogrel
261043|NCT02048072|relapsing remitting|relapsing remitting
261044|NCT02048072|multiple sclerosis|multiple sclerosis
261045|NCT02048072|fingolimod|fingolimod
261046|NCT02048072|Gilenya|gilenya
261047|NCT02048072|autonomic nervous system|autonomic nervous system
261048|NCT02048059|ANG1005|ang1005
261049|NCT02048059|GRN1005|grn1005
261050|NCT02048059|Low-density lipoprotein receptor-related protein (LRP-1)|low-density lipoprotein receptor-related protein (lrp-1)
261051|NCT02048059|Targeted therapy|targeted therapy
261052|NCT02048059|Breast cancer|breast cancer
261053|NCT02048059|Brain metastases|brain metastases
261054|NCT02048059|Brain tumor|brain tumor
261055|NCT02048059|Blood-brain barrier|blood-brain barrier
261056|NCT02048059|Trastuzumab|trastuzumab
261057|NCT02048059|Herceptin|herceptin
261058|NCT02048059|Paclitaxel|paclitaxel
261059|NCT02048059|Taxol|taxol
261060|NCT02048059|Breast cancer with brain metastases|breast cancer with brain metastases
261061|NCT02048059|Triple Negative|triple negative
261062|NCT02048059|Triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
261063|NCT02048059|Herceptin 2 (HER2)-positive|herceptin 2 (her2)-positive
261064|NCT02048059|HER2-negative|her2-negative
261065|NCT02048059|Metastatic brain tumors|metastatic brain tumors
261066|NCT02048046|ECMO|ecmo
261067|NCT02048046|Nutrition therapy|nutrition therapy
261068|NCT02048033|Obesity|obesity
261069|NCT02048033|Endogastric suturing|endogastric suturing
261070|NCT02048033|Jujenal anastomosis|jujenal anastomosis
261071|NCT02048033|weight regain|weight regain
261072|NCT02048007|Childhood mortality|childhood mortality
261073|NCT02048007|Azithromycin|azithromycin
261074|NCT02048007|Mass treatment|mass treatment
261075|NCT02048007|Infection|infection
261076|NCT02048007|Bacterial infections|bacterial infections
261077|NCT02048007|Trachoma|trachoma
261078|NCT02048007|Chlamydia infections|chlamydia infections
261079|NCT02048007|Malaria|malaria
261080|NCT02048007|Diarrhea|diarrhea
261081|NCT02048007|Respiratory Infections|respiratory infections
261082|NCT02048007|Antibiotic resistance|antibiotic resistance
261083|NCT02048007|Verbal Autopsy|verbal autopsy
261085|NCT02047994|Gastric cancer|gastric cancer
261086|NCT02047994|Gastric cancer mortality|gastric cancer mortality
261087|NCT02047994|Helicobacter pylori treatment|helicobacter pylori treatment
261088|NCT02047994|Pepsinogen testing|pepsinogen testing
261089|NCT02047994|Endoscopy|endoscopy
261090|NCT02047994|Volatile marker|volatile marker
261091|NCT02047981|Childhood mortality|childhood mortality
261092|NCT02047981|Azithromycin|azithromycin
261093|NCT02047981|Mass treatment|mass treatment
261094|NCT02047981|Infection|infection
261095|NCT02047981|Verbal Autopsy|verbal autopsy
261096|NCT02047968|Wake therapy|wake therapy
261097|NCT02047968|Sleep deprivation|sleep deprivation
261098|NCT02047968|Light therapy|light therapy
261099|NCT02047968|Bipolar depression|bipolar depression
261100|NCT02047968|Sleep-wake cycle|sleep-wake cycle
261101|NCT02047968|Major depression|major depression
261102|NCT02047968|Depression|depression
261103|NCT02047968|Depressive Disorder|depressive disorder
261104|NCT02047968|Major Behavioural Symptoms|major behavioural symptoms
261105|NCT02047968|Mood Disorders|mood disorders
261106|NCT02047968|Mental Disorders|mental disorders
261107|NCT02047968|Dyssomnias|dyssomnias
261108|NCT02047968|Sleep Disorders|sleep disorders
261109|NCT02047968|Affective Disorders|affective disorders
261110|NCT02047929|Asthma|asthma
261111|NCT02047929|Shared decision making|shared decision making
261112|NCT02047929|Participatory methods|participatory methods
261113|NCT02047929|Practice facilitator|practice facilitator
261114|NCT02047929|Health coach|health coach
261115|NCT02047916|Neonates|neonates
261116|NCT02047916|Superior Vena Cava Flow|superior vena cava flow
261117|NCT02047916|Pleth variabilty index|pleth variabilty index
261118|NCT02047890|CDK inhibitor|cdk inhibitor
261119|NCT02047890|BAY1000394|bay1000394
261120|NCT02047890|Advanced malignancies|advanced malignancies
261121|NCT02047890|Japanese|japanese
261122|NCT02047877|Respiratory Secretions|respiratory secretions
261123|NCT02047877|Tracheal Secretions|tracheal secretions
261124|NCT02047877|Bronchial Secretions|bronchial secretions
261125|NCT02047877|NonBronchoscopic BAL|nonbronchoscopic bal
261126|NCT02047877|Interleukin 10|interleukin 10
261127|NCT02047877|Interleukin 12p70|interleukin 12p70
261128|NCT02047864|Osteoporosis|osteoporosis
261129|NCT02047864|Sarcopenia|sarcopenia
261130|NCT02047864|Strength|strength
261131|NCT02047864|Bone|bone
261132|NCT02047864|Muscle|muscle
261133|NCT02047864|Creatine|creatine
261134|NCT02047825|Multiple sclerosis|multiple sclerosis
261135|NCT02047825|Dexterity|dexterity
261136|NCT02047825|Upper limbs|upper limbs
261137|NCT02047812|Laparotomy|laparotomy
261138|NCT02047812|General Surgery|general surgery
261139|NCT02047812|Hospitals,General|hospitals,general
261140|NCT02047812|Hospitals,High-Volume|hospitals,high-volume
261141|NCT02047812|Hospitals,Low-Volume|hospitals,low-volume
261142|NCT02047812|Outcome Assessment (Health Care)|outcome assessment (health care)
261143|NCT02047799|elderly people, high blood pressure, vitamin D.|elderly people, high blood pressure, vitamin d.
261144|NCT02047786|Outcome Assessment (Health Care)|outcome assessment (health care)
261145|NCT02047786|Appendectomy|appendectomy
261146|NCT02047786|Child|child
261147|NCT02047786|Hospitals, Pediatric|hospitals, pediatric
261148|NCT02047786|Hospitals, General|hospitals, general
261149|NCT02047773|bronchiectasis|bronchiectasis
261150|NCT02047773|intravenous antibiotics|intravenous antibiotics
261151|NCT02047773|duration of antibiotic course|duration of antibiotic course
261152|NCT02047773|side effects|side effects
261153|NCT02047773|bacterial load|bacterial load
261154|NCT02047747|Brain|brain
261155|NCT02047747|Metastasis|metastasis
261156|NCT02047747|human epidermal receptor (HER)|human epidermal receptor (her)
261157|NCT02047695|migraine with aura|migraine with aura
261158|NCT02047695|migraine|migraine
261159|NCT02047695|case-control study|case-control study
261160|NCT02047695|magnetic resonance imaging|magnetic resonance imaging
261161|NCT02047695|brain diseases|brain diseases
261162|NCT02047656|Healthy volunteers, hypertension|healthy volunteers, hypertension
261163|NCT02047643|Type 1 diabetes|type 1 diabetes
261164|NCT02047643|Hypoglycemia|hypoglycemia
261165|NCT02047643|Accelerometer|accelerometer
261166|NCT02047630|Primary open angle glaucoma|primary open angle glaucoma
261167|NCT02047630|Ocular hypertension|ocular hypertension
261168|NCT02047630|latanoprost|latanoprost
261169|NCT02047630|generic|generic
261170|NCT02047630|intraocular pressure|intraocular pressure
261171|NCT02047617|Muscle Weakness|muscle weakness
261172|NCT02047617|Exercise therapy|exercise therapy
261173|NCT02047617|Physiotherapy|physiotherapy
261174|NCT02047617|Critical illness|critical illness
261175|NCT02047617|Intensive care|intensive care
261176|NCT02047617|Mechanical ventilation|mechanical ventilation
261177|NCT02047617|Rehabilitation|rehabilitation
261178|NCT02047604|Phase 2a multiple ascending dose, Anti-Very Late Antigen-1|phase 2a multiple ascending dose, anti-very late antigen-1
261179|NCT02047578|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
261180|NCT02047565|punch biopsy|punch biopsy
261181|NCT02047552|trauma|trauma
261182|NCT02047552|iron|iron
261183|NCT02047552|anemia|anemia
261184|NCT02047552|red blood cell transfusion|red blood cell transfusion
261185|NCT02047526|Heart Failure|heart failure
261186|NCT02047526|Cardiovascular disease|cardiovascular disease
261187|NCT02047526|Congestive Heart Failure|congestive heart failure
261188|NCT02047500|TH-302|th-302
261189|NCT02047500|Nab-paclitaxel|nab-paclitaxel
261190|NCT02047500|Gemcitabine|gemcitabine
261191|NCT02047500|Evofosfamide|evofosfamide
261192|NCT02047461|Molybdenum cofactor deficiency (MoCD)|molybdenum cofactor deficiency (mocd)
261193|NCT02047461|molybdenum cofactor (MoCo) biosynthesis|molybdenum cofactor (moco) biosynthesis
261194|NCT02047461|sulfite oxidase (SO)|sulfite oxidase (so)
261195|NCT02047461|xanthine dehydrogenase|xanthine dehydrogenase
261196|NCT02047461|aldehyde oxidase|aldehyde oxidase
261197|NCT02047461|S sulfocysteine (SSC)|s sulfocysteine (ssc)
261198|NCT02047448|transition of care|transition of care
261199|NCT02047448|care transitions|care transitions
261200|NCT02047448|readmission|readmission
261201|NCT02047448|medication|medication
261202|NCT02047448|adherence|adherence
261203|NCT02047448|medication management|medication management
261204|NCT02047448|medication reconciliation|medication reconciliation
261205|NCT02047448|patient counseling|patient counseling
261206|NCT02047448|pharmacist|pharmacist
261207|NCT02047435|Social participation|social participation
261208|NCT02047435|Loneliness|loneliness
261209|NCT02047435|General practice|general practice
261210|NCT02047435|Cultural institutions|cultural institutions
261211|NCT02047422|Heart failure, diuretics, kidney, glomerular filtration rate|heart failure, diuretics, kidney, glomerular filtration rate
261212|NCT02047383|respiratory infection|respiratory infection
261213|NCT02047383|physical variables|physical variables
261214|NCT02047370|stretching, diaphragm, asthma, manual therapy|stretching, diaphragm, asthma, manual therapy
261215|NCT02047357|Maternal depression|maternal depression
261216|NCT02047357|Mother|mother
261217|NCT02047357|Child|child
261218|NCT02047357|LTP|ltp
261219|NCT02047357|Learning Through Play|learning through play
261220|NCT02047357|Healthy thinking|healthy thinking
261221|NCT02047344|NSCLC|nsclc
261222|NCT02047331|periarticular drug injection|periarticular drug injection
261223|NCT02047331|fascia iliaca block|fascia iliaca block
261224|NCT02047331|knee arthroplasty|knee arthroplasty
261225|NCT02047305|ESCN|escn
261226|NCT02047305|RFA|rfa
261227|NCT02047292|Gait analysis|gait analysis
261228|NCT02047292|3D videofluoroscopy|3d videofluoroscopy
261229|NCT02047292|Femoroacetabular impingement|femoroacetabular impingement
261230|NCT02047292|Neck-cup impingement|neck-cup impingement
261231|NCT02047292|Head-neck ratio|head-neck ratio
261232|NCT02047292|Hip scores|hip scores
261233|NCT02047292|Functional assessment|functional assessment
261234|NCT02047292|Cup size|cup size
261235|NCT02047292|Range of motion|range of motion
261236|NCT02047292|Unilateral Primary|unilateral primary
261237|NCT02047292|Secondary|secondary
261238|NCT02047279|Atrial fibrillation|atrial fibrillation
261239|NCT02047279|Mitral valve|mitral valve
261240|NCT02047266|MICS CABG OPCABG ONCABG CAD|mics cabg opcabg oncabg cad
261241|NCT02047253|carfilzomib|carfilzomib
261242|NCT02047253|prostate cancer|prostate cancer
261243|NCT02047253|PSA (prostate-specific antigen)|psa (prostate-specific antigen)
261244|NCT02047253|CRPC (castration-resistant prostate cancer)|crpc (castration-resistant prostate cancer)
261245|NCT02047240|liver cirrhosis|liver cirrhosis
261246|NCT02047240|glomerular filtration|glomerular filtration
261247|NCT02047240|cystatin C|cystatin c
261248|NCT02047227|ESPART|espart
261249|NCT02047227|Reproductive Techniques, Assisted|reproductive techniques, assisted
261250|NCT02047227|Infertility|infertility
261251|NCT02047227|Pergoveris®|pergoveris®
261252|NCT02047227|GONAL-f®|gonal-f®
261253|NCT02047214|Glioblastoma multiforme|glioblastoma multiforme
261254|NCT02047214|Glioblastoma|glioblastoma
261255|NCT02047214|Radiotherapy|radiotherapy
261256|NCT02047214|Temozolomide|temozolomide
261257|NCT02047214|TPI 287|tpi 287
261258|NCT02047214|Taxoid|taxoid
261259|NCT02047214|Avastin|avastin
261260|NCT02047214|Bevacizumab|bevacizumab
261261|NCT02047201|Head and neck cancer|head and neck cancer
261262|NCT02047201|PET/CT|pet/ct
261263|NCT02047201|induction chemotherapy|induction chemotherapy
261264|NCT02047201|IMRT|imrt
261265|NCT02047188|narrow band imaging,microvessels,matrix metalloproteinase-7|narrow band imaging,microvessels,matrix metalloproteinase-7
261266|NCT02047162|diarrhea|diarrhea
261267|NCT02047162|gastroenteritis|gastroenteritis
261268|NCT02047162|antimicrobial drug resistance|antimicrobial drug resistance
261269|NCT02047162|antimicrobial agents|antimicrobial agents
261270|NCT02047162|Pakistan|pakistan
261271|NCT02047162|ambulatory care|ambulatory care
261272|NCT02047162|bismuth|bismuth
261273|NCT02047149|Myelogenous Leukemia|myelogenous leukemia
261274|NCT02047123|commercial flaxseed|commercial flaxseed
261275|NCT02047123|cholesterol|cholesterol
261276|NCT02047123|lipidic profile|lipidic profile
261277|NCT02047123|yoghurt|yoghurt
261278|NCT02047123|consumption|consumption
261279|NCT02047110|ABBV-066|abbv-066
261280|NCT02047110|BI 655066|bi 655066
261281|NCT02047110|risankizumab|risankizumab
261385|NCT02046681|Oxycodone|oxycodone
261282|NCT02047071|Obstructive sleep apnea|obstructive sleep apnea
261283|NCT02047071|Female gender|female gender
261284|NCT02047071|Continuous Positive Airway Pressure|continuous positive airway pressure
261285|NCT02047058|biomarker|biomarker
261286|NCT02047058|Q cell|q cell
261287|NCT02047058|Overall survival|overall survival
261288|NCT02047058|Progression-free survival|progression-free survival
261289|NCT02047045|severe chronic constipation|severe chronic constipation
261290|NCT02047045|randomized controlled|randomized controlled
261291|NCT02047045|electro-acupuncture|electro-acupuncture
261292|NCT02047045|prucalopride|prucalopride
261293|NCT02047032|electroacupuncture|electroacupuncture
261294|NCT02047032|urinary incontinence|urinary incontinence
261295|NCT02047032|PFMT|pfmt
261296|NCT02047032|Solifenacin|solifenacin
261297|NCT02047019|Drug combination|drug combination
261298|NCT02047019|Nifedipine GITS|nifedipine gits
261299|NCT02047019|Candesartan Cilexetil|candesartan cilexetil
261300|NCT02047019|Hypertension|hypertension
261301|NCT02047019|Combination therapy|combination therapy
261302|NCT02047006|Hemodialysis|hemodialysis
261303|NCT02047006|Rivaroxaban|rivaroxaban
261304|NCT02047006|AUC|auc
261305|NCT02046993|Hypertension|hypertension
261306|NCT02046993|self blood pressure monitoring|self blood pressure monitoring
261307|NCT02046993|smartphone based telemonitoring|smartphone based telemonitoring
261308|NCT02046993|primary care|primary care
261309|NCT02046967|endovenous laser ablation|endovenous laser ablation
261310|NCT02046967|endovenous steam ablation|endovenous steam ablation
261311|NCT02046967|great saphenous veins|great saphenous veins
261312|NCT02046967|quality of life|quality of life
261313|NCT02046954|transesophageal echocardiography|transesophageal echocardiography
261314|NCT02046954|tee|tee
261315|NCT02046954|toe|toe
261316|NCT02046954|cardiac surgery|cardiac surgery
261317|NCT02046941|aphasia|aphasia
261318|NCT02046941|stroke|stroke
261319|NCT02046941|Magnetic Resonance Imaging|magnetic resonance imaging
261320|NCT02046941|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
261321|NCT02046928|Leukemia|leukemia
261322|NCT02046928|Lymphoma|lymphoma
261323|NCT02046902|coronary artery disease|coronary artery disease
261324|NCT02046902|cardiac stent|cardiac stent
261325|NCT02046902|PCI procedure|pci procedure
261326|NCT02046902|Patient preference|patient preference
261327|NCT02046876|neck pain|neck pain
261328|NCT02046876|physiotherapy|physiotherapy
261329|NCT02046876|adapted swimming|adapted swimming
261330|NCT02046876|therapeutic exercises|therapeutic exercises
261331|NCT02046876|health education|health education
261332|NCT02046863|Parkinson's disease|parkinson's disease
261333|NCT02046863|Tremor|tremor
261334|NCT02046863|Bradykinesia|bradykinesia
261335|NCT02046863|Deep brain stimulation|deep brain stimulation
261336|NCT02046863|Kinesia|kinesia
261337|NCT02046850|Phase I, healthy, pharmacokinetics,|phase i, healthy, pharmacokinetics,
261338|NCT02046837|Prostate cancer|prostate cancer
261339|NCT02046837|Exercise|exercise
261340|NCT02046837|Elderly|elderly
261341|NCT02046837|Quality of life|quality of life
261342|NCT02046837|Fatigue|fatigue
261343|NCT02046837|Physical fitness|physical fitness
261344|NCT02046837|Adherence|adherence
261345|NCT02046837|Cost-effectiveness|cost-effectiveness
261346|NCT02046811|Skin neoplasms|skin neoplasms
261347|NCT02046811|Radiation|radiation
261348|NCT02046811|Screening|screening
261349|NCT02046811|Self-examination|self-examination
261350|NCT02046811|Comparative effectiveness research|comparative effectiveness research
261351|NCT02046811|Dermoscopy|dermoscopy
261352|NCT02046798|Pharmacokinetics|pharmacokinetics
261353|NCT02046798|ASP3652|asp3652
261354|NCT02046798|14C radio-labeled|14c radio-labeled
261355|NCT02046798|Phase 1|phase 1
261356|NCT02046785|Fluid administration|fluid administration
261357|NCT02046785|Cardiac output|cardiac output
261358|NCT02046785|Right atrial pressure|right atrial pressure
261359|NCT02046785|Resuscitation|resuscitation
261360|NCT02046772|hemorrhoidectomy|hemorrhoidectomy
261361|NCT02046772|analgesia|analgesia
261362|NCT02046772|anaesthetic|anaesthetic
261363|NCT02046772|bupivacaine|bupivacaine
261364|NCT02046772|morphine chloride|morphine chloride
261365|NCT02046733|SCLC|sclc
261366|NCT02046733|CTLA-4|ctla-4
261367|NCT02046694|acute lymphoblastic leukemia|acute lymphoblastic leukemia
261368|NCT02046694|ALL|all
261369|NCT02046694|pediatric|pediatric
261370|NCT02046694|maintenance|maintenance
261371|NCT02046694|allopurinol|allopurinol
261372|NCT02046694|6-MP|6-mp
261373|NCT02046694|6-mercaptopurine|6-mercaptopurine
261374|NCT02046681|Medication Adherence|medication adherence
261375|NCT02046681|Medication Compliance|medication compliance
261376|NCT02046681|Medication Therapy Management|medication therapy management
261377|NCT02046681|Side effects|side effects
261378|NCT02046681|Analgesics|analgesics
261379|NCT02046681|Emergency Medicine|emergency medicine
261380|NCT02046681|Home care|home care
261381|NCT02046681|Aged|aged
261382|NCT02046681|Acetaminophen|acetaminophen
261383|NCT02046681|codeine|codeine
261384|NCT02046681|ibuprofen|ibuprofen
261386|NCT02046668|Osteoarthritis of knee|osteoarthritis of knee
261387|NCT02046642|Amniotic fluid index;|amniotic fluid index;
261388|NCT02046642|amniotic fluid volume;|amniotic fluid volume;
261389|NCT02046642|intervention studies;|intervention studies;
261390|NCT02046642|maternal care patterns;|maternal care patterns;
261391|NCT02046642|mother-fetus relationships;|mother-fetus relationships;
261392|NCT02046642|rest;|rest;
261393|NCT02046642|sonography;|sonography;
261394|NCT02046642|transplacental exposure|transplacental exposure
261395|NCT02046590|Propofol|propofol
261396|NCT02046590|remifentanil|remifentanil
261397|NCT02046590|safety|safety
261398|NCT02046590|gastro-intestinal|gastro-intestinal
261399|NCT02046590|ERCP|ercp
261400|NCT02046590|minimally invasive|minimally invasive
261401|NCT02046590|intubation|intubation
261402|NCT02046590|ventilation|ventilation
261403|NCT02046577|Acute respiratory tract infections|acute respiratory tract infections
261404|NCT02046577|vitamin D|vitamin d
261405|NCT02046577|cholecalciferol|cholecalciferol
261406|NCT02046577|children|children
261407|NCT02046577|bronchiolitis|bronchiolitis
261408|NCT02046577|pneumonia|pneumonia
261409|NCT02046577|prevention|prevention
261410|NCT02046551|nicotine|nicotine
261411|NCT02046551|smoking|smoking
261412|NCT02046551|atomoxetine|atomoxetine
261413|NCT02046551|stress|stress
261414|NCT02046525|Fecal microbiota therapy|fecal microbiota therapy
261415|NCT02046512|Probiotics|probiotics
261416|NCT02046499|Prevention, post partum haemorrhage|prevention, post partum haemorrhage
261417|NCT02046486|ticagrelor|ticagrelor
261418|NCT02046486|ST elevation myocardial infarction|st elevation myocardial infarction
261419|NCT02046486|liquid formulation|liquid formulation
261420|NCT02046447|dystonia|dystonia
261421|NCT02046447|cervical dystonia|cervical dystonia
261422|NCT02046447|DYT1|dyt1
261423|NCT02046447|DYT 1|dyt 1
261424|NCT02046447|DYT-1|dyt-1
261425|NCT02046447|Dystonia 1|dystonia 1
261426|NCT02046447|fMRI|fmri
261427|NCT02046447|healthy|healthy
261428|NCT02046447|trihexyphenidyl|trihexyphenidyl
261429|NCT02046447|Artane|artane
261430|NCT02046447|Apo-Trihex|apo-trihex
261431|NCT02046447|Parkin|parkin
261432|NCT02046447|Pacitane|pacitane
261433|NCT02046447|Benzhexol|benzhexol
261434|NCT02046447|Trihex|trihex
261435|NCT02046408|Smoking|smoking
261436|NCT02046408|5A's for smoking cessation|5a's for smoking cessation
261437|NCT02046408|tailored health messages|tailored health messages
261438|NCT02046408|Patient-facing information technology|patient-facing information technology
261439|NCT02046408|Mobile health|mobile health
261440|NCT02046408|behavioral health|behavioral health
261441|NCT02046395|Type 2 Diabetes|type 2 diabetes
261442|NCT02046395|Hypertension|hypertension
261443|NCT02046382|IV Acetaminophen|iv acetaminophen
261444|NCT02046382|Cesarean Section|cesarean section
261445|NCT02046382|Pain, Postoperative|pain, postoperative
261446|NCT02046369|Lurasidone, Latuda, Bipolar Depression|lurasidone, latuda, bipolar depression
261447|NCT02046356|hepatocellular carcinoma|hepatocellular carcinoma
261448|NCT02046356|radiofrequency ablation|radiofrequency ablation
261449|NCT02046356|Milan Criteria|milan criteria
261450|NCT02046356|recurrence|recurrence
261451|NCT02046356|risk factor|risk factor
261452|NCT02046343|physical activity|physical activity
261453|NCT02046343|prevention|prevention
261454|NCT02046343|health disparities|health disparities
261455|NCT02046343|behavior|behavior
261456|NCT02046343|community based intervention|community based intervention
261457|NCT02046330|Deep Brain Stimulation|deep brain stimulation
261458|NCT02046330|Treatment Resistant Depression|treatment resistant depression
261459|NCT02046330|Major Depressive Disorder|major depressive disorder
261460|NCT02046330|Depression|depression
261461|NCT02046330|ECT|ect
261462|NCT02046330|TNS|tns
261463|NCT02046304|Sarcoma|sarcoma
261464|NCT02046304|Soft Tissue Sarcomas|soft tissue sarcomas
261465|NCT02046304|STS|sts
261466|NCT02046304|Extremity and Trunk|extremity and trunk
261467|NCT02046304|Gemcitabine|gemcitabine
261468|NCT02046304|Gemcitabine Hydrochloride|gemcitabine hydrochloride
261469|NCT02046304|Gemzar|gemzar
261470|NCT02046304|External beam radiation therapy|external beam radiation therapy
261471|NCT02046304|EBRT|ebrt
261472|NCT02046304|Radiotherapy|radiotherapy
261473|NCT02046304|XRT|xrt
261474|NCT02046291|umbilical cord transplant|umbilical cord transplant
261475|NCT02046291|acute leukemia|acute leukemia
261476|NCT02046291|UCBT|ucbt
261477|NCT02046291|Hodgkin's Lymphoma|hodgkin's lymphoma
261478|NCT02046291|Lymphoid Leukemia|lymphoid leukemia
261479|NCT02046291|Multiple Myeloma|multiple myeloma
261480|NCT02046291|Myeloid and Monocytic Leukemia|myeloid and monocytic leukemia
261481|NCT02046291|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
261482|NCT02046291|Hematopoietic malignancies|hematopoietic malignancies
261483|NCT02046265|Cervical cancer prevention|cervical cancer prevention
261484|NCT02046226|Critical Limb Ischemia|critical limb ischemia
261485|NCT02046226|Non Healing Wounds|non healing wounds
261486|NCT02046226|Diabetic Wounds|diabetic wounds
261487|NCT02046226|Foot Ulcers|foot ulcers
261488|NCT02046213|Metabolism and Excretion|metabolism and excretion
261489|NCT02046200|ivermectin, alcoholism, alcohol use disorder, treatment|ivermectin, alcoholism, alcohol use disorder, treatment
261490|NCT02046187|Ketogenic Diet|ketogenic diet
261491|NCT02046187|Brain tumor|brain tumor
261492|NCT02046187|Glioma|glioma
261493|NCT02046187|Glioblastoma|glioblastoma
261494|NCT02046187|Radiation|radiation
261495|NCT02046187|Chemotherapy|chemotherapy
261496|NCT02046187|temozolomide|temozolomide
261497|NCT02046174|colon|colon
261498|NCT02046174|colorectal|colorectal
261499|NCT02046174|rectal|rectal
261500|NCT02046174|cancer|cancer
261501|NCT02046174|macrobead|macrobead
261502|NCT02046174|stage IV|stage iv
261503|NCT02046174|metastatic|metastatic
261504|NCT02046174|biological|biological
261505|NCT02046174|mouse cells|mouse cells
261506|NCT02046174|new york|new york
261507|NCT02046174|new jersey|new jersey
261508|NCT02046174|clinical research|clinical research
261509|NCT02046161|colon preparation|colon preparation
261510|NCT02046148|Maternal vaccine|maternal vaccine
261511|NCT02046148|IgG|igg
261512|NCT02046148|IgA|iga
261513|NCT02046148|GBS|gbs
261514|NCT02046148|pregnant women|pregnant women
261515|NCT02046135|Pediatric|pediatric
261516|NCT02046135|Sodium bicarbonate|sodium bicarbonate
261517|NCT02046135|Acute kidney injury|acute kidney injury
261518|NCT02046135|Cardiac surgery|cardiac surgery
261519|NCT02046109|Repair|repair
261520|NCT02046109|Replace|replace
261521|NCT02046109|Composite|composite
261522|NCT02046109|restoration|restoration
261523|NCT02046109|failing dental restoration|failing dental restoration
261524|NCT02046109|filling|filling
261525|NCT02046109|dental|dental
261526|NCT02046109|dentistry|dentistry
261527|NCT02046096|Venous thrombosis|venous thrombosis
261528|NCT02046096|pulmonary embolism|pulmonary embolism
261529|NCT02046096|vena cava, inferior|vena cava, inferior
261530|NCT02046096|vena cava filters|vena cava filters
261531|NCT02046096|venous thromboembolism|venous thromboembolism
261532|NCT02046083|Teenager|teenager
261533|NCT02046083|Peanut|peanut
261534|NCT02046083|OIT (Oral Induction Tolerance)|oit (oral induction tolerance)
261535|NCT02046070|MLN9708|mln9708
261536|NCT02046070|Newly diagnosed|newly diagnosed
261537|NCT02046070|NDMM|ndmm
261538|NCT02046070|IXAZOMIB|ixazomib
261539|NCT02046070|RRMM|rrmm
261540|NCT02046057|Sentinel Lymph Node|sentinel lymph node
261541|NCT02046057|Ultrasound Guided Needle Core Biopsy|ultrasound guided needle core biopsy
261542|NCT02046044|Heart failure|heart failure
261543|NCT02046044|Digoxin|digoxin
261544|NCT02046044|Ivabradine|ivabradine
261545|NCT02046031|Ischemic stroke|ischemic stroke
261546|NCT02046031|safety|safety
261547|NCT02046031|Pharmacokinetics|pharmacokinetics
261548|NCT02046031|Ginkgolides Meglumine Injection|ginkgolides meglumine injection
261549|NCT02046018|Maternal and Child Health|maternal and child health
261550|NCT02046018|Rural Uganda|rural uganda
261551|NCT02046005|Family History|family history
261552|NCT02046005|RA|ra
261553|NCT02046005|Rheumatoid Arthritis|rheumatoid arthritis
261554|NCT02046005|Genetics|genetics
261555|NCT02046005|Rheumatoid Factor|rheumatoid factor
261556|NCT02046005|Shared Epitope|shared epitope
261557|NCT02046005|Anti-CCP|anti-ccp
261558|NCT02045953|Healthy Subjects|healthy subjects
261559|NCT02045953|SERETIDE|seretide
261560|NCT02045953|Pharmocokinetics|pharmocokinetics
261561|NCT02045953|FLIXOTIDE|flixotide
261562|NCT02045953|VENTOLIN Mini-Spacer|ventolin mini-spacer
261563|NCT02045940|FTIH|ftih
261564|NCT02045940|pharmacokinetics|pharmacokinetics
261565|NCT02045940|SARM|sarm
261566|NCT02045940|safety|safety
261567|NCT02045927|sedation|sedation
261568|NCT02045927|BIS|bis
261569|NCT02045927|monitoring|monitoring
261570|NCT02045914|calcium ionophore|calcium ionophore
261571|NCT02045914|fertilization rate|fertilization rate
261572|NCT02045914|poor ovarian reserve|poor ovarian reserve
261573|NCT02045901|Nausea|nausea
261574|NCT02045901|Vomiting|vomiting
261575|NCT02045901|Pregnancy|pregnancy
261576|NCT02045901|Adolescent|adolescent
261577|NCT02045901|Diclegis|diclegis
261578|NCT02045901|Morning|morning
261579|NCT02045901|Sickness|sickness
261580|NCT02045888|Hamstring|hamstring
261581|NCT02045888|Tear|tear
261582|NCT02045888|Muscle|muscle
261583|NCT02045888|Grade|grade
261584|NCT02045888|adipose|adipose
261585|NCT02045888|cells|cells
261586|NCT02045888|regenerative|regenerative
261587|NCT02045888|Celution|celution
261588|NCT02045888|stem|stem
261589|NCT02045888|cell|cell
261590|NCT02045888|liposuction|liposuction
261591|NCT02045888|fat|fat
261592|NCT02045875|Adherence monitoring|adherence monitoring
261593|NCT02045875|Motivational Interviewing Adherence strategies|motivational interviewing adherence strategies
261594|NCT02045862|Solifenacin Succinate|solifenacin succinate
261595|NCT02045862|Mirabegron|mirabegron
261596|NCT02045862|Urinary Incontinence|urinary incontinence
261597|NCT02045862|Combination Therapy|combination therapy
261598|NCT02045862|Urgency|urgency
261599|NCT02045862|Nocturia|nocturia
261600|NCT02045862|Overactive Bladder|overactive bladder
261601|NCT02045849|pharmacokinetics|pharmacokinetics
261602|NCT02045849|GSK2140944|gsk2140944
261603|NCT02045849|tolerability|tolerability
261604|NCT02045849|drug interaction|drug interaction
261605|NCT02045849|safety|safety
261606|NCT02045849|itraconazole|itraconazole
261607|NCT02045849|elderly healthy subjects|elderly healthy subjects
261608|NCT02045849|food effect|food effect
261609|NCT02045849|relative bioavailability|relative bioavailability
261610|NCT02045836|Pneumovax 23|pneumovax 23
261611|NCT02045836|Co-administration|co-administration
261612|NCT02045836|Herpes zoster|herpes zoster
261613|NCT02045836|Immunogenicity|immunogenicity
261614|NCT02045836|Safety|safety
261615|NCT02045836|Adults|adults
261616|NCT02045810|Measurement|measurement
261617|NCT02045810|nosiseption|nosiseption
261618|NCT02045797|Dose ranging|dose ranging
261619|NCT02045797|Intravenous|intravenous
261620|NCT02045797|Adaptive design|adaptive design
261621|NCT02045797|suspected or confirmed gram-positive acute bacterial skin and skin structure infection|suspected or confirmed gram-positive acute bacterial skin and skin structure infection
261622|NCT02045797|Subjects|subjects
261623|NCT02045797|infection|infection
261624|NCT02045797|Oral|oral
261625|NCT02045797|GSK2140944|gsk2140944
261626|NCT02045771|Depression|depression
261627|NCT02045771|Behavioral Activation|behavioral activation
261628|NCT02045745|Postoperative air leaks in risk patients.|postoperative air leaks in risk patients.
261629|NCT02045732|Multiple Sclerosis|multiple sclerosis
261630|NCT02045732|MRI|mri
261631|NCT02045719|cat´s claw|cat´s claw
261632|NCT02045719|uncaria tomentosa|uncaria tomentosa
261633|NCT02045719|quality of life|quality of life
261634|NCT02045719|no further therapeutic options|no further therapeutic options
261635|NCT02045706|Community Health Workers|community health workers
261636|NCT02045706|Service|service
261637|NCT02045706|Volunteerism|volunteerism
261638|NCT02045706|Health Behaviors|health behaviors
261639|NCT02045680|colorectal cancer|colorectal cancer
261640|NCT02045680|laparoscopy|laparoscopy
261641|NCT02045680|neuromuscular block|neuromuscular block
261642|NCT02045680|oxygen delivery|oxygen delivery
261643|NCT02045667|Becker's myotonia congenita (BMC)|becker's myotonia congenita (bmc)
261644|NCT02045667|Thomson's myotonia congenita (TMC)|thomson's myotonia congenita (tmc)
261645|NCT02045667|Paramyotonia Congenita (PMC)|paramyotonia congenita (pmc)
261646|NCT02045667|Sodium Channel Myotonia (SCM)|sodium channel myotonia (scm)
261647|NCT02045641|cardiac surgery|cardiac surgery
261648|NCT02045641|postoperative treatment|postoperative treatment
261649|NCT02045641|pleural effusion|pleural effusion
261650|NCT02045641|physical performance|physical performance
261651|NCT02045628|Bariatric Surgery|bariatric surgery
261652|NCT02045628|Health Psychology|health psychology
261653|NCT02045602|Cancer|cancer
261654|NCT02045602|Solid Tumors|solid tumors
261655|NCT02045602|Gemcitabine|gemcitabine
261656|NCT02045602|Oncolytic virus|oncolytic virus
261657|NCT02045602|Metastatic|metastatic
261658|NCT02045602|Pancreatic cancer|pancreatic cancer
261659|NCT02045589|Cancer|cancer
261660|NCT02045589|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
261661|NCT02045589|Locally advanced|locally advanced
261662|NCT02045589|Metastatic|metastatic
261663|NCT02045589|Gemcitabine|gemcitabine
261664|NCT02045589|Oncolytic virus|oncolytic virus
261665|NCT02045589|Abraxane®|abraxane®
261666|NCT02045576|Obstructive Sleep Apnea|obstructive sleep apnea
261667|NCT02045576|sleep position trainer|sleep position trainer
261668|NCT02045576|oral appliance therapy|oral appliance therapy
261669|NCT02045576|mandibular advancement device or splint|mandibular advancement device or splint
261670|NCT02045537|HIV|hiv
261671|NCT02045498|cpr|cpr
261672|NCT02045498|feedback|feedback
261673|NCT02045498|capnography|capnography
261674|NCT02045498|outcome|outcome
261675|NCT02045498|quality|quality
261676|NCT02045498|resuscitation|resuscitation
261677|NCT02045472|Influenza|influenza
261678|NCT02045472|Monoclonal antibody|monoclonal antibody
261679|NCT02045459|Microvascular Disease|microvascular disease
261680|NCT02045459|Exercise|exercise
261681|NCT02045459|Angina|angina
261682|NCT02045459|Chest pain|chest pain
261683|NCT02045420|Idiopathic Parkinson's Disease|idiopathic parkinson's disease
261684|NCT02045420|Magnetic Resonance Imaging|magnetic resonance imaging
261685|NCT02045420|MR Venography|mr venography
261686|NCT02045420|Flow Quantification|flow quantification
261687|NCT02045420|Susceptibility Weighted Imaging|susceptibility weighted imaging
261688|NCT02045407|Brain Death|brain death
261689|NCT02045407|Neurological Death|neurological death
261690|NCT02045407|Cerebral circulatory arrest|cerebral circulatory arrest
261691|NCT02045407|Computed Tomography Angiography|computed tomography angiography
261692|NCT02045394|haemoptysis|haemoptysis
261693|NCT02045394|hemoptysis|hemoptysis
261694|NCT02045394|airway bleeding|airway bleeding
261695|NCT02045381|Cancer|cancer
261696|NCT02045381|MRI|mri
261697|NCT02045368|refractory|refractory
261698|NCT02045368|intolerant|intolerant
261699|NCT02045368|solid tumors|solid tumors
261792|NCT02045004|Geriatrics|geriatrics
261994|NCT02044003|dissections|dissections
261700|NCT02045329|Staphylococcus aureus, mupirocin, decolonization|staphylococcus aureus, mupirocin, decolonization
261701|NCT02045316|Preeclampsia|preeclampsia
261702|NCT02045316|Aquaporins|aquaporins
261703|NCT02045316|Placenta|placenta
261704|NCT02045303|Sub-acute wound|sub-acute wound
261705|NCT02045303|Chronic wound|chronic wound
261706|NCT02045303|wound|wound
261707|NCT02045303|MIST|mist
261708|NCT02045303|Soring|soring
261709|NCT02045303|Contact Ultrasound|contact ultrasound
261710|NCT02045303|Noncontact ultrasound|noncontact ultrasound
261711|NCT02045303|Wound Care|wound care
261712|NCT02045303|VIP Ultrasound Protocol|vip ultrasound protocol
261713|NCT02045303|Ultrasound|ultrasound
261714|NCT02045264|Firazyr|firazyr
261715|NCT02045264|Angioedema|angioedema
261716|NCT02045264|Angioedemas, Hereditary|angioedemas, hereditary
261717|NCT02045264|Vascular Diseases|vascular diseases
261718|NCT02045264|Cardiovascular Diseases|cardiovascular diseases
261719|NCT02045264|Urticaria|urticaria
261720|NCT02045264|Skin Diseases, Vascular|skin diseases, vascular
261721|NCT02045264|Skin Diseases|skin diseases
261722|NCT02045264|Hypersensitivity, Immediate|hypersensitivity, immediate
261723|NCT02045264|Hypersensitivity|hypersensitivity
261724|NCT02045264|Immune System Diseases|immune system diseases
261725|NCT02045264|Genetic Diseases, Inborn|genetic diseases, inborn
261726|NCT02045264|Icatibant|icatibant
261727|NCT02045264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
261728|NCT02045264|Analgesics, Non-Narcotic|analgesics, non-narcotic
261729|NCT02045264|Analgesics|analgesics
261730|NCT02045264|Sensory System Agents|sensory system agents
261731|NCT02045264|Peripheral Nervous System Agents|peripheral nervous system agents
261732|NCT02045264|Physiological Effects of Drugs|physiological effects of drugs
261733|NCT02045264|Pharmacologic Actions|pharmacologic actions
261734|NCT02045264|Anti-Inflammatory Agents|anti-inflammatory agents
261735|NCT02045264|Therapeutic Uses|therapeutic uses
261736|NCT02045264|Antirheumatic Agents|antirheumatic agents
261737|NCT02045264|Adrenergic beta-Antagonists|adrenergic beta-antagonists
261738|NCT02045264|Adrenergic Antagonists|adrenergic antagonists
261739|NCT02045264|Adrenergic Agents|adrenergic agents
261740|NCT02045264|Neurotransmitter Agents|neurotransmitter agents
261741|NCT02045264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
261742|NCT02045264|Central Nervous System Agents|central nervous system agents
261743|NCT02045251|Helicobacter pylori|helicobacter pylori
261744|NCT02045251|H. pylori|h. pylori
261745|NCT02045251|Pylera|pylera
261746|NCT02045238|Bronchiolitis|bronchiolitis
261747|NCT02045238|Therapeutics|therapeutics
261748|NCT02045238|Saline Solution, Hypertonic|saline solution, hypertonic
261749|NCT02045225|social anxiety in sexual situations|social anxiety in sexual situations
261750|NCT02045212|Ischemic Optic Neuropathy|ischemic optic neuropathy
261751|NCT02045212|Traumatic Neuropathy|traumatic neuropathy
261752|NCT02045212|Non Arteritic Ischemic Neuropathy (NAION)|non arteritic ischemic neuropathy (naion)
261753|NCT02045199|Diabetic Neuropathies|diabetic neuropathies
261754|NCT02045199|Diabetes Mellitus|diabetes mellitus
261755|NCT02045199|Diabetic Foot|diabetic foot
261756|NCT02045199|Diabetes Complications|diabetes complications
261757|NCT02045186|Human Papilloma Virus|human papilloma virus
261758|NCT02045186|Oropharynx|oropharynx
261759|NCT02045186|Oropharyngeal Squamous Cell Carcinoma|oropharyngeal squamous cell carcinoma
261760|NCT02045186|Squamous Cell Carcinoma|squamous cell carcinoma
261761|NCT02045186|Radiation Therapy|radiation therapy
261762|NCT02045186|Chemotherapy|chemotherapy
261763|NCT02045173|Sleep apnea, Arrhythmias, Heart Failure, ICD, CRT-D, Apneascan|sleep apnea, arrhythmias, heart failure, icd, crt-d, apneascan
261764|NCT02045147|Home Bound Care Transitions|home bound care transitions
261765|NCT02045134|Post Operative Atrial Fibrillation after a cardiac surgery|post operative atrial fibrillation after a cardiac surgery
261766|NCT02045082|Flocked swab|flocked swab
261767|NCT02045082|Traditional fiber swab|traditional fiber swab
261768|NCT02045082|Herpes simplex epithelial keratitis|herpes simplex epithelial keratitis
261769|NCT02045082|Quantitative PCR|quantitative pcr
261770|NCT02045056|Alzheimer disease|alzheimer disease
261771|NCT02045056|mild cognitive impairment|mild cognitive impairment
261772|NCT02045056|normal cognition|normal cognition
261773|NCT02045043|Sudden Cardiac Death|sudden cardiac death
261774|NCT02045043|Arrhythmias|arrhythmias
261775|NCT02045043|Congestive Heart Failure|congestive heart failure
261776|NCT02045043|Cardiomyopathy|cardiomyopathy
261777|NCT02045043|Single Nucleotide Polymorphisms|single nucleotide polymorphisms
261778|NCT02045043|Genomics|genomics
261779|NCT02045030|metastatic|metastatic
261780|NCT02045030|colorectal|colorectal
261781|NCT02045030|cancer|cancer
261782|NCT02045030|aflibercept|aflibercept
261783|NCT02045030|FOLFIRI|folfiri
261784|NCT02045017|Multiple Myeloma|multiple myeloma
261785|NCT02045017|Relapsed Multiple Myeloma|relapsed multiple myeloma
261786|NCT02045017|Refactory Multiple Myeloma|refactory multiple myeloma
261787|NCT02045017|Renal Insufficiency|renal insufficiency
261788|NCT02045017|Pomalidomide|pomalidomide
261789|NCT02045017|Dexamethasone|dexamethasone
261790|NCT02045004|Anesthesia|anesthesia
261791|NCT02045004|Surgery|surgery
261793|NCT02045004|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
261794|NCT02045004|Postoperative delirium|postoperative delirium
261795|NCT02045004|Dementia|dementia
261796|NCT02045004|Postoperative complications|postoperative complications
261797|NCT02045004|Neurological complications|neurological complications
261798|NCT02045004|Psychological complications|psychological complications
261799|NCT02044991|Sciatica|sciatica
261800|NCT02044991|Pelvic girdle pain|pelvic girdle pain
261801|NCT02044965|urinary tract infection|urinary tract infection
261802|NCT02044965|antibiotic prophylaxis|antibiotic prophylaxis
261803|NCT02044965|probiotics|probiotics
261804|NCT02044965|neurogenic bladder|neurogenic bladder
261805|NCT02044965|clean intermittent catheterization|clean intermittent catheterization
261806|NCT02044952|Crohn's Disease|crohn's disease
261807|NCT02044952|mesalazine|mesalazine
261808|NCT02044952|Tripterygium Glycosides|tripterygium glycosides
261809|NCT02044952|induction remission|induction remission
261810|NCT02044939|Sarcoidosis, pulmonary rehabilitation|sarcoidosis, pulmonary rehabilitation
261811|NCT02044900|obstructive sleep apnea|obstructive sleep apnea
261812|NCT02044900|polysomnography|polysomnography
261813|NCT02044900|heart rate variability|heart rate variability
261814|NCT02044900|mathematical biomarker|mathematical biomarker
261815|NCT02044887|Physical activity|physical activity
261816|NCT02044887|dementia|dementia
261817|NCT02044887|relative caregivers|relative caregivers
261818|NCT02044887|podometer|podometer
261819|NCT02044887|cardiovascular risk|cardiovascular risk
261820|NCT02044848|type 1 diabetes mellitus|type 1 diabetes mellitus
261821|NCT02044835|atherosclerotic renal artery stenosis, herbal medicine|atherosclerotic renal artery stenosis, herbal medicine
261822|NCT02044822|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
261823|NCT02044822|CLL|cll
261824|NCT02044783|Adults|adults
261825|NCT02044783|Elderly|elderly
261826|NCT02044770|laparoscopic|laparoscopic
261827|NCT02044770|colectomy|colectomy
261828|NCT02044770|ENSEAL|enseal
261829|NCT02044757|Caffeine|caffeine
261830|NCT02044757|Addiction|addiction
261831|NCT02044757|Withdrawal symptoms|withdrawal symptoms
261832|NCT02044757|Pediatric|pediatric
261833|NCT02044757|Adolescent|adolescent
261834|NCT02044757|Overweight|overweight
261835|NCT02044744|Obesity|obesity
261836|NCT02044744|Pediatric Obesity|pediatric obesity
261837|NCT02044744|Physical Activity|physical activity
261838|NCT02044744|Physical Fitness|physical fitness
261839|NCT02044744|Primary Health Care|primary health care
261840|NCT02044744|Referral and Consultation|referral and consultation
261841|NCT02044731|Schools|schools
261842|NCT02044731|Pediatrics|pediatrics
261843|NCT02044731|Obesity|obesity
261844|NCT02044731|Overweight|overweight
261845|NCT02044731|Intervention Studies|intervention studies
261846|NCT02044731|African Americans|african americans
261847|NCT02044731|Family|family
261848|NCT02044731|Body mass index|body mass index
261849|NCT02044718|adverse events|adverse events
261850|NCT02044718|unplanned admission intensive care|unplanned admission intensive care
261851|NCT02044718|chart review|chart review
261852|NCT02044705|Primary Health Care|primary health care
261853|NCT02044705|Pediatrics|pediatrics
261854|NCT02044705|Obesity|obesity
261855|NCT02044705|Overweight|overweight
261856|NCT02044705|Clinical trial|clinical trial
261857|NCT02044705|Hispanic Americans|hispanic americans
261858|NCT02044705|Family|family
261859|NCT02044705|Body mass index|body mass index
261860|NCT02044692|Hunter syndrome|hunter syndrome
261861|NCT02044692|Mucopolysaccharidosis II|mucopolysaccharidosis ii
261862|NCT02044692|Hunterase|hunterase
261863|NCT02044666|Critical Limb Ischemia|critical limb ischemia
261864|NCT02044666|Amputation|amputation
261865|NCT02044653|Phase 2|phase 2
261866|NCT02044614|Hemodialysis/Peritoneal Dialysis|hemodialysis/peritoneal dialysis
261867|NCT02044614|functionally anuric|functionally anuric
261868|NCT02044614|Icodextrin|icodextrin
261869|NCT02044614|Kidney Disease Quality of Life|kidney disease quality of life
261870|NCT02044601|Lung Cancer|lung cancer
261871|NCT02044601|Non-small cell lung cancer|non-small cell lung cancer
261872|NCT02044601|NSCLC|nsclc
261873|NCT02044601|Squamous cell carcinoma of the lung|squamous cell carcinoma of the lung
261874|NCT02044601|Adenocarcinoma of the lung|adenocarcinoma of the lung
261875|NCT02044601|Radiation therapy|radiation therapy
261876|NCT02044601|Proton therapy|proton therapy
261877|NCT02044601|XRT|xrt
261878|NCT02044601|Carboplatin|carboplatin
261879|NCT02044601|Paraplatin|paraplatin
261880|NCT02044601|Paclitaxel|paclitaxel
261881|NCT02044601|Taxol|taxol
261882|NCT02044601|Onartuzumab|onartuzumab
261883|NCT02044601|Erlotinib|erlotinib
261884|NCT02044601|Erlotinib hydrochloride|erlotinib hydrochloride
261885|NCT02044601|OSI-774|osi-774
261886|NCT02044601|CP358774|cp358774
261887|NCT02044601|Tarceva|tarceva
261888|NCT02044588|HBsAg(+) donor|hbsag(+) donor
261889|NCT02044588|HBsAg(-) donor|hbsag(-) donor
261890|NCT02044588|Anti-hepatitis B antibody|anti-hepatitis b antibody
261891|NCT02044588|Kidney allograft|kidney allograft
261892|NCT02044575|Clock genes, circadian regulation|clock genes, circadian regulation
261893|NCT02044562|dietary nitrate|dietary nitrate
261894|NCT02044562|radiotherapy|radiotherapy
261895|NCT02044562|nasopharyngeal carcinoma|nasopharyngeal carcinoma
261896|NCT02044549|Carbetocin|carbetocin
261897|NCT02044549|syntometrine|syntometrine
261898|NCT02044549|postpartum hemorrhage|postpartum hemorrhage
261899|NCT02044549|cesarean section|cesarean section
261900|NCT02044536|biopsy; endoscopy; neoplasms|biopsy; endoscopy; neoplasms
261901|NCT02044523|Chronic liver disease|chronic liver disease
261902|NCT02044523|Fibrosis|fibrosis
261903|NCT02044523|Elastography|elastography
261904|NCT02044523|Ultrasound|ultrasound
261905|NCT02044523|Magnetic resonance elastography|magnetic resonance elastography
261906|NCT02044523|Diagnostic performance|diagnostic performance
261907|NCT02044523|Sensitivity and specificity|sensitivity and specificity
261908|NCT02044510|Multiple Sclerosis|multiple sclerosis
261909|NCT02044510|Spinal Cord Injuries|spinal cord injuries
261910|NCT02044510|mirabegron|mirabegron
261911|NCT02044510|Urodynamics|urodynamics
261912|NCT02044497|pharmacokinetics|pharmacokinetics
261913|NCT02044497|pharmacogenomics|pharmacogenomics
261914|NCT02044497|oral oxycodone|oral oxycodone
261915|NCT02044497|pediatric surgical patients|pediatric surgical patients
261916|NCT02044484|HIV|hiv
261917|NCT02044484|AIDS|aids
261918|NCT02044484|Viral load|viral load
261919|NCT02044484|Primary care|primary care
261920|NCT02044471|left ventricular assist device|left ventricular assist device
261921|NCT02044471|continuous flow|continuous flow
261922|NCT02044471|remote ischemic conditioning|remote ischemic conditioning
261923|NCT02044471|hypertension|hypertension
261924|NCT02044471|sympathetic tone|sympathetic tone
261925|NCT02044471|endothelial dysfunction|endothelial dysfunction
261926|NCT02044458|Foley Catheterization|foley catheterization
261927|NCT02044458|Induction of Labor|induction of labor
261928|NCT02044458|5 French Stylette|5 french stylette
261929|NCT02044445|IVF, hCG, oocyte retrieval, time interval|ivf, hcg, oocyte retrieval, time interval
261930|NCT02044419|Comparative|comparative
261931|NCT02044419|Bioavailability|bioavailability
261932|NCT02044419|lomitapide|lomitapide
261933|NCT02044341|Acute Otitis Media|acute otitis media
261934|NCT02044341|Pain|pain
261935|NCT02044341|Ear Pain|ear pain
261936|NCT02044341|Ear Ache|ear ache
261937|NCT02044341|Ear infection|ear infection
261938|NCT02044341|middle ear infection|middle ear infection
261939|NCT02044302|pain|pain
261940|NCT02044302|breast cancer|breast cancer
261941|NCT02044302|breast implant|breast implant
261942|NCT02044302|breast reconstruction|breast reconstruction
261943|NCT02044289|depression|depression
261944|NCT02044289|electroconvulsive therapy (ECT)|electroconvulsive therapy (ect)
261945|NCT02044289|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
261946|NCT02044276|Neutropenia|neutropenia
261947|NCT02044276|NHL|nhl
261948|NCT02044276|Non-Hodgkin lymphomas|non-hodgkin lymphomas
261949|NCT02044276|R-CHOP-21|r-chop-21
261950|NCT02044263|Cognitive therapy|cognitive therapy
261951|NCT02044263|Behavior therapy|behavior therapy
261952|NCT02044263|Waiting lists|waiting lists
261953|NCT02044263|Therapy, computer-assisted|therapy, computer-assisted
261954|NCT02044263|Internet|internet
261955|NCT02044250|Aspirin|aspirin
261956|NCT02044250|Clopidogrel|clopidogrel
261957|NCT02044250|Antiplatelet monotherapy|antiplatelet monotherapy
261958|NCT02044250|Drug-eluting stent|drug-eluting stent
261959|NCT02044237|trichotillomania|trichotillomania
261960|NCT02044237|online therapy|online therapy
261961|NCT02044211|Heart Failure, Systolic|heart failure, systolic
261962|NCT02044211|Depressive Disorder|depressive disorder
261963|NCT02044211|Depressive Disorder, Major|depressive disorder, major
261964|NCT02044211|Mood Disorder|mood disorder
261965|NCT02044198|Plasmodium Falciparum|plasmodium falciparum
261966|NCT02044198|Malaria|malaria
261967|NCT02044198|Vaccine|vaccine
261968|NCT02044198|Plasmodium|plasmodium
261969|NCT02044198|Falciparum|falciparum
261970|NCT02044185|HMGB1 Protein|hmgb1 protein
261971|NCT02044185|Graft versus Host Disease|graft versus host disease
261972|NCT02044185|Immunosuppressive Agents|immunosuppressive agents
261973|NCT02044185|oral mucositis|oral mucositis
261974|NCT02044172|Prostate cancer|prostate cancer
261975|NCT02044172|Treatment|treatment
261976|NCT02044172|Screening|screening
261977|NCT02044172|Surgery|surgery
261978|NCT02044172|Radiotherapy|radiotherapy
261979|NCT02044172|Active monitoring|active monitoring
261980|NCT02044159|Hydrocortisone|hydrocortisone
261981|NCT02044159|Pediatrics|pediatrics
261982|NCT02044159|Adrenal Insufficiency|adrenal insufficiency
261983|NCT02044107|Diarrhea,|diarrhea,
261984|NCT02044107|Pneumonia,|pneumonia,
261985|NCT02044107|Zinc treatment,|zinc treatment,
261986|NCT02044107|Patient Compliance.|patient compliance.
261987|NCT02044094|Opioid dependent|opioid dependent
261988|NCT02044094|Buprenorphine|buprenorphine
261989|NCT02044094|Suboxone Film|suboxone film
261990|NCT02044094|Opioid blockade|opioid blockade
261991|NCT02044094|Hydromorphone challenge|hydromorphone challenge
261992|NCT02044016|Achilles tendon rupture, lengthening, validity, goniometer.|achilles tendon rupture, lengthening, validity, goniometer.
261993|NCT02044003|angioplasty|angioplasty
261995|NCT02043990|NAVA|nava
261996|NCT02043990|noninvasive ventilation|noninvasive ventilation
261997|NCT02043990|infants|infants
261998|NCT02043977|Propofol|propofol
261999|NCT02043977|Insomnia|insomnia
262000|NCT02043977|Sleep disorder|sleep disorder
262001|NCT02043977|Sleep deprivation|sleep deprivation
262002|NCT02043977|Chronic insomnia|chronic insomnia
262003|NCT02043977|Refractory insomnia|refractory insomnia
262004|NCT02043977|Primary insomnia|primary insomnia
262005|NCT02043964|Multiple Sclerosis|multiple sclerosis
262006|NCT02043964|Clinically Isolated Syndrome|clinically isolated syndrome
262007|NCT02043964|Tears|tears
262008|NCT02043964|Isoelectric focusing|isoelectric focusing
262009|NCT02043964|Oligoclonal profile|oligoclonal profile
262010|NCT02043938|Electroencephalography|electroencephalography
262011|NCT02043938|pharmacological|pharmacological
262012|NCT02043925|QT-prolongation|qt-prolongation
262013|NCT02043925|Torsade de Pointes|torsade de pointes
262014|NCT02043925|drug interactions|drug interactions
262015|NCT02043925|psychiatry|psychiatry
262016|NCT02043912|QT-prolongation|qt-prolongation
262017|NCT02043912|Torsade de Pointes|torsade de pointes
262018|NCT02043912|Haloperidol|haloperidol
262019|NCT02043912|Drug interactions|drug interactions
262020|NCT02043899|Neuroblastoma|neuroblastoma
262021|NCT02043899|Positron emission tomography|positron emission tomography
262022|NCT02043899|124-iodine|124-iodine
262023|NCT02043899|Meta-Iodobenzylguanidine|meta-iodobenzylguanidine
262024|NCT02043886|Type 2 Diabetes, Postprandial Hypotension, Acarbose|type 2 diabetes, postprandial hypotension, acarbose
262025|NCT02043873|Clinical Trial|clinical trial
262026|NCT02043873|Composite Restorations|composite restorations
262027|NCT02043873|Restorations Repair|restorations repair
262028|NCT02043873|Replacement Restorations|replacement restorations
262029|NCT02043873|Operative Dentistry.|operative dentistry.
262030|NCT02043860|Multiple Myeloma|multiple myeloma
262031|NCT02043860|High Risk|high risk
262032|NCT02043860|Intermediate Risk|intermediate risk
262033|NCT02043860|Symptomatic|symptomatic
262034|NCT02043847|Multiple Myeloma|multiple myeloma
262035|NCT02043847|Relapsed|relapsed
262036|NCT02043847|Refractory|refractory
262037|NCT02043847|Progressive Disease|progressive disease
262038|NCT02043847|Symptomatic|symptomatic
262039|NCT02043795|Bioresorbable Vascular Scaffold System|bioresorbable vascular scaffold system
262040|NCT02043795|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
262041|NCT02043795|Stent|stent
262042|NCT02043769|South Africa|south africa
262043|NCT02043769|Eastern Cape|eastern cape
262044|NCT02043769|Child ARV|child arv
262045|NCT02043769|CLWHIV|clwhiv
262046|NCT02043756|Mitoxantrone Hydrochloride Liposome Injection|mitoxantrone hydrochloride liposome injection
262047|NCT02043730|pancreatic cancer|pancreatic cancer
262048|NCT02043730|locally advanced|locally advanced
262049|NCT02043730|unresectable cancer|unresectable cancer
262050|NCT02043717|Cystic Fibrosis|cystic fibrosis
262051|NCT02043717|Vitamin D|vitamin d
262052|NCT02043717|Lung function|lung function
262053|NCT02043704|IV Acetaminophen|iv acetaminophen
262054|NCT02043704|Vaginal Reconstruction|vaginal reconstruction
262055|NCT02043704|Pain, Postoperative|pain, postoperative
262056|NCT02043691|Endovascular|endovascular
262057|NCT02043691|Aortic|aortic
262058|NCT02043691|Aneurysm|aneurysm
262059|NCT02043691|Thoracoabdominal|thoracoabdominal
262060|NCT02043691|Juxtarenal|juxtarenal
262061|NCT02043691|Suprarenal|suprarenal
262062|NCT02043691|Endograft|endograft
262063|NCT02043691|Fenestrated|fenestrated
262064|NCT02043691|Branched|branched
262065|NCT02043691|Complex|complex
262066|NCT02043691|Abdominal|abdominal
262067|NCT02043691|Thoracic|thoracic
262068|NCT02043691|Stent|stent
262069|NCT02043691|Stentgraft|stentgraft
262070|NCT02043678|Phase III|phase iii
262071|NCT02043678|Radium-223 dichloride|radium-223 dichloride
262072|NCT02043678|Abiraterone acetate|abiraterone acetate
262073|NCT02043678|Combination therapy|combination therapy
262074|NCT02043678|Chemotherapy-naive|chemotherapy-naive
262075|NCT02043678|Bone metastasis|bone metastasis
262076|NCT02043678|Castration-resistant prostate cancer (CRPC)|castration-resistant prostate cancer (crpc)
262077|NCT02043665|CAVATAK|cavatak
262078|NCT02043665|KEYNOTE-200|keynote-200
262079|NCT02043665|pembrolizumab|pembrolizumab
262080|NCT02043665|lung cancer|lung cancer
262081|NCT02043665|bladder cancer|bladder cancer
262082|NCT02043639|rotation|rotation
262083|NCT02043639|shoulder|shoulder
262084|NCT02043639|joint|joint
262085|NCT02043639|ROM|rom
262086|NCT02043639|abduction,|abduction,
262087|NCT02043639|internal rotation,|internal rotation,
262088|NCT02043639|external rotation,|external rotation,
262089|NCT02043639|flexion|flexion
262090|NCT02043639|normal|normal
262091|NCT02043639|joint movement|joint movement
262092|NCT02043639|physical examination|physical examination
262093|NCT02043626|childhood nutrition|childhood nutrition
262094|NCT02043626|physical activity|physical activity
262095|NCT02043626|school wellness|school wellness
262096|NCT02043626|school health|school health
262097|NCT02043626|nutritional policies|nutritional policies
262098|NCT02043626|childhood obesity|childhood obesity
262099|NCT02043613|Joint pain|joint pain
262100|NCT02043613|Context effects|context effects
262101|NCT02043613|Placebo effect|placebo effect
262102|NCT02043613|Exercise treatment|exercise treatment
262103|NCT02043600|Colitis, ulcerative|colitis, ulcerative
262104|NCT02043600|Yoga|yoga
262105|NCT02043587|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
262106|NCT02043587|Lymphoblastic leukemia|lymphoblastic leukemia
262107|NCT02043587|Lymphoblastic lymphoma|lymphoblastic lymphoma
262108|NCT02043574|Aerobic Exercise|aerobic exercise
262109|NCT02043574|Treadmill Test|treadmill test
262110|NCT02043574|Sedentary Lifestyle|sedentary lifestyle
262111|NCT02043548|dermatomyositis|dermatomyositis
262112|NCT02043548|polymyositis|polymyositis
262113|NCT02043548|tocilizumab|tocilizumab
262114|NCT02043548|Actemra|actemra
262115|NCT02043535|myocardial perfusion imaging|myocardial perfusion imaging
262116|NCT02043535|myocardial blood flow|myocardial blood flow
262117|NCT02043535|pharmacologic stress agents|pharmacologic stress agents
262118|NCT02043535|carbon dioxide|carbon dioxide
262119|NCT02043535|rubidium 82 radioisotope|rubidium 82 radioisotope
262120|NCT02043535|positron emission tomography|positron emission tomography
262121|NCT02043522|123I-mIBG|123i-mibg
262122|NCT02043522|SPECT Imaging|spect imaging
262123|NCT02043522|Phantom imaging|phantom imaging
262124|NCT02043522|Heart failure|heart failure
262125|NCT02043522|Coronary artery disease|coronary artery disease
262126|NCT02043522|Heart to mediastinum ratios|heart to mediastinum ratios
262127|NCT02043522|heart to calibration ratios|heart to calibration ratios
262128|NCT02043522|Myocardial blood flow|myocardial blood flow
262129|NCT02043522|Myocardial blood flow researve|myocardial blood flow researve
262130|NCT02043509|smoking cessation|smoking cessation
262131|NCT02043509|pregnancy|pregnancy
262132|NCT02043509|cessation support|cessation support
262133|NCT02043509|tailored text messages|tailored text messages
262134|NCT02043509|self-help|self-help
262135|NCT02043509|MiQuit|miquit
262136|NCT02043496|Binge Eating Disorder|binge eating disorder
262137|NCT02043496|Binge Eating|binge eating
262138|NCT02043496|Eating Disorders|eating disorders
262139|NCT02043496|Obesity|obesity
262140|NCT02043496|Psychotherapy|psychotherapy
262141|NCT02043496|Cognitive Behavioral Therapy|cognitive behavioral therapy
262142|NCT02043483|CPAP|cpap
262143|NCT02043483|OSAS|osas
262144|NCT02043483|CEDOC (Centro de Estudos de Doenças Crónicas)|cedoc (centro de estudos de doenças crónicas)
262145|NCT02043483|FCM (Faculdade de Ciências Médicas)|fcm (faculdade de ciências médicas)
262146|NCT02043483|UNL (Universidade Nova de Lisboa|unl (universidade nova de lisboa
262147|NCT02043483|NOVA MEDICAL SCHOOL|nova medical school
262148|NCT02043483|FCT (Fundação para a Ciência e Tecnologia)|fct (fundação para a ciência e tecnologia)
262149|NCT02043470|Sinus/nasal cancer|sinus/nasal cancer
262150|NCT02043431|Heart failure|heart failure
262151|NCT02043431|Electronic medical records|electronic medical records
262152|NCT02043431|Genomics|genomics
262153|NCT02043431|Biobank|biobank
262154|NCT02043418|HIV|hiv
262155|NCT02043418|ARV|arv
262156|NCT02043418|Pediatric|pediatric
262157|NCT02043418|Cameroon|cameroon
262158|NCT02043392|intestinal anastomosis|intestinal anastomosis
262159|NCT02043392|non-emergent|non-emergent
262160|NCT02043392|intestinal revision|intestinal revision
262161|NCT02043392|magnetic compression|magnetic compression
262162|NCT02043392|anastomotic leak|anastomotic leak
262163|NCT02043379|congenital heart disease|congenital heart disease
262164|NCT02043379|Cardiopulmonary Bypass|cardiopulmonary bypass
262165|NCT02043379|Hypogammaglobulinemia|hypogammaglobulinemia
262166|NCT02043366|Remifentanil|remifentanil
262167|NCT02043366|Opioid-induced hyperalgesia|opioid-induced hyperalgesia
262168|NCT02043366|Postoperative pain|postoperative pain
262169|NCT02043366|Pain Intensity|pain intensity
262170|NCT02043340|Periodontitis|periodontitis
262171|NCT02043340|Bacterial viability|bacterial viability
262172|NCT02043340|Lactate dehydrogenase levels|lactate dehydrogenase levels
262173|NCT02043340|Indocyanine green|indocyanine green
262174|NCT02043340|Scaling and root planing|scaling and root planing
262175|NCT02043340|Antimicrobial photodynamic therapy.|antimicrobial photodynamic therapy.
262176|NCT02043327|Colonoscopy|colonoscopy
262177|NCT02043327|assessment|assessment
262178|NCT02043327|certification,|certification,
262179|NCT02043327|simulation,|simulation,
262180|NCT02043327|standard setting|standard setting
262181|NCT02043301|pharmacokinetics|pharmacokinetics
262182|NCT02043301|bioavailability|bioavailability
262183|NCT02043301|PF-04950615|pf-04950615
262184|NCT02043288|Pancreatic cancer|pancreatic cancer
262185|NCT02043288|Platinum|platinum
262186|NCT02043288|Micelle|micelle
262187|NCT02043275|resistance training|resistance training
262188|NCT02043262|Elderly|elderly
262189|NCT02043262|Home-based rehabilitation|home-based rehabilitation
262190|NCT02043262|Activities of daily living|activities of daily living
262191|NCT02043262|Restorative care|restorative care
262192|NCT02043262|Reablement|reablement
262193|NCT02043262|Everyday rehabilitation|everyday rehabilitation
262194|NCT02043249|DELAYED CORD CLAMPING|delayed cord clamping
262195|NCT02043249|MILKING OF CORD|milking of cord
262196|NCT02043249|PREMATURE INFANTS|premature infants
262197|NCT02043249|LEVEL OF IgG IN NEONATES|level of igg in neonates
262198|NCT02043236|Prostate cancer|prostate cancer
262199|NCT02043236|Androgen deprivation therapy|androgen deprivation therapy
262200|NCT02043236|Bone health|bone health
262201|NCT02043236|Bone mineral density|bone mineral density
262202|NCT02043223|Vitamin A|vitamin a
262203|NCT02043223|Breast milk|breast milk
262204|NCT02043223|Postpartum vitamin A supplementation|postpartum vitamin a supplementation
262205|NCT02043223|Infant vaccine response|infant vaccine response
262206|NCT02043210|substance use, Spanish speaking, CBT4CBT|substance use, spanish speaking, cbt4cbt
262207|NCT02043197|Depression,|depression,
262208|NCT02043197|depressive symptoms,|depressive symptoms,
262209|NCT02043197|major depressive disorder,|major depressive disorder,
262210|NCT02043197|Fevarine,|fevarine,
262211|NCT02043197|fluvoxamine,|fluvoxamine,
262212|NCT02043197|cognitive function,|cognitive function,
262213|NCT02043197|neurological disorders,|neurological disorders,
262214|NCT02043197|sleep state|sleep state
262215|NCT02043184|Neoplasms|neoplasms
262216|NCT02043184|Medication Adherence|medication adherence
262217|NCT02043184|Administration, Oral|administration, oral
262218|NCT02043184|Symptom Assessment|symptom assessment
262219|NCT02043184|Neurobehavioral Manifestations|neurobehavioral manifestations
262220|NCT02043184|Depression|depression
262221|NCT02043184|Behavioral Symptoms|behavioral symptoms
262222|NCT02043184|Utilization|utilization
262223|NCT02043158|Ovarian Cancer|ovarian cancer
262224|NCT02043158|Short term survivors|short term survivors
262225|NCT02043158|Long term survivors|long term survivors
262226|NCT02043158|Biobehavioral characteristics|biobehavioral characteristics
262227|NCT02043158|Sociodemographic characteristics|sociodemographic characteristics
262228|NCT02043158|Questionnaire|questionnaire
262229|NCT02043158|Survey|survey
262230|NCT02043158|Interview|interview
262231|NCT02043132|reverse shoulder arthroplasty|reverse shoulder arthroplasty
262232|NCT02043132|Rotator cuff|rotator cuff
262233|NCT02043132|Orthopedic joint surgery|orthopedic joint surgery
262234|NCT02043132|Total shoulder|total shoulder
262235|NCT02043132|Perioperative bleeding|perioperative bleeding
262236|NCT02043132|Tranexamic acid|tranexamic acid
262237|NCT02043132|Orthopedic complications|orthopedic complications
262238|NCT02043132|Hemorrhage|hemorrhage
262239|NCT02043132|Postoperative Hemorrhage|postoperative hemorrhage
262240|NCT02043132|Pathologic Processes|pathologic processes
262241|NCT02043132|Arthritis|arthritis
262242|NCT02043132|Joint Diseases|joint diseases
262243|NCT02043132|Musculoskeletal Diseases|musculoskeletal diseases
262244|NCT02043132|Postoperative Complications|postoperative complications
262245|NCT02043132|Antifibrinolytic Agents|antifibrinolytic agents
262246|NCT02043132|Fibrin Modulating Agents|fibrin modulating agents
262247|NCT02043132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
262248|NCT02043132|Pharmacologic Actions|pharmacologic actions
262249|NCT02043132|Hemostatics|hemostatics
262250|NCT02043132|Coagulants|coagulants
262251|NCT02043132|Hematologic Agents|hematologic agents
262252|NCT02043132|Therapeutic Uses|therapeutic uses
262253|NCT02043093|Adolescent suicide prevention|adolescent suicide prevention
262254|NCT02043093|Peer Leader prevention model|peer leader prevention model
262255|NCT02043093|Universal school-based prevention|universal school-based prevention
262256|NCT02043080|Tuberculosis|tuberculosis
262257|NCT02043080|HIV|hiv
262258|NCT02043080|Xpert MTB/RIF|xpert mtb/rif
262259|NCT02043080|Determine TB-LAM|determine tb-lam
262260|NCT02043080|UNC|unc
262261|NCT02043080|Zambia|zambia
262262|NCT02043080|Cost Effectiveness Analysis Curve|cost effectiveness analysis curve
262263|NCT02043080|Centre for Infectious Disease Research in Zambia|centre for infectious disease research in zambia
262264|NCT02043067|TB|tb
262265|NCT02043067|HIV|hiv
262266|NCT02043067|Extensively resistant TB|extensively resistant tb
262267|NCT02043067|Extra pulmonary TB|extra pulmonary tb
262268|NCT02043054|Type 2 Diabetes Mellitus (T2DM)|type 2 diabetes mellitus (t2dm)
262269|NCT02043054|Young Adults|young adults
262270|NCT02043054|Cardiovascular Disease (CVD)|cardiovascular disease (cvd)
262271|NCT02043054|GLP1 Analogue|glp1 analogue
262272|NCT02043054|DPP IV Inhibitor|dpp iv inhibitor
262273|NCT02043054|Obesity|obesity
262274|NCT02043054|Cardiometabolic Effects|cardiometabolic effects
262275|NCT02043054|Cardiac MRI|cardiac mri
262276|NCT02043028|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
262277|NCT02043028|Chest compression|chest compression
262278|NCT02043028|Advanced cardiac life support|advanced cardiac life support
262279|NCT02043028|Posture|posture
262280|NCT02043015|voluntary counseling and testing (VCT)|voluntary counseling and testing (vct)
262281|NCT02043015|couples voluntary counseling and testing (CVCT)|couples voluntary counseling and testing (cvct)
262282|NCT02043015|pre-exposure prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
262283|NCT02043015|homosexuality|homosexuality
262284|NCT02043015|male|male
262285|NCT02043015|South Africa|south africa
262286|NCT02042989|Advanced Cancers|advanced cancers
262287|NCT02042989|Advanced solid tumor|advanced solid tumor
262288|NCT02042989|Advanced p53 Mutant Malignancies|advanced p53 mutant malignancies
262289|NCT02042989|MLN9708|mln9708
262290|NCT02042989|Vorinostat|vorinostat
262291|NCT02042989|SAHA|saha
262292|NCT02042989|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
262293|NCT02042989|MSK-390|msk-390
262294|NCT02042989|Zolinza|zolinza
262295|NCT02042976|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
262296|NCT02042976|Mindfulness-based cognitive therapy (MBCT)|mindfulness-based cognitive therapy (mbct)
262297|NCT02042976|Behavioural intervention|behavioural intervention
262298|NCT02042976|Quality-of-life|quality-of-life
262299|NCT02042976|Anxiety|anxiety
262300|NCT02042976|Depression|depression
262301|NCT02042976|Physical health status|physical health status
262302|NCT02042963|The cohort of Asian kidney transplant recipients|the cohort of asian kidney transplant recipients
262303|NCT02042963|The cohort of metabolic complication after kidney transplant|the cohort of metabolic complication after kidney transplant
262304|NCT02042963|The biorepository of Asian kidney transplant recipients|the biorepository of asian kidney transplant recipients
262305|NCT02042950|Lymphoma|lymphoma
262306|NCT02042950|Mantle Cell Lymphoma|mantle cell lymphoma
262307|NCT02042950|MCL|mcl
262308|NCT02042950|Relapsed|relapsed
262309|NCT02042950|Refractory|refractory
262310|NCT02042950|Carfilzomib|carfilzomib
262311|NCT02042937|Knee|knee
262312|NCT02042937|Hip|hip
262313|NCT02042937|Muscle Strength|muscle strength
262314|NCT02042937|Electromyography|electromyography
262315|NCT02042937|Biomechanical Phenomena|biomechanical phenomena
262316|NCT02042924|Leukemia|leukemia
262317|NCT02042924|Lymphoma|lymphoma
262318|NCT02042924|Myeloma|myeloma
262319|NCT02042924|Myelodysplastic Syndrome|myelodysplastic syndrome
262320|NCT02042898|Cardiac Surgery|cardiac surgery
262321|NCT02042898|Transfusion|transfusion
262322|NCT02042885|Prostate cancer|prostate cancer
262323|NCT02042872|Spinal Cord Injury|spinal cord injury
262324|NCT02042872|Disuse Osteoporosis|disuse osteoporosis
262325|NCT02042872|Zoledronic acid|zoledronic acid
262326|NCT02042872|Bisphosphonates|bisphosphonates
262327|NCT02042872|Dual Energy X-ray Absorptiometry|dual energy x-ray absorptiometry
262328|NCT02042859|EndoHPB|endohpb
262329|NCT02042820|Dry Eye|dry eye
262330|NCT02042781|PG545|pg545
262331|NCT02042781|Phase I|phase i
262332|NCT02042781|Progen|progen
262333|NCT02042781|antimetastatic|antimetastatic
262334|NCT02042781|antiangiogenic|antiangiogenic
262335|NCT02042781|advanced cancer patients|advanced cancer patients
262336|NCT02042781|solid tumors|solid tumors
262337|NCT02042781|solid tumours|solid tumours
262338|NCT02042781|tumor microenvironment|tumor microenvironment
262339|NCT02042768|Glucose|glucose
262340|NCT02042768|Dialysate|dialysate
262341|NCT02042768|Peritoneal Dialysis|peritoneal dialysis
262342|NCT02042768|patients|patients
262343|NCT02042768|non-diabetic|non-diabetic
262344|NCT02042755|cataract|cataract
262345|NCT02042755|IOL|iol
262346|NCT02042755|trifocal|trifocal
262347|NCT02042755|FineVision|finevision
262348|NCT02042742|Cross-over studies|cross-over studies
262349|NCT02042742|Antioxidants|antioxidants
262350|NCT02042742|Hydroxytyrosol|hydroxytyrosol
262351|NCT02042742|Punicalagin|punicalagin
262352|NCT02042742|Treatment outcome|treatment outcome
262353|NCT02042742|Inflammatory markers|inflammatory markers
262354|NCT02042742|Endothelial function|endothelial function
262355|NCT02042742|Humans|humans
262356|NCT02042742|Adults|adults
262357|NCT02042742|volunteers|volunteers
262358|NCT02042729|volunteer|volunteer
262359|NCT02042716|preterm and term newborns|preterm and term newborns
262360|NCT02042716|diagnosis of cerebral white matter damage|diagnosis of cerebral white matter damage
262361|NCT02042716|quantitative brain elasticity|quantitative brain elasticity
262362|NCT02042716|Transfontanel ultrafast doppler|transfontanel ultrafast doppler
262363|NCT02042690|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
262364|NCT02042690|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
262365|NCT02042690|chemotherapy|chemotherapy
262366|NCT02042677|ileostomy|ileostomy
262367|NCT02042677|1-piece|1-piece
262368|NCT02042677|assessment|assessment
262369|NCT02042677|Nova|nova
262370|NCT02042677|NovaLife|novalife
262371|NCT02042677|Dansac|dansac
262372|NCT02042651|ESWT|eswt
262373|NCT02042651|Chronic pelvic pain|chronic pelvic pain
262374|NCT02042651|randomized|randomized
262375|NCT02042651|sham controlled|sham controlled
262376|NCT02042612|Pharmacokinetics|pharmacokinetics
262377|NCT02042612|Sevoflurane|sevoflurane
262379|NCT02042612|Sedation|sedation
262380|NCT02042612|ICU patients|icu patients
262381|NCT02042599|Pharmacokinetics|pharmacokinetics
262382|NCT02042599|Sevoflurane|sevoflurane
262383|NCT02042599|Acute kidney injury|acute kidney injury
262384|NCT02042599|Sedation|sedation
262385|NCT02042599|ICU patients|icu patients
262386|NCT02042534|stroke|stroke
262387|NCT02042534|TIA|tia
262388|NCT02042521|Cigarette|cigarette
262389|NCT02042521|Withdrawal|withdrawal
262390|NCT02042521|Nicotine|nicotine
262391|NCT02042482|Ultra coenzyme Q10|ultra coenzyme q10
262392|NCT02042482|L-carnitine|l-carnitine
262393|NCT02042469|awareness, clinical research, Saudi arabia|awareness, clinical research, saudi arabia
262394|NCT02042456|breast cancer|breast cancer
262395|NCT02042456|dense breasts|dense breasts
262396|NCT02042456|mammography screening|mammography screening
262397|NCT02042456|Screening techniques|screening techniques
262398|NCT02042456|women|women
262399|NCT02042404|Hearing impairment|hearing impairment
262400|NCT02042404|Hearing loss|hearing loss
262401|NCT02042391|PTLD|ptld
262402|NCT02042391|CD20-positive|cd20-positive
262403|NCT02042391|solid organ transplantation|solid organ transplantation
262404|NCT02042378|BRCA|brca
262405|NCT02042378|BRCA mutation|brca mutation
262406|NCT02042378|germline BRCA|germline brca
262407|NCT02042378|somatic BRCA|somatic brca
262408|NCT02042378|PARP inhibitor|parp inhibitor
262409|NCT02042378|rucaparib|rucaparib
262410|NCT02042378|CO-338|co-338
262411|NCT02042378|PF 01367338|pf 01367338
262412|NCT02042378|AG 14699|ag 14699
262413|NCT02042378|Clovis|clovis
262414|NCT02042378|Clovis Oncology|clovis oncology
262415|NCT02042378|RucaPanc|rucapanc
262416|NCT02042365|Enhanced recovery,|enhanced recovery,
262417|NCT02042365|sleeve gastrectomy,|sleeve gastrectomy,
262418|NCT02042339|Hyperbaric Oxygen|hyperbaric oxygen
262419|NCT02042339|Diabetic ulcer|diabetic ulcer
262420|NCT02042339|Wound healing|wound healing
262421|NCT02042339|3-D life-viz- system|3-d life-viz- system
262422|NCT02042339|Indocyanine green video angiography|indocyanine green video angiography
262423|NCT02042339|Transcutaneous oxygen pressure|transcutaneous oxygen pressure
262424|NCT02042339|Endothelial progenitor cells|endothelial progenitor cells
262425|NCT02042326|Arteriovenous Malformations|arteriovenous malformations
262426|NCT02042326|Sirolimus|sirolimus
262427|NCT02042326|Maxillofacial Surgery|maxillofacial surgery
262428|NCT02042300|XIENCE Xpedition|xience xpedition
262429|NCT02042300|Routine Clinical Practice|routine clinical practice
262430|NCT02042300|Alpine|alpine
262431|NCT02042287|Bacterial Infections and Mycoses|bacterial infections and mycoses
262432|NCT02042287|Pharmaceutical Preparations|pharmaceutical preparations
262433|NCT02042287|Health Occupations|health occupations
262434|NCT02042274|Fish oil|fish oil
262435|NCT02042274|EPA|epa
262436|NCT02042274|DHA|dha
262437|NCT02042274|fatty acids|fatty acids
262438|NCT02042274|genetic variation|genetic variation
262439|NCT02042274|gene expression|gene expression
262440|NCT02042248|HIV|hiv
262441|NCT02042248|Acute HIV Infection|acute hiv infection
262442|NCT02042248|Chronic HIV Infection|chronic hiv infection
262443|NCT02042248|AGS-004|ags-004
262444|NCT02042248|Phase 1|phase 1
262445|NCT02042248|Antiretroviral Therapy|antiretroviral therapy
262446|NCT02042248|ART|art
262447|NCT02042248|UNC|unc
262448|NCT02042248|Argos Therapeutics|argos therapeutics
262449|NCT02042248|The CARE Collaboratory of AIDS|the care collaboratory of aids
262450|NCT02042248|Immunization|immunization
262451|NCT02042248|vaccination|vaccination
262452|NCT02042235|prematurity|prematurity
262453|NCT02042235|language|language
262454|NCT02042235|parent-implemented intervention|parent-implemented intervention
262455|NCT02042235|speech therapy|speech therapy
262456|NCT02042235|neurodevelopment|neurodevelopment
262457|NCT02042222|Sickle cell|sickle cell
262458|NCT02042222|Hydroxyurea|hydroxyurea
262459|NCT02042222|Dose prediction|dose prediction
262460|NCT02042222|Maximum tolerated dose|maximum tolerated dose
262461|NCT02042209|acute coronary syndrome|acute coronary syndrome
262462|NCT02042209|thoracic pain|thoracic pain
262463|NCT02042209|prehospital|prehospital
262464|NCT02042209|diagnostic score|diagnostic score
262465|NCT02042196|endothelial function|endothelial function
262466|NCT02042196|women|women
262467|NCT02042196|estrogen deficiency|estrogen deficiency
262468|NCT02042196|sex hormones|sex hormones
262469|NCT02042196|adiposity|adiposity
262470|NCT02042196|oxidative stress|oxidative stress
262471|NCT02042196|antioxidants|antioxidants
262472|NCT02042157|Quality of Life|quality of life
262473|NCT02042157|Caregivers|caregivers
262474|NCT02042157|Caregiver burden|caregiver burden
262475|NCT02042157|Urinary Tract Infections|urinary tract infections
262476|NCT02042157|Bidet|bidet
262477|NCT02042157|Women's health|women's health
262478|NCT02042157|Toileting|toileting
262479|NCT02042157|Hygiene|hygiene
262480|NCT02042157|Activities of Daily Living|activities of daily living
262481|NCT02042157|Functional impairment|functional impairment
262482|NCT02042157|Geriatrics|geriatrics
262483|NCT02042144|Neoplasms, Colorectal|neoplasms, colorectal
262484|NCT02042131|suicide|suicide
262485|NCT02042131|suicidal ideation|suicidal ideation
262486|NCT02042131|ambivalence|ambivalence
262487|NCT02042131|suicide ambivalence|suicide ambivalence
262488|NCT02042131|reasons for living|reasons for living
262489|NCT02042131|reasons for dying|reasons for dying
262490|NCT02042131|military|military
262491|NCT02042131|veteran|veteran
262492|NCT02042131|clinical trial|clinical trial
262493|NCT02042131|cognitive behavioral therapy|cognitive behavioral therapy
262494|NCT02042131|psychotherapy|psychotherapy
262495|NCT02042131|crisis|crisis
262496|NCT02042131|Treatment As Usual (TAU)|treatment as usual (tau)
262497|NCT02042131|Crisis Response Plan (CRP)|crisis response plan (crp)
262498|NCT02042131|Enhanced Crisis Response Plan (E-CRP)|enhanced crisis response plan (e-crp)
262499|NCT02042118|Neonatal resuscitation|neonatal resuscitation
262500|NCT02042118|Laryngeal Mask Airway (LMA)|laryngeal mask airway (lma)
262501|NCT02042118|Face mask ventilation (FMV)|face mask ventilation (fmv)
262502|NCT02042118|Uganda|uganda
262503|NCT02042118|Africa|africa
262504|NCT02042105|non-small-cell lung cancer|non-small-cell lung cancer
262505|NCT02042105|anaplastic lymphoma kinase|anaplastic lymphoma kinase
262506|NCT02042105|immunohistochemistry|immunohistochemistry
262507|NCT02042092|Ultrasound|ultrasound
262508|NCT02042092|MRA|mra
262509|NCT02042092|Large Vessel Vasculitis|large vessel vasculitis
262510|NCT02042092|Giant Cell Arteritis|giant cell arteritis
262511|NCT02042092|Takayasu Arteritis|takayasu arteritis
262512|NCT02042092|Immunological abnormalities|immunological abnormalities
262513|NCT02042079|Endoscopic full-thickness resection|endoscopic full-thickness resection
262514|NCT02042079|gastric subepithelial tumor|gastric subepithelial tumor
262515|NCT02042079|hybrid-NOTES|hybrid-notes
262516|NCT02042066|Resistant Hypertension|resistant hypertension
262517|NCT02042066|RH|rh
262518|NCT02042066|RHT|rht
262519|NCT02042066|Blood Pressure|blood pressure
262520|NCT02042066|Kidney|kidney
262521|NCT02042066|Shockwave|shockwave
262522|NCT02042053|imaging|imaging
262523|NCT02042053|diagnostic|diagnostic
262524|NCT02042053|castration resistant|castration resistant
262525|NCT02042053|metastatic prostate cancer|metastatic prostate cancer
262526|NCT02042053|immunotherapy|immunotherapy
262527|NCT02042027|corneal neovascularization|corneal neovascularization
262528|NCT02042027|Gamunex-C|gamunex-c
262529|NCT02042027|IVI-g|ivi-g
262530|NCT02042027|anterior segment inflammation|anterior segment inflammation
262531|NCT02042014|Pulmonary arterial hypertension, QTI571, open label study|pulmonary arterial hypertension, qti571, open label study
262532|NCT02041988|premedication|premedication
262533|NCT02041988|oral morphine|oral morphine
262534|NCT02041988|preemptive analgesia|preemptive analgesia
262535|NCT02041975|Prebiotics|prebiotics
262536|NCT02041975|Gut health|gut health
262537|NCT02041975|Satisfaction|satisfaction
262538|NCT02041962|Care Management|care management
262539|NCT02041962|Chronic Care Model|chronic care model
262540|NCT02041962|Mood Disorders|mood disorders
262541|NCT02041936|irreversible electroporation|irreversible electroporation
262542|NCT02041936|Nanoknife|nanoknife
262543|NCT02041936|pancreatic cancer|pancreatic cancer
262544|NCT02041923|preterm infant|preterm infant
262545|NCT02041923|stable infant|stable infant
262546|NCT02041923|mother-infant interaction|mother-infant interaction
262547|NCT02041923|health care cost|health care cost
262548|NCT02041923|H-HOPE intervention|h-hope intervention
262549|NCT02041923|mother outcomes|mother outcomes
262550|NCT02041923|infant behavioral organization|infant behavioral organization
262551|NCT02041923|infant growth|infant growth
262552|NCT02041897|EUS-FNA|eus-fna
262553|NCT02041897|Pancreatic cystic lesion|pancreatic cystic lesion
262554|NCT02041897|Diagnosis|diagnosis
262555|NCT02041884|Cognitive Behavioral Therapy|cognitive behavioral therapy
262556|NCT02041884|Dialectical Behavioral Therapy|dialectical behavioral therapy
262557|NCT02041884|Applied Relaxation|applied relaxation
262558|NCT02041884|Stress-reduction|stress-reduction
262559|NCT02041884|Smartphone application|smartphone application
262560|NCT02041884|ADHD|adhd
262561|NCT02041884|Randomized controlled trial|randomized controlled trial
262562|NCT02041884|Psychological treatment|psychological treatment
262563|NCT02041884|Efficacy|efficacy
262564|NCT02041871|Liver Surgery|liver surgery
262565|NCT02041871|Hepatectomy|hepatectomy
262566|NCT02041871|Immunonutrition|immunonutrition
262567|NCT02041871|Cancer|cancer
262568|NCT02041871|Morbidity|morbidity
262569|NCT02041871|Postoperative complication|postoperative complication
262570|NCT02041858|Alarms|alarms
262571|NCT02041858|Physiologic Monitoring|physiologic monitoring
262572|NCT02041858|Critical Care|critical care
262573|NCT02041858|Alarm fatigue|alarm fatigue
262574|NCT02041858|Adverse Events|adverse events
262575|NCT02041845|Radiotherapy|radiotherapy
262576|NCT02041845|Radiotherapy dosage|radiotherapy dosage
262577|NCT02041845|Dose fractionation|dose fractionation
262578|NCT02041845|Radiotherapy, image-guided|radiotherapy, image-guided
262579|NCT02041845|Thorax|thorax
262580|NCT02041819|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
262581|NCT02041819|Nimotuzumab|nimotuzumab
262582|NCT02041819|Nab-Paclitaxel|nab-paclitaxel
262583|NCT02041819|Carcinoma of Esophagus|carcinoma of esophagus
262584|NCT02041793|Acute pancreatitis|acute pancreatitis
262585|NCT02041793|Pseudocyst|pseudocyst
262586|NCT02041780|Diagnostic|diagnostic
262587|NCT02041780|Liver fibrosis|liver fibrosis
262588|NCT02041780|Ishak score|ishak score
262589|NCT02041780|Fibrotest|fibrotest
262590|NCT02041780|ShearWave elastography|shearwave elastography
262591|NCT02041780|Liver biopsies|liver biopsies
262692|NCT02041299|deferoxamine|deferoxamine
262693|NCT02041299|Chelation|chelation
262694|NCT02041273|bioavailability|bioavailability
262592|NCT02041767|Ertapenem; prostatic diffusion; antibioprophylaxy; pharmacokinetics; benign prostatic hyperplasia|ertapenem; prostatic diffusion; antibioprophylaxy; pharmacokinetics; benign prostatic hyperplasia
262593|NCT02041741|happiness|happiness
262594|NCT02041741|well-being|well-being
262595|NCT02041741|distress|distress
262596|NCT02041741|positive psychology|positive psychology
262597|NCT02041715|Virus Diseases|virus diseases
262598|NCT02041715|Hemorrhagic Fever, Ebola|hemorrhagic fever, ebola
262599|NCT02041715|Hemorrhagic Fevers, Viral|hemorrhagic fevers, viral
262600|NCT02041715|RNA Virus Infections|rna virus infections
262601|NCT02041715|Filoviridae Infections|filoviridae infections
262602|NCT02041715|Mononegavirales Infections|mononegavirales infections
262603|NCT02041702|Bradycardia|bradycardia
262604|NCT02041702|Pacemaker|pacemaker
262605|NCT02041702|Magnetic|magnetic
262606|NCT02041702|Conditional|conditional
262607|NCT02041702|St Jude|st jude
262608|NCT02041702|Accent|accent
262609|NCT02041702|Tendril|tendril
262610|NCT02041689|Children|children
262611|NCT02041689|Cancer|cancer
262612|NCT02041689|Learning|learning
262613|NCT02041689|Education|education
262614|NCT02041689|Qualitative|qualitative
262615|NCT02041676|Chest|chest
262616|NCT02041676|Physiotherapy|physiotherapy
262617|NCT02041676|Increased Inspiratory Flow Technique|increased inspiratory flow technique
262618|NCT02041676|Prematurity|prematurity
262619|NCT02041676|Non Invasive Ventilation|non invasive ventilation
262620|NCT02041663|brain natriuretic peptide|brain natriuretic peptide
262621|NCT02041663|cardiac function|cardiac function
262622|NCT02041663|meningococcal infections|meningococcal infections
262623|NCT02041663|septic shock|septic shock
262624|NCT02041663|severe sepsis|severe sepsis
262625|NCT02041637|liver failure|liver failure
262626|NCT02041637|etiology|etiology
262627|NCT02041637|liver transplantation|liver transplantation
262628|NCT02041624|allergic|allergic
262629|NCT02041624|rhinitis|rhinitis
262630|NCT02041624|conjunctivitis|conjunctivitis
262631|NCT02041624|grass pollen|grass pollen
262632|NCT02041624|Allergen ImmunoTherapy (AIT)|allergen immunotherapy (ait)
262633|NCT02041624|grass mix|grass mix
262634|NCT02041611|WHO grade III and IV|who grade iii and iv
262635|NCT02041585|Hospital Readmission|hospital readmission
262636|NCT02041585|Social Isolation and Hospital Readmission|social isolation and hospital readmission
262637|NCT02041585|Age and Hospital Readmission|age and hospital readmission
262638|NCT02041585|Functional Status and Hospital Readmission|functional status and hospital readmission
262639|NCT02041585|Charlson Score and Hospital Readmission|charlson score and hospital readmission
262640|NCT02041585|Length of Stay and Hospital Readmission|length of stay and hospital readmission
262641|NCT02041546|Lung lavage,|lung lavage,
262642|NCT02041546|Surfactant,|surfactant,
262643|NCT02041546|Duration of mechanical|duration of mechanical
262644|NCT02041546|ventilation|ventilation
262645|NCT02041520|Seropositive HIV|seropositive hiv
262646|NCT02041520|Omega 3 fatty acids|omega 3 fatty acids
262647|NCT02041520|Oxidative stress|oxidative stress
262648|NCT02041507|Water-aided colonoscopy|water-aided colonoscopy
262649|NCT02041507|Water Immersion|water immersion
262650|NCT02041507|Water Exchange|water exchange
262651|NCT02041507|On-demand sedation|on-demand sedation
262652|NCT02041507|Unsedated colonoscopy|unsedated colonoscopy
262653|NCT02041507|Adenoma detection rate|adenoma detection rate
262654|NCT02041507|Mean adenomas per procedure|mean adenomas per procedure
262655|NCT02041494|Hernia|hernia
262656|NCT02041494|Ventral|ventral
262657|NCT02041494|Incisional|incisional
262658|NCT02041494|Abdominal|abdominal
262659|NCT02041494|Herniorrhaphy|herniorrhaphy
262660|NCT02041494|Recurrence|recurrence
262661|NCT02041494|Infection|infection
262662|NCT02041494|Mesh|mesh
262663|NCT02041494|Biologic|biologic
262664|NCT02041494|Synthetic|synthetic
262665|NCT02041468|ALK-positive|alk-positive
262666|NCT02041455|Fibromyalgia|fibromyalgia
262667|NCT02041455|Melatonin|melatonin
262668|NCT02041455|Amitriptylin|amitriptylin
262669|NCT02041455|Imune-pineal axis|imune-pineal axis
262670|NCT02041442|overactive bladder|overactive bladder
262671|NCT02041442|cystoscopy|cystoscopy
262672|NCT02041429|Recurrent Breast Cancer|recurrent breast cancer
262673|NCT02041429|Advanced Breast Cancer|advanced breast cancer
262674|NCT02041429|Metastatic Breast Cancer|metastatic breast cancer
262675|NCT02041416|Geriatric assessment|geriatric assessment
262676|NCT02041416|REDCap|redcap
262677|NCT02041416|touchscreen|touchscreen
262678|NCT02041416|age 65|age 65
262679|NCT02041364|Fatigue|fatigue
262680|NCT02041364|Biomarkers|biomarkers
262681|NCT02041364|Breast Cancer|breast cancer
262682|NCT02041351|metastatic breast cancer|metastatic breast cancer
262683|NCT02041351|taxanes|taxanes
262684|NCT02041351|heavily pretreated|heavily pretreated
262685|NCT02041312|Cholesterol|cholesterol
262686|NCT02041312|Gastric cancer|gastric cancer
262687|NCT02041312|Stage|stage
262688|NCT02041299|sickle cell disease|sickle cell disease
262689|NCT02041299|Iron overload|iron overload
262690|NCT02041299|Deferiprone|deferiprone
262691|NCT02041299|Ferriprox|ferriprox
262695|NCT02041273|bioequivalence|bioequivalence
262696|NCT02041273|AUC|auc
262697|NCT02041273|Cmax|cmax
262698|NCT02041260|Adult|adult
262699|NCT02041260|differentiated thyroid cancer (DTC),|differentiated thyroid cancer (dtc),
262700|NCT02041260|poorly differentiated thyroid cancer|poorly differentiated thyroid cancer
262701|NCT02041260|not anaplastic thyroid cancer|not anaplastic thyroid cancer
262702|NCT02041234|Diabetes|diabetes
262703|NCT02041234|surgical treatment|surgical treatment
262704|NCT02041234|medical treatment|medical treatment
262705|NCT02041221|pharmacokinetics, pharmacodynamics, asthma|pharmacokinetics, pharmacodynamics, asthma
262706|NCT02041208|Chronic renal anemia|chronic renal anemia
262707|NCT02041208|Hemoglobin|hemoglobin
262708|NCT02041208|Kidney transplant|kidney transplant
262709|NCT02041195|Overweight|overweight
262710|NCT02041182|youth violence|youth violence
262711|NCT02041182|doctor-patient communication|doctor-patient communication
262712|NCT02041182|health risk behaviors|health risk behaviors
262713|NCT02041182|pre-visit questionnaires|pre-visit questionnaires
262714|NCT02041130|Heart Failure|heart failure
262715|NCT02041130|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
262716|NCT02041104|Metabolic syndrome|metabolic syndrome
262717|NCT02041104|4 -week intervention|4 -week intervention
262718|NCT02041104|Randomised placebo controlled parallel study|randomised placebo controlled parallel study
262719|NCT02041104|Beta-glucans|beta-glucans
262720|NCT02041104|Abdominal fat|abdominal fat
262721|NCT02041104|Dyslipidemia|dyslipidemia
262722|NCT02041104|Insulin resistance|insulin resistance
262723|NCT02041104|Hypertension|hypertension
262724|NCT02041104|Gut Microbiota Composition|gut microbiota composition
262725|NCT02041104|Oral Glucose Tolerance Test|oral glucose tolerance test
262726|NCT02041104|Lipid Profile|lipid profile
262727|NCT02041104|Real-Time Polymerase Chain Reaction|real-time polymerase chain reaction
262728|NCT02041104|Denaturating Gradient Gel Electrophoresis|denaturating gradient gel electrophoresis
262729|NCT02041078|Liver surgery|liver surgery
262730|NCT02041078|Blood loss|blood loss
262731|NCT02041078|CUSA|cusa
262732|NCT02041078|Hepatic transection|hepatic transection
262733|NCT02041065|Liver transection|liver transection
262734|NCT02041065|Bloodloss|bloodloss
262735|NCT02041065|Operation time|operation time
262736|NCT02041065|Safety|safety
262737|NCT02041065|feasibility|feasibility
262738|NCT02041026|probiotic|probiotic
262739|NCT02041026|Yoghurt|yoghurt
262740|NCT02041026|NN20|nn20
262741|NCT02041013|Asthma|asthma
262742|NCT02041013|Health Literacy|health literacy
262743|NCT02041000|COPD|copd
262744|NCT02041000|pulmonary|pulmonary
262745|NCT02041000|stem cells|stem cells
262746|NCT02041000|emphysema|emphysema
262747|NCT02041000|lungs|lungs
262748|NCT02040987|Thorough QT study|thorough qt study
262749|NCT02040974|immunotherapy, house dust mites, pollens, allergic rhinitis|immunotherapy, house dust mites, pollens, allergic rhinitis
262750|NCT02040961|Patients|patients
262751|NCT02040961|Undergoing|undergoing
262752|NCT02040961|Elective|elective
262753|NCT02040961|Thoracic|thoracic
262754|NCT02040961|Surgery|surgery
262755|NCT02040922|Antibiotics|antibiotics
262756|NCT02040922|Campylobacter|campylobacter
262757|NCT02040922|Diarrhoea|diarrhoea
262758|NCT02040922|Enteritis|enteritis
262759|NCT02040922|Microbiota|microbiota
262760|NCT02040922|Calprotectin|calprotectin
262761|NCT02040909|sedation|sedation
262762|NCT02040909|quality of intubation|quality of intubation
262763|NCT02040909|hypotension|hypotension
262764|NCT02040909|pharmacodynamics|pharmacodynamics
262765|NCT02040909|pharmacokinetics|pharmacokinetics
262766|NCT02040896|computed tomography|computed tomography
262767|NCT02040896|emergency|emergency
262768|NCT02040896|CT scan|ct scan
262769|NCT02040896|ordering behavior|ordering behavior
262770|NCT02040896|diagnosis|diagnosis
262771|NCT02040896|radiation|radiation
262772|NCT02040883|Schizophrenia|schizophrenia
262773|NCT02040883|Tandospirone|tandospirone
262774|NCT02040883|Cognitive Therapy|cognitive therapy
262775|NCT02040870|Non-Small Cell lung Cancer, NSCLC, ALK, LDK378|non-small cell lung cancer, nsclc, alk, ldk378
262776|NCT02040857|Breast Cancer|breast cancer
262777|NCT02040805|compulsive hoarding|compulsive hoarding
262778|NCT02040805|clutter|clutter
262779|NCT02040805|hoarding disorder|hoarding disorder
262780|NCT02040792|COPD|copd
262781|NCT02040792|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
262782|NCT02040779|asthma|asthma
262783|NCT02040779|breath-actuated inhaler|breath-actuated inhaler
262784|NCT02040779|beclomethasone|beclomethasone
262785|NCT02040766|asthma|asthma
262786|NCT02040766|breath-actuated inhaler|breath-actuated inhaler
262787|NCT02040766|metered dose inhaler|metered dose inhaler
262788|NCT02040753|Lifestyle intervention|lifestyle intervention
262789|NCT02040753|Change of body composition|change of body composition
262790|NCT02040753|Physical activity|physical activity
262791|NCT02040753|Weight loss maintenance|weight loss maintenance
262792|NCT02040727|Myokines|myokines
262793|NCT02040727|Osteokines|osteokines
262794|NCT02040727|Glucose homeostasis|glucose homeostasis
262795|NCT02040727|Puberty|puberty
262796|NCT02040714|femur head necrosis|femur head necrosis
262797|NCT02040714|hip|hip
262798|NCT02040714|pediatric orthopedics|pediatric orthopedics
262799|NCT02040714|MRI|mri
262800|NCT02040714|Osteonecrosis|osteonecrosis
262801|NCT02040714|Bone diseases|bone diseases
262802|NCT02040714|Legg Calve Perthes Syndrome|legg calve perthes syndrome
262803|NCT02040662|paravertebral block|paravertebral block
262804|NCT02040662|thoracic epidural analgesia|thoracic epidural analgesia
262805|NCT02040662|videothoracoscopic surgery|videothoracoscopic surgery
262806|NCT02040662|lung lobectomy|lung lobectomy
262807|NCT02040649|Critical care|critical care
262808|NCT02040649|Respiration, artificial|respiration, artificial
262809|NCT02040636|Pertussis|pertussis
262810|NCT02040636|Tetanus|tetanus
262811|NCT02040636|Diphtheria|diphtheria
262812|NCT02040636|Poliomyelitis|poliomyelitis
262813|NCT02040636|Hepatitis B|hepatitis b
262814|NCT02040636|Acellular Pertussis Vaccines|acellular pertussis vaccines
262815|NCT02040623|Chronic Graft versus Host Disease|chronic graft versus host disease
262816|NCT02040623|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
262817|NCT02040610|Low Risk Prostate Cancer|low risk prostate cancer
262818|NCT02040610|Intermediate Risk Prostate Cancer|intermediate risk prostate cancer
262819|NCT02040610|Hypofractionated|hypofractionated
262820|NCT02040610|Image Guided Proton Therapy|image guided proton therapy
262821|NCT02040584|De Novo Liver Transplant Recipients, Tacrolimus Minimisation, Everolimus, Renal Function|de novo liver transplant recipients, tacrolimus minimisation, everolimus, renal function
262822|NCT02040545|Infertility|infertility
262823|NCT02040545|In Vitro Fertilization (IVF)|in vitro fertilization (ivf)
262824|NCT02040545|Venopuncture-free treatment|venopuncture-free treatment
262825|NCT02040545|Needle-free treatment|needle-free treatment
262826|NCT02040519|Overactive bladder|overactive bladder
262827|NCT02040519|Non obstructive urinary retention|non obstructive urinary retention
262828|NCT02040519|Sacral neuromodulation|sacral neuromodulation
262829|NCT02040506|Acute Myelogenous Leukemia|acute myelogenous leukemia
262830|NCT02040506|Acute Myeloid Leukemia|acute myeloid leukemia
262831|NCT02040506|Drug therapy|drug therapy
262832|NCT02040506|CD98|cd98
262833|NCT02040506|Relapsed|relapsed
262834|NCT02040506|Refractory|refractory
262835|NCT02040506|Monoclonal antibody|monoclonal antibody
262836|NCT02040493|breast cancer|breast cancer
262837|NCT02040493|IORT|iort
262838|NCT02040493|brachytherapy|brachytherapy
262839|NCT02040480|bioavailability|bioavailability
262840|NCT02040480|food effect|food effect
262841|NCT02040480|formulation|formulation
262842|NCT02040480|GSK2110183|gsk2110183
262843|NCT02040480|afuresertib|afuresertib
262844|NCT02040480|AKT inhibitor|akt inhibitor
262845|NCT02040441|Proteomics|proteomics
262846|NCT02040441|Diabetes|diabetes
262847|NCT02040441|Chronic kidney disease|chronic kidney disease
262848|NCT02040441|Diabetic nephropathy|diabetic nephropathy
262849|NCT02040441|Diabetic retinopathy|diabetic retinopathy
262850|NCT02040441|Mineralocorticoid receptor antagonists|mineralocorticoid receptor antagonists
262851|NCT02040441|Spironolactone|spironolactone
262852|NCT02040441|Microalbuminuria|microalbuminuria
262853|NCT02040428|Cardiovascular Diseases|cardiovascular diseases
262854|NCT02040428|Fibrin Sealant|fibrin sealant
262855|NCT02040428|Hemostatics|hemostatics
262856|NCT02040428|Coagulants|coagulants
262857|NCT02040402|Comparison of pneumococcal conjugated vaccine regimes|comparison of pneumococcal conjugated vaccine regimes
262858|NCT02040389|children|children
262859|NCT02040389|penile|penile
262860|NCT02040389|inguinal|inguinal
262861|NCT02040389|kidney parents|kidney parents
262862|NCT02040389|anxiety|anxiety
262863|NCT02040376|Paediatrics|paediatrics
262864|NCT02040376|Medulloblastoma|medulloblastoma
262865|NCT02040376|Metformin|metformin
262866|NCT02040363|COPD|copd
262867|NCT02040363|skeletal muscle|skeletal muscle
262868|NCT02040363|angiogenesis|angiogenesis
262869|NCT02040363|exercise training|exercise training
262870|NCT02040363|intensity|intensity
262871|NCT02040350|Pralidoxime, atropine, organophosphorous poisoning.|pralidoxime, atropine, organophosphorous poisoning.
262872|NCT02040285|CT colonography|ct colonography
262873|NCT02040259|ischemic stroke|ischemic stroke
262874|NCT02040259|mechanical thrombectomy device|mechanical thrombectomy device
262875|NCT02040259|Retriever|retriever
262876|NCT02040220|CRVO, Macular edema, Aflibercept, anti-VEGF|crvo, macular edema, aflibercept, anti-vegf
262877|NCT02040181|renal function, creatinine clearance|renal function, creatinine clearance
262878|NCT02040168|Ventilation|ventilation
262879|NCT02040168|PTSD|ptsd
262880|NCT02040168|sedation|sedation
262881|NCT02040142|Hyperthermic Intraperitoneal Mitomycin c|hyperthermic intraperitoneal mitomycin c
262882|NCT02040142|HIPEC|hipec
262883|NCT02040142|Cytoreduction|cytoreduction
262884|NCT02040116|Rapid Infusion Rituximab|rapid infusion rituximab
262885|NCT02040103|Deep Vein Thrombosis|deep vein thrombosis
262886|NCT02040103|Pulmonary Embolism|pulmonary embolism
262887|NCT02040103|Intermittent Pneumatic Compression|intermittent pneumatic compression
262888|NCT02040103|Pharmacologic DVT|pharmacologic dvt
262889|NCT02040103|Prophylaxis|prophylaxis
262890|NCT02040103|Critically Ill Patients.|critically ill patients.
262891|NCT02040077|opioid|opioid
262892|NCT02040077|overdose|overdose
262893|NCT02040077|OD|od
262894|NCT02040077|opiate|opiate
262895|NCT02040077|prescription opioids|prescription opioids
262896|NCT02040077|prescription pain medication|prescription pain medication
262897|NCT02040077|heroin|heroin
262898|NCT02040077|detoxification|detoxification
262899|NCT02040077|prevention|prevention
262900|NCT02040051|intensive care units|intensive care units
262901|NCT02040051|mechanical ventilation|mechanical ventilation
262902|NCT02040051|music therapy|music therapy
262903|NCT02040038|Diabetes|diabetes
262904|NCT02040038|Virtual Environment|virtual environment
262905|NCT02040038|Self-Management|self-management
262906|NCT02040025|hypertension|hypertension
262907|NCT02040025|diabetes mellitus|diabetes mellitus
262908|NCT02040025|hemoglobin A1C|hemoglobin a1c
262909|NCT02040025|peripheral vascular resistance|peripheral vascular resistance
262910|NCT02040025|EECP|eecp
262911|NCT02040025|Blood pressure|blood pressure
262912|NCT02040025|angiogenesis|angiogenesis
262913|NCT02040025|Coronary Artery Disease|coronary artery disease
262914|NCT02040025|Coronary Disease|coronary disease
262915|NCT02040025|Heart Diseases|heart diseases
262916|NCT02040025|Cardiovascular Diseases|cardiovascular diseases
262917|NCT02040012|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
262918|NCT02039999|chronic|chronic
262919|NCT02039999|cough|cough
262920|NCT02039999|challenge|challenge
262921|NCT02039999|ATP|atp
262922|NCT02039999|hypersensitivity|hypersensitivity
262923|NCT02039999|TRPA1|trpa1
262924|NCT02039986|cystic fibrosis|cystic fibrosis
262925|NCT02039986|CF|cf
262926|NCT02039986|cystic fibrosis related diabetes|cystic fibrosis related diabetes
262927|NCT02039986|CFRD|cfrd
262928|NCT02039986|kalydeco|kalydeco
262929|NCT02039986|ivacaftor|ivacaftor
262930|NCT02039973|HIV|hiv
262931|NCT02039973|AIDS|aids
262932|NCT02039973|Tanzania|tanzania
262933|NCT02039973|depression|depression
262934|NCT02039973|perinatal|perinatal
262935|NCT02039973|psychotherapy|psychotherapy
262936|NCT02039973|task-sharing|task-sharing
262937|NCT02039973|problem-solving|problem-solving
262938|NCT02039960|Epidemiology|epidemiology
262939|NCT02039960|Drug Abuse Warning Network (DAWN)|drug abuse warning network (dawn)
262940|NCT02039960|bupropion|bupropion
262941|NCT02039960|abuse|abuse
262942|NCT02039947|BRAF V600K mutation|braf v600k mutation
262943|NCT02039947|Metastatic Melanoma|metastatic melanoma
262944|NCT02039947|BRAF V600R mutation|braf v600r mutation
262945|NCT02039947|BRAF V600D mutation|braf v600d mutation
262946|NCT02039947|BRAF V600E mutation|braf v600e mutation
262947|NCT02039947|Brain metastases BRAF inhibitor|brain metastases braf inhibitor
262948|NCT02039947|Intracranial|intracranial
262949|NCT02039934|type 2 diabetes|type 2 diabetes
262950|NCT02039934|exercise intervention|exercise intervention
262951|NCT02039934|high intensity interval training|high intensity interval training
262952|NCT02039908|Tolerance to stimulant medication|tolerance to stimulant medication
262953|NCT02039895|Cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
262954|NCT02039895|Helical irradiation of the total skin|helical irradiation of the total skin
262955|NCT02039895|Refractory|refractory
262956|NCT02039895|Total skin electron beam therapy|total skin electron beam therapy
262957|NCT02039882|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
262958|NCT02039882|Percutaneous Coronary Intervention PCI|percutaneous coronary intervention pci
262959|NCT02039882|Normals|normals
262960|NCT02039882|Myocardial Infarction MI|myocardial infarction mi
262961|NCT02039882|Point of Care POC|point of care poc
262962|NCT02039882|Hypoxanthine|hypoxanthine
262963|NCT02039882|Inosine|inosine
262964|NCT02039882|HPLC High Pressure Liquid Chromatography|hplc high pressure liquid chromatography
262965|NCT02039869|NERD|nerd
262966|NCT02039869|Non erosive reflux disease|non erosive reflux disease
262967|NCT02039869|functional dyspepsia|functional dyspepsia
262968|NCT02039869|erosive esophagitis|erosive esophagitis
262969|NCT02039869|confocal endomicroscopy|confocal endomicroscopy
262970|NCT02039869|cell visio|cell visio
262971|NCT02039869|proton pump inhibitor|proton pump inhibitor
262972|NCT02039869|sucralfate|sucralfate
262973|NCT02039856|Patient-centered medical homes|patient-centered medical homes
262974|NCT02039856|Primary care|primary care
262975|NCT02039856|Women's health|women's health
262976|NCT02039856|Veterans|veterans
262977|NCT02039830|female|female
262978|NCT02039830|aging|aging
262979|NCT02039830|physiotherapy|physiotherapy
262980|NCT02039830|pelvic floor|pelvic floor
262981|NCT02039830|rehabilitation|rehabilitation
262982|NCT02039817|pharmacokinetics|pharmacokinetics
262983|NCT02039817|pharmacodynamics|pharmacodynamics
262984|NCT02039817|renal impairment|renal impairment
262985|NCT02039778|Glioblastoma|glioblastoma
262986|NCT02039778|High-grade Glioma|high-grade glioma
262987|NCT02039778|Brain Tums|brain tums
262988|NCT02039778|Temozolomide|temozolomide
262989|NCT02039778|Stem cell radiation therapy|stem cell radiation therapy
262990|NCT02039778|IMRT|imrt
262991|NCT02039778|Proton beam radiotherapy|proton beam radiotherapy
262992|NCT02039778|Conventional external beam radiotherapy|conventional external beam radiotherapy
262993|NCT02039778|Quality of Life|quality of life
262994|NCT02039778|Neurocognition|neurocognition
262995|NCT02039765|Ocular Redness|ocular redness
262996|NCT02039752|Multivessel|multivessel
262997|NCT02039739|Orsiro|orsiro
262998|NCT02039739|Drug Eluting Stent|drug eluting stent
262999|NCT02039739|Routine Clinical Practice|routine clinical practice
263000|NCT02039739|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
263001|NCT02039739|Coronary Artery Disease|coronary artery disease
263002|NCT02039726|Acute Myeloid Leukemia|acute myeloid leukemia
263003|NCT02039726|AML|aml
263004|NCT02039726|FMS-like tyrosine kinase 3|fms-like tyrosine kinase 3
263005|NCT02039726|FLT3-ITD|flt3-itd
263006|NCT02039726|Quizartinib|quizartinib
263007|NCT02039726|Leukemia|leukemia
263009|NCT02039713|DeSyne|desyne
263010|NCT02039713|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
263011|NCT02039713|Coronary Artery Disease|coronary artery disease
263012|NCT02039687|neuropathy|neuropathy
263013|NCT02039687|sarcoidosis|sarcoidosis
263014|NCT02039674|PD-1|pd-1
263015|NCT02039674|PD1|pd1
263016|NCT02039674|Programmed Cell Death-1|programmed cell death-1
263017|NCT02039674|Programmed Cell Death 1|programmed cell death 1
263018|NCT02039674|Chemotherapy|chemotherapy
263019|NCT02039674|Pemetrexed|pemetrexed
263020|NCT02039674|Paclitaxel|paclitaxel
263021|NCT02039674|Bevacizumab|bevacizumab
263022|NCT02039674|Erlotinib|erlotinib
263023|NCT02039674|Gefitinib|gefitinib
263024|NCT02039674|Ipilimumab|ipilimumab
263025|NCT02039674|Carboplatin|carboplatin
263026|NCT02039661|Curettage;|curettage;
263027|NCT02039661|Pain Score|pain score
263028|NCT02039648|Periodontitis|periodontitis
263029|NCT02039648|Porphyromonas gingivalis|porphyromonas gingivalis
263030|NCT02039648|Rumex acetosa L.|rumex acetosa l.
263031|NCT02039648|Proanthocyanidins|proanthocyanidins
263032|NCT02039635|cancer|cancer
263033|NCT02039635|cancer related fatigue|cancer related fatigue
263034|NCT02039635|Korean red ginseng|korean red ginseng
263035|NCT02039635|chemotherapy|chemotherapy
263036|NCT02039583|live birth|live birth
263037|NCT02039583|infant|infant
263038|NCT02039583|infant, newborn|infant, newborn
263039|NCT02039583|second-hand smoke|second-hand smoke
263040|NCT02039583|tobacco smoke pollution|tobacco smoke pollution
263041|NCT02039583|smoke-free|smoke-free
263042|NCT02039583|smoke-free policy|smoke-free policy
263043|NCT02039570|haemorrhoids|haemorrhoids
263044|NCT02039570|pelvic reflux|pelvic reflux
263045|NCT02039531|Knee|knee
263046|NCT02039531|osteoarthritis|osteoarthritis
263047|NCT02039531|plasma rich in growth factors|plasma rich in growth factors
263048|NCT02039531|platelet rich plasma|platelet rich plasma
263049|NCT02039531|hyaluronic acid|hyaluronic acid
263050|NCT02039518|Progression free Survival|progression free survival
263051|NCT02039505|Drug therapy|drug therapy
263052|NCT02039479|anti-suicide|anti-suicide
263053|NCT02039479|Lithium|lithium
263054|NCT02039479|Depression|depression
263055|NCT02039479|suicidal Ideation/behavior|suicidal ideation/behavior
263056|NCT02039453|Colonoscopy|colonoscopy
263057|NCT02039453|sedation|sedation
263058|NCT02039453|propofol|propofol
263059|NCT02039453|fentanyl|fentanyl
263060|NCT02039453|pethidine|pethidine
263061|NCT02039427|Sore throat|sore throat
263062|NCT02039427|Hoarseness|hoarseness
263063|NCT02039427|Intubation|intubation
263064|NCT02039427|Thyroidectomy|thyroidectomy
263065|NCT02039427|Ketorolac|ketorolac
263066|NCT02039427|Dexamethasone|dexamethasone
263067|NCT02039414|Obesity|obesity
263068|NCT02039414|Physical Inactivity|physical inactivity
263069|NCT02039414|Lipid Oxidation|lipid oxidation
263070|NCT02039414|Oxidative stress|oxidative stress
263071|NCT02039414|pregnancy|pregnancy
263072|NCT02039414|neonatal adiposity|neonatal adiposity
263073|NCT02039414|neonatal insulin sensitivity|neonatal insulin sensitivity
263074|NCT02039401|ALS|als
263075|NCT02039401|Lou Gehrig's disease|lou gehrig's disease
263076|NCT02039401|neurodegenerative disease|neurodegenerative disease
263077|NCT02039388|Ovarian Epithelial Cancer|ovarian epithelial cancer
263078|NCT02039388|Serous Intraepithelial Carcinoma (STIC)|serous intraepithelial carcinoma (stic)
263079|NCT02039388|BRCA1 gene|brca1 gene
263080|NCT02039388|BRCA2 gene|brca2 gene
263081|NCT02039388|Mutation|mutation
263082|NCT02039388|Neoplasms|neoplasms
263083|NCT02039388|Glandular and Epithelial|glandular and epithelial
263084|NCT02039388|Ovarian Neoplasms|ovarian neoplasms
263085|NCT02039388|Ovarian cancer|ovarian cancer
263086|NCT02039388|Carcinoma in situ|carcinoma in situ
263087|NCT02039388|family history breast cancer|family history breast cancer
263088|NCT02039388|family history ovarian cancer|family history ovarian cancer
263089|NCT02039375|IV tPA|iv tpa
263090|NCT02039375|Thrombolysis|thrombolysis
263091|NCT02039375|Stroke|stroke
263092|NCT02039375|Ischemic|ischemic
263093|NCT02039375|Monitoring|monitoring
263094|NCT02039349|Alcoholism|alcoholism
263095|NCT02039349|Ghrelin|ghrelin
263890|NCT02035631|Recurrence|recurrence
263096|NCT02039349|Ghrelin Antagonism|ghrelin antagonism
263097|NCT02039323|Tenofovir|tenofovir
263098|NCT02039323|Tenofovir disoproxil|tenofovir disoproxil
263099|NCT02039323|Maraviroc|maraviroc
263100|NCT02039323|Pharmacologic Actions|pharmacologic actions
263101|NCT02039323|Anti-HIV agents|anti-hiv agents
263102|NCT02039323|Pharmacodynamics|pharmacodynamics
263103|NCT02039297|AWARE, Checklist, ICU, Outcome, Adults|aware, checklist, icu, outcome, adults
263104|NCT02039284|Cerebral palsy|cerebral palsy
263105|NCT02039284|novel intervention|novel intervention
263106|NCT02039284|sensory electrical stimulation|sensory electrical stimulation
263107|NCT02039284|virtual reality|virtual reality
263108|NCT02039284|cycling training|cycling training
263109|NCT02039284|constraint-induced therapy|constraint-induced therapy
263110|NCT02039284|biomechanical|biomechanical
263111|NCT02039284|physiology|physiology
263112|NCT02039284|outcome|outcome
263113|NCT02039271|music|music
263114|NCT02039271|total knee replacement|total knee replacement
263115|NCT02039271|Pain management|pain management
263116|NCT02039258|Healthy Volunteers|healthy volunteers
263117|NCT02039258|Canagliflozin|canagliflozin
263118|NCT02039258|Metformin|metformin
263119|NCT02039258|INVOKANA®|invokana®
263120|NCT02039258|Type 2 diabetes mellitus|type 2 diabetes mellitus
263121|NCT02039245|Healthy Volunteers|healthy volunteers
263122|NCT02039245|Canagliflozin|canagliflozin
263123|NCT02039245|Metformin|metformin
263124|NCT02039245|INVOKANA®|invokana®
263125|NCT02039245|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
263126|NCT02039206|Machado Joseph disease|machado joseph disease
263127|NCT02039206|Deep TMS|deep tms
263128|NCT02039206|TMS|tms
263129|NCT02039206|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
263130|NCT02039206|SCA3|sca3
263131|NCT02039206|Magnetic Stimulation|magnetic stimulation
263132|NCT02039206|Brainsway|brainsway
263133|NCT02039193|Generalized anxiety disorder|generalized anxiety disorder
263134|NCT02039193|cognitive behavior therapy|cognitive behavior therapy
263135|NCT02039193|adherence|adherence
263136|NCT02039180|phase I|phase i
263137|NCT02039180|healthy volunteers|healthy volunteers
263138|NCT02039180|AZD3293|azd3293
263139|NCT02039180|bioavailability|bioavailability
263140|NCT02039180|Pharmacokinetics|pharmacokinetics
263141|NCT02039154|Exercise|exercise
263142|NCT02039154|Exercise tolerance|exercise tolerance
263143|NCT02039154|Aging|aging
263144|NCT02039154|Physical activity|physical activity
263145|NCT02039141|diabetes prevention program|diabetes prevention program
263146|NCT02039141|community based interventions|community based interventions
263147|NCT02039141|childhood obesity|childhood obesity
263148|NCT02039141|insulin resistance|insulin resistance
263149|NCT02039141|glucose tolerance|glucose tolerance
263150|NCT02039141|quality of life|quality of life
263151|NCT02039141|Latino youth|latino youth
263152|NCT02039141|physical activity|physical activity
263153|NCT02039141|nutrition|nutrition
263154|NCT02039102|hormonal contraceptives|hormonal contraceptives
263155|NCT02039102|combined pills|combined pills
263156|NCT02039102|progesterone-only contraceptives|progesterone-only contraceptives
263157|NCT02039102|body mass index|body mass index
263158|NCT02039102|asthma|asthma
263159|NCT02039102|Scotland|scotland
263160|NCT02039102|women|women
263161|NCT02039076|Healthy|healthy
263162|NCT02039063|Crohn's Disease|crohn's disease
263163|NCT02039050|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
263164|NCT02039050|Long-acting muscarinic antagonists|long-acting muscarinic antagonists
263165|NCT02039050|Impulse oscillometry|impulse oscillometry
263166|NCT02039024|18F-DTBZ|18f-dtbz
263167|NCT02039011|Asthma|asthma
263168|NCT02039011|Long acting beta-agonists|long acting beta-agonists
263169|NCT02039011|Long acting muscarinic antagonists|long acting muscarinic antagonists
263170|NCT02039011|Mannitol challenge|mannitol challenge
263171|NCT02038998|stroke|stroke
263172|NCT02038998|periodic acceleration|periodic acceleration
263173|NCT02038998|endothelium release|endothelium release
263174|NCT02038998|ischemic penumbra|ischemic penumbra
263175|NCT02038998|shear stress|shear stress
263176|NCT02038998|adrenomedullin|adrenomedullin
263177|NCT02038985|Endometriosis|endometriosis
263178|NCT02038985|Robotic Surgery|robotic surgery
263179|NCT02038985|Diagnostic Imaging|diagnostic imaging
263180|NCT02038959|Parkinson disease|parkinson disease
263181|NCT02038959|Parkinson's|parkinson's
263182|NCT02038959|Parkinson's disease|parkinson's disease
263183|NCT02038959|telemedicine|telemedicine
263184|NCT02038959|virtual visits|virtual visits
263185|NCT02038959|video calls|video calls
263186|NCT02038959|video conferencing|video conferencing
263187|NCT02038959|virtual house calls|virtual house calls
263188|NCT02038920|Drug Therapy|drug therapy
263189|NCT02038907|Norovirus, vaccination|norovirus, vaccination
263190|NCT02038894|Anesthetic|anesthetic
263191|NCT02038894|Pediatric|pediatric
263192|NCT02038894|Esophagogastroduodenoscopies|esophagogastroduodenoscopies
263193|NCT02038894|Eosinophilic esophagitis|eosinophilic esophagitis
263194|NCT02038894|Gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
263892|NCT02035631|Diet|diet
263195|NCT02038894|Abdominal Pain|abdominal pain
263196|NCT02038894|Vomiting|vomiting
263197|NCT02038894|Sevofluorane|sevofluorane
263198|NCT02038894|Propofol|propofol
263199|NCT02038894|Nasal cannula|nasal cannula
263200|NCT02038894|Intubation|intubation
263201|NCT02038894|Endotracheal tube|endotracheal tube
263203|NCT02038868|ASP4901|asp4901
263204|NCT02038855|Dual-diagnosis|dual-diagnosis
263205|NCT02038855|Latino|latino
263206|NCT02038855|Mental health|mental health
263207|NCT02038855|Substance use|substance use
263208|NCT02038855|HIV risk|hiv risk
263209|NCT02038829|COPD|copd
263210|NCT02038803|Cystic Fibrosis Medication Adherence|cystic fibrosis medication adherence
263211|NCT02038790|opioid dependence|opioid dependence
263212|NCT02038790|buprenorphine/naloxone|buprenorphine/naloxone
263213|NCT02038790|Opioid-Related Disorders|opioid-related disorders
263214|NCT02038777|Hematologic Malignancies|hematologic malignancies
263215|NCT02038764|Phase 1|phase 1
263216|NCT02038764|RN168|rn168
263217|NCT02038764|Adults|adults
263218|NCT02038764|Type 1 Diabetes|type 1 diabetes
263219|NCT02038764|T1D|t1d
263220|NCT02038751|Genotyping|genotyping
263221|NCT02038751|Phenotyping|phenotyping
263222|NCT02038751|Sleep Apnea|sleep apnea
263223|NCT02038751|Genetic Association Studies|genetic association studies
263224|NCT02038751|Phenotype|phenotype
263225|NCT02038738|gallium|gallium
263226|NCT02038738|Ga|ga
263227|NCT02038738|PET Scan|pet scan
263228|NCT02038725|Risks|risks
263229|NCT02038725|Risk Factors|risk factors
263230|NCT02038725|ABCD2 score|abcd2 score
263231|NCT02038725|Predictive Value of Tests|predictive value of tests
263232|NCT02038725|Risk Assessment|risk assessment
263233|NCT02038725|Severity of Illness Index|severity of illness index
263234|NCT02038725|Decision Support Techniques|decision support techniques
263235|NCT02038712|Obesity|obesity
263236|NCT02038712|Binge eating disorder|binge eating disorder
263237|NCT02038712|fMRI|fmri
263238|NCT02038712|gut hormones|gut hormones
263239|NCT02038686|Hip fracture|hip fracture
263240|NCT02038686|Unstable (31A2 and 31A3)|unstable (31a2 and 31a3)
263241|NCT02038686|Proximal femoral nail|proximal femoral nail
263242|NCT02038673|ASP5878|asp5878
263243|NCT02038673|FGFR 1,2,3 and 4 inhibitor|fgfr 1,2,3 and 4 inhibitor
263244|NCT02038660|Coronary Artery Disease|coronary artery disease
263245|NCT02038660|Angioplasty, Balloon|angioplasty, balloon
263246|NCT02038647|Drug therapy|drug therapy
263247|NCT02038634|wrist|wrist
263248|NCT02038634|tendonitis|tendonitis
263249|NCT02038634|dequervain's|dequervain's
263250|NCT02038634|tenosynovitis|tenosynovitis
263251|NCT02038608|Parkinson|parkinson
263252|NCT02038608|serotonin|serotonin
263253|NCT02038608|dopamine|dopamine
263254|NCT02038608|non motor|non motor
263255|NCT02038608|progression|progression
263256|NCT02038608|PET|pet
263257|NCT02038595|brown adipose tissue|brown adipose tissue
263258|NCT02038582|HIV|hiv
263259|NCT02038582|HIV Counseling and Testing|hiv counseling and testing
263260|NCT02038582|Linkages to Care|linkages to care
263261|NCT02038582|Point of Care CD4|point of care cd4
263262|NCT02038582|Point of Care Viral Load|point of care viral load
263263|NCT02038543|Hyperoxaluria|hyperoxaluria
263264|NCT02038543|Oxalate|oxalate
263265|NCT02038543|Primary Hyperoxaluria|primary hyperoxaluria
263266|NCT02038530|Deep Vein Thrombosis|deep vein thrombosis
263267|NCT02038517|Insulin secretion|insulin secretion
263268|NCT02038517|Insulin sensitivity|insulin sensitivity
263269|NCT02038517|Orthotopic liver transplantation|orthotopic liver transplantation
263270|NCT02038517|Type 2 diabetes|type 2 diabetes
263271|NCT02038517|Metabolic syndrome|metabolic syndrome
263272|NCT02038517|Cardiovascular disease|cardiovascular disease
263273|NCT02038504|gastrointestinal fistula|gastrointestinal fistula
263274|NCT02038504|enteral nutrition|enteral nutrition
263275|NCT02038504|thyroid function|thyroid function
263276|NCT02038491|Epidural anesthesia|epidural anesthesia
263277|NCT02038491|Spinal anesthesia|spinal anesthesia
263278|NCT02038491|nerve blocks|nerve blocks
263279|NCT02038491|complications|complications
263280|NCT02038478|Sickle Cell Disease|sickle cell disease
263281|NCT02038478|Thalassemia|thalassemia
263282|NCT02038452|hand|hand
263283|NCT02038452|wrist|wrist
263284|NCT02038452|carpal|carpal
263285|NCT02038452|tunnel|tunnel
263286|NCT02038452|syndrome|syndrome
263287|NCT02038452|pragmatic|pragmatic
263288|NCT02038452|randomised|randomised
263289|NCT02038452|steroid|steroid
263290|NCT02038452|splint|splint
263291|NCT02038439|Evidence-Based Medicine|evidence-based medicine
263292|NCT02038439|Evidence Retrieval|evidence retrieval
263293|NCT02038439|Knowledge Translation|knowledge translation
263294|NCT02038439|Medical Education|medical education
263295|NCT02038413|NSCLC|nsclc
263296|NCT02038413|cT1/cT2aN0M0|ct1/ct2an0m0
263297|NCT02038413|Stereotactic lung treatment|stereotactic lung treatment
263298|NCT02038413|MAASTRO|maastro
263299|NCT02038413|age >18 years|age >18 years
263300|NCT02038335|immune cells|immune cells
263301|NCT02038335|contraception|contraception
263302|NCT02038335|intrauterine device|intrauterine device
263303|NCT02038335|IUD|iud
263304|NCT02038335|copper|copper
263305|NCT02038335|microbiota|microbiota
263306|NCT02038335|DMPA|dmpa
263307|NCT02038335|etonogestrel|etonogestrel
263308|NCT02038335|subdermal implant|subdermal implant
263309|NCT02038335|NET-EN|net-en
263310|NCT02038335|Jadelle|jadelle
263311|NCT02038335|Implanon|implanon
263312|NCT02038335|Cyclofem|cyclofem
263313|NCT02038322|OTC Home Use Conception Aid Cervical Cap Insemination|otc home use conception aid cervical cap insemination
263314|NCT02038309|Acute coronary syndrome|acute coronary syndrome
263315|NCT02038309|persistent platelet reactivity|persistent platelet reactivity
263316|NCT02038296|Hepatocellular carcinoma|hepatocellular carcinoma
263317|NCT02038296|Transarterial chemoembolization|transarterial chemoembolization
263318|NCT02038296|Gemcitabine|gemcitabine
263319|NCT02038283|Colorectal Neoplasms|colorectal neoplasms
263320|NCT02038283|Early Detection of Cancer|early detection of cancer
263321|NCT02038283|Quality of Life|quality of life
263322|NCT02038283|Quality-Adjusted Life Years|quality-adjusted life years
263323|NCT02038283|Direct Service Costs|direct service costs
263324|NCT02038283|Cost-Benefit Analysis|cost-benefit analysis
263325|NCT02038231|Adolescence|adolescence
263326|NCT02038231|Substance abuse|substance abuse
263327|NCT02038231|Mindfulness|mindfulness
263328|NCT02038218|DM-CHOC-PEN|dm-choc-pen
263329|NCT02038218|CNS|cns
263330|NCT02038218|brain|brain
263331|NCT02038218|melanoma|melanoma
263332|NCT02038218|lung cancer|lung cancer
263333|NCT02038218|breast cancer|breast cancer
263334|NCT02038218|glioblastoma multiforme|glioblastoma multiforme
263335|NCT02038218|primary brain tumors|primary brain tumors
263336|NCT02038192|Caregiver|caregiver
263337|NCT02038192|Dementia|dementia
263338|NCT02038192|Long Term Care|long term care
263339|NCT02038192|Hope|hope
263340|NCT02038192|Quality of Life|quality of life
263341|NCT02038192|Intervention|intervention
263342|NCT02038179|Pre-hypertension|pre-hypertension
263343|NCT02038179|JNC 7 stage I hypertension|jnc 7 stage i hypertension
263344|NCT02038140|Primary Ankle Replacement|primary ankle replacement
263345|NCT02038140|Total Ankle Arthroplasty|total ankle arthroplasty
263346|NCT02038140|Total Ankle Replacement|total ankle replacement
263347|NCT02038140|Trabecular Metal Total Ankle|trabecular metal total ankle
263348|NCT02038114|Odette Cancer Centre at Sunnybrook Health Sciences Centre|odette cancer centre at sunnybrook health sciences centre
263349|NCT02038114|Toronto|toronto
263350|NCT02038114|Ontario|ontario
263351|NCT02038088|Need general anesthesia|need general anesthesia
263352|NCT02038075|suicide|suicide
263353|NCT02038075|suicidal ideation|suicidal ideation
263354|NCT02038075|military|military
263355|NCT02038075|veteran|veteran
263356|NCT02038075|cognitive behavioral therapy|cognitive behavioral therapy
263357|NCT02038075|behavioral therapy|behavioral therapy
263358|NCT02038075|psychotherapy|psychotherapy
263359|NCT02038075|Brief Cognitive Behavioral Therapy (BCBT)|brief cognitive behavioral therapy (bcbt)
263360|NCT02038075|Treatement As Usual (TAU)|treatement as usual (tau)
263361|NCT02038049|Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis, Magnetic Resonance Imaging, VAY736, monoclonal antibody, gadolinium [Gd]-enhancing lesions, B-Cell|multiple sclerosis, relapsing-remitting multiple sclerosis, magnetic resonance imaging, vay736, monoclonal antibody, gadolinium [gd]-enhancing lesions, b-cell
263362|NCT02038036|Polycythemia Vera|polycythemia vera
263363|NCT02038036|Hematologic Diseases|hematologic diseases
263364|NCT02038036|Myeloproliferative Disorders|myeloproliferative disorders
263365|NCT02038036|Bone Marrow Diseases|bone marrow diseases
263366|NCT02038036|Hydroxyurea|hydroxyurea
263367|NCT02038036|INC424|inc424
263368|NCT02038036|Ruxolitinib|ruxolitinib
263369|NCT02038023|Iv iron in pregnant women|iv iron in pregnant women
263370|NCT02038023|second and third trimester|second and third trimester
263371|NCT02037997|PFS|pfs
263372|NCT02037971|Systemic Lupus Erythematosus|systemic lupus erythematosus
263373|NCT02037971|Lupus|lupus
263374|NCT02037971|Sleep disorders|sleep disorders
263375|NCT02037971|Sleep disturbed|sleep disturbed
263376|NCT02037971|Physical exercise|physical exercise
263377|NCT02037971|Aerobic exercise|aerobic exercise
263378|NCT02037945|18F-Fluorocholine (18F-FCho)|18f-fluorocholine (18f-fcho)
263379|NCT02037945|Pet Scan|pet scan
263380|NCT02037945|MRI|mri
263381|NCT02037945|13-199|13-199
263382|NCT02037932|Aneurysm|aneurysm
263383|NCT02037932|Brain Aneurysm|brain aneurysm
263384|NCT02037906|Renal stones|renal stones
263385|NCT02037906|SWL|swl
263386|NCT02037880|Mucopolysaccharidosis|mucopolysaccharidosis
263387|NCT02037880|MPS|mps
263388|NCT02037880|Sanfilippo|sanfilippo
263389|NCT02037867|alcohol|alcohol
263390|NCT02037867|type 2 diabetes|type 2 diabetes
263391|NCT02037867|ALT|alt
263392|NCT02037867|abnormal liver enzymes|abnormal liver enzymes
263393|NCT02037867|hepatic fibrosis|hepatic fibrosis
263394|NCT02037867|cirrhosis|cirrhosis
263395|NCT02037841|Asthma|asthma
263396|NCT02037841|Nursing|nursing
263397|NCT02037841|Protocol|protocol
263398|NCT02037841|PRAM|pram
263399|NCT02037841|Length of Stay|length of stay
263400|NCT02037841|Weaning|weaning
263401|NCT02037841|Clinical pathway|clinical pathway
263402|NCT02037841|Asthma exacerbation|asthma exacerbation
263403|NCT02037828|COPD|copd
263404|NCT02037828|biomarker|biomarker
263405|NCT02037828|EBC|ebc
263406|NCT02037828|FEV1|fev1
263407|NCT02037815|hyperosmolar drugs|hyperosmolar drugs
263408|NCT02037815|mannitol|mannitol
263409|NCT02037815|hypertonic saline|hypertonic saline
263410|NCT02037815|serum osmolality|serum osmolality
263411|NCT02037815|correlation|correlation
263412|NCT02037802|caudal|caudal
263413|NCT02037802|epidural|epidural
263414|NCT02037802|pediatric|pediatric
263415|NCT02037802|renal|renal
263416|NCT02037802|transplant|transplant
263417|NCT02037802|hemodynamics|hemodynamics
263418|NCT02037789|pain|pain
263419|NCT02037789|low back pain|low back pain
263420|NCT02037789|GWAS|gwas
263421|NCT02037789|glycomics|glycomics
263422|NCT02037789|activomics|activomics
263423|NCT02037776|Rikkunshito|rikkunshito
263424|NCT02037776|Double blind|double blind
263425|NCT02037776|Functional dyspepsia (FD)|functional dyspepsia (fd)
263426|NCT02037763|Low back pain|low back pain
263427|NCT02037763|GWAS|gwas
263428|NCT02037763|Glycomics|glycomics
263429|NCT02037763|Activomics|activomics
263430|NCT02037763|Epigenetics|epigenetics
263431|NCT02037750|foster care|foster care
263432|NCT02037750|school adjustment|school adjustment
263433|NCT02037711|Laparoscopic|laparoscopic
263434|NCT02037711|Levobupivacaine|levobupivacaine
263435|NCT02037711|Pediatric|pediatric
263436|NCT02037711|Anesthesia|anesthesia
263437|NCT02037711|Instillation|instillation
263438|NCT02037711|surgeries|surgeries
263439|NCT02037698|CTO|cto
263440|NCT02037698|CT|ct
263441|NCT02037698|Revascularization|revascularization
263442|NCT02037685|Statins|statins
263443|NCT02037685|Cholesterol lowering medications|cholesterol lowering medications
263444|NCT02037685|Adherence|adherence
263445|NCT02037685|Motivational interviewing|motivational interviewing
263446|NCT02037685|Minority populations|minority populations
263447|NCT02037672|PCOS|pcos
263448|NCT02037672|PDE-4 inhibitor|pde-4 inhibitor
263449|NCT02037672|roflumilast|roflumilast
263450|NCT02037672|metformin|metformin
263451|NCT02037672|obesity|obesity
263452|NCT02037646|Colorectal cancer|colorectal cancer
263453|NCT02037646|Screening|screening
263454|NCT02037646|Fecal occult blood|fecal occult blood
263455|NCT02037646|Fecal immunochemical test|fecal immunochemical test
263456|NCT02037646|Qualitative|qualitative
263457|NCT02037646|Quantitative|quantitative
263458|NCT02037620|Epidural Stimulation|epidural stimulation
263459|NCT02037607|Deep vein thrombosis|deep vein thrombosis
263460|NCT02037607|Children|children
263461|NCT02037607|Pediatric|pediatric
263462|NCT02037607|Anti-coagulant|anti-coagulant
263463|NCT02037607|Neurosurgical procedures|neurosurgical procedures
263464|NCT02037607|Blood Clot|blood clot
263465|NCT02037594|HIV|hiv
263466|NCT02037594|Pre-exposure prophylaxis|pre-exposure prophylaxis
263467|NCT02037594|PrEP|prep
263468|NCT02037594|MSM|msm
263469|NCT02037594|Demonstration Project|demonstration project
263470|NCT02037581|integrated care|integrated care
263471|NCT02037581|hometreatment|hometreatment
263472|NCT02037581|assertive community treatment (ACT)|assertive community treatment (act)
263473|NCT02037581|psychosis|psychosis
263474|NCT02037581|schizophrenia|schizophrenia
263475|NCT02037581|bipolar disorder|bipolar disorder
263476|NCT02037581|first episode|first episode
263477|NCT02037568|depression|depression
263478|NCT02037568|stress|stress
263479|NCT02037568|caregiving|caregiving
263480|NCT02037568|anxiety|anxiety
263481|NCT02037568|psychoeducation intervention|psychoeducation intervention
263482|NCT02037568|psycho-oncology|psycho-oncology
263483|NCT02037568|allogeneic hematopoietic stem cell transplant|allogeneic hematopoietic stem cell transplant
263484|NCT02037555|Antithrombin|antithrombin
263485|NCT02037555|Cardiopulmonary bypass|cardiopulmonary bypass
263486|NCT02037542|BMI, Lipid profile|bmi, lipid profile
263487|NCT02037516|residual muscle weakness, respiratory events|residual muscle weakness, respiratory events
263488|NCT02037490|Infants|infants
263489|NCT02037490|Mothers|mothers
263490|NCT02037490|Social media|social media
263491|NCT02037490|Obesity prevention|obesity prevention
263492|NCT02037464|Prostate Cancer|prostate cancer
263493|NCT02037464|Active Surveillance|active surveillance
263494|NCT02037464|Radical Prostatectomy|radical prostatectomy
263495|NCT02037451|Parkinson's disease|parkinson's disease
263496|NCT02037451|Auditory Cueing|auditory cueing
263497|NCT02037438|Clinical sleep medicine|clinical sleep medicine
263498|NCT02037438|New methodology for healthcare delivery|new methodology for healthcare delivery
263499|NCT02037438|Diagnosis and treatment of sleep disorders|diagnosis and treatment of sleep disorders
263500|NCT02037438|Electronic health records|electronic health records
263501|NCT02037438|Clinical informatics|clinical informatics
263502|NCT02037438|Evidence-based comparative effectiveness research|evidence-based comparative effectiveness research
263503|NCT02037438|Sleep specialists|sleep specialists
263504|NCT02037438|Primary care providers|primary care providers
263505|NCT02037438|Allied health professionals|allied health professionals
263506|NCT02037438|Patient-centered care|patient-centered care
263507|NCT02037425|Chronic Migraine|chronic migraine
263508|NCT02037425|onabotulinumtoxinA|onabotulinumtoxina
263509|NCT02037425|Headache|headache
263510|NCT02037425|Migraine|migraine
263511|NCT02037425|Neuronal regrowth|neuronal regrowth
263512|NCT02037425|Botox|botox
263513|NCT02037412|Ticagrelor|ticagrelor
263514|NCT02037412|strut coverage|strut coverage
263515|NCT02037412|DES|des
263516|NCT02037412|ACS|acs
263517|NCT02037412|OCT|oct
263518|NCT02037399|Endoscopic submucosal dissection|endoscopic submucosal dissection
263519|NCT02037399|early gastric cancer|early gastric cancer
263520|NCT02037399|pain relief|pain relief
263521|NCT02037399|intravenous dexamethasone|intravenous dexamethasone
263522|NCT02037399|present pain intensity|present pain intensity
263523|NCT02037386|Side branch stent|side branch stent
263524|NCT02037386|Coronary bifurcation lesion|coronary bifurcation lesion
263525|NCT02037373|intra and post-op coagulopathy in patients undergoing OLT|intra and post-op coagulopathy in patients undergoing olt
263526|NCT02037360|Smoking|smoking
263527|NCT02037360|Cessation|cessation
263528|NCT02037334|Preterm delivery|preterm delivery
263529|NCT02037334|Diagnostics|diagnostics
263530|NCT02037334|Biomechanics|biomechanics
263531|NCT02037321|Systematic review and meta-analysis|systematic review and meta-analysis
263532|NCT02037308|Glu298Asp polymorphism|glu298asp polymorphism
263533|NCT02037308|Blood pressure|blood pressure
263534|NCT02037308|Plasma NOx|plasma nox
263535|NCT02037308|Beetroot|beetroot
263536|NCT02037295|Gut Microbiota|gut microbiota
263537|NCT02037295|Obesity|obesity
263538|NCT02037295|Absorption|absorption
263539|NCT02037295|Overfeeding|overfeeding
263540|NCT02037282|HAI Titer|hai titer
263541|NCT02037282|Hemagglutination Inhibition Assays|hemagglutination inhibition assays
263542|NCT02037282|Immunogenicity|immunogenicity
263543|NCT02037282|Serum Antibody Response|serum antibody response
263544|NCT02037269|Cerenkov Luminescence Imaging, CLI, margin status|cerenkov luminescence imaging, cli, margin status
263545|NCT02037243|behavior change|behavior change
263546|NCT02037243|handwashing|handwashing
263547|NCT02037243|water treatment|water treatment
263548|NCT02037243|disgust|disgust
263549|NCT02037243|shame|shame
263550|NCT02037243|neighbour|neighbour
263551|NCT02037243|willingness to pay|willingness to pay
263552|NCT02037204|IMPACT|impact
263553|NCT02037204|Chondrons|chondrons
263554|NCT02037204|Mesenchymal stem cells|mesenchymal stem cells
263555|NCT02037204|Allogeneic MSCs|allogeneic mscs
263556|NCT02037204|single-stage|single-stage
263557|NCT02037204|Cartilage repair|cartilage repair
263558|NCT02037204|Safety|safety
263559|NCT02037204|Efficacy|efficacy
263560|NCT02037191|ALOPECIA AREATA|alopecia areata
263561|NCT02037191|TREATMENT METHOTREXATE|treatment methotrexate
263562|NCT02037178|Peripheral Obliterative Arteriopathy of the legs|peripheral obliterative arteriopathy of the legs
263563|NCT02037178|Screening by generalists|screening by generalists
263564|NCT02037178|Ultrasound|ultrasound
263565|NCT02037152|Chronic pain|chronic pain
263566|NCT02037152|Mobile applications|mobile applications
263567|NCT02037152|Mindfulness|mindfulness
263568|NCT02037152|Meditation|meditation
263569|NCT02037152|Telemedicine|telemedicine
263570|NCT02037152|Cellular phone|cellular phone
263571|NCT02037152|Pain Management|pain management
263572|NCT02037152|Therapy, computer-assisted|therapy, computer-assisted
263573|NCT02037139|Hearing loss|hearing loss
263574|NCT02037139|Screening|screening
263575|NCT02037139|Primary Care|primary care
263576|NCT02037113|IVUS|ivus
263577|NCT02037113|PAD|pad
263578|NCT02037113|Femoro-popliteal disease|femoro-popliteal disease
263579|NCT02037113|Intravascular ultrasound|intravascular ultrasound
263580|NCT02037087|Short Message Service|short message service
263581|NCT02037087|newborn health|newborn health
263582|NCT02037087|maternal behavior|maternal behavior
263583|NCT02037087|good household pregnancy practice|good household pregnancy practice
263584|NCT02037087|care seeking|care seeking
263585|NCT02037074|Phosphodiesterase 10 inhibitor|phosphodiesterase 10 inhibitor
263586|NCT02037022|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
263587|NCT02037022|Autism|autism
263588|NCT02036983|Ultrasound guided|ultrasound guided
263589|NCT02036983|Bilateral Transversus abdominis Plane Block|bilateral transversus abdominis plane block
263590|NCT02036983|Dexamethasone|dexamethasone
263591|NCT02036983|Preperitoneal Instillation|preperitoneal instillation
263592|NCT02036983|Local Analgesic|local analgesic
263593|NCT02036983|Efficacy|efficacy
263594|NCT02036983|Total Extraperitoneal Bilateral Inguinal hernia repair|total extraperitoneal bilateral inguinal hernia repair
263595|NCT02036970|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
263596|NCT02036970|PAH|pah
263597|NCT02036970|Bardoxolone methyl|bardoxolone methyl
263598|NCT02036970|6-minute walk distance|6-minute walk distance
263599|NCT02036970|CDDO-me|cddo-me
263600|NCT02036970|RTA 402|rta 402
263601|NCT02036970|Pulmonary Hypertension|pulmonary hypertension
263602|NCT02036970|Interstitial Lung Disease|interstitial lung disease
263993|NCT02035150|cholesterol|cholesterol
263603|NCT02036970|Idiopathic Interstitial Pneumonia|idiopathic interstitial pneumonia
263604|NCT02036970|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
263605|NCT02036970|Sarcoidosis|sarcoidosis
263606|NCT02036970|Respiratory Bronchiolitis Associated ILD|respiratory bronchiolitis associated ild
263607|NCT02036970|Desquamative Interstitial Pneumonia|desquamative interstitial pneumonia
263608|NCT02036970|Cryptogenic Organizing Pneumonia|cryptogenic organizing pneumonia
263609|NCT02036970|Acute Interstitial Pneumonitis|acute interstitial pneumonitis
263610|NCT02036970|Idiopathic Lymphoid Interstitial Pneumonia|idiopathic lymphoid interstitial pneumonia
263611|NCT02036970|Idiopathic Pleuroparenchymal Fibroelastosis|idiopathic pleuroparenchymal fibroelastosis
263612|NCT02036957|capecitabine|capecitabine
263613|NCT02036957|dermatologic toxicity|dermatologic toxicity
263614|NCT02036944|Celiac Disease|celiac disease
263615|NCT02036944|Celiac Sprue|celiac sprue
263616|NCT02036944|Iron-Deficiency Anemia|iron-deficiency anemia
263617|NCT02036931|Joint|joint
263618|NCT02036931|Osteoarthritis|osteoarthritis
263619|NCT02036931|Avascular Necrosis|avascular necrosis
263620|NCT02036918|castrate resistant prostate cancer|castrate resistant prostate cancer
263621|NCT02036918|metastatic|metastatic
263622|NCT02036918|sipuleucel-T|sipuleucel-t
263623|NCT02036918|lymphadenectomy|lymphadenectomy
263624|NCT02036918|Excisional lymph node biopsy|excisional lymph node biopsy
263625|NCT02036905|neck pain, orthopedic manual therapy|neck pain, orthopedic manual therapy
263626|NCT02036892|Diabetes|diabetes
263627|NCT02036879|Cystic Fibrosis|cystic fibrosis
263628|NCT02036879|Loestrin|loestrin
263629|NCT02036879|Hormone|hormone
263630|NCT02036866|knee osteoarthritis|knee osteoarthritis
263631|NCT02036866|grade I and II knee osteoarthritis|grade i and ii knee osteoarthritis
263632|NCT02036866|arthritis|arthritis
263633|NCT02036853|Triheptanoin|triheptanoin
263634|NCT02036853|Glut1 DS|glut1 ds
263635|NCT02036853|Epilepsy|epilepsy
263636|NCT02036853|Seizures|seizures
263637|NCT02036827|Pain, Postoperative|pain, postoperative
263638|NCT02036827|Neuromuscular Blocking Agents|neuromuscular blocking agents
263639|NCT02036827|Laparoscopy|laparoscopy
263640|NCT02036814|Hypertension|hypertension
263641|NCT02036814|Nursing|nursing
263642|NCT02036814|Therapeutic compliance|therapeutic compliance
263643|NCT02036814|Quality of life|quality of life
263644|NCT02036814|Health education|health education
263645|NCT02036801|ARDS|ards
263646|NCT02036801|Lung|lung
263647|NCT02036801|Specific Elastance|specific elastance
263648|NCT02036801|Pediatric patients|pediatric patients
263649|NCT02036788|Esophageal pressure, Mechanical ventilation|esophageal pressure, mechanical ventilation
263650|NCT02036762|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
263651|NCT02036762|Thoracoabdominal Mechanics|thoracoabdominal mechanics
263652|NCT02036762|Functional capacity|functional capacity
263653|NCT02036762|Quality of life|quality of life
263654|NCT02036736|Orthopedic Surgery|orthopedic surgery
263655|NCT02036736|Total hip prosthesis|total hip prosthesis
263656|NCT02036736|Total knee replacement|total knee replacement
263657|NCT02036736|Intraoperative anesthetic strategy|intraoperative anesthetic strategy
263658|NCT02036736|Propofol|propofol
263659|NCT02036736|Desflurane|desflurane
263660|NCT02036723|Macular Degeneration|macular degeneration
263661|NCT02036723|Eye Diseases|eye diseases
263662|NCT02036723|Neovascular Macular Degeneration|neovascular macular degeneration
263663|NCT02036723|Choroidal Neovascularization|choroidal neovascularization
263664|NCT02036723|Geographic Atrophy|geographic atrophy
263665|NCT02036710|GLP-1|glp-1
263666|NCT02036710|PYY|pyy
263667|NCT02036710|Leptin|leptin
263668|NCT02036710|Duodenal Switch|duodenal switch
263669|NCT02036697|Cesarean section|cesarean section
263670|NCT02036697|spinal anesthesia|spinal anesthesia
263671|NCT02036697|low dose spinal|low dose spinal
263672|NCT02036697|bupivacaine|bupivacaine
263673|NCT02036697|hemodynamics|hemodynamics
263674|NCT02036697|blood pressure|blood pressure
263675|NCT02036697|cardiac output|cardiac output
263676|NCT02036684|Prostate cancer|prostate cancer
263677|NCT02036684|Radical prostatectomy|radical prostatectomy
263678|NCT02036684|Prehabilitation|prehabilitation
263679|NCT02036684|Pelvic floor muscle exercises|pelvic floor muscle exercises
263680|NCT02036671|Arteriovenous fistula|arteriovenous fistula
263681|NCT02036671|Fistula|fistula
263682|NCT02036671|Chronic kidney disease|chronic kidney disease
263683|NCT02036671|Percutaneous|percutaneous
263684|NCT02036671|Kidney Disease|kidney disease
263685|NCT02036671|Kidney Failure, Chronic|kidney failure, chronic
263686|NCT02036671|Urologic Diseases|urologic diseases
263687|NCT02036671|Renal Insufficiency, Chronic|renal insufficiency, chronic
263688|NCT02036671|Renal Insufficiency|renal insufficiency
263689|NCT02036671|CKD|ckd
263690|NCT02036671|hemodialysis|hemodialysis
263691|NCT02036658|social anxiety|social anxiety
263692|NCT02036658|treatment|treatment
263693|NCT02036658|cognitive-behavioral therapy|cognitive-behavioral therapy
263694|NCT02036658|mindfulness-based stress reduction|mindfulness-based stress reduction
263695|NCT02036658|emotion regulation|emotion regulation
263696|NCT02036658|randomized controlled trial|randomized controlled trial
263697|NCT02036658|neuroimaging|neuroimaging
263698|NCT02036658|functional magnetic resonance imaging|functional magnetic resonance imaging
263699|NCT02036658|mediators|mediators
263700|NCT02036658|mechanisms|mechanisms
263701|NCT02036619|gestational diabetes|gestational diabetes
263702|NCT02036619|pregestational diabetes|pregestational diabetes
263703|NCT02036619|screening|screening
263704|NCT02036619|diagnostic criteria|diagnostic criteria
263705|NCT02036619|IADPSG|iadpsg
263706|NCT02036593|Cardiovascular Risk Factors|cardiovascular risk factors
263707|NCT02036580|Japan|japan
263708|NCT02036580|Phase2|phase2
263709|NCT02036580|Safety|safety
263710|NCT02036580|Tolerability|tolerability
263711|NCT02036580|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
263712|NCT02036580|IPF|ipf
263713|NCT02036580|CAT-354|cat-354
263714|NCT02036580|Tralokinumab|tralokinumab
263715|NCT02036541|Glaucoma Implant|glaucoma implant
263716|NCT02036541|Trabeculectomy|trabeculectomy
263717|NCT02036541|POAG|poag
263718|NCT02036541|Primary Open Angle Glaucoma|primary open angle glaucoma
263719|NCT02036541|Pseudoexfoliation Glaucoma|pseudoexfoliation glaucoma
263720|NCT02036541|Pigmentary Glaucoma|pigmentary glaucoma
263721|NCT02036528|Foot Ulcer|foot ulcer
263722|NCT02036528|Diabetic Foot|diabetic foot
263723|NCT02036528|Gentamicins|gentamicins
263724|NCT02036528|infection|infection
263725|NCT02036502|PD1|pd1
263726|NCT02036502|PD-1|pd-1
263727|NCT02036502|PDL1|pdl1
263728|NCT02036502|PD-L1|pd-l1
263729|NCT02036476|Merkel Cell Carcinoma|merkel cell carcinoma
263730|NCT02036476|Skin Cancer|skin cancer
263731|NCT02036463|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
263732|NCT02036463|Corticosteroids|corticosteroids
263733|NCT02036450|atrial fibrillation|atrial fibrillation
263734|NCT02036450|cardiac arrhythmia|cardiac arrhythmia
263735|NCT02036450|stroke|stroke
263736|NCT02036450|implantable loop recorder|implantable loop recorder
263737|NCT02036450|bleeding|bleeding
263738|NCT02036450|anticoagulation|anticoagulation
263739|NCT02036450|hypertension|hypertension
263740|NCT02036450|diabetes|diabetes
263741|NCT02036450|heart failure|heart failure
263742|NCT02036450|mortality|mortality
263743|NCT02036437|Induction of Labor|induction of labor
263744|NCT02036437|Misoprostol|misoprostol
263745|NCT02036411|clomiphene citrate|clomiphene citrate
263746|NCT02036411|amh|amh
263747|NCT02036411|inhibin b|inhibin b
263748|NCT02036398|Percutaneous Nephrolithotomy (PCNL)|percutaneous nephrolithotomy (pcnl)
263749|NCT02036398|Nephrostomy|nephrostomy
263750|NCT02036398|Double J stent|double j stent
263751|NCT02036398|PleuraL Effusion|pleural effusion
263752|NCT02036398|Pain|pain
263753|NCT02036372|glucose|glucose
263754|NCT02036372|diabetes mellitus|diabetes mellitus
263755|NCT02036372|perioperative|perioperative
263756|NCT02036359|Non-small Cell Lung Cancer(NSCLC)|non-small cell lung cancer(nsclc)
263757|NCT02036346|ileostomy|ileostomy
263758|NCT02036346|colorectal resection|colorectal resection
263759|NCT02036346|dehydration|dehydration
263760|NCT02036346|nutritional status|nutritional status
263761|NCT02036333|near infrared spectroscopy|near infrared spectroscopy
263762|NCT02036333|pediatrics|pediatrics
263763|NCT02036307|Fish oils|fish oils
263764|NCT02036307|Triglycerides|triglycerides
263765|NCT02036307|Blood pressure|blood pressure
263766|NCT02036294|Patient self-care behaviors|patient self-care behaviors
263767|NCT02036294|Patient activation|patient activation
263768|NCT02036294|Family caregiver support|family caregiver support
263769|NCT02036294|Patient-centered care|patient-centered care
263770|NCT02036281|Terminally ill , histologically-confirmed advanced cancer|terminally ill , histologically-confirmed advanced cancer
263771|NCT02036281|Pain unrelieved by opioids|pain unrelieved by opioids
263772|NCT02036268|Ostomy education|ostomy education
263773|NCT02036268|Education|education
263774|NCT02036268|care of ostomy site|care of ostomy site
263775|NCT02036255|Prevention, Thrombosis, Hemodialysis, Vascular access device|prevention, thrombosis, hemodialysis, vascular access device
263776|NCT02036242|Opioid|opioid
263777|NCT02036242|Local anesthetic|local anesthetic
263778|NCT02036242|Labor delivery|labor delivery
263779|NCT02036242|Safety|safety
263780|NCT02036229|demodex|demodex
263781|NCT02036229|demodicidosis|demodicidosis
263782|NCT02036229|rosacea|rosacea
263783|NCT02036229|ivermectin|ivermectin
263784|NCT02036216|Hepatocellular Carcinoma；cell free tumor DNA; Mutation;|hepatocellular carcinoma；cell free tumor dna; mutation;
263785|NCT02036190|COPD, chronic obstructive pulmonary disease, emphysema|copd, chronic obstructive pulmonary disease, emphysema
263786|NCT02036164|Locally advanced cervical cancer|locally advanced cervical cancer
263787|NCT02036164|Concurrent chemoradiation|concurrent chemoradiation
263788|NCT02036164|Adjuvant chemotherapy|adjuvant chemotherapy
263789|NCT02036151|Xylitol|xylitol
263790|NCT02036151|prevention|prevention
263791|NCT02036151|Mutans streptococci|mutans streptococci
263792|NCT02036151|caries|caries
263793|NCT02036151|plaque|plaque
263794|NCT02036151|children|children
263795|NCT02036125|Corticosteroid|corticosteroid
263796|NCT02036125|Ultrasound|ultrasound
263797|NCT02036125|Guided injection|guided injection
263891|NCT02035631|Motor Activity|motor activity
263798|NCT02036112|Advanced Lower rectal cancer|advanced lower rectal cancer
263799|NCT02036112|Extralevator abdominoperineal excision|extralevator abdominoperineal excision
263800|NCT02036112|Circumferential resection margin|circumferential resection margin
263801|NCT02036112|Morbidity|morbidity
263802|NCT02036112|Survival|survival
263803|NCT02036099|Dementia|dementia
263804|NCT02036099|Automobile driving|automobile driving
263805|NCT02036099|Accidents, traffic|accidents, traffic
263806|NCT02036086|Melanoma stage IIIB or C with BRAF mutation|melanoma stage iiib or c with braf mutation
263807|NCT02036086|Recurrent regional lymphadenopathy not suitable for surgery|recurrent regional lymphadenopathy not suitable for surgery
263808|NCT02036086|Eligible for neoadjuvant vemurafenib and cobimetinib|eligible for neoadjuvant vemurafenib and cobimetinib
263809|NCT02036073|erythropoietin|erythropoietin
263810|NCT02036073|preterm|preterm
263811|NCT02036073|brain injury|brain injury
263812|NCT02036073|cerebral palsy|cerebral palsy
263813|NCT02036073|PVL|pvl
263814|NCT02036060|Metastatic prostate cancer|metastatic prostate cancer
263815|NCT02036060|Abiraterone acetate|abiraterone acetate
263816|NCT02036021|pediatric anesthesia|pediatric anesthesia
263817|NCT02036021|perioperative respiratory events|perioperative respiratory events
263818|NCT02036021|days of hospitalization|days of hospitalization
263819|NCT02036021|cost of hospitalization|cost of hospitalization
263820|NCT02036008|Liver metastases|liver metastases
263821|NCT02036008|MRI|mri
263822|NCT02036008|Contrast Agents|contrast agents
263823|NCT02035995|gestational diabetes mellitus; optical coherence tomography; pregnancy; retinal nerve fiber layer.|gestational diabetes mellitus; optical coherence tomography; pregnancy; retinal nerve fiber layer.
263824|NCT02035956|IVAC MUTANOME|ivac mutanome
263825|NCT02035956|IVAC|ivac
263826|NCT02035956|personalized therapy|personalized therapy
263827|NCT02035956|personalized immuno therapy|personalized immuno therapy
263828|NCT02035956|RB_0004-01|rb_0004-01
263829|NCT02035956|Ribological|ribological
263830|NCT02035956|Melanoma|melanoma
263831|NCT02035956|cancer vaccine|cancer vaccine
263832|NCT02035930|Bispectral Index Monitor, Menstrual Cycle, Dexmedetomidine|bispectral index monitor, menstrual cycle, dexmedetomidine
263833|NCT02035891|colchicine|colchicine
263834|NCT02035891|urinary albumin-to-creatinine ratio|urinary albumin-to-creatinine ratio
263835|NCT02035891|carotid Intima-Media Thickness|carotid intima-media thickness
263836|NCT02035891|overt nephropathy|overt nephropathy
263837|NCT02035891|Type 2 diabetes|type 2 diabetes
263838|NCT02035878|anxiety|anxiety
263839|NCT02035878|depression|depression
263840|NCT02035878|probiotics|probiotics
263841|NCT02035878|adult|adult
263842|NCT02035878|human|human
263843|NCT02035878|depression anxiety stress scale|depression anxiety stress scale
263844|NCT02035878|anxiety sensitivity index|anxiety sensitivity index
263845|NCT02035865|Psychiatric morbidity|psychiatric morbidity
263846|NCT02035865|Cognitive function|cognitive function
263847|NCT02035865|Heart transplantation|heart transplantation
263848|NCT02035865|Mortality|mortality
263849|NCT02035865|Cardiac allograft vasculopathy|cardiac allograft vasculopathy
263850|NCT02035839|Target Temperature Management|target temperature management
263851|NCT02035839|Cooling comatose survivors from OHCA|cooling comatose survivors from ohca
263852|NCT02035839|Good neurological outcome at modified Rankin Score (mRS) ≤ 3|good neurological outcome at modified rankin score (mrs) ≤ 3
263853|NCT02035813|metastatic breast cancer|metastatic breast cancer
263854|NCT02035813|circulating tumor cells|circulating tumor cells
263855|NCT02035813|everolimus|everolimus
263856|NCT02035813|eribulin|eribulin
263857|NCT02035800|Rheumatoid Arthritis|rheumatoid arthritis
263858|NCT02035800|Adalimumab|adalimumab
263859|NCT02035800|Humira|humira
263860|NCT02035787|metformin|metformin
263861|NCT02035787|endometrial cancer|endometrial cancer
263862|NCT02035787|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
263863|NCT02035787|complex atypical hyperplasia|complex atypical hyperplasia
263864|NCT02035774|Brachial plexus block|brachial plexus block
263865|NCT02035774|Suprascapular nerve block|suprascapular nerve block
263866|NCT02035761|MSA|msa
263867|NCT02035761|Shy-Dragers Syndrome|shy-dragers syndrome
263868|NCT02035761|Possible or Probable|possible or probable
263869|NCT02035748|Vitreomacular traction|vitreomacular traction
263870|NCT02035748|Symptomatic vitreomacular adhesion|symptomatic vitreomacular adhesion
263871|NCT02035748|Ocriplasmin|ocriplasmin
263872|NCT02035748|JETREA|jetrea
263873|NCT02035735|NBI,|nbi,
263874|NCT02035735|squamous cell carcinoma,|squamous cell carcinoma,
263875|NCT02035735|pharynx, larynx, surgical margins.|pharynx, larynx, surgical margins.
263876|NCT02035709|Therapy|therapy
263877|NCT02035696|influenza|influenza
263878|NCT02035696|children|children
263879|NCT02035696|safety|safety
263880|NCT02035696|tolerability|tolerability
263881|NCT02035696|immunogenicity|immunogenicity
263882|NCT02035683|metabolic response|metabolic response
263883|NCT02035683|chemotherapy|chemotherapy
263884|NCT02035670|diagnostic strategy|diagnostic strategy
263885|NCT02035670|effectiveness|effectiveness
263886|NCT02035670|fever of unknown origin|fever of unknown origin
263887|NCT02035657|Merkel cell carcinoma|merkel cell carcinoma
263888|NCT02035657|MCC|mcc
263889|NCT02035631|Breast Neoplasms|breast neoplasms
263893|NCT02035631|Quality of Life|quality of life
263894|NCT02035579|concussion|concussion
263895|NCT02035579|mild traumatic brain injury|mild traumatic brain injury
263896|NCT02035579|post-concussion syndrome|post-concussion syndrome
263897|NCT02035579|adolescents|adolescents
263898|NCT02035579|sports injury|sports injury
263899|NCT02035579|aerobic training|aerobic training
263900|NCT02035579|stretching training|stretching training
263901|NCT02035566|Minority Health|minority health
263902|NCT02035566|Health Status Disparities|health status disparities
263903|NCT02035566|Health Care Disparities|health care disparities
263904|NCT02035566|Rural Health|rural health
263905|NCT02035566|Telemedicine|telemedicine
263906|NCT02035566|Health Services Research|health services research
263907|NCT02035566|Social Determinants of Health|social determinants of health
263908|NCT02035566|Ecological Theory of Health|ecological theory of health
263909|NCT02035527|squamous cell carcinoma|squamous cell carcinoma
263910|NCT02035527|head and neck|head and neck
263911|NCT02035514|multiple sclerosis|multiple sclerosis
263912|NCT02035514|mesenchymal stem cells|mesenchymal stem cells
263913|NCT02035514|autologous transplantation|autologous transplantation
263914|NCT02035514|MRI efficacy|mri efficacy
263915|NCT02035514|clinical safety|clinical safety
263916|NCT02035488|Dry powder inhalation|dry powder inhalation
263917|NCT02035488|Bronchiectasis|bronchiectasis
263918|NCT02035488|Tobramycin|tobramycin
263919|NCT02035475|Prevention|prevention
263920|NCT02035475|Pelvic Lymph Node Dissection|pelvic lymph node dissection
263921|NCT02035475|Lymphoceles|lymphoceles
263922|NCT02035475|Prostate Malignancies|prostate malignancies
263923|NCT02035475|daVinci|davinci
263924|NCT02035475|Vessel Sealer|vessel sealer
263925|NCT02035475|EndoWrist One|endowrist one
263926|NCT02035449|Video laryngoscope|video laryngoscope
263927|NCT02035449|Pre-hospital|pre-hospital
263928|NCT02035449|Endotracheal intubation|endotracheal intubation
263929|NCT02035449|Difficult endotracheal intubation|difficult endotracheal intubation
263930|NCT02035449|Pre hospital Critical care|pre hospital critical care
263931|NCT02035449|McGrath MAC|mcgrath mac
263932|NCT02035449|Airway device|airway device
263933|NCT02035436|Respiration, artificial|respiration, artificial
263934|NCT02035436|Critcal care|critcal care
263935|NCT02035423|Vitamin D Deficiency|vitamin d deficiency
263936|NCT02035423|Compliance|compliance
263937|NCT02035423|Milk|milk
263938|NCT02035410|cardiac devices|cardiac devices
263939|NCT02035410|prevention|prevention
263940|NCT02035410|infection|infection
263941|NCT02035397|botulinum toxin|botulinum toxin
263942|NCT02035397|Endoscopy|endoscopy
263943|NCT02035397|Satiation|satiation
263944|NCT02035397|Diet|diet
263945|NCT02035397|Weight Loss|weight loss
263946|NCT02035358|Metastatic|metastatic
263947|NCT02035358|Recurrent|recurrent
263948|NCT02035358|Refractory|refractory
263949|NCT02035358|Renal Cell Carcinoma|renal cell carcinoma
263950|NCT02035358|Kidney|kidney
263951|NCT02035358|clear-cell renal cancer|clear-cell renal cancer
263952|NCT02035358|Cancer|cancer
263953|NCT02035345|Recurrent Ovarian Cancer|recurrent ovarian cancer
263954|NCT02035345|Platinum Sensitive Ovarian Cancer|platinum sensitive ovarian cancer
263955|NCT02035332|Excessive Uterine Bleeding|excessive uterine bleeding
263956|NCT02035332|Menorrhagia|menorrhagia
263957|NCT02035332|Endometrial Ablation|endometrial ablation
263958|NCT02035293|COPD Exacerbation|copd exacerbation
263959|NCT02035293|Pulmonary embolism|pulmonary embolism
263960|NCT02035293|Standardized and consensus diagnostic strategy|standardized and consensus diagnostic strategy
263961|NCT02035280|Spine|spine
263962|NCT02035280|Deformity|deformity
263963|NCT02035280|Fusion|fusion
263964|NCT02035280|Elderly|elderly
263965|NCT02035280|SRS-22r|srs-22r
263966|NCT02035241|Spices|spices
263967|NCT02035241|Herbs|herbs
263968|NCT02035241|Functional food|functional food
263969|NCT02035241|Cardiometabolic risk|cardiometabolic risk
263970|NCT02035241|Metabolic syndrome|metabolic syndrome
263971|NCT02035241|Inflammation|inflammation
263972|NCT02035241|Appetite|appetite
263973|NCT02035241|Gut hormone|gut hormone
263974|NCT02035228|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
263975|NCT02035228|Lung Hyperinflation|lung hyperinflation
263976|NCT02035228|Abdominal Muscle|abdominal muscle
263977|NCT02035228|Functional Electrical Stimulation|functional electrical stimulation
263978|NCT02035215|Hyperlipidemia, Familial Combined|hyperlipidemia, familial combined
263979|NCT02035215|Omega 3 acids ethylesters 90|omega 3 acids ethylesters 90
263980|NCT02035215|Atorvastatin|atorvastatin
263981|NCT02035176|autism|autism
263982|NCT02035176|ADHD|adhd
263983|NCT02035176|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
263984|NCT02035176|behavioral assessment|behavioral assessment
263985|NCT02035176|behavior|behavior
263986|NCT02035163|Atrial fibrillation|atrial fibrillation
263987|NCT02035163|coronary artery bypass graft|coronary artery bypass graft
263988|NCT02035163|cryoablation|cryoablation
263989|NCT02035163|ganglionic plexi|ganglionic plexi
263990|NCT02035150|breakfast|breakfast
263991|NCT02035150|oatmeal|oatmeal
263992|NCT02035150|appetite|appetite
263994|NCT02035124|Prostate|prostate
263995|NCT02035124|Metastatic|metastatic
263996|NCT02035124|Refractory|refractory
263997|NCT02035124|mCRPC|mcrpc
263998|NCT02035111|Migraine|migraine
263999|NCT02035111|Tianshu capsule|tianshu capsule
264000|NCT02035098|cancer, pain, cluster trial, quality improvement|cancer, pain, cluster trial, quality improvement
264001|NCT02035085|19F MRI|19f mri
264002|NCT02035059|Oral Glucose Tolerance Test|oral glucose tolerance test
264003|NCT02035059|Fibronectin|fibronectin
264004|NCT02035059|Adiponectin|adiponectin
264005|NCT02035059|Copeptin|copeptin
264006|NCT02035059|Cortisol|cortisol
264007|NCT02035046|Gitelman|gitelman
264008|NCT02035046|Heterozygous SLC12A3 mutation|heterozygous slc12a3 mutation
264009|NCT02035046|Blood pressure|blood pressure
264010|NCT02035046|Hypokalemia|hypokalemia
264011|NCT02035020|frataxin, gamma interferon, Friedreich ataxia|frataxin, gamma interferon, friedreich ataxia
264012|NCT02034994|school-based intervention|school-based intervention
264013|NCT02034994|after school physical activity|after school physical activity
264014|NCT02034994|sugar sweetened beverages|sugar sweetened beverages
264015|NCT02034994|sedentary behavior|sedentary behavior
264016|NCT02034994|schoolchildren|schoolchildren
264017|NCT02034981|metastatic or unresectable locally advanced malignancies.|metastatic or unresectable locally advanced malignancies.
264018|NCT02034981|genomic alterations.|genomic alterations.
264019|NCT02034981|biological crizotinib targets (ALK, MET, ROS1, RON, AXL).|biological crizotinib targets (alk, met, ros1, ron, axl).
264020|NCT02034968|Nimotuzumab|nimotuzumab
264021|NCT02034968|Nab-Paclitaxel|nab-paclitaxel
264022|NCT02034968|Carcinoma of Esophagus|carcinoma of esophagus
264023|NCT02034955|Prostate Cancer|prostate cancer
264024|NCT02034955|Adaptive Radiotherapy|adaptive radiotherapy
264025|NCT02034955|Prostatectomy|prostatectomy
264026|NCT02034955|Patients who had a prostatectomy|patients who had a prostatectomy
264027|NCT02034942|non-sedation|non-sedation
264028|NCT02034929|colon cancer|colon cancer
264029|NCT02034929|adenoma|adenoma
264030|NCT02034929|colon polyps|colon polyps
264031|NCT02034916|Breast cancer|breast cancer
264032|NCT02034916|BRCA mutation|brca mutation
264033|NCT02034916|PARP inhibitor|parp inhibitor
264034|NCT02034916|BRCA 1|brca 1
264035|NCT02034916|BRCA 2|brca 2
264036|NCT02034903|Enteral Feeding|enteral feeding
264037|NCT02034903|Infant, Premature|infant, premature
264038|NCT02034890|orthotopic neobladder|orthotopic neobladder
264039|NCT02034890|urinary tract infection|urinary tract infection
264040|NCT02034890|intravesical instillation|intravesical instillation
264041|NCT02034890|hyaluronic acid|hyaluronic acid
264042|NCT02034877|13-valent pneunococcal conjugate vaccine|13-valent pneunococcal conjugate vaccine
264043|NCT02034877|pneumococcal disease prevention; safety and immunogenicity study|pneumococcal disease prevention; safety and immunogenicity study
264044|NCT02034864|low back pain|low back pain
264045|NCT02034864|manual therapy|manual therapy
264046|NCT02034864|randomizer controlled trial|randomizer controlled trial
264047|NCT02034851|Acute pyelonephritis|acute pyelonephritis
264048|NCT02034851|Renal scarring|renal scarring
264049|NCT02034851|Dexamethasone|dexamethasone
264050|NCT02034851|Children|children
264051|NCT02034851|Corticoids|corticoids
264052|NCT02034851|Complementary treatment|complementary treatment
264053|NCT02034851|Prevention strategy|prevention strategy
264054|NCT02034838|PK|pk
264055|NCT02034838|pharmacokinetic|pharmacokinetic
264056|NCT02034838|HIV-infected|hiv-infected
264057|NCT02034838|atazanavir|atazanavir
264058|NCT02034838|ritonavir|ritonavir
264059|NCT02034786|Mesenchymal stem cell|mesenchymal stem cell
264060|NCT02034786|Hyaluronic acid|hyaluronic acid
264061|NCT02034786|Adipose Tissue|adipose tissue
264062|NCT02034786|Filler Agent|filler agent
264063|NCT02034773|Safety, Pharmacokinetics, Pharmacodynamics, Healthy Subjects|safety, pharmacokinetics, pharmacodynamics, healthy subjects
264064|NCT02034760|Frailty|frailty
264065|NCT02034760|Ageing|ageing
264066|NCT02034760|Protein supplementation|protein supplementation
264067|NCT02034760|Protein quality|protein quality
264068|NCT02034760|Gut microbiota|gut microbiota
264069|NCT02034760|Metabolome|metabolome
264070|NCT02034760|Exercise training|exercise training
264071|NCT02034760|Sarcopenia|sarcopenia
264072|NCT02034747|Advagraf|advagraf
264073|NCT02034747|kidney transplant|kidney transplant
264074|NCT02034747|Corticosteroid|corticosteroid
264075|NCT02034747|Immunosuppressive regimen|immunosuppressive regimen
264076|NCT02034734|Phase 1|phase 1
264077|NCT02034734|ASP3652|asp3652
264078|NCT02034734|Cerebrospinal fluid (CSF)|cerebrospinal fluid (csf)
264079|NCT02034734|Multiple doses|multiple doses
264080|NCT02034721|Muscle damage|muscle damage
264081|NCT02034721|Muscle soreness|muscle soreness
264082|NCT02034721|Muscle function|muscle function
264083|NCT02034721|Innate immune function|innate immune function
264084|NCT02034721|Inflammation|inflammation
264085|NCT02034708|Primary brain tumor|primary brain tumor
264086|NCT02034695|Diabetes mellitus|diabetes mellitus
264087|NCT02034669|Acute Spinal cord Injury, Adipose derived stem cells|acute spinal cord injury, adipose derived stem cells
264088|NCT02034656|imatinib resistance|imatinib resistance
264089|NCT02034656|mutation|mutation
264090|NCT02034630|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
264091|NCT02034617|Cognition|cognition
264092|NCT02034617|Family nursing|family nursing
264093|NCT02034617|Infant, premature|infant, premature
264094|NCT02034617|Object attachment|object attachment
264095|NCT02034617|Stress, physiological|stress, physiological
264096|NCT02034617|Stress, psychological|stress, psychological
264097|NCT02034604|Naftopidil|naftopidil
264098|NCT02034604|safety|safety
264099|NCT02034539|peripheral artery disease|peripheral artery disease
264100|NCT02034539|critical limb ischemia|critical limb ischemia
264101|NCT02034539|VADOplex|vadoplex
264102|NCT02034539|intermittent foot compression|intermittent foot compression
264103|NCT02034526|Sinus node disease|sinus node disease
264104|NCT02034526|Atrial fibrillation|atrial fibrillation
264105|NCT02034526|Pacing|pacing
264106|NCT02034500|prevention|prevention
264107|NCT02034500|Shigella sonnei|shigella sonnei
264108|NCT02034487|Delayed Puberty|delayed puberty
264109|NCT02034487|Boys|boys
264110|NCT02034487|Hormones|hormones
264111|NCT02034487|Polymorphism, Genetic|polymorphism, genetic
264112|NCT02034461|Micro-Electrodes|micro-electrodes
264113|NCT02034461|Peripheral Nerve Injury|peripheral nerve injury
264114|NCT02034461|Amputation|amputation
264115|NCT02034461|Spinal Cord Injury|spinal cord injury
264116|NCT02034448|CRRT|crrt
264117|NCT02034448|Renal|renal
264118|NCT02034448|Kidney|kidney
264119|NCT02034448|adults|adults
264120|NCT02034448|registry|registry
264121|NCT02034448|AKI|aki
264122|NCT02034422|Exercise|exercise
264123|NCT02034409|Knee Osteoarthritis|knee osteoarthritis
264124|NCT02034409|Pulsed Low Intensity Ultrasound|pulsed low intensity ultrasound
264125|NCT02034396|Ulcers, venous, unna's boot|ulcers, venous, unna's boot
264126|NCT02034370|Interscalene nerve block|interscalene nerve block
264127|NCT02034370|Shoulder surgery|shoulder surgery
264128|NCT02034370|Obstructive Sleep Apnea|obstructive sleep apnea
264129|NCT02034370|Sleep Disordered Breathing|sleep disordered breathing
264130|NCT02034357|Parkinson Disease|parkinson disease
264131|NCT02034357|Sleep Disordered Breathing|sleep disordered breathing
264132|NCT02034357|Sleep Obstructive Apnea|sleep obstructive apnea
264133|NCT02034357|Polysomnography|polysomnography
264260|NCT02033915|Suicide risk assessment|suicide risk assessment
264134|NCT02034357|CPAP (continuous positive airway pressure) titration|cpap (continuous positive airway pressure) titration
264135|NCT02034357|CPAP (continuous positive airway pressure) treatment|cpap (continuous positive airway pressure) treatment
264136|NCT02034344|Lupus Erythematosus, Cutaneous|lupus erythematosus, cutaneous
264137|NCT02034344|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
264138|NCT02034344|Lupus Erythematosus, Discoid|lupus erythematosus, discoid
264139|NCT02034344|Healthy|healthy
264140|NCT02034344|Active Cutaneous Lupus Erythematosus|active cutaneous lupus erythematosus
264141|NCT02034344|Longitudinal Study|longitudinal study
264142|NCT02034344|Biomarkers|biomarkers
264143|NCT02034344|Subacute Cutaneous Lupus Erythematosus|subacute cutaneous lupus erythematosus
264144|NCT02034344|Skin Biopsy|skin biopsy
264145|NCT02034331|Insulin Sensitivity|insulin sensitivity
264146|NCT02034331|Microvascular permeability|microvascular permeability
264147|NCT02034331|Sympathetic nervous system|sympathetic nervous system
264148|NCT02034318|Fatigue|fatigue
264149|NCT02034318|Cardiac Sympathetic Denervation|cardiac sympathetic denervation
264150|NCT02034318|Parkinson Disease|parkinson disease
264151|NCT02034305|Airway Clearance|airway clearance
264152|NCT02034305|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
264153|NCT02034305|Peak Cough Flow|peak cough flow
264154|NCT02034279|cirrhosis|cirrhosis
264155|NCT02034266|Type one diabetes|type one diabetes
264156|NCT02034266|nerve damage|nerve damage
264157|NCT02034266|neuropathy|neuropathy
264158|NCT02034266|omega-3 fatty acid|omega-3 fatty acid
264159|NCT02034266|supplementation|supplementation
264160|NCT02034266|nutrition|nutrition
264161|NCT02034253|duration of untreated psychosis|duration of untreated psychosis
264162|NCT02034253|glutamate|glutamate
264163|NCT02034253|functional connectivity|functional connectivity
264164|NCT02034253|structural connectivity|structural connectivity
264165|NCT02034253|schizophrenia|schizophrenia
264166|NCT02034253|psychosis|psychosis
264167|NCT02034227|leukemia|leukemia
264168|NCT02034214|HIV|hiv
264169|NCT02034214|adolescents|adolescents
264170|NCT02034188|multiple sclerosis|multiple sclerosis
264171|NCT02034188|umbilical cord|umbilical cord
264172|NCT02034188|mesenchymal|mesenchymal
264173|NCT02034188|stem cells|stem cells
264174|NCT02034175|apnea|apnea
264175|NCT02034175|hypopnea|hypopnea
264176|NCT02034175|polysomnography|polysomnography
264177|NCT02034175|respiratory|respiratory
264178|NCT02034175|cheyne|cheyne
264179|NCT02034162|Helminth infections|helminth infections
264180|NCT02034162|Helminths|helminths
264181|NCT02034162|Pediatric|pediatric
264182|NCT02034162|Preschool aged|preschool aged
264183|NCT02034162|School aged|school aged
264184|NCT02034162|Mebendazole|mebendazole
264185|NCT02034162|Vermox|vermox
264186|NCT02034162|Placebo|placebo
264187|NCT02034149|chronic kidney disease|chronic kidney disease
264188|NCT02034149|high risk|high risk
264189|NCT02034149|intervention|intervention
264190|NCT02034149|hypertension|hypertension
264191|NCT02034149|hyperglycemia|hyperglycemia
264192|NCT02034149|hyperlipidemia|hyperlipidemia
264193|NCT02034123|First time in humans|first time in humans
264194|NCT02034123|Small cell lung carcinoma|small cell lung carcinoma
264195|NCT02034123|Oncology|oncology
264196|NCT02034123|GSK2879552|gsk2879552
264197|NCT02034123|LSD1 inhibitor|lsd1 inhibitor
264198|NCT02034110|solid tumors|solid tumors
264199|NCT02034110|efficacy|efficacy
264200|NCT02034110|BRAF V600E mutation|braf v600e mutation
264201|NCT02034110|trametinib|trametinib
264202|NCT02034110|safety|safety
264203|NCT02034110|Dabrafenib|dabrafenib
264204|NCT02034097|ROS1|ros1
264205|NCT02034097|erlotinib|erlotinib
264206|NCT02034097|EGFR|egfr
264207|NCT02034097|non-small cell lung cancer|non-small cell lung cancer
264208|NCT02034097|foretinib|foretinib
264209|NCT02034084|Transradial approach,|transradial approach,
264210|NCT02034084|Coronary angiography|coronary angiography
264211|NCT02034071|Prader-Willi syndrome|prader-willi syndrome
264212|NCT02034058|Wingspan Stent System|wingspan stent system
264213|NCT02034058|Wingspan Stent|wingspan stent
264214|NCT02034058|Intracranial Stent|intracranial stent
264215|NCT02034058|Ischemic Stroke|ischemic stroke
264216|NCT02034058|Intracranial Atherosclerotic Disease|intracranial atherosclerotic disease
264217|NCT02034058|Intracranial Stenosis|intracranial stenosis
264218|NCT02034032|Osteoarthritis|osteoarthritis
264219|NCT02034032|Knee|knee
264220|NCT02034032|Arthritis|arthritis
264221|NCT02034032|TKA|tka
264222|NCT02034032|Total Knee Arthroplasty|total knee arthroplasty
264223|NCT02034006|pathological myopia|pathological myopia
264224|NCT02034006|choroidal neovascularization|choroidal neovascularization
264225|NCT02034006|ranibizumab|ranibizumab
264226|NCT02034006|mono-bilateral|mono-bilateral
264227|NCT02034006|poor visual acuity|poor visual acuity
264228|NCT02034006|retinal disease|retinal disease
264229|NCT02034006|eye disease|eye disease
264230|NCT02034006|Angiogenesis Inhibitors|angiogenesis inhibitors
264231|NCT02034006|Angiogenesis Modulating Agents|angiogenesis modulating agents
264232|NCT02033980|narrow band imaging(NBI)|narrow band imaging(nbi)
264233|NCT02033980|NICE classification|nice classification
264234|NCT02033980|colorectal lesions|colorectal lesions
264235|NCT02033980|predicting histology|predicting histology
264236|NCT02033967|liver donor|liver donor
264237|NCT02033967|hepatectomy|hepatectomy
264238|NCT02033967|vasodilator|vasodilator
264239|NCT02033967|central venous pressure|central venous pressure
264240|NCT02033967|stroke volume variation|stroke volume variation
264241|NCT02033954|Embolization|embolization
264242|NCT02033954|Hemorrhage|hemorrhage
264243|NCT02033954|TIPS|tips
264244|NCT02033954|GI Bleeding|gi bleeding
264245|NCT02033954|AV Fistula|av fistula
264246|NCT02033954|AV Malformation|av malformation
264247|NCT02033954|Traumatic Vascular Injury|traumatic vascular injury
264248|NCT02033941|Alzheimer's Disease|alzheimer's disease
264249|NCT02033941|Grapeseed Extract|grapeseed extract
264250|NCT02033941|Clinical Trial|clinical trial
264251|NCT02033941|Meganatural-AZ|meganatural-az
264252|NCT02033941|anti-oligomerization|anti-oligomerization
264253|NCT02033941|Phase 2|phase 2
264254|NCT02033941|Dietary Supplement|dietary supplement
264255|NCT02033941|Nutraceutical|nutraceutical
264256|NCT02033928|Myeloma|myeloma
264257|NCT02033928|MGUS (monoclonal gammopathy of undetermined significance)|mgus (monoclonal gammopathy of undetermined significance)
264258|NCT02033928|amyloidosis|amyloidosis
264259|NCT02033928|stem cell transplant|stem cell transplant
264261|NCT02033915|interactive discussion group|interactive discussion group
264262|NCT02033915|suicide attempt|suicide attempt
264263|NCT02033915|self-harm|self-harm
264264|NCT02033915|randomized control study|randomized control study
264265|NCT02033915|identifying high risk group for suicide|identifying high risk group for suicide
264266|NCT02033902|Epilepsy|epilepsy
264267|NCT02033863|Varicocele|varicocele
264268|NCT02033863|Pelvic Congestion Syndrome|pelvic congestion syndrome
264269|NCT02033863|Pelvic Venous Incompetence|pelvic venous incompetence
264270|NCT02033863|Ovarian Varices|ovarian varices
264271|NCT02033850|small vessel disease|small vessel disease
264272|NCT02033850|cognition|cognition
264273|NCT02033850|treatment|treatment
264274|NCT02033850|rehabilitation|rehabilitation
264275|NCT02033850|attention|attention
264276|NCT02033850|fMRI|fmri
264277|NCT02033850|vascular dementia|vascular dementia
264278|NCT02033837|Coronary artery disease|coronary artery disease
264279|NCT02033837|Cardiac CT|cardiac ct
264280|NCT02033837|Appropriate Use Criteria (AUC)|appropriate use criteria (auc)
264281|NCT02033811|mitral regurgitation|mitral regurgitation
264282|NCT02033811|MitraClip system|mitraclip system
264283|NCT02033811|percutaneous mitral valve repair|percutaneous mitral valve repair
264284|NCT02033798|Urodynamics|urodynamics
264285|NCT02033798|Glomerular Filtration Rate|glomerular filtration rate
264286|NCT02033785|Prostatic hyperplasia|prostatic hyperplasia
264287|NCT02033759|Lymphedema|lymphedema
264288|NCT02033733|Post cardiac arrest|post cardiac arrest
264476|NCT02033018|Myopia|myopia
264289|NCT02033733|Postcardiac arrest therapeutic hypothermia|postcardiac arrest therapeutic hypothermia
264290|NCT02033733|Therapeutic hypothermia protocol|therapeutic hypothermia protocol
264291|NCT02033733|Neuromuscular blocking agents|neuromuscular blocking agents
264292|NCT02033733|Muscle relaxants|muscle relaxants
264293|NCT02033733|Hypothermia-induced increased muscle tone|hypothermia-induced increased muscle tone
264294|NCT02033733|Microshivering|microshivering
264295|NCT02033720|postcardiac arrest|postcardiac arrest
264296|NCT02033720|post cardiac arrest syndrome|post cardiac arrest syndrome
264297|NCT02033720|post cardiac arrest hypothermia|post cardiac arrest hypothermia
264298|NCT02033720|pulseless electrical activity|pulseless electrical activity
264299|NCT02033720|asystole|asystole
264300|NCT02033720|therapeutic hypothermia|therapeutic hypothermia
264301|NCT02033720|therapeutic hypothermia after cardiac arrest|therapeutic hypothermia after cardiac arrest
264302|NCT02033720|therapeutic hypothermia neurologic outcome|therapeutic hypothermia neurologic outcome
264303|NCT02033707|Hallucinogen|hallucinogen
264304|NCT02033707|Cognitive effects|cognitive effects
264305|NCT02033707|Subjective effects|subjective effects
264306|NCT02033694|Lipid|lipid
264307|NCT02033694|Vulnerable Plaque|vulnerable plaque
264308|NCT02033694|Plaque|plaque
264309|NCT02033694|Cholesterol|cholesterol
264310|NCT02033694|Near Infrared Spectroscopy|near infrared spectroscopy
264311|NCT02033694|NIRS-IVUS|nirs-ivus
264312|NCT02033694|Intravascular Ultrasound|intravascular ultrasound
264313|NCT02033694|Angiography|angiography
264314|NCT02033694|Coronary Imaging|coronary imaging
264315|NCT02033681|epinephrine|epinephrine
264316|NCT02033681|hand|hand
264317|NCT02033681|ischemia|ischemia
264318|NCT02033681|lidocaine|lidocaine
264319|NCT02033681|upper extremity|upper extremity
264320|NCT02033668|bioavailability|bioavailability
264321|NCT02033668|Pharmacokinetics|pharmacokinetics
264322|NCT02033668|intravenous|intravenous
264323|NCT02033668|subcutaneous and intramuscular administration|subcutaneous and intramuscular administration
264324|NCT02033668|amyloid beta|amyloid beta
264325|NCT02033668|monoclonal antibody|monoclonal antibody
264326|NCT02033655|weight loss|weight loss
264327|NCT02033655|older adults|older adults
264328|NCT02033655|obesity|obesity
264329|NCT02033629|Anesthesia|anesthesia
264330|NCT02033629|remifentanil|remifentanil
264331|NCT02033629|propofol|propofol
264332|NCT02033629|target-controlled infusion|target-controlled infusion
264333|NCT02033629|cardiac surgery|cardiac surgery
264334|NCT02033603|Total knee arthroplasty|total knee arthroplasty
264335|NCT02033603|Total knee replacement|total knee replacement
264336|NCT02033603|Femoral Nerve Block|femoral nerve block
264337|NCT02033603|Adductor Canal Block|adductor canal block
264338|NCT02033564|Sore Throat|sore throat
264339|NCT02033564|Intubation|intubation
264340|NCT02033564|Laryngoscopy|laryngoscopy
264341|NCT02033564|Anesthesiology|anesthesiology
264342|NCT02033564|Perioperative|perioperative
264343|NCT02033564|Airway Management|airway management
264344|NCT02033551|Gastric Cancer|gastric cancer
264345|NCT02033551|Lung Cancer|lung cancer
264346|NCT02033551|PARP Inhibitor|parp inhibitor
264347|NCT02033551|Ovarian Cancer|ovarian cancer
264348|NCT02033551|Solid Tumors|solid tumors
264349|NCT02033551|Breast Cancer|breast cancer
264350|NCT02033551|Colon Cancer|colon cancer
264351|NCT02033538|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
264352|NCT02033538|Nab-Paclitaxel|nab-paclitaxel
264353|NCT02033538|Carcinoma of Esophagus|carcinoma of esophagus
264354|NCT02033525|Chronic Meniscal Injury|chronic meniscal injury
264355|NCT02033525|Degenerative meniscus|degenerative meniscus
264356|NCT02033525|Meniscus injury|meniscus injury
264357|NCT02033525|Meniscal injury|meniscal injury
264358|NCT02033525|Mesenchymal stromal cells|mesenchymal stromal cells
264359|NCT02033525|Mesenchymal stem cells|mesenchymal stem cells
264360|NCT02033525|Advanced Therapy|advanced therapy
264361|NCT02033525|Bone marrow|bone marrow
264362|NCT02033512|Post-menopause|post-menopause
264363|NCT02033512|Hormone Replacement Therapy|hormone replacement therapy
264364|NCT02033512|Nanotechnology|nanotechnology
264365|NCT02033512|Biolipid B2|biolipid b2
264366|NCT02033499|Blood Glucose Self-Monitoring|blood glucose self-monitoring
264367|NCT02033499|Self-Monitoring, Blood Glucose|self-monitoring, blood glucose
264368|NCT02033499|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
264369|NCT02033499|Quality of Life|quality of life
264370|NCT02033486|diffuse optical tomography|diffuse optical tomography
264371|NCT02033486|digital breast tomosynthesis|digital breast tomosynthesis
264372|NCT02033486|breast cancer|breast cancer
264373|NCT02033486|solid benign lesions|solid benign lesions
264374|NCT02033486|cysts|cysts
264375|NCT02033486|malignant lesions|malignant lesions
264376|NCT02033473|Apelin|apelin
264377|NCT02033473|insulin|insulin
264378|NCT02033473|volunteers|volunteers
264379|NCT02033460|Manual therapy|manual therapy
264380|NCT02033460|Exercise|exercise
264381|NCT02033460|Education|education
264382|NCT02033447|Prostate Cancer|prostate cancer
264383|NCT02033434|intranasal|intranasal
264384|NCT02033434|ketamine|ketamine
264385|NCT02033434|analgesia|analgesia
264386|NCT02033434|mountain medicine|mountain medicine
264387|NCT02033434|pre-hospital care|pre-hospital care
264388|NCT02033434|patient transport|patient transport
264389|NCT02033434|pilot study|pilot study
264390|NCT02033434|mountain environment|mountain environment
264391|NCT02033421|Infective endocarditis|infective endocarditis
264392|NCT02033421|Therapeutic drug monitoring|therapeutic drug monitoring
264393|NCT02033408|IBD: Inflammatory Bowel Diseases|ibd: inflammatory bowel diseases
264394|NCT02033408|CD: Crohn's Disease|cd: crohn's disease
264395|NCT02033408|UC: Ulcerative Colitis|uc: ulcerative colitis
264396|NCT02033408|ASC: Acute Severe Colitis|asc: acute severe colitis
264397|NCT02033408|FMT: Fecal Microbiota Transplantation|fmt: fecal microbiota transplantation
264398|NCT02033408|PUCAI: Pediatric Ulcerative Colitis Activity Index|pucai: pediatric ulcerative colitis activity index
264399|NCT02033408|Ciprofloxacin, Doxycycline, Gentamycin, amoxicillin, vancomycin, metronidazole,ciprofloxacin|ciprofloxacin, doxycycline, gentamycin, amoxicillin, vancomycin, metronidazole,ciprofloxacin
264400|NCT02033369|Major depressive disorder|major depressive disorder
264401|NCT02033369|MDD|mdd
264402|NCT02033369|depression|depression
264403|NCT02033369|pramipexole|pramipexole
264404|NCT02033356|adductor canal block|adductor canal block
264405|NCT02033356|volunteers|volunteers
264406|NCT02033356|US-guided peripheral nerve block|us-guided peripheral nerve block
264407|NCT02033356|lower limb|lower limb
264408|NCT02033356|MRI|mri
264409|NCT02033343|Prostate Cancer|prostate cancer
264410|NCT02033343|Real-time tracking|real-time tracking
264411|NCT02033343|Radiotherapy|radiotherapy
264412|NCT02033343|Dynamic Multileaf Collimator|dynamic multileaf collimator
264413|NCT02033330|phenolics|phenolics
264414|NCT02033330|orange peel|orange peel
264415|NCT02033330|bioavailability|bioavailability
264416|NCT02033304|Cesarean section|cesarean section
264417|NCT02033304|Pain|pain
264418|NCT02033304|Wound hyperalgesia|wound hyperalgesia
264419|NCT02033291|Cerebral Small Vessel Disease|cerebral small vessel disease
264420|NCT02033291|Blood-Brain Barrier permeability|blood-brain barrier permeability
264421|NCT02033291|Dynamic contrast enhanced Magnetic Resonance Imaging|dynamic contrast enhanced magnetic resonance imaging
264422|NCT02033291|Pharmacokinetic modeling|pharmacokinetic modeling
264423|NCT02033291|Reproducibility|reproducibility
264424|NCT02033265|Ultrasound-guided Axillary Brachial Plexus Block|ultrasound-guided axillary brachial plexus block
264425|NCT02033265|Obesity|obesity
264426|NCT02033265|Performance time|performance time
264427|NCT02033265|Failure rate|failure rate
264428|NCT02033265|Acute complications|acute complications
264429|NCT02033226|Periodontitis|periodontitis
264430|NCT02033226|Periodontal Regeneration|periodontal regeneration
264431|NCT02033226|Amniotic membrane|amniotic membrane
264432|NCT02033226|Guided tissue regeneration|guided tissue regeneration
264433|NCT02033226|Anti-inflammatory|anti-inflammatory
264434|NCT02033226|Periodontal Therapy.|periodontal therapy.
264435|NCT02033213|intraoperative|intraoperative
264436|NCT02033213|fluid management|fluid management
264437|NCT02033213|esophageal carcinoma|esophageal carcinoma
264438|NCT02033213|surgery|surgery
264439|NCT02033213|gas exchange|gas exchange
264440|NCT02033213|tissue perfusion|tissue perfusion
264441|NCT02033200|vision|vision
264442|NCT02033200|Stendra|stendra
264443|NCT02033200|avanafil|avanafil
264444|NCT02033200|PDE5 inhibitor|pde5 inhibitor
264445|NCT02033200|visual acuity|visual acuity
264446|NCT02033200|intraocular pressure|intraocular pressure
264447|NCT02033200|pupillometry|pupillometry
264448|NCT02033200|color vision discrimination|color vision discrimination
264449|NCT02033200|healthy males|healthy males
264450|NCT02033174|alcohol, inflammation, oxidation.|alcohol, inflammation, oxidation.
264451|NCT02033161|Functional gastrointestinal disorders|functional gastrointestinal disorders
264452|NCT02033161|FGID|fgid
264453|NCT02033161|Recurrent abdominal pain|recurrent abdominal pain
264454|NCT02033161|Abdominal pain|abdominal pain
264455|NCT02033161|pain-related functional gastrointestinal disorders|pain-related functional gastrointestinal disorders
264456|NCT02033135|Atherosclerosis|atherosclerosis
264457|NCT02033135|Intermittent claudication|intermittent claudication
264458|NCT02033135|Angioplasty|angioplasty
264459|NCT02033122|exercise, bronchial hyperresponsiveness, inflammation|exercise, bronchial hyperresponsiveness, inflammation
264460|NCT02033096|stannsoporfin|stannsoporfin
264461|NCT02033096|hyperbilirubinemia|hyperbilirubinemia
264462|NCT02033096|heme oxygenase|heme oxygenase
264463|NCT02033083|abortion|abortion
264464|NCT02033083|cervical dilation|cervical dilation
264465|NCT02033070|RFA|rfa
264466|NCT02033057|Muscular electrostimulation, mechanically ventilated, critically ill patients, muscular weakness.|muscular electrostimulation, mechanically ventilated, critically ill patients, muscular weakness.
264467|NCT02033044|borderline personality disorder|borderline personality disorder
264468|NCT02033044|cognitive rehabilitation|cognitive rehabilitation
264469|NCT02033044|psychoeducation|psychoeducation
264470|NCT02033044|psychosocial functioning|psychosocial functioning
264471|NCT02033031|branch retinal vein occlusion|branch retinal vein occlusion
264472|NCT02033031|central retinal thickness|central retinal thickness
264473|NCT02033031|visual acuity|visual acuity
264474|NCT02033031|central reintal sensitivity|central reintal sensitivity
264475|NCT02033018|Aflibercept|aflibercept
264477|NCT02033018|Complications|complications
264478|NCT02033018|Neovascularization|neovascularization
264479|NCT02033018|OCT|oct
264480|NCT02033005|Body Composition|body composition
264481|NCT02033005|Adipose Tissue|adipose tissue
264482|NCT02033005|Intrahepatocellular Lipid|intrahepatocellular lipid
264483|NCT02033005|Infant|infant
264484|NCT02033005|Magnetic Resonance Imaging|magnetic resonance imaging
264485|NCT02033005|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
264486|NCT02032966|outcomes|outcomes
264487|NCT02032966|surgical|surgical
264488|NCT02032966|non-surgical|non-surgical
264489|NCT02032966|ankle|ankle
264490|NCT02032966|malleolus|malleolus
264491|NCT02032966|fracture|fracture
264492|NCT02032966|tibia|tibia
264493|NCT02032966|fibula|fibula
264494|NCT02032966|bimalleolar|bimalleolar
264495|NCT02032966|trimalleolar|trimalleolar
264496|NCT02032953|colorectal cancer|colorectal cancer
264497|NCT02032953|protein recovery|protein recovery
264498|NCT02032953|perioperative nutrition|perioperative nutrition
264499|NCT02032953|hyperinsulinemia|hyperinsulinemia
264500|NCT02032953|normoglycemia|normoglycemia
264501|NCT02032953|hyperinsulinemic-normoglycemic clamp|hyperinsulinemic-normoglycemic clamp
264502|NCT02032953|anabolism|anabolism
264503|NCT02032940|MRI, Angiography, Pulse Sequence|mri, angiography, pulse sequence
264504|NCT02032927|osteoarthritis|osteoarthritis
264505|NCT02032927|pain|pain
264506|NCT02032927|opioids|opioids
264507|NCT02032914|pyogenic liver abscess|pyogenic liver abscess
264508|NCT02032914|colon cancer|colon cancer
264509|NCT02032862|menopause, hot flushes, hot flashes, salvia, sage, sweating|menopause, hot flushes, hot flashes, salvia, sage, sweating
264510|NCT02032849|ventilator associated pneumonia|ventilator associated pneumonia
264511|NCT02032849|subglottic secretion drainage|subglottic secretion drainage
264512|NCT02032849|manual air-impingement operation|manual air-impingement operation
264513|NCT02032849|prolonged intubation|prolonged intubation
264514|NCT02032823|Breast Cancer|breast cancer
264515|NCT02032823|Adjuvant|adjuvant
264516|NCT02032823|Olaparib|olaparib
264517|NCT02032823|BRCA 1/2|brca 1/2
264518|NCT02032823|HER2|her2
264519|NCT02032810|Stage III Melanoma|stage iii melanoma
264520|NCT02032810|Stage IV Melanoma|stage iv melanoma
264521|NCT02032810|HDAC Inhibitor|hdac inhibitor
264522|NCT02032758|Occupational; Cramp(s)|occupational; cramp(s)
264523|NCT02032719|Hypertension, Systolic, Uncontrolled|hypertension, systolic, uncontrolled
264524|NCT02032706|obstructive sleep apnea|obstructive sleep apnea
264525|NCT02032706|position therapy|position therapy
264526|NCT02032706|snoring|snoring
264527|NCT02032706|positional|positional
264528|NCT02032693|Everycell|everycell
264529|NCT02032693|DNA damage|dna damage
264530|NCT02032693|DNA inflammation|dna inflammation
264531|NCT02032693|DNA stress|dna stress
264532|NCT02032667|physical activity|physical activity
264533|NCT02032667|exergames|exergames
264534|NCT02032654|antibiotics|antibiotics
264535|NCT02032654|flucloxacillin|flucloxacillin
264536|NCT02032654|therapy duration|therapy duration
264537|NCT02032654|cellulitis|cellulitis
264538|NCT02032654|erysipelas|erysipelas
264539|NCT02032654|skin infections|skin infections
264540|NCT02032654|hospital|hospital
264541|NCT02032641|Non-ablative laser|non-ablative laser
264542|NCT02032641|Scar revision|scar revision
264543|NCT02032641|direct brow lift|direct brow lift
264544|NCT02032628|epigenetics|epigenetics
264545|NCT02032628|cancer|cancer
264546|NCT02032628|exercise|exercise
264547|NCT02032628|intensity|intensity
264548|NCT02032628|duration|duration
264549|NCT02032615|anemia|anemia
264550|NCT02032602|Myofascial Pain Syndromes|myofascial pain syndromes
264551|NCT02032602|Trigger Point|trigger point
264552|NCT02032602|Shoulder Pain|shoulder pain
264553|NCT02032602|Aged|aged
264554|NCT02032576|major depressive episode, electroconvulsive therapy|major depressive episode, electroconvulsive therapy
264555|NCT02032563|neoadjuvant therapy|neoadjuvant therapy
264556|NCT02032550|Localized prostate cancer|localized prostate cancer
264557|NCT02032550|Patient preference|patient preference
264558|NCT02032550|Treatment choice|treatment choice
264559|NCT02032550|Decision making|decision making
264560|NCT02032550|Patient centered outcomes|patient centered outcomes
264561|NCT02032537|callmax cream|callmax cream
264562|NCT02032537|uremic pruritus|uremic pruritus
264563|NCT02032498|sentinel lymph nodes|sentinel lymph nodes
264564|NCT02032498|radiocolloids|radiocolloids
264565|NCT02032498|Indocyanine Green|indocyanine green
264566|NCT02032498|complementarity|complementarity
264567|NCT02032498|axillary lymph node dissection|axillary lymph node dissection
264568|NCT02032485|colorectal cancer|colorectal cancer
264569|NCT02032485|Indocyanine Green|indocyanine green
264570|NCT02032485|visualization of peritoneal metastases|visualization of peritoneal metastases
264571|NCT02032472|Blood Pressure Monitoring, Ambulatory|blood pressure monitoring, ambulatory
264572|NCT02032472|Arterial Pressure|arterial pressure
264573|NCT02032472|Hypertension Controlled|hypertension controlled
264574|NCT02032472|Pharmacies|pharmacies
264575|NCT02032459|Pregnancy|pregnancy
264576|NCT02032459|Minority Women|minority women
264577|NCT02032459|Preterm delivery|preterm delivery
264578|NCT02032459|Fetal growth restriction|fetal growth restriction
264579|NCT02032459|Preeclampsia|preeclampsia
264580|NCT02032459|Gestational Diabetes|gestational diabetes
264581|NCT02032459|Vitamin D|vitamin d
264582|NCT02032433|extended-release naltrexone (Vivitrol)|extended-release naltrexone (vivitrol)
264583|NCT02032433|buprenorphine-naloxone (Suboxone)|buprenorphine-naloxone (suboxone)
264584|NCT02032433|comparative effective|comparative effective
264585|NCT02032433|relapse prevention|relapse prevention
264586|NCT02032394|Chlorhexidine|chlorhexidine
264587|NCT02032394|Povidone-iodine|povidone-iodine
264588|NCT02032394|bacteriuria|bacteriuria
264589|NCT02032394|Urinary Catheterization|urinary catheterization
264590|NCT02032394|Urinary tract infection|urinary tract infection
264591|NCT02032381|non infectious pulmonary complications after hematopoietic cell transplant|non infectious pulmonary complications after hematopoietic cell transplant
264592|NCT02032381|functional respiratory test and exercise test|functional respiratory test and exercise test
264593|NCT02032381|thoracic tomodensitometry|thoracic tomodensitometry
264594|NCT02032368|circulating tumour cell;|circulating tumour cell;
264595|NCT02032368|transarterial chemoembolization;|transarterial chemoembolization;
264596|NCT02032368|hepatocellular carcinoma;|hepatocellular carcinoma;
264597|NCT02032368|recurrence|recurrence
264598|NCT02032329|Functional Electrical Stimulation (FES)|functional electrical stimulation (fes)
264599|NCT02032316|Renal Stone|renal stone
264600|NCT02032316|Ureteroscopy|ureteroscopy
264601|NCT02032316|Ureteral Stent|ureteral stent
264602|NCT02032316|post-uncomplicated ureteroscopy|post-uncomplicated ureteroscopy
264603|NCT02032316|UURS|uurs
264604|NCT02032277|Oncology|oncology
264605|NCT02032277|Triple negative breast cancer|triple negative breast cancer
264606|NCT02032277|German Breast Group - GBG 81|german breast group - gbg 81
264607|NCT02032277|United States Oncology - 12152|united states oncology - 12152
264608|NCT02032277|National Surgical Adjuvant Breast and Bowel Project - B-56-I|national surgical adjuvant breast and bowel project - b-56-i
264609|NCT02032277|Alliance - AFT-04|alliance - aft-04
264610|NCT02032277|Grupo Español de Investigación en Cáncer de Mama - GEICAM/2014-02|grupo español de investigación en cáncer de mama - geicam/2014-02
264611|NCT02032264|Next generation sequencing|next generation sequencing
264612|NCT02032264|Embryonic aneuploidy|embryonic aneuploidy
264613|NCT02032251|Sperm DNA damage ejaculated spermatozoa Ginger Herbal Drug Herbal medicine|sperm dna damage ejaculated spermatozoa ginger herbal drug herbal medicine
264614|NCT02032199|Gastric bypass|gastric bypass
264615|NCT02032199|Health-related quality of life|health-related quality of life
264616|NCT02032199|SF-36|sf-36
264617|NCT02032199|Questionnaire|questionnaire
264618|NCT02032199|Treatment guidelines|treatment guidelines
264619|NCT02032186|magnesium|magnesium
264620|NCT02032186|prematurity|prematurity
264621|NCT02032173|Ranibizumab|ranibizumab
264622|NCT02032173|Diabetic Macular Edema|diabetic macular edema
264623|NCT02032160|ADITEC|aditec
264624|NCT02032160|Immunology|immunology
264625|NCT02032160|Vaccines|vaccines
264626|NCT02032160|Hepatitis B|hepatitis b
264627|NCT02032160|Investigational study|investigational study
264628|NCT02032160|innate and adaptive immune responses|innate and adaptive immune responses
264629|NCT02032160|Hepatitis B vaccinations|hepatitis b vaccinations
264630|NCT02032134|Cryopreserved platelets, thrombocytopenia, DMSO|cryopreserved platelets, thrombocytopenia, dmso
264631|NCT02032121|Cancer survivors|cancer survivors
264632|NCT02032121|Long-term cancer survivor|long-term cancer survivor
264633|NCT02032108|Diabetes lifestyle intervention Rwanda|diabetes lifestyle intervention rwanda
264634|NCT02032095|IVIG|ivig
264635|NCT02032095|Renal transplantation|renal transplantation
264636|NCT02032095|desensitization|desensitization
264637|NCT02032056|Infections|infections
264638|NCT02032056|Allergy|allergy
264639|NCT02032056|Immune function|immune function
264640|NCT02032056|Microbiota|microbiota
264641|NCT02032056|infant|infant
264642|NCT02032043|Filariasis|filariasis
264643|NCT02032043|Onchocerciasis|onchocerciasis
264644|NCT02032043|Albendazole|albendazole
264645|NCT02032043|Ivermectin|ivermectin
264646|NCT02032043|STH Soil Transmitted Helminth infections|sth soil transmitted helminth infections
264647|NCT02032043|MDA Mass Drug Administration|mda mass drug administration
264648|NCT02032030|quality of Life|quality of life
264649|NCT02032030|pain|pain
264650|NCT02032030|nausea|nausea
264651|NCT02032030|falls|falls
264652|NCT02032030|intraoperative awareness|intraoperative awareness
264653|NCT02032030|anesthesia awareness|anesthesia awareness
264654|NCT02032030|cognition|cognition
264655|NCT02032030|activities of daily living|activities of daily living
264656|NCT02032030|major morbidity|major morbidity
264657|NCT02032030|all-cause mortality|all-cause mortality
264658|NCT02032017|Total Hip Arthroplasty|total hip arthroplasty
264659|NCT02032017|Gluteus medius|gluteus medius
264660|NCT02032017|Approach|approach
264661|NCT02032017|Rehabilitation|rehabilitation
264662|NCT02032017|Functional outcome|functional outcome
264663|NCT02032004|Chronic Heart Failure|chronic heart failure
264664|NCT02032004|CHF|chf
264665|NCT02032004|Left Ventricular Systolic Dysfunction|left ventricular systolic dysfunction
264666|NCT02032004|Ischemic Heart Failure|ischemic heart failure
264667|NCT02032004|Nonischemic Heart Failure|nonischemic heart failure
264668|NCT02032004|Stem Cells|stem cells
264669|NCT02032004|Allogeneic Mesenchymal Precursor Cells|allogeneic mesenchymal precursor cells
264670|NCT02031991|Bioequivalence|bioequivalence
264671|NCT02031991|Biosimilarity|biosimilarity
264672|NCT02031991|Similarity|similarity
264673|NCT02031991|PK|pk
264674|NCT02031991|Phase 1|phase 1
264675|NCT02031991|Bevacizumab|bevacizumab
264676|NCT02031991|Healthy Volunteers|healthy volunteers
264677|NCT02031991|Single-Dose|single-dose
264678|NCT02031991|Oncology|oncology
264679|NCT02031978|Breast Feeding|breast feeding
264680|NCT02031978|Infant Nutrition|infant nutrition
264681|NCT02031978|Childhood Obesity|childhood obesity
264682|NCT02031978|Infant feeding patterns|infant feeding patterns
264683|NCT02031978|WIC|wic
264684|NCT02031952|hepatocellular carcinoma|hepatocellular carcinoma
264685|NCT02031952|hepatectomy|hepatectomy
264686|NCT02031952|lymphadenectomy|lymphadenectomy
264687|NCT02031952|complication|complication
264688|NCT02031952|prognosis|prognosis
264689|NCT02031939|Rectal cancer|rectal cancer
264690|NCT02031939|neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
264691|NCT02031939|optimization|optimization
264692|NCT02031913|Chronic hepatitis B|chronic hepatitis b
264693|NCT02031913|Hepatic fibrosis|hepatic fibrosis
264694|NCT02031913|Steatosis|steatosis
264695|NCT02031887|starter formula|starter formula
264696|NCT02031887|stool microbiota|stool microbiota
264697|NCT02031887|infants|infants
264698|NCT02031887|caesarean section delivery|caesarean section delivery
264699|NCT02031874|H1N1|h1n1
264700|NCT02031874|HIV|hiv
264701|NCT02031874|Immunogenecity|immunogenecity
264702|NCT02031848|weight loss|weight loss
264703|NCT02031848|diet|diet
264704|NCT02031822|Primary Headache|primary headache
264705|NCT02031822|Greater Occipital Nerve|greater occipital nerve
264706|NCT02031822|Ultrasound|ultrasound
264707|NCT02031822|Chronic Pain|chronic pain
264708|NCT02031822|Cervicogenic|cervicogenic
264709|NCT02031822|Occipital Neuralgia|occipital neuralgia
264710|NCT02031822|Migraine|migraine
264711|NCT02031822|Tension type headache|tension type headache
264712|NCT02031822|Cluster headache|cluster headache
264713|NCT02031809|Thoracic Surgery, Video-Assisted|thoracic surgery, video-assisted
264714|NCT02031770|vascular endothelial cells|vascular endothelial cells
264715|NCT02031757|Balance control|balance control
264716|NCT02031757|Aging|aging
264717|NCT02031757|Balance reactions|balance reactions
264718|NCT02031757|Perturbation|perturbation
264719|NCT02031705|Fibrillation|fibrillation
264720|NCT02031705|Catheter ablation|catheter ablation
264721|NCT02031692|Benign paroxysmal positional vertigo|benign paroxysmal positional vertigo
264722|NCT02031692|Vitamin D|vitamin d
264723|NCT02031692|Calcium|calcium
264724|NCT02031692|Prevention|prevention
264725|NCT02031679|Chronic Idiopathic Urticaria|chronic idiopathic urticaria
264726|NCT02031666|Healthy|healthy
264727|NCT02031666|JNJ-56021927|jnj-56021927
264728|NCT02031666|ARN-509|arn-509
264729|NCT02031666|Bioavailability|bioavailability
264730|NCT02031653|Penile Cuff Test|penile cuff test
264731|NCT02031640|asthma|asthma
264732|NCT02031640|breath-actuated inhaler|breath-actuated inhaler
264733|NCT02031640|metered-dose inhaler|metered-dose inhaler
264734|NCT02031627|lymphedema|lymphedema
264735|NCT02031627|lymphoedema|lymphoedema
264736|NCT02031627|leg lymphoedema|leg lymphoedema
264737|NCT02031627|lower extremity lymphoedema|lower extremity lymphoedema
264738|NCT02031627|pneumatic compression device|pneumatic compression device
264739|NCT02031614|anemia|anemia
264740|NCT02031614|blood withdrawal|blood withdrawal
264741|NCT02031614|phlebotomy|phlebotomy
264742|NCT02031614|innate immunity|innate immunity
264743|NCT02031614|Immune reponse|immune reponse
264744|NCT02031588|Study of commensal flora|study of commensal flora
264745|NCT02031588|Fluoroquinolones|fluoroquinolones
264746|NCT02031575|Reproductive Health|reproductive health
264747|NCT02031575|Contraception|contraception
264748|NCT02031575|Public Health|public health
264749|NCT02031575|Sexual Health|sexual health
264750|NCT02031575|Adolescents|adolescents
264751|NCT02031575|Mobile Health|mobile health
264752|NCT02031562|Balance|balance
264753|NCT02031562|Falls|falls
264754|NCT02031562|Low back pain|low back pain
264755|NCT02031562|Geriatric|geriatric
264756|NCT02031523|endometriosis|endometriosis
264757|NCT02031523|dysmenorrhea|dysmenorrhea
264758|NCT02031523|Sanjie analgesic capsule|sanjie analgesic capsule
264759|NCT02031523|effect/safety|effect/safety
264760|NCT02031497|Sweetener, insulin, body mass index, physical activity|sweetener, insulin, body mass index, physical activity
264761|NCT02031432|cancer-related pain|cancer-related pain
264762|NCT02031432|cebranopadol|cebranopadol
264763|NCT02031419|CC-122|cc-122
264764|NCT02031419|CC-223|cc-223
264765|NCT02031419|CC-292|cc-292
264766|NCT02031419|Rituximab|rituximab
264767|NCT02031419|Lymphoma|lymphoma
264768|NCT02031419|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
264769|NCT02031419|Lenalidomide naïve Follicular Lymphoma|lenalidomide naïve follicular lymphoma
264770|NCT02031419|Lenalidomide exposed Follicular Lymphoma|lenalidomide exposed follicular lymphoma
264771|NCT02031380|Glaucoma|glaucoma
264772|NCT02031380|Open angle glaucoma|open angle glaucoma
264773|NCT02031380|ocular hypertension|ocular hypertension
264774|NCT02031380|compliance|compliance
264775|NCT02031354|Lysine Chloride|lysine chloride
264776|NCT02031328|prostate|prostate
264777|NCT02031328|radiation|radiation
264778|NCT02031328|stereotactic body radiation|stereotactic body radiation
264779|NCT02031315|sudden death|sudden death
264780|NCT02031315|sudden cardiac arrest|sudden cardiac arrest
264781|NCT02031302|Lotus|lotus
264782|NCT02031302|Valve|valve
264783|NCT02031302|Real world|real world
264784|NCT02031302|Aortic stenosis|aortic stenosis
264785|NCT02031302|High risk|high risk
264786|NCT02031289|Anemia|anemia
264787|NCT02031289|Iron deficiency|iron deficiency
264788|NCT02031289|Cardiac surgery|cardiac surgery
264789|NCT02031289|Perioperative Care|perioperative care
264790|NCT02031276|ABBV-066|abbv-066
264791|NCT02031276|BI 655066|bi 655066
264792|NCT02031276|risankizumab|risankizumab
264793|NCT02031224|Chronic Kidney Disease|chronic kidney disease
264794|NCT02031224|Restricted protein diets|restricted protein diets
264795|NCT02031224|Nutritional status|nutritional status
264796|NCT02031198|Alzheimer's disease|alzheimer's disease
264797|NCT02031198|tau|tau
264798|NCT02031198|dementia|dementia
264799|NCT02031198|elderly|elderly
264800|NCT02031198|cognitive|cognitive
264801|NCT02031198|disease modifying|disease modifying
264802|NCT02031198|treatment|treatment
264803|NCT02031198|immunization|immunization
264804|NCT02031198|vaccine|vaccine
264805|NCT02031172|Dry Eye Disease|dry eye disease
264806|NCT02031172|Sjogren's Syndrome|sjogren's syndrome
264807|NCT02031172|Tear Film|tear film
264808|NCT02031172|Ocular Surface|ocular surface
264809|NCT02031172|Aqueous Tear Deficiency|aqueous tear deficiency
264810|NCT02031159|perioperative hypothermia|perioperative hypothermia
264811|NCT02031159|zero heat flux|zero heat flux
264812|NCT02031159|non-invasive measurement of body core temperature|non-invasive measurement of body core temperature
264813|NCT02031107|stroke|stroke
264814|NCT02031107|brain stimulation|brain stimulation
264815|NCT02031107|electroencephalography|electroencephalography
264816|NCT02031107|functional magnetic resonance imaging|functional magnetic resonance imaging
264817|NCT02031107|functional connectivity|functional connectivity
264818|NCT02031068|active rehabilitation|active rehabilitation
264819|NCT02031068|exercise|exercise
264820|NCT02031068|concussion|concussion
264821|NCT02031055|Advanced solid tumors|advanced solid tumors
264822|NCT02031042|neoadjuvant chemotherapy|neoadjuvant chemotherapy
264823|NCT02031042|breast cancer|breast cancer
264824|NCT02031042|sentinel lymph node biopsy|sentinel lymph node biopsy
264825|NCT02031042|false negative rate|false negative rate
264826|NCT02031042|identification rate|identification rate
264827|NCT02031029|personality scores|personality scores
264828|NCT02031016|Chronic thoracic pain|chronic thoracic pain
264829|NCT02031016|Remifentanil|remifentanil
264830|NCT02031016|Fentanyl|fentanyl
264831|NCT02031016|sternotomy|sternotomy
264832|NCT02030990|photorefractive keratectomy|photorefractive keratectomy
264833|NCT02030990|corneal haze|corneal haze
264834|NCT02030990|mitomycin-C|mitomycin-c
264835|NCT02030990|postoperative steroids|postoperative steroids
264836|NCT02030951|preterm infant behavior|preterm infant behavior
264837|NCT02030951|tube feeding|tube feeding
264838|NCT02030951|feeding efficiency|feeding efficiency
264839|NCT02030938|breast implant|breast implant
264840|NCT02030938|revision augmentation|revision augmentation
264841|NCT02030938|stretch deformity|stretch deformity
264842|NCT02030938|fold malposition|fold malposition
264843|NCT02030938|bottoming out|bottoming out
264844|NCT02030912|The impact of a number of different types of antibiotics|the impact of a number of different types of antibiotics
264845|NCT02030912|The emergence and persistence of antibiotic resistance|the emergence and persistence of antibiotic resistance
264846|NCT02030899|Cervical vertebrae|cervical vertebrae
264847|NCT02030899|single|single
264848|NCT02030899|degenerative disease|degenerative disease
264849|NCT02030899|Fusion|fusion
264850|NCT02030899|Sagittal angle|sagittal angle
264851|NCT02030873|virtual simulation|virtual simulation
264852|NCT02030873|temporal bone|temporal bone
264853|NCT02030873|surgical training|surgical training
264854|NCT02030873|medical education|medical education
264855|NCT02030873|self-directed learning|self-directed learning
264856|NCT02030873|final product assessment|final product assessment
264857|NCT02030873|cognitive load|cognitive load
264858|NCT02030873|reaction time|reaction time
264859|NCT02030873|skills training|skills training
264860|NCT02030873|simulator metrics|simulator metrics
264861|NCT02030808|Thoracic surgery|thoracic surgery
264862|NCT02030808|non-muscle relaxant|non-muscle relaxant
264863|NCT02030808|target-controlled infusion|target-controlled infusion
264864|NCT02030808|remifentanil|remifentanil
264865|NCT02030808|surgical conditions|surgical conditions
264866|NCT02030795|Thoracic surgery|thoracic surgery
264867|NCT02030795|Arndt® blocker|arndt® blocker
264868|NCT02030795|lung deflation|lung deflation
264869|NCT02030795|Disconnection technique|disconnection technique
264870|NCT02030795|Continuous suction|continuous suction
264871|NCT02030795|Elective video-assisted thoracoscopic|elective video-assisted thoracoscopic
264872|NCT02030782|depression|depression
264873|NCT02030782|quality improvement|quality improvement
264874|NCT02030782|treatment|treatment
264875|NCT02030782|adolescents|adolescents
264876|NCT02030769|Esophageal Neoplasms|esophageal neoplasms
264877|NCT02030769|Lugol's solution|lugol's solution
264878|NCT02030769|Pronase|pronase
264879|NCT02030769|Endoscopy, Digestive System|endoscopy, digestive system
264880|NCT02030769|Pretreatment method|pretreatment method
264881|NCT02030756|constipation|constipation
264882|NCT02030743|Falls|falls
264883|NCT02030743|Older adults|older adults
264884|NCT02030743|Balance|balance
264885|NCT02030743|Mobility|mobility
264886|NCT02030743|Visual attention|visual attention
264887|NCT02030730|Brief Parenting Training|brief parenting training
264888|NCT02030730|Early Intervention|early intervention
264889|NCT02030730|Child Behavior|child behavior
264890|NCT02030730|Greece|greece
264891|NCT02030717|Spinal anesthesia|spinal anesthesia
264892|NCT02030717|Epidural anesthesia|epidural anesthesia
264893|NCT02030717|Klonidin|klonidin
264894|NCT02030717|renal cell carcinoma|renal cell carcinoma
264895|NCT02030691|Neonatal respiratory distress|neonatal respiratory distress
264896|NCT02030691|nHFPV|nhfpv
264897|NCT02030691|nCPAP|ncpap
264898|NCT02030691|cerebral tissue oxygenation|cerebral tissue oxygenation
264899|NCT02030691|NIRS|nirs
264900|NCT02030665|Marijuana Dependence|marijuana dependence
264901|NCT02030665|Individualized treatment|individualized treatment
264902|NCT02030665|Motivational Enhancement Treatment|motivational enhancement treatment
264903|NCT02030665|Cognitive-Behavioral Treatment|cognitive-behavioral treatment
264904|NCT02030665|Contingency Management|contingency management
264905|NCT02030652|premature newborn|premature newborn
264906|NCT02030652|nasal ventilation|nasal ventilation
264907|NCT02030652|noninvasive ventilation|noninvasive ventilation
264908|NCT02030652|continuous positive airway pressure|continuous positive airway pressure
264909|NCT02030626|Neuropathic pain|neuropathic pain
264910|NCT02030626|lumbar radiculopathy|lumbar radiculopathy
264911|NCT02030626|rTMS|rtms
264912|NCT02030626|tDCS|tdcs
264913|NCT02030626|placebo controlled study|placebo controlled study
264914|NCT02030613|juvenile idiopathic arthritis|juvenile idiopathic arthritis
264915|NCT02030613|etanercept|etanercept
264916|NCT02030587|Hyperaldosteronism|hyperaldosteronism
264917|NCT02030587|Adrenocortical adenoma|adrenocortical adenoma
264918|NCT02030587|Adrenalectomy|adrenalectomy
264919|NCT02030587|Catheter ablation|catheter ablation
264920|NCT02030561|NK cells|nk cells
264921|NCT02030561|trastuzumab|trastuzumab
264922|NCT02030561|immunotherapy|immunotherapy
264923|NCT02030548|CABG|cabg
264924|NCT02030548|dual antiplatelet therapy|dual antiplatelet therapy
264925|NCT02030548|aspirin|aspirin
264926|NCT02030548|clopidogrel|clopidogrel
264927|NCT02030548|prasugrel|prasugrel
264928|NCT02030548|ticagrelor|ticagrelor
264929|NCT02030522|Post-traumatic stress disorder|post-traumatic stress disorder
264930|NCT02030522|PTSD|ptsd
264931|NCT02030522|Accelerated Resolution Therapy|accelerated resolution therapy
264932|NCT02030522|Military|military
264933|NCT02030522|Veterans|veterans
264934|NCT02030522|Exposure therapy|exposure therapy
264935|NCT02030522|Eye movements|eye movements
264936|NCT02030509|cancer diagnosis|cancer diagnosis
264937|NCT02030496|distal radius fractures|distal radius fractures
264938|NCT02030496|Closed reduction|closed reduction
264939|NCT02030496|Open reduction internal fixation|open reduction internal fixation
264940|NCT02030496|Volar plate|volar plate
264941|NCT02030496|Redislocation|redislocation
264942|NCT02030496|Unstable fracture|unstable fracture
264943|NCT02030496|Extra-articular fracture|extra-articular fracture
264944|NCT02030496|Colles fracture|colles fracture
264945|NCT02030496|Barton fracture|barton fracture
264946|NCT02030470|Periodontitis, treatment, photodynamic, mid-term, bacteria|periodontitis, treatment, photodynamic, mid-term, bacteria
264947|NCT02030444|Neoplasms Staging|neoplasms staging
264948|NCT02030444|Bronchoscopy|bronchoscopy
264949|NCT02030444|Nuclear Medicine|nuclear medicine
264950|NCT02030444|Radiology|radiology
264951|NCT02030392|Functional abdominal pain|functional abdominal pain
264952|NCT02030392|psychological intervention|psychological intervention
264953|NCT02030392|quality of life|quality of life
264954|NCT02030392|Randomized controlled trial|randomized controlled trial
264955|NCT02030392|children|children
264956|NCT02030379|Cancer|cancer
264957|NCT02030353|Lifestyle intervention|lifestyle intervention
264958|NCT02030353|Internet intervention|internet intervention
264959|NCT02030353|Breast neoplasms|breast neoplasms
264960|NCT02030353|Body weight|body weight
264961|NCT02030353|Body weight changes|body weight changes
264962|NCT02030340|urodynamic investigation|urodynamic investigation
264963|NCT02030340|lower urinary tract dysfunction|lower urinary tract dysfunction
264964|NCT02030340|catheter|catheter
264965|NCT02030340|air-charged|air-charged
264966|NCT02030340|water filled|water filled
264967|NCT02030327|proteomics|proteomics
264968|NCT02030327|multiple trauma|multiple trauma
264969|NCT02030327|organ dysfunction|organ dysfunction
264970|NCT02030314|Chlorthalidone|chlorthalidone
264971|NCT02030314|Resistant Hypertension|resistant hypertension
264972|NCT02030314|Kidney Transplant Patients|kidney transplant patients
264973|NCT02030301|Herpes Simplex Virus, Type 2|herpes simplex virus, type 2
264974|NCT02030301|Herpes|herpes
264975|NCT02030301|HSV-2|hsv-2
264976|NCT02030288|alcohol|alcohol
264977|NCT02030288|substance use|substance use
264978|NCT02030288|eHealth|ehealth
264979|NCT02030275|Hypertrophic scar|hypertrophic scar
264980|NCT02030275|Cicatrix|cicatrix
264981|NCT02030275|Scar prevention|scar prevention
264982|NCT02030275|Scar revision|scar revision
264983|NCT02030249|Pre-diabetes|pre-diabetes
264984|NCT02030249|Obesity|obesity
264985|NCT02030249|Low calorie diet|low calorie diet
264986|NCT02030249|Diet - reducing|diet - reducing
264987|NCT02030249|Appetite|appetite
264988|NCT02030249|Visual analogue scale|visual analogue scale
264989|NCT02030249|Ghrelin|ghrelin
264990|NCT02030249|Peptide YY|peptide yy
264991|NCT02030249|Bone mass|bone mass
264992|NCT02030249|Bone turnover|bone turnover
264993|NCT02030249|Muscle strength|muscle strength
264994|NCT02030236|hypothermia, induced|hypothermia, induced
264995|NCT02030236|rewarming|rewarming
264996|NCT02030236|therapeutic|therapeutic
264997|NCT02030236|heart arrest|heart arrest
264998|NCT02030236|asystole|asystole
264999|NCT02030236|frostbite|frostbite
265000|NCT02030223|transversus abdominis plane block|transversus abdominis plane block
265001|NCT02030223|inguinal hernia repair|inguinal hernia repair
265002|NCT02030223|acute postoperative pain|acute postoperative pain
265003|NCT02030223|neuropathic pain|neuropathic pain
265004|NCT02030210|Quality improvement|quality improvement
265005|NCT02030210|STEMI|stemi
265006|NCT02030210|Belgium|belgium
265007|NCT02030184|Lung cancer|lung cancer
265008|NCT02030184|Small cell lung cancer|small cell lung cancer
265009|NCT02030184|Neuroendocrine tumor|neuroendocrine tumor
265010|NCT02030184|Rhenium|rhenium
265011|NCT02030184|Re 188-P2045|re 188-p2045
265012|NCT02030171|Chronic low back pain|chronic low back pain
265013|NCT02030158|Severe sepsis|severe sepsis
265014|NCT02030158|Septic shock|septic shock
265015|NCT02030158|Early goal directed therapy|early goal directed therapy
265016|NCT02030158|Individual patient data meta-analysis|individual patient data meta-analysis
265017|NCT02030145|COPD|copd
265018|NCT02030145|Pulmonary|pulmonary
265019|NCT02030132|Physical activity|physical activity
265020|NCT02030132|Sedentary lifestyle|sedentary lifestyle
265021|NCT02030132|Pedometers|pedometers
265022|NCT02030132|Walking|walking
265023|NCT02030132|Financial Incentives|financial incentives
265024|NCT02030132|Behavioral Economics|behavioral economics
265025|NCT02030119|Sedentary lifestyle|sedentary lifestyle
265026|NCT02030119|Pedometers|pedometers
265027|NCT02030119|Obesity|obesity
265028|NCT02030119|Physical Activity|physical activity
265029|NCT02030119|Financial Incentives|financial incentives
265030|NCT02030119|Behavioral Economics|behavioral economics
265031|NCT02030106|Cervicovaginal microbiome|cervicovaginal microbiome
265032|NCT02030106|Microbiome|microbiome
265033|NCT02030106|Preterm Birth|preterm birth
265034|NCT02030106|Cervical Remodeling|cervical remodeling
265035|NCT02030106|Preterm delivery|preterm delivery
265036|NCT02030106|Microbiota|microbiota
265037|NCT02030093|Alcohol dependence|alcohol dependence
265038|NCT02030093|Telephone-based continuing care|telephone-based continuing care
265039|NCT02030093|Outcome monitoring|outcome monitoring
265040|NCT02030080|Pedometers|pedometers
265041|NCT02030080|Walking|walking
265042|NCT02030080|Financial incentives|financial incentives
265043|NCT02030080|Sedentary lifestyle|sedentary lifestyle
265044|NCT02030080|Behavioral economics|behavioral economics
265045|NCT02030067|oncology|oncology
265046|NCT02030067|tumor|tumor
265047|NCT02030067|metastatic|metastatic
265048|NCT02030041|simvastatin|simvastatin
265049|NCT02030041|cardiorespiratory fitness|cardiorespiratory fitness
265050|NCT02030041|vitamin D|vitamin d
265051|NCT02030041|exercise|exercise
265052|NCT02030041|mitochondria|mitochondria
265053|NCT02030028|Rheumatoid Arthritis|rheumatoid arthritis
265054|NCT02030028|ACTH gel|acth gel
265055|NCT02030015|infantile Tay-Sachs disease|infantile tay-sachs disease
265056|NCT02030015|juvenile Tay-Sachs disease|juvenile tay-sachs disease
265057|NCT02030015|infantile GM1 gangliosidosis|infantile gm1 gangliosidosis
265058|NCT02030015|juvenile GM1 gangliosidosis|juvenile gm1 gangliosidosis
265059|NCT02030015|infantile GM2 gangliosidosis|infantile gm2 gangliosidosis
265060|NCT02030015|juvenile GM2 gangliosidosis|juvenile gm2 gangliosidosis
265061|NCT02030015|Sandhoff disease|sandhoff disease
265062|NCT02030015|gangliosidoses|gangliosidoses
265063|NCT02030015|miglustat|miglustat
265064|NCT02030015|ketogenic diet|ketogenic diet
265065|NCT02030015|SYNER-G regimen|syner-g regimen
265066|NCT02030015|Syner-G|syner-g
265067|NCT02030015|Zavesca|zavesca
265068|NCT02030015|Tay-Sachs disease|tay-sachs disease
265266|NCT02029053|Dyspareunia|dyspareunia
265069|NCT02030015|Tay Sachs disease|tay sachs disease
265070|NCT02029989|Metabolic Syndrome|metabolic syndrome
265071|NCT02029989|Antipsychotics|antipsychotics
265072|NCT02029989|Schizophrenia|schizophrenia
265073|NCT02029989|Bipolar Disorder|bipolar disorder
265074|NCT02029989|Diabetes|diabetes
265075|NCT02029989|Dyslipidemia|dyslipidemia
265076|NCT02029989|Hyperlipidemia|hyperlipidemia
265077|NCT02029989|Hypertension|hypertension
265078|NCT02029989|Obesity|obesity
265079|NCT02029989|Medication Therapy Management|medication therapy management
265080|NCT02029989|MTM|mtm
265081|NCT02029989|Pharmacist|pharmacist
265082|NCT02029989|Comprehensive Medication Management|comprehensive medication management
265083|NCT02029989|CMM|cmm
265084|NCT02029989|Health Disparity|health disparity
265085|NCT02029989|Monitoring|monitoring
265086|NCT02029989|Point of Care Testing|point of care testing
265087|NCT02029989|Chronic Persistent Mental Illness|chronic persistent mental illness
265088|NCT02029937|Squamous cell neoplasia|squamous cell neoplasia
265089|NCT02029937|Proflavine|proflavine
265090|NCT02029937|Lugol's chromoendoscopy|lugol's chromoendoscopy
265091|NCT02029911|Menorrhagia|menorrhagia
265092|NCT02029911|Excessive uterine bleeding|excessive uterine bleeding
265093|NCT02029911|Endometrial Ablation|endometrial ablation
265094|NCT02029898|cesarean section|cesarean section
265095|NCT02029898|anesthesia|anesthesia
265096|NCT02029898|children|children
265097|NCT02029885|Hypertension|hypertension
265098|NCT02029885|Renal Denervation|renal denervation
265099|NCT02029872|MRSA|mrsa
265100|NCT02029872|colonization|colonization
265101|NCT02029872|decolonization|decolonization
265102|NCT02029859|pregnancy (after 30 weeks of amenorhea)|pregnancy (after 30 weeks of amenorhea)
265103|NCT02029859|obesity (BMI>35)|obesity (bmi>35)
265104|NCT02029859|sleep apnea syndrom|sleep apnea syndrom
265105|NCT02029859|preeclampsy|preeclampsy
265106|NCT02029859|intrauterine growth restriction|intrauterine growth restriction
265107|NCT02029820|Contrast Nephropathy|contrast nephropathy
265108|NCT02029820|Prevention|prevention
265109|NCT02029820|Renalguard|renalguard
265110|NCT02029794|Cervical Cancer|cervical cancer
265111|NCT02029794|Cervical Cancer Screening|cervical cancer screening
265112|NCT02029794|Low Resource setting|low resource setting
265113|NCT02029794|HPV|hpv
265114|NCT02029794|Self-Collection|self-collection
265115|NCT02029794|VIA|via
265116|NCT02029781|Appendicitis|appendicitis
265117|NCT02029781|Laparoscopy|laparoscopy
265118|NCT02029781|Appendectomy|appendectomy
265119|NCT02029781|Negative appendectomy|negative appendectomy
265120|NCT02029781|Morbidity|morbidity
265121|NCT02029768|outcome|outcome
265122|NCT02029755|transversus abdominis plane block|transversus abdominis plane block
265123|NCT02029755|local infiltration|local infiltration
265124|NCT02029755|ropivacaine|ropivacaine
265125|NCT02029755|heart rate variability|heart rate variability
265126|NCT02029755|postoperative analgesia|postoperative analgesia
265127|NCT02029742|Sickle cell disease|sickle cell disease
265128|NCT02029742|Medication adherence|medication adherence
265129|NCT02029742|Hydroxyurea|hydroxyurea
265130|NCT02029742|Community health worker intervention|community health worker intervention
265131|NCT02029742|Sickle Cell Treatment|sickle cell treatment
265132|NCT02029729|RTA 408|rta 408
265133|NCT02029729|RTA 408 Capsules|rta 408 capsules
265134|NCT02029729|Non-small cell lung cancer|non-small cell lung cancer
265135|NCT02029729|Metastatic non-small cell lung cancer|metastatic non-small cell lung cancer
265136|NCT02029729|Incurable non-small cell lung cancer|incurable non-small cell lung cancer
265137|NCT02029729|Refractory melanoma|refractory melanoma
265138|NCT02029729|Relapsed melanoma|relapsed melanoma
265139|NCT02029716|RTA 408|rta 408
265140|NCT02029716|RTA 408 Lotion|rta 408 lotion
265141|NCT02029716|Oxidative stress|oxidative stress
265142|NCT02029716|Inflammation|inflammation
265143|NCT02029716|Volunteers|volunteers
265144|NCT02029703|Knee Osteoarthritis|knee osteoarthritis
265145|NCT02029703|Knee Pain|knee pain
265146|NCT02029703|Synvisc-One|synvisc-one
265147|NCT02029690|argininosuccinate synthetase|argininosuccinate synthetase
265148|NCT02029690|arginine|arginine
265149|NCT02029690|arginine deiminase|arginine deiminase
265150|NCT02029651|Stroke|stroke
265151|NCT02029651|Hand|hand
265152|NCT02029651|Rehabilitation|rehabilitation
265153|NCT02029651|Game|game
265154|NCT02029638|Kidney Transplantation|kidney transplantation
265155|NCT02029638|Renal Transplantation|renal transplantation
265156|NCT02029612|Tobacco Use Cessation|tobacco use cessation
265157|NCT02029612|Cancer Prevention|cancer prevention
265158|NCT02029612|HIV/AIDS|hiv/aids
265159|NCT02029612|Questionnaires|questionnaires
265160|NCT02029612|Surveys|surveys
265161|NCT02029612|Nicotine patch|nicotine patch
265162|NCT02029612|Breath test|breath test
265163|NCT02029612|Cell Phone Calls for Smoking Cessation Counseling|cell phone calls for smoking cessation counseling
265164|NCT02029612|Text Message Smoking Cessation Support|text message smoking cessation support
265165|NCT02029573|Phase II|phase ii
265166|NCT02029573|Atorvastatin|atorvastatin
265167|NCT02029573|Temozolomide|temozolomide
265168|NCT02029573|Radiotherapy|radiotherapy
265169|NCT02029573|Glioblastoma Multiforme (GBM)|glioblastoma multiforme (gbm)
265170|NCT02029534|post-operative atrial fibrillation|post-operative atrial fibrillation
265171|NCT02029534|POAF|poaf
265172|NCT02029534|A-Fib|a-fib
265173|NCT02029521|cystic fibrosis|cystic fibrosis
265174|NCT02029521|growth Failure|growth failure
265175|NCT02029521|glutathione|glutathione
265176|NCT02029508|PSCC(Posterior semicircular canal)|pscc(posterior semicircular canal)
265177|NCT02029508|BPPV(Bening paroxysmal positional vertigo)|bppv(bening paroxysmal positional vertigo)
265178|NCT02029508|Vertigo|vertigo
265179|NCT02029508|Otorhinolaryngologic Diseases|otorhinolaryngologic diseases
265180|NCT02029495|Psoriatic Arthritis|psoriatic arthritis
265181|NCT02029495|Brodalumab|brodalumab
265182|NCT02029495|AMG 827|amg 827
265183|NCT02029482|ACT-128800|act-128800
265184|NCT02029469|Humeral Resurfacing|humeral resurfacing
265185|NCT02029469|Humeral Resurfacing Arthroplasty|humeral resurfacing arthroplasty
265186|NCT02029456|Massive Pulmonary embolism|massive pulmonary embolism
265187|NCT02029456|thrombolytic therapy|thrombolytic therapy
265188|NCT02029456|high risk|high risk
265189|NCT02029456|elderly|elderly
265190|NCT02029443|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
265191|NCT02029430|HIV +|hiv +
265192|NCT02029430|HIV positive|hiv positive
265193|NCT02029430|AIDS|aids
265194|NCT02029430|Kaposi's sarcoma|kaposi's sarcoma
265195|NCT02029430|Sarcoma|sarcoma
265196|NCT02029430|tumor|tumor
265197|NCT02029430|cancer|cancer
265198|NCT02029391|Myofascial pain syndrome|myofascial pain syndrome
265199|NCT02029391|taping|taping
265200|NCT02029391|manual therapies|manual therapies
265201|NCT02029365|Infertility|infertility
265202|NCT02029365|desire for children|desire for children
265203|NCT02029365|eating disorder|eating disorder
265204|NCT02029365|anorexia nervosa|anorexia nervosa
265205|NCT02029365|bulimia nervosa|bulimia nervosa
265206|NCT02029365|eating disorders not otherwise specified|eating disorders not otherwise specified
265207|NCT02029352|Treatment|treatment
265208|NCT02029352|Sinecatechins|sinecatechins
265209|NCT02029339|Negative pressure wound therapy|negative pressure wound therapy
265210|NCT02029339|Acute wound infection|acute wound infection
265211|NCT02029339|complicated abdominal infection|complicated abdominal infection
265212|NCT02029339|Cytokines|cytokines
265213|NCT02029339|Matrix metalloproteinase|matrix metalloproteinase
265214|NCT02029326|colorectal cancer, cetuximab, biomarker, prometheus|colorectal cancer, cetuximab, biomarker, prometheus
265215|NCT02029300|pediatrics|pediatrics
265216|NCT02029300|fiberoptic intubation|fiberoptic intubation
265217|NCT02029300|oral intubation|oral intubation
265218|NCT02029300|nasal intubation|nasal intubation
265219|NCT02029300|children under the age of 2|children under the age of 2
265220|NCT02029287|Chronic heart failure|chronic heart failure
265221|NCT02029287|telemedicine|telemedicine
265222|NCT02029287|health service platform|health service platform
265223|NCT02029274|Dermatomyositis|dermatomyositis
265224|NCT02029261|Burn|burn
265225|NCT02029248|Anorectal malformation|anorectal malformation
265226|NCT02029248|fecal incontinence|fecal incontinence
265227|NCT02029248|quality of life|quality of life
265228|NCT02029248|child|child
265229|NCT02029235|Adult|adult
265230|NCT02029235|soft-tissue hand surgery|soft-tissue hand surgery
265231|NCT02029183|stroke, SAHS, BiPAP|stroke, sahs, bipap
265232|NCT02029170|ankle fracture|ankle fracture
265233|NCT02029170|weightbearing|weightbearing
265234|NCT02029170|cast|cast
265235|NCT02029118|Acupoint Application,Stable Angina Pectoris,herbal medicine|acupoint application,stable angina pectoris,herbal medicine
265236|NCT02029105|Mesothelioma,|mesothelioma,
265237|NCT02029105|Pleural diseases,|pleural diseases,
265238|NCT02029105|Mesothelin,|mesothelin,
265239|NCT02029105|Osteopontin,|osteopontin,
265240|NCT02029105|Hyaluronan,|hyaluronan,
265241|NCT02029105|Syndecan-1|syndecan-1
265242|NCT02029092|International|international
265243|NCT02029092|Multicenter|multicenter
265244|NCT02029092|Observational registry|observational registry
265245|NCT02029092|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
265246|NCT02029092|Stenting|stenting
265247|NCT02029092|Treatment of coronary artery disease|treatment of coronary artery disease
265248|NCT02029092|Coronary revascularization|coronary revascularization
265249|NCT02029092|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
265250|NCT02029092|STEMI|stemi
265251|NCT02029092|NSTEMI|nstemi
265252|NCT02029092|Ischemia|ischemia
265253|NCT02029092|Angina|angina
265254|NCT02029092|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
265255|NCT02029092|Small Vessels|small vessels
265256|NCT02029092|Chronical Total Occlusion (CTO)|chronical total occlusion (cto)
265257|NCT02029079|Malnutrition|malnutrition
265258|NCT02029066|actinic keratosis|actinic keratosis
265259|NCT02029066|SR-T100|sr-t100
265260|NCT02029066|pharmacokinetics|pharmacokinetics
265261|NCT02029053|Vaginal dryness|vaginal dryness
265262|NCT02029053|Vaginal lubrication|vaginal lubrication
265263|NCT02029053|Post-menopausal symptoms|post-menopausal symptoms
265264|NCT02029053|Peri-menopausal symptoms|peri-menopausal symptoms
265265|NCT02029053|Urogenital atrophy|urogenital atrophy
265267|NCT02029053|Painful intercourse|painful intercourse
265268|NCT02029040|Bronchiolitis|bronchiolitis
265269|NCT02029040|Hypertonic saline|hypertonic saline
265270|NCT02029040|Emergency Department|emergency department
265271|NCT02029027|Urinary Stress Incontinence|urinary stress incontinence
265272|NCT02029027|Urinary Mixed Incontinence|urinary mixed incontinence
265273|NCT02029014|LAmbre|lambre
265274|NCT02029001|Solid tumor|solid tumor
265275|NCT02029001|Recurrent/metastatic|recurrent/metastatic
265276|NCT02029001|Personalized medicine|personalized medicine
265277|NCT02029001|Genomic alteration|genomic alteration
265278|NCT02029001|Targeted therapy|targeted therapy
265279|NCT02029001|Nilotinib|nilotinib
265280|NCT02029001|Everolimus|everolimus
265281|NCT02029001|Sorafenib|sorafenib
265282|NCT02029001|Lapatinib|lapatinib
265283|NCT02029001|Pazopanib|pazopanib
265284|NCT02028988|Intermediate Risk Prostate Cancer|intermediate risk prostate cancer
265285|NCT02028962|Smoking cessation|smoking cessation
265286|NCT02028962|Romanian adults|romanian adults
265287|NCT02028923|topical morphine|topical morphine
265288|NCT02028910|gastroenteritis|gastroenteritis
265289|NCT02028910|pediatrics|pediatrics
265290|NCT02028910|vomiting|vomiting
265291|NCT02028897|In vitro fertilization|in vitro fertilization
265292|NCT02028897|IVF|ivf
265293|NCT02028897|Embryo culture|embryo culture
265294|NCT02028897|Blastocyst transfer|blastocyst transfer
265295|NCT02028832|pain|pain
265296|NCT02028832|nausea/vomiting|nausea/vomiting
265297|NCT02028832|anxiety|anxiety
265298|NCT02028832|complementary and alternative medicine|complementary and alternative medicine
265299|NCT02028832|pediatric|pediatric
265300|NCT02028832|oncology|oncology
265301|NCT02028832|cost-effectiveness|cost-effectiveness
265302|NCT02028793|Pharmaceutical Care, Taiwan, pharmacist, Workload, pressure|pharmaceutical care, taiwan, pharmacist, workload, pressure
265303|NCT02028741|neck pain|neck pain
265304|NCT02028741|transverse vertebral pressures|transverse vertebral pressures
265305|NCT02028741|thoracic mobilization|thoracic mobilization
265306|NCT02028728|International|international
265307|NCT02028728|Multicenter|multicenter
265308|NCT02028728|Observational registry|observational registry
265309|NCT02028728|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
265310|NCT02028728|Stenting|stenting
265311|NCT02028728|Treatment of coronary artery disease|treatment of coronary artery disease
265312|NCT02028728|Coronary revascularization|coronary revascularization
265313|NCT02028728|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
265314|NCT02028728|STEMI|stemi
265315|NCT02028728|NSTEMI|nstemi
265316|NCT02028728|Ischemia|ischemia
265317|NCT02028728|Angina|angina
265318|NCT02028728|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
265319|NCT02028728|Small Vessels|small vessels
265320|NCT02028728|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
265321|NCT02028715|IV Acetaminophen|iv acetaminophen
265322|NCT02028715|Ofirmev|ofirmev
265323|NCT02028715|Post-operative pain|post-operative pain
265324|NCT02028702|red clover|red clover
265325|NCT02028702|menopause|menopause
265326|NCT02028702|bioactive compounds|bioactive compounds
265327|NCT02028702|isoflavones|isoflavones
265328|NCT02028702|phytoestrogen|phytoestrogen
265329|NCT02028676|HIV|hiv
265330|NCT02028676|Africa|africa
265331|NCT02028676|children|children
265332|NCT02028676|antiretroviral therapy|antiretroviral therapy
265333|NCT02028676|laboratory monitoring|laboratory monitoring
265334|NCT02028676|toxicity|toxicity
265335|NCT02028676|CD4|cd4
265336|NCT02028676|induction maintenance|induction maintenance
265337|NCT02028676|cotrimoxazole|cotrimoxazole
265338|NCT02028676|prophylaxis|prophylaxis
265339|NCT02028676|abacavir|abacavir
265340|NCT02028676|lamivudine|lamivudine
265341|NCT02028676|once daily|once daily
265342|NCT02028663|P-CAB|p-cab
265343|NCT02028663|APA(Acid Pump Antagonist)|apa(acid pump antagonist)
265344|NCT02028650|relapse leukemia|relapse leukemia
265345|NCT02028650|DSI|dsi
265346|NCT02028637|asthma|asthma
265347|NCT02028637|toll like receptor|toll like receptor
265348|NCT02028637|innate immunity|innate immunity
265349|NCT02028624|Rheumatoid arthritis|rheumatoid arthritis
265350|NCT02028624|Mediterranean diet|mediterranean diet
265351|NCT02028624|Lifestyle intervention|lifestyle intervention
265352|NCT02028624|Adiponectin|adiponectin
265353|NCT02028624|Telephone counseling|telephone counseling
265354|NCT02028611|Rib fracture|rib fracture
265355|NCT02028611|Inverted grayscale|inverted grayscale
265356|NCT02028598|Clomipramine|clomipramine
265357|NCT02028598|Premature ejaculation|premature ejaculation
265358|NCT02028585|low-fat milk|low-fat milk
265359|NCT02028585|metabolic syndrome|metabolic syndrome
265360|NCT02028585|lipid profile|lipid profile
265361|NCT02028585|inflammation|inflammation
265362|NCT02028585|oxidative stress|oxidative stress
265363|NCT02028585|endothelial function|endothelial function
265364|NCT02028572|Structure function correlation|structure function correlation
265365|NCT02028572|Optical coherence tomography|optical coherence tomography
265366|NCT02028572|Retinal Nerve fibre layer thickness|retinal nerve fibre layer thickness
265367|NCT02028572|Visual fields|visual fields
265368|NCT02028572|Primary open angle glaucoma|primary open angle glaucoma
265369|NCT02028559|stones|stones
265370|NCT02028559|kidney|kidney
265371|NCT02028559|stone fragments|stone fragments
265372|NCT02028559|lithotripsy|lithotripsy
265373|NCT02028546|atopic dermatitis, skin cleansing, cleanser, moisturizer, skin hydration|atopic dermatitis, skin cleansing, cleanser, moisturizer, skin hydration
265374|NCT02028533|addiction|addiction
265375|NCT02028533|oxytocin|oxytocin
265376|NCT02028533|tolerability|tolerability
265377|NCT02028507|Palbociclib|palbociclib
265378|NCT02028507|Capecitabine|capecitabine
265379|NCT02028507|Hormonal Receptor positive|hormonal receptor positive
265380|NCT02028507|HER2 negative|her2 negative
265381|NCT02028507|Metastatic Breast Cancer|metastatic breast cancer
265382|NCT02028507|Resistance to non-steroidal Aromatase inhibitors|resistance to non-steroidal aromatase inhibitors
265383|NCT02028507|Fulvestrant|fulvestrant
265384|NCT02028507|Exemestane|exemestane
265385|NCT02028507|Aromatase inhibitor|aromatase inhibitor
265386|NCT02028481|Macular hole|macular hole
265387|NCT02028481|Vitreoretinal surgery|vitreoretinal surgery
265388|NCT02028481|Macular surgery|macular surgery
265389|NCT02028481|Air tamponade|air tamponade
265390|NCT02028468|Femoral Neck Fracture|femoral neck fracture
265391|NCT02028468|Anterolateral approach|anterolateral approach
265392|NCT02028468|Trans-gluteal approach|trans-gluteal approach
265393|NCT02028468|Watson Jones approach|watson jones approach
265394|NCT02028468|Hardinge approach|hardinge approach
265395|NCT02028455|pediatric|pediatric
265396|NCT02028455|young adult|young adult
265397|NCT02028455|acute lymphoblastic leukemia|acute lymphoblastic leukemia
265398|NCT02028455|CD19|cd19
265399|NCT02028455|leukemia|leukemia
265400|NCT02028455|Chimeric Antigen Receptor|chimeric antigen receptor
265401|NCT02028455|T cell|t cell
265402|NCT02028429|Minimal Hepatic Encephalopathy (MHE)|minimal hepatic encephalopathy (mhe)
265403|NCT02028429|Psychometric Hepatic Encephalopathy Score (PHES)|psychometric hepatic encephalopathy score (phes)
265404|NCT02028429|Sickness Impact Profile (SIP)|sickness impact profile (sip)
265405|NCT02028429|Model for End-stage Liver Disease (MELD)|model for end-stage liver disease (meld)
265406|NCT02028429|Child-Turcotte-Pugh score (CTP)|child-turcotte-pugh score (ctp)
265407|NCT02028416|pancytopenia|pancytopenia
265408|NCT02028416|aplastic anemia|aplastic anemia
265410|NCT02028416|Cyclosporin|cyclosporin
265411|NCT02028390|wounds|wounds
265412|NCT02028390|thermal|thermal
265413|NCT02028390|temperature|temperature
265414|NCT02028390|periwound|periwound
265415|NCT02028390|camera|camera
265416|NCT02028390|imaging|imaging
265417|NCT02028377|Adenocarcinoma|adenocarcinoma
265418|NCT02028377|imaging|imaging
265419|NCT02028377|PET|pet
265420|NCT02028377|MRI|mri
265421|NCT02028364|Locally advanced breast cancer|locally advanced breast cancer
265422|NCT02028364|HER2 negative|her2 negative
265423|NCT02028364|NSAI refractory|nsai refractory
265424|NCT02028364|Metastatic breast cancer|metastatic breast cancer
265425|NCT02028364|Estrogen-receptor positive (ER+)|estrogen-receptor positive (er+)
265426|NCT02028351|visual acuity|visual acuity
265427|NCT02028351|contrast sensitivity|contrast sensitivity
265428|NCT02028351|cataract|cataract
265429|NCT02028351|maculopathy|maculopathy
265430|NCT02028312|Dry Eye|dry eye
265431|NCT02028299|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
265432|NCT02028299|Pulmonary Vascular Resistance|pulmonary vascular resistance
265433|NCT02028299|Right Heart Catheterization|right heart catheterization
265434|NCT02028286|Rosacea|rosacea
265435|NCT02028273|Neurogenesis|neurogenesis
265436|NCT02028273|Addiction|addiction
265437|NCT02028273|Cocaine|cocaine
265438|NCT02028273|MRI|mri
265439|NCT02028273|MRS|mrs
265440|NCT02028247|Autism spectrum disorders|autism spectrum disorders
265441|NCT02028247|Autism|autism
265442|NCT02028247|Asperger's syndrome|asperger's syndrome
265443|NCT02028247|Pervasive developmental disability - not otherwise specified|pervasive developmental disability - not otherwise specified
265444|NCT02028247|obsessive-compulsive disorder|obsessive-compulsive disorder
265445|NCT02028247|Social phobia|social phobia
265446|NCT02028247|Generalized anxiety disorder|generalized anxiety disorder
265447|NCT02028247|Specific phobia|specific phobia
265448|NCT02028247|Separation anxiety disorder|separation anxiety disorder
265449|NCT02028247|Counseling|counseling
265450|NCT02028247|Cognitive-behavioral therapy|cognitive-behavioral therapy
265451|NCT02028247|Psychotherapy|psychotherapy
265452|NCT02028221|Breast cancer prevention|breast cancer prevention
265453|NCT02028221|metformin|metformin
265454|NCT02028221|Breast cancer risk reduction|breast cancer risk reduction
265455|NCT02028208|Patch Test|patch test
265456|NCT02028208|Allergy Testing|allergy testing
265457|NCT02028208|Contact Dermatitis|contact dermatitis
265458|NCT02028208|Mercury, Aluminum or Palladium skin allergy|mercury, aluminum or palladium skin allergy
265459|NCT02028195|Health check|health check
265460|NCT02028195|Health promotion|health promotion
265461|NCT02028195|prevention diabetes|prevention diabetes
265462|NCT02028195|prevention cardiovascular disease|prevention cardiovascular disease
265463|NCT02028195|mental health|mental health
265464|NCT02028182|Patch Test|patch test
265465|NCT02028182|Allergy Testing|allergy testing
265466|NCT02028182|Contact dermatitis|contact dermatitis
265467|NCT02028182|Lyral allergen|lyral allergen
265468|NCT02028182|Fragrance Mix allergen|fragrance mix allergen
265469|NCT02028169|Work Productivity|work productivity
265470|NCT02028169|Anti-TNFs|anti-tnfs
265471|NCT02028169|Psoriatic Arthritis|psoriatic arthritis
265472|NCT02028143|Atrial Fibrillation|atrial fibrillation
265473|NCT02028130|Atrial fibrillation|atrial fibrillation
265474|NCT02028130|Ablation|ablation
265475|NCT02028130|Left atrial appendage occlusion|left atrial appendage occlusion
265476|NCT02028130|Stroke prevention|stroke prevention
265477|NCT02028091|Pulse walve arrival time differences|pulse walve arrival time differences
265478|NCT02028078|Endogenous glucose production|endogenous glucose production
265479|NCT02028078|Type 1 diabetes mellitus|type 1 diabetes mellitus
265480|NCT02028078|hypoglycaemic clamp|hypoglycaemic clamp
265481|NCT02028078|tracer to technique|tracer to technique
265482|NCT02028078|pharmacodynamics|pharmacodynamics
265483|NCT02028078|pharmacokinetics|pharmacokinetics
265484|NCT02028065|reversal of neuromuscular blockade|reversal of neuromuscular blockade
265485|NCT02028052|enlarged mediastinal nodes|enlarged mediastinal nodes
265486|NCT02028052|enlarged hilar lymph nodes|enlarged hilar lymph nodes
265487|NCT02028039|Leukemia|leukemia
265488|NCT02028039|Refractory Acute Lymphoblastic Leukemia|refractory acute lymphoblastic leukemia
265489|NCT02028039|ALL|all
265490|NCT02028039|Burkitt's lymphoma|burkitt's lymphoma
265491|NCT02028039|Lymphoblastic lymphoma|lymphoblastic lymphoma
265492|NCT02028039|IPI-145|ipi-145
265493|NCT02028026|Depressive Disorder|depressive disorder
265494|NCT02028026|Anxiety|anxiety
265495|NCT02028026|Comorbidity|comorbidity
265496|NCT02028026|Magnetic Resonance Imaging|magnetic resonance imaging
265497|NCT02028026|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
265498|NCT02028026|Citalopram|citalopram
265499|NCT02028026|Vilazodone|vilazodone
265500|NCT02028026|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
265501|NCT02028026|Receptor, Serotonin, 5-HT1A|receptor, serotonin, 5-ht1a
265502|NCT02028013|Erectile dysfunction, sexual dysfunction, bioresonance|erectile dysfunction, sexual dysfunction, bioresonance
265503|NCT02028000|Pregnancy|pregnancy
265504|NCT02028000|Pregnant|pregnant
265505|NCT02028000|Cesarean Section Delivery|cesarean section delivery
265506|NCT02027987|valproate acid|valproate acid
265507|NCT02027987|traumatic brain injury|traumatic brain injury
265508|NCT02027987|brain protection|brain protection
265509|NCT02027987|epilepsy|epilepsy
265510|NCT02027974|Hip|hip
265511|NCT02027974|Arthroplasty|arthroplasty
265512|NCT02027974|Arthroplasties|arthroplasties
265513|NCT02027974|Prosthesis|prosthesis
265514|NCT02027974|Iconacy|iconacy
265515|NCT02027974|Osteoarthritis|osteoarthritis
265516|NCT02027974|Arthritis|arthritis
265517|NCT02027974|THA|tha
265518|NCT02027974|THR|thr
265519|NCT02027974|DJD|djd
265520|NCT02027961|Metastatic or Unresectable Melanoma, MEDI4736, dafrafenib, trametinib, BRAF-mutation positive, wild-type BRAF, PD-L1, PD-1|metastatic or unresectable melanoma, medi4736, dafrafenib, trametinib, braf-mutation positive, wild-type braf, pd-l1, pd-1
265521|NCT02027948|nutritional management algorithm|nutritional management algorithm
265522|NCT02027948|nutritional and functional assessments|nutritional and functional assessments
265523|NCT02027948|13-264|13-264
265524|NCT02027935|Melanoma|melanoma
265525|NCT02027935|Metastatic|metastatic
265526|NCT02027935|CD8+ T cells|cd8+ t cells
265527|NCT02027935|White blood cell|white blood cell
265528|NCT02027935|Leukapheresis|leukapheresis
265529|NCT02027935|Cyclophosphamide|cyclophosphamide
265530|NCT02027935|Cytoxan|cytoxan
265531|NCT02027935|Neosar|neosar
265532|NCT02027935|Interleukin-2|interleukin-2
265533|NCT02027935|Aldesleukin|aldesleukin
265534|NCT02027935|IL-2|il-2
265535|NCT02027935|Proleukin|proleukin
265536|NCT02027935|Ipilimumab|ipilimumab
265537|NCT02027935|Yervoy|yervoy
265538|NCT02027935|BMS-734016|bms-734016
265539|NCT02027935|MDX010|mdx010
265540|NCT02027922|white spot lesion|white spot lesion
265541|NCT02027922|caries|caries
265542|NCT02027909|Sinus Node Dysfunction|sinus node dysfunction
265543|NCT02027896|Perioperative outcomes|perioperative outcomes
265544|NCT02027883|Defibrillators|defibrillators
265545|NCT02027883|Ventricular Fibrillation Induction Testing|ventricular fibrillation induction testing
265546|NCT02027870|DES|des
265547|NCT02027870|CAD|cad
265548|NCT02027870|EXCEL-II|excel-ii
265549|NCT02027870|JWMS|jwms
265550|NCT02027870|PCI|pci
265551|NCT02027857|brain electrical impedance;|brain electrical impedance;
265552|NCT02027857|traumatic brain injury;|traumatic brain injury;
265553|NCT02027857|brain edema;|brain edema;
265554|NCT02027857|intracranial pressure|intracranial pressure
265555|NCT02027831|lymph nodes|lymph nodes
265556|NCT02027818|margins|margins
265557|NCT02027818|tumorectomy|tumorectomy
265558|NCT02027805|Steroid-resistant|steroid-resistant
265559|NCT02027805|Graft vs Host Disease|graft vs host disease
265560|NCT02027805|Refractory acute Graft vs Host Disease|refractory acute graft vs host disease
265561|NCT02027805|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
265562|NCT02027805|Stem Cell Transplantation|stem cell transplantation
265563|NCT02027805|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
265564|NCT02027805|Immune System Diseases|immune system diseases
265565|NCT02027805|Antibodies, monoclonal|antibodies, monoclonal
265566|NCT02027805|Immunotoxins|immunotoxins
265567|NCT02027805|Immunosuppressive agents|immunosuppressive agents
265568|NCT02027779|GreenGene™ F, Previously Treated Patients|greengene™ f, previously treated patients
265569|NCT02027727|inflammatory bowel disease|inflammatory bowel disease
265570|NCT02027727|infliximab|infliximab
265571|NCT02027727|trough level|trough level
265572|NCT02027727|crohn's disease|crohn's disease
265573|NCT02027727|ulcerative colitis|ulcerative colitis
265574|NCT02027714|Discordant|discordant
265575|NCT02027714|Lesotho|lesotho
265576|NCT02027714|Couples|couples
265577|NCT02027714|Enhanced Prevention Package (EPP)|enhanced prevention package (epp)
265578|NCT02027714|ART|art
265579|NCT02027714|Counseling|counseling
265580|NCT02027714|Male Circumcision|male circumcision
265581|NCT02027688|Oral feeding|oral feeding
265582|NCT02027688|Premature|premature
265583|NCT02027688|Infants|infants
265584|NCT02027688|Neonatal Intensive Care Unit|neonatal intensive care unit
265585|NCT02027675|exercise|exercise
265586|NCT02027675|immune function|immune function
265587|NCT02027675|inflammation|inflammation
265588|NCT02027675|immunity|immunity
265589|NCT02027675|diet|diet
265590|NCT02027675|obesity|obesity
265591|NCT02027675|asthma|asthma
265592|NCT02027649|Bladder cancer|bladder cancer
265593|NCT02027649|Keratin 14|keratin 14
265594|NCT02027649|Pronostic marker|pronostic marker
265595|NCT02027649|Diagnostic marker|diagnostic marker
265596|NCT02027649|Noninvasive technique|noninvasive technique
265597|NCT02027636|Depression|depression
265598|NCT02027636|Latinos|latinos
265599|NCT02027636|Mental Health|mental health
265600|NCT02027636|Disparities|disparities
265601|NCT02027623|Mechanical low back pain|mechanical low back pain
265602|NCT02027623|Non-specific low back pain|non-specific low back pain
265603|NCT02027623|Exercise|exercise
265604|NCT02027623|Motor skill training|motor skill training
265605|NCT02027610|Infant|infant
265606|NCT02027610|Bangladesh|bangladesh
265607|NCT02027610|vitamin A|vitamin a
265608|NCT02027610|microbiota|microbiota
265609|NCT02027610|vaccine|vaccine
265610|NCT02027610|immunity|immunity
265611|NCT02027597|video games|video games
265612|NCT02027597|oral health|oral health
265613|NCT02027597|social cognitive theory|social cognitive theory
265614|NCT02027597|behavior change|behavior change
265615|NCT02027597|randomized trial|randomized trial
265616|NCT02027597|growth modeling|growth modeling
265617|NCT02027597|minority|minority
265618|NCT02027597|gender|gender
265619|NCT02027584|infant, premature|infant, premature
265620|NCT02027584|infant, newborn|infant, newborn
265621|NCT02027584|choline|choline
265622|NCT02027571|Diabetes|diabetes
265623|NCT02027571|Race/Ethnicity|race/ethnicity
265624|NCT02027571|Offspring Cohort|offspring cohort
265625|NCT02027571|African Americans|african americans
265626|NCT02027571|Prediabetes Reversal|prediabetes reversal
265627|NCT02027571|Lifestyle Intervention|lifestyle intervention
265628|NCT02027571|Insulin Sensitivity|insulin sensitivity
265629|NCT02027571|Beta-cell Function|beta-cell function
265630|NCT02027571|Diabetes Prevention|diabetes prevention
265631|NCT02027558|cognitive behavioral therapy|cognitive behavioral therapy
265632|NCT02027558|insomnia|insomnia
265633|NCT02027558|apnea|apnea
265634|NCT02027545|cancer screening|cancer screening
265635|NCT02027545|decision making|decision making
265636|NCT02027519|Self-testing|self-testing
265637|NCT02027519|Home-based testing|home-based testing
265638|NCT02027519|Lesotho|lesotho
265639|NCT02027519|Discordant|discordant
265641|NCT02027506|aVL|avl
265642|NCT02027506|CHRONIC STABLE ANGINA|chronic stable angina
265643|NCT02027506|T WAVE|t wave
265644|NCT02027493|Children|children
265645|NCT02027493|Chronic hepatitis C|chronic hepatitis c
265646|NCT02027493|Hansenula polymorpha|hansenula polymorpha
265647|NCT02027493|Pegylated interferon|pegylated interferon
265648|NCT02027493|Response rate|response rate
265649|NCT02027493|Ribavirin|ribavirin
265650|NCT02027493|Treatment|treatment
265651|NCT02027480|Antiretroviral Therapy (ART)|antiretroviral therapy (art)
265652|NCT02027480|Biomarkers|biomarkers
265653|NCT02027480|Nyanza Province|nyanza province
265654|NCT02027480|Kenya|kenya
265655|NCT02027467|Hematopoietic stem cells|hematopoietic stem cells
265656|NCT02027467|Herbal|herbal
265657|NCT02027467|Dietary|dietary
265658|NCT02027467|CD cells|cd cells
265659|NCT02027467|Basic research|basic research
265660|NCT02027454|GSK1265744|gsk1265744
265661|NCT02027454|HIV|hiv
265662|NCT02027454|placebo|placebo
265663|NCT02027454|cardiac repolarization|cardiac repolarization
265664|NCT02027454|12-lead ECG|12-lead ecg
265665|NCT02027454|moxifloxacin|moxifloxacin
265666|NCT02027454|QTc|qtc
265667|NCT02027441|Serodiscordant|serodiscordant
265668|NCT02027441|Lesotho|lesotho
265669|NCT02027441|Home-based testing|home-based testing
265670|NCT02027428|Nab-paclitaxel|nab-paclitaxel
265671|NCT02027428|Albumin bound paclitaxel|albumin bound paclitaxel
265672|NCT02027428|Taxanes|taxanes
265673|NCT02027428|Maintenance trials|maintenance trials
265674|NCT02027428|Celgene|celgene
265675|NCT02027428|Abraxane|abraxane
265676|NCT02027428|ABI-007|abi-007
265677|NCT02027428|NSCLC|nsclc
265678|NCT02027428|Non-Small Cell Lung Cancer|non-small cell lung cancer
265679|NCT02027428|Cancer of the Lung|cancer of the lung
265680|NCT02027428|Carcinoma, Squamous Cell|carcinoma, squamous cell
265681|NCT02027428|Lung Neoplasms|lung neoplasms
265682|NCT02027428|Abound.sqm|abound.sqm
265683|NCT02027415|air pollution|air pollution
265684|NCT02027415|food|food
265685|NCT02027415|nitrites|nitrites
265686|NCT02027415|nitrates|nitrates
265687|NCT02027415|breath tests/methods|breath tests/methods
265688|NCT02027389|MSSA, MRSA|mssa, mrsa
265689|NCT02027376|Advanced Breast Cancer|advanced breast cancer
265690|NCT02027376|LDE225|lde225
265691|NCT02027376|Triple Negative|triple negative
265692|NCT02027376|Hormonal Receptor negative|hormonal receptor negative
265693|NCT02027376|Her2 negative|her2 negative
265694|NCT02027363|Metastasis colorectal cancer|metastasis colorectal cancer
265695|NCT02027363|Maintenance|maintenance
265696|NCT02027363|First-line treatment|first-line treatment
265697|NCT02027363|Capecitabine|capecitabine
265698|NCT02027337|combined oral contraceptives|combined oral contraceptives
265699|NCT02027337|drospirenone|drospirenone
265700|NCT02027337|cyproterone|cyproterone
265701|NCT02027337|hemostasis|hemostasis
265702|NCT02027337|antioxidants|antioxidants
265703|NCT02027324|Surgical site infection|surgical site infection
265704|NCT02027324|Cesarean delivery|cesarean delivery
265705|NCT02027324|Antisepsis|antisepsis
265706|NCT02027324|Povidone iodine|povidone iodine
265707|NCT02027324|Chlorhexidine alcohol|chlorhexidine alcohol
265708|NCT02027324|Endometritis|endometritis
265709|NCT02027311|Endoscopic Retrograde Cholangiopancreatography (ERCP)|endoscopic retrograde cholangiopancreatography (ercp)
265710|NCT02027311|Conscious Sedation|conscious sedation
265711|NCT02027311|etomidate|etomidate
265712|NCT02027311|midazolam|midazolam
265713|NCT02027298|Abatacept|abatacept
265714|NCT02027298|Sjogren's Syndrome|sjogren's syndrome
265715|NCT02027298|Rheumatoid Arthritis|rheumatoid arthritis
265716|NCT02027285|fortified milk, aging, health status|fortified milk, aging, health status
265717|NCT02027272|Eclampsia|eclampsia
265718|NCT02027259|Diabetes|diabetes
265719|NCT02027259|Depression|depression
265720|NCT02027259|Group|group
265721|NCT02027246|spinal cord injury|spinal cord injury
265722|NCT02027246|autologous bone marrow mononuclear cells|autologous bone marrow mononuclear cells
265723|NCT02027246|stem cell therapy|stem cell therapy
265724|NCT02027233|Prevention|prevention
265725|NCT02027233|Influenza|influenza
265726|NCT02027233|Adults hospitalized|adults hospitalized
265727|NCT02027233|Vaccines|vaccines
265728|NCT02027233|Effectiveness|effectiveness
265729|NCT02027207|Cholera|cholera
265730|NCT02027207|Oral cholera vaccine|oral cholera vaccine
265731|NCT02027207|Shanchol|shanchol
265732|NCT02027207|Protective efficacy|protective efficacy
265733|NCT02027207|Bangladesh|bangladesh
265734|NCT02027194|Allergic Rhinitis|allergic rhinitis
265735|NCT02027194|Chinese herbal medicine|chinese herbal medicine
265736|NCT02027194|Adolescents|adolescents
265737|NCT02027194|Double-blinded|double-blinded
265738|NCT02027194|Randomized controlled trial|randomized controlled trial
265739|NCT02027168|infertility|infertility
265740|NCT02027168|elevated FSH|elevated fsh
265741|NCT02027168|alternative treatment|alternative treatment
265742|NCT02027168|Clear Passage Approach|clear passage approach
265743|NCT02027168|Clear Passage Physical Therapy|clear passage physical therapy
265744|NCT02027155|healthy volunteers|healthy volunteers
265745|NCT02027129|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
265746|NCT02027129|Cor Pulmonale|cor pulmonale
265747|NCT02027129|High Frequency Ventilaiton|high frequency ventilaiton
265748|NCT02027116|chronic hepatitis C|chronic hepatitis c
265749|NCT02027116|DNA Vaccine|dna vaccine
265750|NCT02027116|Electroporation|electroporation
265751|NCT02027116|Intramuscular (IM) Injection|intramuscular (im) injection
265752|NCT02027103|Fetuin-A|fetuin-a
265753|NCT02027103|OPG|opg
265754|NCT02027103|Metformin|metformin
265755|NCT02027103|Pioglitazone|pioglitazone
265756|NCT02027077|physical activity|physical activity
265757|NCT02027077|diet|diet
265758|NCT02027077|small change|small change
265759|NCT02027077|behavior change|behavior change
265760|NCT02027051|population genetics|population genetics
265761|NCT02027025|Spasticity, Multiple sclerosis|spasticity, multiple sclerosis
265762|NCT02026934|Graft-Versus-Host Disease(GVHD)|graft-versus-host disease(gvhd)
265763|NCT02026934|Hematopoietic Stem Cell Transplantation.|hematopoietic stem cell transplantation.
265764|NCT02026934|Graft failure|graft failure
265765|NCT02026934|Graft exhaustion|graft exhaustion
265766|NCT02026921|Phase II study,|phase ii study,
265767|NCT02026921|Recurrent platinum-sensitive ovarian cancer|recurrent platinum-sensitive ovarian cancer
265768|NCT02026921|docetaxel|docetaxel
265769|NCT02026921|Carboplatin|carboplatin
265770|NCT02026921|Toxicity|toxicity
265771|NCT02026908|Prostate Artery Embolization|prostate artery embolization
265772|NCT02026908|PAE|pae
265773|NCT02026908|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
265774|NCT02026908|BPH|bph
265775|NCT02026908|Lower Urinary Tract Symptoms|lower urinary tract symptoms
265776|NCT02026908|LUTS|luts
265777|NCT02026882|Airway, Caesarean|airway, caesarean
265778|NCT02026869|Vaginal administration, PCOS, Metformin|vaginal administration, pcos, metformin
265779|NCT02026856|oxidative stress, sepsis, selenium|oxidative stress, sepsis, selenium
265780|NCT02026830|Diabetic foot infections|diabetic foot infections
265781|NCT02026830|microorganisms|microorganisms
265782|NCT02026791|Supraglottic airway device|supraglottic airway device
265783|NCT02026791|I-gel|i-gel
265784|NCT02026791|SupremeLMA|supremelma
265785|NCT02026791|Elderly patient|elderly patient
265786|NCT02026739|minimally invasive esophagectomy; pulmonary function|minimally invasive esophagectomy; pulmonary function
265787|NCT02026674|urineflow|urineflow
265788|NCT02026674|luts|luts
265789|NCT02026674|urine flow|urine flow
265790|NCT02026674|uroflometry|uroflometry
265791|NCT02026674|bph|bph
265792|NCT02026635|heart failure|heart failure
265793|NCT02026635|Optivol® cardiac device|optivol® cardiac device
265794|NCT02026635|Medtronic CareLink|medtronic carelink
265795|NCT02026622|major depressive disorder|major depressive disorder
265796|NCT02026622|cerebrovascular reactivity|cerebrovascular reactivity
265797|NCT02026622|emotional reactivity|emotional reactivity
265798|NCT02026609|TIPS|tips
265799|NCT02026609|Hepatic encephalopathy|hepatic encephalopathy
265800|NCT02026609|Oral glutamine challenge|oral glutamine challenge
265801|NCT02026609|Psychometric tests|psychometric tests
265802|NCT02026609|Portal hypertension|portal hypertension
265803|NCT02026609|Cirrhosis|cirrhosis
265804|NCT02026596|subrachnoid hemorrhage|subrachnoid hemorrhage
265805|NCT02026596|secondary brain injury|secondary brain injury
265806|NCT02026570|Prosthesis|prosthesis
265807|NCT02026570|Falls|falls
265808|NCT02026570|Training|training
265809|NCT02026544|low frequency ultrasound|low frequency ultrasound
265810|NCT02026544|glomerular filtration rate|glomerular filtration rate
265811|NCT02026492|exercise-induced bronchoconstriction|exercise-induced bronchoconstriction
265812|NCT02026492|exercise-induced asthma|exercise-induced asthma
265813|NCT02026492|cold chamber|cold chamber
265814|NCT02026492|exercise challenge|exercise challenge
265815|NCT02026492|cold air challenge|cold air challenge
265816|NCT02026492|combined exercise- and cold-air challenge|combined exercise- and cold-air challenge
265817|NCT02026492|methacholine challenge|methacholine challenge
265818|NCT02026479|full-frequency sudden hearing loss|full-frequency sudden hearing loss
265819|NCT02026479|post auricular injection|post auricular injection
265820|NCT02026479|glucocorticoid|glucocorticoid
265821|NCT02026479|multi-center|multi-center
265822|NCT02026466|Coronary Artery Disease|coronary artery disease
265823|NCT02026466|Chronic Total Occlusion|chronic total occlusion
265824|NCT02026453|Adverse drug events|adverse drug events
265825|NCT02026440|oral fluid collection device cotinine detection|oral fluid collection device cotinine detection
265826|NCT02026414|PrimaVie|primavie
265827|NCT02026414|Herbal Supplement|herbal supplement
265828|NCT02026414|Muscle biopsy|muscle biopsy
265829|NCT02026414|Energy|energy
265830|NCT02026414|Exercise|exercise
265831|NCT02026414|Human skeletal muscle adaptation|human skeletal muscle adaptation
265832|NCT02026414|Muscle function|muscle function
265833|NCT02026388|PH|ph
265834|NCT02026388|primary hyperoxaluria|primary hyperoxaluria
265835|NCT02026388|hyperoxaluria|hyperoxaluria
265836|NCT02026388|primary oxalosis|primary oxalosis
265837|NCT02026388|Primary Hyperoxaluria Type 1|primary hyperoxaluria type 1
265838|NCT02026388|Primary Hyperoxaluria Type 2|primary hyperoxaluria type 2
265839|NCT02026388|Primary Hyperoxaluria Type 3|primary hyperoxaluria type 3
265840|NCT02026388|Dent|dent
265841|NCT02026388|Dents|dents
265842|NCT02026388|Dent Disease|dent disease
265843|NCT02026388|Dent 1|dent 1
265844|NCT02026388|Dent 2|dent 2
265845|NCT02026388|Cystinuria|cystinuria
265846|NCT02026388|APRT|aprt
265847|NCT02026388|APRT deficiency|aprt deficiency
265848|NCT02026388|Biobank|biobank
265849|NCT02026362|HCC|hcc
265850|NCT02026362|DC|dc
265851|NCT02026362|CTL|ctl
265852|NCT02026349|influenza|influenza
265853|NCT02026349|flu|flu
265854|NCT02026349|fever|fever
265855|NCT02026349|cough|cough
265856|NCT02026349|body aches|body aches
265857|NCT02026349|headache|headache
265858|NCT02026349|nasal congestion|nasal congestion
265859|NCT02026349|body pains|body pains
265860|NCT02026349|sore throat|sore throat
265861|NCT02026349|fatigue|fatigue
265862|NCT02026349|T-705|t-705
265863|NCT02026349|favipiravir|favipiravir
265864|NCT02026349|favor|favor
265865|NCT02026349|flu symptoms|flu symptoms
265866|NCT02026336|asthma; inflammation; electronic nose|asthma; inflammation; electronic nose
265867|NCT02026310|glimepiride|glimepiride
265868|NCT02026310|metformin|metformin
265869|NCT02026310|basal insulin|basal insulin
265870|NCT02026310|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
265871|NCT02026310|glucose fluctuation|glucose fluctuation
265872|NCT02026310|hypoglycemia|hypoglycemia
265873|NCT02026297|postpartum hemorrhage|postpartum hemorrhage
265874|NCT02026297|estimated blood loss|estimated blood loss
265875|NCT02026297|coagulation|coagulation
265876|NCT02026297|thromboelastography|thromboelastography
265877|NCT02026297|tranexamic acid|tranexamic acid
265878|NCT02026284|Caesarean section|caesarean section
265879|NCT02026284|Anaesthesia|anaesthesia
265880|NCT02026284|Questionnaires|questionnaires
265881|NCT02026245|Arthritis|arthritis
265882|NCT02026245|rheumatoid|rheumatoid
265883|NCT02026245|joints|joints
265884|NCT02026245|swelling|swelling
265885|NCT02026245|measurement|measurement
265886|NCT02026245|movement|movement
265887|NCT02026245|electronic|electronic
265888|NCT02026245|data|data
265889|NCT02026245|glove|glove
265890|NCT02026245|goniometry|goniometry
265891|NCT02026245|outcome|outcome
265892|NCT02026245|stiffness|stiffness
265893|NCT02026232|Type 2 Diabetes|type 2 diabetes
265894|NCT02026232|Overweight|overweight
265895|NCT02026206|Primary Dysmenorrhea|primary dysmenorrhea
265896|NCT02026206|Pain|pain
265897|NCT02026167|Chronic Pain|chronic pain
265898|NCT02026167|Mood|mood
265899|NCT02026167|Physical Activity|physical activity
265900|NCT02026154|hypertension, biomarkers, echocardiography, heart failure|hypertension, biomarkers, echocardiography, heart failure
265901|NCT02026128|Uveitis|uveitis
265902|NCT02026128|Inflammation|inflammation
265903|NCT02026128|OCT|oct
265904|NCT02026128|Grading|grading
265905|NCT02026115|cancer|cancer
265906|NCT02026115|hospice|hospice
265907|NCT02026115|pain|pain
265908|NCT02026102|decision aid|decision aid
265909|NCT02026102|patient decision making|patient decision making
265910|NCT02026102|heart failure|heart failure
265911|NCT02026102|ejection fraction|ejection fraction
265912|NCT02026102|primary prevention|primary prevention
265913|NCT02026102|implantable cardioverter defibrillator|implantable cardioverter defibrillator
265914|NCT02026102|ICD|icd
265915|NCT02026102|pilot trial|pilot trial
265916|NCT02026102|patient centered health care|patient centered health care
265917|NCT02026076|low back pain|low back pain
265918|NCT02026076|traction|traction
265919|NCT02026076|unloading|unloading
265920|NCT02026050|dexamethasone|dexamethasone
265921|NCT02026050|intraarticular injection|intraarticular injection
265922|NCT02026050|interscalene brachial plexus block|interscalene brachial plexus block
265923|NCT02026037|Stress Disorders|stress disorders
265924|NCT02026037|Post-Traumatic|post-traumatic
265925|NCT02026037|Burns|burns
265926|NCT02026037|Brief Psychotherapy|brief psychotherapy
265927|NCT02026037|Cognitive Behavior Therapy|cognitive behavior therapy
265928|NCT02026011|alcohol use disorder|alcohol use disorder
265929|NCT02026011|naltrexone|naltrexone
265930|NCT02026011|Asian American|asian american
265931|NCT02026011|pharmacogenetics|pharmacogenetics
265932|NCT02026011|OPRM1 gene|oprm1 gene
265933|NCT02025998|ibudilast, alcoholism|ibudilast, alcoholism
265934|NCT02025985|Karyopharm|karyopharm
265935|NCT02025985|KPT-330|kpt-330
265936|NCT02025985|Selinexor|selinexor
265937|NCT02025985|SIGN|sign
265938|NCT02025985|ovarian cancer|ovarian cancer
265939|NCT02025985|endometrial cancer|endometrial cancer
265940|NCT02025985|cervical cancer|cervical cancer
265941|NCT02025985|SINE™|sine™
265942|NCT02025985|breast cancer|breast cancer
265943|NCT02025985|HER2 negative|her2 negative
265944|NCT02025972|Cerebral palsy|cerebral palsy
265945|NCT02025972|Umbilical cord blood|umbilical cord blood
265946|NCT02025972|Rehabilitation|rehabilitation
265947|NCT02025972|Cytokine|cytokine
265948|NCT02025972|Outcome|outcome
265949|NCT02025959|staff empowerment|staff empowerment
265950|NCT02025959|Sleep Apnea|sleep apnea
265951|NCT02025959|educational intervention|educational intervention
265952|NCT02025933|Children|children
265953|NCT02025933|Age 9-12 years|age 9-12 years
265954|NCT02025933|Overweight (iso-BMI > 25)|overweight (iso-bmi > 25)
265955|NCT02025907|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
265956|NCT02025907|Canagliflozin|canagliflozin
265957|NCT02025907|Hemoglobin A1c|hemoglobin a1c
265958|NCT02025907|Metformin|metformin
265959|NCT02025907|Sitagliptin|sitagliptin
265960|NCT02025907|T2DM|t2dm
265961|NCT02025907|JNJ-28431754|jnj-28431754
265962|NCT02025894|neoplastic solid tumour|neoplastic solid tumour
265963|NCT02025894|PCVC|pcvc
265964|NCT02025894|thromboembolic complications|thromboembolic complications
265965|NCT02025894|infectious complications|infectious complications
265966|NCT02025894|risk factors|risk factors
265967|NCT02025868|Africa|africa
265968|NCT02025868|Antiretroviral Treatment|antiretroviral treatment
265969|NCT02025868|Adherence reinforcement|adherence reinforcement
265970|NCT02025868|Third line ART|third line art
265971|NCT02025868|Second line ART|second line art
265972|NCT02025868|Virologic failure|virologic failure
265973|NCT02025868|Adults|adults
266272|NCT02024672|postpartum|postpartum
265974|NCT02025855|Iatrogenic opioid abstinence syndrome|iatrogenic opioid abstinence syndrome
265975|NCT02025855|Methadone|methadone
265976|NCT02025855|Mechanical ventilation|mechanical ventilation
265977|NCT02025855|ICU delirium|icu delirium
265978|NCT02025855|Continuous sedation|continuous sedation
265979|NCT02025842|Hepatocellular carcinoma|hepatocellular carcinoma
265980|NCT02025842|Hepatitis B|hepatitis b
265981|NCT02025829|cystic fibrosis|cystic fibrosis
265982|NCT02025829|IL-17 neutrophils|il-17 neutrophils
265983|NCT02025803|Advanced solid tumors|advanced solid tumors
265984|NCT02025790|Achalasia|achalasia
265985|NCT02025790|POEM|poem
265986|NCT02025790|Pneumatic dilatation|pneumatic dilatation
265987|NCT02025790|Eckardt score|eckardt score
265988|NCT02025777|Ulcerative Colitis|ulcerative colitis
265989|NCT02025777|PillCam|pillcam
265990|NCT02025777|IBD|ibd
265991|NCT02025751|Diabetes|diabetes
265992|NCT02025751|Gastroparesis|gastroparesis
265993|NCT02025751|Delayed gastric emptying|delayed gastric emptying
265994|NCT02025751|Nausea|nausea
265995|NCT02025751|Vomiting|vomiting
265996|NCT02025751|Bloating|bloating
265997|NCT02025751|Abdominal pain|abdominal pain
265998|NCT02025751|Early Satiety|early satiety
265999|NCT02025751|Gastric stasis|gastric stasis
266000|NCT02025751|Gastropathy|gastropathy
266001|NCT02025725|Gastroparesis|gastroparesis
266002|NCT02025725|Diabetic|diabetic
266003|NCT02025725|Delayed gastric emptying|delayed gastric emptying
266004|NCT02025725|Gastric stasis|gastric stasis
266005|NCT02025725|Nausea|nausea
266006|NCT02025725|Vomiting|vomiting
266007|NCT02025725|Bloating|bloating
266008|NCT02025725|Abdominal pain|abdominal pain
266009|NCT02025725|Early satiety|early satiety
266010|NCT02025725|Gastropathy|gastropathy
266011|NCT02025686|Pain|pain
266012|NCT02025686|Inflammation|inflammation
266013|NCT02025686|Hyperalgesia|hyperalgesia
266014|NCT02025686|burn injury|burn injury
266015|NCT02025686|Hyperbaric Oxygen|hyperbaric oxygen
266016|NCT02025660|Mw|mw
266017|NCT02025660|Mycobacterium indicum prannii|mycobacterium indicum prannii
266018|NCT02025660|Mycobacterium w|mycobacterium w
266019|NCT02025660|Severe sepsis|severe sepsis
266020|NCT02025660|Septic shock|septic shock
266021|NCT02025647|Mood disorders|mood disorders
266022|NCT02025647|Anxiety disorders|anxiety disorders
266023|NCT02025647|Eating concerns|eating concerns
266024|NCT02025647|Pain concerns|pain concerns
266025|NCT02025647|Alcohol abuse|alcohol abuse
266026|NCT02025647|Self harm|self harm
266027|NCT02025647|Mental health|mental health
266028|NCT02025647|Clinical Decision Support|clinical decision support
266029|NCT02025634|Pain, Postoperative|pain, postoperative
266030|NCT02025634|Ofirmev|ofirmev
266031|NCT02025634|Acetaminophen|acetaminophen
266032|NCT02025634|Analgesics, Non-Narcotic|analgesics, non-narcotic
266033|NCT02025634|Arthroscopy|arthroscopy
266034|NCT02025621|coronary artery bypass grafting|coronary artery bypass grafting
266035|NCT02025621|CABG|cabg
266036|NCT02025621|mitral valve|mitral valve
266037|NCT02025621|LCOS|lcos
266038|NCT02025621|low cardiac output syndrome|low cardiac output syndrome
266039|NCT02025621|levosimendan|levosimendan
266040|NCT02025608|Restless legs syndrome|restless legs syndrome
266041|NCT02025595|Brain|brain
266042|NCT02025595|Genes|genes
266043|NCT02025595|Environment|environment
266044|NCT02025595|Etiology|etiology
266045|NCT02025595|Reward|reward
266046|NCT02025595|Satiety Response|satiety response
266047|NCT02025595|Central Nervous System|central nervous system
266048|NCT02025595|Magnetic Resonance Imaging|magnetic resonance imaging
266049|NCT02025595|Twins, Monozygotic|twins, monozygotic
266050|NCT02025595|Overweight|overweight
266051|NCT02025595|Obesity|obesity
266052|NCT02025582|idiopathic toe walking|idiopathic toe walking
266053|NCT02025582|gait disorder|gait disorder
266054|NCT02025582|gait analysis|gait analysis
266055|NCT02025582|kinesio taping|kinesio taping
266056|NCT02025582|ultrasound elastography|ultrasound elastography
266057|NCT02025582|pediatric|pediatric
266058|NCT02025582|children|children
266059|NCT02025582|muscle stiffness|muscle stiffness
266060|NCT02025582|muscle elasticity|muscle elasticity
266061|NCT02025569|chronic ankle instability|chronic ankle instability
266062|NCT02025569|lateral ankle sprain|lateral ankle sprain
266063|NCT02025569|manual therapy|manual therapy
266064|NCT02025569|star excursion balance test|star excursion balance test
266065|NCT02025569|strain and counterstrain|strain and counterstrain
266066|NCT02025556|High Frequency Episodic Migraine Headache|high frequency episodic migraine headache
266067|NCT02025556|Episodic Migraine Headache|episodic migraine headache
266068|NCT02025556|Migraine Headache|migraine headache
266069|NCT02025543|MRI|mri
266070|NCT02025543|Iron overload|iron overload
266071|NCT02025530|Stillbirth|stillbirth
266072|NCT02025530|Modifiable risk factors|modifiable risk factors
266073|NCT02025517|Parkinson's disease|parkinson's disease
266074|NCT02025517|rehabilitation|rehabilitation
266075|NCT02025517|kinematics|kinematics
266076|NCT02025517|cognition|cognition
266270|NCT02024672|Intrauterine devices|intrauterine devices
266077|NCT02025504|Colonoscopy, Looping, Sigmoid Looping, ColoWrap, Binder, Patient Satisfaction|colonoscopy, looping, sigmoid looping, colowrap, binder, patient satisfaction
266078|NCT02025491|Disseminated leishmaniasis|disseminated leishmaniasis
266079|NCT02025491|Liposomal Amphotericin B|liposomal amphotericin b
266080|NCT02025491|Leishmania braziliensis|leishmania braziliensis
266081|NCT02025478|children|children
266082|NCT02025478|bone marrow transplant|bone marrow transplant
266083|NCT02025478|autologous|autologous
266084|NCT02025478|allogeneic|allogeneic
266085|NCT02025478|breastmilk|breastmilk
266086|NCT02025478|hematopoietic stem cell transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
266087|NCT02025465|Atrial Fibrillation|atrial fibrillation
266088|NCT02025465|Atrial Flutter|atrial flutter
266089|NCT02025465|Metoprolol|metoprolol
266090|NCT02025465|Diltiazem|diltiazem
266091|NCT02025452|diarrhoea|diarrhoea
266092|NCT02025452|gastroenteritis|gastroenteritis
266093|NCT02025452|rapid diagnostics|rapid diagnostics
266094|NCT02025452|probiotics|probiotics
266095|NCT02025452|sub-Saharan Africa|sub-saharan africa
266096|NCT02025439|Traumatic Brain Injury|traumatic brain injury
266097|NCT02025439|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
266098|NCT02025439|Amantadine|amantadine
266099|NCT02025439|Vegetative State|vegetative state
266100|NCT02025439|Minimally Conscious State|minimally conscious state
266101|NCT02025426|Cesarean delivery|cesarean delivery
266102|NCT02025426|Spinal Anesthesia|spinal anesthesia
266103|NCT02025400|Rehabilitation|rehabilitation
266104|NCT02025400|eRehab|erehab
266105|NCT02025400|Physical Therapy|physical therapy
266106|NCT02025400|e-Health|e-health
266107|NCT02025400|Telemedicine|telemedicine
266108|NCT02025400|Telerehabilitation|telerehabilitation
266109|NCT02025400|Patient-Centered|patient-centered
266110|NCT02025374|spinal anesthesia|spinal anesthesia
266111|NCT02025374|cesarean section|cesarean section
266112|NCT02025374|hyperbaric levobupivacaine|hyperbaric levobupivacaine
266113|NCT02025361|prostate biopsy, local anesthesia, cancer detection rate.|prostate biopsy, local anesthesia, cancer detection rate.
266114|NCT02025322|HIV/AIDS|hiv/aids
266115|NCT02025322|Peer Mentoring|peer mentoring
266116|NCT02025322|Medication Adherence|medication adherence
266117|NCT02025322|Medication Non-adherent|medication non-adherent
266118|NCT02025322|Newly diagnosed|newly diagnosed
266119|NCT02025322|HIV-positive individuals|hiv-positive individuals
266120|NCT02025322|HIV viral load|hiv viral load
266121|NCT02025322|CD4 lymphocyte cell counts|cd4 lymphocyte cell counts
266122|NCT02025322|Treatment adherence|treatment adherence
266123|NCT02025322|Health literacy|health literacy
266124|NCT02025322|Self-efficacy|self-efficacy
266125|NCT02025309|train of four|train of four
266126|NCT02025309|neuromuscular recovery|neuromuscular recovery
266127|NCT02025309|sugammadex|sugammadex
266128|NCT02025296|Telemedicine|telemedicine
266129|NCT02025296|Clinical decision support system|clinical decision support system
266130|NCT02025296|Ubiquitous healthcare|ubiquitous healthcare
266131|NCT02025296|Diabetes Care|diabetes care
266132|NCT02025296|Multifactorial Intervention|multifactorial intervention
266133|NCT02025283|Intervertebral disc disease|intervertebral disc disease
266134|NCT02025283|Radiculopathy|radiculopathy
266135|NCT02025283|Chronic pain|chronic pain
266136|NCT02025283|Thermocoagulation|thermocoagulation
266137|NCT02025270|Azoospermia, Spermatogonial Arrest, Maturation Arrest.|azoospermia, spermatogonial arrest, maturation arrest.
266138|NCT02025257|coronary artery disease|coronary artery disease
266139|NCT02025257|elderly|elderly
266140|NCT02025257|exercise|exercise
266141|NCT02025257|exercise-based cardiac rehabilitation|exercise-based cardiac rehabilitation
266142|NCT02025244|Key hole biopsy|key hole biopsy
266143|NCT02025244|Upper Gastrointestinal Submucosal Tumors|upper gastrointestinal submucosal tumors
266144|NCT02025244|EUS-FNA|eus-fna
266145|NCT02025244|Mitototic Activity|mitototic activity
266146|NCT02025244|GIST|gist
266147|NCT02025231|reirradiation|reirradiation
266148|NCT02025231|recurrent glioma|recurrent glioma
266149|NCT02025231|positron emission tomography|positron emission tomography
266150|NCT02025231|amino acid tracer|amino acid tracer
266151|NCT02025218|NSCLC|nsclc
266152|NCT02025218|EGFR|egfr
266153|NCT02025218|TKI|tki
266154|NCT02025218|Re-challenge|re-challenge
266155|NCT02025218|Lung Cancer|lung cancer
266156|NCT02025218|Resistance|resistance
266157|NCT02025192|ONT-380|ont-380
266158|NCT02025192|Capecitabine|capecitabine
266159|NCT02025192|Trastuzumab|trastuzumab
266160|NCT02025192|Xeloda|xeloda
266161|NCT02025192|Herceptin|herceptin
266162|NCT02025192|HER2 positive breast cancer|her2 positive breast cancer
266163|NCT02025192|Breast cancer|breast cancer
266164|NCT02025192|ARRY-380|arry-380
266165|NCT02025192|Tucatinib|tucatinib
266166|NCT02025179|Teriparatide|teriparatide
266167|NCT02025179|Osteoporosis|osteoporosis
266168|NCT02025179|Spinal Cord Injury|spinal cord injury
266169|NCT02025179|Bone Diseases|bone diseases
266170|NCT02025179|Metabolic Bone Diseases|metabolic bone diseases
266171|NCT02025179|Musculoskeletal Diseases|musculoskeletal diseases
266172|NCT02025179|Spinal Cord Diseases|spinal cord diseases
266173|NCT02025179|Central Nervous System Diseases|central nervous system diseases
266174|NCT02025179|Nervous System Diseases|nervous system diseases
266175|NCT02025179|Nervous System|nervous system
266176|NCT02025179|Wounds and Injuries|wounds and injuries
266177|NCT02025179|Bone Density Conservation Agents|bone density conservation agents
266178|NCT02025179|Physiological Effects of Drugs|physiological effects of drugs
266179|NCT02025179|Pharmacologic Actions|pharmacologic actions
266180|NCT02025179|Vibration|vibration
266181|NCT02025166|Pain|pain
266182|NCT02025166|abortion|abortion
266183|NCT02025166|paracetamol|paracetamol
266184|NCT02025166|lornoxicam|lornoxicam
266185|NCT02025140|Computer controlled anesthesia (CCLAD)|computer controlled anesthesia (cclad)
266186|NCT02025140|pain perception|pain perception
266187|NCT02025140|Effectiveness|effectiveness
266188|NCT02025140|primary molars|primary molars
266189|NCT02025140|Behavior|behavior
266190|NCT02025127|septic shock|septic shock
266191|NCT02025127|mechanical ventilation|mechanical ventilation
266192|NCT02025127|enteral nutrition|enteral nutrition
266193|NCT02025127|trophic feeding|trophic feeding
266194|NCT02025114|NSCLC, EGFR mutation|nsclc, egfr mutation
266195|NCT02025101|Slow Coronary Flow|slow coronary flow
266196|NCT02025075|Tomography|tomography
266197|NCT02025075|Oximetry|oximetry
266198|NCT02025075|Echocardiography|echocardiography
266199|NCT02025062|head and neck squamous cell carcinomas (HNSCCs)|head and neck squamous cell carcinomas (hnsccs)
266200|NCT02025062|elderly|elderly
266201|NCT02025062|cancer|cancer
266202|NCT02025062|comprehensive geriatric assessment|comprehensive geriatric assessment
266203|NCT02025062|functional status|functional status
266204|NCT02025062|malnutrition|malnutrition
266205|NCT02025062|survival|survival
266206|NCT02025049|pancreatitis|pancreatitis
266207|NCT02025036|Chemoradiotherapy， Esophageal Squamous Cancer|chemoradiotherapy， esophageal squamous cancer
266208|NCT02025023|Size|size
266209|NCT02025023|Pain|pain
266210|NCT02025023|Resolution|resolution
266211|NCT02025023|Complications|complications
266212|NCT02025023|Swelling|swelling
266213|NCT02025010|castration-resistant prostate cancer|castration-resistant prostate cancer
266214|NCT02024997|Pancreatic malignancy|pancreatic malignancy
266215|NCT02024997|Radiation Therapy|radiation therapy
266216|NCT02024984|LPFPCCPCOS|lpfpccpcos
266217|NCT02024971|Drug therapy|drug therapy
266218|NCT02024958|Adult ICU patients|adult icu patients
266219|NCT02024958|spontaneous breathing|spontaneous breathing
266220|NCT02024958|invasive ventilation|invasive ventilation
266221|NCT02024958|non-invasive ventilation|non-invasive ventilation
266222|NCT02024945|Drug therapy|drug therapy
266223|NCT02024906|isoflavone|isoflavone
266224|NCT02024906|CVD|cvd
266225|NCT02024906|soy intake|soy intake
266226|NCT02024906|subclinical hypothyroid|subclinical hypothyroid
266227|NCT02024893|Humeral retroversion|humeral retroversion
266228|NCT02024893|dynamic control ratio|dynamic control ratio
266229|NCT02024893|GIRD|gird
266230|NCT02024880|in vitro fertilization|in vitro fertilization
266231|NCT02024880|embryo transfer|embryo transfer
266232|NCT02024880|transfer catheter|transfer catheter
266233|NCT02024867|Methicillin resistent Staphylococcus aureus|methicillin resistent staphylococcus aureus
266234|NCT02024867|Staphylococcus aureus|staphylococcus aureus
266235|NCT02024854|Kangaroo-Mother Care Method|kangaroo-mother care method
266236|NCT02024854|Stress, Physiological|stress, physiological
266237|NCT02024841|Gastric cancer|gastric cancer
266238|NCT02024841|Peritoneal carcinomatosis|peritoneal carcinomatosis
266239|NCT02024841|Intraperitoneal docetaxel|intraperitoneal docetaxel
266240|NCT02024841|Cisplatin|cisplatin
266241|NCT02024841|TS-ONE|ts-one
266242|NCT02024828|Infant feeding|infant feeding
266243|NCT02024802|Pain|pain
266244|NCT02024802|Pain Cream|pain cream
266245|NCT02024802|Nociceptive pain|nociceptive pain
266246|NCT02024802|neurologic pain|neurologic pain
266247|NCT02024802|transdermal|transdermal
266248|NCT02024802|compounding|compounding
266249|NCT02024802|compound|compound
266250|NCT02024776|Training|training
266251|NCT02024776|Wellness|wellness
266252|NCT02024776|Aerobic capacity|aerobic capacity
266253|NCT02024776|Information and communication technology, surgical risk|information and communication technology, surgical risk
266254|NCT02024776|Abdominal surgery|abdominal surgery
266255|NCT02024763|Energy Expenditure|energy expenditure
266256|NCT02024763|Physical Education|physical education
266257|NCT02024763|Children|children
266258|NCT02024763|Randomized Controlled Trial|randomized controlled trial
266259|NCT02024750|Family centered care|family centered care
266260|NCT02024750|Patient centered care|patient centered care
266261|NCT02024750|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
266262|NCT02024750|Problem Recognition in Illness Self-Management (PRISM)|problem recognition in illness self-management (prism)
266263|NCT02024711|Cataract|cataract
266264|NCT02024711|Intraocular Lens|intraocular lens
266265|NCT02024711|IOL|iol
266266|NCT02024711|Aphakia|aphakia
266267|NCT02024685|Prostate|prostate
266268|NCT02024685|Localized Prostate Cancer|localized prostate cancer
266269|NCT02024685|Decision making|decision making
266271|NCT02024672|IUDs|iuds
266273|NCT02024672|contraception|contraception
266274|NCT02024659|nasal polyps|nasal polyps
266275|NCT02024659|remodeling|remodeling
266276|NCT02024659|inflammatory cells|inflammatory cells
266277|NCT02024659|budesonide|budesonide
266278|NCT02024646|Psoriatic Arthritis|psoriatic arthritis
266279|NCT02024646|Brodalumab|brodalumab
266280|NCT02024646|AMG 827|amg 827
266281|NCT02024620|depression|depression
266282|NCT02024620|technology|technology
266283|NCT02024620|psychotherapy|psychotherapy
266284|NCT02024620|behavioral activation|behavioral activation
266285|NCT02024594|Nitrous Oxide-Oxygen conscious sedation|nitrous oxide-oxygen conscious sedation
266286|NCT02024594|Cognitive Behavioral Therapy|cognitive behavioral therapy
266287|NCT02024594|Children, Preschool|children, preschool
266288|NCT02024594|dental anxiety|dental anxiety
266289|NCT02024594|Patient Cooperation|patient cooperation
266290|NCT02024581|pediatric|pediatric
266291|NCT02024581|dermatology|dermatology
266292|NCT02024581|East Indian sandalwood oil|east indian sandalwood oil
266293|NCT02024581|pox virus|pox virus
266294|NCT02024568|Pregabalin|pregabalin
266295|NCT02024568|Arthralgia Myalgia Syndrome|arthralgia myalgia syndrome
266296|NCT02024568|Paclitaxel|paclitaxel
266297|NCT02024568|Pain management|pain management
266298|NCT02024568|Breast cancer|breast cancer
266299|NCT02024542|Bariatric Surgery|bariatric surgery
266300|NCT02024542|Obesity|obesity
266301|NCT02024542|Metabolic syndrome|metabolic syndrome
266302|NCT02024542|Diabetes|diabetes
266303|NCT02024516|Type 2 diabetes|type 2 diabetes
266304|NCT02024516|Pomegranate|pomegranate
266305|NCT02024516|Inflammation|inflammation
266306|NCT02024516|lipid profiles|lipid profiles
266307|NCT02024503|stroke|stroke
266308|NCT02024503|fMRI|fmri
266309|NCT02024503|DTI|dti
266310|NCT02024490|vitamin D, prematurity, RDS, BPD, maternal, neonatal|vitamin d, prematurity, rds, bpd, maternal, neonatal
266311|NCT02024477|endothelial cells|endothelial cells
266312|NCT02024477|cellular biomarker|cellular biomarker
266313|NCT02024477|endothelial dysfunction|endothelial dysfunction
266314|NCT02024464|Primary open angle glaucoma|primary open angle glaucoma
266315|NCT02024464|POAG|poag
266316|NCT02024464|Pseudoexfoliative glaucoma|pseudoexfoliative glaucoma
266317|NCT02024464|PXG|pxg
266318|NCT02024464|Pigmentary dispersion glaucoma|pigmentary dispersion glaucoma
266319|NCT02024464|PDG|pdg
266320|NCT02024464|Hydrus|hydrus
266321|NCT02024451|Radial shock wave|radial shock wave
266322|NCT02024451|Acupuncture|acupuncture
266323|NCT02024438|metastatic gastric cancer|metastatic gastric cancer
266324|NCT02024438|neurotoxicity|neurotoxicity
266325|NCT02024438|mFOLFOX6|mfolfox6
266326|NCT02024438|monosialotetrahexosylganglioside Sodium Injection|monosialotetrahexosylganglioside sodium injection
266327|NCT02024425|Clinical trials|clinical trials
266328|NCT02024425|Adult|adult
266329|NCT02024425|Women|women
266330|NCT02024425|Functional food|functional food
266331|NCT02024425|Dietary Supplements|dietary supplements
266332|NCT02024425|Overweight|overweight
266333|NCT02024425|Obese|obese
266334|NCT02024425|Absorptiometry, Dual X-Ray|absorptiometry, dual x-ray
266335|NCT02024425|Rosmarinus|rosmarinus
266336|NCT02024425|Oligosaccharides|oligosaccharides
266337|NCT02024425|Lactulose|lactulose
266338|NCT02024425|Bioactive peptide|bioactive peptide
266339|NCT02024412|metastatic colorectal cancer|metastatic colorectal cancer
266340|NCT02024412|neurotoxicity|neurotoxicity
266341|NCT02024412|mFOLFOX6|mfolfox6
266342|NCT02024412|monosialotetrahexosylganglioside Sodium Injection|monosialotetrahexosylganglioside sodium injection
266343|NCT02024399|Pediatric Overweight/Obesity, DEXA, Fitness|pediatric overweight/obesity, dexa, fitness
266344|NCT02024386|Guanylate Cyclase|guanylate cyclase
266345|NCT02024386|Pulmonary Edema of Mountaineers|pulmonary edema of mountaineers
266346|NCT02024386|Mountaineering|mountaineering
266347|NCT02024386|Performance-Enhancing Substances|performance-enhancing substances
266348|NCT02024386|Athletic Performance|athletic performance
266349|NCT02024373|chronic subdural hematoma|chronic subdural hematoma
266350|NCT02024373|Atorvastatin|atorvastatin
266351|NCT02024373|oral administration therapy|oral administration therapy
266352|NCT02024360|obesity|obesity
266353|NCT02024360|overweight|overweight
266354|NCT02024360|children|children
266355|NCT02024360|prevention|prevention
266356|NCT02024334|JIA|jia
266357|NCT02024334|LEFLUNOMIDE|leflunomide
266358|NCT02024334|EFFICACY|efficacy
266359|NCT02024321|abdominal surgery|abdominal surgery
266360|NCT02024321|TPN|tpn
266361|NCT02024321|blood glucose|blood glucose
266362|NCT02024308|acute myeloid leukemia,|acute myeloid leukemia,
266363|NCT02024308|AML1-ETO fusion protein,|aml1-eto fusion protein,
266364|NCT02024308|Fludarabine,|fludarabine,
266365|NCT02024308|recurrence|recurrence
266366|NCT02024269|macular degeneration|macular degeneration
266367|NCT02024269|stem cells|stem cells
266368|NCT02024269|adipose stem cells|adipose stem cells
266369|NCT02024256|Vaginal delivery|vaginal delivery
266370|NCT02024256|Perineal swelling|perineal swelling
266371|NCT02024256|Perineal pain|perineal pain
266372|NCT02024256|MgSo4|mgso4
266373|NCT02024256|Magnesium sulfate|magnesium sulfate
266374|NCT02024256|Cold water|cold water
266375|NCT02024243|Micro RNA|micro rna
266376|NCT02024243|Wound|wound
266377|NCT02024243|Chronic Venous Leg Ulcer|chronic venous leg ulcer
266378|NCT02024243|VLU|vlu
266379|NCT02024243|miR210|mir210
266380|NCT02024243|OSU Comprehensive Wound Center|osu comprehensive wound center
266381|NCT02024204|World Trade Center Disaster|world trade center disaster
266382|NCT02024204|Environmental Exposure|environmental exposure
266383|NCT02024204|Respiratory Physiology|respiratory physiology
266384|NCT02024204|Inflammation|inflammation
266385|NCT02024204|Gastrointestinal Diseases|gastrointestinal diseases
266386|NCT02024204|Sinus Symptoms|sinus symptoms
266387|NCT02024204|PTSD|ptsd
266388|NCT02024204|Anxiety|anxiety
266389|NCT02024204|Depression|depression
266390|NCT02024204|Hypersensitivity|hypersensitivity
266391|NCT02024204|Spirometry|spirometry
266392|NCT02024204|Oscillometry|oscillometry
266393|NCT02024191|glutamine|glutamine
266394|NCT02024191|oxaliplatin|oxaliplatin
266395|NCT02024191|peripheral neuropathy|peripheral neuropathy
266396|NCT02024178|Prostate Cancer|prostate cancer
266397|NCT02024178|Radical Prostatectomy|radical prostatectomy
266398|NCT02024178|Ultrasound Imaging|ultrasound imaging
266399|NCT02024165|Ultrasound|ultrasound
266400|NCT02024165|FSE|fse
266401|NCT02024165|IUPC|iupc
266402|NCT02024139|Orthodontic pain|orthodontic pain
266403|NCT02024139|Chewing gum|chewing gum
266404|NCT02024126|Knee osteoarthritis|knee osteoarthritis
266405|NCT02024126|Exercise therapy|exercise therapy
266406|NCT02024126|RCT|rct
266407|NCT02024126|Intervention|intervention
266408|NCT02024126|Knee pain|knee pain
266409|NCT02024126|Muticenter|muticenter
266410|NCT02024126|Knee function|knee function
266411|NCT02024113|validation|validation
266412|NCT02024113|model|model
266413|NCT02024113|metabolic profile|metabolic profile
266414|NCT02024113|positron emission tomography|positron emission tomography
266415|NCT02024061|Adolescents|adolescents
266416|NCT02024061|Obesity|obesity
266417|NCT02024061|Physical activity|physical activity
266418|NCT02024061|Sedentary behavior|sedentary behavior
266419|NCT02024061|Psychosocial health|psychosocial health
266420|NCT02024048|Pregnancy|pregnancy
266421|NCT02024048|OCT|oct
266422|NCT02024048|Enhanced depth imaging|enhanced depth imaging
266423|NCT02024048|Choroid|choroid
266424|NCT02024035|Tomotherapy|tomotherapy
266425|NCT02024035|Head and neck squamous celle carcinoma|head and neck squamous celle carcinoma
266426|NCT02024035|Health economic evaluation|health economic evaluation
266427|NCT02024022|colonoscopy|colonoscopy
266428|NCT02024022|bowel cleansing|bowel cleansing
266429|NCT02024022|polyethylene glycol|polyethylene glycol
266430|NCT02024022|sodium picosulphate / magnesium citrate|sodium picosulphate / magnesium citrate
266431|NCT02024009|chemoradiotherapy|chemoradiotherapy
266432|NCT02024009|nelfinavir|nelfinavir
266433|NCT02024009|abraxane|abraxane
266434|NCT02024009|gemcitabine|gemcitabine
266435|NCT02024009|radiotherapy|radiotherapy
266436|NCT02024009|capecitabine|capecitabine
266437|NCT02023996|HER2 positive|her2 positive
266438|NCT02023996|PET Imaging|pet imaging
266439|NCT02023996|89Zr-DFO-trastuzumab|89zr-dfo-trastuzumab
266440|NCT02023996|13-165|13-165
266441|NCT02023983|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
266442|NCT02023983|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
266443|NCT02023983|Low risk|low risk
266444|NCT02023983|Early discharge|early discharge
266445|NCT02023970|Bioprosthetic heart valves, immune response, structural valve deterioration, valvular disease.|bioprosthetic heart valves, immune response, structural valve deterioration, valvular disease.
266446|NCT02023957|Interactive Health-risk assessment|interactive health-risk assessment
266447|NCT02023957|Primary Care|primary care
266448|NCT02023957|Randomized|randomized
266449|NCT02023957|Open Label|open label
266450|NCT02023957|Efficacy Study|efficacy study
266451|NCT02023944|Memory|memory
266452|NCT02023944|Aging|aging
266453|NCT02023944|Healthy People|healthy people
266454|NCT02023944|Intervention|intervention
266455|NCT02023931|Oral mucosa|oral mucosa
266456|NCT02023931|Nrf2 pathway|nrf2 pathway
266457|NCT02023931|Broccoli Sprout Extract|broccoli sprout extract
266458|NCT02023931|Head and Neck Cancer|head and neck cancer
266459|NCT02023918|Growth hormone antagonism|growth hormone antagonism
266460|NCT02023866|Leigh Syndrome|leigh syndrome
266461|NCT02023866|Leber's hereditary optic neuropathy|leber's hereditary optic neuropathy
266462|NCT02023866|myoclonic epilepsy|myoclonic epilepsy
266463|NCT02023866|mitochondrial encephalomyopathy|mitochondrial encephalomyopathy
266464|NCT02023866|Kearn-Sayre syndrome|kearn-sayre syndrome
266465|NCT02023866|POLG-related disorders|polg-related disorders
266466|NCT02023866|Neurogastrointestinal encephalopathy|neurogastrointestinal encephalopathy
266467|NCT02023840|periodontitis|periodontitis
266468|NCT02023840|pockets|pockets
266469|NCT02023827|Transtheoretical Model|transtheoretical model
266470|NCT02023827|Stages of change|stages of change
266471|NCT02023827|Computer-tailored intervention|computer-tailored intervention
266472|NCT02023827|Delinquency|delinquency
266473|NCT02023827|Substance abuse|substance abuse
266474|NCT02023827|Juvenile offender|juvenile offender
266475|NCT02023827|Juvenile justice|juvenile justice
266476|NCT02023827|Rise Above Your Situation (RAYS) program|rise above your situation (rays) program
266477|NCT02023801|Menorrhagia|menorrhagia
266478|NCT02023801|Dysfunctional Uterine Bleeding|dysfunctional uterine bleeding
266479|NCT02023801|Endometrial Ablation|endometrial ablation
266480|NCT02023788|human umbilical cord blood-derived mesenchymal stem cells|human umbilical cord blood-derived mesenchymal stem cells
266481|NCT02023788|bronchopulmonary dysplasia|bronchopulmonary dysplasia
266482|NCT02023788|respiratory tract infection|respiratory tract infection
266483|NCT02023788|Premature infants|premature infants
266484|NCT02023762|mitral regurgitation|mitral regurgitation
266485|NCT02023762|local anaesthesia|local anaesthesia
266486|NCT02023762|percutaneous repair|percutaneous repair
266487|NCT02023749|nuts|nuts
266488|NCT02023749|metabolic syndrome|metabolic syndrome
266489|NCT02023749|lipid profile|lipid profile
266490|NCT02023749|inflammation|inflammation
266491|NCT02023749|oxidative stress|oxidative stress
266492|NCT02023749|endothelial function|endothelial function
266493|NCT02023723|Energy Drink|energy drink
266494|NCT02023723|Electrocardiograph|electrocardiograph
266495|NCT02023723|Hemodynamic|hemodynamic
266496|NCT02023710|mucosal melanoma|mucosal melanoma
266497|NCT02023710|Bevacizumab|bevacizumab
266498|NCT02023710|Carboplatin|carboplatin
266499|NCT02023710|Paclitaxel|paclitaxel
266500|NCT02023684|Sleeve Gastrectomy|sleeve gastrectomy
266501|NCT02023684|Lidocaine|lidocaine
266502|NCT02023684|ropivacaine|ropivacaine
266503|NCT02023658|HIV|hiv
266504|NCT02023658|pMTCT|pmtct
266505|NCT02023645|lutein|lutein
266506|NCT02023645|cognition|cognition
266507|NCT02023645|neural efficiency|neural efficiency
266508|NCT02023645|aging|aging
266509|NCT02023632|older adults|older adults
266510|NCT02023632|physical activity|physical activity
266511|NCT02023632|self-categorization|self-categorization
266512|NCT02023632|group dynamics|group dynamics
266513|NCT02023632|self-identity|self-identity
266514|NCT02023619|Keratoconus|keratoconus
266515|NCT02023619|Astigmatism|astigmatism
266516|NCT02023619|Cornea|cornea
266517|NCT02023619|SD-OCT|sd-oct
266518|NCT02023606|Impulsive Aggression|impulsive aggression
266519|NCT02023606|ADHD|adhd
266520|NCT02023580|Viral suppression|viral suppression
266521|NCT02023580|Sexual risk|sexual risk
266522|NCT02023554|azithromycin|azithromycin
266523|NCT02023554|theophylline|theophylline
266524|NCT02023554|CYP3A4|cyp3a4
266525|NCT02023515|weight loss|weight loss
266526|NCT02023515|metabolic syndrome|metabolic syndrome
266527|NCT02023515|stress|stress
266528|NCT02023515|obesity|obesity
266529|NCT02023502|female stress urinary incontinence|female stress urinary incontinence
266530|NCT02023502|proteomics|proteomics
266531|NCT02023502|biomarker|biomarker
266532|NCT02023424|BDNF|bdnf
266533|NCT02023424|GLATIRAMER ACETATE|glatiramer acetate
266534|NCT02023424|RETT SYNDROME|rett syndrome
266535|NCT02023424|COPAXONE|copaxone
266536|NCT02023424|Bruria Ben-Zeev|bruria ben-zeev
266537|NCT02023411|Teriparatide|teriparatide
266538|NCT02023411|Inactive Charcot's neuroarthropathy|inactive charcot's neuroarthropathy
266539|NCT02023398|High Frequency|high frequency
266540|NCT02023398|Waist circumferential reduction|waist circumferential reduction
266541|NCT02023385|Low Level Laser Therapy|low level laser therapy
266542|NCT02023385|LLLT|lllt
266543|NCT02023385|Waist circumferential reduction|waist circumferential reduction
266544|NCT02023372|NuCel|nucel
266545|NCT02023372|Lumbar Spine|lumbar spine
266546|NCT02023372|Degenerative Disease|degenerative disease
266547|NCT02023372|Efficacy|efficacy
266548|NCT02023372|Fusion|fusion
266549|NCT02023359|Advanced breast cancer|advanced breast cancer
266550|NCT02023359|Everolimus|everolimus
266551|NCT02023346|Patient-Physician Communication|patient-physician communication
266552|NCT02023346|Brain cancer|brain cancer
266553|NCT02023346|13-253|13-253
266554|NCT02023333|Regorafenib|regorafenib
266555|NCT02023333|Performance Status|performance status
266556|NCT02023333|13-211|13-211
266557|NCT02023281|Depression|depression
266558|NCT02023281|Exercise|exercise
266559|NCT02023281|Neurotransmitters|neurotransmitters
266560|NCT02023281|Catecholimines|catecholimines
266561|NCT02023281|EEG|eeg
266562|NCT02023255|Healthy|healthy
266563|NCT02023255|JNJ-39393406|jnj-39393406
266564|NCT02023255|Safety|safety
266565|NCT02023255|Tolerability|tolerability
266566|NCT02023255|Pharmacokinetics|pharmacokinetics
266567|NCT02023242|Primary open angle glaucoma|primary open angle glaucoma
266568|NCT02023242|POAG|poag
266569|NCT02023242|Pseudoexfoliative glaucoma|pseudoexfoliative glaucoma
266570|NCT02023242|PXG|pxg
266571|NCT02023242|Pigmentary glaucoma|pigmentary glaucoma
266572|NCT02023242|PG|pg
266573|NCT02023242|Hydrus|hydrus
266574|NCT02023229|Branched chain aminoacids|branched chain aminoacids
266575|NCT02023229|Nutritional status|nutritional status
266576|NCT02023229|Hepatic encephalopathy|hepatic encephalopathy
266577|NCT02023216|Preterm infants|preterm infants
267167|NCT02020239|females|females
266578|NCT02023216|Non-nutritive sucking|non-nutritive sucking
266579|NCT02023216|Pacifier|pacifier
266580|NCT02023216|Gastro-esophageal reflux|gastro-esophageal reflux
266581|NCT02023216|pH-multiple intraluminal impedance|ph-multiple intraluminal impedance
266582|NCT02023216|Apneas|apneas
266583|NCT02023216|Bradycardias|bradycardias
266584|NCT02023216|Hypoxic episodes|hypoxic episodes
266585|NCT02023216|Polysomnographic monitoring|polysomnographic monitoring
266586|NCT02023190|liver cirrhosis|liver cirrhosis
266587|NCT02023190|liver transplant|liver transplant
266588|NCT02023190|nutritional status|nutritional status
266589|NCT02023190|bioelectrical impedance vector analysis|bioelectrical impedance vector analysis
266590|NCT02023177|phase angle|phase angle
266591|NCT02023177|liver cirrhosis|liver cirrhosis
266592|NCT02023177|mortality|mortality
266593|NCT02023177|malnutrition|malnutrition
266594|NCT02023138|Clinical practice guideline|clinical practice guideline
266595|NCT02023138|Brain injury|brain injury
266596|NCT02023138|Acceptability|acceptability
266597|NCT02023138|Feasibility|feasibility
266598|NCT02023138|Effectiveness|effectiveness
266599|NCT02023112|Japanese|japanese
266600|NCT02023112|Hepatitis C|hepatitis c
266601|NCT02023112|Treatment naive|treatment naive
266602|NCT02023112|Treatment experienced|treatment experienced
266603|NCT02023112|Genotype 2|genotype 2
266604|NCT02023112|Ombitasvir|ombitasvir
266605|NCT02023112|Paritaprevir|paritaprevir
266606|NCT02023112|Ritonavir|ritonavir
266607|NCT02023112|Ribavirin|ribavirin
266608|NCT02023112|VIEKIRAX Combination Tablets|viekirax combination tablets
266609|NCT02023099|Hepatitis C|hepatitis c
266610|NCT02023099|Genotype 1b|genotype 1b
266611|NCT02023099|Cirrhotic|cirrhotic
266612|NCT02023099|Treatment Experienced|treatment experienced
266613|NCT02023099|Treatment Naive|treatment naive
266614|NCT02023099|Japanese|japanese
266615|NCT02023099|ombitasvir|ombitasvir
266616|NCT02023099|paritaprevir|paritaprevir
266617|NCT02023099|ritonavir|ritonavir
266618|NCT02023099|VIEKIRAX Combination Tablets|viekirax combination tablets
266619|NCT02023086|Visual field defect|visual field defect
266620|NCT02023086|Blood oxygenation|blood oxygenation
266621|NCT02023086|Optic nerve Head|optic nerve head
266622|NCT02023047|Anal Fissure|anal fissure
266623|NCT02023047|Nifedipine|nifedipine
266624|NCT02023034|Parkinson's disease, Physical Therapy, Fatigue, Quality of Life|parkinson's disease, physical therapy, fatigue, quality of life
266625|NCT02023021|Pancreatic Cancer; Pancreatic Adenocarcinoma; Nab-paclitaxel; Gemcitabine; Adjuvant Therapy|pancreatic cancer; pancreatic adenocarcinoma; nab-paclitaxel; gemcitabine; adjuvant therapy
266626|NCT02022995|EGFR|egfr
266627|NCT02022995|cetuximab|cetuximab
266628|NCT02022995|colon cancer|colon cancer
266629|NCT02022982|KRAS mutant Non-Small Cell Lung Cancer|kras mutant non-small cell lung cancer
266630|NCT02022982|Solid Tumors|solid tumors
266631|NCT02022969|atelectasis|atelectasis
266632|NCT02022969|SPO2 - oscillations|spo2 - oscillations
266633|NCT02022943|Alzheimer's|alzheimer's
266634|NCT02022943|prevention|prevention
266635|NCT02022930|Osteoarthritis|osteoarthritis
266636|NCT02022930|Knee|knee
266637|NCT02022917|ovarian cancer.|ovarian cancer.
266638|NCT02022917|tubal cancer|tubal cancer
266639|NCT02022917|peritoneal cancer|peritoneal cancer
266640|NCT02022904|prostate cancer|prostate cancer
266641|NCT02022904|metastatic|metastatic
266642|NCT02022904|castrate resistant|castrate resistant
266643|NCT02022891|Sickle cell disease|sickle cell disease
266644|NCT02022891|psychological support|psychological support
266645|NCT02022891|quality of life|quality of life
266646|NCT02022878|Chronic total occlusion|chronic total occlusion
266647|NCT02022878|Percutaneous coronary intervention|percutaneous coronary intervention
266648|NCT02022878|Coronary computed tomography angiography|coronary computed tomography angiography
266649|NCT02022878|Coronary angiography|coronary angiography
266650|NCT02022865|periodontitis|periodontitis
266651|NCT02022865|cytokines|cytokines
266652|NCT02022865|adverse pregnancy outcome|adverse pregnancy outcome
266653|NCT02022852|Rectal Cancer|rectal cancer
266654|NCT02022852|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
266655|NCT02022852|Sequential Therapy|sequential therapy
266656|NCT02022839|mechanical ventilation, weaning|mechanical ventilation, weaning
266657|NCT02022839|ultrasonography|ultrasonography
266658|NCT02022826|Gastroparesis|gastroparesis
266659|NCT02022826|SmartPill Monitoring System (SPM)|smartpill monitoring system (spm)
266660|NCT02022826|Gastric Emptying Scintigraphy (GES)|gastric emptying scintigraphy (ges)
266661|NCT02022813|Energy requirements, Glucose turnover, Protein turnover|energy requirements, glucose turnover, protein turnover
266663|NCT02022787|Chemokines|chemokines
266664|NCT02022787|nephrectomy|nephrectomy
266665|NCT02022787|partial nephrectomy|partial nephrectomy
266666|NCT02022761|Mild or moderate asthmatics|mild or moderate asthmatics
266667|NCT02022761|Adults|adults
266668|NCT02022761|Laninamivir|laninamivir
266669|NCT02022735|Deep Brain Stimulation|deep brain stimulation
266670|NCT02022722|Pelvic Floor Myalgia|pelvic floor myalgia
266671|NCT02022722|Trigger Point Injections|trigger point injections
266672|NCT02022722|Pelvic Rehabilitation|pelvic rehabilitation
266673|NCT02022722|Dyspareunia|dyspareunia
268274|NCT02015299|Linagliptin|linagliptin
266674|NCT02022709|Cognitive Behavior Therapy|cognitive behavior therapy
266675|NCT02022709|Exposure and Response/Ritual Prevention|exposure and response/ritual prevention
266676|NCT02022709|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors
266677|NCT02022709|Psychotherapy|psychotherapy
266678|NCT02022709|Pharmacotherapy|pharmacotherapy
266679|NCT02022709|Citalopram|citalopram
266680|NCT02022709|Fluoxetine|fluoxetine
266681|NCT02022709|Paroxetine|paroxetine
266682|NCT02022709|Sertraline|sertraline
266683|NCT02022709|Fluvoxamine|fluvoxamine
266684|NCT02022709|fMRI|fmri
266685|NCT02022709|Stop Signal Task|stop signal task
266686|NCT02022696|Adenosine Deaminase Deficiency|adenosine deaminase deficiency
266687|NCT02022696|Gene Therapy|gene therapy
266688|NCT02022696|Lentiviral Vectors|lentiviral vectors
266689|NCT02022683|Endoscopic lung volume reduction|endoscopic lung volume reduction
266690|NCT02022683|Endobronchial valves|endobronchial valves
266691|NCT02022670|endothelial function|endothelial function
266692|NCT02022670|arterial stiffness|arterial stiffness
266693|NCT02022670|flow-mediated dilation|flow-mediated dilation
266694|NCT02022670|pulse wave velocity|pulse wave velocity
266695|NCT02022670|sodium nitrite|sodium nitrite
266696|NCT02022670|aging|aging
266697|NCT02022670|vascular diseases|vascular diseases
266698|NCT02022657|Pre exposure prophylaxis|pre exposure prophylaxis
266699|NCT02022657|Dried blood spots|dried blood spots
266700|NCT02022618|Hypertension|hypertension
266701|NCT02022618|Target organ damage|target organ damage
266702|NCT02022618|polymorphism|polymorphism
266703|NCT02022618|Hypertensive patients|hypertensive patients
266704|NCT02022605|ERCP, trainning, trainees, EMS|ercp, trainning, trainees, ems
266705|NCT02022579|Breast Cancer|breast cancer
266706|NCT02022579|Diagnosis|diagnosis
266707|NCT02022579|Malignant|malignant
266708|NCT02022579|Benign|benign
266709|NCT02022579|Biopsy|biopsy
266710|NCT02022566|Osteoarthritis knee|osteoarthritis knee
266711|NCT02022566|Osteoarthritis hip|osteoarthritis hip
266712|NCT02022566|Physical activity|physical activity
266713|NCT02022566|accelerometer|accelerometer
266714|NCT02022553|rectal cancer|rectal cancer
266715|NCT02022553|RACHEL|rachel
266716|NCT02022553|oil chemoembolization|oil chemoembolization
266717|NCT02022540|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
266718|NCT02022540|AMD|amd
266719|NCT02022540|Macular Degeneration|macular degeneration
266720|NCT02022540|Age-Related Macular Degeneration|age-related macular degeneration
266721|NCT02022540|wet AMD|wet amd
266722|NCT02022540|neovascular AMD|neovascular amd
266723|NCT02022540|exudative AMD|exudative amd
266724|NCT02022527|Cost-Effectiveness,|cost-effectiveness,
266725|NCT02022527|Heart valve prosthesis|heart valve prosthesis
266726|NCT02022527|Warfarin,|warfarin,
266727|NCT02022527|Aspirin,|aspirin,
266728|NCT02022527|Egypt|egypt
266729|NCT02022501|Macular Degeneration|macular degeneration
266730|NCT02022488|Child|child
266731|NCT02022488|Sevoflurane|sevoflurane
266732|NCT02022488|Emergence delirium|emergence delirium
266733|NCT02022488|General anesthesia|general anesthesia
266734|NCT02022488|Premedication.|premedication.
266735|NCT02022475|vitamin D|vitamin d
266736|NCT02022475|fatigue|fatigue
266737|NCT02022462|Serious mental illnesses|serious mental illnesses
266738|NCT02022462|peer navigator|peer navigator
266739|NCT02022462|integrated health care|integrated health care
266740|NCT02022449|Maternal depression|maternal depression
266741|NCT02022449|Maternal psychosocial stress and distress|maternal psychosocial stress and distress
266742|NCT02022449|Maternal health outcomes|maternal health outcomes
266743|NCT02022449|Social support|social support
266744|NCT02022449|Pediatric cancer|pediatric cancer
266745|NCT02022410|CAS|cas
266746|NCT02022410|Length of stay|length of stay
266747|NCT02022410|Rehabilitation localisation|rehabilitation localisation
266748|NCT02022410|TKA|tka
266749|NCT02022397|tracheal intubation|tracheal intubation
266750|NCT02022397|predicting difficult intubation|predicting difficult intubation
266751|NCT02022397|general anesthesia|general anesthesia
266752|NCT02022397|difficult ventilation|difficult ventilation
266753|NCT02022384|Malignant glioma|malignant glioma
266754|NCT02022384|Anaplastic astrocytoma|anaplastic astrocytoma
266755|NCT02022384|Glioblastoma multiforme|glioblastoma multiforme
266756|NCT02022384|Immune|immune
266757|NCT02022384|Immunophenotyping|immunophenotyping
266758|NCT02022384|Immune cells|immune cells
266759|NCT02022384|activation state|activation state
266760|NCT02022384|Quality of live|quality of live
266761|NCT02022384|translational research|translational research
266762|NCT02022358|Osteosarcoma|osteosarcoma
266763|NCT02022358|Methotrexate|methotrexate
266764|NCT02022358|Glucarpidase|glucarpidase
266765|NCT02022358|Mucositis|mucositis
266766|NCT02022345|Percutaneous Coronary Intervention|percutaneous coronary intervention
266767|NCT02022345|Coronary Artery Disease|coronary artery disease
266768|NCT02022345|Angioplasty|angioplasty
266769|NCT02022345|Offsite cardiac surgery|offsite cardiac surgery
266770|NCT02022345|Heart disease|heart disease
266771|NCT02022345|Ischemic Heart Disease|ischemic heart disease
266772|NCT02022306|Hepatitis C|hepatitis c
266773|NCT02022293|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
266774|NCT02022293|Radiotherapy|radiotherapy
266775|NCT02022293|Carotid Stenosis|carotid stenosis
266776|NCT02022293|Atorvastatin|atorvastatin
266777|NCT02022267|clubfoot|clubfoot
266778|NCT02022267|gait analysis|gait analysis
266779|NCT02022267|outcome questionaire|outcome questionaire
266780|NCT02022267|Ponseti method|ponseti method
266781|NCT02022241|Ovarian Hyperstimulation Syndrome|ovarian hyperstimulation syndrome
266782|NCT02022241|Luteinizing Hormone|luteinizing hormone
266783|NCT02022241|Polycystic Ovarian Syndrome|polycystic ovarian syndrome
266784|NCT02022241|Ovarian Yield|ovarian yield
266785|NCT02022241|Ovarian Maturity|ovarian maturity
266786|NCT02022228|Ovarian Hyperstimulation Syndrome|ovarian hyperstimulation syndrome
266787|NCT02022228|Luteinizing Hormone|luteinizing hormone
266788|NCT02022228|Polycystic Ovarian Syndrome|polycystic ovarian syndrome
266789|NCT02022228|Ovarian Yield|ovarian yield
266790|NCT02022228|Ovarian Maturity|ovarian maturity
266791|NCT02022228|Gonadotropin Releasing Hormone Agonist|gonadotropin releasing hormone agonist
266792|NCT02022228|Human Chorionic Gonadotropin|human chorionic gonadotropin
266793|NCT02022189|Dent|dent
266794|NCT02022189|Dents|dents
266795|NCT02022189|Dent Disease|dent disease
266796|NCT02022189|Renal Biopsy|renal biopsy
266797|NCT02022189|Kidney Biopsy|kidney biopsy
266798|NCT02022189|Clinical Biopsy|clinical biopsy
266799|NCT02022176|Nitrate|nitrate
266800|NCT02022176|Nitrite|nitrite
266801|NCT02022176|Nitric oxide|nitric oxide
266802|NCT02022176|Resting metabolic rate|resting metabolic rate
266803|NCT02022176|Glucose uptake|glucose uptake
266804|NCT02022176|Insulin sensitivity|insulin sensitivity
266805|NCT02022176|Reactive oxygen species production|reactive oxygen species production
266806|NCT02022176|inorganic nitrate|inorganic nitrate
266807|NCT02022176|Sodium nitrite infusion|sodium nitrite infusion
266808|NCT02022163|Influenza, Human|influenza, human
266809|NCT02022163|RNA Virus Infections|rna virus infections
266810|NCT02022163|Respiratory Tract Diseases|respiratory tract diseases
266811|NCT02022163|Respiratory Tract Infections|respiratory tract infections
266812|NCT02022163|Aluminum Hydroxide|aluminum hydroxide
266813|NCT02022163|Adjuvants, Immunologic|adjuvants, immunologic
266814|NCT02022163|Immunogenic Factors|immunogenic factors
266815|NCT02022163|Physiological Effects of Drugs|physiological effects of drugs
266816|NCT02022163|Virus Diseases|virus diseases
266817|NCT02022163|Orthomyxoviridae Infections|orthomyxoviridae infections
266818|NCT02022163|Infection|infection
266819|NCT02022150|Paracentesis|paracentesis
266820|NCT02022150|Liver Cirrhosis|liver cirrhosis
266821|NCT02022150|ascites|ascites
266822|NCT02022150|body composition|body composition
266823|NCT02022137|Minimal hepatic encephalopathy|minimal hepatic encephalopathy
266824|NCT02022137|Hepatic encephalopathy|hepatic encephalopathy
266825|NCT02022124|chronic low back pain|chronic low back pain
266826|NCT02022124|open-label placebo|open-label placebo
266827|NCT02022046|chronic kidney disease|chronic kidney disease
266828|NCT02022046|cardiovascular disease|cardiovascular disease
266829|NCT02022046|nitric oxide|nitric oxide
266830|NCT02022046|homocysteine|homocysteine
266831|NCT02022046|asymmetric dimethylarginine|asymmetric dimethylarginine
266832|NCT02022046|methylation|methylation
266833|NCT02022033|Pancreatic Cancer|pancreatic cancer
266834|NCT02022033|Adjuvant|adjuvant
266835|NCT02022033|Pancreas|pancreas
266836|NCT02022033|Resected|resected
266837|NCT02022033|Invasive adenocarcinoma|invasive adenocarcinoma
266838|NCT02022033|adenosquamous cancer|adenosquamous cancer
266839|NCT02022033|Intraductal papillary mucinous neoplasm|intraductal papillary mucinous neoplasm
266840|NCT02022007|PCOS|pcos
266841|NCT02022007|IGT|igt
266842|NCT02022007|DPP-4 inhibitor|dpp-4 inhibitor
266843|NCT02021981|Quality Improvement|quality improvement
266844|NCT02021981|Primary Care|primary care
266845|NCT02021981|Blood Pressure, High|blood pressure, high
266846|NCT02021981|Feedback|feedback
266847|NCT02021981|Knowledge|knowledge
266848|NCT02021955|randomized controlled trial|randomized controlled trial
266849|NCT02021955|quality of life|quality of life
266850|NCT02021955|patient readmission|patient readmission
266851|NCT02021955|mortality|mortality
266852|NCT02021955|patient satisfaction|patient satisfaction
266853|NCT02021955|intervention studies|intervention studies
266854|NCT02021955|multicenter study|multicenter study
266855|NCT02021942|primary inoperable thymoma|primary inoperable thymoma
266856|NCT02021942|local recurrent thymoma|local recurrent thymoma
266857|NCT02021942|reduction of tumor size|reduction of tumor size
266858|NCT02021942|SOM230 LAR|som230 lar
266859|NCT02021929|Randomized Controlled Trial|randomized controlled trial
266860|NCT02021929|Clinical Trial|clinical trial
266861|NCT02021929|sorafenib|sorafenib
266862|NCT02021929|Hepatopulmonary Syndrome|hepatopulmonary syndrome
266863|NCT02021903|arterial hypotension|arterial hypotension
266864|NCT02021903|postprandial sleepiness|postprandial sleepiness
266865|NCT02021903|orthostatic hypotension|orthostatic hypotension
266866|NCT02021903|synucleinopathies|synucleinopathies
266867|NCT02021903|hyperglycemia|hyperglycemia
266868|NCT02021890|Dance|dance
268580|NCT02014233|Wingate|wingate
266869|NCT02021890|Physical activity|physical activity
266870|NCT02021890|Physical fitness|physical fitness
266871|NCT02021890|Weight loss|weight loss
266872|NCT02021877|Brain trauma|brain trauma
266873|NCT02021877|ICP measurement|icp measurement
266874|NCT02021877|cranial CT / MRI|cranial ct / mri
266875|NCT02021877|Glasgow Coma Score|glasgow coma score
266876|NCT02021877|acute TBI|acute tbi
266877|NCT02021877|EEG|eeg
266878|NCT02021877|metabolic, proteomic, and genetic biomarkers of TBIs|metabolic, proteomic, and genetic biomarkers of tbis
266879|NCT02021877|injury mechanism|injury mechanism
266880|NCT02021864|hypocalcemia, pregnancy, vitamin D|hypocalcemia, pregnancy, vitamin d
266881|NCT02021851|Dexamethasone,|dexamethasone,
266882|NCT02021851|Ondansetron|ondansetron
266883|NCT02021851|Aprepitant|aprepitant
266884|NCT02021851|PONV|ponv
266885|NCT02021851|Laparoscopic surgery|laparoscopic surgery
267012|NCT02021175|Youth|youth
266886|NCT02021838|domestic violence homicide prevention|domestic violence homicide prevention
266887|NCT02021825|mitoxantrone|mitoxantrone
266888|NCT02021825|neuromyelitis optica|neuromyelitis optica
266889|NCT02021825|relapse|relapse
266890|NCT02021799|Gut microbiome|gut microbiome
266891|NCT02021799|Vaginal microbiome|vaginal microbiome
266892|NCT02021799|Oral microbiome|oral microbiome
266893|NCT02021799|Human milk microbiome|human milk microbiome
266894|NCT02021799|Nutritional Status|nutritional status
266895|NCT02021773|Headache|headache
266896|NCT02021773|Migraine|migraine
266897|NCT02021773|Chronic Migraine|chronic migraine
266898|NCT02021682|Aβ|aβ
266899|NCT02021682|ABeta|abeta
266900|NCT02021682|ABeta kinetics|abeta kinetics
266901|NCT02021682|Alzheimer's Disease|alzheimer's disease
266902|NCT02021682|Alzheimer's|alzheimer's
266903|NCT02021682|amyloid beta|amyloid beta
266904|NCT02021682|biomarker|biomarker
266905|NCT02021682|dementia|dementia
266906|NCT02021682|PET/PIB|pet/pib
266907|NCT02021669|Antidepressive agents|antidepressive agents
266908|NCT02021669|Coronary disease|coronary disease
266909|NCT02021669|Depression|depression
266910|NCT02021669|Depressive disorder|depressive disorder
266911|NCT02021669|Fatty Acids, Omega-3|fatty acids, omega-3
266912|NCT02021630|Obesity|obesity
266913|NCT02021630|Bariatric Surgery|bariatric surgery
266914|NCT02021630|Weight Loss|weight loss
266915|NCT02021630|Physical Activity|physical activity
266916|NCT02021630|Body Composition|body composition
266917|NCT02021617|Intraosseous Access|intraosseous access
266918|NCT02021617|EZ-IO|ez-io
266919|NCT02021604|Congenital Hyperinsulinism|congenital hyperinsulinism
266920|NCT02021604|HI|hi
266921|NCT02021604|Hypoglycemia|hypoglycemia
266922|NCT02021604|FDOPA|fdopa
266923|NCT02021604|18F-DOPA|18f-dopa
266924|NCT02021604|Hyperinsulinism|hyperinsulinism
266925|NCT02021591|Diabetes|diabetes
266926|NCT02021591|Chronic disease|chronic disease
266927|NCT02021591|problem solving|problem solving
266928|NCT02021591|self management|self management
266929|NCT02021578|Depression|depression
266930|NCT02021578|Mood disorder|mood disorder
266931|NCT02021565|Caregivers|caregivers
266932|NCT02021565|Activities of Daily Living|activities of daily living
266933|NCT02021565|Dementia|dementia
266934|NCT02021565|Veterans|veterans
266935|NCT02021565|Self-Help Devices|self-help devices
266936|NCT02021565|Telemedicine|telemedicine
266937|NCT02021552|Trauma|trauma
266938|NCT02021552|Sepsis|sepsis
266939|NCT02021539|Elastography of the cervix|elastography of the cervix
266940|NCT02021539|Cervical elastography|cervical elastography
266941|NCT02021539|Predicting delivery|predicting delivery
266942|NCT02021526|G1D|g1d
266943|NCT02021526|Glut1 Deficiency|glut1 deficiency
266944|NCT02021526|Glucose Transporter Type 1 Deficiency|glucose transporter type 1 deficiency
266945|NCT02021526|Glucose Transporter Type I Deficiency|glucose transporter type i deficiency
266946|NCT02021513|SLE|sle
266947|NCT02021513|Fish Oil|fish oil
266948|NCT02021513|Omega-3|omega-3
266949|NCT02021448|OHS|ohs
266950|NCT02021422|metastatic pancreatic ductal adenocarcinoma (PDAC)|metastatic pancreatic ductal adenocarcinoma (pdac)
266951|NCT02021422|pancreatic cancer|pancreatic cancer
266952|NCT02021422|pancreas cancer|pancreas cancer
266953|NCT02021422|pancreatic adenocarcinoma|pancreatic adenocarcinoma
266954|NCT02021422|metastatic pancreas cancer|metastatic pancreas cancer
266955|NCT02021422|metastatic pancreatic cancer|metastatic pancreatic cancer
266956|NCT02021409|Anemia on CKD|anemia on ckd
266957|NCT02021396|Rescue splenic trauma patients at high risk of splenectomy|rescue splenic trauma patients at high risk of splenectomy
266958|NCT02021383|Weight loss|weight loss
266959|NCT02021383|Weight maintenance|weight maintenance
266960|NCT02021383|Contingency Management|contingency management
266961|NCT02021383|College students|college students
266962|NCT02021383|Financial incentives|financial incentives
266963|NCT02021370|Anemia of CKD|anemia of ckd
266964|NCT02021357|Facial Pain|facial pain
266965|NCT02021357|Physical Therapy Modalities|physical therapy modalities
266966|NCT02021357|Temporomandibular Joint Disorders|temporomandibular joint disorders
266967|NCT02021357|Exercise Therapy|exercise therapy
266968|NCT02021331|jaw, edentulous, partially|jaw, edentulous, partially
266969|NCT02021318|Non-dialysis|non-dialysis
266970|NCT02021318|Roxadustat|roxadustat
266971|NCT02021318|ASP1517|asp1517
266972|NCT02021318|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
266973|NCT02021318|Anemia|anemia
266974|NCT02021318|Hemoglobin|hemoglobin
266975|NCT02021305|Toll like Receptors|toll like receptors
266976|NCT02021305|TLR 4|tlr 4
266977|NCT02021305|Urinary track infections in children|urinary track infections in children
266978|NCT02021305|TLR 4 polymorphisms|tlr 4 polymorphisms
266979|NCT02021305|Innate immunity|innate immunity
266980|NCT02021305|Defence mechanisms|defence mechanisms
266981|NCT02021305|Immune responses|immune responses
266982|NCT02021292|Chronic thromboembolic pulmonary hypertension (CTEPH)|chronic thromboembolic pulmonary hypertension (cteph)
266983|NCT02021279|pelvic organ prolapse|pelvic organ prolapse
266984|NCT02021279|MatriStem|matristem
266985|NCT02021279|pelvic floor matrix|pelvic floor matrix
266986|NCT02021279|ACell|acell
266987|NCT02021279|native tissue repair|native tissue repair
266988|NCT02021253|Endotoxemia|endotoxemia
266989|NCT02021253|Probiotic|probiotic
266990|NCT02021253|Leaky gut|leaky gut
266991|NCT02021253|Gut permeability|gut permeability
266992|NCT02021253|Liver cirrhosis|liver cirrhosis
266993|NCT02021253|Liver fibrosis|liver fibrosis
266994|NCT02021253|Hepatocellular carcinoma|hepatocellular carcinoma
266995|NCT02021227|Acute respiratory failure|acute respiratory failure
266996|NCT02021227|Mechanical ventilation|mechanical ventilation
266997|NCT02021227|Rehabilitation|rehabilitation
266998|NCT02021227|Exercise chair sitting|exercise chair sitting
266999|NCT02021227|Weaning|weaning
267000|NCT02021227|Chronic respiratory failure|chronic respiratory failure
267001|NCT02021214|Methylphenidate|methylphenidate
267002|NCT02021214|Fear extinction|fear extinction
267003|NCT02021214|fMRI|fmri
267004|NCT02021214|mPFC|mpfc
267005|NCT02021188|Vascular inflammation|vascular inflammation
267006|NCT02021188|Atherosclerosis|atherosclerosis
267007|NCT02021188|Positron Emission Tomography|positron emission tomography
267008|NCT02021188|Molecular Imaging|molecular imaging
267009|NCT02021188|68Ga-DOTATATE|68ga-dotatate
267010|NCT02021175|Smoking Cessation|smoking cessation
267011|NCT02021175|Korean|korean
267013|NCT02021175|Adolescent|adolescent
267014|NCT02021175|Dependence|dependence
267015|NCT02021175|Teen Smoking|teen smoking
267016|NCT02021175|Smoking and Youth|smoking and youth
267017|NCT02021175|Youth and Tobacco|youth and tobacco
267018|NCT02021175|Cognitive-Behavioral Motivational Enhancement|cognitive-behavioral motivational enhancement
267019|NCT02021175|Technology|technology
267020|NCT02021175|Nicotine Dependence|nicotine dependence
267021|NCT02021175|Cell Phone|cell phone
267022|NCT02021175|Smart Phone|smart phone
267023|NCT02021175|Internet|internet
267024|NCT02021175|Web|web
267025|NCT02021162|Multiple sclerosis|multiple sclerosis
267026|NCT02021162|Gilenya|gilenya
267027|NCT02021162|Healthy controls|healthy controls
267028|NCT02021162|Thalamic atrophy|thalamic atrophy
267029|NCT02021162|MRI|mri
267030|NCT02021149|Major Depressive Disorder|major depressive disorder
267031|NCT02021149|Whole Body Hyperthermia|whole body hyperthermia
267032|NCT02021149|Psychotherapy|psychotherapy
267033|NCT02021149|Therapist and patient alliance|therapist and patient alliance
267034|NCT02021123|Anidulafungin|anidulafungin
267035|NCT02021123|Gastric bypass|gastric bypass
267036|NCT02021123|Morbidly obese|morbidly obese
267037|NCT02021123|Pharmacokinetics|pharmacokinetics
267038|NCT02021123|Prophylaxis|prophylaxis
267039|NCT02021123|Yeast infection|yeast infection
267040|NCT02021097|Levonorgestrel；|levonorgestrel；
267041|NCT02021097|Ethinyl Estradiol；|ethinyl estradiol；
267042|NCT02021097|Oral Contraceptive|oral contraceptive
267043|NCT02021084|Familial Mediterranean Fever (FMF), probiotics|familial mediterranean fever (fmf), probiotics
267044|NCT02021032|BPH|bph
267045|NCT02021006|antibiotic prophylaxis|antibiotic prophylaxis
267046|NCT02021006|vesicoureteral reflux|vesicoureteral reflux
267047|NCT02021006|congenital abnormalities of kidney|congenital abnormalities of kidney
267048|NCT02021006|renal hypodysplasia|renal hypodysplasia
267049|NCT02021006|chronic kidney disease|chronic kidney disease
267050|NCT02020993|Nt-proBNP, newborn, preterm|nt-probnp, newborn, preterm
267051|NCT02020928|Oral Mucositis|oral mucositis
267052|NCT02020928|chemotherapy|chemotherapy
267053|NCT02020928|Bone Marrow Transplantation|bone marrow transplantation
267054|NCT02020889|eosinophils|eosinophils
267055|NCT02020889|SB 240563|sb 240563
267056|NCT02020889|Churg-Strauss Syndrome|churg-strauss syndrome
267057|NCT02020889|quality of life|quality of life
267058|NCT02020889|mepolizumab|mepolizumab
267059|NCT02020889|safety|safety
267060|NCT02020889|biomarkers|biomarkers
267061|NCT02020889|efficacy|efficacy
267062|NCT02020889|corticosteroids|corticosteroids
267063|NCT02020889|Eosinophilic granulomatosis with polyangiitis|eosinophilic granulomatosis with polyangiitis
267064|NCT02020850|Toe-Brachial Index|toe-brachial index
267065|NCT02020850|Ankle-Brachial Index|ankle-brachial index
267066|NCT02020850|Systolic blood pressure|systolic blood pressure
267067|NCT02020824|Acrophobia|acrophobia
267068|NCT02020785|proteinuria|proteinuria
268971|NCT02012309|Pneumovax|pneumovax
267069|NCT02020772|primary health care|primary health care
267070|NCT02020772|Physical Therapy Specialty|physical therapy specialty
267071|NCT02020772|General Practitioners|general practitioners
267072|NCT02020772|General Practice|general practice
267073|NCT02020733|Hysterosalpingography|hysterosalpingography
267074|NCT02020733|balloon catheter|balloon catheter
267075|NCT02020733|metal cannula|metal cannula
267076|NCT02020733|pain assessment|pain assessment
267077|NCT02020694|Obesity|obesity
267078|NCT02020694|Insulin resistance|insulin resistance
267079|NCT02020694|Vitamin D|vitamin d
267080|NCT02020694|Cardiovascular risk factors|cardiovascular risk factors
267081|NCT02020681|Dental caries|dental caries
267082|NCT02020681|Curodont Repair|curodont repair
267083|NCT02020681|P11-4|p11-4
267084|NCT02020668|Pain|pain
267085|NCT02020668|Functional capacity|functional capacity
267086|NCT02020668|Quality of Life|quality of life
267087|NCT02020655|IL-1 alpha, Sebutape, shear- force|il-1 alpha, sebutape, shear- force
267088|NCT02020642|polysomnography|polysomnography
267089|NCT02020642|bioimpedance|bioimpedance
267090|NCT02020642|leg fluid shift|leg fluid shift
267091|NCT02020642|neck circumference|neck circumference
267092|NCT02020642|Sleep Apnea Syndromes|sleep apnea syndromes
267093|NCT02020642|Sleep Apnea, Obstructive|sleep apnea, obstructive
267094|NCT02020642|Sleep Disorders, Intrinsic|sleep disorders, intrinsic
267095|NCT02020642|Sleep Disorders|sleep disorders
267096|NCT02020642|Apnea|apnea
267097|NCT02020642|Kidney Diseases|kidney diseases
267098|NCT02020642|Kidney Failure, Chronic|kidney failure, chronic
267099|NCT02020642|Renal Insufficiency, Chronic|renal insufficiency, chronic
267100|NCT02020642|Renal Insufficiency|renal insufficiency
267101|NCT02020642|Dyssomnias|dyssomnias
267102|NCT02020629|Glucagon|glucagon
267103|NCT02020629|Hypoglycemia|hypoglycemia
267104|NCT02020629|Counterregulation|counterregulation
267105|NCT02020603|peptic ulcer bleeding|peptic ulcer bleeding
267106|NCT02020603|hemostatic forceps|hemostatic forceps
267107|NCT02020603|soft coagulation|soft coagulation
267108|NCT02020603|argon plasma coagulation|argon plasma coagulation
267109|NCT02020590|Delayed-Union Fractures|delayed-union fractures
267110|NCT02020590|Impaired Healing|impaired healing
267111|NCT02020590|Fractures|fractures
267112|NCT02020590|Orthopedics|orthopedics
267113|NCT02020590|Bone|bone
267114|NCT02020590|Musculoskeletal Disorders|musculoskeletal disorders
267115|NCT02020564|Processing Speed|processing speed
267116|NCT02020564|Cognition|cognition
267117|NCT02020564|Intervention|intervention
267118|NCT02020564|Traumatic Brain Injury|traumatic brain injury
267119|NCT02020564|Mild Cognitive Impairment|mild cognitive impairment
267120|NCT02020551|Scores During IUD insertion.|scores during iud insertion.
267121|NCT02020538|Thoracic surgery|thoracic surgery
267122|NCT02020538|cardiac surgery|cardiac surgery
267123|NCT02020538|acute kidney injury|acute kidney injury
267124|NCT02020538|hyperchloremia|hyperchloremia
267125|NCT02020538|intravenous fluid|intravenous fluid
267126|NCT02020486|Healthy|healthy
267127|NCT02020473|Informed consents|informed consents
267128|NCT02020473|Withholding/withdrawing life support (WLS)|withholding/withdrawing life support (wls)
267129|NCT02020473|Intensive care unit (ICU)|intensive care unit (icu)
267130|NCT02020460|post-laminectomy pain syndrome,|post-laminectomy pain syndrome,
267131|NCT02020460|refractory,|refractory,
267132|NCT02020460|refractory chronic neuropathic pain,|refractory chronic neuropathic pain,
267133|NCT02020460|failed back surgery syndrome.|failed back surgery syndrome.
267134|NCT02020421|ischemic stroke|ischemic stroke
267135|NCT02020421|rehabilitation|rehabilitation
267136|NCT02020421|aphasia|aphasia
267137|NCT02020421|non-invasive brain stimulation|non-invasive brain stimulation
267138|NCT02020382|microRNAs|micrornas
267139|NCT02020382|IBD|ibd
267140|NCT02020382|Crohn's disease|crohn's disease
267141|NCT02020382|Ulcerative colitis|ulcerative colitis
267142|NCT02020382|colonic polyps screening|colonic polyps screening
267143|NCT02020382|controls|controls
267144|NCT02020356|Alzheimer's disease|alzheimer's disease
267145|NCT02020356|Neuroleptics|neuroleptics
267146|NCT02020356|Music therapy|music therapy
267147|NCT02020330|falciparum, malaria|falciparum, malaria
267148|NCT02020317|drug interactions|drug interactions
267149|NCT02020317|Drug Monitoring|drug monitoring
267150|NCT02020317|Potassium|potassium
267151|NCT02020317|Hyperkalemia|hyperkalemia
267152|NCT02020304|Combined spinal epidural duration|combined spinal epidural duration
267153|NCT02020304|labor pain|labor pain
267154|NCT02020291|Foxy-5|foxy-5
267155|NCT02020291|Wnt-5A|wnt-5a
267156|NCT02020278|Hyponatremia|hyponatremia
267157|NCT02020278|Euvolemic|euvolemic
267158|NCT02020278|Hypervolemic|hypervolemic
267159|NCT02020278|Serum sodium|serum sodium
267160|NCT02020278|Dilutional hyponatremia|dilutional hyponatremia
267161|NCT02020278|Electrolyte abnormality|electrolyte abnormality
267162|NCT02020278|Electrolyte imbalance|electrolyte imbalance
267163|NCT02020278|Metabolic disease|metabolic disease
267164|NCT02020278|Water-Electrolyte Imbalance|water-electrolyte imbalance
267165|NCT02020265|stress and depression related symptoms|stress and depression related symptoms
267166|NCT02020239|physical activity|physical activity
267168|NCT02020239|body composition|body composition
267169|NCT02020226|TH-302|th-302
267170|NCT02020226|Solid Tumors|solid tumors
267171|NCT02020226|QTc|qtc
267172|NCT02020226|Cardiac|cardiac
267173|NCT02020226|Evofosfamide|evofosfamide
267174|NCT02020213|successful percentage|successful percentage
267175|NCT02020200|Bipolar Disorder|bipolar disorder
267176|NCT02020200|Methylphenidate|methylphenidate
267177|NCT02020200|Cognitive Function|cognitive function
267178|NCT02020187|Congenital myopathy|congenital myopathy
267179|NCT02020187|Exercise|exercise
267180|NCT02020174|Preeclampsia|preeclampsia
267181|NCT02020174|Eclampsia|eclampsia
267182|NCT02020174|HELLP|hellp
267183|NCT02020174|HELLP Syndrome|hellp syndrome
267184|NCT02020174|Toxemia|toxemia
267185|NCT02020174|Hypertensive Disorder of Pregnancy|hypertensive disorder of pregnancy
267186|NCT02020174|Registry|registry
267187|NCT02020174|Pregnancy Complication|pregnancy complication
267188|NCT02020174|Pregnancy|pregnancy
267189|NCT02020174|Maternal Death|maternal death
267190|NCT02020174|Premature|premature
267191|NCT02020174|High Blood Pressure|high blood pressure
267192|NCT02020174|Hypertension|hypertension
267193|NCT02020148|pregnancy|pregnancy
267194|NCT02020148|oxytocin|oxytocin
267195|NCT02020148|postpartum depression|postpartum depression
267196|NCT02020148|depression|depression
267197|NCT02020148|pregnant women|pregnant women
267198|NCT02020148|mood|mood
267199|NCT02020148|anxiety|anxiety
267200|NCT02020148|hormones|hormones
267201|NCT02020148|women's health|women's health
267202|NCT02020148|mental health|mental health
267203|NCT02020148|baby blues|baby blues
267204|NCT02020148|mood disorders|mood disorders
267205|NCT02020122|endogenous pain modulation|endogenous pain modulation
267206|NCT02020122|coronary artery bypass grafting|coronary artery bypass grafting
267207|NCT02020122|quantitative sensory testings|quantitative sensory testings
267208|NCT02020122|duloxetine|duloxetine
267209|NCT02020122|pregabalin|pregabalin
267210|NCT02020122|preemptive treatment|preemptive treatment
267211|NCT02020096|Lumbar plexus block|lumbar plexus block
267212|NCT02020096|Ultrasound guidance|ultrasound guidance
267213|NCT02020096|Nerve stimulator|nerve stimulator
267214|NCT02020083|VIH ; Placental transfer ; Tenofovir ; Emtricitabine ; Membrane transporter|vih ; placental transfer ; tenofovir ; emtricitabine ; membrane transporter
267215|NCT02020070|Ipilimumab|ipilimumab
267216|NCT02020070|Degarelix|degarelix
267217|NCT02020070|Radical Prostatectomy|radical prostatectomy
267218|NCT02020070|13-134|13-134
267219|NCT02020031|Revision knee joint|revision knee joint
267220|NCT02020005|menthol cigarettes|menthol cigarettes
267221|NCT02020005|smoking cessation|smoking cessation
267222|NCT02019992|sepsis|sepsis
267223|NCT02019992|mitochondrial DNA|mitochondrial dna
267224|NCT02019992|systemic inflammation|systemic inflammation
267225|NCT02019992|outcome|outcome
267226|NCT02019979|non squamous|non squamous
267227|NCT02019979|non small cell|non small cell
267228|NCT02019979|lung cancer|lung cancer
267229|NCT02019979|metformin|metformin
267230|NCT02019927|NAION|naion
267231|NCT02019927|Decreased vision|decreased vision
267232|NCT02019927|Eye trauma|eye trauma
267233|NCT02019927|TES|tes
267234|NCT02019927|Electrical stimulation|electrical stimulation
267235|NCT02019927|Multiple Sclerosis|multiple sclerosis
267236|NCT02019927|Optic Neuritis|optic neuritis
267237|NCT02019914|PTSD|ptsd
267238|NCT02019914|CPAP|cpap
267239|NCT02019914|OSA|osa
267240|NCT02019901|Rheumatoid arthritis|rheumatoid arthritis
267241|NCT02019901|Person-centered care|person-centered care
267242|NCT02019901|Tight control|tight control
267243|NCT02019888|Ear, Middle|ear, middle
267244|NCT02019888|Ear, Inner|ear, inner
267245|NCT02019888|Audiometry|audiometry
267246|NCT02019888|Acoustic impedance tests|acoustic impedance tests
267247|NCT02019875|Vitamin D|vitamin d
267248|NCT02019875|CYP3A4|cyp3a4
267249|NCT02019875|Calcium|calcium
267250|NCT02019862|Total hip arthroplasty|total hip arthroplasty
267251|NCT02019862|TRJ|trj
267252|NCT02019862|PMCF|pmcf
267253|NCT02019862|Hip stem|hip stem
267254|NCT02019849|THA, Plasmafit®|tha, plasmafit®
267255|NCT02019836|vit D; sepsis; newborn; maternal; neonatal|vit d; sepsis; newborn; maternal; neonatal
267256|NCT02019823|SMS-text|sms-text
267257|NCT02019823|mobile health|mobile health
267258|NCT02019823|mHealth|mhealth
267259|NCT02019823|treatment|treatment
267260|NCT02019823|adherence|adherence
267261|NCT02019797|aortic valve replacement|aortic valve replacement
267262|NCT02019784|Cirrhosis|cirrhosis
267263|NCT02019784|Hepatic encephalopathy|hepatic encephalopathy
267264|NCT02019771|HIV Infection|hiv infection
267265|NCT02019771|Men who have sex with men|men who have sex with men
267266|NCT02019771|Chlamydia|chlamydia
267267|NCT02019771|Gonorrhea|gonorrhea
267268|NCT02019745|Live attenuated influenza virus (LAIV)|live attenuated influenza virus (laiv)
267269|NCT02019745|Flu vaccine|flu vaccine
267270|NCT02019745|FluMist|flumist
267271|NCT02019745|Smokers|smokers
267272|NCT02019745|New and emerging tobacco products|new and emerging tobacco products
267273|NCT02019732|Mild outcomes|mild outcomes
267274|NCT02019732|Database|database
267275|NCT02019732|Influenza-attributable|influenza-attributable
267276|NCT02019732|Retrospective|retrospective
267277|NCT02019732|Influenza|influenza
267278|NCT02019732|United States of America (USA)|united states of america (usa)
267279|NCT02019719|Hemodialysis|hemodialysis
267280|NCT02019719|GSK1278863|gsk1278863
267281|NCT02019719|Pharmacokinetics|pharmacokinetics
267282|NCT02019719|Erythropoiesis Stimulating Agents|erythropoiesis stimulating agents
267283|NCT02019719|Chronic Kidney Disease|chronic kidney disease
267284|NCT02019719|Hemoglobin|hemoglobin
267285|NCT02019719|Recombinant Erythropoietin|recombinant erythropoietin
267286|NCT02019719|Prolyl Hydroxylase Inhibitor|prolyl hydroxylase inhibitor
267287|NCT02019719|Anemia|anemia
267288|NCT02019706|Cushing Syndrome|cushing syndrome
267289|NCT02019706|Ectopic ACTH Secretion|ectopic acth secretion
267290|NCT02019706|Imaging|imaging
267291|NCT02019693|MET Inhibitor|met inhibitor
267292|NCT02019693|Sporadic|sporadic
267293|NCT02019693|Hereditary|hereditary
267294|NCT02019693|Multifocal|multifocal
267295|NCT02019693|HGF/MET Pathway|hgf/met pathway
267296|NCT02019680|Endothelial Function|endothelial function
267297|NCT02019680|Biomarkers|biomarkers
267298|NCT02019680|Atherosclerosis|atherosclerosis
267299|NCT02019680|Blood Flow|blood flow
267300|NCT02019680|Blood Pressure|blood pressure
267301|NCT02019667|GABA|gaba
267302|NCT02019667|Seizures|seizures
267303|NCT02019667|Neurotransmitters|neurotransmitters
267304|NCT02019654|Post -Traumatic Stress Disorder (PTSD)|post -traumatic stress disorder (ptsd)
267305|NCT02019654|Traumatic Brain Injury|traumatic brain injury
267306|NCT02019654|Neuroendocrine|neuroendocrine
267307|NCT02019654|Epigenetics|epigenetics
267308|NCT02019641|Exercise|exercise
267309|NCT02019641|Interstitial Lung Disease|interstitial lung disease
267310|NCT02019641|Pulmonary Rehabilitation|pulmonary rehabilitation
267311|NCT02019628|NK cells cytotoxicity, dietary supplementation|nk cells cytotoxicity, dietary supplementation
267312|NCT02019615|disorders of consciousness|disorders of consciousness
267313|NCT02019615|minimally conscious state|minimally conscious state
267314|NCT02019615|traumatic brain injury|traumatic brain injury
267315|NCT02019615|stroke|stroke
267316|NCT02019615|transcranial direct current stimulation|transcranial direct current stimulation
267317|NCT02019602|Cimzia®|cimzia®
267318|NCT02019602|CZP|czp
267319|NCT02019602|Placental transfer|placental transfer
267320|NCT02019602|Autoimmune diseases and pregnancy|autoimmune diseases and pregnancy
267321|NCT02019589|Secondary Amenorrhea|secondary amenorrhea
267322|NCT02019589|SPRY Trial|spry trial
267323|NCT02019576|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
267324|NCT02019576|mRCC|mrcc
267325|NCT02019576|Clear cell|clear cell
267326|NCT02019563|pediatrics|pediatrics
267327|NCT02019563|dental caries|dental caries
267328|NCT02019563|dental pulp exposure|dental pulp exposure
267329|NCT02019563|incisor|incisor
267330|NCT02019550|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
267331|NCT02019550|Rebif®Rebidose®|rebif®rebidose®
267332|NCT02019550|Rebiject II®|rebiject ii®
267333|NCT02019524|Stage I breast cancer|stage i breast cancer
267334|NCT02019524|Stage II breast cancer|stage ii breast cancer
267335|NCT02019524|Stage IIIA, IIIB, and IIIC breast cancer|stage iiia, iiib, and iiic breast cancer
267336|NCT02019524|Male breast cancer|male breast cancer
267337|NCT02019524|Ovarian cancer|ovarian cancer
267338|NCT02019511|Orthopedic surgery|orthopedic surgery
267339|NCT02019511|Infections|infections
267340|NCT02019511|Steroid|steroid
267341|NCT02019511|Fast-track|fast-track
267342|NCT02019511|Total knee arthroplasty|total knee arthroplasty
267343|NCT02019511|Safety|safety
267344|NCT02019498|low back pain|low back pain
267345|NCT02019498|relaxation|relaxation
267346|NCT02019485|Healthy|healthy
267347|NCT02019485|Tapentadol|tapentadol
267348|NCT02019485|Tapentadol extended-release tamper-resistant formulation|tapentadol extended-release tamper-resistant formulation
267349|NCT02019485|Tapentadol extended-release prolonged-release formulation|tapentadol extended-release prolonged-release formulation
267350|NCT02019485|Bioequivalence|bioequivalence
267351|NCT02019485|Fasted Conditions|fasted conditions
267352|NCT02019472|Rheumatoid arthritis|rheumatoid arthritis
267353|NCT02019472|CNTO 136|cnto 136
267354|NCT02019472|Sirukumab|sirukumab
267355|NCT02019472|Adalimumab|adalimumab
267356|NCT02019472|HUMIRA®|humira®
267357|NCT02019446|type 2 diabetes mellitus|type 2 diabetes mellitus
267358|NCT02019446|onychomycosis|onychomycosis
267359|NCT02019446|laser treatment|laser treatment
267360|NCT02019446|antifungal|antifungal
267361|NCT02019433|THA, augment, revision, pelvis|tha, augment, revision, pelvis
267362|NCT02019420|Pneumonia|pneumonia
267363|NCT02019420|Tedizolid Phosphate|tedizolid phosphate
267364|NCT02019420|TR-701|tr-701
267365|NCT02019407|atrial fibrillation|atrial fibrillation
267366|NCT02019407|atrial flutter|atrial flutter
267367|NCT02019407|catheter ablation|catheter ablation
267368|NCT02019407|cavo-tricuspid isthmus block|cavo-tricuspid isthmus block
267369|NCT02019342|blood pressure|blood pressure
269065|NCT02011815|distress|distress
267370|NCT02019342|mean arterial pressure|mean arterial pressure
267371|NCT02019342|MAP|map
267372|NCT02019342|intraoperative|intraoperative
267373|NCT02019342|postoperative|postoperative
267374|NCT02019342|anesthesia|anesthesia
267375|NCT02019316|Supplementation|supplementation
267376|NCT02019316|Performance|performance
267377|NCT02019316|Cognitive Function|cognitive function
267378|NCT02019316|Muscular Endurance|muscular endurance
267379|NCT02019316|BioSteel|biosteel
267380|NCT02019316|BCAA|bcaa
267381|NCT02019316|Branched Chain Amino Acids|branched chain amino acids
267382|NCT02019316|Sprint Interval Exercise|sprint interval exercise
267383|NCT02019264|Diabetes|diabetes
267384|NCT02019264|Cardiovascular Disease|cardiovascular disease
267385|NCT02019264|Multiple Cardiovascular Risk Factors|multiple cardiovascular risk factors
267386|NCT02019264|Obesity|obesity
267387|NCT02019264|Overweight|overweight
267388|NCT02019264|MACE|mace
267389|NCT02019264|Conversion to Diabetes|conversion to diabetes
267390|NCT02019225|dialysis|dialysis
267391|NCT02019225|hemodialysis|hemodialysis
267392|NCT02019225|pragmatic trial|pragmatic trial
267393|NCT02019225|end stage renal disease|end stage renal disease
267394|NCT02019225|randomized clinical trial|randomized clinical trial
267395|NCT02019212|99mTc-tetrofosmin|99mtc-tetrofosmin
267396|NCT02019212|myocardial perfusion imaging|myocardial perfusion imaging
267397|NCT02019212|SPECT|spect
267398|NCT02019212|radiation|radiation
267399|NCT02019186|type 1 diabetes|type 1 diabetes
267400|NCT02019186|endothelial function|endothelial function
267401|NCT02019186|adolescents|adolescents
267402|NCT02019186|vitamin C|vitamin c
267403|NCT02019186|vitamin E|vitamin e
267404|NCT02019173|exercise therapy|exercise therapy
267405|NCT02019173|brain injury|brain injury
267406|NCT02019173|postural balance|postural balance
267407|NCT02019160|silver nitrate|silver nitrate
267408|NCT02019160|sodium fluoride|sodium fluoride
267409|NCT02019160|silver diamine fluoride|silver diamine fluoride
267410|NCT02019160|caries|caries
267411|NCT02019160|non-inferiority trial|non-inferiority trial
267412|NCT02019147|HIE|hie
267413|NCT02019147|Biomarker|biomarker
267414|NCT02019134|chronic neck pain|chronic neck pain
267415|NCT02019134|relaxation technique|relaxation technique
267416|NCT02019134|comparative effectiveness research|comparative effectiveness research
267417|NCT02019108|osteoarthritis|osteoarthritis
267418|NCT02019108|knee|knee
267419|NCT02019108|walking|walking
267420|NCT02019108|toeout|toeout
267421|NCT02019108|gait modification|gait modification
267422|NCT02019095|Pneumonia, Ventilator-Associated|pneumonia, ventilator-associated
267423|NCT02019095|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
267424|NCT02019095|Pulmonary Surfactant-Associated Proteins|pulmonary surfactant-associated proteins
267425|NCT02019095|activin A|activin a
267426|NCT02019030|benign prostatic hyperplasia|benign prostatic hyperplasia
267427|NCT02019030|Transurethral vaporization of prostate|transurethral vaporization of prostate
267428|NCT02019017|Cluster Headache|cluster headache
267429|NCT02019017|Botulinum Toxin Type A|botulinum toxin type a
267430|NCT02019017|Sphenopalatine Ganglion Block|sphenopalatine ganglion block
267431|NCT02019017|Autonomic Nerve Block|autonomic nerve block
267432|NCT02018978|HIV prevention|hiv prevention
267433|NCT02018978|Behavioral intervention|behavioral intervention
267434|NCT02018978|Community-randomized trial|community-randomized trial
267435|NCT02018965|HIV|hiv
267436|NCT02018965|Extended-release Niacin|extended-release niacin
267437|NCT02018965|Immune activation|immune activation
267438|NCT02018952|Septic arthritis|septic arthritis
267439|NCT02018952|Ultrasonography|ultrasonography
267440|NCT02018952|Prognosis parameters|prognosis parameters
267441|NCT02018939|pharmacokinetics, doripenem, renal replacement therapy, MARS, organ replacement therapy|pharmacokinetics, doripenem, renal replacement therapy, mars, organ replacement therapy
267442|NCT02018926|Mocetinostat|mocetinostat
267443|NCT02018926|Azacitidine|azacitidine
267444|NCT02018926|Vidaza|vidaza
267445|NCT02018926|Myelodysplastic syndrome|myelodysplastic syndrome
267446|NCT02018926|HDAC|hdac
267447|NCT02018926|HMA|hma
267448|NCT02018926|MDS|mds
267449|NCT02018900|Synbiotics|synbiotics
267450|NCT02018900|Intestinal permeability|intestinal permeability
267451|NCT02018900|Microbiota|microbiota
267452|NCT02018900|Immune response|immune response
267453|NCT02018848|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
267454|NCT02018848|Attention Training|attention training
267455|NCT02018848|Attention Bias Modification|attention bias modification
267456|NCT02018848|Dot-Probe Task|dot-probe task
267457|NCT02018848|Randomized Controlled Trial|randomized controlled trial
267458|NCT02018848|Online Treatment|online treatment
267459|NCT02018848|Washing|washing
267460|NCT02018848|Checking|checking
267461|NCT02018822|restorative material|restorative material
267462|NCT02018809|Medication Adherence|medication adherence
267463|NCT02018809|High Blood Pressure|high blood pressure
267464|NCT02018809|Diabetes|diabetes
267465|NCT02018809|Statins|statins
267466|NCT02018770|Temporomandibular Disorders, Electromyogram,|temporomandibular disorders, electromyogram,
267663|NCT02017951|Hospitals,Rural|hospitals,rural
267467|NCT02018770|Modalities of physiotherapy,|modalities of physiotherapy,
267468|NCT02018770|Temporomandibular dysfunction syndrome,|temporomandibular dysfunction syndrome,
267469|NCT02018770|Lasers.|lasers.
267470|NCT02018757|Carcinoma, Hepatocellular|carcinoma, hepatocellular
267471|NCT02018757|primary liver cancer|primary liver cancer
267472|NCT02018757|primary hepatocellular carcinoma|primary hepatocellular carcinoma
267473|NCT02018757|transarterial chemoembolization|transarterial chemoembolization
267474|NCT02018757|Chemoembolization, Therapeutic|chemoembolization, therapeutic
267475|NCT02018757|arsenic trioxide|arsenic trioxide
267476|NCT02018757|arsenous anhydride|arsenous anhydride
267477|NCT02018757|diarsenic trioxide|diarsenic trioxide
267478|NCT02018757|randomized controlled trial|randomized controlled trial
267479|NCT02018757|multicenter study|multicenter study
267480|NCT02018757|HCC|hcc
267481|NCT02018757|TACE|tace
267482|NCT02018731|Becker's Muscular dystrophy|becker's muscular dystrophy
267483|NCT02018731|BMD|bmd
267484|NCT02018731|Metformin|metformin
267485|NCT02018731|L-citrulline|l-citrulline
267486|NCT02018718|Skeletal muscle|skeletal muscle
267487|NCT02018718|Marathon|marathon
267488|NCT02018718|MRI|mri
267489|NCT02018705|POEM|poem
267490|NCT02018705|LHM|lhm
267491|NCT02018705|Achalasia treatment|achalasia treatment
267492|NCT02018705|LES sphincter myotomy|les sphincter myotomy
267493|NCT02018679|Nodular basal cell carcinoma|nodular basal cell carcinoma
267494|NCT02018679|Er:YAG|er:yag
267495|NCT02018679|AFL-assisted|afl-assisted
267496|NCT02018679|MAL-PDT|mal-pdt
267497|NCT02018653|Cancer|cancer
267498|NCT02018653|Diarrhea|diarrhea
267499|NCT02018653|Calcium Alumina-Silicate|calcium alumina-silicate
267500|NCT02018653|CASAD|casad
267501|NCT02018653|Calcium Aluminosilicate anti-diarrheal|calcium aluminosilicate anti-diarrheal
267502|NCT02018653|Placebo|placebo
267503|NCT02018653|Sugar pill|sugar pill
267504|NCT02018653|Questionnaire|questionnaire
267505|NCT02018653|Survey|survey
267506|NCT02018640|cancer|cancer
267507|NCT02018640|tobacco use|tobacco use
267508|NCT02018640|pregnancy|pregnancy
267509|NCT02018627|bionic pancreas|bionic pancreas
267510|NCT02018627|artificial pancreas|artificial pancreas
267511|NCT02018627|insulin|insulin
267512|NCT02018627|glucagon|glucagon
267513|NCT02018627|clamp|clamp
267514|NCT02018614|Pain|pain
267515|NCT02018614|elderly|elderly
267516|NCT02018614|aged 65 or above 65|aged 65 or above 65
267517|NCT02018614|communication disorders|communication disorders
267518|NCT02018614|Algoplus® scale|algoplus® scale
267519|NCT02018588|requirements|requirements
267520|NCT02018588|amino acid|amino acid
267521|NCT02018588|tryptophan|tryptophan
267522|NCT02018575|lysine|lysine
267523|NCT02018575|bioavailability|bioavailability
267524|NCT02018575|amino acids|amino acids
267525|NCT02018575|corn|corn
267526|NCT02018562|Quality of Life|quality of life
267527|NCT02018562|Talking Tracheostomy Tube|talking tracheostomy tube
267528|NCT02018562|Speech|speech
267529|NCT02018562|Mechanically ventilated patients|mechanically ventilated patients
267530|NCT02018549|COPD|copd
267531|NCT02018549|placebo|placebo
267532|NCT02018549|inhalatory profile|inhalatory profile
267533|NCT02018536|Healthy|healthy
267534|NCT02018536|TMC435|tmc435
267535|NCT02018536|GSK2336805|gsk2336805
267536|NCT02018536|Pharmacokinetic|pharmacokinetic
267537|NCT02018536|Safety|safety
267538|NCT02018536|Tolerability|tolerability
267539|NCT02018523|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
267540|NCT02018523|Stage 3B/4|stage 3b/4
267541|NCT02018523|Maintenance Therapy|maintenance therapy
267542|NCT02018523|Lenalidomide|lenalidomide
267543|NCT02018510|Healthy Volunteers|healthy volunteers
267544|NCT02018510|HIV|hiv
267545|NCT02018497|Essential arterial hypotension|essential arterial hypotension
267546|NCT02018497|Arterial hypotension|arterial hypotension
267547|NCT02018497|Low blood pressure|low blood pressure
267548|NCT02018497|Hypotension|hypotension
267549|NCT02018497|Essential arterial hypertension|essential arterial hypertension
267550|NCT02018497|Syncope|syncope
267551|NCT02018497|Dysautonomia|dysautonomia
267552|NCT02018497|Stress|stress
267553|NCT02018497|Adaptability|adaptability
267554|NCT02018497|Reactivity|reactivity
267555|NCT02018497|Homeostasis|homeostasis
267556|NCT02018497|Allostasis|allostasis
267557|NCT02018497|Allostatic load|allostatic load
267558|NCT02018497|Distress|distress
267559|NCT02018497|Epigenetic|epigenetic
267560|NCT02018497|Plasticity|plasticity
267561|NCT02018484|Surgery / Knee / Replacement / MRI / Specific cutting guides|surgery / knee / replacement / mri / specific cutting guides
267562|NCT02018471|anxiety|anxiety
267563|NCT02018471|psychoeducational training|psychoeducational training
267564|NCT02018471|coping|coping
267565|NCT02018471|relaxation|relaxation
267566|NCT02018458|Dendritic cell vaccine|dendritic cell vaccine
267567|NCT02018458|Breast Cancer|breast cancer
267568|NCT02018458|Doxorubicin|doxorubicin
267569|NCT02018458|Paclitaxel|paclitaxel
267570|NCT02018458|Cyclophosphamide|cyclophosphamide
267571|NCT02018458|Carboplatin|carboplatin
267762|NCT02017509|RNA Later|rna later
267572|NCT02018406|Hematopoietic Growth Factors (EPO, G-CSF),|hematopoietic growth factors (epo, g-csf),
267573|NCT02018406|Neurological Diseases,|neurological diseases,
267574|NCT02018406|Neurorehabilitation,|neurorehabilitation,
267575|NCT02018406|Neurotrophic and Neuroprotective Effects|neurotrophic and neuroprotective effects
267576|NCT02018393|FEIBA®|feiba®
267577|NCT02018367|Barrett's esophagus|barrett's esophagus
267578|NCT02018367|proflavine|proflavine
267579|NCT02018367|Microscopic imaging|microscopic imaging
267580|NCT02018354|Orthopaedics|orthopaedics
267581|NCT02018354|Anterior cruciate ligament (ACL) reconstruction|anterior cruciate ligament (acl) reconstruction
267582|NCT02018354|Anterolateral ligament|anterolateral ligament
267583|NCT02018354|Lateral Extra-articular Tenodesis (LET)|lateral extra-articular tenodesis (let)
267584|NCT02018341|Assessment of biologic activity of a homeopathic remedy|assessment of biologic activity of a homeopathic remedy
267585|NCT02018315|G1D|g1d
267586|NCT02018315|Glut1 Disorder|glut1 disorder
267587|NCT02018315|Glucose Transporter Type 1 Disorder|glucose transporter type 1 disorder
267588|NCT02018315|Glucose Transporter Type I Disorder|glucose transporter type i disorder
267589|NCT02018302|G1D|g1d
267590|NCT02018302|Glut1 Deficiency|glut1 deficiency
267591|NCT02018302|Glucose Transporter Type 1 Deficiency|glucose transporter type 1 deficiency
267592|NCT02018302|Glucose Transporter Type I Deficiency|glucose transporter type i deficiency
267593|NCT02018289|Triclosan coated suture|triclosan coated suture
267594|NCT02018289|Surgical site infection|surgical site infection
267595|NCT02018289|Fecal peritonitis|fecal peritonitis
267596|NCT02018289|Superficial|superficial
267597|NCT02018289|incisional|incisional
267598|NCT02018276|Lidocaine|lidocaine
267599|NCT02018276|Magnesium|magnesium
267600|NCT02018276|Functional recovery|functional recovery
267601|NCT02018237|Obesity|obesity
267602|NCT02018237|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
267603|NCT02018237|High fructose corn syrup|high fructose corn syrup
267604|NCT02018224|Achilles tendon rupture, operative treatment, elongation, long-term follow up.|achilles tendon rupture, operative treatment, elongation, long-term follow up.
267605|NCT02018211|delayed onset muscle soreness|delayed onset muscle soreness
267606|NCT02018211|muscle damage|muscle damage
267607|NCT02018211|muscle function|muscle function
267608|NCT02018211|inflammation|inflammation
267609|NCT02018146|Laryngeal Masks|laryngeal masks
267610|NCT02018146|Airway Management|airway management
267611|NCT02018133|CKD|ckd
267612|NCT02018133|chronic|chronic
267613|NCT02018133|kidney|kidney
267614|NCT02018133|vitamin D|vitamin d
267615|NCT02018120|multiple gingival recession|multiple gingival recession
267616|NCT02018120|platelet rich fibrin|platelet rich fibrin
267617|NCT02018120|connective tissue graft|connective tissue graft
267618|NCT02018120|microsurgery|microsurgery
267619|NCT02018120|periodontal diseases|periodontal diseases
267620|NCT02018120|gingival recession|gingival recession
267621|NCT02018107|Liver Tumor Ablation|liver tumor ablation
267622|NCT02018107|Liver Neoplasms|liver neoplasms
267623|NCT02018107|Positron Emission Tomography|positron emission tomography
267624|NCT02018107|Computed Tomography|computed tomography
267625|NCT02018094|Amputation|amputation
267626|NCT02018094|Infection|infection
267627|NCT02018094|Skin Preparation|skin preparation
267628|NCT02018094|SSI|ssi
267629|NCT02018094|Stump|stump
267630|NCT02018094|Wound|wound
267631|NCT02018081|pharmacokinetic study : open, prospective, monocentric|pharmacokinetic study : open, prospective, monocentric
267632|NCT02018068|Patient-controlled Perineural analgesia|patient-controlled perineural analgesia
267633|NCT02018068|Postoperative|postoperative
267634|NCT02018068|Orthopedic surgery|orthopedic surgery
267635|NCT02018068|"Remote Control versus at bedside care"|"remote control versus at bedside care"
267636|NCT02018068|Comparative medico-economic evaluation|comparative medico-economic evaluation
267637|NCT02018042|Alopecia Areata|alopecia areata
267638|NCT02018042|AA|aa
267639|NCT02018029|Heart failure|heart failure
267764|NCT02017496|locally advanced|locally advanced
267640|NCT02018029|Cardiac Resynchronisation Therapy|cardiac resynchronisation therapy
267641|NCT02018029|collagen peptides|collagen peptides
267642|NCT02018029|MIBG scintigraphy|mibg scintigraphy
267643|NCT02018016|Appendectomy|appendectomy
267644|NCT02018016|Hospitals,General|hospitals,general
267645|NCT02018016|Hospitals,High-Volume|hospitals,high-volume
267646|NCT02018016|Hospitals,Low-Volume|hospitals,low-volume
267647|NCT02018016|Outcome Assessment (Health Care)|outcome assessment (health care)
267648|NCT02017990|Renal transplantation|renal transplantation
267649|NCT02017990|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
267650|NCT02017990|Mortality|mortality
267651|NCT02017990|Graft loss|graft loss
267652|NCT02017990|Rejection|rejection
267653|NCT02017977|Laparotomy|laparotomy
267654|NCT02017977|General Surgery|general surgery
267655|NCT02017977|Hospitals,General|hospitals,general
267656|NCT02017977|Hospitals,Rural|hospitals,rural
267657|NCT02017977|Hospitals,Urban|hospitals,urban
267658|NCT02017977|Rural Health Services|rural health services
267659|NCT02017977|Geography, Medical|geography, medical
267660|NCT02017977|Outcome Assessment (Health Care)|outcome assessment (health care)
267661|NCT02017951|Appendectomy|appendectomy
267662|NCT02017951|Hospitals,General|hospitals,general
267664|NCT02017951|Hospitals,Urban|hospitals,urban
267665|NCT02017951|Rural Health Services|rural health services
267666|NCT02017951|Geography, Medical|geography, medical
267667|NCT02017951|Outcome Assessment (Health Care)|outcome assessment (health care)
267668|NCT02017938|Fatigue|fatigue
267669|NCT02017938|electromyography (EMG)|electromyography (emg)
267670|NCT02017938|central fatigue|central fatigue
267671|NCT02017938|cycling training|cycling training
267672|NCT02017925|Pulmonary Rehabilitation|pulmonary rehabilitation
267673|NCT02017925|Non-Small Cell Lung Cancer|non-small cell lung cancer
267674|NCT02017925|NSCLC|nsclc
267675|NCT02017912|Mesenchymal Stromal cells|mesenchymal stromal cells
267676|NCT02017912|MSC-NTF|msc-ntf
267677|NCT02017912|Cell therapy|cell therapy
267678|NCT02017912|ALS|als
267679|NCT02017899|prevention|prevention
267680|NCT02017899|Shigella sonnei|shigella sonnei
267681|NCT02017886|Probiotics|probiotics
267682|NCT02017886|Oral health|oral health
267683|NCT02017886|Innate immunity|innate immunity
267684|NCT02017873|bleaching|bleaching
267685|NCT02017873|smokers|smokers
267686|NCT02017873|effectiveness|effectiveness
267687|NCT02017873|pain|pain
267688|NCT02017860|RAD001, everolimus, roll-over|rad001, everolimus, roll-over
267689|NCT02017847|oxygen consumption|oxygen consumption
267690|NCT02017847|activity monitors|activity monitors
267691|NCT02017847|METs|mets
267692|NCT02017847|intensity|intensity
267693|NCT02017834|oral cavity squamous cell carcinoma|oral cavity squamous cell carcinoma
267694|NCT02017834|head and neck cancer|head and neck cancer
267695|NCT02017834|oral cancer|oral cancer
267696|NCT02017821|Exercise|exercise
267697|NCT02017821|Oxygen Consumption|oxygen consumption
267698|NCT02017821|mental health|mental health
267699|NCT02017808|OCT|oct
267700|NCT02017808|Copaxone|copaxone
267701|NCT02017808|Multiple sclerosis|multiple sclerosis
267702|NCT02017808|relapsing-remitting|relapsing-remitting
267703|NCT02017795|asthma, mixed asthma, telehealth, action plan, exacerbation|asthma, mixed asthma, telehealth, action plan, exacerbation
267704|NCT02017782|Dust|dust
267705|NCT02017782|Ozone|ozone
267706|NCT02017782|Indoor air quality|indoor air quality
267707|NCT02017782|Indoor environment|indoor environment
267708|NCT02017782|Indoor climate|indoor climate
267709|NCT02017782|Cardiovascular diseases|cardiovascular diseases
267710|NCT02017782|Full body exposure|full body exposure
267711|NCT02017782|Exposure experiment with dust and ozone|exposure experiment with dust and ozone
267712|NCT02017782|Acute exposure to ozone and dust|acute exposure to ozone and dust
267713|NCT02017782|Respiratory outcomes|respiratory outcomes
267714|NCT02017782|Cardiovascular outcomes|cardiovascular outcomes
267715|NCT02017782|Acoustic rhinometry|acoustic rhinometry
267716|NCT02017782|Body inflammatory markers|body inflammatory markers
267717|NCT02017782|Cytokines|cytokines
267718|NCT02017782|Exhaled FeNO|exhaled feno
267719|NCT02017782|Nasal Lavage|nasal lavage
267720|NCT02017782|Heart rate variability|heart rate variability
267721|NCT02017782|Blood biomarkers|blood biomarkers
267722|NCT02017782|Subjective discomfort|subjective discomfort
267723|NCT02017782|General mucosal irritation|general mucosal irritation
267724|NCT02017769|Subcutaneous immunoglobulin|subcutaneous immunoglobulin
267725|NCT02017769|Magnetic resonance imaging|magnetic resonance imaging
267726|NCT02017756|Carotid artery|carotid artery
267727|NCT02017756|Atherosclerosis|atherosclerosis
267728|NCT02017756|Vulnerable plaque|vulnerable plaque
267729|NCT02017756|Magnetic resonance imaging|magnetic resonance imaging
267730|NCT02017756|Arterial wall|arterial wall
267731|NCT02017704|Endorectal Brachytherapy Radiation Therapy|endorectal brachytherapy radiation therapy
267732|NCT02017704|Intensity Modulated Radiation Therapy and Capecitabine|intensity modulated radiation therapy and capecitabine
267733|NCT02017678|JX-594|jx-594
267734|NCT02017678|Ovarian cancer|ovarian cancer
267735|NCT02017678|Peritoneal|peritoneal
267736|NCT02017678|Carcinomatosis|carcinomatosis
267737|NCT02017678|Vaccinia virus|vaccinia virus
267738|NCT02017678|Oncolytic virus|oncolytic virus
267739|NCT02017665|encephalitis|encephalitis
267740|NCT02017665|viral infections|viral infections
267741|NCT02017665|central nervous system|central nervous system
267742|NCT02017652|bowel motility|bowel motility
267743|NCT02017652|cerebral perfusion|cerebral perfusion
267744|NCT02017652|intestinal perfusion|intestinal perfusion
267745|NCT02017626|Fish allergy|fish allergy
267746|NCT02017626|immunotherapy|immunotherapy
267747|NCT02017626|hypoallergen|hypoallergen
267748|NCT02017613|CLL, SLL, NHL, SLL, PTCL, CTCL, MM, AML|cll, sll, nhl, sll, ptcl, ctcl, mm, aml
267749|NCT02017574|Stroke|stroke
267750|NCT02017574|Cerebral Infarction|cerebral infarction
267751|NCT02017561|Diastolic dysfunction|diastolic dysfunction
267752|NCT02017561|Metabolic syndrome|metabolic syndrome
267753|NCT02017561|Metformin|metformin
267754|NCT02017548|advance directives, advance care planning|advance directives, advance care planning
267755|NCT02017522|PET|pet
267756|NCT02017522|Cardiac sarcoidosis|cardiac sarcoidosis
267757|NCT02017522|FDG|fdg
267758|NCT02017522|Cardiac MRI|cardiac mri
267759|NCT02017509|Immunophenotype|immunophenotype
267760|NCT02017509|Immunoscore|immunoscore
267761|NCT02017509|MRI|mri
267763|NCT02017496|Breast cancer|breast cancer
267765|NCT02017496|neoadjuvant treatment|neoadjuvant treatment
267766|NCT02017496|breast conserving surgery|breast conserving surgery
267767|NCT02017483|ADHD,|adhd,
267768|NCT02017483|emotion recognition|emotion recognition
267769|NCT02017483|attention|attention
267770|NCT02017470|Women Heart Health|women heart health
267771|NCT02017470|Cardiovascular Disease|cardiovascular disease
267772|NCT02017470|focus group|focus group
267773|NCT02017470|advisory board|advisory board
267774|NCT02017470|one-on-one interview|one-on-one interview
267775|NCT02017457|Hematology|hematology
267776|NCT02017457|Acute Myelogenous Leukemia|acute myelogenous leukemia
267777|NCT02017457|Myelodysplasic syndrome|myelodysplasic syndrome
267778|NCT02017457|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
267779|NCT02017457|Donor lymphocyte infusion|donor lymphocyte infusion
267780|NCT02017457|DLI|dli
267781|NCT02017457|Azacytidine|azacytidine
267782|NCT02017457|Vidaza|vidaza
267783|NCT02017457|Overall response rate|overall response rate
267784|NCT02017457|Relapse|relapse
267785|NCT02017444|Pseudotumor Cerebri|pseudotumor cerebri
267786|NCT02017444|Benign Intracranial Hypertension|benign intracranial hypertension
267787|NCT02017444|Headaches|headaches
267788|NCT02017444|Tinnitus|tinnitus
267789|NCT02017444|Papilledema|papilledema
267790|NCT02017444|Blindness|blindness
267791|NCT02017444|Optic Disk|optic disk
267792|NCT02017444|Intracranial Hypertension|intracranial hypertension
267793|NCT02017444|Clinical Trial, Phase 2|clinical trial, phase 2
267794|NCT02017444|11beta-Hydroxysteroid Dehydrogenase Type 1|11beta-hydroxysteroid dehydrogenase type 1
267795|NCT02017444|Obesity|obesity
267796|NCT02017431|Diesel exhaust|diesel exhaust
267797|NCT02017431|Particle depleted diesel exhaust|particle depleted diesel exhaust
267798|NCT02017431|Air pollution|air pollution
267799|NCT02017431|Airway responsiveness|airway responsiveness
267800|NCT02017431|Allergies|allergies
267801|NCT02017418|zeaxanthin|zeaxanthin
267802|NCT02017418|visual function|visual function
267803|NCT02017418|reaction time|reaction time
267804|NCT02017418|processing speed|processing speed
267805|NCT02017405|Digestibility|digestibility
267806|NCT02017405|Healthy volunteers|healthy volunteers
267807|NCT02017405|serum-derived bovine immunoglobulin protein isolate|serum-derived bovine immunoglobulin protein isolate
267808|NCT02017405|bovine IgG|bovine igg
267809|NCT02017405|adults|adults
267810|NCT02017392|postoperative agitation|postoperative agitation
267811|NCT02017392|endotracheal intubation|endotracheal intubation
267812|NCT02017392|general anesthesia|general anesthesia
267813|NCT02017379|upper gastrointestinal bleeding|upper gastrointestinal bleeding
267814|NCT02017379|melena|melena
267815|NCT02017379|hematemesis|hematemesis
267816|NCT02017366|Surgery|surgery
267817|NCT02017366|Malnutrition|malnutrition
267818|NCT02017366|Nutrition, Enteral|nutrition, enteral
267819|NCT02017340|Alzheimer's Disease|alzheimer's disease
267820|NCT02017340|Investigator-driven clinical trial|investigator-driven clinical trial
267821|NCT02017340|Nilvadipine|nilvadipine
267822|NCT02017340|Calcium Channel blocker|calcium channel blocker
267823|NCT02017340|Elderly|elderly
267824|NCT02017340|Therapeutic Intervention|therapeutic intervention
267825|NCT02017314|morbid obesity|morbid obesity
267826|NCT02017314|postoperative pain|postoperative pain
267827|NCT02017301|Liver Cirrhosis,Infection, Impedance, Body Composition|liver cirrhosis,infection, impedance, body composition
267828|NCT02017288|Head and Neck Cancers|head and neck cancers
267829|NCT02017288|Larynx|larynx
267830|NCT02017288|Oropharynx|oropharynx
267831|NCT02017288|Oral Cavity|oral cavity
267832|NCT02017262|Self-care|self-care
267833|NCT02017262|Patient education|patient education
267834|NCT02017236|Food Effect|food effect
267835|NCT02017236|Health subjects|health subjects
267836|NCT02017223|Physical activity|physical activity
267837|NCT02017197|Therapeutic Equivalency|therapeutic equivalency
267838|NCT02017197|Warfarin|warfarin
267839|NCT02017197|Drugs, Generic|drugs, generic
267840|NCT02017197|Anticoagulants|anticoagulants
267841|NCT02017197|Anticoagulants [Pharmacological Action]|anticoagulants [pharmacological action]
267842|NCT02017197|Coumarins|coumarins
267843|NCT02017184|Body Temperature Regulation Sensor Noninvasive|body temperature regulation sensor noninvasive
267844|NCT02017171|Kidney Diseases|kidney diseases
267845|NCT02017171|Diabetic Nephropathies|diabetic nephropathies
267846|NCT02017171|Diabetes Mellitus|diabetes mellitus
267847|NCT02017171|Diabetes Complications|diabetes complications
267848|NCT02017171|Uric acid|uric acid
267849|NCT02017171|Allopurinol|allopurinol
267850|NCT02017171|Glomerular filtration rate|glomerular filtration rate
267851|NCT02017171|Coronary artery disease|coronary artery disease
267852|NCT02017158|Obesity|obesity
267853|NCT02017158|Nutrition|nutrition
267854|NCT02017158|Children|children
267855|NCT02017145|infection|infection
267856|NCT02017145|chloraprep|chloraprep
267857|NCT02017145|chlorhexidine|chlorhexidine
267858|NCT02017145|lower extremity surgery|lower extremity surgery
267859|NCT02017145|antiseptic|antiseptic
267860|NCT02017145|bacterial colonization|bacterial colonization
267861|NCT02017132|Pomegranate|pomegranate
267862|NCT02017132|Blood pressure|blood pressure
267863|NCT02017132|Body composition|body composition
267864|NCT02017132|Weight-loss|weight-loss
267865|NCT02017132|Fat mass|fat mass
267866|NCT02017132|Polyphenols|polyphenols
267867|NCT02017132|Quality of Life|quality of life
267868|NCT02017106|Varicose Veins|varicose veins
267869|NCT02017093|CVA, rehabilitation|cva, rehabilitation
267870|NCT02017080|fetal thyroid ultrasound|fetal thyroid ultrasound
267871|NCT02017080|fetal fT4|fetal ft4
267872|NCT02017080|antithyroid antibodies|antithyroid antibodies
267873|NCT02017080|pregnancy|pregnancy
267874|NCT02017080|autoimmune thyroid disease|autoimmune thyroid disease
267875|NCT02017067|Resistance training|resistance training
267876|NCT02017067|musculoskeletal conditions|musculoskeletal conditions
267877|NCT02017067|RFD|rfd
267878|NCT02017041|opioid dependence, buprenorphine, smartphone, suboxone|opioid dependence, buprenorphine, smartphone, suboxone
267879|NCT02017015|Pancreatic cancer|pancreatic cancer
267880|NCT02017015|Metastatic pancreatic cancer|metastatic pancreatic cancer
267881|NCT02017015|treatment for pancreatic cancer|treatment for pancreatic cancer
267882|NCT02017015|Abraxane clinical research trials|abraxane clinical research trials
267883|NCT02017015|Celgene clinical research trials|celgene clinical research trials
267884|NCT02017002|Esophageal cancer|esophageal cancer
267885|NCT02017002|minimally invasive|minimally invasive
267886|NCT02017002|Surgical Procedures|surgical procedures
267887|NCT02017002|Esophagectomy|esophagectomy
267888|NCT02016989|Bacterial keratitis|bacterial keratitis
267889|NCT02016989|OTR4120|otr4120
267890|NCT02016989|Matrix therapy|matrix therapy
267891|NCT02016963|Monoclonal Antibody|monoclonal antibody
267892|NCT02016963|Safety|safety
267893|NCT02016963|Raxibacumab|raxibacumab
267894|NCT02016963|HGS1021|hgs1021
267895|NCT02016963|Immunogenicity|immunogenicity
267896|NCT02016937|Anesthesia , lactation, birth|anesthesia , lactation, birth
267897|NCT02016924|Pediatrics|pediatrics
267898|NCT02016924|Adolescents|adolescents
267899|NCT02016924|HIV|hiv
267900|NCT02016924|HIV-1|hiv-1
267901|NCT02016924|Treatment experienced|treatment experienced
267902|NCT02016898|Primary open angle glaucoma|primary open angle glaucoma
267903|NCT02016898|trabeculectomy|trabeculectomy
267904|NCT02016898|mitomycin-C|mitomycin-c
267905|NCT02016898|express mini-shunt|express mini-shunt
267906|NCT02016872|PET/CT|pet/ct
267907|NCT02016872|18F-FMISO|18f-fmiso
267908|NCT02016872|tumor hypoxia|tumor hypoxia
267909|NCT02016872|13-186|13-186
267910|NCT02016859|IPF Immature platelet fraction|ipf immature platelet fraction
267911|NCT02016859|ICU neutropenic fever|icu neutropenic fever
267912|NCT02016859|hip fracture|hip fracture
267913|NCT02016859|critically ill|critically ill
267914|NCT02016833|Ovarian Cancer|ovarian cancer
267915|NCT02016833|Cervical Cancer|cervical cancer
267916|NCT02016833|Leukemia|leukemia
267917|NCT02016833|Immunity|immunity
267918|NCT02016833|WT-1|wt-1
267919|NCT02016833|Survivin|survivin
267920|NCT02016833|HPV|hpv
267921|NCT02016820|Clostridium Difficile Infection|clostridium difficile infection
267922|NCT02016820|Proton Pump Inhibitors|proton pump inhibitors
267923|NCT02016820|Histamine-2 Receptor Antagonists|histamine-2 receptor antagonists
267924|NCT02016820|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
267925|NCT02016807|Mucositis|mucositis
267926|NCT02016807|Sucralfate|sucralfate
267927|NCT02016807|Prothelial|prothelial
267928|NCT02016807|High potency sucralfate|high potency sucralfate
267929|NCT02016807|Ulcerations|ulcerations
267930|NCT02016807|Chemotherapy induced diarrhea|chemotherapy induced diarrhea
267931|NCT02016807|Radiation induced mucositis|radiation induced mucositis
267932|NCT02016807|Chemotherapy colitis|chemotherapy colitis
267933|NCT02016807|Radiation colitis|radiation colitis
267934|NCT02016807|Mucosal erosions|mucosal erosions
267935|NCT02016794|cervical|cervical
267936|NCT02016794|interbody|interbody
267937|NCT02016794|spacer|spacer
267938|NCT02016794|degenerative|degenerative
267939|NCT02016794|pain|pain
267940|NCT02016794|neck|neck
267941|NCT02016794|decompression|decompression
267942|NCT02016794|fusion|fusion
267943|NCT02016794|implant|implant
267944|NCT02016781|Myelodysplastic Syndrome|myelodysplastic syndrome
267945|NCT02016755|Peripheral Arterial Disease|peripheral arterial disease
267946|NCT02016755|Vascular Disease|vascular disease
267947|NCT02016755|CLI|cli
267948|NCT02016755|Critical Limb Ischemia|critical limb ischemia
267949|NCT02016755|PAD|pad
267950|NCT02016755|AnGes|anges
267951|NCT02016755|HGF Plasmid|hgf plasmid
267952|NCT02016755|HGF|hgf
267953|NCT02016755|Hepatocyte Growth Factor Plasmid|hepatocyte growth factor plasmid
267954|NCT02016755|gene therapy|gene therapy
267955|NCT02016742|Pharmacokinetics|pharmacokinetics
267956|NCT02016729|AML|aml
267957|NCT02016716|Postmenopausal Osteoporosis|postmenopausal osteoporosis
267958|NCT02016703|erythritol|erythritol
267959|NCT02016703|polyol|polyol
267960|NCT02016703|laxation|laxation
267961|NCT02016703|gastrointestinal|gastrointestinal
267962|NCT02016703|tolerance|tolerance
267963|NCT02016703|soft drinks|soft drinks
267964|NCT02016703|child|child
267965|NCT02016703|diarrhoea|diarrhoea
267966|NCT02016690|Prevention of severe RSV infection|prevention of severe rsv infection
267967|NCT02016690|Respiratory syncytial virus (RSV) infection|respiratory syncytial virus (rsv) infection
267968|NCT02016690|Down Syndrome|down syndrome
267969|NCT02016690|Immunocompromised|immunocompromised
267970|NCT02016690|Effectiveness of palivizumab|effectiveness of palivizumab
267971|NCT02016677|Breast reduction|breast reduction
267972|NCT02016677|Mastopexy|mastopexy
267973|NCT02016677|Sagging|sagging
267974|NCT02016664|Chronic Pain, Ketamine, Safety|chronic pain, ketamine, safety
267975|NCT02016638|Obstructive Sleep Apnea in pregnancy|obstructive sleep apnea in pregnancy
267976|NCT02016638|Pregnancy induced hypertension|pregnancy induced hypertension
267977|NCT02016638|Restless leg syndrome|restless leg syndrome
267978|NCT02016638|Sleep|sleep
267979|NCT02016612|Recurrent|recurrent
267980|NCT02016612|Ptosis|ptosis
267981|NCT02016612|Reduction|reduction
267982|NCT02016612|Mammoplasty|mammoplasty
267983|NCT02016612|Mastopexy|mastopexy
267984|NCT02016599|Hypotension|hypotension
267985|NCT02016599|Low blood pressure|low blood pressure
267986|NCT02016599|Neonate|neonate
267987|NCT02016599|Extremely Low Birth Weight Infant|extremely low birth weight infant
267988|NCT02016573|renal denervation|renal denervation
267989|NCT02016573|blood pressure|blood pressure
267990|NCT02016573|cardiovascular risk|cardiovascular risk
267991|NCT02016573|target organ damage|target organ damage
267992|NCT02016573|sympathetic activity|sympathetic activity
267993|NCT02016547|Stroke|stroke
267994|NCT02016547|Middle Cerebral Artery|middle cerebral artery
267995|NCT02016547|Thrombectomy|thrombectomy
267996|NCT02016547|Mechanical Thrombolysis|mechanical thrombolysis
267997|NCT02016547|Abciximab|abciximab
267998|NCT02016534|MET Amplified Gastric / Gastroesophageal Junction / Esophageal Adenocarcinoma, or other solid tumors.|met amplified gastric / gastroesophageal junction / esophageal adenocarcinoma, or other solid tumors.
267999|NCT02016521|Exercise|exercise
268000|NCT02016521|Clothing|clothing
268001|NCT02016521|Core body temperature|core body temperature
268002|NCT02016521|Skin Temperature|skin temperature
268003|NCT02016521|Performance|performance
268004|NCT02016508|Adult bone marrow stem cells|adult bone marrow stem cells
268005|NCT02016508|AMD|amd
268006|NCT02016482|Nail Psoriasis|nail psoriasis
268007|NCT02016482|Plaque Psoriasis|plaque psoriasis
268008|NCT02016456|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
268009|NCT02016456|Neuronavigation|neuronavigation
268010|NCT02016456|Magnetic Resonance Imaging|magnetic resonance imaging
268011|NCT02016443|inguinal hernia|inguinal hernia
268012|NCT02016430|TMAO|tmao
268013|NCT02016430|Gut Flora|gut flora
268014|NCT02016430|Dietary Intervention|dietary intervention
268015|NCT02016430|Choline|choline
268016|NCT02016430|Carnitine|carnitine
268017|NCT02016417|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
268018|NCT02016417|Induction chemotherapy|induction chemotherapy
268019|NCT02016417|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
268020|NCT02016417|Gemcitabine|gemcitabine
268021|NCT02016417|Docetaxel|docetaxel
268022|NCT02016404|blood pressure|blood pressure
268023|NCT02016404|sodium|sodium
268024|NCT02016404|salt|salt
268025|NCT02016404|low sodium high potassium salt|low sodium high potassium salt
268026|NCT02016404|potassium|potassium
268027|NCT02016404|Vietnam|vietnam
268028|NCT02016404|randomized controlled trial|randomized controlled trial
268029|NCT02016365|Transthyretin amyloidosis|transthyretin amyloidosis
268030|NCT02016365|Cardiomyopathy|cardiomyopathy
268031|NCT02016365|ATTR|attr
268032|NCT02016365|neuropathy|neuropathy
268033|NCT02016352|hydrocephalus|hydrocephalus
268034|NCT02016352|proteomic|proteomic
268035|NCT02016352|cerebrospinal fluid|cerebrospinal fluid
268036|NCT02016326|Colonoscopy|colonoscopy
268037|NCT02016326|High Definition White Light|high definition white light
268038|NCT02016326|I-Scan|i-scan
268039|NCT02016326|Adenomas|adenomas
268040|NCT02016300|cartilage|cartilage
268041|NCT02016300|microfracture|microfracture
268042|NCT02016300|knee|knee
268043|NCT02016300|bracing|bracing
268044|NCT02016261|Cognitive function|cognitive function
268045|NCT02016248|CyberKnife|cyberknife
268046|NCT02016248|Prostate Cancer|prostate cancer
268047|NCT02016248|Stereotactic Body Radiation|stereotactic body radiation
268048|NCT02016248|SBRT|sbrt
268049|NCT02016248|Radiosurgery|radiosurgery
268050|NCT02016248|SABR|sabr
268051|NCT02016248|Stereotactic Ablative Body Radiotherapy|stereotactic ablative body radiotherapy
268052|NCT02016248|Boost|boost
268053|NCT02016235|Dent|dent
268054|NCT02016235|Dents|dents
268055|NCT02016235|Dent Disease|dent disease
268056|NCT02016235|Phosphorus Supplements|phosphorus supplements
268057|NCT02016235|FGF 23|fgf 23
268058|NCT02016222|primary progressive multiple sclerosis|primary progressive multiple sclerosis
268059|NCT02016222|diagnosis|diagnosis
268060|NCT02016222|tears|tears
268061|NCT02016222|isoelectric focusing|isoelectric focusing
268062|NCT02016222|oligoclonal bands|oligoclonal bands
268063|NCT02016196|TIPS|tips
268064|NCT02016196|portal pressure|portal pressure
268065|NCT02016196|rifaximin|rifaximin
268066|NCT02016196|overt hepatic encephalopathy|overt hepatic encephalopathy
268067|NCT02016196|microbiota|microbiota
268068|NCT02016183|Drug Therapy|drug therapy
268069|NCT02016170|platelet reactivity|platelet reactivity
268070|NCT02016170|ticagrelor|ticagrelor
268071|NCT02016170|prasugrel|prasugrel
268072|NCT02016157|Moxifloxacin|moxifloxacin
268073|NCT02016157|Chlorhexidine|chlorhexidine
268074|NCT02016157|In situ gel|in situ gel
268075|NCT02016157|Chronic periodontitis|chronic periodontitis
268076|NCT02016144|Airway management; Fiber optic technology; Intubation|airway management; fiber optic technology; intubation
268077|NCT02016131|endoleak|endoleak
268078|NCT02016131|EVAR|evar
268079|NCT02016131|AAA|aaa
268080|NCT02016131|CQDSA|cqdsa
268081|NCT02016118|RUTI|ruti
268082|NCT02016105|plaque type psoriasis|plaque type psoriasis
268083|NCT02016105|equivalent efficacy|equivalent efficacy
268084|NCT02016105|safety and immunogenicity|safety and immunogenicity
268085|NCT02016105|GP2017|gp2017
268086|NCT02016105|Humira®|humira®
268087|NCT02016092|Parkinson's disease|parkinson's disease
268088|NCT02016092|biomarkers|biomarkers
268089|NCT02016092|blood|blood
268090|NCT02016092|urine,|urine,
268091|NCT02016092|proteomics|proteomics
268092|NCT02016092|lipidomics|lipidomics
268093|NCT02016092|metabolomics|metabolomics
268094|NCT02016079|randomized controlled trial|randomized controlled trial
268095|NCT02016079|omega-3|omega-3
268096|NCT02016079|nutrition|nutrition
268097|NCT02016079|behavior problems|behavior problems
268098|NCT02016079|externalizing|externalizing
268099|NCT02016079|internalizing|internalizing
268100|NCT02016079|antisocial|antisocial
268101|NCT02016079|aggressive|aggressive
268102|NCT02016066|Healthy|healthy
268103|NCT02016066|CR6261|cr6261
268104|NCT02016066|Japanese|japanese
268105|NCT02016066|Safety|safety
268106|NCT02016066|Pharmacokinetics|pharmacokinetics
268107|NCT02016066|Immunogenicity|immunogenicity
268108|NCT02016040|Prostate cancer|prostate cancer
268109|NCT02016040|HIFU Hemi-ablation|hifu hemi-ablation
268110|NCT02016040|Prostate biopsies|prostate biopsies
268111|NCT02016014|Physical activity|physical activity
268112|NCT02016014|Alimentation|alimentation
268113|NCT02016014|Information and communication Technology|information and communication technology
268114|NCT02016014|Arterial aging|arterial aging
268115|NCT02016001|fluoride|fluoride
268116|NCT02016001|dental caries|dental caries
268117|NCT02016001|prevention|prevention
268118|NCT02015988|Acute coronary syndrome|acute coronary syndrome
268119|NCT02015988|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
268120|NCT02015988|Hypertriglyceridemia|hypertriglyceridemia
268121|NCT02015988|Simvastatin|simvastatin
268122|NCT02015988|Fenofibrate|fenofibrate
268123|NCT02015975|patellar fracture|patellar fracture
268124|NCT02015975|fracture of patella|fracture of patella
268125|NCT02015975|patella|patella
268126|NCT02015975|locking plate osteosynthesis|locking plate osteosynthesis
268127|NCT02015975|osteosynthesis|osteosynthesis
268128|NCT02015975|star-plate|star-plate
268129|NCT02015975|arrow-plate|arrow-plate
268130|NCT02015962|Hypokalemia|hypokalemia
268131|NCT02015962|Intravenous|intravenous
268132|NCT02015962|Enteral|enteral
268133|NCT02015962|post-cardiac surgery|post-cardiac surgery
268134|NCT02015936|stage III cancer|stage iii cancer
268135|NCT02015936|stage IV cancer|stage iv cancer
268136|NCT02015936|cancer|cancer
268137|NCT02015936|advanced stage cancer|advanced stage cancer
268138|NCT02015936|Nintendo Wii training|nintendo wii training
268139|NCT02015936|exercise|exercise
268140|NCT02015936|physical training|physical training
268141|NCT02015936|physical function|physical function
268142|NCT02015936|physical fitness test|physical fitness test
268143|NCT02015923|Colonic cancer|colonic cancer
268144|NCT02015923|Metastasis|metastasis
268145|NCT02015884|Incivility|incivility
268146|NCT02015884|Rudeness|rudeness
268147|NCT02015884|Aggression|aggression
268148|NCT02015884|Violent act|violent act
268149|NCT02015884|Healthcare workers|healthcare workers
268150|NCT02015884|Emergency unit|emergency unit
268151|NCT02015832|SYNTAX II Score|syntax ii score
268152|NCT02015832|Pressure wires|pressure wires
268153|NCT02015832|instantaneous wave-free ratio|instantaneous wave-free ratio
268154|NCT02015832|fractional flow reserve|fractional flow reserve
268155|NCT02015832|intravascular ultrasound|intravascular ultrasound
268156|NCT02015832|Drug eluting stents|drug eluting stents
268157|NCT02015832|Stents|stents
268158|NCT02015832|Angioplasty|angioplasty
268159|NCT02015832|multi slice computed tomography|multi slice computed tomography
268160|NCT02015806|Quality improvement|quality improvement
268161|NCT02015806|Randomized controlled trial|randomized controlled trial
268162|NCT02015806|Medication adherence|medication adherence
268163|NCT02015806|RxTimer Cap|rxtimer cap
268164|NCT02015806|PillMinder|pillminder
268165|NCT02015806|Take-N-Slide|take-n-slide
268166|NCT02015806|Low-touch devices|low-touch devices
268167|NCT02015806|Medication management|medication management
268168|NCT02015793|Crohn's Disease|crohn's disease
268169|NCT02015793|Pharmacokinetics|pharmacokinetics
268170|NCT02015780|Drug therapy|drug therapy
268171|NCT02015767|Drug therapy|drug therapy
268172|NCT02015728|Refractory|refractory
268173|NCT02015728|Recurrent|recurrent
268174|NCT02015728|Brain|brain
268175|NCT02015728|Tumor|tumor
268176|NCT02015728|Pediatric|pediatric
268177|NCT02015728|Biologically Targeted Therapy|biologically targeted therapy
268178|NCT02015728|Sorafenib|sorafenib
268179|NCT02015728|Everolimus|everolimus
268180|NCT02015728|Erlotinib|erlotinib
268181|NCT02015728|Dasatinib|dasatinib
268182|NCT02015728|Temozolomide|temozolomide
268183|NCT02015728|Etoposide|etoposide
268184|NCT02015702|Physicians|physicians
268185|NCT02015702|Electronic Health Record|electronic health record
268186|NCT02015702|Education|education
268187|NCT02015663|Cystic Fibrosis|cystic fibrosis
268188|NCT02015663|CF|cf
268189|NCT02015650|Locally advanced squamous cell carcinomas of head and neck|locally advanced squamous cell carcinomas of head and neck
268190|NCT02015637|Gonorrhea|gonorrhea
268191|NCT02015637|N. gonorrhoeae|n. gonorrhoeae
268192|NCT02015637|bacterial infection|bacterial infection
268193|NCT02015637|Anti-Infective Agents|anti-infective agents
268194|NCT02015637|Anti-Bacterial Agents|anti-bacterial agents
268195|NCT02015624|Acute coronary syndromes|acute coronary syndromes
268196|NCT02015624|Intensive Care Unit|intensive care unit
268197|NCT02015611|Vitamin D|vitamin d
268198|NCT02015611|Muscle power|muscle power
268199|NCT02015611|Muscle fiber|muscle fiber
268200|NCT02015611|Falls|falls
268201|NCT02015611|Aging|aging
268202|NCT02015598|Obstructive sleep apnoea|obstructive sleep apnoea
268203|NCT02015598|Antioxidant|antioxidant
268204|NCT02015598|drug treatment|drug treatment
268205|NCT02015598|oxidative stress|oxidative stress
268206|NCT02015598|Continuous Positive Airway Pressure|continuous positive airway pressure
268207|NCT02015572|Low back pain|low back pain
268208|NCT02015572|Return to work|return to work
268209|NCT02015572|Sickness absence|sickness absence
268210|NCT02015572|Rehabilitation|rehabilitation
268211|NCT02015572|Occupational intervention|occupational intervention
268212|NCT02015546|Major Depressive Disorder|major depressive disorder
268213|NCT02015546|Vilazodone|vilazodone
268214|NCT02015533|Healthy|healthy
268215|NCT02015533|CR8020|cr8020
268216|NCT02015533|Japanese|japanese
268217|NCT02015533|Safety|safety
268218|NCT02015533|Pharmacokinetics|pharmacokinetics
268219|NCT02015533|Immunogenicity|immunogenicity
268220|NCT02015494|Safety|safety
268221|NCT02015494|Immunogenicity|immunogenicity
268222|NCT02015481|Case control, safety, tolerability, efficacy.|case control, safety, tolerability, efficacy.
268223|NCT02015468|Distal radius fracture|distal radius fracture
268224|NCT02015468|Wrist fracture|wrist fracture
268225|NCT02015468|Physiotherapy|physiotherapy
268226|NCT02015468|Immobilization|immobilization
268227|NCT02015468|Volar locking plates|volar locking plates
268228|NCT02015468|Mobilization|mobilization
268229|NCT02015455|pragmatic trial|pragmatic trial
268230|NCT02015455|stepped-wedge design|stepped-wedge design
268231|NCT02015455|cluster-randomized trial|cluster-randomized trial
268232|NCT02015442|Sucrose in diet|sucrose in diet
268233|NCT02015429|Food intake|food intake
268234|NCT02015429|satiety|satiety
268235|NCT02015429|glycemia|glycemia
268236|NCT02015429|appetite|appetite
268237|NCT02015429|blood glucose|blood glucose
268238|NCT02015429|yellow peas|yellow peas
268239|NCT02015429|fibre|fibre
268240|NCT02015429|protein|protein
268241|NCT02015429|mixed meal|mixed meal
268242|NCT02015416|Melanoma|melanoma
268243|NCT02015416|Ovarian cancer|ovarian cancer
268244|NCT02015416|Sarcoma|sarcoma
268245|NCT02015416|Non-small cell lung cancer|non-small cell lung cancer
268246|NCT02015416|NSCLC|nsclc
268247|NCT02015416|Breast cancer|breast cancer
268248|NCT02015390|bone defects|bone defects
268249|NCT02015390|iatrogenic resection|iatrogenic resection
268250|NCT02015390|titanium mesh cage|titanium mesh cage
268251|NCT02015390|biomembrane|biomembrane
268252|NCT02015390|Masquelet technique|masquelet technique
268253|NCT02015364|Achilles tendon|achilles tendon
268254|NCT02015364|Rupture|rupture
268255|NCT02015364|Rehabilitation|rehabilitation
268256|NCT02015364|Dynamic rehabilitation|dynamic rehabilitation
268257|NCT02015351|Choroidal neovascularization|choroidal neovascularization
268258|NCT02015351|Vogt Koyanagi Harada Disease|vogt koyanagi harada disease
268259|NCT02015351|Inflammatory choroidal neovascularization|inflammatory choroidal neovascularization
268260|NCT02015351|Anti-VEGF|anti-vegf
268261|NCT02015338|Hemiparesis|hemiparesis
268262|NCT02015338|Cerebral Palsy|cerebral palsy
268263|NCT02015338|Congenital Stroke|congenital stroke
268264|NCT02015338|Congenital Infarct|congenital infarct
268265|NCT02015325|Water|water
268266|NCT02015325|Sanitation|sanitation
268267|NCT02015325|Hygiene|hygiene
268268|NCT02015325|Education|education
268269|NCT02015325|Evaluation|evaluation
268270|NCT02015312|Amyloidosis|amyloidosis
268271|NCT02015299|Diabetes|diabetes
268272|NCT02015299|Pulse Wave Velocity|pulse wave velocity
268273|NCT02015299|Dipeptidyl peptidase (DPP)-4 inhibitors|dipeptidyl peptidase (dpp)-4 inhibitors
268275|NCT02015299|Arterial Stiffness|arterial stiffness
268276|NCT02015299|Subclinical arterial inflammation|subclinical arterial inflammation
268277|NCT02015286|Growth disorders|growth disorders
268278|NCT02015286|Saizen|saizen
268279|NCT02015286|Easypod|easypod
268280|NCT02015286|Growth hormone|growth hormone
268281|NCT02015286|Pediatric subject|pediatric subject
268282|NCT02015273|easypod™|easypod™
268283|NCT02015273|SAIZEN®|saizen®
268284|NCT02015260|human papilloma virus infection|human papilloma virus infection
268285|NCT02015260|Anogenital warts|anogenital warts
268286|NCT02015260|condylomata acuminata|condylomata acuminata
268287|NCT02015234|TNX-102 SL|tnx-102 sl
268288|NCT02015234|bedtime|bedtime
268289|NCT02015234|sublingual|sublingual
268290|NCT02015234|12-month|12-month
268291|NCT02015234|long term safety|long term safety
268292|NCT02015234|long term efficacy|long term efficacy
268293|NCT02015234|Fibromyalgia|fibromyalgia
268294|NCT02015221|chronic venous insufficiency|chronic venous insufficiency
268295|NCT02015221|venous leg ulcers|venous leg ulcers
268296|NCT02015221|pneumatic compression|pneumatic compression
268297|NCT02015208|CLL|cll
268298|NCT02015208|cytokine signaling|cytokine signaling
268299|NCT02015208|signal transduction inhibitors|signal transduction inhibitors
268300|NCT02015208|elderly|elderly
268301|NCT02015208|p53|p53
268302|NCT02015195|Jellyfish stings|jellyfish stings
268303|NCT02015195|Treatment|treatment
268304|NCT02015195|Humans|humans
268305|NCT02015195|Topical Treatments|topical treatments
268306|NCT02015195|Pain|pain
268307|NCT02015195|Erythema|erythema
268308|NCT02015182|Bupivacaine|bupivacaine
268309|NCT02015182|Sensorcaine|sensorcaine
268310|NCT02015182|Population pharmacokinetics|population pharmacokinetics
268311|NCT02015182|Children|children
268312|NCT02015182|Pediatrics|pediatrics
268313|NCT02015182|Transversus abdominis plane (TAP) block|transversus abdominis plane (tap) block
268314|NCT02015182|Regional Anesthesia|regional anesthesia
268315|NCT02015169|gastric cancer|gastric cancer
268316|NCT02015169|neoadjuvant chemotherapy|neoadjuvant chemotherapy
268317|NCT02015169|capecitabine|capecitabine
268318|NCT02015169|oxaliplatin|oxaliplatin
268319|NCT02015169|lapatinib|lapatinib
268320|NCT02015156|Trastuzumab|trastuzumab
268321|NCT02015156|Healthy Male Volunteers|healthy male volunteers
268322|NCT02015156|Single-Dose|single-dose
268323|NCT02015156|Phase 1|phase 1
268324|NCT02015156|Biosimilarity|biosimilarity
268325|NCT02015130|Type 2 diabetes|type 2 diabetes
268326|NCT02015130|hypertension|hypertension
268327|NCT02015130|individual|individual
268328|NCT02015104|Urothelial Cancinoma|urothelial cancinoma
268329|NCT02015104|Vaccines|vaccines
268330|NCT02015104|Immunotherapy|immunotherapy
268331|NCT02015104|TICE BCG|tice bcg
268332|NCT02015104|Intravesical Treatment|intravesical treatment
268333|NCT02015091|Healthy Subjects|healthy subjects
268334|NCT02015091|Vaccine-Mediated Protection|vaccine-mediated protection
268335|NCT02015091|Immunogenicity|immunogenicity
268336|NCT02015091|Sporozoites|sporozoites
268337|NCT02015091|Parasitemia|parasitemia
268338|NCT02015078|Eating Behavior|eating behavior
268339|NCT02015078|Cancer|cancer
268340|NCT02015078|Chronic Diseases|chronic diseases
268341|NCT02015078|Obesity|obesity
268342|NCT02015065|GIST|gist
268343|NCT02015065|Toxicity|toxicity
268344|NCT02015065|Mesenchymal Tumor|mesenchymal tumor
268345|NCT02015065|Clinical Activity|clinical activity
268346|NCT02015065|Survival|survival
268347|NCT02015039|Occupational Therapy|occupational therapy
268348|NCT02015039|Botulinum Toxin|botulinum toxin
268349|NCT02015039|Writer's Cramp|writer's cramp
268350|NCT02015026|Biospecimen Repository|biospecimen repository
268351|NCT02015026|Disease Progression Pattern|disease progression pattern
268352|NCT02015026|Specimen Analysis|specimen analysis
268353|NCT02015026|Genetic Analysis|genetic analysis
268354|NCT02015013|Leukapheresis|leukapheresis
268355|NCT02015013|Progenitor Cells|progenitor cells
268356|NCT02015000|Pterygium|pterygium
268357|NCT02015000|Recurrence|recurrence
268358|NCT02014987|Running related injury|running related injury
268359|NCT02014987|Overuse injury|overuse injury
268360|NCT02014987|Running pattern|running pattern
268361|NCT02014974|Fractures|fractures
268362|NCT02014974|burden of fractures|burden of fractures
268363|NCT02014974|orthopaedic fractures|orthopaedic fractures
268364|NCT02014974|orthopaedic injuries|orthopaedic injuries
268365|NCT02014974|orthopaedic trauma|orthopaedic trauma
268366|NCT02014974|fractures India|fractures india
268367|NCT02014974|observational study|observational study
268368|NCT02014974|outcomes of fracture care|outcomes of fracture care
268369|NCT02014974|wait times India|wait times india
268370|NCT02014974|epidemiology|epidemiology
268371|NCT02014948|Low Back Pain|low back pain
268372|NCT02014948|Physiotherapy|physiotherapy
268373|NCT02014935|Low-intensity Laser|low-intensity laser
268374|NCT02014935|Spasticity|spasticity
268375|NCT02014935|pain,|pain,
268376|NCT02014935|Fatigue|fatigue
268377|NCT02014909|KTN3379|ktn3379
268378|NCT02014909|Advanced cancer|advanced cancer
268379|NCT02014909|Phase 1|phase 1
268380|NCT02014909|Monoclonal antibody|monoclonal antibody
268381|NCT02014909|Safety and pharmacokinetics|safety and pharmacokinetics
268382|NCT02014909|CDX3379|cdx3379
268383|NCT02014896|Ischemic Stroke|ischemic stroke
268384|NCT02014896|Transient Ischemic Attack|transient ischemic attack
268385|NCT02014896|Transient Neurological Event|transient neurological event
268386|NCT02014896|Atrial Fibrillation|atrial fibrillation
268387|NCT02014896|Cryptogenic Stroke|cryptogenic stroke
268388|NCT02014896|Gene Expression|gene expression
268389|NCT02014896|RNA|rna
268390|NCT02014896|Anticoagulant|anticoagulant
268391|NCT02014896|NOAC|noac
268392|NCT02014896|Antiplatelet|antiplatelet
268393|NCT02014896|Cardiac monitoring|cardiac monitoring
268394|NCT02014896|Point of Care|point of care
268395|NCT02014896|tPA|tpa
268396|NCT02014896|Atheroembolic|atheroembolic
268397|NCT02014870|Influenza|influenza
268398|NCT02014870|Vaccine|vaccine
268399|NCT02014870|Virus|virus
268400|NCT02014870|H1N1|h1n1
268401|NCT02014870|Challenge|challenge
268402|NCT02014870|Vismederi|vismederi
268528|NCT02014402|Vascular surgery|vascular surgery
268403|NCT02014857|Smoking, gingival crevicular fluid, matrix metalloproteinases, intercellular signaling peptides and proteins, healthy volunteers|smoking, gingival crevicular fluid, matrix metalloproteinases, intercellular signaling peptides and proteins, healthy volunteers
268404|NCT02014844|glioblastoma|glioblastoma
268405|NCT02014844|aldoxorubicin|aldoxorubicin
268406|NCT02014844|temozolomide|temozolomide
268407|NCT02014844|brain cancer|brain cancer
268408|NCT02014844|brain tumor|brain tumor
268409|NCT02014831|Squamous Cell Carcinoma of the penis|squamous cell carcinoma of the penis
268410|NCT02014831|Stage N3|stage n3
268411|NCT02014831|Metastasis|metastasis
268412|NCT02014831|TIP|tip
268413|NCT02014831|Cetuximab|cetuximab
268414|NCT02014831|Objective Response Rate|objective response rate
268415|NCT02014831|Safety profile|safety profile
268416|NCT02014831|Overall Survival|overall survival
268417|NCT02014831|Progression Free Survival|progression free survival
268418|NCT02014831|Quality of Life|quality of life
268419|NCT02014805|postoperative|postoperative
268420|NCT02014805|conformal|conformal
268421|NCT02014805|radiotherapy|radiotherapy
268422|NCT02014805|thymoma|thymoma
268423|NCT02014792|Haemodialysis|haemodialysis
268424|NCT02014792|Heart rate variability|heart rate variability
268425|NCT02014792|n-3 PUFA|n-3 pufa
268426|NCT02014779|Randomized Controlled Trial|randomized controlled trial
268427|NCT02014779|Alcohol|alcohol
268428|NCT02014779|Internet|internet
268429|NCT02014779|Internet based therapy|internet based therapy
268430|NCT02014779|Cognitive behavioral therapy|cognitive behavioral therapy
268431|NCT02014753|AMI|ami
268432|NCT02014753|STEMI|stemi
268433|NCT02014753|ACS|acs
268434|NCT02014740|Epicardial fat|epicardial fat
268435|NCT02014740|Type 2 diabetes|type 2 diabetes
268436|NCT02014740|Obesity|obesity
268437|NCT02014740|GLP-1 analogs|glp-1 analogs
268438|NCT02014727|Malaria vaccine|malaria vaccine
268439|NCT02014727|phase 1,|phase 1,
268440|NCT02014727|AMA1-DiCO|ama1-dico
268441|NCT02014701|echocardiogram|echocardiogram
268442|NCT02014701|regional wall motion abnormalities|regional wall motion abnormalities
268443|NCT02014701|myocardial contrast|myocardial contrast
268444|NCT02014688|Normal subjects|normal subjects
268445|NCT02014675|ICD|icd
268446|NCT02014675|CRT-D|crt-d
268447|NCT02014675|Lead|lead
268448|NCT02014662|Muscle function, Muscle damage and recovery, Eccentric exercise, Muscle soreness, Protein synthesis|muscle function, muscle damage and recovery, eccentric exercise, muscle soreness, protein synthesis
268449|NCT02014649|Influenza treatment|influenza treatment
268450|NCT02014649|pediatric|pediatric
268451|NCT02014649|laninamivir|laninamivir
268452|NCT02014636|Pazopanib (GW786034)|pazopanib (gw786034)
268453|NCT02014636|MK 3475|mk 3475
268454|NCT02014636|Renal cell carcinoma|renal cell carcinoma
268455|NCT02014623|Allergic rhinitis|allergic rhinitis
268456|NCT02014623|Asthma|asthma
268457|NCT02014623|Regulatory T cells|regulatory t cells
268458|NCT02014623|IgE|ige
268459|NCT02014623|IgG4|igg4
268460|NCT02014610|Neutrophil|neutrophil
268461|NCT02014610|Lymphocyte|lymphocyte
268462|NCT02014610|Eosinophil|eosinophil
268463|NCT02014610|Leukocyte count|leukocyte count
268464|NCT02014610|Cardiovascular disease|cardiovascular disease
268465|NCT02014610|Atherosclerosis|atherosclerosis
268466|NCT02014610|Monocyte|monocyte
268467|NCT02014610|Basophil|basophil
268468|NCT02014597|Glaucoma|glaucoma
268469|NCT02014584|quality of life|quality of life
268470|NCT02014584|safety|safety
268471|NCT02014584|sexual function|sexual function
268472|NCT02014584|male pattern hair loss (MPHL)|male pattern hair loss (mphl)
268473|NCT02014584|Androgenic alopecia (AGA)|androgenic alopecia (aga)
268474|NCT02014584|dutasteride|dutasteride
268475|NCT02014584|satisfaction with hair growth|satisfaction with hair growth
268476|NCT02014571|NS5B|ns5b
268477|NCT02014571|chronic hepatitis C (CHC)|chronic hepatitis c (chc)
268478|NCT02014571|antiviral activity|antiviral activity
268479|NCT02014571|pharmacokinetics (PK)|pharmacokinetics (pk)
268480|NCT02014571|Safety|safety
268481|NCT02014571|hepatitis C virus (HCV)|hepatitis c virus (hcv)
268482|NCT02014571|GSK2878175|gsk2878175
268483|NCT02014558|Acute Myeloid Leukemia|acute myeloid leukemia
268484|NCT02014558|Gilteritinib|gilteritinib
268485|NCT02014558|ASP2215|asp2215
268486|NCT02014545|brain metastases|brain metastases
268487|NCT02014545|non-small cell lung cancer|non-small cell lung cancer
268488|NCT02014545|whole brain radiation therapy|whole brain radiation therapy
268489|NCT02014545|lucanthone|lucanthone
268490|NCT02014532|Leukotriene receptor antagonist|leukotriene receptor antagonist
268491|NCT02014532|Chronic periodontitis|chronic periodontitis
268492|NCT02014532|Scaling and root planing|scaling and root planing
268493|NCT02014532|C- reactive protein|c- reactive protein
268494|NCT02014519|Adults|adults
268495|NCT02014519|Hungary|hungary
268496|NCT02014519|Bordetella pertussis|bordetella pertussis
268497|NCT02014519|Seroprevalence|seroprevalence
268498|NCT02014519|Pertussis antibodies|pertussis antibodies
268499|NCT02014506|Children and adolescents|children and adolescents
268500|NCT02014506|Malignant disease|malignant disease
268501|NCT02014506|Non-malignant disease|non-malignant disease
268502|NCT02014506|TCRαβ depletion|tcrαβ depletion
268503|NCT02014506|Haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
268504|NCT02014493|Respiration|respiration
268505|NCT02014493|Noninvasive Ventilation|noninvasive ventilation
268506|NCT02014493|Work of breathing|work of breathing
268507|NCT02014493|Infant, premature|infant, premature
268508|NCT02014493|Electromyography|electromyography
268509|NCT02014493|Diaphragm|diaphragm
268510|NCT02014480|Long-acting beta-agonist|long-acting beta-agonist
268511|NCT02014480|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
268512|NCT02014480|Umeclidinium|umeclidinium
268513|NCT02014480|Long-acting muscarinic antagonist|long-acting muscarinic antagonist
268514|NCT02014480|Vilanterol|vilanterol
268515|NCT02014454|Retinopathy of prematurity|retinopathy of prematurity
268516|NCT02014454|Propranolol|propranolol
268517|NCT02014454|Eye drops|eye drops
268518|NCT02014454|Newborns|newborns
268519|NCT02014454|Retinal angiogenesis|retinal angiogenesis
268520|NCT02014454|Retinal neovascularization|retinal neovascularization
268521|NCT02014415|Alpha-1|alpha-1
268522|NCT02014415|AAT Deficiency|aat deficiency
268523|NCT02014415|AATD|aatd
268524|NCT02014415|Liver|liver
268525|NCT02014415|Fibrosis|fibrosis
268526|NCT02014415|Liver Transplant|liver transplant
268527|NCT02014415|Cirrhosis|cirrhosis
268529|NCT02014402|Hepatic surgery|hepatic surgery
268530|NCT02014402|Soft tissue surgery|soft tissue surgery
268531|NCT02014402|Spinal surgery|spinal surgery
268532|NCT02014389|Retinal Dystrophies|retinal dystrophies
268533|NCT02014389|Retinitis Pigmentosa|retinitis pigmentosa
268534|NCT02014389|Glaucoma|glaucoma
268535|NCT02014389|Visual Field|visual field
268536|NCT02014376|Epidermolysis Bullosa|epidermolysis bullosa
268537|NCT02014376|Simplex|simplex
268538|NCT02014376|Recessive Dystrophic|recessive dystrophic
268539|NCT02014376|Junctional non-Herlitz|junctional non-herlitz
268540|NCT02014337|Mifepristone|mifepristone
268541|NCT02014337|Eribulin Mesylate|eribulin mesylate
268542|NCT02014337|Breast Cancer|breast cancer
268543|NCT02014337|Ovarian Cancer|ovarian cancer
268544|NCT02014337|Sarcoma|sarcoma
268545|NCT02014337|Non-small cell lung cancer|non-small cell lung cancer
268546|NCT02014337|Carcinoma, transitional cell|carcinoma, transitional cell
268547|NCT02014337|Prostate cancer|prostate cancer
268548|NCT02014337|Prostatic neoplasms|prostatic neoplasms
268549|NCT02014311|Multidetector Computed Tomography|multidetector computed tomography
268550|NCT02014311|Myocardial Perfusion Imaging|myocardial perfusion imaging
268551|NCT02014311|Coronary Stenosis|coronary stenosis
268552|NCT02014311|Coronary Artery Disease|coronary artery disease
268553|NCT02014311|Angina Pectoris|angina pectoris
268554|NCT02014298|Burns|burns
268555|NCT02014298|Non-ablative fractional laser|non-ablative fractional laser
268556|NCT02014298|scar texture|scar texture
268557|NCT02014298|histology|histology
268558|NCT02014298|laser treatment|laser treatment
268559|NCT02014298|erbium:glass laser|erbium:glass laser
268560|NCT02014298|meshed skin-grafts|meshed skin-grafts
268561|NCT02014298|photothermolysis|photothermolysis
268562|NCT02014298|skin|skin
268563|NCT02014285|Acute Respiratory Failure|acute respiratory failure
268564|NCT02014285|Critical Illness|critical illness
268565|NCT02014285|Mechanical Ventilation|mechanical ventilation
268566|NCT02014285|Muscle Architecture|muscle architecture
268567|NCT02014285|Muscle Ultrasound|muscle ultrasound
268568|NCT02014272|Bioequivalence|bioequivalence
268569|NCT02014272|RIN 150|rin 150
268570|NCT02014272|Healthy volunteers|healthy volunteers
268571|NCT02014246|Movement Disorders|movement disorders
268572|NCT02014246|Polymorphisms|polymorphisms
268573|NCT02014246|DNA|dna
268574|NCT02014246|Lymphoblast Cell Lines|lymphoblast cell lines
268575|NCT02014233|Randomized clinical trial|randomized clinical trial
268576|NCT02014233|Humans|humans
268577|NCT02014233|Omega-3 fatty acids|omega-3 fatty acids
268578|NCT02014233|Essential fatty acid|essential fatty acid
268579|NCT02014233|Neuromuscular function|neuromuscular function
268581|NCT02014233|Maximum voluntary contraction|maximum voluntary contraction
268582|NCT02014233|Electromyography|electromyography
268583|NCT02014233|Seal oil|seal oil
268584|NCT02014233|Cycling time trial|cycling time trial
268585|NCT02014233|Placebo controlled|placebo controlled
268586|NCT02014194|Attentional Bias|attentional bias
268587|NCT02014194|Attentional Bias modification treatment|attentional bias modification treatment
268588|NCT02014181|cystic fibrosis|cystic fibrosis
268589|NCT02014181|isoprostanes|isoprostanes
268590|NCT02014181|8-oxo-dGuo|8-oxo-dguo
268591|NCT02014181|oxidative stress|oxidative stress
268592|NCT02014181|inflammation|inflammation
268593|NCT02014181|flaxseed|flaxseed
268594|NCT02014181|enterodiol|enterodiol
268595|NCT02014181|enterolactone|enterolactone
268596|NCT02014155|Chronic Obstructive Pulmonary Disease,|chronic obstructive pulmonary disease,
268597|NCT02014103|bioequivalence|bioequivalence
268598|NCT02014103|tacrolimus|tacrolimus
268599|NCT02014103|transplant|transplant
268600|NCT02014103|CYP3A5 expressors/non expressors|cyp3a5 expressors/non expressors
268601|NCT02014090|ECP|ecp
268602|NCT02014090|Endurance exercise|endurance exercise
268603|NCT02014090|myocardial perfusion|myocardial perfusion
268604|NCT02014077|VATS( Video-Assisted Thoracoscopy )|vats( video-assisted thoracoscopy )
268605|NCT02014077|Thoracostomy Tube|thoracostomy tube
268606|NCT02014077|Empyema|empyema
268607|NCT02014077|Thoracotomy|thoracotomy
268608|NCT02014064|Methamphetamine, Atomoxetine, Clinical Pharmacology|methamphetamine, atomoxetine, clinical pharmacology
268609|NCT02014038|Ultrarunners|ultrarunners
268610|NCT02014038|ultramarathon runners|ultramarathon runners
268611|NCT02014038|ULTRA|ultra
268612|NCT02014038|Physical activity|physical activity
268613|NCT02014038|Health Risks|health risks
268614|NCT02014038|sedentary|sedentary
268615|NCT02014038|moderately active|moderately active
268616|NCT02014025|Laparoscope hepatectomy|laparoscope hepatectomy
268617|NCT02014025|Open hepatectomy|open hepatectomy
268618|NCT02014025|large PHC|large phc
268619|NCT02014025|safety and sensibility|safety and sensibility
268620|NCT02013986|salivary cortisol|salivary cortisol
268621|NCT02013986|circadian rhythm|circadian rhythm
268622|NCT02013986|children|children
268623|NCT02013986|etomidate|etomidate
268624|NCT02013973|Anti mullerian hormone|anti mullerian hormone
268625|NCT02013973|In vitro fertilization|in vitro fertilization
268626|NCT02013973|Optimal treatment|optimal treatment
268627|NCT02013973|Randomized controlled trial|randomized controlled trial
268628|NCT02013947|Exercise, moderate altitude, hypoxia, metabolic syndrome|exercise, moderate altitude, hypoxia, metabolic syndrome
268629|NCT02013921|Physical activity|physical activity
268630|NCT02013921|Cancer|cancer
268631|NCT02013908|acupuncture|acupuncture
268632|NCT02013908|emergency department|emergency department
268633|NCT02013908|acute pain|acute pain
268634|NCT02013908|ankle sprain|ankle sprain
268635|NCT02013908|neck pain|neck pain
268636|NCT02013908|primary headache|primary headache
268637|NCT02013895|liver|liver
268638|NCT02013895|surgery|surgery
268639|NCT02013895|liver function|liver function
268640|NCT02013895|GSA|gsa
268641|NCT02013895|ICG|icg
268642|NCT02013882|low flow anesthesia|low flow anesthesia
268643|NCT02013882|wash-in|wash-in
268644|NCT02013882|desflurane|desflurane
268645|NCT02013869|fresh gas flow|fresh gas flow
268646|NCT02013869|quality of anaesthesia|quality of anaesthesia
268647|NCT02013869|minimal alveolar concentration|minimal alveolar concentration
268648|NCT02013856|Blood pressure|blood pressure
268649|NCT02013856|Flavanols|flavanols
268650|NCT02013856|Cardiovascular disease|cardiovascular disease
268651|NCT02013843|Pediatric obesity|pediatric obesity
268652|NCT02013843|Community-based treatment|community-based treatment
268653|NCT02013843|dyslipidemia|dyslipidemia
268654|NCT02013843|hypertension|hypertension
268655|NCT02013843|diabetes|diabetes
268656|NCT02013778|outside of transplant criteria|outside of transplant criteria
268657|NCT02013752|Delivery tears|delivery tears
268658|NCT02013752|Birth injuries|birth injuries
268659|NCT02013752|Perineal protection device|perineal protection device
268660|NCT02013713|Cardiology|cardiology
268661|NCT02013713|Family Hypercholesterolemia|family hypercholesterolemia
268662|NCT02013700|IPF|ipf
268663|NCT02013700|Pulmonary fibrosis|pulmonary fibrosis
268664|NCT02013674|Cardiovascular, Chronic Ischemic Left Ventricular Dysfunction|cardiovascular, chronic ischemic left ventricular dysfunction
268665|NCT02013661|periodontal debridement|periodontal debridement
268666|NCT02013661|sutures|sutures
268667|NCT02013661|tissue reaction|tissue reaction
268668|NCT02013648|AML|aml
268669|NCT02013648|Dasatinib|dasatinib
268670|NCT02013648|Core Binding Factor (CBF)|core binding factor (cbf)
268671|NCT02013635|cerebral venous thrombosis|cerebral venous thrombosis
268672|NCT02013635|thrombin generation|thrombin generation
268673|NCT02013635|d-dimers|d-dimers
268674|NCT02013635|clinical evolution|clinical evolution
268675|NCT02013622|schizophrenia|schizophrenia
268676|NCT02013622|Mental Disorders|mental disorders
268677|NCT02013622|Psychotic Disorders|psychotic disorders
268678|NCT02013622|social avoidance|social avoidance
268679|NCT02013622|emotional withdrawal|emotional withdrawal
268680|NCT02013622|passive/apathetic|passive/apathetic
268681|NCT02013622|social withdrawal|social withdrawal
268682|NCT02013622|antipsychotic|antipsychotic
268683|NCT02013609|schizophrenia|schizophrenia
268684|NCT02013609|Major depressive disorder|major depressive disorder
268685|NCT02013609|Anxiety Symptoms|anxiety symptoms
268686|NCT02013609|School, Work environment|school, work environment
268687|NCT02013609|Mental Disorders|mental disorders
268688|NCT02013609|Psychotic Disorders|psychotic disorders
268689|NCT02013609|antipsychotic|antipsychotic
268690|NCT02013596|hepatic dysfunction|hepatic dysfunction
268691|NCT02013596|renal dysfunction|renal dysfunction
268692|NCT02013596|pneumoperitoneum|pneumoperitoneum
268693|NCT02013596|Transcutaneous electric stimulation|transcutaneous electric stimulation
268694|NCT02013583|Glucose Transporter Type I Deficiency|glucose transporter type i deficiency
268695|NCT02013583|Glucose Transporter Type 1 Deficiency|glucose transporter type 1 deficiency
268696|NCT02013583|G1D|g1d
268697|NCT02013583|Glut1 Deficiency|glut1 deficiency
268698|NCT02013570|postoperative pain; dexmedetomidine; adenotonsillectomy|postoperative pain; dexmedetomidine; adenotonsillectomy
268699|NCT02013557|Gestational Diabetes|gestational diabetes
268700|NCT02013557|Postpartum screening|postpartum screening
268701|NCT02013557|Text-messages|text-messages
268702|NCT02013557|75-g oral glucose tolerance test|75-g oral glucose tolerance test
268703|NCT02013544|Vulvovaginal atrophy (VVA)|vulvovaginal atrophy (vva)
268704|NCT02013544|Vaginal atrophy|vaginal atrophy
268705|NCT02013544|Atrophic vaginitis|atrophic vaginitis
268706|NCT02013544|prasterone|prasterone
268707|NCT02013544|DHEA|dhea
268708|NCT02013544|Intrarosa|intrarosa
268709|NCT02013531|schizophrenia|schizophrenia
268710|NCT02013531|Major depressive disorder|major depressive disorder
268711|NCT02013531|Anxiety Symptoms|anxiety symptoms
268712|NCT02013531|Mental Disorders|mental disorders
268713|NCT02013531|Psychotic Disorders|psychotic disorders
268714|NCT02013531|emotional withdrawal|emotional withdrawal
268715|NCT02013531|antipsychotic|antipsychotic
268716|NCT02013518|Alzheimers' disease|alzheimers' disease
268717|NCT02013518|Cognitive behavioral therapy|cognitive behavioral therapy
268718|NCT02013518|Depression|depression
268719|NCT02013518|Self-efficacy|self-efficacy
268720|NCT02013518|Quality of Life|quality of life
268721|NCT02013505|Colonoscopy|colonoscopy
268722|NCT02013492|Beta-Blocker|beta-blocker
268723|NCT02013492|metastatic melanoma|metastatic melanoma
268724|NCT02013492|hepatocellular carcinoma|hepatocellular carcinoma
268725|NCT02013466|Bioavailability|bioavailability
268726|NCT02013466|Amino Acids|amino acids
268727|NCT02013466|Elderly|elderly
268728|NCT02013466|Supplement|supplement
268729|NCT02013427|chronic|chronic
268730|NCT02013427|back|back
268731|NCT02013427|pain|pain
268732|NCT02013427|brain|brain
268733|NCT02013427|MRI|mri
268734|NCT02013401|mother-infant dyadic regulation|mother-infant dyadic regulation
268735|NCT02013401|stress|stress
268736|NCT02013401|psychophysiology|psychophysiology
268737|NCT02013401|emotion regulation|emotion regulation
268738|NCT02013388|N91115|n91115
268739|NCT02013388|GSNORi|gsnori
268740|NCT02013388|SNO|sno
268741|NCT02013388|Cavosonstat|cavosonstat
268742|NCT02013336|pediatric|pediatric
268743|NCT02013336|MM-398|mm-398
268744|NCT02013336|cyclophosphamide|cyclophosphamide
268745|NCT02013336|irinotecan|irinotecan
268746|NCT02013323|Septiline, chronic periodontitis, Immunomodulator, microbiology|septiline, chronic periodontitis, immunomodulator, microbiology
268747|NCT02013297|Pediatrics|pediatrics
268748|NCT02013297|SBRT|sbrt
268749|NCT02013297|Brain metastasis|brain metastasis
268750|NCT02013297|Pulmonary metastasis|pulmonary metastasis
268751|NCT02013297|Spinal metastasis|spinal metastasis
268752|NCT02013297|Pulmonary primary tumor|pulmonary primary tumor
268753|NCT02013297|Spinal primary tumor|spinal primary tumor
268754|NCT02013297|Relapsed ependymoma|relapsed ependymoma
268755|NCT02013297|Relapsed irradiated tumors|relapsed irradiated tumors
268756|NCT02013297|Local control rate|local control rate
268757|NCT02013297|Safety|safety
268758|NCT02013297|Overall survival|overall survival
268759|NCT02013297|Progression Free Survival|progression free survival
268760|NCT02013258|Prader Willi syndrome|prader willi syndrome
268761|NCT02013258|Oxytocin|oxytocin
268762|NCT02013232|Risperidone;|risperidone;
268763|NCT02013232|Aripiprazole;|aripiprazole;
268764|NCT02013232|Hyperprolactinemia;|hyperprolactinemia;
268765|NCT02013232|dose effects|dose effects
268766|NCT02013193|drug-coated balloon|drug-coated balloon
268767|NCT02013193|drug-eluting balloon|drug-eluting balloon
268768|NCT02013193|peripheral artery disease|peripheral artery disease
268769|NCT02013193|claudication|claudication
268770|NCT02013180|Prostate cancer, PSA, zinc, zinc/PSA|prostate cancer, psa, zinc, zinc/psa
268771|NCT02013167|Relapsed; Refractory; B-precursor; Acute Lymphoblastic Leukemia; Philadelphia Negative; ALL; Blinatumomab; Leukemia; Standard of Care; SOC|relapsed; refractory; b-precursor; acute lymphoblastic leukemia; philadelphia negative; all; blinatumomab; leukemia; standard of care; soc
268772|NCT02013141|Gram positive bacteria|gram positive bacteria
268773|NCT02013141|Telavancin|telavancin
268774|NCT02013141|VIBATIV|vibativ
268775|NCT02013141|Pediatric|pediatric
268776|NCT02013141|Pharmacokinetics|pharmacokinetics
268777|NCT02013115|infant|infant
268778|NCT02013115|respiratory distress syndrome|respiratory distress syndrome
268779|NCT02013089|genomic sequencing, Integrated genomic network analysis|genomic sequencing, integrated genomic network analysis
268780|NCT02013076|Asthma; Children; Cohort study; Corticosteroids|asthma; children; cohort study; corticosteroids
268781|NCT02013063|Single Pulmonary Nodule|single pulmonary nodule
268782|NCT02013063|SPN|spn
268783|NCT02013063|Lung cancer|lung cancer
268784|NCT02013063|Diagnostic|diagnostic
268785|NCT02013063|Computed Tomography|computed tomography
268786|NCT02013063|CT scan|ct scan
268787|NCT02013063|FDG-PET scan|fdg-pet scan
268788|NCT02013063|Dynamic CT scan|dynamic ct scan
268789|NCT02013063|DCE-CT scan|dce-ct scan
268790|NCT02013063|Dynamic contrast enhanced CT scan|dynamic contrast enhanced ct scan
268791|NCT02013063|soft tissue solitary dominant|soft tissue solitary dominant
268792|NCT02013063|≥ 8mm and ≤30mm|≥ 8mm and ≤30mm
268793|NCT02013037|cardiac transplantation|cardiac transplantation
268794|NCT02013037|immunosuppression|immunosuppression
268795|NCT02013037|acute cellular rejection|acute cellular rejection
268796|NCT02013037|antibody mediated rejection|antibody mediated rejection
268797|NCT02013037|sensitization|sensitization
268798|NCT02013037|antibody production in cardiac patients|antibody production in cardiac patients
268799|NCT02013037|panel reactive antibodies|panel reactive antibodies
268800|NCT02013037|desensitization strategies in heart transplant patients|desensitization strategies in heart transplant patients
268801|NCT02013037|complement activation|complement activation
268802|NCT02013037|complement c3d and c4d deposition|complement c3d and c4d deposition
268803|NCT02013037|terminal complement inhibition|terminal complement inhibition
268804|NCT02013037|complement C5 binding|complement c5 binding
268805|NCT02013037|Eculizumab|eculizumab
268806|NCT02013037|monoclonal antibody|monoclonal antibody
268807|NCT02013037|donor specific antibodies|donor specific antibodies
268808|NCT02012985|hyperoxaluria|hyperoxaluria
268809|NCT02012985|oxalate|oxalate
268810|NCT02012985|PH|ph
268811|NCT02012972|Antiretroviral therapy|antiretroviral therapy
268812|NCT02012972|HIV/AIDS|hiv/aids
268813|NCT02012972|Non-communicable diseases|non-communicable diseases
268814|NCT02012972|South Africa|south africa
268815|NCT02012959|Hyponatremia|hyponatremia
268816|NCT02012959|Euvolemic|euvolemic
268817|NCT02012959|Hypervolemic|hypervolemic
268818|NCT02012959|Serum sodium|serum sodium
268819|NCT02012959|Dilutional hyponatremia|dilutional hyponatremia
268820|NCT02012959|Electrolyte abnormality|electrolyte abnormality
268821|NCT02012959|Electrolyte imbalance|electrolyte imbalance
268822|NCT02012959|Metabolic disease|metabolic disease
268823|NCT02012933|3,4DAP, LEMS, CM|3,4dap, lems, cm
268824|NCT02012920|castration-resistant prostate cancer|castration-resistant prostate cancer
268825|NCT02012920|CYP17|cyp17
268826|NCT02012920|P450c17a|p450c17a
268827|NCT02012920|lyase|lyase
268828|NCT02012920|Prostate Cancer|prostate cancer
268829|NCT02012894|Obesity|obesity
268830|NCT02012894|Gastroesophageal reflux|gastroesophageal reflux
268831|NCT02012894|sleeve gastrectomy|sleeve gastrectomy
268832|NCT02012894|pH-monitoring|ph-monitoring
268833|NCT02012894|manometry|manometry
268834|NCT02012868|obstructive sleep apnoea|obstructive sleep apnoea
268835|NCT02012868|weight loss|weight loss
268836|NCT02012868|bariatric surgery|bariatric surgery
268837|NCT02012842|Metabolic Syndrome|metabolic syndrome
268838|NCT02012842|Periodontal Disease|periodontal disease
268839|NCT02012842|Periodontal therapy|periodontal therapy
268840|NCT02012842|inflammatory markers|inflammatory markers
268841|NCT02012842|C reactive protein|c reactive protein
268842|NCT02012842|serum fibrinogen|serum fibrinogen
268843|NCT02012842|glycated hemoglobin|glycated hemoglobin
268844|NCT02012829|cancer, CRC screening, communication|cancer, crc screening, communication
268845|NCT02012816|Uncircumcised men|uncircumcised men
268846|NCT02012816|Voluntary Medical Male circumcision|voluntary medical male circumcision
268847|NCT02012816|Peer-referral incentive|peer-referral incentive
268848|NCT02012803|Achilles tendon rupture|achilles tendon rupture
268849|NCT02012803|treatment, elongation|treatment, elongation
268850|NCT02012803|operative treatment of achilles tendon rupture|operative treatment of achilles tendon rupture
268851|NCT02012803|conservative treatment of achilles tendon rupture|conservative treatment of achilles tendon rupture
268852|NCT02012790|Migraine disorders|migraine disorders
268853|NCT02012777|sickle cell disease|sickle cell disease
268854|NCT02012777|propanolol|propanolol
268855|NCT02012777|red blood cell adhesion|red blood cell adhesion
268856|NCT02012764|Anti-CCP antibody|anti-ccp antibody
268857|NCT02012764|Inflammatory arthritis|inflammatory arthritis
268858|NCT02012764|Rheumatoid arthritis|rheumatoid arthritis
268859|NCT02012764|Musculoskeletal symptom|musculoskeletal symptom
268860|NCT02012751|Computer-assisted diagnosis|computer-assisted diagnosis
268861|NCT02012751|General practice|general practice
268862|NCT02012751|Dermatoscopy|dermatoscopy
268863|NCT02012751|Melanoma|melanoma
268864|NCT02012751|Nevus|nevus
268865|NCT02012725|Healthy|healthy
268866|NCT02012725|Myocardial fibrosis|myocardial fibrosis
268867|NCT02012725|Chronic kidney disease|chronic kidney disease
268868|NCT02012712|Personal health record|personal health record
268869|NCT02012712|medication management|medication management
268870|NCT02012712|patient safety|patient safety
268871|NCT02012699|Pancreatic Cancer|pancreatic cancer
268872|NCT02012699|Thyroid Cancer|thyroid cancer
268873|NCT02012699|Esophageal cancer|esophageal cancer
268874|NCT02012699|Thymus cancer|thymus cancer
268875|NCT02012699|Pancreatic tumor|pancreatic tumor
268876|NCT02012699|Esophageal tumor|esophageal tumor
268877|NCT02012699|Thymus tumor|thymus tumor
268878|NCT02012699|Thyroid Tumor|thyroid tumor
268879|NCT02012699|Thyroid Nodule|thyroid nodule
268880|NCT02012699|Lung Tumor|lung tumor
268881|NCT02012686|transcutaneous electric nerve stimulation|transcutaneous electric nerve stimulation
268882|NCT02012686|thyroidectomy|thyroidectomy
268883|NCT02012686|neck pain|neck pain
268884|NCT02012686|pain management|pain management
268885|NCT02012673|COPD|copd
268886|NCT02012673|Emphysema|emphysema
268887|NCT02012673|Bronchoscopy|bronchoscopy
268888|NCT02012673|Lung Volume Reduction|lung volume reduction
268889|NCT02012647|parkinson|parkinson
268890|NCT02012647|PD|pd
268891|NCT02012647|parkinson disease|parkinson disease
268892|NCT02012647|parkinson's|parkinson's
268893|NCT02012647|parkinson's disease|parkinson's disease
268894|NCT02012647|parkinsons|parkinsons
268895|NCT02012647|parkinsons disease|parkinsons disease
268896|NCT02012647|TMS|tms
268897|NCT02012647|DBS|dbs
268898|NCT02012647|transcranial magnetic stimulation|transcranial magnetic stimulation
268899|NCT02012647|deep brain stimulation|deep brain stimulation
268900|NCT02012634|Breast Cancer|breast cancer
268901|NCT02012634|Capecitabine|capecitabine
268902|NCT02012634|Triple Negative Breast CancerTNBC（TNBC）|triple negative breast cancertnbc（tnbc）
268903|NCT02012621|HIV/AIDS|hiv/aids
268904|NCT02012621|Adherence|adherence
268905|NCT02012621|Tenofovir|tenofovir
268906|NCT02012621|Dried Blood Spots|dried blood spots
268907|NCT02012608|breast|breast
268908|NCT02012569|skin grafting|skin grafting
268909|NCT02012569|elective treatment|elective treatment
268910|NCT02012543|constipation, agar|constipation, agar
268911|NCT02012530|Articular cartilage|articular cartilage
268912|NCT02012530|Hyaluronic Acid (HA)|hyaluronic acid (ha)
268913|NCT02012530|Platelet rich plasma (PRP)|platelet rich plasma (prp)
268914|NCT02012517|surgical site infection|surgical site infection
268915|NCT02012517|breast reconstruction|breast reconstruction
268916|NCT02012517|drains|drains
268917|NCT02012517|prophylaxis|prophylaxis
268918|NCT02012491|Spontaneous abortion|spontaneous abortion
268919|NCT02012491|Early Pregnancy Failure|early pregnancy failure
268920|NCT02012491|Mifepristone|mifepristone
268921|NCT02012491|Misoprostol|misoprostol
268922|NCT02012465|Steroid induced hyperglycemia|steroid induced hyperglycemia
268923|NCT02012465|Glucocorticoid induced hyperglycemia|glucocorticoid induced hyperglycemia
268924|NCT02012452|posttraumatic stress disorder|posttraumatic stress disorder
268925|NCT02012452|tobacco dependence|tobacco dependence
268926|NCT02012452|cognitive behavioral therapy|cognitive behavioral therapy
268927|NCT02012439|multiple sclerosis|multiple sclerosis
268928|NCT02012439|chronic pain|chronic pain
268929|NCT02012439|treatment|treatment
268930|NCT02012439|nonpharmacological|nonpharmacological
268931|NCT02012439|mindfulness|mindfulness
268932|NCT02012439|cognitive therapy|cognitive therapy
268933|NCT02012413|knee|knee
268934|NCT02012413|chondromalacia|chondromalacia
268935|NCT02012413|patella|patella
268936|NCT02012413|pulsed signal therapy|pulsed signal therapy
268937|NCT02012413|PST|pst
268938|NCT02012400|Asthma|asthma
268939|NCT02012400|Exercise|exercise
268940|NCT02012400|Asthma control|asthma control
268941|NCT02012400|Physical fitness|physical fitness
268942|NCT02012400|Quality of life|quality of life
268943|NCT02012387|Cholinergic urticaria|cholinergic urticaria
268944|NCT02012387|Omalizumab|omalizumab
268945|NCT02012374|aphasia|aphasia
268946|NCT02012374|anomia|anomia
268947|NCT02012374|speech therapy|speech therapy
268948|NCT02012374|rehabilitation|rehabilitation
268949|NCT02012374|neuroplasticity|neuroplasticity
268950|NCT02012374|fMRI|fmri
268951|NCT02012374|quality of life|quality of life
268952|NCT02012361|Ischemic preconditioning|ischemic preconditioning
268953|NCT02012361|Human limb ischemia|human limb ischemia
268954|NCT02012361|Total knee arthroplasty|total knee arthroplasty
268955|NCT02012361|Supplemental inspired helium|supplemental inspired helium
268956|NCT02012348|bacteria survival, surfactants|bacteria survival, surfactants
268957|NCT02012322|Aging|aging
268958|NCT02012322|Coenzyme Q10|coenzyme q10
268959|NCT02012322|Q10|q10
268960|NCT02012322|Quality of Life|quality of life
268961|NCT02012322|Oxidative Stress|oxidative stress
268962|NCT02012322|Mitochondrial Function|mitochondrial function
268963|NCT02012322|Cell Energetics|cell energetics
268964|NCT02012322|Fatigue|fatigue
268965|NCT02012322|Ubiquinone|ubiquinone
268966|NCT02012309|HIV|hiv
268967|NCT02012309|Streptococcus pneumoniae infection|streptococcus pneumoniae infection
268968|NCT02012309|Streptococcus pneumoniae colonization|streptococcus pneumoniae colonization
268969|NCT02012309|Pneumococcal vaccines|pneumococcal vaccines
268970|NCT02012309|Prevnar|prevnar
268972|NCT02012309|Nasopharyngeal microbiome|nasopharyngeal microbiome
268973|NCT02012283|spices and vegetables|spices and vegetables
268974|NCT02012270|Aortic Aneurysm|aortic aneurysm
268975|NCT02012270|Hernia|hernia
268976|NCT02012270|Abdominal Wound Closure Techniques|abdominal wound closure techniques
268977|NCT02012257|anterior middle superior alveolar nerve|anterior middle superior alveolar nerve
268978|NCT02012257|electric pulp tester|electric pulp tester
268979|NCT02012257|local anesthesia|local anesthesia
268980|NCT02012244|analgesia; colorectal surgery; immunity; local anesthetics; opioids|analgesia; colorectal surgery; immunity; local anesthetics; opioids
268981|NCT02012231|melanoma|melanoma
268982|NCT02012231|anaplastic thyroid cancer|anaplastic thyroid cancer
268983|NCT02012231|advanced papillary thyroid cancer|advanced papillary thyroid cancer
268984|NCT02012231|colorectal cancer|colorectal cancer
268985|NCT02012231|non-small cell lung cancer|non-small cell lung cancer
268986|NCT02012231|cholangiocarcinoma|cholangiocarcinoma
268987|NCT02012231|histiocytosis|histiocytosis
268988|NCT02012231|hairy cell leukemia|hairy cell leukemia
268989|NCT02012218|Major Depressive Disorder, Depression|major depressive disorder, depression
268990|NCT02012205|wet cupping - back pain - NSLBP - Saudi|wet cupping - back pain - nslbp - saudi
268991|NCT02012192|High-grade serous|high-grade serous
268992|NCT02012192|high-grade endometrioid|high-grade endometrioid
268993|NCT02012192|undifferentiated|undifferentiated
268994|NCT02012179|Diet|diet
268995|NCT02012179|Dietary sodium reduction|dietary sodium reduction
268996|NCT02012179|Salt restriction|salt restriction
268997|NCT02012179|Nutrition|nutrition
268998|NCT02012166|Diabetes Mellitus|diabetes mellitus
268999|NCT02012166|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
269000|NCT02012166|Glucose Metabolism Disorders|glucose metabolism disorders
269001|NCT02012166|Metabolic Diseases|metabolic diseases
269002|NCT02012166|Endocrine System Diseases|endocrine system diseases
269003|NCT02012166|Therapeutic Uses|therapeutic uses
269004|NCT02012166|Pharmacologic Actions|pharmacologic actions
269005|NCT02012166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
269006|NCT02012166|Physiological Effects of Drugs|physiological effects of drugs
269007|NCT02012153|Mesenchymal stromal cells|mesenchymal stromal cells
269008|NCT02012153|Kidney transplantation|kidney transplantation
269009|NCT02012153|Tolerance|tolerance
269010|NCT02012114|Cystinosis, compliance, cysteamine, neurological assessments|cystinosis, compliance, cysteamine, neurological assessments
269011|NCT02012101|COPD|copd
269012|NCT02012101|dyspnea|dyspnea
269013|NCT02012101|exercise|exercise
269014|NCT02012101|Noninvasive Ventilation|noninvasive ventilation
269015|NCT02012088|Follicular lymphoma, large B-cell lymphoma|follicular lymphoma, large b-cell lymphoma
269016|NCT02012062|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
269017|NCT02012062|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
269018|NCT02012062|Concurrent chemotherapy|concurrent chemotherapy
269019|NCT02012062|Nimotuzumab|nimotuzumab
269020|NCT02012049|Healthy|healthy
269021|NCT02012049|Risperdal OD|risperdal od
269022|NCT02012049|Risperdal Quicklet|risperdal quicklet
269023|NCT02012049|Korea|korea
269024|NCT02012023|Low anterior resection|low anterior resection
269025|NCT02012023|Anastomotic leakage|anastomotic leakage
269026|NCT02012023|Defunctioning stoma|defunctioning stoma
269027|NCT02012023|Controllable tube ileostomy|controllable tube ileostomy
269028|NCT02012023|Loop ileostomy|loop ileostomy
269029|NCT02012010|hysteroscopy, water intoxication, hyponatremia|hysteroscopy, water intoxication, hyponatremia
269030|NCT02011971|epilepsy|epilepsy
269031|NCT02011971|cognition|cognition
269032|NCT02011971|memory|memory
269033|NCT02011958|Visceral Leishmaniasis|visceral leishmaniasis
269034|NCT02011958|HIV positive patients|hiv positive patients
269035|NCT02011958|Phase III trial|phase iii trial
269036|NCT02011958|Randomised|randomised
269037|NCT02011958|Liposomal amphotericin B|liposomal amphotericin b
269038|NCT02011958|Ambisome|ambisome
269039|NCT02011958|Miltefosine|miltefosine
269040|NCT02011958|Pentamidine|pentamidine
269041|NCT02011958|Efficacy|efficacy
269042|NCT02011958|Safety|safety
269043|NCT02011906|antioxidant enzymes|antioxidant enzymes
269044|NCT02011906|omega 3|omega 3
269045|NCT02011906|vitamin E|vitamin e
269046|NCT02011906|CAD|cad
269047|NCT02011906|Sirtuins|sirtuins
269048|NCT02011906|FOXOs|foxos
269049|NCT02011880|breast cancer|breast cancer
269050|NCT02011880|bone metastasis|bone metastasis
269051|NCT02011880|traditional Chinese medicine(TCM)|traditional chinese medicine(tcm)
269052|NCT02011867|Inner Ear Malformations|inner ear malformations
269053|NCT02011867|Gusher|gusher
269054|NCT02011867|Cochlear Implantation|cochlear implantation
269055|NCT02011854|acupuncture，rehabilitation,Shoulder-hand Syndrome|acupuncture，rehabilitation,shoulder-hand syndrome
269056|NCT02011841|liver cirrhosis|liver cirrhosis
269057|NCT02011841|ascites|ascites
269058|NCT02011841|spontaneous bacterial peritonitis|spontaneous bacterial peritonitis
269059|NCT02011841|recurrence|recurrence
269060|NCT02011828|Hemodialysis, paricalcitol|hemodialysis, paricalcitol
269061|NCT02011815|Breast neoplasms|breast neoplasms
269062|NCT02011815|Circadian rhythm|circadian rhythm
269063|NCT02011815|sleep|sleep
269064|NCT02011815|survival|survival
269066|NCT02011815|anxiety|anxiety
269067|NCT02011815|depression|depression
269068|NCT02011815|quality of life|quality of life
269069|NCT02011815|actigraph|actigraph
269070|NCT02011815|fatigue|fatigue
269071|NCT02011802|Sorbact TM|sorbact tm
269072|NCT02011802|Alginates|alginates
269073|NCT02011802|Dressing|dressing
269074|NCT02011802|Wound healing|wound healing
269075|NCT02011789|hypercholesterolemia|hypercholesterolemia
269076|NCT02011789|inflammation|inflammation
269077|NCT02011789|citrus limonoids|citrus limonoids
269078|NCT02011776|Corticosteroids Dry Eye Sjögren syndrome inflammation treatment|corticosteroids dry eye sjögren syndrome inflammation treatment
269079|NCT02011763|Hepatitis A|hepatitis a
269080|NCT02011763|hepatitis A virus|hepatitis a virus
269081|NCT02011763|Avaxim® 80U Pediatric|avaxim® 80u pediatric
269082|NCT02011750|schizophrenia|schizophrenia
269083|NCT02011750|toxoplasmosis|toxoplasmosis
269084|NCT02011737|Medical Expulsive therapy|medical expulsive therapy
269085|NCT02011698|Groin hernia|groin hernia
269086|NCT02011698|lichtenstein herniorrhaphy|lichtenstein herniorrhaphy
269087|NCT02011672|dairy|dairy
269088|NCT02011672|glucose|glucose
269089|NCT02011672|inflammation|inflammation
269090|NCT02011659|Ramosetron, postoperative nausea and vomiting, laparoscopy|ramosetron, postoperative nausea and vomiting, laparoscopy
269091|NCT02011646|diet|diet
269092|NCT02011646|body weight|body weight
269093|NCT02011646|eating|eating
269094|NCT02011646|eating disorder|eating disorder
269095|NCT02011646|exercise|exercise
269096|NCT02011581|Overweight|overweight
269097|NCT02011568|Therapeutic Hypothermia|therapeutic hypothermia
269098|NCT02011568|Out of hospital cardiac arrest|out of hospital cardiac arrest
269099|NCT02011568|Mild hypothermia|mild hypothermia
269100|NCT02011568|Moderate hypothermia|moderate hypothermia
269101|NCT02011542|Irritable Bowel Syndrome|irritable bowel syndrome
269102|NCT02011542|Gulf War Illness|gulf war illness
269103|NCT02011516|Marijuana|marijuana
269104|NCT02011516|Addiction|addiction
269105|NCT02011516|fMRI|fmri
269106|NCT02011516|Baclofen|baclofen
269107|NCT02011516|Treatment|treatment
269108|NCT02011477|Neural mobilization|neural mobilization
269109|NCT02011477|Physical therapy|physical therapy
269110|NCT02011477|Asymptomatic subjects|asymptomatic subjects
269111|NCT02011451|Multiple Sclerosis|multiple sclerosis
269112|NCT02011451|Green Tea|green tea
269113|NCT02011451|ECGC|ecgc
269114|NCT02011451|Theaphenon|theaphenon
269115|NCT02011451|Randomized placebo controlled trial|randomized placebo controlled trial
269116|NCT02011451|NAA|naa
269117|NCT02011451|Spectroscopy|spectroscopy
269118|NCT02011451|Brain Atrophy|brain atrophy
269119|NCT02011451|SIENA|siena
269120|NCT02011438|Social Anxiety|social anxiety
269121|NCT02011438|Prevention|prevention
269122|NCT02011438|Peer Relations|peer relations
269123|NCT02011438|Depression|depression
269124|NCT02011438|Adolescent|adolescent
269125|NCT02011438|High School|high school
269126|NCT02011438|Interpersonal|interpersonal
269127|NCT02011438|Peer Victimization|peer victimization
269128|NCT02011425|obstructive sleep apnea|obstructive sleep apnea
269129|NCT02011425|oral appliance|oral appliance
269130|NCT02011425|therapy|therapy
269131|NCT02011425|masseter muscle activity|masseter muscle activity
269132|NCT02011425|randomized controlled trial|randomized controlled trial
269133|NCT02011425|mandibular advancement device|mandibular advancement device
269134|NCT02011425|mandibular advancement appliance|mandibular advancement appliance
269135|NCT02011425|arousals|arousals
269136|NCT02011412|Trauma|trauma
269137|NCT02011412|Scoring Systems|scoring systems
269138|NCT02011412|Intermountain Risk Score|intermountain risk score
269139|NCT02011399|brain|brain
269140|NCT02011399|computer|computer
269141|NCT02011399|interfaces|interfaces
269142|NCT02011399|mobility impairments|mobility impairments
269143|NCT02011373|prolapse, laparoscopic sacrocolpopexy, IFABONDTM glue|prolapse, laparoscopic sacrocolpopexy, ifabondtm glue
269144|NCT02011360|Prader Willi syndrome|prader willi syndrome
269145|NCT02011360|childhood obesity|childhood obesity
269146|NCT02011360|ghrelin|ghrelin
269147|NCT02011360|appetite regulation|appetite regulation
269148|NCT02011321|subarachnoid hemorrhage|subarachnoid hemorrhage
269149|NCT02011321|aneurysm|aneurysm
269150|NCT02011321|vasospasm|vasospasm
269151|NCT02011321|clevidipine|clevidipine
269152|NCT02011321|transcranial dopplers|transcranial dopplers
269154|NCT02011295|Surgical Intervention|surgical intervention
269155|NCT02011295|BMAC|bmac
269156|NCT02011282|ICU,|icu,
269157|NCT02011282|MYOPATHY,|myopathy,
269158|NCT02011282|NEUROPATHY,|neuropathy,
269159|NCT02011282|PNEUMONIA|pneumonia
269160|NCT02011269|TSO|tso
269161|NCT02011269|Ova|ova
269162|NCT02011269|Psoriasis|psoriasis
269163|NCT02011269|plaque psoriasis|plaque psoriasis
269164|NCT02011269|plaque-type|plaque-type
269165|NCT02011269|Coronado|coronado
269166|NCT02011269|Moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
269167|NCT02011256|Transient Ischemic Attack|transient ischemic attack
269168|NCT02011256|Atrial Fibrillation|atrial fibrillation
269169|NCT02011256|NOTICE|notice
269170|NCT02011256|Implantable loop-recorder|implantable loop-recorder
269171|NCT02011256|Holter-monitoring|holter-monitoring
269172|NCT02011243|deficit|deficit
269173|NCT02011243|internal rotation|internal rotation
269174|NCT02011243|gleno humeral articulation|gleno humeral articulation
269175|NCT02011243|hand ball|hand ball
269176|NCT02011230|Dehydration|dehydration
269177|NCT02011230|Hoist|hoist
269178|NCT02011230|pain control|pain control
269179|NCT02011230|The intervention is to provide a commercially available isotonic hydration solution (Hoist®) to the patients.|the intervention is to provide a commercially available isotonic hydration solution (hoist®) to the patients.
269180|NCT02011230|Patients will drink this solution post procedure as needed.|patients will drink this solution post procedure as needed.
269181|NCT02011230|Patients in the control group will use their discretion to drink any solution they feel suitable|patients in the control group will use their discretion to drink any solution they feel suitable
269182|NCT02011217|Rye|rye
269183|NCT02011217|Dietary Fibre|dietary fibre
269184|NCT02011217|Bread|bread
269185|NCT02011217|Crisp bread|crisp bread
269186|NCT02011217|Appetite|appetite
269187|NCT02011217|Satiety|satiety
269188|NCT02011217|Hunger|hunger
269189|NCT02011217|Desire to eat|desire to eat
269190|NCT02011217|Metabolism|metabolism
269191|NCT02011217|Glucose|glucose
269192|NCT02011217|Insulin|insulin
269193|NCT02011217|Gut hormones|gut hormones
269194|NCT02011217|Gastric emptying rate|gastric emptying rate
269195|NCT02011191|Biotin|biotin
269196|NCT02011191|Restless|restless
269197|NCT02011191|Kidney|kidney
269198|NCT02011191|Dialysis|dialysis
269199|NCT02011191|Renal|renal
269200|NCT02011165|Macular hole|macular hole
269201|NCT02011165|Vitrectomy|vitrectomy
269202|NCT02011165|Gas tamponade|gas tamponade
269203|NCT02011165|Vitreomacular traction in danger of macular hole formation|vitreomacular traction in danger of macular hole formation
269204|NCT02011165|Epiretinal membrane in danger of macular hole formation|epiretinal membrane in danger of macular hole formation
269205|NCT02011113|Pomalidomide,|pomalidomide,
269206|NCT02011113|CC-4047,|cc-4047,
269207|NCT02011113|Dexamethasone,|dexamethasone,
269208|NCT02011113|Relapsed and refractory multiple myeloma,|relapsed and refractory multiple myeloma,
269209|NCT02011113|phase 2|phase 2
269210|NCT02011061|Multidetector Computed Tomography|multidetector computed tomography
269211|NCT02011061|Coronary Stenosis|coronary stenosis
269212|NCT02011061|Coronary Artery Disease|coronary artery disease
269213|NCT02011061|Angina Pectoris|angina pectoris
269214|NCT02011035|Oral health|oral health
269215|NCT02011035|Mouth health|mouth health
269216|NCT02011035|Halitosis|halitosis
269217|NCT02011035|Oral bacteria|oral bacteria
269218|NCT02011035|Sore throat|sore throat
269219|NCT02011035|Colds|colds
269220|NCT02011022|Methotrexate,|methotrexate,
269221|NCT02011022|Pharmacokinetic|pharmacokinetic
269222|NCT02011022|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
269223|NCT02011022|Model|model
269224|NCT02010970|phase I|phase i
269225|NCT02010970|healthy volunteers|healthy volunteers
269226|NCT02010970|AZD3293|azd3293
269227|NCT02010970|itraconazole|itraconazole
269228|NCT02010970|diltiazem|diltiazem
269229|NCT02010970|medazolam|medazolam
269230|NCT02010970|drug interactions|drug interactions
269231|NCT02010970|Pharmacokinetics|pharmacokinetics
269232|NCT02010957|123I Iodometomidate imaging|123i iodometomidate imaging
269233|NCT02010957|18F FDG positron emission tomography|18f fdg positron emission tomography
269234|NCT02010957|Adrenal tumour|adrenal tumour
269235|NCT02010944|Solifenacin|solifenacin
269236|NCT02010944|Mirabegron|mirabegron
269237|NCT02010944|Fixed-dose combination (FDC)|fixed-dose combination (fdc)
269238|NCT02010944|Single Entity Tablet (SET)|single entity tablet (set)
269239|NCT02010944|Pharmacokinetics|pharmacokinetics
269240|NCT02010944|Bioavailability|bioavailability
269241|NCT02010918|Knee Osteoarthritis;|knee osteoarthritis;
269242|NCT02010918|Glucosamine;|glucosamine;
269243|NCT02010918|Chondroitin.|chondroitin.
269244|NCT02010905|Losartan|losartan
269245|NCT02010879|patent ductus arterioses|patent ductus arterioses
269246|NCT02010879|ductal closure|ductal closure
269247|NCT02010879|thrombocyte|thrombocyte
269248|NCT02010866|internship and residency|internship and residency
269249|NCT02010866|physicians|physicians
269250|NCT02010866|prevention|prevention
269251|NCT02010866|counseling|counseling
269252|NCT02010866|suicide|suicide
269253|NCT02010866|depression|depression
269254|NCT02010866|burnout|burnout
269255|NCT02010853|Transient Global amnesia|transient global amnesia
269256|NCT02010853|fMRI|fmri
269257|NCT02010853|resting state|resting state
269258|NCT02010840|Depressive symptoms, marital relationship, quality of life|depressive symptoms, marital relationship, quality of life
269259|NCT02010827|Diabetes mellitus|diabetes mellitus
269260|NCT02010827|Glucagon|glucagon
269261|NCT02010827|Endogenous glucose production|endogenous glucose production
269262|NCT02010827|Incretin hormones|incretin hormones
269263|NCT02010814|PCOS|pcos
269264|NCT02010814|Inflammation|inflammation
269265|NCT02010814|Body Composition|body composition
269266|NCT02010801|hepatocellular carcinoma|hepatocellular carcinoma
269267|NCT02010801|irreversible electroporation|irreversible electroporation
269268|NCT02010801|liver cancer|liver cancer
269269|NCT02010762|Crohn's disease|crohn's disease
269270|NCT02010762|Vitamin D|vitamin d
269271|NCT02010762|Postoperative|postoperative
269272|NCT02010762|Recurrence|recurrence
269273|NCT02010762|Inflammatory bowel disease|inflammatory bowel disease
269274|NCT02010762|Gastroenteritis|gastroenteritis
269275|NCT02010762|Gastrointestinal Diseases|gastrointestinal diseases
269276|NCT02010762|Digestive System Diseases|digestive system diseases
269277|NCT02010762|Colonic Diseases|colonic diseases
269278|NCT02010762|Intestinal Diseases|intestinal diseases
269279|NCT02010762|Pathologic Processes|pathologic processes
269280|NCT02010736|Cerebral palsy|cerebral palsy
269281|NCT02010736|Gait|gait
269282|NCT02010736|Weight Bearing|weight bearing
269283|NCT02010736|Rehabilitation|rehabilitation
269284|NCT02010723|varicosis|varicosis
269285|NCT02010723|foam sclerotherapy|foam sclerotherapy
269286|NCT02010723|surgery|surgery
269287|NCT02010710|continuous electronic fetal monitoring|continuous electronic fetal monitoring
269288|NCT02010710|labour|labour
269289|NCT02010710|pregnancy|pregnancy
269290|NCT02010710|fetal distress|fetal distress
269291|NCT02010697|smoking cessation|smoking cessation
269292|NCT02010697|nonsmokers|nonsmokers
269293|NCT02010697|proxy|proxy
269294|NCT02010697|mail intervention|mail intervention
269295|NCT02010697|self-help|self-help
269296|NCT02010697|behavioral intervention|behavioral intervention
269297|NCT02010684|Diabetes|diabetes
269298|NCT02010684|Depression|depression
269299|NCT02010684|Self care|self care
269300|NCT02010684|Empowerment|empowerment
269301|NCT02010684|Behavioral intervention|behavioral intervention
269302|NCT02010684|Cognitive behavioral therapy|cognitive behavioral therapy
269303|NCT02010684|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
269304|NCT02010671|Pregnancy|pregnancy
269305|NCT02010671|Cesarean Section|cesarean section
269306|NCT02010671|Survey|survey
269307|NCT02010671|Delivery|delivery
269308|NCT02010645|Leukemia|leukemia
269309|NCT02010645|Advanced Myelodysplastic Syndrome|advanced myelodysplastic syndrome
269310|NCT02010645|MDS|mds
269311|NCT02010645|Intermediate-2 Myelodysplastic Syndrome|intermediate-2 myelodysplastic syndrome
269312|NCT02010645|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
269313|NCT02010645|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
269314|NCT02010645|CMML|cmml
269315|NCT02010645|Eltrombopag|eltrombopag
269316|NCT02010645|Promacta|promacta
269317|NCT02010645|Decitabine|decitabine
269318|NCT02010645|Dacogen|dacogen
269319|NCT02010632|Clopidogrel|clopidogrel
269320|NCT02010632|Platelet inhibition|platelet inhibition
269321|NCT02010632|Platelet aggregation|platelet aggregation
269322|NCT02010606|Newly diagnosed glioblastoma|newly diagnosed glioblastoma
269323|NCT02010606|Recurrent glioblastoma|recurrent glioblastoma
269324|NCT02010606|Dendritic cell vaccine|dendritic cell vaccine
269325|NCT02010606|Immunotherapy|immunotherapy
269326|NCT02010606|Cancer stem cells|cancer stem cells
269327|NCT02010606|Glioma stem cells|glioma stem cells
269328|NCT02010606|Glioma stem-like cells|glioma stem-like cells
269329|NCT02010606|Cancer stem-like cells|cancer stem-like cells
269330|NCT02010606|Neurosphere|neurosphere
269331|NCT02010606|Therapeutic Uses|therapeutic uses
269332|NCT02010606|Antineoplastic Agents|antineoplastic agents
269333|NCT02010606|Neoplasms|neoplasms
269334|NCT02010606|Immunologic Factors|immunologic factors
269335|NCT02010606|Interferon Inducers|interferon inducers
269336|NCT02010606|Physiological Effects of Drugs|physiological effects of drugs
269337|NCT02010606|Pharmacologic Actions|pharmacologic actions
269338|NCT02010567|rectal cancer|rectal cancer
269339|NCT02010567|colorectal cancer|colorectal cancer
269340|NCT02010567|locally advanced rectal cancer|locally advanced rectal cancer
269341|NCT02010567|locally advanced rectal cancer (resectable)|locally advanced rectal cancer (resectable)
269342|NCT02010567|locally advanced rectal cancer (non-resectable)|locally advanced rectal cancer (non-resectable)
269343|NCT02010567|chemoradiotherapy|chemoradiotherapy
269344|NCT02010567|nanopharmaceutical|nanopharmaceutical
269345|NCT02010567|CLRX101|clrx101
269346|NCT02010567|camptothecin|camptothecin
269347|NCT02010567|capecitabine|capecitabine
269348|NCT02010554|Multiple Sclerosis|multiple sclerosis
269349|NCT02010554|Disease modifying medication|disease modifying medication
269350|NCT02010554|Relapsing-Remitting MS|relapsing-remitting ms
269351|NCT02010554|Motivational Interviewing|motivational interviewing
269352|NCT02010554|Telephone Counseling|telephone counseling
269353|NCT02010541|type 1 diabetes among young children, sensor, insulin pump, education, psychological support|type 1 diabetes among young children, sensor, insulin pump, education, psychological support
269354|NCT02010528|Diabetes related distress, children, T1D, family hardiness, psychological well-being|diabetes related distress, children, t1d, family hardiness, psychological well-being
269355|NCT02010515|sudden cardiac death|sudden cardiac death
269356|NCT02010515|risk stratification|risk stratification
269357|NCT02010515|t-wave alternans|t-wave alternans
269358|NCT02010515|Holter electrocardiography|holter electrocardiography
269359|NCT02010515|heart rate turbulence|heart rate turbulence
269360|NCT02010502|Beet root|beet root
269361|NCT02010502|exercise performance|exercise performance
269362|NCT02010502|cyclists|cyclists
269363|NCT02010489|Bariatric Surgery|bariatric surgery
269364|NCT02010489|Exercise|exercise
269365|NCT02010489|Physical Fitness|physical fitness
269366|NCT02010476|Alzheimer's disease, CSF biomarkers, Insulin resistance|alzheimer's disease, csf biomarkers, insulin resistance
269367|NCT02010463|reward processing|reward processing
269368|NCT02010463|impulse control|impulse control
269369|NCT02010463|obese|obese
269370|NCT02010463|clinically obese|clinically obese
269371|NCT02010450|Sudden Infant Death Syndrome|sudden infant death syndrome
269372|NCT02010450|SIDS|sids
269373|NCT02010450|safe sleep|safe sleep
269374|NCT02010450|safe sleep message|safe sleep message
269375|NCT02010437|Superficial Venous Insufficiency|superficial venous insufficiency
269376|NCT02010424|reduced fertility|reduced fertility
269377|NCT02010398|Resistance training/methods|resistance training/methods
269378|NCT02010398|contralateral strength training|contralateral strength training
269379|NCT02010398|ipsilateral strength training|ipsilateral strength training
269380|NCT02010398|Isokinetic contraction|isokinetic contraction
269381|NCT02010398|Adaptation, Physiological/physiology|adaptation, physiological/physiology
269382|NCT02010398|Electromyography/methods|electromyography/methods
269383|NCT02010398|Transcranial Magnetic Stimulation/methods|transcranial magnetic stimulation/methods
269384|NCT02010398|Evoked Potentials, Motor|evoked potentials, motor
269385|NCT02010385|RYGB|rygb
269386|NCT02010385|Bariatric surgery|bariatric surgery
269387|NCT02010385|Taste|taste
269388|NCT02010385|Reward|reward
269389|NCT02010385|Food behaviour|food behaviour
269390|NCT02010385|Gut hormones|gut hormones
269391|NCT02010372|Immunization Registry|immunization registry
269392|NCT02010372|Human Papillomavirus|human papillomavirus
269393|NCT02010346|Early orthodontic treatment|early orthodontic treatment
269394|NCT02010346|Class II treatment|class ii treatment
269395|NCT02010346|Orthodontic treatment outcome|orthodontic treatment outcome
269396|NCT02010320|population model|population model
269397|NCT02010320|pharmacokinetic|pharmacokinetic
269398|NCT02010320|tacrolimus|tacrolimus
269399|NCT02010320|therapeutic drug monitoring|therapeutic drug monitoring
269400|NCT02010320|individualized dosing|individualized dosing
269401|NCT02010294|Invasive GAS infection|invasive gas infection
269402|NCT02010294|emm genotypes|emm genotypes
269403|NCT02010294|Bacterial virulence factors|bacterial virulence factors
269404|NCT02010294|Mendelian susceptibility to infections|mendelian susceptibility to infections
269405|NCT02010281|rTMS|rtms
269406|NCT02010281|peripheral neuropathic pain|peripheral neuropathic pain
269407|NCT02010281|randomized controlled trial|randomized controlled trial
269408|NCT02010268|Faecal calprotectin|faecal calprotectin
269409|NCT02010268|Feces|feces
269410|NCT02010268|Preterm neonates|preterm neonates
269411|NCT02010268|Enterocolitis|enterocolitis
269412|NCT02010268|Enteropathy|enteropathy
269413|NCT02010268|Necrotizing|necrotizing
269414|NCT02010242|Type 2 diabetes|type 2 diabetes
269415|NCT02010242|Proteinuria|proteinuria
269416|NCT02010242|Albuminuria|albuminuria
269417|NCT02010229|Placenta accreta|placenta accreta
269418|NCT02010229|previous caesarean|previous caesarean
269419|NCT02010229|placenta praevia|placenta praevia
269420|NCT02010229|severe obstetric haemorrhage|severe obstetric haemorrhage
269421|NCT02010229|population-based study|population-based study
269422|NCT02010203|TURBT|turbt
269423|NCT02010203|Bladder|bladder
269424|NCT02010203|Cancer|cancer
269425|NCT02010203|GP96|gp96
269426|NCT02010203|Vaccine|vaccine
269427|NCT02010203|Immunotherapy|immunotherapy
269428|NCT02010203|Heat Biologics|heat biologics
269429|NCT02010203|BCG|bcg
269430|NCT02010203|Bacillus Calmette-Guerin|bacillus calmette-guerin
269431|NCT02010203|Bacillus Calmette-Guérin|bacillus calmette-guérin
269432|NCT02010190|Pediatric malignancies|pediatric malignancies
269433|NCT02010190|Cancer survivors|cancer survivors
269434|NCT02010190|Coronary artery risk|coronary artery risk
269435|NCT02010190|Vascular function|vascular function
269436|NCT02010190|Cardiovascular risk in survivors of pediatric cancer|cardiovascular risk in survivors of pediatric cancer
269437|NCT02010164|Reproductive aging|reproductive aging
269438|NCT02010164|Mitochondria|mitochondria
269439|NCT02010151|Out of Hospital Cardiac Arrest|out of hospital cardiac arrest
269440|NCT02010151|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
269441|NCT02010151|dispatch|dispatch
269442|NCT02010151|emergency medicine|emergency medicine
269443|NCT02010138|Internal Limiting Membrane|internal limiting membrane
269444|NCT02010138|Metamorphopsia|metamorphopsia
269445|NCT02010125|Anterior Cruciate Ligament (ACL)|anterior cruciate ligament (acl)
269446|NCT02010125|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
269447|NCT02010125|Osteoarthritis (OA)|osteoarthritis (oa)
269448|NCT02010125|Bio-specimens|bio-specimens
269449|NCT02010125|Acute ACL Injury|acute acl injury
269450|NCT02010125|Arthritis Foundation (AF)|arthritis foundation (af)
269451|NCT02010112|H.Pylori|h.pylori
269452|NCT02010086|Intervention|intervention
269453|NCT02010086|Autism|autism
269454|NCT02010086|Treatment sensitivity|treatment sensitivity
269455|NCT02010086|School aged|school aged
269456|NCT02010086|Cognitive behavioral therapy|cognitive behavioral therapy
269457|NCT02010086|Social Skills Intervention|social skills intervention
269458|NCT02010073|Lung|lung
269459|NCT02010073|ARDS|ards
269460|NCT02010073|acute|acute
269461|NCT02010073|respiratory|respiratory
269462|NCT02010073|syndrome|syndrome
269463|NCT02010073|prognosis|prognosis
269464|NCT02010073|outcome research|outcome research
269465|NCT02010073|respiratory infection|respiratory infection
269466|NCT02010073|sepsis|sepsis
269467|NCT02010073|organ failure|organ failure
269468|NCT02010073|hypoxaemia|hypoxaemia
269469|NCT02010060|Exercise training|exercise training
269470|NCT02010060|Non-exercise physical activity|non-exercise physical activity
269471|NCT02010060|pedometers|pedometers
269472|NCT02010047|Anaplastic lymphoma kinase gene|anaplastic lymphoma kinase gene
269473|NCT02010047|Polymerase chain reaction|polymerase chain reaction
269474|NCT02010047|Immunohistochemistry|immunohistochemistry
269475|NCT02010047|Fluorescence in situ hybridization|fluorescence in situ hybridization
269476|NCT02010034|TPN|tpn
269477|NCT02010034|Liver Function|liver function
269478|NCT02010034|parenteral nutritional fat emulsions|parenteral nutritional fat emulsions
269479|NCT02010021|breast cancer|breast cancer
269480|NCT02010021|postmenopausal|postmenopausal
269481|NCT02010021|letrozole|letrozole
269482|NCT02010021|RAD001|rad001
269483|NCT02010021|Everolimus|everolimus
269484|NCT02010008|breast cancer|breast cancer
269485|NCT02010008|cancer disparities|cancer disparities
269486|NCT02010008|Latino women|latino women
269487|NCT02010008|Hispanic women|hispanic women
269488|NCT02010008|mammography|mammography
269489|NCT02010008|multi-level intervention|multi-level intervention
269490|NCT02009995|Diabetes Mellitus|diabetes mellitus
269491|NCT02009995|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
269492|NCT02009995|Resistance Training|resistance training
269493|NCT02009995|Resistance Exercise|resistance exercise
269494|NCT02009995|Resistance Band|resistance band
269495|NCT02009995|Thera-band|thera-band
269496|NCT02009995|elastic band|elastic band
269497|NCT02009995|exercise band|exercise band
269498|NCT02009982|Fainting|fainting
269499|NCT02009982|Ablation|ablation
269500|NCT02009982|Cardiology|cardiology
269501|NCT02009982|Cardiac Electrophysiology|cardiac electrophysiology
269502|NCT02009969|Psychosis|psychosis
269503|NCT02009969|Adverse effects|adverse effects
269504|NCT02009969|Symptom Severity|symptom severity
269505|NCT02009969|Magnetic Resonance Imaging|magnetic resonance imaging
269506|NCT02009943|critical illness|critical illness
269507|NCT02009943|iron supplementation|iron supplementation
269508|NCT02009943|functional iron deficiency|functional iron deficiency
269509|NCT02009943|ICU anemia|icu anemia
269510|NCT02009943|red blood cell transfusion|red blood cell transfusion
269511|NCT02009930|Enlisted military members|enlisted military members
269512|NCT02009930|CAC|cac
269513|NCT02009930|Coronary Artery Calcium|coronary artery calcium
269514|NCT02009930|Cardiovascular|cardiovascular
269515|NCT02009917|Indicator Amino Acid Oxidation|indicator amino acid oxidation
269516|NCT02009917|Non essential Amino acids|non essential amino acids
269517|NCT02009917|Protein|protein
269518|NCT02009917|Amino acid|amino acid
269519|NCT02009904|PKU|pku
269520|NCT02009904|Phenylketonuria|phenylketonuria
269521|NCT02009904|Phenylalanine|phenylalanine
269522|NCT02009904|Children|children
269523|NCT02009904|Stable isotopes|stable isotopes
269524|NCT02009904|Sapropterin dihydrochloride responsiveness|sapropterin dihydrochloride responsiveness
269525|NCT02009891|predictive model|predictive model
269526|NCT02009891|in vitro fertilization|in vitro fertilization
269527|NCT02009891|elective single embryo transfer|elective single embryo transfer
269528|NCT02009878|SIADH|siadh
269529|NCT02009865|Hypertriglyceridemia|hypertriglyceridemia
269530|NCT02009865|Dyslipidemia|dyslipidemia
269531|NCT02009865|Eicosapentaenoic acid|eicosapentaenoic acid
269532|NCT02009865|EPA|epa
269533|NCT02009865|Docosahexaenoic acid|docosahexaenoic acid
269534|NCT02009865|DHA|dha
269535|NCT02009852|microRNA-29b|microrna-29b
269536|NCT02009852|Oral squamous cell carcinoma|oral squamous cell carcinoma
269537|NCT02009852|migration|migration
269538|NCT02009852|prognosis|prognosis
269539|NCT02009839|anxiety|anxiety
269540|NCT02009839|frequency of speech|frequency of speech
269541|NCT02009839|selective mutism|selective mutism
269542|NCT02009826|Schizophrenia|schizophrenia
269543|NCT02009826|Psychosis|psychosis
269544|NCT02009826|Neuroinflammation|neuroinflammation
269545|NCT02009826|Microglial activation|microglial activation
269546|NCT02009813|Insulin resistance|insulin resistance
269547|NCT02009813|Inflammation|inflammation
269548|NCT02009813|Hypoxia|hypoxia
269549|NCT02009787|hypercholesterolemia; vitamin D; adjuvant therapy|hypercholesterolemia; vitamin d; adjuvant therapy
269550|NCT02009774|Colonoscopy|colonoscopy
269551|NCT02009774|Adenoma detection rate|adenoma detection rate
269552|NCT02009774|Narrow band imaging|narrow band imaging
269553|NCT02009774|Optical biopsy|optical biopsy
269554|NCT02009774|Accuracy|accuracy
269555|NCT02009735|Enterovirus 71 and Influenza Virus|enterovirus 71 and influenza virus
269556|NCT02009722|Cesarean Delivery|cesarean delivery
269557|NCT02009722|Intrathecal Morphine|intrathecal morphine
269558|NCT02009722|Intrathecal Hydromorphone|intrathecal hydromorphone
269559|NCT02009722|Obstetrical Analgesia|obstetrical analgesia
269560|NCT02009722|Spinal Anesthesia|spinal anesthesia
269561|NCT02009709|keratoconus|keratoconus
269562|NCT02009709|collagen crosslinking|collagen crosslinking
269563|NCT02009709|crosslinking|crosslinking
269564|NCT02009709|ectasia|ectasia
269565|NCT02009644|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
269566|NCT02009644|AAA|aaa
269567|NCT02009644|Aneurysm|aneurysm
269568|NCT02009631|Solid Tumors|solid tumors
269569|NCT02009631|Ovarian Cancer|ovarian cancer
269570|NCT02009631|Colon Cancer|colon cancer
269571|NCT02009631|Lung Cancer|lung cancer
269572|NCT02009631|Breast Cancer|breast cancer
269573|NCT02009631|Gastric Cancer|gastric cancer
269574|NCT02009618|IBS|ibs
269575|NCT02009618|Rifaximin|rifaximin
269576|NCT02009605|icotinib, SCC|icotinib, scc
269577|NCT02009592|Hepatosteatosis|hepatosteatosis
269578|NCT02009592|Steatohepatitis|steatohepatitis
269579|NCT02009592|Rifaximin|rifaximin
269580|NCT02009592|Inflammatory cytokines|inflammatory cytokines
269581|NCT02009579|Uterine Cervical Cancer|uterine cervical cancer
269582|NCT02009579|Paclitaxel|paclitaxel
269583|NCT02009579|Carboplatin|carboplatin
269584|NCT02009579|Nintedanib|nintedanib
269585|NCT02009553|Anxiety|anxiety
269586|NCT02009553|Urodynamics|urodynamics
269587|NCT02009514|Hemodialysis|hemodialysis
269588|NCT02009514|Continuous glucose monitoring|continuous glucose monitoring
269589|NCT02009514|Hypoglycemia|hypoglycemia
269590|NCT02009514|Hyperglycemia|hyperglycemia
269591|NCT02009501|Infected wounds|infected wounds
269592|NCT02009501|NPWTi|npwti
269593|NCT02009501|VAC Instill|vac instill
269594|NCT02009501|Biofilm|biofilm
269595|NCT02009488|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
269596|NCT02009488|Metformin|metformin
269597|NCT02009488|Canagliflozin|canagliflozin
269598|NCT02009488|INVOKANA®|invokana®
269599|NCT02009488|Insulin sensitivity|insulin sensitivity
269600|NCT02009488|DPP-4 inhibitor|dpp-4 inhibitor
269601|NCT02009488|dipeptidyl peptidase-4|dipeptidyl peptidase-4
269602|NCT02009475|Rehabilitation|rehabilitation
269603|NCT02009475|Exercise Training|exercise training
269604|NCT02009475|Interval training|interval training
269605|NCT02009462|HIV|hiv
269606|NCT02009462|Facial lipoatrophy|facial lipoatrophy
269607|NCT02009449|Phase 1/Phase 1b|phase 1/phase 1b
269608|NCT02009449|Oncology|oncology
269609|NCT02009449|Cancer|cancer
269610|NCT02009449|Solid Tumors|solid tumors
269611|NCT02009423|Gastro-Intestinal Stromal Tumour, GIST, localized primary tumor, complete surgery, adjuvant therapy.|gastro-intestinal stromal tumour, gist, localized primary tumor, complete surgery, adjuvant therapy.
269612|NCT02009410|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
269613|NCT02009358|mental health promotion|mental health promotion
269614|NCT02009358|depression|depression
269615|NCT02009358|migrant workers|migrant workers
269616|NCT02009358|China|china
269617|NCT02009345|Familial hypercholesterolemia,|familial hypercholesterolemia,
269618|NCT02009345|High LDL-cholesterol|high ldl-cholesterol
269619|NCT02009345|Registry|registry
269620|NCT02009345|Coronary artery disease|coronary artery disease
269621|NCT02009319|endobronchial ultrasound|endobronchial ultrasound
269622|NCT02009319|EBUS - TBNA|ebus - tbna
269623|NCT02009319|elastography|elastography
269624|NCT02009319|strain ratio|strain ratio
269625|NCT02009319|lung cancer staging|lung cancer staging
269626|NCT02009306|Palliative|palliative
269627|NCT02009306|Symptom control|symptom control
269628|NCT02009306|Hospice|hospice
269629|NCT02009306|Opioid|opioid
269630|NCT02009306|Benzodiazepine|benzodiazepine
269631|NCT02009293|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
269632|NCT02009293|cough|cough
269633|NCT02009293|quality of life|quality of life
269634|NCT02009280|Propofol|propofol
269635|NCT02009280|Lung transplantation|lung transplantation
269636|NCT02009280|Extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
269637|NCT02009280|Acute kidney injury|acute kidney injury
269638|NCT02009241|Lymphangioleiomyomatosis|lymphangioleiomyomatosis
269639|NCT02009241|Rehabilitation|rehabilitation
269640|NCT02009241|Exercise|exercise
269641|NCT02009228|Single-port laparoscopy|single-port laparoscopy
269642|NCT02009228|Abdominal pain|abdominal pain
269643|NCT02009228|Ovarian spillage|ovarian spillage
269644|NCT02009228|Endobag rupture|endobag rupture
269645|NCT02009228|Ovarian reserve|ovarian reserve
269646|NCT02009215|Uganda|uganda
269647|NCT02009215|intermittent preventive treatment|intermittent preventive treatment
269648|NCT02009215|dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
269649|NCT02009215|schoolchildren|schoolchildren
269650|NCT02009215|malaria|malaria
269651|NCT02009202|Colon preparation|colon preparation
269652|NCT02009202|Child|child
269653|NCT02009189|home parenteral nutrition|home parenteral nutrition
269654|NCT02009189|central venous catheter|central venous catheter
269655|NCT02009176|Hepatocellular Carcinoma|hepatocellular carcinoma
269656|NCT02009176|Laparoscopic|laparoscopic
269657|NCT02009176|Aon-anatomical hepatectomy|aon-anatomical hepatectomy
269658|NCT02009176|Anatomical hepatectomy|anatomical hepatectomy
269659|NCT02009176|Micrometastases|micrometastases
269660|NCT02009137|small breast|small breast
269661|NCT02009137|augmentation|augmentation
269662|NCT02009137|breast volume|breast volume
269663|NCT02009137|External Soft Tissue Expansion System(ESTES)|external soft tissue expansion system(estes)
269664|NCT02009124|spinal cord injury|spinal cord injury
269665|NCT02009124|stem cell therapy|stem cell therapy
269666|NCT02009124|bone marrow|bone marrow
269667|NCT02009124|mononuclear cells|mononuclear cells
269668|NCT02009124|autologous|autologous
269669|NCT02009111|Transition to parenthood|transition to parenthood
269670|NCT02009111|Relationship intervention|relationship intervention
269671|NCT02009098|Randomized Controlled Trial|randomized controlled trial
269672|NCT02009098|Caesarean Section|caesarean section
269673|NCT02009098|preoperative|preoperative
269674|NCT02009098|intraoperative|intraoperative
269675|NCT02009098|prophylactic antibiotics|prophylactic antibiotics
269676|NCT02009098|antibiotics|antibiotics
269677|NCT02009098|timing|timing
269678|NCT02009098|surgical site infections|surgical site infections
269679|NCT02009098|endometritis|endometritis
269680|NCT02009098|wound infections|wound infections
269681|NCT02009098|urinary tract infections|urinary tract infections
269682|NCT02009098|infectious morbidity|infectious morbidity
269683|NCT02009098|neonatal antibiotics exposure|neonatal antibiotics exposure
269684|NCT02009098|Antibiotic Prophylaxis|antibiotic prophylaxis
269685|NCT02009072|Pterygium surgery|pterygium surgery
269686|NCT02009072|Sutureless glue free conjunctival autograft|sutureless glue free conjunctival autograft
269687|NCT02009072|Amniotic membrane graft.|amniotic membrane graft.
269688|NCT02009059|hypothermia|hypothermia
269689|NCT02009059|Temperature|temperature
269690|NCT02009059|epitympanic|epitympanic
269691|NCT02009059|pre-hospital|pre-hospital
269692|NCT02009046|Adolescent|adolescent
269693|NCT02009046|Sex education|sex education
269694|NCT02009046|Sexuality education|sexuality education
269695|NCT02009046|Sexually transmitted diseases|sexually transmitted diseases
269696|NCT02009046|Pregnancy|pregnancy
269697|NCT02009046|Sexual behavior|sexual behavior
269698|NCT02009046|Sexuality|sexuality
269699|NCT02009046|Relationship rights|relationship rights
269700|NCT02009046|Gender norms|gender norms
269701|NCT02009046|Human rights|human rights
269702|NCT02009046|Intervention studies|intervention studies
269703|NCT02009046|Parent intervention|parent intervention
269704|NCT02009046|Peer intervention|peer intervention
269705|NCT02009007|cerebral oximeter|cerebral oximeter
269706|NCT02009007|one lung ventilation|one lung ventilation
269707|NCT02009007|dopamine|dopamine
269708|NCT02009007|phenylephrine|phenylephrine
269709|NCT02008994|metastatic breast cancer|metastatic breast cancer
269710|NCT02008994|breast cancer|breast cancer
269711|NCT02008994|genomics|genomics
269712|NCT02008994|personalized medicine|personalized medicine
269713|NCT02008994|precision oncology|precision oncology
269714|NCT02008994|breast cancer treatment|breast cancer treatment
269715|NCT02008994|metastatic breast cancer treatment|metastatic breast cancer treatment
269716|NCT02008994|genetic testing and breast cancer treatment|genetic testing and breast cancer treatment
269717|NCT02008994|breast cancer trial|breast cancer trial
269718|NCT02008994|metastatic breast cancer trial|metastatic breast cancer trial
269719|NCT02008955|lysine, indicator amino acid oxidation, elderly females|lysine, indicator amino acid oxidation, elderly females
269720|NCT02008929|NKCELL|nkcell
269721|NCT02008916|AIN457, ankylosing spondylitis, chronic inflammatory disease, inflammatory back pain, secukinumab, self-injection|ain457, ankylosing spondylitis, chronic inflammatory disease, inflammatory back pain, secukinumab, self-injection
269722|NCT02008890|palmoplantar, pustular, psoriasis|palmoplantar, pustular, psoriasis
269723|NCT02008877|Malignant Peripheral Nerve Sheath Tumors|malignant peripheral nerve sheath tumors
269724|NCT02008877|MPNST|mpnst
269725|NCT02008877|Sarcoma|sarcoma
269726|NCT02008877|Ganetespib|ganetespib
269727|NCT02008877|Sirolimus|sirolimus
269728|NCT02008877|mTOR inhibitor|mtor inhibitor
269729|NCT02008877|Heat shock protein|heat shock protein
269730|NCT02008877|Hsp90|hsp90
269731|NCT02008864|End stage renal diseases|end stage renal diseases
269732|NCT02008864|Hemodialysis|hemodialysis
269733|NCT02008864|Uremic pruritus|uremic pruritus
269734|NCT02008864|Iranian traditional medicine|iranian traditional medicine
269735|NCT02008864|Cassia angustifolia|cassia angustifolia
269736|NCT02008851|Chronic kidney disease|chronic kidney disease
269737|NCT02008851|Type 2 Diabetes|type 2 diabetes
269738|NCT02008851|Neo-kidney augment|neo-kidney augment
269739|NCT02008851|Regenerative medicine|regenerative medicine
269740|NCT02008825|ViSiGi|visigi
269741|NCT02008825|Calibration tube|calibration tube
269742|NCT02008825|Sleeve gastrectomy|sleeve gastrectomy
269743|NCT02008812|Adenovirus|adenovirus
269744|NCT02008799|Stem cell, infertility, Azoospermia|stem cell, infertility, azoospermia
269745|NCT02008786|Coronary Artery Dissection, Spontaneous|coronary artery dissection, spontaneous
269746|NCT02008786|Angina|angina
269747|NCT02008773|schizophrenia|schizophrenia
269748|NCT02008773|schizoaffective|schizoaffective
269749|NCT02008773|schizophreniform|schizophreniform
269750|NCT02008773|inflammatory markers|inflammatory markers
269751|NCT02008773|HSV1|hsv1
269752|NCT02008773|cognition|cognition
269753|NCT02008773|early psychosis|early psychosis
269754|NCT02008773|valacyclovir|valacyclovir
269755|NCT02008760|pain|pain
269756|NCT02008760|quality of life|quality of life
269757|NCT02008760|ADL|adl
269758|NCT02008760|DOLO test|dolo test
269759|NCT02008760|compliance|compliance
269760|NCT02008760|D3|d3
269761|NCT02008747|Atrial fibrillation|atrial fibrillation
269762|NCT02008747|Neuropathic pain|neuropathic pain
269763|NCT02008747|Posterolateral thoracotomy|posterolateral thoracotomy
269764|NCT02008747|Lung resection|lung resection
269765|NCT02008721|Multiple System Atrophy|multiple system atrophy
269766|NCT02008721|epigallocatechin gallate|epigallocatechin gallate
269767|NCT02008708|Health|health
269768|NCT02008708|Microfinance|microfinance
269769|NCT02008695|Health|health
269770|NCT02008695|Youth|youth
269771|NCT02008695|Microfinance|microfinance
269772|NCT02008669|Multiple Sclerosis, Fatigue, Nutritional Status, Disability.|multiple sclerosis, fatigue, nutritional status, disability.
269773|NCT02008656|CAPECITABINE (ORAL)|capecitabine (oral)
269774|NCT02008656|FLUOROURACIL|fluorouracil
269775|NCT02008656|LEUCOVORIN|leucovorin
269776|NCT02008656|OXALIPLATIN|oxaliplatin
269777|NCT02008656|Total mesorectal excision|total mesorectal excision
269778|NCT02008656|Chemoradiation therapy|chemoradiation therapy
269779|NCT02008656|Total neoadjuvant therapy|total neoadjuvant therapy
269780|NCT02008656|13-213|13-213
269781|NCT02008643|Health related quality of life, food allergy, children, chronic diseases|health related quality of life, food allergy, children, chronic diseases
269782|NCT02008617|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
269783|NCT02008604|ischemia|ischemia
269784|NCT02008604|stroke|stroke
269785|NCT02008604|transient ischemic attack (TIA)|transient ischemic attack (tia)
269786|NCT02008604|microbiome|microbiome
269787|NCT02008604|microbiota|microbiota
269788|NCT02008604|gut|gut
269789|NCT02008591|Neuraxial Technique|neuraxial technique
269790|NCT02008591|Epidural Technique|epidural technique
269791|NCT02008591|Dural Puncture Epidural Technique|dural puncture epidural technique
269792|NCT02008591|Combined Spinal Epidural Technique|combined spinal epidural technique
269793|NCT02008591|Labor Analgesia|labor analgesia
269794|NCT02008591|Obstetric|obstetric
269795|NCT02008578|Antiviral|antiviral
269796|NCT02008578|Adjunctive Therapy|adjunctive therapy
269797|NCT02008578|Antibody|antibody
269798|NCT02008565|Fecal incontinence|fecal incontinence
269799|NCT02008565|Loperamide|loperamide
269800|NCT02008565|anal exercises|anal exercises
269801|NCT02008565|biofeedback|biofeedback
269802|NCT02008552|Genetic factor|genetic factor
269803|NCT02008552|Valvulopathy|valvulopathy
269804|NCT02008552|Mediator|mediator
269805|NCT02008526|Text Messaging|text messaging
269806|NCT02008526|mHealth|mhealth
269807|NCT02008526|Methamphetamine|methamphetamine
269808|NCT02008526|HIV|hiv
269809|NCT02008526|AIDS|aids
269810|NCT02008513|AFFITOPE® AD02|affitope® ad02
269811|NCT02008513|Alzheimer Disease|alzheimer disease
269812|NCT02008513|Dementia|dementia
269813|NCT02008513|Brain Disease|brain disease
269814|NCT02008513|Nervous System Diseases|nervous system diseases
269815|NCT02008513|Tauopathies|tauopathies
269816|NCT02008513|Neurodegenerative Diseases|neurodegenerative diseases
269817|NCT02008513|Mental Disorders|mental disorders
269818|NCT02008500|Dentinal Hypersensitivity|dentinal hypersensitivity
269819|NCT02008500|Gingival Recession|gingival recession
269820|NCT02008500|Visual Analogue Score|visual analogue score
269821|NCT02008487|wound|wound
269822|NCT02008487|palliative care|palliative care
269823|NCT02008487|hospice|hospice
269824|NCT02008487|pressure ulcers|pressure ulcers
269825|NCT02008435|Group-delivered Diabetes Prevention Program|group-delivered diabetes prevention program
269826|NCT02008435|Obesity|obesity
269827|NCT02008435|Overweight|overweight
269828|NCT02008435|Lifestyle change|lifestyle change
269829|NCT02008435|Healthy eating|healthy eating
269830|NCT02008435|Weight loss|weight loss
269831|NCT02008435|Exercise|exercise
269832|NCT02008435|Cognitive-behavioral intervention|cognitive-behavioral intervention
269833|NCT02008435|Implementation intentions|implementation intentions
269834|NCT02008435|Mental imagery|mental imagery
269835|NCT02008435|Mental practice|mental practice
269836|NCT02008435|If-then plans|if-then plans
269837|NCT02008409|Minimally Invasive Surgery|minimally invasive surgery
269838|NCT02008409|EndoLift Liver Retractor|endolift liver retractor
269839|NCT02008396|MDMA|mdma
269840|NCT02008396|autism|autism
269841|NCT02008396|social anxiety|social anxiety
269842|NCT02008383|Colorectal cancer|colorectal cancer
269843|NCT02008383|Panitumumab|panitumumab
269844|NCT02008383|Cabozantinib|cabozantinib
269845|NCT02008370|minimally invasive cardiac surgery|minimally invasive cardiac surgery
269846|NCT02008370|Exparel|exparel
269847|NCT02008357|Cognition|cognition
269848|NCT02008357|Prevention|prevention
269849|NCT02008344|influenza|influenza
269850|NCT02008344|flu|flu
269851|NCT02008344|fever|fever
269852|NCT02008344|cough|cough
269853|NCT02008344|body aches|body aches
269854|NCT02008344|headache|headache
269855|NCT02008344|nasal congestion|nasal congestion
269856|NCT02008344|body pains|body pains
269857|NCT02008344|sore throat|sore throat
269858|NCT02008344|fatigue|fatigue
269859|NCT02008344|T-705|t-705
269860|NCT02008344|favipiravir|favipiravir
269861|NCT02008344|favor|favor
269862|NCT02008344|flu symptoms|flu symptoms
269863|NCT02008331|chronic kidney disease|chronic kidney disease
269864|NCT02008331|p-cresol|p-cresol
269865|NCT02008331|synbiotic|synbiotic
269866|NCT02008292|smoking|smoking
269867|NCT02008292|schizophrenia|schizophrenia
269868|NCT02008292|acetylcholine|acetylcholine
269869|NCT02008279|Healthy|healthy
269870|NCT02008279|CNTO 3157|cnto 3157
269871|NCT02008279|Pharmacokinetics|pharmacokinetics
269872|NCT02008253|INTRASTROMAL CORNEAL RING|intrastromal corneal ring
269873|NCT02008253|ASTIGMATISM|astigmatism
269874|NCT02008240|Infertility|infertility
269875|NCT02008240|Hydrosalpinx|hydrosalpinx
269876|NCT02008240|IVF-ET|ivf-et
269877|NCT02008240|Salpingectomy|salpingectomy
269878|NCT02008214|Pentoxifylline|pentoxifylline
269879|NCT02008214|Sustained virologic response|sustained virologic response
269880|NCT02008214|Hepatic fibrosis|hepatic fibrosis
269881|NCT02008201|dose-response study|dose-response study
269882|NCT02008188|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
269883|NCT02008188|Artificial Pancreas|artificial pancreas
269884|NCT02008188|Closed Loop Control|closed loop control
269885|NCT02008188|Diabetes Assistant (DiAs)|diabetes assistant (dias)
269886|NCT02008188|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
269887|NCT02008188|Insulin Pump|insulin pump
269888|NCT02008188|Metabolic Diseases|metabolic diseases
269889|NCT02008188|Endocrine System Diseases|endocrine system diseases
269890|NCT02008188|Autoimmune Diseases|autoimmune diseases
269891|NCT02008175|paediatric, keratoconus, collagen cross linking|paediatric, keratoconus, collagen cross linking
269892|NCT02008162|Emphysema, COPD, bronchoreversibility, ventilatory obstruction, lung volume reduction surgery, LVRS|emphysema, copd, bronchoreversibility, ventilatory obstruction, lung volume reduction surgery, lvrs
269893|NCT02008149|Osteoporosis|osteoporosis
269894|NCT02008136|myofascial pain|myofascial pain
269895|NCT02008136|muscle spasm|muscle spasm
269896|NCT02008136|botulinum toxin|botulinum toxin
269897|NCT02008136|cervicalgia|cervicalgia
269898|NCT02008136|lumbago|lumbago
269899|NCT02008136|low back pain|low back pain
269900|NCT02008123|Clopidogrel|clopidogrel
269901|NCT02008123|Clopidogrel Resistance|clopidogrel resistance
269902|NCT02008123|Primidone|primidone
269903|NCT02008123|Secondary Stroke Prevention|secondary stroke prevention
269904|NCT02008110|Heart failure|heart failure
269905|NCT02008110|Biomarker guided-therapy|biomarker guided-therapy
269906|NCT02008110|Carbohydrate antigen 125|carbohydrate antigen 125
269907|NCT02008110|Clinical outcomes.|clinical outcomes.
269908|NCT02008097|Ultrasound|ultrasound
269909|NCT02008097|Ultrasonography|ultrasonography
269910|NCT02008097|Liver transplantation|liver transplantation
269911|NCT02008097|Arterial Occlusive Diseases|arterial occlusive diseases
269912|NCT02008097|Hypertension|hypertension
269913|NCT02008097|Pregnancy, High Risk|pregnancy, high risk
269914|NCT02008097|Pregnancy|pregnancy
269915|NCT02008084|hypertriglyceridemia|hypertriglyceridemia
269916|NCT02008084|mixed hyperlipidemia|mixed hyperlipidemia
269917|NCT02008058|Metastatic Castrate-Resistant Prostate Cancer|metastatic castrate-resistant prostate cancer
269918|NCT02008058|LCCC 1231|lccc 1231
269919|NCT02008058|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
269920|NCT02008058|UNC Lineberger|unc lineberger
269921|NCT02008058|Prostate Cancer|prostate cancer
269922|NCT02008058|Pain|pain
269923|NCT02008045|MRI|mri
269924|NCT02008045|Imaging|imaging
269925|NCT02008045|Neurocognitive|neurocognitive
269926|NCT02008045|White matter injury|white matter injury
269927|NCT02008032|Mammography|mammography
269928|NCT02008032|Breast|breast
269929|NCT02008032|Implants|implants
269930|NCT02008019|Chondrosarcoma|chondrosarcoma
269931|NCT02008019|Neoadjuvant therapy|neoadjuvant therapy
269932|NCT02008019|Phase II|phase ii
269933|NCT02008019|Everolimus|everolimus
269934|NCT02008019|Success Rate|success rate
269935|NCT02008019|Progression Free Survival|progression free survival
269936|NCT02008019|Overall Survival|overall survival
269937|NCT02008019|Safety|safety
269938|NCT02008019|Quality of Life|quality of life
269939|NCT02008019|Molecular study (ancillary study)|molecular study (ancillary study)
269940|NCT02008006|Follicular Lymphoma|follicular lymphoma
269941|NCT02008006|Chemosensitive relapse|chemosensitive relapse
269942|NCT02008006|High Dose Chemotherapy|high dose chemotherapy
269943|NCT02008006|Bendamustine|bendamustine
269944|NCT02008006|BeEAM|beeam
269945|NCT02008006|Autologous Stem Cell Transplantation|autologous stem cell transplantation
269946|NCT02008006|Safety|safety
269947|NCT02008006|Event Free Survival|event free survival
269948|NCT02008006|Overall Response Rate|overall response rate
269949|NCT02008006|Progression Free Survival|progression free survival
270050|NCT02007616|Attention|attention
269950|NCT02008006|Overall Survival|overall survival
269951|NCT02008006|Phase II|phase ii
269952|NCT02008006|World Health Organization (WHO) 1 grade|world health organization (who) 1 grade
269953|NCT02008006|WHO 2 grade|who 2 grade
269954|NCT02008006|WHO 3a grade|who 3a grade
269955|NCT02007993|Halitosis,|halitosis,
269956|NCT02007993|Photodynamic Therapy,|photodynamic therapy,
269957|NCT02007993|Adolescent|adolescent
269958|NCT02007980|urological problems|urological problems
269959|NCT02007980|indwelling urologic stent|indwelling urologic stent
269960|NCT02007980|kidney stone disease|kidney stone disease
269961|NCT02007980|urinary system obstruction|urinary system obstruction
269962|NCT02007980|hydronephrosis|hydronephrosis
269963|NCT02007980|ureteral damage|ureteral damage
269964|NCT02007954|HCC|hcc
269965|NCT02007915|Adolescent|adolescent
269966|NCT02007915|Avascular Necrosis|avascular necrosis
269967|NCT02007915|Bisphosphonates|bisphosphonates
269968|NCT02007915|Pamidronate|pamidronate
269969|NCT02007902|Preterm baby|preterm baby
269970|NCT02007902|Total plasma protein|total plasma protein
269971|NCT02007902|Albumin|albumin
269972|NCT02007902|Hemodynamic disturbances|hemodynamic disturbances
269973|NCT02007902|Perfusion|perfusion
269974|NCT02007902|Near Infra Red Spectroscopy (NIRS)|near infra red spectroscopy (nirs)
269975|NCT02007902|Ultrasound|ultrasound
269976|NCT02007876|Mobility|mobility
269977|NCT02007876|Activity|activity
269978|NCT02007876|Training|training
269979|NCT02007876|Abdominal|abdominal
269980|NCT02007876|Surgery|surgery
269981|NCT02007876|Adult|adult
269982|NCT02007863|Leukemia|leukemia
269983|NCT02007863|Myelodysplasia|myelodysplasia
269984|NCT02007863|Acute lymphocytic leukemia|acute lymphocytic leukemia
269985|NCT02007863|ALL|all
269986|NCT02007863|Acute myelogenous leukemia|acute myelogenous leukemia
269987|NCT02007863|AML|aml
269988|NCT02007863|Pediatric|pediatric
269989|NCT02007850|continuous femoral nerve block|continuous femoral nerve block
269990|NCT02007850|knee arthroplasty|knee arthroplasty
269991|NCT02007850|quadriceps muscle strength|quadriceps muscle strength
269992|NCT02007837|pregnancy induced hypertension|pregnancy induced hypertension
269993|NCT02007837|gestational hypertension|gestational hypertension
269994|NCT02007837|pre-eclampsia|pre-eclampsia
269995|NCT02007837|preeclampsia|preeclampsia
269996|NCT02007837|hypertensive disorders in pregnancy|hypertensive disorders in pregnancy
269997|NCT02007824|pressure ulcer|pressure ulcer
269998|NCT02007824|chronic wound|chronic wound
269999|NCT02007824|tissue necrosis|tissue necrosis
270000|NCT02007824|slough|slough
270001|NCT02007824|ultra sound|ultra sound
270002|NCT02007798|dexmedetomidine|dexmedetomidine
270003|NCT02007798|supratentorial tumors|supratentorial tumors
270004|NCT02007785|Cognitive Orientation to daily Occupational Performance|cognitive orientation to daily occupational performance
270005|NCT02007785|CO-OP|co-op
270006|NCT02007772|COPD, nHF, BiPAP|copd, nhf, bipap
270007|NCT02007759|Dysphagia|dysphagia
270008|NCT02007759|neuromuscular electrical stimulation|neuromuscular electrical stimulation
270009|NCT02007759|NMES|nmes
270010|NCT02007759|Neonates|neonates
270011|NCT02007759|Vitalstim|vitalstim
270012|NCT02007746|sickle cell disease|sickle cell disease
270013|NCT02007746|hemochromatosis|hemochromatosis
270014|NCT02007746|liver fibrosis|liver fibrosis
270015|NCT02007746|liver cirrhosis|liver cirrhosis
270016|NCT02007746|FibroScan|fibroscan
270017|NCT02007746|Ferriscan|ferriscan
270018|NCT02007746|liver iron|liver iron
270019|NCT02007733|Diarrhea|diarrhea
270020|NCT02007733|Dehydration|dehydration
270021|NCT02007733|Children|children
270022|NCT02007733|Resuscitation|resuscitation
270023|NCT02007733|Clinical Prediction Rule|clinical prediction rule
270024|NCT02007733|Low Income Country|low income country
270025|NCT02007733|Bangladesh|bangladesh
270026|NCT02007720|Serelaxin,|serelaxin,
270027|NCT02007720|WHF,|whf,
270028|NCT02007720|Likert Scale,|likert scale,
270029|NCT02007720|RELAX-AHF-ASIA,|relax-ahf-asia,
270030|NCT02007720|RLX030,|rlx030,
270031|NCT02007720|AHF,|ahf,
270032|NCT02007720|acute heart failure|acute heart failure
270033|NCT02007707|Asian American|asian american
270034|NCT02007707|Vietnamese American|vietnamese american
270035|NCT02007707|Smoking cessation|smoking cessation
270036|NCT02007707|Community Health Worker|community health worker
270037|NCT02007707|Lay Health Worker Outreach|lay health worker outreach
270038|NCT02007707|Family Intervention|family intervention
270039|NCT02007694|Phobic Disorders (Fear of Flying and acrophobia)|phobic disorders (fear of flying and acrophobia)
270040|NCT02007694|Virtual Reality Exposure Therapy|virtual reality exposure therapy
270041|NCT02007694|Fear extinction|fear extinction
270042|NCT02007694|propranolol|propranolol
270043|NCT02007694|Yohimbine|yohimbine
270044|NCT02007681|Sedentary Behavior; Breaks; Workplace; Energy Expenditure; Physical activity; doubly labeled water|sedentary behavior; breaks; workplace; energy expenditure; physical activity; doubly labeled water
270045|NCT02007668|low back pain|low back pain
270046|NCT02007668|kinesio taping|kinesio taping
270047|NCT02007655|Cardiovascular|cardiovascular
270048|NCT02007616|Cognitive aging|cognitive aging
270049|NCT02007616|Video games training|video games training
270051|NCT02007616|Memory|memory
270052|NCT02007616|Wellbeing|wellbeing
270053|NCT02007616|Speed of processing|speed of processing
270054|NCT02007616|Executive functions|executive functions
270055|NCT02007603|chronic hemodialysis|chronic hemodialysis
270056|NCT02007603|ampicillin|ampicillin
270057|NCT02007603|sulbactam|sulbactam
270058|NCT02007603|amoxicillin|amoxicillin
270059|NCT02007603|clavulanic acid|clavulanic acid
270060|NCT02007603|pharmacokinetics|pharmacokinetics
270061|NCT02007577|insulin resistant|insulin resistant
270062|NCT02007564|Palliative care dyads|palliative care dyads
270063|NCT02007564|Volunteers|volunteers
270064|NCT02007564|Community-based|community-based
270065|NCT02007564|Mixed methods|mixed methods
270066|NCT02007551|Social Isolation|social isolation
270067|NCT02007551|Nutrition Assessments|nutrition assessments
270068|NCT02007551|Food Habits|food habits
270069|NCT02007551|Meals|meals
270070|NCT02007551|Self Efficacy|self efficacy
270071|NCT02007551|Quality of Life|quality of life
270072|NCT02007551|Peer Group|peer group
270073|NCT02007538|Lung Cancer|lung cancer
270074|NCT02007538|Bronchoscopy|bronchoscopy
270075|NCT02007538|Fine Need Aspiration|fine need aspiration
270076|NCT02007538|Cytochemical Assays|cytochemical assays
270077|NCT02007512|advanced breast cancer|advanced breast cancer
270078|NCT02007512|enzalutamide|enzalutamide
270079|NCT02007512|MDV3100|mdv3100
270080|NCT02007512|Estrogen receptor positive (ER +)|estrogen receptor positive (er +)
270081|NCT02007512|Progesterone receptor positive (PgR +)|progesterone receptor positive (pgr +)
270082|NCT02007512|HER-2 normal|her-2 normal
270083|NCT02007499|Prehospital emergency care|prehospital emergency care
270084|NCT02007499|Out of hospital cardiac arrest|out of hospital cardiac arrest
270085|NCT02007499|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
270086|NCT02007499|CPR|cpr
270087|NCT02007499|Heart arrest|heart arrest
270088|NCT02007499|Outcome|outcome
270089|NCT02007499|Bystander|bystander
270090|NCT02007486|Heart Failure|heart failure
270091|NCT02007486|Exercise|exercise
270092|NCT02007486|Dyspnea|dyspnea
270093|NCT02007486|Diaphragm electromyogram|diaphragm electromyogram
270094|NCT02007486|Respiratory mechanics|respiratory mechanics
270095|NCT02007473|Haemovigilance|haemovigilance
270096|NCT02007473|Plasma|plasma
270097|NCT02007473|Pathogen reduction|pathogen reduction
270098|NCT02007473|Methylene Blue|methylene blue
270099|NCT02007447|autism, oxytocin, autism spectrum disorder, social skills.|autism, oxytocin, autism spectrum disorder, social skills.
270100|NCT02007421|Human Papillomavirus,|human papillomavirus,
270101|NCT02007421|Anal High Grade Squamous intraepithelial lesions,|anal high grade squamous intraepithelial lesions,
270102|NCT02007421|Homosexual Men|homosexual men
270103|NCT02007421|High resolution anoscopy,|high resolution anoscopy,
270104|NCT02007421|Cancer Screening|cancer screening
270105|NCT02007421|HIV|hiv
270106|NCT02007408|abortion|abortion
270107|NCT02007408|analgesia|analgesia
270108|NCT02007408|paracervical block|paracervical block
270109|NCT02007408|lidocaine spray|lidocaine spray
270110|NCT02007343|Enterobacteriaceae|enterobacteriaceae
270111|NCT02007343|Pseudomonas|pseudomonas
270112|NCT02007343|Acinetobacter|acinetobacter
270113|NCT02007343|Stenotrophomonas|stenotrophomonas
270114|NCT02007343|Mortality|mortality
270115|NCT02007343|Morbidity|morbidity
270116|NCT02007343|Cost of Illness|cost of illness
270117|NCT02007343|Causality|causality
270118|NCT02007343|Multicenter Study|multicenter study
270119|NCT02007343|Cohort Studies|cohort studies
270120|NCT02007343|Case-Control Studies|case-control studies
270121|NCT02007343|Prospective Studies|prospective studies
270122|NCT02007343|Follow-up Studies|follow-up studies
270123|NCT02007330|systemic lidocaine|systemic lidocaine
270124|NCT02007330|postoperative pain|postoperative pain
270125|NCT02007330|recovery, pediatric|recovery, pediatric
270126|NCT02007330|inguinal hernia|inguinal hernia
270127|NCT02007330|laparoscopy|laparoscopy
270128|NCT02007317|BCC|bcc
270129|NCT02007291|Alzheimer, MMSE, response, colinesterase inhibitors (ChEI)|alzheimer, mmse, response, colinesterase inhibitors (chei)
270130|NCT02007278|diabetes|diabetes
270131|NCT02007278|hypoglycemia|hypoglycemia
270132|NCT02007278|glycemic variability|glycemic variability
270133|NCT02007278|vildagliptin|vildagliptin
270134|NCT02007278|glimepiride|glimepiride
270135|NCT02007252|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
270136|NCT02007252|AAA|aaa
270137|NCT02007252|IL-1b|il-1b
270138|NCT02007252|Abdominal ultrasound|abdominal ultrasound
270139|NCT02007239|tocilizumab|tocilizumab
270140|NCT02007239|hemophagocytic lymphohistiocytosis (HLH)|hemophagocytic lymphohistiocytosis (hlh)
270141|NCT02007239|cytokine|cytokine
270142|NCT02007239|cytokine release syndrome|cytokine release syndrome
270143|NCT02007226|Coronary Heart Disease|coronary heart disease
270144|NCT02007226|spinal cord injury|spinal cord injury
270145|NCT02007226|risk factor|risk factor
270146|NCT02007226|postprandial lipemia|postprandial lipemia
270147|NCT02007213|Neuromuscular Disease|neuromuscular disease
270148|NCT02007213|Motor Function|motor function
270149|NCT02007213|Proxy Reported Outcome|proxy reported outcome
270150|NCT02007213|Young Children|young children
270151|NCT02007187|Unstable Angina Pectoris|unstable angina pectoris
270152|NCT02007187|Randomized Controlled Trial|randomized controlled trial
270153|NCT02007187|Traditional Chinese Medicine|traditional chinese medicine
270154|NCT02007174|recurrent pterygium|recurrent pterygium
270155|NCT02007174|bevacizumab|bevacizumab
270156|NCT02007174|triple dose|triple dose
270157|NCT02007148|gastric adenocarcinoma,|gastric adenocarcinoma,
270158|NCT02007148|capecitabine,|capecitabine,
270159|NCT02007148|second line treatment,|second line treatment,
270160|NCT02007148|recurrent or metastatic disease,|recurrent or metastatic disease,
270161|NCT02007148|overall survival,|overall survival,
270162|NCT02007148|tumor response,|tumor response,
270163|NCT02007148|quality of life|quality of life
270164|NCT02007122|HD|hd
270165|NCT02007122|CVVH|cvvh
270166|NCT02007122|renal replacement therapy|renal replacement therapy
270167|NCT02007122|ceftaroline|ceftaroline
270168|NCT02007122|pharmacokinetics|pharmacokinetics
270169|NCT02007096|Transabdominal plane block|transabdominal plane block
270170|NCT02007096|ventral hernia|ventral hernia
270171|NCT02007096|umbilical hernia|umbilical hernia
270172|NCT02007096|incisional hernia|incisional hernia
270173|NCT02007096|hernia repair|hernia repair
270174|NCT02007083|Lumbar Spinal stenosis|lumbar spinal stenosis
270175|NCT02007083|Surgical treatment of LSS.|surgical treatment of lss.
270176|NCT02007070|PD1|pd1
270177|NCT02007070|PD-1|pd-1
270178|NCT02007070|PDL1|pdl1
270179|NCT02007070|PD-L1|pd-l1
270180|NCT02007057|Suprascapular nerve block|suprascapular nerve block
270181|NCT02007057|Interscalene nerve block|interscalene nerve block
270182|NCT02007044|Leukemia|leukemia
270183|NCT02007044|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
270184|NCT02007044|CLL|cll
270185|NCT02007044|Relapsed|relapsed
270186|NCT02007044|Ibrutinib|ibrutinib
270187|NCT02007044|PCI-32765|pci-32765
270188|NCT02007044|Rituximab|rituximab
270189|NCT02007044|Rituxan|rituxan
270190|NCT02007031|Hypertension|hypertension
270191|NCT02007031|Cold temperature|cold temperature
270192|NCT02007031|Blood pressure|blood pressure
270193|NCT02007031|Electrocardiography|electrocardiography
270194|NCT02007018|Surgical Site Infections|surgical site infections
270195|NCT02007018|Colorectal Resection|colorectal resection
270196|NCT02007018|Negative Pressure Wound Therapy|negative pressure wound therapy
270197|NCT02007005|superficial bladder cancer|superficial bladder cancer
270198|NCT02007005|mistletoe extract|mistletoe extract
270199|NCT02007005|maximum tolerated dose|maximum tolerated dose
270200|NCT02007005|marker tumor|marker tumor
270201|NCT02007005|remission|remission
270202|NCT02007005|recurrence rate|recurrence rate
270203|NCT02006979|cardiotoxicity|cardiotoxicity
270204|NCT02006979|Chemotherapy, Adjuvant|chemotherapy, adjuvant
270205|NCT02006979|Breast Neoplasms|breast neoplasms
270206|NCT02006979|Exercise|exercise
270207|NCT02006979|Cardiotoxins|cardiotoxins
270208|NCT02006979|Echocardiography|echocardiography
270209|NCT02006979|Speckle tracking|speckle tracking
270210|NCT02006979|Biological Markers|biological markers
270211|NCT02006979|Electrocardiography|electrocardiography
270212|NCT02006966|Systemic lidocaine|systemic lidocaine
270213|NCT02006966|postoperative pain|postoperative pain
270214|NCT02006966|Video-assisted thoracic surgery|video-assisted thoracic surgery
270215|NCT02006966|VATS|vats
270216|NCT02006953|gastrostomy|gastrostomy
270217|NCT02006953|enteral|enteral
270218|NCT02006940|alveoflex|alveoflex
270219|NCT02006940|probe-based confocal laser endomicroscopy|probe-based confocal laser endomicroscopy
270220|NCT02006940|pCLE|pcle
270221|NCT02006940|alveoscopy|alveoscopy
270222|NCT02006940|morphology|morphology
270223|NCT02006940|high resolution computed tomography|high resolution computed tomography
270224|NCT02006927|Prostate Cancer|prostate cancer
270225|NCT02006914|Insulin resistance|insulin resistance
270226|NCT02006914|HIV disease|hiv disease
270227|NCT02006914|chromium picolinate|chromium picolinate
270228|NCT02006901|surgical procedures, operative|surgical procedures, operative
270229|NCT02006901|lumbar vertebrae|lumbar vertebrae
270230|NCT02006901|decompression, surgical|decompression, surgical
270231|NCT02006901|microdecompression|microdecompression
270232|NCT02006901|laminectomy|laminectomy
270233|NCT02006901|registries|registries
270234|NCT02006888|Inflammation|inflammation
270235|NCT02006888|cataract surgery|cataract surgery
270236|NCT02006875|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
270237|NCT02006875|postural|postural
270238|NCT02006875|balance|balance
270239|NCT02006875|mobility|mobility
270240|NCT02006875|leg|leg
270241|NCT02006875|stroke|stroke
270242|NCT02006862|olanzapine|olanzapine
270243|NCT02006862|olanzapine treatment efficacy|olanzapine treatment efficacy
270244|NCT02006849|AfricanAmericans|africanamericans
270245|NCT02006849|Hypertension|hypertension
270246|NCT02006849|Proteinuria|proteinuria
270247|NCT02006849|ApoL1 gene|apol1 gene
270248|NCT02006836|glycemic index|glycemic index
270249|NCT02006836|glycemic response|glycemic response
270250|NCT02006836|diabetes|diabetes
270251|NCT02006836|pomelo|pomelo
270252|NCT02006823|Chronic Hepatitis C|chronic hepatitis c
270253|NCT02006810|Endothelium biomarkers|endothelium biomarkers
270254|NCT02006810|Atherosclerotic disease|atherosclerotic disease
270255|NCT02006810|Endothelial function|endothelial function
270256|NCT02006810|Nutritional stimuli|nutritional stimuli
270257|NCT02006797|reconciliation|reconciliation
270258|NCT02006797|discharge|discharge
270259|NCT02006797|pharmacist|pharmacist
270260|NCT02006797|drug related problems|drug related problems
270261|NCT02006771|Meal|meal
270262|NCT02006771|Postprandial oxidative stress|postprandial oxidative stress
270263|NCT02006719|Adhesive Capsulitis|adhesive capsulitis
270264|NCT02006719|Frozen Shoulder|frozen shoulder
270265|NCT02006719|Shoulder Range of Motion limitation|shoulder range of motion limitation
270266|NCT02006719|Shoulder Pain|shoulder pain
270267|NCT02006693|XEN|xen
270268|NCT02006693|Primary Open Angle Glaucoma|primary open angle glaucoma
270269|NCT02006693|Filtration Device|filtration device
270270|NCT02006693|Ab interno|ab interno
270271|NCT02006680|Central Precocious Puberty|central precocious puberty
270272|NCT02006680|Suppression|suppression
270273|NCT02006680|Alpha Subunit|alpha subunit
270274|NCT02006680|Leuprolide Stimulation Test|leuprolide stimulation test
270275|NCT02006628|GWP42003|gwp42003
270276|NCT02006628|Cannabinoids|cannabinoids
270277|NCT02006628|Schizophrenia|schizophrenia
270278|NCT02006602|Candesartan cilexetil|candesartan cilexetil
270279|NCT02006602|Healthy adult human subjects|healthy adult human subjects
270280|NCT02006602|Bioequivalence|bioequivalence
270281|NCT02006589|Bioequivalence|bioequivalence
270282|NCT02006589|Candesartan cilexetil|candesartan cilexetil
270283|NCT02006589|Healthy adult human subjects|healthy adult human subjects
270284|NCT02006576|Emphysema|emphysema
270285|NCT02006576|Prostaglandin E|prostaglandin e
270286|NCT02006576|Bronchoalveolar lavage|bronchoalveolar lavage
270287|NCT02006563|Brain Tumor|brain tumor
270288|NCT02006563|Glioblastoma multiforme|glioblastoma multiforme
270289|NCT02006563|GBM|gbm
270290|NCT02006563|Metabolic Tumor Volume|metabolic tumor volume
270291|NCT02006563|MTV|mtv
270292|NCT02006563|Clinical Tumor Volume|clinical tumor volume
270293|NCT02006563|CTV|ctv
270294|NCT02006550|Wnt|wnt
270295|NCT02006550|Notch|notch
270296|NCT02006550|Hedgehog|hedgehog
270297|NCT02006550|Tumor Sample|tumor sample
270298|NCT02006537|soluble epoxide hydrolase inhibitor|soluble epoxide hydrolase inhibitor
270299|NCT02006537|Entero-Test|entero-test
270300|NCT02006537|pharmacokinetics|pharmacokinetics
270301|NCT02006537|COPD|copd
270302|NCT02006537|safety|safety
270303|NCT02006524|Silent atrial fibrillation|silent atrial fibrillation
270304|NCT02006524|primary care|primary care
270305|NCT02006524|screening|screening
270306|NCT02006524|influenza vaccination|influenza vaccination
270307|NCT02006511|incisional negative pressure wound therapy|incisional negative pressure wound therapy
270308|NCT02006511|groin incision|groin incision
270309|NCT02006511|incisional VAC|incisional vac
270310|NCT02006511|Prevena|prevena
270311|NCT02006511|groin wound|groin wound
270312|NCT02006498|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
270313|NCT02006498|sillymarin|sillymarin
270314|NCT02006498|randomised trial|randomised trial
270315|NCT02006498|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
270316|NCT02006472|Huntington's Disease|huntington's disease
270317|NCT02006472|Pridopidine|pridopidine
270318|NCT02006472|Pride-HD|pride-hd
270319|NCT02006459|Gastrointestinal-mediated glucose disposal|gastrointestinal-mediated glucose disposal
270320|NCT02006459|Total pancreatectomy|total pancreatectomy
270321|NCT02006459|Incretin hormones|incretin hormones
270322|NCT02006459|Glucagon|glucagon
270323|NCT02006446|Male infertility|male infertility
270324|NCT02006446|sperm head vacuoles|sperm head vacuoles
270325|NCT02006446|sperm morphology|sperm morphology
270326|NCT02006446|aneuploidy|aneuploidy
270327|NCT02006446|DNA fragmentation|dna fragmentation
270328|NCT02006446|abnormal chromatin condensation|abnormal chromatin condensation
270329|NCT02006446|telomere abnormalities|telomere abnormalities
270330|NCT02006394|Inflammation|inflammation
270331|NCT02006394|Monocytes|monocytes
270332|NCT02006381|healthy boys|healthy boys
270333|NCT02006381|plasma oxytocin|plasma oxytocin
270334|NCT02006381|pediatric|pediatric
270335|NCT02006368|Volunteers|volunteers
270336|NCT02006368|Blood Platelets|blood platelets
270337|NCT02006368|Platelet Transfusion|platelet transfusion
270338|NCT02006342|Diabetes Mellitus|diabetes mellitus
270339|NCT02006342|Diabetic Ketoacidosis|diabetic ketoacidosis
270340|NCT02006342|Insulin Glargine|insulin glargine
270341|NCT02006342|Anion gap|anion gap
270342|NCT02006342|Metabolic acidosis|metabolic acidosis
270343|NCT02006303|Benign Prostate Hyperplasia|benign prostate hyperplasia
270344|NCT02006303|Green light|green light
270345|NCT02006303|Photoselective vaporization of the prostate|photoselective vaporization of the prostate
270346|NCT02006303|Prostatic artery embolization|prostatic artery embolization
270347|NCT02006303|Outcome|outcome
270348|NCT02006277|healthy volunteers|healthy volunteers
270349|NCT02006277|taste|taste
270350|NCT02006277|bioavailability|bioavailability
270351|NCT02006238|Hot flash|hot flash
270352|NCT02006238|Farabloc|farabloc
270353|NCT02006238|menopausal women|menopausal women
270354|NCT02006225|autologous|autologous
270355|NCT02006225|stem cell|stem cell
270356|NCT02006225|transplantation|transplantation
270357|NCT02006199|obsessive-compulsive disorder|obsessive-compulsive disorder
270358|NCT02006199|mindfulness|mindfulness
270359|NCT02006199|meditation|meditation
270360|NCT02006186|Bicycling|bicycling
270361|NCT02006173|Hya-Dermis mixed with lidocaine on reducing pain|hya-dermis mixed with lidocaine on reducing pain
270362|NCT02006134|Vasculitis|vasculitis
270363|NCT02006134|Primary CNS Vasculitis|primary cns vasculitis
270364|NCT02006134|Systemic vasculitis|systemic vasculitis
270365|NCT02006134|Churg-Strauss Syndrome|churg-strauss syndrome
270366|NCT02006134|Polyarteritis Nodosa|polyarteritis nodosa
270367|NCT02006134|Wegener Granulomatosis|wegener granulomatosis
270368|NCT02006134|Pediatric vasculitis|pediatric vasculitis
270369|NCT02006134|Childhood vasculitis|childhood vasculitis
270370|NCT02006134|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
270371|NCT02006134|Microscopic Polyangiitis|microscopic polyangiitis
270372|NCT02006134|Takayasu Arteritis|takayasu arteritis
270373|NCT02006134|Autoimmune|autoimmune
270374|NCT02006134|ANCA-associated vasculitis|anca-associated vasculitis
270375|NCT02006121|Parkinson's disease|parkinson's disease
270376|NCT02006121|motor fluctuations|motor fluctuations
270377|NCT02006121|not well controlled|not well controlled
270378|NCT02006121|medical treatment|medical treatment
270379|NCT02006108|kidney|kidney
270380|NCT02006108|transplant|transplant
270381|NCT02006108|rejection|rejection
270382|NCT02006108|Feraheme|feraheme
270383|NCT02006108|ferumoxytol|ferumoxytol
270384|NCT02006095|carotid artery stenting|carotid artery stenting
270385|NCT02006095|carotid endarterectomy|carotid endarterectomy
270386|NCT02006095|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
270387|NCT02006095|neuropsychological testing|neuropsychological testing
270388|NCT02006095|microemboli|microemboli
270389|NCT02006082|Telemedicine video-consultation (TVC)|telemedicine video-consultation (tvc)
270390|NCT02006082|Re-admission to hospital|re-admission to hospital
270391|NCT02006082|Time to re-admission|time to re-admission
270392|NCT02006082|Length if hospital stay|length if hospital stay
270393|NCT02006082|Patient satisfaction|patient satisfaction
270394|NCT02006082|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
270395|NCT02006069|CRT, non responders, MultiPoint Pacing (MPP)|crt, non responders, multipoint pacing (mpp)
270396|NCT02006030|Unresectable Hepatocellular Carcinoma|unresectable hepatocellular carcinoma
270397|NCT02006030|Liver Cancer|liver cancer
270398|NCT02006030|ADI|adi
270399|NCT02006030|ADI-PEG 20|adi-peg 20
270400|NCT02006004|AML|aml
270401|NCT02005991|PF-05212377|pf-05212377
270402|NCT02005991|phase 1|phase 1
270403|NCT02005991|open-label|open-label
270404|NCT02005991|5-HT2a receptor occupancy|5-ht2a receptor occupancy
270405|NCT02005991|positron emission tomography|positron emission tomography
270406|NCT02005991|healthy subjects|healthy subjects
270407|NCT02005991|brain|brain
270408|NCT02005991|cortex|cortex
270409|NCT02005991|alzheimers disease|alzheimers disease
270410|NCT02005965|Rectal Cancer|rectal cancer
270411|NCT02005965|Low Rectal Cancer|low rectal cancer
270412|NCT02005965|MERCURY|mercury
270413|NCT02005965|Cancer|cancer
270414|NCT02005965|CRM|crm
270415|NCT02005965|Circumferential Margin|circumferential margin
270416|NCT02005965|Quality of Life|quality of life
270417|NCT02005965|MRI|mri
270418|NCT02005965|Radiology|radiology
270419|NCT02005965|Abdominoperineal Excision|abdominoperineal excision
270420|NCT02005965|Anterior Resection|anterior resection
270421|NCT02005965|Surgery|surgery
270422|NCT02005965|Pathology|pathology
270423|NCT02005939|Pomegranate|pomegranate
270424|NCT02005939|Blood pressure|blood pressure
270425|NCT02005939|Insulin sensitivity|insulin sensitivity
270426|NCT02005939|Cortisol|cortisol
270427|NCT02005939|Quality of life|quality of life
270428|NCT02005939|Body composition|body composition
270429|NCT02005926|Breast cancer|breast cancer
270430|NCT02005926|Sentinel lymph node biopsy|sentinel lymph node biopsy
270431|NCT02005926|Ultrasonography|ultrasonography
270432|NCT02005926|Fine needle aspiration|fine needle aspiration
270433|NCT02005900|DHA|dha
270434|NCT02005900|Omega 3|omega 3
270435|NCT02005900|Polyunsaturated Fatty Acids|polyunsaturated fatty acids
270436|NCT02005900|Dyslipidemia induced by HAART|dyslipidemia induced by haart
270437|NCT02005900|Lipid metabolic alterations|lipid metabolic alterations
270438|NCT02005900|HIV|hiv
270439|NCT02005887|Premenopausal patients|premenopausal patients
270440|NCT02005887|ER-positive|er-positive
270441|NCT02005887|PgR+ (>50%)|pgr+ (>50%)
270442|NCT02005887|HER2-negative or not amplified|her2-negative or not amplified
270443|NCT02005861|osteochondral lesion|osteochondral lesion
270444|NCT02005861|talus|talus
270445|NCT02005861|ankle|ankle
270446|NCT02005861|cartilage repair|cartilage repair
270447|NCT02005848|Type-1 Diabetes|type-1 diabetes
270448|NCT02005848|T1D|t1d
270449|NCT02005848|Diabetes Mellitus|diabetes mellitus
270450|NCT02005835|HIV|hiv
270451|NCT02005835|Option B+|option b+
270452|NCT02005835|Prevention of Mother to Child Transmission|prevention of mother to child transmission
270453|NCT02005822|Cytomegalovirus|cytomegalovirus
270454|NCT02005822|Congenital infection|congenital infection
270455|NCT02005822|Sensorineural hearing loss|sensorineural hearing loss
270456|NCT02005822|Valganciclovir|valganciclovir
270457|NCT02005809|Endoscopic submucosal dissection|endoscopic submucosal dissection
270458|NCT02005809|gastric neoplasm|gastric neoplasm
270459|NCT02005809|second look endoscopy|second look endoscopy
270460|NCT02005783|incidence of grade 3/4 neutropenia|incidence of grade 3/4 neutropenia
270461|NCT02005783|incidence of febrile neutropenia|incidence of febrile neutropenia
270462|NCT02005783|time to neutropenia recovery|time to neutropenia recovery
270463|NCT02005783|safety|safety
270464|NCT02005757|rheumatoid arthritis|rheumatoid arthritis
270465|NCT02005757|RA|ra
270466|NCT02005757|Mizoribine|mizoribine
270467|NCT02005757|DAS28|das28
270468|NCT02005757|European League Against Rheumatism|european league against rheumatism
270469|NCT02005744|CKD-501|ckd-501
270470|NCT02005731|Low Intensity Shockwave|low intensity shockwave
270471|NCT02005731|Extracorporeal shockwave therapy|extracorporeal shockwave therapy
270472|NCT02005731|Erectile dysfunction|erectile dysfunction
270473|NCT02005692|pressure ulcers|pressure ulcers
270474|NCT02005692|bed sores|bed sores
270475|NCT02005692|patient turn protocol|patient turn protocol
270476|NCT02005692|patient movement|patient movement
270477|NCT02005692|patient monitoring|patient monitoring
270478|NCT02005679|Prelingual Deafness|prelingual deafness
270479|NCT02005679|Retention Disorders, Cognitive|retention disorders, cognitive
270480|NCT02005679|Sign language|sign language
270481|NCT02005679|Mini-Mental State|mini-mental state
270482|NCT02005666|Acne Vulgaris|acne vulgaris
270483|NCT02005666|DUAC|duac
270484|NCT02005666|CADILA|cadila
270485|NCT02005666|CLIANTHA|cliantha
270486|NCT02005653|Lymphatic filariasis|lymphatic filariasis
270487|NCT02005653|W. bancrofti|w. bancrofti
270488|NCT02005653|DEC|dec
270489|NCT02005653|Albendazole|albendazole
270490|NCT02005653|Doxycycline|doxycycline
270491|NCT02005627|grass pollen allergy|grass pollen allergy
270492|NCT02005627|hayfever|hayfever
270493|NCT02005627|atopy|atopy
270494|NCT02005627|allergic rhinitis|allergic rhinitis
270495|NCT02005627|sublingual immunotherapy tablets|sublingual immunotherapy tablets
270496|NCT02005614|Rational dose selection|rational dose selection
270497|NCT02005614|gamma knife radiosurgery|gamma knife radiosurgery
270498|NCT02005588|amino acid chelated iron|amino acid chelated iron
270499|NCT02005588|iron salt|iron salt
270500|NCT02005588|iron deficiency anemia|iron deficiency anemia
270501|NCT02005536|Poliomyelitis|poliomyelitis
270502|NCT02005536|Poliovirus|poliovirus
270503|NCT02005536|Polio|polio
270504|NCT02005536|IMOVAX POLIO®|imovax polio®
270505|NCT02005536|Inactivated polio vaccine|inactivated polio vaccine
270506|NCT02005510|cervical cancer|cervical cancer
270507|NCT02005510|screening|screening
270508|NCT02005510|human papillomavirus|human papillomavirus
270509|NCT02005510|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
270510|NCT02005497|Cancer prevention and control|cancer prevention and control
270511|NCT02005497|Health promotion|health promotion
270512|NCT02005497|Workplace|workplace
270513|NCT02005497|Dissemination|dissemination
270514|NCT02005497|Implementation|implementation
270515|NCT02005458|Neutropenia|neutropenia
270516|NCT02005458|Febrile neutropenia|febrile neutropenia
270517|NCT02005458|PEG-rhG-CSF|peg-rhg-csf
270518|NCT02005458|Myelosuppressive chemotherapy|myelosuppressive chemotherapy
270519|NCT02005445|Obstructive sleep apnea|obstructive sleep apnea
270520|NCT02005445|Coronary heart disease|coronary heart disease
270521|NCT02005445|Cardiac rehabilitation|cardiac rehabilitation
270522|NCT02005445|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
270523|NCT02005432|Diabetis|diabetis
270524|NCT02005432|Retinal Neovascularization|retinal neovascularization
270525|NCT02005432|laser treatment|laser treatment
270526|NCT02005419|Pancreatic Cancer|pancreatic cancer
270527|NCT02005419|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
270528|NCT02005419|Metformin|metformin
270529|NCT02005419|Gemcitabine|gemcitabine
270530|NCT02005419|Adjuvant Therapy|adjuvant therapy
270531|NCT02005406|Wei JET|wei jet
270532|NCT02005393|FICE|fice
270533|NCT02005393|NBI|nbi
270534|NCT02005380|Alzheimer's Disease Rehabilitation|alzheimer's disease rehabilitation
270535|NCT02005367|substance use treatment|substance use treatment
270536|NCT02005367|person-centered treatment|person-centered treatment
270537|NCT02005367|residential treatment outcomes|residential treatment outcomes
270538|NCT02005367|dual diagnosis|dual diagnosis
270539|NCT02005367|recovery model|recovery model
270540|NCT02005367|psychosocial treatment|psychosocial treatment
270541|NCT02005354|Pain|pain
270542|NCT02005354|Bone marrow aspiration|bone marrow aspiration
270543|NCT02005354|trephine biopsy|trephine biopsy
270544|NCT02005341|Lumbar|lumbar
270545|NCT02005341|fusion|fusion
270546|NCT02005328|Xerostomia|xerostomia
270547|NCT02005328|hyposialia|hyposialia
270548|NCT02005328|hyposalivation|hyposalivation
270549|NCT02005328|saliva substitute|saliva substitute
270550|NCT02005328|Salivary Gland|salivary gland
270551|NCT02005328|Mouth Diseases|mouth diseases
270552|NCT02005328|Dry mouth|dry mouth
270553|NCT02005315|Pancreatic Cancer|pancreatic cancer
270554|NCT02005315|Stage IV Pancreatic Cancer|stage iv pancreatic cancer
270555|NCT02005302|chronic kidney disease|chronic kidney disease
270556|NCT02005302|mineral and bone disease|mineral and bone disease
270557|NCT02005302|Malnutrition|malnutrition
270558|NCT02005302|Vitamin D|vitamin d
270559|NCT02005302|low protein diet|low protein diet
270560|NCT02005289|CLL|cll
270561|NCT02005289|SLL|sll
270562|NCT02005289|PLL|pll
270563|NCT02005289|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
270564|NCT02005289|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
270565|NCT02005289|Prolymphocytic Leukemia|prolymphocytic leukemia
270566|NCT02005289|MOR00208|mor00208
270567|NCT02005289|MOR208|mor208
270568|NCT02005276|Sedentary|sedentary
270569|NCT02005276|Behavioral Economic Intervention|behavioral economic intervention
270570|NCT02005276|Team Studies|team studies
270571|NCT02005276|Financial Incentives|financial incentives
270572|NCT02005276|Workplace Wellness|workplace wellness
270573|NCT02005276|Team Incentives|team incentives
270574|NCT02005263|Hysteroscopy|hysteroscopy
270575|NCT02005250|osteoporosis|osteoporosis
270576|NCT02005250|hyperthyroidism|hyperthyroidism
270577|NCT02005250|hypothyroidism|hypothyroidism
270578|NCT02005237|Exercise|exercise
270579|NCT02005237|Cognition|cognition
270580|NCT02005237|Neuroimaging|neuroimaging
270581|NCT02005237|Rehabilitation|rehabilitation
270582|NCT02005237|Connectivity|connectivity
270583|NCT02005224|Insulin sensitivity|insulin sensitivity
270584|NCT02005224|Lipid profile|lipid profile
270585|NCT02005224|Body composition|body composition
270586|NCT02005224|Weight|weight
270587|NCT02005211|AZD3293|azd3293
270588|NCT02005211|Healthy volunteers|healthy volunteers
270589|NCT02005211|Young volunteers|young volunteers
270590|NCT02005211|Elderly volunteers|elderly volunteers
270591|NCT02005211|Japanese volunteers|japanese volunteers
270592|NCT02005211|Phase 1|phase 1
270593|NCT02005211|Single and multiple ascending dose study|single and multiple ascending dose study
270594|NCT02005172|arrhythmia, palpitations, lightheadedness|arrhythmia, palpitations, lightheadedness
270595|NCT02005159|Enterobacteria|enterobacteria
270596|NCT02005159|Bacteremia|bacteremia
270597|NCT02005159|Minimum inhibitory concentration|minimum inhibitory concentration
270598|NCT02005159|Susceptible|susceptible
270599|NCT02005159|Prognosis|prognosis
270600|NCT02005146|Hepatitis B|hepatitis b
270601|NCT02005146|Nucleoside/nucleotide|nucleoside/nucleotide
270602|NCT02005146|HBsAg loss|hbsag loss
270603|NCT02005133|Wet age-related macular degeneration|wet age-related macular degeneration
270604|NCT02005068|Osteoarticular infections|osteoarticular infections
270605|NCT02005068|Osteomyelitis|osteomyelitis
270606|NCT02005068|Joint infections|joint infections
270607|NCT02005068|MRSA (Methicillin- Resistant Staphylococcus Aureus)|mrsa (methicillin- resistant staphylococcus aureus)
270608|NCT02005068|MSSA (Methicillin- Susceptible Staphylococcus Aureus)|mssa (methicillin- susceptible staphylococcus aureus)
270609|NCT02005055|Brachytherapy|brachytherapy
270610|NCT02005055|Radiotherapy|radiotherapy
270611|NCT02005055|Scar treatment|scar treatment
270612|NCT02005042|Physical activity|physical activity
270613|NCT02005042|Ecological Momentary Assessment|ecological momentary assessment
270614|NCT02005042|Ecological Momentary Intervention|ecological momentary intervention
270615|NCT02005042|Accelerometer|accelerometer
270616|NCT02005042|Smartphone|smartphone
270617|NCT02005029|Parkinson's Disease|parkinson's disease
270618|NCT02005029|Levodopa|levodopa
270619|NCT02005029|motor fluctuations|motor fluctuations
270620|NCT02005029|gastroparesis|gastroparesis
270621|NCT02005016|Aphasia|aphasia
270622|NCT02005016|Language Therapy|language therapy
270623|NCT02005016|Acquired Language Disorders|acquired language disorders
270624|NCT02005016|Semantics|semantics
270625|NCT02005016|Stroke|stroke
270626|NCT02004990|Children, Plaque|children, plaque
270627|NCT02004951|Superficial femoral artery|superficial femoral artery
270628|NCT02004951|paclitaxel|paclitaxel
270629|NCT02004951|stent|stent
270630|NCT02004951|self expandable|self expandable
270631|NCT02004951|restenosis|restenosis
270632|NCT02004951|endovascular|endovascular
270633|NCT02004951|above-the-knee intermediate length|above-the-knee intermediate length
270634|NCT02004938|measurements|measurements
270635|NCT02004938|jugular|jugular
270636|NCT02004938|ultrasound|ultrasound
270637|NCT02004938|pediatric|pediatric
270638|NCT02004938|respiratory|respiratory
270639|NCT02004938|diameter|diameter
270640|NCT02004925|pneumoperitoneum|pneumoperitoneum
270641|NCT02004925|free peritoneal air|free peritoneal air
270642|NCT02004925|ultrasonography|ultrasonography
270643|NCT02004912|maternal|maternal
270644|NCT02004912|neonatal|neonatal
270645|NCT02004912|child|child
270646|NCT02004912|health services|health services
270647|NCT02004912|health care|health care
270648|NCT02004912|Karnataka|karnataka
270649|NCT02004912|India|india
270650|NCT02004899|Labor epidural analgesia|labor epidural analgesia
270651|NCT02004899|Fentanyl|fentanyl
270652|NCT02004899|Bupivacaine|bupivacaine
270653|NCT02004899|Onset|onset
270654|NCT02004886|Diabetes Mellitus|diabetes mellitus
270655|NCT02004886|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
270656|NCT02004886|Glucose Metabolism Disorders|glucose metabolism disorders
270657|NCT02004886|Metabolic Diseases|metabolic diseases
270658|NCT02004886|Endocrine System Diseases|endocrine system diseases
270659|NCT02004886|Therapeutic Uses|therapeutic uses
270660|NCT02004886|Pharmacologic Actions|pharmacologic actions
270661|NCT02004886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
270662|NCT02004886|Physiological Effects of Drugs|physiological effects of drugs
270663|NCT02004886|Metformin|metformin
270664|NCT02004873|pacemaker|pacemaker
270665|NCT02004873|leadless|leadless
270666|NCT02004873|single chamber|single chamber
270667|NCT02004860|local immunosuppressive|local immunosuppressive
270668|NCT02004860|Maintenance therapy|maintenance therapy
270669|NCT02004795|Boron Neutron Capture Therapy|boron neutron capture therapy
270670|NCT02004795|Image-guided intensity modulation radiotherapy|image-guided intensity modulation radiotherapy
270671|NCT02004769|Metastatic gastric or gastro-esophageal junction cancer|metastatic gastric or gastro-esophageal junction cancer
270672|NCT02004769|Trastuzumab|trastuzumab
270673|NCT02004769|HER2-positive|her2-positive
270674|NCT02004769|Capecitabine|capecitabine
270675|NCT02004769|Docetaxel|docetaxel
270676|NCT02004769|First-line therapy|first-line therapy
270677|NCT02004756|pediatric|pediatric
270678|NCT02004756|fontan|fontan
270679|NCT02004756|congenital heart disease|congenital heart disease
270680|NCT02004756|cardiac and musculoskeletal funion|cardiac and musculoskeletal funion
270681|NCT02004756|cardiac and/or musculoskeletal metabolism|cardiac and/or musculoskeletal metabolism
270682|NCT02004756|exercise training intervention|exercise training intervention
270683|NCT02004743|Early Intervention|early intervention
270684|NCT02004743|Prevention|prevention
270685|NCT02004743|Risk Factors|risk factors
270686|NCT02004743|Exposure Therapy|exposure therapy
270687|NCT02004743|Psychoeducation|psychoeducation
270688|NCT02004717|advanced solid tumor|advanced solid tumor
270689|NCT02004717|Phase 1|phase 1
270690|NCT02004717|Oncology|oncology
270691|NCT02004652|Prucalopride|prucalopride
270692|NCT02004652|Gastrointestinal Diseases|gastrointestinal diseases
270693|NCT02004652|Postoperative ileus|postoperative ileus
270694|NCT02004652|Randomised trial|randomised trial
270695|NCT02004639|IMRT or HT with chemotherapy|imrt or ht with chemotherapy
270696|NCT02004626|Collagenase|collagenase
270697|NCT02004626|Phase III|phase iii
270698|NCT02004626|National|national
270699|NCT02004626|Noninferiority|noninferiority
270700|NCT02004626|Double-blind|double-blind
270701|NCT02004626|Multicenter|multicenter
270702|NCT02004626|Prospective.|prospective.
270703|NCT02004587|Hepatic impairment|hepatic impairment
270704|NCT02004587|Pharmacokinetics|pharmacokinetics
270705|NCT02004587|Pharmacodynamics|pharmacodynamics
270706|NCT02004587|Gemigliptin|gemigliptin
270707|NCT02004561|bariatric_surgery|bariatric_surgery
270708|NCT02004561|pediatric obesity|pediatric obesity
270709|NCT02004561|diabetes|diabetes
270710|NCT02004535|Hearing loss|hearing loss
270711|NCT02004535|Asymmetric hearing loss|asymmetric hearing loss
270712|NCT02004535|Cochlear implantation|cochlear implantation
270713|NCT02004522|Phase 3|phase 3
270714|NCT02004522|CLL/SLL|cll/sll
270715|NCT02004522|Pi3K|pi3k
270716|NCT02004509|atrial fibrillation|atrial fibrillation
270717|NCT02004509|stroke|stroke
270718|NCT02004509|pacemaker|pacemaker
270719|NCT02004509|anticoagulant|anticoagulant
270720|NCT02004483|percutaneous coronary intervention|percutaneous coronary intervention
270721|NCT02004483|ischemia|ischemia
270722|NCT02004483|strain|strain
270723|NCT02004483|coronary stenosis|coronary stenosis
270724|NCT02004470|post laparoscopic shoulder pain|post laparoscopic shoulder pain
270725|NCT02004470|active suction|active suction
270726|NCT02004470|lavage and suction|lavage and suction
270727|NCT02004470|right shoulder pain|right shoulder pain
270728|NCT02004470|post operative shoulder pain|post operative shoulder pain
270730|NCT02004457|Primary care|primary care
270731|NCT02004457|Engagement|engagement
270732|NCT02004457|Acceptance|acceptance
270733|NCT02004457|Disclosure|disclosure
270734|NCT02004457|Stigma|stigma
270735|NCT02004444|JC Virus|jc virus
270736|NCT02004444|Natalizumab|natalizumab
270737|NCT02004431|Chronic post surgical pain|chronic post surgical pain
270738|NCT02004431|Orthopaedic|orthopaedic
270739|NCT02004431|Anxiety|anxiety
270740|NCT02004431|depression|depression
270741|NCT02004418|C-Choline PET scans|c-choline pet scans
270742|NCT02004418|external beam radiotherapy|external beam radiotherapy
270743|NCT02004405|autonomic nervous system|autonomic nervous system
270744|NCT02004405|fibromyalgia|fibromyalgia
270745|NCT02004405|autonomic dysfunction|autonomic dysfunction
270746|NCT02004405|strengthening|strengthening
270747|NCT02004405|flexibility|flexibility
270748|NCT02004405|exercise|exercise
270749|NCT02004405|heart rate variability|heart rate variability
270750|NCT02004392|Alzheimer's disease|alzheimer's disease
270751|NCT02004392|Cognition|cognition
270752|NCT02004392|Alpha-7 nAChR|alpha-7 nachr
270753|NCT02004379|HCV|hcv
270754|NCT02004379|Hepatitis C|hepatitis c
270755|NCT02004379|telaprevir|telaprevir
270756|NCT02004379|boceprevir|boceprevir
270757|NCT02004379|clinical practice|clinical practice
270758|NCT02004366|Diabetes|diabetes
270759|NCT02004366|Linagliptin|linagliptin
270760|NCT02004366|hospital hyperglycemia|hospital hyperglycemia
270761|NCT02004366|inpatient diabetes|inpatient diabetes
270762|NCT02004353|Cochlear® Hearing Implants|cochlear® hearing implants
270763|NCT02004340|pediatric epilepsy|pediatric epilepsy
270764|NCT02004340|transcutaneous vagus nerve stimulation|transcutaneous vagus nerve stimulation
270765|NCT02004314|Chloroquine|chloroquine
270766|NCT02004314|T cell immune activation|t cell immune activation
270767|NCT02004314|CD4 recovery|cd4 recovery
270768|NCT02004314|HIV|hiv
270769|NCT02004301|Formulation behaviour|formulation behaviour
270770|NCT02004301|Drug absorption profile|drug absorption profile
270771|NCT02004288|Probiotics|probiotics
270772|NCT02004288|Anorexia nervosa|anorexia nervosa
270773|NCT02004288|Constipation|constipation
270774|NCT02004288|Body weight|body weight
270775|NCT02004262|cancer|cancer
270776|NCT02004262|cancer vaccine|cancer vaccine
270777|NCT02004262|Listeria monocytogenes|listeria monocytogenes
270778|NCT02004262|Listeria-based vaccine|listeria-based vaccine
270779|NCT02004262|GVAX|gvax
270780|NCT02004262|cyclophosphamide|cyclophosphamide
270781|NCT02004262|Cytoxan|cytoxan
270782|NCT02004262|immunotherapy|immunotherapy
270783|NCT02004262|mesothelin|mesothelin
270784|NCT02004236|tRNS|trns
270785|NCT02004236|QEEG|qeeg
270786|NCT02004236|ERP|erp
270787|NCT02004236|ASD|asd
270788|NCT02004236|Autism|autism
270789|NCT02004236|verbal fluency|verbal fluency
270790|NCT02004236|empathy|empathy
270791|NCT02004236|noninvasive brain stimulation|noninvasive brain stimulation
270792|NCT02004236|tDCS|tdcs
270793|NCT02004223|Prostate Cancer|prostate cancer
270794|NCT02004223|Dose escalation|dose escalation
270795|NCT02004223|Stereotactic|stereotactic
270796|NCT02004223|SBRT|sbrt
270797|NCT02004223|Hypofractionation|hypofractionation
270798|NCT02004210|transarterial chemoembolization|transarterial chemoembolization
270799|NCT02004210|transarterial radioembolization|transarterial radioembolization
270800|NCT02004210|advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
270801|NCT02004184|Pemetrexed|pemetrexed
270802|NCT02004184|drug therapy|drug therapy
270803|NCT02004171|electronic cigarette|electronic cigarette
270804|NCT02004171|nicotine inhaler|nicotine inhaler
270805|NCT02004171|smoking cessation|smoking cessation
270806|NCT02004158|Acute coronary syndrome|acute coronary syndrome
270807|NCT02004158|Health behavior|health behavior
270808|NCT02004158|Mental health|mental health
270809|NCT02004145|MDD|mdd
270810|NCT02004145|Positive Psychology|positive psychology
270811|NCT02004145|Suicidality|suicidality
270812|NCT02004080|TBI|tbi
270813|NCT02004080|ICU|icu
270814|NCT02004080|Comparative Effectiveness Research|comparative effectiveness research
270815|NCT02004067|Evaporative|evaporative
270816|NCT02004067|Aqueous deficient|aqueous deficient
270817|NCT02004067|Dry eye disease|dry eye disease
270818|NCT02004054|multiple sclerosis|multiple sclerosis
270819|NCT02004054|diameter pupil|diameter pupil
270820|NCT02004041|pruritus|pruritus
270821|NCT02004041|atopic dermatitis|atopic dermatitis
270822|NCT02004041|VLY-686|vly-686
270823|NCT02004028|Mesothelioma|mesothelioma
270824|NCT02004028|adenoma|adenoma
270825|NCT02004028|Neoplasms, Mesothelial|neoplasms, mesothelial
270826|NCT02004028|Focal Adhesion Kinase Inhibitor|focal adhesion kinase inhibitor
270827|NCT02004015|Analytical|analytical
270828|NCT02004015|Diagnostic|diagnostic
270829|NCT02004015|Anesthesia|anesthesia
270830|NCT02004015|Analgesia|analgesia
270831|NCT02003976|knee osteoarthritis|knee osteoarthritis
270832|NCT02003976|high tibial osteotomy|high tibial osteotomy
270833|NCT02003976|gait analysis|gait analysis
270834|NCT02003976|muscular strength|muscular strength
270835|NCT02003976|body composition|body composition
270836|NCT02003976|magnetic resonance imaging|magnetic resonance imaging
270837|NCT02003976|biological markers|biological markers
270838|NCT02003963|Physical Activity|physical activity
270839|NCT02003963|Sedentary Behavior|sedentary behavior
270840|NCT02003963|Video Games|video games
270841|NCT02003963|Exergames|exergames
270842|NCT02003911|Asthma|asthma
270843|NCT02003911|Acute asthma exacerbation|acute asthma exacerbation
270844|NCT02003911|Pediatric|pediatric
270845|NCT02003911|Azithromycin|azithromycin
270846|NCT02003911|Macrolide|macrolide
270847|NCT02003911|Length of Stay|length of stay
270848|NCT02003911|Hospital Medicine|hospital medicine
270849|NCT02003898|Diabetes|diabetes
270850|NCT02003898|Insulin pump|insulin pump
270851|NCT02003898|Threshold Suspend|threshold suspend
270852|NCT02003885|Desflurane, mitral annular velocity, tissue Doppler imaging|desflurane, mitral annular velocity, tissue doppler imaging
270853|NCT02003859|IBD|ibd
270854|NCT02003859|Pediatrics|pediatrics
270855|NCT02003859|pCLE|pcle
270856|NCT02003833|Poly-L-lactic acid|poly-l-lactic acid
270857|NCT02003833|Sculptra Aesthetic|sculptra aesthetic
270858|NCT02003833|Skin Quality|skin quality
270859|NCT02003833|Wrinkles|wrinkles
270860|NCT02003833|Filler|filler
270861|NCT02003820|Autism|autism
270862|NCT02003820|Dental Caries|dental caries
270863|NCT02003820|Prevention|prevention
270864|NCT02003820|Oral Hygiene|oral hygiene
270865|NCT02003794|acute ischemic stroke|acute ischemic stroke
270866|NCT02003794|intravenous fluid|intravenous fluid
270867|NCT02003794|้hydration|้hydration
270868|NCT02003781|cardiovascular disease|cardiovascular disease
270869|NCT02003781|metabolic disease|metabolic disease
270870|NCT02003781|high risk|high risk
270871|NCT02003781|prospective cohort|prospective cohort
270872|NCT02003768|pneumoperitoneum|pneumoperitoneum
270873|NCT02003768|optic nerve sheath diameter|optic nerve sheath diameter
270874|NCT02003768|laparoscopy|laparoscopy
270875|NCT02003768|Patients|patients
270876|NCT02003768|general anesthesia|general anesthesia
270877|NCT02003768|diameter|diameter
270878|NCT02003755|Cerebral palsy|cerebral palsy
270879|NCT02003755|Continuous passive motion|continuous passive motion
270880|NCT02003755|Hypertonia|hypertonia
270881|NCT02003742|LUTS|luts
270882|NCT02003742|BPH|bph
270883|NCT02003729|obstructive sleep apnea|obstructive sleep apnea
270884|NCT02003729|Portable Monitor|portable monitor
270885|NCT02003729|AHI|ahi
270886|NCT02003729|ESS|ess
270887|NCT02003729|Cost effectiveness|cost effectiveness
270888|NCT02003703|Vaccine|vaccine
270889|NCT02003703|Primary Prevention|primary prevention
270890|NCT02003703|Immunogenicity|immunogenicity
270891|NCT02003690|Bipolar disorder|bipolar disorder
270892|NCT02003690|Adolescent suicidal behavior|adolescent suicidal behavior
270893|NCT02003690|Psychotherapy|psychotherapy
270894|NCT02003664|Cocaine|cocaine
270895|NCT02003664|Treatment|treatment
270896|NCT02003664|fMRI|fmri
270897|NCT02003664|Outcomes|outcomes
270898|NCT02003651|Common cold|common cold
270899|NCT02003625|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
270900|NCT02003625|Hodgkin's lymphoma|hodgkin's lymphoma
270901|NCT02003625|Multiple myeloma|multiple myeloma
270902|NCT02003625|Hematopoietic stem cells|hematopoietic stem cells
270903|NCT02003599|Radiodermatitis|radiodermatitis
270904|NCT02003599|Breast neoplasms|breast neoplasms
270905|NCT02003599|Laser Therapy, Low- Level|laser therapy, low- level
270906|NCT02003586|subjects|subjects
270907|NCT02003560|breast cancer|breast cancer
270908|NCT02003560|breast conserving therapy|breast conserving therapy
270909|NCT02003560|accelerated partial breast irradiation|accelerated partial breast irradiation
270910|NCT02003560|3D conformal radiotherapy|3d conformal radiotherapy
270911|NCT02003560|intensity modulated radiotherapy|intensity modulated radiotherapy
270912|NCT02003521|Lung Flute|lung flute
270913|NCT02003508|Prevalence|prevalence
270914|NCT02003508|HPV|hpv
270915|NCT02003508|Human papillomavirus|human papillomavirus
270916|NCT02003508|Vaccination|vaccination
270917|NCT02003495|Immunogenicity, Safety, Meningococcal Conjugate Vaccine|immunogenicity, safety, meningococcal conjugate vaccine
270918|NCT02003482|Head and Neck Cancer|head and neck cancer
270919|NCT02003482|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
270920|NCT02003482|Intensity modulated radiation therapy|intensity modulated radiation therapy
270921|NCT02003482|IMRT|imrt
270922|NCT02003482|Anatomic Changes|anatomic changes
270923|NCT02003482|Postoperative|postoperative
270924|NCT02003482|Unresectable|unresectable
270925|NCT02003469|hypertension|hypertension
270926|NCT02003469|kidney disease|kidney disease
270927|NCT02003469|cardiovascular disease|cardiovascular disease
270928|NCT02003456|positron emission tomography|positron emission tomography
270929|NCT02003456|rubidium|rubidium
270930|NCT02003456|myocardial perfusion imaging|myocardial perfusion imaging
270931|NCT02003456|viability|viability
270932|NCT02003456|FDG|fdg
270933|NCT02003443|Acupressure|acupressure
270934|NCT02003443|Older Adults|older adults
270935|NCT02003443|Knee pain|knee pain
270936|NCT02003443|Pain Treatment|pain treatment
270937|NCT02003430|gynecologic malignancy|gynecologic malignancy
270938|NCT02003430|non-ovarian gynecological cancer|non-ovarian gynecological cancer
270939|NCT02003430|cervical cancer|cervical cancer
270940|NCT02003430|vaginal cancer|vaginal cancer
270941|NCT02003430|vulvar cancer|vulvar cancer
270942|NCT02003430|endometrial cancer|endometrial cancer
270943|NCT02003417|Prostate cancer|prostate cancer
270944|NCT02003417|External beam radiation treatment|external beam radiation treatment
270945|NCT02003417|Androgen deprivation therapy|androgen deprivation therapy
270946|NCT02003417|Definitive treatment|definitive treatment
270947|NCT02003417|Cardiovascular risk factors|cardiovascular risk factors
270948|NCT02003417|Quality of life|quality of life
270949|NCT02003404|ostomy appliance|ostomy appliance
270950|NCT02003391|Open Angle Glaucoma|open angle glaucoma
270951|NCT02003391|Ocular Hypertension|ocular hypertension
270952|NCT02003391|Intraocular Pressure|intraocular pressure
270953|NCT02003378|Chronotropic incompetence|chronotropic incompetence
270954|NCT02003365|osteoarthritis|osteoarthritis
270955|NCT02003365|knee|knee
270956|NCT02003365|corticosteroids|corticosteroids
270957|NCT02003365|triamcinolone acetonide|triamcinolone acetonide
270958|NCT02003365|synovial fluid|synovial fluid
270959|NCT02003352|TBI|tbi
270960|NCT02003352|PTSD|ptsd
270961|NCT02003352|Functional Neurology|functional neurology
270962|NCT02003352|Vestibular Rehabilitation|vestibular rehabilitation
270963|NCT02003352|Dynamic Computerized Posturography|dynamic computerized posturography
270964|NCT02003352|Saccadometry|saccadometry
270965|NCT02003313|safety, immunogenicity, Meningococcal Polysaccharide Vaccine|safety, immunogenicity, meningococcal polysaccharide vaccine
270966|NCT02003300|Oxygen uptake|oxygen uptake
270967|NCT02003300|Anesthetic gas uptake|anesthetic gas uptake
270968|NCT02003287|Deglutition Disorders|deglutition disorders
270969|NCT02003287|Intensive Care Units, Neonatal|intensive care units, neonatal
270970|NCT02003274|Mixed Meal Test|mixed meal test
270971|NCT02003274|Insulin Pump|insulin pump
270972|NCT02003274|Continuous Glucose Monitoring|continuous glucose monitoring
270973|NCT02003274|Metabolic Control Analysis|metabolic control analysis
270974|NCT02003274|Closed Loop Control|closed loop control
270975|NCT02003274|Artificial Pancreas|artificial pancreas
270976|NCT02003248|Parkinson's disease|parkinson's disease
270977|NCT02003248|ultrasound|ultrasound
270978|NCT02003248|dyskinesia|dyskinesia
270979|NCT02003248|magnetic resonance|magnetic resonance
270980|NCT02003235|Amblyopia|amblyopia
270981|NCT02003196|Brain injury|brain injury
270982|NCT02003196|virus|virus
270983|NCT02003196|immunosuppression|immunosuppression
270984|NCT02003196|mechanical ventilation|mechanical ventilation
270985|NCT02003183|CTE|cte
270986|NCT02003183|TBI|tbi
270987|NCT02003183|Cognitive Impairment|cognitive impairment
270988|NCT02003183|Brain Imaging|brain imaging
270989|NCT02003183|PET|pet
270990|NCT02003170|Autism|autism
270991|NCT02003170|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
270992|NCT02003170|Pervasive Developmental Disorder (PDD)|pervasive developmental disorder (pdd)
270993|NCT02003170|Developmental delays|developmental delays
270994|NCT02003170|Genetic disorder|genetic disorder
270995|NCT02003170|Mitochondrial disorder|mitochondrial disorder
270996|NCT02003157|hypnosis embryo transfer IVF ICSI|hypnosis embryo transfer ivf icsi
270997|NCT02003144|Long-term safety study|long-term safety study
270998|NCT02003144|Extension trial|extension trial
270999|NCT02003144|Eculizumab|eculizumab
271000|NCT02003144|Neuromyelitis Optica Spectrum Disorder|neuromyelitis optica spectrum disorder
271001|NCT02003144|Devic's disease|devic's disease
271002|NCT02003144|Transverse Myelitis|transverse myelitis
271003|NCT02003144|Optic Neuritis|optic neuritis
271004|NCT02003144|Relapse|relapse
271005|NCT02003144|NMO-IgG|nmo-igg
271006|NCT02003144|CNS Autoimmune Disorders|cns autoimmune disorders
271007|NCT02003144|Demyelinating Disorders|demyelinating disorders
271008|NCT02003131|osteoarthritis|osteoarthritis
271009|NCT02003131|umbilical cord|umbilical cord
271010|NCT02003131|mesenchymal|mesenchymal
271011|NCT02003131|stem cells|stem cells
271012|NCT02003131|trophic factors|trophic factors
271013|NCT02003092|Metastatic|metastatic
271014|NCT02003092|Rexahn|rexahn
271015|NCT02003092|Phase 1|phase 1
271016|NCT02003092|Triple Negative Breast Cancer|triple negative breast cancer
271017|NCT02003092|Phase 2|phase 2
271018|NCT02003092|Relapsed|relapsed
271019|NCT02003066|Fluid Therapy|fluid therapy
271020|NCT02003066|Head and Neck Neoplasms|head and neck neoplasms
271021|NCT02003066|Surgical Flaps|surgical flaps
271022|NCT02003053|Critically ill|critically ill
271023|NCT02003053|intubated|intubated
271024|NCT02003053|safety|safety
271025|NCT02003053|feasibility|feasibility
271026|NCT02003053|inspiratory muscle training|inspiratory muscle training
271027|NCT02003014|Drug Therapy|drug therapy
271028|NCT02002975|Drug Therapy|drug therapy
271029|NCT02002949|Hemodialysis|hemodialysis
271030|NCT02002910|iFR|ifr
271031|NCT02002910|FFR|ffr
271032|NCT02002910|Medical Economy|medical economy
271033|NCT02002910|physiological assessment|physiological assessment
271034|NCT02002910|SYNTAX score|syntax score
271035|NCT02002897|Localized scleroderma UVA1 fractional carbon dioxide laser|localized scleroderma uva1 fractional carbon dioxide laser
271036|NCT02002884|Upper limb spasticity|upper limb spasticity
271037|NCT02002884|lower limb spasticity|lower limb spasticity
271038|NCT02002884|combined upper and lower limb spasticity|combined upper and lower limb spasticity
271039|NCT02002858|smoking|smoking
271040|NCT02002858|cessation|cessation
271041|NCT02002858|anxiety|anxiety
271042|NCT02002858|anxious|anxious
271043|NCT02002858|depression|depression
271044|NCT02002858|depressed|depressed
271045|NCT02002858|smoker|smoker
271046|NCT02002858|stress|stress
271047|NCT02002845|Tongue base resection, partial glossectomy|tongue base resection, partial glossectomy
271048|NCT02002819|Alzheimer's disease|alzheimer's disease
271049|NCT02002819|AD|ad
271050|NCT02002819|Early-onset AD|early-onset ad
271051|NCT02002819|EOAD|eoad
271052|NCT02002819|Early-onset Alzheimer's|early-onset alzheimer's
271053|NCT02002819|Early-onset Alzheimer's disease|early-onset alzheimer's disease
271054|NCT02002806|Pancreatic cancer|pancreatic cancer
271055|NCT02002806|Pain|pain
271056|NCT02002793|pancreatitis|pancreatitis
271057|NCT02002793|early stage|early stage
271058|NCT02002793|mini-invasive abdominal drainage|mini-invasive abdominal drainage
271059|NCT02002780|pediatrics|pediatrics
271060|NCT02002780|stress|stress
271061|NCT02002780|cardiac surgery|cardiac surgery
271062|NCT02002754|eosinophilic bronchitis|eosinophilic bronchitis
271063|NCT02002754|cough variant asthma|cough variant asthma
271064|NCT02002754|bronchodilator|bronchodilator
271065|NCT02002741|patent ductus arteriosus|patent ductus arteriosus
271066|NCT02002741|PDA|pda
271067|NCT02002741|Preterm|preterm
271068|NCT02002741|Infant|infant
271069|NCT02002741|Electrocardiography|electrocardiography
271070|NCT02002741|Paracetamol|paracetamol
271071|NCT02002741|Acamol|acamol
271072|NCT02002741|ibuprofen|ibuprofen
271073|NCT02002741|Placebo|placebo
271074|NCT02002715|eosinophilic bronchitis|eosinophilic bronchitis
271075|NCT02002715|inhaled corticosteroids|inhaled corticosteroids
271076|NCT02002715|therapeutic effect|therapeutic effect
271077|NCT02002702|Acute heart failure (AHF),|acute heart failure (ahf),
271078|NCT02002702|Japanese,|japanese,
271079|NCT02002702|Safety and tolerability, Pharmacokinetics,|safety and tolerability, pharmacokinetics,
271080|NCT02002702|Renal Impairment|renal impairment
271081|NCT02002689|Solid tumor malignancy,|solid tumor malignancy,
271082|NCT02002689|hematologic malignancy,|hematologic malignancy,
271083|NCT02002689|mutation, translocations,|mutation, translocations,
271084|NCT02002689|signature,|signature,
271085|NCT02002689|PTCH1,|ptch1,
271086|NCT02002689|SMO,|smo,
271087|NCT02002689|LDE225,|lde225,
271088|NCT02002689|endometrial cancer,|endometrial cancer,
271089|NCT02002689|colon cancer,|colon cancer,
271090|NCT02002689|bladder,|bladder,
271091|NCT02002689|NSCLC|nsclc
271092|NCT02002676|rest energy expenditure,critical ill, outcome|rest energy expenditure,critical ill, outcome
271093|NCT02002650|Indomethacin, pancreatitis, ERCP|indomethacin, pancreatitis, ercp
271094|NCT02002611|Lobeglitazone|lobeglitazone
271095|NCT02002611|Warfarin|warfarin
271096|NCT02002611|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
271097|NCT02002611|Drug-Drug interaction|drug-drug interaction
271098|NCT02002611|Phase 1|phase 1
271099|NCT02002598|Newly diagnosed|newly diagnosed
271100|NCT02002598|multiple myeloma|multiple myeloma
271101|NCT02002598|myeloma|myeloma
271102|NCT02002598|bendamustine|bendamustine
271103|NCT02002598|treanda|treanda
271104|NCT02002598|carfilzomib|carfilzomib
271105|NCT02002598|dexamethasone|dexamethasone
271106|NCT02002598|phase I|phase i
271107|NCT02002598|phase II|phase ii
271108|NCT02002598|dose escalation|dose escalation
271109|NCT02002598|transplant|transplant
271110|NCT02002598|non-transplant, plasma cells|non-transplant, plasma cells
271111|NCT02002585|Renal protection|renal protection
271112|NCT02002585|Renal sympathetic denervation|renal sympathetic denervation
271113|NCT02002572|Facial Mimic Muscle|facial mimic muscle
271114|NCT02002572|MRI|mri
271115|NCT02002572|Segmentation|segmentation
271116|NCT02002572|Three dimensional assessment|three dimensional assessment
271117|NCT02002572|Motion capture|motion capture
271118|NCT02002572|Movement analysis|movement analysis
271119|NCT02002572|Digital Image Correlation|digital image correlation
271120|NCT02002546|Heart Attack|heart attack
271121|NCT02002546|Myocardial Infarction|myocardial infarction
271122|NCT02002546|Angina|angina
271123|NCT02002546|Chest Pain|chest pain
271124|NCT02002520|Acute pain|acute pain
271125|NCT02002520|Epigenetic|epigenetic
271126|NCT02002520|Dental pain|dental pain
271127|NCT02002468|Risk Communication|risk communication
271128|NCT02002468|Follow-up|follow-up
271129|NCT02002468|Organisation of screening|organisation of screening
271130|NCT02002455|FACBC|facbc
271131|NCT02002455|PET/CT|pet/ct
271132|NCT02002455|PET/MRI|pet/mri
271133|NCT02002455|Radical prostatectomy|radical prostatectomy
271134|NCT02002455|Radiotherapy|radiotherapy
271135|NCT02002442|Mouthwash|mouthwash
271136|NCT02002442|Chlorhexidine|chlorhexidine
271137|NCT02002442|cetylpyridinium chloride|cetylpyridinium chloride
271138|NCT02002442|Saline|saline
271139|NCT02002442|Implants|implants
271140|NCT02002442|Saliva Collection|saliva collection
271141|NCT02002429|Facet joint|facet joint
271142|NCT02002429|Medial branch block|medial branch block
271143|NCT02002429|Radiofrequency denervation|radiofrequency denervation
271144|NCT02002429|Zygapophysial joint|zygapophysial joint
271145|NCT02002429|Low back pain|low back pain
271146|NCT02002416|C-met expression, gastric cancer, overall survival|c-met expression, gastric cancer, overall survival
271147|NCT02002403|Edema|edema
271148|NCT02002403|Macular Edema|macular edema
271149|NCT02002403|Retinal Diseases|retinal diseases
271150|NCT02002403|Eye Diseases|eye diseases
271151|NCT02002403|Danazol|danazol
271152|NCT02002403|Estrogen Antagonists|estrogen antagonists
271153|NCT02002403|Estrogen Receptor Modulators|estrogen receptor modulators
271154|NCT02002403|Hormone Antagonists|hormone antagonists
271155|NCT02002403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
271249|NCT02001961|MRI|mri
271156|NCT02002403|Physiological Effects of Drugs|physiological effects of drugs
271157|NCT02002403|Pharmacologic Actions|pharmacologic actions
271158|NCT02002390|Stroke,Fingolimod(FTY 720), treatment|stroke,fingolimod(fty 720), treatment
271159|NCT02002377|Age Related Macular Degeneration, wet|age related macular degeneration, wet
271160|NCT02002377|aflibercept|aflibercept
271161|NCT02002364|tracheal intubation|tracheal intubation
271162|NCT02002338|pterygium surgery|pterygium surgery
271163|NCT02002338|refractive changes|refractive changes
271164|NCT02002338|surgical technique|surgical technique
271165|NCT02002312|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
271166|NCT02002312|Clear Cell Renal Cell Carcinoma (ccRCC)|clear cell renal cell carcinoma (ccrcc)
271167|NCT02002312|Lutetium-177|lutetium-177
271168|NCT02002312|Lu-177|lu-177
271169|NCT02002312|girentuximab|girentuximab
271170|NCT02002312|cG250|cg250
271171|NCT02002312|Monoclonal Antibody|monoclonal antibody
271172|NCT02002299|colorectal cancer|colorectal cancer
271173|NCT02002299|surface|surface
271174|NCT02002299|invasive front|invasive front
271175|NCT02002299|tumor budding|tumor budding
271176|NCT02002286|HIV-infected immunological non-responders|hiv-infected immunological non-responders
271177|NCT02002286|Tripterygium Wilfordii Hook F|tripterygium wilfordii hook f
271178|NCT02002286|Immune activation|immune activation
271179|NCT02002247|antioxidants|antioxidants
271180|NCT02002247|selenium|selenium
271181|NCT02002247|heart disease|heart disease
271182|NCT02002247|cardiac surgery|cardiac surgery
271183|NCT02002247|perioperative|perioperative
271184|NCT02002234|Hemicraniectomy, stroke, decompressive surgery, HeMMI|hemicraniectomy, stroke, decompressive surgery, hemmi
271185|NCT02002221|Diabetes Mellitus (DM) ,|diabetes mellitus (dm) ,
271186|NCT02002221|diabetes,|diabetes,
271187|NCT02002221|noninsulin-dependent diabetes mellitus (NIDDM),|noninsulin-dependent diabetes mellitus (niddm),
271188|NCT02002221|adult-onset diabetes,|adult-onset diabetes,
271189|NCT02002221|high blood sugar,|high blood sugar,
271190|NCT02002221|T2DM|t2dm
271191|NCT02002195|metastatic gastric cancer,|metastatic gastric cancer,
271192|NCT02002195|elderly,|elderly,
271193|NCT02002195|folinic acid,|folinic acid,
271194|NCT02002195|fluorouracil,|fluorouracil,
271195|NCT02002195|oxaliplatin,|oxaliplatin,
271196|NCT02002195|capecitabine,|capecitabine,
271197|NCT02002195|overall survival,|overall survival,
271198|NCT02002195|progression free survival|progression free survival
271199|NCT02002182|HPV|hpv
271200|NCT02002182|oropharynx|oropharynx
271201|NCT02002182|squamous cell carcinoma|squamous cell carcinoma
271202|NCT02002182|head and neck cancer|head and neck cancer
271203|NCT02002182|transoral robotic surgery|transoral robotic surgery
271204|NCT02002169|Catheter Related Bacteremia|catheter related bacteremia
271205|NCT02002143|Diabetes|diabetes
271206|NCT02002143|Older People|older people
271207|NCT02002143|Seniors|seniors
271208|NCT02002143|Group Appointments|group appointments
271209|NCT02002143|Group Medical Visits|group medical visits
271210|NCT02002143|Shared Appointments|shared appointments
271211|NCT02002143|Quality of Life|quality of life
271212|NCT02002143|Physical Activity|physical activity
271213|NCT02002143|Health care Utilization|health care utilization
271214|NCT02002143|Depression|depression
271215|NCT02002143|Anxiety|anxiety
271216|NCT02002130|Diabetes|diabetes
271217|NCT02002104|Expanded polytetrafluoroethylene( ePTFE)|expanded polytetrafluoroethylene( eptfe)
271218|NCT02002091|Type2 diabetes mellitus|type2 diabetes mellitus
271219|NCT02002091|Microangiopathy|microangiopathy
271220|NCT02002091|Chronic Kidney disease|chronic kidney disease
271221|NCT02002091|Cardiovascular disease|cardiovascular disease
271222|NCT02002078|caustic|caustic
271223|NCT02002078|corticosteroid therapy|corticosteroid therapy
271224|NCT02002078|stricture|stricture
271225|NCT02002078|children|children
271226|NCT02002065|hepatitis A|hepatitis a
271227|NCT02002065|inactivated hepatitis A vaccine|inactivated hepatitis a vaccine
271228|NCT02002065|attenuated alive hepatitis A vaccine|attenuated alive hepatitis a vaccine
271229|NCT02002065|immune persistence|immune persistence
271230|NCT02002052|non-small cell lung cancer, radiotherapy, chemotherapy, pneumonitis, functional lung avoidance|non-small cell lung cancer, radiotherapy, chemotherapy, pneumonitis, functional lung avoidance
271231|NCT02002039|Perinatal asphyxia|perinatal asphyxia
271232|NCT02002039|erythropoietin|erythropoietin
271233|NCT02002026|placenta previa, uterine artery ligation|placenta previa, uterine artery ligation
271234|NCT02002013|Adult|adult
271235|NCT02002013|ICU patient|icu patient
271236|NCT02002013|Fluid resuscitation|fluid resuscitation
271237|NCT02002013|observational study|observational study
271238|NCT02002000|Vitamin D deficiency|vitamin d deficiency
271239|NCT02002000|Musculoskeletal pain|musculoskeletal pain
271240|NCT02002000|Vitamin D supplementation|vitamin d supplementation
271241|NCT02001974|HER 2 negative|her 2 negative
271242|NCT02001974|metastatic breast cancer|metastatic breast cancer
271243|NCT02001974|Cancer Stem Cells|cancer stem cells
271244|NCT02001961|Fibrosis|fibrosis
271245|NCT02001961|collagen metabolism|collagen metabolism
271246|NCT02001961|paediatric, dilated cardiomyopathy|paediatric, dilated cardiomyopathy
271247|NCT02001961|biomarkers|biomarkers
271248|NCT02001961|T1 mapping|t1 mapping
271250|NCT02001948|Spinal anaesthesia|spinal anaesthesia
271251|NCT02001948|morphine|morphine
271252|NCT02001948|postoperative analgesia|postoperative analgesia
271253|NCT02001948|vomiting|vomiting
271254|NCT02001935|COPD|copd
271255|NCT02001935|theophylline|theophylline
271256|NCT02001935|CYP1A2|cyp1a2
271257|NCT02001935|CYP2E1|cyp2e1
271258|NCT02001922|COPD|copd
271259|NCT02001922|Pulmonary disease, chronic obstructive|pulmonary disease, chronic obstructive
271260|NCT02001922|Integrated care|integrated care
271261|NCT02001922|Outcome and process assessment|outcome and process assessment
271262|NCT02001922|Quality indicators, Health care|quality indicators, health care
271263|NCT02001922|Self-management,|self-management,
271264|NCT02001922|Patient empowerment|patient empowerment
271265|NCT02001922|Quantitative and qualitative methods|quantitative and qualitative methods
271266|NCT02001909|Regorafenib|regorafenib
271267|NCT02001909|Neomycin|neomycin
271268|NCT02001909|Cancer|cancer
271269|NCT02001909|Pharmacokinetics|pharmacokinetics
271270|NCT02001909|Safety|safety
271271|NCT02001896|NSCLC|nsclc
271272|NCT02001896|EGFR-TKI|egfr-tki
271273|NCT02001883|Coronary artery disease, nutraceuticals, statins|coronary artery disease, nutraceuticals, statins
271274|NCT02001870|Infertility|infertility
271275|NCT02001870|female age|female age
271276|NCT02001870|intra-uterine insemination|intra-uterine insemination
271277|NCT02001870|in vitro fecundation|in vitro fecundation
271278|NCT02001870|assisted reproductive technology center|assisted reproductive technology center
271279|NCT02001857|patients,|patients,
271280|NCT02001857|undergoing|undergoing
271281|NCT02001857|pelvic|pelvic
271282|NCT02001857|lymph|lymph
271283|NCT02001857|node|node
271284|NCT02001857|dissection.|dissection.
271285|NCT02001831|Sarcopenia|sarcopenia
271286|NCT02001831|Frailty|frailty
271287|NCT02001831|Aging|aging
271288|NCT02001831|Skeletal muscle|skeletal muscle
271289|NCT02001831|Nutrition|nutrition
271290|NCT02001792|sedation|sedation
271291|NCT02001792|endoscopy|endoscopy
271292|NCT02001792|patient positioning|patient positioning
271293|NCT02001792|hypoxemia|hypoxemia
271294|NCT02001779|Malignant biliary obstruction|malignant biliary obstruction
271295|NCT02001779|Obstruction/stricture|obstruction/stricture
271296|NCT02001779|Stent|stent
271297|NCT02001779|Brachytherapy|brachytherapy
271298|NCT02001779|Bile duct|bile duct
271299|NCT02001766|High intensity exercise|high intensity exercise
271300|NCT02001766|Glycemic control|glycemic control
271301|NCT02001766|Exercise|exercise
271302|NCT02001740|shoulder|shoulder
271303|NCT02001701|vitreomacular adhesion|vitreomacular adhesion
271304|NCT02001701|vitreomacular traction|vitreomacular traction
271305|NCT02001701|macular hole|macular hole
271306|NCT02001701|epiretinal membrane|epiretinal membrane
271307|NCT02001701|intravitreal gas|intravitreal gas
271308|NCT02001701|sulfahexafluoride gas|sulfahexafluoride gas
271309|NCT02001701|perfluoropropane gas|perfluoropropane gas
271310|NCT02001701|ocriplasmin|ocriplasmin
271311|NCT02001701|vitrectomy|vitrectomy
271312|NCT02001675|Neuromuscular electrical stimulation (NMES)|neuromuscular electrical stimulation (nmes)
271313|NCT02001662|Minor arthroscopic knee surgery including ACL-reconstruction (hamstrins graft)|minor arthroscopic knee surgery including acl-reconstruction (hamstrins graft)
271314|NCT02001662|High pain responders|high pain responders
271315|NCT02001662|Adductore Canal Block|adductore canal block
271316|NCT02001662|Analgesics|analgesics
271317|NCT02001662|Ultrasound guided nerve block|ultrasound guided nerve block
271318|NCT02001649|suicide|suicide
271319|NCT02001649|adolescent|adolescent
271320|NCT02001649|genetic|genetic
271321|NCT02001649|SNP|snp
271322|NCT02001636|Bariatric surgery|bariatric surgery
271323|NCT02001636|Protein malnutrition|protein malnutrition
271324|NCT02001636|Protein supplementation|protein supplementation
271325|NCT02001636|Body composition|body composition
271326|NCT02001636|Body fat mass|body fat mass
271327|NCT02001636|Protein intake|protein intake
271328|NCT02001623|ovary cancer|ovary cancer
271329|NCT02001623|cervix cancer|cervix cancer
271330|NCT02001623|endometrium cancer|endometrium cancer
271331|NCT02001623|bladder cancer|bladder cancer
271332|NCT02001623|prostate cancer (CRPC)|prostate cancer (crpc)
271333|NCT02001623|esophagus cancer|esophagus cancer
271334|NCT02001623|lung cancer(NSCLC)|lung cancer(nsclc)
271335|NCT02001623|Squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
271336|NCT02001610|microbiota|microbiota
271337|NCT02001610|probiotics|probiotics
271338|NCT02001610|fecal markers|fecal markers
271339|NCT02001597|surgery|surgery
271340|NCT02001597|robotic|robotic
271341|NCT02001597|ultrasound|ultrasound
271342|NCT02001597|guidance|guidance
271343|NCT02001597|endorectal|endorectal
271344|NCT02001571|Prostate Cancer|prostate cancer
271345|NCT02001571|Abiraterone acetate|abiraterone acetate
271346|NCT02001571|Pharmacokinetics|pharmacokinetics
271347|NCT02001558|Spinal cord injuries|spinal cord injuries
271348|NCT02001558|Pressure ulcer|pressure ulcer
271445|NCT02001090|Heart-Lung Machine|heart-lung machine
271446|NCT02001090|Coronary Artery Bypass|coronary artery bypass
271349|NCT02001545|acute coronary syndrome, antithrombotic management patterns,quality of life, acute clinical management strategies|acute coronary syndrome, antithrombotic management patterns,quality of life, acute clinical management strategies
271350|NCT02001532|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
271351|NCT02001532|Diabetes Complications|diabetes complications
271352|NCT02001532|Diabetic Angiopathies|diabetic angiopathies
271353|NCT02001532|Diabetic Nephropathies|diabetic nephropathies
271354|NCT02001532|Myocardial Infarction|myocardial infarction
271355|NCT02001532|Stroke|stroke
271356|NCT02001532|Vascular Stiffness|vascular stiffness
271357|NCT02001532|Pulse Wave Analysis|pulse wave analysis
271358|NCT02001506|breast cancer|breast cancer
271359|NCT02001506|neoadjuvant|neoadjuvant
271360|NCT02001506|different number of chemotherapy cycles|different number of chemotherapy cycles
271361|NCT02001441|Physical Activity, Aging, Memory, Cognitive Impairment, MRI, Neuroscience|physical activity, aging, memory, cognitive impairment, mri, neuroscience
271362|NCT02001428|malaria|malaria
271363|NCT02001428|vivax|vivax
271364|NCT02001428|falciparum|falciparum
271365|NCT02001428|infants|infants
271366|NCT02001415|Progressive Myopia|progressive myopia
271367|NCT02001415|Contact Lenses|contact lenses
271368|NCT02001415|Spectacles|spectacles
271369|NCT02001402|climacteric symptoms ; nurse ;|climacteric symptoms ; nurse ;
271370|NCT02001402|intervention;follow-up|intervention;follow-up
271371|NCT02001389|Enzyme occupancy|enzyme occupancy
271372|NCT02001389|Positron emission tomography (PET)|positron emission tomography (pet)
271373|NCT02001389|Phosphodiesterase 10 inhibitor|phosphodiesterase 10 inhibitor
271374|NCT02001363|Reperfusion injury|reperfusion injury
271375|NCT02001363|Liraglutide|liraglutide
271376|NCT02001337|pancreatic cancer|pancreatic cancer
271377|NCT02001337|new-onset diabetic|new-onset diabetic
271378|NCT02001337|diabetes|diabetes
271379|NCT02001324|quality of life, heavy menstrual bleeding, electronic data collection|quality of life, heavy menstrual bleeding, electronic data collection
271380|NCT02001311|chlorhexidine gel|chlorhexidine gel
271381|NCT02001311|orthodontic brackets|orthodontic brackets
271382|NCT02001311|orthodontic patients|orthodontic patients
271383|NCT02001311|bacterial count|bacterial count
271384|NCT02001311|friction|friction
271385|NCT02001298|remifentanil|remifentanil
271386|NCT02001298|nitroprusside|nitroprusside
271387|NCT02001298|hypotension|hypotension
271388|NCT02001285|remifentanil|remifentanil
271389|NCT02001272|Elderly|elderly
271390|NCT02001272|Vulnerable|vulnerable
271391|NCT02001272|Ovarian cancer|ovarian cancer
271392|NCT02001272|Chemotherapy|chemotherapy
271393|NCT02001259|post-operative pain control|post-operative pain control
271394|NCT02001259|total knee arthroplasty|total knee arthroplasty
271395|NCT02001259|epidural steroid injection|epidural steroid injection
271396|NCT02001246|mindfulness|mindfulness
271397|NCT02001246|cognitive behavior therapy|cognitive behavior therapy
271398|NCT02001246|awareness|awareness
271399|NCT02001246|anger|anger
271400|NCT02001246|aggression|aggression
271401|NCT02001233|EV71 vaccine|ev71 vaccine
271402|NCT02001233|EV71-associated HFMD|ev71-associated hfmd
271403|NCT02001233|efficacy|efficacy
271404|NCT02001233|safety|safety
271405|NCT02001233|immune persistence|immune persistence
271406|NCT02001220|screening|screening
271407|NCT02001220|invasive ventilation|invasive ventilation
271408|NCT02001220|mechanical ventilation|mechanical ventilation
271409|NCT02001220|weaning|weaning
271410|NCT02001220|spontaneous breathing trials|spontaneous breathing trials
271411|NCT02001194|Sedentary|sedentary
271412|NCT02001194|Behavioral Economic Intervention|behavioral economic intervention
271413|NCT02001194|Team Studies|team studies
271414|NCT02001194|Financial Incentives|financial incentives
271415|NCT02001194|Workplace Wellness|workplace wellness
271416|NCT02001194|Team Incentives|team incentives
271417|NCT02001181|Atopic Dermatitis|atopic dermatitis
271418|NCT02001181|Atopic Eczema|atopic eczema
271419|NCT02001181|Eczema|eczema
271420|NCT02001181|topical treatment|topical treatment
271421|NCT02001181|skin diseases|skin diseases
271422|NCT02001181|tofacitinib|tofacitinib
271423|NCT02001181|CP-690|cp-690
271424|NCT02001181|550|550
271425|NCT02001181|Janus Kinase inhibitor|janus kinase inhibitor
271426|NCT02001155|Water drinking test|water drinking test
271427|NCT02001155|trabeculectomy|trabeculectomy
271428|NCT02001155|tube shunt|tube shunt
271429|NCT02001142|Insulin Sensitivity|insulin sensitivity
271430|NCT02001142|Exercise|exercise
271431|NCT02001142|Metabolism|metabolism
271432|NCT02001129|Eye care adherence|eye care adherence
271433|NCT02001129|health care utilization|health care utilization
271434|NCT02001116|Quality of care|quality of care
271435|NCT02001116|Hospital|hospital
271436|NCT02001116|Children|children
271437|NCT02001116|WHO guideline|who guideline
271438|NCT02001103|adjuvant therapy|adjuvant therapy
271439|NCT02001103|cognitive deficits|cognitive deficits
271440|NCT02001103|first episode schizophrenia|first episode schizophrenia
271441|NCT02001103|glutamate hypothesis|glutamate hypothesis
271442|NCT02001103|memantine|memantine
271443|NCT02001103|negative symptoms|negative symptoms
271444|NCT02001090|Cardiac Surgical Procedures|cardiac surgical procedures
271447|NCT02001090|Brachial Artery|brachial artery
271448|NCT02001090|Vasodilation|vasodilation
271449|NCT02001090|Regional Blood Flow|regional blood flow
271450|NCT02001090|Ultrasonography|ultrasonography
271451|NCT02001064|interventions|interventions
271452|NCT02001064|technology|technology
271453|NCT02001064|adherence|adherence
271454|NCT02001064|ARV|arv
271455|NCT02001051|Diabetes, Hypertension, Hypercholesterolemia, Obesity, and Osteoporosis.|diabetes, hypertension, hypercholesterolemia, obesity, and osteoporosis.
271456|NCT02001051|Nonoperative and Operative Management|nonoperative and operative management
271457|NCT02001051|Adrenal Incidentalomas|adrenal incidentalomas
271458|NCT02001051|Excess of Cortisol|excess of cortisol
271459|NCT02001025|coronary vessels|coronary vessels
271460|NCT02001025|coronary stenosis|coronary stenosis
271461|NCT02001025|percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
271462|NCT02001025|stents|stents
271463|NCT02001025|drug-eluting stents|drug-eluting stents
271464|NCT02001025|bioresorbable scaffolds|bioresorbable scaffolds
271465|NCT02001025|optical coherence tomography|optical coherence tomography
271466|NCT02001012|uncomplicated|uncomplicated
271467|NCT02001012|plasmodium|plasmodium
271468|NCT02001012|knowlesi|knowlesi
271469|NCT02001012|malaria|malaria
271470|NCT02001012|infection|infection
271471|NCT02000999|Bile duct stricture|bile duct stricture
271472|NCT02000999|Cholangiocarcinoma|cholangiocarcinoma
271473|NCT02000999|Pancreatic cancer|pancreatic cancer
271474|NCT02000999|Chronic pancreatitis|chronic pancreatitis
271475|NCT02000986|Hodgkin's Lymphoma|hodgkin's lymphoma
271476|NCT02000986|Brain and Nervous System|brain and nervous system
271477|NCT02000986|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
271478|NCT02000986|Leukemia, not otherwise specified|leukemia, not otherwise specified
271479|NCT02000960|Glut1 DS|glut1 ds
271480|NCT02000947|anti-CTLA-4|anti-ctla-4
271481|NCT02000947|anti-PD-L1|anti-pd-l1
271482|NCT02000947|immunotherapy|immunotherapy
271483|NCT02000947|IMTC|imtc
271484|NCT02000934|TAK-659|tak-659
271485|NCT02000934|Solid Tumors|solid tumors
271486|NCT02000934|CLL|cll
271487|NCT02000934|DLBCL|dlbcl
271488|NCT02000921|Cigarette Smoking|cigarette smoking
271489|NCT02000921|Very Low Nicotine Content cigarettes (VLNC)|very low nicotine content cigarettes (vlnc)
271490|NCT02000921|Dual Tobacco Use|dual tobacco use
271491|NCT02000908|gynecological cancer|gynecological cancer
271492|NCT02000908|ovarian cancer|ovarian cancer
271493|NCT02000908|primary peritoneal cancer|primary peritoneal cancer
271494|NCT02000908|cervical caner|cervical caner
271495|NCT02000908|peripheral neuropathy|peripheral neuropathy
271496|NCT02000882|Breast Cancer|breast cancer
271497|NCT02000882|Triple Negative Breast Cancer|triple negative breast cancer
271498|NCT02000882|Brain Metastases|brain metastases
271499|NCT02000882|Capecitabine|capecitabine
271500|NCT02000882|Metastatic Breast Cancer|metastatic breast cancer
271501|NCT02000843|perforation|perforation
271502|NCT02000843|tympanoplasty|tympanoplasty
271503|NCT02000843|conchal cavum approach|conchal cavum approach
271504|NCT02000843|perichondrium/ cartilage|perichondrium/ cartilage
271505|NCT02000843|scar|scar
271506|NCT02000830|stannsoporfin|stannsoporfin
271507|NCT02000817|Beta Cell|beta cell
271508|NCT02000817|Monoclonal Antibody|monoclonal antibody
271509|NCT02000817|Otelixizumab|otelixizumab
271510|NCT02000817|Cytokine Release Syndrome|cytokine release syndrome
271511|NCT02000817|Epstein-Barr Virus|epstein-barr virus
271512|NCT02000817|Diabetes Mellitus|diabetes mellitus
271513|NCT02000804|Darapladib, Safety, Pharmacokinetics, Pharmacodynamics, Healthy Chinese Subjects|darapladib, safety, pharmacokinetics, pharmacodynamics, healthy chinese subjects
271514|NCT02000791|cLMA|clma
271515|NCT02000791|laryngoscopy|laryngoscopy
271516|NCT02000791|fiberoptic|fiberoptic
271517|NCT02000778|Occult Ovarian Carcinoma|occult ovarian carcinoma
271518|NCT02000765|oral|oral
271519|NCT02000765|ADME|adme
271520|NCT02000765|IV|iv
271521|NCT02000765|antibiotic|antibiotic
271522|NCT02000765|healthy volunteer|healthy volunteer
271523|NCT02000765|[14C]-GSK2140944|[14c]-gsk2140944
271524|NCT02000765|mass balance|mass balance
271525|NCT02000765|radiolabel|radiolabel
271526|NCT02000752|Labor|labor
271527|NCT02000752|Acupuncture|acupuncture
271528|NCT02000752|Placental expulsion time|placental expulsion time
271529|NCT02000752|Postpartum hemorrhage|postpartum hemorrhage
271530|NCT02000739|Breast cancer|breast cancer
271531|NCT02000739|melanoma|melanoma
271532|NCT02000739|GI cancer|gi cancer
271533|NCT02000739|ovarian cancer|ovarian cancer
271534|NCT02000739|lung cancer|lung cancer
271535|NCT02000739|metastatic cancer|metastatic cancer
271536|NCT02000739|brain cancer|brain cancer
271537|NCT02000739|head and neck cancer|head and neck cancer
271538|NCT02000700|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
271539|NCT02000700|Canagliflozin|canagliflozin
271540|NCT02000700|JNJ-28431754|jnj-28431754
271541|NCT02000700|Pharmacokinetics|pharmacokinetics
271542|NCT02000700|Pharmacodynamics|pharmacodynamics
271543|NCT02000700|Children|children
271544|NCT02000700|Adolescents|adolescents
271545|NCT02000674|tracheal intubation|tracheal intubation
271546|NCT02000674|pre hospital emergency|pre hospital emergency
271547|NCT02000661|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
271548|NCT02000661|FFR guided coronary interventions|ffr guided coronary interventions
271549|NCT02000661|Percutaneous Coronary Intervention|percutaneous coronary intervention
271550|NCT02000648|Allergic Rhinitis|allergic rhinitis
271551|NCT02000648|Non-allergic Rhinitis|non-allergic rhinitis
271552|NCT02000648|Chronic urticaria|chronic urticaria
271553|NCT02000622|Breast Cancer|breast cancer
271554|NCT02000622|Metastatic|metastatic
271555|NCT02000622|Olaparib|olaparib
271556|NCT02000622|BRCA|brca
271557|NCT02000622|PARP inhibitor|parp inhibitor
271558|NCT02000622|HER2|her2
271559|NCT02000622|chemotherapy|chemotherapy
271560|NCT02000609|pharmacodynamics COPD|pharmacodynamics copd
271561|NCT02000596|HER2 overexpressed|her2 overexpressed
271562|NCT02000596|Metastatic Breast Cancer|metastatic breast cancer
271563|NCT02000596|Elderly|elderly
271564|NCT02000583|Alzheimer's Disease|alzheimer's disease
271565|NCT02000583|AD|ad
271566|NCT02000583|Aerobic Exercise|aerobic exercise
271567|NCT02000583|Exercise|exercise
271568|NCT02000570|sitting position|sitting position
271569|NCT02000570|PPV|ppv
271570|NCT02000570|SVV|svv
271571|NCT02000570|PVI|pvi
271572|NCT02000570|fluid challenge|fluid challenge
271573|NCT02000570|preload indicators|preload indicators
271574|NCT02000557|Photographic analysis|photographic analysis
271575|NCT02000557|Cephalometric analysis|cephalometric analysis
271576|NCT02000557|Standardized photographs|standardized photographs
271577|NCT02000557|Angular measurements|angular measurements
271578|NCT02000557|Linear measurements|linear measurements
271579|NCT02000557|Malocclusion|malocclusion
271580|NCT02000557|Facial Profile|facial profile
271581|NCT02000544|Extracorporeal Circulation|extracorporeal circulation
271582|NCT02000544|Cardiopulmonary Bypass|cardiopulmonary bypass
271583|NCT02000544|Cardiac surgery|cardiac surgery
271584|NCT02000531|Non-small-cell lung cancer (NSCLC)|non-small-cell lung cancer (nsclc)
271585|NCT02000518|emergency radiotherapy|emergency radiotherapy
271586|NCT02000518|MSCC|mscc
271587|NCT02000518|spine|spine
271588|NCT02000518|neurological outcome|neurological outcome
271589|NCT02000466|Women|women
271590|NCT02000466|Pregnancy exposure|pregnancy exposure
271591|NCT02000466|FluLaval Quadrivalent|flulaval quadrivalent
271592|NCT02000466|Pregnancy outcome|pregnancy outcome
271593|NCT02000466|Pregnancy Registry|pregnancy registry
271594|NCT02000453|Quality of Life|quality of life
271595|NCT02000453|Infection|infection
271596|NCT02000453|GSK2586184|gsk2586184
271597|NCT02000453|ulcerative colitis|ulcerative colitis
271598|NCT02000440|GW856553|gw856553
271599|NCT02000440|Focal segmental glomerulosclerosis (FSGS)|focal segmental glomerulosclerosis (fsgs)
271600|NCT02000440|p38 mitogen-activated protein kinase (MAPK) inhibitor|p38 mitogen-activated protein kinase (mapk) inhibitor
271601|NCT02000440|losmapimod|losmapimod
271602|NCT02000440|nephrotic syndrome|nephrotic syndrome
271603|NCT02000427|Relapsed; Refractory; Philadelphia Positive; B-precursor; Acute Lymphoblastic Leukemia; ALL; Blinatumomab; Leukemia;|relapsed; refractory; philadelphia positive; b-precursor; acute lymphoblastic leukemia; all; blinatumomab; leukemia;
271604|NCT02000414|intraperitoneal|intraperitoneal
271605|NCT02000414|peritoneal dialysis|peritoneal dialysis
271606|NCT02000414|daptomycin|daptomycin
271607|NCT02000414|pharmacokinetics|pharmacokinetics
271608|NCT02000414|peritonitis|peritonitis
271609|NCT02000375|metastatic breastcancer|metastatic breastcancer
271610|NCT02000375|ER/PgR-negative/AR-positive|er/pgr-negative/ar-positive
271611|NCT02000375|ER and/or PgR-positive/AR-positive|er and/or pgr-positive/ar-positive
271612|NCT02000375|Androgen Receptor positve|androgen receptor positve
271613|NCT02000362|Crohn's Disease|crohn's disease
271614|NCT02000362|Stem cell|stem cell
271615|NCT02000362|Cell therapy|cell therapy
271616|NCT02000362|Auto-immune disease|auto-immune disease
271617|NCT02000362|furestem|furestem
271618|NCT02000362|CD|cd
271619|NCT02000362|inflammatory bowel disease|inflammatory bowel disease
271620|NCT02000362|MSCs|mscs
271621|NCT02000362|Mesenchymal Stem Cells|mesenchymal stem cells
271622|NCT02000362|hUCB-MSC|hucb-msc
271623|NCT02000362|UCB-MSC|ucb-msc
271624|NCT02000362|Umbilical cord Blood|umbilical cord blood
271625|NCT02000349|infertility|infertility
271626|NCT02000349|next generation sequencing|next generation sequencing
271627|NCT02000336|radiographic damage|radiographic damage
271628|NCT02000336|rheumatoid arthritis|rheumatoid arthritis
271629|NCT02000323|pancreatitis|pancreatitis
271630|NCT02000323|enteral nutrition|enteral nutrition
271631|NCT02000310|Gaucher disease|gaucher disease
271632|NCT02000310|Fabry disease|fabry disease
271633|NCT02000310|Pompe disease|pompe disease
271634|NCT02000310|Niemann-Pick disease|niemann-pick disease
271635|NCT02000297|Osteoarthritis|osteoarthritis
271636|NCT02000297|Knee|knee
271637|NCT02000297|High tibial osteotomy|high tibial osteotomy
271638|NCT02000297|Calcium phosphate|calcium phosphate
271639|NCT02000297|Calcium sulfate|calcium sulfate
271640|NCT02000284|Autism Spectrum Disorder|autism spectrum disorder
271641|NCT02000284|ASD|asd
271642|NCT02000284|Autism|autism
275546|NCT01982383|Edema|edema
271643|NCT02000284|Pervasive developmental disorder - Not Otherwise Specified|pervasive developmental disorder - not otherwise specified
271644|NCT02000284|PDD-NOS|pdd-nos
271645|NCT02000284|Asperger's Syndrome|asperger's syndrome
271646|NCT02000284|Mitochondrial Disease|mitochondrial disease
271647|NCT02000284|Developmental Delay|developmental delay
271648|NCT02000284|Typical Development|typical development
271649|NCT02000258|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
271650|NCT02000258|Double-bundle|double-bundle
271651|NCT02000258|MRI|mri
271652|NCT02000258|Graft location|graft location
271653|NCT02000245|bronchoscopy|bronchoscopy
271654|NCT02000245|anxiety|anxiety
271655|NCT02000245|touch|touch
271656|NCT02000245|sympathy|sympathy
271657|NCT02000232|gout|gout
271658|NCT02000232|colchicine|colchicine
271659|NCT02000219|hyperoxaluria|hyperoxaluria
271660|NCT02000219|oxalate|oxalate
271661|NCT02000219|PH|ph
271662|NCT02000219|dialysis|dialysis
271663|NCT02000206|Ketamine|ketamine
271664|NCT02000206|Alfentanil|alfentanil
271665|NCT02000206|Propofol|propofol
271666|NCT02000206|Oxygen saturation|oxygen saturation
271667|NCT02000206|Percutaneous carbon dioxide|percutaneous carbon dioxide
271668|NCT02000206|Bronchoscopy|bronchoscopy
271669|NCT02000167|Electron Transport Chain|electron transport chain
271670|NCT02000167|Mitochondrial Disease|mitochondrial disease
271671|NCT02000167|Chromosomal Deletion|chromosomal deletion
271672|NCT02000128|Peritoneal Dialysis|peritoneal dialysis
271673|NCT02000128|fluid overload|fluid overload
271674|NCT02000128|bioimpedance analysis|bioimpedance analysis
271675|NCT02000128|Randomized Controlled Trial|randomized controlled trial
271676|NCT02000089|familial pancreas cancer|familial pancreas cancer
271677|NCT02000089|(Peutz-Jeghers Syndrome) PJS|(peutz-jeghers syndrome) pjs
271678|NCT02000089|Breast cancer (BRCA) 2|breast cancer (brca) 2
271679|NCT02000089|Partner and Locator of BRCA2 (PALB2)|partner and locator of brca2 (palb2)
271680|NCT02000089|Familial Atypical Multiple Mole- Melanoma (FAMMM)|familial atypical multiple mole- melanoma (fammm)
271681|NCT02000089|p16|p16
271682|NCT02000089|Breast Cancer (BRCA)1|breast cancer (brca)1
271683|NCT02000089|(hereditary non-polyposis colorectal cancer or Lynch syndrome) HNPCC|(hereditary non-polyposis colorectal cancer or lynch syndrome) hnpcc
271684|NCT02000089|Lynch Syndrome|lynch syndrome
271685|NCT02000089|hereditary pancreatitis|hereditary pancreatitis
271686|NCT02000089|Protease Serine (PRSS)|protease serine (prss)
271687|NCT02000089|Chymotrypsin C (CTRC)|chymotrypsin c (ctrc)
271688|NCT02000089|Ataxia Telangiectasia Mutated(ATM)|ataxia telangiectasia mutated(atm)
271689|NCT02000076|Sleep|sleep
271690|NCT02000076|resting state|resting state
271691|NCT02000076|functional connectivity|functional connectivity
271692|NCT02000076|emotional contagion|emotional contagion
271693|NCT02000076|empathy|empathy
271694|NCT02000076|emotional regulation|emotional regulation
271695|NCT02000063|Hepatitis C|hepatitis c
271696|NCT02000063|acute|acute
271697|NCT02000063|early chronic|early chronic
271698|NCT02000050|resectable rectal cancer|resectable rectal cancer
271699|NCT02000050|up-front chemotherapy|up-front chemotherapy
271700|NCT02000050|neo-adjuvant short course radiotherapy|neo-adjuvant short course radiotherapy
271701|NCT02000050|short course radiotherapy|short course radiotherapy
271702|NCT02000011|patients|patients
271703|NCT02000011|aged 70 years old|aged 70 years old
271704|NCT02000011|thoracic,|thoracic,
271705|NCT02000011|digestive or|digestive or
271706|NCT02000011|urological|urological
271707|NCT02000011|resectable|resectable
271708|NCT01999985|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
271709|NCT01999985|Tyrosine kinase inhibitors|tyrosine kinase inhibitors
271710|NCT01999985|Neoplasms|neoplasms
271711|NCT01999985|Lung Diseases|lung diseases
271712|NCT01999985|Respiratory Tract Diseases|respiratory tract diseases
271713|NCT01999985|Pleural Diseases|pleural diseases
271714|NCT01999985|Pleural Neoplasms|pleural neoplasms
271715|NCT01999985|Lung Neoplasms|lung neoplasms
271716|NCT01999985|Pleural Effusion|pleural effusion
271717|NCT01999985|Pleural Effusion, Malignant|pleural effusion, malignant
271718|NCT01999985|Respiratory Tract Neoplasms|respiratory tract neoplasms
271719|NCT01999985|Thoracic Neoplasms|thoracic neoplasms
271720|NCT01999985|Neoplasms by Site|neoplasms by site
271721|NCT01999985|EGFR mutation|egfr mutation
271722|NCT01999985|Afatinib|afatinib
271723|NCT01999985|Dasatinib|dasatinib
271724|NCT01999985|Carcinoma, Bronchogenic|carcinoma, bronchogenic
271725|NCT01999985|Gene Mutation|gene mutation
271726|NCT01999985|T790M mutation.|t790m mutation.
271727|NCT01999985|Non-small cell lung cancer|non-small cell lung cancer
271728|NCT01999972|Carcinoma|carcinoma
271729|NCT01999972|Renal Cell|renal cell
271730|NCT01999959|Unexplained Infertility, Pertubation, Gonadotrophin, Ovulation Induction, Intrauterine Insemination|unexplained infertility, pertubation, gonadotrophin, ovulation induction, intrauterine insemination
271731|NCT01999946|Heroin Dependence|heroin dependence
271732|NCT01999946|Opioid-Related Disorders|opioid-related disorders
271733|NCT01999933|Cervical cancer|cervical cancer
271734|NCT01999933|postoperative risk factor|postoperative risk factor
271735|NCT01999933|treatment|treatment
271940|NCT01998828|Polycythemia Vera|polycythemia vera
271736|NCT01999920|Adult separation anxiety disorder|adult separation anxiety disorder
271737|NCT01999920|ASAD|asad
271738|NCT01999907|asthma|asthma
271739|NCT01999907|virus diseases|virus diseases
271740|NCT01999907|pediatric|pediatric
271741|NCT01999907|RCT|rct
271742|NCT01999907|steroid|steroid
271743|NCT01999894|Namenda|namenda
271744|NCT01999894|Autism|autism
271745|NCT01999894|Memantine|memantine
271746|NCT01999894|Pediatric|pediatric
271747|NCT01999894|Forest Laboratories|forest laboratories
271748|NCT01999868|psoriasis vulgaris|psoriasis vulgaris
271749|NCT01999868|ustekinumab|ustekinumab
271750|NCT01999868|abatacept|abatacept
271751|NCT01999842|H7N9|h7n9
271752|NCT01999842|Influenza|influenza
271753|NCT01999842|Safety|safety
271754|NCT01999842|Adults|adults
271755|NCT01999842|Adjuvant|adjuvant
271756|NCT01999842|Immunogenicity|immunogenicity
271757|NCT01999816|pressure ulcer|pressure ulcer
271758|NCT01999816|lifestyle redesign|lifestyle redesign
271759|NCT01999816|spinal cord injury|spinal cord injury
271760|NCT01999790|upper lid|upper lid
271761|NCT01999790|exophthalmos|exophthalmos
271762|NCT01999790|grave's orbitopathy|grave's orbitopathy
271763|NCT01999777|Epilepsy|epilepsy
271764|NCT01999777|seizure clusters|seizure clusters
271765|NCT01999777|acute repetitive seizures|acute repetitive seizures
271766|NCT01999777|rescue treatment|rescue treatment
271767|NCT01999751|Magnetic Resonance Imaging|magnetic resonance imaging
271768|NCT01999751|Pacemaker, Artificial|pacemaker, artificial
271769|NCT01999751|Defibrillators, Implantable|defibrillators, implantable
271770|NCT01999725|Normal Volunteers, Safety, Pharmacokinetics|normal volunteers, safety, pharmacokinetics
271771|NCT01999712|heart failure|heart failure
271772|NCT01999712|left ventricular assist device|left ventricular assist device
271773|NCT01999712|right ventricular failure|right ventricular failure
271774|NCT01999699|Heplisav|heplisav
271775|NCT01999686|Polycystic ovarium syndrome|polycystic ovarium syndrome
271776|NCT01999686|DLBS3233|dlbs3233
271777|NCT01999686|metformin|metformin
271778|NCT01999686|insulin resistance|insulin resistance
271779|NCT01999686|Female|female
271780|NCT01999673|SUNRISE|sunrise
271781|NCT01999673|PPHM 1202|pphm 1202
271782|NCT01999673|Bavituximab|bavituximab
271783|NCT01999673|Peregrine|peregrine
271784|NCT01999660|Prostatic Neoplasms|prostatic neoplasms
271785|NCT01999660|Radiotherapy|radiotherapy
271786|NCT01999660|rectal toxicity|rectal toxicity
271787|NCT01999647|Lower Extremity|lower extremity
271788|NCT01999647|Sciatic Nerve|sciatic nerve
271789|NCT01999647|Anesthetics, Local|anesthetics, local
271790|NCT01999647|Ropivacaine|ropivacaine
271791|NCT01999647|Ultrasonography|ultrasonography
271792|NCT01999634|rectum|rectum
271793|NCT01999634|microdialysis|microdialysis
271794|NCT01999634|anastomotic leaks|anastomotic leaks
271795|NCT01999621|organ failure|organ failure
271796|NCT01999621|intensive care|intensive care
271797|NCT01999621|palliative care|palliative care
271798|NCT01999621|patient's wishes|patient's wishes
271799|NCT01999608|Infertility|infertility
271800|NCT01999595|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
271801|NCT01999595|pad size|pad size
271802|NCT01999595|pulse frequency|pulse frequency
271803|NCT01999595|blunt pressure pain|blunt pressure pain
271804|NCT01999595|healthy humans.|healthy humans.
271805|NCT01999582|Anemia|anemia
271806|NCT01999582|End Stage Kidney Disease|end stage kidney disease
271807|NCT01999582|Chronic Kidney Disease|chronic kidney disease
271808|NCT01999582|Dialysis|dialysis
271809|NCT01999582|Erythrpoietin Stimulating Agent (ESA)|erythrpoietin stimulating agent (esa)
271810|NCT01999543|Blood glucose|blood glucose
271811|NCT01999530|prazosin|prazosin
271812|NCT01999530|dopamine|dopamine
271813|NCT01999530|healthy|healthy
271814|NCT01999530|Positron Emission Tomography|positron emission tomography
271815|NCT01999530|PHNO|phno
271816|NCT01999530|scan|scan
271817|NCT01999530|effect|effect
271818|NCT01999504|Glucagon-like peptide-1|glucagon-like peptide-1
271819|NCT01999504|Glucose-dependent Insulinotropic Peptide|glucose-dependent insulinotropic peptide
271820|NCT01999504|Peptide YY|peptide yy
271821|NCT01999504|Glucagon|glucagon
271822|NCT01999504|Satiety|satiety
271823|NCT01999504|Meal|meal
271824|NCT01999504|palaeolithic|palaeolithic
271825|NCT01999465|Brachial plexus injury|brachial plexus injury
271826|NCT01999465|Brachial plexus palsy|brachial plexus palsy
271827|NCT01999465|Neonate|neonate
271828|NCT01999452|Paleolithic diet|paleolithic diet
271829|NCT01999426|Physical Therapy Modalities|physical therapy modalities
271830|NCT01999426|Pediatrics|pediatrics
271831|NCT01999426|Critical Care|critical care
271832|NCT01999426|Respiration, Artificial|respiration, artificial
271833|NCT01999413|AML|aml
271834|NCT01999413|high-risk cytogenetics|high-risk cytogenetics
271835|NCT01999413|younger patients|younger patients
271836|NCT01999413|Induction treatment|induction treatment
271837|NCT01999413|OMEGAVEN|omegaven
271838|NCT01999387|food|food
271839|NCT01999387|consumption|consumption
271941|NCT01998828|Essential Thrombocythemia|essential thrombocythemia
271840|NCT01999309|Schizophrenia spectrum disorders|schizophrenia spectrum disorders
271841|NCT01999283|Cervical pain|cervical pain
271842|NCT01999283|yoga|yoga
271843|NCT01999283|pilates|pilates
271844|NCT01999283|exercise|exercise
271845|NCT01999257|Genetic Counseling|genetic counseling
271846|NCT01999257|Technology|technology
271847|NCT01999257|Ashkenazi Jewish|ashkenazi jewish
271848|NCT01999257|Carrier screening|carrier screening
271849|NCT01999244|Overweight|overweight
271850|NCT01999244|Obesity|obesity
271851|NCT01999244|Weight Loss|weight loss
271852|NCT01999244|Self-monitoring|self-monitoring
271853|NCT01999244|Food Records|food records
271854|NCT01999244|Self-weighing|self-weighing
271855|NCT01999244|Technology|technology
271856|NCT01999231|Safety|safety
271857|NCT01999231|Tolerability|tolerability
271858|NCT01999231|ESAT6|esat6
271859|NCT01999231|CFP10|cfp10
271860|NCT01999231|skin test|skin test
271861|NCT01999231|diagnostic test|diagnostic test
271862|NCT01999205|workplace|workplace
271863|NCT01999205|intervention|intervention
271864|NCT01999205|physical activity|physical activity
271865|NCT01999205|sedentary behavior|sedentary behavior
271866|NCT01999205|evaluation|evaluation
271867|NCT01999192|inadequate response to MTX|inadequate response to mtx
271868|NCT01999192|Methotrexate|methotrexate
271869|NCT01999192|rheumatoid Arthritis|rheumatoid arthritis
271870|NCT01999192|Phase 2b|phase 2b
271871|NCT01999179|catheter related thrombosis|catheter related thrombosis
271872|NCT01999179|upper extremity deep venous thrombosis|upper extremity deep venous thrombosis
271873|NCT01999179|central venous catheters|central venous catheters
271874|NCT01999179|cancer|cancer
271875|NCT01999179|Catheters|catheters
271876|NCT01999153|skin graft|skin graft
271877|NCT01999153|donor site|donor site
271878|NCT01999114|Healthy subjects|healthy subjects
271879|NCT01999114|Opioid|opioid
271880|NCT01999114|Transdermal|transdermal
271881|NCT01999114|ECG|ecg
271882|NCT01999088|Fatty Acids, Omega-3|fatty acids, omega-3
271883|NCT01999088|Rosemary extract|rosemary extract
271884|NCT01999088|Functional meat|functional meat
271885|NCT01999088|Cardiovascular disease|cardiovascular disease
271886|NCT01999075|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
271887|NCT01999075|Pulmonary complications|pulmonary complications
271888|NCT01999075|Lung volume recruitment,|lung volume recruitment,
271889|NCT01999075|Breath-stacking,|breath-stacking,
271890|NCT01999075|Cough efficacy,|cough efficacy,
271891|NCT01999075|Maximal insufflation capacity|maximal insufflation capacity
271892|NCT01999062|Breast RT|breast rt
271893|NCT01999062|Breast radiation therapy|breast radiation therapy
271894|NCT01999036|cardiac arrest, CPR, resuscitation|cardiac arrest, cpr, resuscitation
271895|NCT01999010|psychiatry|psychiatry
271896|NCT01999010|mental health|mental health
271897|NCT01999010|major depressive disorder|major depressive disorder
271898|NCT01999010|self-management|self-management
271899|NCT01999010|data visualization|data visualization
271900|NCT01999010|mood diaries|mood diaries
271901|NCT01999010|electronic diaries|electronic diaries
271902|NCT01999010|cell phones|cell phones
271903|NCT01999010|software|software
271904|NCT01999010|mental health telemetry|mental health telemetry
271905|NCT01999010|ecological momentary assessment|ecological momentary assessment
271906|NCT01998997|Delirium|delirium
271907|NCT01998997|Hospitalized elderly|hospitalized elderly
271908|NCT01998971|Multiple myeloma|multiple myeloma
271909|NCT01998971|Daratumumab|daratumumab
271910|NCT01998971|JNJ-54767414|jnj-54767414
271911|NCT01998971|Velcade-dexamethasone|velcade-dexamethasone
271912|NCT01998971|Velcade-melphalan-prednisone|velcade-melphalan-prednisone
271913|NCT01998971|Velcade-thalidomide-dexamethasone|velcade-thalidomide-dexamethasone
271914|NCT01998971|Pomalidomide-dexamethasone|pomalidomide-dexamethasone
271915|NCT01998971|Carfilzomib-dexamethasone|carfilzomib-dexamethasone
271916|NCT01998971|Carfilzomib-lenalidomide-dexamethasone|carfilzomib-lenalidomide-dexamethasone
271917|NCT01998971|Anti-CD38 Monoclonal Antibody|anti-cd38 monoclonal antibody
271918|NCT01998971|Immunomodulatory drug|immunomodulatory drug
271919|NCT01998971|IMiD|imid
271920|NCT01998958|Treatment resistant depressive disorder|treatment resistant depressive disorder
271921|NCT01998958|Intranasal esketamine|intranasal esketamine
271922|NCT01998958|Efficacy|efficacy
271923|NCT01998958|SYNAPSE|synapse
271924|NCT01998958|JNJ-54135419|jnj-54135419
271925|NCT01998945|Exposure therapy|exposure therapy
271926|NCT01998945|Cognitive behavioral therapy|cognitive behavioral therapy
271927|NCT01998945|Relaxation Training|relaxation training
271928|NCT01998945|Older Adults|older adults
271929|NCT01998945|Fall Injury|fall injury
271930|NCT01998945|Anxiety|anxiety
271931|NCT01998945|Posttraumatic Stress|posttraumatic stress
271932|NCT01998932|Venous Ulcer|venous ulcer
271933|NCT01998932|Leg Ulcer|leg ulcer
271934|NCT01998932|Metabonomics|metabonomics
271935|NCT01998932|Ulcer Fluid|ulcer fluid
271936|NCT01998854|Menorrhagia|menorrhagia
271937|NCT01998854|Leiomyoma|leiomyoma
271938|NCT01998854|Uterine Fibroids|uterine fibroids
271939|NCT01998828|Polycythemia|polycythemia
271942|NCT01998828|Thrombocytosis|thrombocytosis
271943|NCT01998828|Myeloproliferative Disorders|myeloproliferative disorders
271944|NCT01998828|Bone Marrow Diseases|bone marrow diseases
271945|NCT01998828|Hematologic Diseases|hematologic diseases
271946|NCT01998828|Blood Coagulation Disorders|blood coagulation disorders
271947|NCT01998828|Blood Platelet Disorders|blood platelet disorders
271948|NCT01998828|Hemorrhagic Disorders|hemorrhagic disorders
271949|NCT01998789|Liver Transplantation|liver transplantation
271950|NCT01998789|Everolimus|everolimus
271951|NCT01998789|Immunosuppression|immunosuppression
271952|NCT01998776|ulcer|ulcer
271953|NCT01998763|Vitamin D3 supplementation|vitamin d3 supplementation
271954|NCT01998763|metabolite profile|metabolite profile
271955|NCT01998763|SNPs|snps
271956|NCT01998763|bone-turnover marker|bone-turnover marker
271957|NCT01998750|obesity|obesity
271958|NCT01998750|genetics|genetics
271959|NCT01998750|early-onset|early-onset
271960|NCT01998750|childhood|childhood
271961|NCT01998737|Osteoporosis, diagnostics, ultrasound|osteoporosis, diagnostics, ultrasound
271962|NCT01998724|Chronic bronchitis|chronic bronchitis
271963|NCT01998724|Emphysema|emphysema
271964|NCT01998724|Pulmonary|pulmonary
271965|NCT01998724|COPD|copd
271966|NCT01998711|Alzheimer's disease|alzheimer's disease
271967|NCT01998711|Mild cognitive impairment|mild cognitive impairment
271968|NCT01998711|Memory intervention|memory intervention
271969|NCT01998711|Strategy use|strategy use
271970|NCT01998711|Memory group|memory group
271971|NCT01998698|cataract|cataract
271972|NCT01998698|phacoemulsification|phacoemulsification
271973|NCT01998698|monovision|monovision
271974|NCT01998698|multifocal lens|multifocal lens
271975|NCT01998685|Prostatectomy|prostatectomy
271976|NCT01998685|Coagulation Factor|coagulation factor
271977|NCT01998685|Balanced Anesthesia|balanced anesthesia
271978|NCT01998685|Intravenous Anesthesia,|intravenous anesthesia,
271979|NCT01998646|ASP4058|asp4058
271980|NCT01998646|healthy subjects|healthy subjects
271981|NCT01998633|Hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
271982|NCT01998633|Chronic Active EBV|chronic active ebv
271983|NCT01998633|Chronic Granulomatous Disease|chronic granulomatous disease
271984|NCT01998633|Hyperimmunoglobulin M Syndrome (Hyper IGM)|hyperimmunoglobulin m syndrome (hyper igm)
271985|NCT01998633|Leukocyte Adhesion Deficiency|leukocyte adhesion deficiency
271986|NCT01998633|IPEX|ipex
271987|NCT01998633|Hematopoietic Stem Cell Transplant (HSCT)|hematopoietic stem cell transplant (hsct)
271988|NCT01998633|Non-Myeloablative Transplant (NST)|non-myeloablative transplant (nst)
271989|NCT01998633|Reduced-Intensity Conditioning (RIC)|reduced-intensity conditioning (ric)
271990|NCT01998620|Hepatitis B|hepatitis b
271991|NCT01998620|Cholestasis|cholestasis
271992|NCT01998607|Solid tumours|solid tumours
271993|NCT01998607|Bone Metastasis|bone metastasis
271994|NCT01998594|Thumb arthritis|thumb arthritis
271995|NCT01998594|CMC arthritis|cmc arthritis
271996|NCT01998594|Arthroplasty|arthroplasty
271997|NCT01998568|Intraocular pressure|intraocular pressure
271998|NCT01998568|Corneal edema|corneal edema
271999|NCT01998568|Tonometer|tonometer
272000|NCT01998568|Dynamic contour tonometer|dynamic contour tonometer
272001|NCT01998568|Tonopen|tonopen
272002|NCT01998568|iCare|icare
272003|NCT01998568|Goldmann applanation|goldmann applanation
272004|NCT01998542|Head and neck cancers|head and neck cancers
272005|NCT01998542|tumor vaccine|tumor vaccine
272006|NCT01998542|immunotherapy|immunotherapy
272007|NCT01998542|personalized anti-cancer vaccine|personalized anti-cancer vaccine
272008|NCT01998529|Lung Cancer|lung cancer
272009|NCT01998529|Unilateral Pleural Malignancy|unilateral pleural malignancy
272010|NCT01998529|Metastatic active pleural malignancy|metastatic active pleural malignancy
272011|NCT01998529|Lung tumors|lung tumors
272012|NCT01998529|Sarcomas|sarcomas
272013|NCT01998529|Cytoreductive Surgery|cytoreductive surgery
272014|NCT01998529|Hyperthermic Intrathoracic Pleural Chemotherapy|hyperthermic intrathoracic pleural chemotherapy
272015|NCT01998529|HITC|hitc
272016|NCT01998529|Cisplatin|cisplatin
272017|NCT01998529|Platinol-AQ|platinol-aq
272018|NCT01998529|Platinol|platinol
272019|NCT01998529|CDDP|cddp
272020|NCT01998529|Amifostine|amifostine
272021|NCT01998529|Ethyol|ethyol
272022|NCT01998529|Ethiofos|ethiofos
272023|NCT01998529|Gammaphos|gammaphos
272024|NCT01998516|Emotional Intelligence|emotional intelligence
272025|NCT01998503|AL amyloidosis|al amyloidosis
272026|NCT01998503|bortezomib|bortezomib
272027|NCT01998503|autologous stem cell transplantation|autologous stem cell transplantation
272028|NCT01998477|Influenza|influenza
272029|NCT01998477|Vaccine|vaccine
272030|NCT01998477|Flu|flu
272031|NCT01998477|Children|children
272032|NCT01998477|Adolescents|adolescents
272033|NCT01998464|Retinal Vasculitis|retinal vasculitis
272034|NCT01998464|Optical coherence tomography|optical coherence tomography
272035|NCT01998464|OCT|oct
272036|NCT01998464|Imaging|imaging
272037|NCT01998451|double sphincter in gallbladder|double sphincter in gallbladder
272038|NCT01998451|recurrence rate of gallstones|recurrence rate of gallstones
272039|NCT01998438|tranexamic acid|tranexamic acid
273029|NCT01994265|Cognition|cognition
272040|NCT01998438|cardiac surgery|cardiac surgery
272041|NCT01998438|cardiopulmonary bypass|cardiopulmonary bypass
272042|NCT01998425|circulating fibrocytes|circulating fibrocytes
272043|NCT01998425|fibrocyte|fibrocyte
272044|NCT01998425|NSCLC|nsclc
272045|NCT01998425|treatment response|treatment response
272046|NCT01998425|survival|survival
272047|NCT01998425|stage|stage
272048|NCT01998399|CAP|cap
272049|NCT01998399|Pneumonia|pneumonia
272050|NCT01998399|Intensive Care Unit|intensive care unit
272051|NCT01998399|Mechanical Ventilation|mechanical ventilation
272052|NCT01998386|Tooth Whitening|tooth whitening
272053|NCT01998386|Adolescent|adolescent
272054|NCT01998386|Clinical Trial|clinical trial
272055|NCT01998373|Patient training|patient training
272056|NCT01998373|Rheumatoid arthritis|rheumatoid arthritis
272057|NCT01998373|Quality of life|quality of life
272058|NCT01998360|Circumcision|circumcision
272059|NCT01998360|Voluntary medical male circumcision|voluntary medical male circumcision
272060|NCT01998360|Minimally-invasive|minimally-invasive
272061|NCT01998360|HIV prevention|hiv prevention
272062|NCT01998334|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
272063|NCT01998334|Continuous Blood Purification|continuous blood purification
272064|NCT01998321|PSI: Patient Specific Instrument|psi: patient specific instrument
272065|NCT01998321|TKA: Total Knee Arthroplasty|tka: total knee arthroplasty
272066|NCT01998321|Articular Deformity|articular deformity
272067|NCT01998321|Varus|varus
272068|NCT01998295|Clearance time|clearance time
272069|NCT01998295|Recurrence time|recurrence time
272070|NCT01998295|Artemether/lumefantrine|artemether/lumefantrine
272071|NCT01998295|P. falciparum|p. falciparum
272072|NCT01998295|Uncomplicated malaria|uncomplicated malaria
272073|NCT01998295|Children|children
272074|NCT01998282|Focus of study is to assess filter/stove use and efficacy in reducing exposure to waterborne and airborne pathogens.|focus of study is to assess filter/stove use and efficacy in reducing exposure to waterborne and airborne pathogens.
272075|NCT01998256|AV optimization|av optimization
272076|NCT01998256|Interatrial conduction delay|interatrial conduction delay
272077|NCT01998243|morbid obesity|morbid obesity
272078|NCT01998243|bioenterics intragastric balloon|bioenterics intragastric balloon
272079|NCT01998243|bariatric surgery|bariatric surgery
272080|NCT01998230|esophageal cancer|esophageal cancer
272081|NCT01998230|esophagectomy|esophagectomy
272082|NCT01998230|oral feeding|oral feeding
272083|NCT01998217|extracorporeal shock wave lithotripsy|extracorporeal shock wave lithotripsy
272084|NCT01998217|remifentanil|remifentanil
272085|NCT01998217|flurbiprofen|flurbiprofen
272086|NCT01998217|pancreatic stone|pancreatic stone
272087|NCT01998204|Parkinson's disease|parkinson's disease
272088|NCT01998204|propofol|propofol
272089|NCT01998204|deep brain stimulator|deep brain stimulator
272090|NCT01998191|mortality|mortality
272091|NCT01998191|adverse events|adverse events
272092|NCT01998165|Anesthesia|anesthesia
272093|NCT01998165|Remifentanil|remifentanil
272094|NCT01998165|Ultiva|ultiva
272095|NCT01998113|gestational diabetes mellitus|gestational diabetes mellitus
272096|NCT01998113|glyburide|glyburide
272097|NCT01998113|metformin|metformin
272098|NCT01998113|oral agents|oral agents
272099|NCT01998113|insulin|insulin
272100|NCT01998113|outcomes|outcomes
272101|NCT01998100|PTSD|ptsd
272102|NCT01998100|Anxiety|anxiety
272103|NCT01998100|Behavior Therapy|behavior therapy
272104|NCT01998100|Prolonged Exposure|prolonged exposure
272105|NCT01998100|Exercise|exercise
272106|NCT01998100|Wellness|wellness
272107|NCT01998100|Post-traumatic|post-traumatic
272108|NCT01998100|Stress|stress
272109|NCT01998087|Exclusive breastfeeding|exclusive breastfeeding
272110|NCT01998087|Breastfeeding|breastfeeding
272111|NCT01998087|Proactive breastfeeding support|proactive breastfeeding support
272112|NCT01998087|Telephone breastfeeding support|telephone breastfeeding support
272113|NCT01998087|Infant feeding attitudes|infant feeding attitudes
272114|NCT01998087|Breastfeeding self-efficacy|breastfeeding self-efficacy
272115|NCT01998087|Breastfeeding difficulties|breastfeeding difficulties
272116|NCT01998074|Cow's Milk protein Allergy|cow's milk protein allergy
272117|NCT01998048|surgical treatment|surgical treatment
272118|NCT01998048|Bankart|bankart
272119|NCT01998048|Latarjet|latarjet
272120|NCT01998048|redislocation|redislocation
272121|NCT01998035|Lymphoid Malignancies|lymphoid malignancies
272122|NCT01998035|Lymphoma|lymphoma
272123|NCT01998035|Hodgkin Lymphoma|hodgkin lymphoma
272124|NCT01998035|Non-hodgkin Lymphoma|non-hodgkin lymphoma
272125|NCT01998035|Follicular Lymphoma|follicular lymphoma
272126|NCT01998035|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
272127|NCT01998035|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
272128|NCT01998035|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
272129|NCT01998035|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
272130|NCT01998035|Mantle Cell Lymphoma|mantle cell lymphoma
272131|NCT01998035|Marginal Zone Lymphoma|marginal zone lymphoma
272132|NCT01998035|Burkitt Lymphoma|burkitt lymphoma
272133|NCT01998035|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
272134|NCT01998035|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
272135|NCT01998035|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
272136|NCT01998022|hypertension|hypertension
272137|NCT01998022|knowledge|knowledge
272138|NCT01998022|blood pressure control|blood pressure control
272139|NCT01998009|colorectal cancer|colorectal cancer
272140|NCT01998009|mass screening|mass screening
272141|NCT01998009|fecal occult blood|fecal occult blood
272142|NCT01997996|Pelvic Organ Prolapse|pelvic organ prolapse
272143|NCT01997996|PROLIFT+M|prolift+m
272144|NCT01997996|Vita sexualis|vita sexualis
272145|NCT01997983|interstitial cystitis|interstitial cystitis
272146|NCT01997983|PBS/IC|pbs/ic
272147|NCT01997983|IC|ic
272148|NCT01997983|Botox|botox
272149|NCT01997983|Botulinum toxin|botulinum toxin
272150|NCT01997983|TC-3 Gel|tc-3 gel
272151|NCT01997983|TCGel|tcgel
272152|NCT01997983|TheraCoat|theracoat
272153|NCT01997970|NEAT|neat
272154|NCT01997970|Treadmill desk|treadmill desk
272155|NCT01997957|Hepatocellular Carcinoma|hepatocellular carcinoma
272156|NCT01997957|Transarterial Chemoembolization|transarterial chemoembolization
272157|NCT01997957|Hepatic Arterial Infusion Chemotherapy|hepatic arterial infusion chemotherapy
272158|NCT01997957|Efficacy|efficacy
272159|NCT01997931|bispectral index|bispectral index
272160|NCT01997931|sedation|sedation
272161|NCT01997931|intensive care|intensive care
272162|NCT01997931|mechanical ventilation|mechanical ventilation
272163|NCT01997918|Secondary allogeneic HSCT|secondary allogeneic hsct
272164|NCT01997918|Haploidentical HSCT|haploidentical hsct
272165|NCT01997905|Left Atrial Appendage|left atrial appendage
272166|NCT01997905|LAA|laa
272167|NCT01997905|Atrial Fibrillation|atrial fibrillation
272168|NCT01997905|AFib|afib
272169|NCT01997905|AF|af
272170|NCT01997905|IRB approved|irb approved
272171|NCT01997905|clinical|clinical
272172|NCT01997905|Stroke|stroke
272173|NCT01997905|TIA|tia
272174|NCT01997905|contraindication to oral anticoagulation therapy|contraindication to oral anticoagulation therapy
272175|NCT01997905|Arrhythmias, Cardiac|arrhythmias, cardiac
272176|NCT01997905|OAC|oac
272177|NCT01997905|trial|trial
272178|NCT01997905|study|study
272179|NCT01997905|LAA occlusion|laa occlusion
272180|NCT01997905|occluded|occluded
272181|NCT01997905|prevent|prevent
272182|NCT01997892|CKD|ckd
272183|NCT01997892|Darbepoetin Alfa|darbepoetin alfa
272184|NCT01997892|Dialysis|dialysis
272185|NCT01997892|Hemodialysis|hemodialysis
272186|NCT01997892|Anemia|anemia
272187|NCT01997892|Peg epoetin beta|peg epoetin beta
272188|NCT01997866|Obstructive Sleep Apnea|obstructive sleep apnea
272189|NCT01997866|Sleep Apnea|sleep apnea
272190|NCT01997866|Congestive Heart Failure|congestive heart failure
272191|NCT01997866|Heart Failure|heart failure
272192|NCT01997853|Omega 3 fatty acids|omega 3 fatty acids
272193|NCT01997853|C Reactive Protein|c reactive protein
272194|NCT01997853|Host Modulation|host modulation
272195|NCT01997853|Chronic Periodontitis|chronic periodontitis
272196|NCT01997840|Multiple Myeloma|multiple myeloma
272197|NCT01997840|Neoplasms, Plasma Cell|neoplasms, plasma cell
272198|NCT01997840|Neoplasms by Histologic Type|neoplasms by histologic type
272199|NCT01997840|Neoplasms|neoplasms
272200|NCT01997840|Blood Protein Disorders|blood protein disorders
272201|NCT01997840|Hematologic Diseases|hematologic diseases
272202|NCT01997840|Dexamethasone|dexamethasone
272203|NCT01997840|Dexamethasone acetate|dexamethasone acetate
272204|NCT01997840|Pomalidomide|pomalidomide
272205|NCT01997814|Herbal medicine,|herbal medicine,
272206|NCT01997814|Host modulation therapy,|host modulation therapy,
272207|NCT01997814|Periodontitis,|periodontitis,
272208|NCT01997814|Meta-analysis,|meta-analysis,
272209|NCT01997814|Scaling and root planing.|scaling and root planing.
272210|NCT01997801|Thyroidectomy|thyroidectomy
272211|NCT01997801|Endoscopy|endoscopy
272212|NCT01997801|Ketamine|ketamine
272213|NCT01997801|Acute Pain|acute pain
272214|NCT01997801|Chronic Pain|chronic pain
272215|NCT01997801|Postoperative period|postoperative period
272216|NCT01997788|Injection, Spinal|injection, spinal
272217|NCT01997788|Morphine|morphine
272218|NCT01997788|Analgesia|analgesia
272219|NCT01997788|Patient-Controlled|patient-controlled
272220|NCT01997788|Pain|pain
272221|NCT01997788|Postoperative|postoperative
272222|NCT01997788|Combined Modality Therapy|combined modality therapy
272223|NCT01997788|Nephrectomy|nephrectomy
272224|NCT01997775|IL-6|il-6
272225|NCT01997775|Metformin|metformin
272226|NCT01997775|Non-small cell lung cancer|non-small cell lung cancer
272227|NCT01997775|Lung adenocarcinoma|lung adenocarcinoma
272228|NCT01997762|resveratrol,|resveratrol,
272229|NCT01997762|gestational diabetes,|gestational diabetes,
272230|NCT01997762|beta cell function|beta cell function
272231|NCT01997762|history|history
272232|NCT01997749|stroke, ketogenic diet, ketosis, ischemia, brain, ketones, hyperglycemia, neuroprotection|stroke, ketogenic diet, ketosis, ischemia, brain, ketones, hyperglycemia, neuroprotection
272233|NCT01997736|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
272234|NCT01997736|Catheter Ablation|catheter ablation
272235|NCT01997736|Ablation Techniques|ablation techniques
273129|NCT01993732|In Vitro|in vitro
272236|NCT01997723|OSA, portable monitoring, home diagnosis|osa, portable monitoring, home diagnosis
272237|NCT01997684|Colorectal Cancer|colorectal cancer
272238|NCT01997684|Colonic Obstruction|colonic obstruction
272239|NCT01997671|Primary Care|primary care
272240|NCT01997671|Lipid-lowering therapy|lipid-lowering therapy
272241|NCT01997671|Prescription|prescription
272242|NCT01997671|Adequacy|adequacy
272243|NCT01997671|Primary prevention|primary prevention
272244|NCT01997671|Cardiovascular diseases|cardiovascular diseases
272245|NCT01997671|Electronic Medical records|electronic medical records
272246|NCT01997671|Clinical Practice Guideline|clinical practice guideline
272247|NCT01997658|Glucocorticoids|glucocorticoids
272248|NCT01997658|Total complication rate|total complication rate
272249|NCT01997658|Hepatectomy.|hepatectomy.
272250|NCT01997645|Anal fistula|anal fistula
272251|NCT01997645|Rectal fistula|rectal fistula
272252|NCT01997645|Intersphincteric fistula|intersphincteric fistula
272253|NCT01997645|Perianal fistula|perianal fistula
272254|NCT01997632|Poliomyelitis|poliomyelitis
272255|NCT01997632|Vaccine|vaccine
272256|NCT01997619|biological mesh|biological mesh
272257|NCT01997619|contaminated hernia|contaminated hernia
272258|NCT01997619|abdominal wall reconstruction|abdominal wall reconstruction
272259|NCT01997593|analgesia|analgesia
272260|NCT01997593|pediatric|pediatric
272261|NCT01997593|pain|pain
272262|NCT01997593|laparoscopy|laparoscopy
272263|NCT01997593|ropivacaine|ropivacaine
272264|NCT01997580|depression|depression
272265|NCT01997580|treatment|treatment
272266|NCT01997580|electrophysiology|electrophysiology
272267|NCT01997580|biomarker|biomarker
272268|NCT01997567|Hip Arthroscopy|hip arthroscopy
272269|NCT01997567|Regional Anesthesia|regional anesthesia
272270|NCT01997567|Peripheral Nerve block|peripheral nerve block
272271|NCT01997554|TSH Testing|tsh testing
272272|NCT01997554|sub-clinical hypothyroidism|sub-clinical hypothyroidism
272273|NCT01997515|QOR-40|qor-40
272274|NCT01997515|Pain|pain
272275|NCT01997515|Hypoxia|hypoxia
272276|NCT01997515|Gastric Surgery|gastric surgery
272277|NCT01997515|Obesity|obesity
272278|NCT01997515|Ketamine|ketamine
272279|NCT01997502|Hemoglobin|hemoglobin
272280|NCT01997502|Non-invasive|non-invasive
272281|NCT01997489|Eye|eye
272282|NCT01997489|Fabry|fabry
272283|NCT01997489|vessels|vessels
272284|NCT01997476|Combined Endoscopic Ultrasound Morphologic Evaluation.|combined endoscopic ultrasound morphologic evaluation.
272285|NCT01997450|Q/LAIV/FluMist® Quadrivalent Vaccine|q/laiv/flumist® quadrivalent vaccine
272286|NCT01997450|Inactivated Influenza Vaccine (IIV)|inactivated influenza vaccine (iiv)
272287|NCT01997450|Effectiveness|effectiveness
272288|NCT01997450|Influenza|influenza
272289|NCT01997437|Tissue-engineered tracheal transplantation|tissue-engineered tracheal transplantation
272290|NCT01997411|Diabetes Mellitus|diabetes mellitus
272291|NCT01997411|Glucagon|glucagon
272292|NCT01997398|Deep brain stimulation surgery under general anesthesia|deep brain stimulation surgery under general anesthesia
272293|NCT01997398|Deep brain stimulation target accuracy|deep brain stimulation target accuracy
272294|NCT01997398|Deep brain stimulation for Parkinsons's disease|deep brain stimulation for parkinsons's disease
272295|NCT01997398|Deep brain stimulation functional outcomes|deep brain stimulation functional outcomes
272296|NCT01997398|Deep brain stimulation quality of life outcomes|deep brain stimulation quality of life outcomes
272297|NCT01997385|adapted APD|adapted apd
272298|NCT01997385|dwell time|dwell time
272299|NCT01997385|fill volume|fill volume
272300|NCT01997372|ATG|atg
272301|NCT01997372|SAA|saa
272302|NCT01997372|immunosuppressive treatment|immunosuppressive treatment
272303|NCT01997372|cyclosporine|cyclosporine
272304|NCT01997359|ART initiation|art initiation
272305|NCT01997359|HIV|hiv
272306|NCT01997359|AIDS|aids
272307|NCT01997359|Ethiopia|ethiopia
272308|NCT01997346|ART initiation|art initiation
272309|NCT01997346|Ethiopia|ethiopia
272310|NCT01997346|Clinic observation|clinic observation
272311|NCT01997346|VCT observation|vct observation
272312|NCT01997333|Metastatic Breast Cancer|metastatic breast cancer
272313|NCT01997333|Locally advanced breast cancer|locally advanced breast cancer
272314|NCT01997333|Breast cancer|breast cancer
272315|NCT01997333|Triple negative|triple negative
272316|NCT01997333|Estrogen|estrogen
272317|NCT01997333|Progesterone|progesterone
272318|NCT01997333|HER2 receptors|her2 receptors
272319|NCT01997333|Targeted treatment for breast cancer|targeted treatment for breast cancer
272320|NCT01997333|Antibody-drug-conjugate|antibody-drug-conjugate
272321|NCT01997333|Breast Neoplasms|breast neoplasms
272322|NCT01997333|CDX-011|cdx-011
272323|NCT01997333|gpNMB|gpnmb
272324|NCT01997333|METRIC|metric
272325|NCT01997333|Glembatumumab vedotin|glembatumumab vedotin
272326|NCT01997333|Triple Negative Breast Cancer|triple negative breast cancer
272327|NCT01997333|TNBC|tnbc
272328|NCT01997320|Sarcopenia|sarcopenia
272329|NCT01997320|Frailty|frailty
272330|NCT01997320|Strength|strength
272331|NCT01997320|Protein supplementation|protein supplementation
272332|NCT01997320|Ageing|ageing
272333|NCT01997307|acute coronary syndrome, coronary arteriography, menopause|acute coronary syndrome, coronary arteriography, menopause
272334|NCT01997294|sequential therapy|sequential therapy
272335|NCT01997294|atorvastatin|atorvastatin
272336|NCT01997294|acute myocardial infarction|acute myocardial infarction
272337|NCT01997281|dietary fiber|dietary fiber
272338|NCT01997281|diabetes mellitus|diabetes mellitus
272339|NCT01997281|gut hormone|gut hormone
272340|NCT01997268|Dyslipidemia|dyslipidemia
272341|NCT01997268|Hyperlipidemia|hyperlipidemia
272342|NCT01997268|Omega-3 Fatty Acids|omega-3 fatty acids
272343|NCT01997268|Metabolic Diseases|metabolic diseases
272344|NCT01997268|TG ≥500 mg/dL and ≤ 2,000 mg/dL|tg ≥500 mg/dl and ≤ 2,000 mg/dl
272345|NCT01997255|Everolimus|everolimus
272346|NCT01997255|Epilepsy|epilepsy
272347|NCT01997255|Sturge Weber Syndrome|sturge weber syndrome
272348|NCT01997255|Port wine stain|port wine stain
272349|NCT01997255|Glaucoma|glaucoma
272350|NCT01997242|CORONARY STENT|coronary stent
272351|NCT01997242|CARDIAC SURGERY|cardiac surgery
272352|NCT01997242|NON CARDIAC SURGEY|non cardiac surgey
272353|NCT01997229|Myasthenia Gravis|myasthenia gravis
272354|NCT01997229|Eculizumab|eculizumab
272355|NCT01997229|safety|safety
272356|NCT01997229|efficacy|efficacy
272357|NCT01997216|contact lenses|contact lenses
272358|NCT01997216|multifocal|multifocal
272359|NCT01997203|hepatitis C infection|hepatitis c infection
272360|NCT01997203|vitamin D|vitamin d
272361|NCT01997190|Immunotherapy|immunotherapy
272362|NCT01997190|Gene therapy|gene therapy
272363|NCT01997190|Tumor vaccine|tumor vaccine
272364|NCT01997177|simulation|simulation
272365|NCT01997177|training|training
272366|NCT01997177|colonoscopy|colonoscopy
272367|NCT01997177|standard setting|standard setting
272368|NCT01997138|pain, inflammation, surgery|pain, inflammation, surgery
272369|NCT01997112|Blood pressure|blood pressure
272370|NCT01997112|Hypertension|hypertension
272371|NCT01997112|Paracetamol|paracetamol
272372|NCT01997112|Acetaminophen|acetaminophen
272373|NCT01997099|Drug Library|drug library
272374|NCT01997099|Ambulatory Infusion Pump|ambulatory infusion pump
272375|NCT01997099|Medication Safety Software|medication safety software
272376|NCT01997099|CADD®-Solis VIP|cadd®-solis vip
272377|NCT01997099|Pump Programming|pump programming
272378|NCT01997099|Home Infusion Workflow|home infusion workflow
272379|NCT01997073|Respiratory enthalpy|respiratory enthalpy
272380|NCT01997073|One Lung Ventilation|one lung ventilation
272381|NCT01997060|Lifestyle intervention|lifestyle intervention
272382|NCT01997060|Body weight|body weight
272383|NCT01997060|Body composition|body composition
272384|NCT01997060|Weight loss maintenance|weight loss maintenance
272385|NCT01997060|Physical activity|physical activity
272386|NCT01997047|Pneumonia|pneumonia
272387|NCT01997047|bronchiolitis|bronchiolitis
272388|NCT01997047|asthma|asthma
272389|NCT01997047|children|children
272390|NCT01997047|tachypnea|tachypnea
272391|NCT01997047|developing countries|developing countries
272392|NCT01997047|diagnostic criteria|diagnostic criteria
272393|NCT01997034|Weight loss maintenance|weight loss maintenance
272394|NCT01997034|Body composition|body composition
272395|NCT01997034|Physical activity|physical activity
272396|NCT01997034|Lifestyle intervention|lifestyle intervention
272397|NCT01997021|Sedentary behavior|sedentary behavior
272398|NCT01997021|physical activity|physical activity
272399|NCT01997021|older adults|older adults
272400|NCT01996982|Induced therapeutic hypothermia|induced therapeutic hypothermia
272401|NCT01996969|metastatic colorectal cancer|metastatic colorectal cancer
272402|NCT01996969|refractory|refractory
272403|NCT01996969|regorafenib|regorafenib
272404|NCT01996969|biomarker|biomarker
272405|NCT01996969|gene sequencing|gene sequencing
272406|NCT01996956|stroke volume variation,|stroke volume variation,
272407|NCT01996956|cardiac output,|cardiac output,
272408|NCT01996956|fluid responsiveness,|fluid responsiveness,
272409|NCT01996956|noninvasive cardiac output monitor|noninvasive cardiac output monitor
272410|NCT01996943|Atrial Fibrillation|atrial fibrillation
272411|NCT01996943|Alcohol|alcohol
272412|NCT01996943|Electrophysiologic properties of the atria|electrophysiologic properties of the atria
272413|NCT01996943|Randomized Clinical Study|randomized clinical study
272414|NCT01996917|wound closure|wound closure
272415|NCT01996917|prineo|prineo
272416|NCT01996917|scar|scar
272417|NCT01996904|subscapularis tear|subscapularis tear
272418|NCT01996904|arthroscopic tendon repair|arthroscopic tendon repair
272419|NCT01996904|arthroscopic tendon debridement|arthroscopic tendon debridement
272420|NCT01996904|ASES|ases
272421|NCT01996891|Asthma|asthma
272422|NCT01996891|Nutrition|nutrition
272423|NCT01996891|Anti-inflammatory diet|anti-inflammatory diet
272424|NCT01996878|Parkinson's disease|parkinson's disease
272425|NCT01996878|Genetic Polymorphism|genetic polymorphism
272426|NCT01996865|Lymphoma, Mantle cell Lymphoma, Follicular Lymphoma, Marginal zone Lymphoma, Lenalidomide treatment, rituximab treatment, Non Hodgkins Lymphoma|lymphoma, mantle cell lymphoma, follicular lymphoma, marginal zone lymphoma, lenalidomide treatment, rituximab treatment, non hodgkins lymphoma
272427|NCT01996852|Erectile dysfunction|erectile dysfunction
272428|NCT01996852|ED|ed
272429|NCT01996852|Prostate|prostate
272430|NCT01996852|Prostatectomy|prostatectomy
272431|NCT01996826|Corneal Neovascularization|corneal neovascularization
272432|NCT01996826|Cornea Blood Vessels|cornea blood vessels
272433|NCT01996826|Corneal Graft Failure|corneal graft failure
272434|NCT01996826|High-Risk Penetrating Keratoplasty|high-risk penetrating keratoplasty
272435|NCT01996826|Corneal Transplant|corneal transplant
272436|NCT01996813|arthroscopy|arthroscopy
272437|NCT01996813|shoulder|shoulder
272438|NCT01996813|obesity|obesity
272439|NCT01996813|beach chair|beach chair
272440|NCT01996813|compression hose|compression hose
272441|NCT01996787|visibility tinted silicone hydrogel contact lenses for daily wear|visibility tinted silicone hydrogel contact lenses for daily wear
272442|NCT01996735|Endothelial function|endothelial function
272443|NCT01996735|Adenosine receptor stimulation|adenosine receptor stimulation
272444|NCT01996709|Silicone hydrogel contact lenses|silicone hydrogel contact lenses
272445|NCT01996709|Multi-purpose solution|multi-purpose solution
272446|NCT01996709|Lid Papillae|lid papillae
272447|NCT01996709|Palpebral Roughness|palpebral roughness
272448|NCT01996696|metformin|metformin
272449|NCT01996696|metabolic syndrome|metabolic syndrome
272450|NCT01996696|weight gain|weight gain
272451|NCT01996683|B-thalassemia|b-thalassemia
272452|NCT01996683|ferritin|ferritin
272453|NCT01996657|mechanical valves replacement|mechanical valves replacement
272454|NCT01996657|INR|inr
272455|NCT01996657|D-dimer|d-dimer
272456|NCT01996657|thromboembolic events|thromboembolic events
272457|NCT01996644|Anorexia, Bulimia, Anxiety, Exposure|anorexia, bulimia, anxiety, exposure
272458|NCT01996618|Premature Ventricular Beats|premature ventricular beats
272459|NCT01996618|Premature Heart Beats|premature heart beats
272460|NCT01996618|Ranolazine|ranolazine
272461|NCT01996592|chronic pain|chronic pain
272462|NCT01996592|cesarean section pain|cesarean section pain
272463|NCT01996579|Critically Ill|critically ill
272464|NCT01996579|Intensive care|intensive care
272465|NCT01996579|Nasogastric tube|nasogastric tube
272466|NCT01996579|Orogastric tube|orogastric tube
272467|NCT01996579|mechanically ventilated|mechanically ventilated
272468|NCT01996579|nosocomially acquired infections|nosocomially acquired infections
272469|NCT01996579|length of stay|length of stay
272470|NCT01996579|lactoferrin|lactoferrin
272471|NCT01996579|placebo controlled|placebo controlled
272472|NCT01996579|antibiotic free days|antibiotic free days
272473|NCT01996566|taste|taste
272474|NCT01996566|non-esterified fatty acids|non-esterified fatty acids
272475|NCT01996566|threshold|threshold
272476|NCT01996566|sensitivity|sensitivity
272477|NCT01996566|human|human
272478|NCT01996553|blood flow, regional|blood flow, regional
272479|NCT01996553|complications|complications
272480|NCT01996553|disease, arterial obstructive|disease, arterial obstructive
272481|NCT01996553|cardiac catheterization|cardiac catheterization
272482|NCT01996553|radial artery|radial artery
272483|NCT01996540|gastric neoplasm|gastric neoplasm
272484|NCT01996540|pancreatic neoplasm|pancreatic neoplasm
272485|NCT01996540|advanced|advanced
272486|NCT01996540|palliative care|palliative care
272487|NCT01996514|Children|children
272488|NCT01996514|Food advertisement|food advertisement
272489|NCT01996514|Obesity|obesity
272490|NCT01996514|Television viewing|television viewing
272491|NCT01996514|Food intake|food intake
272492|NCT01996449|Hypertension|hypertension
272493|NCT01996449|blood pressure|blood pressure
272494|NCT01996449|Aldosterone|aldosterone
272495|NCT01996449|Eplerenone|eplerenone
272496|NCT01996449|Amlodipine|amlodipine
272497|NCT01996449|Primary aldosteronism|primary aldosteronism
272498|NCT01996449|Exercise pressor reflex|exercise pressor reflex
272499|NCT01996449|handgrip exercise|handgrip exercise
272500|NCT01996449|passive arm cycling|passive arm cycling
272501|NCT01996449|active arm cycling|active arm cycling
272502|NCT01996436|cerebral vasospasm|cerebral vasospasm
272503|NCT01996436|aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
272504|NCT01996436|intra arterial drug treatment for cerebral vasospasm|intra arterial drug treatment for cerebral vasospasm
272505|NCT01996436|nicardipine milrinone nitroglycerin verapamil|nicardipine milrinone nitroglycerin verapamil
272506|NCT01996423|Atopic dermatitis|atopic dermatitis
272507|NCT01996423|vitamin D|vitamin d
272508|NCT01996410|Breast Cancer|breast cancer
272509|NCT01996410|Acupuncture|acupuncture
272510|NCT01996410|Taxol|taxol
272511|NCT01996410|Cytoxan|cytoxan
272512|NCT01996410|Adriamycin|adriamycin
272513|NCT01996410|Taxotere|taxotere
272514|NCT01996410|Carboplatin|carboplatin
272515|NCT01996410|Perjeta|perjeta
272516|NCT01996410|Chemotherapy|chemotherapy
272517|NCT01996410|Chemotherapy-induced nausea, vomiting|chemotherapy-induced nausea, vomiting
272518|NCT01996410|Chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
272519|NCT01996410|Adriamycin (60 mg/m2), Cytoxan (600 mg/m2), Taxol (175 mg/m2)|adriamycin (60 mg/m2), cytoxan (600 mg/m2), taxol (175 mg/m2)
272520|NCT01996410|Adriamycin (60 mg/m2), Cytoxan (600 mg/m2), Taxol (80 g/m2)|adriamycin (60 mg/m2), cytoxan (600 mg/m2), taxol (80 g/m2)
272521|NCT01996410|Taxotere (75mg/m2), Cytoxan (600 mg/m2)|taxotere (75mg/m2), cytoxan (600 mg/m2)
272522|NCT01996410|Taxotere (75 mg/m2), Carboplatin (AUC 6), Perjeta (840 mg loading fixed dose)|taxotere (75 mg/m2), carboplatin (auc 6), perjeta (840 mg loading fixed dose)
272523|NCT01996397|Heart failure|heart failure
272524|NCT01996397|Bundle branch block|bundle branch block
272525|NCT01996397|CRT response|crt response
272526|NCT01996384|Vulvodynia|vulvodynia
272527|NCT01996384|Provoked, localized vulvodynia|provoked, localized vulvodynia
272528|NCT01996384|vulvar vestibulitis|vulvar vestibulitis
272529|NCT01996384|provoked vestibulodynia|provoked vestibulodynia
272530|NCT01996384|vulvovaginal pain|vulvovaginal pain
272531|NCT01996384|vulvar pain|vulvar pain
272532|NCT01996384|vaginal pain|vaginal pain
272533|NCT01996384|chronic pain|chronic pain
272534|NCT01996384|lidocaine|lidocaine
272535|NCT01996384|numbing agent|numbing agent
272536|NCT01996384|anesthetic cream|anesthetic cream
272537|NCT01996384|acupuncture|acupuncture
272538|NCT01996384|electroacupuncture|electroacupuncture
272539|NCT01996384|electrical stimulated acupuncture|electrical stimulated acupuncture
272540|NCT01996384|manual acupuncture|manual acupuncture
272541|NCT01996384|classical acupuncture|classical acupuncture
272542|NCT01996384|non-classical acupuncture|non-classical acupuncture
272543|NCT01996384|Traditional Chinese Medicine|traditional chinese medicine
272544|NCT01996384|TCM|tcm
272545|NCT01996384|Chinese medicine|chinese medicine
272546|NCT01996384|Acupuncture and Oriental Medicine|acupuncture and oriental medicine
272547|NCT01996384|AOM|aom
272548|NCT01996384|treatment|treatment
272549|NCT01996384|feasibility|feasibility
272550|NCT01996384|pilot study|pilot study
272551|NCT01996384|Patient Reported Outcomes Measure Information System|patient reported outcomes measure information system
272552|NCT01996384|Tampon Test|tampon test
272553|NCT01996384|cotton swab test|cotton swab test
272554|NCT01996384|pain diary|pain diary
272555|NCT01996384|Research Electronic Data Capture|research electronic data capture
272556|NCT01996384|REDCap|redcap
272557|NCT01996358|Succinylcholine|succinylcholine
272558|NCT01996358|Rocuronium|rocuronium
272559|NCT01996358|Rigid Bronchoscopy|rigid bronchoscopy
272560|NCT01996345|Placenta Previa|placenta previa
272561|NCT01996345|Vaginal Pessary|vaginal pessary
272562|NCT01996345|Premature Birth|premature birth
272563|NCT01996319|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
272564|NCT01996319|COPD|copd
272565|NCT01996306|AXEPT|axept
272566|NCT01996306|Fluorouracil|fluorouracil
272567|NCT01996306|CPT-11|cpt-11
272568|NCT01996306|XELIRI|xeliri
272569|NCT01996306|Bevacizumab|bevacizumab
272570|NCT01996306|FOLFIRI|folfiri
272571|NCT01996306|Capecitabine|capecitabine
272572|NCT01996306|2nd-line metastatic colorectal cancer|2nd-line metastatic colorectal cancer
272573|NCT01996293|pregnant|pregnant
272574|NCT01996293|bipolar|bipolar
272575|NCT01996293|lamotrigine|lamotrigine
272576|NCT01996293|lamictal|lamictal
272577|NCT01996293|women|women
272578|NCT01996293|female|female
272579|NCT01996267|neoadjuvant|neoadjuvant
272580|NCT01996267|breast cancer|breast cancer
272581|NCT01996267|HER2 positive|her2 positive
272582|NCT01996254|electrical stimulation|electrical stimulation
272583|NCT01996254|neurostimulation|neurostimulation
272584|NCT01996254|neuromodulation|neuromodulation
272585|NCT01996254|post-amputation pain|post-amputation pain
272586|NCT01996254|phantom limb pain|phantom limb pain
272587|NCT01996254|residual limb pain|residual limb pain
272588|NCT01996254|neuropathic pain|neuropathic pain
272589|NCT01996254|amputee pain|amputee pain
272590|NCT01996241|adolescent girls|adolescent girls
272591|NCT01996241|female sex work|female sex work
272592|NCT01996241|age at marriage|age at marriage
272593|NCT01996241|retention in school|retention in school
272594|NCT01996241|sexual debut|sexual debut
272595|NCT01996241|India|india
272596|NCT01996241|Karnataka|karnataka
272597|NCT01996228|Type 1 diabetes|type 1 diabetes
272598|NCT01996228|autoimmune|autoimmune
272599|NCT01996228|cord blood stem cell|cord blood stem cell
272600|NCT01996228|stem cell educator|stem cell educator
272601|NCT01996228|immune modulation|immune modulation
272602|NCT01996228|children|children
272603|NCT01996228|Control autoimmunity|control autoimmunity
272604|NCT01996228|stimulate the regeneration of islet beta cells|stimulate the regeneration of islet beta cells
272605|NCT01996202|Melanoma|melanoma
272606|NCT01996176|Sedentary Lifestyle|sedentary lifestyle
272607|NCT01996176|Sedentary work|sedentary work
272608|NCT01996176|Office workers|office workers
272609|NCT01996176|Work|work
272610|NCT01996176|Workplace intervention|workplace intervention
272611|NCT01996176|Sitting time|sitting time
272612|NCT01996150|atopic dermatitis|atopic dermatitis
272613|NCT01996150|eczema|eczema
272614|NCT01996150|bleach bath|bleach bath
272615|NCT01996150|itch|itch
272616|NCT01996150|skin barrier|skin barrier
272617|NCT01996150|staphylococcus aureus|staphylococcus aureus
272618|NCT01996137|Stroke|stroke
272619|NCT01996137|Treadmill|treadmill
272620|NCT01996137|Gait Speed|gait speed
272621|NCT01996124|COPD|copd
272622|NCT01996124|Pulmonary Hyperinflation|pulmonary hyperinflation
272623|NCT01996124|Ultra Long Acting Beta 2 Agonists|ultra long acting beta 2 agonists
272624|NCT01996124|Cor Pulmonale|cor pulmonale
272625|NCT01996124|Cardiac performance|cardiac performance
273130|NCT01993719|Metastatic|metastatic
272626|NCT01996111|plantar fasciitis|plantar fasciitis
272627|NCT01996085|arterial hypertension|arterial hypertension
272628|NCT01996085|hemodynamics|hemodynamics
272629|NCT01996085|impedance cardiography|impedance cardiography
272630|NCT01996085|hypotensive therapy|hypotensive therapy
272631|NCT01996072|Primary hyperparathyroidism|primary hyperparathyroidism
272632|NCT01996072|Parathyroid|parathyroid
272633|NCT01996059|nutritional status|nutritional status
272634|NCT01996059|functional jejunal interposition|functional jejunal interposition
272635|NCT01996059|Roux-en-Y|roux-en-y
272636|NCT01996059|gastrectomy|gastrectomy
272637|NCT01996033|uncontrolled hypertension|uncontrolled hypertension
272638|NCT01996033|Renal Denervation|renal denervation
272639|NCT01996007|Pneumococcus|pneumococcus
272640|NCT01996007|Carriage|carriage
272641|NCT01996007|Children|children
272643|NCT01996007|Immunogenicity|immunogenicity
272644|NCT01996007|PCV13|pcv13
272645|NCT01995981|Sarcoma, Soft Tissue|sarcoma, soft tissue
272646|NCT01995981|Pazopanib|pazopanib
272647|NCT01995981|Positron-Emission Tomography|positron-emission tomography
272648|NCT01995981|Pharmacokinetics|pharmacokinetics
272649|NCT01995981|Biomarker|biomarker
272650|NCT01995968|Stillbirth|stillbirth
272651|NCT01995968|Fetal growth restriction|fetal growth restriction
272652|NCT01995968|Small for gestational age|small for gestational age
272653|NCT01995968|Antenatal detection|antenatal detection
272654|NCT01995968|Prenatal Care|prenatal care
272655|NCT01995968|Mass Screening|mass screening
272656|NCT01995955|Coronary Microvascular Dysfunction|coronary microvascular dysfunction
272657|NCT01995955|coronary artery disease|coronary artery disease
272658|NCT01995955|index of myocardial resistance|index of myocardial resistance
272659|NCT01995942|Rectal Cancer|rectal cancer
272660|NCT01995942|EMVI|emvi
272661|NCT01995942|Extramural Venous Invasion|extramural venous invasion
272662|NCT01995942|Microarray|microarray
272663|NCT01995942|Biomarker|biomarker
272664|NCT01995942|mrEMVI|mremvi
272665|NCT01995942|Tumour Regression Grade|tumour regression grade
272666|NCT01995942|Cancer|cancer
272667|NCT01995942|Circumferential Resection Margin|circumferential resection margin
272668|NCT01995942|CRM|crm
272669|NCT01995942|MRI|mri
272670|NCT01995942|Radiology|radiology
272671|NCT01995942|Surgery|surgery
272672|NCT01995942|Pathology|pathology
272673|NCT01995929|neurogenic dysphagia|neurogenic dysphagia
272674|NCT01995929|transnasal endoscopy|transnasal endoscopy
272675|NCT01995929|functional endoscopy|functional endoscopy
272676|NCT01995890|nepafenac eye drops|nepafenac eye drops
272677|NCT01995890|intraocular pressure|intraocular pressure
272678|NCT01995864|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
272679|NCT01995864|Community Psychiatry|community psychiatry
272680|NCT01995851|Influenza|influenza
272681|NCT01995851|Vaccine|vaccine
272682|NCT01995838|Chronic Insomnia|chronic insomnia
272683|NCT01995838|Adults|adults
272684|NCT01995838|Elderly|elderly
272685|NCT01995825|bioequivalence|bioequivalence
272686|NCT01995825|lamotrigine|lamotrigine
272687|NCT01995825|epilepsy|epilepsy
272688|NCT01995799|Myocardial Infarction (and related inflammation)|myocardial infarction (and related inflammation)
272689|NCT01995786|Fluid Therapy|fluid therapy
272690|NCT01995786|Cost-Benefit Analysis|cost-benefit analysis
272691|NCT01995786|Hemodynamics|hemodynamics
272692|NCT01995786|Cost Control|cost control
272693|NCT01995773|Healthy women|healthy women
272694|NCT01995773|Quality of life|quality of life
272695|NCT01995773|Glucose metabolism|glucose metabolism
272696|NCT01995773|Adrenal reactivity|adrenal reactivity
272697|NCT01995773|Physical activity|physical activity
272698|NCT01995773|Body Composition|body composition
272699|NCT01995760|vancomycin|vancomycin
272700|NCT01995760|therapeutic response monitoring|therapeutic response monitoring
272701|NCT01995760|AUC/MIC|auc/mic
272702|NCT01995747|IgE|ige
272703|NCT01995747|Atopic Dermatitis|atopic dermatitis
272704|NCT01995747|antibody|antibody
272705|NCT01995747|allergy|allergy
272706|NCT01995734|Acromegaly, Pituitary diseases|acromegaly, pituitary diseases
272707|NCT01995721|recurrent respiratory papillomatosis|recurrent respiratory papillomatosis
272708|NCT01995721|human papillomavirus|human papillomavirus
272709|NCT01995721|vaccine|vaccine
272710|NCT01995721|treatment|treatment
272711|NCT01995721|immunology|immunology
272712|NCT01995721|relapse|relapse
272713|NCT01995708|CT7|ct7
272714|NCT01995708|MAGE-A3|mage-a3
272715|NCT01995708|WT1 mRNA-electroporated Autologous Langerhans|wt1 mrna-electroporated autologous langerhans
272716|NCT01995708|vaccine|vaccine
272717|NCT01995708|Autologous Stem Cell Transplantation|autologous stem cell transplantation
272718|NCT01995708|13-009|13-009
272719|NCT01995682|Independent living|independent living
272720|NCT01995682|walk with or without walking aids|walk with or without walking aids
272721|NCT01995669|Lymphoma|lymphoma
272722|NCT01995669|Relapsed Indolent Non-Hodgkin's Lymphoma|relapsed indolent non-hodgkin's lymphoma
272723|NCT01995669|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
272724|NCT01995669|NHL|nhl
272725|NCT01995669|Relapsed/refractory indolent lymphoma|relapsed/refractory indolent lymphoma
272726|NCT01995669|Small lymphocytic lymphoma|small lymphocytic lymphoma
272727|NCT01995669|SLL|sll
272728|NCT01995669|Follicular lymphoma|follicular lymphoma
272729|NCT01995669|Marginal zone lymphoma|marginal zone lymphoma
272730|NCT01995669|Lenalidomide|lenalidomide
272731|NCT01995669|CC-5013|cc-5013
272732|NCT01995669|Revlimid|revlimid
272733|NCT01995669|Obinutuzumab|obinutuzumab
272734|NCT01995669|GA101|ga101
272735|NCT01995643|Grape seed extract|grape seed extract
272736|NCT01995643|Polyphenols|polyphenols
272737|NCT01995643|Insulin|insulin
272738|NCT01995643|Oxidative stress Marker|oxidative stress marker
272739|NCT01995643|Inflammatory marker|inflammatory marker
272740|NCT01995643|Healthy human|healthy human
272741|NCT01995617|vaccine|vaccine
272742|NCT01995617|Streptococcus pneumoniae|streptococcus pneumoniae
272743|NCT01995617|Strep pneumo|strep pneumo
272744|NCT01995591|colon cancer|colon cancer
272745|NCT01995591|sentinel lymph node|sentinel lymph node
272746|NCT01995591|Indocyanine Green|indocyanine green
272747|NCT01995578|5'-Azacitidine|5'-azacitidine
272748|NCT01995578|Stem cell transplant|stem cell transplant
272749|NCT01995578|13-192|13-192
272750|NCT01995552|Post myocardial infarction patients with low EF.|post myocardial infarction patients with low ef.
272751|NCT01995539|Type 2|type 2
272752|NCT01995500|CAD|cad
272753|NCT01995500|PCI|pci
272754|NCT01995500|ACS|acs
272755|NCT01995500|non ACS|non acs
272756|NCT01995500|BioNIR|bionir
272757|NCT01995500|DES|des
272758|NCT01995487|more comers|more comers
272759|NCT01995487|DES|des
272760|NCT01995487|BioNIR|bionir
272761|NCT01995487|ACS|acs
272762|NCT01995487|non ACS|non acs
272763|NCT01995487|complex lesions|complex lesions
272764|NCT01995474|EUS|eus
272765|NCT01995474|pancreatic cancer|pancreatic cancer
272766|NCT01995474|cytology|cytology
272767|NCT01995474|fine needle aspiration|fine needle aspiration
272768|NCT01995448|The acute phase of Sepsis|the acute phase of sepsis
272769|NCT01995448|multiparameter 8-color flow cytometry|multiparameter 8-color flow cytometry
272770|NCT01995422|Major depressive disorder|major depressive disorder
272771|NCT01995422|Follow-up study|follow-up study
272772|NCT01995422|Ecological momentary assessment|ecological momentary assessment
272773|NCT01995422|Physical activity|physical activity
272774|NCT01995422|Depression|depression
272775|NCT01995422|Self-esteem|self-esteem
272776|NCT01995422|Anxiety|anxiety
272777|NCT01995422|Rumination|rumination
272778|NCT01995422|Quality of life|quality of life
272779|NCT01995396|rectal cancer,|rectal cancer,
272780|NCT01995396|fecal incontinence,|fecal incontinence,
272781|NCT01995396|severe co-morbidity,|severe co-morbidity,
272782|NCT01995396|Hartmann´s procedure,|hartmann´s procedure,
272783|NCT01995396|abdominoperineal excision with intersphincteric dissection,|abdominoperineal excision with intersphincteric dissection,
272784|NCT01995396|postoperative complications,|postoperative complications,
272785|NCT01995396|pelvic abscess,|pelvic abscess,
272786|NCT01995396|perineal infections|perineal infections
272787|NCT01995370|Noncardioembolic cerebral infarction|noncardioembolic cerebral infarction
272788|NCT01995370|Dual antiplatelet therapy (DAPT)|dual antiplatelet therapy (dapt)
272789|NCT01995370|Cilostazol|cilostazol
272790|NCT01995370|Aspirin|aspirin
272791|NCT01995370|Clopidogrel|clopidogrel
272792|NCT01995331|aplastic anemia;|aplastic anemia;
272793|NCT01995331|cyclophosphamide;|cyclophosphamide;
272794|NCT01995331|immunosuppressive therapy;|immunosuppressive therapy;
272795|NCT01995331|cyclosporine A|cyclosporine a
272796|NCT01995318|Kinesiotaping|kinesiotaping
272797|NCT01995305|fanconi anemia|fanconi anemia
272798|NCT01995305|hematopoiesis maintainance|hematopoiesis maintainance
272799|NCT01995292|awake fiberoptic intubation|awake fiberoptic intubation
272800|NCT01995292|spray as you go technique|spray as you go technique
272801|NCT01995292|anesthesia|anesthesia
272802|NCT01995292|Enk Fiberoptic Atomizer Set|enk fiberoptic atomizer set
272803|NCT01995279|low back pain|low back pain
272804|NCT01995279|French Auriculotherapy|french auriculotherapy
272805|NCT01995279|postural control|postural control
272806|NCT01995279|balance|balance
272807|NCT01995279|posture|posture
272808|NCT01995240|pancreatic cancer|pancreatic cancer
272809|NCT01995240|MRI|mri
272810|NCT01995240|reproducibility|reproducibility
272811|NCT01995240|optimalization|optimalization
272812|NCT01995227|liver cancer|liver cancer
272813|NCT01995227|HCC|hcc
272814|NCT01995227|tumor vaccine|tumor vaccine
272815|NCT01995227|immunotherapy|immunotherapy
272816|NCT01995227|personalized anti-cancer vaccine|personalized anti-cancer vaccine
272817|NCT01995214|Postoperative delirium|postoperative delirium
272818|NCT01995214|Geriatric|geriatric
272819|NCT01995214|General anesthesia|general anesthesia
272820|NCT01995214|Propofol|propofol
272821|NCT01995214|Sevoflurane|sevoflurane
272822|NCT01995175|Asthma|asthma
272823|NCT01995175|Respiratory Syncytial virus|respiratory syncytial virus
272824|NCT01995175|Cohort study|cohort study
272825|NCT01995175|Quarterly phone contacts|quarterly phone contacts
272826|NCT01995175|Wheeze|wheeze
272827|NCT01995175|New born|new born
272828|NCT01995175|Lower Respiratory Tract Infection|lower respiratory tract infection
272829|NCT01995149|Familial Hypercholesterolemia|familial hypercholesterolemia
272830|NCT01995149|Familial Combined Hypercholesterolemia|familial combined hypercholesterolemia
272831|NCT01995149|Weight loss; Lipids; Phytosterols|weight loss; lipids; phytosterols
272832|NCT01995149|Obesity|obesity
272833|NCT01995149|Overweight.|overweight.
272834|NCT01995149|Lipids|lipids
272835|NCT01995136|Glaucoma|glaucoma
272836|NCT01995136|Ocular hypertension|ocular hypertension
272837|NCT01995123|Tobacco dependence|tobacco dependence
272838|NCT01995123|PTSD|ptsd
272839|NCT01995123|Behavioral Activation Therapy|behavioral activation therapy
272840|NCT01995097|smoking cessation|smoking cessation
272841|NCT01995097|smoking reduction|smoking reduction
272842|NCT01995097|scheduled gradual reduction|scheduled gradual reduction
272843|NCT01995097|pregnancy|pregnancy
272844|NCT01995097|text message intervention|text message intervention
272845|NCT01995084|hypoxia|hypoxia
272846|NCT01995084|HX4|hx4
272847|NCT01995084|PET|pet
272848|NCT01995084|cancer|cancer
272849|NCT01995071|Chronic Hepatitis C|chronic hepatitis c
272850|NCT01995071|Cirrhosis|cirrhosis
272851|NCT01995071|Child Pugh A|child pugh a
272852|NCT01995071|Hepatitis C virus|hepatitis c virus
272853|NCT01995071|Compensated Cirrhosis|compensated cirrhosis
272854|NCT01995071|Hepatitis C Genotype 1|hepatitis c genotype 1
272855|NCT01995071|Hepatitis C|hepatitis c
272856|NCT01995071|Interferon-Free|interferon-free
272857|NCT01995071|Cirrhotic|cirrhotic
272858|NCT01995058|CRPC|crpc
272859|NCT01995058|castration resistant prostate cancer|castration resistant prostate cancer
272860|NCT01995058|prostate cancer|prostate cancer
272861|NCT01995045|Retina|retina
272862|NCT01995045|Vitreoretinal|vitreoretinal
272863|NCT01995045|Surgery|surgery
272864|NCT01995032|Duchenne's muscular dystrophy|duchenne's muscular dystrophy
272865|NCT01995032|DMD|dmd
272866|NCT01995019|Arthralgia|arthralgia
272867|NCT01995019|Temporomandibular joint|temporomandibular joint
272868|NCT01995019|corticosteroids|corticosteroids
272869|NCT01995019|injection|injection
272870|NCT01995019|intra-articular|intra-articular
272871|NCT01995006|Effect|effect
272872|NCT01995006|metamizole|metamizole
272873|NCT01995006|salt-depleted|salt-depleted
272874|NCT01995006|subjects|subjects
272875|NCT01994993|Antibiotics|antibiotics
272876|NCT01994993|ampicillin|ampicillin
272877|NCT01994993|metronidazole|metronidazole
272878|NCT01994993|clindamycin|clindamycin
272879|NCT01994993|piperacillin-tazobactam|piperacillin-tazobactam
272880|NCT01994993|Safety|safety
272881|NCT01994993|Infants|infants
272882|NCT01994993|Intra abdominal infections|intra abdominal infections
272883|NCT01994967|Phase III|phase iii
272884|NCT01994967|Noninferiority|noninferiority
272885|NCT01994967|Controlled|controlled
272886|NCT01994967|Double-blind|double-blind
272887|NCT01994967|Randomized|randomized
272888|NCT01994967|Spinal|spinal
272889|NCT01994967|Anesthetic|anesthetic
272890|NCT01994967|Lower limb|lower limb
272891|NCT01994954|newborn intensive care unit|newborn intensive care unit
272892|NCT01994954|NICU|nicu
272893|NCT01994954|supplemental oxygen|supplemental oxygen
272894|NCT01994941|Acute Coronary Syndrome|acute coronary syndrome
272895|NCT01994941|Platelet Reactivity|platelet reactivity
272896|NCT01994941|P2Y12 Receptor Blocker|p2y12 receptor blocker
272897|NCT01994941|CYP2C19 Genotyping|cyp2c19 genotyping
272898|NCT01994915|exacerbation|exacerbation
272899|NCT01994915|functionality|functionality
272900|NCT01994915|occupational therapy|occupational therapy
272901|NCT01994915|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
272902|NCT01994889|amyloidosis|amyloidosis
272903|NCT01994889|amyloid|amyloid
272904|NCT01994889|transthyretin|transthyretin
272905|NCT01994889|TTR|ttr
272906|NCT01994837|GDC-0199|gdc-0199
272907|NCT01994837|Acute Myelogenous Leukemia|acute myelogenous leukemia
272908|NCT01994837|AML|aml
272909|NCT01994837|ABT-199|abt-199
272910|NCT01994837|Acute Myeloid Leukemia|acute myeloid leukemia
272911|NCT01994837|Myeloid Leukemia|myeloid leukemia
272912|NCT01994811|cancer|cancer
272913|NCT01994811|cardiovascular disease|cardiovascular disease
272914|NCT01994811|diabetes|diabetes
272915|NCT01994785|Sedation|sedation
272916|NCT01994785|Endoscopy|endoscopy
272917|NCT01994785|Capnography|capnography
272918|NCT01994772|Therapeutic hypothermia|therapeutic hypothermia
272919|NCT01994772|Targeted controlled temperature|targeted controlled temperature
272920|NCT01994772|Cardiac arrest|cardiac arrest
272921|NCT01994772|Non shockable rhythm|non shockable rhythm
272922|NCT01994772|successful resuscitation|successful resuscitation
272923|NCT01994759|Plantar fasciitis|plantar fasciitis
272924|NCT01994759|Treatment|treatment
272925|NCT01994759|Training|training
272926|NCT01994759|Glucocorticosteroid injection|glucocorticosteroid injection
272927|NCT01994746|Diabetes Mellitus|diabetes mellitus
272928|NCT01994746|Hypoglycemia|hypoglycemia
272929|NCT01994746|Glucagon|glucagon
272930|NCT01994733|end-stage renal disease|end-stage renal disease
272931|NCT01994733|hemodialysis|hemodialysis
272932|NCT01994733|mineral metabolism|mineral metabolism
273131|NCT01993719|Melanoma|melanoma
272933|NCT01994733|serum phosphate|serum phosphate
272934|NCT01994733|phosphate binders|phosphate binders
272935|NCT01994720|Acute ischaemic stroke.|acute ischaemic stroke.
272936|NCT01994720|Transient ischaemic attack.|transient ischaemic attack.
272937|NCT01994707|Remote ischemic preconditioning|remote ischemic preconditioning
272938|NCT01994707|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
272939|NCT01994707|Troponin T|troponin t
272940|NCT01994707|Apoptosis|apoptosis
272941|NCT01994707|Experimental|experimental
272942|NCT01994707|Cardioprotection|cardioprotection
272943|NCT01994668|lorazepam|lorazepam
272944|NCT01994668|intravenous|intravenous
272945|NCT01994668|pharmacolinetics|pharmacolinetics
272946|NCT01994668|healthy|healthy
272947|NCT01994668|Japanese|japanese
272948|NCT01994655|climacteric symptoms|climacteric symptoms
272949|NCT01994655|menopause|menopause
272950|NCT01994655|nurses|nurses
272951|NCT01994629|meningococcal disease|meningococcal disease
272952|NCT01994629|children|children
272953|NCT01994629|vaccination|vaccination
272954|NCT01994616|Keloid, hypertrophic scar|keloid, hypertrophic scar
272955|NCT01994603|Prevention|prevention
272956|NCT01994603|HIV|hiv
272957|NCT01994603|AIDS|aids
272958|NCT01994603|Fetal Alcohol Syndrome (FAS)|fetal alcohol syndrome (fas)
272959|NCT01994603|Alcohol Related Neurodevelopmental Disorder (ARND)|alcohol related neurodevelopmental disorder (arnd)
272960|NCT01994590|Prostate Cancer|prostate cancer
272961|NCT01994590|Metastatic Castrate-Resistant Prostate Cancer|metastatic castrate-resistant prostate cancer
272962|NCT01994590|mCRPC|mcrpc
272963|NCT01994590|Dovitinib|dovitinib
272964|NCT01994590|TKI258|tki258
272965|NCT01994590|Abiraterone Acetate|abiraterone acetate
272966|NCT01994590|Zytiga|zytiga
272967|NCT01994590|Prednisone|prednisone
272968|NCT01994577|Emergency Department|emergency department
272969|NCT01994577|Cardiac troponin|cardiac troponin
272970|NCT01994577|Myocardial infarction|myocardial infarction
272971|NCT01994564|OAG|oag
272972|NCT01994538|Urinary Tract Infections|urinary tract infections
272973|NCT01994538|Urinary antiinfective agents|urinary antiinfective agents
272974|NCT01994512|Spinal stenosis|spinal stenosis
272975|NCT01994512|Decompression|decompression
272976|NCT01994512|Fusion|fusion
272977|NCT01994512|Olisthesis|olisthesis
272978|NCT01994486|HCV Genotype 1|hcv genotype 1
272979|NCT01994486|Hepatitis C Virus Genotype 1|hepatitis c virus genotype 1
272980|NCT01994486|HCV|hcv
272981|NCT01994486|TVR|tvr
272982|NCT01994473|Schizophrenia|schizophrenia
272983|NCT01994460|Tuberculosis|tuberculosis
272984|NCT01994447|Informed Consent|informed consent
272985|NCT01994447|Instructional Films and Video|instructional films and video
272986|NCT01994447|Consent Comprehension|consent comprehension
272987|NCT01994447|Multimedia Consent|multimedia consent
272988|NCT01994447|Parent|parent
272989|NCT01994434|Deep branch of the ulnar nerve|deep branch of the ulnar nerve
272990|NCT01994434|Distal ulnar nerve compression|distal ulnar nerve compression
272991|NCT01994421|Facilitating kinesiotape|facilitating kinesiotape
272992|NCT01994421|Inhibiting kinesiotape|inhibiting kinesiotape
272993|NCT01994421|Classical tape|classical tape
272994|NCT01994421|No tape|no tape
272995|NCT01994408|physician inertia|physician inertia
272996|NCT01994408|hypertension|hypertension
272997|NCT01994408|telemedicine|telemedicine
272998|NCT01994408|mobile technology|mobile technology
272999|NCT01994395|Stroke|stroke
273000|NCT01994395|Gait|gait
273001|NCT01994395|Stride Management Assist|stride management assist
273002|NCT01994395|Mild-moderate Stroke, post 30 days or longer|mild-moderate stroke, post 30 days or longer
273003|NCT01994382|Leukemia|leukemia
273004|NCT01994382|Lymphocytic|lymphocytic
273005|NCT01994382|Chronic|chronic
273006|NCT01994382|B Cell|b cell
273007|NCT01994369|Breast Cancer|breast cancer
273008|NCT01994356|Contraceptive counseling|contraceptive counseling
273009|NCT01994356|Physician self disclosure|physician self disclosure
273010|NCT01994356|Satisfaction|satisfaction
273011|NCT01994356|Intrauterine contraceptive use|intrauterine contraceptive use
273012|NCT01994343|Chronic pelvic pain, women, pain, posture.|chronic pelvic pain, women, pain, posture.
273013|NCT01994330|acquired von Willebrand disease|acquired von willebrand disease
273014|NCT01994330|severe aortic stenosis|severe aortic stenosis
273015|NCT01994330|Heye´s syndrome|heye´s syndrome
273016|NCT01994330|desmopressin|desmopressin
273017|NCT01994330|von Willebrand multimers|von willebrand multimers
273018|NCT01994304|Safe Childbirth Checklist|safe childbirth checklist
273019|NCT01994304|Intrapartum mortality, Quality of Institutional delivery care|intrapartum mortality, quality of institutional delivery care
273268|NCT01992965|critically ill;|critically ill;
273020|NCT01994304|Maternal & newborn care practices|maternal & newborn care practices
273021|NCT01994291|Chemokine Antagonist|chemokine antagonist
273022|NCT01994291|Diabetic Macular Edema|diabetic macular edema
273023|NCT01994291|Diabetes|diabetes
273024|NCT01994291|Diabetes Mellitus|diabetes mellitus
273025|NCT01994291|Macular Edema|macular edema
273026|NCT01994291|Diabetic Retinopathy|diabetic retinopathy
273027|NCT01994291|Anti-VEGF|anti-vegf
273028|NCT01994265|Atrial fibrillation|atrial fibrillation
273030|NCT01994265|Cognitive impairment|cognitive impairment
273031|NCT01994265|Anticoagulation|anticoagulation
273032|NCT01994265|Dabigatran|dabigatran
273033|NCT01994265|Warfarin|warfarin
273034|NCT01994265|Efficacy|efficacy
273035|NCT01994252|defibrillator|defibrillator
273036|NCT01994252|cardiac resynchronization|cardiac resynchronization
273037|NCT01994239|Prostate-Specific Antigen|prostate-specific antigen
273038|NCT01994239|LHRH antagonist|lhrh antagonist
273039|NCT01994239|Radiotherapy|radiotherapy
273040|NCT01994213|Famitinib|famitinib
273041|NCT01994213|Gastroenteropancreatic Neuroendocrine Tumor|gastroenteropancreatic neuroendocrine tumor
273042|NCT01994213|GEPNET|gepnet
273043|NCT01994200|Thyroid cancer|thyroid cancer
273044|NCT01994200|New diagnosis|new diagnosis
273045|NCT01994200|Dedicated Nurse|dedicated nurse
273046|NCT01994200|Interdisciplinary team|interdisciplinary team
273047|NCT01994200|Randomized Controlled Trial|randomized controlled trial
273048|NCT01994200|Intervention|intervention
273049|NCT01994200|Supportive care|supportive care
273050|NCT01994187|Carotid stenosis|carotid stenosis
273051|NCT01994187|Angioplasty|angioplasty
273052|NCT01994187|Carotid endarterectomy|carotid endarterectomy
273053|NCT01994187|Stroke|stroke
273054|NCT01994174|vascular|vascular
273055|NCT01994174|retina|retina
273056|NCT01994174|Anti-VEGF|anti-vegf
273057|NCT01994174|Aqueous humor dynamics|aqueous humor dynamics
273058|NCT01994161|ischemic stroke|ischemic stroke
273059|NCT01994161|intracranial stenting|intracranial stenting
273060|NCT01994161|vascular risk factor management|vascular risk factor management
273061|NCT01994148|Trauma|trauma
273062|NCT01994148|Gastrointestinal injury|gastrointestinal injury
273063|NCT01994148|Laparoscopy|laparoscopy
273064|NCT01994109|Sialorrhea|sialorrhea
273065|NCT01994109|Parkinson's disease|parkinson's disease
273066|NCT01994109|Amyotrophic lateral sclerosis (ALS)|amyotrophic lateral sclerosis (als)
273067|NCT01994109|stroke|stroke
273068|NCT01994109|neuroleptics|neuroleptics
273069|NCT01994057|Non-small cell lung cancer (NSCLC);|non-small cell lung cancer (nsclc);
273070|NCT01994057|EGFR-TKI;|egfr-tki;
273071|NCT01994057|Pharmacogenetics;|pharmacogenetics;
273072|NCT01994057|Precision medicine|precision medicine
273073|NCT01994057|somatic mutations ,germline mutations;|somatic mutations ,germline mutations;
273074|NCT01994044|Whiplash, surgery, multimodal rehabilitation, independent examiners|whiplash, surgery, multimodal rehabilitation, independent examiners
273075|NCT01994031|paclitaxel liposome injection|paclitaxel liposome injection
273076|NCT01994031|paclitaxel|paclitaxel
273077|NCT01994018|Vitamin D|vitamin d
273078|NCT01994018|Interferon Beta|interferon beta
273079|NCT01994018|Glatiramer Acetate|glatiramer acetate
273080|NCT01994018|Relapse rates|relapse rates
273081|NCT01993992|Anesthesia|anesthesia
273082|NCT01993979|Adjuvant chemotherapy|adjuvant chemotherapy
273083|NCT01993979|Surveillance|surveillance
273084|NCT01993979|Nephro-ureterectomy|nephro-ureterectomy
273085|NCT01993966|Urothelial carcinoma (UC),|urothelial carcinoma (uc),
273086|NCT01993966|(-)-epigallocatechin-3-gallate(EGCG),|(-)-epigallocatechin-3-gallate(egcg),
273087|NCT01993966|chemotherapy,|chemotherapy,
273088|NCT01993966|cytotoxicity,|cytotoxicity,
273089|NCT01993966|drug resistance,|drug resistance,
273090|NCT01993966|xenograft.|xenograft.
273091|NCT01993953|Muscle strength|muscle strength
273092|NCT01993953|Body composition|body composition
273093|NCT01993953|Body weight|body weight
273094|NCT01993953|Resistance training|resistance training
273095|NCT01993953|Personal training|personal training
273096|NCT01993953|BodyPump|bodypump
273097|NCT01993940|Opioid-induced Constipation|opioid-induced constipation
273098|NCT01993927|Drug Therapy|drug therapy
273099|NCT01993901|lung SBRT, ESAS, anxiety|lung sbrt, esas, anxiety
273100|NCT01993888|Hepatobiliary Surgery|hepatobiliary surgery
273101|NCT01993849|Anxiety|anxiety
273102|NCT01993849|Impulse control|impulse control
273103|NCT01993849|Depression|depression
273104|NCT01993849|ADHD|adhd
273105|NCT01993849|Fingernail Biting|fingernail biting
273106|NCT01993849|N-Acetylcysteine|n-acetylcysteine
273107|NCT01993849|NAC|nac
273108|NCT01993836|isoflurane|isoflurane
273109|NCT01993836|propofol|propofol
273110|NCT01993836|total intravenous anesthesia|total intravenous anesthesia
273111|NCT01993836|inhaled anesthetic|inhaled anesthetic
273112|NCT01993836|volatile anesthetic|volatile anesthetic
273113|NCT01993836|anesthesia|anesthesia
273114|NCT01993836|delirium|delirium
273115|NCT01993836|Post Operative Cognitive Dysfunction|post operative cognitive dysfunction
273116|NCT01993836|Alzheimer's Disease|alzheimer's disease
273117|NCT01993836|Mild Cognitive Impairment|mild cognitive impairment
273118|NCT01993810|Non small cell lung cancer|non small cell lung cancer
273119|NCT01993810|NSCLC|nsclc
273120|NCT01993810|proton radiotherapy|proton radiotherapy
273121|NCT01993797|Bronchiolitis|bronchiolitis
273122|NCT01993758|tourniquet pressure|tourniquet pressure
273123|NCT01993758|total knee arthroplasty|total knee arthroplasty
273124|NCT01993745|ECMO|ecmo
273125|NCT01993745|APACH II score|apach ii score
273126|NCT01993732|Cancer|cancer
273127|NCT01993732|Cryopreservation|cryopreservation
273128|NCT01993732|Ovarian Function|ovarian function
273132|NCT01993719|Adoptive Cell Therapy|adoptive cell therapy
273133|NCT01993706|Broadly HIV-1 Neutralizing Activity|broadly hiv-1 neutralizing activity
273134|NCT01993706|Healthy Adults|healthy adults
273135|NCT01993706|Placebo|placebo
273136|NCT01993706|HIV Prevention|hiv prevention
273137|NCT01993706|Monoclonal Antibodies|monoclonal antibodies
273138|NCT01993706|Antibodies|antibodies
273139|NCT01993693|knee|knee
273140|NCT01993693|pain|pain
273141|NCT01993693|osteoarthritis|osteoarthritis
273142|NCT01993693|ultrasound|ultrasound
273143|NCT01993654|Pigmented Lesions|pigmented lesions
273144|NCT01993654|PAM|pam
273145|NCT01993654|Ocular lesion|ocular lesion
273146|NCT01993641|Myelodysplastic Syndrome|myelodysplastic syndrome
273147|NCT01993641|MDS|mds
273148|NCT01993641|pracinostat|pracinostat
273149|NCT01993641|Hypomethylating Agent|hypomethylating agent
273150|NCT01993641|HMA|hma
273151|NCT01993641|azacitadine|azacitadine
273152|NCT01993641|Vidaza|vidaza
273153|NCT01993641|decitabine|decitabine
273154|NCT01993641|dacogen|dacogen
273155|NCT01993615|FAI|fai
273156|NCT01993615|femoroacetabular impingement|femoroacetabular impingement
273157|NCT01993615|hip pain|hip pain
273158|NCT01993615|hip arthroscopy|hip arthroscopy
273159|NCT01993615|physical therapy|physical therapy
273160|NCT01993602|general surgery|general surgery
273161|NCT01993602|postoperative care|postoperative care
273162|NCT01993602|breathing exercises|breathing exercises
273163|NCT01993602|respiratory muscle|respiratory muscle
273164|NCT01993602|postoperative complications|postoperative complications
273165|NCT01993602|lung volume measurements|lung volume measurements
273166|NCT01993602|pulmonary ventilations|pulmonary ventilations
273167|NCT01993602|thoracic wall|thoracic wall
273168|NCT01993589|Curettage; analgesia; paracetamol; lidocaine; Dexketoprofen trometamol; pethidine; diclofenac.|curettage; analgesia; paracetamol; lidocaine; dexketoprofen trometamol; pethidine; diclofenac.
273169|NCT01993563|Stroke|stroke
273170|NCT01993563|Rehabilitation|rehabilitation
273171|NCT01993563|Motor Imagery|motor imagery
273172|NCT01993563|Upper Extremity|upper extremity
273173|NCT01993563|Mirror Therapy|mirror therapy
273174|NCT01993550|lung cancer|lung cancer
273175|NCT01993550|family caregiving|family caregiving
273176|NCT01993550|behavioral intervention|behavioral intervention
273177|NCT01993550|counseling|counseling
273178|NCT01993550|symptom management|symptom management
273179|NCT01993498|cancer toxicities|cancer toxicities
273180|NCT01993498|cohort|cohort
273181|NCT01993498|breast cancer|breast cancer
273182|NCT01993485|transaortic valve replacement (TAVI)|transaortic valve replacement (tavi)
273183|NCT01993485|endothelial function|endothelial function
273184|NCT01993485|circulating microparticles|circulating microparticles
273185|NCT01993459|Quality of Recovery|quality of recovery
273186|NCT01993394|human centrifuge, oxygen, imaging, stroke volume, lung|human centrifuge, oxygen, imaging, stroke volume, lung
273187|NCT01993381|chemotherapy-induced nausea and vomiting|chemotherapy-induced nausea and vomiting
273188|NCT01993368|wisdom teeth extraction|wisdom teeth extraction
273189|NCT01993355|non-specific chronic low back pain,|non-specific chronic low back pain,
273190|NCT01993355|health-related quality of life,|health-related quality of life,
273191|NCT01993355|physioterapy,|physioterapy,
273192|NCT01993355|sophrology,|sophrology,
273193|NCT01993355|cognitive-behavioral therapy,|cognitive-behavioral therapy,
273194|NCT01993355|motivational interviewing|motivational interviewing
273195|NCT01993342|adipocytokines|adipocytokines
273196|NCT01993342|osteoarthritis|osteoarthritis
273197|NCT01993342|inflammation|inflammation
273198|NCT01993342|ultrasonography|ultrasonography
273199|NCT01993316|neurofeedback|neurofeedback
273200|NCT01993316|EEG|eeg
273201|NCT01993316|transcranial magnetic stimulation|transcranial magnetic stimulation
273202|NCT01993303|Myocardial Perfusion Imaging|myocardial perfusion imaging
273203|NCT01993303|PET|pet
273204|NCT01993303|Rb-82|rb-82
273205|NCT01993264|Heart disease|heart disease
273206|NCT01993264|Echocardiogram|echocardiogram
273207|NCT01993264|Ultrasound|ultrasound
273208|NCT01993264|Heart defect|heart defect
273209|NCT01993264|Heart Dysfunction|heart dysfunction
273210|NCT01993264|Pediatric Cardiologists|pediatric cardiologists
273211|NCT01993264|Prenatal|prenatal
273212|NCT01993251|sleep,melatonin,autism,children|sleep,melatonin,autism,children
273213|NCT01993225|Low Testosterone|low testosterone
273214|NCT01993212|Low Testosterone|low testosterone
273215|NCT01993186|Glucose Transporter Type 1 Deficiency Syndrome Glut1|glucose transporter type 1 deficiency syndrome glut1
273216|NCT01993173|Diphtheria|diphtheria
273217|NCT01993173|Tetanus|tetanus
273218|NCT01993173|Pertussis|pertussis
273219|NCT01993173|ADACEL®|adacel®
273220|NCT01993173|Tdap vaccine|tdap vaccine
273221|NCT01993160|Fluorocholine (FCH)|fluorocholine (fch)
273222|NCT01993160|Positron emission tomography (PET)|positron emission tomography (pet)
273223|NCT01993160|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
273224|NCT01993147|Methylphenidate|methylphenidate
273225|NCT01993147|Placebo|placebo
273226|NCT01993147|functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
273227|NCT01993147|Attention Control|attention control
274115|NCT01988844|Handwriting|handwriting
273228|NCT01993134|Postoperative infection|postoperative infection
273229|NCT01993134|Antibiotic prophylaxis|antibiotic prophylaxis
273230|NCT01993134|Cefazolin|cefazolin
273231|NCT01993121|diabetes|diabetes
273232|NCT01993121|exercise|exercise
273233|NCT01993121|heart|heart
273234|NCT01993121|cardiovascular|cardiovascular
273235|NCT01993108|Methylphenidate|methylphenidate
273236|NCT01993108|Naltrexone|naltrexone
273237|NCT01993108|Placebo|placebo
273238|NCT01993108|Neuroimaging|neuroimaging
273239|NCT01993108|Prefrontal Control Circuits|prefrontal control circuits
273240|NCT01993108|Attention Control|attention control
273241|NCT01993108|Motor Control|motor control
273242|NCT01993108|Appetitive Control|appetitive control
273243|NCT01993095|Multiple Sclerosis|multiple sclerosis
273244|NCT01993095|Quality of Life|quality of life
273245|NCT01993095|Functional Fitness|functional fitness
273246|NCT01993082|Caregivers|caregivers
273247|NCT01993082|Telomerase|telomerase
273248|NCT01993082|Telomere Length|telomere length
273249|NCT01993082|Psychological Stress|psychological stress
273250|NCT01993082|Cardiovascular Risk|cardiovascular risk
273251|NCT01993082|Exercise|exercise
273252|NCT01993056|injury incidence, male veteran soccer, 11+, Functional Movement Screen, FMS, warm-up|injury incidence, male veteran soccer, 11+, functional movement screen, fms, warm-up
273253|NCT01993043|ROP|rop
273254|NCT01993043|Bevacizumab|bevacizumab
273255|NCT01993043|Laser|laser
273256|NCT01993043|Development|development
273257|NCT01993017|Acute Coronary Syndrome|acute coronary syndrome
273258|NCT01993017|Depressive Symptoms|depressive symptoms
273259|NCT01992991|transcranial stimulation|transcranial stimulation
273260|NCT01992991|Intracranial hemorrhage|intracranial hemorrhage
273261|NCT01992991|Home training|home training
273262|NCT01992991|Occupational Therapy|occupational therapy
273263|NCT01992991|Jebsen Taylor Hand Function Test|jebsen taylor hand function test
273264|NCT01992978|radiofrequency-assisted（RF）|radiofrequency-assisted（rf）
273265|NCT01992978|hepatectomy|hepatectomy
273266|NCT01992978|postoperative liver injury|postoperative liver injury
273267|NCT01992965|continuous glucose monitoring；|continuous glucose monitoring；
273269|NCT01992939|pulse|pulse
273270|NCT01992939|heat|heat
273271|NCT01992939|blood circulation|blood circulation
273272|NCT01992926|health literacy|health literacy
273273|NCT01992926|health numeracy|health numeracy
273274|NCT01992913|Schizophrenia|schizophrenia
273275|NCT01992913|Cognitive Behavioral Therapy|cognitive behavioral therapy
273276|NCT01992913|Cognition|cognition
273277|NCT01992913|Vocational Rehabilitation|vocational rehabilitation
273278|NCT01992913|Supported Employment|supported employment
273279|NCT01992913|Schizoaffective Disorder|schizoaffective disorder
273280|NCT01992900|Plasmodium falciparum Malaria|plasmodium falciparum malaria
273281|NCT01992900|Eurartesim|eurartesim
273282|NCT01992900|ACT|act
273283|NCT01992887|HIV/AIDS|hiv/aids
273284|NCT01992887|Retention|retention
273285|NCT01992887|ART (anti-retroviral therapy) ineligible|art (anti-retroviral therapy) ineligible
273286|NCT01992874|Neoplasms|neoplasms
273287|NCT01992874|Pimasertib|pimasertib
273288|NCT01992874|Cancer|cancer
273289|NCT01992822|rTMS|rtms
273290|NCT01992822|fibromyalgia|fibromyalgia
273291|NCT01992822|experimental pain|experimental pain
273292|NCT01992809|Nonalcoholic fatty liver|nonalcoholic fatty liver
273293|NCT01992809|omega 3|omega 3
273294|NCT01992796|irbesartan, angiotensin, sepsis|irbesartan, angiotensin, sepsis
273295|NCT01992783|Resistant Starch|resistant starch
273296|NCT01992783|Antioxidant Status|antioxidant status
273297|NCT01992783|Insulin Resistance|insulin resistance
273298|NCT01992783|Overweight|overweight
273299|NCT01992783|Obesity|obesity
273300|NCT01992770|behavioural medicine|behavioural medicine
273301|NCT01992770|pain|pain
273302|NCT01992770|physical therapy|physical therapy
273303|NCT01992770|physical exercise|physical exercise
273304|NCT01992770|primary care|primary care
273305|NCT01992757|functional fibrinogen assay|functional fibrinogen assay
273306|NCT01992757|cardiac surgery|cardiac surgery
273307|NCT01992744|pregnancy|pregnancy
273308|NCT01992744|brain-derived neurotrophic factor|brain-derived neurotrophic factor
273309|NCT01992744|birth outcomes|birth outcomes
273310|NCT01992731|Age (38-42 years)|age (38-42 years)
273311|NCT01992731|pregnancy rates|pregnancy rates
273312|NCT01992731|3 IUI cycles|3 iui cycles
273313|NCT01992731|1 IVF/ICSI cycle|1 ivf/icsi cycle
273314|NCT01992705|pancreatic cancer|pancreatic cancer
273315|NCT01992692|Parkinson's disease|parkinson's disease
273316|NCT01992692|remifentanil|remifentanil
273317|NCT01992692|deep brain stimulator|deep brain stimulator
273318|NCT01992692|cardiovascular response|cardiovascular response
273319|NCT01992666|Systemic lupus erythematosus|systemic lupus erythematosus
273320|NCT01992666|genetic|genetic
273321|NCT01992666|immunological|immunological
273322|NCT01992666|pediatric|pediatric
273323|NCT01992666|mutation|mutation
273324|NCT01992666|lupus|lupus
273325|NCT01992627|High Intensity Laser Therapy|high intensity laser therapy
273326|NCT01992627|elbow epicondylosis|elbow epicondylosis
273327|NCT01992614|Single Ascending Dose|single ascending dose
273328|NCT01992614|healthy subjects|healthy subjects
273329|NCT01992614|Hypercholesterolemia|hypercholesterolemia
273330|NCT01992614|Hyperlipidemias|hyperlipidemias
273331|NCT01992614|Dyslipidemias|dyslipidemias
273332|NCT01992614|Lipid Metabolism Disorders|lipid metabolism disorders
273333|NCT01992614|Metabolic Diseases|metabolic diseases
273334|NCT01992601|Drug interaction|drug interaction
273335|NCT01992601|Rosuvastatin|rosuvastatin
273336|NCT01992601|Telmisartan|telmisartan
273337|NCT01992601|Pharmacokinetic|pharmacokinetic
273338|NCT01992601|(Pharmacokinetics and Drug Interaction)|(pharmacokinetics and drug interaction)
273339|NCT01992575|Retinal vein occlusion|retinal vein occlusion
273340|NCT01992575|OCT|oct
273341|NCT01992575|Optical coherence tomography|optical coherence tomography
273342|NCT01992575|Imaging|imaging
273343|NCT01992536|Meningococcal|meningococcal
273344|NCT01992536|Booster|booster
273345|NCT01992536|MenABCWY|menabcwy
273346|NCT01992536|Menveo|menveo
273347|NCT01992536|Vaccine Adolescents|vaccine adolescents
273348|NCT01992536|Immune Response|immune response
273349|NCT01992536|N. Meningitidis|n. meningitidis
273350|NCT01992523|Ticagrelor|ticagrelor
273351|NCT01992523|antiplatelet|antiplatelet
273352|NCT01992523|Acute Coronary Syndrome|acute coronary syndrome
273353|NCT01992497|Cesarean section, probiotic, formula fed, gut microbiota|cesarean section, probiotic, formula fed, gut microbiota
273354|NCT01992484|platelets, Acute coronary Syndrome (ACS), prasugrel, ticagrelor, aspirin|platelets, acute coronary syndrome (acs), prasugrel, ticagrelor, aspirin
273355|NCT01992471|BRCA1 testing|brca1 testing
273356|NCT01992471|BRCA2 testing|brca2 testing
273357|NCT01992471|13-215|13-215
273358|NCT01992458|implantable cardioverter defibrillator|implantable cardioverter defibrillator
273359|NCT01992458|death|death
273360|NCT01992458|shock|shock
273361|NCT01992458|mortality|mortality
273362|NCT01992458|complication|complication
273363|NCT01992458|sudden death|sudden death
273364|NCT01992445|suicide|suicide
273365|NCT01992445|suicidal intent|suicidal intent
273366|NCT01992445|thought markers|thought markers
273367|NCT01992432|Brain magnetic resonance imaging|brain magnetic resonance imaging
273368|NCT01992432|chemotherapy toxicity|chemotherapy toxicity
273369|NCT01992432|older woman|older woman
273370|NCT01992432|breast cancer|breast cancer
273371|NCT01992419|Out-of-hospital Cardiac arrest|out-of-hospital cardiac arrest
273372|NCT01992419|telephone dispatch assisted resuscitation|telephone dispatch assisted resuscitation
273373|NCT01992419|cardiac arrest phone detection|cardiac arrest phone detection
273374|NCT01992393|Epilepsy|epilepsy
273375|NCT01992393|Schizophrenia|schizophrenia
273376|NCT01992393|Schizoaffective Disorder|schizoaffective disorder
273377|NCT01992393|Bipolar Disorder|bipolar disorder
273378|NCT01992393|Depression|depression
273379|NCT01992393|Intervention|intervention
273380|NCT01992393|Treatment|treatment
273381|NCT01992393|Adherence|adherence
273382|NCT01992341|sarcomas|sarcomas
273383|NCT01992341|carcinomas|carcinomas
273384|NCT01992328|Immunoglobulin G Deficiency|immunoglobulin g deficiency
273385|NCT01992315|Scar|scar
273386|NCT01992315|Soft tissue defect|soft tissue defect
273387|NCT01992302|Rapid cycling|rapid cycling
273388|NCT01992289|XLHED|xlhed
273389|NCT01992289|HED|hed
273390|NCT01992289|Hypohidrotic ectodermal dysplasia|hypohidrotic ectodermal dysplasia
273391|NCT01992289|Christ-Siemens-Touraine Syndrome|christ-siemens-touraine syndrome
273392|NCT01992276|Influenza|influenza
273393|NCT01992276|Virus|virus
273394|NCT01992276|Monoclonal Antibody|monoclonal antibody
273395|NCT01992276|Immunization|immunization
273396|NCT01992276|Treatment|treatment
273397|NCT01992263|tuberculosis|tuberculosis
273398|NCT01992263|vitamin D|vitamin d
273399|NCT01992263|immunity|immunity
273400|NCT01992250|Cryoablation|cryoablation
273401|NCT01992237|ALI,|ali,
273402|NCT01992237|ARDS,|ards,
273403|NCT01992237|ECMO,|ecmo,
273404|NCT01992237|energy expenditure,|energy expenditure,
273405|NCT01992237|mechanical ventilation,|mechanical ventilation,
273406|NCT01992237|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
273407|NCT01992237|Nutrition Assessment|nutrition assessment
273408|NCT01992237|Pulmonary Ventilation|pulmonary ventilation
273409|NCT01992224|severe acute pancreatitis|severe acute pancreatitis
273410|NCT01992224|mechanical ventilation|mechanical ventilation
273411|NCT01992198|antibiothearpy strategy|antibiothearpy strategy
273412|NCT01992198|cefoperazone|cefoperazone
273413|NCT01992198|metronidazole|metronidazole
273414|NCT01992198|meropenem|meropenem
273415|NCT01992159|Osteoporosis, Osteoporosis-Postmenopausal, Bone Diseases-Metabolic, Bone Diseases, Musculoskeletal Diseases|osteoporosis, osteoporosis-postmenopausal, bone diseases-metabolic, bone diseases, musculoskeletal diseases
273416|NCT01992146|central sensitization|central sensitization
273417|NCT01992146|endogenous opioids|endogenous opioids
273418|NCT01992146|humans|humans
273419|NCT01992146|latent sensitization|latent sensitization
273420|NCT01992146|naloxone|naloxone
273421|NCT01992146|open groin hernia repair|open groin hernia repair
273422|NCT01992146|pain|pain
273423|NCT01992146|randomized controlled trial|randomized controlled trial
273424|NCT01992146|secondary hyperalgesia|secondary hyperalgesia
273425|NCT01992146|target-controlled infusion|target-controlled infusion
273426|NCT01992133|Former gestational Diabetes|former gestational diabetes
273427|NCT01992133|Vitamin D deficiency|vitamin d deficiency
273428|NCT01992133|insulin resistance|insulin resistance
273429|NCT01992133|beta cell function|beta cell function
273430|NCT01992120|Simulation|simulation
273431|NCT01992120|Sepsis|sepsis
273432|NCT01992120|High-fidelity|high-fidelity
273433|NCT01992120|Severe Sepsis|severe sepsis
273434|NCT01992120|Septic Shock|septic shock
273435|NCT01992120|Education|education
273436|NCT01992107|Influenza|influenza
273437|NCT01992107|Influenza vaccine|influenza vaccine
273438|NCT01992107|Novartis|novartis
273439|NCT01992107|children|children
273440|NCT01992094|Influenza|influenza
273441|NCT01992094|Influenza vaccine|influenza vaccine
273442|NCT01992094|Novartis|novartis
273443|NCT01992094|Adults|adults
273444|NCT01992081|COPD, Physical Activity, Telecoaching, PROactive|copd, physical activity, telecoaching, proactive
273445|NCT01992068|lung cancer|lung cancer
273446|NCT01992055|Executive dysfunction|executive dysfunction
273447|NCT01992055|Neuropsychological rehabilitation|neuropsychological rehabilitation
273448|NCT01992055|Goal Management Training|goal management training
273450|NCT01992029|miRNA|mirna
273451|NCT01992029|biomarker|biomarker
273452|NCT01992029|monocentric observational study|monocentric observational study
273453|NCT01992016|Prostate cancer|prostate cancer
273454|NCT01992016|F18 FDG-PET|f18 fdg-pet
273455|NCT01992016|Imaging|imaging
273456|NCT01992016|Ranolazine|ranolazine
273457|NCT01992016|Bone metastases|bone metastases
273458|NCT01992016|Soft tissue metastases|soft tissue metastases
273459|NCT01991964|stridor|stridor
273460|NCT01991964|laryngomalacia|laryngomalacia
273461|NCT01991964|ultrasound|ultrasound
273462|NCT01991938|PI3K Inhibitor|pi3k inhibitor
273463|NCT01991938|mTOR Inhibitor|mtor inhibitor
273464|NCT01991938|Dual PI3K/mTOR Inhibitor|dual pi3k/mtor inhibitor
273465|NCT01991938|CSC|csc
273466|NCT01991938|Cancer Stem Cells|cancer stem cells
273467|NCT01991912|irrigation endoscopic decompression|irrigation endoscopic decompression
273468|NCT01991912|minimally invasive surgery|minimally invasive surgery
273469|NCT01991912|spinal stenosis|spinal stenosis
273470|NCT01991899|Measles, mumps and rubella vaccine|measles, mumps and rubella vaccine
273471|NCT01991899|Tetraviral vaccine|tetraviral vaccine
273472|NCT01991899|Immunogenicity, Reactogenicity and Safety|immunogenicity, reactogenicity and safety
273473|NCT01991899|Consistency of production|consistency of production
273474|NCT01991886|nasal High Flow|nasal high flow
273475|NCT01991886|premature baby|premature baby
273476|NCT01991886|CPAP (Continuous positive airways pressure)|cpap (continuous positive airways pressure)
273477|NCT01991873|metastatic colorectal cancer|metastatic colorectal cancer
273478|NCT01991873|maintenance therapy|maintenance therapy
273479|NCT01991873|Panitumumab|panitumumab
273480|NCT01991873|Vectibix®|vectibix®
273481|NCT01991847|colon|colon
273482|NCT01991847|cancer|cancer
273483|NCT01991847|prevention|prevention
273484|NCT01991847|exercise|exercise
273485|NCT01991847|physical activity|physical activity
273486|NCT01991847|rectal|rectal
273487|NCT01991834|laparoscopy|laparoscopy
273488|NCT01991834|surgical wound infection|surgical wound infection
273489|NCT01991834|antibiotic prophylaxis|antibiotic prophylaxis
273490|NCT01991834|gynecologic surgical procedures|gynecologic surgical procedures
273491|NCT01991795|Diabetes|diabetes
273492|NCT01991795|Coronary artery disease|coronary artery disease
273493|NCT01991795|Outcome|outcome
273494|NCT01991795|Prevention|prevention
273495|NCT01991795|Antiplatelet|antiplatelet
273496|NCT01991782|Telemedicine|telemedicine
273497|NCT01991782|Fracture|fracture
273498|NCT01991782|Orthopaedics|orthopaedics
273499|NCT01991769|exercise|exercise
273500|NCT01991769|endothelium|endothelium
273501|NCT01991769|postprandial period|postprandial period
273502|NCT01991756|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
273503|NCT01991756|AAA|aaa
273504|NCT01991743|Version|version
273505|NCT01991743|Pregnancy|pregnancy
273506|NCT01991743|Vaginal Delivery|vaginal delivery
273507|NCT01991743|Pain Control|pain control
273508|NCT01991743|Combined Spinal Epidural|combined spinal epidural
273509|NCT01991717|Victus|victus
273510|NCT01991717|lensfragmentation|lensfragmentation
273511|NCT01991717|femtosecond laser assisted|femtosecond laser assisted
273512|NCT01991717|capsulotomy,|capsulotomy,
273513|NCT01991717|manual, continuous curvilinear capsulorhexis (CCC)|manual, continuous curvilinear capsulorhexis (ccc)
273514|NCT01991717|effective phaco time, phaco|effective phaco time, phaco
273515|NCT01991704|incubation|incubation
273516|NCT01991704|Craving|craving
273517|NCT01991704|alcohol dependence|alcohol dependence
273518|NCT01991691|Antineoplastic Agents|antineoplastic agents
273519|NCT01991665|Intrapartum Ultrasound|intrapartum ultrasound
273520|NCT01991665|Vacuum|vacuum
273521|NCT01991665|Occiput position|occiput position
273522|NCT01991652|Wilms tumour|wilms tumour
273523|NCT01991652|Childhood cancer|childhood cancer
273524|NCT01991652|Africa|africa
273525|NCT01991639|frailty|frailty
273526|NCT01991639|community-dwelling|community-dwelling
273527|NCT01991639|malnutrition|malnutrition
273528|NCT01991639|physical activity|physical activity
273529|NCT01991639|nutritional intervention|nutritional intervention
273530|NCT01991600|iron absorption|iron absorption
273531|NCT01991600|bioavailability|bioavailability
273532|NCT01991600|anaemia|anaemia
273533|NCT01991600|iron deficiency|iron deficiency
273534|NCT01991600|ferrous sulphate|ferrous sulphate
273535|NCT01991587|Influenza|influenza
273536|NCT01991587|Human|human
273537|NCT01991587|RNA Virus Infections|rna virus infections
273538|NCT01991587|Immunologic|immunologic
273539|NCT01991587|Immunogenic Factors|immunogenic factors
273540|NCT01991587|Physiological Effects of Drugs|physiological effects of drugs
273541|NCT01991587|Virus diseases|virus diseases
273542|NCT01991587|Orthomyxoviridae Infections|orthomyxoviridae infections
273543|NCT01991587|Infection|infection
273544|NCT01991574|urinary phosphate|urinary phosphate
273545|NCT01991574|iron hydroxide|iron hydroxide
273546|NCT01991574|hypophosphatemia|hypophosphatemia
273547|NCT01991574|phosphate binder|phosphate binder
273548|NCT01991574|ferric hydroxide adipate|ferric hydroxide adipate
273549|NCT01991561|Influenza, Human|influenza, human
273550|NCT01991561|RNA Virus Infections|rna virus infections
273551|NCT01991561|Respiratory Tract Diseases|respiratory tract diseases
273552|NCT01991561|Respiratory Tract Infections|respiratory tract infections
273553|NCT01991561|Aluminum Hydroxide|aluminum hydroxide
273554|NCT01991561|Adjuvants, Immunologic|adjuvants, immunologic
273555|NCT01991561|Immunogenic Factors|immunogenic factors
273556|NCT01991561|GLA-SE|gla-se
273557|NCT01991561|Physiological Effects of Drugs|physiological effects of drugs
273558|NCT01991561|Virus Diseases|virus diseases
273559|NCT01991561|Orthomyxoviridae Infections|orthomyxoviridae infections
273560|NCT01991561|Infection|infection
273561|NCT01991548|Insulin pump|insulin pump
273562|NCT01991470|Insulin requiring diabetes|insulin requiring diabetes
273563|NCT01991470|Children|children
273564|NCT01991470|Sensor|sensor
273565|NCT01991470|Accuracy|accuracy
273566|NCT01991457|ALL|all
273567|NCT01991418|non-small cell lung cancer|non-small cell lung cancer
273568|NCT01991418|thioredoxin reductase|thioredoxin reductase
273569|NCT01991418|carcina embryonic antigen|carcina embryonic antigen
273570|NCT01991405|Mild Cognitive Impairment|mild cognitive impairment
273571|NCT01991405|Working Memory Training|working memory training
273572|NCT01991405|Neuropsychological function in MCI|neuropsychological function in mci
273573|NCT01991392|Pancreaticoduodenectomy|pancreaticoduodenectomy
273574|NCT01991392|nasogastric tube|nasogastric tube
273575|NCT01991379|MEK162|mek162
273576|NCT01991379|Imatinib|imatinib
273577|NCT01991379|13-162|13-162
273578|NCT01991366|Major adverse microvascular integrity|major adverse microvascular integrity
273579|NCT01991366|all cause mortality|all cause mortality
273580|NCT01991366|Q Wave MI|q wave mi
273581|NCT01991353|Knee|knee
273582|NCT01991353|meniscus|meniscus
273583|NCT01991353|platelet rich plasma|platelet rich plasma
273584|NCT01991301|graft-versus-host disease|graft-versus-host disease
273585|NCT01991301|stem cell transplantation|stem cell transplantation
273586|NCT01991301|matched unrelated donors|matched unrelated donors
273587|NCT01991301|proteosmoe inhibitor|proteosmoe inhibitor
273588|NCT01991301|carfilzumib|carfilzumib
273589|NCT01991288|Total Knee Replacement|total knee replacement
273590|NCT01991288|Bupivacaine|bupivacaine
273591|NCT01991288|Levobupivacaine|levobupivacaine
273592|NCT01991288|Saphenous Nerve Block|saphenous nerve block
273593|NCT01991288|Local Infiltration Analgesia|local infiltration analgesia
273594|NCT01991275|Prostatic Neoplasms|prostatic neoplasms
273595|NCT01991275|Laparoscopy|laparoscopy
273596|NCT01991275|Injections, Spinal|injections, spinal
273597|NCT01991275|Morphine|morphine
273598|NCT01991249|pediatric acute leukemia|pediatric acute leukemia
273599|NCT01991249|Targeted high throughput sequencing|targeted high throughput sequencing
273600|NCT01991249|messenger RNA|messenger rna
273601|NCT01991197|Psoriasis|psoriasis
273602|NCT01991197|Type 2 Diabetes|type 2 diabetes
273603|NCT01991197|Dipeptidyl peptidase-4 inhibition|dipeptidyl peptidase-4 inhibition
273604|NCT01991197|Sitagliptin|sitagliptin
273605|NCT01991197|Gliclazide|gliclazide
273606|NCT01991197|Psoriasis area and severity index|psoriasis area and severity index
273607|NCT01991171|kinesio taping|kinesio taping
273608|NCT01991171|Muscle activation|muscle activation
273609|NCT01991171|Muscle inhibition|muscle inhibition
273610|NCT01991158|GAD-M regimen|gad-m regimen
273611|NCT01991158|first line chemotherapy|first line chemotherapy
273612|NCT01991158|NK/T-cell Lymphoma|nk/t-cell lymphoma
273613|NCT01991145|Cerebral Palsy|cerebral palsy
273614|NCT01991145|Umbilical Cord Blood|umbilical cord blood
273615|NCT01991145|Erythropoietin|erythropoietin
273616|NCT01991145|Rehabilitation|rehabilitation
273617|NCT01991132|Dry Eyes|dry eyes
273618|NCT01991132|Meibomian glands|meibomian glands
273619|NCT01991132|Algorithm|algorithm
273620|NCT01991132|MediView software|mediview software
273621|NCT01991119|Atrial fibrillation|atrial fibrillation
273622|NCT01991119|Propafenone|propafenone
273623|NCT01991119|Dronedarone|dronedarone
273624|NCT01991106|Exercise|exercise
273625|NCT01991106|Myocardial function|myocardial function
273626|NCT01991106|Vascular function|vascular function
273627|NCT01991106|Cardiovascular disease/prevention & control|cardiovascular disease/prevention & control
273628|NCT01991106|Paediatric obesity|paediatric obesity
273629|NCT01991106|Visceral adipose tissue|visceral adipose tissue
273630|NCT01991093|light transmittance aggregometry (LTA),multiple electrode aggregometry, clopidogrel-resistance|light transmittance aggregometry (lta),multiple electrode aggregometry, clopidogrel-resistance
273631|NCT01991080|biofeedback|biofeedback
273632|NCT01991080|relaxation|relaxation
273633|NCT01991080|Wheat germ juice|wheat germ juice
273634|NCT01991067|Marrow transplant recipients|marrow transplant recipients
273635|NCT01991054|Diabetes mellitus|diabetes mellitus
273636|NCT01991054|HgA1C|hga1c
273637|NCT01991054|25(OH) vitamin D|25(oh) vitamin d
273638|NCT01991054|HgA1C levels above 7.5%|hga1c levels above 7.5%
273639|NCT01991041|Lennox-Gastaut Syndrome|lennox-gastaut syndrome
273640|NCT01991002|14/21 diet|14/21 diet
273641|NCT01991002|BMI|bmi
273642|NCT01991002|biochemical blood markers|biochemical blood markers
273643|NCT01991002|quality of life|quality of life
273644|NCT01990989|clopidogrel|clopidogrel
273645|NCT01990989|pharmacogenomics|pharmacogenomics
273646|NCT01990989|CYP2C19|cyp2c19
273647|NCT01990989|platelet aggregation|platelet aggregation
273648|NCT01990989|score system|score system
273649|NCT01990989|ischemic cardiovascular outcomes|ischemic cardiovascular outcomes
273650|NCT01990989|hemorrhage complications|hemorrhage complications
273651|NCT01990976|Muscular Dystrophy|muscular dystrophy
273652|NCT01990976|Facioscapulohumeral|facioscapulohumeral
273653|NCT01990976|Physical training|physical training
273654|NCT01990976|Magnetic Resonance Imaging|magnetic resonance imaging
273655|NCT01990976|Muscle Biopsy|muscle biopsy
273656|NCT01990963|Brain trauma;|brain trauma;
273657|NCT01990963|MALUNA;|maluna;
273658|NCT01990963|densitometric data|densitometric data
273659|NCT01990963|CT|ct
273660|NCT01990950|Aneurysm|aneurysm
273661|NCT01990950|Aortic Aneurysm|aortic aneurysm
273662|NCT01990950|Iliac Aneurysm|iliac aneurysm
273663|NCT01990950|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
273664|NCT01990950|Vascular Diseases|vascular diseases
273665|NCT01990950|Cardiovascular Diseases|cardiovascular diseases
273666|NCT01990950|Aortic Diseases|aortic diseases
273667|NCT01990937|oral midazolam|oral midazolam
273668|NCT01990937|sedation|sedation
273669|NCT01990937|premedication|premedication
273670|NCT01990937|upper gastrointestinal endoscopy|upper gastrointestinal endoscopy
273671|NCT01990937|EGD|egd
273672|NCT01990924|fluoroscopy|fluoroscopy
273673|NCT01990924|radiation|radiation
273674|NCT01990924|transradial|transradial
273675|NCT01990924|diagnostic|diagnostic
273676|NCT01990924|angiography|angiography
273677|NCT01990924|cardiac|cardiac
273678|NCT01990924|coronary|coronary
273679|NCT01990924|angioplasty|angioplasty
273680|NCT01990911|hypertension|hypertension
273681|NCT01990911|hypertensive heart disease|hypertensive heart disease
273682|NCT01990911|atrial fibrillation|atrial fibrillation
273683|NCT01990911|autonomic imbalance|autonomic imbalance
273684|NCT01990872|Vitamin D status|vitamin d status
273685|NCT01990872|25-hydroxyvitamin D|25-hydroxyvitamin d
273686|NCT01990872|Vitamin D3|vitamin d3
273687|NCT01990872|RCT|rct
273688|NCT01990872|Calcium intake|calcium intake
273689|NCT01990872|Dietary requirement|dietary requirement
273690|NCT01990846|antiviral, influenza|antiviral, influenza
273691|NCT01990820|Pediatric Chronic Rhinosinusitis|pediatric chronic rhinosinusitis
273692|NCT01990807|high risk|high risk
273693|NCT01990807|Philadelphia Chromosome absent|philadelphia chromosome absent
273694|NCT01990807|Childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
273695|NCT01990794|Cobalt|cobalt
273696|NCT01990794|Dietary Supplements|dietary supplements
273697|NCT01990794|Hematological|hematological
273698|NCT01990794|Thyroid|thyroid
273699|NCT01990781|Lidocaine, Dexamethasone, Postoperative sore throat|lidocaine, dexamethasone, postoperative sore throat
273700|NCT01990768|tranexamic acid|tranexamic acid
273701|NCT01990768|traumatic brain injury|traumatic brain injury
273702|NCT01990768|intracranial hemorrhage|intracranial hemorrhage
273703|NCT01990768|prehospital|prehospital
273704|NCT01990768|neurologic outcome|neurologic outcome
273705|NCT01990768|glasgow outcome scale extended|glasgow outcome scale extended
273706|NCT01990768|disability rating scale|disability rating scale
273707|NCT01990716|Adult|adult
273708|NCT01990716|Colonoscopy|colonoscopy
273709|NCT01990703|Contraception|contraception
273710|NCT01990703|Birth Control|birth control
273711|NCT01990703|Levonorgestrel IUD|levonorgestrel iud
273712|NCT01990703|Mirena IUD|mirena iud
273713|NCT01990690|oligohydramnios,antioxidant,oxidative stress and pregnancy outcomes|oligohydramnios,antioxidant,oxidative stress and pregnancy outcomes
273714|NCT01990677|Central Serous Chorioretinopathy|central serous chorioretinopathy
273715|NCT01990677|csr|csr
273716|NCT01990677|cscr|cscr
273717|NCT01990677|eplerenone|eplerenone
273718|NCT01990677|vision|vision
273719|NCT01990677|choroid|choroid
273720|NCT01990677|retina|retina
273721|NCT01990677|acute|acute
273722|NCT01990677|chronic|chronic
275128|NCT01984047|GSK3050002|gsk3050002
273723|NCT01990638|coronary artery bypass graft|coronary artery bypass graft
273724|NCT01990638|Diabetes mellitus, type 2|diabetes mellitus, type 2
273725|NCT01990625|Maternal Near Miss Morbidity|maternal near miss morbidity
273726|NCT01990625|Maternal Mortality|maternal mortality
273727|NCT01990625|Neonatal Mortality|neonatal mortality
273728|NCT01990625|Gestational Age Dating|gestational age dating
273729|NCT01990625|Pregnancy Complications|pregnancy complications
273730|NCT01990625|Ultrasound|ultrasound
273731|NCT01990625|Stillbirth|stillbirth
273732|NCT01990612|Induction of labor|induction of labor
273733|NCT01990612|Expectant management of labor|expectant management of labor
273734|NCT01990612|39 weeks gestation|39 weeks gestation
273735|NCT01990599|nasopharyngeal tube|nasopharyngeal tube
273736|NCT01990599|airway management|airway management
273737|NCT01990599|thermal coagulation of the Gasserian ganglion|thermal coagulation of the gasserian ganglion
273738|NCT01990573|spinal surgery|spinal surgery
273739|NCT01990573|Methadone|methadone
273740|NCT01990560|mild hypercortisolism|mild hypercortisolism
273741|NCT01990560|Subclinical Cushing's Syndrome|subclinical cushing's syndrome
273742|NCT01990560|Preclinical Cushing's Syndrome|preclinical cushing's syndrome
273743|NCT01990547|Virtual Reality Exposure Therapy|virtual reality exposure therapy
273744|NCT01990547|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
273745|NCT01990547|Traumatic Event|traumatic event
273746|NCT01990547|Trauma Survivor|trauma survivor
273747|NCT01990547|Combat-related PTSD|combat-related ptsd
273748|NCT01990547|mTBI|mtbi
273749|NCT01990547|mild TBI|mild tbi
273750|NCT01990547|PTSD|ptsd
273751|NCT01990547|Veteran|veteran
273752|NCT01990534|Lymphoma|lymphoma
273753|NCT01990534|Hodgkin|hodgkin
273754|NCT01990534|Relapsed|relapsed
273755|NCT01990534|Refractory|refractory
273756|NCT01990534|Antigens, CD30|antigens, cd30
273757|NCT01990534|Antibody-Drug Conjugate|antibody-drug conjugate
273758|NCT01990534|Antibodies, Monoclonal|antibodies, monoclonal
273759|NCT01990534|Monomethyl auristatin E|monomethyl auristatin e
273760|NCT01990534|Drug Therapy|drug therapy
273761|NCT01990534|Immunotherapy|immunotherapy
273762|NCT01990534|Hematologic Diseases|hematologic diseases
273763|NCT01990534|Additional Relevant MeSH terms:|additional relevant mesh terms:
273764|NCT01990534|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
273765|NCT01990534|Lymphoma, Hodgkin|lymphoma, hodgkin
273888|NCT01989897|allergic|allergic
273766|NCT01990534|Neoplasms by Histologic Type|neoplasms by histologic type
273767|NCT01990534|Neoplasms|neoplasms
273768|NCT01990534|Lymphoproliferative Disorders|lymphoproliferative disorders
273769|NCT01990534|Lymphatic Diseases|lymphatic diseases
273770|NCT01990534|Immunoproliferative Disorders|immunoproliferative disorders
273771|NCT01990534|Immune System Diseases|immune system diseases
273772|NCT01990534|Lymphoma, B-Cell|lymphoma, b-cell
273773|NCT01990534|Lymphoma, T-Cell|lymphoma, t-cell
273774|NCT01990534|Immunologic Factors|immunologic factors
273775|NCT01990534|Physiological Effects of Drugs|physiological effects of drugs
273776|NCT01990534|Pharmacologic Actions|pharmacologic actions
273777|NCT01990508|sugar-sweetened beverages|sugar-sweetened beverages
273778|NCT01990508|traffic-light labels|traffic-light labels
273779|NCT01990508|financial incentives|financial incentives
273780|NCT01990508|low-income community|low-income community
273781|NCT01990508|obesity prevention|obesity prevention
273782|NCT01990495|Renal failure|renal failure
273783|NCT01990495|Exercise testing|exercise testing
273784|NCT01990495|Exercise training|exercise training
273785|NCT01990495|Protein signaling|protein signaling
273786|NCT01990495|Skeletal muscle|skeletal muscle
273787|NCT01990469|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
273788|NCT01990456|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
273789|NCT01990456|Ventilator-Induced Lung Injury|ventilator-induced lung injury
273790|NCT01990456|Ventilators, Mechanical|ventilators, mechanical
273791|NCT01990456|Pulmonary Heart Disease|pulmonary heart disease
273792|NCT01990456|Ultrasonography|ultrasonography
273793|NCT01990443|Reslizumab|reslizumab
273794|NCT01990443|monoclonal antibody|monoclonal antibody
273795|NCT01990417|Muscle Stretching Exercises|muscle stretching exercises
273796|NCT01990417|Joint range of motion|joint range of motion
273797|NCT01990417|Resistance Training|resistance training
273798|NCT01990417|Physical Therapy|physical therapy
273799|NCT01990404|Premixed nitrous oxide and oxygen|premixed nitrous oxide and oxygen
273800|NCT01990404|Severe acute pain|severe acute pain
273801|NCT01990404|Prehospital setting|prehospital setting
273802|NCT01990365|Vertebral fracture, low back pain, gips, mobility|vertebral fracture, low back pain, gips, mobility
273803|NCT01990313|Parkinson's Disease|parkinson's disease
273804|NCT01990313|DBS|dbs
273805|NCT01990313|Deep Brain Stimulation|deep brain stimulation
273806|NCT01990313|Subthalamic Nucleus|subthalamic nucleus
273807|NCT01990300|Drug Therapy|drug therapy
273808|NCT01990287|Low Back Pain|low back pain
273809|NCT01990287|Failed Back surgery Syndrome|failed back surgery syndrome
273810|NCT01990287|Post-Laminectomy Syndrome|post-laminectomy syndrome
273811|NCT01990287|Spinal Cord Stimulation|spinal cord stimulation
273812|NCT01990287|Peripheral Nerve field Stimulation|peripheral nerve field stimulation
273813|NCT01990287|Pain|pain
273814|NCT01990274|Tuberculosis|tuberculosis
273815|NCT01990274|Diagnosis|diagnosis
273816|NCT01990274|GeneXpert MTB/RIF|genexpert mtb/rif
273817|NCT01990274|Point-of-treatment|point-of-treatment
273818|NCT01990274|Mobile unit|mobile unit
273819|NCT01990235|Advance care planning|advance care planning
273820|NCT01990235|Aging|aging
273821|NCT01990235|Health communication|health communication
273822|NCT01990235|Health literacy|health literacy
273823|NCT01990235|Medical decision making|medical decision making
273824|NCT01990235|primary care|primary care
273825|NCT01990235|vulnerable population|vulnerable population
273826|NCT01990235|chronic illness|chronic illness
273827|NCT01990222|ADHD|adhd
273828|NCT01990209|triple-negative breast cancer|triple-negative breast cancer
273829|NCT01990209|orteronel|orteronel
273830|NCT01990209|TAK-700|tak-700
273831|NCT01990209|metastatic breast cancer|metastatic breast cancer
273832|NCT01990196|prostate cancer|prostate cancer
273833|NCT01990196|hormone therapy|hormone therapy
273834|NCT01990196|radical prostatectomy|radical prostatectomy
273835|NCT01990183|preterm infants|preterm infants
273836|NCT01990183|early intervention|early intervention
273837|NCT01990183|enrichment|enrichment
273838|NCT01990183|cognitive, motor, visual development|cognitive, motor, visual development
273839|NCT01990183|tele-rehabilitation|tele-rehabilitation
273840|NCT01990131|computerized intervention|computerized intervention
273841|NCT01990131|cognitive bias modification|cognitive bias modification
273842|NCT01990131|anxiety|anxiety
273843|NCT01990131|suicide|suicide
273844|NCT01990118|Renal transplant|renal transplant
273845|NCT01990118|Renal allograft rejection|renal allograft rejection
273846|NCT01990118|Cyclosporine|cyclosporine
273847|NCT01990118|Gengraf|gengraf
273848|NCT01990105|atrial fibrillation|atrial fibrillation
273849|NCT01990105|anticoagulation|anticoagulation
273850|NCT01990105|antiarrhythmic medication|antiarrhythmic medication
273851|NCT01990105|CHA2DS2VASc score|cha2ds2vasc score
273852|NCT01990105|HAS-BLED score|has-bled score
273853|NCT01990105|CHADS2 score|chads2 score
273854|NCT01990092|Metanx|metanx
273855|NCT01990092|B vitamins|b vitamins
273856|NCT01990092|neuropathy|neuropathy
273857|NCT01990092|nutrition|nutrition
273858|NCT01990079|PTSD|ptsd
273859|NCT01990079|smoking|smoking
273860|NCT01990066|Quality of Life|quality of life
273861|NCT01990066|Physical Function|physical function
273862|NCT01990040|Short Bowel Syndrome|short bowel syndrome
273863|NCT01990040|SBS|sbs
273864|NCT01990040|teduglutide|teduglutide
273865|NCT01990040|Gattex|gattex
273866|NCT01990027|kidney stone|kidney stone
273867|NCT01990001|contraception, adherence, medication reminder|contraception, adherence, medication reminder
273868|NCT01989988|Type 2 Diabetes Mellitus (T2DM)|type 2 diabetes mellitus (t2dm)
273869|NCT01989988|Obesity|obesity
273870|NCT01989988|Laparoscopic gastric bypass|laparoscopic gastric bypass
273871|NCT01989988|Duodenum exclusion|duodenum exclusion
273872|NCT01989975|Sensor-Augmented Pump Therapy|sensor-augmented pump therapy
273873|NCT01989975|Connected Care|connected care
273874|NCT01989962|Aboriginal Health|aboriginal health
273875|NCT01989962|Diabetes Mellitus Type 2|diabetes mellitus type 2
273876|NCT01989962|Cultural Competency|cultural competency
273877|NCT01989962|Continuing Medical Education|continuing medical education
273878|NCT01989923|Smoking cessation|smoking cessation
273879|NCT01989923|Traditional nicotine replacement therapy|traditional nicotine replacement therapy
273880|NCT01989923|Electronic nicotine delivery devices|electronic nicotine delivery devices
273881|NCT01989923|electronic cigarettes|electronic cigarettes
273882|NCT01989923|cervical dysplasia|cervical dysplasia
273883|NCT01989910|Efavirenz|efavirenz
273884|NCT01989910|Raltegravir|raltegravir
273885|NCT01989910|Combination antiretroviral therapy|combination antiretroviral therapy
273886|NCT01989897|diluent|diluent
273887|NCT01989897|rhinitis|rhinitis
273890|NCT01989871|oral feeding|oral feeding
273891|NCT01989871|outcome|outcome
273892|NCT01989858|localized gastric adenocarcinoma, operable considered.|localized gastric adenocarcinoma, operable considered.
273893|NCT01989832|cohort|cohort
273894|NCT01989832|pharmaco-economic|pharmaco-economic
273895|NCT01989832|kidney|kidney
273896|NCT01989832|transplantation|transplantation
273897|NCT01989832|quality of life|quality of life
273898|NCT01989806|Spinal cord injury|spinal cord injury
273899|NCT01989806|robotic|robotic
273900|NCT01989806|locomotion|locomotion
273901|NCT01989793|sarcopenia|sarcopenia
273902|NCT01989793|frailty|frailty
273903|NCT01989793|losartan|losartan
273904|NCT01989767|sickness absence|sickness absence
273905|NCT01989767|rehabilitation|rehabilitation
273906|NCT01989767|mental disorders|mental disorders
273907|NCT01989767|screening|screening
273908|NCT01989754|Albuminuria|albuminuria
273909|NCT01989754|Canagliflozin|canagliflozin
273910|NCT01989754|Cardiovascular outcomes|cardiovascular outcomes
273911|NCT01989754|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
273912|NCT01989754|T2DM|t2dm
273913|NCT01989754|JNJ-28431754|jnj-28431754
273914|NCT01989754|Antihyperglycemic Agent|antihyperglycemic agent
273915|NCT01989741|sleep restriction, decision making, wakefullness|sleep restriction, decision making, wakefullness
273916|NCT01989728|sickness absence, return to work, psychiatric examination, feedback, psychological distress, quality of life, attrition analysis, multiple imputation|sickness absence, return to work, psychiatric examination, feedback, psychological distress, quality of life, attrition analysis, multiple imputation
273917|NCT01989689|PSORIASIS|psoriasis
273918|NCT01989676|Phase 3|phase 3
273919|NCT01989676|trastuzumab|trastuzumab
273920|NCT01989676|Breast Neoplasms|breast neoplasms
273921|NCT01989663|Healthy Women|healthy women
273922|NCT01989624|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
273923|NCT01989624|diagnosis|diagnosis
273924|NCT01989624|treatment|treatment
273925|NCT01989572|locally advanced or stage IV melanoma|locally advanced or stage iv melanoma
273926|NCT01989572|GM-CSF|gm-csf
273927|NCT01989572|peptide vaccine|peptide vaccine
273928|NCT01989546|DNA Damage|dna damage
273929|NCT01989546|Advanced Solid Tumors|advanced solid tumors
273930|NCT01989546|BRCA Mutations|brca mutations
273931|NCT01989546|PARP Inhibitor|parp inhibitor
273932|NCT01989546|Pharmacodynamics|pharmacodynamics
273933|NCT01989533|HIV Vaccine|hiv vaccine
273934|NCT01989533|Adenovirus|adenovirus
273935|NCT01989520|Relative bioavailability, Healthy volunteers, Neutrophils|relative bioavailability, healthy volunteers, neutrophils
273936|NCT01989507|tobacco smoking|tobacco smoking
273937|NCT01989507|smoking cessation|smoking cessation
273938|NCT01989507|nicotine dependence|nicotine dependence
273939|NCT01989507|tobacco use disorder|tobacco use disorder
273940|NCT01989494|anesthesiologists|anesthesiologists
273941|NCT01989494|physical activity|physical activity
273942|NCT01989494|pedometer|pedometer
273943|NCT01989494|wellness|wellness
273944|NCT01989494|exercise|exercise
273945|NCT01989468|Psoriatic arthritis|psoriatic arthritis
273946|NCT01989468|AIN457|ain457
273947|NCT01989468|PsA|psa
273948|NCT01989468|ACR|acr
273949|NCT01989468|CASPAR|caspar
273950|NCT01989468|PASDAS|pasdas
273951|NCT01989468|secukinumab|secukinumab
273952|NCT01989468|autoinjector|autoinjector
273953|NCT01989455|Healthy|healthy
273954|NCT01989455|Deferiprone|deferiprone
273955|NCT01989455|DFP|dfp
273956|NCT01989455|L1|l1
273957|NCT01989442|cpap failure|cpap failure
273958|NCT01989442|bronchopulmonary dysplasia|bronchopulmonary dysplasia
273959|NCT01989442|nasal trauma|nasal trauma
273960|NCT01989442|ventilation duration|ventilation duration
273961|NCT01989442|non-invasive ventilation|non-invasive ventilation
273962|NCT01989429|psoriasis|psoriasis
273963|NCT01989429|Vitamin D3|vitamin d3
273964|NCT01989429|topical|topical
273965|NCT01989429|ointments|ointments
273966|NCT01989416|colonization|colonization
273967|NCT01989338|hallux valgus|hallux valgus
273968|NCT01989338|pain|pain
273969|NCT01989338|functional status|functional status
273970|NCT01989338|quality of life|quality of life
273971|NCT01989312|ultrasound|ultrasound
273972|NCT01989312|peripheral nerves|peripheral nerves
273973|NCT01989312|anesthetics|anesthetics
273974|NCT01989312|local|local
273975|NCT01989299|Heart failure with preserved ejection fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
273976|NCT01989299|ILR|ilr
273977|NCT01989299|ventricular tachyarrhythmias|ventricular tachyarrhythmias
273978|NCT01989299|Safety|safety
273979|NCT01989286|Plagiocephaly|plagiocephaly
273980|NCT01989286|Posture|posture
273981|NCT01989286|Spine|spine
273982|NCT01989260|Endometriosis|endometriosis
273983|NCT01989247|Depression|depression
273984|NCT01989247|Anxiety|anxiety
273985|NCT01989247|Randomized Controlled Trial|randomized controlled trial
273986|NCT01989247|Self Care|self care
273987|NCT01989247|Intervention Studies|intervention studies
273988|NCT01989247|Health Education|health education
273989|NCT01989208|Heart Failure|heart failure
273990|NCT01989208|Congestive Heart Failure|congestive heart failure
273991|NCT01989208|Oxidative Stress|oxidative stress
273992|NCT01989208|Hydrogen Sulfide|hydrogen sulfide
273993|NCT01989195|ISCHEMIC OR CORONARY HEART DISEASE|ischemic or coronary heart disease
273994|NCT01989195|MYOCARDIAL INFARCTION|myocardial infarction
273995|NCT01989195|MAGNETIC RESONANCE IMAGING|magnetic resonance imaging
273996|NCT01989195|DELAYED GADOLINIUM ENHANCEMENT MRI|delayed gadolinium enhancement mri
273997|NCT01989195|MANGANESE-ENHANCED MRI|manganese-enhanced mri
273998|NCT01989195|INFARCT VOLUME/SIZE|infarct volume/size
273999|NCT01989195|ALL CAUSE MORTALITY|all cause mortality
274000|NCT01989195|VENTRICULAR ARRHYTHMIAS|ventricular arrhythmias
274001|NCT01989182|Endobronchial Valves|endobronchial valves
274002|NCT01989182|Intrabronchial Valves|intrabronchial valves
274003|NCT01989182|Bronchial Valve|bronchial valve
274004|NCT01989182|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
274005|NCT01989182|COPD|copd
274006|NCT01989182|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
274007|NCT01989182|Bronchoscopic Lung Volume Reduction|bronchoscopic lung volume reduction
274008|NCT01989182|BLVR|blvr
274009|NCT01989182|TLVR|tlvr
274010|NCT01989182|Emphysema|emphysema
274011|NCT01989182|Pulmonary Emphysema|pulmonary emphysema
274012|NCT01989182|Pathologic Process|pathologic process
274013|NCT01989182|Lung Diseases|lung diseases
275239|NCT01983774|CF|cf
274014|NCT01989182|Respiratory Tract Disease|respiratory tract disease
274016|NCT01989182|Spiration Valve System (SVS)|spiration valve system (svs)
274017|NCT01989156|Smoking|smoking
274018|NCT01989156|Candidate modified risk tobacco product|candidate modified risk tobacco product
274019|NCT01989156|Menthol conventional cigarettes|menthol conventional cigarettes
274020|NCT01989156|Reduced exposure|reduced exposure
274021|NCT01989156|HPHCs|hphcs
274022|NCT01989156|Ambulatory|ambulatory
274023|NCT01989143|Phase 1|phase 1
274024|NCT01989143|Randomized|randomized
274025|NCT01989143|Double-blind|double-blind
274026|NCT01989143|Placebo-controlled|placebo-controlled
274027|NCT01989143|Dose escalating|dose escalating
274028|NCT01989143|Single and Multiple doses|single and multiple doses
274029|NCT01989143|Safety|safety
274030|NCT01989143|Tolerability|tolerability
274031|NCT01989143|PK/PD|pk/pd
274032|NCT01989143|PF-06480605|pf-06480605
274033|NCT01989130|antimicrobial stewardship|antimicrobial stewardship
274034|NCT01989130|Cepheid Xpert CT/NG|cepheid xpert ct/ng
274035|NCT01989130|chlamydia|chlamydia
274036|NCT01989130|gonorrhea|gonorrhea
274037|NCT01989130|emergency department|emergency department
274038|NCT01989130|Diagnostic Techniques, Obstetrical and Gynecological|diagnostic techniques, obstetrical and gynecological
274039|NCT01989130|Diagnostic Techniques, Urological|diagnostic techniques, urological
274040|NCT01989104|Indirect calorimetry|indirect calorimetry
274041|NCT01989091|kidney dialysis|kidney dialysis
274042|NCT01989091|hemodialysis|hemodialysis
274043|NCT01989091|locking solution|locking solution
274044|NCT01989091|antimicrobial|antimicrobial
274045|NCT01989091|thrombolytic|thrombolytic
274046|NCT01989078|Kidney disorder|kidney disorder
274047|NCT01989078|Blood disorder|blood disorder
274048|NCT01989078|Pediatrics|pediatrics
274049|NCT01989065|Child obesity|child obesity
274050|NCT01989065|childhood obesity|childhood obesity
274051|NCT01989065|obesity treatment|obesity treatment
274052|NCT01989065|text messaging|text messaging
274053|NCT01989065|Lifestyle|lifestyle
274054|NCT01989052|Carboxyamidotriazole Orotate|carboxyamidotriazole orotate
274055|NCT01989052|CTO|cto
274056|NCT01989052|Lomustine|lomustine
274057|NCT01989052|N-(2-chloroethyl)-N'-cyclo-hexyl-N-nitrosourea (CCNU)|n-(2-chloroethyl)-n'-cyclo-hexyl-n-nitrosourea (ccnu)
274058|NCT01989052|CeeNU|ceenu
274059|NCT01989052|Malignant Glioma|malignant glioma
274060|NCT01989052|Pro00047969|pro00047969
274061|NCT01989052|Desjardins|desjardins
274062|NCT01989052|Duke|duke
274063|NCT01989052|The Preston Robert Tisch Brain Tumor Center|the preston robert tisch brain tumor center
274064|NCT01989026|BCG|bcg
274065|NCT01989026|non-specific effects|non-specific effects
274066|NCT01989026|neonatal mortality|neonatal mortality
274067|NCT01989026|vaccines|vaccines
274068|NCT01989013|Parkinson's disease|parkinson's disease
274069|NCT01989013|Craniosacral therapy|craniosacral therapy
274070|NCT01989013|cranial osteopathy|cranial osteopathy
274071|NCT01989000|Pancreatic cancer|pancreatic cancer
274072|NCT01989000|Hypoxia|hypoxia
274073|NCT01989000|Vasculature|vasculature
274074|NCT01989000|Stroma|stroma
274075|NCT01988987|Gestational diabetes|gestational diabetes
274076|NCT01988987|Postpartum glucose testing|postpartum glucose testing
274077|NCT01988987|Impaired glucose metabolism|impaired glucose metabolism
274078|NCT01988987|Diabetes mellitus|diabetes mellitus
274079|NCT01988961|Colitis, Ulcerative|colitis, ulcerative
274080|NCT01988961|Golimumab|golimumab
274081|NCT01988961|CNTO148|cnto148
274082|NCT01988961|SIMPONI|simponi
274083|NCT01988961|Length-109 Probe Set Panel|length-109 probe set panel
274084|NCT01988948|Human papilloma virus|human papilloma virus
274085|NCT01988948|Young women|young women
274086|NCT01988948|I-Share|i-share
274087|NCT01988922|ketamine polymorphisms|ketamine polymorphisms
274088|NCT01988909|Cutaneous leishmaniasis|cutaneous leishmaniasis
274089|NCT01988909|Paromomycin + Gentamicin Topical Cream|paromomycin + gentamicin topical cream
274090|NCT01988909|Safety|safety
274091|NCT01988909|Efficacy|efficacy
274092|NCT01988883|Postural Tachycardia Syndrome|postural tachycardia syndrome
274093|NCT01988883|Tachycardia|tachycardia
274094|NCT01988883|Orthostatic Intolerance|orthostatic intolerance
274095|NCT01988883|Autonomic Nervous System Diseases|autonomic nervous system diseases
274096|NCT01988883|Primary Dysautonomias|primary dysautonomias
274097|NCT01988883|Nervous System Diseases|nervous system diseases
274098|NCT01988883|Cardiovascular Diseases|cardiovascular diseases
274099|NCT01988883|Modafinil|modafinil
274100|NCT01988883|Propranolol|propranolol
274101|NCT01988883|Neurobehavioral Manifestations|neurobehavioral manifestations
274102|NCT01988883|Neurologic Manifestations|neurologic manifestations
274103|NCT01988883|Cognitive Symptoms|cognitive symptoms
274104|NCT01988883|Neuropsychological Tests|neuropsychological tests
274105|NCT01988857|Vietnam|vietnam
274106|NCT01988857|Children|children
274107|NCT01988857|Reactogenicity|reactogenicity
274108|NCT01988857|BoostrixTM|boostrixtm
274109|NCT01988857|Safety|safety
274110|NCT01988857|dTpa|dtpa
274111|NCT01988857|Booster|booster
274112|NCT01988857|Healthy|healthy
274113|NCT01988844|functionality|functionality
274114|NCT01988844|Cerebral palsy|cerebral palsy
274116|NCT01988831|Malignant melanoma|malignant melanoma
274117|NCT01988831|betablocker|betablocker
274118|NCT01988831|propranolol|propranolol
274119|NCT01988831|interventional|interventional
274120|NCT01988831|prospective|prospective
274121|NCT01988831|adjuvant|adjuvant
274122|NCT01988831|recurrence|recurrence
274123|NCT01988818|wound dressing|wound dressing
274124|NCT01988818|silicone|silicone
274125|NCT01988818|standard wound dressing|standard wound dressing
274126|NCT01988766|Thrombosis|thrombosis
274127|NCT01988766|Central Venosis Catheter|central venosis catheter
274128|NCT01988766|Renal Disease|renal disease
274129|NCT01988766|Vascular Access|vascular access
274130|NCT01988753|Serum Biomarkers|serum biomarkers
274131|NCT01988753|Sheer-wave Elastography|sheer-wave elastography
274132|NCT01988753|Ultrasound imaging|ultrasound imaging
274133|NCT01988753|Viral hepatitis|viral hepatitis
274134|NCT01988753|Liver Fibrosis|liver fibrosis
274135|NCT01988753|Liver disease|liver disease
274136|NCT01988753|Hepatitis B|hepatitis b
274137|NCT01988753|Hepatitis C|hepatitis c
274138|NCT01988740|Ischemia-modified albumin|ischemia-modified albumin
274139|NCT01988740|Recurrent pregnancy loss|recurrent pregnancy loss
274140|NCT01988740|Abnormal placenta|abnormal placenta
274141|NCT01988714|Targeted cognitive training (TCT) plus evidence-based SE|targeted cognitive training (tct) plus evidence-based se
274142|NCT01988714|Computer games (CG) plus evidence-based SE|computer games (cg) plus evidence-based se
274143|NCT01988701|GVHD|gvhd
274144|NCT01988701|chronic Graft versus Host Disease|chronic graft versus host disease
274145|NCT01988688|deep brain stimulation|deep brain stimulation
274146|NCT01988662|nAMD, VEGF, VEGF agent, BCVA, CRT, Ranibizumab, Lucentis, Aflibercept, Eylea|namd, vegf, vegf agent, bcva, crt, ranibizumab, lucentis, aflibercept, eylea
274147|NCT01988649|Pain|pain
274148|NCT01988649|Oxytocin|oxytocin
274149|NCT01988636|Randomized|randomized
274150|NCT01988636|Double Blinded|double blinded
274151|NCT01988636|Mali|mali
274152|NCT01988636|Malaria|malaria
274153|NCT01988636|Transmission|transmission
274154|NCT01988623|Intellectual Disabilities|intellectual disabilities
274155|NCT01988623|Speech Delay|speech delay
274156|NCT01988623|Language Disorder|language disorder
274157|NCT01988610|cognition|cognition
274158|NCT01988610|prediabetes|prediabetes
274159|NCT01988610|mood|mood
274160|NCT01988597|Dry Eyes|dry eyes
274161|NCT01988597|Quality of life|quality of life
274162|NCT01988597|Utility assessment|utility assessment
274163|NCT01988584|Cerebral Palsy|cerebral palsy
274164|NCT01988584|Brain Injury|brain injury
274165|NCT01988584|Stem Cells|stem cells
274166|NCT01988584|Mononuclear Cells|mononuclear cells
274167|NCT01988584|Bone Morrow|bone morrow
274168|NCT01988584|Umbilical Cord Blood|umbilical cord blood
274169|NCT01988571|Stage I breast cancer|stage i breast cancer
274170|NCT01988571|Stage II breast cancer|stage ii breast cancer
274171|NCT01988571|Stage III breast cancer|stage iii breast cancer
274172|NCT01988558|Recurrent Tonsillitis|recurrent tonsillitis
274173|NCT01988558|Streptococcus A|streptococcus a
274174|NCT01988545|GLP-1|glp-1
274175|NCT01988545|blood flow|blood flow
274176|NCT01988545|cardiac out put|cardiac out put
274177|NCT01988545|stroke volume|stroke volume
274178|NCT01988545|beat to beat|beat to beat
274179|NCT01988545|effect of GLP-1 on cardiac parameters and blood flow|effect of glp-1 on cardiac parameters and blood flow
274180|NCT01988506|IL2,|il2,
274181|NCT01988506|Interleukin 2,|interleukin 2,
274182|NCT01988506|ILT101|ilt101
274183|NCT01988506|Proleukin®, RhIL-2|proleukin®, rhil-2
274184|NCT01988506|Auto-immune disease|auto-immune disease
274185|NCT01988506|Inflammatory disease|inflammatory disease
274186|NCT01988506|Inflammation|inflammation
274187|NCT01988506|Regulatory T cells,|regulatory t cells,
274188|NCT01988506|Treg|treg
274189|NCT01988506|Immunoregulation|immunoregulation
274190|NCT01988506|Immune tolerance|immune tolerance
274191|NCT01988493|Carcinoma, Hepatocellular|carcinoma, hepatocellular
274192|NCT01988493|MSC2156119J|msc2156119j
274193|NCT01988493|Sorafenib|sorafenib
274194|NCT01988493|Recommended Phase 2 dose|recommended phase 2 dose
274195|NCT01988480|Guided surgery|guided surgery
274196|NCT01988480|Sinus graft|sinus graft
274197|NCT01988467|nasal breathing, oral breathing, secondhand smoking,|nasal breathing, oral breathing, secondhand smoking,
274198|NCT01988441|autophagy|autophagy
274199|NCT01988441|children|children
274200|NCT01988441|polymorphism|polymorphism
274201|NCT01988428|sepsis|sepsis
274202|NCT01988428|severe sepsis|severe sepsis
274203|NCT01988428|septic shock|septic shock
274204|NCT01988402|gout|gout
274205|NCT01988402|allopurinol|allopurinol
274206|NCT01988363|greater occipital nerve|greater occipital nerve
274207|NCT01988363|occipital neuralgia|occipital neuralgia
274208|NCT01988363|cervicogenic headache|cervicogenic headache
274209|NCT01988350|pancreatic insufficiency|pancreatic insufficiency
274210|NCT01988350|pancreatic elastase|pancreatic elastase
274211|NCT01988350|fecal elastase|fecal elastase
274212|NCT01988350|smoking|smoking
274213|NCT01988350|tobacco|tobacco
274214|NCT01988311|Psilocybin|psilocybin
274215|NCT01988311|Hallucinogens|hallucinogens
274216|NCT01988311|Pharmacologic Actions|pharmacologic actions
274217|NCT01988311|Central Nervous System Agents|central nervous system agents
274218|NCT01988311|Therapeutic Uses|therapeutic uses
274219|NCT01988311|Psychotropic Drugs|psychotropic drugs
274220|NCT01988285|Esophagitis|esophagitis
274221|NCT01988285|Eosinophilic Esophagitis|eosinophilic esophagitis
274222|NCT01988285|Esophageal Diseases|esophageal diseases
274223|NCT01988285|Gastrointestinal Diseases|gastrointestinal diseases
274224|NCT01988285|Digestive System Diseases|digestive system diseases
274225|NCT01988272|SPECT/CT|spect/ct
274226|NCT01988272|Dosimetry|dosimetry
274227|NCT01988272|Radiation absorbed dose|radiation absorbed dose
274228|NCT01988272|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
274229|NCT01988272|I-131 tositumomab radioimmunotherapy|i-131 tositumomab radioimmunotherapy
274230|NCT01988246|Diabetes|diabetes
274231|NCT01988246|Diabetic Retinopathy|diabetic retinopathy
274232|NCT01988233|Physical activity|physical activity
274233|NCT01988233|Dance|dance
274234|NCT01988233|Latinos|latinos
274235|NCT01988233|Aging|aging
274236|NCT01988233|Older adults|older adults
274237|NCT01988233|Health disparities|health disparities
274238|NCT01988220|stroke|stroke
274239|NCT01988220|sensory deficit|sensory deficit
274240|NCT01988220|sensory retraining|sensory retraining
274241|NCT01988220|perceptual learning|perceptual learning
274242|NCT01988220|lower extremity|lower extremity
274243|NCT01988207|Muscle Tension Dysphonia|muscle tension dysphonia
274244|NCT01988207|Voice|voice
274245|NCT01988207|Hyperfunction|hyperfunction
274246|NCT01988194|acupuncture|acupuncture
274247|NCT01988194|postoperative pain|postoperative pain
274248|NCT01988194|nausea|nausea
274249|NCT01988194|vomiting|vomiting
274250|NCT01988194|anxiety|anxiety
274251|NCT01988194|depression|depression
274252|NCT01988194|hospitalization|hospitalization
274253|NCT01988194|inpatient|inpatient
274254|NCT01988181|Intradialytic Hypotension|intradialytic hypotension
274255|NCT01988181|Renal Dialysis|renal dialysis
274256|NCT01988181|Blood Volume Determination|blood volume determination
274257|NCT01988181|Clinical Trials, Randomized|clinical trials, randomized
274258|NCT01988181|Crossover Studies|crossover studies
274259|NCT01988168|Suture Techniques|suture techniques
274260|NCT01988168|Sutures|sutures
274261|NCT01988168|Surgical Staplers|surgical staplers
274262|NCT01988142|Spinal Cord Injury|spinal cord injury
274263|NCT01988142|Passive motion|passive motion
274264|NCT01988142|Fatigue index|fatigue index
274265|NCT01988142|Hypertonia|hypertonia
274266|NCT01988129|sleep|sleep
274267|NCT01988129|firefighter|firefighter
274268|NCT01988129|fire|fire
274269|NCT01988129|apnea|apnea
274270|NCT01988129|insomnia|insomnia
274271|NCT01988129|shift|shift
274272|NCT01988129|narcolepsy|narcolepsy
274273|NCT01988129|restless leg|restless leg
274274|NCT01988129|rls|rls
274275|NCT01988129|fatigue|fatigue
274276|NCT01988129|actigraph|actigraph
274277|NCT01988129|actigraphy|actigraphy
274278|NCT01988129|actiwatch|actiwatch
274279|NCT01988129|safety|safety
274280|NCT01988129|sleepiness|sleepiness
274281|NCT01988129|sleepy|sleepy
274282|NCT01988129|work|work
274283|NCT01988129|hours|hours
274284|NCT01988129|Federal Emergency Management Agency|federal emergency management agency
274285|NCT01988129|drowsy|drowsy
274286|NCT01988116|Chronic kidney disease|chronic kidney disease
274287|NCT01988116|Anemia of chronic disease|anemia of chronic disease
274288|NCT01988116|Iron Metabolism|iron metabolism
274289|NCT01988116|Iron Homeostasis|iron homeostasis
274290|NCT01988116|Vitamin D|vitamin d
274291|NCT01988116|Calcitriol|calcitriol
274292|NCT01988116|hemojuvelin|hemojuvelin
274293|NCT01988116|hepcidin|hepcidin
274294|NCT01988116|anemia|anemia
274295|NCT01988116|ferroportin|ferroportin
274296|NCT01988103|Psoriasis; Psoriatic Arthritis|psoriasis; psoriatic arthritis
274297|NCT01988090|Breast Cancer|breast cancer
274298|NCT01988090|Hormone Receptor Positive|hormone receptor positive
274299|NCT01988090|Vitamin D|vitamin d
274300|NCT01988064|pulse rate|pulse rate
274301|NCT01988064|patient education|patient education
274302|NCT01988064|training|training
274303|NCT01988038|Polycystic Kidney Disease|polycystic kidney disease
274304|NCT01988038|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
274305|NCT01988038|Disease Progression|disease progression
274306|NCT01987986|cellulite|cellulite
274307|NCT01987986|dimple|dimple
274308|NCT01987986|orange peel|orange peel
274309|NCT01987986|cottage cheese|cottage cheese
274310|NCT01987986|mattress texture|mattress texture
274311|NCT01987947|MEMP1972A|memp1972a
274312|NCT01987934|Squamous Cell Carcinoma of the Head and Neck|squamous cell carcinoma of the head and neck
274313|NCT01987934|Methyl Green Pyronin Staining|methyl green pyronin staining
274314|NCT01987934|AgNORs|agnors
274315|NCT01987934|Morphometry|morphometry
274316|NCT01987921|Acute kidney injury|acute kidney injury
274317|NCT01987921|Pediatrics|pediatrics
274318|NCT01987921|Critical Care|critical care
274319|NCT01987908|Pain|pain
274320|NCT01987908|Biomarkers|biomarkers
274321|NCT01987908|6 minute walk test|6 minute walk test
274322|NCT01987908|5-HMF|5-hmf
274323|NCT01987908|Pharmacokinetics|pharmacokinetics
274324|NCT01987908|Analgesic use|analgesic use
274325|NCT01987908|Sickle cell disease|sickle cell disease
274326|NCT01987908|Aes-103|aes-103
274327|NCT01987908|SpO2|spo2
274328|NCT01987908|Anemia|anemia
274329|NCT01987908|Hemoglobin|hemoglobin
274330|NCT01987895|Post-antibiotic diarrhea|post-antibiotic diarrhea
274331|NCT01987895|Clostridium difficile infection|clostridium difficile infection
274332|NCT01987882|Outcomes research, treatment effectiveness, quality of life|outcomes research, treatment effectiveness, quality of life
274333|NCT01987869|hiperemesis gravidarum,vomiting,serotonin levels,ketonuria|hiperemesis gravidarum,vomiting,serotonin levels,ketonuria
274334|NCT01987856|aCGH|acgh
274335|NCT01987856|chromosome|chromosome
274336|NCT01987856|blastocyst|blastocyst
274337|NCT01987856|trophectoderm|trophectoderm
274338|NCT01987856|vitrification|vitrification
274339|NCT01987856|natural cycle|natural cycle
274340|NCT01987856|pregnancy|pregnancy
274341|NCT01987856|live birth|live birth
274342|NCT01987843|Psoriasis|psoriasis
274343|NCT01987843|Plaque Psoriasis|plaque psoriasis
274344|NCT01987830|Recurrent glioblastoma|recurrent glioblastoma
274345|NCT01987817|Characterized Peanut Allergen|characterized peanut allergen
274346|NCT01987817|Peanut|peanut
274347|NCT01987817|OIT|oit
274348|NCT01987817|Oral Desensitization|oral desensitization
274349|NCT01987817|Peanut Allergen|peanut allergen
274350|NCT01987817|Allergy|allergy
274351|NCT01987817|Peanut Allergy|peanut allergy
274352|NCT01987817|Peanut-Allergic Children|peanut-allergic children
274353|NCT01987817|Children|children
274354|NCT01987817|Peanut-Allergic Adults|peanut-allergic adults
274355|NCT01987778|Hot flashes|hot flashes
274356|NCT01987778|Menopause|menopause
274357|NCT01987778|HRQoL|hrqol
274358|NCT01987778|Resistance training|resistance training
274359|NCT01987778|Physical activity|physical activity
274360|NCT01987778|Adipose tissue|adipose tissue
274361|NCT01987739|Almorexant|almorexant
274362|NCT01987739|Zolpidem|zolpidem
274363|NCT01987726|Solid Tumor Malignancies|solid tumor malignancies
274364|NCT01987700|Abdominal Hernia Repair|abdominal hernia repair
274365|NCT01987700|Dermal Allograft|dermal allograft
274366|NCT01987700|Mesh|mesh
274367|NCT01987700|Component Separation|component separation
274368|NCT01987661|COPD|copd
274369|NCT01987661|NIV|niv
274370|NCT01987661|Airtrapping|airtrapping
274371|NCT01987661|Ventimotion2|ventimotion2
274372|NCT01987648|Craniotomy|craniotomy
274373|NCT01987648|Postoperative complications|postoperative complications
274374|NCT01987648|Perioperative care|perioperative care
274375|NCT01987648|Postoperative intracerebral hemorrhage|postoperative intracerebral hemorrhage
274376|NCT01987648|Postoperative seizure|postoperative seizure
274377|NCT01987635|Mitral valve disease|mitral valve disease
274378|NCT01987635|primarily regurgitation|primarily regurgitation
274379|NCT01987635|necessitating surgical repair|necessitating surgical repair
274380|NCT01987622|lumbar spinal stenosis|lumbar spinal stenosis
274381|NCT01987622|claudication|claudication
274382|NCT01987622|low back pain|low back pain
274383|NCT01987622|radiculopathy|radiculopathy
274384|NCT01987622|acupuncture|acupuncture
274385|NCT01987622|Korean medicine|korean medicine
274386|NCT01987622|randomized controlled trial|randomized controlled trial
274387|NCT01987609|Psoriasis|psoriasis
274388|NCT01987609|Dendritic cells|dendritic cells
274389|NCT01987609|Hyaluronidase|hyaluronidase
274390|NCT01987609|Hylenex|hylenex
274391|NCT01987570|Xanthine oxidase|xanthine oxidase
274392|NCT01987570|Magnetic resonance|magnetic resonance
274393|NCT01987570|Oxidative stress|oxidative stress
274394|NCT01987570|Inflammation|inflammation
274395|NCT01987557|treadmill|treadmill
274396|NCT01987557|parkinson's|parkinson's
274397|NCT01987557|proprioception|proprioception
274398|NCT01987557|cadence|cadence
274399|NCT01987557|step length|step length
274400|NCT01987557|intrinsic feedback|intrinsic feedback
274401|NCT01987544|COPD|copd
274402|NCT01987544|telemonitoring|telemonitoring
274403|NCT01987544|training|training
274404|NCT01987544|ergometer|ergometer
274405|NCT01987544|telemedicine|telemedicine
274406|NCT01987531|after open cardiac chamber cardiac surgery|after open cardiac chamber cardiac surgery
274407|NCT01987466|Neutrophil Gelatinase-associated Lipocalin(NGAL)|neutrophil gelatinase-associated lipocalin(ngal)
274408|NCT01987466|Acute renal failure|acute renal failure
274409|NCT01987466|Cardiac arrest|cardiac arrest
274410|NCT01987466|Hypothermia|hypothermia
274411|NCT01987453|genotype 1|genotype 1
274412|NCT01987427|Overweight|overweight
274413|NCT01987427|Obese|obese
274414|NCT01987427|Weight Management|weight management
274415|NCT01987414|Stroke|stroke
274416|NCT01987414|Cardiovascular Accident|cardiovascular accident
274417|NCT01987414|Task-oriented approach|task-oriented approach
274418|NCT01987414|Orthosis|orthosis
274419|NCT01987414|occupational therapy|occupational therapy
274420|NCT01987401|pulmonary|pulmonary
274421|NCT01987401|lung|lung
274422|NCT01987401|military and environmental exposures|military and environmental exposures
274423|NCT01987401|epidemiologic|epidemiologic
274424|NCT01987401|observational|observational
274425|NCT01987401|interview or questionnaire|interview or questionnaire
274426|NCT01987401|deployment related|deployment related
274427|NCT01987401|Enduring Freedom|enduring freedom
274428|NCT01987401|Iraqi Freedom|iraqi freedom
274429|NCT01987375|HNSCC|hnscc
274430|NCT01987375|Imaging|imaging
274431|NCT01987349|Influenza vaccines|influenza vaccines
274432|NCT01987349|healthy participants|healthy participants
274433|NCT01987349|immunity to influenza|immunity to influenza
274434|NCT01987349|identical twins|identical twins
274435|NCT01987349|fraternal twins|fraternal twins
274436|NCT01987349|non-twins|non-twins
274437|NCT01987336|Standard Foley Catheter|standard foley catheter
274438|NCT01987323|glaucoma|glaucoma
274439|NCT01987323|raised intraocular pressure|raised intraocular pressure
274440|NCT01987310|non alcoholic fatty liver disease|non alcoholic fatty liver disease
274441|NCT01987310|endothelial function|endothelial function
274442|NCT01987310|liver steatosis|liver steatosis
274443|NCT01987310|liver fibrosis|liver fibrosis
274444|NCT01987310|statin treatment|statin treatment
274445|NCT01987297|arsenic|arsenic
274446|NCT01987297|acute promyelocytic leukemia|acute promyelocytic leukemia
274447|NCT01987297|outcome|outcome
274448|NCT01987271|exercise tolerance|exercise tolerance
274449|NCT01987271|exercise test|exercise test
274450|NCT01987271|noninvasive ventilation|noninvasive ventilation
274451|NCT01987258|Glycemic control|glycemic control
274452|NCT01987258|excess post-exercise oxygen consumption|excess post-exercise oxygen consumption
274453|NCT01987219|familial dysautonomia|familial dysautonomia
274454|NCT01987206|artificial pancreas|artificial pancreas
274455|NCT01987193|Proton radiation|proton radiation
274456|NCT01987193|tumor blood flow|tumor blood flow
274457|NCT01987180|self-efficacy|self-efficacy
274458|NCT01987167|acute optic neuritis|acute optic neuritis
274459|NCT01987115|Trigger Finger|trigger finger
274460|NCT01987115|Physiotherapy|physiotherapy
274461|NCT01987115|Fascial Manipulation|fascial manipulation
274462|NCT01987102|Methotrexate|methotrexate
274463|NCT01987102|rescue treatment|rescue treatment
274464|NCT01987089|Insomnia|insomnia
274465|NCT01987089|Sleep initiation and maintenance disorder|sleep initiation and maintenance disorder
274466|NCT01987089|Alcoholism|alcoholism
274467|NCT01987089|Cognitive behavioral therapy for insomnia|cognitive behavioral therapy for insomnia
274468|NCT01987076|DRESS|dress
274469|NCT01987076|Systemic steroid|systemic steroid
274470|NCT01987076|Topical steroid|topical steroid
274471|NCT01987076|Treatment|treatment
274472|NCT01987063|Twin delivery|twin delivery
274473|NCT01987063|Planned vaginal delivery|planned vaginal delivery
274474|NCT01987063|Planned cesarean delivery|planned cesarean delivery
274475|NCT01987063|Total breech extraction|total breech extraction
274476|NCT01987063|Internal cephalic version|internal cephalic version
274477|NCT01987063|External cephalic version|external cephalic version
274478|NCT01987037|autism spectrum disorder|autism spectrum disorder
274479|NCT01987037|neuropsychomotor assessment|neuropsychomotor assessment
274480|NCT01987037|NP-MOT|np-mot
274481|NCT01987037|motor skills|motor skills
274482|NCT01987037|gross motor|gross motor
274483|NCT01987011|Avian influenza|avian influenza
274484|NCT01986998|Multiple sclerosis relapse|multiple sclerosis relapse
274485|NCT01986998|oral methylprednisolone|oral methylprednisolone
274486|NCT01986998|EDSS|edss
274487|NCT01986998|gadolinium|gadolinium
274488|NCT01986972|Toothbrushing|toothbrushing
274489|NCT01986972|Dental plaque|dental plaque
274490|NCT01986972|Dentifrice|dentifrice
274491|NCT01986972|Oral hygiene|oral hygiene
274492|NCT01986959|Periodontal Dressings|periodontal dressings
274493|NCT01986959|Surgical crown lengthening|surgical crown lengthening
274494|NCT01986959|Periodontal surgery|periodontal surgery
274495|NCT01986920|SK|sk
274496|NCT01986907|wet AMD|wet amd
274497|NCT01986907|macular degeneration|macular degeneration
274498|NCT01986907|ranibizumab|ranibizumab
274499|NCT01986907|mono-bilateral|mono-bilateral
274500|NCT01986907|poor visual acuity|poor visual acuity
274501|NCT01986907|retinal disease|retinal disease
274502|NCT01986907|eye disease|eye disease
274503|NCT01986907|Angiogenesis Inhibitors|angiogenesis inhibitors
274504|NCT01986907|Angiogenesis Modulating Agents|angiogenesis modulating agents
274505|NCT01986894|TQT|tqt
274506|NCT01986894|Pharmacokinetic|pharmacokinetic
274507|NCT01986894|Healthy|healthy
274508|NCT01986868|Coronary Magnetic Resonance Angiography|coronary magnetic resonance angiography
274509|NCT01986868|CMRA|cmra
274510|NCT01986868|MRI with contrast|mri with contrast
274511|NCT01986868|MultiHance|multihance
274512|NCT01986868|Optimark|optimark
274513|NCT01986868|Gadolinium-based contrast|gadolinium-based contrast
274514|NCT01986868|MRA|mra
274515|NCT01986868|MR angiography|mr angiography
274516|NCT01986842|Muscle protein synthesis|muscle protein synthesis
274517|NCT01986842|Digestion and absorption kinetics|digestion and absorption kinetics
274518|NCT01986842|Leucine|leucine
274519|NCT01986842|Whey protein|whey protein
274520|NCT01986816|Obesity|obesity
274521|NCT01986816|Bariatric surgery|bariatric surgery
274522|NCT01986816|Laparoscopic gastric bypass|laparoscopic gastric bypass
274523|NCT01986816|Quality of life|quality of life
274524|NCT01986816|QALY|qaly
274525|NCT01986803|ST-elevation Myocardial Infarction (STEMI)|st-elevation myocardial infarction (stemi)
274526|NCT01986803|Primary Percutaneous Coronary Intervention within 24 hrs|primary percutaneous coronary intervention within 24 hrs
274527|NCT01986803|Healing score|healing score
274528|NCT01986803|OFDI|ofdi
274529|NCT01986790|Health insurance|health insurance
274530|NCT01986790|Health services accessibility|health services accessibility
274531|NCT01986790|Decision making|decision making
274532|NCT01986790|Health literacy|health literacy
274533|NCT01986777|cognitive complains|cognitive complains
274534|NCT01986777|RRSO|rrso
274535|NCT01986777|oophorectomy|oophorectomy
274536|NCT01986777|memory|memory
274537|NCT01986777|cognition|cognition
274538|NCT01986777|early menopause|early menopause
274539|NCT01986764|oophorectomy|oophorectomy
274540|NCT01986764|RRSO|rrso
274541|NCT01986764|menopause|menopause
274542|NCT01986764|early menopause|early menopause
274543|NCT01986764|cognition|cognition
274544|NCT01986764|memory|memory
274545|NCT01986764|brain-imaging|brain-imaging
274546|NCT01986751|nerve|nerve
274547|NCT01986751|block|block
274548|NCT01986751|motor blockade|motor blockade
274549|NCT01986751|lower extremity pain|lower extremity pain
274550|NCT01986751|nerve block|nerve block
274551|NCT01986725|vulvar neoplasia|vulvar neoplasia
274552|NCT01986725|vulvar cancer|vulvar cancer
274553|NCT01986725|vulvar intraepithelial neoplasia|vulvar intraepithelial neoplasia
274554|NCT01986725|self management|self management
274555|NCT01986725|symptom management|symptom management
274556|NCT01986712|Melanoma, Stage III, adjuvant, Quality of Life|melanoma, stage iii, adjuvant, quality of life
274557|NCT01986699|polypectomy|polypectomy
274558|NCT01986699|laparoscopic|laparoscopic
274559|NCT01986673|Pharmacokinetic Characterization|pharmacokinetic characterization
274560|NCT01986660|Pharmacokinetic Study|pharmacokinetic study
274561|NCT01986647|exercise|exercise
274562|NCT01986647|older adults|older adults
274563|NCT01986647|mobility disability|mobility disability
274564|NCT01986634|Laser Resurfacing|laser resurfacing
274565|NCT01986634|Rhytids|rhytids
274566|NCT01986634|Perioral|perioral
274567|NCT01986621|Percutaneous Coronary Intervention|percutaneous coronary intervention
274568|NCT01986621|Cardiac troponin|cardiac troponin
274569|NCT01986621|Antiplatelet therapy|antiplatelet therapy
274570|NCT01986608|Lacosamide|lacosamide
274571|NCT01986608|Vimpat|vimpat
274572|NCT01986608|Bioequivalence|bioequivalence
274573|NCT01986608|Bioavailability|bioavailability
274574|NCT01986608|Japanese|japanese
274575|NCT01986595|Neuroblastoma|neuroblastoma
274576|NCT01986595|anaplastic lymphoma kinase|anaplastic lymphoma kinase
274577|NCT01986595|cancer genetics|cancer genetics
274578|NCT01986595|target therapy|target therapy
274579|NCT01986595|RNA and genomic DNA extraction|rna and genomic dna extraction
274580|NCT01986595|complementary DNA(cDNA) preparation|complementary dna(cdna) preparation
274581|NCT01986595|Array-comparative genomic hybridization|array-comparative genomic hybridization
274582|NCT01986595|Multiplex ligation-dependent probe amplification (MLPA)|multiplex ligation-dependent probe amplification (mlpa)
274583|NCT01986595|Sequencing of cDNA prepared from NB|sequencing of cdna prepared from nb
274584|NCT01986595|Pyrosequencing|pyrosequencing
274585|NCT01986595|Quantitative real-time polymerase chain reaction(RT-PCR)|quantitative real-time polymerase chain reaction(rt-pcr)
274586|NCT01986595|Immunohistochemistry|immunohistochemistry
274587|NCT01986582|Allergic Rhinitis|allergic rhinitis
274588|NCT01986582|Congestion|congestion
274589|NCT01986582|Mucoadhesive Treatment|mucoadhesive treatment
274590|NCT01986582|Nasal Decongestant|nasal decongestant
274591|NCT01986569|Fluoroestradiol (FES)|fluoroestradiol (fes)
274592|NCT01986569|PET/CT scan|pet/ct scan
274593|NCT01986569|Estrogen Receptor|estrogen receptor
274594|NCT01986569|Recurrent breast cancer|recurrent breast cancer
274595|NCT01986569|Stage IV breast cancer|stage iv breast cancer
274596|NCT01986543|Pharmacokinetic|pharmacokinetic
274597|NCT01986530|irisin|irisin
274598|NCT01986530|adiponectin|adiponectin
274599|NCT01986530|leptin|leptin
274600|NCT01986530|lean body mass|lean body mass
274601|NCT01986530|fat mass|fat mass
274602|NCT01986517|Feedback|feedback
274603|NCT01986517|Therapeutic competencies|therapeutic competencies
274604|NCT01986517|Training|training
274605|NCT01986504|Infection|infection
274606|NCT01986504|Cohort|cohort
274607|NCT01986504|Prospective|prospective
274608|NCT01986504|Epidemiology|epidemiology
274609|NCT01986504|Outcome|outcome
274610|NCT01986491|Healthy|healthy
274611|NCT01986491|JNJ-39393406|jnj-39393406
274612|NCT01986491|Relative Bioavailability|relative bioavailability
274613|NCT01986491|Solid Formulation|solid formulation
274614|NCT01986465|lateral epicondylitis|lateral epicondylitis
274615|NCT01986465|treatment|treatment
274616|NCT01986465|steroid|steroid
274617|NCT01986465|immobilization|immobilization
274618|NCT01986452|OSA|osa
274619|NCT01986452|Apoplexy|apoplexy
274620|NCT01986452|CPAP|cpap
274621|NCT01986452|adherence|adherence
274622|NCT01986452|telemonitoring|telemonitoring
274623|NCT01986426|Transdermal accessible tumours|transdermal accessible tumours
274624|NCT01986413|COPD|copd
274625|NCT01986413|chronic hypercapnic respiratory failure|chronic hypercapnic respiratory failure
274626|NCT01986413|NIV|niv
274627|NCT01986413|respiratory events|respiratory events
274628|NCT01986413|IVAPS|ivaps
274629|NCT01986400|Adolescent|adolescent
274630|NCT01986400|Skype|skype
274631|NCT01986400|Peer Mentorship|peer mentorship
274632|NCT01986400|Internet Self-Management|internet self-management
274633|NCT01986387|adolescent|adolescent
274634|NCT01986387|Skype|skype
274635|NCT01986387|peer mentorship|peer mentorship
274636|NCT01986387|internet self-management|internet self-management
274637|NCT01986374|IVF , embryo implantation, HCG|ivf , embryo implantation, hcg
274638|NCT01986361|Pharyngitis|pharyngitis
274639|NCT01986361|Sore Throat|sore throat
274640|NCT01986361|acute upper respiratory tract infection (URTI)|acute upper respiratory tract infection (urti)
274641|NCT01986348|GBM|gbm
274642|NCT01986348|Glioblastoma|glioblastoma
274643|NCT01986348|selinexor|selinexor
274644|NCT01986348|KPT-330|kpt-330
274645|NCT01986348|Karyopharm|karyopharm
274646|NCT01986348|brain tumor|brain tumor
274647|NCT01986348|brain cancer|brain cancer
274648|NCT01986348|Glioma|glioma
274649|NCT01986348|Astrocytoma|astrocytoma
274650|NCT01986348|Oligodendrogliomas|oligodendrogliomas
274651|NCT01986348|Oligo-astrocytomas|oligo-astrocytomas
274652|NCT01986335|Combined pentavalent DTP/HB/Hib vaccine|combined pentavalent dtp/hb/hib vaccine
274653|NCT01986335|Infants|infants
274654|NCT01986335|Primary vaccination|primary vaccination
274655|NCT01986322|DTP/HB/Hib vaccine|dtp/hb/hib vaccine
274656|NCT01986322|Immunogenicity|immunogenicity
274657|NCT01986322|Infants|infants
274658|NCT01986322|Safety|safety
274659|NCT01986309|Postoperative|postoperative
274660|NCT01986309|Nausea|nausea
274661|NCT01986309|Vomiting|vomiting
274662|NCT01986309|Pain|pain
274663|NCT01986309|Surgery|surgery
274664|NCT01986283|Abuse potential|abuse potential
274665|NCT01986283|PF-00345439|pf-00345439
274666|NCT01986283|drug abuse|drug abuse
274667|NCT01986244|Osteoarthritis|osteoarthritis
274668|NCT01986244|Arthritis|arthritis
274669|NCT01986244|Joint Diseases|joint diseases
274670|NCT01986231|diabetes|diabetes
274671|NCT01986231|insulin|insulin
274672|NCT01986231|glucagon|glucagon
274673|NCT01986231|glycogen|glycogen
274674|NCT01986231|MRS|mrs
274675|NCT01986205|Concussion, mild|concussion, mild
274676|NCT01986205|Traumatic brain injury|traumatic brain injury
274677|NCT01986205|Hyperbaric oxygenation|hyperbaric oxygenation
274678|NCT01986205|Post-concussion symptoms|post-concussion symptoms
274679|NCT01986205|Headache|headache
274680|NCT01986192|anticoagulation|anticoagulation
274681|NCT01986192|pharmacomechanical thrombolysis|pharmacomechanical thrombolysis
274682|NCT01986192|aspiration thrombectomy|aspiration thrombectomy
274683|NCT01986153|Fatty acid, essential|fatty acid, essential
274684|NCT01986153|Immune system|immune system
274685|NCT01986153|Home parenteral nutrition|home parenteral nutrition
274686|NCT01986140|Breast Cancer|breast cancer
274687|NCT01986140|Alopecia|alopecia
274688|NCT01986140|Scalp|scalp
274689|NCT01986140|Cooling|cooling
274690|NCT01986127|Crohn disease|crohn disease
274691|NCT01986075|Cocaine Dependence Treatment|cocaine dependence treatment
274692|NCT01986075|Computer-assisted therapy|computer-assisted therapy
274693|NCT01986075|Pharmacotherapy|pharmacotherapy
274694|NCT01986062|ADHD|adhd
274695|NCT01986062|AR11|ar11
274696|NCT01986062|classroom design|classroom design
274697|NCT01986062|amphetamine sulfate|amphetamine sulfate
274698|NCT01986023|Stroke|stroke
274699|NCT01986023|Medication Adherence|medication adherence
274700|NCT01986023|SMS|sms
274701|NCT01986023|Randomised|randomised
274702|NCT01985997|FluMist, Quadrivalent, Vaccine|flumist, quadrivalent, vaccine
274703|NCT01985984|Head and neck cancer|head and neck cancer
274704|NCT01985906|Aorta|aorta
274705|NCT01985906|Aneurysm|aneurysm
274706|NCT01985906|Stents|stents
274707|NCT01985906|Collateral Circulation|collateral circulation
274708|NCT01985893|Metastatic|metastatic
274709|NCT01985893|breast|breast
274710|NCT01985893|cancer|cancer
274711|NCT01985880|Biomarkers|biomarkers
274712|NCT01985854|Desflurane|desflurane
274713|NCT01985854|Propofol|propofol
274714|NCT01985854|Total intravenous anesthesia|total intravenous anesthesia
274715|NCT01985854|Neurosurgery|neurosurgery
274716|NCT01985841|Early breast cancer|early breast cancer
274717|NCT01985841|Primary operable breast cancer|primary operable breast cancer
274718|NCT01985841|HER2- negative|her2- negative
274719|NCT01985841|bevacizumab|bevacizumab
274720|NCT01985828|Prostate neoplasm|prostate neoplasm
274721|NCT01985828|Prostate Cancer|prostate cancer
274722|NCT01985815|obsessive-compulsive disorder|obsessive-compulsive disorder
274723|NCT01985815|Deep Brain Stimulation|deep brain stimulation
274724|NCT01985815|Psychosurgery|psychosurgery
274725|NCT01985789|airway hyperresponsiveness|airway hyperresponsiveness
274726|NCT01985776|Exercise|exercise
275545|NCT01982383|CSC|csc
274727|NCT01985776|Electric Stimulation|electric stimulation
274728|NCT01985763|Genistein|genistein
274729|NCT01985763|soy supplements|soy supplements
274730|NCT01985763|phytoestrogens|phytoestrogens
274731|NCT01985763|colon cancer|colon cancer
274732|NCT01985763|rectal cancer|rectal cancer
274733|NCT01985763|colorectal cancer|colorectal cancer
274734|NCT01985763|metastatic|metastatic
274735|NCT01985763|stage IV|stage iv
274736|NCT01985763|FOLFOX|folfox
274737|NCT01985763|FOLFOX-Avastin|folfox-avastin
274738|NCT01985763|Chemotherapy|chemotherapy
274739|NCT01985750|dyspnea|dyspnea
274740|NCT01985750|fmri|fmri
274741|NCT01985750|d-cycloserine|d-cycloserine
274742|NCT01985737|Neonatal Intensive Care Units (NICUs)|neonatal intensive care units (nicus)
274743|NCT01985737|NICUs|nicus
274744|NCT01985737|Neonates|neonates
274745|NCT01985737|CLABSI|clabsi
274746|NCT01985737|Microbiome|microbiome
274747|NCT01985737|DNA signature|dna signature
274748|NCT01985737|Catheter infections|catheter infections
274749|NCT01985724|Early breast cancer|early breast cancer
274750|NCT01985724|Axillary node positive|axillary node positive
274751|NCT01985724|HER-2 negative|her-2 negative
274752|NCT01985724|Adjuvant chemotherapy|adjuvant chemotherapy
274753|NCT01985724|Dose dense|dose dense
274754|NCT01985724|Docetaxel|docetaxel
274755|NCT01985724|FEC|fec
274756|NCT01985711|Motivational Interviewing|motivational interviewing
274757|NCT01985711|Cognitive Behavioral Therapy|cognitive behavioral therapy
274758|NCT01985711|Transtheoretical Model of behavior change|transtheoretical model of behavior change
274759|NCT01985711|Questionnaires|questionnaires
274760|NCT01985711|Telemedicine/*methods|telemedicine/*methods
274761|NCT01985711|Comorbidity|comorbidity
274762|NCT01985711|Diabetes|diabetes
274763|NCT01985711|Glucose/metabolism|glucose/metabolism
274764|NCT01985711|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
274765|NCT01985711|Blood Pressure|blood pressure
274766|NCT01985711|Cholesterol, LDL/blood|cholesterol, ldl/blood
274767|NCT01985711|Quality of life|quality of life
274768|NCT01985711|Depressive Disorder/psychology/*therapy|depressive disorder/psychology/*therapy
274769|NCT01985711|Randomized Controlled Trials|randomized controlled trials
274770|NCT01985698|Low rectal cancer|low rectal cancer
274771|NCT01985698|Robotic|robotic
274772|NCT01985698|Laparoscopic|laparoscopic
274773|NCT01985698|Abdominoperineal resection|abdominoperineal resection
274774|NCT01985685|VO2, critically ill, oxygen consumption|vo2, critically ill, oxygen consumption
274775|NCT01985672|Infertility|infertility
274776|NCT01985659|Lymph Node Excision|lymph node excision
274777|NCT01985659|Thoracic Surgical Procedures|thoracic surgical procedures
274778|NCT01985659|Thoracic Surgery, Video-Assisted|thoracic surgery, video-assisted
274779|NCT01985659|Thoracotomy|thoracotomy
274780|NCT01985646|Hirschsprung disease|hirschsprung disease
274781|NCT01985646|conservative treatment|conservative treatment
274782|NCT01985646|surgery treatment|surgery treatment
274784|NCT01985633|Osteoarthritis|osteoarthritis
274785|NCT01985633|stem cells|stem cells
274786|NCT01985633|Platelet gel|platelet gel
274787|NCT01985633|Functional outcome|functional outcome
274788|NCT01985620|Vaccination|vaccination
274789|NCT01985620|RSV|rsv
274790|NCT01985620|Influenza|influenza
274791|NCT01985620|Prematurity|prematurity
274792|NCT01985594|preterm labor|preterm labor
274793|NCT01985581|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
274794|NCT01985581|Intuniv extended release|intuniv extended release
274795|NCT01985581|Executive Function|executive function
274796|NCT01985581|Quality of Life|quality of life
274797|NCT01985568|Obesity|obesity
274798|NCT01985568|weight-loss|weight-loss
274799|NCT01985568|Physical activity|physical activity
274800|NCT01985555|Phase I|phase i
274801|NCT01985555|Safety|safety
274802|NCT01985555|Pharmacokinetics|pharmacokinetics
274803|NCT01985516|Pain|pain
274804|NCT01985516|Urethra|urethra
274805|NCT01985516|Catheter|catheter
274806|NCT01985503|positron emission tomography|positron emission tomography
274807|NCT01985503|magnetic resonance imaging|magnetic resonance imaging
274808|NCT01985503|brown adipose tissue|brown adipose tissue
274809|NCT01985503|obesity|obesity
274810|NCT01985503|cardiovascular disease|cardiovascular disease
274811|NCT01985503|subclinical atherosclerosis|subclinical atherosclerosis
274812|NCT01985490|epiretinal membrane|epiretinal membrane
274813|NCT01985490|foveal avascular zone|foveal avascular zone
274814|NCT01985490|internal limiting membrane|internal limiting membrane
274815|NCT01985477|Myeloma|myeloma
274816|NCT01985477|Multiple myeloma|multiple myeloma
274817|NCT01985477|MM|mm
274818|NCT01985477|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
274819|NCT01985477|RR MM|rr mm
274820|NCT01985477|Lenalidomide|lenalidomide
274821|NCT01985477|CC-5013|cc-5013
274822|NCT01985477|Revlimid|revlimid
274823|NCT01985477|Dexamethasone|dexamethasone
274824|NCT01985477|Decadron|decadron
274825|NCT01985477|All-Trans Retinoic Acid|all-trans retinoic acid
274826|NCT01985477|ATRA|atra
274827|NCT01985477|Tretinoin (Oral)|tretinoin (oral)
274828|NCT01985477|Vesanoid|vesanoid
274829|NCT01985464|rheumatoid arthritis|rheumatoid arthritis
274830|NCT01985464|umbilical cord|umbilical cord
274831|NCT01985464|mesenchymal|mesenchymal
274832|NCT01985464|stem cells|stem cells
274833|NCT01985451|Lymphoma|lymphoma
274834|NCT01985438|Head and Neck Neoplasms|head and neck neoplasms
274835|NCT01985438|Nutritional Support|nutritional support
274836|NCT01985438|Randomized Controlled Trial|randomized controlled trial
274837|NCT01985438|Percutaneous Endoscopic Gastrostomy tube|percutaneous endoscopic gastrostomy tube
274838|NCT01985438|Nasogastric tube|nasogastric tube
274839|NCT01985438|Radiation Effects|radiation effects
274840|NCT01985438|Pakistan|pakistan
274841|NCT01985412|Rejection|rejection
274842|NCT01985412|Transplant|transplant
274843|NCT01985412|Cardiac|cardiac
274844|NCT01985412|Pulmonary|pulmonary
274845|NCT01985412|Heart|heart
274846|NCT01985412|Lung|lung
274847|NCT01985412|Cell-Free DNA|cell-free dna
274848|NCT01985412|cfDNA|cfdna
274849|NCT01985412|Cell|cell
274850|NCT01985412|Free|free
274851|NCT01985412|DNA|dna
274852|NCT01985412|Biopsy|biopsy
274853|NCT01985412|Non-Invasive|non-invasive
274854|NCT01985399|HIV|hiv
274855|NCT01985399|AIDS|aids
274856|NCT01985399|Aging|aging
274857|NCT01985386|Iron absorption|iron absorption
274858|NCT01985386|Slow release iron|slow release iron
274859|NCT01985386|Gastric delivery system|gastric delivery system
274860|NCT01985386|Iron deficiency|iron deficiency
274861|NCT01985373|intravenous immunoglobulin|intravenous immunoglobulin
274862|NCT01985373|pharmacokinetics|pharmacokinetics
274863|NCT01985373|10% IVIG|10% ivig
274864|NCT01985334|Moderate COPD, glycopyrronium bromide, indacaterol maleate and glycopyrronium bromide FDC, NVA237, QVA149|moderate copd, glycopyrronium bromide, indacaterol maleate and glycopyrronium bromide fdc, nva237, qva149
274865|NCT01985321|herpes labialis|herpes labialis
274866|NCT01985321|cold sore|cold sore
274867|NCT01985269|High risk|high risk
274868|NCT01985269|ART naive|art naive
274869|NCT01985256|glioma|glioma
274870|NCT01985256|glioblastoma|glioblastoma
274871|NCT01985256|glioblastoma multiforme|glioblastoma multiforme
274872|NCT01985256|Grade IV astrocytoma|grade iv astrocytoma
274873|NCT01985256|brain cancer|brain cancer
274874|NCT01985256|recurrent glioblastoma|recurrent glioblastoma
274875|NCT01985256|GBM|gbm
274876|NCT01985256|AA|aa
274877|NCT01985256|AOD|aod
274878|NCT01985256|anaplastic astrocytoma|anaplastic astrocytoma
274879|NCT01985256|anaplastic oligodendroglioma|anaplastic oligodendroglioma
274880|NCT01985256|anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
274881|NCT01985256|malignant glioma|malignant glioma
274882|NCT01985256|high grade glioma|high grade glioma
274883|NCT01985243|Dietary diversity|dietary diversity
274884|NCT01985243|Infant and young child|infant and young child
274885|NCT01985243|Adolescents|adolescents
274886|NCT01985243|Anemia|anemia
274887|NCT01985243|Rural health|rural health
274888|NCT01985204|iodine|iodine
274889|NCT01985204|thyroid hormones|thyroid hormones
274890|NCT01985204|obesity|obesity
274891|NCT01985204|TSH|tsh
274892|NCT01985204|dyslipidemia|dyslipidemia
274893|NCT01985204|insulin resistance|insulin resistance
274894|NCT01985139|Obesity, food pleasure, behavioral tasks, endocannabinoids|obesity, food pleasure, behavioral tasks, endocannabinoids
274895|NCT01985126|Multiple myeloma|multiple myeloma
274896|NCT01985126|Daratumumab|daratumumab
274897|NCT01985126|Proteasome inhibitor|proteasome inhibitor
274898|NCT01985126|Immunomodulatory drug|immunomodulatory drug
274899|NCT01985126|IMiD|imid
274900|NCT01985113|thioredoxin reductase|thioredoxin reductase
274901|NCT01985113|non-small cell lung cancer|non-small cell lung cancer
274902|NCT01985074|case management, disease management, emergency|case management, disease management, emergency
274903|NCT01985074|department|department
274904|NCT01985061|Myelodysplasic syndrome|myelodysplasic syndrome
274905|NCT01985061|Acute Myeloid leukemia|acute myeloid leukemia
274906|NCT01985035|Obstructive sleep apnea|obstructive sleep apnea
274907|NCT01985035|obesity|obesity
274908|NCT01985035|diet|diet
274909|NCT01985035|energy expenditure|energy expenditure
274910|NCT01985022|autism|autism
274911|NCT01985022|autism spectrum disorders|autism spectrum disorders
274912|NCT01985022|pervasive developmental disorders|pervasive developmental disorders
274913|NCT01985022|toddlers|toddlers
274914|NCT01985022|intervention|intervention
274915|NCT01984983|Venezuelan equine encephalitis virus|venezuelan equine encephalitis virus
274916|NCT01984983|DNA vaccine|dna vaccine
274917|NCT01984983|electroporation|electroporation
274918|NCT01984983|intradermal|intradermal
274919|NCT01984983|intramuscular|intramuscular
274920|NCT01984970|McGrath Videolaryngoscope|mcgrath videolaryngoscope
274921|NCT01984970|double-lumen tube intubation|double-lumen tube intubation
274922|NCT01984970|Thoracic surgery|thoracic surgery
274923|NCT01984957|ALS|als
274924|NCT01984957|Motor neuron diseases|motor neuron diseases
274925|NCT01984957|Transcriptome|transcriptome
274926|NCT01984944|circadian rhythm|circadian rhythm
274927|NCT01984931|post operative nausea and vomiting|post operative nausea and vomiting
274928|NCT01984931|Trimebutine Maleate|trimebutine maleate
274929|NCT01984905|18 FDG PET-scan|18 fdg pet-scan
274930|NCT01984905|angioscan|angioscan
274931|NCT01984905|aortic dissection|aortic dissection
274932|NCT01984892|Autologous Vaccination|autologous vaccination
274933|NCT01984892|Intratumoral Injections|intratumoral injections
274934|NCT01984892|Intramuscular Injections|intramuscular injections
274935|NCT01984892|Advanced Accessible Solid Tumors|advanced accessible solid tumors
274936|NCT01984892|Poly-ICLC|poly-iclc
274937|NCT01984892|Phase II Clinical Trial|phase ii clinical trial
274938|NCT01984892|Safety|safety
274939|NCT01984892|Efficacy|efficacy
274940|NCT01984892|Autovaccination|autovaccination
274941|NCT01984892|In Situ|in situ
274942|NCT01984892|Host Targeted Strategy|host targeted strategy
274943|NCT01984892|Overall Survival|overall survival
274944|NCT01984892|Immunotherapy|immunotherapy
274945|NCT01984892|Adjuvant|adjuvant
274946|NCT01984866|CPR: Complete Pathological Response|cpr: complete pathological response
274947|NCT01984853|ACS|acs
274948|NCT01984853|repository|repository
274949|NCT01984853|Observational|observational
274950|NCT01984827|Hyperglycaemia|hyperglycaemia
274951|NCT01984827|Moxifloxacin|moxifloxacin
274952|NCT01984827|QTc prolongation|qtc prolongation
274953|NCT01984827|C-peptide|c-peptide
274954|NCT01984827|Dead in bed syndrome|dead in bed syndrome
274955|NCT01984801|SCD1|scd1
274956|NCT01984801|Gel|gel
274957|NCT01984801|Topical Administration|topical administration
274958|NCT01984801|Acne|acne
274959|NCT01984788|Oral Prophylaxis|oral prophylaxis
274960|NCT01984775|safety|safety
274961|NCT01984775|dermal|dermal
274962|NCT01984775|GSK2894512|gsk2894512
274963|NCT01984775|Cumulative irritation|cumulative irritation
274964|NCT01984736|Pharmacokinetic|pharmacokinetic
274965|NCT01984736|Safety|safety
274966|NCT01984723|Pharmacokinetic|pharmacokinetic
274967|NCT01984723|Safety|safety
274968|NCT01984710|Treatment Resistant Depression|treatment resistant depression
274969|NCT01984710|Deep Brain Stimulation|deep brain stimulation
274970|NCT01984710|Psychiatry|psychiatry
274971|NCT01984710|Neuro Surgery|neuro surgery
274972|NCT01984684|Bacterial skin infection|bacterial skin infection
274973|NCT01984684|infection|infection
274974|NCT01984684|skin|skin
274975|NCT01984684|delafloxacin|delafloxacin
274976|NCT01984684|vancomycin|vancomycin
274977|NCT01984684|aztreonam|aztreonam
274978|NCT01984684|methicillin-resistant Staphylococcus aureus (MRSA) bacteria|methicillin-resistant staphylococcus aureus (mrsa) bacteria
274979|NCT01984684|bacterial infection|bacterial infection
274980|NCT01984684|Anti-Infective Agents|anti-infective agents
274981|NCT01984658|pancreatic cancer|pancreatic cancer
274982|NCT01984645|Emergency Visit|emergency visit
274983|NCT01984645|Secure Health messaging|secure health messaging
274984|NCT01984645|Inpatient|inpatient
274985|NCT01984593|Yoga|yoga
274986|NCT01984593|Hypertension|hypertension
274987|NCT01984593|Quality of Life|quality of life
274988|NCT01984593|Primary Health Care|primary health care
274989|NCT01984593|Stress|stress
274990|NCT01984593|Anxiety|anxiety
274991|NCT01984593|Depression|depression
274992|NCT01984580|Barrett's esophagus|barrett's esophagus
274993|NCT01984580|Esophagus|esophagus
274994|NCT01984580|Adenocarcinoma|adenocarcinoma
274995|NCT01984567|Oxyphytosterols|oxyphytosterols
274996|NCT01984567|Oxidative stress|oxidative stress
274997|NCT01984567|Vitamin E|vitamin e
274998|NCT01984567|Lipoic acid|lipoic acid
274999|NCT01984541|Pollen|pollen
275000|NCT01984528|Immunotherapy|immunotherapy
275001|NCT01984528|Skin prick test|skin prick test
275002|NCT01984528|Standardization|standardization
275003|NCT01984528|Alternaria alternata|alternaria alternata
275004|NCT01984515|Post-traumatic Stress Disorder|post-traumatic stress disorder
275005|NCT01984515|Evidence-Based Psychotherapy|evidence-based psychotherapy
275006|NCT01984515|Treatment Engagement|treatment engagement
275007|NCT01984515|Cognitive Behavioral Therapy|cognitive behavioral therapy
275008|NCT01984515|Implementation Science|implementation science
275009|NCT01984502|Larynx Cancer|larynx cancer
275010|NCT01984489|SHR117887, Metformin,combination,PhaseII|shr117887, metformin,combination,phaseii
275011|NCT01984476|spinal cord injury|spinal cord injury
275012|NCT01984476|autonomic dysreflexia|autonomic dysreflexia
275013|NCT01984476|baroreceptor integrity|baroreceptor integrity
275014|NCT01984476|sympathetic integrity|sympathetic integrity
275015|NCT01984476|vagal integrity|vagal integrity
275016|NCT01984476|autonomic integrity|autonomic integrity
275017|NCT01984476|arterial stiffness|arterial stiffness
275018|NCT01984476|cognitive function|cognitive function
275019|NCT01984476|traumatic brain injury|traumatic brain injury
275020|NCT01984476|cerebral blood flow|cerebral blood flow
275021|NCT01984476|white matter hyperintensities|white matter hyperintensities
275022|NCT01984476|cerebral vascular resistance index|cerebral vascular resistance index
275023|NCT01984463|Postoperative pain|postoperative pain
275024|NCT01984463|Shoulder pain|shoulder pain
275025|NCT01984463|Thoracotomy|thoracotomy
275026|NCT01984450|Articular cartilage|articular cartilage
275027|NCT01984450|Autologous collagen|autologous collagen
275028|NCT01984450|BMAC|bmac
275029|NCT01984437|Vascular disease|vascular disease
275030|NCT01984437|Minimally invasive treatment|minimally invasive treatment
275031|NCT01984437|Endovascular treatment|endovascular treatment
275032|NCT01984437|Magellan|magellan
275033|NCT01984437|Robotic|robotic
275034|NCT01984424|High Cholesterol, Treatment for high cholesterol, Lowering cholesterol, Lowering high cholesterol, Hypercholesterolemia|high cholesterol, treatment for high cholesterol, lowering cholesterol, lowering high cholesterol, hypercholesterolemia
275035|NCT01984346|Atrial Fibrillation|atrial fibrillation
275036|NCT01984346|Convergent Procedure|convergent procedure
275037|NCT01984346|Combined Epicardial/ Endocardial Ablation|combined epicardial/ endocardial ablation
275038|NCT01984346|Hybrid Procedure|hybrid procedure
275039|NCT01984346|Radiofrequency Ablation|radiofrequency ablation
275040|NCT01984346|Arrhythmia|arrhythmia
275041|NCT01984346|RF Ablation|rf ablation
275042|NCT01984333|trichotillomania|trichotillomania
275043|NCT01984333|response inhibition|response inhibition
275044|NCT01984333|cognitive retraining|cognitive retraining
275045|NCT01984320|OHSS|ohss
275046|NCT01984320|ICSI|icsi
275047|NCT01984320|Coasting|coasting
275048|NCT01984320|Cabergoline|cabergoline
275049|NCT01984307|Acute coronary syndrome|acute coronary syndrome
275050|NCT01984307|Myocardial infarction|myocardial infarction
275051|NCT01984307|retrospective|retrospective
275052|NCT01984307|cohort study|cohort study
275053|NCT01984307|Healthcare resources utilization|healthcare resources utilization
275054|NCT01984294|HCV genotype 1|hcv genotype 1
275055|NCT01984294|HCV|hcv
275056|NCT01984294|Sustained Virologic Response|sustained virologic response
275057|NCT01984294|Direct-Acting Antiviral|direct-acting antiviral
275058|NCT01984294|Combination Therapy|combination therapy
275059|NCT01984294|GS-7977|gs-7977
275060|NCT01984294|GS-5885|gs-5885
275061|NCT01984294|Ribavirin|ribavirin
275062|NCT01984294|Open Label|open label
275063|NCT01984294|Sofosbuvir|sofosbuvir
275064|NCT01984294|Treatment-Naive|treatment-naive
275065|NCT01984294|Protease Inhibitors|protease inhibitors
275066|NCT01984294|PI|pi
275067|NCT01984294|Treatment experienced|treatment experienced
275068|NCT01984294|Cirrhotic|cirrhotic
275069|NCT01984281|Physical Activity|physical activity
275070|NCT01984281|Pedometers|pedometers
275071|NCT01984281|Quality of Life|quality of life
275072|NCT01984268|Rheumatoid arthritis|rheumatoid arthritis
275073|NCT01984268|ACTHAR|acthar
275074|NCT01984268|Methotrexate|methotrexate
275075|NCT01984268|Inadequate response|inadequate response
275076|NCT01984203|Shoulder|shoulder
275077|NCT01984203|Impingement|impingement
275078|NCT01984203|Rotator Cuff Syndrome|rotator cuff syndrome
275079|NCT01984203|Subacromial Impingement Syndrome|subacromial impingement syndrome
275080|NCT01984203|Exercise|exercise
275081|NCT01984203|Physiotherapy|physiotherapy
275082|NCT01984190|venous thromboembolism|venous thromboembolism
275083|NCT01984190|deep vein thrombosis|deep vein thrombosis
275084|NCT01984190|pulmonary emboli|pulmonary emboli
275085|NCT01984190|hip arthroplasty|hip arthroplasty
275086|NCT01984190|knee arthroplasty|knee arthroplasty
275087|NCT01984190|efficacy|efficacy
275088|NCT01984190|mobile compression device|mobile compression device
275089|NCT01984190|mechanical device|mechanical device
275090|NCT01984190|prophylaxis.|prophylaxis.
275091|NCT01984177|Cocaine|cocaine
275092|NCT01984177|Substance-Related Disorders|substance-related disorders
275093|NCT01984177|Drug Addiction|drug addiction
275094|NCT01984177|Substance Addiction|substance addiction
275095|NCT01984177|Dopamine|dopamine
275096|NCT01984177|Receptors, Dopamine D2|receptors, dopamine d2
275097|NCT01984177|Receptors, Dopamine D3|receptors, dopamine d3
275098|NCT01984177|Stress, Psychological|stress, psychological
275099|NCT01984177|Corticorelin|corticorelin
275100|NCT01984177|Neuroendocrine System|neuroendocrine system
275101|NCT01984177|Cortisol|cortisol
275102|NCT01984177|Adrenocorticotropic Hormone|adrenocorticotropic hormone
275103|NCT01984177|Positron-Emission Tomography|positron-emission tomography
275104|NCT01984177|11C-PHNO|11c-phno
275105|NCT01984164|cerebrovascular function|cerebrovascular function
275106|NCT01984138|estrogen receptor positive breast cancer|estrogen receptor positive breast cancer
275107|NCT01984138|breast cancer|breast cancer
275108|NCT01984125|Adolescent Immunization Rates|adolescent immunization rates
275109|NCT01984125|Provider prompts|provider prompts
275110|NCT01984112|Humerus|humerus
275111|NCT01984112|fracture|fracture
275112|NCT01984112|nail|nail
275113|NCT01984112|plate|plate
275114|NCT01984112|tuberosity|tuberosity
275115|NCT01984099|Postmolar Gestational Trophoblastic Disease, Hydatidiform Mole|postmolar gestational trophoblastic disease, hydatidiform mole
275116|NCT01984086|COPD|copd
275117|NCT01984086|Asthma|asthma
275118|NCT01984086|Respiratory|respiratory
275119|NCT01984073|Atherogenic dyslipidemia phenotype|atherogenic dyslipidemia phenotype
275120|NCT01984060|Aging|aging
275121|NCT01984060|Physical Activity|physical activity
275122|NCT01984060|Physical Function|physical function
275123|NCT01984060|HIV|hiv
275124|NCT01984060|Frailty|frailty
275125|NCT01984060|Autonomous Motivation|autonomous motivation
275126|NCT01984060|Depression|depression
275127|NCT01984047|safety|safety
275129|NCT01984047|CCR6 receptor|ccr6 receptor
275130|NCT01984047|single dose escalation|single dose escalation
275131|NCT01984047|Phase 1|phase 1
275132|NCT01984047|CCL20|ccl20
275133|NCT01984034|Educational outreach|educational outreach
275134|NCT01984034|Academic detailing|academic detailing
275135|NCT01984034|Guideline adherence|guideline adherence
275136|NCT01984034|Family Practice|family practice
275137|NCT01984034|Drug utilization|drug utilization
275138|NCT01984034|Program evaluation|program evaluation
275139|NCT01984034|Cost effectiveness|cost effectiveness
275140|NCT01984021|Physical Therapy Modalities|physical therapy modalities
275141|NCT01984021|Neck pain|neck pain
275142|NCT01984021|Acupuncture|acupuncture
275143|NCT01983995|Breast Cancer|breast cancer
275144|NCT01983995|Aromatase Inhibitors|aromatase inhibitors
275145|NCT01983995|Actigraphy|actigraphy
275146|NCT01983995|Pain|pain
275147|NCT01983995|Fatigue|fatigue
275148|NCT01983995|Sleep quality|sleep quality
275149|NCT01983982|Breast Cancer|breast cancer
275150|NCT01983982|Chemotherapy|chemotherapy
275151|NCT01983982|Chronic Pain|chronic pain
275152|NCT01983982|Survivorship|survivorship
275153|NCT01983969|Advanced Cancers|advanced cancers
275154|NCT01983969|Lymphoma|lymphoma
275155|NCT01983969|Recurrent Hodgkin's|recurrent hodgkin's
275156|NCT01983969|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
275157|NCT01983969|Stem cell transplant|stem cell transplant
275158|NCT01983969|Azacitidine|azacitidine
275159|NCT01983969|5-azacytidine|5-azacytidine
275160|NCT01983969|5-aza|5-aza
275161|NCT01983969|Vidaza|vidaza
275162|NCT01983969|5-AZC|5-azc
275163|NCT01983969|AZA-CR|aza-cr
275164|NCT01983969|Ladakamycin|ladakamycin
275165|NCT01983969|NSC-102816|nsc-102816
275166|NCT01983969|Azacytidine|azacytidine
275167|NCT01983969|Vorinostat|vorinostat
275168|NCT01983969|SAHA|saha
275169|NCT01983969|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
275170|NCT01983969|MSK-390|msk-390
275171|NCT01983969|Zolinza|zolinza
275172|NCT01983969|Gemcitabine|gemcitabine
275173|NCT01983969|Gemcitabine Hydrochloride|gemcitabine hydrochloride
275174|NCT01983969|Gemzar|gemzar
275175|NCT01983969|Busulfan|busulfan
275176|NCT01983969|Busulfex|busulfex
275177|NCT01983969|Myleran|myleran
275178|NCT01983969|Melphalan|melphalan
275179|NCT01983969|Alkeran|alkeran
275180|NCT01983969|Dexamethasone|dexamethasone
275181|NCT01983969|Decadron|decadron
275182|NCT01983969|Caphosol|caphosol
275183|NCT01983969|Glutamine|glutamine
275184|NCT01983969|Enterex|enterex
275185|NCT01983969|Glutapak-10|glutapak-10
275186|NCT01983969|NutreStore|nutrestore
275187|NCT01983969|Resource|resource
275188|NCT01983969|GlutaSolve|glutasolve
275189|NCT01983969|Sympt-X G.I.|sympt-x g.i.
275190|NCT01983969|Sympt-X|sympt-x
275191|NCT01983969|Pyridoxine|pyridoxine
275192|NCT01983969|Rituximab|rituximab
275193|NCT01983969|Rituxan|rituxan
275194|NCT01983956|early palliative care|early palliative care
275195|NCT01983956|patient empowerment|patient empowerment
275196|NCT01983956|cancer|cancer
275197|NCT01983956|assessment|assessment
275198|NCT01983956|end of life|end of life
275199|NCT01983930|Memory impairment|memory impairment
275200|NCT01983930|Meditation|meditation
275201|NCT01983930|Yoga|yoga
275202|NCT01983930|memory training|memory training
275203|NCT01983930|Mild cognitive impairment|mild cognitive impairment
275204|NCT01983930|MCI|mci
275205|NCT01983930|geriatric|geriatric
275206|NCT01983930|fMRI|fmri
275207|NCT01983917|diabetes|diabetes
275208|NCT01983917|mobile application|mobile application
275209|NCT01983917|diabetic retinopathy|diabetic retinopathy
275210|NCT01983904|Major depressive disorder (MDD)|major depressive disorder (mdd)
275211|NCT01983904|Bi-polar disorder (BP)|bi-polar disorder (bp)
275212|NCT01983891|food shelf|food shelf
275213|NCT01983891|nutrition education|nutrition education
275214|NCT01983891|cooking course|cooking course
275215|NCT01983852|End of Life Care|end of life care
275216|NCT01983852|Paediatric|paediatric
275217|NCT01983852|Experiences|experiences
275218|NCT01983852|Needs|needs
275219|NCT01983852|Current Practices|current practices
275220|NCT01983839|Moxifloxacin|moxifloxacin
275221|NCT01983839|Pneumonia|pneumonia
275222|NCT01983839|Pharmacokinetics|pharmacokinetics
275223|NCT01983826|nitrates|nitrates
275224|NCT01983826|blood flow|blood flow
275225|NCT01983826|vascular function|vascular function
275226|NCT01983826|exercise|exercise
275227|NCT01983813|Diabetes|diabetes
275228|NCT01983813|High Blood Pressure|high blood pressure
275229|NCT01983813|High Cholesterol|high cholesterol
275230|NCT01983813|Heart Irregularity|heart irregularity
275231|NCT01983813|Stroke|stroke
275232|NCT01983800|Mechanical Ventilation|mechanical ventilation
275233|NCT01983800|Volatile Sedation|volatile sedation
275234|NCT01983800|Intravenous Sedation|intravenous sedation
275235|NCT01983800|Delirium|delirium
275236|NCT01983787|Cystic Fibrosis|cystic fibrosis
275237|NCT01983787|Continuous infusion|continuous infusion
275238|NCT01983787|Pharmacokinetics|pharmacokinetics
275240|NCT01983748|Uveal Melanoma, Monosomy 3|uveal melanoma, monosomy 3
275241|NCT01983735|TELMINUVO Tab.|telminuvo tab.
275242|NCT01983735|CKD-828|ckd-828
275243|NCT01983735|Hypertension|hypertension
275244|NCT01983735|Stage 2 Hypertension|stage 2 hypertension
275245|NCT01983735|S-Amlodipine|s-amlodipine
275246|NCT01983735|Telmisartan|telmisartan
275247|NCT01983696|low oxygen tension|low oxygen tension
275248|NCT01983696|embryo quality|embryo quality
275249|NCT01983683|Clostridium difficile infection|clostridium difficile infection
275250|NCT01983683|Post-antibiotic diarrhea|post-antibiotic diarrhea
275251|NCT01983670|Pre-movement facilitation|pre-movement facilitation
275252|NCT01983670|Fast goal directed movement|fast goal directed movement
275253|NCT01983670|Triphasic EMG pattern|triphasic emg pattern
275254|NCT01983670|Temporal electrical stimulation,|temporal electrical stimulation,
275255|NCT01983670|Spinocerebellar Ataxia|spinocerebellar ataxia
275256|NCT01983657|Pulmonary|pulmonary
275257|NCT01983657|Pulmonary Alveolar Proteinosis|pulmonary alveolar proteinosis
275258|NCT01983657|PAP|pap
275259|NCT01983644|acute ischemic stroke,endovascular recanalization|acute ischemic stroke,endovascular recanalization
275260|NCT01983644|mechanical thrombectomy|mechanical thrombectomy
275261|NCT01983631|Whole body vibration|whole body vibration
275262|NCT01983631|Reciprocal inhibition|reciprocal inhibition
275263|NCT01983631|Spinocerebellar ataxia|spinocerebellar ataxia
275264|NCT01983631|voluntary activation level|voluntary activation level
275265|NCT01983618|Cerebral ischemia|cerebral ischemia
275266|NCT01983618|Beachchair position|beachchair position
275267|NCT01983618|Interscalene nerve block|interscalene nerve block
275268|NCT01983592|Homeopathy|homeopathy
275269|NCT01983592|Fatigue|fatigue
275270|NCT01983592|Chemotherapy|chemotherapy
275271|NCT01983592|Cancer|cancer
275272|NCT01983553|Dengue Virus|dengue virus
275273|NCT01983553|Dengue Fever|dengue fever
275274|NCT01983553|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
275275|NCT01983553|CYD Dengue Vaccine|cyd dengue vaccine
275276|NCT01983540|Diphtheria|diphtheria
275277|NCT01983540|Tetanus|tetanus
275278|NCT01983540|Whooping Cough|whooping cough
275279|NCT01983540|Hepatitis B|hepatitis b
275280|NCT01983540|Poliomyelitis|poliomyelitis
275281|NCT01983540|Pediatric combined vaccine|pediatric combined vaccine
275282|NCT01983527|Arthrographic distention|arthrographic distention
275283|NCT01983527|Hydrodilatation|hydrodilatation
275284|NCT01983527|Intra-articular corticosteroid injection|intra-articular corticosteroid injection
275285|NCT01983514|oxytocin|oxytocin
275286|NCT01983514|fMRI|fmri
275287|NCT01983514|social cognition|social cognition
275288|NCT01983514|heart rate variability|heart rate variability
275289|NCT01983514|pupillometry|pupillometry
275290|NCT01983514|eye tracking|eye tracking
275291|NCT01983501|ONT-380|ont-380
275292|NCT01983501|T-DM1|t-dm1
275293|NCT01983501|Kadcyla|kadcyla
275294|NCT01983501|HER2 positive breast cancer|her2 positive breast cancer
275295|NCT01983501|Breast cancer|breast cancer
275296|NCT01983501|ARRY-380|arry-380
275297|NCT01983501|Tucatinib|tucatinib
275298|NCT01983501|Tucatinib (ONT-380)|tucatinib (ont-380)
275299|NCT01983488|Uveitis|uveitis
275300|NCT01983488|Vision Loss|vision loss
275301|NCT01983475|Spinal Cord Injury|spinal cord injury
275302|NCT01983475|Denosumab|denosumab
275303|NCT01983475|Osteoporosis|osteoporosis
275304|NCT01983475|Dual Energy X-ray Absorptiometry|dual energy x-ray absorptiometry
275305|NCT01983462|Prehypertension|prehypertension
275306|NCT01983462|Hypertension|hypertension
275307|NCT01983462|Obese|obese
275308|NCT01983462|Sympathetic Nervous System|sympathetic nervous system
275309|NCT01983462|renin-angiotensin system|renin-angiotensin system
275310|NCT01983462|Endothelial function|endothelial function
275311|NCT01983449|Adventitia|adventitia
275312|NCT01983449|Peripheral Artery Disease|peripheral artery disease
275313|NCT01983449|Restenosis|restenosis
275314|NCT01983449|Inflammation|inflammation
275315|NCT01983449|Anti-Inflammatory|anti-inflammatory
275316|NCT01983449|Dexamethasone|dexamethasone
275317|NCT01983436|Maxillofacial Orthognathic Surgery|maxillofacial orthognathic surgery
275318|NCT01983436|Manual lymphatic drainage|manual lymphatic drainage
275319|NCT01983423|Endometrial Biopsy|endometrial biopsy
275320|NCT01983423|Endometrial Sampling|endometrial sampling
275321|NCT01983423|In Vitro Fertilization|in vitro fertilization
275322|NCT01983423|Pregnancy|pregnancy
275323|NCT01983423|Implantation|implantation
275324|NCT01983410|BRCA Mutation Carriers|brca mutation carriers
275325|NCT01983410|PDAC carriers|pdac carriers
275326|NCT01983410|BRCAmut carriers|brcamut carriers
275327|NCT01983410|Registry|registry
275328|NCT01983410|13-217|13-217
275329|NCT01983397|aged, 80 and over|aged, 80 and over
275330|NCT01983397|Exercise|exercise
275331|NCT01983397|Cognition|cognition
275332|NCT01983397|Balance|balance
275333|NCT01983397|Randomized controlled trial|randomized controlled trial
275334|NCT01983384|Delirium|delirium
275335|NCT01983384|Cognition|cognition
275336|NCT01983384|Surgery|surgery
275337|NCT01983384|Anesthesia|anesthesia
275338|NCT01983384|Aging|aging
275339|NCT01983358|PARP-1 inhibitor|parp-1 inhibitor
275340|NCT01983345|Myelomeningocele|myelomeningocele
275341|NCT01983345|Arnold Chiari malformation|arnold chiari malformation
275342|NCT01983345|Spina bifida|spina bifida
275343|NCT01983332|MDACC|mdacc
275344|NCT01983332|MOHO|moho
275345|NCT01983306|Constipation|constipation
275346|NCT01983306|Opioid|opioid
275347|NCT01983306|GC C Agonist|gc c agonist
275348|NCT01983306|Pain|pain
275349|NCT01983293|Non-left bundle branch block|non-left bundle branch block
275351|NCT01983293|LV lead pacing location|lv lead pacing location
275352|NCT01983293|CRT-D|crt-d
275353|NCT01983280|polysomnography|polysomnography
275354|NCT01983280|sleep|sleep
275355|NCT01983280|healing touch|healing touch
275356|NCT01983280|pediatric burn|pediatric burn
275357|NCT01983254|coping|coping
275358|NCT01983254|acute respiratory failure|acute respiratory failure
275359|NCT01983254|critical illness|critical illness
275360|NCT01983254|depression|depression
275361|NCT01983254|anxiety|anxiety
275362|NCT01983254|post-traumatic stress|post-traumatic stress
275363|NCT01983254|intensive care unit|intensive care unit
275364|NCT01983241|Pulmonary Emphysema|pulmonary emphysema
275365|NCT01983241|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
275366|NCT01983241|AATD|aatd
275367|NCT01983241|Alpha-1 PI Deficiency|alpha-1 pi deficiency
275368|NCT01983241|Alpha-1 Protienase Inhibitor|alpha-1 protienase inhibitor
275369|NCT01983228|Musculoskeletal Pain|musculoskeletal pain
275370|NCT01983228|Walking|walking
275371|NCT01983228|African American|african american
275372|NCT01983228|Telephone Coaching|telephone coaching
275373|NCT01983228|Pedometer|pedometer
275374|NCT01983215|groin incisions|groin incisions
275375|NCT01983202|PCOS|pcos
275376|NCT01983202|Pregnancy|pregnancy
275377|NCT01983202|Obstetric|obstetric
275378|NCT01983189|TMS|tms
275379|NCT01983189|transcranial magnetic stimulation|transcranial magnetic stimulation
275380|NCT01983189|rTMS|rtms
275381|NCT01983189|recurrent transcranial magnetic stimulation|recurrent transcranial magnetic stimulation
275382|NCT01983189|fMRI|fmri
275383|NCT01983189|functional magnetic resonance imaging.|functional magnetic resonance imaging.
275384|NCT01983176|Parotid tumor|parotid tumor
275385|NCT01983176|Partial superficial parotidectomy|partial superficial parotidectomy
275386|NCT01983176|Facial palsy|facial palsy
275387|NCT01983150|Population Health|population health
275388|NCT01983150|Smoking cessation|smoking cessation
275389|NCT01983150|Young adults|young adults
275390|NCT01983150|Cancer prevention|cancer prevention
275391|NCT01983150|Tobacco control strategies|tobacco control strategies
275392|NCT01983150|Behaviour modification|behaviour modification
275393|NCT01983150|Social Media|social media
275394|NCT01983150|Smartphone technology|smartphone technology
275395|NCT01983137|Chronic pain|chronic pain
275396|NCT01983137|Severe pain|severe pain
275397|NCT01983137|oxycodon|oxycodon
275398|NCT01983137|naloxon|naloxon
275399|NCT01983137|opioid-induced constipation|opioid-induced constipation
275400|NCT01983137|opioid|opioid
275401|NCT01983137|quality of life|quality of life
275402|NCT01983137|laxative|laxative
275403|NCT01983137|analgesic rescue medication|analgesic rescue medication
275404|NCT01983124|Advanced Melanoma|advanced melanoma
275405|NCT01983098|Colorectal cancer|colorectal cancer
275406|NCT01983098|Metastatic|metastatic
275407|NCT01983098|Circulating tumor DNA|circulating tumor dna
275408|NCT01983098|Biomaker|biomaker
275409|NCT01983085|Nitric Oxide Dressing|nitric oxide dressing
275410|NCT01983085|Nitric oxide|nitric oxide
275411|NCT01983085|Superficial partial thickness wound|superficial partial thickness wound
275412|NCT01983085|Burns|burns
275413|NCT01983085|Skin graft donor sites|skin graft donor sites
275414|NCT01983085|Improved healing|improved healing
275415|NCT01983085|Vasodilation|vasodilation
275416|NCT01983085|Angiogenesis|angiogenesis
275417|NCT01983085|Anti-microbial|anti-microbial
275418|NCT01983072|colonization of the gastrointestinal tract with bacteria|colonization of the gastrointestinal tract with bacteria
275419|NCT01983007|Diabetes Mellitus.|diabetes mellitus.
275420|NCT01982994|Physical Activity Education|physical activity education
275421|NCT01982994|Caregivers|caregivers
275422|NCT01982981|perception|perception
275423|NCT01982981|wellbeing|wellbeing
275424|NCT01982981|plain water|plain water
275425|NCT01982968|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
275426|NCT01982968|IPF|ipf
275427|NCT01982968|Gastroesophageal reflux|gastroesophageal reflux
275428|NCT01982968|GER|ger
275429|NCT01982968|GERD|gerd
275430|NCT01982955|MSC2156119J|msc2156119j
275431|NCT01982955|Gefitinib|gefitinib
275432|NCT01982955|Pemetrexed|pemetrexed
275433|NCT01982955|Cisplatin|cisplatin
275434|NCT01982955|MET positive|met positive
275435|NCT01982955|Tepotinib|tepotinib
275436|NCT01982955|Carboplatin|carboplatin
275437|NCT01982955|INSIGHT|insight
275438|NCT01982916|Allergic Rhinitis|allergic rhinitis
275439|NCT01982916|Perennial Allergic Rhinitis|perennial allergic rhinitis
275440|NCT01982916|Non-seasonal Allergic Rhinitis|non-seasonal allergic rhinitis
275441|NCT01982916|PAR|par
275442|NCT01982903|kidney transplantation|kidney transplantation
275443|NCT01982903|connective tissue growth factor|connective tissue growth factor
275444|NCT01982903|fibrosis|fibrosis
275445|NCT01982890|Telomere length|telomere length
275446|NCT01982890|Longitudinal observation|longitudinal observation
275447|NCT01982877|decision making|decision making
275448|NCT01982877|values elicitation|values elicitation
275449|NCT01982877|patient centered care|patient centered care
275450|NCT01982877|Four Supports|four supports
275451|NCT01982877|Family Support|family support
275452|NCT01982864|Aminoglycosides|aminoglycosides
275453|NCT01982864|hemodialysis|hemodialysis
275454|NCT01982864|clinical pharmacokinetics|clinical pharmacokinetics
275455|NCT01982864|pharmacokinetic modelling|pharmacokinetic modelling
275456|NCT01982864|Bayesian estimation|bayesian estimation
275457|NCT01982864|Necessity|necessity
275458|NCT01982864|of the treatment|of the treatment
275459|NCT01982864|gentamicin|gentamicin
275460|NCT01982851|pain|pain
275461|NCT01982851|epidural|epidural
275462|NCT01982851|combined spinal epidural|combined spinal epidural
275463|NCT01982838|pain|pain
275464|NCT01982838|epidural|epidural
275465|NCT01982838|combined spinal epidural|combined spinal epidural
275466|NCT01982825|Tobacco use cessation|tobacco use cessation
275467|NCT01982825|Cigarette smoking|cigarette smoking
275468|NCT01982799|Endodontic treatment, analgesics, anesthesia, post-operative pain|endodontic treatment, analgesics, anesthesia, post-operative pain
275469|NCT01982773|Virtual Hope Box|virtual hope box
275470|NCT01982760|Rhinoplasty|rhinoplasty
275471|NCT01982760|Ecchymosis|ecchymosis
275472|NCT01982760|Edema|edema
275473|NCT01982747|Cardiac Safety|cardiac safety
275474|NCT01982747|General Safety|general safety
275475|NCT01982747|Pharmacokinetics|pharmacokinetics
275476|NCT01982734|bioavailability|bioavailability
275477|NCT01982734|curcumin|curcumin
275478|NCT01982734|pharmacokinetic|pharmacokinetic
275479|NCT01982734|curcuma longa|curcuma longa
275480|NCT01982734|age differences|age differences
275481|NCT01982734|sex differences|sex differences
275482|NCT01982708|Evaluation|evaluation
275483|NCT01982695|Duchenne muscular Dystrophy (DMD)|duchenne muscular dystrophy (dmd)
275484|NCT01982695|Cardiomyopathy|cardiomyopathy
275485|NCT01982695|Losartan|losartan
275486|NCT01982695|Lisinopril|lisinopril
275487|NCT01982669|Salty taste|salty taste
275488|NCT01982669|Urinary sodium excretion|urinary sodium excretion
275489|NCT01982669|Spicy hedonic|spicy hedonic
275490|NCT01982669|Blood pressure|blood pressure
275491|NCT01982617|Transtheoretical Model|transtheoretical model
275492|NCT01982617|Stages of Change|stages of change
275493|NCT01982617|Nicotine Dependence|nicotine dependence
275494|NCT01982617|Severe Mental Illness|severe mental illness
275495|NCT01982578|Treatment|treatment
275496|NCT01982578|Genistein|genistein
275497|NCT01982578|Alzheimer's disease|alzheimer's disease
275498|NCT01982578|Cerebrospinal fluid|cerebrospinal fluid
275499|NCT01982578|Amyloid beta|amyloid beta
275500|NCT01982565|Nitric oxide|nitric oxide
275501|NCT01982565|Nitric oxide dressing|nitric oxide dressing
275502|NCT01982565|NOx|nox
275503|NCT01982565|NOx dressing|nox dressing
275504|NCT01982565|Diabetic|diabetic
275505|NCT01982565|Foot|foot
275506|NCT01982565|Ulcers|ulcers
275507|NCT01982565|Chronic|chronic
275508|NCT01982552|Plaque psoriasis|plaque psoriasis
275509|NCT01982552|calcipotriene|calcipotriene
275510|NCT01982552|betamethasone dipropionate|betamethasone dipropionate
275511|NCT01982552|topical|topical
275512|NCT01982539|pain|pain
275513|NCT01982539|NSAID|nsaid
275514|NCT01982539|moderate pain|moderate pain
275515|NCT01982539|mild pain|mild pain
275516|NCT01982539|acute pain|acute pain
275517|NCT01982539|mild acute pain|mild acute pain
275518|NCT01982539|moderate acute pain|moderate acute pain
275519|NCT01982539|mild or moderate acute pain|mild or moderate acute pain
275520|NCT01982526|Ovarian reserve|ovarian reserve
275521|NCT01982526|Antimullerian hormone|antimullerian hormone
275522|NCT01982513|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
275523|NCT01982513|Pregnancy|pregnancy
275524|NCT01982513|Ultrasound|ultrasound
275525|NCT01982513|Inferior Vena Cava|inferior vena cava
275526|NCT01982500|Ovarian Cancer|ovarian cancer
275527|NCT01982500|Chemotherapy|chemotherapy
275528|NCT01982500|Anti-angiogenic agent|anti-angiogenic agent
275529|NCT01982500|Bevacizumab|bevacizumab
275530|NCT01982500|Front Line|front line
275531|NCT01982474|allergic rhinitis|allergic rhinitis
275532|NCT01982448|TRIPLE NEGATIVE BREAST CANCER WITHOUT GERMLINE BRCA MUTATIONS|triple negative breast cancer without germline brca mutations
275533|NCT01982448|CISPLATIN|cisplatin
275534|NCT01982448|PACLITAXEL|paclitaxel
275535|NCT01982435|Diabetes|diabetes
275536|NCT01982435|Macular Edema|macular edema
275537|NCT01982422|Attention Deficit and Hyperactivity Disorder|attention deficit and hyperactivity disorder
275538|NCT01982422|Nutrition|nutrition
275539|NCT01982422|Diet|diet
275540|NCT01982422|Developmental Origins of Disease|developmental origins of disease
275541|NCT01982396|HIV|hiv
275542|NCT01982396|paediatric|paediatric
275543|NCT01982396|Abacavir|abacavir
275544|NCT01982396|lamivudine|lamivudine
275547|NCT01982383|Retinopathy|retinopathy
275548|NCT01982344|mini-exchange-room|mini-exchange-room
275549|NCT01982344|physical activity|physical activity
275550|NCT01982344|quality of life|quality of life
275551|NCT01982344|peritoneal dialysis|peritoneal dialysis
275552|NCT01982331|H2N2|h2n2
275553|NCT01982331|vaccine|vaccine
275554|NCT01982318|Venous Leg Ulcer|venous leg ulcer
275555|NCT01982318|Leg Ulcer|leg ulcer
275556|NCT01982318|Venous Hypertension|venous hypertension
275557|NCT01982318|Venous Reflux|venous reflux
275558|NCT01982318|Deep Venous System|deep venous system
275559|NCT01982318|Chronic leg ulceration|chronic leg ulceration
275560|NCT01982318|Calf perforator|calf perforator
275561|NCT01982292|Chronic Heart Failure, CHF, Heart Failure, HF, Immunogenicity, Anti-bodies, Hypersensitivity, Serelaxin, RELAX-REPEAT|chronic heart failure, chf, heart failure, hf, immunogenicity, anti-bodies, hypersensitivity, serelaxin, relax-repeat
275562|NCT01982279|Caloric compensation|caloric compensation
275563|NCT01982279|Eating in the absence of hunger|eating in the absence of hunger
275564|NCT01982279|Preschool children|preschool children
275565|NCT01982279|Maternal feeding practices|maternal feeding practices
275566|NCT01982279|Maternal eating behavior|maternal eating behavior
275567|NCT01982279|one year|one year
275568|NCT01982279|children|children
275569|NCT01982253|Drug therapy|drug therapy
275570|NCT01982240|CIC|cic
275571|NCT01982240|Constipation|constipation
275572|NCT01982240|Chronic Constipation|chronic constipation
275573|NCT01982240|Synergy|synergy
275574|NCT01982240|Plecanatide|plecanatide
275575|NCT01982227|colorectal cancer metastatic|colorectal cancer metastatic
275576|NCT01982227|indocyanine green|indocyanine green
275577|NCT01982214|osteopenia|osteopenia
275578|NCT01982214|whole body vibration|whole body vibration
275579|NCT01982214|women|women
275580|NCT01982214|bone microarchitecture|bone microarchitecture
275581|NCT01982214|bone density|bone density
275582|NCT01982188|single incision sling|single incision sling
275583|NCT01982188|cough stress test|cough stress test
275584|NCT01982188|MiniArc|miniarc
275585|NCT01982188|UDI-6|udi-6
275586|NCT01982188|UIQ-7|uiq-7
275587|NCT01982188|Sandvick Severity Index (SSI)|sandvick severity index (ssi)
275588|NCT01982175|Alemtuzumab|alemtuzumab
275589|NCT01982175|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
275590|NCT01982175|CD52|cd52
275591|NCT01982162|Sputum|sputum
275592|NCT01982162|Clinical cohorts|clinical cohorts
275593|NCT01982162|Smokers|smokers
275594|NCT01982162|Asthma|asthma
275595|NCT01982162|Biopsies|biopsies
275596|NCT01982162|Severe asthma|severe asthma
275597|NCT01982162|Collaborative research|collaborative research
275598|NCT01982162|Phenotyping|phenotyping
275599|NCT01982162|Lipidomics|lipidomics
275600|NCT01982162|Transcriptomics|transcriptomics
275601|NCT01982162|Proteomics|proteomics
275602|NCT01982162|Paediatric cohort|paediatric cohort
275603|NCT01982162|Systems Biology|systems biology
275604|NCT01982149|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
275605|NCT01982149|COPD|copd
275606|NCT01982149|Smokers|smokers
275607|NCT01982149|Nonsmokers|nonsmokers
275608|NCT01982110|smoking cessation|smoking cessation
275609|NCT01982110|mindfulness|mindfulness
275610|NCT01982110|behavioral intervention|behavioral intervention
275611|NCT01982097|Non-interventional|non-interventional
275612|NCT01982097|Nexavar|nexavar
275613|NCT01982097|Sorafenib|sorafenib
275614|NCT01982097|Carcinoma, renal cell|carcinoma, renal cell
275615|NCT01982097|Neoadjuvant|neoadjuvant
275616|NCT01982097|Nephrectomy|nephrectomy
275617|NCT01982097|Russian Federation|russian federation
275618|NCT01982084|Group B streptococcus|group b streptococcus
275619|NCT01982084|Immunisation|immunisation
275620|NCT01982084|Pregnancy|pregnancy
275621|NCT01982084|Attitudes|attitudes
275622|NCT01982071|Micafungin|micafungin
275623|NCT01982071|candidiasis|candidiasis
275624|NCT01982071|candidemia|candidemia
275625|NCT01982071|Open-label design|open-label design
275626|NCT01982045|Bone graft|bone graft
275627|NCT01982045|Ceramic|ceramic
275628|NCT01982045|Spinal fusion|spinal fusion
275629|NCT01982045|RCT|rct
275630|NCT01982045|Thoracolumbar region|thoracolumbar region
275631|NCT01982032|Periprosthetic aortic valve regurgitation|periprosthetic aortic valve regurgitation
275632|NCT01982032|3D transesophageal echocardiography|3d transesophageal echocardiography
275633|NCT01982032|Cardiac MRI|cardiac mri
275634|NCT01982019|26RFa|26rfa
275635|NCT01982019|sleeve gastrectomy|sleeve gastrectomy
275636|NCT01982019|diabetes|diabetes
275637|NCT01982019|obesity|obesity
275638|NCT01982006|cataract surgery|cataract surgery
275639|NCT01982006|femtosecond laser cataract surgery|femtosecond laser cataract surgery
275640|NCT01982006|phacoemulsification|phacoemulsification
275641|NCT01982006|Cost-Benefit Analysis|cost-benefit analysis
275642|NCT01982006|Cost Effectiveness|cost effectiveness
275643|NCT01982006|Hospital Costs|hospital costs
275644|NCT01981980|Carbon dioxide|carbon dioxide
275645|NCT01981980|Carboxytherapy|carboxytherapy
275646|NCT01981980|Radiofrequency|radiofrequency
275647|NCT01981967|Japanese encephalitis|japanese encephalitis
275648|NCT01981967|IMOJEV®|imojev®
275649|NCT01981967|Japanese encephalitis chimeric virus vaccine|japanese encephalitis chimeric virus vaccine
275650|NCT01981954|Solifenacin succinate suspension|solifenacin succinate suspension
275651|NCT01981954|Efficacy|efficacy
275652|NCT01981954|Safety|safety
275653|NCT01981941|Gabapentin|gabapentin
275654|NCT01981941|Restless legs syndrome (RLS)|restless legs syndrome (rls)
275655|NCT01981928|Phase 1|phase 1
275656|NCT01981928|Healthy Subjects|healthy subjects
275657|NCT01981928|Safety|safety
275658|NCT01981928|Tolerability|tolerability
275659|NCT01981928|Pharmacokinetics|pharmacokinetics
275660|NCT01981928|Single Ascending Oral Dose|single ascending oral dose
275661|NCT01981928|Food Effect|food effect
275662|NCT01981915|Cough augmentation|cough augmentation
275663|NCT01981915|Peak cough flow|peak cough flow
275664|NCT01981915|hyperinsufflation|hyperinsufflation
275665|NCT01981902|Dehydration|dehydration
275666|NCT01981889|steroid, inflammatory bowel diseases|steroid, inflammatory bowel diseases
275667|NCT01981876|Dysplasia|dysplasia
275668|NCT01981876|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
275669|NCT01981863|cardiac surgery|cardiac surgery
275670|NCT01981863|cardiopulmonary bypass|cardiopulmonary bypass
275671|NCT01981863|fibrinolysis|fibrinolysis
275672|NCT01981863|thromboelastography|thromboelastography
275673|NCT01981863|D-Dimers|d-dimers
275674|NCT01981863|antifibrinolytic agents|antifibrinolytic agents
275675|NCT01981850|fibrosis|fibrosis
275676|NCT01981837|RNAi therapeutic|rnai therapeutic
275677|NCT01981824|prediction IUGR FL/MTC|prediction iugr fl/mtc
275678|NCT01981811|OPC-14597 Digital|opc-14597 digital
275679|NCT01981811|Aripiprazole|aripiprazole
275680|NCT01981811|Medical Information Device #1 System (MIND1)|medical information device #1 system (mind1)
275681|NCT01981811|Treatment Adherence|treatment adherence
275682|NCT01981811|Ingestible Event Marker|ingestible event marker
275683|NCT01981798|outpatient intervention program|outpatient intervention program
275684|NCT01981798|behavioral therapy approach|behavioral therapy approach
275685|NCT01981798|unspecific back pain|unspecific back pain
275686|NCT01981798|unspecific neck pain|unspecific neck pain
275687|NCT01981798|chronic pain|chronic pain
275688|NCT01981798|physiotherapy|physiotherapy
275689|NCT01981798|occupational therapy|occupational therapy
275690|NCT01981798|psychosocial aspects|psychosocial aspects
275691|NCT01981798|fear avoidance beliefs|fear avoidance beliefs
275692|NCT01981798|health-related quality of life|health-related quality of life
275693|NCT01981785|Primary immune deficiencies|primary immune deficiencies
275694|NCT01981785|Autoimmune diseases|autoimmune diseases
275695|NCT01981785|Inflammatory diseases|inflammatory diseases
275696|NCT01981785|Common variable immune deficiencies|common variable immune deficiencies
275697|NCT01981785|Primary Immunodeficiencies|primary immunodeficiencies
275698|NCT01981785|Immunoglobulin|immunoglobulin
275700|NCT01981785|IVIG|ivig
275701|NCT01981785|Recurrent Infections|recurrent infections
275702|NCT01981759|Schizophrenia|schizophrenia
275703|NCT01981759|Delusions|delusions
275704|NCT01981759|D-Cycloserine|d-cycloserine
275705|NCT01981759|CBT|cbt
275706|NCT01981746|adductor canal block|adductor canal block
275707|NCT01981746|healthy volunteers|healthy volunteers
275708|NCT01981746|US-guided peripheral nerve block|us-guided peripheral nerve block
275709|NCT01981746|lower limb|lower limb
275710|NCT01981733|Deep Vein Thrombosis|deep vein thrombosis
275711|NCT01981720|PRX-102|prx-102
275712|NCT01981720|pegunigalsidase alfa|pegunigalsidase alfa
275713|NCT01981720|Fabry Disease|fabry disease
275714|NCT01981707|castration-resistant prostate cancer|castration-resistant prostate cancer
275715|NCT01981707|abiraterone acetate|abiraterone acetate
275716|NCT01981707|enzalutamide|enzalutamide
275717|NCT01981707|choline pet|choline pet
275718|NCT01981694|Phase 1|phase 1
275719|NCT01981694|Randomized|randomized
275720|NCT01981694|Double Blind|double blind
275721|NCT01981694|Placebo-Controlled|placebo-controlled
275722|NCT01981694|Single-Dose Escalation|single-dose escalation
275723|NCT01981694|Safety|safety
275724|NCT01981694|Tolerability|tolerability
275725|NCT01981694|PK|pk
275726|NCT01981694|PD|pd
275727|NCT01981694|PF-06649751|pf-06649751
275728|NCT01981681|Phase 1|phase 1
275729|NCT01981681|Randomized|randomized
275730|NCT01981681|Placebo-Controlled|placebo-controlled
275731|NCT01981681|Multiple Dose Escalation|multiple dose escalation
275732|NCT01981681|Tolerability|tolerability
275733|NCT01981681|Safety|safety
275734|NCT01981681|PK|pk
275735|NCT01981681|Topical|topical
275736|NCT01981681|Healthy|healthy
275737|NCT01981681|PF-06263276|pf-06263276
275738|NCT01981655|Sodium Lactate|sodium lactate
275739|NCT01981655|Acute|acute
275740|NCT01981655|Heart|heart
275741|NCT01981655|Failure|failure
275742|NCT01981655|Perfusion|perfusion
275743|NCT01981629|Shock|shock
275744|NCT01981629|USCOM|uscom
275745|NCT01981629|Cardiac Ultrasound|cardiac ultrasound
275746|NCT01981629|Emergency Department|emergency department
275747|NCT01981616|Drug therapy|drug therapy
275748|NCT01981603|Navigators|navigators
275749|NCT01981603|Kidney Transplant|kidney transplant
275946|NCT01980654|Rituxan|rituxan
275750|NCT01981603|Hemodialysis|hemodialysis
275751|NCT01981590|breathing, heart failure, sleep apnea|breathing, heart failure, sleep apnea
275752|NCT01981577|Parkinson Disease|parkinson disease
275753|NCT01981577|Subthalamic Nucleus|subthalamic nucleus
275754|NCT01981577|Ultrahigh field Magnetic Resonance imaging|ultrahigh field magnetic resonance imaging
275755|NCT01981577|Functional connectivity|functional connectivity
275756|NCT01981577|Structural connectivity|structural connectivity
275757|NCT01981564|Pediatric|pediatric
275758|NCT01981564|Emergency department visit|emergency department visit
275759|NCT01981551|Desmoid Tumor|desmoid tumor
275760|NCT01981551|Aggressive Fibromatosis|aggressive fibromatosis
275761|NCT01981551|Gamma-secretase Inhibitor|gamma-secretase inhibitor
275762|NCT01981551|Notch Pathway|notch pathway
275763|NCT01981538|Web-Based Survey|web-based survey
275764|NCT01981538|Cancer Caregivers|cancer caregivers
275765|NCT01981525|TP53 Mutation|tp53 mutation
275766|NCT01981525|Autosomal Dominant Hereditary Disorder|autosomal dominant hereditary disorder
275767|NCT01981525|Chemoprevention|chemoprevention
275768|NCT01981499|PF-05180999|pf-05180999
275769|NCT01981499|safety|safety
275770|NCT01981499|tolerability|tolerability
275771|NCT01981499|pharmacokinetics|pharmacokinetics
275772|NCT01981499|histamine|histamine
275773|NCT01981499|wheal|wheal
275774|NCT01981499|flare|flare
275775|NCT01981499|migraine|migraine
275776|NCT01981499|PDE2|pde2
275777|NCT01981486|PF-05180999|pf-05180999
275778|NCT01981486|safety|safety
275779|NCT01981486|tolerability|tolerability
275780|NCT01981486|pharmacokinetics|pharmacokinetics
275781|NCT01981486|migraine|migraine
275782|NCT01981486|PDE2|pde2
275783|NCT01981486|cAMP|camp
275784|NCT01981486|cGMP|cgmp
275785|NCT01981486|cantharidin|cantharidin
275786|NCT01981486|blister|blister
275787|NCT01981486|CYP3A induction|cyp3a induction
275788|NCT01981473|rheumatoid arthritis|rheumatoid arthritis
275789|NCT01981473|etanercept|etanercept
275790|NCT01981473|adalimumab|adalimumab
275791|NCT01981473|infliximab|infliximab
275792|NCT01981473|anti-drug antibody|anti-drug antibody
275793|NCT01981473|immunogenicity|immunogenicity
275794|NCT01981473|drug concentration|drug concentration
275795|NCT01981447|epilepsy|epilepsy
275796|NCT01981421|Liver fibrosis|liver fibrosis
275797|NCT01981421|Elastography|elastography
275798|NCT01981421|MR Elastography|mr elastography
275799|NCT01981421|Quantitative imaging|quantitative imaging
275800|NCT01981395|fenobam|fenobam
275801|NCT01981395|heat|heat
275802|NCT01981395|capsaicin|capsaicin
275803|NCT01981395|hyperalgesia|hyperalgesia
275804|NCT01981395|allodynia|allodynia
275805|NCT01981395|mood|mood
275806|NCT01981395|cognitive function|cognitive function
275807|NCT01981382|low back pain|low back pain
275808|NCT01981382|pain sensitivity|pain sensitivity
275809|NCT01981382|genes|genes
275810|NCT01981382|gene expression,|gene expression,
275811|NCT01981382|quantitative sensory testing|quantitative sensory testing
275812|NCT01981369|Dexmedetomidine sedation|dexmedetomidine sedation
275813|NCT01981369|Regional Anesthesia|regional anesthesia
275814|NCT01981369|Infraclavicular block|infraclavicular block
275815|NCT01981356|Psychotic Disorders|psychotic disorders
275816|NCT01981356|Acceptance and Commitment Therapy|acceptance and commitment therapy
275817|NCT01981356|Inpatient psychiatry|inpatient psychiatry
275818|NCT01981356|Schizophrenia|schizophrenia
275819|NCT01981356|Acute psychiatric disorder|acute psychiatric disorder
275820|NCT01981343|Gallbladder motility|gallbladder motility
275821|NCT01981343|A-F Betafood|a-f betafood
275822|NCT01981343|Betaine|betaine
275823|NCT01981343|Ejection fraction|ejection fraction
275824|NCT01981343|Ejection rate|ejection rate
275825|NCT01981343|Ultrasound|ultrasound
275826|NCT01981330|vocal fold scarring|vocal fold scarring
275827|NCT01981330|mesenchymal stem cells|mesenchymal stem cells
275828|NCT01981317|Obsessive Compulsive Disorder|obsessive compulsive disorder
275829|NCT01981317|Cognitive Behavioral Therapy|cognitive behavioral therapy
275830|NCT01981317|Stepped Care CBT|stepped care cbt
275831|NCT01981317|Exposure and Response Prevention|exposure and response prevention
275832|NCT01981317|Psychotherapy|psychotherapy
275833|NCT01981317|Counseling|counseling
275834|NCT01981304|Coronary artery disease|coronary artery disease
275835|NCT01981304|Percutaneous coronary intervention|percutaneous coronary intervention
275836|NCT01981291|Lower Extremity|lower extremity
275837|NCT01981291|Sciatic Nerve|sciatic nerve
275838|NCT01981291|Anesthesia, Regional|anesthesia, regional
275839|NCT01981291|Anesthetics, Local|anesthetics, local
275840|NCT01981291|Mepivacaine|mepivacaine
275841|NCT01981291|Ultrasonography|ultrasonography
275842|NCT01981278|Healthy|healthy
275843|NCT01981278|Tapentadol|tapentadol
275844|NCT01981278|Bioequivalence|bioequivalence
275845|NCT01981278|Fasted|fasted
275846|NCT01981252|Ulthera® System|ulthera® system
275847|NCT01981252|Ultherapy™ Treatment|ultherapy™ treatment
275848|NCT01981252|Ulthera, Inc.|ulthera, inc.
275849|NCT01981252|Micro-focused Ultrasound with Visualization (MFU-V)|micro-focused ultrasound with visualization (mfu-v)
276051|NCT01980121|Pregnancy|pregnancy
275850|NCT01981239|voice analysis aspiration prediction|voice analysis aspiration prediction
275851|NCT01981213|Acetaminophen|acetaminophen
275852|NCT01981213|Suicide|suicide
275853|NCT01981213|Attempts|attempts
275854|NCT01981213|Early Predictors of Hepatic Injury|early predictors of hepatic injury
275855|NCT01981213|Childhood Suicidal Behaviour|childhood suicidal behaviour
275856|NCT01981200|COPD acute exacerbation|copd acute exacerbation
275857|NCT01981200|Physiotherapy|physiotherapy
275858|NCT01981200|Resistance training|resistance training
275859|NCT01981200|Muscle strength|muscle strength
275860|NCT01981200|Handheld dynamometer|handheld dynamometer
275861|NCT01981161|progressive multifocal leucoencephalopathy|progressive multifocal leucoencephalopathy
275862|NCT01981161|JC virus|jc virus
275863|NCT01981161|Zoster infection|zoster infection
275864|NCT01981135|Controlled Human exposure study|controlled human exposure study
275865|NCT01981135|Air Pollution|air pollution
275866|NCT01981135|Temperature|temperature
275867|NCT01981135|Lung Function|lung function
275868|NCT01981135|Cardiovascular|cardiovascular
275869|NCT01981096|juvenile fibromyalgia|juvenile fibromyalgia
275870|NCT01981096|pain in children|pain in children
275871|NCT01981096|musculoskeletal pain|musculoskeletal pain
275872|NCT01981096|cognitive behavioral therapy|cognitive behavioral therapy
275873|NCT01981096|coping skills training|coping skills training
275874|NCT01981083|Protein-Energy Malnutrition|protein-energy malnutrition
275875|NCT01981083|Chronic Kidney Disease|chronic kidney disease
275876|NCT01981083|Malnutrition-Inflammation Score|malnutrition-inflammation score
275877|NCT01981083|Subjective Global Assessment|subjective global assessment
275878|NCT01981083|Hemodialysis|hemodialysis
275879|NCT01981083|Egg albumin|egg albumin
275880|NCT01981070|parent support|parent support
275881|NCT01981070|mindfulness|mindfulness
275882|NCT01981070|intellectual disability|intellectual disability
275883|NCT01981070|developmental disability|developmental disability
275884|NCT01981070|empowerment|empowerment
275885|NCT01981070|psychological acceptance|psychological acceptance
275886|NCT01981070|parental stress|parental stress
275887|NCT01981070|parental depression|parental depression
275888|NCT01981057|parenteral nutrition|parenteral nutrition
275889|NCT01981057|Numeta|numeta
275890|NCT01981057|prescription software Cato Pan|prescription software cato pan
275891|NCT01981018|Mental imagery, CBT, anxiety, mood instability|mental imagery, cbt, anxiety, mood instability
275892|NCT01980992|Food Allergy|food allergy
275893|NCT01980992|Wheat Allergy|wheat allergy
275894|NCT01980992|Oral Immunotherapy|oral immunotherapy
275895|NCT01980979|congenital heart disease,pulmonary hypertension,prostacyclin|congenital heart disease,pulmonary hypertension,prostacyclin
275896|NCT01980927|Migraine|migraine
275897|NCT01980927|National Upper Cervical Chiropractic Association atlas correction|national upper cervical chiropractic association atlas correction
275898|NCT01980914|hypoglycemia|hypoglycemia
275899|NCT01980914|type 2 diabetes|type 2 diabetes
275900|NCT01980914|insulin glargine|insulin glargine
275901|NCT01980914|cardiac function|cardiac function
275902|NCT01980914|myocardial ischemia|myocardial ischemia
275903|NCT01980914|cardiac rhythm|cardiac rhythm
275904|NCT01980914|autonomic cardiovascular function|autonomic cardiovascular function
275905|NCT01980901|AAA|aaa
275906|NCT01980849|Nadroparin|nadroparin
275907|NCT01980849|venous thromboembolism prophylaxis|venous thromboembolism prophylaxis
275908|NCT01980836|Rheumatoid arthritis|rheumatoid arthritis
275909|NCT01980836|Tocilizumab|tocilizumab
275910|NCT01980836|Seasonal influenza vaccine|seasonal influenza vaccine
275911|NCT01980823|Breast Cancer|breast cancer
275912|NCT01980823|Metformin|metformin
275913|NCT01980823|Atorvastatin|atorvastatin
275914|NCT01980823|Ki-67|ki-67
275915|NCT01980797|Bicuspid aortic valve disease|bicuspid aortic valve disease
275916|NCT01980797|Thoracic aortic disease|thoracic aortic disease
275917|NCT01980797|Genetics|genetics
275918|NCT01980797|Echocardiography|echocardiography
275919|NCT01980797|Cardiac CT|cardiac ct
275920|NCT01980797|Cardiac MRI|cardiac mri
275921|NCT01980784|Spinal Cord Injury|spinal cord injury
275922|NCT01980771|HIV|hiv
275923|NCT01980771|prevention|prevention
275924|NCT01980771|men|men
275925|NCT01980771|African American|african american
275926|NCT01980758|obesity, pediatric obesity, bariatric, bariatric surgery|obesity, pediatric obesity, bariatric, bariatric surgery
275927|NCT01980745|autoimmune hepatitis|autoimmune hepatitis
275928|NCT01980745|recurrence|recurrence
275929|NCT01980745|treatment withdrawal|treatment withdrawal
275930|NCT01980745|chloroquine|chloroquine
275931|NCT01980745|maintenance of remission|maintenance of remission
275932|NCT01980706|Baclofen|baclofen
275933|NCT01980706|Alcohol Dependence|alcohol dependence
275934|NCT01980667|lurbinectedin|lurbinectedin
275935|NCT01980667|PM01183|pm01183
275936|NCT01980667|tumors|tumors
275937|NCT01980667|cancer|cancer
275938|NCT01980667|Pharma Mar|pharma mar
275939|NCT01980654|Pharmacyclics|pharmacyclics
275940|NCT01980654|PCYC|pcyc
275941|NCT01980654|Lymphoma|lymphoma
275942|NCT01980654|Follicular Lymphoma|follicular lymphoma
275943|NCT01980654|FL|fl
275944|NCT01980654|Rituximab|rituximab
275945|NCT01980654|Ibrutinib|ibrutinib
275947|NCT01980654|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
275948|NCT01980654|NHL|nhl
275949|NCT01980654|B-cell Lymphoma|b-cell lymphoma
275950|NCT01980641|Stroke|stroke
275951|NCT01980641|ADL|adl
275952|NCT01980641|mHealth|mhealth
275953|NCT01980641|App|app
275954|NCT01980641|Adherence|adherence
275955|NCT01980641|Home|home
275956|NCT01980641|Environment|environment
275957|NCT01980641|Tool|tool
275958|NCT01980641|Advice|advice
275959|NCT01980641|Smartphone|smartphone
275960|NCT01980628|MZL|mzl
275961|NCT01980628|NHL|nhl
275962|NCT01980628|SMZL|smzl
275963|NCT01980628|NMZL|nmzl
275964|NCT01980628|MALT|malt
275965|NCT01980602|Intermittent claudication|intermittent claudication
275966|NCT01980602|endothelial function|endothelial function
275967|NCT01980602|cardiopulmonary testing|cardiopulmonary testing
275968|NCT01980602|inflammation|inflammation
275969|NCT01980602|muscle architecture|muscle architecture
275970|NCT01980589|multiple myeloma|multiple myeloma
275971|NCT01980576|Pain|pain
275972|NCT01980576|Sensitization|sensitization
275973|NCT01980576|Spondylitis|spondylitis
275974|NCT01980485|smoker|smoker
275975|NCT01980459|Hypomagnesemia, Cellular Mg, Inflammation, Diabetes Mellitus|hypomagnesemia, cellular mg, inflammation, diabetes mellitus
275976|NCT01980446|Coma|coma
275977|NCT01980446|Cardiac arrest|cardiac arrest
275978|NCT01980446|Neurophysiology|neurophysiology
275979|NCT01980446|Auditory evoked potential|auditory evoked potential
275980|NCT01980433|Wilson disease|wilson disease
275981|NCT01980433|Dystonia|dystonia
275982|NCT01980433|Movement Disorders|movement disorders
275983|NCT01980433|Handwriting|handwriting
275984|NCT01980433|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
275985|NCT01980420|Sleeve gastrectomy|sleeve gastrectomy
275986|NCT01980420|Oesogastric junction - GEJ|oesogastric junction - gej
275987|NCT01980420|Dynamic MRI Imaging|dynamic mri imaging
275988|NCT01980407|S-1|s-1
275989|NCT01980407|Oxaliplatin|oxaliplatin
275990|NCT01980407|Leucovorin|leucovorin
275991|NCT01980407|Gastric Cancer|gastric cancer
275992|NCT01980394|esophagus|esophagus
275993|NCT01980394|gastro-esophegeal junction|gastro-esophegeal junction
275994|NCT01980394|cancer|cancer
275995|NCT01980394|tumor seeding|tumor seeding
275996|NCT01980394|free viable tumor cells|free viable tumor cells
275997|NCT01980394|surgery|surgery
275998|NCT01980394|intraluminal tumor cells|intraluminal tumor cells
275999|NCT01980394|stump washout|stump washout
276000|NCT01980355|cancer|cancer
276001|NCT01980355|surgery|surgery
276002|NCT01980355|oncology|oncology
276003|NCT01980355|major|major
276004|NCT01980355|surgical oncology|surgical oncology
276005|NCT01980355|tranexamic acid|tranexamic acid
276006|NCT01980342|Long acting reversible contraception|long acting reversible contraception
276007|NCT01980342|HIV|hiv
276008|NCT01980329|CYP3A5|cyp3a5
276009|NCT01980329|maraviroc|maraviroc
276010|NCT01980329|polymorphism|polymorphism
276011|NCT01980316|Argatroban|argatroban
276012|NCT01980316|Extracranial vertebral Artery Stenting|extracranial vertebral artery stenting
276013|NCT01980316|restenosis|restenosis
276014|NCT01980303|Healthy|healthy
276015|NCT01980303|Japanese|japanese
276016|NCT01980303|Caucasian|caucasian
276017|NCT01980303|Anesthetics|anesthetics
276018|NCT01980303|Intranasal|intranasal
276019|NCT01980303|Esketamine|esketamine
276020|NCT01980303|Pharmacokinetics|pharmacokinetics
276021|NCT01980290|HCV genotype 1|hcv genotype 1
276022|NCT01980290|Liver Fibrosis|liver fibrosis
276023|NCT01980290|ex-People who INject Drugs (ex-PWIDs)|ex-people who inject drugs (ex-pwids)
276024|NCT01980264|BD, AK|bd, ak
276025|NCT01980251|Delirium, electroencephalography, CSD|delirium, electroencephalography, csd
276026|NCT01980238|LAR|lar
276027|NCT01980238|anastomotic leakage|anastomotic leakage
276028|NCT01980238|Cannula ileostomy|cannula ileostomy
276029|NCT01980238|loop ileostomy|loop ileostomy
276030|NCT01980225|vitrification, blastocyst, artificial shrinkage, collapse|vitrification, blastocyst, artificial shrinkage, collapse
276031|NCT01980212|non-small cell lung cancer|non-small cell lung cancer
276032|NCT01980212|thioredoxin reductase|thioredoxin reductase
276033|NCT01980199|visceral leishmaniasis|visceral leishmaniasis
276034|NCT01980199|fexinidazole|fexinidazole
276035|NCT01980199|adults|adults
276036|NCT01980199|proof of concept|proof of concept
276037|NCT01980199|efficacy|efficacy
276038|NCT01980199|safety|safety
276039|NCT01980199|pharmacokinetic|pharmacokinetic
276040|NCT01980199|pharmacodynamic|pharmacodynamic
276041|NCT01980186|transcranial ultrasound|transcranial ultrasound
276042|NCT01980186|autism|autism
276043|NCT01980186|cortical dysplasia|cortical dysplasia
276044|NCT01980186|extra-axial fluid|extra-axial fluid
276045|NCT01980173|Bakri balloon|bakri balloon
276046|NCT01980147|Severe Mental Illness|severe mental illness
276170|NCT01979393|Locally advanced|locally advanced
276047|NCT01980134|adenomatous colorectal lesions|adenomatous colorectal lesions
276048|NCT01980134|colorectal polyps|colorectal polyps
276049|NCT01980134|polyps|polyps
276050|NCT01980121|Respiratory Aspiration|respiratory aspiration
276052|NCT01980121|Ultrasound|ultrasound
276053|NCT01980121|Gastric Contents|gastric contents
276054|NCT01980108|Pregnancy|pregnancy
276055|NCT01980108|Respiratory Aspiration|respiratory aspiration
276056|NCT01980108|Gastric Contents|gastric contents
276057|NCT01980108|Ultrasound|ultrasound
276058|NCT01980095|Helicobacter pylori|helicobacter pylori
276059|NCT01980095|H. pylori|h. pylori
276060|NCT01980095|Dyspepsia|dyspepsia
276061|NCT01980082|head and neck surgery|head and neck surgery
276062|NCT01980082|surgical wound infection|surgical wound infection
276063|NCT01980082|antibiotic prophylaxis|antibiotic prophylaxis
276064|NCT01980069|Sugammadex|sugammadex
276065|NCT01980069|Neostigmine|neostigmine
276066|NCT01980069|Surgery|surgery
276067|NCT01980056|INT-2 or high-risk MDS|int-2 or high-risk mds
276068|NCT01980017|Diabetes Type 2 Mellitus|diabetes type 2 mellitus
276069|NCT01980017|Ottawa Model for Smoking Cessation|ottawa model for smoking cessation
276070|NCT01980017|Diabetes Education Programs|diabetes education programs
276071|NCT01979965|Mitral Regurgitation|mitral regurgitation
276072|NCT01979965|cardiac resynchronization therapy|cardiac resynchronization therapy
276073|NCT01979965|ranolazine|ranolazine
276074|NCT01979965|maximal medical therapy|maximal medical therapy
276075|NCT01979965|ischemic cardiomyopathy|ischemic cardiomyopathy
276076|NCT01979913|Primary Open Angle Glaucoma|primary open angle glaucoma
276077|NCT01979913|Ocular Hypertension|ocular hypertension
276078|NCT01979913|Tafluprost|tafluprost
276079|NCT01979913|Saflutan|saflutan
276080|NCT01979913|Intraocular pressure|intraocular pressure
276081|NCT01979913|Preservative free|preservative free
276082|NCT01979913|Single dose unit|single dose unit
276083|NCT01979900|TB Infection|tb infection
276084|NCT01979900|Lesion Degree|lesion degree
276085|NCT01979900|Bacteriology Indicators|bacteriology indicators
276086|NCT01979900|Cavity|cavity
276087|NCT01979900|Humoral Immunity|humoral immunity
276088|NCT01979900|Cellular Immunologic Response|cellular immunologic response
276089|NCT01979861|Endometrial ablation with vapor|endometrial ablation with vapor
276090|NCT01979848|continence outcomes|continence outcomes
276091|NCT01979848|sexual function|sexual function
276092|NCT01979848|Robotic Assisted Radical Prostatectomy|robotic assisted radical prostatectomy
276093|NCT01979848|thermal imaging|thermal imaging
276094|NCT01979848|localized hypothermia|localized hypothermia
276095|NCT01979835|intrauterine device, contraception|intrauterine device, contraception
276096|NCT01979822|medication pump, complications, safety observation|medication pump, complications, safety observation
276097|NCT01979809|Dietary change|dietary change
276098|NCT01979809|Young adult|young adult
276099|NCT01979809|Prevention|prevention
276100|NCT01979809|Web-based intervention|web-based intervention
276101|NCT01979809|eCoaching|ecoaching
276102|NCT01979796|Addiction, Schizophrenia, Electronic cigarettes|addiction, schizophrenia, electronic cigarettes
276103|NCT01979770|Adolescent|adolescent
276104|NCT01979770|Nutritional status|nutritional status
276105|NCT01979770|Body composition|body composition
276106|NCT01979770|Biochemical status|biochemical status
276107|NCT01979744|Intravenous ultrasound,|intravenous ultrasound,
276108|NCT01979744|third generation drug-eluting stent|third generation drug-eluting stent
276109|NCT01979731|Occupational health|occupational health
276110|NCT01979731|Ergonomics|ergonomics
276111|NCT01979731|Environments|environments
276112|NCT01979731|Prevention and Control|prevention and control
276114|NCT01979692|The study will|the study will
276115|NCT01979692|focus on using|focus on using
276116|NCT01979692|CLM to|clm to
276117|NCT01979692|distinguish between|distinguish between
276118|NCT01979692|viable and|viable and
276119|NCT01979692|necrotic tissue|necrotic tissue
276120|NCT01979692|at TTNB in real time|at ttnb in real time
276121|NCT01979666|Knee AVN, Nitrates|knee avn, nitrates
276122|NCT01979640|bronchial cuff|bronchial cuff
276123|NCT01979640|double lumen tube|double lumen tube
276124|NCT01979640|blood tight seal|blood tight seal
276125|NCT01979627|transulnar approach|transulnar approach
276126|NCT01979627|transradial approach|transradial approach
276127|NCT01979627|angiography|angiography
276128|NCT01979627|angioplasty|angioplasty
276129|NCT01979614|coronary artery disease|coronary artery disease
276130|NCT01979601|hypercholesterolemia,|hypercholesterolemia,
276131|NCT01979601|LGT209,|lgt209,
276132|NCT01979601|PCSK9,|pcsk9,
276133|NCT01979601|LDL-C|ldl-c
276134|NCT01979575|Nexfin|nexfin
276135|NCT01979575|Flotrac|flotrac
276136|NCT01979575|Esophageal|esophageal
276137|NCT01979575|Cardiac output|cardiac output
276138|NCT01979562|Overuse injury|overuse injury
276139|NCT01979562|Femur|femur
276140|NCT01979562|Tibia|tibia
276141|NCT01979562|Running|running
276142|NCT01979562|Prevention|prevention
276143|NCT01979549|Adverse events|adverse events
276144|NCT01979549|Upper gastrointestinal endoscopy|upper gastrointestinal endoscopy
276145|NCT01979549|Sedation|sedation
276146|NCT01979484|bioavailability|bioavailability
276147|NCT01979471|Cardiovascular risk reduction|cardiovascular risk reduction
276148|NCT01979471|Diabetes|diabetes
276149|NCT01979471|Chronic Kidney Disease|chronic kidney disease
276150|NCT01979471|Atherosclerotic vascular disease|atherosclerotic vascular disease
276151|NCT01979471|Community Pharmacist|community pharmacist
276152|NCT01979471|Randomized controlled trial|randomized controlled trial
276153|NCT01979471|[eGFR <60 ml/min/1.73m2 and/or (ACR >= 30 mg/mmol or two consecutive ACR tests which are >= 3 mg/mmol)]|[egfr <60 ml/min/1.73m2 and/or (acr >= 30 mg/mmol or two consecutive acr tests which are >= 3 mg/mmol)]
276154|NCT01979458|Colonoscopy|colonoscopy
276155|NCT01979445|CAD|cad
276156|NCT01979432|Alzheimer, cognitive diseases, Ankle-to-brachial index|alzheimer, cognitive diseases, ankle-to-brachial index
276157|NCT01979419|mild cognitive impairment|mild cognitive impairment
276158|NCT01979419|Alzheimer's disease|alzheimer's disease
276159|NCT01979419|subcortical Vascular Dementia|subcortical vascular dementia
276160|NCT01979419|amyloid|amyloid
276161|NCT01979419|plaques|plaques
276162|NCT01979419|neuroimaging|neuroimaging
276163|NCT01979419|biomarkers|biomarkers
276164|NCT01979419|cognition disorder|cognition disorder
276165|NCT01979419|early detection|early detection
276166|NCT01979419|pre-dementia|pre-dementia
276167|NCT01979419|dementia|dementia
276168|NCT01979419|vascular MCI|vascular mci
276169|NCT01979406|Anthrax vaccine|anthrax vaccine
276171|NCT01979393|stage III|stage iii
276172|NCT01979393|stage IV|stage iv
276173|NCT01979393|residual disease after primary surgery|residual disease after primary surgery
276174|NCT01979393|newly diagnosed HGUS|newly diagnosed hgus
276175|NCT01979393|Metastatic|metastatic
276177|NCT01979380|Anti-obesity Agents|anti-obesity agents
276178|NCT01979354|spinal morphine|spinal morphine
276179|NCT01979354|VATs lobectomy|vats lobectomy
276180|NCT01979341|dual trigger|dual trigger
276181|NCT01979341|hCG|hcg
276182|NCT01979341|GnRH agonist|gnrh agonist
276183|NCT01979341|ICSI|icsi
276184|NCT01979341|pregnancy|pregnancy
276185|NCT01979341|OHSS|ohss
276186|NCT01979328|Deep Vein Thrombosis|deep vein thrombosis
276187|NCT01979302|Geriatric Depression|geriatric depression
276188|NCT01979302|Depression Care Management|depression care management
276189|NCT01979302|home healthcare|home healthcare
276190|NCT01979302|nurse training intervention|nurse training intervention
276191|NCT01979289|Executive Dysfunction|executive dysfunction
276192|NCT01979289|Cognitive Remediation|cognitive remediation
276193|NCT01979289|Geriatric|geriatric
276194|NCT01979289|Depression|depression
276195|NCT01979250|endothelial keratoplasty|endothelial keratoplasty
276196|NCT01979250|Descemet's stripping automated endothelial keratoplasty|descemet's stripping automated endothelial keratoplasty
276197|NCT01979250|lamellar keratoplasty|lamellar keratoplasty
276198|NCT01979224|educational intervention, Asthma control, asthma knowledge|educational intervention, asthma control, asthma knowledge
276199|NCT01979211|head and neck cancer|head and neck cancer
276200|NCT01979198|burst fracture, kyphotic angle, surgical outcome|burst fracture, kyphotic angle, surgical outcome
276201|NCT01979172|LASIK|lasik
276202|NCT01979172|Intraocular lens|intraocular lens
276203|NCT01979172|Biometry|biometry
276204|NCT01979172|IOL master|iol master
276205|NCT01979159|aphasia|aphasia
276206|NCT01979159|apraxia of speech|apraxia of speech
276207|NCT01979159|outcomes|outcomes
276208|NCT01979146|Cancer|cancer
276209|NCT01979120|Sleep-disordered breathing|sleep-disordered breathing
276210|NCT01979120|Chronic heart failure|chronic heart failure
276211|NCT01979120|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
276212|NCT01979120|Apnea-Hypopnea-Index|apnea-hypopnea-index
276213|NCT01979120|Portable Polygraphy Monitoring|portable polygraphy monitoring
276214|NCT01979120|Polysomnography|polysomnography
276215|NCT01979107|Health behavior|health behavior
276216|NCT01979107|Chronic disease|chronic disease
276217|NCT01979107|Proactive action|proactive action
276218|NCT01979107|General practitioner|general practitioner
276219|NCT01979107|Preventive health check|preventive health check
276220|NCT01979107|Social inequality in health|social inequality in health
276221|NCT01979107|Randomised controlled trial|randomised controlled trial
276222|NCT01979055|asthma|asthma
276223|NCT01979055|older adults|older adults
276224|NCT01979055|elderly|elderly
276225|NCT01979055|behavior|behavior
276226|NCT01979042|renal colic|renal colic
276227|NCT01979042|acute renal failure|acute renal failure
276228|NCT01979042|Neutrophil gelatinase associated lipocalin|neutrophil gelatinase associated lipocalin
276229|NCT01978977|mBC|mbc
276230|NCT01978977|HER2 negative|her2 negative
276231|NCT01978977|Chemotherapy|chemotherapy
276232|NCT01978977|Anti-angiogenic agent|anti-angiogenic agent
276233|NCT01978977|Bevacizumab|bevacizumab
276234|NCT01978977|1st Line|1st line
276235|NCT01978964|ONT-10|ont-10
276236|NCT01978964|MUC1|muc1
276237|NCT01978964|Vaccine|vaccine
276238|NCT01978964|Phase 1b|phase 1b
276239|NCT01978964|Solid tumors|solid tumors
276240|NCT01978964|Maintenance therapy|maintenance therapy
276241|NCT01978951|Chronic Kidney Disease|chronic kidney disease
276242|NCT01978951|Integrated Chronic Kidney Disease Care|integrated chronic kidney disease care
276243|NCT01978951|Village Health Volunteers|village health volunteers
276244|NCT01978925|Pharmaceutical care|pharmaceutical care
276245|NCT01978925|Medication Adherence|medication adherence
276246|NCT01978925|Blood Pressure|blood pressure
276247|NCT01978925|Diabetes|diabetes
276248|NCT01978925|Emergency|emergency
276249|NCT01978886|Diabetes Mellitus|diabetes mellitus
276250|NCT01978886|frozen shoulder|frozen shoulder
276251|NCT01978886|adhesive capsulitis|adhesive capsulitis
276252|NCT01978860|CABG Coronary artery bypass grafting|cabg coronary artery bypass grafting
276253|NCT01978860|CTO Chronic Total Occlusion|cto chronic total occlusion
276254|NCT01978860|PCI Percutaneous coronary intervention|pci percutaneous coronary intervention
276255|NCT01978860|MACE Major adverse cardiovascular event(s)|mace major adverse cardiovascular event(s)
276256|NCT01978860|MI Myocardial infarction|mi myocardial infarction
276257|NCT01978834|Osteoporosis, diagnosis, ultrasound|osteoporosis, diagnosis, ultrasound
276258|NCT01978821|Cerebral Palsy|cerebral palsy
276259|NCT01978821|autologous bone marrow mononuclear cells|autologous bone marrow mononuclear cells
276260|NCT01978821|stem cell therapy|stem cell therapy
276261|NCT01978795|concussion|concussion
276262|NCT01978795|high school|high school
276263|NCT01978795|web-based training|web-based training
276264|NCT01978795|school-based health care|school-based health care
276265|NCT01978782|raltegravir|raltegravir
276266|NCT01978782|citalopram|citalopram
276267|NCT01978782|pharmacokinetics|pharmacokinetics
276268|NCT01978782|drug-drug interaction|drug-drug interaction
276269|NCT01978756|Outpatient clinic|outpatient clinic
276270|NCT01978756|Breast cancer|breast cancer
276271|NCT01978756|Late toxicity|late toxicity
276272|NCT01978743|HIV|hiv
276273|NCT01978743|HIV-associated neurocognitive disorder|hiv-associated neurocognitive disorder
276274|NCT01978743|neurotoxicity|neurotoxicity
276275|NCT01978730|vascular dementia|vascular dementia
276276|NCT01978730|cognition|cognition
276277|NCT01978730|stroke|stroke
276278|NCT01978717|Anesthesia|anesthesia
276279|NCT01978717|T-helper|t-helper
276280|NCT01978717|MDSCs|mdscs
276281|NCT01978717|Colorectal cancer|colorectal cancer
276282|NCT01978717|Fast track|fast track
276283|NCT01978691|Obesity|obesity
276284|NCT01978691|Blood glucose|blood glucose
276285|NCT01978691|Waist circumference|waist circumference
276286|NCT01978691|Lipid metabolism|lipid metabolism
276287|NCT01978691|Probiotics|probiotics
276288|NCT01978691|Prebiotics|prebiotics
276289|NCT01978691|Dietary supplements|dietary supplements
276290|NCT01978691|Endotoxemia|endotoxemia
276291|NCT01978665|COPD exercise inflammation prednisone|copd exercise inflammation prednisone
276292|NCT01978626|Insomnia|insomnia
276293|NCT01978626|Comorbid insomnia|comorbid insomnia
276294|NCT01978626|Cognitive Behavioral Therapy|cognitive behavioral therapy
276295|NCT01978600|Open-Angle Glaucoma|open-angle glaucoma
276296|NCT01978600|Ocular Hypertension|ocular hypertension
276297|NCT01978600|Simbrinza™|simbrinza™
276298|NCT01978600|Intraocular Pressure|intraocular pressure
276299|NCT01978587|End-stage Renal Disease|end-stage renal disease
276300|NCT01978587|Hemodialysis|hemodialysis
276301|NCT01978587|Pharmacokinetics|pharmacokinetics
276302|NCT01978574|Cognitive reserve|cognitive reserve
276303|NCT01978574|intellectual enrichment|intellectual enrichment
276304|NCT01978548|Alzheimer Disease|alzheimer disease
276305|NCT01978548|Prodromal Alzheimer Disease|prodromal alzheimer disease
276306|NCT01978548|Safety|safety
276307|NCT01978548|Tolerability|tolerability
276308|NCT01978548|Pharmacokinetic|pharmacokinetic
276309|NCT01978548|Proof of Mechanism|proof of mechanism
276310|NCT01978548|JNJ-54861911|jnj-54861911
276311|NCT01978535|POTS|pots
276312|NCT01978522|Randomised trial|randomised trial
276313|NCT01978522|postal questionnaires|postal questionnaires
276314|NCT01978522|return rates|return rates
276315|NCT01978509|Colonoscopy|colonoscopy
276316|NCT01978483|Humans|humans
276317|NCT01978483|Adult|adult
276318|NCT01978483|skin|skin
276319|NCT01978483|metabolism|metabolism
276320|NCT01978483|radiation effects|radiation effects
276321|NCT01978483|Ultraviolet Rays|ultraviolet rays
276322|NCT01978483|RANKL|rankl
276323|NCT01978483|RANK Ligand|rank ligand
276324|NCT01978483|denosumab|denosumab
276325|NCT01978483|diphenylcyclopropenone|diphenylcyclopropenone
276326|NCT01978483|diphencyprone|diphencyprone
276327|NCT01978483|immunology|immunology
276328|NCT01978483|immunosuppression|immunosuppression
276329|NCT01978483|Antibodies, Monoclonal|antibodies, monoclonal
276330|NCT01978483|Dermatitis, Allergic Contact|dermatitis, allergic contact
276331|NCT01978483|Hypersensitivity, Delayed|hypersensitivity, delayed
276332|NCT01978470|epilepsy|epilepsy
276333|NCT01978470|drug resistent epilepsy|drug resistent epilepsy
276334|NCT01978470|partial onset seizures|partial onset seizures
276335|NCT01978470|trigeminal nerve stimulation|trigeminal nerve stimulation
276336|NCT01978470|neuromodulation|neuromodulation
276337|NCT01978444|D2 lymphadenectomy|d2 lymphadenectomy
276338|NCT01978444|Complete Mesogastrium Excision|complete mesogastrium excision
276339|NCT01978418|Lung fluid|lung fluid
276340|NCT01978418|Postnatal adaptation|postnatal adaptation
276341|NCT01978418|Salbutamol|salbutamol
276342|NCT01978418|Albuterol|albuterol
276343|NCT01978418|Epithelial Sodium Channel|epithelial sodium channel
276344|NCT01978405|Type 2 diabetes|type 2 diabetes
276345|NCT01978405|Nephropathy|nephropathy
276346|NCT01978405|Contrast medium|contrast medium
276347|NCT01978405|Alpha lipoic acid|alpha lipoic acid
276348|NCT01978392|disability|disability
276349|NCT01978392|self-management|self-management
276350|NCT01978392|chronic illness|chronic illness
276351|NCT01978392|chronic pain|chronic pain
276352|NCT01978392|occupation|occupation
276353|NCT01978392|> 6 months|> 6 months
276354|NCT01978379|General Anesthesia|general anesthesia
276355|NCT01978379|Nociception Level|nociception level
276356|NCT01978366|Duchenne muscular dystrophy|duchenne muscular dystrophy
276357|NCT01978366|halofuginone hydrobromide|halofuginone hydrobromide
276358|NCT01978366|anti-fibrotic|anti-fibrotic
276359|NCT01978366|anti-inflammatory|anti-inflammatory
276360|NCT01978366|muscle regeneration|muscle regeneration
276361|NCT01978366|protein synthesis inhibitor|protein synthesis inhibitor
276362|NCT01978353|Mild cognitive impairment|mild cognitive impairment
276363|NCT01978353|Dementia|dementia
276364|NCT01978353|Alzheimer's disease|alzheimer's disease
276365|NCT01978353|Memory Training|memory training
276366|NCT01978353|Cognitive Training|cognitive training
276367|NCT01978353|Cognitive Rehabilitation|cognitive rehabilitation
276368|NCT01978353|Neuropsychological Rehabilitation|neuropsychological rehabilitation
276369|NCT01978327|Alzheimer's disease|alzheimer's disease
276370|NCT01978327|GSK2647544|gsk2647544
276371|NCT01978327|drug-drug interaction|drug-drug interaction
276372|NCT01978327|healthy subjects|healthy subjects
276373|NCT01978327|Lp-PLA2|lp-pla2
276374|NCT01978327|simvastatin|simvastatin
276375|NCT01978314|Chronic Kidney Disease|chronic kidney disease
276376|NCT01978314|Acute Kidney Injury|acute kidney injury
276377|NCT01978314|AKI|aki
276378|NCT01978314|CKD|ckd
276379|NCT01978314|Plasma Volume|plasma volume
276380|NCT01978314|GFR|gfr
276381|NCT01978314|Glomerular Filtration Rate|glomerular filtration rate
276382|NCT01978314|Blood volume|blood volume
276383|NCT01978314|mGFR|mgfr
276384|NCT01978314|measured GFR|measured gfr
276385|NCT01978314|kidney biomarker|kidney biomarker
276386|NCT01978314|renal disease|renal disease
276387|NCT01978314|renal biomarker|renal biomarker
276388|NCT01978314|Renal function|renal function
276389|NCT01978314|kidney function|kidney function
276390|NCT01978314|organ function|organ function
276391|NCT01978314|kidney monitor|kidney monitor
276392|NCT01978314|kidney device|kidney device
276393|NCT01978301|triamcinolone acetonide (TAC)|triamcinolone acetonide (tac)
276394|NCT01978301|heavy water|heavy water
276395|NCT01978301|fibrosis|fibrosis
276396|NCT01978301|deuterium|deuterium
276397|NCT01978301|collagen degradation|collagen degradation
276398|NCT01978301|collagen synthesis|collagen synthesis
276399|NCT01978301|Keloid|keloid
276400|NCT01978301|patient|patient
276401|NCT01978275|total knee arthroplasty|total knee arthroplasty
276402|NCT01978275|lumbar plexus block|lumbar plexus block
276403|NCT01978275|stimulating catheters|stimulating catheters
276404|NCT01978275|peripheral nerve blocks|peripheral nerve blocks
276405|NCT01978262|influenza vaccine|influenza vaccine
276406|NCT01978262|cytokines|cytokines
276407|NCT01978262|hormones|hormones
276408|NCT01978262|progesterone|progesterone
276409|NCT01978249|Colorectal cancer|colorectal cancer
276410|NCT01978249|Primary tumor resection|primary tumor resection
276411|NCT01978249|Chemotherapy|chemotherapy
276412|NCT01978249|Overall survival|overall survival
276413|NCT01978249|Quality of life|quality of life
276414|NCT01978236|BRAF V600E mutation|braf v600e mutation
276415|NCT01978236|brain metastases|brain metastases
276416|NCT01978236|BRAF V600K mutation|braf v600k mutation
276417|NCT01978236|Metastatic melanoma|metastatic melanoma
276418|NCT01978236|BRAF inhibitor|braf inhibitor
276419|NCT01978236|brain neoplasms|brain neoplasms
276420|NCT01978236|GSK2118436|gsk2118436
276421|NCT01978223|Rotarix™|rotarix™
276422|NCT01978223|Case-control|case-control
276423|NCT01978223|Venezuela|venezuela
276424|NCT01978223|Vaccine effectiveness|vaccine effectiveness
276425|NCT01978223|Rotavirus Severe Gastroenteritis|rotavirus severe gastroenteritis
276426|NCT01978223|Children|children
276427|NCT01978223|Hospitalised|hospitalised
276428|NCT01978210|autism|autism
276429|NCT01978210|enuresis|enuresis
276430|NCT01978210|toilet-training|toilet-training
276431|NCT01978184|Pancreatic Cancer, resectable adenocarcinoma of the pancreas|pancreatic cancer, resectable adenocarcinoma of the pancreas
276432|NCT01978171|breast neoplasms|breast neoplasms
276433|NCT01978171|everolimus|everolimus
276434|NCT01978171|interstitial lung disease|interstitial lung disease
276435|NCT01978171|pneumonitis|pneumonitis
276436|NCT01978158|Oxygen|oxygen
276437|NCT01978158|Hypoxia|hypoxia
276438|NCT01978158|Hyperoxia|hyperoxia
276439|NCT01978158|Inflammation|inflammation
276440|NCT01978158|Innate immunity|innate immunity
276441|NCT01978145|efficacy|efficacy
276442|NCT01978145|tolerability|tolerability
276443|NCT01978145|capsule-based inhaler|capsule-based inhaler
276444|NCT01978145|quality of life|quality of life
276445|NCT01978145|safety|safety
276446|NCT01978145|multi-dose inhaler|multi-dose inhaler
276447|NCT01978145|fluticasone propionate/salmeterol (FSC) 250/50 mcg|fluticasone propionate/salmeterol (fsc) 250/50 mcg
276448|NCT01978145|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
276449|NCT01978132|primary hyperaldosteronism|primary hyperaldosteronism
276450|NCT01978132|primary hypertension|primary hypertension
276451|NCT01978132|forearm ischemia-reperfusion|forearm ischemia-reperfusion
276452|NCT01978132|(reduction) in brachial artery FMD|(reduction) in brachial artery fmd
276453|NCT01978132|endothelial ischemia-reperfusion injury|endothelial ischemia-reperfusion injury
276454|NCT01978119|Multi-Dose Inhaler|multi-dose inhaler
276455|NCT01978119|safety|safety
276456|NCT01978119|Asthma|asthma
276457|NCT01978119|efficacy|efficacy
276458|NCT01978119|pharmacodynamics|pharmacodynamics
276459|NCT01978119|fluticasone propionate/salmeterol (FSC) 250/50 mcg|fluticasone propionate/salmeterol (fsc) 250/50 mcg
276460|NCT01978119|tolerability|tolerability
276461|NCT01978119|Capsule-Based Inhaler|capsule-based inhaler
276462|NCT01978106|toric calculator|toric calculator
276463|NCT01978106|toric intraocular lens power|toric intraocular lens power
276464|NCT01978106|Acrysof|acrysof
276465|NCT01978106|Tecnis|tecnis
276466|NCT01978106|iTrace|itrace
276467|NCT01978093|Conjugate|conjugate
276468|NCT01978093|Immunogenicity|immunogenicity
276469|NCT01978093|Hib-MenCY-TT vaccine|hib-mency-tt vaccine
276470|NCT01978093|Haemophilus type b|haemophilus type b
276471|NCT01978093|Safety|safety
276472|NCT01978093|Reactogenicity|reactogenicity
276473|NCT01978067|Uterine Scar From Previous Cesarean Delivery|uterine scar from previous cesarean delivery
276474|NCT01978067|previous caesarean scar deficiency|previous caesarean scar deficiency
276475|NCT01978067|transvaginal resection|transvaginal resection
276476|NCT01978067|quality of life|quality of life
276477|NCT01978067|sexual activity|sexual activity
276478|NCT01978054|Information Dissemination|information dissemination
276479|NCT01978054|Information Sharing|information sharing
276480|NCT01978054|Innovation Diffusion|innovation diffusion
276481|NCT01978054|Public Health Practice|public health practice
276482|NCT01978054|Evidence-Based Public Health|evidence-based public health
276483|NCT01978054|Chronic Disease Prevention|chronic disease prevention
276484|NCT01978054|Cancer Prevention and Control|cancer prevention and control
276485|NCT01978041|pharmacokinetics, saliva, plasma, fluoride, dental fluorosis, dental caries|pharmacokinetics, saliva, plasma, fluoride, dental fluorosis, dental caries
276486|NCT01978028|heart failure|heart failure
276487|NCT01978015|primary open angle glaucoma|primary open angle glaucoma
276488|NCT01978015|timolol|timolol
276489|NCT01978015|prostaglandin analogues|prostaglandin analogues
276490|NCT01977976|Endometrial injury|endometrial injury
276491|NCT01977976|Pipelle|pipelle
276492|NCT01977976|Implantation|implantation
276493|NCT01977976|Ongoing pregnancy rate|ongoing pregnancy rate
276495|NCT01977950|Undernutrition, Nutritional risk, NRS2002, nutritional care practices, hospital, elderly patients, nursing students|undernutrition, nutritional risk, nrs2002, nutritional care practices, hospital, elderly patients, nursing students
276496|NCT01977937|gabapentin|gabapentin
276497|NCT01977937|Analgesic Drugs|analgesic drugs
276498|NCT01977937|Analgesics, Nonopioid|analgesics, nonopioid
276499|NCT01977924|sleep apnea|sleep apnea
276500|NCT01977924|polyphenols|polyphenols
276501|NCT01977924|endothelial function|endothelial function
276502|NCT01977911|Airway reconstruction|airway reconstruction
276503|NCT01977911|Regenerative medicine|regenerative medicine
276504|NCT01977898|Postdural puncture headache|postdural puncture headache
276505|NCT01977898|Intrathecal morphine|intrathecal morphine
276506|NCT01977898|Intrathecal catheter|intrathecal catheter
276507|NCT01977898|Headache|headache
276508|NCT01977898|Labor and delivery|labor and delivery
276509|NCT01977898|Unintentional dural puncture|unintentional dural puncture
276510|NCT01977885|epigenetics|epigenetics
276511|NCT01977885|obesity|obesity
276512|NCT01977885|overweight|overweight
276513|NCT01977885|high protein diet|high protein diet
276514|NCT01977885|exercise|exercise
276515|NCT01977885|post menopausal women|post menopausal women
276516|NCT01977872|Arthritis|arthritis
276517|NCT01977872|Physical Activity|physical activity
276518|NCT01977872|Diet|diet
276519|NCT01977859|B-type Natriuretic Peptide|b-type natriuretic peptide
276520|NCT01977859|Metabolism|metabolism
276521|NCT01977859|Insulin infusion|insulin infusion
276522|NCT01977846|genetic testing|genetic testing
276523|NCT01977846|ABCA4|abca4
276524|NCT01977846|Stargardt|stargardt
276525|NCT01977846|retina|retina
276526|NCT01977846|retinal degeneration|retinal degeneration
276527|NCT01977833|BTdiet|btdiet
276528|NCT01977833|Dtdiet|dtdiet
276529|NCT01977833|High Calorie Breakfast diet (BTdiet)|high calorie breakfast diet (btdiet)
276530|NCT01977833|High Calorie Dinner diet (DTdiet)|high calorie dinner diet (dtdiet)
276531|NCT01977820|Phenylketonuria|phenylketonuria
276532|NCT01977820|Sapropterin|sapropterin
276533|NCT01977820|Placebo|placebo
276534|NCT01977820|Cognitive Abilities|cognitive abilities
276535|NCT01977820|Kuvan®|kuvan®
276536|NCT01977807|Myopia|myopia
276537|NCT01977807|Hyperopia|hyperopia
276538|NCT01977807|Presbyopia|presbyopia
276539|NCT01977807|Supracor|supracor
276540|NCT01977807|Zyoptix|zyoptix
276541|NCT01977807|Proscan|proscan
276542|NCT01977807|LASIK|lasik
276543|NCT01977794|Bisoprolol|bisoprolol
276544|NCT01977794|Amlodipine|amlodipine
276741|NCT01977053|phone calls|phone calls
276545|NCT01977794|Fixed dose combination (FDC)|fixed dose combination (fdc)
276546|NCT01977794|Systolic Blood Pressure (SBP)|systolic blood pressure (sbp)
276547|NCT01977794|Diastolic Blood Pressure (DBP)|diastolic blood pressure (dbp)
276548|NCT01977781|GVHD|gvhd
276549|NCT01977781|Ocular GVHD|ocular gvhd
276550|NCT01977781|Tacrolimus|tacrolimus
276551|NCT01977781|Methylprednisolone|methylprednisolone
276552|NCT01977768|M. vaccae|m. vaccae
276553|NCT01977768|TB|tb
276554|NCT01977768|MDR-TB|mdr-tb
276555|NCT01977768|V7-immunitor|v7-immunitor
276556|NCT01977729|anxiety|anxiety
276557|NCT01977716|Peritonitis|peritonitis
276558|NCT01977716|loss of residual renal function|loss of residual renal function
276559|NCT01977716|technique survival|technique survival
276560|NCT01977703|Heart Failure|heart failure
276561|NCT01977703|Advanced Heart Failure|advanced heart failure
276562|NCT01977703|LVAD|lvad
276563|NCT01977703|Left Ventricular Assist Device|left ventricular assist device
276564|NCT01977703|Heart-Assist Devices|heart-assist devices
276565|NCT01977664|oocyte maturation failure|oocyte maturation failure
276566|NCT01977664|Maturation induction in vitro|maturation induction in vitro
276567|NCT01977651|enzalutamide|enzalutamide
276568|NCT01977651|Xtandi|xtandi
276569|NCT01977651|seizure|seizure
276570|NCT01977651|Central Nervous System|central nervous system
276571|NCT01977651|MDV3100|mdv3100
276572|NCT01977651|metastatic castration-resistant prostate cancer (mCRPC)|metastatic castration-resistant prostate cancer (mcrpc)
276573|NCT01977638|Advanced solid tumours|advanced solid tumours
276574|NCT01977638|Lymphoma|lymphoma
276575|NCT01977638|Myeloma|myeloma
276576|NCT01977625|Menopause|menopause
276577|NCT01977625|fMRI|fmri
276578|NCT01977625|Vyvanse|vyvanse
276579|NCT01977612|Wound infection|wound infection
276580|NCT01977612|Wound separation|wound separation
276581|NCT01977612|Skin staples|skin staples
276582|NCT01977612|Subcuticular suture|subcuticular suture
276583|NCT01977599|Text message reminders|text message reminders
276584|NCT01977599|Short Message Service (SMS) Reminders|short message service (sms) reminders
276585|NCT01977599|Social Health Inequalities|social health inequalities
276586|NCT01977599|Breast Screening|breast screening
276587|NCT01977599|Screening|screening
276588|NCT01977599|Public Health Intervention|public health intervention
276589|NCT01977599|Missed Appointments|missed appointments
276590|NCT01977599|Non-attendance|non-attendance
276591|NCT01977586|Clear cell renal cell carcinoma|clear cell renal cell carcinoma
276592|NCT01977586|Stage IV renal cell carcinoma|stage iv renal cell carcinoma
276593|NCT01977586|Anti-angiogenic therapy|anti-angiogenic therapy
276594|NCT01977586|Response assessment|response assessment
276595|NCT01977586|Magnetic resonance imaging|magnetic resonance imaging
276596|NCT01977573|Prolyl hydroxylase inhibitor|prolyl hydroxylase inhibitor
276597|NCT01977573|pharmacokinetics|pharmacokinetics
276598|NCT01977573|GSK1278863|gsk1278863
276599|NCT01977573|Anemia|anemia
276600|NCT01977573|hemoglobin|hemoglobin
276601|NCT01977573|erythropoiesis stimulating agents|erythropoiesis stimulating agents
276602|NCT01977573|Chronic kidney disease|chronic kidney disease
276603|NCT01977560|Type 2 diabetes|type 2 diabetes
276604|NCT01977560|Exercise|exercise
276605|NCT01977560|High protein|high protein
276606|NCT01977547|Red blood cell transfusions|red blood cell transfusions
276607|NCT01977547|Red blood cell storage age|red blood cell storage age
276608|NCT01977547|Pediatrics|pediatrics
276609|NCT01977547|Critical Care|critical care
276610|NCT01977534|Bioabsorbable|bioabsorbable
276611|NCT01977534|Coronary Stent|coronary stent
276612|NCT01977534|Everolimus|everolimus
276613|NCT01977534|drug eluting stents|drug eluting stents
276614|NCT01977534|stents|stents
276615|NCT01977534|angioplasty|angioplasty
276616|NCT01977534|coronary artery disease|coronary artery disease
276617|NCT01977534|total coronary occlusion|total coronary occlusion
276618|NCT01977534|coronary artery restenosis|coronary artery restenosis
276619|NCT01977534|stent thrombosis|stent thrombosis
276620|NCT01977534|vascular disease|vascular disease
276621|NCT01977534|myocardial ischemia|myocardial ischemia
276622|NCT01977534|coronary artery stenosis|coronary artery stenosis
276623|NCT01977534|CAD|cad
276624|NCT01977534|CAOD|caod
276625|NCT01977508|Vascular access grafts|vascular access grafts
276626|NCT01977508|Haemodialysis|haemodialysis
276627|NCT01977495|Diabetes|diabetes
276628|NCT01977495|Enrollment methods|enrollment methods
276629|NCT01977495|Behavioral Economic Intervention|behavioral economic intervention
276630|NCT01977495|Opt-in Enrollment|opt-in enrollment
276631|NCT01977495|Opt-out Enrollment|opt-out enrollment
276632|NCT01977495|lottery|lottery
276633|NCT01977495|financial incentives|financial incentives
276634|NCT01977482|hemoglobin|hemoglobin
276635|NCT01977482|recombinant human erythropoietin|recombinant human erythropoietin
276636|NCT01977482|Chronic kidney disease|chronic kidney disease
276637|NCT01977482|hemodialysis|hemodialysis
276638|NCT01977482|pharmacokinetics|pharmacokinetics
276639|NCT01977482|erythropoiesis stimulating agents|erythropoiesis stimulating agents
276640|NCT01977482|Anemia|anemia
276641|NCT01977482|GSK1278863|gsk1278863
276740|NCT01977053|adjuvant chemotherapy|adjuvant chemotherapy
276642|NCT01977469|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
276643|NCT01977469|Activities of Daily Living|activities of daily living
276644|NCT01977469|Mortality|mortality
276645|NCT01977469|Strength Training|strength training
276646|NCT01977456|acute ischemic stroke|acute ischemic stroke
276647|NCT01977456|stroke|stroke
276648|NCT01977456|rt-PA, thrombolytic|rt-pa, thrombolytic
276649|NCT01977456|t-PA|t-pa
276650|NCT01977456|recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
276651|NCT01977456|Activase|activase
276652|NCT01977456|eptifibatide|eptifibatide
276653|NCT01977456|Integrilin|integrilin
276654|NCT01977456|fibrinolytic agents|fibrinolytic agents
276655|NCT01977456|clot dissolving|clot dissolving
276656|NCT01977456|blood clot|blood clot
276657|NCT01977430|Residual renal function|residual renal function
276658|NCT01977430|Combined thiazide-furosemide therapy|combined thiazide-furosemide therapy
276659|NCT01977430|Haemodialysis|haemodialysis
276660|NCT01977417|Endothelial Function|endothelial function
276661|NCT01977417|Arterial Stiffness|arterial stiffness
276662|NCT01977417|Inflammation|inflammation
276663|NCT01977417|Muscle Sympathetic Nervous System|muscle sympathetic nervous system
276664|NCT01977417|Prediabetes|prediabetes
276665|NCT01977417|Autonomic function|autonomic function
276666|NCT01977404|Congestive heart failure|congestive heart failure
276667|NCT01977404|Energy expenditure|energy expenditure
276668|NCT01977404|Body composition|body composition
276669|NCT01977404|Caloric intake|caloric intake
276670|NCT01977365|Cluster Randomized Trial,|cluster randomized trial,
276671|NCT01977365|Nutrition counseling,|nutrition counseling,
276672|NCT01977365|Caretaker's knowledge|caretaker's knowledge
276673|NCT01977365|Child growth,|child growth,
276674|NCT01977365|Prevention,|prevention,
276675|NCT01977365|Acute malnutrition|acute malnutrition
276676|NCT01977352|Exparel|exparel
276677|NCT01977352|Liposomal Bupivacaine|liposomal bupivacaine
276678|NCT01977352|Arthroscopic Shoulder Surgery|arthroscopic shoulder surgery
276679|NCT01977339|Femoral Nerve Block|femoral nerve block
276680|NCT01977339|Liposomal Bupivacaine|liposomal bupivacaine
276681|NCT01977326|task sharing|task sharing
276682|NCT01977326|task shifting|task shifting
276683|NCT01977326|prenatal depression|prenatal depression
276684|NCT01977326|counselling|counselling
276685|NCT01977326|lay health workers|lay health workers
276686|NCT01977287|Multiple Sclerosis|multiple sclerosis
276687|NCT01977287|Functional Electrical Stimulation|functional electrical stimulation
276688|NCT01977287|Ankle Foot Orthosis|ankle foot orthosis
276689|NCT01977287|Walking performance|walking performance
276690|NCT01977287|gait analysis|gait analysis
276691|NCT01977287|fatigue|fatigue
276692|NCT01977287|activity monitoring|activity monitoring
276693|NCT01977274|ovarian, endometrium, cervix cancer|ovarian, endometrium, cervix cancer
276694|NCT01977235|Irinotecan; Cisplatin; Small-cell lung cancer; UGT1A1|irinotecan; cisplatin; small-cell lung cancer; ugt1a1
276695|NCT01977209|NSCLC; Gossypol; APE1; Chemotherapy|nsclc; gossypol; ape1; chemotherapy
276696|NCT01977196|DTB/HB/Hib vaccine|dtb/hb/hib vaccine
276697|NCT01977196|Infants|infants
276698|NCT01977196|Phase I|phase i
276699|NCT01977183|gastrointestinal|gastrointestinal
276700|NCT01977183|microbiome|microbiome
276701|NCT01977183|prebiotic|prebiotic
276702|NCT01977183|starch|starch
276703|NCT01977170|Adults|adults
276704|NCT01977170|Hib vaccines|hib vaccines
276705|NCT01977170|Immunogenicity|immunogenicity
276706|NCT01977170|Safety|safety
276707|NCT01977157|Impedance cardiography|impedance cardiography
276708|NCT01977157|bioimpedance|bioimpedance
276709|NCT01977157|spectroscopy|spectroscopy
276710|NCT01977157|extracellular resistance|extracellular resistance
276711|NCT01977157|body composition|body composition
276712|NCT01977157|hemodynamics|hemodynamics
276713|NCT01977157|alcohol|alcohol
276714|NCT01977144|Single Embryo Transfer|single embryo transfer
276715|NCT01977144|Double Embryo Transfer|double embryo transfer
276716|NCT01977144|CCS (Comprehensive Chromosome Screening)|ccs (comprehensive chromosome screening)
276717|NCT01977144|Aneuploidy|aneuploidy
276718|NCT01977144|Low Responders|low responders
276719|NCT01977118|Streptokinase|streptokinase
276720|NCT01977118|Percutaneous catheter drainage|percutaneous catheter drainage
276721|NCT01977118|Pancreatic necrosis|pancreatic necrosis
276722|NCT01977118|peripancreatic necrosis|peripancreatic necrosis
276723|NCT01977105|Infants|infants
276724|NCT01977105|Mothers|mothers
276725|NCT01977105|Social media|social media
276726|NCT01977105|Obesity prevention|obesity prevention
276727|NCT01977092|sober living houses|sober living houses
276728|NCT01977092|HIV|hiv
276729|NCT01977092|alcohol and drugs|alcohol and drugs
276730|NCT01977079|pregnancy|pregnancy
276731|NCT01977079|premature birth|premature birth
276732|NCT01977079|procalcitonin|procalcitonin
276733|NCT01977066|pancreatic cancer|pancreatic cancer
276734|NCT01977066|exercise training|exercise training
276735|NCT01977066|quality of life|quality of life
276736|NCT01977066|physical functioning|physical functioning
276737|NCT01977053|breast cancer|breast cancer
276738|NCT01977053|colon cancer|colon cancer
276739|NCT01977053|rectal cancer|rectal cancer
276742|NCT01977053|emotional states|emotional states
276743|NCT01977053|quality of life|quality of life
276744|NCT01977040|Vasa Previa|vasa previa
276745|NCT01977027|Rehabilitation|rehabilitation
276746|NCT01977027|Fingers|fingers
276747|NCT01977027|Grasp|grasp
276748|NCT01977027|Strength|strength
276749|NCT01977027|Hand Function|hand function
276750|NCT01977027|Motor Function|motor function
276751|NCT01977027|Post Stroke|post stroke
276752|NCT01977027|Brain Infraction|brain infraction
276753|NCT01977027|Biomechanis|biomechanis
276754|NCT01977027|Neuronal Plasticity|neuronal plasticity
276755|NCT01977027|Weight-Bearing|weight-bearing
276756|NCT01977001|Primary headache|primary headache
276757|NCT01977001|Headache|headache
276758|NCT01977001|MigraineBox|migrainebox
276759|NCT01976975|Depression|depression
276760|NCT01976975|Major Depressive Disorder|major depressive disorder
276761|NCT01976975|Bipolar Disorder|bipolar disorder
276762|NCT01976975|Mania|mania
276763|NCT01976975|Hypomania|hypomania
276764|NCT01976975|EEG|eeg
276765|NCT01976975|MRI|mri
276766|NCT01976975|Reward|reward
276767|NCT01976962|Prostatic neoplasms|prostatic neoplasms
276768|NCT01976962|Radiotherapy|radiotherapy
276769|NCT01976962|Dose fractionation|dose fractionation
276770|NCT01976962|Magnetic resonance imaging|magnetic resonance imaging
276771|NCT01976949|Cancer, social-networking intervention, cancer-related distress, internet health services, intervention delivery|cancer, social-networking intervention, cancer-related distress, internet health services, intervention delivery
276772|NCT01976936|Stroke|stroke
276773|NCT01976936|Rhabdomyolysis|rhabdomyolysis
276774|NCT01976936|Jaundice|jaundice
276775|NCT01976923|Intravitreal Bevacizumab|intravitreal bevacizumab
276776|NCT01976923|Tractional Retinal Detachment|tractional retinal detachment
276777|NCT01976923|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
276778|NCT01976923|Small gauge pars plana vitrectomy|small gauge pars plana vitrectomy
276779|NCT01976923|Intraoperative bleeding|intraoperative bleeding
276780|NCT01976923|Post-operative vitreous hemorrhage|post-operative vitreous hemorrhage
276781|NCT01976923|Visual acuity|visual acuity
276782|NCT01976910|Glioblastoma multiforme|glioblastoma multiforme
276783|NCT01976910|Advanced cancers|advanced cancers
276784|NCT01976910|Brain Neoplasms, Malignant, Primary|brain neoplasms, malignant, primary
276785|NCT01976910|Brain Tumor, Recurrent|brain tumor, recurrent
276786|NCT01976910|Advanced cancer|advanced cancer
276787|NCT01976897|heel - mattress pressure interface|heel - mattress pressure interface
276788|NCT01976897|flexion|flexion
276789|NCT01976897|knee angular position|knee angular position
276790|NCT01976884|sepsis|sepsis
276791|NCT01976884|immunosuppression|immunosuppression
276792|NCT01976884|PD-L1|pd-l1
276793|NCT01976871|Restless Legs Syndrome|restless legs syndrome
276794|NCT01976871|Ekbom Syndrome|ekbom syndrome
276795|NCT01976871|Willis-Ekbom Disease|willis-ekbom disease
276796|NCT01976871|Rotigotine|rotigotine
276797|NCT01976871|Neupro|neupro
276798|NCT01976871|Dopamine Agonist|dopamine agonist
276799|NCT01976858|PEX168, diabetes, phase I|pex168, diabetes, phase i
276800|NCT01976845|propofol|propofol
276801|NCT01976845|midazolam|midazolam
276802|NCT01976845|sedative|sedative
276803|NCT01976845|anxiolytic|anxiolytic
276804|NCT01976845|amnesic|amnesic
276805|NCT01976845|recall|recall
276806|NCT01976845|Memory|memory
276807|NCT01976845|Perioperative outcomes|perioperative outcomes
276808|NCT01976819|Tracheotomy|tracheotomy
276809|NCT01976819|Tracheostomy|tracheostomy
276810|NCT01976819|Speaking valve|speaking valve
276812|NCT01976819|patients|patients
276813|NCT01976806|Docosahexaenoic acid|docosahexaenoic acid
276814|NCT01976806|DHA|dha
276815|NCT01976806|Periodontitis|periodontitis
276816|NCT01976806|Gingivitis|gingivitis
276817|NCT01976806|Omega-3 fatty acid|omega-3 fatty acid
276818|NCT01976806|Fish oil|fish oil
276819|NCT01976793|Recurrent depressive disorder|recurrent depressive disorder
276820|NCT01976793|Depression|depression
276821|NCT01976793|Depressive episode|depressive episode
276822|NCT01976793|Atypical antipsychotics|atypical antipsychotics
276823|NCT01976780|Malaria|malaria
276824|NCT01976780|P. falciparum mono infection|p. falciparum mono infection
276825|NCT01976780|Early Treatment Failure|early treatment failure
276826|NCT01976780|Late Treatment Failure|late treatment failure
276827|NCT01976767|Sputum|sputum
276828|NCT01976767|Clinical cohorts|clinical cohorts
276829|NCT01976767|Smokers|smokers
276830|NCT01976767|Asthma|asthma
276831|NCT01976767|Biopsies|biopsies
276832|NCT01976767|Severe asthma|severe asthma
276833|NCT01976767|Collaborative research|collaborative research
276834|NCT01976767|Phenotyping|phenotyping
276835|NCT01976767|Lipidomics|lipidomics
276836|NCT01976767|Transcriptomics|transcriptomics
276837|NCT01976767|Proteomics|proteomics
276838|NCT01976767|Paediatric cohort|paediatric cohort
276839|NCT01976767|Systems Biology|systems biology
276840|NCT01976741|Phase I|phase i
276841|NCT01976741|Dose escalation|dose escalation
276842|NCT01976741|refractory, locally advanced or metastatic solid tumor|refractory, locally advanced or metastatic solid tumor
276843|NCT01976741|Bladder cancer|bladder cancer
276844|NCT01976741|squamous non-small cell lung cancer|squamous non-small cell lung cancer
276845|NCT01976741|pan-FGFR inhibitor|pan-fgfr inhibitor
276846|NCT01976741|lung adenocarcinoma|lung adenocarcinoma
276847|NCT01976741|head and neck cancer|head and neck cancer
276848|NCT01976715|HIV|hiv
276849|NCT01976715|Treatment Failure|treatment failure
276850|NCT01976715|Drug Resistance|drug resistance
276851|NCT01976702|HIV risk behaviors|hiv risk behaviors
276852|NCT01976702|Pregnant drug abusers|pregnant drug abusers
276853|NCT01976689|Glucose Regulation|glucose regulation
276854|NCT01976689|Left Ventricular Hypertrophy|left ventricular hypertrophy
276855|NCT01976689|New-onset Diabetes|new-onset diabetes
276856|NCT01976689|Renal Transplantation|renal transplantation
276857|NCT01976598|chronic|chronic
276858|NCT01976598|back|back
276859|NCT01976598|leg|leg
276860|NCT01976598|pain|pain
276861|NCT01976598|sub-sensory|sub-sensory
276862|NCT01976598|stimulation|stimulation
276863|NCT01976598|Neuromodulation|neuromodulation
276864|NCT01976598|Yearwood|yearwood
276865|NCT01976585|Intratumoral injections|intratumoral injections
276866|NCT01976585|rhuFlt3L|rhuflt3l
276867|NCT01976585|Flt3L|flt3l
276868|NCT01976585|CDX-301|cdx-301
276869|NCT01976585|Vaccine|vaccine
276870|NCT01976585|Poly-ICLC|poly-iclc
276871|NCT01976585|iNHL|inhl
276872|NCT01976585|TLR3|tlr3
276873|NCT01976585|Low-Grade B-cell Lymphoma|low-grade b-cell lymphoma
276874|NCT01976585|Follicular|follicular
276875|NCT01976585|Marginal Zone|marginal zone
276876|NCT01976585|SLL|sll
276877|NCT01976585|Small lymphocytic|small lymphocytic
276878|NCT01976572|CKD Stage V|ckd stage v
276879|NCT01976572|dialysis|dialysis
276880|NCT01976559|ICP|icp
276881|NCT01976559|Intracranial pressure|intracranial pressure
276882|NCT01976559|Hydrocephalus|hydrocephalus
276883|NCT01976559|Idiopathic normal pressure hydrocephalus|idiopathic normal pressure hydrocephalus
276884|NCT01976559|CSF|csf
276885|NCT01976559|Cerebrospinal fluid|cerebrospinal fluid
276886|NCT01976559|Noninvasive ICP|noninvasive icp
276887|NCT01976520|Cancer vaccine|cancer vaccine
276888|NCT01976520|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
276889|NCT01976520|CLL|cll
276890|NCT01976520|Autologous vaccine|autologous vaccine
276891|NCT01976520|B cell leukemia|b cell leukemia
276892|NCT01976494|Patient controlled analgesia equipment|patient controlled analgesia equipment
276893|NCT01976494|efficacy|efficacy
276894|NCT01976494|safety|safety
276895|NCT01976494|Accufuser Omnibus®|accufuser omnibus®
276896|NCT01976494|Upper abdominal surgery|upper abdominal surgery
276897|NCT01976494|laparotomy|laparotomy
276898|NCT01976455|obesity|obesity
276899|NCT01976455|carbon13|carbon13
276900|NCT01976455|over-eating|over-eating
276901|NCT01976455|metabolic chamber|metabolic chamber
276902|NCT01976455|room calorimeter|room calorimeter
276903|NCT01976442|Leukemia|leukemia
276904|NCT01976442|Transfusion|transfusion
276905|NCT01976429|barotrauma|barotrauma
276906|NCT01976429|barotitis|barotitis
276907|NCT01976429|middle ear|middle ear
276908|NCT01976429|flying|flying
276909|NCT01976429|diving|diving
276910|NCT01976429|Eustachian tube|eustachian tube
276911|NCT01976416|Hydroxyurea|hydroxyurea
276912|NCT01976390|Kidney|kidney
276913|NCT01976390|Kidney transplant|kidney transplant
276914|NCT01976390|Renal failure|renal failure
276915|NCT01976390|End Stage Renal Disease|end stage renal disease
276916|NCT01976390|kidney transplant recipient|kidney transplant recipient
276917|NCT01976364|Tofacitinib|tofacitinib
276918|NCT01976364|Psoriatic Arthritis|psoriatic arthritis
276919|NCT01976364|Xeljanz|xeljanz
276920|NCT01976364|CP-690550|cp-690550
276921|NCT01976364|Jak-inhibitor|jak-inhibitor
276922|NCT01976364|oral treatment|oral treatment
276923|NCT01976364|psoriasis|psoriasis
276924|NCT01976364|OPAL BALANCE|opal balance
276925|NCT01976364|methotrexate|methotrexate
276926|NCT01976364|pruritus|pruritus
276927|NCT01976364|itch|itch
276928|NCT01976364|DLQI|dlqi
276929|NCT01976351|Barrett's esophagus|barrett's esophagus
276930|NCT01976351|image-enhanced endoscopy|image-enhanced endoscopy
276931|NCT01976338|BRVO|brvo
276932|NCT01976338|macular edema|macular edema
276933|NCT01976338|vision impairment|vision impairment
276934|NCT01976338|retinal vein occlusion|retinal vein occlusion
276935|NCT01976338|ranibizumab|ranibizumab
276936|NCT01976338|branch retinal vein occlusion|branch retinal vein occlusion
276937|NCT01976338|anti-VEGF therapy|anti-vegf therapy
276938|NCT01976338|RFB002|rfb002
276939|NCT01976325|decision aid|decision aid
276940|NCT01976325|imported malaria|imported malaria
276941|NCT01976325|malaria prevention and control|malaria prevention and control
276942|NCT01976325|malaria chemoprophylaxis|malaria chemoprophylaxis
276943|NCT01976325|mefloquine|mefloquine
276944|NCT01976325|lariam|lariam
276945|NCT01976325|atovaquone-proguanil|atovaquone-proguanil
276946|NCT01976325|malarone|malarone
276947|NCT01976325|doxycycline|doxycycline
276948|NCT01976325|vibramycin|vibramycin
276949|NCT01976312|CRVO, macular edema, vision impairment, retinal vein occlusion, ranibizumab|crvo, macular edema, vision impairment, retinal vein occlusion, ranibizumab
276950|NCT01976221|Comprehensive referrals|comprehensive referrals
276951|NCT01976221|Appropriate referring|appropriate referring
276952|NCT01976221|Priority setting|priority setting
276953|NCT01976221|Waiting time in hospital|waiting time in hospital
276954|NCT01976208|Omalizumab|omalizumab
276956|NCT01976208|Asthma|asthma
276957|NCT01976195|Thalidomide|thalidomide
276958|NCT01976195|Dexamethasone|dexamethasone
276959|NCT01976195|ITP|itp
276960|NCT01976182|large granular lymphocytes leukemia|large granular lymphocytes leukemia
276961|NCT01976182|immunosuppressive drugs|immunosuppressive drugs
276962|NCT01976182|methotrexate|methotrexate
276963|NCT01976182|cyclophosphamide|cyclophosphamide
276964|NCT01976182|efficiency|efficiency
276965|NCT01976182|phase II randomized controlled trial|phase ii randomized controlled trial
276966|NCT01976169|Breast Cancer|breast cancer
276967|NCT01976169|Advanced Breast Cancer|advanced breast cancer
276968|NCT01976104|Thrombocytopenia|thrombocytopenia
276969|NCT01976104|Chronic Liver Disease|chronic liver disease
276970|NCT01976091|limb girdle muscular dystrophy|limb girdle muscular dystrophy
276971|NCT01976091|LGMD2D|lgmd2d
276972|NCT01976091|alpha-sarcoglycan|alpha-sarcoglycan
276973|NCT01976091|gene transfer|gene transfer
276974|NCT01976091|adeno-associated virus|adeno-associated virus
276975|NCT01976078|Voriconazole|voriconazole
276976|NCT01976078|Pharmacokinetics|pharmacokinetics
276977|NCT01976078|Ontogeny|ontogeny
276978|NCT01976078|Modeling|modeling
276979|NCT01976078|Bayesian|bayesian
276980|NCT01976065|Necrotic tooth pulp|necrotic tooth pulp
276981|NCT01976065|Immature permanent teeth|immature permanent teeth
276982|NCT01976065|Regeneration|regeneration
276983|NCT01976052|Biomarkers|biomarkers
276984|NCT01976052|Genomics|genomics
276985|NCT01976039|motorcyclist|motorcyclist
276986|NCT01976039|nasal mucociliary clearance|nasal mucociliary clearance
276987|NCT01976039|physical therapy|physical therapy
276988|NCT01976026|Flow Diversion|flow diversion
276989|NCT01976026|Aneurysm|aneurysm
276990|NCT01976026|Intracranial|intracranial
276991|NCT01976026|Cerebral|cerebral
276992|NCT01976026|Vertebral|vertebral
276993|NCT01976026|blood blister-like|blood blister-like
276994|NCT01976026|ruptured aneurysm|ruptured aneurysm
276995|NCT01976026|Pipeline Flow Diversion|pipeline flow diversion
276996|NCT01976026|Pipeline Flow Diverter|pipeline flow diverter
276997|NCT01976026|Best-Standard Treatment|best-standard treatment
276998|NCT01976013|PT|pt
276999|NCT01976013|INR|inr
277000|NCT01976013|intraventricular haemorrhage|intraventricular haemorrhage
277001|NCT01976013|pulmonary haemorrhage|pulmonary haemorrhage
277002|NCT01976013|ELBW infants|elbw infants
277003|NCT01975987|Intubation|intubation
277004|NCT01975987|Bonfils fiberscope|bonfils fiberscope
277005|NCT01975974|vascular|vascular
277006|NCT01975974|access|access
277007|NCT01975974|ultrasound|ultrasound
277008|NCT01975948|Mental Health|mental health
277009|NCT01975948|Education and Practice Support Program|education and practice support program
277010|NCT01975948|Depression|depression
277011|NCT01975948|Primary Care|primary care
277012|NCT01975948|Skill-based training|skill-based training
277013|NCT01975948|Patient centered outcomes|patient centered outcomes
277014|NCT01975935|diabetes mellitus type 2|diabetes mellitus type 2
277015|NCT01975935|non-alcoholic fatt liver disease|non-alcoholic fatt liver disease
277016|NCT01975935|obesity|obesity
277017|NCT01975922|language impairment|language impairment
277018|NCT01975922|language disorder|language disorder
277019|NCT01975922|language delay|language delay
277020|NCT01975922|late talkers|late talkers
277021|NCT01975922|late talking|late talking
277022|NCT01975909|Spinocerebellar Ataxia|spinocerebellar ataxia
277023|NCT01975909|SCA|sca
277024|NCT01975909|Ataxia|ataxia
277025|NCT01975909|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
277026|NCT01975909|TMS|tms
277027|NCT01975883|Blood Glucose|blood glucose
277028|NCT01975883|Postoperative Complications|postoperative complications
277029|NCT01975883|Spine|spine
277030|NCT01975883|Orthopedic surgery|orthopedic surgery
277031|NCT01975870|Sedentary behavior, smartphone, application|sedentary behavior, smartphone, application
277032|NCT01975857|mild traumatic brain injury|mild traumatic brain injury
277033|NCT01975857|sleep|sleep
277034|NCT01975857|mind body intervention|mind body intervention
277035|NCT01975857|mind body bridging|mind body bridging
277036|NCT01975844|Anemia|anemia
277037|NCT01975844|End Stage Renal Disease|end stage renal disease
277038|NCT01975831|Non Triple Negative Breast Cancer|non triple negative breast cancer
277039|NCT01975818|Anemia of CKD on dialysis|anemia of ckd on dialysis
277040|NCT01975805|cesarean delivery|cesarean delivery
277041|NCT01975805|chlorhexidine|chlorhexidine
277042|NCT01975805|iodine|iodine
277043|NCT01975805|skin disinfectant|skin disinfectant
277044|NCT01975792|PPROM|pprom
277045|NCT01975792|Pregnant|pregnant
277046|NCT01975792|Preterm|preterm
277047|NCT01975792|Premature, labor|premature, labor
277048|NCT01975766|Carcinoma, squamous cell of head and neck|carcinoma, squamous cell of head and neck
277049|NCT01975766|Head and neck cancer|head and neck cancer
277349|NCT01974115|Cellulite|cellulite
277050|NCT01975766|ketogenic diet|ketogenic diet
277051|NCT01975766|radiotherapy|radiotherapy
277052|NCT01975766|cisplatin|cisplatin
277053|NCT01975753|pain|pain
277054|NCT01975727|PONV|ponv
277055|NCT01975727|Dexamethasone|dexamethasone
277056|NCT01975727|Treatment|treatment
277057|NCT01975714|Glaucoma|glaucoma
277058|NCT01975714|Ocular hypertension|ocular hypertension
277059|NCT01975714|Preservative-free prostaglandins|preservative-free prostaglandins
277060|NCT01975701|BGJ398,|bgj398,
277061|NCT01975701|recurrent glioblastoma'|recurrent glioblastoma'
277062|NCT01975701|recurrent GBM,|recurrent gbm,
277063|NCT01975701|FGFR,|fgfr,
277064|NCT01975662|MRSA|mrsa
277065|NCT01975662|bacteremia|bacteremia
277066|NCT01975662|vancomycin|vancomycin
277067|NCT01975662|daptomycin|daptomycin
277068|NCT01975649|postmenopausal|postmenopausal
277069|NCT01975649|hypoactive|hypoactive
277070|NCT01975649|sexual disorder|sexual disorder
277071|NCT01975649|androgen|androgen
277072|NCT01975636|Metabolism and Elimination|metabolism and elimination
277073|NCT01975623|Video assisted thoracoscopic surgery (VATS)|video assisted thoracoscopic surgery (vats)
277074|NCT01975610|Arthritis, Rheumatoid, Autoimmune, Inflammatory, Synovial, Bruton's tyrosine kinase (Btk), CC-292, Joint Disease|arthritis, rheumatoid, autoimmune, inflammatory, synovial, bruton's tyrosine kinase (btk), cc-292, joint disease
277075|NCT01975571|residual hearing|residual hearing
277076|NCT01975571|hybrid|hybrid
277077|NCT01975571|hearing preservation|hearing preservation
277078|NCT01975545|Down syndrome|down syndrome
277079|NCT01975545|Caries|caries
277080|NCT01975545|Dental varnish|dental varnish
277081|NCT01975519|TRC105|trc105
277082|NCT01975519|CD105|cd105
277083|NCT01975519|Endoglin|endoglin
277084|NCT01975519|Angiogenesis Inhibitor|angiogenesis inhibitor
277085|NCT01975519|STS|sts
277086|NCT01975519|Soft Tissue Sarcoma|soft tissue sarcoma
277087|NCT01975519|TKI|tki
277088|NCT01975519|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
277089|NCT01975519|Pazopanib|pazopanib
277090|NCT01975519|Votrient|votrient
277091|NCT01975519|Advanced Soft Tissue Sarcoma|advanced soft tissue sarcoma
277092|NCT01975519|Angiosarcoma|angiosarcoma
277093|NCT01975506|Head Start|head start
277094|NCT01975506|Occupational Therapy|occupational therapy
277095|NCT01975493|Infectious Diseases|infectious diseases
277096|NCT01975493|Paediatrics|paediatrics
277097|NCT01975493|Neonatology|neonatology
277098|NCT01975493|Pharmacokinetics|pharmacokinetics
277099|NCT01975493|Antimicrobials|antimicrobials
277100|NCT01975467|midshaft clavicle fracture|midshaft clavicle fracture
277101|NCT01975467|intramedullary nail|intramedullary nail
277102|NCT01975467|sling|sling
277103|NCT01975454|Metastatic colorectal cancer|metastatic colorectal cancer
277104|NCT01975454|Chemotherapy|chemotherapy
277105|NCT01975454|Traditional Chinese Medicine (TCM)|traditional chinese medicine (tcm)
277106|NCT01975454|Teng-Long-Bu-Zhong-Tang|teng-long-bu-zhong-tang
277107|NCT01975441|Diethycarbamazine|diethycarbamazine
277108|NCT01975441|Albendazole|albendazole
277109|NCT01975441|Ivermectin|ivermectin
277110|NCT01975441|Lymphatic filariasis|lymphatic filariasis
277111|NCT01975415|Meditation|meditation
277112|NCT01975415|Sensors|sensors
277113|NCT01975415|Digital medicine|digital medicine
277114|NCT01975402|Congestive Heart Failure|congestive heart failure
277115|NCT01975389|myocardial infarction|myocardial infarction
277116|NCT01975389|stroke|stroke
277117|NCT01975389|hyperlipidemia|hyperlipidemia
277118|NCT01975376|myocardial infarction|myocardial infarction
277119|NCT01975376|stroke|stroke
277120|NCT01975376|hyperlipidemia|hyperlipidemia
277121|NCT01975363|Breast Cancer|breast cancer
277122|NCT01975350|Colistimethate sodium inhalation|colistimethate sodium inhalation
277123|NCT01975324|Ampyra|ampyra
277124|NCT01975324|NAION|naion
277125|NCT01975324|Dalfampridine|dalfampridine
277126|NCT01975298|RRMS|rrms
277127|NCT01975285|Pain management|pain management
277128|NCT01975285|Postoperative opioid requirements|postoperative opioid requirements
277129|NCT01975285|Perioperative outcomes|perioperative outcomes
277130|NCT01975285|Dexamethasone|dexamethasone
277131|NCT01975285|Anesthetic adjuvant|anesthetic adjuvant
277132|NCT01975285|Analgesic adjuvant|analgesic adjuvant
277133|NCT01975272|postoperative|postoperative
277134|NCT01975272|anemia|anemia
277135|NCT01975272|gynaecologic|gynaecologic
277136|NCT01975272|surgery|surgery
277137|NCT01975233|Endovascular|endovascular
277138|NCT01975233|Brain Aneurysm|brain aneurysm
277139|NCT01975181|cardiovascular health|cardiovascular health
277140|NCT01975181|lifestyle modification|lifestyle modification
277141|NCT01975181|patient reported outcomes|patient reported outcomes
277142|NCT01975181|risk assessment|risk assessment
277143|NCT01975168|laser acupuncture|laser acupuncture
277144|NCT01975168|obesity|obesity
277145|NCT01975155|Celiac disease|celiac disease
277146|NCT01975155|Gluten free diet nutrient content|gluten free diet nutrient content
277147|NCT01975155|mycotoxins|mycotoxins
277148|NCT01975155|Gluten free diet|gluten free diet
277149|NCT01975142|Metastatic breast cancer|metastatic breast cancer
277150|NCT01975142|Primary tumor HER2 negative|primary tumor her2 negative
277151|NCT01975142|CTC HER2 positive|ctc her2 positive
277152|NCT01975077|patients with mCRC who failed 2nd therapy or more|patients with mcrc who failed 2nd therapy or more
277153|NCT01975064|Breast neoplasms|breast neoplasms
277154|NCT01975064|Colonic neoplasms|colonic neoplasms
277155|NCT01975064|Rectal neoplasms|rectal neoplasms
277156|NCT01975051|Kala- azar|kala- azar
277157|NCT01975051|PKDL|pkdl
277158|NCT01975051|Treatment|treatment
277159|NCT01975051|Pathogenesis|pathogenesis
277160|NCT01975051|Bangladesh|bangladesh
277161|NCT01975038|Melanin Index|melanin index
277162|NCT01975038|Fitzpatrick Skin Phototype|fitzpatrick skin phototype
277163|NCT01975038|Spectrophotometry|spectrophotometry
277164|NCT01975038|Skin Diseases|skin diseases
277165|NCT01975025|Renal Dialysis|renal dialysis
277166|NCT01974999|Kidney|kidney
277167|NCT01974999|Transplant|transplant
277168|NCT01974999|Rejection|rejection
277169|NCT01974986|dehydration|dehydration
277170|NCT01974986|exercise|exercise
277171|NCT01974986|rehydration|rehydration
277172|NCT01974986|sodium|sodium
277173|NCT01974986|water|water
277174|NCT01974986|carbohydrate|carbohydrate
277175|NCT01974973|autism spectrum disorders|autism spectrum disorders
277176|NCT01974973|stem cells|stem cells
277177|NCT01974947|Metabolic syndrome|metabolic syndrome
277178|NCT01974947|Epigenetic|epigenetic
277179|NCT01974947|Male infertility|male infertility
277180|NCT01974947|Sperm parameters|sperm parameters
277181|NCT01974947|Biomarkers|biomarkers
277182|NCT01974921|Asthma|asthma
277183|NCT01974921|Bronchial Thermoplasty|bronchial thermoplasty
277184|NCT01974921|Bronchial smooth muscle|bronchial smooth muscle
277185|NCT01974908|Ventricular Tachycardia|ventricular tachycardia
277186|NCT01974895|Children|children
277187|NCT01974895|Immunogenicity|immunogenicity
277188|NCT01974895|Fluzone®|fluzone®
277189|NCT01974895|6 to 35 months of age|6 to 35 months of age
277190|NCT01974895|Seasonal influenza|seasonal influenza
277191|NCT01974895|Safety|safety
277192|NCT01974882|abdominal surgery|abdominal surgery
277193|NCT01974882|cryotherapy|cryotherapy
277194|NCT01974882|pain score|pain score
277195|NCT01974882|narcotic utilization|narcotic utilization
277196|NCT01974869|Surgery,Crohn's disease,Ulcerative colitis|surgery,crohn's disease,ulcerative colitis
277197|NCT01974830|alpha-1|alpha-1
277198|NCT01974830|anti-trypsin|anti-trypsin
277199|NCT01974830|pulmonary function|pulmonary function
277200|NCT01974830|augmentation therayp|augmentation therayp
277201|NCT01974830|home care|home care
277202|NCT01974817|pneumococcal vaccine|pneumococcal vaccine
277203|NCT01974817|end stage renal disease|end stage renal disease
277204|NCT01974817|dialysis|dialysis
277205|NCT01974804|MRI|mri
277206|NCT01974804|Brain metastases|brain metastases
277207|NCT01974804|13-094|13-094
277208|NCT01974765|Enzalutamide|enzalutamide
277209|NCT01974765|Androgen Receptor Positive (AR+)|androgen receptor positive (ar+)
277210|NCT01974765|13-119|13-119
277211|NCT01974752|uveal melanoma|uveal melanoma
277212|NCT01974739|intensive care|intensive care
277213|NCT01974739|diuretics|diuretics
277214|NCT01974726|ear|ear
277215|NCT01974726|middle ear|middle ear
277216|NCT01974726|Eustachian tube|eustachian tube
277217|NCT01974726|Eustachian tube dysfunction|eustachian tube dysfunction
277218|NCT01974726|Eustachian tube function|eustachian tube function
277219|NCT01974713|CKD progression|ckd progression
277220|NCT01974713|Inflammation|inflammation
277221|NCT01974713|FGF23|fgf23
277222|NCT01974713|Genetic biomarkers|genetic biomarkers
277223|NCT01974687|Hepatitis C virus|hepatitis c virus
277224|NCT01974687|HCV|hcv
277225|NCT01974674|diabetes|diabetes
277226|NCT01974674|transplantation|transplantation
277227|NCT01974648|Laryngeal Mask Airway Supreme|laryngeal mask airway supreme
277228|NCT01974648|propofol|propofol
277229|NCT01974648|remifentanil|remifentanil
277230|NCT01974648|effective dose of intravenous propofol|effective dose of intravenous propofol
277231|NCT01974648|ED50|ed50
277232|NCT01974635|Spinal Cord Injury|spinal cord injury
277233|NCT01974635|Robotic therapy|robotic therapy
277234|NCT01974635|Rehabilitation|rehabilitation
277235|NCT01974635|Sensation|sensation
277236|NCT01974635|Movement|movement
277237|NCT01974635|Proprioception|proprioception
277238|NCT01974635|Stroke|stroke
277239|NCT01974635|Acquired Brain Injury|acquired brain injury
277240|NCT01974609|pain relief|pain relief
277241|NCT01974609|narcotic pain relief|narcotic pain relief
277242|NCT01974609|non-narcotic pain relief|non-narcotic pain relief
277243|NCT01974609|post-operative pain relief|post-operative pain relief
277244|NCT01974609|carpal tunnel|carpal tunnel
277245|NCT01974596|Dental implants|dental implants
277246|NCT01974596|Probiotics|probiotics
277247|NCT01974596|Lactobacillus reuteri|lactobacillus reuteri
277248|NCT01974596|Periimplant mucositis|periimplant mucositis
277249|NCT01974596|Cytokines|cytokines
277250|NCT01974596|Bacterial load|bacterial load
277251|NCT01974583|the split-thickness skin graft （STSG） donor site|the split-thickness skin graft （stsg） donor site
277252|NCT01974583|regraft|regraft
277253|NCT01974583|wound healing|wound healing
277254|NCT01974570|Prehypertension|prehypertension
277255|NCT01974570|Hypertension|hypertension
277256|NCT01974570|Shrimp protein hydrolysate|shrimp protein hydrolysate
277257|NCT01974570|Marine protein hydrolysate|marine protein hydrolysate
277258|NCT01974570|Ambulatory blood pressure|ambulatory blood pressure
277259|NCT01974570|Blood pressure|blood pressure
277260|NCT01974557|Cardiac physiology|cardiac physiology
277261|NCT01974557|ageing|ageing
277262|NCT01974557|gender differences|gender differences
277263|NCT01974557|diastole|diastole
277264|NCT01974557|fluid challenge|fluid challenge
277265|NCT01974544|diabetes complications|diabetes complications
277266|NCT01974544|metabolic surgery|metabolic surgery
277267|NCT01974544|Intensive medicines|intensive medicines
277268|NCT01974518|Pemphigus|pemphigus
277269|NCT01974518|Rituximab|rituximab
277270|NCT01974518|Rituximab and IV cyclophosphamide combination|rituximab and iv cyclophosphamide combination
277271|NCT01974518|B cell re-population characteristics following Rituximab|b cell re-population characteristics following rituximab
277272|NCT01974492|saphenous vein graft|saphenous vein graft
277273|NCT01974492|composite graft|composite graft
277274|NCT01974492|coronary artery bypass grafting|coronary artery bypass grafting
277275|NCT01974492|graft remodeling|graft remodeling
277276|NCT01974479|Redirected Natural Killer Cells|redirected natural killer cells
277277|NCT01974479|Haploidentical Cell Therapy|haploidentical cell therapy
277278|NCT01974466|pancreatitis|pancreatitis
277279|NCT01974466|resuscitation goal|resuscitation goal
277280|NCT01974453|Radiation dose, transradial approach, percutaneous coronary interventions, coronary angiography|radiation dose, transradial approach, percutaneous coronary interventions, coronary angiography
277281|NCT01974440|Lymphoma|lymphoma
277282|NCT01974440|Follicular lymphoma|follicular lymphoma
277283|NCT01974440|Marginal zone lymphoma|marginal zone lymphoma
277284|NCT01974440|Indolent Non-Hodgkin lymphoma|indolent non-hodgkin lymphoma
277285|NCT01974440|PCI-32765|pci-32765
277286|NCT01974440|Ibrutinib|ibrutinib
277287|NCT01974440|Bendamustine|bendamustine
277288|NCT01974440|Rituximab|rituximab
277289|NCT01974440|Cyclophosphamide|cyclophosphamide
277290|NCT01974440|Doxorubicin|doxorubicin
277291|NCT01974440|Vincristine|vincristine
277292|NCT01974440|Prednisone|prednisone
277293|NCT01974440|R-CHOP|r-chop
277294|NCT01974427|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
277295|NCT01974427|Functional Imaging|functional imaging
277296|NCT01974427|BOLD Effect|bold effect
277297|NCT01974427|EEG|eeg
277298|NCT01974427|MEG|meg
277299|NCT01974414|oral lichen planus|oral lichen planus
277300|NCT01974414|cedar honey|cedar honey
277301|NCT01974414|atrophic|atrophic
277302|NCT01974414|erosive|erosive
277303|NCT01974414|pain|pain
277304|NCT01974414|treatment|treatment
277305|NCT01974414|clinical trial|clinical trial
277306|NCT01974401|oral irrigator|oral irrigator
277307|NCT01974401|leukemia|leukemia
277308|NCT01974401|blood dyscrasia|blood dyscrasia
277309|NCT01974401|Oral Health Index Simplified (OHI-S)|oral health index simplified (ohi-s)
277310|NCT01974401|supra gingival irrigator|supra gingival irrigator
277311|NCT01974388|Bariatric surgery, sleeve gastrectomy, gastric leak|bariatric surgery, sleeve gastrectomy, gastric leak
277312|NCT01974375|Living donor|living donor
277313|NCT01974375|Liver transplant|liver transplant
277314|NCT01974375|antifungal prevention|antifungal prevention
277315|NCT01974362|Monolithic Zirconia|monolithic zirconia
277316|NCT01974362|Zirconia-Feldspathic zirconia|zirconia-feldspathic zirconia
277317|NCT01974362|Dental Implants|dental implants
277318|NCT01974362|Fracture|fracture
277319|NCT01974362|Chipping|chipping
277320|NCT01974349|Phase I, healthy, pharmacokinetics, food effect.|phase i, healthy, pharmacokinetics, food effect.
277321|NCT01974310|Macular Holes|macular holes
277322|NCT01974310|Non face down positioning|non face down positioning
277323|NCT01974310|Face down positioning|face down positioning
277324|NCT01974297|Hyperlipidemia|hyperlipidemia
277325|NCT01974297|Atorvastatin|atorvastatin
277326|NCT01974297|Fenofibric acid|fenofibric acid
277327|NCT01974297|combination|combination
277328|NCT01974297|monotherapy|monotherapy
277329|NCT01974245|Cholecalciferol|cholecalciferol
277330|NCT01974245|Kidney diseases|kidney diseases
277331|NCT01974232|Immune Thrombocytopenia (ITP), Thrombopoietin (TPO) agents, children, romiplostim and eltrombopag|immune thrombocytopenia (itp), thrombopoietin (tpo) agents, children, romiplostim and eltrombopag
277332|NCT01974219|HIV|hiv
277333|NCT01974219|COPD|copd
277334|NCT01974219|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
277335|NCT01974219|Smoking|smoking
277336|NCT01974206|ASP0113|asp0113
277337|NCT01974206|Cytomegalovirus (CMV)|cytomegalovirus (cmv)
277338|NCT01974206|Kidney Transplantation|kidney transplantation
277339|NCT01974180|Smoking|smoking
277340|NCT01974180|COPD|copd
277341|NCT01974180|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
277342|NCT01974180|Healthy Smoker|healthy smoker
277343|NCT01974180|Non-smoker|non-smoker
277344|NCT01974167|glucocorticoid-induced osteoporosis|glucocorticoid-induced osteoporosis
277345|NCT01974154|COPD|copd
277346|NCT01974154|Smoking|smoking
277347|NCT01974154|Non-smoker|non-smoker
277348|NCT01974128|MI|mi
277350|NCT01974115|Extracorporeal shock wave therapy|extracorporeal shock wave therapy
277351|NCT01974115|ESWT|eswt
277352|NCT01974115|Radial shock wave therapy|radial shock wave therapy
277353|NCT01974115|RSWT|rswt
277354|NCT01974089|Dysphagia|dysphagia
277355|NCT01974089|Modified diet|modified diet
277356|NCT01974089|Community acquired pneumonia|community acquired pneumonia
277357|NCT01974089|Mortality|mortality
277358|NCT01974089|Rehospitalization|rehospitalization
277359|NCT01974063|Smoking|smoking
277360|NCT01974063|Smoking Cessation|smoking cessation
277361|NCT01974063|Healthy Smoker|healthy smoker
277362|NCT01974063|Shisha Smoker|shisha smoker
277363|NCT01974063|Non-smoker|non-smoker
277364|NCT01974050|Influenza vaccination|influenza vaccination
277365|NCT01974024|Dexamethasone|dexamethasone
277366|NCT01974024|Hiccup|hiccup
277367|NCT01974024|Chemotherapy|chemotherapy
277368|NCT01974024|Methylprednisolone|methylprednisolone
277369|NCT01973998|COPD|copd
277370|NCT01973998|Emphysema|emphysema
277371|NCT01973998|Roflumilast|roflumilast
277372|NCT01973998|readmission|readmission
277373|NCT01973985|Pleural Effusion|pleural effusion
277374|NCT01973972|Diabetes|diabetes
277375|NCT01973972|Obesity|obesity
277376|NCT01973972|Complex Care|complex care
277377|NCT01973972|Primary Care|primary care
277378|NCT01973972|Chronic Disease|chronic disease
277379|NCT01973946|Cancer|cancer
277380|NCT01973933|Metformin|metformin
277381|NCT01973933|Pyrimethamine|pyrimethamine
277382|NCT01973933|Drug interaction|drug interaction
277383|NCT01973920|Diabetes Mellitus|diabetes mellitus
277384|NCT01973920|Oral Insulin|oral insulin
277385|NCT01973907|Sepsis|sepsis
277386|NCT01973907|Septic Shock|septic shock
277387|NCT01973907|Fluid Therapy|fluid therapy
277388|NCT01973907|Pediatrics|pediatrics
277389|NCT01973907|Resuscitation|resuscitation
277390|NCT01973907|Emergency Medicine|emergency medicine
277391|NCT01973907|Critical Care|critical care
277392|NCT01973894|PBPK|pbpk
277393|NCT01973894|Midazolam|midazolam
277394|NCT01973894|Pharmacokinetics|pharmacokinetics
277395|NCT01973894|Critically ill patients|critically ill patients
277396|NCT01973868|Regorafenib|regorafenib
277397|NCT01973868|Cetuximab|cetuximab
277398|NCT01973868|Solid tumors|solid tumors
277399|NCT01973868|Cancer|cancer
277400|NCT01973868|Safety|safety
277401|NCT01973868|Tolerability|tolerability
277402|NCT01973868|Pharmacokinetics|pharmacokinetics
277403|NCT01973842|GnRH agonist|gnrh agonist
277404|NCT01973842|OHSS|ohss
277405|NCT01973842|Triggering final oocyte maturation|triggering final oocyte maturation
277406|NCT01973829|CERTAIN, Checklist, ICU, Outcome, Adults|certain, checklist, icu, outcome, adults
277407|NCT01973816|deep endometriosis;|deep endometriosis;
277408|NCT01973816|rectal endometriosis;|rectal endometriosis;
277409|NCT01973816|rectal shaving;|rectal shaving;
277410|NCT01973816|colorectal resection;|colorectal resection;
277411|NCT01973816|bowel endometriosis|bowel endometriosis
277412|NCT01973803|Carpometacarpal joint|carpometacarpal joint
277413|NCT01973803|Osteoarthritis of CMC-1 joint|osteoarthritis of cmc-1 joint
277414|NCT01973790|Z-338|z-338
277415|NCT01973790|Functional Dyspepsia|functional dyspepsia
277416|NCT01973790|Postprandial Distress Syndrome|postprandial distress syndrome
277417|NCT01973777|intrauterine device, contraception|intrauterine device, contraception
277418|NCT01973764|Intraoperative ultrasound|intraoperative ultrasound
277419|NCT01973764|Ventricular System|ventricular system
277420|NCT01973764|Puncture|puncture
277421|NCT01973764|Ventricular catheter|ventricular catheter
277422|NCT01973764|Ventriculostomy|ventriculostomy
277423|NCT01973764|Hydrocephalus|hydrocephalus
277424|NCT01973764|Excessive accumulation of cerebrospinal fluids within the cranium. Often associated with dilatation of cerebral ventricles|excessive accumulation of cerebrospinal fluids within the cranium. often associated with dilatation of cerebral ventricles
277425|NCT01973764|Intracranial Hypertension|intracranial hypertension
277426|NCT01973764|increased pressure within the cranial vault. This may result from several conditions, including hydrocephalus, brain edema.|increased pressure within the cranial vault. this may result from several conditions, including hydrocephalus, brain edema.
277427|NCT01973738|raloxifene|raloxifene
277428|NCT01973738|bazedoxifene|bazedoxifene
277429|NCT01973738|bone mineral density|bone mineral density
277430|NCT01973738|bone turnover markers|bone turnover markers
277431|NCT01973738|bone quality|bone quality
277432|NCT01973699|shoulder arthroscopy, epinephrine, visualization|shoulder arthroscopy, epinephrine, visualization
277433|NCT01973673|prostate cancer|prostate cancer
277434|NCT01973673|ADT|adt
277435|NCT01973673|bone health|bone health
277436|NCT01973660|Human Epidermal Growth Factor Receptor 2|human epidermal growth factor receptor 2
277437|NCT01973660|HER2|her2
277438|NCT01973660|HER2 positive|her2 positive
277439|NCT01973660|PAM50|pam50
277440|NCT01973660|lapatinib|lapatinib
277441|NCT01973660|trastuzumab|trastuzumab
277442|NCT01973660|dual HER2 blockade|dual her2 blockade
277443|NCT01973660|neoadjuvant|neoadjuvant
277444|NCT01973647|insomnia|insomnia
277445|NCT01973647|cognitive behavioral therapy|cognitive behavioral therapy
277446|NCT01973647|COPD|copd
277447|NCT01973647|fatigue|fatigue
277448|NCT01973634|Radiotherapy|radiotherapy
277449|NCT01973608|Melanoma|melanoma
277450|NCT01973608|MSB0010445|msb0010445
277451|NCT01973608|Dose limiting toxicity|dose limiting toxicity
277452|NCT01973608|Stereotactic body radiation therapy|stereotactic body radiation therapy
277453|NCT01973595|almonds|almonds
277454|NCT01973595|inflammation|inflammation
277455|NCT01973595|immunity|immunity
277456|NCT01973595|gut microbiota|gut microbiota
277457|NCT01973595|stress|stress
277458|NCT01973595|diet quality|diet quality
277459|NCT01973582|Hepatitis B|hepatitis b
277460|NCT01973582|epidemiology|epidemiology
277461|NCT01973582|youth|youth
277462|NCT01973582|vaccine|vaccine
277463|NCT01973569|Rheumatoid Arthritis|rheumatoid arthritis
277464|NCT01973569|Denosumab|denosumab
277465|NCT01973569|RANKL|rankl
277466|NCT01973569|RANK|rank
277467|NCT01973569|AMG 162|amg 162
277468|NCT01973569|joint damage|joint damage
277469|NCT01973569|Developmental Phase III|developmental phase iii
277470|NCT01973543|PD|pd
277471|NCT01973543|Parkinson's disease|parkinson's disease
277472|NCT01973543|Aromatic Amino Acid Decarboxylase|aromatic amino acid decarboxylase
277473|NCT01973543|AADC|aadc
277474|NCT01973543|AAV2-AADC|aav2-aadc
277475|NCT01973543|AAV2|aav2
277476|NCT01973543|Viral Vector|viral vector
277477|NCT01973543|Gene Therapy|gene therapy
277478|NCT01973543|Gene Transfer|gene transfer
277479|NCT01973543|MRI|mri
277480|NCT01973543|PET|pet
277481|NCT01973543|VY-AADC01|vy-aadc01
277482|NCT01973530|femoral nerve block|femoral nerve block
277483|NCT01973530|adductor canal block|adductor canal block
277484|NCT01973530|steroid|steroid
277485|NCT01973530|total knee replacement|total knee replacement
277486|NCT01973517|Multiple sclerosis|multiple sclerosis
277487|NCT01973517|MRI|mri
277488|NCT01973517|USPIO|uspio
277489|NCT01973517|Ferumoxytol|ferumoxytol
277490|NCT01973517|Feraheme|feraheme
277491|NCT01973504|Trauma|trauma
277492|NCT01973504|Hemorrhagic shock|hemorrhagic shock
277493|NCT01973504|Hemorrhage|hemorrhage
277494|NCT01973504|Lactic acidosis|lactic acidosis
277495|NCT01973504|Oxygen therapeutics|oxygen therapeutics
277496|NCT01973504|Oxygen carriers|oxygen carriers
277497|NCT01973504|Ischemic rescue therapy|ischemic rescue therapy
277498|NCT01973504|Hemoglobin solutions|hemoglobin solutions
277499|NCT01973504|PEGylated hemoglobin|pegylated hemoglobin
277500|NCT01973491|ATX-MS-1467 (MSC2358825A)|atx-ms-1467 (msc2358825a)
277501|NCT01973491|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
277502|NCT01973491|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
277503|NCT01973491|M2736|m2736
277504|NCT01973478|Major depressive disorder|major depressive disorder
277505|NCT01973478|Recurrent depressive disorder|recurrent depressive disorder
277506|NCT01973478|Bipolar disorder|bipolar disorder
277507|NCT01973478|Deep brain stimulation|deep brain stimulation
277508|NCT01973478|Accumbens|accumbens
277509|NCT01973465|C-Diff|c-diff
277510|NCT01973465|Diarrhea|diarrhea
277511|NCT01973452|Dexmedetomidine|dexmedetomidine
277512|NCT01973452|Opioid|opioid
277513|NCT01973452|Thoracic Surgery|thoracic surgery
277514|NCT01973439|HIV|hiv
277515|NCT01973439|Abacavir|abacavir
277516|NCT01973439|Lamivudine|lamivudine
277517|NCT01973439|Pharmacokinetics|pharmacokinetics
277518|NCT01973426|Robot|robot
277519|NCT01973426|Thumb|thumb
277520|NCT01973426|Orthosis|orthosis
277521|NCT01973426|Hemiplegia|hemiplegia
277522|NCT01973426|Hemiplegic Stroke|hemiplegic stroke
277523|NCT01973426|Hemiplegic Cerebral Palsy|hemiplegic cerebral palsy
277524|NCT01973426|Stroke|stroke
277525|NCT01973426|Cerebral Palsy|cerebral palsy
277526|NCT01973426|Grasp assistance|grasp assistance
277527|NCT01973413|Artificial Pancreas Project|artificial pancreas project
277528|NCT01973413|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
277529|NCT01973413|Insulin pump therapy|insulin pump therapy
277530|NCT01973413|Continuous Glucose Monitors (CGM)|continuous glucose monitors (cgm)
277531|NCT01973413|Juvenile-Onset Diabetes|juvenile-onset diabetes
277532|NCT01973413|Autoimmune Diabetes|autoimmune diabetes
277533|NCT01973413|Closed-to-Range|closed-to-range
277534|NCT01973413|Diabetes Assistant (DiAs)|diabetes assistant (dias)
277535|NCT01973387|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
277536|NCT01973387|Small lymphocytic lymphoma|small lymphocytic lymphoma
277537|NCT01973387|Relapsed or refractory chronic lymphocytic leukemia|relapsed or refractory chronic lymphocytic leukemia
277538|NCT01973387|Relapsed or refractory small lymphocytic lymphoma|relapsed or refractory small lymphocytic lymphoma
277539|NCT01973387|Ibrutinib|ibrutinib
277540|NCT01973387|PCI-32765|pci-32765
277541|NCT01973387|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
277542|NCT01973387|Rituximab|rituximab
277543|NCT01973387|Asia Pacific region participants|asia pacific region participants
277544|NCT01973361|Wounds|wounds
277545|NCT01973361|Lower extremity|lower extremity
277546|NCT01973361|Diabetes|diabetes
277547|NCT01973361|Arterial Insufficiency|arterial insufficiency
277548|NCT01973361|Debridement|debridement
277854|NCT01971892|Hypoxemia;|hypoxemia;
277549|NCT01973361|Low frequency ultrasound|low frequency ultrasound
277550|NCT01973361|Contact ultrasound|contact ultrasound
277551|NCT01973361|Wound clinic|wound clinic
277552|NCT01973361|Wound bed preparation|wound bed preparation
277553|NCT01973361|Wound infection|wound infection
277554|NCT01973361|Chronic wound inflammation|chronic wound inflammation
277555|NCT01973348|amblyopia|amblyopia
277556|NCT01973335|acetazolamide|acetazolamide
277557|NCT01973335|bumetanide|bumetanide
277558|NCT01973335|cardio-renal syndrome|cardio-renal syndrome
277559|NCT01973335|diuretics|diuretics
277560|NCT01973335|heart failure|heart failure
277561|NCT01973335|natriuresis|natriuresis
277562|NCT01973335|spironolactone|spironolactone
277563|NCT01973322|Malignant melanoma stage III or IV|malignant melanoma stage iii or iv
277564|NCT01973322|pretreated melanoma|pretreated melanoma
277565|NCT01973322|vaccination|vaccination
277566|NCT01973322|autologous dendritic cells|autologous dendritic cells
277567|NCT01973322|autologous tumor lysate or homogenate|autologous tumor lysate or homogenate
277568|NCT01973322|immunomodulating radiotherapy|immunomodulating radiotherapy
277569|NCT01973309|Locally Recurrent|locally recurrent
277570|NCT01973309|Metastatic Breast Cancer|metastatic breast cancer
277571|NCT01973296|Health Literacy|health literacy
277572|NCT01973296|Care Transition Intervention|care transition intervention
277573|NCT01973296|Emergency Department Population|emergency department population
277574|NCT01973296|Access to Care|access to care
277575|NCT01973218|Meningitis, adolescents, Meningococcal B|meningitis, adolescents, meningococcal b
277576|NCT01973205|Migraine|migraine
277577|NCT01973205|acetaminophen|acetaminophen
277578|NCT01973205|aspirin|aspirin
277579|NCT01973166|Tattoo Removal|tattoo removal
277580|NCT01973166|Q-switched laser|q-switched laser
277581|NCT01973166|Nd:YAG laser|nd:yag laser
277582|NCT01973166|Nanosecond laser|nanosecond laser
277583|NCT01973166|Picosecond laser|picosecond laser
277584|NCT01973166|Laser therapy|laser therapy
277585|NCT01973166|Tattoo|tattoo
277586|NCT01973166|pulsed-laser|pulsed-laser
277587|NCT01973166|laser treatment|laser treatment
277588|NCT01973166|remove tattoo|remove tattoo
277589|NCT01973166|tattoo clearing|tattoo clearing
277590|NCT01973166|tattoo lightening|tattoo lightening
277591|NCT01973166|tattoo lighten|tattoo lighten
277592|NCT01973153|Obesity prevention|obesity prevention
277593|NCT01973153|Weight management|weight management
277594|NCT01973153|Motivational Interviewing|motivational interviewing
277595|NCT01973140|Tolvaptan|tolvaptan
277596|NCT01973140|Aquaretic Efficacy|aquaretic efficacy
277597|NCT01973127|alcohol|alcohol
277598|NCT01973127|addiction|addiction
277599|NCT01973127|TMS|tms
277600|NCT01973127|craving|craving
277601|NCT01973127|use|use
277602|NCT01973127|rTMS|rtms
277603|NCT01973127|EEG|eeg
277604|NCT01973127|LPP|lpp
277605|NCT01973127|p300|p300
277606|NCT01973127|ERN|ern
277607|NCT01973127|SST|sst
277608|NCT01973127|CCT|cct
277609|NCT01973127|AAAT|aaat
277610|NCT01973114|Menière's disease|menière's disease
277611|NCT01973114|Vertigo|vertigo
277612|NCT01973114|Hearing loss|hearing loss
277613|NCT01973114|Tinnitus|tinnitus
277614|NCT01973101|Advanced carcinomas of uterine cervix|advanced carcinomas of uterine cervix
277615|NCT01973101|Chemoradiation|chemoradiation
277616|NCT01973101|Chemo-induction|chemo-induction
277617|NCT01973101|Cisplatin|cisplatin
277618|NCT01973101|Gemcitabine|gemcitabine
277619|NCT01973075|Premature Ovarian Insufficiency (POI)|premature ovarian insufficiency (poi)
277620|NCT01973036|foley catheter|foley catheter
277621|NCT01973036|foley bulb|foley bulb
277622|NCT01973036|oxytocin|oxytocin
277623|NCT01973023|botulinum toxin injection|botulinum toxin injection
277624|NCT01973023|stroke|stroke
277625|NCT01973023|3D motion analysis|3d motion analysis
277626|NCT01973023|gait pattern|gait pattern
277627|NCT01973010|massage|massage
277628|NCT01973010|low back pain|low back pain
277629|NCT01972984|Estrogen receptor positive|estrogen receptor positive
277630|NCT01972971|warfarin|warfarin
277631|NCT01972971|pharmacist|pharmacist
277632|NCT01972971|anticoagulation|anticoagulation
277633|NCT01972945|vaginoscopy|vaginoscopy
277634|NCT01972945|hysteroscopy|hysteroscopy
277635|NCT01972945|office hysteroscopy|office hysteroscopy
277636|NCT01972945|outpatient hysteroscopy|outpatient hysteroscopy
277637|NCT01972932|Bio-K+®|bio-k+®
277638|NCT01972932|Placebo|placebo
277639|NCT01972932|AAD|aad
277640|NCT01972932|CDI|cdi
277641|NCT01972932|hospitalized subjects|hospitalized subjects
277642|NCT01972906|moxibustion|moxibustion
277643|NCT01972906|primary dysmenorrhea|primary dysmenorrhea
277644|NCT01972893|Selective GLP-1 agonist|selective glp-1 agonist
277645|NCT01972880|Open-label design|open-label design
277646|NCT01972880|Bioequivalence|bioequivalence
277647|NCT01972880|ASP1941|asp1941
277648|NCT01972867|Focal|focal
277649|NCT01972867|Prostate|prostate
277650|NCT01972867|Cancer|cancer
277651|NCT01972867|Irreversible|irreversible
277652|NCT01972867|Electroporation|electroporation
277653|NCT01972867|NanoKnife|nanoknife
277654|NCT01972854|keratoconus|keratoconus
277655|NCT01972854|cross-linking|cross-linking
277656|NCT01972854|KXL|kxl
277657|NCT01972841|Combination Therapy|combination therapy
277658|NCT01972841|Mirabegron|mirabegron
277659|NCT01972841|Overactive Bladder|overactive bladder
277660|NCT01972841|Urgency|urgency
277661|NCT01972841|Urinary Incontinence|urinary incontinence
277662|NCT01972841|Nocturia|nocturia
277663|NCT01972841|Solifenacin Succinate|solifenacin succinate
277664|NCT01972828|Septic shock|septic shock
277665|NCT01972828|Randomized controlled trial|randomized controlled trial
277666|NCT01972828|Preload dependence|preload dependence
277667|NCT01972828|Pulmonary thermodilution|pulmonary thermodilution
277668|NCT01972802|HEAD AND NECK|head and neck
277669|NCT01972789|Subfoveal choroidal neovascularization (CNV)|subfoveal choroidal neovascularization (cnv)
277670|NCT01972789|wet age-related macular degeneration(AMD)|wet age-related macular degeneration(amd)
277671|NCT01972789|inject and extend|inject and extend
277672|NCT01972789|retinal fluid|retinal fluid
277673|NCT01972776|COPD, inflammation, small airways, LCI, PFTs, lung heterogeneity|copd, inflammation, small airways, lci, pfts, lung heterogeneity
277674|NCT01972750|glioblastoma|glioblastoma
277675|NCT01972750|recurrence|recurrence
277676|NCT01972737|Vaccine|vaccine
277677|NCT01972737|Colon cancer|colon cancer
277678|NCT01972737|safety|safety
277679|NCT01972737|tolerability|tolerability
277680|NCT01972737|antibody responses|antibody responses
277681|NCT01972737|T cell responses|t cell responses
277682|NCT01972724|Drug therapy|drug therapy
277683|NCT01972711|Schizophrenia|schizophrenia
277684|NCT01972698|Focused Cardiac Ultrasound|focused cardiac ultrasound
277685|NCT01972698|Lung Ultrasound|lung ultrasound
277686|NCT01972698|Simulation|simulation
277687|NCT01972698|Education|education
277688|NCT01972698|Web-based learning|web-based learning
277689|NCT01972685|ILD, transbronchial, cryoprobe, VATS|ild, transbronchial, cryoprobe, vats
277690|NCT01972659|sugammadex|sugammadex
277691|NCT01972659|rocuronium|rocuronium
277692|NCT01972659|magnesium|magnesium
277694|NCT01972646|Cellulitis, treatment failure, skin and soft tissue infections, risk factors.|cellulitis, treatment failure, skin and soft tissue infections, risk factors.
277695|NCT01972633|endovenous treatment|endovenous treatment
277696|NCT01972633|Laser, Vnus Closure Fast|laser, vnus closure fast
277697|NCT01972633|Varicosis|varicosis
277698|NCT01972633|great saphenous vein|great saphenous vein
277699|NCT01972633|small saphenous vein|small saphenous vein
277700|NCT01972633|Venous Insufficiency|venous insufficiency
277701|NCT01972620|gallstones|gallstones
277702|NCT01972620|cholelithiasis|cholelithiasis
277703|NCT01972620|cholecystectomy, laparoscopic|cholecystectomy, laparoscopic
277704|NCT01972620|pain|pain
277705|NCT01972607|Migraine, aerobic exercise, prevention|migraine, aerobic exercise, prevention
277706|NCT01972581|neurocognitive visual reaction training|neurocognitive visual reaction training
277707|NCT01972581|baseball|baseball
277708|NCT01972568|Atacicept|atacicept
277709|NCT01972568|Placebo|placebo
277710|NCT01972542|Postprandial period|postprandial period
277711|NCT01972542|triglyceride|triglyceride
277712|NCT01972542|Diabetes mellitus, type 2|diabetes mellitus, type 2
277713|NCT01972542|Prediabetic state|prediabetic state
277714|NCT01972529|Thrombocytopenia|thrombocytopenia
277715|NCT01972529|Chronic Liver Disease|chronic liver disease
277716|NCT01972516|Platinum-Sensitive|platinum-sensitive
277717|NCT01972516|Ovarian Cancer|ovarian cancer
277718|NCT01972516|Fallopian Tube Cancer|fallopian tube cancer
277719|NCT01972516|Primary Peritoneal Cancer|primary peritoneal cancer
277720|NCT01972516|High-grade Serous|high-grade serous
277721|NCT01972503|Colorectal Neoplasms|colorectal neoplasms
277722|NCT01972503|Liver|liver
277723|NCT01972503|Neoplasm Metastasis|neoplasm metastasis
277724|NCT01972503|Tegafur|tegafur
277725|NCT01972503|oxaliplatin|oxaliplatin
277726|NCT01972490|colorectal neoplasms|colorectal neoplasms
277727|NCT01972490|liver metastasis|liver metastasis
277728|NCT01972490|chemotherapy|chemotherapy
277729|NCT01972490|avastin|avastin
277730|NCT01972477|DLBS1449|dlbs1449
277731|NCT01972477|diabetes mellitus|diabetes mellitus
277732|NCT01972477|HDL-cholesterol|hdl-cholesterol
277733|NCT01972464|Progesterone|progesterone
277734|NCT01972464|Placebo|placebo
277735|NCT01972464|Postpartum|postpartum
277736|NCT01972464|Tobacco|tobacco
277737|NCT01972464|Pregnancy|pregnancy
277738|NCT01972438|Graft Versus Host Disease|graft versus host disease
277739|NCT01972438|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
277740|NCT01972412|nursing care|nursing care
277741|NCT01972412|diabetes mellitus|diabetes mellitus
277742|NCT01972412|phone support|phone support
277743|NCT01972412|chronic care model|chronic care model
277744|NCT01972373|VEGF|vegf
277745|NCT01972373|Fluorescence|fluorescence
277746|NCT01972373|Endoscopy|endoscopy
277747|NCT01972373|Rectal cancer|rectal cancer
277748|NCT01972360|SPECT|spect
277749|NCT01972360|CMR|cmr
277750|NCT01972360|High risk for ischemic cardiovascular events|high risk for ischemic cardiovascular events
277751|NCT01972347|Melanoma|melanoma
277752|NCT01972347|Cutaneous melanoma|cutaneous melanoma
277855|NCT01971892|Intubation;|intubation;
277753|NCT01972347|Malignant melanoma|malignant melanoma
277754|NCT01972347|Stage III B / C melanoma|stage iii b / c melanoma
277755|NCT01972347|Neoadjuvant treatment|neoadjuvant treatment
277756|NCT01972347|Pyrexia|pyrexia
277757|NCT01972347|Biomarkers|biomarkers
277758|NCT01972347|Dabrafenib|dabrafenib
277759|NCT01972347|Trametinib|trametinib
277760|NCT01972334|clostridium difficile|clostridium difficile
277761|NCT01972334|children|children
277762|NCT01972334|fecal transplant|fecal transplant
277763|NCT01972321|Community health worker|community health worker
277764|NCT01972321|Motivation|motivation
277765|NCT01972321|Performance|performance
277766|NCT01972321|Quality of care|quality of care
277767|NCT01972321|Africa|africa
277768|NCT01972308|asthma|asthma
277769|NCT01972308|patient advocate|patient advocate
277770|NCT01972308|health disparity|health disparity
277771|NCT01972308|patient-provider communication|patient-provider communication
277772|NCT01972282|Atrial fibrillation|atrial fibrillation
277773|NCT01972282|Stroke|stroke
277774|NCT01972282|Thrombus|thrombus
277775|NCT01972282|Thromboembolism|thromboembolism
277776|NCT01972282|Left atrial appendage|left atrial appendage
277777|NCT01972269|Epidural|epidural
277778|NCT01972269|Labor Analgesia|labor analgesia
277779|NCT01972269|Bupivacaine|bupivacaine
277780|NCT01972269|Minimum effective volume|minimum effective volume
277781|NCT01972243|risk of recurrent|risk of recurrent
277782|NCT01972217|Olaparib|olaparib
277783|NCT01972217|castration-resistant, metastatic prostate cancer|castration-resistant, metastatic prostate cancer
277784|NCT01972217|Prior Docetaxel Chemotherapy|prior docetaxel chemotherapy
277785|NCT01972191|Toric marking, Corneal horizontal marking|toric marking, corneal horizontal marking
277786|NCT01972165|Carpal tunnel syndrome|carpal tunnel syndrome
277787|NCT01972152|Hypoglycemia|hypoglycemia
277788|NCT01972152|Glucagon|glucagon
277789|NCT01972139|Uncontrolled hypertension|uncontrolled hypertension
277790|NCT01972139|blood pressure|blood pressure
277791|NCT01972139|renal denervation|renal denervation
277792|NCT01972139|HTN-4|htn-4
277793|NCT01972139|SYMPLICITY|symplicity
277794|NCT01972113|Vitamin K|vitamin k
277795|NCT01972113|Vitamin K2|vitamin k2
277796|NCT01972113|Menaquinone-7|menaquinone-7
277797|NCT01972113|Osteocalcin|osteocalcin
277798|NCT01972113|Children|children
277799|NCT01972113|Obesity|obesity
277800|NCT01972113|Insulin resistance|insulin resistance
277801|NCT01972113|Insulin sensitivity|insulin sensitivity
277802|NCT01972113|Beta-cell function|beta-cell function
277803|NCT01972113|Prediabetes|prediabetes
277804|NCT01972113|Matrix Gla protein|matrix gla protein
277805|NCT01972113|Arterial stiffness|arterial stiffness
277806|NCT01972113|Endothelial function|endothelial function
277807|NCT01972100|Low-level laser therapy|low-level laser therapy
277808|NCT01972100|Muscle fatigue resistance|muscle fatigue resistance
277809|NCT01972074|Autism spectrum disorder|autism spectrum disorder
277810|NCT01972074|Treatment|treatment
277811|NCT01972074|Adolescents|adolescents
277812|NCT01972074|Memantine|memantine
277813|NCT01972074|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
277814|NCT01972074|MRS|mrs
277815|NCT01972074|Neuroimaging|neuroimaging
277816|NCT01972048|breast cancer|breast cancer
277817|NCT01972048|breast cancer screening|breast cancer screening
277818|NCT01972048|mammogram|mammogram
277819|NCT01972035|EBV|ebv
277820|NCT01972035|CMV|cmv
277821|NCT01972035|Kidney transplant|kidney transplant
277822|NCT01972035|valganciclovir|valganciclovir
277823|NCT01972035|valacyclovir|valacyclovir
277824|NCT01972022|Drug Eluting Stents|drug eluting stents
277825|NCT01972022|Bioabsorbale Polymer Coating|bioabsorbale polymer coating
277826|NCT01972022|Neoatherosclerosis|neoatherosclerosis
277827|NCT01972022|Stent Coverage|stent coverage
277828|NCT01972022|Stent Failure|stent failure
277829|NCT01971996|Near infrared Spectroscopy|near infrared spectroscopy
277830|NCT01971983|Low back pain|low back pain
277831|NCT01971983|Spinal manipulation|spinal manipulation
277832|NCT01971983|Osteopathy|osteopathy
277833|NCT01971983|Muscle energy technique|muscle energy technique
277834|NCT01971983|Muscle thickness|muscle thickness
277835|NCT01971970|Inflammatory bowel disease|inflammatory bowel disease
277836|NCT01971970|Pediatric|pediatric
277837|NCT01971970|Adult|adult
277838|NCT01971970|Biomarker|biomarker
277839|NCT01971970|Anti-TNF response|anti-tnf response
277840|NCT01971970|Infliximab|infliximab
277841|NCT01971970|Adalimumab|adalimumab
277842|NCT01971957|ichthyosis|ichthyosis
277843|NCT01971957|spasticity|spasticity
277844|NCT01971957|spastic diplegia|spastic diplegia
277845|NCT01971957|intellectual disability|intellectual disability
277846|NCT01971944|Beta Blocker|beta blocker
277847|NCT01971944|Inotrope|inotrope
277848|NCT01971918|spondyloarthritis|spondyloarthritis
277849|NCT01971918|monoclonal antibodies anti-TNF|monoclonal antibodies anti-tnf
277850|NCT01971918|secondary treatment failure|secondary treatment failure
277851|NCT01971892|Abdominal surgery;|abdominal surgery;
277852|NCT01971892|Postoperative complication;|postoperative complication;
277853|NCT01971892|Acute respiratory failure;|acute respiratory failure;
277856|NCT01971892|Non-invasive ventilation|non-invasive ventilation
277857|NCT01971879|Remote ischemic preconditioning|remote ischemic preconditioning
277858|NCT01971879|Obliterating Arteriopathy of the Lower Limbs|obliterating arteriopathy of the lower limbs
277859|NCT01971866|Proton radiation|proton radiation
277860|NCT01971866|AlignRT|alignrt
277861|NCT01971853|Analgesia|analgesia
277862|NCT01971840|Physical activity|physical activity
277863|NCT01971840|Physical fitness|physical fitness
277864|NCT01971840|Obesity|obesity
277865|NCT01971840|Adiposity|adiposity
277866|NCT01971840|Adiposity rebound period|adiposity rebound period
277867|NCT01971840|Children|children
277868|NCT01971840|Blood pressure|blood pressure
277869|NCT01971840|Randomized controlled trials|randomized controlled trials
277870|NCT01971840|Barriers and facilitators of the environment|barriers and facilitators of the environment
277871|NCT01971827|Physical activity|physical activity
277872|NCT01971827|Obesity|obesity
277873|NCT01971827|Adiposity rebound period|adiposity rebound period
277874|NCT01971827|Children with ADHD|children with adhd
277875|NCT01971827|Children without ADHD|children without adhd
277876|NCT01971827|Academic performance|academic performance
277877|NCT01971827|Motor skills|motor skills
277878|NCT01971827|Health related-quality of life|health related-quality of life
277879|NCT01971827|Sleep|sleep
277880|NCT01971801|urinary incontinence|urinary incontinence
277881|NCT01971801|bowel incontinence|bowel incontinence
277882|NCT01971801|vitamin D|vitamin d
277883|NCT01971801|overactive bladder|overactive bladder
277884|NCT01971801|lower urinary tract symptoms|lower urinary tract symptoms
277885|NCT01971801|quality of life|quality of life
277886|NCT01971775|Ultrasonically Activated Shear|ultrasonically activated shear
277887|NCT01971775|Conventional Monopolar Electrocautery|conventional monopolar electrocautery
277888|NCT01971775|Gastric Cancer|gastric cancer
277889|NCT01971762|multiresistant bacteremia|multiresistant bacteremia
277890|NCT01971762|bacteremia management|bacteremia management
277891|NCT01971762|blood culture|blood culture
277892|NCT01971749|Coronary stent procedure (CSP|coronary stent procedure (csp
277893|NCT01971749|Coronary-artery bypass grafting (CABG)|coronary-artery bypass grafting (cabg)
277894|NCT01971736|1064nm YAG laser|1064nm yag laser
277895|NCT01971736|laxity|laxity
277896|NCT01971736|rhytides|rhytides
277897|NCT01971736|asian|asian
277898|NCT01971723|Testosterone|testosterone
277899|NCT01971723|Estrogen|estrogen
277900|NCT01971723|Insulin|insulin
277901|NCT01971723|Blood Lipid|blood lipid
277902|NCT01971723|Glucose|glucose
277903|NCT01971723|Creatine Kinase|creatine kinase
277904|NCT01971723|Strength|strength
277905|NCT01971723|Power Athlete|power athlete
277906|NCT01971710|HIV|hiv
277907|NCT01971710|AIDS|aids
277908|NCT01971710|PMTCT|pmtct
277909|NCT01971684|ITP|itp
277910|NCT01971684|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
277911|NCT01971684|bleeding score|bleeding score
277912|NCT01971684|platelet count|platelet count
277913|NCT01971684|health-related quality of life|health-related quality of life
277914|NCT01971684|HRQL|hrql
277915|NCT01971684|Purpura|purpura
277916|NCT01971684|Purpura, Thrombocytopenic|purpura, thrombocytopenic
277917|NCT01971684|Purpura, Thrombocytopenic, Idiopathic|purpura, thrombocytopenic, idiopathic
277918|NCT01971684|Blood Coagulation Disorders|blood coagulation disorders
277919|NCT01971684|Hematologic Diseases|hematologic diseases
277920|NCT01971684|Hemorrhage|hemorrhage
277921|NCT01971684|Skin Manifestations|skin manifestations
277922|NCT01971684|Thrombocytopenia|thrombocytopenia
277923|NCT01971684|Blood Platelet Disorders|blood platelet disorders
277924|NCT01971684|Immune System Diseases|immune system diseases
277925|NCT01971684|Hemorrhagic Disorders|hemorrhagic disorders
277926|NCT01971684|Autoimmune Diseases|autoimmune diseases
277927|NCT01971684|Therapeutic Uses|therapeutic uses
277928|NCT01971658|Multiple myeloma|multiple myeloma
277929|NCT01971658|Newly Diagnosed|newly diagnosed
277930|NCT01971645|Dexamethasone|dexamethasone
277931|NCT01971645|Ropivacaine|ropivacaine
277932|NCT01971645|Knee arthroscopy|knee arthroscopy
277933|NCT01971645|Femoral nerve blocks|femoral nerve blocks
277934|NCT01971645|Peripheral nerve blocks|peripheral nerve blocks
277935|NCT01971645|Adjuvant|adjuvant
277936|NCT01971645|Pediatrics|pediatrics
277937|NCT01971606|Statin, coronary artery bypass grafting, off-pump surgery, acute coronary syndrome|statin, coronary artery bypass grafting, off-pump surgery, acute coronary syndrome
277938|NCT01971567|Insomnia|insomnia
277939|NCT01971567|Electroencephalic|electroencephalic
277940|NCT01971567|Biofeedback|biofeedback
277941|NCT01971567|Neural oscillations|neural oscillations
277942|NCT01971567|Auto calibration|auto calibration
277943|NCT01971567|Relaxation|relaxation
277944|NCT01971541|mindfulness|mindfulness
277945|NCT01971541|behavior therapies, cognitive|behavior therapies, cognitive
277946|NCT01971541|posttraumatic stress disorder|posttraumatic stress disorder
277947|NCT01971541|group therapy|group therapy
277948|NCT01971528|Muscle strength, fatigue, electromyography (EMG), central fatigue, strength straining|muscle strength, fatigue, electromyography (emg), central fatigue, strength straining
277949|NCT01971515|MSC2363318A|msc2363318a
278052|NCT01971099|hypoactive|hypoactive
277950|NCT01971515|Maximum tolerated dose|maximum tolerated dose
277951|NCT01971515|Dose limiting toxicities|dose limiting toxicities
277952|NCT01971515|Recommended phase 2 dose|recommended phase 2 dose
277953|NCT01971515|M2698|m2698
277954|NCT01971515|Metastatic Breast Cancer|metastatic breast cancer
277955|NCT01971515|HER2+ Metastatic Breast Cancer|her2+ metastatic breast cancer
277956|NCT01971515|Hormone refractory ER/PR+ breast cancer|hormone refractory er/pr+ breast cancer
277957|NCT01971515|Tamoxifen|tamoxifen
277958|NCT01971515|PAM Pathway Alteration(s)|pam pathway alteration(s)
277959|NCT01971515|PAM Pathway|pam pathway
277960|NCT01971515|Targeted Therapy|targeted therapy
277961|NCT01971515|P70S6K|p70s6k
277962|NCT01971515|AKT Inhibition|akt inhibition
277963|NCT01971515|PI3K Pathway|pi3k pathway
277964|NCT01971515|HER2+ Trastuzumab Resistance|her2+ trastuzumab resistance
277965|NCT01971450|Non-interventional|non-interventional
277966|NCT01971450|Ventavis|ventavis
277967|NCT01971450|Iloprost|iloprost
277968|NCT01971450|Pulmonary hypertension|pulmonary hypertension
277969|NCT01971450|Compliance|compliance
277970|NCT01971450|Russian Federation|russian federation
277971|NCT01971437|Overactive Bladder|overactive bladder
277972|NCT01971437|OAB|oab
277973|NCT01971437|Cystoscopy|cystoscopy
277974|NCT01971437|Cystodistension|cystodistension
277975|NCT01971437|UTI|uti
277976|NCT01971437|Cytokines|cytokines
277977|NCT01971424|magnesium|magnesium
277978|NCT01971424|SPPB|sppb
277979|NCT01971424|strength|strength
277980|NCT01971424|physical performance|physical performance
277981|NCT01971424|24 hour magnesuria|24 hour magnesuria
277982|NCT01971411|Hyperparathyroidism|hyperparathyroidism
277983|NCT01971411|Hypoparathyroidism|hypoparathyroidism
277984|NCT01971411|Calcium|calcium
277985|NCT01971411|Vitamin D|vitamin d
277986|NCT01971411|Bone mineral density|bone mineral density
277987|NCT01971411|African American|african american
277988|NCT01971411|Female|female
277989|NCT01971411|Elderly|elderly
277990|NCT01971398|Fetal Alcohol Spectrum Disorders (FASD)|fetal alcohol spectrum disorders (fasd)
277991|NCT01971398|Prevention|prevention
277992|NCT01971398|Alcohol-Exposed Pregnancy|alcohol-exposed pregnancy
277993|NCT01971398|Knowledge|knowledge
277994|NCT01971398|Attitudes|attitudes
277995|NCT01971359|Stroke, Intracerebral Hemorrhage, ICH|stroke, intracerebral hemorrhage, ich
277996|NCT01971346|Psoriasis|psoriasis
277997|NCT01971346|ENBREL|enbrel
277998|NCT01971346|etanercept|etanercept
277999|NCT01971346|anti-TNF|anti-tnf
278000|NCT01971333|pulse pressure variation|pulse pressure variation
278001|NCT01971333|stroke volume variation|stroke volume variation
278002|NCT01971333|plethysmographic variation index|plethysmographic variation index
278003|NCT01971333|fluid responsiveness|fluid responsiveness
278004|NCT01971294|Urinary symptoms|urinary symptoms
278005|NCT01971294|Systemic sclerosis|systemic sclerosis
278006|NCT01971294|Severity index|severity index
278007|NCT01971294|Urinary tract infection|urinary tract infection
278008|NCT01971294|mortality|mortality
278009|NCT01971294|Quality of life|quality of life
278010|NCT01971281|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
278011|NCT01971281|Pancreas tumor|pancreas tumor
278012|NCT01971281|Treatment|treatment
278013|NCT01971281|Minimal toxicity|minimal toxicity
278014|NCT01971281|TTFields|ttfields
278015|NCT01971281|Tumor Treating Fields|tumor treating fields
278016|NCT01971281|Novocure|novocure
278017|NCT01971268|T3 dental implants|t3 dental implants
278018|NCT01971268|Marginal bone loss|marginal bone loss
278019|NCT01971268|Survival rate|survival rate
278020|NCT01971255|Influenza A|influenza a
278021|NCT01971255|HAI|hai
278022|NCT01971255|H1N1|h1n1
278023|NCT01971255|Challenge Study|challenge study
278024|NCT01971255|Correlates of Protection|correlates of protection
278025|NCT01971242|Parkinson's|parkinson's
278026|NCT01971242|Parkinson's Disease|parkinson's disease
278027|NCT01971242|Exenatide|exenatide
278028|NCT01971242|Bydureon|bydureon
278029|NCT01971216|Breastfeeding, relaxation, anxiety, infant growth|breastfeeding, relaxation, anxiety, infant growth
278030|NCT01971203|seroquel XR|seroquel xr
278031|NCT01971203|quetiapine XR|quetiapine xr
278032|NCT01971203|major depression|major depression
278033|NCT01971203|generalized anxiety disorder|generalized anxiety disorder
278034|NCT01971203|CBT|cbt
278035|NCT01971203|co-morbid MDD|co-morbid mdd
278036|NCT01971164|anemia|anemia
278037|NCT01971164|chronic kidney disease|chronic kidney disease
278038|NCT01971164|hemodialysis|hemodialysis
278039|NCT01971151|Chronic|chronic
278040|NCT01971151|Back pain|back pain
278041|NCT01971151|Low back|low back
278042|NCT01971125|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
278043|NCT01971125|Heart Diseases|heart diseases
278044|NCT01971125|Left Ventricular Dysfunction|left ventricular dysfunction
278045|NCT01971112|Multi-vitamins|multi-vitamins
278046|NCT01971112|Minerals|minerals
278047|NCT01971112|Respiratory infections|respiratory infections
278048|NCT01971112|DTH|dth
278049|NCT01971112|CRP|crp
278050|NCT01971112|Cathelicidin|cathelicidin
278051|NCT01971099|sexual function|sexual function
278053|NCT01971099|desire|desire
278054|NCT01971099|androgens|androgens
278055|NCT01971073|schizophrenic patients|schizophrenic patients
278056|NCT01971073|tDCS|tdcs
278057|NCT01971073|Executive functions|executive functions
278058|NCT01971073|Dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
278059|NCT01971060|uterine fibroids|uterine fibroids
278060|NCT01971060|barbed suture|barbed suture
278061|NCT01971060|infertility|infertility
278062|NCT01971060|adhesions|adhesions
278063|NCT01971047|Diabetes|diabetes
278064|NCT01971047|Surgery|surgery
278065|NCT01971047|anesthesiology|anesthesiology
278066|NCT01971047|endocrinology|endocrinology
278067|NCT01970995|Candidate modified risk tobacco product|candidate modified risk tobacco product
278068|NCT01970995|Conventional cigarettes|conventional cigarettes
278069|NCT01970995|Reduced exposure|reduced exposure
278070|NCT01970995|HPHCs|hphcs
278071|NCT01970995|Ambulatory|ambulatory
278072|NCT01970982|Candidate modified risk tobacco product|candidate modified risk tobacco product
278073|NCT01970982|Conventional cigarette|conventional cigarette
278074|NCT01970982|Reduced exposure|reduced exposure
278075|NCT01970982|HPHCs|hphcs
278076|NCT01970982|Confinement|confinement
278077|NCT01970969|Atrial Fibrillation|atrial fibrillation
278078|NCT01970969|Cardiac monitoring|cardiac monitoring
278079|NCT01970969|Genomics|genomics
278080|NCT01970943|migraine, headache, episodic, chronic, pain|migraine, headache, episodic, chronic, pain
278081|NCT01970930|Tissue banking|tissue banking
278082|NCT01970917|tear film thickness|tear film thickness
278083|NCT01970917|optical coherence tomography|optical coherence tomography
278084|NCT01970917|topical lubricants|topical lubricants
278085|NCT01970917|tear film thickness in healthy subjects|tear film thickness in healthy subjects
278086|NCT01970904|Chronic hepatitis C|chronic hepatitis c
278087|NCT01970904|DEB025|deb025
278088|NCT01970904|Alisporivir|alisporivir
278089|NCT01970904|ribavirin therapy|ribavirin therapy
278090|NCT01970904|genotype 2/3 treatment naive patients|genotype 2/3 treatment naive patients
278091|NCT01970891|Freezing of Gait|freezing of gait
278092|NCT01970891|Gait|gait
278093|NCT01970891|Comfort|comfort
278094|NCT01970891|Pain tolerance|pain tolerance
278095|NCT01970891|Pain|pain
278096|NCT01970891|Sensory threshold|sensory threshold
278097|NCT01970891|Motor threshold|motor threshold
278098|NCT01970891|Pain threshold|pain threshold
278099|NCT01970865|Phase 1|phase 1
278100|NCT01970865|Phase 2|phase 2
278101|NCT01970865|safety|safety
278102|NCT01970865|pharmacokinetic|pharmacokinetic
278103|NCT01970865|pharmacodynamic|pharmacodynamic
278104|NCT01970865|efficacy|efficacy
278105|NCT01970852|Inpatient|inpatient
278106|NCT01970852|PHR Portal|phr portal
278107|NCT01970852|Information Technology|information technology
278108|NCT01970839|Tourniquet|tourniquet
278109|NCT01970839|Endoneural|endoneural
278110|NCT01970839|Ischemia|ischemia
278111|NCT01970826|aseptic sterilized field|aseptic sterilized field
278112|NCT01970826|clean sterilized field|clean sterilized field
278113|NCT01970826|dental implants|dental implants
278114|NCT01970826|Surgery|surgery
278115|NCT01970813|Parkinson's disease|parkinson's disease
278116|NCT01970813|Idiopathic Parkinson's disease|idiopathic parkinson's disease
278117|NCT01970813|acupuncture|acupuncture
278118|NCT01970813|bee venom acupuncture|bee venom acupuncture
278119|NCT01970800|IGF-1|igf-1
278120|NCT01970800|Short Stature|short stature
278121|NCT01970800|GH|gh
278122|NCT01970748|Variceal bleeding|variceal bleeding
278123|NCT01970748|Portal hypertension|portal hypertension
278124|NCT01970748|Hepatocellular carcinoma|hepatocellular carcinoma
278125|NCT01970748|Endoscopic variceal ligation|endoscopic variceal ligation
278126|NCT01970748|Non-selective beta-blocker|non-selective beta-blocker
278127|NCT01970709|Adverse Drug Reactions|adverse drug reactions
278128|NCT01970709|Emergency Department Visits|emergency department visits
278129|NCT01970709|Hospitalizations|hospitalizations
278130|NCT01970709|Pharmacogenomic|pharmacogenomic
278131|NCT01970696|ovarian|ovarian
278132|NCT01970696|testicular|testicular
278133|NCT01970696|stromal|stromal
278134|NCT01970696|Sertoli|sertoli
278135|NCT01970696|Leydig|leydig
278136|NCT01970696|gynandroblastoma|gynandroblastoma
278137|NCT01970696|juvenile granulosa cell tumor|juvenile granulosa cell tumor
278138|NCT01970696|DICER1|dicer1
278139|NCT01970657|Venous Stasis Ulcer|venous stasis ulcer
278140|NCT01970657|VLU|vlu
278141|NCT01970644|Neoplasm metastasis|neoplasm metastasis
278142|NCT01970644|Brain neoplasms|brain neoplasms
278143|NCT01970644|Radiosurgery|radiosurgery
278144|NCT01970644|Cognition disorders|cognition disorders
278145|NCT01970644|Cranial irradiation|cranial irradiation
278146|NCT01970631|Osteoarthritis|osteoarthritis
278147|NCT01970631|Total Knee Replacement|total knee replacement
278148|NCT01970631|total Knee Arthroplasty|total knee arthroplasty
278149|NCT01970631|Post-operative recovery TKR|post-operative recovery tkr
278150|NCT01970631|Physical Activity|physical activity
278151|NCT01970631|Motivational Interviewing|motivational interviewing
278152|NCT01970631|Financial Incentives|financial incentives
278153|NCT01970592|exercise|exercise
278154|NCT01970592|rehabilitation|rehabilitation
278155|NCT01970592|walking|walking
278156|NCT01970566|Intense Exercise/Moderate Calorie Restriction|intense exercise/moderate calorie restriction
278157|NCT01970566|Topiramate-Phentermine|topiramate-phentermine
278158|NCT01970553|lurbinectedin|lurbinectedin
278159|NCT01970553|PM01183|pm01183
278160|NCT01970553|tumors|tumors
278161|NCT01970553|cancer|cancer
278162|NCT01970553|Pharma Mar|pharma mar
278163|NCT01970540|lurbinectedin|lurbinectedin
278164|NCT01970540|PM01183|pm01183
278165|NCT01970540|tumors|tumors
278166|NCT01970540|cancer|cancer
278167|NCT01970540|Pharma Mar|pharma mar
278168|NCT01970501|atrial fibrillation|atrial fibrillation
278169|NCT01970501|atrial flutter|atrial flutter
278170|NCT01970501|heart failure|heart failure
278171|NCT01970501|reduced left ventricle ejection fraction|reduced left ventricle ejection fraction
278172|NCT01970501|electrical cardioversion|electrical cardioversion
278173|NCT01970501|GENETIC-AF|genetic-af
278174|NCT01970501|Medtronic|medtronic
278175|NCT01970501|bucindolol|bucindolol
278176|NCT01970501|pharmacogenetic|pharmacogenetic
278177|NCT01970501|ARCA|arca
278178|NCT01970501|Toprol|toprol
278179|NCT01970501|Toprol-XL|toprol-xl
278180|NCT01970501|Metoprolol|metoprolol
278181|NCT01970501|Metoprolol succinate|metoprolol succinate
278182|NCT01970488|Plaque Psoriasis|plaque psoriasis
278183|NCT01970475|Arthritis|arthritis
278184|NCT01970475|Rheumatoid|rheumatoid
278185|NCT01970436|Prenatal care|prenatal care
278186|NCT01970436|Pregnancy|pregnancy
278187|NCT01970436|Obstetrics|obstetrics
278188|NCT01970436|Telemedicine|telemedicine
278189|NCT01970423|Patients with pacemaker or ICD therapy|patients with pacemaker or icd therapy
278190|NCT01970410|teriflunomide|teriflunomide
278191|NCT01970410|natalizumab|natalizumab
278192|NCT01970410|relapsing multiple sclerosis|relapsing multiple sclerosis
278193|NCT01970384|transcranial direct current stimulation|transcranial direct current stimulation
278194|NCT01970384|stroke-related dysphagia|stroke-related dysphagia
278195|NCT01970384|cortical plasticity|cortical plasticity
278196|NCT01970371|Gram-negative|gram-negative
278197|NCT01970371|bacterial infection|bacterial infection
278198|NCT01970371|antibacterial|antibacterial
278199|NCT01970371|antimicrobial|antimicrobial
278200|NCT01970371|CRE|cre
278201|NCT01970371|CPE|cpe
278202|NCT01970371|BSI|bsi
278203|NCT01970371|pneumonia|pneumonia
278204|NCT01970371|HABP|habp
278205|NCT01970371|VABP|vabp
278206|NCT01970371|AP|ap
278207|NCT01970371|cUTI|cuti
278208|NCT01970371|UTI|uti
278209|NCT01970358|melanoma|melanoma
278210|NCT01970358|melanoma vaccine|melanoma vaccine
278211|NCT01970358|adjuvant therapy|adjuvant therapy
278212|NCT01970345|Autism Spectrum Disorder|autism spectrum disorder
278213|NCT01970345|IGF-1|igf-1
278214|NCT01970332|Peripheral Arterial Disease|peripheral arterial disease
278215|NCT01970332|Peripheral Vascular Disease|peripheral vascular disease
278216|NCT01970332|Claudication|claudication
278217|NCT01970332|Myopathy|myopathy
278218|NCT01970332|Oxidative stress|oxidative stress
278219|NCT01970332|Mitochondrial dysfunction|mitochondrial dysfunction
278220|NCT01970332|Biomechanics|biomechanics
278221|NCT01970332|Inflammation|inflammation
278222|NCT01970306|Esophageal Reinforcement|esophageal reinforcement
278223|NCT01970306|ACell MatriStem|acell matristem
278224|NCT01970306|13-178|13-178
278225|NCT01970293|Alcohol use|alcohol use
278226|NCT01970293|STI|sti
278227|NCT01970293|Incarcerated women|incarcerated women
278228|NCT01970293|AA|aa
278229|NCT01970254|hepatitis B virus infection|hepatitis b virus infection
278230|NCT01970254|HBV|hbv
278231|NCT01970254|Cancer Patients|cancer patients
278232|NCT01970254|chemotherapy|chemotherapy
278233|NCT01970254|HBV screening strategy|hbv screening strategy
278234|NCT01970254|HBV care|hbv care
278235|NCT01970254|chronic HBV|chronic hbv
278236|NCT01970254|concomitant HBV infection|concomitant hbv infection
278237|NCT01970254|viral infections|viral infections
278238|NCT01970241|corticosteroid|corticosteroid
278239|NCT01970241|diabetes|diabetes
278240|NCT01970241|insulin|insulin
278241|NCT01970202|obesity|obesity
278242|NCT01970202|overweight|overweight
278243|NCT01970202|sleeve gastrectomy|sleeve gastrectomy
278244|NCT01970189|Immune Thrombocytopenia|immune thrombocytopenia
278245|NCT01970189|Primary Immune Thrombocytopenia|primary immune thrombocytopenia
278246|NCT01970189|Purpura, Thrombocytopenic, Idiopathic|purpura, thrombocytopenic, idiopathic
278247|NCT01970189|Autoimmune Thrombocytopenia|autoimmune thrombocytopenia
278248|NCT01970189|Thrombocytopenia|thrombocytopenia
278249|NCT01970163|Diabetic foot ulcer|diabetic foot ulcer
278250|NCT01970163|Venous stasis ulcer|venous stasis ulcer
278251|NCT01970163|Wound of the lower extremity|wound of the lower extremity
278252|NCT01970163|Skin substitute|skin substitute
278253|NCT01970163|Acellular Dermal Matrix|acellular dermal matrix
278254|NCT01970150|rTMS|rtms
278255|NCT01970150|Alzheimer Disease|alzheimer disease
278256|NCT01970150|Memory|memory
278257|NCT01970150|attention|attention
278258|NCT01970150|EEG|eeg
278259|NCT01970137|Spinocerebellar degeneration (SCD)|spinocerebellar degeneration (scd)
278260|NCT01970137|Thyrotropin-Releasing Hormone (TRH)|thyrotropin-releasing hormone (trh)
278261|NCT01970137|Spinocerebellar Ataxia (SCA)|spinocerebellar ataxia (sca)
278262|NCT01970124|Spinocerebellar degeneration (SCD)|spinocerebellar degeneration (scd)
278263|NCT01970124|Thyrotropin-Releasing Hormone (TRH)|thyrotropin-releasing hormone (trh)
278264|NCT01970124|Spinocerebellar Ataxia (SCA)|spinocerebellar ataxia (sca)
278265|NCT01970111|Spinocerebellar degeneration (SCD)|spinocerebellar degeneration (scd)
278266|NCT01970111|Thyrotropin-Releasing Hormone (TRH)|thyrotropin-releasing hormone (trh)
278267|NCT01970111|Spinocerebellar Ataxia (SCA)|spinocerebellar ataxia (sca)
278268|NCT01970111|Cortical Cerebellar Atrophy (CCA)|cortical cerebellar atrophy (cca)
278269|NCT01970098|Spinocerebellar degeneration (SCD)|spinocerebellar degeneration (scd)
278270|NCT01970098|Thyrotropin-Releasing Hormone (TRH)|thyrotropin-releasing hormone (trh)
278271|NCT01970098|Spinocerebellar Ataxia (SCA)|spinocerebellar ataxia (sca)
278272|NCT01970098|Cortical Cerebellar Atrophy (CCA)|cortical cerebellar atrophy (cca)
278273|NCT01970072|Remimazolam Tosylate|remimazolam tosylate
278274|NCT01970072|Phase Ⅰ study|phase ⅰ study
278275|NCT01970072|Health|health
278276|NCT01970059|Hypertension|hypertension
278277|NCT01970046|SP2086|sp2086
278278|NCT01970046|Phase III|phase iii
278279|NCT01970046|combination therapy|combination therapy
278280|NCT01970033|SP2086|sp2086
278281|NCT01970033|Phase III|phase iii
278282|NCT01970033|Monotherapy|monotherapy
278283|NCT01970020|Healthy|healthy
278284|NCT01970020|JNJ-38518168|jnj-38518168
278285|NCT01970020|14C-JNJ-38518168|14c-jnj-38518168
278286|NCT01970020|Absorption|absorption
278287|NCT01970020|Metabolism|metabolism
278288|NCT01970020|Excretion|excretion
278289|NCT01970007|venous|venous
278290|NCT01970007|outflow obstruction|outflow obstruction
278291|NCT01970007|iliofemoral vein|iliofemoral vein
278292|NCT01969994|Epicatechin|epicatechin
278293|NCT01969994|Flavanols|flavanols
278294|NCT01969994|Procyanidins|procyanidins
278295|NCT01969994|Polyphenols|polyphenols
278296|NCT01969994|Phytonutrients|phytonutrients
278297|NCT01969994|AMDE|amde
278298|NCT01969994|Antioxidants|antioxidants
278299|NCT01969981|Peripheral Inserted Central Catheter|peripheral inserted central catheter
278300|NCT01969955|nanoparticle albumin-bound paclitaxel|nanoparticle albumin-bound paclitaxel
278301|NCT01969955|Squamous Cell Carcinoma of Lung|squamous cell carcinoma of lung
278302|NCT01969942|Ewings sarcoma|ewings sarcoma
278303|NCT01969916|Cardiac CT imaging|cardiac ct imaging
278304|NCT01969916|Myocardial ischemia|myocardial ischemia
278305|NCT01969916|Myocardial perfusion|myocardial perfusion
278306|NCT01969916|Vasodilator stress testing|vasodilator stress testing
278307|NCT01969916|Regadenoson|regadenoson
278308|NCT01969903|brachial plexus block|brachial plexus block
278309|NCT01969903|lidocaine|lidocaine
278310|NCT01969903|dexmedetomidine|dexmedetomidine
278311|NCT01969903|bradycardia|bradycardia
278312|NCT01969903|hypotension|hypotension
278313|NCT01969877|Head and neck cancer|head and neck cancer
278314|NCT01969877|Cetuximab|cetuximab
278315|NCT01969877|Cisplatin|cisplatin
278316|NCT01969877|Radiotherapy|radiotherapy
278317|NCT01969877|Quality of life|quality of life
278318|NCT01969877|Human papilloma virus|human papilloma virus
278319|NCT01969877|Health economy|health economy
278320|NCT01969877|Biomarker investigations|biomarker investigations
278321|NCT01969864|Randomized Controlled Trial|randomized controlled trial
278322|NCT01969864|Healthcare Disparities|healthcare disparities
278323|NCT01969851|Lacosamide|lacosamide
278324|NCT01969851|Vimpat|vimpat
278325|NCT01969851|Epilepsy|epilepsy
278326|NCT01969851|Children|children
278327|NCT01969825|Infertility|infertility
278328|NCT01969825|Intrauterine insemination|intrauterine insemination
278329|NCT01969825|Male factor infertility|male factor infertility
278330|NCT01969825|Massage|massage
278331|NCT01969825|Total motile sperm count|total motile sperm count
278332|NCT01969812|Infertility|infertility
278333|NCT01969812|Intrauterine Insemination|intrauterine insemination
278334|NCT01969812|Slow-release Insemination|slow-release insemination
278335|NCT01969812|Evie|evie
278336|NCT01969799|Gram-negative pneumonia|gram-negative pneumonia
278337|NCT01969799|Aerosol antibiotics|aerosol antibiotics
278338|NCT01969799|Mechanical ventilation|mechanical ventilation
278339|NCT01969799|Amikacin|amikacin
278340|NCT01969799|Fosfomycin|fosfomycin
278341|NCT01969799|Pneumonia, Bacterial|pneumonia, bacterial
278342|NCT01969799|Pneumonia|pneumonia
278343|NCT01969799|Bacterial Infections|bacterial infections
278344|NCT01969799|Lung Diseases|lung diseases
278345|NCT01969799|Respiratory Tract Diseases|respiratory tract diseases
278346|NCT01969799|Respiratory Tract Infections|respiratory tract infections
278347|NCT01969799|Anti-Bacterial Agents|anti-bacterial agents
278348|NCT01969799|Anti-Infective Agents|anti-infective agents
278349|NCT01969799|Therapeutic Uses|therapeutic uses
278350|NCT01969799|Pharmacologic Actions|pharmacologic actions
278351|NCT01969773|Botulinum Toxin A (BoNT-A)|botulinum toxin a (bont-a)
278352|NCT01969773|Interstitial Cystitis|interstitial cystitis
278353|NCT01969734|Emphysema|emphysema
278354|NCT01969734|Moderate COPD|moderate copd
278355|NCT01969734|Hyperinflation|hyperinflation
278356|NCT01969734|Endobronchial valves|endobronchial valves
278357|NCT01969695|ABT-199|abt-199
278358|NCT01969695|Cancer|cancer
278359|NCT01969695|GDC-0199|gdc-0199
278360|NCT01969695|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
278361|NCT01969695|Relapsed|relapsed
278362|NCT01969695|Refractory|refractory
278363|NCT01969695|Safety|safety
278364|NCT01969682|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
278365|NCT01969682|GDC-0199|gdc-0199
278366|NCT01969682|Safety|safety
278367|NCT01969682|Relapsed|relapsed
278368|NCT01969682|Refractory|refractory
278369|NCT01969682|ABT-199|abt-199
278370|NCT01969682|Pharmacokinetics|pharmacokinetics
278371|NCT01969682|Cancer|cancer
278372|NCT01969669|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
278373|NCT01969669|GDC-0199|gdc-0199
278374|NCT01969669|Safety|safety
278375|NCT01969669|Relapsed|relapsed
278376|NCT01969669|Refractory|refractory
278377|NCT01969669|ABT-199|abt-199
278378|NCT01969669|Pharmacokinetics|pharmacokinetics
278379|NCT01969669|Cancer|cancer
278380|NCT01969656|vitamin D analog|vitamin d analog
278381|NCT01969643|Breast cancer|breast cancer
278382|NCT01969643|Monomethyl auristatin E|monomethyl auristatin e
278383|NCT01969643|Antibody-drug conjugate|antibody-drug conjugate
278384|NCT01969643|Drug therapy|drug therapy
278385|NCT01969643|Metastatic|metastatic
278386|NCT01969643|LIV-1 protein, human|liv-1 protein, human
278387|NCT01969643|Trastuzumab|trastuzumab
278388|NCT01969630|femoropopliteal lesions|femoropopliteal lesions
278389|NCT01969604|Rheumatoid Arthritis|rheumatoid arthritis
278390|NCT01969604|Sedentary Behaviour|sedentary behaviour
278391|NCT01969604|Motivational Counselling|motivational counselling
278392|NCT01969604|Short Text Message Service|short text message service
278393|NCT01969604|Fatigue|fatigue
278394|NCT01969604|Pain|pain
278395|NCT01969604|Self-efficacy|self-efficacy
278396|NCT01969604|ActivPAL|activpal
278397|NCT01969591|Fast track surgery, Laparoscopic surgery, colorectal cancer|fast track surgery, laparoscopic surgery, colorectal cancer
278398|NCT01969578|salivary duct cancer|salivary duct cancer
278399|NCT01969578|adenocarcinoma, NOS|adenocarcinoma, nos
278400|NCT01969578|androgen deprivation|androgen deprivation
278401|NCT01969578|androgen receptor|androgen receptor
278402|NCT01969552|TSH, thyroid hormones, thyroid tresting, levothyroxine|tsh, thyroid hormones, thyroid tresting, levothyroxine
278403|NCT01969526|Frail elderly|frail elderly
278404|NCT01969513|Vestibular Diseases|vestibular diseases
278405|NCT01969513|Vertigo|vertigo
278406|NCT01969513|Primary care|primary care
278407|NCT01969513|Epley maneuver|epley maneuver
278408|NCT01969500|Schizophrenia|schizophrenia
278409|NCT01969500|Schizoaffective Disorder|schizoaffective disorder
278410|NCT01969500|Self Management of Schizophrenia|self management of schizophrenia
278412|NCT01969500|SMI|smi
278413|NCT01969500|Psychosis|psychosis
278414|NCT01969500|Social Dysfunction|social dysfunction
278415|NCT01969500|Medication Adherence|medication adherence
278416|NCT01969500|Mobile Application|mobile application
278417|NCT01969500|EHealth|ehealth
278418|NCT01969500|E-Health|e-health
278419|NCT01969500|Health Technology|health technology
278420|NCT01969500|mHealth|mhealth
278421|NCT01969500|m-Health|m-health
278422|NCT01969474|Tinnitus Cannabis|tinnitus cannabis
278423|NCT01969461|HIV positive|hiv positive
278424|NCT01969461|Adolescents|adolescents
278425|NCT01969461|Adolescent Trials Network|adolescent trials network
278426|NCT01969461|Comparative Effectiveness Trial|comparative effectiveness trial
278427|NCT01969461|Implementation|implementation
278428|NCT01969461|Adherence Intervention|adherence intervention
278429|NCT01969461|Alcohol Intervention|alcohol intervention
278430|NCT01969448|Nipple-areola skin sparing mastectomy|nipple-areola skin sparing mastectomy
278431|NCT01969448|Immediate reconstruction|immediate reconstruction
278432|NCT01969448|Prophylactic Mastectomy|prophylactic mastectomy
278433|NCT01969448|Breast-Q|breast-q
278434|NCT01969448|Breast Cancer|breast cancer
278435|NCT01969448|Ductal Carcinoma in Situ - Category|ductal carcinoma in situ - category
278436|NCT01969409|Lung|lung
278437|NCT01969409|Fibrosis|fibrosis
278438|NCT01969396|Biopsy|biopsy
278439|NCT01969396|Endometrial biopsy|endometrial biopsy
278440|NCT01969396|Endometrial sampling|endometrial sampling
278441|NCT01969396|sonohysterography|sonohysterography
278442|NCT01969383|healthy|healthy
278443|NCT01969370|Cancer|cancer
278444|NCT01969370|Cardiovascular disease|cardiovascular disease
278445|NCT01969370|Neurodegenerative disease|neurodegenerative disease
278446|NCT01969370|Neurodevelopmental disease|neurodevelopmental disease
278447|NCT01969370|Dysmorphology|dysmorphology
278448|NCT01969370|Hearing loss|hearing loss
278449|NCT01969370|Other conditions, including ophthalmic conditions|other conditions, including ophthalmic conditions
278450|NCT01969357|Sp2086|sp2086
278451|NCT01969357|Phase II|phase ii
278452|NCT01969357|monotherapy|monotherapy
278453|NCT01969331|Gastritis|gastritis
278454|NCT01969331|Helicobacter pylori|helicobacter pylori
278455|NCT01969318|SP2086|sp2086
278456|NCT01969318|Phase II|phase ii
278457|NCT01969318|combination therapy|combination therapy
278458|NCT01969305|Kazakhstan|kazakhstan
278459|NCT01969305|Central Asia|central asia
278460|NCT01969305|HIV prevention|hiv prevention
278461|NCT01969305|Adolescents|adolescents
278462|NCT01969305|Sexual risk behaviors|sexual risk behaviors
278463|NCT01969305|Drug abuse prevention|drug abuse prevention
278464|NCT01969305|Multi-media intervention|multi-media intervention
278465|NCT01969305|Drug use|drug use
278466|NCT01969292|colonoscopy|colonoscopy
278467|NCT01969292|quality assurance|quality assurance
278468|NCT01969279|Osteoporosis|osteoporosis
278469|NCT01969279|Bisphosphonate|bisphosphonate
278470|NCT01969279|Atypical femoral fracture|atypical femoral fracture
278471|NCT01969279|Side effect|side effect
278472|NCT01969266|Healthy volunteer|healthy volunteer
278473|NCT01969266|PCI-32765|pci-32765
278474|NCT01969266|PCI 45227|pci 45227
278475|NCT01969266|JNJ-54179060|jnj-54179060
278476|NCT01969266|Pharmacokinetic|pharmacokinetic
278477|NCT01969253|Breast Cancer, Axillary Lymph Node Dissection, Lymphedema|breast cancer, axillary lymph node dissection, lymphedema
278478|NCT01969240|Chest Pain|chest pain
278479|NCT01969240|Decision Aid|decision aid
278480|NCT01969240|Acute Coronary Syndrome|acute coronary syndrome
278481|NCT01969240|Cardiac|cardiac
278482|NCT01969240|Emergency Department|emergency department
278483|NCT01969240|Cardiac Testing|cardiac testing
278484|NCT01969240|Healthcare Utilization|healthcare utilization
278485|NCT01969240|Patient Centered Outcomes|patient centered outcomes
278486|NCT01969240|Shared Decision Making|shared decision making
278487|NCT01969240|Unnecessary hospital admissions|unnecessary hospital admissions
278488|NCT01969201|In vitro fertilization (IVF)|in vitro fertilization (ivf)
278489|NCT01969201|Assisted reproduction technologies (ART)|assisted reproduction technologies (art)
278490|NCT01969201|GnRH-antagonist|gnrh-antagonist
278491|NCT01969201|Follicle stimulating hormone (FSH)|follicle stimulating hormone (fsh)
278492|NCT01969188|spondyloarthritis|spondyloarthritis
278493|NCT01969188|ankylosing spondylitis|ankylosing spondylitis
278494|NCT01969188|psoriatic arthritis|psoriatic arthritis
278495|NCT01969149|Stress Hyperglycemia|stress hyperglycemia
278496|NCT01969149|Perioperative glycemic control|perioperative glycemic control
278497|NCT01969149|Cardiac surgery|cardiac surgery
278498|NCT01969149|Coronary artery bypass surgery|coronary artery bypass surgery
278499|NCT01969136|Alzheimer's disease|alzheimer's disease
278500|NCT01969136|Cognition|cognition
278501|NCT01969136|Alpha-7 nAChR|alpha-7 nachr
278502|NCT01969123|Alzheimer's disease|alzheimer's disease
278503|NCT01969123|Cognition|cognition
278504|NCT01969123|Alpha-7 nAChR|alpha-7 nachr
278505|NCT01969110|Immunonutrition|immunonutrition
278506|NCT01969097|Stroke|stroke
278507|NCT01969097|Hemiparesis|hemiparesis
278508|NCT01969097|tDCS|tdcs
278509|NCT01969097|Motor cortex|motor cortex
278510|NCT01969084|Type II Diabetes Mellitus|type ii diabetes mellitus
278511|NCT01969084|Diabetes|diabetes
278512|NCT01969084|Metabolism|metabolism
278513|NCT01969084|Linagliptin|linagliptin
278514|NCT01969084|Tradjenta|tradjenta
278515|NCT01969084|Glucose|glucose
278516|NCT01969071|levosimendan|levosimendan
278517|NCT01969071|mitral valve surgery|mitral valve surgery
278518|NCT01969071|cardiopulmonary bypass|cardiopulmonary bypass
278519|NCT01969071|serum creatinine|serum creatinine
278520|NCT01969071|estimated glomerular filtration rate|estimated glomerular filtration rate
278521|NCT01969071|ejection fraction|ejection fraction
278522|NCT01969058|Isotretinoin|isotretinoin
278523|NCT01969058|HIV-1|hiv-1
278524|NCT01969058|immunology markers|immunology markers
278525|NCT01969058|immune activation|immune activation
278526|NCT01969058|viral suppression|viral suppression
278527|NCT01969045|felxible bronchoscopy|felxible bronchoscopy
278528|NCT01969045|anaesthetics|anaesthetics
278529|NCT01969045|transcutaneous pCO2|transcutaneous pco2
278530|NCT01969045|capillary pCO2|capillary pco2
278531|NCT01969006|inguinal hernia, postoperative pain, localanesthesia, nerve blockage|inguinal hernia, postoperative pain, localanesthesia, nerve blockage
278532|NCT01968993|Degenerative Disc Disease|degenerative disc disease
278533|NCT01968980|High Risk of cardiovascular events|high risk of cardiovascular events
278534|NCT01968980|Heterozygous familial hypercholesterolemia|heterozygous familial hypercholesterolemia
278535|NCT01968967|mixed dyslipidemia|mixed dyslipidemia
278536|NCT01968967|high risk of cardiovascular events|high risk of cardiovascular events
278537|NCT01968967|multiple cardiovascular disease risk factors|multiple cardiovascular disease risk factors
278538|NCT01968954|mixed dyslipidemia|mixed dyslipidemia
278539|NCT01968954|high risk of cardiovascular events|high risk of cardiovascular events
278540|NCT01968941|stereotactic body radiotherapy|stereotactic body radiotherapy
278541|NCT01968941|conventional radiotherapy|conventional radiotherapy
278542|NCT01968941|inoperable patients|inoperable patients
278543|NCT01968941|local control|local control
278544|NCT01968941|cancer recurrence|cancer recurrence
278545|NCT01968941|toxicity|toxicity
278546|NCT01968941|survival|survival
278547|NCT01968928|Bladder urothelial carcinoma (UC)|bladder urothelial carcinoma (uc)
278548|NCT01968928|pyruvate kinase|pyruvate kinase
278549|NCT01968928|drug resistance|drug resistance
278550|NCT01968928|shikonin|shikonin
279332|NCT01965665|Honey|honey
278551|NCT01968915|LCL161, Paclitaxel, Japanese patient, Neoplasms|lcl161, paclitaxel, japanese patient, neoplasms
278552|NCT01968902|spasticity|spasticity
278553|NCT01968902|lower limb|lower limb
278554|NCT01968902|multiple sclerosis|multiple sclerosis
278555|NCT01968902|toxin|toxin
278556|NCT01968889|Critical illness neuromyopathy|critical illness neuromyopathy
278557|NCT01968889|Diaphragm dysfunction|diaphragm dysfunction
278558|NCT01968889|Mechanical ventilation|mechanical ventilation
278559|NCT01968889|Weaning|weaning
278560|NCT01968889|Ultrasound|ultrasound
278561|NCT01968850|osteoporosis|osteoporosis
278562|NCT01968850|HIV|hiv
278563|NCT01968850|bone Mineral Density|bone mineral density
278564|NCT01968850|alendronate|alendronate
278565|NCT01968850|vitamin D|vitamin d
278566|NCT01968824|pain|pain
278567|NCT01968798|ACES|aces
278568|NCT01968798|ASPREE Cancer Endpoints Study|aspree cancer endpoints study
278569|NCT01968798|Cancer|cancer
278570|NCT01968798|Aspirin|aspirin
278571|NCT01968798|Tumor|tumor
278572|NCT01968772|Fibromyalgia|fibromyalgia
278573|NCT01968772|Fibromyalgia Syndrome|fibromyalgia syndrome
278574|NCT01968772|Magnesium Chloride|magnesium chloride
278575|NCT01968772|Transdermal Magnesium Chloride|transdermal magnesium chloride
278576|NCT01968759|Chronic kidney disease|chronic kidney disease
278577|NCT01968759|Sevelamer carbonate|sevelamer carbonate
278578|NCT01968759|Proteinuria|proteinuria
278579|NCT01968759|Phosphate binders|phosphate binders
278580|NCT01968746|Sepsis|sepsis
278581|NCT01968746|Shock|shock
278582|NCT01968733|Pneumonia|pneumonia
278583|NCT01968733|CABP|cabp
278584|NCT01968733|CAP|cap
278585|NCT01968733|Macrolide|macrolide
278586|NCT01968707|surgical prep|surgical prep
278587|NCT01968707|CHG|chg
278588|NCT01968707|IPA|ipa
278589|NCT01968694|endometriosis|endometriosis
278590|NCT01968694|chronic pain|chronic pain
278591|NCT01968694|intravenous lidocaine|intravenous lidocaine
278592|NCT01968668|BAY94-8862|bay94-8862
278593|NCT01968668|MR antagonist|mr antagonist
278594|NCT01968668|Diabetic nephropathy|diabetic nephropathy
278595|NCT01968668|Japanese patients|japanese patients
278596|NCT01968655|Factor VIII Inhibitory Auto-antibodies|factor viii inhibitory auto-antibodies
278597|NCT01968642|Transthoracic echocardiograms|transthoracic echocardiograms
278598|NCT01968642|Appropriate Use Criteria|appropriate use criteria
278599|NCT01968642|Medical Education|medical education
278600|NCT01968629|Hepatocellular Carcinoma|hepatocellular carcinoma
278601|NCT01968590|Vitamin D|vitamin d
278602|NCT01968590|Cholecalciferol|cholecalciferol
278603|NCT01968590|Bone density|bone density
278604|NCT01968577|Coronary angioplasty|coronary angioplasty
278605|NCT01968577|Myocardial infarction|myocardial infarction
278606|NCT01968551|HIV-1|hiv-1
278607|NCT01968551|HIV|hiv
278608|NCT01968551|Treatment-Experienced|treatment-experienced
278609|NCT01968525|anemia|anemia
278610|NCT01968525|non-hypoxic apnoea|non-hypoxic apnoea
278611|NCT01968525|tracheal intubation|tracheal intubation
278612|NCT01968525|anesthesia|anesthesia
278613|NCT01968512|Attention Deficit Hyperactivity Disorder (ADHD);|attention deficit hyperactivity disorder (adhd);
278614|NCT01968512|Transcranial Direct Current Stimulation (tDCS);|transcranial direct current stimulation (tdcs);
278615|NCT01968512|Control Inhibitory;|control inhibitory;
278616|NCT01968512|Quantitative electroencephalography;|quantitative electroencephalography;
278617|NCT01968512|Functional Brain Network;|functional brain network;
278618|NCT01968512|Go/No Go test.|go/no go test.
278619|NCT01968499|coronary stent implantation; clopidogrel low response|coronary stent implantation; clopidogrel low response
278620|NCT01968473|Parkinson's disease|parkinson's disease
278621|NCT01968473|Freezing of Gait|freezing of gait
278622|NCT01968473|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
278623|NCT01968473|Comfort|comfort
278624|NCT01968473|Pain tolerance|pain tolerance
278625|NCT01968473|Pain|pain
278626|NCT01968473|Sensory threshold|sensory threshold
278627|NCT01968473|Motor threshold|motor threshold
278628|NCT01968473|Pain threshold|pain threshold
278629|NCT01968460|Parkinson's Disease, Rasagiline, Pramipexole|parkinson's disease, rasagiline, pramipexole
278630|NCT01968434|cough|cough
278631|NCT01968434|common cold|common cold
278632|NCT01968434|antitussive agents|antitussive agents
278633|NCT01968434|mucosal protection|mucosal protection
278634|NCT01968434|medical device|medical device
278635|NCT01968421|OM-85, bronchiectasis, placebo, acute exacerbation|om-85, bronchiectasis, placebo, acute exacerbation
278636|NCT01968408|nosocomial diarrhea|nosocomial diarrhea
278637|NCT01968408|Lactobacillus reuteri DSM 17938|lactobacillus reuteri dsm 17938
278638|NCT01968408|rotavirus diarrhea|rotavirus diarrhea
278639|NCT01968408|probiotics|probiotics
278640|NCT01968382|IMM 124-E|imm 124-e
278641|NCT01968382|Bovine Colostrum|bovine colostrum
278642|NCT01968382|Alcoholic|alcoholic
278643|NCT01968382|Hepatitis|hepatitis
278644|NCT01968382|LPS|lps
278645|NCT01968382|Hyper-immune|hyper-immune
278646|NCT01968369|flow mediated vasodilatation|flow mediated vasodilatation
278647|NCT01968369|tomato|tomato
278648|NCT01968369|arterial stiffness|arterial stiffness
278649|NCT01968369|lycopene|lycopene
278650|NCT01968356|surgical skin prep|surgical skin prep
278651|NCT01968356|CHG|chg
278652|NCT01968356|IPA|ipa
278653|NCT01968317|Endometrial Atypical Hyperplasia|endometrial atypical hyperplasia
278654|NCT01968317|Endometrial Adenocarcinoma|endometrial adenocarcinoma
278655|NCT01968317|Conservative Medication|conservative medication
278656|NCT01968304|Iron Status, Cancer|iron status, cancer
278657|NCT01968291|Health Literacy|health literacy
278658|NCT01968291|Teach-back|teach-back
278659|NCT01968291|Emergency|emergency
278660|NCT01968265|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
278661|NCT01968265|T2DM|t2dm
278662|NCT01968252|Speckle-tracking echocardiography|speckle-tracking echocardiography
278663|NCT01968252|Transthoracic echocardiography|transthoracic echocardiography
278664|NCT01968252|Transesophageal echocardiography|transesophageal echocardiography
278665|NCT01968239|BRVO|brvo
278666|NCT01968239|Macular edema|macular edema
278667|NCT01968239|Ranibizumab|ranibizumab
278668|NCT01968239|re-treatment|re-treatment
278669|NCT01968226|carotid artery disease|carotid artery disease
278670|NCT01968226|carotid stenosis|carotid stenosis
278671|NCT01968226|carotid endarterectomy|carotid endarterectomy
278672|NCT01968226|RDG-K5|rdg-k5
278673|NCT01968226|PET imaging|pet imaging
278674|NCT01968213|ARIEL3|ariel3
278675|NCT01968213|ARIEL 3|ariel 3
278676|NCT01968213|platinum sensitive|platinum sensitive
278677|NCT01968213|PARP Inhibitor|parp inhibitor
278678|NCT01968213|rucaparib|rucaparib
278679|NCT01968213|homologous recombination|homologous recombination
278680|NCT01968213|homologous recombination deficiency|homologous recombination deficiency
278681|NCT01968213|CO-338|co-338
278682|NCT01968213|PF 01367338|pf 01367338
278683|NCT01968213|AG 14699|ag 14699
278684|NCT01968213|platinum sensitive ovarian cancer|platinum sensitive ovarian cancer
278685|NCT01968213|platinum sensitive fallopian tube cancer|platinum sensitive fallopian tube cancer
278686|NCT01968213|platinum sensitive primary peritoneal cancer|platinum sensitive primary peritoneal cancer
278687|NCT01968213|platinum sensitive peritoneal cancer|platinum sensitive peritoneal cancer
278688|NCT01968213|gynecological cancer|gynecological cancer
278689|NCT01968213|Clovis|clovis
278690|NCT01968213|Clovis Oncology|clovis oncology
278691|NCT01968200|cancer|cancer
278692|NCT01968200|chemotherapy|chemotherapy
278693|NCT01968200|anthracyclines|anthracyclines
278694|NCT01968174|astigmatism|astigmatism
278695|NCT01968174|lid surgery|lid surgery
278696|NCT01968174|older than 40 years|older than 40 years
278697|NCT01968174|can sign an acceptance form|can sign an acceptance form
278698|NCT01968174|uper lid surgery|uper lid surgery
278699|NCT01968148|glucose|glucose
278700|NCT01968148|cardiac arrest|cardiac arrest
278701|NCT01968148|resuscitation|resuscitation
278702|NCT01968148|insulin|insulin
278703|NCT01968148|GLP-1|glp-1
278704|NCT01968122|symptomatic Intracranial artery stenosis|symptomatic intracranial artery stenosis
278705|NCT01968122|conventional treatment|conventional treatment
278706|NCT01968122|stenting|stenting
278707|NCT01968122|stroke prevention|stroke prevention
278708|NCT01968122|medical treatment|medical treatment
278709|NCT01968122|endovascular treatment|endovascular treatment
278710|NCT01968096|Reflex|reflex
278711|NCT01968096|Post activation|post activation
278712|NCT01968096|Spinal cord injury|spinal cord injury
278713|NCT01968096|Pre-synaptic inhibition|pre-synaptic inhibition
278714|NCT01968096|Machine driven passive strech|machine driven passive strech
278715|NCT01968044|renal impairment|renal impairment
278716|NCT01968031|Parkinson's disease|parkinson's disease
278717|NCT01968031|Moderate to Severe Parkinson's Disease|moderate to severe parkinson's disease
278718|NCT01968018|Cancer|cancer
278719|NCT01968018|Chronic Cancer Pain|chronic cancer pain
278720|NCT01968018|Tramadol HCI|tramadol hci
278721|NCT01968018|Acetaminophen|acetaminophen
278722|NCT01968018|Analgesics|analgesics
278723|NCT01968018|Pain assessment|pain assessment
278724|NCT01967992|diabetes|diabetes
278725|NCT01967992|obesity|obesity
278726|NCT01967992|mindful eating|mindful eating
278727|NCT01967992|positive affect|positive affect
278728|NCT01967992|low carbohydrate|low carbohydrate
278729|NCT01967992|ketogenic|ketogenic
278730|NCT01967992|diet|diet
278731|NCT01967940|HIV-1|hiv-1
278732|NCT01967940|HIV|hiv
278733|NCT01967940|Treatment-Experienced|treatment-experienced
278734|NCT01967927|carcinoma|carcinoma
278735|NCT01967927|cancer|cancer
278736|NCT01967927|head|head
278737|NCT01967927|neck|neck
278738|NCT01967927|otolaryngology|otolaryngology
278739|NCT01967901|Diabetic nephropathies|diabetic nephropathies
278740|NCT01967901|Nursing|nursing
278741|NCT01967901|Multidisciplinary|multidisciplinary
278742|NCT01967901|Self-care|self-care
278743|NCT01967901|Quality of Life|quality of life
278744|NCT01967888|Pancreatic islet auto-transplantation|pancreatic islet auto-transplantation
278745|NCT01967875|Gastric Cancer|gastric cancer
278746|NCT01967875|ERCC1|ercc1
278747|NCT01967875|Platinum|platinum
278748|NCT01967875|Chemotherapy|chemotherapy
278749|NCT01967849|obesity|obesity
278750|NCT01967849|type 2 diabetes|type 2 diabetes
278751|NCT01967836|Invasive Line|invasive line
278752|NCT01967836|IV Dressing protection|iv dressing protection
278753|NCT01967836|Hygiene|hygiene
278754|NCT01967836|Oncology|oncology
278755|NCT01967836|Ambulatory Care|ambulatory care
278756|NCT01967823|Metastatic Cancer|metastatic cancer
278757|NCT01967823|Gene Therapy|gene therapy
278758|NCT01967823|Immunotherapy|immunotherapy
278759|NCT01967823|Tumor Regression|tumor regression
278760|NCT01967823|Melanoma|melanoma
278761|NCT01967810|glioma|glioma
278762|NCT01967810|glioblastoma|glioblastoma
278763|NCT01967810|brain cancer|brain cancer
278764|NCT01967810|brain tumor|brain tumor
278765|NCT01967810|recurrent|recurrent
278766|NCT01967797|Obesity|obesity
278767|NCT01967784|Influenza|influenza
278768|NCT01967784|Quadrivalent Inactivated Influenza Vaccine|quadrivalent inactivated influenza vaccine
278769|NCT01967771|healthy volunteers|healthy volunteers
278770|NCT01967771|drug interaction|drug interaction
278771|NCT01967771|carbamazepine|carbamazepine
278772|NCT01967771|Dolutegravir|dolutegravir
278773|NCT01967771|pharmacokinetics|pharmacokinetics
278774|NCT01967758|Astrocytic Tumors|astrocytic tumors
278775|NCT01967758|Glioblastoma Multiforme|glioblastoma multiforme
278776|NCT01967758|Anaplastic Astrocytoma|anaplastic astrocytoma
278777|NCT01967758|Brain Tumor|brain tumor
278778|NCT01967758|Brain Cancer|brain cancer
278779|NCT01967758|Immunotherapy|immunotherapy
278780|NCT01967745|open appendectomy|open appendectomy
278781|NCT01967745|laparoscopic appendectomy|laparoscopic appendectomy
278782|NCT01967745|appendicitis|appendicitis
278783|NCT01967732|Smoking|smoking
278784|NCT01967732|Nicotine absorption|nicotine absorption
278785|NCT01967732|Modified risk tobacco product|modified risk tobacco product
278786|NCT01967732|Conventional cigarette|conventional cigarette
278787|NCT01967732|Nicotine replacement therapy|nicotine replacement therapy
278788|NCT01967732|Nicotine nasal spray|nicotine nasal spray
278789|NCT01967719|Smoking|smoking
278790|NCT01967719|Nicotine absorption|nicotine absorption
278791|NCT01967719|Candidate modified risk tobacco product|candidate modified risk tobacco product
278792|NCT01967719|Conventional cigarette|conventional cigarette
278793|NCT01967719|Nicotine replacement therapy: nasal spray|nicotine replacement therapy: nasal spray
278794|NCT01967706|Smoking|smoking
278795|NCT01967706|Nicotine absorption|nicotine absorption
278796|NCT01967706|Candidate modified risk tobacco product|candidate modified risk tobacco product
278797|NCT01967706|Cigarette|cigarette
278798|NCT01967706|Nicotine replacement therapy|nicotine replacement therapy
278799|NCT01967706|Nicotine gum|nicotine gum
278800|NCT01967693|Laryngeal contact granuloma|laryngeal contact granuloma
278801|NCT01967693|Treatment type|treatment type
278802|NCT01967693|Outcome|outcome
278803|NCT01967641|opioid dependence|opioid dependence
278804|NCT01967641|opioid abuse|opioid abuse
278805|NCT01967641|suboxone|suboxone
278806|NCT01967641|prescription pain medications|prescription pain medications
278807|NCT01967628|Vitamin D|vitamin d
278808|NCT01967628|Respiratory infection|respiratory infection
278809|NCT01967628|Innate immunity|innate immunity
278810|NCT01967615|PCI,|pci,
278811|NCT01967615|CTO,|cto,
278812|NCT01967615|bifurcation,|bifurcation,
278813|NCT01967615|clopidogrel,|clopidogrel,
278814|NCT01967615|prasugrel,|prasugrel,
278815|NCT01967615|ticagrelor|ticagrelor
278816|NCT01967602|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
278817|NCT01967602|Extracorporeal membrane oxygenation (ECMO)|extracorporeal membrane oxygenation (ecmo)
278818|NCT01967602|biomarker|biomarker
278819|NCT01967576|Mutation in SDHB gene|mutation in sdhb gene
278820|NCT01967576|Mutation in SDHV gene|mutation in sdhv gene
278821|NCT01967576|Mutation in VHL gene|mutation in vhl gene
278822|NCT01967576|Pharmacogenomics analyses|pharmacogenomics analyses
278823|NCT01967576|Germline DNA examination|germline dna examination
278824|NCT01967563|Energy Expenditure|energy expenditure
278825|NCT01967563|Obesity|obesity
278826|NCT01967563|Carbohydrate|carbohydrate
278827|NCT01967563|Fat|fat
278828|NCT01967563|Ketones|ketones
278829|NCT01967550|Symptomatic knee OA Kellgren-Lawrence grade 1-3|symptomatic knee oa kellgren-lawrence grade 1-3
278830|NCT01967537|NET|net
278831|NCT01967537|MEN1|men1
278832|NCT01967537|Von Hippel Lindau (VHL)|von hippel lindau (vhl)
278833|NCT01967537|Surgical Resection|surgical resection
278834|NCT01967537|Somatostatin Receptor Status|somatostatin receptor status
278835|NCT01967524|Myofascial pain|myofascial pain
278836|NCT01967524|Perineal pain|perineal pain
278837|NCT01967524|Chronic pelvic pain|chronic pelvic pain
278838|NCT01967524|Botulinum toxin type A|botulinum toxin type a
278839|NCT01967524|Ropivacaïne|ropivacaïne
278840|NCT01967511|Cross-sectional study|cross-sectional study
278841|NCT01967511|Fibromuscular dysplasia|fibromuscular dysplasia
278842|NCT01967511|Fibroblast|fibroblast
278843|NCT01967511|Spontaneous Coronary Artery Dissection|spontaneous coronary artery dissection
278844|NCT01967511|Cervical Artery Dissection|cervical artery dissection
278845|NCT01967498|chronic otitis media with effusion|chronic otitis media with effusion
278846|NCT01967498|conductive hearing loss|conductive hearing loss
278847|NCT01967485|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
278848|NCT01967485|Medication adherence|medication adherence
278849|NCT01967485|Disease management|disease management
278850|NCT01967485|Text message|text message
278851|NCT01967485|ADHD|adhd
278852|NCT01967485|Children|children
278853|NCT01967485|Reminder systems|reminder systems
278854|NCT01967485|Text Messaging|text messaging
278855|NCT01967485|Telemedicine|telemedicine
278856|NCT01967433|Fentanyl|fentanyl
278857|NCT01967433|Midazolam|midazolam
278858|NCT01967433|Sedation|sedation
278859|NCT01967433|Patient tolerance|patient tolerance
278860|NCT01967433|Duration of colonoscopy|duration of colonoscopy
278861|NCT01967420|Cognitive remediation|cognitive remediation
278862|NCT01967420|Social cognition training|social cognition training
278863|NCT01967420|First episode psychosis|first episode psychosis
278864|NCT01967420|Schizophrenia|schizophrenia
278865|NCT01967407|kidney tumor|kidney tumor
278866|NCT01967407|renal cell cancer|renal cell cancer
278867|NCT01967407|RCC|rcc
278868|NCT01967407|irreversible electroporation|irreversible electroporation
278869|NCT01967407|IRE|ire
278870|NCT01967407|partial kidney resection|partial kidney resection
278871|NCT01967407|percutaneous|percutaneous
278872|NCT01967407|ablation|ablation
278873|NCT01967407|IRENE|irene
278874|NCT01967394|Health Care Quality|health care quality
278875|NCT01967394|Access|access
278876|NCT01967394|Evaluation|evaluation
278877|NCT01967368|Influenza vaccine|influenza vaccine
278878|NCT01967368|intradermal|intradermal
278879|NCT01967368|intramuscular|intramuscular
278880|NCT01967368|efficacy|efficacy
278881|NCT01967368|safety|safety
278882|NCT01967355|preeclampsia|preeclampsia
278883|NCT01967355|lipid apheresis|lipid apheresis
278884|NCT01967355|apheresis|apheresis
278885|NCT01967342|chronic pain|chronic pain
278886|NCT01967342|pain|pain
278887|NCT01967342|chronic pain syndrome|chronic pain syndrome
278888|NCT01967342|widespread chronic pain|widespread chronic pain
278889|NCT01967342|back pain|back pain
278890|NCT01967342|literacy|literacy
278891|NCT01967342|health literacy|health literacy
278892|NCT01967342|group therapy|group therapy
278893|NCT01967342|psychosocial treatment|psychosocial treatment
278894|NCT01967342|cognitive-behavioral therapy|cognitive-behavioral therapy
278895|NCT01967342|pain education|pain education
278896|NCT01967342|health disparities|health disparities
278897|NCT01967342|patient-centered outcomes|patient-centered outcomes
278898|NCT01967303|Restless legs syndrome|restless legs syndrome
278899|NCT01967303|Stroke|stroke
278900|NCT01967303|Transient ischemic attack|transient ischemic attack
278901|NCT01967303|Cerebrovascular risk factors|cerebrovascular risk factors
278902|NCT01967290|stroke|stroke
278903|NCT01967290|motor deficits|motor deficits
278904|NCT01967290|motor rehabilitation|motor rehabilitation
278905|NCT01967290|neurorehabilitation|neurorehabilitation
278906|NCT01967290|medical devices|medical devices
278907|NCT01967290|wearable devices|wearable devices
278908|NCT01967290|e-health systems|e-health systems
278909|NCT01967264|Drug therapy|drug therapy
278910|NCT01967251|Prostatic Hyperplasia|prostatic hyperplasia
278911|NCT01967251|Phosphodiesterase 5 inhibitors|phosphodiesterase 5 inhibitors
278912|NCT01967251|Erectile DysfunctionDrug Therapy|erectile dysfunctiondrug therapy
278913|NCT01967238|immune response|immune response
278914|NCT01967225|Methicillin Resistant Staphylococcus Aureus,|methicillin resistant staphylococcus aureus,
278915|NCT01967225|Skin and soft tissue infection,|skin and soft tissue infection,
278916|NCT01967225|Bacteremia,|bacteremia,
278917|NCT01967225|Tedizolid|tedizolid
278918|NCT01967212|stroke|stroke
278919|NCT01967212|swallowing training|swallowing training
278920|NCT01967212|game-based|game-based
278921|NCT01967212|biofeedback|biofeedback
278922|NCT01967199|drug-eluting stent|drug-eluting stent
278923|NCT01967199|drug-coated Balloon|drug-coated balloon
278924|NCT01967199|recurrent In-Stent restenosis|recurrent in-stent restenosis
278925|NCT01967186|Type 1 diabetes|type 1 diabetes
278926|NCT01967186|islets|islets
278927|NCT01967186|transplantation|transplantation
278928|NCT01967186|nephropathy|nephropathy
278929|NCT01967186|intramuscular|intramuscular
278930|NCT01967173|Asthma|asthma
278931|NCT01967173|Fluticasone|fluticasone
278932|NCT01967173|Salmeterol|salmeterol
278933|NCT01967147|Dry eye|dry eye
278934|NCT01967147|Lipid deficiency|lipid deficiency
278935|NCT01967147|Tear film break-up time|tear film break-up time
278936|NCT01967134|HIV Negative|hiv negative
278937|NCT01967121|Compex, ice|compex, ice
278938|NCT01967095|Erlotinib|erlotinib
278939|NCT01967095|12-278|12-278
278940|NCT01967095|CNS involvement|cns involvement
278941|NCT01967082|Cancer Prevention|cancer prevention
278942|NCT01967082|Tobacco Control Program for Youth|tobacco control program for youth
278943|NCT01967082|Smoking cessation|smoking cessation
278944|NCT01967082|Smoking prevention|smoking prevention
278945|NCT01967082|Smokers|smokers
278946|NCT01967082|Non smokers|non smokers
278947|NCT01967082|Students|students
278948|NCT01967082|University of Houston|university of houston
278949|NCT01967082|Survey|survey
278950|NCT01967082|Questionnaire|questionnaire
278951|NCT01967082|Telephone survey|telephone survey
278952|NCT01967082|Smart phone application|smart phone application
278953|NCT01967056|Muscle strength|muscle strength
278954|NCT01967056|respiratory failure|respiratory failure
278955|NCT01967056|extubation failure|extubation failure
278956|NCT01967056|intensive care unit|intensive care unit
278957|NCT01967056|outcome prediction|outcome prediction
278958|NCT01967030|gestational diabetes mellitus|gestational diabetes mellitus
278959|NCT01967030|breastfeeding|breastfeeding
278960|NCT01967030|obesity|obesity
278961|NCT01967030|diabetes|diabetes
278962|NCT01967030|lactation|lactation
278963|NCT01967017|Intrauterine device|intrauterine device
278964|NCT01967017|Paracervical block|paracervical block
278965|NCT01966991|Down syndrome|down syndrome
278966|NCT01966991|prenatal screening|prenatal screening
278967|NCT01966991|trisomy 21|trisomy 21
278968|NCT01966991|patient satisfaction|patient satisfaction
278969|NCT01966978|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
278970|NCT01966978|Insulin|insulin
278971|NCT01966978|Insulin, Long-Acting|insulin, long-acting
278972|NCT01966978|Insulin, Short Acting|insulin, short acting
278973|NCT01966978|Detemir|detemir
278974|NCT01966978|Liraglutide|liraglutide
278975|NCT01966978|GLP-1|glp-1
278976|NCT01966978|Glucagon Like Peptide|glucagon like peptide
278977|NCT01966978|Metformin|metformin
278978|NCT01966978|Uncontrolled Diabetes|uncontrolled diabetes
278979|NCT01966978|Elevated A1c|elevated a1c
278980|NCT01966978|Incretins|incretins
278981|NCT01966965|PIOLIN®, PEDICULOSIS, EFFICACY, SAFETY, PHYTOMEDICINE,|piolin®, pediculosis, efficacy, safety, phytomedicine,
278982|NCT01966965|ARRUDA, RUTA|arruda, ruta
278983|NCT01966952|Hypertension|hypertension
278984|NCT01966939|craniotomy|craniotomy
278985|NCT01966939|craniectomy|craniectomy
278986|NCT01966939|temporalis|temporalis
278987|NCT01966939|TMJ|tmj
278988|NCT01966939|mastication|mastication
278989|NCT01966939|QoL|qol
278990|NCT01966926|self monitoring|self monitoring
278991|NCT01966926|self weighing|self weighing
278992|NCT01966926|weight tracking|weight tracking
278993|NCT01966926|psychosocial outcomes|psychosocial outcomes
278994|NCT01966926|feasibility|feasibility
278995|NCT01966913|Germ Cell Tumors|germ cell tumors
278996|NCT01966913|Bevacizumab|bevacizumab
278997|NCT01966913|salvage therapy|salvage therapy
278998|NCT01966900|Human immunodeficiency disease|human immunodeficiency disease
278999|NCT01966900|HIV|hiv
279000|NCT01966900|Vaccine|vaccine
279001|NCT01966900|CN54gp140|cn54gp140
279002|NCT01966900|Glucopyranosyl lipid adjuvant|glucopyranosyl lipid adjuvant
279003|NCT01966900|GLA|gla
279004|NCT01966900|GLA-AF|gla-af
279005|NCT01966887|Heart failure|heart failure
279006|NCT01966887|Gene therapy|gene therapy
279007|NCT01966887|Serca2a|serca2a
279008|NCT01966887|Cardiomyopathy|cardiomyopathy
279009|NCT01966874|Medical abortion|medical abortion
279010|NCT01966874|Mifepristone|mifepristone
279011|NCT01966874|Misoprostol|misoprostol
279012|NCT01966874|Zacafemyl|zacafemyl
279013|NCT01966874|Mexico|mexico
279014|NCT01966861|mechanical ventilation|mechanical ventilation
279015|NCT01966861|weaning|weaning
279016|NCT01966861|acute respiratory failure|acute respiratory failure
279017|NCT01966861|weaning failure|weaning failure
279018|NCT01966861|lung ultrasound|lung ultrasound
279019|NCT01966848|Knee|knee
279020|NCT01966848|osteoarthritis|osteoarthritis
279021|NCT01966848|arthroplasty|arthroplasty
279022|NCT01966848|tka|tka
279023|NCT01966848|rsa|rsa
279024|NCT01966835|sleep quality|sleep quality
279025|NCT01966835|sleep disturbances|sleep disturbances
279026|NCT01966835|high intensity aerobic interval training|high intensity aerobic interval training
279027|NCT01966835|rheumatoid arthritis|rheumatoid arthritis
279028|NCT01966835|fatigue|fatigue
279029|NCT01966835|pain|pain
279030|NCT01966835|polysomnography|polysomnography
279031|NCT01966835|watt max|watt max
279032|NCT01966822|Osteoporosis|osteoporosis
279033|NCT01966822|Bone mineral density|bone mineral density
279034|NCT01966822|Dual-energy X-ray absorptiometry|dual-energy x-ray absorptiometry
279035|NCT01966822|HIV infection|hiv infection
279036|NCT01966822|Dolutegravir|dolutegravir
279037|NCT01966822|Integrase inhibitor|integrase inhibitor
279038|NCT01966809|Brain Tumor|brain tumor
279039|NCT01966809|Photodynamic Therapy|photodynamic therapy
279040|NCT01966809|Photochemotherapy|photochemotherapy
279041|NCT01966809|Astrocytoma|astrocytoma
279042|NCT01966809|Pilocytic Astrocytoma|pilocytic astrocytoma
279043|NCT01966809|Low grade Astrocytoma|low grade astrocytoma
279044|NCT01966809|Anaplastic Astrocytoma|anaplastic astrocytoma
279045|NCT01966809|Glioblastoma|glioblastoma
279046|NCT01966809|GBM|gbm
279047|NCT01966809|Chordoma|chordoma
279048|NCT01966809|Germinoma|germinoma
279049|NCT01966809|Germ Cell Tumor|germ cell tumor
279050|NCT01966809|Non-germinoma|non-germinoma
279051|NCT01966809|CNS Lymphoma|cns lymphoma
279052|NCT01966809|Craniopharyngioma|craniopharyngioma
279053|NCT01966809|Mixed Glioma|mixed glioma
279054|NCT01966809|Optic Nerve Glioma|optic nerve glioma
279055|NCT01966809|Meningioma|meningioma
279056|NCT01966809|Oligodendroglioma|oligodendroglioma
279057|NCT01966809|Pituitary Tumors|pituitary tumors
279058|NCT01966809|Desmoplastic Neuroepithelial Tumor|desmoplastic neuroepithelial tumor
279059|NCT01966809|DNET|dnet
279060|NCT01966809|glioblastoma multiforme|glioblastoma multiforme
279061|NCT01966809|glioma|glioma
279062|NCT01966809|glioblastoma survivors|glioblastoma survivors
279063|NCT01966809|what is glioblastoma|what is glioblastoma
279064|NCT01966809|gbm cancer|gbm cancer
279065|NCT01966809|oligoastrocytoma|oligoastrocytoma
279066|NCT01966809|gbm tumor|gbm tumor
279067|NCT01966809|anaplastic oligodendroglioma|anaplastic oligodendroglioma
279068|NCT01966809|High-Grade Glioma|high-grade glioma
279069|NCT01966809|high grade glioma|high grade glioma
279070|NCT01966809|glioblastomas|glioblastomas
279071|NCT01966809|glioblastoma cancer|glioblastoma cancer
279072|NCT01966809|anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
279073|NCT01966809|astrocytoma glioma|astrocytoma glioma
279074|NCT01966809|glioblastoma clinical trials|glioblastoma clinical trials
279075|NCT01966809|photodynamic therapy for cancer|photodynamic therapy for cancer
279076|NCT01966809|glioblastoma multiforme clinical trials|glioblastoma multiforme clinical trials
279077|NCT01966809|astrocytoma glioblastoma|astrocytoma glioblastoma
279078|NCT01966809|gbm grade 4|gbm grade 4
279079|NCT01966809|clinical trials for glioblastoma|clinical trials for glioblastoma
279080|NCT01966809|photodynamic therapy cancer|photodynamic therapy cancer
279081|NCT01966809|clinical trials glioblastoma|clinical trials glioblastoma
279082|NCT01966809|glioblastoma clinical trials 2015|glioblastoma clinical trials 2015
279083|NCT01966809|glioblastoma clinical trials 2014 not open in 2014|glioblastoma clinical trials 2014 not open in 2014
279084|NCT01966809|glioblastoma trials|glioblastoma trials
279085|NCT01966809|gbm clinical trials|gbm clinical trials
279086|NCT01966809|glioblastoma immunotherapy|glioblastoma immunotherapy
279087|NCT01966809|malignant gliomas|malignant gliomas
279088|NCT01966809|anaplastic astrocytomas|anaplastic astrocytomas
279089|NCT01966809|immunotherapy for glioblastoma|immunotherapy for glioblastoma
279090|NCT01966809|immunotherapy glioblastoma|immunotherapy glioblastoma
279091|NCT01966809|High Grade Glioblastoma Multiforme|high grade glioblastoma multiforme
279092|NCT01966809|clinical trial glioblastoma|clinical trial glioblastoma
279093|NCT01966809|glioblastoma clinical trial|glioblastoma clinical trial
279094|NCT01966809|glioblastoma trial|glioblastoma trial
279095|NCT01966809|brain tumors|brain tumors
279096|NCT01966809|recurrent brain tumors|recurrent brain tumors
279097|NCT01966809|glioma grade 3|glioma grade 3
279098|NCT01966809|grade 3 brain tumor|grade 3 brain tumor
279099|NCT01966809|grade 4 brain tumor|grade 4 brain tumor
279100|NCT01966796|healthcare associated pneumonia|healthcare associated pneumonia
279101|NCT01966796|drug-resistant bacteria|drug-resistant bacteria
279102|NCT01966796|pneumonia severity index|pneumonia severity index
279103|NCT01966757|Neuronal Ceroid Lipofuscinosis|neuronal ceroid lipofuscinosis
279104|NCT01966757|NCL|ncl
279105|NCT01966757|Batten's Disease|batten's disease
279106|NCT01966757|Children's Sleep Habits Questionnaire|children's sleep habits questionnaire
279107|NCT01966757|Restless Leg Syndrome|restless leg syndrome
279108|NCT01966731|Africa|africa
279109|NCT01966718|Rheumatoid arthritis|rheumatoid arthritis
279110|NCT01966718|Joint pain|joint pain
279111|NCT01966718|Repository corticotropin injection|repository corticotropin injection
279112|NCT01966705|severe health anxiety|severe health anxiety
279113|NCT01966705|somatic symptom disorder|somatic symptom disorder
279114|NCT01966705|illness anxiety disorder|illness anxiety disorder
279115|NCT01966705|cognitive behavior therapy|cognitive behavior therapy
279116|NCT01966705|bibliotherapy|bibliotherapy
279117|NCT01966705|internet|internet
279118|NCT01966705|exposure|exposure
279119|NCT01966692|Bioequivalence|bioequivalence
279120|NCT01966692|Fluticasone Propionate|fluticasone propionate
279121|NCT01966666|Alzheimer's disease|alzheimer's disease
279122|NCT01966666|mild to moderate|mild to moderate
279123|NCT01966653|nitrofurantoin|nitrofurantoin
279124|NCT01966653|fosfomycin|fosfomycin
279125|NCT01966653|urinary tract infection|urinary tract infection
279126|NCT01966653|clinical efficacy|clinical efficacy
279127|NCT01966653|bacteriologic response|bacteriologic response
279128|NCT01966640|diagnosis of allergy|diagnosis of allergy
279129|NCT01966640|Basophil Activation Test|basophil activation test
279130|NCT01966627|non alcoholic fatty liver|non alcoholic fatty liver
279131|NCT01966627|childhood obesity|childhood obesity
279132|NCT01966627|genetic variants|genetic variants
279133|NCT01966614|Benign prostatic hyperplasia|benign prostatic hyperplasia
279134|NCT01966614|BPH|bph
279135|NCT01966614|Enlarged prostate|enlarged prostate
279136|NCT01966614|Lower urinary tract symptoms (LUTS)|lower urinary tract symptoms (luts)
279137|NCT01966588|Antipsychotic agents|antipsychotic agents
279138|NCT01966588|Adverse effects|adverse effects
279139|NCT01966588|Genomics|genomics
279140|NCT01966588|Transcriptome|transcriptome
279141|NCT01966575|Polycystic ovary syndrome|polycystic ovary syndrome
279142|NCT01966575|Progestin|progestin
279143|NCT01966575|Endometrial shedding|endometrial shedding
279144|NCT01966575|Ovulation induction cycles|ovulation induction cycles
279145|NCT01966575|Clomiphene citrate|clomiphene citrate
279146|NCT01966575|Clinical pregnancy rate|clinical pregnancy rate
279147|NCT01966549|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
279148|NCT01966549|Moderate to Severe Chronic Obstructive Pulmonary Disease|moderate to severe chronic obstructive pulmonary disease
279149|NCT01966549|CNTO 6785|cnto 6785
279150|NCT01966549|Placebo|placebo
279151|NCT01966510|cord blood transplant|cord blood transplant
279152|NCT01966510|advanced lymphoid malignancies|advanced lymphoid malignancies
279153|NCT01966497|AML|aml
279154|NCT01966484|Succinylcholine|succinylcholine
279155|NCT01966484|Mivacurium|mivacurium
279156|NCT01966484|Rigid Bronchoscopy|rigid bronchoscopy
279157|NCT01966484|Intubating conditions|intubating conditions
279158|NCT01966484|Short Procedure|short procedure
279159|NCT01966445|GSK2849330|gsk2849330
279160|NCT01966445|Oncology|oncology
279161|NCT01966445|First Time in Human|first time in human
279162|NCT01966445|HER3|her3
279163|NCT01966432|Substance abuse|substance abuse
279164|NCT01966432|Alcohol use|alcohol use
279165|NCT01966432|Tobacco use|tobacco use
279166|NCT01966432|Brief intervention|brief intervention
279167|NCT01966432|Referral to treatment|referral to treatment
279168|NCT01966419|hepatic encephalopathy|hepatic encephalopathy
279169|NCT01966419|hyperammonemia|hyperammonemia
279170|NCT01966419|cirrhosis|cirrhosis
279171|NCT01966419|ornithine phenylacetate|ornithine phenylacetate
279172|NCT01966419|OCR-002|ocr-002
279173|NCT01966406|Pancreaticoduodenectomy|pancreaticoduodenectomy
279174|NCT01966406|nasogastric tube|nasogastric tube
279175|NCT01966393|Type 1 diabetes|type 1 diabetes
279176|NCT01966393|Hypoglycemia|hypoglycemia
279177|NCT01966393|Insulin|insulin
279178|NCT01966393|Glucagon|glucagon
279179|NCT01966393|Closed-loop strategy|closed-loop strategy
279180|NCT01966393|Artificial pancreas|artificial pancreas
279181|NCT01966367|Unrelated donor transplant|unrelated donor transplant
279182|NCT01966367|Haploidentical donor transplant|haploidentical donor transplant
279183|NCT01966367|Peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
279184|NCT01966367|CD34+ selection|cd34+ selection
279185|NCT01966367|Non-malignant disease|non-malignant disease
279186|NCT01966367|Bone marrow failure syndrome|bone marrow failure syndrome
279187|NCT01966367|Severe Aplastic Anemia|severe aplastic anemia
279188|NCT01966367|Severe Congenital Neutropenia|severe congenital neutropenia
279189|NCT01966367|Amegakaryocytic Thrombocytopenia|amegakaryocytic thrombocytopenia
279190|NCT01966367|Diamond-Blackfan Anemia|diamond-blackfan anemia
279191|NCT01966367|Schwachman Diamond Syndrome|schwachman diamond syndrome
279192|NCT01966367|Primary Immunodeficiency Syndrome|primary immunodeficiency syndrome
279193|NCT01966367|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
279194|NCT01966367|Histiocytic Syndrome|histiocytic syndrome
279195|NCT01966367|Familial Hemophagocytic Lymphocytosis|familial hemophagocytic lymphocytosis
279196|NCT01966367|Lymphohistiocytosis|lymphohistiocytosis
279197|NCT01966367|Macrophage Activation Syndrome|macrophage activation syndrome
279198|NCT01966367|Langerhans Cell Histiocytosis (LCH)|langerhans cell histiocytosis (lch)
279199|NCT01966367|Hemoglobinopathies|hemoglobinopathies
279200|NCT01966367|Sickle Cell Disease|sickle cell disease
279201|NCT01966367|Sickle Cell-beta-thalassemia|sickle cell-beta-thalassemia
279202|NCT01966354|adult|adult
279203|NCT01966354|catheterization, central venous|catheterization, central venous
279204|NCT01966354|ultrasonography, interventional|ultrasonography, interventional
279205|NCT01966354|evidence-based medicine|evidence-based medicine
279206|NCT01966354|cost-benefit analysis|cost-benefit analysis
279207|NCT01966302|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
279208|NCT01966302|prostacyclin|prostacyclin
279209|NCT01966302|oral|oral
279210|NCT01966289|Colorectal Neoplasms|colorectal neoplasms
279211|NCT01966289|Intestinal Neoplasms|intestinal neoplasms
279212|NCT01966289|Gastrointestinal Neoplasms|gastrointestinal neoplasms
279213|NCT01966289|Digestive System Neoplasms|digestive system neoplasms
279214|NCT01966289|Neoplasms by Site|neoplasms by site
279215|NCT01966289|Neoplasms|neoplasms
279216|NCT01966289|Digestive System Diseases|digestive system diseases
279217|NCT01966289|Gastrointestinal Diseases|gastrointestinal diseases
279218|NCT01966289|Colonic Diseases|colonic diseases
279219|NCT01966289|Intestinal Diseases|intestinal diseases
279220|NCT01966289|Rectal Diseases|rectal diseases
279221|NCT01966276|Chronic Fatigue Syndrome (CFS)|chronic fatigue syndrome (cfs)
279222|NCT01966276|Myalgic Encephalomyelitis (ME)|myalgic encephalomyelitis (me)
279223|NCT01966276|central nervous system (CNS)|central nervous system (cns)
279224|NCT01966276|fatigue|fatigue
279225|NCT01966276|alertness|alertness
279226|NCT01966276|brain fog|brain fog
279227|NCT01966276|mitochondria|mitochondria
279228|NCT01966276|methylphenidate|methylphenidate
279229|NCT01966276|Ritalin|ritalin
279230|NCT01966276|stimulant|stimulant
279231|NCT01966276|multivitamin|multivitamin
279232|NCT01966276|multimineral|multimineral
279233|NCT01966276|micronutrients|micronutrients
279234|NCT01966276|supplements|supplements
279235|NCT01966263|total knee arthroplasty|total knee arthroplasty
279236|NCT01966263|femoral nerve block|femoral nerve block
279237|NCT01966263|local infiltration analgesia|local infiltration analgesia
279238|NCT01966263|fast track|fast track
279239|NCT01966198|pulse plethysmography, autonomic nervous system, heart rate variability, baro-reflex|pulse plethysmography, autonomic nervous system, heart rate variability, baro-reflex
279240|NCT01966185|virtual simulation|virtual simulation
279241|NCT01966185|temporal bone|temporal bone
279242|NCT01966185|surgical training|surgical training
279243|NCT01966185|medical education|medical education
279244|NCT01966185|self-directed learning|self-directed learning
279245|NCT01966185|final product assessment|final product assessment
279246|NCT01966185|cognitive load|cognitive load
279247|NCT01966185|reaction time|reaction time
279248|NCT01966185|skills training|skills training
279249|NCT01966185|simulator metrics|simulator metrics
279250|NCT01966172|NSAID, gabapentin, multimodal, morphine, dexamethasone, cardiac surgery, postoperative pain, analgesia.|nsaid, gabapentin, multimodal, morphine, dexamethasone, cardiac surgery, postoperative pain, analgesia.
279251|NCT01966133|HCC|hcc
279252|NCT01966133|Randomised controlled trial|randomised controlled trial
279253|NCT01966133|TACE|tace
279254|NCT01966133|Resection|resection
279255|NCT01966120|Photodynamic Therapy|photodynamic therapy
279256|NCT01966120|Field-directed Treatment|field-directed treatment
279257|NCT01966068|Asthma|asthma
279258|NCT01966068|Pediatrics|pediatrics
279259|NCT01966068|Health Technology|health technology
279260|NCT01966068|Meaningful Use Stage-3|meaningful use stage-3
279261|NCT01966068|Web Portal|web portal
279262|NCT01966042|Refractory angina|refractory angina
279263|NCT01966042|Cell Therapy|cell therapy
279264|NCT01966042|Bone Marrow|bone marrow
279265|NCT01966042|Mononuclear Cells|mononuclear cells
279266|NCT01966016|LV- Left Ventricular|lv- left ventricular
279267|NCT01966016|CRT- Cardiac resynchronization therapy|crt- cardiac resynchronization therapy
279268|NCT01966016|MSCRT- Multisite Cardiac resynchronization therapy (P-pacemaker; D-defibrillator)|mscrt- multisite cardiac resynchronization therapy (p-pacemaker; d-defibrillator)
279269|NCT01966016|BBB -bundle branch block|bbb -bundle branch block
279270|NCT01965990|Enteral nutrition|enteral nutrition
279271|NCT01965990|very low-calorie diet|very low-calorie diet
279272|NCT01965990|severe obesity|severe obesity
279273|NCT01965990|weight loss|weight loss
279274|NCT01965990|ketosis|ketosis
279275|NCT01965964|Dysphagia, Swallowing functions, Questionnaire in German|dysphagia, swallowing functions, questionnaire in german
279276|NCT01965925|Cognition|cognition
279277|NCT01965925|Sleep problems|sleep problems
279278|NCT01965925|Bipolar Disorder|bipolar disorder
279279|NCT01965912|Phenylketonuria|phenylketonuria
279280|NCT01965912|Kuvan|kuvan
279281|NCT01965912|Sapropterin dihydrochloride|sapropterin dihydrochloride
279282|NCT01965886|osteoarthritis|osteoarthritis
279283|NCT01965886|knee|knee
279284|NCT01965886|arthroplasty|arthroplasty
279285|NCT01965886|replacement|replacement
279286|NCT01965873|Pancreatitis, Acute necrotizing|pancreatitis, acute necrotizing
279287|NCT01965873|Enteral nutrition|enteral nutrition
279288|NCT01965873|Fasting|fasting
279289|NCT01965873|Complications|complications
279290|NCT01965873|Mortality|mortality
279291|NCT01965834|Multiple Myeloma|multiple myeloma
279292|NCT01965834|Fenofibrate|fenofibrate
279293|NCT01965821|tracheal cuff pressure|tracheal cuff pressure
279294|NCT01965821|continuous control|continuous control
279295|NCT01965821|microaspiration|microaspiration
279296|NCT01965795|Brain-derived neurotrophic factor|brain-derived neurotrophic factor
279297|NCT01965795|Cognitive function|cognitive function
279298|NCT01965795|Dietary supplement|dietary supplement
279299|NCT01965795|Coffee plant extract|coffee plant extract
279300|NCT01965769|Very low birth weight infants|very low birth weight infants
279301|NCT01965769|premature|premature
279302|NCT01965769|nutrition|nutrition
279303|NCT01965769|gastric residual|gastric residual
279304|NCT01965756|Alzheimer's Disease|alzheimer's disease
279305|NCT01965756|Vascular Dementia|vascular dementia
279306|NCT01965756|Dementia|dementia
279307|NCT01965756|Memory Impairment|memory impairment
279308|NCT01965743|intrauterine contraception (IUC)|intrauterine contraception (iuc)
279309|NCT01965743|social networks|social networks
279310|NCT01965743|social influence|social influence
279311|NCT01965743|diffusion of innovation|diffusion of innovation
279312|NCT01965743|intrauterine device (IUD)|intrauterine device (iud)
279313|NCT01965743|LARC|larc
279314|NCT01965730|dilated ascending aorta|dilated ascending aorta
279315|NCT01965717|endoleak|endoleak
279316|NCT01965717|MMP- 9|mmp- 9
279317|NCT01965717|biomarker|biomarker
279318|NCT01965704|Narcotic addiction during pregnancy|narcotic addiction during pregnancy
279319|NCT01965704|Neonatal abstinence syndrome|neonatal abstinence syndrome
279320|NCT01965704|NAS|nas
279321|NCT01965691|Phenylketonuria|phenylketonuria
279322|NCT01965691|PKU|pku
279323|NCT01965691|Phenylalanine metabolism|phenylalanine metabolism
279324|NCT01965691|Protein requirements|protein requirements
279325|NCT01965691|Indicator Amino acid Oxidation|indicator amino acid oxidation
279326|NCT01965691|Stable isotopes|stable isotopes
279327|NCT01965678|Osteopathic manipulative treatment|osteopathic manipulative treatment
279328|NCT01965678|muscle-skeletal disorder|muscle-skeletal disorder
279329|NCT01965678|quality of life|quality of life
279330|NCT01965665|Diabetes|diabetes
279331|NCT01965665|Surgical Intervention|surgical intervention
279333|NCT01965652|Opioid Induced Constipation|opioid induced constipation
279334|NCT01965639|Diabetes Mellitus Type 2|diabetes mellitus type 2
279335|NCT01965639|Standard of care|standard of care
279336|NCT01965639|Quality of life|quality of life
279337|NCT01965639|Disease management|disease management
279338|NCT01965626|Oseltamivir|oseltamivir
279339|NCT01965626|Dexamethasone|dexamethasone
279340|NCT01965626|ITP|itp
279341|NCT01965613|Pyoderma Gangrenosum|pyoderma gangrenosum
279342|NCT01965600|Endotoxin challenge|endotoxin challenge
279343|NCT01965587|novasure|novasure
279344|NCT01965587|Mirena IUS|mirena ius
279345|NCT01965587|menorrhagia|menorrhagia
279346|NCT01965587|pelvic pain|pelvic pain
279347|NCT01965587|ashermanns|ashermanns
279348|NCT01965574|ARDS - FLUID LOADING - PRELOAD DEPENDENCE|ards - fluid loading - preload dependence
279349|NCT01965548|spleen|spleen
279350|NCT01965548|injury|injury
279351|NCT01965548|patient transfer|patient transfer
279352|NCT01965548|splenectomy|splenectomy
279353|NCT01965548|embolization, theurapeutic|embolization, theurapeutic
279354|NCT01965535|Hepatitis C|hepatitis c
279355|NCT01965535|HCV|hcv
279356|NCT01965535|Cirrhosis|cirrhosis
279357|NCT01965522|Breast cancer|breast cancer
279358|NCT01965522|melatonin|melatonin
279359|NCT01965522|vitamin d|vitamin d
279360|NCT01965522|ki67|ki67
279361|NCT01965509|PEX168|pex168
279362|NCT01965509|Phase I/II|phase i/ii
279363|NCT01965509|add on to metformin|add on to metformin
279364|NCT01965496|PEX168|pex168
279365|NCT01965496|Phase I|phase i
279366|NCT01965496|titration|titration
279367|NCT01965483|radiotherapy|radiotherapy
279368|NCT01965483|adjuvant|adjuvant
279369|NCT01965483|weekly hypofractionation|weekly hypofractionation
279370|NCT01965457|obstructive sleep apnea|obstructive sleep apnea
279371|NCT01965457|pediatric|pediatric
279372|NCT01965457|adenoid hypertrophy|adenoid hypertrophy
279373|NCT01965444|Sub-epidermal moisture|sub-epidermal moisture
279374|NCT01965444|Pressure Ulcers|pressure ulcers
279375|NCT01965405|HIV|hiv
279376|NCT01965405|AIDS|aids
279377|NCT01965405|Nicotine Dependence|nicotine dependence
279378|NCT01965405|Smoking|smoking
279379|NCT01965405|Smoking cessation|smoking cessation
279380|NCT01965405|Contingency Management|contingency management
279381|NCT01965379|Dialysis|dialysis
279382|NCT01965379|Phosphorus|phosphorus
279383|NCT01965379|Diet|diet
279384|NCT01965366|Dexamethasone|dexamethasone
279385|NCT01965366|Virtual Reality|virtual reality
279386|NCT01965366|Military|military
279387|NCT01965366|PTSD|ptsd
279388|NCT01965353|Relapsed Multiple Myeloma|relapsed multiple myeloma
279389|NCT01965353|Relapse-Refractory Multiple Myeloma|relapse-refractory multiple myeloma
279390|NCT01965340|patients|patients
279391|NCT01965327|Friedreich ataxia|friedreich ataxia
279392|NCT01965327|Interferon gamma-1b|interferon gamma-1b
279393|NCT01965327|FRDA|frda
279394|NCT01965314|ultrasound guided regional anaesthesia|ultrasound guided regional anaesthesia
279395|NCT01965314|upper limb surgery|upper limb surgery
279396|NCT01965314|ultrasound guided axillary brachial plexus blockade|ultrasound guided axillary brachial plexus blockade
279397|NCT01965275|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
279398|NCT01965275|High-dose|high-dose
279399|NCT01965275|Pulsatile|pulsatile
279400|NCT01965275|EGFR-TKIs|egfr-tkis
279401|NCT01965249|Laparotomy|laparotomy
279402|NCT01965249|short stitch|short stitch
279403|NCT01965249|long stitch|long stitch
279404|NCT01965249|MonoMax|monomax
279405|NCT01965236|hypertension, sodium intake, left ventricular function|hypertension, sodium intake, left ventricular function
279406|NCT01965223|Oligometastatic|oligometastatic
279407|NCT01965223|Neoplasia|neoplasia
279408|NCT01965223|Radiosurgery|radiosurgery
279409|NCT01965223|Stereotactic Ablative Body Radiotherapy|stereotactic ablative body radiotherapy
279410|NCT01965223|SABR|sabr
279411|NCT01965223|Metastases to the Lung|metastases to the lung
279412|NCT01965223|Non Haematological|non haematological
279413|NCT01965210|Rye|rye
279414|NCT01965210|Fermentable dietary fibre|fermentable dietary fibre
279415|NCT01965210|Inulin|inulin
279416|NCT01965210|Plant protein|plant protein
279417|NCT01965210|Gluten|gluten
279418|NCT01965210|Porridge|porridge
279419|NCT01965210|Bread|bread
279420|NCT01965210|Appetite|appetite
279421|NCT01965210|Satiety|satiety
279422|NCT01965210|Hunger|hunger
279423|NCT01965210|Desire to eat|desire to eat
279424|NCT01965210|Metabolism|metabolism
279425|NCT01965210|Glucose|glucose
279426|NCT01965210|Insulin|insulin
279427|NCT01965210|Gut hormones|gut hormones
279428|NCT01965210|Metabolomics|metabolomics
279429|NCT01965210|Gastric emptying rate|gastric emptying rate
279430|NCT01965210|Breath hydrogen and methane excretion|breath hydrogen and methane excretion
279431|NCT01965184|child|child
279432|NCT01965184|cognitive behavioral therapy|cognitive behavioral therapy
279433|NCT01965184|CBT|cbt
279434|NCT01965184|aggression|aggression
279435|NCT01965184|disruptive behavior|disruptive behavior
279436|NCT01965184|treatment|treatment
279437|NCT01965184|frustrative non-reward|frustrative non-reward
279438|NCT01965171|hematologic malignancy|hematologic malignancy
279439|NCT01965171|iron overload|iron overload
279440|NCT01965171|magnetic resonance imaging|magnetic resonance imaging
279441|NCT01965171|childhood cancer survivors|childhood cancer survivors
279442|NCT01965158|Opioid-induced Constipation|opioid-induced constipation
279443|NCT01965132|Rheumatiod Arhthritis|rheumatiod arhthritis
279444|NCT01965132|Ankylosing spondylitis|ankylosing spondylitis
279445|NCT01965132|Psoriatic arthritis|psoriatic arthritis
279446|NCT01965132|Biologic agents|biologic agents
279447|NCT01965132|Cohort studies|cohort studies
279448|NCT01965106|Glaucoma, Angle-Closure|glaucoma, angle-closure
279449|NCT01965106|Glaucoma, Closed-Angle|glaucoma, closed-angle
279450|NCT01965106|Primary angle closure|primary angle closure
279451|NCT01965106|Acute angle closure|acute angle closure
279452|NCT01965106|Acute angle-closure glaucoma|acute angle-closure glaucoma
279453|NCT01965093|perioperative|perioperative
279454|NCT01965093|desaturation|desaturation
279455|NCT01965093|growth development|growth development
279456|NCT01965093|intelligence outcome|intelligence outcome
279457|NCT01965080|Endometrial cancer|endometrial cancer
279458|NCT01965054|Intrahepatic cholestasis of pregnancy|intrahepatic cholestasis of pregnancy
279459|NCT01965054|fish oil|fish oil
279460|NCT01965054|omega-3|omega-3
279461|NCT01965054|Docosahexaenoic acid,|docosahexaenoic acid,
279462|NCT01965054|eicosapentaenoic acid|eicosapentaenoic acid
279463|NCT01965041|AVA Study|ava study
279464|NCT01965028|tinnitus|tinnitus
279465|NCT01965028|transcranial random noise stimulation|transcranial random noise stimulation
279466|NCT01965028|tRNS|trns
279467|NCT01965028|auditory cortex|auditory cortex
279468|NCT01965028|non-invasive brain stimulation|non-invasive brain stimulation
279469|NCT01965015|Heart Failure (HF)|heart failure (hf)
279470|NCT01965015|Left Atrial Pressure|left atrial pressure
279471|NCT01964989|Influenza|influenza
279472|NCT01964989|children|children
279473|NCT01964950|drug therapy|drug therapy
279474|NCT01964911|Martorell ulcer|martorell ulcer
279475|NCT01964911|Hypertensive leg ulcer|hypertensive leg ulcer
279476|NCT01964911|Pain|pain
279477|NCT01964911|Continuous nerve block|continuous nerve block
279478|NCT01964911|Ropivacaïne|ropivacaïne
279479|NCT01964911|Local anesthesic|local anesthesic
279480|NCT01964898|Smoking|smoking
279481|NCT01964898|Mood Management|mood management
279482|NCT01964898|Depression|depression
279483|NCT01964898|Behavioral Activation|behavioral activation
279484|NCT01964898|Acute Coronary Syndrome|acute coronary syndrome
279485|NCT01964898|Myocardial Infarction|myocardial infarction
279486|NCT01964872|Healthy volunteers|healthy volunteers
279487|NCT01964872|JNJ-38877618|jnj-38877618
279488|NCT01964872|Pharmacokinetic|pharmacokinetic
279489|NCT01964872|Safety|safety
279490|NCT01964872|Single-ascending dose|single-ascending dose
279491|NCT01964872|Multiple-ascending dose|multiple-ascending dose
279492|NCT01964859|healthy skin|healthy skin
279493|NCT01964859|wounds and injuries|wounds and injuries
279494|NCT01964859|prosthetics|prosthetics
279495|NCT01964859|amputations|amputations
279496|NCT01964859|dermal fibroblasts|dermal fibroblasts
279497|NCT01964846|inflammation|inflammation
279498|NCT01964846|high fat meal|high fat meal
279499|NCT01964846|resveratrol|resveratrol
279500|NCT01964846|curcumin|curcumin
279501|NCT01964846|gene expression|gene expression
279502|NCT01964833|clinical trial|clinical trial
279503|NCT01964833|DMT2|dmt2
279504|NCT01964833|periodontitis|periodontitis
279505|NCT01964833|PDT|pdt
279506|NCT01964807|Cardiovascular|cardiovascular
279507|NCT01964807|tobacco|tobacco
279508|NCT01964807|cigarettes|cigarettes
279509|NCT01964807|secondhand cigarette smoke|secondhand cigarette smoke
279510|NCT01964807|SHS|shs
279511|NCT01964807|smokeless tobacco|smokeless tobacco
279512|NCT01964807|chewing tobacco|chewing tobacco
279513|NCT01964807|snus|snus
279514|NCT01964807|electronic cigarettes|electronic cigarettes
279515|NCT01964807|vapor|vapor
279516|NCT01964807|particles|particles
279517|NCT01964807|oxidative stress|oxidative stress
279518|NCT01964807|flow-mediated dilation|flow-mediated dilation
279519|NCT01964807|FMD|fmd
279520|NCT01964794|Warfarin|warfarin
279521|NCT01964781|Administration, topical|administration, topical
279522|NCT01964781|tranexamic acid|tranexamic acid
279523|NCT01964781|adrenaline|adrenaline
279524|NCT01964781|bupivacaine|bupivacaine
279525|NCT01964781|surgery|surgery
279526|NCT01964755|EBV+|ebv+
279527|NCT01964755|NHL|nhl
279528|NCT01964755|HL|hl
279529|NCT01964755|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
279530|NCT01964755|Hodgkin's Lymphoma|hodgkin's lymphoma
279531|NCT01964755|Epstein Barr Virus|epstein barr virus
279532|NCT01964755|Epstein Barr Virus Associated Non Hodgkin's Lymphoma|epstein barr virus associated non hodgkin's lymphoma
279533|NCT01964755|Epstein Barr Virus Associated Hodgkin's Lymphoma|epstein barr virus associated hodgkin's lymphoma
279534|NCT01964755|Post-Transplant Lymphoproliferative Disease|post-transplant lymphoproliferative disease
279535|NCT01964729|rTMS|rtms
279536|NCT01964729|Pain threshold|pain threshold
279537|NCT01964729|Neuromodulation|neuromodulation
279538|NCT01964729|Myofascial|myofascial
279539|NCT01964716|Prevenar 13|prevenar 13
279540|NCT01964716|13vPnC|13vpnc
279541|NCT01964716|Healthy Subjects|healthy subjects
279542|NCT01964690|Lactate|lactate
279543|NCT01964690|Sepsis|sepsis
279544|NCT01964690|Capillary lactate|capillary lactate
279545|NCT01964690|Venous lactate|venous lactate
279546|NCT01964690|Quick test|quick test
279547|NCT01964677|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
279548|NCT01964677|High Intensity Focused Ultrasound (HIFU)|high intensity focused ultrasound (hifu)
279549|NCT01964664|Mindfulness|mindfulness
279550|NCT01964664|Meditation|meditation
279551|NCT01964664|acute lateral sclerosis|acute lateral sclerosis
279552|NCT01964664|Cerebral Palsy|cerebral palsy
279553|NCT01964664|Cerebral Ataxia|cerebral ataxia
279554|NCT01964664|Locked-in Syndrome|locked-in syndrome
279555|NCT01964651|Healthy|healthy
279556|NCT01964651|JNJ-42165279|jnj-42165279
279557|NCT01964651|Pharmacokinetics|pharmacokinetics
279558|NCT01964651|Elderly|elderly
279559|NCT01964651|Young|young
279560|NCT01964638|Prostate Cancer|prostate cancer
279561|NCT01964638|Prostate Biopsy|prostate biopsy
279562|NCT01964638|Targeted Biopsy|targeted biopsy
279563|NCT01964625|Chronic GvHD|chronic gvhd
279564|NCT01964599|Fiber|fiber
279565|NCT01964599|Gastrointestinal|gastrointestinal
279566|NCT01964586|Septoplasty, Dexmedetomidine, Surgical Conditions|septoplasty, dexmedetomidine, surgical conditions
279567|NCT01964573|Parkinson's Disease|parkinson's disease
279568|NCT01964573|Rotigotine|rotigotine
279569|NCT01964573|Pharmacokinetics|pharmacokinetics
279570|NCT01964573|Healthy subjects|healthy subjects
279571|NCT01964560|Lacosamide|lacosamide
279572|NCT01964560|Vimpat|vimpat
279573|NCT01964560|UCB|ucb
279574|NCT01964560|Epilepsy|epilepsy
279575|NCT01964560|Partial Onset Seizures|partial onset seizures
279576|NCT01964560|Pediatric|pediatric
279577|NCT01964547|Cognition|cognition
279578|NCT01964547|Mood|mood
279579|NCT01964534|Metastatic|metastatic
279580|NCT01964534|Pancreatic|pancreatic
279581|NCT01964534|Cancer|cancer
279582|NCT01964534|Pancreas|pancreas
279583|NCT01964534|GERCOR|gercor
279584|NCT01964534|Gemcitabine|gemcitabine
279585|NCT01964534|LV5FU2|lv5fu2
279586|NCT01964534|ABI-007|abi-007
279587|NCT01964534|PACLITAXEL ALBUMIN-BOUND PARTICLES|paclitaxel albumin-bound particles
279588|NCT01964482|Hospitalization|hospitalization
279589|NCT01964482|Older|older
279590|NCT01964482|Medical patient|medical patient
279591|NCT01964482|Strength training|strength training
279592|NCT01964456|Bodily self-consciousness|bodily self-consciousness
279593|NCT01964456|intersubjective body|intersubjective body
279594|NCT01964456|Anorexia Nervosa|anorexia nervosa
279595|NCT01964456|Joint perception task|joint perception task
279596|NCT01964456|Interoceptive awareness|interoceptive awareness
279597|NCT01964443|Plaque Psoriasis|plaque psoriasis
279598|NCT01964443|Alexithymia|alexithymia
279599|NCT01964443|Quality of life|quality of life
279600|NCT01964430|Resectable pancreatic cancer|resectable pancreatic cancer
279601|NCT01964430|resected|resected
279602|NCT01964430|resectable PDA|resectable pda
279603|NCT01964430|adenocarcinoma|adenocarcinoma
279604|NCT01964430|surgically resected|surgically resected
279605|NCT01964430|adjuvant|adjuvant
279606|NCT01964430|Abraxane|abraxane
279607|NCT01964430|nab-paclitaxel|nab-paclitaxel
279608|NCT01964430|ABI-007|abi-007
279609|NCT01964430|gemcitabine|gemcitabine
279610|NCT01964430|Gemzar|gemzar
279611|NCT01964430|Phase 3|phase 3
279612|NCT01964417|BOWEL PREPARATION|bowel preparation
279613|NCT01964417|PEG|peg
279614|NCT01964417|Low-volume PEG Plus Ascorbic Acid|low-volume peg plus ascorbic acid
279615|NCT01964404|Dronabinol|dronabinol
279616|NCT01964404|Schizophrenia|schizophrenia
279617|NCT01964404|Dual Diagnosis|dual diagnosis
279618|NCT01964404|Substance Abuse|substance abuse
279619|NCT01964404|Cannabis Use Disorder|cannabis use disorder
279620|NCT01964378|cancer-related pain|cancer-related pain
279621|NCT01964378|neuropathic related cancer pain|neuropathic related cancer pain
279622|NCT01964378|morphine|morphine
279623|NCT01964378|cebranopadol (GRT6005)|cebranopadol (grt6005)
279624|NCT01964378|Numerical Rating Scale|numerical rating scale
279625|NCT01964326|atorvastatin|atorvastatin
279626|NCT01964326|Hypercholesterolemia|hypercholesterolemia
279627|NCT01964313|Acute coronary syndrome|acute coronary syndrome
279628|NCT01964313|treatment strategy|treatment strategy
279629|NCT01964313|genetics|genetics
279630|NCT01964274|Nursing Delirium Screening Scale,|nursing delirium screening scale,
279631|NCT01964274|Acetylcholinesterase Activity|acetylcholinesterase activity
279632|NCT01964261|Neural|neural
279633|NCT01964261|Prosthetic|prosthetic
279634|NCT01964261|Brain machine interface|brain machine interface
279635|NCT01964261|brain computer interface|brain computer interface
279636|NCT01964261|brain control|brain control
279637|NCT01964261|paralysis|paralysis
279638|NCT01964261|tetraplegia|tetraplegia
279639|NCT01964261|quadriplegia|quadriplegia
279640|NCT01964261|spinal cord injury|spinal cord injury
279641|NCT01964261|stimulation|stimulation
279642|NCT01964261|sensory feedback|sensory feedback
279643|NCT01964248|Blood gas analysis|blood gas analysis
279644|NCT01964248|Arterial puncture|arterial puncture
279645|NCT01964248|Local anesthesia|local anesthesia
279646|NCT01964248|Eutectic mixture|eutectic mixture
279647|NCT01964248|Lidocaïne/prilocaïne cream (5%)|lidocaïne/prilocaïne cream (5%)
279648|NCT01964248|Placebo|placebo
279649|NCT01964248|Pain Intensity Scale|pain intensity scale
279650|NCT01964248|Numerical Rating Scale|numerical rating scale
279651|NCT01964235|INC280, advanced hepatocellular carcinoma, c-MET pathway dysregulation.|inc280, advanced hepatocellular carcinoma, c-met pathway dysregulation.
279652|NCT01964222|Cancer|cancer
279653|NCT01964222|Clinical trials|clinical trials
279654|NCT01964222|Informed consent|informed consent
279655|NCT01964222|Health literacy|health literacy
279656|NCT01964209|ADHD|adhd
279657|NCT01964209|Validation|validation
279658|NCT01964209|Quality Improvement|quality improvement
279659|NCT01964209|Vanderbilt|vanderbilt
279660|NCT01964209|Conners 3rd Edition|conners 3rd edition
279661|NCT01964209|ADHD Measures|adhd measures
279662|NCT01964209|ADHD Adolescent|adhd adolescent
279663|NCT01964209|ADHD Questionnaire|adhd questionnaire
279664|NCT01964209|ICISS|iciss
279665|NCT01964209|Integrated Clinical Information Sharing System|integrated clinical information sharing system
279666|NCT01964196|Renal anemia|renal anemia
279667|NCT01964196|Chronic Renal Failure|chronic renal failure
279668|NCT01964196|ASP1517|asp1517
279669|NCT01964183|Open-label design|open-label design
279670|NCT01964183|Pharmacokinetics|pharmacokinetics
279671|NCT01964183|Drug-Drug Interaction|drug-drug interaction
279672|NCT01964183|Mirabegron|mirabegron
279673|NCT01964170|ASP3550|asp3550
279674|NCT01964170|Prostate cancer|prostate cancer
279675|NCT01964157|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
279676|NCT01964144|thyroid cancer, dovitinib|thyroid cancer, dovitinib
279677|NCT01964131|Bioequivalence|bioequivalence
279678|NCT01964131|pharmacodynamics|pharmacodynamics
279679|NCT01964131|pharmacokinetics|pharmacokinetics
279680|NCT01964131|safety|safety
279681|NCT01964131|tolerability|tolerability
279682|NCT01964131|D961H|d961h
279683|NCT01964131|Japanese|japanese
279684|NCT01964118|intermittent fasting|intermittent fasting
279685|NCT01964118|obesity|obesity
279686|NCT01964118|calorie restriction|calorie restriction
279687|NCT01964105|Hypomastia|hypomastia
279688|NCT01964105|Augmentation|augmentation
279689|NCT01964105|Breast|breast
279690|NCT01964105|3D|3d
279691|NCT01964105|Breast Q|breast q
279692|NCT01964092|Disability|disability
279693|NCT01964092|Individual placement and support|individual placement and support
279694|NCT01964092|Mental health|mental health
279695|NCT01964092|Quality of life|quality of life
279696|NCT01964092|Randomized controlled trial|randomized controlled trial
279697|NCT01964092|Rehabilitation|rehabilitation
279698|NCT01964092|Return to work|return to work
279699|NCT01964092|Supported employment|supported employment
279700|NCT01964066|therapeutic ERCP|therapeutic ercp
279701|NCT01964066|prevention of post-ERCP pancreatitis|prevention of post-ercp pancreatitis
279702|NCT01964066|thoracic epidural analgesia|thoracic epidural analgesia
279703|NCT01964053|Self-management adherence|self-management adherence
279704|NCT01964053|post acute care|post acute care
279705|NCT01964053|critical access hospitals|critical access hospitals
279706|NCT01964053|patient activation|patient activation
279707|NCT01964053|hospital readmission|hospital readmission
279708|NCT01964040|femoral nerve block|femoral nerve block
279709|NCT01964040|peri-neural dexmedetomidine|peri-neural dexmedetomidine
279710|NCT01964027|second line chemoregime|second line chemoregime
279711|NCT01964027|gastric cancer|gastric cancer
279712|NCT01964014|once|once
279713|NCT01963988|Bladder Pain Syndrome|bladder pain syndrome
279714|NCT01963988|Transurethral Resection of Ulcer|transurethral resection of ulcer
279715|NCT01963988|Transurethral Coagulation of Ulcer|transurethral coagulation of ulcer
279716|NCT01963962|Emergency contraception|emergency contraception
279717|NCT01963962|Levonorgestrel IUD|levonorgestrel iud
279718|NCT01963962|Copper IUD|copper iud
279719|NCT01963962|Oral Levonorgestrel|oral levonorgestrel
279720|NCT01963936|Infant newborn|infant newborn
279721|NCT01963936|Laryngeal mask airway|laryngeal mask airway
279722|NCT01963936|Positive pressure ventilation|positive pressure ventilation
279723|NCT01963936|Resuscitation|resuscitation
279724|NCT01963923|Pulmonary Rehabilitation|pulmonary rehabilitation
279725|NCT01963923|Lung Cancer Resection|lung cancer resection
279726|NCT01963923|Video-assisted thoracic surgery|video-assisted thoracic surgery
279727|NCT01963923|Exercise tolerance|exercise tolerance
279728|NCT01963923|Quality of life|quality of life
279729|NCT01963910|Mannitol|mannitol
279730|NCT01963910|TRPV1 receptor|trpv1 receptor
279731|NCT01963910|Pain|pain
279732|NCT01963910|Burning pain|burning pain
279733|NCT01963910|neuropathy|neuropathy
279734|NCT01963910|neuropathic pain|neuropathic pain
279735|NCT01963897|Genotype/phenotype correlations|genotype/phenotype correlations
279736|NCT01963897|Growth|growth
279737|NCT01963897|Bone health|bone health
279738|NCT01963897|Puberty|puberty
279739|NCT01963897|Quality of life|quality of life
279740|NCT01963884|Extraction Sockets|extraction sockets
279741|NCT01963884|Ridge dimensions|ridge dimensions
279742|NCT01963884|Dental Alveolar Anatomy|dental alveolar anatomy
279743|NCT01963884|Dental Implants|dental implants
279744|NCT01963884|Bone Physiology|bone physiology
279745|NCT01963871|chronic low back pain|chronic low back pain
279746|NCT01963871|low back pain|low back pain
279747|NCT01963871|yoga|yoga
279748|NCT01963832|stroke|stroke
279749|NCT01963832|Fluoxetine (FLX)|fluoxetine (flx)
279750|NCT01963832|eCIMT|ecimt
279751|NCT01963832|Central Nervous System|central nervous system
279752|NCT01963793|Pruritus|pruritus
279753|NCT01963780|lung transplantation|lung transplantation
279754|NCT01963780|lung preservation|lung preservation
279755|NCT01963780|breathing lung transplant|breathing lung transplant
279756|NCT01963767|memory|memory
279757|NCT01963767|cognition|cognition
279758|NCT01963767|dietary supplements|dietary supplements
279759|NCT01963754|Articaine 1:100.000|articaine 1:100.000
279760|NCT01963754|Dental Implants|dental implants
279761|NCT01963754|Posterior mandible|posterior mandible
279762|NCT01963754|Loco-regional Anesthesia|loco-regional anesthesia
279763|NCT01963754|Subperiosteal Anesthesia|subperiosteal anesthesia
279764|NCT01963741|Leukotriene D4|leukotriene d4
279765|NCT01963741|allergic rhinitis|allergic rhinitis
279766|NCT01963741|nasal airway resistance|nasal airway resistance
279767|NCT01963741|nasal provocation test|nasal provocation test
279768|NCT01963741|nasal hyperreactivity|nasal hyperreactivity
279769|NCT01963741|airway inflammation|airway inflammation
279770|NCT01963741|asthma|asthma
279771|NCT01963728|post-transplant|post-transplant
279772|NCT01963728|diabetes mellitus|diabetes mellitus
279773|NCT01963728|renal transplant|renal transplant
279774|NCT01963728|kidney transplant|kidney transplant
279775|NCT01963728|lung transplant|lung transplant
279776|NCT01963728|heart transplant|heart transplant
279777|NCT01963728|insulin|insulin
279778|NCT01963715|IMGN289|imgn289
279779|NCT01963715|Antibody Drug Conjugate|antibody drug conjugate
279780|NCT01963715|antibody|antibody
279781|NCT01963715|EGFR|egfr
279782|NCT01963715|NSCLC|nsclc
279783|NCT01963715|SCCHN|scchn
279784|NCT01963715|Head and neck|head and neck
279785|NCT01963715|Squamous cell carcinoma|squamous cell carcinoma
279786|NCT01963715|Solid tumor|solid tumor
279787|NCT01963715|Immunogen|immunogen
279788|NCT01963715|Lung|lung
279789|NCT01963715|Phase 1|phase 1
279790|NCT01963702|predictive factor|predictive factor
279791|NCT01963702|response|response
279792|NCT01963702|gastric neoplasm|gastric neoplasm
279793|NCT01963702|oxaliplatin|oxaliplatin
279794|NCT01963702|docetaxol|docetaxol
279795|NCT01963702|capecitabine|capecitabine
279796|NCT01963689|Anxiety|anxiety
279797|NCT01963689|Self-Esteem|self-esteem
279798|NCT01963676|schizophrenia|schizophrenia
279799|NCT01963676|auditory hallucinations|auditory hallucinations
279800|NCT01963676|transcranial stimulation|transcranial stimulation
279801|NCT01963676|tDCS|tdcs
279802|NCT01963676|tACS|tacs
279803|NCT01963663|YKL-40|ykl-40
279804|NCT01963663|Chronic low grade inflammation|chronic low grade inflammation
279805|NCT01963663|type 2 diabetes mellitus|type 2 diabetes mellitus
279806|NCT01963663|metformin|metformin
279807|NCT01963663|pioglitazone|pioglitazone
279808|NCT01963637|obesity, sleeve gastrectomy, gastric bypass, gastric tomodensitometry, gastric pouch size, weight regain|obesity, sleeve gastrectomy, gastric bypass, gastric tomodensitometry, gastric pouch size, weight regain
279809|NCT01963624|Breast|breast
279810|NCT01963624|Screening|screening
279811|NCT01963624|Ultrasound|ultrasound
279812|NCT01963624|Elastography|elastography
279813|NCT01963624|Doppler ultrasonography|doppler ultrasonography
279814|NCT01963611|Multiple Sclerosis|multiple sclerosis
279815|NCT01963611|Relapsing Remitting|relapsing remitting
279816|NCT01963611|Plovamer acetate|plovamer acetate
279817|NCT01963611|Copaxone|copaxone
279818|NCT01963585|C reactive protein|c reactive protein
279819|NCT01963585|Airway hyperreactivity|airway hyperreactivity
279820|NCT01963585|Body mass index|body mass index
279821|NCT01963572|Breast cancer|breast cancer
279822|NCT01963572|Care model|care model
279823|NCT01963572|Physical Therapy|physical therapy
279824|NCT01963546|diabetic|diabetic
279825|NCT01963546|laparoscopic gastric bypass surgery|laparoscopic gastric bypass surgery
279826|NCT01963546|stress response|stress response
279827|NCT01963546|anesthesia|anesthesia
279828|NCT01963546|dexmedetomidine|dexmedetomidine
279829|NCT01963533|lung cancer|lung cancer
279830|NCT01963533|telomere length|telomere length
279831|NCT01963533|comorbidity|comorbidity
279832|NCT01963533|Eastern Cooperation Oncology Group (ECOG)|eastern cooperation oncology group (ecog)
279833|NCT01963533|chemotherapy|chemotherapy
279834|NCT01963520|Hip prosthesis infection|hip prosthesis infection
279835|NCT01963520|Reinfection|reinfection
279836|NCT01963520|Excision-synovectomy|excision-synovectomy
279837|NCT01963520|One stage/two stage revision|one stage/two stage revision
279838|NCT01963520|Antibiotherapy|antibiotherapy
279839|NCT01963494|Physical activity|physical activity
279840|NCT01963494|Health-behavior-change|health-behavior-change
279841|NCT01963494|Dyadic Planning|dyadic planning
279842|NCT01963494|Individual Planning|individual planning
279843|NCT01963481|hormonal therapy|hormonal therapy
279844|NCT01963481|immunotherapy|immunotherapy
279845|NCT01963468|Hearing Loss|hearing loss
279846|NCT01963468|Cochlear Implant|cochlear implant
279847|NCT01963468|Deaf|deaf
279848|NCT01963468|Hearing Impairment|hearing impairment
279849|NCT01963468|Hard of Hearing|hard of hearing
279850|NCT01963455|transplantation autologous stress urinary incontinence|transplantation autologous stress urinary incontinence
279851|NCT01963455|muscle derived cells|muscle derived cells
279852|NCT01963429|hepatocellular|hepatocellular
279853|NCT01963429|Proton|proton
279854|NCT01963429|RFA|rfa
279855|NCT01963403|etonogestrel implant|etonogestrel implant
279856|NCT01963403|birth control|birth control
279857|NCT01963403|irregular bleeding|irregular bleeding
279858|NCT01963403|heavy bleeding|heavy bleeding
279859|NCT01963390|Hypogonadism|hypogonadism
279860|NCT01963390|Testosterone Deficiency|testosterone deficiency
279861|NCT01963377|bronchoscopy|bronchoscopy
279862|NCT01963377|O2-supplementation|o2-supplementation
279863|NCT01963364|fructans|fructans
279864|NCT01963364|inulin|inulin
279865|NCT01963364|oligofructose|oligofructose
279866|NCT01963364|colonic fermentation|colonic fermentation
279867|NCT01963364|microbiota|microbiota
279868|NCT01963364|whoe gut transit|whoe gut transit
279869|NCT01963351|NSCLC|nsclc
279870|NCT01963351|Non-squamous|non-squamous
279871|NCT01963286|ICD|icd
279872|NCT01963286|CRT-D|crt-d
279873|NCT01963286|Sudden cardiac death|sudden cardiac death
279874|NCT01963286|Device settings|device settings
279875|NCT01963286|Optimized programming strategy|optimized programming strategy
279876|NCT01963221|elderly|elderly
279877|NCT01963221|aorta|aorta
279878|NCT01963221|inflammation|inflammation
279879|NCT01963221|arterial stiffness|arterial stiffness
279880|NCT01963221|PET/CT Imaging|pet/ct imaging
279881|NCT01963221|hypertension|hypertension
279882|NCT01963221|MRI|mri
279883|NCT01963208|partial onset seizures|partial onset seizures
279884|NCT01963208|complex partial seizures|complex partial seizures
279885|NCT01963208|simple partial seizures|simple partial seizures
279886|NCT01963208|anticonvulsant|anticonvulsant
279887|NCT01963208|ganaxolone|ganaxolone
279888|NCT01963208|neurosteroid|neurosteroid
279889|NCT01963208|Marinus|marinus
279890|NCT01963208|epilepsy|epilepsy
279891|NCT01963195|Adverse Reaction to Drug|adverse reaction to drug
279892|NCT01963195|Self Efficacy|self efficacy
279893|NCT01963169|Bone Health|bone health
279894|NCT01963169|Online intervention|online intervention
279895|NCT01963169|Dissemination|dissemination
279896|NCT01963169|Theory-based intervention|theory-based intervention
279897|NCT01963156|Prescription synchronization|prescription synchronization
279898|NCT01963156|Cardiovascular disease|cardiovascular disease
279899|NCT01963156|Medication adherence|medication adherence
279900|NCT01963156|Randomized controlled trial|randomized controlled trial
279901|NCT01963156|Chronic disease|chronic disease
279902|NCT01963156|Pharmacy benefit design|pharmacy benefit design
279903|NCT01963156|Quality improvement|quality improvement
279904|NCT01963130|Vildagliptin|vildagliptin
279905|NCT01963130|Portal Vein Pressure|portal vein pressure
279906|NCT01963130|Hepatosteatosis|hepatosteatosis
279907|NCT01963104|hearing test, audiology, healthcare utilization,|hearing test, audiology, healthcare utilization,
279908|NCT01963104|patient education, hearing screening|patient education, hearing screening
279909|NCT01963065|Children's environmental health|children's environmental health
279910|NCT01963065|preterm birth|preterm birth
279911|NCT01963065|newborns|newborns
279912|NCT01963065|bisphenol A|bisphenol a
279913|NCT01963065|BPA|bpa
279914|NCT01963065|phthalates|phthalates
279915|NCT01963065|metals exposure|metals exposure
279916|NCT01963065|very low birth weight|very low birth weight
279917|NCT01963065|NICU|nicu
279918|NCT01963052|Metastatic Urothelial Cancer|metastatic urothelial cancer
279919|NCT01963052|AGS15E|ags15e
279920|NCT01963052|AGS15E-13-1|ags15e-13-1
279921|NCT01963052|ASG-15ME|asg-15me
279922|NCT01963052|Pharmacokinetics of AGS15E|pharmacokinetics of ags15e
279923|NCT01963026|spinal cord injury|spinal cord injury
279924|NCT01963026|upper extremity|upper extremity
279925|NCT01963026|skill performance|skill performance
279926|NCT01963026|motor learning|motor learning
279927|NCT01963013|Non-returning catheter valve|non-returning catheter valve
279928|NCT01963013|Catheter associated urinary tract infection|catheter associated urinary tract infection
279929|NCT01963013|Critically ill patients|critically ill patients
279930|NCT01963013|Prevention|prevention
279931|NCT01963000|Community Acquired Pneumonia|community acquired pneumonia
279932|NCT01963000|Emergency Department|emergency department
279933|NCT01963000|Standardized Care|standardized care
279934|NCT01963000|Reduced Mortality|reduced mortality
279935|NCT01963000|CRB-65 Risk Classes|crb-65 risk classes
279936|NCT01963000|Antibiotic Therapy|antibiotic therapy
279937|NCT01962974|Arthritis, Rheumatoid|arthritis, rheumatoid
279938|NCT01962961|HIV|hiv
279939|NCT01962961|Endothelial function|endothelial function
279940|NCT01962961|Oxidative stress|oxidative stress
279941|NCT01962961|Cardiovascular disease|cardiovascular disease
279942|NCT01962961|N-acetylcysteine|n-acetylcysteine
279943|NCT01962935|Healthy volunteer|healthy volunteer
279944|NCT01962935|Multiple ascending dose|multiple ascending dose
279945|NCT01962909|Pancreatic Resection|pancreatic resection
279946|NCT01962883|Post Concussion Syndrome|post concussion syndrome
279947|NCT01962883|Vestibular disturbance|vestibular disturbance
279948|NCT01962883|Balance|balance
279949|NCT01962883|Dizziness|dizziness
279950|NCT01962883|Dizziness handicap inventory|dizziness handicap inventory
279951|NCT01962883|Balance Error Scoring System|balance error scoring system
279952|NCT01962857|Physical activity|physical activity
279953|NCT01962857|Exercise|exercise
279954|NCT01962857|Insulin resistance|insulin resistance
279955|NCT01962857|High intensity interval training|high intensity interval training
279956|NCT01962857|Fat oxidation|fat oxidation
279957|NCT01962857|Fitness|fitness
279958|NCT01962857|Lipids|lipids
279959|NCT01962857|Blood pressure|blood pressure
279960|NCT01962844|chronic coronary artery disease|chronic coronary artery disease
279961|NCT01962844|coconut oil extra virgin|coconut oil extra virgin
279962|NCT01962844|index of diet quality|index of diet quality
279963|NCT01962844|nutritional treatment|nutritional treatment
279964|NCT01962831|obesity|obesity
279965|NCT01962831|labor, induced|labor, induced
279966|NCT01962831|pregnancy|pregnancy
279967|NCT01962831|cervical ripening|cervical ripening
279968|NCT01962831|dinoprostone|dinoprostone
279969|NCT01962818|Respiratory Distress Syndrome In Premature Infants|respiratory distress syndrome in premature infants
279970|NCT01962818|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
279971|NCT01962818|Ventilator-Induced Lung Injury|ventilator-induced lung injury
279972|NCT01962818|Functional Residual Capacity|functional residual capacity
279973|NCT01962818|Electric impedance tomography|electric impedance tomography
279974|NCT01962792|PCI-32765|pci-32765
279975|NCT01962792|Multiple Myeloma|multiple myeloma
279976|NCT01962792|Relapsed Refractory Multiple Myeloma|relapsed refractory multiple myeloma
279977|NCT01962792|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
279978|NCT01962792|Carfilzomib|carfilzomib
279979|NCT01962792|Dexamethasone|dexamethasone
279980|NCT01962792|Ibrutinib|ibrutinib
279981|NCT01962779|Sleep Disordered Breathing|sleep disordered breathing
279982|NCT01962779|Cognitively normal elderly|cognitively normal elderly
279983|NCT01962779|Alzheimer's disease|alzheimer's disease
279984|NCT01962779|Prevention|prevention
279985|NCT01962779|Continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
279986|NCT01962753|Affective symptoms as prodromal stage of Alzheimer|affective symptoms as prodromal stage of alzheimer
279987|NCT01962727|scapular dyskinesis, kinematics, muscular activities|scapular dyskinesis, kinematics, muscular activities
279988|NCT01962714|Behavior therapies, cognitive|behavior therapies, cognitive
279989|NCT01962714|Mindfulness|mindfulness
279990|NCT01962714|Emotion|emotion
279991|NCT01962714|Group therapy|group therapy
279992|NCT01962701|C-section|c-section
279993|NCT01962688|Heart Failure|heart failure
279994|NCT01962688|Handheld ultrasound|handheld ultrasound
279995|NCT01962688|Inferior Vena Cava|inferior vena cava
279996|NCT01962675|tDCS|tdcs
279997|NCT01962675|motor training|motor training
279998|NCT01962675|SCI|sci
279999|NCT01962662|stroke|stroke
280000|NCT01962662|transcranial magnetic stimulation|transcranial magnetic stimulation
280001|NCT01962662|EMG biofeedback|emg biofeedback
280002|NCT01962662|motor function|motor function
280003|NCT01962662|neural plasticity|neural plasticity
280004|NCT01962662|force|force
280005|NCT01962649|Hepatocellular carcinoma|hepatocellular carcinoma
280006|NCT01962636|Umbilical Cord Transplant|umbilical cord transplant
280007|NCT01962636|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
280008|NCT01962636|Acute Lymphocytic Leukemia (ALL)|acute lymphocytic leukemia (all)
280009|NCT01962636|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
280010|NCT01962636|Plasma Cell Leukemia|plasma cell leukemia
280011|NCT01962636|Myelofibrosis|myelofibrosis
280012|NCT01962636|Myelodysplasia|myelodysplasia
280013|NCT01962636|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
280014|NCT01962636|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
280015|NCT01962636|Marginal Zone B-Cell Lymphoma|marginal zone b-cell lymphoma
280016|NCT01962636|Follicular Lymphoma|follicular lymphoma
280017|NCT01962636|Lymphoplasmacytic Lymphoma|lymphoplasmacytic lymphoma
280018|NCT01962636|Mantle-Cell Lymphoma|mantle-cell lymphoma
280019|NCT01962636|Prolymphocytic Leukemia|prolymphocytic leukemia
280020|NCT01962636|Large Cell Non-Hodgkin Lymphoma|large cell non-hodgkin lymphoma
280021|NCT01962636|Lymphoblastic Lymphoma|lymphoblastic lymphoma
280022|NCT01962636|Burkitt's Lymphoma|burkitt's lymphoma
280023|NCT01962636|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
280024|NCT01962636|Multiple Myeloma|multiple myeloma
280025|NCT01962623|Severe Mood Dysregulation|severe mood dysregulation
280026|NCT01962623|Mood Disorders|mood disorders
280027|NCT01962623|Irritability|irritability
280028|NCT01962623|Disruptive Mood Dysregulation Disorder|disruptive mood dysregulation disorder
280029|NCT01962623|Interpersonal Psychotherapy|interpersonal psychotherapy
280030|NCT01962610|Pain care|pain care
280031|NCT01962610|emergency|emergency
280032|NCT01962610|clinical decision support|clinical decision support
280033|NCT01962610|abdominal pain|abdominal pain
280034|NCT01962597|hemodialysis|hemodialysis
280035|NCT01962597|aerobic exercise|aerobic exercise
280036|NCT01962597|resistance training|resistance training
280037|NCT01962597|walking speed|walking speed
280038|NCT01962597|randomized controlled trial|randomized controlled trial
280039|NCT01962571|Optic neuritis|optic neuritis
280040|NCT01962571|Multiple Sclerosis|multiple sclerosis
280041|NCT01962571|Clinically isolated syndrome|clinically isolated syndrome
280042|NCT01962571|Erythropoietin|erythropoietin
280043|NCT01962558|Tinnitus|tinnitus
280044|NCT01962558|Medical Device|medical device
280045|NCT01962558|Randomized|randomized
280046|NCT01962558|Vagus Nerve Stimulation|vagus nerve stimulation
280047|NCT01962545|Atrial Fibrillation|atrial fibrillation
280048|NCT01962545|Percutaneous coronary intervention|percutaneous coronary intervention
280049|NCT01962545|Stent|stent
280050|NCT01962545|Anticoagulant therapy|anticoagulant therapy
280051|NCT01962545|Antiplatelet therapy|antiplatelet therapy
280052|NCT01962545|Warfarin|warfarin
280053|NCT01962545|NOAC|noac
280054|NCT01962545|Aspirin|aspirin
280055|NCT01962545|Clopidogrel|clopidogrel
280056|NCT01962532|Neoplasms|neoplasms
280057|NCT01962532|Lymphoma|lymphoma
280058|NCT01962532|Advanced or refractory solid tumors|advanced or refractory solid tumors
280059|NCT01962532|Advanced or refractory lymphoma|advanced or refractory lymphoma
280060|NCT01962532|Gastric adenocarcinoma|gastric adenocarcinoma
280061|NCT01962532|Gastroesophageal junctions|gastroesophageal junctions
280062|NCT01962532|JNJ-42756493|jnj-42756493
280063|NCT01962532|Pharmacokinetics|pharmacokinetics
280064|NCT01962532|Japanese|japanese
280065|NCT01962532|Asian|asian
280066|NCT01962532|Pharmacodynamics|pharmacodynamics
280067|NCT01962519|gastrectomy|gastrectomy
280068|NCT01962519|gastric cancer|gastric cancer
280069|NCT01962519|oral feeding|oral feeding
280070|NCT01962519|complications|complications
280071|NCT01962506|Chest pain|chest pain
280072|NCT01962506|Copeptin|copeptin
280073|NCT01962506|High-sensitivity cardiac troponin|high-sensitivity cardiac troponin
280074|NCT01962506|Non-ST-Elevation (NSTE) - ACS|non-st-elevation (nste) - acs
280075|NCT01962467|Allergic rhinitis|allergic rhinitis
280076|NCT01962467|healthy volunteers|healthy volunteers
280077|NCT01962467|fluticasone furoate|fluticasone furoate
280078|NCT01962467|levocabastine|levocabastine
280079|NCT01962467|fixed dose combination|fixed dose combination
280080|NCT01962467|pharmacokinetics|pharmacokinetics
280081|NCT01962454|muscle mass|muscle mass
280082|NCT01962454|dynamic proteomics|dynamic proteomics
280083|NCT01962454|Duke University|duke university
280084|NCT01962454|Microbiopsy|microbiopsy
280085|NCT01962454|D2O|d2o
280086|NCT01962454|testosterone|testosterone
280087|NCT01962454|skeletal muscle|skeletal muscle
280088|NCT01962441|7977|7977
280089|NCT01962441|GS-7977|gs-7977
280090|NCT01962441|PSI-7977|psi-7977
280091|NCT01962441|Sofosbuvir (SOF)|sofosbuvir (sof)
280092|NCT01962441|Pegylated Interferon (Peg-IFN)|pegylated interferon (peg-ifn)
280093|NCT01962441|Ribavirin (RBV)|ribavirin (rbv)
280094|NCT01962428|ticagrelor|ticagrelor
280095|NCT01962428|loading dose|loading dose
280096|NCT01962428|non-ST-segment elevation acute coronary syndromes|non-st-segment elevation acute coronary syndromes
280097|NCT01962428|percutaneous coronary intervention|percutaneous coronary intervention
280098|NCT01962428|the antiplatelet effects|the antiplatelet effects
280099|NCT01962428|bleeding events|bleeding events
280100|NCT01962428|major adverse cardiac events|major adverse cardiac events
280101|NCT01962415|Severe Combined Immune Deficiency (SCID)|severe combined immune deficiency (scid)
280102|NCT01962415|Omenn Syndrome|omenn syndrome
280103|NCT01962415|Bare Lymphocyte Syndrome (BLS)|bare lymphocyte syndrome (bls)
280104|NCT01962415|Combined Immune Deficiency (CID) syndromes|combined immune deficiency (cid) syndromes
280105|NCT01962415|Combined Variable Immune Deficiency (CVID) syndrome|combined variable immune deficiency (cvid) syndrome
280106|NCT01962415|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
280107|NCT01962415|Leukocyte adhesion deficiency|leukocyte adhesion deficiency
280108|NCT01962415|Chronic granulomatous disease (CGD)|chronic granulomatous disease (cgd)
280109|NCT01962415|X-linked Hyper IgM (XHIM) syndrome|x-linked hyper igm (xhim) syndrome
280110|NCT01962415|IPEX syndrome|ipex syndrome
280111|NCT01962415|Chediak - Higashi Syndrome|chediak - higashi syndrome
280112|NCT01962415|Autoimmune Lymphoproliferative Syndrome (ALPS)|autoimmune lymphoproliferative syndrome (alps)
280113|NCT01962415|Hemophagocytic Lymphohistiocytosis (HLH) syndromes|hemophagocytic lymphohistiocytosis (hlh) syndromes
280114|NCT01962415|Lymphocyte Signaling defects|lymphocyte signaling defects
280115|NCT01962415|Dyskeratosis Congenita (DC)|dyskeratosis congenita (dc)
280116|NCT01962415|Congenital Amegakaryocytic Thrombocytopenia (CAMT)|congenital amegakaryocytic thrombocytopenia (camt)
280117|NCT01962415|Osteopetrosis|osteopetrosis
280118|NCT01962415|Mucopolysaccharidoses|mucopolysaccharidoses
280119|NCT01962415|Hurler syndrome (MPS I)|hurler syndrome (mps i)
280120|NCT01962415|Hunter syndrome (MPS II)|hunter syndrome (mps ii)
280121|NCT01962415|Sanfilippo syndrome (MPS II)|sanfilippo syndrome (mps ii)
280122|NCT01962415|Leukodystrophies|leukodystrophies
280123|NCT01962415|Krabbe Disease|krabbe disease
280124|NCT01962415|Metachromatic leukodystrophy (MLD)|metachromatic leukodystrophy (mld)
280125|NCT01962415|X-linked adrenoleukodystrophy (ALD)|x-linked adrenoleukodystrophy (ald)
280126|NCT01962415|Alpha mannosidosis|alpha mannosidosis
280127|NCT01962415|Gaucher Disease|gaucher disease
280128|NCT01962415|Thalassemia major|thalassemia major
280129|NCT01962415|Sickle cell disease (SCD)|sickle cell disease (scd)
280130|NCT01962415|Diamond Blackfan Anemia (DBA)|diamond blackfan anemia (dba)
280131|NCT01962415|Crohn's Disease|crohn's disease
280132|NCT01962415|Inflammatory Bowel Disease|inflammatory bowel disease
280133|NCT01962415|Hematopoietic Stem Cell Transplant (HSCT)|hematopoietic stem cell transplant (hsct)
280134|NCT01962415|Congenital transfusion dependent anemias|congenital transfusion dependent anemias
280135|NCT01962415|Globoid cell leukodystrophy|globoid cell leukodystrophy
280136|NCT01962389|ISR, Laser, SFA, PAD|isr, laser, sfa, pad
280137|NCT01962376|Capecitabine|capecitabine
280138|NCT01962376|Oxaliplatin|oxaliplatin
280139|NCT01962376|Bevacizumab|bevacizumab
280140|NCT01962376|Potentially Resectable Gastric Cancer Liver Metastasis|potentially resectable gastric cancer liver metastasis
280141|NCT01962363|Friedreich's ataxia point mutation|friedreich's ataxia point mutation
280142|NCT01962350|Deep Brain Transcranial Magnetic Stimulation;|deep brain transcranial magnetic stimulation;
280143|NCT01962350|H1-Coil deep brain rTMS;|h1-coil deep brain rtms;
280144|NCT01962350|H1-Coil;|h1-coil;
280145|NCT01962350|Bipolar Depression;|bipolar depression;
280146|NCT01962350|Cognition.|cognition.
280147|NCT01962324|Quality of Life|quality of life
280148|NCT01962324|Radiotherapy|radiotherapy
280149|NCT01962324|Radiotherapy, dose-escalation|radiotherapy, dose-escalation
280150|NCT01962311|ALS|als
280151|NCT01962311|Spinal Cerebrospinal Fluid|spinal cerebrospinal fluid
280152|NCT01962311|Urine|urine
280153|NCT01962311|SERUM|serum
280154|NCT01962311|Diagnosis|diagnosis
280155|NCT01962285|neuronal inertia|neuronal inertia
280156|NCT01962285|loss of consciousness|loss of consciousness
280157|NCT01962285|propofol pharmacodynamics|propofol pharmacodynamics
280158|NCT01962285|Bispectral index|bispectral index
280159|NCT01962285|anesthesia, general/pharmacology|anesthesia, general/pharmacology
280160|NCT01962272|cancer|cancer
280161|NCT01962272|radiotherapy|radiotherapy
280162|NCT01962272|chemotherapy|chemotherapy
280163|NCT01962272|nutrition|nutrition
280164|NCT01962272|dietary counseling|dietary counseling
280165|NCT01962272|quality of life|quality of life
280166|NCT01962246|Capecitabine|capecitabine
280167|NCT01962246|Oxaliplatin|oxaliplatin
280168|NCT01962246|Preoperative Concurrent Chemoradiotherapy|preoperative concurrent chemoradiotherapy
280169|NCT01962246|Gastroesophageal Junction Adenocarcinoma|gastroesophageal junction adenocarcinoma
280170|NCT01962220|HIV/AIDS|hiv/aids
280171|NCT01962220|PMTCT|pmtct
280172|NCT01962220|Pregnant Women|pregnant women
280173|NCT01962220|Kenya|kenya
280174|NCT01962220|Maternal Health|maternal health
280175|NCT01962207|10 years Meningitec|10 years meningitec
280176|NCT01962207|Safety|safety
280177|NCT01962207|booster response|booster response
280178|NCT01962207|Adolescents|adolescents
280179|NCT01962207|Adults|adults
280180|NCT01962207|Immunogenicity|immunogenicity
280181|NCT01962207|Mencevax ACWY|mencevax acwy
280182|NCT01962181|EEG Attention Deficit / Hyperactivity Disorder (ADHD) Ritalin machine learning|eeg attention deficit / hyperactivity disorder (adhd) ritalin machine learning
280183|NCT01962168|Biliary Tract Neoplasms|biliary tract neoplasms
280184|NCT01962168|Neoplasms|neoplasms
280185|NCT01962168|Gastrointestinal Diseases|gastrointestinal diseases
280186|NCT01962168|Digestive System Diseases|digestive system diseases
280187|NCT01962168|Biliary Tract|biliary tract
280188|NCT01962168|Stents|stents
280189|NCT01962155|Fibrosis|fibrosis
280190|NCT01962155|Liver Cirrhosis|liver cirrhosis
280191|NCT01962155|non-invasive|non-invasive
280192|NCT01962155|biopsy|biopsy
280193|NCT01962155|hepatitis B virus|hepatitis b virus
280194|NCT01962103|Neuroblastoma|neuroblastoma
280195|NCT01962103|Rhabdomyosarcoma|rhabdomyosarcoma
280196|NCT01962103|Soft Tissue|soft tissue
280197|NCT01962103|Pediatric Oncology|pediatric oncology
280198|NCT01962103|Abraxane|abraxane
280199|NCT01962103|albumin-bound paclitaxel|albumin-bound paclitaxel
280200|NCT01962103|nab-paclitaxel|nab-paclitaxel
280201|NCT01962103|ABI-007|abi-007
280202|NCT01962103|taxane|taxane
280203|NCT01962103|solid tumors|solid tumors
280204|NCT01962090|Neck Pain|neck pain
280205|NCT01962090|Thoracic spine thrust manipulation|thoracic spine thrust manipulation
280206|NCT01962090|Osteopathic Manipulation|osteopathic manipulation
280207|NCT01962090|Dentistry|dentistry
280208|NCT01962090|Range of Motion|range of motion
280209|NCT01962077|pulpotomy|pulpotomy
280210|NCT01962077|MTA|mta
280211|NCT01962077|primary teeth|primary teeth
280212|NCT01962077|formocresol|formocresol
280213|NCT01962038|Mild Cognitive Impairment|mild cognitive impairment
280214|NCT01962038|Aging|aging
280215|NCT01962025|Renal failure|renal failure
280216|NCT01962025|Hemodialysis|hemodialysis
280217|NCT01962025|Canulation technique|canulation technique
280218|NCT01962025|Training time|training time
280219|NCT01962025|Cost|cost
280513|NCT01960504|Scaffold|scaffold
280220|NCT01962025|Patient discomfort with cannulation technique|patient discomfort with cannulation technique
280221|NCT01962012|Orthodontic|orthodontic
280222|NCT01962012|Orthodontic Treatment|orthodontic treatment
280223|NCT01962012|Accelerated Tooth Movement|accelerated tooth movement
280224|NCT01962012|Malocclusion|malocclusion
280225|NCT01962012|Device|device
280226|NCT01962012|AcceleDent Aura|acceledent aura
280227|NCT01962012|Clear Aligners|clear aligners
280228|NCT01961999|Acute kidney injury|acute kidney injury
280229|NCT01961999|Cardiac surgery|cardiac surgery
280230|NCT01961999|Renal replacement therapy|renal replacement therapy
280231|NCT01961986|Rotator Cuff|rotator cuff
280232|NCT01961986|Rotator Cuff Sparing|rotator cuff sparing
280233|NCT01961986|Shoulder Replacement|shoulder replacement
280234|NCT01961986|Total Shoulder Replacement|total shoulder replacement
280235|NCT01961986|Total Shoulder Arthroplasty|total shoulder arthroplasty
280236|NCT01961986|Arthritis|arthritis
280237|NCT01961973|Articular cartilage|articular cartilage
280238|NCT01961973|Chondrocytes|chondrocytes
280239|NCT01961973|BMAC|bmac
280240|NCT01961960|ASP7374|asp7374
280241|NCT01961960|Prevention of seasonal influenza|prevention of seasonal influenza
280242|NCT01961947|ASP7374|asp7374
280243|NCT01961947|Approved egg-derived vaccine|approved egg-derived vaccine
280244|NCT01961947|Prevention of seasonal influenza|prevention of seasonal influenza
280245|NCT01961934|glioblastoma|glioblastoma
280246|NCT01961934|high grade brain tumors|high grade brain tumors
280247|NCT01961934|recurrent|recurrent
280248|NCT01961934|pseudo-progression|pseudo-progression
280249|NCT01961934|radionecrosis|radionecrosis
280250|NCT01961934|carbon acetate|carbon acetate
280251|NCT01961934|C11 aceate|c11 aceate
280252|NCT01961934|PET|pet
280253|NCT01961934|positron emission tomography|positron emission tomography
280254|NCT01961921|RNAi therapeutic|rnai therapeutic
280255|NCT01961895|Continuous lumbar plexus (LP) block analgesia|continuous lumbar plexus (lp) block analgesia
280256|NCT01961882|OCV-501|ocv-501
280257|NCT01961882|Acute Myeloid Leukemia|acute myeloid leukemia
280258|NCT01961882|Antigen specific cancer immunotherapeutic|antigen specific cancer immunotherapeutic
280259|NCT01961869|black raspberry|black raspberry
280260|NCT01961869|chemoprevention|chemoprevention
280261|NCT01961869|oral delivery|oral delivery
280262|NCT01961856|platelet reactivity|platelet reactivity
280263|NCT01961856|ticagrelor loading dose|ticagrelor loading dose
280264|NCT01961856|clopidogrel loading dose|clopidogrel loading dose
280265|NCT01961843|Castration Resistant|castration resistant
280266|NCT01961817|Retromolar|retromolar
280267|NCT01961817|Difficult Intubation|difficult intubation
280268|NCT01961791|gastric cancer, staging system, prognosis|gastric cancer, staging system, prognosis
280269|NCT01961765|Relapsed acute myeloid leukemia|relapsed acute myeloid leukemia
280270|NCT01961765|Refractory acute myeloid leukemia|refractory acute myeloid leukemia
280271|NCT01961752|bupivacaine,|bupivacaine,
280272|NCT01961752|triamcinolone acetonide,|triamcinolone acetonide,
280273|NCT01961752|endoscopic|endoscopic
280274|NCT01961752|submucosal|submucosal
280275|NCT01961752|dissection|dissection
280276|NCT01961752|Patients|patients
280277|NCT01961739|Hemorrhoids|hemorrhoids
280278|NCT01961739|Lidocaine|lidocaine
280279|NCT01961713|circulating tumor cells|circulating tumor cells
280280|NCT01961713|CTC-Chip|ctc-chip
280281|NCT01961661|intestinal inflammation|intestinal inflammation
280282|NCT01961661|intestinal microflora|intestinal microflora
280283|NCT01961661|children|children
280284|NCT01961648|Apnea|apnea
280285|NCT01961648|Sleep Apnea Disorder|sleep apnea disorder
280286|NCT01961648|Respiratory chemical drive|respiratory chemical drive
280287|NCT01961648|CO2|co2
280288|NCT01961635|Dental Implants|dental implants
280289|NCT01961635|Zirconia Abutments|zirconia abutments
280290|NCT01961635|Titanium abutments|titanium abutments
280291|NCT01961635|Acrylic abutments|acrylic abutments
280292|NCT01961635|Gingival Healing|gingival healing
280293|NCT01961635|Inflammation|inflammation
280294|NCT01961635|Bone loss|bone loss
280295|NCT01961622|Type 1 diabetes|type 1 diabetes
280296|NCT01961622|Closed loop insulin delivery|closed loop insulin delivery
280297|NCT01961622|Continuous subcutaneous glucose monitoring|continuous subcutaneous glucose monitoring
280298|NCT01961622|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
280299|NCT01961609|Chronic plaque psoriasis|chronic plaque psoriasis
280300|NCT01961596|Cooling ice spray|cooling ice spray
280301|NCT01961596|Time to stability|time to stability
280302|NCT01961596|Jump|jump
280303|NCT01961570|Early stage hand osteoarthritis|early stage hand osteoarthritis
280304|NCT01961570|Carpometacarpal osteoarthritis|carpometacarpal osteoarthritis
280305|NCT01961557|EEG|eeg
280306|NCT01961557|Cerebral Palsy|cerebral palsy
280307|NCT01961557|Knee|knee
280308|NCT01961544|Breast Cancer|breast cancer
280309|NCT01961544|Metastatic|metastatic
280310|NCT01961531|DCIS|dcis
280311|NCT01961531|IDC|idc
280312|NCT01961531|Invasive breast carcinoma|invasive breast carcinoma
280313|NCT01961479|Premenstrual syndrome (PMS)|premenstrual syndrome (pms)
280314|NCT01961479|Premenstrual Dysphoric Disorder (PMDD)|premenstrual dysphoric disorder (pmdd)
280897|NCT01958476|Opioids|opioids
280315|NCT01961479|Internet-based Therapy|internet-based therapy
280316|NCT01961479|Cognitive Behavioural Therapy (CBT)|cognitive behavioural therapy (cbt)
280317|NCT01961453|Hypertension|hypertension
280318|NCT01961453|Isosorbide Mononitrate|isosorbide mononitrate
280319|NCT01961453|Myocardial fibrosis|myocardial fibrosis
280320|NCT01961427|dietary nitrate|dietary nitrate
280321|NCT01961427|beetroot juice|beetroot juice
280322|NCT01961427|exercise performance|exercise performance
280323|NCT01961427|oxygen consumption|oxygen consumption
280324|NCT01961414|Exudative|exudative
280325|NCT01961414|AMD|amd
280326|NCT01961414|Macular|macular
280327|NCT01961414|Degeneration|degeneration
280328|NCT01961414|Aflibercept|aflibercept
280329|NCT01961414|Eylea|eylea
280330|NCT01961414|Intravitreal|intravitreal
280331|NCT01961401|exercise|exercise
280332|NCT01961401|exercise therapy|exercise therapy
280333|NCT01961401|insulin resistance|insulin resistance
280334|NCT01961388|Type 2 Diabetes|type 2 diabetes
280335|NCT01961362|Pulmonary fibrosis|pulmonary fibrosis
280336|NCT01961362|Interstitial lung disease|interstitial lung disease
280337|NCT01961362|Connective tissue disease|connective tissue disease
280338|NCT01961362|Chronic hypersensitivity pneumonitis|chronic hypersensitivity pneumonitis
280339|NCT01961362|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
280340|NCT01961362|Pulmonary fibrosis of any cause|pulmonary fibrosis of any cause
280341|NCT01961362|Primary supporters/caregivers|primary supporters/caregivers
280342|NCT01961349|sedation, propofol, gastrointestinal endoscopy|sedation, propofol, gastrointestinal endoscopy
280343|NCT01961336|IVF, poor responder, testosterone|ivf, poor responder, testosterone
280344|NCT01961323|Hypertension|hypertension
280345|NCT01961323|high blood pressure|high blood pressure
280346|NCT01961323|stress echocardiogram|stress echocardiogram
280347|NCT01961323|nebivolol|nebivolol
280348|NCT01961323|left ventricular diastolic dysfunction|left ventricular diastolic dysfunction
280349|NCT01961310|bacterial translocation|bacterial translocation
280350|NCT01961310|intestinal microbiota|intestinal microbiota
280351|NCT01961297|dystonia|dystonia
280352|NCT01961297|tremor|tremor
280353|NCT01961297|treatment|treatment
280354|NCT01961297|sodium oxybate|sodium oxybate
280355|NCT01961297|brain activity|brain activity
280356|NCT01961271|Norspan|norspan
280357|NCT01961271|buprenorphine|buprenorphine
280358|NCT01961271|transdermal|transdermal
280359|NCT01961271|patch|patch
280360|NCT01961271|chronic pain|chronic pain
280361|NCT01961271|non-malignant|non-malignant
280362|NCT01961271|osteoarthritis|osteoarthritis
280363|NCT01961271|rheumatoid arthritis|rheumatoid arthritis
280364|NCT01961271|lower back pain|lower back pain
280365|NCT01961271|joint pain|joint pain
280366|NCT01961271|muscle pain|muscle pain
280367|NCT01961271|opioid|opioid
280368|NCT01961271|analgesic|analgesic
280369|NCT01961271|painkiller|painkiller
280370|NCT01961271|Mundipharma|mundipharma
280371|NCT01961258|Severe Asthma, Community, comorbidities, patient compliance,PFT, anti-IgE therapy|severe asthma, community, comorbidities, patient compliance,pft, anti-ige therapy
280372|NCT01961232|Pulmonary Hypertension|pulmonary hypertension
280373|NCT01961232|biomarker|biomarker
280374|NCT01961232|cardiac|cardiac
280375|NCT01961232|circulation|circulation
280376|NCT01961232|heart disease|heart disease
280377|NCT01961232|lung disease|lung disease
280378|NCT01961193|critically ill patients|critically ill patients
280379|NCT01961193|punctal plug|punctal plug
280380|NCT01961193|corneal injuries|corneal injuries
280381|NCT01961180|Quality of Life|quality of life
280382|NCT01961180|Adrenal hyper activity|adrenal hyper activity
280383|NCT01961180|Glucose metabolism|glucose metabolism
280384|NCT01961154|Asthma|asthma
280385|NCT01961154|medication reduction|medication reduction
280386|NCT01961154|asthma exacerbation|asthma exacerbation
280387|NCT01961141|Ultrasound Doppler|ultrasound doppler
280388|NCT01961141|Pulmonary diseases|pulmonary diseases
280389|NCT01961141|Cardiopulmonary conditions|cardiopulmonary conditions
280390|NCT01961128|High risk|high risk
280391|NCT01961102|postmenopausal bleeding|postmenopausal bleeding
280392|NCT01961102|postmenopausal hyperplasia|postmenopausal hyperplasia
280393|NCT01961102|endometrial cancer|endometrial cancer
280394|NCT01961102|atypical hyperplasia|atypical hyperplasia
280395|NCT01961102|curettage|curettage
280396|NCT01961102|intraoperative rapid section|intraoperative rapid section
280397|NCT01961050|alcohol|alcohol
280398|NCT01961050|pregnancy|pregnancy
280399|NCT01961050|fetal exposure|fetal exposure
280400|NCT01961050|prevention|prevention
280401|NCT01961050|FAS|fas
280402|NCT01961050|Alcohol-Related Neurodevelopmental Disorder (ARND)|alcohol-related neurodevelopmental disorder (arnd)
280403|NCT01961037|Accidental Falls|accidental falls
280404|NCT01961037|Tai Chi|tai chi
280405|NCT01961037|Older Adults|older adults
280406|NCT01961037|Balance|balance
280407|NCT01961037|Moving for Better Balance|moving for better balance
280408|NCT01961037|Church|church
280409|NCT01961037|Congregational Intervention|congregational intervention
280410|NCT01961037|Rural|rural
280411|NCT01961037|West Virginia|west virginia
280412|NCT01961024|VLDL-TG kinetics|vldl-tg kinetics
281092|NCT01957566|children|children
280413|NCT01961024|Postprandial state|postprandial state
280414|NCT01961024|Obesity|obesity
280415|NCT01961011|nerve compression, carpal tunnel, clinical decision making|nerve compression, carpal tunnel, clinical decision making
280416|NCT01960998|radical prostatectomy|radical prostatectomy
280417|NCT01960998|urinary incontinence|urinary incontinence
280418|NCT01960998|prostate cancer|prostate cancer
280419|NCT01960998|telehealth|telehealth
280420|NCT01960998|pelvic floor muscle training|pelvic floor muscle training
280421|NCT01960985|Balance, Postural|balance, postural
280422|NCT01960985|Parkinson´s Disease|parkinson´s disease
280423|NCT01960985|H&Y 1-3|h&y 1-3
280424|NCT01960985|Exrecice|exrecice
280425|NCT01960985|Postural adjustments|postural adjustments
280426|NCT01960985|antecipatory postural|antecipatory postural
280427|NCT01960985|compensatory postural adjustments|compensatory postural adjustments
280428|NCT01960972|Blood pressure|blood pressure
280429|NCT01960972|Hypertension|hypertension
280430|NCT01960972|Stepped wedge trial design|stepped wedge trial design
280431|NCT01960946|Hypertension|hypertension
280432|NCT01960946|Galectin 3|galectin 3
280433|NCT01960946|Fibrosis|fibrosis
280434|NCT01960946|Vascular Stiffness|vascular stiffness
280435|NCT01960946|Echocardiography|echocardiography
280436|NCT01960933|STEMI|stemi
280437|NCT01960933|MVD|mvd
280438|NCT01960933|Full revascularization|full revascularization
280439|NCT01960933|Culprit lesion revascularization only|culprit lesion revascularization only
280440|NCT01960933|Primary PCI|primary pci
280441|NCT01960920|Air Pollution|air pollution
280442|NCT01960920|Heart Failure|heart failure
280443|NCT01960920|Endothelium|endothelium
280444|NCT01960920|Autonomic Dysfunction|autonomic dysfunction
280445|NCT01960920|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
280446|NCT01960907|COPD|copd
280447|NCT01960907|CHF|chf
280448|NCT01960907|SDB|sdb
280449|NCT01960881|Prostate cancer|prostate cancer
280450|NCT01960855|anti-inflammatory agents|anti-inflammatory agents
280451|NCT01960855|Joint Diseases|joint diseases
280452|NCT01960855|Arthritis|arthritis
280453|NCT01960855|Musculoskeletal Disease|musculoskeletal disease
280454|NCT01960855|antirheumatic agents|antirheumatic agents
280455|NCT01960842|levodopa|levodopa
280456|NCT01960842|Advanced Parkinson's Disease|advanced parkinson's disease
280457|NCT01960842|carbidopa|carbidopa
280458|NCT01960842|levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
280459|NCT01960842|Safety and Efficacy|safety and efficacy
280460|NCT01960829|melanoma|melanoma
280461|NCT01960829|TOR Serine-Threonine Kinases|tor serine-threonine kinases
280462|NCT01960816|nasal obstruction|nasal obstruction
280463|NCT01960803|Stage I Breast Carcinoma|stage i breast carcinoma
280464|NCT01960790|Humira®|humira®
280465|NCT01960790|Behcet's Disease|behcet's disease
280466|NCT01960790|Adalimumab|adalimumab
280467|NCT01960777|Hernia, Inguinal|hernia, inguinal
280468|NCT01960777|Laparoscopy|laparoscopy
280469|NCT01960777|Onstep|onstep
280470|NCT01960764|Autologous microbiome transplant|autologous microbiome transplant
280471|NCT01960764|Bacteria transplant|bacteria transplant
280472|NCT01960764|Treatment for atopic dermatitis|treatment for atopic dermatitis
280473|NCT01960738|Diving|diving
280474|NCT01960738|Water|water
280475|NCT01960738|Recreation|recreation
280476|NCT01960738|Precursor|precursor
280477|NCT01960725|Gastroenteritis|gastroenteritis
280478|NCT01960725|Diarrhea|diarrhea
280479|NCT01960725|Rotavirus|rotavirus
280480|NCT01960725|Vaccine|vaccine
280481|NCT01960725|Dehydration|dehydration
280482|NCT01960699|Prognosis|prognosis
280483|NCT01960699|Neurological outcome|neurological outcome
280484|NCT01960699|Resuscitation|resuscitation
280485|NCT01960699|Biomarker|biomarker
280486|NCT01960673|supraglottic airway,igel-LMA, ambu-LMA, changing position, head and neck position, oropharyngeal leak pressure,degree of rotation|supraglottic airway,igel-lma, ambu-lma, changing position, head and neck position, oropharyngeal leak pressure,degree of rotation
280487|NCT01960660|Fish Oil|fish oil
280488|NCT01960660|EPA|epa
280489|NCT01960660|DHA|dha
280490|NCT01960660|Omega-Score|omega-score
280491|NCT01960660|Lipemic Index|lipemic index
280492|NCT01960660|ethyl esters|ethyl esters
280493|NCT01960660|triglycerides|triglycerides
280494|NCT01960660|phospholipids|phospholipids
280495|NCT01960595|PCA,Nerve block,Hullax Valgus|pca,nerve block,hullax valgus
280496|NCT01960582|Housing adaptation|housing adaptation
280497|NCT01960582|Independence|independence
280498|NCT01960582|Costs|costs
280499|NCT01960569|Thrombexx|thrombexx
280500|NCT01960569|Topical r-Hirudin|topical r-hirudin
280501|NCT01960569|Efficacy|efficacy
280502|NCT01960569|haematoma|haematoma
280503|NCT01960556|simulation|simulation
280504|NCT01960543|Intrathecal anesthesia|intrathecal anesthesia
280505|NCT01960543|Levobupivacaine|levobupivacaine
280506|NCT01960543|Bupivacaine|bupivacaine
280507|NCT01960543|Hip fracture|hip fracture
280508|NCT01960517|Urinary|urinary
280509|NCT01960517|Incontinence|incontinence
280510|NCT01960517|Catheter|catheter
280511|NCT01960504|DREAMS|dreams
280512|NCT01960504|Drug Eluting Absorbable Metal Scaffold|drug eluting absorbable metal scaffold
280514|NCT01960504|Coronary Artery Disease|coronary artery disease
280515|NCT01960504|Myocardial Ischemia|myocardial ischemia
280516|NCT01960504|Atherosclerosis|atherosclerosis
280517|NCT01960465|CPAP treatment|cpap treatment
280518|NCT01960465|hypertension|hypertension
280519|NCT01960452|Insomnia|insomnia
280520|NCT01960452|Primary insomnia|primary insomnia
280521|NCT01960452|High density EEG|high density eeg
280522|NCT01960452|Polysomnography|polysomnography
280523|NCT01960452|Healthy sleeping controls|healthy sleeping controls
280524|NCT01960439|disease activity|disease activity
280525|NCT01960439|central reader|central reader
280526|NCT01960439|endoscopic indices|endoscopic indices
280527|NCT01960426|Harvey Bradshaw score|harvey bradshaw score
280528|NCT01960426|Partial Mayo Clinical Score|partial mayo clinical score
280529|NCT01960426|Infliximab|infliximab
280530|NCT01960426|Adalimumab|adalimumab
280531|NCT01960400|Complex regional pain syndrome type 1 (CRPS)|complex regional pain syndrome type 1 (crps)
280532|NCT01960400|Transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
280533|NCT01960400|Graded motor imagery (GMI)|graded motor imagery (gmi)
280534|NCT01960400|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
280535|NCT01960400|Functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
280536|NCT01960387|AML|aml
280537|NCT01960387|clofarabine|clofarabine
280538|NCT01960387|cytarabine|cytarabine
280539|NCT01960387|persistent AML|persistent aml
280540|NCT01960387|induction therapy|induction therapy
280541|NCT01960374|RAS or RAF oncogenes, Inhibition of MEK pathway, inhibition cancer cell proliferation promising anti-cancer therapeutic strategy.|ras or raf oncogenes, inhibition of mek pathway, inhibition cancer cell proliferation promising anti-cancer therapeutic strategy.
280542|NCT01960348|RNAi therapeutic|rnai therapeutic
280543|NCT01960348|FAP|fap
280544|NCT01960348|Familial Amyloid Polyneuropathy|familial amyloid polyneuropathy
280545|NCT01960348|TTR|ttr
280546|NCT01960348|Transthyretin|transthyretin
280547|NCT01960348|Amyloidosis|amyloidosis
280548|NCT01960335|whey protein intake|whey protein intake
280550|NCT01960335|visceral fat|visceral fat
280551|NCT01960335|resistance exercise training|resistance exercise training
280552|NCT01960335|sprint interval training|sprint interval training
280553|NCT01960335|endurance exercise training|endurance exercise training
280554|NCT01960335|yoga training|yoga training
280555|NCT01960335|healthy eating|healthy eating
280556|NCT01960335|healthy lifestyle strategies|healthy lifestyle strategies
280557|NCT01960335|leptin|leptin
280558|NCT01960335|hunger|hunger
280559|NCT01960322|adherence|adherence
280560|NCT01960322|nonadherence|nonadherence
280561|NCT01960322|compliance|compliance
280562|NCT01960322|noncompliance|noncompliance
280563|NCT01960322|liver transplantation|liver transplantation
280564|NCT01960296|clopidogrel|clopidogrel
280565|NCT01960296|general surgery|general surgery
280566|NCT01960270|relapse after an initial clinical response|relapse after an initial clinical response
280567|NCT01960257|tuberculosis|tuberculosis
280568|NCT01960257|tuberculosis treatment|tuberculosis treatment
280569|NCT01960257|wirelessly observed therapy|wirelessly observed therapy
280570|NCT01960257|proteus digital health|proteus digital health
280571|NCT01960257|digital health feedback system|digital health feedback system
280572|NCT01960244|familial|familial
280573|NCT01960244|hypercholesterolemia|hypercholesterolemia
280574|NCT01960244|FH|fh
280575|NCT01960218|acute decompensated heart failure|acute decompensated heart failure
280576|NCT01960218|gas exchange|gas exchange
280577|NCT01960218|cardiopulmonary|cardiopulmonary
280578|NCT01960218|dyspnea|dyspnea
280579|NCT01960218|cardiopulmonary analyzer|cardiopulmonary analyzer
280580|NCT01960218|heart disease|heart disease
280581|NCT01960218|cardiovascular disease|cardiovascular disease
280582|NCT01960218|cardiopulmonary exercise|cardiopulmonary exercise
280583|NCT01960205|Saxagliptin, prediabetes, glucose intolerance,obesity|saxagliptin, prediabetes, glucose intolerance,obesity
280584|NCT01960192|primary CNS lymphoma;chemotherapy;|primary cns lymphoma;chemotherapy;
280585|NCT01960192|RR;PFS;OS|rr;pfs;os
280586|NCT01960153|Heart failure|heart failure
280587|NCT01960153|Pulmonary hypertension|pulmonary hypertension
280588|NCT01960153|tadalafil|tadalafil
280589|NCT01960153|Phosphodiesterase Type 5 Inhibition|phosphodiesterase type 5 inhibition
280590|NCT01960114|Acetaminophen|acetaminophen
280591|NCT01960114|Paracetamol Analgesics|paracetamol analgesics
280592|NCT01960114|Analgesics|analgesics
280593|NCT01960114|Non-Narcotic Pain|non-narcotic pain
280594|NCT01960114|Postoperative Pain|postoperative pain
280595|NCT01960114|Antipyretics Dental Surgery|antipyretics dental surgery
280596|NCT01960114|Third molar extraction|third molar extraction
280597|NCT01960101|xerostomia|xerostomia
280598|NCT01960101|Saliva|saliva
280599|NCT01960101|iatrogenic oral dryness|iatrogenic oral dryness
280600|NCT01960101|antidepressants|antidepressants
280601|NCT01960101|mouth dryness|mouth dryness
280602|NCT01960101|milk product|milk product
280603|NCT01960088|Adolescent vaccines|adolescent vaccines
280604|NCT01960088|HPV vaccine|hpv vaccine
280605|NCT01960088|Pharmacies|pharmacies
280701|NCT01959568|Perfluorocarbon liquids|perfluorocarbon liquids
280702|NCT01959568|Vitrectomy|vitrectomy
280606|NCT01960075|status epilepticus, refractory, benzodiazepine, fosphenytoin, levetiracetam, valproic acid|status epilepticus, refractory, benzodiazepine, fosphenytoin, levetiracetam, valproic acid
280607|NCT01960062|diabetes|diabetes
280608|NCT01960062|web-based|web-based
280609|NCT01960062|software|software
280610|NCT01960062|device|device
280611|NCT01960049|Postoperative pain|postoperative pain
280612|NCT01960049|Liver resection|liver resection
280613|NCT01960049|Medial Open Transversus Abdominis Plane catheter|medial open transversus abdominis plane catheter
280614|NCT01960036|Substance Use Disorders|substance use disorders
280615|NCT01960036|Complementary Therapies|complementary therapies
280616|NCT01960036|Women|women
280617|NCT01960036|Mind-Body Therapies|mind-body therapies
280618|NCT01960036|Behavior and Behavior Mechanisms|behavior and behavior mechanisms
280619|NCT01960023|Colorectal cancer|colorectal cancer
280620|NCT01960023|KRAS|kras
280621|NCT01960023|BRAF|braf
280622|NCT01960023|NRAS|nras
280623|NCT01960023|PIK3CA|pik3ca
280624|NCT01960023|NSABP|nsabp
280625|NCT01959958|Nocturnal enuresis|nocturnal enuresis
280626|NCT01959958|Barriers to treatment|barriers to treatment
280627|NCT01959945|Prevention|prevention
280628|NCT01959932|Smoking|smoking
280629|NCT01959932|Candidate Modified Risk Tobacco Product|candidate modified risk tobacco product
280630|NCT01959932|Conventional cigarettes|conventional cigarettes
280631|NCT01959932|Reduced exposure|reduced exposure
280632|NCT01959932|Confinement|confinement
280633|NCT01959906|Esophagectomy|esophagectomy
280634|NCT01959880|Breast Augmentation|breast augmentation
280635|NCT01959880|Breast Reconstruction|breast reconstruction
280636|NCT01959880|Breast Revision|breast revision
280637|NCT01959880|Silicone Gel|silicone gel
280638|NCT01959880|Contour Profile Gel|contour profile gel
280639|NCT01959880|Siltex|siltex
280640|NCT01959880|CPG Styles|cpg styles
280641|NCT01959867|mastectomy|mastectomy
280642|NCT01959867|breast reconstruction|breast reconstruction
280643|NCT01959867|bovine|bovine
280644|NCT01959867|ADM|adm
280645|NCT01959867|breast cancer|breast cancer
280646|NCT01959867|breast implants|breast implants
280647|NCT01959867|breast expanders|breast expanders
280648|NCT01959867|radiation therapy|radiation therapy
280649|NCT01959828|pulmonary hypertension|pulmonary hypertension
280650|NCT01959828|cardiac surgery|cardiac surgery
280651|NCT01959828|Glenn surgery|glenn surgery
280652|NCT01959828|fontan surgery|fontan surgery
280653|NCT01959828|left ventricular assist device|left ventricular assist device
280654|NCT01959828|LVAD|lvad
280655|NCT01959802|Macular pseudohole|macular pseudohole
280656|NCT01959802|Cone outer segment tips line|cone outer segment tips line
280657|NCT01959789|Randomized Controlled Clinical Trial|randomized controlled clinical trial
280658|NCT01959789|Tooth Bleaching|tooth bleaching
280659|NCT01959776|cone outer segment tips line, foveal displacement|cone outer segment tips line, foveal displacement
280660|NCT01959763|Metabolic syndrome|metabolic syndrome
280661|NCT01959763|obesity|obesity
280662|NCT01959763|overweight|overweight
280663|NCT01959763|weight loss intervention|weight loss intervention
280664|NCT01959763|cognitive behavioral therapy|cognitive behavioral therapy
280665|NCT01959763|ICT intervention|ict intervention
280666|NCT01959763|cardiovascular disease|cardiovascular disease
280667|NCT01959763|persuasive systems design|persuasive systems design
280668|NCT01959737|reactivity of HPA axis|reactivity of hpa axis
280669|NCT01959724|Macular detachment|macular detachment
280670|NCT01959724|Macular retinoschisis|macular retinoschisis
280671|NCT01959724|Vitrectomy|vitrectomy
280672|NCT01959711|Lateral transperitoneal laparoscopic adrenalectomy|lateral transperitoneal laparoscopic adrenalectomy
280673|NCT01959711|Posterior retroperitoneoscopic adrenalectomy|posterior retroperitoneoscopic adrenalectomy
280674|NCT01959646|Immune Function|immune function
280675|NCT01959646|Aged Garlic Extract|aged garlic extract
280676|NCT01959646|Supplementation|supplementation
280677|NCT01959646|Inflammation|inflammation
280678|NCT01959620|PTSD|ptsd
280679|NCT01959607|Smoking|smoking
280680|NCT01959607|Nicotine absorption|nicotine absorption
280681|NCT01959607|Candidate modified risk tobacco product|candidate modified risk tobacco product
280682|NCT01959607|Cigarettes|cigarettes
280683|NCT01959607|Nicotine Replacement Therapy gum (NRT gum)|nicotine replacement therapy gum (nrt gum)
280684|NCT01959594|multiple doses|multiple doses
280685|NCT01959594|pharmacokinetics|pharmacokinetics
280686|NCT01959594|safety|safety
280687|NCT01959594|tolerability|tolerability
280688|NCT01959594|healthy volunteers|healthy volunteers
280689|NCT01959594|steady state|steady state
280690|NCT01959594|cognitive impairment associated with schizophrenia|cognitive impairment associated with schizophrenia
280691|NCT01959581|Wilmington Robotic Exoskeleton|wilmington robotic exoskeleton
280692|NCT01959581|Reaching|reaching
280693|NCT01959581|Upper extremity function|upper extremity function
280694|NCT01959581|Preterm Infants|preterm infants
280695|NCT01959581|Brain injury|brain injury
280696|NCT01959581|Pediatrics|pediatrics
280697|NCT01959581|Early Intervention|early intervention
280698|NCT01959581|Arthrogryposis|arthrogryposis
280699|NCT01959568|Retinal Detachment|retinal detachment
280700|NCT01959568|Double Tamponade|double tamponade
280703|NCT01959542|Prostate Cancer|prostate cancer
280704|NCT01959516|COPD, early morning symptoms|copd, early morning symptoms
280705|NCT01959503|Aorta|aorta
280706|NCT01959503|Aortic|aortic
280707|NCT01959503|Reconstruction|reconstruction
280708|NCT01959503|CABG|cabg
280709|NCT01959503|Bypass|bypass
280710|NCT01959464|Assisted reproductive technology|assisted reproductive technology
280711|NCT01959464|Infertility|infertility
280712|NCT01959464|Progesterone|progesterone
280713|NCT01959464|Vaginal gel|vaginal gel
280714|NCT01959464|Luteal-phase support|luteal-phase support
280715|NCT01959451|Prasugrel|prasugrel
280716|NCT01959451|Clopidogrel|clopidogrel
280717|NCT01959438|Phase I study for safety|phase i study for safety
280718|NCT01959438|Later Phase II study for responses|later phase ii study for responses
280719|NCT01959425|Anticoagulation|anticoagulation
280720|NCT01959425|Oral|oral
280721|NCT01959425|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
280722|NCT01959425|Patients post successful cardiac ablation|patients post successful cardiac ablation
280723|NCT01959425|Symptomatic high-burden paroxysmal AF|symptomatic high-burden paroxysmal af
280724|NCT01959425|3 months post procedure|3 months post procedure
280725|NCT01959425|Remain free from AF recurrence|remain free from af recurrence
280726|NCT01959412|wheezing, short of breath, laba, inhaler|wheezing, short of breath, laba, inhaler
280727|NCT01959399|ASP015K|asp015k
280728|NCT01959399|healthy subjects|healthy subjects
280729|NCT01959360|Arthroplasty, Total Hip Replacement, Hip|arthroplasty, total hip replacement, hip
280730|NCT01959360|Surgical Procedures, Operative|surgical procedures, operative
280731|NCT01959360|Surgical Procedures, Minimally Invasive|surgical procedures, minimally invasive
280732|NCT01959347|urinary incontinence|urinary incontinence
280733|NCT01959347|midurethral sling|midurethral sling
280734|NCT01959347|pelvic floor therapy|pelvic floor therapy
280735|NCT01959334|Diabetes Mellitus|diabetes mellitus
280736|NCT01959334|Hypoglycemia|hypoglycemia
280737|NCT01959334|Glucagon|glucagon
280738|NCT01959334|Anti-glucagon Antibody|anti-glucagon antibody
280739|NCT01959334|Immunogenicity|immunogenicity
280740|NCT01959308|Adherence|adherence
280741|NCT01959308|Compliance|compliance
280742|NCT01959308|Immunosuppressive Therapy|immunosuppressive therapy
280743|NCT01959308|Liver Transplant|liver transplant
280744|NCT01959308|Liver Recipients|liver recipients
280745|NCT01959308|Adult|adult
280746|NCT01959308|Adolescent|adolescent
280747|NCT01959282|Colitis, Ulcerative|colitis, ulcerative
280748|NCT01959282|JNJ-54781532|jnj-54781532
280749|NCT01959282|Moderate|moderate
280750|NCT01959282|Severe|severe
280751|NCT01959282|Active|active
280752|NCT01959256|Stroke|stroke
280753|NCT01959256|Visual Field Defect|visual field defect
280754|NCT01959256|Visual perceptual learning|visual perceptual learning
280755|NCT01959256|Brain connectivity|brain connectivity
280756|NCT01959243|Ocular redness|ocular redness
280757|NCT01959230|Ocular redness|ocular redness
280758|NCT01959217|HIV|hiv
280759|NCT01959217|Substance Abuse|substance abuse
280760|NCT01959217|Prospective Memory|prospective memory
280761|NCT01959204|pharmacokinetics|pharmacokinetics
280762|NCT01959204|safety|safety
280763|NCT01959191|Platelet activity, CABG, off-pump surgery|platelet activity, cabg, off-pump surgery
280764|NCT01959165|Ulcerative Colitis, Japanese, subcutaneously|ulcerative colitis, japanese, subcutaneously
280765|NCT01959152|Cochlear Implant|cochlear implant
280766|NCT01959152|HiRes™ 90K Advantage implant|hires™ 90k advantage implant
280767|NCT01959152|Cochlear Implantation|cochlear implantation
280768|NCT01959152|HiFocus™ Mid-Scala electrode|hifocus™ mid-scala electrode
280769|NCT01959152|Listening Benefits|listening benefits
280770|NCT01959152|Adults|adults
280771|NCT01959152|Cochlear Implant Benefit|cochlear implant benefit
280772|NCT01959152|HiRes Fidelity 120™|hires fidelity 120™
280773|NCT01959152|Electrical Stimulation|electrical stimulation
280774|NCT01959126|Telomerase|telomerase
280775|NCT01959126|Telomere length|telomere length
280776|NCT01959126|Psychological Sress|psychological sress
280777|NCT01959126|Mindfulness|mindfulness
280778|NCT01959113|Microbiome|microbiome
280779|NCT01959113|Bacteria transplant|bacteria transplant
280780|NCT01959113|Atopic dermatitis treatments|atopic dermatitis treatments
280781|NCT01959100|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
280782|NCT01959100|pulmonary non-infectious complications|pulmonary non-infectious complications
280783|NCT01959100|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
280784|NCT01959087|Single port surgery|single port surgery
280785|NCT01959087|Colonic surgery|colonic surgery
280786|NCT01959087|Postoperative morbidity|postoperative morbidity
280787|NCT01959087|Postoperative outcomes|postoperative outcomes
280788|NCT01959061|Advanced colorectal cancer of liver metastatic|advanced colorectal cancer of liver metastatic
280789|NCT01959048|Clostridium difficile associated disease|clostridium difficile associated disease
280790|NCT01959048|fecal microbiota transplantation|fecal microbiota transplantation
280791|NCT01959022|Posttramatic Stress Disorder|posttramatic stress disorder
280792|NCT01959022|Post-traumatic Stress Disorder|post-traumatic stress disorder
280793|NCT01959022|PTSD|ptsd
280794|NCT01959022|Doxazosin|doxazosin
280795|NCT01959022|Nightmares|nightmares
280796|NCT01959022|Sleep Disturbance|sleep disturbance
280797|NCT01959009|newborn, lung disease, mechanical ventilation, lung recruitment, high frequency ventilation|newborn, lung disease, mechanical ventilation, lung recruitment, high frequency ventilation
280798|NCT01958983|dementia|dementia
280799|NCT01958983|drumming|drumming
280800|NCT01958983|emotion|emotion
280801|NCT01958983|cognition|cognition
280802|NCT01958983|functional MRI|functional mri
280803|NCT01958970|End Stage Renal Disease|end stage renal disease
280804|NCT01958970|ESRD|esrd
280805|NCT01958970|Maintenance Hemodialysis|maintenance hemodialysis
280806|NCT01958970|Hemodialysis|hemodialysis
280807|NCT01958970|Dialysis|dialysis
280808|NCT01958970|MHD|mhd
280809|NCT01958970|Protein Energy Wasting|protein energy wasting
280810|NCT01958970|PEW|pew
280811|NCT01958957|ischemic stroke|ischemic stroke
280812|NCT01958957|safety|safety
280813|NCT01958957|Ginkgolides Meglumine Injection|ginkgolides meglumine injection
280814|NCT01958944|CF|cf
280815|NCT01958944|Cystic Fibrosis|cystic fibrosis
280816|NCT01958944|NO|no
280817|NCT01958944|nitric oxide|nitric oxide
280818|NCT01958944|inhalation|inhalation
280819|NCT01958918|neovascular AMD|neovascular amd
280820|NCT01958918|ranibizumab|ranibizumab
280821|NCT01958918|aflibercept|aflibercept
280822|NCT01958918|BCVA|bcva
280823|NCT01958918|SD OCT|sd oct
280824|NCT01958892|BPH|bph
280825|NCT01958879|internal derangement,arthrocentesis,corticosteroid|internal derangement,arthrocentesis,corticosteroid
280826|NCT01958866|Fever|fever
280827|NCT01958866|Body temperature|body temperature
280828|NCT01958853|Pain|pain
280829|NCT01958840|Behavioral|behavioral
280830|NCT01958840|Activation|activation
280831|NCT01958840|Treatment|treatment
280832|NCT01958827|Dose Escalation|dose escalation
280833|NCT01958827|Crohn's Disease|crohn's disease
280834|NCT01958801|Supraclavicular brachial plexus block|supraclavicular brachial plexus block
280835|NCT01958801|Interscalene brachial plexus block|interscalene brachial plexus block
280836|NCT01958801|Arthroscopic shoulder surgery|arthroscopic shoulder surgery
280837|NCT01958788|Cognitive-behavioral treatment|cognitive-behavioral treatment
280838|NCT01958788|Generalized anxiety disorder|generalized anxiety disorder
280839|NCT01958788|Worry|worry
280840|NCT01958788|Behavioral experiments|behavioral experiments
280841|NCT01958788|Safety behaviors|safety behaviors
280842|NCT01958788|Anxiety|anxiety
280843|NCT01958775|Lipoproteins, apoB, GLP-2|lipoproteins, apob, glp-2
280844|NCT01958762|Screening|screening
280845|NCT01958762|Cancer|cancer
280846|NCT01958762|Tobacco|tobacco
280847|NCT01958762|General Practitioner|general practitioner
280848|NCT01958762|Precancerous Lesion|precancerous lesion
280849|NCT01958762|Dysplasia|dysplasia
280850|NCT01958762|Tobacco vendor|tobacco vendor
280851|NCT01958723|Problem Specific Template|problem specific template
280852|NCT01958723|Physician Documentation|physician documentation
280853|NCT01958723|Electronic Medical Record Documentation|electronic medical record documentation
280854|NCT01958710|Catheterization, Bronchial|catheterization, bronchial
280855|NCT01958710|Pneumonectomy|pneumonectomy
280856|NCT01958710|Lobectomy|lobectomy
280857|NCT01958710|Thoracoplasty|thoracoplasty
280858|NCT01958697|Nutritional Disorders|nutritional disorders
280859|NCT01958697|Feeding Behavior|feeding behavior
280860|NCT01958684|Bleeding pattern|bleeding pattern
280861|NCT01958684|LNG-IUS|lng-ius
280862|NCT01958684|Cu-IUD|cu-iud
280863|NCT01958684|postabortion|postabortion
280864|NCT01958645|Phase 1, healthy male subjects, safety and tolerability, pharmacodynamic, pharmacokinetic|phase 1, healthy male subjects, safety and tolerability, pharmacodynamic, pharmacokinetic
280865|NCT01958619|open label|open label
280866|NCT01958619|healthy volunteers|healthy volunteers
280867|NCT01958619|pharmacokinetic|pharmacokinetic
280868|NCT01958619|parallel group|parallel group
280869|NCT01958606|Stroke|stroke
280870|NCT01958606|Rehabilitation|rehabilitation
280871|NCT01958606|Exercise|exercise
280872|NCT01958606|Intensity|intensity
280873|NCT01958606|Gait|gait
280874|NCT01958593|PTSD|ptsd
280875|NCT01958593|Posttraumatic stress disorder|posttraumatic stress disorder
280876|NCT01958593|MDMA|mdma
280877|NCT01958593|psychotherapy|psychotherapy
280878|NCT01958567|Scleritis|scleritis
280879|NCT01958567|Episcleritis|episcleritis
280880|NCT01958567|Optical coherence Tomography|optical coherence tomography
280881|NCT01958541|Sleep|sleep
280882|NCT01958541|Insomnia|insomnia
280883|NCT01958541|Suicidal Symptoms|suicidal symptoms
280884|NCT01958541|Suicidal Ideation|suicidal ideation
280885|NCT01958541|Military Veteran|military veteran
280886|NCT01958541|Service Member|service member
280887|NCT01958541|Depression|depression
280888|NCT01958515|Radiation Therapy|radiation therapy
280889|NCT01958515|Chemotherapy|chemotherapy
280890|NCT01958515|Chemoradiation Therapy|chemoradiation therapy
280891|NCT01958502|nonunion|nonunion
280892|NCT01958502|mesenchymal stem cell|mesenchymal stem cell
280893|NCT01958502|scaffold|scaffold
280894|NCT01958502|BMP2|bmp2
280895|NCT01958502|long bone|long bone
280896|NCT01958476|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
280898|NCT01958463|Clostridium Difficile Infection|clostridium difficile infection
280899|NCT01958463|Fecal Microbiota Transplantation|fecal microbiota transplantation
280900|NCT01958450|acne scar|acne scar
280901|NCT01958450|Laser therapy|laser therapy
280902|NCT01958450|wound healing|wound healing
280903|NCT01958437|Aging|aging
280904|NCT01958437|Alzheimer's Disease/Dementia|alzheimer's disease/dementia
280905|NCT01958437|Cognitive Disorders|cognitive disorders
280906|NCT01958437|Imaging|imaging
280907|NCT01958437|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
280908|NCT01958437|Neurology|neurology
280909|NCT01958437|Physical Medicine & Rehabilitation|physical medicine & rehabilitation
280910|NCT01958437|transcranial direct current stimulation|transcranial direct current stimulation
280911|NCT01958424|metabolic syndrome|metabolic syndrome
280912|NCT01958424|in vitro fertilization|in vitro fertilization
280913|NCT01958424|c reactive protein|c reactive protein
280914|NCT01958424|over-weight women|over-weight women
280915|NCT01958424|ovarian stimulation|ovarian stimulation
280916|NCT01958398|Randomized Controlled Trial|randomized controlled trial
280917|NCT01958398|Alcohol|alcohol
280918|NCT01958398|Internet|internet
280919|NCT01958398|Mobile phone|mobile phone
280920|NCT01958398|Screening|screening
280921|NCT01958398|Brief intervention|brief intervention
280922|NCT01958385|Total Body Weight Loss|total body weight loss
280923|NCT01958359|Randomized Controlled Trial|randomized controlled trial
280924|NCT01958359|Alcohol|alcohol
280925|NCT01958359|Telephone|telephone
280926|NCT01958359|Mobile phone|mobile phone
280927|NCT01958359|Screening|screening
280928|NCT01958359|Brief intervention|brief intervention
280929|NCT01958359|IVR-based conversation menu with exercises and vignettes|ivr-based conversation menu with exercises and vignettes
280930|NCT01958333|Health-Related Physical Fitness|health-related physical fitness
280931|NCT01958333|Aerobic Endurance|aerobic endurance
280932|NCT01958333|Muscular Endurance|muscular endurance
280933|NCT01958333|Flexibility|flexibility
280934|NCT01958320|patent ductus arteriosus|patent ductus arteriosus
280935|NCT01958320|patent ductus arteriosus ligation|patent ductus arteriosus ligation
280936|NCT01958320|necrotizing enterocolitis|necrotizing enterocolitis
280937|NCT01958320|spontaneous intestinal perforation|spontaneous intestinal perforation
280938|NCT01958255|tobacco quit rates|tobacco quit rates
280939|NCT01958242|Cardiopulmonary bypass|cardiopulmonary bypass
280940|NCT01958242|pediatric|pediatric
280941|NCT01958242|blood products|blood products
280942|NCT01958242|conservation|conservation
280943|NCT01958216|TICE-human-stable isotopes|tice-human-stable isotopes
280944|NCT01958190|Liver transplantation long term renal function|liver transplantation long term renal function
280945|NCT01958190|tacrolimus sirolimus|tacrolimus sirolimus
280946|NCT01958177|stem cell|stem cell
280947|NCT01958177|cerebellar ataxia|cerebellar ataxia
280948|NCT01958177|BMMNC|bmmnc
280949|NCT01958151|colonoscopy|colonoscopy
280950|NCT01958151|deep sedation|deep sedation
280951|NCT01958151|anxiety|anxiety
280952|NCT01958138|Laryngeal Mask Airway|laryngeal mask airway
280953|NCT01958138|Propofol|propofol
280954|NCT01958138|Isoflurane|isoflurane
280955|NCT01958138|Pediatric patients|pediatric patients
280956|NCT01958138|Emergence|emergence
280957|NCT01958125|vagus nerve stimulation|vagus nerve stimulation
280958|NCT01958125|vagal nerve stimulation|vagal nerve stimulation
280959|NCT01958125|nVNS|nvns
280960|NCT01958125|VNS|vns
280961|NCT01958125|cluster headache|cluster headache
280962|NCT01958125|non invasive|non invasive
280963|NCT01958125|gammacore|gammacore
280964|NCT01958112|Cervical Cancer|cervical cancer
280965|NCT01958112|Cervical|cervical
280966|NCT01958112|Cervix|cervix
280967|NCT01958099|Injury Prevention|injury prevention
280968|NCT01958086|Neural|neural
280969|NCT01958086|Prosthetic|prosthetic
280970|NCT01958086|brain machine interface|brain machine interface
280971|NCT01958086|brain computer interface|brain computer interface
280972|NCT01958086|brain control|brain control
280973|NCT01958086|paralysis|paralysis
280974|NCT01958086|tetraplegia|tetraplegia
280975|NCT01958086|quadriplegia|quadriplegia
280976|NCT01958086|spinal cord injury|spinal cord injury
280977|NCT01958073|Recurrent Urinary Tract Infection|recurrent urinary tract infection
280978|NCT01958073|Postmenopausal|postmenopausal
280979|NCT01958073|Vaginal Estrogen|vaginal estrogen
280980|NCT01958047|Phase I|phase i
280981|NCT01958047|ASP3652|asp3652
280982|NCT01958047|Single dose|single dose
280983|NCT01958047|Dietary intake|dietary intake
280984|NCT01958021|HR-positive|hr-positive
280985|NCT01958021|HER2-negative|her2-negative
280986|NCT01958021|Advanced breast cancer|advanced breast cancer
280987|NCT01958021|LEE011|lee011
280988|NCT01958021|Letrozole|letrozole
280989|NCT01958021|CDK|cdk
280990|NCT01958021|CDK4|cdk4
280991|NCT01958021|CDK6|cdk6
280992|NCT01958021|CDK4/6|cdk4/6
280993|NCT01958021|Phase III|phase iii
280994|NCT01958021|ER-positive|er-positive
280995|NCT01958021|PR-positive|pr-positive
280996|NCT01958021|Postmenopausal|postmenopausal
280997|NCT01957943|Omega 3 lipid emulsions|omega 3 lipid emulsions
281391|NCT01955902|Suboxone|suboxone
280998|NCT01957943|Liver transplantation|liver transplantation
280999|NCT01957943|Ischemia reperfusion injury|ischemia reperfusion injury
281000|NCT01957943|graft function|graft function
281001|NCT01957930|HbA1c|hba1c
281002|NCT01957930|Iontophoresis|iontophoresis
281003|NCT01957930|Intensified insulin treatment|intensified insulin treatment
281004|NCT01957930|Ischemic foot ulcer|ischemic foot ulcer
281005|NCT01957930|Type 1 diabetes|type 1 diabetes
281006|NCT01957917|HIV|hiv
281007|NCT01957917|Food Insecurity|food insecurity
281008|NCT01957917|Antiretroviral Therapy|antiretroviral therapy
281009|NCT01957904|ArterX, surgical sealant|arterx, surgical sealant
281010|NCT01957891|Hypoxia|hypoxia
281011|NCT01957891|Multiple wavelengths|multiple wavelengths
281012|NCT01957865|HIV/AIDS|hiv/aids
281013|NCT01957865|adherence|adherence
281014|NCT01957865|real time monitoring|real time monitoring
281015|NCT01957865|SMS|sms
281016|NCT01957865|mHealth|mhealth
281017|NCT01957865|social support|social support
281018|NCT01957826|mesenchymal|mesenchymal
281019|NCT01957826|stem cells|stem cells
281020|NCT01957826|transendocardial injection|transendocardial injection
281021|NCT01957826|dilated idiopathic cardiomyopathy|dilated idiopathic cardiomyopathy
281022|NCT01957826|idiopathic cardiomyopathy|idiopathic cardiomyopathy
281023|NCT01957813|APHIA AIDS, Population and Health Integrated Assistance|aphia aids, population and health integrated assistance
281024|NCT01957813|DIC Drop-in center|dic drop-in center
281025|NCT01957813|DMPA depot medroxyprogesterone acetate|dmpa depot medroxyprogesterone acetate
281026|NCT01957813|DRH Division of Reproductive Health|drh division of reproductive health
281027|NCT01957813|FAIR Family AIDS Initiative Response|fair family aids initiative response
281028|NCT01957813|FHOK Family Health Options Kenya|fhok family health options kenya
281029|NCT01957813|FP Family planning|fp family planning
281030|NCT01957813|FGD Focus group discussion|fgd focus group discussion
281031|NCT01957813|FSW Female sex worker|fsw female sex worker
281032|NCT01957813|GSKenya Gold Star Kenya|gskenya gold star kenya
281033|NCT01957813|HTC HIV testing and counseling|htc hiv testing and counseling
281034|NCT01957813|HIV Human Immunodeficiency Virus|hiv human immunodeficiency virus
281035|NCT01957813|KNASP Kenya National AIDS Strategic Plan|knasp kenya national aids strategic plan
281036|NCT01957813|MARPS Most at-risk populations|marps most at-risk populations
281037|NCT01957813|MoPHS Ministry of Public Health and Sanitation|mophs ministry of public health and sanitation
281038|NCT01957813|MMS Ministry of Medical Services|mms ministry of medical services
281039|NCT01957813|NASCOP National AIDS and STI Control Program|nascop national aids and sti control program
281040|NCT01957813|RH Reproductive health|rh reproductive health
281041|NCT01957813|SRH Sexual and reproductive health|srh sexual and reproductive health
281042|NCT01957813|STI Sexually transmitted infection|sti sexually transmitted infection
281043|NCT01957813|USAID United States Agency for International Development|usaid united states agency for international development
281044|NCT01957800|weight loss|weight loss
281045|NCT01957800|healthy diet|healthy diet
281046|NCT01957800|website|website
281047|NCT01957800|action planning|action planning
281048|NCT01957800|phone|phone
281049|NCT01957800|social|social
281050|NCT01957787|Metastatic lung tumors|metastatic lung tumors
281051|NCT01957787|Pulmonary metastatic disease|pulmonary metastatic disease
281052|NCT01957748|Retention|retention
281053|NCT01957748|Care|care
281054|NCT01957748|Engagement|engagement
281055|NCT01957735|metastatic cancer|metastatic cancer
281056|NCT01957735|solid tumor|solid tumor
281057|NCT01957735|unresectable tumor|unresectable tumor
281058|NCT01957735|brain cancer|brain cancer
281059|NCT01957735|lymphoma|lymphoma
281060|NCT01957696|Diabetes mellitus|diabetes mellitus
281061|NCT01957696|Pancreas transplantation|pancreas transplantation
281062|NCT01957696|Rejection|rejection
281063|NCT01957696|Surgical complications|surgical complications
281064|NCT01957696|Allograft biopsies|allograft biopsies
281065|NCT01957696|Immunological analyses|immunological analyses
281066|NCT01957696|Pancreas graft survival|pancreas graft survival
281067|NCT01957683|intracranial aneurysm|intracranial aneurysm
281068|NCT01957683|bifurcation|bifurcation
281069|NCT01957683|wide-neck|wide-neck
281070|NCT01957683|saccular|saccular
281071|NCT01957683|endovascular treatment|endovascular treatment
281072|NCT01957683|coil embolization|coil embolization
281073|NCT01957683|stent|stent
281074|NCT01957683|bare platinum|bare platinum
281075|NCT01957670|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
281076|NCT01957670|Dry Eye Syndromes|dry eye syndromes
281077|NCT01957631|Plantar Fasciitis|plantar fasciitis
281078|NCT01957631|Steroid|steroid
281079|NCT01957631|Platelet rich plasma|platelet rich plasma
281080|NCT01957631|Injection|injection
281081|NCT01957631|Ultrasound|ultrasound
281082|NCT01957605|prone position|prone position
281083|NCT01957605|hemodynamic variation|hemodynamic variation
281084|NCT01957605|mean systemic pressure|mean systemic pressure
281085|NCT01957579|Phase I|phase i
281086|NCT01957579|advanced|advanced
281087|NCT01957579|B cell malignancies|b cell malignancies
281088|NCT01957579|dose escalation|dose escalation
281089|NCT01957579|CD19|cd19
281090|NCT01957579|Japanese|japanese
281091|NCT01957566|propofol sedation|propofol sedation
281093|NCT01957566|procedure sedation|procedure sedation
281094|NCT01957540|ticagrelor|ticagrelor
281095|NCT01957540|prasugrel|prasugrel
281096|NCT01957540|endothelial function|endothelial function
281097|NCT01957527|ticagrelor|ticagrelor
281098|NCT01957527|endothelial function|endothelial function
281099|NCT01957527|peripheral arterial tonometry|peripheral arterial tonometry
281100|NCT01957501|Major Depressive Disorder|major depressive disorder
281101|NCT01957501|Bipolar Disorder|bipolar disorder
281102|NCT01957501|Adolescents|adolescents
281103|NCT01957501|Biomarker|biomarker
281104|NCT01957436|prostate|prostate
281105|NCT01957436|cancer|cancer
281106|NCT01957436|metastatic hormone-naive|metastatic hormone-naive
281107|NCT01957436|radiotherapy|radiotherapy
281108|NCT01957436|abiraterone acetate|abiraterone acetate
281109|NCT01957436|docetaxel|docetaxel
281110|NCT01957423|Crohn's disease|crohn's disease
281111|NCT01957423|whey protein|whey protein
281112|NCT01957423|soy protein|soy protein
281113|NCT01957423|nutritional status|nutritional status
281114|NCT01957423|activity of disease|activity of disease
281115|NCT01957410|Major Depressive Disorder|major depressive disorder
281116|NCT01957410|Ketamine|ketamine
281117|NCT01957410|Evoked potentials|evoked potentials
281118|NCT01957410|Somatosensory evoked potentials|somatosensory evoked potentials
281119|NCT01957410|Motor evoked potentials|motor evoked potentials
281120|NCT01957410|Cortical plasticity|cortical plasticity
281121|NCT01957371|PTSD|ptsd
281122|NCT01957371|Yoga|yoga
281123|NCT01957371|Complementary and Alternative Medicine (CAM)|complementary and alternative medicine (cam)
281124|NCT01957371|Chronic Pain|chronic pain
281125|NCT01957345|constitutional functional disorders of platelets|constitutional functional disorders of platelets
281126|NCT01957345|platelet signalling defects|platelet signalling defects
281127|NCT01957332|molecular imaging|molecular imaging
281128|NCT01957332|HER2-PET|her2-pet
281129|NCT01957332|89Zr-trastuzumab|89zr-trastuzumab
281130|NCT01957332|FES-PET|fes-pet
281131|NCT01957332|metastatic breast cancer|metastatic breast cancer
281132|NCT01957332|clinical utility|clinical utility
281133|NCT01957306|hot flashes, night sweats|hot flashes, night sweats
281134|NCT01957280|HER3|her3
281135|NCT01957267|Glaucoma|glaucoma
281136|NCT01957267|Optical Coherence Tomography|optical coherence tomography
281137|NCT01957267|Intraocular pressure|intraocular pressure
281138|NCT01957267|Optic nervehead|optic nervehead
281139|NCT01957267|Nerve fiber layer|nerve fiber layer
281140|NCT01957202|levocabastine fixed dose combination, Rhinitis, Allergic, Perennial and Seasonal, Allergic Rhinitis, fluticasone furoate|levocabastine fixed dose combination, rhinitis, allergic, perennial and seasonal, allergic rhinitis, fluticasone furoate
281141|NCT01957189|pharmacokinetics, Chinese|pharmacokinetics, chinese
281142|NCT01957189|Avodart, Duodart, dutasteride, tamsulosin, drug-drug interaction,|avodart, duodart, dutasteride, tamsulosin, drug-drug interaction,
281143|NCT01957176|myelodysplastic syndromes|myelodysplastic syndromes
281144|NCT01957176|thrombocytopenia|thrombocytopenia
281145|NCT01957176|acute myeloid leukemia|acute myeloid leukemia
281146|NCT01957176|, idiopathic thrombocytopenic purpura|, idiopathic thrombocytopenic purpura
281147|NCT01957176|Eltrombopag|eltrombopag
281148|NCT01957176|pediatrics|pediatrics
281149|NCT01957163|dry powder inhaler|dry powder inhaler
281150|NCT01957163|fluticasone furoate/vilanterol|fluticasone furoate/vilanterol
281151|NCT01957163|umeclidinium bromide|umeclidinium bromide
281152|NCT01957163|safety|safety
281153|NCT01957163|long acting beta2- receptor agonist|long acting beta2- receptor agonist
281154|NCT01957163|long acting muscarininc receptor antagonist|long acting muscarininc receptor antagonist
281155|NCT01957163|efficacy|efficacy
281156|NCT01957163|COPD|copd
281157|NCT01957163|inhaled corticosteroid|inhaled corticosteroid
281158|NCT01957137|Urinary|urinary
281159|NCT01957137|Urge|urge
281160|NCT01957137|Incontinence|incontinence
281161|NCT01957098|L-arabinose|l-arabinose
281162|NCT01957098|D-xylose|d-xylose
281164|NCT01957098|glucose|glucose
281165|NCT01957098|insulin|insulin
281166|NCT01957098|C-peptide|c-peptide
281167|NCT01957098|GLP-1|glp-1
281168|NCT01957085|Hepatitis C|hepatitis c
281169|NCT01957072|Cystic fibrosis|cystic fibrosis
281170|NCT01957072|Nutrition|nutrition
281171|NCT01957072|Weight|weight
281172|NCT01957072|BMI|bmi
281173|NCT01957072|Behaviour change|behaviour change
281174|NCT01957059|DMD|dmd
281175|NCT01957059|Duchenne muscular dystrophy|duchenne muscular dystrophy
281176|NCT01957059|Duchenne|duchenne
281177|NCT01957059|BMN053|bmn053
281178|NCT01957059|BioMarin|biomarin
281179|NCT01957046|Opioid induced constipation|opioid induced constipation
281180|NCT01957046|Laxatives|laxatives
281181|NCT01957033|whiplash|whiplash
281182|NCT01957033|neck pain|neck pain
281183|NCT01957033|manual therapy|manual therapy
281184|NCT01957033|exercise|exercise
281185|NCT01957033|dosage|dosage
281186|NCT01957007|Phase 1|phase 1
281187|NCT01957007|dose escalation|dose escalation
281188|NCT01957007|histologically confirmed|histologically confirmed
281189|NCT01957007|malignancy metastatic|malignancy metastatic
281190|NCT01956994|Whey Protein|whey protein
281392|NCT01955889|Exercise|exercise
281191|NCT01956994|Arterial Stiffness|arterial stiffness
281192|NCT01956994|Neurovascular Coupling|neurovascular coupling
281193|NCT01956994|Cerebrovascular Reactivity|cerebrovascular reactivity
281194|NCT01956994|Hemodynamics|hemodynamics
281195|NCT01956994|Blood Flow|blood flow
281196|NCT01956994|Pulsatility|pulsatility
281197|NCT01956981|controlled hypotension, dexmedetomidine, magnesium sulfate.|controlled hypotension, dexmedetomidine, magnesium sulfate.
281198|NCT01956968|Shoulder pain, Scapular dyskinesia, Physical examination|shoulder pain, scapular dyskinesia, physical examination
281199|NCT01956942|GLAUCOMA|glaucoma
281200|NCT01956942|MICROPULSE|micropulse
281201|NCT01956942|LASER|laser
281202|NCT01956942|TRABECULOPLASTY|trabeculoplasty
281203|NCT01956942|OPEN ANGLE|open angle
281204|NCT01956942|INTRAOCULAR PRESSURE|intraocular pressure
281205|NCT01956929|Insulin Resistance|insulin resistance
281206|NCT01956929|Prediabetic State|prediabetic state
281207|NCT01956929|Metformin|metformin
281208|NCT01956916|Pulmonary exacerbation|pulmonary exacerbation
281209|NCT01956916|Inflammation|inflammation
281210|NCT01956916|Intestinal microbiota|intestinal microbiota
281211|NCT01956903|mesenchymal stem cell transplantation|mesenchymal stem cell transplantation
281212|NCT01956890|Breast neoplasms|breast neoplasms
281213|NCT01956890|PET|pet
281214|NCT01956890|MRI|mri
281215|NCT01956864|Vitamin D|vitamin d
281216|NCT01956851|insulin, kisspeptin, GLP 1|insulin, kisspeptin, glp 1
281217|NCT01956838|food intake|food intake
281218|NCT01956838|tastants|tastants
281219|NCT01956838|obesity|obesity
281220|NCT01956825|non alcoholic fatty liver disease|non alcoholic fatty liver disease
281221|NCT01956825|LCARNITINE amino acid|lcarnitine amino acid
281222|NCT01956825|magnesium|magnesium
281223|NCT01956825|fat content|fat content
281224|NCT01956812|clivatuzumab tetraxetan|clivatuzumab tetraxetan
281225|NCT01956812|90Y-clivatuzumab tetraxetan|90y-clivatuzumab tetraxetan
281226|NCT01956812|IMMU-107|immu-107
281227|NCT01956799|MDS|mds
281228|NCT01956799|PMF|pmf
281229|NCT01956799|CMML|cmml
281230|NCT01956799|AA|aa
281231|NCT01956786|Amlodipine|amlodipine
281232|NCT01956786|Folic Acid|folic acid
281233|NCT01956786|Homocysteine|homocysteine
281234|NCT01956786|Blood Pressure|blood pressure
281235|NCT01956773|family health history|family health history
281236|NCT01956773|prevention|prevention
281237|NCT01956773|genetic risk|genetic risk
281238|NCT01956773|clinical decision support|clinical decision support
281239|NCT01956760|Insomnia|insomnia
281240|NCT01956734|glioblastoma|glioblastoma
281241|NCT01956734|first recurrence|first recurrence
281242|NCT01956734|temozolomide|temozolomide
281243|NCT01956721|Heart Failure , Skeletal muscle,Calcium,Ryanodine Receptor, Mitochondria, Exercise training, Muscle biopsy, Healthy volunteers|heart failure , skeletal muscle,calcium,ryanodine receptor, mitochondria, exercise training, muscle biopsy, healthy volunteers
281244|NCT01956669|VEGF|vegf
281245|NCT01956669|Pazopanib|pazopanib
281246|NCT01956669|Sarcoma|sarcoma
281247|NCT01956669|GW786034|gw786034
281248|NCT01956669|Refractory Solid Tumors|refractory solid tumors
281249|NCT01956656|lotus leaf, mouthwash, gingivitis|lotus leaf, mouthwash, gingivitis
281250|NCT01956643|sham feeding|sham feeding
281251|NCT01956643|postoperative ileus|postoperative ileus
281252|NCT01956643|liver transplantation|liver transplantation
281253|NCT01956591|Treatment efficacy|treatment efficacy
281254|NCT01956591|Long-term effects|long-term effects
281255|NCT01956591|Tachyphylaxis|tachyphylaxis
281256|NCT01956591|Undesirable effects|undesirable effects
281257|NCT01956591|Side effects|side effects
281258|NCT01956591|Self-assessment|self-assessment
281259|NCT01956591|Hyperhidrosis|hyperhidrosis
281260|NCT01956591|Quality of life|quality of life
281261|NCT01956565|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
281262|NCT01956565|Rehabilitation|rehabilitation
281263|NCT01956565|Physiotherapy|physiotherapy
281264|NCT01956565|Patient Compliance|patient compliance
281265|NCT01956565|Inspiratory Muscle Training|inspiratory muscle training
281266|NCT01956565|Respiratory Muscle Training|respiratory muscle training
281267|NCT01956552|Metastatic breast cancer|metastatic breast cancer
281268|NCT01956552|Tumor biopsy|tumor biopsy
281269|NCT01956552|Phenotype and genotype characterization|phenotype and genotype characterization
281270|NCT01956526|Heart Failure with Preserved Ejection Fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
281271|NCT01956526|Diastolic Heart Failure (DHF)|diastolic heart failure (dhf)
281272|NCT01956526|Diastolic Dysfunction (DD)|diastolic dysfunction (dd)
281273|NCT01956513|ADC|adc
281274|NCT01956513|breast cancer|breast cancer
281275|NCT01956513|complete pathological response|complete pathological response
281276|NCT01956500|glucosamine|glucosamine
281277|NCT01956500|inflammation|inflammation
281278|NCT01956500|quality of life|quality of life
281279|NCT01956500|physical function|physical function
281280|NCT01956487|Bioequivalence|bioequivalence
281281|NCT01956487|RYTHMOL SR®|rythmol sr®
281282|NCT01956487|Atrial fibrillation|atrial fibrillation
281283|NCT01956487|Propafenone|propafenone
281284|NCT01956487|Pharmavokinetics|pharmavokinetics
281285|NCT01956474|keratoconus|keratoconus
281286|NCT01956474|cross-linking|cross-linking
281287|NCT01956474|Post-LASIK ectasia|post-lasik ectasia
281288|NCT01956474|Pellucid marginal degeneration|pellucid marginal degeneration
281289|NCT01956474|Forme fruste pellucid marginal degeneration|forme fruste pellucid marginal degeneration
281290|NCT01956474|FFKC|ffkc
281291|NCT01956474|Radial Keratotomy|radial keratotomy
281292|NCT01956474|Terrien's Marginal Degeneration|terrien's marginal degeneration
281293|NCT01956461|osteoporosis|osteoporosis
281294|NCT01956461|BMD|bmd
281295|NCT01956461|teriparatide|teriparatide
281296|NCT01956461|nursing home|nursing home
281297|NCT01956448|Percutaneous coronary intervention|percutaneous coronary intervention
281298|NCT01956448|DES|des
281299|NCT01956448|Angina pectoris|angina pectoris
281300|NCT01956448|Stent|stent
281301|NCT01956409|breast neoplasms|breast neoplasms
281302|NCT01956409|18F-FCH PET|18f-fch pet
281303|NCT01956409|MRI|mri
281304|NCT01956396|male circumcision|male circumcision
281305|NCT01956396|HIV|hiv
281306|NCT01956396|Zimbabwe|zimbabwe
281307|NCT01956383|male circumcision|male circumcision
281308|NCT01956383|HIV|hiv
281309|NCT01956383|Zimbabwe|zimbabwe
281310|NCT01956370|Male Circumcision|male circumcision
281311|NCT01956370|HIV Prevention|hiv prevention
281312|NCT01956370|Medical Device|medical device
281313|NCT01956357|aquatic exercises;|aquatic exercises;
281314|NCT01956357|deep water running;|deep water running;
281315|NCT01956357|diabetes;|diabetes;
281316|NCT01956357|blood glucose;|blood glucose;
281317|NCT01956357|inflammation.|inflammation.
281318|NCT01956344|Hoarding Disorder|hoarding disorder
281319|NCT01956344|Clutter|clutter
281320|NCT01956344|CBT|cbt
281321|NCT01956344|Cognitive behavior therapy|cognitive behavior therapy
281322|NCT01956344|fMRI|fmri
281323|NCT01956344|Obsessive compulsive disorder (OCD)|obsessive compulsive disorder (ocd)
281324|NCT01956344|Healthy control|healthy control
281325|NCT01956331|NSC lung Cancer,Elderly patients,post operative,|nsc lung cancer,elderly patients,post operative,
281326|NCT01956318|Chronic venous insufficiency|chronic venous insufficiency
281327|NCT01956318|Varicose vein|varicose vein
281328|NCT01956318|Crenobalneotherapy|crenobalneotherapy
281329|NCT01956318|Balneotherapy|balneotherapy
281330|NCT01956318|Spa therapy|spa therapy
281331|NCT01956279|Pregnenolone|pregnenolone
281332|NCT01956279|Gulf War Veteran|gulf war veteran
281333|NCT01956279|Fatigue|fatigue
281334|NCT01956279|Musculoskeletal Pain|musculoskeletal pain
281335|NCT01956279|Cognitive Decline|cognitive decline
281336|NCT01956279|Placebo Control|placebo control
281337|NCT01956266|Prosody|prosody
281338|NCT01956266|Communication|communication
281339|NCT01956266|Dysarthria|dysarthria
281340|NCT01956253|Bladder Cancer|bladder cancer
281341|NCT01956253|Neratinib|neratinib
281342|NCT01956253|13-2526|13-2526
281343|NCT01956240|shoulder|shoulder
281344|NCT01956240|pectoralis minor|pectoralis minor
281345|NCT01956240|stretching|stretching
281346|NCT01956240|scapular kinematics|scapular kinematics
281347|NCT01956214|hemodialysis|hemodialysis
281348|NCT01956214|exercise|exercise
281349|NCT01956214|electrical stimulation|electrical stimulation
281350|NCT01956175|electrical pharyngeal stimulation|electrical pharyngeal stimulation
281351|NCT01956175|stroke-related dysphagia|stroke-related dysphagia
281352|NCT01956175|tracheostomy|tracheostomy
281353|NCT01956175|decannulation|decannulation
281354|NCT01956149|gastric cancer|gastric cancer
281355|NCT01956149|second-line treatment|second-line treatment
281356|NCT01956149|Cabazitaxel|cabazitaxel
281357|NCT01956149|response|response
281358|NCT01956045|Intensive Care Units|intensive care units
281359|NCT01956045|Judgment|judgment
281360|NCT01956045|Disability Evaluation|disability evaluation
281361|NCT01956045|Autonomy|autonomy
281362|NCT01956032|LCIG|lcig
281363|NCT01956032|Parkinson's disease|parkinson's disease
281364|NCT01956032|levodopa carbidopa intestinal gel|levodopa carbidopa intestinal gel
281365|NCT01956032|Telemedicine|telemedicine
281366|NCT01955993|Obesity, adolescence,pharmacokinetics,fentanyl|obesity, adolescence,pharmacokinetics,fentanyl
281367|NCT01955980|CRS|crs
281368|NCT01955980|without polyposis|without polyposis
281369|NCT01955967|Effect|effect
281370|NCT01955967|Lidocaine|lidocaine
281371|NCT01955954|carbon dioxide monitoring|carbon dioxide monitoring
281372|NCT01955954|panic disorder|panic disorder
281373|NCT01955954|biofeedback|biofeedback
281374|NCT01955954|breathing training|breathing training
281375|NCT01955954|Primary diagnosis|primary diagnosis
281376|NCT01955954|panic attacks|panic attacks
281377|NCT01955941|Uveal melanoma|uveal melanoma
281378|NCT01955941|brachytherapy|brachytherapy
281379|NCT01955941|radiation|radiation
281380|NCT01955941|ciliary body|ciliary body
281381|NCT01955941|choroid|choroid
281382|NCT01955941|I-125 plaque brachytherapy|i-125 plaque brachytherapy
281383|NCT01955915|choroid|choroid
281384|NCT01955915|tumor|tumor
281385|NCT01955915|OCT|oct
281386|NCT01955915|malignant melanoma|malignant melanoma
281387|NCT01955902|Opioid dependence|opioid dependence
281388|NCT01955902|Buprenorphine|buprenorphine
281389|NCT01955902|Adherence|adherence
281390|NCT01955902|Substance use|substance use
281393|NCT01955889|Rehabilitation|rehabilitation
281394|NCT01955889|Telemedicine|telemedicine
281395|NCT01955876|Fosrenol|fosrenol
281396|NCT01955876|hyperphosphatemia|hyperphosphatemia
281397|NCT01955876|chronic kidney disease not on dialysis|chronic kidney disease not on dialysis
281398|NCT01955863|Prostatic Neoplasms|prostatic neoplasms
281399|NCT01955863|Prostatectomy, Retropubic|prostatectomy, retropubic
281400|NCT01955863|Patient Discharge|patient discharge
281401|NCT01955824|bronchoscopy|bronchoscopy
281402|NCT01955824|lignocaine|lignocaine
281403|NCT01955824|cough|cough
281404|NCT01955811|platelet transfusion|platelet transfusion
281405|NCT01955811|Fibrinogen|fibrinogen
281406|NCT01955811|blood coagulation|blood coagulation
281407|NCT01955811|Thrombocytopenia|thrombocytopenia
281408|NCT01955811|in-vitro experiments|in-vitro experiments
281409|NCT01955811|FGTW|fgtw
281410|NCT01955811|Fit2012|fit2012
281411|NCT01955811|factor I|factor i
281412|NCT01955811|Fibrin|fibrin
281413|NCT01955798|Laparoscopy|laparoscopy
281414|NCT01955798|Gyneacological|gyneacological
281415|NCT01955798|Entry techniques|entry techniques
281416|NCT01955785|Traumatic brain injury|traumatic brain injury
281417|NCT01955785|Intracranial pressure|intracranial pressure
281418|NCT01955785|Ventilation|ventilation
281419|NCT01955785|Respiratory therapy|respiratory therapy
281420|NCT01955772|Haematopoietic stem cell transplantation|haematopoietic stem cell transplantation
281421|NCT01955772|Malignant hemopathy|malignant hemopathy
281422|NCT01955772|Artificial nutrition|artificial nutrition
281423|NCT01955694|BAY94-8862|bay94-8862
281424|NCT01955694|MR antagonist|mr antagonist
281425|NCT01955694|Heart failure|heart failure
281426|NCT01955694|Japanese patients|japanese patients
281427|NCT01955681|Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor retrement.|epidermal growth factor receptor tyrosine kinase inhibitor retrement.
281428|NCT01955668|11q-deleted relapsed/refractory chronic lymphocytic leukaemia|11q-deleted relapsed/refractory chronic lymphocytic leukaemia
281429|NCT01955668|Prolymphocytic leukaemia|prolymphocytic leukaemia
281430|NCT01955668|B cell lymphomas|b cell lymphomas
281431|NCT01955655|Baclofen|baclofen
281432|NCT01955655|cerebral palsy|cerebral palsy
281433|NCT01955655|colic|colic
281434|NCT01955655|crying infant|crying infant
281435|NCT01955655|recurrent crying spells|recurrent crying spells
281436|NCT01955655|spasticity|spasticity
281437|NCT01955655|therapy|therapy
281438|NCT01955642|Clopidogrel|clopidogrel
281439|NCT01955642|Brain Ischemia|brain ischemia
281440|NCT01955642|Ischemic attack|ischemic attack
281441|NCT01955642|Biological response to clopidogrel|biological response to clopidogrel
281442|NCT01955616|Parkinson's disease, chronic constipation|parkinson's disease, chronic constipation
281443|NCT01955590|Metacognitive therapy|metacognitive therapy
281444|NCT01955590|Eye Movement Desensitization Reprocessing (EMDR)|eye movement desensitization reprocessing (emdr)
281445|NCT01955590|Cognitive therapy|cognitive therapy
281446|NCT01955577|Vitamin D deficiency|vitamin d deficiency
281447|NCT01955577|Ring fixator|ring fixator
281448|NCT01955577|Tibial fracture|tibial fracture
281449|NCT01955525|Acute coronary syndrome|acute coronary syndrome
281450|NCT01955525|health related quality of life|health related quality of life
281451|NCT01955525|mortality|mortality
281452|NCT01955486|flight simulation|flight simulation
281453|NCT01955486|middle ear|middle ear
281454|NCT01955486|Eustachian tube function|eustachian tube function
281455|NCT01955473|Solid tumors|solid tumors
281456|NCT01955473|Sym004|sym004
281457|NCT01955473|Phase 1|phase 1
281458|NCT01955460|Melanoma|melanoma
281459|NCT01955460|Metastatic|metastatic
281460|NCT01955460|T-cells|t-cells
281461|NCT01955460|Autologous tumor infiltrating lymphocytes|autologous tumor infiltrating lymphocytes
281462|NCT01955460|TIL|til
281463|NCT01955460|DNRII|dnrii
281464|NCT01955460|NGFR|ngfr
281465|NCT01955460|Cyclophosphamide|cyclophosphamide
281466|NCT01955460|Cytoxan|cytoxan
281467|NCT01955460|Neosar|neosar
281468|NCT01955460|Mesna|mesna
281469|NCT01955460|Mesnex|mesnex
281470|NCT01955460|Fludarabine|fludarabine
281471|NCT01955460|Fludarabine phosphate|fludarabine phosphate
281472|NCT01955460|Fludara|fludara
281473|NCT01955460|Interleukin-2|interleukin-2
281474|NCT01955460|IL-2|il-2
281475|NCT01955460|Aldesleukin|aldesleukin
281476|NCT01955460|Proleukin|proleukin
281477|NCT01955447|Blood glucose|blood glucose
281478|NCT01955421|NSCLC|nsclc
281479|NCT01955421|stage IIIB|stage iiib
281480|NCT01955421|stage IV)|stage iv)
281481|NCT01955421|confirmed by histology or cytology methods|confirmed by histology or cytology methods
281482|NCT01955421|Harboring a PCR-confirmed activating mutation of EGFR, including an exon 19 deletion or an exon 21 L858R point mutation|harboring a pcr-confirmed activating mutation of egfr, including an exon 19 deletion or an exon 21 l858r point mutation
281483|NCT01955408|overactive bladder|overactive bladder
281484|NCT01955408|bladder cancer|bladder cancer
281485|NCT01955408|Synergo|synergo
281486|NCT01955408|urodynamic study|urodynamic study
281487|NCT01955395|Relaxation Response Resiliency Program (3RP)|relaxation response resiliency program (3rp)
281488|NCT01955395|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
281489|NCT01955395|smoldering multiple myeloma|smoldering multiple myeloma
281490|NCT01955382|Parasite Clearance Rate|parasite clearance rate
281491|NCT01955382|Parasite Half Life|parasite half life
281492|NCT01955382|Actidose Aqua|actidose aqua
281493|NCT01955382|Severe Malaria|severe malaria
281494|NCT01955369|incidence|incidence
281495|NCT01955369|phenotype|phenotype
281496|NCT01955369|mortality|mortality
281497|NCT01955356|Scratching|scratching
281498|NCT01955356|Endometrial biopsy|endometrial biopsy
281499|NCT01955356|Ongoing embryo implantation|ongoing embryo implantation
281500|NCT01955356|Assisted reproductive techniques|assisted reproductive techniques
281501|NCT01955343|Immune response|immune response
281502|NCT01955343|Cancer|cancer
281503|NCT01955330|CABG, Hybrid, Robotic surgery|cabg, hybrid, robotic surgery
281504|NCT01955317|Neonate|neonate
281505|NCT01955317|Bangladesh|bangladesh
281506|NCT01955317|Health behavior|health behavior
281507|NCT01955317|Handwashing|handwashing
281508|NCT01955317|Developing countries|developing countries
281509|NCT01955317|Infectious disease|infectious disease
281510|NCT01955291|Virtual Reality, Motor Learning, Rehabilitation, Upper Limb|virtual reality, motor learning, rehabilitation, upper limb
281511|NCT01955278|Laparoscopic colorectal surgery|laparoscopic colorectal surgery
281512|NCT01955278|Parastomal hernia|parastomal hernia
281513|NCT01955278|Prophylactic|prophylactic
281514|NCT01955278|Mesh|mesh
281515|NCT01955265|Positive youth development|positive youth development
281516|NCT01955265|Sports / physical activity|sports / physical activity
281517|NCT01955252|Endemic treponematoses|endemic treponematoses
281518|NCT01955252|Azithromycin|azithromycin
281519|NCT01955252|Mass drug administration|mass drug administration
281520|NCT01955252|Eradication|eradication
281521|NCT01955239|Head and Neck Cancer|head and neck cancer
281522|NCT01955239|Radiotherapy|radiotherapy
281523|NCT01955239|IMRT|imrt
281524|NCT01955239|Stem cell|stem cell
281525|NCT01955239|Parotid gland|parotid gland
281526|NCT01955213|constipation, methylnaltrexone, opoid|constipation, methylnaltrexone, opoid
281527|NCT01955200|Stent implantation|stent implantation
281528|NCT01955200|Clopidogrel low response|clopidogrel low response
281529|NCT01955200|Ticagrelor|ticagrelor
281530|NCT01955200|Cilostazol|cilostazol
281531|NCT01955200|Clopidogrel|clopidogrel
281532|NCT01955187|SEQUENTIAL THERAPY|sequential therapy
281533|NCT01955187|PRIMARY MEMBRANOUS NEPHROPATHY|primary membranous nephropathy
281534|NCT01955187|TACROLIMUS|tacrolimus
281535|NCT01955187|RITUXIMAB|rituximab
281536|NCT01955174|Botulinum toxin|botulinum toxin
281537|NCT01955174|Esophageal motility disorder|esophageal motility disorder
281538|NCT01955174|Distal esophageal spasm|distal esophageal spasm
281539|NCT01955148|PTB|ptb
281540|NCT01955148|sPTB|sptb
281541|NCT01955148|cervical cerclage|cervical cerclage
281542|NCT01955148|LEEP|leep
281543|NCT01955148|PROM|prom
281544|NCT01955148|short cervix|short cervix
281545|NCT01955135|Prematurity, Retinopathy, propofol, ketamine, sedation|prematurity, retinopathy, propofol, ketamine, sedation
281546|NCT01955122|polyp/adenoma miss rate|polyp/adenoma miss rate
281547|NCT01955122|colonoscopy add-on device|colonoscopy add-on device
281548|NCT01955122|enhanced screening|enhanced screening
281549|NCT01955109|Food allergy|food allergy
281550|NCT01955109|Immediate hypersensitivity|immediate hypersensitivity
281551|NCT01955109|Whole peanut extract|whole peanut extract
281552|NCT01955109|Allergenic product|allergenic product
281553|NCT01955109|Specific Immunotherapy|specific immunotherapy
281554|NCT01955109|Epicutaneous Immunotherapy (EPIT)|epicutaneous immunotherapy (epit)
281555|NCT01955096|fast-track surgery, laparoscopic gastrectomy|fast-track surgery, laparoscopic gastrectomy
281556|NCT01955083|Obstructive sleep apnea|obstructive sleep apnea
281557|NCT01955083|snoring|snoring
281558|NCT01955083|radiofrequency|radiofrequency
281559|NCT01955083|pillar implant|pillar implant
281560|NCT01955083|snore sound analysis|snore sound analysis
281561|NCT01955070|Informed consent|informed consent
281562|NCT01955070|Ethics|ethics
281563|NCT01955044|neonatal prematurity|neonatal prematurity
281564|NCT01955044|infant, extremely low birth weight|infant, extremely low birth weight
281565|NCT01955044|fatty acids, polyunsaturated|fatty acids, polyunsaturated
281566|NCT01955031|Telemedicine|telemedicine
281567|NCT01955031|Telemonitoring|telemonitoring
281568|NCT01955031|Education|education
281569|NCT01955031|Nutrition|nutrition
281570|NCT01955031|Food behaviour|food behaviour
281571|NCT01955031|Weight|weight
281572|NCT01955031|Physical activity|physical activity
281573|NCT01955031|Glycaemia|glycaemia
281574|NCT01955031|Self-monitoring blood glucose|self-monitoring blood glucose
281575|NCT01955018|computed tomography|computed tomography
281576|NCT01955018|radiation|radiation
281577|NCT01955018|screening|screening
281578|NCT01955018|asbestos|asbestos
281579|NCT01955018|workers|workers
281580|NCT01955018|cancer|cancer
281581|NCT01955005|Health Records, Personal|health records, personal
281582|NCT01955005|Delivery of healthcare|delivery of healthcare
281583|NCT01955005|Consumer Participation|consumer participation
281584|NCT01955005|Internet|internet
281585|NCT01954992|glufosfamide|glufosfamide
281586|NCT01954992|5-FU|5-fu
281587|NCT01954992|metastatic pancreatic adenocarcinoma|metastatic pancreatic adenocarcinoma
281588|NCT01954979|Graft versus Host Disease|graft versus host disease
281589|NCT01954979|ABATACEPT|abatacept
281590|NCT01954966|Nicotine|nicotine
281591|NCT01954966|Smoking|smoking
281592|NCT01954953|Retinitis Pigmentosa Syndromic|retinitis pigmentosa syndromic
281593|NCT01954953|Congenital Deafness|congenital deafness
281594|NCT01954953|Usher Syndrome Retinitis Pigmentosa and Deafness|usher syndrome retinitis pigmentosa and deafness
281595|NCT01954953|Progressive Hearing Loss|progressive hearing loss
281596|NCT01954953|Retinitis Pigmentosa|retinitis pigmentosa
281597|NCT01954940|Whole body vibration therapy, muscle strength testing, bone health, ambulatory, endurance.|whole body vibration therapy, muscle strength testing, bone health, ambulatory, endurance.
281598|NCT01954927|Pain control|pain control
281599|NCT01954914|Plerixafor|plerixafor
281600|NCT01954914|donor|donor
281601|NCT01954914|allogeneic peripheral stam cell donation|allogeneic peripheral stam cell donation
281602|NCT01954914|PBSC|pbsc
281603|NCT01954914|poor donors|poor donors
281604|NCT01954875|neurodegenerative diseases|neurodegenerative diseases
281605|NCT01954875|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
281606|NCT01954875|multiple sclerosis|multiple sclerosis
281607|NCT01954875|Parkinson's Disease|parkinson's disease
281608|NCT01954862|Water-aided colonoscopy|water-aided colonoscopy
281609|NCT01954862|Water Immersion colonoscopy|water immersion colonoscopy
281610|NCT01954862|Water Exchange colonoscopy|water exchange colonoscopy
281611|NCT01954862|Carbon-dioxide colonoscopy|carbon-dioxide colonoscopy
281612|NCT01954862|Painless unsedated colonoscopy|painless unsedated colonoscopy
281613|NCT01954862|Adenoma detection rate|adenoma detection rate
281614|NCT01954862|Mean Adenomas per Procedure|mean adenomas per procedure
281615|NCT01954849|gingivitis|gingivitis
281616|NCT01954849|inflammation|inflammation
281617|NCT01954849|plaque|plaque
281618|NCT01954849|orthodontics|orthodontics
281619|NCT01954836|short-term fasting|short-term fasting
281620|NCT01954836|adjuvant chemotherapy|adjuvant chemotherapy
281621|NCT01954836|toxicity|toxicity
281622|NCT01954836|side-effects|side-effects
281623|NCT01954836|ovarial carinoma|ovarial carinoma
281624|NCT01954836|breast cancer|breast cancer
281625|NCT01954823|Multiple sclerosis, Patient-reported outcomes, patient diary|multiple sclerosis, patient-reported outcomes, patient diary
281626|NCT01954810|JECV|jecv
281627|NCT01954810|IMOJEV|imojev
281628|NCT01954810|Booster response|booster response
281629|NCT01954810|Children|children
281630|NCT01954810|antibody response|antibody response
281631|NCT01954810|Duration|duration
281632|NCT01954797|Physical fitness|physical fitness
281633|NCT01954797|relaxation|relaxation
281634|NCT01954797|stroke|stroke
281635|NCT01954797|cerebral ischemia|cerebral ischemia
281636|NCT01954797|cerebral perfusion|cerebral perfusion
281637|NCT01954797|biomarkers|biomarkers
281638|NCT01954797|MRI|mri
281639|NCT01954771|Diabetes mellitus|diabetes mellitus
281640|NCT01954771|Coronary artery disease|coronary artery disease
281641|NCT01954771|SMBG|smbg
281642|NCT01954771|Elderly|elderly
281643|NCT01954758|Window of implantation|window of implantation
281644|NCT01954758|Personalized embryo transfer|personalized embryo transfer
281645|NCT01954758|Fresh embryo transfer|fresh embryo transfer
281646|NCT01954758|Delayed embryo transfer|delayed embryo transfer
281647|NCT01954758|Elective deferred embryo transfer|elective deferred embryo transfer
281648|NCT01954758|Endometrial receptivity array|endometrial receptivity array
281649|NCT01954758|Endometrial receptivity analysis|endometrial receptivity analysis
281650|NCT01954758|Endometrial receptivity test|endometrial receptivity test
281651|NCT01954745|Bile Duct Cancer|bile duct cancer
281652|NCT01954745|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
281653|NCT01954745|extrahepatic cholangiocarcinoma|extrahepatic cholangiocarcinoma
281654|NCT01954745|Cabozantinib|cabozantinib
281655|NCT01954719|Cervix Uteri, Cesarean Section, Infection, Dilatation|cervix uteri, cesarean section, infection, dilatation
281656|NCT01954693|Tuberous Sclerosis|tuberous sclerosis
281657|NCT01954693|Everolimus|everolimus
281658|NCT01954693|Neurocognitive functioning|neurocognitive functioning
281659|NCT01954680|bipolar disorder|bipolar disorder
281660|NCT01954680|child|child
281661|NCT01954680|adolescent|adolescent
281662|NCT01954667|Gastroesophageal Reflux Disease; Anthropometric Measures; Leptin|gastroesophageal reflux disease; anthropometric measures; leptin
281663|NCT01954641|breast cancer|breast cancer
281664|NCT01954641|lung cancer|lung cancer
281665|NCT01954641|cancer treatments|cancer treatments
281666|NCT01954641|racial inequity|racial inequity
281667|NCT01954641|health systems change|health systems change
281668|NCT01954641|transparency|transparency
281669|NCT01954641|accountability|accountability
281670|NCT01954628|Exacerbation of COPD|exacerbation of copd
281671|NCT01954628|Unstable COPD|unstable copd
281672|NCT01954615|ACT-281959|act-281959
281673|NCT01954615|ACT-246475|act-246475
281674|NCT01954602|Biliary cannulation|biliary cannulation
281675|NCT01954602|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
281676|NCT01954602|Touch guide-wire techniques|touch guide-wire techniques
281677|NCT01954602|No touch guide-wire techniques|no touch guide-wire techniques
281678|NCT01954589|ACT-462206|act-462206
281679|NCT01954589|Selective dual orexin receptor antagonist|selective dual orexin receptor antagonist
281680|NCT01954576|bevacizumab-naïve recurrent GBM|bevacizumab-naïve recurrent gbm
281681|NCT01954576|bevacizumab-refractory GBM|bevacizumab-refractory gbm
281682|NCT01954563|Tuberculosis|tuberculosis
281683|NCT01954563|Vaccine|vaccine
281684|NCT01954563|Immunogenicity|immunogenicity
281685|NCT01954550|Exercise|exercise
281686|NCT01954550|Dementia|dementia
281687|NCT01954550|Cognition|cognition
281688|NCT01954550|Brain Volume|brain volume
281689|NCT01954550|Aging|aging
281690|NCT01954537|Exertional heat illness|exertional heat illness
281691|NCT01954537|Hydration Status|hydration status
281692|NCT01954537|Preseason football|preseason football
281693|NCT01954537|heat stroke|heat stroke
281694|NCT01954511|Stomatognathic diseases;|stomatognathic diseases;
281695|NCT01954511|Temporomandibular Joint Dysfunction Syndrome|temporomandibular joint dysfunction syndrome
281696|NCT01954498|Randomized controlled trial|randomized controlled trial
281697|NCT01954498|Spermatozoa|spermatozoa
281698|NCT01954498|Sperm|sperm
281699|NCT01954498|Male Infertility|male infertility
281700|NCT01954498|Walnuts|walnuts
281701|NCT01954498|Nutrition|nutrition
281702|NCT01954498|Male Reproduction|male reproduction
281703|NCT01954485|LaserLok, connective tissue, adhesion|laserlok, connective tissue, adhesion
281704|NCT01954472|Portfolio diet|portfolio diet
281705|NCT01954472|dietary modification|dietary modification
281706|NCT01954472|hypercholesterolemia|hypercholesterolemia
281707|NCT01954472|diabetes|diabetes
281708|NCT01954472|Exercise|exercise
281709|NCT01954472|CVD risk|cvd risk
281710|NCT01954472|glycemic index|glycemic index
281711|NCT01954472|inflammatory biomarkers|inflammatory biomarkers
281712|NCT01954472|monounsaturated fat|monounsaturated fat
281713|NCT01954472|saturated fat|saturated fat
281714|NCT01954472|nuts|nuts
281715|NCT01954472|plant sterols|plant sterols
281716|NCT01954472|vegetable protein|vegetable protein
281717|NCT01954472|viscous fiber|viscous fiber
281718|NCT01954472|soy|soy
281719|NCT01954459|Type 1 diabetes|type 1 diabetes
281720|NCT01954459|Continuous glucose sensor|continuous glucose sensor
281721|NCT01954459|Insupatch|insupatch
281722|NCT01954433|Cost-effectiveness analyses|cost-effectiveness analyses
281723|NCT01954433|Cost-utility analyses|cost-utility analyses
281724|NCT01954433|Upper extremity|upper extremity
281725|NCT01954433|Orthopedic|orthopedic
281726|NCT01954433|Shoulder arthroplasty|shoulder arthroplasty
281727|NCT01954433|Rotator cuff tear repair|rotator cuff tear repair
281728|NCT01954433|Resection interposition suspension arthroplasty|resection interposition suspension arthroplasty
281729|NCT01954420|Pain|pain
281730|NCT01954420|Fatigue|fatigue
281731|NCT01954420|Sleep|sleep
281732|NCT01954420|Cancer|cancer
281733|NCT01954420|Relaxation|relaxation
281734|NCT01954420|Distraction|distraction
281735|NCT01954420|Symptoms|symptoms
281736|NCT01954407|smoking-related messages|smoking-related messages
281737|NCT01954407|anti-smoking messages|anti-smoking messages
281738|NCT01954407|smoking-related beliefs|smoking-related beliefs
281739|NCT01954407|anti-smoking intentions|anti-smoking intentions
281740|NCT01954355|advanced solid tumor|advanced solid tumor
281741|NCT01954355|ovarian cancer|ovarian cancer
281742|NCT01954355|LDE225|lde225
281743|NCT01954355|Paclitaxel|paclitaxel
281744|NCT01954355|Hedgehog inhibitor|hedgehog inhibitor
281745|NCT01954342|Pregnancy|pregnancy
281746|NCT01954342|Postpartum|postpartum
281747|NCT01954329|Biomarkers|biomarkers
281748|NCT01954329|TIA|tia
281749|NCT01954329|Diagnosis|diagnosis
281750|NCT01954316|advanced cancer|advanced cancer
281751|NCT01954316|CFI-400945 fumarate|cfi-400945 fumarate
281752|NCT01954316|polo-like kinase 4|polo-like kinase 4
281753|NCT01954316|PLK4|plk4
281754|NCT01954316|tablet|tablet
281755|NCT01954316|dose escalation|dose escalation
281756|NCT01954316|genetic testing|genetic testing
281757|NCT01954290|Stroke|stroke
281758|NCT01954290|Brain Edema|brain edema
281759|NCT01954290|Brain Herniation|brain herniation
281760|NCT01954290|Conivaptan|conivaptan
281761|NCT01954277|Chronic Tension-Type Headache|chronic tension-type headache
281762|NCT01954277|Electroacupuncture|electroacupuncture
281763|NCT01954277|Headache Impact|headache impact
281764|NCT01954277|BDNF|bdnf
281765|NCT01954277|TNF|tnf
281766|NCT01954264|Saharan Western Africa|saharan western africa
281767|NCT01954264|Epidemiology|epidemiology
281768|NCT01954264|Post-Approval Programme study|post-approval programme study
281769|NCT01954264|Malaria|malaria
281770|NCT01954264|Burden of Disease Study|burden of disease study
281771|NCT01954251|FLU-D-QIV|flu-d-qiv
281772|NCT01954251|Adults|adults
281773|NCT01954251|Safety|safety
281774|NCT01954251|Immunogenicity|immunogenicity
281775|NCT01954251|co-administration|co-administration
281776|NCT01954251|Herpes zoster|herpes zoster
281777|NCT01954238|Anti-coagulant|anti-coagulant
281778|NCT01954238|Coagulation factor Xa inhibitor|coagulation factor xa inhibitor
281779|NCT01954225|Fistula in ano|fistula in ano
281780|NCT01954225|Bhagandara|bhagandara
281781|NCT01954225|Udumbara sutra|udumbara sutra
281782|NCT01954212|Oral health|oral health
281783|NCT01954199|Sciatica|sciatica
281784|NCT01954199|Nerve pain|nerve pain
281785|NCT01954199|Low back pain|low back pain
281786|NCT01954186|Oxytocin|oxytocin
281914|NCT01953705|ASL|asl
281787|NCT01954186|Active Management of Third Stage of Labour|active management of third stage of labour
281788|NCT01954134|Tumor Suppressor Protein p53,|tumor suppressor protein p53,
281789|NCT01954134|Iodine Radioisotopes|iodine radioisotopes
281790|NCT01954121|Levetiracetam|levetiracetam
281791|NCT01954121|Keppra|keppra
281792|NCT01954121|Monotherapy|monotherapy
281793|NCT01954121|China|china
281794|NCT01954121|Epilepsy|epilepsy
281795|NCT01954121|Partial-onset Seizures|partial-onset seizures
281796|NCT01954108|tendinopathy|tendinopathy
281797|NCT01954108|hyaluronan|hyaluronan
281798|NCT01954108|tendon|tendon
281799|NCT01954108|hyaluronic acid|hyaluronic acid
281800|NCT01954108|extracorporeal shock wave|extracorporeal shock wave
281801|NCT01954095|17-OHPC, Prometrium, Cerclage, Pre-term birth, Short cervix|17-ohpc, prometrium, cerclage, pre-term birth, short cervix
281802|NCT01954082|Retinopathy|retinopathy
281803|NCT01954082|Prematurity|prematurity
281804|NCT01954082|Infant, Newborn, Diseases|infant, newborn, diseases
281805|NCT01954056|NICHD Neonatal Research Network|nichd neonatal research network
281806|NCT01954056|Mechanical ventilation|mechanical ventilation
281807|NCT01954056|Intubation|intubation
281808|NCT01954056|Neurodevelopmental impairment|neurodevelopmental impairment
281809|NCT01954043|melanoma|melanoma
281810|NCT01954043|dabrafenib|dabrafenib
281811|NCT01954043|BRAF V600|braf v600
281812|NCT01954043|rabeprazole|rabeprazole
281813|NCT01954043|rifampin|rifampin
281814|NCT01954030|Carboxyamidotriazole Orotate|carboxyamidotriazole orotate
281815|NCT01954030|CTO|cto
281816|NCT01954030|Bevacizumab|bevacizumab
281817|NCT01954030|Avastin|avastin
281818|NCT01954030|Malignant Glioma|malignant glioma
281819|NCT01954030|Pro00044274|pro00044274
281820|NCT01954030|Desjardins|desjardins
281821|NCT01954030|Duke|duke
281822|NCT01954030|The Preston Robert Tisch Brain Tumor Center|the preston robert tisch brain tumor center
281823|NCT01953978|Pain|pain
281824|NCT01953978|Analgesia|analgesia
281825|NCT01953978|Postoperative|postoperative
281826|NCT01953978|Dexamethasone|dexamethasone
281827|NCT01953978|Spine surgery|spine surgery
281828|NCT01953926|Neratinib|neratinib
281829|NCT01953926|Nerlynx|nerlynx
281830|NCT01953926|Breast|breast
281831|NCT01953926|Gastroesophageal|gastroesophageal
281832|NCT01953926|Endometrial|endometrial
281833|NCT01953926|Ovarian|ovarian
281834|NCT01953926|Biliary Tract|biliary tract
281835|NCT01953926|Solid Tumors|solid tumors
281836|NCT01953926|Cancer|cancer
281837|NCT01953926|HER2|her2
281838|NCT01953926|HER4|her4
281839|NCT01953926|EGFR|egfr
281840|NCT01953926|Bladder/Urinary Tract|bladder/urinary tract
281841|NCT01953926|Paclitaxel|paclitaxel
281842|NCT01953926|Fulvestrant|fulvestrant
281843|NCT01953926|Trastuzumab|trastuzumab
281844|NCT01953900|Sarcoma|sarcoma
281845|NCT01953900|T-Cells|t-cells
281846|NCT01953900|varicella zoster virus (VZV)|varicella zoster virus (vzv)
281847|NCT01953900|GD2|gd2
281848|NCT01953887|Phase I|phase i
281849|NCT01953887|Final formulation EC905|final formulation ec905
281850|NCT01953887|Solifenacin succinate|solifenacin succinate
281851|NCT01953887|Tamsulosin HCl|tamsulosin hcl
281852|NCT01953887|Marketed drugs|marketed drugs
281853|NCT01953874|heart failure|heart failure
281854|NCT01953874|congestive heart failure|congestive heart failure
281855|NCT01953874|acute decompensated heart failure|acute decompensated heart failure
281856|NCT01953874|chronic heart failure|chronic heart failure
281857|NCT01953874|left-sided heart failure|left-sided heart failure
281858|NCT01953874|heart failure decompensation|heart failure decompensation
281859|NCT01953874|sleep apnea|sleep apnea
281860|NCT01953874|sleep disordered breathing|sleep disordered breathing
281861|NCT01953874|central sleep apnea|central sleep apnea
281862|NCT01953874|obstructive sleep apnea|obstructive sleep apnea
281863|NCT01953874|cheyne-stokes respiration|cheyne-stokes respiration
281864|NCT01953861|Phase I|phase i
281865|NCT01953861|Combination tablet EC905|combination tablet ec905
281866|NCT01953861|Omnic OCAS®|omnic ocas®
281867|NCT01953861|Vesicare®|vesicare®
281868|NCT01953861|Food effect|food effect
281869|NCT01953861|Vesomni|vesomni
281870|NCT01953861|VesiFlow|vesiflow
281871|NCT01953861|Urizia|urizia
281872|NCT01953848|Phase I|phase i
281873|NCT01953848|Combination tablet EC905|combination tablet ec905
281874|NCT01953848|Steady-state|steady-state
281875|NCT01953848|Vesomni|vesomni
281876|NCT01953848|VesiFlow|vesiflow
281877|NCT01953848|Urizia|urizia
281878|NCT01953835|Pharmacokinetics|pharmacokinetics
281879|NCT01953835|GSK2586184|gsk2586184
281880|NCT01953835|Simvastatin|simvastatin
281881|NCT01953835|Rosuvastatin|rosuvastatin
281882|NCT01953835|Poloxamer|poloxamer
281883|NCT01953822|Observational|observational
281884|NCT01953822|Cohort|cohort
281885|NCT01953822|Autoimmune disease|autoimmune disease
281886|NCT01953822|Cervarix®|cervarix®
281887|NCT01953822|Women aged 9 to 25 years|women aged 9 to 25 years
281888|NCT01953822|United Kingdom|united kingdom
281889|NCT01953809|oral|oral
281890|NCT01953809|oral contraceptive|oral contraceptive
281891|NCT01953809|pharmacokinetics|pharmacokinetics
281892|NCT01953809|drug interaction|drug interaction
281893|NCT01953809|pharmacodynamics|pharmacodynamics
281894|NCT01953809|GSK1322322|gsk1322322
281895|NCT01953809|antibiotic|antibiotic
281896|NCT01953809|safety|safety
281897|NCT01953796|Polycystic Ovarian Syndrome stair step traditional protocol|polycystic ovarian syndrome stair step traditional protocol
281898|NCT01953770|Acute lymphoblastic leukemia, children, adolescents, L-asparaginase, methotrexate|acute lymphoblastic leukemia, children, adolescents, l-asparaginase, methotrexate
281899|NCT01953757|diabetic neuropathy, diet, vegan, vegetarian|diabetic neuropathy, diet, vegan, vegetarian
281900|NCT01953744|Fluconazole; Meglumine antimoniate;L.Braziliensis;|fluconazole; meglumine antimoniate;l.braziliensis;
281901|NCT01953744|L.Guyanensis|l.guyanensis
281902|NCT01953731|palbociclib|palbociclib
281903|NCT01953731|PD-0332991|pd-0332991
281904|NCT01953731|rifampin|rifampin
281905|NCT01953731|drug-drug interaction study|drug-drug interaction study
281906|NCT01953705|omega 3 fatty acids|omega 3 fatty acids
281907|NCT01953705|cognitive decline|cognitive decline
281908|NCT01953705|MRI|mri
281909|NCT01953705|endothelial function|endothelial function
281910|NCT01953705|white matter|white matter
281911|NCT01953705|executive function|executive function
281912|NCT01953705|prevention|prevention
281913|NCT01953705|DTI|dti
281915|NCT01953692|PD1|pd1
281916|NCT01953692|PD-1|pd-1
281917|NCT01953692|PDL1|pdl1
281918|NCT01953692|PD-L1|pd-l1
281919|NCT01953666|word prediction software, text input speed, copm, occupational therapist, rehabilitation, spinal cord injury|word prediction software, text input speed, copm, occupational therapist, rehabilitation, spinal cord injury
281920|NCT01953614|quantitative encephalography|quantitative encephalography
281921|NCT01953614|brain computer interface|brain computer interface
281922|NCT01953614|chiropractic|chiropractic
281923|NCT01953614|sacro-occipital technique|sacro-occipital technique
281924|NCT01953575|Mucosal Impedance|mucosal impedance
281925|NCT01953575|Eosinophilic Esophagitis|eosinophilic esophagitis
281926|NCT01953575|EoE|eoe
281927|NCT01953562|infants|infants
281928|NCT01953562|NICU|nicu
281929|NCT01953562|intubated|intubated
281930|NCT01953562|ventilator|ventilator
281931|NCT01953549|physical activity, relaxation, activities of daily living, motor functions, cognitive functions|physical activity, relaxation, activities of daily living, motor functions, cognitive functions
281932|NCT01953523|erectile dysfunction|erectile dysfunction
281933|NCT01953523|peyronies|peyronies
281934|NCT01953523|interstitial cystitis|interstitial cystitis
281935|NCT01953523|cardiomyopathy|cardiomyopathy
281936|NCT01953523|emphysema|emphysema
281937|NCT01953523|copd|copd
281938|NCT01953523|arthritis|arthritis
281939|NCT01953523|multiple sclerosis|multiple sclerosis
281940|NCT01953523|parkinson's|parkinson's
281941|NCT01953510|Pneumococcal vaccines|pneumococcal vaccines
281942|NCT01953510|10-valent pneumococcal vaccine|10-valent pneumococcal vaccine
281943|NCT01953510|13-valent pneumococcal vaccine|13-valent pneumococcal vaccine
281944|NCT01953510|Immunization Schedule|immunization schedule
281945|NCT01953510|Public Health|public health
281946|NCT01953458|Hepatitis B and C|hepatitis b and c
281947|NCT01953458|ANRS HEPATHER French Cohort|anrs hepather french cohort
281948|NCT01953432|Cocaine-Related Disorders|cocaine-related disorders
281949|NCT01953432|Cocaine|cocaine
281950|NCT01953432|Doxazosin|doxazosin
281951|NCT01953432|Cardiovascular Agents|cardiovascular agents
281952|NCT01953432|Antihypertensive Agents|antihypertensive agents
281953|NCT01953432|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists
281954|NCT01953432|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists
281955|NCT01953432|Adrenergic Antagonists|adrenergic antagonists
281956|NCT01953432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
281957|NCT01953432|Neurotransmitter Agents|neurotransmitter agents
281958|NCT01953432|Therapeutic Uses|therapeutic uses
281959|NCT01953432|Pharmacologic Actions|pharmacologic actions
281960|NCT01953432|Substance-Related Disorders|substance-related disorders
281961|NCT01953406|hepatocellular carcinoma|hepatocellular carcinoma
281962|NCT01953406|lung metastasis|lung metastasis
281963|NCT01953406|5-fluorouracil/mitomycin|5-fluorouracil/mitomycin
281964|NCT01953380|Intervention Studies|intervention studies
281965|NCT01953380|Eczema|eczema
281966|NCT01953380|Randomized Controlled Trial|randomized controlled trial
281967|NCT01953380|Knowledge|knowledge
281968|NCT01953380|Quality of Life|quality of life
281969|NCT01953367|Bioequivalence|bioequivalence
281970|NCT01953367|AUC|auc
281971|NCT01953367|Cmax|cmax
281972|NCT01953354|Ulcerative colitis (UC)|ulcerative colitis (uc)
281973|NCT01953354|Inflammatory Bowel Disease (IBD)|inflammatory bowel disease (ibd)
281974|NCT01953354|Trichuris suis ova (TSO)|trichuris suis ova (tso)
281975|NCT01953341|Migraine|migraine
281976|NCT01953328|Japanese, high cholesterol, LDL-C, High Cardiovascular Risk|japanese, high cholesterol, ldl-c, high cardiovascular risk
282077|NCT01952847|Questionnaires|questionnaires
281977|NCT01953315|urinary incontinence, muscle progenitor cells, MPCs|urinary incontinence, muscle progenitor cells, mpcs
281978|NCT01953302|ventral hernia|ventral hernia
281979|NCT01953302|infection|infection
281980|NCT01953302|hematoma|hematoma
281981|NCT01953302|seroma|seroma
281982|NCT01953302|recurrence|recurrence
281983|NCT01953302|mesh technique|mesh technique
281984|NCT01953289|Appendicitis|appendicitis
281985|NCT01953289|Free fluid|free fluid
281986|NCT01953276|Acute Coronary Syndrome|acute coronary syndrome
281987|NCT01953276|Chest pain|chest pain
281988|NCT01953276|Electrocardiograms|electrocardiograms
281989|NCT01953276|Risk Stratification|risk stratification
281990|NCT01953276|Emergency Department|emergency department
281991|NCT01953263|urinary incontinence, muscle fibers|urinary incontinence, muscle fibers
281992|NCT01953250|Deep infiltrating endometriosis|deep infiltrating endometriosis
281993|NCT01953250|Laparoscopic sigmoid resection|laparoscopic sigmoid resection
281994|NCT01953250|laparoscopic rectum resection|laparoscopic rectum resection
281995|NCT01953250|Colorectal surgery|colorectal surgery
281996|NCT01953237|Schizophrenia|schizophrenia
281997|NCT01953237|antipsychotic medication adherence|antipsychotic medication adherence
281998|NCT01953237|mobile phones|mobile phones
281999|NCT01953224|Physical activity|physical activity
282000|NCT01953224|Video game|video game
282001|NCT01953224|Mobile|mobile
282002|NCT01953224|Technology|technology
282003|NCT01953224|Obesity|obesity
282004|NCT01953198|hypoxia hypobaric|hypoxia hypobaric
282005|NCT01953185|elderly|elderly
282006|NCT01953185|subjects|subjects
282007|NCT01953146|PCOS|pcos
282008|NCT01953107|Anemia|anemia
282009|NCT01953107|Ovarian cancer|ovarian cancer
282010|NCT01953107|Uterine cancer|uterine cancer
282011|NCT01953107|Cervical cancer|cervical cancer
282012|NCT01953107|Oral iron|oral iron
282013|NCT01953094|Cervical|cervical
282014|NCT01953081|Enteral feeding|enteral feeding
282015|NCT01953068|POCD|pocd
282016|NCT01953068|Executive Reaction Time Test|executive reaction time test
282017|NCT01953068|Aortic valve surgery|aortic valve surgery
282018|NCT01953068|Cognitive functions|cognitive functions
282019|NCT01953068|Transcatheter Aortic Valve Implantation|transcatheter aortic valve implantation
282020|NCT01953055|stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
282021|NCT01953055|androgen deprivation therapy|androgen deprivation therapy
282022|NCT01953042|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
282023|NCT01953042|Health Education|health education
282024|NCT01953016|ADA-SCID/SCID all forms|ada-scid/scid all forms
282025|NCT01953016|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
282026|NCT01953016|GATA2|gata2
282027|NCT01953016|Primary Immunodeficiencies|primary immunodeficiencies
282028|NCT01953016|CGD (Chronic Granulomatous Disease)|cgd (chronic granulomatous disease)
282029|NCT01952990|Pharmacokinetic|pharmacokinetic
282030|NCT01952964|exit site infection|exit site infection
282031|NCT01952964|skin allergy|skin allergy
282032|NCT01952964|physical damage|physical damage
282033|NCT01952951|rectal neoplasms|rectal neoplasms
282034|NCT01952951|radiotherapy|radiotherapy
282035|NCT01952951|Antineoplastic Agents|antineoplastic agents
282036|NCT01952938|knee revision surgery,|knee revision surgery,
282037|NCT01952938|rotating hinge prosthesis|rotating hinge prosthesis
282038|NCT01952899|Intensive Care Unit|intensive care unit
282039|NCT01952899|Delirium|delirium
282040|NCT01952899|Implementation|implementation
282041|NCT01952899|Guideline|guideline
282042|NCT01952886|malignant glioma|malignant glioma
282043|NCT01952886|antiemetic|antiemetic
282044|NCT01952886|ondansetron|ondansetron
282045|NCT01952886|granisetron|granisetron
282046|NCT01952886|Preston Robert Tisch Brain Tumor Center|preston robert tisch brain tumor center
282047|NCT01952886|Pro00041233|pro00041233
282048|NCT01952886|Duke|duke
282049|NCT01952873|stents|stents
282050|NCT01952873|angioplasty, balloon, coronary|angioplasty, balloon, coronary
282051|NCT01952873|coronary artery stenosis|coronary artery stenosis
282052|NCT01952873|optical coherence tomography|optical coherence tomography
282053|NCT01952860|Lung Cancer|lung cancer
282054|NCT01952860|Non-small cell lung cancer|non-small cell lung cancer
282055|NCT01952860|NSCLC|nsclc
282056|NCT01952860|Caregiving partner|caregiving partner
282057|NCT01952860|Hatha Yoga|hatha yoga
282058|NCT01952860|Radiation therapy|radiation therapy
282059|NCT01952860|XRT|xrt
282060|NCT01952860|Questionnaires|questionnaires
282061|NCT01952860|Surveys|surveys
282062|NCT01952847|Advanced Cancers|advanced cancers
282063|NCT01952847|Mucositis|mucositis
282064|NCT01952847|Esophagitis|esophagitis
282065|NCT01952847|mTOR Inhibitor-based Regimen|mtor inhibitor-based regimen
282066|NCT01952847|Radiation to the Esophagus|radiation to the esophagus
282067|NCT01952847|Thoracic malignancies|thoracic malignancies
282068|NCT01952847|Placebo|placebo
282069|NCT01952847|Glutamine|glutamine
282070|NCT01952847|Enterex|enterex
282071|NCT01952847|Glutapak-10|glutapak-10
282072|NCT01952847|NutreStore|nutrestore
282073|NCT01952847|Resource|resource
282074|NCT01952847|GlutaSolve|glutasolve
282075|NCT01952847|Sympt-X G.I.|sympt-x g.i.
282076|NCT01952847|Sympt-X|sympt-x
282078|NCT01952847|Surveys|surveys
282079|NCT01952834|coronary artery disease|coronary artery disease
282080|NCT01952834|probiotic|probiotic
282081|NCT01952834|endothelial function|endothelial function
282082|NCT01952834|brachial artery|brachial artery
282083|NCT01952834|ntric oxide|ntric oxide
282084|NCT01952821|Head and Neck Cancer|head and neck cancer
282085|NCT01952821|Physical function|physical function
282086|NCT01952821|Cancer Related Fatigue|cancer related fatigue
282087|NCT01952821|Gait Speed|gait speed
282088|NCT01952821|6MWT|6mwt
282089|NCT01952821|10-Meter Walk Test|10-meter walk test
282090|NCT01952821|30-Second Chair Stand|30-second chair stand
282091|NCT01952821|Linear Analog Scale of Function|linear analog scale of function
282092|NCT01952821|Modified Brief Fatigue Inventory|modified brief fatigue inventory
282093|NCT01952769|anti PD1,diffuse pontine glioma|anti pd1,diffuse pontine glioma
282094|NCT01952756|cilostazol|cilostazol
282095|NCT01952756|endothelial progenitor cells|endothelial progenitor cells
282096|NCT01952756|vasculogenesis|vasculogenesis
282097|NCT01952756|angiogenesis|angiogenesis
282098|NCT01952756|peripheral arterial disease|peripheral arterial disease
282099|NCT01952756|biomarkers|biomarkers
282100|NCT01952743|Atrial Fibrillation|atrial fibrillation
282101|NCT01952743|Hypertension|hypertension
282102|NCT01952743|Renal Denervation|renal denervation
282103|NCT01952730|Stage IV|stage iv
282104|NCT01952730|Hepatic Lesions|hepatic lesions
282105|NCT01952691|hallux valgus|hallux valgus
282106|NCT01952691|pain|pain
282107|NCT01952691|conservative|conservative
282108|NCT01952691|treatment|treatment
282109|NCT01952678|DaTscan|datscan
282110|NCT01952678|Parkinson's Disease|parkinson's disease
282111|NCT01952652|Naproxen-codeine|naproxen-codeine
282112|NCT01952652|preemptive analgesia|preemptive analgesia
282113|NCT01952652|day case surgery|day case surgery
282114|NCT01952626|intrathecal|intrathecal
282115|NCT01952626|morphine|morphine
282116|NCT01952626|ondansetron|ondansetron
282117|NCT01952626|palonosetron|palonosetron
282118|NCT01952626|pruritus|pruritus
282119|NCT01952613|Foot drop|foot drop
282120|NCT01952613|Functional Electrical Stimulation|functional electrical stimulation
282121|NCT01952600|Chronic Kidney Disease|chronic kidney disease
282122|NCT01952600|Hemodialysis|hemodialysis
282123|NCT01952600|Peritoneal Dialysis|peritoneal dialysis
282124|NCT01952574|migraine, headache, prevention, prophylaxis|migraine, headache, prevention, prophylaxis
282125|NCT01952561|pharmacokinetics|pharmacokinetics
282126|NCT01952561|vaginal ring|vaginal ring
282127|NCT01952522|Resistance training|resistance training
282128|NCT01952522|Walking|walking
282129|NCT01952522|Weight bearing|weight bearing
282130|NCT01952496|Cerebral Palsy|cerebral palsy
282131|NCT01952496|Non ambulatory|non ambulatory
282132|NCT01952496|Neuromuscular disability|neuromuscular disability
282133|NCT01952496|Children|children
282134|NCT01952483|Multiple Sclerosis (MS)|multiple sclerosis (ms)
282135|NCT01952470|Lung transplantation|lung transplantation
282136|NCT01952470|Respiratory Tract Infections|respiratory tract infections
282137|NCT01952470|Respiratory Therapy|respiratory therapy
282138|NCT01952470|Isotonic Solutions|isotonic solutions
282139|NCT01952470|Sodium Chloride|sodium chloride
282140|NCT01952470|Postoperative complications|postoperative complications
282141|NCT01952470|Postoperative care|postoperative care
282142|NCT01952470|dornase alpha|dornase alpha
282143|NCT01952431|Total Lung Capacity|total lung capacity
282144|NCT01952392|Effectiveness study|effectiveness study
282145|NCT01952392|Acute coronary Syndrome|acute coronary syndrome
282146|NCT01952392|Real-life|real-life
282147|NCT01952392|France|france
282148|NCT01952379|Melasma|melasma
282149|NCT01952379|Lymphocytes|lymphocytes
282150|NCT01952379|Macrophages|macrophages
282151|NCT01952379|Mast cells|mast cells
282152|NCT01952379|Interleukin 17|interleukin 17
282153|NCT01952379|COX-2|cox-2
282154|NCT01952379|Inflammation|inflammation
282155|NCT01952366|Aged|aged
282156|NCT01952366|Depression|depression
282157|NCT01952366|Cognition|cognition
282158|NCT01952366|Longitudinal study|longitudinal study
282159|NCT01952353|Hepatocellular Carcinoma; Transarterial Chemoembolization; Hepatic Resection; Portal Vein Tumor Thrombosis|hepatocellular carcinoma; transarterial chemoembolization; hepatic resection; portal vein tumor thrombosis
282160|NCT01952301|Autologous; Collagen Matrix; Keratinized Tissue|autologous; collagen matrix; keratinized tissue
282161|NCT01952262|ultrasound|ultrasound
282162|NCT01952262|diaphragm|diaphragm
282163|NCT01952262|intensive care|intensive care
282164|NCT01952262|critical care|critical care
282165|NCT01952249|Ovarian|ovarian
282166|NCT01952249|Primary Peritoneal|primary peritoneal
282167|NCT01952249|Fallopian Tube Cancer|fallopian tube cancer
282168|NCT01952236|Smoking|smoking
282169|NCT01952236|Quit|quit
282170|NCT01952236|Tobacco|tobacco
282171|NCT01952236|Abstinence|abstinence
282172|NCT01952236|Adult|adult
282173|NCT01952236|Text Messaging|text messaging
282174|NCT01952236|Web-based|web-based
282175|NCT01952236|Mobile phone|mobile phone
282176|NCT01952236|smartphone|smartphone
282177|NCT01952236|internet|internet
282178|NCT01952236|web|web
282179|NCT01952223|adenocarcinome|adenocarcinome
282180|NCT01952223|prostate|prostate
282181|NCT01952223|relapse|relapse
282182|NCT01952223|Radiotherapy|radiotherapy
282183|NCT01952223|Androgen Deprivation Therapy|androgen deprivation therapy
282184|NCT01952223|Cabazitaxel|cabazitaxel
282185|NCT01952197|Passive Leg Raise|passive leg raise
282186|NCT01952197|Cardiac arrest|cardiac arrest
282187|NCT01952197|Survival after CPR|survival after cpr
282188|NCT01952184|vitrification|vitrification
282189|NCT01952184|oocyte|oocyte
282190|NCT01952184|donor|donor
282191|NCT01952184|open|open
282192|NCT01952184|closed|closed
282193|NCT01952171|Genomics|genomics
282194|NCT01952171|Congenital Malformations|congenital malformations
282195|NCT01952171|Birth Defects|birth defects
282196|NCT01952171|Heart Disease|heart disease
282197|NCT01952158|Multidrug-Resistant Organisms|multidrug-resistant organisms
282198|NCT01952158|Hospital Infection|hospital infection
282199|NCT01952158|Colonization|colonization
282200|NCT01952158|Healthcare Personnel|healthcare personnel
282201|NCT01952132|Schizophrenia|schizophrenia
282202|NCT01952119|hypertension|hypertension
282203|NCT01952106|venepuncture|venepuncture
282204|NCT01952106|distraction|distraction
282205|NCT01952106|distress|distress
282206|NCT01952093|Early intervention|early intervention
282207|NCT01952093|Mother-child interaction|mother-child interaction
282208|NCT01952093|Neurodevelopment|neurodevelopment
282209|NCT01952093|Parenting|parenting
282210|NCT01952093|Prematurity|prematurity
282211|NCT01952093|School age|school age
282212|NCT01952080|Short Bowel Syndrome|short bowel syndrome
282213|NCT01952080|SBS|sbs
282214|NCT01952080|Pediatric SBS|pediatric sbs
282215|NCT01952067|Hip Prosthesis|hip prosthesis
282216|NCT01952067|surgery|surgery
282217|NCT01952067|cements|cements
282218|NCT01952067|Radiostereometric Analysis|radiostereometric analysis
282219|NCT01952054|Breast cancer|breast cancer
282220|NCT01952054|Breast carcinoma|breast carcinoma
282221|NCT01952054|Bone metastasis|bone metastasis
282222|NCT01952054|Cancer that has spread to the bone|cancer that has spread to the bone
282223|NCT01952054|Denosumab|denosumab
282224|NCT01952054|AMG 162|amg 162
282225|NCT01952054|Prolia|prolia
282226|NCT01952054|Hormonal agent|hormonal agent
282227|NCT01952041|Schizophrenia|schizophrenia
282228|NCT01952041|Schizoaffective Disorder|schizoaffective disorder
282229|NCT01952041|Mobile Application|mobile application
282230|NCT01952041|Relapse Signature|relapse signature
282231|NCT01952041|Relapse|relapse
282232|NCT01952041|SMI|smi
282233|NCT01952041|EHealth|ehealth
282234|NCT01952041|E-Health|e-health
282235|NCT01952041|Health Technology|health technology
282236|NCT01952041|mHealth|mhealth
282237|NCT01952041|m-Health|m-health
282238|NCT01952028|MDC1A|mdc1a
282239|NCT01952028|Congenital Muscular Dystrophy|congenital muscular dystrophy
282240|NCT01952028|Merosin Deficient|merosin deficient
282241|NCT01952028|LAMA2|lama2
282242|NCT01952028|brain white matter abnormalities|brain white matter abnormalities
282243|NCT01952028|Seizure|seizure
282244|NCT01952015|generalized pustular psoriasis|generalized pustular psoriasis
282245|NCT01952002|Blood Pressure|blood pressure
282246|NCT01952002|heart rate|heart rate
282247|NCT01952002|electrocardiogram|electrocardiogram
282248|NCT01952002|Cardiac arrhythmias|cardiac arrhythmias
282249|NCT01952002|respiratory exercise|respiratory exercise
282250|NCT01951989|Gaucher disease|gaucher disease
282251|NCT01951989|Imiglucerase|imiglucerase
282252|NCT01951989|Pharmacokinetics|pharmacokinetics
282253|NCT01951976|breast|breast
282254|NCT01951976|carcinoma|carcinoma
282255|NCT01951976|stage 0-III breast cancer|stage 0-iii breast cancer
282256|NCT01951976|post-menopausal|post-menopausal
282257|NCT01951976|aromatase inhibitor (AI)|aromatase inhibitor (ai)
282258|NCT01951976|joint pain|joint pain
282259|NCT01951976|AI-associated joint pain|ai-associated joint pain
282260|NCT01951963|pain management|pain management
282261|NCT01951963|ketamine|ketamine
282262|NCT01951963|morphine|morphine
282263|NCT01951963|pediatrics|pediatrics
282264|NCT01951963|emergency medicine|emergency medicine
282265|NCT01951937|Cognitive Test|cognitive test
282266|NCT01951937|Omega-3 Fatty acids|omega-3 fatty acids
282267|NCT01951924|Multifocal Motor Neuropathy|multifocal motor neuropathy
282268|NCT01951911|Pain Management|pain management
282269|NCT01951911|Ketamine|ketamine
282270|NCT01951911|Palliative care|palliative care
282271|NCT01951898|asthma|asthma
282272|NCT01951898|regulatory T cells|regulatory t cells
282273|NCT01951898|leukotriene antagonist|leukotriene antagonist
282274|NCT01951872|caffeine dependence|caffeine dependence
282275|NCT01951872|caffeine withdrawal|caffeine withdrawal
282276|NCT01951872|caffeine use disorder|caffeine use disorder
282277|NCT01951833|Lung clearance index (LCI)|lung clearance index (lci)
282278|NCT01951807|Psychosocial Effects of Cancer and Treatment|psychosocial effects of cancer and treatment
282279|NCT01951807|Coping|coping
282280|NCT01951794|HIV infected|hiv infected
282281|NCT01951794|HIV exposed|hiv exposed
282282|NCT01951794|HIV-free|hiv-free
282283|NCT01951781|marker CD64|marker cd64
282284|NCT01951781|blood sample|blood sample
282285|NCT01951781|nosocomial infection|nosocomial infection
282286|NCT01951781|preterm newborn|preterm newborn
282287|NCT01951755|Inoperable NSCLC|inoperable nsclc
282288|NCT01951755|TKIs|tkis
282289|NCT01951742|wrinkles|wrinkles
282290|NCT01951729|Blood sugar|blood sugar
282291|NCT01951729|GIP|gip
282292|NCT01951729|Xenin-25|xenin-25
282293|NCT01951729|Cholinergic Signaling|cholinergic signaling
282294|NCT01951729|Atropine|atropine
282295|NCT01951729|Insulin|insulin
282296|NCT01951729|Glucagon|glucagon
282297|NCT01951729|Pancreatic polypeptide|pancreatic polypeptide
282298|NCT01951716|Vagotomy|vagotomy
282299|NCT01951716|Vagus Nerve|vagus nerve
282300|NCT01951716|Xenin-25|xenin-25
282301|NCT01951716|GIP|gip
282302|NCT01951716|Insulin Secretion|insulin secretion
282303|NCT01951716|Glucagon Secretion|glucagon secretion
282304|NCT01951716|Gastric Emptying|gastric emptying
282305|NCT01951690|Focal Adhesion Kinase inhibitor|focal adhesion kinase inhibitor
282306|NCT01951690|FAK inhibitor|fak inhibitor
282307|NCT01951690|Cancer Stem Cells|cancer stem cells
282308|NCT01951690|CSC|csc
282309|NCT01951690|KRAS mutation|kras mutation
282310|NCT01951677|hepatitis B virus|hepatitis b virus
282311|NCT01951677|vaccine|vaccine
282312|NCT01951677|adjuvant|adjuvant
282313|NCT01951677|prophylaxis|prophylaxis
282314|NCT01951651|Diabetes|diabetes
282315|NCT01951638|Worsening Heart Failure|worsening heart failure
282316|NCT01951638|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
282317|NCT01951625|Worsening Heart Failure|worsening heart failure
282318|NCT01951625|Heart Failure with Reduced Ejection Fraction|heart failure with reduced ejection fraction
282319|NCT01951612|cognitive impairment|cognitive impairment
282320|NCT01951612|ischemic white matter disease|ischemic white matter disease
282321|NCT01951612|small vessel disease|small vessel disease
282322|NCT01951612|transient ischemic attack|transient ischemic attack
282323|NCT01951612|mild stroke|mild stroke
282324|NCT01951612|stroke risk|stroke risk
282325|NCT01951599|Phase I, healthy, bioavailability, pharmacokinetics, safety, tolerability.|phase i, healthy, bioavailability, pharmacokinetics, safety, tolerability.
282326|NCT01951573|contact lenses|contact lenses
282327|NCT01951573|multifocal|multifocal
282328|NCT01951573|daily disposable|daily disposable
282329|NCT01951573|silicone hydrogel|silicone hydrogel
282330|NCT01951573|presbyopia|presbyopia
282331|NCT01951547|HbA1c|hba1c
282332|NCT01951547|hs-CRP|hs-crp
282333|NCT01951547|non-surgical periodontal therapy|non-surgical periodontal therapy
282334|NCT01951547|oral health education|oral health education
282335|NCT01951547|probing pocket depth|probing pocket depth
282336|NCT01951547|plaque index|plaque index
282337|NCT01951547|gingival bleeding index.|gingival bleeding index.
282338|NCT01951534|breast reconstruction|breast reconstruction
282339|NCT01951521|Rectal cancer|rectal cancer
282340|NCT01951521|Locally advanced rectal cancer|locally advanced rectal cancer
282341|NCT01951521|Radiotherapy|radiotherapy
282342|NCT01951521|Boost|boost
282343|NCT01951521|Dose-escalation|dose-escalation
282344|NCT01951521|Pathological complete response|pathological complete response
282345|NCT01951521|Response|response
282346|NCT01951508|Methylphenidate|methylphenidate
282347|NCT01951508|Modafinil|modafinil
282348|NCT01951508|MDMA|mdma
282349|NCT01951508|fMRI|fmri
282350|NCT01951508|emotion-processing|emotion-processing
282351|NCT01951508|social cognition|social cognition
282352|NCT01951456|Smoking cessation|smoking cessation
282353|NCT01951456|resistance training|resistance training
282354|NCT01951443|ginseng|ginseng
282355|NCT01951443|clinical trial|clinical trial
282356|NCT01951443|vascular|vascular
282357|NCT01951443|ginsenosides|ginsenosides
282358|NCT01951443|blood pressure|blood pressure
282359|NCT01951430|Adult patients|adult patients
282360|NCT01951430|Infective events|infective events
282361|NCT01951430|Antibiotic|antibiotic
282362|NCT01951430|Antifungal|antifungal
282363|NCT01951430|Myelodysplastic syndrome|myelodysplastic syndrome
282364|NCT01951404|Left Ventricular Hypertrophy|left ventricular hypertrophy
282365|NCT01951404|Allopurinol|allopurinol
282366|NCT01951404|End Stage Renal Disease|end stage renal disease
282367|NCT01951404|Haemodialysis|haemodialysis
282368|NCT01951404|Renal Replacement Therapy|renal replacement therapy
282369|NCT01951404|MRI|mri
282370|NCT01951391|study|study
282371|NCT01951391|subjects|subjects
282372|NCT01951378|Asthma|asthma
282373|NCT01951378|Asthma exacerbation|asthma exacerbation
282374|NCT01951365|Schwannoma|schwannoma
282375|NCT01951365|Growth|growth
282376|NCT01951365|intradural|intradural
282377|NCT01951365|natural history|natural history
282378|NCT01951352|study|study
282379|NCT01951352|meant|meant
282380|NCT01951352|individuals|individuals
282381|NCT01951339|diabetes|diabetes
282382|NCT01951339|type 2 diabetes|type 2 diabetes
282383|NCT01951339|exercise|exercise
282384|NCT01951339|echo|echo
282385|NCT01951339|heart|heart
282386|NCT01951339|sitagliptin|sitagliptin
282387|NCT01951339|glimepiride|glimepiride
282388|NCT01951339|cardiovascular|cardiovascular
282389|NCT01951326|Crohn's Disease|crohn's disease
282390|NCT01951326|moderate to severe|moderate to severe
282391|NCT01951326|remission|remission
282392|NCT01951326|MAP|map
282393|NCT01951326|antibiotic|antibiotic
282394|NCT01951313|Meal tolerance test focusing on carotenoids absorption|meal tolerance test focusing on carotenoids absorption
282395|NCT01951261|Telemonitoring|telemonitoring
282396|NCT01951261|COPD|copd
282397|NCT01951261|Home care|home care
282398|NCT01951248|chronic kidney disease|chronic kidney disease
282399|NCT01951248|obstructive sleep apnea|obstructive sleep apnea
282400|NCT01951248|24-h blood pressure|24-h blood pressure
282401|NCT01951248|central blood pressure|central blood pressure
282402|NCT01951248|peripheral blood pressure|peripheral blood pressure
282403|NCT01951222|Asthma, COPD, broncodilator, airway, lung, inhalation, antimuscarinic|asthma, copd, broncodilator, airway, lung, inhalation, antimuscarinic
282404|NCT01951209|Human|human
282405|NCT01951209|Hepatitis C|hepatitis c
282406|NCT01951209|Cirrhosis|cirrhosis
282407|NCT01951209|B-cell|b-cell
282408|NCT01951209|Rifaximin|rifaximin
282409|NCT01951196|Chronic kidney disease|chronic kidney disease
282410|NCT01951196|24 hour blood pressure|24 hour blood pressure
282411|NCT01951196|central blood pressure|central blood pressure
282412|NCT01951196|peripheral blood pressure|peripheral blood pressure
282413|NCT01951196|obstructive sleep apnea|obstructive sleep apnea
282414|NCT01951144|Phase 1|phase 1
282415|NCT01951144|Single Dose|single dose
282416|NCT01951144|Pharmacokinetics|pharmacokinetics
282417|NCT01951144|Safety|safety
282418|NCT01951144|Toleration|toleration
282419|NCT01951144|Pharmacodynamics|pharmacodynamics
282420|NCT01951118|Smell|smell
282421|NCT01951118|Olfaction Disorders|olfaction disorders
282422|NCT01951118|Atropine|atropine
282423|NCT01951118|Donepezil|donepezil
282424|NCT01951118|Cholinesterase Inhibitors|cholinesterase inhibitors
282425|NCT01951118|Cognition Disorders|cognition disorders
282426|NCT01951105|Subacute|subacute
282427|NCT01951105|Back|back
282428|NCT01951105|Pain|pain
282429|NCT01951105|Brain|brain
282430|NCT01951105|MRI|mri
282431|NCT01951092|HIV|hiv
282432|NCT01951092|adherence|adherence
282433|NCT01951092|retention|retention
282434|NCT01951092|texting|texting
282435|NCT01951079|Digoxin|digoxin
282436|NCT01951079|Intra-amniotic injection|intra-amniotic injection
282437|NCT01951079|feticide|feticide
282438|NCT01951079|second trimester abortion|second trimester abortion
282439|NCT01951053|Healthy|healthy
282440|NCT01951053|Safety|safety
282441|NCT01951053|Tolerability|tolerability
282442|NCT01951053|Pharmacokinetics|pharmacokinetics
282443|NCT01951053|Pharmacodynamics|pharmacodynamics
282444|NCT01951053|JNJ-40411813|jnj-40411813
282445|NCT01951053|Positive allosteric modulator|positive allosteric modulator
282446|NCT01951040|Oxytocin, breastfeeding|oxytocin, breastfeeding
282447|NCT01951027|Safety|safety
282448|NCT01951027|Pharmacokinetics|pharmacokinetics
282449|NCT01951027|Pharmacodynamics|pharmacodynamics
282450|NCT01951027|DLT|dlt
282451|NCT01951027|Immunogenecity|immunogenecity
282452|NCT01951014|Adolescence|adolescence
282453|NCT01951014|Pregnancy|pregnancy
282454|NCT01951014|Telemedicine|telemedicine
282455|NCT01951001|Acute Coronary Syndrome, Asians, platelet, prasugrel|acute coronary syndrome, asians, platelet, prasugrel
282456|NCT01950936|Infection|infection
282457|NCT01950936|Antibiotics|antibiotics
282458|NCT01950936|COLD|cold
282459|NCT01950910|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
282460|NCT01950910|motor neuron disease|motor neuron disease
282461|NCT01950910|biological markers|biological markers
282462|NCT01950910|biomarkers|biomarkers
282463|NCT01950897|muscular dystrophies|muscular dystrophies
282464|NCT01950897|muscular dystrophy|muscular dystrophy
282465|NCT01950884|•Non-alcoholic Steatohepatitis (NASH)|•non-alcoholic steatohepatitis (nash)
282466|NCT01950871|HistoScanning|histoscanning
282467|NCT01950871|TRUS|trus
282468|NCT01950871|Prostate cancer|prostate cancer
282469|NCT01950871|Biopsy guidance|biopsy guidance
282470|NCT01950845|anesthesiology, Closed-Loop system, automated fluid management, cardiac output optimization, high risk surgical patient, major abdominal surgery|anesthesiology, closed-loop system, automated fluid management, cardiac output optimization, high risk surgical patient, major abdominal surgery
282471|NCT01950832|Structure of Retina|structure of retina
282472|NCT01950832|Macular Thickness|macular thickness
282473|NCT01950832|Retinal Nerve Fiber Layer|retinal nerve fiber layer
282474|NCT01950832|Choroidal Thickness|choroidal thickness
282475|NCT01950832|PCOS|pcos
282476|NCT01950832|Optical Coherence Tomography|optical coherence tomography
282477|NCT01950819|kidney failure|kidney failure
282478|NCT01950819|dialysis|dialysis
282479|NCT01950819|renal failure|renal failure
282480|NCT01950819|transplantation|transplantation
282481|NCT01950793|Hyaluronic acid, trigger finger|hyaluronic acid, trigger finger
282482|NCT01950780|Alopecia Areata|alopecia areata
282483|NCT01950780|Ruxolitinib|ruxolitinib
282484|NCT01950728|volunteers|volunteers
282485|NCT01950728|18 to 65 years|18 to 65 years
282486|NCT01950728|Males and Females|males and females
282487|NCT01950715|Irritable Bowel Syndrome|irritable bowel syndrome
282488|NCT01950715|Sacral Nerve Stimulation|sacral nerve stimulation
282489|NCT01950715|Gastro-colic response|gastro-colic response
282490|NCT01950715|Multimodal Stimulation|multimodal stimulation
282491|NCT01950663|Diagnostic Equipment|diagnostic equipment
282492|NCT01950663|Validation Studies|validation studies
282493|NCT01950624|Patient Registry|patient registry
282494|NCT01950624|Down Syndrome|down syndrome
282495|NCT01950611|acute promyelocytic leukemia|acute promyelocytic leukemia
282496|NCT01950611|arsenic trioxide|arsenic trioxide
282497|NCT01950611|proteasome inhibition|proteasome inhibition
282498|NCT01950611|bortezomib|bortezomib
282499|NCT01950598|Boston Keratoprosthesis type I surgery, frozen corneal graft|boston keratoprosthesis type i surgery, frozen corneal graft
282500|NCT01950585|Hydroxyurea|hydroxyurea
282501|NCT01950585|Pulmonary Hypertension|pulmonary hypertension
282502|NCT01950585|Idiopathic Pulmonary Arterial Hypertension|idiopathic pulmonary arterial hypertension
282503|NCT01950585|Familial Pulmonary Arterial Hypertension|familial pulmonary arterial hypertension
282504|NCT01950585|CD34 + Cells|cd34 + cells
282505|NCT01950572|Samples|samples
282506|NCT01950572|Biobank|biobank
282507|NCT01950572|Lung Neoplasms|lung neoplasms
282508|NCT01950572|Ovarian Neoplasms|ovarian neoplasms
282509|NCT01950559|soy allergy|soy allergy
282510|NCT01950559|food allergy|food allergy
282511|NCT01950559|pediatric|pediatric
282512|NCT01950559|adult|adult
282513|NCT01950546|silver nanoparticles|silver nanoparticles
282514|NCT01950546|antimicrobial activity|antimicrobial activity
282515|NCT01950546|toxicity|toxicity
282516|NCT01950546|biofilm|biofilm
282517|NCT01950546|cariostatic agents|cariostatic agents
282518|NCT01950533|Peanut allergy|peanut allergy
282519|NCT01950533|Milk allergy|milk allergy
282520|NCT01950533|Egg allergy|egg allergy
282521|NCT01950533|Pediatric|pediatric
282522|NCT01950533|Adult|adult
282523|NCT01950533|Food allergy|food allergy
282524|NCT01950520|Adipose Tissue|adipose tissue
282525|NCT01950520|Adult|adult
282526|NCT01950520|Body Composition|body composition
282527|NCT01950520|Brown Adipose Tissue|brown adipose tissue
282528|NCT01950520|Non-Shivering Thermogenesis|non-shivering thermogenesis
282529|NCT01950507|Fluconazole|fluconazole
282530|NCT01950507|Graft Versus Host Disease|graft versus host disease
282531|NCT01950507|Voriconazole|voriconazole
282532|NCT01950507|Azoles|azoles
282533|NCT01950494|hand dermatitis|hand dermatitis
282534|NCT01950494|health care workers|health care workers
282535|NCT01950494|hand sanitizer|hand sanitizer
282536|NCT01950481|LDK378|ldk378
282537|NCT01950481|pharmacokinetics|pharmacokinetics
282538|NCT01950481|hepatic impairment|hepatic impairment
282539|NCT01950468|Parkinson's Disease|parkinson's disease
282540|NCT01950455|Parkinson's Disease|parkinson's disease
282541|NCT01950442|malignant strictures|malignant strictures
282542|NCT01950442|esophageal staging|esophageal staging
282543|NCT01950429|Microbiome|microbiome
282544|NCT01950429|Sickle Cell Disease|sickle cell disease
282545|NCT01950429|Bone Marrow Transplant|bone marrow transplant
282546|NCT01950416|ST elevation myocardial infarction|st elevation myocardial infarction
282547|NCT01950416|Fibrinolysis|fibrinolysis
282548|NCT01950416|Ticagrelor|ticagrelor
282549|NCT01950416|Clopidogrel|clopidogrel
282550|NCT01950416|Platelet reactivity|platelet reactivity
282551|NCT01950377|Dopamine Transporter|dopamine transporter
282552|NCT01950377|D2 Dopamine Receptor Subtype|d2 dopamine receptor subtype
282553|NCT01950377|Dopamine|dopamine
282554|NCT01950377|Dopamine Genes|dopamine genes
282555|NCT01950377|Dopaminergic Mechanisms|dopaminergic mechanisms
282556|NCT01950364|Lymphoma|lymphoma
282557|NCT01950364|Hodgkin|hodgkin
282558|NCT01950364|Anaplastic Large-cell|anaplastic large-cell
282559|NCT01950364|Relapsed|relapsed
282560|NCT01950364|Refractory|refractory
282561|NCT01950364|Antigens, CD30|antigens, cd30
282562|NCT01950364|Antibody-Drug Conjugate|antibody-drug conjugate
282563|NCT01950364|Antibodies, Monoclonal|antibodies, monoclonal
282564|NCT01950364|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
282565|NCT01950364|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
282566|NCT01950364|Monomethyl auristatin E|monomethyl auristatin e
282567|NCT01950364|Drug Therapy|drug therapy
282568|NCT01950364|Immunotherapy|immunotherapy
282569|NCT01950364|Hematologic Diseases|hematologic diseases
282570|NCT01950351|Prostate Cancer|prostate cancer
282571|NCT01950351|Localized prostate cancer|localized prostate cancer
282572|NCT01950351|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
282573|NCT01950351|Proton therapy|proton therapy
282574|NCT01950351|Radiation therapy|radiation therapy
282575|NCT01950351|XRT|xrt
282576|NCT01950351|Gray|gray
282577|NCT01950351|Gy|gy
282578|NCT01950351|Questionnaire|questionnaire
282579|NCT01950351|Survey|survey
282580|NCT01950325|HIV-1 Viral Load|hiv-1 viral load
282581|NCT01950325|CD4 Count|cd4 count
282582|NCT01950325|Antiviral|antiviral
282583|NCT01950325|HIV-1 Infection|hiv-1 infection
282584|NCT01950325|Broadly Neutralizing Antibody|broadly neutralizing antibody
282585|NCT01950312|Autoimmune Inner Ear Disease|autoimmune inner ear disease
282586|NCT01950312|Inner Ear Disease|inner ear disease
282587|NCT01950312|Meniere's Disease|meniere's disease
282588|NCT01950312|Sudden Sensorineural Hearing Loss|sudden sensorineural hearing loss
282589|NCT01950286|T-cell Acute Lymphoblastic Leukemia|t-cell acute lymphoblastic leukemia
282590|NCT01950286|chemotherapy|chemotherapy
282591|NCT01950286|allogeneic stem cell transplantation|allogeneic stem cell transplantation
282592|NCT01950260|Graves' disease|graves' disease
282593|NCT01950260|Radioactive iodine|radioactive iodine
282594|NCT01950260|Hypothyroidism|hypothyroidism
282595|NCT01950221|Double-blind Trial|double-blind trial
282596|NCT01950221|Placebo-controlled|placebo-controlled
282597|NCT01950221|Pomegranate|pomegranate
282598|NCT01950221|Memory|memory
282599|NCT01950221|Memory Impairment|memory impairment
282600|NCT01950221|Cognition|cognition
282601|NCT01950221|Ages 50-75|ages 50-75
282602|NCT01950208|Assessment|assessment
282603|NCT01950195|Melanoma|melanoma
282604|NCT01950195|Metastases|metastases
282605|NCT01950195|Brain|brain
282606|NCT01950195|Spine|spine
282607|NCT01950195|SRS(Stereotactic Radiosurgery))|srs(stereotactic radiosurgery))
282608|NCT01950195|Ipilimumab|ipilimumab
282609|NCT01950182|Luminal B2 subtype|luminal b2 subtype
282610|NCT01950182|First line treatment|first line treatment
282611|NCT01950169|Hip fracture|hip fracture
282612|NCT01950169|Nutritional supplement|nutritional supplement
282613|NCT01950169|Bisphosphonates|bisphosphonates
282614|NCT01950169|Bone mineral density|bone mineral density
282615|NCT01950169|Body composition|body composition
282616|NCT01950143|prostate cancer prevention|prostate cancer prevention
282617|NCT01950143|diet|diet
282618|NCT01950143|global gene expression|global gene expression
282619|NCT01950143|metabolic changes|metabolic changes
282620|NCT01950130|IABP|iabp
282621|NCT01950130|IABC|iabc
282622|NCT01950130|coronary artery disease|coronary artery disease
282623|NCT01950130|prophylactic|prophylactic
282624|NCT01950130|cardiac assist|cardiac assist
282625|NCT01950117|nonpedunculated|nonpedunculated
282626|NCT01950117|neoplastic|neoplastic
282627|NCT01950117|colorectal|colorectal
282628|NCT01950117|polyps|polyps
282629|NCT01950104|Embryo biopsy|embryo biopsy
282630|NCT01950104|Blastocyst stage|blastocyst stage
282631|NCT01950104|Day 3|day 3
282632|NCT01950104|Preimplantation genetic screening|preimplantation genetic screening
282633|NCT01950091|low back pain|low back pain
282634|NCT01950091|internet|internet
282635|NCT01950091|app|app
282636|NCT01950091|prevention|prevention
282637|NCT01950091|treatment|treatment
282638|NCT01950078|gene polymorphism|gene polymorphism
282639|NCT01950078|pain perception|pain perception
282640|NCT01950078|postoperative pain|postoperative pain
282641|NCT01950052|VLCD|vlcd
282642|NCT01950052|Low calorie diet|low calorie diet
282643|NCT01950052|very low calorie diet|very low calorie diet
282644|NCT01950052|pre-operative diet|pre-operative diet
282645|NCT01950052|liver shrinking diet|liver shrinking diet
282646|NCT01950052|bariatric surgery|bariatric surgery
282647|NCT01950052|gastric bypass|gastric bypass
282648|NCT01950039|Obesity|obesity
282649|NCT01950039|Glucose Intolerance|glucose intolerance
282650|NCT01950026|skin temperature|skin temperature
282651|NCT01950026|ethnic groups|ethnic groups
282652|NCT01950026|cryotherapy|cryotherapy
282653|NCT01950013|Presbycusis|presbycusis
282654|NCT01950013|Aging|aging
282655|NCT01950013|hearing aids|hearing aids
282656|NCT01950013|hearing training|hearing training
282657|NCT01950000|Pain. Analgesia. Prevention|pain. analgesia. prevention
282658|NCT01949974|Palliative Chemotherapy|palliative chemotherapy
282659|NCT01949974|Integral Attention Program|integral attention program
282660|NCT01949974|Advanced cancer|advanced cancer
282661|NCT01949974|Randomized Clinical Trial|randomized clinical trial
282662|NCT01949961|intervention|intervention
282663|NCT01949961|sonothrombolysis|sonothrombolysis
282664|NCT01949961|Ultrasound treatment|ultrasound treatment
282665|NCT01949948|treatment, intervention, thrombolysis|treatment, intervention, thrombolysis
282666|NCT01949935|Mupirocin|mupirocin
282667|NCT01949935|Surgical Site Infections|surgical site infections
282668|NCT01949935|Coronary Artery Bypass Grafting|coronary artery bypass grafting
282669|NCT01949922|regenerative medicine|regenerative medicine
282670|NCT01949922|fecal incontinence|fecal incontinence
282671|NCT01949922|muscle fiber injection|muscle fiber injection
282672|NCT01949909|plasmodium falciparum|plasmodium falciparum
282673|NCT01949909|long synthetic peptide|long synthetic peptide
282674|NCT01949909|antibody|antibody
282675|NCT01949909|T cell|t cell
282676|NCT01949909|cytokine|cytokine
282677|NCT01949909|vaccine|vaccine
282678|NCT01949909|safety|safety
282679|NCT01949909|phase 1|phase 1
282680|NCT01949896|Pro inflammatory cytokine|pro inflammatory cytokine
282681|NCT01949896|Necrotizing enterocolitis|necrotizing enterocolitis
282682|NCT01949896|Packed red blood cell transfusion|packed red blood cell transfusion
282683|NCT01949883|Phase 1|phase 1
282684|NCT01949883|Oncology|oncology
282685|NCT01949883|BET Inhibitor|bet inhibitor
282686|NCT01949857|Hepatitis A|hepatitis a
282687|NCT01949857|Vaccine|vaccine
282688|NCT01949857|Safety|safety
282689|NCT01949857|efficacy|efficacy
282690|NCT01949844|MRI|mri
282691|NCT01949844|Magnetic Resonance Imaging|magnetic resonance imaging
282692|NCT01949844|myocardial perfusion|myocardial perfusion
282693|NCT01949844|myocardial perfusion imaging|myocardial perfusion imaging
282694|NCT01949844|Novel MRI Techniques|novel mri techniques
282695|NCT01949831|functional assessment|functional assessment
282696|NCT01949831|acute care|acute care
282697|NCT01949831|older medical patients|older medical patients
282698|NCT01949753|Obsessive-compulsive disorder (OCD)|obsessive-compulsive disorder (ocd)
282699|NCT01949753|Exposure therapy|exposure therapy
282700|NCT01949753|Extinction learning|extinction learning
282701|NCT01949753|Pregnenolone|pregnenolone
282702|NCT01949727|AECOPD|aecopd
282703|NCT01949727|COPD|copd
282704|NCT01949727|Emphysema|emphysema
282705|NCT01949727|Chronic bronchitis|chronic bronchitis
282706|NCT01949675|Cholera|cholera
282707|NCT01949675|Shanchol™|shanchol™
282708|NCT01949675|Cholera Vaccine|cholera vaccine
282709|NCT01949662|Advanced Cancers|advanced cancers
282710|NCT01949662|Locally advanced cancer|locally advanced cancer
282711|NCT01949662|Metastatic cancer|metastatic cancer
282712|NCT01949662|Recurrent cancer|recurrent cancer
282713|NCT01949662|Incurable cancer|incurable cancer
282714|NCT01949662|Delirium|delirium
282715|NCT01949662|Agitation|agitation
282716|NCT01949662|Lorazepam|lorazepam
282717|NCT01949662|Haloperidol|haloperidol
282718|NCT01949662|Placebo|placebo
282719|NCT01949662|Questionnaires|questionnaires
282720|NCT01949662|Surveys|surveys
282721|NCT01949662|Acute palliative care unit|acute palliative care unit
282722|NCT01949649|body image|body image
282723|NCT01949649|body dissatisfaction|body dissatisfaction
282724|NCT01949623|RP|rp
282725|NCT01949610|Healthy Participants|healthy participants
282726|NCT01949610|JNJ26489112|jnj26489112
282727|NCT01949610|14C-JNJ26489112|14c-jnj26489112
282728|NCT01949610|Absorption|absorption
282729|NCT01949610|Metabolism|metabolism
282730|NCT01949610|Excretion|excretion
282731|NCT01949571|Mirtazapine.|mirtazapine.
282732|NCT01949571|Addiction.|addiction.
282733|NCT01949571|Cocaine.|cocaine.
282734|NCT01949571|Cocaine-craving.|cocaine-craving.
282735|NCT01949571|Cocaine-withdrawal|cocaine-withdrawal
282736|NCT01949558|diet|diet
282737|NCT01949558|lifestyle|lifestyle
282738|NCT01949519|prostate cancer|prostate cancer
282739|NCT01949519|lycopene|lycopene
282740|NCT01949519|docetaxel|docetaxel
282741|NCT01949519|metastatic|metastatic
282742|NCT01949519|castration resistant|castration resistant
282743|NCT01949506|Lung metastases|lung metastases
282744|NCT01949506|Radiation Therapy|radiation therapy
282745|NCT01949506|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
282746|NCT01949493|carpal tunnel syndrome|carpal tunnel syndrome
282747|NCT01949493|traction|traction
282748|NCT01949493|mechanical traction|mechanical traction
282749|NCT01949493|Phystrac|phystrac
282750|NCT01949480|Peripheral nerve block|peripheral nerve block
282751|NCT01949480|Ultrasound guidance|ultrasound guidance
282752|NCT01949480|Postoperative pain management post status thoracotomy|postoperative pain management post status thoracotomy
282753|NCT01949480|Postoperative pain management post status VATS|postoperative pain management post status vats
282754|NCT01949467|ferroportin disease|ferroportin disease
282755|NCT01949467|dysmetabolic hepatosiderosis|dysmetabolic hepatosiderosis
282756|NCT01949467|genetic hemochromatosis|genetic hemochromatosis
282757|NCT01949467|hyperferritinemia|hyperferritinemia
282758|NCT01949467|hepcidin|hepcidin
282759|NCT01949467|iron fumarate|iron fumarate
282760|NCT01949467|physiopathological study|physiopathological study
282761|NCT01949467|diagnosis|diagnosis
282762|NCT01949467|HFE gene|hfe gene
282763|NCT01949467|TRF2 gene|trf2 gene
282764|NCT01949467|iron parameters|iron parameters
282765|NCT01949467|divalent cations|divalent cations
282766|NCT01949454|trachoma|trachoma
282767|NCT01949454|trichiasis|trichiasis
282768|NCT01949454|trachomatous trichiasis|trachomatous trichiasis
282769|NCT01949454|bilamellar tarsal rotation|bilamellar tarsal rotation
282770|NCT01949454|fluorometholone|fluorometholone
282771|NCT01949454|placebo controlled|placebo controlled
282772|NCT01949441|HDM Allergy|hdm allergy
282773|NCT01949441|Rhinoconjunctivitis|rhinoconjunctivitis
282774|NCT01949441|Immunotherapy|immunotherapy
282775|NCT01949441|ToleroMune HDM|toleromune hdm
282776|NCT01949428|HDM Allergy|hdm allergy
282777|NCT01949428|Rhinoconjunctivitis|rhinoconjunctivitis
282778|NCT01949415|House Dust Mite|house dust mite
282779|NCT01949415|Rhinoconjunctivitis|rhinoconjunctivitis
282780|NCT01949415|ToleroMune|toleromune
282781|NCT01949376|breast cancer|breast cancer
282782|NCT01949376|invasive ductal carcinoma|invasive ductal carcinoma
282783|NCT01949376|cognitive impairment|cognitive impairment
282784|NCT01949376|adjuvant therapy|adjuvant therapy
282785|NCT01949376|hormone therapy|hormone therapy
282786|NCT01949376|hormonal therapy|hormonal therapy
282787|NCT01949376|chemotherapy|chemotherapy
282788|NCT01949376|chemo brain|chemo brain
282789|NCT01949376|MRI|mri
282790|NCT01949363|Gonococcal Infections, Cefixime, Neisseria gonorrhoeae, Azithromycin, antibiotic, cephalosporin|gonococcal infections, cefixime, neisseria gonorrhoeae, azithromycin, antibiotic, cephalosporin
282791|NCT01949324|MacTel|mactel
282792|NCT01949298|immediate loading of dental implant|immediate loading of dental implant
282793|NCT01949298|implant supported over denture|implant supported over denture
282794|NCT01949285|Spinal cord injury|spinal cord injury
282795|NCT01949285|Paralysis|paralysis
282796|NCT01949285|Rehabilitation|rehabilitation
282797|NCT01949285|Assessment|assessment
282798|NCT01949285|Theranostics|theranostics
282799|NCT01949272|ARDS|ards
282800|NCT01949259|Retrospective|retrospective
282801|NCT01949259|Lung cancer|lung cancer
282802|NCT01949246|Biomarkers|biomarkers
282803|NCT01949220|Inherited|inherited
282804|NCT01949220|Von Willebrand disease|von willebrand disease
282805|NCT01949220|Von Willebrand factor|von willebrand factor
282806|NCT01949220|Deficiency|deficiency
282807|NCT01949220|safety|safety
282808|NCT01949207|Incompetent perforating veins|incompetent perforating veins
282809|NCT01949207|EVLA|evla
282810|NCT01949207|Phlebectomies|phlebectomies
282811|NCT01949207|TRansluminal Occlusion of Perforators (TRLOP) closure of incompetent perforators.|transluminal occlusion of perforators (trlop) closure of incompetent perforators.
282812|NCT01949194|liver metastases|liver metastases
282813|NCT01949181|Metals|metals
282814|NCT01949181|Metalloids|metalloids
282815|NCT01949181|Blood|blood
282816|NCT01949181|Hair|hair
282817|NCT01949181|Lung|lung
282818|NCT01949181|Lung cancer|lung cancer
282819|NCT01949181|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
282820|NCT01949155|otitis media|otitis media
282821|NCT01949155|otorrhea|otorrhea
282822|NCT01949155|middle ear effusion|middle ear effusion
282823|NCT01949155|tympanostomy tubes|tympanostomy tubes
282824|NCT01949142|otitis media|otitis media
282825|NCT01949142|otorrhea|otorrhea
282826|NCT01949142|middle ear effusion|middle ear effusion
282827|NCT01949142|tympanostomy tubes|tympanostomy tubes
282828|NCT01949129|stem cell transplantation|stem cell transplantation
282829|NCT01949129|children and adolescents|children and adolescents
282830|NCT01949129|high risk acute lymphoblastic leukaemia|high risk acute lymphoblastic leukaemia
282831|NCT01949103|Gram-positive|gram-positive
282832|NCT01949090|H7N1|h7n1
282833|NCT01949090|AS03 adjuvant|as03 adjuvant
282834|NCT01949090|Safety|safety
282835|NCT01949090|Immunogenicity|immunogenicity
282836|NCT01949090|Influenza|influenza
282837|NCT01949090|Adults|adults
282838|NCT01949090|Elderly adults|elderly adults
282839|NCT01949077|Hepatitis|hepatitis
282840|NCT01949077|Hepatitis C|hepatitis c
282841|NCT01949077|Observational study|observational study
282842|NCT01949077|Biomarkers of treatment response|biomarkers of treatment response
282843|NCT01949051|Allergic rhinitis|allergic rhinitis
282844|NCT01949051|levocabastine|levocabastine
282845|NCT01949051|allergen challenge|allergen challenge
282846|NCT01949038|Pain|pain
282847|NCT01949038|Discomfort|discomfort
282848|NCT01949038|Anxiety|anxiety
282849|NCT01949038|Satisfaction|satisfaction
282850|NCT01949038|Compliance|compliance
282851|NCT01949012|Midazolam|midazolam
282852|NCT01949012|Endtidal carbon dioxide|endtidal carbon dioxide
282853|NCT01949012|Desaturation|desaturation
282854|NCT01948999|electroconvulsive therapy|electroconvulsive therapy
282855|NCT01948999|treatment-refractory schizophrenia|treatment-refractory schizophrenia
282856|NCT01948973|Irritable Bowel Syndrome|irritable bowel syndrome
282857|NCT01948973|Sacral Nerve Stimulation|sacral nerve stimulation
282858|NCT01948973|Symptoms|symptoms
282859|NCT01948973|Quality of Life|quality of life
282860|NCT01948973|Bowel habits|bowel habits
282861|NCT01948960|Breast Neoplasms|breast neoplasms
282862|NCT01948960|everolimus|everolimus
282863|NCT01948960|pharmacokinetics|pharmacokinetics
282864|NCT01948960|elderly patients|elderly patients
282865|NCT01948960|obese patients|obese patients
282866|NCT01948934|Skin|skin
282867|NCT01948934|Injury|injury
282868|NCT01948934|Membrane amniotic|membrane amniotic
282869|NCT01948934|Wound|wound
282870|NCT01948921|EGD|egd
282871|NCT01948921|tolerance|tolerance
282872|NCT01948921|discomfort|discomfort
282873|NCT01948908|Sedation|sedation
282874|NCT01948908|Laceration repair|laceration repair
282875|NCT01948908|Children|children
282876|NCT01948908|Intranasal|intranasal
282877|NCT01948908|Midazolam|midazolam
282878|NCT01948895|Desvenlafaxine|desvenlafaxine
282879|NCT01948895|Open-label|open-label
282880|NCT01948895|Flexible-dose|flexible-dose
282881|NCT01948895|Dysthymic disorder|dysthymic disorder
282882|NCT01948895|Anxiety disorders|anxiety disorders
282883|NCT01948895|Generalized anxiety disorder|generalized anxiety disorder
282884|NCT01948895|Social anxiety disorder|social anxiety disorder
282885|NCT01948895|Post-traumatic stress disorder|post-traumatic stress disorder
282886|NCT01948882|Birth control|birth control
282887|NCT01948869|Phoenix|phoenix
282888|NCT01948869|Mild atopic dermatitis|mild atopic dermatitis
282889|NCT01948869|efficacy|efficacy
282890|NCT01948869|safety|safety
282891|NCT01948856|Recurrent common cold|recurrent common cold
282892|NCT01948856|laryngitis|laryngitis
282893|NCT01948856|pharyngitis/tonsillitis|pharyngitis/tonsillitis
282894|NCT01948856|acute rhinitis|acute rhinitis
282895|NCT01948856|acute rhinosinusitis|acute rhinosinusitis
282896|NCT01948856|acute otitis media|acute otitis media
282897|NCT01948843|HER2 Negative Metastatic Breast Cancer|her2 negative metastatic breast cancer
282898|NCT01948830|Ranibizumab, Lucentis, choroidal neovascularization, age-related macular degeneration, treat and extend regimen|ranibizumab, lucentis, choroidal neovascularization, age-related macular degeneration, treat and extend regimen
282899|NCT01948817|Thalassemia|thalassemia
282900|NCT01948791|Alzheimer's disease|alzheimer's disease
282901|NCT01948791|ENA713|ena713
282902|NCT01948791|Chinese patients|chinese patients
282903|NCT01948791|INSTINCT|instinct
282904|NCT01948765|xenon anesthesia|xenon anesthesia
282905|NCT01948765|Off-pump coronary artery bypass graft surgery|off-pump coronary artery bypass graft surgery
282906|NCT01948752|Nutrition policy|nutrition policy
282907|NCT01948752|food labelling|food labelling
282908|NCT01948752|diet|diet
282909|NCT01948752|obesity|obesity
282910|NCT01948752|health behavior|health behavior
282911|NCT01948739|Brain machine interface|brain machine interface
282912|NCT01948739|Rehabilitation robotics|rehabilitation robotics
282913|NCT01948739|Stroke|stroke
282914|NCT01948739|Hemiparesis|hemiparesis
282915|NCT01948726|Breast cancer|breast cancer
282916|NCT01948726|Hypofractionation|hypofractionation
282917|NCT01948726|Simultaneous integrated boost|simultaneous integrated boost
282918|NCT01948726|Toxicity|toxicity
282919|NCT01948700|Motivational Interviewing|motivational interviewing
282920|NCT01948700|Problem Drinking|problem drinking
282921|NCT01948700|Adolescents|adolescents
282922|NCT01948700|Minority Health|minority health
282923|NCT01948687|real time elastography|real time elastography
282924|NCT01948687|hepatitis|hepatitis
282925|NCT01948648|plant sterols|plant sterols
282926|NCT01948648|cholesterol|cholesterol
282927|NCT01948648|colesevelam|colesevelam
282928|NCT01948648|phytosterolemia|phytosterolemia
282929|NCT01948648|fish oil|fish oil
282930|NCT01948635|tracheal cuff shape|tracheal cuff shape
282931|NCT01948635|microaspiration|microaspiration
282932|NCT01948635|pepsin|pepsin
282933|NCT01948635|ventilator-associated pneumonia|ventilator-associated pneumonia
282934|NCT01948622|Anxiety|anxiety
282935|NCT01948622|Third molar surgery|third molar surgery
282936|NCT01948622|Blood pressure|blood pressure
282937|NCT01948622|Heart rate|heart rate
282938|NCT01948622|Oxygen saturation|oxygen saturation
282939|NCT01948596|pregnant women|pregnant women
282940|NCT01948596|depression|depression
282941|NCT01948596|depressive symptoms|depressive symptoms
282942|NCT01948596|omega-3 fatty acids|omega-3 fatty acids
282943|NCT01948583|vaginal dryness|vaginal dryness
282944|NCT01948583|hyaluronic acid|hyaluronic acid
282945|NCT01948583|menopause|menopause
282946|NCT01948570|acne,comedones, oily skin|acne,comedones, oily skin
282947|NCT01948557|Breastfeeding|breastfeeding
282948|NCT01948557|Infants|infants
282949|NCT01948557|Mother to child transmission of HIV|mother to child transmission of hiv
282950|NCT01948557|Survival|survival
282951|NCT01948544|COPD|copd
282952|NCT01948544|LTOT|ltot
282953|NCT01948544|Long-Term Oxygen Therapy|long-term oxygen therapy
282954|NCT01948544|Portable Oxygen Concentrator|portable oxygen concentrator
282955|NCT01948544|Quality of Life|quality of life
282956|NCT01948544|Six Minute Walk Distance Test|six minute walk distance test
282957|NCT01948531|Antiage|antiage
282958|NCT01948518|Pulmonary hypertension|pulmonary hypertension
282959|NCT01948518|Parenchymal Lung Disease|parenchymal lung disease
282960|NCT01948518|Diffusion Capacity|diffusion capacity
282961|NCT01948505|Craniotomy|craniotomy
282962|NCT01948466|Nutrition|nutrition
282963|NCT01948466|Commercials|commercials
282964|NCT01948466|Elementary|elementary
282965|NCT01948466|Lunchroom|lunchroom
282966|NCT01948466|Fruits|fruits
282967|NCT01948466|Vegetables|vegetables
282968|NCT01948453|CAD|cad
282969|NCT01948453|CIMT|cimt
282970|NCT01948453|FMD|fmd
282971|NCT01948440|Substance abuse, early recovery, relapse prevention|substance abuse, early recovery, relapse prevention
282972|NCT01948427|UCD|ucd
282973|NCT01948427|BUPHENYL|buphenyl
282974|NCT01948427|RAVICTI|ravicti
282975|NCT01948427|Urea|urea
282976|NCT01948427|Urea cycle disorder|urea cycle disorder
282977|NCT01948427|Glycerol phenylbutyrate|glycerol phenylbutyrate
282978|NCT01948427|Benzoate|benzoate
282979|NCT01948427|Sodium phenylbutyrate|sodium phenylbutyrate
282980|NCT01948427|Ornithine transcarbamylase (OTC)|ornithine transcarbamylase (otc)
282981|NCT01948427|Argininosuccinate synthetase (ASS)|argininosuccinate synthetase (ass)
282982|NCT01948427|Argininosuccinate lyase (ASL)|argininosuccinate lyase (asl)
282983|NCT01948427|Carbamyl phosphate synthetase (CPS)|carbamyl phosphate synthetase (cps)
282984|NCT01948427|Arginine|arginine
282985|NCT01948427|Citrulline|citrulline
282986|NCT01948427|Ammonia|ammonia
282987|NCT01948414|Obesity|obesity
282988|NCT01948414|Hyperalimentation|hyperalimentation
282989|NCT01948414|Event-Related Potential|event-related potential
282990|NCT01948414|P300|p300
282991|NCT01948388|Rheumatoid arthritis|rheumatoid arthritis
282992|NCT01948375|subject blinding|subject blinding
282993|NCT01948375|placebo needle|placebo needle
282994|NCT01948336|Contrast-induced nephropathy, Dexmedetomidine, Endothelin-1|contrast-induced nephropathy, dexmedetomidine, endothelin-1
282995|NCT01948323|Pregnancy|pregnancy
282996|NCT01948323|Maternal health|maternal health
282997|NCT01948323|Newborn health|newborn health
282998|NCT01948323|Information technology|information technology
282999|NCT01948323|Health education|health education
283000|NCT01948323|Cellphone|cellphone
283001|NCT01948323|Touch screen technology|touch screen technology
283002|NCT01948323|Pregnancy outcome|pregnancy outcome
283003|NCT01948323|Low-Middle income|low-middle income
283004|NCT01948323|Nurse-led|nurse-led
283005|NCT01948323|Nutrition|nutrition
283006|NCT01948323|Exercise|exercise
283007|NCT01948284|cecal intubation time|cecal intubation time
283008|NCT01948284|water exchange|water exchange
283009|NCT01948284|pain|pain
283010|NCT01948271|Psoriasis|psoriasis
283011|NCT01948271|Trichuris suis ova|trichuris suis ova
283012|NCT01948271|T-lymphocytes|t-lymphocytes
283013|NCT01948258|Pregnancy|pregnancy
283014|NCT01948245|Catheter Related Blood Stream Infection|catheter related blood stream infection
283015|NCT01948245|Long-term intestinal Failure|long-term intestinal failure
283016|NCT01948245|Taurolidine|taurolidine
283017|NCT01948245|Catheter lock solution|catheter lock solution
283018|NCT01948245|Antimicrobial agent|antimicrobial agent
283019|NCT01948245|Home Parenteral Nutrition|home parenteral nutrition
283020|NCT01948245|Anti-infective agents|anti-infective agents
283021|NCT01948206|Sudden Cardiac Death|sudden cardiac death
283022|NCT01948206|Implantable Cardioverter-Defibrillator|implantable cardioverter-defibrillator
283023|NCT01948206|Cardiomyopathy|cardiomyopathy
283024|NCT01948206|Prolonged Paced QRS Duration|prolonged paced qrs duration
283025|NCT01948193|Diphtheria|diphtheria
283026|NCT01948193|Tetanus|tetanus
283027|NCT01948193|Whooping Cough|whooping cough
283028|NCT01948193|Hepatitis B|hepatitis b
283029|NCT01948193|Poliomyelitis|poliomyelitis
283030|NCT01948193|DTaP IPV-Hep B-PRP~T combined vaccine (Hexaxim™)|dtap ipv-hep b-prp~t combined vaccine (hexaxim™)
283031|NCT01948180|NKTCL|nktcl
283032|NCT01948180|T cell|t cell
283033|NCT01948180|CITADEL|citadel
283034|NCT01948180|Epstein-Barr Virus|epstein-barr virus
283035|NCT01948180|Natural Killer|natural killer
283036|NCT01948167|Depression|depression
283037|NCT01948167|Prevention|prevention
283038|NCT01948167|Adolescents|adolescents
283039|NCT01948154|Cerebral Palsy|cerebral palsy
283040|NCT01948154|Early Intervention|early intervention
283041|NCT01948154|Speech Function|speech function
283042|NCT01948154|Quality of Life|quality of life
283043|NCT01948128|Breast|breast
283044|NCT01948115|Breech presentation|breech presentation
283045|NCT01948115|equimolar mixture of oxygen and nitrous oxide|equimolar mixture of oxygen and nitrous oxide
283046|NCT01948115|external cephalic version|external cephalic version
283047|NCT01948102|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
283048|NCT01948102|motor neuron disease|motor neuron disease
283049|NCT01948102|biological markers|biological markers
283050|NCT01948102|biomarkers|biomarkers
283051|NCT01948089|Chronic Stroke|chronic stroke
283052|NCT01948089|near transfer|near transfer
283053|NCT01948089|far transfer|far transfer
283054|NCT01948089|working memory|working memory
283055|NCT01948089|fluid intelligence|fluid intelligence
283056|NCT01948089|cognitive training|cognitive training
283057|NCT01948089|dual n-back|dual n-back
283058|NCT01948076|splenomegaly|splenomegaly
283059|NCT01948076|pleural effusion|pleural effusion
283060|NCT01948037|hydrotherapy|hydrotherapy
283061|NCT01948037|randomized controlled trial|randomized controlled trial
283062|NCT01948037|lower extremity arterial disease|lower extremity arterial disease
283063|NCT01948037|diabetes|diabetes
283064|NCT01947998|Rivaroxaban|rivaroxaban
283065|NCT01947998|Stroke Prevention in Atrial Fibrillation,|stroke prevention in atrial fibrillation,
283066|NCT01947998|Anticoagulants|anticoagulants
283067|NCT01947998|Hematologic Agents|hematologic agents
283068|NCT01947998|Therapeutic Uses|therapeutic uses
283069|NCT01947998|Observational|observational
283070|NCT01947998|Venous Thromboembolism|venous thromboembolism
283071|NCT01947998|Secondary Prevention of Acute Coronary Syndrome|secondary prevention of acute coronary syndrome
283072|NCT01947998|Intracranial Hemorrhages|intracranial hemorrhages
283073|NCT01947998|Gastrointestinal Hemorrhage,|gastrointestinal hemorrhage,
283074|NCT01947985|Rivaroxaban|rivaroxaban
283075|NCT01947985|Stroke Prevention in Atrial Fibrillation,|stroke prevention in atrial fibrillation,
283076|NCT01947985|Anticoagulants|anticoagulants
283077|NCT01947985|Hematologic Agents|hematologic agents
283078|NCT01947985|Therapeutic Uses|therapeutic uses
283079|NCT01947985|Observational|observational
283080|NCT01947985|Venous Thromboembolism|venous thromboembolism
283081|NCT01947985|Secondary Prevention of Acute Coronary Syndrome|secondary prevention of acute coronary syndrome
283082|NCT01947985|Intracranial Hemorrhages|intracranial hemorrhages
283083|NCT01947985|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
283084|NCT01947972|preterm neonate|preterm neonate
283085|NCT01947972|tailored fortification|tailored fortification
283086|NCT01947972|nutrition|nutrition
283087|NCT01947972|maternal breast milk composition|maternal breast milk composition
283088|NCT01947959|Rivaroxaban|rivaroxaban
283089|NCT01947959|Stroke Prevention in Atrial Fibrillation,|stroke prevention in atrial fibrillation,
283090|NCT01947959|Anticoagulants|anticoagulants
283091|NCT01947959|Hematologic Agents|hematologic agents
283092|NCT01947959|Therapeutic Uses|therapeutic uses
283093|NCT01947959|Observational|observational
283094|NCT01947959|Venous Thromboembolism|venous thromboembolism
283095|NCT01947959|Secondary Prevention of Acute Coronary Syndrome|secondary prevention of acute coronary syndrome
283096|NCT01947959|Intracranial Hemorrhages|intracranial hemorrhages
283097|NCT01947959|Gastrointestinal Hemorrhage,|gastrointestinal hemorrhage,
283098|NCT01947946|Asthma, Bronchial Diseases, Respiratory Tract Diseases, Lung Diseases, Obstructive Lung Diseases|asthma, bronchial diseases, respiratory tract diseases, lung diseases, obstructive lung diseases
283099|NCT01947920|Healthy|healthy
283100|NCT01947920|Pain|pain
283101|NCT01947920|Tramadol hydrochloride|tramadol hydrochloride
283102|NCT01947920|Tramadol HCl|tramadol hcl
283103|NCT01947920|Analgesic|analgesic
283104|NCT01947920|QT prolongation|qt prolongation
283105|NCT01947920|RWJ-26898-002|rwj-26898-002
283106|NCT01947907|Human Growth Hormone|human growth hormone
283107|NCT01947907|rhGH|rhgh
283108|NCT01947907|hGH|hgh
283109|NCT01947907|GHD|ghd
283110|NCT01947881|Diabetic Macular Edema|diabetic macular edema
283111|NCT01947881|anti-VEGF|anti-vegf
283112|NCT01947881|Treatment Response|treatment response
283113|NCT01947842|Smartphone|smartphone
283114|NCT01947842|adherence|adherence
283115|NCT01947842|contraceptives|contraceptives
283116|NCT01947842|college|college
283117|NCT01947842|females|females
283118|NCT01947829|hemodialysis|hemodialysis
283119|NCT01947829|dialysis dose|dialysis dose
283120|NCT01947816|Ulcerative Colitis|ulcerative colitis
283121|NCT01947803|Schizophrenia|schizophrenia
283122|NCT01947803|Paliperidone|paliperidone
283123|NCT01947803|Safety|safety
283124|NCT01947803|Effectiveness|effectiveness
283125|NCT01947803|Chinese|chinese
283126|NCT01947790|Type 2 diabetes|type 2 diabetes
283127|NCT01947790|left ventricular mass|left ventricular mass
283128|NCT01947790|pioglitazone|pioglitazone
283129|NCT01947777|Phase 1|phase 1
283130|NCT01947777|Healthy subjects|healthy subjects
283131|NCT01947777|DDI|ddi
283132|NCT01947777|CYP3A|cyp3a
283133|NCT01947764|HIV|hiv
283134|NCT01947764|Disclosure|disclosure
283135|NCT01947764|Pediatrics|pediatrics
283136|NCT01947751|Catheter related infection|catheter related infection
283137|NCT01947751|Central venous catheter|central venous catheter
283138|NCT01947751|CVC infection|cvc infection
283139|NCT01947738|Healthy|healthy
283140|NCT01947738|Subjects|subjects
283141|NCT01947738|Safety|safety
283142|NCT01947738|Tolerability|tolerability
283143|NCT01947738|VBY891|vby891
283144|NCT01947738|Maximum|maximum
283145|NCT01947738|Pharmacodynamic|pharmacodynamic
283146|NCT01947738|Pharmacokinetic|pharmacokinetic
283147|NCT01947712|Peripheral arterial disease|peripheral arterial disease
283148|NCT01947712|Oxidative stress|oxidative stress
283149|NCT01947712|Cocoa|cocoa
283150|NCT01947712|polyphenols|polyphenols
283151|NCT01947712|NADPH oxidase|nadph oxidase
283152|NCT01947686|osteoarthritis, patellofemoral|osteoarthritis, patellofemoral
283153|NCT01947647|behavior therapy|behavior therapy
283154|NCT01947647|Randomized Controlled Trials|randomized controlled trials
283155|NCT01947647|Depressive Disorder|depressive disorder
283156|NCT01947647|Anxiety Disorders|anxiety disorders
283157|NCT01947647|comorbidity|comorbidity
283158|NCT01947621|Broken heart syndrome, stress cardiomyopathy|broken heart syndrome, stress cardiomyopathy
283159|NCT01947595|diabetes mellitus type 2|diabetes mellitus type 2
283160|NCT01947595|impaired glucose tolerance|impaired glucose tolerance
283161|NCT01947595|lifestyle intervention|lifestyle intervention
283162|NCT01947595|body fat distribution|body fat distribution
283163|NCT01947595|prevention|prevention
283164|NCT01947582|multiple sclerosis|multiple sclerosis
283165|NCT01947582|gait|gait
283166|NCT01947582|ankle foot orthosis (AFO)|ankle foot orthosis (afo)
283167|NCT01947556|diabetes|diabetes
283168|NCT01947556|insulin administration|insulin administration
283169|NCT01947556|hyperglycaemia|hyperglycaemia
283170|NCT01947556|insulin aspart|insulin aspart
283171|NCT01947478|Drug-Eluting Angioplasty Balloon|drug-eluting angioplasty balloon
283172|NCT01947478|Drug Coated Angioplasty Balloon|drug coated angioplasty balloon
283173|NCT01947478|Peripheral Artery Disease|peripheral artery disease
283174|NCT01947478|Experimental|experimental
283175|NCT01947478|Percutaneous Transluminal Angioplasty (PTA)|percutaneous transluminal angioplasty (pta)
283176|NCT01947452|Youth violence reduction|youth violence reduction
283177|NCT01947452|Youth crime reduction|youth crime reduction
283178|NCT01947452|School engagement|school engagement
283179|NCT01947452|Employment|employment
283180|NCT01947452|Social-emotional learning|social-emotional learning
283181|NCT01947439|multivessel stenting|multivessel stenting
283182|NCT01947426|DHA, term neonates, mother milk|dha, term neonates, mother milk
283183|NCT01947413|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
283184|NCT01947413|BoNTA|bonta
283185|NCT01947413|stroke|stroke
283186|NCT01947413|optimal treatment protocol|optimal treatment protocol
283187|NCT01947413|randomized controlled trial|randomized controlled trial
283188|NCT01947413|motor control|motor control
283189|NCT01947413|clinical predictors|clinical predictors
283190|NCT01947400|Physician and Patient Communication|physician and patient communication
283191|NCT01947400|Acknowledge Introduce Duration Explanation Thank|acknowledge introduce duration explanation thank
283192|NCT01947400|Hospital Consumer Assessment of Health Plans Survey|hospital consumer assessment of health plans survey
283193|NCT01947374|Cartilage|cartilage
283194|NCT01947374|Articular|articular
283195|NCT01947335|Coronary|coronary
283196|NCT01947335|Angioplasty|angioplasty
283197|NCT01947335|Percutaneous coronary intervention|percutaneous coronary intervention
283198|NCT01947335|Stent|stent
283199|NCT01947335|Contrast|contrast
283200|NCT01947335|Acute Renal failure|acute renal failure
283201|NCT01947335|Intravascular ultrasound|intravascular ultrasound
283202|NCT01947335|Prevention|prevention
283203|NCT01947322|Natural killer cell|natural killer cell
283204|NCT01947322|Haploidentical|haploidentical
283205|NCT01947322|Acute myeloid leukemia|acute myeloid leukemia
283206|NCT01947322|Chemotherapy|chemotherapy
283207|NCT01947309|Revlimid, lenalidomide, multiple myeloma, PFS, Response Rates|revlimid, lenalidomide, multiple myeloma, pfs, response rates
283208|NCT01947296|Oral antineoplastic agent|oral antineoplastic agent
283209|NCT01947296|Adverse Effects|adverse effects
283210|NCT01947296|Cancer Networks|cancer networks
283211|NCT01947296|Continuity of care|continuity of care
283212|NCT01947296|Coordination of patient's care|coordination of patient's care
283213|NCT01947283|Patient-Provider Relationship|patient-provider relationship
283214|NCT01947283|Shared Decision Making|shared decision making
283215|NCT01947283|Therapeutic Alliance|therapeutic alliance
283216|NCT01947283|Mental Health|mental health
283217|NCT01947283|Minority Health|minority health
283218|NCT01947283|Patient Activation|patient activation
283219|NCT01947283|Communication|communication
283220|NCT01947270|Potentially inappropriate medications|potentially inappropriate medications
283221|NCT01947270|Elderly|elderly
283222|NCT01947270|Prevention|prevention
283223|NCT01947270|Multidisciplinary program|multidisciplinary program
283224|NCT01947270|Checklist|checklist
283225|NCT01947270|Stepped wedge design|stepped wedge design
283226|NCT01947270|AGED, 75 AND OVER|aged, 75 and over
283227|NCT01947244|Doulas|doulas
283228|NCT01947244|Parenting|parenting
283229|NCT01947244|Breast Feeding|breast feeding
283230|NCT01947244|Pregnancy in Adolescence|pregnancy in adolescence
283231|NCT01947244|Child Development|child development
283232|NCT01947231|neck pain|neck pain
283233|NCT01947231|chronic|chronic
283234|NCT01947231|Global Postural Re-education|global postural re-education
283235|NCT01947231|manual therapy|manual therapy
283236|NCT01947231|physical therapy|physical therapy
283237|NCT01947205|Curettage|curettage
283238|NCT01947205|analgesia|analgesia
283239|NCT01947205|paracervical block|paracervical block
283240|NCT01947205|paracetamol|paracetamol
283241|NCT01947205|lidocaine|lidocaine
283242|NCT01947205|Dexketoprofen trometamol|dexketoprofen trometamol
283243|NCT01947192|Chlorhexidine|chlorhexidine
283244|NCT01947192|Matrix metalloproteinases (MMP) inhibitor|matrix metalloproteinases (mmp) inhibitor
283245|NCT01947192|Adhesive system|adhesive system
283246|NCT01947192|Controlled clinical trial|controlled clinical trial
283247|NCT01947192|Dental restoration|dental restoration
283248|NCT01947192|Noncarious cervical lesions|noncarious cervical lesions
283249|NCT01947192|Dental restoration failure|dental restoration failure
283250|NCT01947166|Whipple|whipple
283251|NCT01947140|Lymphoid Malignancies|lymphoid malignancies
283252|NCT01947140|Multiple Myeloma|multiple myeloma
283253|NCT01947140|Lymphoma|lymphoma
283254|NCT01947140|Hodgkin Lymphoma|hodgkin lymphoma
283255|NCT01947140|Non-hodgkin Lymphoma|non-hodgkin lymphoma
283256|NCT01947140|Follicular Lymphoma|follicular lymphoma
283257|NCT01947140|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
283258|NCT01947140|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
283259|NCT01947140|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
283260|NCT01947140|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
283261|NCT01947140|Mantle Cell Lymphoma|mantle cell lymphoma
283262|NCT01947140|Marginal Zone Lymphoma|marginal zone lymphoma
283263|NCT01947140|Burkitt Lymphoma|burkitt lymphoma
283264|NCT01947140|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
283265|NCT01947140|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
283266|NCT01947140|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
283267|NCT01947127|Lactate|lactate
283268|NCT01947127|Sepsis|sepsis
283269|NCT01947127|Septic shock|septic shock
283270|NCT01947127|Disease progression|disease progression
283271|NCT01947127|Prognosis|prognosis
283272|NCT01947114|General anesthesia,|general anesthesia,
283273|NCT01947114|Children,|children,
283274|NCT01947114|Rigid Bronchoscopy,|rigid bronchoscopy,
283275|NCT01947114|Remifentanil,|remifentanil,
283276|NCT01947114|Propofol,|propofol,
283277|NCT01947114|Ketamine.|ketamine.
283278|NCT01947101|Stool transplant|stool transplant
283279|NCT01947101|Ulcerative Colitis|ulcerative colitis
283280|NCT01947101|Fecal transplant|fecal transplant
283281|NCT01947101|Inflammatory Bowel Disease|inflammatory bowel disease
283282|NCT01947088|Epilepsy, seizure disorder|epilepsy, seizure disorder
283283|NCT01947075|Fever|fever
283284|NCT01947075|Tanzania|tanzania
283285|NCT01947075|Pneumonia|pneumonia
283286|NCT01947075|HIV|hiv
283287|NCT01947075|Diabetes|diabetes
283288|NCT01947075|Indoor Air Pollution|indoor air pollution
283289|NCT01947062|NSCLC|nsclc
283290|NCT01947062|Metronomic chemotherapy|metronomic chemotherapy
283291|NCT01947062|Metronomic cyclophosphamide|metronomic cyclophosphamide
283292|NCT01947049|Influenza|influenza
283293|NCT01947049|diagnostic testing|diagnostic testing
283294|NCT01947049|antiviral treatment|antiviral treatment
283295|NCT01947049|rapid influenza testing|rapid influenza testing
283296|NCT01947036|autoimmune disease|autoimmune disease
283297|NCT01947036|immune-mediated disease|immune-mediated disease
283298|NCT01947036|T and B cells immunophenotype|t and b cells immunophenotype
283299|NCT01947036|IL23 signaling|il23 signaling
283300|NCT01947036|genetic risk variants|genetic risk variants
283301|NCT01947010|antibodies|antibodies
283302|NCT01946984|diclofenac, ERCP and pancreatitis|diclofenac, ercp and pancreatitis
283303|NCT01946958|Triple P|triple p
283304|NCT01946945|infertility|infertility
283305|NCT01946945|recurrent pregnancy loss|recurrent pregnancy loss
283306|NCT01946945|miscarriage|miscarriage
283307|NCT01946945|Next Generation Sequencing|next generation sequencing
283308|NCT01946932|Induced hypothermia|induced hypothermia
283309|NCT01946932|Mild induced hypothermia|mild induced hypothermia
283310|NCT01946932|Resuscitation|resuscitation
283311|NCT01946932|Therapeutic hypothermia|therapeutic hypothermia
283312|NCT01946932|Neurological function|neurological function
283313|NCT01946932|Cardiovascular diseases|cardiovascular diseases
283314|NCT01946932|Rehabilitation|rehabilitation
283315|NCT01946932|Quality of life|quality of life
283316|NCT01946932|Cognition|cognition
283317|NCT01946919|Cinepazide|cinepazide
283318|NCT01946919|Adverse Drug Reaction|adverse drug reaction
283319|NCT01946919|Safety|safety
283320|NCT01946919|Real World Study|real world study
283321|NCT01946893|meditation|meditation
283322|NCT01946893|education|education
283323|NCT01946893|stress, psychological|stress, psychological
283324|NCT01946893|aged|aged
283325|NCT01946880|Systemic Lupus Erythematosus|systemic lupus erythematosus
283326|NCT01946880|Mycophenolate Mofetil (MMF)|mycophenolate mofetil (mmf)
283327|NCT01946867|Oral cavity Cancer|oral cavity cancer
283328|NCT01946867|Oropharynx Cancer|oropharynx cancer
283329|NCT01946854|Gastrointestinal|gastrointestinal
283330|NCT01946854|Metastatic Well-differentiated Mucinous Appendiceal Adenocarcinomas with Pseudomyxoma Peritonea|metastatic well-differentiated mucinous appendiceal adenocarcinomas with pseudomyxoma peritonea
283331|NCT01946854|Appendiceal cancer|appendiceal cancer
283332|NCT01946854|Surgically unresectable|surgically unresectable
283333|NCT01946854|Chemotherapy|chemotherapy
283334|NCT01946854|Observation|observation
283335|NCT01946854|Questionnaires|questionnaires
283336|NCT01946841|Chronic kidney disease|chronic kidney disease
283337|NCT01946841|Hemodialysis|hemodialysis
283338|NCT01946841|Severe malnutrition|severe malnutrition
283339|NCT01946841|Enteral nutrition|enteral nutrition
283340|NCT01946828|Field Induced Mydriasis|field induced mydriasis
283341|NCT01946828|FIM|fim
283342|NCT01946828|ATI|ati
283343|NCT01946802|Heart arrest|heart arrest
283344|NCT01946802|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
283345|NCT01946802|Hypothermia induced|hypothermia induced
283346|NCT01946802|Seizures|seizures
283347|NCT01946802|Electroencephalography|electroencephalography
283348|NCT01946789|cancer|cancer
283349|NCT01946789|IL-15|il-15
283350|NCT01946789|melanoma|melanoma
283351|NCT01946789|metastatic|metastatic
283352|NCT01946789|unresectable|unresectable
283353|NCT01946789|solid tumors|solid tumors
283354|NCT01946789|renal cell|renal cell
283355|NCT01946789|non-small cell lung|non-small cell lung
283356|NCT01946789|squamous cell head and neck|squamous cell head and neck
283357|NCT01946737|Coronary|coronary
283358|NCT01946737|Artery|artery
283359|NCT01946737|Disease|disease
283360|NCT01946737|Diagnostic|diagnostic
283361|NCT01946737|Performance|performance
283362|NCT01946737|Angiography|angiography
283363|NCT01946711|CRS|crs
283364|NCT01946711|polyposis|polyposis
283365|NCT01946672|gynaecological malignancy|gynaecological malignancy
283366|NCT01946672|pelvic lymphadenectomy|pelvic lymphadenectomy
283367|NCT01946672|lymphedema|lymphedema
283368|NCT01946672|sentinel node|sentinel node
283369|NCT01946672|reverse mapping|reverse mapping
283370|NCT01946659|Tailored Telephone Intervention|tailored telephone intervention
283371|NCT01946620|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
283372|NCT01946620|Exacerbations|exacerbations
283373|NCT01946620|FEV1 ≤ 50%|fev1 ≤ 50%
283374|NCT01946607|Neuroticism|neuroticism
283375|NCT01946607|Emotion processing|emotion processing
283376|NCT01946607|Eye gaze movements|eye gaze movements
283377|NCT01946607|Heart Rate Variability|heart rate variability
283378|NCT01946594|fever|fever
283379|NCT01946594|antipyretics|antipyretics
283380|NCT01946594|acetaminophen|acetaminophen
283381|NCT01946594|influenza vaccine|influenza vaccine
283382|NCT01946594|influenza, human|influenza, human
283383|NCT01946594|body temperature changes|body temperature changes
283384|NCT01946594|Orthomyxoviridae Infections|orthomyxoviridae infections
283385|NCT01946594|RNA virus infections|rna virus infections
283386|NCT01946594|Virus Diseases|virus diseases
283387|NCT01946594|Respiratory Tract Infections|respiratory tract infections
283388|NCT01946594|Respiratory Tract Diseases|respiratory tract diseases
283389|NCT01946555|Breakthrough cancer pain|breakthrough cancer pain
283390|NCT01946555|Neuropathic pain|neuropathic pain
283391|NCT01946555|Major opioid|major opioid
283392|NCT01946555|Analgesics|analgesics
283393|NCT01946542|exercise|exercise
283394|NCT01946542|heart failure|heart failure
283395|NCT01946542|fatigue|fatigue
283396|NCT01946542|physical endurance|physical endurance
283397|NCT01946542|functional food|functional food
283398|NCT01946516|viral screening|viral screening
283399|NCT01946503|Short Gut|short gut
283400|NCT01946503|Short Bowel Syndrome|short bowel syndrome
283401|NCT01946503|Intestinal Failure|intestinal failure
283402|NCT01946503|Home parenteral nutrition|home parenteral nutrition
283403|NCT01946503|Feeding Behavior|feeding behavior
283404|NCT01946503|Enteral Nutrition|enteral nutrition
283405|NCT01946503|Parent-Child Relations|parent-child relations
283406|NCT01946503|Parenteral Nutrition|parenteral nutrition
283407|NCT01946503|Digestive System Diseases|digestive system diseases
283408|NCT01946477|Multiple Myeloma, MM, cancer, oncology, hematology, plasma, neoplasm, plasmacytoma|multiple myeloma, mm, cancer, oncology, hematology, plasma, neoplasm, plasmacytoma
283409|NCT01946464|edentulous|edentulous
283410|NCT01946464|bearded|bearded
283411|NCT01946464|patients|patients
283412|NCT01946464|requiring|requiring
283413|NCT01946464|general anesthesia|general anesthesia
283414|NCT01946464|Mallampati Class II or IV|mallampati class ii or iv
283415|NCT01946451|idiopathic epiretinal membranes|idiopathic epiretinal membranes
283416|NCT01946451|secondary epiretinal membranes|secondary epiretinal membranes
283417|NCT01946438|Influenza|influenza
283418|NCT01946438|Fluzone® Quadrivalent, Influenza Virus Vaccine (2013-2014 formulation),|fluzone® quadrivalent, influenza virus vaccine (2013-2014 formulation),
283419|NCT01946438|Fluzone® Intradermal, Influenza Virus Vaccine (2013-2014 formulation),|fluzone® intradermal, influenza virus vaccine (2013-2014 formulation),
283420|NCT01946438|Fluzone® High-Dose, Influenza Virus Vaccine (2013-2014 formulation)|fluzone® high-dose, influenza virus vaccine (2013-2014 formulation)
283421|NCT01946425|Influenza|influenza
283422|NCT01946425|Influenza virus vaccine|influenza virus vaccine
283423|NCT01946425|Fluzone® Quadrivalent Influenza Vaccine (No Preservative)|fluzone® quadrivalent influenza vaccine (no preservative)
283424|NCT01946412|Cystic Fibrosis|cystic fibrosis
283425|NCT01946373|Melanoma|melanoma
283426|NCT01946373|Dendritic cell vaccination|dendritic cell vaccination
283427|NCT01946373|Lymphodepletion|lymphodepletion
283428|NCT01946373|Adoptive cell transfer|adoptive cell transfer
283429|NCT01946373|T cells|t cells
283430|NCT01946373|Tumor infiltrating lymphocytes|tumor infiltrating lymphocytes
283431|NCT01946373|Fludarabine|fludarabine
283432|NCT01946373|IL-2|il-2
283433|NCT01946373|Interleukin-2|interleukin-2
283434|NCT01946373|Cyclophosphamide|cyclophosphamide
283435|NCT01946373|Phase I study|phase i study
283436|NCT01946373|Monocytes|monocytes
283437|NCT01946373|Autologous|autologous
283438|NCT01946373|NY-ESO-1|ny-eso-1
283439|NCT01946347|Insulin Resistance|insulin resistance
283440|NCT01946347|Hyperglycemia|hyperglycemia
283441|NCT01946347|Endothelial function|endothelial function
283442|NCT01946347|Oxidative stress|oxidative stress
283443|NCT01946308|sleep|sleep
283444|NCT01946308|sleep efficiency|sleep efficiency
283445|NCT01946308|active sleep|active sleep
283446|NCT01946308|quiet sleep|quiet sleep
283447|NCT01946308|arousals|arousals
283448|NCT01946308|premature infant|premature infant
283449|NCT01946308|conformational positioning|conformational positioning
283450|NCT01946308|mattress|mattress
283451|NCT01946308|feeding difficulty|feeding difficulty
283452|NCT01946308|neonatal intensive care unit|neonatal intensive care unit
283453|NCT01946308|sleep state|sleep state
283454|NCT01946308|behavioral observation|behavioral observation
283455|NCT01946308|stress behavior|stress behavior
283456|NCT01946308|self-regulatory behavior|self-regulatory behavior
283457|NCT01946308|surgery|surgery
283458|NCT01946308|gastrointestinal|gastrointestinal
283459|NCT01946282|neoplasm|neoplasm
283460|NCT01946282|colorectal|colorectal
283461|NCT01946282|cancer|cancer
283462|NCT01946282|uninsured|uninsured
283463|NCT01946282|FIT|fit
283464|NCT01946282|Fecal Immunochemical Test|fecal immunochemical test
283465|NCT01946204|Prostate neoplasms|prostate neoplasms
283466|NCT01946204|Prostate cancer|prostate cancer
283467|NCT01946204|Castration-resistant prostate cancer|castration-resistant prostate cancer
284062|NCT01943487|Solifenacin|solifenacin
283468|NCT01946204|Non-metastatic castration-resistant prostate cancer|non-metastatic castration-resistant prostate cancer
283469|NCT01946204|ARN-509|arn-509
283470|NCT01946204|Apalutamide|apalutamide
283471|NCT01946191|Weight maintenance|weight maintenance
283472|NCT01946191|Electronic health record|electronic health record
283473|NCT01946191|Primary care|primary care
283474|NCT01946178|Uterine Fibroids|uterine fibroids
283475|NCT01946178|Leiomyomas|leiomyomas
283476|NCT01946178|High-Intensity Focused Ultrasound Ablation|high-intensity focused ultrasound ablation
283477|NCT01946178|Ultrasonography|ultrasonography
283478|NCT01946165|Prostate Cancer|prostate cancer
283479|NCT01946165|High risk prostate cancer|high risk prostate cancer
283480|NCT01946165|Abiraterone acetate|abiraterone acetate
283481|NCT01946165|Zytiga|zytiga
283482|NCT01946165|Prednisone|prednisone
283483|NCT01946165|Enzalutamide|enzalutamide
283484|NCT01946165|MDV3100|mdv3100
283485|NCT01946165|XTANDI|xtandi
283486|NCT01946165|Androgen ablation|androgen ablation
283487|NCT01946165|LHRHa|lhrha
283488|NCT01946165|Hormonal therapy|hormonal therapy
283489|NCT01946152|Myeloma|myeloma
283490|NCT01946152|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
283491|NCT01946152|MM|mm
283492|NCT01946152|Pomalidomide|pomalidomide
283493|NCT01946152|CC-4047|cc-4047
283494|NCT01946152|Dexamethasone|dexamethasone
283495|NCT01946152|Decadron|decadron
283496|NCT01946152|C-CSF|c-csf
283497|NCT01946152|Filgrastim|filgrastim
283498|NCT01946152|Neupogen|neupogen
283499|NCT01946152|Granulocyte colony stimulating factor|granulocyte colony stimulating factor
283500|NCT01946100|multifocal|multifocal
283501|NCT01946100|genetic|genetic
283502|NCT01946100|bronchoalveolar carcinoma|bronchoalveolar carcinoma
283503|NCT01946100|adenocarcinoma in situ|adenocarcinoma in situ
283504|NCT01946100|ground glass opacity|ground glass opacity
283505|NCT01946100|next generation sequencing|next generation sequencing
283506|NCT01946087|Remote ischemic preconditioning|remote ischemic preconditioning
283507|NCT01946087|cardiac surgery|cardiac surgery
283508|NCT01946087|left ventricular hypertrophy|left ventricular hypertrophy
283509|NCT01946087|reperfusion injury salvage kinase|reperfusion injury salvage kinase
283510|NCT01946074|cancer|cancer
283511|NCT01946074|neoplasm|neoplasm
283512|NCT01946074|advanced solid tumor|advanced solid tumor
283513|NCT01946074|colorectal cancer|colorectal cancer
283514|NCT01946061|Oxaliplatin, S-1, Gastric cancer, Adjuvant chemotherapy|oxaliplatin, s-1, gastric cancer, adjuvant chemotherapy
283515|NCT01946022|infertility|infertility
283516|NCT01946022|ovulation induction|ovulation induction
283517|NCT01946022|luteal phase|luteal phase
283518|NCT01946022|granulosa cells function|granulosa cells function
283519|NCT01946022|GnRH agonist and antagonist|gnrh agonist and antagonist
283520|NCT01946022|HMG|hmg
283521|NCT01946022|FSHr|fshr
283522|NCT01945996|Hispanic Americans|hispanic americans
283523|NCT01945996|Cellular Phone|cellular phone
283524|NCT01945996|Behavior|behavior
283525|NCT01945983|Septic shock|septic shock
283526|NCT01945983|Severe sepsis|severe sepsis
283527|NCT01945983|Norepinephrine|norepinephrine
283528|NCT01945970|Vascular function|vascular function
283529|NCT01945970|Flow mediated dilation|flow mediated dilation
283530|NCT01945970|Tea|tea
283531|NCT01945957|autism|autism
283532|NCT01945957|brain|brain
283533|NCT01945957|functional magnetic resonance imaging|functional magnetic resonance imaging
283534|NCT01945957|oxytocin|oxytocin
283535|NCT01945944|pediatric|pediatric
283536|NCT01945944|mucolytic|mucolytic
283537|NCT01945944|respiratory failure|respiratory failure
283538|NCT01945944|atelectasis|atelectasis
283539|NCT01945944|hypertonic saline|hypertonic saline
283540|NCT01945931|Maternal health|maternal health
283541|NCT01945931|perinatal health|perinatal health
283542|NCT01945931|mHealth|mhealth
283543|NCT01945931|smartphone|smartphone
283544|NCT01945931|mobile phone|mobile phone
283545|NCT01945931|Ethiopia|ethiopia
283546|NCT01945918|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
283547|NCT01945918|Diabetes Mellitus|diabetes mellitus
283548|NCT01945918|Primary Health Care|primary health care
283549|NCT01945918|Self care|self care
283550|NCT01945905|Tuberculosis|tuberculosis
283551|NCT01945905|Adherence, medication|adherence, medication
283552|NCT01945905|Patient compliance|patient compliance
283553|NCT01945892|macular edema, irvine gass syndrome, ozurdex|macular edema, irvine gass syndrome, ozurdex
283554|NCT01945879|pancreatic cancer|pancreatic cancer
283555|NCT01945879|heparin|heparin
283556|NCT01945879|thromboembolic events|thromboembolic events
283557|NCT01945879|bleedings|bleedings
283558|NCT01945866|Diabetic Macular Edema|diabetic macular edema
283559|NCT01945866|Anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
283560|NCT01945866|Dexamethasone Intravitreal implant|dexamethasone intravitreal implant
283561|NCT01945866|Ranibizumab intravitreal injection|ranibizumab intravitreal injection
283562|NCT01945801|Sleep apnea|sleep apnea
283563|NCT01945801|Treatment|treatment
283564|NCT01945801|Sodium-Restricted Diet|sodium-restricted diet
283565|NCT01945801|Diuretic|diuretic
283566|NCT01945801|Lasilactone|lasilactone
283567|NCT01945775|Breast cancer|breast cancer
283568|NCT01945775|BRCA mutation|brca mutation
283569|NCT01945775|PARP inhibitor|parp inhibitor
283570|NCT01945775|BRCA 1|brca 1
283571|NCT01945775|BRCA 2|brca 2
283572|NCT01945762|RET Mutation|ret mutation
283573|NCT01945762|DIagnostics|diagnostics
283574|NCT01945762|Medullary Thyroid Cancer|medullary thyroid cancer
283576|NCT01945736|Opiate withdrawal in children|opiate withdrawal in children
283577|NCT01945723|Endoscopy|endoscopy
283578|NCT01945723|Gastrointestinal tract|gastrointestinal tract
283579|NCT01945723|Bacterial markers|bacterial markers
283580|NCT01945723|volunteers|volunteers
283581|NCT01945710|Tumors|tumors
283582|NCT01945697|DNA methylation, biomarkers, oral cancer|dna methylation, biomarkers, oral cancer
283583|NCT01945645|Prevention|prevention
283584|NCT01945645|Screening|screening
283585|NCT01945645|Type 2 diabetes|type 2 diabetes
283586|NCT01945645|Action Competence|action competence
283587|NCT01945645|Family practice|family practice
283588|NCT01945645|Health Services Research|health services research
283589|NCT01945619|CMV|cmv
283590|NCT01945619|Adenovirus|adenovirus
283591|NCT01945619|EBV|ebv
283592|NCT01945619|Stem cell transplant|stem cell transplant
283593|NCT01945619|cytotoxic T-lymphocytes|cytotoxic t-lymphocytes
283594|NCT01945580|POP|pop
283595|NCT01945580|Transvaginal|transvaginal
283596|NCT01945580|Native Tissue Repair|native tissue repair
283597|NCT01945580|Repair Augmented with Mesh|repair augmented with mesh
283598|NCT01945580|Biologic Graft|biologic graft
283599|NCT01945580|Pelvic Organ Prolapse|pelvic organ prolapse
283600|NCT01945567|Parkinson's disease|parkinson's disease
283601|NCT01945567|Essential tremor|essential tremor
283602|NCT01945567|Tremor|tremor
283603|NCT01945567|Deep brain stimulation|deep brain stimulation
283604|NCT01945567|Posterior subthalamic area|posterior subthalamic area
283605|NCT01945567|Zona incerta|zona incerta
283606|NCT01945554|infiltrative therapy|infiltrative therapy
283607|NCT01945554|cervical disc herniation|cervical disc herniation
283608|NCT01945554|lumbar disc herniation|lumbar disc herniation
283609|NCT01945541|Intraoperative Fluid Administration|intraoperative fluid administration
283610|NCT01945541|Body Composition Measurement|body composition measurement
283611|NCT01945528|Platelet Rich Plasma|platelet rich plasma
283612|NCT01945528|tendinopathy|tendinopathy
283613|NCT01945528|epicondylitis|epicondylitis
283614|NCT01945528|ultrasound|ultrasound
283615|NCT01945528|injection therapy|injection therapy
283616|NCT01945528|needle tenotomy|needle tenotomy
283617|NCT01945515|Stroke|stroke
283618|NCT01945515|transcranial direct current stimulation|transcranial direct current stimulation
283619|NCT01945515|robotic rehabilitation|robotic rehabilitation
283620|NCT01945515|gait|gait
283621|NCT01945476|midazolam|midazolam
283622|NCT01945476|premedication|premedication
283623|NCT01945476|functional recovery|functional recovery
283624|NCT01945476|breast cancer|breast cancer
283625|NCT01945424|Quadrivalent Influenza Vaccine|quadrivalent influenza vaccine
283626|NCT01945424|Pregnancy Registry|pregnancy registry
283627|NCT01945424|Influenza|influenza
283628|NCT01945411|Airway Management|airway management
283629|NCT01945411|Ventilation|ventilation
283630|NCT01945398|Pulmonary Rehabilitation|pulmonary rehabilitation
283631|NCT01945398|Inspiratory Muscle Training|inspiratory muscle training
283632|NCT01945398|Inspiratory Muscle Strength|inspiratory muscle strength
283633|NCT01945398|Vascular Resistance|vascular resistance
283634|NCT01945398|Exercise|exercise
283635|NCT01945398|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
283636|NCT01945385|Abortion|abortion
283637|NCT01945385|LARC|larc
283638|NCT01945385|Contraception|contraception
283639|NCT01945385|IUD|iud
283640|NCT01945385|Contraceptive implant|contraceptive implant
283641|NCT01945385|behavioral change|behavioral change
283642|NCT01945385|video intervention|video intervention
283643|NCT01945359|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
283644|NCT01945359|Dimethyl Fumarate|dimethyl fumarate
283645|NCT01945359|Natalizumab|natalizumab
283646|NCT01945346|PRX167700|prx167700
283647|NCT01945346|Osteoarthritis|osteoarthritis
283648|NCT01945333|Cognitive remediation|cognitive remediation
283649|NCT01945333|Schizophrenia|schizophrenia
283650|NCT01945333|Schizoaffective disorder|schizoaffective disorder
283651|NCT01945320|hemodialysis|hemodialysis
283652|NCT01945320|wasting and malnutrition|wasting and malnutrition
283653|NCT01945320|nutrition status|nutrition status
283654|NCT01945320|bioelectrical impedance analysis|bioelectrical impedance analysis
283655|NCT01945320|body composition|body composition
283656|NCT01945307|Complement|complement
283657|NCT01945307|Serum Bactericidal Assay|serum bactericidal assay
283658|NCT01945268|vascular, influenza, vaccine, heart failure|vascular, influenza, vaccine, heart failure
283659|NCT01945255|Calcification|calcification
283660|NCT01945255|aortic pulse wave velocity|aortic pulse wave velocity
283661|NCT01945255|peripheral artery occlusion disease|peripheral artery occlusion disease
283662|NCT01945255|hemodialysis|hemodialysis
283663|NCT01945255|metabolic syndrome|metabolic syndrome
283664|NCT01945242|Drug Therapy|drug therapy
284260|NCT01942538|rTMS|rtms
283665|NCT01945216|Drug therapy|drug therapy
283666|NCT01945203|Calcification|calcification
283667|NCT01945203|aortic pulse wave velocity|aortic pulse wave velocity
283668|NCT01945203|peripheral artery occlusion disease|peripheral artery occlusion disease
283669|NCT01945203|peritoneal dialysis|peritoneal dialysis
283670|NCT01945203|metabolic syndrome|metabolic syndrome
283671|NCT01945177|endoscopy|endoscopy
283672|NCT01945177|gastric intestinal metaplasia|gastric intestinal metaplasia
283673|NCT01945177|gastric cancer|gastric cancer
283674|NCT01945164|XL999|xl999
283675|NCT01945164|Advanced Malignancy|advanced malignancy
283676|NCT01945151|spastic hemiparesis|spastic hemiparesis
283677|NCT01945138|Total Pancreatectomy|total pancreatectomy
283678|NCT01945138|Islet Auto-Transplantation|islet auto-transplantation
283679|NCT01945138|Closed Loop Insulin Pump|closed loop insulin pump
283680|NCT01945099|diabetes, insulin,post prandial, closed loop, artificial pancreas, hyperglycemia|diabetes, insulin,post prandial, closed loop, artificial pancreas, hyperglycemia
283681|NCT01945086|Dermatitis, Atopic|dermatitis, atopic
283682|NCT01945086|Eczema|eczema
283683|NCT01945086|Ustekinumab|ustekinumab
283684|NCT01945086|CNTO1275|cnto1275
283685|NCT01945086|STELARA|stelara
283686|NCT01945073|Educational intervention|educational intervention
283687|NCT01945073|Formal Counselling|formal counselling
283688|NCT01945073|Knowledge|knowledge
283689|NCT01945073|Illness Perception|illness perception
283690|NCT01945060|Artificial Pancreas Project|artificial pancreas project
283691|NCT01945060|Diabetes Assistant (DiAs) Medical Platform System|diabetes assistant (dias) medical platform system
283692|NCT01945060|Artificial Pancreas Platform|artificial pancreas platform
283693|NCT01945060|Insulin Pump|insulin pump
283694|NCT01945060|Continuous Glucose Monitor|continuous glucose monitor
283695|NCT01945060|Closed-Loop Control|closed-loop control
283696|NCT01945060|heart rate Control to Range System (hrCTR)|heart rate control to range system (hrctr)
283697|NCT01945047|depression|depression
283698|NCT01945047|treatment|treatment
283699|NCT01945047|ketamine|ketamine
283700|NCT01945047|ottawa|ottawa
283701|NCT01945047|treatment-resistant|treatment-resistant
283702|NCT01945047|infusion|infusion
283703|NCT01945034|topical ibuprofen|topical ibuprofen
283704|NCT01945034|ankle sprain|ankle sprain
283705|NCT01945021|Non small cell lung cancer|non small cell lung cancer
283706|NCT01945021|NSCLC|nsclc
283707|NCT01945021|ROS1|ros1
283708|NCT01945021|ROS1 positive|ros1 positive
283709|NCT01945021|ROS1 proto oncogene|ros1 proto oncogene
283710|NCT01945021|c ros tyrosine kinases|c ros tyrosine kinases
283711|NCT01945021|ROS1 positive NSCLC|ros1 positive nsclc
283712|NCT01945021|ROS1 lung cancer|ros1 lung cancer
283713|NCT01945021|ALK negative|alk negative
283714|NCT01945021|Lung Carcinoma|lung carcinoma
283715|NCT01945021|Neoplasm|neoplasm
283716|NCT01945021|Crizotinib|crizotinib
283717|NCT01945021|Xalkori|xalkori
283718|NCT01945021|Previously treated or untreated|previously treated or untreated
283719|NCT01945021|North East Asian|north east asian
283720|NCT01945008|HCV|hcv
283721|NCT01945008|observational study|observational study
283722|NCT01945008|HCV direct-acting antiviral agents|hcv direct-acting antiviral agents
283723|NCT01944982|Immunotherapy|immunotherapy
283724|NCT01944982|NKAEs|nkaes
283725|NCT01944982|Expanded haploidentical natural killer cells|expanded haploidentical natural killer cells
283726|NCT01944982|Activated natural killer cells|activated natural killer cells
283727|NCT01944956|Maturation|maturation
283728|NCT01944956|preterm infants|preterm infants
283729|NCT01944956|sucking and swallowing|sucking and swallowing
283730|NCT01944943|refractory/relapsed|refractory/relapsed
283731|NCT01944943|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
283732|NCT01944943|indolent non-hodgkin lymphoma|indolent non-hodgkin lymphoma
283733|NCT01944943|Primary central nervous system lymphoma|primary central nervous system lymphoma
283734|NCT01944943|chronic lymphocytic leukemia|chronic lymphocytic leukemia
283735|NCT01944917|Electromagnetic field|electromagnetic field
283736|NCT01944917|VAS score|vas score
283737|NCT01944917|Heart Rate Variability|heart rate variability
283738|NCT01944904|XOS|xos
283739|NCT01944904|pre-diabetic|pre-diabetic
283740|NCT01944904|abnormal glucose levels|abnormal glucose levels
283741|NCT01944891|Adolescent girls|adolescent girls
283742|NCT01944891|Mozambique|mozambique
283743|NCT01944891|Diet|diet
283744|NCT01944891|Anthropometrics|anthropometrics
283745|NCT01944891|Serum biomarkers|serum biomarkers
283746|NCT01944878|Peptic ulcer|peptic ulcer
283747|NCT01944878|Liver cirrhosis|liver cirrhosis
283748|NCT01944878|Portal hypertension|portal hypertension
283749|NCT01944865|Aerobic Interval Training|aerobic interval training
283750|NCT01944865|Supramaximal Training|supramaximal training
283751|NCT01944852|icodextrin|icodextrin
283752|NCT01944852|double dose|double dose
283753|NCT01944852|elderly incident CAPD patients|elderly incident capd patients
283754|NCT01944852|DIDo study|dido study
283755|NCT01944839|Wet AMD|wet amd
283756|NCT01944839|choroidal neovascularization|choroidal neovascularization
283757|NCT01944839|Fovista®|fovista®
283758|NCT01944839|E10030|e10030
283759|NCT01944839|Lucentis®|lucentis®
283760|NCT01944826|Dyspnea|dyspnea
283761|NCT01944826|Angina pectoris|angina pectoris
283762|NCT01944813|Advance Care planning|advance care planning
283763|NCT01944813|End-of-life Discussions|end-of-life discussions
283764|NCT01944813|Questionaires|questionaires
283765|NCT01944813|Palliative Care|palliative care
283766|NCT01944800|Ticagrelor|ticagrelor
283767|NCT01944800|Prasugrel|prasugrel
283768|NCT01944800|Acute coronary syndrome|acute coronary syndrome
283769|NCT01944800|Percutaneous coronary intervention|percutaneous coronary intervention
283770|NCT01944774|Moxifloxacin|moxifloxacin
283771|NCT01944761|pediatrics|pediatrics
283772|NCT01944761|Brain Tumor|brain tumor
283773|NCT01944761|Neuro-radiation|neuro-radiation
283774|NCT01944761|Exercise|exercise
283775|NCT01944709|melanoma|melanoma
283776|NCT01944709|dendritic cells|dendritic cells
283777|NCT01944709|peptide|peptide
283778|NCT01944709|Melan-A|melan-a
283779|NCT01944696|hyperbilirubinemia|hyperbilirubinemia
283780|NCT01944696|prematurity|prematurity
283781|NCT01944696|extremely low birth weight (ELBW)|extremely low birth weight (elbw)
283782|NCT01944696|phototherapy|phototherapy
283783|NCT01944696|cycled phototherapy|cycled phototherapy
283784|NCT01944696|intermittent phototherapy|intermittent phototherapy
283785|NCT01944657|Major Depressive Disorder Clinical Outcomes|major depressive disorder clinical outcomes
283786|NCT01944657|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
283787|NCT01944657|Standard Medication Monotherapy|standard medication monotherapy
283788|NCT01944657|Exploratory Field Study|exploratory field study
283789|NCT01944605|Endotoxin|endotoxin
283790|NCT01944605|Cytokine|cytokine
283791|NCT01944605|Metabolism|metabolism
283792|NCT01944592|Gynaecology Teaching Associate|gynaecology teaching associate
283793|NCT01944592|Pelvic examination|pelvic examination
283794|NCT01944592|Students|students
283795|NCT01944553|Spine|spine
283796|NCT01944553|Accurancy|accurancy
283797|NCT01944553|Robotic|robotic
283798|NCT01944553|Screw placement|screw placement
283799|NCT01944553|Degenerative|degenerative
283800|NCT01944514|Action potential duration restitution|action potential duration restitution
283801|NCT01944514|Ventricular arrhythmia|ventricular arrhythmia
283802|NCT01944514|Sudden cardiac death|sudden cardiac death
283803|NCT01944514|Peri-infarct zone|peri-infarct zone
283804|NCT01944514|Electrocardiogram|electrocardiogram
283805|NCT01944501|tinnitus|tinnitus
283806|NCT01944501|hearing loss|hearing loss
283807|NCT01944501|Transcranial magnetic stimulation|transcranial magnetic stimulation
283808|NCT01944501|Transcranial direct current stimulation|transcranial direct current stimulation
283809|NCT01944488|Precocious puberty|precocious puberty
283810|NCT01944488|GnRH-test|gnrh-test
283811|NCT01944475|Precocious puberty|precocious puberty
283812|NCT01944475|Premature thelarche|premature thelarche
283813|NCT01944475|Tanner-stage|tanner-stage
283814|NCT01944475|GnRH-test|gnrh-test
283815|NCT01944462|pneumococcal vaccine|pneumococcal vaccine
283816|NCT01944462|pharmacist vaccination|pharmacist vaccination
283817|NCT01944462|Pneumovax 23|pneumovax 23
283818|NCT01944462|pneumococcal vaccine polyvalent|pneumococcal vaccine polyvalent
283819|NCT01944449|Type 2 diabetes (T2D)|type 2 diabetes (t2d)
283820|NCT01944449|Whey Protein Concentrate (WPC)|whey protein concentrate (wpc)
283821|NCT01944436|Pharmacogenomics|pharmacogenomics
283822|NCT01944436|Dementia with Lewy bodies|dementia with lewy bodies
283823|NCT01944436|Adverse events|adverse events
283824|NCT01944436|Polymorphisms|polymorphisms
283825|NCT01944436|Acetylcholinesterase|acetylcholinesterase
283826|NCT01944436|Parkinson's Disease Dementia|parkinson's disease dementia
283827|NCT01944436|Cognitive enhancers|cognitive enhancers
283828|NCT01944436|Clinical efficacy|clinical efficacy
283829|NCT01944436|Cytochrome P450|cytochrome p450
283830|NCT01944436|Butyrylcholinesterase|butyrylcholinesterase
283831|NCT01944410|PRP|prp
283832|NCT01944410|TBC|tbc
283833|NCT01944410|Treatment|treatment
283834|NCT01944397|Atrial fibrillation|atrial fibrillation
283835|NCT01944397|Heart failure|heart failure
283836|NCT01944397|Stroke|stroke
283837|NCT01944397|Myocardial infarction|myocardial infarction
283838|NCT01944371|Latent reservoir|latent reservoir
283839|NCT01944358|Syphilis; human immunodeficiency virus; penicillin|syphilis; human immunodeficiency virus; penicillin
283840|NCT01944332|gamete treatment|gamete treatment
283841|NCT01944332|ICSI|icsi
283842|NCT01944332|IVF|ivf
283843|NCT01944332|infertility|infertility
283844|NCT01944332|oocyte activation|oocyte activation
283845|NCT01944319|Infection; Meropenem; Pharmacokinetics; Pharmacodynamics|infection; meropenem; pharmacokinetics; pharmacodynamics
283846|NCT01944306|Pharmacokinetics|pharmacokinetics
283847|NCT01944306|Pharmacology, Clinical|pharmacology, clinical
283848|NCT01944306|Drug Efficacy|drug efficacy
283849|NCT01944306|Drug Failure|drug failure
283850|NCT01944306|Contraceptive Agents|contraceptive agents
283851|NCT01944293|Ketamine|ketamine
283852|NCT01944293|Midazolam|midazolam
283853|NCT01944293|Bipolar Disorder|bipolar disorder
283854|NCT01944293|Major Depressive Episode|major depressive episode
283855|NCT01944293|Suicidal Ideation|suicidal ideation
283856|NCT01944293|Suicide|suicide
283857|NCT01944293|Depression|depression
283858|NCT01944293|Treatment|treatment
283859|NCT01944293|Ketamine Treatment|ketamine treatment
283860|NCT01944254|Cardiac surgical procedures|cardiac surgical procedures
283861|NCT01944254|Pulmonary Artery Catheterizations|pulmonary artery catheterizations
283862|NCT01944254|Cardiac output|cardiac output
283863|NCT01944254|Swan Ganz Catheterization|swan ganz catheterization
283864|NCT01944241|cervical surgery|cervical surgery
283865|NCT01944241|LLETZ|lletz
283866|NCT01944241|LEEP|leep
283867|NCT01944241|Cone biopsy|cone biopsy
283868|NCT01944241|Fertility|fertility
283869|NCT01944228|inflammation|inflammation
283870|NCT01944228|vagus nerve stimulation|vagus nerve stimulation
283871|NCT01944228|chronic heart failure|chronic heart failure
283872|NCT01944228|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
283873|NCT01944228|sepsis|sepsis
283874|NCT01944228|auto-immune diseases|auto-immune diseases
283875|NCT01944215|Normal subjects|normal subjects
283876|NCT01944215|Female|female
283877|NCT01944215|Molecular Breast Imaging|molecular breast imaging
283878|NCT01944215|Fasting|fasting
283879|NCT01944215|Exercise|exercise
283880|NCT01944215|Tracer Uptake|tracer uptake
283881|NCT01944215|Tc-99m Sestamibi|tc-99m sestamibi
283882|NCT01944215|Prandial status|prandial status
283883|NCT01944215|metabolic status|metabolic status
283884|NCT01944215|negative mammogram|negative mammogram
283885|NCT01944215|Caffeine|caffeine
283886|NCT01944215|External Warming|external warming
283887|NCT01944202|Echocardiography|echocardiography
283888|NCT01944202|Appropriate Use Criteria|appropriate use criteria
283889|NCT01944202|Educational Intervention|educational intervention
283890|NCT01944189|lumefantrine pharmacokinetics & bioavailability|lumefantrine pharmacokinetics & bioavailability
283891|NCT01944176|COPD|copd
283892|NCT01944176|Statins|statins
283893|NCT01944176|Cytokines|cytokines
283894|NCT01944163|Low back pain|low back pain
283895|NCT01944163|Impact analysis|impact analysis
283896|NCT01944163|Cluster randomized trial|cluster randomized trial
283897|NCT01944163|Referral rule|referral rule
283898|NCT01944163|Axial spondyloarthritis|axial spondyloarthritis
283899|NCT01944150|Hypnosis|hypnosis
283900|NCT01944150|chronic pain|chronic pain
283901|NCT01944150|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
283902|NCT01944150|nociceptive pain|nociceptive pain
283903|NCT01944150|neuropathic pain|neuropathic pain
283904|NCT01944150|complementary therapies|complementary therapies
283905|NCT01944137|colonic neoplasms|colonic neoplasms
283906|NCT01944137|Lung neoplasms|lung neoplasms
283907|NCT01944137|patient-centered nursing|patient-centered nursing
283908|NCT01944137|breast neoplasms|breast neoplasms
283909|NCT01944124|Mobile health|mobile health
283910|NCT01944124|Metabolic syndrome|metabolic syndrome
283911|NCT01944124|Exercise prescription|exercise prescription
283912|NCT01944124|Exercise intervention|exercise intervention
283913|NCT01944124|Disease prevention|disease prevention
283914|NCT01944124|Rural health|rural health
283915|NCT01944111|Gastric plication|gastric plication
283916|NCT01944085|children|children
283917|NCT01944085|supracondylar fracture|supracondylar fracture
283918|NCT01944085|pin removal|pin removal
283919|NCT01944085|analgesia|analgesia
283920|NCT01944085|pain score|pain score
283921|NCT01944072|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
283922|NCT01944072|COPD|copd
283923|NCT01944072|Pulmonary rehabilitation|pulmonary rehabilitation
283924|NCT01944072|Aerobic exercise|aerobic exercise
283925|NCT01944072|CEDOC|cedoc
283926|NCT01944072|FCM|fcm
283927|NCT01944072|UNL|unl
283928|NCT01944072|NOVA MEDICAL SCHOOL|nova medical school
283929|NCT01944046|autism, ASD, autistic, Asperger's, PDD-NOS, oxytocin|autism, asd, autistic, asperger's, pdd-nos, oxytocin
283930|NCT01944033|β2-agonist|β2-agonist
283931|NCT01944033|Ipratropium Bromide|ipratropium bromide
283932|NCT01944033|Chronic Obstructive Pulmonary Disease Exacerbation|chronic obstructive pulmonary disease exacerbation
283933|NCT01944033|Emergency departement|emergency departement
283934|NCT01944020|Sleep Apnea, Obstructive|sleep apnea, obstructive
283935|NCT01944020|Energy Balance|energy balance
283936|NCT01944020|Food Intake|food intake
283937|NCT01944020|Energy Expenditure|energy expenditure
283938|NCT01944020|Sleep|sleep
283939|NCT01944020|Obesity|obesity
283940|NCT01944007|CLP|clp
283941|NCT01943994|Psilocybin|psilocybin
283942|NCT01943994|Smoking cessation|smoking cessation
283943|NCT01943955|dizziness|dizziness
283944|NCT01943955|vertigo|vertigo
283945|NCT01943955|unsteadiness|unsteadiness
283946|NCT01943955|unbalance|unbalance
283947|NCT01943955|falls|falls
283948|NCT01943942|Mexico|mexico
283949|NCT01943942|Montelukast|montelukast
283950|NCT01943942|Pharmacokinetics|pharmacokinetics
283951|NCT01943942|Bioequivalence|bioequivalence
283952|NCT01943929|Nasal septum|nasal septum
283953|NCT01943929|Headache|headache
283954|NCT01943929|Mucosa contact point headache|mucosa contact point headache
283955|NCT01943916|breast imaging diagnosis|breast imaging diagnosis
283956|NCT01943916|breast ultrasound|breast ultrasound
283957|NCT01943916|Imagio|imagio
284061|NCT01943487|Tamsulosin OCAS|tamsulosin ocas
283958|NCT01943916|Seno Medical Instruments, Inc.|seno medical instruments, inc.
283959|NCT01943916|Seno|seno
283960|NCT01943916|opto-acoustics|opto-acoustics
283961|NCT01943916|OA|oa
283962|NCT01943916|angiogenesis|angiogenesis
283963|NCT01943916|blood map|blood map
283964|NCT01943890|Hypertonic saline|hypertonic saline
283965|NCT01943890|Lung physiotherapy|lung physiotherapy
283966|NCT01943864|pharmacokinetics|pharmacokinetics
283967|NCT01943864|second line monotherapy|second line monotherapy
283968|NCT01943864|GSK1120212 (trametinib)|gsk1120212 (trametinib)
283969|NCT01943864|MEK inhibitor|mek inhibitor
283970|NCT01943864|locally advanced or metastatic biliary tract cancers|locally advanced or metastatic biliary tract cancers
283971|NCT01943851|leukemia|leukemia
283972|NCT01943851|Acute myeloid leukemia|acute myeloid leukemia
283973|NCT01943851|BET inhibitor|bet inhibitor
283974|NCT01943851|lymphoma|lymphoma
283975|NCT01943851|Myelodysplastic syndromes|myelodysplastic syndromes
283976|NCT01943851|Oncology|oncology
283977|NCT01943851|multiple myeloma|multiple myeloma
283978|NCT01943851|GSK525762|gsk525762
283979|NCT01943825|Dengue|dengue
283980|NCT01943825|Dengue fever|dengue fever
283981|NCT01943825|CYD dengue vaccine|cyd dengue vaccine
283982|NCT01943825|IXIARO JE vaccine|ixiaro je vaccine
283983|NCT01943825|Flavivirus|flavivirus
283984|NCT01943799|Hepatitis B (HBV)|hepatitis b (hbv)
283985|NCT01943799|Oral antiviral (OAV)|oral antiviral (oav)
283986|NCT01943799|GS-4774|gs-4774
283987|NCT01943786|Wild type KRAS|wild type kras
283988|NCT01943773|delirium|delirium
283989|NCT01943773|surgery|surgery
283990|NCT01943773|operation|operation
283991|NCT01943773|geriatric|geriatric
283992|NCT01943773|complication|complication
283993|NCT01943760|Tramadol|tramadol
283994|NCT01943760|Children|children
283995|NCT01943760|Hernioplasty|hernioplasty
283996|NCT01943760|Wound infiltration|wound infiltration
283997|NCT01943747|sepsis|sepsis
283998|NCT01943747|severe sepsis|severe sepsis
283999|NCT01943747|septic shock|septic shock
284000|NCT01943747|infection|infection
284001|NCT01943747|organ dysfunction|organ dysfunction
284002|NCT01943747|quality improvement|quality improvement
284003|NCT01943734|Information|information
284004|NCT01943734|Lifestyle|lifestyle
284005|NCT01943734|Occupational Health|occupational health
284006|NCT01943695|Breast Cancer|breast cancer
284007|NCT01943695|Exercise|exercise
284008|NCT01943695|Chemotherapy|chemotherapy
284009|NCT01943695|15-178|15-178
284010|NCT01943682|Relapsed acute myeloid leukemia|relapsed acute myeloid leukemia
284011|NCT01943682|non-therapy related acute myeloid leukemia|non-therapy related acute myeloid leukemia
284012|NCT01943682|Refractory acute myeloid leukemia|refractory acute myeloid leukemia
284013|NCT01943682|Untreated acute myeloid leukemia|untreated acute myeloid leukemia
284014|NCT01943682|Lymphoma|lymphoma
284015|NCT01943682|Leukemia|leukemia
284016|NCT01943669|Spinal Cord Injury|spinal cord injury
284017|NCT01943656|Spinal Cord Injury|spinal cord injury
284018|NCT01943643|angiography, bifurcation, stenting, CT|angiography, bifurcation, stenting, ct
284019|NCT01943630|HPV condyloma acuminata|hpv condyloma acuminata
284020|NCT01943617|Liver Cirrhosis|liver cirrhosis
284021|NCT01943617|Hepatitis B|hepatitis b
284022|NCT01943617|Compensation|compensation
284023|NCT01943617|Efficacy|efficacy
284024|NCT01943604|Neuropsychology|neuropsychology
284025|NCT01943604|Breakfast eating patters|breakfast eating patters
284026|NCT01943604|Glucose|glucose
284027|NCT01943604|Child Psychology|child psychology
284028|NCT01943591|treatment trial|treatment trial
284029|NCT01943591|cerebral aneurysm|cerebral aneurysm
284030|NCT01943591|randomized|randomized
284031|NCT01943591|coils|coils
284032|NCT01943591|endovascular|endovascular
284033|NCT01943591|Aneurysm|aneurysm
284034|NCT01943591|Intracranial Aneurysm|intracranial aneurysm
284035|NCT01943591|Vascular Diseases|vascular diseases
284036|NCT01943591|Cardiovascular Diseases|cardiovascular diseases
284037|NCT01943591|Intracranial Arterial Diseases|intracranial arterial diseases
284038|NCT01943591|Cerebrovascular Disorders|cerebrovascular disorders
284039|NCT01943591|Brain Diseases|brain diseases
284040|NCT01943591|Central Nervous System Diseases|central nervous system diseases
284041|NCT01943591|Nervous System Diseases|nervous system diseases
284042|NCT01943565|Pregnancy|pregnancy
284043|NCT01943565|Healthy|healthy
284044|NCT01943565|Intrathecal|intrathecal
284045|NCT01943565|Opioids|opioids
284046|NCT01943565|Spinal|spinal
284047|NCT01943565|Anesthesia|anesthesia
284048|NCT01943565|Pain|pain
284049|NCT01943565|Cesarean|cesarean
284050|NCT01943565|Delivery|delivery
284051|NCT01943565|Human|human
284052|NCT01943526|Ireland|ireland
284053|NCT01943526|Natalizumab|natalizumab
284054|NCT01943513|Muscle Disuse Atrophy|muscle disuse atrophy
284055|NCT01943500|Breast cancer|breast cancer
284056|NCT01943500|Prostate cancer|prostate cancer
284057|NCT01943500|Colorectal cancer|colorectal cancer
284058|NCT01943500|Circulating tumor cell (CTC)|circulating tumor cell (ctc)
284059|NCT01943487|Phase I|phase i
284060|NCT01943487|Verapamil|verapamil
284063|NCT01943487|Pharmacokinetics|pharmacokinetics
284064|NCT01943487|EC905|ec905
284065|NCT01943474|IV Catheter comparison|iv catheter comparison
284066|NCT01943474|AccuCath versus Conventional IV Catheters|accucath versus conventional iv catheters
284067|NCT01943474|IV Catheter Study|iv catheter study
284068|NCT01943474|IV Catheter User Preference Comparison|iv catheter user preference comparison
284069|NCT01943474|First Attempt Success Rate for IV Catheters|first attempt success rate for iv catheters
284070|NCT01943474|AccuCath Device Performance|accucath device performance
284071|NCT01943474|Complication Rates for IV Catheters|complication rates for iv catheters
284072|NCT01943474|Average Dwell Time for IV Catheters|average dwell time for iv catheters
284073|NCT01943474|Patient Satisfaction with IV Catheters|patient satisfaction with iv catheters
284074|NCT01943474|Clinician Satisfaction with AccuCath Device Performance|clinician satisfaction with accucath device performance
284075|NCT01943461|Solid Tumors|solid tumors
284076|NCT01943461|MSB0010718C|msb0010718c
284077|NCT01943461|anti PD-L1|anti pd-l1
284078|NCT01943461|avelumab|avelumab
284079|NCT01943461|Phase 1|phase 1
284080|NCT01943448|Macula Lutea Hemorrhage|macula lutea hemorrhage
284081|NCT01943448|High Myopia|high myopia
284082|NCT01943448|Optical Coherence Tomography|optical coherence tomography
284083|NCT01943435|Spinal Stenosis|spinal stenosis
284084|NCT01943435|Spinal manipulation|spinal manipulation
284085|NCT01943435|Exercise|exercise
284086|NCT01943435|Epidural injection|epidural injection
284087|NCT01943422|advanced|advanced
284088|NCT01943422|melanoma|melanoma
284089|NCT01943422|Vemurafenib|vemurafenib
284090|NCT01943422|High-dose Interferon alfa-2b|high-dose interferon alfa-2b
284091|NCT01943409|Parenteral nutrition|parenteral nutrition
284092|NCT01943409|lipid emulsion|lipid emulsion
284093|NCT01943409|Intralipid|intralipid
284094|NCT01943409|ClinOleic|clinoleic
284095|NCT01943409|Inflammation|inflammation
284096|NCT01943409|Infection|infection
284097|NCT01943409|Bloodstream Infection|bloodstream infection
284098|NCT01943409|length of stay|length of stay
284099|NCT01943409|mortality|mortality
284100|NCT01943396|age-related macular degeneration|age-related macular degeneration
284102|NCT01943396|rheohemapheresis|rheohemapheresis
284103|NCT01943396|plasma filtration|plasma filtration
284104|NCT01943396|electroretinography|electroretinography
284105|NCT01943396|ERG|erg
284106|NCT01943396|multifocal ERG|multifocal erg
284107|NCT01943396|double plasma filtration|double plasma filtration
284108|NCT01943383|Hypertension|hypertension
284109|NCT01943370|endoscopic sinus surgery|endoscopic sinus surgery
284110|NCT01943370|post-operative irrigation|post-operative irrigation
284111|NCT01943370|pain|pain
284112|NCT01943370|debridement|debridement
284113|NCT01943357|diabetes|diabetes
284114|NCT01943357|patient education|patient education
284115|NCT01943357|self management|self management
284116|NCT01943357|health improvement|health improvement
284117|NCT01943344|vascular large hole closure|vascular large hole closure
284118|NCT01943344|arteriotomy closure|arteriotomy closure
284119|NCT01943344|Large hole vascular closure device|large hole vascular closure device
284120|NCT01943344|vascular closure device|vascular closure device
284121|NCT01943344|percutaneous vascular closure device|percutaneous vascular closure device
284122|NCT01943318|Liver Cirrhosis|liver cirrhosis
284123|NCT01943318|Hepatocellular carcinoma|hepatocellular carcinoma
284124|NCT01943305|Yellow Fever|yellow fever
284125|NCT01943305|vaccination|vaccination
284126|NCT01943305|Japanese encephalitis|japanese encephalitis
284127|NCT01943305|antibodies|antibodies
284128|NCT01943292|Focal Adhesion Kinase inhibitor|focal adhesion kinase inhibitor
284129|NCT01943292|FAK inhibitor|fak inhibitor
284130|NCT01943292|Cancer Stem Cells|cancer stem cells
284131|NCT01943292|CSC|csc
284132|NCT01943279|medical abortion|medical abortion
284133|NCT01943279|telephone follow-up|telephone follow-up
284134|NCT01943279|ultrasound|ultrasound
284135|NCT01943279|serum hCG|serum hcg
284136|NCT01943279|methotrexate|methotrexate
284137|NCT01943279|misoprostol|misoprostol
284138|NCT01943253|Early gastric cancer,|early gastric cancer,
284139|NCT01943253|endoscopic submucosal dissection (ESD)|endoscopic submucosal dissection (esd)
284140|NCT01943253|water-jet assisted ESD|water-jet assisted esd
284141|NCT01943227|humidity|humidity
284142|NCT01943227|enthalpy|enthalpy
284143|NCT01943227|mechanical ventilation|mechanical ventilation
284144|NCT01943214|Diabetes Mellitus|diabetes mellitus
284145|NCT01943214|Body constitution|body constitution
284146|NCT01943175|schizophrenia|schizophrenia
284147|NCT01943175|stem cells|stem cells
284148|NCT01943175|neurons|neurons
284149|NCT01943175|genetic hish risk for schizophrenia|genetic hish risk for schizophrenia
284150|NCT01943136|impetigo|impetigo
284151|NCT01943136|papaya extract ointment|papaya extract ointment
284152|NCT01943123|probiotics,|probiotics,
284153|NCT01943123|streptococcus mutans,|streptococcus mutans,
284154|NCT01943123|lactobacilli,|lactobacilli,
284155|NCT01943123|plaque index,|plaque index,
284156|NCT01943123|gingival index|gingival index
284157|NCT01943110|Intradermal injections|intradermal injections
284158|NCT01943110|Vaccine delivery devices|vaccine delivery devices
284159|NCT01943071|dementia|dementia
284160|NCT01943071|day care centre programs|day care centre programs
284161|NCT01943071|patients|patients
284162|NCT01943071|family carers|family carers
284163|NCT01943071|cost-consequence analysis|cost-consequence analysis
284164|NCT01943006|Mucopolysaccaride polysulfate (MPS)|mucopolysaccaride polysulfate (mps)
284165|NCT01943006|MPS|mps
284166|NCT01943006|Heparinoide|heparinoide
284167|NCT01943006|Infusionphlebitis|infusionphlebitis
284168|NCT01943006|Prevention|prevention
284169|NCT01943006|Superficial thrombophlebitis|superficial thrombophlebitis
284170|NCT01943006|Treatment|treatment
284171|NCT01942993|melanoma|melanoma
284172|NCT01942993|unresectable|unresectable
284173|NCT01942993|mutation|mutation
284174|NCT01942993|BRAF protein|braf protein
284175|NCT01942980|Breast cancer|breast cancer
284176|NCT01942980|one brain metastasis|one brain metastasis
284177|NCT01942967|Neonate|neonate
284178|NCT01942967|Hemodynamic|hemodynamic
284179|NCT01942967|Tissue oxygenation|tissue oxygenation
284180|NCT01942967|Non invasive ventilation|non invasive ventilation
284181|NCT01942954|Alcohol Dependence|alcohol dependence
284182|NCT01942954|Cognitive Therapy|cognitive therapy
284183|NCT01942954|Executive Function|executive function
284184|NCT01942954|Mobile Health|mobile health
284185|NCT01942954|Recovery of Function|recovery of function
284186|NCT01942954|Rehabilitation|rehabilitation
284187|NCT01942889|COPD|copd
284188|NCT01942889|exercise training|exercise training
284189|NCT01942889|pulmonary rehabilitation|pulmonary rehabilitation
284190|NCT01942889|antioxidant|antioxidant
284191|NCT01942889|muscle|muscle
284192|NCT01942876|Drugs|drugs
284193|NCT01942876|at risk|at risk
284194|NCT01942876|community health center patients|community health center patients
284195|NCT01942837|Enzalutamid|enzalutamid
284196|NCT01942837|Prostate Cancer|prostate cancer
284197|NCT01942811|DRUG PREVENTION|drug prevention
284198|NCT01942811|BINATIONAL|binational
284199|NCT01942811|CASUAL USE OF ILLICIT DRUGS|casual use of illicit drugs
284200|NCT01942811|BRIEF INTERVENTION|brief intervention
284201|NCT01942811|SBIRT|sbirt
284202|NCT01942798|Rehabilitation|rehabilitation
284203|NCT01942798|Lower Limb Amputation|lower limb amputation
284204|NCT01942798|Prosthetic|prosthetic
284205|NCT01942798|Walking|walking
284206|NCT01942798|unilateral transtibial amputation|unilateral transtibial amputation
284207|NCT01942798|unilateral transfemoral amputation|unilateral transfemoral amputation
284208|NCT01942798|older adults|older adults
284209|NCT01942798|cognitive computer games|cognitive computer games
284210|NCT01942798|home-based training|home-based training
284211|NCT01942798|Nintendo Wii|nintendo wii
284212|NCT01942798|virtual reality|virtual reality
284213|NCT01942772|powered ankle-foot orthosis|powered ankle-foot orthosis
284214|NCT01942772|mechanical structure|mechanical structure
284215|NCT01942772|optimization|optimization
284216|NCT01942772|dorsiflexion|dorsiflexion
284217|NCT01942772|plantar flexion|plantar flexion
284218|NCT01942772|gait|gait
284219|NCT01942772|servomotor|servomotor
284220|NCT01942772|ankle rehabilitation|ankle rehabilitation
284221|NCT01942759|Breast Neoplasms|breast neoplasms
284222|NCT01942759|Positron-Emission Tomography|positron-emission tomography
284223|NCT01942759|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
284224|NCT01942746|blueberry|blueberry
284225|NCT01942746|anthocyanin|anthocyanin
284226|NCT01942746|dark vision|dark vision
284227|NCT01942746|photo bleaching|photo bleaching
284228|NCT01942746|Visual Perception|visual perception
284229|NCT01942746|Photic Stimulation|photic stimulation
284230|NCT01942707|Abdominoplasty,Seroma,Bariatric surgery|abdominoplasty,seroma,bariatric surgery
284231|NCT01942694|Prediabetes|prediabetes
284232|NCT01942694|Vitamin D|vitamin d
284233|NCT01942681|female|female
284234|NCT01942681|mixed urinary incontinence|mixed urinary incontinence
284235|NCT01942668|Vasomotor symptoms|vasomotor symptoms
284236|NCT01942668|Hot flashes|hot flashes
284237|NCT01942668|Endometrial protection|endometrial protection
284238|NCT01942655|HIV|hiv
284239|NCT01942655|Chronic inflammatory bowel disease|chronic inflammatory bowel disease
284240|NCT01942655|Reservoirs|reservoirs
284241|NCT01942655|IL-17|il-17
284242|NCT01942655|IL-23|il-23
284243|NCT01942655|Intestinal biopsies|intestinal biopsies
284244|NCT01942642|cataract surgery, meibomian gland dysfunction, meibum expressibility, meibography|cataract surgery, meibomian gland dysfunction, meibum expressibility, meibography
284245|NCT01942629|prognostic markers,Pancreatic ductal adenocarcinoma|prognostic markers,pancreatic ductal adenocarcinoma
284246|NCT01942616|IPV|ipv
284247|NCT01942603|Minimal (SN) tumor burden|minimal (sn) tumor burden
284248|NCT01942603|Stage III|stage iii
284249|NCT01942603|Patients|patients
284250|NCT01942603|Lymphnode Dissections|lymphnode dissections
284251|NCT01942590|Pompe disease|pompe disease
284252|NCT01942577|NoSting|nosting
284253|NCT01942577|Skin protectants|skin protectants
284254|NCT01942577|Emollients|emollients
284255|NCT01942577|Skin microbiome|skin microbiome
284256|NCT01942564|traumatic brain injury|traumatic brain injury
284257|NCT01942564|photophobia|photophobia
284258|NCT01942564|photosensitivity|photosensitivity
284259|NCT01942564|pupil|pupil
284261|NCT01942538|fibromyalgia|fibromyalgia
284262|NCT01942538|sham|sham
284263|NCT01942538|maintenance session|maintenance session
284264|NCT01942538|pain|pain
284265|NCT01942525|IUGR|iugr
284266|NCT01942525|aEEG|aeeg
284267|NCT01942525|preterm infants|preterm infants
284268|NCT01942525|neurodevelopmental outcome|neurodevelopmental outcome
284269|NCT01942512|Intracranial Aneurysm - Endovascular treatment -|intracranial aneurysm - endovascular treatment -
284270|NCT01942512|Coiling - Stenting - Flow diversion - Flow disruption -|coiling - stenting - flow diversion - flow disruption -
284271|NCT01942512|Recanalization - Risk factors|recanalization - risk factors
284272|NCT01942499|COPD, exercise, community|copd, exercise, community
284273|NCT01942486|migraine|migraine
284274|NCT01942486|photophobia|photophobia
284275|NCT01942486|light sensitivity|light sensitivity
284276|NCT01942486|melanopsin cells|melanopsin cells
284277|NCT01942486|intrinsically photosensitive retinal ganglion cells|intrinsically photosensitive retinal ganglion cells
284278|NCT01942460|Iron|iron
284279|NCT01942460|Anemia|anemia
284280|NCT01942460|Chronic Kidney Disease|chronic kidney disease
284281|NCT01942460|Peritoneal Dialysis|peritoneal dialysis
284282|NCT01942460|Inflammation|inflammation
284283|NCT01942460|Oxidative stress|oxidative stress
284284|NCT01942447|Fecal microbiota transplantation|fecal microbiota transplantation
284285|NCT01942447|microbiota|microbiota
284286|NCT01942447|clostridium difficile|clostridium difficile
284287|NCT01942447|clostridium difficile infection|clostridium difficile infection
284288|NCT01942447|Efficacy of FMT|efficacy of fmt
284289|NCT01942434|Fatty acids|fatty acids
284290|NCT01942434|Breast milk nutrients|breast milk nutrients
284291|NCT01942434|Cognitive development|cognitive development
284292|NCT01942434|Electrophysiology|electrophysiology
284293|NCT01942434|Long-term assessment|long-term assessment
284294|NCT01942421|Limbal deficiency|limbal deficiency
284295|NCT01942421|Cultivated limbal transplantation|cultivated limbal transplantation
284296|NCT01942421|Ex vivo limbal transplantation|ex vivo limbal transplantation
284297|NCT01942421|Cultivated autologous mucosal epithelial transplantation|cultivated autologous mucosal epithelial transplantation
284298|NCT01942408|Atrial fibrillation|atrial fibrillation
284299|NCT01942408|Pulmonary vein isolation|pulmonary vein isolation
284300|NCT01942408|Pulmonary vein reconnection|pulmonary vein reconnection
284301|NCT01942395|Diet|diet
284302|NCT01942395|Sodium|sodium
284303|NCT01942395|Hypertension|hypertension
284304|NCT01942395|Potassium|potassium
284305|NCT01942395|Antioxidants|antioxidants
284306|NCT01942395|Congestive Heart Failure|congestive heart failure
284307|NCT01942395|Heart failure with normal ejection fraction|heart failure with normal ejection fraction
284308|NCT01942395|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
284309|NCT01942382|Schizophrenia|schizophrenia
284310|NCT01942382|JNS010|jns010
284311|NCT01942382|Paliperidone Palmitate|paliperidone palmitate
284312|NCT01942382|Clinical Pharmacology|clinical pharmacology
284313|NCT01942369|Endometriosis|endometriosis
284314|NCT01942304|Sinus Floor Augmentation|sinus floor augmentation
284315|NCT01942304|Maxillary Sinus|maxillary sinus
284316|NCT01942304|Bone Substitutes|bone substitutes
284317|NCT01942304|Bone Regeneration|bone regeneration
284318|NCT01942291|Niacin|niacin
284319|NCT01942291|Endothelial function|endothelial function
284320|NCT01942291|Laropiprant|laropiprant
284322|NCT01942278|Healthcare|healthcare
284323|NCT01942278|Patients|patients
284324|NCT01942265|Influenza, Immunogenicity, Monovalent, A/H7N9, Vaccine, AS03, Adjuvant|influenza, immunogenicity, monovalent, a/h7n9, vaccine, as03, adjuvant
284325|NCT01942252|Secondhand smoking, pain, postoperative complications|secondhand smoking, pain, postoperative complications
284326|NCT01942239|hypoglycemia|hypoglycemia
284327|NCT01942239|very low birth weight neonate|very low birth weight neonate
284328|NCT01942239|continuous glucose monitoring|continuous glucose monitoring
284329|NCT01942226|Dry eye syndrome|dry eye syndrome
284330|NCT01942213|Macular|macular
284331|NCT01942213|Degeneration|degeneration
284332|NCT01942213|Age related|age related
284333|NCT01942213|Neovascular|neovascular
284334|NCT01942200|carcinoma|carcinoma
284335|NCT01942200|colon cancer|colon cancer
284336|NCT01942200|colorectal cancer|colorectal cancer
284337|NCT01942200|ambulant chemotherapy|ambulant chemotherapy
284338|NCT01942200|treatment cycles|treatment cycles
284339|NCT01942200|Oxaliplatin|oxaliplatin
284340|NCT01942200|Oxaliplatin onkovis|oxaliplatin onkovis
284341|NCT01942200|Quantity of Oxaliplatin|quantity of oxaliplatin
284342|NCT01942200|Packaging Sizes|packaging sizes
284343|NCT01942174|Antipneumococcal vaccination|antipneumococcal vaccination
284344|NCT01942174|Methotrexate treatment|methotrexate treatment
284345|NCT01942161|Schyzophrenia, pediatric patients|schyzophrenia, pediatric patients
284346|NCT01942148|Schizophrenia, Pediatric patients|schizophrenia, pediatric patients
284347|NCT01942135|Palbociclib (PD-0332991)|palbociclib (pd-0332991)
284348|NCT01942135|Fulvestrant|fulvestrant
284349|NCT01942135|Goserelin|goserelin
284350|NCT01942135|Hormone receptor-+|hormone receptor-+
284351|NCT01942135|HER2-negative|her2-negative
284352|NCT01942135|Prior Endocrine treatment|prior endocrine treatment
285150|NCT01938547|pediatrics|pediatrics
284353|NCT01942135|any menopausal status|any menopausal status
284354|NCT01942135|PALOMA-3|paloma-3
284355|NCT01942122|DLBS1442|dlbs1442
284356|NCT01942122|Endometriosis|endometriosis
284357|NCT01942122|Pain|pain
284358|NCT01942122|Visual Analogue Scale|visual analogue scale
284359|NCT01942122|Endometriosis Health Profile (EHP-30TM)|endometriosis health profile (ehp-30tm)
284360|NCT01942109|heart failure|heart failure
284361|NCT01942109|diuretics|diuretics
284362|NCT01942109|furosemide|furosemide
284363|NCT01942109|torasemide|torasemide
284364|NCT01942070|Cardiovascular Disease|cardiovascular disease
284365|NCT01942070|Myocardial Infarction|myocardial infarction
284366|NCT01942070|Bioresorbable vascular scaffold|bioresorbable vascular scaffold
284367|NCT01942070|Durable polymer everolimus-eluting stent|durable polymer everolimus-eluting stent
284368|NCT01942070|Primary angioplasty|primary angioplasty
284369|NCT01942070|Stent|stent
284370|NCT01942044|Shear stress|shear stress
284371|NCT01942044|Optical coherence tomography|optical coherence tomography
284372|NCT01942044|Drug-eluting stents|drug-eluting stents
284373|NCT01942031|Ischemic stroke|ischemic stroke
284374|NCT01942031|Hemorrhagic stroke|hemorrhagic stroke
284375|NCT01942031|TIA|tia
284376|NCT01942031|Atrial fibrillation|atrial fibrillation
284377|NCT01942031|prevention|prevention
284378|NCT01942031|primary care|primary care
284379|NCT01942018|esophagogastric junction outflow obstruction|esophagogastric junction outflow obstruction
284380|NCT01942018|EGOO|egoo
284381|NCT01942018|Per oral endoscopic myotomy|per oral endoscopic myotomy
284382|NCT01942018|POEM|poem
284383|NCT01942018|Gastroesophageal reflux disease|gastroesophageal reflux disease
284384|NCT01942018|GERD|gerd
284385|NCT01941992|head and neck|head and neck
284386|NCT01941992|Squamous Cell Carcinoma|squamous cell carcinoma
284387|NCT01941992|oral mucositis|oral mucositis
284388|NCT01941992|Chemo-radiotherapy|chemo-radiotherapy
284389|NCT01941966|Anal canal cancer;capecitabine; mitomycin; radiotherapy.|anal canal cancer;capecitabine; mitomycin; radiotherapy.
284390|NCT01941953|Metformin|metformin
284391|NCT01941953|Metastatic Colorectal Cancer|metastatic colorectal cancer
284392|NCT01941953|Fluorouracil|fluorouracil
284393|NCT01941927|Melanoma|melanoma
284394|NCT01941927|Wild-type|wild-type
284395|NCT01941927|BRAF|braf
284396|NCT01941914|Calcium electroporation|calcium electroporation
284397|NCT01941914|calcium|calcium
284398|NCT01941914|electroporation|electroporation
284399|NCT01941914|electrotransfer|electrotransfer
284400|NCT01941914|keloid|keloid
284401|NCT01941901|Cutaneous metastases|cutaneous metastases
284402|NCT01941875|controlled ovarian hyperstimulation|controlled ovarian hyperstimulation
284403|NCT01941875|gonadotropins|gonadotropins
284404|NCT01941875|intrauterine insemination|intrauterine insemination
284405|NCT01941875|infertility|infertility
284406|NCT01941875|luteal progesterone|luteal progesterone
284407|NCT01941862|computerized intervention|computerized intervention
284408|NCT01941862|cognitive bias modification|cognitive bias modification
284409|NCT01941862|anxiety|anxiety
284410|NCT01941862|mood|mood
284411|NCT01941862|perceived burdensomeness|perceived burdensomeness
284412|NCT01941862|thwarted belongingness|thwarted belongingness
284413|NCT01941862|suicide|suicide
284414|NCT01941862|post-traumatic stress disorder|post-traumatic stress disorder
284415|NCT01941849|Phaeochromocytoma|phaeochromocytoma
284416|NCT01941849|Paraganglioma|paraganglioma
284417|NCT01941849|Neuroendocrine Tumour|neuroendocrine tumour
284418|NCT01941849|Vandetanib|vandetanib
284419|NCT01941849|131I-mIBG|131i-mibg
284420|NCT01941849|Radionucleotide Therapy|radionucleotide therapy
284421|NCT01941849|Vascular Endothelial Growth Factor (VEGF)|vascular endothelial growth factor (vegf)
284422|NCT01941849|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
284423|NCT01941849|RET|ret
284424|NCT01941849|Tyrosine Kinase|tyrosine kinase
284425|NCT01941836|Statin intolerant|statin intolerant
284426|NCT01941836|Statin tolerant|statin tolerant
284427|NCT01941836|LDL|ldl
284428|NCT01941836|Cholesterol|cholesterol
284429|NCT01941823|acute renal failure|acute renal failure
284430|NCT01941823|CRRT|crrt
284431|NCT01941823|continuous dialysis|continuous dialysis
284432|NCT01941823|carnitine|carnitine
284433|NCT01941823|cardiac strain|cardiac strain
284434|NCT01941771|Breast cancer|breast cancer
284435|NCT01941771|Metronomic chemotherapy|metronomic chemotherapy
284436|NCT01941771|Vinorelbine|vinorelbine
284437|NCT01941771|Navelbine|navelbine
284438|NCT01941771|Capecitabine|capecitabine
284439|NCT01941771|Xeloda|xeloda
284440|NCT01941771|Antineoplastic Agents|antineoplastic agents
284441|NCT01941719|Diabetes Mellitus|diabetes mellitus
284442|NCT01941719|Diabetic Foot|diabetic foot
284443|NCT01941719|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
284444|NCT01941719|Diabetic Foot Education|diabetic foot education
284445|NCT01941706|Epilepsy|epilepsy
284446|NCT01941706|Seizure|seizure
284447|NCT01941706|Cognitive Behavioral Therapy|cognitive behavioral therapy
284448|NCT01941706|Mindfulness|mindfulness
284449|NCT01941706|Depression|depression
284450|NCT01941706|Depressive symptoms|depressive symptoms
284451|NCT01941706|prevention|prevention
284452|NCT01941706|Coping skills|coping skills
284453|NCT01941706|Quality of life|quality of life
284454|NCT01941706|Telehealth|telehealth
284455|NCT01941706|Phone intervention|phone intervention
284456|NCT01941706|Internet-based intervention|internet-based intervention
284457|NCT01941693|alcohol|alcohol
284458|NCT01941693|anxiety|anxiety
284459|NCT01941693|depression|depression
284460|NCT01941693|comorbidity|comorbidity
284461|NCT01941693|CBT|cbt
284462|NCT01941667|Congenital Heart Disease|congenital heart disease
284463|NCT01941667|Neonates and infants|neonates and infants
284464|NCT01941667|Telehealth|telehealth
284465|NCT01941667|Virtual Home Visits|virtual home visits
284466|NCT01941628|Cesarean section|cesarean section
284467|NCT01941628|General anesthesia|general anesthesia
284468|NCT01941628|neuromuscular blockade|neuromuscular blockade
284469|NCT01941628|Surgical conditions|surgical conditions
284470|NCT01941602|surgery|surgery
284471|NCT01941602|enoxaparin|enoxaparin
284472|NCT01941602|venous thromboembolism|venous thromboembolism
284473|NCT01941602|perioperative care|perioperative care
284474|NCT01941576|Heart defects, Congenital|heart defects, congenital
284475|NCT01941576|rhBNP|rhbnp
284476|NCT01941576|heart failure|heart failure
284477|NCT01941550|untreated, high risk prostate cancer|untreated, high risk prostate cancer
284478|NCT01941537|Atopic Dermatitis|atopic dermatitis
284479|NCT01941524|Brain oxygenation|brain oxygenation
284480|NCT01941524|NIRS|nirs
284481|NCT01941524|aEEG|aeeg
284482|NCT01941524|surfactant|surfactant
284483|NCT01941511|QTc|qtc
284484|NCT01941511|African-American|african-american
284485|NCT01941511|GMI-1070|gmi-1070
284486|NCT01941511|QT/QTc interval prolongation|qt/qtc interval prolongation
284487|NCT01941498|nearsighted|nearsighted
284488|NCT01941498|farsighted|farsighted
284489|NCT01941498|astigmatism|astigmatism
284490|NCT01941498|LASIK|lasik
284491|NCT01941498|refractive surgery|refractive surgery
284492|NCT01941498|WaveLight|wavelight
284493|NCT01941485|nearsighted|nearsighted
284494|NCT01941485|astigmatism|astigmatism
284495|NCT01941485|LASIK|lasik
284496|NCT01941485|refractive surgery|refractive surgery
284497|NCT01941485|WaveLight|wavelight
284498|NCT01941459|CK-MB|ck-mb
284499|NCT01941459|troponin-T|troponin-t
284500|NCT01941433|rheumatoid arthritis|rheumatoid arthritis
284501|NCT01941433|self-management|self-management
284502|NCT01941433|online|online
284503|NCT01941433|patient passport|patient passport
284504|NCT01941420|CK-MB|ck-mb
284505|NCT01941420|troponin-T|troponin-t
284506|NCT01941420|Cytokines under ischemia|cytokines under ischemia
284507|NCT01941394|GVHD|gvhd
284508|NCT01941394|Relapse|relapse
284509|NCT01941394|Overall Survival|overall survival
284510|NCT01941381|Otitis Media|otitis media
284511|NCT01941381|Tympanometry|tympanometry
284512|NCT01941368|Performance|performance
284513|NCT01941368|Aerobic Exercise|aerobic exercise
284514|NCT01941342|Obstructive Jaundice|obstructive jaundice
284515|NCT01941342|Preoperative Biliary Drainage|preoperative biliary drainage
284516|NCT01941342|Pancreatoduodenectomy|pancreatoduodenectomy
284517|NCT01941329|Diabetes|diabetes
284518|NCT01941329|Proliferative Retinopathy|proliferative retinopathy
284519|NCT01941329|Ranibizumab|ranibizumab
284520|NCT01941329|Panretinal Photocoagulation|panretinal photocoagulation
284521|NCT01941316|Carfilzomib|carfilzomib
284522|NCT01941316|Irinotecan|irinotecan
284523|NCT01941316|Small Cell Lung Cancer|small cell lung cancer
284524|NCT01941316|Non Small Cell Lung Cancer|non small cell lung cancer
284525|NCT01941316|Ovarian Cancer|ovarian cancer
284526|NCT01941316|Gastric Cancer|gastric cancer
284527|NCT01941316|Esophageal Cancer|esophageal cancer
284528|NCT01941316|Cervical Cancer|cervical cancer
284529|NCT01941303|Non-small cell lung cancer|non-small cell lung cancer
284530|NCT01941290|International|international
284531|NCT01941290|Multicenter|multicenter
284532|NCT01941290|Observational registry|observational registry
284533|NCT01941290|Orsiro Drug Eluting Stents (DES)|orsiro drug eluting stents (des)
284534|NCT01941290|Stenting|stenting
284535|NCT01941290|Treatment of Coronary Artery Disease|treatment of coronary artery disease
284536|NCT01941290|Coronary Revascularization|coronary revascularization
284537|NCT01941290|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
284538|NCT01941290|Diabetes Mellitus Type 1|diabetes mellitus type 1
284539|NCT01941290|Diabetes Mellitus Type 2|diabetes mellitus type 2
284540|NCT01941290|STEMI|stemi
284541|NCT01941290|NSTEMI|nstemi
284542|NCT01941290|Ischemia|ischemia
284543|NCT01941290|Angina|angina
284544|NCT01941290|Subgroups|subgroups
284545|NCT01941290|Acute Myocardial Infarction|acute myocardial infarction
284546|NCT01941290|Small Vessels|small vessels
284547|NCT01941290|Chronic Total Occlusion|chronic total occlusion
284548|NCT01941264|malaria|malaria
284549|NCT01941264|placenta|placenta
284550|NCT01941264|pregnancy|pregnancy
284551|NCT01941264|plasmodium falciparum|plasmodium falciparum
284552|NCT01941264|screening and treatment|screening and treatment
284553|NCT01941264|rapid diagnostic test|rapid diagnostic test
284554|NCT01941264|coartem|coartem
284555|NCT01941264|artemether-lumefantrine|artemether-lumefantrine
284556|NCT01941264|community health worker|community health worker
284557|NCT01941251|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
284558|NCT01941251|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
284559|NCT01941251|Schizophrenia|schizophrenia
284560|NCT01941251|Schizoaffective Disorder|schizoaffective disorder
284561|NCT01941251|Treatment|treatment
284562|NCT01941251|Negative Symptoms|negative symptoms
284563|NCT01941251|Positive Symptoms|positive symptoms
284565|NCT01941251|rTMS|rtms
284566|NCT01941238|Ramadan|ramadan
284567|NCT01941238|Fasting|fasting
284568|NCT01941238|Diabetes|diabetes
284569|NCT01941238|Type1|type1
284570|NCT01941238|Insulin|insulin
284571|NCT01941238|Pump|pump
284572|NCT01941225|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
284573|NCT01941225|Pulmonary vasculature|pulmonary vasculature
284574|NCT01941225|Inhaled iloprost|inhaled iloprost
284575|NCT01941225|Inhaled prostacyclin|inhaled prostacyclin
284576|NCT01941225|Dynamic hyperinflation|dynamic hyperinflation
284577|NCT01941225|Oxidative stress|oxidative stress
284578|NCT01941225|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
284579|NCT01941225|B-type natriuretic peptide|b-type natriuretic peptide
284580|NCT01941212|Music therapy|music therapy
284581|NCT01941212|pain|pain
284582|NCT01941212|gynecological surgeries|gynecological surgeries
284583|NCT01941186|Children|children
284584|NCT01941186|Developmental Delays|developmental delays
284585|NCT01941186|Early Intervention (EI)|early intervention (ei)
284586|NCT01941186|Patient Decision Aid (PDA)|patient decision aid (pda)
284587|NCT01941147|Acute Stroke|acute stroke
284588|NCT01941147|Brain Ischemia|brain ischemia
284589|NCT01941147|Extremely Low Frequency Magnetic Fields|extremely low frequency magnetic fields
284590|NCT01941121|HIV Screening|hiv screening
284591|NCT01941121|Linkage to PrEP|linkage to prep
284592|NCT01941121|Linkage to Care|linkage to care
284593|NCT01941121|CCTG|cctg
284594|NCT01941121|593|593
284595|NCT01941108|AIDS|aids
284596|NCT01941108|peer navigation|peer navigation
284597|NCT01941108|ecological momentary assessment|ecological momentary assessment
284598|NCT01941108|eMOCHA|emocha
284599|NCT01941108|Baltimore|baltimore
284600|NCT01941108|IDU|idu
284601|NCT01941030|Peripheral Artery Disease|peripheral artery disease
284602|NCT01941030|Critical Limb Ischemia|critical limb ischemia
284603|NCT01941030|Orbital Atherectomy|orbital atherectomy
284604|NCT01941030|Balloon Angioplasty|balloon angioplasty
284605|NCT01941030|Intravascular Ultrasound (IVUS)|intravascular ultrasound (ivus)
284606|NCT01941030|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
284607|NCT01941004|multiple sclerosis (MS)|multiple sclerosis (ms)
284608|NCT01941004|relapsing remitting multiple sclerosis (RRMS)|relapsing remitting multiple sclerosis (rrms)
284609|NCT01941004|fingolimod|fingolimod
284610|NCT01940978|Methamphetamine|methamphetamine
284611|NCT01940978|Methylphenidate|methylphenidate
284612|NCT01940978|ADHD|adhd
284613|NCT01940939|schizophrenia|schizophrenia
284614|NCT01940926|rheumatoid arthritis|rheumatoid arthritis
284615|NCT01940926|angiogenesis|angiogenesis
284616|NCT01940926|68Ga-PRGD2|68ga-prgd2
284617|NCT01940926|18F-FDG|18f-fdg
284618|NCT01940926|positron emission tomography/computed tomography|positron emission tomography/computed tomography
284619|NCT01940900|Wet AMD|wet amd
284620|NCT01940900|choroidal neovascularization|choroidal neovascularization
284621|NCT01940900|Fovista®|fovista®
284622|NCT01940900|E10030|e10030
284623|NCT01940900|Lucentis®|lucentis®
284624|NCT01940887|Wet AMD|wet amd
284625|NCT01940887|choroidal neovascularization|choroidal neovascularization
284626|NCT01940887|Fovista®|fovista®
284627|NCT01940887|E10030|e10030
284628|NCT01940887|Avastin®|avastin®
284629|NCT01940887|Eylea®|eylea®
284630|NCT01940874|Cerebral Oximetry.|cerebral oximetry.
284631|NCT01940874|Aortic valve stenosis.|aortic valve stenosis.
284632|NCT01940874|Aortic valve regurgitation.|aortic valve regurgitation.
284633|NCT01940874|Coronary artery disease.|coronary artery disease.
284634|NCT01940848|Iberogast|iberogast
284635|NCT01940848|efficacy|efficacy
284636|NCT01940848|safety|safety
284637|NCT01940796|Brentuximab Vedotin|brentuximab vedotin
284638|NCT01940796|GVHD|gvhd
284639|NCT01940796|Refractory Chronic Graft vs Host Disease|refractory chronic graft vs host disease
284640|NCT01940770|Diabetes Mellitus(DM)|diabetes mellitus(dm)
284641|NCT01940770|Bydureon|bydureon
284642|NCT01940770|Exenatide|exenatide
284643|NCT01940757|Necator americanus|necator americanus
284644|NCT01940757|Hookworm Infection|hookworm infection
284645|NCT01940757|Experimental challenge infection|experimental challenge infection
284646|NCT01940744|Low back pain|low back pain
284647|NCT01940744|Non-specific Low back pain|non-specific low back pain
284648|NCT01940718|Priapism|priapism
284649|NCT01940718|Sickle cell disease|sickle cell disease
284650|NCT01940718|Testosterone|testosterone
284651|NCT01940718|Androgen deficiency|androgen deficiency
284652|NCT01940705|hearing aids|hearing aids
284653|NCT01940705|counseling|counseling
285540|NCT01936519|Everolimus|everolimus
284654|NCT01940705|outcomes assessment (health care)|outcomes assessment (health care)
284655|NCT01940705|rehabilitation|rehabilitation
284656|NCT01940666|Hyperandrogenism/|hyperandrogenism/
284657|NCT01940666|FAI/|fai/
284658|NCT01940666|Metabolic syndrome/|metabolic syndrome/
284659|NCT01940666|Adipocytokines/|adipocytokines/
284660|NCT01940666|Insulin resistance.|insulin resistance.
284661|NCT01940640|neonates, DHA|neonates, dha
284662|NCT01940627|Ubiquinol, exercise|ubiquinol, exercise
284663|NCT01940614|Copeptin|copeptin
284664|NCT01940614|differential diagnosis of polyuria polydipsia syndrome|differential diagnosis of polyuria polydipsia syndrome
284665|NCT01940614|diabetes insipidus|diabetes insipidus
284666|NCT01940614|compulsive water drinking|compulsive water drinking
284667|NCT01940614|water deprivation test|water deprivation test
284668|NCT01940614|Diabetes insipidus (central and nephrogenic)|diabetes insipidus (central and nephrogenic)
284669|NCT01940601|solid tumors|solid tumors
284670|NCT01940601|balugrastim|balugrastim
284671|NCT01940575|Tissue restorative biomaterial|tissue restorative biomaterial
284672|NCT01940575|Hyaluronic acid|hyaluronic acid
284673|NCT01940575|Restylane®|restylane®
284674|NCT01940575|Wrinkle Severity Rating Scale (WSRS)|wrinkle severity rating scale (wsrs)
284675|NCT01940575|Global Aesthetic Improvement Scale (GAIS)|global aesthetic improvement scale (gais)
284676|NCT01940575|Nasolabial fold(NLF)|nasolabial fold(nlf)
284677|NCT01940562|cord blood transplantation|cord blood transplantation
284678|NCT01940562|platelets|platelets
284679|NCT01940562|eltrombopag|eltrombopag
284680|NCT01940549|PTSD|ptsd
284681|NCT01940549|tDCS|tdcs
284682|NCT01940549|Trauma|trauma
284683|NCT01940536|Hip Fracture|hip fracture
284684|NCT01940536|Blood Transfusion|blood transfusion
284685|NCT01940536|Blood Loss|blood loss
284686|NCT01940536|Tranexamic Acid|tranexamic acid
284687|NCT01940523|total knee arthroplasty|total knee arthroplasty
284688|NCT01940523|total knee replacement|total knee replacement
284689|NCT01940523|tranexamic acid|tranexamic acid
284690|NCT01940523|osteoarthritis|osteoarthritis
284691|NCT01940523|degenerative joint disease|degenerative joint disease
284692|NCT01940471|Hepatitis|hepatitis
284693|NCT01940471|Tenofovir|tenofovir
284694|NCT01940471|Viread|viread
284695|NCT01940432|simple stress urinary incontinence|simple stress urinary incontinence
284696|NCT01940419|Reduction of blood loss|reduction of blood loss
284697|NCT01940419|Surgical complication|surgical complication
284698|NCT01940419|Hysterectomy|hysterectomy
284699|NCT01940419|Antifibrinolytic Agents|antifibrinolytic agents
284700|NCT01940419|Randomized Controlled Trials|randomized controlled trials
284701|NCT01940406|Essential Tremor|essential tremor
284702|NCT01940406|Parkinson Disease|parkinson disease
284703|NCT01940406|Electrical Stimulation|electrical stimulation
284704|NCT01940406|Tremor|tremor
284705|NCT01940393|urticaria|urticaria
284706|NCT01940393|bilastine|bilastine
284707|NCT01940393|fexofenadine|fexofenadine
284708|NCT01940393|cetirizine|cetirizine
284709|NCT01940393|ebastine|ebastine
284710|NCT01940393|desloratadine|desloratadine
284711|NCT01940367|Overactive Bladder|overactive bladder
284712|NCT01940367|TENS|tens
284713|NCT01940367|PTNS|ptns
284714|NCT01940367|Electrical Nerve Stimulation|electrical nerve stimulation
284715|NCT01940367|Urge Urinary Incontinence|urge urinary incontinence
284716|NCT01940354|IV Catheter comparison|iv catheter comparison
284717|NCT01940354|AccuCath versus Conventional IV Catheters|accucath versus conventional iv catheters
284718|NCT01940354|IV Catheter Study|iv catheter study
284719|NCT01940354|IV Catheter User Preference Comparison|iv catheter user preference comparison
284720|NCT01940354|First Attempt Success Rate for IV Catheters|first attempt success rate for iv catheters
284721|NCT01940354|AccuCath Device Performance|accucath device performance
284722|NCT01940354|Patient Satisfaction with IV Catheters|patient satisfaction with iv catheters
284723|NCT01940354|Clinician Satisfaction with AccuCath Device Performance|clinician satisfaction with accucath device performance
284724|NCT01940341|Hepatitis|hepatitis
284725|NCT01940341|Tenofovir|tenofovir
284726|NCT01940341|Viread|viread
284727|NCT01940328|Ultrasound Doppler|ultrasound doppler
284728|NCT01940328|Congestive heart failure|congestive heart failure
284729|NCT01940328|Pulmonary Edema|pulmonary edema
284730|NCT01940315|Defender Study|defender study
284731|NCT01940315|experimental vaccine|experimental vaccine
284732|NCT01940315|inhalational intoxication|inhalational intoxication
284733|NCT01940302|Malnutrition; Metabolic disorders|malnutrition; metabolic disorders
284734|NCT01940289|algometry|algometry
284735|NCT01940289|pain|pain
284737|NCT01940276|Prostate cancer|prostate cancer
284738|NCT01940276|metastatic|metastatic
284739|NCT01940276|castrate resistant|castrate resistant
284740|NCT01940276|abiraterone acetate|abiraterone acetate
284741|NCT01940276|prednisone|prednisone
284742|NCT01940276|metastatic prostate cancer|metastatic prostate cancer
284743|NCT01940263|oxidative stress|oxidative stress
284744|NCT01940263|dyslipidemia|dyslipidemia
284745|NCT01940263|inflammation|inflammation
284746|NCT01940263|apoptosis|apoptosis
284747|NCT01940250|Hand, foot and mouth disease|hand, foot and mouth disease
284748|NCT01940250|Autonomic nervous system dysregulation|autonomic nervous system dysregulation
284749|NCT01940250|Magnesium sulphate|magnesium sulphate
284750|NCT01940237|Depression|depression
284751|NCT01940237|Psychotherapy|psychotherapy
284752|NCT01940237|Cancer|cancer
284753|NCT01940237|Pancreatic Cancer|pancreatic cancer
284754|NCT01940237|Lung Cancer|lung cancer
284755|NCT01940237|Colon Cancer|colon cancer
284756|NCT01940237|Prostate Cancer|prostate cancer
284757|NCT01940224|Pregabalin|pregabalin
284758|NCT01940224|Laparoscopic colorectal surgery|laparoscopic colorectal surgery
284759|NCT01940224|Postoperative pain|postoperative pain
284760|NCT01940224|Opioid consumption|opioid consumption
284761|NCT01940198|Atazanavir|atazanavir
284762|NCT01940198|long-term|long-term
284763|NCT01940198|primary care setting|primary care setting
284764|NCT01940198|sydney|sydney
284765|NCT01940159|Schizophrenia|schizophrenia
284766|NCT01940159|Schizoaffective disorders|schizoaffective disorders
284767|NCT01940120|Mitral Valve Insufficiency|mitral valve insufficiency
284768|NCT01940120|Mitral Valve Regurgitation|mitral valve regurgitation
284769|NCT01940120|Mitral Valve Incompetence|mitral valve incompetence
284770|NCT01940120|Mitral Regurgitation|mitral regurgitation
284771|NCT01940120|Mitral Insufficiency|mitral insufficiency
284772|NCT01940120|Mitral Valve|mitral valve
284773|NCT01940120|MR|mr
284774|NCT01940120|Mitral Valve Prolapse|mitral valve prolapse
284775|NCT01940120|Edge to Edge (E2E)|edge to edge (e2e)
284776|NCT01940120|Alfieri Technique|alfieri technique
284777|NCT01940120|MitraClip|mitraclip
284778|NCT01940120|Functional MR|functional mr
284779|NCT01940120|Degenerative MR|degenerative mr
284780|NCT01940120|Echocardiogram|echocardiogram
284781|NCT01940120|Coronary Artery Disease (CAD)|coronary artery disease (cad)
284782|NCT01940120|Heart Failure|heart failure
284783|NCT01940120|Heart Attack|heart attack
284784|NCT01940120|EVEREST|everest
284785|NCT01940120|EVEREST I|everest i
284786|NCT01940120|EVEREST II|everest ii
284787|NCT01940120|REALISM|realism
284788|NCT01940107|breast cancer,|breast cancer,
284789|NCT01940107|radiotherapy,|radiotherapy,
284790|NCT01940107|physical therapy,|physical therapy,
284791|NCT01940107|upper limb|upper limb
284792|NCT01940094|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
284793|NCT01940094|Wegener's granulomatosis|wegener's granulomatosis
284794|NCT01940094|WG|wg
284795|NCT01940094|GPA|gpa
284796|NCT01940094|ANCA-Associated Vasculitis|anca-associated vasculitis
284797|NCT01940094|AAV|aav
284798|NCT01940094|Vasculitis|vasculitis
284799|NCT01940094|Prednisone|prednisone
284800|NCT01940094|Glucocorticoid|glucocorticoid
284801|NCT01940094|Taper|taper
284802|NCT01940081|Cardiomyopathy, Dilated|cardiomyopathy, dilated
284803|NCT01940081|Tachycardia, Ventricular|tachycardia, ventricular
284804|NCT01940081|Ventricular Fibrillation|ventricular fibrillation
284805|NCT01940081|Arrhythmias, Cardiac/etiology|arrhythmias, cardiac/etiology
284806|NCT01940081|Arrhythmias, Cardiac/physiopathology|arrhythmias, cardiac/physiopathology
284807|NCT01940081|Magnetic Resonance Imaging|magnetic resonance imaging
284808|NCT01940081|3-Iodobenzylguanidine/diagnostic use|3-iodobenzylguanidine/diagnostic use
284809|NCT01940081|Sympathetic Nervous System/radionuclide imaging|sympathetic nervous system/radionuclide imaging
284810|NCT01940081|Electrophysiologic Techniques, Cardiac|electrophysiologic techniques, cardiac
284811|NCT01940081|Biopsy|biopsy
284812|NCT01940081|Genetic Testing|genetic testing
284813|NCT01940081|Echocardiography|echocardiography
284814|NCT01940081|Electrocardiography, Ambulatory|electrocardiography, ambulatory
284815|NCT01940081|Exercise Test|exercise test
284816|NCT01940068|Hypersensitivity|hypersensitivity
284817|NCT01940068|Milk Hypersensitivity|milk hypersensitivity
284818|NCT01940068|Immune System Diseases|immune system diseases
284819|NCT01940068|Food Hypersensitivity|food hypersensitivity
284820|NCT01940055|Balance|balance
284821|NCT01940055|Gait|gait
284822|NCT01940055|Instrumented Treadmill|instrumented treadmill
284823|NCT01940055|Recumbent cycle|recumbent cycle
284824|NCT01940055|Cognitive games|cognitive games
284825|NCT01940029|vancomycin, neurosurgery, critical ill, pharmacokinetics|vancomycin, neurosurgery, critical ill, pharmacokinetics
284826|NCT01940016|Feasibility study|feasibility study
284827|NCT01940016|Interactive voice response system (IVR)|interactive voice response system (ivr)
284828|NCT01940016|health coach|health coach
284829|NCT01940016|no evidence of disease|no evidence of disease
284830|NCT01940003|Diabetes, Gestational|diabetes, gestational
284831|NCT01940003|Pregnancy Outcome|pregnancy outcome
284832|NCT01940003|Exercise|exercise
284833|NCT01940003|glycemic control|glycemic control
284834|NCT01939990|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
284835|NCT01939977|Hyperparathyroidism|hyperparathyroidism
284836|NCT01939977|Hyperparathyroidism Secondary|hyperparathyroidism secondary
284837|NCT01939977|Paricalcitol|paricalcitol
284838|NCT01939977|Calcifediol|calcifediol
284839|NCT01939977|Parathyroid hormone|parathyroid hormone
284840|NCT01939977|Renal transplantation|renal transplantation
284841|NCT01939964|Wrinkles|wrinkles
284842|NCT01939964|Activation Mist|activation mist
284843|NCT01939951|Asthma|asthma
284844|NCT01939951|Persistent|persistent
284845|NCT01939925|patient education|patient education
284846|NCT01939925|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
284847|NCT01939925|comprehension|comprehension
284848|NCT01939925|consumer health information|consumer health information
284849|NCT01939899|MLN9708|mln9708
284850|NCT01939899|Lymphoma|lymphoma
284851|NCT01939899|IXAZOMIB|ixazomib
284852|NCT01939886|Malaria treatment efficacy|malaria treatment efficacy
284853|NCT01939886|Malaria transmission|malaria transmission
284854|NCT01939873|Kristeller maneuver; Second stage of labor;|kristeller maneuver; second stage of labor;
284855|NCT01939873|Perineal laceration; Obstetrical outcome;|perineal laceration; obstetrical outcome;
284856|NCT01939873|Neonatal outcome|neonatal outcome
284857|NCT01939847|Metastatic breast cancer|metastatic breast cancer
284858|NCT01939847|Breast cancer|breast cancer
284859|NCT01939847|Molecular profiling|molecular profiling
284860|NCT01939847|Personalized medicine|personalized medicine
284861|NCT01939834|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
284862|NCT01939834|Artificial Pancreas|artificial pancreas
284863|NCT01939834|Diabetes Assistant (DiAs)|diabetes assistant (dias)
284864|NCT01939834|Continuous Glucose Monitor|continuous glucose monitor
284865|NCT01939821|Fecal incontinence|fecal incontinence
284866|NCT01939821|attitudes|attitudes
284867|NCT01939821|knowledge|knowledge
284868|NCT01939821|quality of care|quality of care
284869|NCT01939795|cardiac resynchronization therapy (CRT)|cardiac resynchronization therapy (crt)
284870|NCT01939782|Metabolic CLock Genes (MCG)|metabolic clock genes (mcg)
284871|NCT01939782|Type 2 Diabetes (T2D)|type 2 diabetes (t2d)
284872|NCT01939769|fMRI|fmri
284873|NCT01939769|Catecholamines|catecholamines
284874|NCT01939769|Stress|stress
284875|NCT01939769|Exercise|exercise
284876|NCT01939769|Memory|memory
284877|NCT01939756|High risk non-muscle invasive urothelial bladder cancer|high risk non-muscle invasive urothelial bladder cancer
284878|NCT01939756|Intravesical BCG|intravesical bcg
284879|NCT01939756|Local toxicity|local toxicity
284880|NCT01939756|Natural baobab oil|natural baobab oil
284881|NCT01939730|Lymphoma|lymphoma
284882|NCT01939730|Follicular B-Cell Lymphoma|follicular b-cell lymphoma
284883|NCT01939730|Rituximab|rituximab
284884|NCT01939730|Rituxan|rituxan
284885|NCT01939730|GM-CSF|gm-csf
284886|NCT01939730|Sargramostim|sargramostim
284887|NCT01939730|Leukine|leukine
284888|NCT01939717|Parkinson's disease|parkinson's disease
284889|NCT01939717|Irish set dancing|irish set dancing
284890|NCT01939691|difluprednate|difluprednate
284891|NCT01939691|prednisolone acetate|prednisolone acetate
284892|NCT01939691|nepafenac|nepafenac
284893|NCT01939665|Locally advanced pancreatic carcinoma|locally advanced pancreatic carcinoma
284894|NCT01939665|LAPC|lapc
284895|NCT01939665|Irreversible electroporation|irreversible electroporation
284896|NCT01939665|NanoKnife|nanoknife
284897|NCT01939665|IRE|ire
284898|NCT01939665|Safety|safety
284899|NCT01939665|Efficacy|efficacy
284900|NCT01939665|Non-thermal ablation|non-thermal ablation
284901|NCT01939665|Percutaneous ablation|percutaneous ablation
284902|NCT01939665|Low Energy Direct Current|low energy direct current
284903|NCT01939652|minilaparotomy|minilaparotomy
284904|NCT01939652|AAA|aaa
284905|NCT01939652|fluid regime|fluid regime
284906|NCT01939639|Oxytocin|oxytocin
284907|NCT01939639|fMRI|fmri
284908|NCT01939626|embryo|embryo
284909|NCT01939626|culture|culture
284910|NCT01939613|fluid resuscitation|fluid resuscitation
284911|NCT01939613|burn|burn
284912|NCT01939613|colloid,|colloid,
284913|NCT01939613|multiple organ dysfunction|multiple organ dysfunction
284914|NCT01939613|intra-abdominal pressure|intra-abdominal pressure
284915|NCT01939600|Resistant starch|resistant starch
284916|NCT01939600|Ileostomy|ileostomy
284917|NCT01939600|In vivo|in vivo
284918|NCT01939600|Carbohydrate digestibility|carbohydrate digestibility
284919|NCT01939587|Adenosine A1 receptor antagonist|adenosine a1 receptor antagonist
284920|NCT01939587|Asthma|asthma
284921|NCT01939587|adenosine receptor modulator|adenosine receptor modulator
284922|NCT01939587|COPD|copd
284923|NCT01939574|Glioblastoma|glioblastoma
284924|NCT01939574|Potential Image Biomarkers|potential image biomarkers
284925|NCT01939574|PFS|pfs
284926|NCT01939574|Bevacizumab|bevacizumab
284927|NCT01939574|Conventional Therapy|conventional therapy
284928|NCT01939561|Myotonia|myotonia
284929|NCT01939561|Lamotrigine|lamotrigine
284930|NCT01939561|RCT|rct
284931|NCT01939561|treatment|treatment
284932|NCT01939548|PF-02545920|pf-02545920
284933|NCT01939548|schizophrenia|schizophrenia
284934|NCT01939548|outpatient|outpatient
284935|NCT01939548|safety|safety
284936|NCT01939548|efficacy|efficacy
284937|NCT01939548|suboptimal response|suboptimal response
284938|NCT01939535|Endometriosis|endometriosis
284939|NCT01939535|Magnetic resonance imaging|magnetic resonance imaging
284940|NCT01939522|diabetes|diabetes
284941|NCT01939522|pneumococcal|pneumococcal
284942|NCT01939496|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
284943|NCT01939496|Hypertension|hypertension
284944|NCT01939496|Canagliflozin|canagliflozin
284945|NCT01939496|JNJ 28431754|jnj 28431754
285046|NCT01939041|Motor control|motor control
284946|NCT01939496|Sodium-Glucose Transporter 2|sodium-glucose transporter 2
284947|NCT01939496|Blood Glucose|blood glucose
284948|NCT01939496|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
284949|NCT01939483|Irinotecan hydrochloride|irinotecan hydrochloride
284950|NCT01939483|Irinotecan|irinotecan
284951|NCT01939483|CAMPTOSAR|camptosar
284952|NCT01939470|osteoporosis|osteoporosis
284953|NCT01939470|bone|bone
284954|NCT01939470|inflammation|inflammation
284955|NCT01939470|diabetes|diabetes
284956|NCT01939470|vitamin D|vitamin d
284957|NCT01939444|Antidotes|antidotes
284958|NCT01939444|naloxone|naloxone
284959|NCT01939444|administration, intravenous|administration, intravenous
284960|NCT01939444|administration, intranasal|administration, intranasal
284961|NCT01939444|pharmacology|pharmacology
284962|NCT01939431|Podoconiosis|podoconiosis
284963|NCT01939431|Gene Expression|gene expression
284964|NCT01939431|Genomics|genomics
284965|NCT01939431|Pathogenesis|pathogenesis
284966|NCT01939418|metastatic breast cancer|metastatic breast cancer
284967|NCT01939418|triple negative breast cancer|triple negative breast cancer
284968|NCT01939418|gemcitabine|gemcitabine
284969|NCT01939418|RAD001|rad001
284970|NCT01939405|Obesity|obesity
284971|NCT01939405|Overweight|overweight
284972|NCT01939405|Physical Activity|physical activity
284973|NCT01939405|Built Environment|built environment
284974|NCT01939405|counseling|counseling
284975|NCT01939392|Resistant hypertension|resistant hypertension
284976|NCT01939392|Uncontrolled hypertension|uncontrolled hypertension
284977|NCT01939392|Renal artery ablation|renal artery ablation
284978|NCT01939379|Total knee arthroplasty|total knee arthroplasty
284979|NCT01939379|nerve block|nerve block
284980|NCT01939379|Pain control after surgery|pain control after surgery
284981|NCT01939366|Painful Diabetic Peripheral Neuropathy|painful diabetic peripheral neuropathy
284982|NCT01939353|Adult ADHD|adult adhd
284983|NCT01939327|diffuse large B cell|diffuse large b cell
284984|NCT01939327|non-Hodgkin lymphoma|non-hodgkin lymphoma
284985|NCT01939314|Headache|headache
284986|NCT01939314|Migraine|migraine
284987|NCT01939301|Pulmonary embolism clot|pulmonary embolism clot
284988|NCT01939262|Arthritis|arthritis
284989|NCT01939262|Pain|pain
284990|NCT01939262|Function|function
284991|NCT01939262|Diet|diet
284992|NCT01939262|Vegan|vegan
284993|NCT01939262|Vegetarian|vegetarian
284994|NCT01939262|Restriction|restriction
284995|NCT01939236|chronic heart failure|chronic heart failure
284996|NCT01939236|traditional Chinese medicine|traditional chinese medicine
284997|NCT01939236|syndrome differentiation|syndrome differentiation
284998|NCT01939223|Stage IV colorectal cancer / Liver Metastasis|stage iv colorectal cancer / liver metastasis
284999|NCT01939197|HCV Genotype 4|hcv genotype 4
285000|NCT01939197|Interferon-Free|interferon-free
285001|NCT01939197|Hepatitis C Genotype 1|hepatitis c genotype 1
285002|NCT01939197|Compensated Cirrhosis|compensated cirrhosis
285003|NCT01939197|Hepatitis C Genotype 4|hepatitis c genotype 4
285004|NCT01939197|HCV / HIV coinfection|hcv / hiv coinfection
285005|NCT01939197|Cirrhotic|cirrhotic
285006|NCT01939197|Hepatitis C|hepatitis c
285007|NCT01939197|HIV-1|hiv-1
285008|NCT01939197|HCV Genotype 1|hcv genotype 1
285009|NCT01939171|Thymoglobulin|thymoglobulin
285010|NCT01939171|Cadaver donor|cadaver donor
285011|NCT01939171|Kidney injury brain death related|kidney injury brain death related
285012|NCT01939158|Co-administration|co-administration
285013|NCT01939158|Safety|safety
285014|NCT01939158|Persistence|persistence
285015|NCT01939158|Immunogenicity|immunogenicity
285016|NCT01939158|Prevenar 13|prevenar 13
285017|NCT01939158|Meningococcal vaccine|meningococcal vaccine
285018|NCT01939158|Toddlers|toddlers
285019|NCT01939158|5 years|5 years
285020|NCT01939145|hospital admission|hospital admission
285021|NCT01939132|Psoriatic Arthritis|psoriatic arthritis
285022|NCT01939132|ACTH|acth
285023|NCT01939132|Acthar|acthar
285024|NCT01939119|retinal vascular occlusion|retinal vascular occlusion
285025|NCT01939119|drinking habits|drinking habits
285026|NCT01939119|body hydration|body hydration
285027|NCT01939119|body-fluid balance|body-fluid balance
285028|NCT01939106|Stoma|stoma
285029|NCT01939106|Ileostomy|ileostomy
285030|NCT01939106|pouch|pouch
285031|NCT01939106|Drainable Pouch for collection of stool|drainable pouch for collection of stool
285032|NCT01939093|Quetiapine|quetiapine
285033|NCT01939093|Haloperidol|haloperidol
285034|NCT01939093|Methamphetamine|methamphetamine
285035|NCT01939093|Psychosis|psychosis
285036|NCT01939080|moderate risk|moderate risk
285037|NCT01939080|high risk|high risk
285038|NCT01939067|respiratory distress|respiratory distress
285039|NCT01939067|Heated Humidified High Flow Nasal Cannula (HHHFNC)|heated humidified high flow nasal cannula (hhhfnc)
285040|NCT01939067|HHHFNC|hhhfnc
285041|NCT01939067|noninvasive nasal continuous positive airway pressure (NCPAP)|noninvasive nasal continuous positive airway pressure (ncpap)
285042|NCT01939067|NCPAP|ncpap
285043|NCT01939041|Subacute Stroke|subacute stroke
285044|NCT01939041|Unilateral Robot-Assisted Training|unilateral robot-assisted training
285045|NCT01939041|Bilateral Robot-Assisted Training|bilateral robot-assisted training
285047|NCT01939041|Physiological Response|physiological response
285048|NCT01939015|3D miniplate|3d miniplate
285049|NCT01939015|angle mandibular fracture|angle mandibular fracture
285050|NCT01939015|champy technique|champy technique
285051|NCT01939015|internal rigid fixation|internal rigid fixation
285052|NCT01939002|flu-like symptoms|flu-like symptoms
285053|NCT01938989|cataract|cataract
285054|NCT01938989|intraocular lens|intraocular lens
285055|NCT01938989|IOL|iol
285056|NCT01938989|blue light filter|blue light filter
285057|NCT01938976|Asthma|asthma
285058|NCT01938976|Tobacco|tobacco
285059|NCT01938976|Waterpipe|waterpipe
285060|NCT01938976|Cigarettes|cigarettes
285061|NCT01938976|Adolescents|adolescents
285062|NCT01938976|Peer education|peer education
285063|NCT01938976|Jordan|jordan
285064|NCT01938963|Depression|depression
285065|NCT01938963|Hypertension|hypertension
285066|NCT01938963|Older Adults|older adults
285067|NCT01938911|Trier social stress test|trier social stress test
285068|NCT01938911|Oxytocin|oxytocin
285069|NCT01938911|Hypertension|hypertension
285070|NCT01938898|Randomized trial|randomized trial
285071|NCT01938898|Invitation letter|invitation letter
285072|NCT01938898|Recruitment|recruitment
285073|NCT01938898|Retention|retention
285074|NCT01938872|critical limb ischemia|critical limb ischemia
285075|NCT01938872|drug-eluting balloon|drug-eluting balloon
285076|NCT01938872|restenosis|restenosis
285077|NCT01938859|bipolar disorder|bipolar disorder
285078|NCT01938859|lithium|lithium
285079|NCT01938859|quetiapine|quetiapine
285080|NCT01938859|Medicine, Chinese Traditional|medicine, chinese traditional
285081|NCT01938859|efficacy|efficacy
285082|NCT01938859|safety|safety
285083|NCT01938859|Recurrence|recurrence
285084|NCT01938820|Hepatitis B|hepatitis b
285085|NCT01938820|Liver Cirrhosis|liver cirrhosis
285086|NCT01938820|Regression|regression
285087|NCT01938820|Efficacy|efficacy
285088|NCT01938807|type 1 diabetes|type 1 diabetes
285089|NCT01938807|parents|parents
285090|NCT01938807|mobile application|mobile application
285091|NCT01938807|diabetes management|diabetes management
285092|NCT01938781|Hepatitis B|hepatitis b
285093|NCT01938781|Liver fibrosis|liver fibrosis
285094|NCT01938781|Regression|regression
285095|NCT01938781|Efficacy|efficacy
285096|NCT01938768|Multiple trauma|multiple trauma
285097|NCT01938768|Polytrauma|polytrauma
285098|NCT01938768|Hyperfibrinolysis|hyperfibrinolysis
285099|NCT01938768|Tranexamic acid|tranexamic acid
285100|NCT01938768|Thrombelastometry|thrombelastometry
285101|NCT01938742|A/H7N9,Adjuvant,Immunogenicity,Influenza,MF59,Monovalent,Vaccine|a/h7n9,adjuvant,immunogenicity,influenza,mf59,monovalent,vaccine
285102|NCT01938729|HEPATIC ARTERIAL INFUSION|hepatic arterial infusion
285103|NCT01938729|FLOXURIDINE|floxuridine
285104|NCT01938729|DEXAMETHASONE|dexamethasone
285105|NCT01938729|GEMCITABINE|gemcitabine
285106|NCT01938729|Pump|pump
285107|NCT01938729|13-148|13-148
285108|NCT01938716|Pancreatic Cancer|pancreatic cancer
285109|NCT01938716|Adenocarcinoma of the Pancreas|adenocarcinoma of the pancreas
285110|NCT01938716|Intratumoral gemcitabine levels|intratumoral gemcitabine levels
285111|NCT01938716|Pancreatic surgery|pancreatic surgery
285112|NCT01938716|Pharmacokinetic testing|pharmacokinetic testing
285113|NCT01938716|PK|pk
285114|NCT01938716|Gemcitabine|gemcitabine
285115|NCT01938716|Gemcitabine Hydrochloride|gemcitabine hydrochloride
285116|NCT01938716|Gemzar|gemzar
285117|NCT01938690|stroke, transcranial magnetic stimulation, rehabilitation|stroke, transcranial magnetic stimulation, rehabilitation
285118|NCT01938677|Vestibular schwannoma|vestibular schwannoma
285119|NCT01938677|Gamma knife radiosurgery|gamma knife radiosurgery
285120|NCT01938677|Hearing preservation|hearing preservation
285121|NCT01938664|cocaine|cocaine
285122|NCT01938664|dependence|dependence
285123|NCT01938664|pharmacotherapy|pharmacotherapy
285124|NCT01938638|Advanced malignancies|advanced malignancies
285125|NCT01938638|TNBC|tnbc
285126|NCT01938638|DLBCL|dlbcl
285127|NCT01938638|Gastric cancer|gastric cancer
285128|NCT01938625|Hepatitis C, Chronic|hepatitis c, chronic
285129|NCT01938625|Recurrent Chronic Hepatitis C|recurrent chronic hepatitis c
285130|NCT01938625|Pharmacokinetics|pharmacokinetics
285131|NCT01938625|Simeprevir|simeprevir
285132|NCT01938625|Daclatasvir|daclatasvir
285133|NCT01938625|Ribavirin|ribavirin
285134|NCT01938625|Orthotopic Liver Transplantation|orthotopic liver transplantation
285135|NCT01938625|TMC435|tmc435
285136|NCT01938625|BMS-790052|bms-790052
285137|NCT01938625|RBV|rbv
285138|NCT01938612|MEDI4736|medi4736
285139|NCT01938612|Advanced solid tumors|advanced solid tumors
285140|NCT01938612|squamous cell carcinoma of the head and Neck|squamous cell carcinoma of the head and neck
285141|NCT01938612|biliary tract cancer|biliary tract cancer
285142|NCT01938612|squamous cell carcinoma of esophagus cancer|squamous cell carcinoma of esophagus cancer
285143|NCT01938612|B7-H1|b7-h1
285144|NCT01938612|PD-L1|pd-l1
285145|NCT01938599|Plaque Psoriasis|plaque psoriasis
285146|NCT01938586|Scar|scar
285147|NCT01938586|Appearance|appearance
285148|NCT01938547|perioperative|perioperative
285149|NCT01938547|blood pressure|blood pressure
285151|NCT01938547|pediatric surgery|pediatric surgery
285152|NCT01938521|Red Grape Cells powder (RGC)|red grape cells powder (rgc)
285153|NCT01938521|Placebo (PLA)|placebo (pla)
285154|NCT01938508|dermatitis|dermatitis
285155|NCT01938508|Minocycline|minocycline
285156|NCT01938508|bioavailability|bioavailability
285157|NCT01938495|ALS|als
285158|NCT01938495|DPS|dps
285159|NCT01938495|Diaphragm Pacing|diaphragm pacing
285160|NCT01938482|SCD1|scd1
285161|NCT01938482|Topical Administration|topical administration
285162|NCT01938482|Acne|acne
285163|NCT01938482|Gel|gel
285164|NCT01938469|Bariatric|bariatric
285165|NCT01938469|Gastric Bypass|gastric bypass
285166|NCT01938469|Gastric Banding,|gastric banding,
285167|NCT01938469|Incretins|incretins
285168|NCT01938469|glucagon-like peptide-1(GLP-1)|glucagon-like peptide-1(glp-1)
285169|NCT01938469|gastric inhibitory peptide (GIP)|gastric inhibitory peptide (gip)
285170|NCT01938456|Non-small cell lung cancer|non-small cell lung cancer
285171|NCT01938456|GSK1120212 (trametinib)|gsk1120212 (trametinib)
285172|NCT01938456|Japanese|japanese
285173|NCT01938456|Phase Ib|phase ib
285174|NCT01938456|combination therapy|combination therapy
285175|NCT01938456|docetaxel|docetaxel
285176|NCT01938456|MEK inhibitor|mek inhibitor
285177|NCT01938443|pharmacodynamics|pharmacodynamics
285178|NCT01938443|MEK inhibitor|mek inhibitor
285179|NCT01938443|Focal adhesion kinase inhibitor|focal adhesion kinase inhibitor
285180|NCT01938443|cancer|cancer
285181|NCT01938443|pharmacokinetic|pharmacokinetic
285182|NCT01938443|mesothelioma|mesothelioma
285183|NCT01938443|Phase 1|phase 1
285184|NCT01938417|tobramycin|tobramycin
285185|NCT01938417|bone graft substitute|bone graft substitute
285186|NCT01938417|pharmacokinetics|pharmacokinetics
285187|NCT01938417|renal failure|renal failure
285188|NCT01938404|Plasma exchange|plasma exchange
285189|NCT01938404|Thrombotic Thrombocytopenic Purpura|thrombotic thrombocytopenic purpura
285190|NCT01938404|TTP|ttp
285191|NCT01938391|Peripheral Artery Disease|peripheral artery disease
285192|NCT01938391|PAD|pad
285193|NCT01938391|Claudication|claudication
285194|NCT01938391|Peripheral Vascular Disease|peripheral vascular disease
285195|NCT01938391|PVD|pvd
285196|NCT01938391|Orbital Atherectomy|orbital atherectomy
285197|NCT01938391|Balloon Angioplasty|balloon angioplasty
285198|NCT01938391|Intravascular Ultrasound (IVUS)|intravascular ultrasound (ivus)
285199|NCT01938378|Octaplas|octaplas
285200|NCT01938352|Influenza|influenza
285201|NCT01938352|Virus|virus
285202|NCT01938352|Monoclonal Antibody|monoclonal antibody
285203|NCT01938352|Immunization|immunization
285204|NCT01938352|Treatment|treatment
285205|NCT01938339|prostate cancer|prostate cancer
285206|NCT01938339|MRI|mri
285207|NCT01938339|PET|pet
285208|NCT01938326|Stomach neoplasm|stomach neoplasm
285209|NCT01938326|TLDG|tldg
285210|NCT01938326|SIDG|sidg
285211|NCT01938326|single-port|single-port
285212|NCT01938326|inflammatory response|inflammatory response
285213|NCT01938313|gastric cancer|gastric cancer
285214|NCT01938313|ERAS (early recovery after surgery)|eras (early recovery after surgery)
285215|NCT01938313|fast track|fast track
285216|NCT01938313|laparoscopic gastrectomy|laparoscopic gastrectomy
285217|NCT01938274|Hip|hip
285218|NCT01938274|Knee|knee
285219|NCT01938274|Osteoarthritis|osteoarthritis
285220|NCT01938274|Arthroplasty|arthroplasty
285221|NCT01938274|Physical Activity|physical activity
285222|NCT01938274|Expectations|expectations
285223|NCT01938274|Leisure Activity|leisure activity
285224|NCT01938248|Pacemaker, Artificial|pacemaker, artificial
285225|NCT01938248|Defibrillators, Implantable|defibrillators, implantable
285226|NCT01938248|Atrial Fibrillation|atrial fibrillation
285227|NCT01938248|Stroke Risk|stroke risk
285228|NCT01938235|Myocardial infarction|myocardial infarction
285229|NCT01938235|Percutaneous coronary intervention|percutaneous coronary intervention
285230|NCT01938235|Reperfusion injury|reperfusion injury
285231|NCT01938235|Exenatide|exenatide
285232|NCT01938235|Magnetic resonance imaging|magnetic resonance imaging
285233|NCT01938222|abdominal wall closure|abdominal wall closure
285234|NCT01938222|short stitch technique|short stitch technique
285235|NCT01938196|Chronic Constipation|chronic constipation
285236|NCT01938196|Constipation|constipation
285237|NCT01938196|Functional gastrointestinal disorders|functional gastrointestinal disorders
285238|NCT01938183|chronic periodontitis|chronic periodontitis
285239|NCT01938183|metronidazole|metronidazole
285240|NCT01938157|High Risk of Breast Cancer|high risk of breast cancer
285241|NCT01938157|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
285242|NCT01938144|Common cold|common cold
285243|NCT01938144|efficacy|efficacy
285244|NCT01938144|symptoms|symptoms
285245|NCT01938144|Wisconsin Upper Respiratory Symptom Survey - 21|wisconsin upper respiratory symptom survey - 21
285246|NCT01938144|ibuprofen|ibuprofen
285247|NCT01938144|phenylephrine|phenylephrine
285248|NCT01938144|pseudoephedrine|pseudoephedrine
285249|NCT01938131|knee, osteoarthritis, muscle vibration|knee, osteoarthritis, muscle vibration
285250|NCT01938118|Infant diet|infant diet
285251|NCT01938118|Family diet|family diet
285541|NCT01936519|Zortress|zortress
285252|NCT01938118|Responsive feeding|responsive feeding
285253|NCT01938118|Infant temperament|infant temperament
285254|NCT01938118|Physical activity|physical activity
285255|NCT01938118|Television|television
285256|NCT01938105|Cervical cancer|cervical cancer
285257|NCT01938105|Nimotuzumab|nimotuzumab
285258|NCT01938105|Intensity-modulated radiation therapy|intensity-modulated radiation therapy
285259|NCT01938105|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
285260|NCT01938092|High-tone pelvic floor dysfunction|high-tone pelvic floor dysfunction
285261|NCT01938092|Spasm|spasm
285262|NCT01938092|Pelvic pain|pelvic pain
285263|NCT01938092|Diazepam|diazepam
285264|NCT01938092|Female|female
285265|NCT01938092|Randomized trial|randomized trial
285266|NCT01938079|ECMO|ecmo
285267|NCT01938079|Ketamine|ketamine
285268|NCT01938079|Opiates|opiates
285269|NCT01938079|Lung failure|lung failure
285270|NCT01938079|Extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
285271|NCT01938079|Mechanical ventilation|mechanical ventilation
285272|NCT01938079|Sedation|sedation
285273|NCT01938066|procellera|procellera
285274|NCT01938053|STI, STD|sti, std
285275|NCT01938040|laparoscopic cholecystectomy|laparoscopic cholecystectomy
285276|NCT01938027|Rectal Neoplasms|rectal neoplasms
285277|NCT01938027|Colorectal Neoplasms|colorectal neoplasms
285278|NCT01938027|transanal surgery|transanal surgery
285279|NCT01938014|MPS I|mps i
285280|NCT01938014|MPS II|mps ii
285281|NCT01938014|MPS III|mps iii
285282|NCT01938014|MPS VI|mps vi
285283|NCT01938014|Krabbe disease|krabbe disease
285284|NCT01938014|globoid cell leukodystrophy|globoid cell leukodystrophy
285285|NCT01938014|galactosylceramide lipidosis|galactosylceramide lipidosis
285286|NCT01938014|mucopolysaccharidoses|mucopolysaccharidoses
285287|NCT01938014|mucopolysaccharidosis|mucopolysaccharidosis
285288|NCT01938014|Rare Diseases Clinical Research Network|rare diseases clinical research network
285289|NCT01938014|Lysosomal Disease Network|lysosomal disease network
285290|NCT01938014|enzyme replacement therapy|enzyme replacement therapy
285291|NCT01938014|hematopoietic stem cell transplant|hematopoietic stem cell transplant
285292|NCT01938014|telephone-based surveillance|telephone-based surveillance
285293|NCT01938014|Hurler syndrome|hurler syndrome
285294|NCT01938014|Hunter syndrome|hunter syndrome
285295|NCT01938014|Scheie syndrome|scheie syndrome
285296|NCT01938014|Hurler-Scheie syndrome|hurler-scheie syndrome
285297|NCT01938014|Sanfilippo syndrome|sanfilippo syndrome
285298|NCT01938014|Maroteaux-Lamy syndrome|maroteaux-lamy syndrome
285299|NCT01938001|Non-Hodgkins Follicular lymphoma, Non-Hodgkins Marginal zone lymphoma, treatment for follicular lymphoma, treatment for Marginal zone lymphoma|non-hodgkins follicular lymphoma, non-hodgkins marginal zone lymphoma, treatment for follicular lymphoma, treatment for marginal zone lymphoma
285300|NCT01937988|Doula|doula
285301|NCT01937988|Abortion|abortion
285302|NCT01937988|Pain|pain
285303|NCT01937988|support|support
285304|NCT01937949|Aortic aneurysm|aortic aneurysm
285305|NCT01937936|caregiver stress|caregiver stress
285306|NCT01937936|depression|depression
285307|NCT01937936|quality of life|quality of life
285308|NCT01937936|cognitive behavioral therapy|cognitive behavioral therapy
285309|NCT01937910|neuroplastic change|neuroplastic change
285310|NCT01937910|myelin|myelin
285311|NCT01937897|Unilateral Massage|unilateral massage
285312|NCT01937897|Depression|depression
285313|NCT01937858|HbA1c|hba1c
285314|NCT01937858|glycated hemoglobin|glycated hemoglobin
285315|NCT01937858|correlation|correlation
285316|NCT01937858|diabetes|diabetes
285317|NCT01937858|renal failure|renal failure
285318|NCT01937819|BOWEL PREPARATION|bowel preparation
285319|NCT01937819|SMARTPHONE APPLICATION|smartphone application
285320|NCT01937806|Chronic hepatitis B|chronic hepatitis b
285321|NCT01937793|radiation|radiation
285322|NCT01937793|speech-language pathology|speech-language pathology
285323|NCT01937754|Prehypertension|prehypertension
285324|NCT01937754|Nitric Oxide|nitric oxide
285325|NCT01937754|Blood Pressure|blood pressure
285326|NCT01937754|Functional Capacity|functional capacity
285327|NCT01937754|Quality of Life|quality of life
285328|NCT01937728|Hepatitis C|hepatitis c
285329|NCT01937728|Genotype 1|genotype 1
285330|NCT01937728|Peg interferon|peg interferon
285331|NCT01937728|alfa 1a|alfa 1a
285332|NCT01937728|Ribavirin|ribavirin
285333|NCT01937689|Breast cancer|breast cancer
285334|NCT01937689|advanced|advanced
285335|NCT01937689|Pyrotinib|pyrotinib
285336|NCT01937689|Phase I|phase i
285337|NCT01937689|HER2 positive advanced breast cancer|her2 positive advanced breast cancer
285338|NCT01937663|Chronic Constipation|chronic constipation
285339|NCT01937663|Constipation|constipation
285340|NCT01937663|Functional gastrointestinal disorders|functional gastrointestinal disorders
285341|NCT01937650|Radiotherapy, metronidazole, cervical cancer, Mulago|radiotherapy, metronidazole, cervical cancer, mulago
285342|NCT01937637|Cognitive Behavioral Intervention for Breathlessness|cognitive behavioral intervention for breathlessness
285343|NCT01937624|Diagnostic ultrasound|diagnostic ultrasound
285344|NCT01937611|dexmedetomidine|dexmedetomidine
285345|NCT01937611|intramuscular premedication|intramuscular premedication
285346|NCT01937611|bradycardiac|bradycardiac
285642|NCT01936038|CPAP|cpap
285347|NCT01937598|Incretin, DPP-4 inhibitor|incretin, dpp-4 inhibitor
285348|NCT01937585|prostate cancer|prostate cancer
285349|NCT01937585|partner|partner
285350|NCT01937585|communication messages|communication messages
285351|NCT01937585|monitoring style|monitoring style
285352|NCT01937585|AA men|aa men
285353|NCT01937572|Total knee arthroplasty (TKA)|total knee arthroplasty (tka)
285354|NCT01937572|Computer aided systems|computer aided systems
285355|NCT01937559|tranexaminic acid (TXA)|tranexaminic acid (txa)
285356|NCT01937546|Anal Canal/injuries|anal canal/injuries
285357|NCT01937546|Delivery, Obstetric/methods|delivery, obstetric/methods
285358|NCT01937546|Labour Stage, Second|labour stage, second
285359|NCT01937546|Lacerations/prevention & control|lacerations/prevention & control
285360|NCT01937546|Obstetric Labour Complications/prevention & control|obstetric labour complications/prevention & control
285361|NCT01937546|perineum/injuries|perineum/injuries
285362|NCT01937533|Magnetic Resonance Imaging|magnetic resonance imaging
285363|NCT01937520|acupuncture|acupuncture
285364|NCT01937520|inflammation|inflammation
285365|NCT01937520|thyroid|thyroid
285366|NCT01937520|parathyroid|parathyroid
285367|NCT01937494|asthma|asthma
285368|NCT01937494|bronchial hyperresponsiveness|bronchial hyperresponsiveness
285369|NCT01937494|histamine challenge test|histamine challenge test
285370|NCT01937494|spirometry|spirometry
285371|NCT01937481|Child, Preschool|child, preschool
285372|NCT01937481|Parents|parents
285373|NCT01937481|Family|family
285374|NCT01937481|Obesity|obesity
285375|NCT01937481|Overweight|overweight
285376|NCT01937481|Diet|diet
285377|NCT01937481|Overnutrition|overnutrition
285378|NCT01937481|Motor Activity|motor activity
285379|NCT01937481|Child Care|child care
285380|NCT01937481|Schools|schools
285381|NCT01937468|Chronic GVHD|chronic gvhd
285382|NCT01937468|Chronic graft versus host disease|chronic graft versus host disease
285383|NCT01937468|Allogeneic stem cell transplant|allogeneic stem cell transplant
285384|NCT01937455|HIV|hiv
285385|NCT01937455|AIDS|aids
285386|NCT01937455|HIV vaccine|hiv vaccine
285387|NCT01937455|HIV prevention|hiv prevention
285388|NCT01937455|AAV|aav
285389|NCT01937455|PG9|pg9
285390|NCT01937442|Multiple myeloma|multiple myeloma
285391|NCT01937442|Pharmacokinetics|pharmacokinetics
285392|NCT01937442|Thalidomide|thalidomide
285393|NCT01937429|Colonoscopy - Chromoendoscopy - Indigo Carmin® - Adenoma detection - Tepid water|colonoscopy - chromoendoscopy - indigo carmin® - adenoma detection - tepid water
285394|NCT01937403|Physical Therapy|physical therapy
285395|NCT01937403|Return to sport|return to sport
285396|NCT01937351|Atherectomy|atherectomy
285397|NCT01937351|Optical Coherence Tomography|optical coherence tomography
285398|NCT01937351|Lumivascular|lumivascular
285399|NCT01937338|Healthy volunteers, Phase 1|healthy volunteers, phase 1
285400|NCT01937325|Eligible CF patients with G551D gene mutation|eligible cf patients with g551d gene mutation
285401|NCT01937312|glaucoma|glaucoma
285402|NCT01937312|prostaglandin analogue|prostaglandin analogue
285403|NCT01937312|brinzolamide|brinzolamide
285404|NCT01937312|brimonidine|brimonidine
285405|NCT01937299|glaucoma|glaucoma
285406|NCT01937299|prostaglandin analogue|prostaglandin analogue
285407|NCT01937299|brinzolamide|brinzolamide
285408|NCT01937299|brimonidine|brimonidine
285409|NCT01937286|LDLT,HCC, Microvascular invasion|ldlt,hcc, microvascular invasion
285410|NCT01937273|Nutritional status, malnutrition, chemo-radiotherapy|nutritional status, malnutrition, chemo-radiotherapy
285411|NCT01937247|Operative Time|operative time
285412|NCT01937247|Operating Rooms|operating rooms
285413|NCT01937247|Efficiency|efficiency
285414|NCT01937221|mild cognitive impairment|mild cognitive impairment
285415|NCT01937221|mild to moderate cognitive impairment|mild to moderate cognitive impairment
285416|NCT01937208|Esophageal Carcinoma|esophageal carcinoma
285417|NCT01937208|chemoradiation|chemoradiation
285418|NCT01937208|radiation dose|radiation dose
285419|NCT01937195|IV Catheter comparison|iv catheter comparison
285420|NCT01937195|AccuCath versus Conventional IV Catheters|accucath versus conventional iv catheters
285421|NCT01937195|IV Catheter Study|iv catheter study
285422|NCT01937195|IV Catheter User Preference Comparison|iv catheter user preference comparison
285423|NCT01937195|First Attempt Success Rate for IV Catheters|first attempt success rate for iv catheters
285424|NCT01937195|AccuCath Device Performance|accucath device performance
285425|NCT01937195|Complication Rates for IV Catheters|complication rates for iv catheters
285426|NCT01937195|Average Dwell Time for IV Catheters|average dwell time for iv catheters
285427|NCT01937195|Patient Satisfaction with IV Catheters|patient satisfaction with iv catheters
285428|NCT01937195|Clinician Satisfaction with AccuCath Device Performance|clinician satisfaction with accucath device performance
285429|NCT01937182|Stroke|stroke
285430|NCT01937182|SSRI (Selective Serotonin Reuptake Inhibitors)|ssri (selective serotonin reuptake inhibitors)
285431|NCT01937182|Serotonin|serotonin
285432|NCT01937182|5-HT (5-Hydroxytryptamine)|5-ht (5-hydroxytryptamine)
285433|NCT01937182|Neuroprotection|neuroprotection
285434|NCT01937182|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
285435|NCT01937182|Platelet|platelet
285436|NCT01937182|CT (computerized tomography)|ct (computerized tomography)
285437|NCT01937182|Post Stroke Depression|post stroke depression
285742|NCT01935492|bevacizumab|bevacizumab
285438|NCT01937143|parent education|parent education
285439|NCT01937143|immunization|immunization
285440|NCT01937143|vaccination|vaccination
285441|NCT01937143|infant|infant
285442|NCT01937143|pain management|pain management
285443|NCT01937130|Liver Failure|liver failure
285444|NCT01937130|Cirrhosis|cirrhosis
285445|NCT01937130|Alcoholic Hepatitis|alcoholic hepatitis
285446|NCT01937117|Breast cancer|breast cancer
285447|NCT01937117|Preoperative treatment|preoperative treatment
285448|NCT01937117|Neoadjuvant treatment|neoadjuvant treatment
285449|NCT01937104|Intracranial pressure|intracranial pressure
285450|NCT01937104|Laparoscopy|laparoscopy
285451|NCT01937104|Optic nerve sheath diameter|optic nerve sheath diameter
285452|NCT01937104|Position|position
285453|NCT01937091|HIV|hiv
285454|NCT01937091|clinical trials|clinical trials
285455|NCT01937013|Frontotemporal Dementia|frontotemporal dementia
285456|NCT01937013|emotion|emotion
285457|NCT01937013|oxytocin|oxytocin
285458|NCT01937013|fMRI|fmri
285459|NCT01936961|Cancer|cancer
285460|NCT01936948|Large colon polyps|large colon polyps
285461|NCT01936948|Polyp resection|polyp resection
285462|NCT01936948|Colon cancer screening|colon cancer screening
285463|NCT01936948|Colonoscopy|colonoscopy
285464|NCT01936948|Endoscopic mucosal resection|endoscopic mucosal resection
285465|NCT01936935|Insulin sensitivity|insulin sensitivity
285466|NCT01936922|Fall accidents|fall accidents
285467|NCT01936922|Gait|gait
285468|NCT01936922|Balance|balance
285469|NCT01936922|Fear of falling|fear of falling
285470|NCT01936922|Virtual reality|virtual reality
285471|NCT01936896|Acute myocardial infarction|acute myocardial infarction
285472|NCT01936896|Heart Failure|heart failure
285473|NCT01936896|Inflammation|inflammation
285474|NCT01936883|prostatic neoplasm|prostatic neoplasm
285475|NCT01936883|brachytherapy|brachytherapy
285476|NCT01936883|quality of life|quality of life
285477|NCT01936883|high dose rate|high dose rate
285478|NCT01936883|low dose rate|low dose rate
285479|NCT01936870|Toviaz|toviaz
285480|NCT01936870|Fesoterodine|fesoterodine
285481|NCT01936870|Post marketing surveillance|post marketing surveillance
285482|NCT01936870|Japanese|japanese
285483|NCT01936870|Overactive Bladder|overactive bladder
285484|NCT01936870|OAB|oab
285485|NCT01936870|Good post marketing practice|good post marketing practice
285486|NCT01936870|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
285487|NCT01936792|Concussion|concussion
285488|NCT01936792|Mild Traumatic Brain Injury|mild traumatic brain injury
285489|NCT01936792|Traumatic Brain Injury|traumatic brain injury
285490|NCT01936779|plasma triglycerides|plasma triglycerides
285491|NCT01936779|dietary fat|dietary fat
285492|NCT01936779|liver fat metabolism|liver fat metabolism
285493|NCT01936779|human|human
285494|NCT01936766|malaria, falciparum|malaria, falciparum
285495|NCT01936766|sepsis|sepsis
285496|NCT01936766|fluid therapy|fluid therapy
285497|NCT01936766|thermodilution|thermodilution
285498|NCT01936766|extravascular lung water|extravascular lung water
285499|NCT01936766|acute kidney injury|acute kidney injury
285500|NCT01936753|PMTCT|pmtct
285501|NCT01936753|HIV|hiv
285502|NCT01936753|Mentor Mothers|mentor mothers
285503|NCT01936753|Nigeria|nigeria
285504|NCT01936753|Retention|retention
285505|NCT01936753|Adherence|adherence
285506|NCT01936740|Efficacy and Safety|efficacy and safety
285507|NCT01936727|efficiency and safety|efficiency and safety
285508|NCT01936714|Efficacy and Safety|efficacy and safety
285509|NCT01936675|Coronary Artery Disease|coronary artery disease
285510|NCT01936675|Myocardial Infarction|myocardial infarction
285511|NCT01936675|Genomic Risk Communication|genomic risk communication
285512|NCT01936675|Risk Stratification|risk stratification
285513|NCT01936662|Airway management comparison|airway management comparison
285514|NCT01936649|Nuclear imaging|nuclear imaging
285515|NCT01936649|Radiopharmaceutical|radiopharmaceutical
285516|NCT01936649|Iobenguane|iobenguane
285517|NCT01936649|I-123|i-123
285518|NCT01936649|reproducibility|reproducibility
285519|NCT01936649|Quantitative measurements|quantitative measurements
285520|NCT01936649|myocardial uptake|myocardial uptake
285521|NCT01936649|SPECT imaging|spect imaging
285522|NCT01936649|planar imaging|planar imaging
285523|NCT01936649|AdreView™|adreview™
285524|NCT01936636|Breakthrough cancer pain|breakthrough cancer pain
285525|NCT01936636|diary|diary
285526|NCT01936636|quality of life|quality of life
285527|NCT01936636|Abstral|abstral
285528|NCT01936636|BTcP|btcp
285529|NCT01936623|brief intervention|brief intervention
285530|NCT01936623|computerized brief intervention|computerized brief intervention
285531|NCT01936610|Lecture|lecture
285532|NCT01936610|Role-playing|role-playing
285533|NCT01936610|Knowledge|knowledge
285534|NCT01936610|Attitude|attitude
285535|NCT01936610|Decision making|decision making
285536|NCT01936610|Type of delivery|type of delivery
285537|NCT01936597|external cardiac massage, medical hotline,|external cardiac massage, medical hotline,
285538|NCT01936545|Liver transplantation, reactive oxygen species, antioxidant|liver transplantation, reactive oxygen species, antioxidant
285539|NCT01936532|multiple myeloma|multiple myeloma
285542|NCT01936519|Renal Function|renal function
285543|NCT01936519|Tacrolimus|tacrolimus
285544|NCT01936519|Cyclosporine|cyclosporine
285545|NCT01936519|Myfortic|myfortic
285546|NCT01936519|Mycophenolic Acid|mycophenolic acid
285547|NCT01936519|Liver Transplantation|liver transplantation
285548|NCT01936506|Cognitive training|cognitive training
285549|NCT01936506|Depression|depression
285550|NCT01936493|Uterine leiomyomas (fibroids or myomas)|uterine leiomyomas (fibroids or myomas)
285551|NCT01936493|Uterine fibroids|uterine fibroids
285552|NCT01936493|Fibroids|fibroids
285553|NCT01936493|Uterine leiomyomas|uterine leiomyomas
285554|NCT01936467|Pancreatic solid lesions|pancreatic solid lesions
285555|NCT01936467|Pancreatic mass|pancreatic mass
285556|NCT01936467|Pancreatic cancer|pancreatic cancer
285557|NCT01936467|Endoscopic Ultrasound|endoscopic ultrasound
285558|NCT01936467|EUS|eus
285559|NCT01936467|Fine needle aspiration|fine needle aspiration
285560|NCT01936467|FNA|fna
285561|NCT01936467|EUS-FNA|eus-fna
285562|NCT01936441|Menopause|menopause
285563|NCT01936441|Vasomotor|vasomotor
285564|NCT01936441|Symptoms|symptoms
285565|NCT01936441|Sleep|sleep
285566|NCT01936441|Cognitive Behavioral Therapy|cognitive behavioral therapy
285567|NCT01936415|Knee prosthesis|knee prosthesis
285568|NCT01936402|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
285569|NCT01936376|kidney safety|kidney safety
285570|NCT01936376|biomarkers|biomarkers
285571|NCT01936376|serum creatinine|serum creatinine
285572|NCT01936376|BUN|bun
285573|NCT01936376|cystic fibrosis|cystic fibrosis
285574|NCT01936376|head and neck cancer|head and neck cancer
285575|NCT01936376|renal injury|renal injury
285576|NCT01936376|drug induced acute kidney injury|drug induced acute kidney injury
285577|NCT01936376|aminoglycoside|aminoglycoside
285578|NCT01936376|cisplatin|cisplatin
285579|NCT01936376|nephrotoxicity|nephrotoxicity
285580|NCT01936376|biomarker qualification|biomarker qualification
285581|NCT01936363|Ovarian Cancer|ovarian cancer
285582|NCT01936363|Pimasertib|pimasertib
285583|NCT01936363|Placebo|placebo
285584|NCT01936363|SAR245409|sar245409
285585|NCT01936350|Heart failure|heart failure
285586|NCT01936324|acne vulgaris|acne vulgaris
285587|NCT01936311|Health Behavior|health behavior
285588|NCT01936311|Behavior change|behavior change
285589|NCT01936311|self-management goal|self-management goal
285590|NCT01936311|health goal|health goal
285591|NCT01936298|Hand Edema|hand edema
285592|NCT01936298|Exercise Therapy|exercise therapy
285593|NCT01936233|Hepatocellular Carcinoma|hepatocellular carcinoma
285594|NCT01936233|Aspirin|aspirin
285595|NCT01936233|antiviral treatment|antiviral treatment
285596|NCT01936233|recurrence free survival|recurrence free survival
285597|NCT01936233|radical therapy|radical therapy
285598|NCT01936220|Schizophrenia|schizophrenia
285599|NCT01936220|First-psychotic episode|first-psychotic episode
285600|NCT01936220|Initial phase|initial phase
285601|NCT01936220|Relapse prevention|relapse prevention
285602|NCT01936220|Specialized treatment|specialized treatment
285603|NCT01936220|Parent groups|parent groups
285604|NCT01936220|Social functioning|social functioning
285605|NCT01936207|acute|acute
285606|NCT01936207|respiratory|respiratory
285607|NCT01936207|syndrome|syndrome
285608|NCT01936207|prognosis|prognosis
285609|NCT01936207|outcome research|outcome research
285610|NCT01936207|respiratory infection|respiratory infection
285611|NCT01936207|sepsis|sepsis
285612|NCT01936207|organ failure|organ failure
285613|NCT01936181|Rheumatoid Arthritis|rheumatoid arthritis
285614|NCT01936181|Infliximab|infliximab
285615|NCT01936181|Biosimilar|biosimilar
285616|NCT01936168|GSV|gsv
285617|NCT01936168|Primary Varicose Veins|primary varicose veins
285618|NCT01936168|Great Saphenous Vein|great saphenous vein
285619|NCT01936168|Treatment|treatment
285620|NCT01936155|Joint Mobility|joint mobility
285621|NCT01936155|Skin Tissue Oxygenation|skin tissue oxygenation
285622|NCT01936155|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
285623|NCT01936155|Goniometry|goniometry
285624|NCT01936155|Transcutaneous Oxygen Measurements (tcpO2)|transcutaneous oxygen measurements (tcpo2)
285625|NCT01936155|Water Displacement|water displacement
285626|NCT01936142|Resynchroniztion therapy|resynchroniztion therapy
285627|NCT01936142|Kidney|kidney
285628|NCT01936142|Contrast media|contrast media
285629|NCT01936142|Prevention|prevention
285630|NCT01936116|Sonohysterography|sonohysterography
285631|NCT01936116|catheter placement|catheter placement
285632|NCT01936116|pain magnitude|pain magnitude
285633|NCT01936116|vasovagal reaction|vasovagal reaction
285634|NCT01936103|Acute anterior myocardial infarction|acute anterior myocardial infarction
285635|NCT01936103|Percutaneous coronary stent implantation|percutaneous coronary stent implantation
285636|NCT01936103|Intensive statin therapy|intensive statin therapy
285637|NCT01936103|Left ventricular function|left ventricular function
285638|NCT01936077|Infertility, IVF, ovarian stimulation, rec LH, GnRH antagonist|infertility, ivf, ovarian stimulation, rec lh, gnrh antagonist
285639|NCT01936064|Breast Cancer|breast cancer
285640|NCT01936064|Jobelyn|jobelyn
285641|NCT01936064|Sorghum bicolor|sorghum bicolor
285643|NCT01936038|Upper Airway Toning|upper airway toning
285644|NCT01936038|Obstructive Sleep Apnoea|obstructive sleep apnoea
285645|NCT01936025|Diabetes mellitus|diabetes mellitus
285646|NCT01936012|Lisinopril|lisinopril
285647|NCT01936012|Bioequivalence|bioequivalence
285648|NCT01936012|Bioavailability|bioavailability
285649|NCT01936012|Pharmacokinetic|pharmacokinetic
285650|NCT01936012|Angiotensin-converting enzyme inhibitor|angiotensin-converting enzyme inhibitor
285651|NCT01935999|Colostomy|colostomy
285652|NCT01935999|peristomal skin|peristomal skin
285653|NCT01935999|stoma|stoma
285654|NCT01935999|pouch|pouch
285655|NCT01935908|Subarachnoid Hemorrhage|subarachnoid hemorrhage
285656|NCT01935908|Seizures|seizures
285657|NCT01935908|Prophylaxis|prophylaxis
285658|NCT01935908|Levetiracetam|levetiracetam
285659|NCT01935895|blood pressure reduction|blood pressure reduction
285660|NCT01935895|vascular reactivity|vascular reactivity
285661|NCT01935895|combined exercise session|combined exercise session
285662|NCT01935856|patients|patients
285663|NCT01935856|receiving|receiving
285664|NCT01935856|hemodialysis|hemodialysis
285665|NCT01935856|Secondary|secondary
285666|NCT01935843|CART-HER-2|cart-her-2
285667|NCT01935843|HER-2 positive|her-2 positive
285668|NCT01935843|Advanced|advanced
285669|NCT01935843|Refactory|refactory
285670|NCT01935843|Solid tumors|solid tumors
285671|NCT01935830|PET Imaging|pet imaging
285672|NCT01935830|Efavirenz|efavirenz
285673|NCT01935830|Ritonavior [11C] LAAM|ritonavior [11c] laam
285674|NCT01935830|Healthy volunteers|healthy volunteers
285675|NCT01935804|pioglitazone|pioglitazone
285676|NCT01935804|metformin|metformin
285677|NCT01935804|hyperglycemic agents|hyperglycemic agents
285678|NCT01935804|physiological effects of drugs|physiological effects of drugs
285679|NCT01935804|bone health|bone health
285680|NCT01935765|Type 1 diabetes, sleep apnea, polysomnography,|type 1 diabetes, sleep apnea, polysomnography,
285681|NCT01935765|autonomic neuropathy, intima media thickness|autonomic neuropathy, intima media thickness
285682|NCT01935752|fibromuscular|fibromuscular
285683|NCT01935752|dysplasia|dysplasia
285684|NCT01935752|endothelium|endothelium
285685|NCT01935752|microparticles|microparticles
285686|NCT01935752|microRNA|microrna
285687|NCT01935726|Pulmonary fibrosis|pulmonary fibrosis
285688|NCT01935726|Interstitial lung disease|interstitial lung disease
285689|NCT01935726|Connective tissue disease|connective tissue disease
285690|NCT01935726|Chronic hypersensitivity pneumonitis|chronic hypersensitivity pneumonitis
285691|NCT01935726|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
285692|NCT01935700|hepatocellular carcinoma|hepatocellular carcinoma
285693|NCT01935700|colchicine|colchicine
285694|NCT01935687|Instrumented Wheel|instrumented wheel
285695|NCT01935687|Manual Wheelchair|manual wheelchair
285696|NCT01935687|Spinal Cord Injury (SCI)|spinal cord injury (sci)
285697|NCT01935687|Manual wheelchair Users|manual wheelchair users
285698|NCT01935687|Aged between 18-70 years|aged between 18-70 years
285699|NCT01935674|Hypercholesterolaemia|hypercholesterolaemia
285700|NCT01935674|HIV|hiv
285701|NCT01935674|Rosuvastatin|rosuvastatin
285702|NCT01935674|Protease inhibitor switching|protease inhibitor switching
285703|NCT01935661|Blood transfusion|blood transfusion
285704|NCT01935661|Hemosiderosis|hemosiderosis
285705|NCT01935661|ERP|erp
285706|NCT01935648|Knee arthroplasty|knee arthroplasty
285707|NCT01935635|CHB|chb
285708|NCT01935635|Antiviral|antiviral
285709|NCT01935635|Dentritic cells|dentritic cells
285710|NCT01935635|Immune Therapy|immune therapy
285711|NCT01935622|heart failure|heart failure
285712|NCT01935622|non-ischemic cardiomyopathy|non-ischemic cardiomyopathy
285713|NCT01935609|traumatic brain injury|traumatic brain injury
285714|NCT01935609|acquired brain injury|acquired brain injury
285715|NCT01935596|Anesthesia|anesthesia
285716|NCT01935596|Randomized study|randomized study
285717|NCT01935596|Lower limbs surgery|lower limbs surgery
285718|NCT01935583|traumatic brain injury|traumatic brain injury
285719|NCT01935570|Bioavailability of magnesium|bioavailability of magnesium
285720|NCT01935570|Digestive and general tolerance|digestive and general tolerance
285721|NCT01935557|Continuous heparin infusion|continuous heparin infusion
285722|NCT01935557|Intermittent heparin infusion|intermittent heparin infusion
285723|NCT01935557|during catheter ablation|during catheter ablation
285724|NCT01935544|Botulinum Toxin|botulinum toxin
285725|NCT01935544|Ultrasound-guidance|ultrasound-guidance
285726|NCT01935544|Stroke|stroke
285727|NCT01935544|Spasticity|spasticity
285728|NCT01935544|Ultrasonography|ultrasonography
285729|NCT01935544|Hemiplegia|hemiplegia
285730|NCT01935531|actinic keratoses|actinic keratoses
285731|NCT01935531|tumor metabolism|tumor metabolism
285732|NCT01935531|glycolysis|glycolysis
285733|NCT01935531|diclofenac|diclofenac
285734|NCT01935531|warburg effect|warburg effect
285735|NCT01935505|smoking cessation|smoking cessation
285736|NCT01935505|intervention model|intervention model
285737|NCT01935505|Chinese|chinese
285738|NCT01935505|quitting rate|quitting rate
285739|NCT01935492|metastatic breast cancer|metastatic breast cancer
285740|NCT01935492|HER2/neu negative|her2/neu negative
285741|NCT01935492|paclitaxel|paclitaxel
285743|NCT01935492|liposomal doxorubicine|liposomal doxorubicine
285744|NCT01935492|capecitabine|capecitabine
285745|NCT01935479|AK159, teriparatide acetate|ak159, teriparatide acetate
285746|NCT01935466|Pioglitazone|pioglitazone
285747|NCT01935466|Bladder cancer|bladder cancer
285748|NCT01935466|Type 2 Diabetes|type 2 diabetes
285749|NCT01935440|HIV, drug use|hiv, drug use
285750|NCT01935427|Pulse Oximeter|pulse oximeter
285751|NCT01935427|Stroke Volume|stroke volume
285752|NCT01935427|Hemorrhagic shock|hemorrhagic shock
285753|NCT01935427|Compensatory Reserve Index|compensatory reserve index
285754|NCT01935401|Bulimia Nervosa|bulimia nervosa
285755|NCT01935401|Bulimia|bulimia
285756|NCT01935401|Response Inhibition|response inhibition
285757|NCT01935401|fNIR|fnir
285758|NCT01935401|Neuroimaging|neuroimaging
285759|NCT01935388|Mechanical ventilation|mechanical ventilation
285760|NCT01935388|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
285761|NCT01935388|asthma|asthma
285762|NCT01935388|common canister|common canister
285763|NCT01935388|MDI|mdi
285764|NCT01935388|ventilator associated pneumonia|ventilator associated pneumonia
285765|NCT01935375|Postpartum Depression|postpartum depression
285766|NCT01935375|Nurse Midwife|nurse midwife
285767|NCT01935375|Interpersonal Psychotherapy|interpersonal psychotherapy
285768|NCT01935362|Flavanones|flavanones
285769|NCT01935362|Bioavailability|bioavailability
285770|NCT01935362|Blood vessel health|blood vessel health
285771|NCT01935362|Blood glucose|blood glucose
285772|NCT01935349|Diabetes mellitus (DM)|diabetes mellitus (dm)
285773|NCT01935349|hypertension (HT)|hypertension (ht)
285774|NCT01935349|Hong Kong|hong kong
285775|NCT01935336|Lung Cancer|lung cancer
285776|NCT01935336|Malignancy|malignancy
285777|NCT01935336|Predictive biomarkers|predictive biomarkers
285778|NCT01935323|high intensity interval training|high intensity interval training
285779|NCT01935323|aerobic exercise|aerobic exercise
285780|NCT01935323|insulin sensitivity|insulin sensitivity
285781|NCT01935323|obesity|obesity
285782|NCT01935323|cardiovascular fitness|cardiovascular fitness
285783|NCT01935310|Photoaging|photoaging
285784|NCT01935310|imiquimod|imiquimod
285785|NCT01935310|wrinkles|wrinkles
285786|NCT01935310|elastosis|elastosis
285787|NCT01935271|immunosenescence|immunosenescence
285788|NCT01935271|sarcopenia|sarcopenia
285789|NCT01935258|Medically unexplained symptoms|medically unexplained symptoms
285790|NCT01935258|Somatization|somatization
285791|NCT01935258|Psychosomatic therapy|psychosomatic therapy
285792|NCT01935245|Coronary artery bypass grafting|coronary artery bypass grafting
285793|NCT01935245|Extracorporeal circulation|extracorporeal circulation
285794|NCT01935245|Minimal extracorporeal circulation|minimal extracorporeal circulation
285795|NCT01935245|Coagulopathy|coagulopathy
285796|NCT01935245|Thrombocytopathy|thrombocytopathy
285797|NCT01935245|Platelet dysfunction|platelet dysfunction
285798|NCT01935232|Osteoporosis, diagnostics, ultrasound|osteoporosis, diagnostics, ultrasound
285799|NCT01935219|mild cognitive impairment|mild cognitive impairment
285800|NCT01935219|seniors|seniors
285801|NCT01935219|cognitive training|cognitive training
285802|NCT01935219|driving|driving
285803|NCT01935219|driving simulation|driving simulation
285804|NCT01935219|intervention|intervention
285805|NCT01935219|goal management training|goal management training
285806|NCT01935219|process speed training|process speed training
285807|NCT01935206|secondary hyperalgesia|secondary hyperalgesia
285808|NCT01935206|allodynia|allodynia
285809|NCT01935206|mechanical pain threshold|mechanical pain threshold
285810|NCT01935206|naloxone|naloxone
285811|NCT01935206|endogenous opioids|endogenous opioids
285812|NCT01935206|pain|pain
285813|NCT01935193|platelets aggregation|platelets aggregation
285814|NCT01935193|asa resistance|asa resistance
285815|NCT01935180|colon polyps|colon polyps
285816|NCT01935180|adenoma resection|adenoma resection
285817|NCT01935180|colon cancer screening|colon cancer screening
285818|NCT01935180|colonoscopy|colonoscopy
285819|NCT01935180|polyp detection|polyp detection
285820|NCT01935167|Microalbuminuria|microalbuminuria
285821|NCT01935154|NSCLC|nsclc
285822|NCT01935154|Vaccine|vaccine
285823|NCT01935141|Pulmonary Embolus|pulmonary embolus
285824|NCT01935141|Radio Contrast Material|radio contrast material
285825|NCT01935141|Computed Tomography|computed tomography
285826|NCT01935128|Renal Transplant|renal transplant
285827|NCT01935128|Immunosuppression|immunosuppression
285828|NCT01935128|Steroid Avoidance|steroid avoidance
285829|NCT01935128|Calcineurin Avoidance|calcineurin avoidance
285830|NCT01935128|Mammalian Target of Rapamycin (mTOR)|mammalian target of rapamycin (mtor)
285831|NCT01935128|Kidney|kidney
285832|NCT01935115|Depression|depression
285834|NCT01935115|Treatment Resistant Depression|treatment resistant depression
285835|NCT01935115|Electroconvulsive Therapy|electroconvulsive therapy
285836|NCT01935115|ECT|ect
285837|NCT01935115|Ketamine|ketamine
285838|NCT01935115|Propofol|propofol
285839|NCT01935115|NMDA|nmda
285840|NCT01935102|metastatic breast cancer|metastatic breast cancer
285841|NCT01935102|bevacizumab|bevacizumab
285842|NCT01935102|single nucleotide polymorphism|single nucleotide polymorphism
285843|NCT01935102|VEGF-A|vegf-a
285844|NCT01935102|VEGFR-2|vegfr-2
285845|NCT01935102|IL-8|il-8
285846|NCT01935089|HIV-1|hiv-1
285847|NCT01935089|Interferon alpha|interferon alpha
285848|NCT01935089|Integrated DNA|integrated dna
285849|NCT01935089|Latent reservoir|latent reservoir
285850|NCT01935076|Maternal obesity|maternal obesity
285851|NCT01935076|Macrosomic|macrosomic
285852|NCT01935076|miRNA|mirna
285853|NCT01935076|Fetal overgrowth|fetal overgrowth
285854|NCT01935063|Vulvodynia|vulvodynia
285855|NCT01935063|Provoked vestibulodynia|provoked vestibulodynia
285856|NCT01935063|Vulvar pain|vulvar pain
285857|NCT01935063|Dyspareunia|dyspareunia
285858|NCT01935063|Couples therapy|couples therapy
285859|NCT01935063|Lidocaine|lidocaine
285860|NCT01935063|Cognitive behavioral couple therapy|cognitive behavioral couple therapy
285861|NCT01935063|Cognitive behavioral therapy|cognitive behavioral therapy
285862|NCT01935063|Pain|pain
285863|NCT01935063|Pain during sexual intercourse|pain during sexual intercourse
285864|NCT01935050|Depression|depression
285865|NCT01935050|Parkinson's disease|parkinson's disease
285866|NCT01935050|Cognitive-Behavioral Treatment|cognitive-behavioral treatment
285867|NCT01935024|Alzheimer's disease|alzheimer's disease
285868|NCT01935024|dementia|dementia
285869|NCT01935024|aerobic exercise|aerobic exercise
285870|NCT01934998|SCA6, parkinsonism, Datscan|sca6, parkinsonism, datscan
285871|NCT01934985|Single-Photon Emission-Computed Tomography|single-photon emission-computed tomography
285872|NCT01934985|Myocardial Perfusion Imaging|myocardial perfusion imaging
285873|NCT01934985|Ischemia|ischemia
285874|NCT01934985|Stress test|stress test
285875|NCT01934985|Coronary Artery Disease (CAD)|coronary artery disease (cad)
285876|NCT01934985|Coronary Flow Reserve (CFR)|coronary flow reserve (cfr)
285877|NCT01934985|Coronary Angiography|coronary angiography
285878|NCT01934972|Bipolar disorder|bipolar disorder
285879|NCT01934946|hip fracture|hip fracture
285880|NCT01934933|ossification|ossification
285881|NCT01934933|etanercept|etanercept
285882|NCT01934894|HER2-positive breast cancer|her2-positive breast cancer
285883|NCT01934894|intracranial metastases|intracranial metastases
285884|NCT01934894|lapatinib|lapatinib
285885|NCT01934894|cabazitaxel|cabazitaxel
285886|NCT01934868|low back pain|low back pain
285887|NCT01934868|sciatica|sciatica
285888|NCT01934868|spinal stenosis|spinal stenosis
285889|NCT01934868|epidural injections|epidural injections
285890|NCT01934868|prolotherapy|prolotherapy
285891|NCT01934868|sacroiliac pain or dysfunction.|sacroiliac pain or dysfunction.
285892|NCT01934855|cancer|cancer
285893|NCT01934855|radiotherapy|radiotherapy
285894|NCT01934855|4D-MRI|4d-mri
285895|NCT01934855|4D-CT|4d-ct
285896|NCT01934855|MRI|mri
285897|NCT01934816|Incretins, KATP channels, intradermal injection|incretins, katp channels, intradermal injection
285898|NCT01934803|Alcohol Use|alcohol use
285899|NCT01934803|Microbial Translocation|microbial translocation
285900|NCT01934803|Inflammation|inflammation
285901|NCT01934803|Altered Coagulation|altered coagulation
285902|NCT01934803|Russia|russia
285903|NCT01934803|Zinc|zinc
285904|NCT01934803|AMI|ami
285905|NCT01934803|VACS index|vacs index
285906|NCT01934803|Reynolds risk score|reynolds risk score
285907|NCT01934777|NAFLD|nafld
285908|NCT01934777|NASH|nash
285909|NCT01934777|fibrosis|fibrosis
285910|NCT01934738|Multiple dose|multiple dose
285911|NCT01934738|safety|safety
285912|NCT01934738|tolerability|tolerability
285913|NCT01934738|PK|pk
285914|NCT01934725|Ischemic Stroke|ischemic stroke
285915|NCT01934725|Brain Infarction|brain infarction
285916|NCT01934725|Patent Foramen Ovale|patent foramen ovale
285917|NCT01934725|Stroke in the Young|stroke in the young
285918|NCT01934725|Myocardial Infarction|myocardial infarction
285919|NCT01934725|Cerebral Venous Thrombosis|cerebral venous thrombosis
285920|NCT01934725|Pulmonary Embolism|pulmonary embolism
285921|NCT01934725|Deep Vein Thrombosis|deep vein thrombosis
285922|NCT01934725|Subarachnoid Hemorrhage|subarachnoid hemorrhage
285923|NCT01934725|Prognosis|prognosis
285924|NCT01934725|Databases, Genetic|databases, genetic
285925|NCT01934699|Coronary stenosis|coronary stenosis
285926|NCT01934699|Angina pectoris|angina pectoris
285927|NCT01934699|Left ventricular wall motion abnormalities|left ventricular wall motion abnormalities
285928|NCT01934699|2D-Strain|2d-strain
285929|NCT01934660|Cardiovascular Disease|cardiovascular disease
285930|NCT01934660|Diabetes Mellitus|diabetes mellitus
285931|NCT01934660|Inflammation|inflammation
285932|NCT01934634|Pancreatic Cancer|pancreatic cancer
285933|NCT01934634|Stage IV Pancreatic Cancer|stage iv pancreatic cancer
285934|NCT01934634|Stage IV metastatic pancreatic ductal adenocarcinoma|stage iv metastatic pancreatic ductal adenocarcinoma
285935|NCT01934621|Stroke|stroke
285936|NCT01934621|Rehabilitation|rehabilitation
285937|NCT01934621|Cognition|cognition
285938|NCT01934621|Disability|disability
285939|NCT01934595|Critically ill|critically ill
285940|NCT01934595|Protein|protein
285941|NCT01934595|Supplement|supplement
285942|NCT01934595|ICU|icu
285943|NCT01934595|Protein synthesis|protein synthesis
285944|NCT01934530|implant complications|implant complications
285945|NCT01934530|esthetics|esthetics
285946|NCT01934530|soft tissue grafting|soft tissue grafting
285947|NCT01934504|clinical tolerance|clinical tolerance
285948|NCT01934504|biomarker(s) identification|biomarker(s) identification
285949|NCT01934491|Cognitive training|cognitive training
285950|NCT01934491|Depression|depression
285951|NCT01934478|Breast|breast
285952|NCT01934478|Cancer|cancer
285953|NCT01934478|Human Epidermal Growth Factor 2 (Her2)|human epidermal growth factor 2 (her2)
285954|NCT01934478|irradiation|irradiation
285955|NCT01934465|NSCLC|nsclc
285956|NCT01934465|Chemotherapy|chemotherapy
285957|NCT01934465|Anti-angiogenic agent|anti-angiogenic agent
285958|NCT01934465|Bevacizumab|bevacizumab
285959|NCT01934465|1st Line|1st line
285960|NCT01934452|complete remission|complete remission
285961|NCT01934439|Stroke|stroke
285962|NCT01934439|Rehabilitation|rehabilitation
285963|NCT01934439|Dyssynergia|dyssynergia
285964|NCT01934439|Robotics|robotics
285965|NCT01934439|AMES|ames
285966|NCT01934439|Cerebrovascular Accident|cerebrovascular accident
285967|NCT01934426|Admission High Risk Elderly|admission high risk elderly
285968|NCT01934413|Palliative Care|palliative care
285969|NCT01934413|Technology|technology
285970|NCT01934413|Rural|rural
285971|NCT01934413|Transitional Care|transitional care
285972|NCT01934400|Osteoporosis|osteoporosis
285973|NCT01934400|fall prevention|fall prevention
285974|NCT01934400|high risk population|high risk population
285975|NCT01934387|World Health Organization Fracture Risk Assessment Tool|world health organization fracture risk assessment tool
285976|NCT01934387|Osteoporosis|osteoporosis
285977|NCT01934387|Aged|aged
285978|NCT01934387|Prevention|prevention
285979|NCT01934387|Fracture|fracture
285980|NCT01934387|FRAX|frax
285981|NCT01934374|task-oriented training, long-term effects, plasticity|task-oriented training, long-term effects, plasticity
285982|NCT01934361|BKM120|bkm120
285983|NCT01934361|Recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
285984|NCT01934361|rGBM|rgbm
285985|NCT01934361|buparlisib|buparlisib
285986|NCT01934335|breast cancer, TKI, tyrosine kinase inhibitor, vandetanib, Ki-67|breast cancer, tki, tyrosine kinase inhibitor, vandetanib, ki-67
285987|NCT01934322|frequent users of the emergency department|frequent users of the emergency department
285988|NCT01934322|vulnerable populations|vulnerable populations
285989|NCT01934322|case management|case management
285990|NCT01934322|cost savings intervention|cost savings intervention
285991|NCT01934322|quality of life|quality of life
285992|NCT01934322|number of emergency department visits|number of emergency department visits
285993|NCT01934309|tuberculosis|tuberculosis
285994|NCT01934309|isoniazid preventative therapy|isoniazid preventative therapy
285995|NCT01934309|clinical decision support|clinical decision support
285996|NCT01934309|HIV|hiv
285997|NCT01934309|Kenya|kenya
285998|NCT01934309|eHealth|ehealth
285999|NCT01934296|deep brain stimulation|deep brain stimulation
286000|NCT01934296|cortical recording|cortical recording
286001|NCT01934296|neuroprosthesis|neuroprosthesis
286002|NCT01934231|Acute bacterial rhinosinusitis|acute bacterial rhinosinusitis
286003|NCT01934231|Amoxicilin|amoxicilin
286004|NCT01934231|Infection|infection
286005|NCT01934231|Potassium clavulanate|potassium clavulanate
286006|NCT01934218|Knee|knee
286007|NCT01934218|Osteoarthritis|osteoarthritis
286008|NCT01934218|Intra-articular injection|intra-articular injection
286009|NCT01934205|GSK2140944|gsk2140944
286010|NCT01934205|pharmacokinetics|pharmacokinetics
286011|NCT01934205|bronchoalveolar lavage|bronchoalveolar lavage
286012|NCT01934205|pulmonary|pulmonary
286013|NCT01934205|antimicrobial|antimicrobial
286014|NCT01934205|healthy volunteer|healthy volunteer
286015|NCT01934192|tolerability|tolerability
286016|NCT01934192|camicinal|camicinal
286017|NCT01934192|single dose|single dose
286018|NCT01934192|acetaminophen|acetaminophen
286019|NCT01934192|gastric emptying|gastric emptying
286020|NCT01934192|critically ill|critically ill
286021|NCT01934192|GSK962040|gsk962040
286022|NCT01934192|pharmacokinetics|pharmacokinetics
286023|NCT01934192|pharmacodynamics|pharmacodynamics
286024|NCT01934192|gut motility|gut motility
286025|NCT01934153|hyperhidrosis|hyperhidrosis
286026|NCT01934153|topical|topical
286027|NCT01934153|[14C] radiolabel|[14c] radiolabel
286028|NCT01934153|palm|palm
286029|NCT01934153|GSK573719|gsk573719
286030|NCT01934153|axilla|axilla
286031|NCT01934153|Umeclidinium|umeclidinium
286032|NCT01934140|Healthy|healthy
286033|NCT01934140|Adults|adults
286034|NCT01934140|Safety|safety
286035|NCT01934140|Neisseria meningitidis|neisseria meningitidis
286036|NCT01934140|Booster response|booster response
286037|NCT01934140|Immunogenicity|immunogenicity
286038|NCT01934140|Adolescents|adolescents
286039|NCT01934140|Serogroups A, C, W-135, and Y|serogroups a, c, w-135, and y
286040|NCT01934140|long-term antibody persistence|long-term antibody persistence
286041|NCT01934127|Immunogenicity|immunogenicity
286042|NCT01934127|H7N1|h7n1
286043|NCT01934127|Influenza|influenza
286044|NCT01934127|Safety|safety
286045|NCT01934127|AS03 adjuvant|as03 adjuvant
286046|NCT01934127|Adults|adults
286047|NCT01934088|Inflammatory Bowel disease|inflammatory bowel disease
286048|NCT01934088|IBD|ibd
286049|NCT01934088|Sedation|sedation
286050|NCT01934088|NAPS|naps
286051|NCT01934088|Propofol|propofol
286052|NCT01934088|Midazolam|midazolam
286053|NCT01934088|Satisfaction|satisfaction
286054|NCT01934088|Feasibility|feasibility
286055|NCT01934075|Obstetric fistula|obstetric fistula
286056|NCT01934075|Mental health|mental health
286057|NCT01934075|Tanzania|tanzania
286058|NCT01934036|Weight loss|weight loss
286059|NCT01934036|Nutritional supplement|nutritional supplement
286060|NCT01934036|Waist|waist
286061|NCT01934036|Body composition|body composition
286062|NCT01934036|Skinfolds|skinfolds
286063|NCT01934023|plasticity, schizophrenia, varenicline, non smokers,|plasticity, schizophrenia, varenicline, non smokers,
286064|NCT01933997|pharmacokinetics|pharmacokinetics
286065|NCT01933997|metadoxine|metadoxine
286066|NCT01933984|Bronchodilator agents,|bronchodilator agents,
286067|NCT01933984|chronic obstructive pulmonary disease,|chronic obstructive pulmonary disease,
286068|NCT01933984|endotracheal intubation,|endotracheal intubation,
286069|NCT01933984|mechanical ventilator|mechanical ventilator
286070|NCT01933958|Regorafenib|regorafenib
286071|NCT01933958|Gastrointestinal stromal tumors|gastrointestinal stromal tumors
286072|NCT01933932|Mitogen-Activated Protein Kinase Kinase inhibitor; Non Small Cell Lung Cancer; metastatic; second line treatment for Non Small Cell Lung Cancer; KRAS mutation|mitogen-activated protein kinase kinase inhibitor; non small cell lung cancer; metastatic; second line treatment for non small cell lung cancer; kras mutation
286073|NCT01933919|Obsessive Compulsive Disorder|obsessive compulsive disorder
286074|NCT01933919|Adolescent Subjects|adolescent subjects
286075|NCT01933919|Pediatric Subjects|pediatric subjects
286076|NCT01933906|CML|cml
286077|NCT01933906|Chronic myeloid leukemia|chronic myeloid leukemia
286078|NCT01933906|Chronic myeloid leukaemia|chronic myeloid leukaemia
286079|NCT01933906|PEG-Proline-Interferon-alpha 2b|peg-proline-interferon-alpha 2b
286080|NCT01933906|Interferon|interferon
286081|NCT01933906|P1101|p1101
286082|NCT01933906|Imatinib|imatinib
286083|NCT01933893|Pipelle, luteal, follicular, implantation|pipelle, luteal, follicular, implantation
286084|NCT01933880|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
286085|NCT01933880|Methylphenidate Hydrochloride|methylphenidate hydrochloride
286086|NCT01933880|CONCERTA|concerta
286087|NCT01933867|water|water
286088|NCT01933867|colonoscopy|colonoscopy
286089|NCT01933867|Crohn´s disease|crohn´s disease
286090|NCT01933867|ulcerative colitis|ulcerative colitis
286091|NCT01933854|Urinary incontinence|urinary incontinence
286092|NCT01933854|riverside|riverside
286093|NCT01933854|women|women
286094|NCT01933854|Amapa|amapa
286095|NCT01933841|Post operative residual curarization|post operative residual curarization
286096|NCT01933841|Neuromuscular blocking drugs|neuromuscular blocking drugs
286097|NCT01933828|Lung cancer|lung cancer
286098|NCT01933828|surgery video-assisted|surgery video-assisted
286099|NCT01933828|robot|robot
286100|NCT01933828|surgical treatment|surgical treatment
286101|NCT01933815|Glioblastoma multiforme|glioblastoma multiforme
286102|NCT01933815|Glioblastoma|glioblastoma
286103|NCT01933815|Radiotherapy|radiotherapy
286104|NCT01933815|Temozolomide|temozolomide
286105|NCT01933815|TPI 287|tpi 287
286106|NCT01933815|Taxoid|taxoid
286107|NCT01933815|Avastin|avastin
286108|NCT01933815|Bevacizumab|bevacizumab
286109|NCT01933802|mesenchymal stem cells|mesenchymal stem cells
286110|NCT01933802|neural progenitors|neural progenitors
286111|NCT01933802|autologous|autologous
286112|NCT01933802|bone marrow|bone marrow
286113|NCT01933802|multiple sclerosis|multiple sclerosis
286114|NCT01933789|Palliative Care|palliative care
286115|NCT01933789|End-of-Life Issues|end-of-life issues
286116|NCT01933789|Patient/Clinician Communication|patient/clinician communication
286117|NCT01933789|Patient/Family Communication|patient/family communication
286118|NCT01933789|Concordance|concordance
286119|NCT01933789|Treatment Preferences|treatment preferences
286120|NCT01933789|Anxiety|anxiety
286121|NCT01933789|Depressive Symptoms|depressive symptoms
286122|NCT01933789|Talking with Your Doctor|talking with your doctor
286123|NCT01933789|Coping with Serious Illness|coping with serious illness
286124|NCT01933789|Outpatient Collaboration|outpatient collaboration
286125|NCT01933776|Diphtheria|diphtheria
286126|NCT01933776|Tetanus|tetanus
286127|NCT01933776|Pertussis|pertussis
286128|NCT01933776|ADACEL®|adacel®
286129|NCT01933776|Tdap vaccine|tdap vaccine
286130|NCT01933750|Presbyopia|presbyopia
286131|NCT01933750|Reading Glasses|reading glasses
286132|NCT01933750|Near Vision|near vision
286133|NCT01933737|postural balance;|postural balance;
286134|NCT01933737|elderly;|elderly;
286135|NCT01933737|proprioception;|proprioception;
286136|NCT01933737|prevention;|prevention;
286137|NCT01933737|fall|fall
286138|NCT01933724|granulomatosis with polyangiitis|granulomatosis with polyangiitis
286139|NCT01933724|GPA|gpa
286140|NCT01933724|Wegeners'|wegeners'
286141|NCT01933724|WG|wg
286142|NCT01933724|vasculitis|vasculitis
286143|NCT01933724|taper|taper
286144|NCT01933724|prednisone|prednisone
286145|NCT01933724|glucocorticoid|glucocorticoid
286146|NCT01933724|ANCA-associated vasculitis|anca-associated vasculitis
286147|NCT01933724|AAV|aav
286148|NCT01933724|Wegener Granulomatosis|wegener granulomatosis
286149|NCT01933724|Systemic Vasculitis|systemic vasculitis
286150|NCT01933724|Lung diseases, interstitial|lung diseases, interstitial
286151|NCT01933724|Lung diseases|lung diseases
286152|NCT01933724|Respiratory Tract Diseases|respiratory tract diseases
286153|NCT01933724|Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis|anti-neutrophil cytoplasmic antibody-associated vasculitis
286154|NCT01933724|Vascular Diseases|vascular diseases
286155|NCT01933724|Cardiovascular Diseases|cardiovascular diseases
286156|NCT01933724|Glucocorticoids|glucocorticoids
286157|NCT01933724|Hormones|hormones
286158|NCT01933724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
286159|NCT01933724|Physiological Effects of Drugs|physiological effects of drugs
286160|NCT01933724|Pharmacologic Actions|pharmacologic actions
286161|NCT01933724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal
286162|NCT01933724|Antineoplastic Agents|antineoplastic agents
286163|NCT01933724|Therapeutic Uses|therapeutic uses
286164|NCT01933724|Anti-Inflammatory Agents|anti-inflammatory agents
286165|NCT01933711|CD20+ aggressive lymphoma|cd20+ aggressive lymphoma
286166|NCT01933711|mantle cell lymphoma|mantle cell lymphoma
286167|NCT01933711|rituximab|rituximab
286168|NCT01933711|maintenance|maintenance
286169|NCT01933698|Bioequivalence|bioequivalence
286170|NCT01933698|Amoxicillin|amoxicillin
286171|NCT01933698|Human|human
286172|NCT01933672|Phase 1b|phase 1b
286173|NCT01933672|type 2 diabetes|type 2 diabetes
286174|NCT01933672|metformin background|metformin background
286175|NCT01933672|PF-04937319|pf-04937319
286176|NCT01933659|Helicobacter pylori|helicobacter pylori
286177|NCT01933659|deep see water|deep see water
286178|NCT01933646|Group B streptococcus|group b streptococcus
286179|NCT01933646|Incidence|incidence
286180|NCT01933646|Case fatality rate|case fatality rate
286181|NCT01933646|Serotype distribution|serotype distribution
286182|NCT01933633|Pregnancy|pregnancy
286183|NCT01933633|Fertility|fertility
286184|NCT01933633|exercise|exercise
286185|NCT01933633|Fertilization in vitro|fertilization in vitro
286186|NCT01933620|Microbiome|microbiome
286187|NCT01933620|Nosocomial Infection|nosocomial infection
286188|NCT01933620|Multidrug Resistance|multidrug resistance
286189|NCT01933542|Chlorzoxazone|chlorzoxazone
286190|NCT01933542|Postoperative pain|postoperative pain
286191|NCT01933542|Spine surgery|spine surgery
286192|NCT01933542|Opioid consumption|opioid consumption
286193|NCT01933529|diabetes|diabetes
286194|NCT01933529|glucose tolerance|glucose tolerance
286195|NCT01933529|insulin secretion|insulin secretion
286196|NCT01933529|insulin sensitivity|insulin sensitivity
286197|NCT01933529|erythropoietin|erythropoietin
286198|NCT01933529|inflammation|inflammation
286199|NCT01933529|cytokines|cytokines
286200|NCT01933516|GP2013|gp2013
286201|NCT01933516|Japanese|japanese
286202|NCT01933516|indolent B-cell non-Hodgkin's lymphoma|indolent b-cell non-hodgkin's lymphoma
286203|NCT01933516|biosimilar|biosimilar
286204|NCT01933516|CD20|cd20
286205|NCT01933516|GP13-101|gp13-101
286206|NCT01933503|MAD|mad
286207|NCT01933503|SAD|sad
286208|NCT01933503|Obeticholic Acid (OCA)|obeticholic acid (oca)
286209|NCT01933490|hyperinsulinemic hypoglycemia|hyperinsulinemic hypoglycemia
286210|NCT01933477|Maternal Health|maternal health
286211|NCT01933477|Child Health|child health
286212|NCT01933477|HIV infection|hiv infection
286213|NCT01933477|Antenatal care|antenatal care
286214|NCT01933477|Postpartum care|postpartum care
286215|NCT01933477|Prevention of mother to child transmission (PMTCT)|prevention of mother to child transmission (pmtct)
286216|NCT01933477|Breast feeding|breast feeding
286217|NCT01933477|Antiretrovirals|antiretrovirals
286218|NCT01933464|Rosacea|rosacea
286219|NCT01933464|Cromolyn sodium|cromolyn sodium
286220|NCT01933451|fluid therapy|fluid therapy
286221|NCT01933451|Intraoperative care|intraoperative care
286222|NCT01933451|Patient Outcome Assessment|patient outcome assessment
286223|NCT01933451|pulse pressure variation|pulse pressure variation
286224|NCT01933451|restrictive fluid therapy|restrictive fluid therapy
286225|NCT01933451|goal-directed fluid therapy|goal-directed fluid therapy
286226|NCT01933451|esophagectomy|esophagectomy
286227|NCT01933438|birth related brachial plexus injury|birth related brachial plexus injury
286228|NCT01933438|brachial plexus|brachial plexus
286229|NCT01933438|splint|splint
286230|NCT01933425|surgical conditions|surgical conditions
286231|NCT01933425|laparoscopy|laparoscopy
286232|NCT01933412|Dialysis|dialysis
286233|NCT01933412|Hepatitis B|hepatitis b
286234|NCT01933399|Low back pain|low back pain
286235|NCT01933399|Back brace|back brace
286236|NCT01933399|Lumbar orthoses|lumbar orthoses
286237|NCT01933399|Lumbosacral orthoses|lumbosacral orthoses
286238|NCT01933399|Low back pain treatment|low back pain treatment
286239|NCT01933386|Single Sided Deafness|single sided deafness
286240|NCT01933386|SSD|ssd
286241|NCT01933386|Unilateral hearing loss|unilateral hearing loss
286242|NCT01933373|Randomized|randomized
286243|NCT01933373|Toupet|toupet
286244|NCT01933373|Dor|dor
286245|NCT01933373|Achalasia|achalasia
286246|NCT01933360|Misoprostol|misoprostol
286247|NCT01933360|First trimester pregnancy|first trimester pregnancy
286248|NCT01933360|Surgical abortion|surgical abortion
286249|NCT01933360|Cervical priming|cervical priming
286250|NCT01933334|pirfenidone|pirfenidone
286251|NCT01933334|SSc-ILD|ssc-ild
286252|NCT01933334|scleroderma|scleroderma
286253|NCT01933334|systemic sclerosis|systemic sclerosis
286254|NCT01933334|interstitial lung disease|interstitial lung disease
286255|NCT01933321|ALS, stem cells|als, stem cells
286256|NCT01933308|Pulmonary Rehabilitation|pulmonary rehabilitation
286257|NCT01933308|Comparison of exercise training protocol|comparison of exercise training protocol
286258|NCT01933308|Exercise tolerance|exercise tolerance
286259|NCT01933308|Functional and quality of life status|functional and quality of life status
286260|NCT01933308|Cognitive and psychological status|cognitive and psychological status
286261|NCT01933308|Compliance to exercise recommendations|compliance to exercise recommendations
286262|NCT01933308|Long term adherence to exercise recommendations|long term adherence to exercise recommendations
286263|NCT01933295|treatment|treatment
286264|NCT01933282|MESA, chemotherapy,NK/T cell lymphoma|mesa, chemotherapy,nk/t cell lymphoma
286265|NCT01933256|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
286266|NCT01933256|HIP2B|hip2b
286267|NCT01933256|Placebo|placebo
286268|NCT01933256|islet β cell|islet β cell
286269|NCT01933243|Anxiety|anxiety
286270|NCT01933243|Anorexia nervosa|anorexia nervosa
286271|NCT01933243|Adolescents|adolescents
286272|NCT01933243|Fish oil|fish oil
286273|NCT01933217|TBI|tbi
286274|NCT01933217|traumatic brain injury|traumatic brain injury
286275|NCT01933217|ADHD|adhd
286276|NCT01933217|methylphenidate|methylphenidate
286277|NCT01933217|Concerta|concerta
286278|NCT01933217|attention problems|attention problems
286279|NCT01933204|perimenopause|perimenopause
286280|NCT01933204|hot flash|hot flash
286281|NCT01933204|palpitation|palpitation
286282|NCT01933191|Dental Anxiety, Physical Activity, Dental Phobia|dental anxiety, physical activity, dental phobia
286283|NCT01933191|Cortisol, Amylase|cortisol, amylase
286284|NCT01933178|Dry eyes|dry eyes
286285|NCT01933178|Cirrus AS-OCT|cirrus as-oct
286286|NCT01933178|Excess folds of the conjunctiva|excess folds of the conjunctiva
286287|NCT01933165|Dry Eyes|dry eyes
286288|NCT01933165|LipiView|lipiview
286289|NCT01933165|Lipid thickness|lipid thickness
286290|NCT01933152|wAMD|wamd
286291|NCT01933152|anti-VEGF|anti-vegf
286292|NCT01933139|Informed consent|informed consent
286293|NCT01933139|preoperative counseling|preoperative counseling
286294|NCT01933139|hysterectomy|hysterectomy
286295|NCT01933113|Obesity|obesity
286296|NCT01933113|Deep Brain Stimulation|deep brain stimulation
286297|NCT01933113|LHA|lha
286298|NCT01933100|Functional constipation|functional constipation
286299|NCT01933100|Brown rice based-meal|brown rice based-meal
286300|NCT01933100|Polished rice based-meal|polished rice based-meal
286301|NCT01933100|Wheat based-meal|wheat based-meal
286302|NCT01933087|Hand hygiene,|hand hygiene,
286303|NCT01933087|Randonmised Controlled Trials,|randonmised controlled trials,
286304|NCT01933087|Hospital|hospital
286305|NCT01933074|Urinary Urgency|urinary urgency
286306|NCT01933061|Skin cancer, Melanoma|skin cancer, melanoma
286307|NCT01933048|influenza|influenza
286308|NCT01933035|ITP|itp
286309|NCT01933035|Thrombocytopenia|thrombocytopenia
286310|NCT01933035|mean platelet mass|mean platelet mass
286311|NCT01933035|mean platelet component|mean platelet component
286312|NCT01933022|Exploratory|exploratory
286313|NCT01933022|Biomarkers|biomarkers
286314|NCT01933022|Eligard|eligard
286315|NCT01933022|Metastatic prostate cancer|metastatic prostate cancer
286316|NCT01932996|Smoking Cessation|smoking cessation
286317|NCT01932996|Smoking Cessation Products|smoking cessation products
286318|NCT01932996|Tobacco Use Cessation Products|tobacco use cessation products
286319|NCT01932983|Neuromuscular blockade|neuromuscular blockade
286320|NCT01932983|TOF test|tof test
286321|NCT01932983|Quantitative TOF method|quantitative tof method
286322|NCT01932983|Visual interpretation of TOF|visual interpretation of tof
286323|NCT01932970|Secondary Hyperparathyroidism (SHPT), chronic kidney disease (CKD), hemodialysis, parathyroid hormone (PTH), hypocalcemia, bone and mineral metabolism|secondary hyperparathyroidism (shpt), chronic kidney disease (ckd), hemodialysis, parathyroid hormone (pth), hypocalcemia, bone and mineral metabolism
286324|NCT01932957|Laparoscopy|laparoscopy
286325|NCT01932957|Ruptured ectopic pregnancy|ruptured ectopic pregnancy
286326|NCT01932931|Vitamin D|vitamin d
286327|NCT01932931|Major depression|major depression
286328|NCT01932931|SSRIs|ssris
286329|NCT01932931|Osteoporosis|osteoporosis
286330|NCT01932918|reactive oxygen species|reactive oxygen species
286331|NCT01932918|ischemia reperfusion injury|ischemia reperfusion injury
286332|NCT01932905|deep repetitive transcranial magnetic stimulation|deep repetitive transcranial magnetic stimulation
286333|NCT01932905|chronic pain|chronic pain
286334|NCT01932905|assessment|assessment
286335|NCT01932905|neuropathic pain|neuropathic pain
286336|NCT01932905|central pain|central pain
286337|NCT01932905|treatment|treatment
286338|NCT01932892|transhumeral|transhumeral
286339|NCT01932866|pre-diabetes|pre-diabetes
286340|NCT01932866|diabetes risk score|diabetes risk score
286341|NCT01932866|motivation|motivation
286342|NCT01932866|Air Force|air force
286343|NCT01932866|Military|military
286344|NCT01932866|Lifestyle change|lifestyle change
286345|NCT01932840|attitudes and understanding of plant sterol claims|attitudes and understanding of plant sterol claims
286346|NCT01932840|general Canadian population|general canadian population
286347|NCT01932827|Attitudes and understanding of oat fibre claims|attitudes and understanding of oat fibre claims
286348|NCT01932827|Food labels|food labels
286349|NCT01932827|General Canadian population|general canadian population
286350|NCT01932814|Aminoglycosides|aminoglycosides
286351|NCT01932814|Acute kidney injury|acute kidney injury
286352|NCT01932814|Severe sepsis|severe sepsis
286353|NCT01932814|Critically ill patient|critically ill patient
286354|NCT01932801|harm reduction, naltrexone, alcohol dependence, homelessness|harm reduction, naltrexone, alcohol dependence, homelessness
286355|NCT01932788|pregnancy|pregnancy
286356|NCT01932788|Vitamin D status|vitamin d status
286357|NCT01932736|middle ear|middle ear
286358|NCT01932736|Eustachian tube|eustachian tube
286359|NCT01932736|fMRI|fmri
286360|NCT01932723|Stabilization exercises, Pain, Disability, Menstruation|stabilization exercises, pain, disability, menstruation
286361|NCT01932710|Leukemia|leukemia
286362|NCT01932710|Acute myelogenous leukemia|acute myelogenous leukemia
286363|NCT01932710|AML|aml
286364|NCT01932710|High-risk myelodysplastic leukemia|high-risk myelodysplastic leukemia
286365|NCT01932710|MDS|mds
286366|NCT01932710|Infection risk|infection risk
286367|NCT01932710|White Blood Cell transfusion|white blood cell transfusion
286368|NCT01932710|Prophylactic therapy|prophylactic therapy
286369|NCT01932671|Cardiovascular diseases|cardiovascular diseases
286370|NCT01932671|Atherosclerosis|atherosclerosis
286371|NCT01932671|Multidetector Computed Tomography|multidetector computed tomography
286372|NCT01932671|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
286373|NCT01932658|autologous|autologous
286374|NCT01932658|Lymphoablation|lymphoablation
286375|NCT01932658|hematopoietic|hematopoietic
286376|NCT01932658|immune system|immune system
286377|NCT01932645|prostatitis|prostatitis
286378|NCT01932645|pelvic pain|pelvic pain
286379|NCT01932645|urinary symptoms|urinary symptoms
286380|NCT01932645|sexual dysfunction|sexual dysfunction
286381|NCT01932632|Polypharmacy|polypharmacy
286382|NCT01932632|De-prescribing|de-prescribing
286383|NCT01932632|Frailty|frailty
286384|NCT01932593|multiple sclerosis|multiple sclerosis
286385|NCT01932593|bone marrow|bone marrow
286386|NCT01932593|stem cell therapy|stem cell therapy
286387|NCT01932580|gastric|gastric
286388|NCT01932580|esophageal|esophageal
286389|NCT01932580|adenocarcinoma|adenocarcinoma
286390|NCT01932554|Sickle Cell Pain Crisis|sickle cell pain crisis
286391|NCT01932554|Abciximab|abciximab
286392|NCT01932554|Integrins|integrins
286393|NCT01932554|Cell Adhesion Molecules|cell adhesion molecules
286394|NCT01932541|Bipolar Disorder|bipolar disorder
286395|NCT01932541|Mania|mania
286396|NCT01932541|Bipolar I|bipolar i
286397|NCT01932541|Bipolar II|bipolar ii
286398|NCT01932541|Bipolar Spectrum Disorder|bipolar spectrum disorder
286399|NCT01932541|Pediatric|pediatric
286400|NCT01932528|Absorption|absorption
286401|NCT01932528|Metabolism|metabolism
286402|NCT01932528|Excretion|excretion
286403|NCT01932502|epilepsy|epilepsy
286404|NCT01932502|Onfi|onfi
286405|NCT01932502|clonazepam|clonazepam
286406|NCT01932463|Tremor|tremor
286407|NCT01932463|Essential Tremor|essential tremor
286652|NCT01931462|Cancer of the Kidney|cancer of the kidney
286408|NCT01932463|Medication-refractory Essential Tremor|medication-refractory essential tremor
286409|NCT01932450|hypertension|hypertension
286410|NCT01932450|radiofrequency ablation|radiofrequency ablation
286411|NCT01932450|autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
286412|NCT01932424|Children|children
286413|NCT01932398|Alpha|alpha
286414|NCT01932398|Lateralization|lateralization
286415|NCT01932398|Attention|attention
286416|NCT01932398|ADHD|adhd
286417|NCT01932398|Oscillation|oscillation
286418|NCT01932385|Sorafenib|sorafenib
286419|NCT01932385|Hepatocellular carcinoma|hepatocellular carcinoma
286420|NCT01932385|Best supportive care|best supportive care
286421|NCT01932385|Survival|survival
286422|NCT01932372|Rheumatoid Arthritis|rheumatoid arthritis
286423|NCT01932372|Good Post Marketing Study Practice|good post marketing study practice
286424|NCT01932372|Tofacitinib|tofacitinib
286425|NCT01932372|Xeljanz|xeljanz
286426|NCT01932372|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
286427|NCT01932359|Scar outcome|scar outcome
286428|NCT01932359|Mohs surgery|mohs surgery
286429|NCT01932359|face|face
286430|NCT01932346|near infra-red spectroscopy, coronary artery bypass grafting|near infra-red spectroscopy, coronary artery bypass grafting
286431|NCT01932333|Healthy|healthy
286432|NCT01932333|Safety|safety
286433|NCT01932333|Tolerability|tolerability
286434|NCT01932333|Pharmacokinetics|pharmacokinetics
286435|NCT01932333|Pharmacodynamics|pharmacodynamics
286722|NCT01931033|Oxytocin|oxytocin
286436|NCT01932333|JNJ-40411813|jnj-40411813
286437|NCT01932333|Positive allosteric modulator|positive allosteric modulator
286438|NCT01932320|Healthy|healthy
286439|NCT01932320|Relative Bioavailability|relative bioavailability
286440|NCT01932320|Food effect|food effect
286441|NCT01932320|JNJ-40411813|jnj-40411813
286442|NCT01932320|Positive allosteric modulator|positive allosteric modulator
286443|NCT01932320|Solid Dosage Formulation of JNJ-40411813|solid dosage formulation of jnj-40411813
286444|NCT01932320|Ketoconazole|ketoconazole
286445|NCT01932307|Surgeon neck health|surgeon neck health
286446|NCT01932294|Advanced Heart Failure|advanced heart failure
286447|NCT01932294|Refractory Heart Failure|refractory heart failure
286448|NCT01932294|Mechanical Circulatory Support Device|mechanical circulatory support device
286449|NCT01932294|Ventricular Assist Device|ventricular assist device
286450|NCT01932294|Medamacs|medamacs
286451|NCT01932281|muscle power|muscle power
286452|NCT01932281|muscle fatigue|muscle fatigue
286453|NCT01932281|SierraSil|sierrasil
286454|NCT01932255|microvascular decompression surgery|microvascular decompression surgery
286455|NCT01932255|cerebrospinal fluid leakage|cerebrospinal fluid leakage
286456|NCT01932255|postoperative complications|postoperative complications
286457|NCT01932229|Advanced NSCLC|advanced nsclc
286458|NCT01932229|EGFR mutation|egfr mutation
286459|NCT01932229|TKIs|tkis
286460|NCT01932229|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors
286461|NCT01932216|robotic single-site cholecystectomy|robotic single-site cholecystectomy
286462|NCT01932216|laparoscopic cholecystectomy|laparoscopic cholecystectomy
286463|NCT01932216|cosmesis|cosmesis
286464|NCT01932216|quality of life|quality of life
286465|NCT01932203|Cerebral small vessel disease|cerebral small vessel disease
286466|NCT01932203|Leukoaraiosis|leukoaraiosis
286467|NCT01932203|Magnetic Resonance Imaging|magnetic resonance imaging
286468|NCT01932203|Diffusion Tensor Imaging|diffusion tensor imaging
286469|NCT01932190|Acute Kidney Injury|acute kidney injury
286470|NCT01932190|Critical Care|critical care
286471|NCT01932190|Renal Replacement Therapy|renal replacement therapy
286472|NCT01932190|Treatment Outcome|treatment outcome
286473|NCT01932177|Everolimus ; Sorafenib ; Phase 1 trial ; Solid tumor|everolimus ; sorafenib ; phase 1 trial ; solid tumor
286474|NCT01932164|Cleft lip and palate|cleft lip and palate
286475|NCT01932164|Deciduous dental pulp stem cells|deciduous dental pulp stem cells
286476|NCT01932164|mesenchymal stem cells|mesenchymal stem cells
286477|NCT01932164|tissue engineering|tissue engineering
286478|NCT01932164|bone tissue engineering|bone tissue engineering
286479|NCT01932164|bioengineering|bioengineering
286480|NCT01932151|type-1 HRS|type-1 hrs
286481|NCT01932151|active bacterial infections|active bacterial infections
286482|NCT01932151|terlipressin and albumin|terlipressin and albumin
286483|NCT01932151|kidney function|kidney function
286484|NCT01932138|Community-based intervention|community-based intervention
286485|NCT01932138|Community health workers|community health workers
286486|NCT01932138|Antenatal care|antenatal care
286487|NCT01932138|HIV|hiv
286488|NCT01932138|PMTCT|pmtct
286489|NCT01932138|HIV vertical transmission|hiv vertical transmission
286490|NCT01932138|Public-sector health systems|public-sector health systems
286491|NCT01932112|Pulmonary Vein Isolation|pulmonary vein isolation
286492|NCT01932112|Adenosin effect|adenosin effect
286493|NCT01932112|Atrial fibrillation ablation|atrial fibrillation ablation
286494|NCT01932099|pathological constriction; restricted outflow, stenosis|pathological constriction; restricted outflow, stenosis
286495|NCT01932086|male|male
286496|NCT01932086|Glucose|glucose
286497|NCT01932086|Triglyceride|triglyceride
286498|NCT01932086|Glycemic index|glycemic index
286499|NCT01932086|White rice|white rice
286500|NCT01932086|Brown rice|brown rice
286501|NCT01932086|Black rice|black rice
286502|NCT01932086|Bread|bread
286503|NCT01932073|Radiation|radiation
286504|NCT01932073|dermatitis|dermatitis
286505|NCT01932073|radiodermatitis|radiodermatitis
286506|NCT01932073|radiotherapy induced|radiotherapy induced
286507|NCT01932073|skin reactions|skin reactions
286508|NCT01932073|low level laser therapy|low level laser therapy
286509|NCT01932073|breast cancer|breast cancer
286510|NCT01932060|Oxytocin|oxytocin
286511|NCT01932060|blood loss|blood loss
286512|NCT01932060|Cesarean delivery|cesarean delivery
286513|NCT01932034|Vancomycin|vancomycin
286514|NCT01932034|Pharmacokinetics|pharmacokinetics
286515|NCT01932034|Pharmacodynamics|pharmacodynamics
286516|NCT01932034|Decision support|decision support
286517|NCT01932021|necrotitis angiodermatitis|necrotitis angiodermatitis
286518|NCT01932021|autologous fat transplantation|autologous fat transplantation
286519|NCT01932021|mesenchymal stem cells|mesenchymal stem cells
286520|NCT01932008|Coronary artery bypass grafting|coronary artery bypass grafting
286521|NCT01932008|Chronic kidney disease|chronic kidney disease
286522|NCT01932008|Body composition|body composition
286523|NCT01932008|Physical activity|physical activity
286524|NCT01932008|Physical function|physical function
286525|NCT01931982|diabetes, GLP-1, Victoza, CFR, microvascular dysfunction|diabetes, glp-1, victoza, cfr, microvascular dysfunction
286526|NCT01931969|Vein catheterization; Ultrasound; Landmark; Complication|vein catheterization; ultrasound; landmark; complication
286527|NCT01931956|Mitral Valve Insufficiency|mitral valve insufficiency
286528|NCT01931956|Mitral Valve Regurgitation|mitral valve regurgitation
286529|NCT01931956|Mitral Valve Incompetence|mitral valve incompetence
286530|NCT01931956|Mitral Regurgitation|mitral regurgitation
286531|NCT01931956|Mitral Insufficiency|mitral insufficiency
286532|NCT01931956|Mitral Valve|mitral valve
286533|NCT01931956|Mitral Regurgitation (MR)|mitral regurgitation (mr)
286534|NCT01931956|Mitral Valve Prolapse|mitral valve prolapse
286535|NCT01931956|Edge to Edge (E2E)|edge to edge (e2e)
286536|NCT01931956|Alfieri Technique|alfieri technique
286537|NCT01931956|MitraClip|mitraclip
286538|NCT01931956|Functional MR|functional mr
286539|NCT01931956|Degenerative MR|degenerative mr
286540|NCT01931956|Echocardiogram|echocardiogram
286541|NCT01931956|Coronary Artery Disease (CAD)|coronary artery disease (cad)
286542|NCT01931956|Heart Failure|heart failure
286543|NCT01931956|Heart Attack|heart attack
286544|NCT01931956|EVEREST|everest
286545|NCT01931956|EVEREST I|everest i
286546|NCT01931956|EVEREST II|everest ii
286547|NCT01931956|REALISM|realism
286548|NCT01931930|Gastrointestinal discomfort|gastrointestinal discomfort
286549|NCT01931930|Perilla frutescens|perilla frutescens
286550|NCT01931930|bloating|bloating
286551|NCT01931930|abdominal discomfort|abdominal discomfort
286552|NCT01931930|human study|human study
286553|NCT01931930|healthy subjects|healthy subjects
286554|NCT01931917|Prevention|prevention
286555|NCT01931917|Parenting|parenting
286556|NCT01931917|Infants|infants
286557|NCT01931917|Family programs|family programs
286558|NCT01931917|Early intervention|early intervention
286560|NCT01931904|Glaucoma|glaucoma
286561|NCT01931904|Trabeculectomy|trabeculectomy
286562|NCT01931891|preeclampsia, ADAMTS , wharton jelly, extracellüler matrix, placenta|preeclampsia, adamts , wharton jelly, extracellüler matrix, placenta
286563|NCT01931878|Restless Legs Syndrome|restless legs syndrome
286564|NCT01931878|Leg pain|leg pain
286565|NCT01931878|Sleep|sleep
286566|NCT01931878|Dysesthesias|dysesthesias
286567|NCT01931878|incobotulinumtoxin|incobotulinumtoxin
286568|NCT01931865|cancer pain, radiation therapy, surgery, incobotulinum toxin|cancer pain, radiation therapy, surgery, incobotulinum toxin
286569|NCT01931852|Acute Coronary Syndrome|acute coronary syndrome
286570|NCT01931852|Chest pain|chest pain
286571|NCT01931852|Cardiac MRI|cardiac mri
286572|NCT01931852|Risk Stratification|risk stratification
286573|NCT01931852|Emergency Department|emergency department
286574|NCT01931852|Elevated Troponin|elevated troponin
286575|NCT01931852|Troponin|troponin
286576|NCT01931852|Non-ST Elevation Myocardial Infarction|non-st elevation myocardial infarction
286577|NCT01931826|Schistosomiasis|schistosomiasis
286578|NCT01931826|Surgical treatment|surgical treatment
286579|NCT01931826|Endoscopic treatment|endoscopic treatment
286580|NCT01931774|acne vulgaris cognitive functions|acne vulgaris cognitive functions
286581|NCT01931761|Pharmacokinetics, mass balance, AZD6244|pharmacokinetics, mass balance, azd6244
286582|NCT01931735|menisci|menisci
286583|NCT01931735|tibial|tibial
286584|NCT01931722|branched chain amino acid requirement|branched chain amino acid requirement
286585|NCT01931722|older men|older men
286586|NCT01931722|strength training|strength training
286587|NCT01931722|sarcopenia|sarcopenia
286588|NCT01931696|Efficacy|efficacy
286589|NCT01931696|Acupuncture|acupuncture
286590|NCT01931696|Asthma|asthma
286591|NCT01931683|LMA removal|lma removal
286592|NCT01931683|remifentanil|remifentanil
286593|NCT01931683|propofol|propofol
286594|NCT01931670|Dysmenorrhea (DYS)|dysmenorrhea (dys)
286595|NCT01931670|Elagolix|elagolix
286596|NCT01931670|Gonadotropin-Releasing Hormone Antagonist|gonadotropin-releasing hormone antagonist
286597|NCT01931670|Non-Menstrual Pelvic Pain (NMPP)|non-menstrual pelvic pain (nmpp)
286598|NCT01931670|Endometriosis Associated Pain|endometriosis associated pain
286599|NCT01931657|LNG-IUS|lng-ius
286600|NCT01931657|Mirena|mirena
286601|NCT01931657|Contraception|contraception
286602|NCT01931657|Bleeding|bleeding
286603|NCT01931657|Hormonal effects in the breast|hormonal effects in the breast
286604|NCT01931644|Graft-versus-Host Disease (GVHD)|graft-versus-host disease (gvhd)
286605|NCT01931644|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
286606|NCT01931644|Cancer|cancer
286607|NCT01931644|Diabetes|diabetes
286608|NCT01931644|Melanoma|melanoma
286609|NCT01931644|Hepatitis B|hepatitis b
286610|NCT01931644|Lupus|lupus
286611|NCT01931644|Multiple Sclerosis|multiple sclerosis
286612|NCT01931644|Asthma|asthma
286613|NCT01931644|Crohn's Disease|crohn's disease
286614|NCT01931644|Ulcerative Colitis|ulcerative colitis
286615|NCT01931644|Kidney Disease|kidney disease
286616|NCT01931644|Alzheimer's Disease|alzheimer's disease
286617|NCT01931644|Parkinson's Disease|parkinson's disease
286618|NCT01931644|Huntington's Disease|huntington's disease
286619|NCT01931644|Rheumatoid Arthritis|rheumatoid arthritis
286620|NCT01931644|Sjogren's Syndrome|sjogren's syndrome
286621|NCT01931644|Leukemia|leukemia
286622|NCT01931644|Lymphoma|lymphoma
286623|NCT01931644|Myeloma|myeloma
286624|NCT01931644|CIDP|cidp
286625|NCT01931644|COPD|copd
286723|NCT01931033|Syntocinon|syntocinon
286626|NCT01931644|Idiopathic Thrombocytopenia Purpura|idiopathic thrombocytopenia purpura
286627|NCT01931644|Cystic Fibrosis|cystic fibrosis
286628|NCT01931644|Primary Biliary Cirrhosis|primary biliary cirrhosis
286629|NCT01931631|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
286630|NCT01931631|Diet, Vegetarian|diet, vegetarian
286631|NCT01931631|Diet, Fat-Restricted|diet, fat-restricted
286632|NCT01931631|Glycemic Index|glycemic index
286633|NCT01931618|alcohol|alcohol
286634|NCT01931618|online intervention|online intervention
286635|NCT01931618|hazardous drinking|hazardous drinking
286636|NCT01931618|harmful drinking|harmful drinking
286637|NCT01931618|early intervention|early intervention
286638|NCT01931618|behavior change intervention|behavior change intervention
286639|NCT01931592|ESBL|esbl
286640|NCT01931592|neutropenia|neutropenia
286641|NCT01931592|eradication|eradication
286642|NCT01931592|bloodstream infection|bloodstream infection
286643|NCT01931592|immunosuppression|immunosuppression
286644|NCT01931579|confocal endo-microscopy, lung nodule, respiratory neoplasms|confocal endo-microscopy, lung nodule, respiratory neoplasms
286645|NCT01931566|Drug therapy|drug therapy
286646|NCT01931540|Obesity|obesity
286647|NCT01931540|Epigenesis, Genetic|epigenesis, genetic
286648|NCT01931540|Exercise Therapy|exercise therapy
286649|NCT01931527|Obesity|obesity
286650|NCT01931527|Metabolic syndrome|metabolic syndrome
286651|NCT01931527|Hyperuricemia|hyperuricemia
286653|NCT01931462|Renal Cancer|renal cancer
286654|NCT01931462|Renal Neoplasms|renal neoplasms
286655|NCT01931462|Neoplasms, Kidney|neoplasms, kidney
286656|NCT01931449|Pancreatoduodenectomy|pancreatoduodenectomy
286657|NCT01931449|Digestive Tract Reconstruction|digestive tract reconstruction
286658|NCT01931449|Pancreas|pancreas
286659|NCT01931436|Menopause, pharmacokinetic|menopause, pharmacokinetic
286660|NCT01931397|Dried blood spots|dried blood spots
286661|NCT01931397|kidney transplant|kidney transplant
286662|NCT01931397|Children|children
286663|NCT01931384|Luteal phase support|luteal phase support
286664|NCT01931384|Human chorionic gonadotrophin|human chorionic gonadotrophin
286665|NCT01931384|frozen-thawed embryo transfer cycle|frozen-thawed embryo transfer cycle
286666|NCT01931371|fistula in ano|fistula in ano
286667|NCT01931371|anal fistula|anal fistula
286668|NCT01931371|recurrence|recurrence
286669|NCT01931371|costs|costs
286670|NCT01931345|Rapid HIV testing|rapid hiv testing
286671|NCT01931345|MSM|msm
286672|NCT01931345|Motivational Interviewing|motivational interviewing
286673|NCT01931345|HIV prevention|hiv prevention
286674|NCT01931345|HIV/AIDS|hiv/aids
286675|NCT01931345|At-risk anal intercourse|at-risk anal intercourse
286676|NCT01931345|Randomized trial|randomized trial
286677|NCT01931332|Arthroplasty|arthroplasty
286678|NCT01931332|Analgesia|analgesia
286679|NCT01931319|baclofen withdrawal|baclofen withdrawal
286680|NCT01931319|interruption|interruption
286681|NCT01931319|spasticity|spasticity
286682|NCT01931319|pharmacokinetics|pharmacokinetics
286683|NCT01931319|tolerability|tolerability
286684|NCT01931319|intravenous|intravenous
286685|NCT01931293|atrophic glossitis, burning mouth syndrome, gastric parietal cell antibody, thyroglobulin antibody, thyroid microsomal antibody, HLA-DR, HLA-DQ|atrophic glossitis, burning mouth syndrome, gastric parietal cell antibody, thyroglobulin antibody, thyroid microsomal antibody, hla-dr, hla-dq
286686|NCT01931280|Gestational diabetes|gestational diabetes
286687|NCT01931241|atherosclerosis|atherosclerosis
286688|NCT01931241|atherosclerotic heart disease|atherosclerotic heart disease
286689|NCT01931241|hypercholesteremia|hypercholesteremia
286690|NCT01931241|atherosclerotic plaque|atherosclerotic plaque
286691|NCT01931241|hyperlipidemia|hyperlipidemia
286692|NCT01931228|Intensive care unit|intensive care unit
286693|NCT01931228|acute respiratory insufficiency|acute respiratory insufficiency
286694|NCT01931228|Respiratory failure|respiratory failure
286695|NCT01931228|Mechanical Insufflation-Exsufflation|mechanical insufflation-exsufflation
286696|NCT01931150|Topical Dapsone 5% Gel|topical dapsone 5% gel
286697|NCT01931150|Moisturizer|moisturizer
286698|NCT01931150|rash|rash
286699|NCT01931150|13-012|13-012
286700|NCT01931124|maximal oxygen uptake, activity levels, elderly|maximal oxygen uptake, activity levels, elderly
286701|NCT01931111|physical activity|physical activity
286702|NCT01931111|maximal oxygen uptake|maximal oxygen uptake
286703|NCT01931098|Brain Tumors|brain tumors
286704|NCT01931072|Exercise|exercise
286705|NCT01931072|High-intensity interval training|high-intensity interval training
286706|NCT01931072|Moderate training|moderate training
286707|NCT01931072|Healthy elderly|healthy elderly
286708|NCT01931072|Skeletal muscle|skeletal muscle
286709|NCT01931072|DNA-methylation|dna-methylation
286710|NCT01931072|Gene expression|gene expression
286711|NCT01931072|subjects|subjects
286712|NCT01931059|Imaging|imaging
286713|NCT01931059|Risperidone|risperidone
286714|NCT01931059|Placebo|placebo
286715|NCT01931059|antipsychotic|antipsychotic
286716|NCT01931046|prostate cancer|prostate cancer
286717|NCT01931046|adenocarcinoma of the prostate|adenocarcinoma of the prostate
286718|NCT01931033|Autism Spectrum Disorders|autism spectrum disorders
286719|NCT01931033|Pervasive Developmental Disorders|pervasive developmental disorders
286720|NCT01931033|ASD|asd
286721|NCT01931033|PDD|pdd
286724|NCT01931033|treatment|treatment
286725|NCT01931020|Pain|pain
286726|NCT01931020|Preterm|preterm
286727|NCT01931020|Neonates|neonates
286728|NCT01931020|24% Sucrose|24% sucrose
286729|NCT01931020|25% Dextrose|25% dextrose
286730|NCT01931007|osteoarthritis|osteoarthritis
286731|NCT01930994|LNG: Levonorgestrel|lng: levonorgestrel
286732|NCT01930994|MSI: Marie Stopes International|msi: marie stopes international
286733|NCT01930994|MSK: Marie Stopes Kenya|msk: marie stopes kenya
286734|NCT01930994|PK: Pharmacokinetic|pk: pharmacokinetic
286735|NCT01930981|quality of life|quality of life
286736|NCT01930981|toxicities|toxicities
286737|NCT01930981|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
286738|NCT01930968|Uveal melanoma, ocular melanoma|uveal melanoma, ocular melanoma
286739|NCT01930955|Non-antibiotic prescribing|non-antibiotic prescribing
286740|NCT01930955|acute upper respiratory tract infection|acute upper respiratory tract infection
286741|NCT01930955|white cell count|white cell count
286742|NCT01930955|vomiting|vomiting
286743|NCT01930942|rectal carcinoma|rectal carcinoma
286744|NCT01930942|preoperative concurrent chemoradiotherapy|preoperative concurrent chemoradiotherapy
286745|NCT01930929|Bariatric surgery|bariatric surgery
286746|NCT01930929|Complications|complications
286747|NCT01930929|Drugs|drugs
286748|NCT01930916|Prothrombin Time/instrumentation|prothrombin time/instrumentation
286749|NCT01930916|Prothrombin Time/utilization|prothrombin time/utilization
286750|NCT01930916|Blood Coagulation Disorders/blood|blood coagulation disorders/blood
286751|NCT01930916|Blood Coagulation Disorders/complications|blood coagulation disorders/complications
286752|NCT01930916|Blood Coagulation Disorders/diagnosis|blood coagulation disorders/diagnosis
286753|NCT01930916|Prospective Studies|prospective studies
286754|NCT01930916|Adult|adult
286755|NCT01930916|Reproducibility of Results|reproducibility of results
286756|NCT01930916|Point-of-Care Systems/utilization|point-of-care systems/utilization
286757|NCT01930916|Aged|aged
286758|NCT01930916|Elderly|elderly
286759|NCT01930903|PRO-Kinetic Energy BMS + Pantera Lux DEB combination|pro-kinetic energy bms + pantera lux deb combination
286760|NCT01930877|quality of recovery|quality of recovery
286761|NCT01930877|spine surgery|spine surgery
286762|NCT01930877|intravenous lidocaine|intravenous lidocaine
286763|NCT01930864|metformin|metformin
286764|NCT01930864|colorectal cancer|colorectal cancer
286765|NCT01930864|chemotherapy|chemotherapy
286766|NCT01930851|Bariatric surgery|bariatric surgery
286767|NCT01930851|Quality of life|quality of life
286768|NCT01930851|Complications|complications
286769|NCT01930838|Bariatric surgery|bariatric surgery
286770|NCT01930838|Complications|complications
286771|NCT01930838|Osteoporosis|osteoporosis
286772|NCT01930838|Neuropathy|neuropathy
286773|NCT01930838|Vitamine deficiency|vitamine deficiency
286774|NCT01930812|18F-NaF PET/CT|18f-naf pet/ct
286775|NCT01930812|Bone imaging|bone imaging
286776|NCT01930773|clopidogrel|clopidogrel
286777|NCT01930773|prasugrel|prasugrel
286778|NCT01930773|platelet function testing|platelet function testing
286779|NCT01930773|genotyping|genotyping
286780|NCT01930773|peri-procedural MI|peri-procedural mi
286781|NCT01930760|pediatric|pediatric
286782|NCT01930760|Childhood Obesity|childhood obesity
286783|NCT01930760|motivational interviewing|motivational interviewing
286784|NCT01930760|pediatric primary care physicians|pediatric primary care physicians
286785|NCT01930747|pneumoperitoneum|pneumoperitoneum
286786|NCT01930747|laparoscopy|laparoscopy
286787|NCT01930734|Heart Failure|heart failure
286788|NCT01930734|Dobutamine|dobutamine
286789|NCT01930708|BG-12|bg-12
286790|NCT01930695|DX functionality|dx functionality
286791|NCT01930695|Atrial fibrillation|atrial fibrillation
286792|NCT01930695|CRT-D indication|crt-d indication
286793|NCT01930682|Myocardial Infarction|myocardial infarction
286794|NCT01930682|Catheterization|catheterization
286795|NCT01930682|Fibrinolysis|fibrinolysis
286796|NCT01930669|Heart Rate Variability|heart rate variability
286797|NCT01930669|Multiple Organ Dysfunction Syndrome|multiple organ dysfunction syndrome
286798|NCT01930669|Critically Ill|critically ill
286799|NCT01930656|osteoporisis|osteoporisis
286800|NCT01930656|fracture|fracture
286801|NCT01930656|risk|risk
286802|NCT01930656|cost effectiveness|cost effectiveness
286803|NCT01930656|FRAX|frax
286804|NCT01930656|mobile device|mobile device
286805|NCT01930643|Electric muscle stimulation|electric muscle stimulation
286806|NCT01930643|mechanical ventilation|mechanical ventilation
286807|NCT01930643|chronic respiratory failure|chronic respiratory failure
286808|NCT01930630|extraesophageal saline injection (ESI);|extraesophageal saline injection (esi);
286809|NCT01930630|esophageal squamous cell carcinoma (ESCC);|esophageal squamous cell carcinoma (escc);
286810|NCT01930630|esophageal cancer;|esophageal cancer;
286811|NCT01930630|endoscopic ultrasonography (EUS)|endoscopic ultrasonography (eus)
286812|NCT01930617|surgery|surgery
286813|NCT01930617|trephining|trephining
286814|NCT01930617|drainage|drainage
286815|NCT01930617|therapeutic irrigation|therapeutic irrigation
286816|NCT01930617|subdural space|subdural space
286817|NCT01930617|postoperative complications|postoperative complications
286818|NCT01930617|mortality|mortality
286819|NCT01930604|Palmar hyperhidrosis.|palmar hyperhidrosis.
286820|NCT01930604|Plantar hyperhidrosis.|plantar hyperhidrosis.
286821|NCT01930604|Inguinal (groins and buttocks) hyperhidrosis.|inguinal (groins and buttocks) hyperhidrosis.
286822|NCT01930604|Craniofacial hyperhidrosis.|craniofacial hyperhidrosis.
286823|NCT01930604|Truncal hyperhidrosis.|truncal hyperhidrosis.
286824|NCT01930591|fibrinolytic therapy|fibrinolytic therapy
286825|NCT01930591|stenting|stenting
286826|NCT01930591|platelet activity|platelet activity
286827|NCT01930578|bioimpedance analysis|bioimpedance analysis
286828|NCT01930578|spectroscopy|spectroscopy
286829|NCT01930578|electrolyte sodium bromide|electrolyte sodium bromide
286830|NCT01930578|extracellular water|extracellular water
286831|NCT01930565|acne|acne
286832|NCT01930565|therapeutics|therapeutics
286833|NCT01930565|clinical trial|clinical trial
286834|NCT01930565|natural compound|natural compound
286835|NCT01930565|Lactobacillus fermented Chamaecypris obtuse|lactobacillus fermented chamaecypris obtuse
286836|NCT01930565|tea tree oil|tea tree oil
286837|NCT01930526|COPD|copd
286838|NCT01930526|Exercise|exercise
286839|NCT01930526|Cycling|cycling
286840|NCT01930526|Single leg|single leg
286841|NCT01930526|Pulmonary Rehabilitation|pulmonary rehabilitation
286842|NCT01930513|Obesity|obesity
286843|NCT01930513|Obstructive Sleep Apnea|obstructive sleep apnea
286844|NCT01930513|Exercise|exercise
286845|NCT01930513|Walking tests|walking tests
286846|NCT01930513|Cardiopulmonary exercise tests|cardiopulmonary exercise tests
286847|NCT01930513|Physical activity|physical activity
286848|NCT01930487|Primary open angle glaucoma|primary open angle glaucoma
286849|NCT01930487|intraocular pressure|intraocular pressure
286850|NCT01930487|ocular perfusion pressure|ocular perfusion pressure
286851|NCT01930487|retrobulbar blood flow|retrobulbar blood flow
286852|NCT01930487|retinal capillary blood flow|retinal capillary blood flow
286853|NCT01930487|choroidal blood flow|choroidal blood flow
286854|NCT01930474|lung cancer, plasma DNA, free DNA, EGFR, ALK|lung cancer, plasma dna, free dna, egfr, alk
286855|NCT01930448|Bariatric|bariatric
286856|NCT01930448|Gastric Bypass|gastric bypass
286857|NCT01930448|Gastric Banding,|gastric banding,
286858|NCT01930448|Type 2 Diabetes|type 2 diabetes
286859|NCT01930448|Incretins|incretins
286860|NCT01930448|GLP-1|glp-1
286861|NCT01930448|GIP|gip
286862|NCT01930448|Insulin secretion|insulin secretion
286863|NCT01930448|insulin sensitivity|insulin sensitivity
286864|NCT01930435|Quality of Life|quality of life
286865|NCT01930422|Direct transcranial electrical stimulation (tDCS)|direct transcranial electrical stimulation (tdcs)
286866|NCT01930422|Sham procedure|sham procedure
286867|NCT01930422|Tobacco consumption|tobacco consumption
286868|NCT01930422|Craving|craving
286869|NCT01930409|Femoral Fractures|femoral fractures
286870|NCT01930409|Hip Fractures|hip fractures
286871|NCT01930409|Frail older adults|frail older adults
286872|NCT01930409|Quality of Life|quality of life
286873|NCT01930409|Feasibility Studies|feasibility studies
286874|NCT01930396|Hemodialysis|hemodialysis
286875|NCT01930396|Anticoagulation|anticoagulation
286876|NCT01930396|Tinzaparin|tinzaparin
286877|NCT01930396|Unfractionated Heparin|unfractionated heparin
286878|NCT01930396|Randomized Controlled Trial|randomized controlled trial
286879|NCT01930383|biomarkers|biomarkers
286880|NCT01930370|pediatrics|pediatrics
286881|NCT01930370|phosphate and postassium revmoval|phosphate and postassium revmoval
286882|NCT01930370|dialysate bicarbonate modeling|dialysate bicarbonate modeling
286883|NCT01930357|Rabies|rabies
286884|NCT01930357|Purified Vero Rabies Vaccine - Serum Free (VRVg)|purified vero rabies vaccine - serum free (vrvg)
286885|NCT01930357|Imovax® rabies|imovax® rabies
286886|NCT01930357|Human Diploid Cell Vaccine|human diploid cell vaccine
286887|NCT01930344|stereopsis|stereopsis
286888|NCT01930344|3D laparoscopy|3d laparoscopy
286889|NCT01930344|OCHRA|ochra
286890|NCT01930331|Uncomplicated Plasmodium falciparum Malaria|uncomplicated plasmodium falciparum malaria
286891|NCT01930305|Heating transfusion|heating transfusion
286892|NCT01930279|T cell markers|t cell markers
286893|NCT01930227|hypotension|hypotension
286894|NCT01930227|spinal anesthesia|spinal anesthesia
286895|NCT01930227|cesarean|cesarean
286896|NCT01930175|Pemphigus vulgaris|pemphigus vulgaris
286897|NCT01930175|pemphigus|pemphigus
286898|NCT01930175|blistering disease|blistering disease
286899|NCT01930162|HSC835|hsc835
286900|NCT01930162|single umbilical cord blood transplantation|single umbilical cord blood transplantation
286901|NCT01930162|non-myeloablative conditioning regimen|non-myeloablative conditioning regimen
286902|NCT01930162|Umbilical cord blood|umbilical cord blood
286903|NCT01930162|UCB transplantation|ucb transplantation
286904|NCT01930149|Cholesterol screening|cholesterol screening
286905|NCT01930149|High cholesterol|high cholesterol
286906|NCT01930149|Cardiovascular disease|cardiovascular disease
286907|NCT01930149|Statin treatment|statin treatment
286908|NCT01930136|Calorie restriction|calorie restriction
286909|NCT01930136|Type 2 diabetes|type 2 diabetes
286910|NCT01930136|Obesity|obesity
286911|NCT01930136|Diabetic nephropathy prevention|diabetic nephropathy prevention
286912|NCT01930123|Fructose|fructose
286913|NCT01930123|NASH|nash
287017|NCT01929538|cSEMS|csems
286914|NCT01930123|advanced fibrosis|advanced fibrosis
286915|NCT01930123|biomarker|biomarker
286916|NCT01930123|magnetic resonance|magnetic resonance
286917|NCT01930110|Type 1 diabetes|type 1 diabetes
286918|NCT01930110|Hypoglycemia|hypoglycemia
286919|NCT01930110|Insulin|insulin
286920|NCT01930110|Glucagon|glucagon
286921|NCT01930110|Closed-loop system|closed-loop system
286922|NCT01930110|Artificial pancreas|artificial pancreas
286923|NCT01930097|Type 1 diabetes|type 1 diabetes
286924|NCT01930097|Hypoglycemia|hypoglycemia
286925|NCT01930097|Insulin|insulin
286926|NCT01930097|Glucagon|glucagon
286927|NCT01930097|Closed-loop system|closed-loop system
286928|NCT01930097|Artificial pancreas|artificial pancreas
286929|NCT01930097|Carbohydrate counting|carbohydrate counting
286930|NCT01930084|HIV|hiv
286931|NCT01930084|linkage|linkage
286932|NCT01930084|retention|retention
286933|NCT01930032|Clostridium difficile infection|clostridium difficile infection
286934|NCT01930019|etomidate,|etomidate,
286935|NCT01930019|thiopental,|thiopental,
286936|NCT01930019|serum cortisol concentration,|serum cortisol concentration,
286937|NCT01930006|c-Met|c-met
286938|NCT01930006|VEGFR|vegfr
286939|NCT01930006|Ron|ron
286940|NCT01930006|Cancer|cancer
286941|NCT01930006|Tumor|tumor
286942|NCT01930006|Safety|safety
286943|NCT01930006|Phase 1|phase 1
286944|NCT01929993|Conization|conization
286945|NCT01929993|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
286946|NCT01929993|Cervix Dysplasia|cervix dysplasia
286947|NCT01929993|Therapy|therapy
286948|NCT01929993|Electrosurgery|electrosurgery
286949|NCT01929980|HSCT|hsct
286950|NCT01929980|cytopenia|cytopenia
286951|NCT01929980|immune suppression|immune suppression
286952|NCT01929980|proteasome inhibitor|proteasome inhibitor
286953|NCT01929967|Heterotaxy syndrome|heterotaxy syndrome
286954|NCT01929967|Asplenia|asplenia
286955|NCT01929967|Polysplenia|polysplenia
286956|NCT01929889|schizophrenia|schizophrenia
286957|NCT01929889|schizoaffective disorder|schizoaffective disorder
286958|NCT01929889|iloperidone|iloperidone
286959|NCT01929889|Fanapt|fanapt
286960|NCT01929889|social cognition|social cognition
286961|NCT01929889|cognition|cognition
286962|NCT01929863|Metformin|metformin
286963|NCT01929863|Diabetes|diabetes
286964|NCT01929837|Tinnitus|tinnitus
286965|NCT01929837|Transcranial magnetic stimulation|transcranial magnetic stimulation
286966|NCT01929824|dysphagia, trouble swallowing, chest pain|dysphagia, trouble swallowing, chest pain
286967|NCT01929798|artificial pancreas|artificial pancreas
286968|NCT01929785|post tranplant heart allograft|post tranplant heart allograft
286969|NCT01929759|HIV|hiv
286970|NCT01929759|neurocognitive symptoms|neurocognitive symptoms
286971|NCT01929759|efavirenz|efavirenz
286972|NCT01929759|elvitegravir|elvitegravir
286973|NCT01929759|neurometabolites|neurometabolites
286974|NCT01929733|Patent Ductus Arteriosus|patent ductus arteriosus
286975|NCT01929720|cancer|cancer
286976|NCT01929720|cancer survivors|cancer survivors
286977|NCT01929720|worry|worry
286978|NCT01929720|insomnia|insomnia
286979|NCT01929720|symptoms|symptoms
286980|NCT01929720|fatigue|fatigue
286981|NCT01929720|depression|depression
286982|NCT01929720|anxiety|anxiety
286983|NCT01929681|Low Field Magnetic Stimulation|low field magnetic stimulation
286984|NCT01929681|bipolar|bipolar
286985|NCT01929681|depression|depression
286986|NCT01929681|alternative treatment|alternative treatment
286987|NCT01929668|ulcerative colitis|ulcerative colitis
286988|NCT01929668|bowel preparation|bowel preparation
286989|NCT01929655|Phase II|phase ii
286990|NCT01929655|symptomatic castration-resistant prostate cancer|symptomatic castration-resistant prostate cancer
286991|NCT01929655|bone metastases|bone metastases
286992|NCT01929642|Tuberous Sclerosis Complex (TSC)|tuberous sclerosis complex (tsc)
286993|NCT01929642|self-injury|self-injury
286994|NCT01929642|Autism|autism
286995|NCT01929629|Phase 1|phase 1
286996|NCT01929629|Healthy Volunteers|healthy volunteers
286997|NCT01929629|First Time in Man|first time in man
286998|NCT01929629|Pharmacokinetics|pharmacokinetics
286999|NCT01929616|adenocarcinoma, colorectal,regorafenib|adenocarcinoma, colorectal,regorafenib
287000|NCT01929603|oncology, cancer, tumour, anticancer drug, pharmacokinetics, olaparib, rifampicin, neoplasm, CYP P450 inducer|oncology, cancer, tumour, anticancer drug, pharmacokinetics, olaparib, rifampicin, neoplasm, cyp p450 inducer
287001|NCT01929590|Colonoscopy|colonoscopy
287002|NCT01929590|Preparation|preparation
287003|NCT01929590|Polyp|polyp
287004|NCT01929590|Polyethylene glycol|polyethylene glycol
287005|NCT01929577|ASP015K|asp015k
287006|NCT01929577|healthy subjects|healthy subjects
287007|NCT01929564|cardiovascular disease|cardiovascular disease
287008|NCT01929564|risk factor|risk factor
287009|NCT01929564|broccoli|broccoli
287010|NCT01929564|GST|gst
287011|NCT01929564|blood pressure|blood pressure
287012|NCT01929564|Total cholesterol|total cholesterol
287013|NCT01929551|glycemic index|glycemic index
287014|NCT01929538|Chronic pancreatitis|chronic pancreatitis
287015|NCT01929538|Biliary stricture|biliary stricture
287016|NCT01929538|Endoscopic treatment|endoscopic treatment
287018|NCT01929499|Colon cancer|colon cancer
287019|NCT01929499|Cytokine-induced killer cells|cytokine-induced killer cells
287020|NCT01929499|Adjuvant immunotherapy|adjuvant immunotherapy
287021|NCT01929499|Adjuvant chemotherapy|adjuvant chemotherapy
287022|NCT01929473|Pertussis infection|pertussis infection
287023|NCT01929473|Risk factors|risk factors
287024|NCT01929447|sleep disorders|sleep disorders
287025|NCT01929447|sleep apnea|sleep apnea
287026|NCT01929447|ambulatory device|ambulatory device
287027|NCT01929447|WatchPAT|watchpat
287028|NCT01929434|cerebral palsy|cerebral palsy
287029|NCT01929434|cell transplantation|cell transplantation
287030|NCT01929434|rehabilitation|rehabilitation
287031|NCT01929421|colorectal cancer|colorectal cancer
287032|NCT01929421|gemcitabine|gemcitabine
287033|NCT01929421|S-1|s-1
287034|NCT01929395|Breast Cancer|breast cancer
287035|NCT01929395|Breast Conserving Surgery|breast conserving surgery
287036|NCT01929395|Breast diagnostics|breast diagnostics
287037|NCT01929395|Breast imaging|breast imaging
287038|NCT01929382|dose titration|dose titration
287039|NCT01929382|FLS|fls
287040|NCT01929382|flu like symptoms|flu like symptoms
287041|NCT01929382|Actimmune|actimmune
287042|NCT01929369|ESRD|esrd
287043|NCT01929369|CKD|ckd
287044|NCT01929369|AV GRAFTS|av grafts
287045|NCT01929369|THROMBOSED AV GRAFTS|thrombosed av grafts
287046|NCT01929356|lung function tests|lung function tests
287047|NCT01929356|chest physiotherapy|chest physiotherapy
287048|NCT01929343|cocaine|cocaine
287049|NCT01929343|addiction|addiction
287050|NCT01929343|lidocaine|lidocaine
287051|NCT01929343|memory|memory
287052|NCT01929343|drug abuse|drug abuse
287053|NCT01929330|Bioequivalence|bioequivalence
287054|NCT01929330|Healthy Male Volunteers|healthy male volunteers
287055|NCT01929330|Androgenetic Alopecia|androgenetic alopecia
287056|NCT01929330|Dutasteride|dutasteride
287057|NCT01929330|Safety|safety
287058|NCT01929330|Tolerability|tolerability
287059|NCT01929317|Ropinirole|ropinirole
287060|NCT01929317|Parkinson's disease|parkinson's disease
287061|NCT01929291|Korea|korea
287062|NCT01929291|Post-marketing surveillance|post-marketing surveillance
287063|NCT01929291|Boostrix|boostrix
287064|NCT01929291|Prescribing information|prescribing information
287065|NCT01929291|Safety|safety
287066|NCT01929265|INFL|infl
287067|NCT01929265|Indolent non-follicular|indolent non-follicular
287068|NCT01929265|untreated INFL|untreated infl
287069|NCT01929252|dexmedetomidine|dexmedetomidine
287070|NCT01929252|wound infiltration|wound infiltration
287071|NCT01929252|postoperative analgesia|postoperative analgesia
287072|NCT01929187|Onychomycosis, BioEqual carrier system, amorolfine.|onychomycosis, bioequal carrier system, amorolfine.
287073|NCT01929174|Congenital heart disease|congenital heart disease
287074|NCT01929174|Myocardial fibrosis|myocardial fibrosis
287075|NCT01929174|Diastolic dysfunction|diastolic dysfunction
287076|NCT01929161|positive emotions|positive emotions
287077|NCT01929161|meditation|meditation
287078|NCT01929161|oxytocin|oxytocin
287079|NCT01929148|risk-reducing salpingectomy|risk-reducing salpingectomy
287080|NCT01929148|prophylactic bilateral salpingectomy|prophylactic bilateral salpingectomy
287081|NCT01929148|ovarian cancer prevention|ovarian cancer prevention
287082|NCT01929148|ovarian reserve|ovarian reserve
287083|NCT01929135|Periodontal Disease|periodontal disease
287084|NCT01929135|Chronic Periodontitis|chronic periodontitis
287085|NCT01929135|Atorvastatin|atorvastatin
287086|NCT01929135|Statins|statins
287087|NCT01929135|Hydroxymethylglutaryl-coenzyme A Reductase Inhibitors|hydroxymethylglutaryl-coenzyme a reductase inhibitors
287088|NCT01929135|Dentifrice|dentifrice
287089|NCT01929122|Prevention & control|prevention & control
287090|NCT01929122|Diet|diet
287091|NCT01929122|Functional food|functional food
287092|NCT01929122|Nutrition Assessment|nutrition assessment
287093|NCT01929122|Oryza sativa|oryza sativa
287094|NCT01929122|Rice Bran|rice bran
287095|NCT01929122|Phaseolus vulgaris L.|phaseolus vulgaris l.
287096|NCT01929122|Legumes|legumes
287097|NCT01929122|Microbiome|microbiome
287098|NCT01929122|Metabolomics|metabolomics
287099|NCT01929122|Prebiotics|prebiotics
287100|NCT01929083|Torsades de pointes|torsades de pointes
287101|NCT01929083|Progesterone|progesterone
287102|NCT01929083|Clinical trial|clinical trial
287103|NCT01929083|Risk reduction|risk reduction
287104|NCT01929083|Electrocardiography|electrocardiography
287105|NCT01929070|HCP1007|hcp1007
287106|NCT01929070|Rosuvastatin|rosuvastatin
287107|NCT01929070|Omega-3|omega-3
287108|NCT01929018|Amputation|amputation
287109|NCT01929018|Rehabilitation|rehabilitation
287110|NCT01929018|Exercise|exercise
287111|NCT01929018|Movement|movement
287112|NCT01929005|Comprehensive care|comprehensive care
287113|NCT01929005|Medicare|medicare
287114|NCT01929005|Cost-sharing|cost-sharing
287115|NCT01929005|Quality of care|quality of care
287116|NCT01928992|Mammography|mammography
287117|NCT01928992|3D|3d
287118|NCT01928992|Breast Cancer Detection|breast cancer detection
287119|NCT01928979|LA/LAA Thrombus|la/laa thrombus
287120|NCT01928979|Atrial Fibrillation|atrial fibrillation
287121|NCT01928979|Observation|observation
287122|NCT01928966|dietary fat|dietary fat
287123|NCT01928966|fat intake|fat intake
287124|NCT01928966|blood pressure|blood pressure
287125|NCT01928966|women|women
287126|NCT01928966|phytoestrogen|phytoestrogen
287127|NCT01928966|pumpkin seeds|pumpkin seeds
287128|NCT01928966|cardiovascular disease|cardiovascular disease
287129|NCT01928966|heart disease|heart disease
287130|NCT01928966|secoisolariciresinol|secoisolariciresinol
287131|NCT01928966|monounsaturated fat|monounsaturated fat
287132|NCT01928966|polyunsaturated fat|polyunsaturated fat
287133|NCT01928966|feeding study|feeding study
287134|NCT01928953|opioid induced constipation in patients without cancer and with cancer|opioid induced constipation in patients without cancer and with cancer
287135|NCT01928940|Advanced solid tumors|advanced solid tumors
287136|NCT01928940|BRAF|braf
287137|NCT01928940|Melanoma|melanoma
287138|NCT01928888|Acute heartburn episodes|acute heartburn episodes
287139|NCT01928849|Amputation|amputation
287140|NCT01928849|Post-amputation Pain|post-amputation pain
287141|NCT01928849|Neuropathic pain|neuropathic pain
287142|NCT01928849|Valproic Acid|valproic acid
287143|NCT01928849|Anesthesia, Conduction|anesthesia, conduction
287144|NCT01928849|Neuralgia, stump|neuralgia, stump
287145|NCT01928836|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
287146|NCT01928836|Small Cell Lung Carcinoma|small cell lung carcinoma
287147|NCT01928836|Biological Markers|biological markers
287148|NCT01928836|ROC Curve|roc curve
287149|NCT01928836|Delayed Diagnosis|delayed diagnosis
287150|NCT01928823|agoraphobia|agoraphobia
287151|NCT01928823|panic disorder|panic disorder
287152|NCT01928823|D-Cycloserine|d-cycloserine
287154|NCT01928823|exposure|exposure
287155|NCT01928823|cognitive behavioral therapy|cognitive behavioral therapy
287156|NCT01928823|CBT|cbt
287157|NCT01928823|augmentation|augmentation
287158|NCT01928810|Panic Disorder|panic disorder
287159|NCT01928810|Agoraphobia|agoraphobia
287160|NCT01928810|Physical Activity|physical activity
287161|NCT01928797|cardiac output pregnancy spinal anesthesia|cardiac output pregnancy spinal anesthesia
287162|NCT01928784|Low back pain|low back pain
287163|NCT01928784|extracorporeal shock wave therapy|extracorporeal shock wave therapy
287164|NCT01928784|Trigger Points|trigger points
287165|NCT01928771|Asthma,|asthma,
287166|NCT01928771|Bronchial Diseases,|bronchial diseases,
287167|NCT01928771|Respiratory Tract Diseases,|respiratory tract diseases,
287168|NCT01928771|Lung Diseases,|lung diseases,
287169|NCT01928771|Obstructive Lung Diseases|obstructive lung diseases
287170|NCT01928758|Smoking|smoking
287171|NCT01928758|Nicotine|nicotine
287172|NCT01928745|Stewart approach|stewart approach
287173|NCT01928745|sepsis|sepsis
287174|NCT01928745|SIRS|sirs
287175|NCT01928745|cardiothoracic surgery|cardiothoracic surgery
287176|NCT01928745|CABG|cabg
287177|NCT01928719|Smoking|smoking
287178|NCT01928719|Nicotine|nicotine
287179|NCT01928706|edentulism|edentulism
287180|NCT01928706|denture liner|denture liner
287181|NCT01928706|prosthodontics|prosthodontics
287182|NCT01928706|OHIP EDENT|ohip edent
287183|NCT01928693|infectious corneal ulcers|infectious corneal ulcers
287184|NCT01928680|Triple Negative Breast Cancer, Cisplatin, Capecitabine|triple negative breast cancer, cisplatin, capecitabine
287185|NCT01928654|Edema|edema
287186|NCT01928654|Diabetic|diabetic
287187|NCT01928654|Laser|laser
287188|NCT01928654|Treatment|treatment
287189|NCT01928602|Crossover|crossover
287190|NCT01928602|Chronic stroke|chronic stroke
287191|NCT01928602|Stroke|stroke
287192|NCT01928602|Rehabilitation|rehabilitation
287193|NCT01928602|Language Therapy|language therapy
287194|NCT01928602|Aphasia|aphasia
287195|NCT01928602|Aphasia Therapy|aphasia therapy
287196|NCT01928602|Computerised Therapy|computerised therapy
287197|NCT01928602|Computerised Rehabilitation|computerised rehabilitation
287198|NCT01928602|Tablet|tablet
287199|NCT01928602|Apps|apps
287200|NCT01928602|Aphasia Rehabilitation|aphasia rehabilitation
287201|NCT01928602|Rehabilitation on Portable Tablets|rehabilitation on portable tablets
287202|NCT01928589|Cyclophosphamide|cyclophosphamide
287203|NCT01928589|Doxorubicin|doxorubicin
287204|NCT01928589|Docetaxel|docetaxel
287205|NCT01928589|Carboplatin|carboplatin
287206|NCT01928589|Herceptin|herceptin
287207|NCT01928589|Partial Breast Irradiation|partial breast irradiation
287208|NCT01928589|Concurrent Chemotherapy|concurrent chemotherapy
287209|NCT01928550|Diabetes|diabetes
287210|NCT01928550|OCT|oct
287211|NCT01928550|PDR|pdr
287212|NCT01928537|International Working Group|international working group
287213|NCT01928537|azacitidine|azacitidine
287214|NCT01928537|decitabine|decitabine
287215|NCT01928524|Gastric cancer|gastric cancer
287216|NCT01928524|Cancer of the esophagus|cancer of the esophagus
287217|NCT01928524|Oxaliplatin|oxaliplatin
287218|NCT01928524|Docetaxel|docetaxel
287219|NCT01928524|S1|s1
287220|NCT01928511|Hepatitis B virus|hepatitis b virus
287221|NCT01928511|HBeAg positive|hbeag positive
287222|NCT01928511|HBeAg negative|hbeag negative
287223|NCT01928511|antiviral therapy|antiviral therapy
287224|NCT01928511|nucleoside analogues|nucleoside analogues
287225|NCT01928498|arteriovenous fistulae|arteriovenous fistulae
287226|NCT01928498|arteriovenous graft|arteriovenous graft
287227|NCT01928498|restenosis|restenosis
287228|NCT01928498|angioplasty|angioplasty
287229|NCT01928498|drug eluting balloon|drug eluting balloon
287230|NCT01928472|Influenza, H7N9, Vaccine|influenza, h7n9, vaccine
287231|NCT01928459|BGJ398|bgj398
287232|NCT01928459|BYL719|byl719
287233|NCT01928459|advanced solid tumor|advanced solid tumor
287234|NCT01928459|metastatic breast cancer|metastatic breast cancer
287235|NCT01928459|PK3CA|pk3ca
287236|NCT01928459|FGFR|fgfr
287237|NCT01928459|fibroblast growth factor receptor|fibroblast growth factor receptor
287238|NCT01928446|Lithium|lithium
287239|NCT01928446|Placebo|placebo
287240|NCT01928446|Double-blind methods|double-blind methods
287241|NCT01928446|Clinical Trials, Randomized|clinical trials, randomized
287242|NCT01928446|Veterans|veterans
287243|NCT01928433|Urinary Tract Infection|urinary tract infection
287244|NCT01928433|Pyelonephritis|pyelonephritis
287245|NCT01928420|Alzheimer Disease|alzheimer disease
287246|NCT01928420|Alzheimer Type Senile Dementia|alzheimer type senile dementia
287247|NCT01928420|Alzheimer's Disease|alzheimer's disease
287248|NCT01928420|clinical trial|clinical trial
287249|NCT01928420|dementia|dementia
287250|NCT01928420|diabetes|diabetes
287251|NCT01928420|dietary supplements|dietary supplements
287252|NCT01928420|Senile Dementia, Alzheimer|senile dementia, alzheimer
287253|NCT01928420|Therapeutics|therapeutics
287254|NCT01928420|Brain Diseases|brain diseases
287255|NCT01928420|Central Nervous System Diseases|central nervous system diseases
287256|NCT01928420|Nervous System Diseases|nervous system diseases
287257|NCT01928420|Neurodegenerative Diseases|neurodegenerative diseases
287258|NCT01928420|Delirium, Dementia, Amnestic, Cognitive|delirium, dementia, amnestic, cognitive
287259|NCT01928420|Disorders|disorders
287260|NCT01928420|Mental Disorders|mental disorders
287261|NCT01928407|naives, CD4 < 200 cell/mm3, Atazanavir, Darunavir|naives, cd4 < 200 cell/mm3, atazanavir, darunavir
287262|NCT01928368|Mild asthma|mild asthma
287263|NCT01928368|Atopic asthma|atopic asthma
287264|NCT01928368|Healthy volunteers|healthy volunteers
287265|NCT01928368|First-in-human|first-in-human
287266|NCT01928316|Healthy|healthy
287267|NCT01928316|Bioequivalence|bioequivalence
287268|NCT01928316|Mizolastine|mizolastine
287269|NCT01928316|Domestic|domestic
287270|NCT01928316|Imported|imported
287271|NCT01928303|opioids|opioids
287272|NCT01928303|chronic pain|chronic pain
287273|NCT01928303|oxycodone|oxycodone
287274|NCT01928303|oxymorphone|oxymorphone
287275|NCT01928303|patients using opioid pain medication|patients using opioid pain medication
287276|NCT01928277|Symptom assessment agreement|symptom assessment agreement
287277|NCT01928277|Work of breathing|work of breathing
287278|NCT01928264|Mental disorders|mental disorders
287279|NCT01928264|Physical activity|physical activity
287280|NCT01928264|Disability pension|disability pension
287281|NCT01928264|Disability pension due to mental illness|disability pension due to mental illness
287282|NCT01928264|Ability to work|ability to work
287283|NCT01928264|Mental toughness|mental toughness
287284|NCT01928238|NIV|niv
287285|NCT01928238|NAVA|nava
287286|NCT01928238|noninvasive neurally adjusted ventilatory|noninvasive neurally adjusted ventilatory
287287|NCT01928238|noninvasive pressure support ventilation|noninvasive pressure support ventilation
287288|NCT01928225|HSIL|hsil
287289|NCT01928225|CIN|cin
287290|NCT01928225|HPV|hpv
287291|NCT01928225|HPV vaccination|hpv vaccination
287292|NCT01928225|gardasil|gardasil
287293|NCT01928225|HIV|hiv
287294|NCT01928225|cervical dysplasia|cervical dysplasia
287295|NCT01928225|LEEP|leep
287296|NCT01928225|cervical cancer|cervical cancer
287297|NCT01928212|retinal nerve fiber layer thickness|retinal nerve fiber layer thickness
287298|NCT01928212|optical coherence tomography|optical coherence tomography
287299|NCT01928212|Parkinson disease|parkinson disease
287300|NCT01928199|diabetes|diabetes
287301|NCT01928199|transplant|transplant
287302|NCT01928199|kidney|kidney
287303|NCT01928173|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
287304|NCT01928173|Cognitive Therapy|cognitive therapy
287305|NCT01928160|Non-small cell lung cancer, EGFR mutation, erlotinib acquired resistance|non-small cell lung cancer, egfr mutation, erlotinib acquired resistance
287306|NCT01928147|NS5B polymerase inhibitor|ns5b polymerase inhibitor
287307|NCT01928147|Phase 1|phase 1
287308|NCT01928147|Genotype 1|genotype 1
287309|NCT01928134|Vitamin K2|vitamin k2
287310|NCT01928134|Vitamin D3|vitamin d3
287311|NCT01928134|Bioavailability of calcium|bioavailability of calcium
287312|NCT01928134|volunteers|volunteers
287313|NCT01928134|Men|men
287314|NCT01928134|non-pregnant women|non-pregnant women
287315|NCT01928134|twenty years of age|twenty years of age
287316|NCT01928121|nurse|nurse
287317|NCT01928121|expert program|expert program
287318|NCT01928121|primary care|primary care
287319|NCT01928121|implementation|implementation
287320|NCT01928121|interdisciplinary|interdisciplinary
287321|NCT01928121|effectiveness|effectiveness
287322|NCT01928121|disease management system|disease management system
287625|NCT01926743|gastrectomy|gastrectomy
287323|NCT01928095|atherosclerosis|atherosclerosis
287324|NCT01928095|carotid endartherectomy|carotid endartherectomy
287325|NCT01928082|Hypercalciuria, Familial Idiopathic|hypercalciuria, familial idiopathic
287326|NCT01928082|Hypercalciuria|hypercalciuria
287327|NCT01928082|Osteopenia|osteopenia
287328|NCT01928082|Osteoporosis|osteoporosis
287329|NCT01928082|Postmenopausal women|postmenopausal women
287330|NCT01928004|edentulous|edentulous
287331|NCT01928004|complete denture|complete denture
287332|NCT01927991|tinnitus|tinnitus
287333|NCT01927991|cognitive behavioural therapy|cognitive behavioural therapy
287334|NCT01927991|internet treatment|internet treatment
287335|NCT01927978|Esophageal cancer|esophageal cancer
287336|NCT01927978|18F-FDG PET|18f-fdg pet
287337|NCT01927978|staging|staging
287338|NCT01927978|therapy planning|therapy planning
287339|NCT01927978|therapy response monitoring|therapy response monitoring
287340|NCT01927978|prognosis|prognosis
287341|NCT01927965|gastrointestinal tract|gastrointestinal tract
287342|NCT01927965|GI tract|gi tract
287343|NCT01927965|advanced gastrointestinal tumors|advanced gastrointestinal tumors
287344|NCT01927965|gastrointestinal tumors|gastrointestinal tumors
287345|NCT01927965|GI tumors|gi tumors
287346|NCT01927965|biliary|biliary
287347|NCT01927965|gallbladder,|gallbladder,
287348|NCT01927965|colorectal,|colorectal,
287349|NCT01927965|gastric,|gastric,
287350|NCT01927965|hepatocellular|hepatocellular
287351|NCT01927965|esophageal|esophageal
287352|NCT01927965|pancreatic|pancreatic
287353|NCT01927952|hammertoe|hammertoe
287354|NCT01927939|Breast cancer; bone metastases; 18F-FDG PET; 99mTc bone scintigraphy; therapy response monitoring; prognosis|breast cancer; bone metastases; 18f-fdg pet; 99mtc bone scintigraphy; therapy response monitoring; prognosis
287355|NCT01927926|Energy intake|energy intake
287356|NCT01927926|appetite|appetite
287357|NCT01927926|satiety|satiety
287358|NCT01927926|gut hormones|gut hormones
287359|NCT01927900|Human milk oligosaccharides|human milk oligosaccharides
287360|NCT01927900|Microbiota|microbiota
287361|NCT01927900|Prebiotics|prebiotics
287362|NCT01927887|Papillary Carcinoma of Thyroid|papillary carcinoma of thyroid
287363|NCT01927887|Follicular thyroid cancer lymph node metastasis|follicular thyroid cancer lymph node metastasis
287364|NCT01927887|Metastatic medullary thyroid cancer|metastatic medullary thyroid cancer
287365|NCT01927874|infiltration|infiltration
287366|NCT01927874|hemorrhoidectomy|hemorrhoidectomy
287367|NCT01927874|Postoperative pain|postoperative pain
287368|NCT01927822|termination of pregnancy, abortion|termination of pregnancy, abortion
287369|NCT01927809|Hereditary Diseases|hereditary diseases
287370|NCT01927809|Colon|colon
287371|NCT01927783|Cardiovascular Disease|cardiovascular disease
287372|NCT01927783|Obesity|obesity
287373|NCT01927770|Whole Genome Sequencing|whole genome sequencing
287374|NCT01927770|Informed Choice|informed choice
287375|NCT01927757|rheumatoid arthritis|rheumatoid arthritis
287376|NCT01927757|etanercept|etanercept
287377|NCT01927757|arthritis|arthritis
287378|NCT01927757|adalimumab failure to respond|adalimumab failure to respond
287379|NCT01927757|loss of response to adalimumab|loss of response to adalimumab
287380|NCT01927757|ACR20|acr20
287381|NCT01927757|methotrexate|methotrexate
287382|NCT01927757|Swollen joints|swollen joints
287383|NCT01927757|tender joints|tender joints
287384|NCT01927744|Head and Neck Cancer|head and neck cancer
287385|NCT01927744|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
287386|NCT01927744|SCCHN|scchn
287387|NCT01927744|Oral cavity squamous cell carcinomas|oral cavity squamous cell carcinomas
287388|NCT01927744|Docetaxel|docetaxel
287389|NCT01927744|Taxotere|taxotere
287390|NCT01927744|Erlotinib|erlotinib
287391|NCT01927744|Erlotinib Hydrochloride|erlotinib hydrochloride
287392|NCT01927744|OSI-774|osi-774
287393|NCT01927744|CP358774|cp358774
287394|NCT01927744|Tarceva|tarceva
287395|NCT01927744|Questionnaire|questionnaire
287396|NCT01927744|Survey|survey
287397|NCT01927744|Phone call|phone call
287398|NCT01927731|Blood And Marrow Transplantation|blood and marrow transplantation
287399|NCT01927731|Cord blood transplantation|cord blood transplantation
287400|NCT01927731|CBT|cbt
287401|NCT01927731|Platelet count|platelet count
287529|NCT01927250|laying-on-of-hands|laying-on-of-hands
287402|NCT01927731|Haploidentical donor stem cell transplant|haploidentical donor stem cell transplant
287403|NCT01927731|Eltrombopag|eltrombopag
287404|NCT01927731|Promacta|promacta
287405|NCT01927718|Blood And Marrow Transplantation|blood and marrow transplantation
287406|NCT01927718|Myeloma|myeloma
287407|NCT01927718|Multiple myeloma|multiple myeloma
287408|NCT01927718|MM|mm
287409|NCT01927718|Autologous stem cell transplantation|autologous stem cell transplantation
287410|NCT01927718|ASCT|asct
287411|NCT01927718|Thalidomide|thalidomide
287412|NCT01927718|Thalomid|thalomid
287413|NCT01927718|Lenalidomide|lenalidomide
287414|NCT01927718|CC-5013|cc-5013
287415|NCT01927718|Revlimid|revlimid
287416|NCT01927718|Questionnaires|questionnaires
287417|NCT01927718|Surveys|surveys
287418|NCT01927705|Atopic dermatitis|atopic dermatitis
287419|NCT01927705|Stem cell|stem cell
287420|NCT01927705|Cell therapy|cell therapy
287421|NCT01927705|skin disease|skin disease
287422|NCT01927705|furestem|furestem
287423|NCT01927705|AD|ad
287424|NCT01927705|hUCB-MSC|hucb-msc
287425|NCT01927705|UCB-MSC|ucb-msc
287426|NCT01927705|Umbilical cord Blood|umbilical cord blood
287427|NCT01927692|MG|mg
287428|NCT01927666|glucoraphanin|glucoraphanin
287429|NCT01927666|broccoli|broccoli
287430|NCT01927666|gut microbiota|gut microbiota
287431|NCT01927653|Amnestic mild cognitive impairment|amnestic mild cognitive impairment
287432|NCT01927653|Dysexecutive mild cognitive impairment|dysexecutive mild cognitive impairment
287433|NCT01927653|Diffusion MRI|diffusion mri
287434|NCT01927640|Cocaine|cocaine
287435|NCT01927640|Dexmedetomidine|dexmedetomidine
287436|NCT01927640|Myocardial Contrast Echocardiography|myocardial contrast echocardiography
287437|NCT01927627|Prostate cancer|prostate cancer
287438|NCT01927627|adenocarcinoma of the prostate|adenocarcinoma of the prostate
287439|NCT01927627|Enzalutamide|enzalutamide
287440|NCT01927614|Cardiac Allograft Vasculopathy|cardiac allograft vasculopathy
287441|NCT01927614|Cardiac MRI|cardiac mri
287442|NCT01927614|Cardiac CT|cardiac ct
287443|NCT01927614|Observational study|observational study
287444|NCT01927601|TAVR|tavr
287445|NCT01927601|aortic disease|aortic disease
287446|NCT01927588|Certican|certican
287447|NCT01927588|Renal Transplant|renal transplant
287448|NCT01927588|Cytomegalovirus Infection|cytomegalovirus infection
287449|NCT01927575|TOMOSYNTHESIS|tomosynthesis
287450|NCT01927549|cardiogenic shock|cardiogenic shock
287451|NCT01927549|infarction|infarction
287452|NCT01927549|multivessel coronary artery disease|multivessel coronary artery disease
287453|NCT01927549|angioplasty|angioplasty
287454|NCT01927523|Youth violence|youth violence
287455|NCT01927523|Crime|crime
287456|NCT01927523|Educational achievement|educational achievement
287457|NCT01927510|Early mobilization, rehabilitation, intensive care|early mobilization, rehabilitation, intensive care
287458|NCT01927497|Rectal cancer|rectal cancer
287459|NCT01927497|Extralevator abdominoperineal resection|extralevator abdominoperineal resection
287460|NCT01927497|Biological Mesh|biological mesh
287461|NCT01927497|Primary closure|primary closure
287462|NCT01927484|methotrexate,|methotrexate,
287463|NCT01927484|osteoarthritis,|osteoarthritis,
287464|NCT01927484|pain,|pain,
287465|NCT01927484|function,|function,
287466|NCT01927484|synovitis|synovitis
287467|NCT01927471|Menstrual cycles|menstrual cycles
287468|NCT01927471|Ultrasound|ultrasound
287469|NCT01927471|Ovary|ovary
287470|NCT01927471|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
287471|NCT01927471|Physical activity|physical activity
287472|NCT01927471|Diet|diet
287473|NCT01927432|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
287474|NCT01927432|Nutrition|nutrition
287475|NCT01927432|Metabolism|metabolism
287476|NCT01927432|Antral follicle growth|antral follicle growth
287477|NCT01927432|Menstrual Cyclicity|menstrual cyclicity
287478|NCT01927406|Thyroid Eye Disease|thyroid eye disease
287479|NCT01927406|Graves' Disease|graves' disease
287480|NCT01927406|Prostaglandin Analogues|prostaglandin analogues
287481|NCT01927380|autonomic nervous system modulation|autonomic nervous system modulation
287482|NCT01927380|heart rate variability|heart rate variability
287483|NCT01927380|prostatectomy|prostatectomy
287484|NCT01927380|steep trendelenburg|steep trendelenburg
287485|NCT01927380|pneumoperitoneum|pneumoperitoneum
287486|NCT01927367|Clinical Decision Support System|clinical decision support system
287487|NCT01927367|Primary Health Care|primary health care
287488|NCT01927367|Clinical Practice Guidelines|clinical practice guidelines
287489|NCT01927354|Head-and-Neck squamous cell carcinoma (HNSCC)|head-and-neck squamous cell carcinoma (hnscc)
287490|NCT01927354|epithelial-mesenchymal transition (EMT)|epithelial-mesenchymal transition (emt)
287491|NCT01927354|microRNA29|microrna29
287492|NCT01927354|Twist1|twist1
287493|NCT01927341|MEK162,|mek162,
287494|NCT01927341|panitumumab,|panitumumab,
287495|NCT01927341|mutant RAS,|mutant ras,
287496|NCT01927341|wild-type RAS,|wild-type ras,
287497|NCT01927341|metastatic colorectal cancer,|metastatic colorectal cancer,
287498|NCT01927341|adult mCRC patient|adult mcrc patient
287499|NCT01927328|Adenocarcinoma|adenocarcinoma
287500|NCT01927328|Anemia|anemia
287501|NCT01927328|Palliative therapy|palliative therapy
287502|NCT01927328|Palliative care|palliative care
287503|NCT01927328|Palliative treatments|palliative treatments
287504|NCT01927328|Chemotherapy|chemotherapy
287505|NCT01927328|Esophageal Cancer|esophageal cancer
287506|NCT01927328|Gastric Cancer|gastric cancer
287507|NCT01927315|Stem cells|stem cells
287508|NCT01927315|Regeneration|regeneration
287509|NCT01927315|Angiogenesis|angiogenesis
287510|NCT01927315|Prevention|prevention
287511|NCT01927302|Aphasia|aphasia
287512|NCT01927302|Dysgraphia|dysgraphia
287513|NCT01927302|Anomia|anomia
287514|NCT01927302|Agrammatism|agrammatism
287515|NCT01927302|Stroke|stroke
287516|NCT01927302|Language Recovery|language recovery
287517|NCT01927302|Treatment|treatment
287518|NCT01927302|Biomarkers of Recovery|biomarkers of recovery
287519|NCT01927289|Ultrasound|ultrasound
287520|NCT01927289|supraclavicular block|supraclavicular block
287521|NCT01927289|distal forearm block|distal forearm block
287522|NCT01927289|Grip Strength|grip strength
287523|NCT01927289|Satisfaction|satisfaction
287524|NCT01927276|Schizophrenia|schizophrenia
287525|NCT01927276|Gluten|gluten
287526|NCT01927250|cohort study|cohort study
287527|NCT01927250|diet program|diet program
287528|NCT01927250|art therapy|art therapy
287530|NCT01927250|quality of life|quality of life
287531|NCT01927237|pulmonary artery pressure|pulmonary artery pressure
287532|NCT01927237|ARDS|ards
287533|NCT01927237|alveolar hypoventilation|alveolar hypoventilation
287534|NCT01927237|hypercapnic acidosis|hypercapnic acidosis
287535|NCT01927237|permissive hypercapnia|permissive hypercapnia
287536|NCT01927237|myocardial strain|myocardial strain
287537|NCT01927211|cesarean section incisions|cesarean section incisions
287538|NCT01927211|silver|silver
287539|NCT01927211|C-section|c-section
287540|NCT01927211|wound infection|wound infection
287541|NCT01927211|scar appearance|scar appearance
287542|NCT01927211|pain|pain
287543|NCT01927185|central venous access|central venous access
287544|NCT01927185|ultrasonography|ultrasonography
287545|NCT01927185|subclavian vein|subclavian vein
287546|NCT01927185|pneumothorax|pneumothorax
287547|NCT01927185|vessel view|vessel view
287548|NCT01927159|Tuberculosis|tuberculosis
287549|NCT01927159|TB|tb
287550|NCT01927159|Pulmonary|pulmonary
287551|NCT01927159|Vaccine|vaccine
287552|NCT01927159|Adjuvant|adjuvant
287553|NCT01927146|Lauren classification|lauren classification
287554|NCT01927146|HER2 status|her2 status
287555|NCT01927146|Resectable gastric cancer|resectable gastric cancer
287556|NCT01927133|Fibrosis, HBV, HCV, ALD, NAFLD|fibrosis, hbv, hcv, ald, nafld
287557|NCT01927120|GVHD|gvhd
287558|NCT01927120|Allogeneic|allogeneic
287559|NCT01927120|Hematopoietic Cell Transplant|hematopoietic cell transplant
287560|NCT01927107|probiotics|probiotics
287561|NCT01927107|obesity|obesity
287562|NCT01927107|oxidative stress|oxidative stress
287563|NCT01927094|probiotics, diarrhea|probiotics, diarrhea
287564|NCT01927055|NOH|noh
287565|NCT01927055|OH|oh
287566|NCT01927055|PD|pd
287567|NCT01927055|MSA|msa
287568|NCT01927055|PAF|paf
287569|NCT01927055|DBH|dbh
287570|NCT01927042|Eating Disorders|eating disorders
287571|NCT01927042|Carers|carers
287572|NCT01927029|twin pregnancy|twin pregnancy
287573|NCT01927029|progesterone|progesterone
287574|NCT01927029|preterm delivery|preterm delivery
287575|NCT01927029|>14 years|>14 years
287576|NCT01927029|Abscense of cerclage,|abscense of cerclage,
287577|NCT01927029|TTTS, hemorrage,|ttts, hemorrage,
287578|NCT01927029|history of thrombosis.|history of thrombosis.
287579|NCT01927029|cervix >15mm|cervix >15mm
287580|NCT01927016|Esophageal Neoplasm|esophageal neoplasm
287581|NCT01927016|Esophagus|esophagus
287582|NCT01927016|Surgery|surgery
287583|NCT01927016|Outcome assessment|outcome assessment
287584|NCT01927003|defect,|defect,
287585|NCT01927003|dorsal branch of the digital artery,|dorsal branch of the digital artery,
287586|NCT01927003|dorsal digital flap,|dorsal digital flap,
287587|NCT01927003|dorsal metacarpal artery flap.|dorsal metacarpal artery flap.
287588|NCT01926964|Adjuvant treatment recommendation|adjuvant treatment recommendation
287589|NCT01926964|Early breast cancer|early breast cancer
287590|NCT01926964|Oncotype DX|oncotype dx
287591|NCT01926964|Genetic profiling|genetic profiling
287592|NCT01926951|hypertension|hypertension
287593|NCT01926925|Type 2 diabetes, Endothelium, children/adolescents|type 2 diabetes, endothelium, children/adolescents
287594|NCT01926912|Schizophrenia|schizophrenia
287595|NCT01926912|Paliperidone Palmitate|paliperidone palmitate
287596|NCT01926912|Hospital setting|hospital setting
287597|NCT01926912|Schizophrenic Disorders|schizophrenic disorders
287598|NCT01926860|Prevenar13|prevenar13
287599|NCT01926860|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
287600|NCT01926860|Epaxal|epaxal
287601|NCT01926860|hepatitis A vaccine|hepatitis a vaccine
287602|NCT01926847|Digital ischemia|digital ischemia
287603|NCT01926847|Raynaud's phenomenon|raynaud's phenomenon
287604|NCT01926834|promoting angiogenesis in multiple targets|promoting angiogenesis in multiple targets
287605|NCT01926834|herbal medicine|herbal medicine
287606|NCT01926834|traditional chinese medicine|traditional chinese medicine
287607|NCT01926834|random clinical trial|random clinical trial
287608|NCT01926795|toddler's fracture|toddler's fracture
287609|NCT01926795|tibial fracture|tibial fracture
287610|NCT01926795|children|children
287611|NCT01926769|Colorectal cancer|colorectal cancer
287612|NCT01926769|Metformin|metformin
287613|NCT01926769|FOLFOX6|folfox6
287614|NCT01926769|FOFIRI|fofiri
287615|NCT01926769|5FU|5fu
287616|NCT01926769|irinotecan|irinotecan
287617|NCT01926769|oxaliplatin|oxaliplatin
287618|NCT01926756|bacteriuria|bacteriuria
287619|NCT01926756|straight catheterization|straight catheterization
287620|NCT01926756|urinary tract infections|urinary tract infections
287621|NCT01926756|iatrogenic|iatrogenic
287622|NCT01926743|near infrared|near infrared
287623|NCT01926743|fluorescence imaging|fluorescence imaging
287624|NCT01926743|indocyanine green|indocyanine green
287626|NCT01926717|Single Roux-y of Pancreaticojejunostomy-choledochojejunostomy|single roux-y of pancreaticojejunostomy-choledochojejunostomy
287627|NCT01926691|dementia|dementia
287628|NCT01926691|poststroke cognitive impairment|poststroke cognitive impairment
287629|NCT01926691|inflammation|inflammation
287630|NCT01926691|stress|stress
287631|NCT01926678|swedish massage|swedish massage
287632|NCT01926678|fatigue|fatigue
287633|NCT01926678|light touch|light touch
287634|NCT01926678|inflammation|inflammation
287635|NCT01926665|Blood And Marrow Transplantation|blood and marrow transplantation
287636|NCT01926665|Mantle cell lymphoma|mantle cell lymphoma
287637|NCT01926665|MCL|mcl
287638|NCT01926665|T-cell lymphoma|t-cell lymphoma
287639|NCT01926665|TCL|tcl
287640|NCT01926665|Diffuse large b-cell lymphoma|diffuse large b-cell lymphoma
287641|NCT01926665|DLBCL|dlbcl
287642|NCT01926665|Autologous stem cell transplantation|autologous stem cell transplantation
287643|NCT01926665|ASCT|asct
287644|NCT01926665|Carfilzomib|carfilzomib
287645|NCT01926665|CFZ|cfz
287646|NCT01926665|Dexamethasone|dexamethasone
287647|NCT01926665|Decadron|decadron
287648|NCT01926639|Follicular lymphoma|follicular lymphoma
287649|NCT01926639|Rituximab|rituximab
287650|NCT01926639|Autologous dendritic cells|autologous dendritic cells
287651|NCT01926639|Cancer vaccine|cancer vaccine
287652|NCT01926626|Nicotine addiction|nicotine addiction
287653|NCT01926626|Smoking Cessation|smoking cessation
287654|NCT01926626|Quit Smoking|quit smoking
287655|NCT01926626|moclobemide|moclobemide
287656|NCT01926626|Nicotine Patch|nicotine patch
287657|NCT01926613|Schizophrenia|schizophrenia
287658|NCT01926613|Chronic Mental Disorder|chronic mental disorder
287659|NCT01926613|Employment|employment
287660|NCT01926613|Cognitive remediation|cognitive remediation
287661|NCT01926613|Vocational rehabilitation|vocational rehabilitation
287662|NCT01926600|gastric ulcer|gastric ulcer
287663|NCT01926600|duodenal ulcer|duodenal ulcer
287664|NCT01926600|re-bleeding rate|re-bleeding rate
287665|NCT01926600|intragastric pH|intragastric ph
287666|NCT01926600|proton pump inhibitor|proton pump inhibitor
287667|NCT01926587|rigosertib|rigosertib
287668|NCT01926587|ON 01910.Na|on 01910.na
287669|NCT01926587|azacitidine|azacitidine
287670|NCT01926587|Vidaza|vidaza
287671|NCT01926574|absenteeism|absenteeism
287672|NCT01926574|rehabilitation|rehabilitation
287673|NCT01926574|return to work|return to work
287674|NCT01926561|Hypotensive bradycardic event|hypotensive bradycardic event
287675|NCT01926561|Interscalene brachial plexus block|interscalene brachial plexus block
287676|NCT01926561|Sitting position|sitting position
287677|NCT01926561|Shoulder arthroscopic surgery|shoulder arthroscopic surgery
287678|NCT01926548|Pharmacokinetics|pharmacokinetics
287679|NCT01926548|Safety|safety
287680|NCT01926535|amniotic membrane|amniotic membrane
287681|NCT01926535|contact lens|contact lens
287682|NCT01926535|bullous keratopathy|bullous keratopathy
287683|NCT01926522|Exercise Therapy|exercise therapy
287684|NCT01926483|Stage IIIA-N2 NSCLC|stage iiia-n2 nsclc
287685|NCT01926470|epidural injections, intravascular injection|epidural injections, intravascular injection
287686|NCT01926457|First trimester treatment of prediabetes|first trimester treatment of prediabetes
287687|NCT01926457|First trimester treatment of gestational diabetes|first trimester treatment of gestational diabetes
287688|NCT01926457|Umbilical cord C-Peptide|umbilical cord c-peptide
287689|NCT01926457|Neonatal fat mass|neonatal fat mass
287690|NCT01926457|Gestational weight gain|gestational weight gain
287691|NCT01926457|Infant obesity|infant obesity
287692|NCT01926444|colonoscopy|colonoscopy
287693|NCT01926444|sedation-free|sedation-free
287694|NCT01926444|colorectal cancer|colorectal cancer
287695|NCT01926444|CRC screening|crc screening
287696|NCT01926444|prevention|prevention
287697|NCT01926444|analgesia|analgesia
287698|NCT01926444|colonic|colonic
287699|NCT01926444|kappa|kappa
287700|NCT01926444|opioid agonist|opioid agonist
287701|NCT01926444|pain management|pain management
287702|NCT01926444|oral|oral
287703|NCT01926444|hydrogen sulfide|hydrogen sulfide
287704|NCT01926444|peripheral|peripheral
287705|NCT01926418|HIV|hiv
287706|NCT01926418|Condoms|condoms
287707|NCT01926418|Men who have sex with men|men who have sex with men
287708|NCT01926418|implementation intentions|implementation intentions
287709|NCT01926418|executive function|executive function
287710|NCT01926405|hypersomnia|hypersomnia
287711|NCT01926405|narcolepsy|narcolepsy
287712|NCT01926405|amylase|amylase
287713|NCT01926405|salivary sampling|salivary sampling
287714|NCT01926379|Ethiopia|ethiopia
287715|NCT01926379|TB|tb
287716|NCT01926379|tuberculosis|tuberculosis
287717|NCT01926379|HIV|hiv
287718|NCT01926379|IPT|ipt
287719|NCT01926379|isoniazid|isoniazid
287720|NCT01926379|adherence|adherence
287721|NCT01926379|combination intervention package|combination intervention package
287722|NCT01926379|retention|retention
287723|NCT01926353|Vesicoureteral Reflux (VUR)|vesicoureteral reflux (vur)
287724|NCT01926353|Complicated Urinary Tract Infection|complicated urinary tract infection
287725|NCT01926353|Vantris|vantris
287726|NCT01926353|Polyacrylate Polyalcohol Copolymer|polyacrylate polyalcohol copolymer
287727|NCT01926327|PRP PRGF Osteoarthritis|prp prgf osteoarthritis
287728|NCT01926301|sepsis|sepsis
287729|NCT01926301|cerebrovascular autoregulation|cerebrovascular autoregulation
287730|NCT01926301|delirium|delirium
287731|NCT01926275|COPD|copd
287732|NCT01926275|Noninvasive Positive Pressure Ventilation|noninvasive positive pressure ventilation
287733|NCT01926275|Respiratory Muscle Training|respiratory muscle training
287734|NCT01926262|Pain, Neck, Exercise, Pilots, Crewmembers,|pain, neck, exercise, pilots, crewmembers,
287735|NCT01926249|Alzheimer's disease|alzheimer's disease
287736|NCT01926249|Mild Cognitive Impairment|mild cognitive impairment
287737|NCT01926210|Poor ovarian response|poor ovarian response
287738|NCT01926210|in vitro fertilization|in vitro fertilization
287739|NCT01926210|mild ovarian stimulation|mild ovarian stimulation
287740|NCT01926210|controlled ovarian stimulation|controlled ovarian stimulation
287741|NCT01926184|HIV/AIDS|hiv/aids
287742|NCT01926184|Treatment as Prevention|treatment as prevention
287743|NCT01926184|Methamphetamine|methamphetamine
287744|NCT01926184|Cocaine|cocaine
287745|NCT01926184|HIV viral Load|hiv viral load
287746|NCT01926158|Denosumab|denosumab
287747|NCT01926158|Osteoporosis|osteoporosis
287748|NCT01926158|Hip replacement|hip replacement
287749|NCT01926158|Osteoarthritis|osteoarthritis
287750|NCT01926158|Radiostereometric analysis (RSA)|radiostereometric analysis (rsa)
287751|NCT01926158|Dual energy X-ray absorptiometry (DXA)|dual energy x-ray absorptiometry (dxa)
287752|NCT01926132|ascorbic acid|ascorbic acid
287753|NCT01926132|fatigue|fatigue
287754|NCT01926132|mitochondrial DNA|mitochondrial dna
287755|NCT01926132|patient for more than 6 months|patient for more than 6 months
287756|NCT01926106|Nasal Intermittent Positive-Pressure Ventilation|nasal intermittent positive-pressure ventilation
287757|NCT01926106|Nasal Continuous Positive Airway Pressure|nasal continuous positive airway pressure
287758|NCT01926106|twin|twin
287759|NCT01926106|respiratory distress syndrome|respiratory distress syndrome
287760|NCT01926093|Acute Respiratory Distress Syndrome (ARDS)|acute respiratory distress syndrome (ards)
287761|NCT01926080|Depression|depression
287762|NCT01926080|Spirituality|spirituality
287763|NCT01926080|Neonatal death|neonatal death
287764|NCT01926080|Bereavement|bereavement
287765|NCT01926080|Randomized controlled trial|randomized controlled trial
287766|NCT01926067|Accelerometer|accelerometer
287767|NCT01926067|Cardiopulmonary by pass|cardiopulmonary by pass
287768|NCT01926041|community|community
287769|NCT01926041|preventive medicine|preventive medicine
287770|NCT01926041|prediabetes|prediabetes
287771|NCT01926041|smoking cessation|smoking cessation
287772|NCT01926028|recurrent vulvovaginal candidiasis|recurrent vulvovaginal candidiasis
287773|NCT01926028|candida|candida
287774|NCT01926028|NDV3|ndv3
287775|NCT01926028|vaginal thrush|vaginal thrush
287776|NCT01926028|chronic yeast infection|chronic yeast infection
287777|NCT01925976|obesity|obesity
287778|NCT01925976|dietetic intervention|dietetic intervention
287779|NCT01925976|eating behaviors|eating behaviors
287780|NCT01925976|children|children
287781|NCT01925976|healthy eating|healthy eating
287782|NCT01925976|energy dense foods|energy dense foods
287783|NCT01925963|Normal|normal
287784|NCT01925963|Traumatic brain injury|traumatic brain injury
287785|NCT01925963|Neuroimaging|neuroimaging
287786|NCT01925963|Hyperbaric oxygen|hyperbaric oxygen
287787|NCT01925963|Neurobehavioral symptom inventory|neurobehavioral symptom inventory
287788|NCT01925950|BDP|bdp
287789|NCT01925950|orBec|orbec
287790|NCT01925950|GVHD|gvhd
287791|NCT01925950|beclomethasone dipropionate|beclomethasone dipropionate
287792|NCT01925950|bone marrow transplant|bone marrow transplant
287793|NCT01925950|hematopoietic cell transplant|hematopoietic cell transplant
287794|NCT01925950|HCT|hct
287795|NCT01925950|stem cell transplant|stem cell transplant
287796|NCT01925950|marrow transplant|marrow transplant
287797|NCT01925950|SCT|sct
287798|NCT01925950|beclomethasone 17,21-dipropionate|beclomethasone 17,21-dipropionate
287799|NCT01925937|Coenzyme Q10|coenzyme q10
287800|NCT01925937|Atorvastatin|atorvastatin
287801|NCT01925937|clinical trial|clinical trial
287802|NCT01925937|congestive heart failure|congestive heart failure
287803|NCT01925924|Dental cements|dental cements
287804|NCT01925924|Orthodontic adhesives|orthodontic adhesives
287805|NCT01925924|Glass ionomer cement|glass ionomer cement
287806|NCT01925924|Tooth demineralization|tooth demineralization
287807|NCT01925911|Phase 1|phase 1
287808|NCT01925911|Healthy subjects|healthy subjects
287809|NCT01925911|DDI|ddi
287810|NCT01925911|CYP3A|cyp3a
287811|NCT01925898|Laceration|laceration
287812|NCT01925898|Sedation|sedation
287813|NCT01925898|Pediatrics|pediatrics
287814|NCT01925885|Atrial Arrhythmia|atrial arrhythmia
287815|NCT01925872|ischemic cerebrovascular disease|ischemic cerebrovascular disease
287816|NCT01925872|Percutaneous transluminal angioplasty and stenting|percutaneous transluminal angioplasty and stenting
287817|NCT01925872|Clopidogrel resistance|clopidogrel resistance
287818|NCT01925859|Pharmacokinetic analysis|pharmacokinetic analysis
287819|NCT01925859|EryDex|erydex
287820|NCT01925846|Pseudomonas aeruginosa|pseudomonas aeruginosa
287821|NCT01925846|type three secretory system|type three secretory system
288628|NCT01922258|Dementia|dementia
287822|NCT01925846|contact lens associated microbial keratitis|contact lens associated microbial keratitis
287823|NCT01925820|Hepatitis B,Entecavir,Pegylated IFN|hepatitis b,entecavir,pegylated ifn
287824|NCT01925807|Adolescent|adolescent
287825|NCT01925807|Suicidal Ideation|suicidal ideation
287826|NCT01925807|Emergency Department|emergency department
287827|NCT01925807|Crisis|crisis
287828|NCT01925807|Attachment|attachment
287829|NCT01925807|Coping|coping
287830|NCT01925794|Stent, Coronary Arteries for Early healing|stent, coronary arteries for early healing
287831|NCT01925781|Smoking Cessation|smoking cessation
287832|NCT01925781|Nicotine Addiction|nicotine addiction
287833|NCT01925781|e-Cigarette|e-cigarette
287834|NCT01925781|electronic nicotine delivery device|electronic nicotine delivery device
287835|NCT01925781|electronic cigarette|electronic cigarette
287836|NCT01925781|nicotine replacement therapy|nicotine replacement therapy
287837|NCT01925768|Apremilast, Psoriatic Arthritis, PDE4 inhibitor|apremilast, psoriatic arthritis, pde4 inhibitor
287838|NCT01925755|Non-interventional|non-interventional
287839|NCT01925755|Rivaroxaban|rivaroxaban
287840|NCT01925755|Prevention in prior stroke or TIA|prevention in prior stroke or tia
287841|NCT01925755|Russian Federation|russian federation
287842|NCT01925742|Fetal aneuploidy|fetal aneuploidy
287843|NCT01925729|middle ear|middle ear
287844|NCT01925729|allergy|allergy
287845|NCT01925729|nose|nose
287846|NCT01925716|cholesterol,LDL|cholesterol,ldl
287847|NCT01925716|vegetable oils|vegetable oils
287848|NCT01925716|heart diseases|heart diseases
287849|NCT01925690|Multiple Sclerosis|multiple sclerosis
287850|NCT01925690|Disease modifying medication|disease modifying medication
287851|NCT01925690|Relapsing-Remitting MS|relapsing-remitting ms
287852|NCT01925690|Motivational Interviewing|motivational interviewing
287853|NCT01925690|Telephone Counseling|telephone counseling
287854|NCT01925677|Transplant|transplant
287855|NCT01925677|donor|donor
287856|NCT01925677|nephrectomy|nephrectomy
287857|NCT01925677|robotic|robotic
287858|NCT01925677|laparoscopy|laparoscopy
287859|NCT01925677|single-port|single-port
287860|NCT01925664|Doulas|doulas
287861|NCT01925664|Parenting|parenting
287862|NCT01925664|Breastfeeding|breastfeeding
287863|NCT01925664|Pregnancy in Adolescence|pregnancy in adolescence
287864|NCT01925651|Post Mastectomy Radiotherapy|post mastectomy radiotherapy
287865|NCT01925651|Breast Cancer|breast cancer
287866|NCT01925651|Bolus|bolus
287867|NCT01925651|Radiodermatitis|radiodermatitis
287868|NCT01925638|Healthy Volunteers|healthy volunteers
287869|NCT01925638|Refametinib|refametinib
287870|NCT01925638|Ketoconazole|ketoconazole
287871|NCT01925638|Pharmacokinetics|pharmacokinetics
287872|NCT01925612|Antibodies, Monoclonal|antibodies, monoclonal
287873|NCT01925612|Antibody-Drug Conjugate|antibody-drug conjugate
287874|NCT01925612|Antigens, CD30|antigens, cd30
287875|NCT01925612|Drug Therapy|drug therapy
287876|NCT01925612|Hematologic Diseases|hematologic diseases
287877|NCT01925612|Lymphoma, B-cell|lymphoma, b-cell
287878|NCT01925612|Lymphoma, Large B-cell, Diffuse|lymphoma, large b-cell, diffuse
287879|NCT01925612|Monomethyl auristatin E|monomethyl auristatin e
287880|NCT01925599|Nevus|nevus
287881|NCT01925599|Choroidal Melanoma|choroidal melanoma
287882|NCT01925599|BAP1 mutation|bap1 mutation
287883|NCT01925573|RECURRENT GLIOBLASTOMA|recurrent glioblastoma
287884|NCT01925573|Brain Tumor|brain tumor
287885|NCT01925534|Optiflow|optiflow
287886|NCT01925534|Humidified high-flow oxygen therapy|humidified high-flow oxygen therapy
287887|NCT01925534|Noninvasive ventilation|noninvasive ventilation
287888|NCT01925534|Acute respiratory failure|acute respiratory failure
287889|NCT01925534|Standard oxygen therapy|standard oxygen therapy
287890|NCT01925521|Intestinal Infection|intestinal infection
287891|NCT01925495|otitis media|otitis media
287892|NCT01925495|middle ear|middle ear
287893|NCT01925495|feedback pathways|feedback pathways
287894|NCT01925495|middle-ear pressure|middle-ear pressure
287895|NCT01925482|middle ear|middle ear
287896|NCT01925482|otitis|otitis
287897|NCT01925482|gas exchange|gas exchange
287898|NCT01925469|Hysterosalpingogram|hysterosalpingogram
287899|NCT01925469|HSG|hsg
287900|NCT01925469|Pain relief|pain relief
287901|NCT01925469|Analgesia|analgesia
287902|NCT01925469|Benzocaine|benzocaine
287903|NCT01925456|urge urinary incontinence|urge urinary incontinence
287904|NCT01925443|diabetes mellitus non-insulin-dependent|diabetes mellitus non-insulin-dependent
287905|NCT01925443|low level laser therapy|low level laser therapy
287906|NCT01925430|Observational|observational
287907|NCT01925430|Sleep|sleep
287908|NCT01925430|Algorithm|algorithm
287909|NCT01925417|Clostridium difficile|clostridium difficile
287910|NCT01925417|C diff|c diff
287911|NCT01925417|Microbiota Restoration Therapy|microbiota restoration therapy
287912|NCT01925417|MRT|mrt
287913|NCT01925417|microbiota suspension|microbiota suspension
287914|NCT01925417|CDI|cdi
287915|NCT01925417|CDAD|cdad
287916|NCT01925417|Fecal transplant|fecal transplant
287917|NCT01925417|Fecal Microbiota Transplant|fecal microbiota transplant
287918|NCT01925417|FMT|fmt
287919|NCT01925417|Diarrhea|diarrhea
287920|NCT01925417|Fecal bacteriotherapy|fecal bacteriotherapy
288730|NCT01921673|Docetaxel|docetaxel
287921|NCT01925404|Physical activity|physical activity
287922|NCT01925404|parks|parks
287923|NCT01925404|programming|programming
287924|NCT01925404|public health|public health
287925|NCT01925391|Pediatric glaucoma|pediatric glaucoma
287926|NCT01925391|Intraocular pressure|intraocular pressure
287927|NCT01925391|pediatric glaucoma diagnosis|pediatric glaucoma diagnosis
287928|NCT01925391|Volatiles and intraocular pressure|volatiles and intraocular pressure
287929|NCT01925391|nitrous oxide|nitrous oxide
287930|NCT01925391|Tetracaine|tetracaine
287931|NCT01925378|Cervical Dysplasia|cervical dysplasia
287932|NCT01925352|ischemic heart disease|ischemic heart disease
287933|NCT01925352|adenovirus|adenovirus
287934|NCT01925352|hepatocyte growth factor|hepatocyte growth factor
287935|NCT01925313|Safety|safety
287936|NCT01925313|Pharmacokinetics|pharmacokinetics
287937|NCT01925300|Pharmacokinetics|pharmacokinetics
287938|NCT01925300|Pharmacodynamics|pharmacodynamics
287939|NCT01925300|Safety|safety
287940|NCT01925300|Tolerability|tolerability
287941|NCT01925287|bioavailability|bioavailability
287942|NCT01925287|curcumin|curcumin
287943|NCT01925287|curcuma longa|curcuma longa
287944|NCT01925287|healthy humans|healthy humans
287945|NCT01925287|safety|safety
287946|NCT01925287|sex differences|sex differences
287947|NCT01925274|metastatic colorectal cancer|metastatic colorectal cancer
287948|NCT01925274|colorectal cancer|colorectal cancer
287949|NCT01925274|KRAS|kras
287950|NCT01925274|colon cancer|colon cancer
287951|NCT01925274|mCRC|mcrc
287952|NCT01925274|CRC|crc
287953|NCT01925274|PF-05212384|pf-05212384
287954|NCT01925274|KRAS wild type colorectal cancer|kras wild type colorectal cancer
287955|NCT01925274|irinotecan|irinotecan
287956|NCT01925274|cetuximab|cetuximab
287957|NCT01925274|NRAS|nras
287958|NCT01925261|knee osteoarthritis|knee osteoarthritis
287959|NCT01925261|bilateral|bilateral
287960|NCT01925261|osteoarthritis|osteoarthritis
287961|NCT01925248|Whey protein|whey protein
287962|NCT01925248|protein supplement|protein supplement
287963|NCT01925248|Diabetes|diabetes
287964|NCT01925248|Type 2 DM|type 2 dm
287965|NCT01925248|Hyperglycemia|hyperglycemia
287966|NCT01925248|Insulin secretagogue|insulin secretagogue
287967|NCT01925235|remote ischemic preconditioning|remote ischemic preconditioning
287968|NCT01925235|acute kidney injury|acute kidney injury
287969|NCT01925235|TAVI|tavi
287970|NCT01925235|RenPRO trial|renpro trial
287971|NCT01925235|parameters|parameters
287972|NCT01925209|sporadic inclusion body myositis,|sporadic inclusion body myositis,
287973|NCT01925209|myositis,|myositis,
287974|NCT01925209|muscle wasting,|muscle wasting,
287975|NCT01925209|controlled clinical trial,|controlled clinical trial,
287976|NCT01925209|randomized,|randomized,
287977|NCT01925209|body mass,|body mass,
287978|NCT01925209|muscle function,|muscle function,
287979|NCT01925209|strength,|strength,
287980|NCT01925209|performance,|performance,
287981|NCT01925209|physical function|physical function
287982|NCT01925196|Motor Neuron Disease|motor neuron disease
287983|NCT01925196|Frontotemporal Dementia|frontotemporal dementia
287984|NCT01925196|Cognitive Testing|cognitive testing
287985|NCT01925196|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
287986|NCT01925196|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
287987|NCT01925183|Boceprevir|boceprevir
287988|NCT01925183|HIV/HCV-coinfection|hiv/hcv-coinfection
287989|NCT01925183|HIV/HCV coinfection|hiv/hcv coinfection
287990|NCT01925183|HIV/HCV|hiv/hcv
287991|NCT01925183|Response-guided therapy|response-guided therapy
287992|NCT01925170|Dense breast tissue|dense breast tissue
287993|NCT01925170|Breast Cancer Screening|breast cancer screening
287994|NCT01925170|Molecular Breast Imaging|molecular breast imaging
287995|NCT01925170|Breast Cancer|breast cancer
287996|NCT01925170|Breast|breast
287997|NCT01925105|Polypharmacy|polypharmacy
287998|NCT01925092|Cushing's disease|cushing's disease
287999|NCT01925092|Mifepristone|mifepristone
288000|NCT01925092|Cushing's syndrome|cushing's syndrome
288001|NCT01925092|Pharmacokinetic-pharmacodynamic|pharmacokinetic-pharmacodynamic
288002|NCT01925092|Child/pediatric population|child/pediatric population
288003|NCT01925092|Safety-efficacy|safety-efficacy
288004|NCT01925079|acute coronary syndrome|acute coronary syndrome
288005|NCT01925079|statins|statins
288006|NCT01925079|LDL-C|ldl-c
288007|NCT01925079|intensive education|intensive education
288008|NCT01925027|Nano+ DES|nano+ des
288009|NCT01925027|OCT|oct
288010|NCT01925027|Neointimal hyperplasia|neointimal hyperplasia
288011|NCT01925027|DAPT|dapt
288012|NCT01925027|3 month|3 month
288013|NCT01925014|Appendectomy|appendectomy
288014|NCT01925014|Appendicitis|appendicitis
288015|NCT01925014|False Positive Reactions|false positive reactions
288016|NCT01925014|Humans|humans
288017|NCT01925014|Radiation Dosage|radiation dosage
288018|NCT01925014|Tomography, X-Ray Computed|tomography, x-ray computed
288019|NCT01925014|Young Adult|young adult
288020|NCT01925001|Sickle cell anemia|sickle cell anemia
288021|NCT01925001|Sickle cell disease|sickle cell disease
288022|NCT01925001|Sickling crisis|sickling crisis
288023|NCT01925001|Vaso-occlusive crisis|vaso-occlusive crisis
288024|NCT01925001|Carboxyhemoglobin|carboxyhemoglobin
288025|NCT01925001|Oxygen therapeutic|oxygen therapeutic
288026|NCT01925001|Ischemic rescue therapy|ischemic rescue therapy
288027|NCT01925001|Hemoglobin solution|hemoglobin solution
288028|NCT01925001|Pegylated hemoglobin|pegylated hemoglobin
288029|NCT01924988|BPH, benign prostatic hyperplasia|bph, benign prostatic hyperplasia
288030|NCT01924962|chronic occlusion of coronary artery|chronic occlusion of coronary artery
288031|NCT01924962|left ventricular function|left ventricular function
288032|NCT01924962|revascularisation|revascularisation
288033|NCT01924949|7977|7977
288034|NCT01924949|5885|5885
288035|NCT01924949|GS-7977|gs-7977
288036|NCT01924949|GS-5885|gs-5885
288037|NCT01924949|SOF|sof
288038|NCT01924949|LDV|ldv
288039|NCT01924949|Sofosbuvir|sofosbuvir
288040|NCT01924949|Ledipasvir|ledipasvir
288041|NCT01924949|FDC|fdc
288042|NCT01924923|uveal melanoma|uveal melanoma
288043|NCT01924923|biopsy|biopsy
288044|NCT01924923|enucleation|enucleation
288045|NCT01924923|ocular cancer|ocular cancer
288046|NCT01924910|Healthy, by self report|healthy, by self report
288047|NCT01924897|CPET test|cpet test
288048|NCT01924897|Exercise training|exercise training
288049|NCT01924897|Prehabilitation|prehabilitation
288050|NCT01924897|Exercise Test|exercise test
288051|NCT01924884|Vacuum-Assisted Closure|vacuum-assisted closure
288052|NCT01924884|Topical Negative-Pressure Therapy|topical negative-pressure therapy
288053|NCT01924884|Negative-Pressure Dressings|negative-pressure dressings
288054|NCT01924858|PET, healthy subjects|pet, healthy subjects
288055|NCT01924858|Lp-PLA2|lp-pla2
288056|NCT01924858|positron emission tomography|positron emission tomography
288057|NCT01924858|Alzheimer's disease|alzheimer's disease
288058|NCT01924858|brain exposure|brain exposure
288059|NCT01924858|GSK2647544|gsk2647544
288060|NCT01924819|Gastric cancer|gastric cancer
288061|NCT01924819|Stomach cancer|stomach cancer
288062|NCT01924819|Chemoradiotherapy|chemoradiotherapy
288063|NCT01924819|Surgery|surgery
288064|NCT01924819|Chemotherapy|chemotherapy
288065|NCT01924819|Neoadjuvant|neoadjuvant
288066|NCT01924806|debridement|debridement
288067|NCT01924806|post-debridement|post-debridement
288068|NCT01924806|infection|infection
288069|NCT01924806|prevention|prevention
288070|NCT01924806|wound|wound
288071|NCT01924806|wound tissue|wound tissue
288072|NCT01924806|wound management|wound management
288073|NCT01924806|WoundWand|woundwand
288074|NCT01924806|wound size reduction|wound size reduction
288075|NCT01924806|wound bed debridement|wound bed debridement
288076|NCT01924806|WoundWand Debridement Device|woundwand debridement device
288077|NCT01924806|chronic wound|chronic wound
288078|NCT01924806|delayed healing|delayed healing
288079|NCT01924806|cellular senescence|cellular senescence
288080|NCT01924806|acute wound|acute wound
288081|NCT01924806|diabetic foot ulcer|diabetic foot ulcer
288082|NCT01924806|venous leg ulcers|venous leg ulcers
288083|NCT01924806|radiofrequency debridement|radiofrequency debridement
288084|NCT01924806|necrotic tissue|necrotic tissue
288085|NCT01924806|wound healing|wound healing
288086|NCT01924806|skin|skin
288087|NCT01924780|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
288088|NCT01924754|HPV|hpv
288089|NCT01924754|Gardasil|gardasil
288090|NCT01924754|seroconversion|seroconversion
288091|NCT01924741|Liver neoplasms|liver neoplasms
288092|NCT01924741|Liver regeneration|liver regeneration
288093|NCT01924715|somatoform disorder|somatoform disorder
288094|NCT01924715|psychotherapy|psychotherapy
288095|NCT01924715|depression|depression
288096|NCT01924715|anxiety|anxiety
288097|NCT01924715|personality disorder|personality disorder
288098|NCT01924689|Phase 1|phase 1
288099|NCT01924689|Metastatic Disease|metastatic disease
288100|NCT01924689|Solid Tumor|solid tumor
288101|NCT01924689|Malignancy|malignancy
288102|NCT01924689|Metastases|metastases
288103|NCT01924689|Clinical Trial|clinical trial
288104|NCT01924689|Hypoxia|hypoxia
288105|NCT01924689|Necrosis|necrosis
288106|NCT01924689|Intratumoral|intratumoral
288107|NCT01924689|Locally advanced cancer|locally advanced cancer
288108|NCT01924689|Immunotherapy|immunotherapy
288109|NCT01924689|Sarcoma|sarcoma
288110|NCT01924689|Chordoma|chordoma
288111|NCT01924689|Bacteriolytic|bacteriolytic
288112|NCT01924676|food effect|food effect
288113|NCT01924676|pharmacokinetics|pharmacokinetics
288114|NCT01924676|bioavailability|bioavailability
288115|NCT01924676|oxycodone|oxycodone
288116|NCT01924676|management of moderate to severe pain|management of moderate to severe pain
288117|NCT01924663|Heart Failure|heart failure
288118|NCT01924663|Acute Kidney Injury|acute kidney injury
288119|NCT01924663|Myocardial Dysfunction|myocardial dysfunction
288120|NCT01924663|Pediatric Critical Care|pediatric critical care
288121|NCT01924663|Pediatric Intensive Care Units|pediatric intensive care units
288122|NCT01924663|Respiratory Virus|respiratory virus
288123|NCT01924611|Dental caries|dental caries
288124|NCT01924611|Atraumatic Restorative Technique|atraumatic restorative technique
288125|NCT01924598|Anorexia Nervosa|anorexia nervosa
288126|NCT01924598|Treatment Development|treatment development
288127|NCT01924598|Capacity|capacity
288128|NCT01924598|Neuroimaging|neuroimaging
288129|NCT01924598|Magnetoencephalography|magnetoencephalography
288130|NCT01924598|functional MRI|functional mri
288131|NCT01924598|Reward processing|reward processing
288132|NCT01924598|Habit formation|habit formation
288133|NCT01924585|Colorectal|colorectal
288134|NCT01924585|Surgery|surgery
288135|NCT01924585|Frailty|frailty
288136|NCT01924585|Elderly|elderly
288137|NCT01924585|Quality of Life|quality of life
288138|NCT01924572|umbilical cord clamping|umbilical cord clamping
288139|NCT01924572|Placental residual blood volume|placental residual blood volume
288140|NCT01924572|hematocrit|hematocrit
288141|NCT01924572|hemoglobin|hemoglobin
288142|NCT01924572|bilirubin|bilirubin
288143|NCT01924559|Airway|airway
288144|NCT01924546|cognition|cognition
288145|NCT01924546|hydration|hydration
288146|NCT01924546|schoolchildren|schoolchildren
288147|NCT01924520|Antipsychotic|antipsychotic
288148|NCT01924520|FK949E|fk949e
288149|NCT01924520|Quetiapine|quetiapine
288150|NCT01924507|Sleep medicine|sleep medicine
288151|NCT01924507|Sleep apnea|sleep apnea
288152|NCT01924507|Acute myocardial infarction|acute myocardial infarction
288153|NCT01924507|Heart failure|heart failure
288154|NCT01924507|CPAP|cpap
288155|NCT01924494|telemedicine, tele-endoscopy|telemedicine, tele-endoscopy
288156|NCT01924481|Caffeine|caffeine
288157|NCT01924481|Flavonoids|flavonoids
288158|NCT01924481|MRI|mri
288159|NCT01924481|Brain blood flow|brain blood flow
288160|NCT01924481|Cognition|cognition
288161|NCT01924481|Perfusion|perfusion
288288|NCT01923909|WOMAC|womac
288162|NCT01924481|Resting functional magnetic resonance imaging (fMRI)|resting functional magnetic resonance imaging (fmri)
288163|NCT01924468|Cognitive Control|cognitive control
288164|NCT01924468|fMRI|fmri
288165|NCT01924468|Genetics|genetics
288166|NCT01924468|Dopamine|dopamine
288167|NCT01924455|HIV|hiv
288168|NCT01924455|HBV|hbv
288169|NCT01924442|Coronary Artery Disease|coronary artery disease
288170|NCT01924442|Off-Pump|off-pump
288171|NCT01924442|Myocardial Ischemia|myocardial ischemia
288172|NCT01924442|Heart Disease|heart disease
288173|NCT01924429|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
288174|NCT01924429|ADHD|adhd
288175|NCT01924429|fMRI|fmri
288176|NCT01924429|Imaging|imaging
288177|NCT01924429|Vyvanse|vyvanse
288178|NCT01924429|Stimulant Medication|stimulant medication
288179|NCT01924429|Treatment|treatment
288180|NCT01924429|Clinical Trial|clinical trial
288181|NCT01924429|Adult|adult
288182|NCT01924403|TKA|tka
288183|NCT01924403|Wound Closure|wound closure
288184|NCT01924403|Wound Perfusion|wound perfusion
288185|NCT01924390|Tooth extraction|tooth extraction
288186|NCT01924377|AF|af
288187|NCT01924364|Craniomaxillofacial (CMF) Battle-injured (BI)|craniomaxillofacial (cmf) battle-injured (bi)
288188|NCT01924364|Facial Trauma|facial trauma
288189|NCT01924364|Fat Grafts|fat grafts
288190|NCT01924364|Autogenous Fat Transfers (AFT)|autogenous fat transfers (aft)
288191|NCT01924364|Wounded warriors|wounded warriors
288192|NCT01924351|Breast Cancer with Brain Metastasis|breast cancer with brain metastasis
288193|NCT01924351|HER2-positive|her2-positive
288194|NCT01924351|HER-2 therapy|her-2 therapy
288195|NCT01924338|Patient|patient
288196|NCT01924338|localisation|localisation
288197|NCT01924338|in cranial|in cranial
288198|NCT01924338|radiation|radiation
288199|NCT01924338|therapy|therapy
288200|NCT01924338|thickness of|thickness of
288201|NCT01924325|apixaban|apixaban
288202|NCT01924325|clopidogrel|clopidogrel
288203|NCT01924325|aspirin|aspirin
288204|NCT01924325|new oral anticoagulant|new oral anticoagulant
288205|NCT01924325|TIA|tia
288206|NCT01924325|acute minor ischemic stroke|acute minor ischemic stroke
288207|NCT01924312|stroke, dementia, hypertension, diabetes, hyperlipidemia, smoking, obesity|stroke, dementia, hypertension, diabetes, hyperlipidemia, smoking, obesity
288208|NCT01924286|HIV|hiv
288209|NCT01924286|Tuberculosis|tuberculosis
288210|NCT01924286|Immune reconstitution inflammatory syndrome|immune reconstitution inflammatory syndrome
288211|NCT01924286|Highly active antiretroviral therapy|highly active antiretroviral therapy
288212|NCT01924286|Glucocorticoids|glucocorticoids
288213|NCT01924286|Prednisone|prednisone
288214|NCT01924286|Preventive therapy|preventive therapy
288215|NCT01924273|Port Wine Stain Birthmarks|port wine stain birthmarks
288216|NCT01924234|Remifentanil|remifentanil
288217|NCT01924234|Pharyngeal dysfunction|pharyngeal dysfunction
288218|NCT01924234|Subjective swallowing difficulties|subjective swallowing difficulties
288219|NCT01924234|Pulmonary aspiration|pulmonary aspiration
288220|NCT01924208|Timothy|timothy
288221|NCT01924208|Influenza|influenza
288222|NCT01924208|Interferon|interferon
288223|NCT01924208|T cell|t cell
288224|NCT01924208|Tonsil|tonsil
288225|NCT01924195|lung|lung
288226|NCT01924195|Anlotinib|anlotinib
288227|NCT01924195|AL3818|al3818
288228|NCT01924195|NSCLC|nsclc
288229|NCT01924195|Cancer|cancer
288230|NCT01924182|chronic pain|chronic pain
288231|NCT01924182|inadequate pain relief|inadequate pain relief
288232|NCT01924182|intolerable side effects|intolerable side effects
288233|NCT01924169|Hematologic Disorder|hematologic disorder
288234|NCT01924169|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
288235|NCT01924169|CLL|cll
288236|NCT01924169|Hypogammaglobulinemia|hypogammaglobulinemia
288237|NCT01924169|Impaired Response to Vaccinations|impaired response to vaccinations
288238|NCT01924169|Immunoglobulins|immunoglobulins
288239|NCT01924169|Immune system's function|immune system's function
288240|NCT01924169|Lenalidomide|lenalidomide
288241|NCT01924169|CC-5013|cc-5013
288242|NCT01924169|Revlimid|revlimid
288243|NCT01924169|Flu vaccine|flu vaccine
288244|NCT01924169|TIV|tiv
288245|NCT01924169|Pneumonia vaccine|pneumonia vaccine
288246|NCT01924143|ADHD|adhd
288247|NCT01924143|Fibromyalgia|fibromyalgia
288248|NCT01924117|cervical intraepithelial neoplasia, HPV, Cancer|cervical intraepithelial neoplasia, hpv, cancer
288249|NCT01924104|IVF failure, implantation rate, heparin & aspirin|ivf failure, implantation rate, heparin & aspirin
288250|NCT01924078|breast cancer|breast cancer
288251|NCT01924078|metronomic chemotherapy|metronomic chemotherapy
288252|NCT01924078|aromatase inhibitors|aromatase inhibitors
288253|NCT01924065|Atrial fibrillation, conversion, stroke|atrial fibrillation, conversion, stroke
288254|NCT01924039|Psychosis|psychosis
288255|NCT01924039|Substance Use|substance use
288256|NCT01924039|Motivational Enhancement Therapy|motivational enhancement therapy
288257|NCT01924026|Phenylketonuria|phenylketonuria
288258|NCT01924026|Mild Hyperphenylalaninemia|mild hyperphenylalaninemia
288259|NCT01924026|PKU|pku
288260|NCT01924026|MHP|mhp
288261|NCT01924013|Pregnancy|pregnancy
288262|NCT01924013|Infant Growth|infant growth
288263|NCT01924013|Vitamin D|vitamin d
288264|NCT01924013|Bangladesh|bangladesh
288265|NCT01923987|Short course radiotherapy|short course radiotherapy
288266|NCT01923987|Modified FOLFOX6|modified folfox6
288267|NCT01923987|Delayed surgery|delayed surgery
288268|NCT01923987|Rectal cancer|rectal cancer
288269|NCT01923987|Synchronous metastasis|synchronous metastasis
288270|NCT01923987|Liver metastasis|liver metastasis
288271|NCT01923987|Lung metastasis|lung metastasis
288272|NCT01923961|Maintenance hemodialysis or hemodiafiltration|maintenance hemodialysis or hemodiafiltration
288273|NCT01923961|>18 years|>18 years
288274|NCT01923961|Stable condition|stable condition
288275|NCT01923948|Hepatocellular carcinoma|hepatocellular carcinoma
288276|NCT01923948|Hepatectomy|hepatectomy
288277|NCT01923948|randomized controlled trials(RCTs)|randomized controlled trials(rcts)
288278|NCT01923948|Postoperative Pain|postoperative pain
288279|NCT01923935|Multiple myeloma, busulfan, melphalan,transplantation|multiple myeloma, busulfan, melphalan,transplantation
288280|NCT01923922|glioblastoma multiforme|glioblastoma multiforme
288281|NCT01923922|CT Perfusion|ct perfusion
288282|NCT01923922|Survival|survival
288283|NCT01923909|Knee|knee
288284|NCT01923909|Osteoarthritis|osteoarthritis
288285|NCT01923909|Bahrain|bahrain
288286|NCT01923909|PRP|prp
288287|NCT01923909|Steroid|steroid
288289|NCT01923909|Oxford Knee Score|oxford knee score
288290|NCT01923909|Platelet-rich plasma|platelet-rich plasma
288291|NCT01923896|food refusal|food refusal
288292|NCT01923896|behavioral intervention|behavioral intervention
288293|NCT01923896|D-cycloserine|d-cycloserine
288295|NCT01923844|perfusion index|perfusion index
288296|NCT01923844|pulsatility index|pulsatility index
288297|NCT01923844|respiratory distress syndrome|respiratory distress syndrome
288298|NCT01923844|surfactant|surfactant
288299|NCT01923844|transcutaneous carbon monoxide|transcutaneous carbon monoxide
288300|NCT01923831|Magnesium, Post operative sore throat, Prone position, Tracheal intubation|magnesium, post operative sore throat, prone position, tracheal intubation
288301|NCT01923818|rivaroxaban|rivaroxaban
288302|NCT01923818|aspirin|aspirin
288303|NCT01923818|new oral anticoagulant|new oral anticoagulant
288304|NCT01923818|TIA|tia
288305|NCT01923818|acute minor ischemic stroke|acute minor ischemic stroke
288306|NCT01923792|House Dust Mite Allergy|house dust mite allergy
288307|NCT01923792|Rhinoconjunctivitis|rhinoconjunctivitis
288308|NCT01923792|Environmental Exposure Unit|environmental exposure unit
288309|NCT01923792|Immunotherapy|immunotherapy
288310|NCT01923792|ToleroMune HDM|toleromune hdm
288311|NCT01923779|Grass allergy|grass allergy
288312|NCT01923779|Rhinoconjunctivitis|rhinoconjunctivitis
288313|NCT01923779|Environmental Exposure Unit|environmental exposure unit
288314|NCT01923779|Immunotherapy|immunotherapy
288315|NCT01923779|ToleroMune Grass|toleromune grass
288316|NCT01923766|Transplantation|transplantation
288317|NCT01923753|Cystic Fibrosis|cystic fibrosis
288318|NCT01923753|Neural respiratory drive|neural respiratory drive
288319|NCT01923753|Airway clearance technique|airway clearance technique
288320|NCT01923753|Expectoration|expectoration
288321|NCT01923753|Positive expiratory pressure device|positive expiratory pressure device
288322|NCT01923740|Absorb™ BVS|absorb™ bvs
288323|NCT01923740|Angioplasty|angioplasty
288324|NCT01923740|Bioabsorbable|bioabsorbable
288325|NCT01923740|BVS|bvs
288326|NCT01923740|Bioresorbable|bioresorbable
288327|NCT01923740|Coronary Artery Disease|coronary artery disease
288827|NCT01921205|Epilepsy|epilepsy
288328|NCT01923740|Coronary Artery Endothelial Responsiveness|coronary artery endothelial responsiveness
288329|NCT01923740|Coronary artery restenosis|coronary artery restenosis
288330|NCT01923740|Coronary artery stenosis|coronary artery stenosis
288331|NCT01923740|Coronary scaffold|coronary scaffold
288332|NCT01923740|Coronary Stent|coronary stent
288333|NCT01923740|Drug eluting stents|drug eluting stents
288334|NCT01923740|Everolimus|everolimus
288335|NCT01923740|Myocardial ischemia|myocardial ischemia
288336|NCT01923740|Stent thrombosis|stent thrombosis
288337|NCT01923740|Stents|stents
288338|NCT01923727|[89Zr]Df-IAB2M|[89zr]df-iab2m
288339|NCT01923727|Prostate|prostate
288340|NCT01923727|PET Scan|pet scan
288341|NCT01923714|Glaucoma|glaucoma
288342|NCT01923701|At Risk Mental State|at risk mental state
288343|NCT01923701|Attenuated Psychosis Syndrome|attenuated psychosis syndrome
288344|NCT01923701|Prodrom|prodrom
288345|NCT01923701|Paranoia|paranoia
288346|NCT01923701|Psychosis|psychosis
288347|NCT01923701|Cognitive Behavioral Therapy|cognitive behavioral therapy
288348|NCT01923701|Group|group
288349|NCT01923701|Family|family
288350|NCT01923701|ARMS|arms
288351|NCT01923688|Prediction Prevention Severe Hypoglycemia RealTime Alert|prediction prevention severe hypoglycemia realtime alert
288352|NCT01923675|myopia|myopia
288353|NCT01923675|nearsightedness|nearsightedness
288354|NCT01923675|axial elongation of the eye|axial elongation of the eye
288355|NCT01923675|refractive error|refractive error
288356|NCT01923662|Paraplegia|paraplegia
288357|NCT01923662|Tetraplegia|tetraplegia
288358|NCT01923662|Spinal Cord Injury|spinal cord injury
288359|NCT01923662|FES|fes
288360|NCT01923649|postoperative dumping|postoperative dumping
288361|NCT01923649|somatostatin analogues|somatostatin analogues
288362|NCT01923649|somatulin|somatulin
288363|NCT01923649|lanreotide|lanreotide
288364|NCT01923649|dumping syndrome|dumping syndrome
288365|NCT01923636|Cytomegalovirus, congenital, handicap|cytomegalovirus, congenital, handicap
288366|NCT01923610|Low risk HIV infection|low risk hiv infection
288367|NCT01923610|HIV Seronegativity|hiv seronegativity
288368|NCT01923610|HIV Preventive Vaccine|hiv preventive vaccine
288369|NCT01923597|Proteinuria|proteinuria
288370|NCT01923597|Oxidative stress|oxidative stress
288371|NCT01923597|Epigallocatechin gallate|epigallocatechin gallate
288372|NCT01923545|PEG-G-CSF|peg-g-csf
288373|NCT01923493|neck pain|neck pain
288374|NCT01923493|tuina|tuina
288375|NCT01923467|smoking|smoking
288376|NCT01923467|nicotine replacement|nicotine replacement
288377|NCT01923467|internet|internet
288378|NCT01923454|paracentesis|paracentesis
288379|NCT01923454|primary acute angle closure|primary acute angle closure
288380|NCT01923454|iridotomy|iridotomy
288381|NCT01923454|filtration|filtration
288382|NCT01923454|glaucoma|glaucoma
288383|NCT01923415|Lupus Erythematosus, Subacute, Cutaneous|lupus erythematosus, subacute, cutaneous
288384|NCT01923415|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
288385|NCT01923415|Lupus Erythematosus, Discoid|lupus erythematosus, discoid
288386|NCT01923415|Active Cutaneous Lupus Erythematosus|active cutaneous lupus erythematosus
288387|NCT01923415|Systemic Cutaneous Lupus Erythematosus|systemic cutaneous lupus erythematosus
288388|NCT01923415|Skin Biopsy|skin biopsy
288389|NCT01923415|Lesions|lesions
288390|NCT01923402|Biomarkers|biomarkers
288391|NCT01923402|Metabolic Profiling|metabolic profiling
288392|NCT01923402|Metabolomics|metabolomics
288393|NCT01923402|Tobacco|tobacco
288394|NCT01923402|Smokeless Tobacco|smokeless tobacco
288395|NCT01923402|Moist Snuff|moist snuff
288396|NCT01923389|T2DM|t2dm
288397|NCT01923389|obesity|obesity
288398|NCT01923389|safety|safety
288399|NCT01923389|multiple dose|multiple dose
288400|NCT01923389|intravenous|intravenous
288401|NCT01923376|hepatic encephalopathy|hepatic encephalopathy
288402|NCT01923376|hepatic coma|hepatic coma
288403|NCT01923376|HE|he
288404|NCT01923376|PSE|pse
288405|NCT01923376|lactulose|lactulose
288406|NCT01923376|golytely|golytely
288407|NCT01923376|cirrhosis|cirrhosis
288408|NCT01923376|Hepatic Insufficiency|hepatic insufficiency
288409|NCT01923376|Liver Cirrhosis|liver cirrhosis
288410|NCT01923376|Fibrosis|fibrosis
288411|NCT01923376|Brain Damage, Chronic|brain damage, chronic
288412|NCT01923376|Delirium|delirium
288413|NCT01923376|Encephalitis|encephalitis
288414|NCT01923376|Neurotoxicity Syndromes|neurotoxicity syndromes
288415|NCT01923376|Liver Failure|liver failure
288416|NCT01923376|Liver Diseases|liver diseases
288417|NCT01923376|Digestive System Diseases|digestive system diseases
288418|NCT01923376|Brain Diseases, Metabolic|brain diseases, metabolic
288419|NCT01923376|Brain Diseases|brain diseases
288420|NCT01923376|Central Nervous System Diseases|central nervous system diseases
288421|NCT01923376|Nervous System Diseases|nervous system diseases
288422|NCT01923376|Metabolic Diseases|metabolic diseases
288423|NCT01923376|Pathologic Processes|pathologic processes
288424|NCT01923376|Confusion|confusion
288425|NCT01923376|Neurobehavioral Manifestations|neurobehavioral manifestations
288426|NCT01923376|Neurologic Manifestations|neurologic manifestations
288427|NCT01923376|Signs and Symptoms|signs and symptoms
288428|NCT01923376|Delirium, Dementia, Amnestic, Cognitive Disorders|delirium, dementia, amnestic, cognitive disorders
288429|NCT01923376|Mental Disorders|mental disorders
288430|NCT01923376|Central Nervous System Viral Diseases|central nervous system viral diseases
288431|NCT01923376|Virus Diseases|virus diseases
288432|NCT01923376|Central Nervous System Infections|central nervous system infections
288433|NCT01923376|Poisoning|poisoning
288434|NCT01923376|Substance-Related Disorders|substance-related disorders
288435|NCT01923376|Citric Acid|citric acid
288436|NCT01923363|pharmacokinetics|pharmacokinetics
288437|NCT01923363|obesity|obesity
288438|NCT01923363|piperacillin-tazobactam combination product|piperacillin-tazobactam combination product
288439|NCT01923363|pharmacodynamics|pharmacodynamics
288440|NCT01923363|piperacillin/tazobactam|piperacillin/tazobactam
288441|NCT01923350|Weight reduction|weight reduction
288442|NCT01923350|Behavioral intervention|behavioral intervention
288443|NCT01923350|Gestational diabetes mellitus|gestational diabetes mellitus
288444|NCT01923350|Type 2 diabetes|type 2 diabetes
288445|NCT01923350|Diabetes testing|diabetes testing
288446|NCT01923337|Colorectal cancer|colorectal cancer
288447|NCT01923311|Pediatrics|pediatrics
288448|NCT01923311|Adolescents|adolescents
288449|NCT01923311|HIV|hiv
288450|NCT01923311|HIV-1|hiv-1
288451|NCT01923311|Treatment-experienced|treatment-experienced
288452|NCT01923246|Alcohol consumption|alcohol consumption
288453|NCT01923246|Brief intervention|brief intervention
288454|NCT01923246|Automated techniques|automated techniques
288455|NCT01923233|liver cancer|liver cancer
288456|NCT01923233|HCC|hcc
288457|NCT01923233|tumor vaccine|tumor vaccine
288458|NCT01923233|immunotherapy|immunotherapy
288459|NCT01923220|Breast Cancer|breast cancer
288460|NCT01923220|Radiation Therapy|radiation therapy
288461|NCT01923220|Radiation Dermatitis|radiation dermatitis
288462|NCT01923168|Breast Cancer, Pathological Complete Response, neoadjuvant, hormone receptor-positive|breast cancer, pathological complete response, neoadjuvant, hormone receptor-positive
288463|NCT01923142|Vitiligo|vitiligo
288464|NCT01923142|Outer-Root-Sheath|outer-root-sheath
288465|NCT01923142|Melanocytes|melanocytes
288466|NCT01923142|Hair Follicles|hair follicles
288467|NCT01923129|indwelling catheter|indwelling catheter
288468|NCT01923129|foley|foley
288469|NCT01923129|duration|duration
288470|NCT01923116|Anal intraepithelial neoplasia|anal intraepithelial neoplasia
288471|NCT01923116|HIV|hiv
288472|NCT01923116|HPV|hpv
288473|NCT01923116|Vaccination|vaccination
288474|NCT01923116|Treatment|treatment
288475|NCT01923077|acute myocardial infarction|acute myocardial infarction
288476|NCT01923077|Statin|statin
288477|NCT01923077|speckle tracking echocardiography|speckle tracking echocardiography
288478|NCT01923077|Strain|strain
288479|NCT01923077|MSCT|msct
288480|NCT01923077|plaque|plaque
288481|NCT01923077|vulnerable plaque|vulnerable plaque
288482|NCT01923051|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
288483|NCT01923051|COPD|copd
288484|NCT01923051|national database|national database
288485|NCT01923051|observational|observational
288486|NCT01923038|atelectasis|atelectasis
288487|NCT01923038|laparoscopic surgery|laparoscopic surgery
288488|NCT01923038|anesthesia|anesthesia
288489|NCT01923038|mechanical ventilation|mechanical ventilation
288490|NCT01923038|Prevent|prevent
288491|NCT01923038|shape of the airway|shape of the airway
288492|NCT01923038|pressure-time curve|pressure-time curve
288493|NCT01922986|stroke|stroke
288494|NCT01922986|rehabilitation|rehabilitation
288495|NCT01922986|hemiplegia|hemiplegia
288496|NCT01922986|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
288497|NCT01922973|ghrelin|ghrelin
288498|NCT01922973|growth hormone|growth hormone
288499|NCT01922973|aging|aging
288500|NCT01922973|normal volunteers|normal volunteers
288501|NCT01922960|trauma|trauma
288502|NCT01922960|multiple organ dysfunction syndrome|multiple organ dysfunction syndrome
288503|NCT01922908|Ischemic|ischemic
288504|NCT01922908|Stroke|stroke
288505|NCT01922908|Stem Cells|stem cells
288506|NCT01922908|MSC|msc
288507|NCT01922908|Allogeneic|allogeneic
288508|NCT01922908|Bone Marrow|bone marrow
288509|NCT01922895|Alcoholic Hepatitis|alcoholic hepatitis
288510|NCT01922895|MELD < 20|meld < 20
288511|NCT01922895|Probiotic|probiotic
288512|NCT01922895|Nutritional Supplement|nutritional supplement
288513|NCT01922895|Lactobacillus Rhamnosus GG|lactobacillus rhamnosus gg
288514|NCT01922882|HIV|hiv
288515|NCT01922882|Maternal disclosure|maternal disclosure
288516|NCT01922882|Health promotion|health promotion
288517|NCT01922882|Maternal mental health|maternal mental health
288518|NCT01922882|Child behavior|child behavior
288519|NCT01922869|Absorption|absorption
288520|NCT01922869|Metabolism|metabolism
288521|NCT01922869|Excretion|excretion
288522|NCT01922869|Flavonoids|flavonoids
288523|NCT01922869|Polyphenols|polyphenols
288524|NCT01922869|Genes|genes
288525|NCT01922869|Gut-microflora|gut-microflora
288526|NCT01922843|Hemodialysis|hemodialysis
288527|NCT01922830|Sleeve Gastrectomy|sleeve gastrectomy
288528|NCT01922830|NAFLD|nafld
288529|NCT01922830|gut microbiot|gut microbiot
288530|NCT01922830|Bariatric surgery|bariatric surgery
288531|NCT01922791|Nutrition|nutrition
288532|NCT01922791|Probiotics|probiotics
288533|NCT01922791|Fish oil|fish oil
288534|NCT01922765|Helicobacter|helicobacter
288535|NCT01922765|Eradication|eradication
288536|NCT01922752|CEP-37440|cep-37440
288537|NCT01922752|Advanced solid tumors|advanced solid tumors
288538|NCT01922752|Metastatic solid tumors|metastatic solid tumors
288539|NCT01922739|low back pain|low back pain
288540|NCT01922739|hydrocodone bitartrate|hydrocodone bitartrate
288541|NCT01922739|opioids|opioids
288542|NCT01922713|biofortification|biofortification
288543|NCT01922713|vitamin A|vitamin a
288544|NCT01922713|maize|maize
288545|NCT01922713|beta-carotene|beta-carotene
288546|NCT01922713|breastmilk|breastmilk
288547|NCT01922713|Zambia|zambia
288548|NCT01922700|Pepper spray|pepper spray
288549|NCT01922700|bronchospasm|bronchospasm
288550|NCT01922700|lacrimation|lacrimation
288551|NCT01922648|RSV|rsv
288552|NCT01922648|Immune response|immune response
288553|NCT01922648|Paediatric|paediatric
288554|NCT01922635|Primary lymphedema quality of life, genetic research|primary lymphedema quality of life, genetic research
288555|NCT01922622|minimum effective dose of local anaesthetic|minimum effective dose of local anaesthetic
288556|NCT01922622|spinal catheter|spinal catheter
288557|NCT01922622|fractured neck of femur|fractured neck of femur
288558|NCT01922622|a step up, step down methodology|a step up, step down methodology
288559|NCT01922609|Carotid stenting|carotid stenting
288560|NCT01922609|Proximal protection system|proximal protection system
288561|NCT01922609|Transcranial Doppler ultrasound|transcranial doppler ultrasound
288562|NCT01922609|Cerebrovascular reserve|cerebrovascular reserve
288563|NCT01922596|Total Knee Arthroplasty|total knee arthroplasty
288564|NCT01922596|Adductor Canal Blockade|adductor canal blockade
288565|NCT01922596|Us-guided nerve blockade|us-guided nerve blockade
288566|NCT01922583|NSCLC, EGFR mutation|nsclc, egfr mutation
288567|NCT01922570|Enteral nutrition|enteral nutrition
288568|NCT01922570|Supplemental parenteral nutrition|supplemental parenteral nutrition
288569|NCT01922570|Critical illness|critical illness
288570|NCT01922570|ICU patients|icu patients
288571|NCT01922570|diarrhea|diarrhea
288572|NCT01922544|heart failure|heart failure
288573|NCT01922544|cardiac resynchronization therapy|cardiac resynchronization therapy
288574|NCT01922544|coronary sinus lead|coronary sinus lead
288575|NCT01922531|mTBI|mtbi
288576|NCT01922531|Mild Traumatic Brain Injury|mild traumatic brain injury
288577|NCT01922531|Axonal Injury|axonal injury
288578|NCT01922518|atrioventricular block, cardiomyopathy|atrioventricular block, cardiomyopathy
288579|NCT01922492|autologous islet transplantation|autologous islet transplantation
288580|NCT01922492|partial pancreatectomy|partial pancreatectomy
288581|NCT01922492|pancreatogenic diabetes|pancreatogenic diabetes
288582|NCT01922479|Heart Failure|heart failure
288583|NCT01922479|Anemia|anemia
288584|NCT01922479|Iron Deficiency|iron deficiency
288585|NCT01922479|Ferric Carboxymaltose|ferric carboxymaltose
288586|NCT01922479|Asian|asian
288587|NCT01922466|chronic neck pain|chronic neck pain
288588|NCT01922466|combined treatment between conventional and complementary alternative medical treatment|combined treatment between conventional and complementary alternative medical treatment
288589|NCT01922466|bee venom acupuncture|bee venom acupuncture
288590|NCT01922466|NSAIDs|nsaids
288591|NCT01922453|breech presentation|breech presentation
288592|NCT01922453|vertex presentation|vertex presentation
288593|NCT01922440|Chronic Hypoparathyroidism|chronic hypoparathyroidism
288594|NCT01922440|rhPTH(1-84)|rhpth(1-84)
288595|NCT01922440|Observational study|observational study
288596|NCT01922440|parathyroid hormone (PTH)|parathyroid hormone (pth)
288597|NCT01922440|Drug registry|drug registry
288598|NCT01922414|Staghorn stones|staghorn stones
288599|NCT01922414|Percutaneous nephrolithotomy|percutaneous nephrolithotomy
288600|NCT01922414|Laser|laser
288601|NCT01922414|Randomized trial|randomized trial
288602|NCT01922414|Lithotripsy|lithotripsy
288603|NCT01922388|Parkinson disease|parkinson disease
288604|NCT01922388|deep brain stimulation|deep brain stimulation
288605|NCT01922388|subthalamic nucleus|subthalamic nucleus
288606|NCT01922388|motor complication|motor complication
288607|NCT01922388|quality of life|quality of life
288608|NCT01922362|STSG|stsg
288609|NCT01922362|wound healing|wound healing
288610|NCT01922336|Pharmacokinetics|pharmacokinetics
288611|NCT01922323|Living liver donor|living liver donor
288612|NCT01922297|Delinquency|delinquency
288613|NCT01922297|HIV Associated Risk Behavior|hiv associated risk behavior
288614|NCT01922297|Juveniles|juveniles
288615|NCT01922297|Family based treatment|family based treatment
288616|NCT01922297|Multidimensional Family Therapy|multidimensional family therapy
288617|NCT01922284|HIV|hiv
288618|NCT01922284|Vaccine|vaccine
288619|NCT01922284|Immunisation|immunisation
288620|NCT01922284|DNA|dna
288621|NCT01922284|Adverse events|adverse events
288622|NCT01922284|MVA-C|mva-c
288623|NCT01922284|GLA-AF|gla-af
288624|NCT01922284|Antibody|antibody
288625|NCT01922271|COPD|copd
288626|NCT01922258|OPC-34712|opc-34712
288627|NCT01922258|brexpiprazole|brexpiprazole
288629|NCT01922258|Alzheimer's Disease|alzheimer's disease
288630|NCT01922258|Cognitive Disorders|cognitive disorders
288631|NCT01922258|Memory|memory
288632|NCT01922258|Agitation|agitation
288633|NCT01922245|aphasia|aphasia
288634|NCT01922245|therapy|therapy
288635|NCT01922245|stroke|stroke
288636|NCT01922245|language|language
288637|NCT01922245|naming|naming
288638|NCT01922245|quality of life|quality of life
288639|NCT01922245|tDCS|tdcs
288640|NCT01922245|treatment|treatment
288641|NCT01922219|depression|depression
288642|NCT01922219|cognitive therapy|cognitive therapy
288643|NCT01922219|cognitive behavioral therapy|cognitive behavioral therapy
288644|NCT01922219|CBT|cbt
288645|NCT01922219|psychotherapy|psychotherapy
288646|NCT01922219|MDD|mdd
288647|NCT01922219|major depressive disorder|major depressive disorder
288648|NCT01922219|MRI|mri
288649|NCT01922219|fMRI|fmri
288650|NCT01922206|HIV|hiv
288651|NCT01922206|Maternal Disclosure|maternal disclosure
288652|NCT01922180|Chest Computed Tomography|chest computed tomography
288653|NCT01922167|Aging|aging
288654|NCT01922167|Frailty|frailty
288655|NCT01922167|Leucine|leucine
288656|NCT01922167|Resistance Exercise|resistance exercise
288657|NCT01922154|Angiogenesis inhibitors|angiogenesis inhibitors
288658|NCT01922154|Neovascular|neovascular
288659|NCT01922154|Intraocular pressure|intraocular pressure
288660|NCT01922154|Retinal Vein Occlusion|retinal vein occlusion
288661|NCT01922154|Vascular Endothelial Growth Factor|vascular endothelial growth factor
288662|NCT01922141|High blood pressure, stage 1 and 2 hypertension|high blood pressure, stage 1 and 2 hypertension
288663|NCT01922128|Non-exudative, dry AMD|non-exudative, dry amd
288664|NCT01922115|COGNITIVE FUNCTION|cognitive function
288665|NCT01922115|OVERACTIVE BLADDER|overactive bladder
288666|NCT01922115|[C23.888.942.343.780]|[c23.888.942.343.780]
288667|NCT01922102|Pathologic myopia (PM), choroidal neovascularization (CNV), ranibizumab, verteporfin PDT, Brilliance|pathologic myopia (pm), choroidal neovascularization (cnv), ranibizumab, verteporfin pdt, brilliance
288668|NCT01922089|Heart failure, reduced ejection fraction, LCZ696, titration, safety, tolerability|heart failure, reduced ejection fraction, lcz696, titration, safety, tolerability
288669|NCT01922063|disc herniation surgery|disc herniation surgery
288670|NCT01922063|physiotherapy, exercise therapy|physiotherapy, exercise therapy
288671|NCT01922063|randomized|randomized
288672|NCT01922063|long term|long term
288673|NCT01922063|follow up|follow up
288674|NCT01921972|AD, Dementia|ad, dementia
288675|NCT01921946|Fimasartan|fimasartan
288676|NCT01921933|End-stage renal disease|end-stage renal disease
288677|NCT01921933|ESRD|esrd
288678|NCT01921933|AVF|avf
288679|NCT01921933|Fistulas|fistulas
288680|NCT01921920|Omeprazole, Prilosec, Phase I, Healthy Subjects, Pharmacokinetics, Bioequivalence|omeprazole, prilosec, phase i, healthy subjects, pharmacokinetics, bioequivalence
288681|NCT01921907|Actinic keratosis|actinic keratosis
288682|NCT01921907|topical|topical
288683|NCT01921907|dermatology|dermatology
288684|NCT01921907|treatment|treatment
288685|NCT01921907|clinical study|clinical study
288686|NCT01921907|double blinded|double blinded
288687|NCT01921894|asthma|asthma
288688|NCT01921894|vitamin D|vitamin d
288689|NCT01921881|Glucose tolerance|glucose tolerance
288690|NCT01921829|Cardiorenal failure|cardiorenal failure
288691|NCT01921829|Cardiorenal syndrome|cardiorenal syndrome
288692|NCT01921829|Diuretic resistance|diuretic resistance
288693|NCT01921829|Volume overload|volume overload
288694|NCT01921829|Edema|edema
288695|NCT01921829|Health-related quality of life|health-related quality of life
288696|NCT01921829|Outcomes|outcomes
288697|NCT01921829|Treatment protocol|treatment protocol
288698|NCT01921790|Avastin+ GemAOD|avastin+ gemaod
288699|NCT01921790|first line chemotherapy|first line chemotherapy
288700|NCT01921790|NK/T-cell Lymphoma|nk/t-cell lymphoma
288701|NCT01921777|Muscle|muscle
288702|NCT01921777|exercise|exercise
288703|NCT01921777|soreness|soreness
288704|NCT01921777|Damage|damage
288705|NCT01921777|Traumeel|traumeel
288706|NCT01921777|homeopathy|homeopathy
288707|NCT01921751|SMAD4|smad4
288708|NCT01921751|IMRT|imrt
288709|NCT01921751|gemcitabine|gemcitabine
288710|NCT01921751|high-dose radiotherapy|high-dose radiotherapy
288711|NCT01921738|Chronic Periodontitis, Azithromycin, SRP|chronic periodontitis, azithromycin, srp
288712|NCT01921725|wound healing|wound healing
288713|NCT01921725|carbon|carbon
288714|NCT01921712|COPD|copd
288715|NCT01921712|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
288716|NCT01921699|macrophages|macrophages
288717|NCT01921699|adenocarcinoma|adenocarcinoma
288718|NCT01921699|chemoresistance|chemoresistance
288719|NCT01921686|Eosinophil|eosinophil
288720|NCT01921686|Reflux|reflux
288721|NCT01921686|Esophagus|esophagus
288722|NCT01921686|Food allergy|food allergy
288723|NCT01921686|Trouble Swallowing|trouble swallowing
288724|NCT01921686|Pediatrics|pediatrics
288725|NCT01921686|Healthy Volunteers|healthy volunteers
288726|NCT01921673|Gastric cancer|gastric cancer
288727|NCT01921673|Phase I/II|phase i/ii
288728|NCT01921673|Second-line chemotherapy|second-line chemotherapy
288729|NCT01921673|Dovitinib|dovitinib
288731|NCT01921673|Refractory to first-line chemotherapy|refractory to first-line chemotherapy
288732|NCT01921647|safety/tolerability and pharmacokinetics/pharmacodynamics|safety/tolerability and pharmacokinetics/pharmacodynamics
288733|NCT01921621|proficiency based progression|proficiency based progression
288734|NCT01921621|surgical skill|surgical skill
288735|NCT01921621|metric validation|metric validation
288736|NCT01921621|formative feedback|formative feedback
288737|NCT01921621|simulator model|simulator model
288738|NCT01921608|Male Circumcision|male circumcision
288739|NCT01921608|HIV Prevention|hiv prevention
288740|NCT01921608|HIV Infections|hiv infections
288741|NCT01921595|balanced salt colloid, coagulation profiles, spinal cord tumor|balanced salt colloid, coagulation profiles, spinal cord tumor
288742|NCT01921543|Deep Brain Stimulation|deep brain stimulation
288743|NCT01921543|Major Depressive Disorder|major depressive disorder
288744|NCT01921543|Psychosurgery|psychosurgery
288745|NCT01921543|Electrical stimulation|electrical stimulation
288746|NCT01921530|Posterolateral Fusion|posterolateral fusion
288747|NCT01921530|Interbody Fusion|interbody fusion
288748|NCT01921530|Lumbar|lumbar
288749|NCT01921530|Spinal Stenosis|spinal stenosis
288750|NCT01921530|Degenerative Spondylolisthesis|degenerative spondylolisthesis
288751|NCT01921517|Biomechanics|biomechanics
288752|NCT01921517|Osteogenesis|osteogenesis
288753|NCT01921504|Functional Dyspepsia|functional dyspepsia
288754|NCT01921504|Acupuncture|acupuncture
288755|NCT01921504|Genotype|genotype
288756|NCT01921504|Ghrelin|ghrelin
288757|NCT01921465|outpatient care|outpatient care
288758|NCT01921465|videoconferencing|videoconferencing
288759|NCT01921465|elective cesarean section|elective cesarean section
288760|NCT01921452|Hypothyroidism|hypothyroidism
288761|NCT01921452|Third generation TSH kit|third generation tsh kit
288762|NCT01921452|Quantitative POC TSH kit|quantitative poc tsh kit
288763|NCT01921452|Qualitative POC TSH kit|qualitative poc tsh kit
288764|NCT01921439|smoking|smoking
288765|NCT01921439|quit smoking|quit smoking
288766|NCT01921439|smoking cessation|smoking cessation
288767|NCT01921439|smoking study|smoking study
288768|NCT01921439|secondhand smoke|secondhand smoke
288769|NCT01921439|smokers|smokers
288770|NCT01921426|Squamous Cell Carcinoma of the Head and Neck|squamous cell carcinoma of the head and neck
288771|NCT01921426|Oral Cavity|oral cavity
288772|NCT01921426|Oropharynx|oropharynx
288773|NCT01921426|Radiation|radiation
288774|NCT01921426|Chemotherapy|chemotherapy
288775|NCT01921426|Cisplatin|cisplatin
288776|NCT01921426|Oral Mucositis|oral mucositis
288777|NCT01921426|Superoxide Dismutase|superoxide dismutase
288778|NCT01921413|Plasmodium falciparum|plasmodium falciparum
288779|NCT01921413|Clinical Malaria|clinical malaria
288780|NCT01921413|Fever|fever
288781|NCT01921413|Schistosoma hematobium|schistosoma hematobium
288782|NCT01921413|Rheumatoid arthritis|rheumatoid arthritis
288783|NCT01921400|Hepatitis C (HCV)|hepatitis c (hcv)
288784|NCT01921400|Infection Transmission, Maternal-Fetal|infection transmission, maternal-fetal
288785|NCT01921400|Placenta|placenta
288786|NCT01921400|Trophoblast|trophoblast
288787|NCT01921374|Duchenne;|duchenne;
288788|NCT01921374|mothers caregivers;|mothers caregivers;
288789|NCT01921374|sleep;|sleep;
288790|NCT01921374|hormonal profile;|hormonal profile;
288791|NCT01921374|cardiac profile;|cardiac profile;
288792|NCT01921374|biochemical profile;|biochemical profile;
288793|NCT01921374|inflammatory profile.|inflammatory profile.
288794|NCT01921361|Shivering|shivering
288795|NCT01921361|Dexmedetomidine|dexmedetomidine
288796|NCT01921361|Spinal anesthesia|spinal anesthesia
288797|NCT01921348|Hay Fever|hay fever
288798|NCT01921348|Hayfever|hayfever
288799|NCT01921348|Pollen Allergy|pollen allergy
288800|NCT01921348|Pollinosis|pollinosis
288801|NCT01921348|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
288802|NCT01921335|ARRY-380|arry-380
288803|NCT01921335|Trastuzumab|trastuzumab
288804|NCT01921335|Advanced HER2-positive breast cancer|advanced her2-positive breast cancer
288805|NCT01921309|osteoarthritis|osteoarthritis
288806|NCT01921309|avascular necrosis|avascular necrosis
288807|NCT01921309|rheumatoid arthritis|rheumatoid arthritis
288808|NCT01921309|correction of functional deformity|correction of functional deformity
288809|NCT01921309|dysplasia of the hip|dysplasia of the hip
288810|NCT01921296|Breast cancer|breast cancer
288811|NCT01921296|Aromatase inhibitor|aromatase inhibitor
288812|NCT01921283|propofol, endoscopy, bispectral index|propofol, endoscopy, bispectral index
288813|NCT01921270|Oromandibular Dystonia|oromandibular dystonia
288814|NCT01921270|Oral Dystonia|oral dystonia
288815|NCT01921270|Tardive Dystonia|tardive dystonia
288816|NCT01921270|botulinum toxin|botulinum toxin
288817|NCT01921270|abobotulinumtoxinA|abobotulinumtoxina
288818|NCT01921257|Cat Allergy|cat allergy
288819|NCT01921257|Rhinoconjunctivitis|rhinoconjunctivitis
288820|NCT01921244|Autistic Disorder|autistic disorder
288821|NCT01921244|Decision Making|decision making
288822|NCT01921244|Medication Therapy Management|medication therapy management
288823|NCT01921218|Kidney transplant|kidney transplant
288824|NCT01921205|Lacosamide|lacosamide
288825|NCT01921205|Vimpat|vimpat
288826|NCT01921205|UCB|ucb
288828|NCT01921205|Partial Onset Seizures|partial onset seizures
288829|NCT01921205|Pediatric|pediatric
288830|NCT01921179|Post Traumatic Stress Disorder,|post traumatic stress disorder,
288831|NCT01921179|Mild Traumatic Brain Injury|mild traumatic brain injury
288832|NCT01921179|Concussion|concussion
288833|NCT01921179|Cognitive Rehabilitation|cognitive rehabilitation
288834|NCT01921166|infertility|infertility
288835|NCT01921166|diminished ovarian reserve|diminished ovarian reserve
288836|NCT01921166|fertilization in vitro|fertilization in vitro
288837|NCT01921166|ovulation inducion|ovulation inducion
288838|NCT01921166|vitrification|vitrification
288839|NCT01921140|Oncology, cancer, tumour, neoplasm, anticancer drug, food, area under the curve, pharmacokinetics, olaparib, neoplasm, metabolites, QT interval effects|oncology, cancer, tumour, neoplasm, anticancer drug, food, area under the curve, pharmacokinetics, olaparib, neoplasm, metabolites, qt interval effects
288840|NCT01921127|COPD, Comparative effectiveness, Symbicort|copd, comparative effectiveness, symbicort
288841|NCT01921101|nutrition|nutrition
288842|NCT01921101|enteral feeding|enteral feeding
288843|NCT01921101|parenteral feeding|parenteral feeding
288844|NCT01921101|hospital malnutrition|hospital malnutrition
288845|NCT01921088|fMRI|fmri
288846|NCT01921088|Neurofeedback|neurofeedback
288847|NCT01921088|Blood pressure|blood pressure
288848|NCT01921088|Psychophysiology|psychophysiology
288849|NCT01921075|physiology, normal function|physiology, normal function
288850|NCT01921062|Distal radius fracture|distal radius fracture
288851|NCT01921062|Motor imagery|motor imagery
288852|NCT01921062|Immobilisation|immobilisation
288853|NCT01921062|Effectivity|effectivity
288854|NCT01921023|Blood Gas analysis|blood gas analysis
288855|NCT01920997|Healthy|healthy
288856|NCT01920997|normal menstrual cycles|normal menstrual cycles
288857|NCT01920971|chronic low back pain|chronic low back pain
288858|NCT01920971|infrared energy|infrared energy
288859|NCT01920971|effects|effects
288860|NCT01920932|Pediatric cancer|pediatric cancer
288861|NCT01920932|Hodgkin lymphoma|hodgkin lymphoma
288862|NCT01920932|Targeted therapy|targeted therapy
288863|NCT01920932|Frontline therapy|frontline therapy
288864|NCT01920932|Brentuximab vedotin|brentuximab vedotin
288865|NCT01920932|Quality of Life|quality of life
288866|NCT01920932|OEPA/COPDac|oepa/copdac
288867|NCT01920906|Psoriasis|psoriasis
288868|NCT01920906|Korean|korean
288869|NCT01920906|Healthy Volunteers|healthy volunteers
288870|NCT01920880|Anterior cutaneous nerve entrapment syndrome|anterior cutaneous nerve entrapment syndrome
288871|NCT01920880|ACNES|acnes
288872|NCT01920880|chronic abdominal wall pain|chronic abdominal wall pain
288873|NCT01920880|CAWP|cawp
288874|NCT01920867|Stem Cells|stem cells
288875|NCT01920867|Bone Marrow Derived Stem Cells|bone marrow derived stem cells
288876|NCT01920867|BMSC|bmsc
288877|NCT01920867|BMC (Bone Marrow Cell)|bmc (bone marrow cell)
288878|NCT01920867|Mesenchymal Stem Cells|mesenchymal stem cells
288879|NCT01920867|MSC|msc
288880|NCT01920867|Eye Disease|eye disease
288881|NCT01920867|Eye Stem Cells|eye stem cells
288882|NCT01920867|Ophthalmology|ophthalmology
288883|NCT01920867|Ophthalmic Disease|ophthalmic disease
288884|NCT01920867|Retina|retina
288885|NCT01920867|Retinal Disease|retinal disease
288886|NCT01920867|Macular Degeneration|macular degeneration
288887|NCT01920867|Age Related Macular Degeneration|age related macular degeneration
288888|NCT01920867|Myopic Macular Degeneration|myopic macular degeneration
288889|NCT01920867|Geographic Atrophy|geographic atrophy
288890|NCT01920867|Dry Macular Degeneration|dry macular degeneration
288891|NCT01920867|Wet Macular Degeneration|wet macular degeneration
288892|NCT01920867|Retinal Atrophy|retinal atrophy
288893|NCT01920867|Retinal Dystrophy|retinal dystrophy
288894|NCT01920867|Hereditary Retinal Dystrophy|hereditary retinal dystrophy
288895|NCT01920867|Retinitis Pigmentosa|retinitis pigmentosa
288896|NCT01920867|Stargardt Disease|stargardt disease
288897|NCT01920867|Cone Dystrophy|cone dystrophy
288898|NCT01920867|Cone Rod Dystrophy|cone rod dystrophy
288899|NCT01920867|Maculopathy|maculopathy
288900|NCT01920867|Optic Nerve Disease|optic nerve disease
288901|NCT01920867|Optic Nerve Atrophy|optic nerve atrophy
288902|NCT01920867|Optic Atrophy|optic atrophy
288903|NCT01920867|Ischemic Optic Neuropathy|ischemic optic neuropathy
288904|NCT01920867|Optic Nerve Damage|optic nerve damage
288905|NCT01920867|Optic Nerve Compression|optic nerve compression
288906|NCT01920867|Compressive Optic Neuropathy|compressive optic neuropathy
288907|NCT01920867|Devics Syndrome|devics syndrome
288908|NCT01920854|Soluble Ferric Pyrophosphate, Pharmacokinetics, Iron, Hemodialysis|soluble ferric pyrophosphate, pharmacokinetics, iron, hemodialysis
288909|NCT01920841|lipolytic|lipolytic
288910|NCT01920841|herbal extracts|herbal extracts
288911|NCT01920841|thigh girth|thigh girth
288912|NCT01920841|thigh smoothness|thigh smoothness
288913|NCT01920789|Non-small call lung cancer|non-small call lung cancer
288914|NCT01920789|Medically inoperable|medically inoperable
288915|NCT01920789|Stage one|stage one
288916|NCT01920789|Radiotherapy|radiotherapy
288918|NCT01920789|Hypofractionation|hypofractionation
288919|NCT01920789|Conventional fractionation|conventional fractionation
288920|NCT01920776|critical ultrasound|critical ultrasound
288921|NCT01920763|Intracerebral hemorrhage|intracerebral hemorrhage
288922|NCT01920763|Surgical evacuation|surgical evacuation
288923|NCT01920763|Minimally-invasive surgery|minimally-invasive surgery
288924|NCT01920750|Leprosy, skin test, MLSA-LAM, MLCwA, diagnosis, Protocol 98-202|leprosy, skin test, mlsa-lam, mlcwa, diagnosis, protocol 98-202
288925|NCT01920737|ALL|all
288926|NCT01920737|Bone Marrow|bone marrow
288927|NCT01920737|Ph Negative|ph negative
288928|NCT01920737|Daunorubicin|daunorubicin
288929|NCT01920737|Vincristine|vincristine
288930|NCT01920737|Prednisone|prednisone
288931|NCT01920737|PEG-Asparaginase|peg-asparaginase
288932|NCT01920737|Methotrexate|methotrexate
288933|NCT01920737|16-MP (6-Mercaptopurine)|16-mp (6-mercaptopurine)
288934|NCT01920737|Cyclophosphamide|cyclophosphamide
288935|NCT01920737|Cytarabine|cytarabine
288936|NCT01920737|Leucovorin|leucovorin
288937|NCT01920737|Dexamethasone|dexamethasone
288938|NCT01920737|12-266|12-266
288939|NCT01920724|Preschool children|preschool children
288940|NCT01920724|Body composition|body composition
288941|NCT01920711|Heart failure|heart failure
288942|NCT01920711|preserved ejection fraction|preserved ejection fraction
288943|NCT01920711|diastolic heart failure|diastolic heart failure
288944|NCT01920698|Heart Valve Diseases|heart valve diseases
288945|NCT01920698|Heart failure|heart failure
288946|NCT01920698|Heart diseases|heart diseases
288947|NCT01920698|Mitral valve insufficiency|mitral valve insufficiency
288948|NCT01920685|Paranoia|paranoia
288949|NCT01920685|CBT|cbt
288950|NCT01920685|Reasoning|reasoning
288951|NCT01920685|Anxiety|anxiety
288952|NCT01920659|High Intensity Training|high intensity training
288953|NCT01920659|Insulin sensitivity|insulin sensitivity
288954|NCT01920659|Fitness|fitness
288955|NCT01920620|obesity, inpatient, intervention, weight loss|obesity, inpatient, intervention, weight loss
288956|NCT01920607|Fecal Incontinence.|fecal incontinence.
288957|NCT01920607|Anal Incontinence.|anal incontinence.
288958|NCT01920607|Functional Bowel Disorders.|functional bowel disorders.
288959|NCT01920607|SNS.|sns.
288960|NCT01920607|Artificial Sphincters.|artificial sphincters.
288961|NCT01920607|Magnetic Anal Sphincter.|magnetic anal sphincter.
288962|NCT01920594|GSK1278863|gsk1278863
288963|NCT01920594|Thoracic Aortic Aneurysm Repair|thoracic aortic aneurysm repair
288964|NCT01920581|CEIP|ceip
288965|NCT01920581|pharmacodependance|pharmacodependance
288966|NCT01920581|addictovigilance|addictovigilance
288967|NCT01920581|benzodiazepines and benzodiazepines related drugs|benzodiazepines and benzodiazepines related drugs
288968|NCT01920581|elderly|elderly
288969|NCT01920568|GSK2371746|gsk2371746
288970|NCT01920568|Denosumab|denosumab
288971|NCT01920568|China|china
288972|NCT01920568|skeletal-related events|skeletal-related events
288973|NCT01920568|bone metastases|bone metastases
288974|NCT01920568|bridging study|bridging study
288975|NCT01920568|solid tumors|solid tumors
288976|NCT01920555|Depression|depression
288977|NCT01920555|Treatment Resistant Depression|treatment resistant depression
288978|NCT01920555|Ketamine|ketamine
288979|NCT01920555|Antidepressant|antidepressant
288980|NCT01920555|MDD|mdd
288981|NCT01920555|Major Depression|major depression
288982|NCT01920529|asthma, aerobic exercise, child, cytokines|asthma, aerobic exercise, child, cytokines
288983|NCT01920516|Isolated limb infusion|isolated limb infusion
288984|NCT01920516|Melphalan|melphalan
288985|NCT01920516|Limb Melanoma|limb melanoma
288986|NCT01920516|Tumor response|tumor response
288987|NCT01920503|cholangiocarcinoma|cholangiocarcinoma
288988|NCT01920503|transarterial chemoembolization|transarterial chemoembolization
288989|NCT01920503|doxorubicin|doxorubicin
288990|NCT01920503|tumor response|tumor response
288991|NCT01920477|Pemphigus|pemphigus
288992|NCT01920477|(MAB)|(mab)
288993|NCT01920477|autoimmune disorder|autoimmune disorder
288994|NCT01920477|human CD20 antigen|human cd20 antigen
288995|NCT01920477|subcutaneous|subcutaneous
288996|NCT01920477|Pemphigus vulgaris|pemphigus vulgaris
288997|NCT01920477|Phase 3|phase 3
288998|NCT01920477|monoclonal antibody|monoclonal antibody
288999|NCT01920477|ofatumumab|ofatumumab
289000|NCT01920477|PV|pv
289001|NCT01920477|rare disease|rare disease
289002|NCT01920451|sleep|sleep
289003|NCT01920451|insomnia|insomnia
289004|NCT01920451|posttraumatic stress disorder|posttraumatic stress disorder
289005|NCT01920451|hypertension|hypertension
289006|NCT01920451|cardiovascular disease|cardiovascular disease
289007|NCT01920438|Percutaneous endoscopic gastrostomy,|percutaneous endoscopic gastrostomy,
289008|NCT01920438|Radiologically inserted gastrostomy,|radiologically inserted gastrostomy,
289009|NCT01920438|Complications|complications
289010|NCT01920425|Parkinson's disease|parkinson's disease
289011|NCT01920425|dyskinesia|dyskinesia
289012|NCT01920425|fluctuations|fluctuations
289013|NCT01920425|tremor|tremor
289014|NCT01920425|bradykinesia|bradykinesia
289015|NCT01920425|levodopa|levodopa
289016|NCT01920412|Atrial fibrillation|atrial fibrillation
289017|NCT01920412|Thrombosis|thrombosis
289018|NCT01920412|Ischemic stroke|ischemic stroke
289019|NCT01920412|Left atrial appendage occluder|left atrial appendage occluder
289020|NCT01920412|Intervention method|intervention method
289021|NCT01920399|CAZ-AVI China phase I PK study|caz-avi china phase i pk study
289022|NCT01920386|Acute Toothache|acute toothache
289023|NCT01920386|Wontran|wontran
289024|NCT01920386|Wontran SR Tab.|wontran sr tab.
289025|NCT01920386|Tramadol Hydrochloride/Acetaminophen|tramadol hydrochloride/acetaminophen
289026|NCT01920373|degenerative joint disease|degenerative joint disease
289027|NCT01920373|temporomandibular joint|temporomandibular joint
289028|NCT01920360|KNEE OSTEOARTHRITIS|knee osteoarthritis
289029|NCT01920360|BALNEOTHERAPY|balneotherapy
289030|NCT01920360|SULPHUROUS WATERS|sulphurous waters
289031|NCT01920360|WOMAC|womac
289032|NCT01920360|LEQUESNE|lequesne
289033|NCT01920360|HEALTH ASSESSMENT QUESTIONNAIRE|health assessment questionnaire
289034|NCT01920360|SHORT FORM - 36|short form - 36
289035|NCT01920360|VAS|vas
289036|NCT01920347|hypoxic encephalopathy|hypoxic encephalopathy
289037|NCT01920347|cardiac arrest|cardiac arrest
289038|NCT01920347|outcome|outcome
289039|NCT01920347|pupillary reflex|pupillary reflex
289040|NCT01920334|coronary disease|coronary disease
289041|NCT01920334|heart diseases|heart diseases
289042|NCT01920334|enzymes|enzymes
289043|NCT01920334|sleep|sleep
289044|NCT01920334|troponin|troponin
289045|NCT01920334|zolpidem|zolpidem
289046|NCT01920321|COPD|copd
289047|NCT01920321|Bronchoscopic LVR|bronchoscopic lvr
289048|NCT01920321|Emphysema|emphysema
289049|NCT01920321|Hot injury|hot injury
289050|NCT01920269|non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
289051|NCT01920269|intravesical chemotherapy|intravesical chemotherapy
289052|NCT01920269|mitomycin|mitomycin
289053|NCT01920269|passive diffusion|passive diffusion
289054|NCT01920269|electromotive drug administration|electromotive drug administration
289055|NCT01920256|Insulin therapy|insulin therapy
289056|NCT01920256|Type 2 diabetes|type 2 diabetes
289057|NCT01920243|Telemedicine|telemedicine
289058|NCT01920243|self-management|self-management
289059|NCT01920243|Medical psychology|medical psychology
289060|NCT01920243|Health psychology|health psychology
289061|NCT01920243|Rehabilitation|rehabilitation
289062|NCT01920243|Education, Health|education, health
289063|NCT01920230|Burnout|burnout
289064|NCT01920230|Stress|stress
289065|NCT01920230|Mindfulness|mindfulness
289066|NCT01920230|Acceptance-commitment therapy (ACT)|acceptance-commitment therapy (act)
289067|NCT01920230|Intervention|intervention
289068|NCT01920230|Effectiveness|effectiveness
289069|NCT01920230|Working conditions|working conditions
289070|NCT01920230|Work engagement|work engagement
289071|NCT01920230|Psychological well-being|psychological well-being
289072|NCT01920230|Life situation|life situation
289073|NCT01920217|sepsis|sepsis
289075|NCT01920217|mortality|mortality
289076|NCT01920204|Mastocytosis|mastocytosis
289077|NCT01920204|ISM|ism
289078|NCT01920204|SSM|ssm
289079|NCT01920191|Glioblastoma|glioblastoma
289080|NCT01920165|respiratory tract infections|respiratory tract infections
289081|NCT01920165|upper respiratory tract infections|upper respiratory tract infections
289082|NCT01920165|lower respiratory tract infections|lower respiratory tract infections
289083|NCT01920165|hospitalisation|hospitalisation
289084|NCT01920165|child|child
289085|NCT01920165|children|children
289086|NCT01920165|minors|minors
289087|NCT01920165|infants|infants
289088|NCT01920165|second-hand smoke|second-hand smoke
289089|NCT01920165|tobacco smoke pollution|tobacco smoke pollution
289090|NCT01920165|smoke-free|smoke-free
289091|NCT01920165|smoke-free policy|smoke-free policy
289092|NCT01920165|smoke-free legislation|smoke-free legislation
289093|NCT01920165|public places|public places
289094|NCT01920152|Hip, Chondropenia, Osteoarthritis.|hip, chondropenia, osteoarthritis.
289095|NCT01920126|sodium bicarbonate, renal function, infective endocarditis, open heart surgery|sodium bicarbonate, renal function, infective endocarditis, open heart surgery
289096|NCT01920113|Endoscopic submucosal dissection|endoscopic submucosal dissection
289097|NCT01920113|propofol|propofol
289098|NCT01920113|remifentanil|remifentanil
289099|NCT01920113|dexmedetomidine|dexmedetomidine
289100|NCT01920113|efficacy|efficacy
289101|NCT01920113|safeness|safeness
289102|NCT01920100|Health Care Costs|health care costs
289103|NCT01920100|Genetic Polymorphism|genetic polymorphism
289104|NCT01920087|Atypical Facial Pain|atypical facial pain
289105|NCT01920087|Persistent Idiopathic Facial Pain|persistent idiopathic facial pain
289106|NCT01920087|Atypical Trigeminal Neuralgia|atypical trigeminal neuralgia
289107|NCT01920087|Orofacial Pain|orofacial pain
289108|NCT01920087|Orofacial neuropathic pain|orofacial neuropathic pain
289109|NCT01920087|Fothergill Disease|fothergill disease
289110|NCT01920087|Tic Douloureux|tic douloureux
289111|NCT01920087|Prosopalgia|prosopalgia
289112|NCT01920074|Anal Fissure|anal fissure
289113|NCT01920074|Nitroglycerin|nitroglycerin
289114|NCT01920074|Pediatrics|pediatrics
289115|NCT01920074|RECTIV®|rectiv®
289116|NCT01920074|Pediatric Research Equity Act|pediatric research equity act
289117|NCT01920061|Advanced cancer|advanced cancer
289118|NCT01920061|solid tumors|solid tumors
289119|NCT01920061|PI3K|pi3k
289120|NCT01920061|mTOR|mtor
289121|NCT01920061|PI3K/mTOR|pi3k/mtor
289122|NCT01920061|metastatic|metastatic
289221|NCT01919723|Ticagrelor|ticagrelor
289123|NCT01920061|Triple Negative Breast Cancer (TNBC)|triple negative breast cancer (tnbc)
289124|NCT01920048|Heart Failure|heart failure
289125|NCT01920048|Ventricular Dysfunction|ventricular dysfunction
289126|NCT01920048|Ischemic Cardiomyopathy|ischemic cardiomyopathy
289127|NCT01920048|Ischemic Heart Disease|ischemic heart disease
289128|NCT01920048|Revascularization|revascularization
289129|NCT01920048|Percutaneous Coronary Intervention|percutaneous coronary intervention
289130|NCT01920048|Randomized Control Trial|randomized control trial
289131|NCT01920048|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
289132|NCT01920035|Incontinence post RARP|incontinence post rarp
289133|NCT01920035|Surgery induced incontinence|surgery induced incontinence
289134|NCT01920035|Incontinence after prostatectomy|incontinence after prostatectomy
289135|NCT01920035|Neuropathy-induced incontinence|neuropathy-induced incontinence
289136|NCT01920022|medical abortion|medical abortion
289137|NCT01920022|postabortion contraception|postabortion contraception
289138|NCT01920022|LARC|larc
289139|NCT01920022|Nexplanon|nexplanon
289140|NCT01920022|subdermal contraceptive implant|subdermal contraceptive implant
289141|NCT01920009|pharmacy care|pharmacy care
289142|NCT01920009|adherence|adherence
289143|NCT01920009|coronary heart disease|coronary heart disease
289144|NCT01919996|Ocular safety|ocular safety
289145|NCT01919996|azithromycin|azithromycin
289146|NCT01919996|pharyngitis|pharyngitis
289147|NCT01919996|tonsillitis|tonsillitis
289148|NCT01919983|cardiac|cardiac
289149|NCT01919983|innervation|innervation
289150|NCT01919983|inflammation|inflammation
289151|NCT01919983|sudden|sudden
289152|NCT01919983|death|death
289153|NCT01919970|Autism|autism
289154|NCT01919970|Asperger's Syndrome|asperger's syndrome
289155|NCT01919970|Pervasive Developmental Disorder Not Otherwise Specified|pervasive developmental disorder not otherwise specified
289156|NCT01919970|Treatment|treatment
289157|NCT01919970|Cognitive-behavioral therapy|cognitive-behavioral therapy
289158|NCT01919970|Anxiety|anxiety
289159|NCT01919970|Children|children
289160|NCT01919970|Therapy|therapy
289161|NCT01919970|Generalized Anxiety Disorder|generalized anxiety disorder
289162|NCT01919970|Social Phobia|social phobia
289163|NCT01919970|Separation Anxiety Disorder|separation anxiety disorder
289164|NCT01919970|Obsessive-compulsive Disorder|obsessive-compulsive disorder
289165|NCT01919970|Specific Phobia|specific phobia
289166|NCT01919957|epilepsy|epilepsy
289167|NCT01919957|surgery|surgery
289168|NCT01919957|functional MRI|functional mri
289169|NCT01919957|memory outcome|memory outcome
289170|NCT01919944|itch|itch
289171|NCT01919931|Candida albicans|candida albicans
289172|NCT01919931|Candidiasis|candidiasis
289173|NCT01919931|Biofilm|biofilm
289174|NCT01919931|Flow cytometry|flow cytometry
289175|NCT01919931|Mannose Binding Lectin|mannose binding lectin
289176|NCT01919905|Mozzarella cheese fortification|mozzarella cheese fortification
289177|NCT01919905|Bioavailability of Vitamin D|bioavailability of vitamin d
289178|NCT01919892|predictors of response|predictors of response
289179|NCT01919892|bipolar disorder|bipolar disorder
289180|NCT01919892|depression|depression
289181|NCT01919892|lithium treatment|lithium treatment
289182|NCT01919892|biomarkers|biomarkers
289183|NCT01919879|Chemotherapy refractory|chemotherapy refractory
289184|NCT01919879|wtKRAS metastatic colorectal cancer|wtkras metastatic colorectal cancer
289185|NCT01919879|cross over|cross over
289186|NCT01919853|Cancer|cancer
289187|NCT01919853|Fatigue|fatigue
289188|NCT01919853|Mindfulness|mindfulness
289189|NCT01919853|Meditation|meditation
289190|NCT01919853|Neoplasms|neoplasms
289191|NCT01919853|Signs and symptoms|signs and symptoms
289192|NCT01919840|hemostatic disorders|hemostatic disorders
289193|NCT01919840|ardiac surgery|ardiac surgery
289194|NCT01919840|cardiopulmonary bypass|cardiopulmonary bypass
289195|NCT01919827|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
289196|NCT01919827|Stem cells|stem cells
289197|NCT01919827|Mesenchymal stem cells|mesenchymal stem cells
289198|NCT01919801|ACE-I|ace-i
289199|NCT01919801|Firazyr|firazyr
289200|NCT01919801|icatibant|icatibant
289201|NCT01919788|Diabetes Mellitus Type I|diabetes mellitus type i
289202|NCT01919788|Hypoglycemia|hypoglycemia
289203|NCT01919788|Counter-regulatory mechanisms|counter-regulatory mechanisms
289204|NCT01919762|Bacteremia|bacteremia
289205|NCT01919762|Sepsis|sepsis
289206|NCT01919762|Acinetobacter baumannii|acinetobacter baumannii
289207|NCT01919762|Staphylococcus aureus|staphylococcus aureus
289208|NCT01919762|Klebsiella pneumonia|klebsiella pneumonia
289209|NCT01919762|Pseudomonas aeruginosa|pseudomonas aeruginosa
289210|NCT01919762|Enterococcus faecalis|enterococcus faecalis
289211|NCT01919762|Magnetic Relaxation Detection|magnetic relaxation detection
289212|NCT01919762|Nuclear Magnetic Resonance Detection|nuclear magnetic resonance detection
289213|NCT01919762|Blood culture|blood culture
289214|NCT01919749|breast cancer metastatic|breast cancer metastatic
289215|NCT01919749|molecular profiling|molecular profiling
289216|NCT01919749|sequencing|sequencing
289217|NCT01919749|profiling|profiling
289218|NCT01919749|breast cancer|breast cancer
289219|NCT01919736|knee OA|knee oa
289220|NCT01919723|PCI|pci
289222|NCT01919723|Eptifibatide|eptifibatide
289223|NCT01919710|Neutropenia|neutropenia
289224|NCT01919710|chemotherapy|chemotherapy
289225|NCT01919710|rHSA/GCSF|rhsa/gcsf
289226|NCT01919697|Plecantaide|plecantaide
289227|NCT01919697|Chronic Idiopathic Constipation|chronic idiopathic constipation
289228|NCT01919697|Chronic|chronic
289229|NCT01919697|Idiopathic|idiopathic
289230|NCT01919697|Constipation|constipation
289231|NCT01919697|Synergy|synergy
289232|NCT01919697|CIC|cic
289233|NCT01919697|CIC study|cic study
289234|NCT01919697|CIC OLE|cic ole
289235|NCT01919697|CIC OLE study|cic ole study
289236|NCT01919697|OLE|ole
289237|NCT01919697|OLE CIC|ole cic
289238|NCT01919697|OLE CIC3|ole cic3
289239|NCT01919697|Open label|open label
289240|NCT01919697|Open label study|open label study
289241|NCT01919697|Long term|long term
289242|NCT01919697|Long term study|long term study
289243|NCT01919697|Extension|extension
289244|NCT01919697|Extension study|extension study
289245|NCT01919684|Glucagon receptor antagonist|glucagon receptor antagonist
289246|NCT01919671|Ischemic Stroke|ischemic stroke
289247|NCT01919671|Tongxinluo capsule|tongxinluo capsule
289248|NCT01919658|nerve blocks in Anterior cruciate ligament surgery|nerve blocks in anterior cruciate ligament surgery
289249|NCT01919645|Rheumatoid Arthritis|rheumatoid arthritis
289250|NCT01919645|Sleep Disorders|sleep disorders
289251|NCT01919645|Polysomnography|polysomnography
289252|NCT01919645|Sleep Stages|sleep stages
289253|NCT01919645|Physical Exercise|physical exercise
289254|NCT01919632|lifestyle|lifestyle
289255|NCT01919632|physical activity|physical activity
289256|NCT01919632|endothelial function|endothelial function
289257|NCT01919632|cardiovascular|cardiovascular
289258|NCT01919632|occupational|occupational
289259|NCT01919632|prevention|prevention
289260|NCT01919619|Blood And Marrow Transplantation|blood and marrow transplantation
289261|NCT01919619|Leukemia|leukemia
289262|NCT01919619|Lymphoma|lymphoma
289263|NCT01919619|Allogeneic stem cell transplant|allogeneic stem cell transplant
289264|NCT01919619|Autologous stem cell transplant|autologous stem cell transplant
289265|NCT01919619|SCT|sct
289266|NCT01919619|Lenalidomide CC-5013|lenalidomide cc-5013
289267|NCT01919619|Revlimid|revlimid
289268|NCT01919619|Ipilimumab|ipilimumab
289269|NCT01919619|Yervoy|yervoy
289270|NCT01919619|BMS-734016|bms-734016
289271|NCT01919619|MDX010|mdx010
289272|NCT01919606|hysterectomy|hysterectomy
289273|NCT01919606|analgesia|analgesia
289274|NCT01919593|Blood culture|blood culture
289275|NCT01919593|Contamination|contamination
289276|NCT01919593|Chlorhexidine gluconate|chlorhexidine gluconate
289277|NCT01919593|Povidone iodine|povidone iodine
289278|NCT01919580|Gα12|gα12
289279|NCT01919580|Oral cancer|oral cancer
289280|NCT01919567|SOX-9|sox-9
289281|NCT01919567|Oral cancer|oral cancer
289282|NCT01919567|arecoline|arecoline
289283|NCT01919554|House Dust Mite Allergic Rhinitis|house dust mite allergic rhinitis
289284|NCT01919554|Phase I|phase i
289285|NCT01919554|House Dust Mite Allergen Extract|house dust mite allergen extract
289286|NCT01919541|Colorectal Surgery|colorectal surgery
289287|NCT01919528|ultrasonography|ultrasonography
289288|NCT01919528|catheterization|catheterization
289289|NCT01919528|central line|central line
289290|NCT01919528|mechanical ventilation|mechanical ventilation
289291|NCT01919528|intensive care|intensive care
289292|NCT01919528|axillary vein|axillary vein
289293|NCT01919515|pediatric|pediatric
289294|NCT01919515|primary molars|primary molars
289295|NCT01919515|stainless steel crowns|stainless steel crowns
289296|NCT01919489|Incretins|incretins
289297|NCT01919489|Liraglutide|liraglutide
289298|NCT01919489|Glargine|glargine
289299|NCT01919489|Randomized controlled trial|randomized controlled trial
289300|NCT01919489|basal insulin|basal insulin
289301|NCT01919489|hospital discharge|hospital discharge
289302|NCT01919489|inpatient diabetes|inpatient diabetes
289303|NCT01919476|Postprandial|postprandial
289304|NCT01919476|Insulin resistance|insulin resistance
289305|NCT01919476|Lipids|lipids
289306|NCT01919476|Satiety|satiety
289307|NCT01919476|Almonds|almonds
289308|NCT01919463|Colonoscopy|colonoscopy
289309|NCT01919463|Lower Gastrointestinal Tract|lower gastrointestinal tract
289310|NCT01919463|Magnetic Endoscopic Imaging|magnetic endoscopic imaging
289311|NCT01919463|Abdominal Compression|abdominal compression
289313|NCT01919450|Lexiscan|lexiscan
289314|NCT01919450|Regadenoson|regadenoson
289315|NCT01919450|Rubidium|rubidium
289316|NCT01919450|Blood Flow Reserve|blood flow reserve
289317|NCT01919450|Myocardial Perfusion|myocardial perfusion
289318|NCT01919450|Quantitated Myocardial Perfusion|quantitated myocardial perfusion
289319|NCT01919411|Chronic rhinosinusitis|chronic rhinosinusitis
289320|NCT01919411|Sinus surgery|sinus surgery
289321|NCT01919411|Antibiotics|antibiotics
289322|NCT01919385|Type 1 diabetes|type 1 diabetes
289323|NCT01919385|Insulin Pump|insulin pump
289324|NCT01919359|ablative laser|ablative laser
289325|NCT01919359|soft tissue filler|soft tissue filler
289326|NCT01919346|Kidney Transplantation|kidney transplantation
289814|NCT01917240|Sequential|sequential
289327|NCT01919346|Delayed Graft Function|delayed graft function
289328|NCT01919320|SynCardia|syncardia
289329|NCT01919320|Total Artificial Heart|total artificial heart
289330|NCT01919320|TAH-t|tah-t
289331|NCT01919307|Seizures|seizures
289332|NCT01919307|Convulsions|convulsions
289333|NCT01919307|Anticonvulsants|anticonvulsants
289334|NCT01919307|Epilepsy|epilepsy
289335|NCT01919307|Neurologic|neurologic
289336|NCT01919294|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
289337|NCT01919294|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
289338|NCT01919294|hypogonadism|hypogonadism
289339|NCT01919294|testosterone replacement therapy|testosterone replacement therapy
289340|NCT01919281|exercise|exercise
289341|NCT01919281|resistance training|resistance training
289342|NCT01919281|insulin resistance|insulin resistance
289343|NCT01919281|high intensity interval training|high intensity interval training
289344|NCT01919268|Pilates-based exercises|pilates-based exercises
289345|NCT01919268|Electrotherapy|electrotherapy
289346|NCT01919268|Interferencial current|interferencial current
289347|NCT01919255|Colonoscopy|colonoscopy
289348|NCT01919255|Bowel preparation|bowel preparation
289349|NCT01919255|Picolight|picolight
289350|NCT01919255|Clicolon|clicolon
289351|NCT01919255|Coolprep|coolprep
289352|NCT01919229|HR-positive|hr-positive
289353|NCT01919229|HER2-negative|her2-negative
289354|NCT01919229|Breast cancer|breast cancer
289355|NCT01919229|LEE011|lee011
289356|NCT01919229|Letrozole|letrozole
289357|NCT01919229|CDK|cdk
289358|NCT01919229|CDK4|cdk4
289359|NCT01919229|CDK6|cdk6
289360|NCT01919229|CDK4/6|cdk4/6
289361|NCT01919229|Pharmacodynamics|pharmacodynamics
289362|NCT01919229|Pre-surgical|pre-surgical
289363|NCT01919229|Postmenopausal|postmenopausal
289364|NCT01919177|Heart Failure|heart failure
289365|NCT01919177|Arterial hemodynamics|arterial hemodynamics
289366|NCT01919177|Exercise capacity|exercise capacity
289367|NCT01919177|Mitochondrial oxidative capacity|mitochondrial oxidative capacity
289368|NCT01919164|Osteoarthritis of knee|osteoarthritis of knee
289369|NCT01919164|AS902330|as902330
289370|NCT01919164|Recombinant Human Fibroblast Growth Factor-18 (rhFGF-18)|recombinant human fibroblast growth factor-18 (rhfgf-18)
289371|NCT01919164|Sprifermin|sprifermin
289372|NCT01919164|Placebo|placebo
289373|NCT01919151|survival|survival
289374|NCT01919125|Chronic hepatitis C|chronic hepatitis c
289375|NCT01919125|Hepatitis C virus|hepatitis c virus
289376|NCT01919125|HCV|hcv
289377|NCT01919112|Brain stimulation|brain stimulation
289378|NCT01919099|Transplantation Costs|transplantation costs
289379|NCT01919099|Risk Factors|risk factors
289380|NCT01919099|Transplant Infections|transplant infections
289381|NCT01919086|Bortezomib|bortezomib
289382|NCT01919086|Dexamethasone|dexamethasone
289383|NCT01919086|Lenalidomide|lenalidomide
289384|NCT01919086|13-064|13-064
289385|NCT01919073|Attention Deficit, ADD, ADHD, ODD, Oppositional Behavior, Disruptive Behavior, Behavior Modification, Parent Management Training, Pre-School|attention deficit, add, adhd, odd, oppositional behavior, disruptive behavior, behavior modification, parent management training, pre-school
289386|NCT01919047|overactive bladder|overactive bladder
289387|NCT01919047|mirabegron|mirabegron
289388|NCT01919047|occurrence of adverse events|occurrence of adverse events
289389|NCT01919047|Overactive Bladder Symptom Score|overactive bladder symptom score
289390|NCT01919034|Interleukin-20, Thrombomodulin, Huntington disease, patient control analgesic|interleukin-20, thrombomodulin, huntington disease, patient control analgesic
289391|NCT01919008|FK949E|fk949e
289392|NCT01919008|Pharmacokinetics|pharmacokinetics
289393|NCT01919008|Major Depressive Disorder|major depressive disorder
289394|NCT01918995|CVT3146|cvt3146
289395|NCT01918995|Regadenoson|regadenoson
289396|NCT01918982|Aortic aneurysm|aortic aneurysm
289397|NCT01918982|circulating endothelial progenitor cells|circulating endothelial progenitor cells
289398|NCT01918969|Endothelial progenitor cells|endothelial progenitor cells
289399|NCT01918969|Healthy blood donors|healthy blood donors
289400|NCT01918956|immunotherapy|immunotherapy
289401|NCT01918956|birch pollen|birch pollen
289402|NCT01918956|seasonal allergy|seasonal allergy
289403|NCT01918956|up-dosing|up-dosing
289404|NCT01918943|Spine|spine
289405|NCT01918943|Aspen device|aspen device
289406|NCT01918943|PLIF|plif
289407|NCT01918943|Low back pain|low back pain
289408|NCT01918930|Melanoma|melanoma
289409|NCT01918930|Accessible tumors|accessible tumors
289410|NCT01918930|B7-H3 positive tumors|b7-h3 positive tumors
289411|NCT01918917|Arthroscopic knee surgery|arthroscopic knee surgery
289412|NCT01918917|Dexmedetomidine|dexmedetomidine
289413|NCT01918917|Analgesia|analgesia
289414|NCT01918904|calcinosis|calcinosis
289415|NCT01918904|sodium thiosulfate|sodium thiosulfate
289416|NCT01918904|topical treatment|topical treatment
289417|NCT01918904|connective tissue disease|connective tissue disease
289418|NCT01918891|stroke|stroke
289419|NCT01918891|transient ischemic attack|transient ischemic attack
289420|NCT01918891|High blood pressure|high blood pressure
289421|NCT01918891|Hypertension|hypertension
289422|NCT01918878|age-related macular degeneration|age-related macular degeneration
289423|NCT01918878|intravitreal injections|intravitreal injections
289424|NCT01918878|Aflibercept|aflibercept
289425|NCT01918878|EYLEA|eylea
289426|NCT01918865|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
289427|NCT01918865|T2DM|t2dm
289428|NCT01918852|Hand-foot syndrome|hand-foot syndrome
289429|NCT01918852|Toxicity|toxicity
289430|NCT01918852|Fluoropyrimidine|fluoropyrimidine
289431|NCT01918852|Capecitabine|capecitabine
289432|NCT01918852|Teysuno|teysuno
289433|NCT01918852|S1|s1
289434|NCT01918839|Investigational Device (VINCI Plus)|investigational device (vinci plus)
289435|NCT01918839|Correction of nasolabial fold|correction of nasolabial fold
289436|NCT01918839|Wrinkle improvement|wrinkle improvement
289437|NCT01918839|Wrinkle correction|wrinkle correction
289438|NCT01918800|fatigue|fatigue
289439|NCT01918800|quality of life|quality of life
289440|NCT01918800|rehabilitation|rehabilitation
289441|NCT01918800|self management|self management
289442|NCT01918800|energy effectiveness|energy effectiveness
289443|NCT01918774|Unemployment|unemployment
289444|NCT01918774|Cognitive Behavioral Therapy|cognitive behavioral therapy
289445|NCT01918774|Mental Disorders|mental disorders
289446|NCT01918761|NSCLC|nsclc
289447|NCT01918761|Stage IV|stage iv
289448|NCT01918761|Pemetrexed|pemetrexed
289449|NCT01918761|Dacomitinib|dacomitinib
289450|NCT01918735|Safety|safety
289451|NCT01918735|Tolerability|tolerability
289452|NCT01918735|Assessment of potential adverse events|assessment of potential adverse events
289453|NCT01918735|Assessment of potential laboratory abnormalities|assessment of potential laboratory abnormalities
289454|NCT01918722|Activating blood stagnation and expelling blood stasis|activating blood stagnation and expelling blood stasis
289455|NCT01918722|Hematoma enlargement|hematoma enlargement
289456|NCT01918722|herbal medicine|herbal medicine
289457|NCT01918722|traditional chinese medicine|traditional chinese medicine
289458|NCT01918722|random clinical trial|random clinical trial
289459|NCT01918696|suicide|suicide
289460|NCT01918696|anger|anger
289461|NCT01918696|interpretation modification|interpretation modification
289462|NCT01918696|computerized treatment|computerized treatment
289463|NCT01918670|atrial fibrillation; catheter ablation; relapse; stroke; death|atrial fibrillation; catheter ablation; relapse; stroke; death
289464|NCT01918657|Interventional|interventional
289465|NCT01918657|Randomized|randomized
289466|NCT01918657|Double blind|double blind
289467|NCT01918657|Placebo controlled|placebo controlled
289468|NCT01918657|Pediatric|pediatric
289469|NCT01918618|levosimendan|levosimendan
289470|NCT01918618|renal effects|renal effects
289471|NCT01918618|cardiac surgery|cardiac surgery
289472|NCT01918618|left heart insufficiency|left heart insufficiency
289473|NCT01918605|prostate cancer|prostate cancer
289474|NCT01918605|brachytherapy|brachytherapy
289475|NCT01918605|spacer|spacer
289476|NCT01918605|side effect|side effect
289477|NCT01918592|bladder cancer|bladder cancer
289478|NCT01918592|neoadjuvant chemotherapy|neoadjuvant chemotherapy
289479|NCT01918592|radical cystectomy|radical cystectomy
289480|NCT01918592|lymphadenectomy|lymphadenectomy
289481|NCT01918592|biomarker|biomarker
289482|NCT01918553|AMD|amd
289483|NCT01918553|epidemiology|epidemiology
289484|NCT01918553|risk factors|risk factors
289485|NCT01918553|cohort study|cohort study
289486|NCT01918540|Radiostereometry|radiostereometry
289487|NCT01918540|Total Hip Arthroplasty|total hip arthroplasty
289488|NCT01918540|Stem design|stem design
289489|NCT01918527|Locally advanced colon cancer|locally advanced colon cancer
289490|NCT01918527|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
289491|NCT01918514|Magnesium sulfate|magnesium sulfate
289492|NCT01918514|epidural|epidural
289493|NCT01918514|interscalene|interscalene
289494|NCT01918514|NMDA receptor|nmda receptor
289495|NCT01918501|multiple sclerosis|multiple sclerosis
289496|NCT01918501|Remyelination|remyelination
289497|NCT01918501|Mitochondria|mitochondria
289498|NCT01918501|fatty acids|fatty acids
289499|NCT01918488|Diabetic Nephropathies|diabetic nephropathies
289500|NCT01918488|Hypertension|hypertension
289501|NCT01918488|Proteinuria|proteinuria
289502|NCT01918488|Albuminuria|albuminuria
289503|NCT01918488|Epithelial Sodium Channels|epithelial sodium channels
289504|NCT01918488|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers
289505|NCT01918488|Amiloride|amiloride
289506|NCT01918475|randomized controlled trial|randomized controlled trial
289507|NCT01918475|placebo controlled trial|placebo controlled trial
289508|NCT01918475|cross over trial|cross over trial
289509|NCT01918462|Alcoholic hepatitis|alcoholic hepatitis
289510|NCT01918462|IL-22|il-22
289511|NCT01918462|Kupffer cells|kupffer cells
289512|NCT01918449|OSA|osa
289513|NCT01918449|CPAP treatment|cpap treatment
289514|NCT01918449|primary care|primary care
289515|NCT01918449|efficacy|efficacy
289516|NCT01918436|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
289517|NCT01918436|Neurocognitive training for preschool children with ADHD|neurocognitive training for preschool children with adhd
289518|NCT01918436|Play intervention for children with ADHD|play intervention for children with adhd
289519|NCT01918423|Childhood adiposity|childhood adiposity
289520|NCT01918423|Metabolic risk factors|metabolic risk factors
289521|NCT01918423|Bone mineralization|bone mineralization
289522|NCT01918410|contact lens|contact lens
289523|NCT01918410|alginic|alginic
289524|NCT01918410|dry eyes|dry eyes
289525|NCT01918384|Duchenne muscular dystrophy|duchenne muscular dystrophy
289526|NCT01918384|NPC-14|npc-14
289527|NCT01918384|Arbekacin|arbekacin
289528|NCT01918384|nonsense|nonsense
289529|NCT01918384|readthrough|readthrough
289530|NCT01918345|Diabetes|diabetes
289531|NCT01918345|Diabetes Mellitus|diabetes mellitus
289532|NCT01918345|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
289533|NCT01918345|Diabetes, gestational|diabetes, gestational
289534|NCT01918345|Prevention & control|prevention & control
289535|NCT01918345|Postpartum Period|postpartum period
289536|NCT01918345|Mothers|mothers
289537|NCT01918345|Diet|diet
289538|NCT01918345|Diabetic Diet|diabetic diet
289539|NCT01918345|Exercise|exercise
289540|NCT01918345|Life Style|life style
289541|NCT01918345|Motivation|motivation
289542|NCT01918345|Health Behavior|health behavior
289543|NCT01918345|Insulin-Secreting Cells|insulin-secreting cells
289544|NCT01918345|Randomized Controlled Trial|randomized controlled trial
289545|NCT01918345|Clinical Trial|clinical trial
289546|NCT01918345|Pilot Projects|pilot projects
289547|NCT01918345|Feasibility Studies|feasibility studies
289548|NCT01918306|Triple Negative Breast Cancer|triple negative breast cancer
289549|NCT01918306|Estrogen receptor negative breast cancer|estrogen receptor negative breast cancer
289550|NCT01918306|Metastatic breast cancer|metastatic breast cancer
289551|NCT01918306|Stage IV breast cancer|stage iv breast cancer
289552|NCT01918306|HER2 negative breast cancer|her2 negative breast cancer
289553|NCT01918293|ASTHMA|asthma
289554|NCT01918293|SMARTPHONE APPLICATION|smartphone application
289555|NCT01918280|Klinefelter Syndrome|klinefelter syndrome
289556|NCT01918280|Azoospermia|azoospermia
289557|NCT01918280|Seminal analyses|seminal analyses
289558|NCT01918280|Testicular biopsy|testicular biopsy
289559|NCT01918241|Pegylation|pegylation
289560|NCT01918241|G-CSF|g-csf
289561|NCT01918241|Efficacy|efficacy
289562|NCT01918241|Satety|satety
289563|NCT01918202|Enzyme occupancy|enzyme occupancy
289564|NCT01918202|PET|pet
289565|NCT01918202|Phosphodiesterase 10 inhibitor|phosphodiesterase 10 inhibitor
289566|NCT01918189|back pain|back pain
289567|NCT01918189|low back pain|low back pain
289568|NCT01918189|chronic pain|chronic pain
289569|NCT01918189|cognitive behavior therapy|cognitive behavior therapy
289570|NCT01918189|behavior therapy|behavior therapy
289571|NCT01918176|Palbociclib|palbociclib
289572|NCT01918176|PD-0332991|pd-0332991
289573|NCT01918176|Proton Pump Inhibitor|proton pump inhibitor
289574|NCT01918176|DDI|ddi
289575|NCT01918176|Healthy Volunteers|healthy volunteers
289576|NCT01918176|Pharmacokinetics|pharmacokinetics
289577|NCT01918176|Rabeprazole|rabeprazole
289578|NCT01918163|pomegranate pills, male infertility, pregnancy rate, semen analysis, ROS, oxidative stress|pomegranate pills, male infertility, pregnancy rate, semen analysis, ros, oxidative stress
289579|NCT01918124|disease free survival, overall survival|disease free survival, overall survival
289580|NCT01918111|Renal denervation, Exercise diastolic function, Atherosclerosis, New methods|renal denervation, exercise diastolic function, atherosclerosis, new methods
289581|NCT01918072|Women's Health|women's health
289582|NCT01918072|Hospitals, Veterans|hospitals, veterans
289583|NCT01918072|Education|education
289584|NCT01918072|Remote consultation|remote consultation
289585|NCT01918072|Videoconferencing|videoconferencing
289586|NCT01918059|Trauma|trauma
289587|NCT01918059|Eyelid|eyelid
289588|NCT01918059|Laceration|laceration
289589|NCT01918059|Tissue adhesive|tissue adhesive
289590|NCT01918059|suture|suture
289591|NCT01918059|cosmetic|cosmetic
289592|NCT01918059|octyl-2-cyanoacrylate|octyl-2-cyanoacrylate
289593|NCT01918046|biomarker|biomarker
289594|NCT01918046|MIOX|miox
289595|NCT01918033|Rhinitis|rhinitis
289596|NCT01918033|Allergic Rhinitis|allergic rhinitis
289597|NCT01918033|Nose Diseases|nose diseases
289598|NCT01918033|Respiratory Tract Diseases|respiratory tract diseases
289599|NCT01918033|Immune System Diseases|immune system diseases
289600|NCT01918033|Cholinergic Antagonists|cholinergic antagonists
289601|NCT01918033|Cholinergic Agents|cholinergic agents
289602|NCT01918033|Neurotransmitter Agents|neurotransmitter agents
289603|NCT01918033|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating
289604|NCT01918033|Histamine H1 Antagonists|histamine h1 antagonists
289605|NCT01918033|Histamine Antagonists|histamine antagonists
289606|NCT01918033|Histamine Agents|histamine agents
289607|NCT01918020|Fruit|fruit
289608|NCT01918020|Vegetables|vegetables
289609|NCT01918020|Motor Activity|motor activity
289610|NCT01918007|Apnea|apnea
289611|NCT01918007|Sleep Apnea Syndromes|sleep apnea syndromes
289612|NCT01918007|Snoring|snoring
289613|NCT01918007|Sleep Apnea, Obstructive|sleep apnea, obstructive
289614|NCT01918007|Respiration Disorders|respiration disorders
289615|NCT01918007|Respiratory Tract Diseases|respiratory tract diseases
289616|NCT01918007|Signs and Symptoms, Respiratory Signs and Symptoms|signs and symptoms, respiratory signs and symptoms
289617|NCT01918007|Sleep Disorders, Intrinsic|sleep disorders, intrinsic
289618|NCT01918007|Dyssomnias|dyssomnias
289619|NCT01918007|Sleep Disorders|sleep disorders
289620|NCT01918007|Respiratory Sounds|respiratory sounds
289621|NCT01917981|Intermittent cardiac monitoring|intermittent cardiac monitoring
289622|NCT01917981|Implantable device|implantable device
289623|NCT01917968|POP|pop
289624|NCT01917968|Transvaginal|transvaginal
289625|NCT01917968|Native Tissue Repair|native tissue repair
289626|NCT01917968|Repair Augmented with Mesh|repair augmented with mesh
289627|NCT01917968|Pelvic Organ Prolapse|pelvic organ prolapse
289628|NCT01917955|MRI|mri
289629|NCT01917942|Radiotherapy|radiotherapy
289630|NCT01917942|Humidification|humidification
289631|NCT01917942|Mucositis|mucositis
289632|NCT01917929|[E04.555.110.110.110]|[e04.555.110.110.110]
289633|NCT01917903|walking|walking
289634|NCT01917903|Parkinson's disease|parkinson's disease
289635|NCT01917903|traumatic brain injury|traumatic brain injury
289636|NCT01917903|multiple sclerosis|multiple sclerosis
289637|NCT01917903|physical therapy|physical therapy
289638|NCT01917903|falls|falls
289639|NCT01917903|memory|memory
289640|NCT01917903|attention|attention
289641|NCT01917903|multitasking|multitasking
289642|NCT01917903|exercise|exercise
289643|NCT01917890|curcumin|curcumin
289644|NCT01917890|radioprotective|radioprotective
289645|NCT01917890|radiosensitizer|radiosensitizer
289646|NCT01917877|Becacizumab|becacizumab
289647|NCT01917877|pulmonary fibrosis|pulmonary fibrosis
289648|NCT01917877|irradiation|irradiation
289649|NCT01917877|chemotherapy|chemotherapy
289650|NCT01917864|Autism|autism
289651|NCT01917864|Autism Spectrum Disorders|autism spectrum disorders
289652|NCT01917864|Prosody|prosody
289653|NCT01917864|Speech treatment|speech treatment
289654|NCT01917851|Accurate|accurate
289655|NCT01917851|Hb|hb
289656|NCT01917851|noninvasive measurement|noninvasive measurement
289657|NCT01917838|Mental Health Services|mental health services
289658|NCT01917825|radicular pain|radicular pain
289659|NCT01917812|physical activity|physical activity
289660|NCT01917812|exercise|exercise
289661|NCT01917812|mHealth|mhealth
289662|NCT01917812|smartphone|smartphone
289663|NCT01917812|activity tracker|activity tracker
289664|NCT01917812|pedometer|pedometer
289665|NCT01917812|text messaging|text messaging
289666|NCT01917812|SMS|sms
289667|NCT01917799|Aspirin|aspirin
289668|NCT01917799|Heparin|heparin
289669|NCT01917799|pregnancy|pregnancy
289670|NCT01917799|miscarriage|miscarriage
289671|NCT01917760|Gamma-aminobutyric acid|gamma-aminobutyric acid
289672|NCT01917760|Pharmacokinetics|pharmacokinetics
289673|NCT01917760|Pharmacodynamics|pharmacodynamics
289674|NCT01917760|Insulin|insulin
289675|NCT01917760|C-peptide|c-peptide
289676|NCT01917760|Glucagon|glucagon
289677|NCT01917747|Infant hearing screening|infant hearing screening
289678|NCT01917747|Patient Navigator|patient navigator
289679|NCT01917734|severe acute malnutrition|severe acute malnutrition
289680|NCT01917734|severe wasting|severe wasting
289681|NCT01917734|facility-based care|facility-based care
289682|NCT01917734|community-based care|community-based care
289683|NCT01917734|Madhya Pradesh|madhya pradesh
289684|NCT01917734|India|india
289685|NCT01917721|Kawasaki disease|kawasaki disease
289686|NCT01917721|doxycycline|doxycycline
289687|NCT01917721|coronary artery aneurysm|coronary artery aneurysm
289688|NCT01917708|non malignant conditions|non malignant conditions
289689|NCT01917708|blood and marrow transplant|blood and marrow transplant
289690|NCT01917695|Bulky cervical cancers|bulky cervical cancers
289691|NCT01917695|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
289692|NCT01917695|Neoadjuvant Chemoradiotherapy|neoadjuvant chemoradiotherapy
289693|NCT01917682|robotic-assisted PCI|robotic-assisted pci
289694|NCT01917682|coronary intervention|coronary intervention
289695|NCT01917682|CorPath PRECISION Registry|corpath precision registry
289696|NCT01917682|PCI|pci
289697|NCT01917682|angioplasty|angioplasty
289698|NCT01917643|COPD, Comparative Effectiveness, Symbicort|copd, comparative effectiveness, symbicort
289699|NCT01917630|Celiac disease|celiac disease
289700|NCT01917630|Gluten-free diet|gluten-free diet
289701|NCT01917630|Coeliac disease|coeliac disease
289702|NCT01917630|Celiac sprue|celiac sprue
289703|NCT01917604|open versus closed surgical technique|open versus closed surgical technique
289704|NCT01917604|impacted maxillary canine|impacted maxillary canine
289705|NCT01917604|orthodontic disimpaction|orthodontic disimpaction
289706|NCT01917591|Bandages|bandages
289707|NCT01917591|Biological Dressings|biological dressings
289708|NCT01917591|Chronic Disease|chronic disease
289709|NCT01917591|Collagen|collagen
289710|NCT01917591|Epithelium|epithelium
289711|NCT01917591|Extracellular Matrix|extracellular matrix
289712|NCT01917591|Extra Cellular Matrix|extra cellular matrix
289713|NCT01917591|Fibroblasts|fibroblasts
289714|NCT01917591|Granulation Tissue|granulation tissue
289715|NCT01917591|Leg Ulcer|leg ulcer
289716|NCT01917591|Middle Aged|middle aged
289717|NCT01917591|Prospective Studies|prospective studies
289718|NCT01917591|Soft Tissue Injuries|soft tissue injuries
289719|NCT01917591|Treatment Outcome|treatment outcome
289720|NCT01917591|Varicose Ulcer|varicose ulcer
289721|NCT01917591|Wound Healing|wound healing
289722|NCT01917591|Wounds and Injuries|wounds and injuries
289723|NCT01917591|biopsy|biopsy
289724|NCT01917591|autoimmunity|autoimmunity
289725|NCT01917578|Breast Cancer|breast cancer
289726|NCT01917578|shrinkage modes|shrinkage modes
289727|NCT01917578|three-dimensional reconstruction|three-dimensional reconstruction
289728|NCT01917578|neoadjuvant chemotherapy|neoadjuvant chemotherapy
289729|NCT01917578|Magnetic Resonance Imaging|magnetic resonance imaging
289730|NCT01917565|airway management|airway management
289731|NCT01917565|laryngoscope|laryngoscope
289732|NCT01917565|Airtraq|airtraq
289733|NCT01917565|Macintosh laryngoscope|macintosh laryngoscope
289734|NCT01917565|fiberoptic bronchoscope|fiberoptic bronchoscope
289735|NCT01917565|intubation|intubation
289736|NCT01917552|Gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, adjuvant, capecitabine, gastric cancer, stage 1b|gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, adjuvant, capecitabine, gastric cancer, stage 1b
289737|NCT01917526|Oxygen|oxygen
289738|NCT01917526|PACU|pacu
289739|NCT01917526|Hypoxemia|hypoxemia
289740|NCT01917513|Adenoma|adenoma
289741|NCT01917513|Polyps|polyps
289742|NCT01917513|CRC|crc
289743|NCT01917513|Colonoscopy|colonoscopy
289744|NCT01917513|Detection Yield|detection yield
289745|NCT01917500|Continues non-invasive Blood pressure measurement|continues non-invasive blood pressure measurement
289746|NCT01917500|Continues non-invasive Cardiac Output measurement|continues non-invasive cardiac output measurement
289747|NCT01917474|low-lipid diet|low-lipid diet
289748|NCT01917474|normal lipid intake|normal lipid intake
289749|NCT01917474|saturated fats reduction|saturated fats reduction
289750|NCT01917474|headache attacks|headache attacks
289751|NCT01917448|postoperative pain|postoperative pain
289752|NCT01917448|spinal morphine|spinal morphine
289753|NCT01917448|video-assisted thoracoscopic surgery|video-assisted thoracoscopic surgery
289754|NCT01917435|fiberoptic bronchoscopy,|fiberoptic bronchoscopy,
289755|NCT01917435|Video-stylet,|video-stylet,
289756|NCT01917435|Nasotracheal Intubation|nasotracheal intubation
289757|NCT01917409|Conventional Laryngoscopy ,|conventional laryngoscopy ,
289758|NCT01917409|Video-stylet ,|video-stylet ,
289759|NCT01917409|Nasotracheal Intubation|nasotracheal intubation
289760|NCT01917396|caesarean, bowel, gass|caesarean, bowel, gass
289761|NCT01917383|glaucoma|glaucoma
289762|NCT01917383|primary open angle glaucoma|primary open angle glaucoma
289763|NCT01917383|ocular hypertension|ocular hypertension
289764|NCT01917383|adenosine agonist|adenosine agonist
289765|NCT01917383|eye drop|eye drop
289766|NCT01917383|trabodenoson|trabodenoson
289767|NCT01917383|trabecular meshwork|trabecular meshwork
289768|NCT01917370|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
289769|NCT01917370|icc|icc
289770|NCT01917370|vegf signal pathway|vegf signal pathway
289771|NCT01917357|Vaccination|vaccination
289772|NCT01917357|Immunisation|immunisation
289773|NCT01917357|Virus|virus
289774|NCT01917357|Diphtheria|diphtheria
289775|NCT01917357|Pertussis|pertussis
289776|NCT01917357|Tetanus|tetanus
289777|NCT01917357|Hepatitis B|hepatitis b
289778|NCT01917357|Haemophilus Influenzae|haemophilus influenzae
289779|NCT01917357|Immunity|immunity
289780|NCT01917344|Phenylketonuria|phenylketonuria
289781|NCT01917344|MRI|mri
289782|NCT01917344|Neuropsychological functioning|neuropsychological functioning
289783|NCT01917344|Neurological functioning|neurological functioning
289784|NCT01917344|EEG|eeg
289785|NCT01917331|spirometry|spirometry
289786|NCT01917331|severe COPD|severe copd
289787|NCT01917331|lung disease|lung disease
289788|NCT01917331|fixed combination|fixed combination
289789|NCT01917318|Post traumatic stress disorder|post traumatic stress disorder
289790|NCT01917318|Treatment of post traumatic stress disorder|treatment of post traumatic stress disorder
289791|NCT01917318|Symptoms of arousal in post traumatic stress disorder|symptoms of arousal in post traumatic stress disorder
289792|NCT01917318|Iloperidone in post traumatic stress disorder|iloperidone in post traumatic stress disorder
289793|NCT01917305|Bacteria|bacteria
289794|NCT01917305|bone level|bone level
289795|NCT01917305|bone loss|bone loss
289796|NCT01917305|dental implants|dental implants
289797|NCT01917305|implant design|implant design
289798|NCT01917305|platform-shifting|platform-shifting
289799|NCT01917305|platform-matching|platform-matching
289800|NCT01917292|Periodontitis|periodontitis
289801|NCT01917292|Prehypertension|prehypertension
289802|NCT01917292|Periodontal Intervention|periodontal intervention
289803|NCT01917279|Metastatic Breast Cancer|metastatic breast cancer
289804|NCT01917279|Antineoplastic Agents|antineoplastic agents
289805|NCT01917279|Therapeutic Uses|therapeutic uses
289806|NCT01917279|Antimetabolites|antimetabolites
289807|NCT01917279|Tubulin Modulators|tubulin modulators
289808|NCT01917279|Maintenance chemotherapy|maintenance chemotherapy
289809|NCT01917279|Metronomic chemotherapy|metronomic chemotherapy
289810|NCT01917279|Capecitabine|capecitabine
289811|NCT01917279|Docetaxel|docetaxel
289812|NCT01917253|infiltration, phlebitis, occlusion, thrombosis|infiltration, phlebitis, occlusion, thrombosis
289813|NCT01917240|Monophasic|monophasic
289815|NCT01917240|Media|media
289816|NCT01917201|Coronary Artery Disease|coronary artery disease
289817|NCT01917201|Drug Eluting Stents|drug eluting stents
289818|NCT01917201|Intravascular Ultrasound|intravascular ultrasound
289819|NCT01917201|Optical Coherence Tomography|optical coherence tomography
289820|NCT01917201|Intravascular Visualization|intravascular visualization
289821|NCT01917175|HIV|hiv
289822|NCT01917175|Cohort|cohort
289823|NCT01917175|Early HIV infection|early hiv infection
289824|NCT01917175|Côte d'Ivoire|côte d'ivoire
289825|NCT01917175|Disease progression|disease progression
289826|NCT01917162|contact lenses|contact lenses
289827|NCT01917162|daily disposable contact lenses|daily disposable contact lenses
289828|NCT01917162|silicone hydrogel|silicone hydrogel
289829|NCT01917162|contact lens comfort|contact lens comfort
289830|NCT01917162|near-sighted|near-sighted
289831|NCT01917149|Dilated cardiomyopathy|dilated cardiomyopathy
289832|NCT01917149|High dose ACEI/ARB|high dose acei/arb
289833|NCT01917136|pulmonary hypertension|pulmonary hypertension
289834|NCT01917136|right ventricular function|right ventricular function
289835|NCT01917136|11C acetate|11c acetate
289836|NCT01917136|FDG|fdg
289837|NCT01917136|ranolazine|ranolazine
289838|NCT01917123|L-Citrulline malate,Coronary Heart Disease, Brachial Index|l-citrulline malate,coronary heart disease, brachial index
289839|NCT01917084|Passive range of motion|passive range of motion
289840|NCT01917084|Single ventricle|single ventricle
289841|NCT01917084|Infants|infants
289842|NCT01917084|Congenital heart disease|congenital heart disease
289843|NCT01917058|Alopecia Areata|alopecia areata
289844|NCT01917058|Abatacept|abatacept
289845|NCT01917045|sufentanil|sufentanil
289846|NCT01917045|morphine|morphine
289847|NCT01917045|postoperative pain control|postoperative pain control
289848|NCT01917045|body fat percentage|body fat percentage
289849|NCT01917045|gynecology laparoscopic surgery|gynecology laparoscopic surgery
289850|NCT01917045|lipid solubility|lipid solubility
289851|NCT01917032|Trace Elements|trace elements
289852|NCT01917032|Preschool|preschool
289853|NCT01917032|Malnutrition|malnutrition
289854|NCT01917032|Fortified Food|fortified food
289855|NCT01917019|Japan|japan
289856|NCT01916980|Dermatitis|dermatitis
289857|NCT01916980|Dermatitis, Atopic|dermatitis, atopic
289858|NCT01916980|Skin Diseases|skin diseases
289859|NCT01916980|Skin Diseases, Genetic|skin diseases, genetic
289860|NCT01916980|Genetic Diseases, Inborn|genetic diseases, inborn
289861|NCT01916980|Skin Diseases, Eczematous|skin diseases, eczematous
289862|NCT01916980|Hypersensitivity, Immediate|hypersensitivity, immediate
289863|NCT01916980|Hypersensitivity|hypersensitivity
289864|NCT01916980|Immune System Diseases|immune system diseases
289865|NCT01916967|Urticaria|urticaria
289866|NCT01916967|Skin Diseases, Vascular|skin diseases, vascular
289867|NCT01916967|Skin Diseases|skin diseases
289868|NCT01916967|Hypersensitivity, Immediate|hypersensitivity, immediate
289869|NCT01916967|Hypersensitivity|hypersensitivity
289870|NCT01916967|Immune System Diseases|immune system diseases
289871|NCT01916967|Cholinergic Antagonists|cholinergic antagonists
289872|NCT01916967|Cholinergic Agents|cholinergic agents
289873|NCT01916967|Neurotransmitter Agents|neurotransmitter agents
289874|NCT01916967|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating
289875|NCT01916967|Histamine H1 Antagonists|histamine h1 antagonists
289876|NCT01916967|Histamine Antagonists|histamine antagonists
289877|NCT01916967|Histamine Agents|histamine agents
289878|NCT01916954|Malaria|malaria
289879|NCT01916954|Pregnancy|pregnancy
289880|NCT01916954|Plasmodium falciparum|plasmodium falciparum
289881|NCT01916928|Circulating cell free fetal DNA|circulating cell free fetal dna
289882|NCT01916928|Intrauterine fetal demise|intrauterine fetal demise
289883|NCT01916928|Miscarriage|miscarriage
289884|NCT01916902|Optical Coherence Tomography|optical coherence tomography
289885|NCT01916902|Ticagrelor|ticagrelor
289886|NCT01916889|Delirium|delirium
289887|NCT01916876|medical in-patients|medical in-patients
289888|NCT01916876|follow-up care|follow-up care
289889|NCT01916876|developing country|developing country
289890|NCT01916837|Breast cancer|breast cancer
289891|NCT01916837|Feasibility|feasibility
289892|NCT01916837|Genomic grade index|genomic grade index
289893|NCT01916824|depression|depression
289894|NCT01916824|melancholia|melancholia
289895|NCT01916824|treatment|treatment
289896|NCT01916811|Low Back Pain|low back pain
289897|NCT01916811|Load quantitative MRI|load quantitative mri
289898|NCT01916798|Infertility|infertility
289899|NCT01916798|intralipid|intralipid
289900|NCT01916798|invitro fertilization|invitro fertilization
289901|NCT01916798|repeated implantation failure|repeated implantation failure
289902|NCT01916798|repeated miscarriage|repeated miscarriage
289903|NCT01916772|cherubism|cherubism
289904|NCT01916772|bone tumors|bone tumors
289905|NCT01916759|immunization|immunization
289906|NCT01916746|Caesarean Scar Pregnancy|caesarean scar pregnancy
289907|NCT01916746|Transvaginal Resection|transvaginal resection
289908|NCT01916746|treatment|treatment
289909|NCT01916707|trauma|trauma
289910|NCT01916707|enoxaparin|enoxaparin
289911|NCT01916707|weight based|weight based
289912|NCT01916707|prophylaxis|prophylaxis
289913|NCT01916694|Gestational diabetes mellitus|gestational diabetes mellitus
289914|NCT01916694|m Health|m health
289915|NCT01916694|Smartphone|smartphone
289916|NCT01916694|Blood glucose monitoring|blood glucose monitoring
289917|NCT01916681|Induction|induction
289918|NCT01916681|Labor|labor
289919|NCT01916681|Cervical foley|cervical foley
289920|NCT01916681|Misoprostol|misoprostol
289921|NCT01916681|Pitocin|pitocin
289922|NCT01916681|Oxytocin|oxytocin
289923|NCT01916681|Cytotec|cytotec
289924|NCT01916681|Delivery|delivery
289925|NCT01916681|IOL|iol
289926|NCT01916655|Obstructive Sleep Apnea|obstructive sleep apnea
289927|NCT01916655|Adherence|adherence
289928|NCT01916655|Chronic Disease|chronic disease
289929|NCT01916655|Telemedicine|telemedicine
289930|NCT01916655|Continuous Positive Airway Pressure|continuous positive airway pressure
289931|NCT01916655|Mobile Health|mobile health
289932|NCT01916642|iv lidocaine|iv lidocaine
289933|NCT01916642|inducing dose|inducing dose
289934|NCT01916642|etomidate|etomidate
289935|NCT01916642|dose response|dose response
289936|NCT01916616|paradoxical vocal fold motion|paradoxical vocal fold motion
289937|NCT01916616|cognitive-behavioral therapy|cognitive-behavioral therapy
289938|NCT01916590|Post-operative pain|post-operative pain
289939|NCT01916590|Anterior Cruciate Ligament repair|anterior cruciate ligament repair
289940|NCT01916577|Stem Cell Mobilization|stem cell mobilization
289941|NCT01916577|Stem Cells|stem cells
289942|NCT01916577|Transplantation|transplantation
289943|NCT01916577|Autologous|autologous
289944|NCT01916564|Bowel preparation|bowel preparation
289945|NCT01916564|Morning colonoscopy|morning colonoscopy
289946|NCT01916564|Split-dose|split-dose
289947|NCT01916564|Same-morning whole-dose|same-morning whole-dose
289948|NCT01916564|Reduced-volume PEG-ELS|reduced-volume peg-els
289949|NCT01916538|anorexia nervosa|anorexia nervosa
289950|NCT01916538|genetics|genetics
289951|NCT01916538|gene|gene
289952|NCT01916538|eating disorder|eating disorder
289953|NCT01916525|Acute coronary syndrome|acute coronary syndrome
289954|NCT01916525|Cost-effectiveness|cost-effectiveness
289955|NCT01916525|Cardiac rehabilitation|cardiac rehabilitation
289956|NCT01916525|Exercise|exercise
289957|NCT01916525|Physical activity|physical activity
289958|NCT01916525|Home monitoring|home monitoring
289959|NCT01916512|CETP, HDL, LDL, apoB-100, apoB-48, remnants|cetp, hdl, ldl, apob-100, apob-48, remnants
289960|NCT01916499|Child, adolescent|child, adolescent
289961|NCT01916499|Coronary artery disease|coronary artery disease
289962|NCT01916499|Magnetic resonance imaging|magnetic resonance imaging
289963|NCT01916473|Epidural analgesia|epidural analgesia
289964|NCT01916473|continuous wound infusion|continuous wound infusion
289965|NCT01916473|ropivacaine|ropivacaine
289966|NCT01916473|total abdominal hysterectomy|total abdominal hysterectomy
289967|NCT01916460|Gastroparesis|gastroparesis
289968|NCT01916460|Endoscopic ultrasound|endoscopic ultrasound
289969|NCT01916460|Interstitial cell of Cajal|interstitial cell of cajal
289970|NCT01916447|Angiogenesis Inhibitor|angiogenesis inhibitor
289971|NCT01916447|Monoclonal Antibody|monoclonal antibody
289972|NCT01916447|Vascular Endothelial Growth Factor A (VEGF-A)|vascular endothelial growth factor a (vegf-a)
289973|NCT01916434|Farmed fish|farmed fish
289974|NCT01916434|Dietary intervention|dietary intervention
289975|NCT01916434|Long-term intervention|long-term intervention
289976|NCT01916434|Omega-3 index|omega-3 index
289977|NCT01916434|Cardiovascular risk markers|cardiovascular risk markers
289978|NCT01916434|Coagulation and endothelial activation|coagulation and endothelial activation
289979|NCT01916434|Bleeding time|bleeding time
289980|NCT01916434|Inflammation|inflammation
289981|NCT01916434|Oxidative stress|oxidative stress
289982|NCT01916434|Gut health|gut health
289983|NCT01916434|Micronutrient availability|micronutrient availability
289984|NCT01916421|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
289985|NCT01916421|lymphadenopathy|lymphadenopathy
289986|NCT01916421|Endoscopic ultrasound|endoscopic ultrasound
289987|NCT01916408|Exercise|exercise
289988|NCT01916408|Inflammation|inflammation
289989|NCT01916408|Upper Respiratory Tract Illness|upper respiratory tract illness
289990|NCT01916408|Oral Proteolytic and Hydrolytic Enzymes|oral proteolytic and hydrolytic enzymes
289991|NCT01916408|Flavinoids|flavinoids
289992|NCT01916395|Migraine|migraine
289993|NCT01916382|Alkaptonuria, nitisinone,Ochronosis, Homogentisic acid|alkaptonuria, nitisinone,ochronosis, homogentisic acid
289994|NCT01916369|Peripheral Arterial Disease|peripheral arterial disease
289995|NCT01916369|Fontaine Stage II, III or IV|fontaine stage ii, iii or iv
289996|NCT01916369|Vascular disease|vascular disease
289997|NCT01916369|Cardiovascular diseases|cardiovascular diseases
289998|NCT01916369|Neural stem cell|neural stem cell
289999|NCT01916356|Infertility|infertility
290000|NCT01916356|Education|education
290001|NCT01916356|Risk Factors|risk factors
290002|NCT01916356|Fertility knowledge|fertility knowledge
290003|NCT01916356|Fertility myths|fertility myths
290004|NCT01916343|Laparoscopy|laparoscopy
290005|NCT01916343|Surgical skills|surgical skills
290006|NCT01916343|Team training|team training
290007|NCT01916343|Obstetrics and Gynecology|obstetrics and gynecology
290008|NCT01916343|Curriculum|curriculum
290009|NCT01916304|Drug Therapy|drug therapy
290010|NCT01916252|Multiple Myeloma|multiple myeloma
290011|NCT01916252|MEL200|mel200
290012|NCT01916252|BUMEL|bumel
290013|NCT01916239|Pomegranate|pomegranate
290014|NCT01916239|Urolithins|urolithins
290015|NCT01916239|Colorectal cancer|colorectal cancer
290016|NCT01916239|Colon cancer|colon cancer
290017|NCT01916239|Metabolite|metabolite
290018|NCT01916239|Gene expression|gene expression
290019|NCT01916239|microRNA|microrna
290020|NCT01916239|Nutraceutical|nutraceutical
290021|NCT01916239|Food supplement|food supplement
290022|NCT01916239|Polyphenol|polyphenol
290023|NCT01916239|Gut microbiota|gut microbiota
290024|NCT01916226|cetirizine|cetirizine
290025|NCT01916226|seasonal allergic rhinitis|seasonal allergic rhinitis
290026|NCT01916226|Quality of Life|quality of life
290027|NCT01916226|fluticasone propionate nasal spray|fluticasone propionate nasal spray
290028|NCT01916161|Crohn's disease|crohn's disease
290029|NCT01916161|ulcerative colitis|ulcerative colitis
290030|NCT01916161|anxiety|anxiety
290031|NCT01916161|patient knowledge|patient knowledge
290032|NCT01916161|information sources|information sources
290033|NCT01916148|Hypoglycemia|hypoglycemia
290034|NCT01916148|Hyperinsulinism|hyperinsulinism
290035|NCT01916135|[18F]-SKI-249380|[18f]-ski-249380
290036|NCT01916135|PET Imaging|pet imaging
290037|NCT01916135|CT Imaging|ct imaging
290038|NCT01916135|12-182|12-182
290039|NCT01916122|Fluorestradiol (FES)|fluorestradiol (fes)
290040|NCT01916122|PET/CT scan|pet/ct scan
290041|NCT01916122|Estrogen Receptor|estrogen receptor
290042|NCT01916122|13-071|13-071
290043|NCT01916109|Gemcitabine|gemcitabine
290044|NCT01916109|Carboplatin|carboplatin
290045|NCT01916109|Panitumumab|panitumumab
290046|NCT01916109|(GCaP)|(gcap)
290047|NCT01916109|radical cystectomy|radical cystectomy
290048|NCT01916109|10-103|10-103
290049|NCT01916070|syncope|syncope
290050|NCT01916070|near syncope|near syncope
290051|NCT01916070|prognosis|prognosis
290052|NCT01916070|emergency department|emergency department
290053|NCT01916057|Positron-Emission Tomography Scan|positron-emission tomography scan
290054|NCT01916057|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
290055|NCT01916057|Magnetic Resonance Imaging|magnetic resonance imaging
290056|NCT01916057|Enzyme-Linked Immunospot Assay|enzyme-linked immunospot assay
290057|NCT01916057|Immune Reconstitution Inflammatory Syndrome|immune reconstitution inflammatory syndrome
290058|NCT01916057|Real-Time Polymerase Chain Reaction|real-time polymerase chain reaction
290059|NCT01916057|beta-1,3-D-glucan|beta-1,3-d-glucan
290060|NCT01916057|Candida spp.|candida spp.
290061|NCT01916057|Genetic Susceptibility|genetic susceptibility
290062|NCT01916057|Genotype|genotype
290063|NCT01916044|caesarean,|caesarean,
290064|NCT01916044|trial of labor,|trial of labor,
290065|NCT01916044|ultrasound|ultrasound
290066|NCT01916018|Congenital hypothyroidism|congenital hypothyroidism
290067|NCT01916018|Thyroid dysgenesis|thyroid dysgenesis
290068|NCT01916018|Genetics|genetics
290069|NCT01916018|Associated malformations|associated malformations
290070|NCT01916018|Psychomotor delay|psychomotor delay
290071|NCT01916018|Mental retardation|mental retardation
290072|NCT01915979|plasma rich in growth factors, tendinopathy, traumatology|plasma rich in growth factors, tendinopathy, traumatology
290073|NCT01915979|,rotator cuff, effectiveness, plasma rich in platelets|,rotator cuff, effectiveness, plasma rich in platelets
290074|NCT01915953|Accurte Hb noninvasive measurement|accurte hb noninvasive measurement
290075|NCT01915940|Glaucoma|glaucoma
290076|NCT01915940|Primary Open-Angle Glaucoma|primary open-angle glaucoma
290077|NCT01915940|Ocular Hypertension|ocular hypertension
290078|NCT01915888|Clinical|clinical
290079|NCT01915888|Children|children
290080|NCT01915888|Rotavirus|rotavirus
290081|NCT01915888|Cost|cost
290082|NCT01915888|Rotarix vaccination|rotarix vaccination
290083|NCT01915875|Cystic fibrosis-pain-sophrology|cystic fibrosis-pain-sophrology
290084|NCT01915862|Acute ischemic stroke|acute ischemic stroke
290085|NCT01915862|Blood pressure variability|blood pressure variability
290086|NCT01915862|Ambulatory arterial stiffness index|ambulatory arterial stiffness index
290087|NCT01915862|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
290088|NCT01915862|Outcome|outcome
290089|NCT01915836|11-043|11-043
290090|NCT01915836|MSKCC Tobacco Cessation Program|mskcc tobacco cessation program
290091|NCT01915810|Tobacco Use Cessation|tobacco use cessation
290092|NCT01915810|Smoking Cessation with Physical Activity|smoking cessation with physical activity
290093|NCT01915810|SCwPA|scwpa
290094|NCT01915810|Cancer Prevention|cancer prevention
290095|NCT01915810|African American cigarette smoker|african american cigarette smoker
290096|NCT01915810|Questionnaires|questionnaires
290097|NCT01915810|Surveys|surveys
290098|NCT01915810|Phone Counseling|phone counseling
290099|NCT01915810|Breath Test|breath test
290100|NCT01915810|Walking Program|walking program
290101|NCT01915810|Nicotine Patch|nicotine patch
290102|NCT01915810|Audio Recorded Focus Group|audio recorded focus group
290103|NCT01915797|Pediatric patients, tumor, developmental abnormalities|pediatric patients, tumor, developmental abnormalities
290104|NCT01915745|Osteoporosis|osteoporosis
290105|NCT01915745|Bone densitometry|bone densitometry
290106|NCT01915745|Fracture|fracture
290107|NCT01915745|Anti-osteoporotic treatment|anti-osteoporotic treatment
290108|NCT01915745|Short message service|short message service
290109|NCT01915706|Glaucoma drainage device|glaucoma drainage device
290110|NCT01915706|Baerveldt 350|baerveldt 350
290111|NCT01915706|Ripcord|ripcord
290112|NCT01915706|Complications|complications
290113|NCT01915693|Radiotherapy|radiotherapy
290114|NCT01915693|stent|stent
290115|NCT01915693|quality of life|quality of life
290116|NCT01915654|Cardiac surgery|cardiac surgery
290117|NCT01915654|Transfusion|transfusion
290118|NCT01915641|walking capacity|walking capacity
290119|NCT01915641|COPD|copd
290120|NCT01915641|OSA|osa
290121|NCT01915641|CPAP|cpap
290122|NCT01915628|MACE|mace
290123|NCT01915628|Safety|safety
290124|NCT01915628|Efficacy|efficacy
290125|NCT01915628|On label|on label
290126|NCT01915628|Myocardial Infarction|myocardial infarction
290127|NCT01915628|Cardiac death|cardiac death
290128|NCT01915628|TVR|tvr
290129|NCT01915628|stent thrombosis|stent thrombosis
290130|NCT01915615|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
290131|NCT01915615|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
290132|NCT01915615|CMR|cmr
290133|NCT01915615|Genetics|genetics
290134|NCT01915615|Biomarkers|biomarkers
290135|NCT01915615|Late gadolinium enhancement|late gadolinium enhancement
290136|NCT01915615|T1 mapping|t1 mapping
290137|NCT01915602|Hepatocellular Carcinoma|hepatocellular carcinoma
290138|NCT01915602|Mitogen-activated Extracellular-signal-regulated kinase (MEK) inhibitor|mitogen-activated extracellular-signal-regulated kinase (mek) inhibitor
290139|NCT01915602|Sorafenib|sorafenib
290140|NCT01915602|Objective tumor response rate (ORR)|objective tumor response rate (orr)
290141|NCT01915602|modified RECIST criteria|modified recist criteria
290142|NCT01915589|Hepatocellular Carcinoma|hepatocellular carcinoma
290143|NCT01915589|Mitogen-activated Extracellular-signal-regulated kinase (MEK) inhibitor|mitogen-activated extracellular-signal-regulated kinase (mek) inhibitor
290144|NCT01915589|Objective tumor response rate (ORR)|objective tumor response rate (orr)
290145|NCT01915589|modified RECIST criteria|modified recist criteria
290146|NCT01915563|Mechanical ventilation|mechanical ventilation
290147|NCT01915563|Weaning|weaning
290148|NCT01915563|Extubation failure|extubation failure
290149|NCT01915550|Diabetes mellitus|diabetes mellitus
290150|NCT01915550|Pregnancy|pregnancy
290151|NCT01915550|Insulin|insulin
290152|NCT01915550|Metformin|metformin
290153|NCT01915537|poor prognosis|poor prognosis
290154|NCT01915537|severe RA|severe ra
290155|NCT01915537|infliximab|infliximab
290156|NCT01915511|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
290157|NCT01915511|Pulmonary fibrosis|pulmonary fibrosis
290158|NCT01915511|IPF|ipf
290159|NCT01915511|Registry|registry
290160|NCT01915511|1199.174|1199.174
290161|NCT01915498|acute myeloid leukemia|acute myeloid leukemia
290162|NCT01915498|AML|aml
290163|NCT01915498|myelodysplastic syndrome|myelodysplastic syndrome
290164|NCT01915498|MDS|mds
290165|NCT01915498|hematologic malignancies|hematologic malignancies
290166|NCT01915498|IDH2|idh2
290167|NCT01915498|Phase I|phase i
290168|NCT01915498|Phase II|phase ii
290169|NCT01915498|AG-221|ag-221
290170|NCT01915498|relapse AML|relapse aml
290171|NCT01915498|refractory AML|refractory aml
290172|NCT01915472|Metastatic Colorectal Cancer|metastatic colorectal cancer
290173|NCT01915472|Colorectal Cancer|colorectal cancer
290174|NCT01915472|Rectal Cancer|rectal cancer
290175|NCT01915472|previously treated|previously treated
290176|NCT01915459|Stroke|stroke
290177|NCT01915459|Spasticity|spasticity
290178|NCT01915446|EVAR|evar
290179|NCT01915446|endovascular aortic repair|endovascular aortic repair
290180|NCT01915446|acute kidney failure|acute kidney failure
290181|NCT01915446|mesenteric ischemia|mesenteric ischemia
290182|NCT01915433|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
290183|NCT01915433|Primary Progressive Multiple Sclerosis|primary progressive multiple sclerosis
290184|NCT01915433|Relapsing progressive multiple sclerosis|relapsing progressive multiple sclerosis
290185|NCT01915433|relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
290186|NCT01915433|Fatigue|fatigue
290187|NCT01915433|Quality of life|quality of life
290188|NCT01915433|Paleo|paleo
290189|NCT01915433|Nutrition|nutrition
290190|NCT01915433|Ketogenic|ketogenic
290191|NCT01915420|Drug eluting stent|drug eluting stent
290192|NCT01915420|Bioabsorbable|bioabsorbable
290193|NCT01915420|Bioresorbable|bioresorbable
290194|NCT01915420|Coronary Stent|coronary stent
290195|NCT01915420|Scaffold|scaffold
290196|NCT01915420|Stents|stents
290197|NCT01915420|Angioplasty|angioplasty
290198|NCT01915420|Coronary Artery Disease|coronary artery disease
290199|NCT01915420|Stentthrombosis|stentthrombosis
290200|NCT01915420|Rotational atherectomy|rotational atherectomy
290201|NCT01915394|Respiratory Syncytial Virus Infections|respiratory syncytial virus infections
290202|NCT01915394|Epidemics|epidemics
290203|NCT01915394|Neonatal Intensive Care Unit|neonatal intensive care unit
290204|NCT01915394|Newborn infants|newborn infants
290399|NCT01914523|Macintosh|macintosh
290205|NCT01915381|Intellectual disability|intellectual disability
290206|NCT01915381|mHealth|mhealth
290207|NCT01915381|App|app
290208|NCT01915381|Physical activity|physical activity
290209|NCT01915381|Adherence|adherence
290210|NCT01915368|Exercise|exercise
290211|NCT01915368|Rehabilitation|rehabilitation
290212|NCT01915368|Dose|dose
290213|NCT01915368|Randomized controlled trial|randomized controlled trial
290214|NCT01915368|Stroke|stroke
290215|NCT01915355|onychomycosis|onychomycosis
290216|NCT01915355|nail|nail
290217|NCT01915355|fungus|fungus
290218|NCT01915342|Monosynaptic reflex|monosynaptic reflex
290219|NCT01915342|H-reflex|h-reflex
290220|NCT01915329|CRPS|crps
290221|NCT01915329|repetitive sensory stimulation|repetitive sensory stimulation
290222|NCT01915329|cortical reorganization|cortical reorganization
290223|NCT01915329|2-point-discrimination|2-point-discrimination
290224|NCT01915303|Cushing's disease, pituitary tumors, pasireotide, cabergoline, combination treatment, UFC, hormone disorder, cortisol, adrenocorticotropic hormone|cushing's disease, pituitary tumors, pasireotide, cabergoline, combination treatment, ufc, hormone disorder, cortisol, adrenocorticotropic hormone
290225|NCT01915290|physical activity|physical activity
290226|NCT01915290|maximal oxygen uptake|maximal oxygen uptake
290227|NCT01915277|Pediatric corrective cardiac surgery|pediatric corrective cardiac surgery
290228|NCT01915264|Diabetes Mellitus|diabetes mellitus
290229|NCT01915264|Type 2 Diabetes|type 2 diabetes
290230|NCT01915264|Acarbose (25/50mg) and Metformin (500mg) in fixed dose combination|acarbose (25/50mg) and metformin (500mg) in fixed dose combination
290231|NCT01915251|Vulvovaginal Candidiasis|vulvovaginal candidiasis
290232|NCT01915251|Amoxicilin|amoxicilin
290233|NCT01915251|Microbiome|microbiome
290234|NCT01915238|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
290235|NCT01915238|AMD|amd
290236|NCT01915225|Tissue Procurement|tissue procurement
290237|NCT01915225|Surgery|surgery
290238|NCT01915225|Metastasectomy|metastasectomy
290239|NCT01915212|Vaccination|vaccination
290240|NCT01915212|Replication-Defective|replication-defective
290241|NCT01915212|Genital Herpes|genital herpes
290242|NCT01915212|Safety|safety
290243|NCT01915212|Immune Responses|immune responses
290244|NCT01915186|DHEA|dhea
290245|NCT01915186|Poor ovarian reserve|poor ovarian reserve
290246|NCT01915186|Normal ovarian reserve|normal ovarian reserve
290247|NCT01915186|In vitro fertilization treatment|in vitro fertilization treatment
290248|NCT01915186|Ovarian response|ovarian response
290249|NCT01915186|Pregnancy outcomes|pregnancy outcomes
290250|NCT01915173|Gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
290251|NCT01915173|Heartburn|heartburn
290252|NCT01915173|Dyspepsia|dyspepsia
290253|NCT01915147|oxycodone naloxone combination|oxycodone naloxone combination
290254|NCT01915147|severe chronic pain|severe chronic pain
290255|NCT01915147|non-malignant pain|non-malignant pain
290256|NCT01915147|Non-malignant pain that requires around-the-clock opioid therapy|non-malignant pain that requires around-the-clock opioid therapy
290257|NCT01915134|nasopharyngeal carcinoma|nasopharyngeal carcinoma
290258|NCT01915134|Recombinant Human Endostatin|recombinant human endostatin
290259|NCT01915134|chemotherapy|chemotherapy
290260|NCT01915134|gemcitabine and cisplatin|gemcitabine and cisplatin
290261|NCT01915121|Bladder Cancer|bladder cancer
290262|NCT01915121|Intervention|intervention
290263|NCT01915121|Education|education
290264|NCT01915121|Randomized Controlled Trials|randomized controlled trials
290265|NCT01915095|spinal cord injury|spinal cord injury
290266|NCT01915095|neural control|neural control
290267|NCT01915095|motor function|motor function
290268|NCT01915095|hand movement|hand movement
290269|NCT01915082|Lung Function|lung function
290270|NCT01915082|Allograft Outcome|allograft outcome
290271|NCT01915069|contraception|contraception
290272|NCT01915069|Cilostazol|cilostazol
290273|NCT01915069|phosphodiesterase inhibitors|phosphodiesterase inhibitors
290274|NCT01915069|To assess the ability of Cilostazol to act as a contraceptive agent|to assess the ability of cilostazol to act as a contraceptive agent
290275|NCT01915056|Comprehensive Geriatric Assessment (CGA)|comprehensive geriatric assessment (cga)
290276|NCT01915056|GA-driven interventions|ga-driven interventions
290277|NCT01915056|Toxicity|toxicity
290278|NCT01915056|Outcomes|outcomes
290279|NCT01915056|providing information|providing information
290280|NCT01915056|older cancer patients|older cancer patients
290281|NCT01915056|first-line chemotherapy|first-line chemotherapy
290282|NCT01915056|second-line chemotherapy|second-line chemotherapy
290283|NCT01915043|lymphedema, prevention, ehealth, cancer|lymphedema, prevention, ehealth, cancer
290284|NCT01915030|Muscle|muscle
290285|NCT01915030|Physical performance|physical performance
290286|NCT01915030|Protein|protein
290287|NCT01915030|Diet|diet
290288|NCT01915030|Caloric restriction|caloric restriction
290289|NCT01915017|Cognitive Adaptation Training|cognitive adaptation training
290290|NCT01915017|Cognitive Behavior Therapy for Psychosis|cognitive behavior therapy for psychosis
290291|NCT01915017|Schizophrenia|schizophrenia
290292|NCT01915004|Pediatric Urology|pediatric urology
290293|NCT01915004|Urotherapy|urotherapy
290294|NCT01915004|Nonneurogenic Lower Urinary Tract Dysfunction|nonneurogenic lower urinary tract dysfunction
290295|NCT01915004|Dysfunctional Elimination Syndrome|dysfunctional elimination syndrome
290296|NCT01915004|Randomized Controlled Trial|randomized controlled trial
290297|NCT01914991|proximal interphalangeal joint|proximal interphalangeal joint
290298|NCT01914991|Orthoses|orthoses
290299|NCT01914965|Huntington's disease|huntington's disease
290300|NCT01914965|Apathy|apathy
290301|NCT01914965|Bupropion|bupropion
290302|NCT01914952|CaHMB|cahmb
290303|NCT01914952|HMB free acid|hmb free acid
290304|NCT01914952|HMB|hmb
290305|NCT01914939|autism spectrum disorder|autism spectrum disorder
290306|NCT01914939|social skills deficits|social skills deficits
290307|NCT01914939|cognitive behavioral therapy|cognitive behavioral therapy
290308|NCT01914939|oxytocin|oxytocin
290309|NCT01914939|young adult|young adult
290310|NCT01914926|metoprolol|metoprolol
290311|NCT01914926|diltiazem|diltiazem
290312|NCT01914926|heart rate|heart rate
290313|NCT01914913|retinitis pigmentosa|retinitis pigmentosa
290314|NCT01914913|Bone marrow|bone marrow
290315|NCT01914913|stem cell|stem cell
290316|NCT01914913|BMMNC|bmmnc
290317|NCT01914900|oral cavity cancer|oral cavity cancer
290318|NCT01914900|induction chemotherapy|induction chemotherapy
290319|NCT01914900|TP53|tp53
290320|NCT01914900|beta tubulin II|beta tubulin ii
290321|NCT01914887|Ulcerative Colitis|ulcerative colitis
290322|NCT01914887|Inflammatory Bowel Disease|inflammatory bowel disease
290323|NCT01914887|Mesenchymal stem cells|mesenchymal stem cells
290324|NCT01914874|Community Sample|community sample
290325|NCT01914835|cocaine dependence|cocaine dependence
290326|NCT01914835|neuropsychological rehabilitation|neuropsychological rehabilitation
290327|NCT01914835|executive functions|executive functions
290328|NCT01914822|Ritalin|ritalin
290329|NCT01914822|methylphenidate hydrochloride|methylphenidate hydrochloride
290330|NCT01914822|experimental pain|experimental pain
290331|NCT01914796|Phase 1|phase 1
290332|NCT01914796|Randomized|randomized
290333|NCT01914796|Double Blind|double blind
290334|NCT01914796|Placebo-Controlled|placebo-controlled
290335|NCT01914796|Single-Dose Escalation|single-dose escalation
290336|NCT01914796|Safety|safety
290337|NCT01914796|Tolerability|tolerability
290338|NCT01914796|PK|pk
290339|NCT01914796|PD|pd
290340|NCT01914796|PF-06412562|pf-06412562
290341|NCT01914783|air pollution|air pollution
290342|NCT01914783|ozone|ozone
290343|NCT01914783|fine particle|fine particle
290344|NCT01914783|cytokine|cytokine
290345|NCT01914783|chemokine|chemokine
290346|NCT01914783|oxidative stress|oxidative stress
290347|NCT01914783|inflammation|inflammation
290348|NCT01914783|heart rate variability|heart rate variability
290349|NCT01914783|autonomic nervous system|autonomic nervous system
290350|NCT01914783|sympathetic nerve activity|sympathetic nerve activity
290351|NCT01914783|plasma catecholamine|plasma catecholamine
290352|NCT01914770|pooled analyses|pooled analyses
290353|NCT01914770|quality of life|quality of life
290354|NCT01914770|SELENA SLEDAI|selena sledai
290355|NCT01914770|SLE|sle
290356|NCT01914770|steroid use|steroid use
290357|NCT01914770|responder rate|responder rate
290358|NCT01914770|flares|flares
290359|NCT01914770|belimumab|belimumab
290360|NCT01914770|BILAG|bilag
290361|NCT01914757|Asthma, Bronchial Diseases, Respiratory Tract Diseases, Lung Diseases, Obstructive Lung Diseases|asthma, bronchial diseases, respiratory tract diseases, lung diseases, obstructive lung diseases
290362|NCT01914744|NHL|nhl
290363|NCT01914744|HBV|hbv
290364|NCT01914744|entecavir|entecavir
290365|NCT01914744|lamivudine|lamivudine
290366|NCT01914731|Fecal Microbiota Transplant|fecal microbiota transplant
290367|NCT01914731|Clostridium difficile|clostridium difficile
290368|NCT01914731|Diarrhea|diarrhea
290369|NCT01914718|DLBCL|dlbcl
290370|NCT01914718|DA-EPOCH-R|da-epoch-r
290371|NCT01914705|Landmark|landmark
290372|NCT01914705|Ultrasound|ultrasound
290373|NCT01914705|central venous catheter|central venous catheter
290374|NCT01914679|Fibromyalgia|fibromyalgia
290375|NCT01914679|Pain|pain
290376|NCT01914679|Brain|brain
290377|NCT01914679|Stimulation|stimulation
290378|NCT01914679|Device|device
290379|NCT01914679|Treatment|treatment
290380|NCT01914666|Chronic Low Back Pain|chronic low back pain
290381|NCT01914666|CLBP|clbp
290382|NCT01914640|Waist circumference, Metabolic Syndrome, Cardiovascular risk|waist circumference, metabolic syndrome, cardiovascular risk
290383|NCT01914627|Psoriasis capitis|psoriasis capitis
290384|NCT01914627|Scaling|scaling
290385|NCT01914627|Salicylic acid|salicylic acid
290386|NCT01914627|Dimethicone|dimethicone
290387|NCT01914627|Plaque removal|plaque removal
290388|NCT01914614|Breast Cancer|breast cancer
290389|NCT01914614|Working Women|working women
290390|NCT01914601|Laryngoscope|laryngoscope
290391|NCT01914601|Macintosh|macintosh
290392|NCT01914601|King Vision|king vision
290393|NCT01914601|tracheal intubation|tracheal intubation
290394|NCT01914601|cervical spines|cervical spines
290395|NCT01914536|POMPE|pompe
290396|NCT01914536|Glycogenosis type II|glycogenosis type ii
290397|NCT01914536|Acid maltase deficiency|acid maltase deficiency
290398|NCT01914523|Laryngoscope|laryngoscope
290400|NCT01914523|Glidescope|glidescope
290401|NCT01914523|King Vision|king vision
290402|NCT01914523|AirTraq|airtraq
290403|NCT01914523|tracheal intubation|tracheal intubation
290404|NCT01914510|ovarian|ovarian
290405|NCT01914510|cancer|cancer
290406|NCT01914510|clear cell|clear cell
290407|NCT01914510|ENMD-2076|enmd-2076
290408|NCT01914510|oral|oral
290409|NCT01914510|capsule|capsule
290410|NCT01914484|tyrosine kinase inhibitor resistance|tyrosine kinase inhibitor resistance
290411|NCT01914484|chronic myeloid leukemia|chronic myeloid leukemia
290412|NCT01914484|acute lymphoblastic leukemia|acute lymphoblastic leukemia
290413|NCT01914484|nilotinib|nilotinib
290414|NCT01914484|ruxolitinib|ruxolitinib
290415|NCT01914458|Lung cancer|lung cancer
290416|NCT01914458|Low-dose computed tomography scan|low-dose computed tomography scan
290417|NCT01914419|Postpartum hemorrhage|postpartum hemorrhage
290418|NCT01914419|Oxytocin|oxytocin
290419|NCT01914419|Prevention|prevention
290420|NCT01914419|Third stage of labor|third stage of labor
290421|NCT01914419|Hemoglobin|hemoglobin
290422|NCT01914419|Intravenous|intravenous
290423|NCT01914419|Intramuscular|intramuscular
290424|NCT01914419|Bolus|bolus
290425|NCT01914406|Heart transplant recipients|heart transplant recipients
290426|NCT01914406|Exercise capacity|exercise capacity
290427|NCT01914406|endothelial function|endothelial function
290428|NCT01914406|Quality of life|quality of life
290429|NCT01914393|Schizophrenia|schizophrenia
290430|NCT01914393|Autism|autism
290431|NCT01914393|Lurasidone|lurasidone
290432|NCT01914393|Latuda|latuda
290433|NCT01914380|Wet age-related macular degeneration|wet age-related macular degeneration
290434|NCT01914380|Anti-VEGF-Therapy|anti-vegf-therapy
290435|NCT01914380|Observational study|observational study
290436|NCT01914354|T cells|t cells
290437|NCT01914354|Human Alloimmune Reactivity|human alloimmune reactivity
290438|NCT01914354|immunosuppression|immunosuppression
290439|NCT01914341|Infant|infant
290440|NCT01914341|Newborn|newborn
290441|NCT01914341|Music|music
290442|NCT01914328|Postoperative Pulmonary Complications|postoperative pulmonary complications
290443|NCT01914328|PORC|porc
290444|NCT01914328|Surgical Related Outcome|surgical related outcome
290445|NCT01914328|Surgical Related Mortality|surgical related mortality
290446|NCT01914328|Postoperative ICU length of stay|postoperative icu length of stay
290447|NCT01914315|Rehabilitation|rehabilitation
290448|NCT01914315|Heart failure|heart failure
290449|NCT01914315|HFPEF|hfpef
290450|NCT01914315|Exercise training|exercise training
290451|NCT01914289|Intrahepatic Cholangiocarcinoma|intrahepatic cholangiocarcinoma
290452|NCT01914289|Prognosis|prognosis
290453|NCT01914289|Resection|resection
290454|NCT01914289|Radiotherapy|radiotherapy
290455|NCT01914263|Cord blood-Derived cytokine induced killer cells,|cord blood-derived cytokine induced killer cells,
290456|NCT01914263|Radical resection|radical resection
290457|NCT01914250|Frenotomy|frenotomy
290458|NCT01914250|Pain|pain
290459|NCT01914237|Single-Branched Stent Graft System|single-branched stent graft system
290460|NCT01914237|Aortic Dissection|aortic dissection
290461|NCT01914237|Endovascular Repair|endovascular repair
290462|NCT01914224|Prehypertension|prehypertension
290463|NCT01914224|Hypertension|hypertension
290464|NCT01914224|Sodium|sodium
290465|NCT01914224|Potassium|potassium
290466|NCT01914224|renin|renin
290467|NCT01914224|aldosterone|aldosterone
290468|NCT01914198|sleep study|sleep study
290469|NCT01914198|NCH|nch
290470|NCT01914185|Childhood|childhood
290471|NCT01914185|Physical activity|physical activity
290472|NCT01914185|Nutrition|nutrition
290473|NCT01914185|Health Promotion|health promotion
290474|NCT01914172|rare disease|rare disease
290475|NCT01914172|community-based participatory research|community-based participatory research
290476|NCT01914172|health promotion|health promotion
290477|NCT01914172|quantitative research|quantitative research
290478|NCT01914172|qualitative research|qualitative research
290479|NCT01914172|focus group|focus group
290480|NCT01914146|Diabetes|diabetes
290481|NCT01914146|Insulin|insulin
290482|NCT01914146|Orthostatic Hypotension|orthostatic hypotension
290483|NCT01914146|Falls|falls
290484|NCT01914146|Syncope|syncope
290485|NCT01914133|Acarbose|acarbose
290486|NCT01914133|PPH (Post Prandial Hypotension)|pph (post prandial hypotension)
290487|NCT01914133|Falls|falls
290488|NCT01914133|Syncope|syncope
290489|NCT01914133|Elderly|elderly
290490|NCT01914120|lung cancer|lung cancer
290491|NCT01914120|quality of life|quality of life
290492|NCT01914120|FACT-L|fact-l
290493|NCT01914107|malignancy|malignancy
290494|NCT01914107|solid tumor|solid tumor
290495|NCT01914107|cancer pain|cancer pain
290496|NCT01914094|Preoperative care|preoperative care
290497|NCT01914094|Exercise therapy|exercise therapy
290498|NCT01914094|Cardiac surgery|cardiac surgery
290499|NCT01914081|Non-ischemic cardiomyopathy|non-ischemic cardiomyopathy
290500|NCT01914081|Resveratrol|resveratrol
290501|NCT01914068|Neoadjuvant chemoradiotherapy (NACRT)|neoadjuvant chemoradiotherapy (nacrt)
290502|NCT01914068|Rectal cancer|rectal cancer
290503|NCT01914068|Physical fitness|physical fitness
290504|NCT01914068|Exercise programme|exercise programme
290505|NCT01914068|Surgery|surgery
290506|NCT01914068|Stage III/IV|stage iii/iv
290507|NCT01914068|Locally advanced operable|locally advanced operable
290508|NCT01914068|patients|patients
290509|NCT01914042|Opioid induced hyperalgesia|opioid induced hyperalgesia
290510|NCT01914042|Neuropathic pain|neuropathic pain
290511|NCT01914042|Opioids|opioids
290512|NCT01914042|Sciatica|sciatica
290513|NCT01914042|Serotonin-norepinephrine reuptake inhibitor (SNRI)|serotonin-norepinephrine reuptake inhibitor (snri)
290514|NCT01913990|Nausea|nausea
290515|NCT01913990|Vomiting|vomiting
290516|NCT01913938|Hemophagocytosis, adults, rhG-CSF|hemophagocytosis, adults, rhg-csf
290517|NCT01913899|phantom limb pain|phantom limb pain
290518|NCT01913899|mirror therapy|mirror therapy
290519|NCT01913899|amputees|amputees
290520|NCT01913899|phantom limb|phantom limb
290521|NCT01913899|occupational therapy|occupational therapy
290522|NCT01913886|Cardiovascular Diseases|cardiovascular diseases
290523|NCT01913886|Myocardial Ischemia|myocardial ischemia
290524|NCT01913886|Coronary Artery Disease|coronary artery disease
290525|NCT01913886|Heart Diseases|heart diseases
290526|NCT01913886|Coronary Disease|coronary disease
290527|NCT01913886|Ventricular Dysfunction|ventricular dysfunction
290528|NCT01913886|Arteriosclerosis|arteriosclerosis
290529|NCT01913873|High-sensitivity Cardiac Troponin|high-sensitivity cardiac troponin
290530|NCT01913873|Creatinin Kinase MB|creatinin kinase mb
290531|NCT01913873|Cardiac Surgery|cardiac surgery
290532|NCT01913873|Myocardial injury|myocardial injury
290533|NCT01913873|Myocardial infarction|myocardial infarction
290534|NCT01913873|Concentration change|concentration change
290535|NCT01913860|UTI|uti
290536|NCT01913860|antibiotics|antibiotics
290537|NCT01913860|prescribing|prescribing
290538|NCT01913860|primary care|primary care
290539|NCT01913834|Parathyroid hormone 1-34|parathyroid hormone 1-34
290540|NCT01913808|Postoperative anemia|postoperative anemia
290541|NCT01913808|Total knee arthroplasty|total knee arthroplasty
290542|NCT01913808|Iron therapy|iron therapy
290543|NCT01913782|Chronic low back pain, CLBC, fMRI|chronic low back pain, clbc, fmri
290544|NCT01913769|post-RT|post-rt
290545|NCT01913769|myocardial perfusion images|myocardial perfusion images
290546|NCT01913743|fMRI|fmri
290547|NCT01913743|cognitive strategies|cognitive strategies
290548|NCT01913743|obesity|obesity
290549|NCT01913743|weight loss|weight loss
290550|NCT01913743|mindsets|mindsets
290551|NCT01913730|Multiple Myeloma|multiple myeloma
290552|NCT01913730|Refractory|refractory
290553|NCT01913730|Relapsed|relapsed
290554|NCT01913717|Prostate cancer|prostate cancer
290555|NCT01913717|Radiotherapy|radiotherapy
290556|NCT01913717|hypofractionated radiotherapy|hypofractionated radiotherapy
290557|NCT01913704|venous leg ulcer|venous leg ulcer
290558|NCT01913704|mixed aetiology leg ulcers|mixed aetiology leg ulcers
290559|NCT01913691|Neuroendocrine Skin Cancer|neuroendocrine skin cancer
290560|NCT01913691|Merkel Cell Polyomavirus|merkel cell polyomavirus
290561|NCT01913691|Immunotherapy|immunotherapy
290562|NCT01913652|dedifferentiated liposarcoma|dedifferentiated liposarcoma
290563|NCT01913652|cabazitaxel|cabazitaxel
290564|NCT01913639|BAY 73-4506 (REGORAFENIB)|bay 73-4506 (regorafenib)
290565|NCT01913639|FLUOROURACIL|fluorouracil
290566|NCT01913639|LEUCOVORIN|leucovorin
290567|NCT01913639|OXALIPLATIN|oxaliplatin
290568|NCT01913626|subjective memory complains|subjective memory complains
290569|NCT01913600|TARGET LESION REVASCULARIZATION (TLR)|target lesion revascularization (tlr)
290570|NCT01913600|TARGET VESSEL REVASCULARIZATION (TVR)|target vessel revascularization (tvr)
290571|NCT01913600|Coronary Artery Disease|coronary artery disease
290572|NCT01913600|MYOCARDIAL INFARCTION (MI)|myocardial infarction (mi)
290573|NCT01913600|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
290574|NCT01913600|STENT THROMBOSIS|stent thrombosis
290575|NCT01913600|TARGET LESION FAILURE (TLF)|target lesion failure (tlf)
290576|NCT01913561|Electrocardiogram|electrocardiogram
290577|NCT01913561|gel electrodes|gel electrodes
290578|NCT01913561|textile electrodes|textile electrodes
290579|NCT01913535|Depression|depression
290580|NCT01913535|Treatment Resistant Depression|treatment resistant depression
290581|NCT01913535|Antidepressant|antidepressant
290582|NCT01913535|Major Depression|major depression
290583|NCT01913535|MDD|mdd
290584|NCT01913509|hemiplegic shoulder pain|hemiplegic shoulder pain
290585|NCT01913509|poststroke fatigue|poststroke fatigue
290586|NCT01913509|functional electrical stimulation|functional electrical stimulation
290587|NCT01913509|stroke rehabilitation|stroke rehabilitation
290588|NCT01913496|web application|web application
290589|NCT01913496|nutrition knowledge|nutrition knowledge
290590|NCT01913496|physical activity|physical activity
290591|NCT01913470|NAFLD|nafld
290592|NCT01913470|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
290593|NCT01913470|Obesity|obesity
290594|NCT01913470|Pediatrics|pediatrics
290595|NCT01913470|Children|children
290596|NCT01913470|Losartan|losartan
290597|NCT01913470|Cozaar|cozaar
290598|NCT01913457|Ultrasound Doppler|ultrasound doppler
290599|NCT01913457|Lungs|lungs
290698|NCT01912807|Children|children
290600|NCT01913457|Pulmonary artery hypertension|pulmonary artery hypertension
290601|NCT01913444|Recombinant Antithrombin|recombinant antithrombin
290602|NCT01913444|ATryn|atryn
290603|NCT01913444|Pharmacokinetics|pharmacokinetics
290604|NCT01913444|ECMO|ecmo
290605|NCT01913444|Neonates|neonates
290606|NCT01913418|Traditional Chinese Medicine|traditional chinese medicine
290607|NCT01913418|Suan-Zao-Ren Tang|suan-zao-ren tang
290608|NCT01913418|Methadone|methadone
290609|NCT01913418|Opiate dependence|opiate dependence
290610|NCT01913418|Sleep|sleep
290611|NCT01913379|Phase 1|phase 1
290612|NCT01913379|MDV3100|mdv3100
290613|NCT01913379|Gemfibrozil|gemfibrozil
290614|NCT01913379|Itraconazole|itraconazole
290615|NCT01913379|Xtandi|xtandi
290616|NCT01913379|enzalutamide|enzalutamide
290617|NCT01913340|erythropoietin|erythropoietin
290618|NCT01913340|therapeutic hypothermia|therapeutic hypothermia
290619|NCT01913327|cognition|cognition
290620|NCT01913327|executive function|executive function
290621|NCT01913327|prefrontal cortex|prefrontal cortex
290622|NCT01913327|locus coeruleus|locus coeruleus
290623|NCT01913288|neonatal care, preterm, maternal sounds, auditory stimulation|neonatal care, preterm, maternal sounds, auditory stimulation
290624|NCT01913275|cholecystojejunostomy|cholecystojejunostomy
290625|NCT01913275|whipple's pancreaticoduodenectomy|whipple's pancreaticoduodenectomy
290626|NCT01913275|endoscopic stenting|endoscopic stenting
290627|NCT01913275|hyperbilirubinemia|hyperbilirubinemia
290628|NCT01913262|depression|depression
290629|NCT01913262|phq9|phq9
290630|NCT01913262|phq-9|phq-9
290631|NCT01913262|standard treatment|standard treatment
290632|NCT01913249|Anorectal fistula|anorectal fistula
290633|NCT01913249|LIFT|lift
290634|NCT01913249|Seton|seton
290635|NCT01913236|Tailored implementation interventions|tailored implementation interventions
290636|NCT01913236|Primary care|primary care
290637|NCT01913236|Depression in the elderly|depression in the elderly
290638|NCT01913223|Endoscopic submucosal dissection|endoscopic submucosal dissection
290639|NCT01913223|jet injector|jet injector
290640|NCT01913223|saline solution|saline solution
290641|NCT01913223|safety|safety
290642|NCT01913223|effectiveness|effectiveness
290643|NCT01913197|Prostate Brachytherapy|prostate brachytherapy
290644|NCT01913119|extranodal NKTcell lymphoma|extranodal nktcell lymphoma
290645|NCT01913093|Childhood leukemia survivors|childhood leukemia survivors
290646|NCT01913093|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
290647|NCT01913093|Leukemia|leukemia
290648|NCT01913093|Late effects|late effects
290649|NCT01913093|Folate|folate
290650|NCT01913093|Blood folate|blood folate
290651|NCT01913093|Neurotoxicity|neurotoxicity
290652|NCT01913093|Methotrexate|methotrexate
290653|NCT01913093|Pharmacogenetics|pharmacogenetics
290654|NCT01913093|Cognitive|cognitive
290655|NCT01913093|Cognitive late effects|cognitive late effects
290656|NCT01913093|N-PhenoGENICS|n-phenogenics
290657|NCT01913080|health management|health management
290658|NCT01913067|brain metastasis|brain metastasis
290659|NCT01913067|breast cancer|breast cancer
290660|NCT01913067|HER2 negative|her2 negative
290661|NCT01913067|NSCLC|nsclc
290662|NCT01913054|Etomidate|etomidate
290663|NCT01913054|Propofol|propofol
290664|NCT01913054|Painless gastroscopy|painless gastroscopy
290665|NCT01913041|perioperative hypothermia|perioperative hypothermia
290666|NCT01913041|Epidemiology|epidemiology
290667|NCT01913041|Tympanic temperature|tympanic temperature
290668|NCT01913028|safety, tolerability, pharmacokinetics,immunogenicity, MEDI9929, Japanese|safety, tolerability, pharmacokinetics,immunogenicity, medi9929, japanese
290669|NCT01912989|motivational interviewing|motivational interviewing
290670|NCT01912989|obesity|obesity
290671|NCT01912989|parent|parent
290672|NCT01912976|Bowen's disease|bowen's disease
290673|NCT01912976|Er:YAG|er:yag
290674|NCT01912976|AFL-assisted|afl-assisted
290675|NCT01912976|MAL-PDT|mal-pdt
290676|NCT01912963|HER-2 Positive Breast Cancer|her-2 positive breast cancer
290677|NCT01912950|intense pulsed light|intense pulsed light
290678|NCT01912950|IPL|ipl
290679|NCT01912950|healthy volunteer|healthy volunteer
290680|NCT01912950|light-based hair removal|light-based hair removal
290681|NCT01912950|hair removal|hair removal
290682|NCT01912950|epilation|epilation
290683|NCT01912950|laser hair removal|laser hair removal
290684|NCT01912950|permanent hair reduction|permanent hair reduction
290685|NCT01912937|Paclitaxel|paclitaxel
290686|NCT01912937|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
290687|NCT01912937|Balloon Catheter|balloon catheter
290688|NCT01912937|Pharmacokinetic|pharmacokinetic
290689|NCT01912937|Peripheral Artery Disease|peripheral artery disease
290690|NCT01912937|PAD|pad
290691|NCT01912924|chronic pain from failed knee surgery|chronic pain from failed knee surgery
290692|NCT01912846|End-of-life care|end-of-life care
290693|NCT01912846|Preference of end-of-life care|preference of end-of-life care
290694|NCT01912846|RCT|rct
290695|NCT01912846|Terminally ill cancer patients|terminally ill cancer patients
290696|NCT01912833|postpartum depression|postpartum depression
290697|NCT01912807|Postoperative vomiting|postoperative vomiting
290699|NCT01912794|Cerebrovascular Accident|cerebrovascular accident
290700|NCT01912794|Rehabilitation|rehabilitation
290701|NCT01912794|Sensory System|sensory system
290702|NCT01912781|contact lenses|contact lenses
290703|NCT01912781|contact lens solution|contact lens solution
290704|NCT01912781|gas permeable contact lenses|gas permeable contact lenses
290705|NCT01912768|contact lenses|contact lenses
290706|NCT01912768|contact lens solution|contact lens solution
290707|NCT01912768|soft contact lenses|soft contact lenses
290708|NCT01912755|Pulpitis|pulpitis
290709|NCT01912755|Hot tooth|hot tooth
290710|NCT01912755|Articaine|articaine
290711|NCT01912755|Lidocaine|lidocaine
290712|NCT01912755|Local anesthetics|local anesthetics
290713|NCT01912742|Weight loss|weight loss
290714|NCT01912742|Speed of weight loss|speed of weight loss
290715|NCT01912742|Metabolic compensation|metabolic compensation
290716|NCT01912742|Diet therapy|diet therapy
290717|NCT01912729|Depression prevention|depression prevention
290718|NCT01912729|Technology Assisted|technology assisted
290719|NCT01912729|Adolescents|adolescents
290720|NCT01912729|Peer networked|peer networked
290721|NCT01912716|pancreatitis|pancreatitis
290722|NCT01912716|ERCP|ercp
290723|NCT01912677|hypertension in pregnancy|hypertension in pregnancy
290724|NCT01912677|preeclampsia|preeclampsia
290725|NCT01912677|anti-hypertension|anti-hypertension
290726|NCT01912677|labetalol|labetalol
290727|NCT01912677|nifedipine|nifedipine
290728|NCT01912677|methyldopa|methyldopa
290729|NCT01912651|facial skin wound|facial skin wound
290730|NCT01912651|facial wound|facial wound
290731|NCT01912651|skin wound|skin wound
290732|NCT01912651|facial defect|facial defect
290733|NCT01912651|reconstructive skin graft|reconstructive skin graft
290734|NCT01912638|Trabeculectomy|trabeculectomy
290735|NCT01912638|Glaucoma|glaucoma
290736|NCT01912638|Steroids|steroids
290737|NCT01912638|Ologen|ologen
290738|NCT01912638|Viscoelastic|viscoelastic
290739|NCT01912612|Breast cancer|breast cancer
290740|NCT01912612|Pain sensitivity|pain sensitivity
290741|NCT01912599|Glaucoma|glaucoma
290742|NCT01912599|Intraocular Pressure|intraocular pressure
290743|NCT01912599|Blood Pressure|blood pressure
290744|NCT01912586|erectile dysfunction|erectile dysfunction
290745|NCT01912586|laparoscopic surgery|laparoscopic surgery
290746|NCT01912586|rectal cancer|rectal cancer
290747|NCT01912586|sildenafil|sildenafil
290748|NCT01912586|vacuum erection device|vacuum erection device
290749|NCT01912573|heroin|heroin
290750|NCT01912573|prescription pain killers|prescription pain killers
290751|NCT01912573|narcotics|narcotics
290752|NCT01912534|Sarcomere Mutations|sarcomere mutations
290753|NCT01912521|HIV|hiv
290754|NCT01912521|Stigma|stigma
290755|NCT01912521|Social support|social support
290756|NCT01912521|Social network|social network
290757|NCT01912521|Kenya|kenya
290758|NCT01912508|cervical length|cervical length
290759|NCT01912508|cervical curvature|cervical curvature
290760|NCT01912469|Muscle|muscle
290761|NCT01912469|exercise|exercise
290762|NCT01912469|soreness|soreness
290763|NCT01912469|Damage|damage
290764|NCT01912469|Traumeel|traumeel
290765|NCT01912456|Hereditary Angioedema|hereditary angioedema
290766|NCT01912430|Integrated Care Coaching|integrated care coaching
290767|NCT01912430|Chronic Care Coaching|chronic care coaching
290768|NCT01912430|Care Coaching|care coaching
290769|NCT01912417|HEMODIALYSIS|hemodialysis
290770|NCT01912417|Kidney Failure, Chronic|kidney failure, chronic
290771|NCT01912417|AEROBIC EXERCISE|aerobic exercise
290772|NCT01912404|alcoholic hepatitis|alcoholic hepatitis
290773|NCT01912391|Depression|depression
290774|NCT01912391|Anxiety|anxiety
290775|NCT01912391|Headaches|headaches
290776|NCT01912391|Migraines|migraines
290777|NCT01912391|Irritable Bowel Syndrome IBS|irritable bowel syndrome ibs
290778|NCT01912391|Neurodermatitis|neurodermatitis
290779|NCT01912391|Fibromyalgia|fibromyalgia
290780|NCT01912391|Premenstrual Syndrome PMS|premenstrual syndrome pms
290781|NCT01912391|Temporomandibular Joint Dysfunction TMJ|temporomandibular joint dysfunction tmj
290782|NCT01912365|Fracture|fracture
290783|NCT01912365|Supracondylar|supracondylar
290784|NCT01912365|Pediatric|pediatric
290785|NCT01912365|Orthopedic|orthopedic
290786|NCT01912352|ADHD|adhd
290787|NCT01912352|ADRA2A|adra2a
290788|NCT01912352|Methylphenidate|methylphenidate
290789|NCT01912352|Response|response
290790|NCT01912339|Hyperlasia|hyperlasia
290791|NCT01912339|Retention|retention
290792|NCT01912339|Prostate|prostate
290793|NCT01912326|pacemaker|pacemaker
290794|NCT01912326|atrial fibrillation|atrial fibrillation
290795|NCT01912313|IBS patients|ibs patients
290796|NCT01912313|healthy subjects|healthy subjects
290797|NCT01912287|Generalized Anxiety Disorder|generalized anxiety disorder
290798|NCT01912287|GAD|gad
290799|NCT01912287|Yoga|yoga
290800|NCT01912287|CBT|cbt
290801|NCT01912274|AML|aml
290802|NCT01912274|open label|open label
290803|NCT01912274|nonrandomized|nonrandomized
290804|NCT01912274|single arm|single arm
290805|NCT01912274|elderly patients|elderly patients
290806|NCT01912274|HMA|hma
290807|NCT01912274|newly diagnosed|newly diagnosed
290808|NCT01912261|Coronary artery bypass gafting|coronary artery bypass gafting
290809|NCT01912261|Anemia|anemia
290810|NCT01912261|Postoperative fatigue|postoperative fatigue
290811|NCT01912261|Functional Capacity|functional capacity
290812|NCT01912261|Iron|iron
290813|NCT01912261|Adherence|adherence
290814|NCT01912248|acute rise of systolic and diastolic bloodpressure|acute rise of systolic and diastolic bloodpressure
290815|NCT01912235|Arginine synthesis|arginine synthesis
290816|NCT01912235|15N2 arginine, 1-13C Glutamine, 2-15N Glutamine, 15N Proline|15n2 arginine, 1-13c glutamine, 2-15n glutamine, 15n proline
290817|NCT01912209|employees|employees
290818|NCT01912209|metabolic syndrome|metabolic syndrome
290819|NCT01912209|obesity|obesity
290820|NCT01912209|sub-clinical cardiovascular disease|sub-clinical cardiovascular disease
290821|NCT01912209|weight loss|weight loss
290822|NCT01912209|diet|diet
290823|NCT01912196|Depressive Disorder|depressive disorder
290824|NCT01912183|pediatric obesity|pediatric obesity
290825|NCT01912183|e-learning|e-learning
290826|NCT01912183|personal health record|personal health record
290827|NCT01912183|personal electronic device|personal electronic device
290828|NCT01912183|pilot|pilot
290829|NCT01912170|omega-3 fatty acid|omega-3 fatty acid
290830|NCT01912170|gestational diabetes|gestational diabetes
290831|NCT01912170|insulin sensitivity|insulin sensitivity
290832|NCT01912131|13-120|13-120
290833|NCT01912118|Nociception|nociception
290834|NCT01912118|General anesthesia|general anesthesia
290835|NCT01912105|endotracheal tube|endotracheal tube
290836|NCT01912105|ct scan|ct scan
290837|NCT01912105|cleaning device|cleaning device
290838|NCT01912105|biofilm|biofilm
290839|NCT01912105|mechanical ventilation|mechanical ventilation
290840|NCT01912053|Intra-hepatic Cholangiocarcinoma treatment|intra-hepatic cholangiocarcinoma treatment
290841|NCT01912040|Safety profile|safety profile
290842|NCT01912040|locally produced 123 Iodine MIBG|locally produced 123 iodine mibg
290843|NCT01912014|stroke|stroke
290844|NCT01912014|psychosocial|psychosocial
290845|NCT01912014|intervention|intervention
290846|NCT01912014|quality of life|quality of life
290847|NCT01912001|end stage renal disease|end stage renal disease
290848|NCT01912001|kidney failure|kidney failure
290849|NCT01912001|home dialysis|home dialysis
290850|NCT01912001|hemodialysis|hemodialysis
290851|NCT01912001|peritoneal dialysis|peritoneal dialysis
290852|NCT01912001|gaps in care|gaps in care
290853|NCT01912001|co-morbidity|co-morbidity
290854|NCT01912001|transitions of care settings|transitions of care settings
290855|NCT01911988|Peripheral immune cells|peripheral immune cells
290856|NCT01911988|Colorectal Cancers|colorectal cancers
290857|NCT01911988|Stage II/ Stage III|stage ii/ stage iii
290858|NCT01911988|Recurrence|recurrence
290859|NCT01911988|Metastasis|metastasis
290860|NCT01911975|Small Fiber Neuropathy|small fiber neuropathy
290861|NCT01911975|Painful Neuropathy|painful neuropathy
290862|NCT01911975|NAV1.7 Voltage-Gated Sodium Channel|nav1.7 voltage-gated sodium channel
290863|NCT01911975|SCN9A|scn9a
290864|NCT01911949|femoral nerve block|femoral nerve block
290865|NCT01911949|ultrasound guided|ultrasound guided
290866|NCT01911949|total hip arthroplasty|total hip arthroplasty
290867|NCT01911936|CLJM716,|cljm716,
290868|NCT01911936|Japanese patients,|japanese patients,
290869|NCT01911936|Neoplasms|neoplasms
290870|NCT01911910|primary prevention|primary prevention
290871|NCT01911910|Cardiovascular disease|cardiovascular disease
290872|NCT01911910|Cardiovascular magnetic resonance (CMR)|cardiovascular magnetic resonance (cmr)
290873|NCT01911910|Electronic coaching (e-coaching)|electronic coaching (e-coaching)
290874|NCT01911897|Hypertension|hypertension
290875|NCT01911884|Rokitansky syndrome|rokitansky syndrome
290876|NCT01911884|surgical or vaginal dilatation of vaginal aplasia|surgical or vaginal dilatation of vaginal aplasia
290877|NCT01911884|quality of global and sexual life|quality of global and sexual life
290878|NCT01911871|Thalassemia|thalassemia
290879|NCT01911871|sickle cell disease|sickle cell disease
290880|NCT01911871|myelodysplasia|myelodysplasia
290881|NCT01911871|transfusion|transfusion
290882|NCT01911871|chelation|chelation
290883|NCT01911845|HCV Genotype 1|hcv genotype 1
290884|NCT01911845|Hepatitis Genotype 1|hepatitis genotype 1
290885|NCT01911845|Interferon Free|interferon free
290886|NCT01911845|methadone|methadone
290887|NCT01911845|HCV|hcv
290888|NCT01911845|Buprenorphine|buprenorphine
290889|NCT01911845|Hepatitis C|hepatitis c
290890|NCT01911845|Viekira Pak|viekira pak
290891|NCT01911845|paritaprevir|paritaprevir
290892|NCT01911845|Viekira|viekira
290893|NCT01911845|ombitasvir|ombitasvir
290894|NCT01911845|dasabuvir|dasabuvir
290895|NCT01911832|Cancer of the esophagogastric junction|cancer of the esophagogastric junction
290896|NCT01911832|Reconstruction of gastric tube|reconstruction of gastric tube
290897|NCT01911832|Quality of life|quality of life
290898|NCT01911832|Width|width
290899|NCT01911832|Regurgitation|regurgitation
290900|NCT01911819|Histomorphometric Analysis|histomorphometric analysis
290901|NCT01911819|New bone Formation|new bone formation
290902|NCT01911819|Sinus Augmentation|sinus augmentation
290903|NCT01911819|Bone Graft Materials|bone graft materials
290904|NCT01911806|Back care pillow|back care pillow
290905|NCT01911806|chronic non-specific low back pain|chronic non-specific low back pain
290906|NCT01911806|randomized controlled trial|randomized controlled trial
290907|NCT01911793|stoma|stoma
290908|NCT01911793|ileus|ileus
290909|NCT01911793|postoperative|postoperative
290910|NCT01911793|stoma tube|stoma tube
290911|NCT01911741|Phase I|phase i
290912|NCT01911741|Enzalutamide|enzalutamide
290913|NCT01911741|Relative bioavailability of MDV3100|relative bioavailability of mdv3100
290914|NCT01911741|Immediate release oral formulation|immediate release oral formulation
290915|NCT01911741|Xtandi|xtandi
290916|NCT01911728|Drug-Drug Interaction|drug-drug interaction
290917|NCT01911728|Phase 1|phase 1
290918|NCT01911728|MDV3100|mdv3100
290919|NCT01911728|Xtandi|xtandi
290920|NCT01911728|Enzalutamide|enzalutamide
290921|NCT01911715|Phase 1|phase 1
290922|NCT01911715|Mass Balance|mass balance
290923|NCT01911715|MDV3100|mdv3100
290924|NCT01911715|Xtandi|xtandi
290925|NCT01911715|Enzalutamide|enzalutamide
290926|NCT01911715|Metabolism|metabolism
290927|NCT01911715|Excretion|excretion
290928|NCT01911689|pancreatitis|pancreatitis
290929|NCT01911689|MRI|mri
290930|NCT01911689|APACHEⅡ|apacheⅱ
290931|NCT01911689|T2*|t2*
290932|NCT01911689|T2 star|t2 star
290933|NCT01911650|Achilles|achilles
290934|NCT01911650|tendinopathy|tendinopathy
290935|NCT01911637|Healthy|healthy
290936|NCT01911637|Subjects|subjects
290937|NCT01911637|Safety|safety
290938|NCT01911637|Tolerability|tolerability
290939|NCT01911637|VBY-036|vby-036
290940|NCT01911637|Maximum|maximum
290941|NCT01911637|Pharmacodynamic|pharmacodynamic
290942|NCT01911637|Pharmacokinetic|pharmacokinetic
290943|NCT01911585|Posttraumatic Stress Disorder|posttraumatic stress disorder
290944|NCT01911585|PTSD|ptsd
290945|NCT01911585|Prolonged Exposure Therapy|prolonged exposure therapy
290946|NCT01911585|Cognitive Behavioral Therapy|cognitive behavioral therapy
290947|NCT01911572|Streptococcus species|streptococcus species
290948|NCT01911572|Streptococcus pyogenes|streptococcus pyogenes
290949|NCT01911572|Streptococcus agalactiae|streptococcus agalactiae
290950|NCT01911572|Necrotising fasciitis|necrotising fasciitis
290951|NCT01911572|Sepsis|sepsis
290952|NCT01911559|Standing-frame|standing-frame
290953|NCT01911559|Chronic constipation|chronic constipation
290954|NCT01911559|Cerebral palsy|cerebral palsy
290955|NCT01911559|Quadriplegia|quadriplegia
290956|NCT01911559|Severe diplegia|severe diplegia
290957|NCT01911494|cluster randomized controlled trial|cluster randomized controlled trial
290958|NCT01911494|pre-eclampsia|pre-eclampsia
290959|NCT01911494|eclampsia|eclampsia
290960|NCT01911494|maternal mortality|maternal mortality
290961|NCT01911468|PCOS|pcos
290962|NCT01911468|obesity|obesity
290963|NCT01911468|GLP-1 receptor agonist|glp-1 receptor agonist
290964|NCT01911468|liraglutide|liraglutide
290965|NCT01911468|metformin|metformin
290966|NCT01911455|Fragile X Syndrome|fragile x syndrome
290967|NCT01911442|Autism, Lurasidone, Latuda|autism, lurasidone, latuda
290968|NCT01911429|schizophrenia|schizophrenia
290969|NCT01911429|Lurasidone|lurasidone
290970|NCT01911429|Latuda|latuda
290971|NCT01911403|Femoral Artery puncture|femoral artery puncture
290972|NCT01911390|High cholesterol.|high cholesterol.
290973|NCT01911364|Frequent exacerbators|frequent exacerbators
290974|NCT01911351|nitrous oxide|nitrous oxide
290975|NCT01911351|pediatric pain and anxiety|pediatric pain and anxiety
290976|NCT01911338|Spinal Manipulation|spinal manipulation
290977|NCT01911338|Teaching|teaching
290978|NCT01911338|Thoracic Vertebrae|thoracic vertebrae
290979|NCT01911338|Feedback|feedback
290980|NCT01911325|Squamous non-small cell lung cancer|squamous non-small cell lung cancer
290981|NCT01911325|NSCLC|nsclc
290982|NCT01911325|Docetaxel|docetaxel
290983|NCT01911325|Buparlisib|buparlisib
290984|NCT01911325|BKM120|bkm120
290985|NCT01911325|Metastatic|metastatic
290986|NCT01911325|Stage IIIb|stage iiib
290987|NCT01911325|Stage IV|stage iv
290988|NCT01911325|PI3K inhibitor|pi3k inhibitor
290989|NCT01911299|Choline|choline
290990|NCT01911299|Glycerophosphocholine|glycerophosphocholine
290991|NCT01911299|Choline alphoscerate|choline alphoscerate
290992|NCT01911299|Fetal alcohol spectrum disorders|fetal alcohol spectrum disorders
290993|NCT01911299|Fetal alcohol syndrome|fetal alcohol syndrome
290994|NCT01911299|Partial fetal alcohol syndrome|partial fetal alcohol syndrome
290995|NCT01911299|Alcohol-related neurodevelopmental disorder|alcohol-related neurodevelopmental disorder
290996|NCT01911299|Prenatal alcohol exposure|prenatal alcohol exposure
290997|NCT01911299|Fetal Alcohol Effects|fetal alcohol effects
290998|NCT01911299|Pregnancy Complications|pregnancy complications
290999|NCT01911299|Alcohol-Induced Disorders|alcohol-induced disorders
291000|NCT01911299|Alcohol-Related Disorders|alcohol-related disorders
291001|NCT01911299|Central Nervous System Agents|central nervous system agents
291002|NCT01911299|Therapeutic Uses|therapeutic uses
291003|NCT01911273|Hepatocellular carcinoma|hepatocellular carcinoma
291004|NCT01911273|monoclonal antibody|monoclonal antibody
291005|NCT01911273|ALK-1|alk-1
291006|NCT01911273|best supportive care|best supportive care
291007|NCT01911260|Zinc|zinc
291008|NCT01911260|Growth|growth
291009|NCT01911260|Child|child
291010|NCT01911260|Dietary Supplements|dietary supplements
291011|NCT01911260|Randomized Controlled Trial|randomized controlled trial
291012|NCT01911221|Meningococcal disease,|meningococcal disease,
291013|NCT01911221|Adults|adults
291014|NCT01911208|Minority|minority
291015|NCT01911208|Recruitment|recruitment
291016|NCT01911195|General anesthesia|general anesthesia
291017|NCT01911195|cognition|cognition
291018|NCT01911195|consciousness|consciousness
291019|NCT01911182|apnea of prematurity|apnea of prematurity
291020|NCT01911182|control of breathing|control of breathing
291021|NCT01911182|newborn|newborn
291022|NCT01911182|CO2 inhalation|co2 inhalation
291023|NCT01911169|atherosclerosis|atherosclerosis
291024|NCT01911169|systemic lupus erythematosus|systemic lupus erythematosus
291025|NCT01911169|flow mediated dilation|flow mediated dilation
291026|NCT01911169|interferon gene signature|interferon gene signature
291027|NCT01911156|Chronic Hepatitis B|chronic hepatitis b
291028|NCT01911130|outcomes measures|outcomes measures
291029|NCT01911130|strength measurement|strength measurement
291030|NCT01911130|disease progression|disease progression
291031|NCT01911104|muscle|muscle
291032|NCT01911104|mitochondrial function|mitochondrial function
291033|NCT01911104|exercise resistance|exercise resistance
291034|NCT01911104|human|human
291035|NCT01911104|myotubes|myotubes
291036|NCT01911104|epigenetics|epigenetics
291037|NCT01911091|skeletal muscle|skeletal muscle
291038|NCT01911091|adipose tissue|adipose tissue
291039|NCT01911091|metabolism|metabolism
291040|NCT01911091|oxidation|oxidation
291041|NCT01911091|mitochondrial capacity|mitochondrial capacity
291042|NCT01911078|Metabolic syndrome|metabolic syndrome
291043|NCT01911078|Renal denervation|renal denervation
291044|NCT01911078|Renal artery|renal artery
291045|NCT01911078|Muscle sympathetic nerve activity|muscle sympathetic nerve activity
291046|NCT01911065|Herpes zoster|herpes zoster
291047|NCT01911065|immune response|immune response
291048|NCT01911065|Zostavax|zostavax
291049|NCT01911065|twins|twins
291050|NCT01911065|non-twins|non-twins
291051|NCT01911052|Bowel preparation|bowel preparation
291052|NCT01911039|GVHD|gvhd
291053|NCT01911039|cGVHD|cgvhd
291054|NCT01911026|Bowel preparation|bowel preparation
291055|NCT01911013|degenerative cervical disease|degenerative cervical disease
291056|NCT01911013|anterior cervical discectomy and fusion|anterior cervical discectomy and fusion
291057|NCT01911013|plate and cage|plate and cage
291058|NCT01911013|cage alone|cage alone
291059|NCT01910987|Multiple Myeloma|multiple myeloma
291060|NCT01910987|bortezomib|bortezomib
291061|NCT01910987|Velcade|velcade
291062|NCT01910987|First or Second Relapse|first or second relapse
291063|NCT01910987|retreatment|retreatment
291064|NCT01910987|Prolonged therapy|prolonged therapy
291065|NCT01910974|oesophagus|oesophagus
291066|NCT01910974|stomach|stomach
291067|NCT01910974|intestine|intestine
291068|NCT01910974|rectum|rectum
291069|NCT01910948|omega-3 gastric cancer perioperation|omega-3 gastric cancer perioperation
291070|NCT01910935|Physical activity|physical activity
291071|NCT01910935|Hypertension|hypertension
291072|NCT01910935|Scheme reference|scheme reference
291073|NCT01910935|Primary care|primary care
291074|NCT01910922|vegetable acceptance|vegetable acceptance
291075|NCT01910922|vegetable intake|vegetable intake
291076|NCT01910922|vegetable liking|vegetable liking
291077|NCT01910922|learning mechanisms|learning mechanisms
291078|NCT01910922|repeated exposure to flavor|repeated exposure to flavor
291079|NCT01910922|flavor learning|flavor learning
291080|NCT01910922|replace salt with spice|replace salt with spice
291081|NCT01910909|Hepatocellular carcinoma|hepatocellular carcinoma
291082|NCT01910909|unresectable|unresectable
291083|NCT01910909|small size|small size
291084|NCT01910909|Stereotactic body radiotherapy|stereotactic body radiotherapy
291085|NCT01910883|Safety|safety
291086|NCT01910883|Tolerability|tolerability
291087|NCT01910883|Pharmacokinetic|pharmacokinetic
291088|NCT01910870|Early-relapse|early-relapse
291089|NCT01910844|triple negative breast cancer|triple negative breast cancer
291090|NCT01910844|late-relapse|late-relapse
291091|NCT01910831|bruising, reduction, older age, aging|bruising, reduction, older age, aging
291092|NCT01910818|radiation|radiation
291093|NCT01910818|dermatitis|dermatitis
291094|NCT01910818|laser|laser
291095|NCT01910818|fractional|fractional
291096|NCT01910818|CO2|co2
291097|NCT01910818|chronic|chronic
291098|NCT01910818|fibrosis|fibrosis
291099|NCT01910818|scar|scar
291100|NCT01910805|Gestational diabetes|gestational diabetes
291101|NCT01910805|Diabetes mellitus|diabetes mellitus
291102|NCT01910805|diabetes in pregnancy|diabetes in pregnancy
291103|NCT01910805|diabetes risk|diabetes risk
291104|NCT01910805|diabetes risk awareness|diabetes risk awareness
291105|NCT01910805|African-American|african-american
291106|NCT01910805|Women|women
291107|NCT01910779|Atrial Fibrillation|atrial fibrillation
291108|NCT01910779|Cardioversion|cardioversion
291109|NCT01910779|Biphasic Shock|biphasic shock
291110|NCT01910766|pcos|pcos
291111|NCT01910766|coenzymeQ10|coenzymeq10
291112|NCT01910766|clomiphene citrate|clomiphene citrate
291113|NCT01910753|Head and neck cancer,|head and neck cancer,
291114|NCT01910753|physical activity,|physical activity,
291115|NCT01910753|nutrition therapeutic education|nutrition therapeutic education
291116|NCT01910740|Randomized Controlled Trial|randomized controlled trial
291117|NCT01910740|Exercise Movement Techniques|exercise movement techniques
291118|NCT01910740|Frail Elderly|frail elderly
291119|NCT01910740|Gait|gait
291120|NCT01910727|American Indian|american indian
291121|NCT01910727|Diabetes|diabetes
291122|NCT01910727|Pre-diabetes|pre-diabetes
291123|NCT01910727|Family health Coach|family health coach
291124|NCT01910714|HIV/AIDS|hiv/aids
291125|NCT01910714|Prevention|prevention
291126|NCT01910714|American Indian|american indian
291127|NCT01910714|Substance use|substance use
291128|NCT01910714|CBPR|cbpr
291129|NCT01910701|Home visiting interventions|home visiting interventions
291130|NCT01910701|American Indian|american indian
291131|NCT01910701|Community based participatory research|community based participatory research
291132|NCT01910688|RGB Salvage, RFA|rgb salvage, rfa
291133|NCT01910662|Suction Skin Blister|suction skin blister
291134|NCT01910662|Induration|induration
291135|NCT01910662|Tuberculin Purified Protein Derivative|tuberculin purified protein derivative
291136|NCT01910662|Erythema|erythema
291137|NCT01910662|Biopsy|biopsy
291138|NCT01910662|Keyhole Limpet Hemocyanin|keyhole limpet hemocyanin
291139|NCT01910662|Delayed Type Hypersensitivity|delayed type hypersensitivity
291140|NCT01910649|drisapersen|drisapersen
291141|NCT01910636|HCV genotype 2 (GT-2)|hcv genotype 2 (gt-2)
291142|NCT01910623|Quality of life|quality of life
291143|NCT01910623|Health related quality of life outcomes|health related quality of life outcomes
291144|NCT01910623|Long-term|long-term
291145|NCT01910623|Aida 0493|aida 0493
291146|NCT01910623|AIDA 2000|aida 2000
291147|NCT01910610|wild-type RAS metastatic colorectal cancer|wild-type ras metastatic colorectal cancer
291148|NCT01910584|quality of life|quality of life
291149|NCT01910584|sexual activity|sexual activity
291150|NCT01910584|Novasure endometrial ablation|novasure endometrial ablation
291151|NCT01910584|menorrhagia|menorrhagia
291152|NCT01910558|Alpha-cyclodextrin|alpha-cyclodextrin
291153|NCT01910558|Dietary fiber|dietary fiber
291154|NCT01910558|Fecal fat|fecal fat
291155|NCT01910558|Saturated fat|saturated fat
291156|NCT01910519|influenza A (H5N1) virus|influenza a (h5n1) virus
291157|NCT01910519|H5N1 influenza|h5n1 influenza
291158|NCT01910519|influenza A/H5/N1|influenza a/h5/n1
291159|NCT01910519|monovalent H5N1 influenza vaccine|monovalent h5n1 influenza vaccine
291160|NCT01910519|systems biology|systems biology
291161|NCT01910519|AS03 adjuvant|as03 adjuvant
291162|NCT01910519|unadjuvanted|unadjuvanted
291163|NCT01910493|mhealth|mhealth
291164|NCT01910493|mobile health|mobile health
291165|NCT01910493|SMS|sms
291166|NCT01910493|SMS reminders|sms reminders
291167|NCT01910493|ART retention in care|art retention in care
291168|NCT01910493|PMTCT|pmtct
291169|NCT01910493|PMTCT cascade|pmtct cascade
291170|NCT01910493|retention in care|retention in care
291171|NCT01910454|Stroke|stroke
291172|NCT01910454|Occupational Therapy|occupational therapy
291173|NCT01910454|Cognition|cognition
291174|NCT01910441|Type 2 Diabetes Mellitus, Glycemic variability|type 2 diabetes mellitus, glycemic variability
291175|NCT01910428|L-asparaginase encapsulated in RBCs, leukemia, lymphoma|l-asparaginase encapsulated in rbcs, leukemia, lymphoma
291176|NCT01910402|antiretroviral therapy naïve|antiretroviral therapy naïve
291177|NCT01910402|women|women
291178|NCT01910402|once daily|once daily
291179|NCT01910402|HIV infection|hiv infection
291180|NCT01910402|atazanavir|atazanavir
291181|NCT01910402|tenofovir/emtricitabine|tenofovir/emtricitabine
291182|NCT01910402|dolutegravir/abacavir/lamivudine fixed dose combination|dolutegravir/abacavir/lamivudine fixed dose combination
291183|NCT01910402|integrase inhibitor|integrase inhibitor
291184|NCT01910402|ritonavir|ritonavir
291185|NCT01910389|Heart failure|heart failure
291186|NCT01910389|Pulmonary hypertension|pulmonary hypertension
291187|NCT01910389|tadalafil|tadalafil
291188|NCT01910389|Phosphodiesterase Type 5 Inhibition|phosphodiesterase type 5 inhibition
291189|NCT01910363|poststroke spasticity|poststroke spasticity
291190|NCT01910363|lower limb|lower limb
291191|NCT01910363|botulinum toxin|botulinum toxin
291192|NCT01910363|A2|a2
291193|NCT01910350|Breast & cervical cancer prevention & screening|breast & cervical cancer prevention & screening
291194|NCT01910337|ASA I patients|asa i patients
291195|NCT01910324|Juvenile Offenders|juvenile offenders
291196|NCT01910324|HIV/STD Prevention|hiv/std prevention
291197|NCT01910324|Adolescent Substance Abuse|adolescent substance abuse
291198|NCT01910324|Multidimensional Family Therapy|multidimensional family therapy
291199|NCT01910298|Breast reconstruction|breast reconstruction
291200|NCT01910298|Breast implant|breast implant
291201|NCT01910298|Breast cancer|breast cancer
291202|NCT01910298|Mastectomy|mastectomy
291203|NCT01910285|Anesthetic induction|anesthetic induction
291405|NCT01909427|CNTO 6785|cnto 6785
291204|NCT01910285|Intubation conditions|intubation conditions
291205|NCT01910285|Tooth extraction|tooth extraction
291206|NCT01910285|Propofol|propofol
291207|NCT01910285|Sufentanil|sufentanil
291208|NCT01910285|Remifentanil|remifentanil
291209|NCT01910272|Radiation attenuation|radiation attenuation
291210|NCT01910272|Fluoroscopy|fluoroscopy
291211|NCT01910272|Invasive cardiac procedures|invasive cardiac procedures
291212|NCT01910272|Cardiac Catheterization|cardiac catheterization
291213|NCT01910259|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
291214|NCT01910259|Neuroprotective|neuroprotective
291215|NCT01910259|Repurposed drugs|repurposed drugs
291216|NCT01910259|Brain atrophy|brain atrophy
291217|NCT01910259|Percentage Brain Volume Change|percentage brain volume change
291218|NCT01910259|Magnetic Resonance Imaging|magnetic resonance imaging
291219|NCT01910259|Optical Coherence Tomography|optical coherence tomography
291220|NCT01910259|Cerebrospinal fluid|cerebrospinal fluid
291221|NCT01910259|Amiloride|amiloride
291222|NCT01910259|Riluzole|riluzole
291223|NCT01910259|Double blind|double blind
291224|NCT01910259|Placebo|placebo
291225|NCT01910259|Fluoxetine|fluoxetine
291226|NCT01910246|Metformin|metformin
291227|NCT01910246|Insulin Resistance|insulin resistance
291228|NCT01910246|Cardiac Function|cardiac function
291229|NCT01910233|dyspnea|dyspnea
291230|NCT01910233|registry|registry
291231|NCT01910233|baseline characteristics|baseline characteristics
291232|NCT01910233|mortality|mortality
291233|NCT01910233|risk assessment|risk assessment
291234|NCT01910233|emergency department|emergency department
291235|NCT01910142|bone metabolism|bone metabolism
291236|NCT01910129|vagus nerve stimulation|vagus nerve stimulation
291237|NCT01910129|vagal nerve stimulation|vagal nerve stimulation
291238|NCT01910129|nVNS|nvns
291239|NCT01910129|VNS|vns
291240|NCT01910129|epilepsy|epilepsy
291241|NCT01910129|non invasive|non invasive
291242|NCT01910129|gammacore|gammacore
291243|NCT01910116|osteoarthritis|osteoarthritis
291244|NCT01910116|hand|hand
291245|NCT01910116|Shinbaro|shinbaro
291246|NCT01910116|GCSB-5|gcsb-5
291247|NCT01910103|Breast Neoplasms/radiography|breast neoplasms/radiography
291248|NCT01910103|Mammography/methods|mammography/methods
291249|NCT01910103|Mass Screening|mass screening
291250|NCT01910103|Tomography, X-Ray Computed/methods|tomography, x-ray computed/methods
291251|NCT01910103|Predictive Value of Tests|predictive value of tests
291252|NCT01910103|False Positive Reactions|false positive reactions
291253|NCT01910090|fasting condition|fasting condition
291254|NCT01910077|tacrolimus|tacrolimus
291255|NCT01910077|tacrobell capsule|tacrobell capsule
291256|NCT01910077|prograf capsule|prograf capsule
291257|NCT01910077|bioequivalence|bioequivalence
291258|NCT01910064|Acne Vulgaris|acne vulgaris
291259|NCT01910025|Argininosuccinate Synthetase|argininosuccinate synthetase
291260|NCT01910025|Arginine|arginine
291261|NCT01910025|Arginine deiminase|arginine deiminase
291262|NCT01910012|Argininosuccinate Synthetase|argininosuccinate synthetase
291263|NCT01910012|Arginine|arginine
291264|NCT01910012|Arginine deiminase|arginine deiminase
291265|NCT01909999|Dental Implants|dental implants
291266|NCT01909999|Osseointegration|osseointegration
291267|NCT01909999|Immediate Dental Implant Loading|immediate dental implant loading
291268|NCT01909999|Bone formation|bone formation
291269|NCT01909986|ONO-4053|ono-4053
291270|NCT01909986|Healthy adult male subjects|healthy adult male subjects
291271|NCT01909986|pharmacokinetics|pharmacokinetics
291272|NCT01909986|metabolism|metabolism
291273|NCT01909986|excretion|excretion
291274|NCT01909986|mass balance|mass balance
291275|NCT01909973|Depression|depression
291276|NCT01909973|Antidepressant Medication|antidepressant medication
291277|NCT01909973|Adherence|adherence
291278|NCT01909973|Mobile Smartphone Intervention|mobile smartphone intervention
291279|NCT01909973|Telemedicine|telemedicine
291280|NCT01909973|Primary Care|primary care
291281|NCT01909960|Normal pressure hydrocephalus|normal pressure hydrocephalus
291282|NCT01909960|Flow MRI|flow mri
291283|NCT01909960|Dementia|dementia
291284|NCT01909960|Cerebrospinal fluid|cerebrospinal fluid
291285|NCT01909960|Shunt|shunt
291286|NCT01909947|Respiratory rate variability|respiratory rate variability
291287|NCT01909947|Heart rate variability|heart rate variability
291288|NCT01909947|Extubation readiness|extubation readiness
291289|NCT01909947|Extubation failure|extubation failure
291290|NCT01909947|Clinical predictors|clinical predictors
291291|NCT01909934|Lymphoma|lymphoma
291292|NCT01909934|Anaplastic Large-cell|anaplastic large-cell
291293|NCT01909934|Relapsed|relapsed
291294|NCT01909934|Refractory|refractory
291295|NCT01909934|Antigens, CD30|antigens, cd30
291296|NCT01909934|Antibody-Drug Conjugate|antibody-drug conjugate
291297|NCT01909934|Antibodies, Monoclonal|antibodies, monoclonal
291298|NCT01909934|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
291299|NCT01909934|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
291300|NCT01909934|monomethyl auristatin E|monomethyl auristatin e
291301|NCT01909934|Drug Therapy|drug therapy
291302|NCT01909934|Immunotherapy|immunotherapy
291303|NCT01909934|Hematologic Diseases|hematologic diseases
291304|NCT01909908|Wounds and injuries|wounds and injuries
291305|NCT01909908|Ulcer|ulcer
291306|NCT01909908|Diabetic angiopathies|diabetic angiopathies
291307|NCT01909908|Diabetic foot|diabetic foot
291308|NCT01909908|Venous insufficiency|venous insufficiency
291309|NCT01909908|Extracellular matrix|extracellular matrix
291310|NCT01909882|Family member's massage therapy|family member's massage therapy
291311|NCT01909882|Vital signs|vital signs
291312|NCT01909882|Glasgow coma scale|glasgow coma scale
291313|NCT01909882|Intensive care unit|intensive care unit
291314|NCT01909882|Randomized controlled Clinical Trial|randomized controlled clinical trial
291315|NCT01909882|Iran|iran
291316|NCT01909869|MACE|mace
291317|NCT01909869|TVR|tvr
291318|NCT01909869|MI|mi
291319|NCT01909869|TLF|tlf
291320|NCT01909869|Death|death
291321|NCT01909830|Colorectal Cancer Metastatic|colorectal cancer metastatic
291322|NCT01909830|pretreated|pretreated
291323|NCT01909804|Hepatitis|hepatitis
291324|NCT01909804|Genotype 1|genotype 1
291325|NCT01909804|Genotype 3|genotype 3
291326|NCT01909804|Treatment experienced|treatment experienced
291327|NCT01909791|Diabetic Macular Edema|diabetic macular edema
291328|NCT01909791|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
291329|NCT01909765|Circumcision|circumcision
291330|NCT01909765|postoperative pain|postoperative pain
291331|NCT01909752|Lung cancer|lung cancer
291332|NCT01909752|DRibble Vaccine|dribble vaccine
291333|NCT01909752|Imiquimod|imiquimod
291334|NCT01909752|GM-CSF|gm-csf
291335|NCT01909752|HPV vaccine (Ceravix)|hpv vaccine (ceravix)
291336|NCT01909752|Cyclophosphamide|cyclophosphamide
291337|NCT01909739|AKI, atrovastatin, Valvular heart surgery|aki, atrovastatin, valvular heart surgery
291338|NCT01909726|Hospital Design|hospital design
291339|NCT01909726|Technology|technology
291340|NCT01909726|Anxiety|anxiety
291341|NCT01909713|acne, pediatric|acne, pediatric
291342|NCT01909700|Single Incision, Mesh, Complications|single incision, mesh, complications
291343|NCT01909687|blood glucose monitoring systems|blood glucose monitoring systems
291344|NCT01909687|ISO 15197|iso 15197
291345|NCT01909687|system accuracy|system accuracy
291346|NCT01909661|allergy|allergy
291347|NCT01909661|Cow's milk protein|cow's milk protein
291348|NCT01909661|Tolerance|tolerance
291349|NCT01909661|Efficacy|efficacy
291350|NCT01909661|Infants' growth|infants' growth
291351|NCT01909622|Vitamin D|vitamin d
291352|NCT01909622|Milk fortification|milk fortification
291353|NCT01909622|Children|children
291354|NCT01909622|Colombia|colombia
291355|NCT01909609|male|male
291356|NCT01909583|congenital|congenital
291357|NCT01909583|surgery|surgery
291358|NCT01909583|peri-operative|peri-operative
291359|NCT01909583|counselling|counselling
291360|NCT01909557|Acetyl-L-carnitine|acetyl-l-carnitine
291361|NCT01909557|Interferons|interferons
291362|NCT01909557|Ribavirin|ribavirin
291363|NCT01909557|Hepatitis C|hepatitis c
291364|NCT01909557|Fatigue|fatigue
291365|NCT01909544|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
291366|NCT01909544|Muscle fatigue|muscle fatigue
291367|NCT01909544|Energy metabolism|energy metabolism
291368|NCT01909544|Muscle oxygenation|muscle oxygenation
291369|NCT01909531|Deep Brain Stimulation|deep brain stimulation
291370|NCT01909531|Parkinsons Disease|parkinsons disease
291371|NCT01909531|Essential Tremor|essential tremor
291372|NCT01909531|Asleep DBS|asleep dbs
291373|NCT01909518|Esophageal Squamous Intraepithelial Neoplasia|esophageal squamous intraepithelial neoplasia
291374|NCT01909518|surface maturation scoring|surface maturation scoring
291375|NCT01909518|probe-based confocal laser endomicroscopy|probe-based confocal laser endomicroscopy
291376|NCT01909518|virtual chromoendoscopy|virtual chromoendoscopy
291377|NCT01909492|Multiple Sclerosis|multiple sclerosis
291378|NCT01909492|MS|ms
291379|NCT01909492|Relaxin|relaxin
291380|NCT01909466|OPC-14597|opc-14597
291381|NCT01909466|Aripiprazole|aripiprazole
291382|NCT01909466|Schizophrenia|schizophrenia
291383|NCT01909453|Melanoma|melanoma
291384|NCT01909453|Cutaneous melanoma|cutaneous melanoma
291385|NCT01909453|Skin disease|skin disease
291386|NCT01909453|Skin cancer|skin cancer
291387|NCT01909453|Skin Neoplasms|skin neoplasms
291388|NCT01909453|Neoplasm Metastasis|neoplasm metastasis
291389|NCT01909453|BRAF mutant|braf mutant
291390|NCT01909453|BRAF V600E|braf v600e
291391|NCT01909453|BRAF V600K|braf v600k
291392|NCT01909453|Cancer|cancer
291393|NCT01909453|LGX818|lgx818
291394|NCT01909453|MEK162|mek162
291395|NCT01909453|vemurafenib|vemurafenib
291396|NCT01909453|combination|combination
291397|NCT01909453|BRAF inhibitor|braf inhibitor
291398|NCT01909453|resistance|resistance
291399|NCT01909453|The combination of a selective BRAF- and a MEK1/2-inhibitor|the combination of a selective braf- and a mek1/2-inhibitor
291400|NCT01909453|Prior immunotherapy|prior immunotherapy
291401|NCT01909453|MEK inhibitor|mek inhibitor
291402|NCT01909453|Phase III|phase iii
291403|NCT01909453|Combo 300, Combo 450|combo 300, combo 450
291404|NCT01909427|Active rheumatoid arthritis despite methotrexate therapy|active rheumatoid arthritis despite methotrexate therapy
291406|NCT01909427|Methotrexate|methotrexate
291407|NCT01909401|Liver Transplantation|liver transplantation
291408|NCT01909388|Cancer|cancer
291409|NCT01909388|Prostate Cancer|prostate cancer
291410|NCT01909388|Brachytherapy|brachytherapy
291411|NCT01909388|Dose escalation|dose escalation
291412|NCT01909388|High Dose Rate|high dose rate
291413|NCT01909388|MRI-TRUS fusion|mri-trus fusion
291414|NCT01909388|Detection of DILs by MRI|detection of dils by mri
291415|NCT01909362|advanced metastatic colorectal cancer|advanced metastatic colorectal cancer
291416|NCT01909362|mCRC|mcrc
291417|NCT01909362|Colorectal Cancer|colorectal cancer
291418|NCT01909362|Colorectal Carcinoma|colorectal carcinoma
291419|NCT01909362|Colorectal Tumors|colorectal tumors
291420|NCT01909362|Genetic mutation testing|genetic mutation testing
291421|NCT01909362|Tumor tissue sampling|tumor tissue sampling
291422|NCT01909349|medical rehabilitation|medical rehabilitation
291423|NCT01909349|aftercare|aftercare
291424|NCT01909349|multiple health behavior change|multiple health behavior change
291425|NCT01909349|diet|diet
291426|NCT01909349|physical activity|physical activity
291427|NCT01909349|computer|computer
291428|NCT01909349|international study|international study
291429|NCT01909349|ETHNOPSYCHOLOGY|ethnopsychology
291430|NCT01909349|HABIT|habit
291431|NCT01909349|HEALTH|health
291432|NCT01909349|eHealth|ehealth
291433|NCT01909349|eLearning|elearning
291434|NCT01909310|anesthesia, cardiac arrest, resuscitation, ventilation|anesthesia, cardiac arrest, resuscitation, ventilation
291435|NCT01909297|airway management|airway management
291436|NCT01909271|Stroke|stroke
291437|NCT01909271|Community Health Education|community health education
291438|NCT01909271|Minority Health|minority health
291439|NCT01909271|healthcare disparities|healthcare disparities
291440|NCT01909245|Islet cells|islet cells
291441|NCT01909245|hypoglycemia|hypoglycemia
291442|NCT01909245|hypoglycemia unawareness|hypoglycemia unawareness
291443|NCT01909245|islet after kidney transplantation|islet after kidney transplantation
291444|NCT01909245|islet transplant|islet transplant
291445|NCT01909245|insulin independence|insulin independence
291446|NCT01909245|insulin dependence|insulin dependence
291447|NCT01909232|Depression|depression
291448|NCT01909232|Depressive Disorder|depressive disorder
291449|NCT01909232|Major depression|major depression
291450|NCT01909232|Major depressive disorder|major depressive disorder
291451|NCT01909232|MDD|mdd
291452|NCT01909232|Treatment resistant depression|treatment resistant depression
291453|NCT01909232|Treatment intolerant depression|treatment intolerant depression
291454|NCT01909232|TRMD|trmd
291455|NCT01909232|TIMD|timd
291456|NCT01909232|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
291457|NCT01909232|TMS|tms
291458|NCT01909219|preparation, cleansing, colon|preparation, cleansing, colon
291459|NCT01909167|Pregnancy|pregnancy
291460|NCT01909167|symptoms of depression|symptoms of depression
291461|NCT01909167|anxiety|anxiety
291462|NCT01909167|online CBT therapy|online cbt therapy
291463|NCT01909167|treatment as usual|treatment as usual
291464|NCT01909167|maternal bonding|maternal bonding
291465|NCT01909167|postnatal period|postnatal period
291466|NCT01909154|neurophysiological parameters improvement|neurophysiological parameters improvement
291467|NCT01909154|spinal cord injury|spinal cord injury
291468|NCT01909154|biology therapy|biology therapy
291469|NCT01909141|letrozole|letrozole
291470|NCT01909141|clomiphene citrate|clomiphene citrate
291471|NCT01909141|pioglitazone|pioglitazone
291472|NCT01909141|metformin|metformin
291473|NCT01909141|ovulation induction|ovulation induction
291474|NCT01909141|PCOS|pcos
291475|NCT01909128|children, fermented milk fermented rice, gastrointestinal infections, respiratory infections|children, fermented milk fermented rice, gastrointestinal infections, respiratory infections
291476|NCT01909102|Acceptance and Commitment Therapy|acceptance and commitment therapy
291477|NCT01909102|Cardiac rehabilitation|cardiac rehabilitation
291478|NCT01909050|celiac disease|celiac disease
291479|NCT01909050|refractory celiac disease|refractory celiac disease
291480|NCT01909050|gluten sensitivity|gluten sensitivity
291481|NCT01909037|osteoarthritis|osteoarthritis
291482|NCT01909037|curcumin|curcumin
291483|NCT01909037|biomarker|biomarker
291484|NCT01909037|pain|pain
291485|NCT01909024|Randomised controlled trial|randomised controlled trial
291486|NCT01909024|Endovenous laser treatment|endovenous laser treatment
291487|NCT01909024|Transjugular coil embolisation|transjugular coil embolisation
291488|NCT01908998|Y-Balance test|y-balance test
291489|NCT01908985|glaucoma|glaucoma
291490|NCT01908985|high intensity focused ultrasound|high intensity focused ultrasound
291491|NCT01908985|aqueous humor|aqueous humor
291492|NCT01908985|fluorophotometry|fluorophotometry
291493|NCT01908972|Hemangioma|hemangioma
291494|NCT01908972|Propranolol|propranolol
291495|NCT01908972|prednisolone|prednisolone
291496|NCT01908972|steroid|steroid
291497|NCT01908959|Hispanic Women|hispanic women
291498|NCT01908959|Postpartum|postpartum
291499|NCT01908959|Overweight Hispanic Women|overweight hispanic women
291500|NCT01908959|Low-income|low-income
291501|NCT01908959|Physical Activity|physical activity
291502|NCT01908959|Walking|walking
291503|NCT01908946|Polio|polio
291504|NCT01908933|Advanced Emphysema|advanced emphysema
291505|NCT01908933|Heterogeneous Lower Lobe Predominant Emphysema|heterogeneous lower lobe predominant emphysema
291506|NCT01908933|Heterogeneous Upper and Lower Lobe Predominant|heterogeneous upper and lower lobe predominant
291507|NCT01908907|Premature Infants|premature infants
291508|NCT01908907|DHA(docosahexaenoic acid)|dha(docosahexaenoic acid)
291509|NCT01908907|DHA deficit|dha deficit
291510|NCT01908881|Child Development|child development
291511|NCT01908881|Mother-Child relations|mother-child relations
291512|NCT01908881|Primary Health Care|primary health care
291513|NCT01908881|Public Policy|public policy
291514|NCT01908855|somatoform symptoms|somatoform symptoms
291515|NCT01908855|somatic symptoms|somatic symptoms
291516|NCT01908855|somatoform disorder|somatoform disorder
291517|NCT01908855|somatic symptom disorder|somatic symptom disorder
291518|NCT01908855|cognitive-behavioral therapy|cognitive-behavioral therapy
291519|NCT01908855|emotion regulation training|emotion regulation training
291520|NCT01908842|Opioid|opioid
291521|NCT01908842|Dependence|dependence
291522|NCT01908842|agonist|agonist
291523|NCT01908842|buprenorphine|buprenorphine
291524|NCT01908842|naloxone|naloxone
291525|NCT01908842|BUP/NAL|bup/nal
291526|NCT01908829|Vesitrim|vesitrim
291527|NCT01908829|Betanis|betanis
291528|NCT01908829|Urgency|urgency
291529|NCT01908829|Frequency|frequency
291530|NCT01908829|Mirabegron|mirabegron
291531|NCT01908829|YM178|ym178
291532|NCT01908829|Betmiga|betmiga
291533|NCT01908829|Vesicare|vesicare
291534|NCT01908829|Micturition|micturition
291535|NCT01908829|YM905|ym905
291536|NCT01908829|Solifenacin|solifenacin
291537|NCT01908829|Urinary incontinence|urinary incontinence
291538|NCT01908829|Overactive Bladder (OAB)|overactive bladder (oab)
291539|NCT01908829|Myrbetriq|myrbetriq
291540|NCT01908829|Vesikur|vesikur
291541|NCT01908829|Urgency incontinence|urgency incontinence
291542|NCT01908803|AOMT|aomt
291543|NCT01908803|tympanostomy tubes|tympanostomy tubes
291544|NCT01908803|Otorrhea|otorrhea
291545|NCT01908803|anti-infective|anti-infective
291546|NCT01908790|venous oximeter|venous oximeter
291547|NCT01908790|non-invasive monitor|non-invasive monitor
291548|NCT01908790|heart failure (HF)|heart failure (hf)
291549|NCT01908764|ear tubes|ear tubes
291550|NCT01908764|tympanostomy tubes|tympanostomy tubes
291551|NCT01908764|Otitis Media at the time of Tympanostomy Tube surgery|otitis media at the time of tympanostomy tube surgery
291552|NCT01908764|OMTT|omtt
291553|NCT01908738|Endometrial biopsy|endometrial biopsy
291554|NCT01908738|paracervical block|paracervical block
291555|NCT01908738|Lidocaine spray|lidocaine spray
291556|NCT01908738|women|women
291557|NCT01908738|abnormal uterine bleeding|abnormal uterine bleeding
291558|NCT01908686|ASD|asd
291559|NCT01908673|heart rate variability biofeedback|heart rate variability biofeedback
291560|NCT01908673|automatic self transcedental meditation|automatic self transcedental meditation
291561|NCT01908660|HIV|hiv
291562|NCT01908660|hepatitis C virus|hepatitis c virus
291563|NCT01908660|hepatitis B virus|hepatitis b virus
291564|NCT01908660|antiretroviral drugs|antiretroviral drugs
291565|NCT01908660|nucleos(t)ide reverse transcriptase inhibitors|nucleos(t)ide reverse transcriptase inhibitors
291566|NCT01908660|non-nucleos(t)ide reverse transcriptase inhibitors|non-nucleos(t)ide reverse transcriptase inhibitors
291567|NCT01908660|protease inhibitors|protease inhibitors
291568|NCT01908660|integrase inhibitors|integrase inhibitors
291569|NCT01908660|entry inhibitors|entry inhibitors
291570|NCT01908660|transaminase elevations|transaminase elevations
291571|NCT01908660|alanine aminotransferase|alanine aminotransferase
291572|NCT01908660|aspartate aminotransferase|aspartate aminotransferase
291573|NCT01908660|bilirubin elevations|bilirubin elevations
291574|NCT01908660|hepatic fibrosis|hepatic fibrosis
291575|NCT01908647|mTBI|mtbi
291576|NCT01908647|PTSD|ptsd
291577|NCT01908634|Bioavailability|bioavailability
291578|NCT01908634|Strawberry polyphenols|strawberry polyphenols
291579|NCT01908634|Fruit Beverage Matrix|fruit beverage matrix
291580|NCT01908621|multiple myeloma|multiple myeloma
291581|NCT01908621|mobilization|mobilization
291582|NCT01908621|G-CSF|g-csf
291583|NCT01908621|filgrastim|filgrastim
291584|NCT01908621|cytosine arabinoside|cytosine arabinoside
291585|NCT01908621|autologous stem cell transplantation|autologous stem cell transplantation
291586|NCT01908569|MACS, time-lapse, embryo, spermatozoid, sperm|macs, time-lapse, embryo, spermatozoid, sperm
291587|NCT01908543|Iron deficiency|iron deficiency
291588|NCT01908543|Nosebleeds|nosebleeds
291589|NCT01908530|Diabetes,Continuous Glucose Monitoring,Microprobes|diabetes,continuous glucose monitoring,microprobes
291590|NCT01908517|HPV Vaccine Adherence|hpv vaccine adherence
291591|NCT01908517|Electronic Reminders|electronic reminders
291592|NCT01908491|patient controlled analgesia|patient controlled analgesia
291593|NCT01908491|wound catheter infusion|wound catheter infusion
291594|NCT01908491|postoperative pain control|postoperative pain control
291595|NCT01908491|pectus excavatum|pectus excavatum
291596|NCT01908491|pain score|pain score
291597|NCT01908478|locally advanced|locally advanced
291598|NCT01908478|unresectable|unresectable
291599|NCT01908478|pancreatic|pancreatic
291600|NCT01908478|pancreas|pancreas
291601|NCT01908478|pancreatic adenocarcinoma|pancreatic adenocarcinoma
291602|NCT01908452|Schizophrenia|schizophrenia
291603|NCT01908452|pyridoxal kinase activity|pyridoxal kinase activity
291604|NCT01908452|plasma pyridoxal level|plasma pyridoxal level
291605|NCT01908439|muscle electrical activity|muscle electrical activity
291606|NCT01908439|whole-body vibration|whole-body vibration
291607|NCT01908439|latency|latency
291608|NCT01908426|cabozantinib|cabozantinib
291609|NCT01908426|XL184|xl184
291610|NCT01908426|liver cancer|liver cancer
291611|NCT01908426|hepatocellular carcinoma|hepatocellular carcinoma
291612|NCT01908426|tyrosine kinase inhibitor|tyrosine kinase inhibitor
291613|NCT01908426|MET|met
291614|NCT01908426|vascular endothelial growth factor receptor 2 (VEGFR2)|vascular endothelial growth factor receptor 2 (vegfr2)
291615|NCT01908413|Advanced Solid Tumors|advanced solid tumors
291616|NCT01908413|Lymphoma|lymphoma
291617|NCT01908413|Open-Label|open-label
291618|NCT01908413|Dose-Escalation|dose-escalation
291619|NCT01908413|IAP|iap
291620|NCT01908400|Mental retardation , stem cell,BMMNC|mental retardation , stem cell,bmmnc
291621|NCT01908387|Oral azacitidine|oral azacitidine
291622|NCT01908387|CC-486|cc-486
291623|NCT01908387|Hematological neoplasms|hematological neoplasms
291624|NCT01908387|Phase 1|phase 1
291625|NCT01908374|Active-placebo controlled double blind cross over|active-placebo controlled double blind cross over
291626|NCT01908361|comparative efficacy research|comparative efficacy research
291627|NCT01908361|combination therapy|combination therapy
291628|NCT01908361|neurorehabilitation|neurorehabilitation
291629|NCT01908361|robotic rehabilitation|robotic rehabilitation
291630|NCT01908361|restraint therapy|restraint therapy
291631|NCT01908348|Erythritol|erythritol
291632|NCT01908348|Endothelial function|endothelial function
291633|NCT01908335|interferon|interferon
291634|NCT01908335|ribavirin|ribavirin
291635|NCT01908335|virological response|virological response
291636|NCT01908322|Hepatocellular carcinoma|hepatocellular carcinoma
291637|NCT01908322|Intermediate stage|intermediate stage
291638|NCT01908322|Observational study|observational study
291639|NCT01908309|acute kidney injury|acute kidney injury
291640|NCT01908309|contrast media|contrast media
291641|NCT01908309|cystatin-C|cystatin-c
291642|NCT01908296|FK949E|fk949e
291643|NCT01908296|fluvoxamine|fluvoxamine
291644|NCT01908296|Antipsychotic|antipsychotic
291645|NCT01908296|Quetiapine|quetiapine
291646|NCT01908244|Preterm infants, music, Neonatal Intensive Care Unit (NICU)|preterm infants, music, neonatal intensive care unit (nicu)
291647|NCT01908231|Pulmonary embolism, plasma lactate, right ventricular dysfunction|pulmonary embolism, plasma lactate, right ventricular dysfunction
291648|NCT01908218|ULBT, diffficult laryngoscopy, Predictive Value of Tests|ulbt, diffficult laryngoscopy, predictive value of tests
291649|NCT01908205|Autism|autism
291650|NCT01908205|Social|social
291651|NCT01908205|Functioning|functioning
291652|NCT01908205|Cognition|cognition
291653|NCT01908205|Repetitive Behaviors|repetitive behaviors
291654|NCT01908205|Anxiety|anxiety
291655|NCT01908205|Quality of Life|quality of life
291656|NCT01908192|Sodium Benzoate|sodium benzoate
291657|NCT01908192|Schizophrenia|schizophrenia
291658|NCT01908192|Adolescent|adolescent
291659|NCT01908192|Antipsychotic|antipsychotic
291660|NCT01908192|Anti-psychotic|anti-psychotic
291661|NCT01908192|NMDA|nmda
291662|NCT01908192|NaBen|naben
291663|NCT01908192|pediatric|pediatric
291664|NCT01908179|Sterotactic Radiosurgery|sterotactic radiosurgery
291665|NCT01908153|Picture food type|picture food type
291666|NCT01908153|Taste type|taste type
291667|NCT01908127|film modelling|film modelling
291668|NCT01908127|dental anxiety|dental anxiety
291669|NCT01908127|cooperative behaviour|cooperative behaviour
291670|NCT01908127|children|children
291671|NCT01908114|Polio disease|polio disease
291672|NCT01908114|Intervention Package|intervention package
291673|NCT01908114|Polio sero prevalence and sero conversion|polio sero prevalence and sero conversion
291674|NCT01908114|Polio high risk areas of Pakistan|polio high risk areas of pakistan
291675|NCT01908088|Epidermolysis Bullosa mitten hand deformity autologous cultured fibroblast|epidermolysis bullosa mitten hand deformity autologous cultured fibroblast
291676|NCT01908088|amniotic membrane|amniotic membrane
291677|NCT01908075|Primary care|primary care
291678|NCT01908075|Asthma management|asthma management
291679|NCT01908075|Real-world|real-world
291680|NCT01908075|Observational|observational
291681|NCT01908075|Fostair|fostair
291682|NCT01908075|Seretide|seretide
291683|NCT01908062|Substance related disorders|substance related disorders
291684|NCT01908062|HIV|hiv
291685|NCT01908062|naltrexone|naltrexone
291686|NCT01908049|Probiotic|probiotic
291687|NCT01908049|HIV|hiv
291688|NCT01908049|Microbial translocation|microbial translocation
291689|NCT01908049|inflammation|inflammation
291690|NCT01908049|microbiota composition|microbiota composition
291691|NCT01908036|Chronic fatigue syndrome|chronic fatigue syndrome
291692|NCT01908036|CFS|cfs
291693|NCT01908036|myalgic encephalomyelitis|myalgic encephalomyelitis
291694|NCT01908036|M.E.|m.e.
291695|NCT01908036|activity monitor|activity monitor
291696|NCT01908023|exercise therapy|exercise therapy
291697|NCT01908023|oxygen consumption|oxygen consumption
291698|NCT01908010|Alzheimer's disease|alzheimer's disease
291699|NCT01907997|Systemic lidocaine, Intravenous lidocaine infusion, postoperative pain, quality of recovery, Robot-assisted thyroidectomy, thyroid cancer|systemic lidocaine, intravenous lidocaine infusion, postoperative pain, quality of recovery, robot-assisted thyroidectomy, thyroid cancer
291700|NCT01907984|premedication|premedication
291701|NCT01907984|diclofenac|diclofenac
291702|NCT01907984|postoperative headache|postoperative headache
291703|NCT01907984|Visual Analog Scale|visual analog scale
291704|NCT01907958|Microalbuminuria|microalbuminuria
291705|NCT01907958|Hypertensive|hypertensive
291706|NCT01907958|Diabetics|diabetics
291707|NCT01907958|urine albumin|urine albumin
291708|NCT01907945|Household water treatment|household water treatment
291709|NCT01907945|Waterborne illness|waterborne illness
291710|NCT01907945|ceramic filters|ceramic filters
291711|NCT01907945|social network|social network
291712|NCT01907932|splenomegaly|splenomegaly
291713|NCT01907932|ultrasound|ultrasound
291714|NCT01907932|VScan|vscan
291715|NCT01907919|Pulp capping, Diode laser 808 nm, Tertiary dentin, RM-GIC|pulp capping, diode laser 808 nm, tertiary dentin, rm-gic
291716|NCT01907906|Pathogen reduction technology|pathogen reduction technology
291717|NCT01907880|breast|breast
291718|NCT01907880|bone|bone
291719|NCT01907880|pain|pain
291720|NCT01907841|Investigate IPC on EIMD|investigate ipc on eimd
291721|NCT01907789|Ovarian Carcinoma|ovarian carcinoma
291722|NCT01907789|Ovary|ovary
291723|NCT01907789|BRCA Mutation Carriers|brca mutation carriers
291724|NCT01907789|BRCA1 or BRCA2 mutation|brca1 or brca2 mutation
291725|NCT01907789|High risk for developing ovarian cancer|high risk for developing ovarian cancer
291726|NCT01907789|Ovarian cancer screening|ovarian cancer screening
291727|NCT01907789|Risk-reducing salpingo-oophorectomy|risk-reducing salpingo-oophorectomy
291728|NCT01907789|RRSO|rrso
291729|NCT01907789|Prophylactic salpingectomy with delayed oophorectomy|prophylactic salpingectomy with delayed oophorectomy
291730|NCT01907789|PSDO|psdo
291731|NCT01907789|Questionnaire|questionnaire
291732|NCT01907789|Quality of life|quality of life
291733|NCT01907789|QOL|qol
291734|NCT01907789|Survey|survey
291735|NCT01907789|Transvaginal ultrasound|transvaginal ultrasound
291736|NCT01907789|Phone call|phone call
291737|NCT01907763|asthma|asthma
291738|NCT01907763|SOTB07|sotb07
291739|NCT01907750|biliary fistula|biliary fistula
291740|NCT01907750|biliary stricture|biliary stricture
291741|NCT01907750|biliary drainage tube|biliary drainage tube
291742|NCT01907724|Chronic hepatitis C|chronic hepatitis c
291743|NCT01907724|Hepatitis C virus|hepatitis c virus
291744|NCT01907724|HCV|hcv
291745|NCT01907711|Acupuncture.|acupuncture.
291746|NCT01907711|Fatigue syndrome chronic.|fatigue syndrome chronic.
291747|NCT01907711|Sleep disturbances.|sleep disturbances.
291748|NCT01907711|Pain.|pain.
291749|NCT01907711|Cognitive impairment.|cognitive impairment.
291750|NCT01907698|vaginal intercourse|vaginal intercourse
291751|NCT01907698|labour|labour
291752|NCT01907698|term pregnancy|term pregnancy
291753|NCT01907672|Malaria|malaria
291754|NCT01907672|Rapid Diagnostic Tests for Malaria|rapid diagnostic tests for malaria
291755|NCT01907672|Chemical Shops|chemical shops
291756|NCT01907672|Drug Shops|drug shops
291757|NCT01907672|Diagnostics|diagnostics
291758|NCT01907672|Testing for Malaria|testing for malaria
291759|NCT01907659|Respiratory|respiratory
291760|NCT01907659|Viruses|viruses
291761|NCT01907659|Bacterial|bacterial
291762|NCT01907659|Antibiotics|antibiotics
291763|NCT01907659|Procalcitonin|procalcitonin
291764|NCT01907646|bladder training, radical hysterectomy,gynaecologic cancer|bladder training, radical hysterectomy,gynaecologic cancer
291765|NCT01907633|Death, Sudden, Cardiac|death, sudden, cardiac
291766|NCT01907633|Risk of Sudden Cardiac Death|risk of sudden cardiac death
291767|NCT01907633|Domperidone|domperidone
291768|NCT01907633|Proton Pump Inhibitors (PPI)|proton pump inhibitors (ppi)
291769|NCT01907633|Metoclopramide|metoclopramide
291770|NCT01907633|Observational Study|observational study
291771|NCT01907607|Advanced Gastrointestinal Stromal Tumor Refractory to Imatinib and Sunitinib|advanced gastrointestinal stromal tumor refractory to imatinib and sunitinib
291772|NCT01907607|PD-0332991|pd-0332991
291773|NCT01907607|Orally|orally
291774|NCT01907607|Efficacy and safety|efficacy and safety
291775|NCT01907607|Adult patients|adult patients
291776|NCT01907607|Refractory|refractory
291777|NCT01907607|Imatinib|imatinib
291778|NCT01907607|Sunitinib|sunitinib
291779|NCT01907490|Topical treatment of Head Lice Infestation|topical treatment of head lice infestation
291780|NCT01907464|Anorexia nervosa|anorexia nervosa
291781|NCT01907464|Bone mineral density|bone mineral density
291782|NCT01907464|Teenagers or young women|teenagers or young women
291783|NCT01907464|Bone remodelling markers|bone remodelling markers
291784|NCT01907438|BRCA|brca
291785|NCT01907438|estrogen|estrogen
291786|NCT01907438|epithelial breast cells|epithelial breast cells
291787|NCT01907438|genome profile|genome profile
291788|NCT01907412|First time parents|first time parents
291789|NCT01907412|Coparenting|coparenting
291790|NCT01907412|Family Foundations|family foundations
291791|NCT01907399|obese patients|obese patients
291792|NCT01907399|obese patients with type 2 diabetes|obese patients with type 2 diabetes
291793|NCT01907399|healthy volunteers|healthy volunteers
291794|NCT01907386|Endoleaks|endoleaks
291795|NCT01907386|Non-invasive vascular elastography|non-invasive vascular elastography
291796|NCT01907373|olmesartan|olmesartan
291797|NCT01907373|probenecid|probenecid
291798|NCT01907373|pharmacokinetics|pharmacokinetics
291799|NCT01907373|tolerability|tolerability
291800|NCT01907347|intensive care unit (ICU)|intensive care unit (icu)
291801|NCT01907347|body composition|body composition
291802|NCT01907347|phase angle|phase angle
291803|NCT01907347|mortality|mortality
291804|NCT01907347|nosocomial infection|nosocomial infection
291805|NCT01907347|bioimpedance analysis|bioimpedance analysis
291806|NCT01907347|nutrition|nutrition
291807|NCT01907334|oscillometry|oscillometry
291808|NCT01907334|asthma|asthma
291809|NCT01907334|methacholine|methacholine
291810|NCT01907321|stroke|stroke
291811|NCT01907321|dysphagia|dysphagia
291812|NCT01907321|dystussia|dystussia
291813|NCT01907321|cough|cough
291814|NCT01907321|maximum expiratory pressure|maximum expiratory pressure
291815|NCT01907308|Bladder cancer|bladder cancer
291816|NCT01907308|Urothelial cancer|urothelial cancer
291817|NCT01907308|Urothelial carcinoma|urothelial carcinoma
291818|NCT01907295|idiopathic|idiopathic
291819|NCT01907295|heritable|heritable
291820|NCT01907295|anorexigen|anorexigen
291821|NCT01907282|Schizophrenia|schizophrenia
291822|NCT01907282|psychosis|psychosis
291823|NCT01907230|Rheumatoid arthritis|rheumatoid arthritis
291824|NCT01907230|Inactive HBV carrier|inactive hbv carrier
291825|NCT01907230|Resolved Hepatitis B|resolved hepatitis b
291826|NCT01907230|HBV reactivation|hbv reactivation
291827|NCT01907230|Anti-tumor necrotic factor-alfa|anti-tumor necrotic factor-alfa
291828|NCT01907217|Electroconvulsive therapy|electroconvulsive therapy
291829|NCT01907217|ECT|ect
291830|NCT01907217|electrode placement|electrode placement
291831|NCT01907217|effectiveness|effectiveness
291832|NCT01907217|cognition|cognition
291833|NCT01907217|autobiographical memory|autobiographical memory
291834|NCT01907191|Hip Arthroscopy|hip arthroscopy
291835|NCT01907191|Liposomal Bupivacaine|liposomal bupivacaine
291836|NCT01907191|Bupivacaine|bupivacaine
291837|NCT01907178|total knee arthroplasty|total knee arthroplasty
291838|NCT01907152|malnutrition|malnutrition
291839|NCT01907152|undernourishment|undernourishment
291840|NCT01907152|loss of muscle mass|loss of muscle mass
291841|NCT01907139|comparative efficacy research|comparative efficacy research
291842|NCT01907139|combination therapy|combination therapy
291843|NCT01907139|neurorehabilitation|neurorehabilitation
291844|NCT01907139|robot-assisted therapy|robot-assisted therapy
291845|NCT01907139|constraint-induced therapy|constraint-induced therapy
291846|NCT01907126|HIV|hiv
291847|NCT01907126|Sexually transmitted infections|sexually transmitted infections
291848|NCT01907126|Sexual abuse|sexual abuse
291849|NCT01907126|Physical abuse|physical abuse
291850|NCT01907126|Women|women
291851|NCT01907126|Prison|prison
291852|NCT01907087|Late infantile Neuronal Ceroid Lipofuscinosis Type 2|late infantile neuronal ceroid lipofuscinosis type 2
291853|NCT01907087|LINCL|lincl
291854|NCT01907087|NCL2|ncl2
291855|NCT01907087|CLN2|cln2
291856|NCT01907087|Jansky-Bielschowsky disease|jansky-bielschowsky disease
291857|NCT01907074|liver function tests|liver function tests
291858|NCT01907074|end stage liver disease|end stage liver disease
291859|NCT01907074|cirrhosis|cirrhosis
291860|NCT01907074|living liver donor|living liver donor
291861|NCT01907061|acute renal failure|acute renal failure
291862|NCT01907061|post liver transplant|post liver transplant
291863|NCT01907048|Survey|survey
291864|NCT01907048|Effectiveness of risk minimization measures|effectiveness of risk minimization measures
291865|NCT01907048|Rivaroxaban|rivaroxaban
291866|NCT01907048|Anticoagulants|anticoagulants
291867|NCT01907022|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
291868|NCT01907022|chronic tinnitus|chronic tinnitus
291869|NCT01907022|relaxation|relaxation
291870|NCT01906944|trigger point injection|trigger point injection
291871|NCT01906944|transversus abdominis plane|transversus abdominis plane
291872|NCT01906944|abdominal wall pain|abdominal wall pain
291873|NCT01906931|Interstitial lung disease|interstitial lung disease
291874|NCT01906931|Oxygen therapy|oxygen therapy
291875|NCT01906931|Walk|walk
291876|NCT01906918|ischemia|ischemia
291877|NCT01906918|reperfusion|reperfusion
291878|NCT01906918|myocardial ischemia|myocardial ischemia
291879|NCT01906918|myocardial reperfusion|myocardial reperfusion
291880|NCT01906866|Sleep disturbance|sleep disturbance
291881|NCT01906866|Circadian|circadian
291882|NCT01906866|Prolong release melatonin|prolong release melatonin
291883|NCT01906866|Autism Spectrum Disorder|autism spectrum disorder
291884|NCT01906866|Smith-Magenis Syndrome|smith-magenis syndrome
291885|NCT01906866|Angelman Syndrome|angelman syndrome
291886|NCT01906866|tuberous sclerosis|tuberous sclerosis
291887|NCT01906853|BCG|bcg
291888|NCT01906853|Bacille Calmette Guérin|bacille calmette guérin
291889|NCT01906853|Allergy|allergy
291890|NCT01906853|Immunity|immunity
291891|NCT01906853|Immune response|immune response
291892|NCT01906853|Vaccine|vaccine
291893|NCT01906853|Infants|infants
291894|NCT01906853|Children|children
291895|NCT01906853|Infection|infection
291896|NCT01906840|Chronic renal failure|chronic renal failure
291897|NCT01906840|Hemodialysis|hemodialysis
291898|NCT01906840|Oxidative stress|oxidative stress
291899|NCT01906840|Turmeric|turmeric
291900|NCT01906827|cholestasis|cholestasis
291901|NCT01906827|pregnancy|pregnancy
291902|NCT01906827|p wave dispersion|p wave dispersion
291903|NCT01906827|arrhythmia|arrhythmia
291904|NCT01906801|Osteoarthritis|osteoarthritis
291905|NCT01906801|Glucosamine sulfate|glucosamine sulfate
291906|NCT01906801|Diacerein|diacerein
291907|NCT01906801|Randomized controlled trial|randomized controlled trial
291908|NCT01906775|ICD|icd
291909|NCT01906775|ventricular tachyarrhythmia|ventricular tachyarrhythmia
291910|NCT01906775|shock|shock
291911|NCT01906775|sub-threshold pacing|sub-threshold pacing
291912|NCT01906762|Morphine, Acetaminophen, Renal colic, Emergency treatment|morphine, acetaminophen, renal colic, emergency treatment
291913|NCT01906749|Acute coronary syndrome|acute coronary syndrome
291914|NCT01906749|Colchicine|colchicine
291915|NCT01906710|Adverse Drug Events|adverse drug events
291916|NCT01906710|Drug related problems|drug related problems
291917|NCT01906710|Medication Reconciliation|medication reconciliation
291918|NCT01906710|Medication review|medication review
291919|NCT01906710|discharge counseling|discharge counseling
291920|NCT01906710|Hospital Pharmacy based|hospital pharmacy based
291921|NCT01906710|integrated medicines management|integrated medicines management
291922|NCT01906710|patient safety|patient safety
291923|NCT01906684|Acthar Gel|acthar gel
291924|NCT01906684|MS relapse|ms relapse
291925|NCT01906684|7T MRI imaging|7t mri imaging
291926|NCT01906684|Quality of Life|quality of life
291927|NCT01906671|6-mercaptopurine|6-mercaptopurine
291928|NCT01906671|Drug formulation|drug formulation
291929|NCT01906658|H.P. Acthar Gel|h.p. acthar gel
291930|NCT01906658|Acthar|acthar
291931|NCT01906658|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
291932|NCT01906658|ALS|als
291933|NCT01906645|Patient Readmission|patient readmission
291934|NCT01906645|Continuity of Patient Care|continuity of patient care
291935|NCT01906619|Febrile Seizure|febrile seizure
291936|NCT01906619|Respiratory physiology|respiratory physiology
291937|NCT01906619|Respiratory drive|respiratory drive
291938|NCT01906619|Respiratory alkalosis|respiratory alkalosis
291939|NCT01906606|child nutritional status|child nutritional status
291940|NCT01906606|child development|child development
291941|NCT01906606|maternal depression|maternal depression
291942|NCT01906593|safety|safety
291943|NCT01906593|influenza vaccine|influenza vaccine
291944|NCT01906593|post-marketing|post-marketing
291945|NCT01906580|HBV|hbv
291946|NCT01906580|entecavir|entecavir
291947|NCT01906580|peginterferon|peginterferon
291948|NCT01906567|cadmium|cadmium
291949|NCT01906567|lead|lead
291950|NCT01906567|mercury|mercury
291951|NCT01906567|preeclampsia|preeclampsia
291952|NCT01906567|pregnancy|pregnancy
291953|NCT01906541|X-CGD|x-cgd
291954|NCT01906541|chronic granulomatous disease|chronic granulomatous disease
291955|NCT01906541|gene-therapy|gene-therapy
291956|NCT01906528|Nondepolarizing neuromuscular blocking drug|nondepolarizing neuromuscular blocking drug
291957|NCT01906528|Mivacurium|mivacurium
291958|NCT01906528|Sensitivity|sensitivity
291959|NCT01906528|Sex|sex
291960|NCT01906515|Anemia|anemia
291961|NCT01906515|Blood transfusion|blood transfusion
291962|NCT01906515|non invasive hemoglobin monitoring|non invasive hemoglobin monitoring
291963|NCT01906515|patient safety|patient safety
291964|NCT01906489|anemia|anemia
291965|NCT01906489|chronic kidney disease|chronic kidney disease
291966|NCT01906489|CKD|ckd
291967|NCT01906489|chronic renal insufficiency|chronic renal insufficiency
291968|NCT01906489|renal impairment|renal impairment
291969|NCT01906489|erythropoietin|erythropoietin
291970|NCT01906489|kidney|kidney
291971|NCT01906489|oral anemia treatment|oral anemia treatment
291972|NCT01906489|hemoglobin|hemoglobin
291973|NCT01906489|hypoxia-inducible factor|hypoxia-inducible factor
291974|NCT01906489|HIF|hif
291975|NCT01906489|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
291976|NCT01906489|HIF-PHI|hif-phi
291977|NCT01906489|efficacy|efficacy
291978|NCT01906489|safety|safety
291979|NCT01906489|pharmacokinetics|pharmacokinetics
291980|NCT01906476|Depression|depression
291981|NCT01906476|Telephone Cognitive Behavior Therapy|telephone cognitive behavior therapy
291982|NCT01906476|Internet Cognitive Behavioral Therapy|internet cognitive behavioral therapy
291983|NCT01906437|Cardiac fibrosis and Lymphoma|cardiac fibrosis and lymphoma
291984|NCT01906424|spinal cord injury|spinal cord injury
291985|NCT01906424|quadriplegia|quadriplegia
291986|NCT01906424|tetraplegia|tetraplegia
291987|NCT01906424|stimulation|stimulation
291988|NCT01906398|Refractory epilepsy|refractory epilepsy
291989|NCT01906398|ketogenic diet|ketogenic diet
291990|NCT01906398|efficacy|efficacy
291991|NCT01906385|Glioblastoma|glioblastoma
291992|NCT01906385|Astrocytoma|astrocytoma
291993|NCT01906385|Brain Tumor|brain tumor
291994|NCT01906385|Radiotherapy|radiotherapy
291995|NCT01906372|dermatomyositis|dermatomyositis
291996|NCT01906372|polymyositis|polymyositis
291997|NCT01906359|Interesterified fat|interesterified fat
291998|NCT01906359|Stereospecific number 2|stereospecific number 2
291999|NCT01906359|Gut hormones|gut hormones
292000|NCT01906359|GIP|gip
292001|NCT01906359|Insulin sensitivity|insulin sensitivity
292002|NCT01906359|Postprandial lipaemia|postprandial lipaemia
292003|NCT01906359|Haemostatic markers|haemostatic markers
292004|NCT01906333|Exercise|exercise
292005|NCT01906333|Ectopic fat accumulation|ectopic fat accumulation
292006|NCT01906320|anorexia nervosa|anorexia nervosa
292007|NCT01906320|restricting type|restricting type
292008|NCT01906320|muscle strength|muscle strength
292009|NCT01906320|exercise|exercise
292010|NCT01906320|body composition|body composition
292011|NCT01906320|physical activity|physical activity
292012|NCT01906307|hepatorenal syndrome|hepatorenal syndrome
292013|NCT01906294|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
292014|NCT01906281|adipocytokines|adipocytokines
292015|NCT01906281|osteoarthritis|osteoarthritis
292016|NCT01906281|cardiovascular risk|cardiovascular risk
292017|NCT01906268|Generalized Anxiety Disorder|generalized anxiety disorder
292018|NCT01906268|Social Anxiety Disorder|social anxiety disorder
292019|NCT01906268|Panic Disorder|panic disorder
292020|NCT01906268|Antidepressants Resistant|antidepressants resistant
292021|NCT01906268|Attentional Bias Modification Treatment (ABMT)|attentional bias modification treatment (abmt)
292022|NCT01906268|Attentional Retraining|attentional retraining
292023|NCT01906268|Adjuvant Therapy|adjuvant therapy
292024|NCT01906255|HIV-1|hiv-1
292025|NCT01906255|Truvada|truvada
292026|NCT01906255|FTC/TDF|ftc/tdf
292027|NCT01906255|Pre-exposure prophylaxy|pre-exposure prophylaxy
292028|NCT01906255|PrEP|prep
292029|NCT01906255|Adherence|adherence
292030|NCT01906255|Resistance|resistance
292031|NCT01906216|Hepatocellular carcinoma|hepatocellular carcinoma
292032|NCT01906216|sorafenib|sorafenib
292033|NCT01906216|transarterial chemoembolization|transarterial chemoembolization
292034|NCT01906203|Ultramarathon|ultramarathon
292035|NCT01906203|bioelectrical impedance|bioelectrical impedance
292036|NCT01906203|Phase-Angle|phase-angle
292037|NCT01906190|influenza vaccine|influenza vaccine
292038|NCT01906190|immune response|immune response
292039|NCT01906190|persistence|persistence
292040|NCT01906164|RSV|rsv
292041|NCT01906125|Bioequivalence|bioequivalence
292042|NCT01906125|Cmax|cmax
292043|NCT01906125|AUC|auc
292044|NCT01906073|fentanyl|fentanyl
292045|NCT01906073|administration, intranasal|administration, intranasal
292046|NCT01906073|morphine|morphine
292047|NCT01906073|patient satisfaction|patient satisfaction
292048|NCT01906073|patient preference|patient preference
292049|NCT01906047|Non-cystic fibrosis bronchiectasis|non-cystic fibrosis bronchiectasis
292050|NCT01906021|Thermomap|thermomap
292051|NCT01906021|Hepatic Lesions|hepatic lesions
292052|NCT01906021|Radiofrequency Ablation|radiofrequency ablation
292053|NCT01906021|Microwave|microwave
292054|NCT01906021|Non-Invasive Technique|non-invasive technique
292055|NCT01906008|Colorectal cancer|colorectal cancer
292056|NCT01906008|CRC|crc
292057|NCT01906008|Acute peripheral neuropathy|acute peripheral neuropathy
292058|NCT01906008|Numbness|numbness
292059|NCT01906008|Pain|pain
292060|NCT01906008|Loss of motor function|loss of motor function
292061|NCT01906008|Minocycline|minocycline
292062|NCT01906008|Dynacin|dynacin
292063|NCT01906008|Minocin|minocin
292064|NCT01906008|Minocin PAC|minocin pac
292065|NCT01906008|Myrac|myrac
292066|NCT01906008|Solodyn|solodyn
292067|NCT01906008|Placebo|placebo
292068|NCT01906008|Questionnaires|questionnaires
292069|NCT01906008|Surveys|surveys
292070|NCT01906008|Sensory tests|sensory tests
292071|NCT01905995|deep brain sitimulation|deep brain sitimulation
292072|NCT01905995|local field potentials|local field potentials
292073|NCT01905969|Gastric caner, adjuvant chemotherapy|gastric caner, adjuvant chemotherapy
292074|NCT01905917|Stroke|stroke
292075|NCT01905904|electroconvulsive therapy|electroconvulsive therapy
292076|NCT01905904|seizures|seizures
292077|NCT01905904|sevoflurane|sevoflurane
292078|NCT01905891|Non melanoma skin cancer|non melanoma skin cancer
292079|NCT01905891|Field of cancerization|field of cancerization
292080|NCT01905891|Skin carcinogenesis|skin carcinogenesis
292081|NCT01905865|Uncertainty|uncertainty
292082|NCT01905865|Undiagnosed Disease|undiagnosed disease
292083|NCT01905865|Coping|coping
292084|NCT01905852|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
292085|NCT01905852|Ejection Fraction|ejection fraction
292086|NCT01905852|Fractional Flow Reserve|fractional flow reserve
292087|NCT01905852|Myocardial Fibrosis|myocardial fibrosis
292088|NCT01905839|Rigidity|rigidity
292089|NCT01905839|Assessment|assessment
292090|NCT01905839|Parkinson's Disease|parkinson's disease
292091|NCT01905839|Physiological Measures|physiological measures
292092|NCT01905826|Hematopoiesis|hematopoiesis
292093|NCT01905826|Immunodeficiency|immunodeficiency
292094|NCT01905826|Myelodysplasia/Leukemia|myelodysplasia/leukemia
292095|NCT01905826|Lymphedema|lymphedema
292096|NCT01905826|Pulmonary Alveolar Proteinosis|pulmonary alveolar proteinosis
292097|NCT01905800|Vertigo and dizziness.|vertigo and dizziness.
292098|NCT01905800|semicircular canals|semicircular canals
292099|NCT01905774|Renal Function|renal function
292100|NCT01905761|obesity|obesity
292101|NCT01905748|Coagulation|coagulation
292102|NCT01905735|RA|ra
292103|NCT01905722|MRI|mri
292104|NCT01905722|metabolism|metabolism
292105|NCT01905722|healthy|healthy
292106|NCT01905722|7 Tesla|7 tesla
292107|NCT01905709|C diff|c diff
292108|NCT01905709|CDI|cdi
292109|NCT01905709|clostridium difficile associated diarrhea|clostridium difficile associated diarrhea
292110|NCT01905670|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
292111|NCT01905670|cardiac pacing|cardiac pacing
292112|NCT01905670|electrical stimulation|electrical stimulation
292113|NCT01905670|bi-ventricular pacing|bi-ventricular pacing
292114|NCT01905657|PD1|pd1
292115|NCT01905657|PD-1|pd-1
292116|NCT01905657|PDL1|pdl1
292117|NCT01905657|PD-L1|pd-l1
292118|NCT01905644|Vaginal delivery|vaginal delivery
292119|NCT01905644|Perineal lesions|perineal lesions
292120|NCT01905644|Anal sphincter rupture|anal sphincter rupture
292121|NCT01905644|Ultrasound|ultrasound
292122|NCT01905618|Medical Education|medical education
292123|NCT01905618|Tobacco Dependence Treatment|tobacco dependence treatment
292124|NCT01905618|Physician Delivered Intervention|physician delivered intervention
292125|NCT01905592|Human Epidermal Growth Factor 2 Negative Carcinoma of Breast|human epidermal growth factor 2 negative carcinoma of breast
292126|NCT01905592|BRCA1 Gene Mutation|brca1 gene mutation
292127|NCT01905592|BRCA2 Gene Mutation|brca2 gene mutation
292128|NCT01905592|Parp Inhibitor|parp inhibitor
292129|NCT01905592|BRCA|brca
292130|NCT01905579|flaremetry|flaremetry
292131|NCT01905579|aqueous proteins|aqueous proteins
292132|NCT01905579|clinical grading|clinical grading
292133|NCT01905579|Compare flaremetry readings with the protein content of the aqueous|compare flaremetry readings with the protein content of the aqueous
292134|NCT01905579|Compare flaremetry readings with clinical grading of flare|compare flaremetry readings with clinical grading of flare
292135|NCT01905566|Plaque, Atherosclerotic|plaque, atherosclerotic
292136|NCT01905566|clopidogrel|clopidogrel
292137|NCT01905566|ticagrelor|ticagrelor
292138|NCT01905566|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
292139|NCT01905566|Positron-Emission Tomography and Computed Tomography|positron-emission tomography and computed tomography
292140|NCT01905527|Multiple Sclerosis|multiple sclerosis
292141|NCT01905527|Relapsing-Remitting|relapsing-remitting
292142|NCT01905527|Rebif|rebif
292143|NCT01905527|Quintiles Geographic Area Group|quintiles geographic area group
292144|NCT01905527|Standard Subgroup|standard subgroup
292145|NCT01905527|Custom Subgroup|custom subgroup
292146|NCT01905527|RxCrossroads Geographic Area Group|rxcrossroads geographic area group
292147|NCT01905501|Balanced anesthesia|balanced anesthesia
292148|NCT01905501|Inhalation anesthesia|inhalation anesthesia
292149|NCT01905501|Reperfusion injury|reperfusion injury
292150|NCT01905501|Microsurgical Free flap|microsurgical free flap
292151|NCT01905475|STEMI|stemi
292152|NCT01905475|AMI|ami
292153|NCT01905475|repair|repair
292154|NCT01905462|Cervarix|cervarix
292155|NCT01905462|Spontaneous abortion|spontaneous abortion
292156|NCT01905462|Vaccine|vaccine
292157|NCT01905462|Human Papillomavirus|human papillomavirus
292158|NCT01905436|Filariasis|filariasis
292159|NCT01905436|Onchocerciasis|onchocerciasis
292160|NCT01905436|Albendazole|albendazole
292161|NCT01905436|Ivermectin|ivermectin
292162|NCT01905436|STH Soil Transmitted Helminth infections|sth soil transmitted helminth infections
292163|NCT01905436|MDA Mass Drug Administration|mda mass drug administration
292164|NCT01905423|Filariasis|filariasis
292165|NCT01905423|Albendazole|albendazole
292166|NCT01905423|Diethylcarbamazine|diethylcarbamazine
292167|NCT01905423|STH Soil Transmitted Helminths|sth soil transmitted helminths
292168|NCT01905423|MDA Mass Drug Administration|mda mass drug administration
292169|NCT01905384|pancreatic cancer|pancreatic cancer
292170|NCT01905384|cholangiocarcinoma|cholangiocarcinoma
292171|NCT01905384|metastatic malignancy|metastatic malignancy
292172|NCT01905384|jaundice|jaundice
292173|NCT01905371|amphetamine|amphetamine
292174|NCT01905371|stroke recovery|stroke recovery
292175|NCT01905319|juvenile idiopathic arthritis|juvenile idiopathic arthritis
292176|NCT01905319|incidence rate|incidence rate
292177|NCT01905306|dental implants|dental implants
292178|NCT01905306|immediate loading|immediate loading
292179|NCT01905306|full-arch|full-arch
292180|NCT01905306|computer guided implant surgery|computer guided implant surgery
292181|NCT01905280|allograft|allograft
292182|NCT01905280|acellular dermal matrix|acellular dermal matrix
292183|NCT01905280|alveolar ridge|alveolar ridge
292184|NCT01905267|mindfulness|mindfulness
292185|NCT01905267|relapse prevention|relapse prevention
292186|NCT01905267|recovery|recovery
292187|NCT01905267|depression|depression
292188|NCT01905267|adolescents|adolescents
292189|NCT01905254|Transient elastography|transient elastography
292190|NCT01905254|mini-laparoscopy|mini-laparoscopy
292191|NCT01905254|liver biopsy|liver biopsy
292192|NCT01905254|liver cirrhosis|liver cirrhosis
292193|NCT01905254|autoimmune hepatitis|autoimmune hepatitis
292194|NCT01905228|Metastatic Advance Solid Neoplasms|metastatic advance solid neoplasms
292195|NCT01905228|Unresectable Advance Solid Neoplasms|unresectable advance solid neoplasms
292196|NCT01905215|Immunogenicity|immunogenicity
292197|NCT01905215|Respiratory Syncytial Virus|respiratory syncytial virus
292198|NCT01905215|Reactogenicity|reactogenicity
292199|NCT01905215|Vaccination|vaccination
292200|NCT01905215|Safety|safety
292201|NCT01905202|Proton Pump Inhibitor|proton pump inhibitor
292202|NCT01905202|Safety|safety
292203|NCT01905202|Tolerability|tolerability
292204|NCT01905202|pH control|ph control
292205|NCT01905202|Bile Acid|bile acid
292206|NCT01905189|pulmonary arterial hypertension|pulmonary arterial hypertension
292207|NCT01905189|cardiac resynchronization therapy|cardiac resynchronization therapy
292208|NCT01905176|Heart Failure|heart failure
292209|NCT01905176|Randomized Control Trial|randomized control trial
292210|NCT01905176|Disease management|disease management
292211|NCT01905176|Self-care|self-care
292212|NCT01905176|Nursing|nursing
292213|NCT01905176|Patient education as topic|patient education as topic
292214|NCT01905163|Laparoscopy, interval debulking surgery|laparoscopy, interval debulking surgery
292215|NCT01905150|pancreatic Cancer|pancreatic cancer
292216|NCT01905150|G-FLIP, Gemcitabine 5FU Leucovorin Irinotecan Oxaliplatin|g-flip, gemcitabine 5fu leucovorin irinotecan oxaliplatin
292217|NCT01905150|G-FLIP-DM (G-FLIP + Low doses Docetaxel and Mitomycin C)|g-flip-dm (g-flip + low doses docetaxel and mitomycin c)
292218|NCT01905150|Vitamin C (ascorbic acid)|vitamin c (ascorbic acid)
292219|NCT01905137|Myofascial pelvic pain|myofascial pelvic pain
292220|NCT01905124|Uveitis|uveitis
292221|NCT01905124|Intermediate uveitis|intermediate uveitis
292222|NCT01905124|Posterior uveitis|posterior uveitis
292223|NCT01905098|Detoxification|detoxification
292224|NCT01905098|Sauna|sauna
292225|NCT01905098|Hyperthermia|hyperthermia
292226|NCT01905072|Obesity|obesity
292227|NCT01905072|Breastfeeding|breastfeeding
292228|NCT01905072|Educational Intervention|educational intervention
292229|NCT01905059|HIV infection|hiv infection
292230|NCT01905059|second line ART|second line art
292231|NCT01905059|maintenance strategies|maintenance strategies
292232|NCT01905059|Protease inhibitors|protease inhibitors
292233|NCT01905059|mono or bi-therapy|mono or bi-therapy
292234|NCT01905033|Sepsis|sepsis
292235|NCT01905033|Pneumonia|pneumonia
292236|NCT01905033|Peritonitis|peritonitis
292237|NCT01905033|Biomarkers|biomarkers
292238|NCT01905033|Transcriptomics|transcriptomics
292239|NCT01905033|Pathogen detection|pathogen detection
292240|NCT01905020|Type 1 diabetes|type 1 diabetes
292241|NCT01905020|Hypoglycemia|hypoglycemia
292242|NCT01905020|Insulin|insulin
292243|NCT01905020|Glucagon|glucagon
292244|NCT01905020|Closed-loop system|closed-loop system
292245|NCT01905020|Artificial pancreas|artificial pancreas
292246|NCT01905007|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
292247|NCT01905007|Defibrillation threshold testing|defibrillation threshold testing
292248|NCT01904994|HIV (Human Immunodeficiency Virus)|hiv (human immunodeficiency virus)
292249|NCT01904994|ART (antiretroviral therapy)|art (antiretroviral therapy)
292250|NCT01904994|financial incentive|financial incentive
292251|NCT01904994|linkage|linkage
292252|NCT01904994|retention|retention
292253|NCT01904994|SMS (Short Message Service) appointment reminder|sms (short message service) appointment reminder
292254|NCT01904994|accelerated ART|accelerated art
292255|NCT01904994|CD4+ count|cd4+ count
292256|NCT01904903|Breast Cancer HER2 Positive|breast cancer her2 positive
292257|NCT01904903|Cardiac Safety|cardiac safety
292258|NCT01904890|Asian Americans|asian americans
292259|NCT01904890|colorectal cancer screening|colorectal cancer screening
292260|NCT01904890|cancer prevention|cancer prevention
292261|NCT01904890|Filipinos Americans|filipinos americans
292262|NCT01904890|Hmong Americans|hmong americans
292263|NCT01904890|Korean Americans|korean americans
292264|NCT01904890|Randomized Controlled Trials|randomized controlled trials
292265|NCT01904877|HIV testing|hiv testing
292266|NCT01904877|linkage|linkage
292267|NCT01904877|care|care
292268|NCT01904864|randomized controlled trial|randomized controlled trial
292269|NCT01904864|iron medication|iron medication
292270|NCT01904864|Anemia|anemia
292271|NCT01904864|Hematologic Disease|hematologic disease
292272|NCT01904864|Anemia, Iron deficiency|anemia, iron deficiency
292273|NCT01904864|anemia, nutritional|anemia, nutritional
292274|NCT01904864|ferrous sulfate|ferrous sulfate
292275|NCT01904864|NovaFerrum®|novaferrum®
292276|NCT01904851|Peripheral Arterial Disease|peripheral arterial disease
292277|NCT01904851|Stents|stents
292278|NCT01904851|Registry|registry
292279|NCT01904851|Angioplasty|angioplasty
292280|NCT01904851|Endovascular Procedures|endovascular procedures
292281|NCT01904786|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
292282|NCT01904786|Newborn|newborn
292283|NCT01904786|Outcomes|outcomes
292284|NCT01904786|Melatonin|melatonin
292384|NCT01904448|post-meningitis cochlear ossification|post-meningitis cochlear ossification
292385|NCT01904448|cochlear malformation|cochlear malformation
292285|NCT01904773|Combined Multiple Motor and Vocal Tic Disorder; Tourette Disorder; Gilles de la Tourette Syndrome; Tourette Disease|combined multiple motor and vocal tic disorder; tourette disorder; gilles de la tourette syndrome; tourette disease
292286|NCT01904760|agitation|agitation
292287|NCT01904760|delirium|delirium
292288|NCT01904760|dexmedetomidine|dexmedetomidine
292289|NCT01904760|head and neck surgery|head and neck surgery
292290|NCT01904760|microvascular free tissue transfer|microvascular free tissue transfer
292291|NCT01904760|flap|flap
292292|NCT01904747|Food|food
292293|NCT01904747|Bioavailability|bioavailability
292294|NCT01904747|Fasted|fasted
292295|NCT01904747|Fed|fed
292296|NCT01904734|testosterone|testosterone
292297|NCT01904734|hypogonadism|hypogonadism
292298|NCT01904734|pituitary|pituitary
292299|NCT01904708|Phenylketonuria|phenylketonuria
292300|NCT01904708|PKU|pku
292301|NCT01904708|Exercise|exercise
292302|NCT01904708|Muscle Protein Synthesis|muscle protein synthesis
292303|NCT01904708|Plasma Phenylalanine concentration|plasma phenylalanine concentration
292304|NCT01904695|resistant hypertension|resistant hypertension
292305|NCT01904695|causal inference|causal inference
292306|NCT01904695|a chorot study|a chorot study
292307|NCT01904695|recipe of removing both phlegm and blood stasis|recipe of removing both phlegm and blood stasis
292308|NCT01904682|Erythrocyte transfusion|erythrocyte transfusion
292309|NCT01904682|Erythropoiesis-stimulating agent|erythropoiesis-stimulating agent
292310|NCT01904682|International Prognostic Scoring System|international prognostic scoring system
292311|NCT01904669|Fertility|fertility
292312|NCT01904669|Infertility|infertility
292313|NCT01904669|Pregnancy|pregnancy
292314|NCT01904669|Conception|conception
292315|NCT01904669|Behavioral|behavioral
292316|NCT01904669|Lifestyle|lifestyle
292317|NCT01904669|Preconception Care|preconception care
292318|NCT01904669|Women's Health|women's health
292319|NCT01904669|Abortion, Spontaneous|abortion, spontaneous
292320|NCT01904669|Cohort Studies|cohort studies
292321|NCT01904669|Epidemiology|epidemiology
292322|NCT01904669|Internet|internet
292323|NCT01904656|Colorectal Cancer Screening|colorectal cancer screening
292324|NCT01904656|Ohio Appalachia|ohio appalachia
292325|NCT01904630|gene sequencing|gene sequencing
292326|NCT01904630|familial|familial
292327|NCT01904630|risk factors|risk factors
292328|NCT01904617|Length of labor|length of labor
292329|NCT01904617|second stage of labor|second stage of labor
292330|NCT01904617|intravenous hydration of labor|intravenous hydration of labor
292331|NCT01904617|intravenous glucose|intravenous glucose
292332|NCT01904604|Peanut Allergy|peanut allergy
292333|NCT01904604|Food Allergy|food allergy
292334|NCT01904604|Viaskin peanut patch|viaskin peanut patch
292335|NCT01904604|Allergen Immunotherapy|allergen immunotherapy
292336|NCT01904604|Epicutaneous Immunotherapy|epicutaneous immunotherapy
292337|NCT01904604|Whole peanut extract|whole peanut extract
292338|NCT01904604|Allergenic product|allergenic product
292339|NCT01904604|Immediate hypersensitivity|immediate hypersensitivity
292340|NCT01904591|Spinal Cord Injury|spinal cord injury
292341|NCT01904591|Antioxidants|antioxidants
292342|NCT01904591|tractography|tractography
292343|NCT01904591|ASIA assessment|asia assessment
292344|NCT01904578|Menopause|menopause
292345|NCT01904578|Sleep quality|sleep quality
292346|NCT01904578|Acupressure|acupressure
292347|NCT01904565|Hyperthermia,|hyperthermia,
292348|NCT01904565|Proton beam therapy|proton beam therapy
292349|NCT01904565|Soft Tissue Sarcoma|soft tissue sarcoma
292350|NCT01904565|Radiotherapy|radiotherapy
292351|NCT01904565|Phase I/II trial|phase i/ii trial
292352|NCT01904552|Apical periodontitis|apical periodontitis
292353|NCT01904552|Dentaport ZX|dentaport zx
292354|NCT01904552|electronic apex locators|electronic apex locators
292355|NCT01904552|i-Root|i-root
292356|NCT01904552|Raypex 5|raypex 5
292357|NCT01904552|working length|working length
292358|NCT01904526|Guanfacine|guanfacine
292359|NCT01904526|PK/PD|pk/pd
292360|NCT01904526|Smokers|smokers
292361|NCT01904513|Metals|metals
292362|NCT01904513|Pesticides|pesticides
292363|NCT01904513|Toxicity|toxicity
292364|NCT01904500|Cesarean delivery|cesarean delivery
292365|NCT01904474|obesity|obesity
292366|NCT01904474|overweight|overweight
292367|NCT01904474|technology|technology
292368|NCT01904474|internet|internet
292369|NCT01904474|intervention|intervention
292370|NCT01904474|adolescents|adolescents
292371|NCT01904461|tonsillectomy|tonsillectomy
292372|NCT01904461|children|children
292373|NCT01904461|vacuum|vacuum
292374|NCT01904461|medical device|medical device
292375|NCT01904461|pain|pain
292376|NCT01904461|hemorrhage|hemorrhage
292377|NCT01904461|post-surgical complications|post-surgical complications
292378|NCT01904448|pediatric|pediatric
292379|NCT01904448|profound hearing loss|profound hearing loss
292380|NCT01904448|auditory brainstem implant|auditory brainstem implant
292381|NCT01904448|cochlear implant|cochlear implant
292382|NCT01904448|developmental or acquired cochlear nerve deficiency (CND)|developmental or acquired cochlear nerve deficiency (cnd)
292383|NCT01904448|cochlear aplasia (Michel)|cochlear aplasia (michel)
292386|NCT01904448|CND|cnd
292387|NCT01904422|Diabetes mellitus.|diabetes mellitus.
292388|NCT01904422|Periodontitis|periodontitis
292389|NCT01904422|Periodontal treatment.|periodontal treatment.
292390|NCT01904357|Cefazolin, Pediatric|cefazolin, pediatric
292391|NCT01904344|Sleep|sleep
292392|NCT01904344|Sleep- related breathing disorders|sleep- related breathing disorders
292393|NCT01904344|Respiratory pathology|respiratory pathology
292394|NCT01904331|Cardiotoxicity|cardiotoxicity
292395|NCT01904331|long-term effects|long-term effects
292396|NCT01904331|chemotherapy|chemotherapy
292397|NCT01904331|radiotherapy|radiotherapy
292398|NCT01904318|male|male
292399|NCT01904318|Phase I|phase i
292400|NCT01904318|A dose block-randomized|a dose block-randomized
292401|NCT01904318|Double-blinded|double-blinded
292402|NCT01904318|Placebo controlled|placebo controlled
292403|NCT01904318|Single Dose|single dose
292404|NCT01904318|dose Escalation|dose escalation
292405|NCT01904318|IDP-73152 mesylate|idp-73152 mesylate
292406|NCT01904318|Food Effect|food effect
292407|NCT01904318|Pharmacokinetics|pharmacokinetics
292408|NCT01904318|health male volunteer|health male volunteer
292409|NCT01904318|PDF inhibitor|pdf inhibitor
292410|NCT01904305|Pneumonia|pneumonia
292411|NCT01904253|Second line Small Cell Lung Cancer, (SCLC), Refractory or Sensitive to First line Platinum based chemotherapy|second line small cell lung cancer, (sclc), refractory or sensitive to first line platinum based chemotherapy
292412|NCT01904240|Parkinson's disease|parkinson's disease
292413|NCT01904240|GI tract|gi tract
292414|NCT01904240|Lipopolysaccharide binding protein|lipopolysaccharide binding protein
292415|NCT01904227|Borderline Personality Disorder|borderline personality disorder
292416|NCT01904227|Dialectical Behavior Therapy|dialectical behavior therapy
292417|NCT01904214|renal impairement|renal impairement
292418|NCT01904214|pharmacokinetics|pharmacokinetics
292419|NCT01904201|Immune function|immune function
292420|NCT01904201|Interferon-gamma release assays|interferon-gamma release assays
292421|NCT01904201|Active HIV cell Reservoirs|active hiv cell reservoirs
292422|NCT01904188|microbial identification|microbial identification
292423|NCT01904188|antibiotic resistance|antibiotic resistance
292424|NCT01904188|GeneZ and other techniques as developed|genez and other techniques as developed
292425|NCT01904188|sepsis|sepsis
292426|NCT01904188|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
292427|NCT01904175|Stem cell transplantation, non-myeloablative|stem cell transplantation, non-myeloablative
292428|NCT01904149|Moderate to severe acute pain|moderate to severe acute pain
292429|NCT01904149|Postoperative pain|postoperative pain
292430|NCT01904149|Abdominal hysterectomy|abdominal hysterectomy
292431|NCT01904149|Analgesics|analgesics
292432|NCT01904149|Dexketoprofen|dexketoprofen
292433|NCT01904149|Tramadol|tramadol
292434|NCT01904136|Leukemia|leukemia
292435|NCT01904136|Myeloproliferative Diseases|myeloproliferative diseases
292436|NCT01904136|Blood And Marrow Transplantation|blood and marrow transplantation
292437|NCT01904136|High Risk Myeloid Malignancies|high risk myeloid malignancies
292438|NCT01904136|Acute myeloid leukemia|acute myeloid leukemia
292439|NCT01904136|AML|aml
292440|NCT01904136|Myelodysplastic syndrome|myelodysplastic syndrome
292441|NCT01904136|MDS|mds
292442|NCT01904136|Chronic myeloid leukemia|chronic myeloid leukemia
292443|NCT01904136|CML|cml
292444|NCT01904136|Haploidentical Stem-cell Transplantation|haploidentical stem-cell transplantation
292445|NCT01904136|HaploSCT|haplosct
292446|NCT01904136|Expanded natural killer cells|expanded natural killer cells
292447|NCT01904136|NK|nk
292448|NCT01904136|Melphalan|melphalan
292449|NCT01904136|Alkeran|alkeran
292450|NCT01904136|Mesna|mesna
292451|NCT01904136|Mesnex|mesnex
292452|NCT01904136|Cyclophosphamide|cyclophosphamide
292453|NCT01904136|Cytoxan|cytoxan
292454|NCT01904136|Neosar|neosar
292455|NCT01904136|Tacrolimus|tacrolimus
292456|NCT01904136|Prograf|prograf
292457|NCT01904136|Mycophenolate mofetil|mycophenolate mofetil
292458|NCT01904136|MMF|mmf
292459|NCT01904136|CellCept|cellcept
292460|NCT01904136|G-CSF|g-csf
292461|NCT01904136|Filgrastim|filgrastim
292462|NCT01904136|Neupogen|neupogen
292463|NCT01904136|Fludarabine|fludarabine
292464|NCT01904136|Fludarabine phosphate|fludarabine phosphate
292465|NCT01904136|Fludara|fludara
292466|NCT01904123|Brain cancer|brain cancer
292467|NCT01904123|Central nervous system neoplasms|central nervous system neoplasms
292468|NCT01904123|CNS|cns
292469|NCT01904123|Melanoma|melanoma
292470|NCT01904123|Glioblastoma Multiforme|glioblastoma multiforme
292471|NCT01904123|GBM|gbm
292472|NCT01904123|Solid tumors|solid tumors
292473|NCT01904123|Metastatic to the brain|metastatic to the brain
292474|NCT01904123|WP1066|wp1066
292475|NCT01904123|Recurrent malignant glioma|recurrent malignant glioma
292476|NCT01904123|Glioblastoma|glioblastoma
292477|NCT01904123|Anaplastic glioma|anaplastic glioma
292478|NCT01904123|Advanced Brain Tumor Imaging|advanced brain tumor imaging
292479|NCT01904123|ABTI|abti
292480|NCT01904110|Risedronate,cholecalciferol,BMD,montly,weekly,compliance|risedronate,cholecalciferol,bmd,montly,weekly,compliance
292481|NCT01904097|Fibromyalgia|fibromyalgia
292482|NCT01904097|Transcranial Direct Current Stimulation|transcranial direct current stimulation
292483|NCT01904097|tDCS|tdcs
292484|NCT01904097|Pregabalin|pregabalin
292485|NCT01904097|Functional Neuroimaging|functional neuroimaging
292486|NCT01904097|Near Infrared Spectroscopy|near infrared spectroscopy
292487|NCT01904097|NIRS|nirs
292488|NCT01904097|Chronic Pain|chronic pain
292489|NCT01904097|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
292490|NCT01904097|TMS|tms
292491|NCT01904084|Distal radius fracture|distal radius fracture
292492|NCT01904071|Hip Fracture|hip fracture
292493|NCT01904071|Ultrasound|ultrasound
292494|NCT01904071|Nerve Block|nerve block
292495|NCT01904058|PBC|pbc
292496|NCT01904032|Vitamin D|vitamin d
292497|NCT01904032|Diabetes|diabetes
292498|NCT01904032|Self-Management|self-management
292499|NCT01904032|Depression|depression
292500|NCT01904032|Women|women
292501|NCT01904019|arthroplasty|arthroplasty
292502|NCT01904019|trapezio-metacarpial|trapezio-metacarpial
292503|NCT01904006|grouped embryo culture|grouped embryo culture
292504|NCT01904006|embryo density|embryo density
292505|NCT01904006|low oxygen|low oxygen
292506|NCT01904006|benchtop incubator|benchtop incubator
292507|NCT01904006|culture condition|culture condition
292508|NCT01903980|Epipericardial Fat Necrosis|epipericardial fat necrosis
292509|NCT01903980|Fat Necrosis|fat necrosis
292510|NCT01903980|Chest Pain|chest pain
292511|NCT01903980|Pericardial Necrosis|pericardial necrosis
292512|NCT01903980|Pleuritic pain|pleuritic pain
292513|NCT01903967|Pituitary|pituitary
292514|NCT01903967|CGH array|cgh array
292515|NCT01903967|Tumor|tumor
292516|NCT01903941|exercise|exercise
292517|NCT01903928|cytomegalovirus|cytomegalovirus
292518|NCT01903928|DNA vaccine|dna vaccine
292519|NCT01903928|transplantation|transplantation
292520|NCT01903928|HCT|hct
292521|NCT01903902|Coronary artery disease|coronary artery disease
292522|NCT01903902|Balloon angioplasty|balloon angioplasty
292523|NCT01903902|Drug-eluting balloon|drug-eluting balloon
292524|NCT01903889|AE adverse event|ae adverse event
292525|NCT01903889|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
292526|NCT01903889|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
292527|NCT01903889|ART antiretroviral therapy|art antiretroviral therapy
292528|NCT01903889|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
292529|NCT01903889|DCF data collection forms|dcf data collection forms
292530|NCT01903889|DMC Data Monitoring Committee|dmc data monitoring committee
292531|NCT01903889|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
292532|NCT01903889|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
292533|NCT01903889|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
292534|NCT01903889|ICH International Conference of Harmonization|ich international conference of harmonization
292535|NCT01903889|IND Investigational New Drug Application|ind investigational new drug application
292536|NCT01903889|IRB Institutional Review Board|irb institutional review board
292537|NCT01903889|IU International units|iu international units
292538|NCT01903889|mg milligram(s)|mg milligram(s)
292539|NCT01903889|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
292540|NCT01903889|PCR polymerase chain reaction|pcr polymerase chain reaction
292541|NCT01903889|SAE serious adverse event|sae serious adverse event
292542|NCT01903889|µg microgram|µg microgram
292543|NCT01903889|ULN upper limit of the normal range|uln upper limit of the normal range
292544|NCT01903889|WB Western Blot|wb western blot
292545|NCT01903889|ANC Antenatal care|anc antenatal care
292546|NCT01903889|ARV Antiretroviral|arv antiretroviral
292547|NCT01903889|C&T Care and treatment|c&t care and treatment
292548|NCT01903889|CPR Contraceptive prevalence rate|cpr contraceptive prevalence rate
292549|NCT01903889|DHS Demographic and Health Survey|dhs demographic and health survey
292550|NCT01903889|EGPAF Elizabeth Glaser Pediatric AIDS Foundation|egpaf elizabeth glaser pediatric aids foundation
292551|NCT01903889|FP Family planning|fp family planning
292552|NCT01903889|HIV Human immunodeficiency virus|hiv human immunodeficiency virus
292553|NCT01903889|HTC HIV testing and counseling|htc hiv testing and counseling
292554|NCT01903889|IUCD Intrauterine contraceptive device|iucd intrauterine contraceptive device
292555|NCT01903889|MCH Maternal/child health|mch maternal/child health
292556|NCT01903889|PDA Personal digital assistant|pda personal digital assistant
292557|NCT01903889|PEPFAR President's Emergency Plan for AIDS Relief|pepfar president's emergency plan for aids relief
292558|NCT01903889|PHSC Protection of Human Subjects Committee|phsc protection of human subjects committee
292559|NCT01903889|PMTCT Prevention of maternal to child transmission|pmtct prevention of maternal to child transmission
292560|NCT01903889|STAR-SW Strengthening TB and HIV/AIDS Response in the South Western Region of Uganda|star-sw strengthening tb and hiv/aids response in the south western region of uganda
292561|NCT01903889|STI Sexually transmitted infection|sti sexually transmitted infection
292562|NCT01903889|TM Technical monitor|tm technical monitor
292563|NCT01903889|USAID United States Agency for International Development|usaid united states agency for international development
292564|NCT01903889|WHO World Health Organization|who world health organization
292565|NCT01903863|FFP|ffp
292566|NCT01903863|fresh frozen plasma|fresh frozen plasma
292567|NCT01903863|ECMO|ecmo
292568|NCT01903863|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
292569|NCT01903863|anticoagulation|anticoagulation
292570|NCT01903863|transfusion|transfusion
292571|NCT01903850|Benign central airway obstruction|benign central airway obstruction
292572|NCT01903850|Malignant central airway obstruction|malignant central airway obstruction
292573|NCT01903850|Spray cryotherapy|spray cryotherapy
292574|NCT01903850|Endoluminal tumors|endoluminal tumors
292575|NCT01903850|Airway granulation tissue|airway granulation tissue
292576|NCT01903837|Schizophrenia|schizophrenia
292577|NCT01903837|Olanzapine|olanzapine
292578|NCT01903837|Samidorphan|samidorphan
292579|NCT01903837|Alkermes|alkermes
292580|NCT01903824|Irdabisant|irdabisant
292581|NCT01903824|cognitive impairment|cognitive impairment
292582|NCT01903811|carfilzomib|carfilzomib
292583|NCT01903811|relapsed|relapsed
292584|NCT01903811|refractory|refractory
292585|NCT01903811|multiple myeloma|multiple myeloma
292586|NCT01903785|exercise-induced bronchoconstriction (EIB)|exercise-induced bronchoconstriction (eib)
292587|NCT01903785|inhaled salbutamol|inhaled salbutamol
292588|NCT01903785|performance enhancing|performance enhancing
292589|NCT01903785|cycling|cycling
292590|NCT01903733|Subjects|subjects
292591|NCT01903733|Chronic Myeloid Leukemia|chronic myeloid leukemia
292592|NCT01903733|CML|cml
292593|NCT01903733|Bosutinib|bosutinib
292594|NCT01903733|Extension|extension
292595|NCT01903707|Schizophrenia|schizophrenia
292596|NCT01903707|Psychosis|psychosis
292597|NCT01903707|Cognitive deficits|cognitive deficits
292598|NCT01903681|Sleep problems, autism spectrum disorder, prolonged-release melatonin, Circadin, endogenous saliva melatonin|sleep problems, autism spectrum disorder, prolonged-release melatonin, circadin, endogenous saliva melatonin
292599|NCT01903681|Smith-Magenis syndrome, Angelman syndrome, Tuberous Sclerosis|smith-magenis syndrome, angelman syndrome, tuberous sclerosis
292600|NCT01903603|cerebral palsy|cerebral palsy
292601|NCT01903603|multi-modal brain techniques|multi-modal brain techniques
292602|NCT01903603|MRI|mri
292603|NCT01903603|Kinematic|kinematic
292604|NCT01903603|motor control|motor control
292605|NCT01903590|TVT,TOT,Randomized|tvt,tot,randomized
292606|NCT01903577|Ergonomics|ergonomics
292607|NCT01903577|Robotic Surgery|robotic surgery
292608|NCT01903577|Laparoscopic Surgery|laparoscopic surgery
292609|NCT01903564|fetus|fetus
292610|NCT01903564|fetal arrhythmia|fetal arrhythmia
292611|NCT01903564|fetal heart rate|fetal heart rate
292612|NCT01903564|long QT syndrome|long qt syndrome
292613|NCT01903551|post-operative pain|post-operative pain
292614|NCT01903551|loco-regional analgesia|loco-regional analgesia
292615|NCT01903551|minimally invasive surgery|minimally invasive surgery
292616|NCT01903512|TMJ arthrocentesis|tmj arthrocentesis
292617|NCT01903512|internal derangement|internal derangement
292618|NCT01903512|conservative treatment|conservative treatment
292619|NCT01903486|Trouble swallowing|trouble swallowing
292620|NCT01903486|dysphagia|dysphagia
292621|NCT01903486|disorder of the esophagus|disorder of the esophagus
292622|NCT01903473|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
292623|NCT01903473|GVHD|gvhd
292624|NCT01903473|Regulatory T cells|regulatory t cells
292625|NCT01903473|Steroid refractory|steroid refractory
292626|NCT01903473|Rapamycin|rapamycin
292627|NCT01903473|Immune recovery|immune recovery
292628|NCT01903473|Infusion|infusion
292629|NCT01903473|HLA-identical sibling|hla-identical sibling
292630|NCT01903473|HLA-matched unrelated donor|hla-matched unrelated donor
292631|NCT01903447|Internalizing psychopathologies|internalizing psychopathologies
292632|NCT01903447|Depression|depression
292633|NCT01903447|Anxiety|anxiety
292634|NCT01903447|MRI|mri
292635|NCT01903447|medication treatment|medication treatment
292636|NCT01903447|psychotherapy|psychotherapy
292637|NCT01903447|brain function|brain function
292638|NCT01903421|Elderly surgical patients|elderly surgical patients
292639|NCT01903421|Alzheimer's disease|alzheimer's disease
292640|NCT01903421|Dementia|dementia
292641|NCT01903421|Elderly|elderly
292642|NCT01903421|Surgery|surgery
292643|NCT01903395|Colorectal Neoplasms/*drug therapy/*secondary|colorectal neoplasms/*drug therapy/*secondary
292644|NCT01903395|Health Services Accessibility|health services accessibility
292645|NCT01903395|Humans|humans
292646|NCT01903395|Supportive Care Needs|supportive care needs
292647|NCT01903395|Psychooncology|psychooncology
292648|NCT01903395|Primary Health Care/*methods|primary health care/*methods
292649|NCT01903395|Treatment Outcome|treatment outcome
292650|NCT01903395|Socioeconomic Factors|socioeconomic factors
292651|NCT01903395|Quality Assurance, Health Care|quality assurance, health care
292653|NCT01903395|Aged|aged
292654|NCT01903395|Aged, 80 and over|aged, 80 and over
292655|NCT01903369|Shear wave|shear wave
292656|NCT01903369|Elastography|elastography
292657|NCT01903369|Repeatability and Reproducibility|repeatability and reproducibility
292658|NCT01903343|Shear wave|shear wave
292659|NCT01903343|Elastography|elastography
292660|NCT01903343|Repeatability and Reproducibility|repeatability and reproducibility
292661|NCT01903330|ERC1671|erc1671
292662|NCT01903330|GM-CSF|gm-csf
292663|NCT01903330|Cyclophosphamide|cyclophosphamide
292664|NCT01903330|Bevacizumab|bevacizumab
292665|NCT01903304|Olive oil|olive oil
292666|NCT01903304|DTH|dth
292667|NCT01903304|elderly|elderly
292668|NCT01903278|interferon|interferon
292669|NCT01903278|ribavirin|ribavirin
292670|NCT01903278|sustained virological response|sustained virological response
292671|NCT01903265|pain|pain
292672|NCT01903265|sleep|sleep
292673|NCT01903252|UC|uc
292674|NCT01903226|spinal cord injury|spinal cord injury
292675|NCT01903226|physical capacity|physical capacity
292676|NCT01903226|energy expenditure|energy expenditure
292677|NCT01903226|training|training
292678|NCT01903213|Peritoneal dialysis|peritoneal dialysis
292679|NCT01903213|Bixalomer|bixalomer
292680|NCT01903213|Chronic renal failure patients with Hyperphosphatemia|chronic renal failure patients with hyperphosphatemia
292681|NCT01903213|Kiklin®|kiklin®
292682|NCT01903200|Antipsychotic|antipsychotic
292683|NCT01903200|FK949E|fk949e
292684|NCT01903200|Quetiapine|quetiapine
292685|NCT01903200|Elderly|elderly
292686|NCT01903187|hypertension|hypertension
292687|NCT01903187|resistant hypertension|resistant hypertension
292688|NCT01903187|renal denervation|renal denervation
292689|NCT01903174|Breast Cancer|breast cancer
292690|NCT01903174|Breast Reconstruction|breast reconstruction
292691|NCT01903174|Breast Tissue Expansion|breast tissue expansion
292692|NCT01903174|Breast Tissue Expander|breast tissue expander
292693|NCT01903174|Two Stage Breast Reconstruction|two stage breast reconstruction
292694|NCT01903161|delayed remote ischemic preconditioning|delayed remote ischemic preconditioning
292695|NCT01903161|troponin|troponin
292696|NCT01903161|valve replacement surgery|valve replacement surgery
292697|NCT01903148|ANEMIA IN CHRONIC KIDNEY DISEASE PATIENTS NOT ON DIALYSIS|anemia in chronic kidney disease patients not on dialysis
292698|NCT01903135|Obesity Hypoventilation Syndrome|obesity hypoventilation syndrome
292699|NCT01903135|Prevalence|prevalence
292700|NCT01903135|Bicarbonate|bicarbonate
292701|NCT01903096|Panic disorder|panic disorder
292702|NCT01903096|Generalized anxiety disorder|generalized anxiety disorder
292703|NCT01903096|Social phobia|social phobia
292704|NCT01903096|Specific phobia|specific phobia
292705|NCT01903096|Major depressive disorder|major depressive disorder
292706|NCT01903096|Dysthymia|dysthymia
292707|NCT01903096|Somatizations disorder|somatizations disorder
292708|NCT01903096|Pain disorder|pain disorder
292709|NCT01903083|Pancreas|pancreas
292710|NCT01903083|Pancreatic cancer|pancreatic cancer
292711|NCT01903083|Immunotherapy|immunotherapy
292712|NCT01903083|Chemotherapy|chemotherapy
292713|NCT01903083|Radiation|radiation
292714|NCT01903083|Surgery|surgery
292715|NCT01903083|Pancreaticoduodenectomy|pancreaticoduodenectomy
292716|NCT01903057|Mass Drug Administration|mass drug administration
292717|NCT01903057|Neglected Tropical Diseases|neglected tropical diseases
292718|NCT01903057|Preventive Chemotherapy and Transmission Control|preventive chemotherapy and transmission control
292719|NCT01903057|Preventive Chemotherapy|preventive chemotherapy
292720|NCT01903044|Lowe extremity ischemia|lowe extremity ischemia
292721|NCT01903044|Bone marrow|bone marrow
292722|NCT01903044|Neoangiogenesis|neoangiogenesis
292723|NCT01903005|Opioid, Dependence, agonist, Buprenorphine, Naloxone|opioid, dependence, agonist, buprenorphine, naloxone
292724|NCT01902966|Cervical Cancer|cervical cancer
292725|NCT01902966|Propranolol|propranolol
292726|NCT01902966|Betachron|betachron
292727|NCT01902966|Inderal|inderal
292728|NCT01902966|Beta blocker|beta blocker
292729|NCT01902966|Questionnaires|questionnaires
292730|NCT01902966|Surveys|surveys
292731|NCT01902966|Symptom inventory|symptom inventory
292732|NCT01902966|Anxiety and depression survey|anxiety and depression survey
292733|NCT01902966|Pain inventory|pain inventory
292734|NCT01902966|Quality of life survey|quality of life survey
292735|NCT01902966|Relaxation audio recording|relaxation audio recording
292736|NCT01902966|MP3 player|mp3 player
292737|NCT01902966|Diary|diary
292738|NCT01902953|Sentinel lymph nodes|sentinel lymph nodes
292739|NCT01902953|colon cancer|colon cancer
292740|NCT01902953|rectal cancer|rectal cancer
292741|NCT01902953|immunohistochemistry|immunohistochemistry
292742|NCT01902927|Exercise tolerance|exercise tolerance
292743|NCT01902927|Dyspnea|dyspnea
292744|NCT01902927|Affective distraction|affective distraction
292745|NCT01902914|hearing aids|hearing aids
292746|NCT01902914|hearing disability|hearing disability
292747|NCT01902914|community|community
292748|NCT01902914|hearing aids service|hearing aids service
292749|NCT01902901|Whole Genome Sequencing|whole genome sequencing
292750|NCT01902901|Carrier status|carrier status
292751|NCT01902901|Genetics|genetics
292752|NCT01902888|popliteal artery|popliteal artery
292753|NCT01902888|aneurysm|aneurysm
292754|NCT01902888|popliteal artery aneurysm|popliteal artery aneurysm
292755|NCT01902888|asymptomatic aneurysm|asymptomatic aneurysm
292756|NCT01902888|mural thrombus|mural thrombus
292757|NCT01902888|Viabahn|viabahn
292758|NCT01902888|Gore|gore
292759|NCT01902888|Endoprosthesis|endoprosthesis
292760|NCT01902862|Lymphoma, follicular|lymphoma, follicular
292761|NCT01902862|Bortezomib|bortezomib
292762|NCT01902862|Rituximab|rituximab
292763|NCT01902849|intravenous anesthesia|intravenous anesthesia
292764|NCT01902849|inhalational anesthesia|inhalational anesthesia
292765|NCT01902849|interleukins|interleukins
292766|NCT01902849|colorectal surgery|colorectal surgery
292767|NCT01902836|Dialyzable Leukocyte Extracts|dialyzable leukocyte extracts
292768|NCT01902836|Transferon|transferon
292769|NCT01902836|atopic dermatitis|atopic dermatitis
292770|NCT01902823|Nurse Navigator|nurse navigator
292771|NCT01902823|Satisfaction with Care|satisfaction with care
292772|NCT01902823|Quality of Life|quality of life
292773|NCT01902823|Symptom Distress|symptom distress
292774|NCT01902797|Refugee camps|refugee camps
292775|NCT01902797|Household residence|household residence
292776|NCT01902797|Treated bednets|treated bednets
292777|NCT01902797|PCR|pcr
292778|NCT01902784|Intensive Care Unit patients and families|intensive care unit patients and families
292779|NCT01902784|Surrogate decision making|surrogate decision making
292780|NCT01902784|Life Sustaining Treatments (LST)|life sustaining treatments (lst)
292781|NCT01902771|Dendritic Cell Vaccine|dendritic cell vaccine
292782|NCT01902771|DCV|dcv
292783|NCT01902771|Pediatric|pediatric
292784|NCT01902771|Brain Tumor|brain tumor
292785|NCT01902771|In Situ|in situ
292786|NCT01902771|Lysate|lysate
292787|NCT01902771|Tumor Lysate|tumor lysate
292788|NCT01902771|Glioblastoma Multiforme|glioblastoma multiforme
292789|NCT01902771|GBM|gbm
292790|NCT01902771|Pheresis|pheresis
292791|NCT01902771|Leukapheresis|leukapheresis
292792|NCT01902771|High Grade Glioma|high grade glioma
292793|NCT01902771|HGG|hgg
292794|NCT01902758|exercise performance|exercise performance
292795|NCT01902693|HIV|hiv
292796|NCT01902693|Chemotherapy|chemotherapy
292797|NCT01902693|Cohort|cohort
292798|NCT01902693|Cancer|cancer
292799|NCT01902693|HAART|haart
292800|NCT01902693|Malignancy|malignancy
292801|NCT01902680|Prostate cancer, permanent implant brachytherapy, image fusion, focal therapy, active surveillance|prostate cancer, permanent implant brachytherapy, image fusion, focal therapy, active surveillance
292802|NCT01902667|Retroperitoneal Sarcoma|retroperitoneal sarcoma
292803|NCT01902667|Magnetic Resonance Imaging|magnetic resonance imaging
292804|NCT01902654|Osteoarthritis|osteoarthritis
292805|NCT01902654|cardiovascular disease|cardiovascular disease
292806|NCT01902641|succinylcholine|succinylcholine
292807|NCT01902641|rocuronium|rocuronium
292808|NCT01902641|sugammadex|sugammadex
292809|NCT01902641|Intubating Conditions|intubating conditions
292810|NCT01902641|short Procedures|short procedures
292811|NCT01902563|osteopathic manipulative treatment|osteopathic manipulative treatment
292812|NCT01902563|newborns|newborns
292813|NCT01902563|preterm infants|preterm infants
292814|NCT01902563|procedures|procedures
292815|NCT01902550|Healthy|healthy
292816|NCT01902550|JNJ-54452840|jnj-54452840
292817|NCT01902550|Metoprolol Tartrate Immediate-Release|metoprolol tartrate immediate-release
292818|NCT01902550|Placebo|placebo
292819|NCT01902550|Male|male
292820|NCT01902537|Constipation|constipation
292821|NCT01902537|Prucalopride|prucalopride
292822|NCT01902524|Chronic Pain|chronic pain
292823|NCT01902524|Fentanyl-TTS|fentanyl-tts
292824|NCT01902524|Fentanyl Patch|fentanyl patch
292825|NCT01902524|Transdermal|transdermal
292826|NCT01902524|Non-cancer Pain|non-cancer pain
292827|NCT01902498|aspirin|aspirin
292828|NCT01902485|Contraception|contraception
292829|NCT01902485|Medical Abortion|medical abortion
292830|NCT01902485|Implant|implant
292831|NCT01902485|Injectable|injectable
292832|NCT01902485|Quickstart|quickstart
292833|NCT01902472|HIV-1|hiv-1
292834|NCT01902472|Truvada|truvada
292835|NCT01902472|FTC/TDF|ftc/tdf
292836|NCT01902472|Pre-exposure prophylaxy|pre-exposure prophylaxy
292837|NCT01902472|PrEP|prep
292838|NCT01902472|Resistance|resistance
292839|NCT01902459|Hemostasis|hemostasis
292840|NCT01902446|Chlorhexidine|chlorhexidine
292841|NCT01902446|Randomized Controlled Trial|randomized controlled trial
292842|NCT01902446|Emergency Medical Services|emergency medical services
292843|NCT01902446|Intubation, Endotracheal|intubation, endotracheal
292844|NCT01902407|Pcrit|pcrit
292845|NCT01902407|Critical closing pressure|critical closing pressure
292846|NCT01902407|Down syndrome|down syndrome
292847|NCT01902407|Obstructive Sleep Apnea|obstructive sleep apnea
292848|NCT01902407|Sleep MRI|sleep mri
292849|NCT01902394|digestive health and natural defenses|digestive health and natural defenses
292850|NCT01902368|Gluten free diet|gluten free diet
292851|NCT01902355|Central Venous Catheterization|central venous catheterization
292852|NCT01902329|Acute Myeloid Leukemia|acute myeloid leukemia
292853|NCT01902329|Antibody-Drug Conjugate|antibody-drug conjugate
292854|NCT01902329|CD33 Antigen|cd33 antigen
292855|NCT01902329|Immunotherapy|immunotherapy
292856|NCT01902329|Drug Therapy|drug therapy
292857|NCT01902329|Acute Myelogenous Leukemia|acute myelogenous leukemia
292858|NCT01902329|Acute Promyelocytic Leukemia|acute promyelocytic leukemia
292859|NCT01902329|APL|apl
292860|NCT01902316|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
292861|NCT01902316|peptide biomarker|peptide biomarker
292862|NCT01902316|early diagnosis|early diagnosis
292863|NCT01902316|label free|label free
292864|NCT01902303|Herpes Labialis|herpes labialis
292865|NCT01902303|Herpes Simplex|herpes simplex
292866|NCT01902303|Herpes|herpes
293367|NCT01900002|Nexavar|nexavar
292867|NCT01902303|Ultra Violet (UV) Induced|ultra violet (uv) induced
292868|NCT01902290|Inadequately controlled asthma, brodalumab, AMG 827|inadequately controlled asthma, brodalumab, amg 827
292869|NCT01902277|Delirium|delirium
292870|NCT01902277|Intensive Care Unit|intensive care unit
292871|NCT01902277|Critical illness|critical illness
292872|NCT01902264|Levomefolate calcium|levomefolate calcium
292873|NCT01902264|Contraceptives, oral, combined|contraceptives, oral, combined
292874|NCT01902264|Neural tube defects|neural tube defects
292875|NCT01902251|Phase 1|phase 1
292876|NCT01902251|Prostate cancer|prostate cancer
292877|NCT01902251|Bioavailability|bioavailability
292878|NCT01902251|Food effect|food effect
292879|NCT01902251|Pharmacokinetics|pharmacokinetics
292880|NCT01902251|Xtandi|xtandi
292881|NCT01902251|Enzalutamide|enzalutamide
292882|NCT01902251|MDV3100|mdv3100
292883|NCT01902238|neuroendocrine tumor|neuroendocrine tumor
292884|NCT01902238|ethanol|ethanol
292885|NCT01902238|endoscopic ultrasonography|endoscopic ultrasonography
292886|NCT01902225|Lymphoma|lymphoma
292887|NCT01902225|T-Cell|t-cell
292888|NCT01902225|Cutaneous|cutaneous
292889|NCT01902225|Doxil|doxil
292890|NCT01902225|romidepsin|romidepsin
292891|NCT01902225|skin|skin
292892|NCT01902186|HIV|hiv
292893|NCT01902186|osteopenia|osteopenia
292894|NCT01902186|t-score|t-score
292895|NCT01902186|DEXA|dexa
292896|NCT01902186|tenofovir|tenofovir
292897|NCT01902186|raltegravir|raltegravir
292898|NCT01902147|abdominal|abdominal
292899|NCT01902147|thoracic|thoracic
292900|NCT01902147|arthroplasty|arthroplasty
292901|NCT01902134|Moderate to severe acute pain|moderate to severe acute pain
292902|NCT01902134|Postoperative pain|postoperative pain
292903|NCT01902134|Hip arthroplasty|hip arthroplasty
292904|NCT01902134|Analgesics|analgesics
292905|NCT01902134|Dexketoprofen|dexketoprofen
292906|NCT01902134|Tramadol|tramadol
292907|NCT01902108|clonidine|clonidine
292908|NCT01902108|bupivacaine|bupivacaine
292909|NCT01902108|post-operative pain|post-operative pain
292910|NCT01902108|arthrodesis|arthrodesis
292911|NCT01902108|discectomy|discectomy
292912|NCT01902108|local infiltration|local infiltration
292913|NCT01902095|tooth pastes|tooth pastes
292914|NCT01902095|tooth powders|tooth powders
292915|NCT01902095|Stain Index|stain index
292916|NCT01902082|ARDS|ards
292917|NCT01902082|mesenchymal stem cells|mesenchymal stem cells
292918|NCT01902082|Safety|safety
292919|NCT01902082|Cytokines|cytokines
292920|NCT01902069|sweet and fat preference|sweet and fat preference
292921|NCT01902056|allograft|allograft
292922|NCT01902056|acellular dermal matrix|acellular dermal matrix
292923|NCT01902056|Alloderm|alloderm
292924|NCT01902043|diabetes mellitus|diabetes mellitus
292925|NCT01902043|cohort study|cohort study
292926|NCT01902043|quality of care|quality of care
292927|NCT01902043|quality indicators, Health care|quality indicators, health care
292928|NCT01902043|quality of Health Care|quality of health care
292929|NCT01902043|outcome and process assessment|outcome and process assessment
292930|NCT01902043|health services research|health services research
292931|NCT01902043|chronic diseases prevention and management|chronic diseases prevention and management
292932|NCT01902017|Joint|joint
292933|NCT01902017|Contracture|contracture
292934|NCT01902017|Elbow|elbow
292935|NCT01902017|Fracture|fracture
292936|NCT01902017|Dislocation|dislocation
292937|NCT01902004|Major Depression|major depression
292938|NCT01902004|Geriatric Major Depression|geriatric major depression
292939|NCT01902004|Executive Cognitive Dysfunction|executive cognitive dysfunction
292940|NCT01902004|Mild Cognitive Impairment|mild cognitive impairment
292941|NCT01902004|Older Adults|older adults
292942|NCT01902004|Geriatric|geriatric
292943|NCT01902004|Executive Cognitive Impairment|executive cognitive impairment
292944|NCT01902004|Quality of Life|quality of life
292945|NCT01902004|Disability|disability
292946|NCT01902004|Comorbidity|comorbidity
292947|NCT01902004|Medical Burden|medical burden
292948|NCT01902004|Safety|safety
292949|NCT01902004|Candidate Genes|candidate genes
292950|NCT01901991|Nonpalpable breast lesions|nonpalpable breast lesions
292951|NCT01901991|Breast Cancer and carcinoma in situ|breast cancer and carcinoma in situ
292952|NCT01901991|Radioactive seed localization|radioactive seed localization
292953|NCT01901991|Wire-guided localization|wire-guided localization
292954|NCT01901991|Randomized study|randomized study
292955|NCT01901978|Obesity|obesity
292956|NCT01901978|Insulin Resistance|insulin resistance
292957|NCT01901978|Weight loss|weight loss
292958|NCT01901978|Women|women
292959|NCT01901952|Self management diabetes intervention|self management diabetes intervention
292960|NCT01901939|exercise|exercise
292961|NCT01901939|elderly|elderly
292962|NCT01901939|activities of daily living|activities of daily living
292963|NCT01901939|disability|disability
292964|NCT01901913|Type 1 Diabetes|type 1 diabetes
292965|NCT01901913|Artificial pancreas|artificial pancreas
292966|NCT01901913|Closed loop|closed loop
292967|NCT01901887|Adults|adults
292968|NCT01901887|Suicidality|suicidality
292969|NCT01901861|GLP-1, GIP, DPP-4 inhibition, iset function|glp-1, gip, dpp-4 inhibition, iset function
292970|NCT01901848|Smoking Cessation|smoking cessation
292971|NCT01901848|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
292972|NCT01901848|Psychotherapy|psychotherapy
292973|NCT01901822|acellular dermal matrix|acellular dermal matrix
292974|NCT01901809|Heart failure, diastolic|heart failure, diastolic
292975|NCT01901809|HFpEF|hfpef
292976|NCT01901809|Diuretics|diuretics
292977|NCT01901809|Dopamine|dopamine
292978|NCT01901796|Anxiety|anxiety
292979|NCT01901796|Depression|depression
292981|NCT01901783|allograft|allograft
292982|NCT01901783|regeneration|regeneration
292983|NCT01901783|alveolar ridge|alveolar ridge
292984|NCT01901770|HPV|hpv
292985|NCT01901770|Ohio Appalachia|ohio appalachia
292986|NCT01901770|HPV vaccine|hpv vaccine
292987|NCT01901770|No evidence of disease|no evidence of disease
292988|NCT01901744|Contrast Sensitivity , Pediatric Cataract Surgery,|contrast sensitivity , pediatric cataract surgery,
292989|NCT01901731|transjugular coil embolisation|transjugular coil embolisation
292990|NCT01901731|endovenous treatment of varicose veins|endovenous treatment of varicose veins
292991|NCT01901731|pelvic venous reflux|pelvic venous reflux
292992|NCT01901731|recurrent varicose veins|recurrent varicose veins
292993|NCT01901718|Breakthrough Pain|breakthrough pain
292994|NCT01901718|Subsys|subsys
292995|NCT01901718|Fentanyl|fentanyl
292996|NCT01901718|Opioid|opioid
292997|NCT01901718|Persistent Pain|persistent pain
292998|NCT01901705|Psoriasis|psoriasis
292999|NCT01901705|Indigo Naturalis|indigo naturalis
293000|NCT01901705|chinese medicine|chinese medicine
293001|NCT01901692|liver cancer|liver cancer
293002|NCT01901692|first-line|first-line
293003|NCT01901692|tumor thrombus|tumor thrombus
293004|NCT01901692|vascular invasion|vascular invasion
293005|NCT01901679|Obesity|obesity
293006|NCT01901679|Post-menopausal|post-menopausal
293007|NCT01901666|growth hormone, Chronic Myelogenous Leukemia, Imatinib,serum IGF-1|growth hormone, chronic myelogenous leukemia, imatinib,serum igf-1
293008|NCT01901653|Small cell lung cancer|small cell lung cancer
293009|NCT01901627|Spondylitis, Ankylosing|spondylitis, ankylosing
293010|NCT01901627|adalimumab|adalimumab
293011|NCT01901627|Prospective Studies|prospective studies
293012|NCT01901614|Keratoconus|keratoconus
293013|NCT01901614|Corneal Opacity|corneal opacity
293014|NCT01901614|Keratoplasty|keratoplasty
293015|NCT01901601|KERATOPLASTY|keratoplasty
293016|NCT01901601|STROMAL OPACITIES|stromal opacities
293017|NCT01901588|strabismus|strabismus
293018|NCT01901588|pediatric|pediatric
293019|NCT01901588|emergence delirium|emergence delirium
293020|NCT01901588|precedex/dexmedetomidine|precedex/dexmedetomidine
293021|NCT01901575|idiopathic ventricular tachycardia|idiopathic ventricular tachycardia
293022|NCT01901562|ductoscopy|ductoscopy
293023|NCT01901562|nipple discharge|nipple discharge
293024|NCT01901562|breast|breast
293025|NCT01901562|papilloma|papilloma
293026|NCT01901536|First time parents|first time parents
293027|NCT01901536|Coparenting|coparenting
293028|NCT01901536|Family Foundations|family foundations
293029|NCT01901523|Discrepancy|discrepancy
293030|NCT01901523|Committee on Publication Ethics|committee on publication ethics
293031|NCT01901523|Correction|correction
293032|NCT01901523|Erratum|erratum
293033|NCT01901523|Retraction|retraction
293034|NCT01901510|polyp|polyp
293035|NCT01901497|non invasive ventilation|non invasive ventilation
293036|NCT01901497|single limb circuit ventilator|single limb circuit ventilator
293037|NCT01901497|bilevel|bilevel
293038|NCT01901497|nebulization|nebulization
293039|NCT01901497|nebulizer|nebulizer
293040|NCT01901497|vibrating mesh nebulizer|vibrating mesh nebulizer
293041|NCT01901497|amikacin|amikacin
293042|NCT01901484|Schistosoma mansoni|schistosoma mansoni
293043|NCT01901484|morbidity|morbidity
293044|NCT01901484|chemotherapy|chemotherapy
293045|NCT01901471|Cyclosporine, cardiogenic shock, SOFA score,|cyclosporine, cardiogenic shock, sofa score,
293046|NCT01901458|apheresis|apheresis
293047|NCT01901458|peripheral blood progenitor cells|peripheral blood progenitor cells
293048|NCT01901458|peripheral blood stem cells|peripheral blood stem cells
293049|NCT01901445|Quality of life|quality of life
293050|NCT01901445|Constipation|constipation
293051|NCT01901445|Focus groups|focus groups
293052|NCT01901445|Health education|health education
293053|NCT01901445|Problem-based learning|problem-based learning
293054|NCT01901432|chronic myeloproliferative neoplasms|chronic myeloproliferative neoplasms
293055|NCT01901432|Polycythemia Vera|polycythemia vera
293056|NCT01901432|Essential Thrombocythemia|essential thrombocythemia
293057|NCT01901432|Primary Myelofibrosis|primary myelofibrosis
293058|NCT01901432|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
293059|NCT01901432|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
293060|NCT01901432|Givinostat|givinostat
293061|NCT01901419|nitroglycerin|nitroglycerin
293062|NCT01901419|cardiopulmonary bypass|cardiopulmonary bypass
293063|NCT01901419|cardiac surgery|cardiac surgery
293064|NCT01901406|epiretinal membrane, stereopsis, aniseikonia|epiretinal membrane, stereopsis, aniseikonia
293065|NCT01901393|Post Operative Pain,|post operative pain,
293066|NCT01901393|Pail relief|pail relief
293368|NCT01900002|BAY 43-9006|bay 43-9006
293067|NCT01901367|Adiponectin, Glucose, Insulin, Leptin|adiponectin, glucose, insulin, leptin
293068|NCT01901354|Acute lung injury (ALI)|acute lung injury (ali)
293069|NCT01901354|Adult respiratory distress syndrome (ARDS)|adult respiratory distress syndrome (ards)
293070|NCT01901354|Low-tidal-volume strategy|low-tidal-volume strategy
293071|NCT01901354|ARDSNet|ardsnet
293072|NCT01901354|airway pressure release ventilation (APRV)|airway pressure release ventilation (aprv)
293073|NCT01901354|biomarkers of lung injury|biomarkers of lung injury
293074|NCT01901341|Opioid|opioid
293075|NCT01901341|Constipation|constipation
293076|NCT01901341|Chronic|chronic
293077|NCT01901341|Pain|pain
293078|NCT01901328|Opioid|opioid
293079|NCT01901328|Constipation|constipation
293080|NCT01901328|Chronic|chronic
293081|NCT01901328|Pain|pain
293082|NCT01901315|telepsychiatry|telepsychiatry
293083|NCT01901315|telemental health|telemental health
293084|NCT01901315|teleassistance|teleassistance
293085|NCT01901315|health care delivery|health care delivery
293086|NCT01901315|depression|depression
293087|NCT01901315|Telemedicine|telemedicine
293088|NCT01901315|Remote Consultation|remote consultation
293089|NCT01901315|Videoconferencing|videoconferencing
293090|NCT01901315|Community Mental Health Services|community mental health services
293091|NCT01901302|Opioid|opioid
293092|NCT01901302|Constipation|constipation
293093|NCT01901302|Chronic|chronic
293094|NCT01901302|Pain|pain
293095|NCT01901289|Peripheral Vascular Disease|peripheral vascular disease
293096|NCT01901289|Femoral Artery|femoral artery
293097|NCT01901289|Popliteal Artery|popliteal artery
293098|NCT01901289|Drug-Eluting Stent|drug-eluting stent
293099|NCT01901276|Proton Pump Inhibitors|proton pump inhibitors
293100|NCT01901276|Microbiome|microbiome
293101|NCT01901276|Clostridium difficile|clostridium difficile
293102|NCT01901263|Cognitive and behavioral units|cognitive and behavioral units
293103|NCT01901263|Alzheimer Disease|alzheimer disease
293104|NCT01901263|Dementia|dementia
293105|NCT01901250|Dental Caries|dental caries
293106|NCT01901250|Xylitol|xylitol
293107|NCT01901250|Prevention|prevention
293108|NCT01901237|Cancer|cancer
293109|NCT01901237|Adolescent and Young Adult|adolescent and young adult
293110|NCT01901237|Exercise|exercise
293111|NCT01901237|Physical Activity|physical activity
293112|NCT01901237|Quality of Life|quality of life
293113|NCT01901237|End-of-Life|end-of-life
293114|NCT01901237|Palliative|palliative
293115|NCT01901237|Terminal|terminal
293116|NCT01901237|Yoga|yoga
293117|NCT01901237|Alternative Therapies|alternative therapies
293118|NCT01901237|Fitness|fitness
293119|NCT01901237|Fatigue|fatigue
293120|NCT01901211|Cerebral palsy|cerebral palsy
293121|NCT01901211|Interactive computer play|interactive computer play
293122|NCT01901211|Multi-player gaming|multi-player gaming
293123|NCT01901211|Exercise|exercise
293124|NCT01901146|Human Epidermal Growth Factor Receptor 2 (HER2)|human epidermal growth factor receptor 2 (her2)
293125|NCT01901146|Positive Early Breast Cancer|positive early breast cancer
293126|NCT01901133|Phase 1|phase 1
293127|NCT01901133|MDV3100|mdv3100
293128|NCT01901133|Hepatic Impairment|hepatic impairment
293129|NCT01901133|Kidney Diseases|kidney diseases
293130|NCT01901133|Xtandi|xtandi
293131|NCT01901133|enzalutamide|enzalutamide
293132|NCT01901120|Betanis®|betanis®
293133|NCT01901120|mirabegron|mirabegron
293134|NCT01901120|Overactive Bladder|overactive bladder
293135|NCT01901107|Hemodialysis|hemodialysis
293136|NCT01901107|CKD (chronic kidney disease)|ckd (chronic kidney disease)
293137|NCT01901107|ASP1585|asp1585
293138|NCT01901107|Hyperphosphatemia|hyperphosphatemia
293139|NCT01901081|Implantable Myoelectric Sensor|implantable myoelectric sensor
293140|NCT01901081|IMES|imes
293141|NCT01901081|transradial|transradial
293142|NCT01901081|amputation|amputation
293143|NCT01901081|myoelectric|myoelectric
293144|NCT01901081|prosthesis|prosthesis
293145|NCT01901081|prosthetic control|prosthetic control
293146|NCT01901068|Laparotomy|laparotomy
293147|NCT01901068|Surgical Procedures, Elective|surgical procedures, elective
293148|NCT01901068|Sutures|sutures
293149|NCT01901068|Abdominal Wound Closure Techniques|abdominal wound closure techniques
293150|NCT01901055|sleep apnea|sleep apnea
293151|NCT01901055|diabetes|diabetes
293152|NCT01901042|Quality of life|quality of life
293153|NCT01901042|Symbiotic|symbiotic
293154|NCT01901042|Proctitis/Radiotherapy|proctitis/radiotherapy
293155|NCT01901029|Male Reproductive Health|male reproductive health
293156|NCT01901029|Floating Population|floating population
293157|NCT01901029|Sexual Behavior|sexual behavior
293158|NCT01901029|Erectile Dysfunction|erectile dysfunction
293159|NCT01901029|Premature Ejaculation|premature ejaculation
293161|NCT01901016|depressive symptoms|depressive symptoms
293162|NCT01901016|quality of life|quality of life
293163|NCT01901016|relaxation|relaxation
293164|NCT01901016|viral load|viral load
293165|NCT01901016|CD4+ T cell count|cd4+ t cell count
293166|NCT01900990|Noninvasive Positive Pressure Ventilation|noninvasive positive pressure ventilation
293167|NCT01900990|Invasive Positive Pressure Ventilation|invasive positive pressure ventilation
293168|NCT01900990|tracheotomy|tracheotomy
293169|NCT01900977|Universal Test and Treat (UTT)|universal test and treat (utt)
293170|NCT01900977|Combination Prevention|combination prevention
293171|NCT01900964|Regeneration|regeneration
293172|NCT01900964|Bone regeneration|bone regeneration
293173|NCT01900964|Grafting, Bone|grafting, bone
293174|NCT01900964|Allograft|allograft
293175|NCT01900964|Xenograft|xenograft
293176|NCT01900951|Small cell lung cancer|small cell lung cancer
293177|NCT01900951|temozolomide|temozolomide
293178|NCT01900951|Maintenance chemotherapy|maintenance chemotherapy
293179|NCT01900938|Cholangiopancreatography|cholangiopancreatography
293180|NCT01900938|Endoscopic Retrograde|endoscopic retrograde
293181|NCT01900925|Low back pain, non-specific low back pain|low back pain, non-specific low back pain
293182|NCT01900912|sanitation|sanitation
293183|NCT01900912|diarrhea prevalence|diarrhea prevalence
293184|NCT01900912|health|health
293185|NCT01900912|social networks|social networks
293186|NCT01900912|cooperation|cooperation
293187|NCT01900899|Healthy|healthy
293188|NCT01900899|Immunogenicity|immunogenicity
293189|NCT01900899|Children|children
293190|NCT01900899|Neisseria meningitidis|neisseria meningitidis
293191|NCT01900899|Long-term antibody persistence|long-term antibody persistence
293192|NCT01900899|Safety|safety
293193|NCT01900899|Serogroups A, C, W-135, and Y|serogroups a, c, w-135, and y
293194|NCT01900886|prison, disorder, hepatitis c|prison, disorder, hepatitis c
293195|NCT01900873|Inspiratory Muscle Training|inspiratory muscle training
293196|NCT01900873|COPD|copd
293197|NCT01900873|Inspiratory Muscle Function|inspiratory muscle function
293198|NCT01900873|Dyspnea|dyspnea
293199|NCT01900860|Vitamin D|vitamin d
293200|NCT01900860|Bone quality|bone quality
293201|NCT01900860|Bone density|bone density
293202|NCT01900860|calcium metabolism|calcium metabolism
293203|NCT01900860|High resolution peripheral quantitative computed tomography|high resolution peripheral quantitative computed tomography
293204|NCT01900860|Dual X-ray absorptiometry|dual x-ray absorptiometry
293205|NCT01900860|Quality of life|quality of life
293206|NCT01900847|Ketamine|ketamine
293207|NCT01900847|Acute Pain|acute pain
293208|NCT01900795|Postsurgical pain|postsurgical pain
293209|NCT01900743|Sarcoma|sarcoma
293210|NCT01900743|Metastatic|metastatic
293211|NCT01900743|Regorafenib|regorafenib
293212|NCT01900730|Breast cancer|breast cancer
293213|NCT01900730|Metastatic|metastatic
293214|NCT01900730|Indwelling pleural catheter|indwelling pleural catheter
293215|NCT01900730|Valproic acid|valproic acid
293216|NCT01900730|VPA|vpa
293217|NCT01900730|Depakene|depakene
293218|NCT01900730|Placebo|placebo
293219|NCT01900730|Pill diary|pill diary
293220|NCT01900730|Drainage diary|drainage diary
293221|NCT01900730|Questionnaires|questionnaires
293222|NCT01900730|Surveys|surveys
293223|NCT01900691|Esophageal Fistula|esophageal fistula
293224|NCT01900691|Esophageal Neoplasms|esophageal neoplasms
293225|NCT01900691|Esophageal Perforation|esophageal perforation
293226|NCT01900691|Esophageal Stenosis|esophageal stenosis
293227|NCT01900691|Stents|stents
293228|NCT01900639|aspirin|aspirin
293229|NCT01900639|circadian rhythm|circadian rhythm
293230|NCT01900639|platelet reactivity|platelet reactivity
293231|NCT01900639|platelet activation|platelet activation
293232|NCT01900639|time dependent|time dependent
293233|NCT01900613|child obesity|child obesity
293234|NCT01900613|Mexican-American|mexican-american
293235|NCT01900613|Nutrition education|nutrition education
293236|NCT01900613|Intervention|intervention
293237|NCT01900587|Healthy|healthy
293238|NCT01900587|Bio-equivalence|bio-equivalence
293239|NCT01900587|Tapentadol extended release|tapentadol extended release
293240|NCT01900587|Tamper-resistant formulation|tamper-resistant formulation
293241|NCT01900574|Colitis, Ulcerative|colitis, ulcerative
293242|NCT01900574|Ulcerative Colitis|ulcerative colitis
293243|NCT01900574|Moderately to Severely Active Ulcerative Colitis|moderately to severely active ulcerative colitis
293244|NCT01900574|Golimumab|golimumab
293245|NCT01900574|Simponi|simponi
293246|NCT01900574|Human anti-TNFα Antibody|human anti-tnfα antibody
293247|NCT01900574|Pediatric participants|pediatric participants
293248|NCT01900574|Safety and Pharmacokinetics|safety and pharmacokinetics
293249|NCT01900561|prostate cancer|prostate cancer
293250|NCT01900561|survivorship|survivorship
293251|NCT01900561|intervention|intervention
293252|NCT01900561|telemedicine|telemedicine
293253|NCT01900548|Osteopenia|osteopenia
293254|NCT01900548|Sarcopenia|sarcopenia
293255|NCT01900548|Osteoporosis|osteoporosis
293256|NCT01900548|Physical function|physical function
293257|NCT01900548|Body composition|body composition
293258|NCT01900548|Muscle protein|muscle protein
293259|NCT01900548|Leucine|leucine
293260|NCT01900548|Ketogenic amino acids|ketogenic amino acids
293261|NCT01900548|Resistance Training|resistance training
293262|NCT01900548|Whey protein|whey protein
293263|NCT01900548|Soy protein|soy protein
293264|NCT01900548|Bone turnover|bone turnover
293265|NCT01900535|chlorhexidine|chlorhexidine
293266|NCT01900535|gingivitis|gingivitis
293267|NCT01900535|periodontitis|periodontitis
293268|NCT01900522|Drug therapy|drug therapy
293269|NCT01900509|Childhood leukemia|childhood leukemia
293270|NCT01900509|Childhood lymphoma|childhood lymphoma
293271|NCT01900509|Bendamustine|bendamustine
293272|NCT01900496|cHL|chl
293273|NCT01900496|Hodgkin lymphoma|hodgkin lymphoma
293274|NCT01900496|Lymphoma|lymphoma
293275|NCT01900496|relapsed Lymphoma|relapsed lymphoma
293276|NCT01900496|SGN-35|sgn-35
293277|NCT01900496|Brentuximab Vedotin|brentuximab vedotin
293278|NCT01900496|Rituxan|rituxan
293279|NCT01900496|Rituximab|rituximab
293280|NCT01900470|Multiple chronic conditions|multiple chronic conditions
293281|NCT01900444|Japanese encephalitis|japanese encephalitis
293282|NCT01900444|Japanese encephalitis chimeric virus vaccine|japanese encephalitis chimeric virus vaccine
293283|NCT01900444|IMOJEV®|imojev®
293284|NCT01900418|breast cancer|breast cancer
293285|NCT01900418|aromatase inhibitors|aromatase inhibitors
293286|NCT01900418|physical activity|physical activity
293287|NCT01900418|joint pain|joint pain
293288|NCT01900405|Dexmedetomidine|dexmedetomidine
293289|NCT01900405|Administration, Intranasal|administration, intranasal
293290|NCT01900405|Children|children
293291|NCT01900405|Computerized Tomography|computerized tomography
293292|NCT01900379|Obstructive sleep apneas syndrome|obstructive sleep apneas syndrome
293293|NCT01900379|Continuous positive airway pressure treatment|continuous positive airway pressure treatment
293294|NCT01900379|Heart failure|heart failure
293295|NCT01900379|Coronary reperfusion surgery|coronary reperfusion surgery
293296|NCT01900366|Obesity|obesity
293297|NCT01900366|Healthy Volunteers|healthy volunteers
293298|NCT01900340|GLP-1|glp-1
293299|NCT01900340|satiation peptides|satiation peptides
293300|NCT01900340|food intake|food intake
293301|NCT01900327|pancreatic cancer|pancreatic cancer
293302|NCT01900327|surgery|surgery
293303|NCT01900327|chemoradiation|chemoradiation
293304|NCT01900327|neoadjuvant treatment|neoadjuvant treatment
293305|NCT01900327|overall survival|overall survival
293306|NCT01900314|Major Depression|major depression
293307|NCT01900314|Major Depressive Disorder|major depressive disorder
293308|NCT01900314|TMS|tms
293309|NCT01900314|rTMS|rtms
293310|NCT01900301|exposure|exposure
293311|NCT01900301|scopolamine|scopolamine
293312|NCT01900301|extinction learning|extinction learning
293313|NCT01900301|social anxiety|social anxiety
293314|NCT01900288|short bowel disorder|short bowel disorder
293315|NCT01900288|short bowel syndrome|short bowel syndrome
293316|NCT01900288|home parenteral nutrition|home parenteral nutrition
293317|NCT01900288|HPN|hpn
293318|NCT01900288|total parenteral nutrition|total parenteral nutrition
293319|NCT01900288|TPN|tpn
293320|NCT01900288|telehealth|telehealth
293321|NCT01900288|telemedicine|telemedicine
293322|NCT01900275|Sepsis|sepsis
293323|NCT01900275|Trauma|trauma
293324|NCT01900275|Shock|shock
293325|NCT01900275|Acute kidney injury|acute kidney injury
293326|NCT01900275|Heparanase|heparanase
293327|NCT01900262|Biomechanics|biomechanics
293328|NCT01900262|Ankle Strength|ankle strength
293329|NCT01900262|Postural Control|postural control
293330|NCT01900262|Running Mechanics|running mechanics
293331|NCT01900236|Patients newly initiating outpatient HIV medical care|patients newly initiating outpatient hiv medical care
293332|NCT01900210|Criminal justice|criminal justice
293333|NCT01900210|substance abuse treatment|substance abuse treatment
293334|NCT01900210|HIV risk behaviors|hiv risk behaviors
293335|NCT01900158|Phase I, Phase II, Dose Escalation, Safety, Tolerability,|phase i, phase ii, dose escalation, safety, tolerability,
293336|NCT01900158|Efficacy, Amphinex induced Photochemical Internalisation, PCI, Amphinex, Gemcitabine, Cisplatin,|efficacy, amphinex induced photochemical internalisation, pci, amphinex, gemcitabine, cisplatin,
293337|NCT01900158|Inoperable Cholangiocarcinomas, CCA, Cholangiocarcinoma, bile duct cancer, photodynamic therapy|inoperable cholangiocarcinomas, cca, cholangiocarcinoma, bile duct cancer, photodynamic therapy
293338|NCT01900132|Electrophysiology|electrophysiology
293339|NCT01900132|Neuromuscular Disease|neuromuscular disease
293340|NCT01900119|Oral Microbiome|oral microbiome
293341|NCT01900119|Next Generation Sequencing|next generation sequencing
293342|NCT01900106|late presenter|late presenter
293343|NCT01900106|naïve|naïve
293344|NCT01900106|advanced HIV disease|advanced hiv disease
293345|NCT01900080|HIV|hiv
293346|NCT01900080|AIDS|aids
293347|NCT01900080|Antiretroviral therapy|antiretroviral therapy
293348|NCT01900080|Retention in care|retention in care
293349|NCT01900080|Adherence|adherence
293350|NCT01900080|Cost-effectiveness|cost-effectiveness
293351|NCT01900054|TAU-284|tau-284
293352|NCT01900054|Bepotastine besilate|bepotastine besilate
293353|NCT01900054|Histamine H1 receptor antagonists|histamine h1 receptor antagonists
293354|NCT01900054|children|children
293355|NCT01900028|oncology,|oncology,
293356|NCT01900028|cancer,|cancer,
293357|NCT01900028|tumour,|tumour,
293358|NCT01900028|anticancer drug,|anticancer drug,
293359|NCT01900028|pharmacokinetics,|pharmacokinetics,
293360|NCT01900028|olaparib,itraconazole,|olaparib,itraconazole,
293361|NCT01900028|neoplasm,|neoplasm,
293362|NCT01900028|QT interval|qt interval
293363|NCT01900002|Liver Cancer|liver cancer
293364|NCT01900002|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
293365|NCT01900002|HCC|hcc
293366|NCT01900002|Sorafenib|sorafenib
293369|NCT01900002|Yttrium-90|yttrium-90
293370|NCT01900002|Microspheres|microspheres
293371|NCT01900002|Phone calls|phone calls
293372|NCT01899989|Stereotactic Body Radiation Therapy (SBRT)|stereotactic body radiation therapy (sbrt)
293373|NCT01899989|Chemotherapy|chemotherapy
293374|NCT01899989|13-113|13-113
293375|NCT01899976|covered biliary stent|covered biliary stent
293376|NCT01899976|X-Suit NIR Covered Biliary Stent|x-suit nir covered biliary stent
293377|NCT01899976|malignant strictures in biliary tree|malignant strictures in biliary tree
293378|NCT01899963|wet Age Related Macular Degeneration|wet age related macular degeneration
293379|NCT01899963|Diabetic Macular Edema|diabetic macular edema
293380|NCT01899963|Telemedicine|telemedicine
293381|NCT01899963|Teleophthalmology|teleophthalmology
293382|NCT01899963|Time to Treatment|time to treatment
293383|NCT01899950|Niemann-Pick disease type C|niemann-pick disease type c
293384|NCT01899950|Lysosomal disease|lysosomal disease
293385|NCT01899937|Endothelial dysfunction|endothelial dysfunction
293386|NCT01899937|Flow mediated dilation|flow mediated dilation
293387|NCT01899937|Brachial artery flow mediated dilation|brachial artery flow mediated dilation
293388|NCT01899937|FMD|fmd
293389|NCT01899898|Refractory epilepsy|refractory epilepsy
293390|NCT01899898|Dietary therapy|dietary therapy
293391|NCT01899898|Non-Pharmacological therapy|non-pharmacological therapy
293392|NCT01899898|Simplified Modified Atkins Diet|simplified modified atkins diet
293393|NCT01899885|Emergency laparotomy|emergency laparotomy
293394|NCT01899885|Emergency laparoscopy|emergency laparoscopy
293395|NCT01899872|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
293396|NCT01899872|Endothelial progenitor cell|endothelial progenitor cell
293397|NCT01899872|Endothelial function|endothelial function
293398|NCT01899872|Exercise|exercise
293399|NCT01899859|Non-Alcoholic Steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
293400|NCT01899846|Makena|makena
293401|NCT01899846|Pharmacokinetics|pharmacokinetics
293402|NCT01899846|Prior preterm delivery|prior preterm delivery
293403|NCT01899846|Hydroxyprogesterone Caproate|hydroxyprogesterone caproate
293404|NCT01899846|17P|17p
293405|NCT01899833|Coronary Artery Disease|coronary artery disease
293406|NCT01899833|CAD|cad
293407|NCT01899781|Lacerations|lacerations
293408|NCT01899781|Tendons|tendons
293409|NCT01899781|Antobiotic|antobiotic
293410|NCT01899768|efficacy|efficacy
293411|NCT01899768|hypertussive challenge|hypertussive challenge
293412|NCT01899768|voltage gated sodium channels (VGSC)|voltage gated sodium channels (vgsc)
293413|NCT01899768|anaesthesia|anaesthesia
293414|NCT01899768|Safety and tolerability|safety and tolerability
293415|NCT01899768|capsaicin challenge|capsaicin challenge
293416|NCT01899768|cough|cough
293417|NCT01899768|citric acid challenge|citric acid challenge
293418|NCT01899768|pharmacokinetics|pharmacokinetics
293419|NCT01899755|monoclonal antibody|monoclonal antibody
293420|NCT01899755|healthy volunteer|healthy volunteer
293421|NCT01899755|TNF alpha|tnf alpha
293422|NCT01899729|plaque psoriasis|plaque psoriasis
293423|NCT01899729|autoimmune disease|autoimmune disease
293424|NCT01899729|Toll like receptor|toll like receptor
293425|NCT01899716|Severe Depression|severe depression
293426|NCT01899716|Quality of life|quality of life
293427|NCT01899716|Exercise|exercise
293428|NCT01899716|BDNF|bdnf
293429|NCT01899716|TBARS|tbars
293430|NCT01899703|Intestinal bile acid transport inhibitor|intestinal bile acid transport inhibitor
293431|NCT01899703|Pruritus|pruritus
293432|NCT01899703|Primary biliary cirrhosis|primary biliary cirrhosis
293433|NCT01899703|Ursodeoxycholic acid|ursodeoxycholic acid
293434|NCT01899703|GSK2330672|gsk2330672
293435|NCT01899703|Pharmacokinetics|pharmacokinetics
293436|NCT01899690|breast reconstruction|breast reconstruction
293437|NCT01899690|cancer|cancer
293438|NCT01899690|expander|expander
293439|NCT01899690|antibiotics|antibiotics
293440|NCT01899690|infection|infection
293441|NCT01899690|surgical site infection|surgical site infection
293442|NCT01899690|surgery|surgery
293443|NCT01899690|oncology|oncology
293444|NCT01899690|plastic surgery|plastic surgery
293445|NCT01899677|Symbiotic,cytokines, necrotising enterocolitis|symbiotic,cytokines, necrotising enterocolitis
293446|NCT01899664|peripheral nerves|peripheral nerves
293447|NCT01899664|quadriplegia|quadriplegia
293448|NCT01899664|nerve transfer|nerve transfer
293449|NCT01899664|surgical procedures, operative|surgical procedures, operative
293450|NCT01899664|hand|hand
293451|NCT01899664|upper extremity|upper extremity
293452|NCT01899664|quality of life|quality of life
293453|NCT01899651|EEG|eeg
293454|NCT01899651|Brain|brain
293455|NCT01899651|Infants|infants
293456|NCT01899651|Preterm|preterm
293457|NCT01899651|Hemorrhage|hemorrhage
293458|NCT01899651|Bleeding|bleeding
293459|NCT01899625|Obesity|obesity
293460|NCT01899625|weight loss|weight loss
293461|NCT01899625|young adults|young adults
293462|NCT01899612|menopause|menopause
293463|NCT01899612|vaginal atrophy|vaginal atrophy
293464|NCT01899612|cytokine|cytokine
293465|NCT01899612|IL-1beta|il-1beta
293466|NCT01899612|IL-6|il-6
293467|NCT01899612|IL-8|il-8
293468|NCT01899612|TNF-alpha|tnf-alpha
293469|NCT01899586|Aging|aging
293470|NCT01899586|Functional Capacity|functional capacity
293471|NCT01899586|Exercise Independence|exercise independence
293472|NCT01899586|Peripheral Adaptations|peripheral adaptations
293473|NCT01899586|Vascular|vascular
293474|NCT01899573|Heart failure|heart failure
293475|NCT01899573|mitral regurgitation|mitral regurgitation
293476|NCT01899573|mitral valve|mitral valve
293477|NCT01899560|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
293478|NCT01899560|positive end expiratory pressure (PEEP)|positive end expiratory pressure (peep)
293479|NCT01899560|Staircase recruitment maneuver (SRM)|staircase recruitment maneuver (srm)
293480|NCT01899560|Lung elastance|lung elastance
293481|NCT01899560|chest wall elastance|chest wall elastance
293482|NCT01899534|Pregnancy|pregnancy
293483|NCT01899534|Mental Health|mental health
293484|NCT01899534|Screening|screening
293485|NCT01899534|Computer|computer
293486|NCT01899534|Feasibility|feasibility
293487|NCT01899521|alcoholism|alcoholism
293488|NCT01899521|lung health|lung health
293489|NCT01899521|pulmonary|pulmonary
293490|NCT01899521|macrophage|macrophage
293491|NCT01899521|zinc|zinc
293492|NCT01899521|SAMe|same
293493|NCT01899521|S-adenosylmethionine|s-adenosylmethionine
293494|NCT01899521|alveolar|alveolar
293495|NCT01899495|blood pressure|blood pressure
293496|NCT01899495|hypertension|hypertension
293497|NCT01899495|salt sensitivity|salt sensitivity
293498|NCT01899482|Venous Insufficiency|venous insufficiency
293499|NCT01899482|Physical Therapy Techniques|physical therapy techniques
293500|NCT01899482|Manual Lymphatic Drainage|manual lymphatic drainage
293501|NCT01899443|total hip replacement|total hip replacement
293502|NCT01899443|total knee replacement|total knee replacement
293503|NCT01899443|patient outcomes|patient outcomes
293504|NCT01899443|health services research|health services research
293505|NCT01899430|PCOS|pcos
293506|NCT01899430|obesity|obesity
293507|NCT01899430|GLP-1 receptor agonist|glp-1 receptor agonist
293508|NCT01899430|liraglutide|liraglutide
293509|NCT01899430|metformin|metformin
293510|NCT01899417|osteoarthritis|osteoarthritis
293511|NCT01899417|knee replacement|knee replacement
293512|NCT01899417|patient-specific|patient-specific
293513|NCT01899417|economics|economics
293514|NCT01899404|Cervical Cancer|cervical cancer
293515|NCT01899404|PET Scan for cervix|pet scan for cervix
293516|NCT01899404|MRI for cervix|mri for cervix
293517|NCT01899391|Prostate cancer|prostate cancer
293518|NCT01899378|probiotics|probiotics
293519|NCT01899365|anti-pneumococcal vaccination|anti-pneumococcal vaccination
293520|NCT01899365|information|information
293521|NCT01899365|emergency department|emergency department
293522|NCT01899339|submassive pulmonary embolism|submassive pulmonary embolism
293523|NCT01899339|Ultrasonic energy|ultrasonic energy
293524|NCT01899339|Ekosonic Endovascular Device|ekosonic endovascular device
293525|NCT01899339|RV:LV function after Pulmonary Embolism|rv:lv function after pulmonary embolism
293526|NCT01899313|methamphetamine dependence|methamphetamine dependence
293527|NCT01899313|texting|texting
293528|NCT01899313|short message service|short message service
293529|NCT01899313|addiction|addiction
293530|NCT01899313|amphetamine|amphetamine
293531|NCT01899313|outpatient|outpatient
293532|NCT01899300|Refractory Benign Esophageal Strictures caused by Caustic Ingestion|refractory benign esophageal strictures caused by caustic ingestion
293533|NCT01899287|workers education|workers education
293534|NCT01899287|occupational|occupational
293535|NCT01899209|Obstructed Defecation|obstructed defecation
293536|NCT01899209|Rectal rectocele|rectal rectocele
293537|NCT01899209|Intussusception|intussusception
293538|NCT01899209|STARR|starr
293539|NCT01899209|Ventral Rectopexy|ventral rectopexy
293540|NCT01899196|Cardiac surgery|cardiac surgery
293541|NCT01899183|Chronic cough|chronic cough
293542|NCT01899183|Esophagus|esophagus
293543|NCT01899183|Gastro-esophageal reflux disease|gastro-esophageal reflux disease
293544|NCT01899183|Esophageal surgery|esophageal surgery
293545|NCT01899183|Minimally invasive surgery|minimally invasive surgery
293546|NCT01899183|Extra-esophageal reflux symptoms.|extra-esophageal reflux symptoms.
293547|NCT01899170|deep brain stimulation|deep brain stimulation
293548|NCT01899170|multi-coil transcranial magnetic stimulation|multi-coil transcranial magnetic stimulation
293549|NCT01899170|PET-imaging|pet-imaging
293550|NCT01899170|personalized treatment|personalized treatment
293551|NCT01899157|Nutritional status|nutritional status
293552|NCT01899157|Nutritional situation|nutritional situation
293553|NCT01899144|Albuterol Spiromax|albuterol spiromax
293554|NCT01899144|ProAir HFA|proair hfa
293555|NCT01899144|albuterol sulfate|albuterol sulfate
293556|NCT01899131|dental implants|dental implants
293557|NCT01899131|crestal bone|crestal bone
293558|NCT01899131|gingival margin|gingival margin
293559|NCT01899118|locally advanced rectal cancer|locally advanced rectal cancer
293560|NCT01899118|Neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
293561|NCT01899118|Nimotuzumab|nimotuzumab
293562|NCT01899092|Genotype 1|genotype 1
293563|NCT01899092|Chronic Hepatitis C|chronic hepatitis c
293564|NCT01899092|CHC|chc
293565|NCT01899092|HCV|hcv
293566|NCT01899092|Hepatitis|hepatitis
293567|NCT01899092|RNAi|rnai
293568|NCT01899092|shRNA|shrna
293569|NCT01899092|ddRNAi|ddrnai
293570|NCT01899092|AAV8|aav8
293571|NCT01899092|AAV|aav
293572|NCT01899092|Adeno-associated virus|adeno-associated virus
293573|NCT01899092|Adeno-associated viral vectors|adeno-associated viral vectors
293574|NCT01899079|Breast Cancer|breast cancer
293575|NCT01899079|Prosigna|prosigna
293576|NCT01899079|FFPE|ffpe
293577|NCT01899079|node negative|node negative
293578|NCT01899079|estrogen receptor positive|estrogen receptor positive
293579|NCT01899079|HER2 negative|her2 negative
293580|NCT01899066|Efficacy|efficacy
293581|NCT01899053|Solid tumors|solid tumors
293582|NCT01899053|MLN0128|mln0128
293583|NCT01899053|MLN1117|mln1117
293584|NCT01899040|neuromodulation|neuromodulation
293585|NCT01899040|migraine headache|migraine headache
293586|NCT01899027|Arterial hypertension|arterial hypertension
293587|NCT01899027|Radiofrequency ablation|radiofrequency ablation
293588|NCT01899027|Renal function|renal function
293589|NCT01899001|Polycystic Ovary Syndrome|polycystic ovary syndrome
293590|NCT01899001|PCOS|pcos
293591|NCT01899001|Depression|depression
293592|NCT01899001|Anxiety|anxiety
293593|NCT01899001|Weight loss|weight loss
293594|NCT01899001|Exercise|exercise
293595|NCT01899001|Nutrition|nutrition
293596|NCT01899001|Therapy|therapy
293597|NCT01899001|Mood symptoms|mood symptoms
293598|NCT01899001|Stress|stress
293599|NCT01898975|Neurosurgical patients|neurosurgical patients
293600|NCT01898975|Fluid loading|fluid loading
293601|NCT01898975|Fluid responsiveness|fluid responsiveness
293602|NCT01898975|NICOM|nicom
293603|NCT01898975|Stroke volume variation|stroke volume variation
293604|NCT01898975|Pulse pressure variation|pulse pressure variation
293605|NCT01898975|Total peripheral resistance|total peripheral resistance
293606|NCT01898975|Gray zone approach|gray zone approach
293607|NCT01898962|Oligometastases|oligometastases
293608|NCT01898962|Metastatic cancer|metastatic cancer
293609|NCT01898962|Stereotactic radiosurgery|stereotactic radiosurgery
293610|NCT01898949|Diet-induced thermogenesis|diet-induced thermogenesis
293611|NCT01898949|Cold-induced thermogenesis|cold-induced thermogenesis
293612|NCT01898949|Brown adipose tissue|brown adipose tissue
293613|NCT01898949|Brown fat|brown fat
293614|NCT01898923|WH-1,Diabetic Foot,Ulcer|wh-1,diabetic foot,ulcer
293615|NCT01898845|Neoplasms|neoplasms
293616|NCT01898832|Cholestasis, pregnant, interleukin 17|cholestasis, pregnant, interleukin 17
293617|NCT01898819|DEXMEDETOMIDINE|dexmedetomidine
293618|NCT01898819|intraocular pressure|intraocular pressure
293619|NCT01898806|Alopecia Areata|alopecia areata
293620|NCT01898806|Kenalog|kenalog
293621|NCT01898806|Triamcinolone|triamcinolone
293622|NCT01898767|mild|mild
293623|NCT01898767|asthma|asthma
293624|NCT01898767|allergic|allergic
293625|NCT01898754|Transmitted Drug Resistance|transmitted drug resistance
293626|NCT01898741|Pancreatic cancer|pancreatic cancer
293627|NCT01898741|Radiotherapy|radiotherapy
293628|NCT01898741|SBRT|sbrt
293629|NCT01898715|Adrenocortical carcinoma|adrenocortical carcinoma
293630|NCT01898715|Adrenal cancer|adrenal cancer
293631|NCT01898715|ACC|acc
293632|NCT01898676|Extended-release divalproex sodium|extended-release divalproex sodium
293633|NCT01898676|Depakote ER|depakote er
293634|NCT01898650|craniosynostosis|craniosynostosis
293635|NCT01898650|sagittal synostosis|sagittal synostosis
293636|NCT01898650|metopic synostosis|metopic synostosis
293637|NCT01898650|coronal synostosis|coronal synostosis
293638|NCT01898650|lambdoid synostosis|lambdoid synostosis
293639|NCT01898637|pulmonary embolism|pulmonary embolism
293640|NCT01898637|pulse oximetry|pulse oximetry
293641|NCT01898637|change in oxygen saturation|change in oxygen saturation
293642|NCT01898637|hypoxemia|hypoxemia
293643|NCT01898637|emergency department|emergency department
293644|NCT01898637|deep inspiration|deep inspiration
293645|NCT01898637|vital capacity|vital capacity
293646|NCT01898637|clinical diagnosis|clinical diagnosis
293647|NCT01898624|mirabegron|mirabegron
293648|NCT01898624|Overactive Bladder|overactive bladder
293649|NCT01898624|Betanis®|betanis®
293650|NCT01898624|glaucoma|glaucoma
293651|NCT01898611|Frailty|frailty
293652|NCT01898611|Sarcopenia|sarcopenia
293653|NCT01898611|Weight Loss|weight loss
293654|NCT01898611|Exercise|exercise
293655|NCT01898611|Aging|aging
293656|NCT01898611|Ghrelin|ghrelin
293657|NCT01898611|Elderly|elderly
293658|NCT01898572|Newly Diagnosed Type II Diabetes Mellitus|newly diagnosed type ii diabetes mellitus
293659|NCT01898572|Carotid Intimae-media Thickness|carotid intimae-media thickness
293660|NCT01898572|Carotid Plaque|carotid plaque
293661|NCT01898572|Cardiovascular Disease|cardiovascular disease
293662|NCT01898559|little cigars|little cigars
293663|NCT01898559|cigarettes|cigarettes
293664|NCT01898559|smoking|smoking
293665|NCT01898546|Ischemic postconditioning|ischemic postconditioning
293666|NCT01898546|Myocardial Infarction|myocardial infarction
293667|NCT01898546|Microvascular Obstruction|microvascular obstruction
293668|NCT01898520|Spasticity|spasticity
293669|NCT01898507|low nicotine|low nicotine
293670|NCT01898507|cigarettes|cigarettes
293671|NCT01898507|NMR|nmr
293672|NCT01898481|Health care decision making|health care decision making
293673|NCT01898468|Neuropathic pain symptoms|neuropathic pain symptoms
293674|NCT01898468|Intracostal Closure Technique|intracostal closure technique
293675|NCT01898468|Pericostal Suture Closure Technique|pericostal suture closure technique
293676|NCT01898468|Post surgical pain|post surgical pain
293677|NCT01898468|Post thoracotomy pain|post thoracotomy pain
293678|NCT01898455|Migraine|migraine
293679|NCT01898455|Cluster headache|cluster headache
293680|NCT01898455|headache|headache
293681|NCT01898442|platelet function|platelet function
293682|NCT01898442|ticagrelor|ticagrelor
293683|NCT01898442|STEMI|stemi
293684|NCT01898429|Treatment Resistant Depression|treatment resistant depression
293685|NCT01898429|Treatment Refractory Depression|treatment refractory depression
293686|NCT01898429|Treatment Resistant Bipolar Disorder|treatment resistant bipolar disorder
293687|NCT01898429|Treatment Refractory Bipolar Disorder|treatment refractory bipolar disorder
293688|NCT01898429|Deep brain stimulation|deep brain stimulation
293689|NCT01898429|DBS|dbs
293690|NCT01898390|Parkinson's Disease|parkinson's disease
293691|NCT01898390|Allo-Transplantation|allo-transplantation
293692|NCT01898390|Fetal Ventral Mesencephalic Tissue|fetal ventral mesencephalic tissue
293693|NCT01898377|Children|children
293694|NCT01898377|Chronic graft-versus-host disease|chronic graft-versus-host disease
293695|NCT01898351|Alternative sources of plant proteins|alternative sources of plant proteins
293696|NCT01898351|High protein diets|high protein diets
293697|NCT01898351|Satiety|satiety
293698|NCT01898351|Postprandial effects|postprandial effects
293699|NCT01898351|Bioactive phytochemicals|bioactive phytochemicals
293700|NCT01898351|Phytochemicals bioactivity and metabolism|phytochemicals bioactivity and metabolism
293701|NCT01898351|Macronutrients metabolism|macronutrients metabolism
293702|NCT01898351|Health effects of plant proteins vs. meat proteins|health effects of plant proteins vs. meat proteins
293703|NCT01898351|Partial meat proteins replacement with plant proteins|partial meat proteins replacement with plant proteins
293704|NCT01898351|Satiety of meals rich in plant proteins|satiety of meals rich in plant proteins
293705|NCT01898351|Postprandial effects of meals rich in plant proteins|postprandial effects of meals rich in plant proteins
293706|NCT01898351|Plant phytochemicals and macronutrients bioavailability and metabolism|plant phytochemicals and macronutrients bioavailability and metabolism
293707|NCT01898338|MRSA|mrsa
293708|NCT01898338|bacteremia|bacteremia
293709|NCT01898338|therapy|therapy
293710|NCT01898325|Fibrosis|fibrosis
293711|NCT01898325|Gaucher disease|gaucher disease
293712|NCT01898299|Schizophrenia|schizophrenia
293713|NCT01898286|C peptide|c peptide
293714|NCT01898286|beta cell function|beta cell function
293715|NCT01898286|immune modulation of type 1 diabetes|immune modulation of type 1 diabetes
293716|NCT01898286|immune intervention in type 1 diabetes|immune intervention in type 1 diabetes
293717|NCT01898273|Glioma|glioma
293718|NCT01898273|Glioblastoma Multiforme|glioblastoma multiforme
293719|NCT01898273|PET|pet
293720|NCT01898273|Imaging|imaging
293721|NCT01898273|Radiopharmaceutical|radiopharmaceutical
293722|NCT01898273|Diagnostic|diagnostic
293723|NCT01898260|contact lenses|contact lenses
293724|NCT01898260|daily disposable contact lenses|daily disposable contact lenses
293725|NCT01898260|silicone hydrogel|silicone hydrogel
293726|NCT01898260|contact lens comfort|contact lens comfort
293727|NCT01898260|near-sighted|near-sighted
293728|NCT01898247|Thoracentesis|thoracentesis
293729|NCT01898247|Simulation Based Mastery Learning|simulation based mastery learning
293730|NCT01898247|Medical Education|medical education
293731|NCT01898247|Length of Stay|length of stay
293732|NCT01898247|Cost of Care|cost of care
293733|NCT01898234|Hemodynamics|hemodynamics
293734|NCT01898234|intradialytic hypotension|intradialytic hypotension
293735|NCT01898234|subjective tolerance|subjective tolerance
293736|NCT01898234|dialysis membranes|dialysis membranes
293737|NCT01898234|high flux|high flux
293738|NCT01898234|low flux|low flux
293739|NCT01898234|hemodialysis|hemodialysis
293740|NCT01898208|Bacteremia|bacteremia
293741|NCT01898208|Fungemia|fungemia
293742|NCT01898208|Bloodstream infection|bloodstream infection
293743|NCT01898208|susceptibility|susceptibility
293744|NCT01898208|MRSA|mrsa
293745|NCT01898208|VRE|vre
293746|NCT01898143|Whole body vibration, cardiorespiratory response|whole body vibration, cardiorespiratory response
293747|NCT01898117|Triple negative|triple negative
293748|NCT01898117|Metastatic|metastatic
293749|NCT01898104|rectal|rectal
293750|NCT01898104|low risk|low risk
293751|NCT01898104|moderate risk|moderate risk
293752|NCT01898091|Oral|oral
293753|NCT01898091|Mucositis|mucositis
293754|NCT01898091|Stomatitis|stomatitis
293755|NCT01898091|Radiotherapy|radiotherapy
293756|NCT01898078|MLN8237|mln8237
293757|NCT01898078|alisertib|alisertib
293758|NCT01898078|food effects|food effects
293759|NCT01898065|Hypoxia|hypoxia
293760|NCT01898065|radiotherapy|radiotherapy
293761|NCT01898065|PET with 18-F-MISO|pet with 18-f-miso
293762|NCT01898065|MRI|mri
293763|NCT01898052|pain control|pain control
294258|NCT01895582|Ageing|ageing
293764|NCT01898052|periarticular injection|periarticular injection
293765|NCT01898052|Total knee arthroplasty|total knee arthroplasty
293766|NCT01898052|levobupivacaine|levobupivacaine
293767|NCT01898052|multimodal drug injection|multimodal drug injection
293768|NCT01898039|malignant melanoma|malignant melanoma
293769|NCT01898039|vaccine|vaccine
293770|NCT01898039|cell line|cell line
293771|NCT01898039|high risk|high risk
293772|NCT01898039|residual disease|residual disease
293773|NCT01898026|PGX|pgx
293774|NCT01898026|fibre|fibre
293775|NCT01898026|postprandial glycemia|postprandial glycemia
293776|NCT01898013|pain|pain
293777|NCT01898013|pregnenolone|pregnenolone
293778|NCT01898013|Veterans|veterans
293779|NCT01898013|clinical trial|clinical trial
293780|NCT01898013|neurosteroid|neurosteroid
293781|NCT01898013|allopregnanolone|allopregnanolone
293782|NCT01898013|low back|low back
293783|NCT01898013|placebo controlled|placebo controlled
293784|NCT01898013|randomized|randomized
293785|NCT01898013|musculoskeletal|musculoskeletal
293786|NCT01898000|Gingivitis|gingivitis
293787|NCT01898000|Herbal medicine|herbal medicine
293788|NCT01898000|Plaque control|plaque control
293789|NCT01897987|Human Umbilical Cord Blood Derived Mesenchymal Stem Cells|human umbilical cord blood derived mesenchymal stem cells
293790|NCT01897987|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
293791|NCT01897987|Premature infants|premature infants
293792|NCT01897935|Uveitis|uveitis
293793|NCT01897896|Chorea|chorea
293794|NCT01897896|Huntington Disease|huntington disease
293795|NCT01897870|continuity of care|continuity of care
293796|NCT01897870|medicines management|medicines management
293797|NCT01897870|home visit|home visit
293798|NCT01897870|drug-related problems|drug-related problems
293799|NCT01897857|diabetes mellitus(DM)|diabetes mellitus(dm)
293800|NCT01897857|radial artery cannulation|radial artery cannulation
293801|NCT01897857|artery blood flow|artery blood flow
293802|NCT01897857|complication|complication
293803|NCT01897857|End stage renal disease undergoing kidney transplantation|end stage renal disease undergoing kidney transplantation
293804|NCT01897844|volunteers|volunteers
293805|NCT01897831|Piperacillin Sodium and sulbactam sodium|piperacillin sodium and sulbactam sodium
293806|NCT01897831|Phase IV clinical studies|phase iv clinical studies
293807|NCT01897831|Respiratory and urinary tract infections|respiratory and urinary tract infections
293808|NCT01897805|Coronary artery disease|coronary artery disease
293809|NCT01897766|Genotropin|genotropin
293810|NCT01897766|Somatropin|somatropin
293811|NCT01897766|Long Term Follow-Up|long term follow-up
293812|NCT01897766|Special Investigation|special investigation
293813|NCT01897766|Small for Gestational Age|small for gestational age
293814|NCT01897766|SGA|sga
293815|NCT01897753|SGA|sga
293816|NCT01897753|Growth hormone|growth hormone
293817|NCT01897740|sildenafil|sildenafil
293818|NCT01897740|pulmonary arterial hypertension|pulmonary arterial hypertension
293819|NCT01897740|PAH|pah
293820|NCT01897727|sleep apnea|sleep apnea
293821|NCT01897727|hypertension|hypertension
293822|NCT01897727|aldosterone|aldosterone
293823|NCT01897727|hyperaldosteronism|hyperaldosteronism
293824|NCT01897727|spironolactone|spironolactone
293825|NCT01897727|blood pressure|blood pressure
293826|NCT01897727|resistant|resistant
293827|NCT01897701|H7N9|h7n9
293828|NCT01897688|Diabetes|diabetes
293829|NCT01897688|Islet|islet
293830|NCT01897688|Pancreas|pancreas
293831|NCT01897688|Hypoglycemia|hypoglycemia
293832|NCT01897688|T1D|t1d
293833|NCT01897688|Transplant|transplant
293834|NCT01897675|Cutaneous Abscess|cutaneous abscess
293835|NCT01897675|Emergency Department|emergency department
293836|NCT01897662|overweight|overweight
293837|NCT01897662|satiety|satiety
293838|NCT01897662|functional food|functional food
293839|NCT01897662|food intake|food intake
293840|NCT01897662|digestive tolerance|digestive tolerance
293841|NCT01897649|functional food|functional food
293842|NCT01897649|digestive tolerance|digestive tolerance
293843|NCT01897649|microbiota|microbiota
293844|NCT01897649|bifidogenic effect|bifidogenic effect
293845|NCT01897636|endoscopic ultrasound-guided fine-needle injection|endoscopic ultrasound-guided fine-needle injection
293846|NCT01897636|dendritic cell|dendritic cell
293847|NCT01897636|vaccination|vaccination
293848|NCT01897610|Immuncell-LC, advanced hepatocellular carcinoma|immuncell-lc, advanced hepatocellular carcinoma
293849|NCT01897584|laparoscopy, Trendelenburg Position, ventilation|laparoscopy, trendelenburg position, ventilation
293850|NCT01897545|Arterial hypertension|arterial hypertension
293851|NCT01897545|Atrial Fibrillation|atrial fibrillation
293852|NCT01897545|Percutaneous renal denervation|percutaneous renal denervation
293853|NCT01897519|High risk surgery|high risk surgery
293854|NCT01897519|Acute Kidney Injury|acute kidney injury
293855|NCT01897506|Food insecurity|food insecurity
293856|NCT01897506|Health literacy|health literacy
293857|NCT01897506|Quality of life|quality of life
293858|NCT01897402|Central Nervous System Infections|central nervous system infections
293859|NCT01897402|Meningitis|meningitis
293860|NCT01897402|toxoid|toxoid
293861|NCT01897402|Meningococcal vaccine|meningococcal vaccine
293862|NCT01897402|conjugate vaccines|conjugate vaccines
293863|NCT01897389|Healthy volunteers|healthy volunteers
293864|NCT01897389|Bioavailability|bioavailability
293865|NCT01897389|Abiraterone acetate|abiraterone acetate
293866|NCT01897389|ZYTIGA|zytiga
293867|NCT01897376|wound|wound
293868|NCT01897376|infection|infection
293869|NCT01897376|cesarean delivery|cesarean delivery
293870|NCT01897376|obesity|obesity
293871|NCT01897363|Prader Willi Syndrome|prader willi syndrome
293872|NCT01897363|Hypoglycemia|hypoglycemia
293873|NCT01897363|Fasting study|fasting study
293874|NCT01897350|STEMI|stemi
293875|NCT01897350|Myocardial edema|myocardial edema
293876|NCT01897350|Cardiovascular magnetic resonance|cardiovascular magnetic resonance
293877|NCT01897324|Poor Ovarian Response|poor ovarian response
293878|NCT01897324|Poor Responders|poor responders
293879|NCT01897324|IVF/ICSI|ivf/icsi
293880|NCT01897324|Growth Hormone|growth hormone
293881|NCT01897311|cesarean section|cesarean section
293882|NCT01897311|pain|pain
293883|NCT01897311|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
293884|NCT01897311|postpartum period|postpartum period
293885|NCT01897298|chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
293886|NCT01897298|urban training|urban training
293887|NCT01897298|physical activity|physical activity
293888|NCT01897298|active aging|active aging
293889|NCT01897285|Performance and safety of the AQUACEL® foam adhesive dressing|performance and safety of the aquacel® foam adhesive dressing
293890|NCT01897272|carpal tunnel syndrome|carpal tunnel syndrome
293891|NCT01897272|splinting|splinting
293892|NCT01897272|nerve decompression|nerve decompression
293893|NCT01897259|tennis elbow|tennis elbow
293894|NCT01897259|lateral epicondylitis|lateral epicondylitis
293895|NCT01897246|distal radius malunion|distal radius malunion
293896|NCT01897246|extra-articular|extra-articular
293897|NCT01897220|Noncardiac surgery;|noncardiac surgery;
293898|NCT01897220|Perioperative ischemic complications;|perioperative ischemic complications;
293899|NCT01897220|Perioperative bleeding complications;|perioperative bleeding complications;
293900|NCT01897220|Antithrombotic therapy;|antithrombotic therapy;
293901|NCT01897220|Coronary artery disease;|coronary artery disease;
293902|NCT01897220|Stent thrombosis;|stent thrombosis;
293903|NCT01897220|Perioperative infarction.|perioperative infarction.
293904|NCT01897207|prostate cancer|prostate cancer
293905|NCT01897207|dendritic cells|dendritic cells
293906|NCT01897207|vaccination|vaccination
293907|NCT01897181|Central auditory processing|central auditory processing
293908|NCT01897181|Bilateral sensorineural hearing loss|bilateral sensorineural hearing loss
293909|NCT01897181|Hearing aids|hearing aids
293910|NCT01897155|analgesia, postoperative;|analgesia, postoperative;
293911|NCT01897155|analgesics opioid;|analgesics opioid;
293912|NCT01897155|hyperalgesia;|hyperalgesia;
293913|NCT01897155|remifentanil;|remifentanil;
293914|NCT01897155|hypertension.|hypertension.
293915|NCT01897103|Peripheral Artery Disease|peripheral artery disease
293916|NCT01897103|Endarterectomy (Carotid)|endarterectomy (carotid)
293917|NCT01897103|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
293918|NCT01897103|Aortic Aneurysm, Thoracic|aortic aneurysm, thoracic
293919|NCT01897103|Amputation|amputation
293920|NCT01897103|Platelet Activity|platelet activity
293921|NCT01897103|Thrombin|thrombin
293922|NCT01897103|Transcriptomics|transcriptomics
293923|NCT01897090|Elimination Diet|elimination diet
293924|NCT01897090|Crohn's disease|crohn's disease
293925|NCT01897077|Food Allergy|food allergy
293926|NCT01897077|Peanut|peanut
293927|NCT01897077|Sublingual Immunotherapy|sublingual immunotherapy
293928|NCT01897064|Schizophrenia|schizophrenia
293929|NCT01897064|Cognition|cognition
293930|NCT01897064|Aerobic Exercise|aerobic exercise
293931|NCT01897051|Liver cirrhosis|liver cirrhosis
293932|NCT01897051|Portal hypertension|portal hypertension
293933|NCT01897051|Hepatic Venous Pressure Gradient|hepatic venous pressure gradient
293934|NCT01897051|Rifaximin|rifaximin
293935|NCT01897025|Stroke|stroke
293936|NCT01897025|Noninvasive brain stimulation|noninvasive brain stimulation
293937|NCT01897025|Brain-computer interface|brain-computer interface
293938|NCT01897025|Motor imagery|motor imagery
293939|NCT01897025|Rehabilitation|rehabilitation
293940|NCT01896986|Special risk patients|special risk patients
293941|NCT01896986|Immunosuppressive biologic treatments|immunosuppressive biologic treatments
293942|NCT01896986|PRD (Paediatric Rheumatological Disease)|prd (paediatric rheumatological disease)
293943|NCT01896986|IBD (Inflammatory Bowel Disease)|ibd (inflammatory bowel disease)
293944|NCT01896973|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
293945|NCT01896973|BPH|bph
293946|NCT01896973|LUTS|luts
293947|NCT01896973|Vortx Rx|vortx rx
293948|NCT01896973|Histotripsy|histotripsy
293949|NCT01896960|Post spinal hypotension|post spinal hypotension
293950|NCT01896960|Cesarian Section|cesarian section
293951|NCT01896960|ET50|et50
293952|NCT01896960|Bupivacaine|bupivacaine
293953|NCT01896960|Fentanyl|fentanyl
293954|NCT01896934|Depression|depression
293955|NCT01896934|Antidepressants|antidepressants
293956|NCT01896934|Elderly|elderly
293957|NCT01896934|Geriatrics|geriatrics
293958|NCT01896921|HIV|hiv
293959|NCT01896908|diastolic dysfunction|diastolic dysfunction
293960|NCT01896908|Sodium restriction|sodium restriction
293961|NCT01896908|Randomized clinical trial|randomized clinical trial
293962|NCT01896882|Diet, Sodium-Restricted|diet, sodium-restricted
293963|NCT01896882|Food and Nutrition Education|food and nutrition education
293964|NCT01896882|Renal Dialyisis|renal dialyisis
293965|NCT01896869|Pancreatic Cancer|pancreatic cancer
293966|NCT01896869|Vaccine|vaccine
293967|NCT01896869|Immunotherapy|immunotherapy
293968|NCT01896869|Ipilimumab|ipilimumab
293969|NCT01896869|CTLA-4|ctla-4
293970|NCT01896869|antibody|antibody
293971|NCT01896869|FOLFIRINOX|folfirinox
293972|NCT01896856|SGI-110|sgi-110
293973|NCT01896856|irinotecan|irinotecan
293974|NCT01896856|regorafenib|regorafenib
293975|NCT01896856|methylation|methylation
293976|NCT01896856|colorectal|colorectal
293977|NCT01896856|metastatic|metastatic
293978|NCT01896856|TAS-102|tas-102
293979|NCT01896856|lonsurf|lonsurf
293980|NCT01896843|Positron Emission Tomography (PET)|positron emission tomography (pet)
293981|NCT01896843|Metabotropic Glutamate Receptors|metabotropic glutamate receptors
293982|NCT01896830|Clostridium difficile infection|clostridium difficile infection
293983|NCT01896830|Clostridium difficile Toxoid Vaccine|clostridium difficile toxoid vaccine
293984|NCT01896739|Healthy infants with over than 37 weeks gestation periods.|healthy infants with over than 37 weeks gestation periods.
293985|NCT01896739|over than 2.5Kg at at birth weight.|over than 2.5kg at at birth weight.
293986|NCT01896713|Prostate Cancer|prostate cancer
293987|NCT01896713|MRI|mri
293988|NCT01896713|TRUSBx|trusbx
293989|NCT01896700|Multiple sclerosis|multiple sclerosis
293990|NCT01896700|postural balance|postural balance
293991|NCT01896700|walking|walking
293992|NCT01896687|nonspecific low back pain|nonspecific low back pain
293993|NCT01896687|chronic low back pain|chronic low back pain
293994|NCT01896674|Computed tomography|computed tomography
293995|NCT01896661|Sleep apnea|sleep apnea
293996|NCT01896661|Hypertension|hypertension
293997|NCT01896661|Treatment|treatment
293998|NCT01896661|Diuretics|diuretics
293999|NCT01896661|Chlorthalidone|chlorthalidone
294000|NCT01896661|Amlodipine|amlodipine
294001|NCT01896635|Ulcerative Colitis|ulcerative colitis
294002|NCT01896635|Inflammatory Bowel Disease|inflammatory bowel disease
294003|NCT01896635|Fecal Transplantation|fecal transplantation
294004|NCT01896635|Fecal Microbiota Transplantation|fecal microbiota transplantation
294005|NCT01896622|Dabigatran Etexilate|dabigatran etexilate
294006|NCT01896622|Ritonavir|ritonavir
294007|NCT01896622|Cobicistat|cobicistat
294008|NCT01896622|P-Glycoprotein|p-glycoprotein
294009|NCT01896609|Chronic hepatitis c|chronic hepatitis c
294010|NCT01896609|Egyptian population|egyptian population
294011|NCT01896609|Reiferon Retard|reiferon retard
294012|NCT01896609|Ribavirin|ribavirin
294013|NCT01896609|Nitazoxanide|nitazoxanide
294014|NCT01896609|Bon one|bon one
294015|NCT01896596|vaccines|vaccines
294016|NCT01896596|immunogenicity|immunogenicity
294017|NCT01896596|adverse reactions|adverse reactions
294018|NCT01896570|atrial fibrillation|atrial fibrillation
294019|NCT01896570|catheter ablation|catheter ablation
294020|NCT01896570|subsequent atrial tachycardia|subsequent atrial tachycardia
294021|NCT01896570|mechanisms|mechanisms
294022|NCT01896557|clopidogrel|clopidogrel
294023|NCT01896557|omeprazole|omeprazole
294024|NCT01896557|ranitidin|ranitidin
294025|NCT01896557|interaction|interaction
294026|NCT01896557|aggregability|aggregability
294027|NCT01896544|cholecalciferol|cholecalciferol
294028|NCT01896544|vitamin D|vitamin d
294029|NCT01896544|sepsis|sepsis
294030|NCT01896544|infection|infection
294031|NCT01896518|second hand smoke exposure; children|second hand smoke exposure; children
294032|NCT01896505|bone|bone
294033|NCT01896505|soft-tissue|soft-tissue
294034|NCT01896505|sarcoma|sarcoma
294035|NCT01896505|KPT-330|kpt-330
294036|NCT01896505|food|food
294037|NCT01896505|effects|effects
294038|NCT01896505|Selinexor|selinexor
294039|NCT01896492|PCOS,|pcos,
294040|NCT01896492|NAC,|nac,
294041|NCT01896492|OVULATION INDUCTION,|ovulation induction,
294042|NCT01896492|CLOMOPHEN CITRATE|clomophen citrate
294043|NCT01896479|thyroid cancer|thyroid cancer
294044|NCT01896479|medullary thyroid cancer|medullary thyroid cancer
294045|NCT01896466|Fall Risk|fall risk
294046|NCT01896466|Gait|gait
294047|NCT01896466|Dynamic Balance|dynamic balance
294048|NCT01896466|Static Balance|static balance
294049|NCT01896466|Neuromodulation|neuromodulation
294050|NCT01896440|Pediatric|pediatric
294051|NCT01896440|Ondansetron|ondansetron
294052|NCT01896440|Cardiac repolarization|cardiac repolarization
294053|NCT01896440|QTc interval|qtc interval
294054|NCT01896427|Third Molar|third molar
294055|NCT01896427|Edema|edema
294056|NCT01896427|pain|pain
294057|NCT01896427|trismus|trismus
294058|NCT01896414|Metabolic Syndrome|metabolic syndrome
294059|NCT01896414|Omega 3 Fish Oil|omega 3 fish oil
294060|NCT01896401|large bore endovascular catheterization procedures|large bore endovascular catheterization procedures
294061|NCT01896401|Vascular Closure Device|vascular closure device
294455|NCT01894633|Metastasis|metastasis
294062|NCT01896388|PTSD/ifenprodil|ptsd/ifenprodil
294063|NCT01896375|Gutkha|gutkha
294064|NCT01896375|Pan masala ban|pan masala ban
294065|NCT01896375|Legislation|legislation
294066|NCT01896375|Smokeless tobacco|smokeless tobacco
294067|NCT01896349|Psychotherapy, Treatment Resistant Depression, depression|psychotherapy, treatment resistant depression, depression
294068|NCT01896271|kidney cancer|kidney cancer
294069|NCT01896271|metastatic cancer|metastatic cancer
294070|NCT01896245|hoarseness|hoarseness
294071|NCT01896245|sore throat|sore throat
294072|NCT01896245|intubating conditions|intubating conditions
294073|NCT01896245|vocal cord injuries|vocal cord injuries
294074|NCT01896245|sevoflurane|sevoflurane
294075|NCT01896232|Secondary Hyperparathyroidism, renal, kidney, kidneys, dialysis, hemodialysis, chronic kidney disease, CKD, SHPT|secondary hyperparathyroidism, renal, kidney, kidneys, dialysis, hemodialysis, chronic kidney disease, ckd, shpt
294076|NCT01896219|Medical device|medical device
294077|NCT01896219|CT|ct
294078|NCT01896219|Needle|needle
294079|NCT01896219|Navigation|navigation
294080|NCT01896219|IMACTIS-CT®|imactis-ct®
294081|NCT01896219|Thoraco-abdominal level|thoraco-abdominal level
294082|NCT01896219|anesthesia needles|anesthesia needles
294083|NCT01896180|POAG|poag
294084|NCT01896180|OHT|oht
294085|NCT01896180|OHTN|ohtn
294086|NCT01896180|IOP|iop
294087|NCT01896167|Headache|headache
294088|NCT01896167|Migraine|migraine
294089|NCT01896167|Aura|aura
294090|NCT01896167|Cerebral hemodynamics|cerebral hemodynamics
294091|NCT01896154|dietary fibers, influenza vaccination, HI titres|dietary fibers, influenza vaccination, hi titres
294092|NCT01896128|stroke|stroke
294093|NCT01896128|CVA|cva
294094|NCT01896128|cerebrovascular accident|cerebrovascular accident
294095|NCT01896128|hemiparesis|hemiparesis
294096|NCT01896128|impairment|impairment
294097|NCT01896128|motor recovery|motor recovery
294098|NCT01896128|neuroplasticity|neuroplasticity
294099|NCT01896128|nuvigil|nuvigil
294100|NCT01896128|armodafinil|armodafinil
294101|NCT01896115|Stimulation, implantable pulse generator, deep brain stimulation|stimulation, implantable pulse generator, deep brain stimulation
294102|NCT01896102|Adrenoleukodystrophy|adrenoleukodystrophy
294103|NCT01896102|X-linked adrenoleukodystrophy|x-linked adrenoleukodystrophy
294104|NCT01896102|Gene therapy|gene therapy
294105|NCT01896102|Hematopoietic stem cell|hematopoietic stem cell
294106|NCT01896076|caudal space|caudal space
294107|NCT01896076|children|children
294108|NCT01896076|ultrasound evaluation|ultrasound evaluation
294109|NCT01896063|Electroacupuncture, Sedation|electroacupuncture, sedation
294110|NCT01896050|Joint pain|joint pain
294111|NCT01896050|Grip strength|grip strength
294112|NCT01896050|Hormone receptor positive breast cancer|hormone receptor positive breast cancer
294113|NCT01896037|Spinal cord injury|spinal cord injury
294114|NCT01896037|Tetraplegia|tetraplegia
294115|NCT01896037|Quadraplegia|quadraplegia
294116|NCT01896037|Cholesterol|cholesterol
294117|NCT01896037|HDL-c|hdl-c
294118|NCT01896037|LDL-c|ldl-c
294119|NCT01896037|Omega-3 fatty acids|omega-3 fatty acids
294120|NCT01895998|sickle cell disease|sickle cell disease
294121|NCT01895998|pulmonary hypertension|pulmonary hypertension
294122|NCT01895998|airway hyperreactivity|airway hyperreactivity
294123|NCT01895998|acute chest syndrome|acute chest syndrome
294124|NCT01895959|knee osteoarthritis (OA)|knee osteoarthritis (oa)
294125|NCT01895959|hyaluronic acid injection|hyaluronic acid injection
294126|NCT01895946|Advanced solid malignancy, AZD5363,|advanced solid malignancy, azd5363,
294127|NCT01895946|food effect,|food effect,
294128|NCT01895946|formulation comparison|formulation comparison
294129|NCT01895933|Investigational device (chitosan gel)|investigational device (chitosan gel)
294130|NCT01895933|Wound healing|wound healing
294131|NCT01895933|Endoscopic sinus surgery|endoscopic sinus surgery
294132|NCT01895933|SurgiShield|surgishield
294133|NCT01895920|HIV|hiv
294134|NCT01895920|Biofilm|biofilm
294135|NCT01895920|Transmission|transmission
294136|NCT01895907|Special Olympics|special olympics
294137|NCT01895907|occupational therapy|occupational therapy
294138|NCT01895907|SCOPE|scope
294139|NCT01895907|life participation improvement|life participation improvement
294140|NCT01895894|Mycophenolate mofetil|mycophenolate mofetil
294141|NCT01895894|Immunosuppressive Agents|immunosuppressive agents
294142|NCT01895894|Nephrosis|nephrosis
294143|NCT01895881|Intracranial Aneurysm|intracranial aneurysm
294144|NCT01895881|Estradiol|estradiol
294145|NCT01895868|Ultrasound training|ultrasound training
294146|NCT01895868|Ultrasound simulation|ultrasound simulation
294147|NCT01895868|Ultrasound assessment|ultrasound assessment
294148|NCT01895868|Technology-enhanced learning|technology-enhanced learning
294149|NCT01895868|virtual reality simulation|virtual reality simulation
294150|NCT01895842|Leukemia|leukemia
294151|NCT01895842|Myelodysplastic syndrome|myelodysplastic syndrome
294152|NCT01895842|MDS|mds
294153|NCT01895842|Low or intermediate-1 risk|low or intermediate-1 risk
294154|NCT01895842|Maximum tolerated dose|maximum tolerated dose
294155|NCT01895842|MTD|mtd
294156|NCT01895842|Ruxolitinib|ruxolitinib
294157|NCT01895842|Jakafi|jakafi
294158|NCT01895842|INCB018424|incb018424
294159|NCT01895842|INC424|inc424
294160|NCT01895829|Head and Neck Cancer|head and neck cancer
294161|NCT01895829|Squamous cell carcinomas of the head and neck|squamous cell carcinomas of the head and neck
294162|NCT01895829|HNSCC|hnscc
294163|NCT01895829|Magnetic resonance imaging|magnetic resonance imaging
294164|NCT01895829|MRI|mri
294165|NCT01895829|Ferumoxytol|ferumoxytol
294166|NCT01895829|Ultra-small superparamagnetic iron oxide nanoparticle|ultra-small superparamagnetic iron oxide nanoparticle
294167|NCT01895829|USPIO|uspio
294168|NCT01895829|Contrast agent|contrast agent
294169|NCT01895829|Dynamic contrast imaging|dynamic contrast imaging
294170|NCT01895829|DCI|dci
294171|NCT01895816|male infertility,oligo spermia|male infertility,oligo spermia
294172|NCT01895803|smoking woman|smoking woman
294173|NCT01895790|Pancreatic Cancer|pancreatic cancer
294174|NCT01895790|Pancreatic Duct|pancreatic duct
294175|NCT01895790|Stent|stent
294176|NCT01895790|Pancreatic Duct Stent|pancreatic duct stent
294177|NCT01895790|Cancer|cancer
294178|NCT01895790|Pain|pain
294179|NCT01895790|Obstructive Pain|obstructive pain
294180|NCT01895790|Palliative|palliative
294181|NCT01895764|ankylosing spondylitis|ankylosing spondylitis
294182|NCT01895751|Non-ST elevation myocardial infarction (NSTEMI)|non-st elevation myocardial infarction (nstemi)
294183|NCT01895751|Non-ST elevation acute coronary syndrome (NSTE-ACS)|non-st elevation acute coronary syndrome (nste-acs)
294184|NCT01895751|Unstable Angina|unstable angina
294185|NCT01895751|Medical therapy|medical therapy
294186|NCT01895751|Coronary angiogram|coronary angiogram
294187|NCT01895751|Percutaneous coronary intervention|percutaneous coronary intervention
294188|NCT01895751|Coronary artery bypass surgery|coronary artery bypass surgery
294189|NCT01895751|Coronary revascularization|coronary revascularization
294190|NCT01895751|Health economics|health economics
294191|NCT01895738|Trauma|trauma
294192|NCT01895738|Injuries|injuries
294193|NCT01895738|Violence|violence
294194|NCT01895738|Adolescent|adolescent
294195|NCT01895738|WrapAround care|wraparound care
294196|NCT01895712|International|international
294197|NCT01895712|Multicenter|multicenter
294198|NCT01895712|Observational registry|observational registry
294199|NCT01895712|Orsiro Drug Eluting Stents (DES)|orsiro drug eluting stents (des)
294200|NCT01895712|Stenting|stenting
294201|NCT01895712|Treatment of Coronary Artery Disease|treatment of coronary artery disease
294202|NCT01895712|Coronary revascularization|coronary revascularization
294203|NCT01895712|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
294204|NCT01895712|Diabetes Mellitus Type 1|diabetes mellitus type 1
294205|NCT01895712|Diabetes Mellitus Type 2|diabetes mellitus type 2
294206|NCT01895712|STEMI|stemi
294207|NCT01895712|NSTEMI|nstemi
294208|NCT01895712|Ischemia|ischemia
294209|NCT01895712|Angina|angina
294210|NCT01895712|Subgroups|subgroups
294211|NCT01895712|Acute Myocardial Infarction|acute myocardial infarction
294212|NCT01895712|Small vessels|small vessels
294213|NCT01895712|Chronic Total Occlusion|chronic total occlusion
294214|NCT01895699|Contrast agent|contrast agent
294215|NCT01895699|endothelium|endothelium
294216|NCT01895699|Free radical|free radical
294217|NCT01895699|Alpha lipoic acid|alpha lipoic acid
294218|NCT01895686|open angle glaucoma|open angle glaucoma
294219|NCT01895686|narrow angles|narrow angles
294220|NCT01895686|angle closure glaucoma|angle closure glaucoma
294221|NCT01895686|gonioscopy|gonioscopy
294222|NCT01895686|anterior segment OCT|anterior segment oct
294223|NCT01895673|FDG-PET|fdg-pet
294224|NCT01895673|Radiofrequency Ablation|radiofrequency ablation
294225|NCT01895673|Magnetic Resonance Imaging|magnetic resonance imaging
294226|NCT01895660|P-CIMT|p-cimt
294227|NCT01895660|Pediatric Constraint Induced Movement Therapy|pediatric constraint induced movement therapy
294228|NCT01895660|Hemiparesis|hemiparesis
294229|NCT01895660|Cerebral Palsy|cerebral palsy
294230|NCT01895660|Children|children
294231|NCT01895647|electric muscle stimulation|electric muscle stimulation
294232|NCT01895647|respiratory failure|respiratory failure
294233|NCT01895647|sepsis|sepsis
294234|NCT01895647|interleukin 6|interleukin 6
294235|NCT01895647|interleukin 15|interleukin 15
294236|NCT01895634|Ischemia|ischemia
294237|NCT01895634|Stroke|stroke
294238|NCT01895634|Ischemic Stroke|ischemic stroke
294239|NCT01895634|Thrombectomy|thrombectomy
294240|NCT01895634|Brain clot|brain clot
294241|NCT01895634|Cerebrovascular disease|cerebrovascular disease
294242|NCT01895634|Recanalization|recanalization
294243|NCT01895634|Revascularization|revascularization
294244|NCT01895634|Clot Retriever|clot retriever
294245|NCT01895634|Neurovascular Intervention|neurovascular intervention
294246|NCT01895634|Interventional Neuroradiology|interventional neuroradiology
294247|NCT01895634|neurovascular clinical trial|neurovascular clinical trial
294248|NCT01895608|aged or aged 80 and over|aged or aged 80 and over
294249|NCT01895608|gait disorder|gait disorder
294250|NCT01895608|attention|attention
294251|NCT01895595|obesity|obesity
294252|NCT01895595|stress|stress
294253|NCT01895595|intuitive eating|intuitive eating
294254|NCT01895595|guided imagery|guided imagery
294255|NCT01895595|latinos|latinos
294256|NCT01895595|adolescents|adolescents
294257|NCT01895595|insulin resistance|insulin resistance
294259|NCT01895582|Tuberculosis|tuberculosis
294260|NCT01895582|Interferon gamma releasing tests|interferon gamma releasing tests
294261|NCT01895556|Malawi|malawi
294262|NCT01895556|Risk Compensation|risk compensation
294263|NCT01895556|Male Circumcision|male circumcision
294264|NCT01895556|Demand|demand
294265|NCT01895530|Probiotics|probiotics
294266|NCT01895530|colorectal cancer|colorectal cancer
294267|NCT01895530|postoperative infection|postoperative infection
294268|NCT01895530|immune function|immune function
294269|NCT01895530|bacterial translocation|bacterial translocation
294270|NCT01895530|gastrointestinal surgery|gastrointestinal surgery
294271|NCT01895504|Colonoscopy|colonoscopy
294272|NCT01895504|Colorectal cancer|colorectal cancer
294273|NCT01895504|Adenoma|adenoma
294274|NCT01895478|asthma|asthma
294275|NCT01895478|pediatrics|pediatrics
294276|NCT01895478|control|control
294277|NCT01895478|medication adherence|medication adherence
294278|NCT01895465|urine collection, contamination|urine collection, contamination
294279|NCT01895452|Schizophrenia|schizophrenia
294280|NCT01895439|Bone marrow derived Mesenchymal Stem Cells|bone marrow derived mesenchymal stem cells
294281|NCT01895439|Multiple Sclerosis|multiple sclerosis
294282|NCT01895439|Oligodendrocytes|oligodendrocytes
294283|NCT01895439|Neuroimmunology|neuroimmunology
294284|NCT01895439|Autoimmune disease|autoimmune disease
294285|NCT01895413|Cartilage injury|cartilage injury
294286|NCT01895413|Osteoarthritis|osteoarthritis
294287|NCT01895413|Mesenchymal stem cells|mesenchymal stem cells
294288|NCT01895400|Renexin for Recurrent Vestibulopathy|renexin for recurrent vestibulopathy
294289|NCT01895374|Laser therapy|laser therapy
294290|NCT01895374|Biological dressing|biological dressing
294291|NCT01895374|Amniotic membrane|amniotic membrane
294292|NCT01895374|Hydrocolloid bandages|hydrocolloid bandages
294293|NCT01895374|wound healing|wound healing
294294|NCT01895361|SelG1|selg1
294295|NCT01895361|P-selectin|p-selectin
294296|NCT01895361|monoclonal antibody|monoclonal antibody
294297|NCT01895361|sickle cell disease|sickle cell disease
294298|NCT01895361|sickle cell anemia|sickle cell anemia
294299|NCT01895361|sickle cell|sickle cell
294300|NCT01895361|pain crisis|pain crisis
294301|NCT01895361|pain crises|pain crises
294302|NCT01895361|vasoocclusion|vasoocclusion
294303|NCT01895361|vaso-occlusion|vaso-occlusion
294304|NCT01895361|priapism|priapism
294305|NCT01895361|hepatic sequestration|hepatic sequestration
294306|NCT01895361|splenic sequestration|splenic sequestration
294307|NCT01895361|chest syndrome|chest syndrome
294308|NCT01895322|Tolvaptan|tolvaptan
294309|NCT01895322|dialysis|dialysis
294310|NCT01895309|Rheumatoid Arthritis|rheumatoid arthritis
294311|NCT01895309|Etanercept|etanercept
294312|NCT01895309|Biosimilar|biosimilar
294313|NCT01895296|dumping syndrome|dumping syndrome
294314|NCT01895296|OGTT|ogtt
294315|NCT01895296|hypoglycemia|hypoglycemia
294316|NCT01895283|Aerobic training|aerobic training
294317|NCT01895283|VO2max|vo2max
294318|NCT01895283|Bethlem myopathy|bethlem myopathy
294319|NCT01895270|opioid dependence|opioid dependence
294320|NCT01895270|buprenorphine|buprenorphine
294321|NCT01895270|isradipine|isradipine
294322|NCT01895270|opioid withdrawal|opioid withdrawal
294323|NCT01895270|opioid detoxification|opioid detoxification
294324|NCT01895257|TTP1|ttp1
294325|NCT01895257|TTP2|ttp2
294326|NCT01895257|PFS|pfs
294327|NCT01895257|Safety|safety
294328|NCT01895257|R0 resection rate|r0 resection rate
294329|NCT01895257|Quality of life|quality of life
294330|NCT01895257|Overall Survival|overall survival
294331|NCT01895244|scleroderma|scleroderma
294332|NCT01895244|autologous stem cell transplantation|autologous stem cell transplantation
294333|NCT01895244|thiotepa|thiotepa
294334|NCT01895244|cluster of differentiation (CD) 34 selection|cluster of differentiation (cd) 34 selection
294335|NCT01895192|sperm morphology|sperm morphology
294336|NCT01895192|vacuoles|vacuoles
294337|NCT01895192|fertile|fertile
294338|NCT01895192|Motile Sperm Organellar Morphology Examination|motile sperm organellar morphology examination
294339|NCT01895192|high magnification|high magnification
294340|NCT01895192|reference values|reference values
294341|NCT01895179|Time-restricted feeding|time-restricted feeding
294342|NCT01895179|Intermittent fasting|intermittent fasting
294343|NCT01895179|Prediabetes|prediabetes
294344|NCT01895179|Insulin resistance|insulin resistance
294345|NCT01895179|Glucose tolerance|glucose tolerance
294346|NCT01895179|Insulin sensitivity|insulin sensitivity
294347|NCT01895179|Circadian rhythms|circadian rhythms
294348|NCT01895179|Diurnal|diurnal
294349|NCT01895166|Endobronchial ultrasonography with a guide sheath|endobronchial ultrasonography with a guide sheath
294350|NCT01895166|Peripheral pulmonary lesions|peripheral pulmonary lesions
294351|NCT01895166|Transbronchial biopsy|transbronchial biopsy
294352|NCT01895153|bladder pain syndrome|bladder pain syndrome
294353|NCT01895153|pentosan polysulfate|pentosan polysulfate
294354|NCT01895153|hydrodistension|hydrodistension
294355|NCT01895140|Treatment-resistant hypertension|treatment-resistant hypertension
294356|NCT01895140|Renal denervation|renal denervation
294357|NCT01895140|Ambulatory blood pressure|ambulatory blood pressure
294358|NCT01895127|Kidney Transplant|kidney transplant
294359|NCT01895127|Renal Transplant|renal transplant
294360|NCT01895127|Rejection|rejection
294361|NCT01895127|Antibody mediated|antibody mediated
294362|NCT01895127|Humoral|humoral
294363|NCT01895127|Eculizumab|eculizumab
294364|NCT01895114|Renal function|renal function
294365|NCT01895114|cirrhotic patients|cirrhotic patients
294366|NCT01895114|transplant evaluation|transplant evaluation
294367|NCT01895101|blood loss|blood loss
294368|NCT01895101|tranexamix acid|tranexamix acid
294369|NCT01895101|cardiac surgery|cardiac surgery
294370|NCT01895088|presbyopia|presbyopia
294371|NCT01895075|Budesonide|budesonide
294372|NCT01895075|Inhalation|inhalation
294373|NCT01895075|Premature infants|premature infants
294374|NCT01895062|colonoscopy|colonoscopy
294375|NCT01895062|oxygen desaturation|oxygen desaturation
294376|NCT01895049|Tacrolimus|tacrolimus
294377|NCT01895049|Everolimus|everolimus
294378|NCT01895049|Cytomegalovirus|cytomegalovirus
294379|NCT01895049|Thymoglobulin|thymoglobulin
294380|NCT01895049|Deceased donors|deceased donors
294381|NCT01895049|Expanded criteria|expanded criteria
294382|NCT01895036|maintained on 2 mg or less of buprenorphine, in which discontinuation of agonist treatment is clinically feasible but difficult|maintained on 2 mg or less of buprenorphine, in which discontinuation of agonist treatment is clinically feasible but difficult
294383|NCT01895010|prevention and treatment|prevention and treatment
294384|NCT01895010|improvement of the patient's appetite|improvement of the patient's appetite
294385|NCT01895010|TACE|tace
294386|NCT01894997|Deep Vein Thrombosis|deep vein thrombosis
294387|NCT01894997|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
294388|NCT01894997|Intermittent Pneumatic Compression|intermittent pneumatic compression
294389|NCT01894997|Doppler Ultrasound|doppler ultrasound
294390|NCT01894984|Schizophrenia|schizophrenia
294391|NCT01894984|Risperidone|risperidone
294392|NCT01894984|Risperdal Consta|risperdal consta
294393|NCT01894984|Oral antipsychotic|oral antipsychotic
294394|NCT01894958|Fragile X disorder|fragile x disorder
294395|NCT01894958|Autism|autism
294396|NCT01894932|Psychotherapy, Group|psychotherapy, group
294397|NCT01894919|Meningococcal B disease,|meningococcal b disease,
294398|NCT01894919|Antibody persistence|antibody persistence
294399|NCT01894906|Soluble Ferric Pyrophosphate,|soluble ferric pyrophosphate,
294400|NCT01894906|Pharmacokinetics,|pharmacokinetics,
294401|NCT01894906|Iron, Mass Transfer,|iron, mass transfer,
294402|NCT01894906|Hemodialysis|hemodialysis
294403|NCT01894906|chronic therapy;|chronic therapy;
294404|NCT01894867|LIVER CIRRHOSIS|liver cirrhosis
294405|NCT01894867|MAGNESIUM|magnesium
294406|NCT01894867|MINIMAL ENCEPHALOPATHY|minimal encephalopathy
294407|NCT01894867|MUSCLE WEAKNESS|muscle weakness
294408|NCT01894854|Radiostereometry|radiostereometry
294409|NCT01894854|Total Hip Arthroplasty|total hip arthroplasty
294410|NCT01894854|Stem design|stem design
294411|NCT01894841|depression|depression
294412|NCT01894841|prevention|prevention
294413|NCT01894841|Veterans health|veterans health
294414|NCT01894828|Nutritional support|nutritional support
294415|NCT01894828|Gastrointestinal cancer|gastrointestinal cancer
294416|NCT01894828|Malnutrition|malnutrition
294417|NCT01894815|major depressive disorder|major depressive disorder
294418|NCT01894815|major depression|major depression
294419|NCT01894815|depressive disorder|depressive disorder
294420|NCT01894815|major depressive episode|major depressive episode
294421|NCT01894802|Tetraplegia|tetraplegia
294422|NCT01894802|Quadriplegia|quadriplegia
294423|NCT01894802|Spinal cord injury|spinal cord injury
294424|NCT01894802|Brainstem or spinal stroke|brainstem or spinal stroke
294425|NCT01894802|Neuroprosthetic|neuroprosthetic
294426|NCT01894802|Brain-machine interface|brain-machine interface
294427|NCT01894802|Brain-computer interface|brain-computer interface
294428|NCT01894802|Neural activity|neural activity
294429|NCT01894802|Sensory stimulation|sensory stimulation
294430|NCT01894802|Microstimulation|microstimulation
294431|NCT01894789|myocardial blood flow|myocardial blood flow
294432|NCT01894789|myocardial perfusion imaging|myocardial perfusion imaging
294433|NCT01894789|myocardial blood flow reserve|myocardial blood flow reserve
294434|NCT01894789|positron emission tomography|positron emission tomography
294435|NCT01894789|adenosine|adenosine
294436|NCT01894789|ticagrelor|ticagrelor
294437|NCT01894789|clopidogrel|clopidogrel
294438|NCT01894776|healthy volunteers|healthy volunteers
294439|NCT01894763|esophagus|esophagus
294440|NCT01894763|cancer|cancer
294441|NCT01894750|Heart Failure|heart failure
294442|NCT01894750|Self-Care|self-care
294443|NCT01894685|Colorectal|colorectal
294444|NCT01894685|Adenoma|adenoma
294445|NCT01894685|Recurrence|recurrence
294446|NCT01894685|Mesalazine|mesalazine
294447|NCT01894685|Chemoprevention|chemoprevention
294448|NCT01894672|LGX818|lgx818
294449|NCT01894672|BRAF Inhibitor|braf inhibitor
294450|NCT01894672|Stage IV melanoma|stage iv melanoma
294451|NCT01894672|unresectable stage III melanoma|unresectable stage iii melanoma
294452|NCT01894672|BRAFV600 mutation|brafv600 mutation
294453|NCT01894672|13-053|13-053
294454|NCT01894633|Prophylactic Cranial Irradiation|prophylactic cranial irradiation
294456|NCT01894633|Cloroquine|cloroquine
294457|NCT01894620|Alzheimer's|alzheimer's
294458|NCT01894620|rTMS|rtms
294459|NCT01894620|sleep quality|sleep quality
294460|NCT01894620|dementia|dementia
294461|NCT01894620|memory|memory
294462|NCT01894607|Kidney Cancer|kidney cancer
294463|NCT01894607|Renal Mass|renal mass
294464|NCT01894607|Open partial nephrectomy|open partial nephrectomy
294465|NCT01894607|Ultrasound-guided surgery|ultrasound-guided surgery
294466|NCT01894607|DEFINITY|definity
294467|NCT01894607|Contrast agent|contrast agent
294468|NCT01894607|Phone call|phone call
294469|NCT01894594|Sickle cell disease|sickle cell disease
294470|NCT01894594|Chronic kidney disease|chronic kidney disease
294471|NCT01894594|Bicarbonate therapy|bicarbonate therapy
294472|NCT01894555|Platelet Transcriptome|platelet transcriptome
294473|NCT01894555|Coronary Artery Disease|coronary artery disease
294474|NCT01894555|Myocardial Ischemia|myocardial ischemia
294475|NCT01894555|Coronary Disease|coronary disease
294476|NCT01894555|Heart Diseases|heart diseases
294477|NCT01894555|Cardiovascular Diseases|cardiovascular diseases
294478|NCT01894555|Arteriosclerosis|arteriosclerosis
294479|NCT01894555|Arterial Occlusive Diseases|arterial occlusive diseases
294480|NCT01894555|Vascular Diseases|vascular diseases
294481|NCT01894555|Aspirin|aspirin
294482|NCT01894529|ischemic stroke|ischemic stroke
294483|NCT01894529|immune biomarkers|immune biomarkers
294484|NCT01894529|stroke-associated infection|stroke-associated infection
294485|NCT01894529|functional outcome|functional outcome
294486|NCT01894529|prediction|prediction
294487|NCT01894490|Gastrointestinal surgery, complications, length of hospital stay, mortality|gastrointestinal surgery, complications, length of hospital stay, mortality
294488|NCT01894464|truancy|truancy
294489|NCT01894464|attendance|attendance
294490|NCT01894464|education|education
294491|NCT01894464|primary school|primary school
294492|NCT01894464|elementary school|elementary school
294493|NCT01894451|Inflammatory Breast Carcinoma|inflammatory breast carcinoma
294494|NCT01894451|89Zr-bevacizumab|89zr-bevacizumab
294495|NCT01894438|NAFLD|nafld
294496|NCT01894438|NASH|nash
294497|NCT01894438|Mediterranean diet|mediterranean diet
294498|NCT01894438|Mediterranean lifestyle|mediterranean lifestyle
294499|NCT01894425|Medically assisted procreation|medically assisted procreation
294500|NCT01894425|Assisted reproductive technology|assisted reproductive technology
294501|NCT01894425|Human papilloma virus|human papilloma virus
294502|NCT01894399|HM61713|hm61713
294503|NCT01894399|pharmacokinetics|pharmacokinetics
294504|NCT01894399|Phase I|phase i
294505|NCT01894399|healthy|healthy
294506|NCT01894399|olmutinib|olmutinib
294507|NCT01894386|GW642444 (Vilanterol)|gw642444 (vilanterol)
294508|NCT01894386|GSK573719 (Umeclidinium)|gsk573719 (umeclidinium)
294509|NCT01894386|GW685698 (Fluticasone Furoate)|gw685698 (fluticasone furoate)
294510|NCT01894386|pharmacokinetics|pharmacokinetics
294511|NCT01894386|Healthy subjects|healthy subjects
294512|NCT01894360|Pharmacokinetics|pharmacokinetics
294513|NCT01894360|Phase 1|phase 1
294514|NCT01894360|Healthy Subjects|healthy subjects
294515|NCT01894360|Comparability|comparability
294516|NCT01894360|Belimumab|belimumab
294517|NCT01894347|Colistin, MDR, inhalative therapy|colistin, mdr, inhalative therapy
294518|NCT01894334|Aortic dissection|aortic dissection
294519|NCT01894334|acute lung injury|acute lung injury
294520|NCT01894334|injury mechanism|injury mechanism
294521|NCT01894334|early intervention|early intervention
294522|NCT01894321|Acute cholecystitis|acute cholecystitis
294523|NCT01894321|Elderly|elderly
294524|NCT01894321|Critically ill patients|critically ill patients
294525|NCT01894321|Surgical high risk|surgical high risk
294526|NCT01894321|Percutaneous cholecystostomy|percutaneous cholecystostomy
294527|NCT01894321|Cholecystectomy|cholecystectomy
294528|NCT01894308|Male Hormone Replacement|male hormone replacement
294529|NCT01894308|Multiple Dose|multiple dose
294530|NCT01894308|Single Period|single period
294531|NCT01894308|Phase II|phase ii
294532|NCT01894308|Dose Ranging|dose ranging
294533|NCT01894308|Adult Male Subjects|adult male subjects
294534|NCT01894308|Testosterone Replacement|testosterone replacement
294535|NCT01894295|Vitamin D analogues|vitamin d analogues
294536|NCT01894295|Resting Metabolic rate|resting metabolic rate
294537|NCT01894295|obesity|obesity
294538|NCT01894282|Chronic Lower Back Pain|chronic lower back pain
294539|NCT01894282|Manual Therapy|manual therapy
294540|NCT01894282|Cognitive Behavioral Therapy|cognitive behavioral therapy
294541|NCT01894256|oncology,|oncology,
294542|NCT01894256|cancer,|cancer,
294543|NCT01894256|neoplasm,|neoplasm,
294544|NCT01894256|anticancer drug,|anticancer drug,
294545|NCT01894256|pharmacokinetics,|pharmacokinetics,
294546|NCT01894256|area under curve,|area under curve,
294547|NCT01894256|olaparib,|olaparib,
294548|NCT01894256|solid tumour,|solid tumour,
294549|NCT01894256|mild renal impairment,|mild renal impairment,
294550|NCT01894256|moderate renal impairment|moderate renal impairment
294551|NCT01894243|oncology,|oncology,
294552|NCT01894243|cancer,|cancer,
294553|NCT01894243|neoplasm,|neoplasm,
294554|NCT01894243|anticancer drug,|anticancer drug,
294555|NCT01894243|pharmacokinetics,|pharmacokinetics,
294556|NCT01894243|area under curve,|area under curve,
294557|NCT01894243|olaparib,|olaparib,
294558|NCT01894243|solid tumour,|solid tumour,
294559|NCT01894243|mild hepatic impairment,|mild hepatic impairment,
294560|NCT01894243|moderate hepatic impairment|moderate hepatic impairment
294561|NCT01894230|high cholesterol|high cholesterol
294562|NCT01894230|genetic testing|genetic testing
294563|NCT01894230|medication adherence|medication adherence
294564|NCT01894230|statins|statins
294565|NCT01894230|Adverse Effects|adverse effects
294566|NCT01894230|pharmacogenetics|pharmacogenetics
294567|NCT01894217|high cholesterol|high cholesterol
294568|NCT01894217|genetic testing|genetic testing
294569|NCT01894217|medication adherence|medication adherence
294570|NCT01894217|statins|statins
294571|NCT01894217|Adverse Effects|adverse effects
294572|NCT01894217|Pharmacogenetic|pharmacogenetic
294573|NCT01894204|HTTPE|httpe
294574|NCT01894204|Idiopathic Pulmonary embolism|idiopathic pulmonary embolism
294575|NCT01894191|adenoma detection rate|adenoma detection rate
294576|NCT01894191|colonoscopy|colonoscopy
294577|NCT01894191|water exchange|water exchange
294578|NCT01894165|molybdenum cofactor deficiency (MoCD)|molybdenum cofactor deficiency (mocd)
294579|NCT01894165|deficiency of activity of molybdenum-dependent enzymes|deficiency of activity of molybdenum-dependent enzymes
294580|NCT01894152|XIENCE PRIME EECSS|xience prime eecss
294581|NCT01894152|XIENCE V EECSS|xience v eecss
294582|NCT01894152|XIENCE PRIME|xience prime
294583|NCT01894152|SPIRIT PRIME|spirit prime
294584|NCT01894152|XIENCE PRIME SV (Small Vessel)|xience prime sv (small vessel)
294585|NCT01894152|XIENCE PRIME LL (Long Lesion)|xience prime ll (long lesion)
294586|NCT01894152|Coronary Artery Disease|coronary artery disease
294587|NCT01894152|Coronary Heart Disease|coronary heart disease
294588|NCT01894152|Cardiovascular Disease|cardiovascular disease
294589|NCT01894152|Myocardial Infarction|myocardial infarction
294590|NCT01894152|Stent Thrombosis|stent thrombosis
294591|NCT01894139|Gestational weight gain|gestational weight gain
294592|NCT01894139|Obese women|obese women
294593|NCT01894139|Fetal programming|fetal programming
294594|NCT01894139|Metabolic disorders|metabolic disorders
294595|NCT01894139|Development of obesity|development of obesity
294596|NCT01894139|Development og overweight|development og overweight
294597|NCT01894139|Complications during pregnancy and birth|complications during pregnancy and birth
294598|NCT01894113|interstitial lung disease|interstitial lung disease
294599|NCT01894113|transbronchial biopsy|transbronchial biopsy
294600|NCT01894113|cryobiopsy|cryobiopsy
294601|NCT01894074|Subfertility|subfertility
294602|NCT01894074|Anovulatory|anovulatory
294603|NCT01894074|Obese|obese
294604|NCT01894074|Women|women
294605|NCT01894061|adult giant cell glioblastoma|adult giant cell glioblastoma
294606|NCT01894061|adult glioblastoma|adult glioblastoma
294607|NCT01894061|adult gliosarcoma|adult gliosarcoma
294608|NCT01894061|recurrent adult brain tumor|recurrent adult brain tumor
294609|NCT01894061|Bevacizumab-naive|bevacizumab-naive
294610|NCT01894061|NovoTTF-100A|novottf-100a
294611|NCT01894048|asthma control|asthma control
294612|NCT01894048|small airways|small airways
294613|NCT01894048|extra-fine particle inhaled corticosteroids|extra-fine particle inhaled corticosteroids
294614|NCT01894035|Pulmonary Hypertension|pulmonary hypertension
294615|NCT01894035|Ventavis|ventavis
294616|NCT01894035|Patient compliance|patient compliance
294617|NCT01894022|Inoperable chronic thromboembolic pulmonary hypertension, endothelin receptor antagonist|inoperable chronic thromboembolic pulmonary hypertension, endothelin receptor antagonist
294618|NCT01894009|Osteopathic manipulation|osteopathic manipulation
294619|NCT01894009|Exercise therapy|exercise therapy
294620|NCT01894009|Pregnancy pelvic girdle pain|pregnancy pelvic girdle pain
294621|NCT01893996|rheumatoid|rheumatoid
294622|NCT01893996|arthritis|arthritis
294623|NCT01893996|cardiovascular|cardiovascular
294624|NCT01893996|adalimumab|adalimumab
294626|NCT01893996|biologic|biologic
294627|NCT01893983|Mental Health|mental health
294628|NCT01893983|Veterans Health|veterans health
294629|NCT01893983|Rural|rural
294630|NCT01893983|Motivational Interviewing|motivational interviewing
294631|NCT01893957|breast cancer|breast cancer
294632|NCT01893957|physical therapy|physical therapy
294633|NCT01893957|electrical stimulation|electrical stimulation
294634|NCT01893957|tactile sensitivity|tactile sensitivity
294635|NCT01893957|flow blood|flow blood
294636|NCT01893944|Breast cancer|breast cancer
294637|NCT01893944|vibratory therapy|vibratory therapy
294638|NCT01893944|virtual reality|virtual reality
294639|NCT01893931|Geriatrics|geriatrics
294640|NCT01893931|Emergency Medicine|emergency medicine
294641|NCT01893931|Care Transitions|care transitions
294642|NCT01893918|Smoking|smoking
294643|NCT01893918|Dyspnea|dyspnea
294644|NCT01893892|Basal Cell Carcinoma|basal cell carcinoma
294645|NCT01893892|Gorlin syndrome|gorlin syndrome
294646|NCT01893892|Erivedge|erivedge
294647|NCT01893892|Basal Cell Nevus Syndrome|basal cell nevus syndrome
294648|NCT01893853|dehydration|dehydration
294649|NCT01893853|fluid balance|fluid balance
294650|NCT01893853|exercise|exercise
294651|NCT01893853|heat|heat
294652|NCT01893853|body weight|body weight
294653|NCT01893853|performance|performance
294654|NCT01893827|Naltrexone|naltrexone
294655|NCT01893827|Extended-release naltrexone|extended-release naltrexone
294656|NCT01893827|Oral naltrexone|oral naltrexone
294657|NCT01893827|Vivitrol|vivitrol
294658|NCT01893827|XR-NTX|xr-ntx
294659|NCT01893827|alcohol dependence|alcohol dependence
294660|NCT01893827|primary care|primary care
294661|NCT01893827|Medical Management|medical management
294662|NCT01893801|pancreatic cancer|pancreatic cancer
294663|NCT01893801|pancreatic adenocarcinoma|pancreatic adenocarcinoma
294664|NCT01893801|Stage IV pancreatic cancer|stage iv pancreatic cancer
294665|NCT01893801|pancreas|pancreas
294666|NCT01893801|pancreatic|pancreatic
294667|NCT01893788|hypertension|hypertension
294668|NCT01893788|left ventricular hypertrophy|left ventricular hypertrophy
294669|NCT01893788|renin angiotensin system|renin angiotensin system
294670|NCT01893788|aldosterone|aldosterone
294671|NCT01893788|aliskiren|aliskiren
294672|NCT01893788|eplerenone|eplerenone
294673|NCT01893788|P3NP|p3np
294674|NCT01893775|Anti CD 122|anti cd 122
294675|NCT01893775|Monoclonal Antibody Therapy|monoclonal antibody therapy
294676|NCT01893775|Autoimmune Inflammatory Enteropathy|autoimmune inflammatory enteropathy
294677|NCT01893762|neutrophil|neutrophil
294678|NCT01893762|exercise|exercise
294679|NCT01893762|URTI|urti
294680|NCT01893762|Innate|innate
294681|NCT01893762|Immune|immune
294682|NCT01893749|depression|depression
294683|NCT01893749|prevention|prevention
294684|NCT01893749|teen|teen
294685|NCT01893749|at risk|at risk
294686|NCT01893749|internet|internet
294687|NCT01893736|Breastfeeding|breastfeeding
294688|NCT01893736|professional support|professional support
294689|NCT01893736|postnatal|postnatal
294690|NCT01893736|interventions|interventions
294691|NCT01893736|exclusive breastfeeding|exclusive breastfeeding
294692|NCT01893736|randomized controlled trial|randomized controlled trial
294693|NCT01893723|autonomous nervous system monitoring|autonomous nervous system monitoring
294694|NCT01893723|analgesia nociception balance|analgesia nociception balance
294695|NCT01893723|remifentanil|remifentanil
294696|NCT01893723|analgesia nociception index|analgesia nociception index
294697|NCT01893723|hemodynamic reactivity|hemodynamic reactivity
294698|NCT01893710|peritoneal dialysis|peritoneal dialysis
294699|NCT01893710|parietal peritoneum|parietal peritoneum
294700|NCT01893710|omentum|omentum
294701|NCT01893710|children|children
294702|NCT01893684|protein|protein
294703|NCT01893684|physical function|physical function
294704|NCT01893684|muscle quality|muscle quality
294705|NCT01893684|fatigue|fatigue
294706|NCT01893684|weight loss|weight loss
294707|NCT01893671|LASIK|lasik
294708|NCT01893671|corneal power|corneal power
294709|NCT01893671|astigmatism|astigmatism
294710|NCT01893671|HOA|hoa
294711|NCT01893671|Optical Coherence Tomography|optical coherence tomography
294712|NCT01893658|Interstitial Nephritis|interstitial nephritis
294713|NCT01893658|Nephritis|nephritis
294714|NCT01893658|Tubulointerstitial|tubulointerstitial
294715|NCT01893658|Renal disease|renal disease
294716|NCT01893658|Kidney|kidney
294717|NCT01893645|Pronto-7|pronto-7
294718|NCT01893645|SpHb|sphb
294719|NCT01893645|Obstetric patients|obstetric patients
294720|NCT01893632|Benzodiazepines|benzodiazepines
294721|NCT01893632|clonazepam|clonazepam
294722|NCT01893632|alprazolam|alprazolam
294723|NCT01893632|Klonopin|klonopin
294724|NCT01893632|Xanax|xanax
294725|NCT01893632|diazepam|diazepam
294726|NCT01893632|Valium|valium
294727|NCT01893632|lorazepam|lorazepam
294728|NCT01893632|Ativan|ativan
294729|NCT01893619|Chronic fatigue syndrome|chronic fatigue syndrome
294730|NCT01893619|Karnofsky score|karnofsky score
294731|NCT01893619|supplements|supplements
294732|NCT01893606|diarrhea|diarrhea
294733|NCT01893606|abdominal pain|abdominal pain
294734|NCT01893593|Cardiovascular risk|cardiovascular risk
294735|NCT01893593|lifestyle change|lifestyle change
294736|NCT01893593|blood pressure|blood pressure
294737|NCT01893593|body mass index|body mass index
294738|NCT01893593|tobacco|tobacco
294739|NCT01893580|Cancer|cancer
294740|NCT01893580|Rehabilitation|rehabilitation
294741|NCT01893580|Exercise|exercise
294742|NCT01893580|Lung cancer|lung cancer
294743|NCT01893580|NSCLC|nsclc
294744|NCT01893541|CIRRHOTIC|cirrhotic
294745|NCT01893541|VARICEAL BLEEDING|variceal bleeding
294746|NCT01893541|PRIMARY PROPHYLAXIS|primary prophylaxis
294747|NCT01893489|positron emission tomography|positron emission tomography
294748|NCT01893489|macrophage|macrophage
294749|NCT01893489|neomannosyl human serum albumin|neomannosyl human serum albumin
294750|NCT01893476|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
294751|NCT01893476|implementation|implementation
294752|NCT01893463|hemorrhage control|hemorrhage control
294753|NCT01893463|wound closure|wound closure
294754|NCT01893450|Graves ophthalmopathy|graves ophthalmopathy
294755|NCT01893450|Exophthalmos|exophthalmos
294756|NCT01893450|Proptosis|proptosis
294757|NCT01893450|Quality of life|quality of life
294758|NCT01893424|Biological Availability|biological availability
294759|NCT01893424|Pharmacokinetics|pharmacokinetics
294760|NCT01893385|vitamin D|vitamin d
294761|NCT01893385|supplementation|supplementation
294762|NCT01893385|immunocompetente cells, immune system|immunocompetente cells, immune system
294763|NCT01893385|influenza vaccine|influenza vaccine
294764|NCT01893385|elderly|elderly
294765|NCT01893372|Leukemia|leukemia
294766|NCT01893372|Myelodysplastic syndrome|myelodysplastic syndrome
294767|NCT01893372|MDS|mds
294768|NCT01893372|Overall response rate|overall response rate
294769|NCT01893372|ORR|orr
294770|NCT01893372|Eltrombopag|eltrombopag
294771|NCT01893372|Promacta|promacta
294772|NCT01893372|Hypomethylating Agent|hypomethylating agent
294773|NCT01893359|hyperopia|hyperopia
294774|NCT01893359|hyperopic astigmatism|hyperopic astigmatism
294775|NCT01893359|cross-linking|cross-linking
294776|NCT01893346|Ceftazidime, Avibactam, Anti-Infectives|ceftazidime, avibactam, anti-infectives
294777|NCT01893333|cervical cancer|cervical cancer
294778|NCT01893333|nerve sparing radical hysterectomy|nerve sparing radical hysterectomy
294779|NCT01893320|Leukemia|leukemia
294780|NCT01893320|Acute Myeloid Leukemia|acute myeloid leukemia
294782|NCT01893320|High-risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
294783|NCT01893320|MDS|mds
294784|NCT01893320|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
294785|NCT01893320|CMM|cmm
294786|NCT01893320|Maximum tolerated dose|maximum tolerated dose
294787|NCT01893320|MTD|mtd
294788|NCT01893320|Vosaroxin|vosaroxin
294789|NCT01893320|Decitabine|decitabine
294790|NCT01893320|Dacogen|dacogen
294791|NCT01893307|Head And Neck Cancer|head and neck cancer
294792|NCT01893307|Oropharyngeal Cancer|oropharyngeal cancer
294793|NCT01893307|Squamous cell carcinoma of the oropharynx|squamous cell carcinoma of the oropharynx
294794|NCT01893307|Acute and late toxicity|acute and late toxicity
294795|NCT01893307|Intensity modulated photon therapy|intensity modulated photon therapy
294796|NCT01893307|IMRT|imrt
294797|NCT01893307|Intensity modulated proton therapy|intensity modulated proton therapy
294798|NCT01893307|IMPT|impt
294799|NCT01893307|Modified barium swallow|modified barium swallow
294800|NCT01893307|MBS|mbs
294801|NCT01893307|Questionnaires|questionnaires
294802|NCT01893307|Surveys|surveys
294803|NCT01893229|Bipolar disorder|bipolar disorder
294804|NCT01893229|Comparative Effectiveness Research|comparative effectiveness research
294805|NCT01893229|Therapeutics|therapeutics
294806|NCT01893229|Patient Dropouts|patient dropouts
294807|NCT01893216|anxiety|anxiety
294808|NCT01893216|depression|depression
294809|NCT01893216|sexual dysfunction|sexual dysfunction
294810|NCT01893216|infertility|infertility
294811|NCT01893190|Ruptured saccular aneurysm|ruptured saccular aneurysm
294812|NCT01893190|nimodipine|nimodipine
294813|NCT01893190|safety|safety
294814|NCT01893190|tolerability|tolerability
294815|NCT01893190|Subarachnoid hemorrhage|subarachnoid hemorrhage
294816|NCT01893177|Influenza|influenza
294817|NCT01893177|Virus|virus
294818|NCT01893177|Vaccination|vaccination
294819|NCT01893177|Inflexal V|inflexal v
294820|NCT01893164|cubital tunnel syndrome|cubital tunnel syndrome
294821|NCT01893164|simple decompression|simple decompression
294822|NCT01893164|anterior subcutaneous transposition of ulnar nerve|anterior subcutaneous transposition of ulnar nerve
294823|NCT01893164|anterior intramuscular transposition of ulnar nerve|anterior intramuscular transposition of ulnar nerve
294824|NCT01893164|severity scale|severity scale
294825|NCT01893151|Iguratimod|iguratimod
294826|NCT01893151|MRI|mri
294827|NCT01893151|Rheumatoid Arthritis|rheumatoid arthritis
294828|NCT01893138|Urinary Incontinence, Stress|urinary incontinence, stress
294829|NCT01893138|Tissue Therapy (Cell Therapy)|tissue therapy (cell therapy)
294830|NCT01893138|Transplantation, Autologous|transplantation, autologous
294831|NCT01893060|Prematurity|prematurity
294832|NCT01893060|Central line care|central line care
294833|NCT01893060|Umbilical line colonization|umbilical line colonization
294834|NCT01893060|Colonization|colonization
294835|NCT01893060|Newborn Intensive Care Unit|newborn intensive care unit
294836|NCT01893060|Neonatal Intensive Care Unit|neonatal intensive care unit
294837|NCT01893047|breast milk production|breast milk production
294838|NCT01893034|Femoroacetabular Impingement|femoroacetabular impingement
294839|NCT01893034|Arthroscopy|arthroscopy
294840|NCT01893034|Physiotherapy|physiotherapy
294841|NCT01893034|Randomised Controlled Trial|randomised controlled trial
294842|NCT01893008|Esophageal cancer|esophageal cancer
294843|NCT01893008|Surgery|surgery
294844|NCT01892995|suicide|suicide
294845|NCT01892995|ketamine|ketamine
294846|NCT01892995|low-dose ketamine|low-dose ketamine
294847|NCT01892995|suicidal ideations|suicidal ideations
294848|NCT01892995|emergency department|emergency department
294849|NCT01892982|Maternal Depression|maternal depression
294850|NCT01892982|Preterm Birth|preterm birth
294851|NCT01892982|Preterm Outcomes|preterm outcomes
294852|NCT01892982|Child Development|child development
294853|NCT01892917|International|international
294854|NCT01892917|Multicenter|multicenter
294855|NCT01892917|Observational registry|observational registry
294856|NCT01892917|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
294857|NCT01892917|Stenting|stenting
294858|NCT01892917|Treatment of Coronary Artery Disease|treatment of coronary artery disease
294859|NCT01892917|Coronary revascularization|coronary revascularization
294860|NCT01892917|Percutaneous Coronary Intervention|percutaneous coronary intervention
294861|NCT01892917|STEMI|stemi
294862|NCT01892917|NSTEMI|nstemi
294863|NCT01892917|Ischemia|ischemia
294864|NCT01892917|Subgroups|subgroups
294865|NCT01892917|Acute Myocardial Infarction|acute myocardial infarction
294866|NCT01892917|Diabetes|diabetes
294867|NCT01892917|Small Vessels|small vessels
294868|NCT01892917|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
294869|NCT01892904|YAZ|yaz
294870|NCT01892904|Flexible regimen|flexible regimen
294871|NCT01892904|Drospirenone|drospirenone
294872|NCT01892904|Ethinylestradiol Betadex|ethinylestradiol betadex
294873|NCT01892904|Dysmenorrhea|dysmenorrhea
294874|NCT01892904|Japanese patients|japanese patients
294875|NCT01892891|Healthy|healthy
294876|NCT01892891|Subjects|subjects
294877|NCT01892891|Safety|safety
294878|NCT01892891|Tolerability|tolerability
294879|NCT01892891|VBY036|vby036
294880|NCT01892891|maximum|maximum
294881|NCT01892891|pharmacodynamic|pharmacodynamic
294882|NCT01892891|pharmacokinetic|pharmacokinetic
294883|NCT01892865|Operating room utilization|operating room utilization
294884|NCT01892852|Acupuncture|acupuncture
294885|NCT01892852|Traditional Korean Medicine|traditional korean medicine
294886|NCT01892826|FET|fet
294887|NCT01892826|Blastocyst|blastocyst
294888|NCT01892826|natural cycle|natural cycle
294889|NCT01892826|hCG|hcg
294890|NCT01892826|Spontaneous LH pic|spontaneous lh pic
294891|NCT01892813|Nicotine dependence|nicotine dependence
294892|NCT01892813|Smoking cessation|smoking cessation
294893|NCT01892813|Telehealth|telehealth
294894|NCT01892813|Alcohol use|alcohol use
294895|NCT01892813|Depression|depression
294896|NCT01892813|Body weight|body weight
294897|NCT01892800|Lung Cancer|lung cancer
294898|NCT01892800|Ventricular function, Right|ventricular function, right
294899|NCT01892787|Asthma|asthma
294900|NCT01892787|Small airways|small airways
294901|NCT01892787|Extra fine particle long-acting beta agonists|extra fine particle long-acting beta agonists
294902|NCT01892774|LSPAF|lspaf
294903|NCT01892774|asymptomatic|asymptomatic
294904|NCT01892774|exercise tolerance|exercise tolerance
294905|NCT01892761|mycophenolate mofetil|mycophenolate mofetil
294906|NCT01892761|mycophenolic acid|mycophenolic acid
294908|NCT01892761|MMF|mmf
294909|NCT01892761|Pharmacokinetics|pharmacokinetics
294910|NCT01892761|renal transplantation|renal transplantation
294911|NCT01892748|Lupus|lupus
294912|NCT01892748|Juvenile|juvenile
294913|NCT01892748|Cholecalciferol|cholecalciferol
294914|NCT01892748|Disease activity|disease activity
294915|NCT01892748|Bone Mass|bone mass
294916|NCT01892748|Fatigue|fatigue
294917|NCT01892748|Safety|safety
294918|NCT01892722|pediatric|pediatric
294919|NCT01892722|multiple sclerosis|multiple sclerosis
294920|NCT01892709|acute|acute
294921|NCT01892709|pain|pain
294922|NCT01892709|emergency department|emergency department
294923|NCT01892709|hydromorphone|hydromorphone
294924|NCT01892709|in ER|in er
294925|NCT01892696|inspiratory flow pattern|inspiratory flow pattern
294926|NCT01892696|mechanical ventilation|mechanical ventilation
294927|NCT01892696|cardiac preload|cardiac preload
294928|NCT01892696|arterial pulse pressure variation|arterial pulse pressure variation
294929|NCT01892696|inferior vena cava collapsibility|inferior vena cava collapsibility
294930|NCT01892683|propofol|propofol
294931|NCT01892683|exhaled|exhaled
294932|NCT01892683|monitoring|monitoring
294933|NCT01892683|anesthesia|anesthesia
294934|NCT01892670|Blood|blood
294935|NCT01892670|Whole blood|whole blood
294936|NCT01892670|Cold-storage|cold-storage
294937|NCT01892670|Filtration|filtration
294938|NCT01892670|Transfusion|transfusion
294939|NCT01892670|Platelet-function|platelet-function
294940|NCT01892657|Cetaphil Daily Facial Moisturizer with SPF 50+|cetaphil daily facial moisturizer with spf 50+
294941|NCT01892657|Hypoallergenicity|hypoallergenicity
294942|NCT01892657|Skin Irritation|skin irritation
294943|NCT01892644|Hemochromatosis|hemochromatosis
294944|NCT01892644|Myelodysplastic syndromes|myelodysplastic syndromes
294945|NCT01892644|Iron overload|iron overload
294946|NCT01892644|Deferasirox|deferasirox
294947|NCT01892644|Chelation therapy|chelation therapy
294948|NCT01892644|Venesection|venesection
294949|NCT01892644|Phlebotomy|phlebotomy
294950|NCT01892644|Ferritin|ferritin
294951|NCT01892644|Transfusional siderosis|transfusional siderosis
294952|NCT01892631|Text messaging|text messaging
294953|NCT01892605|Mozart K.448|mozart k.448
294954|NCT01892605|first unprovoked seizure|first unprovoked seizure
294955|NCT01892605|epileptiform discharges|epileptiform discharges
294956|NCT01892605|music therapy|music therapy
294957|NCT01892605|children|children
294958|NCT01892592|Hypertension|hypertension
294959|NCT01892592|African American|african american
294960|NCT01892592|Health Disparities|health disparities
294961|NCT01892592|Stroke|stroke
295545|NCT01890369|Muscle|muscle
294962|NCT01892592|Cardiovascular Disease|cardiovascular disease
294963|NCT01892579|Agitation|agitation
294964|NCT01892579|Dementia|dementia
294965|NCT01892579|Alzheimer's Disease|alzheimer's disease
294966|NCT01892579|Neuropsychiatric Behaviors|neuropsychiatric behaviors
294967|NCT01892566|HIV|hiv
294968|NCT01892566|mobile health|mobile health
294969|NCT01892566|spirometry|spirometry
294970|NCT01892553|Dyspnea|dyspnea
294971|NCT01892553|Transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
294972|NCT01892553|Perception|perception
294973|NCT01892527|Colorectal Cancer Metastatic|colorectal cancer metastatic
294974|NCT01892527|wild type KRAS|wild type kras
294975|NCT01892527|C-met overexpression|c-met overexpression
294976|NCT01892527|Tivantinib|tivantinib
294977|NCT01892527|Cetuximab|cetuximab
294978|NCT01892514|osteonecrosis|osteonecrosis
294979|NCT01892514|bone marrow concentrate|bone marrow concentrate
294980|NCT01892514|demineralized bone matrix|demineralized bone matrix
294981|NCT01892514|homologous lyophilized bone chips|homologous lyophilized bone chips
294982|NCT01892514|autologous platelet rich fibrin|autologous platelet rich fibrin
294983|NCT01892514|mesenchymal stromal cells|mesenchymal stromal cells
294984|NCT01892501|Mediastinal lymphadenopathy|mediastinal lymphadenopathy
294985|NCT01892501|PET CT to 18FDG|pet ct to 18fdg
294986|NCT01892501|EUS|eus
294987|NCT01892488|COPD|copd
294988|NCT01892488|AE-COPD|ae-copd
294989|NCT01892488|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
294990|NCT01892488|acute exacerbations of Chronic obstructive pulmonary disease|acute exacerbations of chronic obstructive pulmonary disease
294991|NCT01892475|Physical Activity|physical activity
294992|NCT01892475|Incentives|incentives
294993|NCT01892475|Mental Accounting|mental accounting
294994|NCT01892475|Older adults|older adults
294995|NCT01892436|Extension study, psoriatic arthritis, pre-filled syringe|extension study, psoriatic arthritis, pre-filled syringe
294996|NCT01892397|intracranial supratentorial meningioma|intracranial supratentorial meningioma
294997|NCT01892397|Atypical and Anaplastic Meningioma|atypical and anaplastic meningioma
294998|NCT01892397|Optune (NovoTTF-100A)|optune (novottf-100a)
294999|NCT01892397|13-067|13-067
295000|NCT01892371|Leukemia|leukemia
295001|NCT01892371|Acute Myeloid Leukemia|acute myeloid leukemia
295002|NCT01892371|AML|aml
295003|NCT01892371|Myelodysplastic Syndrome|myelodysplastic syndrome
295004|NCT01892371|MDS|mds
295005|NCT01892371|Quizartinib|quizartinib
295006|NCT01892371|AC220|ac220
295007|NCT01892371|ASP2689|asp2689
295008|NCT01892371|Cytarabine|cytarabine
295009|NCT01892371|Ara-C|ara-c
295010|NCT01892371|Cytosar|cytosar
295011|NCT01892371|DepoCyt|depocyt
295012|NCT01892371|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
295013|NCT01892371|AZA|aza
295014|NCT01892371|Vidaza|vidaza
295015|NCT01892371|Azacitidine|azacitidine
295016|NCT01892371|5-Azacytidine|5-azacytidine
295017|NCT01892371|5-AZA|5-aza
295018|NCT01892371|5-AZC|5-azc
295019|NCT01892371|AZA-CR|aza-cr
295020|NCT01892371|Ladakamycin|ladakamycin
295021|NCT01892371|NSC-102816|nsc-102816
295022|NCT01892371|Azacytidine|azacytidine
295023|NCT01892371|Maximum tolerated dose|maximum tolerated dose
295024|NCT01892371|MTD|mtd
295025|NCT01892371|Overall response|overall response
295026|NCT01892371|Complete remission|complete remission
295027|NCT01892371|CR|cr
295028|NCT01892371|Complete remission with incomplete blood count recovery|complete remission with incomplete blood count recovery
295029|NCT01892371|Cri|cri
295030|NCT01892371|Partial remission|partial remission
295031|NCT01892371|PR|pr
295032|NCT01892371|Hematologic improvement|hematologic improvement
295033|NCT01892371|HI|hi
295034|NCT01892358|injection drug use|injection drug use
295035|NCT01892345|Neuromyelitis Optica|neuromyelitis optica
295036|NCT01892345|Neuromyelitis Optica Spectrum Disorder|neuromyelitis optica spectrum disorder
295037|NCT01892345|Devic's disease, Transverse Myelitis|devic's disease, transverse myelitis
295038|NCT01892345|Optic Neuritis|optic neuritis
295039|NCT01892345|relapse|relapse
295040|NCT01892345|eculizumab|eculizumab
295041|NCT01892345|soliris|soliris
295042|NCT01892345|NMO-IgG|nmo-igg
295043|NCT01892345|CNS Autoimmune Disorders|cns autoimmune disorders
295044|NCT01892345|Demyelinating Disorders|demyelinating disorders
295045|NCT01892345|NMO|nmo
295046|NCT01892345|NMOSD|nmosd
295047|NCT01892293|Multiple Myeloma|multiple myeloma
295048|NCT01892293|Autologous stem cell transplantation|autologous stem cell transplantation
295049|NCT01892293|Received initial treatment previously|received initial treatment previously
295050|NCT01892267|PEGJ|pegj
295051|NCT01892267|PEG-J|peg-j
295052|NCT01892267|Percutaneous Endoscopic Gastrostomy|percutaneous endoscopic gastrostomy
295053|NCT01892267|Feeding tube|feeding tube
295054|NCT01892267|Gastroparesis|gastroparesis
295055|NCT01892267|Acute pancreatitis|acute pancreatitis
295056|NCT01892267|Stroke|stroke
295057|NCT01892267|Respiratory failure|respiratory failure
295058|NCT01892267|GERD|gerd
295059|NCT01892267|Balloon|balloon
295060|NCT01892267|Self-propelled|self-propelled
295061|NCT01892254|incretin effect|incretin effect
295062|NCT01892254|PCOS|pcos
295063|NCT01892254|insulin resistance|insulin resistance
295064|NCT01892254|OGTT|ogtt
295065|NCT01892254|IIGI|iigi
295066|NCT01892241|Chronic hepatitis B,Spontaneous Decline of HBV DNA,Peginterferon a-2a, entecavir|chronic hepatitis b,spontaneous decline of hbv dna,peginterferon a-2a, entecavir
295067|NCT01892228|antiretroviral therapy|antiretroviral therapy
295068|NCT01892228|education|education
295069|NCT01892228|mortality|mortality
295070|NCT01892215|Uterine incision.|uterine incision.
295071|NCT01892215|Blunt transversal expansion.|blunt transversal expansion.
295072|NCT01892215|Blunt cephalad-caudad expansion.|blunt cephalad-caudad expansion.
295073|NCT01892189|Drug therapy|drug therapy
295074|NCT01892176|coenzyme Q10, Parkinson disease, oxidative damage|coenzyme q10, parkinson disease, oxidative damage
295075|NCT01892163|Diabetic macular edema, Ozurdex|diabetic macular edema, ozurdex
295076|NCT01892137|Actinic Keratosis|actinic keratosis
295077|NCT01892137|Histopathology|histopathology
295078|NCT01892137|Reflectance Confocal Microscopy|reflectance confocal microscopy
295079|NCT01892137|Local Skin Reaction|local skin reaction
295080|NCT01892124|Motivational Interviewing|motivational interviewing
295081|NCT01892124|Cognitive Therapy|cognitive therapy
295082|NCT01892124|Community-Based Participatory Research|community-based participatory research
295083|NCT01892124|Indians, North American|indians, north american
295084|NCT01892111|SET|set
295085|NCT01892111|infertility|infertility
295086|NCT01892111|IVF/ICSI|ivf/icsi
295087|NCT01892111|pregnancy|pregnancy
295088|NCT01892098|Zinc|zinc
295089|NCT01892098|Bone|bone
295090|NCT01892098|Adolescents|adolescents
295091|NCT01892098|Growth|growth
295092|NCT01892085|Breast milk|breast milk
295093|NCT01892085|lactogenesis stage two|lactogenesis stage two
295094|NCT01892085|premature infant|premature infant
295095|NCT01892085|insufficient milk supply|insufficient milk supply
295096|NCT01892085|breast milk expression|breast milk expression
295097|NCT01892072|hepatocellular carcinoma|hepatocellular carcinoma
295098|NCT01892072|HCC|hcc
295099|NCT01892072|VEGF signaling pathway|vegf signaling pathway
295100|NCT01892059|renal tumour|renal tumour
295101|NCT01892059|partial nephrectomy|partial nephrectomy
295102|NCT01892059|laparoscope|laparoscope
295103|NCT01892059|segmental renal artery clamping|segmental renal artery clamping
295104|NCT01892046|Small Cell Lung Cancer|small cell lung cancer
295105|NCT01892046|Non Small Cell Lung Cancer|non small cell lung cancer
295106|NCT01892046|Hsp90|hsp90
295107|NCT01892033|Posttraumatic Stress Disorder|posttraumatic stress disorder
295108|NCT01892033|PTSD|ptsd
295109|NCT01892033|Aerobic Exercise|aerobic exercise
295110|NCT01892033|Women|women
295111|NCT01892033|Veteran|veteran
295112|NCT01892007|Hearing loss|hearing loss
295113|NCT01892007|Hearing aid|hearing aid
295114|NCT01892007|Speech intelligibility|speech intelligibility
295115|NCT01892007|Speech perception|speech perception
295116|NCT01892007|Cognitive training|cognitive training
295117|NCT01892007|Working memory|working memory
295118|NCT01892007|Working memory training|working memory training
295119|NCT01891994|Cytokine|cytokine
295120|NCT01891994|Hematopoiesis|hematopoiesis
295121|NCT01891994|Autoimmunity|autoimmunity
295122|NCT01891994|Thrombocytopenia|thrombocytopenia
295123|NCT01891994|Neutropenia|neutropenia
295124|NCT01891981|Leukemia|leukemia
295125|NCT01891981|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
295126|NCT01891981|ALL|all
295127|NCT01891981|Relapsed and/or refractory|relapsed and/or refractory
295128|NCT01891981|Moxetumomab Pasudotox|moxetumomab pasudotox
295129|NCT01891981|Maximum tolerated dose|maximum tolerated dose
295130|NCT01891981|MTD|mtd
295131|NCT01891968|Leukemia|leukemia
295132|NCT01891968|Myelodysplastic syndrome|myelodysplastic syndrome
295133|NCT01891968|MDS|mds
295134|NCT01891968|Low or intermediate-1|low or intermediate-1
295135|NCT01891968|Bortezomib|bortezomib
295136|NCT01891968|Velcade|velcade
295137|NCT01891968|LDP-341|ldp-341
295138|NCT01891968|MLN341|mln341
295139|NCT01891968|PS-341|ps-341
295140|NCT01891955|Diabetes mellitus type 2|diabetes mellitus type 2
295141|NCT01891955|Cereals|cereals
295142|NCT01891955|Dairy|dairy
295143|NCT01891955|Dietary carbohydrates|dietary carbohydrates
295144|NCT01891955|Dietary fiber|dietary fiber
295145|NCT01891955|Food|food
295146|NCT01891955|Metabolic syndrome|metabolic syndrome
295147|NCT01891955|Satiety|satiety
295148|NCT01891942|Normal|normal
295149|NCT01891942|subjects|subjects
295150|NCT01891929|Schizophrenia|schizophrenia
295151|NCT01891929|Cognitive Remediation|cognitive remediation
295152|NCT01891929|Working abilities and social functioning|working abilities and social functioning
295153|NCT01891890|Pediatrics|pediatrics
295154|NCT01891877|Sickle Cell Trait|sickle cell trait
295155|NCT01891877|Football|football
295156|NCT01891877|Sickling|sickling
295157|NCT01891877|Heat Illness|heat illness
295158|NCT01891877|SCT|sct
295159|NCT01891851|Healthy|healthy
295160|NCT01891851|Hepatitis C|hepatitis c
295161|NCT01891851|TMC435350|tmc435350
295162|NCT01891851|Ritonavir|ritonavir
295163|NCT01891851|Pharmacokinetics|pharmacokinetics
295164|NCT01891838|surgery|surgery
295165|NCT01891838|transsphenoidal surgery|transsphenoidal surgery
295166|NCT01891838|pituitary adenoma|pituitary adenoma
295167|NCT01891838|mechanical ventilation|mechanical ventilation
295168|NCT01891838|bleeding|bleeding
295169|NCT01891825|Atrial fibrillation|atrial fibrillation
295170|NCT01891825|Persistent atrial fibrillation|persistent atrial fibrillation
295171|NCT01891825|Atrial fibrillation ablation|atrial fibrillation ablation
295172|NCT01891812|Sickle cell disease|sickle cell disease
295173|NCT01891812|Vaso-occlusive crisis|vaso-occlusive crisis
295174|NCT01891812|Nitrous oxide|nitrous oxide
295175|NCT01891812|Emergency department|emergency department
295176|NCT01891799|HIV/AIDS|hiv/aids
295177|NCT01891799|PMTCT|pmtct
295178|NCT01891799|Option B+|option b+
295179|NCT01891799|Swaziland|swaziland
295180|NCT01891773|Asthma|asthma
295181|NCT01891773|Inhaled Corticosteroids|inhaled corticosteroids
295182|NCT01891773|School Nurses|school nurses
295183|NCT01891747|gliomas|gliomas
295184|NCT01891734|Veterans|veterans
295185|NCT01891734|Health Services|health services
295186|NCT01891734|Mental Health|mental health
295187|NCT01891734|Technology|technology
295188|NCT01891734|Primary Health Care|primary health care
295189|NCT01891734|Psychotherapy|psychotherapy
295190|NCT01891721|cognitive training|cognitive training
295191|NCT01891721|schizophrenia|schizophrenia
295192|NCT01891721|mismatch negativity|mismatch negativity
295193|NCT01891721|cognition|cognition
295194|NCT01891721|functional capacity|functional capacity
295195|NCT01891721|EEG|eeg
295196|NCT01891682|Methionine Metabolism|methionine metabolism
295197|NCT01891682|Parenteral Nutrition|parenteral nutrition
295198|NCT01891682|Pediatric|pediatric
295199|NCT01891682|Pediatrics|pediatrics
295200|NCT01891682|Sepsis|sepsis
295201|NCT01891682|Observational Study|observational study
295202|NCT01891669|ADC 5T4|adc 5t4
295203|NCT01891669|PF-06263507|pf-06263507
295204|NCT01891669|solid tumors|solid tumors
295205|NCT01891669|lung cancer|lung cancer
295206|NCT01891669|breast cancer|breast cancer
295207|NCT01891669|ovarian cancer|ovarian cancer
295208|NCT01891669|cancer|cancer
295209|NCT01891669|tumors|tumors
295210|NCT01891669|neoplasm metastasis|neoplasm metastasis
295211|NCT01891656|Motivational Interviewing|motivational interviewing
295212|NCT01891656|Internet|internet
295213|NCT01891656|Treatment|treatment
295214|NCT01891656|Substance-Related Disorders|substance-related disorders
295215|NCT01891656|Criminal Justice|criminal justice
295216|NCT01891630|African American|african american
295217|NCT01891630|Asthma|asthma
295218|NCT01891617|exercise|exercise
295219|NCT01891617|high carbohydrate and high fat diets|high carbohydrate and high fat diets
295220|NCT01891617|insulin|insulin
295221|NCT01891617|gut peptides|gut peptides
295222|NCT01891617|appetite|appetite
295223|NCT01891617|metabolism|metabolism
295224|NCT01891617|glucose|glucose
295225|NCT01891591|Obesity|obesity
295226|NCT01891591|Gastric bypass|gastric bypass
295227|NCT01891591|Energy balance|energy balance
295228|NCT01891591|Nutritional status|nutritional status
295229|NCT01891591|Protein balance|protein balance
295230|NCT01891552|Colon Cancer, Liver Metastasis, DEBIRI, cetuximab, efficacy|colon cancer, liver metastasis, debiri, cetuximab, efficacy
295231|NCT01891539|Hepatocellular carcinoma, doxorubicin, chemoembolization|hepatocellular carcinoma, doxorubicin, chemoembolization
295232|NCT01891526|Metabolisation of 9-cis-retinoic acid|metabolisation of 9-cis-retinoic acid
295233|NCT01891526|hepatic patients|hepatic patients
295234|NCT01891526|investigation of urine and blood samples|investigation of urine and blood samples
295235|NCT01891513|Physical activity|physical activity
295236|NCT01891513|Hypertension|hypertension
295237|NCT01891513|Physical function|physical function
295238|NCT01891513|Aging|aging
295239|NCT01891500|Persistent Fetal Circulation Syndrome|persistent fetal circulation syndrome
295240|NCT01891500|Infant, Newborn|infant, newborn
295241|NCT01891500|Nitric Oxide|nitric oxide
295242|NCT01891500|Oxidative Stress|oxidative stress
295243|NCT01891500|Endothelin 1|endothelin 1
295244|NCT01891500|Vascular Endothelial Growth Factor|vascular endothelial growth factor
295245|NCT01891487|Eyebrow|eyebrow
295246|NCT01891487|Hypotrichosis|hypotrichosis
295247|NCT01891487|Thinning|thinning
295248|NCT01891487|Bimatoprost|bimatoprost
295249|NCT01891461|total knee arthroplasty|total knee arthroplasty
295250|NCT01891461|post-operative bleeding|post-operative bleeding
295251|NCT01891461|floseal|floseal
295252|NCT01891435|antipyretics|antipyretics
295253|NCT01891435|oral paracetamol|oral paracetamol
295254|NCT01891435|intravenous paracetamol|intravenous paracetamol
295255|NCT01891435|intramuscular diclofenac|intramuscular diclofenac
295256|NCT01891435|emergency department|emergency department
295257|NCT01891422|Glycoprotein Storage Disease|glycoprotein storage disease
295258|NCT01891422|Lysosomal Storage Disease|lysosomal storage disease
295259|NCT01891422|mannosidase deficiency disorders|mannosidase deficiency disorders
295260|NCT01891422|Neuraminidase deficiency with beta-galactosidase deficiency|neuraminidase deficiency with beta-galactosidase deficiency
295261|NCT01891422|mucolipidoses|mucolipidoses
295262|NCT01891422|Oligosaccharidoses|oligosaccharidoses
295263|NCT01891422|Lysosomal Disease|lysosomal disease
295264|NCT01891422|Metabolic Disease, Inborn|metabolic disease, inborn
295265|NCT01891422|aspartylglucosaminuria|aspartylglucosaminuria
295266|NCT01891422|fucosidosis|fucosidosis
295267|NCT01891422|galactosialidosis|galactosialidosis
295268|NCT01891422|alpha mannosidosis|alpha mannosidosis
295269|NCT01891422|beta mannosidosis|beta mannosidosis
295270|NCT01891422|mucolipidosis II|mucolipidosis ii
295271|NCT01891422|mucolipidosis III|mucolipidosis iii
295272|NCT01891422|Schindler disease|schindler disease
295273|NCT01891422|sialidosis|sialidosis
295274|NCT01891409|HIV prevention|hiv prevention
295275|NCT01891409|Male Circumcision|male circumcision
295276|NCT01891409|Children|children
295277|NCT01891409|Childhood|childhood
295278|NCT01891409|Shang Ring|shang ring
295279|NCT01891396|Knee osteoarthritis|knee osteoarthritis
295280|NCT01891396|Hyaluronic acid|hyaluronic acid
295281|NCT01891396|HA Injection|ha injection
295282|NCT01891396|Steroid Injection|steroid injection
295283|NCT01891396|Knee injection|knee injection
295284|NCT01891383|Dementia|dementia
295285|NCT01891383|Traumatic brain injury (TBI)|traumatic brain injury (tbi)
295286|NCT01891383|Mild cognitive impairment (MCI)|mild cognitive impairment (mci)
295287|NCT01891383|Chronic traumatic encephalopathy (CTE)|chronic traumatic encephalopathy (cte)
295288|NCT01891383|Remote effects of TBI|remote effects of tbi
295289|NCT01891383|Post-traumatic stress disorder (PTSD_|post-traumatic stress disorder (ptsd_
295290|NCT01891357|Unilateral primary invasive carcinoma of the breast|unilateral primary invasive carcinoma of the breast
295291|NCT01891344|ovarian cancer|ovarian cancer
295292|NCT01891344|fallopian tube cancer|fallopian tube cancer
295293|NCT01891344|primary peritoneal cancer|primary peritoneal cancer
295294|NCT01891344|peritoneal cancer|peritoneal cancer
295295|NCT01891344|platinum sensitive|platinum sensitive
295296|NCT01891344|relapsed disease|relapsed disease
295297|NCT01891344|PARP Inhibitor|parp inhibitor
295298|NCT01891344|rucaparib|rucaparib
295299|NCT01891344|homologous recombination|homologous recombination
295300|NCT01891344|homologous recombination deficiency|homologous recombination deficiency
295301|NCT01891344|genomic scarring|genomic scarring
295302|NCT01891344|loss of heterozygosity|loss of heterozygosity
295304|NCT01891344|PF 01367338|pf 01367338
295305|NCT01891344|AG 14699|ag 14699
295306|NCT01891344|platinum sensitive ovarian cancer|platinum sensitive ovarian cancer
295307|NCT01891344|platinum sensitive fallopian tube cancer|platinum sensitive fallopian tube cancer
295308|NCT01891344|platinum sensitive primary peritoneal cancer|platinum sensitive primary peritoneal cancer
295309|NCT01891344|platinum sensitive peritoneal cancer|platinum sensitive peritoneal cancer
295310|NCT01891344|gynecological cancer|gynecological cancer
295311|NCT01891344|Clovis|clovis
295312|NCT01891344|Clovis Oncology|clovis oncology
295313|NCT01891344|ARIEL2|ariel2
295314|NCT01891344|ARIEL 2|ariel 2
295315|NCT01891344|ARIEL3|ariel3
295316|NCT01891344|ARIEL 3|ariel 3
295317|NCT01891279|short bowel syndrome|short bowel syndrome
295318|NCT01891279|Elemental formula|elemental formula
295319|NCT01891279|partially hydrolyzed formula|partially hydrolyzed formula
295320|NCT01891279|Enteral feeding|enteral feeding
295321|NCT01891279|TPN dependency|tpn dependency
295322|NCT01891279|Intestinal adaptation|intestinal adaptation
295323|NCT01891279|TPN cholestasis|tpn cholestasis
295324|NCT01891253|cardiac output|cardiac output
295325|NCT01891253|mechanical ventilation|mechanical ventilation
295326|NCT01891253|inert gas rebreathing|inert gas rebreathing
295327|NCT01891253|pulse contour analysis|pulse contour analysis
295328|NCT01891240|Diagnostic|diagnostic
295329|NCT01891240|Pre-eclampsia|pre-eclampsia
295330|NCT01891240|Pregnancy outcome|pregnancy outcome
295331|NCT01891240|Mass screening|mass screening
295332|NCT01891240|Diagnostic Techniques and Procedures|diagnostic techniques and procedures
295333|NCT01891227|Bendamustine|bendamustine
295334|NCT01891227|Capecitabine|capecitabine
295335|NCT01891227|Pretreated|pretreated
295336|NCT01891227|Her2 negative|her2 negative
295337|NCT01891227|Advanced breast cancer|advanced breast cancer
295338|NCT01891227|Metastatic breast cancer|metastatic breast cancer
295339|NCT01891227|Anthracycline pretreatment|anthracycline pretreatment
295340|NCT01891227|Taxane pretreatment|taxane pretreatment
295341|NCT01891214|Inflammatory bowel diseases|inflammatory bowel diseases
295342|NCT01891214|Inflammatory Bowel Disease Questionnaire (IBDQ)|inflammatory bowel disease questionnaire (ibdq)
295343|NCT01891201|Bonding|bonding
295344|NCT01891201|Oxytocin|oxytocin
295345|NCT01891201|Breastfeeding|breastfeeding
295346|NCT01891201|Newborn|newborn
295347|NCT01891201|Delivery|delivery
295348|NCT01891188|hepatic blood,|hepatic blood,
295349|NCT01891188|cardiac cath,|cardiac cath,
295350|NCT01891188|hepatic oxygenation,|hepatic oxygenation,
295351|NCT01891188|pediatrics|pediatrics
295352|NCT01891175|Caesarean|caesarean
295353|NCT01891175|hypotension|hypotension
295354|NCT01891175|Spinal Anaesthesia|spinal anaesthesia
295355|NCT01891175|intermittent pneumatic compression|intermittent pneumatic compression
295356|NCT01891175|lower extremities|lower extremities
295357|NCT01891162|quality of life, incontinence urinary, socioeconomic|quality of life, incontinence urinary, socioeconomic
295358|NCT01891136|Peanut allergy|peanut allergy
295359|NCT01891123|Non-small Cell Lung Cancer|non-small cell lung cancer
295360|NCT01891123|Breast cancer|breast cancer
295361|NCT01891123|plasma drug concentration|plasma drug concentration
295362|NCT01891123|Nasopharygeal carcinoma|nasopharygeal carcinoma
295363|NCT01891110|electric stimulation|electric stimulation
295364|NCT01891110|tilt-table|tilt-table
295365|NCT01891097|Insomnia|insomnia
295366|NCT01891097|Acupuncture|acupuncture
295367|NCT01891097|Electroacupuncture|electroacupuncture
295368|NCT01891097|Aricular acupuncture|aricular acupuncture
295369|NCT01891097|Randomized Clinical Trial|randomized clinical trial
295370|NCT01891097|Traditional Chinese Medicine|traditional chinese medicine
295371|NCT01891084|Influenza|influenza
295372|NCT01891084|Antipyretics|antipyretics
295373|NCT01891084|Fever|fever
295374|NCT01891071|Multiple sclerosis|multiple sclerosis
295375|NCT01891071|Lung volume recruitment|lung volume recruitment
295376|NCT01891071|Pulmonary function impairment|pulmonary function impairment
295377|NCT01891071|Cough impairment|cough impairment
295378|NCT01891045|Psychotherapy|psychotherapy
295379|NCT01891045|Drug addiction|drug addiction
295380|NCT01891045|Drop-out|drop-out
295381|NCT01891045|OQ-45.2|oq-45.2
295382|NCT01891045|Clinical trial|clinical trial
295383|NCT01891045|Randomized Controlled Trail|randomized controlled trail
295384|NCT01891032|acute kidney injury, partial nephrectomy, biomarker|acute kidney injury, partial nephrectomy, biomarker
295385|NCT01891006|Randomized Controlled Trial|randomized controlled trial
295386|NCT01891006|Economical Evaluation|economical evaluation
295387|NCT01891006|Caesarean Section|caesarean section
295388|NCT01891006|Cesarean Section|cesarean section
295389|NCT01891006|Postoperative Wound Treatment|postoperative wound treatment
295390|NCT01891006|Surgical Site Infections|surgical site infections
295391|NCT01891006|Wound Infections|wound infections
295392|NCT01891006|Infectious Morbidity|infectious morbidity
295393|NCT01891006|Negative Pressure Wound Therapy|negative pressure wound therapy
295394|NCT01890980|WT-1-vaccine Montanide|wt-1-vaccine montanide
295395|NCT01890980|GM-CSF|gm-csf
295396|NCT01890980|Wilms Tumor-1 vaccine|wilms tumor-1 vaccine
295397|NCT01890980|immunotherapy|immunotherapy
295398|NCT01890980|Montanide|montanide
295399|NCT01890980|Sargramostim|sargramostim
295400|NCT01890980|Granulocyte Macrophage Colony Stimulating Factor|granulocyte macrophage colony stimulating factor
295401|NCT01890980|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
295402|NCT01890980|MPM|mpm
295403|NCT01890980|soluble mesothelin related protein|soluble mesothelin related protein
295404|NCT01890980|SMRP|smrp
295405|NCT01890967|low density lipoprotein, heterozygous familial hypercholesterolemia, polygenic hypercholesterolemia|low density lipoprotein, heterozygous familial hypercholesterolemia, polygenic hypercholesterolemia
295406|NCT01890954|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
295407|NCT01890954|Closed Loop Control (CLC)|closed loop control (clc)
295408|NCT01890954|Diabetes Assistant (DiAs)|diabetes assistant (dias)
295409|NCT01890954|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
295410|NCT01890941|Dry eye syndromes|dry eye syndromes
295411|NCT01890941|Corneal diseases|corneal diseases
295412|NCT01890941|Conjunctival diseases|conjunctival diseases
295413|NCT01890928|Gluconeogenesis|gluconeogenesis
295414|NCT01890928|Glycogenolysis|glycogenolysis
295415|NCT01890928|Pyruvate cycling|pyruvate cycling
295416|NCT01890928|Glucose production rates|glucose production rates
295417|NCT01890928|Mitochondria|mitochondria
295418|NCT01890928|Acylcarnitines|acylcarnitines
295419|NCT01890915|Spinal cord injury|spinal cord injury
295420|NCT01890915|Body temperature|body temperature
295421|NCT01890915|Executive function|executive function
295422|NCT01890915|Sweat|sweat
295423|NCT01890889|Total Cholesterol|total cholesterol
295424|NCT01890889|LDL|ldl
295425|NCT01890876|glucose tolerance, hypoxia, myokines, exercise|glucose tolerance, hypoxia, myokines, exercise
295426|NCT01890863|asthma|asthma
295427|NCT01890863|fluticasone propionate/salmeterol|fluticasone propionate/salmeterol
295428|NCT01890863|PK equivalence|pk equivalence
295429|NCT01890863|COPD|copd
295430|NCT01890863|pharmacokinetics|pharmacokinetics
295431|NCT01890863|fluticasone propionate/salmeterol in a capsule-based inhaler|fluticasone propionate/salmeterol in a capsule-based inhaler
295432|NCT01890863|fluticasone propionate/salmeterol in a multi-dose dry powder inhaler|fluticasone propionate/salmeterol in a multi-dose dry powder inhaler
295433|NCT01890863|Respiratory|respiratory
295434|NCT01890850|Risk factors|risk factors
295435|NCT01890850|U.S. commercially insured population|u.s. commercially insured population
295436|NCT01890850|Pertussis/whooping cough infection|pertussis/whooping cough infection
295437|NCT01890850|Retrospective database study|retrospective database study
295438|NCT01890837|Rectal Compliance|rectal compliance
295439|NCT01890837|Rectal Sensation|rectal sensation
295440|NCT01890837|Rectal Tone|rectal tone
295441|NCT01890824|Breast Cancer|breast cancer
295442|NCT01890824|Fat metabolism|fat metabolism
295443|NCT01890824|Fat digestion|fat digestion
295444|NCT01890824|physical activity|physical activity
295445|NCT01890824|muscle function|muscle function
295446|NCT01890811|CKD|ckd
295447|NCT01890811|Hemodialysis|hemodialysis
295448|NCT01890811|Protein Digestion|protein digestion
295449|NCT01890811|Fat Digestion|fat digestion
295450|NCT01890811|Gut Function|gut function
295451|NCT01890811|Glucose Absorption|glucose absorption
295452|NCT01890811|Muscle Function|muscle function
295453|NCT01890798|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
295454|NCT01890798|GSK2402968|gsk2402968
295455|NCT01890798|drisapersen|drisapersen
295456|NCT01890772|Hepatitis C Genotype 1|hepatitis c genotype 1
295457|NCT01890772|Vitamin D|vitamin d
295458|NCT01890772|treatment-naive|treatment-naive
295459|NCT01890759|Meningitis|meningitis
295460|NCT01890759|Meningococcal Infection|meningococcal infection
295461|NCT01890759|Menactra®|menactra®
295462|NCT01890746|de novo AML|de novo aml
295463|NCT01890746|Eltrombopag|eltrombopag
295464|NCT01890746|leukemia|leukemia
295465|NCT01890746|sAML/MDS|saml/mds
295466|NCT01890746|acute myeloid leukemia|acute myeloid leukemia
295467|NCT01890746|secondary acute myeloid|secondary acute myeloid
295468|NCT01890746|thrombocytopenia|thrombocytopenia
295469|NCT01890733|Massive Rotator Cuff Tear, Sub-acromial spacer, Best repair of rotator cuff,|massive rotator cuff tear, sub-acromial spacer, best repair of rotator cuff,
295470|NCT01890720|Randomized Controlled Trial|randomized controlled trial
295471|NCT01890720|Economical Evaluation|economical evaluation
295472|NCT01890720|Caesarean Section|caesarean section
295473|NCT01890720|postoperative wound treatment|postoperative wound treatment
295474|NCT01890720|surgical site infections|surgical site infections
295475|NCT01890720|wound infections|wound infections
295476|NCT01890720|infectious morbidity|infectious morbidity
295477|NCT01890720|Negative Pressure Wound Therapy|negative pressure wound therapy
295478|NCT01890720|Incisional Negative Pressure Wound Therapy|incisional negative pressure wound therapy
295479|NCT01890720|Obesity|obesity
295480|NCT01890707|Gynecology|gynecology
295481|NCT01890707|Pain|pain
295482|NCT01890707|Anesthesia|anesthesia
295483|NCT01890707|Quality of Recovery 40|quality of recovery 40
295484|NCT01890694|Hyponatremia|hyponatremia
295485|NCT01890694|Dilutional Hyponatremia|dilutional hyponatremia
295486|NCT01890694|Euvolemic Hyponatremia|euvolemic hyponatremia
295487|NCT01890694|Hypervolemic Hyponatremia|hypervolemic hyponatremia
295488|NCT01890694|Fluid Restriction|fluid restriction
295489|NCT01890694|Tolvaptan|tolvaptan
295490|NCT01890681|childhood obesity|childhood obesity
295491|NCT01890681|child care|child care
295492|NCT01890681|infant|infant
295493|NCT01890681|toddler|toddler
295494|NCT01890668|Breastfeeding behaviour|breastfeeding behaviour
295495|NCT01890668|OMT (Osteopathic Manipulative Treatment)|omt (osteopathic manipulative treatment)
295496|NCT01890668|suboptimal infant breastfeeding behaviour|suboptimal infant breastfeeding behaviour
295497|NCT01890668|healthy newborns|healthy newborns
295498|NCT01890655|relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
295499|NCT01890655|RRMS|rrms
295500|NCT01890642|Pain|pain
295501|NCT01890642|Children|children
295502|NCT01890642|Venipuncture|venipuncture
295503|NCT01890642|J tip|j tip
295504|NCT01890642|Lidocaine|lidocaine
295505|NCT01890642|video observation|video observation
295506|NCT01890629|diabetes mellitus|diabetes mellitus
295507|NCT01890603|Care coordination, primary care|care coordination, primary care
295508|NCT01890603|nurse care management|nurse care management
295509|NCT01890603|practice facilitation|practice facilitation
295510|NCT01890590|Renal Cell Carcinoma|renal cell carcinoma
295511|NCT01890590|Cyberknife|cyberknife
295512|NCT01890577|Chronic kidney disease|chronic kidney disease
295513|NCT01890577|Dialysis|dialysis
295514|NCT01890577|Erythropoiesis stimulating agent|erythropoiesis stimulating agent
295515|NCT01890577|South Africa|south africa
295516|NCT01890551|Adoloescent, patellofemoral, instability,biomechanics, magnetic resonance imaging|adoloescent, patellofemoral, instability,biomechanics, magnetic resonance imaging
295517|NCT01890538|vertigo|vertigo
295518|NCT01890538|dimenhydrinate|dimenhydrinate
295519|NCT01890538|piracetam|piracetam
295520|NCT01890525|radiation|radiation
295521|NCT01890499|tolerability|tolerability
295522|NCT01890499|diet after operation|diet after operation
295523|NCT01890447|Cocooning|cocooning
295524|NCT01890447|Web-based questionnaire|web-based questionnaire
295525|NCT01890447|Italy|italy
295526|NCT01890447|Pertussis|pertussis
295527|NCT01890447|Spain|spain
295528|NCT01890447|Survey|survey
295529|NCT01890434|Myocardial Perfusion Imaging|myocardial perfusion imaging
295530|NCT01890421|Myocardial Perfusion Imaging|myocardial perfusion imaging
295531|NCT01890408|Laparotomy|laparotomy
295532|NCT01890408|Hepatic resection|hepatic resection
295533|NCT01890408|continuous wound catheter analgesia|continuous wound catheter analgesia
295534|NCT01890408|morphine|morphine
295535|NCT01890408|post operative recovery|post operative recovery
295536|NCT01890395|mitochondrial DAMPS|mitochondrial damps
295537|NCT01890382|resistance exercise|resistance exercise
295538|NCT01890382|protein|protein
295539|NCT01890382|creatine|creatine
295540|NCT01890382|leucine|leucine
295541|NCT01890382|aging|aging
295542|NCT01890369|Old Age|old age
295543|NCT01890369|Sarcopenia|sarcopenia
295544|NCT01890369|Amino Acid|amino acid
295546|NCT01890356|Depression|depression
295547|NCT01890356|Treatment|treatment
295548|NCT01890356|Transcranial electrical stimulation|transcranial electrical stimulation
295549|NCT01890356|Maintenance|maintenance
295550|NCT01890330|Canola Oil|canola oil
295551|NCT01890330|Metabolic Syndrome|metabolic syndrome
295552|NCT01890330|Serum LDL cholesterol|serum ldl cholesterol
295553|NCT01890317|Cardiogenic shock|cardiogenic shock
295554|NCT01890317|acute myocardial infarction|acute myocardial infarction
295555|NCT01890317|mild hypothermia|mild hypothermia
295556|NCT01890304|Traumatic Brain Injury|traumatic brain injury
295557|NCT01890304|TBI|tbi
295558|NCT01890304|Concussion|concussion
295559|NCT01890304|Sports related injury|sports related injury
295560|NCT01890291|Immuncell-LC, Hepatocellular carcinoma|immuncell-lc, hepatocellular carcinoma
295561|NCT01890278|Brain Cancer|brain cancer
295562|NCT01890278|Metastatic Brain Cancer|metastatic brain cancer
295563|NCT01890278|IMRT|imrt
295564|NCT01890265|Idiopathic Pulmonary Fibrosis, IPF, Idiopathic Interstitial Pneumonia, Interstitial Lung Disease, Lung Fibrosis|idiopathic pulmonary fibrosis, ipf, idiopathic interstitial pneumonia, interstitial lung disease, lung fibrosis
295565|NCT01890213|alphavirus|alphavirus
295566|NCT01890213|colon cancer|colon cancer
295567|NCT01890213|immune response|immune response
295568|NCT01890213|CEA|cea
295569|NCT01890200|add-on treatment|add-on treatment
295570|NCT01890200|botanical drug|botanical drug
295571|NCT01890200|HCV genotype 1|hcv genotype 1
295572|NCT01890200|TCM-700C|tcm-700c
295573|NCT01890161|asthma|asthma
295574|NCT01890148|Asthma|asthma
295575|NCT01890135|randomized|randomized
295576|NCT01890135|double blind|double blind
295577|NCT01890135|blood flow|blood flow
295578|NCT01890135|muscle perfusion|muscle perfusion
295579|NCT01890135|safety|safety
295580|NCT01890122|Drug therapy|drug therapy
295581|NCT01890109|Vasomotor symptoms; Hot Flashes; Menopause|vasomotor symptoms; hot flashes; menopause
295582|NCT01890096|HDR|hdr
295583|NCT01890096|monotherapy|monotherapy
295584|NCT01890096|low|low
295585|NCT01890096|intermediate|intermediate
295586|NCT01890096|prostate cancer|prostate cancer
295587|NCT01890083|Hepatitis C|hepatitis c
295588|NCT01890083|Interferon-alpha|interferon-alpha
295589|NCT01890083|Depression|depression
295590|NCT01890083|Major Depressive Disorder|major depressive disorder
295591|NCT01890083|Exercise|exercise
295592|NCT01890083|Physical Activity|physical activity
295593|NCT01890070|mediterranean diet, nutrigenomics, body composition, inflammation, oxidative stress|mediterranean diet, nutrigenomics, body composition, inflammation, oxidative stress
295594|NCT01890044|VTE|vte
295595|NCT01890044|DVT|dvt
295596|NCT01890044|Venous Thromboembolism|venous thromboembolism
295597|NCT01890044|Deep Vein Thrombosis|deep vein thrombosis
295598|NCT01890044|Pulmonary embolus|pulmonary embolus
295599|NCT01890044|Trauma|trauma
295600|NCT01890031|cardiovascular disease|cardiovascular disease
295601|NCT01890031|cholesterol|cholesterol
295602|NCT01890018|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
295603|NCT01890018|taking a statin medication|taking a statin medication
295604|NCT01890018|also have a medication adherence ratio (MPR)|also have a medication adherence ratio (mpr)
295605|NCT01890005|Preeclampsia|preeclampsia
295606|NCT01890005|Low dose aspirin|low dose aspirin
295607|NCT01890005|Fetal growth restriction|fetal growth restriction
295608|NCT01890005|Neonatal death|neonatal death
295609|NCT01890005|Stillbirth|stillbirth
295610|NCT01890005|Abruptio placenta|abruptio placenta
295611|NCT01889992|Heart transplantation|heart transplantation
295612|NCT01889992|Cardiac allograft remodeling|cardiac allograft remodeling
295613|NCT01889992|Immunosuppression|immunosuppression
295614|NCT01889992|Cardiac MRI|cardiac mri
295615|NCT01889992|M-TOR inhibitor|m-tor inhibitor
295616|NCT01889979|Pain during labour|pain during labour
295617|NCT01889979|Duration of labour|duration of labour
295618|NCT01889979|Apgar score|apgar score
295619|NCT01889979|Umbilical cord pH|umbilical cord ph
295620|NCT01889966|vasoreactivity testing|vasoreactivity testing
295621|NCT01889966|Sildenafil|sildenafil
295622|NCT01889966|precapillary pulmonary hypertension|precapillary pulmonary hypertension
295623|NCT01889966|connective tissue disease|connective tissue disease
295624|NCT01889966|mean pressure in the pulmonary artery 25 mmHg or more|mean pressure in the pulmonary artery 25 mmhg or more
295625|NCT01889966|mean pulmonary capillary wedge pressure below 16 mmHg|mean pulmonary capillary wedge pressure below 16 mmhg
295626|NCT01889953|EUS-Guided Biliary Drainage|eus-guided biliary drainage
295627|NCT01889953|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
295628|NCT01889953|Malignant Biliary Obstruction|malignant biliary obstruction
295629|NCT01889940|Acute Spinal Cord Injury|acute spinal cord injury
295630|NCT01889940|Patient Satisfaction|patient satisfaction
295631|NCT01889940|Psychological Distress|psychological distress
295632|NCT01889940|Rehabilitation|rehabilitation
295633|NCT01889940|Training Professionals|training professionals
295634|NCT01889940|Burnout|burnout
295635|NCT01889940|Job Content|job content
295636|NCT01889927|exercise|exercise
295637|NCT01889927|physiotherapy|physiotherapy
295638|NCT01889927|lung function|lung function
295639|NCT01889927|quality of life|quality of life
295640|NCT01889901|Physical Activity|physical activity
295641|NCT01889901|Epilepsy|epilepsy
295642|NCT01889901|Seizures|seizures
295643|NCT01889901|Quality of Life|quality of life
295644|NCT01889888|Male urethral stricture|male urethral stricture
295645|NCT01889888|ADRC|adrc
295646|NCT01889888|Adipose-derived regenerative cells|adipose-derived regenerative cells
295647|NCT01889888|Fat tissue|fat tissue
295648|NCT01889888|Stem cells|stem cells
295649|NCT01889862|PKU|pku
295650|NCT01889862|PEG-PAL|peg-pal
295651|NCT01889862|Prism|prism
295652|NCT01889862|BioMarin|biomarin
295653|NCT01889862|rAvPAL-PEG|ravpal-peg
295654|NCT01889862|Pegvaliase|pegvaliase
295655|NCT01889836|meningococcal conjugate vaccine serogroup C|meningococcal conjugate vaccine serogroup c
295656|NCT01889836|Prevention|prevention
295657|NCT01889823|Oxygen|oxygen
295658|NCT01889823|Hypoxia|hypoxia
295659|NCT01889823|Hyperoxia|hyperoxia
295660|NCT01889823|Inflammation|inflammation
295661|NCT01889823|Innate immunity|innate immunity
295662|NCT01889810|Vitamin D, Pre-diabetes, Insulin Resistance|vitamin d, pre-diabetes, insulin resistance
295663|NCT01889797|Untreated Non-Hodgkin's Lymphoma|untreated non-hodgkin's lymphoma
295664|NCT01889797|Low Tumor Burden Non-Hodgkin's Lymphoma|low tumor burden non-hodgkin's lymphoma
295665|NCT01889797|NHL|nhl
295666|NCT01889797|Indolent|indolent
295667|NCT01889797|Rituximab|rituximab
295668|NCT01889797|Rituxan|rituxan
295669|NCT01889797|GA101|ga101
295670|NCT01889797|Obinutuzumab|obinutuzumab
295671|NCT01889784|diabetes mellitus, type 2|diabetes mellitus, type 2
295672|NCT01889784|phototherapy|phototherapy
295673|NCT01889784|physical exercise|physical exercise
295674|NCT01889784|oxygen consumption|oxygen consumption
295675|NCT01889784|arterial blood pressure|arterial blood pressure
295676|NCT01889784|heart rate|heart rate
295677|NCT01889784|baroreflex sensitivity|baroreflex sensitivity
295678|NCT01889784|cardiovascular autonomic control|cardiovascular autonomic control
295679|NCT01889758|bioequivalence|bioequivalence
295680|NCT01889758|tacrolimus|tacrolimus
295681|NCT01889758|kidney|kidney
295682|NCT01889758|liver|liver
295683|NCT01889758|transplant|transplant
295684|NCT01889719|HIV Prevention|hiv prevention
295685|NCT01889706|Type 1 diabetes mellitus,|type 1 diabetes mellitus,
295686|NCT01889706|metformin,|metformin,
295687|NCT01889706|insulin resistance,|insulin resistance,
295688|NCT01889706|obesity|obesity
295689|NCT01889693|positron emission tomography|positron emission tomography
295690|NCT01889693|macrophage|macrophage
295691|NCT01889693|neomannosyl human serum albumin|neomannosyl human serum albumin
295692|NCT01889680|colorectal cancer|colorectal cancer
295693|NCT01889680|metastatic colorectal cancer|metastatic colorectal cancer
295694|NCT01889680|ziv-aflibercept|ziv-aflibercept
295695|NCT01889680|NSABP|nsabp
295696|NCT01889667|Oral Insulin|oral insulin
295697|NCT01889667|Diabetes Mellitus Type 2|diabetes mellitus type 2
295698|NCT01889667|Safety|safety
295699|NCT01889667|Pharmacodynamics|pharmacodynamics
295700|NCT01889667|Pharmacokinetics|pharmacokinetics
295701|NCT01889628|Glycaemic response|glycaemic response
295702|NCT01889628|Glycaemic Index|glycaemic index
295703|NCT01889628|Nutritional formula|nutritional formula
295704|NCT01889628|Asia|asia
295705|NCT01889628|Ethnic differences|ethnic differences
295706|NCT01889628|Chinese|chinese
295707|NCT01889628|Malay|malay
295708|NCT01889628|Indian|indian
295709|NCT01889615|Ovarian cancer|ovarian cancer
295710|NCT01889615|PET/CT|pet/ct
295711|NCT01889615|glucose 6 phosphatase|glucose 6 phosphatase
295712|NCT01889602|Healthy volunteers|healthy volunteers
295713|NCT01889602|Topiramate|topiramate
295714|NCT01889602|Neurocognition|neurocognition
295715|NCT01889602|Drug-induced cognitive deficits|drug-induced cognitive deficits
295716|NCT01889576|glucose|glucose
295717|NCT01889563|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
295718|NCT01889563|heart rate variability|heart rate variability
295719|NCT01889563|physical training|physical training
295720|NCT01889550|Screening|screening
295721|NCT01889550|Downs syndrome|downs syndrome
295722|NCT01889550|Informed choice|informed choice
295723|NCT01889550|eHealth|ehealth
295724|NCT01889537|Virtual Reality Ketamine|virtual reality ketamine
295725|NCT01889511|Text Messaging|text messaging
295726|NCT01889511|Medication Adherence|medication adherence
295727|NCT01889511|Oral Agents|oral agents
295728|NCT01889498|Acetazolamide, intracranial/cerebrospinal fluid pressure, paraplegia, thoracoabdominal aortic surgery|acetazolamide, intracranial/cerebrospinal fluid pressure, paraplegia, thoracoabdominal aortic surgery
295729|NCT01889485|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
295730|NCT01889485|Carotid Stenosis|carotid stenosis
295731|NCT01889485|Peripheral Arterial Disease|peripheral arterial disease
295732|NCT01889485|Health Services Accessibility|health services accessibility
295733|NCT01889472|CPAP compliance|cpap compliance
295734|NCT01889472|leaks|leaks
295735|NCT01889472|Respiratory disturbances index|respiratory disturbances index
295736|NCT01889472|quality of life|quality of life
295737|NCT01889446|Propionic acid|propionic acid
295738|NCT01889446|Food preservatives|food preservatives
295739|NCT01889433|Hepatitis C|hepatitis c
295740|NCT01889433|Cepeginterferon alfa|cepeginterferon alfa
295741|NCT01889433|Peginterferon|peginterferon
295742|NCT01889433|Treatment|treatment
295743|NCT01889420|myeloma|myeloma
295744|NCT01889420|relapse|relapse
295745|NCT01889420|refractory|refractory
295746|NCT01889420|relapsed|relapsed
295747|NCT01889420|pomalidomide|pomalidomide
295748|NCT01889420|pomalyst|pomalyst
295749|NCT01889420|everolimus|everolimus
295750|NCT01889420|afinitor|afinitor
295751|NCT01889420|dexamethasone|dexamethasone
295752|NCT01889407|Acute Myeloid Leukemia|acute myeloid leukemia
295753|NCT01889394|pilonidal sinus|pilonidal sinus
295754|NCT01889394|excision|excision
295755|NCT01889394|primary wound closure|primary wound closure
295756|NCT01889394|limberg flap|limberg flap
295757|NCT01889368|Insulin resistance|insulin resistance
295758|NCT01889368|Central adiposity|central adiposity
295759|NCT01889368|Elevated blood pressure|elevated blood pressure
295760|NCT01889368|Vascular reactivity|vascular reactivity
295761|NCT01889368|Elevated triglycerides|elevated triglycerides
295762|NCT01889368|Low high-density lipoprotein (HDL)|low high-density lipoprotein (hdl)
295763|NCT01889355|diabetes|diabetes
295764|NCT01889355|glucose|glucose
295765|NCT01889355|glucometer|glucometer
295766|NCT01889342|MCT|mct
295767|NCT01889342|Metacognitive therapy|metacognitive therapy
295768|NCT01889342|Anxiety disorders|anxiety disorders
295769|NCT01889342|Transdiagnostic|transdiagnostic
295770|NCT01889316|Fetal monitoring|fetal monitoring
295771|NCT01889316|ECG|ecg
295772|NCT01889303|concurrent chemoradiotherapy|concurrent chemoradiotherapy
295773|NCT01889303|FOLFOX6|folfox6
295774|NCT01889303|chemotherapy|chemotherapy
295775|NCT01889303|docetaxel|docetaxel
295776|NCT01889303|cisplatin|cisplatin
295777|NCT01889303|gastric cancer|gastric cancer
295778|NCT01889290|methylnaltrexone|methylnaltrexone
295779|NCT01889290|opioid-antagonist|opioid-antagonist
295780|NCT01889290|Obstipation|obstipation
295781|NCT01889290|pharmacokinetics|pharmacokinetics
295782|NCT01889277|Diabetic Nephropathy|diabetic nephropathy
295783|NCT01889264|Methionine Metabolism|methionine metabolism
295784|NCT01889264|Enteral Nutrition|enteral nutrition
295785|NCT01889264|Pediatric|pediatric
295786|NCT01889264|Pediatrics|pediatrics
295787|NCT01889264|Sepsis|sepsis
295788|NCT01889264|Observational Study|observational study
295789|NCT01889251|Vitreomacular Adhesion|vitreomacular adhesion
295790|NCT01889251|Vitreomacular Traction|vitreomacular traction
295791|NCT01889251|Vitreomacular Traction Syndrome|vitreomacular traction syndrome
295792|NCT01889251|Vitrectomy|vitrectomy
295793|NCT01889251|Central Visual Field Defect|central visual field defect
295794|NCT01889251|Blind Spot|blind spot
295795|NCT01889251|Intravitreal Injection|intravitreal injection
295796|NCT01889251|Macula|macula
295797|NCT01889251|Retina|retina
295798|NCT01889251|Decreased Visual Acuity|decreased visual acuity
295799|NCT01889251|Visual Complaint|visual complaint
295800|NCT01889251|SD-OCT|sd-oct
295801|NCT01889251|Macular Hole|macular hole
295802|NCT01889238|breast cancer|breast cancer
295803|NCT01889238|triple negative|triple negative
295804|NCT01889238|androgen receptor positive|androgen receptor positive
295805|NCT01889199|polycystic ovary syndrome|polycystic ovary syndrome
295806|NCT01889199|hirsutism|hirsutism
295807|NCT01889199|anovulation|anovulation
295808|NCT01889199|oligomenorrhea|oligomenorrhea
295809|NCT01889199|amenorrhea|amenorrhea
295810|NCT01889199|hyperandrogenism|hyperandrogenism
295811|NCT01889199|antiandrogen effect|antiandrogen effect
295812|NCT01889186|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
295813|NCT01889186|17 p Deletion|17 p deletion
295814|NCT01889160|Healthy volunteers, Phase 1|healthy volunteers, phase 1
295815|NCT01889147|Peak plasma concentration|peak plasma concentration
295816|NCT01889147|safety and efficacy|safety and efficacy
295817|NCT01889147|therapeutic agent|therapeutic agent
295818|NCT01889147|LPS-mediated diseases|lps-mediated diseases
295819|NCT01889147|Pharmacokinetics of administered hRESCAP|pharmacokinetics of administered hrescap
295820|NCT01889147|Determine half-time|determine half-time
295821|NCT01889134|primary hyperparathyroidism|primary hyperparathyroidism
295822|NCT01889134|RANKL|rankl
295823|NCT01889134|osteoprotegerin|osteoprotegerin
295824|NCT01889134|bone mineral density|bone mineral density
295825|NCT01889134|alendronate|alendronate
295826|NCT01889134|parathyroidectomy|parathyroidectomy
295827|NCT01889108|Premature|premature
295828|NCT01889108|Development|development
295829|NCT01889108|Motor|motor
295830|NCT01889108|Cognitive|cognitive
295831|NCT01889108|Parent|parent
295832|NCT01889082|Obesity|obesity
295833|NCT01889082|weight loss|weight loss
295834|NCT01889082|young adults|young adults
295835|NCT01889056|Erythropoietin|erythropoietin
295836|NCT01889056|Cognition|cognition
295837|NCT01889056|Exercise|exercise
295838|NCT01889043|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
295839|NCT01889043|Noninvasive Ventilation|noninvasive ventilation
295840|NCT01889043|Polysomnography|polysomnography
295841|NCT01889030|Cardiovascular primary prevention|cardiovascular primary prevention
296144|NCT01887509|Fluorescein|fluorescein
295842|NCT01889030|Cardiovascular risk strtification|cardiovascular risk strtification
295843|NCT01889017|generic immunosuppressive|generic immunosuppressive
295844|NCT01889004|Cerebral blood flow|cerebral blood flow
295845|NCT01889004|Consciousness|consciousness
295846|NCT01889004|Dexmedetomidine|dexmedetomidine
295847|NCT01889004|EEG|eeg
295848|NCT01889004|Event related potentials|event related potentials
295849|NCT01889004|Functional magnetic resonance imaging|functional magnetic resonance imaging
295850|NCT01889004|General anesthesia|general anesthesia
295851|NCT01889004|Positron emission tomography|positron emission tomography
295852|NCT01889004|Propofol|propofol
295853|NCT01888991|Glucose|glucose
295854|NCT01888991|Exercise|exercise
295855|NCT01888991|Metabolic flexibility|metabolic flexibility
295856|NCT01888991|Substrate Oxidation|substrate oxidation
295857|NCT01888991|Food intake|food intake
295858|NCT01888978|Pancreas|pancreas
295859|NCT01888978|cancer|cancer
295860|NCT01888978|metastatic|metastatic
295861|NCT01888978|chemotherapy|chemotherapy
295862|NCT01888965|Maintenance therapy|maintenance therapy
295863|NCT01888965|Adjuvant Therapy|adjuvant therapy
295864|NCT01888939|Executive Function|executive function
295865|NCT01888939|Child|child
295866|NCT01888939|Obesity|obesity
295867|NCT01888939|Exercise|exercise
295868|NCT01888939|Insulin Sensitivity|insulin sensitivity
295869|NCT01888926|rPAS|rpas
295870|NCT01888926|Dystonia|dystonia
295871|NCT01888913|Body Weight|body weight
295872|NCT01888913|Virtual Reality Technology|virtual reality technology
295873|NCT01888900|Hepatitis C|hepatitis c
295874|NCT01888900|Non-Responders|non-responders
295875|NCT01888900|Direct Acting Antivirals|direct acting antivirals
295876|NCT01888900|Interferon Free|interferon free
295877|NCT01888900|Cirrhosis|cirrhosis
295878|NCT01888874|Methotrexate insufficient responders|methotrexate insufficient responders
295879|NCT01888861|length of stay in ICU|length of stay in icu
295880|NCT01888861|ventilator free days|ventilator free days
295881|NCT01888848|Postural Balance|postural balance
295882|NCT01888848|Walking|walking
295883|NCT01888848|Gait|gait
295884|NCT01888848|Cognition|cognition
295885|NCT01888848|Learning|learning
295886|NCT01888848|Memory|memory
295887|NCT01888848|Blueberry|blueberry
295888|NCT01888848|Antioxidants|antioxidants
295889|NCT01888848|Anti-Inflammatory Agents|anti-inflammatory agents
295890|NCT01888848|Brain|brain
295891|NCT01888835|HIV|hiv
295892|NCT01888835|sexual behavior|sexual behavior
295893|NCT01888822|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
295894|NCT01888822|Prophylactic antibiotics|prophylactic antibiotics
295895|NCT01888809|teen parents|teen parents
295896|NCT01888809|early childhood development|early childhood development
295897|NCT01888809|home visitation|home visitation
295898|NCT01888809|evidence-based treatment|evidence-based treatment
295899|NCT01888796|T2DM|t2dm
295900|NCT01888796|diastolic dysfunction|diastolic dysfunction
295901|NCT01888783|CRPS Type I|crps type i
295902|NCT01888783|tactile acuity|tactile acuity
295903|NCT01888783|2-point-discrimination|2-point-discrimination
295904|NCT01888783|Grating Orientation Task|grating orientation task
295905|NCT01888783|sensory signs|sensory signs
295906|NCT01888757|Bioequivalence|bioequivalence
295907|NCT01888757|Lamotrigine Extended Release|lamotrigine extended release
295908|NCT01888757|crossover|crossover
295909|NCT01888744|Intracytoplasmic sperm injection (ICSI)|intracytoplasmic sperm injection (icsi)
295910|NCT01888744|PGD|pgd
295911|NCT01888744|GnrH agonist|gnrh agonist
295912|NCT01888744|GnRH antagonist|gnrh antagonist
295913|NCT01888731|Bioequivalence|bioequivalence
295914|NCT01888731|Lamotrigine Extended Release|lamotrigine extended release
295915|NCT01888731|crossover|crossover
295916|NCT01888705|COPD|copd
295917|NCT01888705|Complexity|complexity
295918|NCT01888705|Entropy Sampling|entropy sampling
295919|NCT01888705|Variability|variability
295920|NCT01888705|Respiratory Mechanics|respiratory mechanics
295921|NCT01888705|FOT|fot
295922|NCT01888692|PET/CT|pet/ct
295923|NCT01888692|Radiotherapy|radiotherapy
295924|NCT01888692|Lung Cancer|lung cancer
295925|NCT01888679|Airway|airway
295926|NCT01888679|Endotracheal intubation|endotracheal intubation
295927|NCT01888679|selective intubation|selective intubation
295928|NCT01888653|PTSD|ptsd
295929|NCT01888653|Attention Bias to threat|attention bias to threat
295930|NCT01888653|Attention Bias Modification Treatment|attention bias modification treatment
295931|NCT01888640|TENS|tens
295932|NCT01888640|Fibromyalgia|fibromyalgia
295933|NCT01888640|Accelerometer|accelerometer
295934|NCT01888627|Schizophrenia|schizophrenia
295935|NCT01888627|Bipolar disorder|bipolar disorder
295936|NCT01888627|Assertive community treatment|assertive community treatment
295937|NCT01888627|Integrated care|integrated care
295938|NCT01888627|Severe and persistent mental disorder|severe and persistent mental disorder
295939|NCT01888614|carbon mono oxide|carbon mono oxide
295940|NCT01888614|sickle cell|sickle cell
295941|NCT01888614|hemolysis|hemolysis
295942|NCT01888588|Uncomplicated peptic ulcer|uncomplicated peptic ulcer
296145|NCT01887496|Varicella|varicella
295943|NCT01888588|Low dose aspirin (ASA)|low dose aspirin (asa)
295944|NCT01888588|Acid-suppressing drugs|acid-suppressing drugs
295945|NCT01888588|Epidemiology|epidemiology
295946|NCT01888575|Discontinuation of low dose ASA,|discontinuation of low dose asa,
295947|NCT01888575|Secondary cardiovascular prevention,|secondary cardiovascular prevention,
295948|NCT01888575|Acid-suppressing drugs,|acid-suppressing drugs,
295949|NCT01888575|Gastrointestinal risk,|gastrointestinal risk,
295950|NCT01888575|Epidemiology|epidemiology
295951|NCT01888549|Chronic cough, proton pump inhibitor, GERD, nonacid reflux,|chronic cough, proton pump inhibitor, gerd, nonacid reflux,
295952|NCT01888497|Sleeplessness|sleeplessness
295953|NCT01888484|PID|pid
295954|NCT01888471|Streptococcal disease|streptococcal disease
295955|NCT01888471|Feasibility|feasibility
295956|NCT01888471|Infants|infants
295957|NCT01888458|Adult|adult
295958|NCT01888458|allo-Stem Cell Transplantation|allo-stem cell transplantation
295959|NCT01888458|Cord Blood|cord blood
295960|NCT01888445|Renal anemia|renal anemia
295961|NCT01888445|Chronic Renal Failure|chronic renal failure
295962|NCT01888445|ASP1517|asp1517
295963|NCT01888432|liver transplantation|liver transplantation
295964|NCT01888432|everolimus|everolimus
295965|NCT01888432|tacrolimus|tacrolimus
295966|NCT01888432|reduced calcineuron inhibitor|reduced calcineuron inhibitor
295967|NCT01888432|renal function|renal function
295968|NCT01888432|living donor|living donor
295969|NCT01888432|RAD001H2307|rad001h2307
295970|NCT01888432|RAD001H|rad001h
295971|NCT01888419|Post Breast Therapy Pain Syndrome|post breast therapy pain syndrome
295972|NCT01888419|Lipotransplantation|lipotransplantation
295973|NCT01888419|Breast Cancer|breast cancer
295974|NCT01888419|Pain|pain
295975|NCT01888406|Obesity|obesity
295976|NCT01888406|Weight gain prevention|weight gain prevention
295977|NCT01888406|Eating disorder|eating disorder
295978|NCT01888406|Binge eating|binge eating
295979|NCT01888393|pharmacokinetics, hepatic impairment|pharmacokinetics, hepatic impairment
295980|NCT01888380|Autopsy|autopsy
295981|NCT01888380|Minimally invasive|minimally invasive
295982|NCT01888380|Foetuses|foetuses
295983|NCT01888380|Newborns|newborns
295984|NCT01888380|Children|children
295985|NCT01888380|Adolescents|adolescents
295986|NCT01888354|MS|ms
295987|NCT01888354|Multiple Sclerosis|multiple sclerosis
295988|NCT01888315|Hypertension|hypertension
295989|NCT01888315|Heart Failure|heart failure
295990|NCT01888315|Sympathetic activity|sympathetic activity
295991|NCT01888276|Words generation, compulsive gamblers|words generation, compulsive gamblers
295992|NCT01888263|Bioequivalence|bioequivalence
295993|NCT01888263|Lamotrigine Extended Release|lamotrigine extended release
295994|NCT01888263|crossover|crossover
295995|NCT01888250|Bioequivalence|bioequivalence
295996|NCT01888250|Lamotrigine Extended Release|lamotrigine extended release
295997|NCT01888250|crossover|crossover
295998|NCT01888237|Dyspepsia|dyspepsia
295999|NCT01888237|Helicobacter pylori|helicobacter pylori
296000|NCT01888237|Clarithromycin resistance|clarithromycin resistance
296001|NCT01888237|Other Specified Disorders of Function of Stomach|other specified disorders of function of stomach
296002|NCT01888198|ablation|ablation
296003|NCT01888198|quality of Life (QOL)|quality of life (qol)
296004|NCT01888198|kidney|kidney
296005|NCT01888198|registry|registry
296006|NCT01888198|Ablation of Renal Masses Outcomes Registry (ARMOR)|ablation of renal masses outcomes registry (armor)
296007|NCT01888198|13-116|13-116
296008|NCT01888185|Parkinson's|parkinson's
296009|NCT01888185|PD|pd
296010|NCT01888185|nigrostriatal|nigrostriatal
296011|NCT01888185|substantia nigra|substantia nigra
296012|NCT01888185|MRI|mri
296013|NCT01888185|DTI|dti
296014|NCT01888185|FA|fa
296015|NCT01888185|R2*|r2*
296016|NCT01888185|Parkinson's Disease Biomarkers Program|parkinson's disease biomarkers program
296017|NCT01888185|PDBP|pdbp
296018|NCT01888185|ferritin|ferritin
296019|NCT01888185|transferrin|transferrin
296020|NCT01888185|Fe|fe
296021|NCT01888185|iron protein|iron protein
296022|NCT01888185|PSP|psp
296023|NCT01888185|MSA|msa
296024|NCT01888146|Pain management|pain management
296025|NCT01888146|Opioid use|opioid use
296026|NCT01888146|Pragmatic|pragmatic
296027|NCT01888146|Collaborative care|collaborative care
296028|NCT01888146|Primary care|primary care
296029|NCT01888107|Schizophrenia|schizophrenia
296030|NCT01888107|Schizoaffective Disorder|schizoaffective disorder
296031|NCT01888107|Antipsychotics|antipsychotics
296032|NCT01888107|Risperidone|risperidone
296033|NCT01888107|Long-acting injectable|long-acting injectable
296034|NCT01888094|Central venous catheter|central venous catheter
296035|NCT01888094|Complications|complications
296036|NCT01888094|Ultrasound|ultrasound
296037|NCT01888094|Subclavian vein cannulation|subclavian vein cannulation
296038|NCT01888094|Critical care|critical care
296039|NCT01888094|Echocardiography|echocardiography
296040|NCT01888094|Chest radiographyiography|chest radiographyiography
296041|NCT01888055|Healthy older adults Cortical Plasticity|healthy older adults cortical plasticity
296042|NCT01888055|Transcranial Direct Current Stimulation|transcranial direct current stimulation
296043|NCT01888029|mild cognitive impairment|mild cognitive impairment
296044|NCT01888029|Transcranial Direct Current Stimulation|transcranial direct current stimulation
296045|NCT01888029|Cortical Plasticity|cortical plasticity
296046|NCT01888003|anemia|anemia
296047|NCT01887977|Orthognathic surgery|orthognathic surgery
296048|NCT01887977|Speech production|speech production
296049|NCT01887977|MRI|mri
296050|NCT01887964|Diabetes|diabetes
296051|NCT01887964|Obesity|obesity
296052|NCT01887964|Cardiovascular disease|cardiovascular disease
296053|NCT01887964|Metabolic syndrome|metabolic syndrome
296054|NCT01887925|breast neoplasms|breast neoplasms
296055|NCT01887925|sleep|sleep
296056|NCT01887925|anxiety|anxiety
296057|NCT01887925|depression|depression
296058|NCT01887925|life quality|life quality
296059|NCT01887912|Clostridium difficile Toxoid Vaccine|clostridium difficile toxoid vaccine
296060|NCT01887912|Clostridium difficile infection|clostridium difficile infection
296061|NCT01887912|Cdiffense|cdiffense
296062|NCT01887899|cortical plasticity|cortical plasticity
296063|NCT01887899|transcranial direct current stimulation|transcranial direct current stimulation
296064|NCT01887873|open angle glaucoma|open angle glaucoma
296065|NCT01887873|cataract|cataract
296066|NCT01887860|Cetaphil Daily Facial Moisturizer SPF 50|cetaphil daily facial moisturizer spf 50
296067|NCT01887847|nicotine|nicotine
296068|NCT01887847|pharmacokinetics|pharmacokinetics
296069|NCT01887834|bloating|bloating
296070|NCT01887834|constipation|constipation
296071|NCT01887834|diarrhea|diarrhea
296072|NCT01887834|gas|gas
296073|NCT01887834|mucous|mucous
296074|NCT01887834|cramping|cramping
296075|NCT01887808|Determine|determine
296076|NCT01887808|Hypoallergenicity|hypoallergenicity
296077|NCT01887808|Cetaphil DermaControl Oil Control Moisturizer SPF 30|cetaphil dermacontrol oil control moisturizer spf 30
296078|NCT01887795|Informed Consent;|informed consent;
296079|NCT01887795|Ethical Principles;|ethical principles;
296080|NCT01887795|Data collection|data collection
296081|NCT01887782|depression|depression
296082|NCT01887782|magnetic|magnetic
296083|NCT01887782|brain stimulation|brain stimulation
296084|NCT01887782|treatment-resistant|treatment-resistant
296085|NCT01887769|Lung cancer|lung cancer
296086|NCT01887769|Body composition analysis|body composition analysis
296087|NCT01887769|Ct-Scan|ct-scan
296088|NCT01887769|Muscle mass|muscle mass
296089|NCT01887769|Cachexia|cachexia
296090|NCT01887756|telerehabilitation stroke virtual reatlity|telerehabilitation stroke virtual reatlity
296091|NCT01887743|GERD|gerd
296092|NCT01887743|Obesity|obesity
296093|NCT01887743|Pediatric|pediatric
296094|NCT01887743|Pantoprazole|pantoprazole
296095|NCT01887743|CYP2C19|cyp2c19
296096|NCT01887743|Pharmacokinetic|pharmacokinetic
296097|NCT01887730|Hand Hygiene|hand hygiene
296098|NCT01887730|Communicable Diseases|communicable diseases
296099|NCT01887730|Prevention|prevention
296100|NCT01887717|hepatocellular carcinoma|hepatocellular carcinoma
296101|NCT01887717|portal vein thrombosis|portal vein thrombosis
296102|NCT01887691|Diabetes|diabetes
296103|NCT01887691|Prediabetic|prediabetic
296104|NCT01887691|Prediabetes|prediabetes
296105|NCT01887691|Glucose intolerance|glucose intolerance
296106|NCT01887691|Sleep quality|sleep quality
296107|NCT01887691|Continuous glucose monitoring|continuous glucose monitoring
296108|NCT01887691|Diabetes risk|diabetes risk
296109|NCT01887691|eszopiclone|eszopiclone
296110|NCT01887665|substance use disorders|substance use disorders
296111|NCT01887665|substance abuse|substance abuse
296112|NCT01887665|substance abuse treatment|substance abuse treatment
296113|NCT01887665|contingency management|contingency management
296114|NCT01887652|In Vitro Fertilization|in vitro fertilization
296115|NCT01887652|ovulation induction|ovulation induction
296116|NCT01887652|anti-mullerian hormone|anti-mullerian hormone
296117|NCT01887639|Non-psychotic unipolar major depression|non-psychotic unipolar major depression
296118|NCT01887639|Resistant depression|resistant depression
296119|NCT01887626|Phase 1, pharmacokinetic, safety, Ticagrelor|phase 1, pharmacokinetic, safety, ticagrelor
296120|NCT01887613|Gabapentin|gabapentin
296121|NCT01887600|anemia|anemia
296122|NCT01887600|chronic kidney disease (CKD)|chronic kidney disease (ckd)
296123|NCT01887600|Hemoglobin (Hb)|hemoglobin (hb)
296124|NCT01887600|non-dialysis|non-dialysis
296125|NCT01887548|Crohn's disease|crohn's disease
296126|NCT01887548|inflammatory bowel disease|inflammatory bowel disease
296127|NCT01887548|quality of life|quality of life
296128|NCT01887548|personality|personality
296129|NCT01887548|neuroticism|neuroticism
296130|NCT01887535|Healthy|healthy
296131|NCT01887535|Elderly|elderly
296132|NCT01887535|Safety|safety
296133|NCT01887535|Tolerability|tolerability
296134|NCT01887535|Pharmacokinetic|pharmacokinetic
296135|NCT01887535|Alzheimer's Disease|alzheimer's disease
296136|NCT01887535|JNJ-54861911|jnj-54861911
296137|NCT01887522|Children|children
296138|NCT01887522|Adolescents|adolescents
296139|NCT01887522|Young Adults|young adults
296140|NCT01887509|Rectal cancer|rectal cancer
296141|NCT01887509|Tumor margin|tumor margin
296142|NCT01887509|Confocal endomicroscopy|confocal endomicroscopy
296143|NCT01887509|Virtual biopsy|virtual biopsy
296146|NCT01887496|Turkey|turkey
296147|NCT01887496|hospitalization|hospitalization
296148|NCT01887496|varicella vaccine|varicella vaccine
296149|NCT01887483|IBS|ibs
296150|NCT01887483|bowel function|bowel function
296151|NCT01887483|probiotic|probiotic
296152|NCT01887470|Bowel Evacuation|bowel evacuation
296153|NCT01887470|Colonoscopy Preparation|colonoscopy preparation
296154|NCT01887457|voriconazole|voriconazole
296155|NCT01887457|VFEND|vfend
296156|NCT01887457|individualised|individualised
296157|NCT01887457|personalised|personalised
296158|NCT01887444|Pediatric Gastroenterology|pediatric gastroenterology
296159|NCT01887444|Probiotics|probiotics
296160|NCT01887444|Lactobacillus reuteri|lactobacillus reuteri
296161|NCT01887431|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
296162|NCT01887431|Adult|adult
296163|NCT01887431|Insulin Infusion Systems|insulin infusion systems
296164|NCT01887431|Telecare|telecare
296165|NCT01887418|Hypogonadism|hypogonadism
296166|NCT01887418|Testosterone enanthate|testosterone enanthate
296167|NCT01887405|Adrenaline|adrenaline
296168|NCT01887405|Auto-injector|auto-injector
296169|NCT01887405|Jext|jext
296170|NCT01887405|Epipen|epipen
296171|NCT01887392|Long-term Care|long-term care
296172|NCT01887392|Knowledge Translation|knowledge translation
296173|NCT01887379|Gastroretentive drug formulation|gastroretentive drug formulation
296174|NCT01887379|Furosemide|furosemide
296175|NCT01887379|Magnetic Marker Monitoring|magnetic marker monitoring
296176|NCT01887379|Magnetic marker|magnetic marker
296177|NCT01887379|Oedema|oedema
296178|NCT01887366|Cocaine addiction|cocaine addiction
296179|NCT01887366|TV-1380|tv-1380
296180|NCT01887366|Recombinant human serum albumin (HSA) mutated butyrylcholinesterase (AlbuBChE)|recombinant human serum albumin (hsa) mutated butyrylcholinesterase (albubche)
296181|NCT01887353|atrial fibrillation|atrial fibrillation
296182|NCT01887353|heart failure|heart failure
296183|NCT01887353|ranolazine|ranolazine
296184|NCT01887353|cardioversion|cardioversion
296185|NCT01887353|persistent AF|persistent af
296186|NCT01887353|paroxysmal AF|paroxysmal af
296187|NCT01887327|G6PD deficiency|g6pd deficiency
296188|NCT01887327|ABO incompatibility|abo incompatibility
296189|NCT01887327|Coombs positive ABO/RH incompatibility|coombs positive abo/rh incompatibility
296190|NCT01887327|intensive phototherapy in neonates|intensive phototherapy in neonates
296191|NCT01887327|Hyperbilirubinemia|hyperbilirubinemia
296192|NCT01887327|Neonatal Jaundice|neonatal jaundice
296193|NCT01887314|Cancer|cancer
296194|NCT01887314|Cisplatin|cisplatin
296195|NCT01887314|Nausea|nausea
296196|NCT01887314|Ginger|ginger
296197|NCT01887314|Zingiber officinale|zingiber officinale
296198|NCT01887314|5HT3|5ht3
296199|NCT01887314|Dexamethasone|dexamethasone
296200|NCT01887314|Neurokinin-1 (NK-1)|neurokinin-1 (nk-1)
296201|NCT01887314|Interleukin-6 (IL-6)|interleukin-6 (il-6)
296202|NCT01887314|Tumor necrosis factor-alpha (TNF-alpha)|tumor necrosis factor-alpha (tnf-alpha)
296203|NCT01887314|Insulin like growth factor-1 (IGF-1)|insulin like growth factor-1 (igf-1)
296204|NCT01887314|Placebo|placebo
296205|NCT01887314|FLIE|flie
296206|NCT01887314|BFI|bfi
296207|NCT01887275|Chronic hepatitis B|chronic hepatitis b
296208|NCT01887275|Medical Ozone|medical ozone
296209|NCT01887275|Interferon-α|interferon-α
296210|NCT01887275|Efficacy|efficacy
296211|NCT01887262|fluid|fluid
296212|NCT01887262|edema|edema
296213|NCT01887223|Encapsulated blebs|encapsulated blebs
296214|NCT01887223|trabeculectomy failure|trabeculectomy failure
296215|NCT01887223|glaucoma|glaucoma
296216|NCT01887210|HIV|hiv
296217|NCT01887210|youth|youth
296218|NCT01887210|medical adherence|medical adherence
296219|NCT01887197|cystic fibrosis|cystic fibrosis
296220|NCT01887197|mucociliary clearance|mucociliary clearance
296221|NCT01887197|airway surface liquid|airway surface liquid
296222|NCT01887197|nuclear medicine|nuclear medicine
296223|NCT01887197|mannitol|mannitol
296224|NCT01887171|Liver transplantation|liver transplantation
296225|NCT01887171|Early allograft dysfunction|early allograft dysfunction
296226|NCT01887171|Ischemic reperfusion injury|ischemic reperfusion injury
296227|NCT01887171|Portal and arterial ex vivo HTK flush|portal and arterial ex vivo htk flush
296228|NCT01887145|Carpal tunnel syndrome|carpal tunnel syndrome
296229|NCT01887145|Surgery|surgery
296230|NCT01887145|Outcomes|outcomes
296231|NCT01887132|Sleep Architecture|sleep architecture
296232|NCT01887132|Autism|autism
296233|NCT01887132|Language Development|language development
296234|NCT01887093|coronary artery disease|coronary artery disease
296235|NCT01887093|walking|walking
296236|NCT01887093|lipids|lipids
296237|NCT01887093|inflammatory markers|inflammatory markers
296238|NCT01887093|time of day|time of day
296239|NCT01887080|Cardiovascular rehabilitation home-based|cardiovascular rehabilitation home-based
296240|NCT01887080|Acute myocardial infarction|acute myocardial infarction
296241|NCT01887080|Obesity|obesity
296242|NCT01887080|Microcurrent|microcurrent
296243|NCT01887067|Hypertension|hypertension
296244|NCT01887067|Diabetes Mellitus|diabetes mellitus
296245|NCT01887041|Advanced, metastasising pancreatic head carcinoma|advanced, metastasising pancreatic head carcinoma
296246|NCT01887041|Jaundice|jaundice
296247|NCT01887041|Biliodigestive anastomosis|biliodigestive anastomosis
296248|NCT01887041|Endoscopically inserted biliary tract drainage|endoscopically inserted biliary tract drainage
296249|NCT01887041|Quality of Life|quality of life
296250|NCT01887028|Carbon deoxide pneumoperitoneum|carbon deoxide pneumoperitoneum
296251|NCT01887028|Intraperitoneal pressure|intraperitoneal pressure
296252|NCT01887028|Peritoneum|peritoneum
296253|NCT01887028|Gene expression|gene expression
296254|NCT01887028|Post-operative recovery|post-operative recovery
296255|NCT01887028|Laparoscopic Humidification System|laparoscopic humidification system
296256|NCT01887015|Postoperative pulmonary complications|postoperative pulmonary complications
296257|NCT01887015|Oxygen therapy|oxygen therapy
296258|NCT01887015|Nasal high flow oxygen therapy|nasal high flow oxygen therapy
296259|NCT01887015|Nasal high flow cannula|nasal high flow cannula
296260|NCT01887002|Irritable Bowel Syndrome|irritable bowel syndrome
296261|NCT01887002|IBS|ibs
296262|NCT01887002|ONO-2952|ono-2952
296263|NCT01886989|diabetes|diabetes
296264|NCT01886989|cocoa polyphenols|cocoa polyphenols
296265|NCT01886989|postprandial glycemia|postprandial glycemia
296266|NCT01886989|postprandial lipemia|postprandial lipemia
296267|NCT01886976|multiple myeloma|multiple myeloma
296268|NCT01886950|CKD stage 5|ckd stage 5
296269|NCT01886950|Bone histomorphometry|bone histomorphometry
296270|NCT01886950|Renal transplantation|renal transplantation
296271|NCT01886924|Tobacco|tobacco
296272|NCT01886924|Nicotine|nicotine
296273|NCT01886924|Dependence|dependence
296274|NCT01886924|Quitline|quitline
296275|NCT01886911|prosocial behavior|prosocial behavior
296276|NCT01886911|prosocial|prosocial
296277|NCT01886911|attention training|attention training
296278|NCT01886911|attention|attention
296279|NCT01886911|empathy|empathy
296280|NCT01886911|emotion recognition|emotion recognition
296281|NCT01886885|Mindfulness|mindfulness
296282|NCT01886885|Meditation|meditation
296283|NCT01886885|Chronic Pain|chronic pain
296284|NCT01886833|Rotavirus|rotavirus
296285|NCT01886833|Diarrhoea|diarrhoea
296286|NCT01886833|Dmmunisation|dmmunisation
296287|NCT01886833|Seroconversion|seroconversion
296288|NCT01886833|Breastmilk|breastmilk
296289|NCT01886833|HIV|hiv
296290|NCT01886833|Zinc|zinc
296291|NCT01886833|Vitamin A|vitamin a
296292|NCT01886833|Failure|failure
296293|NCT01886820|Dementia|dementia
296294|NCT01886820|Alzheimer's Disease|alzheimer's disease
296295|NCT01886820|Terminally Ill|terminally ill
296296|NCT01886794|pelvic floor dysfunction|pelvic floor dysfunction
296297|NCT01886794|pelvic organ prolapse|pelvic organ prolapse
296298|NCT01886794|vaginal estrogen effects|vaginal estrogen effects
296299|NCT01886781|only constipation and diarrhea predominant|only constipation and diarrhea predominant
296300|NCT01886781|no mixed or alternating types|no mixed or alternating types
296301|NCT01886768|Nasal anesthesia|nasal anesthesia
296302|NCT01886768|endoscopes|endoscopes
296303|NCT01886768|transnasal endoscopy|transnasal endoscopy
296304|NCT01886755|Acute gastroenteritis|acute gastroenteritis
296305|NCT01886755|Probiotics|probiotics
296306|NCT01886755|Lactobacillus reuteri|lactobacillus reuteri
296307|NCT01886755|Zinc supplementation|zinc supplementation
296308|NCT01886755|Infants|infants
296309|NCT01886755|Age 6 months to 36 months|age 6 months to 36 months
296310|NCT01886742|Perioperative antibiotic prophylaxis|perioperative antibiotic prophylaxis
296311|NCT01886742|Morbidly Obese|morbidly obese
296312|NCT01886729|transcranial direct current stimulation|transcranial direct current stimulation
296313|NCT01886729|time shift|time shift
296314|NCT01886716|Alcohol Abuse|alcohol abuse
296315|NCT01886716|Alcohol Dependence|alcohol dependence
296316|NCT01886716|Alcohol Drinking|alcohol drinking
296317|NCT01886716|Social Anxiety|social anxiety
296318|NCT01886716|Social Phobia|social phobia
296319|NCT01886716|Anxiety Disorders|anxiety disorders
296320|NCT01886703|Physical activity|physical activity
296321|NCT01886703|Exercise|exercise
296322|NCT01886703|Quality of Life|quality of life
296323|NCT01886703|Radiation Therapy|radiation therapy
296324|NCT01886703|Breast Cancer|breast cancer
296325|NCT01886703|Head and Neck Cancer|head and neck cancer
296326|NCT01886677|prostate cancer|prostate cancer
296327|NCT01886677|intervention|intervention
296328|NCT01886677|diet|diet
296329|NCT01886677|physical activity|physical activity
296330|NCT01886677|exercise|exercise
296331|NCT01886677|weight loss|weight loss
296332|NCT01886677|biomarkers|biomarkers
296333|NCT01886677|cancer progression|cancer progression
296334|NCT01886651|acute lymphoblastic leukemia|acute lymphoblastic leukemia
296335|NCT01886651|child|child
296336|NCT01886651|6-mercaptopurine|6-mercaptopurine
296337|NCT01886651|methotrexate|methotrexate
296338|NCT01886638|Platelets|platelets
296339|NCT01886638|HIV|hiv
296340|NCT01886638|Cardiovascular disease|cardiovascular disease
296341|NCT01886638|Acute myocardial infarction|acute myocardial infarction
296342|NCT01886638|Abacavir|abacavir
296343|NCT01886638|Antiretrovirals|antiretrovirals
296344|NCT01886612|Deep Vein Thrombosis|deep vein thrombosis
297035|NCT01883518|Myosarcoma|myosarcoma
296345|NCT01886612|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
296346|NCT01886612|Intermittent Pneumatic Compression|intermittent pneumatic compression
296347|NCT01886612|Doppler Ultrasound|doppler ultrasound
296348|NCT01886586|Mild Cognitive Impairment|mild cognitive impairment
296349|NCT01886586|memory impairment|memory impairment
296350|NCT01886586|problem-solving therapy|problem-solving therapy
296351|NCT01886586|depression prevention|depression prevention
296352|NCT01886586|caregiver stress|caregiver stress
296353|NCT01886586|exercise|exercise
296354|NCT01886534|Heart failure|heart failure
296355|NCT01886534|Heart diseases|heart diseases
296356|NCT01886534|Cardiovascular diseases|cardiovascular diseases
296357|NCT01886534|Health information technology|health information technology
296358|NCT01886534|Disease management|disease management
296359|NCT01886534|Patient care management|patient care management
296360|NCT01886534|Self care|self care
296361|NCT01886534|Informal caregiver|informal caregiver
296362|NCT01886534|Care partner|care partner
296363|NCT01886534|Peer support|peer support
296364|NCT01886534|Transitional care|transitional care
296365|NCT01886534|Patient education|patient education
296366|NCT01886534|Teach-back|teach-back
296367|NCT01886534|Clinical decision aid|clinical decision aid
296368|NCT01886443|Liver|liver
296369|NCT01886443|Transplantation|transplantation
296370|NCT01886443|Ischemia-reperfusion|ischemia-reperfusion
296371|NCT01886443|Safety|safety
296372|NCT01886404|HIV|hiv
296373|NCT01886404|efavirenz|efavirenz
296374|NCT01886404|Sustiva|sustiva
296375|NCT01886404|pharmacokinetics|pharmacokinetics
296376|NCT01886404|Pharmacogenomics|pharmacogenomics
296377|NCT01886391|Heart Failure|heart failure
296378|NCT01886391|Dyspnea|dyspnea
296379|NCT01886391|Diaphragmatic breathing retraining|diaphragmatic breathing retraining
296380|NCT01886391|Fatigue|fatigue
296381|NCT01886391|Health-related Outcomes|health-related outcomes
296382|NCT01886378|FAOD|faod
296383|NCT01886378|VLCAD|vlcad
296384|NCT01886378|CPT II|cpt ii
296385|NCT01886378|CPT2|cpt2
296386|NCT01886378|CPT 2|cpt 2
296387|NCT01886378|LCHAD|lchad
296388|NCT01886378|UX007|ux007
296389|NCT01886378|Triheptanoin|triheptanoin
296390|NCT01886378|TFP|tfp
296391|NCT01886378|C7|c7
296392|NCT01886365|Computer based glycemic control, insulin, blood glucose|computer based glycemic control, insulin, blood glucose
296393|NCT01886352|laparoscopic|laparoscopic
296394|NCT01886352|pain|pain
296395|NCT01886326|Obesity|obesity
296396|NCT01886326|energy balance|energy balance
296397|NCT01886326|variety|variety
296398|NCT01886326|nut intake|nut intake
296399|NCT01886313|Herpes Zoster|herpes zoster
296400|NCT01886313|Postherpetic Neuralgia|postherpetic neuralgia
296401|NCT01886313|Shingles|shingles
296402|NCT01886313|Civamide|civamide
296403|NCT01886313|Zucapsaicin|zucapsaicin
296404|NCT01886313|Neuropeptides|neuropeptides
296405|NCT01886313|TRPV-1|trpv-1
296406|NCT01886287|endocrine system|endocrine system
296407|NCT01886287|neuroendocrine tumors|neuroendocrine tumors
296408|NCT01886287|neuroendocrine cancer|neuroendocrine cancer
296409|NCT01886287|metastatic|metastatic
296410|NCT01886287|neuroendocrine|neuroendocrine
296411|NCT01886287|gastrointestinal (GI)|gastrointestinal (gi)
296412|NCT01886287|high-dose octreotide|high-dose octreotide
296413|NCT01886287|flushing|flushing
296414|NCT01886287|diarrhea|diarrhea
296415|NCT01886287|quality of life in patients|quality of life in patients
296416|NCT01886287|disease-related symptoms|disease-related symptoms
296418|NCT01886274|migraine|migraine
296419|NCT01886274|pain|pain
296420|NCT01886274|phosphene|phosphene
296421|NCT01886274|tDCs|tdcs
296422|NCT01886274|TMS|tms
296423|NCT01886261|validation|validation
296424|NCT01886261|physical activity|physical activity
296425|NCT01886261|place-based interventions|place-based interventions
296426|NCT01886261|construct validity|construct validity
296427|NCT01886261|divergent validity|divergent validity
296428|NCT01886261|usability|usability
296429|NCT01886261|gps|gps
296430|NCT01886261|PALMS|palms
296431|NCT01886248|hepatic veno-occlusive disease after hematopoietic stem cell transplantation|hepatic veno-occlusive disease after hematopoietic stem cell transplantation
296432|NCT01886222|Traumatic brain injury|traumatic brain injury
296433|NCT01886196|elderly|elderly
296434|NCT01886196|women|women
296435|NCT01886196|exercise|exercise
296436|NCT01886196|pQCT|pqct
296437|NCT01886196|ibuprofen|ibuprofen
296438|NCT01886183|Postural Balance|postural balance
296439|NCT01886183|Virtual Reality Exposure Therapy|virtual reality exposure therapy
296440|NCT01886183|Gait|gait
296441|NCT01886183|Stroke|stroke
296442|NCT01886170|Adults with self-reported diagnosis of diabetes recruited from waiting rooms at outpatient primary care sites at the University of Pennsylvania|adults with self-reported diagnosis of diabetes recruited from waiting rooms at outpatient primary care sites at the university of pennsylvania
296443|NCT01886157|trigger finger|trigger finger
296444|NCT01886157|orthotic intervention|orthotic intervention
296445|NCT01886144|OA|oa
296446|NCT01886144|arthritis|arthritis
296447|NCT01886144|knee OA|knee oa
296448|NCT01886131|REM behaviour disorder|rem behaviour disorder
296449|NCT01886131|Subthalamic nucleus|subthalamic nucleus
296450|NCT01886131|Local field potential|local field potential
296451|NCT01886131|Motor control|motor control
296452|NCT01886118|In vitro fertilization|in vitro fertilization
296453|NCT01886118|Autologous Endometrial Co-Culture|autologous endometrial co-culture
296454|NCT01886105|Osteosarcoma|osteosarcoma
296455|NCT01886105|Osteogenic Sarcoma|osteogenic sarcoma
296456|NCT01886105|Sarcoma|sarcoma
296457|NCT01886105|Bone Cancer|bone cancer
296458|NCT01886092|tinnitus|tinnitus
296459|NCT01886027|IBS|ibs
296460|NCT01886027|Relaxation|relaxation
296461|NCT01886027|Emotional exposure|emotional exposure
296462|NCT01886027|Emotional Processing|emotional processing
296463|NCT01886014|pain|pain
296464|NCT01886014|pain modulation|pain modulation
296465|NCT01886014|placebo analgesia|placebo analgesia
296466|NCT01886001|Newborn Intensive Care Unit|newborn intensive care unit
296467|NCT01886001|Neonatal Intensive Care Unit|neonatal intensive care unit
296468|NCT01886001|Colonization|colonization
296469|NCT01886001|Line Colonization|line colonization
296470|NCT01886001|Umbilical line|umbilical line
296471|NCT01886001|Umbilical Cord Care|umbilical cord care
296472|NCT01885988|Erectile dysfunction|erectile dysfunction
296473|NCT01885975|Apical Ballooning syndrome|apical ballooning syndrome
296474|NCT01885975|Personality|personality
296475|NCT01885962|pressure ulcer prevention|pressure ulcer prevention
296476|NCT01885962|spinal cord injury|spinal cord injury
296477|NCT01885962|internet delivered pressure ulcer intervention|internet delivered pressure ulcer intervention
296478|NCT01885949|Metastatic|metastatic
296479|NCT01885936|LOPD|lopd
296480|NCT01885936|Pompe Disease|pompe disease
296481|NCT01885923|schizophrenia; relapse prevention; information technology|schizophrenia; relapse prevention; information technology
296482|NCT01885897|Acute myelogenous leukemia (AML)|acute myelogenous leukemia (aml)
296483|NCT01885897|Acute lymphoblastic leukemia (ALL)|acute lymphoblastic leukemia (all)
296484|NCT01885897|Myelodysplastic syndromes (MDS)|myelodysplastic syndromes (mds)
296485|NCT01885897|Lymphoma|lymphoma
296486|NCT01885897|Myeloma|myeloma
296487|NCT01885897|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
296488|NCT01885897|Chronic myelogenous leukemia (CML)|chronic myelogenous leukemia (cml)
296489|NCT01885884|Supportive Care|supportive care
296490|NCT01885884|Palliative Care|palliative care
296491|NCT01885884|Pancreatic Cancer|pancreatic cancer
296492|NCT01885884|Embedded, coordinated model of supportive care within oncology care|embedded, coordinated model of supportive care within oncology care
296493|NCT01885884|Patient and Caregiver support|patient and caregiver support
296494|NCT01885871|Sun|sun
296495|NCT01885871|Age|age
296496|NCT01885871|Spot|spot
296497|NCT01885858|health services research|health services research
296498|NCT01885858|family planning|family planning
296499|NCT01885858|ethnicity|ethnicity
296500|NCT01885858|healthcare disparities|healthcare disparities
296501|NCT01885845|postpartum blood loss measurement|postpartum blood loss measurement
296502|NCT01885845|BRASSS-V drape|brasss-v drape
296503|NCT01885832|autologous adipose stem cells|autologous adipose stem cells
296504|NCT01885832|stromal vascular fraction|stromal vascular fraction
296505|NCT01885832|osteoarthritis|osteoarthritis
296506|NCT01885819|Adipose stromal vascular fraction|adipose stromal vascular fraction
296507|NCT01885819|Rheumatoid arthritis|rheumatoid arthritis
296508|NCT01885819|adult stem cells|adult stem cells
296509|NCT01885806|Apathy; Alzheimer's disease; Cognition; Burden of Care|apathy; alzheimer's disease; cognition; burden of care
296510|NCT01885780|Astigmatism, arcuate incisions, astigmatic keratotomy|astigmatism, arcuate incisions, astigmatic keratotomy
296511|NCT01885767|Neurofibromatosis|neurofibromatosis
296512|NCT01885767|NF|nf
296513|NCT01885767|Neurofibromatosis 1|neurofibromatosis 1
296514|NCT01885767|NF1|nf1
296515|NCT01885767|Neurofibromatosis 2|neurofibromatosis 2
296516|NCT01885767|NF2|nf2
296517|NCT01885767|Schwannomatosis|schwannomatosis
296518|NCT01885754|Biopsy|biopsy
296519|NCT01885754|Maximal incremental cardiopulmonary test|maximal incremental cardiopulmonary test
296520|NCT01885754|Muscle strength test|muscle strength test
296521|NCT01885754|magnetic stimulation|magnetic stimulation
296522|NCT01885702|Dendritic cell vaccination|dendritic cell vaccination
296523|NCT01885702|MSI-high colorectal cancer (CRC)|msi-high colorectal cancer (crc)
296524|NCT01885702|Vaccines|vaccines
296525|NCT01885702|Immunotherapy|immunotherapy
296526|NCT01885702|CRC|crc
296527|NCT01885702|Germline MMR-gene mutation without disease criteria of CRC|germline mmr-gene mutation without disease criteria of crc
296528|NCT01885663|Umbilical cord blood|umbilical cord blood
296529|NCT01885663|Acquired brain injury|acquired brain injury
296530|NCT01885650|Non invasive ventilation|non invasive ventilation
296531|NCT01885650|Chest physiotherapy|chest physiotherapy
296532|NCT01885650|Airway clearance|airway clearance
296533|NCT01885637|Palliative|palliative
296534|NCT01885637|Palliation|palliation
296535|NCT01885637|Cancer|cancer
296536|NCT01885637|Care|care
296537|NCT01885637|SPC|spc
296538|NCT01885637|Caregivers|caregivers
296539|NCT01885637|Home Care Services, Hospital-Based|home care services, hospital-based
296540|NCT01885637|Psychological|psychological
296541|NCT01885637|From Oncological Treatment to Palliative Care at Home|from oncological treatment to palliative care at home
296542|NCT01885637|Place of death|place of death
296543|NCT01885624|TAB08|tab08
296544|NCT01885624|healthy volunteers|healthy volunteers
296545|NCT01885611|Leprosy|leprosy
296546|NCT01885572|breast reconstruction|breast reconstruction
296547|NCT01885572|mastectomy|mastectomy
296548|NCT01885572|mesh|mesh
296549|NCT01885572|breast cancer|breast cancer
296550|NCT01885559|polycystic kidney disease|polycystic kidney disease
296551|NCT01885559|polycystic|polycystic
296552|NCT01885559|kidney|kidney
296553|NCT01885559|disease|disease
296554|NCT01885559|adpkd|adpkd
296555|NCT01885559|halt|halt
296556|NCT01885559|pkd|pkd
296557|NCT01885559|blood pressure|blood pressure
296558|NCT01885559|bp|bp
296559|NCT01885559|hypertension|hypertension
296560|NCT01885559|renal|renal
296561|NCT01885559|renin-angiotensin-aldosterone-system|renin-angiotensin-aldosterone-system
296562|NCT01885559|RAAS|raas
296563|NCT01885546|diabetes|diabetes
296564|NCT01885546|glucose|glucose
296565|NCT01885546|glucometer|glucometer
296566|NCT01885533|Graves' disease|graves' disease
296567|NCT01885533|radioiodine|radioiodine
296568|NCT01885533|thyroid|thyroid
296569|NCT01885533|hypothyroidism|hypothyroidism
296570|NCT01885533|Graves' orbitopathy|graves' orbitopathy
296571|NCT01885520|low back pain|low back pain
296572|NCT01885481|dexamethasone|dexamethasone
296573|NCT01885481|betamethasone|betamethasone
296574|NCT01885481|epidural steroid injection|epidural steroid injection
296575|NCT01885481|comparative effectiveness research|comparative effectiveness research
296576|NCT01885468|Hydrocephalus shunt|hydrocephalus shunt
296577|NCT01885468|proGAV|progav
296578|NCT01885455|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
296579|NCT01885442|mechanical ventilation|mechanical ventilation
296580|NCT01885442|cycle ergometry|cycle ergometry
296581|NCT01885442|intensive care unit|intensive care unit
296582|NCT01885442|rehabilitation|rehabilitation
296583|NCT01885429|Protein Turnover|protein turnover
296584|NCT01885429|Resistance Exercise|resistance exercise
296585|NCT01885429|Whey Protein|whey protein
296586|NCT01885429|Leucine|leucine
296587|NCT01885403|Acute Cardiogenic Pulmonary Edema,|acute cardiogenic pulmonary edema,
296588|NCT01885403|Acute Decompensated Heart Failure,|acute decompensated heart failure,
296589|NCT01885403|BiLevel Positive Airway Pressure,|bilevel positive airway pressure,
296590|NCT01885403|Continuous Positive Airway Pressure|continuous positive airway pressure
296591|NCT01885390|Hypertension|hypertension
296592|NCT01885390|High blood pressure|high blood pressure
296593|NCT01885390|Resistant blood pressure|resistant blood pressure
296594|NCT01885390|Uncontrolled blood pressure|uncontrolled blood pressure
296595|NCT01885377|Subacromial pain|subacromial pain
296596|NCT01885377|Impingement|impingement
296597|NCT01885377|Exercises|exercises
296598|NCT01885377|Physical therapy|physical therapy
296599|NCT01885377|Primary care|primary care
296600|NCT01885364|esmolol|esmolol
296601|NCT01885364|pain|pain
296602|NCT01885364|propofol|propofol
296603|NCT01885364|remifentanil|remifentanil
296604|NCT01885351|Colorectal Cancer Screening|colorectal cancer screening
296605|NCT01885351|Ambulatory Care|ambulatory care
296606|NCT01885351|Patient-Centered Care|patient-centered care
296607|NCT01885351|Intervention Studies|intervention studies
296608|NCT01885351|Longitudinal Studies|longitudinal studies
296609|NCT01885338|Schizophrenia|schizophrenia
296610|NCT01885338|Cognition|cognition
296611|NCT01885338|Neurocognition|neurocognition
296612|NCT01885338|N-Acetylcysteine|n-acetylcysteine
296613|NCT01885338|NAC|nac
296614|NCT01885338|EEG|eeg
296615|NCT01885325|Physical Activity|physical activity
296616|NCT01885325|Sedentary Behavior|sedentary behavior
296617|NCT01885325|Preschool Children|preschool children
296618|NCT01885312|Drinking|drinking
296619|NCT01885312|Heavy Drinking|heavy drinking
296620|NCT01885312|Technology|technology
296621|NCT01885312|Mobile Phone|mobile phone
296622|NCT01885312|Text Message|text message
296623|NCT01885312|Problem Drinking|problem drinking
296624|NCT01885312|Alcohol Problems|alcohol problems
296625|NCT01885312|Alcoholism|alcoholism
296626|NCT01885312|Moderation-Oriented Treatment|moderation-oriented treatment
296627|NCT01885312|Controlled Drinking|controlled drinking
296628|NCT01885312|Reduced Drinking|reduced drinking
296629|NCT01885299|Radiosurgery|radiosurgery
296630|NCT01885299|CyberKnife|cyberknife
296631|NCT01885299|Benign tumors|benign tumors
296632|NCT01885299|Malignant tumors|malignant tumors
296633|NCT01885299|Cranial tumors|cranial tumors
296634|NCT01885299|Extracranial tumors|extracranial tumors
296635|NCT01885299|Lung|lung
296636|NCT01885299|Liver|liver
296637|NCT01885299|Pancreas|pancreas
296638|NCT01885299|Prostate|prostate
296639|NCT01885299|Stereotactic radiosurgery|stereotactic radiosurgery
296640|NCT01885299|Stereotactic body radiotherapy|stereotactic body radiotherapy
296641|NCT01885286|circumcision|circumcision
296642|NCT01885286|HIV prevention|hiv prevention
296643|NCT01885273|pressurized irrigation|pressurized irrigation
296644|NCT01885273|wound cleansing method|wound cleansing method
296645|NCT01885273|irrigation|irrigation
296646|NCT01885273|swabbing|swabbing
296647|NCT01885273|appropriate pressure for irrigation|appropriate pressure for irrigation
296648|NCT01885260|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
296649|NCT01885260|T2DM|t2dm
296650|NCT01885234|Glycated hemoglobin|glycated hemoglobin
296651|NCT01885234|HOMA|homa
296652|NCT01885234|Pregnancy|pregnancy
296653|NCT01885234|aerobic exercise|aerobic exercise
296654|NCT01885221|smokeless tobacco cessation|smokeless tobacco cessation
296655|NCT01885221|social support|social support
296656|NCT01885221|partner support|partner support
296657|NCT01885195|RAS, RAF, MEK, NF1, MEK162, signature, papillary thyroid, small intestine, bladder, esophagus, lung cancer, NSCLC, acute myelogenous leukemia, AML|ras, raf, mek, nf1, mek162, signature, papillary thyroid, small intestine, bladder, esophagus, lung cancer, nsclc, acute myelogenous leukemia, aml
296658|NCT01885169|Cystic fibrosis|cystic fibrosis
296659|NCT01885169|Influenza|influenza
296661|NCT01885143|Mammography|mammography
296662|NCT01885117|Influenza,|influenza,
296663|NCT01885117|Adults,|adults,
296664|NCT01885117|Elderly,|elderly,
296665|NCT01885117|Immunology,|immunology,
296666|NCT01885117|Safety|safety
296667|NCT01885052|Smoking Cessation Clinical Trial|smoking cessation clinical trial
296668|NCT01885052|Text Messaging Program|text messaging program
296669|NCT01885052|Smoking Cessation Aid|smoking cessation aid
296670|NCT01885039|Cancer|cancer
296671|NCT01885039|Breast Cancer|breast cancer
296672|NCT01885039|Molecular Subtypes|molecular subtypes
296673|NCT01885039|Asian Breast Cancer|asian breast cancer
296674|NCT01885026|Randomized Controlled Trial|randomized controlled trial
296675|NCT01885026|Alcohol|alcohol
296676|NCT01885026|Drugs|drugs
296677|NCT01885026|Internet|internet
296678|NCT01885026|Screening|screening
296679|NCT01885026|Brief intervention|brief intervention
296680|NCT01885013|HER2 negative|her2 negative
296681|NCT01885013|metastatic breast cancer|metastatic breast cancer
296682|NCT01885013|non endocrine responsive disease|non endocrine responsive disease
296683|NCT01884974|Myeloproliferative disease|myeloproliferative disease
296684|NCT01884974|Pulmonary Hypertension|pulmonary hypertension
296685|NCT01884948|at least 1 segment|at least 1 segment
296686|NCT01884948|multiple wedge resections (≥3)|multiple wedge resections (≥3)
296687|NCT01884935|Pediatric|pediatric
296688|NCT01884922|Children|children
296689|NCT01884922|adolescents|adolescents
296690|NCT01884922|young adults|young adults
296691|NCT01884870|Asymptomatic|asymptomatic
296692|NCT01884870|ureteral|ureteral
296693|NCT01884870|calculi|calculi
296694|NCT01884870|renal function|renal function
296695|NCT01884870|treatment|treatment
296696|NCT01884831|damage to the skin, the skin equivalent, cell therapy|damage to the skin, the skin equivalent, cell therapy
296697|NCT01884818|Thoracic spine, pain, manipulation|thoracic spine, pain, manipulation
296698|NCT01884805|Adaptive Optics Visual Simulator|adaptive optics visual simulator
296699|NCT01884805|Wavefront aberrometer|wavefront aberrometer
296700|NCT01884805|Optical Aberrations|optical aberrations
296701|NCT01884805|Hyperopia|hyperopia
296702|NCT01884792|prediabetes|prediabetes
296703|NCT01884792|physical inactivity|physical inactivity
296704|NCT01884792|sedentary|sedentary
296705|NCT01884792|standing|standing
296706|NCT01884779|HIV|hiv
296707|NCT01884779|Histoplasmosis|histoplasmosis
296708|NCT01884779|Histoplasma capsulatum var.capsulatum|histoplasma capsulatum var.capsulatum
296709|NCT01884779|ELISA test|elisa test
296710|NCT01884753|lower urinary tract symptoms|lower urinary tract symptoms
296711|NCT01884753|overactive bladder syndrome|overactive bladder syndrome
296712|NCT01884753|antimuscarinic drug|antimuscarinic drug
296713|NCT01884753|three-dimensional power Doppler ultrasound|three-dimensional power doppler ultrasound
296714|NCT01884753|sexual dysfunction|sexual dysfunction
296715|NCT01884740|GBM|gbm
296716|NCT01884740|AA|aa
296717|NCT01884740|FA|fa
296718|NCT01884740|PXA|pxa
296719|NCT01884740|AOA|aoa
296720|NCT01884740|High grade glioma|high grade glioma
296721|NCT01884727|Obesity|obesity
296722|NCT01884727|Overweight|overweight
296723|NCT01884727|Over nutrition|over nutrition
296724|NCT01884727|nutrition disorders|nutrition disorders
296725|NCT01884727|energy expenditure|energy expenditure
296726|NCT01884727|metabolic rate|metabolic rate
296727|NCT01884714|diabetes|diabetes
296728|NCT01884714|obesity|obesity
296729|NCT01884714|metabolism|metabolism
296730|NCT01884714|clinical study|clinical study
296731|NCT01884701|Chronic Total Occlusion CTO|chronic total occlusion cto
296732|NCT01884688|Asymptomatic Multiple Myeloma|asymptomatic multiple myeloma
296733|NCT01884688|Auto-ENK Cell Therapy|auto-enk cell therapy
296734|NCT01884688|Natural Killer Cells|natural killer cells
296735|NCT01884675|Endothelin Receptor Antagonist|endothelin receptor antagonist
296736|NCT01884675|Inoperable Chronic Thromboembolic Pulmonary Hypertension|inoperable chronic thromboembolic pulmonary hypertension
296737|NCT01884662|spinal cord injury|spinal cord injury
296738|NCT01884662|neuropathic pain|neuropathic pain
296739|NCT01884649|Acute phase reactant, fetuin A, Hashimoto thyroiditis|acute phase reactant, fetuin a, hashimoto thyroiditis
296740|NCT01884636|Isavuconazole|isavuconazole
296741|NCT01884636|Pharmacokinetics|pharmacokinetics
296742|NCT01884636|Healthy Subjects|healthy subjects
296743|NCT01884636|BAL8557|bal8557
296744|NCT01884636|BAL4815|bal4815
296745|NCT01884636|methotrexate|methotrexate
296746|NCT01884597|PEARL2|pearl2
296747|NCT01884597|PCV|pcv
296748|NCT01884597|Polypoidal Choroidal Vasculopathy|polypoidal choroidal vasculopathy
296749|NCT01884571|Immunosuppression|immunosuppression
296750|NCT01884571|ALS|als
296751|NCT01884571|Neuromuscular Disorders|neuromuscular disorders
296752|NCT01884558|Isavuconazole|isavuconazole
296753|NCT01884558|Pharmacokinetics|pharmacokinetics
296754|NCT01884558|Healthy Subjects|healthy subjects
296755|NCT01884558|BAL8557|bal8557
296756|NCT01884558|BAL4815|bal4815
296757|NCT01884558|metformin|metformin
296758|NCT01884545|heart disease|heart disease
296759|NCT01884545|type 2 diabetes|type 2 diabetes
296760|NCT01884545|genetic testing|genetic testing
296761|NCT01884545|health coaching|health coaching
296762|NCT01884545|risk assessment|risk assessment
296763|NCT01884532|Adverse Local Tissue Reaction|adverse local tissue reaction
296764|NCT01884532|Metal Ions|metal ions
296765|NCT01884532|Serum|serum
296766|NCT01884532|Whole Blood|whole blood
296767|NCT01884532|Metal-on-Metal|metal-on-metal
296768|NCT01884532|Total Hip Arthroplasty|total hip arthroplasty
296769|NCT01884532|ASR-XL Metal-on-Metal|asr-xl metal-on-metal
296770|NCT01884532|Revised ASR-XL Metal-on-Metal|revised asr-xl metal-on-metal
296771|NCT01884519|Elderly|elderly
296772|NCT01884519|Influenza|influenza
296773|NCT01884519|Safety|safety
296774|NCT01884519|Adults|adults
296775|NCT01884519|Immunogenicity|immunogenicity
296776|NCT01884493|Parkinson's Disease|parkinson's disease
296777|NCT01884493|Freezing of Gait|freezing of gait
296778|NCT01884493|movement-related cortical potential|movement-related cortical potential
296779|NCT01884493|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
296780|NCT01884480|Advagraf, pharmacogenetics, Cyp3A5|advagraf, pharmacogenetics, cyp3a5
296781|NCT01884467|Urinary Tract Infections|urinary tract infections
296782|NCT01884467|Gentamicin|gentamicin
296783|NCT01884454|sleep|sleep
296784|NCT01884454|obstructive sleep apnea|obstructive sleep apnea
296785|NCT01884454|reproduction|reproduction
296786|NCT01884454|sperm|sperm
296787|NCT01884454|hormones|hormones
296788|NCT01884454|men|men
296789|NCT01884441|Hodgkin|hodgkin
296790|NCT01884441|Lymphoma|lymphoma
296791|NCT01884441|refractory|refractory
296792|NCT01884441|relapsed|relapsed
296793|NCT01884428|Hodgkin|hodgkin
296794|NCT01884428|Lymphoma|lymphoma
296795|NCT01884389|HIV|hiv
296796|NCT01884389|Chronic disease|chronic disease
296797|NCT01884389|Early palliative care|early palliative care
296798|NCT01884389|Patient navigation|patient navigation
296799|NCT01884376|nerve biopsy|nerve biopsy
296800|NCT01884376|nerve regeneration|nerve regeneration
296801|NCT01884376|neuroma pain|neuroma pain
296802|NCT01884376|loss of sensation|loss of sensation
296803|NCT01884363|Endothelial function|endothelial function
296804|NCT01884363|walnuts|walnuts
296805|NCT01884363|clinical trial|clinical trial
296806|NCT01884363|Nutrition|nutrition
296807|NCT01884363|cardiovascular disease|cardiovascular disease
296808|NCT01884324|Gastroschisis|gastroschisis
296809|NCT01884324|Cesarean delivery|cesarean delivery
296810|NCT01884324|Neonatal outcomes|neonatal outcomes
296811|NCT01884311|Primary Immune Deficiency Disorders|primary immune deficiency disorders
296812|NCT01884311|Common Variable Immunodeficiency|common variable immunodeficiency
296813|NCT01884311|X-linked agammaglobulinaemia|x-linked agammaglobulinaemia
296814|NCT01884311|Hyper-IgM Syndrome|hyper-igm syndrome
296815|NCT01884311|Subcutaneous|subcutaneous
296816|NCT01884311|Immunoglobulins|immunoglobulins
296817|NCT01884298|remifentanil|remifentanil
296818|NCT01884298|isolated systolic hypertension|isolated systolic hypertension
296819|NCT01884298|morbidity|morbidity
296820|NCT01884298|epidural combined general anesthesia|epidural combined general anesthesia
296821|NCT01884285|Advanced Castrate-resistant Prostate Cancer(CRPC)|advanced castrate-resistant prostate cancer(crpc)
296822|NCT01884285|Squamous Non-Small Cell Lung Cancer(sqNSCLC)|squamous non-small cell lung cancer(sqnsclc)
296823|NCT01884285|Triple Negative Breast Cancer(TNBC)|triple negative breast cancer(tnbc)
296824|NCT01884285|PTEN-deficient/mutated Advanced Solid Malignancies|pten-deficient/mutated advanced solid malignancies
296825|NCT01884285|PIK3CB mutated/amplified advanced solid malignancies|pik3cb mutated/amplified advanced solid malignancies
296826|NCT01884259|local advanced squamous cell carcinoma|local advanced squamous cell carcinoma
296827|NCT01884259|Larynx|larynx
296828|NCT01884259|Hypopharynx|hypopharynx
296829|NCT01884259|Oropharynx|oropharynx
296830|NCT01884259|Cavum oris|cavum oris
296831|NCT01884259|docetaxel|docetaxel
296832|NCT01884259|cisplatin|cisplatin
296833|NCT01884259|5-fluorouracil|5-fluorouracil
296834|NCT01884259|Cetuximab|cetuximab
296835|NCT01884246|lifestyle change|lifestyle change
296836|NCT01884246|behavior change|behavior change
296837|NCT01884246|obesity|obesity
296838|NCT01884246|hypertension|hypertension
296839|NCT01884246|hyperlipidemia|hyperlipidemia
297532|NCT01881373|Food|food
296840|NCT01884246|physical inactivity|physical inactivity
296841|NCT01884246|depression|depression
296842|NCT01884233|HIV|hiv
296843|NCT01884233|Opioid Abuse|opioid abuse
296844|NCT01884233|Mobile technology|mobile technology
296845|NCT01884220|Wolman Disease|wolman disease
296846|NCT01884220|Cholesteryl Ester Storage Disease|cholesteryl ester storage disease
296847|NCT01884220|Enzyme deficiency|enzyme deficiency
296848|NCT01884220|Natural History|natural history
296849|NCT01884220|Medical Records Review|medical records review
296850|NCT01884194|retinoblastoma|retinoblastoma
296851|NCT01884194|pineoblastoma|pineoblastoma
296852|NCT01884181|Huntington Disease, diffusion MRI, diagnosis, fast imaging|huntington disease, diffusion mri, diagnosis, fast imaging
296853|NCT01884129|Circulating tumor cells|circulating tumor cells
296854|NCT01884129|Head and neck cancer|head and neck cancer
296855|NCT01884129|Squamous cell carcinoma|squamous cell carcinoma
296856|NCT01884129|Survival|survival
296857|NCT01884129|Prognosis|prognosis
296858|NCT01884116|Capsaicin|capsaicin
296859|NCT01884116|myofascial pain syndrome|myofascial pain syndrome
296860|NCT01884116|non-steroidal anti-inflammatory agents|non-steroidal anti-inflammatory agents
296861|NCT01884116|transcutaneous electric nerve stimulation|transcutaneous electric nerve stimulation
296862|NCT01884103|TBI|tbi
296863|NCT01884103|Trauma|trauma
296864|NCT01884103|Traumatic Brain Injury|traumatic brain injury
296865|NCT01884090|Empowerment|empowerment
296866|NCT01884090|Youth|youth
296867|NCT01884090|Violence|violence
296868|NCT01884090|Community|community
296869|NCT01884090|Prevention|prevention
296870|NCT01884077|patient outcomes two years after shoulder replacement|patient outcomes two years after shoulder replacement
296871|NCT01884077|seventy years of age and older|seventy years of age and older
296872|NCT01884064|focal hand dystonia|focal hand dystonia
296873|NCT01884064|rehabilitation|rehabilitation
296874|NCT01884064|rTMS|rtms
296875|NCT01884064|writer's cramp|writer's cramp
296876|NCT01884064|clinical|clinical
296877|NCT01884051|Pulmonary arterial hypertension|pulmonary arterial hypertension
296878|NCT01884038|Liver Transplant|liver transplant
296879|NCT01884038|Prostacyclin|prostacyclin
296880|NCT01884038|Treprostinil sodium|treprostinil sodium
296881|NCT01884038|Remodulin|remodulin
296882|NCT01884038|Reperfusion Injury|reperfusion injury
296883|NCT01884038|Primary Nonfunction|primary nonfunction
296884|NCT01884025|patient centered care|patient centered care
296885|NCT01884025|physical activity|physical activity
296886|NCT01884025|behavioral activation|behavioral activation
296887|NCT01884025|self efficacy|self efficacy
296888|NCT01884025|serious mental illness|serious mental illness
296889|NCT01883986|palliative care|palliative care
296890|NCT01883973|PD|pd
296891|NCT01883973|DBS|dbs
296892|NCT01883960|cerebral palsy|cerebral palsy
296893|NCT01883960|cerebral vascular accident|cerebral vascular accident
296894|NCT01883960|multi-modal brain techniques|multi-modal brain techniques
296895|NCT01883960|MRI|mri
296896|NCT01883960|motor control|motor control
296897|NCT01883947|Stroke|stroke
296898|NCT01883947|Massage|massage
296899|NCT01883947|General Health|general health
296900|NCT01883947|Independence|independence
297148|NCT01883076|Stage II Glenn|stage ii glenn
296901|NCT01883934|In Vitro Fertilization (IVF)|in vitro fertilization (ivf)
296902|NCT01883934|Embryo donation|embryo donation
296903|NCT01883921|Primary Immunodeficiency|primary immunodeficiency
296904|NCT01883921|Immunodeficiencies|immunodeficiencies
296905|NCT01883921|Primary Immunodeficiency Diseases|primary immunodeficiency diseases
296906|NCT01883921|PIDD|pidd
296907|NCT01883921|CVID|cvid
296908|NCT01883921|PI|pi
296909|NCT01883921|Common Variable Immunodeficiency|common variable immunodeficiency
296910|NCT01883921|Hypogammaglobulinemia|hypogammaglobulinemia
296911|NCT01883921|Acquired Hypogammaglobulinemia|acquired hypogammaglobulinemia
296912|NCT01883921|Immunology|immunology
296913|NCT01883921|Autoimmune Deficiency|autoimmune deficiency
296914|NCT01883921|Intravenous Immunoglobulin|intravenous immunoglobulin
296915|NCT01883921|Subcutaneous Immunoglobulin|subcutaneous immunoglobulin
296916|NCT01883921|IVIg|ivig
296917|NCT01883921|SCIg|scig
296918|NCT01883921|Immune Globulin|immune globulin
296919|NCT01883921|Outcomes Research|outcomes research
296920|NCT01883921|Immunodeficiency|immunodeficiency
296921|NCT01883908|Acupuncture therapy|acupuncture therapy
296922|NCT01883908|Mucositis|mucositis
296923|NCT01883908|oropharyngeal cancer|oropharyngeal cancer
296924|NCT01883895|Pain|pain
296925|NCT01883895|exercise-induced hypoalgesia|exercise-induced hypoalgesia
296926|NCT01883882|chronic non-cancer pain|chronic non-cancer pain
296927|NCT01883882|opioid taper|opioid taper
296928|NCT01883882|chronic pain self-management|chronic pain self-management
296929|NCT01883882|motivational interviewing|motivational interviewing
296930|NCT01883869|Platelet inhibition|platelet inhibition
296931|NCT01883869|Platelet-leukocyte aggregates|platelet-leukocyte aggregates
296932|NCT01883869|Platelet-neutrophil aggregates|platelet-neutrophil aggregates
296933|NCT01883869|CAP|cap
296934|NCT01883869|HAP|hap
296935|NCT01883869|ALI|ali
296936|NCT01883869|Blood Platelets|blood platelets
296937|NCT01883856|Refractory Glaucoma|refractory glaucoma
296938|NCT01883856|Intractable Glaucoma|intractable glaucoma
296939|NCT01883856|Primary Open Angle Glaucoma|primary open angle glaucoma
296940|NCT01883856|Neovascular Glaucoma|neovascular glaucoma
296941|NCT01883843|Chronic Stroke|chronic stroke
296942|NCT01883843|tDCS|tdcs
296943|NCT01883843|transcranial direct current stimulation|transcranial direct current stimulation
296944|NCT01883843|task oriented circuit training|task oriented circuit training
296945|NCT01883843|TOCT|toct
296946|NCT01883843|gait training|gait training
296947|NCT01883830|traumatic brain injury (TBI)|traumatic brain injury (tbi)
296948|NCT01883830|balance disorders|balance disorders
296949|NCT01883830|attention deficits|attention deficits
296950|NCT01883830|x-box|x-box
296951|NCT01883830|gaming|gaming
296952|NCT01883830|virtual reality|virtual reality
296953|NCT01883817|ADHD|adhd
296954|NCT01883804|Diabetes|diabetes
296955|NCT01883804|Diabetes Mellitus|diabetes mellitus
296956|NCT01883804|Type 1 Diabetes|type 1 diabetes
296957|NCT01883791|substance abuse prevention and treatment|substance abuse prevention and treatment
296958|NCT01883791|comorbidity|comorbidity
296959|NCT01883791|SBIRT|sbirt
296960|NCT01883778|Attitudes of health personnel|attitudes of health personnel
296961|NCT01883778|Attitudes of patients|attitudes of patients
296962|NCT01883778|Medical compliance|medical compliance
296963|NCT01883778|Cost awareness|cost awareness
296964|NCT01883778|Cost analysis|cost analysis
296965|NCT01883778|Patient knowledge|patient knowledge
296966|NCT01883778|Physician knowledge|physician knowledge
296967|NCT01883778|Medical economics|medical economics
296968|NCT01883778|Policy|policy
296969|NCT01883778|Questionnaires|questionnaires
296970|NCT01883778|Health literacy|health literacy
296971|NCT01883765|ADHD, Neurofeedback, CBT|adhd, neurofeedback, cbt
296972|NCT01883752|Goal-directed fluid therapy|goal-directed fluid therapy
296973|NCT01883739|Parental anxiety|parental anxiety
296974|NCT01883739|Children's safety|children's safety
296975|NCT01883739|Family Centered Care|family centered care
296976|NCT01883739|Bedside Transfer Rounds|bedside transfer rounds
296977|NCT01883739|Pediatric Cardiac Intensive Care|pediatric cardiac intensive care
296978|NCT01883726|Unilateral complete cleft lip, Nasoalveolar molding|unilateral complete cleft lip, nasoalveolar molding
296979|NCT01883713|anemia|anemia
296980|NCT01883713|CPB|cpb
296981|NCT01883713|methemoglobin|methemoglobin
296982|NCT01883713|hypoxia|hypoxia
296983|NCT01883700|Healthy|healthy
296984|NCT01883700|Glycemic Index|glycemic index
296985|NCT01883700|Glycemic Load|glycemic load
296986|NCT01883700|Blood Glucose|blood glucose
296987|NCT01883700|Arterial Stiffness|arterial stiffness
296988|NCT01883674|Sarcopenia|sarcopenia
296989|NCT01883674|Physical capacity|physical capacity
296990|NCT01883674|Muscle force|muscle force
296991|NCT01883674|Muscle quality|muscle quality
296992|NCT01883674|Milk proteins|milk proteins
296993|NCT01883674|Essential amino acids|essential amino acids
296994|NCT01883674|Proteins|proteins
296995|NCT01883674|Resistance training|resistance training
296996|NCT01883674|Exercise|exercise
296997|NCT01883661|stem cell|stem cell
296998|NCT01883661|Multiple Sclerosis|multiple sclerosis
296999|NCT01883661|BMMNC|bmmnc
297000|NCT01883648|Mild to Moderate Alzheimer's disease|mild to moderate alzheimer's disease
297001|NCT01883622|diabetes|diabetes
297002|NCT01883622|pregnancy|pregnancy
297003|NCT01883622|glucose variability|glucose variability
297004|NCT01883622|continuous glucose monitoring (CGM)|continuous glucose monitoring (cgm)
297005|NCT01883622|gestational diabetes mellitus (GDM)|gestational diabetes mellitus (gdm)
297006|NCT01883609|Plasmodium Falciparum|plasmodium falciparum
297007|NCT01883609|Malaria|malaria
297008|NCT01883609|Vaccine|vaccine
297009|NCT01883609|Plasmodium|plasmodium
297010|NCT01883609|Falciparum|falciparum
297011|NCT01883583|Ultrasound|ultrasound
297012|NCT01883583|Perfusion Imaging|perfusion imaging
297013|NCT01883583|Elasticity Imaging Techniques|elasticity imaging techniques
297014|NCT01883583|Kidney Transplantation|kidney transplantation
297015|NCT01883583|Graft Rejection|graft rejection
297016|NCT01883583|Chronic allograft nephropathy|chronic allograft nephropathy
297017|NCT01883570|visual search strategy, training, chest x-ray|visual search strategy, training, chest x-ray
297018|NCT01883544|Safety|safety
297019|NCT01883544|Tolerability|tolerability
297020|NCT01883544|Pharmacokinetics|pharmacokinetics
297021|NCT01883544|Pharmacodynamics|pharmacodynamics
297022|NCT01883544|ALXN1007|alxn1007
297023|NCT01883544|Healthy Male and Female Subjects|healthy male and female subjects
297024|NCT01883531|improving lung function|improving lung function
297025|NCT01883531|paediatric and adolescent|paediatric and adolescent
297026|NCT01883531|FEV1|fev1
297027|NCT01883518|Fibrosarcoma|fibrosarcoma
297028|NCT01883518|Neurofibrosarcoma|neurofibrosarcoma
297029|NCT01883518|Histiocytoma|histiocytoma
297030|NCT01883518|Histiocytoma, Malignant Fibrous|histiocytoma, malignant fibrous
297031|NCT01883518|Chondrosarcoma|chondrosarcoma
297032|NCT01883518|Synovial Sarcoma|synovial sarcoma
297033|NCT01883518|Leiomyosarcoma|leiomyosarcoma
297034|NCT01883518|Liposarcoma|liposarcoma
297036|NCT01883518|Rhabdomyosarcoma|rhabdomyosarcoma
297037|NCT01883518|Sarcoma, Alveolar Soft Part|sarcoma, alveolar soft part
297038|NCT01883518|NY-ESO-1|ny-eso-1
297039|NCT01883518|MAGE|mage
297040|NCT01883518|MAGE A3|mage a3
297041|NCT01883518|Vaccine|vaccine
297042|NCT01883518|Immunotherapy|immunotherapy
297043|NCT01883505|Motor fluctuations|motor fluctuations
297044|NCT01883505|levodopa pharmacokinetics|levodopa pharmacokinetics
297045|NCT01883505|levodopa and carbidopa solution|levodopa and carbidopa solution
297046|NCT01883505|continuous subcutaneous delivery|continuous subcutaneous delivery
297047|NCT01883505|Patch-pump|patch-pump
297048|NCT01883492|Only Female|only female
297049|NCT01883492|Age between 20 - 75 at the time of operation|age between 20 - 75 at the time of operation
297050|NCT01883466|Air Pollution|air pollution
297051|NCT01883466|Biodiesel exhaust|biodiesel exhaust
297052|NCT01883466|Diesel exhaust|diesel exhaust
297053|NCT01883466|Vascular function|vascular function
297054|NCT01883466|Fibrinolysis|fibrinolysis
297055|NCT01883466|Acute endothelial responses|acute endothelial responses
297056|NCT01883440|Duration|duration
297057|NCT01883427|Days with URTI symptoms|days with urti symptoms
297058|NCT01883414|Ulthera, Ultherapy, Surgical scar, scar,|ulthera, ultherapy, surgical scar, scar,
297059|NCT01883401|Strawberries|strawberries
297060|NCT01883401|Heart health|heart health
297061|NCT01883401|Anthocyanins|anthocyanins
297062|NCT01883388|Lung Cancer|lung cancer
297063|NCT01883388|blood sample|blood sample
297064|NCT01883375|Palliative Care|palliative care
297065|NCT01883375|Family|family
297066|NCT01883375|adaptation, psychological|adaptation, psychological
297067|NCT01883362|acute myeloid leukemia|acute myeloid leukemia
297068|NCT01883362|AML|aml
297069|NCT01883362|FLT3-ITD|flt3-itd
297070|NCT01883362|midostaurin|midostaurin
297071|NCT01883362|PKC412|pkc412
297072|NCT01883362|allogeneic hematopoeitic stem cell tranplant|allogeneic hematopoeitic stem cell tranplant
297073|NCT01883362|SCT|sct
297074|NCT01883362|HSCT|hsct
297075|NCT01883362|CR1|cr1
297076|NCT01883336|Incidental pancreatic cysts|incidental pancreatic cysts
297077|NCT01883323|Measurable|measurable
297078|NCT01883323|Unresectable|unresectable
297079|NCT01883323|Stage III|stage iii
297080|NCT01883323|Stage IV|stage iv
297081|NCT01883323|Metastatic|metastatic
297082|NCT01883323|Melanoma|melanoma
297083|NCT01883323|Tumor-Infiltrating Lymphocytes|tumor-infiltrating lymphocytes
297084|NCT01883323|Low-Dose Interleukin-2|low-dose interleukin-2
297085|NCT01883323|Cyclophosphamide|cyclophosphamide
297086|NCT01883323|Fludarabine|fludarabine
297087|NCT01883310|Multiple Sclerosis|multiple sclerosis
297088|NCT01883310|transcranial direct current stimulation|transcranial direct current stimulation
297089|NCT01883310|TOCT|toct
297090|NCT01883310|task-oriented circuit training|task-oriented circuit training
297091|NCT01883310|locomotor function|locomotor function
297092|NCT01883310|mobility|mobility
297093|NCT01883310|balance|balance
297094|NCT01883297|Measurable|measurable
297095|NCT01883297|Recurrent|recurrent
297096|NCT01883297|Platinum resistant|platinum resistant
297097|NCT01883297|Tumor-Infiltrating Lymphocytes|tumor-infiltrating lymphocytes
297098|NCT01883297|Low-Dose Interleukin-2|low-dose interleukin-2
297099|NCT01883297|Autologous dendritic cells|autologous dendritic cells
297100|NCT01883297|Anti-CD3 monoclonal antibody|anti-cd3 monoclonal antibody
297101|NCT01883297|High grade serous ovarian, fallopian tube, or primary peritoneal cancer|high grade serous ovarian, fallopian tube, or primary peritoneal cancer
297102|NCT01883297|Cyclophosphamide|cyclophosphamide
297103|NCT01883284|Cystic Fibrosis|cystic fibrosis
297104|NCT01883284|nasal epithelia|nasal epithelia
297105|NCT01883284|mucins|mucins
297106|NCT01883245|Orofacial chronic pain|orofacial chronic pain
297107|NCT01883245|tDCS|tdcs
297108|NCT01883245|Transcranial direct current stimulation|transcranial direct current stimulation
297109|NCT01883245|Brain stimulation|brain stimulation
297110|NCT01883219|Philadelphia chromosome|philadelphia chromosome
297111|NCT01883219|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
297112|NCT01883219|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
297113|NCT01883219|Minimal residual disease|minimal residual disease
297114|NCT01883219|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
297115|NCT01883206|Cytomegalovirus|cytomegalovirus
297116|NCT01883193|preconception maternal nutrition|preconception maternal nutrition
297117|NCT01883193|LBW|lbw
297118|NCT01883193|Length-for-age|length-for-age
297119|NCT01883193|maternal nutrition supplement|maternal nutrition supplement
297120|NCT01883193|multi-micronutrient fortified lipid-based supplement|multi-micronutrient fortified lipid-based supplement
297121|NCT01883193|infant growth|infant growth
297122|NCT01883193|low-resource settings|low-resource settings
297123|NCT01883180|haploidentical hematopoietic Stem Cell Transplantation|haploidentical hematopoietic stem cell transplantation
297124|NCT01883180|Antithymocyte globulin|antithymocyte globulin
297125|NCT01883180|viral infection|viral infection
297126|NCT01883128|Biochemical Failure|biochemical failure
297127|NCT01883128|Radiotherapy|radiotherapy
297128|NCT01883128|Radiorecurrent Prostate Cancer|radiorecurrent prostate cancer
297129|NCT01883128|MRI Prostate|mri prostate
297130|NCT01883128|Whole Body MRI|whole body mri
297131|NCT01883128|Bone Scan|bone scan
297132|NCT01883128|Choline PET|choline pet
297133|NCT01883128|Focal Salvage Treatment|focal salvage treatment
297134|NCT01883128|HIFU|hifu
297135|NCT01883128|Cryotherapy|cryotherapy
297136|NCT01883115|Telescopic extraperitoneal dissection|telescopic extraperitoneal dissection
297137|NCT01883115|Single incision laparosocpic surgery|single incision laparosocpic surgery
297138|NCT01883115|Inguinal hernia|inguinal hernia
297139|NCT01883115|Triport system|triport system
297140|NCT01883076|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
297141|NCT01883076|HLHS|hlhs
297142|NCT01883076|Congenital Heart Disease|congenital heart disease
297143|NCT01883076|Umbilical cord blood|umbilical cord blood
297144|NCT01883076|UCB|ucb
297145|NCT01883076|Cord blood|cord blood
297146|NCT01883076|Stem cells|stem cells
297147|NCT01883076|Regenerative therapy|regenerative therapy
297149|NCT01883076|Glenn Surgery|glenn surgery
297150|NCT01883050|Coronary artery disease|coronary artery disease
297151|NCT01883050|Percutaneous Intervention|percutaneous intervention
297152|NCT01883050|Stent|stent
297153|NCT01883050|Balloon angioplasty|balloon angioplasty
297154|NCT01883050|Angiogram|angiogram
297155|NCT01883050|Coronary angiogram|coronary angiogram
297156|NCT01883037|Cystic Fibrosis|cystic fibrosis
297157|NCT01883037|Cystic Fibrosis related diabetes|cystic fibrosis related diabetes
297158|NCT01883037|Oral glucose tolerance test|oral glucose tolerance test
297159|NCT01883024|Real time continuous glucose monitoring, decision support software, smartphone application.|real time continuous glucose monitoring, decision support software, smartphone application.
297160|NCT01883011|Piracetam|piracetam
297161|NCT01883011|Stroke|stroke
297162|NCT01883011|Aphasia|aphasia
297163|NCT01883011|Acute|acute
297164|NCT01883011|Cerebral|cerebral
297165|NCT01883011|Ischemic|ischemic
297166|NCT01883011|Nootropil|nootropil
297167|NCT01882998|HIV and pregnancy|hiv and pregnancy
297168|NCT01882998|HIV and breastfeeding|hiv and breastfeeding
297169|NCT01882998|Mother-to-child transmission of HIV|mother-to-child transmission of hiv
297170|NCT01882998|Africa|africa
297171|NCT01882998|Uganda|uganda
297172|NCT01882985|docetaxel|docetaxel
297173|NCT01882985|lycopene|lycopene
297174|NCT01882985|prostate cancer|prostate cancer
297175|NCT01882933|Gastric adenocarcinoma|gastric adenocarcinoma
297176|NCT01882933|HIPEC|hipec
297177|NCT01882933|Oxaliplatin|oxaliplatin
297178|NCT01882933|Signet ring cell|signet ring cell
297179|NCT01882920|Cytoreductive surgery|cytoreductive surgery
297180|NCT01882920|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
297181|NCT01882920|Goal directed fluid therapy|goal directed fluid therapy
297182|NCT01882907|vildagliptin|vildagliptin
297183|NCT01882907|metformin|metformin
297184|NCT01882894|Plantar fasciitis, orthotic, functional outcome|plantar fasciitis, orthotic, functional outcome
297185|NCT01882842|Infertility|infertility
297186|NCT01882842|Endometrium|endometrium
297187|NCT01882842|Live birth|live birth
297188|NCT01882829|depression|depression
297189|NCT01882829|major depressive disorder|major depressive disorder
297190|NCT01882829|treatment resistant|treatment resistant
297191|NCT01882829|Nuedexta|nuedexta
297192|NCT01882829|dextromethorphan|dextromethorphan
297193|NCT01882829|antidepressant|antidepressant
297194|NCT01882829|glutamate|glutamate
297195|NCT01882829|NMDA receptor|nmda receptor
297196|NCT01882816|non-anaplastic|non-anaplastic
297197|NCT01882816|non-medullary|non-medullary
297198|NCT01882816|radiation|radiation
297199|NCT01882816|IMRT|imrt
297200|NCT01882816|Doxorubicin|doxorubicin
297201|NCT01882816|13-070|13-070
297202|NCT01882803|PI3K Inhibitor|pi3k inhibitor
297203|NCT01882790|coronary artery spasm|coronary artery spasm
297204|NCT01882790|hypertension|hypertension
297205|NCT01882790|Pathophysiology|pathophysiology
297206|NCT01882790|atrioventricular block|atrioventricular block
297207|NCT01882790|blood pressure|blood pressure
297208|NCT01882790|autonomic nervous function|autonomic nervous function
297209|NCT01882751|kinematics|kinematics
297210|NCT01882751|knee joint|knee joint
297211|NCT01882738|Cervical length|cervical length
297212|NCT01882738|BMI|bmi
297213|NCT01882699|Insomnia|insomnia
297214|NCT01882686|Pain|pain
297215|NCT01882686|Back Pain|back pain
297216|NCT01882686|Low Back Pain|low back pain
297217|NCT01882686|Chronic Low Back Pain|chronic low back pain
297218|NCT01882686|Cognitive Functional Therapy|cognitive functional therapy
297219|NCT01882686|Intervention|intervention
297220|NCT01882686|Subclassification|subclassification
297221|NCT01882686|Multidimensional|multidimensional
297222|NCT01882673|Tobacco|tobacco
297223|NCT01882673|nicotine|nicotine
297224|NCT01882673|dependence|dependence
297225|NCT01882673|quitline|quitline
297226|NCT01882647|psoriasis|psoriasis
297227|NCT01882647|lotion|lotion
297228|NCT01882647|investigator's global assessment|investigator's global assessment
297229|NCT01882621|NSCLC|nsclc
297230|NCT01882621|Monosialoganglioside(GM1)|monosialoganglioside(gm1)
297231|NCT01882621|neurotoxicity|neurotoxicity
297232|NCT01882608|psychiatry|psychiatry
297233|NCT01882608|mental health|mental health
297234|NCT01882608|mood disorders|mood disorders
297235|NCT01882608|mood diaries|mood diaries
297236|NCT01882608|electronic diaries|electronic diaries
297237|NCT01882608|cell phones|cell phones
297238|NCT01882608|software|software
297239|NCT01882608|mental health telemetry|mental health telemetry
297240|NCT01882608|ecological momentary assessment|ecological momentary assessment
297241|NCT01882595|Nebulization aerosol nebulizer tracheostomy|nebulization aerosol nebulizer tracheostomy
297242|NCT01882556|Early treatment of spasticity.|early treatment of spasticity.
297243|NCT01882556|Post stroke spasticity.|post stroke spasticity.
297244|NCT01882543|Interstitial cystitis|interstitial cystitis
297245|NCT01882543|Bladder pain syndrome|bladder pain syndrome
297246|NCT01882543|IC/BPS|ic/bps
297247|NCT01882543|AQX-1125|aqx-1125
297248|NCT01882543|SHIP1|ship1
297249|NCT01882530|Post operative analgesia ;|post operative analgesia ;
297250|NCT01882530|Paracetamol ;|paracetamol ;
297251|NCT01882530|Ketoprofen ;|ketoprofen ;
297252|NCT01882530|Nefopam ;|nefopam ;
297253|NCT01882530|Morphine|morphine
297254|NCT01882504|Pyoderma Gangrenosum|pyoderma gangrenosum
297255|NCT01882504|Classic Pyoderma Gangrenosum|classic pyoderma gangrenosum
297256|NCT01882504|Atypical Pyoderma Gangrenosum|atypical pyoderma gangrenosum
297257|NCT01882504|Peristomal Pyoderma Gangrenosum|peristomal pyoderma gangrenosum
297258|NCT01882491|Erosive Osteoarthritis|erosive osteoarthritis
297259|NCT01882491|Osteoarthritis|osteoarthritis
297260|NCT01882491|Osteoarthritis of the Hand|osteoarthritis of the hand
297261|NCT01882478|Barrett's esophagus|barrett's esophagus
297262|NCT01882478|Early esophageal adenocarcinoma|early esophageal adenocarcinoma
297263|NCT01882478|Radio Frequency Ablation|radio frequency ablation
297264|NCT01882478|Cryotherapy|cryotherapy
297265|NCT01882452|Memory specificity training|memory specificity training
297266|NCT01882452|Autobiographical memory|autobiographical memory
297267|NCT01882452|Major depressive disorder|major depressive disorder
297268|NCT01882439|psoriatic arthritis|psoriatic arthritis
297269|NCT01882439|tofacitinib|tofacitinib
297270|NCT01882439|ACR20|acr20
297271|NCT01882439|HAQ-DI|haq-di
297272|NCT01882439|TNF inhibitor failure|tnf inhibitor failure
297273|NCT01882426|CONSTRUCT|construct
297652|NCT01881048|Breast cancer|breast cancer
297274|NCT01882426|Cluster randomization controlled trial|cluster randomization controlled trial
297275|NCT01882426|Gastroenterology practices in North America|gastroenterology practices in north america
297276|NCT01882400|Osteoporosis|osteoporosis
297277|NCT01882400|Severe muscular dystrophy|severe muscular dystrophy
297278|NCT01882400|Cystic fibrosis|cystic fibrosis
297279|NCT01882387|Allogeneic Peripheral Blood Stem Cell Transplantation|allogeneic peripheral blood stem cell transplantation
297280|NCT01882387|Graft-vs-Host Disease|graft-vs-host disease
297281|NCT01882387|Neutrophil Engraftment|neutrophil engraftment
297282|NCT01882387|Platelet Engraftment|platelet engraftment
297283|NCT01882387|Immune Reconstitution|immune reconstitution
297284|NCT01882387|Mucositis|mucositis
297285|NCT01882374|Double Umbilical Cord Blood Transplantation|double umbilical cord blood transplantation
297286|NCT01882374|Acute Graft versus Host Disease|acute graft versus host disease
297287|NCT01882374|Neutrophil Engraftment|neutrophil engraftment
297288|NCT01882374|Platelet Recovery|platelet recovery
297289|NCT01882374|Immune Reconstitution|immune reconstitution
297290|NCT01882374|Mucositis|mucositis
297291|NCT01882361|opioid addiction|opioid addiction
297292|NCT01882361|opioid treatment|opioid treatment
297293|NCT01882361|naloxone|naloxone
297294|NCT01882348|tobacco control, tobacco treatment, pediatrics, parents|tobacco control, tobacco treatment, pediatrics, parents
297295|NCT01882335|Human capital formation|human capital formation
297296|NCT01882322|FK506|fk506
297297|NCT01882322|tacrolimus|tacrolimus
297298|NCT01882322|immunosuppressant|immunosuppressant
297299|NCT01882283|serum lipids|serum lipids
297300|NCT01882283|cholesterol|cholesterol
297301|NCT01882283|serum cholesterol|serum cholesterol
297302|NCT01882283|black tea|black tea
297303|NCT01882283|flavonoids|flavonoids
297304|NCT01882283|crossover trial|crossover trial
297305|NCT01882283|randomized control trial|randomized control trial
297306|NCT01882283|diet controlled|diet controlled
297307|NCT01882270|pericoronitis|pericoronitis
297308|NCT01882270|periodontal|periodontal
297309|NCT01882257|obstructive sleep apnea|obstructive sleep apnea
297310|NCT01882257|sleep-disordered breathing|sleep-disordered breathing
297311|NCT01882257|hypercapnia|hypercapnia
297312|NCT01882257|spinal cord injury|spinal cord injury
297313|NCT01882244|traumatic brain injury|traumatic brain injury
297314|NCT01882244|cognition|cognition
297315|NCT01882244|rehabilitation|rehabilitation
297316|NCT01882244|attentional regulation|attentional regulation
297317|NCT01882244|working memory|working memory
297318|NCT01882231|Osteosarcoma|osteosarcoma
297319|NCT01882231|Ewing sarcoma|ewing sarcoma
297320|NCT01882231|Paget's disease|paget's disease
297321|NCT01882231|bone cancer|bone cancer
297322|NCT01882231|childhood cancers|childhood cancers
297323|NCT01882231|DCE MRI|dce mri
297324|NCT01882231|DW MRI|dw mri
297325|NCT01882231|CEST MRI|cest mri
297326|NCT01882231|MT MRI|mt mri
297327|NCT01882218|Liver cancer|liver cancer
297328|NCT01882205|Ulcerative colitis|ulcerative colitis
297329|NCT01882205|DALM|dalm
297330|NCT01882205|chromoendoscopy|chromoendoscopy
297331|NCT01882205|dysplasia|dysplasia
297332|NCT01882205|virtual chromoendoscopy|virtual chromoendoscopy
297333|NCT01882205|FICE|fice
297334|NCT01882205|NBI|nbi
297335|NCT01882205|I-scan|i-scan
297336|NCT01882192|family|family
297337|NCT01882192|physical activity|physical activity
297338|NCT01882192|planning|planning
297339|NCT01882179|Reperfusion injury|reperfusion injury
297340|NCT01882179|myocardial infarct size|myocardial infarct size
297341|NCT01882179|MRI|mri
297342|NCT01882179|spironolactone|spironolactone
297343|NCT01882166|Fertilization in Vitro|fertilization in vitro
297344|NCT01882166|Sperm Injections, Intracytoplasmic|sperm injections, intracytoplasmic
297345|NCT01882166|Follicle Stimulating Hormone|follicle stimulating hormone
297346|NCT01882166|Embryonic Development|embryonic development
297347|NCT01882140|burns|burns
297348|NCT01882140|wound healing|wound healing
297349|NCT01882140|magnetic field therapy|magnetic field therapy
297350|NCT01882127|Purpura|purpura
297351|NCT01882127|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
297352|NCT01882114|atherosclerosis|atherosclerosis
297353|NCT01882114|cardiovascular events|cardiovascular events
297354|NCT01882114|ankle-brachial index|ankle-brachial index
297355|NCT01882114|carotid disease|carotid disease
297356|NCT01882114|echocardiography|echocardiography
297357|NCT01882114|mediterranean diet|mediterranean diet
297358|NCT01882114|platelet activation|platelet activation
297359|NCT01882101|Fecal incontinence|fecal incontinence
297360|NCT01882101|posterior tibial nerve stimulation|posterior tibial nerve stimulation
297361|NCT01882101|biofeedback|biofeedback
297362|NCT01882101|quality of life|quality of life
297363|NCT01882075|Anesthesia|anesthesia
297364|NCT01882075|Fluid administration|fluid administration
297365|NCT01882075|Closed-loop|closed-loop
297366|NCT01882023|EDNOS|ednos
297367|NCT01882023|adolescents|adolescents
297368|NCT01882010|Parkinson's disease|parkinson's disease
297369|NCT01882010|motor function|motor function
297370|NCT01882010|immune activation|immune activation
297371|NCT01882010|T cells|t cells
297372|NCT01882010|CD4|cd4
297373|NCT01882010|GMCSF|gmcsf
297374|NCT01882010|leukine|leukine
297375|NCT01882010|sargramostim|sargramostim
297376|NCT01882010|magnetoencephalography|magnetoencephalography
297377|NCT01881997|Procedure|procedure
297378|NCT01881997|Abscess|abscess
297379|NCT01881997|Emergency Department|emergency department
297380|NCT01881997|Opioid|opioid
297381|NCT01881997|Fentanyl|fentanyl
297382|NCT01881984|Medium-chain acyl-CoA dehydrogenase deficiency|medium-chain acyl-coa dehydrogenase deficiency
297383|NCT01881984|MCAD deficiency|mcad deficiency
297384|NCT01881984|MCADD|mcadd
297385|NCT01881984|ACADM deficiency|acadm deficiency
297386|NCT01881984|MCADH deficiency|mcadh deficiency
297387|NCT01881984|985A>G mutation|985a>g mutation
297388|NCT01881984|K304E mutation|k304e mutation
297389|NCT01881984|Ravicti|ravicti
297390|NCT01881984|glycerol phenylbutyrate|glycerol phenylbutyrate
297391|NCT01881971|HIV|hiv
297392|NCT01881971|lung|lung
297393|NCT01881971|lipids|lipids
297394|NCT01881971|no lipid lowering medication|no lipid lowering medication
297395|NCT01881971|normal liver and kidney function|normal liver and kidney function
297396|NCT01881971|on stable ART regimen|on stable art regimen
297397|NCT01881971|not pregnant|not pregnant
297398|NCT01881945|Swallowing|swallowing
297399|NCT01881945|Hyperventilation|hyperventilation
297400|NCT01881932|acupuncture therapy|acupuncture therapy
297401|NCT01881932|sham acupuncture therapy|sham acupuncture therapy
297402|NCT01881932|chemotherapy-induced peripheral neuropathy (CIPN)|chemotherapy-induced peripheral neuropathy (cipn)
297403|NCT01881919|Functional Food|functional food
297404|NCT01881906|aerobic exercise|aerobic exercise
297405|NCT01881906|Lung cancer|lung cancer
297406|NCT01881906|psyco-social|psyco-social
297407|NCT01881893|Quality of life|quality of life
297408|NCT01881893|Psychosocial Support Systems|psychosocial support systems
297409|NCT01881893|Randomized Controls as Topic|randomized controls as topic
297410|NCT01881893|Cognitive Therapy|cognitive therapy
297411|NCT01881893|Feasibility Studies|feasibility studies
297412|NCT01881880|Tomosynthesis|tomosynthesis
297413|NCT01881880|Mammography|mammography
297414|NCT01881880|Breast cancer|breast cancer
297415|NCT01881841|Alcohol abuse|alcohol abuse
297416|NCT01881841|Substance use|substance use
297417|NCT01881841|Tobacco use disorder|tobacco use disorder
297418|NCT01881841|Motivational Enhancement Therapy|motivational enhancement therapy
297419|NCT01881841|Adolescents|adolescents
297420|NCT01881815|Chronic wounds with different etiologies|chronic wounds with different etiologies
297421|NCT01881815|Diabetic foot ulcers|diabetic foot ulcers
297422|NCT01881815|venous leg ulcers|venous leg ulcers
297423|NCT01881815|pressure sores|pressure sores
297424|NCT01881815|acute wounds|acute wounds
297425|NCT01881802|Opioid drug Abuse|opioid drug abuse
297426|NCT01881802|Morphine|morphine
297427|NCT01881802|Immune Function|immune function
297428|NCT01881789|multiple myeloma|multiple myeloma
297429|NCT01881789|proteasome inhibitor|proteasome inhibitor
297430|NCT01881789|oprozomib|oprozomib
297431|NCT01881789|orpozomib tablets|orpozomib tablets
297432|NCT01881776|Single injection interscalene brachial plexus block|single injection interscalene brachial plexus block
297433|NCT01881776|Continuous interscalene brachial plexus block|continuous interscalene brachial plexus block
297434|NCT01881776|General anesthesia|general anesthesia
297435|NCT01881776|Postoperative pain|postoperative pain
297436|NCT01881776|Recovery profile|recovery profile
297437|NCT01881763|Electroconvulsive Therapy|electroconvulsive therapy
297438|NCT01881763|Ketamine|ketamine
297439|NCT01881763|anesthesia|anesthesia
297440|NCT01881763|depression|depression
297441|NCT01881763|unipolar|unipolar
297443|NCT01881750|Autism PRT|autism prt
297444|NCT01881737|autism|autism
297445|NCT01881711|hydrocephalus|hydrocephalus
297446|NCT01881711|CSF shunt|csf shunt
297447|NCT01881711|shunt malfunction|shunt malfunction
297448|NCT01881711|shunt obstruction|shunt obstruction
297449|NCT01881711|ShuntCheck|shuntcheck
297450|NCT01881711|ShuntCheck-Micro-Pumper|shuntcheck-micro-pumper
297451|NCT01881698|pregnancy|pregnancy
297452|NCT01881698|platelet function|platelet function
297453|NCT01881698|monitoring|monitoring
297454|NCT01881698|multiple electrode aggregometry|multiple electrode aggregometry
297455|NCT01881672|Aspiration pneumonia|aspiration pneumonia
297456|NCT01881672|Coma|coma
297457|NCT01881672|Mechanical ventilation|mechanical ventilation
297458|NCT01881659|cervical cancer|cervical cancer
297459|NCT01881659|cancer prevention|cancer prevention
297460|NCT01881659|cervical screening|cervical screening
297461|NCT01881659|HPV testing|hpv testing
297462|NCT01881659|triage techniques|triage techniques
297463|NCT01881646|Neuroinflammation|neuroinflammation
297464|NCT01881646|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
297465|NCT01881633|gaucher disease, imiglucerase, ISU302|gaucher disease, imiglucerase, isu302
297466|NCT01881620|PET scan|pet scan
297467|NCT01881620|CT scan|ct scan
297468|NCT01881620|Diagnostic performance|diagnostic performance
297469|NCT01881607|tobacco smoke pollution|tobacco smoke pollution
297470|NCT01881607|Tobacco use|tobacco use
297471|NCT01881594|ileostomy closure,postoperative ileus,stimulation ileostomy|ileostomy closure,postoperative ileus,stimulation ileostomy
297472|NCT01881581|Therapeutic|therapeutic
297473|NCT01881581|Vaccine|vaccine
297474|NCT01881581|HIV|hiv
297475|NCT01881581|MVA|mva
297476|NCT01881581|DNA|dna
297477|NCT01881568|Total Knee Arthroplasty, TKA, blood loss|total knee arthroplasty, tka, blood loss
297478|NCT01881555|fractional flow reserve|fractional flow reserve
297479|NCT01881555|multivessel coronary artery disease|multivessel coronary artery disease
297480|NCT01881555|angiography|angiography
297481|NCT01881542|preeclampsia|preeclampsia
297482|NCT01881542|proteinuria|proteinuria
297483|NCT01881542|urine collection|urine collection
297484|NCT01881529|limited scleroderma|limited scleroderma
297485|NCT01881529|diffuse scleroderma|diffuse scleroderma
297486|NCT01881529|Sclerosis|sclerosis
297487|NCT01881529|Progressive|progressive
297488|NCT01881529|Limited|limited
297489|NCT01881503|life-threatening anemia|life-threatening anemia
297490|NCT01881503|blood alternative|blood alternative
297491|NCT01881503|HBOC|hboc
297492|NCT01881490|Crohn's Disease|crohn's disease
297493|NCT01881490|MRE|mre
297494|NCT01881490|Pelvic MRI|pelvic mri
297495|NCT01881490|P-MRI|p-mri
297496|NCT01881490|colonoscopy|colonoscopy
297497|NCT01881490|gastroscopy|gastroscopy
297498|NCT01881477|immobilization|immobilization
297499|NCT01881477|physical therapy|physical therapy
297500|NCT01881477|intensive care|intensive care
297501|NCT01881477|bed rest|bed rest
297502|NCT01881477|movement|movement
297503|NCT01881451|Tumour hypoxia|tumour hypoxia
297504|NCT01881451|Clear Cell Ovarian Cancer|clear cell ovarian cancer
297505|NCT01881451|Recurrent|recurrent
297506|NCT01881451|Metastatic|metastatic
297507|NCT01881438|Retinal Detachment|retinal detachment
297508|NCT01881438|Fluoroquinolones|fluoroquinolones
297509|NCT01881438|Ciprofloxacin|ciprofloxacin
297510|NCT01881438|Levofloxacin|levofloxacin
297511|NCT01881438|Gatifloxacin|gatifloxacin
297512|NCT01881438|Gemifloxacin|gemifloxacin
297513|NCT01881438|Moxifloxacin|moxifloxacin
297514|NCT01881438|Norfloxacin|norfloxacin
297515|NCT01881438|Ofloxacin|ofloxacin
297516|NCT01881438|Beta-Lactam|beta-lactam
297517|NCT01881425|POAG|poag
297518|NCT01881412|Asthma|asthma
297519|NCT01881412|Children|children
297520|NCT01881412|Inhaled Corticosteroids|inhaled corticosteroids
297521|NCT01881412|Emergency Department|emergency department
297522|NCT01881399|Cholelithiasis|cholelithiasis
297523|NCT01881399|Gallbladder polyps|gallbladder polyps
297524|NCT01881399|Fluorescence|fluorescence
297525|NCT01881399|Indocyanine green (ICG)|indocyanine green (icg)
297526|NCT01881399|Intraoperative cholangiography (IOC)|intraoperative cholangiography (ioc)
297527|NCT01881399|da Vinci surgical system|da vinci surgical system
297528|NCT01881386|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
297529|NCT01881386|Lactate|lactate
297530|NCT01881373|Obesity|obesity
297531|NCT01881373|Child|child
297533|NCT01881373|Physical Activity|physical activity
297534|NCT01881373|Pacific|pacific
297535|NCT01881360|fibromyalgia|fibromyalgia
297536|NCT01881360|celiac-type symptoms|celiac-type symptoms
297537|NCT01881360|gluten-free diet|gluten-free diet
297538|NCT01881360|hypocaloric diet|hypocaloric diet
297539|NCT01881347|endothelium|endothelium
297540|NCT01881347|mitochondria|mitochondria
297541|NCT01881347|reactive oxygen species|reactive oxygen species
297542|NCT01881347|vascular biology|vascular biology
297543|NCT01881347|arterial stiffness|arterial stiffness
297544|NCT01881347|nitric oxide|nitric oxide
297545|NCT01881334|Haploidentical Donor|haploidentical donor
297546|NCT01881334|T-cell depleted Stem Cells|t-cell depleted stem cells
297547|NCT01881334|Allogeneic Transplant|allogeneic transplant
297548|NCT01881334|Umbilical Cord Blood Donor|umbilical cord blood donor
297549|NCT01881334|High Risk Malignancies|high risk malignancies
297550|NCT01881334|Metabolic Disorders|metabolic disorders
297551|NCT01881334|Immune Deficiency|immune deficiency
297552|NCT01881334|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
297553|NCT01881334|Acute Myelogenous Leukemia|acute myelogenous leukemia
297554|NCT01881334|Myelodysplastic Syndrome|myelodysplastic syndrome
297555|NCT01881334|ALL|all
297556|NCT01881334|AML|aml
297557|NCT01881334|MDS|mds
297558|NCT01881334|CGD|cgd
297559|NCT01881334|SCID|scid
297560|NCT01881334|Adrenoleukodystrophy|adrenoleukodystrophy
297561|NCT01881334|Metachromaticleukodystrophy|metachromaticleukodystrophy
297562|NCT01881334|Krabbe|krabbe
297563|NCT01881334|PMD|pmd
297564|NCT01881334|Hunter's|hunter's
297565|NCT01881334|Hurler's|hurler's
297566|NCT01881334|Severe Aplastic Anemia|severe aplastic anemia
297567|NCT01881334|Lymphoma|lymphoma
297568|NCT01881334|Sickle Cell Disease|sickle cell disease
297569|NCT01881334|Thalassemia|thalassemia
297570|NCT01881321|Contraception|contraception
297571|NCT01881321|Counseling|counseling
297572|NCT01881295|Potassium|potassium
297573|NCT01881295|Potato|potato
297574|NCT01881295|French Fries|french fries
297575|NCT01881295|Bioavailability|bioavailability
297576|NCT01881295|Blood Pressure|blood pressure
297577|NCT01881282|Hemorrhoids|hemorrhoids
297578|NCT01881282|Carraghenates|carraghenates
297579|NCT01881282|Mayinglong Musk|mayinglong musk
297580|NCT01881282|Titanoreine|titanoreine
297581|NCT01881256|Preterm birth|preterm birth
297582|NCT01881256|Parenteral and enteral nutrition|parenteral and enteral nutrition
297583|NCT01881256|Body composition in preterm infants|body composition in preterm infants
297584|NCT01881243|Cardiac Arrest, Hyperoxia, Ischemia-reperfusion Injury, Reactive Oxygen Species, Oxidative Stress, Neuropsychological Tests|cardiac arrest, hyperoxia, ischemia-reperfusion injury, reactive oxygen species, oxidative stress, neuropsychological tests
297585|NCT01881230|Breast Cancer|breast cancer
297586|NCT01881230|Cancer of the Breast|cancer of the breast
297587|NCT01881230|Metastatic Breast Cancer|metastatic breast cancer
297588|NCT01881230|Metastatic Triple Negative Breast Cancer|metastatic triple negative breast cancer
297589|NCT01881230|Triple Negative Breast Cancer|triple negative breast cancer
297590|NCT01881230|Triple Negative Metastatic Breast Cancer|triple negative metastatic breast cancer
297591|NCT01881230|Basal-like breast cancer|basal-like breast cancer
297592|NCT01881230|Hormone receptor negative breast cancer|hormone receptor negative breast cancer
297593|NCT01881230|Estrogen receptor negative breast cancer|estrogen receptor negative breast cancer
297594|NCT01881230|Progesterone negative receptor breast cancer|progesterone negative receptor breast cancer
297595|NCT01881230|HER2 Negative Breast Cancer|her2 negative breast cancer
297596|NCT01881230|Abraxane|abraxane
297597|NCT01881230|nab-Paclitaxel|nab-paclitaxel
297598|NCT01881230|ABI-007|abi-007
297599|NCT01881230|gemcitabine|gemcitabine
297600|NCT01881230|Gemzar|gemzar
297601|NCT01881230|carboplatin|carboplatin
297602|NCT01881230|Paraplatin|paraplatin
297603|NCT01881230|Paraplatin AQ|paraplatin aq
297604|NCT01881230|Phase 2|phase 2
297605|NCT01881230|Phase 3|phase 3
297606|NCT01881217|Phase I|phase i
297607|NCT01881217|Dose escalation|dose escalation
297608|NCT01881217|Advanced, refractory solid tumors|advanced, refractory solid tumors
297609|NCT01881217|FGFR2|fgfr2
297610|NCT01881204|Hesperidin|hesperidin
297611|NCT01881204|Osteoporosis|osteoporosis
297612|NCT01881204|Bone Loss|bone loss
297613|NCT01881191|multiple sclerosis|multiple sclerosis
297614|NCT01881191|relapsing remitting|relapsing remitting
297615|NCT01881191|MRI|mri
297616|NCT01881191|teriflunomide|teriflunomide
297617|NCT01881191|aubagio|aubagio
297618|NCT01881191|gray matter atrophy|gray matter atrophy
297619|NCT01881191|gray matter pathology|gray matter pathology
297620|NCT01881178|CRP|crp
297621|NCT01881178|Nopalea|nopalea
297622|NCT01881178|Fruit|fruit
297623|NCT01881178|Juice|juice
297624|NCT01881152|Stroke|stroke
297625|NCT01881152|Community education|community education
297626|NCT01881152|Awareness|awareness
297627|NCT01881152|Prehospital delay|prehospital delay
297628|NCT01881139|Exercise|exercise
297629|NCT01881139|Lipid|lipid
297630|NCT01881139|Left ventricular|left ventricular
297631|NCT01881139|heart function|heart function
299438|NCT01873170|microflora|microflora
297632|NCT01881100|resin infiltration|resin infiltration
297633|NCT01881100|randomized clinical trial|randomized clinical trial
297634|NCT01881100|fluoride varnish|fluoride varnish
297635|NCT01881100|caries lesion|caries lesion
297636|NCT01881100|deciduous teeth|deciduous teeth
297637|NCT01881087|Knee Arthroscopy|knee arthroscopy
297638|NCT01881087|Levobupivacaine|levobupivacaine
297639|NCT01881087|Spinal Anesthesia|spinal anesthesia
297640|NCT01881087|Motor Block|motor block
297641|NCT01881074|Type II Diabetes|type ii diabetes
297642|NCT01881074|Periodontal Disease|periodontal disease
297643|NCT01881074|Periodontitis|periodontitis
297644|NCT01881074|Gum Disease|gum disease
297645|NCT01881074|Gingivitis|gingivitis
297646|NCT01881074|Triclosan|triclosan
297647|NCT01881074|Inflammatory Markers|inflammatory markers
297648|NCT01881074|Immune Response|immune response
297649|NCT01881061|Sonography|sonography
297650|NCT01881061|ICU|icu
297651|NCT01881061|PEEP|peep
297653|NCT01881048|Omega-3 Fatty Acid|omega-3 fatty acid
297654|NCT01881048|Celecoxib|celecoxib
297655|NCT01881048|Celebrex|celebrex
297656|NCT01881048|Surgery|surgery
297657|NCT01881035|Hypertension|hypertension
297658|NCT01881035|End stage renal disease|end stage renal disease
297659|NCT01881022|Breast Cancer|breast cancer
297660|NCT01881022|Couples|couples
297661|NCT01881022|Sexual Dysfunction|sexual dysfunction
297662|NCT01881022|Psychosexual Intervention|psychosexual intervention
297663|NCT01881022|Sex Therapy|sex therapy
297664|NCT01881022|Online Support|online support
297665|NCT01881022|e-health|e-health
297666|NCT01881009|Diabetes|diabetes
297667|NCT01881009|Insulin|insulin
297668|NCT01881009|Closed loop|closed loop
297669|NCT01881009|Nocturnal glucose control|nocturnal glucose control
297670|NCT01880996|Ovarian Cancer|ovarian cancer
297671|NCT01880996|Gynecological Malignancies|gynecological malignancies
297672|NCT01880996|Chemotherapy|chemotherapy
297673|NCT01880996|Tai-chi|tai-chi
297674|NCT01880996|Qigong|qigong
297675|NCT01880996|Fatigue|fatigue
297676|NCT01880996|Quality of life|quality of life
297677|NCT01880996|Sleep disturbance|sleep disturbance
297679|NCT01880983|Bloomer|bloomer
297680|NCT01880983|Porphyria|porphyria
297681|NCT01880957|bipolar disorder|bipolar disorder
297682|NCT01880957|bipolar depression|bipolar depression
297683|NCT01880957|serotonin transporter|serotonin transporter
297684|NCT01880957|serotonin receptors|serotonin receptors
297685|NCT01880957|binding potential|binding potential
297686|NCT01880957|brain imaging|brain imaging
297687|NCT01880957|unipolar depression|unipolar depression
297688|NCT01880944|spine|spine
297689|NCT01880944|trauma|trauma
297690|NCT01880944|MRI|mri
297691|NCT01880944|contrast|contrast
297692|NCT01880918|Compression Anastomosis|compression anastomosis
297693|NCT01880905|the length of uterine ovarian ligament|the length of uterine ovarian ligament
297694|NCT01880879|coronary artery disease|coronary artery disease
297695|NCT01880879|PCI|pci
297696|NCT01880879|stent|stent
297697|NCT01880866|PAH|pah
297698|NCT01880853|breast cancer|breast cancer
297699|NCT01880853|screening|screening
297700|NCT01880853|mammography|mammography
297701|NCT01880853|ultrasound|ultrasound
297702|NCT01880827|GIP|gip
297703|NCT01880827|GLP-1|glp-1
297704|NCT01880827|type 2 diabetes|type 2 diabetes
297705|NCT01880827|obesity|obesity
297706|NCT01880827|splanchnic blood flow|splanchnic blood flow
297707|NCT01880827|incretin hormones|incretin hormones
297708|NCT01880814|Depression, child, cognitive behavioral treatment, parent training, personalized treatment|depression, child, cognitive behavioral treatment, parent training, personalized treatment
297709|NCT01880801|ITP|itp
297710|NCT01880788|Age Related Macular Degeneration|age related macular degeneration
297711|NCT01880788|Choroidal Neovascularization|choroidal neovascularization
297712|NCT01880788|Central Serous Chorioretinopathy|central serous chorioretinopathy
297713|NCT01880762|PET MR development and validation|pet mr development and validation
297714|NCT01880723|exhaled breath condensate|exhaled breath condensate
297715|NCT01880723|diffusion capacity of the lungs for carbon monoxide and nitric oxide|diffusion capacity of the lungs for carbon monoxide and nitric oxide
297716|NCT01880723|albuterol|albuterol
297717|NCT01880723|peripheral oxygen saturation|peripheral oxygen saturation
297718|NCT01880723|ion regulation|ion regulation
297719|NCT01880710|long term follow-up|long term follow-up
297720|NCT01880710|urinary incontinence|urinary incontinence
297721|NCT01880710|pelvic organ prolapse|pelvic organ prolapse
297722|NCT01880710|total versus subtotal hysterectomy|total versus subtotal hysterectomy
297723|NCT01880697|Influenza|influenza
297724|NCT01880697|adults|adults
297725|NCT01880697|elderly|elderly
297726|NCT01880697|immunology|immunology
297727|NCT01880697|safety|safety
297728|NCT01880684|Thermodilution|thermodilution
297729|NCT01880684|Blood Volume|blood volume
297730|NCT01880684|Cardiac Output|cardiac output
297731|NCT01880684|Leg|leg
297732|NCT01880684|Capnography|capnography
297733|NCT01880684|Blood Pressure|blood pressure
297734|NCT01880658|Maintenance therapy|maintenance therapy
297735|NCT01880658|Capecitabine|capecitabine
299439|NCT01873170|DMPA|dmpa
297736|NCT01880658|Adjuvant chemotherapy|adjuvant chemotherapy
297737|NCT01880658|Post-operation|post-operation
297738|NCT01880645|Breast Cancer|breast cancer
297739|NCT01880645|Invasive breast cancer|invasive breast cancer
297740|NCT01880645|Axillary lymph node metastases|axillary lymph node metastases
297741|NCT01880645|Ultrasound|ultrasound
297742|NCT01880645|Fine needle aspiration|fine needle aspiration
297743|NCT01880645|FNA|fna
297744|NCT01880645|Lymph node surgery|lymph node surgery
297745|NCT01880645|Partial mastectomy|partial mastectomy
297746|NCT01880645|Total mastectomy|total mastectomy
297747|NCT01880632|XELOX|xelox
297748|NCT01880632|perioperative treatment|perioperative treatment
297749|NCT01880632|locally advanced gastric adenocarcinoma|locally advanced gastric adenocarcinoma
297750|NCT01880632|D2 resection|d2 resection
297751|NCT01880619|Double J|double j
297752|NCT01880619|Ureteral stents|ureteral stents
297753|NCT01880619|Symptoms|symptoms
297754|NCT01880619|Alpha blockers|alpha blockers
297755|NCT01880619|Anticholinergic|anticholinergic
297756|NCT01880593|Ketamine|ketamine
297757|NCT01880593|glutamate|glutamate
297758|NCT01880593|N-methyl-D-aspartate|n-methyl-d-aspartate
297759|NCT01880593|depression|depression
297760|NCT01880593|major depressive disorder|major depressive disorder
297761|NCT01880593|treatment resistant|treatment resistant
297762|NCT01880593|antidepressant|antidepressant
297763|NCT01880593|lithium|lithium
297764|NCT01880567|Lymphoma|lymphoma
297765|NCT01880567|Relapsed/Refractory Mantle Cell Lymphoma|relapsed/refractory mantle cell lymphoma
297766|NCT01880567|R/R MCL|r/r mcl
297767|NCT01880567|Ibrutinib|ibrutinib
297768|NCT01880567|PCI-32765|pci-32765
297769|NCT01880567|Rituximab|rituximab
297770|NCT01880567|Rituxan|rituxan
297771|NCT01880567|Newly-Diagnosed Untreated Mantle Cell Lymphoma|newly-diagnosed untreated mantle cell lymphoma
297772|NCT01880567|MCL|mcl
297773|NCT01880554|Liver metastases|liver metastases
297774|NCT01880554|Colorectal primary cancer|colorectal primary cancer
297775|NCT01880554|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
297776|NCT01880554|Sonovue®|sonovue®
297777|NCT01880541|Patients with breast cancer and breast surgery requiring|patients with breast cancer and breast surgery requiring
297778|NCT01880515|Lung cancer|lung cancer
297779|NCT01880515|BIBW 2992|bibw 2992
297780|NCT01880515|Skin Rash|skin rash
297781|NCT01880515|Tetracycline|tetracycline
297782|NCT01880515|Afatinib|afatinib
297783|NCT01880502|Healthy, Volunteers|healthy, volunteers
297784|NCT01880489|transgender women|transgender women
297785|NCT01880489|sexual risk|sexual risk
297786|NCT01880489|substance use|substance use
297787|NCT01880489|HIV prevention|hiv prevention
297788|NCT01880489|behavioral intervention|behavioral intervention
297789|NCT01880476|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
297790|NCT01880476|Comorbidity|comorbidity
297791|NCT01880476|Aged|aged
297792|NCT01880476|Health Services|health services
297793|NCT01880463|Dry eye disease|dry eye disease
297794|NCT01880463|incidence|incidence
297795|NCT01880463|progression|progression
297796|NCT01880411|PEK fusion protein Healthbanks|pek fusion protein healthbanks
297797|NCT01880398|FIstula in ano; Bhagandar|fistula in ano; bhagandar
297798|NCT01880385|bevacizumab|bevacizumab
297799|NCT01880385|inflammatory breast cancer|inflammatory breast cancer
297800|NCT01880385|non metastatic|non metastatic
297801|NCT01880385|Avastin|avastin
297802|NCT01880372|Diabetes|diabetes
297803|NCT01880372|Diabetic Retinopathy|diabetic retinopathy
297804|NCT01880372|Retinopathy|retinopathy
297805|NCT01880372|Free radical|free radical
297806|NCT01880372|Retinal diseases|retinal diseases
297807|NCT01880372|Antioxidants|antioxidants
297808|NCT01880372|Protective agents|protective agents
297809|NCT01880372|Thioctic acid|thioctic acid
297810|NCT01880346|Cystic Fibrosis|cystic fibrosis
297811|NCT01880346|Vitamin D|vitamin d
297812|NCT01880346|absorption|absorption
297813|NCT01880346|vitamin Deficiency|vitamin deficiency
297814|NCT01880346|fat soluble|fat soluble
297815|NCT01880333|Refractory epilepsy|refractory epilepsy
297816|NCT01880333|dietary therapy|dietary therapy
297817|NCT01880333|non-pharmacological therapy|non-pharmacological therapy
297818|NCT01880333|Modified Atkin Diet|modified atkin diet
297819|NCT01880307|Crohn's disease|crohn's disease
297820|NCT01880307|pediatric|pediatric
297821|NCT01880307|infliximab|infliximab
297822|NCT01880307|top-down|top-down
297823|NCT01880307|ITSKids|itskids
297824|NCT01880294|Constipation|constipation
297825|NCT01880294|Chronic constipation|chronic constipation
297826|NCT01880294|Asia-Pacific|asia-pacific
297827|NCT01880294|Gastroentrology|gastroentrology
297828|NCT01880294|Asian participants|asian participants
297829|NCT01880281|G protein-coupled receptor 99 (GPR99)|g protein-coupled receptor 99 (gpr99)
297830|NCT01880281|2-oxoglutarate receptor 1 (OXGR1)|2-oxoglutarate receptor 1 (oxgr1)
297831|NCT01880281|alpha-ketoglutarate|alpha-ketoglutarate
297832|NCT01880281|urine|urine
297833|NCT01880281|pH|ph
297834|NCT01880281|acidosis|acidosis
297835|NCT01880281|alkalosis|alkalosis
297836|NCT01880281|Healthy volunteers|healthy volunteers
297938|NCT01879904|Colorectal Neoplasms|colorectal neoplasms
297837|NCT01880255|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
297838|NCT01880255|Schizophrenia|schizophrenia
297839|NCT01880255|Cognition|cognition
297840|NCT01880255|Working Memory|working memory
297841|NCT01880242|International|international
297842|NCT01880242|Multicenter|multicenter
297843|NCT01880242|Observational registry|observational registry
297844|NCT01880242|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
297845|NCT01880242|Stenting|stenting
297846|NCT01880242|Treatment of Coronary Artery Disease|treatment of coronary artery disease
297847|NCT01880242|Coronary revascularization|coronary revascularization
297848|NCT01880242|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
297849|NCT01880242|STEMI|stemi
297850|NCT01880242|NSTEMI|nstemi
297851|NCT01880242|Ischemia|ischemia
297852|NCT01880242|Angina|angina
297853|NCT01880242|Subgroups|subgroups
297854|NCT01880242|Acute Myocardial Infarction|acute myocardial infarction
297855|NCT01880242|Diabetes|diabetes
297856|NCT01880242|Small Vessels|small vessels
297857|NCT01880242|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
297858|NCT01880216|Deep vein thrombosis|deep vein thrombosis
297859|NCT01880216|DVT|dvt
297860|NCT01880216|Treatment|treatment
297861|NCT01880216|Low molecular weight heparin|low molecular weight heparin
297862|NCT01880216|Bemiparin|bemiparin
297863|NCT01880216|Enoxaparin|enoxaparin
297864|NCT01880203|thyroid|thyroid
297865|NCT01880203|elastography SWE|elastography swe
297866|NCT01880203|indeterminate cytology|indeterminate cytology
297867|NCT01880164|Scoliosis|scoliosis
297868|NCT01880164|Kyphosis|kyphosis
297869|NCT01880164|Sagittal plane deformity|sagittal plane deformity
297870|NCT01880151|Alzheimer's disease|alzheimer's disease
297871|NCT01880151|Dementia|dementia
297872|NCT01880151|Prodromal|prodromal
297873|NCT01880151|EEG|eeg
297874|NCT01880151|ERP|erp
297875|NCT01880151|Biomarkers|biomarkers
297876|NCT01880138|Animated cartoon, Emergence agitation|animated cartoon, emergence agitation
297877|NCT01880125|Tramadol|tramadol
297878|NCT01880125|Acetaminophen|acetaminophen
297879|NCT01880125|Pharmacokinetics|pharmacokinetics
297880|NCT01880125|Sustained release|sustained release
297881|NCT01880125|Immediate release|immediate release
297882|NCT01880112|Infection|infection
297883|NCT01880112|Cesarean delivery|cesarean delivery
297884|NCT01880112|Antibiotic prophylaxis|antibiotic prophylaxis
297885|NCT01880112|Cefazolin dosing|cefazolin dosing
297886|NCT01880099|addiction|addiction
297887|NCT01880099|smoking|smoking
297888|NCT01880099|tobacco|tobacco
297889|NCT01880099|cigarettes|cigarettes
297890|NCT01880086|Chronic pain|chronic pain
297891|NCT01880086|Low testosterone|low testosterone
297892|NCT01880086|Hypogonadism|hypogonadism
297893|NCT01880086|Opioid analgesics|opioid analgesics
297894|NCT01880086|Narcotics|narcotics
297895|NCT01880086|Opioid-induced androgen deficiency|opioid-induced androgen deficiency
297896|NCT01880086|OPIAD|opiad
297897|NCT01880086|Male infertility|male infertility
297898|NCT01880086|Clomiphene citrate|clomiphene citrate
297899|NCT01880086|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators
297900|NCT01880086|Testosterone replacement therapy|testosterone replacement therapy
297901|NCT01880060|Worksite|worksite
297902|NCT01880060|weight loss|weight loss
297903|NCT01880060|obesity|obesity
297904|NCT01880047|Immune Thrombocytopenia|immune thrombocytopenia
297905|NCT01880047|ITP|itp
297906|NCT01880047|Eltrombopag|eltrombopag
297907|NCT01880047|Promacta|promacta
297908|NCT01880008|positron emission tomography|positron emission tomography
297909|NCT01880008|magnetic resonance imaging|magnetic resonance imaging
297910|NCT01880008|diffusion magnetic resonance imaging|diffusion magnetic resonance imaging
297911|NCT01880008|radionuclide imaging|radionuclide imaging
297912|NCT01880008|disease management|disease management
297913|NCT01880008|radiation therapy|radiation therapy
297914|NCT01879982|Bipolar disorder|bipolar disorder
297915|NCT01879982|subtypes|subtypes
297916|NCT01879969|computer-assisted orthognathic surgery; facial asymmetry|computer-assisted orthognathic surgery; facial asymmetry
297917|NCT01879956|Executive Functions|executive functions
297918|NCT01879956|Schizophrenia|schizophrenia
297919|NCT01879956|Occupational Therapy|occupational therapy
297920|NCT01879943|Colorectal cancer|colorectal cancer
297921|NCT01879943|Follow up|follow up
297922|NCT01879943|Colonoscopy|colonoscopy
297923|NCT01879943|Videocapsule|videocapsule
297924|NCT01879930|randomized|randomized
297925|NCT01879930|placebo-controlled|placebo-controlled
297926|NCT01879930|double-blind study|double-blind study
297927|NCT01879930|doxycycline|doxycycline
297928|NCT01879917|c-peptide|c-peptide
297929|NCT01879917|insulin|insulin
297930|NCT01879917|hypoglycemia|hypoglycemia
297931|NCT01879917|Newly onset|newly onset
297932|NCT01879917|Diabetes|diabetes
297933|NCT01879917|Type 1|type 1
297934|NCT01879917|Beta cell|beta cell
297935|NCT01879917|Autoimmune|autoimmune
297936|NCT01879917|Glucagon|glucagon
297937|NCT01879917|Meal test|meal test
299039|NCT01875185|hormones|hormones
297939|NCT01879891|Exercise Intensity|exercise intensity
297940|NCT01879891|Metabolism|metabolism
297941|NCT01879891|Insulin|insulin
297942|NCT01879878|pancreatic adenocarcinoma|pancreatic adenocarcinoma
297943|NCT01879878|broccoli sprouts|broccoli sprouts
297944|NCT01879878|sulforaphane|sulforaphane
297945|NCT01879878|palliative chemotherapy|palliative chemotherapy
297946|NCT01879878|cancer stem cells|cancer stem cells
297947|NCT01879865|PKPD|pkpd
297948|NCT01879865|Dexmedetomidine|dexmedetomidine
297949|NCT01879865|Auditory Stimulation|auditory stimulation
297950|NCT01879865|Cardiac Output|cardiac output
297951|NCT01879852|Quadriceps strength|quadriceps strength
297952|NCT01879852|Knee|knee
297953|NCT01879852|Rehabilitation|rehabilitation
297954|NCT01879826|Aculaser|aculaser
297955|NCT01879826|Microlight ML830|microlight ml830
297956|NCT01879826|Kidney biopsy|kidney biopsy
297957|NCT01879826|Pain|pain
297958|NCT01879826|Anxiety|anxiety
297959|NCT01879826|Sedation|sedation
297960|NCT01879813|Memory|memory
297961|NCT01879813|Attention|attention
297962|NCT01879787|Stroke|stroke
297963|NCT01879787|transcranial direct current stimulation|transcranial direct current stimulation
297964|NCT01879787|constraint-induced movement therapy|constraint-induced movement therapy
297965|NCT01879787|mental practice|mental practice
297966|NCT01879774|Hyponatremia|hyponatremia
297967|NCT01879761|Immunosuppressed|immunosuppressed
297968|NCT01879761|Sepsis|sepsis
297969|NCT01879761|Staphylococcus Aureus|staphylococcus aureus
297970|NCT01879761|Bacteremia|bacteremia
297971|NCT01879761|HLA-DR|hla-dr
297972|NCT01879748|Parkinson's disease|parkinson's disease
297973|NCT01879748|Azilect|azilect
297974|NCT01879748|rasagiline mesylate|rasagiline mesylate
297975|NCT01879722|Drug therapy|drug therapy
297976|NCT01879709|schizophrenia|schizophrenia
297977|NCT01879709|Cognition|cognition
297978|NCT01879709|Independent living skills|independent living skills
297979|NCT01879683|Hunner's lesion|hunner's lesion
297980|NCT01879644|ADHD|adhd
297981|NCT01879644|Neurofeedback|neurofeedback
297982|NCT01879644|Self-Management|self-management
297983|NCT01879644|Parental Psychoeducation|parental psychoeducation
297984|NCT01879644|Social Support|social support
297985|NCT01879631|radial keratotomy; keratoconus; optical rehabilitation|radial keratotomy; keratoconus; optical rehabilitation
297986|NCT01879618|Fragmin|fragmin
297987|NCT01879618|dalteparin|dalteparin
297988|NCT01879618|hemodialysis|hemodialysis
297989|NCT01879618|anticoagulation|anticoagulation
297990|NCT01879618|Renal Failure|renal failure
297991|NCT01879605|Spinal surgery|spinal surgery
297992|NCT01879605|Bowel preparation|bowel preparation
297993|NCT01879605|Ileus|ileus
297994|NCT01879605|Constipation|constipation
297995|NCT01879605|Well-being|well-being
297996|NCT01879592|Sickle cell disease|sickle cell disease
297997|NCT01879592|Asthma|asthma
297998|NCT01879592|Metabolomics|metabolomics
297999|NCT01879592|Gene expression|gene expression
298000|NCT01879579|Insulin|insulin
298001|NCT01879579|Telemedicine|telemedicine
298002|NCT01879553|Influenza,|influenza,
298003|NCT01879553|Adults,|adults,
298004|NCT01879553|Elderly,|elderly,
298005|NCT01879553|Immunology,|immunology,
298006|NCT01879553|Safety|safety
298007|NCT01879540|Influenza,|influenza,
298008|NCT01879540|Elderly,|elderly,
298009|NCT01879540|Immunology,|immunology,
298010|NCT01879540|Safety|safety
298011|NCT01879514|IgA nephropathy|iga nephropathy
298012|NCT01879514|Therapy of Chinese medicine|therapy of chinese medicine
298013|NCT01879501|Low vision|low vision
298014|NCT01879501|Self management|self management
298015|NCT01879501|Randomized controlled trial|randomized controlled trial
298016|NCT01879501|Quality of life|quality of life
298017|NCT01879501|Self efficacy|self efficacy
298018|NCT01879501|Effectiveness|effectiveness
298019|NCT01879501|Chronic eye diseases management|chronic eye diseases management
298020|NCT01879488|Aerosol|aerosol
298021|NCT01879488|Lung deposition|lung deposition
298022|NCT01879488|Mechanical ventilation|mechanical ventilation
298023|NCT01879462|chronic hepatitis C (CHC)|chronic hepatitis c (chc)
298024|NCT01879462|Hepatitis C virus (HCV)|hepatitis c virus (hcv)
298025|NCT01879462|NS5B|ns5b
298026|NCT01879462|pharmacokinetics|pharmacokinetics
298027|NCT01879462|GSK2878175|gsk2878175
298028|NCT01879462|safety|safety
298029|NCT01879462|FTIH|ftih
298030|NCT01879462|healthy subjects|healthy subjects
298031|NCT01879449|Spasticity|spasticity
298032|NCT01879449|Veterans|veterans
298033|NCT01879449|Prevalence|prevalence
298034|NCT01879436|Pregnancy, Placenta, Cancer|pregnancy, placenta, cancer
298035|NCT01879410|GSK573719|gsk573719
298036|NCT01879410|lung function|lung function
298037|NCT01879410|salmeterol (SAL)|salmeterol (sal)
298038|NCT01879410|umeclidinium bromide (UMEC)|umeclidinium bromide (umec)
298039|NCT01879410|GW642444|gw642444
298040|NCT01879410|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
298041|NCT01879410|Novel Dry Powder Inhaler (NDPI)|novel dry powder inhaler (ndpi)
298042|NCT01879410|fluticasone propionate (FP)|fluticasone propionate (fp)
298043|NCT01879410|vilanterol (VI)|vilanterol (vi)
298044|NCT01879397|atherosclerosis|atherosclerosis
298045|NCT01879397|arteriosclerosis|arteriosclerosis
298046|NCT01879397|carotid stenosis|carotid stenosis
298047|NCT01879397|carotid endarterectomy|carotid endarterectomy
298048|NCT01879397|Stroke|stroke
298049|NCT01879384|microdialysis|microdialysis
298050|NCT01879384|bone free flap|bone free flap
298051|NCT01879384|head and neck|head and neck
298052|NCT01879384|monitoring free flap|monitoring free flap
298053|NCT01879384|reconstructive surgery|reconstructive surgery
298054|NCT01879358|Drug-eluting stent|drug-eluting stent
298055|NCT01879358|Safety|safety
298056|NCT01879358|Efficacy|efficacy
298057|NCT01879345|Anticonvulsant|anticonvulsant
298058|NCT01879332|Anticonvulsant|anticonvulsant
298059|NCT01879319|LDL-C, triglycerides, high cholesterol|ldl-c, triglycerides, high cholesterol
298060|NCT01879293|Metformin|metformin
298061|NCT01879293|Left ventricular mass|left ventricular mass
298062|NCT01879293|Endothelial dysfunction|endothelial dysfunction
298063|NCT01879293|cardiac magnetic resonance|cardiac magnetic resonance
298064|NCT01879293|aortic pulse wave|aortic pulse wave
298065|NCT01879280|pterional craniotomy|pterional craniotomy
298066|NCT01879280|osteoplastic craniotomy|osteoplastic craniotomy
298067|NCT01879280|temporalis|temporalis
298068|NCT01879280|minimally-invasive|minimally-invasive
298069|NCT01879254|obsessive compulsive disorder (OCD)|obsessive compulsive disorder (ocd)
298070|NCT01879254|deep brain stimulation (DBS)|deep brain stimulation (dbs)
298071|NCT01879254|psychosurgery|psychosurgery
298072|NCT01879254|long-term follow-up|long-term follow-up
298073|NCT01879241|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
298074|NCT01879241|survival time|survival time
298075|NCT01879241|ALS functioning Rating Scale|als functioning rating scale
298076|NCT01879241|quality of life|quality of life
298077|NCT01879241|survival|survival
298078|NCT01879228|Cystic Fibrosis|cystic fibrosis
298079|NCT01879228|Diabetes|diabetes
298080|NCT01879228|Pancreatic Insufficiency|pancreatic insufficiency
298081|NCT01879202|multiple sclerosis|multiple sclerosis
298082|NCT01879202|fatigue|fatigue
298083|NCT01879202|fatigue severity scale|fatigue severity scale
298084|NCT01879202|fatigue impact scale|fatigue impact scale
298085|NCT01879202|quality of life|quality of life
298086|NCT01879163|Vaccine|vaccine
298087|NCT01879163|Immunogenicity|immunogenicity
298088|NCT01879137|Copeptin|copeptin
298089|NCT01879137|Arginin stimulation test|arginin stimulation test
298090|NCT01879111|Depressive episode|depressive episode
298091|NCT01879111|Chronic ischaemic heart disease|chronic ischaemic heart disease
298092|NCT01879111|Hypertension|hypertension
298093|NCT01879098|probiotics|probiotics
298094|NCT01879098|inflammation|inflammation
298095|NCT01879098|bile|bile
298096|NCT01879098|hunger|hunger
298097|NCT01879098|satiety|satiety
298098|NCT01879085|advanced|advanced
298099|NCT01879085|metastatic|metastatic
298100|NCT01879085|unresectable|unresectable
298101|NCT01879085|soft|soft
298102|NCT01879085|tissue|tissue
298103|NCT01879085|sarcomas|sarcomas
298104|NCT01879072|Biomarkers|biomarkers
298105|NCT01879072|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
298106|NCT01879059|insulin resistance|insulin resistance
298107|NCT01879059|exercise|exercise
298108|NCT01879059|continuous glucose monitoring|continuous glucose monitoring
298109|NCT01879059|blood flow|blood flow
298110|NCT01879059|endothelial function|endothelial function
298111|NCT01879046|Mesenchymal stem cells|mesenchymal stem cells
298112|NCT01879046|articular cartilage|articular cartilage
298113|NCT01879046|tissue engineering|tissue engineering
298114|NCT01879046|immunomodulation|immunomodulation
298115|NCT01879046|osteo-arthritis|osteo-arthritis
298116|NCT01879033|Obesity|obesity
298117|NCT01879033|endothelial function|endothelial function
298118|NCT01879033|Rh-PAT|rh-pat
298119|NCT01879033|adipocytokines|adipocytokines
298120|NCT01879020|MT-8995|mt-8995
298121|NCT01879020|Dyslipidemia|dyslipidemia
298122|NCT01879020|Cholesteryl ester transfer proteins|cholesteryl ester transfer proteins
298123|NCT01878994|Overweight|overweight
298124|NCT01878994|Obesity|obesity
298125|NCT01878994|Children|children
298126|NCT01878994|Behaviour|behaviour
298127|NCT01878994|Physical Activity|physical activity
298128|NCT01878994|Nutrition|nutrition
298129|NCT01878981|Catheter Ablation versus Drug Therapy in AF in China|catheter ablation versus drug therapy in af in china
298130|NCT01878955|Antimullarian hormone(AMH)|antimullarian hormone(amh)
298131|NCT01878955|Polycystic Ovary|polycystic ovary
298132|NCT01878955|Multicystic Ovary|multicystic ovary
298133|NCT01878942|LSD|lsd
298134|NCT01878942|Pharmacology|pharmacology
298135|NCT01878942|Pharmacokinetics|pharmacokinetics
298136|NCT01878942|Pharmacodynamics|pharmacodynamics
298137|NCT01878942|Mechanism of action|mechanism of action
298138|NCT01878942|Psychedelic|psychedelic
298139|NCT01878942|Serotonin|serotonin
298140|NCT01878942|Prepulse inhibition|prepulse inhibition
298141|NCT01878942|LSD-induced neuroendocrine effects|lsd-induced neuroendocrine effects
298142|NCT01878942|Long-term psychological effects|long-term psychological effects
298143|NCT01878929|pollen|pollen
298144|NCT01878929|allergen immunotherapy|allergen immunotherapy
298145|NCT01878929|subcutaneous allergen immunotherapy|subcutaneous allergen immunotherapy
298146|NCT01878929|SCIT|scit
298147|NCT01878916|the incidence of thrombosis,|the incidence of thrombosis,
298148|NCT01878916|the effect of Hcy on thrombosis formation,|the effect of hcy on thrombosis formation,
298149|NCT01878916|the relation between Hcy and plasma vitamin levels,|the relation between hcy and plasma vitamin levels,
298150|NCT01878916|to compare these results with the control group|to compare these results with the control group
298151|NCT01878890|Solid tumors (other than pancreas)|solid tumors (other than pancreas)
298152|NCT01878877|Chronic pain|chronic pain
298153|NCT01878877|neuropathic pain|neuropathic pain
298154|NCT01878864|Pain, Discomfort, Periodontitis, Scaling and Root Planning, Visual Analogue Scale, McGills Pain Questionnaire|pain, discomfort, periodontitis, scaling and root planning, visual analogue scale, mcgills pain questionnaire
298155|NCT01878825|Immunogenicity|immunogenicity
298156|NCT01878825|Trivalent|trivalent
298157|NCT01878825|Safety|safety
298158|NCT01878825|Adults|adults
298159|NCT01878825|Elderly|elderly
298160|NCT01878825|Influenza|influenza
298161|NCT01878812|Immunogenicity|immunogenicity
298162|NCT01878812|Influenza|influenza
298163|NCT01878812|Adults|adults
298164|NCT01878812|Safety|safety
298165|NCT01878812|Elderly|elderly
298166|NCT01878799|Direct Acting Antiviral|direct acting antiviral
298167|NCT01878799|Treatment Naive|treatment naive
298168|NCT01878799|Interferon Sparing|interferon sparing
298169|NCT01878799|Ribavirin Sparing|ribavirin sparing
298170|NCT01878786|kidney failure|kidney failure
298171|NCT01878773|Prostate Cancer|prostate cancer
298172|NCT01878773|MRI scan|mri scan
298173|NCT01878773|External beam radiotherapy|external beam radiotherapy
298174|NCT01878760|APRICOT|apricot
298175|NCT01878760|Anaesthesia|anaesthesia
298176|NCT01878760|Children|children
298177|NCT01878760|kids|kids
298178|NCT01878760|Paediatric Anaesthesia|paediatric anaesthesia
298179|NCT01878760|Observational Trial|observational trial
298180|NCT01878760|epidemiology|epidemiology
298181|NCT01878760|severe critical events in|severe critical events in
298182|NCT01878760|European Society of Anaesthesiology|european society of anaesthesiology
298183|NCT01878760|Europe|europe
298184|NCT01878747|Pediatric|pediatric
298185|NCT01878747|Pain|pain
298186|NCT01878747|Postoperative|postoperative
298187|NCT01878747|General Anesthesia|general anesthesia
298188|NCT01878747|Anesthesia Recovery Period|anesthesia recovery period
298189|NCT01878747|Infant Behavior|infant behavior
298190|NCT01878747|Adolescent Behavior|adolescent behavior
298191|NCT01878747|Patient Satisfaction|patient satisfaction
298192|NCT01878721|PET/CT|pet/ct
298193|NCT01878721|infection|infection
298194|NCT01878721|vasculitis|vasculitis
298195|NCT01878708|T-Cell Lymphoma|t-cell lymphoma
298196|NCT01878708|Relapsed T-Cell Lymphoma|relapsed t-cell lymphoma
298197|NCT01878708|Refractory T-Cell Lymphoma|refractory t-cell lymphoma
298198|NCT01878708|Oncaspar®|oncaspar®
298199|NCT01878708|PEG-L-asparaginase and dexamethasone|peg-l-asparaginase and dexamethasone
298200|NCT01878695|Integrative Medicine|integrative medicine
298201|NCT01878695|Breast Cancer|breast cancer
298202|NCT01878695|Stage 0|stage 0
298203|NCT01878695|Stage 1|stage 1
298204|NCT01878669|n-acetyl cysteine|n-acetyl cysteine
298205|NCT01878669|percutaneous coronary intervention|percutaneous coronary intervention
298206|NCT01878643|aerosolized antibiotic|aerosolized antibiotic
298207|NCT01878643|ventilator-associated pneumonia|ventilator-associated pneumonia
298208|NCT01878643|bacterial resistance|bacterial resistance
298209|NCT01878643|ventilator -associated tracheobronchitis|ventilator -associated tracheobronchitis
298210|NCT01878643|clinical pulmonary infection score|clinical pulmonary infection score
298211|NCT01878630|Chronic Heart Failure|chronic heart failure
298212|NCT01878630|CHF|chf
298213|NCT01878617|SJMB12|sjmb12
298214|NCT01878617|Brain Cancer|brain cancer
298215|NCT01878617|Brain Tumors in Children|brain tumors in children
298216|NCT01878617|Cisplatin|cisplatin
298217|NCT01878617|Cyclophosphamide|cyclophosphamide
298218|NCT01878617|Embryonal Tumors of CNS|embryonal tumors of cns
298219|NCT01878617|GDC-0449|gdc-0449
298220|NCT01878617|Gemcitabine|gemcitabine
298221|NCT01878617|Hedgehog Pathway Inhibitor|hedgehog pathway inhibitor
298222|NCT01878617|Infratentorial|infratentorial
298223|NCT01878617|Mass in Brain|mass in brain
298224|NCT01878617|Medulloblastoma|medulloblastoma
298225|NCT01878617|Medulloblastoma Brain Tumor|medulloblastoma brain tumor
298226|NCT01878617|Medulloblastoma Tumor|medulloblastoma tumor
298227|NCT01878617|Molecular|molecular
298228|NCT01878617|Neuroectodermal Tumor, Primitive|neuroectodermal tumor, primitive
298229|NCT01878617|Newly Diagnosed Childhood Medulloblastoma|newly diagnosed childhood medulloblastoma
298230|NCT01878617|Non-SHH Non-WNT|non-shh non-wnt
298231|NCT01878617|Pediatric Brain Tumor|pediatric brain tumor
298232|NCT01878617|Pemetrexed|pemetrexed
298233|NCT01878617|Posterior Fossa Tumor|posterior fossa tumor
298234|NCT01878617|Proton Beam Therapy|proton beam therapy
298235|NCT01878617|Radiation Therapy|radiation therapy
298236|NCT01878617|Rare Brain Tumor|rare brain tumor
298237|NCT01878617|Risk|risk
298238|NCT01878617|SHH|shh
298239|NCT01878617|Sonic Hedgehog Pathway|sonic hedgehog pathway
298240|NCT01878617|St Jude Medullo|st jude medullo
298241|NCT01878617|St. Jude Brain Tumor Studies|st. jude brain tumor studies
298242|NCT01878617|St. Jude Medullo|st. jude medullo
298243|NCT01878617|St. Jude Studies|st. jude studies
298244|NCT01878617|St. Jude Treatment|st. jude treatment
298245|NCT01878617|Treatment for Brain Tumors in Children|treatment for brain tumors in children
298246|NCT01878617|Untreated Childhood Medulloblastoma|untreated childhood medulloblastoma
298247|NCT01878617|Vincristine|vincristine
298248|NCT01878617|Vismodegib|vismodegib
298249|NCT01878617|WNT|wnt
298250|NCT01878591|labour|labour
298251|NCT01878591|dystocia|dystocia
298252|NCT01878591|operative delivery|operative delivery
298253|NCT01878591|vacuum|vacuum
298254|NCT01878591|ultrasound|ultrasound
298255|NCT01878578|Anticonvulsant, BIA 2-093|anticonvulsant, bia 2-093
298256|NCT01878565|HBIg|hbig
298257|NCT01878565|GM-CSF|gm-csf
298258|NCT01878565|HBV vaccine|hbv vaccine
298259|NCT01878565|immune regulatory therapy|immune regulatory therapy
298260|NCT01878526|gastroesophageal reflux disease|gastroesophageal reflux disease
298261|NCT01878526|heart burn|heart burn
298262|NCT01878526|regurgitation|regurgitation
298263|NCT01878526|systemic sclerosis|systemic sclerosis
298264|NCT01878526|scleroderma|scleroderma
298265|NCT01878526|proton pump inhibitor|proton pump inhibitor
298266|NCT01878526|alginic acid|alginic acid
298267|NCT01878526|omeprazole|omeprazole
298268|NCT01878526|prokinetic|prokinetic
298269|NCT01878500|Bladder exstrophy epispadias complex|bladder exstrophy epispadias complex
298270|NCT01878500|Pelvic floor musculature|pelvic floor musculature
298271|NCT01878500|Intraoperative stereotactic imaging|intraoperative stereotactic imaging
298272|NCT01878487|Acute MI|acute mi
298273|NCT01878487|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
298274|NCT01878487|thrombus aspiration, IVUS|thrombus aspiration, ivus
298275|NCT01878474|MT-8995|mt-8995
298276|NCT01878474|Dyslipidemia|dyslipidemia
298277|NCT01878474|Cholesteryl ester transfer proteins|cholesteryl ester transfer proteins
298278|NCT01878435|Short Message System|short message system
298279|NCT01878435|SMS reminder|sms reminder
298280|NCT01878435|mobile phone|mobile phone
298281|NCT01878435|cell phone|cell phone
298282|NCT01878435|vaccination|vaccination
298283|NCT01878435|immunization|immunization
298284|NCT01878435|mHealth|mhealth
298285|NCT01878409|Sexuality|sexuality
298286|NCT01878409|Parkinson Disease|parkinson disease
298287|NCT01878409|BISF|bisf
298288|NCT01878409|IIEF|iief
298289|NCT01878409|FSFI|fsfi
298290|NCT01878396|Circulating Melanoma cells in metastatic melanoma|circulating melanoma cells in metastatic melanoma
298291|NCT01878383|(HSV)|(hsv)
298292|NCT01878357|MST|mst
298293|NCT01878357|Malaria|malaria
298294|NCT01878357|Indonesia|indonesia
298295|NCT01878357|Transmission|transmission
298296|NCT01878305|hepatic encephalopathy|hepatic encephalopathy
298297|NCT01878305|brain waves|brain waves
298298|NCT01878305|electroencephalogram|electroencephalogram
298299|NCT01878305|transcranial Doppler ultrasonography|transcranial doppler ultrasonography
298300|NCT01878305|physiological monitoring|physiological monitoring
298301|NCT01878305|intensive care|intensive care
298302|NCT01878266|Diffuse Intrinsic Pontine Glioma (DIPG)|diffuse intrinsic pontine glioma (dipg)
298303|NCT01878266|Hypofractionated Radiotherapy|hypofractionated radiotherapy
298304|NCT01878266|Radiotherapy|radiotherapy
298305|NCT01878266|Median survival|median survival
298306|NCT01878240|Vascular surgery|vascular surgery
298307|NCT01878240|Abdominal Aortic aneurysm|abdominal aortic aneurysm
298308|NCT01878240|endovascular|endovascular
298309|NCT01878214|Health communication|health communication
298310|NCT01878214|Smoking cessation|smoking cessation
298311|NCT01878214|Health behavior|health behavior
298312|NCT01878214|Construction industry|construction industry
298313|NCT01878214|Audience segmentation|audience segmentation
298314|NCT01878201|Fimasartan|fimasartan
298315|NCT01878201|24 hours ABP monitoring(ABPM)|24 hours abp monitoring(abpm)
298316|NCT01878201|antihypertension|antihypertension
298317|NCT01878175|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
298318|NCT01878175|Veterans|veterans
298319|NCT01878175|Exercise|exercise
298320|NCT01878162|Prevention|prevention
298321|NCT01878162|Wellness|wellness
298322|NCT01878162|Occupation|occupation
298323|NCT01878162|Work|work
298324|NCT01878162|Law Enforcement|law enforcement
298325|NCT01878162|Exercise|exercise
298326|NCT01878123|Arthritis|arthritis
298327|NCT01878123|Rheumatoid Arthritis|rheumatoid arthritis
298328|NCT01878123|Joint Diseases|joint diseases
298329|NCT01878123|Musculoskeletal Diseases|musculoskeletal diseases
298330|NCT01878123|Rheumatic Diseases|rheumatic diseases
298331|NCT01878123|Connective Tissue Diseases|connective tissue diseases
298332|NCT01878123|Autoimmune Diseases|autoimmune diseases
298333|NCT01878123|Immune System Diseases|immune system diseases
298334|NCT01878123|Antirheumatic agents|antirheumatic agents
298335|NCT01878110|Trichotillomania|trichotillomania
298336|NCT01878110|Hair pulling|hair pulling
299040|NCT01875185|women|women
298337|NCT01878110|Behavior therapy|behavior therapy
298338|NCT01878084|Tissue regeneration|tissue regeneration
298339|NCT01878084|sol gel bioglass|sol gel bioglass
298340|NCT01878084|alveolar ridge preservation|alveolar ridge preservation
298341|NCT01878084|children|children
298342|NCT01878084|Egyptian|egyptian
298343|NCT01878084|class II orthodontic cases|class ii orthodontic cases
298344|NCT01878058|Prostate cancer|prostate cancer
298345|NCT01878058|Brachytherapy|brachytherapy
298346|NCT01878058|Seed implant|seed implant
298347|NCT01878045|American Indians|american indians
298348|NCT01878045|Diabetic Nephropathy|diabetic nephropathy
298349|NCT01878045|Kidney Biopsy|kidney biopsy
298350|NCT01878045|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
298351|NCT01878045|Retinopathy|retinopathy
298352|NCT01878032|Retinal Disease|retinal disease
298353|NCT01878032|Inherited Retinal Degeneration|inherited retinal degeneration
298354|NCT01878019|Pain|pain
298355|NCT01878019|Placebo|placebo
298356|NCT01878019|Opiate Antagonist|opiate antagonist
298357|NCT01878006|Opiate Receptor|opiate receptor
298358|NCT01878006|Genotype|genotype
298359|NCT01878006|PET Imaging|pet imaging
298360|NCT01877993|coronary artery spasm|coronary artery spasm
298361|NCT01877993|pathophysiology|pathophysiology
298362|NCT01877993|atrioventricular block|atrioventricular block
298363|NCT01877993|blood pressure|blood pressure
298364|NCT01877993|autonomic nervous function|autonomic nervous function
298365|NCT01877954|hydrofluoroalkane beclomethasone|hydrofluoroalkane beclomethasone
298366|NCT01877954|fluticasone|fluticasone
298367|NCT01877954|paediatrics|paediatrics
298368|NCT01877954|real-life|real-life
298369|NCT01877954|observational|observational
298370|NCT01877954|primary care|primary care
298371|NCT01877941|cardiac output|cardiac output
298372|NCT01877941|pulse oximetry|pulse oximetry
298373|NCT01877941|hemodynamics|hemodynamics
298374|NCT01877928|Obstructive sleep apnea, CPAP, Boussignac|obstructive sleep apnea, cpap, boussignac
298375|NCT01877915|Heart Failure|heart failure
298376|NCT01877915|Coronary Artery Disease|coronary artery disease
298377|NCT01877915|Stroke|stroke
298378|NCT01877915|Myocardial Infarction|myocardial infarction
298379|NCT01877915|Anticoagulation|anticoagulation
298380|NCT01877889|Healthy|healthy
298381|NCT01877889|Canagliflozin|canagliflozin
298382|NCT01877889|INVOKANA|invokana
298383|NCT01877889|Dapagliflozin|dapagliflozin
298384|NCT01877889|FORXIGA|forxiga
298385|NCT01877889|Pharmacodynamics|pharmacodynamics
298386|NCT01877863|intradialytic exercise|intradialytic exercise
298387|NCT01877863|hemodialysis|hemodialysis
298388|NCT01877837|Stem cell transplant|stem cell transplant
298389|NCT01877837|Sickle cell|sickle cell
298390|NCT01877837|Stem cell transplantation|stem cell transplantation
298391|NCT01877837|Related|related
298392|NCT01877837|Unrelated|unrelated
298393|NCT01877824|Surgery|surgery
298394|NCT01877824|Training|training
298395|NCT01877811|Lung Cancer|lung cancer
298396|NCT01877811|RET Inhibitor|ret inhibitor
298397|NCT01877811|Solid Tumors|solid tumors
298398|NCT01877811|RET mutations or rearrangements|ret mutations or rearrangements
298399|NCT01877811|BRAF mutations or rearrangements|braf mutations or rearrangements
298400|NCT01877811|Squamous NSCLC|squamous nsclc
298401|NCT01877811|KRAS mutation|kras mutation
298402|NCT01877811|Other Lung adenocarcinomas|other lung adenocarcinomas
298403|NCT01877772|cuff repair|cuff repair
298404|NCT01877772|arthroscopic|arthroscopic
298405|NCT01877772|Trephination|trephination
298406|NCT01877772|Bone|bone
298407|NCT01877772|cuff tear|cuff tear
298408|NCT01877759|Stem cell ,liver cirrhosis|stem cell ,liver cirrhosis
298409|NCT01877746|ICM|icm
298410|NCT01877746|myocarditis|myocarditis
298411|NCT01877746|cardiomyopathy|cardiomyopathy
298412|NCT01877746|endomyocardial biopsy|endomyocardial biopsy
298413|NCT01877746|immunosuppression|immunosuppression
298414|NCT01877733|Resistance training|resistance training
298415|NCT01877720|Preterm infant less than 32 weeks of gestation age|preterm infant less than 32 weeks of gestation age
298416|NCT01877720|intubated more than 48 hours after birth|intubated more than 48 hours after birth
298417|NCT01877720|postextubation|postextubation
298418|NCT01877694|pink eye|pink eye
298419|NCT01877668|psoriatic arthritis|psoriatic arthritis
298420|NCT01877668|radiographic changes|radiographic changes
298421|NCT01877668|active comparator|active comparator
298422|NCT01877668|tofacitinib|tofacitinib
298423|NCT01877655|ASP0113|asp0113
298424|NCT01877655|Cytomegalovirus (CMV)|cytomegalovirus (cmv)
298425|NCT01877655|Hematopoietic Cell Transplant (HCT)|hematopoietic cell transplant (hct)
298426|NCT01877642|ADASUVE|adasuve
298427|NCT01877642|inhaled loxapine|inhaled loxapine
298428|NCT01877642|drug drug interaction|drug drug interaction
298429|NCT01877642|lorazepam|lorazepam
298430|NCT01877642|acute treatment of agitation|acute treatment of agitation
298431|NCT01877629|Pharmacokinetics|pharmacokinetics
298432|NCT01877629|Tolerability|tolerability
298433|NCT01877629|Safety|safety
298434|NCT01877629|ACT-129968|act-129968
298435|NCT01877616|sleep disorders|sleep disorders
298436|NCT01877616|insomnia|insomnia
298437|NCT01877616|hypersomnia|hypersomnia
298438|NCT01877616|sleep-disordered breathing|sleep-disordered breathing
298439|NCT01877616|cardiovascular health|cardiovascular health
298440|NCT01877616|stroke|stroke
298441|NCT01877616|ischemic heart disease|ischemic heart disease
298442|NCT01877616|Atahualpa|atahualpa
298444|NCT01877551|Protease inhibitor|protease inhibitor
298445|NCT01877551|insulin resistance|insulin resistance
298446|NCT01877551|Tauroursodeoxycholic acid|tauroursodeoxycholic acid
298447|NCT01877525|colorectal polyps|colorectal polyps
298448|NCT01877525|resect and discard|resect and discard
298449|NCT01877525|endoscopic prediction|endoscopic prediction
298450|NCT01877525|histological diagnosis|histological diagnosis
298451|NCT01877525|narrow band imaging|narrow band imaging
298452|NCT01877499|Hemodiafiltration|hemodiafiltration
298453|NCT01877499|Convection volume|convection volume
298454|NCT01877499|Filtration fraction|filtration fraction
298455|NCT01877499|Blood flow|blood flow
298456|NCT01877499|Treatment time|treatment time
298457|NCT01877486|atrial fibrillation|atrial fibrillation
298458|NCT01877486|cryoballoon ablation|cryoballoon ablation
298459|NCT01877486|persistent AF|persistent af
298460|NCT01877486|paroxysmal AF|paroxysmal af
298461|NCT01877486|dofetilide|dofetilide
298462|NCT01877473|atrial fibrillation|atrial fibrillation
298463|NCT01877473|persistent AF|persistent af
298464|NCT01877473|catheter ablation|catheter ablation
298465|NCT01877473|duration of 7 days to one year|duration of 7 days to one year
298466|NCT01877473|with symptoms and failure of at least one antiarrhythmic drug|with symptoms and failure of at least one antiarrhythmic drug
298467|NCT01877460|sodium alginate|sodium alginate
298468|NCT01877460|chocolate milk|chocolate milk
298469|NCT01877460|satiety|satiety
298470|NCT01877460|energy intake|energy intake
298471|NCT01877460|glycemia|glycemia
298472|NCT01877460|insulinemia|insulinemia
298473|NCT01877447|tDCS|tdcs
298474|NCT01877447|Brain stimulation|brain stimulation
298475|NCT01877447|depressive disorder|depressive disorder
298476|NCT01877434|Reversed shoulder arthroplasty|reversed shoulder arthroplasty
298477|NCT01877434|Treatment|treatment
298478|NCT01877434|TESS|tess
298479|NCT01877421|Reducing plaque|reducing plaque
298480|NCT01877421|Reducing gingivitis|reducing gingivitis
298481|NCT01877421|safety|safety
298482|NCT01877421|proof of concept|proof of concept
298483|NCT01877421|antiplaque chewing gum|antiplaque chewing gum
298484|NCT01877408|disposable circumcision device|disposable circumcision device
298485|NCT01877408|Tissue adhesive|tissue adhesive
298486|NCT01877408|Open surgical circumcision|open surgical circumcision
298487|NCT01877408|Minimally-invasive circumcision|minimally-invasive circumcision
298488|NCT01877395|Rabies|rabies
298489|NCT01877395|Purified Vero Rabies Vaccine - Serum Free|purified vero rabies vaccine - serum free
298490|NCT01877395|Human Diploid Cell Vaccine|human diploid cell vaccine
298491|NCT01877395|Imovax® Rabies|imovax® rabies
298492|NCT01877356|ambulatory surgery|ambulatory surgery
298493|NCT01877356|spinal anesthesia|spinal anesthesia
298494|NCT01877356|micturition|micturition
298495|NCT01877356|bladder retention|bladder retention
298496|NCT01877356|unilateral block|unilateral block
298497|NCT01877356|prilocaine hyperbaric|prilocaine hyperbaric
298498|NCT01877356|prilocaine plain|prilocaine plain
298499|NCT01877356|local anaesthetic dose|local anaesthetic dose
298500|NCT01877343|cardiac functional health classification|cardiac functional health classification
298501|NCT01877343|Congenital heart failure|congenital heart failure
298502|NCT01877343|chronic heart failure|chronic heart failure
298503|NCT01877330|shoulder arthroscopy|shoulder arthroscopy
298504|NCT01877330|ultrasound guided nerve block|ultrasound guided nerve block
298505|NCT01877330|interscalene nerve block|interscalene nerve block
298506|NCT01877317|Audiology|audiology
298507|NCT01877317|hearing loss|hearing loss
298508|NCT01877317|hearing healthcare|hearing healthcare
298509|NCT01877317|mobile app|mobile app
298510|NCT01877317|hearing aid fitting|hearing aid fitting
298511|NCT01877317|audiometry|audiometry
298512|NCT01877317|audiogram|audiogram
298513|NCT01877291|smoking, nasal lavage, exhaled breath condensate, mucociliary transport|smoking, nasal lavage, exhaled breath condensate, mucociliary transport
298514|NCT01877278|Osteoarthritis|osteoarthritis
298515|NCT01877278|Pulsed electromagnetic fields|pulsed electromagnetic fields
298516|NCT01877278|Device|device
298517|NCT01877278|Pain|pain
298518|NCT01877278|Pressure algometry|pressure algometry
298519|NCT01877252|critical limb ischemia|critical limb ischemia
298520|NCT01877252|endovascular treatment|endovascular treatment
298521|NCT01877252|open surgical repair|open surgical repair
298522|NCT01877252|diabetic foot|diabetic foot
298523|NCT01877226|Healthy|healthy
298524|NCT01877226|Tapentadol|tapentadol
298525|NCT01877213|coaching|coaching
298526|NCT01877213|therapeutic education|therapeutic education
298527|NCT01877213|hospital admission|hospital admission
298528|NCT01877213|quality improvement strategies|quality improvement strategies
298529|NCT01877213|management program|management program
298530|NCT01877213|nurse follow up|nurse follow up
298531|NCT01877213|discharge planning|discharge planning
298532|NCT01877213|rehospitalization|rehospitalization
298533|NCT01877187|Primary liver cancer|primary liver cancer
298534|NCT01877187|Metastatic liver cancer|metastatic liver cancer
298535|NCT01877174|Internal Carotid Stenosis|internal carotid stenosis
298536|NCT01877174|Reverse Flow|reverse flow
298537|NCT01877174|Carotid stenting|carotid stenting
298538|NCT01877174|MICHI(TM) NPS+f|michi(tm) nps+f
298539|NCT01877148|Parkinson, rehabilitation, tDCS|parkinson, rehabilitation, tdcs
298540|NCT01877135|anal carcinoma|anal carcinoma
298541|NCT01877135|AIN3|ain3
298542|NCT01877135|cohort study|cohort study
298543|NCT01877109|Lymphoma|lymphoma
298544|NCT01877109|Prognosis|prognosis
298545|NCT01877109|Biomarker|biomarker
298546|NCT01877109|Quality of life|quality of life
298547|NCT01877096|Motivational Interviewing|motivational interviewing
298548|NCT01877096|Screening Colonoscopy|screening colonoscopy
298549|NCT01877096|Cancer Prevention|cancer prevention
298550|NCT01877083|KIF5B-RET-Positive Adenocarcinoma|kif5b-ret-positive adenocarcinoma
298551|NCT01877083|Lung Cancer|lung cancer
298552|NCT01877083|NSCLC|nsclc
298553|NCT01877083|Non-Small Cell Lung Cancer|non-small cell lung cancer
298554|NCT01877070|assessments|assessments
298555|NCT01877070|13-076|13-076
298556|NCT01877057|Pea protein|pea protein
298557|NCT01877057|Satiety hormone|satiety hormone
298558|NCT01877057|Ussing Chamber|ussing chamber
298559|NCT01877044|Prebiotics|prebiotics
298560|NCT01877044|Intestinal permeability|intestinal permeability
298561|NCT01877044|Gut barrier function|gut barrier function
298562|NCT01877044|Immunity|immunity
298563|NCT01877031|central line|central line
298564|NCT01877031|ultrasound guided central line insertion|ultrasound guided central line insertion
298565|NCT01877031|virtual reality|virtual reality
298566|NCT01877031|augmented reality|augmented reality
298567|NCT01877018|Comparative Effectiveness Research|comparative effectiveness research
298568|NCT01877018|Reminder Systems|reminder systems
298569|NCT01877018|Patient Participation|patient participation
298570|NCT01877018|Primary Health Care|primary health care
298571|NCT01877018|Early Detection of Cancer|early detection of cancer
298572|NCT01877018|Colorectal Neoplasms|colorectal neoplasms
298573|NCT01877005|Multicenter, single arm and opened label phase II study|multicenter, single arm and opened label phase ii study
298574|NCT01876992|diabetes|diabetes
298575|NCT01876992|pediatrics|pediatrics
298576|NCT01876992|obesity|obesity
298577|NCT01876992|healthy volunteers|healthy volunteers
298578|NCT01876992|metformin|metformin
298579|NCT01876992|nutrition|nutrition
298580|NCT01876992|healthy controls|healthy controls
298582|NCT01876966|HIV|hiv
298583|NCT01876966|pharmacokinetic interaction|pharmacokinetic interaction
298584|NCT01876966|healthy HIV-negative person|healthy hiv-negative person
298585|NCT01876940|supraglottic airway|supraglottic airway
298586|NCT01876940|children|children
298587|NCT01876940|tracheal intubation|tracheal intubation
298588|NCT01876940|fiberoptic bronchoscopy|fiberoptic bronchoscopy
298589|NCT01876927|Locally|locally
298590|NCT01876927|Advanced|advanced
298591|NCT01876927|Resectable|resectable
298592|NCT01876927|Gastric Cancer|gastric cancer
298593|NCT01876914|Diabetes|diabetes
298594|NCT01876914|Edema|edema
298595|NCT01876914|DME|dme
298596|NCT01876914|OCT|oct
298597|NCT01876901|Rectal cancer|rectal cancer
298598|NCT01876901|Coloanal anastomosis|coloanal anastomosis
298599|NCT01876901|Phase 2 clinical trial|phase 2 clinical trial
298600|NCT01876888|patient satisfaction|patient satisfaction
298601|NCT01876888|physical therapy|physical therapy
298602|NCT01876888|MedRisk instrument|medrisk instrument
298603|NCT01876875|psoriasis|psoriasis
298604|NCT01876875|obesity|obesity
298605|NCT01876862|HIV-1|hiv-1
298606|NCT01876862|chronic infection|chronic infection
298607|NCT01876862|cure|cure
298608|NCT01876862|remission|remission
298609|NCT01876849|diabetes|diabetes
298610|NCT01876849|exenatide|exenatide
298611|NCT01876849|Byetta|byetta
298612|NCT01876849|Amylin|amylin
298613|NCT01876849|Lilly|lilly
298614|NCT01876836|i-gel|i-gel
298615|NCT01876836|C-LMA|c-lma
298616|NCT01876836|gastroeosephageal reflux|gastroeosephageal reflux
298617|NCT01876836|sore troat|sore troat
298618|NCT01876823|Memory Decline|memory decline
298619|NCT01876823|Depression|depression
298620|NCT01876823|Elderly|elderly
298621|NCT01876823|Antidepressants|antidepressants
298622|NCT01876823|Treatment|treatment
298623|NCT01876823|memantine|memantine
298624|NCT01876810|Gemfibrozil|gemfibrozil
298625|NCT01876810|Nicotine Dependence|nicotine dependence
298626|NCT01876810|Smoking|smoking
298627|NCT01876810|Cigarettes|cigarettes
298628|NCT01876784|vandetanib, AZD 6474, Differentiated Thyroid Cancer|vandetanib, azd 6474, differentiated thyroid cancer
298629|NCT01876771|177lutetium-DOTA(O)Tyr3)octreotate|177lutetium-dota(o)tyr3)octreotate
298630|NCT01876758|ECT|ect
298631|NCT01876758|Memory Training|memory training
298632|NCT01876758|Cognitive Remediation|cognitive remediation
298633|NCT01876758|Electroconvulsive Therapy|electroconvulsive therapy
298634|NCT01876758|Treatment Resistant Depression|treatment resistant depression
298635|NCT01876758|Depression|depression
298636|NCT01876758|Geriatric Depression|geriatric depression
298637|NCT01876758|Memory Loss|memory loss
298638|NCT01876758|Cognitive Training|cognitive training
298639|NCT01876732|hemodialysis|hemodialysis
298640|NCT01876732|viatmin B12 deficiency|viatmin b12 deficiency
298641|NCT01876732|Epogen|epogen
298642|NCT01876719|ADHD|adhd
298643|NCT01876719|AR08|ar08
298644|NCT01876719|adrenergic receptor agonists|adrenergic receptor agonists
298645|NCT01876719|randomized, placebo-controlled clinical trial|randomized, placebo-controlled clinical trial
298646|NCT01876706|UroLift System|urolift system
298647|NCT01876680|chronic|chronic
298648|NCT01876680|neck|neck
298649|NCT01876680|shoulder|shoulder
298650|NCT01876680|exercise|exercise
298651|NCT01876654|Total Knee Replacement|total knee replacement
298652|NCT01876654|Patient specific instrumentation|patient specific instrumentation
298653|NCT01876641|Metastatic melanoma|metastatic melanoma
298654|NCT01876641|melanoma|melanoma
298655|NCT01876641|BRAF-mutated Metastatic Melanoma|braf-mutated metastatic melanoma
298656|NCT01876641|V600EBRAF-mutated metastatic melanoma|v600ebraf-mutated metastatic melanoma
298657|NCT01876641|Decitabine|decitabine
298658|NCT01876641|Vemurafenib|vemurafenib
298659|NCT01876628|Clindamycin|clindamycin
298660|NCT01876628|Cellulitis|cellulitis
298661|NCT01876628|Flucloxacillin|flucloxacillin
298662|NCT01876628|Group A streptococcus|group a streptococcus
298663|NCT01876628|Staphylococcus aureus|staphylococcus aureus
298664|NCT01876615|safety/tolerability and pharmacokinetics/pharmacodynamics|safety/tolerability and pharmacokinetics/pharmacodynamics
298665|NCT01876602|adolescents|adolescents
298666|NCT01876602|exercise|exercise
298667|NCT01876602|fitness|fitness
298668|NCT01876602|school-based|school-based
298669|NCT01876589|Coronary Artery Disease (CAD)|coronary artery disease (cad)
298670|NCT01876589|Invasive coronary angiography (ICA)|invasive coronary angiography (ica)
298671|NCT01876589|Positron Emission Tomography (PET)|positron emission tomography (pet)
298672|NCT01876576|colonoscopy|colonoscopy
298673|NCT01876563|thioredoxin|thioredoxin
298674|NCT01876563|TBP-2|tbp-2
298675|NCT01876563|thioredoxin reductase|thioredoxin reductase
298676|NCT01876563|vitamin D|vitamin d
298677|NCT01876563|DIABETES|diabetes
298678|NCT01876550|Mupirocin Calcium Cream 2%|mupirocin calcium cream 2%
298679|NCT01876550|Bactroban® Cream|bactroban® cream
298680|NCT01876550|Secondarily infected traumatic skin lesions|secondarily infected traumatic skin lesions
298681|NCT01876524|Substance Use Disorder|substance use disorder
298682|NCT01876524|Attention Deficit Disorder With Hyperactivity|attention deficit disorder with hyperactivity
298683|NCT01876524|Schizophrenia|schizophrenia
298684|NCT01876524|Bipolar disorder|bipolar disorder
298685|NCT01876524|Personality disorder|personality disorder
298686|NCT01876511|MSI|msi
298687|NCT01876511|MSS|mss
298688|NCT01876511|MLH 1|mlh 1
298689|NCT01876511|MSH 2|msh 2
298690|NCT01876511|MSH 6|msh 6
298691|NCT01876511|PMS2|pms2
298692|NCT01876511|BRAF pV600E|braf pv600e
298693|NCT01876511|TGFBR2|tgfbr2
298694|NCT01876511|Mutation load|mutation load
298695|NCT01876511|tumor mutation load|tumor mutation load
298696|NCT01876511|mutation burden|mutation burden
298697|NCT01876511|tumor mutation burden|tumor mutation burden
298698|NCT01876511|hypermutation|hypermutation
298699|NCT01876511|POLE|pole
298700|NCT01876511|MSI Negative with Mutator Phenotype (High Tumor Mutation Burden)|msi negative with mutator phenotype (high tumor mutation burden)
298701|NCT01876485|Diabetes Mellitus|diabetes mellitus
298702|NCT01876485|health literacy|health literacy
298703|NCT01876485|patient activation|patient activation
298704|NCT01876485|goals of care|goals of care
298705|NCT01876394|Healthy|healthy
298706|NCT01876394|Arterial Stiffness|arterial stiffness
298707|NCT01876394|Blood Pressure|blood pressure
298708|NCT01876394|Blood Glucose|blood glucose
298709|NCT01876394|Vascular Function|vascular function
298710|NCT01876368|hypertension,|hypertension,
298711|NCT01876368|LCZ696,|lcz696,
298712|NCT01876368|olmesartan|olmesartan
298713|NCT01876355|Delirium, clonidine, ICU, sedation|delirium, clonidine, icu, sedation
298714|NCT01876342|sports hernia|sports hernia
298715|NCT01876342|sportsman's hernia|sportsman's hernia
298716|NCT01876342|chronic groin pain|chronic groin pain
298717|NCT01876342|open minimal repair|open minimal repair
298718|NCT01876342|totally extraperitoneal endoscopic technique|totally extraperitoneal endoscopic technique
298719|NCT01876329|Rheumatoid Arthritis|rheumatoid arthritis
298720|NCT01876329|Vitamin B12 deficiency|vitamin b12 deficiency
298721|NCT01876329|Autoimmune Thyroid Disease|autoimmune thyroid disease
298722|NCT01876329|Autoantibodies|autoantibodies
298723|NCT01876316|Moxifloxacin|moxifloxacin
298724|NCT01876316|QT interval prolongation|qt interval prolongation
298725|NCT01876316|Korean|korean
298726|NCT01876316|Japanese|japanese
298727|NCT01876290|Anesthesiology|anesthesiology
298728|NCT01876290|Complications|complications
298729|NCT01876290|Closed-loop|closed-loop
298730|NCT01876277|Cancer|cancer
298731|NCT01876277|Body image|body image
298732|NCT01876277|Adolescent|adolescent
298733|NCT01876264|Colorectal surgery|colorectal surgery
298734|NCT01876264|Colonoscopy|colonoscopy
298735|NCT01876264|Randomized controlled trial|randomized controlled trial
299339|NCT01873690|Antibiotics|antibiotics
298736|NCT01876251|Breast cancer metastatic|breast cancer metastatic
298737|NCT01876251|docetaxel|docetaxel
298738|NCT01876251|PF-03084014|pf-03084014
298739|NCT01876238|Breast Cancer|breast cancer
298740|NCT01876238|Patient-Doctor Communication|patient-doctor communication
298741|NCT01876238|Supportive Care|supportive care
298742|NCT01876225|cervical biopsy|cervical biopsy
298743|NCT01876225|forced cough|forced cough
298744|NCT01876225|pain|pain
298745|NCT01876225|VAS scale|vas scale
298746|NCT01876212|melanoma|melanoma
298747|NCT01876212|metastatic|metastatic
298748|NCT01876212|vaccine|vaccine
298749|NCT01876212|BRAF|braf
298750|NCT01876199|HIV-1|hiv-1
298751|NCT01876199|acute|acute
298752|NCT01876199|diagnosis|diagnosis
298753|NCT01876199|pharmacies|pharmacies
298754|NCT01876199|healthcare facilities|healthcare facilities
298755|NCT01876186|antimuscarinic treatment|antimuscarinic treatment
298756|NCT01876186|urodynamic studies|urodynamic studies
298757|NCT01876186|nerve growth factor|nerve growth factor
298758|NCT01876173|Sudden cardiac death|sudden cardiac death
298759|NCT01876173|implantable cardioverter defibrillator|implantable cardioverter defibrillator
298760|NCT01876173|decision aid|decision aid
298761|NCT01876147|Low vision|low vision
298762|NCT01876147|Vision testing|vision testing
298763|NCT01876147|Retinitis Pigmentosa|retinitis pigmentosa
298764|NCT01876147|AMD|amd
298765|NCT01876147|Visual acuity|visual acuity
298766|NCT01876147|Poor vision|poor vision
298767|NCT01876147|Quantification|quantification
298768|NCT01876134|Cardiac surgery|cardiac surgery
298769|NCT01876134|Acute kidney injury|acute kidney injury
298770|NCT01876134|Cyr-61|cyr-61
298771|NCT01876134|Pulse wave analysis|pulse wave analysis
298772|NCT01876121|NSAIDs|nsaids
298773|NCT01876121|Acute pain|acute pain
298774|NCT01876108|Steatohepatitis|steatohepatitis
298775|NCT01876108|Helicobacter pylori|helicobacter pylori
298776|NCT01876108|Alanine aminotransferase|alanine aminotransferase
298777|NCT01876108|Aspartate aminotransferase|aspartate aminotransferase
298778|NCT01876108|Fatty Liver|fatty liver
298779|NCT01876108|Liver Diseases|liver diseases
298780|NCT01876108|Digestive System Diseases|digestive system diseases
298781|NCT01876082|Desmoids tumors|desmoids tumors
298782|NCT01876082|Pazopanib|pazopanib
298783|NCT01876082|Phase 2 clinical trial|phase 2 clinical trial
298784|NCT01876082|Cross over|cross over
298785|NCT01876056|Psychosis|psychosis
298786|NCT01876056|Culture|culture
298787|NCT01876056|CBT|cbt
298788|NCT01876030|Functional electrical stimulation (FES)|functional electrical stimulation (fes)
298789|NCT01876030|Sub acute stroke|sub acute stroke
298790|NCT01876030|Gait analysis|gait analysis
298791|NCT01876017|CRF|crf
298792|NCT01876017|STEM CELL|stem cell
298793|NCT01876017|CKD|ckd
298794|NCT01876004|ectopic pregnancy|ectopic pregnancy
298795|NCT01876004|methotrexate|methotrexate
298796|NCT01876004|human chorionic gonadotropin beta subunit|human chorionic gonadotropin beta subunit
298797|NCT01876004|expectant management|expectant management
298798|NCT01875978|Phytosterols|phytosterols
298799|NCT01875978|Endothelial progenitor cells|endothelial progenitor cells
298800|NCT01875952|Latent tuberculosis infection|latent tuberculosis infection
298801|NCT01875952|Human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
298802|NCT01875952|Treatment|treatment
298803|NCT01875952|Isoniazid|isoniazid
298804|NCT01875939|healthy volunteers|healthy volunteers
298805|NCT01875913|Curiosity|curiosity
298806|NCT01875913|Intention|intention
298807|NCT01875913|Follow Through|follow through
298808|NCT01875900|neonatal resuscitation|neonatal resuscitation
298809|NCT01875900|video-assisted learning|video-assisted learning
298810|NCT01875900|self-directed training|self-directed training
298811|NCT01875900|simulation|simulation
298812|NCT01875900|simulation-based training|simulation-based training
298813|NCT01875900|simulation-based medical education|simulation-based medical education
298814|NCT01875900|objective structured clinical examination|objective structured clinical examination
298815|NCT01875874|liver failure|liver failure
298816|NCT01875874|acute liver failure|acute liver failure
298817|NCT01875874|fulminant hepatic failure|fulminant hepatic failure
298818|NCT01875874|primary graft non-function|primary graft non-function
298819|NCT01875874|surgically-induced liver failure|surgically-induced liver failure
298820|NCT01875874|ELAD|elad
298821|NCT01875874|ALF|alf
298822|NCT01875874|FHF|fhf
298823|NCT01875874|PNF|pnf
298824|NCT01875861|Antipsychotic Agents|antipsychotic agents
298825|NCT01875861|Metabolic Syndrome|metabolic syndrome
298826|NCT01875861|Quality Improvement|quality improvement
298827|NCT01875848|pain management|pain management
298828|NCT01875835|Acute myocardiac infarction|acute myocardiac infarction
298829|NCT01875835|Bare-metal stent|bare-metal stent
298830|NCT01875835|Everolimus-eluting stent|everolimus-eluting stent
298831|NCT01875835|Optical coherence tomography|optical coherence tomography
298832|NCT01875822|Curcumin|curcumin
298833|NCT01875822|Epigenetics|epigenetics
298834|NCT01875822|Schizophrenia|schizophrenia
298835|NCT01875822|Nitric Oxide synthetase|nitric oxide synthetase
298836|NCT01875822|cognition|cognition
298837|NCT01875822|negative symptoms|negative symptoms
298838|NCT01875809|RDN|rdn
298839|NCT01875809|renal denervation|renal denervation
298840|NCT01875809|catecholamine|catecholamine
298841|NCT01875809|spill-over|spill-over
298842|NCT01875809|blood pressure|blood pressure
298843|NCT01875809|electrophysiology|electrophysiology
298844|NCT01875809|ablation|ablation
298845|NCT01875796|cannabis|cannabis
298846|NCT01875796|marijuana|marijuana
298847|NCT01875796|anxiety|anxiety
298848|NCT01875796|transdiagnostic|transdiagnostic
298849|NCT01875796|dual diagnosis|dual diagnosis
298850|NCT01875796|cannabis abuse|cannabis abuse
298851|NCT01875796|cannabis dependence|cannabis dependence
298852|NCT01875796|cannabis use disorder|cannabis use disorder
298853|NCT01875783|diabetes|diabetes
298854|NCT01875783|diabetic macular edema|diabetic macular edema
298855|NCT01875783|diabetic retinopathy|diabetic retinopathy
298856|NCT01875783|optical coherence tomography|optical coherence tomography
298857|NCT01875770|Retinal Vein Occlusion|retinal vein occlusion
298858|NCT01875757|Vitamin D|vitamin d
298859|NCT01875757|Acute bronchitis|acute bronchitis
298860|NCT01875757|Upper respiratory tract infection|upper respiratory tract infection
298861|NCT01875757|Recurrent bronchitis|recurrent bronchitis
298862|NCT01875757|Acute bronchiolitis|acute bronchiolitis
298863|NCT01875757|Infants|infants
298864|NCT01875744|constipation|constipation
298865|NCT01875744|children|children
298866|NCT01875744|polyethylene glycol|polyethylene glycol
298867|NCT01875731|Pneumonia|pneumonia
298868|NCT01875731|Acute respiratory infection|acute respiratory infection
298869|NCT01875731|Decision-support techniques|decision-support techniques
298870|NCT01875692|Metagenomic|metagenomic
298871|NCT01875692|Ventilator-Associated Pneumonia (VAP)|ventilator-associated pneumonia (vap)
298872|NCT01875679|Surgical education|surgical education
298873|NCT01875679|Deliberate practice|deliberate practice
298874|NCT01875679|Debriefing|debriefing
298875|NCT01875679|Behaviour modelling|behaviour modelling
298876|NCT01875666|breast cancer|breast cancer
298877|NCT01875666|Kinome|kinome
298878|NCT01875666|HER two positive|her two positive
298879|NCT01875653|metastatic melanoma|metastatic melanoma
298880|NCT01875653|dendritic cells|dendritic cells
298881|NCT01875653|immunotherapy|immunotherapy
298882|NCT01875653|Granulocyte-Macrophage Colony Stimulating Factor|granulocyte-macrophage colony stimulating factor
298883|NCT01875653|overall survival|overall survival
298884|NCT01875653|autologous|autologous
298885|NCT01875653|peripheral blood mononuclear cells|peripheral blood mononuclear cells
298886|NCT01875653|treatment|treatment
298887|NCT01875653|phase 3|phase 3
298888|NCT01875653|tumor cells|tumor cells
298889|NCT01875640|disorder of sex development|disorder of sex development
298890|NCT01875640|intersex|intersex
298891|NCT01875640|46,XX congenital adrenal hyperplasia|46,xx congenital adrenal hyperplasia
298892|NCT01875640|hypospadias|hypospadias
298893|NCT01875640|decision support tool|decision support tool
298894|NCT01875601|NK Cells|nk cells
298895|NCT01875601|Cytokine|cytokine
298896|NCT01875601|Lymphodepleting Chemotherapy|lymphodepleting chemotherapy
298897|NCT01875601|Immunotherapy|immunotherapy
298898|NCT01875601|Pediatric|pediatric
298899|NCT01875588|Healthy Controls|healthy controls
298900|NCT01875588|HIV-positive|hiv-positive
298901|NCT01875588|Neurophyschological Testing|neurophyschological testing
298902|NCT01875588|PET/CT Scan|pet/ct scan
298903|NCT01875588|Lumbar Drain/Puncture|lumbar drain/puncture
298904|NCT01875575|glucagon-like peptide-1|glucagon-like peptide-1
298905|NCT01875575|peptide tyrosine tyrosine|peptide tyrosine tyrosine
298906|NCT01875575|ghrelin|ghrelin
298907|NCT01875575|stomach|stomach
298908|NCT01875575|small intestine|small intestine
298909|NCT01875575|gastric emptying|gastric emptying
298910|NCT01875562|Neck pain|neck pain
298911|NCT01875562|Cervical radiculopathy|cervical radiculopathy
298912|NCT01875562|Qishe Pill|qishe pill
298913|NCT01875562|Traditional Chinese Medicine|traditional chinese medicine
298914|NCT01875536|transcranial magnetic stimulation|transcranial magnetic stimulation
298915|NCT01875536|spasticity|spasticity
298916|NCT01875536|physiotherapy|physiotherapy
298917|NCT01875536|Rehabilitation|rehabilitation
298918|NCT01875523|Renal disease|renal disease
298919|NCT01875523|renal impairment|renal impairment
298920|NCT01875523|End stage renal disease|end stage renal disease
298921|NCT01875523|Healthy volunteer|healthy volunteer
298922|NCT01875523|Pharmacokinetics|pharmacokinetics
298923|NCT01875497|athletes, polyphenols, nutrition, oxidative stress|athletes, polyphenols, nutrition, oxidative stress
298924|NCT01875484|miR-126|mir-126
298925|NCT01875484|Left Ventricular Remodeling|left ventricular remodeling
298926|NCT01875484|Myocardial Infarction|myocardial infarction
298927|NCT01875484|primary percutaneous coronary intervention|primary percutaneous coronary intervention
298928|NCT01875484|left ventricular end diastolic volume|left ventricular end diastolic volume
298929|NCT01875484|left ventricular ejection fraction|left ventricular ejection fraction
298930|NCT01875484|major adverse cardiovascular events|major adverse cardiovascular events
298931|NCT01875458|Aclasta|aclasta
298932|NCT01875458|Actonel|actonel
298933|NCT01875458|alendronate|alendronate
298934|NCT01875458|alendronate/cholecalciferol|alendronate/cholecalciferol
298935|NCT01875458|Aredia|aredia
298936|NCT01875458|Atelvia|atelvia
298937|NCT01875458|Boniva|boniva
298938|NCT01875458|Didronel|didronel
298939|NCT01875458|etidronate|etidronate
298940|NCT01875458|Fosamax|fosamax
298941|NCT01875458|Fosamax Plus D|fosamax plus d
298942|NCT01875458|ibandronate|ibandronate
298943|NCT01875458|pamidronate|pamidronate
298944|NCT01875458|Reclast|reclast
298945|NCT01875458|risedronate|risedronate
298946|NCT01875458|Skelid|skelid
298947|NCT01875458|tiludronate|tiludronate
298948|NCT01875458|zoledronic acid|zoledronic acid
298949|NCT01875458|Zometa|zometa
298950|NCT01875458|Bisphosphonate|bisphosphonate
298951|NCT01875458|Atypical Femur Fracture (AFF)|atypical femur fracture (aff)
298952|NCT01875458|Osteoporosis|osteoporosis
298953|NCT01875458|Bisphosphonate Related Osteonecrosis of the Jaw (BRONJ)|bisphosphonate related osteonecrosis of the jaw (bronj)
298954|NCT01875445|Inositol|inositol
298955|NCT01875445|Trichotillomania|trichotillomania
298956|NCT01875445|Hair Pulling|hair pulling
298957|NCT01875445|Impulse Control Disorder|impulse control disorder
298958|NCT01875393|Prostatic Disease|prostatic disease
298959|NCT01875393|Genital Neoplasm,male|genital neoplasm,male
298960|NCT01875393|Urogenital neoplasm|urogenital neoplasm
298961|NCT01875393|Genital disease,male|genital disease,male
298962|NCT01875393|Male urogenital disease|male urogenital disease
298963|NCT01875393|Neoplasms|neoplasms
298964|NCT01875393|Neoplasms by site|neoplasms by site
298965|NCT01875393|Prostatic neoplasm|prostatic neoplasm
298966|NCT01875393|Carcinoma|carcinoma
298967|NCT01875380|metastatic colorectal cancer|metastatic colorectal cancer
298968|NCT01875380|frail and unfit patient|frail and unfit patient
298969|NCT01875380|regorafenib|regorafenib
298970|NCT01875367|Subcutaneous trastuzumab|subcutaneous trastuzumab
298971|NCT01875367|Intravenous trastuzumab|intravenous trastuzumab
298972|NCT01875367|HER2 positive|her2 positive
298973|NCT01875367|Advanced Breast Cancer|advanced breast cancer
298974|NCT01875341|type 2 diabetes|type 2 diabetes
298975|NCT01875341|diabetic nephropathy|diabetic nephropathy
298976|NCT01875341|hypertension|hypertension
298977|NCT01875341|sleep apnea|sleep apnea
298978|NCT01875341|sympathetic hyperactivity|sympathetic hyperactivity
298979|NCT01875328|stroke|stroke
298980|NCT01875328|blood pressure|blood pressure
298981|NCT01875328|telemedicine|telemedicine
298982|NCT01875302|COPD PRO Instraments equivalency|copd pro instraments equivalency
298983|NCT01875276|Rhinitis|rhinitis
298984|NCT01875276|Antihistamine|antihistamine
298985|NCT01875276|Nasal Steroid Therapy|nasal steroid therapy
298986|NCT01875263|catheter-related bacteremia, SAMS|catheter-related bacteremia, sams
298987|NCT01875263|catheter related bacteremia|catheter related bacteremia
298988|NCT01875263|susceptible|susceptible
298989|NCT01875263|aureus meticillin|aureus meticillin
298990|NCT01875250|Gene Transfer|gene transfer
298991|NCT01875250|Androgen Receptor Antagonist|androgen receptor antagonist
298992|NCT01875250|PSA|psa
298993|NCT01875250|Immune Response|immune response
298994|NCT01875250|Immunotherapy|immunotherapy
298995|NCT01875237|Leukemia|leukemia
298996|NCT01875237|Myeloma|myeloma
298997|NCT01875237|Myeloproliferative Diseases|myeloproliferative diseases
298998|NCT01875237|Myelodysplastic syndrome|myelodysplastic syndrome
298999|NCT01875237|MDS|mds
299000|NCT01875237|Lymphoma|lymphoma
299001|NCT01875237|Hodgkin disease|hodgkin disease
299002|NCT01875237|Multiple myeloma|multiple myeloma
299003|NCT01875237|MM|mm
299004|NCT01875237|Transplant donor|transplant donor
299005|NCT01875237|T-cells|t-cells
299006|NCT01875237|G-versus-host disease|g-versus-host disease
299007|NCT01875237|GvHD|gvhd
299008|NCT01875237|G-CSF|g-csf
299009|NCT01875237|Filgrastim|filgrastim
299010|NCT01875237|Neupogen|neupogen
299011|NCT01875237|Fludarabine|fludarabine
299012|NCT01875237|Fludarabine phosphate|fludarabine phosphate
299013|NCT01875237|Fludara|fludara
299014|NCT01875237|Melphalan|melphalan
299015|NCT01875237|Alkeran|alkeran
299016|NCT01875237|Alemtuzumab|alemtuzumab
299017|NCT01875237|CAMPATH-1H|campath-1h
299018|NCT01875237|Campath|campath
299019|NCT01875237|Tacrolimus|tacrolimus
299020|NCT01875237|Prograf|prograf
299021|NCT01875237|Mini-methotrexate|mini-methotrexate
299022|NCT01875237|AP 1903|ap 1903
299023|NCT01875237|Methylprednisolone|methylprednisolone
299024|NCT01875237|Depo-Medrol|depo-medrol
299025|NCT01875237|Medrol|medrol
299026|NCT01875237|Solu-Medrol|solu-medrol
299027|NCT01875237|Stem cell infusion|stem cell infusion
299028|NCT01875237|Donor lymphocyte infusion|donor lymphocyte infusion
299029|NCT01875237|DLI|dli
299030|NCT01875237|Questionnaire|questionnaire
299031|NCT01875237|Survey|survey
299032|NCT01875224|kidney transplant|kidney transplant
299033|NCT01875224|diabetes after transplant|diabetes after transplant
299034|NCT01875224|belatacept|belatacept
299035|NCT01875198|Splenectomy;|splenectomy;
299036|NCT01875198|Spleen-preserving|spleen-preserving
299037|NCT01875185|acute coronary syndrome|acute coronary syndrome
299038|NCT01875185|clotting|clotting
299041|NCT01875172|bupropion SR|bupropion sr
299042|NCT01875172|randomized controlled trial|randomized controlled trial
299043|NCT01875172|pregnancy|pregnancy
299044|NCT01875159|Prematurity|prematurity
299045|NCT01875159|Apnea of prematurity|apnea of prematurity
299046|NCT01875159|Intermittent hypoxia|intermittent hypoxia
299047|NCT01875133|airway disease|airway disease
299048|NCT01875133|bronchitis|bronchitis
299049|NCT01875133|emphysema|emphysema
299050|NCT01875133|lung|lung
299051|NCT01875120|Anxiety|anxiety
299052|NCT01875120|Somatoform Disorders|somatoform disorders
299053|NCT01875068|referrals|referrals
299054|NCT01875068|nurse practitioners|nurse practitioners
299055|NCT01875068|physician assistants|physician assistants
299056|NCT01875068|consultative general internal medicine|consultative general internal medicine
299057|NCT01875055|Cerebral|cerebral
299058|NCT01875055|desaturation|desaturation
299059|NCT01875029|Low back pain|low back pain
299060|NCT01875029|chronic pain|chronic pain
299061|NCT01875029|tDCS|tdcs
299062|NCT01875029|transcranial direct current stimulation|transcranial direct current stimulation
299063|NCT01875016|Cryo ablation|cryo ablation
299064|NCT01875016|Cardiomyopathy|cardiomyopathy
299065|NCT01874977|rheumatoid arthritis|rheumatoid arthritis
299066|NCT01874977|fatigue|fatigue
299067|NCT01874977|physical activity|physical activity
299068|NCT01874964|HIV Prevention|hiv prevention
299069|NCT01874964|Opioid-Related Disorders|opioid-related disorders
299070|NCT01874964|Medication Assisted Treatment|medication assisted treatment
299071|NCT01874964|Methadone|methadone
299072|NCT01874951|Depression|depression
299073|NCT01874951|Recurrence|recurrence
299074|NCT01874951|Relapse|relapse
299075|NCT01874951|Antidepressants|antidepressants
299076|NCT01874951|Naltrexone|naltrexone
299077|NCT01874951|Drug augmentation|drug augmentation
299078|NCT01874886|Magnetic resonance imaging|magnetic resonance imaging
299079|NCT01874886|Diffusion tensor imaging|diffusion tensor imaging
299080|NCT01874886|Hippocampus|hippocampus
299081|NCT01874886|Cannabis|cannabis
299082|NCT01874886|Geriatrics|geriatrics
299083|NCT01874886|Neuropsychology|neuropsychology
299084|NCT01874886|Apolipoprotein E|apolipoprotein e
299085|NCT01874847|melatonin|melatonin
299086|NCT01874847|placebo|placebo
299087|NCT01874847|post-concussion syndrome|post-concussion syndrome
299088|NCT01874847|mild traumatic brain injury|mild traumatic brain injury
299089|NCT01874847|concussion|concussion
299090|NCT01874847|treatment|treatment
299091|NCT01874847|outcome|outcome
299092|NCT01874847|children|children
299093|NCT01874847|functional magnetic resonance imaging|functional magnetic resonance imaging
299094|NCT01874847|transcranial magnetic stimulation|transcranial magnetic stimulation
299095|NCT01874847|sleep|sleep
299096|NCT01874834|ozone|ozone
299097|NCT01874834|diesel|diesel
299098|NCT01874834|lung function|lung function
299099|NCT01874834|cardiac electrophysiology|cardiac electrophysiology
299100|NCT01874834|mediators of inflammation and clotting|mediators of inflammation and clotting
299101|NCT01874821|Frozen Shoulder|frozen shoulder
299102|NCT01874821|Adhesive Capsulitis|adhesive capsulitis
299103|NCT01874821|ROM|rom
299104|NCT01874821|Dynasplint|dynasplint
299105|NCT01874808|movement preparation|movement preparation
299106|NCT01874808|gait|gait
299107|NCT01874808|gait initiation|gait initiation
299108|NCT01874808|postural control|postural control
299109|NCT01874808|neuroimaging|neuroimaging
299110|NCT01874795|Autonomic Nervous System|autonomic nervous system
299111|NCT01874795|Neuromodulation|neuromodulation
299112|NCT01874795|Exercise|exercise
299113|NCT01874795|Pulmonary oxygen kinetics|pulmonary oxygen kinetics
299114|NCT01874795|Oxygen uptake|oxygen uptake
299115|NCT01874782|spinal cord injury|spinal cord injury
299116|NCT01874782|cardiovascular|cardiovascular
299117|NCT01874782|orthostatic hypotension|orthostatic hypotension
299118|NCT01874782|transcranial electrical stimulation|transcranial electrical stimulation
299119|NCT01874782|electrotherapy|electrotherapy
299120|NCT01874769|RDEB|rdeb
299121|NCT01874769|COL7A1|col7a1
299122|NCT01874769|Collagen VII|collagen vii
299123|NCT01874756|schizophrenia|schizophrenia
299124|NCT01874756|Estrogen receptor agonist|estrogen receptor agonist
299125|NCT01874756|cognitive impairment|cognitive impairment
299126|NCT01874756|negative symptoms|negative symptoms
299127|NCT01874743|HIV,|hiv,
299128|NCT01874743|Rosuvastatine,|rosuvastatine,
299129|NCT01874743|Antiretroviral therapy|antiretroviral therapy
299130|NCT01874730|colorectal surgery|colorectal surgery
299131|NCT01874730|fluid therapy|fluid therapy
299132|NCT01874717|Conscious sedation|conscious sedation
299133|NCT01874717|Dental anxiety|dental anxiety
299134|NCT01874717|Oral midazolam|oral midazolam
299135|NCT01874717|Intravenous midazolam|intravenous midazolam
299136|NCT01874717|Behaviour|behaviour
299137|NCT01874704|Stress, occupation, biomarkers, emergency, physicians|stress, occupation, biomarkers, emergency, physicians
299138|NCT01874691|acute myocardial infarction|acute myocardial infarction
299139|NCT01874691|China|china
299140|NCT01874691|Registry|registry
299141|NCT01874665|Gastrointestinal Neoplasms|gastrointestinal neoplasms
299142|NCT01874665|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
299143|NCT01874665|mesenchymal tumor|mesenchymal tumor
299144|NCT01874639|Hepatectomy|hepatectomy
299145|NCT01874639|blood loss|blood loss
299146|NCT01874639|hemostasis|hemostasis
299147|NCT01874639|coagulation|coagulation
299148|NCT01874639|Liver surgery (benign or malign)|liver surgery (benign or malign)
299149|NCT01874639|Resection of 2 or more segments|resection of 2 or more segments
299150|NCT01874626|acute ankle sprain|acute ankle sprain
299151|NCT01874626|Grade I or Grade II|grade i or grade ii
299152|NCT01874613|Craniofacial bone reconstruction|craniofacial bone reconstruction
299153|NCT01874613|Fibre-reinforced composite|fibre-reinforced composite
299154|NCT01874613|Bioactive glass|bioactive glass
299155|NCT01874613|Craniotomy|craniotomy
299156|NCT01874613|Skull bone defect|skull bone defect
299157|NCT01874587|Adaptative radiotherapy|adaptative radiotherapy
299158|NCT01874587|oropharynx carcinoma|oropharynx carcinoma
299159|NCT01874587|xerostomia|xerostomia
299160|NCT01874574|Knee Osteoarthritis|knee osteoarthritis
299161|NCT01874574|Corticosteroid|corticosteroid
299162|NCT01874574|Hyaluronic acid|hyaluronic acid
299163|NCT01874574|Intra-articular injection|intra-articular injection
299164|NCT01874561|Custirsen sodium|custirsen sodium
299165|NCT01874561|TV1011|tv1011
299166|NCT01874561|OGX-011|ogx-011
299167|NCT01874561|Thorough QT study|thorough qt study
299168|NCT01874561|cancer|cancer
299169|NCT01874548|Autophagy|autophagy
299170|NCT01874548|Cancer metabolism|cancer metabolism
299171|NCT01874548|Cervical cancer|cervical cancer
299172|NCT01874548|Diffusion weighted imaging|diffusion weighted imaging
299173|NCT01874548|Human papillomavirus|human papillomavirus
299174|NCT01874548|Magnetic resonance spectroscopy.|magnetic resonance spectroscopy.
299175|NCT01874522|Advanced solid tumors (excluding breast cancer) for which no standard therapy exists|advanced solid tumors (excluding breast cancer) for which no standard therapy exists
299176|NCT01874405|Iron overload|iron overload
299177|NCT01874405|thalassaemia|thalassaemia
299178|NCT01874405|deferasirox|deferasirox
299179|NCT01874405|magnetic resonance|magnetic resonance
299180|NCT01874405|endocrine function|endocrine function
299181|NCT01874379|Joint Replacement|joint replacement
299182|NCT01874379|Hip Replacement|hip replacement
299183|NCT01874379|Knee Replacement|knee replacement
299184|NCT01874379|Complementary Medicine Intervention|complementary medicine intervention
299185|NCT01874353|BRCA|brca
299186|NCT01874353|Ovarian cancer|ovarian cancer
299187|NCT01874353|Chemotherapy|chemotherapy
299188|NCT01874353|PARP Inhibitor|parp inhibitor
299189|NCT01874353|Platinum sensitive|platinum sensitive
299190|NCT01874340|Multiple Sclerosis|multiple sclerosis
299191|NCT01874340|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
299192|NCT01874340|AIN457|ain457
299193|NCT01874340|Secukinumab|secukinumab
299194|NCT01874340|Magnetic Resonance Imaging|magnetic resonance imaging
299195|NCT01874340|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
299196|NCT01874340|Autoimmune Diseases|autoimmune diseases
299197|NCT01874340|Nervous System Diseases|nervous system diseases
299198|NCT01874340|Immune System Diseases|immune system diseases
299199|NCT01874340|Demyelinating Diseases|demyelinating diseases
299200|NCT01874314|tuberculosis, SQ109, QTc, moxifloxacin, crossover, placebo, pharmacokinetic, randomized, single-center|tuberculosis, sq109, qtc, moxifloxacin, crossover, placebo, pharmacokinetic, randomized, single-center
299201|NCT01874288|NHL|nhl
299202|NCT01874288|Immunocytokine|immunocytokine
299203|NCT01874288|Lymphoma|lymphoma
299204|NCT01874288|Non-Hodgkin|non-hodgkin
299205|NCT01874288|B-cell|b-cell
299206|NCT01874288|IL (interleukin)|il (interleukin)
299207|NCT01874249|Hepatic fibrosis|hepatic fibrosis
299208|NCT01874249|Steatosis|steatosis
299209|NCT01874249|Noninvasive markers.|noninvasive markers.
299210|NCT01874236|SI joint pain, SI joint dysfunction, degenerative sacroiliitis, sacroiliac joint disruption|si joint pain, si joint dysfunction, degenerative sacroiliitis, sacroiliac joint disruption
299211|NCT01874223|Interstitial Lung Disease (ILD)|interstitial lung disease (ild)
299212|NCT01874223|Idiopathic Pulmonary Fibrosis (IPF)|idiopathic pulmonary fibrosis (ipf)
299213|NCT01874197|Thoracoabdominal Aortic Aneurysm|thoracoabdominal aortic aneurysm
299214|NCT01874197|Branched vessels|branched vessels
299215|NCT01874158|Trichomonas vaginalis|trichomonas vaginalis
299216|NCT01874145|Multiple Sclerosis|multiple sclerosis
299217|NCT01874145|Relapsing-Remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
299218|NCT01874145|Glatiramer Acetate|glatiramer acetate
299219|NCT01874145|Glatiramer|glatiramer
299220|NCT01874132|Exercise|exercise
299221|NCT01874132|Blood pressure|blood pressure
299222|NCT01874132|Lipids|lipids
299223|NCT01874132|Body composition|body composition
299224|NCT01874132|Fitness|fitness
299225|NCT01874132|Bone density|bone density
299226|NCT01874132|Quality of life|quality of life
299227|NCT01874119|melanoma|melanoma
299228|NCT01874119|renal cell carcinoma|renal cell carcinoma
299229|NCT01874119|interleukin-2|interleukin-2
299230|NCT01874106|Hemodialysis|hemodialysis
299231|NCT01874106|Diet|diet
299232|NCT01874106|Inflammation|inflammation
299233|NCT01874106|Malnutrition|malnutrition
299234|NCT01874054|Antibody-Drug Conjugate|antibody-drug conjugate
299235|NCT01874054|Antibodies, Monoclonal|antibodies, monoclonal
299236|NCT01874054|Hodgkin Disease|hodgkin disease
299237|NCT01874054|Hematologic Diseases|hematologic diseases
299238|NCT01874054|Drug Therapy|drug therapy
299239|NCT01874054|Immunotherapy|immunotherapy
299240|NCT01874054|Antigens, CD30|antigens, cd30
299241|NCT01874054|Lymphoma|lymphoma
299242|NCT01874054|monomethylauristatin E|monomethylauristatin e
299243|NCT01874041|Physical Therapy Modalities|physical therapy modalities
299244|NCT01874041|Facial Pain|facial pain
299245|NCT01874041|Orthodontic Appliances|orthodontic appliances
299246|NCT01874028|Trientine|trientine
299247|NCT01874028|Pharmacokinetics|pharmacokinetics
299248|NCT01874015|Crohn's disease|crohn's disease
299249|NCT01874015|mesenchymal stem cell|mesenchymal stem cell
299250|NCT01874015|fistula|fistula
299251|NCT01874002|Stents|stents
299252|NCT01874002|Stent|stent
299253|NCT01874002|Drug eluting|drug eluting
299254|NCT01874002|Drug eluting stent|drug eluting stent
299255|NCT01874002|Drug eluting stents|drug eluting stents
299256|NCT01874002|Endothelial progenitor cell|endothelial progenitor cell
299257|NCT01874002|Endothelial progenitor cell capturing|endothelial progenitor cell capturing
299258|NCT01874002|Sirolimus|sirolimus
299259|NCT01874002|Sirolimus eluting|sirolimus eluting
299260|NCT01874002|Percutaneous Coronary Intervention|percutaneous coronary intervention
299261|NCT01874002|PCI|pci
299262|NCT01874002|Registry|registry
299263|NCT01874002|Registries|registries
299264|NCT01874002|Multi center|multi center
299265|NCT01874002|Multi centre|multi centre
299266|NCT01873989|Chronic pain|chronic pain
299267|NCT01873989|Opioid addiction|opioid addiction
299268|NCT01873989|Symptomatic hypogonadism|symptomatic hypogonadism
299269|NCT01873989|Testosterone replacement|testosterone replacement
299270|NCT01873989|Opioid agonist maintenance|opioid agonist maintenance
299271|NCT01873989|Methadone|methadone
299272|NCT01873989|Buprenorphine|buprenorphine
299273|NCT01873937|Lasertherapy|lasertherapy
299274|NCT01873937|Ledtherapy|ledtherapy
299275|NCT01873937|TMJs|tmjs
299276|NCT01873937|pain relief|pain relief
299277|NCT01873937|oral aperture|oral aperture
299278|NCT01873924|Batten disease|batten disease
299279|NCT01873924|NCL|ncl
299280|NCT01873924|Neuronal Ceroid Lipofuscinosis|neuronal ceroid lipofuscinosis
299281|NCT01873911|MPS IIIA|mps iiia
299282|NCT01873911|MPS IIIB|mps iiib
299283|NCT01873911|Sanfilippo syndrome type A|sanfilippo syndrome type a
299284|NCT01873911|Sanfilippo syndrome type B|sanfilippo syndrome type b
299285|NCT01873911|Hurler syndrome|hurler syndrome
299286|NCT01873911|cognitive decline|cognitive decline
299287|NCT01873911|MPS IH|mps ih
299288|NCT01873898|femoral artery|femoral artery
299289|NCT01873898|access site|access site
299290|NCT01873898|hemostasis|hemostasis
299291|NCT01873885|PB1046, VIP, Essential Hypertension, Vasomera|pb1046, vip, essential hypertension, vasomera
299292|NCT01873859|Lactic acidosis|lactic acidosis
299293|NCT01873859|Contrast media|contrast media
299294|NCT01873859|Angiography|angiography
299295|NCT01873859|Diabetic|diabetic
299296|NCT01873859|Metformin|metformin
299297|NCT01873820|Vitamin C|vitamin c
299298|NCT01873820|calcium ascorbate|calcium ascorbate
299299|NCT01873820|ascorbic acid|ascorbic acid
299300|NCT01873807|Idarubicin|idarubicin
299301|NCT01873807|Etoposide|etoposide
299302|NCT01873807|HSCT|hsct
299303|NCT01873807|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
299304|NCT01873794|Fatigue|fatigue
299305|NCT01873794|Sleep|sleep
299306|NCT01873794|Quality of life|quality of life
299307|NCT01873794|Cancer|cancer
299308|NCT01873794|Light|light
299309|NCT01873768|Tranexamic acid|tranexamic acid
299310|NCT01873768|6-Aminocaproic Acid|6-aminocaproic acid
299311|NCT01873768|Arthroplasty|arthroplasty
299312|NCT01873768|Osteoarthritis|osteoarthritis
299313|NCT01873768|Arthritis|arthritis
299314|NCT01873768|Joint Diseases|joint diseases
299315|NCT01873768|Musculoskeletal Diseases|musculoskeletal diseases
299316|NCT01873768|Rheumatic Diseases|rheumatic diseases
299317|NCT01873768|Antifibrinolytic Agents|antifibrinolytic agents
299318|NCT01873768|Fibrin Modulating Agents|fibrin modulating agents
299319|NCT01873768|Pharmacologic Actions|pharmacologic actions
299320|NCT01873768|Coagulants|coagulants
299321|NCT01873768|Therapeutic Uses|therapeutic uses
299322|NCT01873755|asthma|asthma
299323|NCT01873755|children|children
299324|NCT01873755|physical activity|physical activity
299325|NCT01873755|school|school
299326|NCT01873742|Psychotherapy feedback|psychotherapy feedback
299327|NCT01873729|ADHD|adhd
299328|NCT01873729|Naltrexone|naltrexone
299329|NCT01873729|Adults|adults
299330|NCT01873716|Atherosclerosis|atherosclerosis
299331|NCT01873716|Molecular Imaging|molecular imaging
299332|NCT01873716|Vascular Biology|vascular biology
299333|NCT01873716|Inflammation|inflammation
299334|NCT01873716|Fluorescence|fluorescence
299335|NCT01873703|MDS|mds
299336|NCT01873703|High risk myelodysplastic syndrome|high risk myelodysplastic syndrome
299337|NCT01873703|Intermediate-2 Myelodysplastic syndrome|intermediate-2 myelodysplastic syndrome
299338|NCT01873703|Untreated|untreated
299340|NCT01873690|Shock Wave Lithotripsy|shock wave lithotripsy
299341|NCT01873690|Urinary Tract Infection|urinary tract infection
299342|NCT01873664|fMRI|fmri
299343|NCT01873664|Jaw tapping|jaw tapping
299344|NCT01873664|Memory disorder|memory disorder
299345|NCT01873664|Mild cognitive impairment|mild cognitive impairment
299346|NCT01873664|MCI|mci
299347|NCT01873664|Working memory|working memory
299348|NCT01873638|5-year outcome after cholecystectomy|5-year outcome after cholecystectomy
299349|NCT01873625|mesenchymal stem cells|mesenchymal stem cells
299350|NCT01873625|osteoarthritis|osteoarthritis
299351|NCT01873625|arthritis rheumatoid|arthritis rheumatoid
299352|NCT01873612|Dexmedetomidine|dexmedetomidine
299353|NCT01873612|Propofol|propofol
299354|NCT01873612|Hypoxic ventilatory response|hypoxic ventilatory response
299355|NCT01873612|Hypercapnic ventilatory response|hypercapnic ventilatory response
299356|NCT01873573|radiation-induced stricture|radiation-induced stricture
299357|NCT01873573|anastomotic stricture|anastomotic stricture
299358|NCT01873573|esophagogastroduodenoscopy (EGD)|esophagogastroduodenoscopy (egd)
299359|NCT01873573|dilation|dilation
299360|NCT01873573|steroid injection|steroid injection
299361|NCT01873573|triamcinolone|triamcinolone
299362|NCT01873573|difficulty swallowing|difficulty swallowing
299363|NCT01873560|fractional flow reserve|fractional flow reserve
299364|NCT01873560|drug eluting stent|drug eluting stent
299365|NCT01873560|coronary atherosclerosis|coronary atherosclerosis
299366|NCT01873547|spinal cord injury|spinal cord injury
299367|NCT01873547|cell transplantation|cell transplantation
299368|NCT01873547|rehabilitation|rehabilitation
299369|NCT01873534|Anemia|anemia
299370|NCT01873521|Positive Pressure Ventilation|positive pressure ventilation
299371|NCT01873521|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
299372|NCT01873521|Patient/ventilator Asynchrony|patient/ventilator asynchrony
299373|NCT01873521|Pediatric patient|pediatric patient
299374|NCT01873521|Infant|infant
299375|NCT01873469|glioblastoma multiforme|glioblastoma multiforme
299376|NCT01873469|radiotherapy|radiotherapy
299377|NCT01873430|Melatonin|melatonin
299378|NCT01873430|Sunburn|sunburn
299379|NCT01873430|Erythema|erythema
299380|NCT01873430|Sunlight|sunlight
299381|NCT01873430|Ultraviolet rays|ultraviolet rays
299382|NCT01873391|Diagnostic hysteroscopy|diagnostic hysteroscopy
299383|NCT01873391|Pain|pain
299384|NCT01873391|VAS|vas
299385|NCT01873391|Multivariate analysis|multivariate analysis
299386|NCT01873391|Normal saline|normal saline
299387|NCT01873391|Carbon dioxide|carbon dioxide
299388|NCT01873378|Uterine myoma|uterine myoma
299389|NCT01873378|GnRHa|gnrha
299390|NCT01873378|Hysteroscopy|hysteroscopy
299391|NCT01873378|Cold loop|cold loop
299392|NCT01873365|Quality of life|quality of life
299393|NCT01873365|Herpes zoster|herpes zoster
299394|NCT01873365|Postherpetic neuralgia|postherpetic neuralgia
299395|NCT01873365|Japan|japan
299396|NCT01873365|Physician-practice|physician-practice
299397|NCT01873365|Adults|adults
299398|NCT01873365|Health economics|health economics
299399|NCT01873339|Drug interaction, healthy volunteer, SB-480848, Lp-PLA2, darapladib, atherosclerosis, midazolam|drug interaction, healthy volunteer, sb-480848, lp-pla2, darapladib, atherosclerosis, midazolam
299400|NCT01873326|newly diagnosed GCT|newly diagnosed gct
299401|NCT01873326|Intermediate|intermediate
299402|NCT01873326|Poor-Risk|poor-risk
299403|NCT01873326|BLEOMYCIN|bleomycin
299404|NCT01873326|CISPLATIN|cisplatin
299405|NCT01873326|ETOPOSIDE (VP-16)|etoposide (vp-16)
299406|NCT01873326|IFOSFAMIDE|ifosfamide
299407|NCT01873326|TAXOL (PACLITAXEL)|taxol (paclitaxel)
299408|NCT01873326|13-074|13-074
299409|NCT01873300|Achalasia|achalasia
299410|NCT01873300|Dysphagia|dysphagia
299411|NCT01873300|Endoscopic|endoscopic
299412|NCT01873300|Myotomy|myotomy
299413|NCT01873300|Heller|heller
299414|NCT01873300|NOTES|notes
299415|NCT01873300|POEM|poem
299416|NCT01873287|Concussions|concussions
299417|NCT01873287|Persistent post-concussion symptoms|persistent post-concussion symptoms
299418|NCT01873287|PCS|pcs
299419|NCT01873287|Clinical Prediction Rule|clinical prediction rule
299420|NCT01873261|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
299421|NCT01873261|Pediatric Acute Respiratory Failure|pediatric acute respiratory failure
299422|NCT01873261|non-invasive ventilation|non-invasive ventilation
299423|NCT01873248|Neuroendocrine Carcinoma|neuroendocrine carcinoma
299424|NCT01873222|Coronary Artery Disease|coronary artery disease
299425|NCT01873222|Percutaneous Coronary Intervention|percutaneous coronary intervention
299426|NCT01873222|Optical Frequency Domain Imaging|optical frequency domain imaging
299427|NCT01873222|Intravascular Ultrasound|intravascular ultrasound
299428|NCT01873183|echocardiography|echocardiography
299429|NCT01873183|morbid obesity|morbid obesity
299430|NCT01873183|bariatric surgery|bariatric surgery
299431|NCT01873183|venous return|venous return
299432|NCT01873183|mean arterial blood pressure|mean arterial blood pressure
299433|NCT01873170|immune cells|immune cells
299434|NCT01873170|contraception|contraception
299435|NCT01873170|intrauterine device|intrauterine device
299436|NCT01873170|IUD|iud
299437|NCT01873170|copper|copper
299440|NCT01873170|etonogestrel|etonogestrel
299441|NCT01873170|subdermal implant|subdermal implant
299442|NCT01873157|Kidney transplantation|kidney transplantation
299443|NCT01873157|Antibody formation|antibody formation
299444|NCT01873157|Graft rejection|graft rejection
299445|NCT01873157|Proteasome inhibitors|proteasome inhibitors
299446|NCT01873157|Randomized controlled trial|randomized controlled trial
299447|NCT01873144|Bronchiolitis|bronchiolitis
299448|NCT01873144|Hypertonic saline solution|hypertonic saline solution
299449|NCT01873144|High-flow oxygen therapy|high-flow oxygen therapy
299450|NCT01873144|Respiratory distress|respiratory distress
299451|NCT01873144|Comfort|comfort
299452|NCT01873131|hemangioma|hemangioma
299453|NCT01873131|infantile hemangioma|infantile hemangioma
299454|NCT01873131|pulsed dye laser|pulsed dye laser
299455|NCT01873131|PDL|pdl
299456|NCT01873131|topical beta blocker|topical beta blocker
299457|NCT01873131|timolol maleate|timolol maleate
299458|NCT01873131|timolol|timolol
299459|NCT01873118|hospital discharge|hospital discharge
299460|NCT01873118|discharge readiness|discharge readiness
299461|NCT01873118|readmission|readmission
299462|NCT01873118|Emergency Department visits|emergency department visits
299463|NCT01873118|Nurse assessment|nurse assessment
299464|NCT01873092|Oximetry|oximetry
299465|NCT01873092|Physical Activity|physical activity
299466|NCT01873079|ERCP|ercp
299467|NCT01873079|sphincterotomy|sphincterotomy
299468|NCT01873079|proton pump inhibitor|proton pump inhibitor
299469|NCT01873066|Type 1 diabetes|type 1 diabetes
299470|NCT01873066|Closed-loop glucose control|closed-loop glucose control
299471|NCT01873066|Artificial Pancreas|artificial pancreas
299472|NCT01873066|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
299473|NCT01873066|Continuous glucose monitoring|continuous glucose monitoring
299474|NCT01873053|Osteoarthritis, Knee|osteoarthritis, knee
299475|NCT01873053|WIN-34B|win-34b
299476|NCT01873040|Social Media|social media
299477|NCT01873040|Vaccine|vaccine
299478|NCT01873040|Immunization|immunization
299479|NCT01873027|Coronary Artery Disease|coronary artery disease
299480|NCT01873027|Percutaneous Coronary Intervention|percutaneous coronary intervention
299481|NCT01873027|Optical Frequency Domain Imaging|optical frequency domain imaging
299482|NCT01873027|Intravascular Ultrasound|intravascular ultrasound
299483|NCT01873001|Healthy volunteers|healthy volunteers
299484|NCT01873001|Drug-drug Interaction|drug-drug interaction
299485|NCT01873001|Pharmacokinetics|pharmacokinetics
299486|NCT01873001|Abiraterone|abiraterone
299487|NCT01873001|JNJ-589485|jnj-589485
299488|NCT01873001|Abiraterone acetate|abiraterone acetate
299489|NCT01873001|JNJ-212082|jnj-212082
299490|NCT01873001|Pioglitazone HCl|pioglitazone hcl
299491|NCT01872988|antiviral therapy|antiviral therapy
299492|NCT01872988|intermediate stage|intermediate stage
299493|NCT01872988|hepatitis B virus|hepatitis b virus
299494|NCT01872962|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
299495|NCT01872962|Induction chemotherapy|induction chemotherapy
299496|NCT01872962|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
299497|NCT01872962|Clinical trial|clinical trial
299498|NCT01872949|Heart Failure|heart failure
299499|NCT01872949|NYHA Class III|nyha class iii
299500|NCT01872949|NYHA Class IV|nyha class iv
299501|NCT01872923|Amphinex|amphinex
299502|NCT01872923|PCI|pci
299503|NCT01872923|Bleomycin|bleomycin
299504|NCT01872923|Cutaneous malignancies|cutaneous malignancies
299505|NCT01872923|Sub-cutaneous malignancies|sub-cutaneous malignancies
299506|NCT01872923|Safety|safety
299507|NCT01872923|Phase I|phase i
299508|NCT01872923|Photochemical Internalisation|photochemical internalisation
299509|NCT01872923|Squamous Cell Carcinoma|squamous cell carcinoma
299510|NCT01872923|Head and Neck cancer|head and neck cancer
299511|NCT01872923|Breast Cancer|breast cancer
299512|NCT01872923|HNSCC|hnscc
299513|NCT01872923|SCCHN|scchn
299514|NCT01872923|Advanced or metastatic cancer|advanced or metastatic cancer
299515|NCT01872923|Dose finding|dose finding
299516|NCT01872910|Wisdom tooth extraction|wisdom tooth extraction
299517|NCT01872897|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
299518|NCT01872897|GERD|gerd
299519|NCT01872897|Acid reflux|acid reflux
299520|NCT01872897|Compound Sodium Alginate Double Action Chewable Tablet|compound sodium alginate double action chewable tablet
299521|NCT01872897|Gaviscon Double Action Tablets|gaviscon double action tablets
299522|NCT01872884|Stroke|stroke
299523|NCT01872884|Ischemic stroke|ischemic stroke
299524|NCT01872884|Acute stroke|acute stroke
299525|NCT01872884|Embolectomy|embolectomy
299526|NCT01872884|Endovascular therapy|endovascular therapy
299527|NCT01872884|Intra-arterial therapy|intra-arterial therapy
299528|NCT01872884|Sedation|sedation
299529|NCT01872884|Anesthesia|anesthesia
299530|NCT01872845|Statin|statin
299531|NCT01872845|CIMT|cimt
299532|NCT01872845|BES|bes
299533|NCT01872793|bioelectrical impedance vector analysis|bioelectrical impedance vector analysis
299534|NCT01872793|nutritional assessment|nutritional assessment
299535|NCT01872793|nutritional status|nutritional status
299536|NCT01872793|mortality|mortality
299537|NCT01872793|complications|complications
299538|NCT01872780|CYP2C8|cyp2c8
299539|NCT01872780|genetic polymorphism|genetic polymorphism
299540|NCT01872780|rosiglitazone|rosiglitazone
299541|NCT01872780|Korean|korean
299542|NCT01872767|Acute on Chronic Liver Failure (ACLF),Cirrhosis,|acute on chronic liver failure (aclf),cirrhosis,
299543|NCT01872767|Institute of Liver & Biliary Sciences (ILBS)|institute of liver & biliary sciences (ilbs)
299544|NCT01872754|Bronchial fibroscopy|bronchial fibroscopy
299545|NCT01872754|Remifentanil|remifentanil
299546|NCT01872754|Propofol|propofol
299547|NCT01872754|Sedation|sedation
299548|NCT01872754|Target Controlled Infusion|target controlled infusion
299549|NCT01872741|craniotomy,|craniotomy,
299550|NCT01872741|intracerebral aneurysms,|intracerebral aneurysms,
299551|NCT01872741|atrophy,|atrophy,
299552|NCT01872741|temporal muscle,|temporal muscle,
299553|NCT01872741|outcome|outcome
299554|NCT01872728|facial block|facial block
299555|NCT01872728|levobupivacaine|levobupivacaine
299556|NCT01872728|regional anesthesia|regional anesthesia
299557|NCT01872728|rhinoplasty|rhinoplasty
299558|NCT01872728|outpatient|outpatient
299559|NCT01872715|Papulopustular Rosacea|papulopustular rosacea
299560|NCT01872715|Oracea|oracea
299561|NCT01872715|anti inflammatory doxycycline|anti inflammatory doxycycline
299562|NCT01872702|Malaria elimination|malaria elimination
299563|NCT01872702|Chemotherapy|chemotherapy
299564|NCT01872702|Epidemiology|epidemiology
299565|NCT01872702|South East Asia|south east asia
299566|NCT01872702|Artemisinin resistance|artemisinin resistance
299567|NCT01872702|Dihydroartemisinin piperaquine|dihydroartemisinin piperaquine
299568|NCT01872702|Primaquine|primaquine
299569|NCT01872676|Thermography|thermography
299570|NCT01872676|Skin Temperature|skin temperature
299571|NCT01872676|Manipulation, Spinal|manipulation, spinal
299572|NCT01872676|Physical Therapy Modalities|physical therapy modalities
299573|NCT01872663|Morbid obesity|morbid obesity
299574|NCT01872663|Bariatric surgery|bariatric surgery
299575|NCT01872663|Pulmonary atelectasis|pulmonary atelectasis
299576|NCT01872663|Spirometry|spirometry
299577|NCT01872663|Continuos Positive Airway Pressure|continuos positive airway pressure
299578|NCT01872663|Physical therapy speciality|physical therapy speciality
299579|NCT01872650|postoperative adhesions|postoperative adhesions
299580|NCT01872650|adhesion prevention|adhesion prevention
299581|NCT01872650|colorectal surgery|colorectal surgery
299582|NCT01872650|temporary ostomy|temporary ostomy
299583|NCT01872611|Diabetes Type I|diabetes type i
299584|NCT01872611|Diabetes Type II|diabetes type ii
299585|NCT01872611|Non-proliferative diabetic retinopathy|non-proliferative diabetic retinopathy
299586|NCT01872611|Macular edema|macular edema
299587|NCT01872611|Cataract|cataract
299588|NCT01872598|Alzheimer|alzheimer
299589|NCT01872598|dementia|dementia
299590|NCT01872598|cognitive disease|cognitive disease
299591|NCT01872598|memory loss|memory loss
299592|NCT01872598|cerebrovascular disease|cerebrovascular disease
299593|NCT01872585|Parenting|parenting
299594|NCT01872585|Mental Illness|mental illness
299595|NCT01872585|Maternal sensitivity|maternal sensitivity
299596|NCT01872585|Parent-child relationship|parent-child relationship
299597|NCT01872533|obesity|obesity
299598|NCT01872533|hypoxia|hypoxia
299599|NCT01872533|insulin sensitivity|insulin sensitivity
299600|NCT01872533|altitude|altitude
299601|NCT01872520|the Injection of DanShenDuoFenSuanYan|the injection of danshenduofensuanyan
299602|NCT01872520|Magnesium Lithospermate B|magnesium lithospermate b
299603|NCT01872520|Safety|safety
299604|NCT01872520|Real World Study|real world study
299605|NCT01872507|cerebral palsy|cerebral palsy
299606|NCT01872507|autonomic nerveus system|autonomic nerveus system
299607|NCT01872507|heart rate variability|heart rate variability
299608|NCT01872494|Local analgesia system|local analgesia system
299609|NCT01872494|Ropivacaine|ropivacaine
299610|NCT01872494|Analgesic efficacy after operation|analgesic efficacy after operation
299611|NCT01872494|Postoperative|postoperative
299612|NCT01872481|Phantom limb pain syndrome|phantom limb pain syndrome
299613|NCT01872481|Neuropathic pain|neuropathic pain
299614|NCT01872481|Antipersonnel landmines|antipersonnel landmines
299615|NCT01872481|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
299616|NCT01872468|Glomerular filtration Rate.|glomerular filtration rate.
299617|NCT01872468|Primary Health Care.|primary health care.
299618|NCT01872468|Cluster Clinical Trial.|cluster clinical trial.
299619|NCT01872429|subtotal parathyroidectomy|subtotal parathyroidectomy
299620|NCT01872429|calcium|calcium
299621|NCT01872429|phosphorus|phosphorus
299622|NCT01872429|parathyroid hormone|parathyroid hormone
299623|NCT01872429|hyperparathyroidism|hyperparathyroidism
299624|NCT01872416|Refractory and relapsed small cell lung cancer|refractory and relapsed small cell lung cancer
299625|NCT01872416|Liposomal Doxorubicin|liposomal doxorubicin
299626|NCT01872416|ifosfamide|ifosfamide
299627|NCT01872403|Squamous Cell Carcinoma of the lung|squamous cell carcinoma of the lung
299628|NCT01872390|Lesotho|lesotho
299629|NCT01872390|TB|tb
299630|NCT01872390|tuberculosis|tuberculosis
299631|NCT01872390|HIV|hiv
299632|NCT01872390|antiretroviral therapy|antiretroviral therapy
299633|NCT01872390|ART|art
299634|NCT01872390|adherence|adherence
299635|NCT01872390|combination intervention package|combination intervention package
299636|NCT01872390|retention|retention
299637|NCT01872377|pancreas|pancreas
299638|NCT01872377|pancreatic|pancreatic
299639|NCT01872377|unresectable|unresectable
299640|NCT01872377|CyberKnife|cyberknife
299641|NCT01872377|SBRT|sbrt
299642|NCT01872364|Hernia repair|hernia repair
299643|NCT01872364|Hydrocelectomy|hydrocelectomy
299644|NCT01872364|Global Health|global health
299645|NCT01872364|Global Disease Burden|global disease burden
299646|NCT01872364|Surgical Mission|surgical mission
299647|NCT01872364|Dominican Republic|dominican republic
299648|NCT01872364|Cost-minimization|cost-minimization
299649|NCT01872364|Procedural cost|procedural cost
299650|NCT01872364|Material cost|material cost
299651|NCT01872364|Item utilization|item utilization
299652|NCT01872364|Excision of benign cutaneous mass|excision of benign cutaneous mass
299653|NCT01872364|Minor procedure|minor procedure
299654|NCT01872351|chronic fatigue syndrome|chronic fatigue syndrome
299655|NCT01872351|mitochondrial disorder|mitochondrial disorder
299656|NCT01872351|conditioning exercise|conditioning exercise
299657|NCT01872351|nutraceutical supplements|nutraceutical supplements
299658|NCT01872351|high protein diet|high protein diet
299659|NCT01872338|suicide prevention|suicide prevention
299660|NCT01872338|minfulness-based cognitive therapy|minfulness-based cognitive therapy
299661|NCT01872338|mindfulness meditation|mindfulness meditation
299662|NCT01872338|Veterans|veterans
299663|NCT01872338|safety planning|safety planning
299664|NCT01872325|cardiac arrest|cardiac arrest
299665|NCT01872325|bystander cardiopulmonary resuscitation CPR|bystander cardiopulmonary resuscitation cpr
299666|NCT01872325|dispatch-assisted CPR instructions|dispatch-assisted cpr instructions
299667|NCT01872325|agonal breathing|agonal breathing
299668|NCT01872312|BPF(Bronchopleural fistulae)|bpf(bronchopleural fistulae)
299669|NCT01872286|Capsule Endoscopy|capsule endoscopy
299670|NCT01872273|Metabolic Syndrome|metabolic syndrome
299671|NCT01872273|Obese|obese
299672|NCT01872273|Overweight|overweight
299673|NCT01872273|Hypertension|hypertension
299674|NCT01872273|Hyperlipidemia|hyperlipidemia
299675|NCT01872273|Glucose Intolerant|glucose intolerant
299676|NCT01872273|High blood sugar|high blood sugar
299677|NCT01872273|Exercise in obesity|exercise in obesity
299678|NCT01872273|Platelets|platelets
299679|NCT01872260|Hormone-receptor positive|hormone-receptor positive
299680|NCT01872234|Heart Failure|heart failure
299681|NCT01872234|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
299682|NCT01872234|Mild systolic dysfunction|mild systolic dysfunction
299683|NCT01872234|Left Bundle Branch Block|left bundle branch block
299684|NCT01872221|Glioblastoma|glioblastoma
299685|NCT01872221|Spectroscopy|spectroscopy
299686|NCT01872221|MRI|mri
299687|NCT01872221|Glioma stem cells|glioma stem cells
299688|NCT01872221|Surgery|surgery
299689|NCT01872221|Radioresistance|radioresistance
299690|NCT01872208|PAD|pad
299691|NCT01872208|Atherosclerosis|atherosclerosis
299692|NCT01872208|Peripheral circulation|peripheral circulation
299693|NCT01872208|Blood Vessel Prosthesis|blood vessel prosthesis
299694|NCT01872208|Tissue-Engineered Vascular Graft|tissue-engineered vascular graft
299695|NCT01872208|Vascular Prosthesis Implantation|vascular prosthesis implantation
299696|NCT01872208|Femoro-Popliteal Bypass|femoro-popliteal bypass
299697|NCT01872195|Checklist|checklist
299698|NCT01872195|In-Hospital Mortality|in-hospital mortality
299699|NCT01872195|In-Hospital Morbidity|in-hospital morbidity
299700|NCT01872156|Smoking|smoking
299701|NCT01872156|Primary care|primary care
299702|NCT01872130|Moh's Surgery|moh's surgery
299703|NCT01872130|mosaicing algorithm|mosaicing algorithm
299704|NCT01872130|intraoperative imaging|intraoperative imaging
299705|NCT01872130|12-239|12-239
299706|NCT01872104|rectal cancer|rectal cancer
299707|NCT01872104|rectal adenocarcinoma|rectal adenocarcinoma
299708|NCT01872104|photodynamic therapy|photodynamic therapy
299709|NCT01872104|chemothrapy|chemothrapy
299710|NCT01872078|Pharmacokinetics, Pharmacodynamics, endocrinopathies, PCOS, female, hormone, LH|pharmacokinetics, pharmacodynamics, endocrinopathies, pcos, female, hormone, lh
299711|NCT01872039|Nicardipine|nicardipine
299712|NCT01872039|Hypertension|hypertension
299713|NCT01872039|Calcium blocker|calcium blocker
299714|NCT01872026|Plasma concentration|plasma concentration
299715|NCT01872026|Pharmacokinetics|pharmacokinetics
299716|NCT01872026|Pharmacodynamics|pharmacodynamics
299717|NCT01872026|ASP7991|asp7991
299718|NCT01872013|Plasma concentration|plasma concentration
299719|NCT01872013|Urinary concentration|urinary concentration
299720|NCT01872013|ASP7991|asp7991
299721|NCT01872000|Intraocular lens|intraocular lens
299722|NCT01872000|Phacoemulsification|phacoemulsification
299723|NCT01871987|FK949E|fk949e
299724|NCT01871987|Quetiapine|quetiapine
299725|NCT01871987|Antipsychotic|antipsychotic
299726|NCT01871974|FK949E|fk949e
299727|NCT01871974|Antipsychotic|antipsychotic
299728|NCT01871974|Quetiapine|quetiapine
299729|NCT01871909|Physical trauma|physical trauma
299730|NCT01871896|Surgical Endoscopy|surgical endoscopy
299731|NCT01871896|Morbid Obesity|morbid obesity
299732|NCT01871896|Weight Loss|weight loss
299733|NCT01871896|Bariatrics|bariatrics
299734|NCT01871896|Surgical Revision|surgical revision
299735|NCT01871883|Sensitive skin|sensitive skin
299736|NCT01871883|Transient potential receptor vanilloid 1|transient potential receptor vanilloid 1
299737|NCT01871883|TRPV1|trpv1
299738|NCT01871883|Transepidermal water loss|transepidermal water loss
299739|NCT01871883|Skin Phototype|skin phototype
299740|NCT01871883|Lactic acid test|lactic acid test
299741|NCT01871883|Skin irritancy tests|skin irritancy tests
299742|NCT01871818|Multiple sclerosis|multiple sclerosis
299743|NCT01871818|Rehabilitation|rehabilitation
299744|NCT01871818|Chronic evolutive disease|chronic evolutive disease
299745|NCT01871818|Physiotherapy|physiotherapy
299746|NCT01871818|Resistance training|resistance training
299747|NCT01871818|Endurance training|endurance training
299748|NCT01871792|Contrast-induced nephropathy|contrast-induced nephropathy
299749|NCT01871792|Prevention|prevention
299750|NCT01871792|Statin|statin
299751|NCT01871792|Pitavastatin|pitavastatin
299752|NCT01871766|Rhabdomyosarcoma|rhabdomyosarcoma
299753|NCT01871766|Radiation therapy|radiation therapy
299754|NCT01871766|Proton beam|proton beam
299755|NCT01871740|Folic acid|folic acid
299756|NCT01871740|Renal function decline|renal function decline
299757|NCT01871740|Hypertension|hypertension
299758|NCT01871740|Hyperhomocysteinemia|hyperhomocysteinemia
299759|NCT01871740|Chronic kidney disease|chronic kidney disease
299760|NCT01871740|MTHFR C677T genotype|mthfr c677t genotype
299761|NCT01871740|Randomized controlled trial|randomized controlled trial
299762|NCT01871727|Persistent or Recurrent Cutaneous T-Cell Lymphoma|persistent or recurrent cutaneous t-cell lymphoma
299763|NCT01871727|E7777|e7777
299764|NCT01871714|XLHED|xlhed
299765|NCT01871714|HED|hed
299766|NCT01871714|Hypohidrotic Ectodermal Dysplasia|hypohidrotic ectodermal dysplasia
299767|NCT01871714|X Linked Hypohidrotic Ectodermal Dysplasia|x linked hypohidrotic ectodermal dysplasia
299768|NCT01871701|Corrected QT interval prolongation|corrected qt interval prolongation
299769|NCT01871701|Psychotropic drugs|psychotropic drugs
299770|NCT01871688|pelvic floor dysfunction|pelvic floor dysfunction
299771|NCT01871688|neuromodulation|neuromodulation
299772|NCT01871688|rehabilitation|rehabilitation
299773|NCT01871675|Lymphoma|lymphoma
299774|NCT01871675|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
299775|NCT01871675|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
299776|NCT01871675|T-cell Lymphoma|t-cell lymphoma
299777|NCT01871675|Rituxan|rituxan
299778|NCT01871675|Bendamustine|bendamustine
299779|NCT01871675|Hematologic Malignancy|hematologic malignancy
299780|NCT01871675|Relapsed|relapsed
299781|NCT01871675|Refractory|refractory
299782|NCT01871662|HCV|hcv
299783|NCT01871662|Hepatitis C|hepatitis c
299784|NCT01871649|psoriatic arthritis|psoriatic arthritis
299785|NCT01871649|golimumab|golimumab
299786|NCT01871649|methotrexate|methotrexate
299787|NCT01871649|minimal disease activity|minimal disease activity
299788|NCT01871649|safety|safety
299789|NCT01871649|withdrawal|withdrawal
299790|NCT01871636|endoscopy|endoscopy
299791|NCT01871636|WESD|wesd
299792|NCT01871636|EMR|emr
299793|NCT01871623|Cleft lip and palate|cleft lip and palate
299794|NCT01871623|Cone-Beam Computed Tomography|cone-beam computed tomography
299795|NCT01871623|Le Fort I Osteotomy|le fort i osteotomy
299796|NCT01871623|Segmental Osteotomy|segmental osteotomy
299797|NCT01871623|Stability|stability
299798|NCT01871610|Traumatic brain injury|traumatic brain injury
299799|NCT01871610|mild TBI|mild tbi
299800|NCT01871610|Alzheimer's disease|alzheimer's disease
299801|NCT01871610|[18F]AV-45 PET amyloid binding imaging|[18f]av-45 pet amyloid binding imaging
299802|NCT01871597|Lung cancer|lung cancer
299803|NCT01871597|VATS procedure|vats procedure
299804|NCT01871597|Pulmonary Artery Sealing|pulmonary artery sealing
299805|NCT01871584|A colon hydrotherapy system|a colon hydrotherapy system
299806|NCT01871584|Hydrocolonic preparation|hydrocolonic preparation
299807|NCT01871584|Preparation for colonoscopy|preparation for colonoscopy
299808|NCT01871558|type 2 diabetes|type 2 diabetes
299809|NCT01871558|basal insulin|basal insulin
299810|NCT01871558|vildagliptin|vildagliptin
299811|NCT01871545|hepatocellular carcinoma|hepatocellular carcinoma
299812|NCT01871545|HCC|hcc
299813|NCT01871545|liver cancer|liver cancer
299814|NCT01871545|liver disease|liver disease
299815|NCT01871545|magnetic resonance imaging|magnetic resonance imaging
299816|NCT01871545|MRI|mri
299817|NCT01871532|Monofollicular Development|monofollicular development
299818|NCT01871532|Gonal-f®|gonal-f®
299819|NCT01871532|Recombinant Follicle Stimulating Hormone|recombinant follicle stimulating hormone
299820|NCT01871532|Ovarian hyperstimulation syndrome (OHSS)|ovarian hyperstimulation syndrome (ohss)
299821|NCT01871519|vertebral body compression fracture|vertebral body compression fracture
299822|NCT01871480|NSCLC|nsclc
299823|NCT01871480|CIK|cik
299824|NCT01871480|Gefitinib|gefitinib
299825|NCT01871480|Adenocarcinoma|adenocarcinoma
299826|NCT01871402|psoriasis|psoriasis
299827|NCT01871402|lotion|lotion
299828|NCT01871402|investigator's global assessment|investigator's global assessment
299829|NCT01871376|PCV|pcv
299830|NCT01871363|Preoperative Chemoradiotherapy|preoperative chemoradiotherapy
299831|NCT01871363|Bevacizumab|bevacizumab
299832|NCT01871363|Locally Advanced Rectal Cancer|locally advanced rectal cancer
299833|NCT01871350|Cancer|cancer
299834|NCT01871350|Chemotherapy|chemotherapy
299835|NCT01871350|Chemo related toxicity|chemo related toxicity
299836|NCT01871350|Protein digestion|protein digestion
299837|NCT01871350|Fat digestion|fat digestion
299838|NCT01871350|Gut function|gut function
299839|NCT01871350|Glucose absorption|glucose absorption
299840|NCT01871350|Muscle function|muscle function
299841|NCT01871337|Multiple Sclerosis|multiple sclerosis
299842|NCT01871337|urinary incontinence|urinary incontinence
299843|NCT01871311|metastatic Kras wildtype|metastatic kras wildtype
299844|NCT01871311|squamous cell carcinoma|squamous cell carcinoma
299845|NCT01871311|cetuximab|cetuximab
299846|NCT01871311|nilotinib|nilotinib
299847|NCT01871298|internet and mobile technology use|internet and mobile technology use
299848|NCT01871298|history of drug use|history of drug use
299849|NCT01871298|injection drug user (IDU) syringe customers|injection drug user (idu) syringe customers
299850|NCT01871285|ATC, Opioid, withdrawal, switch|atc, opioid, withdrawal, switch
299851|NCT01871259|Sedation, sleep apnea, propofol|sedation, sleep apnea, propofol
299852|NCT01871233|anti-epileptic drug|anti-epileptic drug
299853|NCT01871233|Extended Access Program|extended access program
299854|NCT01871233|partial onset seizures|partial onset seizures
299855|NCT01871233|Perampanel|perampanel
299856|NCT01871220|Implant Abutments|implant abutments
299857|NCT01871220|Oral Mucosa Changes|oral mucosa changes
299858|NCT01871220|Implant Esthetics|implant esthetics
299859|NCT01871207|Erythropoietin (EPO)|erythropoietin (epo)
299860|NCT01871207|Diabetes|diabetes
299861|NCT01871207|Diabetic Retinopathy|diabetic retinopathy
299862|NCT01871207|Vascular Endothelial Growth Factor (VEGF)|vascular endothelial growth factor (vegf)
299863|NCT01871207|Erythropoiesis Stimulating Agents (ESA)|erythropoiesis stimulating agents (esa)
299864|NCT01871142|5 Hydroxymethyl 2 Furfural|5 hydroxymethyl 2 furfural
299865|NCT01871142|AES103|aes103
299866|NCT01871142|Exercise|exercise
299867|NCT01871129|Dexmedetomidine|dexmedetomidine
299868|NCT01871129|Postoperative Period|postoperative period
299869|NCT01871129|Airway extubation|airway extubation
299870|NCT01871129|Systolic Pressure|systolic pressure
299871|NCT01871116|breast cancer|breast cancer
299872|NCT01871116|early stage|early stage
299873|NCT01871116|weight loss|weight loss
299874|NCT01871103|Soft tissue defect|soft tissue defect
299875|NCT01871103|dorsal branch of the digital artery|dorsal branch of the digital artery
299876|NCT01871103|dorsal branch of the digital nerve|dorsal branch of the digital nerve
299877|NCT01871103|dorsal homodigital island flap|dorsal homodigital island flap
299878|NCT01871090|Remote Monitoring|remote monitoring
299879|NCT01871090|Remote Care|remote care
299880|NCT01871090|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
299881|NCT01871090|Pacemaker|pacemaker
299882|NCT01871090|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
299883|NCT01871064|Laparotomy|laparotomy
299884|NCT01871064|laparoscopic surgery|laparoscopic surgery
299885|NCT01871064|general anesthesia|general anesthesia
299886|NCT01871064|Neuromuscular Block|neuromuscular block
299887|NCT01871038|vaccine effectiveness|vaccine effectiveness
299888|NCT01871038|rotavirus|rotavirus
299889|NCT01871038|acute gastroenteritis|acute gastroenteritis
299890|NCT01871025|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
299891|NCT01871012|Nerve Block|nerve block
299892|NCT01871012|Intraoperative Care|intraoperative care
299893|NCT01871012|Postoperative Recovery and Complications|postoperative recovery and complications
299894|NCT01871012|Stress and Inflammation|stress and inflammation
299895|NCT01870986|Healthy Volunteers|healthy volunteers
299896|NCT01870986|Phase 1|phase 1
299897|NCT01870986|PK|pk
299898|NCT01870986|adalimumab|adalimumab
299899|NCT01870986|Single-dose|single-dose
299900|NCT01870986|Immunology|immunology
299901|NCT01870986|Bioequivalence|bioequivalence
299902|NCT01870986|Biosimilarity|biosimilarity
299903|NCT01870986|Similarity.|similarity.
299904|NCT01870973|postoperative pain|postoperative pain
299905|NCT01870973|root canal treatment|root canal treatment
299906|NCT01870947|Stage I endometrial adenocarcinoma|stage i endometrial adenocarcinoma
299907|NCT01870947|Obesity|obesity
299908|NCT01870947|Exercise and Physical Fitness|exercise and physical fitness
299909|NCT01870947|Diet|diet
299910|NCT01870947|Cancer|cancer
299911|NCT01870934|Telemedicine|telemedicine
299912|NCT01870934|Diabetes|diabetes
299913|NCT01870934|Foot Ulcers|foot ulcers
299914|NCT01870895|YM060|ym060
299915|NCT01870895|Ramosetron|ramosetron
299916|NCT01870895|Diarrhea-predominant Irritable Bowel Syndrome|diarrhea-predominant irritable bowel syndrome
299917|NCT01870882|Opioid-Related Disorders|opioid-related disorders
299918|NCT01870882|Cocaine-Related Disorders|cocaine-related disorders
299919|NCT01870882|Substance-Related Disorders|substance-related disorders
299920|NCT01870882|Mental Disorders|mental disorders
299921|NCT01870882|Cocaine|cocaine
299922|NCT01870882|Methadone|methadone
299923|NCT01870882|Therapeutic Uses|therapeutic uses
299924|NCT01870856|Ocular discomfort|ocular discomfort
299925|NCT01870856|Contact lenses|contact lenses
299926|NCT01870856|Myopia|myopia
299927|NCT01870843|Depressive Disorder, Major|depressive disorder, major
299928|NCT01870843|Depressive Disorder|depressive disorder
299929|NCT01870843|Depression|depression
299930|NCT01870843|Anxiety|anxiety
299931|NCT01870843|Escitalopram|escitalopram
299932|NCT01870843|Quality of life|quality of life
299933|NCT01870843|Social functionality|social functionality
299934|NCT01870817|Randomized|randomized
299935|NCT01870817|Jejunostomy|jejunostomy
299936|NCT01870817|Enteral|enteral
299937|NCT01870817|Nutrition|nutrition
299938|NCT01870817|Esophagectomy|esophagectomy
299939|NCT01870817|Gastrectomy|gastrectomy
299940|NCT01870804|Statins|statins
299941|NCT01870804|Contrast-Induced Acute Kidney Injury|contrast-induced acute kidney injury
299942|NCT01870804|Periprocedural Myocardial Damage|periprocedural myocardial damage
299943|NCT01870791|Esophageal adenocarcinoma|esophageal adenocarcinoma
299944|NCT01870791|Gastric adenocarcinoma|gastric adenocarcinoma
299945|NCT01870778|acute heart failure,|acute heart failure,
299946|NCT01870778|AHF,|ahf,
299947|NCT01870778|multi-center,|multi-center,
299948|NCT01870778|randomized,|randomized,
299949|NCT01870778|double-blind|double-blind
299950|NCT01870739|LCZ696,|lcz696,
299951|NCT01870739|Hypertension,|hypertension,
299952|NCT01870739|Aortic stiffness,|aortic stiffness,
299953|NCT01870739|Central blood pressure,|central blood pressure,
299954|NCT01870739|Cardiovascular MRI|cardiovascular mri
299955|NCT01870726|Glioblastoma multiforme (GBM), glioblastoma, Grade IV Astrocytoma, brain tumor, brain cancer, giant cell glioblastoma, gliosarcoma|glioblastoma multiforme (gbm), glioblastoma, grade iv astrocytoma, brain tumor, brain cancer, giant cell glioblastoma, gliosarcoma
299956|NCT01870713|gastric bypass surgery|gastric bypass surgery
299957|NCT01870713|proteomics|proteomics
299958|NCT01870687|vitex agnus castus|vitex agnus castus
299959|NCT01870687|clinical trial|clinical trial
299960|NCT01870687|cyclic mastodynia|cyclic mastodynia
299961|NCT01870687|PMS|pms
299962|NCT01870687|prospective|prospective
299963|NCT01870674|safety|safety
299964|NCT01870674|tolerability|tolerability
299965|NCT01870674|pharmacokinetics|pharmacokinetics
299966|NCT01870674|pharmacodynamics|pharmacodynamics
299967|NCT01870661|Intravenous placement|intravenous placement
299968|NCT01870661|Ultrasound|ultrasound
299969|NCT01870648|Low-middle income country|low-middle income country
299970|NCT01870648|Dehydration|dehydration
299971|NCT01870648|Intravenous Rehydration|intravenous rehydration
299972|NCT01870648|Pakistan|pakistan
299973|NCT01870635|Low-middle income country|low-middle income country
299974|NCT01870635|Dehydration|dehydration
299975|NCT01870635|Intravenous Rehydration|intravenous rehydration
299976|NCT01870635|Pakistan|pakistan
299977|NCT01870622|Newborn,|newborn,
299978|NCT01870622|Infant,|infant,
299979|NCT01870622|Endotracheal Intubation,|endotracheal intubation,
299980|NCT01870622|Carbon dioxide detector,|carbon dioxide detector,
299981|NCT01870622|Flow waves|flow waves
299982|NCT01870583|Cesarean delivery|cesarean delivery
299983|NCT01870583|Surgical site infection|surgical site infection
299984|NCT01870583|Pregnancy|pregnancy
299985|NCT01870583|Postpartum|postpartum
299986|NCT01870570|Glycaemia|glycaemia
299987|NCT01870570|Insulinemia|insulinemia
299988|NCT01870557|Diabetes Mellitus|diabetes mellitus
299989|NCT01870557|Bone|bone
299990|NCT01870557|Bone Status|bone status
299991|NCT01870557|Glycemic Markers|glycemic markers
299992|NCT01870557|Osteoporosis|osteoporosis
299993|NCT01870557|Osteopenia|osteopenia
299994|NCT01870544|gastric bypass|gastric bypass
299995|NCT01870544|microbiota|microbiota
299996|NCT01870544|probiotic|probiotic
299997|NCT01870531|Transient Ischemic Attack|transient ischemic attack
299998|NCT01870518|Parkinson's disease|parkinson's disease
299999|NCT01870518|Dementia|dementia
300000|NCT01870505|BYL719|byl719
300001|NCT01870505|Letrozole|letrozole
300002|NCT01870505|Exemestane|exemestane
300003|NCT01870505|13-027|13-027
300004|NCT01870492|IV-tPA|iv-tpa
300005|NCT01870492|Activase|activase
300006|NCT01870492|endovascular therapy|endovascular therapy
300007|NCT01870479|Malignant Lymphoma|malignant lymphoma
300008|NCT01870479|Chemotherapy|chemotherapy
300009|NCT01870479|Music therapy|music therapy
300010|NCT01870453|Alzheimer Disease|alzheimer disease
300011|NCT01870453|Dementia|dementia
300012|NCT01870453|Postoperative Care|postoperative care
300013|NCT01870453|Cognitive Reserve|cognitive reserve
300014|NCT01870440|Uveitis|uveitis
300015|NCT01870440|Macular Edema|macular edema
300016|NCT01870427|Macular Edema|macular edema
300017|NCT01870427|Central Retinal Vein Occlusion|central retinal vein occlusion
300018|NCT01870427|CRVO|crvo
300019|NCT01870427|Aflibercept|aflibercept
300020|NCT01870427|VEGF Trap-Eye|vegf trap-eye
300021|NCT01870427|Eylea|eylea
300022|NCT01870427|Ranibizumab|ranibizumab
300023|NCT01870427|Bevacizumab|bevacizumab
300024|NCT01870375|Mucopolysaccharidosis|mucopolysaccharidosis
300025|NCT01870375|Longitudinal|longitudinal
300026|NCT01870375|Brain|brain
300027|NCT01870375|Cognition|cognition
300028|NCT01870375|Quality-of-Life|quality-of-life
300029|NCT01870375|Hurler syndrome|hurler syndrome
300030|NCT01870375|Hunter syndrome|hunter syndrome
300031|NCT01870375|Hurler-Scheie syndrome|hurler-scheie syndrome
300032|NCT01870375|Scheie syndrome|scheie syndrome
300033|NCT01870375|Maroteaux-Lamy syndrome|maroteaux-lamy syndrome
300034|NCT01870375|MPS I|mps i
300035|NCT01870375|MPS II|mps ii
300036|NCT01870375|MPS VI|mps vi
300037|NCT01870375|Mucopolysaccharidosis type I|mucopolysaccharidosis type i
300038|NCT01870375|Mucopolysaccharidosis type II|mucopolysaccharidosis type ii
300039|NCT01870375|Mucopolysaccharidosis type VI|mucopolysaccharidosis type vi
300040|NCT01870375|MPS IV|mps iv
300041|NCT01870375|MPS VII|mps vii
300042|NCT01870375|Mucopolysaccharidosis type IV|mucopolysaccharidosis type iv
300043|NCT01870375|Mucopolysaccharidosis type VII|mucopolysaccharidosis type vii
300044|NCT01870375|Morquio syndrome|morquio syndrome
300045|NCT01870375|Sly syndrome|sly syndrome
300046|NCT01870349|cytokines|cytokines
300047|NCT01870349|dental implants|dental implants
300048|NCT01870349|peri-implantitis|peri-implantitis
300049|NCT01870310|Heart failure|heart failure
300050|NCT01870310|Renal denervation|renal denervation
300051|NCT01870271|PTSD|ptsd
300052|NCT01870271|childhood sexual abuse|childhood sexual abuse
300053|NCT01870271|physical abuse|physical abuse
300054|NCT01870271|developmentally adapted cognitive processing therapy|developmentally adapted cognitive processing therapy
300055|NCT01870258|Myocardial infarction|myocardial infarction
300056|NCT01870258|artificial neural networks|artificial neural networks
300057|NCT01870258|Electrocardiography|electrocardiography
300058|NCT01870232|Greater palatine nerve Block|greater palatine nerve block
300059|NCT01870232|Inferior Alveolar nerve block|inferior alveolar nerve block
300060|NCT01870232|dental anesthesia|dental anesthesia
300061|NCT01870232|Ultrasonography|ultrasonography
300062|NCT01870219|sevoflurane|sevoflurane
300063|NCT01870219|ketamine|ketamine
300064|NCT01870219|QT interval|qt interval
300065|NCT01870206|Immunogenicity|immunogenicity
300066|NCT01870206|Safety|safety
300067|NCT01870206|Efficacy|efficacy
300068|NCT01870206|Poliomyelitis|poliomyelitis
300069|NCT01870206|Newborn|newborn
300070|NCT01870193|Glutathione deficiency in aging|glutathione deficiency in aging
300071|NCT01870193|Impaired mitochondrial fatty-acid oxidation in aging|impaired mitochondrial fatty-acid oxidation in aging
300072|NCT01870180|Meibomian Glad Dysfunction|meibomian glad dysfunction
300073|NCT01870180|EyeBag|eyebag
300074|NCT01870180|Hot Compress|hot compress
300075|NCT01870180|Dry Eyes|dry eyes
300076|NCT01870167|PEG|peg
300077|NCT01870167|Percutaneous Endoscopic Gastrostomy|percutaneous endoscopic gastrostomy
300078|NCT01870167|antibiotic prophylaxis|antibiotic prophylaxis
300079|NCT01870154|Burnout syndrome|burnout syndrome
300080|NCT01870154|Job stressors|job stressors
300081|NCT01870154|Primary Health Care|primary health care
300082|NCT01870154|Health professional|health professional
300083|NCT01870141|Glucose Control|glucose control
300084|NCT01870141|Depression|depression
300085|NCT01870141|Self-Efficacy|self-efficacy
300086|NCT01870128|Rheumatoid arthritis|rheumatoid arthritis
300087|NCT01870128|Steroid|steroid
300088|NCT01870115|Melatonin|melatonin
300089|NCT01870115|Strontium Citrate|strontium citrate
300090|NCT01870115|Osteoporosis|osteoporosis
300091|NCT01870115|Osteopenia|osteopenia
300092|NCT01870089|Non invasive ventilation|non invasive ventilation
300093|NCT01870089|Computer-driven system|computer-driven system
300094|NCT01870089|Acute respiratory failure|acute respiratory failure
300095|NCT01870063|5 minute bleeding test|5 minute bleeding test
300096|NCT01870063|swamb|swamb
300097|NCT01870063|fibtem|fibtem
300098|NCT01870063|extem|extem
300099|NCT01870050|lichen simplex chronicus|lichen simplex chronicus
300100|NCT01870050|prurigo|prurigo
300101|NCT01870037|OAB, gene therapy|oab, gene therapy
300102|NCT01870024|status epilepticus|status epilepticus
300103|NCT01870024|epilepsy|epilepsy
300104|NCT01870024|seizures|seizures
300105|NCT01870024|convulsive seizures|convulsive seizures
300106|NCT01870024|convulsions|convulsions
300107|NCT01870024|benzodiazepines|benzodiazepines
300108|NCT01870024|anticonvulsants|anticonvulsants
300109|NCT01870011|Propofol, renal protection, kidney transplantation|propofol, renal protection, kidney transplantation
300110|NCT01869998|Vortex|vortex
300111|NCT01869998|Thrombus|thrombus
300112|NCT01869998|Contrast echocardiography|contrast echocardiography
300113|NCT01869998|Prediction and prevention of apical thrombus formation in acute myocardial infarction patient by using Vortex parameters.|prediction and prevention of apical thrombus formation in acute myocardial infarction patient by using vortex parameters.
300114|NCT01869985|HCP1104|hcp1104
300115|NCT01869985|Eperisone Hydrochloride|eperisone hydrochloride
300116|NCT01869985|Aceclofenac|aceclofenac
300117|NCT01869972|PKU|pku
300118|NCT01869972|phenylketonuria|phenylketonuria
300119|NCT01869972|hyperphenylalaninemia|hyperphenylalaninemia
300120|NCT01869972|Kuvan|kuvan
300121|NCT01869972|sapropterin|sapropterin
300122|NCT01869946|Hip arthroplasty|hip arthroplasty
300123|NCT01869933|Proliferative, Diabetic, Retinopathy|proliferative, diabetic, retinopathy
300124|NCT01869920|breastfeeding|breastfeeding
300125|NCT01869920|education|education
300126|NCT01869920|intervention|intervention
300127|NCT01869894|Malignant biliary obstruction|malignant biliary obstruction
300128|NCT01869894|metal stent|metal stent
300129|NCT01869894|patency|patency
300130|NCT01869855|chronic subdural hematoma|chronic subdural hematoma
300131|NCT01869855|traumatic brain injury|traumatic brain injury
300132|NCT01869855|burr hole trepanation|burr hole trepanation
300133|NCT01869855|drainage after evacuation of chronic subdural hematoma|drainage after evacuation of chronic subdural hematoma
300134|NCT01869855|intracranial bleed|intracranial bleed
300135|NCT01869842|Resolute zotarolumus-eluting stent|resolute zotarolumus-eluting stent
300136|NCT01869842|optical coherence tomography|optical coherence tomography
300137|NCT01869829|Candida|candida
300138|NCT01869829|Pediatric|pediatric
300139|NCT01869829|Antifungal|antifungal
300140|NCT01869738|heart attack|heart attack
300141|NCT01869725|Neuroendocrine Tumor|neuroendocrine tumor
300142|NCT01869725|Ga-DOTATOC PET|ga-dotatoc pet
300143|NCT01869725|Imaging|imaging
300144|NCT01869712|cupping therapy|cupping therapy
300145|NCT01869712|acupuncture|acupuncture
300146|NCT01869712|partially randomized|partially randomized
300147|NCT01869712|patient preference|patient preference
300148|NCT01869712|fibromyalgia|fibromyalgia
300149|NCT01869712|criteria formulated by American College Rheumatology 2002|criteria formulated by american college rheumatology 2002
300150|NCT01869699|Fever|fever
300151|NCT01869699|Acetaminophen|acetaminophen
300152|NCT01869699|Critical Care|critical care
300153|NCT01869699|ICU|icu
300154|NCT01869699|Febrile|febrile
300155|NCT01869673|Difficult mask ventilation|difficult mask ventilation
300156|NCT01869673|extubation|extubation
300157|NCT01869673|nasal surgery|nasal surgery
300158|NCT01869660|First hospitalization|first hospitalization
300159|NCT01869647|kidney stones|kidney stones
300160|NCT01869634|HIV|hiv
300161|NCT01869634|cardiovascular risk|cardiovascular risk
300162|NCT01869634|systemic immune activation|systemic immune activation
300163|NCT01869608|postpartum screening|postpartum screening
300164|NCT01869608|type 2 diabetes|type 2 diabetes
300165|NCT01869595|2000 MSM and TG sites in Bangkok,Lampang,Ubonratchathani|2000 msm and tg sites in bangkok,lampang,ubonratchathani
300166|NCT01869582|Fetal hypoxia|fetal hypoxia
300167|NCT01869582|Birth asphyxia|birth asphyxia
300168|NCT01869582|Neonatal resuscitation|neonatal resuscitation
300169|NCT01869569|Radiation|radiation
300170|NCT01869569|Neuropathic Pain|neuropathic pain
300171|NCT01869569|Pregabalin|pregabalin
300172|NCT01869556|pregnancy|pregnancy
300173|NCT01869556|postpartum hemorrhage|postpartum hemorrhage
300174|NCT01869556|Cesarean delivery|cesarean delivery
300175|NCT01869556|failure to progress in labor|failure to progress in labor
300176|NCT01869504|Ballooned intercostal drain|ballooned intercostal drain
300177|NCT01869504|Pleural effusion|pleural effusion
300178|NCT01869491|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
300179|NCT01869491|GERD|gerd
300180|NCT01869491|Dyspepsia|dyspepsia
300181|NCT01869491|Indigestion|indigestion
300182|NCT01869491|Heartburn|heartburn
300183|NCT01869491|Acid reflux|acid reflux
300184|NCT01869491|Compound Sodium Alginate Double Action Chewable Tablets|compound sodium alginate double action chewable tablets
300185|NCT01869491|Gaviscon Double Action Tablets|gaviscon double action tablets
300186|NCT01869452|education|education
300187|NCT01869452|risk factors|risk factors
300188|NCT01869452|quality of life|quality of life
300189|NCT01869452|coronary disease|coronary disease
300190|NCT01869452|telephone follow up|telephone follow up
300191|NCT01869452|dedicated nurse|dedicated nurse
300192|NCT01869439|Pressure Ulcers|pressure ulcers
300193|NCT01869439|Bed Sores|bed sores
300194|NCT01869439|Measuring|measuring
300195|NCT01869439|Visual Images|visual images
300196|NCT01869439|Thermal Images|thermal images
300197|NCT01869439|External Wounds|external wounds
300198|NCT01869439|Area|area
300199|NCT01869439|Length|length
300200|NCT01869439|Width|width
300201|NCT01869439|Gradient|gradient
300202|NCT01869426|colics|colics
300203|NCT01869413|urothelial cell carcinoma|urothelial cell carcinoma
300204|NCT01869413|transition cell carcinoma|transition cell carcinoma
300205|NCT01869413|bladder cancer|bladder cancer
300206|NCT01869413|radical cystectomy|radical cystectomy
300207|NCT01869413|cystectomy|cystectomy
300208|NCT01869413|bladder removal|bladder removal
300209|NCT01869413|tranexamic acid|tranexamic acid
300210|NCT01869413|cyklokapron|cyklokapron
300211|NCT01869374|Depression|depression
300212|NCT01869374|Brain Stimulation|brain stimulation
300213|NCT01869374|Seizure therapy|seizure therapy
300214|NCT01869374|Convulsive Therapy|convulsive therapy
300215|NCT01869361|preterm labor|preterm labor
300216|NCT01869361|tocolysis|tocolysis
300217|NCT01869361|indomethacin|indomethacin
300218|NCT01869348|Physical activity|physical activity
300219|NCT01869348|Activity monitor|activity monitor
300220|NCT01869348|Technology|technology
300221|NCT01869348|Obesity|obesity
300222|NCT01869348|Aging muscle|aging muscle
300223|NCT01869335|breast cancer|breast cancer
300224|NCT01869335|MRI|mri
300225|NCT01869335|mammography|mammography
300715|NCT01867164|Vaginitis|vaginitis
300226|NCT01869335|microcalcifications|microcalcifications
300227|NCT01869335|Local staging of breast microcalcifications|local staging of breast microcalcifications
300228|NCT01869335|Evaluation of ex vivo MRI for breast malignancies detected by MRI only|evaluation of ex vivo mri for breast malignancies detected by mri only
300229|NCT01869322|Humerus|humerus
300230|NCT01869322|Fracture|fracture
300231|NCT01869322|Sling|sling
300232|NCT01869322|Splint|splint
300233|NCT01869322|Coaptation|coaptation
300234|NCT01869309|Coronary artery disease|coronary artery disease
300235|NCT01869309|anti-platelet medications|anti-platelet medications
300236|NCT01869309|Platelet-aggregation Inhibitors|platelet-aggregation inhibitors
300237|NCT01869296|unsedated|unsedated
300238|NCT01869296|water immersion colonoscopy|water immersion colonoscopy
300239|NCT01869296|endoscope water pump flow rates|endoscope water pump flow rates
300240|NCT01869283|Physical Therapy Modalities|physical therapy modalities
300241|NCT01869283|Myofascial Pain Syndromes|myofascial pain syndromes
300242|NCT01869283|Skeletal Muscle|skeletal muscle
300243|NCT01869270|hexosaminidase deficiency|hexosaminidase deficiency
300244|NCT01869270|Tay-Sachs disease|tay-sachs disease
300245|NCT01869270|Sandhoff disease|sandhoff disease
300246|NCT01869270|late-onset Tay-Sachs disease|late-onset tay-sachs disease
300247|NCT01869270|adult-onset Tay-Sachs disease|adult-onset tay-sachs disease
300248|NCT01869270|late onset Tay Sachs disease|late onset tay sachs disease
300249|NCT01869270|adult onset Tay Sachs disease|adult onset tay sachs disease
300250|NCT01869270|retrospective|retrospective
300251|NCT01869270|hexosaminidase A activity|hexosaminidase a activity
300252|NCT01869270|GM2-ganglioside|gm2-ganglioside
300253|NCT01869270|gangliosidoses|gangliosidoses
300254|NCT01869270|natural history|natural history
300255|NCT01869270|hexosaminidase|hexosaminidase
300256|NCT01869257|triclosan|triclosan
300257|NCT01869257|colorectal|colorectal
300258|NCT01869257|surgery|surgery
300259|NCT01869257|surgical site infection|surgical site infection
300260|NCT01869218|Cancer|cancer
300261|NCT01869218|Advanced|advanced
300262|NCT01869218|Solid|solid
300263|NCT01869218|Hematological|hematological
300264|NCT01869218|Malignancy|malignancy
300265|NCT01869218|Tissue|tissue
300266|NCT01869218|Bank|bank
300267|NCT01869205|COPD|copd
300268|NCT01869205|Emphysema|emphysema
300269|NCT01869205|Bronchoscopic lung volume reduction|bronchoscopic lung volume reduction
300270|NCT01869205|Endobronchial valve|endobronchial valve
300271|NCT01869192|Malignant|malignant
300272|NCT01869192|Neoplasm|neoplasm
300273|NCT01869192|Cancer|cancer
300274|NCT01869192|Female|female
300275|NCT01869192|Breast|breast
300276|NCT01869192|Stage II|stage ii
300277|NCT01869192|Stage III|stage iii
300278|NCT01869179|Well being|well being
300279|NCT01869179|Low income|low income
300280|NCT01869179|Choir singing|choir singing
300281|NCT01869179|Spanish speaking|spanish speaking
300282|NCT01869179|Community based|community based
300283|NCT01869179|Seniors|seniors
300284|NCT01869179|60+ aged adults|60+ aged adults
300285|NCT01869166|chemotherapy and/or EGFR-antibody/kinase inhibitor therapy refractory solid tumors|chemotherapy and/or egfr-antibody/kinase inhibitor therapy refractory solid tumors
300286|NCT01869153|Growth, weight|growth, weight
300287|NCT01869127|hookworm|hookworm
300288|NCT01869127|necator americanus|necator americanus
300289|NCT01869127|ancyclostoma duodenale|ancyclostoma duodenale
300290|NCT01869127|shoes|shoes
300291|NCT01869127|anaemia|anaemia
300292|NCT01869127|children|children
300293|NCT01869101|Prediabetes|prediabetes
300294|NCT01869101|Diabetes prevention|diabetes prevention
300295|NCT01869088|TACE|tace
300296|NCT01869088|Carcinoma,Hepatocellular|carcinoma,hepatocellular
300297|NCT01869088|Liver Neoplasms|liver neoplasms
300298|NCT01869088|overall survival|overall survival
300299|NCT01869088|Recombinant Human Adenovirus Type 5 Injection|recombinant human adenovirus type 5 injection
300300|NCT01869075|Quality Improvement|quality improvement
300301|NCT01869075|Patient Safety|patient safety
300302|NCT01869075|Knowledge Translation|knowledge translation
300303|NCT01869062|CRT|crt
300304|NCT01869049|Immune Thrombocytopenia|immune thrombocytopenia
300305|NCT01869049|macrophage|macrophage
300306|NCT01869049|spleen tissue|spleen tissue
300307|NCT01869036|Caudal|caudal
300308|NCT01869036|anesthesia|anesthesia
300309|NCT01869036|morphine|morphine
300310|NCT01869036|children|children
300311|NCT01869023|Advanced Malignant Pleural Mesothelioma|advanced malignant pleural mesothelioma
300312|NCT01869023|Gemcitabine and cisplatin|gemcitabine and cisplatin
300313|NCT01869023|Gemcitabine continuous infusion|gemcitabine continuous infusion
300314|NCT01869010|HIV infection|hiv infection
300315|NCT01869010|Antiretroviral treatment|antiretroviral treatment
300316|NCT01869010|Renal disease|renal disease
300317|NCT01869010|Renal tubular damage|renal tubular damage
300318|NCT01869010|Free-water clearance|free-water clearance
300319|NCT01868997|Thyroid Eye Disease, Graves Orbitopathy, Thyroid Associated|thyroid eye disease, graves orbitopathy, thyroid associated
300320|NCT01868997|Ophthalmopathy|ophthalmopathy
300321|NCT01868971|EndoRings|endorings
300322|NCT01868958|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
300323|NCT01868958|Diffusion tensor imaging|diffusion tensor imaging
300324|NCT01868958|Spine|spine
300325|NCT01868945|Vitamin D3|vitamin d3
300326|NCT01868945|Calcifediol 25|calcifediol 25
300327|NCT01868945|Frail|frail
300328|NCT01868945|Dose-response|dose-response
300329|NCT01868932|wheeze|wheeze
300330|NCT01868932|early childhood|early childhood
300331|NCT01868932|asthma|asthma
300332|NCT01868932|bronchiolitis|bronchiolitis
300333|NCT01868932|infection triggered|infection triggered
300334|NCT01868919|"Pilot Projects[Mesh]"|"pilot projects[mesh]"
300335|NCT01868919|"Parenting[Mesh]"|"parenting[mesh]"
300336|NCT01868919|"Child Behaviour[Mesh]"|"child behaviour[mesh]"
300337|NCT01868919|"Mental Health[Mesh]"|"mental health[mesh]"
300338|NCT01868919|"Family Practice[Mesh]"|"family practice[mesh]"
300339|NCT01868906|Anaplastic Astrocytoma|anaplastic astrocytoma
300340|NCT01868906|Brain Tumors|brain tumors
300341|NCT01868906|Cancer Imaging|cancer imaging
300342|NCT01868906|Fluoromisonidazole|fluoromisonidazole
300343|NCT01868906|FMISO PET|fmiso pet
300344|NCT01868906|Glioblastoma|glioblastoma
300345|NCT01868906|High Grade Glioma|high grade glioma
300346|NCT01868906|Hypoxia Modification|hypoxia modification
300347|NCT01868906|Positron Emission Tomography|positron emission tomography
300348|NCT01868906|Radiation-Sensitizing Agents|radiation-sensitizing agents
300349|NCT01868906|Spinal Cord Stimulation|spinal cord stimulation
300350|NCT01868906|Tumor Hypoxia Measurement|tumor hypoxia measurement
300351|NCT01868854|Tip catheter|tip catheter
300352|NCT01868854|Peritoneal Dialysis|peritoneal dialysis
300353|NCT01868854|Risk Factot|risk factot
300354|NCT01868854|Mecanical Function|mecanical function
300355|NCT01868841|123I-mIBG|123i-mibg
300356|NCT01868841|AdreView|adreview
300357|NCT01868841|SPECT|spect
300358|NCT01868841|Heart to Mediastinal Ratio|heart to mediastinal ratio
300359|NCT01868828|Multiple Myeloma|multiple myeloma
300360|NCT01868828|Combination Therapy|combination therapy
300361|NCT01868802|Ketamine|ketamine
300362|NCT01868802|Depression|depression
300363|NCT01868802|Depressive Disorder|depressive disorder
300364|NCT01868789|Adult-acquired flatfoot disorder (AAFD)|adult-acquired flatfoot disorder (aafd)
300365|NCT01868789|flexible flatfoot|flexible flatfoot
300366|NCT01868789|computed tomography (CT)|computed tomography (ct)
300367|NCT01868763|telemedicine|telemedicine
300368|NCT01868763|coaching|coaching
300369|NCT01868763|lifestyle change|lifestyle change
300370|NCT01868763|weight loss|weight loss
300371|NCT01868737|Human Immunodeficiency Virus|human immunodeficiency virus
300372|NCT01868737|Necrotizing Enterocolitis|necrotizing enterocolitis
300373|NCT01868737|Premature infant|premature infant
300374|NCT01868737|Probiotic|probiotic
300375|NCT01868737|Very Low Birth Weight|very low birth weight
300376|NCT01868724|Kidney Renal|kidney renal
300377|NCT01868711|Major Depressive Disorder|major depressive disorder
300378|NCT01868711|Cognitive Behavior Therapy|cognitive behavior therapy
300379|NCT01868711|Psychological Mindedness|psychological mindedness
300380|NCT01868698|Physical Therapy Modalities|physical therapy modalities
300381|NCT01868698|Electric Stimulation Therapy|electric stimulation therapy
300382|NCT01868698|Hyperthermia, Induced|hyperthermia, induced
300383|NCT01868698|Diabetes Mellitus|diabetes mellitus
300384|NCT01868685|Muscle, anabolism, cachexia, respiratory failure, diaphragm|muscle, anabolism, cachexia, respiratory failure, diaphragm
300385|NCT01868672|Secondhand smoke exposure|secondhand smoke exposure
300386|NCT01868672|Smoke-free homes|smoke-free homes
300387|NCT01868672|Smoke-free home bans|smoke-free home bans
300388|NCT01868646|Combined Treatment of Patients With Type II Diabetes Mellitus|combined treatment of patients with type ii diabetes mellitus
300389|NCT01868633|Cesarean delivery|cesarean delivery
300390|NCT01868633|Analgesia|analgesia
300391|NCT01868633|Pain|pain
300392|NCT01868633|Dexamethasone|dexamethasone
300393|NCT01868633|intrathecal morphine|intrathecal morphine
300394|NCT01868633|spinal anesthesia|spinal anesthesia
300395|NCT01868620|Progressive keratoconus|progressive keratoconus
300396|NCT01868620|standard CXL|standard cxl
300397|NCT01868620|iontophoretic CXL|iontophoretic cxl
300398|NCT01868620|keratometry|keratometry
300399|NCT01868607|Respiratory resistance|respiratory resistance
300400|NCT01868607|Respiratory reactance|respiratory reactance
300401|NCT01868607|Adult lung function|adult lung function
300402|NCT01868607|Forced oscillation technique|forced oscillation technique
300403|NCT01868607|subjects|subjects
300404|NCT01868594|Combined treatment of patients with type I diabetes mellitus|combined treatment of patients with type i diabetes mellitus
300405|NCT01868490|Cholangiocarcinoma|cholangiocarcinoma
300406|NCT01868490|Cytokine induced killer cells|cytokine induced killer cells
300407|NCT01868490|CIK|cik
300408|NCT01868490|Treg|treg
300409|NCT01868490|Th17|th17
300410|NCT01868477|myelodysplastic syndrome|myelodysplastic syndrome
300411|NCT01868477|MDS|mds
300412|NCT01868477|myelodysplasia|myelodysplasia
300413|NCT01868477|blood disorder|blood disorder
300414|NCT01868477|cytopenias|cytopenias
300415|NCT01868477|low blood counts|low blood counts
300416|NCT01868477|progressive bone marrow failure|progressive bone marrow failure
300417|NCT01868464|challenge|challenge
300418|NCT01868464|Mycobacterium tuberculosis|mycobacterium tuberculosis
300419|NCT01868464|parent protocol|parent protocol
300420|NCT01868464|TB|tb
300421|NCT01868464|Tice BCG|tice bcg
300422|NCT01868464|tuberculosis|tuberculosis
300423|NCT01868451|DACARBAZINE|dacarbazine
300424|NCT01868451|DOXORUBICIN/ADRIAMYCIN|doxorubicin/adriamycin
300425|NCT01868451|SGN-35 (BRENTUXIMAB VEDOTIN)|sgn-35 (brentuximab vedotin)
300426|NCT01868451|VINBLASTINE|vinblastine
300427|NCT01868451|Involved-site radiation therapy (ISRT)|involved-site radiation therapy (isrt)
300428|NCT01868451|Early stage|early stage
300429|NCT01868451|13-034|13-034
300430|NCT01868438|Pyronaridine artesunate tablet|pyronaridine artesunate tablet
300431|NCT01868438|Pyronaridine artesunate granules|pyronaridine artesunate granules
300432|NCT01868438|Pyramax tablet|pyramax tablet
300433|NCT01868438|Pyramax granules|pyramax granules
300434|NCT01868438|Bioavailability|bioavailability
300435|NCT01868412|Wound healing|wound healing
300436|NCT01868412|Wound infection|wound infection
300437|NCT01868412|Resin salve|resin salve
300438|NCT01868412|Medical honey|medical honey
300439|NCT01868399|dengue virus|dengue virus
300440|NCT01868386|Radiotherapy, hypofractionated|radiotherapy, hypofractionated
300441|NCT01868386|Salvage therapy|salvage therapy
300442|NCT01868386|Radiotherapy, adjuvant|radiotherapy, adjuvant
300443|NCT01868373|commensal microbiota bacteroides colitis pseudomembranous|commensal microbiota bacteroides colitis pseudomembranous
300444|NCT01868360|cornea|cornea
300445|NCT01868360|transplant|transplant
300446|NCT01868360|graft|graft
300447|NCT01868360|neovascularization|neovascularization
300448|NCT01868347|obese patients|obese patients
300449|NCT01868347|specific elastance|specific elastance
300450|NCT01868347|Trendelenburg Position|trendelenburg position
300451|NCT01868347|Pneumoperitoneum|pneumoperitoneum
300452|NCT01868347|robotic surgery|robotic surgery
300453|NCT01868347|Prostatectomy|prostatectomy
300454|NCT01868334|influenza vaccine|influenza vaccine
300455|NCT01868334|PPSV|ppsv
300456|NCT01868334|Tdap|tdap
300457|NCT01868334|vaccination|vaccination
300458|NCT01868334|adult|adult
300459|NCT01868321|Mechanical ventilation|mechanical ventilation
300460|NCT01868321|Acute respiratory failure|acute respiratory failure
300461|NCT01868321|Acute respiratory distress syndrome|acute respiratory distress syndrome
300462|NCT01868282|anterior cruciate ligament repair, Obturator nerve block, Hamstrings graft, Ropivacaine,|anterior cruciate ligament repair, obturator nerve block, hamstrings graft, ropivacaine,
300463|NCT01868282|Postoperative pain|postoperative pain
300464|NCT01868256|myocardial infarction|myocardial infarction
300465|NCT01868256|primary percutaneous intervention|primary percutaneous intervention
300466|NCT01868256|prognosis|prognosis
300467|NCT01868256|early discharge|early discharge
300468|NCT01868243|Atrial Fibrillation|atrial fibrillation
300469|NCT01868243|Bioprosthesis|bioprosthesis
300470|NCT01868243|Stroke|stroke
300471|NCT01868243|Dabigatran|dabigatran
300472|NCT01868243|Warfarin|warfarin
300473|NCT01868204|Obesity|obesity
300474|NCT01868204|Binge eating disorder|binge eating disorder
300475|NCT01868204|Pharmacogenetic|pharmacogenetic
300476|NCT01868204|Food craving|food craving
300477|NCT01868204|Brain areas|brain areas
300478|NCT01868204|Topiramate|topiramate
300479|NCT01868191|Diabetes|diabetes
300480|NCT01868191|Neuropathy|neuropathy
300481|NCT01868178|awareness|awareness
300482|NCT01868165|Cognitive decline|cognitive decline
300483|NCT01868165|High blood pressure|high blood pressure
300484|NCT01868165|Hypertension|hypertension
300485|NCT01868165|Ageing|ageing
300486|NCT01868165|Dementia|dementia
300487|NCT01868165|Antihypertensives|antihypertensives
300488|NCT01868152|sufentanil|sufentanil
300489|NCT01868152|individual variation|individual variation
300490|NCT01868152|pain threshold|pain threshold
300491|NCT01868152|narcotrend index|narcotrend index
300492|NCT01868139|Cryotherapy|cryotherapy
300493|NCT01868139|Esophageal cancer|esophageal cancer
300494|NCT01868139|Esophageal carcinoma|esophageal carcinoma
300495|NCT01868139|Liquid nitrogen|liquid nitrogen
300496|NCT01868139|Esophageal adenocarcinoma|esophageal adenocarcinoma
300497|NCT01868139|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
300498|NCT01868139|Endoscopy|endoscopy
300499|NCT01868139|Ablation|ablation
300500|NCT01868126|Santen|santen
300501|NCT01868126|Eye|eye
300502|NCT01868126|Glaucoma|glaucoma
300503|NCT01868126|Ocular hypertension|ocular hypertension
300504|NCT01868113|Children U-5|children u-5
300505|NCT01868113|ALRI|alri
300506|NCT01868113|Inhaled Corticosteroids|inhaled corticosteroids
300507|NCT01868100|Cancer|cancer
300508|NCT01868100|quality of life|quality of life
300509|NCT01868100|palliative care|palliative care
300510|NCT01868100|supportive care|supportive care
300511|NCT01868100|Financial distress|financial distress
300512|NCT01868087|nutritional supplement|nutritional supplement
300513|NCT01868087|immune system|immune system
300514|NCT01868087|RC surgery|rc surgery
300515|NCT01868074|pregnancy, arch height, collapsed arch|pregnancy, arch height, collapsed arch
300516|NCT01868048|Spasticity|spasticity
300517|NCT01868048|Multiple Sclerosis|multiple sclerosis
300518|NCT01868035|radioimmunotherapy|radioimmunotherapy
300519|NCT01868035|Iodine 131 Tositumomab|iodine 131 tositumomab
300520|NCT01868022|FGFR1|fgfr1
300521|NCT01868022|FP1039|fp1039
300522|NCT01868022|GSK3052230|gsk3052230
300523|NCT01868022|docetaxel|docetaxel
300524|NCT01868022|FGFR|fgfr
300525|NCT01868022|carboplatin|carboplatin
300526|NCT01868022|HGS1036|hgs1036
300527|NCT01868022|squamous non-small cell lung cancer|squamous non-small cell lung cancer
300528|NCT01868022|paclitaxel|paclitaxel
300529|NCT01868009|fluticasone furoate|fluticasone furoate
300530|NCT01868009|COPD|copd
300531|NCT01868009|ELLIPTA|ellipta
300532|NCT01868009|fluticasone propionate|fluticasone propionate
300533|NCT01868009|DISKUS|diskus
300534|NCT01868009|Novel Dry Powder Inhaler (NDPI)|novel dry powder inhaler (ndpi)
300535|NCT01868009|device preference|device preference
300536|NCT01868009|salmeterol|salmeterol
300537|NCT01868009|vilanterol|vilanterol
300538|NCT01867996|Retosiban, Efavirenz, Induction|retosiban, efavirenz, induction
300539|NCT01867983|Tobacco cessation|tobacco cessation
300540|NCT01867983|Weight gain prevention|weight gain prevention
300541|NCT01867970|remote sensing technology|remote sensing technology
300542|NCT01867970|physical activity|physical activity
300543|NCT01867970|self-management support|self-management support
300544|NCT01867970|primary care nursing|primary care nursing
300545|NCT01867957|anthrax|anthrax
300546|NCT01867957|vaccine|vaccine
300547|NCT01867957|bioterrorism|bioterrorism
300548|NCT01867957|efficacy|efficacy
300549|NCT01867957|safety|safety
300550|NCT01867944|Chronic constipation|chronic constipation
300551|NCT01867944|Hemorrhoids|hemorrhoids
300552|NCT01867944|Acupressure|acupressure
300553|NCT01867905|Severe sepsis|severe sepsis
300554|NCT01867905|Septic shock|septic shock
300555|NCT01867905|Bacteremia|bacteremia
300556|NCT01867905|Antibiotics|antibiotics
300557|NCT01867905|Blood culture positivity|blood culture positivity
300558|NCT01867892|Locally Advanced Pancreatic Cancer|locally advanced pancreatic cancer
300559|NCT01867879|Advanced solid tumors (excluding breast cancer) for which no standard therapy exists|advanced solid tumors (excluding breast cancer) for which no standard therapy exists
300560|NCT01867866|Advanced solid tumors (excluding breast cancer) for which no standard therapy exists|advanced solid tumors (excluding breast cancer) for which no standard therapy exists
300561|NCT01867801|PCI|pci
300562|NCT01867801|Coronary disease|coronary disease
300563|NCT01867801|Ischemia|ischemia
300564|NCT01867775|Alzheimer's disease|alzheimer's disease
300565|NCT01867775|Sleep disorders|sleep disorders
300566|NCT01867775|Mirtazapine|mirtazapine
300567|NCT01867775|Treatment|treatment
300568|NCT01867775|Intervention|intervention
300569|NCT01867775|insomnia|insomnia
300570|NCT01867762|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
300571|NCT01867762|JNJ 49095397|jnj 49095397
300572|NCT01867762|RV568|rv568
300573|NCT01867762|Forced expiratory volume in one second|forced expiratory volume in one second
300574|NCT01867762|FEV1|fev1
300575|NCT01867749|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
300576|NCT01867749|Miscarriage|miscarriage
300577|NCT01867749|Stillbirth|stillbirth
300578|NCT01867749|Neonatal death|neonatal death
300579|NCT01867749|Interpersonal psychotherapy|interpersonal psychotherapy
300580|NCT01867749|Group Therapy|group therapy
300581|NCT01867749|Coping with Depression (CWD)|coping with depression (cwd)
300582|NCT01867736|Stenosis|stenosis
300583|NCT01867736|Occlusions|occlusions
300584|NCT01867736|Infrapopliteal arteries|infrapopliteal arteries
300585|NCT01867736|Below the knee arteries|below the knee arteries
300586|NCT01867736|PTA|pta
300587|NCT01867736|POBA|poba
300588|NCT01867736|DRB|drb
300589|NCT01867723|Cancer internet support program|cancer internet support program
300590|NCT01867710|Mineralocorticoid Excess ; Chemotherapy-Naïve; Metastatic Castration-Resistant Prostate Cancer; Abiraterone Acetate; Zytiga; Prednisone; dexamethasone|mineralocorticoid excess ; chemotherapy-naïve; metastatic castration-resistant prostate cancer; abiraterone acetate; zytiga; prednisone; dexamethasone
300591|NCT01867684|Stroke|stroke
300592|NCT01867684|Acquired brain injury|acquired brain injury
300593|NCT01867671|Allergy, Peanut|allergy, peanut
300594|NCT01867671|Peanut allergy|peanut allergy
300595|NCT01867671|Hypersensitivity|hypersensitivity
300596|NCT01867671|Immunotherapy|immunotherapy
300597|NCT01867671|Desensitization, Immunologic|desensitization, immunologic
300598|NCT01867658|Pleural Air Leak|pleural air leak
300599|NCT01867658|Pulmonary resection|pulmonary resection
300600|NCT01867658|Video Assisted|video assisted
300601|NCT01867658|Robotic Assisted|robotic assisted
300602|NCT01867645|Critical illness|critical illness
300603|NCT01867645|Critical illness polyneuropathy and/or myopathy|critical illness polyneuropathy and/or myopathy
300604|NCT01867645|Intravenous immunoglobulins|intravenous immunoglobulins
300605|NCT01867645|Multiple organ failure|multiple organ failure
300606|NCT01867645|SIRS|sirs
300607|NCT01867645|Sepsis|sepsis
300608|NCT01867632|Palatoplasty|palatoplasty
300609|NCT01867632|Acellular Dermal Matrix|acellular dermal matrix
300610|NCT01867619|Brain Neoplasms|brain neoplasms
300611|NCT01867619|Melanoma|melanoma
300612|NCT01867619|Metastatic Melanoma|metastatic melanoma
300613|NCT01867619|Brain Metastasis|brain metastasis
300614|NCT01867619|Temozolomide|temozolomide
300615|NCT01867619|Temodar|temodar
300616|NCT01867619|Thalidomide|thalidomide
300617|NCT01867619|Thalomid|thalomid
300618|NCT01867619|Lomustine|lomustine
300619|NCT01867619|CCNU|ccnu
300620|NCT01867619|CeeNU|ceenu
300621|NCT01867593|Newly diagnosed|newly diagnosed
300622|NCT01867567|cesarean|cesarean
300623|NCT01867567|bandage removal|bandage removal
300624|NCT01867567|infection|infection
300625|NCT01867567|disruption|disruption
300626|NCT01867567|satisfaction|satisfaction
300627|NCT01867567|patient satisfaction|patient satisfaction
300628|NCT01867554|Intellectual disability|intellectual disability
300629|NCT01867554|Autism spectrum disorders|autism spectrum disorders
300630|NCT01867554|gene|gene
300631|NCT01867554|Next generation sequencing|next generation sequencing
300632|NCT01867541|cataract surgery|cataract surgery
300633|NCT01867541|intraocular lens power calculation|intraocular lens power calculation
300634|NCT01867541|effective lens position|effective lens position
300635|NCT01867541|improving the refractive outcome after cataract surgery|improving the refractive outcome after cataract surgery
300636|NCT01867541|predicting the IOL position|predicting the iol position
300637|NCT01867515|Hearing|hearing
300638|NCT01867515|Hearing Loss, sensorineural|hearing loss, sensorineural
300639|NCT01867515|Speech Perception|speech perception
300640|NCT01867463|Antigen|antigen
300641|NCT01867463|Ookinetes|ookinetes
300642|NCT01867463|Mosquito|mosquito
300643|NCT01867463|Membrane|membrane
300644|NCT01867463|Assay|assay
300645|NCT01867450|Biomarkers|biomarkers
300646|NCT01867450|Deisel Exhaust|deisel exhaust
300647|NCT01867450|Occupational Exposure|occupational exposure
300648|NCT01867450|Cross-Sectional Study|cross-sectional study
300649|NCT01867437|24 Hour Energy Expenditure|24 hour energy expenditure
300650|NCT01867437|Resting Energy Expenditure|resting energy expenditure
300651|NCT01867437|Obesity|obesity
300652|NCT01867437|Healthy Volunteers|healthy volunteers
300653|NCT01867424|Testosterone Membrane Transporter|testosterone membrane transporter
300654|NCT01867424|OATP1B3|oatp1b3
300655|NCT01867424|Castration Resistant Prostate Cancer|castration resistant prostate cancer
300656|NCT01867424|Prostatectomy|prostatectomy
300657|NCT01867424|Gadolinium-Based Contrast Agent|gadolinium-based contrast agent
300658|NCT01867411|Smoking Cessation|smoking cessation
300659|NCT01867411|Biomarkers|biomarkers
300660|NCT01867411|fMRI|fmri
300661|NCT01867411|e-Cigarettes|e-cigarettes
300662|NCT01867398|Conduct Disorder|conduct disorder
300663|NCT01867398|Antipsychotic|antipsychotic
300664|NCT01867398|Treatment Study|treatment study
300665|NCT01867398|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
300666|NCT01867398|Adolescents|adolescents
300667|NCT01867385|Fatigue|fatigue
300668|NCT01867385|Chronic Hepatitis|chronic hepatitis
300669|NCT01867385|Chronic Hepatitis B|chronic hepatitis b
300670|NCT01867385|Chronic Hepatitis C|chronic hepatitis c
300671|NCT01867385|Hepatitis|hepatitis
300672|NCT01867372|Alzheimer's Disease|alzheimer's disease
300673|NCT01867359|Alzheimer Disease|alzheimer disease
300674|NCT01867359|Molecular|molecular
300675|NCT01867359|Molecular Genetics|molecular genetics
300676|NCT01867359|DNA|dna
300677|NCT01867346|Cognition|cognition
300678|NCT01867346|Aging|aging
300679|NCT01867346|Cognitive Decline|cognitive decline
300680|NCT01867346|Dementia|dementia
300681|NCT01867346|Alzheimer's Disease|alzheimer's disease
300682|NCT01867333|Immunotherapy|immunotherapy
300683|NCT01867333|Gene Transfer|gene transfer
300684|NCT01867333|Androgen Receptor Antagonist|androgen receptor antagonist
300685|NCT01867333|PSA|psa
300686|NCT01867333|Immune Response|immune response
300687|NCT01867320|HTLV-1|htlv-1
300688|NCT01867320|HTLV-1 Associated Myelopathy|htlv-1 associated myelopathy
300689|NCT01867281|aspirin|aspirin
300690|NCT01867281|asthma|asthma
300691|NCT01867281|Aspirin desensitization|aspirin desensitization
300692|NCT01867281|Aspirin induced asthma|aspirin induced asthma
300693|NCT01867281|Immune System Diseases|immune system diseases
300694|NCT01867281|Respiratory Hypersensitivity|respiratory hypersensitivity
300695|NCT01867268|Acetazolamide administration|acetazolamide administration
300696|NCT01867268|prone positioning|prone positioning
300697|NCT01867268|Cerebrospinal fluid leakage|cerebrospinal fluid leakage
300698|NCT01867268|Cerebrospinal fluid collection|cerebrospinal fluid collection
300699|NCT01867268|wound dehiscence|wound dehiscence
300700|NCT01867255|venlafaxine|venlafaxine
300701|NCT01867255|Effexor|effexor
300702|NCT01867255|antidepressive agent|antidepressive agent
300703|NCT01867242|cigarette|cigarette
300704|NCT01867242|snus|snus
300705|NCT01867242|smoking|smoking
300706|NCT01867242|tobacco|tobacco
300707|NCT01867229|pre-menauposal|pre-menauposal
300708|NCT01867229|neo-adjuvant or adjuvant chemotherapy|neo-adjuvant or adjuvant chemotherapy
300709|NCT01867229|no metastases|no metastases
300710|NCT01867190|CLI|cli
300711|NCT01867177|HIV|hiv
300712|NCT01867177|health care utilization|health care utilization
300713|NCT01867177|HIV testing|hiv testing
300714|NCT01867177|access to care|access to care
300716|NCT01867164|Infectious vaginosis|infectious vaginosis
300717|NCT01867164|Terconazole|terconazole
300718|NCT01867164|Clindamycin|clindamycin
300719|NCT01867164|Fluocinolone|fluocinolone
300720|NCT01867164|Metronidazole|metronidazole
300721|NCT01867164|Nystatin|nystatin
300722|NCT01867151|Burning Mouth Syndrome|burning mouth syndrome
300723|NCT01867151|Gluten|gluten
300724|NCT01867151|Gluten Free Diet|gluten free diet
300725|NCT01867138|Coagulase negative staphylococcus|coagulase negative staphylococcus
300726|NCT01867138|nosocomial neonatal sepsis|nosocomial neonatal sepsis
300727|NCT01867138|cefazolin|cefazolin
300728|NCT01867138|vancomycin|vancomycin
300729|NCT01867138|newborn|newborn
300730|NCT01867086|ovarian cancer|ovarian cancer
300731|NCT01867060|Cardiac monitoring|cardiac monitoring
300732|NCT01867060|Biomarkers|biomarkers
300733|NCT01867060|Transthoracic echocardiography|transthoracic echocardiography
300734|NCT01867034|non ST segment myocardial infarction|non st segment myocardial infarction
300735|NCT01867021|Trivalent inactivated subunit influenza vaccines|trivalent inactivated subunit influenza vaccines
300736|NCT01867021|50 years and above|50 years and above
300737|NCT01867021|healthy subjects|healthy subjects
300738|NCT01866995|Ginseng|ginseng
300739|NCT01866995|Prostatostasis|prostatostasis
300740|NCT01866995|Erectile Dysfunction|erectile dysfunction
300741|NCT01866982|umbilical cord milking|umbilical cord milking
300742|NCT01866982|delayed cord clamping|delayed cord clamping
300743|NCT01866943|Blood Loss|blood loss
300744|NCT01866943|Tranexamic Acid|tranexamic acid
300745|NCT01866943|Total Hip Arthroplasty|total hip arthroplasty
300746|NCT01866943|Post Op|post op
300747|NCT01866943|Post Operative|post operative
300748|NCT01866943|Prevent Post Operative Blood Loss|prevent post operative blood loss
300749|NCT01866917|Transversis Abdominis Plane Block|transversis abdominis plane block
300750|NCT01866917|obese|obese
300751|NCT01866917|robotic surgery|robotic surgery
300752|NCT01866917|laparoscopic surgery|laparoscopic surgery
300753|NCT01866904|Coronary artery disease, Myocardial infarction|coronary artery disease, myocardial infarction
300754|NCT01866891|hemodialysis|hemodialysis
300755|NCT01866891|microcirculation|microcirculation
300756|NCT01866891|physical perdialytic activity|physical perdialytic activity
300757|NCT01866891|cycling|cycling
300758|NCT01866878|transcutaneous electrical nerve stimulation, sensitivity, multiple sclerosis,Reeducation through labor tactile discrimination|transcutaneous electrical nerve stimulation, sensitivity, multiple sclerosis,reeducation through labor tactile discrimination
300759|NCT01866865|BRCA1|brca1
300760|NCT01866865|BRCA2|brca2
300761|NCT01866852|Longitudinal Study|longitudinal study
300762|NCT01866839|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
300763|NCT01866839|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
300764|NCT01866839|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
300765|NCT01866839|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
300766|NCT01866839|Myelodyplastic Syndrome (MDS)|myelodyplastic syndrome (mds)
300767|NCT01866826|HIV|hiv
300768|NCT01866826|Eradication Strategies|eradication strategies
300769|NCT01866826|Immune Activation|immune activation
300770|NCT01866813|breast cancer|breast cancer
300771|NCT01866813|cancer survivors|cancer survivors
300772|NCT01866800|TAVI|tavi
300773|NCT01866800|TAVR|tavr
300774|NCT01866800|CIN|cin
300775|NCT01866800|AKI|aki
300776|NCT01866787|Postoperative orthostatic intolerance|postoperative orthostatic intolerance
300777|NCT01866787|Surgical inflammatory response|surgical inflammatory response
300778|NCT01866722|nicotine dependence|nicotine dependence
300779|NCT01866722|smoking cessation|smoking cessation
300780|NCT01866722|lapse|lapse
300781|NCT01866722|relapse|relapse
300782|NCT01866722|tobacco|tobacco
300783|NCT01866722|quit attempts|quit attempts
300784|NCT01866722|abstinence|abstinence
300785|NCT01866722|motivation|motivation
300786|NCT01866722|reduction|reduction
300787|NCT01866696|Computer assisted implant surgery,|computer assisted implant surgery,
300788|NCT01866696|Immediate loading,|immediate loading,
300789|NCT01866696|CAD/CAM|cad/cam
300790|NCT01866683|Yoga|yoga
300791|NCT01866683|Electroencephalography|electroencephalography
300792|NCT01866683|Heart rate variability|heart rate variability
300793|NCT01866683|Breathing Exercises|breathing exercises
300794|NCT01866683|Quality of life|quality of life
300795|NCT01866670|spiritual distress|spiritual distress
300796|NCT01866670|nursing|nursing
300797|NCT01866670|breast neoplasms|breast neoplasms
300798|NCT01866657|cerebral oximetry|cerebral oximetry
300799|NCT01866657|randomized controlled pilot study|randomized controlled pilot study
300800|NCT01866657|thoracic surgery|thoracic surgery
300801|NCT01866657|single lung ventilation|single lung ventilation
300802|NCT01866644|Liver transplantation, n-acetylcysteine|liver transplantation, n-acetylcysteine
300803|NCT01866618|Natural|natural
300804|NCT01866618|IVF Cycle|ivf cycle
300805|NCT01866605|anxiety|anxiety
300806|NCT01866605|midazolam|midazolam
300807|NCT01866605|forced-air warming|forced-air warming
300808|NCT01866592|Psoriasis|psoriasis
300809|NCT01866592|Cardiovascular Disease|cardiovascular disease
300810|NCT01866592|Vascular Inflammation|vascular inflammation
300811|NCT01866592|Lipid Biomarkers|lipid biomarkers
300812|NCT01866592|Metabolic biomarkers|metabolic biomarkers
300813|NCT01866592|FDG-PET/CT|fdg-pet/ct
300814|NCT01866579|Retinal Nerve Fiber Layer Thickness, Optical Coherence Tomography, Ethambutol optic neuropathy|retinal nerve fiber layer thickness, optical coherence tomography, ethambutol optic neuropathy
300815|NCT01866553|CML|cml
300816|NCT01866553|suboptimal molecular response|suboptimal molecular response
300817|NCT01866553|nilotinib|nilotinib
300818|NCT01866553|pegylated interferon α2b|pegylated interferon α2b
300819|NCT01866540|influenza, LAIV, immune response|influenza, laiv, immune response
300820|NCT01866527|Developmental dysplasia of the hip,|developmental dysplasia of the hip,
300821|NCT01866527|DDH,|ddh,
300822|NCT01866527|avascular necrosis,|avascular necrosis,
300823|NCT01866527|late detected cases|late detected cases
300824|NCT01866514|EZ-IO|ez-io
300825|NCT01866514|IO|io
300826|NCT01866514|Intraosseous Vascular Access|intraosseous vascular access
300827|NCT01866501|Intraosseous Vascular Access|intraosseous vascular access
300828|NCT01866501|IO Access|io access
300829|NCT01866501|IO Vascular Access|io vascular access
300830|NCT01866501|EZ-IO|ez-io
300831|NCT01866488|Labor induction|labor induction
300832|NCT01866488|Misoprostol|misoprostol
300833|NCT01866488|Cytotec|cytotec
300834|NCT01866488|Cook Obstetric Double Balloon Catheter|cook obstetric double balloon catheter
300835|NCT01866475|IO access|io access
300836|NCT01866475|Intraosseous vascular access|intraosseous vascular access
300837|NCT01866475|EZ-IO|ez-io
300838|NCT01866436|Cognitive skills|cognitive skills
300839|NCT01866436|Multimedia|multimedia
300840|NCT01866436|Education|education
300841|NCT01866436|Colorectal surgery|colorectal surgery
300842|NCT01866397|cidofovir|cidofovir
300843|NCT01866397|cvvh|cvvh
300844|NCT01866397|renal replacement therapy|renal replacement therapy
300845|NCT01866397|HCMV|hcmv
300846|NCT01866397|Pharmacokinetics of cidofovir during CVVH|pharmacokinetics of cidofovir during cvvh
300847|NCT01866397|continuous venovenous hemofiltration|continuous venovenous hemofiltration
300848|NCT01866371|Retina|retina
300849|NCT01866371|imaging|imaging
300850|NCT01866371|retinal degeneration|retinal degeneration
300851|NCT01866345|orthodontics|orthodontics
300852|NCT01866345|Tooth Movement|tooth movement
300853|NCT01866345|Bone Remodeling|bone remodeling
300854|NCT01866345|Mandible|mandible
300855|NCT01866345|Osteotomy|osteotomy
300856|NCT01866332|back pain|back pain
300857|NCT01866332|tape|tape
300858|NCT01866332|chronic|chronic
300859|NCT01866319|PD-1|pd-1
300860|NCT01866319|PD1|pd1
300861|NCT01866319|PD-L1|pd-l1
300862|NCT01866319|PDL1|pdl1
300863|NCT01866293|Cabozantinib (XL184)|cabozantinib (xl184)
300864|NCT01866293|12-240|12-240
300865|NCT01866280|Sleep|sleep
300866|NCT01866280|Sleep duration|sleep duration
300867|NCT01866280|Meals|meals
300868|NCT01866280|Food intake|food intake
300869|NCT01866280|Obesity|obesity
300870|NCT01866267|Human Immunodeficiency Virus|human immunodeficiency virus
300871|NCT01866267|AIDS|aids
300872|NCT01866254|Hydromorphone|hydromorphone
300873|NCT01866254|Morphine|morphine
300874|NCT01866254|cesarean delivery|cesarean delivery
300875|NCT01866254|pain management|pain management
300876|NCT01866254|respiratory depression|respiratory depression
300877|NCT01866228|Consultation Recording|consultation recording
300878|NCT01866228|Brain Tumor|brain tumor
300879|NCT01866228|Neuroendocrine Cancer|neuroendocrine cancer
300880|NCT01866228|Quality of Life|quality of life
300881|NCT01866228|Patient Satisfaction|patient satisfaction
300882|NCT01866215|gluconeogenesis|gluconeogenesis
300883|NCT01866215|de novo lipogenesis|de novo lipogenesis
300884|NCT01866215|intramyocellular lipids|intramyocellular lipids
300885|NCT01866215|muscle glycogen|muscle glycogen
300886|NCT01866215|fructose|fructose
300887|NCT01866189|ischemic stroke|ischemic stroke
300888|NCT01866189|hypoxic tissues|hypoxic tissues
300889|NCT01866189|F-MISO uptake|f-miso uptake
300890|NCT01866189|Magnetic Resonance Imaging|magnetic resonance imaging
300891|NCT01866189|F-MISO Positon Emission Tomography|f-miso positon emission tomography
300892|NCT01866137|Copeptin|copeptin
300893|NCT01866137|psychological stress|psychological stress
300894|NCT01866137|The Trier Social Stress Test (TSST)|the trier social stress test (tsst)
300895|NCT01866124|acute malnutrition|acute malnutrition
300896|NCT01866124|multiannual and seasonal cash transfers|multiannual and seasonal cash transfers
300897|NCT01866124|safety nets|safety nets
300898|NCT01866124|Burkina Faso|burkina faso
300899|NCT01866098|antipsychotic|antipsychotic
300900|NCT01866098|severe mental illness|severe mental illness
300901|NCT01866098|weight loss|weight loss
300902|NCT01866085|stress urinary incontinence|stress urinary incontinence
300903|NCT01866085|post prostatectomy|post prostatectomy
300904|NCT01866072|ACLF|aclf
300905|NCT01866072|AVH|avh
300906|NCT01866072|Fibroscan|fibroscan
300907|NCT01866072|Transient elastography|transient elastography
300908|NCT01866059|root caries|root caries
300910|NCT01866059|RMGIC|rmgic
300911|NCT01866059|Biodentine|biodentine
300912|NCT01866059|Calcium silicate|calcium silicate
300913|NCT01866046|battered women|battered women
300914|NCT01866046|HIV risk|hiv risk
300915|NCT01866046|STI risk|sti risk
300916|NCT01866033|Healthy volunteer|healthy volunteer
300917|NCT01866033|PCI-32765|pci-32765
300918|NCT01866033|PCI 45227|pci 45227
300919|NCT01866033|13C6 PCI-32765|13c6 pci-32765
300920|NCT01866033|Pharmacokinetic|pharmacokinetic
300921|NCT01866033|Bioavailability|bioavailability
300922|NCT01866020|aspergillosis|aspergillosis
300923|NCT01866020|fungal infection|fungal infection
300924|NCT01866020|ICU|icu
300925|NCT01866007|Healthy|healthy
300926|NCT01866007|Guselkumab|guselkumab
300927|NCT01866007|CNTO1959|cnto1959
300928|NCT01866007|Pharmacokinetics|pharmacokinetics
300929|NCT01866007|UltraSafe Passive Delivery System (PFS-U)|ultrasafe passive delivery system (pfs-u)
300930|NCT01866007|Prefilled syringe facilitated injection device (PFS FID)|prefilled syringe facilitated injection device (pfs fid)
300931|NCT01865994|Cardiac Output|cardiac output
300932|NCT01865994|esCCO|escco
300933|NCT01865994|TEE|tee
300934|NCT01865994|Pediatric cardiac surgery|pediatric cardiac surgery
300935|NCT01865981|iPS cells|ips cells
300936|NCT01865981|cardiomyocytes|cardiomyocytes
300937|NCT01865981|Brugada|brugada
300938|NCT01865981|Ventricular Fibrillation|ventricular fibrillation
300939|NCT01865981|electrophysiology|electrophysiology
300940|NCT01865968|inactivated HAV vaccine; live attenuated HAV vaccine; immunogenicity; safety|inactivated hav vaccine; live attenuated hav vaccine; immunogenicity; safety
300941|NCT01865955|Ultrasound|ultrasound
300942|NCT01865955|Spinal anesthesia|spinal anesthesia
300943|NCT01865955|Cesarean section|cesarean section
300944|NCT01865942|spinal metastases|spinal metastases
300945|NCT01865942|spine surgery|spine surgery
300946|NCT01865942|metastatic spinal cord compression|metastatic spinal cord compression
300947|NCT01865942|EQ-5D|eq-5d
300948|NCT01865942|HRQOL|hrqol
300949|NCT01865903|NSCLC|nsclc
300950|NCT01865903|sarcopenia|sarcopenia
300951|NCT01865903|cachexia|cachexia
300952|NCT01865890|Plavix or clopidogrel resistance|plavix or clopidogrel resistance
300953|NCT01865877|Parkinson's disease|parkinson's disease
300954|NCT01865877|Motor|motor
300955|NCT01865877|Non-motor|non-motor
300956|NCT01865877|Progression|progression
300957|NCT01865877|Complications|complications
300958|NCT01865864|CPAP|cpap
300959|NCT01865864|diurnal blood pressure|diurnal blood pressure
300960|NCT01865864|obstructive sleep apnea|obstructive sleep apnea
300961|NCT01865864|24 hour blood pressure monitor|24 hour blood pressure monitor
300962|NCT01865851|Inspired oxygen|inspired oxygen
300963|NCT01865851|end-tidal oxygen|end-tidal oxygen
300964|NCT01865851|end-tidal carbon dioxide|end-tidal carbon dioxide
300965|NCT01865851|respiratory rate|respiratory rate
300966|NCT01865851|preoxygenation|preoxygenation
300967|NCT01865851|classic face mask|classic face mask
300968|NCT01865851|NuMask|numask
300969|NCT01865838|Total thyroidectomy|total thyroidectomy
300970|NCT01865838|Seprafilm|seprafilm
300971|NCT01865838|Swallowing difficulty post thyroidectomy|swallowing difficulty post thyroidectomy
300972|NCT01865825|Erosive Esophagitis|erosive esophagitis
300973|NCT01865825|Gastroesophageal reflux disease|gastroesophageal reflux disease
300974|NCT01865799|FTC/TDF|ftc/tdf
300975|NCT01865799|PrEP|prep
300976|NCT01865799|Truvada|truvada
300977|NCT01865799|Drug utilization|drug utilization
300978|NCT01865786|FTC/TDF|ftc/tdf
300979|NCT01865786|Truvada|truvada
300980|NCT01865786|PrEP|prep
300981|NCT01865786|Antiretroviral Pregnancy Registry|antiretroviral pregnancy registry
300982|NCT01865760|Glucagon like peptide 1|glucagon like peptide 1
300983|NCT01865760|Insulin secretion|insulin secretion
300984|NCT01865760|Hypoglycemia|hypoglycemia
300985|NCT01865747|renal cell cancer|renal cell cancer
300986|NCT01865747|kidney|kidney
300987|NCT01865747|vascular endothelial growth factor receptor 2 (VEGFR2)|vascular endothelial growth factor receptor 2 (vegfr2)
300988|NCT01865747|tyrosine kinase inhibitor|tyrosine kinase inhibitor
300989|NCT01865747|hepatocyte growth factor receptor protein (MET)|hepatocyte growth factor receptor protein (met)
300990|NCT01865747|von Hippel-Lindau gene|von hippel-lindau gene
300991|NCT01865734|Fasciitis, Plantar|fasciitis, plantar
300992|NCT01865734|Heel Pain|heel pain
300993|NCT01865734|Physical Therapy|physical therapy
300994|NCT01865734|Podiatry|podiatry
300995|NCT01865734|Musculoskeletal Manipulations|musculoskeletal manipulations
300996|NCT01865734|Exercise Therapy|exercise therapy
300997|NCT01865721|Bowel cancer screening|bowel cancer screening
300998|NCT01865721|Analgesia|analgesia
300999|NCT01865721|Entonox|entonox
301000|NCT01865721|Pain|pain
301001|NCT01865721|Side effects|side effects
301002|NCT01865721|Colonoscopy|colonoscopy
301003|NCT01865708|Ethanol Lock|ethanol lock
301004|NCT01865708|Alcohol lock|alcohol lock
301005|NCT01865708|Urinary catheter|urinary catheter
301006|NCT01865708|Safety|safety
301007|NCT01865695|pancreatic exocrine insufficiency|pancreatic exocrine insufficiency
301008|NCT01865695|faecal elastase|faecal elastase
301009|NCT01865695|diarrhoea|diarrhoea
301010|NCT01865695|coeliac|coeliac
301011|NCT01865695|creon|creon
301012|NCT01865695|gastrointestinal|gastrointestinal
301013|NCT01865682|Ankle|ankle
301014|NCT01865682|Knee|knee
301015|NCT01865682|Orthosis|orthosis
301016|NCT01865682|Kinematics|kinematics
301017|NCT01865682|Kinetics|kinetics
301018|NCT01865669|Uterine contraction|uterine contraction
301019|NCT01865669|Dose response|dose response
301020|NCT01865669|Oxytocin|oxytocin
301021|NCT01865656|provider skill and self-efficacy|provider skill and self-efficacy
301022|NCT01865656|Appropriate and timely referral for obstetric emergencies|appropriate and timely referral for obstetric emergencies
301023|NCT01865656|Intervention feasibility and acceptability|intervention feasibility and acceptability
301024|NCT01865643|Laryngoscopy|laryngoscopy
301025|NCT01865643|Intubation|intubation
301026|NCT01865643|Glidescope|glidescope
301027|NCT01865630|Prophylactic treatment with Etanercept in aSAH.|prophylactic treatment with etanercept in asah.
301028|NCT01865630|Safety of Etanercept in the prevention of DCI in aSAH.|safety of etanercept in the prevention of dci in asah.
301029|NCT01865591|hypertension|hypertension
301030|NCT01865591|uncontrolled hypertension|uncontrolled hypertension
301031|NCT01865591|resistant hypertension|resistant hypertension
301032|NCT01865565|gastrointestinal stromal tumor|gastrointestinal stromal tumor
301033|NCT01865565|GIST|gist
301034|NCT01865565|neoadjuvant|neoadjuvant
301035|NCT01865565|imatinib|imatinib
301036|NCT01865552|Pharmacokinetics|pharmacokinetics
301037|NCT01865539|Chronic lower back pain|chronic lower back pain
301038|NCT01865539|Custom foot orthotics|custom foot orthotics
301039|NCT01865539|Veterans|veterans
301040|NCT01865526|Chronic kidney disease|chronic kidney disease
301041|NCT01865526|Low protein diet|low protein diet
301042|NCT01865526|CKD stage 3b-5|ckd stage 3b-5
301043|NCT01865513|Anaesthesia|anaesthesia
301044|NCT01865513|Anaesthesiology|anaesthesiology
301045|NCT01865513|muscle Relaxants|muscle relaxants
301046|NCT01865513|POPULAR|popular
301047|NCT01865513|postoperative pulmonary complications|postoperative pulmonary complications
301048|NCT01865513|Respiratory failure|respiratory failure
301049|NCT01865513|Suspected pulmonary infection|suspected pulmonary infection
301050|NCT01865513|Pulmonary infiltrates|pulmonary infiltrates
301051|NCT01865513|Pleural effusion|pleural effusion
301052|NCT01865513|Atelectasis|atelectasis
301053|NCT01865513|Pneumothorax|pneumothorax
301054|NCT01865513|Bronchospasm|bronchospasm
301055|NCT01865513|Aspiration pneumonitis|aspiration pneumonitis
301056|NCT01865513|Cardiopulmonary oedema|cardiopulmonary oedema
301057|NCT01865513|European Society of Anaesthesiology|european society of anaesthesiology
301058|NCT01865513|neuromuscular blockade|neuromuscular blockade
301059|NCT01865513|europe|europe
301060|NCT01865500|COPD exacerbation|copd exacerbation
301061|NCT01865500|Nebulized budesonide|nebulized budesonide
301062|NCT01865500|Parenteral steroid|parenteral steroid
301063|NCT01865487|BCG Vaccinated|bcg vaccinated
301064|NCT01865487|HIV Negative|hiv negative
301065|NCT01865474|DLBS1033, Type 2 DM, fibrinolytic, hypercoagulation|dlbs1033, type 2 dm, fibrinolytic, hypercoagulation
301066|NCT01865461|Magnetic Resonance Imaging|magnetic resonance imaging
301067|NCT01865448|Docosahexaenoic Acids|docosahexaenoic acids
301068|NCT01865448|Fatty Acids, Omega-3|fatty acids, omega-3
301069|NCT01865448|Obesity|obesity
301070|NCT01865448|Inflammation|inflammation
301071|NCT01865409|Newborn|newborn
301072|NCT01865409|Prematures|prematures
301073|NCT01865409|Feeding difficulty|feeding difficulty
301074|NCT01865409|Kangaroo Care|kangaroo care
301075|NCT01865409|Heart rate variability|heart rate variability
301076|NCT01865266|ventilator-associated pneumonia|ventilator-associated pneumonia
301077|NCT01865266|mechanical ventilation|mechanical ventilation
301078|NCT01865266|ulinastatin for injection|ulinastatin for injection
301079|NCT01865266|bronchoalveolar lavage fluid|bronchoalveolar lavage fluid
301080|NCT01865266|inflammatory factors|inflammatory factors
301081|NCT01865253|renal denervation|renal denervation
301082|NCT01865253|blood pressure|blood pressure
301083|NCT01865253|cardiovascular risk|cardiovascular risk
301084|NCT01865253|target organ damage|target organ damage
301085|NCT01865253|sympathetic activity|sympathetic activity
301086|NCT01865253|chronic kidney disease|chronic kidney disease
301087|NCT01865253|non-compliance|non-compliance
301088|NCT01865240|renal denervation|renal denervation
301089|NCT01865240|blood pressure|blood pressure
301090|NCT01865240|cardiovascular risk|cardiovascular risk
301091|NCT01865240|target organ damage|target organ damage
301092|NCT01865240|sympathetic activity|sympathetic activity
301093|NCT01865227|Obesity|obesity
301094|NCT01865227|Bariatric surgery|bariatric surgery
301095|NCT01865227|Binge Eating Disorder|binge eating disorder
301096|NCT01865227|Psychological Health|psychological health
301097|NCT01865227|Counselling|counselling
301098|NCT01865201|Radiotherapy|radiotherapy
301099|NCT01865201|Radiation-induced brain necrosis|radiation-induced brain necrosis
301100|NCT01865201|Edaravone|edaravone
301101|NCT01865201|Effectiveness|effectiveness
301102|NCT01865201|Safety|safety
301103|NCT01865188|LCZ696,|lcz696,
301104|NCT01865188|amlodipine,|amlodipine,
301105|NCT01865188|hypertension,|hypertension,
301106|NCT01865188|ABPM|abpm
301107|NCT01865162|Glioblastoma multiforme, ketogenic diet, neoplasm|glioblastoma multiforme, ketogenic diet, neoplasm
301108|NCT01865149|Child|child
301109|NCT01865149|Optic nerve sheath diameter|optic nerve sheath diameter
301110|NCT01865149|Hydrocephalus|hydrocephalus
301111|NCT01865149|Intracranial hypertension|intracranial hypertension
301112|NCT01865123|post-traumatic stress disorder|post-traumatic stress disorder
301113|NCT01865123|transcendental meditation|transcendental meditation
301114|NCT01865123|cognitive behavioral therapy|cognitive behavioral therapy
301115|NCT01865123|prolonged exposure|prolonged exposure
301116|NCT01865110|Mantle Cell Lymphoma|mantle cell lymphoma
301117|NCT01865110|RCHOP|rchop
301118|NCT01865110|RHAD|rhad
301119|NCT01865110|rituximab|rituximab
301120|NCT01865110|lenalidomide|lenalidomide
301121|NCT01865097|Imagery|imagery
301122|NCT01865097|Pain|pain
301123|NCT01865097|Depression|depression
301124|NCT01865097|Non-Motor|non-motor
301125|NCT01865071|ileostomy|ileostomy
301126|NCT01865071|rectal resection|rectal resection
301127|NCT01865071|proctectomy|proctectomy
301128|NCT01865071|stoma closure|stoma closure
301129|NCT01865071|rectal cancer|rectal cancer
301130|NCT01864993|non celiac gluten sensitivity|non celiac gluten sensitivity
301131|NCT01864993|gluten|gluten
301132|NCT01864993|irritable bowel syndrome|irritable bowel syndrome
301133|NCT01864993|functional disorders|functional disorders
301134|NCT01864967|carbon dioxide infusion|carbon dioxide infusion
301135|NCT01864967|dilatation of peripheral blood vessels|dilatation of peripheral blood vessels
301136|NCT01864967|capillaries|capillaries
301137|NCT01864967|macrophags|macrophags
301138|NCT01864967|fibroblasts|fibroblasts
301139|NCT01864967|Improvement granulation tissue in chronic wounds|improvement granulation tissue in chronic wounds
301140|NCT01864954|Smoking|smoking
301141|NCT01864954|Postpartum|postpartum
301142|NCT01864954|Pregnancy|pregnancy
301143|NCT01864954|Quit|quit
301144|NCT01864954|Tobacco|tobacco
301145|NCT01864954|Abstinence|abstinence
301146|NCT01864954|Relapse|relapse
301147|NCT01864954|Relapse prevention|relapse prevention
301148|NCT01864941|Multiple Sclerosis|multiple sclerosis
301149|NCT01864941|MS|ms
301150|NCT01864941|CCSVI|ccsvi
301151|NCT01864941|Zamboni|zamboni
301152|NCT01864941|catheter venography|catheter venography
301153|NCT01864941|balloon angioplasty|balloon angioplasty
301154|NCT01864928|Acute Ischemic stroke|acute ischemic stroke
301155|NCT01864928|ePRISM|eprism
301156|NCT01864915|colon capsule|colon capsule
301157|NCT01864915|bowel preparation|bowel preparation
301158|NCT01864915|booster|booster
301159|NCT01864915|prucalopride|prucalopride
301160|NCT01864915|picosalax|picosalax
301161|NCT01864902|CD33 positive acute myeloid leukemia (AML)|cd33 positive acute myeloid leukemia (aml)
301162|NCT01864850|HNSCC|hnscc
301163|NCT01864850|Elderly|elderly
301164|NCT01864850|Geriatry|geriatry
301165|NCT01864837|tongue coating thickness|tongue coating thickness
301166|NCT01864837|tongue diagnosis system|tongue diagnosis system
301167|NCT01864837|tongue coating percentage|tongue coating percentage
301168|NCT01864837|availability|availability
301169|NCT01864837|diagnostic device|diagnostic device
301170|NCT01864824|air pollution|air pollution
301171|NCT01864824|particulate matter 2.5 (PM2.5)|particulate matter 2.5 (pm2.5)
301172|NCT01864824|methyl donor|methyl donor
301173|NCT01864824|DNA methylation|dna methylation
301174|NCT01864824|mRNA|mrna
301175|NCT01864824|epigenetics|epigenetics
301176|NCT01864824|controlled human exposures|controlled human exposures
301177|NCT01864824|cardiovascular responses|cardiovascular responses
301178|NCT01864811|infants|infants
301179|NCT01864811|unilateral cerebral pares|unilateral cerebral pares
301180|NCT01864811|hand function|hand function
301181|NCT01864811|early intervention|early intervention
301182|NCT01864811|constraint induced movement therapy|constraint induced movement therapy
301183|NCT01864798|Young|young
301184|NCT01864798|Breast Neoplasms|breast neoplasms
301185|NCT01864798|Denosumab|denosumab
301186|NCT01864798|RANKL|rankl
301187|NCT01864785|Operative treatment|operative treatment
301188|NCT01864785|internal fixation|internal fixation
301189|NCT01864785|posterior spinal fusion|posterior spinal fusion
301190|NCT01864772|HNSCC|hnscc
301191|NCT01864772|Metastatic|metastatic
301192|NCT01864772|Recurrent|recurrent
301193|NCT01864772|Elderly|elderly
301194|NCT01864772|Geriatry|geriatry
301195|NCT01864759|melanoma|melanoma
301196|NCT01864759|oncolytic|oncolytic
301197|NCT01864759|adenovirus|adenovirus
301198|NCT01864759|virotherapy|virotherapy
301199|NCT01864759|locally advanced|locally advanced
301200|NCT01864759|metastatic|metastatic
301201|NCT01864733|Chronic heart failure|chronic heart failure
301202|NCT01864733|Undernutrition|undernutrition
301203|NCT01864733|Rehabilitation|rehabilitation
301204|NCT01864733|Physical exercise|physical exercise
301205|NCT01864733|Nutrition|nutrition
301206|NCT01864733|n-3 fatty acids|n-3 fatty acids
301207|NCT01864733|Androgen|androgen
301208|NCT01864733|Testosterone|testosterone
301209|NCT01864720|stepped care model|stepped care model
301210|NCT01864720|insomnia|insomnia
301211|NCT01864720|cancer|cancer
301714|NCT01862666|Dysplasia|dysplasia
301212|NCT01864720|cognitive-behavioural therapy|cognitive-behavioural therapy
301213|NCT01864720|self-help treatment|self-help treatment
301214|NCT01864720|Internet|internet
301215|NCT01864720|non-inferiority design|non-inferiority design
301216|NCT01864720|cost-effectiveness|cost-effectiveness
301217|NCT01864707|multiple sclerosis, fatigue|multiple sclerosis, fatigue
301218|NCT01864694|behavioral research|behavioral research
301219|NCT01864694|diet|diet
301220|NCT01864694|health information systems|health information systems
301221|NCT01864681|NSCLC|nsclc
301222|NCT01864681|TKIs|tkis
301223|NCT01864681|Metformin|metformin
301224|NCT01864681|PFS|pfs
301225|NCT01864681|overall survival|overall survival
301226|NCT01864681|IL-6|il-6
301227|NCT01864668|Acute respiratory distress syndrome|acute respiratory distress syndrome
301228|NCT01864668|lung strain|lung strain
301229|NCT01864668|small tidal volume|small tidal volume
301230|NCT01864616|Vitamin D|vitamin d
301231|NCT01864616|Crohn disease|crohn disease
301232|NCT01864616|Disease activity|disease activity
301233|NCT01864616|Inflammation|inflammation
301234|NCT01864616|prevention|prevention
301235|NCT01864603|HIV treatment and prevention|hiv treatment and prevention
301236|NCT01864603|Tuberculosis|tuberculosis
301237|NCT01864603|Community health campaign|community health campaign
301238|NCT01864603|PrEP|prep
301239|NCT01864590|Open Abdomen|open abdomen
301240|NCT01864590|Negative Pressure Wound Therapy|negative pressure wound therapy
301241|NCT01864590|Temporary Abdominal Closure|temporary abdominal closure
301242|NCT01864590|Mesh|mesh
301243|NCT01864590|Abdominal reconstruction|abdominal reconstruction
301244|NCT01864564|Gestational diabetes|gestational diabetes
301245|NCT01864564|Screening|screening
301246|NCT01864564|Obesity|obesity
301247|NCT01864564|Anhydroglucitol|anhydroglucitol
301248|NCT01864538|TH-302|th-302
301249|NCT01864538|Advanced Melanoma|advanced melanoma
301250|NCT01864538|Metastatic|metastatic
301251|NCT01864538|Biomarker|biomarker
301252|NCT01864538|Mucosal Melanoma|mucosal melanoma
301253|NCT01864538|Evofosfamide|evofosfamide
301254|NCT01864525|voice|voice
301255|NCT01864525|tremor|tremor
301256|NCT01864525|essential tremor|essential tremor
301257|NCT01864525|essential voice tremor|essential voice tremor
301258|NCT01864525|voice treatment|voice treatment
301259|NCT01864525|octanoic acid|octanoic acid
301260|NCT01864525|octanol|octanol
301261|NCT01864525|voice disorder|voice disorder
301262|NCT01864525|dysphonia|dysphonia
301263|NCT01864512|Immune Thrombocytopenia|immune thrombocytopenia
301264|NCT01864512|eltrombopag|eltrombopag
301265|NCT01864512|immune regulation|immune regulation
301266|NCT01864473|Fistula , Bhagandar|fistula , bhagandar
301267|NCT01864460|autonomic|autonomic
301268|NCT01864460|neuropathy|neuropathy
301269|NCT01864460|balance|balance
301270|NCT01864460|exercise|exercise
301271|NCT01864447|VTE|vte
301272|NCT01864447|Exercise|exercise
301273|NCT01864447|Diet|diet
301274|NCT01864447|Weight loss|weight loss
301275|NCT01864447|DVT|dvt
301276|NCT01864447|PE|pe
301277|NCT01864434|Knee Prosthesis|knee prosthesis
301278|NCT01864434|Total Knee Arthroplasty|total knee arthroplasty
301279|NCT01864434|Cruciate Retaining|cruciate retaining
301280|NCT01864434|Posterior Cruciate Retaining|posterior cruciate retaining
301281|NCT01864421|Infant, Newborn|infant, newborn
301282|NCT01864421|Delivery, Obstetric|delivery, obstetric
301283|NCT01864421|Umbilical Cord|umbilical cord
301284|NCT01864408|Patient counseling|patient counseling
301285|NCT01864408|Patient satisfaction|patient satisfaction
301286|NCT01864408|Pelvic organ prolapse|pelvic organ prolapse
301287|NCT01864395|cardiovascular surgery|cardiovascular surgery
301288|NCT01864395|cardiac surgery|cardiac surgery
301289|NCT01864395|cardiopulmonary bypass|cardiopulmonary bypass
301290|NCT01864395|IV fluids|iv fluids
301291|NCT01864395|blood pressure|blood pressure
301292|NCT01864395|heart-lung machine|heart-lung machine
301293|NCT01864395|hemofilter|hemofilter
301294|NCT01864395|online MUF|online muf
301295|NCT01864395|offline MUF|offline muf
301296|NCT01864395|modified ultrafiltration|modified ultrafiltration
301297|NCT01864395|multiple-pass hemofiltration|multiple-pass hemofiltration
301298|NCT01864395|centrifugation method|centrifugation method
301299|NCT01864395|blood transfusion|blood transfusion
301300|NCT01864395|plasma proteins|plasma proteins
301301|NCT01864395|post-cardiopulmonary bypass|post-cardiopulmonary bypass
301302|NCT01864395|hemoglobin|hemoglobin
301303|NCT01864395|clotting factors|clotting factors
301304|NCT01864395|systemic blood pressure|systemic blood pressure
301305|NCT01864395|cardiac index|cardiac index
301306|NCT01864395|cytokines|cytokines
301307|NCT01864395|post-operative bleeding|post-operative bleeding
301308|NCT01864395|protamine administration|protamine administration
301309|NCT01864395|patient size|patient size
301310|NCT01864395|allogeneic transfusion|allogeneic transfusion
301311|NCT01864395|total protein|total protein
301313|NCT01864395|vasoactive inotrope score|vasoactive inotrope score
301314|NCT01864395|fluid balance|fluid balance
301315|NCT01864395|chest tube loss|chest tube loss
301316|NCT01864395|length of stay|length of stay
301317|NCT01864395|ventilation time|ventilation time
301318|NCT01864395|markers of inflammation|markers of inflammation
301319|NCT01864382|Trunk performance|trunk performance
301320|NCT01864382|exercise,|exercise,
301321|NCT01864382|"core stability,"|"core stability,"
301322|NCT01864382|sitting balance|sitting balance
301323|NCT01864369|Heart Failure|heart failure
301324|NCT01864369|e-counseling|e-counseling
301325|NCT01864369|quality of life|quality of life
301326|NCT01864369|self-care|self-care
301327|NCT01864356|IVF failure|ivf failure
301328|NCT01864356|Repeated IVF failure|repeated ivf failure
301329|NCT01864356|Implantation failure|implantation failure
301330|NCT01864356|Repeated implantation failure|repeated implantation failure
301331|NCT01864356|IVF|ivf
301332|NCT01864356|NT100|nt100
301333|NCT01864343|Myocardial Infarction|myocardial infarction
301334|NCT01864343|Myocardial Reperfusion Injury|myocardial reperfusion injury
301335|NCT01864343|Reperfusion Injury|reperfusion injury
301336|NCT01864343|Anterior Wall Myocardial Infarction|anterior wall myocardial infarction
301337|NCT01864343|Inferior Wall Myocardial Infarction|inferior wall myocardial infarction
301338|NCT01864343|Myocardial Ischemia|myocardial ischemia
301339|NCT01864330|topical lubricants|topical lubricants
301340|NCT01864330|optical coherence tomography|optical coherence tomography
301341|NCT01864330|tear break up time|tear break up time
301342|NCT01864330|Schirmer I test|schirmer i test
301343|NCT01864317|7-Tesla Magnetic Resonance Imaging|7-tesla magnetic resonance imaging
301344|NCT01864317|Intraocular Pressure|intraocular pressure
301345|NCT01864317|Retinal Nerve Fiber Thickness|retinal nerve fiber thickness
301346|NCT01864317|Visual Field Test|visual field test
301347|NCT01864304|Williams Syndrome|williams syndrome
301348|NCT01864291|Auditory Brainstem Implant|auditory brainstem implant
301349|NCT01864291|ABI|abi
301350|NCT01864291|Nucleus 24|nucleus 24
301351|NCT01864291|Deafness|deafness
301352|NCT01864291|Hearing loss|hearing loss
301353|NCT01864291|Non-tumor|non-tumor
301354|NCT01864291|Non-NF2|non-nf2
301355|NCT01864291|Pediatric|pediatric
301356|NCT01864291|ABI541|abi541
301357|NCT01864265|Rheumatoid arthritis|rheumatoid arthritis
301358|NCT01864265|functional MRI|functional mri
301359|NCT01864265|Prediction of Response|prediction of response
301360|NCT01864265|Certolizumab Pegol|certolizumab pegol
301361|NCT01864265|RF and/or ACPA positive|rf and/or acpa positive
301362|NCT01864239|Adherence|adherence
301363|NCT01864187|Pharmacokinetics|pharmacokinetics
301364|NCT01864187|Dexmedetomidine|dexmedetomidine
301365|NCT01864187|Obesity|obesity
301366|NCT01864122|nutrient biomarkers|nutrient biomarkers
301367|NCT01864122|food frequency questionnaire|food frequency questionnaire
301368|NCT01864122|predictors of CVD|predictors of cvd
301369|NCT01864122|fatty acids|fatty acids
301370|NCT01864122|phylloquinone|phylloquinone
301371|NCT01864122|dihydrophylloquinone|dihydrophylloquinone
301372|NCT01864109|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
301373|NCT01864109|DOXORUBICIN/ADRIAMYCIN|doxorubicin/adriamycin
301374|NCT01864109|ETOPOSIDE (VP-16)|etoposide (vp-16)
301375|NCT01864109|IFOSFAMIDE|ifosfamide
301376|NCT01864109|IRINOTECAN (CPT-11) CAMPTOSAR|irinotecan (cpt-11) camptosar
301377|NCT01864109|TEMOZOLOMIDE|temozolomide
301378|NCT01864109|VINCRISTINE|vincristine
301379|NCT01864109|13-068|13-068
301380|NCT01864096|localized|localized
301381|NCT01864096|prostate|prostate
301382|NCT01864096|cancer|cancer
301383|NCT01864096|metformin|metformin
301384|NCT01864096|active surveillance|active surveillance
301385|NCT01864083|FACBC PET/PEM|facbc pet/pem
301386|NCT01864083|MR|mr
301387|NCT01864083|11-177|11-177
301388|NCT01864070|Liver cancer|liver cancer
301389|NCT01864070|Neuroendocrine tumors|neuroendocrine tumors
301390|NCT01864070|NET|net
301391|NCT01864070|Liver dominant disease|liver dominant disease
301392|NCT01864070|TheraSphere|therasphere
301393|NCT01864070|Yttrium-90|yttrium-90
301394|NCT01864070|Y-90|y-90
301395|NCT01864070|Everolimus|everolimus
301396|NCT01864070|Afinitor|afinitor
301397|NCT01864070|Zortress|zortress
301398|NCT01864070|RAD001|rad001
301399|NCT01864070|Microspheres|microspheres
301400|NCT01864057|thiamine deficiency|thiamine deficiency
301401|NCT01864031|Alcohol|alcohol
301402|NCT01864031|Drinking|drinking
301403|NCT01864031|Abstainers|abstainers
301404|NCT01864031|Former drinkers|former drinkers
301405|NCT01864031|Ex-drinkers|ex-drinkers
301406|NCT01864031|Aetiology|aetiology
301407|NCT01864031|Initial presentation|initial presentation
301408|NCT01864031|Chronic Stable Angina|chronic stable angina
301409|NCT01864031|Unstable Angina|unstable angina
301410|NCT01864031|Coronary Heart Disease Not Otherwise Specified|coronary heart disease not otherwise specified
301411|NCT01864031|Acute Myocardial Infarction|acute myocardial infarction
301412|NCT01864031|Heart Failure|heart failure
301413|NCT01864031|ST elevation Myocardial Infarction (STEMI)|st elevation myocardial infarction (stemi)
301414|NCT01864031|non-ST elevation Myocardial Infarction (nSTEMI)|non-st elevation myocardial infarction (nstemi)
301415|NCT01864031|Myocardial Infarction Not Otherwise Specified (MI NOS)|myocardial infarction not otherwise specified (mi nos)
301416|NCT01864031|Ventricular Arrhythmias|ventricular arrhythmias
301417|NCT01864031|Cardiac Arrest|cardiac arrest
301418|NCT01864031|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
301419|NCT01864031|Peripheral Arterial Disease|peripheral arterial disease
301420|NCT01864031|Ischaemic Stroke|ischaemic stroke
301421|NCT01864031|Subarachnoid Haemorrhagic Stroke|subarachnoid haemorrhagic stroke
301422|NCT01864031|Intracerebral haemorrhagic Stroke|intracerebral haemorrhagic stroke
301423|NCT01864031|Stroke Not Otherwise Specified|stroke not otherwise specified
301424|NCT01864031|Sudden Cardiac Death|sudden cardiac death
301425|NCT01864031|Unheralded Coronary Death|unheralded coronary death
301426|NCT01864031|Mortality|mortality
301427|NCT01864031|Coronary Heart Disease (CHD)|coronary heart disease (chd)
301428|NCT01864031|Cardiovascular Disease (CVD)|cardiovascular disease (cvd)
301429|NCT01864031|Fatal Cardiovascular Disease (fatal CVD)|fatal cardiovascular disease (fatal cvd)
301430|NCT01864005|Non-ST or ST Elevation Acute Coronary Syndromes, Ticagrelor, Clopidogrel, Antiplatelet Effect|non-st or st elevation acute coronary syndromes, ticagrelor, clopidogrel, antiplatelet effect
301431|NCT01863992|home ventilation|home ventilation
301432|NCT01863979|Atrial Fibrillation|atrial fibrillation
301433|NCT01863979|Thromboembolism|thromboembolism
301434|NCT01863966|Achalasia|achalasia
301435|NCT01863966|Hot water drinking therapy|hot water drinking therapy
301436|NCT01863966|Pneumatic dilation|pneumatic dilation
301437|NCT01863914|ESRD|esrd
301438|NCT01863914|Diabetes mellitus|diabetes mellitus
301439|NCT01863914|Endothelial progenitor cells|endothelial progenitor cells
301440|NCT01863914|Hemodialysis|hemodialysis
301441|NCT01863914|rosuvastatin|rosuvastatin
301442|NCT01863875|Cochlear Implant|cochlear implant
301443|NCT01863875|Hearing loss|hearing loss
301444|NCT01863875|Language Development|language development
301445|NCT01863875|Quality of life|quality of life
301446|NCT01863862|Rectal cancer|rectal cancer
301447|NCT01863862|Chemoradiation|chemoradiation
301448|NCT01863862|Complete pathological response|complete pathological response
301449|NCT01863849|uncontrolled,|uncontrolled,
301450|NCT01863849|open,|open,
301451|NCT01863849|multi-centre|multi-centre
301452|NCT01863849|immunogenicity and tolerability|immunogenicity and tolerability
301453|NCT01863849|two groups according to age (18-59 years and ≥60 years)|two groups according to age (18-59 years and ≥60 years)
301454|NCT01863836|Radial endobronchial ultrasound|radial endobronchial ultrasound
301455|NCT01863836|Peripheral lung lesion|peripheral lung lesion
301456|NCT01863836|Fluoroscopy|fluoroscopy
301457|NCT01863836|Lung cancer|lung cancer
301458|NCT01863823|Symptomatic patients|symptomatic patients
301459|NCT01863823|asymptomatic individuals|asymptomatic individuals
301460|NCT01863823|clinical trial|clinical trial
301461|NCT01863810|Diabetic Neuropathy|diabetic neuropathy
301462|NCT01863810|Neuropathic Pain|neuropathic pain
301463|NCT01863810|Pregabalin|pregabalin
301464|NCT01863784|Hepatic Impairment|hepatic impairment
301465|NCT01863784|Mild and moderate hepatic impairment|mild and moderate hepatic impairment
301466|NCT01863784|Normal hepatic function|normal hepatic function
301467|NCT01863784|Pharmacokinetics|pharmacokinetics
301468|NCT01863784|JNJ-38518168|jnj-38518168
301469|NCT01863771|Ulcerative Colitis|ulcerative colitis
301470|NCT01863771|Japanese|japanese
301471|NCT01863771|Subcutaneous|subcutaneous
301472|NCT01863771|Golimumab|golimumab
301473|NCT01863745|ggastrointestinal stromal tumors|ggastrointestinal stromal tumors
301474|NCT01863745|gastrointestinal,|gastrointestinal,
301475|NCT01863745|stromal,|stromal,
301476|NCT01863745|tumors,|tumors,
301477|NCT01863745|GIST,|gist,
301478|NCT01863745|AMN107,|amn107,
301479|NCT01863745|nilotinib|nilotinib
301480|NCT01863732|AIN457, ankylosing spondylitis, chronic inflammatory disease, inflammatory back pain, PFS, pre-filled syringe, secukinumab, self-injection|ain457, ankylosing spondylitis, chronic inflammatory disease, inflammatory back pain, pfs, pre-filled syringe, secukinumab, self-injection
301481|NCT01863719|Colistin|colistin
301482|NCT01863719|Multi Drug Resistant|multi drug resistant
301483|NCT01863719|Nosocomial Pneumonia|nosocomial pneumonia
301484|NCT01863719|Pneumococcal Infections|pneumococcal infections
301485|NCT01863706|Misoprostol|misoprostol
301486|NCT01863706|Oxytocin|oxytocin
301487|NCT01863706|Post Partum Hemorrhage (PPH)|post partum hemorrhage (pph)
301488|NCT01863706|Third stage of labour|third stage of labour
301489|NCT01863680|Infertility|infertility
301490|NCT01863680|COL-1620|col-1620
301491|NCT01863680|progesterone gel|progesterone gel
301492|NCT01863680|Fertilization in Vitro|fertilization in vitro
301493|NCT01863680|Embryo Transfer|embryo transfer
301494|NCT01863654|Bioequivalence|bioequivalence
301495|NCT01863654|Mexico|mexico
301496|NCT01863654|Asthma|asthma
301497|NCT01863654|Montelukast|montelukast
301498|NCT01863654|Chewable|chewable
301499|NCT01863641|lupus nephritis|lupus nephritis
301500|NCT01863641|proteinuria|proteinuria
301501|NCT01863641|SLE|sle
301502|NCT01863641|calcitriol|calcitriol
301503|NCT01863628|Prodromal Symptoms|prodromal symptoms
301504|NCT01863628|bipolar disorder|bipolar disorder
301505|NCT01863628|Neuropsychological Tests|neuropsychological tests
301506|NCT01863628|Magnetic Resonance Imaging|magnetic resonance imaging
301507|NCT01863628|Treatment Outcome|treatment outcome
301508|NCT01863628|aerobic exercise|aerobic exercise
301509|NCT01863628|psychotherapy|psychotherapy
301510|NCT01863615|pharmacokinetics|pharmacokinetics
301511|NCT01863615|Isotretinoin|isotretinoin
301512|NCT01863615|bioequivalence|bioequivalence
301513|NCT01863615|Mexico|mexico
301514|NCT01863576|Chagas disease|chagas disease
301515|NCT01863576|Chagas Cardiomyopathy|chagas cardiomyopathy
301516|NCT01863576|Trypanosoma cruzi|trypanosoma cruzi
301517|NCT01863576|Omega-3|omega-3
301518|NCT01863576|Cytokines|cytokines
301519|NCT01863576|Lipid profile|lipid profile
301520|NCT01863576|Nutritional assessment|nutritional assessment
301521|NCT01863563|tonsillectomy|tonsillectomy
301522|NCT01863563|adenoidectomy|adenoidectomy
301523|NCT01863563|obstructive sleep apnea|obstructive sleep apnea
301524|NCT01863524|Abdominal Aortic Aneurysm (AAA),|abdominal aortic aneurysm (aaa),
301525|NCT01863524|Echocardiography (TTE),|echocardiography (tte),
301526|NCT01863524|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
301527|NCT01863524|Patients over 65 years old|patients over 65 years old
301528|NCT01863511|Treatment options for acute decompensated heart failure|treatment options for acute decompensated heart failure
301529|NCT01863511|Ultrafiltration|ultrafiltration
301530|NCT01863511|tolvaptan|tolvaptan
301531|NCT01863498|pectus excavatum|pectus excavatum
301532|NCT01863498|pain control|pain control
301533|NCT01863485|advanced cancer|advanced cancer
301534|NCT01863459|ADHD|adhd
301535|NCT01863459|ADD|add
301536|NCT01863459|Anxiety|anxiety
301537|NCT01863459|Anxiety Disorders|anxiety disorders
301538|NCT01863459|Depression|depression
301539|NCT01863459|Attention|attention
301540|NCT01863459|Attention Deficit|attention deficit
301541|NCT01863446|Pregnancy|pregnancy
301542|NCT01863446|Melatonin|melatonin
301543|NCT01863446|Contractions|contractions
301544|NCT01863446|Light|light
301545|NCT01863420|gastric cancer|gastric cancer
301546|NCT01863420|rectal cancer|rectal cancer
301547|NCT01863420|bone marrow toxicity|bone marrow toxicity
301548|NCT01863420|IMRT|imrt
301549|NCT01863420|hematologic toxicity|hematologic toxicity
301550|NCT01863407|Ileus|ileus
301551|NCT01863407|Intestinal Obstruction|intestinal obstruction
301552|NCT01863407|Intestinal Diseases|intestinal diseases
301553|NCT01863407|Gastrointestinal Diseases|gastrointestinal diseases
301554|NCT01863407|Digestive System Diseases|digestive system diseases
301555|NCT01863394|Screening|screening
301556|NCT01863394|Malnutrition|malnutrition
301557|NCT01863394|Community Management of Acute Malnutrition|community management of acute malnutrition
301558|NCT01863381|Hydrocephalus|hydrocephalus
301559|NCT01863381|Idiopathic intracranial hypertension|idiopathic intracranial hypertension
301560|NCT01863381|Pseudotumor cerebri|pseudotumor cerebri
301561|NCT01863381|ICP|icp
301562|NCT01863381|Intracranial pressure|intracranial pressure
301563|NCT01863381|CSF pressure|csf pressure
301564|NCT01863381|VIIP|viip
301565|NCT01863368|Dry eye syndrome|dry eye syndrome
301566|NCT01863368|Systane Ultra|systane ultra
301567|NCT01863368|Optive|optive
301568|NCT01863368|Ocular Surface Staining|ocular surface staining
301569|NCT01863368|OSDI|osdi
301570|NCT01863368|Eye drops|eye drops
301571|NCT01863355|IntravenousPCA, fentanyl, postoperative pain, laparoscopic gastrectomy|intravenouspca, fentanyl, postoperative pain, laparoscopic gastrectomy
301572|NCT01863342|central sensitization; osteoarthritis; epidural analgesia|central sensitization; osteoarthritis; epidural analgesia
301573|NCT01863329|Optic nerve sheath diameter|optic nerve sheath diameter
301574|NCT01863329|Hydrocephalus|hydrocephalus
301575|NCT01863329|Intracranial hypertension|intracranial hypertension
301576|NCT01863316|LMA Supreme, i-gel, supraglottic airway|lma supreme, i-gel, supraglottic airway
301577|NCT01863303|colorectal cancer|colorectal cancer
301578|NCT01863303|epidemiology|epidemiology
301579|NCT01863303|industry|industry
301580|NCT01863303|genetic|genetic
301581|NCT01863290|prison|prison
301582|NCT01863290|reentry|reentry
301583|NCT01863290|health care utilization|health care utilization
301584|NCT01863264|dysphagia|dysphagia
301585|NCT01863264|swallowing|swallowing
301586|NCT01863264|infant|infant
301587|NCT01863264|premature|premature
301588|NCT01863264|neonate|neonate
301589|NCT01863264|thermal|thermal
301590|NCT01863264|cold|cold
301591|NCT01863264|bolus|bolus
301592|NCT01863264|temperature|temperature
301593|NCT01863264|deglutition|deglutition
301594|NCT01863264|NICU|nicu
301595|NCT01863264|bottle|bottle
301596|NCT01863264|nippling|nippling
301597|NCT01863251|Opiates|opiates
301598|NCT01863251|ATS|ats
301599|NCT01863251|HIV Risks|hiv risks
301600|NCT01863238|Cystic Fibrosis|cystic fibrosis
301601|NCT01863199|Wet AMD|wet amd
301602|NCT01863199|AMD|amd
301603|NCT01863199|Choroidal neovascularization|choroidal neovascularization
301604|NCT01863199|Neovascular membrane|neovascular membrane
301605|NCT01863186|lofexidine|lofexidine
301606|NCT01863186|opioid dependence|opioid dependence
301607|NCT01863186|acute withdrawal syndrome|acute withdrawal syndrome
301608|NCT01863186|opioid withdrawal|opioid withdrawal
301609|NCT01863173|Thalassemia cardiomyopathy|thalassemia cardiomyopathy
301610|NCT01863173|metoprolol succinate|metoprolol succinate
301611|NCT01863173|echocardiography|echocardiography
301612|NCT01863173|six minute walk test|six minute walk test
301613|NCT01863160|Safety|safety
301614|NCT01863160|Tolerability|tolerability
301615|NCT01863160|Pharmacokinetic profile|pharmacokinetic profile
301616|NCT01863160|ZEP-3 Cream (0.1% and 1.0%)|zep-3 cream (0.1% and 1.0%)
301617|NCT01863160|administered topically|administered topically
301618|NCT01863147|Type 2 diabetes|type 2 diabetes
301619|NCT01863147|left ventricular mass|left ventricular mass
301620|NCT01863147|inhibitor of dipeptidyl peptidase-4|inhibitor of dipeptidyl peptidase-4
301621|NCT01863121|cirrhosis|cirrhosis
301622|NCT01863121|CTPK|ctpk
301623|NCT01863121|CTP|ctp
301624|NCT01863121|MELD|meld
301625|NCT01863121|Severity Score|severity score
301626|NCT01863108|Melanoma|melanoma
301627|NCT01863108|Immunotherapy|immunotherapy
301628|NCT01863108|Dermatology|dermatology
301629|NCT01863108|cancer vaccine|cancer vaccine
301630|NCT01863108|Plasmacytoid dendritic cell line|plasmacytoid dendritic cell line
301631|NCT01863108|Advanced Medicinal Therapy Product|advanced medicinal therapy product
301632|NCT01863108|allogeneic|allogeneic
301633|NCT01863082|Resistant Hypertension|resistant hypertension
301634|NCT01863069|inhaled|inhaled
301635|NCT01863069|interferon beta-1a|interferon beta-1a
301636|NCT01863069|healthy subjects|healthy subjects
301637|NCT01863056|Sedentary time|sedentary time
301638|NCT01863056|Non Exercise Activity|non exercise activity
301639|NCT01863056|Sit Stand Workstation|sit stand workstation
301640|NCT01863043|Premature Infant|premature infant
301641|NCT01863043|Nutrition|nutrition
301642|NCT01863043|Enteral|enteral
301643|NCT01863030|Resorbable mesh|resorbable mesh
301644|NCT01863030|Phasix mesh|phasix mesh
301645|NCT01863017|Obesity|obesity
301646|NCT01863017|Over weight|over weight
301647|NCT01862991|Induced Abortion|induced abortion
301648|NCT01862991|Mifepristone|mifepristone
301649|NCT01862991|Dilation and Evacuation|dilation and evacuation
301650|NCT01862991|Cervical Preparation|cervical preparation
301651|NCT01862991|Osmotic Dilators|osmotic dilators
301652|NCT01862978|Stroke|stroke
301653|NCT01862978|Heparin|heparin
301654|NCT01862978|Nadroparin|nadroparin
301655|NCT01862965|firstline|firstline
301656|NCT01862965|treatment|treatment
301657|NCT01862965|prednisone|prednisone
301658|NCT01862965|everolimus|everolimus
301659|NCT01862939|type 2 diabetes mellitus|type 2 diabetes mellitus
301660|NCT01862926|connective tissue disease|connective tissue disease
301661|NCT01862926|interstitial lung disease|interstitial lung disease
301662|NCT01862926|pulmonary fibrosis|pulmonary fibrosis
301663|NCT01862926|rituximab|rituximab
301664|NCT01862926|scleroderma|scleroderma
301665|NCT01862926|polymyositis|polymyositis
301666|NCT01862926|dermatomyositis|dermatomyositis
301667|NCT01862913|depression|depression
301668|NCT01862913|adolescents|adolescents
301669|NCT01862900|Breast Cancer|breast cancer
301670|NCT01862900|Metastatic|metastatic
301671|NCT01862900|Lung metastases|lung metastases
301672|NCT01862900|Liver metastases|liver metastases
301673|NCT01862900|Stereotactic body radiation|stereotactic body radiation
301674|NCT01862900|anti-OX40 antibody|anti-ox40 antibody
301675|NCT01862900|MEDI6469|medi6469
301676|NCT01862900|Immunotherapy|immunotherapy
301677|NCT01862861|Bioidentical Hormone Replacement Therapy|bioidentical hormone replacement therapy
301678|NCT01862848|Topical Compounded Pain Creams and Pain Perception|topical compounded pain creams and pain perception
301679|NCT01862822|Paediatrics|paediatrics
301680|NCT01862822|Urinary tract infection|urinary tract infection
301681|NCT01862822|Urine collection|urine collection
301682|NCT01862809|Oral Microbiota|oral microbiota
301683|NCT01862809|Cigarette Smoking|cigarette smoking
301684|NCT01862809|Tobacco- Related Cancer|tobacco- related cancer
301685|NCT01862796|Food Intake|food intake
301686|NCT01862796|Weight Loss|weight loss
301687|NCT01862796|Compliance|compliance
301688|NCT01862783|Erythrocytes|erythrocytes
301689|NCT01862783|Parasites|parasites
301690|NCT01862783|Plasmodium Falciparum|plasmodium falciparum
301691|NCT01862783|Placenta|placenta
301692|NCT01862783|Resistant|resistant
301693|NCT01862770|Lung Cancer|lung cancer
301694|NCT01862770|Smokers|smokers
301695|NCT01862770|Genetic Risk Communication|genetic risk communication
301696|NCT01862770|Smoking Cessation|smoking cessation
301697|NCT01862757|Obesity|obesity
301698|NCT01862757|Insulin|insulin
301699|NCT01862757|Skeletal Muscle|skeletal muscle
301700|NCT01862757|Strength Testing|strength testing
301701|NCT01862744|Parkinson's Disease|parkinson's disease
301702|NCT01862744|MRI|mri
301703|NCT01862744|Cognitive|cognitive
301704|NCT01862731|Muscle Force|muscle force
301705|NCT01862731|Knee|knee
301706|NCT01862731|Magnetic Resonance Imaging|magnetic resonance imaging
301707|NCT01862731|Quadriceps|quadriceps
301708|NCT01862731|Ultrasound|ultrasound
301709|NCT01862718|Fusion|fusion
301710|NCT01862718|Tracking|tracking
301711|NCT01862718|Ablation|ablation
301712|NCT01862718|Hepatic Neoplasms|hepatic neoplasms
301713|NCT01862666|Barrett's Esophagus|barrett's esophagus
301715|NCT01862666|Intramucosal Adenocarcinoma|intramucosal adenocarcinoma
301716|NCT01862666|EMR|emr
301717|NCT01862666|Endoscopy|endoscopy
301718|NCT01862653|Post Traumatic Stress Disorder|post traumatic stress disorder
301719|NCT01862653|Sleep Disturbance|sleep disturbance
301720|NCT01862653|Acupuncture|acupuncture
301721|NCT01862640|OPC-34712|opc-34712
301722|NCT01862640|brexpiprazole|brexpiprazole
301723|NCT01862640|Dementia|dementia
301724|NCT01862640|Alzheimer's Disease|alzheimer's disease
301725|NCT01862640|Cognitive Disorders|cognitive disorders
301726|NCT01862640|Memory|memory
301727|NCT01862640|Agitation|agitation
301728|NCT01862627|Macular retinoschisis|macular retinoschisis
301729|NCT01862627|Macular detachment|macular detachment
301730|NCT01862627|vitrectomy|vitrectomy
301731|NCT01862614|Degree of pulpal anesthesia obtained.|degree of pulpal anesthesia obtained.
301732|NCT01862614|Primary infiltration in the lower first molar.|primary infiltration in the lower first molar.
301733|NCT01862614|Buffered local anesthetic.|buffered local anesthetic.
301734|NCT01862588|septic shock|septic shock
301735|NCT01862588|acute kidney injury|acute kidney injury
301736|NCT01862588|renal resistive index|renal resistive index
301737|NCT01862562|Laparoscopic surgery|laparoscopic surgery
301738|NCT01862562|Colorectal cancer|colorectal cancer
301739|NCT01862562|Elderly patient|elderly patient
301740|NCT01862562|Randomized control study|randomized control study
301741|NCT01862536|Randomized trial|randomized trial
301742|NCT01862536|COPD|copd
301743|NCT01862536|tadalafil|tadalafil
301744|NCT01862536|Phosphodiesterase inhibitor|phosphodiesterase inhibitor
301745|NCT01862536|Pulmonary hypertension|pulmonary hypertension
301746|NCT01862510|Celiac Disease|celiac disease
301747|NCT01862510|Hypothyroidism|hypothyroidism
301748|NCT01862510|Celiac Sprue|celiac sprue
301749|NCT01862510|Malabsorption|malabsorption
301750|NCT01862497|Intradialytic Hypertension|intradialytic hypertension
301751|NCT01862497|Hemodialysis|hemodialysis
301752|NCT01862497|Hypertension|hypertension
301753|NCT01862497|Extracellular Volume|extracellular volume
301754|NCT01862497|Endothelial Cell Dysfunction|endothelial cell dysfunction
301755|NCT01862497|Endothelin 1|endothelin 1
301756|NCT01862497|Carvedilol|carvedilol
301757|NCT01862484|ADHD|adhd
301758|NCT01862484|Diet|diet
301759|NCT01862484|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
301760|NCT01862471|Deep Vein Thrombosis|deep vein thrombosis
301761|NCT01862471|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
301762|NCT01862471|Intermittent Pneumatic Compression|intermittent pneumatic compression
301763|NCT01862471|Doppler Ultrasound|doppler ultrasound
301764|NCT01862458|empyema|empyema
301765|NCT01862458|tPA|tpa
301766|NCT01862458|dornase|dornase
301767|NCT01862445|Chronic Lymphoid Leukemia, Chlorambucil, Rituximab|chronic lymphoid leukemia, chlorambucil, rituximab
301768|NCT01862393|electrical stimulation|electrical stimulation
301769|NCT01862393|torque|torque
301770|NCT01862380|Adrenocortical function|adrenocortical function
301771|NCT01862380|Adrenal hyperplasia, Congenital|adrenal hyperplasia, congenital
301772|NCT01862380|21-hydroxylase|21-hydroxylase
301773|NCT01862380|deficiency|deficiency
301774|NCT01862380|cortisol|cortisol
301775|NCT01862380|replacement therapy|replacement therapy
301776|NCT01862380|Woman|woman
301777|NCT01862380|Healthy people|healthy people
301778|NCT01862354|Postoperative analgesia|postoperative analgesia
301779|NCT01862354|Abdominoplasty|abdominoplasty
301780|NCT01862354|Continuous wound infusion|continuous wound infusion
301781|NCT01862354|Transverse abdominal plan block|transverse abdominal plan block
301782|NCT01862354|Local anesthetics : Ropivacaine|local anesthetics : ropivacaine
301783|NCT01862354|Regional anesthesia|regional anesthesia
301784|NCT01862341|Constipation|constipation
301785|NCT01862341|Bowel movement|bowel movement
301786|NCT01862341|Intestinal health|intestinal health
301787|NCT01862328|MLN4924|mln4924
301788|NCT01862328|Solid Tumors|solid tumors
301789|NCT01862315|Hepatic Arterial Infusion (HAI)|hepatic arterial infusion (hai)
301790|NCT01862315|Floxuridine (FUDR)|floxuridine (fudr)
301791|NCT01862315|Dexamethasone (DEX)|dexamethasone (dex)
301792|NCT01862315|Gemcitabine|gemcitabine
301793|NCT01862315|Oxaliplatin|oxaliplatin
301794|NCT01862315|13-066|13-066
301795|NCT01862302|Prevention delirium|prevention delirium
301796|NCT01862302|Cardiac surgery|cardiac surgery
301797|NCT01862289|difficult asthma|difficult asthma
301798|NCT01862289|hyperventilation syndrome|hyperventilation syndrome
301799|NCT01862289|prevalence|prevalence
301800|NCT01862263|Diabetes,|diabetes,
301801|NCT01862263|Type 2 diabetes,|type 2 diabetes,
301802|NCT01862263|Diabetes mellitus,|diabetes mellitus,
301803|NCT01862263|insulin,|insulin,
301804|NCT01862237|Type II diabetes|type ii diabetes
301805|NCT01862237|aortic valve stenosis|aortic valve stenosis
301806|NCT01862237|left ventricular remodeling|left ventricular remodeling
301807|NCT01862237|aortic valve replacement surgery|aortic valve replacement surgery
301808|NCT01862224|Active rheumatoid arthritis despite methotrexate therapy|active rheumatoid arthritis despite methotrexate therapy
301809|NCT01862224|JNJ-38518168|jnj-38518168
301810|NCT01862224|Synovial|synovial
302103|NCT01860820|IPC/TEDS|ipc/teds
301811|NCT01862211|alpha antitrypsin, hepatic disease, genetic, polymorphism|alpha antitrypsin, hepatic disease, genetic, polymorphism
301812|NCT01862185|semiquantitative|semiquantitative
301813|NCT01862185|procalcitonin|procalcitonin
301814|NCT01862185|sepsis|sepsis
301815|NCT01862185|antibiotics|antibiotics
301816|NCT01862185|mortality|mortality
301817|NCT01862172|Cortical focal atrophy|cortical focal atrophy
301818|NCT01862172|Stroke|stroke
301819|NCT01862172|Internal capsule|internal capsule
301820|NCT01862172|Corticospinal tract|corticospinal tract
301821|NCT01862172|Wallerian degeneration|wallerian degeneration
301822|NCT01862172|Primary motor area.|primary motor area.
301823|NCT01862159|bariatric surgery|bariatric surgery
301824|NCT01862159|postoperative complications|postoperative complications
301825|NCT01862146|TCA|tca
301826|NCT01862146|FMD|fmd
301827|NCT01862146|IMT|imt
301828|NCT01862146|Smoking|smoking
301829|NCT01862133|Electronic Health Record|electronic health record
301830|NCT01862133|Health Information Technology|health information technology
301831|NCT01862133|Patient Privacy|patient privacy
301832|NCT01862133|Personal Health Information|personal health information
301833|NCT01862120|Recently diagnosed|recently diagnosed
301834|NCT01862120|Regulatory T Cells|regulatory t cells
301835|NCT01862120|Tolerance Induction|tolerance induction
301836|NCT01862120|Paediatrics|paediatrics
301837|NCT01862120|Low dose|low dose
301838|NCT01862120|IL-2|il-2
301839|NCT01862107|Biomarkers|biomarkers
301840|NCT01862107|Immune Responses|immune responses
301841|NCT01862107|Lumbar Puncture|lumbar puncture
301842|NCT01862107|Neurological Diseases|neurological diseases
301843|NCT01862107|Novel Pathogens|novel pathogens
301844|NCT01862068|Pronostic factors|pronostic factors
301845|NCT01862068|Neutrophils|neutrophils
301846|NCT01862068|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
301847|NCT01862068|Microscopic polyangiitis|microscopic polyangiitis
301848|NCT01862068|ANCA associated vasculitis|anca associated vasculitis
301849|NCT01862068|Proteomics|proteomics
301850|NCT01862055|Stress|stress
301851|NCT01862055|Anxiety|anxiety
301852|NCT01862055|Cesarean Section|cesarean section
301853|NCT01862055|Spinal anesthesia|spinal anesthesia
301854|NCT01862055|Hypotension|hypotension
301855|NCT01862042|Spinal Muscular Atrophy (SMA) type 1|spinal muscular atrophy (sma) type 1
301856|NCT01862042|Supportive care|supportive care
301857|NCT01862042|Palliative care|palliative care
301858|NCT01862029|Mitochondria in Diabetes|mitochondria in diabetes
301859|NCT01862029|Obesity|obesity
301860|NCT01862029|Roflumilast|roflumilast
301861|NCT01862029|Phosphodiesterase-4|phosphodiesterase-4
301862|NCT01862029|Pre-Diabetes|pre-diabetes
301863|NCT01862016|Acute respiratory distress syndrome|acute respiratory distress syndrome
301864|NCT01862016|APRV ventilatory mode|aprv ventilatory mode
301865|NCT01862016|Spontaneous breathing|spontaneous breathing
301866|NCT01862016|Intensive Care Unit|intensive care unit
301867|NCT01862003|Colorectal cancer|colorectal cancer
301868|NCT01862003|Metastatic Colorectal cancer|metastatic colorectal cancer
301869|NCT01862003|Recurrent Colorectal cancer|recurrent colorectal cancer
301870|NCT01862003|FOLFIRI|folfiri
301871|NCT01862003|AZD8931|azd8931
301872|NCT01862003|Chemotherapy|chemotherapy
301873|NCT01862003|EGFR|egfr
301874|NCT01861990|Glioma|glioma
301875|NCT01861990|Glioblastoma|glioblastoma
301876|NCT01861990|Pediatric|pediatric
301877|NCT01861990|Child|child
301878|NCT01861990|Brain tumor|brain tumor
301879|NCT01861990|Astrocytoma|astrocytoma
301880|NCT01861990|Medulloblastoma|medulloblastoma
301881|NCT01861990|PNET|pnet
301882|NCT01861977|Cognitive Therapy|cognitive therapy
301883|NCT01861977|Health Education|health education
301884|NCT01861977|Secondary Prevention|secondary prevention
301885|NCT01861977|Cardiovascular Disease|cardiovascular disease
301886|NCT01861964|XOS|xos
301887|NCT01861964|Xylooligosarcharide|xylooligosarcharide
301888|NCT01861964|Prebiotic|prebiotic
301889|NCT01861951|soft tissue sarcoma|soft tissue sarcoma
301890|NCT01861951|firstline treatment|firstline treatment
301891|NCT01861951|eldery patients|eldery patients
301892|NCT01861938|melanoma|melanoma
301893|NCT01861938|vaccine|vaccine
301894|NCT01861938|Resectable AJCC stage IV|resectable ajcc stage iv
301895|NCT01861938|AJCC stages IIb-c, III|ajcc stages iib-c, iii
301896|NCT01861938|Patients with low-burden|patients with low-burden
301897|NCT01861938|failed|failed
301898|NCT01861938|respond|respond
301899|NCT01861938|one treatment line|one treatment line
301900|NCT01861912|Carcinoma, Hepatocellular|carcinoma, hepatocellular
301901|NCT01861912|Arsenic trioxide|arsenic trioxide
301902|NCT01861899|Sacro-iliac Joint|sacro-iliac joint
301903|NCT01861886|Birth control|birth control
301904|NCT01861886|Permanent Contraception|permanent contraception
301905|NCT01861873|liver function|liver function
301906|NCT01861873|galactose|galactose
301907|NCT01861873|18-F-deoxy-galactose|18-f-deoxy-galactose
301908|NCT01861860|stenting using IVUS in long lEsion|stenting using ivus in long lesion
301909|NCT01861834|Total parenteral nutrition|total parenteral nutrition
301910|NCT01861834|TPN|tpn
301911|NCT01861834|Intestinal Failure|intestinal failure
301912|NCT01861834|Short Bowel Syndrome|short bowel syndrome
301913|NCT01861834|Cholestasis|cholestasis
301914|NCT01861834|Intestinal failure associated liver disease|intestinal failure associated liver disease
301915|NCT01861834|Parenteral nutrition associated liver disease|parenteral nutrition associated liver disease
301916|NCT01861821|Epidural catheter|epidural catheter
301917|NCT01861821|Epidural analgesia|epidural analgesia
301918|NCT01861821|Labor epidural analgesia|labor epidural analgesia
301919|NCT01861821|Analgesic efficacy|analgesic efficacy
301920|NCT01861821|Multiport epidural catheter|multiport epidural catheter
301921|NCT01861821|Uniport epidural catheter|uniport epidural catheter
301922|NCT01861821|Flexible epidural catheter|flexible epidural catheter
301923|NCT01861808|Spinal Cord Injuries|spinal cord injuries
301924|NCT01861808|Cerebrospinal Fluid|cerebrospinal fluid
301925|NCT01861795|Drug therapy|drug therapy
301926|NCT01861769|Cognitive Processing Therapy|cognitive processing therapy
301927|NCT01861769|Consultation|consultation
301928|NCT01861756|Shared Decision Making|shared decision making
301929|NCT01861756|Decision Aids|decision aids
301930|NCT01861743|Multi-modal Pain Management|multi-modal pain management
301931|NCT01861743|Lumbar fusion|lumbar fusion
301932|NCT01861743|misTLIF|mistlif
301933|NCT01861730|BCG Vaccinated|bcg vaccinated
301934|NCT01861730|HIV Negative|hiv negative
301935|NCT01861717|excess growth hormone|excess growth hormone
301936|NCT01861717|excess GH|excess gh
301937|NCT01861717|gigantism|gigantism
301938|NCT01861717|pituitary tumor|pituitary tumor
301939|NCT01861717|pituitary adenoma|pituitary adenoma
301940|NCT01861717|growth hormone tumor|growth hormone tumor
301941|NCT01861717|GH secreting adenoma|gh secreting adenoma
301942|NCT01861717|Somatuline|somatuline
301943|NCT01861717|lanreotide|lanreotide
301944|NCT01861704|Mild to moderate hearing loss|mild to moderate hearing loss
301945|NCT01861691|Transverse colon cancer|transverse colon cancer
301946|NCT01861691|Descending colon cancer|descending colon cancer
301947|NCT01861691|Laparoscopic surgery|laparoscopic surgery
301948|NCT01861691|Randomized controlled trial|randomized controlled trial
301949|NCT01861678|Rectal cancer|rectal cancer
301950|NCT01861678|Anterior resection|anterior resection
301951|NCT01861678|High tie of inferior mesenteric artery|high tie of inferior mesenteric artery
301952|NCT01861678|Low tie of inferior mesenteric artery|low tie of inferior mesenteric artery
301953|NCT01861678|Randomized controlled trial|randomized controlled trial
301954|NCT01861652|Restless legs syndrome, Ekbom syndrome, Restless legs|restless legs syndrome, ekbom syndrome, restless legs
301955|NCT01861600|Stool composition|stool composition
301956|NCT01861535|VIN|vin
301957|NCT01861535|Imiquimod|imiquimod
301958|NCT01861535|Surgery|surgery
301959|NCT01861535|HPV|hpv
301960|NCT01861535|Patient satisfaction|patient satisfaction
301961|NCT01861522|TAU-284|tau-284
301962|NCT01861522|Bepotastine besilate|bepotastine besilate
301963|NCT01861522|Histamine H1 receptor antagonists|histamine h1 receptor antagonists
301964|NCT01861522|children|children
301965|NCT01861509|BP-C1|bp-c1
301966|NCT01861509|CDBPA|cdbpa
301967|NCT01861509|Metronomic chemotherapy|metronomic chemotherapy
301968|NCT01861509|Platinum analogue|platinum analogue
301969|NCT01861509|Cis-coordinated complexes of platinum(II) with polymer of benzene polycarboxylic acids derived from lignin|cis-coordinated complexes of platinum(ii) with polymer of benzene polycarboxylic acids derived from lignin
301970|NCT01861509|Benzene polycarboxylic acids complex with cis-diammineplatinum(II)|benzene polycarboxylic acids complex with cis-diammineplatinum(ii)
301971|NCT01861509|Breast cancer|breast cancer
301972|NCT01861509|Cisplatin|cisplatin
301973|NCT01861509|Metastatic Breast Cancer|metastatic breast cancer
301974|NCT01861496|Cisplatin|cisplatin
301975|NCT01861496|Liposomal formulation|liposomal formulation
301976|NCT01861496|DRP (Drug Response Prediction)|drp (drug response prediction)
301977|NCT01861457|nasal sanitizer®|nasal sanitizer®
301978|NCT01861457|S. aureus|s. aureus
301979|NCT01861457|general bacteria|general bacteria
301980|NCT01861457|nasal carriage|nasal carriage
301981|NCT01861457|decolonization|decolonization
301982|NCT01861431|HIV, prevention, microfinance, sex work, Mongolia|hiv, prevention, microfinance, sex work, mongolia
301983|NCT01861418|chronic low back pain|chronic low back pain
301984|NCT01861418|low back pain|low back pain
301985|NCT01861418|lumbopelvic manipulation|lumbopelvic manipulation
301986|NCT01861418|Chicago manipulation|chicago manipulation
301987|NCT01861418|EMG median frequency|emg median frequency
301988|NCT01861418|electromyography|electromyography
301989|NCT01861418|reliability|reliability
301990|NCT01861392|postural balance sensory motor trayning physical therapy modalities diabetes mellitus|postural balance sensory motor trayning physical therapy modalities diabetes mellitus
301991|NCT01861366|Implementation|implementation
301992|NCT01861366|Guidelines|guidelines
301993|NCT01861366|Nutrition|nutrition
301994|NCT01861366|Nursing home|nursing home
301995|NCT01861327|Carbon dioxide|carbon dioxide
301996|NCT01861327|aortic aneurysm|aortic aneurysm
301997|NCT01861327|angioplasty|angioplasty
301998|NCT01861327|Critical lower limb ischemia|critical lower limb ischemia
301999|NCT01861288|Inflammatory Bowel Disease|inflammatory bowel disease
302000|NCT01861288|Fecal Calprotectin|fecal calprotectin
302104|NCT01860820|Geko device|geko device
302001|NCT01861288|Clinical IBD score (SCCAI, PUCAI, aPCDAI)|clinical ibd score (sccai, pucai, apcdai)
302002|NCT01861288|Endoscopic deep remission|endoscopic deep remission
302003|NCT01861288|Histopathologic deep remission|histopathologic deep remission
302004|NCT01861288|Immunological deep remission|immunological deep remission
302005|NCT01861288|Treatment algorithm|treatment algorithm
302006|NCT01861275|osa|osa
302007|NCT01861275|cerebral palsy|cerebral palsy
302008|NCT01861275|thrombolysis in cerebral palsy|thrombolysis in cerebral palsy
302009|NCT01861275|sleep registration|sleep registration
302010|NCT01861262|emergency|emergency
302011|NCT01861262|drug poisoning|drug poisoning
302012|NCT01861262|StO2 measurement|sto2 measurement
302013|NCT01861262|blood pressure|blood pressure
302014|NCT01861262|hemodynamic failure|hemodynamic failure
302015|NCT01861223|acquired resistance|acquired resistance
302016|NCT01861223|gefitinib|gefitinib
302017|NCT01861223|erlotinib|erlotinib
302018|NCT01861210|Homosexuality, Male|homosexuality, male
302019|NCT01861197|Efficacy|efficacy
302020|NCT01861197|Dovitinib|dovitinib
302021|NCT01861197|Squamous NSCLC|squamous nsclc
302022|NCT01861184|Lower respiratory tract infection|lower respiratory tract infection
302023|NCT01861184|LRTI|lrti
302024|NCT01861184|Pneumococcal carriage|pneumococcal carriage
302025|NCT01861158|Parenting|parenting
302026|NCT01861158|Adolescence|adolescence
302027|NCT01861158|Delinquency|delinquency
302028|NCT01861158|Online intervention|online intervention
302029|NCT01861158|Juvenile Justice|juvenile justice
302030|NCT01861145|Intranasal steroids|intranasal steroids
302286|NCT01860183|kidney transplantation|kidney transplantation
302031|NCT01861132|Pregnancy, cesarean delivery, blood pressure, cardiac output|pregnancy, cesarean delivery, blood pressure, cardiac output
302032|NCT01861106|Allogeneic Donors|allogeneic donors
302033|NCT01861106|Peripheral Blood Stem Cell|peripheral blood stem cell
302034|NCT01861106|Immunodeficiency|immunodeficiency
302035|NCT01861106|Myelodysplasia|myelodysplasia
302036|NCT01861106|Haploidentical|haploidentical
302037|NCT01861093|Unrelated Hematopoietic Stem Cell Transplantation|unrelated hematopoietic stem cell transplantation
302038|NCT01861093|Cryopreserved Cord Blood Units|cryopreserved cord blood units
302039|NCT01861093|National Cord Blood Program|national cord blood program
302040|NCT01861080|target organ damage|target organ damage
302041|NCT01861080|incident hypertension|incident hypertension
302042|NCT01861080|cohort|cohort
302043|NCT01861054|Cancer Stem Cells|cancer stem cells
302044|NCT01861054|Novel targeted therapy|novel targeted therapy
302045|NCT01861054|CXCR1/2 Inhibitors|cxcr1/2 inhibitors
302046|NCT01861041|low dose|low dose
302047|NCT01861041|different baricity|different baricity
302048|NCT01861041|spinal anesthesia|spinal anesthesia
302049|NCT01861028|total knee replacement|total knee replacement
302050|NCT01861028|total knee arthroplasty|total knee arthroplasty
302051|NCT01861028|patient-specific|patient-specific
302052|NCT01861002|Relapse|relapse
302053|NCT01861002|Lymphoblastic|lymphoblastic
302054|NCT01861002|Leukemia|leukemia
302055|NCT01861002|Azacytidine|azacytidine
302056|NCT01861002|Refractory|refractory
302057|NCT01861002|Myelogenous|myelogenous
302058|NCT01861002|Acute|acute
302059|NCT01861002|Childhood|childhood
302060|NCT01861002|Pediatric|pediatric
302061|NCT01861002|ALL|all
302062|NCT01861002|AML|aml
302063|NCT01861002|Methylation|methylation
302064|NCT01861002|Epigenetic therapy|epigenetic therapy
302065|NCT01860989|parasitemia|parasitemia
302066|NCT01860963|ASIL|asil
302067|NCT01860963|Anal dysplasia|anal dysplasia
302068|NCT01860963|IBD|ibd
302069|NCT01860963|HPV DNA|hpv dna
302070|NCT01860950|Healthy Adults|healthy adults
302071|NCT01860950|Pain Perception|pain perception
302072|NCT01860937|T cell Immunotherapy|t cell immunotherapy
302073|NCT01860937|CD19 Targeted Therapy|cd19 targeted therapy
302074|NCT01860937|Chimeric Antigen Receptor (CAR) Modified T cells|chimeric antigen receptor (car) modified t cells
302075|NCT01860937|Conditioning Chemotherapy|conditioning chemotherapy
302076|NCT01860937|13-052|13-052
302077|NCT01860924|exercise|exercise
302078|NCT01860924|depression|depression
302079|NCT01860924|smoking|smoking
302080|NCT01860898|lung|lung
302081|NCT01860898|cancer|cancer
302082|NCT01860898|thoracic|thoracic
302083|NCT01860898|chest|chest
302084|NCT01860898|pulmonary|pulmonary
302085|NCT01860885|naloxone|naloxone
302086|NCT01860885|children|children
302087|NCT01860885|opioid|opioid
302088|NCT01860885|respiratory depression|respiratory depression
302089|NCT01860885|safety|safety
302090|NCT01860872|Cystic Fibrosis|cystic fibrosis
302091|NCT01860872|Pulmonary perfusion|pulmonary perfusion
302092|NCT01860872|Inflammatory markers|inflammatory markers
302093|NCT01860872|MRI|mri
302094|NCT01860872|CT of chest|ct of chest
302095|NCT01860872|Lung Clearance Index|lung clearance index
302096|NCT01860859|cesarean|cesarean
302097|NCT01860859|ultrasound|ultrasound
302098|NCT01860859|hysterotomy|hysterotomy
302099|NCT01860859|uterus|uterus
302100|NCT01860859|suture|suture
302101|NCT01860846|Crohn's Disease|crohn's disease
302102|NCT01860833|Knee Osteoarthritis|knee osteoarthritis
302105|NCT01860807|methamphetamine|methamphetamine
302106|NCT01860807|ibudilast|ibudilast
302107|NCT01860807|HIV|hiv
302108|NCT01860781|Schizophrenia|schizophrenia
302109|NCT01860781|Injection|injection
302110|NCT01860781|Switch|switch
302111|NCT01860781|Paliperidone|paliperidone
302112|NCT01860781|refractory, chronic akathisia, poor complianc|refractory, chronic akathisia, poor complianc
302113|NCT01860768|Acute aortic dissection|acute aortic dissection
302114|NCT01860768|Serum biomarkers|serum biomarkers
302115|NCT01860768|Early diagnosis|early diagnosis
302116|NCT01860755|Sport-related concussion|sport-related concussion
302117|NCT01860755|Dizziness|dizziness
302118|NCT01860755|Neck pain|neck pain
302119|NCT01860755|Headaches|headaches
302120|NCT01860755|Physiotherapy|physiotherapy
302121|NCT01860755|Treatment|treatment
302122|NCT01860742|Peptide Receptor Radionuclide Therapy (PRRT)|peptide receptor radionuclide therapy (prrt)
302123|NCT01860742|Neuroendocrine Tumors|neuroendocrine tumors
302124|NCT01860742|Interferon alpha|interferon alpha
302125|NCT01860716|Melatonin, liver transplant, oxidative stress|melatonin, liver transplant, oxidative stress
302126|NCT01860703|Ferriprox®|ferriprox®
302127|NCT01860703|LI|li
302128|NCT01860703|DFP|dfp
302129|NCT01860703|Deferiprone|deferiprone
302130|NCT01860703|Healthy Volunteers|healthy volunteers
302131|NCT01860690|MTX|mtx
302132|NCT01860690|Ectopic pregnancy|ectopic pregnancy
302133|NCT01860690|medical treatment|medical treatment
302134|NCT01860677|cranial stimulation|cranial stimulation
302135|NCT01860677|BOLD (Blood Oxygenation Level Dependent)|bold (blood oxygenation level dependent)
302136|NCT01860677|fMRI (Functional Magnetic Resonance Imaging)|fmri (functional magnetic resonance imaging)
302137|NCT01860677|spectroscopy|spectroscopy
302138|NCT01860664|allergy|allergy
302139|NCT01860664|allergic|allergic
302140|NCT01860664|conjunctivitis|conjunctivitis
302141|NCT01860664|corticosteroid|corticosteroid
302142|NCT01860664|hydrocortisone|hydrocortisone
302143|NCT01860664|ophthalmic|ophthalmic
302144|NCT01860664|ointment|ointment
302145|NCT01860651|Inflammatory Bowel Disease|inflammatory bowel disease
302146|NCT01860651|Ulcerative Colitis|ulcerative colitis
302147|NCT01860651|Crohn´s Disease|crohn´s disease
302148|NCT01860651|Children|children
302149|NCT01860651|Adolescence|adolescence
302150|NCT01860651|E-health web-monitoring|e-health web-monitoring
302151|NCT01860651|Adherence|adherence
302152|NCT01860651|Disease activity|disease activity
302153|NCT01860651|Fecal Calprotectin|fecal calprotectin
302154|NCT01860599|prediabetes|prediabetes
302155|NCT01860599|EPC's|epc's
302156|NCT01860599|vascular reactivity|vascular reactivity
302157|NCT01860586|pvr|pvr
302158|NCT01860586|rd|rd
302159|NCT01860586|Proliferative Vitreoretinopathy|proliferative vitreoretinopathy
302160|NCT01860586|retinal detachment|retinal detachment
302161|NCT01860586|detachment|detachment
302162|NCT01860573|Amino acids|amino acids
302163|NCT01860573|Protein|protein
302164|NCT01860560|OSA|osa
302165|NCT01860560|Obstructive Sleep Apnea|obstructive sleep apnea
302166|NCT01860560|High Flow Therapy|high flow therapy
302167|NCT01860560|CPAP|cpap
302168|NCT01860560|HFT|hft
302169|NCT01860560|Continuous Positive Airway Pressure|continuous positive airway pressure
302170|NCT01860560|Mild OSA|mild osa
302171|NCT01860560|Moderate OSA|moderate osa
302172|NCT01860534|pain|pain
302173|NCT01860534|mydriasis|mydriasis
302174|NCT01860534|light|light
302175|NCT01860521|Termination of pregnancy|termination of pregnancy
302176|NCT01860521|Second trimester|second trimester
302177|NCT01860521|Programmed intermittent epidural bolus|programmed intermittent epidural bolus
302178|NCT01860521|Continuous epidural infusion|continuous epidural infusion
302179|NCT01860521|Epidural analgesia|epidural analgesia
302180|NCT01860521|Legally Induced Abortion|legally induced abortion
302181|NCT01860508|Progression free Survival|progression free survival
302182|NCT01860495|growth factors|growth factors
302183|NCT01860495|periodontal pockets|periodontal pockets
302184|NCT01860482|Refractory Reflux Esophagitis|refractory reflux esophagitis
302185|NCT01860482|GERD|gerd
302186|NCT01860482|Phase 4|phase 4
302187|NCT01860456|Chronic myeloid leukemia|chronic myeloid leukemia
302188|NCT01860456|Imatinib|imatinib
302189|NCT01860456|Nilotinib|nilotinib
302190|NCT01860456|Polymorphism, Single Nucleotide|polymorphism, single nucleotide
302191|NCT01860456|Pharmacokinetics|pharmacokinetics
302192|NCT01860456|ATP-Binding Cassette Transporters|atp-binding cassette transporters
302193|NCT01860456|SLC Transporters|slc transporters
302194|NCT01860456|Treatment outcome|treatment outcome
302195|NCT01860456|Toxicity|toxicity
302196|NCT01860443|depression|depression
302197|NCT01860443|adolescents|adolescents
302198|NCT01860430|Locally Advanced|locally advanced
302199|NCT01860430|Head and Neck Cancer|head and neck cancer
302200|NCT01860430|Ipilimumab (YERVOY®)|ipilimumab (yervoy®)
302201|NCT01860417|Degenerative Disc Disease,|degenerative disc disease,
302202|NCT01860417|Intervertebral Disc Disease|intervertebral disc disease
302203|NCT01860417|Low Back Pain|low back pain
302204|NCT01860417|Nucleus pulposus|nucleus pulposus
302205|NCT01860417|Stem cell|stem cell
302206|NCT01860417|Cellular therapy|cellular therapy
302207|NCT01860417|Regenerative therapy|regenerative therapy
302208|NCT01860417|Mesenchymal stem cells|mesenchymal stem cells
302209|NCT01860417|Bone marrow|bone marrow
302210|NCT01860417|Musculoskeletal Diseases|musculoskeletal diseases
302211|NCT01860417|Mesenchymal Stromal Cells (allogenic)|mesenchymal stromal cells (allogenic)
302212|NCT01860404|Concussion|concussion
302213|NCT01860404|Branched chain amino acids|branched chain amino acids
302214|NCT01860404|BCAA|bcaa
302215|NCT01860404|HIT HEADS|hit heads
302216|NCT01860391|Silver|silver
302217|NCT01860391|Fluoride|fluoride
302218|NCT01860391|Diammine Silver Fluoride|diammine silver fluoride
302219|NCT01860391|Saliva|saliva
302220|NCT01860378|Whooping Cough|whooping cough
302221|NCT01860378|Pertussis|pertussis
302222|NCT01860378|Tdap vaccination|tdap vaccination
302223|NCT01860378|Randomized placebo controlled factorial trial|randomized placebo controlled factorial trial
302224|NCT01860365|Quality of life|quality of life
302225|NCT01860365|Integrative medicine|integrative medicine
302226|NCT01860365|Supportive care|supportive care
302227|NCT01860365|Cancer|cancer
302228|NCT01860365|Chemotherapy|chemotherapy
302229|NCT01860352|Fish Oil|fish oil
302230|NCT01860352|colon health|colon health
302231|NCT01860352|fatty acid metabolism|fatty acid metabolism
302232|NCT01860339|Huntington's Disease|huntington's disease
302233|NCT01860339|HD|hd
302234|NCT01860339|Huntington Disease|huntington disease
302235|NCT01860339|Juvenile Huntington's Disease|juvenile huntington's disease
302236|NCT01860339|JHD|jhd
302237|NCT01860326|hepatic impairment|hepatic impairment
302238|NCT01860326|mild and moderate hepatic impairment|mild and moderate hepatic impairment
302239|NCT01860326|Alisporivir|alisporivir
302240|NCT01860313|effectiveness|effectiveness
302241|NCT01860313|distance learning|distance learning
302242|NCT01860313|mental health|mental health
302243|NCT01860300|Tic Disorders|tic disorders
302244|NCT01860300|Tourette Syndrome|tourette syndrome
302245|NCT01860287|opioid|opioid
302246|NCT01860287|subjective|subjective
302247|NCT01860287|stress|stress
302248|NCT01860287|buprenorphine|buprenorphine
302249|NCT01860274|Mesh|mesh
302250|NCT01860274|Graft|graft
302251|NCT01860274|Patency|patency
302252|NCT01860261|HIV|hiv
302253|NCT01860261|AIDS|aids
302254|NCT01860261|sedentary|sedentary
302255|NCT01860261|fitness|fitness
302256|NCT01860261|aging|aging
302257|NCT01860261|V02max|v02max
302258|NCT01860261|d-dimer|d-dimer
302259|NCT01860261|IL-6|il-6
302260|NCT01860261|CRP|crp
302261|NCT01860261|ChiWalking|chiwalking
302262|NCT01860261|ChiRunning|chirunning
302263|NCT01860261|aerobic exercise|aerobic exercise
302264|NCT01860261|strength training|strength training
302265|NCT01860248|vapocoolant effectiveness|vapocoolant effectiveness
302266|NCT01860248|arterial puncture|arterial puncture
302267|NCT01860235|Local anesthesia|local anesthesia
302268|NCT01860235|Pain measurement|pain measurement
302269|NCT01860235|Pain perception|pain perception
302270|NCT01860235|Dental anesthesia|dental anesthesia
302271|NCT01860235|Root planing|root planing
302272|NCT01860222|Hepatocellular carcinoma|hepatocellular carcinoma
302273|NCT01860222|CSPH|csph
302274|NCT01860222|Hepatectomy|hepatectomy
302275|NCT01860222|percutaneous local ablative|percutaneous local ablative
302276|NCT01860222|therapy (PLAT)|therapy (plat)
302277|NCT01860222|randomized controlled trials(RCTs)|randomized controlled trials(rcts)
302278|NCT01860209|obstructive sleep apnea|obstructive sleep apnea
302279|NCT01860209|overhydration|overhydration
302280|NCT01860209|end stage renal disease|end stage renal disease
302281|NCT01860209|intermittent ambulatory hemodialysis|intermittent ambulatory hemodialysis
302282|NCT01860209|polysomnography|polysomnography
302283|NCT01860209|bioimpedance|bioimpedance
302284|NCT01860209|leg fluid shift|leg fluid shift
302285|NCT01860209|neck circumference|neck circumference
302287|NCT01860183|chronic allograft dysfunction|chronic allograft dysfunction
302288|NCT01860183|mycophenolate mofetil|mycophenolate mofetil
302290|NCT01860170|Blood and Marrow Transplant (BMT)|blood and marrow transplant (bmt)
302291|NCT01860170|MRD|mrd
302292|NCT01860170|MUD|mud
302293|NCT01860170|GVHD|gvhd
302294|NCT01860157|rTMS|rtms
302295|NCT01860157|depression|depression
302296|NCT01860157|magnetic|magnetic
302297|NCT01860144|bevacizumab|bevacizumab
302298|NCT01860144|overall survival|overall survival
302299|NCT01860144|adverse events|adverse events
302300|NCT01860144|tumor resection rate|tumor resection rate
302301|NCT01860131|bariatrics, lifestyle and behavioral modification programs|bariatrics, lifestyle and behavioral modification programs
302302|NCT01860079|Early discharge|early discharge
302303|NCT01860079|STEMI|stemi
302304|NCT01860079|PPCI|ppci
302305|NCT01860066|COPD|copd
302306|NCT01860014|Pulmonary hemorrhage|pulmonary hemorrhage
302307|NCT01860014|Mortality|mortality
302308|NCT01860014|Newborn|newborn
302309|NCT01860001|cancer|cancer
302310|NCT01860001|metabolic acidosis|metabolic acidosis
302311|NCT01859988|Eczema|eczema
302312|NCT01859962|Liver diseases|liver diseases
302313|NCT01859962|Virus diseases|virus diseases
302314|NCT01859962|Ribavirin|ribavirin
302315|NCT01859962|protease inhibitor|protease inhibitor
302316|NCT01859962|NS5B polymerase inhibitor|ns5b polymerase inhibitor
302317|NCT01859962|NS5A inhibitor|ns5a inhibitor
302318|NCT01859949|Genotropin(somatropin)|genotropin(somatropin)
302319|NCT01859949|SGA|sga
302320|NCT01859949|Short Stature|short stature
302321|NCT01859949|Long-term|long-term
302322|NCT01859949|Safety|safety
302323|NCT01859923|Tuberculosis|tuberculosis
302324|NCT01859923|Tuberculosis, Multidrug-Resistant|tuberculosis, multidrug-resistant
302325|NCT01859923|Mycobacterium Infections|mycobacterium infections
302326|NCT01859923|Actinomycetales Infections|actinomycetales infections
302327|NCT01859923|Gram-Positive Infections|gram-positive infections
302328|NCT01859923|Bacterial Infections|bacterial infections
302329|NCT01859923|Pediatric|pediatric
302330|NCT01859884|Kidney transplantation|kidney transplantation
302331|NCT01859884|Increased risk donor kidneys|increased risk donor kidneys
302332|NCT01859884|Kidney donation|kidney donation
302333|NCT01859884|Organ donation|organ donation
302334|NCT01859884|Human Immunodeficiency Virus|human immunodeficiency virus
302335|NCT01859884|Hepatitis B|hepatitis b
302336|NCT01859884|Hepatitis C|hepatitis c
302337|NCT01859884|Infectious disease|infectious disease
302338|NCT01859884|Disease transmission|disease transmission
302339|NCT01859884|Centers for Disease Control (CDC)|centers for disease control (cdc)
302340|NCT01859884|Web-based intervention|web-based intervention
302341|NCT01859871|Living kidney donation|living kidney donation
302342|NCT01859871|End-stage renal disease|end-stage renal disease
302343|NCT01859871|Latinos|latinos
302344|NCT01859871|Undocumented Immigrants|undocumented immigrants
302345|NCT01859871|Bilingual|bilingual
302346|NCT01859871|Spanish|spanish
302347|NCT01859871|Website|website
302348|NCT01859871|Dialysis|dialysis
302349|NCT01859871|Hispanics|hispanics
302350|NCT01859871|Transplantation|transplantation
302351|NCT01859858|mCRC (metastatic colorectal cancer)|mcrc (metastatic colorectal cancer)
302352|NCT01859858|CRC (colorectal cancer)|crc (colorectal cancer)
302353|NCT01859858|Advanced colorectal cancer|advanced colorectal cancer
302354|NCT01859858|Metastatic colorectal cancer|metastatic colorectal cancer
302355|NCT01859858|Colon cancer|colon cancer
302356|NCT01859845|Melanoma|melanoma
302357|NCT01859845|Opportunistic surveillance|opportunistic surveillance
302358|NCT01859845|Melanoma simulation model|melanoma simulation model
302359|NCT01859845|Smartphone devices|smartphone devices
302360|NCT01859832|renal transplant|renal transplant
302361|NCT01859832|kidney transplantation|kidney transplantation
302362|NCT01859832|immune status|immune status
302363|NCT01859832|immunosuppressive medications|immunosuppressive medications
302364|NCT01859819|Pediatric|pediatric
302365|NCT01859819|Lymphoma (NOT primary mediastinal B-cell lymphoma)|lymphoma (not primary mediastinal b-cell lymphoma)
302366|NCT01859819|B-Cell---Burkitt's like|b-cell---burkitt's like
302367|NCT01859819|Rituximab|rituximab
302368|NCT01859819|Liposomal ARA-C|liposomal ara-c
302369|NCT01859806|periampullary tumour|periampullary tumour
302370|NCT01859806|isolated Roux loop PJ|isolated roux loop pj
302371|NCT01859806|PG|pg
302372|NCT01859793|dipeptidyl peptidase-4 inhibitor|dipeptidyl peptidase-4 inhibitor
302373|NCT01859793|endothelium, vascular|endothelium, vascular
302374|NCT01859793|diabetes type 2|diabetes type 2
302375|NCT01859793|nitric oxide|nitric oxide
302376|NCT01859793|inflammation|inflammation
302377|NCT01859780|Poison control|poison control
302378|NCT01859780|Child resistant packaging|child resistant packaging
302379|NCT01859780|prescription vials|prescription vials
302380|NCT01859780|prescription blisters|prescription blisters
302381|NCT01859780|drug packaging|drug packaging
302382|NCT01859767|Alzheimer's disease|alzheimer's disease
302383|NCT01859767|SPECT|spect
302384|NCT01859754|Primary Immune Deficiency Syndrome|primary immune deficiency syndrome
302385|NCT01859754|Primary immunodeficiency Disease (PIDD)|primary immunodeficiency disease (pidd)
302386|NCT01859754|PID|pid
302387|NCT01859741|Newly diagnosed Stage IV Small Cell Lung Cancer|newly diagnosed stage iv small cell lung cancer
302388|NCT01859728|biliary cancer|biliary cancer
302389|NCT01859728|irinotecan|irinotecan
302390|NCT01859728|cisplatin|cisplatin
302391|NCT01859728|gemcitabine|gemcitabine
302392|NCT01859715|Drug Interactions|drug interactions
302393|NCT01859715|CYP2D6|cyp2d6
302394|NCT01859715|opioid efficacy|opioid efficacy
302395|NCT01859715|pain|pain
302396|NCT01859715|nausea|nausea
302397|NCT01859702|Aqueous Humor|aqueous humor
302398|NCT01859702|Moxifloxacin|moxifloxacin
302399|NCT01859702|Vigadexa|vigadexa
302400|NCT01859663|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
302401|NCT01859663|Diet|diet
302402|NCT01859663|Exercise|exercise
302403|NCT01859663|Questionnaires|questionnaires
302404|NCT01859663|Health Beliefs|health beliefs
302405|NCT01859637|Filgrastim, immunogenicity, severe chronic neutropenia|filgrastim, immunogenicity, severe chronic neutropenia
302406|NCT01859624|LOPD|lopd
302407|NCT01859624|Pompe Disease|pompe disease
302408|NCT01859598|diabetes|diabetes
302409|NCT01859598|basal insulin|basal insulin
302410|NCT01859598|effectiveness and safety|effectiveness and safety
302411|NCT01859598|oral antidiabetic drugs|oral antidiabetic drugs
302412|NCT01859598|real world clinical practice|real world clinical practice
302413|NCT01859585|preemptive analgesia|preemptive analgesia
302414|NCT01859585|lumbar fusion|lumbar fusion
302415|NCT01859585|Parecoxib|parecoxib
302416|NCT01859585|Ketorolac|ketorolac
302417|NCT01859572|Stroke|stroke
302418|NCT01859572|Cerebral Infarction|cerebral infarction
302419|NCT01859572|Brain Disorders|brain disorders
302420|NCT01859572|Central Nervous System Diseases|central nervous system diseases
302421|NCT01859572|Nervous System Diseases|nervous system diseases
302422|NCT01859572|Vascular Diseases|vascular diseases
302423|NCT01859572|Cardiovascular Diseases|cardiovascular diseases
302424|NCT01859572|Brain Infarction|brain infarction
302425|NCT01859572|Brain Ischaemia|brain ischaemia
302426|NCT01859559|ultrasound|ultrasound
302427|NCT01859559|peripheral intravenous access|peripheral intravenous access
302428|NCT01859559|operator experience|operator experience
302429|NCT01859546|SMS|sms
302430|NCT01859520|Spermatozoa|spermatozoa
302431|NCT01859520|DNA fragmentation|dna fragmentation
302432|NCT01859520|Swim-up|swim-up
302433|NCT01859520|Density gradient|density gradient
302434|NCT01859507|Vaginismus|vaginismus
302435|NCT01859507|Botox|botox
302436|NCT01859507|Sex|sex
302437|NCT01859507|Clostridium|clostridium
302438|NCT01859507|Botulinum|botulinum
302439|NCT01859507|Neurotoxin|neurotoxin
302440|NCT01859507|Perineal|perineal
302441|NCT01859507|Muscles|muscles
302442|NCT01859455|Hypercholesterolemia,|hypercholesterolemia,
302443|NCT01859455|LDL cholesterol lowering,|ldl cholesterol lowering,
302444|NCT01859455|proprotein convertase subtilisin/kexin type 9 (PCSK9),|proprotein convertase subtilisin/kexin type 9 (pcsk9),
302445|NCT01859455|LGT209,|lgt209,
302446|NCT01859455|drug safety,|drug safety,
302447|NCT01859455|pharmacokinetics,|pharmacokinetics,
302448|NCT01859455|pharmacodynamics|pharmacodynamics
302449|NCT01859429|Cancer patients|cancer patients
302450|NCT01859429|Psycho-oncological Care Provision|psycho-oncological care provision
302451|NCT01859429|Structured Screening|structured screening
302452|NCT01859429|Stepped care|stepped care
302453|NCT01859403|veteran|veteran
302454|NCT01859403|obesity|obesity
302455|NCT01859403|personalized genomics|personalized genomics
302456|NCT01859390|Antioxidants|antioxidants
302457|NCT01859390|Vitamins|vitamins
302458|NCT01859390|Inflammation|inflammation
302459|NCT01859390|Oxidative stress|oxidative stress
302460|NCT01859364|Tobacco|tobacco
302461|NCT01859364|Smoking|smoking
302462|NCT01859364|Smoking Cessation|smoking cessation
302463|NCT01859364|Outcome|outcome
302464|NCT01859364|Nicotine Dependence|nicotine dependence
302465|NCT01859325|HIV-MAG pDNA Prime|hiv-mag pdna prime
302466|NCT01859325|HIV Therapy|hiv therapy
302467|NCT01859325|Therapeutic Vaccine|therapeutic vaccine
302468|NCT01859312|Glucocorticoids|glucocorticoids
302469|NCT01859312|Adrenal Insufficiency|adrenal insufficiency
302470|NCT01859312|Congenital Adrenal Hyperplasia (CAH)|congenital adrenal hyperplasia (cah)
302471|NCT01859312|Adrenal|adrenal
302472|NCT01859299|Oral Tolerance|oral tolerance
302473|NCT01859299|Uveitis|uveitis
302474|NCT01859299|AMD|amd
302475|NCT01859273|renal failure|renal failure
302476|NCT01859273|medication adherence|medication adherence
302477|NCT01859273|hypertension|hypertension
302478|NCT01859260|chronic kidney disease, acute kidney injury, obstructive sleep apnea|chronic kidney disease, acute kidney injury, obstructive sleep apnea
302479|NCT01859247|cervical dystonia|cervical dystonia
302480|NCT01859247|torticollis|torticollis
302481|NCT01859247|rTMS|rtms
302482|NCT01859234|multiple myeloma|multiple myeloma
302483|NCT01859234|PET scan|pet scan
302484|NCT01859221|Prostate cancer|prostate cancer
302485|NCT01859221|Oligometastatic prostate cancer|oligometastatic prostate cancer
302486|NCT01859221|Proton radiation|proton radiation
302487|NCT01859195|HIV/STI|hiv/sti
302488|NCT01859195|Prevention|prevention
302489|NCT01859195|Microbicides, Topical|microbicides, topical
302490|NCT01859169|bili duct neoplasms|bili duct neoplasms
302491|NCT01859169|bile duct cancer|bile duct cancer
302492|NCT01859169|photodynamic therapy|photodynamic therapy
302493|NCT01859169|biliary drainage|biliary drainage
302494|NCT01859156|Carbon Monoxide|carbon monoxide
302495|NCT01859156|Carboxyhemoglobin|carboxyhemoglobin
302496|NCT01859156|End-tidal carbon dioxide|end-tidal carbon dioxide
302497|NCT01859156|Capnography|capnography
302498|NCT01859143|Trivalent|trivalent
302499|NCT01859143|Influenza|influenza
302500|NCT01859143|FluMist Quadrivalent|flumist quadrivalent
302501|NCT01859143|Vaccine|vaccine
302502|NCT01859143|Prevention|prevention
302503|NCT01859143|Healthy|healthy
302504|NCT01859117|Peripheral arterial disease|peripheral arterial disease
302505|NCT01859117|diabetic foot|diabetic foot
302506|NCT01859091|Lipolysis|lipolysis
302507|NCT01859091|Cryolipolysis|cryolipolysis
302508|NCT01859091|Fat Reduction|fat reduction
302509|NCT01859065|Non-urgent ED visits|non-urgent ed visits
302510|NCT01859065|Neonates|neonates
302511|NCT01859065|Newborn care|newborn care
302512|NCT01859052|migraine|migraine
302513|NCT01859052|obesity|obesity
302514|NCT01859052|low fat diet|low fat diet
302515|NCT01859052|low carbohydrate diet|low carbohydrate diet
302516|NCT01859039|Egg allergy|egg allergy
302517|NCT01859039|Anaphylaxis|anaphylaxis
302518|NCT01859039|Children|children
302519|NCT01859039|Influenza vaccine|influenza vaccine
302520|NCT01859026|Epidermal growth factor receptor (EGFR)|epidermal growth factor receptor (egfr)
302521|NCT01859026|EGFR mutation|egfr mutation
302522|NCT01859026|Kirsten rat sarcoma 2 viral oncogene homolog(KRAS)|kirsten rat sarcoma 2 viral oncogene homolog(kras)
302523|NCT01859026|KRAS mutation|kras mutation
302524|NCT01859026|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
302525|NCT01859026|Advanced-stage IV|advanced-stage iv
302526|NCT01859000|Adolescents|adolescents
302527|NCT01859000|Hurricane Katrina|hurricane katrina
302528|NCT01859000|Family-based treatment|family-based treatment
302529|NCT01859000|Multidimensional Family Therapy|multidimensional family therapy
302530|NCT01859000|Group CBT|group cbt
302531|NCT01858974|multiplex PCR|multiplex pcr
302532|NCT01858974|MALDI-TOF|maldi-tof
302533|NCT01858974|pneumonia|pneumonia
302534|NCT01858974|microbiological investigation|microbiological investigation
302535|NCT01858974|intensive care|intensive care
302536|NCT01858948|Bipolar disorder|bipolar disorder
302537|NCT01858948|Second-generation antipsychotics|second-generation antipsychotics
302538|NCT01858948|Obesity|obesity
302539|NCT01858948|Cardiometabolic risk|cardiometabolic risk
302540|NCT01858922|Hodgkin's Lymphoma|hodgkin's lymphoma
302541|NCT01858922|ABVE-PC|abve-pc
302542|NCT01858922|doxorubicin|doxorubicin
302543|NCT01858922|bleomycin|bleomycin
302544|NCT01858922|vincristine|vincristine
302545|NCT01858922|etoposide|etoposide
302546|NCT01858922|prednisone|prednisone
302547|NCT01858922|cyclophosphamide|cyclophosphamide
302548|NCT01858922|DECA|deca
302549|NCT01858922|decadron|decadron
302550|NCT01858922|cisplatin|cisplatin
302551|NCT01858922|cytarabine|cytarabine
302552|NCT01858922|Radiation|radiation
302553|NCT01858909|Sepsis|sepsis
302554|NCT01858896|hypoglycemia|hypoglycemia
302555|NCT01858896|GLP-1|glp-1
302556|NCT01858896|Type 2 diabetes|type 2 diabetes
302557|NCT01858896|endothelial function|endothelial function
302558|NCT01858870|Lacosamide|lacosamide
302559|NCT01858870|Partial Crisis|partial crisis
302560|NCT01858857|geriatric psychiatry|geriatric psychiatry
302561|NCT01858857|pharmacovigilance|pharmacovigilance
302562|NCT01858818|CAIS Computer Assisted Infusion System|cais computer assisted infusion system
302563|NCT01858818|real life drinking behavior|real life drinking behavior
302564|NCT01858818|family history of alcoholism|family history of alcoholism
302565|NCT01858818|conditioning|conditioning
302566|NCT01858818|instrumental learning|instrumental learning
302567|NCT01858818|habitization|habitization
302568|NCT01858805|esophagus carcinoma|esophagus carcinoma
302569|NCT01858805|surgery|surgery
302570|NCT01858805|circulating tumor cells|circulating tumor cells
302571|NCT01858779|stroke|stroke
302572|NCT01858779|atrial fibrillation|atrial fibrillation
302573|NCT01858779|secondary prevention of stroke|secondary prevention of stroke
302574|NCT01858779|peripheral pulse measurement|peripheral pulse measurement
302575|NCT01858766|Hepatitis|hepatitis
302576|NCT01858766|HCV Genotype 1|hcv genotype 1
302577|NCT01858766|HCV Genotype 2|hcv genotype 2
302578|NCT01858766|HCV Genotype 3|hcv genotype 3
302579|NCT01858766|HCV Genotype 4|hcv genotype 4
302580|NCT01858766|HCV Genotype 5|hcv genotype 5
302581|NCT01858766|HCV Genotype 6|hcv genotype 6
302582|NCT01858766|treatment naive|treatment naive
302583|NCT01858753|burn scars|burn scars
302584|NCT01858753|restrictive|restrictive
302585|NCT01858753|contractures|contractures
302586|NCT01858753|autologous fibroblasts|autologous fibroblasts
302587|NCT01858727|forced-air|forced-air
302588|NCT01858727|hypothermia|hypothermia
302589|NCT01858727|TUR-P surgery|tur-p surgery
302590|NCT01858727|core temperatures|core temperatures
302591|NCT01858727|prewarming|prewarming
302592|NCT01858727|general anaesthesia|general anaesthesia
302593|NCT01858714|obesity|obesity
302594|NCT01858714|overweight|overweight
302595|NCT01858714|weight loss|weight loss
302596|NCT01858701|myopia|myopia
302597|NCT01858701|hyperopia|hyperopia
302598|NCT01858701|astigmatism|astigmatism
302599|NCT01858701|contact lenses|contact lenses
302600|NCT01858688|Prostate Cancer|prostate cancer
302601|NCT01858688|MRI|mri
302602|NCT01858688|Active surveillance in prostate cancer|active surveillance in prostate cancer
302603|NCT01858675|ProADM|proadm
302604|NCT01858675|ProANP|proanp
302605|NCT01858675|proendothelin|proendothelin
302606|NCT01858675|proAVP|proavp
302607|NCT01858675|Cr 51|cr 51
302608|NCT01858675|Volemia|volemia
302609|NCT01858675|fluid management|fluid management
302610|NCT01858675|ICU patients|icu patients
302611|NCT01858675|poly trauma patients|poly trauma patients
302612|NCT01858662|metastatic colorectal cancer|metastatic colorectal cancer
302613|NCT01858662|Liver|liver
302614|NCT01858662|cetuximab|cetuximab
302615|NCT01858662|Pathological response|pathological response
302616|NCT01858649|metastatic|metastatic
302617|NCT01858649|colorectal|colorectal
302618|NCT01858649|cancer|cancer
302619|NCT01858649|liver|liver
302620|NCT01858649|Bevacizumab|bevacizumab
302621|NCT01858649|Pathological response|pathological response
302622|NCT01858623|Healthy Normotensive Participants|healthy normotensive participants
302623|NCT01858623|Fixed dose combination|fixed dose combination
302624|NCT01858623|Pharmacokinetics|pharmacokinetics
302625|NCT01858623|Losartan|losartan
302626|NCT01858623|Hydrochlorothiazide|hydrochlorothiazide
302627|NCT01858610|Fixed dose combination|fixed dose combination
302628|NCT01858610|Pharmacokinetics|pharmacokinetics
302629|NCT01858610|Irbesartan|irbesartan
302630|NCT01858610|Hydrochlorothiazide|hydrochlorothiazide
302631|NCT01858610|Pharmacodynamics|pharmacodynamics
302632|NCT01858610|Normotensive Participants|normotensive participants
302633|NCT01858597|GDM, FGF|gdm, fgf
302634|NCT01858584|GER|ger
302635|NCT01858584|Alginate|alginate
302636|NCT01858584|Regurgitation|regurgitation
302637|NCT01858584|questionnaire|questionnaire
302638|NCT01858571|Childhood Cancer|childhood cancer
302639|NCT01858532|Diabetes|diabetes
302640|NCT01858532|Nephropathy|nephropathy
302641|NCT01858519|pancreatic enzyme replacement therapy|pancreatic enzyme replacement therapy
302642|NCT01858519|antibodies|antibodies
302643|NCT01858519|porcine viruses|porcine viruses
302644|NCT01858519|epidemiology|epidemiology
302645|NCT01858519|prospective|prospective
302646|NCT01858506|Type 2 diabetes mellitus|type 2 diabetes mellitus
302647|NCT01858506|Lifestyle counselling|lifestyle counselling
302648|NCT01858506|Lifestyle assessment|lifestyle assessment
302649|NCT01858506|Randomized controlled trial|randomized controlled trial
302650|NCT01858506|Diabetes education|diabetes education
302651|NCT01858493|Urinary incontinence|urinary incontinence
302652|NCT01858493|Falls|falls
302653|NCT01858493|Quality of life|quality of life
302654|NCT01858493|Stigma|stigma
302655|NCT01858493|Community-dwelling older women|community-dwelling older women
302656|NCT01858493|Continence promotion|continence promotion
302657|NCT01858480|CHF|chf
302658|NCT01858467|Airway, Cesarean|airway, cesarean
302659|NCT01858402|Pediatric spinal anesthesia, paracetamol, dipyrone|pediatric spinal anesthesia, paracetamol, dipyrone
302660|NCT01858389|Non-small cell lung cancer|non-small cell lung cancer
302661|NCT01858389|T790M mutation. dacomitinib|t790m mutation. dacomitinib
302662|NCT01858376|LDL cholesterol|ldl cholesterol
302663|NCT01858376|anti-hyperlipidemic|anti-hyperlipidemic
302664|NCT01858376|hyperlipidemic|hyperlipidemic
302665|NCT01858376|Capros|capros
302666|NCT01858376|Natural Supplement|natural supplement
302667|NCT01858363|Peripheral arterial disease|peripheral arterial disease
302668|NCT01858363|claudication|claudication
302669|NCT01858363|drug-coated balloon|drug-coated balloon
302670|NCT01858363|drug-eluting balloon|drug-eluting balloon
302671|NCT01858350|CAM|cam
302672|NCT01858350|Sedation|sedation
302673|NCT01858350|MRI|mri
302674|NCT01858350|Music Therapy|music therapy
302675|NCT01858337|weaning|weaning
302676|NCT01858337|infants|infants
302677|NCT01858337|vegetables|vegetables
302678|NCT01858337|repeated-exposure|repeated-exposure
302679|NCT01858324|Preeclampsia|preeclampsia
302680|NCT01858324|Hypertensive disorders of pregnancy|hypertensive disorders of pregnancy
302681|NCT01858324|Patient education|patient education
302682|NCT01858324|Educationnal tools|educationnal tools
302683|NCT01858324|Pamphlet|pamphlet
302684|NCT01858324|Video|video
302685|NCT01858324|Knowledge|knowledge
302686|NCT01858324|Anxiety|anxiety
302687|NCT01858324|Satisfaction|satisfaction
302688|NCT01858311|Stroke survivors|stroke survivors
302689|NCT01858311|TIA survivors|tia survivors
302690|NCT01858311|Vitamin E|vitamin e
302691|NCT01858311|Carotech|carotech
302692|NCT01858311|Tocotrienol|tocotrienol
302693|NCT01858298|Dental caries|dental caries
302694|NCT01858298|Quality of Life|quality of life
302695|NCT01858298|Pulpectomy|pulpectomy
302696|NCT01858298|Tooth extraction|tooth extraction
302697|NCT01858285|Epilepsy|epilepsy
302698|NCT01858285|Ohtahara|ohtahara
302699|NCT01858285|Dravet|dravet
302700|NCT01858285|MMPEI|mmpei
302701|NCT01858285|EMEE|emee
302702|NCT01858285|EIEE|eiee
302703|NCT01858246|Hearing Loss, Conductive|hearing loss, conductive
302704|NCT01858246|Bone Conduction|bone conduction
302705|NCT01858246|bone conduction thresholds better than 45 dBHL|bone conduction thresholds better than 45 dbhl
302706|NCT01858233|Gestational diabetes|gestational diabetes
302707|NCT01858220|Gastroparesis|gastroparesis
302708|NCT01858220|Small bowel video capsule|small bowel video capsule
302709|NCT01858220|gastric retention|gastric retention
302710|NCT01858207|HCC|hcc
302711|NCT01858207|hepatocellular carcinoma|hepatocellular carcinoma
302712|NCT01858207|liver cancer|liver cancer
302713|NCT01858194|Tachycardia, Renal Sympathetic Denervation|tachycardia, renal sympathetic denervation
302714|NCT01858194|Catheter Ablation|catheter ablation
302715|NCT01858194|Cardioverter-Defibrillator|cardioverter-defibrillator
302716|NCT01858142|Pediatric anesthesia|pediatric anesthesia
302717|NCT01858142|Pre-operative anxiety|pre-operative anxiety
302718|NCT01858142|parental presence|parental presence
302719|NCT01858142|children|children
302720|NCT01858142|elective surgical procedures|elective surgical procedures
302721|NCT01858142|mask induction|mask induction
302722|NCT01858129|TTN|ttn
302723|NCT01858103|Mucopolysaccharidosis IVA Type A|mucopolysaccharidosis iva type a
302724|NCT01858103|MPS IVA Type A|mps iva type a
302725|NCT01858103|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
302726|NCT01858103|MPS IVA|mps iva
302727|NCT01858103|Morquio A Syndrome|morquio a syndrome
302728|NCT01858103|Lysosomal Storage Disorder|lysosomal storage disorder
302729|NCT01858103|LSD|lsd
302730|NCT01858103|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
302731|NCT01858103|N-acetylgalactosamine-6-sulfate|n-acetylgalactosamine-6-sulfate
302732|NCT01858090|spinal anesthesia|spinal anesthesia
302733|NCT01858090|caesarean section|caesarean section
302734|NCT01858090|local anesthetics|local anesthetics
302735|NCT01858090|levobupivacaine|levobupivacaine
302736|NCT01858090|sufentanil|sufentanil
302737|NCT01858090|fentanyl|fentanyl
302738|NCT01858090|above 18 years of age|above 18 years of age
302739|NCT01858090|pregnant women|pregnant women
302740|NCT01858090|multiparous|multiparous
302741|NCT01858090|nulliparous|nulliparous
302742|NCT01858064|ADHD|adhd
302743|NCT01858064|OROS-MPH|oros-mph
302744|NCT01858064|Adults|adults
302745|NCT01858064|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
302746|NCT01858051|Vitamin D|vitamin d
302747|NCT01858051|Perioperative immune regulation|perioperative immune regulation
302748|NCT01858051|LL-37|ll-37
302749|NCT01858051|Hospital-acquired infection|hospital-acquired infection
302750|NCT01858051|Surgical site infections|surgical site infections
302751|NCT01858038|Scar|scar
302752|NCT01858012|insulin resistance|insulin resistance
302753|NCT01857999|Renin-aldosterone system|renin-aldosterone system
302754|NCT01857999|Hemodynamic|hemodynamic
302755|NCT01857999|Low cardiac output|low cardiac output
302756|NCT01857999|Vasodilation|vasodilation
302757|NCT01857999|Natriuretic peptide|natriuretic peptide
302758|NCT01857986|Endotracheal intubation|endotracheal intubation
302759|NCT01857986|Mechanical ventilation|mechanical ventilation
302760|NCT01857986|Critical care|critical care
302761|NCT01857973|HCL|hcl
302762|NCT01857973|Type 1 Diabetes|type 1 diabetes
302763|NCT01857973|Sensor|sensor
302764|NCT01857960|Acne|acne
302765|NCT01857960|Treatment|treatment
302766|NCT01857960|Cost|cost
302767|NCT01857960|Behavior|behavior
302768|NCT01857947|AECOPD Mr ProADM Biomarkers ER Outcome|aecopd mr proadm biomarkers er outcome
302769|NCT01857934|Anti-GD2 monoclonal antibody|anti-gd2 monoclonal antibody
302770|NCT01857934|hu14.18K322A|hu14.18k322a
302771|NCT01857934|High-risk neuroblastoma|high-risk neuroblastoma
302772|NCT01857934|Phase II|phase ii
302773|NCT01857934|Allogeneic NK cells|allogeneic nk cells
302774|NCT01857908|Adenocarcinoma|adenocarcinoma
302775|NCT01857908|Abiraterone|abiraterone
302776|NCT01857908|Abiraterone Acetate|abiraterone acetate
302777|NCT01857908|Zytiga|zytiga
302778|NCT01857908|Correlative study|correlative study
302779|NCT01857908|Castrate Resistant Prostate Cancer|castrate resistant prostate cancer
302780|NCT01857908|Abiraterone Correlative study|abiraterone correlative study
302781|NCT01857895|Nausea|nausea
302782|NCT01857895|subcutaneous infusion|subcutaneous infusion
302783|NCT01857895|exenatide|exenatide
302784|NCT01857882|breast cancer|breast cancer
302785|NCT01857882|breast reconstruction|breast reconstruction
302786|NCT01857882|shared decision making|shared decision making
302787|NCT01857882|decision support intervention|decision support intervention
302788|NCT01857869|Efficacy|efficacy
302789|NCT01857869|Sporozoite challenge model|sporozoite challenge model
302790|NCT01857869|Malaria|malaria
302791|NCT01857869|Immunogenicity|immunogenicity
302792|NCT01857869|Malaria- naïve adults|malaria- naïve adults
302793|NCT01857869|Safety|safety
302794|NCT01857856|Phospholamban|phospholamban
302795|NCT01857856|cardiomyopathy|cardiomyopathy
302796|NCT01857856|Eplerenone|eplerenone
302797|NCT01857856|presymptomatic|presymptomatic
302798|NCT01857830|Telomerase|telomerase
302799|NCT01857830|Telomere Length|telomere length
302800|NCT01857830|Psychological Stress|psychological stress
302801|NCT01857830|Amyloid beta proteins|amyloid beta proteins
302802|NCT01857830|Meditation|meditation
302803|NCT01857804|peri-implantitis|peri-implantitis
302804|NCT01857804|surgical therapy|surgical therapy
302805|NCT01857804|systemic antibiotics|systemic antibiotics
302806|NCT01857804|local antiseptics|local antiseptics
302807|NCT01857778|Breastfeeding|breastfeeding
302808|NCT01857778|Breast tissue|breast tissue
302809|NCT01857778|Breast pump|breast pump
302810|NCT01857765|rehabilitation|rehabilitation
302811|NCT01857765|reconstructive surgery|reconstructive surgery
302812|NCT01857752|Retinoblastoma|retinoblastoma
302813|NCT01857726|hepatocellular carcinoma|hepatocellular carcinoma
302814|NCT01857726|portal vein invasion|portal vein invasion
302815|NCT01857726|transarterial chemoembolization|transarterial chemoembolization
302816|NCT01857726|transarterial chemoinfusion|transarterial chemoinfusion
302817|NCT01857674|Laryngeal edema|laryngeal edema
302818|NCT01857674|Post-extubation|post-extubation
302819|NCT01857674|Acute respiratory distress|acute respiratory distress
302820|NCT01857674|Ultrasonography|ultrasonography
302821|NCT01857674|Intensive care unit|intensive care unit
302822|NCT01857661|tinnitus|tinnitus
302823|NCT01857661|hearing loss|hearing loss
302824|NCT01857661|hearing devices|hearing devices
302825|NCT01857648|Physical Activity|physical activity
302826|NCT01857648|Health Promotion|health promotion
302827|NCT01857648|Primary Health Care|primary health care
302828|NCT01857648|Intervention Studies|intervention studies
302829|NCT01857648|Public health Practice|public health practice
302830|NCT01857635|Acute respiratory failure|acute respiratory failure
302831|NCT01857635|Hypercapnia|hypercapnia
302832|NCT01857635|Non invasive ventilation|non invasive ventilation
302833|NCT01857635|Transcutaneous CO2 measurement|transcutaneous co2 measurement
302834|NCT01857622|anticoagulant|anticoagulant
302835|NCT01857622|DU-176b|du-176b
302836|NCT01857622|edoxaban|edoxaban
302837|NCT01857622|factor Xa|factor xa
302838|NCT01857622|oral|oral
302839|NCT01857622|atrial fibrillation|atrial fibrillation
302840|NCT01857622|severe renal impairment|severe renal impairment
302841|NCT01857609|Metformin|metformin
302842|NCT01857609|Proton pump inhibitor|proton pump inhibitor
302843|NCT01857609|Drug interaction|drug interaction
302844|NCT01857596|Female Sexual Dysfunction|female sexual dysfunction
302845|NCT01857596|Hypoactive Sexual Desire Disorder|hypoactive sexual desire disorder
302846|NCT01857596|Sexual Interest/Arousal Disorder|sexual interest/arousal disorder
302847|NCT01857596|Lorexys|lorexys
302848|NCT01857596|Premenopausal female health|premenopausal female health
302849|NCT01857583|anticoagulant|anticoagulant
302850|NCT01857583|DU-176b|du-176b
302851|NCT01857583|edoxaban|edoxaban
302852|NCT01857583|factor Xa|factor xa
302853|NCT01857583|oral|oral
302854|NCT01857583|orthopedic surgery of lower limbs|orthopedic surgery of lower limbs
302855|NCT01857583|severe renal impairment|severe renal impairment
302856|NCT01857570|Radius fracture|radius fracture
302857|NCT01857570|Scaphoid fracture|scaphoid fracture
302858|NCT01857570|Tomography, x-ray computed|tomography, x-ray computed
302859|NCT01857557|Exercise|exercise
302860|NCT01857557|Fitness program|fitness program
302861|NCT01857544|Retinal Vein Occlusion|retinal vein occlusion
302862|NCT01857544|Central Retinal Vein Occlusion|central retinal vein occlusion
302863|NCT01857544|Macular Edema|macular edema
302864|NCT01857531|Smoking Cessation|smoking cessation
302865|NCT01857531|Quit Smoking|quit smoking
302866|NCT01857531|Ganaxolone|ganaxolone
302867|NCT01857531|Nicotine Patch|nicotine patch
302868|NCT01857505|Total Hip replacement|total hip replacement
302869|NCT01857505|Fracture table|fracture table
302870|NCT01857505|DePuySynthes|depuysynthes
302871|NCT01857505|Direct anterior approach hip replacement|direct anterior approach hip replacement
302872|NCT01857505|Posterior approach hip replacement|posterior approach hip replacement
302873|NCT01857492|abdominal pain|abdominal pain
302874|NCT01857492|pancreatitis|pancreatitis
302875|NCT01857492|chronic abdominal pain|chronic abdominal pain
302876|NCT01857492|visceral pain|visceral pain
302877|NCT01857492|meditation|meditation
302878|NCT01857492|tDCS|tdcs
302879|NCT01857492|noninvasive brain stimulation|noninvasive brain stimulation
302880|NCT01857492|EEG|eeg
302881|NCT01857492|Kirtan Kriya|kirtan kriya
302882|NCT01857479|ABPA|abpa
302883|NCT01857453|Adult Patients Medulloblatoma Standard risk group Chemotherapy Radiotherapy Quality of Life|adult patients medulloblatoma standard risk group chemotherapy radiotherapy quality of life
302884|NCT01857440|Glaucoma|glaucoma
302885|NCT01857440|Pupil|pupil
302886|NCT01857440|Melanopsin|melanopsin
302887|NCT01857414|ST-elevation myocardial infarction|st-elevation myocardial infarction
302888|NCT01857414|Remote Ischaemic Conditioning|remote ischaemic conditioning
302889|NCT01857414|Myocardial Reperfusion Injury|myocardial reperfusion injury
302890|NCT01857414|Cardiovascular mortality|cardiovascular mortality
302891|NCT01857388|school-based program, mental health, implementation|school-based program, mental health, implementation
302892|NCT01857375|Diabetes - insulin administration|diabetes - insulin administration
302893|NCT01857362|Orfadin|orfadin
302894|NCT01857362|Nitisinone|nitisinone
302895|NCT01857362|Bioequivalence|bioequivalence
302896|NCT01857349|Efficacy|efficacy
302897|NCT01857349|surgical scrubs|surgical scrubs
302898|NCT01857349|Total Knee Arthroplasty|total knee arthroplasty
302899|NCT01857323|asthma|asthma
302900|NCT01857323|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
302901|NCT01857323|COPD|copd
302902|NCT01857323|Albuterol Spiromax®|albuterol spiromax®
302903|NCT01857310|Folic Acid|folic acid
302904|NCT01857310|Zinc|zinc
302905|NCT01857310|Semen|semen
302906|NCT01857310|In vitro fertilization|in vitro fertilization
302907|NCT01857310|Assisted reproductive technology|assisted reproductive technology
302908|NCT01857310|Ovulation induction|ovulation induction
302909|NCT01857310|Intrauterine insemination|intrauterine insemination
302910|NCT01857310|Pregnancy|pregnancy
302911|NCT01857310|Live Birth|live birth
302912|NCT01857310|Abortion, spontaneous|abortion, spontaneous
302913|NCT01857284|Tauroursodeoxycholic Acid|tauroursodeoxycholic acid
302914|NCT01857284|Primary Biliary Cirrhosis|primary biliary cirrhosis
302915|NCT01857284|Safety|safety
302916|NCT01857284|Efficacy|efficacy
302917|NCT01857258|green tea|green tea
302918|NCT01857258|catechins|catechins
302919|NCT01857258|vascular endothelial function|vascular endothelial function
302920|NCT01857258|postprandial hyperglycemia|postprandial hyperglycemia
302921|NCT01857258|oxidative stress|oxidative stress
302922|NCT01857245|addiction|addiction
302923|NCT01857245|Adherence (attribute)|adherence (attribute)
302924|NCT01857245|Adverse effects|adverse effects
302925|NCT01857245|Agonist|agonist
302926|NCT01857245|Antiviral Agents|antiviral agents
302928|NCT01857245|base|base
302929|NCT01857245|care delivery|care delivery
302930|NCT01857245|Caring|caring
302931|NCT01857245|Chronic Hepatitis C|chronic hepatitis c
302932|NCT01857245|Clinic|clinic
302933|NCT01857245|Clinical Trials|clinical trials
302934|NCT01857245|Complex|complex
302935|NCT01857245|Computer Simulation|computer simulation
302936|NCT01857245|cost|cost
302937|NCT01857245|cost effective|cost effective
302938|NCT01857245|cost effectiveness|cost effectiveness
302939|NCT01857245|Data|data
302940|NCT01857245|Development|development
302941|NCT01857245|Directly Observed Therapy|directly observed therapy
302942|NCT01857245|Disease|disease
302943|NCT01857245|Dose|dose
302944|NCT01857245|Drug resistance|drug resistance
302945|NCT01857245|drug resistant virus|drug resistant virus
302946|NCT01857245|Educational aspects|educational aspects
302947|NCT01857245|Epidemic|epidemic
302948|NCT01857245|experience|experience
302949|NCT01857245|Frequencies (time pattern)|frequencies (time pattern)
302950|NCT01857245|Fright|fright
302951|NCT01857245|Genotype|genotype
302952|NCT01857245|Group Therapy|group therapy
302953|NCT01857245|Health Care Costs|health care costs
302954|NCT01857245|Health Personnel|health personnel
302955|NCT01857245|Healthcare Systems|healthcare systems
302956|NCT01857245|Hepatitis C|hepatitis c
302957|NCT01857245|Hepatitis C Prevalence|hepatitis c prevalence
302958|NCT01857245|Hepatitis C Transmission|hepatitis c transmission
302959|NCT01857245|Hepatitis C virus|hepatitis c virus
302960|NCT01857245|HIV|hiv
302961|NCT01857245|Homelessness|homelessness
302962|NCT01857245|improved|improved
302963|NCT01857245|Incidence|incidence
302964|NCT01857245|Infection|infection
302965|NCT01857245|Injecting drug user|injecting drug user
302966|NCT01857245|Injection of therapeutic agent|injection of therapeutic agent
302967|NCT01857245|Intensive Care|intensive care
302968|NCT01857245|Interferons|interferons
302969|NCT01857245|Intervention|intervention
302970|NCT01857245|Knowledge|knowledge
302971|NCT01857245|Life|life
302972|NCT01857245|Liver diseases|liver diseases
302973|NCT01857245|Liver Failure|liver failure
302974|NCT01857245|liver transplantation|liver transplantation
302975|NCT01857245|Living Costs|living costs
302976|NCT01857245|Mental disorders|mental disorders
302977|NCT01857245|Methadone|methadone
302978|NCT01857245|methadone clinic/center|methadone clinic/center
302979|NCT01857245|Modeling|modeling
302980|NCT01857245|Mortality Vital Statistics|mortality vital statistics
302981|NCT01857245|Motivation|motivation
302982|NCT01857245|multidisciplinary|multidisciplinary
302983|NCT01857245|Opiates|opiates
302984|NCT01857245|Oral|oral
302985|NCT01857245|Outcome|outcome
302986|NCT01857245|Patients|patients
302987|NCT01857245|Persons|persons
302988|NCT01857245|Pharmaceutical Preparations|pharmaceutical preparations
302989|NCT01857245|Physicians|physicians
302990|NCT01857245|pill (pharmacologic)|pill (pharmacologic)
302991|NCT01857245|Play|play
302992|NCT01857245|Poverty|poverty
302993|NCT01857245|Primary Health Care|primary health care
302994|NCT01857245|programs|programs
302995|NCT01857245|Psychiatric therapeutic procedure|psychiatric therapeutic procedure
302996|NCT01857245|psychosocial|psychosocial
302997|NCT01857245|Publishing|publishing
302998|NCT01857245|Quality-Adjusted Life Years|quality-adjusted life years
302999|NCT01857245|Randomized|randomized
303000|NCT01857245|Randomized Controlled Trials|randomized controlled trials
303001|NCT01857245|randomized trial|randomized trial
303002|NCT01857245|Recruitment Activity|recruitment activity
303003|NCT01857245|Regimen|regimen
303004|NCT01857245|Resistance|resistance
303005|NCT01857245|Resistance development|resistance development
303006|NCT01857245|response|response
303007|NCT01857245|Risk|risk
303008|NCT01857245|risk perception|risk perception
303009|NCT01857245|Role|role
303010|NCT01857245|Site|site
303011|NCT01857245|skills|skills
303012|NCT01857245|Social support|social support
303013|NCT01857245|standard care|standard care
303014|NCT01857245|substance abuse treatment|substance abuse treatment
303015|NCT01857245|success|success
303016|NCT01857245|Time|time
303017|NCT01857245|Treatment outcome|treatment outcome
303018|NCT01857245|Treatment Protocols|treatment protocols
303019|NCT01857245|treatment site|treatment site
303020|NCT01857245|Trust|trust
303021|NCT01857245|United States|united states
303022|NCT01857245|Viral|viral
303023|NCT01857245|Virus|virus
303024|NCT01857219|fMRI|fmri
303025|NCT01857206|Influenza|influenza
303026|NCT01857206|children and adolescents|children and adolescents
303027|NCT01857206|trivalent vaccine|trivalent vaccine
303028|NCT01857206|cell culture|cell culture
303029|NCT01857206|embryonated chicken eggs|embryonated chicken eggs
303030|NCT01857193|Open label; dose escalation; ER+; LEE011; CDK4/6; everolimus; advanced breast cancer; mTOR; HR positive; HER2 negative|open label; dose escalation; er+; lee011; cdk4/6; everolimus; advanced breast cancer; mtor; hr positive; her2 negative
303031|NCT01857167|omega-3 fatty acids|omega-3 fatty acids
303032|NCT01857167|randomized controlled trial|randomized controlled trial
303033|NCT01857154|Bone mineral density|bone mineral density
303034|NCT01857154|Bone mineral content|bone mineral content
303035|NCT01857154|Bone density|bone density
303036|NCT01857154|Bone health|bone health
303037|NCT01857154|Dual-energy x-ray absorptiometry|dual-energy x-ray absorptiometry
303038|NCT01857141|dexmedetomidine|dexmedetomidine
303039|NCT01857141|heart rate variability|heart rate variability
303040|NCT01857141|preemptive epidural|preemptive epidural
303041|NCT01857141|gastrectomy|gastrectomy
303042|NCT01857115|Multiple myeloma|multiple myeloma
303043|NCT01857115|Diagnosis|diagnosis
303044|NCT01857115|Weekly|weekly
303045|NCT01857115|CCyd|ccyd
303046|NCT01857089|Pressure Ulcer|pressure ulcer
303047|NCT01857089|prevention|prevention
303048|NCT01857076|Type 2 Diabetes mellitus|type 2 diabetes mellitus
303049|NCT01857076|Grade I obesity|grade i obesity
303050|NCT01857076|Inadequate glycemic control|inadequate glycemic control
303051|NCT01857011|Anemia, Iron-Deficiency|anemia, iron-deficiency
303052|NCT01857011|bariatric surgery|bariatric surgery
303053|NCT01857011|abdominoplasty|abdominoplasty
303054|NCT01857011|surgery, plastic|surgery, plastic
303055|NCT01857011|iron|iron
303056|NCT01856998|Therapeutic Equivalence|therapeutic equivalence
303057|NCT01856998|Propofol|propofol
303058|NCT01856985|Medical abortion|medical abortion
303059|NCT01856985|Misoprostol|misoprostol
303060|NCT01856985|Mifepristone|mifepristone
303061|NCT01856972|Limited Dorsiflexion Range of Motion|limited dorsiflexion range of motion
303062|NCT01856972|Gastrocnemius tightness|gastrocnemius tightness
303063|NCT01856972|Soleus tightness|soleus tightness
303064|NCT01856959|magnesium sulfate|magnesium sulfate
303065|NCT01856959|nebulized|nebulized
303066|NCT01856959|lung function|lung function
303067|NCT01856933|GBM|gbm
303068|NCT01856933|Glioblastoma Multiforme|glioblastoma multiforme
303069|NCT01856933|Gliosarcoma|gliosarcoma
303070|NCT01856920|Calcitonin|calcitonin
303071|NCT01856920|T-cells|t-cells
303072|NCT01856920|Immune Response|immune response
303073|NCT01856920|HLA Patients|hla patients
303074|NCT01856920|Vaccine|vaccine
303075|NCT01856907|prediabetes|prediabetes
303076|NCT01856907|impaired fasting/impaired glucose tolerance|impaired fasting/impaired glucose tolerance
303077|NCT01856907|post gestational diabetes|post gestational diabetes
303078|NCT01856907|diabetes prevention|diabetes prevention
303079|NCT01856894|polycystic ovary syndrome|polycystic ovary syndrome
303080|NCT01856894|Anti-Mullerian Hormone|anti-mullerian hormone
303081|NCT01856894|obesity|obesity
303082|NCT01856881|Type 2 diabetes|type 2 diabetes
303083|NCT01856868|BMD|bmd
303084|NCT01856868|Becker muscular dystrophy|becker muscular dystrophy
303085|NCT01856868|epicatechin|epicatechin
303086|NCT01856868|clinical trial|clinical trial
303087|NCT01856868|neuromuscular disease|neuromuscular disease
303088|NCT01856855|Prostate Cancer|prostate cancer
303089|NCT01856855|Prostate Adenocarcinoma|prostate adenocarcinoma
303090|NCT01856855|Radiation|radiation
303091|NCT01856855|SBRT|sbrt
303092|NCT01856855|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
303093|NCT01856842|Pulmonary Arteriovenous Malformations|pulmonary arteriovenous malformations
303094|NCT01856842|Hereditary Hemorrhagic Telangiectasia (HHT)|hereditary hemorrhagic telangiectasia (hht)
303095|NCT01856842|Embolization|embolization
303096|NCT01856842|reperfusion rates|reperfusion rates
303097|NCT01856777|Medical Abortion|medical abortion
303098|NCT01856777|Pregnancy Test|pregnancy test
303099|NCT01856777|continuing pregnancy|continuing pregnancy
303100|NCT01856764|Atopic dermatitis|atopic dermatitis
303101|NCT01856751|Haemophilia|haemophilia
303102|NCT01856751|TGA|tga
303103|NCT01856751|TEM|tem
303104|NCT01856738|Parkinson's disease|parkinson's disease
303105|NCT01856738|Visual hallucinations|visual hallucinations
303106|NCT01856738|Rivastigmine|rivastigmine
303107|NCT01856738|Cholinesterase inhibitor|cholinesterase inhibitor
303108|NCT01856738|Randomized controlled trial|randomized controlled trial
303109|NCT01856738|Cost-effectiveness analysis|cost-effectiveness analysis
303110|NCT01856712|alcohol|alcohol
303111|NCT01856712|veterans|veterans
303112|NCT01856699|supratentorial superficial siderosis|supratentorial superficial siderosis
303113|NCT01856699|intracerebral hemorrhage|intracerebral hemorrhage
303114|NCT01856699|cerebral amyloid angiopathy|cerebral amyloid angiopathy
303115|NCT01856686|ADD|add
303116|NCT01856686|ADHD|adhd
303117|NCT01856686|Proteins|proteins
303118|NCT01856686|Dietary|dietary
303119|NCT01856686|Nutrition|nutrition
303120|NCT01856686|QEEG|qeeg
303121|NCT01856686|ERP|erp
303122|NCT01856686|ICA|ica
303123|NCT01856673|Mental Health|mental health
303124|NCT01856673|Displacement|displacement
303125|NCT01856673|Torture|torture
303126|NCT01856673|Violence|violence
303127|NCT01856673|Post-Traumatic Stress Disorder|post-traumatic stress disorder
303128|NCT01856673|Depression|depression
303129|NCT01856673|Anxiety|anxiety
303130|NCT01856673|Community-based intervention|community-based intervention
303131|NCT01856673|Prevention trial|prevention trial
303132|NCT01856673|Disabled Persons|disabled persons
303133|NCT01856660|Obesity|obesity
303134|NCT01856660|Weight Loss|weight loss
303135|NCT01856660|Body Weight Change|body weight change
303136|NCT01856660|Taste|taste
303137|NCT01856660|Taste Phenotype|taste phenotype
303138|NCT01856660|Lifestyle Intervention|lifestyle intervention
303139|NCT01856647|Psoriasis|psoriasis
303140|NCT01856647|Obesity|obesity
303141|NCT01856634|Tuberculosis|tuberculosis
303142|NCT01856634|Tuberculosis, Multidrug-Resistant|tuberculosis, multidrug-resistant
303143|NCT01856634|Mycobacterium Infections|mycobacterium infections
303144|NCT01856634|Actinomycetales Infections|actinomycetales infections
303145|NCT01856634|Gram-Positive Infections|gram-positive infections
303146|NCT01856634|Bacterial Infections|bacterial infections
303147|NCT01856634|Pediatric|pediatric
303148|NCT01856582|Primary Immunodeficiency Disease(s)|primary immunodeficiency disease(s)
303149|NCT01856582|Mixed Donor Chimerism|mixed donor chimerism
303150|NCT01856582|bone marrow failure syndromes|bone marrow failure syndromes
303151|NCT01856582|allogeneic hematopoietic stem cell transplant (HSCT)|allogeneic hematopoietic stem cell transplant (hsct)
303152|NCT01856582|children|children
303153|NCT01856556|safety|safety
303154|NCT01856556|tolerability|tolerability
303155|NCT01856556|pharmacokinetics|pharmacokinetics
303156|NCT01856543|Breast cancer|breast cancer
303157|NCT01856543|Status post mastectomy|status post mastectomy
303158|NCT01856543|plan to receive PMRT|plan to receive pmrt
303159|NCT01856543|Topical|topical
303160|NCT01856543|steroid cream|steroid cream
303161|NCT01856543|emollient skin care|emollient skin care
303162|NCT01856543|Eucerin|eucerin
303163|NCT01856543|Mometasone Furoate 0.1%|mometasone furoate 0.1%
303164|NCT01856517|pressor response|pressor response
303165|NCT01856517|chronotropic response|chronotropic response
303166|NCT01856504|Heart Disease|heart disease
303167|NCT01856504|Coronary Artery Disease|coronary artery disease
303168|NCT01856504|Coronary Arteriosclerosis|coronary arteriosclerosis
303169|NCT01856491|RELIANCE 4-FRONT|reliance 4-front
303170|NCT01856491|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
303420|NCT01855282|Overweight,|overweight,
303171|NCT01856491|Cardiac Resynchronization Therapy - Defibrillator (CRT-D)|cardiac resynchronization therapy - defibrillator (crt-d)
303172|NCT01856465|Bariatric surgery|bariatric surgery
303173|NCT01856465|NAFLD|nafld
303174|NCT01856465|Steatohepatitis|steatohepatitis
303175|NCT01856465|Simple Steatosis|simple steatosis
303176|NCT01856465|Intestinal Microbiota|intestinal microbiota
303177|NCT01856452|Sentinel lymph node|sentinel lymph node
303178|NCT01856452|multimodal|multimodal
303179|NCT01856452|breast cancer|breast cancer
303180|NCT01856439|ProSavin|prosavin
303181|NCT01856439|Gene therapy|gene therapy
303182|NCT01856426|Hepatitis C infected subjects|hepatitis c infected subjects
303183|NCT01856413|Prevention|prevention
303184|NCT01856413|Hepatitis B virus re-infection|hepatitis b virus re-infection
303185|NCT01856413|HBV-DNA negative|hbv-dna negative
303186|NCT01856413|Liver transplantation|liver transplantation
303187|NCT01856400|ventricular arrythmias|ventricular arrythmias
303188|NCT01856400|SERCA2a|serca2a
303189|NCT01856400|Chronic Kidney Disease|chronic kidney disease
303190|NCT01856400|microvolt T wave alternans|microvolt t wave alternans
303191|NCT01856387|preeclampsia|preeclampsia
303192|NCT01856387|eclampsia|eclampsia
303193|NCT01856387|prediction|prediction
303194|NCT01856387|neutrophil-to Lymphocyte ratio|neutrophil-to lymphocyte ratio
303195|NCT01856361|Male infertility|male infertility
303196|NCT01856361|Low sperm count|low sperm count
303197|NCT01856361|Poor sperm motility|poor sperm motility
303198|NCT01856361|Poor Sperm shape and morphology|poor sperm shape and morphology
303199|NCT01856335|Seizures|seizures
303200|NCT01856335|Epilepsy|epilepsy
303201|NCT01856322|Colorectal Cancer|colorectal cancer
303202|NCT01856322|Liver Metastasis|liver metastasis
303203|NCT01856322|Sulindac|sulindac
303204|NCT01856309|Rheumatoid Arthritis|rheumatoid arthritis
303205|NCT01856309|Sirukumab|sirukumab
303206|NCT01856309|CNTO 136|cnto 136
303207|NCT01856309|CNTO136ARA3002|cnto136ara3002
303208|NCT01856309|SIRROUND-D|sirround-d
303209|NCT01856309|CNTO136ARA3003|cnto136ara3003
303210|NCT01856309|SIRROUND-T|sirround-t
303211|NCT01856309|SIRROUND-LTE|sirround-lte
303212|NCT01856270|Traumatic brain injury|traumatic brain injury
303213|NCT01856270|Post-traumatic headache|post-traumatic headache
303214|NCT01856270|Drug therapy|drug therapy
303215|NCT01856257|Kidney Transplantation|kidney transplantation
303316|NCT01855802|Greece|greece
303216|NCT01856257|Transplantation|transplantation
303217|NCT01856257|NULOJIX|nulojix
303218|NCT01856257|belatacept|belatacept
303219|NCT01856257|chronic immunosuppression|chronic immunosuppression
303220|NCT01856244|Parkinson's Disease|parkinson's disease
303221|NCT01856244|treadmill training|treadmill training
303222|NCT01856244|gait|gait
303223|NCT01856244|balance|balance
303224|NCT01856244|mobility|mobility
303225|NCT01856231|COPD|copd
303226|NCT01856231|Physical activity|physical activity
303227|NCT01856218|Mucopolysaccharidosis type 7, MPS 7, Sly syndrome, enzyme replacement therapy, rare disease, lysosomal storage disease, metabolic disorder|mucopolysaccharidosis type 7, mps 7, sly syndrome, enzyme replacement therapy, rare disease, lysosomal storage disease, metabolic disorder
303228|NCT01856205|Japanese Encephalitis, Randomized Controlled Trial, intravenous immunoglobulin, safety, efficacy, Nepal|japanese encephalitis, randomized controlled trial, intravenous immunoglobulin, safety, efficacy, nepal
303229|NCT01856179|Conversion of ALA and SDA|conversion of ala and sda
303230|NCT01856179|Metabolism of n-3 fatty acids|metabolism of n-3 fatty acids
303231|NCT01856166|Nulliparous|nulliparous
303232|NCT01856166|Singleton|singleton
303233|NCT01856166|delivery|delivery
303234|NCT01856166|pregnancy|pregnancy
303235|NCT01856153|Bioavailability|bioavailability
303236|NCT01856153|Strawberry polyphenols|strawberry polyphenols
303237|NCT01856153|Time Influence|time influence
303238|NCT01856140|adipose derived mesenchymal stem cell|adipose derived mesenchymal stem cell
303239|NCT01856140|allogeneic stem cell|allogeneic stem cell
303240|NCT01856127|Sexual Dysfunction|sexual dysfunction
303241|NCT01856127|Antidepressant|antidepressant
303242|NCT01856127|Major Depressant|major depressant
303243|NCT01856127|SSRI|ssri
303244|NCT01856127|SNRI|snri
303245|NCT01856127|Vilazodone|vilazodone
303246|NCT01856127|Sertraline|sertraline
303247|NCT01856114|Advanced Cancers|advanced cancers
303248|NCT01856114|Cancer with evidence of active disease|cancer with evidence of active disease
303249|NCT01856114|Exercise induced breakthrough dyspnea|exercise induced breakthrough dyspnea
303250|NCT01856114|Shortness of breath|shortness of breath
303251|NCT01856114|Fentanyl Buccal Tablets|fentanyl buccal tablets
303253|NCT01856114|Placebo|placebo
303254|NCT01856114|Walk tests|walk tests
303255|NCT01856114|Questionnaires|questionnaires
303256|NCT01856114|Surveys|surveys
303257|NCT01856101|TCC|tcc
303258|NCT01856101|Failure of platinum based chemotherapy|failure of platinum based chemotherapy
303259|NCT01856088|Coronary artery|coronary artery
303260|NCT01856088|Drug eluting stent|drug eluting stent
303261|NCT01856088|thrombosis|thrombosis
303262|NCT01856075|Atrial Fibrillation|atrial fibrillation
303263|NCT01856075|Dronedarone|dronedarone
303264|NCT01856075|Cohort|cohort
303265|NCT01856075|Effectiveness|effectiveness
303266|NCT01856062|ovulation induction|ovulation induction
303267|NCT01856062|dexamethasone|dexamethasone
303268|NCT01856049|HLHS|hlhs
303269|NCT01856049|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
303270|NCT01856049|UCB (umbilical cord blood)|ucb (umbilical cord blood)
303271|NCT01856049|Umbilical cord blood|umbilical cord blood
303272|NCT01856049|Cord blood|cord blood
303273|NCT01856049|Cardiac regeneration|cardiac regeneration
303274|NCT01856036|Ductal Histology|ductal histology
303275|NCT01856036|Unifocal|unifocal
303276|NCT01856036|Estrogen Receptor Positive|estrogen receptor positive
303277|NCT01856036|her2neu negative|her2neu negative
303278|NCT01856023|melanoma|melanoma
303279|NCT01856023|metastatic|metastatic
303280|NCT01856023|skin cancer|skin cancer
303281|NCT01856023|Stage IV|stage iv
303282|NCT01856023|interleukin-2|interleukin-2
303283|NCT01856010|Dementia|dementia
303284|NCT01856010|Aggression|aggression
303285|NCT01856010|Agitation|agitation
303286|NCT01855984|ADHD|adhd
303287|NCT01855984|Children|children
303288|NCT01855984|Tocotrienol|tocotrienol
303289|NCT01855958|Osteoarthritis|osteoarthritis
303290|NCT01855958|Electro acupuncture|electro acupuncture
303291|NCT01855958|Deep intramuscular stimulation|deep intramuscular stimulation
303292|NCT01855958|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
303293|NCT01855958|Pain pressure threshold|pain pressure threshold
303294|NCT01855958|Conditioned pain modulation|conditioned pain modulation
303295|NCT01855958|Clinical trial|clinical trial
303296|NCT01855945|Influenza|influenza
303297|NCT01855919|Chronic Low Back Pain|chronic low back pain
303298|NCT01855919|CLBP|clbp
303299|NCT01855906|Total knee replacement|total knee replacement
303300|NCT01855906|Gap balanced|gap balanced
303301|NCT01855906|Measured resection|measured resection
303302|NCT01855893|Neck pain|neck pain
303303|NCT01855880|psoriasis|psoriasis
303304|NCT01855880|dermatology|dermatology
303305|NCT01855880|monoclonal antibody|monoclonal antibody
303307|NCT01855867|PEP|pep
303308|NCT01855867|nPEP|npep
303309|NCT01855867|Prophylaxis|prophylaxis
303310|NCT01855867|Post Exposure Prophylaxis|post exposure prophylaxis
303311|NCT01855867|exposure to HIV|exposure to hiv
303312|NCT01855867|HIV prevention|hiv prevention
303313|NCT01855841|ERCP|ercp
303314|NCT01855841|virgin papilla|virgin papilla
303315|NCT01855841|risk of post-ERCP acute pancreatitis|risk of post-ercp acute pancreatitis
303317|NCT01855802|Ophthalmology|ophthalmology
303318|NCT01855802|Glaucoma|glaucoma
303319|NCT01855802|Generics|generics
303320|NCT01855802|Perception|perception
303321|NCT01855776|Physical Activity/Walking|physical activity/walking
303322|NCT01855776|Full-time employees|full-time employees
303323|NCT01855776|RCT|rct
303324|NCT01855776|Incentives|incentives
303325|NCT01855776|Wireless pedometer|wireless pedometer
303326|NCT01855763|gestational diabetes|gestational diabetes
303327|NCT01855763|type 2 diabetes|type 2 diabetes
303328|NCT01855763|pregnancy|pregnancy
303329|NCT01855763|metformin|metformin
303330|NCT01855763|insulin|insulin
303331|NCT01855750|Lymphoma|lymphoma
303332|NCT01855750|B-cell lymphoma|b-cell lymphoma
303333|NCT01855750|Non-germinal center B-cell subtype|non-germinal center b-cell subtype
303334|NCT01855750|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
303335|NCT01855750|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
303336|NCT01855750|PCI-32765|pci-32765
303337|NCT01855750|JNJ-54179060|jnj-54179060
303338|NCT01855750|Ibrutinib|ibrutinib
303339|NCT01855750|Rituximab|rituximab
303340|NCT01855750|Cyclophosphamide|cyclophosphamide
303341|NCT01855750|Doxorubicin|doxorubicin
303342|NCT01855750|Vincristine|vincristine
303343|NCT01855750|Prednisone|prednisone
303344|NCT01855737|gene guided|gene guided
303345|NCT01855737|warfarin dose|warfarin dose
303346|NCT01855737|Chinese|chinese
303347|NCT01855711|Alosetron hydrochloride|alosetron hydrochloride
303348|NCT01855711|Global Improvement Scale(GIS)|global improvement scale(gis)
303349|NCT01855711|Diarrhea-predominant IBS|diarrhea-predominant ibs
303350|NCT01855698|hematologic neoplasm, profhylaxis, arterial and venous thromboembolism|hematologic neoplasm, profhylaxis, arterial and venous thromboembolism
303351|NCT01855685|XCGD, lentivirus, cellular therapy|xcgd, lentivirus, cellular therapy
303352|NCT01855672|Migraine, occipital nerve, stimulation|migraine, occipital nerve, stimulation
303353|NCT01855659|Lung diseases,|lung diseases,
303354|NCT01855659|Obstructive,|obstructive,
303355|NCT01855659|Peak Inspiratory Flow|peak inspiratory flow
303356|NCT01855659|[C08.381.495.389]|[c08.381.495.389]
303357|NCT01855620|Contraception|contraception
303358|NCT01855620|Implant|implant
303359|NCT01855620|Obesity|obesity
303360|NCT01855607|chemotherapy induced neuropathy|chemotherapy induced neuropathy
303361|NCT01855542|metabolic acidosis, plasmalyte solution, 0.9% normal saline|metabolic acidosis, plasmalyte solution, 0.9% normal saline
303362|NCT01855529|ropivacaine, pain, mastectomy|ropivacaine, pain, mastectomy
303363|NCT01855516|Antithrombotic prophylaxis|antithrombotic prophylaxis
303364|NCT01855503|Metastatic|metastatic
303365|NCT01855503|Breast Cancer|breast cancer
303366|NCT01855503|Metastatic Breast Cancer|metastatic breast cancer
303367|NCT01855503|Breast|breast
303368|NCT01855503|Biopsy|biopsy
303369|NCT01855503|Molecular|molecular
303370|NCT01855503|Genetic|genetic
303371|NCT01855464|pneumothorax|pneumothorax
303372|NCT01855464|primary pneumothorax|primary pneumothorax
303373|NCT01855464|lung collapse|lung collapse
303374|NCT01855451|Human Papilloma Virus|human papilloma virus
303375|NCT01855451|HPV|hpv
303376|NCT01855451|Oropharyngeal|oropharyngeal
303377|NCT01855451|Squamous Cell|squamous cell
303378|NCT01855451|Carcinoma|carcinoma
303379|NCT01855438|Live donor kidney transplantation|live donor kidney transplantation
303380|NCT01855438|Living donation|living donation
303381|NCT01855438|Patient education|patient education
303382|NCT01855438|Kidney transplant candidates|kidney transplant candidates
303383|NCT01855412|PAD|pad
303384|NCT01855412|LIBERTY|liberty
303385|NCT01855412|Observational|observational
303386|NCT01855399|Peer Support|peer support
303387|NCT01855399|Self Management|self management
303388|NCT01855399|Health Disparities|health disparities
303389|NCT01855373|Blood Sugar|blood sugar
303390|NCT01855373|Endothelial Function|endothelial function
303391|NCT01855373|Blood Vessel Health|blood vessel health
303392|NCT01855360|amyloid|amyloid
303393|NCT01855360|amyloidosis|amyloidosis
303394|NCT01855360|cardiac amyloidosis|cardiac amyloidosis
303395|NCT01855360|senile amyloidosis|senile amyloidosis
303396|NCT01855360|familial amyloidosis|familial amyloidosis
303397|NCT01855360|transthyretin amyloidosis|transthyretin amyloidosis
303398|NCT01855347|Prematurity|prematurity
303399|NCT01855347|Hypoxia|hypoxia
303400|NCT01855347|Necrotizing Enterocolitis|necrotizing enterocolitis
303401|NCT01855347|Near Infrared Spectroscopy|near infrared spectroscopy
303402|NCT01855347|Abdominal tissue oxygenation|abdominal tissue oxygenation
303403|NCT01855347|NICU|nicu
303404|NCT01855334|Dialysis|dialysis
303405|NCT01855334|ESRD|esrd
303406|NCT01855334|Cardiovascular disease|cardiovascular disease
303407|NCT01855334|spironolactone|spironolactone
303408|NCT01855334|L-arginine|l-arginine
303409|NCT01855334|myocardial perfusion|myocardial perfusion
303410|NCT01855334|coronary flow reserve|coronary flow reserve
303411|NCT01855334|diastolic function|diastolic function
303412|NCT01855321|uncontrolled diabetes|uncontrolled diabetes
303413|NCT01855321|vitamin D deficiency|vitamin d deficiency
303414|NCT01855295|Dialysis|dialysis
303415|NCT01855295|End Stage Renal Disease|end stage renal disease
303416|NCT01855295|Protein supplementation|protein supplementation
303417|NCT01855295|Inflammation|inflammation
303418|NCT01855295|Quality of Life|quality of life
303419|NCT01855282|Diabetes Type II,|diabetes type ii,
303421|NCT01855282|Obesity,|obesity,
303422|NCT01855282|Behavioral Intervention,|behavioral intervention,
303423|NCT01855282|Latino, farm worker|latino, farm worker
303424|NCT01855282|randomized controlled intervention|randomized controlled intervention
303425|NCT01855269|probiotic|probiotic
303426|NCT01855269|infantile colic|infantile colic
303427|NCT01855256|hyperhidrosis|hyperhidrosis
303428|NCT01855256|oxybutynin|oxybutynin
303429|NCT01855243|Type 2 D M|type 2 d m
303430|NCT01855243|sliding scale insulin|sliding scale insulin
303431|NCT01855243|70/30 insulin|70/30 insulin
303432|NCT01855243|basals insulin|basals insulin
303433|NCT01855243|supplemental insulin|supplemental insulin
303434|NCT01855217|morbid|morbid
303435|NCT01855217|obesity|obesity
303436|NCT01855217|sugammadex|sugammadex
303437|NCT01855217|pharmacodynamics|pharmacodynamics
303438|NCT01855204|Computed Tomography, Spiral|computed tomography, spiral
303439|NCT01855204|Urography|urography
303440|NCT01855204|Radiation dosage|radiation dosage
303441|NCT01855204|Contrast media|contrast media
303442|NCT01855178|nocturnal|nocturnal
303443|NCT01855178|epilepsy|epilepsy
303444|NCT01855165|chronic heart failure|chronic heart failure
303445|NCT01855165|drug-drug interactions|drug-drug interactions
303446|NCT01855165|pharmacist's intervention|pharmacist's intervention
303447|NCT01855152|Dementia|dementia
303448|NCT01855152|Care Homes|care homes
303449|NCT01855152|Quality of life|quality of life
303450|NCT01855152|Antipsychotic medication|antipsychotic medication
303451|NCT01855152|Behavioural symptoms|behavioural symptoms
303452|NCT01855152|Cost effectiveness|cost effectiveness
303453|NCT01855152|Implementation|implementation
303454|NCT01855152|Person centred care|person centred care
303455|NCT01855152|Social interaction|social interaction
303456|NCT01855139|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
303457|NCT01855139|Stroke|stroke
303458|NCT01855139|Systemic embolism|systemic embolism
303459|NCT01855139|Oral anticoagulation|oral anticoagulation
303460|NCT01855139|Real-life setting|real-life setting
303461|NCT01855139|Preventive measure|preventive measure
303462|NCT01855126|light|light
303463|NCT01855126|circadian rhythms|circadian rhythms
303464|NCT01855126|dim light melatonin onset|dim light melatonin onset
303465|NCT01855126|sleep|sleep
303466|NCT01855113|PAIN|pain
303467|NCT01855113|ORTHODONTIC TREATMENT|orthodontic treatment
303468|NCT01855113|INVISALIGN|invisalign
303469|NCT01855100|Treatment of acute deep vein thrombosis|treatment of acute deep vein thrombosis
303470|NCT01855100|Prevention of recurrence|prevention of recurrence
303471|NCT01855100|Oral anticoagulation|oral anticoagulation
303472|NCT01855100|Real-life setting|real-life setting
303473|NCT01855074|Schizophrenia|schizophrenia
303474|NCT01855074|Schizophreniform Disorder|schizophreniform disorder
303475|NCT01855074|Schizoaffective Disorder|schizoaffective disorder
303476|NCT01855074|Risperidone|risperidone
303477|NCT01855074|Risperdal consta|risperdal consta
303478|NCT01855061|Feasibility studies|feasibility studies
303479|NCT01855061|Sequence analysis, DNA|sequence analysis, dna
303480|NCT01855061|Biological markers|biological markers
303481|NCT01855061|Solid tumors|solid tumors
303482|NCT01855061|Neoplasm metastasis|neoplasm metastasis
303483|NCT01855061|Irinotecan|irinotecan
303484|NCT01855061|Pharmacokinetics SN-38|pharmacokinetics sn-38
303485|NCT01855061|Carboxylesterase activity within metastasis|carboxylesterase activity within metastasis
303486|NCT01855048|N-Rephasin® SAL200|n-rephasin® sal200
303487|NCT01855048|endolysin|endolysin
303488|NCT01855048|Placebo|placebo
303489|NCT01855035|ischemic stroke|ischemic stroke
303490|NCT01855035|ECG monitoring|ecg monitoring
303491|NCT01855035|atrial fibrillation (/flutter)|atrial fibrillation (/flutter)
303492|NCT01855022|Motivational interviewing|motivational interviewing
303493|NCT01855022|Interactive voice response|interactive voice response
303494|NCT01855022|Hospital readmission|hospital readmission
303495|NCT01855009|Quality of Life|quality of life
303496|NCT01855009|Body Weight and Measures|body weight and measures
303497|NCT01855009|Malnutrition|malnutrition
303498|NCT01855009|Adolescent Nutrition Sciences|adolescent nutrition sciences
303499|NCT01855009|Sleep Initiation and Maintenance Disorder|sleep initiation and maintenance disorder
303500|NCT01855009|Motor Activity|motor activity
303501|NCT01855009|Drinking|drinking
303502|NCT01854983|fluorescence colposcopy|fluorescence colposcopy
303503|NCT01854983|cervical cancer|cervical cancer
303504|NCT01854957|Multiple sclerosis|multiple sclerosis
303505|NCT01854957|Mesenchymal stem cells|mesenchymal stem cells
303506|NCT01854931|Tai Ji Quan|tai ji quan
303507|NCT01854931|fall prevention|fall prevention
303508|NCT01854931|community dissemination|community dissemination
303509|NCT01854918|High cholesterol|high cholesterol
303510|NCT01854918|Raised cholesterol|raised cholesterol
303511|NCT01854918|Cholesterol|cholesterol
303512|NCT01854918|Elevated Cholesterol|elevated cholesterol
303513|NCT01854892|low back pain|low back pain
303514|NCT01854892|manipulation|manipulation
303515|NCT01854892|laser therapy|laser therapy
303516|NCT01854892|osteopathic|osteopathic
303517|NCT01854892|chiropractic|chiropractic
303518|NCT01854892|mobilization|mobilization
303519|NCT01854892|muscle energy|muscle energy
303520|NCT01854892|physical therapy|physical therapy
303521|NCT01854892|muscle|muscle
303522|NCT01854892|spine|spine
303523|NCT01854892|adjustment|adjustment
303524|NCT01854892|rehabilitation|rehabilitation
303525|NCT01854866|Pleural Effusion|pleural effusion
303526|NCT01854866|ascites|ascites
303527|NCT01854866|Malignant|malignant
303528|NCT01854853|unsafe sex|unsafe sex
303529|NCT01854853|safer sex|safer sex
303530|NCT01854853|HIV|hiv
303531|NCT01854853|STI|sti
303532|NCT01854853|Pregnancy|pregnancy
303533|NCT01854840|hyaline membrane disease|hyaline membrane disease
303534|NCT01854840|placenta|placenta
303535|NCT01854840|betamethasone|betamethasone
303536|NCT01854827|Biliary atresia|biliary atresia
303537|NCT01854827|Hepatic portoenterostomy|hepatic portoenterostomy
303538|NCT01854827|Intravenous immunoglobulin|intravenous immunoglobulin
303539|NCT01854801|IEI-EMF|iei-emf
303540|NCT01854801|WI-FI|wi-fi
303541|NCT01854801|DECT|dect
303542|NCT01854801|Electro-sensitivity|electro-sensitivity
303543|NCT01854801|Radiofrequency|radiofrequency
303544|NCT01854801|EHS|ehs
303545|NCT01854801|Idiopathic|idiopathic
303546|NCT01854801|Environmental|environmental
303547|NCT01854801|Intolerance fields|intolerance fields
303548|NCT01854801|Mobile phone|mobile phone
303549|NCT01854788|Airway clearance techniques|airway clearance techniques
303550|NCT01854788|Mucus clearance|mucus clearance
303551|NCT01854788|Chest physiotherapy|chest physiotherapy
303552|NCT01854788|Autogenic drainage|autogenic drainage
303553|NCT01854788|Slow expiration with glottis opened in lateral posture(ELTGOL)|slow expiration with glottis opened in lateral posture(eltgol)
303554|NCT01854788|Temporary-positive expiratory pressure (T-PEP)|temporary-positive expiratory pressure (t-pep)
303555|NCT01854788|Non cystic fibrosis bronchiectasis|non cystic fibrosis bronchiectasis
303556|NCT01854775|Adolescents|adolescents
303557|NCT01854775|HIV-1|hiv-1
303559|NCT01854775|Treatment-naive|treatment-naive
303560|NCT01854762|HIV|hiv
303561|NCT01854762|Treatment|treatment
303562|NCT01854762|Pregnancy|pregnancy
303563|NCT01854749|ESCC|escc
303564|NCT01854736|Allergy|allergy
303565|NCT01854736|Phleum pratense|phleum pratense
303566|NCT01854736|Rhinoconjunctivitis|rhinoconjunctivitis
303567|NCT01854736|asthma|asthma
303568|NCT01854736|positive SPT to Phleum pratense|positive spt to phleum pratense
303569|NCT01854723|Diabetes|diabetes
303570|NCT01854723|Insulin glargine|insulin glargine
303571|NCT01854723|NPH insulin|nph insulin
303572|NCT01854710|ADASUVE|adasuve
303573|NCT01854710|inhaled loxapine|inhaled loxapine
303574|NCT01854710|thorough QT/QTc study|thorough qt/qtc study
303575|NCT01854697|Chronic Hepatitis C|chronic hepatitis c
303576|NCT01854697|Interferon Free|interferon free
303577|NCT01854697|Hepatitis C Treatment Naive|hepatitis c treatment naive
303578|NCT01854697|Hepatitis C Virus|hepatitis c virus
303579|NCT01854697|Hepatitis C Genotype 1|hepatitis c genotype 1
303580|NCT01854671|postpartum contraception|postpartum contraception
303581|NCT01854671|contraceptive counseling|contraceptive counseling
303582|NCT01854632|influenza vaccine|influenza vaccine
303583|NCT01854632|trivalent live-attenuated influenza vaccine|trivalent live-attenuated influenza vaccine
303584|NCT01854632|efficacy|efficacy
303585|NCT01854632|Africa|africa
303586|NCT01854632|Senegal|senegal
303587|NCT01854619|chronic rhinosinusitis|chronic rhinosinusitis
303588|NCT01854619|sinusitis|sinusitis
303589|NCT01854619|photodisinfection|photodisinfection
303590|NCT01854619|photodynamic therapy|photodynamic therapy
303591|NCT01854619|antimicrobial photodynamic therapy|antimicrobial photodynamic therapy
303592|NCT01854619|aPDT|apdt
303593|NCT01854619|PDT|pdt
303594|NCT01854619|paranasal sinus diseases|paranasal sinus diseases
303595|NCT01854619|respiratory tract infections|respiratory tract infections
303596|NCT01854619|respiratory tract diseases|respiratory tract diseases
303597|NCT01854606|Diffuse Large B-Cell Lymphoma, DBCL, AEB071, Everolimus|diffuse large b-cell lymphoma, dbcl, aeb071, everolimus
303598|NCT01854580|Comparative effectiveness research|comparative effectiveness research
303599|NCT01854580|health economic evaluation|health economic evaluation
303600|NCT01854567|Cord Blood|cord blood
303601|NCT01854567|Stem Cells|stem cells
303602|NCT01854567|MPC|mpc
303603|NCT01854567|Mesoblast|mesoblast
303604|NCT01854567|Expanded|expanded
303605|NCT01854567|AML|aml
303606|NCT01854567|ALL|all
303607|NCT01854567|NHL|nhl
303608|NCT01854567|Leukemia|leukemia
303609|NCT01854567|Lymphoma|lymphoma
303610|NCT01854554|Brain cancer|brain cancer
303611|NCT01854554|Glioblastoma|glioblastoma
303612|NCT01854554|Glioblastoma Multiforme|glioblastoma multiforme
303613|NCT01854554|GBM|gbm
303614|NCT01854554|Intensity Modulated Proton Radiotherapy|intensity modulated proton radiotherapy
303615|NCT01854554|IMPT|impt
303616|NCT01854554|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
303617|NCT01854554|IMRT|imrt
303618|NCT01854554|Radiotherapy|radiotherapy
303619|NCT01854554|XRT|xrt
303620|NCT01854554|Cognitive tests|cognitive tests
303621|NCT01854554|Thinking skills tests|thinking skills tests
303622|NCT01854554|Questionnaires|questionnaires
303623|NCT01854554|Surveys|surveys
303624|NCT01854554|Quality of life|quality of life
303625|NCT01854554|QOL|qol
303626|NCT01854541|Cancer|cancer
303627|NCT01854541|Radiotherapy|radiotherapy
303628|NCT01854528|Partial responder|partial responder
303629|NCT01854528|Interferon free|interferon free
303630|NCT01854528|Treatment-experienced|treatment-experienced
303631|NCT01854528|Relapser|relapser
303632|NCT01854528|Hepatitis C Virus|hepatitis c virus
303633|NCT01854528|Null responder|null responder
303634|NCT01854528|Hepatitis C Genotype 1|hepatitis c genotype 1
303635|NCT01854528|paritaprevir|paritaprevir
303636|NCT01854528|ombitasvir|ombitasvir
303637|NCT01854528|dasabuvir|dasabuvir
303638|NCT01854528|ribavirin|ribavirin
303639|NCT01854528|Viekira PAK|viekira pak
303640|NCT01854528|Chronic hepatitis C|chronic hepatitis c
303641|NCT01854502|Young children|young children
303642|NCT01854502|counseling|counseling
303643|NCT01854502|fluoride|fluoride
303644|NCT01854502|xylitol|xylitol
303645|NCT01854489|Buprenorphine|buprenorphine
303646|NCT01854489|Rifampicin|rifampicin
303647|NCT01854489|Interactions|interactions
303648|NCT01854489|Pharmakokinetics|pharmakokinetics
303649|NCT01854489|Pharmakodynamics|pharmakodynamics
303650|NCT01854476|Hemodialysis|hemodialysis
303651|NCT01854476|Bleeding|bleeding
303652|NCT01854476|Hemostatic dressing|hemostatic dressing
303653|NCT01854476|Tranexamic Acid|tranexamic acid
303654|NCT01854463|DIABETES MELLITUS|diabetes mellitus
303655|NCT01854463|VITAMIN D|vitamin d
303656|NCT01854463|ARTERIAL STIFFNESS|arterial stiffness
303657|NCT01854463|FATTY LIVER|fatty liver
303658|NCT01854463|BONE TURNOVER|bone turnover
303659|NCT01854450|Occipitoposterior position|occipitoposterior position
303660|NCT01854450|Maternal posturing|maternal posturing
303661|NCT01854450|Labor|labor
303662|NCT01854437|mg oxide|mg oxide
303663|NCT01854437|hyperphosphatemia|hyperphosphatemia
303664|NCT01854437|plasma phosphor level|plasma phosphor level
303665|NCT01854424|Fibrocyte|fibrocyte
303666|NCT01854424|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
303667|NCT01854424|Serum Amyloid P|serum amyloid p
303668|NCT01854424|Fibrosis|fibrosis
303669|NCT01854424|Mortality|mortality
303670|NCT01854411|Analgesics|analgesics
303671|NCT01854411|Ibuprofene|ibuprofene
303672|NCT01854411|Ketoprofene|ketoprofene
303673|NCT01854411|Breastmilk|breastmilk
303674|NCT01854411|Relative Infant Dose|relative infant dose
303675|NCT01854411|Theoric Infant Dose|theoric infant dose
303676|NCT01854398|Obstructive sleep apnea|obstructive sleep apnea
303677|NCT01854398|Continuous positive airway pressure|continuous positive airway pressure
303678|NCT01854398|diastolic function|diastolic function
303679|NCT01854385|Post-traumatic headache|post-traumatic headache
303680|NCT01854385|Traumatic brain injury|traumatic brain injury
303681|NCT01854385|Sumatriptan|sumatriptan
303682|NCT01854359|Multiple Sclerosis|multiple sclerosis
303683|NCT01854359|Extension Trial|extension trial
303684|NCT01854346|Autism spectrum disorder|autism spectrum disorder
303685|NCT01854346|Social skills training|social skills training
303686|NCT01854346|Group training|group training
303687|NCT01854346|Comorbidity|comorbidity
303688|NCT01854346|Intervention|intervention
303689|NCT01854346|Evidence-based|evidence-based
303690|NCT01854333|Diagnostics|diagnostics
303692|NCT01854333|ADI-R|adi-r
303693|NCT01854333|Psychometrics|psychometrics
303694|NCT01854333|Autism spectrum disorders|autism spectrum disorders
303695|NCT01854333|Autism|autism
303696|NCT01854307|Difference of|difference of
303697|NCT01854307|measurements|measurements
303698|NCT01854307|before and after|before and after
303699|NCT01854294|ALS|als
303700|NCT01854294|motorneuron disease|motorneuron disease
303701|NCT01854294|Central Nervous System (CNS) disease|central nervous system (cns) disease
303702|NCT01854294|neurodegeneration|neurodegeneration
303703|NCT01854294|neuroprotective|neuroprotective
303704|NCT01854294|mechanisms of action|mechanisms of action
303705|NCT01854294|pathways|pathways
303706|NCT01854294|biomarkers|biomarkers
303707|NCT01854294|Cerebral Spinal Fluid (CSF)|cerebral spinal fluid (csf)
303708|NCT01854294|blood biomarkers|blood biomarkers
303709|NCT01854294|multi-factorial|multi-factorial
303710|NCT01854294|multisystem|multisystem
303711|NCT01854294|single target|single target
303712|NCT01854294|pathogenic mechanisms|pathogenic mechanisms
303713|NCT01854294|Protein Bands Selection by Function|protein bands selection by function
303714|NCT01854294|in silico analysis|in silico analysis
303715|NCT01854294|active site|active site
303716|NCT01854294|protein|protein
303717|NCT01854294|peptide|peptide
303718|NCT01854294|embryonic stage|embryonic stage
303719|NCT01854294|endogenous|endogenous
303720|NCT01854294|master regulators|master regulators
303721|NCT01854294|fetal development|fetal development
303722|NCT01854294|embryonic development|embryonic development
303723|NCT01854294|common pathways|common pathways
303724|NCT01854294|Blood Brain Barrier (BBB)|blood brain barrier (bbb)
303725|NCT01854294|anti-inflammatory|anti-inflammatory
303726|NCT01854294|anti-apoptotic|anti-apoptotic
303727|NCT01854294|anti-oxidative|anti-oxidative
303728|NCT01854294|regenerative|regenerative
303729|NCT01854294|distress signals|distress signals
303730|NCT01854294|neurotrophin|neurotrophin
303731|NCT01854294|Motoneuronotrophic factor (MNTF)|motoneuronotrophic factor (mntf)
303732|NCT01854294|ALS model|als model
303733|NCT01854294|life span|life span
303734|NCT01854294|disease onset|disease onset
303735|NCT01854294|grip strength|grip strength
303736|NCT01854294|protein expression|protein expression
303737|NCT01854294|DNA microarray|dna microarray
303738|NCT01854294|differential expression|differential expression
303739|NCT01854294|Phase 1 clinical trial|phase 1 clinical trial
303740|NCT01854294|rare disease|rare disease
303741|NCT01854294|common underlying pathogenic mechanisms|common underlying pathogenic mechanisms
303742|NCT01854294|neurological deficits|neurological deficits
303743|NCT01854294|gene mutation|gene mutation
303744|NCT01854294|misfolded proteins|misfolded proteins
303745|NCT01854294|inadvertent errors|inadvertent errors
303746|NCT01854294|modulation of genes|modulation of genes
303747|NCT01854294|master regulator peptide drug|master regulator peptide drug
303748|NCT01854294|ALS related genes|als related genes
303749|NCT01854294|mitochondria dysfunction|mitochondria dysfunction
303750|NCT01854294|excitotoxicity|excitotoxicity
303751|NCT01854294|axonal transport|axonal transport
303752|NCT01854294|oxidative stress|oxidative stress
303753|NCT01854294|protein aggregation|protein aggregation
303754|NCT01854294|pathogenesis|pathogenesis
303755|NCT01854294|target biomarkers|target biomarkers
303756|NCT01854294|efficacy biomarkers|efficacy biomarkers
303757|NCT01854281|Patent foramen ovale|patent foramen ovale
303758|NCT01854281|Catheter-based closure|catheter-based closure
303759|NCT01854281|Nitrogen bubbles|nitrogen bubbles
303760|NCT01854281|Decompression sickness|decompression sickness
303761|NCT01854268|cough|cough
303762|NCT01854255|Gastric|gastric
303763|NCT01854255|Cancer|cancer
303764|NCT01854255|Chemotherapy|chemotherapy
303765|NCT01854255|Intraperitoneal|intraperitoneal
303766|NCT01854229|Morphine|morphine
303767|NCT01854229|Implantable Infusion Pumps|implantable infusion pumps
303768|NCT01854229|Intrathecal Pump|intrathecal pump
303769|NCT01854216|Rotigotine|rotigotine
303770|NCT01854216|Neupro|neupro
303771|NCT01854216|Japanese|japanese
303772|NCT01854216|Caucasian|caucasian
303773|NCT01854216|Male|male
303774|NCT01854216|Female|female
303775|NCT01854216|Single dose|single dose
303776|NCT01854216|Pharmacokinetics|pharmacokinetics
303777|NCT01854203|Cisplatin|cisplatin
303778|NCT01854203|neoadjuvant chemotherapy|neoadjuvant chemotherapy
303779|NCT01854203|intensity-modulated radiation therapy|intensity-modulated radiation therapy
303780|NCT01854203|concurrent chemoradiotherapy|concurrent chemoradiotherapy
303781|NCT01854190|Obstructive sleep apnea|obstructive sleep apnea
303782|NCT01854190|Resistent hypertension|resistent hypertension
303783|NCT01854190|Endothelial function|endothelial function
303784|NCT01854190|Blood pressure|blood pressure
303785|NCT01854177|breathlessness; substance P; beta-endorphin|breathlessness; substance p; beta-endorphin
303786|NCT01854164|HGE, impaired fasting glucose, clinical trial|hge, impaired fasting glucose, clinical trial
303787|NCT01854151|Medication errors|medication errors
303788|NCT01854151|Medication dosing|medication dosing
303789|NCT01854138|primary knee arthroplasty|primary knee arthroplasty
303790|NCT01854138|primary hip arthroplasty|primary hip arthroplasty
303791|NCT01854138|negative pressure wound therapy|negative pressure wound therapy
303792|NCT01854125|immun function|immun function
303793|NCT01854125|liver function|liver function
303794|NCT01854125|ascites|ascites
303795|NCT01854125|quality of life|quality of life
303796|NCT01854125|Child-Pugh score|child-pugh score
303797|NCT01854112|Helical tomotherapy|helical tomotherapy
303798|NCT01854112|total skin electron therapy|total skin electron therapy
303799|NCT01854112|TSEB|tseb
303800|NCT01854112|irradiation 5.|irradiation 5.
303801|NCT01854099|Brain Tumor|brain tumor
303802|NCT01854086|osteoporosis|osteoporosis
303803|NCT01854086|postmenopausal|postmenopausal
303804|NCT01854086|patient compliance|patient compliance
303805|NCT01854086|compliance|compliance
303806|NCT01854086|diphosphonates|diphosphonates
303807|NCT01854086|bisphosphonates|bisphosphonates
303808|NCT01854060|Irritable bowel syndrome|irritable bowel syndrome
303809|NCT01854060|Epidimiology|epidimiology
303810|NCT01854060|Deterioration in the severity of irritable bowel syndrome|deterioration in the severity of irritable bowel syndrome
303811|NCT01854034|Advanced disease|advanced disease
303812|NCT01854034|EGFR mutation|egfr mutation
303813|NCT01854021|Anesthesia|anesthesia
303814|NCT01854021|general|general
303815|NCT01854021|Immunity|immunity
303816|NCT01854021|Tongue neoplasms|tongue neoplasms
303817|NCT01854021|immune|immune
303818|NCT01854021|general anesthesia|general anesthesia
303819|NCT01854008|Exercise, Physical activity, Rehabilitation, COPD.|exercise, physical activity, rehabilitation, copd.
303820|NCT01853995|Fixed Lingual Mandibular Growth Modificator (FLMGM)|fixed lingual mandibular growth modificator (flmgm)
303821|NCT01853995|Class II division 1 malocclusion|class ii division 1 malocclusion
303822|NCT01853995|Sagittal Occlusal Correction|sagittal occlusal correction
303823|NCT01853995|Skeletal changes|skeletal changes
303824|NCT01853995|Dental changes|dental changes
303825|NCT01853956|Mexico|mexico
303826|NCT01853956|Bioequivalence|bioequivalence
303827|NCT01853956|Alprazolam|alprazolam
303828|NCT01853956|Pharmacokinetics|pharmacokinetics
303829|NCT01853943|Transradial approach|transradial approach
303830|NCT01853943|radial occlusion|radial occlusion
303831|NCT01853943|hand grip|hand grip
303832|NCT01853943|coronary angiography|coronary angiography
303833|NCT01853930|reading rehabilitation|reading rehabilitation
303834|NCT01853930|macular degeneration|macular degeneration
303835|NCT01853930|eccentric viewing|eccentric viewing
303836|NCT01853904|Bronchoscopy|bronchoscopy
303837|NCT01853904|BAL|bal
303838|NCT01853904|Suction|suction
303839|NCT01853878|Non-Small Cell Lung Cancer|non-small cell lung cancer
303840|NCT01853878|Immunotherapy|immunotherapy
303841|NCT01853878|Antigen-Specific|antigen-specific
303842|NCT01853865|Endometrial cancer|endometrial cancer
303843|NCT01853865|Follow-up examination|follow-up examination
303844|NCT01853813|colorectal cancer|colorectal cancer
303845|NCT01853813|advanced disease|advanced disease
303846|NCT01853813|LDH|ldh
303847|NCT01853800|Relative bioavailability|relative bioavailability
303848|NCT01853800|Rivaroxaban|rivaroxaban
303849|NCT01853787|COPD|copd
303850|NCT01853787|bronchial inflammation|bronchial inflammation
303851|NCT01853787|NO concentration|no concentration
303852|NCT01853787|small airways|small airways
303853|NCT01853787|LABA|laba
303854|NCT01853787|Small Airways Stretching|small airways stretching
303855|NCT01853787|Stretch and strain of small airways in COPD|stretch and strain of small airways in copd
303856|NCT01853787|Acute LABA effect on NO production|acute laba effect on no production
303857|NCT01853787|Pulmonary desufflation|pulmonary desufflation
303858|NCT01853774|Tailored navigation|tailored navigation
303859|NCT01853774|Tailored messages|tailored messages
303860|NCT01853761|abdominal fat|abdominal fat
303861|NCT01853761|metabolic syndrome|metabolic syndrome
303862|NCT01853761|microcurrent|microcurrent
303863|NCT01853761|aerobic exercise|aerobic exercise
303864|NCT01853722|DCN01|dcn01
303865|NCT01853722|Ocular Surgical Preparation|ocular surgical preparation
303866|NCT01853722|Prophylaxis against infection|prophylaxis against infection
303867|NCT01853722|Pre-operative prep|pre-operative prep
303868|NCT01853683|General Surgery|general surgery
303869|NCT01853644|Cancer|cancer
303870|NCT01853644|Recurrent|recurrent
303871|NCT01853644|Ovary|ovary
303872|NCT01853644|Fallopian Tube|fallopian tube
303873|NCT01853644|Primary Peritioneal|primary peritioneal
303874|NCT01853644|Phase II|phase ii
303875|NCT01853644|Platinum Resistant|platinum resistant
303876|NCT01853631|chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
303877|NCT01853631|refractory|refractory
303878|NCT01853631|recurrent|recurrent
303879|NCT01853631|aggressive B-cell Lymphoma|aggressive b-cell lymphoma
303880|NCT01853631|CD19|cd19
303881|NCT01853631|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
303882|NCT01853631|CD28|cd28
303883|NCT01853631|CD137|cd137
303884|NCT01853631|4-1BB|4-1bb
303885|NCT01853631|acute lymphocytic leukemia|acute lymphocytic leukemia
303886|NCT01853618|Liver Cancer|liver cancer
303887|NCT01853618|Monoclonal Antibody|monoclonal antibody
303888|NCT01853618|CTLA-4|ctla-4
303889|NCT01853618|Ablative Therapy|ablative therapy
303890|NCT01853592|Gadolinium Contrast|gadolinium contrast
303891|NCT01853592|Cardiac MRI|cardiac mri
303892|NCT01853592|MRA|mra
303893|NCT01853592|MRI|mri
303894|NCT01853592|MRI Safety|mri safety
303895|NCT01853579|Randomized controlled trial|randomized controlled trial
303896|NCT01853579|Subclinical hypothyroidism|subclinical hypothyroidism
303897|NCT01853579|Levothyroxine|levothyroxine
303898|NCT01853579|Depression|depression
303899|NCT01853566|Muscle Strength|muscle strength
303900|NCT01853566|Growth Hormone|growth hormone
303901|NCT01853566|men|men
303902|NCT01853540|Ciliary Beat Frequency (CBF)|ciliary beat frequency (cbf)
303903|NCT01853540|Nasal Nitric Oxide (nNO)|nasal nitric oxide (nno)
303904|NCT01853540|Mucociliary Dysfunction|mucociliary dysfunction
303905|NCT01853527|CT coronary angiography|ct coronary angiography
303906|NCT01853527|Contrast stress echocardiography|contrast stress echocardiography
303907|NCT01853527|Arterial stiffness|arterial stiffness
303908|NCT01853527|Quality of life|quality of life
303909|NCT01853527|Biochemical and genetic markers|biochemical and genetic markers
303910|NCT01853514|Low income|low income
303911|NCT01853514|Fruit and vegetables|fruit and vegetables
303912|NCT01853514|Conventional produce|conventional produce
303913|NCT01853514|Organic produce|organic produce
303914|NCT01853514|Pesticide|pesticide
303915|NCT01853514|Purchasing behavior|purchasing behavior
303916|NCT01853514|Message framing|message framing
303917|NCT01853501|POF|pof
303918|NCT01853488|Osteoporosis|osteoporosis
303919|NCT01853488|BMD|bmd
303920|NCT01853488|SCI|sci
303921|NCT01853488|DXA|dxa
303922|NCT01853488|pQCT|pqct
303923|NCT01853475|pharmacokinetics|pharmacokinetics
303924|NCT01853475|safety|safety
303925|NCT01853475|tolerability|tolerability
303926|NCT01853475|bioavailability|bioavailability
303927|NCT01853449|Fentanyl Citrate|fentanyl citrate
303928|NCT01853449|Opioids|opioids
303929|NCT01853449|Exercise|exercise
303930|NCT01853436|Breast Cancer|breast cancer
303931|NCT01853436|Reconstructive Tissue Matrix|reconstructive tissue matrix
303932|NCT01853436|Acellular Dermal Matrices (ADM)|acellular dermal matrices (adm)
303933|NCT01853423|Rapamune|rapamune
303934|NCT01853423|Topical|topical
303935|NCT01853423|Pediatric|pediatric
303936|NCT01853423|Safety|safety
303937|NCT01853423|Efficiency|efficiency
303938|NCT01853423|Angiofibroma|angiofibroma
303939|NCT01853423|Skin Cream|skin cream
303940|NCT01853410|coronary artery disease|coronary artery disease
303941|NCT01853410|coronary flow reserve|coronary flow reserve
303942|NCT01853410|endothelial function|endothelial function
303943|NCT01853384|Venous leg ulcer|venous leg ulcer
303944|NCT01853384|ulcer|ulcer
303945|NCT01853384|venous stasis|venous stasis
303946|NCT01853384|compression|compression
303947|NCT01853384|venous|venous
303948|NCT01853384|venous stasis ulcer|venous stasis ulcer
303949|NCT01853384|vlu|vlu
303950|NCT01853384|wound|wound
303951|NCT01853384|varicose veins|varicose veins
303952|NCT01853384|venous insufficiency|venous insufficiency
303953|NCT01853384|dvt|dvt
303954|NCT01853384|deep vein thrombosis|deep vein thrombosis
303955|NCT01853358|hematological malignancy|hematological malignancy
303956|NCT01853358|stem cell transplantation|stem cell transplantation
303957|NCT01853345|Refractory|refractory
303958|NCT01853345|Recurrent|recurrent
303959|NCT01853345|High Risk|high risk
303960|NCT01853332|Cardiovascular Disease|cardiovascular disease
303961|NCT01853332|Diabetes|diabetes
303962|NCT01853332|Adjustment|adjustment
303963|NCT01853332|Adversity|adversity
303964|NCT01853332|Psychology|psychology
303965|NCT01853332|Midlife|midlife
303966|NCT01853332|Functioning|functioning
303967|NCT01853332|Socioeconomic|socioeconomic
303968|NCT01853332|Psychosocial outcomes|psychosocial outcomes
303969|NCT01853319|Regorafenib|regorafenib
303970|NCT01853319|Metastatic colorectal cancer|metastatic colorectal cancer
303971|NCT01853306|High grade serous ovarian cancer|high grade serous ovarian cancer
303972|NCT01853306|BRCA mutated breast cancer|brca mutated breast cancer
303973|NCT01853306|BRCA mutated|brca mutated
303974|NCT01853306|Oncology|oncology
303975|NCT01853293|Alcohol Abuse|alcohol abuse
303976|NCT01853293|Alcohol Dependence|alcohol dependence
303977|NCT01853293|Heavy drinking days|heavy drinking days
303978|NCT01853293|Kudzu|kudzu
303979|NCT01853280|ADHD|adhd
303980|NCT01853280|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
303981|NCT01853280|Deplin|deplin
303982|NCT01853280|L-methylfolate|l-methylfolate
303983|NCT01853280|Natural Treatments|natural treatments
303984|NCT01853280|Medical Food|medical food
303985|NCT01853267|Colorectal|colorectal
303986|NCT01853267|Surgery|surgery
303987|NCT01853267|Perianal|perianal
303988|NCT01853267|Abscess|abscess
303989|NCT01853241|small intestine|small intestine
303990|NCT01853241|endoscopy, gastrointestinal|endoscopy, gastrointestinal
303991|NCT01853228|Acute myeloid leukemia|acute myeloid leukemia
303992|NCT01853228|Relapsed or refractory acute myeloid leukemia|relapsed or refractory acute myeloid leukemia
303993|NCT01853228|Children|children
303994|NCT01853228|Decitabine|decitabine
303995|NCT01853228|DACOGEN|dacogen
303996|NCT01853228|Cytarabine|cytarabine
303997|NCT01853215|sternal intraosseous infusion study|sternal intraosseous infusion study
303998|NCT01853202|Cancer|cancer
303999|NCT01853202|Chemotherapy|chemotherapy
304000|NCT01853202|Thrombosis|thrombosis
304001|NCT01853202|Prevention|prevention
304002|NCT01853202|Exercise|exercise
304003|NCT01853189|pediatrics|pediatrics
304004|NCT01853189|asthma|asthma
304005|NCT01853189|osteopathic manipulative treatment|osteopathic manipulative treatment
304006|NCT01853176|Pain, Postoperative|pain, postoperative
304007|NCT01853176|Analgesia|analgesia
304008|NCT01853176|Anesthesia, local|anesthesia, local
304009|NCT01853176|Abdominoplasty|abdominoplasty
304010|NCT01853163|Gadolinium|gadolinium
304011|NCT01853163|Contrast Agent|contrast agent
304012|NCT01853163|Long-term retention|long-term retention
304013|NCT01853137|Class II division 1 malocclusion|class ii division 1 malocclusion
304014|NCT01853137|Dentofacial orthopedics|dentofacial orthopedics
304015|NCT01853137|Fixed Lingual Mandibular Growth Modificator (FLMGM)|fixed lingual mandibular growth modificator (flmgm)
304016|NCT01853124|Diarrhea|diarrhea
304017|NCT01853098|loving-kindness meditation|loving-kindness meditation
304018|NCT01853098|mindfulness meditation|mindfulness meditation
304019|NCT01853098|compassion|compassion
304020|NCT01853072|Diabetes Type I|diabetes type i
304021|NCT01853072|Diabetes Type II|diabetes type ii
304022|NCT01853072|non-proliferative diabetic retinopathy|non-proliferative diabetic retinopathy
304023|NCT01853072|macular edema|macular edema
304024|NCT01853072|Cataract|cataract
304025|NCT01853059|Anal cancer|anal cancer
304026|NCT01853059|Squamous cell cancer|squamous cell cancer
304027|NCT01853059|Radiotherapy|radiotherapy
304028|NCT01853059|Chemoradiotherapy|chemoradiotherapy
304029|NCT01853059|Conformational radiotherapy|conformational radiotherapy
304030|NCT01853059|Intensity modulated radiation therapy|intensity modulated radiation therapy
304031|NCT01853059|IMRT|imrt
304032|NCT01853046|Regorafenib|regorafenib
304033|NCT01853046|pharmacokinetics|pharmacokinetics
304034|NCT01853046|safety|safety
304035|NCT01853046|severe renal impairment|severe renal impairment
304036|NCT01853046|Solid tumors|solid tumors
304037|NCT01853033|Tolerability|tolerability
304038|NCT01853033|Immunogenicity|immunogenicity
304039|NCT01853033|Safety|safety
304040|NCT01853033|Rheumatoid Arthritis|rheumatoid arthritis
304041|NCT01853033|Pharmacokinetics|pharmacokinetics
304042|NCT01853020|Cannabinoids|cannabinoids
304043|NCT01853020|Eyeblink Conditioning|eyeblink conditioning
304044|NCT01853020|EBC|ebc
304045|NCT01853007|End stage renal disease|end stage renal disease
304046|NCT01853007|Kidney transplantation|kidney transplantation
304047|NCT01853007|Transplant options (living and deceased donor)|transplant options (living and deceased donor)
304048|NCT01853007|Patient education|patient education
304049|NCT01853007|Communication skills training|communication skills training
304050|NCT01852981|Physical activity promotion|physical activity promotion
304051|NCT01852981|Intervention|intervention
304052|NCT01852981|Public Health|public health
304053|NCT01852968|hypoglycemia|hypoglycemia
304054|NCT01852968|hypoglycemia unawareness|hypoglycemia unawareness
304055|NCT01852968|type 1 diabetes, hippocampus|type 1 diabetes, hippocampus
304056|NCT01852968|glucose transport|glucose transport
304057|NCT01852968|cognitive dysfunction|cognitive dysfunction
304058|NCT01852955|Outpatient|outpatient
304059|NCT01852955|Surgery|surgery
304060|NCT01852955|Breast|breast
304061|NCT01852955|Pain|pain
304062|NCT01852942|Infection|infection
304063|NCT01852942|HIV 1|hiv 1
304064|NCT01852942|HIV|hiv
304065|NCT01852942|Losartan|losartan
304066|NCT01852942|Fibrosis|fibrosis
304067|NCT01852942|Immune Activation|immune activation
304068|NCT01852942|Immune Reconstitution|immune reconstitution
304069|NCT01852929|Memory|memory
304070|NCT01852916|RDS|rds
304071|NCT01852903|vitamin C|vitamin c
304072|NCT01852903|calcium ascorbate|calcium ascorbate
304073|NCT01852903|ascorbic acid|ascorbic acid
304074|NCT01852903|bioavailability|bioavailability
304075|NCT01852890|Ascorbate|ascorbate
304076|NCT01852890|Vitamin C|vitamin c
304077|NCT01852890|Radiation|radiation
304078|NCT01852890|Gemcitabine|gemcitabine
304079|NCT01852890|Ascorbic Acid|ascorbic acid
304080|NCT01852877|HIV Diagnosis|hiv diagnosis
304081|NCT01852877|Case Management|case management
304082|NCT01852877|Telemedicine|telemedicine
304083|NCT01852877|Patient Compliance|patient compliance
304084|NCT01852877|Prisoners|prisoners
304085|NCT01852864|Prostate cancer|prostate cancer
304086|NCT01852864|testosterone|testosterone
304087|NCT01852864|castration|castration
304088|NCT01852864|degarelix|degarelix
304089|NCT01852864|proliferation|proliferation
304090|NCT01852838|lung cancer|lung cancer
304091|NCT01852838|volatile organic compounds|volatile organic compounds
304092|NCT01852838|Warburg effect|warburg effect
304093|NCT01852838|early detection|early detection
304094|NCT01852799|Multiple myeloma|multiple myeloma
304095|NCT01852799|PAD|pad
304096|NCT01852799|ASCT|asct
304097|NCT01852799|Bone metabolites|bone metabolites
304098|NCT01852799|Bone marker|bone marker
304099|NCT01852786|Contraception|contraception
304100|NCT01852786|Hyperandrogenism|hyperandrogenism
304101|NCT01852786|Female sexual function|female sexual function
304102|NCT01852773|blunt|blunt
304103|NCT01852773|injury|injury
304104|NCT01852773|aorta|aorta
304105|NCT01852773|endovascular|endovascular
304106|NCT01852760|endoscopic ultrasound|endoscopic ultrasound
304107|NCT01852760|ulcerative colitis|ulcerative colitis
304108|NCT01852760|inflammatory bowel disease|inflammatory bowel disease
304109|NCT01852747|Spinal Deformity|spinal deformity
304110|NCT01852747|Multilevel|multilevel
304111|NCT01852747|Posterior|posterior
304112|NCT01852747|Lumbar|lumbar
304113|NCT01852747|Fusion|fusion
304114|NCT01852747|Levoscoliosis|levoscoliosis
304115|NCT01852747|Dextroscoliosis|dextroscoliosis
304116|NCT01852747|Graft|graft
304117|NCT01852721|Cardiovascular diseases|cardiovascular diseases
304118|NCT01852721|Nutritional intervention program|nutritional intervention program
304119|NCT01852721|Self-Determination Theory|self-determination theory
304120|NCT01852721|Motivational interviewing|motivational interviewing
304121|NCT01852721|Gender differences|gender differences
304122|NCT01852721|Women|women
304123|NCT01852721|Men|men
304124|NCT01852721|Motivation|motivation
304125|NCT01852721|Dietary intakes|dietary intakes
304126|NCT01852721|Mediterranean diet|mediterranean diet
304127|NCT01852721|Eating behaviors|eating behaviors
304128|NCT01852721|Lipid profile|lipid profile
304129|NCT01852708|22q|22q
304130|NCT01852708|1p36|1p36
304131|NCT01852708|Angelman|angelman
304132|NCT01852708|Cri-du-chat|cri-du-chat
304133|NCT01852708|Prader-Willi|prader-willi
304134|NCT01852708|DiGeorge|digeorge
304135|NCT01852708|Turner syndrome|turner syndrome
304136|NCT01852708|Patau syndrome|patau syndrome
304137|NCT01852708|Edwards syndrome|edwards syndrome
304138|NCT01852708|Down syndrome|down syndrome
304139|NCT01852695|Family integrated Care|family integrated care
304140|NCT01852695|Family centered care|family centered care
304141|NCT01852695|NICU family centered care|nicu family centered care
304142|NCT01852695|NICU parent program|nicu parent program
304143|NCT01852682|Peritoneal Dialysis|peritoneal dialysis
304144|NCT01852682|Hyperphosphatemia|hyperphosphatemia
304145|NCT01852656|Influenza, Human|influenza, human
304146|NCT01852656|Immunization|immunization
304147|NCT01852643|Rhinoplasty|rhinoplasty
304148|NCT01852643|Spreader graft technique|spreader graft technique
304149|NCT01852643|Lateral crural overlay technique|lateral crural overlay technique
304150|NCT01852643|Rhinomanometry|rhinomanometry
304151|NCT01852617|Smoking Cessation|smoking cessation
304152|NCT01852617|Pregnancy|pregnancy
304153|NCT01852617|Implementation|implementation
304154|NCT01852617|Knowledge translation|knowledge translation
304155|NCT01852604|HCV|hcv
304156|NCT01852604|Hepatitis C|hepatitis c
304157|NCT01852604|chronic hepatitis C|chronic hepatitis c
304158|NCT01852604|antiviral|antiviral
304159|NCT01852591|autologous transplant|autologous transplant
304160|NCT01852591|multiple myeloma|multiple myeloma
304161|NCT01852578|Metastatic NSCLC|metastatic nsclc
304162|NCT01852578|2nd Line|2nd line
304163|NCT01852578|Docetaxel-based treatment|docetaxel-based treatment
304164|NCT01852578|Progressed|progressed
304165|NCT01852578|Refractory|refractory
304166|NCT01852565|CYP3A4|cyp3a4
304167|NCT01852565|Lp-PLA2|lp-pla2
304168|NCT01852565|Atherosclerosis|atherosclerosis
304169|NCT01852565|healthy volunteer|healthy volunteer
304170|NCT01852565|Drug interaction|drug interaction
304171|NCT01852552|Aortic stenosis|aortic stenosis
304172|NCT01852552|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
304173|NCT01852552|Aortic valve replacement|aortic valve replacement
304174|NCT01852552|Costs|costs
304175|NCT01852552|Cognitive function|cognitive function
304176|NCT01852552|Quality of life|quality of life
304177|NCT01852539|LMA insertion|lma insertion
304178|NCT01852539|dexmedetomidine|dexmedetomidine
304179|NCT01852539|propofol|propofol
304180|NCT01852526|degenerative disc disease|degenerative disc disease
304181|NCT01852526|spondylolisthesis|spondylolisthesis
304182|NCT01852526|Lumbar spine|lumbar spine
304183|NCT01852526|fusion|fusion
304184|NCT01852526|adjacent instability|adjacent instability
304185|NCT01852487|Pumpkin seed oil|pumpkin seed oil
304186|NCT01852487|Hair growth|hair growth
304187|NCT01852487|Men|men
304188|NCT01852474|motor learning|motor learning
304189|NCT01852474|cortical plasticity|cortical plasticity
304190|NCT01852474|direct current stimulation|direct current stimulation
304191|NCT01852461|natural surfactants; perfusion index|natural surfactants; perfusion index
304192|NCT01852435|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
304193|NCT01852435|follicular lymphoma grade 3B|follicular lymphoma grade 3b
304194|NCT01852409|refractory malignant ascites|refractory malignant ascites
304195|NCT01852409|Bevacizumab|bevacizumab
304196|NCT01852409|intraperitoneal|intraperitoneal
304197|NCT01852409|phase I|phase i
304198|NCT01852396|Infraclavicular block|infraclavicular block
304199|NCT01852396|Brachial Plexus|brachial plexus
304200|NCT01852396|Retroclavicular Approach|retroclavicular approach
304201|NCT01852396|Complications of retroclavicular approach|complications of retroclavicular approach
304202|NCT01852396|Success of retroclavicular approach|success of retroclavicular approach
304203|NCT01852383|Duloxetine|duloxetine
304204|NCT01852383|Antidepressant|antidepressant
304205|NCT01852383|Depression|depression
304206|NCT01852383|Dysthymic Disorder|dysthymic disorder
304207|NCT01852383|Side Effects|side effects
304208|NCT01852383|Elderly|elderly
304209|NCT01852370|Lung transplantation|lung transplantation
304210|NCT01852370|Bone Marrow Transplantation|bone marrow transplantation
304211|NCT01852370|Unrelated Donor|unrelated donor
304212|NCT01852370|Cadaveric Donor|cadaveric donor
304213|NCT01852370|Deceased Donor|deceased donor
304214|NCT01852370|HLA-mismatch|hla-mismatch
304215|NCT01852370|BOLT|bolt
304216|NCT01852370|BMT|bmt
304217|NCT01852370|HSCT|hsct
304218|NCT01852344|Methylphenidate|methylphenidate
304219|NCT01852344|Effortful Control|effortful control
304220|NCT01852344|Attention Control|attention control
304221|NCT01852344|Cognitive functions|cognitive functions
304222|NCT01852331|Schizophrenia|schizophrenia
304223|NCT01852331|Schizophrenic Disorder|schizophrenic disorder
304224|NCT01852331|Hyperprolactinemia|hyperprolactinemia
304225|NCT01852331|Hyperprolactinaemia|hyperprolactinaemia
304226|NCT01852331|Chinese herbal medicine|chinese herbal medicine
304227|NCT01852331|Traditional Chinese medicine|traditional chinese medicine
304228|NCT01852331|Peony-Glycyrrhiza Decoction|peony-glycyrrhiza decoction
304229|NCT01852331|PGD|pgd
304230|NCT01852331|Glycyrrhiza Radix|glycyrrhiza radix
304231|NCT01852331|Liquorice Root|liquorice root
304232|NCT01852331|Gancao|gancao
304233|NCT01852331|Paeoniae Alba Radix|paeoniae alba radix
304234|NCT01852331|White Peony Root|white peony root
304235|NCT01852331|Baishao|baishao
304236|NCT01852318|uremic pruritus|uremic pruritus
304237|NCT01852318|pregabalin|pregabalin
304238|NCT01852318|gabapentin|gabapentin
304239|NCT01852318|fexofenadine|fexofenadine
304240|NCT01852305|Obstructive sleep apnea|obstructive sleep apnea
304241|NCT01852305|Continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
304242|NCT01852305|Oximetry|oximetry
304243|NCT01852305|Bariatric Surgery|bariatric surgery
304244|NCT01852305|Anesthesia|anesthesia
304245|NCT01852305|Oxygen desaturation index (ODI)|oxygen desaturation index (odi)
304246|NCT01852292|platinum pre-treated recurrent or metastatic|platinum pre-treated recurrent or metastatic
304247|NCT01852292|Head and neck squamous cell carcinoma,|head and neck squamous cell carcinoma,
304248|NCT01852292|recurrent|recurrent
304249|NCT01852292|metastatic|metastatic
304250|NCT01852292|BKM120|bkm120
304251|NCT01852253|Dental implants|dental implants
304252|NCT01852253|Periodontal diseases|periodontal diseases
304253|NCT01852253|Peri-implantitis|peri-implantitis
304254|NCT01852253|Chlorhexidine|chlorhexidine
304255|NCT01852253|Microbiology|microbiology
304256|NCT01852214|Diabetes mellitus|diabetes mellitus
304257|NCT01852214|Coronary artery disease|coronary artery disease
304258|NCT01852214|prasugrel|prasugrel
304259|NCT01852214|ticagrelor|ticagrelor
304260|NCT01852188|Intrapartum|intrapartum
304261|NCT01852188|Glove|glove
304262|NCT01852188|Chorioamnionitis|chorioamnionitis
304263|NCT01852175|Coronary artery disease|coronary artery disease
304264|NCT01852175|Dual antiplatelet therapy|dual antiplatelet therapy
304265|NCT01852175|prasugrel|prasugrel
304266|NCT01852175|ticagrelor|ticagrelor
304267|NCT01852162|Coronary artery disease|coronary artery disease
304268|NCT01852162|antiplatelet therapy|antiplatelet therapy
304269|NCT01852162|anticoagulant therapy|anticoagulant therapy
304270|NCT01852149|Mitral Valve Regurgitation|mitral valve regurgitation
304271|NCT01852149|Coaptation|coaptation
304272|NCT01852149|Mitral Valve Repair|mitral valve repair
304273|NCT01852149|Plication|plication
304274|NCT01852149|Leaflet|leaflet
304275|NCT01852149|Annulus|annulus
304276|NCT01852149|Mitral Annuloplasty|mitral annuloplasty
304277|NCT01852136|pen needle|pen needle
304278|NCT01852136|insulin|insulin
304279|NCT01852123|High-sensitivity troponin assay|high-sensitivity troponin assay
304280|NCT01852123|Myocardial infarction|myocardial infarction
304281|NCT01852123|Unstable angina|unstable angina
304282|NCT01852123|Myocardial injury|myocardial injury
304283|NCT01852123|Cluster randomized trial|cluster randomized trial
304284|NCT01852097|Inflammatory Bowel Disease (IBD)|inflammatory bowel disease (ibd)
304285|NCT01852097|Crohn's disease|crohn's disease
304286|NCT01852097|Ulcerative colitis|ulcerative colitis
304287|NCT01852097|Cognitive Behavioural Therapy (CBT)|cognitive behavioural therapy (cbt)
304288|NCT01852097|Medication adherence|medication adherence
304289|NCT01852071|gene therapy, hematopoietic stem cell, SCID, lentivirus|gene therapy, hematopoietic stem cell, scid, lentivirus
304290|NCT01852032|Breast Cancer|breast cancer
304291|NCT01852019|CAD|cad
304292|NCT01851993|Ondansetron|ondansetron
304293|NCT01851993|Exercise|exercise
304294|NCT01851980|Furosemide|furosemide
304295|NCT01851980|Exercise|exercise
304296|NCT01851980|Restrictive pulmonary disorder|restrictive pulmonary disorder
304297|NCT01851967|Major depressive disorder|major depressive disorder
304298|NCT01851967|Cognitive behavioral therapy|cognitive behavioral therapy
304299|NCT01851967|Computerized CBT|computerized cbt
304300|NCT01851967|Online CBT|online cbt
304301|NCT01851915|Major depression|major depression
304302|NCT01851915|Interpersonal psychotherapy|interpersonal psychotherapy
304303|NCT01851915|Cognitive Behavioral Therapy|cognitive behavioral therapy
304304|NCT01851915|Alliance|alliance
304305|NCT01851915|Return to Work|return to work
304306|NCT01851902|Atrial Fibrillation|atrial fibrillation
304307|NCT01851902|Atrial Flutter|atrial flutter
304308|NCT01851902|Arrhythmia|arrhythmia
304309|NCT01851863|functional dyspepsia|functional dyspepsia
304310|NCT01851863|depression|depression
304311|NCT01851863|compliance|compliance
304312|NCT01851850|PD|pd
304313|NCT01851850|Off periods|off periods
304314|NCT01851850|quality of life|quality of life
304315|NCT01851850|dyskinesia|dyskinesia
304316|NCT01851850|end-off-dose motor fluctuations|end-off-dose motor fluctuations
304317|NCT01851811|OSA|osa
304318|NCT01851798|OSA|osa
304319|NCT01851798|Sleep disordered breathing|sleep disordered breathing
304320|NCT01851798|anesthesia|anesthesia
304321|NCT01851798|ambulatory orthopedic surgery|ambulatory orthopedic surgery
304322|NCT01851785|Knee Arthroplasty|knee arthroplasty
304323|NCT01851785|Knee Osteoarthritis|knee osteoarthritis
304324|NCT01851785|Osteoarthritis|osteoarthritis
304325|NCT01851785|disparity|disparity
304326|NCT01851785|joint replacement|joint replacement
304327|NCT01851772|cervical|cervical
304328|NCT01851772|cancer|cancer
304329|NCT01851772|brachytherapy|brachytherapy
304330|NCT01851772|electronic|electronic
304331|NCT01851772|device|device
304332|NCT01851772|applicator|applicator
304333|NCT01851772|toxicity|toxicity
304334|NCT01851772|gynecologic|gynecologic
304335|NCT01851772|high-dose-rate (HDR)|high-dose-rate (hdr)
304336|NCT01851772|x-ray|x-ray
304337|NCT01851772|safety|safety
304338|NCT01851772|external beam radiation therapy (EBRT)|external beam radiation therapy (ebrt)
304339|NCT01851746|recurrent ovarian cancer|recurrent ovarian cancer
304340|NCT01851746|lobaplatin|lobaplatin
304341|NCT01851746|docetaxel|docetaxel
304342|NCT01851746|carboplatin|carboplatin
304343|NCT01851694|Cystic Fibrosis|cystic fibrosis
304344|NCT01851694|Diabetes|diabetes
304345|NCT01851694|Pancreatic insufficiency|pancreatic insufficiency
304346|NCT01851681|dental implants|dental implants
304347|NCT01851681|wound healing|wound healing
304348|NCT01851681|amoxicillin|amoxicillin
304349|NCT01851681|pain|pain
304350|NCT01851668|vibration|vibration
304351|NCT01851668|noise|noise
304352|NCT01851668|transfer|transfer
304353|NCT01851668|intraventricular hemorrhage|intraventricular hemorrhage
304354|NCT01851655|rehabilitation|rehabilitation
304355|NCT01851655|plyometric|plyometric
304356|NCT01851642|Macrophage|macrophage
304357|NCT01851642|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
304358|NCT01851642|Cystic Fibrosis|cystic fibrosis
304359|NCT01851629|Locomotor training|locomotor training
304360|NCT01851629|Walking recovery|walking recovery
304361|NCT01851629|Neuroplasticity|neuroplasticity
304362|NCT01851616|glucose, blood|glucose, blood
304363|NCT01851603|Schizophrenia|schizophrenia
304364|NCT01851590|Dermatophyte onychomycosis|dermatophyte onychomycosis
304365|NCT01851590|Fungal nail infection|fungal nail infection
304366|NCT01851590|Resin Lacquer|resin lacquer
304367|NCT01851590|Amorolfine|amorolfine
304368|NCT01851590|Terbinafine|terbinafine
304369|NCT01851577|Coparenting|coparenting
304370|NCT01851577|Problem solving|problem solving
304371|NCT01851577|Child development|child development
304372|NCT01851577|Father involvement|father involvement
304373|NCT01851564|Gastrointestinal Haemorrhage|gastrointestinal haemorrhage
304374|NCT01851564|Varices|varices
304375|NCT01851564|Liver Cirrhosis|liver cirrhosis
304376|NCT01851564|Stent|stent
304377|NCT01851551|NHL|nhl
304378|NCT01851551|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
304379|NCT01851551|diffuse large b-cell lymphoma|diffuse large b-cell lymphoma
304380|NCT01851551|mantle cell lymphoma|mantle cell lymphoma
304381|NCT01851538|Heart failure|heart failure
304382|NCT01851538|Biomarkers|biomarkers
304383|NCT01851538|Echocardiography|echocardiography
304384|NCT01851525|Atrial fibrillation|atrial fibrillation
304385|NCT01851525|Ablation|ablation
304386|NCT01851499|Neuropathic pain following spinal cord injury|neuropathic pain following spinal cord injury
304387|NCT01851473|Cocaine|cocaine
304388|NCT01851473|Pharmacokinetics|pharmacokinetics
304389|NCT01851473|Pharmacodynamics|pharmacodynamics
304390|NCT01851473|Drug Interactions|drug interactions
304391|NCT01851473|Acetazolamide|acetazolamide
304392|NCT01851460|Staphylococcus Infection|staphylococcus infection
304393|NCT01851460|RFA|rfa
304394|NCT01851460|Hepatic|hepatic
304395|NCT01851460|CGD|cgd
304396|NCT01851447|Muscle|muscle
304397|NCT01851447|Inflammatory Cytokines|inflammatory cytokines
304398|NCT01851447|Exercise|exercise
304399|NCT01851447|Biomarkers|biomarkers
304400|NCT01851447|Predictors of Outcome|predictors of outcome
304401|NCT01851434|OCT|oct
304402|NCT01851434|Multiple Sclerosis|multiple sclerosis
304403|NCT01851434|Optic Neuritis|optic neuritis
304404|NCT01851434|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
304405|NCT01851421|Body Fat|body fat
304406|NCT01851421|Adult|adult
304407|NCT01851421|Obesity|obesity
304408|NCT01851421|Free Fatty Acids|free fatty acids
304409|NCT01851421|Melanocortin-3 Receptor|melanocortin-3 receptor
304410|NCT01851408|Sorafenib|sorafenib
304411|NCT01851408|Temsirolimus|temsirolimus
304412|NCT01851408|Stage IV|stage iv
304413|NCT01851408|recurrent|recurrent
304414|NCT01851408|unresectable|unresectable
304415|NCT01851408|non-choroidal origin|non-choroidal origin
304416|NCT01851408|CCI-779|cci-779
304417|NCT01851408|BAY43-9006|bay43-9006
304418|NCT01851408|metastatic melanoma|metastatic melanoma
304419|NCT01851395|Palliative|palliative
304420|NCT01851395|Tumor Heterogeneity|tumor heterogeneity
304421|NCT01851395|Genomic and Proteomic Alterations|genomic and proteomic alterations
304422|NCT01851395|Deep Sequencing and Global Analysis|deep sequencing and global analysis
304423|NCT01851395|Clonal Evolution|clonal evolution
304424|NCT01851382|ELISA|elisa
304425|NCT01851382|Spectrometry|spectrometry
304426|NCT01851382|Protein Biomarkers|protein biomarkers
304427|NCT01851382|Proteomic Analyses|proteomic analyses
304428|NCT01851369|Solid Tumors|solid tumors
304429|NCT01851369|Lymphomas|lymphomas
304430|NCT01851369|DNA Damage|dna damage
304431|NCT01851369|Pharmacodynamics|pharmacodynamics
304432|NCT01851369|Pharmacokinetics|pharmacokinetics
304433|NCT01851356|PBR28|pbr28
304434|NCT01851356|Depression|depression
304435|NCT01851356|PET Imaging|pet imaging
304436|NCT01851356|Neuroinflammation|neuroinflammation
304437|NCT01851343|Stem Cell Infusion|stem cell infusion
304438|NCT01851343|Crohns|crohns
304439|NCT01851343|Ulcerative Colitis|ulcerative colitis
304440|NCT01851343|Inflammation|inflammation
304441|NCT01851343|Diarrhea|diarrhea
304442|NCT01851330|HCV genotype 1 (GT-1)|hcv genotype 1 (gt-1)
304443|NCT01851330|HCV|hcv
304444|NCT01851330|Sustained Virologic Response|sustained virologic response
304445|NCT01851330|Direct Acting Antiviral|direct acting antiviral
304446|NCT01851330|Combination Therapy|combination therapy
304447|NCT01851330|GS-7977|gs-7977
304448|NCT01851330|GS-5885|gs-5885
304449|NCT01851330|Ribavirin|ribavirin
304450|NCT01851330|Open Label|open label
304451|NCT01851330|Sofosbuvir|sofosbuvir
304452|NCT01851330|Additional relevant MeSH terms:|additional relevant mesh terms:
304453|NCT01851330|Hepatitis|hepatitis
304454|NCT01851330|Hepatitis, Chronic|hepatitis, chronic
304455|NCT01851330|Hepatitis C|hepatitis c
304456|NCT01851330|Hepatitis C, Chronic|hepatitis c, chronic
304457|NCT01851330|Liver Diseases|liver diseases
304458|NCT01851330|Digestive System Diseases|digestive system diseases
304459|NCT01851330|Hepatitis, Viral, Human|hepatitis, viral, human
304460|NCT01851330|Virus Diseases|virus diseases
304461|NCT01851330|Enterovirus Infections|enterovirus infections
304462|NCT01851330|Picornaviridae Infections|picornaviridae infections
304463|NCT01851330|RNA Virus Infections|rna virus infections
304464|NCT01851330|Flaviviridae Infections|flaviviridae infections
304465|NCT01851330|Antiviral Agents|antiviral agents
304466|NCT01851330|Anti-Infective Agents|anti-infective agents
304467|NCT01851330|Therapeutic Uses|therapeutic uses
304468|NCT01851330|Pharmacologic Actions|pharmacologic actions
304469|NCT01851330|Antimetabolites|antimetabolites
304470|NCT01851330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
304471|NCT01851304|beta-Glucans|beta-glucans
304472|NCT01851304|Bitter|bitter
304473|NCT01851304|Bread|bread
304474|NCT01851304|Coffee|coffee
304475|NCT01851304|Gentiana lutea|gentiana lutea
304476|NCT01851304|Melanoidins|melanoidins
304477|NCT01851304|Microencapsulation|microencapsulation
304478|NCT01851278|injection|injection
304479|NCT01851278|arthritis|arthritis
304480|NCT01851278|corticosteroid|corticosteroid
304481|NCT01851265|oncology, cancer, tumour, neoplasm, anticancer drug, food effect, area under the curve, pharmacokinetics, olaparib, solid tumour, metabolites, drug availability|oncology, cancer, tumour, neoplasm, anticancer drug, food effect, area under the curve, pharmacokinetics, olaparib, solid tumour, metabolites, drug availability
304482|NCT01851252|Cirrhotics|cirrhotics
304483|NCT01851252|Esophageal varices|esophageal varices
304484|NCT01851252|Portal Hypertension|portal hypertension
304485|NCT01851239|Venous Thromboembolism Prophylaxis|venous thromboembolism prophylaxis
304486|NCT01851239|ICU|icu
304487|NCT01851213|genomics|genomics
304488|NCT01851213|cancer|cancer
304489|NCT01851213|registry|registry
304490|NCT01851213|neoplasm metastasis|neoplasm metastasis
304491|NCT01851200|Testicular neoplasms|testicular neoplasms
304492|NCT01851200|Germ Cell cancers|germ cell cancers
304493|NCT01851200|Embryonal Carcinoma|embryonal carcinoma
304494|NCT01851200|Metastatic|metastatic
304495|NCT01851200|Brentuximab Vedotin|brentuximab vedotin
304496|NCT01851187|Psychological intervention,|psychological intervention,
304497|NCT01851187|prenatal period,|prenatal period,
304498|NCT01851187|cesarean section rate,|cesarean section rate,
304499|NCT01851187|stage of labor|stage of labor
304500|NCT01851148|osteopathic manipulative treatment|osteopathic manipulative treatment
304501|NCT01851148|migraine|migraine
304502|NCT01851135|Quality of life|quality of life
304503|NCT01851135|Neuropsychological disorders|neuropsychological disorders
304504|NCT01851135|Neurofibromatosis type 1|neurofibromatosis type 1
304505|NCT01851122|l-theanine|l-theanine
304506|NCT01851122|alertness|alertness
304507|NCT01851122|well-being|well-being
304508|NCT01851109|ovarian cancer|ovarian cancer
304509|NCT01851109|prevention|prevention
304510|NCT01851109|prophylactic surgery|prophylactic surgery
304511|NCT01851109|risk|risk
304512|NCT01851109|biomarkers|biomarkers
304513|NCT01851109|screening|screening
304514|NCT01851109|symptoms|symptoms
304515|NCT01851096|Hsp90|hsp90
304516|NCT01851096|SNX-5422|snx-5422
304517|NCT01851096|Erlotinib|erlotinib
304518|NCT01851096|Lung adenocarcinoma|lung adenocarcinoma
304519|NCT01851083|Traumatic Brain Injury|traumatic brain injury
304520|NCT01851083|TBI|tbi
304521|NCT01851083|pediatric|pediatric
304522|NCT01851083|acute|acute
304523|NCT01851083|stem cells|stem cells
304524|NCT01851057|Epilepsy|epilepsy
304525|NCT01851044|Platelet Rich Plasma|platelet rich plasma
304526|NCT01851044|Whole Blood Injection|whole blood injection
304527|NCT01851044|Lateral Epicondylitis|lateral epicondylitis
304528|NCT01851044|Tennis Elbow|tennis elbow
304529|NCT01851031|medial or low condylar fractures|medial or low condylar fractures
304530|NCT01851031|the minor parotid anterior approach|the minor parotid anterior approach
304531|NCT01851031|the retromandibular approach|the retromandibular approach
304532|NCT01851018|Prostate cancer|prostate cancer
304533|NCT01851018|brachytherapy|brachytherapy
304534|NCT01851018|hypofractionated radiation therapy|hypofractionated radiation therapy
304535|NCT01851018|hormonal therapy|hormonal therapy
304536|NCT01851005|Dexmedetomidine|dexmedetomidine
304537|NCT01851005|Anesthesia|anesthesia
304538|NCT01851005|Recovery profile|recovery profile
304539|NCT01850992|Obstructive sleep apnea.|obstructive sleep apnea.
304540|NCT01850992|sleep|sleep
304541|NCT01850992|male hormones|male hormones
304542|NCT01850979|CYCLOSPORINE/TACROLIMUS [VA Drug Interaction]|cyclosporine/tacrolimus [va drug interaction]
304543|NCT01850966|Arthritis, Rheumatoid, Iguratimod|arthritis, rheumatoid, iguratimod
304544|NCT01850953|Varenicline|varenicline
304545|NCT01850953|Schizophrenia|schizophrenia
304546|NCT01850953|smoking|smoking
304547|NCT01850953|Lapse|lapse
304548|NCT01850940|Cirrhotic Patients|cirrhotic patients
304549|NCT01850940|Hyponatremia|hyponatremia
304550|NCT01850940|tolvaptan|tolvaptan
304551|NCT01850914|Normal pressure hydrocephalus|normal pressure hydrocephalus
304552|NCT01850914|Vascular risk factors|vascular risk factors
304553|NCT01850901|Hypertension|hypertension
304554|NCT01850901|Renal denervation|renal denervation
304555|NCT01850901|Sympathetic denervation|sympathetic denervation
304556|NCT01850888|neuroblastoma|neuroblastoma
304557|NCT01850888|pheochromocytoma|pheochromocytoma
304806|NCT01849796|Facial|facial
304558|NCT01850875|Eye-Movement-Desensitization and Reprocessing|eye-movement-desensitization and reprocessing
304559|NCT01850875|EMDR|emdr
304560|NCT01850875|Chronic back pain|chronic back pain
304561|NCT01850875|CBP|cbp
304562|NCT01850875|treatment|treatment
304563|NCT01850836|Aphasia, Stroke, repetitive transcranial magnetic stimulation.|aphasia, stroke, repetitive transcranial magnetic stimulation.
304564|NCT01850797|oral anticoagulants|oral anticoagulants
304565|NCT01850797|ischemic stroke|ischemic stroke
304566|NCT01850797|blood thinner|blood thinner
304567|NCT01850797|intracranial hemorrhage|intracranial hemorrhage
304568|NCT01850784|Congenital heart disease, Growth,Neurodevelopment|congenital heart disease, growth,neurodevelopment
304569|NCT01850771|Lumbar Radiculopathy|lumbar radiculopathy
304570|NCT01850771|Disc bulge|disc bulge
304571|NCT01850771|Disc herniation|disc herniation
304572|NCT01850771|Disc degeneration|disc degeneration
304573|NCT01850758|ACL|acl
304574|NCT01850758|Anterior Cruciate Ligament|anterior cruciate ligament
304575|NCT01850758|ACL Tear|acl tear
304576|NCT01850758|Anterior Cruciate Ligament Tear|anterior cruciate ligament tear
304577|NCT01850758|Partial ACL Tear|partial acl tear
304578|NCT01850745|Chronic hepatitis C virus infection (CHC)|chronic hepatitis c virus infection (chc)
304579|NCT01850719|Tibial meniscus|tibial meniscus
304580|NCT01850719|Arthroscopy|arthroscopy
304581|NCT01850719|Meniscectomy|meniscectomy
304582|NCT01850719|Conservative treatment|conservative treatment
304583|NCT01850719|Physical therapy|physical therapy
304584|NCT01850719|Osteoarthritis knee joint|osteoarthritis knee joint
304585|NCT01850706|uNGF|ungf
304586|NCT01850706|urinary nerve growth factor|urinary nerve growth factor
304587|NCT01850706|detrusor overactivity|detrusor overactivity
304588|NCT01850706|InterStim|interstim
304589|NCT01850706|sacral neuromodulation|sacral neuromodulation
304590|NCT01850706|sacral nerve stimulation|sacral nerve stimulation
304591|NCT01850706|quality of life|quality of life
304592|NCT01850706|questionnaire|questionnaire
304593|NCT01850706|urodynamic detrusor overactivity|urodynamic detrusor overactivity
304594|NCT01850706|overactive bladder|overactive bladder
304595|NCT01850693|coronary artery disease|coronary artery disease
304596|NCT01850693|stroke|stroke
304597|NCT01850693|coronary CT angiography|coronary ct angiography
304598|NCT01850667|Hepatocellular carcinoma|hepatocellular carcinoma
304599|NCT01850667|Stereotactic body radiotherapy|stereotactic body radiotherapy
304600|NCT01850667|Stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
304601|NCT01850654|colorectal cancer|colorectal cancer
304602|NCT01850654|colon cancer|colon cancer
304603|NCT01850654|rectal cancer|rectal cancer
304604|NCT01850654|endometrial cancer|endometrial cancer
304605|NCT01850654|Lynch syndrome|lynch syndrome
304606|NCT01850654|Ohio colon cancer study|ohio colon cancer study
304607|NCT01850654|OSU colon study|osu colon study
304608|NCT01850641|Hemodialysis|hemodialysis
304609|NCT01850641|Hyperphosphatemia|hyperphosphatemia
304610|NCT01850628|National Surgical Adjuvant Breast and Bowel Project (NSABP)|national surgical adjuvant breast and bowel project (nsabp)
304611|NCT01850628|paclitaxel|paclitaxel
304612|NCT01850628|trastuzumab|trastuzumab
304613|NCT01850628|pertuzumab|pertuzumab
304614|NCT01850628|HER2 positive (human epidermal growth factor receptor 2)|her2 positive (human epidermal growth factor receptor 2)
304615|NCT01850628|Proteomics|proteomics
304616|NCT01850628|Neoadjuvant Therapy|neoadjuvant therapy
304617|NCT01850628|Anthracycline therapy|anthracycline therapy
304618|NCT01850628|Locally advanced|locally advanced
304619|NCT01850628|Operable|operable
304620|NCT01850628|Biomarkers|biomarkers
304621|NCT01850602|Hemodialysis|hemodialysis
304622|NCT01850602|Hyperphosphatemia|hyperphosphatemia
304623|NCT01850576|prevention|prevention
304624|NCT01850576|testing|testing
304625|NCT01850576|counseling|counseling
304626|NCT01850576|linkage|linkage
304627|NCT01850563|Demonstrate coordination of HBO with SRS treatments is feasible.|demonstrate coordination of hbo with srs treatments is feasible.
304628|NCT01850563|Demonstrate outcomes for patients treated with combination of HBO and SRS are non-inferior .|demonstrate outcomes for patients treated with combination of hbo and srs are non-inferior .
304629|NCT01850550|Weight loss|weight loss
304630|NCT01850537|DDD|ddd
304631|NCT01850537|PROW|prow
304632|NCT01850537|FUSION|fusion
304633|NCT01850537|eSPIN|espin
304634|NCT01850537|Cage|cage
304635|NCT01850537|IBF|ibf
304636|NCT01850537|Discectomy|discectomy
304637|NCT01850537|Lumbar Fusion|lumbar fusion
304638|NCT01850537|TLIF|tlif
304639|NCT01850537|MIS|mis
304640|NCT01850524|Newly Diagnosed multiple myeloma|newly diagnosed multiple myeloma
304641|NCT01850524|multiple myeloma|multiple myeloma
304642|NCT01850524|MLN9708|mln9708
304643|NCT01850524|IXAZOMIB|ixazomib
304644|NCT01850524|Proteasome inhibitor|proteasome inhibitor
304645|NCT01850524|Tourmaline MM2|tourmaline mm2
304646|NCT01850511|Nasal obstruction|nasal obstruction
304647|NCT01850511|Vibrissae|vibrissae
304648|NCT01850511|Nasal hair|nasal hair
304649|NCT01850498|Epilepsy|epilepsy
304650|NCT01850498|Seizure|seizure
304651|NCT01850498|Motor|motor
304652|NCT01850498|Motion|motion
304653|NCT01850498|Accelerometer|accelerometer
304654|NCT01850485|cardiac arrest|cardiac arrest
304655|NCT01850485|therapeutic hypothermia|therapeutic hypothermia
304656|NCT01850485|microcirculation|microcirculation
304657|NCT01850472|Anhedonia|anhedonia
304658|NCT01850472|Depression|depression
304659|NCT01850472|Stress|stress
304660|NCT01850472|Cortisol|cortisol
304661|NCT01850472|Inflammatory cytokines|inflammatory cytokines
304662|NCT01850472|Learning|learning
304663|NCT01850472|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
304664|NCT01850433|BDD|bdd
304665|NCT01850433|CBT|cbt
304666|NCT01850420|fibromyalgia|fibromyalgia
304667|NCT01850420|Myofascial|myofascial
304668|NCT01850407|Lack of Preparation for Abused Children during Medical Examination|lack of preparation for abused children during medical examination
304669|NCT01850381|Parkinson Disease|parkinson disease
304670|NCT01850381|Efficacy|efficacy
304671|NCT01850381|Safety|safety
304672|NCT01850381|Tolerability|tolerability
304673|NCT01850381|Phase 2A|phase 2a
304674|NCT01850381|Pilot trial|pilot trial
304675|NCT01850381|human Motoneuronotrophic Factor|human motoneuronotrophic factor
304676|NCT01850381|neuroprotective agent|neuroprotective agent
304677|NCT01850381|neurodegenerative diseases|neurodegenerative diseases
304678|NCT01850381|rate of clinical progression of PD|rate of clinical progression of pd
304679|NCT01850381|UPDRS|updrs
304680|NCT01850381|Proof of principle|proof of principle
304681|NCT01850368|Hepatocellular carcinoma|hepatocellular carcinoma
304682|NCT01850368|Stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
304683|NCT01850368|Stereotactic body radiotherapy|stereotactic body radiotherapy
304684|NCT01850368|Portal vein tumor thrombus|portal vein tumor thrombus
304685|NCT01850355|Autism Spectrum Disorders|autism spectrum disorders
304686|NCT01850355|Anxiety|anxiety
304687|NCT01850355|Children|children
304688|NCT01850355|Adolescents|adolescents
304689|NCT01850355|Buspar|buspar
304690|NCT01850355|Buspirone|buspirone
304691|NCT01850355|Pervasive Developmental Disorders|pervasive developmental disorders
304692|NCT01850342|Male stress urinary incontinence|male stress urinary incontinence
304693|NCT01850342|Cell-assisted lipotransfer|cell-assisted lipotransfer
304694|NCT01850342|Adipose-derived regenerative cells|adipose-derived regenerative cells
304695|NCT01850342|ADRC|adrc
304696|NCT01850342|Micrograft|micrograft
304697|NCT01850342|Fat tissue|fat tissue
304698|NCT01850342|Stem cells|stem cells
304699|NCT01850303|Elderly|elderly
304700|NCT01850303|lung cancer|lung cancer
304701|NCT01850303|switch|switch
304702|NCT01850303|maintenance|maintenance
304703|NCT01850303|Elderly patients (between 70 and 89 years)|elderly patients (between 70 and 89 years)
304704|NCT01850303|NSCLC|nsclc
304705|NCT01850290|TBI|tbi
304706|NCT01850277|Atrial fibrillation|atrial fibrillation
304707|NCT01850277|Cardiac resynchronization therapy|cardiac resynchronization therapy
304708|NCT01850277|Heart failure|heart failure
304709|NCT01850277|Rhythm control strategy|rhythm control strategy
304710|NCT01850264|cardiac resynchronization therapy; heart failure, congestive|cardiac resynchronization therapy; heart failure, congestive
304711|NCT01850251|Hip fractures|hip fractures
304712|NCT01850251|Ageing|ageing
304713|NCT01850251|Sarcopenia|sarcopenia
304714|NCT01850251|Function|function
304715|NCT01850238|Alzheimer disease|alzheimer disease
304716|NCT01850238|tau protein|tau protein
304717|NCT01850238|neurofibrillary degeneration|neurofibrillary degeneration
304718|NCT01850238|disease-modifying|disease-modifying
304719|NCT01850212|Treatment Experienced|treatment experienced
304720|NCT01850212|Male greater than or equal to 50 years|male greater than or equal to 50 years
304721|NCT01850212|Female postmenopausal|female postmenopausal
304722|NCT01850199|Gestational diabetes|gestational diabetes
304723|NCT01850199|Telemedicine|telemedicine
304828|NCT01849705|MC4R|mc4r
304724|NCT01850199|Artificial Intelligence|artificial intelligence
304725|NCT01850160|Hypertension|hypertension
304726|NCT01850160|High blood pressure|high blood pressure
304727|NCT01850160|Drug therapy combination|drug therapy combination
304728|NCT01850160|Valsartan|valsartan
304729|NCT01850160|Chlorthalidone|chlorthalidone
304730|NCT01850160|Safety|safety
304731|NCT01850160|Efficacy|efficacy
304732|NCT01850147|sunitinib|sunitinib
304733|NCT01850147|chemotherapy|chemotherapy
304734|NCT01850147|non-small cell lung cancer|non-small cell lung cancer
304735|NCT01850147|NSCLC|nsclc
304736|NCT01850121|Ankylosing Spondylitis|ankylosing spondylitis
304737|NCT01850121|infiximab|infiximab
304738|NCT01850121|single armed trial|single armed trial
304739|NCT01850095|acne|acne
304740|NCT01850095|adult|adult
304741|NCT01850095|women|women
304742|NCT01850095|TLR|tlr
304743|NCT01850095|CD1d|cd1d
304744|NCT01850095|androgens|androgens
304745|NCT01850082|Coronary artery disease|coronary artery disease
304746|NCT01850082|CABG|cabg
304747|NCT01850082|Coronary revascularization|coronary revascularization
304748|NCT01850082|Endoscopic vein harvest|endoscopic vein harvest
304749|NCT01850082|Saphenous vein graft|saphenous vein graft
304750|NCT01850082|Graft failure|graft failure
304751|NCT01850069|Intracranial hypertension|intracranial hypertension
304752|NCT01850069|intracranial elastance|intracranial elastance
304753|NCT01850056|drug eluting balloon catheter|drug eluting balloon catheter
304754|NCT01850017|Opiate consumption|opiate consumption
304755|NCT01850017|Visual Analogue Scale|visual analogue scale
304756|NCT01849991|Crying|crying
304757|NCT01849991|Fussiness|fussiness
304758|NCT01849991|Gas|gas
304759|NCT01849991|Hydrogen Breath|hydrogen breath
304760|NCT01849991|Fecal Calprotectin|fecal calprotectin
304761|NCT01849978|breast cancer|breast cancer
304762|NCT01849978|survivor|survivor
304763|NCT01849978|exercise|exercise
304764|NCT01849978|physical activity|physical activity
304765|NCT01849978|strenuous exercise|strenuous exercise
304766|NCT01849978|moderate exercise|moderate exercise
304767|NCT01849978|enjoyable exercise|enjoyable exercise
304768|NCT01849978|enjoy exercise|enjoy exercise
304769|NCT01849978|breast cancer survivor|breast cancer survivor
304770|NCT01849965|diabetic foot ulcers|diabetic foot ulcers
304771|NCT01849965|Wagner Grade 1 or 2 ulcers|wagner grade 1 or 2 ulcers
304772|NCT01849952|glioblastoma|glioblastoma
304773|NCT01849952|miRNA|mirna
304774|NCT01849952|GBM|gbm
304775|NCT01849952|astrocytoma|astrocytoma
304776|NCT01849939|Allogeneic transplantation of hematopoietic stem cells transplantation|allogeneic transplantation of hematopoietic stem cells transplantation
304777|NCT01849939|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
304778|NCT01849939|Donor Lymphocyte Injection|donor lymphocyte injection
304779|NCT01849939|Preemptive immunointervention|preemptive immunointervention
304780|NCT01849913|neck pain|neck pain
304781|NCT01849913|hydrocortisone|hydrocortisone
304782|NCT01849913|stress|stress
304783|NCT01849913|electromyography|electromyography
304784|NCT01849913|adolescent|adolescent
304785|NCT01849913|low-level laser therapy|low-level laser therapy
304786|NCT01849900|Menstrual cycle|menstrual cycle
304787|NCT01849900|Ovulation time|ovulation time
304788|NCT01849900|pregnancy recognition|pregnancy recognition
304789|NCT01849900|Community-based participatory research|community-based participatory research
304790|NCT01849900|Unintended pregnancy|unintended pregnancy
304791|NCT01849861|Cardiopulmonary Capacity|cardiopulmonary capacity
304792|NCT01849861|Ranges of TSH|ranges of tsh
304793|NCT01849861|Elderly Population|elderly population
304794|NCT01849835|rate of positive detection|rate of positive detection
304795|NCT01849822|neural|neural
304796|NCT01849822|prosthetic|prosthetic
304797|NCT01849822|brain machine interface|brain machine interface
304798|NCT01849822|brain computer interface|brain computer interface
304799|NCT01849822|brain control|brain control
304800|NCT01849822|paralysis|paralysis
304801|NCT01849822|tetraplegia|tetraplegia
304802|NCT01849822|quadriplegia|quadriplegia
304803|NCT01849822|spinal cord injury|spinal cord injury
304804|NCT01849796|tDCS|tdcs
304805|NCT01849796|Neuropathic|neuropathic
304808|NCT01849796|Neuralgia|neuralgia
304809|NCT01849796|deafferentation|deafferentation
304810|NCT01849796|Trigeminal|trigeminal
304811|NCT01849770|SALS|sals
304812|NCT01849770|Mexiletine|mexiletine
304813|NCT01849770|Safety|safety
304814|NCT01849757|Cardiopulmonary bypass|cardiopulmonary bypass
304815|NCT01849757|prime|prime
304816|NCT01849757|crystalloid|crystalloid
304817|NCT01849757|albumin|albumin
304818|NCT01849757|HES 130/0.4|hes 130/0.4
304819|NCT01849744|Focal Adhesion Kinase inhibitor|focal adhesion kinase inhibitor
304820|NCT01849744|FAK inhibitor|fak inhibitor
304821|NCT01849744|Cancer Stem Cells|cancer stem cells
304822|NCT01849744|CSC|csc
304823|NCT01849731|Diabetes Mellitus type 2;|diabetes mellitus type 2;
304824|NCT01849731|Primary Care, healthcare inequalities;|primary care, healthcare inequalities;
304825|NCT01849731|Diabetes self-management,|diabetes self-management,
304826|NCT01849731|Quality of diabetes care|quality of diabetes care
304827|NCT01849705|Obesity|obesity
304829|NCT01849705|Blood pressure|blood pressure
304830|NCT01849705|Blood glucose|blood glucose
304831|NCT01849692|Exudative Age-Related Macular Degeneration|exudative age-related macular degeneration
304832|NCT01849692|Wet AMD|wet amd
304833|NCT01849692|Choroidal neovascularization (CNV)|choroidal neovascularization (cnv)
304834|NCT01849692|Vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
304835|NCT01849679|Dysphagia|dysphagia
304836|NCT01849679|extubation|extubation
304837|NCT01849679|aspiration|aspiration
304838|NCT01849653|vaginal swabs|vaginal swabs
304839|NCT01849653|diagnosis|diagnosis
304840|NCT01849640|Malaria|malaria
304841|NCT01849640|Drug resistance|drug resistance
304842|NCT01849640|DHA-piperaquine|dha-piperaquine
304843|NCT01849640|Cambodia|cambodia
304844|NCT01849640|Transmission Blocking|transmission blocking
304845|NCT01849627|weight loss maintenance|weight loss maintenance
304846|NCT01849588|Hepatitis C positive|hepatitis c positive
304847|NCT01849575|Ultrasonography|ultrasonography
304848|NCT01849575|Cardiovascular diseases|cardiovascular diseases
304849|NCT01849575|Prevention|prevention
304850|NCT01849575|Risk communication|risk communication
304851|NCT01849575|Risk assessment|risk assessment
304852|NCT01849575|Behavioral change|behavioral change
304853|NCT01849562|Hepatitis C, Chronic|hepatitis c, chronic
304854|NCT01849562|Genotype 1|genotype 1
304855|NCT01849562|Hepatitis C|hepatitis c
304856|NCT01849562|Liver Diseases|liver diseases
304857|NCT01849562|Hepatitis, viral, human|hepatitis, viral, human
304858|NCT01849562|ribavirin|ribavirin
304859|NCT01849562|antiviral agents|antiviral agents
304860|NCT01849562|anti-infective agents|anti-infective agents
304861|NCT01849562|protease inhibitors|protease inhibitors
304862|NCT01849562|NS5a inhibitors|ns5a inhibitors
304863|NCT01849549|neuropsychological Study|neuropsychological study
304864|NCT01849549|brain Imaging|brain imaging
304865|NCT01849536|Open angle glaucoma|open angle glaucoma
304866|NCT01849536|Corneal biomechanics|corneal biomechanics
304867|NCT01849536|Intra ocular pressure|intra ocular pressure
304868|NCT01849536|IOP|iop
304869|NCT01849536|IOP fluctuation|iop fluctuation
304870|NCT01849536|Continuous IOP monitoring|continuous iop monitoring
304871|NCT01849536|SENSIMED Triggerfish®|sensimed triggerfish®
304872|NCT01849523|Neuroendocrine tumor|neuroendocrine tumor
304873|NCT01849523|Website|website
304874|NCT01849523|Information|information
304875|NCT01849523|Psychosocial support|psychosocial support
304876|NCT01849510|spinal metastases|spinal metastases
304877|NCT01849510|vertebral body|vertebral body
304878|NCT01849510|stereotaxis|stereotaxis
304879|NCT01849510|image-guided radiotherapy|image-guided radiotherapy
304880|NCT01849510|hypofractionated|hypofractionated
304881|NCT01849510|dose intensified|dose intensified
304882|NCT01849510|dose elevation|dose elevation
304883|NCT01849497|LDL-C, triglycerides, high cholesterol|ldl-c, triglycerides, high cholesterol
304884|NCT01849484|meningioma|meningioma
304885|NCT01849484|skull base meningioma|skull base meningioma
304886|NCT01849484|pituitary adenoma|pituitary adenoma
304887|NCT01849484|brain metastases|brain metastases
304888|NCT01849484|small cell lung carcinoma|small cell lung carcinoma
304889|NCT01849471|socioeconomic aspects|socioeconomic aspects
304890|NCT01849471|costs of therapy|costs of therapy
304891|NCT01849471|follow-up costs|follow-up costs
304892|NCT01849471|primary radiation|primary radiation
304893|NCT01849471|percutaneous|percutaneous
304894|NCT01849471|interstitial|interstitial
304895|NCT01849393|Adolescents|adolescents
304896|NCT01849393|Medication Compliance|medication compliance
304897|NCT01849393|Rewards-Based Incentive Programs|rewards-based incentive programs
304898|NCT01849380|Local Advanced Breast Neoplasms|local advanced breast neoplasms
304899|NCT01849380|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
304900|NCT01849380|S-1|s-1
304901|NCT01849341|COPD|copd
304902|NCT01849302|Appetite|appetite
304903|NCT01849302|Satiety hormones|satiety hormones
304904|NCT01849302|Dietary Protein|dietary protein
304905|NCT01849237|Mesenchymal Stromal Cells|mesenchymal stromal cells
304906|NCT01849237|Septic Shock|septic shock
304907|NCT01849237|Neutropenia|neutropenia
304908|NCT01849237|Procalcitonin|procalcitonin
304909|NCT01849237|Interleukin-6|interleukin-6
304910|NCT01849237|Interleukin-10|interleukin-10
304911|NCT01849237|C-reactive protein|c-reactive protein
304912|NCT01849237|Survival|survival
304913|NCT01849237|Organ dysfunction|organ dysfunction
304914|NCT01849224|Lower extremity edema|lower extremity edema
304915|NCT01849224|Lower leg lymphedema|lower leg lymphedema
304916|NCT01849224|Lower leg edema|lower leg edema
304917|NCT01849224|Lymphedema|lymphedema
304918|NCT01849224|Pelvic lymphadenectomy|pelvic lymphadenectomy
304919|NCT01849224|Exercise|exercise
304920|NCT01849211|ventilation|ventilation
304921|NCT01849211|face mask|face mask
304922|NCT01849211|NMBA|nmba
304923|NCT01849198|accelerometry|accelerometry
304924|NCT01849198|neuromuscular block|neuromuscular block
304925|NCT01849198|m. trapezius|m. trapezius
304926|NCT01849185|Hypercholesterolemia|hypercholesterolemia
304927|NCT01849159|Mesenchymal stem cells|mesenchymal stem cells
304928|NCT01849159|Hypoxia|hypoxia
304929|NCT01849159|Emphysema|emphysema
304930|NCT01849133|Breast cancer|breast cancer
304931|NCT01849133|conservative surgery|conservative surgery
304932|NCT01849133|intraoperative radiation therapy|intraoperative radiation therapy
304933|NCT01849133|mobile linear accelerator|mobile linear accelerator
304934|NCT01849120|near infrared spectroscopy (NIRS)|near infrared spectroscopy (nirs)
304935|NCT01849120|EQUANOX Advance 8004CB probes|equanox advance 8004cb probes
304936|NCT01849120|cerebral vascular circulation|cerebral vascular circulation
304937|NCT01849120|peripheral perfusion|peripheral perfusion
304938|NCT01849107|Radiation-induced small bowel toxicity|radiation-induced small bowel toxicity
304939|NCT01849107|Plasma citrulline|plasma citrulline
304940|NCT01849081|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
304941|NCT01849081|Obstructive sleep apnea|obstructive sleep apnea
304942|NCT01849029|Post traumatic Stress Disorders|post traumatic stress disorders
304943|NCT01849029|PTSD|ptsd
304944|NCT01849029|HIV risk|hiv risk
304945|NCT01849029|sexual risk|sexual risk
304946|NCT01849029|substance use|substance use
304947|NCT01849029|alcohol misuse|alcohol misuse
304948|NCT01849029|Substance Abuse|substance abuse
304949|NCT01849029|Substance Addiction|substance addiction
304950|NCT01849029|Substance Dependence|substance dependence
304951|NCT01849029|Substance Use Disorders|substance use disorders
304952|NCT01849029|Alcohol-Related Disorders|alcohol-related disorders
304953|NCT01849029|Binge Drinking|binge drinking
304954|NCT01849029|Sexual Partners|sexual partners
304955|NCT01849029|Sexual Behavior|sexual behavior
304956|NCT01849029|Unsafe Sex|unsafe sex
304957|NCT01849016|Sickle Cell Disease|sickle cell disease
304958|NCT01849016|Sickle Cell Anemia|sickle cell anemia
304959|NCT01849016|Pain|pain
304960|NCT01849016|N-Acetylcysteine|n-acetylcysteine
304961|NCT01849016|Acetylcysteine|acetylcysteine
304962|NCT01849016|Oxidative stress|oxidative stress
304963|NCT01849003|Long QT Syndrome|long qt syndrome
304964|NCT01849003|LQTS|lqts
304965|NCT01849003|Long QT-3 Syndrome|long qt-3 syndrome
304966|NCT01849003|LQT-3|lqt-3
304967|NCT01849003|prolonged QT interval|prolonged qt interval
304968|NCT01849003|GS-6615|gs-6615
304969|NCT01849003|late sodium current inhibitor|late sodium current inhibitor
304970|NCT01848990|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
304971|NCT01848990|Sub Cutaneous Insulin Infusion|sub cutaneous insulin infusion
304972|NCT01848990|Rapid Acting Analog Insulin|rapid acting analog insulin
304973|NCT01848990|Hylenex|hylenex
304974|NCT01848990|Halozyme|halozyme
304975|NCT01848990|Phase 4|phase 4
304976|NCT01848977|Measures|measures
304977|NCT01848977|near-Infrared spectroscopy|near-infrared spectroscopy
304978|NCT01848977|ischemia|ischemia
304979|NCT01848977|reperfusion|reperfusion
304980|NCT01848964|amputation|amputation
304981|NCT01848964|prosthesis|prosthesis
304982|NCT01848964|stump|stump
304983|NCT01848964|socket|socket
304984|NCT01848964|pressure|pressure
304985|NCT01848964|gait|gait
304986|NCT01848964|posture|posture
304987|NCT01848938|female|female
304988|NCT01848938|stress urinary incontinence|stress urinary incontinence
304989|NCT01848938|treatment|treatment
304990|NCT01848938|pelvic floor muscle training|pelvic floor muscle training
304991|NCT01848938|smartphone|smartphone
304992|NCT01848938|internet|internet
304993|NCT01848938|life style|life style
304994|NCT01848938|eHealth|ehealth
304995|NCT01848925|SANGUINATE|sanguinate
304996|NCT01848899|Coronary angiography|coronary angiography
304997|NCT01848899|Percutaneous coronary intervention|percutaneous coronary intervention
304998|NCT01848899|Contrast media|contrast media
304999|NCT01848899|Platelet activity|platelet activity
305000|NCT01848899|Thrombin generation|thrombin generation
305001|NCT01848899|Fibrinolysis|fibrinolysis
305002|NCT01848886|ERAH|erah
305003|NCT01848886|Endoscopic Radial Artery Harvest|endoscopic radial artery harvest
305004|NCT01848886|Y-graft|y-graft
305005|NCT01848886|Radial Artery Harvest|radial artery harvest
305006|NCT01848886|Total Arterial Revascularisation|total arterial revascularisation
305007|NCT01848886|CABG|cabg
305008|NCT01848886|Radial Artery Conduit|radial artery conduit
305009|NCT01848873|Hyperhomocysteinemia|hyperhomocysteinemia
305010|NCT01848873|Amlodipine-folic acid tablets|amlodipine-folic acid tablets
305011|NCT01848873|Hypertension|hypertension
305012|NCT01848873|MTHFR C677T|mthfr c677t
305013|NCT01848860|Pneumothorax|pneumothorax
305014|NCT01848860|thoracoscopy|thoracoscopy
305015|NCT01848860|mesh|mesh
305016|NCT01848860|pleurodesis|pleurodesis
305017|NCT01848860|treatment|treatment
305018|NCT01848847|Hysteroscopy|hysteroscopy
305019|NCT01848847|Bladder|bladder
305020|NCT01848847|Pain|pain
305021|NCT01848847|Feasibility|feasibility
305022|NCT01848847|Duration|duration
305023|NCT01848834|PD-1|pd-1
305024|NCT01848834|PD1|pd1
305025|NCT01848834|PD-L1|pd-l1
305026|NCT01848834|PDL1|pdl1
305027|NCT01848821|OASIS ultra|oasis ultra
305028|NCT01848821|faster healing time|faster healing time
305029|NCT01848821|better healing quality|better healing quality
305030|NCT01848821|standard of care|standard of care
305031|NCT01848795|Type 2 Diabetes|type 2 diabetes
305032|NCT01848795|Obesity|obesity
305033|NCT01848795|gastrointestinal hormones|gastrointestinal hormones
305034|NCT01848795|intestinal bypass|intestinal bypass
305035|NCT01848795|endoscopy|endoscopy
305036|NCT01848782|abstract|abstract
305037|NCT01848782|meta-analysis|meta-analysis
305038|NCT01848782|systematic review|systematic review
305039|NCT01848782|interpretation|interpretation
305040|NCT01848782|results|results
305041|NCT01848782|quality|quality
305042|NCT01848782|bias|bias
305043|NCT01848782|spin|spin
305044|NCT01848782|limits|limits
305045|NCT01848782|limitation|limitation
305046|NCT01848782|risk of bias|risk of bias
305047|NCT01848769|Asthma|asthma
305048|NCT01848769|ICS+LABA|ics+laba
305049|NCT01848769|Children|children
305050|NCT01848769|Inhalation|inhalation
305051|NCT01848769|pMDI|pmdi
305052|NCT01848756|SNX-5422|snx-5422
305053|NCT01848756|HER2 positive cancer|her2 positive cancer
305054|NCT01848743|tenofovir, lamivudine, hepatitis B, acute exacerbation|tenofovir, lamivudine, hepatitis b, acute exacerbation
305055|NCT01848704|spin|spin
305056|NCT01848704|interpretation|interpretation
305057|NCT01848704|bias|bias
305058|NCT01848652|cerebral lymphoma B cell refractory|cerebral lymphoma b cell refractory
305059|NCT01848652|Myocet|myocet
305060|NCT01848652|efficacy|efficacy
305061|NCT01848652|safety|safety
305062|NCT01848639|chronic kidney disease|chronic kidney disease
305063|NCT01848639|end-stage renal disease|end-stage renal disease
305064|NCT01848639|hemodialysis (ESRD)|hemodialysis (esrd)
305065|NCT01848639|cardiovascular morbimortality|cardiovascular morbimortality
305066|NCT01848639|aldosterone antagonist|aldosterone antagonist
305067|NCT01848639|spironolactone|spironolactone
305068|NCT01848600|limitation|limitation
305069|NCT01848600|quality|quality
305070|NCT01848600|bias|bias
305071|NCT01848600|meta-analysis|meta-analysis
305072|NCT01848600|interpretation|interpretation
305073|NCT01848600|abstract|abstract
305074|NCT01848587|Pregnancy|pregnancy
305075|NCT01848587|Acupuncture|acupuncture
305076|NCT01848587|Pelvic and low back pain|pelvic and low back pain
305077|NCT01848587|Impairment|impairment
305078|NCT01848587|Economic evaluation|economic evaluation
305079|NCT01848574|Understanding|understanding
305080|NCT01848574|Patients|patients
305081|NCT01848574|Emergency|emergency
305082|NCT01848574|Information|information
305083|NCT01848561|Inflammatory Bowel Diseases|inflammatory bowel diseases
305084|NCT01848561|Gastroenteritis|gastroenteritis
305085|NCT01848561|Adalimumab|adalimumab
305086|NCT01848561|Ulcerative Colitis|ulcerative colitis
305087|NCT01848561|Registry|registry
305088|NCT01848561|Gastrointestinal Diseases|gastrointestinal diseases
305089|NCT01848561|Colitis|colitis
305090|NCT01848535|intestinal microbiota composition|intestinal microbiota composition
305091|NCT01848535|intestinal microbiota activity|intestinal microbiota activity
305092|NCT01848535|gastro-intestinal complains|gastro-intestinal complains
305093|NCT01848522|qualitative study|qualitative study
305094|NCT01848522|rehabilitation|rehabilitation
305095|NCT01848522|physical therapy|physical therapy
305096|NCT01848522|patient education|patient education
305097|NCT01848522|health care|health care
305098|NCT01848522|administration|administration
305099|NCT01848522|patient satisfaction|patient satisfaction
305100|NCT01848522|handicap|handicap
305101|NCT01848509|CPAP|cpap
305102|NCT01848509|adherence|adherence
305103|NCT01848509|SAOS|saos
305104|NCT01848509|telemedicine|telemedicine
305105|NCT01848483|Early Palliative Care|early palliative care
305106|NCT01848483|Motivational Interviewing|motivational interviewing
305107|NCT01848483|Persons Living With Human immunodeficiency virus(HIV)|persons living with human immunodeficiency virus(hiv)
305108|NCT01848483|Acquired Immunodeficiency Syndrome (AIDS)|acquired immunodeficiency syndrome (aids)
305109|NCT01848457|Osteosarcoma|osteosarcoma
305110|NCT01848457|Cancer|cancer
305111|NCT01848457|Nephrotoxicity|nephrotoxicity
305112|NCT01848457|Ototoxicity|ototoxicity
305113|NCT01848457|Cisplatin|cisplatin
305114|NCT01848457|High-dose methotrexate|high-dose methotrexate
305115|NCT01848457|Biomarkers|biomarkers
305116|NCT01848457|Patient reported outcomes|patient reported outcomes
305117|NCT01848444|Public Health|public health
305118|NCT01848444|Epidemiology|epidemiology
305119|NCT01848444|Pharmacy Toxicology|pharmacy toxicology
305120|NCT01848444|Perinatal period|perinatal period
305121|NCT01848418|ICF|icf
305122|NCT01848418|Core sets|core sets
305123|NCT01848418|Systemic sclerosis|systemic sclerosis
305124|NCT01848418|Function|function
305125|NCT01848418|Evaluation|evaluation
305126|NCT01848392|Cystic fibrosis|cystic fibrosis
305127|NCT01848392|Adults|adults
305128|NCT01848392|Physical activity|physical activity
305129|NCT01848366|Frequency|frequency
305130|NCT01848366|urgency|urgency
305131|NCT01848366|incontinence|incontinence
305132|NCT01848340|mass balance|mass balance
305133|NCT01848340|GSK1265744|gsk1265744
305134|NCT01848340|supratherapeutic|supratherapeutic
305135|NCT01848340|integrase inhibitor|integrase inhibitor
305136|NCT01848340|healthy volunteer|healthy volunteer
305137|NCT01848327|Cognition|cognition
305138|NCT01848327|Neuropsychology|neuropsychology
305139|NCT01848327|Multiple Sclerosis|multiple sclerosis
305140|NCT01848301|Optical Coherence Tomography|optical coherence tomography
305141|NCT01848301|OCT|oct
305142|NCT01848301|Coronary Allograft Vasculopathy|coronary allograft vasculopathy
305143|NCT01848301|Donor Specific Antibodies|donor specific antibodies
305144|NCT01848301|Acetylcholine|acetylcholine
305145|NCT01848301|Coronary endothelial function|coronary endothelial function
305146|NCT01848301|Brachial Artery Flow Mediated Dilation|brachial artery flow mediated dilation
305147|NCT01848301|Heart transplantation|heart transplantation
305148|NCT01848288|Cataract|cataract
305149|NCT01848288|Phacoemulsification|phacoemulsification
305150|NCT01848288|Cumulative Dissipated Energy (CDE)|cumulative dissipated energy (cde)
305151|NCT01848262|ECALMIST|ecalmist
305152|NCT01848262|InSurE|insure
305153|NCT01848262|CPAP|cpap
305154|NCT01848262|Ventilation|ventilation
305155|NCT01848262|Vascular Catheter|vascular catheter
305156|NCT01848249|deceased donors|deceased donors
305157|NCT01848249|kidney donor|kidney donor
305158|NCT01848249|transplant recipients|transplant recipients
305159|NCT01848249|kidney transplant|kidney transplant
305160|NCT01848249|delayed graft function|delayed graft function
305161|NCT01848249|biomarkers|biomarkers
305162|NCT01848249|end stage renal disease|end stage renal disease
305163|NCT01848249|graft failure|graft failure
305164|NCT01848223|quality of life|quality of life
305165|NCT01848223|QoL|qol
305166|NCT01848223|late menopause|late menopause
305167|NCT01848210|Drug therapy|drug therapy
305168|NCT01848184|PARIETEX Composite Ventral Patch|parietex composite ventral patch
305169|NCT01848184|PCO VP OR PCOVP|pco vp or pcovp
305170|NCT01848184|Primary ventral hernia repair|primary ventral hernia repair
305171|NCT01848184|Panacea|panacea
305172|NCT01848171|Hypothyroidism|hypothyroidism
305173|NCT01848171|Lipid|lipid
305174|NCT01848171|Atherosclerosis|atherosclerosis
305175|NCT01848171|Oxidative Stress|oxidative stress
305176|NCT01848171|Chronic Inflammation|chronic inflammation
305177|NCT01848171|Endothelial Function|endothelial function
305178|NCT01848171|Adipocytokine|adipocytokine
305179|NCT01848171|L-thyroxine|l-thyroxine
305180|NCT01848158|acupuncture|acupuncture
305181|NCT01848158|pediatric|pediatric
305182|NCT01848158|critical care|critical care
305183|NCT01848158|mechanical ventilation|mechanical ventilation
305184|NCT01848158|sedation|sedation
305185|NCT01848158|comfort|comfort
305186|NCT01848145|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
305187|NCT01848145|Ofatumumab|ofatumumab
305188|NCT01848145|Rapid Infusion|rapid infusion
305189|NCT01848132|Lymphoma|lymphoma
305190|NCT01848132|Large B-Cell|large b-cell
305191|NCT01848119|Gabapentin|gabapentin
305192|NCT01848119|Cesarean section|cesarean section
305193|NCT01848106|Percutaneous Coronary Intervention|percutaneous coronary intervention
305194|NCT01848106|Coronary Artery Disease|coronary artery disease
305195|NCT01848106|Acute Coronary Syndrome|acute coronary syndrome
305197|NCT01848106|Reg 1|reg 1
305198|NCT01848106|bivalirudin|bivalirudin
305199|NCT01848093|lung|lung
305200|NCT01848093|airway|airway
305201|NCT01848093|pulmonary exacerbation|pulmonary exacerbation
305202|NCT01848093|mucus|mucus
305203|NCT01848080|Telemedicine|telemedicine
305204|NCT01848080|Telerehabilitation|telerehabilitation
305205|NCT01848080|Acute Stroke|acute stroke
305206|NCT01848080|Tai Chi|tai chi
305207|NCT01848080|Tai Ji|tai ji
305208|NCT01848080|Rehabilitation|rehabilitation
305209|NCT01848080|Home care services|home care services
305210|NCT01848080|Single blind method|single blind method
305211|NCT01848080|Randomized controlled trial|randomized controlled trial
305212|NCT01848054|opioid dependence, buprenorphine/naloxone, sublingual|opioid dependence, buprenorphine/naloxone, sublingual
305213|NCT01848041|Blepharoptosis|blepharoptosis
305214|NCT01848041|Ptosis|ptosis
305215|NCT01848028|Patient registry|patient registry
305216|NCT01848028|Germany|germany
305217|NCT01848028|Psoriasis|psoriasis
305218|NCT01848028|psoriatic-arthritis|psoriatic-arthritis
305219|NCT01848028|Efalizumab|efalizumab
305220|NCT01848028|Psonet|psonet
305221|NCT01848028|Effectiveness|effectiveness
305222|NCT01848028|Safety|safety
305223|NCT01848015|CTCs before and after gastrectomy|ctcs before and after gastrectomy
305224|NCT01847976|breast|breast
305225|NCT01847976|bone pain|bone pain
305226|NCT01847963|Urolithiasis|urolithiasis
305227|NCT01847963|Kalladaippu Kudineer|kalladaippu kudineer
305228|NCT01847963|Siddha|siddha
305229|NCT01847963|Sindhuvallathy|sindhuvallathy
305230|NCT01847963|Kidney stones|kidney stones
305231|NCT01847911|self instructed resuscitation training|self instructed resuscitation training
305232|NCT01847898|Osteoporosis|osteoporosis
305233|NCT01847898|Vertebral Body|vertebral body
305234|NCT01847898|Compression Fracture|compression fracture
305235|NCT01847898|Kyphoplasty|kyphoplasty
305236|NCT01847885|electrical stimulation|electrical stimulation
305237|NCT01847885|neurostimulation|neurostimulation
305238|NCT01847885|neuromodulation|neuromodulation
305239|NCT01847885|post-stroke shoulder pain|post-stroke shoulder pain
305240|NCT01847885|hemiplegic shoulder pain|hemiplegic shoulder pain
305241|NCT01847872|Inactivated Poliovirus Vaccine|inactivated poliovirus vaccine
305242|NCT01847872|Randomised Control Phase IV Study|randomised control phase iv study
305243|NCT01847872|Gambia|gambia
305244|NCT01847872|IPV|ipv
305245|NCT01847872|Safety and Immunogenicity|safety and immunogenicity
305246|NCT01847872|Non-interference study|non-interference study
305247|NCT01847872|IM Jet injector|im jet injector
305248|NCT01847872|ID Jet Injector|id jet injector
305249|NCT01847859|Cardiothoracic surgery|cardiothoracic surgery
305250|NCT01847859|Post-operative|post-operative
305251|NCT01847859|Nurses|nurses
305252|NCT01847859|Cardiac|cardiac
305253|NCT01847859|Echocardiography|echocardiography
305254|NCT01847859|Pocket-size|pocket-size
305255|NCT01847859|Hand-held|hand-held
305256|NCT01847820|ROM|rom
305257|NCT01847820|PROM|prom
305258|NCT01847820|PPROM (preterm premature rupture of membranes)|pprom (preterm premature rupture of membranes)
305259|NCT01847807|5-10 gram astragalus per day|5-10 gram astragalus per day
305260|NCT01847781|Opsonophagocytic antibodies|opsonophagocytic antibodies
305261|NCT01847781|Cellular immunity|cellular immunity
305262|NCT01847781|Vaccine immunity|vaccine immunity
305263|NCT01847781|Antimicrobial peptides|antimicrobial peptides
305264|NCT01847768|asthma|asthma
305265|NCT01847768|rhinovirus|rhinovirus
305266|NCT01847768|remodeling mediators|remodeling mediators
305267|NCT01847768|human rhinovirus infection|human rhinovirus infection
305268|NCT01847729|Opiate dependence|opiate dependence
305269|NCT01847729|Opiate substitution treatment|opiate substitution treatment
305270|NCT01847729|co-addictions|co-addictions
305271|NCT01847729|Patients addicted to opiates|patients addicted to opiates
305272|NCT01847729|methadone|methadone
305273|NCT01847729|buprenorhine|buprenorhine
305274|NCT01847729|morphine|morphine
305275|NCT01847729|OST in place|ost in place
305276|NCT01847729|pathological gambling|pathological gambling
305277|NCT01847729|pharmacokinetic|pharmacokinetic
305278|NCT01847729|pharmacogenetic|pharmacogenetic
305279|NCT01847729|polymorphism|polymorphism
305280|NCT01847729|cytochrome P450 2D6|cytochrome p450 2d6
305281|NCT01847729|Therapeutic Drug Monitoring|therapeutic drug monitoring
305282|NCT01847716|Muscle weakness|muscle weakness
305283|NCT01847716|Pulmonary arterial hypertension|pulmonary arterial hypertension
305284|NCT01847716|Transforming growth factor beta|transforming growth factor beta
305285|NCT01847716|Growth and differentiation factor 15|growth and differentiation factor 15
305286|NCT01847690|Addison Disease|addison disease
305287|NCT01847677|ovarian cancer|ovarian cancer
305288|NCT01847677|neoadyuvant|neoadyuvant
305289|NCT01847677|bevacizumab|bevacizumab
305290|NCT01847651|hepatic encephalopathy|hepatic encephalopathy
305291|NCT01847651|minimal hepatic encephalopathy|minimal hepatic encephalopathy
305292|NCT01847651|cirrhosis|cirrhosis
305293|NCT01847651|lateral vastus|lateral vastus
305294|NCT01847651|muscle biopsy|muscle biopsy
305295|NCT01847651|L ornithine L aspartate|l ornithine l aspartate
305296|NCT01847651|functional magnetic resonance imaging|functional magnetic resonance imaging
305297|NCT01847651|magnetic resonance spectroscopy|magnetic resonance spectroscopy
305298|NCT01847651|cognitive testing|cognitive testing
305299|NCT01847651|Paper and pencil Hepatic Encephalopathy score (PHES)|paper and pencil hepatic encephalopathy score (phes)
305300|NCT01847651|Cogstate|cogstate
305301|NCT01847651|urine metabonomics|urine metabonomics
305302|NCT01847651|plasma metabonomics|plasma metabonomics
305303|NCT01847651|muscle metabonomics|muscle metabonomics
305304|NCT01847638|Retinal edema|retinal edema
305305|NCT01847638|Cataract|cataract
305306|NCT01847638|inflammation|inflammation
305307|NCT01847612|per operative cholangiography|per operative cholangiography
305308|NCT01847612|liver resection|liver resection
305309|NCT01847612|biliary fistula|biliary fistula
305310|NCT01847599|educational intervention|educational intervention
305311|NCT01847599|adherence|adherence
305312|NCT01847599|capecitabine|capecitabine
305313|NCT01847599|lapatinib|lapatinib
305314|NCT01847586|Alzheimer's Disease|alzheimer's disease
305315|NCT01847586|Brain stimulation|brain stimulation
305316|NCT01847586|transcranial magnetic stimulation|transcranial magnetic stimulation
305317|NCT01847573|halofuginone hydrobromide|halofuginone hydrobromide
305318|NCT01847573|anti-fibrotic|anti-fibrotic
305319|NCT01847573|anti-inflammatory|anti-inflammatory
305320|NCT01847573|muscle regeneration|muscle regeneration
305321|NCT01847573|protein synthesis inhibitor|protein synthesis inhibitor
305322|NCT01847495|Stage IV Colorectal Carcinoma|stage iv colorectal carcinoma
305323|NCT01847495|Liver metastasis|liver metastasis
305324|NCT01847495|Cyberknife|cyberknife
305325|NCT01847495|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
305326|NCT01847495|SBRT|sbrt
305327|NCT01847495|Irinotecan HCl|irinotecan hcl
305328|NCT01847495|CPT-11|cpt-11
305329|NCT01847482|Cardiac arrest|cardiac arrest
305330|NCT01847482|Return of Spontaneous Circulation (ROSC)|return of spontaneous circulation (rosc)
305331|NCT01847482|IntraVascular Temperature Management (IVTM)|intravascular temperature management (ivtm)
305332|NCT01847482|Therapeutic Hypothermia|therapeutic hypothermia
305333|NCT01847482|Japan|japan
305334|NCT01847469|Alcohol Dependence|alcohol dependence
305335|NCT01847469|Post-Traumatic Stress Disorder (PTSD)|post-traumatic stress disorder (ptsd)
305336|NCT01847469|Zonisamide|zonisamide
305337|NCT01847469|Cognitive Processing Therapy (CPT)|cognitive processing therapy (cpt)
305338|NCT01847456|whole body insulin sensitivity|whole body insulin sensitivity
305339|NCT01847456|insulin action in the brain|insulin action in the brain
305340|NCT01847443|nicotine|nicotine
305341|NCT01847443|nicotine replacement therapy|nicotine replacement therapy
305342|NCT01847443|nicotine gum|nicotine gum
305343|NCT01847430|Healthy|healthy
305344|NCT01847430|Hepatitis B|hepatitis b
305345|NCT01847430|Adolescents|adolescents
305346|NCT01847430|Engerix™-B Kinder|engerix™-b kinder
305347|NCT01847417|Acetylsalicylic acid|acetylsalicylic acid
305348|NCT01847417|Pantoprazole|pantoprazole
305349|NCT01847417|Fixed dose combination|fixed dose combination
305350|NCT01847404|Fixed dose combination|fixed dose combination
305351|NCT01847404|Acetylsalicylic acid|acetylsalicylic acid
305352|NCT01847404|Pantoprazole|pantoprazole
305353|NCT01847391|Ischemic Heart Disease|ischemic heart disease
305354|NCT01847391|Heart Disease|heart disease
305355|NCT01847378|ventricular tachycardia|ventricular tachycardia
305356|NCT01847378|catheter ablation|catheter ablation
305357|NCT01847378|chagas disease|chagas disease
305358|NCT01847378|epicardial mapping|epicardial mapping
305359|NCT01847378|magnetic resonance imaging|magnetic resonance imaging
305360|NCT01847365|Retinitis Pigmentosa|retinitis pigmentosa
305361|NCT01847365|Transcorneal electrical stimulation|transcorneal electrical stimulation
305362|NCT01847365|Okustim|okustim
305363|NCT01847352|Hypoxia|hypoxia
305364|NCT01847352|Pulmonary hypertension|pulmonary hypertension
305365|NCT01847352|Iron deficiency|iron deficiency
305366|NCT01847352|Hypoxic pulmonary vasoconstriction|hypoxic pulmonary vasoconstriction
305367|NCT01847300|alcohol abuse|alcohol abuse
305368|NCT01847300|tobacco dependence|tobacco dependence
305369|NCT01847300|substance abuse|substance abuse
305370|NCT01847300|SBIRT|sbirt
305371|NCT01847287|Multiple sclerosis|multiple sclerosis
305372|NCT01847287|Tysabri|tysabri
305374|NCT01847287|Natalizumab|natalizumab
305375|NCT01847274|ovarian cancer|ovarian cancer
305376|NCT01847274|platinum sensitive|platinum sensitive
305377|NCT01847274|gBRCAmut|gbrcamut
305378|NCT01847274|BRCA|brca
305379|NCT01847274|high-grade serous histology|high-grade serous histology
305380|NCT01847274|PARP inhibitor|parp inhibitor
305381|NCT01847261|soy|soy
305382|NCT01847261|whey|whey
305383|NCT01847261|muscle|muscle
305384|NCT01847261|older|older
305385|NCT01847261|mTOR|mtor
305386|NCT01847261|sarcopenia|sarcopenia
305387|NCT01847248|sepsis|sepsis
305388|NCT01847248|biomarker|biomarker
305389|NCT01847248|HSPA12B|hspa12b
305390|NCT01847235|Temozolomide|temozolomide
305391|NCT01847209|lung nodule|lung nodule
305392|NCT01847209|lung cancer|lung cancer
305393|NCT01847209|lung mass|lung mass
305394|NCT01847196|Pulmonary Embolism|pulmonary embolism
305395|NCT01847196|PE|pe
305396|NCT01847196|DVT|dvt
305397|NCT01847196|Deep Vein Thrombosis|deep vein thrombosis
305398|NCT01847196|VTE|vte
305399|NCT01847196|Venous Thromboembolism|venous thromboembolism
305400|NCT01847196|prophylaxis|prophylaxis
305401|NCT01847196|thromboprophylaxis|thromboprophylaxis
305402|NCT01847196|contraindications to thromboprophylaxis|contraindications to thromboprophylaxis
305403|NCT01847196|prophylactic|prophylactic
305404|NCT01847196|prevention|prevention
305405|NCT01847196|Inferior vena cava filter|inferior vena cava filter
305406|NCT01847196|IVC filter|ivc filter
305407|NCT01847196|filter|filter
305408|NCT01847196|prevention of pulmonary embolism|prevention of pulmonary embolism
305409|NCT01847196|trauma|trauma
305410|NCT01847196|critically-ill|critically-ill
305411|NCT01847183|heavy drinking|heavy drinking
305412|NCT01847183|prevention|prevention
305413|NCT01847183|high school|high school
305414|NCT01847183|adolescence|adolescence
305415|NCT01847157|recovery of function|recovery of function
305416|NCT01847157|stroke|stroke
305417|NCT01847157|Upper extremity|upper extremity
305418|NCT01847157|Motor|motor
305419|NCT01847157|transcranial direct current stimulation|transcranial direct current stimulation
305420|NCT01847131|Rhinitis|rhinitis
305421|NCT01847131|Oxymetazoline|oxymetazoline
305422|NCT01847092|albuminuria|albuminuria
305423|NCT01847066|wrinkles|wrinkles
305424|NCT01847066|acne scars|acne scars
305425|NCT01847066|pigmentation|pigmentation
305426|NCT01847053|Cinnamon|cinnamon
305427|NCT01847053|Bioavailability|bioavailability
305428|NCT01847053|Glucose|glucose
305429|NCT01847053|Proanthocyanidins|proanthocyanidins
305430|NCT01847040|Traumatic Brain Injury|traumatic brain injury
305431|NCT01847040|Epidemiology|epidemiology
305432|NCT01847040|Concussion|concussion
305433|NCT01847040|Outcomes|outcomes
305434|NCT01847040|PTSD|ptsd
305435|NCT01847040|Prospective|prospective
305436|NCT01847040|Longitudinal|longitudinal
305437|NCT01847040|Military|military
305438|NCT01847040|Symptoms|symptoms
305439|NCT01847040|Validation|validation
305440|NCT01847040|Screening|screening
305441|NCT01847040|Mild Traumatic Brain Injury|mild traumatic brain injury
305442|NCT01847027|Healthy|healthy
305443|NCT01847027|Stem cells|stem cells
305444|NCT01847027|Aging|aging
305445|NCT01847027|Increase stem cell replacement|increase stem cell replacement
305446|NCT01847027|decreased stem cell proliferation|decreased stem cell proliferation
305447|NCT01847014|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
305448|NCT01847014|psychometric instrument|psychometric instrument
305449|NCT01847014|PAH-SYMPACT|pah-sympact
305450|NCT01847001|Breast Cancer|breast cancer
305451|NCT01847001|Neoadjuvant|neoadjuvant
305452|NCT01847001|Experimental|experimental
305453|NCT01847001|Biomarker|biomarker
305454|NCT01847001|Breast imaging|breast imaging
305455|NCT01846988|Obstructive Sleep Apnea|obstructive sleep apnea
305456|NCT01846988|Pediatric Obstructive Sleep Apnea|pediatric obstructive sleep apnea
305457|NCT01846988|Auto PAP|auto pap
305458|NCT01846988|Auto-adjustable Positive Airway Pressure|auto-adjustable positive airway pressure
305459|NCT01846988|APAP|apap
305460|NCT01846988|CPAP|cpap
305461|NCT01846975|Abatacept|abatacept
305462|NCT01846975|Low disease activity|low disease activity
305463|NCT01846975|Intravenous|intravenous
305464|NCT01846975|Subcutaneous|subcutaneous
305465|NCT01846975|Rheumatoid arthritis|rheumatoid arthritis
305466|NCT01846962|Eosinophilic esophagitis (EoE)|eosinophilic esophagitis (eoe)
305467|NCT01846962|budesonide|budesonide
305468|NCT01846962|fluticasione|fluticasione
305469|NCT01846962|six-foods elimination diet|six-foods elimination diet
305470|NCT01846936|one lung ventilation|one lung ventilation
305471|NCT01846936|efficacy|efficacy
305472|NCT01846936|bronchial blocker|bronchial blocker
305473|NCT01846910|Cessation|cessation
305474|NCT01846845|Amputee|amputee
305475|NCT01846832|Hepatitis C, Chronic|hepatitis c, chronic
305476|NCT01846832|Infection|infection
305477|NCT01846832|Triple therapy|triple therapy
305478|NCT01846832|TMC435|tmc435
305479|NCT01846832|simeprevir|simeprevir
305480|NCT01846832|Pegylated interferon alfa-2a (PegIFNα-2a)|pegylated interferon alfa-2a (pegifnα-2a)
305481|NCT01846832|ribavirin (RBV)|ribavirin (rbv)
305482|NCT01846832|PEGASYS|pegasys
305483|NCT01846832|COPEGUS|copegus
305484|NCT01846806|Hepatic Encephalopathy|hepatic encephalopathy
305485|NCT01846793|Benign prostatic hyperplasia|benign prostatic hyperplasia
305486|NCT01846793|BPH|bph
305487|NCT01846793|Lower urinary tract symptoms|lower urinary tract symptoms
305488|NCT01846793|LUTS|luts
305489|NCT01846793|LUTS secondary to BPH|luts secondary to bph
305490|NCT01846793|LUTS/BPH|luts/bph
305491|NCT01846793|Benign prostatic obstruction (BPO)|benign prostatic obstruction (bpo)
305492|NCT01846793|BPO|bpo
305493|NCT01846793|Bladder outlet obstruction|bladder outlet obstruction
305494|NCT01846793|BOO|boo
305495|NCT01846767|13CO2|13co2
305496|NCT01846767|Breath test|breath test
305497|NCT01846767|Glucose oxidation|glucose oxidation
305498|NCT01846767|Diabetes mellitus|diabetes mellitus
305499|NCT01846754|Hemodialysis|hemodialysis
305500|NCT01846754|Fatigue|fatigue
305501|NCT01846754|Muscle strength|muscle strength
305502|NCT01846754|Metabolomics|metabolomics
305503|NCT01846741|Automatic Magnet Mode (AMM)|automatic magnet mode (amm)
305504|NCT01846741|Vagus Nerve Stimulation (VNS)|vagus nerve stimulation (vns)
305505|NCT01846715|Kidney disease|kidney disease
305506|NCT01846715|Renal insufficiency|renal insufficiency
305507|NCT01846715|CKD|ckd
305508|NCT01846715|Autologous cell therapy|autologous cell therapy
305509|NCT01846676|Hearing loss, rehabilitation programs, adherence to hearing aids.|hearing loss, rehabilitation programs, adherence to hearing aids.
305510|NCT01846663|Hepatic Encephalopathy|hepatic encephalopathy
305511|NCT01846663|Liver Failure|liver failure
305512|NCT01846663|Hepatic Insufficiency|hepatic insufficiency
305513|NCT01846663|Liver Diseases|liver diseases
305514|NCT01846663|Brain Diseases|brain diseases
305515|NCT01846663|Rifaximin|rifaximin
305516|NCT01846663|Cirrhosis|cirrhosis
305517|NCT01846611|Ovarian neoplasms|ovarian neoplasms
305518|NCT01846611|Peritoneal neoplasms|peritoneal neoplasms
305519|NCT01846611|Fallopian tube neoplasms|fallopian tube neoplasms
305520|NCT01846611|Advanced-relapsed epithelial ovarian cancer|advanced-relapsed epithelial ovarian cancer
305521|NCT01846611|Advanced-relapsed primary peritoneal cancer|advanced-relapsed primary peritoneal cancer
305522|NCT01846611|Advanced-relapsed fallopian tube cancer|advanced-relapsed fallopian tube cancer
305523|NCT01846611|Trabectedin|trabectedin
305524|NCT01846611|Yondelis|yondelis
305525|NCT01846611|Doxil|doxil
305526|NCT01846611|Caelyx|caelyx
305527|NCT01846611|Platinum sensitive|platinum sensitive
305528|NCT01846611|Tthird-line|tthird-line
305529|NCT01846611|BRCA|brca
305530|NCT01846611|Patient related outcome|patient related outcome
305531|NCT01846572|Stroke|stroke
305532|NCT01846572|Clopidogrel|clopidogrel
305533|NCT01846572|Aggregometry|aggregometry
305534|NCT01846572|Antiplatelet therapy|antiplatelet therapy
305535|NCT01846572|Platelet function tests|platelet function tests
305536|NCT01846559|Immune system processes|immune system processes
305537|NCT01846546|Traumatic brain injury;|traumatic brain injury;
306128|NCT01843673|Larynx|larynx
305538|NCT01846546|Endostatin/collagen XVIII;|endostatin/collagen xviii;
305539|NCT01846546|Cerebrospinal fluid;|cerebrospinal fluid;
305540|NCT01846546|Prognosis|prognosis
305541|NCT01846507|Heavy Menstrual Bleeding|heavy menstrual bleeding
305542|NCT01846507|HMB|hmb
305543|NCT01846507|Lysteda|lysteda
305544|NCT01846481|Cocaine|cocaine
305545|NCT01846468|Healthy volunteers and patients,|healthy volunteers and patients,
305546|NCT01846468|renal insufficiency,|renal insufficiency,
305547|NCT01846455|Hepatic|hepatic
305548|NCT01846455|Hepatitis C Virus|hepatitis c virus
305549|NCT01846455|Suboxone|suboxone
305550|NCT01846455|Buprenorphine|buprenorphine
305551|NCT01846455|Naloxone|naloxone
305552|NCT01846442|Vulvar/vaginal atrophy|vulvar/vaginal atrophy
305553|NCT01846442|Atrophic Vaginitis|atrophic vaginitis
305554|NCT01846442|Dehydroepiandrosterone|dehydroepiandrosterone
305555|NCT01846442|DHEA|dhea
305556|NCT01846442|Prasterone|prasterone
305557|NCT01846442|Vaginorm|vaginorm
305558|NCT01846442|Menopause|menopause
305559|NCT01846442|Intrarosa|intrarosa
305560|NCT01846429|cancer|cancer
305561|NCT01846429|pain fibers|pain fibers
305562|NCT01846429|acid levels|acid levels
305563|NCT01846429|tumor related pain|tumor related pain
305564|NCT01846429|cancer related pain|cancer related pain
305565|NCT01846429|sodium bicarbonate|sodium bicarbonate
305566|NCT01846429|pain reliever|pain reliever
305567|NCT01846429|metastatic|metastatic
305568|NCT01846429|unresectable|unresectable
305569|NCT01846429|solid malignancy|solid malignancy
305570|NCT01846429|hematologic malignancy|hematologic malignancy
305571|NCT01846429|multiple myeloma|multiple myeloma
305572|NCT01846429|lymphoma|lymphoma
305573|NCT01846377|video game|video game
305575|NCT01846377|physical activity|physical activity
305576|NCT01846377|sedentary behavior|sedentary behavior
305577|NCT01846377|obesity|obesity
305578|NCT01846377|diabetes|diabetes
305579|NCT01846364|Thyroid|thyroid
305580|NCT01846364|DIM|dim
305581|NCT01846351|choroidal neovascularization|choroidal neovascularization
305582|NCT01846351|epiretinal membrane|epiretinal membrane
305583|NCT01846351|anti-VEGF|anti-vegf
305584|NCT01846338|acne, EGCG, green tea|acne, egcg, green tea
305585|NCT01846299|Vision Impairment|vision impairment
305586|NCT01846286|Neuropathic Pain|neuropathic pain
305587|NCT01846286|Squamous cell cancer of the head and neck|squamous cell cancer of the head and neck
305588|NCT01846286|acute pain|acute pain
305589|NCT01846286|pain management|pain management
305590|NCT01846286|genome-wide analyses|genome-wide analyses
305591|NCT01846286|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
305592|NCT01846286|chronic pain|chronic pain
305593|NCT01846286|neuropathic|neuropathic
305594|NCT01846286|locoregional squamous cell carcinoma of the head and neck|locoregional squamous cell carcinoma of the head and neck
305595|NCT01846247|stroke|stroke
305596|NCT01846234|Multiple Sclerosis|multiple sclerosis
305597|NCT01846234|Salt|salt
305598|NCT01846221|Analgesia|analgesia
305599|NCT01846221|Epidural|epidural
305600|NCT01846221|Pregnancy|pregnancy
305601|NCT01846221|Labor|labor
305602|NCT01846221|Clonidine|clonidine
305603|NCT01846221|Fentanyl|fentanyl
305604|NCT01846221|Bupivacaine|bupivacaine
305605|NCT01846221|Childbirth|childbirth
305606|NCT01846208|Egg Allergy|egg allergy
305607|NCT01846208|Egg Oral Immunotherapy|egg oral immunotherapy
305608|NCT01846208|Food Allergy|food allergy
305609|NCT01846195|blood loss|blood loss
305610|NCT01846182|Gulf War Illness|gulf war illness
305611|NCT01846182|Pregabalin|pregabalin
305612|NCT01846182|Duloxetine|duloxetine
305613|NCT01846182|Gulf War Veterans|gulf war veterans
305614|NCT01846182|Cymbalta|cymbalta
305615|NCT01846182|Lyrica|lyrica
305616|NCT01846169|food insecurity|food insecurity
305617|NCT01846169|older adults|older adults
305618|NCT01846169|nutrition|nutrition
305619|NCT01846169|food deliveries|food deliveries
305620|NCT01846156|convulsion rate|convulsion rate
305621|NCT01846130|Bed rest,|bed rest,
305622|NCT01846117|lignans|lignans
305623|NCT01846117|oxidative stress|oxidative stress
305624|NCT01846117|inflammation|inflammation
305625|NCT01846117|aging|aging
305626|NCT01846117|muscle weakness|muscle weakness
305627|NCT01846117|pain|pain
305628|NCT01846052|achromatopsia, CNGB3|achromatopsia, cngb3
305629|NCT01846013|Sit-Stand Workstations|sit-stand workstations
305630|NCT01846013|Increase Workplace Physical Activity|increase workplace physical activity
305631|NCT01846000|temporomandibular joint|temporomandibular joint
305632|NCT01846000|temporomandibular disorder|temporomandibular disorder
305633|NCT01846000|electromyography|electromyography
305634|NCT01846000|low-level laser therapy|low-level laser therapy
305635|NCT01845987|Palmoplantaris Pustulosis|palmoplantaris pustulosis
305636|NCT01845987|CNTO 1959|cnto 1959
305637|NCT01845987|Psoriasis|psoriasis
305638|NCT01845987|Anti-IL 23 Monoclonal Antibody|anti-il 23 monoclonal antibody
305639|NCT01845974|Radiofrequency Catheter Ablation|radiofrequency catheter ablation
305640|NCT01845974|Atrial Fibrillation|atrial fibrillation
305641|NCT01845948|parents|parents
305642|NCT01845948|school transition|school transition
305643|NCT01845948|parental-child relationship|parental-child relationship
305644|NCT01845935|Cryoablation|cryoablation
305645|NCT01845935|Venous vascular malformation|venous vascular malformation
305646|NCT01845935|MRI|mri
305647|NCT01845935|safety|safety
305648|NCT01845935|pain|pain
305649|NCT01845922|Refeeding Syndrome|refeeding syndrome
305650|NCT01845922|low sodium|low sodium
305651|NCT01845922|slowly absorbed carbohydrates|slowly absorbed carbohydrates
305652|NCT01845922|hypopotassemia|hypopotassemia
305653|NCT01845922|hypophosphatemia|hypophosphatemia
305654|NCT01845909|Sudden cardiac death|sudden cardiac death
305655|NCT01845909|Young adults|young adults
305656|NCT01845909|Cardiac Disease|cardiac disease
305657|NCT01845909|Arrhythmia|arrhythmia
305658|NCT01845909|Sports|sports
305659|NCT01845896|high intensity interval training|high intensity interval training
305660|NCT01845896|combined training|combined training
305661|NCT01845896|insulin resistance|insulin resistance
305662|NCT01845896|muscle contractile properties|muscle contractile properties
305663|NCT01845857|Long term health problems|long term health problems
305664|NCT01845857|chronic disease|chronic disease
305665|NCT01845831|Diabetes|diabetes
305666|NCT01845831|DPP4 inhibitors|dpp4 inhibitors
305667|NCT01845831|Sitagliptin|sitagliptin
305668|NCT01845831|Glargine|glargine
305669|NCT01845831|RCT|rct
305670|NCT01845831|basal insulin|basal insulin
305671|NCT01845831|hospital hyperglycemia|hospital hyperglycemia
305672|NCT01845831|inpatient diabetes|inpatient diabetes
305673|NCT01845818|work productivity|work productivity
305674|NCT01845818|multicenter study|multicenter study
305675|NCT01845792|Metastatic Castrate Resistant Prostate Cancer|metastatic castrate resistant prostate cancer
305676|NCT01845766|sepsis, septic shock, rehabilitation, exercise|sepsis, septic shock, rehabilitation, exercise
305677|NCT01845740|systemic lupus erythematoses|systemic lupus erythematoses
305678|NCT01845740|lupus|lupus
305679|NCT01845740|SLE|sle
305680|NCT01845727|Cutaneous leishmaniasis|cutaneous leishmaniasis
305681|NCT01845727|Topical treatment|topical treatment
305682|NCT01845727|Colombia|colombia
305683|NCT01845714|Keratoconus|keratoconus
305684|NCT01845714|Corneal cross Linking|corneal cross linking
305685|NCT01845714|Topo guided PRK|topo guided prk
305686|NCT01845714|Quality of Life|quality of life
305687|NCT01845701|malaria, cure rate, efficacy, safety|malaria, cure rate, efficacy, safety
305688|NCT01845688|Idiopathic Membranous Nephropathy|idiopathic membranous nephropathy
305689|NCT01845688|Traditional Chinese Medicine|traditional chinese medicine
305690|NCT01845688|Randomized Control Trial|randomized control trial
305691|NCT01845675|temozolomide|temozolomide
305692|NCT01845675|endostatin|endostatin
305693|NCT01845675|advanced|advanced
305694|NCT01845675|well-differentiated|well-differentiated
305695|NCT01845675|pancreatic neuroendocrine tumor|pancreatic neuroendocrine tumor
305696|NCT01845662|splenectomy|splenectomy
305697|NCT01845662|embolization|embolization
305698|NCT01845662|observation|observation
305699|NCT01845662|blood transfusion|blood transfusion
305700|NCT01845649|Vulvovaginal Atrophy|vulvovaginal atrophy
305701|NCT01845649|Dyspareunia|dyspareunia
305702|NCT01845649|Postmenopausal|postmenopausal
305703|NCT01845636|Olfaction|olfaction
305704|NCT01845636|Donepezil|donepezil
305705|NCT01845636|Alzheimer's Disease|alzheimer's disease
305706|NCT01845636|Mild Cognitive Impairment|mild cognitive impairment
305707|NCT01845636|Memory|memory
305708|NCT01845623|Asthma|asthma
305709|NCT01845623|Indacaterol|indacaterol
305710|NCT01845623|QAB149|qab149
305711|NCT01845584|IVIG in Neuromyelitis Optica spectrum disorder|ivig in neuromyelitis optica spectrum disorder
305712|NCT01845584|Patients with Neuromyelitis Optica spectrum disorder|patients with neuromyelitis optica spectrum disorder
305713|NCT01845558|Muscle soreness|muscle soreness
305714|NCT01845558|Exercise induced muscle damage|exercise induced muscle damage
305715|NCT01845558|Inflammation|inflammation
305716|NCT01845558|Proteolytic enzymes|proteolytic enzymes
305717|NCT01845558|Muscle strength Dynamometer|muscle strength dynamometer
305718|NCT01845545|microfinance|microfinance
305719|NCT01845545|under five mortality|under five mortality
305720|NCT01845545|underweight|underweight
305721|NCT01845545|malnutrition|malnutrition
305722|NCT01845506|wireless pressure sensor|wireless pressure sensor
305723|NCT01845506|Elderly|elderly
305724|NCT01845493|asthma|asthma
305725|NCT01845493|Asthmatics|asthmatics
305726|NCT01845493|allergic|allergic
305727|NCT01845493|allergies|allergies
305728|NCT01845480|health promotion|health promotion
305729|NCT01845480|obesity prevention|obesity prevention
305730|NCT01845480|Childhood obesity|childhood obesity
305731|NCT01845480|home-based|home-based
305732|NCT01845480|Lifestyle intervention|lifestyle intervention
305733|NCT01845480|Body composition|body composition
305734|NCT01845480|quality of life|quality of life
305735|NCT01845480|physical activity|physical activity
305736|NCT01845480|nutrition|nutrition
305737|NCT01845467|Secretin MRCP, diagnosis, Autoimmune pancreatitis|secretin mrcp, diagnosis, autoimmune pancreatitis
305738|NCT01845454|Barrett's Esophagus|barrett's esophagus
306626|NCT01841164|human|human
305739|NCT01845454|Spray cryotherapy|spray cryotherapy
305740|NCT01845441|Dexmedetomidine|dexmedetomidine
305741|NCT01845441|Endovascular procedure|endovascular procedure
305742|NCT01845441|Stroke|stroke
305743|NCT01845441|Vasospasm, intracranial|vasospasm, intracranial
305744|NCT01845441|Conscious sedation|conscious sedation
305745|NCT01845428|nephrotic|nephrotic
305746|NCT01845428|hyperlipidemia|hyperlipidemia
305747|NCT01845428|oxLDL|oxldl
305748|NCT01845428|kidney|kidney
305749|NCT01845402|Kidney Failure, Chronic|kidney failure, chronic
305750|NCT01845402|Adolescent|adolescent
305751|NCT01845402|Heart Defects, Congenital|heart defects, congenital
305752|NCT01845389|Anesthesia|anesthesia
305753|NCT01845389|Regional|regional
305754|NCT01845389|Epidural|epidural
305755|NCT01845389|Continuous spinal|continuous spinal
305756|NCT01845389|Wiley Catheter|wiley catheter
305757|NCT01845389|Geriatric|geriatric
305758|NCT01845389|TURP|turp
305759|NCT01845376|Inflammatory Markers after Inguinal Hernia Repair|inflammatory markers after inguinal hernia repair
305760|NCT01845376|Anesthetic technique for hernia repair|anesthetic technique for hernia repair
305761|NCT01845363|Obesity|obesity
305762|NCT01845363|Bariatric surgery|bariatric surgery
305763|NCT01845363|Cefazolin|cefazolin
305764|NCT01845363|antimicrobial prophylaxis|antimicrobial prophylaxis
305765|NCT01845363|administration and dosage|administration and dosage
305766|NCT01845324|Pregnancy|pregnancy
305767|NCT01845324|Diabetes Mellitus|diabetes mellitus
305768|NCT01845285|transcatheter valve replacement|transcatheter valve replacement
305769|NCT01845285|aortic valve disease|aortic valve disease
305770|NCT01845285|aortic stenosis|aortic stenosis
305771|NCT01845285|Aortic regurgitation,catheter|aortic regurgitation,catheter
305772|NCT01845285|Effective orifice area|effective orifice area
305773|NCT01845246|Colistin|colistin
305774|NCT01845246|Polymyxins|polymyxins
305775|NCT01845246|Therapeutic drug monitoring|therapeutic drug monitoring
305776|NCT01845246|Multi Drug resistant Gram negative bacterial infections|multi drug resistant gram negative bacterial infections
305777|NCT01845220|Broccoli sprouts|broccoli sprouts
305778|NCT01845220|alcohol sensitivity|alcohol sensitivity
305779|NCT01845220|sulforaphane|sulforaphane
305780|NCT01845220|alcohol metabolism|alcohol metabolism
305781|NCT01845220|in the Asian Community|in the asian community
305782|NCT01845207|Aortic stenosis|aortic stenosis
305783|NCT01845207|Aortic valve replacement|aortic valve replacement
305784|NCT01845207|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
305785|NCT01845207|Outcomes|outcomes
305786|NCT01845207|Frailty|frailty
305787|NCT01845207|Elderly|elderly
305788|NCT01845194|pharmacokinetic|pharmacokinetic
305789|NCT01845194|heritability|heritability
305790|NCT01845194|drug membrane transport|drug membrane transport
305791|NCT01845194|drug biotransformation|drug biotransformation
305792|NCT01845181|Adenosine A1 receptor antagonist|adenosine a1 receptor antagonist
305793|NCT01845181|Asthma|asthma
305794|NCT01845181|adenosine receptor modulator|adenosine receptor modulator
305795|NCT01845181|COPD|copd
305796|NCT01845168|Bleeding peptic ulcer|bleeding peptic ulcer
305797|NCT01845168|NSAID and Aspirin|nsaid and aspirin
305798|NCT01845168|Computer-alert|computer-alert
305799|NCT01845168|General practitioner|general practitioner
305800|NCT01845155|Tinnitus|tinnitus
305801|NCT01845155|music therapy|music therapy
305802|NCT01845155|directive counselling|directive counselling
305803|NCT01845155|acoustic stimulation|acoustic stimulation
305804|NCT01845155|group comparison|group comparison
305805|NCT01845155|subjective evaluation|subjective evaluation
305806|NCT01845155|pitch|pitch
305807|NCT01845142|vitamin D|vitamin d
305808|NCT01845142|vitamin D deficiency|vitamin d deficiency
305809|NCT01845142|immune cells|immune cells
305810|NCT01845142|pharmacokinetic|pharmacokinetic
305811|NCT01845142|< 50 nmol/L 25(OH)D serum concentration|< 50 nmol/l 25(oh)d serum concentration
305812|NCT01845116|PNALD|pnald
305813|NCT01845116|Cholestasis|cholestasis
305814|NCT01845116|Omegaven®|omegaven®
305815|NCT01845116|Short Bowel Syndrome|short bowel syndrome
305816|NCT01845103|ANGINA|angina
305817|NCT01845103|Thoracoscopic|thoracoscopic
305818|NCT01845064|type 2 diabetes|type 2 diabetes
305819|NCT01845064|diabetes mellitus|diabetes mellitus
305820|NCT01845064|type 2 diabetes mellitus|type 2 diabetes mellitus
305821|NCT01845064|HbA1c|hba1c
305822|NCT01845064|blood glucose|blood glucose
305823|NCT01845064|glucose control|glucose control
305824|NCT01845064|DiaMedica|diamedica
305825|NCT01845064|DM-199|dm-199
305826|NCT01845064|DM199|dm199
305827|NCT01845064|recombinant human tissue kallikrein-1|recombinant human tissue kallikrein-1
305828|NCT01845064|tissue kallikrein-1|tissue kallikrein-1
305829|NCT01845051|Migraine|migraine
305830|NCT01845051|allergic rhinitis|allergic rhinitis
305831|NCT01845051|Specific Immunoglobulin E (IgE)|specific immunoglobulin e (ige)
305832|NCT01845051|nasal symptoms|nasal symptoms
305833|NCT01845051|signs of allergy.|signs of allergy.
305834|NCT01845025|Asthma|asthma
305835|NCT01845025|formoterol fumarate|formoterol fumarate
305836|NCT01845025|Foradil|foradil
305837|NCT01845025|inhaled corticosteroid|inhaled corticosteroid
305838|NCT01845025|fluticasone propionate|fluticasone propionate
305839|NCT01845025|safety|safety
305840|NCT01845012|Short daily hemodialysis|short daily hemodialysis
305841|NCT01845012|Low dialysate flow|low dialysate flow
305842|NCT01845012|End stage renal disease|end stage renal disease
305843|NCT01844999|Prostate cancer|prostate cancer
305844|NCT01844999|Decision|decision
305845|NCT01844986|BRCA|brca
305846|NCT01844986|Ovarian Cancer|ovarian cancer
305847|NCT01844986|Chemotherapy|chemotherapy
305848|NCT01844986|PARP inhibitor|parp inhibitor
305849|NCT01844986|First Line|first line
305850|NCT01844986|FIGO Stage III|figo stage iii
305851|NCT01844986|FIGO Stage IV|figo stage iv
305852|NCT01844960|Single Incision Surgery|single incision surgery
305853|NCT01844960|SILS|sils
305854|NCT01844960|Laparoscopic Gastric Band|laparoscopic gastric band
305855|NCT01844960|Morbid Obesity|morbid obesity
305856|NCT01844960|Bariatric Surgery|bariatric surgery
305857|NCT01844934|Knee Arthroplasty|knee arthroplasty
305858|NCT01844934|Knee Replacement|knee replacement
305859|NCT01844934|Prehabilitation|prehabilitation
305860|NCT01844882|The effects|the effects
305861|NCT01844882|dietary|dietary
305862|NCT01844882|fiber|fiber
305863|NCT01844882|kidney function|kidney function
305864|NCT01844882|CKD patients|ckd patients
305865|NCT01844869|omacetaxine|omacetaxine
305866|NCT01844869|omacetaxine mepesuccinate|omacetaxine mepesuccinate
305867|NCT01844869|pharmacokinetics|pharmacokinetics
305868|NCT01844869|hematologic malignancies|hematologic malignancies
305869|NCT01844869|advanced solid tumors|advanced solid tumors
305870|NCT01844843|Drug eluting stents|drug eluting stents
305871|NCT01844843|coronary artery disease|coronary artery disease
305872|NCT01844843|Percutaneous Coronary Intervention|percutaneous coronary intervention
305873|NCT01844843|Tomography, Optical Coherence|tomography, optical coherence
305874|NCT01844830|operative|operative
305875|NCT01844830|dental procedure|dental procedure
305876|NCT01844817|untreated|untreated
305877|NCT01844817|metastatic|metastatic
305878|NCT01844817|OGX-427|ogx-427
305879|NCT01844804|Bioequivalence|bioequivalence
305880|NCT01844804|Biosimilarity|biosimilarity
305881|NCT01844804|Similarity|similarity
305882|NCT01844804|PK|pk
305883|NCT01844804|Phase 1|phase 1
305884|NCT01844804|Infliximab|infliximab
305885|NCT01844804|Healthy Volunteers|healthy volunteers
305886|NCT01844804|Single-dose|single-dose
305887|NCT01844804|Immunology|immunology
305888|NCT01844791|Non-small cell lung cancer|non-small cell lung cancer
305889|NCT01844791|OCZ103-OS|ocz103-os
305890|NCT01844791|Pentamidine bis(2-hydroxyethanesulfonate)|pentamidine bis(2-hydroxyethanesulfonate)
305891|NCT01844791|platinum-gemcitabine based doublet first line therapy|platinum-gemcitabine based doublet first line therapy
305892|NCT01844778|Cystic Fibrosis, Pseudomonas aeruginosa, FEV1, tobramycin inhalation powder, TOBI,|cystic fibrosis, pseudomonas aeruginosa, fev1, tobramycin inhalation powder, tobi,
305893|NCT01844778|colistimethate|colistimethate
305894|NCT01844778|Cystic Fibrosis, Pseudomonas aeruginosa, FEV1, tobramycin inhalation powder, TOBI, colistimethate|cystic fibrosis, pseudomonas aeruginosa, fev1, tobramycin inhalation powder, tobi, colistimethate
305895|NCT01844765|Tasigna|tasigna
305896|NCT01844765|nilotinib treatment|nilotinib treatment
305897|NCT01844765|chronic phase|chronic phase
305898|NCT01844765|Ph+ CML|ph+ cml
305899|NCT01844765|accelerated phase|accelerated phase
305900|NCT01844765|newly diagnosed Ph+ CML|newly diagnosed ph+ cml
305901|NCT01844765|pediatric|pediatric
305902|NCT01844765|24 month treatment|24 month treatment
305903|NCT01844752|acne|acne
305904|NCT01844739|Propionibacterium acnes|propionibacterium acnes
305905|NCT01844739|acne|acne
305906|NCT01844726|healthy individuals|healthy individuals
305907|NCT01844726|schizophrenia|schizophrenia
305908|NCT01844726|schizoaffective disorder|schizoaffective disorder
305909|NCT01844726|learning|learning
305910|NCT01844726|memory|memory
305911|NCT01844726|cognitive enhancement|cognitive enhancement
305912|NCT01844726|fMRI|fmri
305913|NCT01844713|Kidney transplant|kidney transplant
305914|NCT01844713|Renal transplant|renal transplant
305915|NCT01844713|Sun protection|sun protection
305916|NCT01844713|Skin cancer|skin cancer
305917|NCT01844700|MC4R genotype|mc4r genotype
305918|NCT01844700|antipsychotic induced weight gain|antipsychotic induced weight gain
305919|NCT01844700|pediatric population|pediatric population
305920|NCT01844687|reinforcement, good drug effect, high, mood, cannabidiol|reinforcement, good drug effect, high, mood, cannabidiol
305921|NCT01844661|Mesenchymal stem cells|mesenchymal stem cells
305922|NCT01844661|Oncolytic adenovirus|oncolytic adenovirus
305923|NCT01844648|Parkinson's disease|parkinson's disease
305924|NCT01844648|Sialorrhea|sialorrhea
305925|NCT01844648|Tropicamide|tropicamide
305926|NCT01844648|Non-motor symptoms|non-motor symptoms
305927|NCT01844648|Thin strip delivery|thin strip delivery
305928|NCT01844622|Digestive System Diseases Disease|digestive system diseases disease
305929|NCT01844609|Comprehension|comprehension
305930|NCT01844609|Verbal Learning|verbal learning
305931|NCT01844609|Writing|writing
305932|NCT01844609|Testing|testing
305933|NCT01844596|linkage to care|linkage to care
305934|NCT01844596|hypertension management|hypertension management
305935|NCT01844596|behavioral science|behavioral science
305936|NCT01844596|cardiovascular health|cardiovascular health
305937|NCT01844596|global health|global health
305938|NCT01844596|multi-disciplinary implementation research approach|multi-disciplinary implementation research approach
305939|NCT01844596|linking and retaining|linking and retaining
305940|NCT01844596|community health workers|community health workers
305941|NCT01844596|CHWs|chws
305942|NCT01844596|behavioral communication strategy|behavioral communication strategy
305943|NCT01844596|smartphone-based tool|smartphone-based tool
305944|NCT01844596|electronic health record|electronic health record
305945|NCT01844596|retention to care|retention to care
305946|NCT01844557|Head And Neck Cancer|head and neck cancer
305947|NCT01844557|Nasopharyngeal cancer|nasopharyngeal cancer
305948|NCT01844557|Oropharyngeal cancer|oropharyngeal cancer
305949|NCT01844557|Hypopharyngeal cancer|hypopharyngeal cancer
305950|NCT01844557|Laryngeal cancer|laryngeal cancer
305951|NCT01844557|Primary cancer with cervical metastases|primary cancer with cervical metastases
305952|NCT01844557|Swallowing exercises|swallowing exercises
305953|NCT01844557|Videotape|videotape
305954|NCT01844557|Videocamera|videocamera
305955|NCT01844557|M.D. Anderson Symptom Inventory|m.d. anderson symptom inventory
305956|NCT01844557|Questionnaires|questionnaires
305957|NCT01844557|Surveys|surveys
305958|NCT01844544|drug related problems|drug related problems
305959|NCT01844544|clinical pharmacist|clinical pharmacist
305960|NCT01844544|femoral neck fractures|femoral neck fractures
305961|NCT01844544|orthopedic patients|orthopedic patients
305962|NCT01844492|decision making for incapacitated patients|decision making for incapacitated patients
305963|NCT01844492|intensive care|intensive care
305964|NCT01844492|surrogate decision making|surrogate decision making
305965|NCT01844492|patient centered care|patient centered care
305966|NCT01844492|Palliative Care|palliative care
305967|NCT01844492|End of Life|end of life
305968|NCT01844492|Quality of Communication|quality of communication
305969|NCT01844479|diabetic foot ulcer|diabetic foot ulcer
305970|NCT01844479|diabetic foot|diabetic foot
305971|NCT01844466|course of motor and visual rehabilitation|course of motor and visual rehabilitation
305972|NCT01844466|improvement of deficits|improvement of deficits
305973|NCT01844466|stroke patients|stroke patients
305974|NCT01844453|Subfertility|subfertility
305975|NCT01844453|Recurrent Implantation Failure|recurrent implantation failure
305976|NCT01844440|GERD|gerd
305977|NCT01844440|tLESR|tlesr
305978|NCT01844440|impedance|impedance
305979|NCT01844440|manometry|manometry
305980|NCT01844427|ADHD|adhd
305981|NCT01844427|Executive function deficits|executive function deficits
305982|NCT01844427|Psychiatry|psychiatry
305983|NCT01844427|Psychopharmacology|psychopharmacology
305984|NCT01844427|Namenda|namenda
305985|NCT01844414|Homeless Men|homeless men
305986|NCT01844414|Parolees|parolees
305987|NCT01844414|Hepatitis B|hepatitis b
305988|NCT01844414|Hepatitis C|hepatitis c
305989|NCT01844414|HIV|hiv
305990|NCT01844414|Community Drug Treatment|community drug treatment
305991|NCT01844414|Recidivism|recidivism
305992|NCT01844401|persistent asthma|persistent asthma
305993|NCT01844401|Albuterol Spiromax®|albuterol spiromax®
305994|NCT01844401|ProAir® HFA|proair® hfa
305995|NCT01844401|Pediatric Patients|pediatric patients
305996|NCT01844401|Phase 1|phase 1
305997|NCT01844375|oral carbohydrate loading|oral carbohydrate loading
305998|NCT01844375|walking capacity|walking capacity
305999|NCT01844362|uterus|uterus
306000|NCT01844362|transplantation|transplantation
306001|NCT01844362|infertility|infertility
306002|NCT01844349|North Africa|north africa
306003|NCT01844349|Urban women|urban women
306004|NCT01844349|Double burden of malnutrition|double burden of malnutrition
306005|NCT01844349|Iron depletion|iron depletion
306006|NCT01844349|Overweight/obesity|overweight/obesity
306007|NCT01844349|Metabolic syndrome|metabolic syndrome
306008|NCT01844349|Abdominal obesity|abdominal obesity
306009|NCT01844349|Excess body fat|excess body fat
306010|NCT01844284|Absorb™ BVS|absorb™ bvs
306011|NCT01844284|Angioplasty|angioplasty
306012|NCT01844284|Bioabsorbable|bioabsorbable
306013|NCT01844284|Bioreabsorbable|bioreabsorbable
306014|NCT01844284|BVS|bvs
306015|NCT01844284|Coronary Artery Disease|coronary artery disease
306016|NCT01844284|Coronary Artery Endothelial Responsiveness|coronary artery endothelial responsiveness
306017|NCT01844284|Coronary artery restenosis|coronary artery restenosis
306018|NCT01844284|Coronary artery stenosis|coronary artery stenosis
306019|NCT01844284|Coronary scaffold|coronary scaffold
306020|NCT01844284|Coronary Stent|coronary stent
306021|NCT01844284|Drug eluting stents|drug eluting stents
306022|NCT01844284|Everolimus|everolimus
306023|NCT01844284|Myocardial ischemia|myocardial ischemia
306024|NCT01844284|Stent thrombosis|stent thrombosis
306025|NCT01844284|Stents|stents
306026|NCT01844271|LLLT|lllt
306027|NCT01844271|muscle fatigue and recovery|muscle fatigue and recovery
306028|NCT01844271|phototherapy parameter|phototherapy parameter
306029|NCT01844258|pediatric cataract|pediatric cataract
306030|NCT01844258|lens regeneration|lens regeneration
306031|NCT01844258|endogenous lens epithelial stem cells|endogenous lens epithelial stem cells
306032|NCT01844258|visual axis opacification|visual axis opacification
306033|NCT01844258|visual function|visual function
306034|NCT01844245|Cholangiocarcinoma|cholangiocarcinoma
306035|NCT01844245|Ampullary carcinoma|ampullary carcinoma
306036|NCT01844245|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
306037|NCT01844245|Radiofrequency ablation|radiofrequency ablation
306038|NCT01844232|Multiple sclerosis|multiple sclerosis
306039|NCT01844232|spasticity|spasticity
306040|NCT01844232|arbaclofen|arbaclofen
306041|NCT01844219|aortic surgery|aortic surgery
306042|NCT01844219|acute kidney injury|acute kidney injury
306043|NCT01844219|gray zone approach|gray zone approach
306044|NCT01844206|Post-cesarean analgesia|post-cesarean analgesia
306045|NCT01844206|Second dose of epidural morphine after surgery|second dose of epidural morphine after surgery
306046|NCT01844206|Post-operative analgesia|post-operative analgesia
306047|NCT01844206|Self-administered epidural morphine|self-administered epidural morphine
306048|NCT01844206|Pain management after cesarean|pain management after cesarean
306049|NCT01844180|Irritable Bowel Syndrome|irritable bowel syndrome
306050|NCT01844180|IBS|ibs
306051|NCT01844180|ONO-2952|ono-2952
306052|NCT01844167|noxipoint|noxipoint
306053|NCT01844167|physical therapy|physical therapy
306054|NCT01844167|cervical pain|cervical pain
306055|NCT01844167|trigger point|trigger point
306056|NCT01844167|neck pain|neck pain
306057|NCT01844167|TENS|tens
306058|NCT01844167|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
306059|NCT01844141|phenol|phenol
306060|NCT01844141|ingrown toenail|ingrown toenail
306061|NCT01844141|chemical matricectomy|chemical matricectomy
306062|NCT01844128|MMA, AFC, Ovarian reserve|mma, afc, ovarian reserve
306063|NCT01844115|Generalized Anxiety Disorder, GAD|generalized anxiety disorder, gad
306064|NCT01844102|HIV Prevention, PrePex, voluntary medical circumcision, non-surgical,|hiv prevention, prepex, voluntary medical circumcision, non-surgical,
306065|NCT01844102|medical device, wound healing, Zambia|medical device, wound healing, zambia
306066|NCT01844089|Postpartum hemorrhage|postpartum hemorrhage
306067|NCT01844089|Bakri Postpartum Balloon|bakri postpartum balloon
306068|NCT01844076|advanced stage colorectal adenocarcinoma|advanced stage colorectal adenocarcinoma
306069|NCT01844050|Chinese herbal medicine|chinese herbal medicine
306070|NCT01844050|diabetes symptoms|diabetes symptoms
306071|NCT01844011|fetal movement|fetal movement
306072|NCT01844011|pregnancy|pregnancy
306073|NCT01843998|Early stage|early stage
306074|NCT01843998|Stage 1A|stage 1a
306075|NCT01843998|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
306076|NCT01843998|CTCL|ctcl
306077|NCT01843985|Stage IV cancer|stage iv cancer
306078|NCT01843985|Survival|survival
306079|NCT01843959|adenovirus-36|adenovirus-36
306080|NCT01843959|Emirati population|emirati population
306081|NCT01843920|eye|eye
306082|NCT01843920|pneumatic retinopexy|pneumatic retinopexy
306083|NCT01843920|topical|topical
306084|NCT01843894|sever dry eye,keratoconjunctivitis sicca|sever dry eye,keratoconjunctivitis sicca
306085|NCT01843881|Gastric Bypass|gastric bypass
306086|NCT01843881|bariatric surgery|bariatric surgery
306087|NCT01843881|carbohydrate metabolism|carbohydrate metabolism
306088|NCT01843868|Lymphoma|lymphoma
306089|NCT01843868|Non-Hodgkin|non-hodgkin
306090|NCT01843868|Emesis|emesis
306091|NCT01843868|Chemotherapy|chemotherapy
306092|NCT01843868|Nausea|nausea
306093|NCT01843868|Vomiting|vomiting
306094|NCT01843868|Aprepitant|aprepitant
306095|NCT01843855|Gastric Bypass|gastric bypass
306096|NCT01843855|bariatric surgery|bariatric surgery
306097|NCT01843855|glucose metabolism|glucose metabolism
306098|NCT01843829|Oesophageal cancer|oesophageal cancer
306099|NCT01843816|Tragus-to-wall distance|tragus-to-wall distance
306100|NCT01843816|obesity|obesity
306101|NCT01843816|body shape|body shape
306102|NCT01843816|height|height
306103|NCT01843816|weight|weight
306104|NCT01843803|patient centered care|patient centered care
306105|NCT01843803|collaborative decision making|collaborative decision making
306106|NCT01843803|cost impact|cost impact
306107|NCT01843777|hearing loss|hearing loss
306108|NCT01843777|hearing aids|hearing aids
306109|NCT01843777|motivational interviewing|motivational interviewing
306110|NCT01843777|counseling|counseling
306111|NCT01843777|rehabilitation|rehabilitation
306112|NCT01843764|RDT|rdt
306113|NCT01843764|malaria|malaria
306114|NCT01843764|treatment follow up|treatment follow up
306115|NCT01843764|diagnosis|diagnosis
306116|NCT01843725|breast cancer|breast cancer
306117|NCT01843725|digestive cancer|digestive cancer
306118|NCT01843712|Caloric compensation|caloric compensation
306119|NCT01843712|Eating in the absence of hunger|eating in the absence of hunger
306120|NCT01843712|Children|children
306121|NCT01843712|Parental feeding practices|parental feeding practices
306122|NCT01843686|Acute 2nd and 3rd Degree Burns|acute 2nd and 3rd degree burns
306123|NCT01843686|Autologous Platelet Rich Plasma (PRP)|autologous platelet rich plasma (prp)
306124|NCT01843686|Skin Grafting|skin grafting
306125|NCT01843686|Magellan® System|magellan® system
306126|NCT01843686|Wounds|wounds
306127|NCT01843673|Lip, Oral Cavity and Pharynx|lip, oral cavity and pharynx
306129|NCT01843660|Low back pain|low back pain
306130|NCT01843660|Shoulder pain|shoulder pain
306131|NCT01843660|Neck pain|neck pain
306132|NCT01843660|Tramadol hydrochloride|tramadol hydrochloride
306133|NCT01843660|Paracetamol|paracetamol
306134|NCT01843621|Dengue, Vaccine, Thailand|dengue, vaccine, thailand
306135|NCT01843608|Physical treatment|physical treatment
306136|NCT01843608|Exercise prescription to breast cancer survival|exercise prescription to breast cancer survival
306137|NCT01843608|Side cancer effect treatment|side cancer effect treatment
306138|NCT01843582|Keyword: blind spot|keyword: blind spot
306139|NCT01843569|In Vitro Maturation|in vitro maturation
306140|NCT01843569|IVM|ivm
306141|NCT01843569|Natural cycle IVF|natural cycle ivf
306142|NCT01843569|PCOS|pcos
306143|NCT01843543|Functional MRI (fMRI)|functional mri (fmri)
306144|NCT01843543|Resting state functional connectivity MRI (rs-fcMRI)|resting state functional connectivity mri (rs-fcmri)
306145|NCT01843543|Diffusion Tensor Imaging (DTI)|diffusion tensor imaging (dti)
306146|NCT01843517|Pain|pain
306147|NCT01843517|Facilitation|facilitation
306148|NCT01843517|Inhibition|inhibition
306149|NCT01843517|Oxytocin|oxytocin
306150|NCT01843517|Postpartum|postpartum
306151|NCT01843504|platelet rich plasma|platelet rich plasma
306152|NCT01843504|PRP|prp
306153|NCT01843504|plasma|plasma
306154|NCT01843504|plasma injection|plasma injection
306155|NCT01843504|patellar tendinopathy|patellar tendinopathy
306156|NCT01843504|patella tendon|patella tendon
306157|NCT01843504|patella|patella
306158|NCT01843504|ultrasound|ultrasound
306159|NCT01843504|shear wave ultrasound|shear wave ultrasound
306160|NCT01843504|tendinosis|tendinosis
306161|NCT01843504|tendinopathy|tendinopathy
306162|NCT01843504|tendinitis|tendinitis
306163|NCT01843504|jumper's knee|jumper's knee
306164|NCT01843478|women|women
306165|NCT01843478|human immunodeficiency virus|human immunodeficiency virus
306166|NCT01843478|cervical cancer screening|cervical cancer screening
306167|NCT01843478|Pap testing|pap testing
306168|NCT01843478|human papillomavirus|human papillomavirus
306169|NCT01843465|atrial fibrillation|atrial fibrillation
306170|NCT01843465|balloon cryoablation|balloon cryoablation
306171|NCT01843465|pulmonary veins|pulmonary veins
306172|NCT01843439|Acute exacerbation|acute exacerbation
306173|NCT01843439|Quality of life|quality of life
306174|NCT01843439|Magnesium deficiency|magnesium deficiency
306175|NCT01843439|Multidisciplinary intervention|multidisciplinary intervention
306176|NCT01843426|Comorbidity|comorbidity
306177|NCT01843413|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
306178|NCT01843400|Regorafenib|regorafenib
306179|NCT01843400|Colorectal Neoplasms|colorectal neoplasms
306180|NCT01843387|Diabetic nephropathy|diabetic nephropathy
306181|NCT01843387|Chronic kidney disease|chronic kidney disease
306182|NCT01843387|Metabolic disease|metabolic disease
306183|NCT01843387|Diabetes mellitus, type 2|diabetes mellitus, type 2
306184|NCT01843374|tremelimumab|tremelimumab
306185|NCT01843374|pleural, peritoneal|pleural, peritoneal
306186|NCT01843374|malignant mesothelioma|malignant mesothelioma
306187|NCT01843374|CTLA-4|ctla-4
306188|NCT01843361|Stroke|stroke
306189|NCT01843361|Clopidogrel|clopidogrel
306190|NCT01843361|Aggregometry|aggregometry
306191|NCT01843361|Antiplatelet therapy|antiplatelet therapy
306192|NCT01843361|Platelet function tests|platelet function tests
306193|NCT01843348|Transplant|transplant
306194|NCT01843348|Renal transplant|renal transplant
306195|NCT01843348|Rejection,allograf|rejection,allograf
306196|NCT01843348|Rejection|rejection
306197|NCT01843348|Xenograft rejection|xenograft rejection
306198|NCT01843348|Host vs graft disease|host vs graft disease
306199|NCT01843348|Kidney Transplant|kidney transplant
306200|NCT01843335|Cardiovascular Diagnostic Technique|cardiovascular diagnostic technique
306201|NCT01843335|Ultrasound|ultrasound
306202|NCT01843322|Image guided therapy|image guided therapy
306203|NCT01843322|Endovascular procedures|endovascular procedures
306204|NCT01843322|Angiography|angiography
306205|NCT01843322|Vascular surgical procedures|vascular surgical procedures
306206|NCT01843296|Spinal Anesthesia|spinal anesthesia
306207|NCT01843296|Bupivacaine|bupivacaine
306208|NCT01843296|Fentanyl|fentanyl
306209|NCT01843296|Magnesium sulfate|magnesium sulfate
306210|NCT01843296|Postoperative Pain|postoperative pain
306211|NCT01843283|Mild Cognitive Impairment|mild cognitive impairment
306212|NCT01843283|Family Caregivers|family caregivers
306213|NCT01843283|Intervention studies|intervention studies
306214|NCT01843270|general anesthesia|general anesthesia
306215|NCT01843270|body weight|body weight
306216|NCT01843270|laryngeal mask airway size|laryngeal mask airway size
306217|NCT01843257|Alcohol intake after bariatric surgery|alcohol intake after bariatric surgery
306218|NCT01843257|Alcohol and bariatric surgery|alcohol and bariatric surgery
306219|NCT01843244|plethysmography|plethysmography
306220|NCT01843231|g-Cath EZ Suture Anchor Delivery Catheter|g-cath ez suture anchor delivery catheter
306221|NCT01843231|Weight Loss Intervention|weight loss intervention
306222|NCT01843218|Localized rectal cancer in a male patient|localized rectal cancer in a male patient
306223|NCT01843179|Newly diagnosed|newly diagnosed
306726|NCT01840722|HIV|hiv
306224|NCT01843179|Complete Remission|complete remission
306225|NCT01843166|Pessary|pessary
306226|NCT01843166|Patient Satisfaction|patient satisfaction
306227|NCT01843166|Estrogen Cream|estrogen cream
306228|NCT01843153|pain score|pain score
306229|NCT01843140|cancer|cancer
306230|NCT01843140|fertility preservation|fertility preservation
306231|NCT01843140|infertility|infertility
306232|NCT01843140|pregnancy|pregnancy
306233|NCT01843114|Retinal blood flow|retinal blood flow
306234|NCT01843114|Retinal vessel diameter|retinal vessel diameter
306235|NCT01843114|Fourier Domain Optical Coherence Tomography|fourier domain optical coherence tomography
306236|NCT01843114|Retinal blood velocities|retinal blood velocities
306237|NCT01843101|Optical Coherence Tomography|optical coherence tomography
306238|NCT01843101|Cornea|cornea
306239|NCT01843101|Imaging|imaging
306240|NCT01843088|Pain|pain
306241|NCT01843088|exercise|exercise
306242|NCT01843088|muscle|muscle
306243|NCT01843062|Selumetinib, Differentiated Thyroid Cancer , AZD6244|selumetinib, differentiated thyroid cancer , azd6244
306244|NCT01843036|Child Abuse|child abuse
306245|NCT01843036|Child Neglect|child neglect
306246|NCT01843036|Child Emergency Medical Care Presentations|child emergency medical care presentations
306247|NCT01843036|Child Well-Care Compliance|child well-care compliance
306248|NCT01843036|Mother Well-Care Compliance|mother well-care compliance
306249|NCT01843036|Mother Emergency Medical Care Presentations|mother emergency medical care presentations
306250|NCT01843036|Mother Mental Health|mother mental health
306251|NCT01843036|Family Connections to Community Resources|family connections to community resources
306252|NCT01843036|Parent-Child Relationship Quality|parent-child relationship quality
306253|NCT01843023|opioid dependence|opioid dependence
306254|NCT01843010|NSAIDs|nsaids
306255|NCT01843010|Hyperalgesia|hyperalgesia
306256|NCT01843010|Postlaparoscopic shoulder pain|postlaparoscopic shoulder pain
306257|NCT01842997|Flu|flu
306258|NCT01842997|non-adjuvanted H1N1 vaccine|non-adjuvanted h1n1 vaccine
306259|NCT01842997|Safety|safety
306260|NCT01842997|pregnant women|pregnant women
306261|NCT01842984|Loneliness|loneliness
306262|NCT01842984|Social isolation|social isolation
306263|NCT01842984|Depression|depression
306264|NCT01842984|Older adults|older adults
306265|NCT01842984|Social competence|social competence
306266|NCT01842984|Social integration|social integration
306267|NCT01842971|two stage hepatectomy|two stage hepatectomy
306268|NCT01842971|liver metastasis|liver metastasis
306269|NCT01842971|colorectal cancer|colorectal cancer
306270|NCT01842958|Dental Implant|dental implant
306271|NCT01842945|Procrastination|procrastination
306272|NCT01842945|internet based cognitive behavior therapy|internet based cognitive behavior therapy
306273|NCT01842945|randomized controlled trial|randomized controlled trial
306274|NCT01842932|Colonoscopy|colonoscopy
306275|NCT01842932|Anticholinergics|anticholinergics
306276|NCT01842906|positive end expiratory pressure|positive end expiratory pressure
306277|NCT01842906|acute mountain sickness|acute mountain sickness
306278|NCT01842906|prevention|prevention
306279|NCT01842906|high altitude|high altitude
306280|NCT01842893|fentanyl|fentanyl
306281|NCT01842893|breakthrough pain|breakthrough pain
306282|NCT01842893|opioid treated cancer patients|opioid treated cancer patients
306283|NCT01842880|MicroRNAs|micrornas
306284|NCT01842880|Chagas disease|chagas disease
306285|NCT01842880|Biomarkers|biomarkers
306286|NCT01842867|Syndecan-4|syndecan-4
306287|NCT01842867|Chagas disease|chagas disease
306288|NCT01842867|Biomarkers|biomarkers
306289|NCT01842854|Galectin-3|galectin-3
306290|NCT01842854|Chagas disease|chagas disease
306291|NCT01842854|Biomarkers|biomarkers
306292|NCT01842789|Acessa|acessa
306293|NCT01842789|Fibroids|fibroids
306294|NCT01842789|Halt|halt
306295|NCT01842789|Targeting Animation|targeting animation
306296|NCT01842789|Image Overlay|image overlay
306297|NCT01842789|Radiofrequency Ablation|radiofrequency ablation
306298|NCT01842789|RFA|rfa
306299|NCT01842763|Chronic daily headache|chronic daily headache
306300|NCT01842763|treated by occipital nerves stimulation|treated by occipital nerves stimulation
306301|NCT01842763|peripheral neuromodulation|peripheral neuromodulation
306302|NCT01842763|occipital nerves|occipital nerves
306303|NCT01842763|network|network
306304|NCT01842763|database|database
306305|NCT01842737|Low Back Pain|low back pain
306306|NCT01842737|Chiropractic|chiropractic
306307|NCT01842737|Spinal Manipulation|spinal manipulation
306308|NCT01842737|Massage|massage
306309|NCT01842698|Thoracotomy surgery|thoracotomy surgery
306310|NCT01842698|Anesthesia|anesthesia
306311|NCT01842698|Ultrasound-guided PVB|ultrasound-guided pvb
306312|NCT01842698|Post-operative pain|post-operative pain
306313|NCT01842685|Overactive Bladder|overactive bladder
306314|NCT01842685|Bladder Distention|bladder distention
306315|NCT01842672|pediatric non-hodgkins lymphoma|pediatric non-hodgkins lymphoma
306316|NCT01842672|pediatric acute leukemia|pediatric acute leukemia
306317|NCT01842672|clofarabine|clofarabine
306318|NCT01842672|mitoxantrone|mitoxantrone
306319|NCT01842659|MI|mi
306320|NCT01842659|amniocentesis|amniocentesis
306321|NCT01842659|cord blood|cord blood
306322|NCT01842659|placenta|placenta
306323|NCT01842659|Silver Russell Syndrome|silver russell syndrome
306324|NCT01842659|Beckwith Wiedemann Syndrome|beckwith wiedemann syndrome
306325|NCT01842646|Leukemia|leukemia
306326|NCT01842646|Myeloid Malignancies|myeloid malignancies
306327|NCT01842620|Metformin|metformin
306328|NCT01842620|Bioequivalence|bioequivalence
306329|NCT01842607|eosinophils|eosinophils
306330|NCT01842607|mepolizumab|mepolizumab
306331|NCT01842607|SB-240563|sb-240563
306332|NCT01842607|safety|safety
306333|NCT01842607|extension study|extension study
306334|NCT01842607|Severe refractory asthma|severe refractory asthma
306335|NCT01842594|Sarcoma, Hydroxychloroquine, Sirolimus, PET|sarcoma, hydroxychloroquine, sirolimus, pet
306336|NCT01842581|Liver Failure|liver failure
306337|NCT01842581|Hepatic Insufficiency|hepatic insufficiency
306338|NCT01842581|Liver Diseases|liver diseases
306339|NCT01842581|Brain Diseases|brain diseases
306340|NCT01842581|Rifaximin|rifaximin
306341|NCT01842581|Cirrhosis|cirrhosis
306342|NCT01842568|Cardiac surgery|cardiac surgery
306343|NCT01842568|Troponin|troponin
306344|NCT01842568|Vascular events|vascular events
306345|NCT01842568|Myocardial injury|myocardial injury
306346|NCT01842568|Observational cohort study|observational cohort study
306347|NCT01842568|Public health|public health
306348|NCT01842555|PDT|pdt
306349|NCT01842555|Photodynamic therapy|photodynamic therapy
306350|NCT01842542|Postpartum Depression, NeuroStar TMS Therapy, TMS|postpartum depression, neurostar tms therapy, tms
306351|NCT01842503|alcohol dependence|alcohol dependence
306352|NCT01842503|cue reactivity|cue reactivity
306353|NCT01842503|alcohol self administration|alcohol self administration
306354|NCT01842490|Biomarker|biomarker
306355|NCT01842490|Carotid enhanced ultrasound|carotid enhanced ultrasound
306356|NCT01842490|Intraplaque neovascularization|intraplaque neovascularization
306357|NCT01842438|Sexual Dysfunctions, Psychological|sexual dysfunctions, psychological
306358|NCT01842425|Liver volume|liver volume
306359|NCT01842425|Gastric bypass|gastric bypass
306360|NCT01842425|Magnetic resonance imaging|magnetic resonance imaging
306361|NCT01842412|Mitochondria, Muscle|mitochondria, muscle
306362|NCT01842412|Exercise|exercise
306363|NCT01842399|Vascular Stiffness|vascular stiffness
306364|NCT01842399|Aging|aging
306365|NCT01842399|Resveratrol|resveratrol
306366|NCT01842399|Aerobic Capacity|aerobic capacity
306367|NCT01842399|Inflammation|inflammation
306368|NCT01842386|Anti-CD20|anti-cd20
306369|NCT01842386|Anticytokine Autoanitbody-Associated Disease|anticytokine autoanitbody-associated disease
306370|NCT01842386|Rituximab|rituximab
306371|NCT01842373|topical anesthetics|topical anesthetics
306372|NCT01842373|laser resurfacing|laser resurfacing
306373|NCT01842360|Vaccine|vaccine
306374|NCT01842360|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
306375|NCT01842334|Nicotine Dependence|nicotine dependence
306376|NCT01842334|Smoking Cessation|smoking cessation
306377|NCT01842334|D-cycloserine|d-cycloserine
306378|NCT01842321|locally advanced|locally advanced
306379|NCT01842321|metastatic|metastatic
306380|NCT01842321|Breast Cancer|breast cancer
306381|NCT01842321|Molecular Apocrine|molecular apocrine
306382|NCT01842321|HER2-negative|her2-negative
306383|NCT01842321|Abiraterone acetate|abiraterone acetate
306384|NCT01842295|Obesity|obesity
306385|NCT01842295|Bariatric surgery|bariatric surgery
306386|NCT01842295|Sperm quality|sperm quality
306387|NCT01842295|Fertility|fertility
306388|NCT01842282|diabetes mellitus type 2|diabetes mellitus type 2
306389|NCT01842282|non alcoholic fatty liver disease|non alcoholic fatty liver disease
306390|NCT01842282|obesity|obesity
306391|NCT01842282|amlexanox|amlexanox
306392|NCT01842269|Mycophenolate Mofetil|mycophenolate mofetil
306393|NCT01842269|MMF|mmf
306394|NCT01842256|Telminouveau|telminouveau
306395|NCT01842256|Atorvastatin|atorvastatin
306396|NCT01842256|Pharmacokinetic|pharmacokinetic
306397|NCT01842256|Healthy volunteers|healthy volunteers
306398|NCT01842243|Ventricular dysfunction|ventricular dysfunction
306399|NCT01842243|MRI|mri
306400|NCT01842243|Echocardiography|echocardiography
306401|NCT01842243|Pacemakers|pacemakers
306402|NCT01842230|Telminuvo|telminuvo
306403|NCT01842230|Telmisartan|telmisartan
306404|NCT01842230|S-amlodipine|s-amlodipine
306405|NCT01842230|Atorvastatin|atorvastatin
306406|NCT01842230|pharmacokinetics|pharmacokinetics
306407|NCT01842230|Healthy volunteers|healthy volunteers
306408|NCT01842217|18F-FES PET|18f-fes pet
306409|NCT01842217|Nuclear Medicine|nuclear medicine
306410|NCT01842217|Premenopausal|premenopausal
306411|NCT01842217|Postmenopausal|postmenopausal
306412|NCT01842217|Estrogen receptor|estrogen receptor
306413|NCT01842217|Anxiety|anxiety
306414|NCT01842217|Depression|depression
306415|NCT01842217|Cognition|cognition
306416|NCT01842204|inguinal hernia|inguinal hernia
306417|NCT01842191|R-R MS|r-r ms
306418|NCT01842165|Peptide Receptor Radionuclide Therapy (PRRT)|peptide receptor radionuclide therapy (prrt)
306419|NCT01842165|Neuroendocrine Tumors|neuroendocrine tumors
306420|NCT01842126|Sciatica|sciatica
306421|NCT01842100|Induced abortion|induced abortion
306422|NCT01842100|Postaboral pelvic inflammatory disease|postaboral pelvic inflammatory disease
306423|NCT01842100|Sexually transmitted infections|sexually transmitted infections
306424|NCT01842100|Universal antibiotic prophylaxis|universal antibiotic prophylaxis
306425|NCT01842100|Screen-and-treat approach|screen-and-treat approach
306426|NCT01842087|Chronic Kidney Disease|chronic kidney disease
306427|NCT01842087|Fiber|fiber
306428|NCT01842087|BUN|bun
306429|NCT01842087|Serum Creatinine|serum creatinine
306430|NCT01842087|Uremic Symptoms|uremic symptoms
306431|NCT01842087|Quality of Life|quality of life
306432|NCT01842074|bortezomib|bortezomib
306433|NCT01842074|desensitization|desensitization
306434|NCT01842074|living kidney transplantation|living kidney transplantation
306435|NCT01842061|active living|active living
306436|NCT01842061|retirement|retirement
306437|NCT01842048|External-beam radiotherapy|external-beam radiotherapy
306438|NCT01842048|Hyperthermia|hyperthermia
306439|NCT01842035|Implantable cardiac defibrillator|implantable cardiac defibrillator
306440|NCT01842035|regadenoson|regadenoson
306441|NCT01842035|sudden cardiac death|sudden cardiac death
306442|NCT01842035|heart rate response|heart rate response
306443|NCT01842022|Glycemic load|glycemic load
306444|NCT01842022|memory|memory
306445|NCT01842022|mood|mood
306446|NCT01842009|transcranial stimulation|transcranial stimulation
306447|NCT01842009|direct current|direct current
306448|NCT01841983|Total worker health|total worker health
306449|NCT01841983|Sleep|sleep
306450|NCT01841983|MSDs|msds
306451|NCT01841983|Diet|diet
306452|NCT01841983|Physical Activity|physical activity
306453|NCT01841957|Bilateral Cataract|bilateral cataract
306454|NCT01841957|Simultaneous Cataract Surgery|simultaneous cataract surgery
306455|NCT01841957|ISBCS|isbcs
306456|NCT01841944|Fatty Acids, Omega-3|fatty acids, omega-3
306457|NCT01841944|Aged|aged
306458|NCT01841944|Myocardial Infarction|myocardial infarction
306459|NCT01841931|Opioids|opioids
306460|NCT01841931|Dependence|dependence
306461|NCT01841931|Buprenorphine|buprenorphine
306462|NCT01841931|Pain|pain
306463|NCT01841905|Alzheimer's Disease|alzheimer's disease
306464|NCT01841905|Family History|family history
306465|NCT01841905|Memory Concerns|memory concerns
306466|NCT01841866|post operative sore throat|post operative sore throat
306467|NCT01841866|laryngeal mask airway|laryngeal mask airway
306468|NCT01841866|children|children
306469|NCT01841853|Elderly|elderly
306470|NCT01841853|Health promotion|health promotion
306471|NCT01841853|Randomized controlled study|randomized controlled study
306472|NCT01841853|Immigrant|immigrant
306473|NCT01841853|Vulnerable population|vulnerable population
306474|NCT01841853|ADL|adl
306475|NCT01841853|KASAM|kasam
306476|NCT01841853|Implementation|implementation
306477|NCT01841840|Stroke|stroke
306478|NCT01841840|Hemiparetic|hemiparetic
306479|NCT01841840|Passive Vibration|passive vibration
306480|NCT01841840|Arterial Stiffness|arterial stiffness
306481|NCT01841840|Pulse Wave Velocity|pulse wave velocity
306482|NCT01841840|Wave Reflection|wave reflection
306483|NCT01841840|Body Composition|body composition
306484|NCT01841840|Autonomic Function|autonomic function
306485|NCT01841814|Lymphoma|lymphoma
306486|NCT01841814|Osteoporosis|osteoporosis
306487|NCT01841814|Chemotherapy|chemotherapy
306488|NCT01841814|Patient with|patient with
306489|NCT01841775|Hepatitis C, Chronic|hepatitis c, chronic
306490|NCT01841775|Genotype 2/3|genotype 2/3
306491|NCT01841775|Interferon α 2b|interferon α 2b
306492|NCT01841775|Ribavirin|ribavirin
306493|NCT01841775|Pharmacovigilance|pharmacovigilance
306494|NCT01841762|PAH-SYMPACT|pah-sympact
306495|NCT01841762|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
306496|NCT01841762|psychometric instrument|psychometric instrument
306497|NCT01841749|Breast cancer|breast cancer
306498|NCT01841710|Bitter Taste|bitter taste
306499|NCT01841710|Pediatric Medications|pediatric medications
306500|NCT01841697|Diabetes Mellitus|diabetes mellitus
306501|NCT01841697|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
306502|NCT01841697|Glucose Metabolism Disorders|glucose metabolism disorders
306503|NCT01841697|Metabolic Diseases|metabolic diseases
306504|NCT01841697|Endocrine System Diseases|endocrine system diseases
306505|NCT01841697|Glimepiride|glimepiride
306506|NCT01841697|Metformin|metformin
306507|NCT01841697|Hypoglycemic Agents|hypoglycemic agents
306508|NCT01841697|Physiological Effects of Drugs|physiological effects of drugs
306509|NCT01841697|Pharmacologic Actions|pharmacologic actions
306510|NCT01841684|HoFH|hofh
306511|NCT01841671|Polio|polio
306512|NCT01841671|IPV|ipv
306513|NCT01841671|bOPV|bopv
306514|NCT01841671|mOPV|mopv
306515|NCT01841671|vaccination|vaccination
306516|NCT01841658|Folate Status|folate status
306517|NCT01841658|Folate Biomarkers|folate biomarkers
306518|NCT01841645|CLA-enriched butter|cla-enriched butter
306519|NCT01841645|CLA metabolism|cla metabolism
306520|NCT01841645|inflammation|inflammation
306521|NCT01841632|Liver transplantation|liver transplantation
306522|NCT01841632|Allogeneic liver transplantation|allogeneic liver transplantation
306523|NCT01841632|Solid organ transplantation|solid organ transplantation
306727|NCT01840722|HCV|hcv
306524|NCT01841619|skin, lupus, intravenous immunoglobulin, ivig|skin, lupus, intravenous immunoglobulin, ivig
306525|NCT01841606|Spinal anesthesia|spinal anesthesia
306526|NCT01841606|Elective cesarean deliveries|elective cesarean deliveries
306527|NCT01841606|Ondansetron|ondansetron
306528|NCT01841580|Tear proteins profiles|tear proteins profiles
306529|NCT01841580|Longitudinal|longitudinal
306530|NCT01841580|Ocular surface damage|ocular surface damage
306531|NCT01841580|Trabeculectomy|trabeculectomy
306532|NCT01841567|hip|hip
306533|NCT01841567|knee|knee
306534|NCT01841554|Mitral Valve|mitral valve
306535|NCT01841554|Annuloplasty|annuloplasty
306536|NCT01841541|Tuberculosis|tuberculosis
306537|NCT01841541|Informal providers|informal providers
306538|NCT01841541|Informal carers|informal carers
306539|NCT01841541|Barriers to health system|barriers to health system
306540|NCT01841528|Polycystic Ovary Syndrome|polycystic ovary syndrome
306541|NCT01841528|Infertility|infertility
306542|NCT01841528|In-vitro fertilization|in-vitro fertilization
306543|NCT01841528|fresh embryo transfer|fresh embryo transfer
306544|NCT01841528|frozen-thawed embryo transfer|frozen-thawed embryo transfer
306545|NCT01841502|telaprevir|telaprevir
306546|NCT01841502|paroxetine|paroxetine
306547|NCT01841502|interaction|interaction
306548|NCT01841502|pharmacokinetics|pharmacokinetics
306549|NCT01841489|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
306550|NCT01841489|CLL|cll
306551|NCT01841476|Peripheral blood|peripheral blood
306552|NCT01841476|HSC|hsc
306553|NCT01841476|Mobilization|mobilization
306554|NCT01841476|CXCR4|cxcr4
306555|NCT01841476|volunteers|volunteers
306556|NCT01841463|Malignant Melanoma|malignant melanoma
306557|NCT01841450|Primary open-angle glaucoma (POAG)|primary open-angle glaucoma (poag)
306558|NCT01841450|Trabecular meshwork|trabecular meshwork
306559|NCT01841450|iStent|istent
306560|NCT01841437|Primary open-angle glaucoma (POAG)|primary open-angle glaucoma (poag)
306561|NCT01841437|Trabecular meshwork|trabecular meshwork
306562|NCT01841437|iStent|istent
306563|NCT01841424|dietary counseling|dietary counseling
306564|NCT01841424|food diary|food diary
306565|NCT01841424|obesity|obesity
306566|NCT01841424|pregnancy|pregnancy
306567|NCT01841424|weight gain|weight gain
306568|NCT01841411|bacterial vaginosis, recurrence, N-Acetyl cysteine|bacterial vaginosis, recurrence, n-acetyl cysteine
306569|NCT01841398|Cardiovascular|cardiovascular
306570|NCT01841398|Prevention|prevention
306571|NCT01841398|Ethnicity|ethnicity
306572|NCT01841398|Culture|culture
306573|NCT01841398|Internet|internet
306574|NCT01841398|Text Message|text message
306575|NCT01841385|Exercise|exercise
306576|NCT01841385|spirometry|spirometry
306577|NCT01841385|muscle strength|muscle strength
306578|NCT01841385|physical therapy modalities|physical therapy modalities
306579|NCT01841372|Obesity|obesity
306580|NCT01841372|Overweight|overweight
306581|NCT01841372|Weight Maintenance|weight maintenance
306582|NCT01841359|Hypoglycemia|hypoglycemia
306583|NCT01841359|Gastric bypass surgery|gastric bypass surgery
306584|NCT01841346|Outcome after PCI|outcome after pci
306585|NCT01841346|Middle Eastern Patients|middle eastern patients
306586|NCT01841333|Lymphoblastic leukemia in remission|lymphoblastic leukemia in remission
306587|NCT01841333|Myeloid leukemia in remission|myeloid leukemia in remission
306588|NCT01841333|Recurrent lymphoblastic leukemia|recurrent lymphoblastic leukemia
306589|NCT01841333|Recurrent myeloid leukemia|recurrent myeloid leukemia
306590|NCT01841281|Asthma|asthma
306591|NCT01841281|Severe Asthma|severe asthma
306592|NCT01841268|premature, preterm, premie, skin|premature, preterm, premie, skin
306593|NCT01841255|Preoxygenation|preoxygenation
306594|NCT01841255|Device|device
306595|NCT01841255|Tolerability|tolerability
306596|NCT01841255|Efficacy|efficacy
306597|NCT01841242|Infection|infection
306598|NCT01841242|Cardiac Resynchronization Device|cardiac resynchronization device
306599|NCT01841242|Heart Failure|heart failure
306600|NCT01841216|Gluteus Maximus|gluteus maximus
306601|NCT01841216|Gluteus Medius|gluteus medius
306602|NCT01841216|TFL|tfl
306603|NCT01841216|EMG|emg
306604|NCT01841216|Perceived Exertion|perceived exertion
306605|NCT01841216|Thera-Band|thera-band
306606|NCT01841203|Diagnosis|diagnosis
306607|NCT01841203|Rapid tests|rapid tests
306608|NCT01841203|non-treponemal serology|non-treponemal serology
306609|NCT01841203|eradication|eradication
306610|NCT01841190|Prognosis|prognosis
306611|NCT01841190|Sepsis|sepsis
306612|NCT01841190|Septic shock|septic shock
306613|NCT01841190|Procalcitonin|procalcitonin
306614|NCT01841190|SOFA|sofa
306615|NCT01841177|Congenital Heart Disease|congenital heart disease
306616|NCT01841177|Pediatrics|pediatrics
306617|NCT01841177|Milrinone|milrinone
306618|NCT01841177|Cardiopulmonary Bypass|cardiopulmonary bypass
306619|NCT01841177|Therapeutic Drug Monitoring|therapeutic drug monitoring
306620|NCT01841164|Leukotriene responsiveness|leukotriene responsiveness
306621|NCT01841164|LTE4|lte4
306622|NCT01841164|asthma|asthma
306623|NCT01841164|airway hyperresponsiveness|airway hyperresponsiveness
306624|NCT01841164|bronchoprovocation|bronchoprovocation
306625|NCT01841164|anti-asthmatic agents|anti-asthmatic agents
306627|NCT01841151|AD/HD in Children and Adolescents|ad/hd in children and adolescents
306628|NCT01841138|colonoscopy|colonoscopy
306629|NCT01841138|bowel preparation|bowel preparation
306630|NCT01841138|electrolytes|electrolytes
306631|NCT01841138|osmolality|osmolality
306632|NCT01841138|water|water
306633|NCT01841125|Alzheimer's Disease|alzheimer's disease
306634|NCT01841125|depressive disorder|depressive disorder
306635|NCT01841073|Prediabetes|prediabetes
306636|NCT01841073|Fermentable carbohydrate|fermentable carbohydrate
306637|NCT01841073|Appetite|appetite
306638|NCT01841073|Glucose homeostasis|glucose homeostasis
306639|NCT01841073|Weight management|weight management
306640|NCT01841060|Malignant Non-small Cell Neoplasm of Lung|malignant non-small cell neoplasm of lung
306641|NCT01841047|Retroperitoneal liposarcoma operable|retroperitoneal liposarcoma operable
306642|NCT01841034|Male|male
306643|NCT01841021|Peripheral T-Cell Lymphoma (PTCL)|peripheral t-cell lymphoma (ptcl)
306644|NCT01841021|Relapsed|relapsed
306645|NCT01841021|Refractory|refractory
306646|NCT01841021|CD30 Receptor|cd30 receptor
306647|NCT01841021|Large B-Cell Lymphoma|large b-cell lymphoma
306648|NCT01841008|[C17.800.621]|[c17.800.621]
306649|NCT01840995|stellate ganglion block|stellate ganglion block
306650|NCT01840982|Mixed grains|mixed grains
306651|NCT01840982|Glycemic index|glycemic index
306652|NCT01840982|Giant embryonic brown rice|giant embryonic brown rice
306653|NCT01840982|Giant embryonic rice|giant embryonic rice
306654|NCT01840982|diabetes|diabetes
306655|NCT01840969|off-pump coronary artery bypass surgery|off-pump coronary artery bypass surgery
306656|NCT01840969|common carotid artery|common carotid artery
306657|NCT01840969|speckle tracking analysis|speckle tracking analysis
306658|NCT01840969|peak strain|peak strain
306659|NCT01840956|End-stage Renal Disease|end-stage renal disease
306660|NCT01840956|Hemodialysis|hemodialysis
306661|NCT01840956|Chronic Renal Insufficiency|chronic renal insufficiency
306662|NCT01840956|Renal Dialysis|renal dialysis
306663|NCT01840956|Hemodiafiltration|hemodiafiltration
306664|NCT01840956|Blood Vessel Prosthesis|blood vessel prosthesis
306665|NCT01840956|Tissue-Engineered Vascular Graft|tissue-engineered vascular graft
306666|NCT01840956|Vascular Prosthesis Implantation|vascular prosthesis implantation
306667|NCT01840956|Kidney Diseases|kidney diseases
306668|NCT01840956|Kidney Failure, Chronic|kidney failure, chronic
306669|NCT01840956|Renal Insufficiency|renal insufficiency
306670|NCT01840956|Urologic Diseases|urologic diseases
306671|NCT01840943|Epithelial ovarian cancer|epithelial ovarian cancer
306672|NCT01840943|Recurrent epithelial ovarian carcinoma|recurrent epithelial ovarian carcinoma
306673|NCT01840943|Carcinoma|carcinoma
306674|NCT01840943|Malignancy|malignancy
306675|NCT01840943|Ovarian carcinoma|ovarian carcinoma
306676|NCT01840943|CAELYX|caelyx
306677|NCT01840943|Topotecan hydrochloride|topotecan hydrochloride
306678|NCT01840943|Topotecan|topotecan
306679|NCT01840943|Platinum-based regimen chemotherapy|platinum-based regimen chemotherapy
306680|NCT01840943|Chinese patients|chinese patients
306681|NCT01840930|Cohort|cohort
306682|NCT01840930|Cerebral Palsy|cerebral palsy
306683|NCT01840930|Children|children
306684|NCT01840930|Pain|pain
306685|NCT01840930|Orthopedic complications|orthopedic complications
306686|NCT01840930|Epidemiology|epidemiology
306687|NCT01840865|young healthy subjects|young healthy subjects
306688|NCT01840865|brain stimulation|brain stimulation
306689|NCT01840865|tSOS|tsos
306690|NCT01840865|tDCS|tdcs
306691|NCT01840865|sleep|sleep
306692|NCT01840865|daytime sleep|daytime sleep
306693|NCT01840865|nap|nap
306694|NCT01840865|memory|memory
306695|NCT01840865|memory consolidation|memory consolidation
306696|NCT01840839|aging|aging
306697|NCT01840839|cognitive decline|cognitive decline
306698|NCT01840839|brain stimulation|brain stimulation
306699|NCT01840839|tSOS|tsos
306700|NCT01840839|tDCS|tdcs
306701|NCT01840839|sleep|sleep
306702|NCT01840839|nap|nap
306703|NCT01840839|daytime sleep|daytime sleep
306704|NCT01840839|memory|memory
306705|NCT01840839|memory consolidation|memory consolidation
306706|NCT01840826|Rehospitalization|rehospitalization
306707|NCT01840826|Reutilization|reutilization
306708|NCT01840826|Depressive Symptoms|depressive symptoms
306709|NCT01840826|Pharmacotherapy|pharmacotherapy
306710|NCT01840826|Cognitive Therapy|cognitive therapy
306711|NCT01840826|Self-help|self-help
306712|NCT01840826|Complementary Therapies|complementary therapies
306713|NCT01840813|Intraumbilical misoprostol|intraumbilical misoprostol
306714|NCT01840813|Retained placenta|retained placenta
306715|NCT01840813|Active management of third stage of labour|active management of third stage of labour
306716|NCT01840800|Postoperative pain|postoperative pain
306717|NCT01840800|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
306718|NCT01840800|ultrasound guided nerve blocks|ultrasound guided nerve blocks
306719|NCT01840800|opioid consumption|opioid consumption
306720|NCT01840761|delayed vasospasm,|delayed vasospasm,
306721|NCT01840761|medicine,|medicine,
306722|NCT01840761|standardization|standardization
306723|NCT01840735|CF|cf
306724|NCT01840735|Cystic Fibrosis|cystic fibrosis
306725|NCT01840735|PK|pk
306728|NCT01840722|Substance abuse|substance abuse
306729|NCT01840722|women|women
306730|NCT01840709|Systemic lupus erythematosus|systemic lupus erythematosus
306731|NCT01840709|Psychotherapy|psychotherapy
306732|NCT01840683|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
306733|NCT01840683|Age Related Eye Disease Study (AREDS)|age related eye disease study (areds)
306734|NCT01840683|Best-Corrected Visual Acuity (BCVA)|best-corrected visual acuity (bcva)
306735|NCT01840683|Early Treatment Diabetic Retinopathy Study (ETDRS)|early treatment diabetic retinopathy study (etdrs)
306736|NCT01840683|Heparin-Induced Extracorporeal LDL-Cholesterol Precipitation (HELP)|heparin-induced extracorporeal ldl-cholesterol precipitation (help)
306737|NCT01840683|Visual Function Questionnaire (VFQ)|visual function questionnaire (vfq)
306738|NCT01840670|Inferior Vena Cava|inferior vena cava
306739|NCT01840670|Central Venous Pressure|central venous pressure
306740|NCT01840670|Abdominal Pressure|abdominal pressure
306741|NCT01840657|CMDIR (Congenital Muscle Disease International Registry)|cmdir (congenital muscle disease international registry)
306742|NCT01840657|X-linked myotubular myopathy|x-linked myotubular myopathy
306743|NCT01840657|centronuclear myopathy|centronuclear myopathy
306744|NCT01840657|myotubularin|myotubularin
306745|NCT01840657|MTM1 gene|mtm1 gene
306746|NCT01840657|mutation|mutation
306747|NCT01840657|survival|survival
306748|NCT01840657|adverse event|adverse event
306749|NCT01840657|disease complication|disease complication
306750|NCT01840657|hospital admission|hospital admission
306751|NCT01840657|emergency room visit|emergency room visit
306752|NCT01840657|motor function|motor function
306753|NCT01840657|respiratory function|respiratory function
306754|NCT01840657|natural history study|natural history study
306755|NCT01840631|Obesity|obesity
306756|NCT01840631|Nutritional counseling|nutritional counseling
306757|NCT01840631|Physical activity|physical activity
306758|NCT01840631|Food diary|food diary
306759|NCT01840618|insulin function|insulin function
306760|NCT01840618|sleep apnea|sleep apnea
306761|NCT01840618|girls|girls
306762|NCT01840618|PCOS|pcos
306763|NCT01840618|insulin action|insulin action
306764|NCT01840592|Liver|liver
306765|NCT01840592|Sorafenib|sorafenib
306766|NCT01840592|Doxorubicin|doxorubicin
306767|NCT01840592|12-259|12-259
306768|NCT01840566|Relapsed|relapsed
306769|NCT01840566|Refractory|refractory
306770|NCT01840566|Autologous Stem Cell Transplantation|autologous stem cell transplantation
306771|NCT01840566|HIGH DOSE CHEMOTHERAPY|high dose chemotherapy
306772|NCT01840566|19-28z T cells/kg|19-28z t cells/kg
306773|NCT01840566|12-117|12-117
306774|NCT01840540|renal artery stenosis|renal artery stenosis
306775|NCT01840540|renovascular hypertension|renovascular hypertension
306776|NCT01840540|ischemic nephropathy|ischemic nephropathy
306777|NCT01840540|chronic kidney disease|chronic kidney disease
306778|NCT01840527|Biomarker|biomarker
306779|NCT01840527|BRAF|braf
306780|NCT01840527|blood-based|blood-based
306781|NCT01840514|recipient|recipient
306782|NCT01840501|Healthy|healthy
306783|NCT01840501|JNJ-42721458|jnj-42721458
306784|NCT01840501|Male|male
306785|NCT01840501|Safety|safety
306786|NCT01840501|Tolerability|tolerability
306787|NCT01840501|Pharmacokinetics|pharmacokinetics
306788|NCT01840501|Pharmacodynamics|pharmacodynamics
306789|NCT01840501|Immunogenicity|immunogenicity
306790|NCT01840436|MUCIPLIQ|mucipliq
306791|NCT01840436|Matrix therapy|matrix therapy
306792|NCT01840436|RGTA|rgta
306793|NCT01840436|Oral mucositis|oral mucositis
306794|NCT01840423|First in man study|first in man study
306795|NCT01840423|Volunteer study|volunteer study
306796|NCT01840410|Vision Impairment|vision impairment
306797|NCT01840410|Abnormal growth of blood vessels|abnormal growth of blood vessels
306798|NCT01840397|S-100B|s-100b
306799|NCT01840397|NSE|nse
306800|NCT01840384|Healthy infants|healthy infants
306801|NCT01840384|Anemia, iron-deficiency|anemia, iron-deficiency
306802|NCT01840371|ERCP|ercp
306803|NCT01840371|Sedation|sedation
306804|NCT01840371|Fentanyl|fentanyl
306805|NCT01840371|Propofol|propofol
306806|NCT01840358|Hypoglycemias|hypoglycemias
306807|NCT01840358|Insulin pump|insulin pump
306808|NCT01840358|Children|children
306809|NCT01840345|uncontrolled|uncontrolled
306810|NCT01840345|neuropathic pain|neuropathic pain
306811|NCT01840332|thyroid cancer|thyroid cancer
306812|NCT01840280|carcinoma|carcinoma
306813|NCT01840280|colorectal cancer|colorectal cancer
306814|NCT01840280|ambulant chemotherapy|ambulant chemotherapy
306815|NCT01840280|treatment cycles|treatment cycles
306816|NCT01840280|Irinotecan|irinotecan
306817|NCT01840280|Irinotecan onkovis|irinotecan onkovis
306818|NCT01840280|Quantity of Irinotecan|quantity of irinotecan
306819|NCT01840280|Packaging Sizes|packaging sizes
306820|NCT01840267|pneumoperitoneum|pneumoperitoneum
306821|NCT01840267|pediatric laparoscopy|pediatric laparoscopy
306822|NCT01840267|optic nerve sheath diameter|optic nerve sheath diameter
306823|NCT01840267|intracranial pressure|intracranial pressure
306824|NCT01840254|PONV|ponv
306825|NCT01840254|IV PCA|iv pca
306826|NCT01840254|dexmedetomidine|dexmedetomidine
306827|NCT01840254|Female|female
306828|NCT01840254|non-smoking|non-smoking
306829|NCT01840254|lumbar spine surgery|lumbar spine surgery
306830|NCT01840241|sodium bicarbonate|sodium bicarbonate
306831|NCT01840241|acute kidney injury|acute kidney injury
306832|NCT01840241|OPCAB|opcab
306833|NCT01840228|Preterm|preterm
306834|NCT01840228|Progesterone|progesterone
306835|NCT01840189|Addison disease|addison disease
306836|NCT01840189|Type 1 diabetes|type 1 diabetes
306837|NCT01840189|treatment|treatment
306838|NCT01840176|McCall culdoplasty|mccall culdoplasty
306839|NCT01840176|Total laparoscopic hysterectomy|total laparoscopic hysterectomy
306840|NCT01840176|Vaginal vault prolapse|vaginal vault prolapse
306841|NCT01840176|Sexual function|sexual function
306842|NCT01840124|Fibroids|fibroids
306843|NCT01840124|Radiofrequency ablation|radiofrequency ablation
306844|NCT01840111|smoking environment|smoking environment
306845|NCT01840111|cue-exposure|cue-exposure
306846|NCT01840111|cigarettes|cigarettes
306847|NCT01840111|nicotine|nicotine
306848|NCT01840111|fMRI|fmri
306849|NCT01840085|Diabetic foot ulcer|diabetic foot ulcer
306850|NCT01840085|plantar neuropathic ulcer|plantar neuropathic ulcer
306851|NCT01840085|plantar neuroischemic ulcer|plantar neuroischemic ulcer
306852|NCT01840085|Wagner Grade 1 or Grade 2 DFU|wagner grade 1 or grade 2 dfu
306853|NCT01840072|Ischemic stroke|ischemic stroke
306854|NCT01840072|Hypertension|hypertension
306855|NCT01840072|Antihypertensive Agents|antihypertensive agents
306856|NCT01840072|Randomized Controlled Trial|randomized controlled trial
306857|NCT01840059|Cardiac Failure|cardiac failure
306858|NCT01840059|Autonomic Denervation|autonomic denervation
306859|NCT01840020|bariatric surgery|bariatric surgery
306860|NCT01840020|alcohol drinking|alcohol drinking
306861|NCT01840020|alcoholism|alcoholism
306862|NCT01840020|ethanol|ethanol
306863|NCT01840020|metabolism|metabolism
306864|NCT01839994|prostate cancer,|prostate cancer,
306865|NCT01839994|high-dose-rate brachytherapy boost,|high-dose-rate brachytherapy boost,
306866|NCT01839994|stereotactic body radiotherapy boost,|stereotactic body radiotherapy boost,
306867|NCT01839994|conformal radiotherapy,|conformal radiotherapy,
306868|NCT01839994|randomized trial|randomized trial
306869|NCT01839942|Hernia, Ventral|hernia, ventral
306870|NCT01839929|tacrolimus|tacrolimus
306871|NCT01839929|immunosuppressant|immunosuppressant
306872|NCT01839929|FK506|fk506
306873|NCT01839903|Smoking|smoking
306874|NCT01839903|Tobacco|tobacco
306875|NCT01839903|Emergency Department|emergency department
306876|NCT01839890|Paclitaxel|paclitaxel
306877|NCT01839890|stent|stent
306878|NCT01839890|Acute infarction|acute infarction
306879|NCT01839890|Systolic time elevation|systolic time elevation
306880|NCT01839877|Metastatic colorectal Cancer|metastatic colorectal cancer
306881|NCT01839864|Promotoras|promotoras
306882|NCT01839864|Hispanic Adults|hispanic adults
306883|NCT01839864|metabolic syndrome|metabolic syndrome
306884|NCT01839864|rural|rural
306885|NCT01839864|patient attitudes|patient attitudes
306886|NCT01839864|provider cultural competency|provider cultural competency
306887|NCT01839864|patient activation measure|patient activation measure
306888|NCT01839851|Hair cortisol|hair cortisol
306889|NCT01839851|asthma|asthma
306890|NCT01839851|allergic rhinitis|allergic rhinitis
306891|NCT01839851|inhaled corticosteroids|inhaled corticosteroids
306892|NCT01839851|intranasal glucocorticoids|intranasal glucocorticoids
306893|NCT01839838|Women|women
306894|NCT01839838|age 50 and above|age 50 and above
306895|NCT01839838|with|with
306896|NCT01839838|that has been|that has been
306897|NCT01839838|surgically excised|surgically excised
306898|NCT01839825|elderly|elderly
306899|NCT01839825|fall|fall
306900|NCT01839825|acute illness|acute illness
306901|NCT01839825|care giver|care giver
306902|NCT01839812|Cardiopulmonary bypass|cardiopulmonary bypass
306903|NCT01839812|Cortisol|cortisol
306904|NCT01839812|Dexamethasone|dexamethasone
306905|NCT01839799|Patients|patients
306906|NCT01839799|with|with
306907|NCT01839799|resected|resected
306908|NCT01839786|Pulmonary Hypertension|pulmonary hypertension
306909|NCT01839786|Doppler|doppler
306910|NCT01839786|Valsalva|valsalva
306911|NCT01839773|Stomach Neoplasms|stomach neoplasms
306912|NCT01839773|Cancer of Stomach|cancer of stomach
306913|NCT01839773|Gastric Cancer|gastric cancer
306914|NCT01839773|Gastric Neoplasms|gastric neoplasms
306915|NCT01839773|Neoplasms, Gastric|neoplasms, gastric
306916|NCT01839773|Neoplasms, Stomach|neoplasms, stomach
306917|NCT01839773|Stomach Cancer|stomach cancer
306918|NCT01839773|paclitaxel|paclitaxel
306919|NCT01839773|Taxol|taxol
306920|NCT01839760|Influenza|influenza
306921|NCT01839760|Virus|virus
306922|NCT01839760|Viral shedding|viral shedding
306923|NCT01839760|Epidemiology|epidemiology
306924|NCT01839747|Pediatric|pediatric
306925|NCT01839734|CD4+|cd4+
306926|NCT01839721|Probiotics|probiotics
306927|NCT01839721|radiation-induced enteritis|radiation-induced enteritis
306928|NCT01839721|radiation-induced diarrhea|radiation-induced diarrhea
306929|NCT01839721|radiation, diarrhea, enteritis|radiation, diarrhea, enteritis
306930|NCT01839721|diet|diet
306931|NCT01839721|nutrition|nutrition
306932|NCT01839708|Intervention|intervention
306933|NCT01839695|Thoracic Aneurysm|thoracic aneurysm
306934|NCT01839695|Endovascular Aortic Repair|endovascular aortic repair
306935|NCT01839695|TEVAR|tevar
306936|NCT01839682|StabiliT|stabilit
306937|NCT01839682|Kyphoplasty|kyphoplasty
306938|NCT01839682|Vertebral|vertebral
306939|NCT01839682|Compression|compression
306940|NCT01839682|Fracture|fracture
306941|NCT01839682|Osteoporosis|osteoporosis
306942|NCT01839669|conservative therapy|conservative therapy
306943|NCT01839669|Foot-Function-Index|foot-function-index
306944|NCT01839669|functional movement changes|functional movement changes
306945|NCT01839669|non-surgical treatment|non-surgical treatment
306946|NCT01839669|pes planovalgus|pes planovalgus
306947|NCT01839669|posterior tibial tendon dysfunction|posterior tibial tendon dysfunction
306948|NCT01839656|Spinal Muscular Atrophy|spinal muscular atrophy
306950|NCT01839656|SMN|smn
306951|NCT01839656|SMNRx|smnrx
306952|NCT01839656|ISIS-SMNRx|isis-smnrx
306953|NCT01839656|ISIS 396443|isis 396443
306954|NCT01839656|IONIS-SMNRx|ionis-smnrx
306955|NCT01839656|Spinraza|spinraza
306956|NCT01839656|Nusinersen|nusinersen
306957|NCT01839643|pharmacokinetic|pharmacokinetic
306958|NCT01839630|Sorafenib|sorafenib
306959|NCT01839630|Hepatocellular cancer|hepatocellular cancer
306960|NCT01839630|TACE combination|tace combination
306961|NCT01839630|Treatment pattern|treatment pattern
306962|NCT01839630|Safety|safety
306963|NCT01839630|Effectiveness|effectiveness
306964|NCT01839617|parenteral nutrition|parenteral nutrition
306965|NCT01839617|early nutrition|early nutrition
306966|NCT01839617|abdominal surgery|abdominal surgery
306967|NCT01839617|cancer|cancer
306968|NCT01839604|Child-Pugh A to B7,|child-pugh a to b7,
306969|NCT01839604|Advanced/Metastatic Hepatocellular Carcinoma,|advanced/metastatic hepatocellular carcinoma,
306970|NCT01839604|AZD9150,|azd9150,
306971|NCT01839604|Antisense Oligonucleotide Inhibitor of STAT3|antisense oligonucleotide inhibitor of stat3
306972|NCT01839578|cytokines|cytokines
306973|NCT01839578|blood purification|blood purification
306974|NCT01839578|super high flux hemodialysis|super high flux hemodialysis
306975|NCT01839565|Adverse events|adverse events
306976|NCT01839565|Osteosynthesis|osteosynthesis
306977|NCT01839565|Quality of life|quality of life
306978|NCT01839552|Fentanyl Citrate Nasal Spray (FCNS)|fentanyl citrate nasal spray (fcns)
306979|NCT01839552|Lazanda|lazanda
306980|NCT01839552|Breakthrough pain in cancer patients|breakthrough pain in cancer patients
306981|NCT01839539|colorectal cancer|colorectal cancer
306982|NCT01839539|DC-CIK|dc-cik
306983|NCT01839539|CRC|crc
306984|NCT01839526|Fabry disease|fabry disease
306985|NCT01839513|Analgesia/nociception index|analgesia/nociception index
306986|NCT01839513|Desflurane|desflurane
306987|NCT01839513|Remifentanil|remifentanil
306988|NCT01839513|Orthopedic surgery|orthopedic surgery
306989|NCT01839513|Ear-nose-throat surgery|ear-nose-throat surgery
306990|NCT01839513|Hemodynamic reactivity|hemodynamic reactivity
306991|NCT01839487|pancreatic ductal carcinoma(PDA)|pancreatic ductal carcinoma(pda)
306992|NCT01839487|Pancreatic ductal carcinoma|pancreatic ductal carcinoma
306993|NCT01839487|PEGPH20|pegph20
306994|NCT01839487|Gemcitabine|gemcitabine
306995|NCT01839487|Nab-paclitaxel|nab-paclitaxel
306996|NCT01839474|Continuous Positive Airway Pressure|continuous positive airway pressure
306997|NCT01839474|Controlled trial|controlled trial
306998|NCT01839474|Pneumonia|pneumonia
306999|NCT01839474|Children|children
307000|NCT01839461|Pharmacogenetics|pharmacogenetics
307001|NCT01839461|postoperative|postoperative
307002|NCT01839461|pediatric|pediatric
307003|NCT01839461|opioid|opioid
307004|NCT01839461|perioperative|perioperative
307005|NCT01839461|respiratory depression|respiratory depression
307006|NCT01839461|chronic pain|chronic pain
307007|NCT01839448|post partum diabetes|post partum diabetes
307008|NCT01839448|impaired fasting glucose|impaired fasting glucose
307009|NCT01839435|appendectomy|appendectomy
307010|NCT01839435|acute appendicitis|acute appendicitis
307011|NCT01839435|outpatient|outpatient
307012|NCT01839409|Circadian Rhythm|circadian rhythm
307013|NCT01839409|Exercise|exercise
307014|NCT01839409|Reflex, Vestibular Ocular|reflex, vestibular ocular
307015|NCT01839409|Postural Balance|postural balance
307016|NCT01839396|Intrepid, Vercise, PD, DBS, Boston Scientific|intrepid, vercise, pd, dbs, boston scientific
307017|NCT01839370|Pramlintide|pramlintide
307018|NCT01839370|Closed Loop|closed loop
307019|NCT01839370|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
307020|NCT01839370|Diabetes Assistant (DiAs)|diabetes assistant (dias)
307021|NCT01839357|Rivaroxaban|rivaroxaban
307022|NCT01839357|Oral anticoagulant|oral anticoagulant
307023|NCT01839357|Nonvalvular atrial fibrillation|nonvalvular atrial fibrillation
307024|NCT01839357|Left atrial thrombus|left atrial thrombus
307025|NCT01839357|Transesophageal echocardiography|transesophageal echocardiography
307026|NCT01839357|Thrombus resolution|thrombus resolution
307027|NCT01839357|Stroke|stroke
307028|NCT01839357|Thromboembolism|thromboembolism
307029|NCT01839344|hyperglycemia|hyperglycemia
307030|NCT01839344|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
307031|NCT01839344|endothelial dysfunction|endothelial dysfunction
307032|NCT01839344|quercetin|quercetin
307033|NCT01839344|Acarbose|acarbose
307034|NCT01839344|glucose tolerance|glucose tolerance
307035|NCT01839344|maltose|maltose
307036|NCT01839331|osteoarthritis|osteoarthritis
307037|NCT01839331|osteoarthrisis of the knee|osteoarthrisis of the knee
307038|NCT01839318|Soft contact lenses|soft contact lenses
307039|NCT01839318|Daily disposable contact lenses|daily disposable contact lenses
307040|NCT01839318|Tear Film Break Up Time|tear film break up time
307041|NCT01839318|Contact lens wettability|contact lens wettability
307042|NCT01839305|Kinematics|kinematics
307043|NCT01839305|Fibromyalgia|fibromyalgia
307044|NCT01839305|Physical Therapy|physical therapy
307045|NCT01839305|3D Kinematics|3d kinematics
307046|NCT01839305|Heart Rate Frequency|heart rate frequency
307047|NCT01839305|Hydrotherapy|hydrotherapy
307048|NCT01839292|gastric outlet obstruction|gastric outlet obstruction
307049|NCT01839292|palliative treatment|palliative treatment
307050|NCT01839292|stent|stent
307051|NCT01839266|acute PTE, prognostic factors|acute pte, prognostic factors
307052|NCT01839253|antihypertensive agents|antihypertensive agents
307053|NCT01839253|hemodynamic|hemodynamic
307054|NCT01839253|anesthetics reduction|anesthetics reduction
307055|NCT01839253|orthognathic surgery|orthognathic surgery
307056|NCT01839227|Post-operative cognitive dysfunction|post-operative cognitive dysfunction
307057|NCT01839227|regional cerebral oxygen saturation|regional cerebral oxygen saturation
307058|NCT01839227|elderly|elderly
307059|NCT01839201|anesthesia|anesthesia
307060|NCT01839201|modification of dreaming|modification of dreaming
307061|NCT01839201|suggestions|suggestions
307062|NCT01839162|Transradial approach|transradial approach
307063|NCT01839162|shield drape|shield drape
307064|NCT01839162|radiation|radiation
307065|NCT01839162|PTCA|ptca
307066|NCT01839149|Refractory Chronic Migraine|refractory chronic migraine
307067|NCT01839149|Medically Intractable Chronic Migraine|medically intractable chronic migraine
307068|NCT01839149|Oxytocin|oxytocin
307069|NCT01839149|Intranasal oxytocin|intranasal oxytocin
307070|NCT01839136|Assisted Reproductive Techniques|assisted reproductive techniques
307071|NCT01839136|Health Services Accessibility|health services accessibility
307072|NCT01839136|Ovulation Induction|ovulation induction
307073|NCT01839136|Embryo Transfer|embryo transfer
307074|NCT01839123|Amputee|amputee
307075|NCT01839110|pulmonary hypertension|pulmonary hypertension
307076|NCT01839110|right ventricular function|right ventricular function
307077|NCT01839110|ranolazine|ranolazine
307078|NCT01839097|PTCL|ptcl
307079|NCT01839097|Maximum Tolerated Dose|maximum tolerated dose
307080|NCT01839097|Belinostat|belinostat
307081|NCT01839084|Xenon|xenon
307082|NCT01839084|Isoflurane|isoflurane
307083|NCT01839084|Anesthetics, Inhalation|anesthetics, inhalation
307084|NCT01839084|Nephroprotection|nephroprotection
307085|NCT01839084|Partial nephrectomy|partial nephrectomy
307086|NCT01839084|Xenon versus Isoflurane anesthesia|xenon versus isoflurane anesthesia
307087|NCT01839058|Non Cardiac Chest Pain|non cardiac chest pain
307088|NCT01839045|Woman|woman
307089|NCT01839045|Breast Cancer|breast cancer
307090|NCT01839045|Cancer|cancer
307091|NCT01839045|Mammogram|mammogram
307092|NCT01839045|Ultrasound|ultrasound
307093|NCT01839045|Imaging|imaging
307094|NCT01839045|Biomarkers|biomarkers
307095|NCT01839045|ACR BI RAD Category 3|acr bi rad category 3
307096|NCT01839045|ACR BI RAD Category 4|acr bi rad category 4
307097|NCT01839019|Healthy volunteers|healthy volunteers
307098|NCT01839006|hydronephrosis|hydronephrosis
307099|NCT01839006|ultrasonography|ultrasonography
307100|NCT01839006|Kidney Function Test|kidney function test
307101|NCT01839006|Patients with unilateral UPJO and patients with preop HN in USG and supranormal renal function in DTPA renography|patients with unilateral upjo and patients with preop hn in usg and supranormal renal function in dtpa renography
307102|NCT01838993|anesthetics,|anesthetics,
307103|NCT01838993|local,|local,
307104|NCT01838993|lidocaine;|lidocaine;
307105|NCT01838993|nebulizers and vaporizers;|nebulizers and vaporizers;
307106|NCT01838993|complications,|complications,
307107|NCT01838993|intubation,|intubation,
307108|NCT01838993|intratracheal.|intratracheal.
307109|NCT01838980|Colonoscopy Cleaning|colonoscopy cleaning
307110|NCT01838967|cilnidipin and valsartn|cilnidipin and valsartn
307111|NCT01838967|pharmacokinetic drug drug interaction|pharmacokinetic drug drug interaction
307112|NCT01838967|oral administration|oral administration
307113|NCT01838967|healthy male subjects|healthy male subjects
307114|NCT01838954|hand osteoarthritis|hand osteoarthritis
307115|NCT01838954|short-wave diathermy|short-wave diathermy
307116|NCT01838941|Peroxisome Biogenesis Disorder|peroxisome biogenesis disorder
307118|NCT01838941|neonatal adrenoleukodystrophy|neonatal adrenoleukodystrophy
307119|NCT01838941|infantile Refsum disease|infantile refsum disease
307120|NCT01838941|PEX1 mutation|pex1 mutation
307121|NCT01838941|Betaine|betaine
307122|NCT01838928|Axillary brachial plexus block|axillary brachial plexus block
307123|NCT01838928|Ultrasound|ultrasound
307124|NCT01838928|Minimum effective concentration|minimum effective concentration
307125|NCT01838928|Bupivacaine|bupivacaine
308205|NCT01833793|Amenorrhea|amenorrhea
307126|NCT01838928|ultrasound-guided axillary brachial plexus block|ultrasound-guided axillary brachial plexus block
307127|NCT01838915|HIV|hiv
307128|NCT01838915|immunoactivation|immunoactivation
307129|NCT01838915|bacterial translocation|bacterial translocation
307130|NCT01838915|prebiotics|prebiotics
307131|NCT01838915|glutamine|glutamine
307132|NCT01838915|microbiota|microbiota
307133|NCT01838902|Malaria|malaria
307134|NCT01838902|Falciparum|falciparum
307135|NCT01838902|Direct membrane feeding|direct membrane feeding
307136|NCT01838902|QT-NASBA|qt-nasba
307137|NCT01838902|Asexual parasite|asexual parasite
307138|NCT01838902|Asymptomatic carrier|asymptomatic carrier
307139|NCT01838902|Gametocytocidal, Gametocyte|gametocytocidal, gametocyte
307140|NCT01838902|Transmission blocking|transmission blocking
307141|NCT01838902|Sexual stage|sexual stage
307142|NCT01838902|Primaquine|primaquine
307143|NCT01838902|Dihydroartemisinin|dihydroartemisinin
307144|NCT01838902|Piperaquine|piperaquine
307145|NCT01838902|Gambia|gambia
307146|NCT01838902|Africa|africa
307147|NCT01838889|Culturally adapted|culturally adapted
307148|NCT01838889|Group psychological intervention|group psychological intervention
307149|NCT01838889|British South Asian women|british south asian women
307150|NCT01838889|CBT|cbt
307151|NCT01838876|Major Depressive Disorder|major depressive disorder
307152|NCT01838876|MDD|mdd
307153|NCT01838876|Depression|depression
307154|NCT01838863|coagulopathy|coagulopathy
307155|NCT01838863|hemorrhagic shock|hemorrhagic shock
307156|NCT01838863|plasma|plasma
307157|NCT01838863|blood product transfusion|blood product transfusion
307158|NCT01838824|Processing Speed|processing speed
307159|NCT01838824|Intervention|intervention
307160|NCT01838824|Multiple Sclerosis|multiple sclerosis
307161|NCT01838824|Cognition|cognition
307162|NCT01838811|Processing Speed|processing speed
307163|NCT01838811|Intervention|intervention
307164|NCT01838811|Traumatic Brain Injury|traumatic brain injury
307165|NCT01838811|Cognition|cognition
307166|NCT01838798|cognitive disorders|cognitive disorders
307167|NCT01838798|quality of life|quality of life
307168|NCT01838798|Intensive care|intensive care
307169|NCT01838785|18F-DTBZ AV-133 imaging|18f-dtbz av-133 imaging
307170|NCT01838772|HCV and HIV co-infection|hcv and hiv co-infection
307171|NCT01838759|Bioimpedance spectroscopy|bioimpedance spectroscopy
307172|NCT01838759|Hypervolemia|hypervolemia
307173|NCT01838759|Hypovolemia|hypovolemia
307174|NCT01838746|Percutaneous coronary intervention|percutaneous coronary intervention
307175|NCT01838746|Coronary artery bypass grafting|coronary artery bypass grafting
307176|NCT01838746|Coronary artery bypass surgery|coronary artery bypass surgery
307177|NCT01838746|Survival|survival
307178|NCT01838746|Acute coronary syndrome|acute coronary syndrome
307179|NCT01838746|ST segment elevation myocardial infarction|st segment elevation myocardial infarction
307180|NCT01838746|Non-ST segment elevation myocardial infarction|non-st segment elevation myocardial infarction
307181|NCT01838746|Younge patient|younge patient
307182|NCT01838720|renal cell carcinoma|renal cell carcinoma
307183|NCT01838720|ischemia|ischemia
307184|NCT01838720|radio frequency ablation|radio frequency ablation
307185|NCT01838707|postoperative|postoperative
307186|NCT01838707|spine surgery|spine surgery
307187|NCT01838655|Albinism|albinism
307188|NCT01838655|Nitisinone|nitisinone
307189|NCT01838655|Melanin|melanin
307190|NCT01838655|Vision Loss|vision loss
307191|NCT01838642|Monoclonal Antibody|monoclonal antibody
307192|NCT01838642|AP24534|ap24534
307193|NCT01838642|RET Mutation Positive|ret mutation positive
307194|NCT01838642|RET Mutation Negative|ret mutation negative
307195|NCT01838642|RET Inhibitor|ret inhibitor
307196|NCT01838616|Severe chronic low back pain|severe chronic low back pain
307197|NCT01838616|Neuropathic pain|neuropathic pain
307198|NCT01838616|Constipation|constipation
307199|NCT01838590|Liver Diseases|liver diseases
307200|NCT01838590|Digestive System Diseases|digestive system diseases
307201|NCT01838590|Hepatitis, Viral, Human|hepatitis, viral, human
307202|NCT01838590|Virus Diseases|virus diseases
307203|NCT01838590|Enterovirus Infections|enterovirus infections
307204|NCT01838590|Picornaviridae Infections|picornaviridae infections
307205|NCT01838590|RNA Virus Infections|rna virus infections
307206|NCT01838590|Flaviviridae Infections|flaviviridae infections
307207|NCT01838590|Antiviral Agents|antiviral agents
307208|NCT01838590|Anti-Infective Agents|anti-infective agents
307209|NCT01838590|Therapeutic Uses|therapeutic uses
307210|NCT01838590|Pharmacologic Actions|pharmacologic actions
307211|NCT01838590|Antimetabolites|antimetabolites
307212|NCT01838590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
307213|NCT01838590|HCV genotype 4 (GT-4)|hcv genotype 4 (gt-4)
307215|NCT01838590|Sustained Virologic Response|sustained virologic response
307216|NCT01838590|Direct Acting Antiviral|direct acting antiviral
307217|NCT01838590|Combination Therapy|combination therapy
307218|NCT01838590|GS-7977|gs-7977
307219|NCT01838590|Ribavirin|ribavirin
307220|NCT01838590|Open Label|open label
307221|NCT01838590|Sofosbuvir|sofosbuvir
307222|NCT01838590|Additional relevant MeSH terms:|additional relevant mesh terms:
307223|NCT01838590|Hepatitis|hepatitis
307224|NCT01838590|Hepatitis, Chronic|hepatitis, chronic
307225|NCT01838590|Hepatitis C|hepatitis c
307226|NCT01838590|Hepatitis C, Chronic|hepatitis c, chronic
307227|NCT01838564|Pediatric Advanced Cancer|pediatric advanced cancer
307228|NCT01838564|Children|children
307229|NCT01838564|Quality of Life|quality of life
307230|NCT01838564|Health Information technology|health information technology
307231|NCT01838564|Patient reported outcomes|patient reported outcomes
307232|NCT01838525|sepsis|sepsis
307233|NCT01838525|alpha-1-acid glycoprotein (AGP)|alpha-1-acid glycoprotein (agp)
307234|NCT01838525|diagnosis|diagnosis
307235|NCT01838525|prognosis|prognosis
307236|NCT01838525|SIRS|sirs
307237|NCT01838486|Interstitial cystitis|interstitial cystitis
307238|NCT01838486|painful bladder syndrome|painful bladder syndrome
307239|NCT01838486|bladder hydrodistention|bladder hydrodistention
307240|NCT01838486|hyperthermia|hyperthermia
307241|NCT01838473|smokeless tobacco|smokeless tobacco
307242|NCT01838473|Nicotine|nicotine
307243|NCT01838473|Cadmium|cadmium
307244|NCT01838473|lead|lead
307245|NCT01838473|Tobacco Specific Nitrosamines|tobacco specific nitrosamines
307246|NCT01838447|Vitamin D|vitamin d
307247|NCT01838447|Congenital Heart Disease|congenital heart disease
307248|NCT01838447|Cardiac Surgery|cardiac surgery
307249|NCT01838447|Pediatrics|pediatrics
307250|NCT01838447|Phase II Clinical Trial|phase ii clinical trial
307251|NCT01838408|screening colonoscopy|screening colonoscopy
307252|NCT01838408|surveillance colonoscopy|surveillance colonoscopy
307253|NCT01838408|colonoscopy|colonoscopy
307254|NCT01838395|AML|aml
307255|NCT01838395|Acute Myeloid Leukemia|acute myeloid leukemia
307256|NCT01838395|Relapsed Acute Myeloid Leukemia|relapsed acute myeloid leukemia
307257|NCT01838395|Refractory Acute Myeloid Leukemia|refractory acute myeloid leukemia
307258|NCT01838382|pain|pain
307259|NCT01838382|total laparoscopic hysterectomy|total laparoscopic hysterectomy
307260|NCT01838356|Depression|depression
307261|NCT01838356|Vascular depression|vascular depression
307262|NCT01838356|Intracranial atherosclerosis|intracranial atherosclerosis
307263|NCT01838356|Coronary artery disease|coronary artery disease
307264|NCT01838356|Coronary artery bypass graft|coronary artery bypass graft
307265|NCT01838356|Cognitive impairment|cognitive impairment
307266|NCT01838330|Kidney Disease|kidney disease
307267|NCT01838330|Fiber|fiber
307268|NCT01838330|Dietary Intervention|dietary intervention
307269|NCT01838304|propofol sedation endoscopy|propofol sedation endoscopy
307270|NCT01838291|Ferriprox|ferriprox
307271|NCT01838291|Deferiprone|deferiprone
307272|NCT01838291|DFP|dfp
307273|NCT01838291|L1|l1
307274|NCT01838278|Vojta therapy|vojta therapy
307275|NCT01838278|Exercise Movement Technique|exercise movement technique
307276|NCT01838278|Early intervention|early intervention
307277|NCT01838252|Ectropion|ectropion
307278|NCT01838252|Hyaluronic Acid|hyaluronic acid
307279|NCT01838252|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
307280|NCT01838252|Lower eyelid retraction|lower eyelid retraction
307281|NCT01838239|Fish oil|fish oil
307282|NCT01838239|Omega-3 fatty acids|omega-3 fatty acids
307283|NCT01838226|Chronic Disease|chronic disease
307284|NCT01838226|Prevention|prevention
307285|NCT01838226|cardiovascular disease|cardiovascular disease
307286|NCT01838213|Urinary tract infection|urinary tract infection
307287|NCT01838213|ESBL|esbl
307288|NCT01838213|treatment|treatment
307289|NCT01838213|carriage|carriage
307290|NCT01838213|risk factors|risk factors
307291|NCT01838213|water contamination|water contamination
307292|NCT01838200|BCG|bcg
307293|NCT01838200|Bacillus Calmette-Guérin|bacillus calmette-guérin
307294|NCT01838200|Ipilimumab|ipilimumab
307295|NCT01838200|YERVOY|yervoy
307296|NCT01838200|Advanced Metastatic Melanoma|advanced metastatic melanoma
307297|NCT01838200|Metastatic Melanoma|metastatic melanoma
307298|NCT01838174|Optic Neuritis|optic neuritis
307299|NCT01838161|adolescents|adolescents
307300|NCT01838161|immunizations|immunizations
307301|NCT01838148|coronary artery disease|coronary artery disease
307302|NCT01838148|angina, stable|angina, stable
307303|NCT01838148|exercise test|exercise test
307304|NCT01838148|biological Markers|biological markers
307305|NCT01838148|SPECT|spect
307306|NCT01838135|wheelchair|wheelchair
307307|NCT01838135|manual wheelchair|manual wheelchair
307308|NCT01838135|rehabilitation|rehabilitation
307309|NCT01838135|self-efficacy|self-efficacy
307310|NCT01838135|older adults|older adults
307311|NCT01838135|feasibility|feasibility
307312|NCT01838135|intervention|intervention
307313|NCT01838135|training|training
307314|NCT01838122|PCOS|pcos
307315|NCT01838122|HbA1C|hba1c
307316|NCT01838122|Insulin resistance|insulin resistance
307317|NCT01838122|OGTT|ogtt
307318|NCT01838122|HOMA-IR|homa-ir
307319|NCT01838122|HOMA-B-cell|homa-b-cell
307320|NCT01838070|Hepatitis A|hepatitis a
307321|NCT01838070|Hepatitis A vaccine|hepatitis a vaccine
307322|NCT01838070|AVAXIM 160U|avaxim 160u
307323|NCT01838031|antenatal thyroid screening|antenatal thyroid screening
307324|NCT01838031|subclinical hypothyroidism|subclinical hypothyroidism
307325|NCT01838031|thyroid function|thyroid function
307326|NCT01838031|thyroid antibody|thyroid antibody
307327|NCT01838031|pregnancy outcome|pregnancy outcome
307328|NCT01838031|childhood cognitive function|childhood cognitive function
307329|NCT01838018|PKAN|pkan
307330|NCT01838018|brain iron|brain iron
307331|NCT01838018|NBIA|nbia
307332|NCT01838018|neurodegeneration with brain iron accumulation|neurodegeneration with brain iron accumulation
307333|NCT01838018|Hallervorden Spatz Syndrome|hallervorden spatz syndrome
307334|NCT01838005|Contingency management|contingency management
307335|NCT01838005|conditional cash transfer|conditional cash transfer
307336|NCT01838005|PMTCT|pmtct
307337|NCT01838005|Retention|retention
307338|NCT01838005|HIV|hiv
307339|NCT01837979|prenatal testing for fetal aneuploidy|prenatal testing for fetal aneuploidy
307340|NCT01837979|dried blood spots|dried blood spots
307341|NCT01837979|cell-free fetal DNA|cell-free fetal dna
307342|NCT01837979|detection rate|detection rate
307343|NCT01837979|cost-effectiveness|cost-effectiveness
307344|NCT01837966|re-operative anxiety|re-operative anxiety
307345|NCT01837966|breast surgery|breast surgery
307346|NCT01837966|lavender oil|lavender oil
307347|NCT01837966|aromatherapy|aromatherapy
307348|NCT01837927|Efficacy, NVA237, Tiotropium, Chronic Obstructive Pulmonary Disease, COPD|efficacy, nva237, tiotropium, chronic obstructive pulmonary disease, copd
307349|NCT01837901|transcorneal electrostimulation|transcorneal electrostimulation
307350|NCT01837888|wheelchair|wheelchair
307351|NCT01837888|manual wheelchair|manual wheelchair
307352|NCT01837888|rehabilitation|rehabilitation
307353|NCT01837888|self-efficacy|self-efficacy
307354|NCT01837888|older adults|older adults
307355|NCT01837888|feasibility|feasibility
307356|NCT01837888|intervention|intervention
307357|NCT01837888|training|training
307358|NCT01837888|Wheelchair mobility|wheelchair mobility
307359|NCT01837875|Intervention|intervention
307360|NCT01837875|Quality of life|quality of life
307361|NCT01837875|African American|african american
307362|NCT01837875|Stress|stress
307363|NCT01837862|pilomyxoid astrocytoma|pilomyxoid astrocytoma
307364|NCT01837862|Pilocytic Astrocytoma|pilocytic astrocytoma
307365|NCT01837862|Glioma|glioma
307366|NCT01837862|Optic Nerve Glioma|optic nerve glioma
307367|NCT01837862|mebendazole|mebendazole
307368|NCT01837862|Pleomorphic Xanthoastrocytoma|pleomorphic xanthoastrocytoma
307369|NCT01837862|glioblastoma multiforme|glioblastoma multiforme
307370|NCT01837862|anaplastic astrocytoma|anaplastic astrocytoma
307371|NCT01837862|gliosarcoma|gliosarcoma
307372|NCT01837862|diffuse intrinsic pontine glioma|diffuse intrinsic pontine glioma
307373|NCT01837862|DIPG|dipg
307374|NCT01837862|low-grade glioma|low-grade glioma
307375|NCT01837862|high-grade glioma|high-grade glioma
307376|NCT01837862|brainstem glioma|brainstem glioma
307377|NCT01837862|pediatric|pediatric
307378|NCT01837849|heart failure|heart failure
307379|NCT01837849|rhBNP|rhbnp
307380|NCT01837849|Dobutamine|dobutamine
307381|NCT01837836|Health education|health education
307382|NCT01837836|water handling practices|water handling practices
307383|NCT01837836|Bacteriological quality of water|bacteriological quality of water
307384|NCT01837823|Coronary artery disease|coronary artery disease
307385|NCT01837823|Lipid|lipid
307386|NCT01837823|Regression|regression
307387|NCT01837823|Plaque|plaque
307388|NCT01837810|Post tonsillectomy hemorrhage|post tonsillectomy hemorrhage
307389|NCT01837810|post operative hemorrhage|post operative hemorrhage
307390|NCT01837810|complications|complications
307391|NCT01837810|tonsillectomy|tonsillectomy
307392|NCT01837758|Platelet function|platelet function
307393|NCT01837758|hemofiltration|hemofiltration
307394|NCT01837758|Multiplate|multiplate
307395|NCT01837732|Chronic pain|chronic pain
307396|NCT01837732|elderly|elderly
307397|NCT01837732|relational touch|relational touch
307398|NCT01837706|Empathy|empathy
307399|NCT01837706|Communication|communication
307400|NCT01837706|Physician litigation|physician litigation
307401|NCT01837693|cervical cancer screening|cervical cancer screening
307402|NCT01837693|CIN|cin
307403|NCT01837693|cervical cancer|cervical cancer
307404|NCT01837693|biomarkers|biomarkers
307405|NCT01837693|sensitivity and specificity|sensitivity and specificity
307406|NCT01837680|Insulin, Long-Acting|insulin, long-acting
307407|NCT01837654|Detrusor Overactivity|detrusor overactivity
307408|NCT01837654|Plantarflexion|plantarflexion
307409|NCT01837654|Urgency|urgency
307410|NCT01837628|Urodynamic|urodynamic
307411|NCT01837628|Paraffin oil|paraffin oil
307412|NCT01837628|Lidocaine gel|lidocaine gel
307413|NCT01837628|Pain|pain
307414|NCT01837615|Ulcerative Colitis|ulcerative colitis
307415|NCT01837615|Ulcerative Proctitis|ulcerative proctitis
307416|NCT01837615|Low Level Light Therapy|low level light therapy
307417|NCT01837615|Safety|safety
307418|NCT01837615|Efficacy|efficacy
307419|NCT01837602|refractory to at least one standard therapy|refractory to at least one standard therapy
307420|NCT01837602|newly diagnosed|newly diagnosed
307421|NCT01837602|with operable triple negative breast cancer|with operable triple negative breast cancer
307422|NCT01837589|Cystic fibrosis-DXA-QCT-Osteopenia- Osteoporosis|cystic fibrosis-dxa-qct-osteopenia- osteoporosis
307423|NCT01837576|Psoriasis Vulgaris|psoriasis vulgaris
307424|NCT01837576|Calcipotriol|calcipotriol
307425|NCT01837576|Betamethasone Dipropionate|betamethasone dipropionate
307426|NCT01837550|audiologic rehabilitation|audiologic rehabilitation
307427|NCT01837550|hearing loss|hearing loss
307428|NCT01837550|patient education|patient education
307429|NCT01837550|patient participation|patient participation
307430|NCT01837550|structured rehabilitation|structured rehabilitation
307431|NCT01837550|counseling|counseling
307432|NCT01837550|Internet|internet
307433|NCT01837524|Dietary advice|dietary advice
307434|NCT01837524|Nutritional knowledge|nutritional knowledge
307435|NCT01837524|Self-efficacy|self-efficacy
307436|NCT01837524|Nutrition|nutrition
307437|NCT01837511|Tumor antigens|tumor antigens
307438|NCT01837511|Asiatic patients|asiatic patients
307439|NCT01837511|Reverse Transciptase-Polymerase chain reaction (RT-PCR)|reverse transciptase-polymerase chain reaction (rt-pcr)
307440|NCT01837511|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
307569|NCT01837017|Older adults|older adults
307570|NCT01837004|adherence|adherence
307441|NCT01837498|residual neuromuscular blockade, sugammadex, neostigmine, thoracic surgery|residual neuromuscular blockade, sugammadex, neostigmine, thoracic surgery
307442|NCT01837485|Irritable bowel syndrome|irritable bowel syndrome
307443|NCT01837485|Functional gastrointestinal disorders|functional gastrointestinal disorders
307444|NCT01837485|Gut flora|gut flora
307445|NCT01837485|Probiotics|probiotics
307446|NCT01837472|Irritable bowel syndrome|irritable bowel syndrome
307447|NCT01837472|Functional gastrointestinal disorders|functional gastrointestinal disorders
307448|NCT01837472|Gut flora|gut flora
307449|NCT01837472|Probiotics|probiotics
307450|NCT01837459|Obstructive Sleep Apnea|obstructive sleep apnea
307451|NCT01837459|Sleep Disordered Breathing|sleep disordered breathing
307452|NCT01837459|Vascular function|vascular function
307453|NCT01837459|Arterial stiffness|arterial stiffness
307454|NCT01837459|Polysomnography|polysomnography
307455|NCT01837459|Cytokines|cytokines
307456|NCT01837446|mucositis|mucositis
307457|NCT01837446|topical morphine|topical morphine
307458|NCT01837446|pain|pain
307459|NCT01837446|head and neck carcinoma|head and neck carcinoma
307460|NCT01837433|Efficacy|efficacy
307461|NCT01837433|safety|safety
307462|NCT01837433|short|short
307463|NCT01837433|term|term
307464|NCT01837433|subacute thyroiditis|subacute thyroiditis
307465|NCT01837407|Soft tissue loss|soft tissue loss
307466|NCT01837407|nerve defect|nerve defect
307467|NCT01837407|dorsal branch of the proper digital nerve|dorsal branch of the proper digital nerve
307468|NCT01837407|heterodigital arterialized nerve pedicle flap|heterodigital arterialized nerve pedicle flap
307469|NCT01837407|Composite Flap|composite flap
307470|NCT01837407|nerve flap|nerve flap
307471|NCT01837407|nerve transfer|nerve transfer
307472|NCT01837394|Nerve block|nerve block
307473|NCT01837394|Ultrasound|ultrasound
307474|NCT01837394|postoperative pain|postoperative pain
307475|NCT01837394|Saphenous nerve|saphenous nerve
307476|NCT01837394|Obturator nerve|obturator nerve
307477|NCT01837329|Non-Squamous|non-squamous
307478|NCT01837329|NSCLC|nsclc
307479|NCT01837329|Adenocarcinoma|adenocarcinoma
307480|NCT01837329|Lung Cancer|lung cancer
307481|NCT01837329|Tetrathiomolybdate|tetrathiomolybdate
307482|NCT01837329|Copper|copper
307483|NCT01837329|Carboplatin|carboplatin
307484|NCT01837329|Pemetrexed Platinum|pemetrexed platinum
307485|NCT01837329|Newly Diagnosed|newly diagnosed
307486|NCT01837329|Chemo-naive|chemo-naive
307487|NCT01837316|pharmacodynamics|pharmacodynamics
307488|NCT01837316|FF/VI|ff/vi
307489|NCT01837316|asthma|asthma
307490|NCT01837316|duration of action|duration of action
307491|NCT01837303|Cervical dysplasia|cervical dysplasia
307492|NCT01837303|Cervical cancer|cervical cancer
307493|NCT01837290|Renal failure,|renal failure,
307494|NCT01837290|hip fracture,|hip fracture,
307495|NCT01837290|spinal anesthesia,|spinal anesthesia,
307496|NCT01837290|dexmedetomidine|dexmedetomidine
307497|NCT01837290|patient|patient
307498|NCT01837264|Magellan MAR01|magellan mar01
307499|NCT01837264|Autologous Platelet Rich Plasma|autologous platelet rich plasma
307500|NCT01837264|Compartment Syndrome|compartment syndrome
307501|NCT01837264|Battlefield Trauma|battlefield trauma
307502|NCT01837264|Fasciotomy|fasciotomy
307503|NCT01837251|Ovarian Carcinoma|ovarian carcinoma
307504|NCT01837251|Bevacizumab|bevacizumab
307505|NCT01837251|Gemcitabine|gemcitabine
307506|NCT01837251|PLD|pld
307507|NCT01837251|pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
307508|NCT01837251|Carboplatin|carboplatin
307509|NCT01837251|best therapeutic index|best therapeutic index
307510|NCT01837251|progression-free survival|progression-free survival
307511|NCT01837238|hemodialysis|hemodialysis
307512|NCT01837238|physical function|physical function
307513|NCT01837225|Fluorescence Imaging|fluorescence imaging
307514|NCT01837225|Breast Tumor Margins|breast tumor margins
307515|NCT01837225|Real-time Assessment|real-time assessment
307516|NCT01837199|Periodontal disease|periodontal disease
307517|NCT01837199|Scaling and root planing|scaling and root planing
307518|NCT01837199|Metronidazole|metronidazole
307519|NCT01837199|Amoxicillin|amoxicillin
307520|NCT01837199|Generalized chronic periodontitis|generalized chronic periodontitis
307521|NCT01837199|Periodontal treatment|periodontal treatment
307522|NCT01837186|Surgery|surgery
307523|NCT01837186|NSCLC|nsclc
307524|NCT01837173|Adenocarcinoma|adenocarcinoma
307525|NCT01837173|Squamous Cell Carcinoma|squamous cell carcinoma
307526|NCT01837173|Neoadjuvant treatment|neoadjuvant treatment
307527|NCT01837173|Esophagectomy|esophagectomy
307528|NCT01837160|Angiogenesis|angiogenesis
307529|NCT01837160|Fibrosis|fibrosis
307530|NCT01837160|Aortic Stenosis|aortic stenosis
307531|NCT01837160|Imaging|imaging
307532|NCT01837160|CT-PET|ct-pet
307533|NCT01837160|PET-CT|pet-ct
307534|NCT01837160|Cardiac MRI|cardiac mri
307535|NCT01837147|primary prevention|primary prevention
307536|NCT01837147|sedentary|sedentary
307537|NCT01837147|overweight|overweight
307538|NCT01837147|obesity|obesity
307539|NCT01837147|breast cancer|breast cancer
307540|NCT01837147|post-menopausal|post-menopausal
307541|NCT01837147|women|women
307542|NCT01837134|telemedicine|telemedicine
307543|NCT01837134|overweight|overweight
307544|NCT01837134|obesity|obesity
307545|NCT01837121|not-attended rate|not-attended rate
307546|NCT01837121|re-visit|re-visit
307547|NCT01837121|vision|vision
307548|NCT01837121|knowledge|knowledge
307549|NCT01837121|satisfaction|satisfaction
307550|NCT01837108|healthy|healthy
307551|NCT01837095|Overall survival|overall survival
307552|NCT01837095|Progression free survival|progression free survival
307553|NCT01837082|Heart Failure|heart failure
307554|NCT01837082|Iron Deficiency|iron deficiency
307555|NCT01837082|Anemia|anemia
307556|NCT01837082|Ferric Carboxymaltose|ferric carboxymaltose
307557|NCT01837069|Hypertension|hypertension
307558|NCT01837069|Diabetes|diabetes
307559|NCT01837069|Coronary Artery Disease|coronary artery disease
307560|NCT01837069|Peripheral Vascular Disease|peripheral vascular disease
307561|NCT01837056|Toxoplasma gondii|toxoplasma gondii
307562|NCT01837056|Toxocara canis|toxocara canis
307563|NCT01837043|Delayed Graft Function|delayed graft function
307564|NCT01837043|Renal Transplantation|renal transplantation
307565|NCT01837043|Kidney Transplant|kidney transplant
307566|NCT01837017|Falls,|falls,
307567|NCT01837017|Balance,|balance,
307568|NCT01837017|Gait,|gait,
307571|NCT01837004|cognition|cognition
307572|NCT01837004|exercise|exercise
307573|NCT01837004|aging|aging
307574|NCT01836991|gastric cancer|gastric cancer
307575|NCT01836991|surgery|surgery
307576|NCT01836991|surgery safety|surgery safety
307577|NCT01836991|effect|effect
307578|NCT01836965|Aspergers|aspergers
307579|NCT01836965|Social Skills|social skills
307580|NCT01836965|Adolescents|adolescents
307581|NCT01836965|High-functioning Autism|high-functioning autism
307582|NCT01836939|psoriasis, oral therapy|psoriasis, oral therapy
307583|NCT01836939|ova|ova
307584|NCT01836939|Trichuris suis ova|trichuris suis ova
307585|NCT01836939|TSO|tso
307586|NCT01836939|CNDO 201 Trichuris suis ova|cndo 201 trichuris suis ova
307587|NCT01836926|sphincter sparing procedures|sphincter sparing procedures
307588|NCT01836926|intersphincteric resection|intersphincteric resection
307589|NCT01836926|rectal cancer|rectal cancer
307590|NCT01836926|low rectal cancer|low rectal cancer
307591|NCT01836926|sphincter preserving procedures|sphincter preserving procedures
307592|NCT01836926|Abdominoperineal resection|abdominoperineal resection
307593|NCT01836926|laparoscopic resection of rectal cancer|laparoscopic resection of rectal cancer
307594|NCT01836926|laparoscopic versus open colorectal resection|laparoscopic versus open colorectal resection
307595|NCT01836926|laparoscopic versus open rectal surgery|laparoscopic versus open rectal surgery
307596|NCT01836926|neoadjuvant chemo-radiotherapy for rectal cancer|neoadjuvant chemo-radiotherapy for rectal cancer
307597|NCT01836913|PET/CT|pet/ct
307598|NCT01836913|Esophageal cancer|esophageal cancer
307599|NCT01836913|Radiotherapy|radiotherapy
307600|NCT01836900|OTSC|otsc
307601|NCT01836900|Upper gastrointestinal bleeding|upper gastrointestinal bleeding
307602|NCT01836887|Polyphenol|polyphenol
307603|NCT01836887|Fruit|fruit
307604|NCT01836887|Metabolic|metabolic
307605|NCT01836887|Healthy|healthy
307606|NCT01836874|Migraine|migraine
307607|NCT01836874|Indian|indian
307608|NCT01836874|Topiramate|topiramate
307609|NCT01836861|Phase I|phase i
307610|NCT01836861|healthy male volunteers|healthy male volunteers
307611|NCT01836861|ADME|adme
307612|NCT01836861|Bioavailability|bioavailability
307613|NCT01836861|PI3K inhibitor|pi3k inhibitor
307614|NCT01836861|Absorption|absorption
307615|NCT01836861|Distribution|distribution
307616|NCT01836861|Metabolism|metabolism
307617|NCT01836861|Excretion|excretion
307618|NCT01836861|safety|safety
307619|NCT01836848|subarachnoid hemorrhage|subarachnoid hemorrhage
307620|NCT01836848|near-infrared-spectroscopy|near-infrared-spectroscopy
307621|NCT01836848|indocyanine green|indocyanine green
307622|NCT01836848|secondary ischemia|secondary ischemia
307623|NCT01836835|Hyperemesis gravidarum|hyperemesis gravidarum
307624|NCT01836835|Pregnancy|pregnancy
307625|NCT01836835|Nausea|nausea
307626|NCT01836835|Nutritional status|nutritional status
307627|NCT01836835|Questionnaire|questionnaire
307628|NCT01836835|Case-control|case-control
307629|NCT01836822|mediastinal lymph node enlargement|mediastinal lymph node enlargement
307630|NCT01836822|sarcoidosis|sarcoidosis
307631|NCT01836822|bronchoscopy|bronchoscopy
307632|NCT01836822|EBUS guided transbronchial needle aspiration (EBUS-TBNA)|ebus guided transbronchial needle aspiration (ebus-tbna)
307633|NCT01836822|transbronchial needle aspiration (EBUS-TBNA)|transbronchial needle aspiration (ebus-tbna)
307634|NCT01836822|EBUS guided transbronchial forceps biopsy EBUS-TBFB)|ebus guided transbronchial forceps biopsy ebus-tbfb)
307635|NCT01836809|Total Artificial Heart|total artificial heart
307636|NCT01836809|Left Ventricular Assist Device|left ventricular assist device
307637|NCT01836809|Natriuretic peptides|natriuretic peptides
307638|NCT01836809|Heart Failure|heart failure
307639|NCT01836809|Cardiorenal Syndrome|cardiorenal syndrome
307640|NCT01836783|Allograft|allograft
307641|NCT01836783|Amnion Allograft|amnion allograft
307642|NCT01836770|Transforaminal Epidural Steroid Injections|transforaminal epidural steroid injections
307643|NCT01836757|osteoarthritis|osteoarthritis
307644|NCT01836757|CAM treatments|cam treatments
307645|NCT01836757|MSM|msm
307646|NCT01836731|weight-for age|weight-for age
307647|NCT01836731|height-for-age|height-for-age
307648|NCT01836731|water sanitation facilities|water sanitation facilities
307649|NCT01836731|hygiene behavior|hygiene behavior
307650|NCT01836718|Hepatitis C Virus|hepatitis c virus
307651|NCT01836718|Liver Transplantation|liver transplantation
307652|NCT01836718|Antiviral Therapy|antiviral therapy
307653|NCT01836718|HCV|hcv
307654|NCT01836679|Chidamide,lung cancer|chidamide,lung cancer
307655|NCT01836653|Bevacizumab|bevacizumab
307656|NCT01836653|Cetuximab|cetuximab
307657|NCT01836653|KRAS wild type colorectal cancer|kras wild type colorectal cancer
307658|NCT01836653|RAS wild type colorectal cancer|ras wild type colorectal cancer
307659|NCT01836653|liver metastasis|liver metastasis
307660|NCT01836627|Congenital Muscular Dystrophy|congenital muscular dystrophy
307661|NCT01836627|Collagen VI Deficiency|collagen vi deficiency
307662|NCT01836627|Hyperinsufflation|hyperinsufflation
307663|NCT01836627|Cough Assist|cough assist
307664|NCT01836627|LAMA2- Muscular Dystrophy|lama2- muscular dystrophy
307665|NCT01836601|safety|safety
307666|NCT01836601|patient experience|patient experience
307667|NCT01836601|family-centered rounds|family-centered rounds
307668|NCT01836575|Advanced NSCLC|advanced nsclc
307669|NCT01836575|PS2|ps2
307670|NCT01836575|Pemetrexed|pemetrexed
307671|NCT01836575|First line|first line
307672|NCT01836575|non squamous|non squamous
307673|NCT01836562|Autism stem cell MNCs|autism stem cell mncs
307674|NCT01836536|High grade glioma|high grade glioma
307675|NCT01836536|Bevacizumab|bevacizumab
307676|NCT01836536|Chemotherapy|chemotherapy
307677|NCT01836536|Myeloid Cells|myeloid cells
307678|NCT01836536|Treg|treg
307679|NCT01836510|Heart Failure|heart failure
307680|NCT01836510|Remote Monitoring|remote monitoring
307681|NCT01836510|Lung Edema|lung edema
307682|NCT01836510|Patient Monitoring|patient monitoring
307683|NCT01836510|Prediction|prediction
307684|NCT01836484|Surgically staged endometrial carcinoma|surgically staged endometrial carcinoma
307685|NCT01836484|Surgically staged cervical carcinoma|surgically staged cervical carcinoma
307686|NCT01836458|Malaria, KAE609|malaria, kae609
307687|NCT01836432|Pancreatic Cancer|pancreatic cancer
307688|NCT01836432|Immunotherapy|immunotherapy
307689|NCT01836432|Vaccine Therapy|vaccine therapy
307690|NCT01836419|classic laryngeal mask airway|classic laryngeal mask airway
307691|NCT01836419|elderly patients|elderly patients
307692|NCT01836406|ketorolac|ketorolac
307693|NCT01836406|remote ischemic preconditioning|remote ischemic preconditioning
307694|NCT01836406|partial nephrectomy|partial nephrectomy
307695|NCT01836393|Plai|plai
307696|NCT01836393|Efficacy|efficacy
307697|NCT01836393|OA knee|oa knee
307698|NCT01836393|The efficacy study of Plai cream for OA knee|the efficacy study of plai cream for oa knee
307699|NCT01836367|Actinic Keratosis|actinic keratosis
307700|NCT01836367|Face|face
307701|NCT01836367|Scalp|scalp
307702|NCT01836367|Ingenol Mebutate|ingenol mebutate
307703|NCT01836354|stroke|stroke
307704|NCT01836354|interactive educational intervention|interactive educational intervention
307705|NCT01836354|acute ischemic stroke|acute ischemic stroke
307706|NCT01836354|transient ischemic attack|transient ischemic attack
307707|NCT01836341|Afatinib|afatinib
307708|NCT01836341|Cisplatin|cisplatin
307709|NCT01836341|Carboplatin|carboplatin
307710|NCT01836341|Pemetrexed|pemetrexed
307711|NCT01836341|Radiation therapy|radiation therapy
307712|NCT01836341|EGFR mutation|egfr mutation
307713|NCT01836341|12-279|12-279
307714|NCT01836328|Methadone|methadone
307715|NCT01836328|Pain|pain
307716|NCT01836328|Neoplasms|neoplasms
307717|NCT01836328|Ratio|ratio
307718|NCT01836237|Surgical site infection rate|surgical site infection rate
307719|NCT01836237|Wound protector use|wound protector use
307720|NCT01836237|Whipple|whipple
307721|NCT01836211|Chest pain|chest pain
307722|NCT01836211|Acute coronary syndrome|acute coronary syndrome
307723|NCT01836211|Cardiac biomarkers|cardiac biomarkers
307724|NCT01836211|Computed coronary tomography angiography|computed coronary tomography angiography
307725|NCT01836211|Emergency department|emergency department
307726|NCT01836172|The treatment of diabetic complication|the treatment of diabetic complication
307727|NCT01836159|Stroke Rehabilitation|stroke rehabilitation
307728|NCT01836159|iPad|ipad
307729|NCT01836159|Fine Motor Function|fine motor function
307730|NCT01836159|Ischemic Stroke|ischemic stroke
307731|NCT01836159|Visual Neglect|visual neglect
307732|NCT01836120|second-line chemotherapy|second-line chemotherapy
307733|NCT01836120|Raltitrexed|raltitrexed
307734|NCT01836107|Clinical notes|clinical notes
307735|NCT01836107|Communication between physicians|communication between physicians
307736|NCT01836107|Quality|quality
307737|NCT01836107|Cross-cultural adaptation|cross-cultural adaptation
307738|NCT01836094|Methylene Blue|methylene blue
307739|NCT01836094|Memory|memory
307740|NCT01836094|Mental Fatigue|mental fatigue
307741|NCT01836094|Brain metabolism|brain metabolism
307742|NCT01836094|fMRI|fmri
307743|NCT01836094|psychomotor vigilance task (PVT)|psychomotor vigilance task (pvt)
307744|NCT01836094|delayed match-to-sample memory task|delayed match-to-sample memory task
307745|NCT01836094|PVT|pvt
307746|NCT01836094|DMS|dms
307747|NCT01836081|fluid responsiveness|fluid responsiveness
307748|NCT01836081|carotid artery peak velocity variation|carotid artery peak velocity variation
307749|NCT01836081|coronary disease|coronary disease
307750|NCT01836068|HIV positive|hiv positive
307751|NCT01836068|HIV-1|hiv-1
307752|NCT01836068|Bone Marrow Transplant|bone marrow transplant
307753|NCT01836068|Allogeneic BMT|allogeneic bmt
307754|NCT01836068|BMT|bmt
307755|NCT01836055|Multiple Sclerosis|multiple sclerosis
307756|NCT01836055|White Matter Lesions|white matter lesions
307757|NCT01836055|Contrast Agent|contrast agent
307758|NCT01836055|Magnetic Resonance Imaging|magnetic resonance imaging
307759|NCT01836042|Primary open-angle glaucoma (POAG)|primary open-angle glaucoma (poag)
307760|NCT01836042|Trabecular meshwork|trabecular meshwork
307761|NCT01836042|iStent|istent
307762|NCT01836029|SCCHN|scchn
307763|NCT01836029|HNSCC|hnscc
307764|NCT01836016|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
307765|NCT01836016|Comparative effectiveness research|comparative effectiveness research
307766|NCT01836016|Medicine, Chinese Traditional|medicine, chinese traditional
307767|NCT01836016|Humans|humans
307768|NCT01836016|Treatment Outcome|treatment outcome
307769|NCT01836003|Pregnancy|pregnancy
307770|NCT01836003|Prevention of Mother to Child Transmission|prevention of mother to child transmission
307771|NCT01836003|Short Message Service (SMS)|short message service (sms)
307772|NCT01836003|HIV infection|hiv infection
307773|NCT01836003|CD4 testing|cd4 testing
307774|NCT01836003|Antiretroviral therapy|antiretroviral therapy
307775|NCT01835990|venous thromboembolism|venous thromboembolism
307776|NCT01835990|trauma|trauma
307777|NCT01835990|mechanical methods of prophylaxis|mechanical methods of prophylaxis
307778|NCT01835977|Focal therapy|focal therapy
307779|NCT01835977|Irreversible electroporation|irreversible electroporation
307780|NCT01835977|Unilateral prostate cancer|unilateral prostate cancer
307781|NCT01835964|Glucose Variability (GV)|glucose variability (gv)
307782|NCT01835964|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
307783|NCT01835951|Simulation|simulation
307784|NCT01835951|Debriefing|debriefing
307785|NCT01835951|Anaesthesia Crisis Management|anaesthesia crisis management
307786|NCT01835951|Cardiac Arrest|cardiac arrest
307787|NCT01835951|Pregnancy|pregnancy
307788|NCT01835938|Hepatitis C Virus infection|hepatitis c virus infection
307789|NCT01835938|entry inhibitor|entry inhibitor
307790|NCT01835938|kinase inhibitor|kinase inhibitor
307791|NCT01835925|adenocarcinoma of rectum|adenocarcinoma of rectum
307792|NCT01835925|rectal cancer|rectal cancer
307793|NCT01835925|stage II|stage ii
307794|NCT01835925|stage III|stage iii
307795|NCT01835912|performance|performance
307796|NCT01835912|speed|speed
307797|NCT01835912|exertion|exertion
307798|NCT01835860|BPH|bph
307799|NCT01835834|zirconia crown|zirconia crown
307800|NCT01835821|zirconia|zirconia
307801|NCT01835821|crown|crown
307802|NCT01835821|IPS e.max CAD|ips e.max cad
307803|NCT01835808|Fractional flow reserve|fractional flow reserve
307804|NCT01835795|Myofascial Pain Syndromes|myofascial pain syndromes
307805|NCT01835795|Myofascial Trigger Point|myofascial trigger point
307806|NCT01835795|Low Back Pain|low back pain
307807|NCT01835795|Lumbago|lumbago
307808|NCT01835795|Shock Waves, High-Energy|shock waves, high-energy
307809|NCT01835795|High-Energy Shock Waves|high-energy shock waves
307810|NCT01835795|Interdisciplinary Health Team|interdisciplinary health team
307811|NCT01835795|Multidisciplinary Pain Centers|multidisciplinary pain centers
307812|NCT01835782|ALS|als
307813|NCT01835782|L-Serine|l-serine
307814|NCT01835782|BMAA|bmaa
307815|NCT01835717|Preclinical phase of Alzheimer's disease|preclinical phase of alzheimer's disease
307816|NCT01835717|Asymptomatic phase of Alzheimer's disease|asymptomatic phase of alzheimer's disease
307817|NCT01835717|Cognitive normal|cognitive normal
307818|NCT01835717|Exogenous factors|exogenous factors
307819|NCT01835717|Endogenous factors|endogenous factors
307820|NCT01835717|Episodic memory test|episodic memory test
307821|NCT01835717|Executive function test|executive function test
307822|NCT01835717|Memory binding test validation into Spanish|memory binding test validation into spanish
307823|NCT01835717|Memory binding test validation into Catalan|memory binding test validation into catalan
307824|NCT01835691|Chronic Kidney Disease|chronic kidney disease
307825|NCT01835691|Vitamin D|vitamin d
307826|NCT01835691|Vitamin D2|vitamin d2
307827|NCT01835691|Vitamin D3|vitamin d3
307828|NCT01835652|Exercise|exercise
307829|NCT01835652|Parkinson's Disease|parkinson's disease
307830|NCT01835652|Positron Emission Tomography|positron emission tomography
307831|NCT01835652|fMRI|fmri
307832|NCT01835639|Glomerular Disease|glomerular disease
307833|NCT01835639|Vitamin D|vitamin d
307834|NCT01835639|Steroid-resistant nephrotic syndrome|steroid-resistant nephrotic syndrome
307835|NCT01835639|Minimal change disease|minimal change disease
307836|NCT01835639|Focal segmental glomerulosclerosis (FSGS)|focal segmental glomerulosclerosis (fsgs)
307837|NCT01835639|Membranous Nephropathy|membranous nephropathy
307838|NCT01835639|Membranoprolfierative Glomerulonephritis|membranoprolfierative glomerulonephritis
307839|NCT01835639|immunoglobulin A (IgA) Nephropathy|immunoglobulin a (iga) nephropathy
307840|NCT01835639|FSGS|fsgs
307841|NCT01835639|IgA Nephropathy|iga nephropathy
307842|NCT01835626|Locally advanced basal cell carcinoma|locally advanced basal cell carcinoma
307843|NCT01835626|Skin cancer|skin cancer
307844|NCT01835626|Radiation therapy|radiation therapy
307845|NCT01835626|Vismodegib|vismodegib
307846|NCT01835626|Head and neck cancer|head and neck cancer
307847|NCT01835626|Cutaneous malignancy|cutaneous malignancy
307848|NCT01835613|Rheumatoid Arthritis|rheumatoid arthritis
307849|NCT01835613|Early RA|early ra
307850|NCT01835613|RA|ra
307851|NCT01835613|IL-6|il-6
307852|NCT01835613|IL-6R|il-6r
307853|NCT01835613|Inhibitor|inhibitor
307854|NCT01835613|Inhibition|inhibition
307855|NCT01835613|Tocilizumab|tocilizumab
307856|NCT01835613|Biomarkers|biomarkers
307857|NCT01835613|DMARDs|dmards
307858|NCT01835613|Biological|biological
307859|NCT01835613|DAS|das
307860|NCT01835613|SDAI|sdai
307861|NCT01835613|AR/BIOM|ar/biom
307862|NCT01835613|OEG|oeg
307863|NCT01835587|Acute myeloid leukemia,|acute myeloid leukemia,
307864|NCT01835587|myelodysplastic syndromes,|myelodysplastic syndromes,
307865|NCT01835587|CC-486, oral Azacitidine,|cc-486, oral azacitidine,
307866|NCT01835587|transplantation,|transplantation,
307867|NCT01835587|allogeneic,|allogeneic,
307868|NCT01835587|HSCT.|hsct.
307869|NCT01835574|Amphetamine-type substance use|amphetamine-type substance use
307870|NCT01835561|Hepatic, Liver disease; Pharmacokinetic; Healthy|hepatic, liver disease; pharmacokinetic; healthy
307871|NCT01835509|Childhood Cancer Survivors|childhood cancer survivors
307872|NCT01835496|sickle cell disease|sickle cell disease
307873|NCT01835496|iron overload|iron overload
307874|NCT01835496|pharmacokinetics|pharmacokinetics
307875|NCT01835496|Ferriprox|ferriprox
307876|NCT01835496|deferiprone|deferiprone
307877|NCT01835457|Endotoxemia|endotoxemia
307878|NCT01835457|Autonomic Nervous System|autonomic nervous system
307879|NCT01835457|Inflammation|inflammation
307880|NCT01835457|Meditation|meditation
307881|NCT01835457|Concentration|concentration
307882|NCT01835457|Iceman|iceman
307883|NCT01835457|LPS|lps
307884|NCT01835457|Cortisol|cortisol
307885|NCT01835457|Catecholamines|catecholamines
307886|NCT01835444|Physician Assistant|physician assistant
307887|NCT01835444|Substitution|substitution
307888|NCT01835444|Hospital ward care|hospital ward care
307889|NCT01835444|Secondary health care|secondary health care
307890|NCT01835418|managed with bedtime administration of lisinopril versus amlodipine|managed with bedtime administration of lisinopril versus amlodipine
307891|NCT01835392|Remote ischemic preconditioning|remote ischemic preconditioning
307892|NCT01835392|Heart defects, congenital|heart defects, congenital
307893|NCT01835392|cardiac surgery|cardiac surgery
307894|NCT01835392|Neurodevelopmental outcomes|neurodevelopmental outcomes
307895|NCT01835379|Diabetes|diabetes
307896|NCT01835379|Diabetic Foot Ulcer|diabetic foot ulcer
307897|NCT01835379|Diabetic Foot Wound|diabetic foot wound
307898|NCT01835379|Non-healing foot wound|non-healing foot wound
307899|NCT01835379|Oasis|oasis
307900|NCT01835379|Diabetic neuropathy|diabetic neuropathy
307901|NCT01835353|prasugrel|prasugrel
307902|NCT01835353|ST elevation myocardial infarction|st elevation myocardial infarction
307903|NCT01835327|intraoperative, post-operative recovery|intraoperative, post-operative recovery
307904|NCT01835327|thoracic surgery|thoracic surgery
307905|NCT01835327|cerebral oximetry|cerebral oximetry
307906|NCT01835262|pain|pain
307907|NCT01835262|Ketamine|ketamine
307908|NCT01835262|Emergency Medicine|emergency medicine
307909|NCT01835262|morphine|morphine
307910|NCT01835249|Hypertension|hypertension
307911|NCT01835249|Nighttime blood pressure|nighttime blood pressure
307912|NCT01835236|Breast cancer|breast cancer
307913|NCT01835236|HER2-positive|her2-positive
307914|NCT01835236|Metastases|metastases
307915|NCT01835197|Phase 1|phase 1
307916|NCT01835197|Randomized|randomized
307917|NCT01835197|Double Blind|double blind
307918|NCT01835197|Placebo-Controlled|placebo-controlled
307919|NCT01835197|Single- & Multiple Dose Escalation|single- & multiple dose escalation
307920|NCT01835197|Safety|safety
307921|NCT01835197|Tolerability|tolerability
307922|NCT01835197|PK|pk
307923|NCT01835197|PD|pd
307924|NCT01835197|Pf-04965842|pf-04965842
307925|NCT01835132|Scleritis|scleritis
307926|NCT01835132|IL-1|il-1
307927|NCT01835119|gynecological malignancies|gynecological malignancies
307928|NCT01835119|postoperative|postoperative
307929|NCT01835119|bowel activity|bowel activity
307930|NCT01835119|gum chewing|gum chewing
307931|NCT01835106|Postoperative Care|postoperative care
307932|NCT01835080|Obstructive Sleep Apnea, OSA, Pulmonary Arterial Hypertension, PAH, sleep study, polysomnogram, Respiratory Disturbance Index, RDI|obstructive sleep apnea, osa, pulmonary arterial hypertension, pah, sleep study, polysomnogram, respiratory disturbance index, rdi
307933|NCT01835067|Macular degeneration|macular degeneration
307934|NCT01835067|Submacular haemorrhage|submacular haemorrhage
307935|NCT01835054|Mitral regurgitation|mitral regurgitation
307936|NCT01835054|Mitral valve prolapse|mitral valve prolapse
307937|NCT01835054|Echocardiography, Doppler|echocardiography, doppler
307938|NCT01835054|Stress echocardiography|stress echocardiography
307939|NCT01835054|Cardiopulmonary exercice testing|cardiopulmonary exercice testing
307940|NCT01835054|Magnetic Resonance Imaging|magnetic resonance imaging
307941|NCT01835054|Cardiac neurohormones|cardiac neurohormones
307942|NCT01835054|Visceral obesity|visceral obesity
307943|NCT01835054|Cardiometabolic risk|cardiometabolic risk
307944|NCT01835054|Risk stratification|risk stratification
307945|NCT01835028|Aortic Stenosis|aortic stenosis
307946|NCT01835028|Low Flow|low flow
307947|NCT01835028|Low Gradient|low gradient
307948|NCT01835028|Left Ventricle|left ventricle
307949|NCT01835028|Echocardiography, Doppler|echocardiography, doppler
307950|NCT01835015|First in human|first in human
307951|NCT01835015|Safety|safety
307952|NCT01835015|Tolerability|tolerability
307953|NCT01835015|Serum PK|serum pk
307954|NCT01835015|Intravitreal (IVT)|intravitreal (ivt)
307955|NCT01835015|Age-related macular degeneration|age-related macular degeneration
307956|NCT01835015|AMD|amd
307957|NCT01835015|Geographic Atrophy|geographic atrophy
307958|NCT01835015|Choroidal neovascularization|choroidal neovascularization
307959|NCT01835002|transcorneal electrostimulation|transcorneal electrostimulation
307960|NCT01834976|cardiac biomarker|cardiac biomarker
307961|NCT01834976|congenital heart disease|congenital heart disease
307962|NCT01834976|surgery|surgery
307963|NCT01834937|ExAblate|exablate
307964|NCT01834937|MRgFUS|mrgfus
307965|NCT01834937|Bone Metastases|bone metastases
307966|NCT01834937|Pain Palliation|pain palliation
307967|NCT01834924|Health literacy|health literacy
307968|NCT01834924|Patient education|patient education
307969|NCT01834911|Huntington disease|huntington disease
307970|NCT01834911|HD|hd
307971|NCT01834911|tetrabenazine|tetrabenazine
307972|NCT01834911|Stroop|stroop
307973|NCT01834898|postoperative|postoperative
307974|NCT01834898|analgesia|analgesia
307975|NCT01834898|adverse effects|adverse effects
307976|NCT01834898|opioid|opioid
307977|NCT01834898|oxycodone|oxycodone
307978|NCT01834885|COPD|copd
307979|NCT01834859|weight reduction programs|weight reduction programs
307980|NCT01834859|diet|diet
307981|NCT01834859|Caloric restriction|caloric restriction
307982|NCT01834859|weight loss|weight loss
307983|NCT01834859|weight gain|weight gain
307984|NCT01834846|comparative study|comparative study
307985|NCT01834846|Cardiac Surgical Procedures|cardiac surgical procedures
307986|NCT01834833|Acute heart failure; rehospitalisation; education; follow-up|acute heart failure; rehospitalisation; education; follow-up
307987|NCT01834820|Bronchiolitis|bronchiolitis
307988|NCT01834820|Epinephrine|epinephrine
307989|NCT01834820|Dexamethasone|dexamethasone
307990|NCT01834820|Hospitalization|hospitalization
307991|NCT01834820|Hypertonic Saline|hypertonic saline
307992|NCT01834794|Tobacco Use|tobacco use
307993|NCT01834781|multiple chemical sensitivity, re5 therapy, pulsed electromagnetic fields|multiple chemical sensitivity, re5 therapy, pulsed electromagnetic fields
307994|NCT01834742|Moviprep|moviprep
307995|NCT01834742|PEG3350|peg3350
307996|NCT01834742|Laxative|laxative
307997|NCT01834742|Stool Output|stool output
307998|NCT01834690|Liver transplantation/epidemiology|liver transplantation/epidemiology
307999|NCT01834690|Liver transplantation/pharmacology|liver transplantation/pharmacology
308000|NCT01834690|Health status/drug effects|health status/drug effects
308001|NCT01834690|Agents, immunosuppressive agents|agents, immunosuppressive agents
308002|NCT01834677|Depression|depression
308003|NCT01834677|Neurocognition|neurocognition
308004|NCT01834677|Electroconvulsive Therapy (ECT)|electroconvulsive therapy (ect)
308005|NCT01834677|Parkinson's Disease|parkinson's disease
308006|NCT01834664|Ataxic Infantile Cerebral Palsy stem cell therapy|ataxic infantile cerebral palsy stem cell therapy
308007|NCT01834651|liver metastasis|liver metastasis
308008|NCT01834651|lung metastasis|lung metastasis
308009|NCT01834651|metastatic castrate-resistant|metastatic castrate-resistant
308010|NCT01834651|prostate cancer|prostate cancer
308011|NCT01834638|schizophrenia|schizophrenia
308621|NCT01832051|HER2-PET|her2-pet
308012|NCT01834612|blood loss, hemorrhage, hemorrhagic shcok|blood loss, hemorrhage, hemorrhagic shcok
308013|NCT01834599|placental oxygenation|placental oxygenation
308014|NCT01834599|obstetric anesthesia|obstetric anesthesia
308015|NCT01834599|NIRS|nirs
308016|NCT01834599|cerebral oximetry|cerebral oximetry
308017|NCT01834599|cerebral oximeter|cerebral oximeter
308018|NCT01834573|inflammatory bowel disease|inflammatory bowel disease
308019|NCT01834573|IBD|ibd
308020|NCT01834573|quality of life|quality of life
308021|NCT01834573|Inflammatory Bowel Disease Questionnaire|inflammatory bowel disease questionnaire
308022|NCT01834560|deep brain stimulation|deep brain stimulation
308023|NCT01834560|subgenual cortex (CG25)|subgenual cortex (cg25)
308024|NCT01834547|chess, cognition|chess, cognition
308025|NCT01834521|Breast cancer|breast cancer
308026|NCT01834521|psychosocial|psychosocial
308027|NCT01834521|website|website
308028|NCT01834521|empowerment|empowerment
308029|NCT01834508|Experienced Treatment|experienced treatment
308030|NCT01834495|Peripheral artery disease|peripheral artery disease
308031|NCT01834495|atherosclerosis|atherosclerosis
308032|NCT01834495|stent|stent
308033|NCT01834482|seizures|seizures
308034|NCT01834482|epilepsy|epilepsy
308035|NCT01834482|adult|adult
308036|NCT01834482|intractable|intractable
308037|NCT01834482|medically refractory|medically refractory
308038|NCT01834482|Atkins|atkins
308039|NCT01834482|ketogenic|ketogenic
308040|NCT01834482|diet|diet
308041|NCT01834469|Ovarian,metastasis|ovarian,metastasis
308042|NCT01834456|Medically Complex Children|medically complex children
308043|NCT01834456|Family Experience in Healthcare|family experience in healthcare
308044|NCT01834456|Patient Centered Care|patient centered care
308045|NCT01834456|Family Centered Care|family centered care
308046|NCT01834456|Case Management|case management
308047|NCT01834456|Care Management|care management
308048|NCT01834456|Care Coordination|care coordination
308049|NCT01834456|Care Plan|care plan
308050|NCT01834456|Extensivist|extensivist
308051|NCT01834456|Medical Home|medical home
308052|NCT01834456|Children with Special Health Care Needs|children with special health care needs
308053|NCT01834456|Coordinated Care|coordinated care
308054|NCT01834456|Quality in Healthcare|quality in healthcare
308055|NCT01834456|Satisfaction in Healthcare|satisfaction in healthcare
308056|NCT01834456|Cost|cost
308057|NCT01834456|Utilization|utilization
308058|NCT01834456|Impact on Family|impact on family
308059|NCT01834456|Quality of Life|quality of life
308060|NCT01834456|Palliative Care|palliative care
308061|NCT01834456|Complex Chronic Conditions|complex chronic conditions
308062|NCT01834456|Life-limiting illness|life-limiting illness
308063|NCT01834456|Integrative Care|integrative care
308064|NCT01834456|Primary Care|primary care
308065|NCT01834456|Comprehensive Care|comprehensive care
308066|NCT01834456|Behavioral Care|behavioral care
308067|NCT01834443|spatial neglect|spatial neglect
308068|NCT01834443|galvanic vestibular stimulation as therapy|galvanic vestibular stimulation as therapy
308069|NCT01834417|Pressure ulcer, spinal cord injury, on-board device|pressure ulcer, spinal cord injury, on-board device
308070|NCT01834404|Obesity|obesity
308071|NCT01834404|BMI|bmi
308072|NCT01834404|Incretin|incretin
308073|NCT01834404|Satiety|satiety
308074|NCT01834404|Phentermine|phentermine
308075|NCT01834404|Topiramate|topiramate
308076|NCT01834378|diabetes|diabetes
308077|NCT01834378|insulin resistance|insulin resistance
308078|NCT01834378|exercise|exercise
308079|NCT01834365|Hypertension|hypertension
308080|NCT01834352|Walnut hypersensitivity|walnut hypersensitivity
308081|NCT01834352|Tree nut hypersensitivity|tree nut hypersensitivity
308082|NCT01834339|vestibuloplasty|vestibuloplasty
308083|NCT01834326|dental implants|dental implants
308084|NCT01834326|deficient keratinized oral mucosa|deficient keratinized oral mucosa
308085|NCT01834313|Willingness-to-pay|willingness-to-pay
308086|NCT01834313|Patient-centredness|patient-centredness
308087|NCT01834313|Health insurers|health insurers
308088|NCT01834313|Fertility care|fertility care
308089|NCT01834300|Hepatic insulin sensitivity|hepatic insulin sensitivity
308090|NCT01834300|Muscle insulin sensitivity|muscle insulin sensitivity
308091|NCT01834300|B cell function|b cell function
308092|NCT01834300|VLDL1 TG metabolism|vldl1 tg metabolism
308093|NCT01834300|VLDL2 TG metabolism|vldl2 tg metabolism
308094|NCT01834287|Physical Activity|physical activity
308095|NCT01834287|Latinas|latinas
308096|NCT01834287|Web-based|web-based
308097|NCT01834287|Spanish-language|spanish-language
308098|NCT01834274|Drug Therapy|drug therapy
308099|NCT01834261|oxytocin|oxytocin
308100|NCT01834261|trust|trust
308101|NCT01834261|kinship|kinship
308102|NCT01834261|kin selection|kin selection
308103|NCT01834235|Pancreatic neoplasms|pancreatic neoplasms
308104|NCT01834235|Pancreatic cancer|pancreatic cancer
308105|NCT01834235|Pancreatic cancer, adult|pancreatic cancer, adult
308106|NCT01834235|Adenoma of the pancreas|adenoma of the pancreas
308107|NCT01834235|Carcinoma of the pancreas|carcinoma of the pancreas
308108|NCT01834209|Prostate neoplasms|prostate neoplasms
308109|NCT01834209|Prostate cancer|prostate cancer
308110|NCT01834209|Metastatic prostate cancer|metastatic prostate cancer
308111|NCT01834209|Metatatic castration resistant prostate cancer|metatatic castration resistant prostate cancer
308112|NCT01834209|Abiraterone acetate|abiraterone acetate
308113|NCT01834209|Prednisone|prednisone
308114|NCT01834209|Prednisolone|prednisolone
308115|NCT01834209|Early access program|early access program
308116|NCT01834196|retinal vascular disease|retinal vascular disease
308117|NCT01834196|Swept-Source Ocular Coherence Tomography|swept-source ocular coherence tomography
308118|NCT01834196|SSOCT|ssoct
308119|NCT01834183|Metastatic|metastatic
308120|NCT01834170|Pancreatic cancer|pancreatic cancer
308121|NCT01834170|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
308122|NCT01834170|Endoscopic ultrasound|endoscopic ultrasound
308123|NCT01834144|Type 1 Diabetes|type 1 diabetes
308124|NCT01834144|Hypoglycaemia|hypoglycaemia
308125|NCT01834144|Glycaemic variability|glycaemic variability
308126|NCT01834144|Vigorous Intensity Physical Activity|vigorous intensity physical activity
308127|NCT01834144|Continuous Glucose Monitoring|continuous glucose monitoring
308128|NCT01834131|hypertension|hypertension
308129|NCT01834131|community health worker|community health worker
308130|NCT01834131|home health education|home health education
308131|NCT01834131|medication adherence|medication adherence
308132|NCT01834131|mobile health|mobile health
308133|NCT01834131|physician education|physician education
308134|NCT01834131|home blood pressure monitoring|home blood pressure monitoring
308135|NCT01834131|implementation|implementation
308136|NCT01834105|Postmenopausal osteoporosis; Kidney Yin deficiency syndrome; Liuwei dihuang pill; CLCF1; JAK - STAT signal pathway|postmenopausal osteoporosis; kidney yin deficiency syndrome; liuwei dihuang pill; clcf1; jak - stat signal pathway
308137|NCT01834092|Abdominal Aortic Aneurism|abdominal aortic aneurism
308138|NCT01834092|Endothelia|endothelia
308139|NCT01834092|Glycocalyx|glycocalyx
308140|NCT01834092|Reperfusion|reperfusion
308141|NCT01834092|Plasma|plasma
308142|NCT01834079|Optic Atrophy,Stem cell therapy|optic atrophy,stem cell therapy
308143|NCT01834066|muscular Dystrophy stem cell|muscular dystrophy stem cell
308144|NCT01834053|Huntington Disease,stem cell therapy|huntington disease,stem cell therapy
308145|NCT01834040|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
308146|NCT01834040|Muscular Dystrophy|muscular dystrophy
308147|NCT01834040|Myopathy|myopathy
308148|NCT01834027|music|music
308149|NCT01834027|stress|stress
308150|NCT01834027|anxiety|anxiety
308151|NCT01834027|post-surgical|post-surgical
308152|NCT01834027|pain|pain
308153|NCT01834014|Liver only metastasis from KRAS Exon 2 wild type|liver only metastasis from kras exon 2 wild type
308154|NCT01834014|Liver only metastasis from RAS wild type|liver only metastasis from ras wild type
308155|NCT01834001|MRI|mri
308156|NCT01834001|Prostate Cancer|prostate cancer
308157|NCT01834001|MRI-Guided Biopsy|mri-guided biopsy
308158|NCT01834001|Radiation|radiation
308159|NCT01834001|Biochemical Failure|biochemical failure
308160|NCT01833988|bionic pancreas|bionic pancreas
308161|NCT01833988|artificial pancreas|artificial pancreas
308162|NCT01833988|insulin|insulin
308163|NCT01833988|glucagon|glucagon
308164|NCT01833988|continuous glucose monitoring (CGM)|continuous glucose monitoring (cgm)
308165|NCT01833988|outpatient|outpatient
308166|NCT01833988|insulin pump|insulin pump
308167|NCT01833988|pediatrics|pediatrics
308168|NCT01833988|children|children
308169|NCT01833988|camp|camp
308170|NCT01833988|summer camp|summer camp
308171|NCT01833975|Spinal Cord Injury stem cell|spinal cord injury stem cell
308172|NCT01833962|Lumbar fusion rates|lumbar fusion rates
308173|NCT01833962|Actifuse synthetic bone graft|actifuse synthetic bone graft
308174|NCT01833962|Baxter Healthcare|baxter healthcare
308175|NCT01833962|Other synthetic bone graft|other synthetic bone graft
308176|NCT01833949|polycystic ovary syndrome,laparoscopic ovarian drilling|polycystic ovary syndrome,laparoscopic ovarian drilling
308177|NCT01833936|Achilles|achilles
308178|NCT01833923|Advanced cancer|advanced cancer
308179|NCT01833910|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
308180|NCT01833910|Education|education
308181|NCT01833897|Bipolar Disorder|bipolar disorder
308182|NCT01833884|Hodgkin Lymphoma, Adult|hodgkin lymphoma, adult
308183|NCT01833884|Cytokines|cytokines
308184|NCT01833884|TARC|tarc
308185|NCT01833884|IL-6|il-6
308186|NCT01833884|IL1-RA|il1-ra
308187|NCT01833884|sCD30|scd30
308188|NCT01833884|TNFR1|tnfr1
308189|NCT01833845|HCV|hcv
308190|NCT01833845|Hepatitis C|hepatitis c
308191|NCT01833845|Hep-C|hep-c
308192|NCT01833832|Synergy for Cisplatin and Hyperthermia|synergy for cisplatin and hyperthermia
308193|NCT01833832|Rare Tumor|rare tumor
308194|NCT01833832|Poor Prognosis|poor prognosis
308195|NCT01833819|Laparoscopic cholecystectomy,|laparoscopic cholecystectomy,
308196|NCT01833819|Total intravenous anesthesia,|total intravenous anesthesia,
308197|NCT01833819|Propofol,|propofol,
308198|NCT01833819|Dexmedetomidine,|dexmedetomidine,
308199|NCT01833819|Lidocaine,|lidocaine,
308200|NCT01833819|Remifentanil,|remifentanil,
308201|NCT01833819|Postoperative analgesic consumption,|postoperative analgesic consumption,
308202|NCT01833819|Postoperative nausea and vomiting|postoperative nausea and vomiting
308203|NCT01833793|Mirena|mirena
308204|NCT01833793|Contraception|contraception
308206|NCT01833780|carriage status|carriage status
308207|NCT01833780|Culture|culture
308208|NCT01833780|PCR|pcr
308209|NCT01833754|Osteoporosis, Bone, Renal, Insufficiency, Kidney, Hemodialysis, Impairment|osteoporosis, bone, renal, insufficiency, kidney, hemodialysis, impairment
308210|NCT01833715|Pain, Postoperative|pain, postoperative
308211|NCT01833715|Analgesics, Opioid|analgesics, opioid
308212|NCT01833715|Methadone|methadone
308213|NCT01833715|Morphine|morphine
308214|NCT01833702|Sickle cell|sickle cell
308215|NCT01833702|Pain|pain
308216|NCT01833689|glucose response|glucose response
308217|NCT01833689|glycaemic index|glycaemic index
308218|NCT01833676|sevoflurane|sevoflurane
308219|NCT01833676|desflurane|desflurane
308220|NCT01833676|protective airway reflexes|protective airway reflexes
308221|NCT01833676|elderly|elderly
308222|NCT01833663|Overactive Bladder|overactive bladder
308223|NCT01833663|Solifenacin Succinate Tablets|solifenacin succinate tablets
308224|NCT01833663|Estrogen|estrogen
308225|NCT01833650|thyroid cancer|thyroid cancer
308226|NCT01833650|radioiodine treatment|radioiodine treatment
308227|NCT01833650|xerostomia|xerostomia
308228|NCT01833650|sialadenitis|sialadenitis
308229|NCT01833637|Advanced Care Planning|advanced care planning
308230|NCT01833637|Palliative Care|palliative care
308231|NCT01833637|Women|women
308232|NCT01833598|Chronic tendinopathy|chronic tendinopathy
308233|NCT01833598|platelet rich plasma|platelet rich plasma
308234|NCT01833598|tendonitis|tendonitis
308235|NCT01833598|percutaneous tendon tenotomy|percutaneous tendon tenotomy
308236|NCT01833598|pain|pain
308237|NCT01833598|shoulder|shoulder
308238|NCT01833598|knee|knee
308239|NCT01833598|ankle|ankle
308240|NCT01833598|foot|foot
308241|NCT01833585|critical limb ischemia|critical limb ischemia
308242|NCT01833585|atherosclerosis|atherosclerosis
308243|NCT01833585|ischemic ulcer|ischemic ulcer
308244|NCT01833585|rest pain|rest pain
308245|NCT01833585|gangrene|gangrene
308246|NCT01833572|epidermal growth factor receptor|epidermal growth factor receptor
308247|NCT01833572|EGFR mutation|egfr mutation
308248|NCT01833572|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
308249|NCT01833572|gefitinib|gefitinib
308250|NCT01833572|neo-adjuvant therapy|neo-adjuvant therapy
308251|NCT01833546|Solid tumor|solid tumor
308252|NCT01833546|Pancreatic cancer|pancreatic cancer
308253|NCT01833546|TH-302|th-302
308254|NCT01833546|gemcitabine|gemcitabine
308255|NCT01833546|Evofosfamide|evofosfamide
308256|NCT01833533|Chronic Hepatitis C|chronic hepatitis c
308257|NCT01833533|Hepatitis C Virus|hepatitis c virus
308258|NCT01833533|Hepatitis C Genotype 1a|hepatitis c genotype 1a
308259|NCT01833533|Hepatitis C|hepatitis c
308260|NCT01833533|Treatment-Naïve|treatment-naïve
308261|NCT01833533|Interferon-Free|interferon-free
308262|NCT01833533|Paritaprevir|paritaprevir
308263|NCT01833533|Ombitasvir|ombitasvir
308264|NCT01833533|Dasabuvir|dasabuvir
308265|NCT01833533|Ribavirin|ribavirin
308266|NCT01833533|Viekira PAK|viekira pak
308267|NCT01833520|Sarcoma|sarcoma
308268|NCT01833520|Osteosarcoma|osteosarcoma
308269|NCT01833520|recurrent or metastatic|recurrent or metastatic
308270|NCT01833520|Ra-223 dichloride|ra-223 dichloride
308271|NCT01833520|Radium-223 chloride|radium-223 chloride
308272|NCT01833520|Alpharadin|alpharadin
308273|NCT01833507|increased activity|increased activity
308274|NCT01833507|weight loss|weight loss
308275|NCT01833507|obesity|obesity
308276|NCT01833494|Hemodialysis|hemodialysis
308277|NCT01833494|Hyperphosphatemia|hyperphosphatemia
308278|NCT01833481|Surgical approach|surgical approach
308279|NCT01833481|Direct-anterior|direct-anterior
308280|NCT01833481|Anterior-lateral|anterior-lateral
308281|NCT01833481|Posterior-lateral|posterior-lateral
308282|NCT01833481|Hip implant|hip implant
308283|NCT01833481|Total Hip Arthroplasty|total hip arthroplasty
308284|NCT01833481|Total Hip replacement|total hip replacement
308285|NCT01833481|Hip replacement|hip replacement
308286|NCT01833481|Hip prosthesis|hip prosthesis
308287|NCT01833468|ankylosing spondylitis|ankylosing spondylitis
308288|NCT01833468|Psoriatic arthritis|psoriatic arthritis
308289|NCT01833468|Foot|foot
308290|NCT01833468|FAOS|faos
308291|NCT01833468|SpA-TRI|spa-tri
308292|NCT01833442|OCD|ocd
308293|NCT01833442|YBOCS|ybocs
308294|NCT01833429|Resistant hypertension|resistant hypertension
308295|NCT01833429|White-coat phenomenon|white-coat phenomenon
308296|NCT01833429|Heart rate variability|heart rate variability
308297|NCT01833429|autonomic activity|autonomic activity
308298|NCT01833416|CMV infection|cmv infection
308299|NCT01833416|CMV disease|cmv disease
308300|NCT01833416|Natural history|natural history
308301|NCT01833416|Kidney transplant|kidney transplant
308302|NCT01833403|bariatric surgery, l|bariatric surgery, l
308303|NCT01833403|liver insulin resistance,|liver insulin resistance,
308304|NCT01833390|Hyperpolarized Xenon|hyperpolarized xenon
308305|NCT01833390|HXe|hxe
308306|NCT01833390|MagniXene|magnixene
308307|NCT01833377|obesity|obesity
308308|NCT01833377|overweight|overweight
308309|NCT01833377|BMI|bmi
308310|NCT01833364|Parkinson's Disease|parkinson's disease
308311|NCT01833364|Deep Brain Stimulation|deep brain stimulation
308312|NCT01833364|Peripheral Nerve Graft|peripheral nerve graft
308313|NCT01833351|Phase I|phase i
308314|NCT01833351|safety and pharmacokinetics,|safety and pharmacokinetics,
308315|NCT01833351|intravenous ascorbate,|intravenous ascorbate,
308316|NCT01833351|IV Vitamin C,|iv vitamin c,
308317|NCT01833351|Oncology|oncology
308318|NCT01833338|Non ST elevation myocardial infarction|non st elevation myocardial infarction
308319|NCT01833338|optical coherence tomography|optical coherence tomography
308320|NCT01833338|intravascular ultrasound|intravascular ultrasound
308321|NCT01833338|multi-slice computed tomography|multi-slice computed tomography
308322|NCT01833325|Age-Related Macular Degeneration|age-related macular degeneration
308323|NCT01833325|Macular Degeneration|macular degeneration
308324|NCT01833325|Proton radiation|proton radiation
308325|NCT01833325|Choroidal Neovascular Membranes|choroidal neovascular membranes
308326|NCT01833312|acute ischemic stroke|acute ischemic stroke
308327|NCT01833312|hypothermia|hypothermia
308328|NCT01833299|TACE|tace
308329|NCT01833299|Sorafenib|sorafenib
308330|NCT01833299|overall survival|overall survival
308331|NCT01833299|time to progression|time to progression
308332|NCT01833286|hepatocellular carcinoma|hepatocellular carcinoma
308333|NCT01833286|repeat hepatectomy|repeat hepatectomy
308334|NCT01833286|radiofrequency ablation|radiofrequency ablation
308335|NCT01833286|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
308336|NCT01833247|epilepsy|epilepsy
308337|NCT01833247|lactic acid|lactic acid
308338|NCT01833247|saliva|saliva
308339|NCT01833247|postictal|postictal
308340|NCT01833234|epilepsy|epilepsy
308341|NCT01833234|quality of life|quality of life
308342|NCT01833234|seizure severity|seizure severity
308343|NCT01833234|antiepileptic drug side effects|antiepileptic drug side effects
308344|NCT01833234|questionnaire|questionnaire
308345|NCT01833234|patient reported outcomes|patient reported outcomes
308346|NCT01833221|facial palsy|facial palsy
308347|NCT01833221|lengthening temporalis myoplasty|lengthening temporalis myoplasty
308348|NCT01833221|neurotization of facial muscles|neurotization of facial muscles
308349|NCT01833195|molecular diagnostics|molecular diagnostics
308350|NCT01833195|heart transplantation|heart transplantation
308351|NCT01833195|risk factors|risk factors
308352|NCT01833195|prognosis|prognosis
308353|NCT01833182|falls in community dwelling older adults|falls in community dwelling older adults
308354|NCT01833182|falls and ADL performance|falls and adl performance
308355|NCT01833182|tailored home intervention|tailored home intervention
308356|NCT01833169|Solid tumor|solid tumor
308357|NCT01833169|malignancy|malignancy
308358|NCT01833169|hematologic malignancy|hematologic malignancy
308359|NCT01833169|PI3K pathway activation|pi3k pathway activation
308360|NCT01833169|P13K activated tumors|p13k activated tumors
308361|NCT01833169|BKM120|bkm120
308362|NCT01833169|signature|signature
308363|NCT01833169|AML|aml
308364|NCT01833169|acute myelogenous leukemia|acute myelogenous leukemia
308365|NCT01833169|cervical|cervical
308366|NCT01833169|ovarian|ovarian
308367|NCT01833169|hepatobiliary|hepatobiliary
308368|NCT01833169|buparlisib|buparlisib
308369|NCT01833156|local edema|local edema
308370|NCT01833156|dielectric constant values|dielectric constant values
308371|NCT01833156|validation study|validation study
308372|NCT01833143|KRAS-Mutant|kras-mutant
308373|NCT01833143|Bortezomib|bortezomib
308374|NCT01833143|KRAS G12D|kras g12d
308375|NCT01833143|12-222|12-222
308376|NCT01833117|Dry eye|dry eye
308377|NCT01833117|Tear film|tear film
308378|NCT01833117|Tear break-up time|tear break-up time
308379|NCT01833117|Ocular surface|ocular surface
308380|NCT01833117|Eye drops|eye drops
308381|NCT01833104|Healthy subjects|healthy subjects
308382|NCT01833039|Mantle Cell Lymphoma|mantle cell lymphoma
308383|NCT01833039|Ibrutinib|ibrutinib
308384|NCT01833026|pulmonary disease|pulmonary disease
308385|NCT01833026|chronic obstructive airflow|chronic obstructive airflow
308386|NCT01833026|spirometry|spirometry
308387|NCT01833026|primary healthcare|primary healthcare
308388|NCT01833026|guideline-based therapy|guideline-based therapy
308389|NCT01833013|Endometriosis|endometriosis
308390|NCT01833013|Cohort study|cohort study
308391|NCT01833013|fertility|fertility
308392|NCT01833013|pregnancy|pregnancy
308393|NCT01833013|assisted reproductive technics|assisted reproductive technics
308394|NCT01833013|laparoscopy|laparoscopy
308395|NCT01833000|rectal bleeding|rectal bleeding
308396|NCT01833000|necrotizing enterolitis|necrotizing enterolitis
308397|NCT01833000|splanchnic oxygenation|splanchnic oxygenation
308398|NCT01833000|mesenteric doppler|mesenteric doppler
308399|NCT01832987|co-trimoxazole|co-trimoxazole
308400|NCT01832987|sulfamethoxazole|sulfamethoxazole
308401|NCT01832987|tuberculosis|tuberculosis
308402|NCT01832987|pharmacokinetics|pharmacokinetics
308403|NCT01832974|Adrenal Gland Cancer|adrenal gland cancer
308404|NCT01832974|Treatment Refractory Malignancies|treatment refractory malignancies
308405|NCT01832974|Metastatic Cancer|metastatic cancer
308406|NCT01832961|COPD|copd
308407|NCT01832961|physiotherapy care|physiotherapy care
308830|NCT01831180|blood flow|blood flow
308408|NCT01832961|lung function testing|lung function testing
308409|NCT01832961|inflammation|inflammation
308410|NCT01832935|Glargin|glargin
308411|NCT01832935|NPH|nph
308412|NCT01832935|Cost-effectiveness|cost-effectiveness
308413|NCT01832922|bendamustine|bendamustine
308414|NCT01832922|rituximab|rituximab
308415|NCT01832922|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
308416|NCT01832922|comorbidities|comorbidities
308417|NCT01832922|renal insufficiency|renal insufficiency
308418|NCT01832909|metabolizable energy|metabolizable energy
308419|NCT01832909|walnuts|walnuts
308420|NCT01832909|Atwater factors|atwater factors
308421|NCT01832909|energy value|energy value
308422|NCT01832896|Hereditary Angioedema|hereditary angioedema
308423|NCT01832896|Children|children
308424|NCT01832896|Adolescents|adolescents
308425|NCT01832896|Ecallantide|ecallantide
308426|NCT01832857|metastatic|metastatic
308427|NCT01832857|advanced|advanced
308428|NCT01832857|solid tumor|solid tumor
308429|NCT01832857|cancer|cancer
308430|NCT01832857|colon cancer|colon cancer
308431|NCT01832857|hepatocellular carcinoma|hepatocellular carcinoma
308432|NCT01832857|breast cancer|breast cancer
308433|NCT01832857|lung cancer|lung cancer
308434|NCT01832857|gastric cancer|gastric cancer
308435|NCT01832857|esophageal cancer|esophageal cancer
308436|NCT01832844|Scan control|scan control
308437|NCT01832844|Epidural infiltration|epidural infiltration
308438|NCT01832844|visual analogue scale (VAS)|visual analogue scale (vas)
308439|NCT01832818|Total Disc Replacement|total disc replacement
308440|NCT01832805|depression|depression
308441|NCT01832779|Achalasia|achalasia
308442|NCT01832766|schizophrenia|schizophrenia
308443|NCT01832766|dronabinol|dronabinol
308444|NCT01832766|P50|p50
308445|NCT01832766|cannabis|cannabis
308446|NCT01832766|memory|memory
308447|NCT01832766|symptoms|symptoms
308448|NCT01832753|Down syndrome|down syndrome
308449|NCT01832753|subclinical hypothyroidism|subclinical hypothyroidism
308450|NCT01832753|thyroid|thyroid
308451|NCT01832753|levothyroxine|levothyroxine
308452|NCT01832740|young healthy subjects|young healthy subjects
308453|NCT01832740|brain stimulation|brain stimulation
308454|NCT01832740|tSOS|tsos
308455|NCT01832740|tDCS|tdcs
308456|NCT01832740|sleep|sleep
308457|NCT01832740|memory|memory
308458|NCT01832740|memory consolidation|memory consolidation
308459|NCT01832727|multiple myeloma|multiple myeloma
308460|NCT01832727|oprozomib|oprozomib
308461|NCT01832727|OPZ|opz
308462|NCT01832727|ONX 0912|onx 0912
308463|NCT01832727|Onyx|onyx
308464|NCT01832727|proteasome inhibitor|proteasome inhibitor
308465|NCT01832727|oprozomib tablets|oprozomib tablets
308466|NCT01832714|Concussion|concussion
308467|NCT01832714|mTBI|mtbi
308468|NCT01832714|military|military
308469|NCT01832714|MACE|mace
308470|NCT01832714|NKI|nki
308471|NCT01832714|NOTC|notc
308472|NCT01832714|VNG|vng
308473|NCT01832714|VOG|vog
308474|NCT01832714|Neuro Kinetics|neuro kinetics
308475|NCT01832714|oculomotor|oculomotor
308476|NCT01832714|vestibular|vestibular
308477|NCT01832714|reaction time|reaction time
308478|NCT01832714|I-Portal|i-portal
308479|NCT01832714|eye tracking|eye tracking
308480|NCT01832714|Dizziness Handicap Inventory|dizziness handicap inventory
308481|NCT01832688|iron and folic acid supplements|iron and folic acid supplements
308482|NCT01832688|anemia|anemia
308483|NCT01832688|gestational weight gain|gestational weight gain
308484|NCT01832675|Endoscopy|endoscopy
308485|NCT01832675|Anesthetics, Local|anesthetics, local
308486|NCT01832675|Bupivacaine|bupivacaine
308487|NCT01832675|Lidocaine|lidocaine
308488|NCT01832649|Exercise|exercise
308489|NCT01832649|Cocaine dependence|cocaine dependence
308490|NCT01832636|L-Alanyl-L-Glutamine|l-alanyl-l-glutamine
308491|NCT01832636|Environmental enteric dysfunction|environmental enteric dysfunction
308492|NCT01832636|Tropical enteropathy|tropical enteropathy
308493|NCT01832623|Vitamin D|vitamin d
308494|NCT01832623|bone|bone
308495|NCT01832623|cardiovascular status|cardiovascular status
308496|NCT01832623|nutritional status|nutritional status
308497|NCT01832584|Red Grapes|red grapes
308498|NCT01832584|polyphenols|polyphenols
308499|NCT01832584|cyclists|cyclists
308500|NCT01832584|resveratrol|resveratrol
308501|NCT01832584|aerobic fitness|aerobic fitness
308502|NCT01832584|trained|trained
308503|NCT01832571|HIV|hiv
308504|NCT01832571|PrEP|prep
308505|NCT01832571|Female Sex Workers|female sex workers
308506|NCT01832571|Kenya|kenya
308507|NCT01832545|Aquatic exercise|aquatic exercise
308508|NCT01832545|Knee Osteoarthritis|knee osteoarthritis
308509|NCT01832545|Exercise|exercise
308510|NCT01832545|Pain|pain
308511|NCT01832545|Obesity.|obesity.
308512|NCT01832532|Sleep Apnea|sleep apnea
308513|NCT01832532|Sleep Disordered Breathing|sleep disordered breathing
308514|NCT01832532|liraglutide|liraglutide
308515|NCT01832532|glucagon-like peptide-1 agonist|glucagon-like peptide-1 agonist
308516|NCT01832532|Orexin|orexin
308517|NCT01832532|leptin,|leptin,
308518|NCT01832519|Cystic Fibrosis|cystic fibrosis
308519|NCT01832519|CF|cf
308520|NCT01832519|MRI|mri
308521|NCT01832519|vascularization|vascularization
308522|NCT01832519|perfusion|perfusion
308523|NCT01832506|Solid Tumors|solid tumors
308524|NCT01832506|MSC2156119J|msc2156119j
308525|NCT01832506|c-Met inhibitor|c-met inhibitor
308526|NCT01832506|Japanese|japanese
308527|NCT01832506|Phase 1|phase 1
308528|NCT01832480|Trichomonas vaginalis|trichomonas vaginalis
308529|NCT01832480|metronidazole|metronidazole
308530|NCT01832467|cetuximab-based chemotherapy|cetuximab-based chemotherapy
308531|NCT01832467|previously treated|previously treated
308532|NCT01832454|cerebral palsy stem cells [MNCS]|cerebral palsy stem cells [mncs]
308533|NCT01832441|Diabetes Mellitus stem cells [MNCS ]|diabetes mellitus stem cells [mncs ]
308534|NCT01832415|First line treatment|first line treatment
308535|NCT01832415|Ovarian cancer|ovarian cancer
308536|NCT01832415|Avastin|avastin
308537|NCT01832415|fallopian tube or primary peritoneal|fallopian tube or primary peritoneal
308538|NCT01832402|Advanced Cancers|advanced cancers
308539|NCT01832402|Exercise-Induced Breakthrough Dyspnea|exercise-induced breakthrough dyspnea
308540|NCT01832402|Shortness of breath|shortness of breath
308541|NCT01832402|Fentanyl pectin nasal spray|fentanyl pectin nasal spray
308542|NCT01832402|Placebo nasal spray|placebo nasal spray
308543|NCT01832402|Walk test|walk test
308544|NCT01832402|Questionnaires|questionnaires
308545|NCT01832402|Surveys|surveys
308546|NCT01832402|Mental ability tests|mental ability tests
308547|NCT01832389|Subarachnoid Haemorrhage (SAH)|subarachnoid haemorrhage (sah)
308548|NCT01832389|vasospasm|vasospasm
308549|NCT01832389|delayed cerebral ischaemia (DCI)|delayed cerebral ischaemia (dci)
308550|NCT01832389|goal directed therapy (GDT)|goal directed therapy (gdt)
308551|NCT01832389|Pulse Contour Cardiac Output (PiCCO)|pulse contour cardiac output (picco)
308552|NCT01832376|Calcific tendinitis|calcific tendinitis
308553|NCT01832376|Shoulder|shoulder
308554|NCT01832376|Needle lavage|needle lavage
308555|NCT01832376|Ultrasound-guided|ultrasound-guided
308556|NCT01832363|Severe asthma|severe asthma
308557|NCT01832363|Bronchial thermoplasty|bronchial thermoplasty
308558|NCT01832363|MagniXene|magnixene
308559|NCT01832363|Hyperpolarized Xenon|hyperpolarized xenon
308560|NCT01832363|HXe|hxe
308561|NCT01832363|HyXe|hyxe
308562|NCT01832324|Food Allergy|food allergy
308563|NCT01832324|Eosinophilic Esophagitis|eosinophilic esophagitis
308564|NCT01832324|Food Protein Induced Enterocolitis|food protein induced enterocolitis
308565|NCT01832324|iNKT Cells|inkt cells
308566|NCT01832324|T cells|t cells
308567|NCT01832311|type 2 diabetes mellitus|type 2 diabetes mellitus
308568|NCT01832311|cataract|cataract
308569|NCT01832311|cytokines|cytokines
308570|NCT01832311|chemokines|chemokines
308571|NCT01832311|aqueous humor|aqueous humor
308572|NCT01832298|Tolerability|tolerability
308573|NCT01832298|Pharmacokinetics|pharmacokinetics
308574|NCT01832285|fluvoxamine|fluvoxamine
308575|NCT01832285|cognition|cognition
308576|NCT01832285|schizophrenia|schizophrenia
308577|NCT01832285|protein expression|protein expression
308578|NCT01832272|Osteoarthritis|osteoarthritis
308579|NCT01832272|Knee|knee
308580|NCT01832272|Total knee arthroplasty|total knee arthroplasty
308581|NCT01832272|Tourniquet|tourniquet
308582|NCT01832272|Early release|early release
308583|NCT01832272|Reinflation|reinflation
308584|NCT01832246|endoscopy|endoscopy
308585|NCT01832246|endosonography|endosonography
308586|NCT01832246|stomach cancer|stomach cancer
308587|NCT01832246|tumor staging|tumor staging
308588|NCT01832220|Genomics|genomics
308589|NCT01832220|Microbiome|microbiome
308590|NCT01832220|Microflora|microflora
308591|NCT01832220|Virome|virome
308592|NCT01832220|Alpha-1|alpha-1
308593|NCT01832194|Scrotal pain|scrotal pain
308594|NCT01832194|Botox|botox
308595|NCT01832181|Diabetes|diabetes
308596|NCT01832181|MiTy|mity
308597|NCT01832181|Metformin in Women|metformin in women
308598|NCT01832181|Type 2 Diabetes Pregnancy|type 2 diabetes pregnancy
308599|NCT01832155|Yoga|yoga
308600|NCT01832155|Knee osteoarthritis|knee osteoarthritis
308601|NCT01832155|Symptom management|symptom management
308602|NCT01832155|Older women|older women
308603|NCT01832155|Pain|pain
308604|NCT01832155|Stiffness|stiffness
308605|NCT01832155|Physical function)|physical function)
308606|NCT01832155|Physical function of the lower extremities|physical function of the lower extremities
308607|NCT01832155|Quality of sleep|quality of sleep
308608|NCT01832155|Quality of life|quality of life
308609|NCT01832116|Pancreatic cancer|pancreatic cancer
308610|NCT01832116|Ovarian cancer|ovarian cancer
308611|NCT01832090|aging|aging
308612|NCT01832090|hands|hands
308613|NCT01832077|sensibility|sensibility
308614|NCT01832077|specificity|specificity
308615|NCT01832077|positive predictive value|positive predictive value
308616|NCT01832077|negative predictive value|negative predictive value
308617|NCT01832077|Cost-effectiveness|cost-effectiveness
308618|NCT01832064|chronic disease|chronic disease
308619|NCT01832064|patient education|patient education
308620|NCT01832064|self management|self management
308622|NCT01832051|89Zr-trastuzumab|89zr-trastuzumab
308623|NCT01832051|metastatic breast cancer|metastatic breast cancer
308624|NCT01832051|clinical dilemma|clinical dilemma
308625|NCT01832038|Lacosamide|lacosamide
308626|NCT01832038|Epilepsy|epilepsy
308627|NCT01832038|Partial-onset Seizures|partial-onset seizures
308628|NCT01832025|intraoperative|intraoperative
308629|NCT01832025|postoperative|postoperative
308630|NCT01832025|complications|complications
308631|NCT01832025|discomfort|discomfort
308632|NCT01832025|external|external
308633|NCT01832025|internal|internal
308634|NCT01832025|maxillary|maxillary
308635|NCT01832025|elevation|elevation
308636|NCT01832025|implant|implant
308637|NCT01832025|reconstruction|reconstruction
308638|NCT01832025|bone|bone
308639|NCT01832025|sinus|sinus
308640|NCT01832012|Eliciting which type of refresher provides the greatest improvement in BLS CPR skills.|eliciting which type of refresher provides the greatest improvement in bls cpr skills.
308641|NCT01831999|Web-based|web-based
308642|NCT01831999|HIV Assessment|hiv assessment
308643|NCT01831999|Outreach|outreach
308644|NCT01831999|Retention|retention
308645|NCT01831999|Substance Abuse Treatment|substance abuse treatment
308646|NCT01831986|Schizophrenia|schizophrenia
308647|NCT01831986|Schizoaffective disorder|schizoaffective disorder
308648|NCT01831986|Pregnenolone|pregnenolone
308649|NCT01831986|L-Theanine|l-theanine
308650|NCT01831986|Augmentation|augmentation
308651|NCT01831960|Intrepid|intrepid
308652|NCT01831960|cortexolone|cortexolone
308653|NCT01831960|cortexolone 17α-propionate|cortexolone 17α-propionate
308654|NCT01831960|anti-androgen|anti-androgen
308655|NCT01831947|age-related macular degeneration|age-related macular degeneration
308656|NCT01831947|Ranibizumab|ranibizumab
308657|NCT01831934|Mitochondrial disorder|mitochondrial disorder
308658|NCT01831934|Trivalent inactivated influenza vaccine|trivalent inactivated influenza vaccine
308659|NCT01831934|Adolescents and adults|adolescents and adults
308660|NCT01831934|Immune response|immune response
308661|NCT01831934|Metabolic response|metabolic response
308662|NCT01831921|pre diabetes|pre diabetes
308663|NCT01831921|obesity|obesity
308664|NCT01831921|weight loss|weight loss
308665|NCT01831921|lifestyle|lifestyle
308666|NCT01831921|prevention|prevention
308667|NCT01831908|cardiovascular health, stroke, ischemic heart disease|cardiovascular health, stroke, ischemic heart disease
308668|NCT01831895|Hypertension|hypertension
308669|NCT01831895|Carotid Sinus|carotid sinus
308670|NCT01831869|Subclinical hypothyroidism|subclinical hypothyroidism
308671|NCT01831869|L-thyroxine|l-thyroxine
308672|NCT01831869|Lipid|lipid
308673|NCT01831869|endothelial function|endothelial function
308674|NCT01831869|inflammatory factor|inflammatory factor
308675|NCT01831869|adipocytokine|adipocytokine
308676|NCT01831856|Cardiovascular diseases|cardiovascular diseases
308677|NCT01831856|Chronic Heart Failure|chronic heart failure
308678|NCT01831843|core body temperature|core body temperature
308679|NCT01831843|humidity|humidity
308680|NCT01831843|circuit temperature|circuit temperature
308681|NCT01831830|traumatic brain injury|traumatic brain injury
308682|NCT01831830|occupational therapy|occupational therapy
308683|NCT01831830|family|family
308684|NCT01831804|diabetic foot ulcer|diabetic foot ulcer
308685|NCT01831804|pharmacodynamics|pharmacodynamics
308686|NCT01831804|pharmacokinetics|pharmacokinetics
308687|NCT01831804|ischemic|ischemic
308688|NCT01831791|male pattern hair loss|male pattern hair loss
308689|NCT01831791|hair growth|hair growth
308690|NCT01831791|hair restoration|hair restoration
308691|NCT01831791|Dutasteride|dutasteride
308692|NCT01831791|Androgenetic alopecia|androgenetic alopecia
308693|NCT01831791|safety|safety
308694|NCT01831791|efficacy|efficacy
308695|NCT01831778|mammography|mammography
308696|NCT01831778|screening|screening
308697|NCT01831752|Diabetes|diabetes
308698|NCT01831752|Type 1|type 1
308699|NCT01831752|Continuous glucose monitor|continuous glucose monitor
308700|NCT01831739|Genomics|genomics
308701|NCT01831739|Microbiome|microbiome
308702|NCT01831739|Microflora|microflora
308703|NCT01831739|Virome|virome
308704|NCT01831726|Solid tumor malignancy|solid tumor malignancy
308705|NCT01831726|hematologic malignancy|hematologic malignancy
308706|NCT01831726|mutation|mutation
308707|NCT01831726|translocations|translocations
308708|NCT01831726|FGFR|fgfr
308709|NCT01831726|PDGFR|pdgfr
308710|NCT01831726|VEGF|vegf
308711|NCT01831726|cKIT|ckit
308712|NCT01831726|FLT3|flt3
308713|NCT01831726|CSR1|csr1
308714|NCT01831726|Trk|trk
308715|NCT01831726|RET|ret
308716|NCT01831726|TKI258|tki258
308717|NCT01831726|dovitinib|dovitinib
308718|NCT01831726|signature|signature
308719|NCT01831726|AML|aml
308720|NCT01831726|acute myelogenous leukemia|acute myelogenous leukemia
308721|NCT01831726|GIST|gist
308722|NCT01831726|gastrointestinal stromal tumor|gastrointestinal stromal tumor
308723|NCT01831726|Head and Neck cancer|head and neck cancer
308724|NCT01831726|Melanoma|melanoma
308725|NCT01831726|NSCLC|nsclc
308831|NCT01831180|Caucasian|caucasian
308726|NCT01831726|non-small cell lung carcinoma|non-small cell lung carcinoma
308727|NCT01831726|lung cancer|lung cancer
308728|NCT01831726|ovarian cancer|ovarian cancer
308729|NCT01831726|thyroid cancer|thyroid cancer
308730|NCT01831726|amplification|amplification
308731|NCT01831648|IGF1|igf1
308732|NCT01831648|standards|standards
308733|NCT01831648|Assays|assays
308734|NCT01831648|Z-score|z-score
308735|NCT01831648|Healthy volunteers|healthy volunteers
308736|NCT01831648|Population|population
308737|NCT01831622|Decision-Making|decision-making
308738|NCT01831622|functional MRI|functional mri
308739|NCT01831622|pharmacological MRI|pharmacological mri
308740|NCT01831622|Reinforcement Learning|reinforcement learning
308741|NCT01831622|Methylphenidate|methylphenidate
308742|NCT01831609|Gastrointestinal|gastrointestinal
308743|NCT01831609|Genitourinary|genitourinary
308744|NCT01831609|Rare Cancer|rare cancer
308745|NCT01831583|sleep apnea|sleep apnea
308746|NCT01831570|Hand osteoarthritis|hand osteoarthritis
308747|NCT01831570|predictive factors|predictive factors
308748|NCT01831570|erosive hand OA|erosive hand oa
308749|NCT01831544|Heart Failure|heart failure
308750|NCT01831518|Heart Failure|heart failure
308751|NCT01831518|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
308752|NCT01831518|ECG Imaging|ecg imaging
308753|NCT01831518|Body Surface Mapping|body surface mapping
308754|NCT01831505|personalized medicine|personalized medicine
308755|NCT01831505|in vivo drug sensitivity|in vivo drug sensitivity
308756|NCT01831505|chemotherapy|chemotherapy
308757|NCT01831505|lymphoma|lymphoma
308758|NCT01831505|microinjection|microinjection
308759|NCT01831492|performance|performance
308760|NCT01831492|acidosis|acidosis
308761|NCT01831492|oxidative stress|oxidative stress
308762|NCT01831492|inflammation|inflammation
308763|NCT01831492|oxygen uptake|oxygen uptake
308764|NCT01831479|Pharmacokinetics, drug-drug interaction|pharmacokinetics, drug-drug interaction
308765|NCT01831466|plaque psoriasis|plaque psoriasis
308766|NCT01831466|vulgaris|vulgaris
308767|NCT01831466|topical treatment|topical treatment
308768|NCT01831466|skin diseases|skin diseases
308769|NCT01831466|papulosquamous|papulosquamous
308770|NCT01831466|Tofacitinib|tofacitinib
308771|NCT01831466|CP-690550|cp-690550
308772|NCT01831466|Xeljanz|xeljanz
308773|NCT01831466|psoriasis|psoriasis
308774|NCT01831466|moderate|moderate
308775|NCT01831466|severe|severe
308776|NCT01831466|itch|itch
308777|NCT01831466|nail psoriasis|nail psoriasis
308778|NCT01831453|omega-3|omega-3
308779|NCT01831453|recurrent aphthous stomatitis|recurrent aphthous stomatitis
308780|NCT01831453|quality of life|quality of life
308781|NCT01831440|depression|depression
308782|NCT01831440|remission|remission
308783|NCT01831440|Pharmacotherapy|pharmacotherapy
308784|NCT01831440|psychotherapy|psychotherapy
308785|NCT01831440|neuroimaging|neuroimaging
308786|NCT01831440|psychology|psychology
308787|NCT01831427|ulcerative colitis|ulcerative colitis
308788|NCT01831427|moderate|moderate
308789|NCT01831427|severe|severe
308790|NCT01831414|Lung function|lung function
308791|NCT01831414|Water immersion|water immersion
308792|NCT01831414|Balneotherapy|balneotherapy
308793|NCT01831401|Acetabular component inclination|acetabular component inclination
308794|NCT01831388|Dyspnea|dyspnea
308795|NCT01831388|Breath Training Exercise|breath training exercise
308796|NCT01831388|12-261|12-261
308797|NCT01831336|International|international
308798|NCT01831336|Multicenter|multicenter
308799|NCT01831336|Observational registry|observational registry
308800|NCT01831336|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
308801|NCT01831336|Stenting|stenting
308802|NCT01831336|Treatment of Coronary Artery Disease|treatment of coronary artery disease
308803|NCT01831336|Coronary revascularization|coronary revascularization
308804|NCT01831336|Percutaneous Coronary Intervention|percutaneous coronary intervention
308805|NCT01831336|STEMI|stemi
308806|NCT01831336|NSTEMI|nstemi
308807|NCT01831336|Ischemia|ischemia
308808|NCT01831336|Angina|angina
308809|NCT01831336|Subgroups|subgroups
308810|NCT01831336|Acute Myocardial Infarction|acute myocardial infarction
308811|NCT01831336|Diabetes|diabetes
308812|NCT01831336|Small Vessels|small vessels
308813|NCT01831336|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
308814|NCT01831310|Colorectal cancer|colorectal cancer
308815|NCT01831310|nutrition|nutrition
308816|NCT01831310|neutrophil phagocytosis|neutrophil phagocytosis
308817|NCT01831310|neutrophil adhesivity|neutrophil adhesivity
308818|NCT01831310|glutamine|glutamine
308819|NCT01831310|omega 3 fatty acids|omega 3 fatty acids
308820|NCT01831271|Exercise, Physical|exercise, physical
308821|NCT01831271|Physical Activity|physical activity
308822|NCT01831271|Outcome Measures|outcome measures
308823|NCT01831219|osteoarthritis|osteoarthritis
308824|NCT01831219|arthroplasty|arthroplasty
308825|NCT01831219|hip arthroplasty|hip arthroplasty
308826|NCT01831206|corneal ulcer|corneal ulcer
308827|NCT01831206|keratitis|keratitis
308828|NCT01831180|hair|hair
308829|NCT01831180|scalp|scalp
308832|NCT01831180|Histamine stimulation|histamine stimulation
308833|NCT01831180|Wake Forest|wake forest
308834|NCT01831167|dynamic light application|dynamic light application
308835|NCT01831167|sustained attention|sustained attention
308836|NCT01831167|divided attention|divided attention
308837|NCT01831167|nursing|nursing
308838|NCT01831154|Glycemic control|glycemic control
308839|NCT01831141|Congenital Solitary Kidney|congenital solitary kidney
308840|NCT01831141|Glomerular filtration rate|glomerular filtration rate
308841|NCT01831141|Chronic kidney damage|chronic kidney damage
308842|NCT01831141|Hypertension|hypertension
308843|NCT01831141|Proteinuria|proteinuria
308844|NCT01831128|Congestive Heart Failure|congestive heart failure
308845|NCT01831128|Central Sleep Apnea|central sleep apnea
308846|NCT01831128|Sleep-Disordered Breathing|sleep-disordered breathing
308847|NCT01831115|heart failure|heart failure
308848|NCT01831115|BNP|bnp
308849|NCT01831115|acute dyspnoea|acute dyspnoea
308850|NCT01831102|insulin resistance|insulin resistance
308851|NCT01831102|ethnic disparities|ethnic disparities
308852|NCT01831102|adiponectin|adiponectin
308853|NCT01831076|Breast cancer|breast cancer
308854|NCT01831076|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
308855|NCT01831076|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
308856|NCT01831076|Postmenopausal|postmenopausal
308857|NCT01831076|Exemestane|exemestane
308858|NCT01831076|Tamoxifen|tamoxifen
308859|NCT01831063|Seizure|seizure
308860|NCT01831063|Caregivers|caregivers
308861|NCT01831063|Family Centered Care|family centered care
308862|NCT01831063|Learning modality|learning modality
308863|NCT01831050|Poliovirus|poliovirus
308864|NCT01831050|Inactivated poliovirus vaccine|inactivated poliovirus vaccine
308865|NCT01831050|Trivalent oral polio vaccine|trivalent oral polio vaccine
308866|NCT01831050|Bivalent oral polio vaccine|bivalent oral polio vaccine
308867|NCT01831050|Stool shedding index|stool shedding index
308868|NCT01831050|Polio eradication|polio eradication
308869|NCT01831037|Hepatocellular carcinoma|hepatocellular carcinoma
308870|NCT01831037|Regressed cirrhosis|regressed cirrhosis
308871|NCT01831037|Hepatitis C|hepatitis c
308872|NCT01831037|Hepatitis B|hepatitis b
308873|NCT01831037|Noninvasive markers of fibrosis|noninvasive markers of fibrosis
308874|NCT01831037|FibroTest|fibrotest
308875|NCT01831037|FibroSure|fibrosure
308876|NCT01831037|FibroScan|fibroscan
308877|NCT01831037|Transient elastography|transient elastography
308878|NCT01831024|Cold cap|cold cap
308879|NCT01831024|Scalp cooling|scalp cooling
308880|NCT01831024|Chemotherapy induced alopecia|chemotherapy induced alopecia
308881|NCT01831024|Breast cancer|breast cancer
308882|NCT01831011|randomized trial|randomized trial
308883|NCT01831011|acute ischemic stroke|acute ischemic stroke
308884|NCT01831011|mildronate|mildronate
308885|NCT01830998|Dementia|dementia
308886|NCT01830998|Olfactory|olfactory
308887|NCT01830959|Sarcoidosis, fibrosis, bronchiectasis|sarcoidosis, fibrosis, bronchiectasis
308888|NCT01830946|Protein|protein
308889|NCT01830946|Metabolism|metabolism
308890|NCT01830946|Nighttime eating|nighttime eating
308891|NCT01830946|Exercise Training|exercise training
308892|NCT01830933|Breast cancer concern, breast cancer risk perception, breast cancer risk|breast cancer concern, breast cancer risk perception, breast cancer risk
308893|NCT01830920|Acute Kidney Injury|acute kidney injury
308894|NCT01830920|AKI|aki
308895|NCT01830920|Cardiac surgery|cardiac surgery
308896|NCT01830907|Malnutrition|malnutrition
308897|NCT01830907|Gastric cancer|gastric cancer
308898|NCT01830907|preoperative nutrition|preoperative nutrition
308899|NCT01830881|pain|pain
308900|NCT01830881|anxiety|anxiety
308901|NCT01830881|surgical abortion|surgical abortion
308902|NCT01830881|midazolam|midazolam
308903|NCT01830881|benzodiazepine|benzodiazepine
308904|NCT01830868|ZNS|zns
308905|NCT01830868|AED|aed
308906|NCT01830868|Partial Onset Seizures|partial onset seizures
308907|NCT01830868|Retention Rate|retention rate
308908|NCT01830868|Seizure Control|seizure control
308909|NCT01830868|Antiepileptic|antiepileptic
308910|NCT01830868|Secondary generalization|secondary generalization
308911|NCT01830868|Seizure freedom rates|seizure freedom rates
308912|NCT01830842|Nicotine|nicotine
308913|NCT01830842|Smoking|smoking
308914|NCT01830842|Cigarettes|cigarettes
308915|NCT01830842|Reinforcement Learning|reinforcement learning
308916|NCT01830842|fMRI|fmri
308917|NCT01830829|BPH|bph
308918|NCT01830829|CPPS|cpps
308919|NCT01830816|Relapsed|relapsed
308920|NCT01830816|Refractory|refractory
308921|NCT01830816|Multiple Myeloma|multiple myeloma
308922|NCT01830816|Advanced solid tumors|advanced solid tumors
308923|NCT01830803|howRU|howru
308924|NCT01830803|howRwe|howrwe
308925|NCT01830803|reliability|reliability
308926|NCT01830803|quality of life|quality of life
308927|NCT01830803|quality of care|quality of care
308928|NCT01830803|patient satisfaction|patient satisfaction
308929|NCT01830751|self treatment technique|self treatment technique
308930|NCT01830751|chronic|chronic
308931|NCT01830751|non specific|non specific
308932|NCT01830751|LBP|lbp
308933|NCT01830751|control trunk flexion|control trunk flexion
308934|NCT01830751|diurnal|diurnal
308935|NCT01830738|laparoscopy|laparoscopy
308936|NCT01830738|hysterectomy|hysterectomy
308937|NCT01830738|single-port trocar|single-port trocar
308938|NCT01830738|surgical technique|surgical technique
308939|NCT01830738|trocar|trocar
308940|NCT01830725|Xanthine Oxidase|xanthine oxidase
308941|NCT01830725|Gout|gout
308942|NCT01830725|Hyperuricemia|hyperuricemia
308943|NCT01830725|SNP|snp
308944|NCT01830725|Single Nucleotide Polymorphisms|single nucleotide polymorphisms
308945|NCT01830699|Rilonacept|rilonacept
308946|NCT01830699|Subacromial Bursitis treatment|subacromial bursitis treatment
308947|NCT01830699|Corticosteroid Injection|corticosteroid injection
308948|NCT01830686|Sugarcane bagasse, glucose tolerance, insulin resistance|sugarcane bagasse, glucose tolerance, insulin resistance
308949|NCT01830673|T-regulatory cells|t-regulatory cells
308950|NCT01830673|TH1, TH2 cells|th1, th2 cells
308951|NCT01830673|specific IgE|specific ige
308952|NCT01830673|specific IgG|specific igg
308953|NCT01830673|specific IgG4|specific igg4
308954|NCT01830673|IL2|il2
308955|NCT01830673|IL5|il5
308956|NCT01830673|IL10|il10
308957|NCT01830673|IL12/23|il12/23
308958|NCT01830673|Y-IFN|y-ifn
308959|NCT01830673|TNF-a|tnf-a
308960|NCT01830634|Community-dwelling elderly|community-dwelling elderly
308961|NCT01830634|Rehabilitation|rehabilitation
308962|NCT01830634|Theraband|theraband
308963|NCT01830634|Strengthening and stretching exercise|strengthening and stretching exercise
308964|NCT01830582|MRI|mri
308965|NCT01830582|rectum|rectum
308966|NCT01830582|13-019|13-019
308967|NCT01830569|Decision Support Systems, Clinical|decision support systems, clinical
308968|NCT01830569|Evidence-Based practice|evidence-based practice
308969|NCT01830569|Family Practice|family practice
308970|NCT01830543|Atrial Fibrillation|atrial fibrillation
308971|NCT01830543|Irregular heart beat|irregular heart beat
308972|NCT01830543|rivaroxaban|rivaroxaban
308973|NCT01830543|aspirin|aspirin
308974|NCT01830543|clopidogrel|clopidogrel
308975|NCT01830543|prasugrel|prasugrel
308976|NCT01830543|ticagrelor|ticagrelor
308977|NCT01830543|vitamin K antagonist|vitamin k antagonist
308978|NCT01830530|arterial hypertension|arterial hypertension
308979|NCT01830530|high altitude|high altitude
308980|NCT01830530|hypobaric hypoxia|hypobaric hypoxia
308981|NCT01830530|combination treatment|combination treatment
308982|NCT01830530|angiotensin receptor blocker|angiotensin receptor blocker
308983|NCT01830530|calcium antagonist|calcium antagonist
308984|NCT01830504|thyroid cancers|thyroid cancers
308985|NCT01830504|refractory|refractory
308986|NCT01830504|PI3K inhibitor|pi3k inhibitor
308987|NCT01830465|Non Hodgkin's Follicular Lymphoma|non hodgkin's follicular lymphoma
308988|NCT01830465|relapsed|relapsed
308989|NCT01830465|progressed|progressed
308990|NCT01830452|Chronic pain|chronic pain
308991|NCT01830452|Progrip Mesh|progrip mesh
308992|NCT01830452|Self gripping mesh|self gripping mesh
308993|NCT01830452|Lichtenstein|lichtenstein
308994|NCT01830439|tuberculosis|tuberculosis
308995|NCT01830439|PK|pk
308996|NCT01830439|PA-824|pa-824
308997|NCT01830439|food effect|food effect
308998|NCT01830439|pretomanid|pretomanid
308999|NCT01830439|CL-009|cl-009
309000|NCT01830413|stent, systematic Intracranial artery stenosis|stent, systematic intracranial artery stenosis
309001|NCT01830400|ESL|esl
309002|NCT01830400|Partial onset seizures|partial onset seizures
309003|NCT01830400|Retention Rate|retention rate
309004|NCT01830400|Seizure Control|seizure control
309005|NCT01830400|Antiepileptic|antiepileptic
309006|NCT01830400|Secondary Generalisation|secondary generalisation
309007|NCT01830387|Polymetric Clips (Hem-o-Lok)|polymetric clips (hem-o-lok)
309008|NCT01830387|Laparoscopic Appendectomy|laparoscopic appendectomy
309009|NCT01830387|Endoscopic Staplers|endoscopic staplers
309010|NCT01830374|Bulimia nervosa|bulimia nervosa
309011|NCT01830374|Eating disorder|eating disorder
309012|NCT01830374|Weight suppression|weight suppression
309013|NCT01830374|Dieting|dieting
309014|NCT01830361|AML|aml
309015|NCT01830361|Acute Myeloid Leukemia|acute myeloid leukemia
309016|NCT01830361|c-KIT|c-kit
309017|NCT01830361|FLT3-ITD|flt3-itd
309018|NCT01830361|t(8;21)|t(8;21)
309019|NCT01830361|chemotherapy|chemotherapy
309020|NCT01830361|midostaurin|midostaurin
309021|NCT01830348|diabetic foot ulcers|diabetic foot ulcers
309022|NCT01830348|Wagner Grade 1 or 2 foot ulcers|wagner grade 1 or 2 foot ulcers
309023|NCT01830322|metastatic|metastatic
309024|NCT01830322|pancreatic|pancreatic
309025|NCT01830322|adenocarcinoma|adenocarcinoma
309026|NCT01830322|cancer|cancer
309027|NCT01830309|Food-Effect|food-effect
309028|NCT01830309|Pharmacokinetics|pharmacokinetics
309029|NCT01830309|Pharmacodynamics|pharmacodynamics
309030|NCT01830296|Postthoracotomy pain,|postthoracotomy pain,
309031|NCT01830296|patient controlled analgesia,|patient controlled analgesia,
309032|NCT01830296|remifentanil and|remifentanil and
309033|NCT01830296|morphine.|morphine.
309034|NCT01830270|medical oncology|medical oncology
309035|NCT01830270|chemotherapy optimization|chemotherapy optimization
309036|NCT01830270|dose density|dose density
309037|NCT01830244|chemotherapy|chemotherapy
309038|NCT01830244|nab paclitaxel|nab paclitaxel
309039|NCT01830244|neoadjuvant therapy|neoadjuvant therapy
309040|NCT01830244|breast cancer|breast cancer
309041|NCT01830244|pathologic complete response|pathologic complete response
309042|NCT01830231|TCCU|tccu
309043|NCT01830231|Vinflunine|vinflunine
309044|NCT01830231|Cabazitaxel|cabazitaxel
309045|NCT01830231|Metastatic|metastatic
309046|NCT01830231|Locally advance|locally advance
309047|NCT01830192|endometrial cancer|endometrial cancer
309048|NCT01830192|score|score
309049|NCT01830192|nomogram|nomogram
309050|NCT01830192|ultrasound|ultrasound
309051|NCT01830192|HE4|he4
309052|NCT01830153|Soft tissue sarcomas|soft tissue sarcomas
309053|NCT01830153|Bone sarcomas|bone sarcomas
309054|NCT01830153|RAD001|rad001
309055|NCT01830153|Refractory to conventional chemotherapy|refractory to conventional chemotherapy
309056|NCT01830114|alcohol abuse|alcohol abuse
309057|NCT01830114|drug abuse|drug abuse
309058|NCT01830114|hazardous alcohol use|hazardous alcohol use
309059|NCT01830114|hazardous drug use|hazardous drug use
309060|NCT01830101|recurrent glioblastoma|recurrent glioblastoma
309061|NCT01830101|re-irradiation|re-irradiation
309062|NCT01830101|continuous low-dose temozolomide|continuous low-dose temozolomide
309063|NCT01830036|cardiological treatment|cardiological treatment
309064|NCT01830036|sleep Apnea|sleep apnea
309065|NCT01830023|cardiac ultrasound|cardiac ultrasound
309066|NCT01830023|vitality|vitality
309067|NCT01830023|data|data
309068|NCT01830023|patients|patients
309069|NCT01830023|examined|examined
309070|NCT01829984|Injection Teaching|injection teaching
309071|NCT01829984|13-057|13-057
309072|NCT01829971|microRNA|microrna
309073|NCT01829971|Advanced cancer|advanced cancer
309074|NCT01829958|Geriatric|geriatric
309075|NCT01829958|Toxicity|toxicity
309076|NCT01829958|rituximab|rituximab
309077|NCT01829958|prednisone|prednisone
309078|NCT01829958|Comprehensive Geriatric Assessment (CGA)|comprehensive geriatric assessment (cga)
309079|NCT01829958|13-028|13-028
309080|NCT01829932|Diet|diet
309081|NCT01829919|Menopause|menopause
309082|NCT01829919|Hot flashes|hot flashes
309083|NCT01829919|Vasomotor symptoms|vasomotor symptoms
309084|NCT01829919|Climacteric symptoms|climacteric symptoms
309085|NCT01829919|perimenopause|perimenopause
309086|NCT01829919|Mesafem|mesafem
309087|NCT01829919|Brisdelle|brisdelle
309088|NCT01829919|Low-Dose Mesylate salt of Paroxetine (LDMP)|low-dose mesylate salt of paroxetine (ldmp)
309089|NCT01829906|weight loss|weight loss
309090|NCT01829906|bariatric surgery|bariatric surgery
309091|NCT01829906|gastric bypass|gastric bypass
309092|NCT01829906|health education|health education
309093|NCT01829906|nutrition therapy|nutrition therapy
309094|NCT01829906|diet|diet
309095|NCT01829906|exercise|exercise
309096|NCT01829906|cognitive therapy|cognitive therapy
309097|NCT01829893|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
309098|NCT01829893|pharmacokinetics|pharmacokinetics
309099|NCT01829893|bioequivalence|bioequivalence
309100|NCT01829893|finasteirde|finasteirde
309101|NCT01829893|tamsulosin|tamsulosin
309102|NCT01829880|Chronic heart failure|chronic heart failure
309103|NCT01829880|Bisoprolol|bisoprolol
309104|NCT01829880|Ramipril|ramipril
309105|NCT01829880|Pharmacokinetic|pharmacokinetic
309106|NCT01829880|Cachexia|cachexia
309107|NCT01829880|Body composition|body composition
309108|NCT01829880|Renal function|renal function
309109|NCT01829880|Iohexol|iohexol
309110|NCT01829841|MRCC|mrcc
309111|NCT01829841|Metastatic Renal Cell Cancer|metastatic renal cell cancer
309112|NCT01829841|Famitinib|famitinib
309113|NCT01829841|Sunitinib|sunitinib
309114|NCT01829828|Pain|pain
309115|NCT01829828|Cancer pain|cancer pain
309116|NCT01829828|Self-reported pain scoring tool|self-reported pain scoring tool
309117|NCT01829828|Opioid analgesics|opioid analgesics
309118|NCT01829815|Child|child
309119|NCT01829815|Parents|parents
309120|NCT01829815|Parenting|parenting
309121|NCT01829815|Child Development|child development
309122|NCT01829815|Parent Child Relations|parent child relations
309123|NCT01829815|Malaria|malaria
309124|NCT01829815|Primary Prevention|primary prevention
309125|NCT01829815|Punishment|punishment
309126|NCT01829815|Education|education
309127|NCT01829802|HIV|hiv
309128|NCT01829802|Raltegravir|raltegravir
309129|NCT01829802|Boosted atazanavir|boosted atazanavir
309130|NCT01829789|Adolescents|adolescents
309131|NCT01829789|Teens|teens
309132|NCT01829789|Parents|parents
309133|NCT01829789|Parenting|parenting
309134|NCT01829789|Substance Abuse|substance abuse
309135|NCT01829789|Treatment Efficacy|treatment efficacy
309136|NCT01829776|Accidental falls|accidental falls
309137|NCT01829776|Multiple Sclerosis|multiple sclerosis
309138|NCT01829776|Education|education
309139|NCT01829776|Exercise|exercise
309140|NCT01829776|Postural balance|postural balance
309141|NCT01829750|Univentricular heart|univentricular heart
309346|NCT01828788|Anesthesia|anesthesia
309142|NCT01829737|Asymptomatic Parasitemia|asymptomatic parasitemia
309143|NCT01829737|RBC Polymorphism|rbc polymorphism
309144|NCT01829737|Acquired Immunity|acquired immunity
309145|NCT01829724|Functional Brain Imaging|functional brain imaging
309146|NCT01829724|Cerebral Palsy|cerebral palsy
309147|NCT01829724|Motion Analysis|motion analysis
309148|NCT01829724|Macro- EMG|macro- emg
309149|NCT01829711|Moxetumomab Paudotox|moxetumomab paudotox
309150|NCT01829711|CAT-8015|cat-8015
309151|NCT01829711|anti-CD22 recombination immunotoxin|anti-cd22 recombination immunotoxin
309152|NCT01829711|Biologic Therapy|biologic therapy
309153|NCT01829711|Recombinant Immunotoxin|recombinant immunotoxin
309154|NCT01829711|Monoclonal Antibody|monoclonal antibody
309155|NCT01829711|Pseudomonas Exotoxin|pseudomonas exotoxin
309156|NCT01829711|Targeted Therapy|targeted therapy
309157|NCT01829698|tudca PBC Cholestasis tauroursodeoxycholic acid taurolite|tudca pbc cholestasis tauroursodeoxycholic acid taurolite
309158|NCT01829672|Early diagnosis of pulmonary arterial hypertension|early diagnosis of pulmonary arterial hypertension
309159|NCT01829672|dynamic dual-energy computed tomography|dynamic dual-energy computed tomography
309160|NCT01829646|DWI|dwi
309161|NCT01829646|DCE MRI|dce mri
309162|NCT01829646|ADC|adc
309163|NCT01829646|FDG PET|fdg pet
309164|NCT01829646|Hypoxia|hypoxia
309165|NCT01829646|Prognostic and predictive model|prognostic and predictive model
309166|NCT01829620|suicide|suicide
309167|NCT01829620|suicide intervention|suicide intervention
309168|NCT01829620|suicide prevention|suicide prevention
309169|NCT01829620|military|military
309170|NCT01829620|military suicide|military suicide
309171|NCT01829620|caring letters|caring letters
309172|NCT01829620|caring contacts|caring contacts
309173|NCT01829620|text messages|text messages
309174|NCT01829594|Case Management|case management
309175|NCT01829594|Frail Elderly|frail elderly
309176|NCT01829594|Health Services Administration|health services administration
309177|NCT01829594|Delivery of Health Care|delivery of health care
309178|NCT01829594|Accidental Falls|accidental falls
309179|NCT01829594|Health Status|health status
309180|NCT01829594|Health Care Economics|health care economics
309181|NCT01829542|flow-mediated dilation|flow-mediated dilation
309182|NCT01829542|blueberry polyphenols|blueberry polyphenols
309183|NCT01829542|dose-dependency|dose-dependency
309184|NCT01829529|Antibiotic prophylaxis|antibiotic prophylaxis
309185|NCT01829503|Phase II|phase ii
309186|NCT01829503|decitabine|decitabine
309187|NCT01829503|cytarabine|cytarabine
309188|NCT01829503|older patients|older patients
309189|NCT01829503|newly diagnosed|newly diagnosed
309190|NCT01829503|AML|aml
309191|NCT01829503|Newly Diagnosed AML|newly diagnosed aml
309192|NCT01829490|Vaccine|vaccine
309193|NCT01829490|Immunogenicity|immunogenicity
309194|NCT01829477|Drug Therapy|drug therapy
309195|NCT01829464|Drug Therapy|drug therapy
309196|NCT01829438|exercise tolerance|exercise tolerance
309197|NCT01829438|6MWT|6mwt
309198|NCT01829425|Hypnosis|hypnosis
309199|NCT01829425|Mind-Body Therapy|mind-body therapy
309200|NCT01829425|Anticholinergics|anticholinergics
309201|NCT01829425|fMRI|fmri
309202|NCT01829425|Functional Neuroimaging|functional neuroimaging
309203|NCT01829425|Gyrus Cinguli|gyrus cinguli
309204|NCT01829425|Female Urogenital Diseases|female urogenital diseases
309205|NCT01829399|Tourniquet pain|tourniquet pain
309206|NCT01829399|Subcutaneous axillary local anesthetic|subcutaneous axillary local anesthetic
309207|NCT01829399|ability to tolerate tourniquet discomfort.|ability to tolerate tourniquet discomfort.
309208|NCT01829373|lung cancer|lung cancer
309209|NCT01829347|liver failure|liver failure
309210|NCT01829347|acute alcoholic hepatitis|acute alcoholic hepatitis
309211|NCT01829347|patients failing steroid therapy|patients failing steroid therapy
309212|NCT01829347|alcoholic hepatitis|alcoholic hepatitis
309213|NCT01829347|steroid failure|steroid failure
309214|NCT01829347|Lille criteria|lille criteria
309215|NCT01829347|ELAD|elad
309216|NCT01829334|dental caries|dental caries
309217|NCT01829308|implementation|implementation
309218|NCT01829308|SBIRT|sbirt
309219|NCT01829308|alcohol screening|alcohol screening
309220|NCT01829308|drug screening|drug screening
309221|NCT01829308|Brief Intervention|brief intervention
309222|NCT01829308|Referral to Treatment|referral to treatment
309223|NCT01829308|adolescents|adolescents
309224|NCT01829308|Federally Qualified Health Centers|federally qualified health centers
309225|NCT01829295|antimetabolite, noninfectious|antimetabolite, noninfectious
309226|NCT01829282|Implementation|implementation
309227|NCT01829282|HIV|hiv
309228|NCT01829282|serodiscordant couples|serodiscordant couples
309229|NCT01829282|African American|african american
309230|NCT01829282|Cultural congruency|cultural congruency
309231|NCT01829243|Milnacipran|milnacipran
309232|NCT01829243|Fibromyalgia|fibromyalgia
309233|NCT01829243|Neurocognition|neurocognition
309234|NCT01829178|cisplatin|cisplatin
309235|NCT01829178|nephrotoxicity|nephrotoxicity
309236|NCT01829178|antioxidant|antioxidant
309237|NCT01829178|urine neutrophil gelatinase-associated lipocalin (NGAL)|urine neutrophil gelatinase-associated lipocalin (ngal)
309238|NCT01829152|heart failure|heart failure
309239|NCT01829139|Common bile duct stone|common bile duct stone
309240|NCT01829139|Gallbladder in situ|gallbladder in situ
309241|NCT01829139|Choleretics|choleretics
309242|NCT01829113|Recurrent Lung Cancer|recurrent lung cancer
309243|NCT01829113|Stage IV Lung Cancer|stage iv lung cancer
309244|NCT01829113|OGX-427|ogx-427
309245|NCT01829113|Sarah Cannon Research Institute|sarah cannon research institute
309246|NCT01829113|SCRI|scri
309247|NCT01829113|OncoGenex|oncogenex
309248|NCT01829113|NSCLC|nsclc
309249|NCT01829113|Non Small Cell Lung Cancer|non small cell lung cancer
309250|NCT01829100|Adolescent|adolescent
309251|NCT01829100|Transdiagnostic therapy|transdiagnostic therapy
309252|NCT01829100|Behavioral activation|behavioral activation
309253|NCT01829100|Exposure therapy|exposure therapy
309254|NCT01829100|Depressive Disorder|depressive disorder
309255|NCT01829100|Anxiety Disorders|anxiety disorders
309256|NCT01829074|Laryngopharyngeal Reflux|laryngopharyngeal reflux
309257|NCT01829074|Hoarseness|hoarseness
309258|NCT01829074|Throat Clearing|throat clearing
309259|NCT01829074|Globus Sensation|globus sensation
309260|NCT01829061|Type I Diabetes|type i diabetes
309261|NCT01829061|Type II Diabetes|type ii diabetes
309262|NCT01829061|HbA1C|hba1c
309263|NCT01829048|PF-02545920|pf-02545920
309264|NCT01829048|safety|safety
309265|NCT01829048|schizophrenia|schizophrenia
309266|NCT01829035|TACE|tace
309267|NCT01829035|Sorafenib|sorafenib
309268|NCT01829022|Myoma|myoma
309269|NCT01829022|Uterine myomectomy|uterine myomectomy
309270|NCT01829009|Sarcopenia|sarcopenia
309271|NCT01829009|Elderly|elderly
309272|NCT01829009|Women|women
309273|NCT01829009|Resistance|resistance
309274|NCT01829009|Exercise|exercise
309275|NCT01828996|Chronic pelvic pain syndrome|chronic pelvic pain syndrome
309276|NCT01828996|Chronic prostatitis|chronic prostatitis
309277|NCT01828996|Shock wave therapy|shock wave therapy
309278|NCT01828996|Prostate|prostate
309279|NCT01828996|Pelvic floor|pelvic floor
309280|NCT01828996|Pain|pain
309281|NCT01828983|Telephone|telephone
309282|NCT01828983|Support groups|support groups
309283|NCT01828983|Social support|social support
309284|NCT01828983|Depression|depression
309285|NCT01828970|Diabetes Mellitus|diabetes mellitus
309286|NCT01828970|Hemodialysis|hemodialysis
309287|NCT01828970|Continuous glucose monitoring|continuous glucose monitoring
309288|NCT01828970|Insulin analogues|insulin analogues
309289|NCT01828957|Human Umbilical Cord Blood Derived Mesenchymal Stem Cells|human umbilical cord blood derived mesenchymal stem cells
309290|NCT01828957|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
309291|NCT01828957|Premature infants|premature infants
309292|NCT01828944|Vitamin D|vitamin d
309293|NCT01828944|bone loss|bone loss
309294|NCT01828918|early diagnosis|early diagnosis
309295|NCT01828918|prediction|prediction
309296|NCT01828918|prognosis|prognosis
309297|NCT01828905|tibia fracture|tibia fracture
309298|NCT01828905|bone graft|bone graft
309299|NCT01828905|iliac crest|iliac crest
309300|NCT01828905|bone graft substitute|bone graft substitute
309301|NCT01828905|Cerament|cerament
309302|NCT01828905|void filler|void filler
309303|NCT01828905|quality of life|quality of life
309304|NCT01828905|pain|pain
309305|NCT01828905|costs of care|costs of care
309306|NCT01828892|Autologous platelet rich fibrin glue|autologous platelet rich fibrin glue
309307|NCT01828892|Enterocutaneous fistulas|enterocutaneous fistulas
309308|NCT01828892|Single low output GI fistulas|single low output gi fistulas
309309|NCT01828879|Dermatitis, Atopic|dermatitis, atopic
309310|NCT01828879|Tacrolimus|tacrolimus
309311|NCT01828866|EMDR|emdr
309312|NCT01828866|Alcohol|alcohol
309313|NCT01828866|Relapse|relapse
309314|NCT01828866|Craving|craving
309315|NCT01828853|Membrane sweeping|membrane sweeping
309316|NCT01828853|Membrane stripping|membrane stripping
309317|NCT01828853|Maternal outcomes|maternal outcomes
309318|NCT01828853|Neonatal outcomes|neonatal outcomes
309319|NCT01828840|morphine|morphine
309320|NCT01828840|fentanyl|fentanyl
309321|NCT01828840|methadone|methadone
309322|NCT01828840|epidural|epidural
309323|NCT01828840|intravenous|intravenous
309324|NCT01828840|pain|pain
309325|NCT01828840|analgesia|analgesia
309326|NCT01828827|tuberculosis|tuberculosis
309327|NCT01828827|PK|pk
309328|NCT01828827|PA-824|pa-824
309329|NCT01828827|food effect,|food effect,
309330|NCT01828827|bioavailability|bioavailability
309331|NCT01828827|pretomanid|pretomanid
309332|NCT01828827|CL-003|cl-003
309333|NCT01828814|pediatrics|pediatrics
309334|NCT01828814|Ready-to-use Supplementary Food|ready-to-use supplementary food
309335|NCT01828814|corn soy blend|corn soy blend
309336|NCT01828814|cash transfer|cash transfer
309337|NCT01828814|prevention of malnutrition|prevention of malnutrition
309338|NCT01828814|Niger|niger
309339|NCT01828801|Adverse Local Tissue Reaction|adverse local tissue reaction
309340|NCT01828801|Metal Ions|metal ions
309341|NCT01828801|Serum|serum
309342|NCT01828801|Whole Blood|whole blood
309343|NCT01828801|Metal-on-Metal|metal-on-metal
309344|NCT01828801|Total Hip Arthroplasty|total hip arthroplasty
309345|NCT01828788|Sternotomy|sternotomy
309347|NCT01828788|Post-operative pain|post-operative pain
309348|NCT01828762|DC|dc
309349|NCT01828762|Immunotherapy|immunotherapy
309350|NCT01828762|TC|tc
309351|NCT01828749|blunt abdominal trauma|blunt abdominal trauma
309352|NCT01828749|CT|ct
309353|NCT01828749|radiation exposure, pediatric|radiation exposure, pediatric
309354|NCT01828736|Urothelial carcinoma|urothelial carcinoma
309355|NCT01828736|Trastuzumab|trastuzumab
309356|NCT01828736|Treatment|treatment
309357|NCT01828723|Autologous Adult Stem Cell|autologous adult stem cell
309358|NCT01828723|Adipose Derived Stem Cell|adipose derived stem cell
309359|NCT01828723|Stromal Vascular Fraction|stromal vascular fraction
309360|NCT01828723|SVF|svf
309361|NCT01828723|Antria|antria
309362|NCT01828723|Shah Rahimian|shah rahimian
309363|NCT01828723|Leonard Maliver|leonard maliver
309364|NCT01828723|David Bizousky|david bizousky
309365|NCT01828723|Rahul Gore|rahul gore
309366|NCT01828723|Lee Quist|lee quist
309367|NCT01828723|Dudley McNitt|dudley mcnitt
309368|NCT01828710|Myo-inositol|myo-inositol
309369|NCT01828710|oligoasthenoteratospermia|oligoasthenoteratospermia
309370|NCT01828710|semen parameters|semen parameters
309371|NCT01828710|IVF|ivf
309372|NCT01828697|Low-molecular-weight heparin|low-molecular-weight heparin
309373|NCT01828697|Pregnancy|pregnancy
309374|NCT01828697|Venous thrombosis|venous thrombosis
309375|NCT01828684|Migraine with Aura|migraine with aura
309376|NCT01828684|Migraine without Aura|migraine without aura
309377|NCT01828684|Photophobia|photophobia
309378|NCT01828684|Chronic Daily Headache|chronic daily headache
309379|NCT01828671|Soy|soy
309380|NCT01828671|Corn|corn
309381|NCT01828671|Flour|flour
309382|NCT01828671|Tortilla|tortilla
309383|NCT01828671|Glycemic|glycemic
309384|NCT01828671|Glucose,|glucose,
309385|NCT01828671|glycemic index|glycemic index
309386|NCT01828658|hemodialysis|hemodialysis
309387|NCT01828658|fluid management|fluid management
309388|NCT01828658|bioimpedance|bioimpedance
309389|NCT01828658|mortality|mortality
309390|NCT01828658|arterial stiffness|arterial stiffness
309391|NCT01828645|gastric emptying|gastric emptying
309392|NCT01828645|whey protein|whey protein
309393|NCT01828645|carbohydrate|carbohydrate
309394|NCT01828645|fasting|fasting
309395|NCT01828632|Obesity, Morbid; Hypoxemia; Postoperative complications; Bariatric surgery; Respiratory physical therapy; Preoperative care.|obesity, morbid; hypoxemia; postoperative complications; bariatric surgery; respiratory physical therapy; preoperative care.
309396|NCT01828619|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
309397|NCT01828619|Busulfan|busulfan
309398|NCT01828619|Fludarabine|fludarabine
309399|NCT01828606|leg lymphedema|leg lymphedema
309400|NCT01828606|volume measurement|volume measurement
309401|NCT01828606|compression therapy|compression therapy
309402|NCT01828606|interface pressure|interface pressure
309403|NCT01828606|static stiffness index (SSI)|static stiffness index (ssi)
309404|NCT01828606|volume change|volume change
309405|NCT01828580|laparoscopic Cholecystectomy|laparoscopic cholecystectomy
309406|NCT01828580|Gallbladder removal|gallbladder removal
309407|NCT01828580|laparoscope holder|laparoscope holder
309408|NCT01828567|veterans|veterans
309409|NCT01828567|health risk assessment|health risk assessment
309410|NCT01828567|primary prevention|primary prevention
309411|NCT01828567|shared decision making|shared decision making
309412|NCT01828567|Healthy Living Assessment|healthy living assessment
309413|NCT01828554|Capecitabine pharmacokinetics PK|capecitabine pharmacokinetics pk
309414|NCT01828554|Elevated Body Mass Index (BMI)|elevated body mass index (bmi)
309415|NCT01828554|Advanced Solid Tumors|advanced solid tumors
309416|NCT01828541|Burn injuries|burn injuries
309417|NCT01828528|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
309418|NCT01828528|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
309419|NCT01828528|Obesity|obesity
309420|NCT01828528|Bariatric surgery|bariatric surgery
309421|NCT01828528|Weight loss|weight loss
309422|NCT01828502|Cotinine|cotinine
309423|NCT01828502|Secondhand Smoke Exposure (SHSE)|secondhand smoke exposure (shse)
309424|NCT01828502|Secondhand Smoke (SHS)|secondhand smoke (shs)
309425|NCT01828476|prostate cancer|prostate cancer
309426|NCT01828476|hormone-resistant prostate cancer|hormone-resistant prostate cancer
309427|NCT01828476|recurrent prostate cancer|recurrent prostate cancer
309428|NCT01828476|stage IV prostate cancer|stage iv prostate cancer
309429|NCT01828424|acute pain|acute pain
309430|NCT01828411|Cardiac surgery|cardiac surgery
309431|NCT01828411|Echocardiography|echocardiography
309432|NCT01828411|Cerebral perfusion|cerebral perfusion
309433|NCT01828411|Intraoperative period|intraoperative period
309434|NCT01828385|Physiological Effects of Drugs|physiological effects of drugs
309435|NCT01828385|Rocuronium|rocuronium
309436|NCT01828385|Sugammadex sodium|sugammadex sodium
309437|NCT01828385|Magnesium|magnesium
309438|NCT01828385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
309439|NCT01828385|Neuromuscular block, antagonism|neuromuscular block, antagonism
309440|NCT01828385|Pharmacologic Actions|pharmacologic actions
309441|NCT01828372|concomitant diseases|concomitant diseases
309544|NCT01828021|Relapsed|relapsed
309442|NCT01828372|multiple drug consumption|multiple drug consumption
309443|NCT01828372|therapeutic drug monitoring|therapeutic drug monitoring
309444|NCT01828372|TDM|tdm
309445|NCT01828372|drug monitoring|drug monitoring
309446|NCT01828372|drug level|drug level
309447|NCT01828372|quantification|quantification
309448|NCT01828372|drug|drug
309449|NCT01828372|drug concentration|drug concentration
309450|NCT01828372|concentration|concentration
309451|NCT01828372|therapeutic range|therapeutic range
309452|NCT01828372|therapeutic index|therapeutic index
309453|NCT01828346|TL32711|tl32711
309454|NCT01828346|Birinapant|birinapant
309455|NCT01828346|5-Azacitidine|5-azacitidine
309456|NCT01828346|Myelodysplastic syndrome|myelodysplastic syndrome
309457|NCT01828346|MDS|mds
309458|NCT01828346|Relapsed|relapsed
309459|NCT01828346|Refractory|refractory
309460|NCT01828346|Failed|failed
309461|NCT01828346|open-label|open-label
309462|NCT01828346|non-Randomized|non-randomized
309463|NCT01828346|dose-escalation|dose-escalation
309464|NCT01828346|dose-expansion|dose-expansion
309465|NCT01828333|Malaria|malaria
309466|NCT01828333|Severe|severe
309467|NCT01828333|Artesunate|artesunate
309468|NCT01828333|Quinine|quinine
309469|NCT01828333|Democratic Republic of Congo|democratic republic of congo
309470|NCT01828320|Risk: Emotional, Cognitive, Behavioral, Social, Physical|risk: emotional, cognitive, behavioral, social, physical
309471|NCT01828294|MG|mg
309472|NCT01828268|HIV|hiv
309473|NCT01828268|Metabolomics Fingerprinting|metabolomics fingerprinting
309474|NCT01828242|HbA1C|hba1c
309475|NCT01828229|Inactivity|inactivity
309476|NCT01828229|Obesity|obesity
309477|NCT01828229|Type 2 diabetes|type 2 diabetes
309478|NCT01828229|glucose metabolism|glucose metabolism
309479|NCT01828229|Lipid metabolism|lipid metabolism
309480|NCT01828229|Cognitive function|cognitive function
309481|NCT01828203|minocycline|minocycline
309482|NCT01828203|randomized control trial|randomized control trial
309483|NCT01828203|phase 3|phase 3
309484|NCT01828203|spinal cord injury|spinal cord injury
309485|NCT01828190|crohn's disease|crohn's disease
309486|NCT01828190|perianal fistulas|perianal fistulas
309487|NCT01828190|TNF alpha blockers|tnf alpha blockers
309488|NCT01828190|hyperbaric oxygen therapy|hyperbaric oxygen therapy
309489|NCT01828177|PreCision|precision
309490|NCT01828177|PDI-320|pdi-320
309491|NCT01828177|Foam|foam
309492|NCT01828164|Orthodontics|orthodontics
309493|NCT01828164|Braces|braces
309494|NCT01828164|Tooth|tooth
309495|NCT01828151|Pressure ulcer|pressure ulcer
309496|NCT01828151|Noninvasive ventilation|noninvasive ventilation
309497|NCT01828138|Proteinuria|proteinuria
309498|NCT01828138|Pregnancy|pregnancy
309499|NCT01828138|Hypertension|hypertension
309500|NCT01828138|Plasmin|plasmin
309501|NCT01828138|Plasminogen|plasminogen
309502|NCT01828138|Aldosterone|aldosterone
309503|NCT01828138|Angiotensin|angiotensin
309504|NCT01828138|Renin|renin
309505|NCT01828138|sodium chloride|sodium chloride
309506|NCT01828138|epithelial sodium channel|epithelial sodium channel
309507|NCT01828138|Placenta|placenta
309508|NCT01828125|Type 1 diabetes|type 1 diabetes
309509|NCT01828125|Hypoglycemia|hypoglycemia
309510|NCT01828125|Glucagon|glucagon
309511|NCT01828125|Hypoglycaemic hyperinsulinemic clamp|hypoglycaemic hyperinsulinemic clamp
309512|NCT01828112|Non-Small Cell Lung Cancer|non-small cell lung cancer
309513|NCT01828112|ALK|alk
309514|NCT01828112|LDK378|ldk378
309515|NCT01828112|Non-small cell lung carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
309516|NCT01828112|treatment of lung cancer after first metastasis|treatment of lung cancer after first metastasis
309517|NCT01828112|lung cancer|lung cancer
309518|NCT01828112|lung adenocarcinoma|lung adenocarcinoma
309519|NCT01828112|Non small cell lung carcinoma|non small cell lung carcinoma
309520|NCT01828112|Non small cell lung cancer|non small cell lung cancer
309521|NCT01828112|NSCLC|nsclc
309522|NCT01828112|chemotherapy|chemotherapy
309523|NCT01828112|ALK-positive|alk-positive
309524|NCT01828112|ALK-rearranged advanced non-small cell lung cancer|alk-rearranged advanced non-small cell lung cancer
309525|NCT01828112|crizotinib|crizotinib
309526|NCT01828099|Non-Small Cell Lung Cancer|non-small cell lung cancer
309527|NCT01828099|NSCLC|nsclc
309528|NCT01828099|ALK|alk
309529|NCT01828099|LDK378|ldk378
309530|NCT01828099|Non-small cell lung carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
309531|NCT01828099|treatment of lung cancer after first metastasis|treatment of lung cancer after first metastasis
309532|NCT01828099|lung cancer|lung cancer
309533|NCT01828099|lung adenocarcinoma|lung adenocarcinoma
309534|NCT01828099|Non small cell lung carcinoma|non small cell lung carcinoma
309535|NCT01828099|Non small cell lung cancer|non small cell lung cancer
309536|NCT01828099|non-squamous non-small cell lung cancer|non-squamous non-small cell lung cancer
309537|NCT01828086|Psoriasis, chronic plaque-type psoriasis, IL17, monoclonal antibody|psoriasis, chronic plaque-type psoriasis, il17, monoclonal antibody
309538|NCT01828034|Gemcitabine|gemcitabine
309539|NCT01828034|Cisplatin|cisplatin
309540|NCT01828034|MEK162|mek162
309541|NCT01828034|13-004|13-004
309542|NCT01828021|HER2 2+|her2 2+
309543|NCT01828021|FISH non-amplified|fish non-amplified
309545|NCT01828021|Refractory|refractory
309546|NCT01828021|Advanced|advanced
309547|NCT01828021|Margetuximab|margetuximab
309548|NCT01828021|MGAH22|mgah22
309549|NCT01828008|Mabthera|mabthera
309550|NCT01828008|cytokine induced killer cell|cytokine induced killer cell
309551|NCT01827995|Low sensitivity urinary hCG|low sensitivity urinary hcg
309552|NCT01827995|follow up|follow up
309553|NCT01827995|medical abortion|medical abortion
309554|NCT01827995|rural India|rural india
309555|NCT01827995|RCT|rct
309556|NCT01827982|Healthy|healthy
309557|NCT01827982|Safety|safety
309558|NCT01827982|Tolerability|tolerability
309559|NCT01827982|Pharmacokinetic|pharmacokinetic
309560|NCT01827982|Alzheimer's Disease|alzheimer's disease
309561|NCT01827982|JNJ-54861911|jnj-54861911
309562|NCT01827969|Women|women
309563|NCT01827969|breast tumor|breast tumor
309564|NCT01827969|planned mastectomy|planned mastectomy
309565|NCT01827956|Upper aero-digestive tract tumours|upper aero-digestive tract tumours
309566|NCT01827956|FCGR3A and FCGR2A receptor polymorphism|fcgr3a and fcgr2a receptor polymorphism
309567|NCT01827956|Cetuximab efficacy|cetuximab efficacy
309568|NCT01827943|Relapsed bladder cancer|relapsed bladder cancer
309569|NCT01827930|chronic myeloid leukemia in chronic phase|chronic myeloid leukemia in chronic phase
309570|NCT01827904|ExAblate Transcranial MRgFUS|exablate transcranial mrgfus
309571|NCT01827891|acute kidney injury|acute kidney injury
309572|NCT01827891|percutaneous coronary intervention|percutaneous coronary intervention
309573|NCT01827891|remote ischemic preconditioning|remote ischemic preconditioning
309574|NCT01827839|Adults|adults
309575|NCT01827839|Safety|safety
309576|NCT01827839|Immunogenicity|immunogenicity
309577|NCT01827839|Zoster|zoster
309578|NCT01827826|Intervention|intervention
309579|NCT01827826|Telephone|telephone
309580|NCT01827826|Diabetes|diabetes
309581|NCT01827826|Prevention|prevention
309582|NCT01827813|prostate-specific antigen|prostate-specific antigen
309583|NCT01827813|digital rectal examination|digital rectal examination
309584|NCT01827813|transrectal ultrasonography|transrectal ultrasonography
309585|NCT01827813|needle biopsy|needle biopsy
309586|NCT01827813|prostate cancer|prostate cancer
309587|NCT01827800|weight loss|weight loss
309588|NCT01827800|primary care|primary care
309589|NCT01827800|eHealth|ehealth
309590|NCT01827774|Pelvic organ prolapse|pelvic organ prolapse
309591|NCT01827774|Graft repair|graft repair
309592|NCT01827761|chemotherapy teaching|chemotherapy teaching
309593|NCT01827761|questionnaire|questionnaire
309594|NCT01827748|Autorefractor|autorefractor
309595|NCT01827735|Interleukin 2|interleukin 2
309596|NCT01827735|Type 1 diabetes|type 1 diabetes
309597|NCT01827735|T regulatory cells|t regulatory cells
309598|NCT01827735|Adaptive trial|adaptive trial
309599|NCT01827722|Macular edema|macular edema
309600|NCT01827722|Central retinal vein occlusion|central retinal vein occlusion
309601|NCT01827722|CRVO|crvo
309602|NCT01827722|Retinal vein occlusion|retinal vein occlusion
309603|NCT01827722|RVO|rvo
309604|NCT01827722|Ozurdex|ozurdex
309605|NCT01827722|Dexamethasone intravitreal implant|dexamethasone intravitreal implant
309606|NCT01827722|Lucentis|lucentis
309607|NCT01827722|Ranibizumab|ranibizumab
309608|NCT01827709|DWI|dwi
309609|NCT01827709|ADC|adc
309610|NCT01827709|DCE-MRI|dce-mri
309611|NCT01827709|FDG-PET|fdg-pet
309612|NCT01827709|SUV|suv
309613|NCT01827709|Hypoxia|hypoxia
309614|NCT01827709|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
309615|NCT01827696|Muscle|muscle
309616|NCT01827696|Soreness|soreness
309617|NCT01827696|Muscle function|muscle function
309618|NCT01827696|Damage|damage
309619|NCT01827696|Ginseng|ginseng
309620|NCT01827683|hyperbaric oxygen|hyperbaric oxygen
309621|NCT01827683|fibromyalgia|fibromyalgia
309622|NCT01827683|chronic pain syndrome|chronic pain syndrome
309623|NCT01827657|plasma|plasma
309624|NCT01827657|tolerability|tolerability
309625|NCT01827657|safety|safety
309626|NCT01827657|matched control|matched control
309627|NCT01827657|GSK2336805|gsk2336805
309628|NCT01827657|hepatic impairment|hepatic impairment
309629|NCT01827657|pharmacokinetics|pharmacokinetics
309630|NCT01827644|AKT inhibitor|akt inhibitor
309631|NCT01827644|formulation|formulation
309632|NCT01827644|food effect|food effect
309633|NCT01827644|bioavailability|bioavailability
309634|NCT01827644|GSK2110183|gsk2110183
309635|NCT01827631|healthy|healthy
309636|NCT01827631|GSK1605786|gsk1605786
309637|NCT01827631|CCR9 receptor antagonist|ccr9 receptor antagonist
309638|NCT01827631|Chinese subjects|chinese subjects
309639|NCT01827631|pharmacokinetics|pharmacokinetics
309640|NCT01827618|bladder|bladder
309641|NCT01827618|Cancer|cancer
309642|NCT01827618|Cystectomy|cystectomy
309643|NCT01827618|Rapamycin|rapamycin
309644|NCT01827605|Relapsed follicular Lymphoma|relapsed follicular lymphoma
309645|NCT01827605|RIT|rit
309646|NCT01827605|Zevalin|zevalin
309647|NCT01827579|Transplant|transplant
309648|NCT01827579|CD25/71 allodepleted donor T cells|cd25/71 allodepleted donor t cells
309649|NCT01827579|Infection|infection
309650|NCT01827579|Acute Myeloid Leukaemia|acute myeloid leukaemia
309651|NCT01827579|Acute Lymphoblastic Leukaemia|acute lymphoblastic leukaemia
309652|NCT01827579|Adult|adult
309653|NCT01827579|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
309654|NCT01827579|Mantle Cell Lymphoma|mantle cell lymphoma
309655|NCT01827566|Celiac Disease|celiac disease
309656|NCT01827566|Gluten Sensitivity|gluten sensitivity
309657|NCT01827566|Gluten|gluten
309658|NCT01827566|Double-blind challenge, placebo-controlled challenge|double-blind challenge, placebo-controlled challenge
309659|NCT01827566|Gluten free flour|gluten free flour
309660|NCT01827553|pancreatic cancer|pancreatic cancer
309661|NCT01827553|chemoradiotherapy|chemoradiotherapy
309662|NCT01827553|chemotherapy|chemotherapy
309663|NCT01827553|FOLFIRINOX|folfirinox
309664|NCT01827553|gemcitabine|gemcitabine
309665|NCT01827540|HIV/AIDS|hiv/aids
309666|NCT01827540|Cenicriviroc (CVC)|cenicriviroc (cvc)
309667|NCT01827540|Dolutegravir (DTG)|dolutegravir (dtg)
309668|NCT01827540|Midazolam|midazolam
309669|NCT01827540|Healthy Subjects|healthy subjects
309670|NCT01827527|Adenosine Triphosphate|adenosine triphosphate
309671|NCT01827527|Validation|validation
309672|NCT01827527|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
309673|NCT01827527|Optical Spectroscopy|optical spectroscopy
309674|NCT01827514|cancer, erythropoetin|cancer, erythropoetin
309675|NCT01827501|postoperative delirium|postoperative delirium
309676|NCT01827501|hemodynamic management|hemodynamic management
309677|NCT01827501|goal directed therapy|goal directed therapy
309678|NCT01827475|musculoskeletal pain|musculoskeletal pain
309679|NCT01827475|acetaminophen|acetaminophen
309680|NCT01827475|ibuprofen|ibuprofen
309681|NCT01827462|Inactivated, trivalent influenza vaccine|inactivated, trivalent influenza vaccine
309682|NCT01827462|elderly|elderly
309683|NCT01827462|immunosenescence|immunosenescence
309684|NCT01827462|longitudinal study|longitudinal study
309685|NCT01827462|Inactivated, High-Dose trivalent influenza vaccine|inactivated, high-dose trivalent influenza vaccine
309686|NCT01827462|Inactivated, quadrivalent influenza vaccine|inactivated, quadrivalent influenza vaccine
309687|NCT01827462|young adults|young adults
309688|NCT01827449|rewarming|rewarming
309689|NCT01827449|core cooling|core cooling
309690|NCT01827449|afterdrop|afterdrop
309691|NCT01827449|hospital treatment|hospital treatment
309692|NCT01827449|hypothermia|hypothermia
309693|NCT01827436|pediatric stroke|pediatric stroke
309694|NCT01827436|hemiplegia|hemiplegia
309695|NCT01827436|physical therapy|physical therapy
309696|NCT01827436|gait training|gait training
309697|NCT01827436|transcranial magnetic stimulation|transcranial magnetic stimulation
309698|NCT01827436|gait asymmetry|gait asymmetry
309699|NCT01827423|squamous cell carcinoma antigen|squamous cell carcinoma antigen
309700|NCT01827423|sinonasal inverted papilloma|sinonasal inverted papilloma
309701|NCT01827423|clinical marker|clinical marker
309702|NCT01827423|hidden reccurence|hidden reccurence
309703|NCT01827423|surgery|surgery
309704|NCT01827397|Safety of this HIV vaccine|safety of this hiv vaccine
309705|NCT01827371|Smallpox, vaccine, IMVAMUNE, Stratis, parent protocol|smallpox, vaccine, imvamune, stratis, parent protocol
309706|NCT01827358|antibacterial agent|antibacterial agent
309707|NCT01827358|children|children
309708|NCT01827358|colonisation|colonisation
309709|NCT01827358|critically ill|critically ill
309710|NCT01827358|infants|infants
309711|NCT01827358|mupirocin|mupirocin
309712|NCT01827358|prevention|prevention
309713|NCT01827358|Staphylococcus aureus|staphylococcus aureus
309714|NCT01827345|Vitamin D|vitamin d
309715|NCT01827345|Falls|falls
309716|NCT01827345|Balance|balance
309717|NCT01827345|Physical Function|physical function
309718|NCT01827332|marijuana|marijuana
309719|NCT01827332|substance abuse|substance abuse
309720|NCT01827332|drug abuse|drug abuse
309721|NCT01827332|marijuana dependence|marijuana dependence
309722|NCT01827332|drug addiction|drug addiction
309723|NCT01827319|Angina|angina
309724|NCT01827319|Transmyocardial revascularization|transmyocardial revascularization
309725|NCT01827280|endothelial function|endothelial function
309726|NCT01827280|microvascular function|microvascular function
309727|NCT01827280|incretins|incretins
309728|NCT01827280|diabetes mellitus|diabetes mellitus
309729|NCT01827280|postprandial lipemia|postprandial lipemia
309730|NCT01827267|Lung cancer|lung cancer
309731|NCT01827267|Puma|puma
309732|NCT01827267|neratinib|neratinib
309733|NCT01827267|HKI-272|hki-272
309734|NCT01827267|PB-272|pb-272
309735|NCT01827267|Nerlynx|nerlynx
309736|NCT01827254|sutent rechallenge|sutent rechallenge
309737|NCT01827241|Gastroenterology|gastroenterology
309738|NCT01827241|Colonoscopy|colonoscopy
309739|NCT01827241|Screening|screening
309740|NCT01827241|Surveillance|surveillance
309741|NCT01827241|Symptom evaluation|symptom evaluation
309742|NCT01827241|Chart review|chart review
309743|NCT01827241|Data review|data review
309744|NCT01827241|Examination findings|examination findings
309745|NCT01827241|Resection techniques|resection techniques
309746|NCT01827241|Pathology reports|pathology reports
309747|NCT01827228|HIV|hiv
309748|NCT01827228|transmission prevention|transmission prevention
310044|NCT01825681|stress|stress
309749|NCT01827228|social network and venue|social network and venue
309750|NCT01827228|community intervention|community intervention
309751|NCT01827228|treatment as prevention|treatment as prevention
309752|NCT01827228|recent infection|recent infection
309753|NCT01827228|phylogenetics|phylogenetics
309754|NCT01827228|infection chains|infection chains
309755|NCT01827215|Preconception Care|preconception care
309756|NCT01827215|Racial Disparities|racial disparities
309757|NCT01827215|Health Information Technology|health information technology
309758|NCT01827202|renin-angiotensin-system|renin-angiotensin-system
309759|NCT01827202|RAS blockade|ras blockade
309760|NCT01827189|primary care, Medicare costs, hospitalizations|primary care, medicare costs, hospitalizations
309761|NCT01827176|Characteristic|characteristic
309762|NCT01827176|Recurrent Acute Rhinosinusitis|recurrent acute rhinosinusitis
309763|NCT01827176|Children|children
309764|NCT01827163|Paclitaxel|paclitaxel
309765|NCT01827163|Trastuzumab|trastuzumab
309766|NCT01827163|Lapatinib|lapatinib
309767|NCT01827163|HER2|her2
309768|NCT01827163|13-002|13-002
309769|NCT01827137|WT1 Analog Peptide Vaccine|wt1 analog peptide vaccine
309770|NCT01827137|12-288|12-288
309771|NCT01827124|CARBETOCIN AND OXYTOCIN AND SECOND TRIMESTER INTERRUPTION|carbetocin and oxytocin and second trimester interruption
309772|NCT01827111|Melanoma|melanoma
309773|NCT01827111|Metastatic Melanoma|metastatic melanoma
309774|NCT01827111|Advanced stage IV melanoma|advanced stage iv melanoma
309775|NCT01827111|Unresectable stage III mucosal melanoma|unresectable stage iii mucosal melanoma
309776|NCT01827111|Cutaneous melanoma|cutaneous melanoma
309777|NCT01827111|Progression-free survival|progression-free survival
309778|NCT01827111|(PFS)|(pfs)
309779|NCT01827111|ABI-007|abi-007
309780|NCT01827111|Nab-paclitaxel|nab-paclitaxel
309781|NCT01827111|Paclitaxel|paclitaxel
309782|NCT01827111|Abraxane|abraxane
309783|NCT01827111|Ipilimumab|ipilimumab
309784|NCT01827111|Yervoy|yervoy
309785|NCT01827111|BMS-734016|bms-734016
309786|NCT01827111|MDX010|mdx010
309787|NCT01827098|Immature teeth|immature teeth
309788|NCT01827098|Calcium Hydroxide|calcium hydroxide
309789|NCT01827098|Blood clot|blood clot
309790|NCT01827098|Revascularization|revascularization
309791|NCT01827098|Revitalization|revitalization
309792|NCT01827072|IVIG in Multifocal Motor Neuropathy|ivig in multifocal motor neuropathy
309793|NCT01827072|Patients with Multifocal Motor Neuropathy|patients with multifocal motor neuropathy
309794|NCT01827046|intracerebral hemorrhage|intracerebral hemorrhage
309795|NCT01827046|ICH|ich
309796|NCT01827046|brain hemorrhage|brain hemorrhage
309797|NCT01827046|minimally invasive surgery|minimally invasive surgery
309798|NCT01827046|rt-PA|rt-pa
309799|NCT01827007|norepinephrine infusion|norepinephrine infusion
309800|NCT01827007|under 48 hours in ICU|under 48 hours in icu
309801|NCT01826968|Lung recruitment, cesarean, lung compliance, atelectasis|lung recruitment, cesarean, lung compliance, atelectasis
309802|NCT01826955|pneumoperitoneum, cognitive function|pneumoperitoneum, cognitive function
309803|NCT01826942|Scar prevention|scar prevention
309804|NCT01826942|CO2 fractional laser|co2 fractional laser
309805|NCT01826929|Health Services Research|health services research
309806|NCT01826929|Cardiovascular Diseases|cardiovascular diseases
309807|NCT01826929|Primary Care|primary care
309808|NCT01826929|Secondary Prevention.|secondary prevention.
309809|NCT01826903|Depression|depression
309810|NCT01826903|Cognitive Behavior Therapy|cognitive behavior therapy
309811|NCT01826903|Child Development|child development
309812|NCT01826890|Ventilator Weaning|ventilator weaning
309813|NCT01826890|Mechanical Ventilation|mechanical ventilation
309814|NCT01826890|Critical Care|critical care
309815|NCT01826890|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
309816|NCT01826890|Diaphragm|diaphragm
309817|NCT01826851|Pain management|pain management
309818|NCT01826851|Anesthetic, local|anesthetic, local
309819|NCT01826851|Nerve blockade|nerve blockade
309820|NCT01826851|Coronary Artery Bypass Surgery|coronary artery bypass surgery
309821|NCT01826851|Analgesics, opioid|analgesics, opioid
309822|NCT01826851|Postoperative complications|postoperative complications
309823|NCT01826851|Bupivacaine|bupivacaine
309824|NCT01826838|Prostate Cancer|prostate cancer
309825|NCT01826825|aging|aging
309826|NCT01826825|cognition|cognition
309827|NCT01826825|surgery|surgery
309828|NCT01826799|sleep|sleep
309829|NCT01826799|noise|noise
309830|NCT01826799|ICU|icu
309831|NCT01826799|delirium|delirium
309832|NCT01826799|RCSQ|rcsq
309833|NCT01826786|Healthy|healthy
309834|NCT01826786|Anxiety Disorders|anxiety disorders
309835|NCT01826786|Anxiety Modulation|anxiety modulation
309836|NCT01826786|Male|male
309837|NCT01826773|CardioPET|cardiopet
309838|NCT01826773|Coronary Artery Disease|coronary artery disease
309839|NCT01826773|Myocardial Perfusion Imaging|myocardial perfusion imaging
309840|NCT01826773|Coronary Angiography|coronary angiography
309841|NCT01826773|Myocardial Fatty Acid Utilization|myocardial fatty acid utilization
309842|NCT01826747|intrauterine insemination|intrauterine insemination
309843|NCT01826747|luteal phase|luteal phase
309844|NCT01826747|gonadotrophins|gonadotrophins
309845|NCT01826734|dacryolith|dacryolith
309846|NCT01826734|dacryocystorhinostomy|dacryocystorhinostomy
309847|NCT01826734|composition|composition
309848|NCT01826734|chemical analysis|chemical analysis
309849|NCT01826734|infrared spectrometry|infrared spectrometry
309850|NCT01826734|scanning electron microscopy|scanning electron microscopy
309851|NCT01826734|elemental analysis|elemental analysis
309852|NCT01826721|Solid organ transplantation|solid organ transplantation
309853|NCT01826721|Immunosuppression|immunosuppression
309854|NCT01826721|Education|education
309855|NCT01826721|E-learning|e-learning
309856|NCT01826721|Medication knowledge|medication knowledge
309857|NCT01826721|Patient satisfaction|patient satisfaction
309858|NCT01826721|Medication adherence|medication adherence
309859|NCT01826708|Chromosomal translocations|chromosomal translocations
309860|NCT01826708|psychomotor delay|psychomotor delay
309861|NCT01826695|Fibromyalgia, neurodynamic, dexterity|fibromyalgia, neurodynamic, dexterity
309862|NCT01826682|COPD, physiotherapy, exacerbation|copd, physiotherapy, exacerbation
309863|NCT01826656|intramembranous bone healing|intramembranous bone healing
309864|NCT01826656|post-menopausal osteoporosis|post-menopausal osteoporosis
309865|NCT01826656|tooth extraction|tooth extraction
309866|NCT01826630|CLn Body Wash|cln body wash
309867|NCT01826630|CLn BodyWash|cln bodywash
309868|NCT01826617|Prostate Disease Nomogram|prostate disease nomogram
309869|NCT01826617|Asian Men|asian men
309870|NCT01826604|cesarean section|cesarean section
309871|NCT01826604|Pregnant|pregnant
309872|NCT01826565|success|success
309873|NCT01826552|Orsiro hybrid stent|orsiro hybrid stent
309874|NCT01826552|Drug-eluting stent|drug-eluting stent
309875|NCT01826552|Zotarolimus-eluting stent|zotarolimus-eluting stent
309876|NCT01826552|Coronary heart disease|coronary heart disease
309877|NCT01826552|Cobalt chromium|cobalt chromium
309878|NCT01826539|Dorsal digital nerve|dorsal digital nerve
309879|NCT01826539|dorsal branch of the digital nerve|dorsal branch of the digital nerve
309880|NCT01826539|dorsal branch of the digital artery|dorsal branch of the digital artery
309881|NCT01826539|dorsal digital island flap|dorsal digital island flap
309882|NCT01826539|finger pulp defect.|finger pulp defect.
309883|NCT01826513|Obstructive sleep apnea|obstructive sleep apnea
309884|NCT01826513|Efficacy|efficacy
309885|NCT01826513|Subjective feedback|subjective feedback
309886|NCT01826513|Preference|preference
309887|NCT01826500|embryo transfer|embryo transfer
309888|NCT01826500|IVF cycle|ivf cycle
309889|NCT01826500|endometriosis|endometriosis
309890|NCT01826487|Duchenne muscular dystrophy|duchenne muscular dystrophy
309891|NCT01826487|Dystrophinopathy|dystrophinopathy
309892|NCT01826487|Nonsense mutation|nonsense mutation
309893|NCT01826487|Premature stop codon|premature stop codon
309894|NCT01826487|Becker muscular dystrophy|becker muscular dystrophy
309895|NCT01826487|DMD/BMD|dmd/bmd
309896|NCT01826487|PTC124|ptc124
309897|NCT01826487|Ataluren|ataluren
309898|NCT01826474|Duchenne muscular dystrophy|duchenne muscular dystrophy
309899|NCT01826474|DMD|dmd
309900|NCT01826474|Prosensa|prosensa
309901|NCT01826474|Duchenne|duchenne
309902|NCT01826461|atopic dermatitis|atopic dermatitis
309903|NCT01826461|eczema|eczema
309904|NCT01826461|PDI-192|pdi-192
309905|NCT01826461|Precision|precision
309906|NCT01826422|Muscular Dystrophy|muscular dystrophy
309907|NCT01826422|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
309908|NCT01826422|Becker Muscular Dystrophy|becker muscular dystrophy
309909|NCT01826422|Omega 3|omega 3
309910|NCT01826422|Eicosapentaenoic fatty acid|eicosapentaenoic fatty acid
309911|NCT01826422|Docosahexaenoic fatty acid|docosahexaenoic fatty acid
309912|NCT01826383|Infant|infant
309913|NCT01826383|Immunization|immunization
309914|NCT01826357|metabolic syndrome|metabolic syndrome
309915|NCT01826357|cluster analysis|cluster analysis
309916|NCT01826357|PCOS|pcos
309917|NCT01826318|Stress|stress
309918|NCT01826318|coping|coping
309919|NCT01826318|simulation|simulation
309920|NCT01826292|Post anesthesia care unit length of stay|post anesthesia care unit length of stay
309921|NCT01826279|Obesity|obesity
309922|NCT01826279|Gastric bypass surgery|gastric bypass surgery
309923|NCT01826279|Resveratrol|resveratrol
309924|NCT01826279|Insulin sensitivity|insulin sensitivity
309925|NCT01826279|Lipid turnover|lipid turnover
309926|NCT01826279|VLDL-triglyceride uptake|vldl-triglyceride uptake
309927|NCT01826279|Liver|liver
309928|NCT01826266|PER977|per977
309929|NCT01826266|Activated partial thromboplastin time|activated partial thromboplastin time
309930|NCT01826266|Assessment|assessment
309931|NCT01826266|D-dimer|d-dimer
309932|NCT01826266|Enrollment|enrollment
309933|NCT01826266|Investigational drug|investigational drug
309934|NCT01826266|Investigational treatment|investigational treatment
309935|NCT01826266|Period|period
309936|NCT01826266|Premature subject withdrawal|premature subject withdrawal
309937|NCT01826266|Prothrombin time|prothrombin time
309938|NCT01826266|Randomization number|randomization number
309939|NCT01826266|Study discontinuation|study discontinuation
309940|NCT01826266|Study drug|study drug
309941|NCT01826266|Subject number|subject number
309942|NCT01826266|Study treatment|study treatment
310045|NCT01825681|mood|mood
309943|NCT01826266|Thromboelastography-reaction time|thromboelastography-reaction time
309944|NCT01826253|Hypovolemia|hypovolemia
309945|NCT01826253|Fluid challenge|fluid challenge
309946|NCT01826253|Fluid expansion|fluid expansion
309947|NCT01826253|Oxygene delivery|oxygene delivery
309948|NCT01826253|Cardiac output|cardiac output
309949|NCT01826227|PET (Positron Emission Tomography)|pet (positron emission tomography)
309950|NCT01826227|18F-FDG|18f-fdg
309951|NCT01826227|Cytoreductive Surgery|cytoreductive surgery
309952|NCT01826227|13-017|13-017
309953|NCT01826214|acute myeloid leukemia|acute myeloid leukemia
309954|NCT01826214|AML|aml
309955|NCT01826214|acute lymphoblastic leukemia|acute lymphoblastic leukemia
309956|NCT01826214|ALL|all
309957|NCT01826214|leukemia|leukemia
309958|NCT01826214|acute|acute
309959|NCT01826214|LDE225|lde225
309960|NCT01826214|adult patients|adult patients
309961|NCT01826214|relapsed/refractory|relapsed/refractory
309962|NCT01826201|psoriasis|psoriasis
309963|NCT01826188|Crohn's disease|crohn's disease
309964|NCT01826188|IBD Cannabis|ibd cannabis
309965|NCT01826188|THC|thc
309966|NCT01826188|CBD|cbd
309967|NCT01826175|Optical Coherence Tomography|optical coherence tomography
309968|NCT01826175|ticagrelor|ticagrelor
309969|NCT01826175|clopidogrel|clopidogrel
309970|NCT01826123|Coagulopathy|coagulopathy
309971|NCT01826123|Hemorrhage|hemorrhage
309972|NCT01826123|Cardiac surgery|cardiac surgery
309973|NCT01826123|Point-of-Care testing|point-of-care testing
309974|NCT01826123|POC|poc
309975|NCT01826123|ROTEM|rotem
309976|NCT01826123|multiplate|multiplate
309977|NCT01826123|Multiple electrode aggregometry (MEA)|multiple electrode aggregometry (mea)
309978|NCT01826097|Cytology|cytology
309979|NCT01826097|Whole body massage vibration|whole body massage vibration
309980|NCT01826071|Osgood-Schlatter syndrome (OSS)|osgood-schlatter syndrome (oss)
309981|NCT01826071|Sinding-Larsen and Johansson syndrome (SLJ)|sinding-larsen and johansson syndrome (slj)
309982|NCT01826071|Sever's disease|sever's disease
309983|NCT01826071|apophysitis|apophysitis
309984|NCT01826058|Stereotactic body radiation therapy|stereotactic body radiation therapy
309985|NCT01826058|Radiosurgery|radiosurgery
309986|NCT01826045|Treatment of Cervical Intraepithelial Neoplasia(CIN1)|treatment of cervical intraepithelial neoplasia(cin1)
309987|NCT01826006|Myocardial Infarction|myocardial infarction
309988|NCT01826006|No-reflow|no-reflow
309989|NCT01826006|Primary PCI|primary pci
309990|NCT01826006|Coronary no-reflow phenomenon|coronary no-reflow phenomenon
309991|NCT01826006|Primary percoutaneous coronary intervention (primary PCI)|primary percoutaneous coronary intervention (primary pci)
309992|NCT01825993|Peridural catheter|peridural catheter
309993|NCT01825993|Morphine PCA|morphine pca
309994|NCT01825993|Transabdominal Block|transabdominal block
309995|NCT01825993|laparoscopic sigmoidectomy|laparoscopic sigmoidectomy
309996|NCT01825954|Fibromyalgia|fibromyalgia
309997|NCT01825954|Pain|pain
309998|NCT01825954|Brain|brain
309999|NCT01825954|Stimulation|stimulation
310000|NCT01825954|Device|device
310001|NCT01825941|migraine|migraine
310002|NCT01825941|headache|headache
310003|NCT01825941|metoclopramide|metoclopramide
310004|NCT01825941|diphenhydramine|diphenhydramine
310005|NCT01825928|Methamphetamine|methamphetamine
310006|NCT01825928|paliperidone|paliperidone
310007|NCT01825915|Laparoscopic|laparoscopic
310008|NCT01825915|Hysterectomy|hysterectomy
310009|NCT01825915|Total|total
310010|NCT01825915|Subtotal|subtotal
310011|NCT01825915|Recovery|recovery
310012|NCT01825915|Outcomes|outcomes
310013|NCT01825915|Surgery|surgery
310014|NCT01825863|Laparoscopy|laparoscopy
310015|NCT01825863|Adult|adult
310016|NCT01825863|Nerve block|nerve block
310017|NCT01825863|Ultrasonography|ultrasonography
310018|NCT01825837|bipolar I disorder|bipolar i disorder
310019|NCT01825837|Eslicarbazepine acetate|eslicarbazepine acetate
310020|NCT01825837|BIA 2-093|bia 2-093
310021|NCT01825824|Hepatocellular carcinoma|hepatocellular carcinoma
310022|NCT01825824|Stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
310023|NCT01825824|Stereotactic body radiotherapy|stereotactic body radiotherapy
310024|NCT01825811|Cell mediated gene therapy|cell mediated gene therapy
310025|NCT01825811|Osteoarthritis|osteoarthritis
310026|NCT01825811|Fibrin-glue|fibrin-glue
310027|NCT01825811|Degenerative Arthritis|degenerative arthritis
310028|NCT01825798|Metformin|metformin
310029|NCT01825798|Overweight|overweight
310030|NCT01825798|Atypical Antipsychotic|atypical antipsychotic
310031|NCT01825798|Medication|medication
310032|NCT01825798|Randomized Clinical Trial|randomized clinical trial
310033|NCT01825798|Children|children
310034|NCT01825772|Cross-Sectional Studies|cross-sectional studies
310035|NCT01825772|Prevalence|prevalence
310036|NCT01825772|Peri-Implantitis|peri-implantitis
310037|NCT01825733|palonosetron, ramosetron, PONV, opioid|palonosetron, ramosetron, ponv, opioid
310038|NCT01825720|GIK, valvular heart surgery, lactate|gik, valvular heart surgery, lactate
310039|NCT01825694|Substance Abuse|substance abuse
310040|NCT01825694|Traumatic Stress|traumatic stress
310041|NCT01825681|positive affect|positive affect
310042|NCT01825681|caregivers|caregivers
310043|NCT01825681|caregiving|caregiving
310046|NCT01825681|dementia|dementia
310047|NCT01825681|Alzheimer's|alzheimer's
310048|NCT01825681|FTD|ftd
310049|NCT01825681|Lewy|lewy
310050|NCT01825681|mindfulness|mindfulness
310051|NCT01825681|help|help
310052|NCT01825642|Prostate cancer|prostate cancer
310053|NCT01825642|sexual function|sexual function
310054|NCT01825642|seminal vesicle sparing|seminal vesicle sparing
310055|NCT01825642|nerve-sparing|nerve-sparing
310056|NCT01825642|radical prostatectomy|radical prostatectomy
310057|NCT01825629|Pain|pain
310058|NCT01825629|Temporomandibular joint|temporomandibular joint
310059|NCT01825629|Manual therapy|manual therapy
310060|NCT01825629|Physical therapy|physical therapy
310061|NCT01825629|Fibromyalgia Syndrome|fibromyalgia syndrome
310062|NCT01825616|Strength|strength
310063|NCT01825616|Anaerobic power|anaerobic power
310064|NCT01825616|Muscle soreness|muscle soreness
310065|NCT01825616|Immune function|immune function
310066|NCT01825590|hemodialysis|hemodialysis
310067|NCT01825590|dialysate and serum sodium|dialysate and serum sodium
310068|NCT01825577|Alzheimer Dementia|alzheimer dementia
310069|NCT01825577|Gait|gait
310070|NCT01825564|G-tube|g-tube
310071|NCT01825564|Feeding tube|feeding tube
310072|NCT01825564|Feeding tube placement verification|feeding tube placement verification
310073|NCT01825564|Enteral feeding|enteral feeding
310074|NCT01825551|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
310075|NCT01825551|Granulocyte Colony Stimulating Factor|granulocyte colony stimulating factor
310076|NCT01825538|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
310077|NCT01825538|Pulmonary fibrosis|pulmonary fibrosis
310078|NCT01825538|Advanced care planning|advanced care planning
310079|NCT01825512|chronic iron overload|chronic iron overload
310080|NCT01825512|hereditary haemoglobinopathy|hereditary haemoglobinopathy
310081|NCT01825512|beta thalassaemia major|beta thalassaemia major
310082|NCT01825512|chelating agents|chelating agents
310083|NCT01825512|deferiprone|deferiprone
310084|NCT01825512|deferasirox|deferasirox
310085|NCT01825512|children|children
310086|NCT01825512|paediatrics|paediatrics
310087|NCT01825499|Birth weight|birth weight
310088|NCT01825499|Gestational age|gestational age
310089|NCT01825499|Very low birth weight|very low birth weight
310090|NCT01825486|Balance|balance
310091|NCT01825486|Gait characteristics|gait characteristics
310092|NCT01825473|neonate|neonate
310093|NCT01825473|apnea|apnea
310094|NCT01825473|preterm|preterm
310095|NCT01825473|reflux|reflux
310096|NCT01825473|gastroesophageal reflux|gastroesophageal reflux
310097|NCT01825473|impedance|impedance
310098|NCT01825473|erythromycin|erythromycin
310099|NCT01825473|desaturation|desaturation
310100|NCT01825473|bradycardia|bradycardia
310101|NCT01825473|hypoxia|hypoxia
310102|NCT01825460|Cervical spine|cervical spine
310103|NCT01825460|Neck pain|neck pain
310104|NCT01825460|Manual therapy|manual therapy
310105|NCT01825460|Controlled clinical trial|controlled clinical trial
310106|NCT01825447|abuse potential|abuse potential
310107|NCT01825447|abuse liability|abuse liability
310108|NCT01825447|drug liking|drug liking
310109|NCT01825447|oxycodone|oxycodone
310110|NCT01825447|naltrexone|naltrexone
310111|NCT01825447|intravenous|intravenous
310112|NCT01825447|pharmacodynamic|pharmacodynamic
310113|NCT01825434|chronic constipation|chronic constipation
310114|NCT01825434|Lactobacillus acidophilus NCFM|lactobacillus acidophilus ncfm
310115|NCT01825434|Bifidobacterium lactis HN019|bifidobacterium lactis hn019
310116|NCT01825421|Infant|infant
310117|NCT01825421|Infection|infection
310118|NCT01825421|Newborn|newborn
310119|NCT01825421|Antibiotics|antibiotics
310120|NCT01825421|Neutrophil CD64|neutrophil cd64
310121|NCT01825421|Blood Culture|blood culture
310122|NCT01825369|congenital heart disease|congenital heart disease
310123|NCT01825369|ventricular septal defect|ventricular septal defect
310124|NCT01825369|atrioventricular septal defect|atrioventricular septal defect
310125|NCT01825369|increased pulmonary blood flow|increased pulmonary blood flow
310126|NCT01825369|nitric oxide|nitric oxide
310127|NCT01825343|fall|fall
310128|NCT01825343|burn|burn
310129|NCT01825343|road traffic crash|road traffic crash
310130|NCT01825330|Alzheimer's Disease|alzheimer's disease
310131|NCT01825330|Alzheimer's|alzheimer's
310132|NCT01825330|TMS|tms
310133|NCT01825330|Cognitive Training|cognitive training
310134|NCT01825330|NeuroAD|neuroad
310135|NCT01825317|Alzheimer's disease|alzheimer's disease
310136|NCT01825317|TMS|tms
310137|NCT01825317|NeuroAd|neuroad
310138|NCT01825317|cognitive training|cognitive training
310139|NCT01825317|ADAS-Cog|adas-cog
310140|NCT01825304|mechanical ventilation|mechanical ventilation
310141|NCT01825304|Intra-abdominal hypertension|intra-abdominal hypertension
310142|NCT01825304|positive end-expiratory pressure|positive end-expiratory pressure
310143|NCT01825291|sleep apnea|sleep apnea
310144|NCT01825291|co-morbidities of sleep apnea|co-morbidities of sleep apnea
310145|NCT01825291|CPAP treatment|cpap treatment
310146|NCT01825278|respiratory rate|respiratory rate
310147|NCT01825278|tidal volume|tidal volume
310148|NCT01825278|minute ventilation|minute ventilation
310149|NCT01825278|obese patients|obese patients
310150|NCT01825278|obstructive sleep apnea|obstructive sleep apnea
310151|NCT01825265|Neoplasm Metastasis|neoplasm metastasis
310152|NCT01825265|Breast Cancer|breast cancer
310153|NCT01825265|Docetaxel|docetaxel
310154|NCT01825265|RAD001|rad001
310155|NCT01825265|Taxotere|taxotere
310156|NCT01825252|HIV|hiv
310157|NCT01825252|sexually transmitted diseases|sexually transmitted diseases
310158|NCT01825239|ischemic cardiomyopathy|ischemic cardiomyopathy
310159|NCT01825239|cardiomyopathy|cardiomyopathy
310160|NCT01825239|left ventricular lead|left ventricular lead
310161|NCT01825239|cardiac electrophysiologic studies|cardiac electrophysiologic studies
310162|NCT01825213|Liver disease|liver disease
310163|NCT01825213|Multi Spectral CT|multi spectral ct
310164|NCT01825200|Influenza|influenza
310165|NCT01825148|Diabetes|diabetes
310166|NCT01825135|muscle strength|muscle strength
310167|NCT01825135|muscle function|muscle function
310168|NCT01825135|functional status|functional status
310169|NCT01825109|Rotavirus|rotavirus
310170|NCT01825109|Immunogenicity|immunogenicity
310171|NCT01825109|vaccine, Bangladesh|vaccine, bangladesh
310172|NCT01825096|cerebral metabolism|cerebral metabolism
310173|NCT01825096|functional magnetic resonance imaging|functional magnetic resonance imaging
310174|NCT01825096|near infrared spectroscopy|near infrared spectroscopy
310175|NCT01825083|Hypercarbia|hypercarbia
310176|NCT01825083|TOSCA monitor|tosca monitor
310177|NCT01825083|Ketamine|ketamine
310178|NCT01825083|Fentanyl|fentanyl
310179|NCT01825083|Intraoperative monitoring|intraoperative monitoring
310180|NCT01825070|Montmorency tart cherries|montmorency tart cherries
310181|NCT01825070|Inflammation|inflammation
310182|NCT01825070|Uric acid|uric acid
310183|NCT01825057|implementation study|implementation study
310184|NCT01825057|motivational interviewing|motivational interviewing
310185|NCT01825057|substance use|substance use
310186|NCT01825044|Traumatic Brain Injury|traumatic brain injury
310187|NCT01825044|TBI|tbi
310188|NCT01825044|ciclosporin|ciclosporin
310189|NCT01825044|pharmacokinetic|pharmacokinetic
310190|NCT01825044|safety|safety
310191|NCT01825044|microdialysis|microdialysis
310192|NCT01825044|mitochondrial protection|mitochondrial protection
310193|NCT01825031|HIV|hiv
310194|NCT01825018|HIV|hiv
310195|NCT01825018|AIDS|aids
310196|NCT01825018|treatment adherence|treatment adherence
310197|NCT01825005|cervical cancer|cervical cancer
310198|NCT01824966|Esophagectomy|esophagectomy
310199|NCT01824966|Signet Ring Cells|signet ring cells
310200|NCT01824953|Gastric atrophy|gastric atrophy
310201|NCT01824953|Helicobacter pylori|helicobacter pylori
310202|NCT01824953|Pepsinogen|pepsinogen
310203|NCT01824953|Gastric cancer|gastric cancer
310204|NCT01824953|Gastric adenoma|gastric adenoma
310205|NCT01824940|Cluster randomized trial|cluster randomized trial
310206|NCT01824940|Nutrition|nutrition
310207|NCT01824940|Water Sanitation Hygiene|water sanitation hygiene
310208|NCT01824940|Environmental enteropathy|environmental enteropathy
310209|NCT01824914|videolaryngoscope|videolaryngoscope
310210|NCT01824914|tracheal intubation|tracheal intubation
310211|NCT01824914|Cormack-Lehane grade|cormack-lehane grade
310212|NCT01824914|airway evaluation|airway evaluation
310213|NCT01824914|sedation|sedation
310214|NCT01824914|anesthesia|anesthesia
310215|NCT01824901|AZD4547|azd4547
310216|NCT01824901|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
310217|NCT01824888|JUC|juc
310218|NCT01824888|hand rub|hand rub
310219|NCT01824888|European standard|european standard
310220|NCT01824862|clinically significant macular edema|clinically significant macular edema
310221|NCT01824862|foveal thickness|foveal thickness
310222|NCT01824862|foveal sensitivity|foveal sensitivity
310223|NCT01824862|perimetry|perimetry
310224|NCT01824862|diabetic retinopathy|diabetic retinopathy
310225|NCT01824849|Vocal cords|vocal cords
310226|NCT01824849|Vocal cord paralysis|vocal cord paralysis
310227|NCT01824849|Arytenoid cartilage|arytenoid cartilage
310228|NCT01824823|afatinib|afatinib
310229|NCT01824823|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
310230|NCT01824810|Intramuscular Stimulation|intramuscular stimulation
310231|NCT01824810|myoActivation|myoactivation
310232|NCT01824810|Neural Prolotherapy|neural prolotherapy
310233|NCT01824810|Whiplash-Associated Disorders|whiplash-associated disorders
310234|NCT01824810|myofascial pain|myofascial pain
310235|NCT01824797|Bone mineral density|bone mineral density
310236|NCT01824797|sleeve gastrectomy|sleeve gastrectomy
310237|NCT01824797|roux-en-y|roux-en-y
310238|NCT01824797|postmenopausal females|postmenopausal females
310239|NCT01824797|bone loss|bone loss
310240|NCT01824784|Normal Eyes|normal eyes
310241|NCT01824771|Continuous veno-venoous haemofiltration|continuous veno-venoous haemofiltration
310242|NCT01824771|Plasma lactate|plasma lactate
310243|NCT01824771|Critical illness|critical illness
310244|NCT01824771|Acute kidney injurytissue perfusion|acute kidney injurytissue perfusion
310245|NCT01824771|Multiple organ dysfunction syndrome|multiple organ dysfunction syndrome
310246|NCT01824758|esmolol, injection pain, lidocaine, rocuronium|esmolol, injection pain, lidocaine, rocuronium
310247|NCT01824706|cranial prosthesis|cranial prosthesis
310248|NCT01824680|Obesity|obesity
310249|NCT01824680|Appetite regulation|appetite regulation
310250|NCT01824680|Hormones|hormones
310251|NCT01824680|Adolescents|adolescents
310252|NCT01824680|Exercise|exercise
310253|NCT01824654|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
310254|NCT01824654|Imaging, Three-Dimensional|imaging, three-dimensional
310255|NCT01824654|Tomography Scanners, X-Ray Computed|tomography scanners, x-ray computed
310256|NCT01824654|Angiography, Digital Subtraction|angiography, digital subtraction
310257|NCT01824654|Endovascular Procedures|endovascular procedures
310258|NCT01824654|Radiography, Interventional|radiography, interventional
310259|NCT01824641|Acute myocardial infarction|acute myocardial infarction
310260|NCT01824641|Manual thrombus aspiration|manual thrombus aspiration
310261|NCT01824641|Coronary physiology|coronary physiology
310262|NCT01824615|Sunitinib|sunitinib
310263|NCT01824615|recurrent ovarian cancer|recurrent ovarian cancer
310264|NCT01824615|clear cell carcinoma|clear cell carcinoma
310265|NCT01824602|BIPOLAR I DISORDER, Eslicarbazepine acetate|bipolar i disorder, eslicarbazepine acetate
310266|NCT01824589|traumatic brain injury|traumatic brain injury
310268|NCT01824589|ITPR|itpr
310269|NCT01824589|intrathoracic pressure regulator|intrathoracic pressure regulator
310270|NCT01824589|hepatic encephalopathy|hepatic encephalopathy
310271|NCT01824589|pseudotumorcerebri|pseudotumorcerebri
310272|NCT01824589|obstructive hydrocephalus|obstructive hydrocephalus
310273|NCT01824589|intracranial hemorrhage|intracranial hemorrhage
310274|NCT01824576|ITPR|itpr
310275|NCT01824576|CPP|cpp
310276|NCT01824576|TBI|tbi
310277|NCT01824576|traumatic brain injury|traumatic brain injury
310278|NCT01824576|cerebral perfusion pressure|cerebral perfusion pressure
310279|NCT01824576|intrathoracic pressure regulator|intrathoracic pressure regulator
310280|NCT01824537|Human papillomavirus (HPV)|human papillomavirus (hpv)
310281|NCT01824537|Vaccination|vaccination
310282|NCT01824537|Cervical cancer prevention|cervical cancer prevention
310283|NCT01824537|Herd immunity|herd immunity
310284|NCT01824524|Pain|pain
310285|NCT01824524|Hydromorphone|hydromorphone
310286|NCT01824524|OROS|oros
310287|NCT01824511|smoking|smoking
310288|NCT01824511|nicotine|nicotine
310289|NCT01824511|tobacco|tobacco
310290|NCT01824511|anhedonia|anhedonia
310291|NCT01824511|reward|reward
310292|NCT01824511|withdrawal|withdrawal
310293|NCT01824498|omega-3 fatty acids|omega-3 fatty acids
310294|NCT01824498|sex hormones|sex hormones
310295|NCT01824498|urinary sex hormone metabolites|urinary sex hormone metabolites
310296|NCT01824485|Osteoarthritis|osteoarthritis
310297|NCT01824485|Knee|knee
310298|NCT01824485|Viscosupplementation|viscosupplementation
310299|NCT01824485|Clinical Trial|clinical trial
310300|NCT01824459|Non-intestinal type gastric cancer|non-intestinal type gastric cancer
310301|NCT01824459|Advance Gastric Cancer|advance gastric cancer
310302|NCT01824459|Recurrent Gastric Cancer|recurrent gastric cancer
310303|NCT01824459|Gastroesophageal Junction Adenocarcinoma|gastroesophageal junction adenocarcinoma
310304|NCT01824459|SOX, S-1+Oxaliplatin|sox, s-1+oxaliplatin
310305|NCT01824459|OS,|os,
310306|NCT01824459|ORR,|orr,
310307|NCT01824459|TTP,|ttp,
310308|NCT01824459|TTF,|ttf,
310309|NCT01824459|safety|safety
310310|NCT01824433|venlafaxine|venlafaxine
310311|NCT01824433|fluoxetine|fluoxetine
310312|NCT01824433|postmenopause|postmenopause
310313|NCT01824433|major depressive disorder|major depressive disorder
310314|NCT01824420|Refractory overactive bladder syndrome|refractory overactive bladder syndrome
310315|NCT01824420|Antimuscarinic agent|antimuscarinic agent
310316|NCT01824407|foot|foot
310317|NCT01824407|ulcers|ulcers
310318|NCT01824407|diabetes|diabetes
310319|NCT01824407|wound|wound
310320|NCT01824407|healing|healing
310321|NCT01824394|nMARQ|nmarq
310322|NCT01824394|Atrial Fibrillation|atrial fibrillation
310323|NCT01824394|Drug Refractory|drug refractory
310324|NCT01824394|Radio Frequency|radio frequency
310325|NCT01824381|extensive wounds|extensive wounds
310326|NCT01824381|amniotic membrane|amniotic membrane
310327|NCT01824381|healing|healing
310328|NCT01824381|patients|patients
310329|NCT01824381|phase granulation|phase granulation
310330|NCT01824329|Bladder Cancer|bladder cancer
310331|NCT01824329|Transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
310332|NCT01824264|Type 2 Diabetes mellitus, SGLT inhibitors, dose-response|type 2 diabetes mellitus, sglt inhibitors, dose-response
310333|NCT01824251|IVIG in Chronic Inflammatory Demyelinating Polyneuropathy|ivig in chronic inflammatory demyelinating polyneuropathy
310334|NCT01824251|Patients with Chronic Inflammatory Demyelinating Polyneuropathy|patients with chronic inflammatory demyelinating polyneuropathy
310335|NCT01824225|aflibercept|aflibercept
310336|NCT01824225|intravitreal injection|intravitreal injection
310337|NCT01824212|Ventricular fibrillation|ventricular fibrillation
310338|NCT01824212|Cardiac arrest|cardiac arrest
310339|NCT01824212|Mobile technology|mobile technology
310340|NCT01824199|Esophagitis|esophagitis
310341|NCT01824173|muscle|muscle
310342|NCT01824173|mitochondria|mitochondria
310343|NCT01824173|amino acids|amino acids
310344|NCT01824173|exercise|exercise
310345|NCT01824147|ASS-Nonresponse|ass-nonresponse
310346|NCT01824147|cardiac|cardiac
310347|NCT01824147|surgery|surgery
310348|NCT01824121|Progressive Supranuclear palsy|progressive supranuclear palsy
310349|NCT01824121|stem cell therapy|stem cell therapy
310350|NCT01824108|Lumbar disc herniation|lumbar disc herniation
310351|NCT01824108|Wallis interspinous implants|wallis interspinous implants
310352|NCT01824108|lumbar discectomy|lumbar discectomy
310353|NCT01824108|interspinous dynamic stability system|interspinous dynamic stability system
310354|NCT01824082|phantom pain|phantom pain
310355|NCT01824082|traumatic limb amputation|traumatic limb amputation
310356|NCT01824082|amputees|amputees
310357|NCT01824069|Critical Ischemia|critical ischemia
310358|NCT01824069|Amputation|amputation
310359|NCT01824056|18F-FDG|18f-fdg
310360|NCT01824043|diabetic retinopathy|diabetic retinopathy
310361|NCT01824043|vitreous hemorrhage|vitreous hemorrhage
310362|NCT01824043|intravitreal ranibizumab|intravitreal ranibizumab
310363|NCT01824030|FFR, OCT, Seattle Angina Questionnaire|ffr, oct, seattle angina questionnaire
310364|NCT01824017|Type 2 diabetes|type 2 diabetes
310365|NCT01824017|metabolic syndrome|metabolic syndrome
310366|NCT01824017|oxidative stress|oxidative stress
310367|NCT01824017|GSH|gsh
310368|NCT01824004|Gastric cancer|gastric cancer
310369|NCT01824004|Adjuvant|adjuvant
310370|NCT01824004|Chemoradiotherapy|chemoradiotherapy
310371|NCT01824004|S-1|s-1
310372|NCT01824004|Cisplatin|cisplatin
310373|NCT01823991|polyphenolics|polyphenolics
310374|NCT01823991|anthocyanins|anthocyanins
310375|NCT01823991|n-3 fatty acids|n-3 fatty acids
310376|NCT01823978|metastatic|metastatic
310377|NCT01823978|castration resistant prostate cancer|castration resistant prostate cancer
310378|NCT01823978|Therapeutic Vaccine|therapeutic vaccine
310379|NCT01823978|Dendritic cell|dendritic cell
310380|NCT01823978|BPX-201|bpx-201
310381|NCT01823978|BPX201|bpx201
310382|NCT01823978|AP1903|ap1903
310383|NCT01823952|HAMS|hams
310384|NCT01823952|ORS|ors
310385|NCT01823952|Cholera|cholera
310386|NCT01823952|Diarrhea|diarrhea
310387|NCT01823939|Cholera|cholera
310388|NCT01823939|V. Cholerae O1|v. cholerae o1
310389|NCT01823939|iOWH032|iowh032
310390|NCT01823939|diarrhoea|diarrhoea
310391|NCT01823939|pharmacokinetic|pharmacokinetic
310392|NCT01823939|Bangladesh|bangladesh
310393|NCT01823926|vibrating mesh nebulizers|vibrating mesh nebulizers
310394|NCT01823926|noninvasive ventilation|noninvasive ventilation
310395|NCT01823926|residual volume|residual volume
310396|NCT01823926|pulmonary scintigraphy|pulmonary scintigraphy
310397|NCT01823926|radioaerosol|radioaerosol
310398|NCT01823926|nebulization.|nebulization.
310399|NCT01823913|Pharmacokinetics|pharmacokinetics
310400|NCT01823900|Pharmacokinetics|pharmacokinetics
310401|NCT01823887|Heart Failure|heart failure
310402|NCT01823887|Vagus Nerve|vagus nerve
310403|NCT01823887|VNS|vns
310404|NCT01823874|Virtual reality analgesia|virtual reality analgesia
310405|NCT01823874|pain control|pain control
310406|NCT01823848|constipation|constipation
310407|NCT01823848|enema|enema
310408|NCT01823822|Anorexia nervosa|anorexia nervosa
310409|NCT01823822|Protein supplements|protein supplements
310410|NCT01823822|IGF-I|igf-i
310411|NCT01823809|Coronary Artery Disease|coronary artery disease
310412|NCT01823809|Computed Tomography|computed tomography
310413|NCT01823809|Cardiac Magnetic Resonance|cardiac magnetic resonance
310414|NCT01823809|Fractional Flow Reserve|fractional flow reserve
310415|NCT01823796|Fibromyalgia|fibromyalgia
310416|NCT01823796|balance|balance
310417|NCT01823796|falls|falls
310418|NCT01823783|Duchenne muscular distrophy|duchenne muscular distrophy
310419|NCT01823783|Endomysial Fibrosis|endomysial fibrosis
310420|NCT01823783|Muscular Inflammatory Response|muscular inflammatory response
310421|NCT01823783|Calcium Homeostasis Dysfunction|calcium homeostasis dysfunction
310422|NCT01823783|Muscle biopsy|muscle biopsy
310423|NCT01823770|Restless Legs Syndrome (RLS)|restless legs syndrome (rls)
310424|NCT01823770|Rotigotine|rotigotine
310425|NCT01823770|HTA|hta
310426|NCT01823770|Cardiovascular diseases|cardiovascular diseases
310427|NCT01823770|Periodic Limb Movements in Sleep (PLMS)|periodic limb movements in sleep (plms)
310428|NCT01823770|dopaminergic agonist|dopaminergic agonist
310429|NCT01823770|Sympathetic overactivity|sympathetic overactivity
310430|NCT01823770|blood pressure|blood pressure
310431|NCT01823757|elderly|elderly
310432|NCT01823757|potential inappropriate medications|potential inappropriate medications
310433|NCT01823757|pharmaceutical care|pharmaceutical care
310434|NCT01823757|quality of life|quality of life
310435|NCT01823757|medical expenditure|medical expenditure
310436|NCT01823744|micronutrient|micronutrient
310437|NCT01823744|genomic|genomic
310438|NCT01823744|SAM/SAH ratio|sam/sah ratio
310439|NCT01823731|PCI,SOTOC, Ovarian cancer|pci,sotoc, ovarian cancer
310440|NCT01823692|Radius Fracture|radius fracture
310441|NCT01823692|Sensitivity|sensitivity
310442|NCT01823692|Reduction|reduction
310443|NCT01823692|Adequacy|adequacy
310444|NCT01823666|Dementia|dementia
310445|NCT01823666|Alzheimer's disease|alzheimer's disease
310446|NCT01823666|mild cognitive impairment|mild cognitive impairment
310447|NCT01823640|HRV|hrv
310448|NCT01823640|Pharmacodynamics / kinetics|pharmacodynamics / kinetics
310449|NCT01823640|Resistance|resistance
310450|NCT01823627|COPD|copd
310451|NCT01823627|Psychiatric inpatient|psychiatric inpatient
310452|NCT01823627|Smoking|smoking
310453|NCT01823614|HIV infection|hiv infection
310454|NCT01823614|tropism determination|tropism determination
310455|NCT01823614|genotypic methodic|genotypic methodic
310456|NCT01823614|R5-tropic variant|r5-tropic variant
310457|NCT01823614|X4-tropic variant|x4-tropic variant
310458|NCT01823601|Well-Being|well-being
310459|NCT01823601|Life Management Program|life management program
310460|NCT01823601|Breathing|breathing
310461|NCT01823601|Meditation|meditation
310462|NCT01823601|Cognitive-Behavioral Training|cognitive-behavioral training
310463|NCT01823575|malignant ureteral obstruction|malignant ureteral obstruction
310464|NCT01823575|silicone-covered metallic ureteral stent|silicone-covered metallic ureteral stent
310465|NCT01823575|double-J stent|double-j stent
310466|NCT01823562|Lyophilized Black Raspberry|lyophilized black raspberry
310467|NCT01823562|Prostate Cancer|prostate cancer
310468|NCT01823562|Surgery|surgery
310469|NCT01823549|CAM|cam
310470|NCT01823549|Alternative Medicine|alternative medicine
310471|NCT01823536|Meningitis|meningitis
310472|NCT01823510|Antiplatelet|antiplatelet
310473|NCT01823510|Ticagrelor|ticagrelor
310474|NCT01823510|Clopidogrel|clopidogrel
310475|NCT01823510|Thrombosis|thrombosis
310476|NCT01823510|Diabetes|diabetes
310477|NCT01823510|Coronary Artery Disease|coronary artery disease
310478|NCT01823497|Neonatal Intensive Care Unit|neonatal intensive care unit
310479|NCT01823497|neonate|neonate
310480|NCT01823497|pain|pain
310481|NCT01823497|morphine|morphine
310482|NCT01823497|Parent/Nurse Controlled Analgesia|parent/nurse controlled analgesia
310483|NCT01823484|hemofilter|hemofilter
310484|NCT01823484|coagulation|coagulation
310485|NCT01823484|CRRT|crrt
310486|NCT01823484|critically ill|critically ill
310487|NCT01823471|HNPCC|hnpcc
310488|NCT01823471|Hereditary non-polyposis colon carcinoma|hereditary non-polyposis colon carcinoma
310489|NCT01823471|Lynch syndrome|lynch syndrome
310490|NCT01823471|i-scan|i-scan
310491|NCT01823471|virtual chromo-endoscopy|virtual chromo-endoscopy
310492|NCT01823471|chromo-endoscopy|chromo-endoscopy
310493|NCT01823471|high definition endoscopy|high definition endoscopy
310494|NCT01823471|polyp detection|polyp detection
310495|NCT01823471|adenoma detection|adenoma detection
310496|NCT01823471|adenoma miss rate|adenoma miss rate
310497|NCT01823458|behavioral economics|behavioral economics
310498|NCT01823458|incentives|incentives
310499|NCT01823458|health behavior|health behavior
310500|NCT01823458|exercise|exercise
310501|NCT01823445|Xylitol|xylitol
310502|NCT01823445|Dental caries|dental caries
310503|NCT01823393|balloon aortic valvuloplasty indication|balloon aortic valvuloplasty indication
310504|NCT01823393|heparin|heparin
310505|NCT01823393|hemorrhagic|hemorrhagic
310506|NCT01823393|ischemic|ischemic
310507|NCT01823380|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
310508|NCT01823380|Vitamin D|vitamin d
310509|NCT01823380|Blood Levels|blood levels
310510|NCT01823367|type 2 diabetes mellitus prevention|type 2 diabetes mellitus prevention
310511|NCT01823367|gestational diabetes mellitus|gestational diabetes mellitus
310512|NCT01823367|pre-diabetes|pre-diabetes
310513|NCT01823367|lifestyle interventions|lifestyle interventions
310514|NCT01823367|pediatric primary prevention of type 2 diabetes|pediatric primary prevention of type 2 diabetes
310515|NCT01823354|Restless Legs Syndrome|restless legs syndrome
310516|NCT01823354|Polysomnography|polysomnography
310517|NCT01823354|Executive cognition|executive cognition
310518|NCT01823341|Type 1 Diabetes|type 1 diabetes
310519|NCT01823341|Hypoglycemia|hypoglycemia
310520|NCT01823341|Continuous Glucose Monitoring|continuous glucose monitoring
310521|NCT01823341|Pump Suspension|pump suspension
310522|NCT01823328|Intubation|intubation
310523|NCT01823328|Airway|airway
310524|NCT01823328|Emergent intubation|emergent intubation
310525|NCT01823328|Rapid sequence intubation|rapid sequence intubation
310526|NCT01823328|Rapid sequence induction|rapid sequence induction
310527|NCT01823328|RSI|rsi
310528|NCT01823328|Ketamine|ketamine
310529|NCT01823328|Etomidate|etomidate
310530|NCT01823328|Sepsis|sepsis
310531|NCT01823328|Sedative|sedative
310532|NCT01823328|Sedation|sedation
310533|NCT01823302|Children with picky-eating behaviors|children with picky-eating behaviors
310534|NCT01823302|Children aged 2.5 - 5 years|children aged 2.5 - 5 years
310535|NCT01823302|reported by caregivers|reported by caregivers
310536|NCT01823302|with weight-for-height z-scores ≤ 25th percentile at enrollment|with weight-for-height z-scores ≤ 25th percentile at enrollment
310537|NCT01823289|Invasive Pulmonary Fungal Infection|invasive pulmonary fungal infection
310538|NCT01823289|Itraconazole|itraconazole
310539|NCT01823250|Hispanic|hispanic
310540|NCT01823250|adolescent|adolescent
310541|NCT01823250|drug abuse treatment|drug abuse treatment
310542|NCT01823250|evidence-based|evidence-based
310543|NCT01823250|family therapy|family therapy
310544|NCT01823250|adaptive family treatment|adaptive family treatment
310644|NCT01822925|Diabetes|diabetes
310545|NCT01823250|Culturally Informed Family-Based Treatment for Adolescents|culturally informed family-based treatment for adolescents
310546|NCT01823237|Dystonia|dystonia
310547|NCT01823237|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
310548|NCT01823237|Rehabilitation|rehabilitation
310549|NCT01823237|Plasticity|plasticity
310550|NCT01823211|ICD (Implantable cardioverter-defibrillator)|icd (implantable cardioverter-defibrillator)
310551|NCT01823211|Heart rate variability|heart rate variability
310552|NCT01823211|MTWA (Microvolt T-alternans)|mtwa (microvolt t-alternans)
310553|NCT01823211|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
310554|NCT01823198|Leukemia|leukemia
310555|NCT01823198|Acute myeloid leukemia|acute myeloid leukemia
310556|NCT01823198|AML|aml
310557|NCT01823198|Myelodysplastic syndromes|myelodysplastic syndromes
310558|NCT01823198|MDS|mds
310559|NCT01823198|Blood And Marrow Transplantation|blood and marrow transplantation
310560|NCT01823198|Myeloproliferative Diseases|myeloproliferative diseases
310561|NCT01823198|High Risk Myeloid Malignancies|high risk myeloid malignancies
310562|NCT01823198|Allogeneic stem cell transplant|allogeneic stem cell transplant
310563|NCT01823198|Natural Killer Cells|natural killer cells
310564|NCT01823198|NK|nk
310565|NCT01823198|Immune cells|immune cells
310566|NCT01823198|Stem cell transplant|stem cell transplant
310567|NCT01823198|Busulfan|busulfan
310568|NCT01823198|Busulfex|busulfex
310569|NCT01823198|Myleran|myleran
310570|NCT01823198|Interleukin-2|interleukin-2
310571|NCT01823198|IL-2|il-2
310572|NCT01823198|Aldesleukin|aldesleukin
310573|NCT01823198|Proleukin|proleukin
310574|NCT01823198|Thymoglobulin|thymoglobulin
310575|NCT01823198|Antithymocyte globulin|antithymocyte globulin
310576|NCT01823198|ATG|atg
310577|NCT01823198|G-CSF|g-csf
310578|NCT01823198|Filgrastim|filgrastim
310579|NCT01823198|Neupogen|neupogen
310580|NCT01823198|Tacrolimus|tacrolimus
310581|NCT01823198|Prograf|prograf
310582|NCT01823198|Methotrexate|methotrexate
310583|NCT01823185|Clopidogrel|clopidogrel
310584|NCT01823185|Ticagrelor|ticagrelor
310585|NCT01823185|Prasugrel|prasugrel
310586|NCT01823185|Platelet aggregation inhibitor|platelet aggregation inhibitor
310587|NCT01823185|Dammam University|dammam university
310588|NCT01823185|King Fahd Hospital|king fahd hospital
310589|NCT01823185|Purinergic P2 receptor Antagonists|purinergic p2 receptor antagonists
310590|NCT01823172|breast cancer|breast cancer
310591|NCT01823172|melanoma|melanoma
310592|NCT01823172|sentinel lymph node biopsy|sentinel lymph node biopsy
310593|NCT01823172|lymphadenectomy|lymphadenectomy
310594|NCT01823159|retigabine|retigabine
310595|NCT01823159|cortical excitability|cortical excitability
310596|NCT01823159|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
310597|NCT01823146|oxytocin|oxytocin
310598|NCT01823146|socioemotional functioning|socioemotional functioning
310599|NCT01823146|trust|trust
310600|NCT01823146|amygdala|amygdala
310601|NCT01823146|aging|aging
310602|NCT01823120|Self harm|self harm
310603|NCT01823120|Emergency Department|emergency department
310604|NCT01823120|Repetition|repetition
310605|NCT01823120|Supportive Text messages|supportive text messages
310606|NCT01823120|Interactive|interactive
310607|NCT01823107|Meso BioMatrix|meso biomatrix
310608|NCT01823107|Breast|breast
310609|NCT01823107|Breast Cancer|breast cancer
310610|NCT01823107|Mastectomy|mastectomy
310611|NCT01823107|Biologic Mesh|biologic mesh
310612|NCT01823107|Breast Reconstruction|breast reconstruction
310613|NCT01823094|lung cancer|lung cancer
310614|NCT01823094|computed tomography|computed tomography
310615|NCT01823094|blood flow|blood flow
310616|NCT01823068|Lung cancer|lung cancer
310617|NCT01823068|RET fusion|ret fusion
310618|NCT01823068|Vandetanib|vandetanib
310619|NCT01823042|Crohn's Disease|crohn's disease
310620|NCT01823042|maintain remission|maintain remission
310621|NCT01823042|postoperative recurrence|postoperative recurrence
310622|NCT01823042|surgery|surgery
310623|NCT01823042|living quality|living quality
310624|NCT01823029|Crohn's Disease|crohn's disease
310625|NCT01823029|intravenous iron|intravenous iron
310626|NCT01823029|iron deficiency anaemia|iron deficiency anaemia
310627|NCT01823029|Oxidative Stress|oxidative stress
310628|NCT01823029|inflammation|inflammation
310629|NCT01823016|Uncontrolled, persistent asthma|uncontrolled, persistent asthma
310630|NCT01823003|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
310631|NCT01823003|Neoplasm Metastasis|neoplasm metastasis
310632|NCT01823003|Radiosurgery|radiosurgery
310633|NCT01822990|Anti-beta2-glycoprotein antibodies|anti-beta2-glycoprotein antibodies
310634|NCT01822990|Peripheral arterial disease|peripheral arterial disease
310635|NCT01822990|Inflammation|inflammation
310636|NCT01822990|Nitric oxide|nitric oxide
310637|NCT01822990|Endothelial dysfunction|endothelial dysfunction
310638|NCT01822977|gut microbiota|gut microbiota
310639|NCT01822977|proton pump inhibitor|proton pump inhibitor
310640|NCT01822977|Clostridium difficile infection|clostridium difficile infection
310641|NCT01822977|Fecal microbiome|fecal microbiome
310642|NCT01822977|single episode of CDI|single episode of cdi
310643|NCT01822951|DAT Study|dat study
310645|NCT01822925|Pain|pain
310646|NCT01822925|Neuropathy|neuropathy
310647|NCT01822912|Skilled Nursing Facility|skilled nursing facility
310648|NCT01822912|Heart Failure|heart failure
310649|NCT01822912|Transitional Care|transitional care
310650|NCT01822899|Novel Dry Powder Inhaler (NDPI)|novel dry powder inhaler (ndpi)
310651|NCT01822899|umeclidinium bromide (UMEC)|umeclidinium bromide (umec)
310652|NCT01822899|GSK573719|gsk573719
310653|NCT01822899|lung function|lung function
310654|NCT01822899|GW642444|gw642444
310655|NCT01822899|salmeterol (SAL)|salmeterol (sal)
310656|NCT01822899|fluticasone propionate (FP)|fluticasone propionate (fp)
310657|NCT01822899|vilanterol (VI)|vilanterol (vi)
310658|NCT01822899|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
310659|NCT01822886|T-cell lymphoma|t-cell lymphoma
310660|NCT01822886|Romidepsin|romidepsin
310661|NCT01822860|Hypertension|hypertension
310662|NCT01822860|Endothelial dysfunction|endothelial dysfunction
310663|NCT01822847|adrenal|adrenal
310664|NCT01822847|steroids|steroids
310665|NCT01822847|cortisol|cortisol
310666|NCT01822847|stress|stress
310667|NCT01822821|Males or females|males or females
310668|NCT01822821|18 years of age or older.|18 years of age or older.
310669|NCT01822821|Non-emergency|non-emergency
310670|NCT01822821|cardiac surgery|cardiac surgery
310671|NCT01822821|midline sternotomy.|midline sternotomy.
310672|NCT01822808|acute heart failure|acute heart failure
310673|NCT01822808|left ventricular dysfunction|left ventricular dysfunction
310674|NCT01822808|hydralazine|hydralazine
310675|NCT01822808|isosorbide dinitrate|isosorbide dinitrate
310676|NCT01822795|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
310677|NCT01822795|Endoscopic lung volume reduction|endoscopic lung volume reduction
310678|NCT01822782|Perineal tear|perineal tear
310679|NCT01822782|Perineal lesion|perineal lesion
310680|NCT01822782|Vaginal flora|vaginal flora
310681|NCT01822782|Birth|birth
310682|NCT01822769|congenital heart disease|congenital heart disease
310683|NCT01822769|adult congenital heart disease|adult congenital heart disease
310684|NCT01822769|cardiac rehabilitation|cardiac rehabilitation
310685|NCT01822769|cardiopulmonary rehabilitation|cardiopulmonary rehabilitation
310686|NCT01822769|exercise|exercise
310687|NCT01822769|cardiopulmonary exercise testing|cardiopulmonary exercise testing
310688|NCT01822769|peak vO2|peak vo2
310689|NCT01822769|quality of life|quality of life
310690|NCT01822743|Osteopathy|osteopathy
310691|NCT01822743|Sleep Apnea Syndromes|sleep apnea syndromes
310692|NCT01822743|Obstructive Sleep Apnea|obstructive sleep apnea
310693|NCT01822743|Pcrit|pcrit
310694|NCT01822743|Polysomnography|polysomnography
310695|NCT01822730|Methamphetamine-Associated Psychosis|methamphetamine-associated psychosis
310696|NCT01822730|Aripiprazole|aripiprazole
310697|NCT01822730|Risperidone|risperidone
310698|NCT01822717|Diabetes|diabetes
310699|NCT01822717|Visual Impairment|visual impairment
310700|NCT01822717|Blindness|blindness
310701|NCT01822717|Foot Care|foot care
310702|NCT01822717|Self-Management|self-management
310703|NCT01822704|Stroke|stroke
310704|NCT01822704|Exercise|exercise
310705|NCT01822704|Rehabilitation|rehabilitation
310706|NCT01822704|Vibration|vibration
310707|NCT01822691|myelodysplastic syndromes (MDS)|myelodysplastic syndromes (mds)
310708|NCT01822691|neoplastic stem cell disorders|neoplastic stem cell disorders
310709|NCT01822691|refractory cytopenias|refractory cytopenias
310710|NCT01822691|dysplastic morphological features|dysplastic morphological features
310711|NCT01822691|acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
310712|NCT01822652|Neuroblastoma|neuroblastoma
310713|NCT01822652|Solid tumor|solid tumor
310714|NCT01822652|Neuroblastoma-specific immunotherapy targeting GD2|neuroblastoma-specific immunotherapy targeting gd2
310715|NCT01822652|CAR T cells|car t cells
310716|NCT01822652|Gene Therapy|gene therapy
310717|NCT01822652|Relapsed|relapsed
310718|NCT01822652|Refractory|refractory
310719|NCT01822639|Hypertension|hypertension
310720|NCT01822639|enalapril maleate|enalapril maleate
310721|NCT01822639|healthy volunteers|healthy volunteers
310722|NCT01822639|amlodipine|amlodipine
310723|NCT01822639|pharmacokinetics|pharmacokinetics
310724|NCT01822626|overweight|overweight
310725|NCT01822626|obesity|obesity
310726|NCT01822626|children|children
310727|NCT01822626|BMI|bmi
310728|NCT01822626|counseling|counseling
310729|NCT01822626|pediatrician|pediatrician
310730|NCT01822613|esophageal cancer|esophageal cancer
310731|NCT01822600|hypoalbuminemia|hypoalbuminemia
310732|NCT01822600|peptic ulcer|peptic ulcer
310733|NCT01822600|rebleeding|rebleeding
310734|NCT01822600|hospitalization|hospitalization
310735|NCT01822587|Drug Abuse|drug abuse
310736|NCT01822587|Cocaine|cocaine
310737|NCT01822587|Addiction|addiction
310738|NCT01822561|Central Serous Chorioretinopathy|central serous chorioretinopathy
310739|NCT01822561|Eplerenone|eplerenone
310740|NCT01822561|Optical Coherence Tomography|optical coherence tomography
310741|NCT01822561|Enhanced Depth Imaging|enhanced depth imaging
310742|NCT01822561|Subretinal Fluid|subretinal fluid
310743|NCT01822548|EPC|epc
310744|NCT01822548|diabetes|diabetes
310745|NCT01822548|DPP IV inhibitors|dpp iv inhibitors
310746|NCT01822535|Quadriplegia|quadriplegia
310747|NCT01822535|Spinal Cord Injuries|spinal cord injuries
310748|NCT01822535|Body Temperature Regulation|body temperature regulation
310749|NCT01822535|Mild Cognitive Impairment|mild cognitive impairment
310750|NCT01822483|Renal transplantation|renal transplantation
310751|NCT01822483|mycophenolic acid|mycophenolic acid
310752|NCT01822483|mycophenolate mofetil|mycophenolate mofetil
310753|NCT01822483|mycophenolate sodium|mycophenolate sodium
310754|NCT01822483|area under the curve|area under the curve
310755|NCT01822470|functional dyspepsia|functional dyspepsia
310756|NCT01822470|post prandial distress syndrome|post prandial distress syndrome
310757|NCT01822470|small bowel bacteria overgrowth|small bowel bacteria overgrowth
310758|NCT01822470|epigastric pain syndrome|epigastric pain syndrome
310759|NCT01822470|diarrhea|diarrhea
310760|NCT01822470|bloating|bloating
310761|NCT01822470|post prandial fullness|post prandial fullness
310762|NCT01822470|weight loss|weight loss
310763|NCT01822444|Colorectal Cancer|colorectal cancer
310764|NCT01822444|Advanced Colorectal Cancer|advanced colorectal cancer
310765|NCT01822444|Metastatic Colorectal Cancer|metastatic colorectal cancer
310766|NCT01822444|Locally Advanced Colorectal Cancer|locally advanced colorectal cancer
310767|NCT01822444|Colon Cancer|colon cancer
310768|NCT01822444|Rectal Cancer|rectal cancer
310769|NCT01822418|Schizophrenia|schizophrenia
310770|NCT01822418|Depression|depression
310771|NCT01822418|Cognition|cognition
310772|NCT01822418|Agomelatine|agomelatine
310773|NCT01822418|Antidepressant|antidepressant
310774|NCT01822392|Online treatment|online treatment
310775|NCT01822392|Treatment of conduct problems|treatment of conduct problems
310776|NCT01822392|Parent training|parent training
310777|NCT01822366|Children|children
310778|NCT01822366|Adolescents|adolescents
310779|NCT01822366|Trauma-focused Cognitive Behavioral Therapy (TF-CBT)|trauma-focused cognitive behavioral therapy (tf-cbt)
310780|NCT01822366|Low- and Middle-Income Countries (LAMIC)|low- and middle-income countries (lamic)
310781|NCT01822366|Randomized Controlled Trial (RCT)|randomized controlled trial (rct)
310782|NCT01822366|Evidence-Based Practice (EBP)|evidence-based practice (ebp)
310783|NCT01822366|Childhood Traumatic Grief (CTG)|childhood traumatic grief (ctg)
310784|NCT01822366|Post-Traumatic Stress Disorder (PTSD)|post-traumatic stress disorder (ptsd)
310785|NCT01822366|Kenya|kenya
310786|NCT01822366|Tanzania|tanzania
310787|NCT01822366|East Africa|east africa
310788|NCT01822366|Mental Health|mental health
310789|NCT01822353|food allergy|food allergy
310790|NCT01822353|milk allergy|milk allergy
310791|NCT01822353|egg allergy|egg allergy
310792|NCT01822353|nut allergy|nut allergy
310793|NCT01822340|AGHD|aghd
310794|NCT01822314|breast|breast
310795|NCT01822314|cancer|cancer
310796|NCT01822314|unilateral|unilateral
310797|NCT01822314|non metastatic|non metastatic
310798|NCT01822314|HER2 negative|her2 negative
310799|NCT01822301|Craniomaxillofacial (CMF) Battle-injured (BI)|craniomaxillofacial (cmf) battle-injured (bi)
310800|NCT01822301|Facial Trauma|facial trauma
310801|NCT01822301|Fat Grafts|fat grafts
310802|NCT01822301|Autogenous Fat Transfers (AFT)|autogenous fat transfers (aft)
310803|NCT01822301|Wounded warriors|wounded warriors
310804|NCT01822288|Menopause|menopause
310805|NCT01822288|Tibolone|tibolone
310806|NCT01822288|Estradiol|estradiol
310807|NCT01822288|Hormone therapy|hormone therapy
310808|NCT01822275|GBM|gbm
310809|NCT01822262|Cholecystolithotomy with gallbladder reservation|cholecystolithotomy with gallbladder reservation
310810|NCT01822262|cholecystolithiasis|cholecystolithiasis
310811|NCT01822249|Rett syndrome|rett syndrome
310812|NCT01822249|EPI-743|epi-743
310813|NCT01822249|Edison|edison
310814|NCT01822236|low back pain|low back pain
310815|NCT01822236|Manual Therapy|manual therapy
310816|NCT01822236|Randomized Controlled Trial|randomized controlled trial
310817|NCT01822236|Quality of life|quality of life
310818|NCT01822223|Dental Implants|dental implants
310819|NCT01822223|Implant abutments|implant abutments
310820|NCT01822210|Botulinum Toxins|botulinum toxins
310821|NCT01822210|Injections|injections
310822|NCT01822210|Stomach|stomach
310823|NCT01822210|Tomography, X-Ray Computed|tomography, x-ray computed
310824|NCT01822197|Phototherapy|phototherapy
310825|NCT01822184|Neurodevelopmental Status|neurodevelopmental status
310826|NCT01822184|Pediatric Hunter syndrome patients|pediatric hunter syndrome patients
310827|NCT01822184|Central Nervous System (CNS) involvement|central nervous system (cns) involvement
310828|NCT01822184|Observational study|observational study
310829|NCT01822184|Cognitive impairment|cognitive impairment
310830|NCT01822171|Heart Failure|heart failure
310831|NCT01822171|Medication Therapy Management|medication therapy management
310832|NCT01822158|Vaginal Delivery|vaginal delivery
310833|NCT01822158|Debrief|debrief
310834|NCT01822158|Medical Team Communication|medical team communication
310835|NCT01822158|Obstetrical Safety|obstetrical safety
310836|NCT01822145|implantable-cardioverter-defibrillator|implantable-cardioverter-defibrillator
310837|NCT01822145|ventricular tachycardia|ventricular tachycardia
310838|NCT01822145|ventricular fibrillation|ventricular fibrillation
311544|NCT01818609|protein|protein
310839|NCT01822145|sudden cardiac arrest|sudden cardiac arrest
310840|NCT01822080|Endometriosis|endometriosis
310841|NCT01822080|Efficacy|efficacy
310842|NCT01822080|Safety|safety
310843|NCT01822080|Dienogest|dienogest
310844|NCT01822041|healthy volunteers|healthy volunteers
310845|NCT01822041|mass balance study|mass balance study
310846|NCT01822041|Pharmacokinetics|pharmacokinetics
310847|NCT01822028|diarrhea|diarrhea
310848|NCT01822002|Vertigo|vertigo
310849|NCT01822002|Nystagmus|nystagmus
310850|NCT01822002|BPPV = benign paroxysmal positional vertigo|bppv = benign paroxysmal positional vertigo
310851|NCT01822002|Treatment outcome|treatment outcome
310852|NCT01821963|Infection|infection
310853|NCT01821963|Hepatitis C Genotype 1 Infection|hepatitis c genotype 1 infection
310854|NCT01821963|Hepatitis C virus|hepatitis c virus
310855|NCT01821963|HCV|hcv
310856|NCT01821963|Hepatocellular Carcinoma|hepatocellular carcinoma
310857|NCT01821963|HCC|hcc
310858|NCT01821963|Liver Transplantation|liver transplantation
310859|NCT01821963|Pegylated Interferon Alfa 2a|pegylated interferon alfa 2a
310860|NCT01821963|PegIFN alfa-2a|pegifn alfa-2a
310861|NCT01821963|Ribavirin|ribavirin
310862|NCT01821963|RBV|rbv
310863|NCT01821963|Telaprevir|telaprevir
310864|NCT01821963|Incivek|incivek
310865|NCT01821963|Antiviral drugs|antiviral drugs
310866|NCT01821950|Mental health|mental health
310867|NCT01821950|Substance use|substance use
310868|NCT01821950|Substance use initiation|substance use initiation
310869|NCT01821950|Education|education
310870|NCT01821950|Mind Body Therapies|mind body therapies
310871|NCT01821950|Yoga|yoga
310872|NCT01821950|Meditation|meditation
310873|NCT01821950|Adolescent|adolescent
310874|NCT01821950|Adolescence|adolescence
310875|NCT01821950|Child|child
310876|NCT01821950|Children|children
310877|NCT01821950|Middle School|middle school
310878|NCT01821898|Eosinophil|eosinophil
310879|NCT01821898|Reflux|reflux
310880|NCT01821898|Esophagus|esophagus
310881|NCT01821898|Food allergy|food allergy
310882|NCT01821898|Trouble Swallowing|trouble swallowing
310883|NCT01821898|Pediatrics|pediatrics
310884|NCT01821885|Spirometry|spirometry
310885|NCT01821885|screening|screening
310886|NCT01821885|smoking cessation|smoking cessation
310887|NCT01821885|tobacco|tobacco
310888|NCT01821885|COPD|copd
310889|NCT01821872|paracetamol|paracetamol
310890|NCT01821872|acetaminophen|acetaminophen
310891|NCT01821872|AM404|am404
310892|NCT01821872|CSF|csf
310893|NCT01821872|pharmacokinetics|pharmacokinetics
310894|NCT01821833|omega-3|omega-3
310895|NCT01821833|fatty acids|fatty acids
310896|NCT01821833|paclitaxel|paclitaxel
310897|NCT01821833|acute pain syndrome|acute pain syndrome
310898|NCT01821833|peripheral neuropathy|peripheral neuropathy
310899|NCT01821833|chemotherapy induced neuropathy|chemotherapy induced neuropathy
310900|NCT01821820|Inflammation|inflammation
310901|NCT01821820|Oxidative stress|oxidative stress
310902|NCT01821820|Immune dysfunction|immune dysfunction
310903|NCT01821820|Metabolites|metabolites
310904|NCT01821807|spinal anesthesia|spinal anesthesia
310905|NCT01821807|spinal needle|spinal needle
310906|NCT01821807|cesarean section|cesarean section
310907|NCT01821807|headache|headache
310908|NCT01821807|backache|backache
310909|NCT01821781|Immune deficiency|immune deficiency
310910|NCT01821781|Immune disorders|immune disorders
310911|NCT01821781|Immune dysregulatory|immune dysregulatory
310912|NCT01821781|Reduced Intensity|reduced intensity
310913|NCT01821781|Alemtuzumab|alemtuzumab
310914|NCT01821781|Campath|campath
310915|NCT01821742|Shock|shock
310916|NCT01821742|Fluid bolus|fluid bolus
310917|NCT01821742|Cardiac output|cardiac output
310918|NCT01821742|Children in intensive care|children in intensive care
310919|NCT01821729|Locally Advanced|locally advanced
310920|NCT01821716|standardization|standardization
310921|NCT01821716|skin prick test|skin prick test
310922|NCT01821716|inmunotherapy|inmunotherapy
310923|NCT01821690|Traumatic Brain Injury|traumatic brain injury
310924|NCT01821690|Buspirone|buspirone
310925|NCT01821690|Behavior|behavior
310926|NCT01821690|Irritability|irritability
310927|NCT01821690|Aggression|aggression
310928|NCT01821664|Prosthetic vascular graft infection|prosthetic vascular graft infection
310929|NCT01821664|negative pressure wound therapy|negative pressure wound therapy
310930|NCT01821664|microbiology|microbiology
310931|NCT01821664|antimicrobial therapy|antimicrobial therapy
310932|NCT01821651|TAVI|tavi
310933|NCT01821651|MitraClip|mitraclip
310934|NCT01821651|image modality|image modality
310935|NCT01821651|echocardiography|echocardiography
310936|NCT01821651|angiography|angiography
310937|NCT01821638|Heart failure|heart failure
310938|NCT01821638|Cognition|cognition
310939|NCT01821638|Brain|brain
310940|NCT01821638|Older adults|older adults
310941|NCT01821625|Thrombocytopenia|thrombocytopenia
310942|NCT01821625|HCV|hcv
310943|NCT01821625|Hepatitis|hepatitis
310944|NCT01821625|Platelets|platelets
310945|NCT01821625|Eltrombopag|eltrombopag
310946|NCT01821625|Liver Disease|liver disease
310947|NCT01821625|Antiviral Treatment|antiviral treatment
310948|NCT01821599|Anterior Cruciate Ligament|anterior cruciate ligament
310949|NCT01821599|Knee|knee
310950|NCT01821599|Rehabilitation|rehabilitation
310951|NCT01821586|Diarrhoea;|diarrhoea;
310952|NCT01821586|Severe malnutrition;|severe malnutrition;
310953|NCT01821586|Benefiber;|benefiber;
310954|NCT01821586|ReSoMal;|resomal;
310955|NCT01821586|modified ORS|modified ors
310956|NCT01821573|botulinum toxin injection,3D motion analysis, muscular lengthening,muscle strength|botulinum toxin injection,3d motion analysis, muscular lengthening,muscle strength
310957|NCT01821560|Nicotine Addiction|nicotine addiction
310958|NCT01821560|fMRI|fmri
310959|NCT01821560|Baclofen|baclofen
310960|NCT01821508|Gastroplasty, Diabetes Mellitus Type II, Obesity|gastroplasty, diabetes mellitus type ii, obesity
310961|NCT01821495|NPC,DC-CIK|npc,dc-cik
310962|NCT01821482|Hepatocellular carcinoma, DC-CIK|hepatocellular carcinoma, dc-cik
310963|NCT01821469|bipolar disorders|bipolar disorders
310964|NCT01821469|euthymic|euthymic
310965|NCT01821469|psychotherapy|psychotherapy
310966|NCT01821469|Functional magnetic resonance imaging|functional magnetic resonance imaging
310967|NCT01821456|hematological malignancies|hematological malignancies
310968|NCT01821456|cancer|cancer
310969|NCT01821456|chemotherapy|chemotherapy
310970|NCT01821456|anti-infectives|anti-infectives
310971|NCT01821456|treatment|treatment
310972|NCT01821456|outcome|outcome
310973|NCT01821443|1 to 10 measurable brain metastases|1 to 10 measurable brain metastases
310974|NCT01821430|Chronic Pain|chronic pain
310975|NCT01821430|Narcotic Abuse|narcotic abuse
310976|NCT01821430|Opioid related disorders|opioid related disorders
310977|NCT01821430|Opiate substitution treatment|opiate substitution treatment
310978|NCT01821430|Buprenorphrine|buprenorphrine
310979|NCT01821430|Pregabalin|pregabalin
310980|NCT01821430|Methadone|methadone
310981|NCT01821417|dental implants|dental implants
310982|NCT01821417|screw-vent dental implants|screw-vent dental implants
310983|NCT01821404|Apoptosis|apoptosis
310984|NCT01821404|Atorvastatin|atorvastatin
310985|NCT01821404|Inflammation|inflammation
310986|NCT01821404|Pre-surgical trial|pre-surgical trial
310987|NCT01821404|Proliferation|proliferation
310988|NCT01821404|Prostate cancer|prostate cancer
310989|NCT01821391|actinic keratoses|actinic keratoses
310990|NCT01821391|photodynamic therapy|photodynamic therapy
310991|NCT01821391|natural daylight|natural daylight
310992|NCT01821378|Schizophrenia|schizophrenia
310993|NCT01821378|Lurasidone|lurasidone
310994|NCT01821378|Latuda|latuda
310995|NCT01821365|COPD,PETCO2,PaCO2|copd,petco2,paco2
310996|NCT01821326|capsule endoscopy|capsule endoscopy
310997|NCT01821326|obscure gastrointestinal bleeding|obscure gastrointestinal bleeding
310998|NCT01821326|rebleeding|rebleeding
310999|NCT01821326|risk factors|risk factors
311000|NCT01821313|Childhood obesity|childhood obesity
311001|NCT01821313|Inflammation|inflammation
311002|NCT01821313|Endothelial function|endothelial function
311003|NCT01821313|Exercise|exercise
311004|NCT01821300|Down syndrome|down syndrome
311005|NCT01821300|Philadelphia|philadelphia
311006|NCT01821300|The Children's Hospital of Philadelphia|the children's hospital of philadelphia
311007|NCT01821300|Body composition|body composition
311008|NCT01821300|Obesity|obesity
311009|NCT01821300|Cardiovascular|cardiovascular
311010|NCT01821222|Maternal health|maternal health
311011|NCT01821222|Neonatal health|neonatal health
311012|NCT01821222|mHealth|mhealth
311013|NCT01821222|Mobile phones|mobile phones
311014|NCT01821222|Access to health services|access to health services
311015|NCT01821222|Health behavior|health behavior
311016|NCT01821209|prostate cancer, robotic surgery, urethral sling,|prostate cancer, robotic surgery, urethral sling,
311017|NCT01821196|Tumor Markers, Biological|tumor markers, biological
311018|NCT01821196|PGP9.5 protein, human|pgp9.5 protein, human
311019|NCT01821196|adenocarcinoma|adenocarcinoma
311020|NCT01821170|ADHD|adhd
311021|NCT01821170|children|children
311022|NCT01821170|cognitive remediation|cognitive remediation
311023|NCT01821170|virtual reality|virtual reality
311024|NCT01821157|crown lengthening|crown lengthening
311025|NCT01821157|gingivoplasty|gingivoplasty
311026|NCT01821157|surgical procedures|surgical procedures
311027|NCT01821157|gingivectomy|gingivectomy
311028|NCT01821157|esthetic surgery|esthetic surgery
311029|NCT01821144|dietary salt|dietary salt
311030|NCT01821144|24 hour urinary sodium|24 hour urinary sodium
311031|NCT01821144|blood pressure|blood pressure
311032|NCT01821131|flax|flax
311033|NCT01821131|muffin|muffin
311034|NCT01821131|cholesterol|cholesterol
311035|NCT01821131|lignan|lignan
311036|NCT01821131|ALA|ala
311037|NCT01821118|Cerebral amyloid angiopathy (CAA)|cerebral amyloid angiopathy (caa)
311038|NCT01821118|cerebrovascular reactivity|cerebrovascular reactivity
311039|NCT01821118|functional MRI|functional mri
311040|NCT01821118|randomized|randomized
311041|NCT01821118|double blind|double blind
311042|NCT01821118|safety|safety
311043|NCT01821118|efficacy|efficacy
311044|NCT01821105|computed tomography|computed tomography
311045|NCT01821105|CT scan|ct scan
311641|NCT01818167|HS|hs
311046|NCT01821105|positron emission tomography|positron emission tomography
311047|NCT01821105|PET|pet
311048|NCT01821105|Metastatic Colorectal Cancer|metastatic colorectal cancer
311049|NCT01821092|osseointegrated Implant, bone level|osseointegrated implant, bone level
311050|NCT01821079|Single dose|single dose
311051|NCT01821079|Relative Bioavailability|relative bioavailability
311052|NCT01821079|Food effect|food effect
311053|NCT01821079|Healthy subjects|healthy subjects
311054|NCT01821079|Diabetes Mellitus Type 2|diabetes mellitus type 2
311055|NCT01821066|PD-0332991|pd-0332991
311056|NCT01821066|palbociclib|palbociclib
311057|NCT01821066|tamoxifen|tamoxifen
311058|NCT01821066|drug-drug interaction (DDI) study|drug-drug interaction (ddi) study
311059|NCT01821053|Preeclampsia|preeclampsia
311060|NCT01821053|Pregestational Type 1 diabetes|pregestational type 1 diabetes
311061|NCT01821053|diabetes mellitus|diabetes mellitus
311062|NCT01821053|proteinuria|proteinuria
311063|NCT01821053|plasminogen|plasminogen
311064|NCT01821053|plasmin|plasmin
311065|NCT01821053|renin|renin
311066|NCT01821053|aldosterone|aldosterone
311067|NCT01821053|angiotensin|angiotensin
311068|NCT01821053|epithelial sodium channel|epithelial sodium channel
311069|NCT01821053|ENaC|enac
311070|NCT01821040|Polymyalgia rheumatica|polymyalgia rheumatica
311071|NCT01821040|PMR|pmr
311072|NCT01821040|Modified release prednisone|modified release prednisone
311073|NCT01821027|Healthy|healthy
311074|NCT01821027|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
311075|NCT01821027|Pharmacokinetics|pharmacokinetics
311076|NCT01821027|Pharmacodynamics|pharmacodynamics
311077|NCT01821027|Simvastatin (ZOCOR)|simvastatin (zocor)
311078|NCT01821014|Diagnostic concordance|diagnostic concordance
311079|NCT01821014|Treatment concordance|treatment concordance
311080|NCT01821014|patient satisfaction|patient satisfaction
311081|NCT01821014|physician satisfaction|physician satisfaction
311082|NCT01821014|Medical Outreach Clinics|medical outreach clinics
311083|NCT01821014|Medical Brigades|medical brigades
311084|NCT01821014|Medical Missions|medical missions
311085|NCT01821014|Telemedicine|telemedicine
311086|NCT01821014|Videoconference|videoconference
311087|NCT01821014|diagnoses|diagnoses
311088|NCT01821014|treatments|treatments
311089|NCT01821014|Satellite Internet|satellite internet
311090|NCT01821014|VSAT|vsat
311091|NCT01821014|cross cultural telemedicine|cross cultural telemedicine
311092|NCT01821001|Adenomyosis|adenomyosis
311093|NCT01821001|Dysmenorrhea|dysmenorrhea
311094|NCT01821001|Abnormal Uterine bleeding|abnormal uterine bleeding
311095|NCT01821001|Heavy Menstrual Bleeding|heavy menstrual bleeding
311096|NCT01821001|Menorrhagia|menorrhagia
311097|NCT01820975|Muscle protein synthesis|muscle protein synthesis
311098|NCT01820975|Dietary protein|dietary protein
311099|NCT01820962|hematological patients|hematological patients
311100|NCT01820962|central venous catheters|central venous catheters
311101|NCT01820962|catheter related thrombosis|catheter related thrombosis
311102|NCT01820962|catheter related infections|catheter related infections
311103|NCT01820962|concentrated citrate|concentrated citrate
311104|NCT01820949|patient blood management|patient blood management
311105|NCT01820949|patients safety|patients safety
311106|NCT01820936|Healthy volunteers|healthy volunteers
311107|NCT01820936|PCI-32765|pci-32765
311108|NCT01820936|PCI-45227|pci-45227
311109|NCT01820936|Pharmacokinetics|pharmacokinetics
311110|NCT01820871|T2DM|t2dm
311111|NCT01820871|smartphone application|smartphone application
311112|NCT01820871|serum fasting glucose|serum fasting glucose
311113|NCT01820871|HbA1c|hba1c
311114|NCT01820845|Plethysmographic Variability Index|plethysmographic variability index
311115|NCT01820845|Esophageal Doppler|esophageal doppler
311116|NCT01820845|Scoliosis|scoliosis
311117|NCT01820845|Children|children
311118|NCT01820845|Age < 18 years|age < 18 years
311119|NCT01820845|Scheduled for Scoliosis Surgery|scheduled for scoliosis surgery
311120|NCT01820832|mild proteinuria|mild proteinuria
311121|NCT01820832|calcitriol|calcitriol
311122|NCT01820832|renal function|renal function
311123|NCT01820832|blood pressure|blood pressure
311124|NCT01820819|Inpatient|inpatient
311125|NCT01820819|Liver cirrhosis|liver cirrhosis
311126|NCT01820819|Liver Cirrhosis, Alcoholic|liver cirrhosis, alcoholic
311127|NCT01820819|Physician's Practice Patterns|physician's practice patterns
311128|NCT01820819|Liver Transplantation|liver transplantation
311129|NCT01820819|Delivery of Health Care|delivery of health care
311130|NCT01820819|Resource Allocation|resource allocation
311131|NCT01820793|antibiotic resistance|antibiotic resistance
311132|NCT01820793|E.coli|e.coli
311133|NCT01820793|cefoxitin|cefoxitin
311134|NCT01820793|pyelonephritis|pyelonephritis
311135|NCT01820780|Heart failure|heart failure
311136|NCT01820780|Disease management program|disease management program
311137|NCT01820767|Chronic Kidney Disease|chronic kidney disease
311138|NCT01820767|Vd-stadium.|vd-stadium.
311139|NCT01820767|Inflammatory patterns|inflammatory patterns
311140|NCT01820767|Paricalcitol|paricalcitol
311141|NCT01820767|Atorvastatin|atorvastatin
311142|NCT01820754|Non Small Cell Lung Cancer|non small cell lung cancer
311143|NCT01820754|Lung Cancer|lung cancer
311144|NCT01820754|Non Small Cell|non small cell
311145|NCT01820702|bone metabolism|bone metabolism
311146|NCT01820702|acid base balance|acid base balance
311147|NCT01820702|bed rest|bed rest
311148|NCT01820663|stroke|stroke
311149|NCT01820663|ketones|ketones
311150|NCT01820663|ketogenic diet|ketogenic diet
311151|NCT01820663|impairment|impairment
311152|NCT01820663|disability|disability
311153|NCT01820650|osteoarthritis|osteoarthritis
311154|NCT01820650|knee replacement|knee replacement
311155|NCT01820650|patient-specific|patient-specific
311156|NCT01820637|atherosclerosis|atherosclerosis
311157|NCT01820637|SFA|sfa
311158|NCT01820637|PPA|ppa
311159|NCT01820637|lower extremities|lower extremities
311160|NCT01820637|stenting|stenting
311161|NCT01820637|paclitaxel|paclitaxel
311162|NCT01820585|fibromyalgia|fibromyalgia
311163|NCT01820585|Eslicarbazepine acetate (BIA 2-093)|eslicarbazepine acetate (bia 2-093)
311164|NCT01820585|ESL|esl
311165|NCT01820559|migraine; ESL; eslicarbazepine acetate|migraine; esl; eslicarbazepine acetate
311166|NCT01820533|Smoking|smoking
311167|NCT01820533|Cellular phones|cellular phones
311168|NCT01820533|Low income population|low income population
311169|NCT01820507|Post-extubation respiratory failure|post-extubation respiratory failure
311170|NCT01820507|Endotracheal intubation|endotracheal intubation
311171|NCT01820507|Mechanical ventilation|mechanical ventilation
311172|NCT01820494|growth|growth
311173|NCT01820494|infants|infants
311174|NCT01820481|Asthma|asthma
311175|NCT01820481|Bronchial Diseases|bronchial diseases
311176|NCT01820481|Respiratory Tract Diseases|respiratory tract diseases
311177|NCT01820481|Lung Diseases, Obstructive|lung diseases, obstructive
311178|NCT01820481|Lung Diseases|lung diseases
311179|NCT01820455|MRSA decolonization|mrsa decolonization
311180|NCT01820455|MRSA subtyping|mrsa subtyping
311181|NCT01820455|MRSA infection rates|mrsa infection rates
311182|NCT01820442|lofexidine|lofexidine
311183|NCT01820442|buprenorphine|buprenorphine
311184|NCT01820442|interaction|interaction
311185|NCT01820442|pharmacodynamic|pharmacodynamic
311186|NCT01820442|ECG|ecg
311187|NCT01820442|QTc|qtc
311188|NCT01820429|Platelet aggregation|platelet aggregation
311189|NCT01820429|Aspirin|aspirin
311190|NCT01820416|Hearing Loss, Bilateral|hearing loss, bilateral
311191|NCT01820416|Hearing Loss, Sensorineural|hearing loss, sensorineural
311192|NCT01820390|Deep Brain Stimulation (DBS)|deep brain stimulation (dbs)
311193|NCT01820390|Parkinson's Disease|parkinson's disease
311194|NCT01820390|Essential Tremor|essential tremor
311195|NCT01820377|Peer-mentoring|peer-mentoring
311196|NCT01820377|Obesity|obesity
311197|NCT01820377|Type 2 Diabetes|type 2 diabetes
311198|NCT01820377|Physical Activity|physical activity
311199|NCT01820377|After-school program|after-school program
311200|NCT01820364|open-label study|open-label study
311201|NCT01820364|BRAF inhibitor|braf inhibitor
311202|NCT01820364|LGX818|lgx818
311203|NCT01820364|MEK1620|mek1620
311204|NCT01820364|MAPK1/2 inhibitor|mapk1/2 inhibitor
311205|NCT01820364|Pi3K inhibitor|pi3k inhibitor
311206|NCT01820364|FGFR|fgfr
311207|NCT01820364|c-Met|c-met
311208|NCT01820364|CDK4/6|cdk4/6
311209|NCT01820364|metastatic melanoma|metastatic melanoma
311210|NCT01820364|BRAF|braf
311211|NCT01820364|V600|v600
311212|NCT01820338|Children, Obesity, Intervention|children, obesity, intervention
311213|NCT01820325|Squamous non-small cell lung cancer|squamous non-small cell lung cancer
311214|NCT01820325|NSCLC|nsclc
311215|NCT01820325|stage IV|stage iv
311216|NCT01820325|BKM120|bkm120
311217|NCT01820286|Bipolar disorder|bipolar disorder
311218|NCT01820286|Depression|depression
311219|NCT01820286|Positive psychology|positive psychology
311220|NCT01820273|Type 2 diabetes|type 2 diabetes
311221|NCT01820273|Bariatric surgery|bariatric surgery
311222|NCT01820273|incretines|incretines
311223|NCT01820273|GLP-1|glp-1
311224|NCT01820273|GIP|gip
311225|NCT01820273|gastric bypass|gastric bypass
311226|NCT01820273|foregut|foregut
311227|NCT01820273|hindgut|hindgut
311228|NCT01820247|Crohn's Disease|crohn's disease
311229|NCT01820247|enteral nutrition|enteral nutrition
311230|NCT01820247|Tripterygium Glycosides|tripterygium glycosides
311231|NCT01820247|induction remission|induction remission
311232|NCT01820234|Skin cancer|skin cancer
311233|NCT01820234|Teledermatology|teledermatology
311234|NCT01820234|Screening|screening
311235|NCT01820234|Store-and-forward|store-and-forward
311236|NCT01820221|cesarean delivery|cesarean delivery
311237|NCT01820221|wound complications|wound complications
311238|NCT01820221|skin closure methods|skin closure methods
311239|NCT01820195|Contrast Nephropathy|contrast nephropathy
311240|NCT01820195|N-Acetyl Cystein|n-acetyl cystein
311241|NCT01820195|Prophylaxy|prophylaxy
311242|NCT01820117|long-term health outcomes|long-term health outcomes
311243|NCT01820078|Chronic|chronic
311244|NCT01820078|Kidney|kidney
311245|NCT01820078|Disease|disease
311246|NCT01820078|Proteinuria|proteinuria
311247|NCT01820078|Albuminuria|albuminuria
311248|NCT01820078|Paricalcitol|paricalcitol
311249|NCT01820052|Fibromyalgia|fibromyalgia
312239|NCT01815424|Tofacitinib|tofacitinib
311250|NCT01820039|e-health intervention|e-health intervention
311251|NCT01820039|infertility|infertility
311252|NCT01820039|primary care|primary care
311253|NCT01820039|referral rate|referral rate
311254|NCT01820026|healthcare infection cirrhosis antibiotic|healthcare infection cirrhosis antibiotic
311255|NCT01820013|Pelvic Girdle pain|pelvic girdle pain
311256|NCT01820013|Symphysis Pubis Dysfunction|symphysis pubis dysfunction
311257|NCT01820013|Sacroiliac Joint|sacroiliac joint
311258|NCT01820013|Sacroiliitis|sacroiliitis
311259|NCT01820013|Physiotherapy|physiotherapy
311260|NCT01820013|Physical Therapy|physical therapy
311261|NCT01820013|Orthotic Devices|orthotic devices
311262|NCT01819987|Overweight|overweight
311263|NCT01819987|mother|mother
311264|NCT01819987|childhood obesity prevention|childhood obesity prevention
311265|NCT01819987|Chinese American|chinese american
311266|NCT01819948|Breast cancer|breast cancer
311267|NCT01819948|Stage 0-IIIA|stage 0-iiia
311268|NCT01819948|No evidence of disease|no evidence of disease
311269|NCT01819935|MRSA. pneumonia|mrsa. pneumonia
311270|NCT01819935|outcomes|outcomes
311271|NCT01819922|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
311272|NCT01819922|metabolic parameters|metabolic parameters
311273|NCT01819922|Diabetes Mellitus Type 2|diabetes mellitus type 2
311274|NCT01819909|Rotator cuff repair|rotator cuff repair
311275|NCT01819909|Shoulder|shoulder
311276|NCT01819909|Surgery|surgery
311277|NCT01819909|Rehabilitation|rehabilitation
311278|NCT01819909|Pulleys|pulleys
311279|NCT01819909|Jackins|jackins
311280|NCT01819870|Carvedilol|carvedilol
311281|NCT01819870|Dilatrend SR capsule|dilatrend sr capsule
311282|NCT01819870|Dilatrend Tablet|dilatrend tablet
311283|NCT01819870|Pharmacokinetics|pharmacokinetics
311284|NCT01819870|Healthy male subjects|healthy male subjects
311285|NCT01819844|Closed-loop blood glucose control|closed-loop blood glucose control
311286|NCT01819844|Continuous glucose monitoring|continuous glucose monitoring
311287|NCT01819844|Bionic pancreas|bionic pancreas
311288|NCT01819844|Artificial pancreas|artificial pancreas
311289|NCT01819831|extremity soft tissue sarcoma|extremity soft tissue sarcoma
311290|NCT01819831|proton radiation|proton radiation
311291|NCT01819831|preoperative radiation|preoperative radiation
311292|NCT01819818|Schizophrenia|schizophrenia
311293|NCT01819818|Paliperidone palmitate|paliperidone palmitate
311294|NCT01819818|Invega|invega
311295|NCT01819818|Sustenna|sustenna
311296|NCT01819818|Korea|korea
311297|NCT01819805|Chronic pain|chronic pain
311298|NCT01819805|Chronic non-malignant pain|chronic non-malignant pain
311299|NCT01819805|Non-malignant|non-malignant
311300|NCT01819805|Pain|pain
311301|NCT01819805|Extended release tablet|extended release tablet
311302|NCT01819805|Tramadol hydrochloride|tramadol hydrochloride
311303|NCT01819805|Tramadol HCl|tramadol hcl
311304|NCT01819805|Acetaminophen|acetaminophen
311305|NCT01819805|Ultracet ER|ultracet er
311306|NCT01819792|Acute Myeloid Leukemia|acute myeloid leukemia
311307|NCT01819766|Cancer|cancer
311308|NCT01819766|Colorectal Cancer|colorectal cancer
311309|NCT01819766|Neoplasm|neoplasm
311310|NCT01819766|Colorectal Neoplasm|colorectal neoplasm
311311|NCT01819766|Intestinal Neoplasms|intestinal neoplasms
311312|NCT01819766|Gastrointestinal Neoplasms|gastrointestinal neoplasms
311313|NCT01819766|Digestive System Neoplasms|digestive system neoplasms
311314|NCT01819766|Neoplasms by Site|neoplasms by site
311315|NCT01819766|Neoplasms|neoplasms
311316|NCT01819766|Digestive System Diseases|digestive system diseases
311317|NCT01819766|Gastrointestinal Diseases|gastrointestinal diseases
311318|NCT01819766|Colonic Diseases|colonic diseases
311319|NCT01819766|Intestinal Diseases|intestinal diseases
311320|NCT01819766|Inflammatory Bowel Disease|inflammatory bowel disease
311321|NCT01819766|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
311322|NCT01819753|percutaneous nephrolithotomy|percutaneous nephrolithotomy
311323|NCT01819753|urinary Stones|urinary stones
311324|NCT01819753|99m-Technetium-Dimercaptosuccinic Acid|99m-technetium-dimercaptosuccinic acid
311325|NCT01819727|PKU|pku
311326|NCT01819727|PEG-PAL|peg-pal
311327|NCT01819727|BioMarin|biomarin
311328|NCT01819727|rAv-PAL PEG|rav-pal peg
311329|NCT01819727|BMN 165|bmn 165
311330|NCT01819727|open label|open label
311331|NCT01819727|Prism301|prism301
311332|NCT01819727|Pegvaliase|pegvaliase
311333|NCT01819714|Snoezelen|snoezelen
311334|NCT01819714|Multi-sensorial care session|multi-sensorial care session
311335|NCT01819714|Alzheimer's-type neurodegenerative disease|alzheimer's-type neurodegenerative disease
311336|NCT01819714|Dementia|dementia
311337|NCT01819688|laparoscopic liver resection|laparoscopic liver resection
311338|NCT01819688|cytokine release|cytokine release
311339|NCT01819675|Neuronal plasticity|neuronal plasticity
311340|NCT01819675|Neurotransmitter agents|neurotransmitter agents
311341|NCT01819675|Receptors, neurotransmitter|receptors, neurotransmitter
311342|NCT01819675|Transcranial magnetic stimulation|transcranial magnetic stimulation
311343|NCT01819675|Stroke|stroke
311344|NCT01819675|gamma-Aminobutyric Acid|gamma-aminobutyric acid
311345|NCT01819662|Pacemaker, heart failure, hospitalisation|pacemaker, heart failure, hospitalisation
311346|NCT01819649|selenium|selenium
311347|NCT01819649|selenium supplementation|selenium supplementation
311348|NCT01819649|randomised controlled trial|randomised controlled trial
311349|NCT01819649|prevention|prevention
311350|NCT01819636|Blood triglyceride|blood triglyceride
311351|NCT01819636|Bicarbonated mineral wate|bicarbonated mineral wate
311352|NCT01819636|Post-prandial triglyceridemia|post-prandial triglyceridemia
311353|NCT01819636|lipid metabolism|lipid metabolism
311354|NCT01819636|Cardiovascular risk|cardiovascular risk
311355|NCT01819623|Mild Cognitive Impairment|mild cognitive impairment
311356|NCT01819623|Cognitive training|cognitive training
311357|NCT01819610|Postoperative pain management|postoperative pain management
311358|NCT01819597|Intracranial Arterial Stenosis|intracranial arterial stenosis
311359|NCT01819597|Atherosclerosis|atherosclerosis
311360|NCT01819597|Stroke|stroke
311361|NCT01819597|EDAS|edas
311362|NCT01819597|Angiogenesis|angiogenesis
311363|NCT01819571|pulse pressure variation|pulse pressure variation
311364|NCT01819571|fluid responsiveness|fluid responsiveness
311365|NCT01819571|diastolic dysfunction|diastolic dysfunction
311366|NCT01819558|acute myeloid leukemia|acute myeloid leukemia
311367|NCT01819558|chronic myeloid leukemia|chronic myeloid leukemia
311368|NCT01819558|myelodysplastic syndrome|myelodysplastic syndrome
311369|NCT01819558|allograft|allograft
311370|NCT01819558|WT1 expression|wt1 expression
311371|NCT01819545|Alzheimer's disease|alzheimer's disease
311372|NCT01819545|diagnosis|diagnosis
311373|NCT01819545|MicRNA|micrna
311374|NCT01819545|mRNA|mrna
311375|NCT01819532|neonate|neonate
311376|NCT01819532|umbilical cord|umbilical cord
311377|NCT01819532|cord milking|cord milking
311378|NCT01819532|prematurity|prematurity
311379|NCT01819519|Intervention studies|intervention studies
311380|NCT01819519|Pregnancy|pregnancy
311381|NCT01819519|Cytomegalovirus Infections|cytomegalovirus infections
311382|NCT01819506|rehabilitation|rehabilitation
311383|NCT01819506|occupational therapy|occupational therapy
311384|NCT01819506|upper extremity|upper extremity
311385|NCT01819493|Diabetes Prevention|diabetes prevention
311386|NCT01819493|Lifestyle Intervention|lifestyle intervention
311387|NCT01819493|African American Families|african american families
311388|NCT01819480|Surgery|surgery
311389|NCT01819480|Robotic|robotic
311390|NCT01819480|Carcinoma|carcinoma
311391|NCT01819480|squamous cell of head and neck|squamous cell of head and neck
311392|NCT01819454|chronic rhinosinusitis|chronic rhinosinusitis
311393|NCT01819454|extraesophageal reflux|extraesophageal reflux
311394|NCT01819454|Restech system|restech system
311395|NCT01819454|antireflux therapy|antireflux therapy
311396|NCT01819441|cerebral small Vessel diseases, blood pressure,CCB, ACEI|cerebral small vessel diseases, blood pressure,ccb, acei
311397|NCT01819428|EGFR mutation|egfr mutation
311398|NCT01819428|Lung Adenocarcinoma|lung adenocarcinoma
311399|NCT01819428|Firstline therapy|firstline therapy
311400|NCT01819428|Second generation of tyrosine kinase|second generation of tyrosine kinase
311401|NCT01819415|wet AMD|wet amd
311402|NCT01819415|Omega-3|omega-3
311403|NCT01819415|VEGF|vegf
311404|NCT01819415|Lipidomics|lipidomics
311405|NCT01819415|DHA|dha
311406|NCT01819415|EPA|epa
311407|NCT01819402|visceral fat metabolism; FDG-PET/CT; pioglitazone; glimepiride; adiponectin|visceral fat metabolism; fdg-pet/ct; pioglitazone; glimepiride; adiponectin
311408|NCT01819389|Chronic myeloid leukemia|chronic myeloid leukemia
311409|NCT01819389|suboptimal response|suboptimal response
311410|NCT01819389|imatinib|imatinib
311411|NCT01819389|nilotinib|nilotinib
311412|NCT01819376|Obesity|obesity
311413|NCT01819376|Overweight|overweight
311414|NCT01819376|Adolescents|adolescents
311415|NCT01819376|Teenagers|teenagers
311416|NCT01819376|Facebook|facebook
311417|NCT01819376|Social Networks|social networks
311418|NCT01819363|Pleural effusion|pleural effusion
311419|NCT01819363|Pleural elastance|pleural elastance
311420|NCT01819363|Pleurodesis|pleurodesis
311421|NCT01819363|Quality of life|quality of life
311422|NCT01819363|Computed Tomography|computed tomography
311423|NCT01819350|Dental caries|dental caries
311424|NCT01819350|Sucrose|sucrose
311425|NCT01819350|Oral administration|oral administration
311426|NCT01819350|Ion Concentration of Hydrogen|ion concentration of hydrogen
311427|NCT01819350|Pediatric medicines|pediatric medicines
311428|NCT01819324|breast cancer survivors|breast cancer survivors
311429|NCT01819324|lifestyle intervention|lifestyle intervention
311430|NCT01819324|health behaviors|health behaviors
311431|NCT01819285|Malignant Neoplasm of Prostate|malignant neoplasm of prostate
311432|NCT01819285|Tumor-node-metastasis (TNM) Staging Regional Lymph Nodes (N0-2)|tumor-node-metastasis (tnm) staging regional lymph nodes (n0-2)
311433|NCT01819285|Not suitable for local treatment with curative intent|not suitable for local treatment with curative intent
311434|NCT01819259|Nonsmoker|nonsmoker
311435|NCT01819259|ADHD|adhd
311436|NCT01819259|Nicotine|nicotine
311437|NCT01819259|Nicotine Nasal Spray|nicotine nasal spray
311438|NCT01819259|Nicotine Reinforcement|nicotine reinforcement
311439|NCT01819181|TAVI|tavi
311440|NCT01819181|women|women
311441|NCT01819181|aortic stenosis|aortic stenosis
311442|NCT01819181|VARC2|varc2
311443|NCT01819155|influenza|influenza
311444|NCT01819155|influenza vaccine|influenza vaccine
311445|NCT01819155|immunogenicity|immunogenicity
311446|NCT01819155|Africa|africa
311447|NCT01819155|Senegal|senegal
311448|NCT01819142|non healing wound|non healing wound
311449|NCT01819142|pressure ulcer|pressure ulcer
311450|NCT01819116|Tissue Oxygen Saturation|tissue oxygen saturation
311451|NCT01819116|Management of the DNC Organ Donor|management of the dnc organ donor
311452|NCT01819103|Mortality|mortality
311453|NCT01819103|Acute Myocardial Infarction|acute myocardial infarction
311454|NCT01819103|Drug Adherence|drug adherence
311455|NCT01819103|Drug Compliance|drug compliance
311456|NCT01819103|Health-related quality of life|health-related quality of life
311457|NCT01819090|Neuromuscular disorder|neuromuscular disorder
311458|NCT01819090|Mechanical ventilation|mechanical ventilation
311459|NCT01819090|Speech|speech
311460|NCT01819090|Respiratory failure|respiratory failure
311461|NCT01819077|Cervical cancer|cervical cancer
311462|NCT01819077|TMMR|tmmr
311463|NCT01819077|therapeutic lymphadenectomy|therapeutic lymphadenectomy
311464|NCT01819077|register study|register study
311465|NCT01819064|Atropine|atropine
311466|NCT01819064|bradycardia|bradycardia
311467|NCT01819064|tachycardia|tachycardia
311468|NCT01819025|Depression|depression
311469|NCT01819025|Behavioral activation|behavioral activation
311470|NCT01819025|Smartphone application|smartphone application
311471|NCT01819025|Face-to-face|face-to-face
311472|NCT01819025|Blended therapy|blended therapy
311473|NCT01819012|Isoflurane|isoflurane
311474|NCT01819012|mitral valve annular velocity|mitral valve annular velocity
311475|NCT01819012|tissue Doppler imaging|tissue doppler imaging
311476|NCT01819012|Monitoring|monitoring
311477|NCT01819012|echocardiography|echocardiography
311478|NCT01818999|METASTATIC BREAST CANCER|metastatic breast cancer
311479|NCT01818973|Rectal Cancer|rectal cancer
311480|NCT01818973|Bevacizumab|bevacizumab
311481|NCT01818973|capecitabine|capecitabine
311482|NCT01818973|oxaliplatin|oxaliplatin
311483|NCT01818973|preoporative IMRT|preoporative imrt
311484|NCT01818960|Stent, Myocardial Infarction, Coronary Intervention|stent, myocardial infarction, coronary intervention
311485|NCT01818947|Lung cancer|lung cancer
311486|NCT01818947|epidermal growth factor receptor mutation|epidermal growth factor receptor mutation
311487|NCT01818947|gefitinib|gefitinib
311488|NCT01818947|Iressa|iressa
311489|NCT01818934|hip dysplasia|hip dysplasia
311490|NCT01818934|screening|screening
311491|NCT01818921|Beloranib|beloranib
311492|NCT01818921|ZGN-440|zgn-440
311493|NCT01818921|ZGN-440 for injectable suspension|zgn-440 for injectable suspension
311494|NCT01818921|ZGN-433|zgn-433
311495|NCT01818908|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
311496|NCT01818908|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
311497|NCT01818908|DA-EPOCH|da-epoch
311498|NCT01818908|rituximab|rituximab
311499|NCT01818895|Mechanical ventilation|mechanical ventilation
311500|NCT01818895|End of life|end of life
311501|NCT01818895|Extubation|extubation
311502|NCT01818895|Terminal weaning|terminal weaning
311503|NCT01818895|Complicated grief|complicated grief
311504|NCT01818882|Vscan|vscan
311505|NCT01818882|portable ultrasound|portable ultrasound
311506|NCT01818882|emergency care|emergency care
311507|NCT01818882|emergency room|emergency room
311508|NCT01818869|Safety,|safety,
311509|NCT01818869|tolerability,|tolerability,
311510|NCT01818869|Phase I,|phase i,
311511|NCT01818869|pharmacokinetic,|pharmacokinetic,
311512|NCT01818869|pharmacodynamic,|pharmacodynamic,
311513|NCT01818869|inhaled|inhaled
311514|NCT01818856|Chronic hepatitis C|chronic hepatitis c
311515|NCT01818856|HIV-infection|hiv-infection
311516|NCT01818856|Drug interaction|drug interaction
311517|NCT01818843|Carbon monoxide|carbon monoxide
311518|NCT01818843|safety|safety
311519|NCT01818843|Adverse Reaction|adverse reaction
311520|NCT01818843|newborn|newborn
311521|NCT01818817|Ultrasound-guided paravertebral block|ultrasound-guided paravertebral block
311522|NCT01818817|regional anesthesia|regional anesthesia
311523|NCT01818817|breast surgery|breast surgery
311524|NCT01818765|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
311525|NCT01818765|Endocardial|endocardial
311526|NCT01818765|Pacing|pacing
311527|NCT01818739|Endometrial Cancer|endometrial cancer
311528|NCT01818739|Robotic-Assisted Staging|robotic-assisted staging
311529|NCT01818726|Aplastic anemia, deferasirox, renal function|aplastic anemia, deferasirox, renal function
311530|NCT01818713|2B3-101, liposomal doxorubicin, leptomeningeal metastases|2b3-101, liposomal doxorubicin, leptomeningeal metastases
311531|NCT01818661|apraxia of speech|apraxia of speech
311532|NCT01818661|non-fluent aphasia|non-fluent aphasia
311533|NCT01818661|aphasia|aphasia
311534|NCT01818622|Bipolar disorder|bipolar disorder
311535|NCT01818622|Mania|mania
311536|NCT01818622|Blue-blockers|blue-blockers
311537|NCT01818622|Virtual darkness therapy|virtual darkness therapy
311538|NCT01818622|Actigraphy|actigraphy
311539|NCT01818622|Randomized controlled trial|randomized controlled trial
311540|NCT01818609|sarcopenia|sarcopenia
311541|NCT01818609|muscle|muscle
311542|NCT01818609|reduced activity|reduced activity
311543|NCT01818609|insulin sensitivity|insulin sensitivity
311545|NCT01818609|step reduction|step reduction
311546|NCT01818609|muscle protein synthesis|muscle protein synthesis
311547|NCT01818609|whey protein|whey protein
311548|NCT01818609|leg strength|leg strength
311549|NCT01818609|whole body protein|whole body protein
311550|NCT01818596|HIV|hiv
311551|NCT01818596|HIV-1 Infected|hiv-1 infected
311552|NCT01818596|Treatment Experienced|treatment experienced
311553|NCT01818596|Treatment Naive|treatment naive
311554|NCT01818583|Atrial fibrillation|atrial fibrillation
311555|NCT01818583|Atrial flutter|atrial flutter
311556|NCT01818583|Potassium|potassium
311557|NCT01818583|Cardioversion|cardioversion
311558|NCT01818570|Gastroesophageal Reflux|gastroesophageal reflux
311559|NCT01818557|glucose monitoring|glucose monitoring
311560|NCT01818557|gestational diabetes|gestational diabetes
311561|NCT01818544|Elastase Inhibition|elastase inhibition
311562|NCT01818531|Partial knee replacement|partial knee replacement
311563|NCT01818518|Preterm delivery|preterm delivery
311564|NCT01818518|Premature delivery|premature delivery
311565|NCT01818518|Premature birth|premature birth
311566|NCT01818505|antiphospholipid syndrome|antiphospholipid syndrome
311567|NCT01818505|gouty arthritis|gouty arthritis
311568|NCT01818505|Hyperuricemia|hyperuricemia
311569|NCT01818505|metabolic syndrome|metabolic syndrome
311570|NCT01818505|osteoarthritis|osteoarthritis
311571|NCT01818505|cardiovascular co-morbidities|cardiovascular co-morbidities
311572|NCT01818492|Emapalumab|emapalumab
311573|NCT01818453|Mood Disorders|mood disorders
311574|NCT01818453|Depression|depression
311575|NCT01818453|Genetics|genetics
311576|NCT01818453|Treatment response|treatment response
311577|NCT01818453|Treatment study|treatment study
311578|NCT01818440|Surgical Navigation|surgical navigation
311579|NCT01818440|Liver|liver
311580|NCT01818440|Cancer|cancer
311581|NCT01818440|Image-guided Therapy|image-guided therapy
311582|NCT01818427|hemmorhagic shock, plasma, air medical transport, randomized, multicenter|hemmorhagic shock, plasma, air medical transport, randomized, multicenter
311583|NCT01818414|Misoprostol administration & dosage|misoprostol administration & dosage
311584|NCT01818414|Abortion techniques|abortion techniques
311585|NCT01818414|Abortion Induced methods|abortion induced methods
311586|NCT01818414|Dilatation and Curettage|dilatation and curettage
311587|NCT01818401|Ancillary tailored|ancillary tailored
311588|NCT01818401|medico-economic study,|medico-economic study,
311589|NCT01818401|total knee replacement|total knee replacement
311590|NCT01818401|primary or secondary osteoarthritis|primary or secondary osteoarthritis
311591|NCT01818362|Influenza|influenza
311592|NCT01818362|T cells|t cells
311593|NCT01818349|stroke|stroke
311594|NCT01818349|exercise|exercise
311595|NCT01818349|muscle strength|muscle strength
311596|NCT01818349|gait|gait
311597|NCT01818349|rehabilitation|rehabilitation
311598|NCT01818336|penicillin allergy|penicillin allergy
311599|NCT01818323|Chimeric antigen receptor|chimeric antigen receptor
311600|NCT01818323|Immunotherapy|immunotherapy
311601|NCT01818323|Head and Neck Cancer|head and neck cancer
311602|NCT01818323|Phase I trial|phase i trial
311603|NCT01818323|Maximum tolerated dose|maximum tolerated dose
311604|NCT01818310|ischemia|ischemia
311605|NCT01818310|diabetes mellitus|diabetes mellitus
311606|NCT01818310|bone marrow aspirate concentrate (BMAC)|bone marrow aspirate concentrate (bmac)
311607|NCT01818284|Blood And Marrow Transplantation|blood and marrow transplantation
311608|NCT01818284|Normal allogeneic donors|normal allogeneic donors
311609|NCT01818284|Stem cell mobilization|stem cell mobilization
311610|NCT01818284|peripheral blood progenitor cells|peripheral blood progenitor cells
311611|NCT01818284|PBPC|pbpc
311612|NCT01818284|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
311613|NCT01818284|HSCT|hsct
311614|NCT01818284|Donating blood stem cells|donating blood stem cells
311615|NCT01818284|C-CSF|c-csf
311616|NCT01818284|Neupogen|neupogen
311617|NCT01818284|Filgrastim|filgrastim
311618|NCT01818284|Plerixafor|plerixafor
311619|NCT01818284|Mobozil|mobozil
311620|NCT01818284|Apheresis|apheresis
311621|NCT01818271|community-stroke-rehabilitation,|community-stroke-rehabilitation,
311622|NCT01818271|group-exercise,|group-exercise,
311623|NCT01818271|balance-mobility-exercise,|balance-mobility-exercise,
311624|NCT01818271|instrumented treadmill|instrumented treadmill
311626|NCT01818258|Children|children
311627|NCT01818258|HAART|haart
311628|NCT01818258|Malnourished|malnourished
311629|NCT01818219|Electrical activity of the diaphragm|electrical activity of the diaphragm
311630|NCT01818219|Neuro regulation of breathing|neuro regulation of breathing
311631|NCT01818219|Abnormal respiratory mechanics|abnormal respiratory mechanics
311632|NCT01818219|Assisted mechanical ventilation|assisted mechanical ventilation
311633|NCT01818219|Pressure support|pressure support
311634|NCT01818219|Neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
311635|NCT01818206|Cystic Fibrosis|cystic fibrosis
311636|NCT01818206|Bacteriophages|bacteriophages
311637|NCT01818206|Pseudomonas aeruginosa|pseudomonas aeruginosa
311638|NCT01818206|Sputum|sputum
311639|NCT01818193|Pulmonary transplant|pulmonary transplant
311640|NCT01818167|Hidradenitis Suppurativa|hidradenitis suppurativa
311642|NCT01818167|Acne Inversa|acne inversa
311643|NCT01818167|Velpeau's disease|velpeau's disease
311644|NCT01818167|Verneuil's disease|verneuil's disease
311645|NCT01818154|phototherapy|phototherapy
311646|NCT01818154|light emitting diode|light emitting diode
311647|NCT01818154|minimal erythema dose|minimal erythema dose
311648|NCT01818154|narrowband UVB|narrowband uvb
311649|NCT01818115|POAG|poag
311650|NCT01818115|PXG|pxg
311651|NCT01818115|IOL Surgery|iol surgery
311652|NCT01818115|CE Surgery|ce surgery
311653|NCT01818024|healthy volunteer|healthy volunteer
311654|NCT01818024|TNFR1|tnfr1
311655|NCT01818024|domain antibody|domain antibody
311656|NCT01818024|Lung injury|lung injury
311657|NCT01818011|Japanese, GSK1322322, pharmacokinetics, relative bioavailability, single dose, repeat dose, healthy subjects, dose-escalation, antimicrobial, over granulation,|japanese, gsk1322322, pharmacokinetics, relative bioavailability, single dose, repeat dose, healthy subjects, dose-escalation, antimicrobial, over granulation,
311658|NCT01817985|Hepatitis C (HCV) Infection|hepatitis c (hcv) infection
311659|NCT01817985|Moderate Hepatic Impairment|moderate hepatic impairment
311660|NCT01817985|Severe Hepatic Impairment|severe hepatic impairment
311661|NCT01817972|Crohn's Disease|crohn's disease
311662|NCT01817972|Crohn's colitis|crohn's colitis
311663|NCT01817972|Crohn's ileocolitis|crohn's ileocolitis
311664|NCT01817959|Pancreatic islet transplantation|pancreatic islet transplantation
311665|NCT01817959|Diabetes Mellitus Type 1|diabetes mellitus type 1
311666|NCT01817959|Islet transplantation graft survival & function|islet transplantation graft survival & function
311667|NCT01817946|Congenital Myopathy|congenital myopathy
311668|NCT01817946|Centronuclear Myopathy|centronuclear myopathy
311669|NCT01817946|Myotubular Myopathy|myotubular myopathy
311670|NCT01817946|Myotubularin|myotubularin
311671|NCT01817946|MTM1 Gene|mtm1 gene
311672|NCT01817946|Genetic testing|genetic testing
311673|NCT01817946|Sequencing|sequencing
311674|NCT01817946|Deletion/Duplication Mutation|deletion/duplication mutation
311675|NCT01817946|CGH array|cgh array
311676|NCT01817907|Apnea- Hypopnea index|apnea- hypopnea index
311677|NCT01817907|Arousal Threshold|arousal threshold
311678|NCT01817894|Unwanted facial hair growth|unwanted facial hair growth
311679|NCT01817868|Hemophilia|hemophilia
311680|NCT01817868|Turkey|turkey
311681|NCT01817868|Observational|observational
311682|NCT01817868|Adult|adult
311683|NCT01817855|Phase 1,|phase 1,
311684|NCT01817855|Safety,|safety,
311685|NCT01817855|Tolerability,|tolerability,
311686|NCT01817855|Healthy,|healthy,
311687|NCT01817855|COPD patients|copd patients
311688|NCT01817842|mHealth|mhealth
311689|NCT01817842|EMA|ema
311690|NCT01817842|Ecological Momentary Assessment|ecological momentary assessment
311691|NCT01817842|Personal Informatics|personal informatics
311692|NCT01817842|Tobacco Quitline|tobacco quitline
311693|NCT01817803|Heart failure|heart failure
311694|NCT01817803|diuretics|diuretics
311695|NCT01817803|kidney|kidney
311696|NCT01817803|glomerular filtration rate|glomerular filtration rate
311697|NCT01817777|Socioeconomic category|socioeconomic category
311698|NCT01817777|Medication compliance|medication compliance
311699|NCT01817777|Metformin|metformin
311700|NCT01817777|small pack|small pack
311701|NCT01817764|umeclidinium bromide (UMEC)|umeclidinium bromide (umec)
311702|NCT01817764|vilanterol (VI)|vilanterol (vi)
311703|NCT01817764|salmeterol (SAL)|salmeterol (sal)
311704|NCT01817764|fluticasone propionate (FP)|fluticasone propionate (fp)
311705|NCT01817764|Novel Dry Powder Inhaler (NDPI)|novel dry powder inhaler (ndpi)
311706|NCT01817764|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
311707|NCT01817764|GW642444|gw642444
311708|NCT01817764|GSK573719|gsk573719
311709|NCT01817764|lung function|lung function
311710|NCT01817751|central nervous system|central nervous system
311711|NCT01817751|Brain and Nervous System|brain and nervous system
311712|NCT01817738|Metastatic|metastatic
311713|NCT01817738|Castrate-refractory|castrate-refractory
311714|NCT01817725|Therapeutic vaccine|therapeutic vaccine
311715|NCT01817725|HBsAg clearance|hbsag clearance
311716|NCT01817725|Immune clearance|immune clearance
311717|NCT01817725|HBsAg clearance induced by vaccination|hbsag clearance induced by vaccination
311718|NCT01817725|s seroconversion in carriers after vaccination|s seroconversion in carriers after vaccination
311719|NCT01817712|Posttraumatic neuroses|posttraumatic neuroses
311720|NCT01817712|posttraumatic stress disorder|posttraumatic stress disorder
311721|NCT01817712|PTSD|ptsd
311722|NCT01817712|Supported employment|supported employment
311723|NCT01817712|IPS|ips
311724|NCT01817712|CWT|cwt
311725|NCT01817712|TWP|twp
311726|NCT01817712|Individual placement and support|individual placement and support
311727|NCT01817712|Compensated work therapy|compensated work therapy
311728|NCT01817712|Transitional work program|transitional work program
311729|NCT01817699|Cholecalciferol|cholecalciferol
311730|NCT01817699|Methoxy polyethylene glycol-epoetin beta|methoxy polyethylene glycol-epoetin beta
311731|NCT01817699|Hematinics|hematinics
311732|NCT01817699|Bone Diseases, Metabolic|bone diseases, metabolic
311733|NCT01817699|Neoplasms|neoplasms
311734|NCT01817699|Cardiovascular Diseases|cardiovascular diseases
311735|NCT01817699|Graft Rejection|graft rejection
311736|NCT01817660|popliteal artery aneurysm|popliteal artery aneurysm
311737|NCT01817660|endovascular repair|endovascular repair
311738|NCT01817660|open surgical repair|open surgical repair
311739|NCT01817660|comparative study|comparative study
311741|NCT01817647|Enhanced recovery after surgery (ERAS)|enhanced recovery after surgery (eras)
311742|NCT01817647|reduce postoperative complications|reduce postoperative complications
311743|NCT01817647|increased risk of delayed diagnosis and treatment of AL|increased risk of delayed diagnosis and treatment of al
311744|NCT01817647|diagnose anastomotic leak|diagnose anastomotic leak
311745|NCT01817634|Malnutrition.|malnutrition.
311746|NCT01817621|Body Image Disturbance|body image disturbance
311747|NCT01817621|Medication Adherence|medication adherence
311748|NCT01817621|Sexual Risk Behavior|sexual risk behavior
311749|NCT01817621|HIV|hiv
311750|NCT01817621|MSM|msm
311751|NCT01817608|sf-36|sf-36
311752|NCT01817608|Katz|katz
311753|NCT01817595|Type 2 Diabetes|type 2 diabetes
311754|NCT01817595|Internet Blood Glucose Monitoring|internet blood glucose monitoring
311755|NCT01817595|iphone|iphone
311756|NCT01817595|meter|meter
311757|NCT01817582|Dry Eye Disease|dry eye disease
311758|NCT01817569|Diabetes Mellitus (DM)|diabetes mellitus (dm)
311759|NCT01817569|Byetta|byetta
311760|NCT01817569|Exenatide|exenatide
311761|NCT01817543|venous leg ulcers|venous leg ulcers
311762|NCT01817543|non healing wounds|non healing wounds
311763|NCT01817530|Uterine Fibroids|uterine fibroids
311764|NCT01817530|Leiomyomata|leiomyomata
311765|NCT01817530|Elagolix|elagolix
311766|NCT01817530|Menorrhagia|menorrhagia
311767|NCT01817530|Elagolix sodium|elagolix sodium
311768|NCT01817530|Heavy Uterine Bleeding|heavy uterine bleeding
311769|NCT01817530|ABT-620|abt-620
311770|NCT01817504|Renal failure,|renal failure,
311771|NCT01817504|Transplantectomy|transplantectomy
311772|NCT01817504|Immunosuppression|immunosuppression
311773|NCT01817504|Sensitization|sensitization
311774|NCT01817491|Vegan Diet|vegan diet
311775|NCT01817491|Hypercholesterolemia|hypercholesterolemia
311776|NCT01817491|American Heart Association Diet|american heart association diet
311777|NCT01817491|Cardiovascular Risk|cardiovascular risk
311778|NCT01817491|Obesity|obesity
311779|NCT01817478|conjunctival flora|conjunctival flora
311780|NCT01817439|oral Amiodarone|oral amiodarone
311781|NCT01817439|IV Amiodarone|iv amiodarone
311782|NCT01817439|phlebitis|phlebitis
311783|NCT01817439|thrombophlebitis|thrombophlebitis
311784|NCT01817439|adverse events|adverse events
311785|NCT01817413|Calcium hydroxide|calcium hydroxide
311786|NCT01817413|Pulp regeneration|pulp regeneration
311787|NCT01817413|Regenerative endodontics|regenerative endodontics
311788|NCT01817413|Pulp revitalisation|pulp revitalisation
311789|NCT01817413|Triple antibiotic paste|triple antibiotic paste
311790|NCT01817413|Root canal therapy|root canal therapy
311791|NCT01817413|Root end closure|root end closure
311792|NCT01817413|Tooth root|tooth root
311793|NCT01817413|Tooth apex|tooth apex
311794|NCT01817413|Dental trauma|dental trauma
311795|NCT01817413|Non-vital|non-vital
311796|NCT01817413|Immature|immature
311797|NCT01817413|Incisor|incisor
311798|NCT01817413|Periapical periodontitis|periapical periodontitis
311799|NCT01817413|Dental pulp|dental pulp
311800|NCT01817374|Breast Cancer|breast cancer
311801|NCT01817374|Definity|definity
311802|NCT01817374|Ultrasound|ultrasound
311803|NCT01817361|oral health|oral health
311804|NCT01817348|Adhesive capsulitis|adhesive capsulitis
311805|NCT01817348|Frozen shoulder|frozen shoulder
311806|NCT01817348|Shoulder pain|shoulder pain
311807|NCT01817348|Intra-articular injection|intra-articular injection
311808|NCT01817348|Lidocaine injection|lidocaine injection
311809|NCT01817348|Physiotherapy|physiotherapy
311810|NCT01817348|Manipulation|manipulation
311811|NCT01817348|Stretch exercise|stretch exercise
311812|NCT01817322|kidney transplantation|kidney transplantation
311813|NCT01817309|renal failure|renal failure
311814|NCT01817309|survival|survival
311815|NCT01817309|peritoneal failure|peritoneal failure
311816|NCT01817296|Klinefelter|klinefelter
311817|NCT01817296|Fertility|fertility
311818|NCT01817283|HIV-infected immunological non-responders|hiv-infected immunological non-responders
311819|NCT01817283|Triptolide|triptolide
311820|NCT01817283|immune activation|immune activation
311821|NCT01817283|inflammation|inflammation
311822|NCT01817283|CD4 T cell|cd4 t cell
311823|NCT01817257|Cancer|cancer
311824|NCT01817257|Thrombosis|thrombosis
311825|NCT01817257|Venous thromboembolism|venous thromboembolism
311826|NCT01817257|Deep vein thrombosis|deep vein thrombosis
311827|NCT01817257|Pulmonary embolus|pulmonary embolus
311828|NCT01817244|care management|care management
311829|NCT01817244|depression|depression
311830|NCT01817244|elderly|elderly
311831|NCT01817244|Korea|korea
311832|NCT01817231|breast cancer|breast cancer
311833|NCT01817231|vitamin D|vitamin d
311834|NCT01817231|25 OH vitamin D|25 oh vitamin d
311835|NCT01817218|PRP|prp
311836|NCT01817218|chronic vascular ulcer|chronic vascular ulcer
311837|NCT01817218|primary care|primary care
311838|NCT01817192|Non-Squamous|non-squamous
311839|NCT01817192|Adjuvant Chemotherapy|adjuvant chemotherapy
311840|NCT01817179|hemiplegia, cerebral palsy, neuroprosthesis, children|hemiplegia, cerebral palsy, neuroprosthesis, children
311841|NCT01817166|cholecalciferol|cholecalciferol
311842|NCT01817166|vitamin D|vitamin d
311843|NCT01817166|immune disease|immune disease
311844|NCT01817166|clinically isolated syndrome|clinically isolated syndrome
311845|NCT01817140|oral cancer|oral cancer
311846|NCT01817140|mandibular invasion|mandibular invasion
311847|NCT01817140|SWIFT MRI|swift mri
311848|NCT01817114|Remote Ischemic Conditioning|remote ischemic conditioning
311849|NCT01817114|PCI|pci
311850|NCT01817114|STEMI|stemi
311851|NCT01817114|LAD|lad
311852|NCT01817088|Deep Brain Stimulation (DBS)|deep brain stimulation (dbs)
311853|NCT01817088|Parkinson disease|parkinson disease
311854|NCT01817088|Stereotaxis Technique|stereotaxis technique
311855|NCT01817088|Subthalamic nucleus|subthalamic nucleus
311856|NCT01817062|Capillary leakage|capillary leakage
311857|NCT01817062|Acute Abdomen|acute abdomen
311858|NCT01817062|Low birth weight|low birth weight
311859|NCT01817049|prevention|prevention
311860|NCT01817049|sport injury|sport injury
311861|NCT01817049|soccer|soccer
311862|NCT01817049|youth|youth
311863|NCT01817049|neuromuscular training|neuromuscular training
311864|NCT01817049|intervention|intervention
311865|NCT01817049|behaviour|behaviour
311866|NCT01817036|vitamin D|vitamin d
311867|NCT01817036|deficiency|deficiency
311868|NCT01817036|dose response|dose response
311869|NCT01817023|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
311870|NCT01817023|current chemotherapy|current chemotherapy
311871|NCT01817023|intensity-modulated radiotherapy|intensity-modulated radiotherapy
311872|NCT01817023|low-risk|low-risk
311873|NCT01817010|Total Hip Arthroplasty|total hip arthroplasty
311874|NCT01817010|Muscle Strength|muscle strength
311875|NCT01817010|Hip Osteoarthritis|hip osteoarthritis
311876|NCT01816997|Statins|statins
311877|NCT01816997|Glucose homeostasis|glucose homeostasis
311878|NCT01816997|Diabetes|diabetes
311879|NCT01816997|Impaired fasting glucose|impaired fasting glucose
311880|NCT01816958|thalamocortical dysrhythmia|thalamocortical dysrhythmia
311881|NCT01816958|transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
311882|NCT01816958|transcranial Electrical Stimulation (tES)|transcranial electrical stimulation (tes)
311883|NCT01816958|(N-methyl-D-aspartate) NMDA-R antagonist|(n-methyl-d-aspartate) nmda-r antagonist
311884|NCT01816958|ketamine infusion|ketamine infusion
311885|NCT01816958|neuromodulation|neuromodulation
311886|NCT01816958|synergistic effect|synergistic effect
311887|NCT01816958|remission|remission
311888|NCT01816945|Depression|depression
311889|NCT01816945|Stress|stress
311890|NCT01816945|Social support|social support
311891|NCT01816945|Social capital|social capital
311892|NCT01816945|Maternal|maternal
311893|NCT01816893|Hypoglycemia|hypoglycemia
311894|NCT01816893|Autonomic Nervous System|autonomic nervous system
311895|NCT01816893|baroreflex sensitivity|baroreflex sensitivity
311896|NCT01816893|muscle sympathetic nerve activity|muscle sympathetic nerve activity
311897|NCT01816893|lower body negative pressure|lower body negative pressure
311898|NCT01816867|hernia|hernia
311899|NCT01816867|Treatment|treatment
311900|NCT01816867|laparoscopic|laparoscopic
311901|NCT01816867|open technique|open technique
311902|NCT01816854|SFA,|sfa,
311903|NCT01816854|stent,|stent,
311904|NCT01816854|endovascular|endovascular
311905|NCT01816854|Patient outcome|patient outcome
311906|NCT01816841|Direct Visual Fluorescense|direct visual fluorescense
311907|NCT01816841|Oral Examination|oral examination
311908|NCT01816841|oral cancer|oral cancer
311909|NCT01816828|HIV, MSM, unprotected anal intercourse, sexual health|hiv, msm, unprotected anal intercourse, sexual health
311910|NCT01816815|PK/PD|pk/pd
311911|NCT01816815|BAY1002670|bay1002670
311912|NCT01816802|In vitro fertilization|in vitro fertilization
311913|NCT01816802|Assisted reproductive therapy|assisted reproductive therapy
311914|NCT01816802|Time-lapse image recording|time-lapse image recording
311915|NCT01816802|Image analysis software|image analysis software
311916|NCT01816789|Starting dose|starting dose
311917|NCT01816789|rFSH|rfsh
311918|NCT01816789|controlled|controlled
311919|NCT01816789|ovarian|ovarian
311920|NCT01816789|stimulation|stimulation
311921|NCT01816789|IVF/ICSI|ivf/icsi
311922|NCT01816789|cycles|cycles
311923|NCT01816763|Health Care Quality, Access, and Evaluation|health care quality, access, and evaluation
311924|NCT01816763|Primary Health Care|primary health care
311925|NCT01816763|Medical Informatics|medical informatics
311926|NCT01816750|CT coronary angiography|ct coronary angiography
311927|NCT01816750|Coronary disease|coronary disease
311928|NCT01816750|Gemstone Spectral Imaging|gemstone spectral imaging
311929|NCT01816750|Diagnostic value|diagnostic value
311930|NCT01816750|Adaptive statistical iterative reconstruction|adaptive statistical iterative reconstruction
311931|NCT01816750|iterative reconstruction|iterative reconstruction
311932|NCT01816750|Feasibility of coronary and myocardial assessment|feasibility of coronary and myocardial assessment
311933|NCT01816750|novel Cardiac CT GSI protocol|novel cardiac ct gsi protocol
311934|NCT01816724|NOCTURIA|nocturia
311935|NCT01816724|SYMPTOMATIC QUESTIONNAIRE|symptomatic questionnaire
311936|NCT01816724|N-QOL|n-qol
311937|NCT01816711|Frail elderly|frail elderly
311938|NCT01816711|Hip fracture|hip fracture
311939|NCT01816711|Vitamin D|vitamin d
311940|NCT01816711|Geriatrics|geriatrics
311941|NCT01816698|Hypertension|hypertension
311942|NCT01816698|Taurine|taurine
311943|NCT01816698|Metabolism|metabolism
311944|NCT01816672|Wagner 1|wagner 1
311945|NCT01816672|Wagner 2|wagner 2
311946|NCT01816672|Non healing diabetic foot wound|non healing diabetic foot wound
311947|NCT01816659|Colorectal Carcinoma|colorectal carcinoma
311948|NCT01816659|Endoscopically Non- Resectable Adenomas|endoscopically non- resectable adenomas
311949|NCT01816659|Colonic lesion|colonic lesion
311950|NCT01816659|Biomarker|biomarker
311951|NCT01816659|Metformin-ER|metformin-er
311952|NCT01816659|Metformin|metformin
311953|NCT01816659|Extended release|extended release
311954|NCT01816659|Colonoscopy|colonoscopy
311955|NCT01816659|Colon cancer surgery|colon cancer surgery
311956|NCT01816646|Blood And Marrow Transplantation|blood and marrow transplantation
311957|NCT01816646|Hemorrhagic Cystitis|hemorrhagic cystitis
311958|NCT01816646|Bleeding from bladder|bleeding from bladder
311959|NCT01816646|Foley catheter|foley catheter
311960|NCT01816646|Probenecid|probenecid
311961|NCT01816646|Cidofovir|cidofovir
311962|NCT01816646|Vistide|vistide
311963|NCT01816633|non healing wound|non healing wound
311964|NCT01816620|POEMS Syndrome|poems syndrome
311965|NCT01816620|lenalidomide|lenalidomide
311966|NCT01816620|newly diagnosed|newly diagnosed
311967|NCT01816620|plasma cell disorder|plasma cell disorder
311968|NCT01816620|Dexamethasone|dexamethasone
311969|NCT01816607|Magnetic Resonance Imaging|magnetic resonance imaging
311970|NCT01816607|Magnetic Resonance Imaging, Functional|magnetic resonance imaging, functional
311971|NCT01816594|HER2, breast cancer, neoadjuvant, PI3K inhibitor, first line chemotherapy, trastuzumab, GBG, SOLTI, BIG|her2, breast cancer, neoadjuvant, pi3k inhibitor, first line chemotherapy, trastuzumab, gbg, solti, big
311972|NCT01816568|appendicitis, laparoscopy, single incision|appendicitis, laparoscopy, single incision
311973|NCT01816542|patch-testing|patch-testing
311974|NCT01816542|personal-care|personal-care
311975|NCT01816542|cosmetic|cosmetic
311976|NCT01816542|dermatitis|dermatitis
311977|NCT01816542|allergy|allergy
311978|NCT01816542|sensitive skin|sensitive skin
311979|NCT01816516|childhood obesity|childhood obesity
311980|NCT01816516|low-income|low-income
311981|NCT01816516|maternal responsiveness|maternal responsiveness
311982|NCT01816516|infant feeding|infant feeding
311983|NCT01816516|infant feeding practices|infant feeding practices
311984|NCT01816516|infant feeding style|infant feeding style
311985|NCT01816516|primary prevention|primary prevention
311986|NCT01816503|Pain|pain
311987|NCT01816503|Cancer pain|cancer pain
311988|NCT01816503|Fentanyl|fentanyl
311989|NCT01816503|Fentanyl matrix|fentanyl matrix
311990|NCT01816503|Opioid analgesic|opioid analgesic
311991|NCT01816464|Influenza|influenza
311992|NCT01816464|Vaccination|vaccination
311993|NCT01816451|aerobic capacity|aerobic capacity
311994|NCT01816451|cardiorespiratory training|cardiorespiratory training
311995|NCT01816451|blood lactate concentration|blood lactate concentration
311996|NCT01816451|heart rate|heart rate
311997|NCT01816438|abnormal histological colorectal lesions|abnormal histological colorectal lesions
311998|NCT01816425|Dental Prosthesis|dental prosthesis
311999|NCT01816425|Dental Prosthesis Design|dental prosthesis design
312000|NCT01816412|Arms|arms
312001|NCT01816412|Experimental|experimental
312002|NCT01816412|Drug Coated Angioplasty Balloon|drug coated angioplasty balloon
312003|NCT01816412|Active Comparator|active comparator
312004|NCT01816412|Standard angioplasty balloon|standard angioplasty balloon
312005|NCT01816386|acupuncture|acupuncture
312006|NCT01816386|anaesthetic recovery|anaesthetic recovery
312007|NCT01816386|perioperative care|perioperative care
312008|NCT01816386|Age 18+|age 18+
312009|NCT01816386|ASA-score ≤ 2|asa-score ≤ 2
312010|NCT01816386|Surgery: Uterus|surgery: uterus
312011|NCT01816386|Surgery: Adnex|surgery: adnex
312012|NCT01816386|Surgery: Ovaries|surgery: ovaries
312013|NCT01816373|Chest wall; Chest, funnel; pectus excavatum; congenital abnormality|chest wall; chest, funnel; pectus excavatum; congenital abnormality
312014|NCT01816360|Womens health|womens health
312015|NCT01816360|Menopause|menopause
312016|NCT01816360|Complementary therapies|complementary therapies
312017|NCT01816360|Aromatherapy|aromatherapy
312018|NCT01816360|Essential oils|essential oils
312019|NCT01816360|Yogatherapy|yogatherapy
312020|NCT01816360|Psychoneuroendocrineimmunology|psychoneuroendocrineimmunology
312021|NCT01816334|sciatica|sciatica
312022|NCT01816334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
312023|NCT01816334|Glucocorticoids|glucocorticoids
312024|NCT01816308|AF|af
312025|NCT01816308|MCI|mci
312026|NCT01816282|TKR|tkr
312027|NCT01816282|Blood loss|blood loss
312028|NCT01816282|Fibrin Sealant|fibrin sealant
312029|NCT01816269|Helicobacter pylori|helicobacter pylori
312030|NCT01816269|Dental scaling|dental scaling
312031|NCT01816269|Eradication|eradication
312032|NCT01816269|Reinfection|reinfection
312033|NCT01816269|Helicobacter status|helicobacter status
312034|NCT01816243|Chronic Pain|chronic pain
312035|NCT01816243|Chronic Non-Malignant Pain|chronic non-malignant pain
312036|NCT01816243|TTS-fentanyl|tts-fentanyl
312037|NCT01816243|Durogesic|durogesic
312038|NCT01816217|Difficult intubation|difficult intubation
312039|NCT01816217|Complications|complications
312040|NCT01816217|Intensive care units|intensive care units
312041|NCT01816217|Videolaryngoscope|videolaryngoscope
312042|NCT01816217|Laryngoscopy|laryngoscopy
312043|NCT01816204|anxiety treatment|anxiety treatment
312044|NCT01816204|anxiety online treatment|anxiety online treatment
312045|NCT01816204|anxiety electronic treatment|anxiety electronic treatment
312046|NCT01816204|anxiety therapist assisted|anxiety therapist assisted
312047|NCT01816178|Autism spectrum Disorders|autism spectrum disorders
312048|NCT01816178|Voice Output Communication|voice output communication
312049|NCT01816165|diabetes|diabetes
312050|NCT01816165|insulin|insulin
312051|NCT01816165|blood vessel|blood vessel
312052|NCT01816165|type 1|type 1
312053|NCT01816152|light treatment|light treatment
312054|NCT01816152|circadian rhythms|circadian rhythms
312055|NCT01816152|sleep|sleep
312056|NCT01816152|agitation|agitation
312057|NCT01816152|depression|depression
312058|NCT01816139|vaginal dryness|vaginal dryness
312059|NCT01816139|vaginal atrophy|vaginal atrophy
312060|NCT01816139|estrogen|estrogen
312061|NCT01816113|PvDBP|pvdbp
312062|NCT01816113|Malaria|malaria
312063|NCT01816113|Plasmodium vivax|plasmodium vivax
312064|NCT01816100|multiple sclerosis|multiple sclerosis
312065|NCT01816100|exercise|exercise
312066|NCT01816100|MEG|meg
312067|NCT01816100|DTI|dti
312068|NCT01816100|Brain changes|brain changes
312069|NCT01816074|Mothers|mothers
312070|NCT01816074|ADHD|adhd
312071|NCT01816074|Treatment|treatment
312072|NCT01816074|Child|child
312073|NCT01816061|Veterans Health|veterans health
312074|NCT01816061|Social Adjustment|social adjustment
312075|NCT01816061|Traumatic Brain Injury (TBI)|traumatic brain injury (tbi)
312076|NCT01816061|Post-Traumatic Stress Disorder (PTSD)|post-traumatic stress disorder (ptsd)
312077|NCT01816061|Independent Living|independent living
312078|NCT01816061|Goals|goals
312079|NCT01816061|Education|education
312080|NCT01816048|prostate, prostate cancer|prostate, prostate cancer
312081|NCT01816022|CMPN|cmpn
312082|NCT01816022|Fracture|fracture
312083|NCT01816022|Osteoporosis|osteoporosis
312084|NCT01816022|Biochemical Bone Markers|biochemical bone markers
312085|NCT01816009|infection|infection
312086|NCT01816009|antibiotic|antibiotic
312087|NCT01816009|prosthesis|prosthesis
312088|NCT01815996|Pregnancy|pregnancy
312089|NCT01815996|pulmonary embolism|pulmonary embolism
312090|NCT01815996|myocardial infarction|myocardial infarction
312091|NCT01815996|autoimmune disease|autoimmune disease
312092|NCT01815996|healthy controls|healthy controls
312093|NCT01815983|Laryngoscopy|laryngoscopy
312094|NCT01815983|Tracheal Intubation|tracheal intubation
312095|NCT01815983|Video Laryngoscopy|video laryngoscopy
312096|NCT01815970|dyspnea|dyspnea
312097|NCT01815970|exercise|exercise
312098|NCT01815970|neuromechanical uncoupling|neuromechanical uncoupling
312099|NCT01815970|COPD|copd
312100|NCT01815970|pulmonary rehabilitation|pulmonary rehabilitation
312101|NCT01815957|coronary microcirculation|coronary microcirculation
312102|NCT01815957|coronary artery disease|coronary artery disease
312103|NCT01815957|myocardial disease|myocardial disease
312104|NCT01815957|ischemia|ischemia
312105|NCT01815944|onset time|onset time
312106|NCT01815944|ultrasound-guided supraclavicular block|ultrasound-guided supraclavicular block
312107|NCT01815944|ropivacaine|ropivacaine
312108|NCT01815944|normal saline|normal saline
312109|NCT01815944|dextrose 5%|dextrose 5%
312110|NCT01815918|Orthopedic Procedures|orthopedic procedures
312111|NCT01815918|Prostheses and Implants|prostheses and implants
312112|NCT01815918|Joint Prosthesis|joint prosthesis
312113|NCT01815918|Knee Prosthesis|knee prosthesis
312114|NCT01815918|Arthroplasty, Knee|arthroplasty, knee
312115|NCT01815918|Thromboembolism|thromboembolism
312116|NCT01815918|Inflammation|inflammation
312117|NCT01815918|B-Cell Differentiation Factor-2|b-cell differentiation factor-2
312118|NCT01815918|Differentiation Factor-2, B-Cell|differentiation factor-2, b-cell
312119|NCT01815918|B-Cell Stimulatory Factor-2|b-cell stimulatory factor-2
312121|NCT01815918|IFN-beta 2|ifn-beta 2
312122|NCT01815918|MGI-2|mgi-2
312123|NCT01815918|Interleukin-6 (IL-6)|interleukin-6 (il-6)
312124|NCT01815918|Steroids|steroids
312125|NCT01815918|Pregnenediones|pregnenediones
312126|NCT01815918|Hydrocortisone|hydrocortisone
312127|NCT01815918|Physiological Effects of Drugs|physiological effects of drugs
312128|NCT01815918|Therapeutic Uses|therapeutic uses
312129|NCT01815892|Hemodialysis|hemodialysis
312130|NCT01815892|Response to Furosemide|response to furosemide
312131|NCT01815879|metastatic colorectal cancer|metastatic colorectal cancer
312132|NCT01815879|liver metastases|liver metastases
312133|NCT01815879|90Y resin microsphere radioembolization|90y resin microsphere radioembolization
312134|NCT01815879|retrospective data analysis|retrospective data analysis
312135|NCT01815866|Positive Nontuberculous Mycobacteria|positive nontuberculous mycobacteria
312136|NCT01815853|pre-operative,|pre-operative,
312137|NCT01815853|chemoradiotherapy,|chemoradiotherapy,
312138|NCT01815853|chemotherapy,|chemotherapy,
312139|NCT01815853|treatment|treatment
312140|NCT01815853|outcome|outcome
312141|NCT01815814|spasticity|spasticity
312142|NCT01815814|cerebral palsy|cerebral palsy
312143|NCT01815814|hemiplegia|hemiplegia
312144|NCT01815814|hemiparesis|hemiparesis
312145|NCT01815814|diplegia|diplegia
312146|NCT01815814|paraplegia|paraplegia
312147|NCT01815814|quadriplegia|quadriplegia
312148|NCT01815814|quadriparesis|quadriparesis
312149|NCT01815775|Normal pressure hydrocephalus|normal pressure hydrocephalus
312150|NCT01815775|flow MRI|flow mri
312151|NCT01815775|dementia|dementia
312152|NCT01815775|cerebrospinal fluid|cerebrospinal fluid
312153|NCT01815775|shunt|shunt
312154|NCT01815762|bioimpedance|bioimpedance
312155|NCT01815762|overhydration|overhydration
312156|NCT01815762|hemodialysis|hemodialysis
312157|NCT01815762|arterial stiffness|arterial stiffness
312158|NCT01815762|mortality|mortality
312159|NCT01815736|HIV|hiv
312160|NCT01815736|HIV 1 Infected|hiv 1 infected
312161|NCT01815736|Virologically-Suppressed|virologically-suppressed
312162|NCT01815723|Psoriasis|psoriasis
312163|NCT01815723|Dimethyl fumarate|dimethyl fumarate
312164|NCT01815723|Fumaderm®|fumaderm®
312165|NCT01815710|Clinical Pathways|clinical pathways
312166|NCT01815710|Knowledge translation|knowledge translation
312167|NCT01815710|Evaluation|evaluation
312168|NCT01815697|Lower Urinary Tract Symptoms|lower urinary tract symptoms
312169|NCT01815697|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
312170|NCT01815697|Urinary Retention|urinary retention
312171|NCT01815697|Vascular Endothelium|vascular endothelium
312172|NCT01815697|Counterpulsation, External|counterpulsation, external
312173|NCT01815684|Phase I|phase i
312174|NCT01815684|ASP3652|asp3652
312175|NCT01815684|Dose escalation|dose escalation
312176|NCT01815684|Maximum Tolerated Dose (MTD)|maximum tolerated dose (mtd)
312177|NCT01815671|colonoscopy|colonoscopy
312178|NCT01815671|technique|technique
312179|NCT01815671|tilt|tilt
312180|NCT01815671|insertion|insertion
312181|NCT01815671|safety|safety
312182|NCT01815671|efficacy|efficacy
312183|NCT01815645|Cocaine related disorders|cocaine related disorders
312184|NCT01815645|Contingency Management|contingency management
312185|NCT01815645|psychosocial treatment|psychosocial treatment
312186|NCT01815632|multiple sclerosis|multiple sclerosis
312187|NCT01815632|progressive MS|progressive ms
312188|NCT01815632|stem cell|stem cell
312189|NCT01815632|cell therapy|cell therapy
312190|NCT01815632|neurodegeneration|neurodegeneration
312191|NCT01815632|CNS repair|cns repair
312192|NCT01815606|Pancreas|pancreas
312193|NCT01815606|cancer|cancer
312194|NCT01815606|EUS-FNA|eus-fna
312195|NCT01815606|19Gauge|19gauge
312196|NCT01815606|25Gauge|25gauge
312197|NCT01815606|35mm mass|35mm mass
312198|NCT01815593|Erectile Dysfunction|erectile dysfunction
312199|NCT01815593|Vascular Endothelium|vascular endothelium
312200|NCT01815593|Counterpulsation, External|counterpulsation, external
312201|NCT01815580|HIV|hiv
312202|NCT01815580|Treatment as Prevention|treatment as prevention
312203|NCT01815580|Seek, Test, Treat, Retain Strategies|seek, test, treat, retain strategies
312204|NCT01815567|Hypertension|hypertension
312205|NCT01815567|Retinal Disorder|retinal disorder
312206|NCT01815567|Cognitive impairment|cognitive impairment
312207|NCT01815554|Tetraplegia|tetraplegia
312208|NCT01815554|Spinal Cord Injury|spinal cord injury
312209|NCT01815554|Ventilator|ventilator
312210|NCT01815554|Diaphragmatic Pacing System|diaphragmatic pacing system
312211|NCT01815541|subcutaneous teicoplanin|subcutaneous teicoplanin
312212|NCT01815541|osteoarticular|osteoarticular
312213|NCT01815541|infections|infections
312214|NCT01815541|tolerance|tolerance
312215|NCT01815541|teicoplanin|teicoplanin
312216|NCT01815528|recurrent epithelial ovarian cancer|recurrent epithelial ovarian cancer
312217|NCT01815515|Metastatic Prostate Cancer|metastatic prostate cancer
312218|NCT01815502|Single ventricle|single ventricle
312219|NCT01815502|Fontan|fontan
312220|NCT01815502|Sildenafil|sildenafil
312221|NCT01815502|Pressure-Volume Loops|pressure-volume loops
312222|NCT01815489|Necrotizing Pancreatitis|necrotizing pancreatitis
312223|NCT01815489|Pancreatitis|pancreatitis
312224|NCT01815489|Infection|infection
312225|NCT01815489|Bacteria|bacteria
312226|NCT01815489|Microbiology|microbiology
312227|NCT01815476|DCIS|dcis
312228|NCT01815476|Early Stage Invasive breast cancer|early stage invasive breast cancer
312229|NCT01815476|Prone breast radiotherapy|prone breast radiotherapy
312230|NCT01815463|stool|stool
312231|NCT01815463|monoclonal antibody|monoclonal antibody
312232|NCT01815463|Adnab-9|adnab-9
312233|NCT01815463|FOBT|fobt
312234|NCT01815463|FIT|fit
312235|NCT01815463|iFOBT|ifobt
312236|NCT01815463|colonoscopy|colonoscopy
312237|NCT01815463|barium enema|barium enema
312238|NCT01815463|flexible sigmoidoscopy|flexible sigmoidoscopy
312240|NCT01815424|CP-690|cp-690
312241|NCT01815424|550|550
312242|NCT01815424|Xeljanz|xeljanz
312243|NCT01815424|Jak-Inhibitor|jak-inhibitor
312244|NCT01815424|Oral Treatment|oral treatment
312245|NCT01815424|Psoriasis vulgaris|psoriasis vulgaris
312246|NCT01815424|Pruritus|pruritus
312247|NCT01815424|Itch|itch
312248|NCT01815424|DLQI|dlqi
312249|NCT01815424|moderate|moderate
312250|NCT01815424|severe|severe
312251|NCT01815424|chronic|chronic
312252|NCT01815424|plaque psoriasis|plaque psoriasis
312253|NCT01815411|Rheumatoid arthritis|rheumatoid arthritis
312254|NCT01815411|symptom score|symptom score
312255|NCT01815411|fatigue|fatigue
312256|NCT01815411|life quality|life quality
312257|NCT01815411|cytokines|cytokines
312258|NCT01815411|mRNA expression|mrna expression
312259|NCT01815411|Quality of Life|quality of life
312260|NCT01815411|Signs and Symptoms|signs and symptoms
312261|NCT01815411|Indication for Modification of Patient Physical Status|indication for modification of patient physical status
312262|NCT01815385|Term gestation|term gestation
312263|NCT01815385|Environmental exposure|environmental exposure
312264|NCT01815385|Benzo(a)pyrene|benzo(a)pyrene
312265|NCT01815385|Polycyclic aromatic hydrocarbons|polycyclic aromatic hydrocarbons
312266|NCT01815385|Adiposity|adiposity
312267|NCT01815385|Cytosine methylation|cytosine methylation
312268|NCT01815372|nerve blocks|nerve blocks
312269|NCT01815372|ultrasound-guided|ultrasound-guided
312270|NCT01815372|leg surgery|leg surgery
312271|NCT01815359|ICARuS|icarus
312272|NCT01815359|Intraperitoneal Chemotherapy|intraperitoneal chemotherapy
312273|NCT01815359|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
312274|NCT01815359|Optimal Surgical Debulking|optimal surgical debulking
312275|NCT01815359|Leucovorin|leucovorin
312276|NCT01815359|Floxuridine (FUDR)|floxuridine (fudr)
312277|NCT01815359|Mitomycin|mitomycin
312278|NCT01815359|12-289|12-289
312279|NCT01815346|Breast Cancer|breast cancer
312280|NCT01815346|Breast cancer survivors|breast cancer survivors
312281|NCT01815346|Chronic, taxane-based chemotherapy-induced peripheral neuropathy|chronic, taxane-based chemotherapy-induced peripheral neuropathy
312282|NCT01815346|CIPN|cipn
312283|NCT01815346|Acupuncture treatments|acupuncture treatments
312284|NCT01815346|Quality of life|quality of life
312285|NCT01815346|Hand function|hand function
312286|NCT01815346|Balance|balance
312287|NCT01815346|Questionnaires|questionnaires
312288|NCT01815346|Surveys|surveys
312289|NCT01815333|Cancer of Lymph Node|cancer of lymph node
312290|NCT01815333|Magnetic resonance imaging|magnetic resonance imaging
312291|NCT01815333|MRI|mri
312292|NCT01815333|Ultrasuperparamagnetic nanoparticle iron oxide|ultrasuperparamagnetic nanoparticle iron oxide
312293|NCT01815333|USPIO|uspio
312294|NCT01815333|Feraheme|feraheme
312295|NCT01815333|Ferumoxytole|ferumoxytole
312296|NCT01815320|Renal Transplant|renal transplant
312297|NCT01815320|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
312298|NCT01815320|Acute allograft rejection|acute allograft rejection
312299|NCT01815294|Ovarian cancer|ovarian cancer
312300|NCT01815294|Breast cancer|breast cancer
312301|NCT01815294|Solid malignancy|solid malignancy
312302|NCT01815294|Advanced or refractory solid malignancy|advanced or refractory solid malignancy
312303|NCT01815294|Metastatic cancer|metastatic cancer
312304|NCT01815294|DOXIL/CAELYX|doxil/caelyx
312305|NCT01815294|Doxorubicin HCL|doxorubicin hcl
312306|NCT01815294|Bioequivalence|bioequivalence
312307|NCT01815268|Randomized Controlled Trial|randomized controlled trial
312308|NCT01815268|Influenza|influenza
312309|NCT01815268|Influenza vaccine|influenza vaccine
312310|NCT01815268|Flu Vaccine|flu vaccine
312311|NCT01815268|Fluzone|fluzone
312312|NCT01815268|HD Fluzone|hd fluzone
312313|NCT01815268|Nursing Home|nursing home
312314|NCT01815268|Hospitalization|hospitalization
312315|NCT01815268|Mortality|mortality
312316|NCT01815268|Health Care worker vaccination|health care worker vaccination
312317|NCT01815268|ADL decline|adl decline
312318|NCT01815268|Effectiveness|effectiveness
312319|NCT01815268|Elderly|elderly
312320|NCT01815268|Morbidity|morbidity
312321|NCT01815268|Nursing Home resident|nursing home resident
312322|NCT01815268|Frail|frail
312323|NCT01815268|Institutionalized|institutionalized
312324|NCT01815268|Epidemiology|epidemiology
312325|NCT01815268|CDC|cdc
312326|NCT01815268|US|us
312327|NCT01815268|city|city
312328|NCT01815255|TDF-based regimen|tdf-based regimen
312329|NCT01815255|HIV-infected children|hiv-infected children
312330|NCT01815255|Thai|thai
312331|NCT01815255|generic|generic
312332|NCT01815255|safety and efficacy|safety and efficacy
312333|NCT01815255|renal status|renal status
312334|NCT01815255|To assess effect of TDF on renal problem in HIV-infected children receiving TDF-based once daily regimen|to assess effect of tdf on renal problem in hiv-infected children receiving tdf-based once daily regimen
312335|NCT01815255|To compare the effectiveness and clinical usefulness of different tools of adherence|to compare the effectiveness and clinical usefulness of different tools of adherence
312336|NCT01815229|endotracheal|endotracheal
312337|NCT01815229|intubation|intubation
312338|NCT01815216|Bariatric surgery|bariatric surgery
312339|NCT01815216|Cognition|cognition
312340|NCT01815216|Satiety hormones|satiety hormones
312341|NCT01815216|Brain networks|brain networks
312342|NCT01815216|Inhibitory control|inhibitory control
312343|NCT01815216|Food intake|food intake
312344|NCT01815203|Caffeine effects|caffeine effects
312345|NCT01815203|Inhibitory control|inhibitory control
312346|NCT01815190|immune complex vasculitis|immune complex vasculitis
312347|NCT01815190|cutaneous vasculitis|cutaneous vasculitis
312348|NCT01815190|IgA vasculitis|iga vasculitis
312349|NCT01815190|IgA nephropathy|iga nephropathy
312350|NCT01815138|OHSS, GnRH agonist trigger, low dose hCG, PCOS, IVF|ohss, gnrh agonist trigger, low dose hcg, pcos, ivf
312351|NCT01815125|Mild traumatic brain injury|mild traumatic brain injury
312352|NCT01815125|Brain concussion|brain concussion
312353|NCT01815125|Post-concussion syndrome|post-concussion syndrome
312354|NCT01815125|Emergency department|emergency department
312355|NCT01815125|Ondansetron|ondansetron
312356|NCT01815112|Neurodegenerative disease|neurodegenerative disease
312357|NCT01815112|Elderly|elderly
312358|NCT01815112|Dementia|dementia
312359|NCT01815112|FDG-PET|fdg-pet
312360|NCT01815112|MRI|mri
312361|NCT01815112|Neuroimaging|neuroimaging
312362|NCT01815086|Radioimmunoimaging|radioimmunoimaging
312363|NCT01815086|AL Amyloidosis|al amyloidosis
312364|NCT01815086|PET/CT|pet/ct
312365|NCT01815047|Vitamin D|vitamin d
312366|NCT01815047|Pregnancy|pregnancy
312367|NCT01815047|Inflammation|inflammation
312368|NCT01815047|Infection|infection
312369|NCT01815047|Placenta|placenta
312370|NCT01815047|Cytokine|cytokine
312371|NCT01815047|Microbiome|microbiome
312372|NCT01815008|Platelet aggregation|platelet aggregation
312373|NCT01815008|Clopidogrel|clopidogrel
312374|NCT01815008|Platelet transcriptome|platelet transcriptome
312375|NCT01814995|behavioural|behavioural
312376|NCT01814995|diabetes prevention|diabetes prevention
312377|NCT01814995|overweight|overweight
312378|NCT01814995|physical activity|physical activity
312379|NCT01814995|gestational diabetes|gestational diabetes
312380|NCT01814982|Traumatic brain injury|traumatic brain injury
312381|NCT01814982|JNJ-17299425|jnj-17299425
312382|NCT01814982|Intracranial pressure|intracranial pressure
312383|NCT01814982|Intravascular bolus injection|intravascular bolus injection
312384|NCT01814969|Rectal neoplasm|rectal neoplasm
312385|NCT01814969|Preoperative hyperfractionated radiotherapy|preoperative hyperfractionated radiotherapy
312386|NCT01814969|Preoperative hyperfractionated radiochemotherapy|preoperative hyperfractionated radiochemotherapy
312387|NCT01814943|Uncomplicated peptic ulcer|uncomplicated peptic ulcer
312388|NCT01814943|Acid-suppressing drugs|acid-suppressing drugs
312389|NCT01814943|Epidemiology|epidemiology
312390|NCT01814891|vitamin A|vitamin a
312391|NCT01814891|maize|maize
312392|NCT01814891|total body reserves|total body reserves
312393|NCT01814891|Condition is vitamin A status.|condition is vitamin a status.
312394|NCT01814891|Focus: change in vitamin A status with maize feeding.|focus: change in vitamin a status with maize feeding.
312395|NCT01814891|Focus: feeding orange maize to children for 90 days.|focus: feeding orange maize to children for 90 days.
312396|NCT01814891|Focus: total body reserves of vitamin A.|focus: total body reserves of vitamin a.
312397|NCT01814878|Pain, Postoperative|pain, postoperative
312398|NCT01814878|Tramadol Hydrochloride|tramadol hydrochloride
312399|NCT01814878|Acetaminophen|acetaminophen
312400|NCT01814878|Ultracet|ultracet
312401|NCT01814865|Post-menopausal|post-menopausal
312402|NCT01814865|ER+|er+
312403|NCT01814865|Stage I-IIIA|stage i-iiia
312404|NCT01814865|Operable|operable
312405|NCT01814865|Breast Cancer|breast cancer
312406|NCT01814852|Low Intensity Shockwave|low intensity shockwave
312407|NCT01814852|Extracorporeal shockwave therapy|extracorporeal shockwave therapy
312408|NCT01814852|Erectile dysfunction|erectile dysfunction
312409|NCT01814839|RNAi therapeutic|rnai therapeutic
312410|NCT01814826|MLN4924|mln4924
312411|NCT01814826|Acute|acute
312412|NCT01814826|Myelogenous|myelogenous
312413|NCT01814826|Leukemia|leukemia
312414|NCT01814800|PIDD, PID, humoral immunity, antibody deficiency|pidd, pid, humoral immunity, antibody deficiency
312415|NCT01814787|Type 2 Diabetes|type 2 diabetes
312416|NCT01814787|Pediatrics|pediatrics
312417|NCT01814787|Computerized Decision Support System|computerized decision support system
312418|NCT01814748|Diabetes Mellitus|diabetes mellitus
312419|NCT01814748|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
312420|NCT01814748|Glucose Metabolism Disorders|glucose metabolism disorders
312421|NCT01814748|Metabolic Diseases|metabolic diseases
312422|NCT01814748|Endocrine System Diseases|endocrine system diseases
312423|NCT01814748|Metformin|metformin
312424|NCT01814748|Hypoglycemic Agents|hypoglycemic agents
312425|NCT01814748|Pharmacologic Actions|pharmacologic actions
312426|NCT01814748|Therapeutic Uses|therapeutic uses
312427|NCT01814722|HIV Infections|hiv infections
312428|NCT01814722|Anti-HIV Agents|anti-hiv agents
312429|NCT01814722|Anti-Retroviral Agents|anti-retroviral agents
312430|NCT01814722|Nucleoside Reverse Transcriptase Inhibitors|nucleoside reverse transcriptase inhibitors
312431|NCT01814722|Non-nucleoside Reverse Transcriptase Inhibitor|non-nucleoside reverse transcriptase inhibitor
312432|NCT01814722|Protease inhibitors|protease inhibitors
312433|NCT01814696|Heart Failure|heart failure
312434|NCT01814696|Congestive Heart Failure|congestive heart failure
312435|NCT01814696|Medication Adherence|medication adherence
312436|NCT01814696|Medication Compliance|medication compliance
312437|NCT01814696|Telemedicine|telemedicine
312438|NCT01814696|Telehealth|telehealth
312439|NCT01814683|Vivax malaria|vivax malaria
312440|NCT01814683|Primaquine|primaquine
312441|NCT01814683|Placebo|placebo
312442|NCT01814683|Recurrence|recurrence
312443|NCT01814657|Infertility|infertility
312444|NCT01814605|Sciatic Nerve Block|sciatic nerve block
312445|NCT01814605|Subgluteal space|subgluteal space
312446|NCT01814605|Infragluteal space|infragluteal space
312447|NCT01814592|coronally positioned flap|coronally positioned flap
312448|NCT01814592|connective tissue|connective tissue
312449|NCT01814592|gingival margin|gingival margin
312450|NCT01814592|gingival recession/ treatment|gingival recession/ treatment
312451|NCT01814592|gingival recession/ surgery|gingival recession/ surgery
312452|NCT01814592|subepithelial connective tissue graft|subepithelial connective tissue graft
312453|NCT01814592|randomized controlled clinical trial|randomized controlled clinical trial
312454|NCT01814592|surgical flaps|surgical flaps
312455|NCT01814592|Treatment outcome|treatment outcome
312456|NCT01814579|vaginal|vaginal
312457|NCT01814579|cuff|cuff
312458|NCT01814579|robotic|robotic
312459|NCT01814579|hysterectomy|hysterectomy
312460|NCT01814579|vloc|vloc
312461|NCT01814579|v-loc|v-loc
312462|NCT01814579|vicryl|vicryl
312463|NCT01814579|unidirectional|unidirectional
312464|NCT01814579|barbed|barbed
312465|NCT01814579|suture|suture
312466|NCT01814527|Fish oil|fish oil
312467|NCT01814527|Omega 3 Fatty acids|omega 3 fatty acids
312468|NCT01814527|Docosahexaenoic acid|docosahexaenoic acid
312469|NCT01814527|Mild Concussion|mild concussion
312470|NCT01814527|Brain Concussion|brain concussion
312471|NCT01814527|Cerebral Concussion|cerebral concussion
312472|NCT01814514|hypertensive|hypertensive
312473|NCT01814514|phase|phase
312474|NCT01814514|success rate|success rate
312475|NCT01814514|AGV|agv
312476|NCT01814501|Metastatic colon cancer|metastatic colon cancer
312477|NCT01814488|Active acute leukemia|active acute leukemia
312478|NCT01814488|PIF|pif
312479|NCT01814488|Allogeneic transplant|allogeneic transplant
312480|NCT01814488|Acute Myeloid Leukemia|acute myeloid leukemia
312481|NCT01814488|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
312482|NCT01814488|Marrow Unrelated Donor|marrow unrelated donor
312483|NCT01814488|Cord Blood|cord blood
312484|NCT01814488|Family Haploidentical donor|family haploidentical donor
312485|NCT01814475|myelofibrosis|myelofibrosis
312486|NCT01814475|unfavourable prognostic factors|unfavourable prognostic factors
312487|NCT01814475|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
312488|NCT01814475|Progression Free Survival|progression free survival
312489|NCT01814475|thrombocythemia vera|thrombocythemia vera
312490|NCT01814475|polycythemia vera|polycythemia vera
312491|NCT01814475|Reduced-intensity conditioning|reduced-intensity conditioning
312492|NCT01814462|Obstructive Sleep Apnea|obstructive sleep apnea
312493|NCT01814462|Pulse wave analysis|pulse wave analysis
312494|NCT01814449|Breast cancer|breast cancer
312495|NCT01814449|Hypoxia|hypoxia
312496|NCT01814449|Hypoxia related gene|hypoxia related gene
312497|NCT01814449|Endocrine therapy|endocrine therapy
312498|NCT01814449|Treatment resistance|treatment resistance
312499|NCT01814423|Plasmodium falciparum|plasmodium falciparum
312500|NCT01814423|malaria|malaria
312501|NCT01814423|chloroquine|chloroquine
312502|NCT01814423|pharmacokinetic|pharmacokinetic
312503|NCT01814423|children|children
312504|NCT01814410|Intravenous Ethanol|intravenous ethanol
312505|NCT01814410|Intravenous Nicotine|intravenous nicotine
312506|NCT01814410|Interactive effects|interactive effects
312507|NCT01814410|cognition|cognition
312508|NCT01814410|subjective effects|subjective effects
312509|NCT01814410|healthy subjects|healthy subjects
312510|NCT01814397|Aromatase inhibitor|aromatase inhibitor
312511|NCT01814397|Pain threshold|pain threshold
312512|NCT01814384|Ancillary tailored|ancillary tailored
312513|NCT01814384|medico-economic study,|medico-economic study,
312514|NCT01814384|total knee replacement|total knee replacement
312515|NCT01814384|primary or secondary osteoarthritis|primary or secondary osteoarthritis
312516|NCT01814371|Abscesses|abscesses
312517|NCT01814371|Furunculosis|furunculosis
312518|NCT01814371|Staphylococcus aureus colonization|staphylococcus aureus colonization
312519|NCT01814371|Staphylococcal Skin Infection|staphylococcal skin infection
312520|NCT01814371|MRSA|mrsa
312521|NCT01814345|Her2 testing (Human Epidermal Growth Factor Receptor 2)|her2 testing (human epidermal growth factor receptor 2)
312522|NCT01814332|Stress disorders, Post-traumatic|stress disorders, post-traumatic
312523|NCT01814332|Sleep|sleep
312524|NCT01814319|heart failure|heart failure
312525|NCT01814319|ejection fraction equal or less than 40%|ejection fraction equal or less than 40%
312526|NCT01814306|LMA Supreme,LMA Proseal,airway management,prone position|lma supreme,lma proseal,airway management,prone position
312527|NCT01814293|Pediatric|pediatric
312528|NCT01814293|Upper Respiratory infection|upper respiratory infection
312529|NCT01814293|Over the Counter Drugs|over the counter drugs
312530|NCT01814293|Drugs, Non-Prescription|drugs, non-prescription
312531|NCT01814293|Vaporizer|vaporizer
312532|NCT01814280|Medication errors|medication errors
312533|NCT01814280|Medication review|medication review
312534|NCT01814280|Risk stratification|risk stratification
312535|NCT01814280|Patient safety|patient safety
312536|NCT01814267|innovative care|innovative care
312537|NCT01814267|telemedicine|telemedicine
312538|NCT01814267|cost effectiveness|cost effectiveness
312539|NCT01814267|diabetes|diabetes
312540|NCT01814241|Peanut allergy|peanut allergy
312541|NCT01814215|Obesity|obesity
312542|NCT01814215|Prevention and Control|prevention and control
312543|NCT01814215|Diet|diet
312544|NCT01814215|Motor Activity|motor activity
312545|NCT01814215|Intervention Studies|intervention studies
312546|NCT01814215|Child, Preschool|child, preschool
312547|NCT01814215|Child Care|child care
312548|NCT01814215|Food Habits|food habits
312549|NCT01814215|Feeding Behavior|feeding behavior
312550|NCT01814215|Child Behavior|child behavior
312551|NCT01814163|First line treatment|first line treatment
312552|NCT01814163|Non small cell lung cancer, non squamous|non small cell lung cancer, non squamous
312553|NCT01814150|Docetaxel|docetaxel
312554|NCT01814150|Alpha 1 Acid Glycoprotein|alpha 1 acid glycoprotein
312555|NCT01814150|Outcome|outcome
312556|NCT01814111|Hypertension|hypertension
312557|NCT01814111|Atrial Fibrillation|atrial fibrillation
312558|NCT01814111|Arrhythmias, Cardiac|arrhythmias, cardiac
312559|NCT01814111|Heart Diseases|heart diseases
312560|NCT01814111|Cardiovascular Diseases|cardiovascular diseases
312561|NCT01814098|Depressive Disorder, Major|depressive disorder, major
312562|NCT01814098|Escitalopram|escitalopram
312563|NCT01814098|Lexapro|lexapro
312564|NCT01814085|Major Depressive Disorder|major depressive disorder
312565|NCT01814085|Escitalopram|escitalopram
312566|NCT01814085|Lexapro|lexapro
312567|NCT01814059|Sirolimus|sirolimus
312568|NCT01814059|Eosinophilic Esophagitis|eosinophilic esophagitis
312569|NCT01814059|Eosinophilic Gastroenteritis|eosinophilic gastroenteritis
312570|NCT01814059|T -Cells|t -cells
312571|NCT01814059|Food Allergy|food allergy
312572|NCT01814046|Metastatic|metastatic
312573|NCT01814046|Ocular Melanoma|ocular melanoma
312574|NCT01814046|Autologous Tumor-Infiltrating Lymphocytes|autologous tumor-infiltrating lymphocytes
312575|NCT01814046|Uveal Melanoma|uveal melanoma
312576|NCT01814046|Adoptive Cell Therapy|adoptive cell therapy
312577|NCT01814033|LRU|lru
312578|NCT01814033|Total Knee Arthroplasty|total knee arthroplasty
312579|NCT01814033|Total Knee Replacement|total knee replacement
312580|NCT01814033|Acute Rehabilitation Total Knee|acute rehabilitation total knee
312581|NCT01814033|Total Knee Range of Motion|total knee range of motion
312582|NCT01814033|Total Knee Acute care Outcomes|total knee acute care outcomes
312583|NCT01814020|DSO|dso
312584|NCT01814007|Lipolysis|lipolysis
312585|NCT01814007|Cryolipolysis|cryolipolysis
312586|NCT01814007|Fat Reduction|fat reduction
312587|NCT01813994|Statin; Gastric inflammation; Gastric cancer|statin; gastric inflammation; gastric cancer
312588|NCT01813968|Ischemic postconditioning|ischemic postconditioning
312589|NCT01813968|Adult cardiac surgery|adult cardiac surgery
312590|NCT01813968|Aortic valve surgery|aortic valve surgery
312591|NCT01813968|Swan-Ganz|swan-ganz
312592|NCT01813968|Cardiac index|cardiac index
312593|NCT01813955|phosphodiesterase inhibitor|phosphodiesterase inhibitor
312594|NCT01813955|Psychophysiology|psychophysiology
312595|NCT01813955|Cognition|cognition
312596|NCT01813955|Schizophrenia|schizophrenia
312597|NCT01813955|Papaverine|papaverine
312598|NCT01813942|clinical narrative report|clinical narrative report
312599|NCT01813942|time series data|time series data
312600|NCT01813942|missing value|missing value
312601|NCT01813929|Diabetes|diabetes
312602|NCT01813929|Insulin|insulin
312603|NCT01813929|Metformin|metformin
312604|NCT01813929|Vascular|vascular
312605|NCT01813929|Vessels|vessels
312606|NCT01813929|Type 1|type 1
312607|NCT01813916|Osteoarthritis|osteoarthritis
312608|NCT01813916|synovial fluid|synovial fluid
312609|NCT01813916|hyaluronic acid|hyaluronic acid
312610|NCT01813890|Bunionectomy|bunionectomy
312611|NCT01813890|Acute pain|acute pain
312612|NCT01813890|Post-operative pain|post-operative pain
312613|NCT01813890|Tapentadol IR|tapentadol ir
312614|NCT01813890|Analgesia|analgesia
312615|NCT01813890|Hallux valgus|hallux valgus
312616|NCT01813864|treatment planning|treatment planning
312617|NCT01813864|resource guide|resource guide
312618|NCT01813864|service matching|service matching
312619|NCT01813864|Service matching for substance abuse clients|service matching for substance abuse clients
312620|NCT01813864|CASPAR resource guide|caspar resource guide
312621|NCT01813864|Improved treatment planning|improved treatment planning
312622|NCT01813851|Dialysis, Exercise, Protein Energy Wasting, Nutrition and Physical Fitness|dialysis, exercise, protein energy wasting, nutrition and physical fitness
312623|NCT01813825|Mammosite|mammosite
312624|NCT01813799|Diabetic Neuropathies|diabetic neuropathies
312625|NCT01813734|RET gene mutation|ret gene mutation
312626|NCT01813721|NHL|nhl
312627|NCT01813721|Breast Cancer|breast cancer
312628|NCT01813721|Lung Cancer|lung cancer
312629|NCT01813708|Type 2 Diabetes|type 2 diabetes
312630|NCT01813708|Intensive Life-Style|intensive life-style
312631|NCT01813708|Collaborative Education|collaborative education
312632|NCT01813708|Clinical Trial|clinical trial
312633|NCT01813708|Metabolic Control|metabolic control
312634|NCT01813695|Preemptive genetic testing|preemptive genetic testing
312635|NCT01813695|Pain|pain
312636|NCT01813695|Pediatrics|pediatrics
312637|NCT01813695|Orthopedics|orthopedics
312638|NCT01813695|Pectus excavatum|pectus excavatum
312639|NCT01813695|Scoliosis|scoliosis
312640|NCT01813682|preterm infant|preterm infant
312641|NCT01813682|anemia|anemia
312642|NCT01813682|iron fortified TPN|iron fortified tpn
312643|NCT01813669|Childhood anxiety|childhood anxiety
312644|NCT01813669|Pediatric Pain|pediatric pain
312645|NCT01813669|Yoga|yoga
312646|NCT01813669|Cognitive behavioral therapy|cognitive behavioral therapy
312647|NCT01813656|Methamphetamine-Associated Psychosis|methamphetamine-associated psychosis
312648|NCT01813656|Aripiprazole|aripiprazole
312649|NCT01813643|Methamphetamine-Associated Psychosis|methamphetamine-associated psychosis
312650|NCT01813643|Aripiprazole|aripiprazole
312651|NCT01813643|Risperidone|risperidone
312652|NCT01813630|Turner's Syndrome|turner's syndrome
312653|NCT01813630|Short Stature|short stature
312654|NCT01813630|Dwarfism|dwarfism
312655|NCT01813617|Polymyositis|polymyositis
312656|NCT01813617|Dermatomyositis|dermatomyositis
312657|NCT01813617|Muscle endurance|muscle endurance
312658|NCT01813617|Muscle stength|muscle stength
312659|NCT01813617|Outcome|outcome
312660|NCT01813604|Polio|polio
312661|NCT01813604|Inactivated polio vaccine|inactivated polio vaccine
312662|NCT01813604|oral polio vaccine|oral polio vaccine
312663|NCT01813604|vaccine trial|vaccine trial
312664|NCT01813591|Chronic Migraine|chronic migraine
312665|NCT01813591|Headache|headache
312666|NCT01813591|Refractory Chronic Migraine|refractory chronic migraine
312667|NCT01813578|Systemic sclerosis|systemic sclerosis
312668|NCT01813578|Exercise|exercise
312669|NCT01813578|Physical capacity|physical capacity
312670|NCT01813578|Aerobic capacity|aerobic capacity
312671|NCT01813578|Muscle function|muscle function
312672|NCT01813578|Fatigue|fatigue
312673|NCT01813552|HCV|hcv
312674|NCT01813552|Hepatitis C|hepatitis c
312675|NCT01813552|antiviral drugs|antiviral drugs
312676|NCT01813552|liver|liver
312677|NCT01813539|malignancy|malignancy
312678|NCT01813513|HCV|hcv
312679|NCT01813513|Hepatitis C Virus|hepatitis c virus
312680|NCT01813513|Hepatitis C|hepatitis c
312681|NCT01813513|antiviral drugs|antiviral drugs
312682|NCT01813513|liver|liver
312683|NCT01813474|Cancer|cancer
312684|NCT01813474|Tumour|tumour
312685|NCT01813474|Solid Malignancies|solid malignancies
312686|NCT01813461|BAL8557|bal8557
312687|NCT01813461|14C-labeled isavuconazole|14c-labeled isavuconazole
312688|NCT01813461|14C-labeled prodrug isavuconazonium sulfate (BAL8557)/([cyano-14C]ASP9766 sulfate)|14c-labeled prodrug isavuconazonium sulfate (bal8557)/([cyano-14c]asp9766 sulfate)
312689|NCT01813448|Fidaxomicin|fidaxomicin
312690|NCT01813448|OPT-80|opt-80
312691|NCT01813448|Healthy Subjects|healthy subjects
312692|NCT01813435|CAD|cad
312693|NCT01813435|ACS|acs
312694|NCT01813435|All comers|all comers
312695|NCT01813435|DAPT|dapt
312696|NCT01813435|PCI|pci
312697|NCT01813422|Cholesterol|cholesterol
312698|NCT01813422|High Cholesterol|high cholesterol
312699|NCT01813422|Elevated Cholesterol|elevated cholesterol
312700|NCT01813422|Raised Cholesterol|raised cholesterol
312701|NCT01813396|shoulder|shoulder
312702|NCT01813396|muscle stiffness|muscle stiffness
312703|NCT01813396|shoulder physical activity|shoulder physical activity
312704|NCT01813396|range of motion|range of motion
312705|NCT01813396|joint mobility|joint mobility
312706|NCT01813383|Celiac disease|celiac disease
312707|NCT01813383|HLA-DQ2.2|hla-dq2.2
312708|NCT01813383|HLA-DQ2.5|hla-dq2.5
312709|NCT01813383|HLA-DR7-DQ2|hla-dr7-dq2
312710|NCT01813383|HLA-DR3-DQ2|hla-dr3-dq2
312711|NCT01813370|TAX 3503|tax 3503
312712|NCT01813370|MSKCC IRB#07-101|mskcc irb#07-101
312713|NCT01813370|12-225|12-225
312714|NCT01813357|HIV|hiv
312715|NCT01813357|Cardiovascular disease|cardiovascular disease
312716|NCT01813357|Inflammation|inflammation
312717|NCT01813357|Statin|statin
312718|NCT01813344|Adult lymphoblastic lymphoma|adult lymphoblastic lymphoma
312719|NCT01813344|Hyper-CVAD|hyper-cvad
312720|NCT01813344|first-line treatment|first-line treatment
312721|NCT01813305|Diabetic Foot Ulcer|diabetic foot ulcer
312722|NCT01813305|Diabetes Mellitus|diabetes mellitus
312723|NCT01813305|Debridement|debridement
312724|NCT01813305|Standard of Care|standard of care
312725|NCT01813305|wounds|wounds
312726|NCT01813292|male patients|male patients
312727|NCT01813292|treated by TRUVADA® or VIREAD® for more than 60 months|treated by truvada® or viread® for more than 60 months
312728|NCT01813253|epidermal growth factor receptor|epidermal growth factor receptor
312729|NCT01813253|second line|second line
312730|NCT01813214|melanoma|melanoma
312731|NCT01813214|vemurafenib|vemurafenib
312732|NCT01813214|cobitmetinib|cobitmetinib
312733|NCT01813201|Testosterone|testosterone
312734|NCT01813201|Anabolic deterioration|anabolic deterioration
312735|NCT01813188|Fractures|fractures
312737|NCT01813188|Stem Cells|stem cells
312738|NCT01813149|Complex Regional Pain Syndrome (CRPS)|complex regional pain syndrome (crps)
312739|NCT01813136|radioiodine refractory Differentiated Thyroid Carcinoma|radioiodine refractory differentiated thyroid carcinoma
312740|NCT01813136|pazopanib|pazopanib
312741|NCT01813136|intermittent administration|intermittent administration
312742|NCT01813136|time to treatment failure|time to treatment failure
312743|NCT01813136|TUTHYREF|tuthyref
312744|NCT01813123|gender-specific|gender-specific
312745|NCT01813123|web-based|web-based
312746|NCT01813123|drug abuse|drug abuse
312747|NCT01813123|prevention|prevention
312748|NCT01813110|inflammation|inflammation
312749|NCT01813110|omega-3|omega-3
312750|NCT01813110|fish oil|fish oil
312751|NCT01813097|To detective the effect of the treatment of combination iodine 125 seed implants and LHRH agonists for the patients with locally advanced prostate cancer.|to detective the effect of the treatment of combination iodine 125 seed implants and lhrh agonists for the patients with locally advanced prostate cancer.
312752|NCT01813071|Enterobacteriaceae Infections|enterobacteriaceae infections
312753|NCT01813071|Gram-Negative Bacterial Infections|gram-negative bacterial infections
312754|NCT01813071|Bacterial Infections|bacterial infections
312755|NCT01813071|Gastroenteritis|gastroenteritis
312756|NCT01813071|Gastrointestinal Diseases|gastrointestinal diseases
312757|NCT01813071|Digestive System Diseases|digestive system diseases
312758|NCT01813071|Intestinal Diseases|intestinal diseases
312759|NCT01813071|Shigellosis|shigellosis
312760|NCT01813058|Tranexamic acid, Blood loss|tranexamic acid, blood loss
312761|NCT01813045|Angiogenesis|angiogenesis
312762|NCT01813045|Fibrosis|fibrosis
312763|NCT01813045|Myocardial Infarction|myocardial infarction
312764|NCT01813045|Imaging|imaging
312765|NCT01813045|CT-PET|ct-pet
312766|NCT01813045|PET-CT|pet-ct
312767|NCT01813045|Cardiac MRI|cardiac mri
312768|NCT01813032|firefighters|firefighters
312769|NCT01813032|police officers|police officers
312770|NCT01813032|emergency service professionals|emergency service professionals
312771|NCT01813032|myocardial infarction|myocardial infarction
312772|NCT01813032|endothelial function|endothelial function
312773|NCT01813032|thrombosis|thrombosis
312774|NCT01813019|Obsessive compulsive disorder (OCD), obsessive fears, obsessions,|obsessive compulsive disorder (ocd), obsessive fears, obsessions,
312775|NCT01813019|compulsions, OCD SSRI resistant|compulsions, ocd ssri resistant
312776|NCT01812993|Ischemic stroke, sleep apnea, non-invasive ventilatory treatment|ischemic stroke, sleep apnea, non-invasive ventilatory treatment
312777|NCT01812980|Influenza|influenza
312778|NCT01812980|Human Immunodeficiency Virus|human immunodeficiency virus
312779|NCT01812954|moderate-to-severe psoriasis|moderate-to-severe psoriasis
312780|NCT01812954|cost utility analysis|cost utility analysis
312781|NCT01812954|cost effectiveness analysis|cost effectiveness analysis
312782|NCT01812954|systemic treatment|systemic treatment
312783|NCT01812941|burns|burns
312784|NCT01812941|trauma|trauma
312785|NCT01812928|Flexible Cystoscopy|flexible cystoscopy
312786|NCT01812928|Pain control|pain control
312787|NCT01812928|Diclofenac|diclofenac
312788|NCT01812928|Non steroidal anti inflammatory drug|non steroidal anti inflammatory drug
312789|NCT01812915|Cuff pressure|cuff pressure
312790|NCT01812915|Cylindrical cuff|cylindrical cuff
312791|NCT01812915|Endotracheal tube|endotracheal tube
312792|NCT01812915|Nitrous oxide|nitrous oxide
312793|NCT01812915|Tapered cuff|tapered cuff
312794|NCT01812902|Prostate cancer|prostate cancer
312795|NCT01812902|Prostate specific antigen|prostate specific antigen
312796|NCT01812902|lymphadenectomy|lymphadenectomy
312797|NCT01812902|Limited lymphadenectomy|limited lymphadenectomy
312798|NCT01812902|Extended lymphadenectomy|extended lymphadenectomy
312799|NCT01812902|Immunohistochemistry|immunohistochemistry
312800|NCT01812889|bacterial vaginosis, vulvovaginal candidiasis, TOL-463, intravaginal therapy, vaginitis, women, cross-over|bacterial vaginosis, vulvovaginal candidiasis, tol-463, intravaginal therapy, vaginitis, women, cross-over
312801|NCT01812863|Pain Management|pain management
312802|NCT01812863|Child|child
312803|NCT01812863|Surgery|surgery
312804|NCT01812850|Temporomandibular joint|temporomandibular joint
312805|NCT01812850|Orofacial muscular complex|orofacial muscular complex
312806|NCT01812850|Bruxism|bruxism
312807|NCT01812850|Clenching|clenching
312808|NCT01812850|Orthodontic treatment|orthodontic treatment
312809|NCT01812850|Invisalign®|invisalign®
312810|NCT01812837|actinic keratosis|actinic keratosis
312811|NCT01812837|microneedles|microneedles
312812|NCT01812837|photodynamic therapy|photodynamic therapy
312813|NCT01812837|levulan|levulan
312814|NCT01812837|Aminolevulinic acid|aminolevulinic acid
312815|NCT01812824|Preconception Health|preconception health
312816|NCT01812824|Health Information Technology|health information technology
312817|NCT01812824|Reproductive Life Plan|reproductive life plan
312818|NCT01812824|Healthcare Disparities|healthcare disparities
312819|NCT01812824|Low birth-weight|low birth-weight
312820|NCT01812824|Preterm Delivery|preterm delivery
312821|NCT01812811|pulse wave analysis|pulse wave analysis
312822|NCT01812811|pulse wave velocity|pulse wave velocity
312823|NCT01812811|Arteriograph24|arteriograph24
312824|NCT01812811|Ambulatory|ambulatory
312825|NCT01812811|diabetes|diabetes
312826|NCT01812811|reproducibility|reproducibility
312827|NCT01812811|diurnal variation|diurnal variation
312828|NCT01812798|Peanut allergy|peanut allergy
312829|NCT01812798|Threshold|threshold
312830|NCT01812798|Modelling|modelling
312831|NCT01812798|Risk assessment|risk assessment
312832|NCT01812785|Fever|fever
312833|NCT01812785|Children|children
312834|NCT01812785|Non-malaria fevers|non-malaria fevers
312835|NCT01812785|Diagnosis|diagnosis
312836|NCT01812772|urinary stents|urinary stents
312837|NCT01812772|ureteroscopy|ureteroscopy
312838|NCT01812759|Pain|pain
312839|NCT01812759|Breakthrough cancer pain|breakthrough cancer pain
312840|NCT01812759|Emergency Department|emergency department
312841|NCT01812759|ED|ed
312842|NCT01812759|Fentanyl nasal spray|fentanyl nasal spray
312843|NCT01812759|Lazanda|lazanda
312844|NCT01812759|Placebo nasal spray|placebo nasal spray
312845|NCT01812759|Hydromorphone PCA|hydromorphone pca
312846|NCT01812759|Dilaudid|dilaudid
312847|NCT01812694|Pregnancy|pregnancy
312848|NCT01812694|Weight Control|weight control
312849|NCT01812694|Weight Gain|weight gain
312850|NCT01812681|vitamin D, Respiratory distress syndrome, sepsis, preterm|vitamin d, respiratory distress syndrome, sepsis, preterm
312851|NCT01812655|pain|pain
312852|NCT01812655|anxiety|anxiety
312853|NCT01812655|children|children
312854|NCT01812655|adolescents|adolescents
312855|NCT01812655|burn|burn
312856|NCT01812655|virtual reality|virtual reality
312857|NCT01812655|distraction|distraction
312858|NCT01812642|Schizophrenia|schizophrenia
312859|NCT01812642|JNJ-37822681|jnj-37822681
312860|NCT01812642|Placebo|placebo
312861|NCT01812616|Cancer|cancer
312862|NCT01812616|Safety|safety
312863|NCT01812603|Cancer|cancer
312864|NCT01812603|Safety|safety
312865|NCT01812564|Platelet rich plasma|platelet rich plasma
312866|NCT01812564|Interventional|interventional
312867|NCT01812564|Randomized|randomized
312868|NCT01812564|Double-blind|double-blind
312869|NCT01812551|cystic fibrosis|cystic fibrosis
312870|NCT01812551|children|children
312871|NCT01812551|adolescents|adolescents
312872|NCT01812551|low bone mass|low bone mass
312873|NCT01812551|osteoporosis|osteoporosis
312874|NCT01812551|alendronate|alendronate
312875|NCT01812551|fractures|fractures
312876|NCT01812525|Bronchiolitis|bronchiolitis
312877|NCT01812525|Moderate to Severe|moderate to severe
312878|NCT01812525|Hypertonic saline|hypertonic saline
312879|NCT01812525|NaCl 3% inhalations|nacl 3% inhalations
312880|NCT01812525|Standard therapy|standard therapy
312881|NCT01812525|Wang score|wang score
312882|NCT01812525|in-patients|in-patients
312883|NCT01812512|Heart Failure|heart failure
312884|NCT01812512|Communication|communication
312885|NCT01812512|Telemedicine|telemedicine
312886|NCT01812512|Veterans|veterans
312887|NCT01812512|Nurse-patient relations|nurse-patient relations
312888|NCT01812499|blood transfusion|blood transfusion
312889|NCT01812499|adverse event|adverse event
312890|NCT01812499|incident reporting|incident reporting
312891|NCT01812473|protein binding|protein binding
312892|NCT01812473|voriconazole|voriconazole
312893|NCT01812473|pediatrics|pediatrics
312894|NCT01812473|hematology|hematology
312895|NCT01812473|intensive care|intensive care
312896|NCT01812473|albumin|albumin
312897|NCT01812473|alpha-1-acid-glycoprotein|alpha-1-acid-glycoprotein
312898|NCT01812460|COPD|copd
312899|NCT01812460|muscle strength|muscle strength
312900|NCT01812460|resistance training|resistance training
312901|NCT01812460|Physiotherapi|physiotherapi
312902|NCT01812460|m. quadriceps|m. quadriceps
312903|NCT01812460|Acute exacerbation|acute exacerbation
312904|NCT01812447|Endobronchial Valves|endobronchial valves
312905|NCT01812447|Intrabronchial Valves|intrabronchial valves
312906|NCT01812447|Bronchial Valve|bronchial valve
312907|NCT01812447|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
312908|NCT01812447|COPD|copd
312909|NCT01812447|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
312910|NCT01812447|Bronchoscopic Lung Volume Reduction|bronchoscopic lung volume reduction
312911|NCT01812447|BLVR|blvr
312912|NCT01812447|TLVR|tlvr
312913|NCT01812447|Emphysema|emphysema
312914|NCT01812447|Pulmonary Emphysema|pulmonary emphysema
312915|NCT01812447|Pathologic Process|pathologic process
312916|NCT01812447|Lung Diseases|lung diseases
312917|NCT01812447|Respiratory Tract Disease|respiratory tract disease
312918|NCT01812395|thyroidectomy|thyroidectomy
312919|NCT01812395|ultrasonic dissector|ultrasonic dissector
312920|NCT01812395|harmonic focus device|harmonic focus device
312921|NCT01812395|superior laryngeal nerve|superior laryngeal nerve
312922|NCT01812382|Penetration|penetration
312923|NCT01812382|Antibiotic|antibiotic
312924|NCT01812382|Microdialysis|microdialysis
312925|NCT01812382|Formulation Pharmacokinetics|formulation pharmacokinetics
312926|NCT01812382|Feasibility|feasibility
313020|NCT01811862|13-038|13-038
312927|NCT01812356|Atrial fibrillation|atrial fibrillation
312928|NCT01812356|maze operation|maze operation
312929|NCT01812356|cryoablation|cryoablation
312930|NCT01812343|Ankle Brachial Index|ankle brachial index
312931|NCT01812343|Maximal Exercise Test|maximal exercise test
312932|NCT01812330|ACS|acs
312933|NCT01812330|CR|cr
312934|NCT01812330|PCI|pci
312935|NCT01812330|Platelet funtion|platelet funtion
312936|NCT01812330|Ticagrelor|ticagrelor
312937|NCT01812317|firefighters|firefighters
312938|NCT01812317|fire-simulation training|fire-simulation training
312939|NCT01812317|myocardial infarction|myocardial infarction
312940|NCT01812317|endothelial function|endothelial function
312941|NCT01812317|thrombosis|thrombosis
312942|NCT01812291|Major Depression|major depression
312943|NCT01812291|Minor Depression|minor depression
312944|NCT01812291|Sub-Threshold Depression|sub-threshold depression
312945|NCT01812291|Affective Condition|affective condition
312946|NCT01812291|Mood Disorder|mood disorder
312947|NCT01812291|Light Affective Disorder|light affective disorder
312948|NCT01812291|Subclinical Depressive Symptoms|subclinical depressive symptoms
312949|NCT01812291|Diabetes Mellitus|diabetes mellitus
312950|NCT01812291|Diabetes-Related Distress|diabetes-related distress
312951|NCT01812291|Self-Care Behaviour|self-care behaviour
312952|NCT01812291|Glycaemic Control|glycaemic control
312953|NCT01812291|Inflammatory Markers|inflammatory markers
312954|NCT01812252|myelodysplastic syndrome|myelodysplastic syndrome
312955|NCT01812252|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
312956|NCT01812252|bone marrow transplant|bone marrow transplant
312957|NCT01812252|hypomethylating agent|hypomethylating agent
312958|NCT01812252|induction chemotherapy|induction chemotherapy
312959|NCT01812239|premature birth|premature birth
312960|NCT01812239|twins|twins
312961|NCT01812239|short cervix|short cervix
312962|NCT01812213|Mild Cognitive Impairment|mild cognitive impairment
312963|NCT01812187|Alcohol|alcohol
312964|NCT01812187|Alcohol Abuse|alcohol abuse
312965|NCT01812187|Alcohol Dependence|alcohol dependence
312966|NCT01812187|Veterans|veterans
312967|NCT01812174|heart valve|heart valve
312968|NCT01812161|Electro-acupuncture|electro-acupuncture
312969|NCT01812161|HCG stimulation test|hcg stimulation test
312970|NCT01812161|Menstrual frequency|menstrual frequency
312971|NCT01812161|polycystic ovary syndrome|polycystic ovary syndrome
312972|NCT01812161|Randomized|randomized
312973|NCT01812161|controlled|controlled
312974|NCT01812161|trial|trial
312975|NCT01812148|Peritoneal Mesotheliomas|peritoneal mesotheliomas
312976|NCT01812148|hyperthermic intra-peritoneal chemotherapy (HIPEC)|hyperthermic intra-peritoneal chemotherapy (hipec)
312977|NCT01812148|Oxaliplatin|oxaliplatin
312978|NCT01812148|Cytoreductive surgery|cytoreductive surgery
312979|NCT01812148|Oxaliplatin HIPEC|oxaliplatin hipec
312980|NCT01812109|Acute Scrotum|acute scrotum
312981|NCT01812109|Testicular Torsion|testicular torsion
312982|NCT01812096|multiple myeloma|multiple myeloma
312983|NCT01812096|bortezomib|bortezomib
312984|NCT01812096|Subcutaneous|subcutaneous
312985|NCT01812083|Periodontitis; adverse pregnancy outcomes; IL-1 polymorphism|periodontitis; adverse pregnancy outcomes; il-1 polymorphism
312986|NCT01812070|smoking cessation|smoking cessation
312987|NCT01812070|quit smoking|quit smoking
312988|NCT01812057|Anesthesia|anesthesia
312989|NCT01812057|Cesarean Section|cesarean section
312990|NCT01812057|Pain, Postoperative|pain, postoperative
312991|NCT01812057|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
312992|NCT01812057|Dexamethasone|dexamethasone
312993|NCT01812057|Injections, Spinal|injections, spinal
312994|NCT01812057|morphine|morphine
312995|NCT01812031|PET/CT|pet/ct
312996|NCT01812031|18F-fluoro-2-deoxyglucose|18f-fluoro-2-deoxyglucose
312997|NCT01812031|lung neoplasms|lung neoplasms
312998|NCT01812031|respiratory motion|respiratory motion
312999|NCT01812018|Soft Tissue Sarcoma|soft tissue sarcoma
313000|NCT01812018|Pulmonary metastases|pulmonary metastases
313001|NCT01812005|MLN8237|mln8237
313002|NCT01812005|B-cell Non Hodgkin Lymphoma|b-cell non hodgkin lymphoma
313003|NCT01812005|Rituximab|rituximab
313004|NCT01811979|eye examination, oral sucrose, premature infant pain scale|eye examination, oral sucrose, premature infant pain scale
313005|NCT01811966|preoperative volume substitution|preoperative volume substitution
313006|NCT01811966|hypovolemia|hypovolemia
313007|NCT01811966|preoperative fasting|preoperative fasting
313008|NCT01811940|cocaine dependence|cocaine dependence
313009|NCT01811940|adderall|adderall
313010|NCT01811940|topiramate|topiramate
313011|NCT01811914|focused TTE|focused tte
313012|NCT01811914|intraoperative TTE|intraoperative tte
313013|NCT01811914|transthoracic echocardiography|transthoracic echocardiography
313014|NCT01811914|high risk non-cardiac surgery|high risk non-cardiac surgery
313015|NCT01811914|hemodynamic instabilities|hemodynamic instabilities
313016|NCT01811901|inhospital delays, door-to-needle time, thrombolysis, acute ischemic stroke, SITS, SITS-WATCH, stroke registry|inhospital delays, door-to-needle time, thrombolysis, acute ischemic stroke, sits, sits-watch, stroke registry
313017|NCT01811875|Haemophilia A|haemophilia a
313018|NCT01811862|Acupuncture|acupuncture
313019|NCT01811862|Hematopoietic stem cell transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
313021|NCT01811849|diabetes|diabetes
313022|NCT01811823|Tuberculosis|tuberculosis
313023|NCT01811823|HIV infection|hiv infection
313024|NCT01811823|Immune responses to Influenza vaccination|immune responses to influenza vaccination
313025|NCT01811810|Men under the age of 75 with histologically confirmed high risk|men under the age of 75 with histologically confirmed high risk
313026|NCT01811797|Erectile Dysfunction|erectile dysfunction
313027|NCT01811797|Extracorporeal shockwave|extracorporeal shockwave
313028|NCT01811797|Low intensity shockwaves|low intensity shockwaves
313029|NCT01811784|Nipah virus infection|nipah virus infection
313030|NCT01811784|date palm sap|date palm sap
313031|NCT01811784|community intervention|community intervention
313032|NCT01811784|capacity building|capacity building
313033|NCT01811784|disease prevention|disease prevention
313034|NCT01811784|Bangladesh|bangladesh
313035|NCT01811784|Healthy Community people|healthy community people
313036|NCT01811784|Sap harvesters|sap harvesters
313037|NCT01811784|Date palm three owners|date palm three owners
313038|NCT01811784|Date palm sap consumers|date palm sap consumers
313039|NCT01811758|Culturally Specific Cognitive Behavioral Therapy|culturally specific cognitive behavioral therapy
313040|NCT01811758|Standard Cognitive Behavioral Therapy|standard cognitive behavioral therapy
313041|NCT01811745|Aged|aged
313042|NCT01811745|Cognition|cognition
313043|NCT01811745|Exercise|exercise
313044|NCT01811745|Falls|falls
313045|NCT01811745|Gait|gait
313046|NCT01811745|Physical function|physical function
313047|NCT01811745|Dual-task|dual-task
313048|NCT01811745|Music|music
313049|NCT01811745|Postural Balance|postural balance
313050|NCT01811745|Randomized controlled trial|randomized controlled trial
313051|NCT01811732|Bacterial skin infection|bacterial skin infection
313052|NCT01811732|skin infection|skin infection
313053|NCT01811732|infection|infection
313054|NCT01811732|skin|skin
313055|NCT01811732|delafloxacin|delafloxacin
313056|NCT01811732|vancomycin|vancomycin
313057|NCT01811732|aztreonam|aztreonam
313058|NCT01811732|MRSA bacteria|mrsa bacteria
313059|NCT01811732|bacterial infection|bacterial infection
313060|NCT01811732|Anti-Infective Agents|anti-infective agents
313061|NCT01811732|Anti-Bacterial Agents|anti-bacterial agents
313062|NCT01811719|Intimate Partner Physical Violence|intimate partner physical violence
313063|NCT01811719|Intimate Partner Emotional Abuse|intimate partner emotional abuse
313064|NCT01811719|Intimate Partner Controlling Behaivor|intimate partner controlling behaivor
313065|NCT01811719|Pregnancy Outcomes|pregnancy outcomes
313066|NCT01811719|Quality of Parental Care Giving|quality of parental care giving
313067|NCT01811719|Maternal Life Course|maternal life course
313068|NCT01811693|Stroke|stroke
313069|NCT01811693|Intracerebral Hemorrhage|intracerebral hemorrhage
313070|NCT01811693|Prehospital|prehospital
313071|NCT01811693|Antihypertensive|antihypertensive
313072|NCT01811680|Stroke|stroke
313073|NCT01811680|Hemiplegia|hemiplegia
313074|NCT01811680|Variable automated treadmill treadmill|variable automated treadmill treadmill
313075|NCT01811667|Vascular Abnormalities|vascular abnormalities
313076|NCT01811654|Patellofemoral|patellofemoral
313077|NCT01811654|Hyaluronan|hyaluronan
313078|NCT01811654|Intra-articular|intra-articular
313079|NCT01811654|Hyaluronic acid|hyaluronic acid
313080|NCT01811641|season of conception|season of conception
313081|NCT01811641|maternal nutritional status|maternal nutritional status
313082|NCT01811641|infant DNA methylation|infant dna methylation
313083|NCT01811628|Cancer Prevention|cancer prevention
313084|NCT01811628|Tobacco Use Cessation|tobacco use cessation
313085|NCT01811628|Smokers|smokers
313086|NCT01811628|Recent quitters|recent quitters
313087|NCT01811628|Latino|latino
313088|NCT01811628|Hispanic|hispanic
313089|NCT01811628|Information|information
313090|NCT01811628|Interview|interview
313091|NCT01811628|Questionnaire|questionnaire
313092|NCT01811628|Survey|survey
313093|NCT01811628|Audio-recorded|audio-recorded
313094|NCT01811602|Training|training
313095|NCT01811602|Physiotherapy|physiotherapy
313096|NCT01811602|Pelvic floor muscles|pelvic floor muscles
313224|NCT01810939|Chronic Kidney Disease|chronic kidney disease
313097|NCT01811589|ventricular catheter, hydrocephalus, shunt, brain disease|ventricular catheter, hydrocephalus, shunt, brain disease
313098|NCT01811576|Growth hormone deficiency|growth hormone deficiency
313099|NCT01811576|Insulin-like growth factor I (IGF-I)|insulin-like growth factor i (igf-i)
313101|NCT01811563|Total Knee Replacement|total knee replacement
313102|NCT01811563|Lower Quarter Y-Balance Test|lower quarter y-balance test
313103|NCT01811563|Functional Outcomes|functional outcomes
313104|NCT01811563|Patient Reported Outcomes|patient reported outcomes
313105|NCT01811537|Artificial Chordae|artificial chordae
313106|NCT01811537|Mitral Valve Repair|mitral valve repair
313107|NCT01811524|Brain tumor|brain tumor
313108|NCT01811524|Glioma|glioma
313109|NCT01811524|Meningioma|meningioma
313110|NCT01811524|Diagnosis|diagnosis
313111|NCT01811524|Prognosis|prognosis
313112|NCT01811524|Heredity|heredity
313113|NCT01811472|Multi-center,|multi-center,
313114|NCT01811472|randomized,|randomized,
313115|NCT01811472|double-blind,|double-blind,
313116|NCT01811472|NAFLD,|nafld,
313117|NCT01811472|elevated triglycerides|elevated triglycerides
313118|NCT01811459|Delirium|delirium
313119|NCT01811459|ICU|icu
313120|NCT01811459|Burn patients|burn patients
313121|NCT01811459|Antipsychotics|antipsychotics
313122|NCT01811459|Haloperidol|haloperidol
313123|NCT01811459|Quetiapine|quetiapine
313124|NCT01811433|Postoperative Period|postoperative period
313125|NCT01811433|Anesthesia Recovery Period|anesthesia recovery period
313126|NCT01811433|Postoperative Complications|postoperative complications
313127|NCT01811433|Pulse Oximetry|pulse oximetry
313128|NCT01811420|dental caries|dental caries
313129|NCT01811420|caries removal|caries removal
313130|NCT01811420|chemomechanical caries removal|chemomechanical caries removal
313131|NCT01811394|sacral chordoma|sacral chordoma
313132|NCT01811394|chordoma|chordoma
313133|NCT01811394|carbon ion therapy|carbon ion therapy
313134|NCT01811394|proton therapy|proton therapy
313135|NCT01811394|hypofractionation|hypofractionation
313136|NCT01811381|Alzheimer|alzheimer
313137|NCT01811381|Prevention|prevention
313138|NCT01811381|mild cognitive impairment|mild cognitive impairment
313139|NCT01811381|physical exercise|physical exercise
313140|NCT01811381|synergism|synergism
313141|NCT01811381|curcumin|curcumin
313142|NCT01811381|dietary supplement|dietary supplement
313143|NCT01811381|anti-inflammatory|anti-inflammatory
313144|NCT01811381|anti-tau|anti-tau
313145|NCT01811381|subjective memory complaints without MCI|subjective memory complaints without mci
313146|NCT01811381|plasma-exosomes|plasma-exosomes
313147|NCT01811381|plasm- extracellular-derived-vesicles|plasm- extracellular-derived-vesicles
313148|NCT01811355|Muscle cramps|muscle cramps
313149|NCT01811355|Cramp|cramp
313150|NCT01811355|ALS|als
313151|NCT01811355|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
313152|NCT01811355|Lou Gehrig's disease|lou gehrig's disease
313153|NCT01811355|Motor Neuron Disease|motor neuron disease
313154|NCT01811355|MND|mnd
313155|NCT01811342|Hemoglobin|hemoglobin
313156|NCT01811342|Patient Monitoring|patient monitoring
313157|NCT01811277|palliative chemotherapy|palliative chemotherapy
313158|NCT01811277|ORR|orr
313159|NCT01811277|PFS|pfs
313160|NCT01811277|OS|os
313161|NCT01811277|safety|safety
313162|NCT01811277|advanced Biliary Tract Carcinoma|advanced biliary tract carcinoma
313163|NCT01811264|Metastatic|metastatic
313164|NCT01811264|Quality of life|quality of life
313165|NCT01811264|Decision making|decision making
313166|NCT01811251|Co-analgesia|co-analgesia
313167|NCT01811251|Dexamethasone|dexamethasone
313168|NCT01811251|Pregabalin|pregabalin
313169|NCT01811251|Lumbar slipped disc surgery|lumbar slipped disc surgery
313170|NCT01811251|Post-operative pain|post-operative pain
313171|NCT01811238|spinal disorders|spinal disorders
313172|NCT01811225|Women|women
313173|NCT01811225|Pregnancy|pregnancy
313174|NCT01811225|Smoking|smoking
313175|NCT01811199|Thyroid cancer|thyroid cancer
313176|NCT01811199|Breast cancer|breast cancer
313177|NCT01811199|Dexamethasone|dexamethasone
313178|NCT01811199|Emesis|emesis
313179|NCT01811186|moderate to severe non-malignant chronic pain|moderate to severe non-malignant chronic pain
313180|NCT01811173|multimorbidity|multimorbidity
313181|NCT01811173|primary care|primary care
313182|NCT01811173|physician - nurse team|physician - nurse team
313183|NCT01811173|proactive monitoring|proactive monitoring
313184|NCT01811173|support for self-care|support for self-care
313185|NCT01811173|primary caregiver|primary caregiver
313186|NCT01811160|Melatonin|melatonin
313187|NCT01811160|Second generation antipsychotic|second generation antipsychotic
313188|NCT01811160|bipolar disorder|bipolar disorder
313189|NCT01811160|schizophrenia|schizophrenia
313190|NCT01811160|Metabolic|metabolic
313191|NCT01811147|Bipolar|bipolar
313192|NCT01811147|Depression|depression
313193|NCT01811147|Mania|mania
313194|NCT01811147|Hypomania|hypomania
313195|NCT01811147|fMRI|fmri
313196|NCT01811147|antidepressant|antidepressant
313197|NCT01811134|endovascular procedure; flow diverter stent|endovascular procedure; flow diverter stent
313198|NCT01811121|Glioblastoma|glioblastoma
313199|NCT01811121|5ALA|5ala
313200|NCT01811121|fluorescence|fluorescence
313201|NCT01811121|resection|resection
313202|NCT01811108|mCRC|mcrc
313203|NCT01811108|KRAS mutation|kras mutation
313204|NCT01811108|Chemotherapy|chemotherapy
313205|NCT01811108|Anti-angiogenic agent|anti-angiogenic agent
313206|NCT01811108|Bevacizumab|bevacizumab
313207|NCT01811108|1st Line|1st line
313208|NCT01811095|Robotics|robotics
313209|NCT01811095|Computer-assisted surgery|computer-assisted surgery
313210|NCT01811095|Computer simulation|computer simulation
313211|NCT01811095|Gynecology|gynecology
313212|NCT01811095|General surgery|general surgery
313213|NCT01811069|Obese patients|obese patients
313214|NCT01811069|Upper airway patency|upper airway patency
313215|NCT01811056|medical abortion|medical abortion
313216|NCT01811056|mifepristone|mifepristone
313217|NCT01811043|breast biopsy|breast biopsy
313218|NCT01811043|anxiety|anxiety
313219|NCT01810978|congenital heart disease, probiotic, prebiotic|congenital heart disease, probiotic, prebiotic
313220|NCT01810965|Hemochromatosis type 1|hemochromatosis type 1
313221|NCT01810952|glucocorticoids|glucocorticoids
313222|NCT01810952|hyperglycemia|hyperglycemia
313223|NCT01810952|diabetes mellitus|diabetes mellitus
313225|NCT01810939|Treatment of Hyperkalemia|treatment of hyperkalemia
313226|NCT01810939|Hyperkalemia|hyperkalemia
313227|NCT01810926|indication for HSCT|indication for hsct
313228|NCT01810926|matched related donor|matched related donor
313229|NCT01810926|MRD|mrd
313230|NCT01810926|Matched Unrelated Donor|matched unrelated donor
313231|NCT01810926|MUD|mud
313232|NCT01810900|anti-adhesive effect and safety, laparoscopic myomectomy|anti-adhesive effect and safety, laparoscopic myomectomy
313233|NCT01810887|Healthy|healthy
313234|NCT01810887|Darunavir|darunavir
313235|NCT01810887|JNS011|jns011
313236|NCT01810887|Ritonavir|ritonavir
313237|NCT01810874|extraperitoneal|extraperitoneal
313238|NCT01810874|transperitoneal|transperitoneal
313239|NCT01810874|laparoscopic aortic lymphadenectomy|laparoscopic aortic lymphadenectomy
313240|NCT01810874|endometrial ovarian cancer|endometrial ovarian cancer
313241|NCT01810874|ovarian cancer|ovarian cancer
313242|NCT01810874|surgical staging|surgical staging
313243|NCT01810861|serotype distribution|serotype distribution
313244|NCT01810861|streptococcus pneumoniae|streptococcus pneumoniae
313245|NCT01810861|pneumonia|pneumonia
313246|NCT01810848|Knee Osteoarthritis|knee osteoarthritis
313247|NCT01810848|Osteoarthritis|osteoarthritis
313248|NCT01810848|Synvisc|synvisc
313249|NCT01810848|Hylan G-F 20|hylan g-f 20
313250|NCT01810848|Exercise|exercise
313251|NCT01810848|Cardiovascular risk|cardiovascular risk
313252|NCT01810848|Knee pain|knee pain
313253|NCT01810848|Pain|pain
313254|NCT01810835|HBV mother-to-child transmission|hbv mother-to-child transmission
313255|NCT01810835|women with HBV DNA > 105 I.U./mL|women with hbv dna > 105 i.u./ml
313256|NCT01810835|France|france
313257|NCT01810822|oxidative stress|oxidative stress
313258|NCT01810822|genetic susceptibility|genetic susceptibility
313259|NCT01810822|GPX4|gpx4
313260|NCT01810822|NOX2|nox2
313261|NCT01810809|Osteoarthritis|osteoarthritis
313262|NCT01810809|Hip|hip
313263|NCT01810809|Viscosupplementation|viscosupplementation
313264|NCT01810809|Clinical Trial|clinical trial
313265|NCT01810770|Radium-223 Dichloride|radium-223 dichloride
313266|NCT01810770|Prostatic Neoplasms|prostatic neoplasms
313267|NCT01810770|Bone Metastasis|bone metastasis
313268|NCT01810731|influenza vaccine immunogenicity|influenza vaccine immunogenicity
313269|NCT01810731|HIV|hiv
313270|NCT01810731|pregnancy|pregnancy
313271|NCT01810731|influenza vaccine safety|influenza vaccine safety
313272|NCT01810718|cGVHD|cgvhd
313273|NCT01810718|steroid therapy|steroid therapy
313274|NCT01810718|Nilotinib|nilotinib
313275|NCT01810718|cGVHD steroid refractory|cgvhd steroid refractory
313276|NCT01810718|intolerant to steroid therapy|intolerant to steroid therapy
313277|NCT01810718|Tasigna|tasigna
313278|NCT01810718|MTD|mtd
313279|NCT01810705|myeloid|myeloid
313280|NCT01810705|leukemia|leukemia
313281|NCT01810679|aortic valve replacement|aortic valve replacement
313282|NCT01810679|aortic stenosis|aortic stenosis
313283|NCT01810679|aortic steno-insufficiency|aortic steno-insufficiency
313284|NCT01810679|Perceval|perceval
313285|NCT01810679|Sutureless aortic heart valve|sutureless aortic heart valve
313286|NCT01810653|Macrogol|macrogol
313287|NCT01810640|Liver biopsy|liver biopsy
313288|NCT01810640|organ donation|organ donation
313289|NCT01810640|donor management|donor management
313290|NCT01810627|Prostate|prostate
313291|NCT01810627|Cancer|cancer
313292|NCT01810614|ADPKD|adpkd
313293|NCT01810614|PKD|pkd
313294|NCT01810614|Kidney Disease|kidney disease
313295|NCT01810614|ADPKD diet|adpkd diet
313296|NCT01810601|Embryo transfer, transabdominal ultrasound, IVF, ICSI|embryo transfer, transabdominal ultrasound, ivf, icsi
313297|NCT01810588|Allogeneic transplant|allogeneic transplant
313298|NCT01810588|Hematologic Malignancies|hematologic malignancies
313299|NCT01810588|Acute Leukemia|acute leukemia
313300|NCT01810588|Myeloproliferative disorders|myeloproliferative disorders
313301|NCT01810588|Lymphoma|lymphoma
313302|NCT01810588|Myeloma|myeloma
313303|NCT01810562|Stroke|stroke
313304|NCT01810562|Tactile|tactile
313305|NCT01810562|Sensibility|sensibility
313306|NCT01810562|Stimulation|stimulation
313307|NCT01810562|Extremities|extremities
313308|NCT01810562|Arm|arm
313309|NCT01810562|Leg|leg
313310|NCT01810549|Fatigue|fatigue
313311|NCT01810536|Cystic fibrosis|cystic fibrosis
313312|NCT01810536|oxygen|oxygen
313313|NCT01810536|respiratory failure|respiratory failure
313314|NCT01810523|Acute|acute
313315|NCT01810523|lower|lower
313316|NCT01810523|extremity|extremity
313317|NCT01810523|not requiring|not requiring
313318|NCT01810523|diagnostic|diagnostic
313319|NCT01810523|imaging|imaging
313320|NCT01810510|respiration, artificial|respiration, artificial
313321|NCT01810497|External ear|external ear
313322|NCT01810497|Ear abnormalities|ear abnormalities
313323|NCT01810497|External ear cartilages|external ear cartilages
313324|NCT01810484|Ulthera® System|ulthera® system
313325|NCT01810484|Ultherapy® Treatment|ultherapy® treatment
313326|NCT01810484|Ulthera, Inc.|ulthera, inc.
313327|NCT01810484|Ultrasound treatment for skin|ultrasound treatment for skin
313328|NCT01810458|Liver|liver
313329|NCT01810458|Fibrosis|fibrosis
313330|NCT01810458|Alpha-1|alpha-1
313331|NCT01810458|AAT|aat
313332|NCT01810458|AATD|aatd
313333|NCT01810445|Bladder Cancer|bladder cancer
313334|NCT01810445|Laser|laser
313335|NCT01810445|Optical|optical
313336|NCT01810419|splenomegaly|splenomegaly
313337|NCT01810419|ultrasound|ultrasound
313338|NCT01810419|Vscan|vscan
313339|NCT01810367|PFS|pfs
313340|NCT01810354|Cefazolin|cefazolin
313341|NCT01810354|Tissue concentration|tissue concentration
313342|NCT01810354|infection|infection
313343|NCT01810354|cesarean section|cesarean section
313344|NCT01810354|obese|obese
313345|NCT01810341|Autism|autism
313346|NCT01810341|Autism Spectrum Disorders|autism spectrum disorders
313347|NCT01810341|RNA|rna
313348|NCT01810341|Gene expression|gene expression
313349|NCT01810341|Developmental Delay|developmental delay
313350|NCT01810341|Metabolites|metabolites
313351|NCT01810341|DNA|dna
313352|NCT01810302|Vasospasm|vasospasm
313353|NCT01810302|Subarachnoid hemorrhage|subarachnoid hemorrhage
313354|NCT01810302|Aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
313355|NCT01810302|Nicardipine|nicardipine
313356|NCT01810302|Intrathecal|intrathecal
313357|NCT01810302|SAH|sah
313358|NCT01810302|aSAH|asah
313359|NCT01810289|HIV, ART, CD4|hiv, art, cd4
313360|NCT01810276|traumatic head injury|traumatic head injury
313361|NCT01810276|intracranial hemorrhage|intracranial hemorrhage
313362|NCT01810276|platelets|platelets
313363|NCT01810276|anti-platelet therapy|anti-platelet therapy
313364|NCT01810276|plavix|plavix
313365|NCT01810276|asprin|asprin
313366|NCT01810263|stroke|stroke
313367|NCT01810263|malnutrition|malnutrition
313368|NCT01810263|high protein|high protein
313369|NCT01810211|Shoulder|shoulder
313370|NCT01810211|Surgery|surgery
313371|NCT01810211|Posterior Shoulder Tightness|posterior shoulder tightness
313372|NCT01810211|Flexibility|flexibility
313373|NCT01810211|Range of Motion|range of motion
313374|NCT01810198|Coronary Artery Disease|coronary artery disease
313375|NCT01810198|Cardiac CT|cardiac ct
313376|NCT01810198|Catheterization|catheterization
313377|NCT01810185|Inflammatory Bowel Disease|inflammatory bowel disease
313378|NCT01810185|Crohn's disease|crohn's disease
313379|NCT01810185|Ulcerative colitis|ulcerative colitis
313380|NCT01810185|Naltrexone|naltrexone
313381|NCT01810185|Low Dose Naltrexone|low dose naltrexone
313382|NCT01810185|Inflammatory Bowel Disease Questionnaire|inflammatory bowel disease questionnaire
313383|NCT01810172|lobectomy|lobectomy
313384|NCT01810172|segmentectomy|segmentectomy
313385|NCT01810172|pneumothorax|pneumothorax
313386|NCT01810172|pleural|pleural
313387|NCT01810172|digital|digital
313388|NCT01810172|air leak|air leak
313389|NCT01810159|substance use disorders|substance use disorders
313390|NCT01810159|implementation science|implementation science
313391|NCT01810159|collaborative care|collaborative care
313392|NCT01810159|opiate disorders|opiate disorders
313393|NCT01810159|alcohol disorders|alcohol disorders
313394|NCT01810146|Patients eligible for bariatric surgery (BMI>40kg/m2)|patients eligible for bariatric surgery (bmi>40kg/m2)
313395|NCT01810133|Comorbidity|comorbidity
313396|NCT01810120|Hematologic|hematologic
313397|NCT01810120|Malignant|malignant
313398|NCT01810120|Non-Malignant|non-malignant
313399|NCT01810120|Allogeneic|allogeneic
313400|NCT01810120|Transplant|transplant
313401|NCT01810120|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
313402|NCT01810120|Pediatric|pediatric
313403|NCT01810120|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
313404|NCT01810120|Acute Myeloid leukemia|acute myeloid leukemia
313405|NCT01810120|Myelodysplastic Syndromes|myelodysplastic syndromes
313406|NCT01810120|T cells receptor alfa beta|t cells receptor alfa beta
313407|NCT01810094|thoracolumbar fracture|thoracolumbar fracture
313408|NCT01810094|fixation|fixation
313409|NCT01810094|fixateur interne|fixateur interne
313410|NCT01810094|minimal invasive|minimal invasive
313411|NCT01810094|percutaneous|percutaneous
313412|NCT01810081|Cholelithiasis|cholelithiasis
313413|NCT01810081|Gastric H.Pylori infection|gastric h.pylori infection
313414|NCT01810081|H.Pylori infection|h.pylori infection
313415|NCT01810081|Gastric mucosa|gastric mucosa
313416|NCT01810068|BPH- Erectile function- Transurethral- Laser|bph- erectile function- transurethral- laser
313417|NCT01810042|age-related macular degeneration|age-related macular degeneration
313418|NCT01810042|choroidal neovascularization|choroidal neovascularization
313419|NCT01810042|ranibizumab|ranibizumab
313420|NCT01810042|indocyanine angiography|indocyanine angiography
313421|NCT01810029|transcendental meditation|transcendental meditation
313422|NCT01810029|cardiac rehabilitation|cardiac rehabilitation
313423|NCT01810016|NY-ESO-1|ny-eso-1
313424|NCT01810016|Metastatic Melanoma|metastatic melanoma
313425|NCT01810016|Ipilimumab|ipilimumab
313426|NCT01810016|Phase I|phase i
313427|NCT01810016|Adjuvant|adjuvant
313428|NCT01810016|Immunologic|immunologic
313429|NCT01810016|Vaccination|vaccination
313430|NCT01810016|Immunotherapy|immunotherapy
313431|NCT01810016|Neoplasm|neoplasm
313432|NCT01810003|Cardiovascular disease|cardiovascular disease
313433|NCT01810003|Inflammation|inflammation
313434|NCT01810003|EPA/DHA supplementation|epa/dha supplementation
313435|NCT01809990|cognitive behavior therapy|cognitive behavior therapy
313436|NCT01809990|pediatric obsessive-compulsive disorder|pediatric obsessive-compulsive disorder
313437|NCT01809990|internet-delivered cognitive behavior therapy|internet-delivered cognitive behavior therapy
313438|NCT01809977|Keratoconus|keratoconus
313439|NCT01809977|remove|remove
313440|NCT01809977|cornea|cornea
313441|NCT01809977|visual acuity|visual acuity
313442|NCT01809938|Gastrointestinal tract emptying|gastrointestinal tract emptying
313443|NCT01809938|Pre-operative fasting|pre-operative fasting
313444|NCT01809938|Ultrasound|ultrasound
313445|NCT01809938|Paracetamol Absorption|paracetamol absorption
313446|NCT01809912|solid tumor|solid tumor
313447|NCT01809899|Trauma|trauma
313448|NCT01809899|Abuse|abuse
313449|NCT01809899|Domestic Violence|domestic violence
313450|NCT01809899|Rape|rape
313451|NCT01809899|Assault|assault
313452|NCT01809899|MRI|mri
313453|NCT01809886|Neuromuscular relaxants|neuromuscular relaxants
313454|NCT01809886|short-term pediatric surgery|short-term pediatric surgery
313455|NCT01809886|reverses neuromuscular blockade|reverses neuromuscular blockade
313456|NCT01809873|Malaria|malaria
313457|NCT01809873|Diagnostics|diagnostics
313458|NCT01809873|Health Services|health services
313459|NCT01809860|isavuconazole|isavuconazole
313460|NCT01809860|sirolimus|sirolimus
313461|NCT01809860|BAL8557|bal8557
313462|NCT01809860|Healthy Volunteers|healthy volunteers
313463|NCT01809847|CLL|cll
313464|NCT01809847|Chronic Lymphatic Leukemia|chronic lymphatic leukemia
313465|NCT01809847|Leukemia|leukemia
313466|NCT01809847|HLA|hla
313467|NCT01809847|Histocompatibility|histocompatibility
313468|NCT01809847|HCT|hct
313469|NCT01809847|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
313470|NCT01809847|Ofatumumab|ofatumumab
313471|NCT01809847|CD20|cd20
313472|NCT01809821|Hypertension|hypertension
313473|NCT01809821|Sleep Disorders|sleep disorders
313474|NCT01809821|Insomnia|insomnia
313475|NCT01809821|Cardiovascular Diseases|cardiovascular diseases
313476|NCT01809821|Internet treatment|internet treatment
313477|NCT01809808|Acromegaly|acromegaly
313478|NCT01809808|Pituitary tumor|pituitary tumor
313479|NCT01809795|Obesity|obesity
313480|NCT01809795|Exercise|exercise
313481|NCT01809795|Blueberry Plant|blueberry plant
313482|NCT01809743|Coronary artery disease|coronary artery disease
313483|NCT01809743|Regadenoson|regadenoson
313484|NCT01809743|Adenosine|adenosine
313485|NCT01809743|Maximal hyperemia|maximal hyperemia
313486|NCT01809743|Fractional flow reserve|fractional flow reserve
313487|NCT01809743|FFR|ffr
313488|NCT01809691|Prostate cancer|prostate cancer
313489|NCT01809691|TAK-700|tak-700
313490|NCT01809691|Bicalutamide|bicalutamide
313491|NCT01809691|S1216|s1216
313492|NCT01809691|androgen therapy|androgen therapy
313493|NCT01809691|Phase III|phase iii
313494|NCT01809678|Smoking|smoking
313495|NCT01809678|Tobacco|tobacco
313496|NCT01809678|Yoga|yoga
313497|NCT01809665|ICD therapy|icd therapy
313498|NCT01809665|CRT-P therapy|crt-p therapy
313499|NCT01809665|MRI|mri
313500|NCT01809652|Pacemaker|pacemaker
313501|NCT01809652|Defibrillator|defibrillator
313502|NCT01809652|Remote Consultation|remote consultation
313503|NCT01809639|Concussion|concussion
313504|NCT01809613|Parkinson disease|parkinson disease
313505|NCT01809613|Deep Brain Stimulation|deep brain stimulation
313506|NCT01809613|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
313507|NCT01809574|Interstitial lung disease|interstitial lung disease
313508|NCT01809574|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
313509|NCT01809574|Connective tissue disease|connective tissue disease
313510|NCT01809561|endometriosis|endometriosis
313511|NCT01809561|telomere|telomere
313512|NCT01809561|telomerase|telomerase
313513|NCT01809548|complementary feeding|complementary feeding
313514|NCT01809548|premature infant|premature infant
313515|NCT01809548|body composition|body composition
313516|NCT01809548|atopy|atopy
313517|NCT01809548|neurodevelopmental outcome|neurodevelopmental outcome
313518|NCT01809548|obesity|obesity
313519|NCT01809535|endoscopic variceal ligation|endoscopic variceal ligation
313520|NCT01809535|post-EVL ulcer|post-evl ulcer
313521|NCT01809535|variceal bleeding|variceal bleeding
313522|NCT01809522|Robotic-assisted radical prostatectomy|robotic-assisted radical prostatectomy
313523|NCT01809522|Urinary continence|urinary continence
313524|NCT01809522|Posterior reconstruction of the rhabdosphincter|posterior reconstruction of the rhabdosphincter
313525|NCT01809522|Posterior musculofascial plate reconstruction|posterior musculofascial plate reconstruction
313526|NCT01809509|CYTOKINES , IL11 IL6 IMLANTATION RATE IVF.|cytokines , il11 il6 imlantation rate ivf.
313527|NCT01809496|hearing loss|hearing loss
313528|NCT01809496|hearing aids|hearing aids
313529|NCT01809496|spouses|spouses
313530|NCT01809496|rehabilitation|rehabilitation
313531|NCT01809483|mechanical corneal erosion|mechanical corneal erosion
313532|NCT01809483|bandage contact lens|bandage contact lens
313533|NCT01809483|pressure patching|pressure patching
313534|NCT01809483|erosion area|erosion area
313535|NCT01809483|pain scale|pain scale
313536|NCT01809470|Blood pressure|blood pressure
313537|NCT01809470|Appetite|appetite
313538|NCT01809470|Heart rate|heart rate
313539|NCT01809470|Salivary cortisol|salivary cortisol
313540|NCT01809457|educational poster, knowledge, dental trauma,|educational poster, knowledge, dental trauma,
313541|NCT01809431|gestational diabetes|gestational diabetes
313542|NCT01809431|women|women
313543|NCT01809431|infants|infants
313544|NCT01809431|blood glucose|blood glucose
313545|NCT01809431|weight|weight
313546|NCT01809431|adiposity|adiposity
313547|NCT01809431|health behaviors|health behaviors
313548|NCT01809431|self-efficacy|self-efficacy
313549|NCT01809392|Decitabine|decitabine
313550|NCT01809392|hematopoietic stem cell transplant|hematopoietic stem cell transplant
313551|NCT01809392|Wilms' tumor 1|wilms' tumor 1
313552|NCT01809392|cytolytic T lymphocyte|cytolytic t lymphocyte
313553|NCT01809392|Regulatory T cell|regulatory t cell
313554|NCT01809379|ovarian cancer, recurrent, chemotherapy, intraperitoneal|ovarian cancer, recurrent, chemotherapy, intraperitoneal
313555|NCT01809366|seminal plasma/uterine receptivity|seminal plasma/uterine receptivity
313556|NCT01809353|Healthy|healthy
313557|NCT01809353|Japanese|japanese
313558|NCT01809353|Caucasian|caucasian
313559|NCT01809353|Male|male
313560|NCT01809353|Pharmacokinetic|pharmacokinetic
313561|NCT01809353|JNJ-54452840|jnj-54452840
313562|NCT01809340|Depressive Disorder|depressive disorder
313563|NCT01809340|Major Depressive Disorder|major depressive disorder
313564|NCT01809340|Depression|depression
313565|NCT01809340|Bipolar Disorder Type II|bipolar disorder type ii
313566|NCT01809340|Anti-depressant|anti-depressant
313567|NCT01809340|Ketamine|ketamine
313568|NCT01809340|Minocycline|minocycline
313569|NCT01809327|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
313570|NCT01809327|Diabetes Mellitus|diabetes mellitus
313571|NCT01809327|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
313572|NCT01809327|Metformin|metformin
313573|NCT01809301|Bioavailability|bioavailability
313574|NCT01809288|Women|women
313575|NCT01809288|Diet|diet
313576|NCT01809288|Obesity|obesity
313577|NCT01809288|African|african
313578|NCT01809288|African Americans|african americans
313579|NCT01809275|Crohn's Disease|crohn's disease
313580|NCT01809275|Inflammatory Bowel Disease|inflammatory bowel disease
313581|NCT01809275|CDAI|cdai
313582|NCT01809249|Living donor liver transplantation|living donor liver transplantation
313583|NCT01809249|Donar safety|donar safety
313584|NCT01809210|MEK1/2 inhibitor,|mek1/2 inhibitor,
313585|NCT01809210|Non Small Cell Lung Cancer,|non small cell lung cancer,
313586|NCT01809210|metastatic,|metastatic,
313587|NCT01809210|first line treatment for Non Small Cell Lung Cancer|first line treatment for non small cell lung cancer
313588|NCT01809197|Refractive error|refractive error
313589|NCT01809197|Myopia|myopia
313590|NCT01809197|Hyperopia|hyperopia
313591|NCT01809197|Astigmatism|astigmatism
313592|NCT01809197|Presbyopia|presbyopia
313593|NCT01809197|Contact lenses|contact lenses
313594|NCT01809197|Contact lens solution|contact lens solution
313595|NCT01809197|Comfort|comfort
313596|NCT01809145|sarcoidosis|sarcoidosis
313597|NCT01809145|occupational exposure|occupational exposure
313598|NCT01809145|MELISA|melisa
313599|NCT01809132|Hepatitis, alcoholic|hepatitis, alcoholic
313600|NCT01809132|pentoxifylline|pentoxifylline
313601|NCT01809132|zinc|zinc
313602|NCT01809132|anakinra|anakinra
313603|NCT01809132|glucocorticoids|glucocorticoids
313604|NCT01809132|MELD score|meld score
313605|NCT01809132|Intestinal mucosa|intestinal mucosa
313606|NCT01809119|Kidney Neoplasms, Minimally invasive surgery, Renal cell carcinoma|kidney neoplasms, minimally invasive surgery, renal cell carcinoma
313607|NCT01809106|cancer pain|cancer pain
313608|NCT01809106|major opioid|major opioid
313609|NCT01809106|analgesics|analgesics
313610|NCT01809093|PEDF|pedf
313611|NCT01809093|TSP1|tsp1
313612|NCT01809093|Thrombospondin|thrombospondin
313613|NCT01809093|pigment epithelium derived factor|pigment epithelium derived factor
313614|NCT01809093|Wills Eye Institute|wills eye institute
313615|NCT01809093|Pars plana vitrectomy|pars plana vitrectomy
313616|NCT01809093|Vitreous levels|vitreous levels
313617|NCT01809093|Mid Atlantic Retina|mid atlantic retina
313618|NCT01809093|Blood draw|blood draw
313619|NCT01809093|Blood test|blood test
313620|NCT01809067|stress|stress
313621|NCT01809067|anxiety|anxiety
313622|NCT01809067|MRI|mri
313623|NCT01809067|aromatherapy|aromatherapy
313624|NCT01809054|Hip, Knee, Arthroplasty, venous thromboembolic events, blood loss|hip, knee, arthroplasty, venous thromboembolic events, blood loss
313625|NCT01809028|cell block, number of passes|cell block, number of passes
313626|NCT01809015|Oral Anticoagulation|oral anticoagulation
313627|NCT01809015|Regular Medical Care|regular medical care
313628|NCT01809015|Coagulation Service|coagulation service
313918|NCT01807741|Depression|depression
313629|NCT01809015|Vitamin-K Antagonists|vitamin-k antagonists
313630|NCT01809015|Quality of therapy|quality of therapy
313631|NCT01809015|Atrial fibrillation|atrial fibrillation
313632|NCT01809015|Venous thromboembolism|venous thromboembolism
313633|NCT01809015|Bypass surgery|bypass surgery
313634|NCT01809015|Prosthetic heart valve|prosthetic heart valve
313635|NCT01808989|peripheral artery disease|peripheral artery disease
313636|NCT01808989|tcpo2|tcpo2
313637|NCT01808989|treadmill walking test|treadmill walking test
313638|NCT01808989|intermittent claudication|intermittent claudication
313639|NCT01808963|Enthalpy|enthalpy
313640|NCT01808963|Physiologic Monitors|physiologic monitors
313641|NCT01808963|Critical Care Medicine|critical care medicine
313642|NCT01808911|Acquired haemophilia|acquired haemophilia
313643|NCT01808911|Comparative and randomized study|comparative and randomized study
313644|NCT01808911|Cyclophosphamide|cyclophosphamide
313645|NCT01808911|Rituximab|rituximab
313646|NCT01808898|Ablation|ablation
313647|NCT01808898|Outpatient|outpatient
313648|NCT01808885|safety|safety
313649|NCT01808885|multiple sclerosis|multiple sclerosis
313650|NCT01808885|olesoxime|olesoxime
313651|NCT01808885|double-blind|double-blind
313652|NCT01808885|randomized|randomized
313653|NCT01808859|Total Knee Arthroplasty|total knee arthroplasty
313654|NCT01808859|Thigh Tourniquet|thigh tourniquet
313655|NCT01808846|Obesity|obesity
313656|NCT01808846|Insulin Resistance|insulin resistance
313657|NCT01808846|functional magnetic resonance imaging|functional magnetic resonance imaging
313658|NCT01808846|glucose|glucose
313659|NCT01808846|fructose|fructose
313660|NCT01808846|hypothalamus|hypothalamus
313661|NCT01808846|neuronal circuits|neuronal circuits
313662|NCT01808846|feeding behavior|feeding behavior
313663|NCT01808833|Frailty|frailty
313664|NCT01808833|Geriatric oncology|geriatric oncology
313665|NCT01808820|Malignant Glioma|malignant glioma
313666|NCT01808820|Glioblastoma Multiforme|glioblastoma multiforme
313667|NCT01808820|Anaplastic Astrocytoma|anaplastic astrocytoma
313668|NCT01808820|High Grade Glioma|high grade glioma
313669|NCT01808820|HGG|hgg
313670|NCT01808820|Dendritic Cell Vaccine|dendritic cell vaccine
313671|NCT01808820|DC Vaccine|dc vaccine
313672|NCT01808820|Leukapheresis|leukapheresis
313673|NCT01808807|cesarean section rate|cesarean section rate
313674|NCT01808807|the cesarean section rate audit|the cesarean section rate audit
313675|NCT01808794|membranes|membranes
313676|NCT01808794|Mucograft|mucograft
313677|NCT01808794|Dynamatrixw|dynamatrixw
313678|NCT01808794|ridge|ridge
313679|NCT01808794|preservation|preservation
313680|NCT01808794|bone|bone
313681|NCT01808794|allograft|allograft
313682|NCT01808794|extraction|extraction
313683|NCT01808794|site|site
313684|NCT01808794|healing|healing
313685|NCT01808781|Power|power
313686|NCT01808781|muscle strength|muscle strength
313687|NCT01808781|total knee replacement|total knee replacement
313688|NCT01808781|physical activity behavior|physical activity behavior
313689|NCT01808755|recurrent urinary tract infections|recurrent urinary tract infections
313690|NCT01808755|D Mannose|d mannose
313691|NCT01808755|cystitis|cystitis
313692|NCT01808755|antibiotic treatment|antibiotic treatment
313693|NCT01808729|fibromuscular dysplasia|fibromuscular dysplasia
313694|NCT01808729|coronary artery disease|coronary artery disease
313695|NCT01808716|low-level laser therapy|low-level laser therapy
313696|NCT01808716|muscle damage|muscle damage
313697|NCT01808703|Periodontitis|periodontitis
313698|NCT01808703|Periodontal pocket|periodontal pocket
313699|NCT01808703|Periodontal diseases|periodontal diseases
313700|NCT01808690|Adolescent|adolescent
313701|NCT01808690|Youth|youth
313702|NCT01808690|Diabetes|diabetes
313703|NCT01808690|Insulin Resistance|insulin resistance
313704|NCT01808690|Cardiovascular|cardiovascular
313705|NCT01808690|Metformin|metformin
313706|NCT01808677|Non-Small Cell Lung Cancer|non-small cell lung cancer
313707|NCT01808677|NSCLC|nsclc
313708|NCT01808677|Thoracic reirradiation|thoracic reirradiation
313709|NCT01808677|Proton beam therapy|proton beam therapy
313710|NCT01808677|PBT|pbt
313711|NCT01808677|Intensity modulated radiation therapy|intensity modulated radiation therapy
313712|NCT01808677|IMRT|imrt
313713|NCT01808677|Registry|registry
313714|NCT01808677|Data|data
313715|NCT01808638|Adenocarcinoma|adenocarcinoma
313716|NCT01808638|Pancreas|pancreas
313717|NCT01808638|Gemcitabine|gemcitabine
313718|NCT01808638|Atu027|atu027
313719|NCT01808625|BRAIN MALIGNANCIES , RADIATION THERAPY|brain malignancies , radiation therapy
313720|NCT01808586|Neck|neck
313721|NCT01808586|chronic pain|chronic pain
313722|NCT01808586|facet injection|facet injection
313723|NCT01808573|Neratinib|neratinib
313724|NCT01808573|Nerlynx|nerlynx
313725|NCT01808521|Purpura, Thrombotic Thrombocytopenic|purpura, thrombotic thrombocytopenic
313726|NCT01808521|TTP|ttp
313727|NCT01808508|Down syndrome|down syndrome
313728|NCT01808508|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
313729|NCT01808508|Continuous positive airway pressure|continuous positive airway pressure
313730|NCT01808508|sham or placebo CPAP|sham or placebo cpap
313731|NCT01808495|Human corneal fibroblasts|human corneal fibroblasts
313732|NCT01808495|Fibulin-1|fibulin-1
313733|NCT01808495|Nuclear accumulation|nuclear accumulation
313734|NCT01808482|monoclonal antibody|monoclonal antibody
313735|NCT01808482|Multiple Sclerosis|multiple sclerosis
313736|NCT01808482|Interleukin-7 Receptor|interleukin-7 receptor
313737|NCT01808456|kidney transplant|kidney transplant
313738|NCT01808456|heart transplant|heart transplant
313739|NCT01808456|lung transplant|lung transplant
313740|NCT01808456|influenza vaccine|influenza vaccine
313741|NCT01808443|cryotherapy|cryotherapy
313742|NCT01808443|laser|laser
313743|NCT01808443|cutaneous warts|cutaneous warts
313744|NCT01808430|NSCLC|nsclc
313745|NCT01808404|Acceptance and Commitment Therapy|acceptance and commitment therapy
313746|NCT01808404|Mindfulness|mindfulness
313747|NCT01808404|Guided Self-Help|guided self-help
313748|NCT01808404|College|college
313749|NCT01808391|Coronary artery disease|coronary artery disease
313750|NCT01808391|Heart disease|heart disease
313751|NCT01808391|Myocardial ischemia|myocardial ischemia
313752|NCT01808391|Cardiovascular disease|cardiovascular disease
313753|NCT01808391|Arteriosclerosis|arteriosclerosis
313754|NCT01808391|Vascular disease|vascular disease
313755|NCT01808378|Bilateral limbic associated keratopathy|bilateral limbic associated keratopathy
313756|NCT01808378|Expanded Adipose Derived Stem Cells|expanded adipose derived stem cells
313757|NCT01808365|Neisseria meningitidis|neisseria meningitidis
313758|NCT01808365|Philippines|philippines
313759|NCT01808365|carriage|carriage
313760|NCT01808365|meningococcus|meningococcus
313761|NCT01808352|AE adverse event|ae adverse event
313762|NCT01808352|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
313763|NCT01808352|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
313764|NCT01808352|ART antiretroviral therapy|art antiretroviral therapy
313765|NCT01808352|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
313766|NCT01808352|DCF data collection forms|dcf data collection forms
313767|NCT01808352|DMC Data Monitoring Committee|dmc data monitoring committee
313768|NCT01808352|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
313769|NCT01808352|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
313770|NCT01808352|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
313771|NCT01808352|ICH International Conference of Harmonisation|ich international conference of harmonisation
313772|NCT01808352|IND Investigational New Drug Application|ind investigational new drug application
313773|NCT01808352|IRB Institutional Review Board|irb institutional review board
313774|NCT01808352|IU International units|iu international units
313775|NCT01808352|mg milligram(s)|mg milligram(s)
313776|NCT01808352|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
313777|NCT01808352|PCR polymerase chain reaction|pcr polymerase chain reaction
313778|NCT01808352|SAE serious adverse event|sae serious adverse event
313779|NCT01808352|µg microgram|µg microgram
313780|NCT01808352|ULN upper limit of the normal range|uln upper limit of the normal range
313781|NCT01808352|WB Western Blot|wb western blot
313782|NCT01808339|Fluticasone Furoate, FF Inhalation Powder, morning dosing, evening dosing, efficacy, FEV1|fluticasone furoate, ff inhalation powder, morning dosing, evening dosing, efficacy, fev1
313783|NCT01808287|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
313784|NCT01808287|Aortic Stenosis|aortic stenosis
313785|NCT01808274|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
313786|NCT01808274|Aortic Stenosis|aortic stenosis
313787|NCT01808261|Ischemic Stroke|ischemic stroke
313788|NCT01808248|HCV genotype 2 (GT-2)|hcv genotype 2 (gt-2)
313789|NCT01808248|HCV genotype 3 (GT-3)|hcv genotype 3 (gt-3)
313790|NCT01808248|HCV|hcv
313791|NCT01808248|Sustained Virologic Response|sustained virologic response
313792|NCT01808248|Direct Acting Antiviral|direct acting antiviral
313793|NCT01808248|Combination Therapy|combination therapy
313794|NCT01808248|Treatment-Naïve|treatment-naïve
313795|NCT01808248|GS-7977|gs-7977
313796|NCT01808248|Ribavirin|ribavirin
313797|NCT01808248|RBV|rbv
313798|NCT01808248|Peginterferon Alfa 2a|peginterferon alfa 2a
313799|NCT01808248|PEG|peg
313800|NCT01808248|Additional relevant MeSH terms:|additional relevant mesh terms:
313801|NCT01808248|Hepatitis|hepatitis
313802|NCT01808248|Hepatitis A|hepatitis a
313803|NCT01808248|Hepatitis, Chronic|hepatitis, chronic
313804|NCT01808248|Hepatitis C|hepatitis c
313805|NCT01808248|Hepatitis C, Chronic|hepatitis c, chronic
313806|NCT01808248|Liver Diseases|liver diseases
313807|NCT01808248|Digestive System Diseases|digestive system diseases
313808|NCT01808248|Hepatitis, Viral, Human|hepatitis, viral, human
313809|NCT01808248|Virus Diseases|virus diseases
313810|NCT01808248|Enterovirus Infections|enterovirus infections
313811|NCT01808248|Picornaviridae Infections|picornaviridae infections
313812|NCT01808248|RNA Virus Infections|rna virus infections
313813|NCT01808248|Flaviviridae Infections|flaviviridae infections
313814|NCT01808248|Peginterferon alfa-2a|peginterferon alfa-2a
313815|NCT01808248|Interferon-alpha|interferon-alpha
313816|NCT01808248|Antiviral Agents|antiviral agents
313817|NCT01808248|Anti-Infective Agents|anti-infective agents
313818|NCT01808248|Therapeutic Uses|therapeutic uses
313819|NCT01808248|Pharmacologic Actions|pharmacologic actions
314219|NCT01806155|headache|headache
313820|NCT01808248|Antimetabolites|antimetabolites
313821|NCT01808248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
313822|NCT01808248|Immunologic Factors|immunologic factors
313823|NCT01808248|Physiological Effects of Drugs|physiological effects of drugs
313824|NCT01808196|Eosinophilic Esophagitis|eosinophilic esophagitis
313825|NCT01808196|Connective Tissue Disorders|connective tissue disorders
313826|NCT01808196|Drug trial|drug trial
313827|NCT01808183|supracondylar|supracondylar
313828|NCT01808183|pediatric|pediatric
313829|NCT01808183|humerus|humerus
313830|NCT01808183|NIRS|nirs
313831|NCT01808183|near Infrared spectroscopy|near infrared spectroscopy
313832|NCT01808183|compartment perfusion|compartment perfusion
313833|NCT01808170|Laparoscopy|laparoscopy
313834|NCT01808170|AMH|amh
313835|NCT01808170|AFC|afc
313836|NCT01808170|Endometrioma|endometrioma
313837|NCT01808170|ovarian reserve|ovarian reserve
313838|NCT01808170|Ovarian cystectomy|ovarian cystectomy
313839|NCT01808170|ovarian cyst deroofing|ovarian cyst deroofing
313840|NCT01808157|atopic dermatitis|atopic dermatitis
313841|NCT01808157|pruritus|pruritus
313842|NCT01808144|Gout|gout
313843|NCT01808131|Gout|gout
313844|NCT01808118|Spondylitis|spondylitis
313845|NCT01808118|Spondylarthropathy|spondylarthropathy
313846|NCT01808118|Ankylosing Spondyloarthritis|ankylosing spondyloarthritis
313847|NCT01808118|Spondyloarthritis|spondyloarthritis
313848|NCT01808118|Spinal Diseases|spinal diseases
313849|NCT01808118|Musculoskeletal Diseases|musculoskeletal diseases
313850|NCT01808118|Arthritis|arthritis
313851|NCT01808118|Joint Diseases|joint diseases
313852|NCT01808118|Adalimumab|adalimumab
313853|NCT01808118|Antirheumatic Agents|antirheumatic agents
313854|NCT01808118|Anti-Inflammatory Agents|anti-inflammatory agents
313855|NCT01808092|Ceftazidime,|ceftazidime,
313856|NCT01808092|Meropenem,|meropenem,
313857|NCT01808092|Anti-Bacterial Agents,|anti-bacterial agents,
313858|NCT01808092|Anti-Infective Agents,|anti-infective agents,
313859|NCT01808092|Therapeutic Uses,|therapeutic uses,
313860|NCT01808092|Pharmacologic Actions,|pharmacologic actions,
313861|NCT01808092|Physiological Effects of Drugs|physiological effects of drugs
313862|NCT01808040|breast cancer|breast cancer
313863|NCT01808040|ER positive|er positive
313864|NCT01808040|PR positive|pr positive
313865|NCT01808040|post menopausal|post menopausal
313866|NCT01808027|quality of life drug adherence drug compliance mortality|quality of life drug adherence drug compliance mortality
313867|NCT01808014|nefopam, spinal surgery, postoperative pain control|nefopam, spinal surgery, postoperative pain control
313868|NCT01807988|Relapse, Recurrence, Depression, Internet, Sick-leave|relapse, recurrence, depression, internet, sick-leave
313869|NCT01807962|Injections, Subcutaneous|injections, subcutaneous
313870|NCT01807962|Cortisone|cortisone
313871|NCT01807962|Anesthetics, Local|anesthetics, local
313872|NCT01807936|Esophageal Neoplasms|esophageal neoplasms
313873|NCT01807936|lymphadenectomy|lymphadenectomy
313874|NCT01807910|Obesity|obesity
313875|NCT01807910|NAFLD|nafld
313876|NCT01807910|NASH|nash
313877|NCT01807910|Steatosis|steatosis
313878|NCT01807897|Heart Failure|heart failure
313879|NCT01807897|Sleep Apnea|sleep apnea
313880|NCT01807897|Ventricular Ejection Fraction|ventricular ejection fraction
313881|NCT01807897|Exercise Test|exercise test
313882|NCT01807884|Microaspiration|microaspiration
313883|NCT01807884|Ventilator acquired Pneumonia|ventilator acquired pneumonia
313884|NCT01807884|Amylase|amylase
313885|NCT01807884|Mechanical ventilation|mechanical ventilation
313886|NCT01807884|Suction|suction
313887|NCT01807871|nicotine dependence|nicotine dependence
313888|NCT01807871|smoking cessation|smoking cessation
313889|NCT01807871|lapse|lapse
313890|NCT01807871|relapse|relapse
313891|NCT01807871|tobacco|tobacco
313892|NCT01807871|nicotine patch|nicotine patch
313893|NCT01807871|nicotine replacement therapy|nicotine replacement therapy
313894|NCT01807871|NRT|nrt
313895|NCT01807858|Necrotizing enterocolitis|necrotizing enterocolitis
313896|NCT01807858|Sepsis|sepsis
313897|NCT01807858|Length of hospital stay|length of hospital stay
313898|NCT01807858|Mortality|mortality
313899|NCT01807845|Casein micelles|casein micelles
313900|NCT01807845|vitamin D3 (cholecalciferol)|vitamin d3 (cholecalciferol)
313901|NCT01807845|Bioavailability|bioavailability
313902|NCT01807845|Nanoencapsulation|nanoencapsulation
313903|NCT01807845|Nutrition|nutrition
313904|NCT01807832|chronic cough|chronic cough
313905|NCT01807832|cough reflex hypersensitivity|cough reflex hypersensitivity
313906|NCT01807832|capsaicin|capsaicin
313907|NCT01807819|Heart Failure|heart failure
313908|NCT01807819|Myocardial Strain|myocardial strain
313909|NCT01807819|Functional Capacity|functional capacity
313910|NCT01807806|veterans, military, families|veterans, military, families
313911|NCT01807793|Stroke|stroke
313912|NCT01807793|TIA|tia
313913|NCT01807793|African American|african american
313914|NCT01807754|automated ultrasound imaging (AUS)|automated ultrasound imaging (aus)
313915|NCT01807754|digital breast tomosynthesis (DBT)|digital breast tomosynthesis (dbt)
313916|NCT01807754|photoacoustic imaging (PAT)|photoacoustic imaging (pat)
313917|NCT01807741|Bipolar Disorder|bipolar disorder
313919|NCT01807728|Quality of life|quality of life
313920|NCT01807728|Participation|participation
313921|NCT01807728|Training|training
313922|NCT01807715|first trimester|first trimester
313923|NCT01807715|surgical abortion|surgical abortion
313924|NCT01807715|contraception|contraception
313925|NCT01807702|dichloroacetate|dichloroacetate
313926|NCT01807702|pyruvate|pyruvate
313927|NCT01807702|lactate|lactate
313928|NCT01807702|pyruvate dehydrogenase|pyruvate dehydrogenase
313929|NCT01807689|Dry mouth|dry mouth
313930|NCT01807689|Dry eyes|dry eyes
313931|NCT01807689|Saliva|saliva
313932|NCT01807689|Salivary gland biopsy|salivary gland biopsy
313933|NCT01807663|neuromuscular disease|neuromuscular disease
313934|NCT01807650|Split-Thickness Skin Graft Donor Site|split-thickness skin graft donor site
313935|NCT01807650|Split-thickness skin graft|split-thickness skin graft
313936|NCT01807650|STSG|stsg
313937|NCT01807650|Wound healing|wound healing
313938|NCT01807650|Skin grafting|skin grafting
313939|NCT01807650|Superficial wound|superficial wound
313940|NCT01807650|Partial-thickness wound|partial-thickness wound
313941|NCT01807650|Time to wound closure|time to wound closure
313942|NCT01807624|Pharmacokinetic|pharmacokinetic
313943|NCT01807611|Haploidentical donor transplantation|haploidentical donor transplantation
313944|NCT01807611|NK cell|nk cell
313945|NCT01807585|GSV|gsv
313946|NCT01807559|Single Sided Deafness|single sided deafness
313947|NCT01807559|Conductive Hearing Loss|conductive hearing loss
313948|NCT01807559|Unilateral Hearing Loss|unilateral hearing loss
313949|NCT01807559|SSD|ssd
313950|NCT01807546|Head and neck cancer|head and neck cancer
313951|NCT01807546|Platinum-resistant|platinum-resistant
313952|NCT01807546|Squamous cell carcinoma|squamous cell carcinoma
313953|NCT01807533|Environment|environment
313954|NCT01807533|Gene|gene
313955|NCT01807533|Intervention|intervention
313956|NCT01807533|Neurodevelopment|neurodevelopment
313957|NCT01807533|Pathways|pathways
313958|NCT01807533|Preterm infants|preterm infants
313959|NCT01807520|Moderate nail psoriasis|moderate nail psoriasis
313960|NCT01807520|Severe nail psoriasis|severe nail psoriasis
313961|NCT01807520|psoriasis|psoriasis
313962|NCT01807520|Secukinumab|secukinumab
313963|NCT01807507|Veins|veins
313964|NCT01807507|Vascular Access|vascular access
313965|NCT01807481|Mircera|mircera
313966|NCT01807481|PD|pd
313967|NCT01807481|Maitenance|maitenance
313968|NCT01807468|haploidentical stem cell transplantation|haploidentical stem cell transplantation
313969|NCT01807468|natural killer cell therapy|natural killer cell therapy
313970|NCT01807468|pediatric solid tumor|pediatric solid tumor
313971|NCT01807442|Acute Coronary Syndrome|acute coronary syndrome
313972|NCT01807442|Positive Psychology|positive psychology
313973|NCT01807442|Adherence to Health Behaviors|adherence to health behaviors
313974|NCT01807429|Ketamine,|ketamine,
313975|NCT01807429|Midazolam,|midazolam,
313976|NCT01807429|Morphine,|morphine,
313977|NCT01807429|visual analogue score|visual analogue score
313978|NCT01807416|Osseointegrated Implant, Bone level|osseointegrated implant, bone level
313979|NCT01807403|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
313980|NCT01807403|Deep brain stimulation|deep brain stimulation
313981|NCT01807403|Subthalamic nucleus|subthalamic nucleus
313982|NCT01807403|Caudate nucleus|caudate nucleus
313983|NCT01807403|Nucleus accumbens|nucleus accumbens
313984|NCT01807390|Minimally invasive surgery|minimally invasive surgery
313985|NCT01807390|Patient perspectives|patient perspectives
313986|NCT01807390|Lung cancer|lung cancer
313987|NCT01807390|Esophageal cancer|esophageal cancer
313988|NCT01807390|Pain|pain
313989|NCT01807364|Congenital adrenal hyperplasia (CAH)|congenital adrenal hyperplasia (cah)
313990|NCT01807364|Cardiovascular risk|cardiovascular risk
313991|NCT01807364|Microvascular dysfunction|microvascular dysfunction
313992|NCT01807351|Diabetes Mellitus|diabetes mellitus
313993|NCT01807351|Hypertension|hypertension
313994|NCT01807351|Impaired Fasting Glucose|impaired fasting glucose
313995|NCT01807351|Primary Health Care|primary health care
313996|NCT01807351|Chinese|chinese
313997|NCT01807312|colonoscopy|colonoscopy
313998|NCT01807299|Physical Training|physical training
313999|NCT01807299|ADHD-Attention deficit hyperactivity disorder|adhd-attention deficit hyperactivity disorder
314000|NCT01807299|Omega 3|omega 3
314001|NCT01807286|Myeloma|myeloma
314002|NCT01807286|Untreated Systemic AL Amyloidosis|untreated systemic al amyloidosis
314003|NCT01807286|Amyloid light-chain (AL) amyloidosis|amyloid light-chain (al) amyloidosis
314004|NCT01807286|Pomalidomide|pomalidomide
314005|NCT01807286|Melphalan|melphalan
314006|NCT01807286|Alkeran|alkeran
314007|NCT01807286|Dexamethasone|dexamethasone
314008|NCT01807286|Decadron|decadron
314009|NCT01807286|Questionnaires|questionnaires
314010|NCT01807286|Surveys|surveys
314011|NCT01807273|hemiplegic|hemiplegic
314012|NCT01807273|time up and go test|time up and go test
314013|NCT01807273|motion analysis|motion analysis
314014|NCT01807273|center of mass|center of mass
314015|NCT01807247|Strengthening muscle|strengthening muscle
314016|NCT01807247|Central nervous system diseases|central nervous system diseases
314017|NCT01807247|Gait|gait
314318|NCT01805765|Sweat|sweat
314018|NCT01807221|Heart Decompensation|heart decompensation
314019|NCT01807208|Acute myocardial infarction|acute myocardial infarction
314020|NCT01807208|patient education|patient education
314021|NCT01807208|prevention|prevention
314022|NCT01807195|contrast|contrast
314023|NCT01807195|Intensive care unit|intensive care unit
314024|NCT01807195|Acute kidney injury|acute kidney injury
314025|NCT01807169|colon|colon
314026|NCT01807169|endoscopy|endoscopy
314027|NCT01807169|resection|resection
314028|NCT01807169|clopidogrel|clopidogrel
314029|NCT01807156|Tivozanib|tivozanib
314030|NCT01807156|Advanced hepatocellular cancer|advanced hepatocellular cancer
314031|NCT01807156|Angiogenesis|angiogenesis
314032|NCT01807130|Heart Failure|heart failure
314033|NCT01807130|Medical Therapy|medical therapy
314034|NCT01807130|ICD|icd
314035|NCT01807130|CRT|crt
314036|NCT01807104|Anterior Approach|anterior approach
314037|NCT01807104|Posterior Approach|posterior approach
314038|NCT01807078|Coronary artery disease|coronary artery disease
314039|NCT01807039|hip fracture|hip fracture
314040|NCT01807039|proximal femur|proximal femur
314041|NCT01807039|pertrochanteric fracture|pertrochanteric fracture
314042|NCT01807039|subtrochanteric fracture|subtrochanteric fracture
314043|NCT01807039|subcapital fracture|subcapital fracture
314044|NCT01807039|safety issue|safety issue
314045|NCT01807039|anesthesia|anesthesia
314046|NCT01807013|cirrhosis|cirrhosis
314047|NCT01807013|liver|liver
314048|NCT01807013|elastometry|elastometry
314049|NCT01807013|ultrasound|ultrasound
314050|NCT01807013|laparoscopy|laparoscopy
314051|NCT01807013|diagnosis|diagnosis
314052|NCT01806987|school readiness|school readiness
314053|NCT01806987|literacy|literacy
314054|NCT01806987|social emotional skills|social emotional skills
314055|NCT01806987|self regulation|self regulation
314056|NCT01806987|caregiver involvement|caregiver involvement
314057|NCT01806987|socioeconomic disadvantage|socioeconomic disadvantage
314058|NCT01806974|Periodontitis|periodontitis
314059|NCT01806974|rheumatoid arthritis|rheumatoid arthritis
314060|NCT01806974|anti-interleukin 6|anti-interleukin 6
314061|NCT01806974|immunotherapy|immunotherapy
314062|NCT01806974|inflammation|inflammation
314063|NCT01806974|bacteria|bacteria
314064|NCT01806974|periodontal sulci|periodontal sulci
314065|NCT01806974|periodontal pockets|periodontal pockets
314066|NCT01806935|associated|associated
314067|NCT01806935|aged population|aged population
314068|NCT01806922|Yoga|yoga
314069|NCT01806922|Stroke|stroke
314070|NCT01806922|Standing balance|standing balance
314071|NCT01806922|Depression|depression
314072|NCT01806909|Flu Vaccine|flu vaccine
314073|NCT01806909|Healthy Volunteer|healthy volunteer
314074|NCT01806883|Hemiparesis,|hemiparesis,
314075|NCT01806883|Rehabilitation,|rehabilitation,
314076|NCT01806883|WII,|wii,
314077|NCT01806883|Upper limb,|upper limb,
314078|NCT01806883|Movement strategies.|movement strategies.
314079|NCT01806870|HIV|hiv
314080|NCT01806870|ART|art
314081|NCT01806857|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
314082|NCT01806857|ALS|als
314083|NCT01806857|Nuedexta|nuedexta
314084|NCT01806857|Bulbar function|bulbar function
314085|NCT01806857|motor neurons|motor neurons
314086|NCT01806844|Cardiac arrest|cardiac arrest
314087|NCT01806844|Cerebral oxygenation|cerebral oxygenation
314088|NCT01806844|Pre-hospital|pre-hospital
314089|NCT01806805|Movement disorder|movement disorder
314090|NCT01806805|Myoclonus dystonia|myoclonus dystonia
314091|NCT01806805|DYT 11|dyt 11
314092|NCT01806805|Antiepileptic drugs|antiepileptic drugs
314093|NCT01806805|Zonisamide|zonisamide
314094|NCT01806805|Clinical Trial|clinical trial
314095|NCT01806805|Double-mind method|double-mind method
314096|NCT01806792|Osteoporosis|osteoporosis
314097|NCT01806779|Nicotine addiction|nicotine addiction
314098|NCT01806779|Cigarette smoking|cigarette smoking
314099|NCT01806779|Smoking cessation|smoking cessation
314100|NCT01806779|Zyban|zyban
314101|NCT01806779|Chantix|chantix
314102|NCT01806779|Nicotine patches|nicotine patches
314103|NCT01806779|varenicline|varenicline
314104|NCT01806779|bupropion|bupropion
314105|NCT01806766|cementless total hip arthroplasty|cementless total hip arthroplasty
314106|NCT01806766|ceramic on ceramic bearing|ceramic on ceramic bearing
314107|NCT01806766|ceramic on highly cross linked polyethylene|ceramic on highly cross linked polyethylene
314108|NCT01806766|young patient|young patient
314109|NCT01806753|Endoscopic submucosal dissection|endoscopic submucosal dissection
314110|NCT01806753|Sedation|sedation
314111|NCT01806753|Propofol|propofol
314112|NCT01806753|Midazolam|midazolam
314113|NCT01806740|DCE-MRI|dce-mri
314114|NCT01806740|Sorafenib response|sorafenib response
314115|NCT01806727|Diabetes|diabetes
314116|NCT01806727|Diabetes Self Management|diabetes self management
314117|NCT01806727|LIFT Diabetes|lift diabetes
314118|NCT01806727|Weight Loss|weight loss
314119|NCT01806727|Diet|diet
314120|NCT01806727|Physical Activity|physical activity
314121|NCT01806727|Overweight|overweight
314122|NCT01806727|Obese|obese
314123|NCT01806714|HPV vaccination|hpv vaccination
314124|NCT01806714|Adolescent well care|adolescent well care
314125|NCT01806714|Adolescent HPV immunization|adolescent hpv immunization
314126|NCT01806714|HPV|hpv
314127|NCT01806701|fMRI|fmri
314128|NCT01806701|neuroimaging|neuroimaging
314129|NCT01806701|PTSD|ptsd
314130|NCT01806701|adolescent|adolescent
314131|NCT01806701|trauma|trauma
314132|NCT01806701|brain|brain
314133|NCT01806688|satiety|satiety
314134|NCT01806688|appetite|appetite
314135|NCT01806688|snack|snack
314136|NCT01806662|Atopic Dermatitis|atopic dermatitis
314137|NCT01806662|Eczema|eczema
314138|NCT01806649|esophageal cancer|esophageal cancer
314139|NCT01806649|second line therapy|second line therapy
314140|NCT01806649|BKM120|bkm120
314141|NCT01806636|Coil|coil
314142|NCT01806636|RePneu|repneu
314143|NCT01806636|PneumRx|pneumrx
314144|NCT01806636|LVRC|lvrc
314145|NCT01806610|Randomized|randomized
314146|NCT01806610|Placebo-controlled trial|placebo-controlled trial
314147|NCT01806610|BPS804|bps804
314148|NCT01806610|Safety, tolerability, and PK|safety, tolerability, and pk
314149|NCT01806610|Patients with late-stage chronic kidney disease.|patients with late-stage chronic kidney disease.
314150|NCT01806597|Skin condition, itching, psoriasis vulgaris, relapsing remitting psoriasis, immune-med systemic disease, skin lesions, scaly patches, papules, plaques|skin condition, itching, psoriasis vulgaris, relapsing remitting psoriasis, immune-med systemic disease, skin lesions, scaly patches, papules, plaques
314151|NCT01806584|Vascular Injury|vascular injury
314152|NCT01806584|Arteriovenous Graft Surgery|arteriovenous graft surgery
314153|NCT01806584|Hemodialysis Access|hemodialysis access
314154|NCT01806558|Breast cancer|breast cancer
314155|NCT01806558|molecular breast imaging|molecular breast imaging
314156|NCT01806558|breast|breast
314157|NCT01806558|breast lesion|breast lesion
314158|NCT01806545|Arteriovenous Fistula Surgery|arteriovenous fistula surgery
314159|NCT01806545|Vascular Injury|vascular injury
314160|NCT01806545|Hemodialysis Access|hemodialysis access
314161|NCT01806532|computed tomography and positron emission tomography|computed tomography and positron emission tomography
314162|NCT01806532|respiration, artificial|respiration, artificial
314163|NCT01806532|respiratory distress syndrome, adult|respiratory distress syndrome, adult
314164|NCT01806519|neck pain|neck pain
314165|NCT01806519|motor control|motor control
314166|NCT01806519|intervention|intervention
314167|NCT01806519|forward head posture|forward head posture
314168|NCT01806506|Bariatric surgery|bariatric surgery
314169|NCT01806506|Gastric bypass|gastric bypass
314170|NCT01806506|Sleeve gastrectomy|sleeve gastrectomy
314171|NCT01806506|Weight loss|weight loss
314172|NCT01806506|Lipoproteins|lipoproteins
314173|NCT01806506|Insulin resistance|insulin resistance
314174|NCT01806506|Incretins|incretins
314175|NCT01806506|Quality of life|quality of life
314176|NCT01806493|body composition|body composition
314177|NCT01806493|obesity|obesity
314178|NCT01806480|Breastfeeding, Preterm Infant, Neonatal Care, Support, Mothers.|breastfeeding, preterm infant, neonatal care, support, mothers.
314179|NCT01806415|Fenobam,|fenobam,
314180|NCT01806415|Pharmacokinetics|pharmacokinetics
314181|NCT01806415|side effects|side effects
314182|NCT01806389|Breast milk|breast milk
314183|NCT01806389|Breastfeeding|breastfeeding
314184|NCT01806389|Lactation|lactation
314185|NCT01806389|Buprenorphine|buprenorphine
314186|NCT01806389|Opioid|opioid
314187|NCT01806363|Pharmacokinetics|pharmacokinetics
314188|NCT01806363|Safety|safety
314189|NCT01806363|Male|male
314190|NCT01806350|Pelvic floor muscle training; incontinence; quality of life|pelvic floor muscle training; incontinence; quality of life
314191|NCT01806337|peripheral T cell lymphoma|peripheral t cell lymphoma
314192|NCT01806337|alemtuzumab|alemtuzumab
314193|NCT01806337|consolidation|consolidation
314194|NCT01806311|Pharmacokinetics|pharmacokinetics
314195|NCT01806311|Safety|safety
314196|NCT01806311|Male|male
314197|NCT01806298|Adult Growth hormone deficiency|adult growth hormone deficiency
314198|NCT01806298|Saizen®|saizen®
314199|NCT01806298|Recombinant human growth hormone (r-hGH)|recombinant human growth hormone (r-hgh)
314200|NCT01806298|Somatropin|somatropin
314201|NCT01806285|Respiratory Virus|respiratory virus
314202|NCT01806272|rhGM-CSF|rhgm-csf
314203|NCT01806272|Oral Mucositis|oral mucositis
314204|NCT01806272|Primary Nasopharyngeal Cancers|primary nasopharyngeal cancers
314205|NCT01806272|Chemoradiotherapy|chemoradiotherapy
314206|NCT01806246|rehabilitation|rehabilitation
314207|NCT01806246|adolescent|adolescent
314208|NCT01806246|heart rate variability biofeedback|heart rate variability biofeedback
314209|NCT01806246|psychoeducation|psychoeducation
314210|NCT01806220|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
314211|NCT01806220|Chronic Laryngitis|chronic laryngitis
314212|NCT01806220|Epidermal Growth factor receptor|epidermal growth factor receptor
314213|NCT01806168|Post-traumatic stress disorder|post-traumatic stress disorder
314214|NCT01806168|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
314215|NCT01806168|Civilians|civilians
314216|NCT01806168|Neurostimulation|neurostimulation
314217|NCT01806168|Dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
314218|NCT01806155|craniotomy|craniotomy
314220|NCT01806155|postoperative|postoperative
314221|NCT01806116|myelodysplastic syndrome|myelodysplastic syndrome
314222|NCT01806116|higher-risk|higher-risk
314223|NCT01806116|acute myeloid leukemia|acute myeloid leukemia
314224|NCT01806116|relapsed /refractory|relapsed /refractory
314225|NCT01806116|decitabine|decitabine
314226|NCT01806116|hematopoietic cell transplantation|hematopoietic cell transplantation
314227|NCT01806116|bridge therapy|bridge therapy
314228|NCT01806103|antimicrobial stewardship program|antimicrobial stewardship program
314229|NCT01806103|inappropriate prescribing of antibiotics|inappropriate prescribing of antibiotics
314230|NCT01806103|physician prescribing|physician prescribing
314231|NCT01806103|antibiotic prescribing for respiratory tract infections|antibiotic prescribing for respiratory tract infections
314232|NCT01806103|respiratory tract infections|respiratory tract infections
314233|NCT01806077|Cardiovascular Diseases|cardiovascular diseases
314234|NCT01806077|Vascular Diseases|vascular diseases
314235|NCT01806077|Coronary Artery Disease|coronary artery disease
314236|NCT01806077|Coronary Disease|coronary disease
314237|NCT01806077|Arteriosclerosis|arteriosclerosis
314238|NCT01806077|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
314239|NCT01806064|TRC105|trc105
314240|NCT01806064|CD105|cd105
314241|NCT01806064|RCC|rcc
314242|NCT01806064|Renal Cell Carcinoma|renal cell carcinoma
314243|NCT01806064|Axitinib|axitinib
314244|NCT01806064|INLYTA|inlyta
314245|NCT01806064|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
314246|NCT01806038|Adverse events|adverse events
314247|NCT01806038|Drug interactions|drug interactions
314248|NCT01806038|Healthcare utilization|healthcare utilization
314249|NCT01806038|Discharge medication counseling|discharge medication counseling
314250|NCT01806025|Cystic Fibrosis|cystic fibrosis
314251|NCT01806025|Haptoglobin|haptoglobin
314252|NCT01806012|Supracervical Hysterectomy|supracervical hysterectomy
314253|NCT01806012|Leiomyomas|leiomyomas
314254|NCT01806012|Adenomyosis|adenomyosis
314255|NCT01805999|Ispaghula|ispaghula
314256|NCT01805999|Gastrointestinal physiology|gastrointestinal physiology
314257|NCT01805999|Gastrointestinal response to sugars|gastrointestinal response to sugars
314258|NCT01805999|MRI|mri
314259|NCT01805999|gastrointestinal|gastrointestinal
314260|NCT01805999|stomach|stomach
314261|NCT01805999|small bowel|small bowel
314262|NCT01805999|colon|colon
314263|NCT01805986|Multiple Sclerosis, other neurological conditions|multiple sclerosis, other neurological conditions
314264|NCT01805934|Helicobacter pylori, rescue, quadruple therapy，dual therapy|helicobacter pylori, rescue, quadruple therapy，dual therapy
314265|NCT01805921|Respiratory Syncytial Virus|respiratory syncytial virus
314266|NCT01805921|RSV|rsv
314267|NCT01805921|Vaccine|vaccine
314268|NCT01805908|metastatic|metastatic
314269|NCT01805908|breast cancer|breast cancer
314270|NCT01805908|herceptin|herceptin
314271|NCT01805908|imaging|imaging
314272|NCT01805908|tumour response|tumour response
314273|NCT01805908|adenocarcinoma|adenocarcinoma
314274|NCT01805908|SPECT-CT|spect-ct
314275|NCT01805908|pertuzumab|pertuzumab
314276|NCT01805908|trastuzumab|trastuzumab
314277|NCT01805908|locally advanced|locally advanced
314278|NCT01805895|Stroke|stroke
314279|NCT01805895|Acute Intracerebral Hemorrhage|acute intracerebral hemorrhage
314280|NCT01805895|Intracerebral Hemorrhage|intracerebral hemorrhage
314281|NCT01805895|Hemorrhagic stroke|hemorrhagic stroke
314282|NCT01805895|Hemorrhage|hemorrhage
314283|NCT01805895|Minocycline|minocycline
314284|NCT01805882|Interferon Sparing|interferon sparing
314285|NCT01805882|Directly Acting Antiviral|directly acting antiviral
314286|NCT01805882|Ribavarin Sparing|ribavarin sparing
314287|NCT01805869|Third Molar|third molar
314288|NCT01805869|Specimen Acquisition|specimen acquisition
314289|NCT01805856|antimicrobial prophylaxis|antimicrobial prophylaxis
314290|NCT01805856|AMP|amp
314291|NCT01805856|surgical site infection|surgical site infection
314292|NCT01805856|SSI|ssi
314293|NCT01805856|thyroid|thyroid
314294|NCT01805856|thyroidectomy|thyroidectomy
314295|NCT01805856|parathyroid|parathyroid
314296|NCT01805856|surgery|surgery
314297|NCT01805843|Pulmonary hypertension|pulmonary hypertension
314298|NCT01805843|chronic myeloid leukemia|chronic myeloid leukemia
314299|NCT01805843|dasatinib|dasatinib
314300|NCT01805843|nilotinib|nilotinib
314301|NCT01805830|Type2DM / DPP-IV inhibitors|type2dm / dpp-iv inhibitors
314302|NCT01805817|lipid profile|lipid profile
314303|NCT01805817|bleeding scores|bleeding scores
314304|NCT01805817|menstrual pattern|menstrual pattern
314305|NCT01805817|beneficial|beneficial
314306|NCT01805817|side effects|side effects
314307|NCT01805817|changes in a year period|changes in a year period
314308|NCT01805804|dual chamber pacing, left ventricle remodeling, valsartan|dual chamber pacing, left ventricle remodeling, valsartan
314309|NCT01805791|Ulcerative Colitis,|ulcerative colitis,
314310|NCT01805791|UC|uc
314311|NCT01805791|Patients|patients
314312|NCT01805791|active|active
314313|NCT01805791|mild|mild
314314|NCT01805791|moderate|moderate
314315|NCT01805765|menopausal syndrome|menopausal syndrome
314316|NCT01805765|climacteric syndrome|climacteric syndrome
314317|NCT01805765|Hot flashes|hot flashes
314319|NCT01805752|Prevention of mother to child HIV transmission|prevention of mother to child hiv transmission
314320|NCT01805752|HIV/AIDS|hiv/aids
314321|NCT01805739|transcatheter aortic valve implantation|transcatheter aortic valve implantation
314322|NCT01805739|CT|ct
314323|NCT01805739|MRI|mri
314324|NCT01805739|angiography|angiography
314325|NCT01805739|echocardiography|echocardiography
314326|NCT01805739|rotational C-arm CT|rotational c-arm ct
314327|NCT01805726|bronchoscopy|bronchoscopy
314328|NCT01805726|sedation|sedation
314329|NCT01805726|pulmonary function|pulmonary function
314330|NCT01805726|tolerance|tolerance
314331|NCT01805726|xylocain|xylocain
314332|NCT01805726|dexmedetomidine|dexmedetomidine
314333|NCT01805726|alfentanil|alfentanil
314334|NCT01805713|Biomarkers|biomarkers
314335|NCT01805700|type 1|type 1
314336|NCT01805700|diabetes|diabetes
314337|NCT01805700|caffeine-enhanced energy drink|caffeine-enhanced energy drink
314338|NCT01805700|cardiac output|cardiac output
314339|NCT01805700|glucose|glucose
314340|NCT01805700|cognitive performance|cognitive performance
314341|NCT01805674|menopause|menopause
314342|NCT01805674|quality of life|quality of life
314343|NCT01805674|soy isoflavones|soy isoflavones
314344|NCT01805674|magnolia extract|magnolia extract
314345|NCT01805661|early ambulation|early ambulation
314346|NCT01805661|knee arthroplasty|knee arthroplasty
314347|NCT01805648|ITP|itp
314348|NCT01805648|rhTPO|rhtpo
314349|NCT01805635|Children|children
314350|NCT01805635|Asthma|asthma
314351|NCT01805635|Allergic rhinitis|allergic rhinitis
314352|NCT01805635|Atopic dermatitis|atopic dermatitis
314353|NCT01805635|Urticaria|urticaria
314354|NCT01805635|Healthy|healthy
314355|NCT01805622|community-based participatory research|community-based participatory research
314356|NCT01805622|colorectal cancer screening|colorectal cancer screening
314357|NCT01805609|practice nurse|practice nurse
314358|NCT01805609|clinical Nurse|clinical nurse
314359|NCT01805609|inpatient staff|inpatient staff
314360|NCT01805609|inpatient social worker|inpatient social worker
314361|NCT01805609|didactic training sessions|didactic training sessions
314362|NCT01805609|13-030|13-030
314363|NCT01805596|coronary artery disease|coronary artery disease
314364|NCT01805596|endothelial function|endothelial function
314365|NCT01805596|antiplatelet agent|antiplatelet agent
314366|NCT01805570|platelet inhibitor|platelet inhibitor
314367|NCT01805570|ST-segment Elevation|st-segment elevation
314368|NCT01805570|Myocardial Infarction|myocardial infarction
314369|NCT01805570|stent|stent
314370|NCT01805570|prasugrel|prasugrel
314371|NCT01805570|ticagrelor|ticagrelor
314372|NCT01805557|Diffuse Large B-cell Lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
314373|NCT01805557|Bortezomib|bortezomib
314374|NCT01805544|SF36 questionnaire|sf36 questionnaire
314375|NCT01805544|Anti Clot Treatment Scale|anti clot treatment scale
314376|NCT01805544|Satisfaction|satisfaction
314377|NCT01805544|Quality of Life|quality of life
314378|NCT01805544|Rivaroxaban|rivaroxaban
314379|NCT01805544|Prevention & control|prevention & control
314380|NCT01805544|Pulmonary embolism|pulmonary embolism
314381|NCT01805531|SF36 questionnaire|sf36 questionnaire
314382|NCT01805531|Anti Clot Treatment Scale|anti clot treatment scale
314383|NCT01805531|Satisfaction|satisfaction
314384|NCT01805531|Quality of Life|quality of life
314385|NCT01805531|Rivaroxaban|rivaroxaban
314386|NCT01805531|Stroke prevention|stroke prevention
314387|NCT01805518|CNSVS|cnsvs
314388|NCT01805518|Tower of London|tower of london
314389|NCT01805518|Letter-Number Test|letter-number test
314390|NCT01805518|Trail Making Test|trail making test
314391|NCT01805518|Vital signs|vital signs
314392|NCT01805518|Mood|mood
314393|NCT01805518|Suicidal ideation|suicidal ideation
314394|NCT01805518|ECG|ecg
314395|NCT01805518|Physical exam|physical exam
314396|NCT01805518|Blood|blood
314397|NCT01805518|Urine (Including pregnancy and drug screen)|urine (including pregnancy and drug screen)
314398|NCT01805518|Cytokines|cytokines
314399|NCT01805518|Side effects|side effects
314400|NCT01805518|Brief Psychiatric Rating Scale|brief psychiatric rating scale
314401|NCT01805518|Positive and Negative Symptom Scale|positive and negative symptom scale
314402|NCT01805505|Female infertility|female infertility
314403|NCT01805505|Oocyte donation|oocyte donation
314404|NCT01805505|Embryo transfer|embryo transfer
314405|NCT01805505|Transvaginal ultrasonography|transvaginal ultrasonography
314406|NCT01805505|Transabdominal ultrasonography|transabdominal ultrasonography
314407|NCT01805492|Heart diseases|heart diseases
314408|NCT01805492|Cardiovascular diseases|cardiovascular diseases
314409|NCT01805492|Lifestyle modification|lifestyle modification
314410|NCT01805492|Diet|diet
314411|NCT01805492|Exercise|exercise
314412|NCT01805479|exercise|exercise
314413|NCT01805479|depression|depression
314414|NCT01805479|traumatic brain injury|traumatic brain injury
314415|NCT01805466|Extracorporeal Vacuum Assisted Device Optimised (EVADO)|extracorporeal vacuum assisted device optimised (evado)
314416|NCT01805453|Glioblastoma|glioblastoma
314417|NCT01805453|Angiotensin-II inhibitors|angiotensin-ii inhibitors
314418|NCT01805453|Losartan|losartan
314419|NCT01805453|steroids|steroids
314420|NCT01805453|Radiotherapy|radiotherapy
314421|NCT01805453|Edema|edema
314422|NCT01805453|Randomized trial|randomized trial
314423|NCT01805440|Adolescent|adolescent
314424|NCT01805440|Bipolar Disorder|bipolar disorder
314425|NCT01805440|Bipolar Depression|bipolar depression
314426|NCT01805440|Manic Depression|manic depression
314427|NCT01805440|Neuroimaging|neuroimaging
314428|NCT01805440|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
314429|NCT01805440|Uridine|uridine
314430|NCT01805440|Pyrimidines|pyrimidines
314431|NCT01805427|trough concentration|trough concentration
314432|NCT01805427|weight|weight
314433|NCT01805427|HIV|hiv
314434|NCT01805427|virological failure|virological failure
314435|NCT01805414|inpatient diabetes|inpatient diabetes
314436|NCT01805414|inpatient diabetes nutrition|inpatient diabetes nutrition
314437|NCT01805401|Decision-making|decision-making
314438|NCT01805401|Impulse control|impulse control
314439|NCT01805401|Transcranial direct current stimulation|transcranial direct current stimulation
314440|NCT01805401|Brain stimulation|brain stimulation
314441|NCT01805401|Neuromodulation|neuromodulation
314442|NCT01805401|tDCS|tdcs
314443|NCT01805401|Iowa Gambling Task|iowa gambling task
314444|NCT01805401|Stroop Word-Color Task|stroop word-color task
314445|NCT01805388|Dental Pulp Regeneration|dental pulp regeneration
314446|NCT01805375|Phase I, Cancer, CD19 positive, B-Cell lymphoma, chronic lymphocytic leukaemia|phase i, cancer, cd19 positive, b-cell lymphoma, chronic lymphocytic leukaemia
314447|NCT01805375|Waldenström Macroglobulinaemia|waldenström macroglobulinaemia
314448|NCT01805336|Relapsing-Remitting MS|relapsing-remitting ms
314449|NCT01805336|cognitive impairment|cognitive impairment
314450|NCT01805336|virtual reality|virtual reality
314451|NCT01805310|Pelvic organ prolapse|pelvic organ prolapse
314452|NCT01805310|Prolapse|prolapse
314453|NCT01805310|Cathartics|cathartics
314454|NCT01805310|Mechanical bowel preparation|mechanical bowel preparation
314455|NCT01805297|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
314456|NCT01805284|pneumonia|pneumonia
314457|NCT01805271|ER-positive HER2-negative|er-positive her2-negative
314458|NCT01805258|India|india
314459|NCT01805258|Nevirapine|nevirapine
314460|NCT01805258|Rifampicin|rifampicin
314461|NCT01805258|Efavirenz|efavirenz
314462|NCT01805258|HIV|hiv
314463|NCT01805258|TB|tb
314464|NCT01805232|severe|severe
314465|NCT01805232|Falciaparum|falciaparum
314466|NCT01805232|Malaria|malaria
314467|NCT01805206|Prematurity|prematurity
314468|NCT01805206|Necrotizing Enterocolitis|necrotizing enterocolitis
314469|NCT01805206|Biomarkers|biomarkers
314470|NCT01805206|Intestinal Fatty Acid Binding Protein|intestinal fatty acid binding protein
314471|NCT01805206|Feeding|feeding
314472|NCT01805193|Coronary heart disease|coronary heart disease
314473|NCT01805193|computed tomography myocardial perfusion|computed tomography myocardial perfusion
314474|NCT01805193|positron emission tomography|positron emission tomography
314475|NCT01805193|oxygen 15 labelled water|oxygen 15 labelled water
314476|NCT01805193|myocardial perfusion|myocardial perfusion
314477|NCT01805193|myocardial blood flow|myocardial blood flow
314478|NCT01805167|Subject with cochlear implant|subject with cochlear implant
314479|NCT01805141|Cervix Uteri|cervix uteri
314480|NCT01805128|Schizophrenia|schizophrenia
314481|NCT01805128|Autistic Disorder|autistic disorder
314482|NCT01805128|social cognition|social cognition
314483|NCT01805115|hysteroscopy|hysteroscopy
314484|NCT01805115|misoprostol|misoprostol
314485|NCT01805102|In vitro fertilization|in vitro fertilization
314486|NCT01805102|implantation|implantation
314487|NCT01805102|miscarriage|miscarriage
314488|NCT01805102|live birth|live birth
314489|NCT01805063|firefighters|firefighters
314490|NCT01805063|myocardial infarction|myocardial infarction
314491|NCT01805063|endothelial function|endothelial function
314492|NCT01805063|thrombosis|thrombosis
314493|NCT01805063|fire suppression|fire suppression
314494|NCT01805063|non-fire emergency duty|non-fire emergency duty
314495|NCT01805063|sedentary shift|sedentary shift
314496|NCT01805050|HAGL|hagl
314497|NCT01805050|Shoulder instability|shoulder instability
314498|NCT01804998|laparoscopic sentinel lymph node biopsy|laparoscopic sentinel lymph node biopsy
314499|NCT01804998|phase 3|phase 3
314500|NCT01804998|early gastric cancer|early gastric cancer
314501|NCT01804972|Patient information|patient information
314502|NCT01804972|Vascular disease|vascular disease
314503|NCT01804972|Abdominal aortic aneurysm|abdominal aortic aneurysm
314504|NCT01804972|Varicose veins|varicose veins
314505|NCT01804972|Web based information|web based information
314506|NCT01804933|profound muscle relaxation|profound muscle relaxation
314507|NCT01804933|muscle trauma|muscle trauma
314508|NCT01804933|postoperative analgesic demand|postoperative analgesic demand
314509|NCT01804933|postoperative pulmonary function|postoperative pulmonary function
314510|NCT01804907|HAART adherence|haart adherence
314511|NCT01804907|HIV|hiv
314512|NCT01804907|Fatigue|fatigue
314513|NCT01804907|treatment|treatment
314514|NCT01804868|case vignette|case vignette
314515|NCT01804868|nurse|nurse
314516|NCT01804868|critical assessment|critical assessment
314815|NCT01803893|miscarriage|miscarriage
314517|NCT01804868|randomized controlled trial|randomized controlled trial
314518|NCT01804855|Obesity; mobile health; telemedicine; family-based treatment|obesity; mobile health; telemedicine; family-based treatment
314519|NCT01804829|HCV Liver Transplant Immunoglobulin PCR SVR|hcv liver transplant immunoglobulin pcr svr
314520|NCT01804816|Chronic Heart Failure|chronic heart failure
314521|NCT01804816|Heart Failure|heart failure
314522|NCT01804803|glycated hemoglobin|glycated hemoglobin
314523|NCT01804803|hyperglycemia|hyperglycemia
314524|NCT01804803|hypoglycemia|hypoglycemia
314525|NCT01804803|insulin|insulin
314526|NCT01804803|self-monitoring of blood glucose|self-monitoring of blood glucose
314527|NCT01804803|telemedicine|telemedicine
314528|NCT01804790|rectum|rectum
314529|NCT01804790|cancer|cancer
314530|NCT01804790|locally advanced|locally advanced
314531|NCT01804777|ENaC|enac
314532|NCT01804777|Amiloride|amiloride
314533|NCT01804777|Hydrochlorothiazide(HCTZ)|hydrochlorothiazide(hctz)
314534|NCT01804777|Hypertension|hypertension
314535|NCT01804777|Type II Diabetes|type ii diabetes
314536|NCT01804777|Natriuresis|natriuresis
314537|NCT01804777|Proteinuria|proteinuria
314538|NCT01804764|Severe Sepsis|severe sepsis
314539|NCT01804764|Septic Shock|septic shock
314540|NCT01804764|Sepsis Six bundle|sepsis six bundle
314541|NCT01804738|Ethnic differences|ethnic differences
314542|NCT01804738|Inter-individual variability|inter-individual variability
314543|NCT01804738|Glycemic response|glycemic response
314544|NCT01804738|Insulin response|insulin response
314545|NCT01804738|Mastication|mastication
314546|NCT01804738|Salivary alpha-amylase|salivary alpha-amylase
314547|NCT01804738|Gastric emptying|gastric emptying
314548|NCT01804738|Metagenome|metagenome
314549|NCT01804725|bike seats|bike seats
314550|NCT01804725|Erectile dysfunction|erectile dysfunction
314551|NCT01804725|Perineum|perineum
314552|NCT01804725|Impotence|impotence
314553|NCT01804712|Prostate|prostate
314554|NCT01804712|Cancer|cancer
314555|NCT01804712|Castration-resistant|castration-resistant
314556|NCT01804712|Rituximab|rituximab
314557|NCT01804712|neoadjuvant|neoadjuvant
314558|NCT01804712|Rituxan|rituxan
314559|NCT01804699|ARVC, Cardiomyopathy|arvc, cardiomyopathy
314560|NCT01804686|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
314561|NCT01804686|Small lymphocytic lymphoma|small lymphocytic lymphoma
314562|NCT01804686|Mantle cell lymphoma|mantle cell lymphoma
314563|NCT01804686|Follicular lymphoma|follicular lymphoma
314564|NCT01804686|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
314565|NCT01804686|PCI-32765|pci-32765
314566|NCT01804686|Ibrutinib|ibrutinib
314567|NCT01804686|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
314568|NCT01804686|IMBRUVICA|imbruvica
314569|NCT01804686|JNJ-54179060|jnj-54179060
314570|NCT01804673|Postoperative Pain|postoperative pain
314571|NCT01804673|Fentanyl Hydrochloride|fentanyl hydrochloride
314572|NCT01804673|IONSYS|ionsys
314573|NCT01804660|Multiple Sclerosis (MS)|multiple sclerosis (ms)
314574|NCT01804660|Multiple Sclerosis associated RetroVirus (MSRV)|multiple sclerosis associated retrovirus (msrv)
314575|NCT01804660|MSRV envelop protein (MSRV-Env)|msrv envelop protein (msrv-env)
314576|NCT01804647|Multiple sclerosis (MS)|multiple sclerosis (ms)
314577|NCT01804647|Relapsing-Remitting MS|relapsing-remitting ms
314578|NCT01804647|Primary progressive MS|primary progressive ms
314579|NCT01804647|Secondary progressive MS|secondary progressive ms
314580|NCT01804647|Clinically Isolated Syndrome (CIS)|clinically isolated syndrome (cis)
314581|NCT01804647|Multiple Sclerosis associated RetroVirus (MSRV)|multiple sclerosis associated retrovirus (msrv)
314582|NCT01804647|MSRV envelop protein (MSRV-Env)|msrv envelop protein (msrv-env)
314583|NCT01804634|Solid Tumors|solid tumors
314584|NCT01804634|Neuroblastoma|neuroblastoma
314585|NCT01804634|Osteosarcoma|osteosarcoma
314586|NCT01804634|Ewing Sarcoma|ewing sarcoma
314587|NCT01804634|Rhabdomyosarcoma|rhabdomyosarcoma
314588|NCT01804634|Hepatoblastoma|hepatoblastoma
314589|NCT01804634|Melanoma|melanoma
314590|NCT01804634|Desmoplastic Round Cell Tumor|desmoplastic round cell tumor
314591|NCT01804634|brain tumors|brain tumors
314592|NCT01804621|Exercise|exercise
314593|NCT01804621|Nutrition|nutrition
314594|NCT01804621|Mammography|mammography
314595|NCT01804621|Colorectal screening|colorectal screening
314596|NCT01804595|Worksite intervention|worksite intervention
314597|NCT01804595|Sun protection intervention|sun protection intervention
314598|NCT01804595|Operating Engineers|operating engineers
314599|NCT01804582|Family navigator|family navigator
314600|NCT01804582|Patient Centered Outcomes|patient centered outcomes
314601|NCT01804582|Pediatric Antipsychotic treatment|pediatric antipsychotic treatment
314602|NCT01804556|muscle cramps, trigger points, sleep disturbance|muscle cramps, trigger points, sleep disturbance
314603|NCT01804530|solid tumors|solid tumors
314604|NCT01804530|activating NTRK point or fusion mutations|activating ntrk point or fusion mutations
314605|NCT01804530|Tenosynovial giant cell tumor|tenosynovial giant cell tumor
314606|NCT01804530|TGCT|tgct
314607|NCT01804517|migraine|migraine
314608|NCT01804504|Metabolic syndrome|metabolic syndrome
314609|NCT01804504|Eating out of home|eating out of home
314610|NCT01804504|Nutrition education|nutrition education
314611|NCT01804465|castration resistant|castration resistant
314612|NCT01804465|prostate|prostate
314613|NCT01804465|cancer|cancer
314614|NCT01804465|ipilimumab|ipilimumab
314615|NCT01804465|provenge|provenge
314616|NCT01804465|SipT|sipt
314617|NCT01804452|Progressive Supranuclear Palsy|progressive supranuclear palsy
314618|NCT01804452|Corticobasal Degeneration|corticobasal degeneration
314619|NCT01804452|Biomarker|biomarker
314620|NCT01804452|Neuroimaging|neuroimaging
314621|NCT01804452|MRI|mri
314622|NCT01804452|Tau|tau
314623|NCT01804452|Oculomotor|oculomotor
314624|NCT01804439|Heart diseases|heart diseases
314625|NCT01804439|Cardiovascular diseases|cardiovascular diseases
314626|NCT01804439|Coronary heart disease not otherwise specified|coronary heart disease not otherwise specified
314627|NCT01804439|Cerebrovascular disorders|cerebrovascular disorders
314628|NCT01804439|Brain diseases|brain diseases
314629|NCT01804439|Central nervous system diseases|central nervous system diseases
314630|NCT01804439|Nervous system diseases|nervous system diseases
314631|NCT01804439|Atherosclerosis|atherosclerosis
314632|NCT01804439|Arteriosclerosis|arteriosclerosis
314633|NCT01804439|Pathologic processes|pathologic processes
314634|NCT01804439|Acute myocardial infarction|acute myocardial infarction
314635|NCT01804439|Myocardial infarction|myocardial infarction
314636|NCT01804439|Myocardial ischemia|myocardial ischemia
314637|NCT01804439|Infarction|infarction
314638|NCT01804439|Necrosis|necrosis
314639|NCT01804439|Unstable angina|unstable angina
314640|NCT01804439|Chronic stable angina|chronic stable angina
314641|NCT01804439|Stable angina|stable angina
314642|NCT01804439|Angina pectoris|angina pectoris
314643|NCT01804439|Chest pain|chest pain
314644|NCT01804439|Pain|pain
314645|NCT01804439|Signs and symptoms|signs and symptoms
314646|NCT01804439|Ischemia|ischemia
314647|NCT01804439|Ischemic stroke|ischemic stroke
314648|NCT01804439|Hemorrhagic stroke|hemorrhagic stroke
314649|NCT01804439|Stroke|stroke
314650|NCT01804439|Subarachnoid hemorrhage|subarachnoid hemorrhage
314651|NCT01804439|Transient ischemic attack|transient ischemic attack
314652|NCT01804439|Abdominal aortic aneurysm|abdominal aortic aneurysm
314653|NCT01804439|Aneurysm|aneurysm
314654|NCT01804439|Aortic aneurysm|aortic aneurysm
314655|NCT01804439|Aortic aneurysm, abdominal|aortic aneurysm, abdominal
314656|NCT01804439|Aortic diseases|aortic diseases
314657|NCT01804439|Peripheral arterial diseases|peripheral arterial diseases
314658|NCT01804439|Peripheral vascular diseases|peripheral vascular diseases
314659|NCT01804439|Vascular diseases|vascular diseases
314660|NCT01804439|Peripheral occlusive diseases|peripheral occlusive diseases
314661|NCT01804439|Sudden coronary death|sudden coronary death
314662|NCT01804439|Ventricular arrhythmia|ventricular arrhythmia
314663|NCT01804439|Sudden cardiac death|sudden cardiac death
314664|NCT01804439|Cardiac arrest|cardiac arrest
314665|NCT01804439|Heart failure|heart failure
314666|NCT01804426|PTSD|ptsd
314667|NCT01804426|Post Traumatic Stress Disorder|post traumatic stress disorder
314668|NCT01804426|Cortisol|cortisol
314669|NCT01804426|Alpha-Amylase|alpha-amylase
314670|NCT01804426|bio-Markers|bio-markers
314671|NCT01804413|Pegvisomant|pegvisomant
314672|NCT01804413|Growth hormone|growth hormone
314673|NCT01804413|Cortisol|cortisol
314674|NCT01804413|Glucagon|glucagon
314675|NCT01804413|Insulin|insulin
314676|NCT01804387|Chronic Hepatitis B|chronic hepatitis b
314677|NCT01804387|Telbivudine|telbivudine
314678|NCT01804387|Adefovir|adefovir
314679|NCT01804387|Lamivudine resistance|lamivudine resistance
314680|NCT01804374|osteosarcoma|osteosarcoma
314681|NCT01804374|sorafenib|sorafenib
314682|NCT01804374|everolimus|everolimus
314683|NCT01804374|sarcoma|sarcoma
314684|NCT01804361|Dry Eye Syndromes|dry eye syndromes
314685|NCT01804348|PROM|prom
314686|NCT01804335|Lymphoma|lymphoma
314687|NCT01804335|Early Stage Cutaneous T-Cell Lymphoma|early stage cutaneous t-cell lymphoma
314688|NCT01804335|CTCL|ctcl
314689|NCT01804335|CD5789 0.01% cream|cd5789 0.01% cream
314690|NCT01804322|epilepsy|epilepsy
314691|NCT01804322|chronic comorbidities|chronic comorbidities
314692|NCT01804322|educational strategies|educational strategies
314693|NCT01804322|drug interactions|drug interactions
314694|NCT01804322|drug adverse effects|drug adverse effects
314695|NCT01804309|axyllary lymph node|axyllary lymph node
314696|NCT01804309|sentinel lymph node|sentinel lymph node
314697|NCT01804309|lymphatic drainage|lymphatic drainage
314698|NCT01804309|early breast cancer|early breast cancer
314699|NCT01804309|axillary lymph node dissection|axillary lymph node dissection
314700|NCT01804296|Teen|teen
314701|NCT01804296|Adolescent|adolescent
314702|NCT01804296|Depression|depression
314703|NCT01804296|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
314704|NCT01804296|TMS|tms
314705|NCT01804270|Teen|teen
314706|NCT01804270|Adolescent|adolescent
314707|NCT01804270|Depression|depression
314708|NCT01804270|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
314709|NCT01804270|TMS|tms
314710|NCT01804257|Adherence|adherence
314711|NCT01804257|Bipolar disorder|bipolar disorder
314712|NCT01804257|Cellular phone|cellular phone
314713|NCT01804257|Cloud computing|cloud computing
314714|NCT01804257|Computers|computers
314715|NCT01804257|Computers, handheld|computers, handheld
314716|NCT01804257|Digital health|digital health
314717|NCT01804257|Digital health feedback system|digital health feedback system
314718|NCT01804257|Ingestion Sensor|ingestion sensor
314719|NCT01804257|Medication adherence|medication adherence
314720|NCT01804257|Medication non-adherence|medication non-adherence
314721|NCT01804257|Medication nonadherence|medication nonadherence
314722|NCT01804257|Mobile phone|mobile phone
314723|NCT01804257|Mobile health|mobile health
314724|NCT01804257|Patient adherence|patient adherence
314725|NCT01804257|Patient non-adherence|patient non-adherence
314726|NCT01804257|Patient nonadherence|patient nonadherence
314727|NCT01804257|Schizophrenia|schizophrenia
314728|NCT01804257|Telehealth|telehealth
314729|NCT01804257|Telemedicine|telemedicine
314730|NCT01804257|Telenursing|telenursing
314731|NCT01804257|Wearable sensor|wearable sensor
314732|NCT01804244|Healthy|healthy
314733|NCT01804244|Pharmacokinetics|pharmacokinetics
314734|NCT01804244|Japanese|japanese
314735|NCT01804231|Prostate Cancer|prostate cancer
314736|NCT01804231|PET|pet
314737|NCT01804231|MRI|mri
314738|NCT01804231|Hybrid|hybrid
314739|NCT01804231|Recurrence|recurrence
314740|NCT01804231|Fluorocholine|fluorocholine
314741|NCT01804205|magnesium sulfate|magnesium sulfate
314742|NCT01804205|rocuronium|rocuronium
314743|NCT01804205|neuromuscular block|neuromuscular block
314744|NCT01804205|onset time|onset time
314745|NCT01804205|elderly|elderly
314746|NCT01804192|Acu-TENS|acu-tens
314747|NCT01804192|MAP|map
314748|NCT01804192|HR|hr
314749|NCT01804192|HRV|hrv
314750|NCT01804179|colon|colon
314751|NCT01804179|rectum|rectum
314752|NCT01804179|cancer|cancer
314753|NCT01804179|screening|screening
314754|NCT01804179|questionnaire|questionnaire
314755|NCT01804179|testing|testing
314756|NCT01804179|educational materials|educational materials
314757|NCT01804166|Lymphoma, T-Cell, Peripheral, Infliximab, Golimumab, Remicade, Simponi, Ulcerative Colitis, Crohn's Disease, Inflammatory Bowel Disease|lymphoma, t-cell, peripheral, infliximab, golimumab, remicade, simponi, ulcerative colitis, crohn's disease, inflammatory bowel disease
314758|NCT01804153|Feminine stress urinary incontinence|feminine stress urinary incontinence
314759|NCT01804153|Autologous expanded stem cells|autologous expanded stem cells
314760|NCT01804127|DLBCL|dlbcl
314761|NCT01804127|R-CHOP|r-chop
314762|NCT01804127|PET/CT|pet/ct
314763|NCT01804088|Peripheral artery disease|peripheral artery disease
314764|NCT01804088|Iliac arteries|iliac arteries
314765|NCT01804088|Balloon-expandable stent|balloon-expandable stent
314766|NCT01804075|NAS|nas
314767|NCT01804075|NICU|nicu
314768|NCT01804075|EMMC|emmc
314769|NCT01804049|metformin|metformin
314770|NCT01804049|muscle|muscle
314771|NCT01804049|insulin resistance|insulin resistance
314772|NCT01804049|sarcopenia|sarcopenia
314773|NCT01804049|older adults|older adults
314774|NCT01804049|impaired fasting glucose|impaired fasting glucose
314775|NCT01803997|Child|child
314776|NCT01803997|Nutrition|nutrition
314777|NCT01803997|resonance Raman spectroscopy|resonance raman spectroscopy
314778|NCT01803997|Fruit & Vegetable|fruit & vegetable
314779|NCT01803997|Children Cooking|children cooking
314780|NCT01803984|Migraine|migraine
314781|NCT01803984|Brain structure|brain structure
314782|NCT01803984|MRI|mri
314783|NCT01803971|cardiac arrest|cardiac arrest
314784|NCT01803971|peripheral venous access|peripheral venous access
314785|NCT01803971|intraosseous access|intraosseous access
314786|NCT01803945|Parkinson's disease|parkinson's disease
314787|NCT01803945|cognitive impairment|cognitive impairment
314788|NCT01803945|movement disorder|movement disorder
314789|NCT01803932|intimate partner violence|intimate partner violence
314790|NCT01803932|gender|gender
314791|NCT01803932|primary prevention intervention|primary prevention intervention
314792|NCT01803932|conflict|conflict
314793|NCT01803932|Cote d'Ivoire|cote d'ivoire
314794|NCT01803932|Ivory Coast|ivory coast
314795|NCT01803919|Spinal cord injuries|spinal cord injuries
314796|NCT01803919|Urinary tract infection|urinary tract infection
314797|NCT01803919|Urinary catheters|urinary catheters
314798|NCT01803919|Protocol|protocol
314799|NCT01803919|Randomized clinical trial|randomized clinical trial
314800|NCT01803906|mitochondrial disorder|mitochondrial disorder
314801|NCT01803906|mitochondria|mitochondria
314802|NCT01803906|oxidative phosphorylation|oxidative phosphorylation
314803|NCT01803906|oxidative phosphorylation disorders|oxidative phosphorylation disorders
314804|NCT01803906|respiratory chain disorders|respiratory chain disorders
314805|NCT01803906|mitochondrial disease|mitochondrial disease
314806|NCT01803906|melas|melas
314807|NCT01803906|kearns sayer|kearns sayer
314808|NCT01803906|NARP|narp
314809|NCT01803906|MNGIE|mngie
314810|NCT01803906|LHON|lhon
314811|NCT01803906|Mitochondrial depletion syndrome|mitochondrial depletion syndrome
314812|NCT01803906|Leigh's disease|leigh's disease
314813|NCT01803893|In vitro fertilization|in vitro fertilization
314814|NCT01803893|implantation|implantation
314816|NCT01803893|live birth|live birth
314817|NCT01803880|Articular cartilage|articular cartilage
314818|NCT01803880|Cartilage lesion|cartilage lesion
314819|NCT01803880|Cartilage defect|cartilage defect
314820|NCT01803880|Radiofrequency|radiofrequency
314821|NCT01803880|Debridement|debridement
314822|NCT01803880|Cartilage|cartilage
314823|NCT01803880|Coblation|coblation
314824|NCT01803880|Knee|knee
314825|NCT01803880|Meniscus|meniscus
314826|NCT01803880|Meniscectomy|meniscectomy
314827|NCT01803880|MR imaging|mr imaging
314828|NCT01803880|Mechanical debridement|mechanical debridement
314829|NCT01803880|Mechanical shaver|mechanical shaver
314830|NCT01803880|Torn meniscus|torn meniscus
314831|NCT01803880|Arthroscopic knee surgery|arthroscopic knee surgery
314832|NCT01803880|Damaged cartilage|damaged cartilage
314833|NCT01803867|MS|ms
314834|NCT01803867|Multiple Sclerosis|multiple sclerosis
314835|NCT01803841|Coronary artery disease|coronary artery disease
314836|NCT01803828|Diabetic Cardiomyopathy|diabetic cardiomyopathy
314837|NCT01803828|Genders|genders
314838|NCT01803828|Phosphodiesterase 5A inhibitors|phosphodiesterase 5a inhibitors
314839|NCT01803828|miRNAs|mirnas
314840|NCT01803828|Chemokines|chemokines
314841|NCT01803815|obstructive sleep apnea|obstructive sleep apnea
314842|NCT01803815|hypertension|hypertension
314843|NCT01803815|antihypertensive drugs|antihypertensive drugs
314844|NCT01803802|childhood sexual abuse|childhood sexual abuse
314845|NCT01803802|depression|depression
314846|NCT01803802|PTSD|ptsd
314847|NCT01803802|sexual function|sexual function
314848|NCT01803802|women|women
314849|NCT01803789|Metacarpal V Fractures|metacarpal v fractures
314850|NCT01803789|Single Kirschner Wires|single kirschner wires
314851|NCT01803789|Double Kirschner Wires|double kirschner wires
314852|NCT01803776|child|child
314853|NCT01803776|physical activity|physical activity
314854|NCT01803776|sedentary activity|sedentary activity
314855|NCT01803776|nutrition|nutrition
314856|NCT01803776|diet|diet
314857|NCT01803776|body composition|body composition
314858|NCT01803776|overweight|overweight
314859|NCT01803776|obesity|obesity
314860|NCT01803776|glucose metabolism disorders|glucose metabolism disorders
314861|NCT01803776|lipid metabolism disorders|lipid metabolism disorders
314862|NCT01803776|physical fitness|physical fitness
314863|NCT01803776|cardiovascular system|cardiovascular system
314864|NCT01803776|musculoskeletal system|musculoskeletal system
314865|NCT01803776|bone mineral density|bone mineral density
314866|NCT01803776|oral health|oral health
314867|NCT01803776|quality of life|quality of life
314868|NCT01803776|wellbeing|wellbeing
314869|NCT01803776|gene-lifestyle interaction|gene-lifestyle interaction
314870|NCT01803776|health economics|health economics
314871|NCT01803763|Omalizumab|omalizumab
314872|NCT01803763|Xolair|xolair
314873|NCT01803763|Urticaria|urticaria
314874|NCT01803763|basophils|basophils
314875|NCT01803763|chronic Urticaria|chronic urticaria
314876|NCT01803763|Fc Receptor|fc receptor
314877|NCT01803750|Primary Care Providers|primary care providers
314878|NCT01803750|Latino Populations|latino populations
314879|NCT01803750|Disseminate Cancer Prevention|disseminate cancer prevention
314880|NCT01803750|semi-structured interviews|semi-structured interviews
314881|NCT01803750|13-031|13-031
314882|NCT01803737|Weight Loss|weight loss
314883|NCT01803737|Physical Activity|physical activity
314884|NCT01803737|Dietary Intake|dietary intake
314885|NCT01803737|Weight Loss Self-Efficacy|weight loss self-efficacy
314886|NCT01803737|Motivation|motivation
314887|NCT01803724|Irritable Bowel Syndrome|irritable bowel syndrome
314888|NCT01803724|Small Intestinal Bacterial Overgrowth|small intestinal bacterial overgrowth
314889|NCT01803724|Lactulose breath test|lactulose breath test
314890|NCT01803724|Glucose breath test|glucose breath test
314891|NCT01803724|Rifaximin|rifaximin
314892|NCT01803711|Omega 3 fatty acid|omega 3 fatty acid
314893|NCT01803711|Fish oil|fish oil
314894|NCT01803711|Depression|depression
314895|NCT01803711|cancer|cancer
314896|NCT01803711|diabetes|diabetes
314897|NCT01803711|high blood pressure|high blood pressure
314898|NCT01803711|cardiovascular|cardiovascular
314899|NCT01803698|Pregnancy|pregnancy
314900|NCT01803698|Gestational weight gain|gestational weight gain
314901|NCT01803698|Primary care|primary care
314902|NCT01803698|Guidelines|guidelines
314903|NCT01803685|Intracranial Arteriovenous Malformations|intracranial arteriovenous malformations
314904|NCT01803685|Surgical removal|surgical removal
314905|NCT01803685|Endovascular embolism|endovascular embolism
314906|NCT01803685|Stereotaxic radiosurgery|stereotaxic radiosurgery
314907|NCT01803685|Outcomes|outcomes
314908|NCT01803672|Adventure-Based training|adventure-based training
314909|NCT01803672|Health education|health education
314910|NCT01803672|childhood cancer|childhood cancer
314911|NCT01803672|physical activity|physical activity
314912|NCT01803659|b-carotene|b-carotene
314913|NCT01803659|breastmilk|breastmilk
314914|NCT01803659|vitamin A|vitamin a
314915|NCT01803568|Myokine|myokine
314916|NCT01803568|Insulin sensitivity|insulin sensitivity
314917|NCT01803568|Exercise|exercise
314918|NCT01803568|Skeletal muscle|skeletal muscle
314919|NCT01803555|Budesonide/Formoterol SPIROMAX®|budesonide/formoterol spiromax®
314920|NCT01803555|SYMBICORT® TURBOHALER®|symbicort® turbohaler®
314921|NCT01803555|Asthma|asthma
314922|NCT01803542|Non-small Cell Lung Cancer|non-small cell lung cancer
314923|NCT01803542|Stereotactic radiation for Lung Cancer|stereotactic radiation for lung cancer
314924|NCT01803542|Cone beam CT for Lung Cancer|cone beam ct for lung cancer
314925|NCT01803542|PET/CT for Lung Cancer|pet/ct for lung cancer
314926|NCT01803529|thorax|thorax
314927|NCT01803529|Intercostal Muscles|intercostal muscles
314928|NCT01803529|massage|massage
314929|NCT01803529|heat-pack|heat-pack
314930|NCT01803529|hot temperature|hot temperature
314931|NCT01803516|Quality of Life|quality of life
314932|NCT01803516|Assessments|assessments
314933|NCT01803516|Radiation|radiation
314934|NCT01803516|Telangiectasias|telangiectasias
314935|NCT01803516|13-013|13-013
314936|NCT01803464|Botox|botox
314937|NCT01803464|Muscle strength|muscle strength
314938|NCT01803451|gastric bypass|gastric bypass
314939|NCT01803451|glucose metabolism|glucose metabolism
314940|NCT01803451|hypoglycemia|hypoglycemia
314941|NCT01803438|paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
314942|NCT01803438|Cryoablation|cryoablation
314943|NCT01803438|Pulmonary Vein Isolation|pulmonary vein isolation
314944|NCT01803425|Post-marketing surveillance|post-marketing surveillance
314945|NCT01803425|Prescribing Information (PI)|prescribing information (pi)
314946|NCT01803425|Healthy infants and children|healthy infants and children
314947|NCT01803425|Streptococcus pneumoniae|streptococcus pneumoniae
314948|NCT01803425|Synflorix™|synflorix™
314949|NCT01803425|Sri Lanka|sri lanka
314950|NCT01803412|GSK2402968|gsk2402968
314951|NCT01803412|open-label extension|open-label extension
314952|NCT01803412|safety|safety
314953|NCT01803412|drisapersen|drisapersen
314954|NCT01803412|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
314955|NCT01803412|tolerability|tolerability
314956|NCT01803412|Quality of Life|quality of life
314957|NCT01803399|cardiac repolarization|cardiac repolarization
314958|NCT01803399|oral|oral
314959|NCT01803399|QTc|qtc
314960|NCT01803399|GSK1322322|gsk1322322
314961|NCT01803399|antibiotic|antibiotic
314962|NCT01803399|12-lead ECG|12-lead ecg
314963|NCT01803399|placebo|placebo
314964|NCT01803399|IV|iv
314965|NCT01803399|moxifloxacin|moxifloxacin
314966|NCT01803386|ALS|als
314967|NCT01803386|EIM|eim
314968|NCT01803373|Healthy|healthy
314969|NCT01803373|Biological Availability|biological availability
314970|NCT01803373|Bioavailability|bioavailability
314971|NCT01803373|TMC207|tmc207
314972|NCT01803373|Bedaquiline|bedaquiline
314973|NCT01803373|R207910|r207910
314974|NCT01803347|phase III|phase iii
314975|NCT01803347|Adipose derived stem cells|adipose derived stem cells
314976|NCT01803347|Anal fistula|anal fistula
314977|NCT01803347|Cell therapy|cell therapy
314978|NCT01803347|Stem cell therapy|stem cell therapy
314979|NCT01803334|surgical incision|surgical incision
314980|NCT01803334|laparoscopy|laparoscopy
314981|NCT01803334|pain|pain
314982|NCT01803321|SJIA|sjia
314983|NCT01803308|Hepatitis C Infection|hepatitis c infection
314984|NCT01803308|Treatment Naïve, Chronic|treatment naïve, chronic
314985|NCT01803308|First In Human|first in human
314986|NCT01803308|Single Ascending Dose|single ascending dose
314987|NCT01803308|Multiple Ascending Dose|multiple ascending dose
314988|NCT01803295|Non Muscle Invasive Bladder Cancer|non muscle invasive bladder cancer
314989|NCT01803295|Intravesical instillation|intravesical instillation
314990|NCT01803295|Mitomycin C|mitomycin c
314991|NCT01803295|Hydrogel Reverse thermal gelation|hydrogel reverse thermal gelation
314992|NCT01803295|Drug retention|drug retention
314993|NCT01803295|Urinary Bladder Neoplasms|urinary bladder neoplasms
314994|NCT01803295|Urologic Neoplasms|urologic neoplasms
314995|NCT01803295|Urinary Bladder Diseases|urinary bladder diseases
314996|NCT01803295|Urologic Diseases|urologic diseases
314997|NCT01803295|Mitomycin|mitomycin
314998|NCT01803282|Solid Tumor|solid tumor
314999|NCT01803282|NSCLC|nsclc
315000|NCT01803282|Pancreatic|pancreatic
315001|NCT01803282|Esophagogastric|esophagogastric
315002|NCT01803282|Colorectal|colorectal
315003|NCT01803282|Breast|breast
315004|NCT01803230|children|children
315005|NCT01803204|Anxiety|anxiety
315006|NCT01803204|Orthognathic surgery|orthognathic surgery
315007|NCT01803204|Patient educational as topic|patient educational as topic
315008|NCT01803204|Patient educational handout|patient educational handout
315009|NCT01803204|Pamphlets|pamphlets
315010|NCT01803191|Transrectal ultrasound-guided prostate biopsy|transrectal ultrasound-guided prostate biopsy
315011|NCT01803191|Bacteriuria|bacteriuria
315012|NCT01803191|Antibiotic prophylaxis|antibiotic prophylaxis
315013|NCT01803191|Prostate-Specific antigen|prostate-specific antigen
315014|NCT01803178|vascular function|vascular function
315015|NCT01803178|plant sterols|plant sterols
315016|NCT01803178|blood lipids|blood lipids
315017|NCT01803165|emesis,post operative.|emesis,post operative.
315018|NCT01803165|cognitive dysfunction, post operative.|cognitive dysfunction, post operative.
315019|NCT01803165|wound infection, post operative.|wound infection, post operative.
315020|NCT01803165|pain, post operative.|pain, post operative.
315021|NCT01803165|Anesthesia, Conduction/methods|anesthesia, conduction/methods
315022|NCT01803165|Anesthesiology/methods|anesthesiology/methods
315023|NCT01803165|Arteriovenous Shunt, Surgical/adverse effects|arteriovenous shunt, surgical/adverse effects
315024|NCT01803165|Regional Blood Flow/drug effects|regional blood flow/drug effects
315025|NCT01803165|Risk Factors|risk factors
315026|NCT01803165|Thrombosis|thrombosis
315027|NCT01803165|Treatment Outcome|treatment outcome
315028|NCT01803165|Vascular Surgical Procedures/methods|vascular surgical procedures/methods
315029|NCT01803165|Vasodilation/drug effects|vasodilation/drug effects
315030|NCT01803152|Metastatic Sarcoma|metastatic sarcoma
315031|NCT01803152|Relapsed Sarcoma|relapsed sarcoma
315032|NCT01803152|Dendritic Cell|dendritic cell
315033|NCT01803152|Myeloid Derived Suppressor Cells|myeloid derived suppressor cells
315034|NCT01803152|MDSC|mdsc
315035|NCT01803152|MDSC Inhibition|mdsc inhibition
315036|NCT01803139|Breast cancer radiotherapy IMRT|breast cancer radiotherapy imrt
315037|NCT01803126|atherosclerosis|atherosclerosis
315038|NCT01803113|Pregnancy|pregnancy
315039|NCT01803113|hCG|hcg
315040|NCT01803100|Bacterial Colonization|bacterial colonization
315041|NCT01803087|adolescents|adolescents
315042|NCT01803087|adults|adults
315043|NCT01803061|Head and neck cancer|head and neck cancer
315044|NCT01803061|Quality of life|quality of life
315045|NCT01803061|Symptom-burden|symptom-burden
315046|NCT01803061|Late effects|late effects
315047|NCT01803048|Traumatic Brain Injury|traumatic brain injury
315048|NCT01803048|Diffusion Weighted Imaging|diffusion weighted imaging
315049|NCT01803048|Resting State Functional Connectivity|resting state functional connectivity
315050|NCT01803048|Cognition|cognition
315051|NCT01803035|Impetigo|impetigo
315052|NCT01803035|LTX-109|ltx-109
315053|NCT01803035|Topical|topical
315054|NCT01803035|Antibiotic|antibiotic
315055|NCT01803035|Placebo|placebo
315056|NCT01803035|Lytic|lytic
315057|NCT01803035|Peptide|peptide
315058|NCT01803035|Gram Positive|gram positive
315059|NCT01803022|Venous Thromboembolism|venous thromboembolism
315060|NCT01803022|Cancer|cancer
315061|NCT01803022|Low Molecular Weight Heparin|low molecular weight heparin
315062|NCT01802983|Aged|aged
315063|NCT01802983|Multiple organ failure|multiple organ failure
315064|NCT01802983|Extubation|extubation
315065|NCT01802983|Prognosis|prognosis
315066|NCT01802983|MODS|mods
315067|NCT01802983|invasive mechanical ventilation|invasive mechanical ventilation
315068|NCT01802970|Anakinra|anakinra
315069|NCT01802970|Nab Paclitaxel|nab paclitaxel
315070|NCT01802970|Capecitabine|capecitabine
315071|NCT01802970|Eribulin|eribulin
315072|NCT01802970|Vinorelbin|vinorelbin
315073|NCT01802931|GSK239512|gsk239512
315074|NCT01802931|H3 receptor antagonist|h3 receptor antagonist
315075|NCT01802931|drug-drug interaction|drug-drug interaction
315076|NCT01802931|pharmacokinetics|pharmacokinetics
315077|NCT01802931|ketoconazole|ketoconazole
315078|NCT01802918|single dose|single dose
315079|NCT01802918|HIV|hiv
315080|NCT01802918|maturation inhibitor|maturation inhibitor
315081|NCT01802918|GSK2838232|gsk2838232
315082|NCT01802918|FTIH|ftih
315083|NCT01802918|healthy subjects|healthy subjects
315084|NCT01802905|neoplasm|neoplasm
315085|NCT01802905|metastatic cancer|metastatic cancer
315086|NCT01802905|cancer genome|cancer genome
315087|NCT01802905|genomic analysis|genomic analysis
315088|NCT01802905|adults|adults
315089|NCT01802892|ronacaleret|ronacaleret
315090|NCT01802892|parathyroid hormone (PTH)|parathyroid hormone (pth)
315091|NCT01802892|CD34+cells|cd34+cells
315092|NCT01802892|calcium sensing receptor antagonist|calcium sensing receptor antagonist
315093|NCT01802892|hematopoietic stem cells|hematopoietic stem cells
315094|NCT01802892|stem cell mobilization|stem cell mobilization
315095|NCT01802892|plerixafor|plerixafor
315096|NCT01802892|healthy human volunteer, phase Ib|healthy human volunteer, phase ib
315097|NCT01802879|Hematologic Neoplasms, LBH589,|hematologic neoplasms, lbh589,
315098|NCT01802879|Panobinostat,|panobinostat,
315099|NCT01802866|Geographic atrophy|geographic atrophy
315100|NCT01802866|GA|ga
315101|NCT01802866|Dry AMD|dry amd
315102|NCT01802827|airway colonization|airway colonization
315103|NCT01802827|tracheobronchitis|tracheobronchitis
315104|NCT01802827|pneumonia|pneumonia
315105|NCT01802814|ALL|all
315106|NCT01802788|Aortic Stenosis|aortic stenosis
315107|NCT01802788|Heart Valve Prosthesis|heart valve prosthesis
315108|NCT01802788|Trans Catheter Aortic Valve Replacement|trans catheter aortic valve replacement
315109|NCT01802788|TAVR|tavr
315110|NCT01802788|Trans Catheter Aortic Valve Implant|trans catheter aortic valve implant
315111|NCT01802788|TAVI|tavi
315112|NCT01802749|second line|second line
315113|NCT01802749|platinum sensitive|platinum sensitive
315114|NCT01802749|first line bevacizumab|first line bevacizumab
315115|NCT01802749|biologic factors|biologic factors
315116|NCT01802749|clinical factors|clinical factors
315117|NCT01802736|Alcohol HIV intervention counselling|alcohol hiv intervention counselling
315315|NCT01801917|PM|pm
315118|NCT01802736|Alcohol Use in HIV infected Persons|alcohol use in hiv infected persons
315119|NCT01802697|volunteers|volunteers
315120|NCT01802684|unresectable|unresectable
315121|NCT01802684|metastatic|metastatic
315122|NCT01802684|colorectal|colorectal
315123|NCT01802684|cancer|cancer
315124|NCT01802684|OPTIMOX|optimox
315125|NCT01802684|aflibercept|aflibercept
315126|NCT01802671|Low back pain|low back pain
315127|NCT01802671|Cognitive behavioural treatment|cognitive behavioural treatment
315128|NCT01802671|internet|internet
315129|NCT01802671|disability|disability
315130|NCT01802658|Bone marrow demineralization lesions,: efficacy and tolerability, zoledronic acid|bone marrow demineralization lesions,: efficacy and tolerability, zoledronic acid
315131|NCT01802645|neoadjuvant|neoadjuvant
315132|NCT01802645|cetuximab|cetuximab
315133|NCT01802645|irinotecan|irinotecan
315134|NCT01802645|bevacizumab|bevacizumab
315135|NCT01802645|oxaliplatin|oxaliplatin
315136|NCT01802645|5-FU|5-fu
315137|NCT01802645|Resection|resection
315138|NCT01802645|colorectal liver metastases|colorectal liver metastases
315139|NCT01802645|liver resection|liver resection
315140|NCT01802645|Chemotherapy|chemotherapy
315141|NCT01802645|k-ras|k-ras
315142|NCT01802645|non-resectable|non-resectable
315143|NCT01802632|Oncology,|oncology,
315144|NCT01802632|Non Small Cell Lung Cancer,|non small cell lung cancer,
315145|NCT01802632|Metastatic,|metastatic,
315146|NCT01802632|EGFR sensitivity mutation,|egfr sensitivity mutation,
315147|NCT01802632|T790M resistance mutation|t790m resistance mutation
315148|NCT01802606|surgery|surgery
315149|NCT01802606|administration|administration
315150|NCT01802606|infection|infection
315151|NCT01802593|Pediatric|pediatric
315152|NCT01802593|Crohn's disease|crohn's disease
315153|NCT01802593|Infliximab|infliximab
315154|NCT01802593|Thiopurine|thiopurine
315155|NCT01802554|Behavioral Activation|behavioral activation
315156|NCT01802554|Caregiver|caregiver
315157|NCT01802554|Dementia|dementia
315158|NCT01802554|Cardiovascular Disease|cardiovascular disease
315159|NCT01802554|Alzheimer's Disease|alzheimer's disease
315160|NCT01802554|Coagulation|coagulation
315161|NCT01802541|diacylglycerol oil|diacylglycerol oil
315162|NCT01802541|insulin sensitivity|insulin sensitivity
315163|NCT01802541|type 2 diabetes|type 2 diabetes
315164|NCT01802541|cardiovascular disease|cardiovascular disease
315165|NCT01802541|risk factors|risk factors
315166|NCT01802528|obturator externus|obturator externus
315167|NCT01802515|addiction|addiction
315168|NCT01802515|cocaine|cocaine
315169|NCT01802515|methadone|methadone
315170|NCT01802515|opiates|opiates
315171|NCT01802515|atomoxetine|atomoxetine
315172|NCT01802502|tuberculous meningitis|tuberculous meningitis
315173|NCT01802502|rifampicin|rifampicin
315174|NCT01802502|bioequivalence|bioequivalence
315175|NCT01802502|oral administration|oral administration
315176|NCT01802502|intravenous administration|intravenous administration
315177|NCT01802489|Optic neuritis|optic neuritis
315178|NCT01802489|Multiple sclerosis|multiple sclerosis
315179|NCT01802489|Retinal nerve fibre layer|retinal nerve fibre layer
315180|NCT01802489|Axonal loss|axonal loss
315181|NCT01802489|Neuroprotection|neuroprotection
315182|NCT01802489|MRI|mri
315183|NCT01802489|Optical coherence tomography|optical coherence tomography
315184|NCT01802489|Amiloride|amiloride
315185|NCT01802489|Acid Sensing Ion Channels|acid sensing ion channels
315186|NCT01802476|PD-0332991|pd-0332991
315187|NCT01802476|Absolute Bioavailability Study|absolute bioavailability study
315188|NCT01802424|Open trial|open trial
315189|NCT01802424|Indicative prevention|indicative prevention
315190|NCT01802424|Youth anxiety|youth anxiety
315191|NCT01802424|Cognitive behavioral therapy|cognitive behavioral therapy
315192|NCT01802411|liposome bupivacaine|liposome bupivacaine
315193|NCT01802411|posterolateral thoracotomy|posterolateral thoracotomy
315194|NCT01802411|intercostal nerve block|intercostal nerve block
315195|NCT01802411|postoperative pain|postoperative pain
315196|NCT01802398|Risk Stratification|risk stratification
315197|NCT01802398|Syncope|syncope
315198|NCT01802398|Geriatric|geriatric
315199|NCT01802385|cryptococcal meningitis|cryptococcal meningitis
315200|NCT01802385|cryptococcus|cryptococcus
315201|NCT01802385|meningitis|meningitis
315202|NCT01802385|yeast|yeast
315203|NCT01802385|fungus|fungus
315204|NCT01802372|Hypertension|hypertension
315205|NCT01802372|High Blood Pressure|high blood pressure
315206|NCT01802372|Cardiovascular Diseases|cardiovascular diseases
315207|NCT01802372|Health Insurance Coverage|health insurance coverage
315208|NCT01802372|Low income countries|low income countries
315209|NCT01802372|Ghana|ghana
315210|NCT01802372|Low resource settings|low resource settings
315211|NCT01802372|Comparative Effectiveness|comparative effectiveness
315212|NCT01802372|Global Health|global health
315213|NCT01802359|Erectile dysfunction|erectile dysfunction
315214|NCT01802359|Mirodenafil|mirodenafil
315215|NCT01802359|Bravonto|bravonto
315216|NCT01802307|Focal therapy|focal therapy
315217|NCT01802307|Brachytherapy|brachytherapy
315218|NCT01802307|Active surveillance|active surveillance
315219|NCT01802307|low risk cancer|low risk cancer
315220|NCT01802294|Randomized Controlled Trials as Topic|randomized controlled trials as topic
315221|NCT01802294|Child|child
315222|NCT01802294|Parents|parents
315223|NCT01802268|sirolimus|sirolimus
315224|NCT01802268|tacrolimus|tacrolimus
315225|NCT01802268|early conversion|early conversion
315226|NCT01802255|Inhalatory sedation|inhalatory sedation
315227|NCT01802255|Sevoflurane|sevoflurane
315228|NCT01802255|AnaConDa|anaconda
315229|NCT01802255|Nephrotoxicity|nephrotoxicity
315230|NCT01802255|Hepatotoxicity|hepatotoxicity
315231|NCT01802255|Midazolam|midazolam
315232|NCT01802255|Propofol|propofol
315233|NCT01802242|Prostate Cancer|prostate cancer
315234|NCT01802242|Prostate tumour|prostate tumour
315235|NCT01802242|Prostate radiotherapy|prostate radiotherapy
315236|NCT01802242|prostate cancer treatment|prostate cancer treatment
315237|NCT01802216|chronic kidney disease progression|chronic kidney disease progression
315238|NCT01802216|periodontal disease|periodontal disease
315361|NCT01801657|exacerbation|exacerbation
315239|NCT01802216|intensive periodontal disease treatment|intensive periodontal disease treatment
315240|NCT01802203|Barrett esophagus|barrett esophagus
315241|NCT01802203|Esophageal dysplasia|esophageal dysplasia
315242|NCT01802203|Upper gastrointestinal squamous dysplasia|upper gastrointestinal squamous dysplasia
315243|NCT01802203|Esophageal cancer|esophageal cancer
315244|NCT01802203|Endobronchial cancer|endobronchial cancer
315245|NCT01802203|Central airway cancer|central airway cancer
315246|NCT01802203|Central airway precancerous disease|central airway precancerous disease
315247|NCT01802203|Central airway granulation tissue|central airway granulation tissue
315248|NCT01802203|Central airway papillomatosis|central airway papillomatosis
315249|NCT01802203|Central airway sarcoidosis|central airway sarcoidosis
315250|NCT01802203|Central airway tuberculosis|central airway tuberculosis
315251|NCT01802203|Tracheal stenosis|tracheal stenosis
315252|NCT01802203|Bronchial stenosis|bronchial stenosis
315253|NCT01802190|Genetic deafness|genetic deafness
315254|NCT01802190|SLC17A8 et POU4F3 genes|slc17a8 et pou4f3 genes
315255|NCT01802177|Alopecia areata|alopecia areata
315256|NCT01802177|Excimer|excimer
315257|NCT01802177|UVB|uvb
315258|NCT01802151|probiotics|probiotics
315259|NCT01802151|microbiota|microbiota
315260|NCT01802151|survival|survival
315261|NCT01802151|gastrointestinal|gastrointestinal
315262|NCT01802151|wellness|wellness
315263|NCT01802138|refractory/relapsed neuroblastoma patients|refractory/relapsed neuroblastoma patients
315264|NCT01802112|Colonic transit|colonic transit
315265|NCT01802112|Dietary Fiber|dietary fiber
315266|NCT01802112|Radiopaque marker|radiopaque marker
315267|NCT01802099|mechanical ventilation|mechanical ventilation
315268|NCT01802099|early enteral nutrition|early enteral nutrition
315269|NCT01802099|intensive care unit|intensive care unit
315270|NCT01802099|early parenteral nutrition|early parenteral nutrition
315271|NCT01802099|critical care medicine|critical care medicine
315272|NCT01802099|nosocomial infection|nosocomial infection
315273|NCT01802099|mortality|mortality
315274|NCT01802099|shock|shock
315275|NCT01802099|vasoactive drug|vasoactive drug
315276|NCT01802086|Children|children
315277|NCT01802086|Pain|pain
315278|NCT01802086|Vaccination|vaccination
315279|NCT01802086|Emla|emla
315280|NCT01802086|Pneumococcal|pneumococcal
315281|NCT01802086|Painscale|painscale
315282|NCT01802073|Inflammation of the bile ducts|inflammation of the bile ducts
315283|NCT01802073|biliary scarring|biliary scarring
315284|NCT01802073|obstruction|obstruction
315285|NCT01802060|Persona|persona
315286|NCT01802060|E3G|e3g
315287|NCT01802060|LH|lh
315288|NCT01802060|ovulation|ovulation
315289|NCT01802047|Mothers of Preterms|mothers of preterms
315290|NCT01802047|Breastfeeding Mothers of Preterm infants|breastfeeding mothers of preterm infants
315291|NCT01802047|mother milk feeding|mother milk feeding
315292|NCT01802021|chinese medicine|chinese medicine
315293|NCT01802021|non-small cell lung cancer|non-small cell lung cancer
315294|NCT01802021|immunosuppression|immunosuppression
315295|NCT01802008|Polyp/adenoma detection rate|polyp/adenoma detection rate
315296|NCT01802008|Polyp/adenoma miss rate|polyp/adenoma miss rate
315297|NCT01802008|Colonoscopy withdrawal time|colonoscopy withdrawal time
315298|NCT01801982|PPHN; development progress after PPHN; developmental progress after sildenafil.|pphn; development progress after pphn; developmental progress after sildenafil.
315299|NCT01801969|Brain injuries|brain injuries
315300|NCT01801969|Rehabilitation services|rehabilitation services
315301|NCT01801969|Return to Work|return to work
315302|NCT01801969|Quality of life|quality of life
315303|NCT01801956|Maximum oxygen uptake|maximum oxygen uptake
315304|NCT01801956|Physical activity|physical activity
315305|NCT01801956|Physical inactivity|physical inactivity
315306|NCT01801956|Motivational interview|motivational interview
315307|NCT01801956|Cardiorespiratory fitness|cardiorespiratory fitness
315308|NCT01801956|Primary care|primary care
315309|NCT01801956|Community care|community care
315310|NCT01801930|OCV-C02|ocv-c02
315311|NCT01801930|Colorectal Cancer|colorectal cancer
315312|NCT01801930|Antigen specific cancer immunotherapeutic|antigen specific cancer immunotherapeutic
315313|NCT01801917|Polymyositis|polymyositis
315314|NCT01801917|Myositis|myositis
315316|NCT01801917|chronic muscle inflammation|chronic muscle inflammation
315317|NCT01801917|inflammatory myopathy|inflammatory myopathy
315318|NCT01801917|inclusion body myositis|inclusion body myositis
315319|NCT01801904|cetuximab-refractory|cetuximab-refractory
315320|NCT01801891|Venous ulceration|venous ulceration
315321|NCT01801891|Leg ulcers|leg ulcers
315322|NCT01801891|Venous haemodynamics|venous haemodynamics
315323|NCT01801891|Surface neuromuscular electrical stimulation|surface neuromuscular electrical stimulation
315324|NCT01801891|SNMES|snmes
315325|NCT01801878|breast cancer|breast cancer
315326|NCT01801878|loss of elasticity in irradiated breast skin|loss of elasticity in irradiated breast skin
315327|NCT01801878|Other Reconstructive Surgery|other reconstructive surgery
315328|NCT01801865|NICU|nicu
315329|NCT01801865|MRI|mri
315330|NCT01801865|Neonatal|neonatal
315331|NCT01801865|Cincinnati|cincinnati
315332|NCT01801813|Neuro-surgery|neuro-surgery
315333|NCT01801813|Post-operative complications|post-operative complications
315334|NCT01801813|Neuro-ICU resources|neuro-icu resources
315335|NCT01801800|Aneurysmal subarachnoid haemorrhage|aneurysmal subarachnoid haemorrhage
315336|NCT01801774|post-operative inflammation|post-operative inflammation
315337|NCT01801774|steroid|steroid
315338|NCT01801774|intraocular pressure|intraocular pressure
315339|NCT01801748|wheat allergy|wheat allergy
315340|NCT01801748|wheat outgrowing|wheat outgrowing
315341|NCT01801748|wheat hypersensitivity|wheat hypersensitivity
315342|NCT01801748|omega-5-gliadin|omega-5-gliadin
315343|NCT01801748|natural history of wheat hypersensitivity|natural history of wheat hypersensitivity
315344|NCT01801709|Brain Gene Therapy|brain gene therapy
315345|NCT01801709|Adeno Associated vector|adeno associated vector
315346|NCT01801709|Lysosomal sotage diseases|lysosomal sotage diseases
315347|NCT01801709|Leukodystrophies|leukodystrophies
315348|NCT01801696|Massage|massage
315349|NCT01801696|effectiveness|effectiveness
315350|NCT01801696|autism|autism
315351|NCT01801696|parent stress|parent stress
315352|NCT01801683|EBM|ebm
315353|NCT01801683|general practice|general practice
315354|NCT01801670|itch|itch
315355|NCT01801670|pruritus|pruritus
315356|NCT01801670|skin|skin
315357|NCT01801670|vorinostat|vorinostat
315358|NCT01801670|cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
315359|NCT01801670|mycosis fungoides|mycosis fungoides
315360|NCT01801657|bronchiectasis|bronchiectasis
315362|NCT01801657|virus|virus
315363|NCT01801644|bladder cancer|bladder cancer
315364|NCT01801644|neoadjuvant chemotherapy|neoadjuvant chemotherapy
315365|NCT01801644|gem/cis|gem/cis
315366|NCT01801631|Type 2 diabetes|type 2 diabetes
315367|NCT01801631|Acute Coronary Event (ACE)|acute coronary event (ace)
315368|NCT01801631|Distress|distress
315369|NCT01801631|Self-efficacy|self-efficacy
315370|NCT01801631|Quality of Life|quality of life
315371|NCT01801631|Depression|depression
315372|NCT01801631|Primary care|primary care
315373|NCT01801631|Illness representations|illness representations
315374|NCT01801618|HIV|hiv
315375|NCT01801618|PI based 2nd line ARV treatment|pi based 2nd line arv treatment
315376|NCT01801618|Virological failure|virological failure
315377|NCT01801618|Drug resistance|drug resistance
315378|NCT01801618|Cambodia|cambodia
315379|NCT01801618|Adherence|adherence
315380|NCT01801605|IBS - rectal hypersensitivity - rectal barostat - rTMS.|ibs - rectal hypersensitivity - rectal barostat - rtms.
315381|NCT01801592|OBSTRUCTIVE SLEEP APNOEA|obstructive sleep apnoea
315382|NCT01801592|INTERMITTENT CLAUDICATION|intermittent claudication
315383|NCT01801592|Respiratory disease|respiratory disease
315384|NCT01801592|Peripheral artery disease|peripheral artery disease
315385|NCT01801579|Ankle Brachial Index|ankle brachial index
315386|NCT01801579|Maximal exercise|maximal exercise
315387|NCT01801566|Mandibular Prosthesis Implantation|mandibular prosthesis implantation
315388|NCT01801566|Prostheses and Implants|prostheses and implants
315389|NCT01801566|Denture, Complete, Lower|denture, complete, lower
315390|NCT01801553|spinal manipulation|spinal manipulation
315391|NCT01801553|low back pain|low back pain
315392|NCT01801553|manual therapy|manual therapy
315393|NCT01801553|clinical predictive rule|clinical predictive rule
315394|NCT01801527|Telehealth|telehealth
315395|NCT01801527|Fatigue|fatigue
315396|NCT01801527|Breast cancer|breast cancer
315397|NCT01801527|Exercise|exercise
315398|NCT01801527|Quality of life|quality of life
315399|NCT01801527|Telerehabilitation|telerehabilitation
315400|NCT01801475|Pharmacokinetics of ondansetron in women|pharmacokinetics of ondansetron in women
315401|NCT01801475|Pharmacokinetics of ondansetron in neonates|pharmacokinetics of ondansetron in neonates
315402|NCT01801475|Term pregnancy|term pregnancy
315403|NCT01801475|Cesarean section|cesarean section
315404|NCT01801462|Medical education|medical education
315405|NCT01801462|Simulation|simulation
315406|NCT01801462|Ultrasound training|ultrasound training
315407|NCT01801462|Patient safety|patient safety
315408|NCT01801449|DIRA|dira
315409|NCT01801449|Clinical Trial|clinical trial
315410|NCT01801449|IL-1|il-1
315411|NCT01801449|Autoinflammatory Syndrome|autoinflammatory syndrome
315412|NCT01801449|Rilonacept|rilonacept
315413|NCT01801436|Multiple Myeloma|multiple myeloma
315414|NCT01801436|Bortezomib|bortezomib
315415|NCT01801436|Velcade|velcade
315416|NCT01801423|transcranial Doppler|transcranial doppler
315417|NCT01801423|stroke|stroke
315418|NCT01801423|sickle cell anemia|sickle cell anemia
315419|NCT01801423|Nigeria|nigeria
315420|NCT01801423|hydroxyurea|hydroxyurea
315421|NCT01801423|low income country|low income country
315422|NCT01801410|pre-eclampsia|pre-eclampsia
315423|NCT01801410|labor induction|labor induction
315424|NCT01801410|misoprostol|misoprostol
315425|NCT01801410|Foley catheter|foley catheter
315426|NCT01801384|pregnancy|pregnancy
315427|NCT01801384|cigarette smoking|cigarette smoking
315428|NCT01801384|incentives|incentives
315429|NCT01801384|smoking cessation|smoking cessation
315430|NCT01801384|birth outcomes|birth outcomes
315431|NCT01801371|Glioma|glioma
315432|NCT01801371|Diagnostic imaging|diagnostic imaging
315433|NCT01801371|Integrin receptor|integrin receptor
315434|NCT01801371|68Ga-BNOTA-PRGD2|68ga-bnota-prgd2
315435|NCT01801371|PET/CT|pet/ct
315436|NCT01801358|Melanoma,|melanoma,
315437|NCT01801358|melanoma of the eye,|melanoma of the eye,
315438|NCT01801358|uveal,|uveal,
315439|NCT01801358|MEK162,|mek162,
315440|NCT01801358|AEB071|aeb071
315441|NCT01801345|Human Performance|human performance
315442|NCT01801345|Clinical Performance|clinical performance
315443|NCT01801319|major depressive disorder (MDD)|major depressive disorder (mdd)
315444|NCT01801319|deep brain stimulation (DBS)|deep brain stimulation (dbs)
315445|NCT01801319|subcallosal cingulate gyrus|subcallosal cingulate gyrus
315446|NCT01801319|Therapy-Resistant Depression|therapy-resistant depression
315447|NCT01801319|Electrical Stimulation of the Brain|electrical stimulation of the brain
315448|NCT01801319|Brain Stimulation, Deep|brain stimulation, deep
315449|NCT01801293|RSV infection|rsv infection
315450|NCT01801280|immunosuppressive medication|immunosuppressive medication
315451|NCT01801280|mycophenolic acid|mycophenolic acid
315452|NCT01801280|interaction|interaction
315453|NCT01801280|proton pump inhibitor|proton pump inhibitor
315454|NCT01801280|pantoprazole|pantoprazole
315455|NCT01801280|renal transplant patients|renal transplant patients
315456|NCT01801280|pharmacokinetics|pharmacokinetics
315457|NCT01801280|pharmacodynamics|pharmacodynamics
315458|NCT01801280|bioavailability|bioavailability
315459|NCT01801267|Hydrocephalus|hydrocephalus
315460|NCT01801267|Pediatric|pediatric
315461|NCT01801267|Ventricular shunt|ventricular shunt
315462|NCT01801267|Ventriculoperitoneal shunt|ventriculoperitoneal shunt
315463|NCT01801267|Third ventriculostomy|third ventriculostomy
315464|NCT01801267|Randomized controlled trial|randomized controlled trial
315465|NCT01801254|Obesity|obesity
315466|NCT01801254|Type II diabetes|type ii diabetes
315467|NCT01801254|Cardiovascular disease|cardiovascular disease
315468|NCT01801254|Health behavior promotion|health behavior promotion
315469|NCT01801254|Neuroeconomics|neuroeconomics
315470|NCT01801254|EEG biofeedback|eeg biofeedback
315471|NCT01801254|Low-resolution electromagnetic tomography (LORETA)|low-resolution electromagnetic tomography (loreta)
315472|NCT01801254|EEG|eeg
315473|NCT01801176|proved by biopsy|proved by biopsy
315474|NCT01801150|Diabetes|diabetes
315475|NCT01801150|Apnea- hypopnea Syndrome|apnea- hypopnea syndrome
315476|NCT01801150|Glycemic control|glycemic control
315477|NCT01801150|Prevalence|prevalence
315478|NCT01801150|SAHS|sahs
315479|NCT01801150|life quality|life quality
315480|NCT01801124|analgesia|analgesia
315481|NCT01801124|hernia repair|hernia repair
315482|NCT01801098|TAVI|tavi
315483|NCT01801098|complete AV-block|complete av-block
315484|NCT01801098|HV-interval|hv-interval
315485|NCT01801098|permanent pacemaker|permanent pacemaker
315486|NCT01801085|Time-and-Motion|time-and-motion
315487|NCT01801085|Neoplasm|neoplasm
315488|NCT01801085|Colorectal Cancer|colorectal cancer
315489|NCT01801059|colon cancer|colon cancer
315490|NCT01801059|Colorectal Cancer Screening|colorectal cancer screening
315491|NCT01801033|Trioodothyronine (T3)|trioodothyronine (t3)
315492|NCT01801033|Thyroid Hormone Action|thyroid hormone action
315493|NCT01801033|Deiodinases|deiodinases
315494|NCT01801033|Hypothyroid|hypothyroid
315495|NCT01801033|Propylthiouracil (PTU)|propylthiouracil (ptu)
315496|NCT01801020|temperature|temperature
315497|NCT01800994|convenience|convenience
315498|NCT01800981|Functionality|functionality
315499|NCT01800981|extremities|extremities
315500|NCT01800981|ROM|rom
315501|NCT01800981|Upper and lower Extremity for burned patients|upper and lower extremity for burned patients
315502|NCT01800955|physical therapy|physical therapy
315503|NCT01800955|diathermy|diathermy
315504|NCT01800955|knee|knee
315505|NCT01800955|osteoarthritis|osteoarthritis
315506|NCT01800955|pain|pain
315507|NCT01800955|physical function|physical function
315508|NCT01800942|prevention|prevention
315509|NCT01800942|bacterial infection|bacterial infection
315510|NCT01800942|neonates|neonates
315511|NCT01800942|women in labour|women in labour
315512|NCT01800942|Azithromycin|azithromycin
315513|NCT01800916|ileostomy|ileostomy
315514|NCT01800916|Subjects|subjects
315515|NCT01800890|stoma ileostomy|stoma ileostomy
315516|NCT01800877|hypotension|hypotension
315517|NCT01800877|vasopressors|vasopressors
315518|NCT01800877|titration|titration
315519|NCT01800877|tissue perfusion|tissue perfusion
315520|NCT01800877|organ failure|organ failure
315521|NCT01800851|Kidney transplantation|kidney transplantation
315522|NCT01800851|Energy expenditure|energy expenditure
315523|NCT01800851|Weight gain|weight gain
315524|NCT01800851|Insulin resistance|insulin resistance
315525|NCT01800825|Pregnancy|pregnancy
315526|NCT01800825|Prematurity|prematurity
315527|NCT01800825|Preterm birth|preterm birth
315528|NCT01800825|bacterial vaginosis|bacterial vaginosis
315529|NCT01800799|Urinary tract infection|urinary tract infection
315530|NCT01800799|Urothelium|urothelium
315531|NCT01800799|Inflammation|inflammation
315532|NCT01800799|Apoptosis|apoptosis
315533|NCT01800773|PTSD|ptsd
315534|NCT01800773|exposure treatment|exposure treatment
315535|NCT01800773|clinical trial|clinical trial
315536|NCT01800773|trauma|trauma
315537|NCT01800760|healthy|healthy
315538|NCT01800760|obese|obese
315539|NCT01800760|women|women
315540|NCT01800747|Delayed antibiotic treatment|delayed antibiotic treatment
315541|NCT01800747|Acute respiratory infections|acute respiratory infections
315542|NCT01800747|Pediatrics|pediatrics
315543|NCT01800747|Satisfaction|satisfaction
315544|NCT01800734|Mixed meal test|mixed meal test
315545|NCT01800734|Insulin pump|insulin pump
315546|NCT01800734|Continuous glucose monitoring|continuous glucose monitoring
315547|NCT01800734|Metabolic control analysis|metabolic control analysis
315548|NCT01800734|Closed loop control|closed loop control
315549|NCT01800734|Artificial pancreas|artificial pancreas
315550|NCT01800721|HIV|hiv
315551|NCT01800721|testing|testing
315552|NCT01800721|Social Network|social network
315553|NCT01800721|African American|african american
315554|NCT01800721|MSM|msm
315555|NCT01800721|Men who have sex with men|men who have sex with men
315556|NCT01800695|GBM|gbm
315557|NCT01800682|Healthy|healthy
315558|NCT01800682|Tramodol|tramodol
315559|NCT01800682|Ultram|ultram
315560|NCT01800669|Computer based clinical decision support|computer based clinical decision support
315561|NCT01800669|medical legal partnership|medical legal partnership
315562|NCT01800669|child|child
315563|NCT01800669|pediatrics|pediatrics
315564|NCT01800643|Busulfan|busulfan
315565|NCT01800643|plasmatic dosage|plasmatic dosage
315566|NCT01800643|Stem Cell Transplantation|stem cell transplantation
315567|NCT01800578|Cerebral State Index Monitor|cerebral state index monitor
315568|NCT01800565|precocious puberty|precocious puberty
315569|NCT01800565|urinary LH|urinary lh
315570|NCT01800565|GnRH stimulation test|gnrh stimulation test
315571|NCT01800565|gonadotropins|gonadotropins
315572|NCT01800552|Infiltration|infiltration
315573|NCT01800552|Extravasation|extravasation
315574|NCT01800552|Leaking|leaking
315575|NCT01800552|PIV Infiltration|piv infiltration
315576|NCT01800552|IV Infiltration|iv infiltration
315577|NCT01800552|Ultrasound Detection of Infiltration|ultrasound detection of infiltration
315578|NCT01800552|Ultrasound Imaging|ultrasound imaging
315579|NCT01800539|Autism|autism
315580|NCT01800539|Early Intervention|early intervention
315581|NCT01800539|Minority|minority
315582|NCT01800526|Sickle Cell Disease|sickle cell disease
315583|NCT01800526|Sickle Cell Anemia|sickle cell anemia
315584|NCT01800513|Implantation Failure|implantation failure
315585|NCT01800513|In-vitro Fertilization|in-vitro fertilization
315586|NCT01800513|Infertility|infertility
315587|NCT01800513|Endometrial Biopsy|endometrial biopsy
315588|NCT01800487|Drug-induced liver injury|drug-induced liver injury
315589|NCT01800487|Tuberculosis|tuberculosis
315590|NCT01800487|Silymarin|silymarin
315591|NCT01800461|Participation|participation
315592|NCT01800461|Occupational Therapy|occupational therapy
315593|NCT01800461|Valued Activities|valued activities
315594|NCT01800448|Respiratory monitoring|respiratory monitoring
315595|NCT01800448|cardiac monitoring|cardiac monitoring
315596|NCT01800448|skin conductance monitoring|skin conductance monitoring
315597|NCT01800448|variability|variability
315598|NCT01800409|Tetraplegia|tetraplegia
315599|NCT01800396|Bacterial infection|bacterial infection
315600|NCT01800396|Dairy|dairy
315601|NCT01800396|Diarrhea|diarrhea
315602|NCT01800396|Diet|diet
315603|NCT01800396|E.Coli|e.coli
315604|NCT01800396|Gastroenteritis|gastroenteritis
315605|NCT01800396|Milk|milk
315606|NCT01800396|Stool consistency|stool consistency
315607|NCT01800383|posttraumatic stress disorder|posttraumatic stress disorder
315608|NCT01800383|fear conditioning|fear conditioning
315609|NCT01800383|proton magnetic resonance spectroscopy|proton magnetic resonance spectroscopy
315610|NCT01800383|GABA|gaba
315611|NCT01800370|Healthy|healthy
315612|NCT01800370|Male|male
315613|NCT01800357|randomized trial|randomized trial
315614|NCT01800357|acute ischemic stroke|acute ischemic stroke
315615|NCT01800357|mildronate|mildronate
315616|NCT01800344|Airway Cuff|airway cuff
315617|NCT01800344|LMA|lma
315618|NCT01800344|Ultra|ultra
315619|NCT01800344|Cuff Pressure|cuff pressure
315620|NCT01800344|Ventilation|ventilation
315621|NCT01800344|Anesthesia|anesthesia
315622|NCT01800344|Intubation|intubation
315623|NCT01800318|NESAP|nesap
315624|NCT01800318|sucrose|sucrose
315625|NCT01800318|pain|pain
315626|NCT01800318|infants|infants
315627|NCT01800305|PK & PD study|pk & pd study
315628|NCT01800305|rhEPO|rhepo
315629|NCT01800305|Pegylated rhEPO|pegylated rhepo
315630|NCT01800305|male healthy subject|male healthy subject
315631|NCT01800292|Pulmonary Artery Hypertension|pulmonary artery hypertension
315632|NCT01800292|pulmonary capillary wedge pressure|pulmonary capillary wedge pressure
315633|NCT01800292|sildenafil|sildenafil
315634|NCT01800292|echocardiography|echocardiography
315635|NCT01800292|left ventricular longitudinal wall strain|left ventricular longitudinal wall strain
315636|NCT01800292|strain rate pre and post medical therapy|strain rate pre and post medical therapy
315637|NCT01800292|speckle tracking|speckle tracking
315638|NCT01800279|Fibromyalgia Syndrome, Temporomandibular Joint, Pain.|fibromyalgia syndrome, temporomandibular joint, pain.
315639|NCT01800266|Supervision|supervision
315640|NCT01800266|Implementation|implementation
315641|NCT01800266|Community Based Mental Health Services|community based mental health services
315642|NCT01800266|Trauma Focused Cognitive Behavioral Therapy|trauma focused cognitive behavioral therapy
315643|NCT01800266|Skill Building and Behavioral Rehearsal|skill building and behavioral rehearsal
315644|NCT01800266|Symptom and Fidelity Monitoring|symptom and fidelity monitoring
315645|NCT01800266|Children|children
315646|NCT01800266|Adolescents|adolescents
315647|NCT01800214|neurodengeneration|neurodengeneration
315648|NCT01800214|neuroimaging|neuroimaging
315649|NCT01800201|Initial occurrence Acute Myocardial Infarction (AMI)|initial occurrence acute myocardial infarction (ami)
315650|NCT01800188|Dialysis|dialysis
315651|NCT01800188|Incretin hormones|incretin hormones
315652|NCT01800149|Tooth extraction|tooth extraction
315653|NCT01800149|Ridge Preservation|ridge preservation
315654|NCT01800149|Ridge Augmentation|ridge augmentation
315655|NCT01800149|Guided Bone Regeneration|guided bone regeneration
315656|NCT01800136|pain|pain
315657|NCT01800136|neuropathic|neuropathic
315658|NCT01800136|cortical stimulation|cortical stimulation
315659|NCT01800136|motor cortex|motor cortex
315660|NCT01800136|plasticity|plasticity
315661|NCT01800136|rTMS|rtms
315662|NCT01800136|tDCS|tdcs
315663|NCT01800123|Intoxication, overdose, poisoning, EtCO2, emergency medicine|intoxication, overdose, poisoning, etco2, emergency medicine
315664|NCT01800097|stroke|stroke
315665|NCT01800097|fatigue|fatigue
315666|NCT01800097|modafinil|modafinil
315667|NCT01800084|ASIR|asir
315668|NCT01800084|image acquisition|image acquisition
315669|NCT01800084|FBP|fbp
315670|NCT01800071|Nasopharyngeal cancer|nasopharyngeal cancer
315671|NCT01800071|Epstein Barr Virus Infections|epstein barr virus infections
315672|NCT01800071|Vaccination|vaccination
315673|NCT01800045|Narcolepsy|narcolepsy
315674|NCT01800045|Cataplexy|cataplexy
315675|NCT01800045|Sleep disorder|sleep disorder
315676|NCT01800045|Excessive daytime sleepiness|excessive daytime sleepiness
315677|NCT01800006|Atrial Fibrillation|atrial fibrillation
315678|NCT01800006|Observation|observation
315679|NCT01800006|Stroke|stroke
315680|NCT01800006|Embolism|embolism
315681|NCT01799993|Gram-negative pneumonia|gram-negative pneumonia
315682|NCT01799993|Intubation|intubation
315683|NCT01799993|Mechanical ventilation|mechanical ventilation
315684|NCT01799993|Amikacin|amikacin
315685|NCT01799980|Lung cancer|lung cancer
315686|NCT01799980|Cervical mediastinoscopy|cervical mediastinoscopy
315687|NCT01799980|Endobronchial ultrasound|endobronchial ultrasound
315688|NCT01799980|Staging|staging
315689|NCT01799967|gastro-esophageal junction|gastro-esophageal junction
315690|NCT01799967|minimally invasive|minimally invasive
315691|NCT01799967|Achalasia|achalasia
315692|NCT01799967|Paraesophageal hernia|paraesophageal hernia
315693|NCT01799967|GERD|gerd
315694|NCT01799967|Epiphrenic diverticula|epiphrenic diverticula
315695|NCT01799967|Zenker's diverticulum|zenker's diverticulum
315696|NCT01799967|All minimally invasive surgeries of the gastro-esophageal junction|all minimally invasive surgeries of the gastro-esophageal junction
315697|NCT01799902|Observational|observational
315698|NCT01799902|Non-Interventional Prospective|non-interventional prospective
315699|NCT01799902|Phase IV Treatment|phase iv treatment
315700|NCT01799902|Overactive Bladder Syndrome|overactive bladder syndrome
315701|NCT01799902|Solifenacin|solifenacin
315702|NCT01799889|GS-US-339-0102|gs-us-339-0102
315703|NCT01799889|SYK inhibitor|syk inhibitor
315704|NCT01799889|GS-9973|gs-9973
315705|NCT01799889|entospletinib|entospletinib
315706|NCT01799889|CLL|cll
315707|NCT01799889|leukemia|leukemia
315708|NCT01799889|lymphoma|lymphoma
315709|NCT01799889|MCL|mcl
315710|NCT01799889|DLBCL|dlbcl
315711|NCT01799889|iNHL|inhl
315712|NCT01799889|FL|fl
315713|NCT01799889|MZL|mzl
315714|NCT01799889|LPL|lpl
315715|NCT01799889|SLL|sll
315716|NCT01799889|WM|wm
315717|NCT01799889|Waldenström's macroglobulinemia|waldenström's macroglobulinemia
315718|NCT01799876|knee|knee
315719|NCT01799876|cartilage|cartilage
315720|NCT01799876|microfracture|microfracture
315721|NCT01799876|cell therapy|cell therapy
315722|NCT01799863|Conjunctivitis, Viral|conjunctivitis, viral
315723|NCT01799863|Ketorolac|ketorolac
315724|NCT01799863|Artificial tears|artificial tears
315725|NCT01799850|muscle|muscle
315726|NCT01799850|glucose transporters|glucose transporters
315727|NCT01799850|GLUT4|glut4
315728|NCT01799850|GLUT5|glut5
315729|NCT01799850|Actos|actos
315730|NCT01799837|PTSD|ptsd
315731|NCT01799811|allograft|allograft
315732|NCT01799811|limb salvage|limb salvage
315733|NCT01799811|patency|patency
315734|NCT01799811|Cryopreserved|cryopreserved
315735|NCT01799811|open bypass|open bypass
315736|NCT01799798|Osteogenesis imperfecta|osteogenesis imperfecta
315737|NCT01799798|COL1A1/A2|col1a1/a2
315738|NCT01799798|Denosumab|denosumab
315739|NCT01799798|Bisphosphonates|bisphosphonates
315740|NCT01799798|Children|children
315741|NCT01799798|Areal bone mineral density|areal bone mineral density
315742|NCT01799759|Body Mass Percentile|body mass percentile
315743|NCT01799759|Authoritative parenting|authoritative parenting
315744|NCT01799759|Online interventions|online interventions
315745|NCT01799759|Prevention|prevention
315746|NCT01799733|Premenstrual Dysphoric Disorder|premenstrual dysphoric disorder
315747|NCT01799733|Women|women
315748|NCT01799733|Depression|depression
315749|NCT01799733|Light therapy|light therapy
315750|NCT01799733|Wake therapy|wake therapy
315751|NCT01799733|Phase|phase
315752|NCT01799733|Chronobiology|chronobiology
315753|NCT01799720|blood cholesterol|blood cholesterol
315754|NCT01799720|blood lipid profile|blood lipid profile
315755|NCT01799720|triglycerides|triglycerides
315756|NCT01799720|commercial pills|commercial pills
315757|NCT01799720|fish oil|fish oil
315758|NCT01799720|lipid peroxidation|lipid peroxidation
315759|NCT01799720|Circulating lipidic profile|circulating lipidic profile
315760|NCT01799707|vision|vision
315761|NCT01799707|restoration|restoration
315762|NCT01799707|visual field|visual field
315763|NCT01799694|Urinary incontinence|urinary incontinence
315764|NCT01799694|Autologous expanded stem cells|autologous expanded stem cells
315765|NCT01799694|Radical prostate cancer surgery|radical prostate cancer surgery
315766|NCT01799681|randomised controlled trial, postural balance, rehabilitation, exercise therapy, accidental falls|randomised controlled trial, postural balance, rehabilitation, exercise therapy, accidental falls
315767|NCT01799668|Psychotherapy|psychotherapy
315768|NCT01799668|Preferences|preferences
315769|NCT01799642|dyspnea|dyspnea
315770|NCT01799642|exercise|exercise
315771|NCT01799642|cystic fibrosis|cystic fibrosis
315772|NCT01799642|neuromechanical dissociation|neuromechanical dissociation
315773|NCT01799629|Glycerin suppositories|glycerin suppositories
315774|NCT01799629|Feeding intolerance|feeding intolerance
315775|NCT01799629|preterm infants|preterm infants
315776|NCT01799629|prophylactic use|prophylactic use
315777|NCT01799629|elimination of meconium|elimination of meconium
315778|NCT01799616|MODIC changes|modic changes
315779|NCT01799616|Chronic low back pain|chronic low back pain
315780|NCT01799616|Pamidronate|pamidronate
315781|NCT01799616|Magnetic resonance imaging|magnetic resonance imaging
315782|NCT01799616|Vertebrae|vertebrae
315783|NCT01799616|Intervertebral disc|intervertebral disc
315784|NCT01799603|Healthy|healthy
315785|NCT01799603|TMC435|tmc435
315786|NCT01799603|G008|g008
315787|NCT01799590|Migraine|migraine
315788|NCT01799590|Topiramate|topiramate
315789|NCT01799577|laparoscopy, accuracy, duration|laparoscopy, accuracy, duration
315790|NCT01799564|Geographic atrophy|geographic atrophy
315791|NCT01799564|Age-related macular degeneration|age-related macular degeneration
315792|NCT01799564|Fundus autofluorescence|fundus autofluorescence
315793|NCT01799551|Depression|depression
315794|NCT01799551|Culture|culture
315795|NCT01799551|CBT|cbt
315796|NCT01799551|Adaptation|adaptation
315797|NCT01799538|Albuterol|albuterol
315798|NCT01799538|Bronchodilator|bronchodilator
315799|NCT01799538|Nebulizer|nebulizer
315800|NCT01799538|Metered Dose Inhaler|metered dose inhaler
315801|NCT01799525|Aneurysm|aneurysm
315802|NCT01799525|subarachnoid hemorrhage|subarachnoid hemorrhage
315803|NCT01799525|vasospasm|vasospasm
315804|NCT01799525|cerebral ischemia|cerebral ischemia
315805|NCT01799525|stroke|stroke
315806|NCT01799512|medical ICU patients|medical icu patients
315807|NCT01799512|APACHE-II score ≥20|apache-ii score ≥20
315808|NCT01799499|Non Muscle Invasive Bladder Cancer|non muscle invasive bladder cancer
315809|NCT01799499|Intravesical instillation|intravesical instillation
315810|NCT01799499|Mitomycin C|mitomycin c
315811|NCT01799499|Hydrogel|hydrogel
315812|NCT01799499|Reverse thermal gelation|reverse thermal gelation
315813|NCT01799499|Drug retention|drug retention
315814|NCT01799499|Urinary Bladder Neoplasms|urinary bladder neoplasms
315815|NCT01799499|Carcinoma|carcinoma
315816|NCT01799499|Urologic Neoplasms|urologic neoplasms
315817|NCT01799499|Urogenital Neoplasms|urogenital neoplasms
315818|NCT01799499|Neoplasms by Site|neoplasms by site
315819|NCT01799499|Neoplasms|neoplasms
315820|NCT01799499|Urinary Bladder Diseases|urinary bladder diseases
315821|NCT01799499|Urologic Diseases|urologic diseases
315822|NCT01799499|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
315823|NCT01799499|Neoplasms by Histologic Type Mitomycins|neoplasms by histologic type mitomycins
315824|NCT01799499|Mitomycin|mitomycin
315825|NCT01799499|Antibiotics, Antineoplastic|antibiotics, antineoplastic
315826|NCT01799499|Antineoplastic Agents|antineoplastic agents
315827|NCT01799499|Therapeutic Uses|therapeutic uses
315828|NCT01799499|Pharmacologic Actions|pharmacologic actions
315829|NCT01799499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors
315830|NCT01799499|Enzyme Inhibitors|enzyme inhibitors
315831|NCT01799499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
315832|NCT01799499|Alkylating Agents|alkylating agents
315833|NCT01799486|Telbivudine|telbivudine
315834|NCT01799486|renoprotective efficacy|renoprotective efficacy
315835|NCT01799486|liver cirrhosis|liver cirrhosis
315836|NCT01799473|Tyvaso|tyvaso
315837|NCT01799473|PAH|pah
315838|NCT01799460|single-nucleotide-polymorphism|single-nucleotide-polymorphism
315839|NCT01799460|Traditional Chinese Medicine|traditional chinese medicine
315840|NCT01799460|the Comprehensive Treatment Regimen|the comprehensive treatment regimen
315841|NCT01799447|Early intervention|early intervention
315842|NCT01799447|Intervention study|intervention study
315843|NCT01799447|Infant mother relations|infant mother relations
315844|NCT01799447|First time mothers|first time mothers
315845|NCT01799447|Parental program|parental program
315846|NCT01799447|Marte Meo method|marte meo method
315847|NCT01799447|Video guidances|video guidances
315848|NCT01799369|Surgical Apgar Score|surgical apgar score
315849|NCT01799356|Treatment, moksifloksasin|treatment, moksifloksasin
315850|NCT01799343|Prenatal care|prenatal care
315851|NCT01799343|Blood flow velocity|blood flow velocity
315852|NCT01799343|Hydrotherapy|hydrotherapy
315853|NCT01799343|Fetalplacental circulation|fetalplacental circulation
315854|NCT01799343|Uteroplacental circulation|uteroplacental circulation
315855|NCT01799330|COPD|copd
315856|NCT01799330|Rehabilitation|rehabilitation
315857|NCT01799330|Exercise|exercise
315858|NCT01799330|TCEMS|tcems
315859|NCT01799304|Locomotion|locomotion
315860|NCT01799304|cerebral palsy|cerebral palsy
315861|NCT01799304|Postural; Defect|postural; defect
315862|NCT01799291|Decision Making|decision making
315863|NCT01799291|Pediatric Bipolar Disorder|pediatric bipolar disorder
315864|NCT01799291|Assessment|assessment
315865|NCT01799291|Intervention|intervention
315866|NCT01799278|Metastatic prostate carcinoma|metastatic prostate carcinoma
315867|NCT01799265|obstructive sleep apnea|obstructive sleep apnea
315869|NCT01799265|AutoPAP|autopap
315870|NCT01799265|PAP|pap
315871|NCT01799265|sleep disordered breathing|sleep disordered breathing
315872|NCT01799265|CPAP|cpap
315873|NCT01799265|Apnea hypopnea index|apnea hypopnea index
315874|NCT01799265|AHI|ahi
315875|NCT01799252|medical abortion|medical abortion
315876|NCT01799252|doxycycline|doxycycline
315877|NCT01799252|antibiotics|antibiotics
315878|NCT01799252|adherence|adherence
315879|NCT01799252|nausea|nausea
315880|NCT01799239|stoma ileostomy|stoma ileostomy
315881|NCT01799213|Knee Osteoarthritis|knee osteoarthritis
315882|NCT01799213|NSAID|nsaid
315883|NCT01799213|Cognitive Behavioral Therapy|cognitive behavioral therapy
315884|NCT01799200|Collegiate Athletes|collegiate athletes
315885|NCT01799200|Hip Pathomorphology|hip pathomorphology
315886|NCT01799200|Age-Matched Controls|age-matched controls
315887|NCT01799200|Femoroacetabular Impingement|femoroacetabular impingement
315888|NCT01799200|Dysplasia|dysplasia
315889|NCT01799187|Immature Permanent Teeth|immature permanent teeth
315890|NCT01799161|NSCLC|nsclc
315891|NCT01799161|Lung Cancer|lung cancer
315892|NCT01799161|gp96|gp96
315893|NCT01799161|gp96 Vaccine|gp96 vaccine
315894|NCT01799161|AD100-gp96Ig-HLA A1|ad100-gp96ig-hla a1
315895|NCT01799148|Acute coronary syndrome|acute coronary syndrome
315896|NCT01799148|Air pollution.|air pollution.
315897|NCT01799148|Inflammation.|inflammation.
315898|NCT01799148|Oxidative Stress.|oxidative stress.
315899|NCT01799148|Prognosis|prognosis
315900|NCT01799109|magnesium sulfate|magnesium sulfate
315901|NCT01799109|nebulization|nebulization
315902|NCT01799109|lung function|lung function
315903|NCT01799083|Advanced solid tumors|advanced solid tumors
315904|NCT01799083|B cell lymphoma|b cell lymphoma
315905|NCT01799070|Prediction|prediction
315906|NCT01799070|Transcranial Doppler|transcranial doppler
315907|NCT01799057|Peripheral Arterial Disease|peripheral arterial disease
315908|NCT01799057|Intermittent Claudication|intermittent claudication
315909|NCT01799057|Peripheral Vascular Diseases|peripheral vascular diseases
315910|NCT01799057|Vascular Diseases|vascular diseases
315911|NCT01799057|Cardiovascular Diseases|cardiovascular diseases
315912|NCT01799057|Arterial Occlusive Diseases|arterial occlusive diseases
315913|NCT01799057|Atherosclerosis|atherosclerosis
315914|NCT01799057|Insulin Resistance|insulin resistance
315915|NCT01799057|Glucose Metabolism|glucose metabolism
315916|NCT01799057|Blood Glucose|blood glucose
315917|NCT01799057|Metformin|metformin
315918|NCT01799057|Biguanides|biguanides
315919|NCT01799057|Hypoglycemic Agents|hypoglycemic agents
315920|NCT01799057|Endothelium, Vascular|endothelium, vascular
315921|NCT01799057|Hemorheology|hemorheology
315922|NCT01799057|Blood Circulation|blood circulation
315923|NCT01799057|Regional Blood Flow|regional blood flow
315924|NCT01799057|Microcirculation|microcirculation
315925|NCT01799057|Exercise|exercise
315926|NCT01799057|Physical Fitness|physical fitness
315927|NCT01799057|Exercise Test|exercise test
315928|NCT01799057|Sedentary Lifestyle|sedentary lifestyle
315929|NCT01799057|Quality of Life|quality of life
315930|NCT01799057|Plethysmography|plethysmography
315931|NCT01799044|Irreversible electroporation|irreversible electroporation
315932|NCT01799044|IRE|ire
315933|NCT01799044|Electroporation|electroporation
315934|NCT01799044|Colorectal liver metastases|colorectal liver metastases
315935|NCT01799044|CRLM|crlm
315936|NCT01799044|Safety|safety
315937|NCT01799044|Feasibility|feasibility
315938|NCT01799044|Efficacy|efficacy
315939|NCT01799044|Single-center|single-center
315940|NCT01799044|Low Energy Direct Current|low energy direct current
315941|NCT01799044|Ablate-and-resect|ablate-and-resect
315942|NCT01799044|Nonthermal ablation|nonthermal ablation
315943|NCT01799044|Ablation|ablation
315944|NCT01799018|Xanthine Oxidase|xanthine oxidase
315945|NCT01799018|Cerebrospinal fluid|cerebrospinal fluid
315946|NCT01799005|flavanols|flavanols
315947|NCT01799005|diet|diet
315948|NCT01799005|endothelial function|endothelial function
315949|NCT01799005|blood pressure|blood pressure
315950|NCT01799005|FLAVIOLA|flaviola
315951|NCT01798992|ejection fraction|ejection fraction
315952|NCT01798992|beta-blocker|beta-blocker
315953|NCT01798992|carvedilol|carvedilol
315954|NCT01798992|metoprolol|metoprolol
315955|NCT01798992|myocardial gene expression|myocardial gene expression
315956|NCT01798992|human heart|human heart
315957|NCT01798992|ventricular remodeling|ventricular remodeling
315958|NCT01798992|wall stress|wall stress
315959|NCT01798992|adrenergic signaling|adrenergic signaling
315960|NCT01798992|myosin heavy chain|myosin heavy chain
315961|NCT01798953|Ulcerative Colitis|ulcerative colitis
315962|NCT01798953|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
315963|NCT01798953|Ileal pouch-anal anastomosis|ileal pouch-anal anastomosis
315964|NCT01798953|Ileorectal anastomosis|ileorectal anastomosis
315965|NCT01798953|Surgical outcome|surgical outcome
315966|NCT01798953|Functional outcome|functional outcome
315967|NCT01798953|Failure|failure
315968|NCT01798927|Parkinson's disease|parkinson's disease
315969|NCT01798927|ankle foot orthosis (AFO)|ankle foot orthosis (afo)
315970|NCT01798927|gait|gait
315971|NCT01798901|Acute Myeloid Leukemia|acute myeloid leukemia
315972|NCT01798901|AML|aml
315973|NCT01798901|AR-42|ar-42
315974|NCT01798901|Decitabine|decitabine
315975|NCT01798888|Deep Brain Stimulation|deep brain stimulation
315976|NCT01798888|Alcohol Dependence|alcohol dependence
315977|NCT01798875|pcos|pcos
315978|NCT01798875|metformin|metformin
315979|NCT01798875|oral contraception|oral contraception
315980|NCT01798875|cyproterone acetate|cyproterone acetate
315981|NCT01798862|Failed IVF cycles|failed ivf cycles
315982|NCT01798862|IVF outcome parameters|ivf outcome parameters
315983|NCT01798862|endometrial injury|endometrial injury
315984|NCT01798862|hysteroscopy|hysteroscopy
315985|NCT01798862|pipelle sampling|pipelle sampling
315986|NCT01798862|Repeated implantation failures|repeated implantation failures
315987|NCT01798836|IVF/ICSI cycles, poor responders, ultrashort flare protocol, antagonist protocol|ivf/icsi cycles, poor responders, ultrashort flare protocol, antagonist protocol
315988|NCT01798823|children|children
315989|NCT01798823|asthma|asthma
315990|NCT01798810|Surgical Site Infection Risk Prediction|surgical site infection risk prediction
315991|NCT01798810|Bacterial species type and antibacterial sensitivities|bacterial species type and antibacterial sensitivities
315992|NCT01798810|Resource Utilization and Cost|resource utilization and cost
315993|NCT01798797|Heart Failure|heart failure
315994|NCT01798797|HFRS|hfrs
315995|NCT01798797|OptiVol|optivol
315996|NCT01798797|ICD|icd
315997|NCT01798797|CRT-D|crt-d
315998|NCT01798771|primary brain tumor|primary brain tumor
315999|NCT01798771|malignant glioma|malignant glioma
316000|NCT01798771|intraoperative MRI|intraoperative mri
316001|NCT01798771|5-ALA|5-ala
316002|NCT01798745|Heart failure|heart failure
316003|NCT01798745|JNJ-54452840|jnj-54452840
316004|NCT01798745|Anti-beta-1 adrenergic receptor auto antibodies|anti-beta-1 adrenergic receptor auto antibodies
316005|NCT01798745|Beta-1 adrenergic receptor|beta-1 adrenergic receptor
316006|NCT01798745|Antibodies|antibodies
316007|NCT01798745|Auto antibodies|auto antibodies
316008|NCT01798745|Systolic function|systolic function
316009|NCT01798719|NAFLD|nafld
316010|NCT01798719|Clinical Trial|clinical trial
316011|NCT01798719|Mediterranean Diet|mediterranean diet
316012|NCT01798719|Low Glycemic Index|low glycemic index
316013|NCT01798693|Shoulder|shoulder
316014|NCT01798693|Supplement|supplement
316015|NCT01798693|Amino Acids|amino acids
316016|NCT01798693|Collagen|collagen
316017|NCT01798693|Standard of Care|standard of care
316018|NCT01798641|Hydrocephalus|hydrocephalus
316019|NCT01798641|Cross-over|cross-over
316020|NCT01798628|Healthy volunteers|healthy volunteers
316021|NCT01798628|Abiraterone acetate|abiraterone acetate
316022|NCT01798628|Pharmacokinetics|pharmacokinetics
316023|NCT01798602|H1N1|h1n1
316024|NCT01798602|Rosuvastatin|rosuvastatin
316025|NCT01798589|ethylenediamine dihydrochloride|ethylenediamine dihydrochloride
316026|NCT01798563|Parkinson|parkinson
316027|NCT01798563|Parkinson Disease|parkinson disease
316028|NCT01798550|Enoxaparin dosing|enoxaparin dosing
316029|NCT01798550|Obesity|obesity
316030|NCT01798524|Transplant|transplant
316031|NCT01798524|Kidney|kidney
316032|NCT01798524|England|england
316033|NCT01798511|enteral nutrition|enteral nutrition
316034|NCT01798511|acute pancreatitis|acute pancreatitis
316035|NCT01798511|oral food intolerance|oral food intolerance
316036|NCT01798472|displaced femoral neck fractures|displaced femoral neck fractures
316037|NCT01798472|treatment|treatment
316038|NCT01798472|uncemented arthroplasty|uncemented arthroplasty
316039|NCT01798472|cemented arthroplasty|cemented arthroplasty
316040|NCT01798459|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
316041|NCT01798459|Methylphenidate|methylphenidate
316042|NCT01798459|Placebo|placebo
316043|NCT01798459|State anxiety|state anxiety
316044|NCT01798446|Renal cell carcinoma|renal cell carcinoma
316045|NCT01798446|Nonclear cell|nonclear cell
316046|NCT01798446|Temsirolimus resistance|temsirolimus resistance
316047|NCT01798433|Angioplasty|angioplasty
316048|NCT01798433|Transluminal|transluminal
316049|NCT01798433|Percutaneous Coronary|percutaneous coronary
316050|NCT01798420|COPD|copd
316051|NCT01798420|Diabetes|diabetes
316052|NCT01798420|steroids|steroids
316053|NCT01798420|Hemoglobin A1C DIFFERENCE|hemoglobin a1c difference
316054|NCT01798407|Deep Brain Stimulation|deep brain stimulation
316055|NCT01798407|Major Depressive Disorder|major depressive disorder
316056|NCT01798407|Depression|depression
316057|NCT01798407|Lateral Habenula|lateral habenula
316058|NCT01798407|Intractable Depression|intractable depression
316059|NCT01798407|Treatment Resistant Depression (TRD)|treatment resistant depression (trd)
316060|NCT01798394|pregnant|pregnant
316061|NCT01798394|smoker|smoker
316062|NCT01798394|cigarette|cigarette
316063|NCT01798394|tobacco|tobacco
316064|NCT01798355|Dental Fear|dental fear
316065|NCT01798355|Dental Phobia|dental phobia
316066|NCT01798355|Cognitive Behavior Therapy|cognitive behavior therapy
316067|NCT01798355|Specific Phobia|specific phobia
316068|NCT01798355|Children and Adolescents anxiety|children and adolescents anxiety
316069|NCT01798355|Self Efficacy|self efficacy
316070|NCT01798342|preoperative care|preoperative care
316071|NCT01798342|maltodextrine|maltodextrine
316072|NCT01798342|glutamine|glutamine
316073|NCT01798342|gastric residual volume|gastric residual volume
316074|NCT01798342|MRI|mri
316075|NCT01798329|Minimal Hepatic Encephalopathy|minimal hepatic encephalopathy
316076|NCT01798329|Pre-hepatic Portal Hypertension|pre-hepatic portal hypertension
316077|NCT01798329|portal vein thrombosis|portal vein thrombosis
316078|NCT01798316|IV Acetaminophen|iv acetaminophen
316079|NCT01798316|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
316080|NCT01798316|Postoperative nausea|postoperative nausea
316081|NCT01798316|Postoperative vomiting|postoperative vomiting
316082|NCT01798277|Keywords provided by Newmarket Electrophysiology Research Group Inc:|keywords provided by newmarket electrophysiology research group inc:
316083|NCT01798277|Ventricular tachycardia|ventricular tachycardia
316084|NCT01798277|Ventricular tachyarrhythmia|ventricular tachyarrhythmia
316085|NCT01798277|Ablation|ablation
316086|NCT01798277|Coronary artery disease|coronary artery disease
316087|NCT01798277|Ischemic heart disease|ischemic heart disease
316088|NCT01798277|Amiodarone|amiodarone
316089|NCT01798277|Sotalol|sotalol
316090|NCT01798277|Anti-Arrhythmia Agents|anti-arrhythmia agents
316091|NCT01798277|Therapeutic Uses|therapeutic uses
316092|NCT01798277|Pharmacologic Actions|pharmacologic actions
316093|NCT01798277|Additional relevant MeSH terms:|additional relevant mesh terms:
316094|NCT01798277|Atrial Fibrillation|atrial fibrillation
316095|NCT01798277|Arrhythmias, Cardiac|arrhythmias, cardiac
316096|NCT01798277|Heart Diseases|heart diseases
316097|NCT01798277|Cardiovascular Diseases|cardiovascular diseases
316098|NCT01798277|Pathologic Processes|pathologic processes
316099|NCT01798277|Catheter Ablation, Radiofrequency|catheter ablation, radiofrequency
316100|NCT01798251|Elderly Gastric Cancer|elderly gastric cancer
316101|NCT01798251|Capecitabine Maintenance|capecitabine maintenance
316102|NCT01798238|Type 2 Diabetes Mellitus / Dipeptidyl peptidase-IV inhibitors|type 2 diabetes mellitus / dipeptidyl peptidase-iv inhibitors
316103|NCT01798225|Periodontal Disease|periodontal disease
316104|NCT01798225|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
316105|NCT01798225|Gullah African Americans|gullah african americans
316106|NCT01798212|GERD|gerd
316107|NCT01798199|Alzheimer|alzheimer
316108|NCT01798199|virtual reality system|virtual reality system
316109|NCT01798199|Alzheimer's disease related conditions|alzheimer's disease related conditions
316110|NCT01798173|Hepatocellular carcinoma|hepatocellular carcinoma
316111|NCT01798173|Cirrhosis|cirrhosis
316112|NCT01798173|Environmental risk factors|environmental risk factors
316113|NCT01798173|Nutrition|nutrition
316114|NCT01798173|Metabolic syndrome|metabolic syndrome
316115|NCT01798147|Cholangiocellular Carcinoma|cholangiocellular carcinoma
316116|NCT01798147|TACE|tace
316117|NCT01798147|SIRT|sirt
316118|NCT01798134|To show safety|to show safety
316119|NCT01798134|and efficacy|and efficacy
316120|NCT01798134|investigational product|investigational product
316121|NCT01798121|PPD|ppd
316122|NCT01798121|Tuberculosis|tuberculosis
316123|NCT01798108|Advanced skeletal metastases|advanced skeletal metastases
316124|NCT01798108|Radium-223|radium-223
316125|NCT01798108|Radium-223 dichloride|radium-223 dichloride
316126|NCT01798108|Alpharadin|alpharadin
316127|NCT01798095|TB, Aplisol|tb, aplisol
316128|NCT01798056|≥18 years of age|≥18 years of age
316129|NCT01798056|Chemotherapy|chemotherapy
316130|NCT01798056|Solid tumours|solid tumours
316131|NCT01798056|Immunogenicity|immunogenicity
316132|NCT01798056|Herpes Zoster|herpes zoster
316133|NCT01798056|Safety|safety
316134|NCT01798056|Shingles|shingles
316135|NCT01798030|Vitamin D|vitamin d
316136|NCT01798030|Diabetes|diabetes
316137|NCT01798030|Osteoporosis|osteoporosis
316138|NCT01798030|Cardiovascular Risk|cardiovascular risk
316139|NCT01798017|menstrual regulation|menstrual regulation
316140|NCT01798017|mifepristone|mifepristone
316141|NCT01798017|misoprostol|misoprostol
316142|NCT01797991|Hypersensitivity, drug|hypersensitivity, drug
316143|NCT01797978|Sepsis|sepsis
316144|NCT01797978|Septic shock|septic shock
316145|NCT01797978|Methylene blue|methylene blue
316146|NCT01797952|lactobacillus CD 2|lactobacillus cd 2
316147|NCT01797952|oral mucositis|oral mucositis
316148|NCT01797952|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
316149|NCT01797939|Erosive reflux disease (ERD)|erosive reflux disease (erd)
316150|NCT01797939|Non-erosive reflux disease (NERD)|non-erosive reflux disease (nerd)
316151|NCT01797939|Functional heartburn (FH)|functional heartburn (fh)
316152|NCT01797926|pharmacokinetics|pharmacokinetics
316153|NCT01797926|Hypertension|hypertension
316154|NCT01797926|losartan|losartan
316155|NCT01797926|healthy volunteers|healthy volunteers
316156|NCT01797926|amlodipine|amlodipine
316157|NCT01797900|adjuvants|adjuvants
316158|NCT01797900|inductive|inductive
316159|NCT01797900|concurrent|concurrent
316160|NCT01797900|chemoradiotherapy|chemoradiotherapy
316161|NCT01797900|high-risk|high-risk
316162|NCT01797900|locally advanced|locally advanced
316163|NCT01797900|NPC|npc
316164|NCT01797887|Burnout-Syndrome|burnout-syndrome
316165|NCT01797887|Ayurveda|ayurveda
316166|NCT01797887|Ayurvedic|ayurvedic
316167|NCT01797887|Traditional Indian Medicine|traditional indian medicine
316168|NCT01797887|CAM|cam
316169|NCT01797887|Whole Medical System|whole medical system
316170|NCT01797887|Diet and Lifestyle Counseling|diet and lifestyle counseling
316171|NCT01797874|pazopanib maintenance|pazopanib maintenance
316172|NCT01797874|efficacy|efficacy
316173|NCT01797874|SCLC|sclc
316174|NCT01797861|chronic central serous chorioretinopathy|chronic central serous chorioretinopathy
316175|NCT01797861|photodynamic therapy|photodynamic therapy
316176|NCT01797861|micropulse laser|micropulse laser
316177|NCT01797835|adolescents|adolescents
316178|NCT01797835|intervention|intervention
316179|NCT01797835|motivational interviewing|motivational interviewing
316180|NCT01797835|alcohol and drug use|alcohol and drug use
316181|NCT01797783|Myopia|myopia
316182|NCT01797783|Presbyopia|presbyopia
316183|NCT01797783|Refractive error|refractive error
316184|NCT01797783|Contact lenses|contact lenses
316185|NCT01797783|Multifocal|multifocal
316186|NCT01797770|mechanical bowel preparation|mechanical bowel preparation
316187|NCT01797770|Colon Cancer|colon cancer
316188|NCT01797757|EPA|epa
316189|NCT01797757|LC-PUFA|lc-pufa
316190|NCT01797757|Orlistat|orlistat
316191|NCT01797757|Obesity|obesity
316192|NCT01797744|Stroke|stroke
316193|NCT01797744|Dizziness|dizziness
316194|NCT01797744|Vestibular rehabiliation|vestibular rehabiliation
316195|NCT01797744|Balance|balance
316196|NCT01797731|Orthalign|orthalign
316197|NCT01797731|KneeAlign|kneealign
316198|NCT01797731|Total Knee Replacement|total knee replacement
316199|NCT01797731|Total Knee Arthroplasty|total knee arthroplasty
316200|NCT01797731|Degenerative joint disease|degenerative joint disease
316201|NCT01797731|Osteoarthritis|osteoarthritis
316202|NCT01797731|Unilateral|unilateral
316203|NCT01797718|Puberty|puberty
316204|NCT01797718|Constitutional|constitutional
316205|NCT01797718|Delay|delay
316206|NCT01797718|Letrozole|letrozole
316207|NCT01797718|Testosterone|testosterone
316208|NCT01797692|prostate cancer cured|prostate cancer cured
316209|NCT01797692|aged patients|aged patients
316210|NCT01797679|Osteoarthritis,Articular Cartilage, Relaxometry, Morphometry, MRI, T2 mapping, T1 rho|osteoarthritis,articular cartilage, relaxometry, morphometry, mri, t2 mapping, t1 rho
316211|NCT01797640|Tibia Fractures|tibia fractures
316212|NCT01797640|Medial Fractures|medial fractures
316213|NCT01797640|Posterior Malleolar Fractures|posterior malleolar fractures
316214|NCT01797627|Pediatric Hydrocephalus|pediatric hydrocephalus
316215|NCT01797627|Ventricular Size|ventricular size
316216|NCT01797627|Neuropsychological Outcomes|neuropsychological outcomes
316217|NCT01797627|Quality of Life|quality of life
316218|NCT01797614|intra-abdominal pressure|intra-abdominal pressure
316219|NCT01797614|spontaneous breathing trail|spontaneous breathing trail
316220|NCT01797614|weaning|weaning
316221|NCT01797588|Total Knee Arthroplasty|total knee arthroplasty
316222|NCT01797588|Pain|pain
316223|NCT01797588|Periarticular infiltration|periarticular infiltration
316224|NCT01797588|Adductor canal block|adductor canal block
316225|NCT01797588|Postoperative|postoperative
316226|NCT01797575|Bipolar Disorder|bipolar disorder
316227|NCT01797575|Mood Disorder|mood disorder
316228|NCT01797575|Bipolar Depression|bipolar depression
316229|NCT01797575|Mood Swings|mood swings
316230|NCT01797562|Contact dermatitis|contact dermatitis
316231|NCT01797562|Eczema|eczema
316232|NCT01797549|Traumatic brain injury|traumatic brain injury
316233|NCT01797549|functional near infrared spectroscopy|functional near infrared spectroscopy
316234|NCT01797523|Endometrial cancer|endometrial cancer
316235|NCT01797523|Advanced or Recurrent Endometrial Carcinoma|advanced or recurrent endometrial carcinoma
316236|NCT01797523|Metformin|metformin
316237|NCT01797523|Letrozole|letrozole
316238|NCT01797523|Femara|femara
316239|NCT01797523|Everolimus|everolimus
316240|NCT01797523|Afinitor|afinitor
316241|NCT01797523|Zortress|zortress
316242|NCT01797523|RAD001|rad001
316243|NCT01797497|Parents|parents
316244|NCT01797497|Primary Care Providers|primary care providers
316245|NCT01797497|Specialists|specialists
316246|NCT01797497|Children with Special Healthcare Needs|children with special healthcare needs
316247|NCT01797497|Referral|referral
316248|NCT01797497|Health Outcomes|health outcomes
316249|NCT01797497|Self-Efficacy|self-efficacy
316250|NCT01797497|Communication|communication
316251|NCT01797484|ischemia|ischemia
316252|NCT01797484|myocardium|myocardium
316253|NCT01797484|Ranolazine|ranolazine
316254|NCT01797484|dyskinesia|dyskinesia
316255|NCT01797484|speckle tracking echocardiography|speckle tracking echocardiography
316256|NCT01797471|Non-Small Cell Lung Cancer|non-small cell lung cancer
316257|NCT01797471|NSCLC|nsclc
316258|NCT01797471|Lung Cancer|lung cancer
316259|NCT01797458|Class II carious primary molar|class ii carious primary molar
316260|NCT01797458|Non-Restorative Caries Treatment|non-restorative caries treatment
316261|NCT01797458|Hall Technique|hall technique
316262|NCT01797458|Conventional restorations|conventional restorations
316263|NCT01797458|Children|children
316264|NCT01797445|HIV|hiv
316265|NCT01797445|Treatment Naive|treatment naive
316266|NCT01797445|HIV 1 Infected|hiv 1 infected
316267|NCT01797445|Women|women
316268|NCT01797445|Female|female
316269|NCT01797419|Respiratory|respiratory
316270|NCT01797419|Syncytial|syncytial
316271|NCT01797419|Virus|virus
316272|NCT01797419|RSV|rsv
316273|NCT01797380|Depression|depression
316274|NCT01797380|HIV|hiv
316275|NCT01797367|HIV|hiv
316276|NCT01797367|COPD|copd
316277|NCT01797367|FEV1|fev1
316278|NCT01797367|respiratory function|respiratory function
316279|NCT01797354|patients at the end of treatment|patients at the end of treatment
316280|NCT01797341|Renal Transplantation|renal transplantation
316281|NCT01797341|Kidney transplantation|kidney transplantation
316282|NCT01797341|Pancreas Transplantation|pancreas transplantation
316283|NCT01797341|Tacrolimus|tacrolimus
316284|NCT01797341|Advagraf|advagraf
316285|NCT01797341|Prograf|prograf
316286|NCT01797341|Drug Adherence|drug adherence
316287|NCT01797328|brown adipose tissue, human|brown adipose tissue, human
316288|NCT01797302|Obesity|obesity
316289|NCT01797302|Vitamin D Deficiency|vitamin d deficiency
316290|NCT01797302|Vascular Function|vascular function
316291|NCT01797302|Insulin resistance|insulin resistance
316292|NCT01797302|metabolic syndrome|metabolic syndrome
316293|NCT01797289|syncope|syncope
316294|NCT01797289|pulmonary embolism|pulmonary embolism
316295|NCT01797276|Dichloroacetate (DCA)|dichloroacetate (dca)
316296|NCT01797276|Congenital Lactic Acidosis (CLA)|congenital lactic acidosis (cla)
316297|NCT01797276|acidosis|acidosis
316298|NCT01797276|orphan disease|orphan disease
316299|NCT01797263|fibromyalgia|fibromyalgia
316300|NCT01797263|yoga|yoga
316301|NCT01797263|exercise|exercise
316302|NCT01797263|pain|pain
316303|NCT01797237|surgery|surgery
316304|NCT01797237|fixation|fixation
316305|NCT01797237|intramedullary nail|intramedullary nail
316306|NCT01797224|Autoimmune disease|autoimmune disease
316307|NCT01797224|certolizumab pegol|certolizumab pegol
316308|NCT01797224|Cimzia|cimzia
316309|NCT01797224|pregnancy|pregnancy
316310|NCT01797224|birth defect|birth defect
316311|NCT01797224|birth outcome|birth outcome
316312|NCT01797224|TNF|tnf
316313|NCT01797224|Tumor necrosis factor|tumor necrosis factor
316314|NCT01797211|Mediterranean diet; FMD; obesity; cardiovascular risk.|mediterranean diet; fmd; obesity; cardiovascular risk.
316315|NCT01797198|Phase I|phase i
316316|NCT01797198|ASP3652|asp3652
316317|NCT01797198|Gemfibrozil|gemfibrozil
316318|NCT01797198|Repaglinide|repaglinide
316319|NCT01797198|Pharmacokinetics|pharmacokinetics
316320|NCT01797185|baclofen, spasticity|baclofen, spasticity
316321|NCT01797172|nucleoplasty|nucleoplasty
316322|NCT01797172|pulsed radio frequency|pulsed radio frequency
316323|NCT01797172|herniated disc|herniated disc
316324|NCT01797172|cervical|cervical
316325|NCT01797172|percutaneous disc decompression|percutaneous disc decompression
316326|NCT01797172|cervical radiculopathy|cervical radiculopathy
316327|NCT01797159|Prophylactic Cranial Irradiation|prophylactic cranial irradiation
316328|NCT01797159|PCI|pci
316329|NCT01797159|Hippocampal-sparing irradiation|hippocampal-sparing irradiation
316330|NCT01797120|Post-Menopausal Patients|post-menopausal patients
316331|NCT01797120|Hormone-Receptor Positive|hormone-receptor positive
316332|NCT01797120|Resistant to Aromatase Inhibitor Therapy|resistant to aromatase inhibitor therapy
316333|NCT01797120|Fulvestrant|fulvestrant
316334|NCT01797120|Faslodex|faslodex
316335|NCT01797120|mTOR Inhibitor|mtor inhibitor
316336|NCT01797120|Everolimus|everolimus
316337|NCT01797120|RAD001|rad001
316338|NCT01797120|Afinitor|afinitor
316339|NCT01797107|Meibomian gland dysfunction|meibomian gland dysfunction
316340|NCT01797068|HEALTHCARE UTILIZATION|healthcare utilization
316341|NCT01797068|ED UTILIZATION|ed utilization
316342|NCT01797068|PRIMARY CARE UTILIZATION|primary care utilization
316343|NCT01797068|PATIENT NAVIGATION|patient navigation
316344|NCT01797068|UNDERSERVED POPULATIONS|underserved populations
316345|NCT01797068|HEALTH DISPARITIES|health disparities
316346|NCT01797055|transferrin|transferrin
316347|NCT01797055|anemia|anemia
316348|NCT01797055|iron overload|iron overload
316349|NCT01797042|Fructose|fructose
316350|NCT01797042|High fructose corn syrup|high fructose corn syrup
316351|NCT01797042|Energy regulation|energy regulation
316352|NCT01797042|Ectopic fat|ectopic fat
316353|NCT01797042|Understanding|understanding
316354|NCT01797042|potential|potential
316355|NCT01797016|Myocardial Infarction|myocardial infarction
316356|NCT01797016|flow cytometry|flow cytometry
316357|NCT01797016|Blood Cell Count|blood cell count
316358|NCT01797016|Platelet Activation|platelet activation
316359|NCT01797003|osteoarthritis|osteoarthritis
316360|NCT01797003|osteotomy|osteotomy
316361|NCT01797003|closing|closing
316362|NCT01797003|opening|opening
316363|NCT01797003|wedge|wedge
316364|NCT01797003|kne|kne
316365|NCT01797003|tibia|tibia
316366|NCT01796990|physical activity|physical activity
316367|NCT01796990|psychological well-being|psychological well-being
316368|NCT01796990|acceptance and commitment therapy|acceptance and commitment therapy
316369|NCT01796990|adults|adults
316622|NCT01795885|Contraception|contraception
316370|NCT01796977|Nipple-sparing Mastectomy|nipple-sparing mastectomy
316372|NCT01796977|Nipple Sparing Mastectomy|nipple sparing mastectomy
316373|NCT01796964|Age-Related Macular Degeneration|age-related macular degeneration
316374|NCT01796964|Wet|wet
316375|NCT01796964|Exudative|exudative
316376|NCT01796964|AMD|amd
316377|NCT01796964|Intravitreal injection|intravitreal injection
316378|NCT01796964|Retina|retina
316379|NCT01796938|Lacosamide|lacosamide
316380|NCT01796938|Vimpat|vimpat
316381|NCT01796938|Single Dose|single dose
316382|NCT01796938|Pharmacokinetics|pharmacokinetics
316383|NCT01796938|Renal Impairment|renal impairment
316384|NCT01796925|Apnea|apnea
316385|NCT01796925|Respiration Disorders|respiration disorders
316386|NCT01796925|Signs and Symptoms|signs and symptoms
316387|NCT01796925|Signs and Symptoms, Respiratory|signs and symptoms, respiratory
316388|NCT01796925|Sleep Apnea Syndromes|sleep apnea syndromes
316389|NCT01796925|Sleep Apnea, Obstructive|sleep apnea, obstructive
316390|NCT01796925|Respiratory Tract Diseases|respiratory tract diseases
316391|NCT01796925|Sleep Disorders, Intrinsic|sleep disorders, intrinsic
316392|NCT01796925|Sleep Disorders|sleep disorders
316393|NCT01796925|Nervous System Diseases|nervous system diseases
316394|NCT01796899|Healthy Volunteers|healthy volunteers
316395|NCT01796899|Brivaracetam|brivaracetam
316396|NCT01796873|Female|female
316397|NCT01796873|Hispanic|hispanic
316398|NCT01796873|Percutaneous Coronary Intervention|percutaneous coronary intervention
316399|NCT01796860|Gait|gait
316400|NCT01796860|AFO|afo
316401|NCT01796860|MS|ms
316402|NCT01796847|ICU|icu
316403|NCT01796847|Hyperglycemia|hyperglycemia
316404|NCT01796847|Length of stay|length of stay
316405|NCT01796834|Mindfulness-Based Stress Reduction|mindfulness-based stress reduction
316406|NCT01796834|Diabetes Management|diabetes management
316407|NCT01796834|Stress Reduction|stress reduction
316408|NCT01796834|Diabetes Testing|diabetes testing
316409|NCT01796821|Condyloma acuminata|condyloma acuminata
316410|NCT01796821|Genital warts|genital warts
316411|NCT01796821|Condylomata acuminata|condylomata acuminata
316412|NCT01796821|Venereal warts|venereal warts
316413|NCT01796808|pedal|pedal
316414|NCT01796808|atrophy|atrophy
316415|NCT01796808|fat grafting|fat grafting
316416|NCT01796808|adipose tissue|adipose tissue
316417|NCT01796795|common wart|common wart
316418|NCT01796795|verruca vulgaris|verruca vulgaris
316419|NCT01796769|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
316420|NCT01796769|Telemedicine|telemedicine
316421|NCT01796769|Patient Compliance|patient compliance
316422|NCT01796756|Handover|handover
316423|NCT01796756|Handoff|handoff
316424|NCT01796756|Signout|signout
316425|NCT01796756|Quality Improvement|quality improvement
316426|NCT01796756|General Internal Medicine|general internal medicine
316427|NCT01796743|MRI|mri
316428|NCT01796743|Double Inversion radial fast Spin Echo T2 mapping|double inversion radial fast spin echo t2 mapping
316429|NCT01796743|Heart failure risk stratification|heart failure risk stratification
316430|NCT01796743|30 day post hospitalization outcome|30 day post hospitalization outcome
316431|NCT01796730|efficacy|efficacy
316432|NCT01796730|safety|safety
316433|NCT01796730|Bambuterol tablets|bambuterol tablets
316434|NCT01796730|COPD|copd
316435|NCT01796717|Piperacillin/tazobactam|piperacillin/tazobactam
316436|NCT01796717|MIC|mic
316437|NCT01796704|functional capacity|functional capacity
316438|NCT01796704|NYHA class|nyha class
316439|NCT01796691|Clopidogrel|clopidogrel
316440|NCT01796691|aspirin|aspirin
316441|NCT01796691|low response|low response
316442|NCT01796691|platelet aggregation|platelet aggregation
316443|NCT01796691|Acute Coronary Syndrome|acute coronary syndrome
316444|NCT01796691|Coronary Stent Implantation|coronary stent implantation
316445|NCT01796678|sickle cell disease|sickle cell disease
316446|NCT01796678|vaso-occlusive pain episodes|vaso-occlusive pain episodes
316447|NCT01796678|arginine|arginine
316448|NCT01796678|nitric oxide|nitric oxide
316449|NCT01796652|Acute interstitial pancreatitis|acute interstitial pancreatitis
316450|NCT01796652|Home therapy|home therapy
316451|NCT01796600|distal limbs fracture, acute trauma, imaging, cone beam computed tomography,|distal limbs fracture, acute trauma, imaging, cone beam computed tomography,
316452|NCT01796574|status epilepticus|status epilepticus
316453|NCT01796574|seizure|seizure
316454|NCT01796574|epilepsy|epilepsy
316455|NCT01796574|ketogenic diet|ketogenic diet
316456|NCT01796574|modified Atkins diet|modified atkins diet
316457|NCT01796548|Detrusor function, overactive|detrusor function, overactive
316458|NCT01796548|Urinary incontinence|urinary incontinence
316459|NCT01796548|Oxybutynin|oxybutynin
316460|NCT01796548|Lyrinel|lyrinel
316461|NCT01796509|Quality of life,|quality of life,
316462|NCT01796509|Sequela disorders,|sequela disorders,
316463|NCT01796509|Socio-professional impact,|socio-professional impact,
316464|NCT01796509|Anxiety, depression,|anxiety, depression,
316465|NCT01796509|Post traumatic stress disorder,|post traumatic stress disorder,
316466|NCT01796509|ICU acquired paresis.|icu acquired paresis.
316467|NCT01796496|Low back pain.|low back pain.
316468|NCT01796496|Manipulative therapy techniques.|manipulative therapy techniques.
316469|NCT01796496|Randomized controlled trial.|randomized controlled trial.
316470|NCT01796496|Chronic pain.|chronic pain.
316471|NCT01796483|Parkinson disease|parkinson disease
316472|NCT01796483|STN-DBS|stn-dbs
316473|NCT01796483|Impulsivity|impulsivity
316474|NCT01796483|Akinesia|akinesia
316475|NCT01796483|Noradrenergic|noradrenergic
316476|NCT01796483|system|system
316477|NCT01796470|GS-US-339-0103|gs-us-339-0103
316478|NCT01796470|SYK inhibitor|syk inhibitor
316479|NCT01796470|PI3K inhibitor|pi3k inhibitor
316480|NCT01796470|GS-9973|gs-9973
316481|NCT01796470|GS 9973|gs 9973
316482|NCT01796470|GS-1101|gs-1101
316483|NCT01796470|GS 1101|gs 1101
316484|NCT01796470|Cal-101|cal-101
316485|NCT01796470|Cal 101|cal 101
316486|NCT01796470|idelalisib|idelalisib
316487|NCT01796470|leukemia|leukemia
316488|NCT01796470|lymphoma|lymphoma
316489|NCT01796470|CLL|cll
316490|NCT01796470|MCL|mcl
316491|NCT01796470|DLBCL|dlbcl
316492|NCT01796470|iNHL|inhl
316493|NCT01796470|FL|fl
316494|NCT01796470|MZL|mzl
316495|NCT01796470|LPL|lpl
316496|NCT01796470|SLL|sll
316497|NCT01796470|WM|wm
316498|NCT01796470|Waldenström's macroglobulinemia|waldenström's macroglobulinemia
316499|NCT01796457|Hepatitis B|hepatitis b
316500|NCT01796457|Immunology|immunology
316501|NCT01796457|HBV|hbv
316502|NCT01796457|Immune tolerant|immune tolerant
316503|NCT01796457|Immune active|immune active
316504|NCT01796444|Breast Cancer|breast cancer
316505|NCT01796444|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
316506|NCT01796444|Axillary Lymph Node Dissection|axillary lymph node dissection
316507|NCT01796392|emphysema|emphysema
316508|NCT01796392|endobronchial valve|endobronchial valve
316509|NCT01796392|treatments|treatments
316510|NCT01796392|pulmonary rehabilitation|pulmonary rehabilitation
316511|NCT01796392|lung volume reduction|lung volume reduction
316512|NCT01796353|heart disease|heart disease
316513|NCT01796353|sexual dysfunction|sexual dysfunction
316514|NCT01796353|exercise test|exercise test
316515|NCT01796353|comprehensive rehabilitation|comprehensive rehabilitation
316516|NCT01796353|complex intervention|complex intervention
316517|NCT01796340|cue exposure|cue exposure
316518|NCT01796340|childhood|childhood
316519|NCT01796340|overeating|overeating
316520|NCT01796340|overweight|overweight
316521|NCT01796340|obese|obese
316522|NCT01796340|treatment|treatment
316523|NCT01796327|dacomitinib|dacomitinib
316524|NCT01796327|PF-00299804|pf-00299804
316525|NCT01796327|pharmacokinetics|pharmacokinetics
316526|NCT01796327|bioavailability|bioavailability
316527|NCT01796314|Therapeutic educational programme for Alzheimer's disease patients and their caregiver|therapeutic educational programme for alzheimer's disease patients and their caregiver
316528|NCT01796314|Alzheimer's disease, mild to moderately severe stages|alzheimer's disease, mild to moderately severe stages
316529|NCT01796314|Community dwelling patients with family caregiver|community dwelling patients with family caregiver
316530|NCT01796314|quality of life|quality of life
316531|NCT01796301|Postmenopausal Osteoporosis|postmenopausal osteoporosis
316532|NCT01796288|NSCLC|nsclc
316533|NCT01796288|oligometastatic|oligometastatic
316534|NCT01796288|second-line|second-line
316535|NCT01796288|Radiotherapy|radiotherapy
316536|NCT01796288|Erlotinib|erlotinib
316537|NCT01796262|ADHD|adhd
316538|NCT01796262|DHA|dha
316539|NCT01796262|neuropsychological task|neuropsychological task
316540|NCT01796262|fNIRS|fnirs
316541|NCT01796262|Docosahexaenoic Acid|docosahexaenoic acid
316542|NCT01796262|n-3 polyunsaturated fatty acid|n-3 polyunsaturated fatty acid
316543|NCT01796262|cognition|cognition
316544|NCT01796262|behavior|behavior
316545|NCT01796249|Analgesia Nociception Index|analgesia nociception index
316546|NCT01796249|ANI|ani
316547|NCT01796236|Bone anchored hearing aid|bone anchored hearing aid
316548|NCT01796236|Bone anchored implant|bone anchored implant
316549|NCT01796236|Abbreviated Profile of Hearing Aid Benefit (APHAB)|abbreviated profile of hearing aid benefit (aphab)
316550|NCT01796236|Health Utility Index (HUI)|health utility index (hui)
316551|NCT01796236|Holgers Index|holgers index
316552|NCT01796236|Implant stability|implant stability
316553|NCT01796223|Community mental health services|community mental health services
316554|NCT01796223|Psychotherapy|psychotherapy
316555|NCT01796223|Physician-Patient Relations|physician-patient relations
316556|NCT01796223|Norway|norway
316557|NCT01796210|Analgesia/nociception index|analgesia/nociception index
316558|NCT01796210|Bispectral index|bispectral index
316559|NCT01796210|Propofol|propofol
316560|NCT01796210|Remifentanil|remifentanil
316561|NCT01796210|Suspension laryngoscopy|suspension laryngoscopy
316562|NCT01796210|Endoscopy|endoscopy
316563|NCT01796210|Ear-nose-throat|ear-nose-throat
316564|NCT01796184|Inflammation|inflammation
316565|NCT01796184|Glycation|glycation
316566|NCT01796184|Continuous glucose monitoring|continuous glucose monitoring
316567|NCT01796184|Adult population|adult population
316568|NCT01796171|Radioimmunotherapy|radioimmunotherapy
316569|NCT01796171|Lu-177|lu-177
316570|NCT01796171|Phase I study|phase i study
316571|NCT01796171|Phase II study|phase ii study
316572|NCT01796171|Betalutin|betalutin
316573|NCT01796158|adolescents|adolescents
316574|NCT01796158|alcohol abuse|alcohol abuse
316575|NCT01796158|drug abuse|drug abuse
316576|NCT01796158|substance use|substance use
316577|NCT01796132|Depression|depression
316578|NCT01796132|Lactation|lactation
316579|NCT01796132|Breastfeeding|breastfeeding
316580|NCT01796132|Pharmacokinetics|pharmacokinetics
316581|NCT01796132|Antidepressant|antidepressant
316582|NCT01796119|Dental implants, Ridge splitting, Ridge expansion|dental implants, ridge splitting, ridge expansion
316583|NCT01796106|caries infiltration|caries infiltration
316584|NCT01796106|caries progression|caries progression
316585|NCT01796106|Icon|icon
316586|NCT01796093|Digoxin|digoxin
316587|NCT01796093|Ivabradine|ivabradine
316588|NCT01796093|Cardiac failure|cardiac failure
316589|NCT01796093|Economics|economics
316590|NCT01796067|Motivational intervention|motivational intervention
316591|NCT01796067|Positive Parenting Intervention|positive parenting intervention
316592|NCT01796067|Obesity|obesity
316593|NCT01796067|Physical Activity|physical activity
316594|NCT01796067|Diet|diet
316595|NCT01796067|African American|african american
316596|NCT01796067|Adolescent|adolescent
316597|NCT01796054|Perceived stress|perceived stress
316598|NCT01796054|Burnout|burnout
316599|NCT01796054|Mindfulness|mindfulness
316600|NCT01796054|Intent to leave nursing|intent to leave nursing
316601|NCT01796028|Prostate Cancer|prostate cancer
316602|NCT01796015|paediatrics|paediatrics
316603|NCT01796015|optic nerve sheath diameter|optic nerve sheath diameter
316604|NCT01796015|ultrasound|ultrasound
316605|NCT01796002|PTCL|ptcl
316606|NCT01795989|Coil|coil
316607|NCT01795989|MRI|mri
316608|NCT01795989|safety|safety
316609|NCT01795989|efficacy|efficacy
316610|NCT01795989|musculoskeletal imaging|musculoskeletal imaging
316611|NCT01795989|Cincinnati|cincinnati
316612|NCT01795989|Safety and efficacy of a new elbow coil on pediatric patients and healthy participants|safety and efficacy of a new elbow coil on pediatric patients and healthy participants
316613|NCT01795976|Oesophageal cancer|oesophageal cancer
316614|NCT01795963|intimate partner violence|intimate partner violence
316615|NCT01795950|cell therapy|cell therapy
316616|NCT01795950|Pulmonary arterial hypertension|pulmonary arterial hypertension
316617|NCT01795898|Osteoarthritis|osteoarthritis
316618|NCT01795898|Low back pain|low back pain
316619|NCT01795898|Fentanyl transdermal patch|fentanyl transdermal patch
316620|NCT01795898|Durogesic-D-Trans|durogesic-d-trans
316621|NCT01795885|Pregnancy in Adolescence|pregnancy in adolescence
316623|NCT01795859|Huntington disease|huntington disease
316624|NCT01795859|Chorea|chorea
316625|NCT01795859|Tetrabenazine|tetrabenazine
316626|NCT01795846|allergen specific immunotherapy, house dust mite (Der p), monosensitization, polysensitization, allergic rhinitis, asthma,|allergen specific immunotherapy, house dust mite (der p), monosensitization, polysensitization, allergic rhinitis, asthma,
316627|NCT01795833|Prediabetes|prediabetes
316628|NCT01795833|Prediabetic State|prediabetic state
316629|NCT01795820|ticagrelor|ticagrelor
316630|NCT01795820|clopidogrel|clopidogrel
316631|NCT01795820|platelet aggregation|platelet aggregation
316632|NCT01795781|Anticoagulant measurement|anticoagulant measurement
316633|NCT01795781|Anticoagulant reversal|anticoagulant reversal
316634|NCT01795781|Dabigatran|dabigatran
316635|NCT01795781|Rivaroxaban|rivaroxaban
316636|NCT01795768|Non randomised|non randomised
316637|NCT01795768|Open label|open label
316638|NCT01795768|Multicentre|multicentre
316639|NCT01795768|Phase II biomarker study|phase ii biomarker study
316640|NCT01795755|Horse Assisted Therapy (HAT)|horse assisted therapy (hat)
316641|NCT01795755|Equine Assisted Psychotherapy (EAP)|equine assisted psychotherapy (eap)
316642|NCT01795755|clinical trial|clinical trial
316643|NCT01795755|Randomised Controlled Trial (RCT)|randomised controlled trial (rct)
316644|NCT01795755|psychotherapy|psychotherapy
316645|NCT01795742|Asthma|asthma
316646|NCT01795742|Nebulizers|nebulizers
316647|NCT01795742|Salbutamol|salbutamol
316648|NCT01795742|Developing Countries|developing countries
316649|NCT01795729|Heart transplant|heart transplant
316650|NCT01795729|Coronary artery disease|coronary artery disease
316651|NCT01795729|Allograft vascular disease|allograft vascular disease
316652|NCT01795729|Coronary stent|coronary stent
316653|NCT01795729|Optimal medical therapy|optimal medical therapy
316654|NCT01795729|Prognosis|prognosis
316655|NCT01795703|Prostate Cancer|prostate cancer
316656|NCT01795703|Abiraterone Acetate|abiraterone acetate
316657|NCT01795703|JNJ-212082|jnj-212082
316658|NCT01795690|Anemia|anemia
316659|NCT01795690|Cancer|cancer
316660|NCT01795690|Hemoglobin|hemoglobin
316661|NCT01795690|Quality of Life|quality of life
316662|NCT01795690|FACT-An|fact-an
316663|NCT01795690|FACT-GP|fact-gp
316664|NCT01795690|Erythropoiesis-Stimulating Agents (ESA)|erythropoiesis-stimulating agents (esa)
316665|NCT01795690|Epoetin|epoetin
316666|NCT01795690|Ferric Carboxymaltose|ferric carboxymaltose
316667|NCT01795690|Blood Transfusions|blood transfusions
316668|NCT01795677|JAK2 inhibitor RUXOLITINIB|jak2 inhibitor ruxolitinib
316669|NCT01795677|Primary or secondary myelofibrosis|primary or secondary myelofibrosis
316670|NCT01795664|Asthma|asthma
316671|NCT01795664|Salmeterol xinafoate and Fluticasone propionate|salmeterol xinafoate and fluticasone propionate
316672|NCT01795664|Seretide Evohaler|seretide evohaler
316673|NCT01795664|Functional Respiratory Imaging|functional respiratory imaging
316674|NCT01795664|Computational Fluid Dynamic|computational fluid dynamic
316675|NCT01795651|teaching|teaching
316676|NCT01795651|knowledge translation|knowledge translation
316677|NCT01795651|ICU|icu
316678|NCT01795651|postgraduate|postgraduate
316679|NCT01795651|lecture|lecture
316680|NCT01795638|anthropometrics|anthropometrics
316681|NCT01795638|weight|weight
316682|NCT01795638|nutrition|nutrition
316683|NCT01795586|breast - female|breast - female
316684|NCT01795586|advanced breast cancer|advanced breast cancer
316685|NCT01795586|histologically confirmed|histologically confirmed
316686|NCT01795586|cytologically confirmed|cytologically confirmed
316687|NCT01795586|metastatic|metastatic
316688|NCT01795586|locally advanced|locally advanced
316689|NCT01795586|unresectable|unresectable
316690|NCT01795573|GVHD|gvhd
316691|NCT01795573|AML|aml
316692|NCT01795573|ALL|all
316693|NCT01795573|MDS|mds
316694|NCT01795573|CLL|cll
316695|NCT01795573|NHL|nhl
316696|NCT01795573|HL|hl
316697|NCT01795573|MM|mm
316698|NCT01795560|Periappendicular abscess|periappendicular abscess
316699|NCT01795560|Ultrasound|ultrasound
316700|NCT01795521|NSCLC, SBRT, PET, Medically Inoperable|nsclc, sbrt, pet, medically inoperable
316701|NCT01795508|Parent training|parent training
316702|NCT01795508|Child behavior|child behavior
316703|NCT01795508|Randomized Controlled Trials|randomized controlled trials
316704|NCT01795495|Spinal Fusion|spinal fusion
316705|NCT01795495|Scoliosis|scoliosis
316706|NCT01795495|Methadone|methadone
316707|NCT01795495|Magnesium|magnesium
316708|NCT01795495|Adolescents|adolescents
316709|NCT01795495|Back Surgery|back surgery
316710|NCT01795482|perioperative hypothermia|perioperative hypothermia
316711|NCT01795482|prewarming|prewarming
316712|NCT01795482|preoperative warming|preoperative warming
316713|NCT01795482|general anaesthesia|general anaesthesia
316714|NCT01795482|epidural anaesthesia|epidural anaesthesia
316715|NCT01795482|temperature measurement|temperature measurement
316716|NCT01795469|POTS|pots
316717|NCT01795469|Orthostatic|orthostatic
316718|NCT01795469|Adolescent|adolescent
316719|NCT01795456|Takayasu's arteritis|takayasu's arteritis
316720|NCT01795456|Giant Cell arteritis|giant cell arteritis
316721|NCT01795456|Arteritis|arteritis
316722|NCT01795456|Vasculitis|vasculitis
316723|NCT01795456|Aortitis|aortitis
316724|NCT01795456|Disease Activity|disease activity
316725|NCT01795456|Carotidynia|carotidynia
316726|NCT01795456|Neovascularization|neovascularization
316727|NCT01795456|Carotid Intima Media Thickness|carotid intima media thickness
316728|NCT01795443|vibration|vibration
316729|NCT01795443|proprioception|proprioception
316730|NCT01795417|wrinkles|wrinkles
316731|NCT01795417|rhytids|rhytids
316732|NCT01795417|periorbital|periorbital
316733|NCT01795404|IBSR|ibsr
316734|NCT01795404|Cancer Survivors|cancer survivors
316735|NCT01795404|Katie Byron|katie byron
316736|NCT01795404|Quality of Life|quality of life
316737|NCT01795404|Stress|stress
316738|NCT01795404|Stress reduction|stress reduction
316739|NCT01795391|Prevention|prevention
316740|NCT01795391|Dressings|dressings
316741|NCT01795391|Catheters|catheters
316742|NCT01795378|acute myelogenous leukemia|acute myelogenous leukemia
316743|NCT01795378|acute lymphoblastic leukemia|acute lymphoblastic leukemia
316744|NCT01795378|donor natural killer cells|donor natural killer cells
316745|NCT01795378|HLA-haploidentical hematopoietic cell transplantation|hla-haploidentical hematopoietic cell transplantation
316746|NCT01795352|EGFR,|egfr,
316747|NCT01795352|lung cancer,|lung cancer,
316748|NCT01795352|mutated|mutated
316749|NCT01795339|AZD3293|azd3293
316750|NCT01795339|Healthy volunteers|healthy volunteers
316751|NCT01795339|Elderly volunteers|elderly volunteers
316752|NCT01795339|Alzheimer's Disease patients|alzheimer's disease patients
316753|NCT01795339|AD patients|ad patients
316754|NCT01795339|Phase 1|phase 1
316755|NCT01795339|Multiple Ascending Dose Study|multiple ascending dose study
316756|NCT01795326|Effectiveness of risk minimization|effectiveness of risk minimization
316757|NCT01795326|Metabolic monitoring|metabolic monitoring
316758|NCT01795326|Seroquel®|seroquel®
316759|NCT01795326|Seroquel® XR/quetiapine fumarate|seroquel® xr/quetiapine fumarate
316760|NCT01795287|tibial fracture|tibial fracture
316761|NCT01795287|intramedullary nailing|intramedullary nailing
316762|NCT01795287|spinal anesthesia|spinal anesthesia
316763|NCT01795287|patient safety|patient safety
316764|NCT01795261|HIV|hiv
316765|NCT01795248|gestational diabetes mellitus|gestational diabetes mellitus
316766|NCT01795248|incretin|incretin
316767|NCT01795248|glucose homeostasis|glucose homeostasis
316768|NCT01795248|GLP-1|glp-1
316769|NCT01795248|type 2 diabetes mellitus|type 2 diabetes mellitus
316770|NCT01795248|liraglutide|liraglutide
316771|NCT01795248|Victoza|victoza
316772|NCT01795235|men|men
316773|NCT01795222|conscious sedation|conscious sedation
316774|NCT01795222|stress psychological|stress psychological
316775|NCT01795222|dental care for children|dental care for children
316776|NCT01795222|child behavior|child behavior
316777|NCT01795222|saliva|saliva
316778|NCT01795209|Branch retinal vein occlusion|branch retinal vein occlusion
316779|NCT01795209|Macular edema|macular edema
316780|NCT01795209|Ranibizumab|ranibizumab
316781|NCT01795196|pediatric extubation failure|pediatric extubation failure
316782|NCT01795196|weaning|weaning
316783|NCT01795196|integrated pulmonary index|integrated pulmonary index
316784|NCT01795196|mechanical ventilation|mechanical ventilation
316785|NCT01795196|extubation readiness|extubation readiness
316786|NCT01795196|respiratory monitoring tool|respiratory monitoring tool
316787|NCT01795196|Endotracheal Extubation|endotracheal extubation
316788|NCT01795196|Pediatric Intensive Care Unit|pediatric intensive care unit
316789|NCT01795196|Rapid Shallow Breathing Index|rapid shallow breathing index
316790|NCT01795196|Physiologic Deadspace|physiologic deadspace
316791|NCT01795170|Pyridoxine Dependant Epilepsy|pyridoxine dependant epilepsy
316792|NCT01795170|Antiquitin Deficiency|antiquitin deficiency
316793|NCT01795170|Lysine Restricted Diet|lysine restricted diet
316794|NCT01795157|decision support systems, clinical|decision support systems, clinical
316795|NCT01795157|decision making, computer assisted|decision making, computer assisted
316796|NCT01795157|evidence based practice|evidence based practice
316797|NCT01795157|practice guidelines as topic|practice guidelines as topic
316798|NCT01795131|Nutritional anemia|nutritional anemia
316799|NCT01795131|Vitamin B12|vitamin b12
316800|NCT01795131|flu vaccine|flu vaccine
316801|NCT01795131|immunity|immunity
316802|NCT01795092|Cellulitis|cellulitis
316803|NCT01795092|Outpatient Medicine|outpatient medicine
316804|NCT01795079|transcranial stimulation|transcranial stimulation
316805|NCT01795079|direct current|direct current
316806|NCT01795053|ADHD preschoolers|adhd preschoolers
316807|NCT01795053|playtraining|playtraining
316808|NCT01795053|child-focused intervention|child-focused intervention
316809|NCT01795040|omega-3/omega-6 fatty acids|omega-3/omega-6 fatty acids
316810|NCT01795040|Pre-school children with ADHD symptoms|pre-school children with adhd symptoms
316811|NCT01795040|randomized controlled trial|randomized controlled trial
316812|NCT01795027|gastric cancer|gastric cancer
316813|NCT01795027|chemotherapy|chemotherapy
316814|NCT01795027|D2 resection|d2 resection
316815|NCT01795027|S-1|s-1
316816|NCT01795001|pathophysiology|pathophysiology
316817|NCT01794988|Acute Pain|acute pain
316818|NCT01794988|Low Back Pain|low back pain
316819|NCT01794988|Back Pain|back pain
316922|NCT01794637|Near infrared spectroscopy|near infrared spectroscopy
316820|NCT01794988|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
316821|NCT01794988|Cognitive Behavioral Therapy|cognitive behavioral therapy
316822|NCT01794988|Pain Education|pain education
316823|NCT01794975|PET|pet
316824|NCT01794975|striatum|striatum
316825|NCT01794975|receptor occupancy|receptor occupancy
316826|NCT01794975|noradrenaline|noradrenaline
316827|NCT01794975|alpha2c|alpha2c
316828|NCT01794962|Classification|classification
316829|NCT01794962|LBP|lbp
316830|NCT01794962|Cognitive functional therapy|cognitive functional therapy
316831|NCT01794962|Manual Therapy|manual therapy
316832|NCT01794949|Angioplasty|angioplasty
316833|NCT01794949|Atherosclerosis|atherosclerosis
316834|NCT01794949|Wound Healing|wound healing
316835|NCT01794936|Prostate cancer|prostate cancer
316836|NCT01794936|Nerve Sparing Prostatectomy|nerve sparing prostatectomy
316837|NCT01794936|VTI Probe|vti probe
316838|NCT01794923|Delayed onset muscle soreness|delayed onset muscle soreness
316839|NCT01794923|ibuprofen|ibuprofen
316840|NCT01794923|topical|topical
316841|NCT01794910|Pregnancy|pregnancy
316842|NCT01794910|Pelvic Floor|pelvic floor
316843|NCT01794910|Muscle strength|muscle strength
316844|NCT01794910|Exercise therapy|exercise therapy
316845|NCT01794910|natural childbirth|natural childbirth
316846|NCT01794910|cesarean section|cesarean section
316847|NCT01794910|physiotherapy|physiotherapy
316848|NCT01794884|Glutamine|glutamine
316849|NCT01794884|Cardiosurgery|cardiosurgery
316850|NCT01794884|Cardiopulmonary bypass|cardiopulmonary bypass
316851|NCT01794884|Cardiac function|cardiac function
316852|NCT01794884|Recovery|recovery
316853|NCT01794845|SCCHN|scchn
316854|NCT01794845|Head and Neck Cancer|head and neck cancer
316855|NCT01794845|Squamous Cell Carcinoma|squamous cell carcinoma
316856|NCT01794845|Recurrent|recurrent
316857|NCT01794832|HRQoL|hrqol
316858|NCT01794832|Aortic stenosis|aortic stenosis
316859|NCT01794832|Aortic valve surgery|aortic valve surgery
316860|NCT01794819|antibiotics|antibiotics
316861|NCT01794819|primary care|primary care
316862|NCT01794819|radiology/radiography|radiology/radiography
316863|NCT01794819|respiratory tract infections|respiratory tract infections
316864|NCT01794793|SOM230,|som230,
316865|NCT01794793|roll-over study|roll-over study
316866|NCT01794793|pasireotide LAR|pasireotide lar
316867|NCT01794793|Cushing's disease|cushing's disease
316868|NCT01794793|Acromegaly|acromegaly
316869|NCT01794793|neuroendocrine tumorsNETs|neuroendocrine tumorsnets
316870|NCT01794793|pituitary tumors|pituitary tumors
316871|NCT01794793|Ectopic ACTH secreting|ectopic acth secreting
316872|NCT01794793|EAS|eas
316873|NCT01794793|Dumping Syndrome|dumping syndrome
316996|NCT01794299|Immune reconstitution|immune reconstitution
316874|NCT01794793|metastatic prostate cancer, metastatic melanoma|metastatic prostate cancer, metastatic melanoma
316876|NCT01794793|nRAS|nras
316877|NCT01794767|peripheral venous catheter, children.|peripheral venous catheter, children.
316878|NCT01794754|Hand osteoarthritis|hand osteoarthritis
316879|NCT01794754|CMC1-joint|cmc1-joint
316880|NCT01794754|surgery|surgery
316881|NCT01794754|occupational therapy|occupational therapy
316882|NCT01794754|hand exercises|hand exercises
316883|NCT01794754|assistive devices|assistive devices
316884|NCT01794754|orthoses|orthoses
316885|NCT01794728|Pain Management|pain management
316886|NCT01794715|Heart failure|heart failure
316887|NCT01794715|Nurse led|nurse led
316888|NCT01794715|Outpatient clinic|outpatient clinic
316889|NCT01794715|Echocardiography|echocardiography
316890|NCT01794715|Pocket-size|pocket-size
316891|NCT01794715|Ultrasound|ultrasound
316892|NCT01794702|Leukemia|leukemia
316893|NCT01794702|Acute Leukemia|acute leukemia
316894|NCT01794702|Acute myelogenous leukemia|acute myelogenous leukemia
316895|NCT01794702|AML|aml
316896|NCT01794702|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
316897|NCT01794702|ALL|all
316898|NCT01794702|Maximum Tolerated Dose|maximum tolerated dose
316899|NCT01794702|MTD|mtd
316900|NCT01794702|Response Rate|response rate
316901|NCT01794702|Decitabine|decitabine
316902|NCT01794702|Dacogen|dacogen
316903|NCT01794702|Idarubicin|idarubicin
316904|NCT01794702|Idamycin|idamycin
316905|NCT01794702|Cytarabine|cytarabine
316906|NCT01794702|Ara-C|ara-c
316907|NCT01794702|Cytosar|cytosar
316908|NCT01794702|DepoCyt|depocyt
316909|NCT01794702|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
316910|NCT01794676|Pancreatic cancer|pancreatic cancer
316911|NCT01794676|Thymic cancer|thymic cancer
316912|NCT01794676|Parathyroid disease|parathyroid disease
316913|NCT01794676|MEN1 syndrome|men1 syndrome
316914|NCT01794676|Genomic DNA|genomic dna
316915|NCT01794676|MEN1 gene sequence|men1 gene sequence
316916|NCT01794663|Early kidney graft dysfunction|early kidney graft dysfunction
316917|NCT01794663|renal transplantation|renal transplantation
316918|NCT01794650|T1DM, Exercise, Hypoglycaemia|t1dm, exercise, hypoglycaemia
316919|NCT01794637|End stage liver disease|end stage liver disease
316920|NCT01794637|Peripheral microcirculatory dysfunction|peripheral microcirculatory dysfunction
316921|NCT01794637|Liver transplantation|liver transplantation
316923|NCT01794624|TMD|tmd
316924|NCT01794624|TMJD|tmjd
316925|NCT01794624|Temporomandibular Joint Disorders|temporomandibular joint disorders
316926|NCT01794624|Sleep Continuity Disturbance|sleep continuity disturbance
316927|NCT01794624|Pain Catastrophizing|pain catastrophizing
316928|NCT01794624|Cognitive Therapy|cognitive therapy
316929|NCT01794624|Behavioral Therapy|behavioral therapy
316930|NCT01794598|Heart failure|heart failure
316931|NCT01794598|depression|depression
316932|NCT01794598|depression care education|depression care education
316933|NCT01794585|traumatic brain injury|traumatic brain injury
316934|NCT01794585|balance deficits|balance deficits
316935|NCT01794585|virtual reality|virtual reality
316936|NCT01794585|home-based therapy|home-based therapy
316937|NCT01794572|Multiple Myeloma|multiple myeloma
316938|NCT01794572|Relapse|relapse
316939|NCT01794572|Complete Remission|complete remission
316940|NCT01794572|Very Good Partial Remission|very good partial remission
316941|NCT01794559|Depression, EEG, QEEG, mTBI, PTSD, efficiency, safety, suicidality|depression, eeg, qeeg, mtbi, ptsd, efficiency, safety, suicidality
316942|NCT01794546|pediatric obesity|pediatric obesity
316943|NCT01794546|telehealth|telehealth
316944|NCT01794533|Irreversible Pulpitis|irreversible pulpitis
316945|NCT01794533|Infiltration injection|infiltration injection
316946|NCT01794533|Fentanyl|fentanyl
316947|NCT01794533|Lidocaine|lidocaine
316948|NCT01794520|relapsed/refractory multiple myeloma|relapsed/refractory multiple myeloma
316949|NCT01794520|multiple myeloma|multiple myeloma
316950|NCT01794520|refractory multiple myeloma|refractory multiple myeloma
316951|NCT01794520|relapsed multiple myeloma|relapsed multiple myeloma
316952|NCT01794507|relapsed/refractory multiple myeloma|relapsed/refractory multiple myeloma
316953|NCT01794507|relapsed multiple myeloma|relapsed multiple myeloma
316954|NCT01794507|refractory multiple myeloma|refractory multiple myeloma
316955|NCT01794507|multiple myeloma|multiple myeloma
316956|NCT01794494|Peripheal arterial disease|peripheal arterial disease
316957|NCT01794494|Critical limb ischemia|critical limb ischemia
316958|NCT01794494|Bypass surgery|bypass surgery
316959|NCT01794494|Subintimal angioplasty|subintimal angioplasty
316960|NCT01794494|Health related cost|health related cost
316961|NCT01794468|Dermal blood flow|dermal blood flow
316962|NCT01794468|critically ill|critically ill
316963|NCT01794455|Depression|depression
316964|NCT01794455|Depressive Disorder|depressive disorder
316965|NCT01794455|Geriatrics|geriatrics
316966|NCT01794455|Hypertension|hypertension
316967|NCT01794429|Obesity|obesity
316968|NCT01794429|The Metabolic Syndrome/disturbances|the metabolic syndrome/disturbances
316969|NCT01794429|Drug-induced adipositas|drug-induced adipositas
316970|NCT01794429|Schizophrenia|schizophrenia
316971|NCT01794429|GLP-1 analogue|glp-1 analogue
316972|NCT01794429|cerebral effects|cerebral effects
316973|NCT01794403|Prostate Cancer|prostate cancer
316974|NCT01794403|Prostate|prostate
316975|NCT01794403|Radiation Therapy|radiation therapy
316976|NCT01794403|Hypofractionation Radiotherapy|hypofractionation radiotherapy
316977|NCT01794403|Extended Hypofractionation Radiotherapy|extended hypofractionation radiotherapy
316978|NCT01794403|Accelerated Hypofractionation Radiotherapy|accelerated hypofractionation radiotherapy
316979|NCT01794403|AHRT|ahrt
316980|NCT01794403|EHRT|ehrt
316981|NCT01794390|COPD (Chronic Obstructive Pulmonary Disease)|copd (chronic obstructive pulmonary disease)
316982|NCT01794390|Asthma|asthma
316983|NCT01794390|Pulmojet|pulmojet
316984|NCT01794390|Inhalers|inhalers
316985|NCT01794390|Respiratory|respiratory
316986|NCT01794390|Inhaler Technique|inhaler technique
316987|NCT01794390|Critical Errors|critical errors
316988|NCT01794377|Obesity|obesity
316989|NCT01794364|T2DM|t2dm
316990|NCT01794364|Diabetes Mellitus Type 2|diabetes mellitus type 2
316991|NCT01794325|Occupational radiation exposure|occupational radiation exposure
316992|NCT01794325|Transradial approach|transradial approach
316993|NCT01794325|Transfemoral approach|transfemoral approach
316994|NCT01794299|Haploidentical stem cell transplantation|haploidentical stem cell transplantation
316995|NCT01794299|Graft-versus-host disease|graft-versus-host disease
316997|NCT01794299|Alloreactive T-cells|alloreactive t-cells
316998|NCT01794299|Photodepletion|photodepletion
316999|NCT01794299|Photodynamic treatment|photodynamic treatment
317000|NCT01794299|TH9402|th9402
317001|NCT01794299|Transplant-related mortality|transplant-related mortality
317002|NCT01794299|Hematologic malignancy|hematologic malignancy
317003|NCT01794273|Ephedrine|ephedrine
317004|NCT01794273|Phenylephrine|phenylephrine
317005|NCT01794273|Vasopressor|vasopressor
317006|NCT01794273|Carotid surgery|carotid surgery
317007|NCT01794273|Hypotension|hypotension
317008|NCT01794273|Haemodynamics|haemodynamics
317009|NCT01794273|Brain ischemia|brain ischemia
317010|NCT01794273|Tissue perfusion|tissue perfusion
317011|NCT01794273|Stroke|stroke
317012|NCT01794273|anaesthesia;|anaesthesia;
317013|NCT01794260|Osteoarthritis|osteoarthritis
317014|NCT01794260|Moderate ot severe pain|moderate ot severe pain
317015|NCT01794260|ZINGIBER CASSUMUNAR ROXB|zingiber cassumunar roxb
317016|NCT01794221|circumcision|circumcision
317017|NCT01794221|2 octyl cyanoacrylate|2 octyl cyanoacrylate
317018|NCT01794221|phimosis|phimosis
317019|NCT01794208|in-vitro fertilization|in-vitro fertilization
317020|NCT01794208|reproductive disorder|reproductive disorder
317021|NCT01794195|Parkinson's disease|parkinson's disease
317022|NCT01794195|Apathy|apathy
317023|NCT01794195|diffusion tensor imaging|diffusion tensor imaging
317024|NCT01794195|tractography|tractography
317025|NCT01794156|Inference-based therapy|inference-based therapy
317026|NCT01794156|Cognitive behavior therapy|cognitive behavior therapy
317027|NCT01794156|Obsessive compulsive disorder|obsessive compulsive disorder
317028|NCT01794156|Randomized clinical trial|randomized clinical trial
317029|NCT01794143|Treatment of Type 2 diabetes|treatment of type 2 diabetes
317030|NCT01794143|Comparative effectiveness research|comparative effectiveness research
317031|NCT01794143|Clinical trial|clinical trial
317032|NCT01794143|Patient-centered outcomes|patient-centered outcomes
317033|NCT01794117|Anakinra|anakinra
317034|NCT01794117|Pustular Psoriasis|pustular psoriasis
317035|NCT01794117|Palmoplantar Pustulosis|palmoplantar pustulosis
317036|NCT01794117|DITRA|ditra
317037|NCT01794117|Subcorneal Pustular Dermatosis|subcorneal pustular dermatosis
317038|NCT01794104|Topoisomerase Inhibitor|topoisomerase inhibitor
317039|NCT01794104|Advanced Malignancies|advanced malignancies
317040|NCT01794104|Pharmacodynamics|pharmacodynamics
317041|NCT01794104|DNA Damage|dna damage
317042|NCT01794104|Pharmacokinetics|pharmacokinetics
317043|NCT01794091|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
317044|NCT01794091|Diabetes|diabetes
317045|NCT01794078|Acute Mountain Sickness|acute mountain sickness
317046|NCT01794078|High altitude induced fatigue|high altitude induced fatigue
317047|NCT01794026|diffusion weighted|diffusion weighted
317048|NCT01794026|magnetic resonance imaging|magnetic resonance imaging
317049|NCT01794026|surgery|surgery
317050|NCT01794026|histopathology|histopathology
317051|NCT01794013|Parent training|parent training
317052|NCT01794013|DIR/ Floortime Approach|dir/ floortime approach
317053|NCT01794013|Children with developmental disabilities|children with developmental disabilities
317054|NCT01793987|blood loss between two groups|blood loss between two groups
317055|NCT01793974|LADA|lada
317056|NCT01793974|Latent Autoimmune Diabetes in Adults|latent autoimmune diabetes in adults
317057|NCT01793974|Latent Autoimmune Diabetes|latent autoimmune diabetes
317058|NCT01793974|Latent Diabetes in Adults|latent diabetes in adults
317059|NCT01793935|Schizophrenia|schizophrenia
317060|NCT01793935|Sensoril|sensoril
317061|NCT01793935|Withania Somnifera extract|withania somnifera extract
317062|NCT01793935|Total/ Positive / Negative Symptoms|total/ positive / negative symptoms
317063|NCT01793935|Stress|stress
317064|NCT01793935|Inflammation|inflammation
317065|NCT01793935|Immunomodulation|immunomodulation
317066|NCT01793909|Type 2 Diabetes|type 2 diabetes
317067|NCT01793909|Exercise Impairment|exercise impairment
317068|NCT01793909|Blood Flow|blood flow
317069|NCT01793909|Muscle Oxygen Uptake|muscle oxygen uptake
317070|NCT01793909|Exercise Training|exercise training
317071|NCT01793896|Metabolic syndrome|metabolic syndrome
317072|NCT01793896|Ageing|ageing
317073|NCT01793896|Mitochondrial density|mitochondrial density
317074|NCT01793896|Oxidative damage|oxidative damage
317075|NCT01793896|Inflammatory mediators|inflammatory mediators
317076|NCT01793896|AMPK|ampk
317077|NCT01793896|Adipogenesis|adipogenesis
317078|NCT01793883|Influenza Laninamivir Octanoate|influenza laninamivir octanoate
317079|NCT01793870|pharmacokinetic|pharmacokinetic
317080|NCT01793870|carvedilol|carvedilol
317081|NCT01793870|Stable isotope technique|stable isotope technique
317082|NCT01793857|Primary caregiver|primary caregiver
317083|NCT01793857|Survey|survey
317084|NCT01793857|Acute Otitis Media|acute otitis media
317085|NCT01793857|Ear infection|ear infection
317086|NCT01793857|Panama|panama
317087|NCT01793857|Healthcare seeking behaviour|healthcare seeking behaviour
317088|NCT01793844|diffuse large B cell lymphoma|diffuse large b cell lymphoma
317089|NCT01793844|DFS|dfs
317090|NCT01793844|OS|os
317091|NCT01793831|Crohn's diseases|crohn's diseases
317092|NCT01793831|Inflammatory bowel disease|inflammatory bowel disease
317093|NCT01793831|Fecal transplantation|fecal transplantation
317094|NCT01793831|Fecal bacteriotherapy|fecal bacteriotherapy
317095|NCT01793831|Fecal microbiota transplantation|fecal microbiota transplantation
317096|NCT01793818|Vaccine|vaccine
317097|NCT01793818|HIV-1|hiv-1
317098|NCT01793818|Tat|tat
317099|NCT01793792|intracranial, saccular, aneurysms, stenting, coiling|intracranial, saccular, aneurysms, stenting, coiling
317100|NCT01793740|sickle cell disease|sickle cell disease
317101|NCT01793740|pediatric|pediatric
317102|NCT01793740|learning disability|learning disability
317103|NCT01793740|cognitive impairment|cognitive impairment
317104|NCT01793740|memory|memory
317105|NCT01793740|attention|attention
317106|NCT01793740|Children with sickle cell disease|children with sickle cell disease
317107|NCT01793727|infants|infants
317108|NCT01793727|general anesthesia|general anesthesia
317109|NCT01793727|tracheal intubation|tracheal intubation
317110|NCT01793714|Magnetic Resonance Imaging|magnetic resonance imaging
317111|NCT01793701|Cervical Cancer, Intensity-modulated radiotherapy|cervical cancer, intensity-modulated radiotherapy
317112|NCT01793688|UNASYN-S|unasyn-s
317113|NCT01793688|High Dose|high dose
317114|NCT01793662|Aortobifemoral bypass|aortobifemoral bypass
317115|NCT01793662|Laparoscopic aortic surgery|laparoscopic aortic surgery
317116|NCT01793662|Aortoiliac occlusive disease|aortoiliac occlusive disease
317117|NCT01793662|TASC Type D Lesions|tasc type d lesions
317118|NCT01793662|Open aortic surgery|open aortic surgery
317119|NCT01793649|Respiratory health|respiratory health
317120|NCT01793649|Cystic Fibrosis|cystic fibrosis
317121|NCT01793649|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
317122|NCT01793623|atrial fibrillation|atrial fibrillation
317123|NCT01793623|genetics|genetics
317124|NCT01793623|cardiac arrhythmias|cardiac arrhythmias
317125|NCT01793623|heart disease|heart disease
317126|NCT01793610|MDMA|mdma
317127|NCT01793610|Posttraumatic stress disorder|posttraumatic stress disorder
317128|NCT01793610|sleep|sleep
317129|NCT01793610|Depression|depression
317130|NCT01793610|Safety|safety
317131|NCT01793597|ticagrelor|ticagrelor
317132|NCT01793597|Coronary artery bypass surgery|coronary artery bypass surgery
317133|NCT01793597|platelet function|platelet function
317134|NCT01793597|receptor binding|receptor binding
317135|NCT01793597|platelet reactivity|platelet reactivity
317136|NCT01793597|reversible binding|reversible binding
317137|NCT01793584|Comparative effectiveness|comparative effectiveness
317138|NCT01793584|Surgical success|surgical success
317139|NCT01793571|Abdominal Muscles/Ultrasonography|abdominal muscles/ultrasonography
317140|NCT01793571|Adult|adult
317141|NCT01793571|Ambulatory Surgical Procedures|ambulatory surgical procedures
317142|NCT01793571|Anesthetics, Local/Administration & Dosage|anesthetics, local/administration & dosage
317143|NCT01793571|Levobupivacaine/Administration & Dosage|levobupivacaine/administration & dosage
317144|NCT01793571|Levobupivacaine/Analogs & Derivatives|levobupivacaine/analogs & derivatives
317145|NCT01793571|Hernia, Inguinal/Surgery|hernia, inguinal/surgery
317146|NCT01793571|Humans|humans
317147|NCT01793571|Nerve Block/Methods|nerve block/methods
317148|NCT01793571|Pain Measurement/Methods|pain measurement/methods
317149|NCT01793571|Pain, Postoperative/Prevention & Control|pain, postoperative/prevention & control
317150|NCT01793571|Ultrasonography, Interventional|ultrasonography, interventional
317151|NCT01793558|Thermoregulation Impairment|thermoregulation impairment
317152|NCT01793558|hypothermia|hypothermia
317153|NCT01793558|Postoperative shivering|postoperative shivering
317154|NCT01793558|cesarean section|cesarean section
317155|NCT01793558|newborn|newborn
317156|NCT01793545|Endometrial Cancer|endometrial cancer
317157|NCT01793545|Gynecological Cancers|gynecological cancers
317158|NCT01793545|Screening|screening
317159|NCT01793532|PET Imaging|pet imaging
317160|NCT01793532|Epilepsy|epilepsy
317161|NCT01793532|Inflammation|inflammation
317162|NCT01793532|Brain Imaging|brain imaging
317163|NCT01793519|Rheumatoid Arthritis|rheumatoid arthritis
317164|NCT01793519|Autoimmune Diseases|autoimmune diseases
317165|NCT01793519|Anti-TNF|anti-tnf
317166|NCT01793506|immunodeficiency|immunodeficiency
317167|NCT01793493|Mild Cognitive Impairment|mild cognitive impairment
317168|NCT01793493|Cognitive Stimulation|cognitive stimulation
317169|NCT01793493|Aging|aging
317170|NCT01793493|Elderly|elderly
317171|NCT01793493|Randomized Controlled Trial|randomized controlled trial
317172|NCT01793480|Methadone in cancer pain|methadone in cancer pain
317173|NCT01793428|adults admitted in vital emergency unit|adults admitted in vital emergency unit
317174|NCT01793389|gingival recession|gingival recession
317175|NCT01793389|fibrin|fibrin
317176|NCT01793389|connective tissue|connective tissue
317177|NCT01793389|root coverage|root coverage
317178|NCT01793389|microsurgery|microsurgery
317179|NCT01793389|case-control studies|case-control studies
317180|NCT01793363|Tracheotomy|tracheotomy
317181|NCT01793363|Weaning from mechanical ventilation|weaning from mechanical ventilation
317182|NCT01793363|Lung ultrasound score|lung ultrasound score
317183|NCT01793350|Diabetes|diabetes
317184|NCT01793350|Mellitus|mellitus
317185|NCT01793350|Painful|painful
317186|NCT01793350|Neuropathy|neuropathy
317187|NCT01793350|Peripheral|peripheral
317188|NCT01793324|Effectiveness of risk minimization|effectiveness of risk minimization
317189|NCT01793324|Metabolic monitoring|metabolic monitoring
317190|NCT01793324|Seroquel® or Seroquel® XR/quetiapine fumarate|seroquel® or seroquel® xr/quetiapine fumarate
317191|NCT01793311|intraocular pressure|intraocular pressure
317192|NCT01793311|caffeine|caffeine
317193|NCT01793311|dosage|dosage
317194|NCT01793246|lung cancer|lung cancer
317195|NCT01793246|lung neoplasms|lung neoplasms
317196|NCT01793246|lung transplant|lung transplant
317197|NCT01793194|venous insufficiency|venous insufficiency
317198|NCT01793194|varicose veins|varicose veins
317199|NCT01793194|pregnancy|pregnancy
317200|NCT01793194|DVT|dvt
317201|NCT01793194|superficial thrombophlebitis|superficial thrombophlebitis
317202|NCT01793181|Vitamin d deficiency|vitamin d deficiency
317203|NCT01793181|Central retinal vein occlusion|central retinal vein occlusion
317204|NCT01793168|Rare Diseases|rare diseases
317205|NCT01793168|Neglected Diseases|neglected diseases
317206|NCT01793168|Orphan Diseases|orphan diseases
317207|NCT01793168|Rare Disease Research|rare disease research
317208|NCT01793168|Registries|registries
317209|NCT01793168|WAGR Syndrome|wagr syndrome
317210|NCT01793168|Ataxia|ataxia
317211|NCT01793168|Cornelia de Lange Syndrome|cornelia de lange syndrome
317212|NCT01793168|Stickler Syndrome|stickler syndrome
317213|NCT01793168|Ataxia Telangiectasia|ataxia telangiectasia
317214|NCT01793168|Kawasaki Disease|kawasaki disease
317215|NCT01793168|Batten Disease|batten disease
317216|NCT01793168|Mucolipidosis IV|mucolipidosis iv
317217|NCT01793168|Klippel-Feil Syndrome|klippel-feil syndrome
317218|NCT01793168|Multiple Endocrine Neoplasia|multiple endocrine neoplasia
317219|NCT01793168|Atypical Hemolytic Uremic Syndrome|atypical hemolytic uremic syndrome
317220|NCT01793168|Undiagnosed|undiagnosed
317221|NCT01793168|Uncommon Disease|uncommon disease
317222|NCT01793168|Kabuki Syndrome|kabuki syndrome
317223|NCT01793168|Hypersomnia|hypersomnia
317224|NCT01793168|Hyperacusis|hyperacusis
317225|NCT01793168|Kleine-Levin Syndrome|kleine-levin syndrome
317226|NCT01793168|Marinesco-Sjogren Syndrome|marinesco-sjogren syndrome
317227|NCT01793168|Leiomyosarcoma|leiomyosarcoma
317228|NCT01793168|4p-/Wolf-Hirschhorn Syndrome|4p-/wolf-hirschhorn syndrome
317229|NCT01793168|Hypophosphatasia|hypophosphatasia
317230|NCT01793168|Narcolepsy|narcolepsy
317231|NCT01793168|Wiedermann-Steiner Syndrome|wiedermann-steiner syndrome
317232|NCT01793168|Breast Implant-Associated Anaplastic Large Cell Lymphoma|breast implant-associated anaplastic large cell lymphoma
317233|NCT01793168|Autoimmune/inflammatory Syndrome Induced by Adjuvants (ASIA)|autoimmune/inflammatory syndrome induced by adjuvants (asia)
317234|NCT01793168|Hemophagocytic Lymphohistiocytosis (HLH)|hemophagocytic lymphohistiocytosis (hlh)
317235|NCT01793168|Behcet's Disease|behcet's disease
317236|NCT01793155|Lung cancer surgery|lung cancer surgery
317237|NCT01793155|Inspiratory muscle training|inspiratory muscle training
317238|NCT01793155|Postoperative pulmonary complications|postoperative pulmonary complications
317239|NCT01793155|Functional outcomes|functional outcomes
317240|NCT01793155|Health related quality of life|health related quality of life
317241|NCT01793142|Osteoporosis|osteoporosis
317242|NCT01793142|postmenopausal|postmenopausal
317243|NCT01793142|SERM|serm
317244|NCT01793129|NICHD Neonatal Research Network|nichd neonatal research network
317245|NCT01793129|Hypoxic-ischemic encephalopathy (HIE)|hypoxic-ischemic encephalopathy (hie)
317246|NCT01793129|Hypothermia|hypothermia
317247|NCT01793129|Neonatal depression|neonatal depression
317248|NCT01793129|Perinatal asphyxia|perinatal asphyxia
317249|NCT01793116|NICHD Neonatal Research Network|nichd neonatal research network
317250|NCT01793116|Moderately Preterm|moderately preterm
317251|NCT01793090|Cobalamin C defect|cobalamin c defect
317252|NCT01793090|methylmalonic aciduria with homocystinuria|methylmalonic aciduria with homocystinuria
317253|NCT01793090|Visual function|visual function
317254|NCT01793090|VEP|vep
317255|NCT01793090|ERG|erg
317256|NCT01793090|antioxidant drugs|antioxidant drugs
317257|NCT01793077|Prostate Cancer|prostate cancer
317258|NCT01793077|Phase 4|phase 4
317259|NCT01793077|Data collection|data collection
317260|NCT01793077|Observational|observational
317261|NCT01793077|Depo-Eligard|depo-eligard
317262|NCT01793077|Prospective|prospective
317263|NCT01793077|Non-interventional|non-interventional
317264|NCT01793077|Treatment|treatment
317265|NCT01793064|Pedometer,|pedometer,
317266|NCT01793064|adaptive,|adaptive,
317267|NCT01793064|exercise,|exercise,
317268|NCT01793064|reinforcement,|reinforcement,
317269|NCT01793064|goal setting,|goal setting,
317270|NCT01793064|technology,|technology,
317271|NCT01793064|email,|email,
317272|NCT01793064|weight loss|weight loss
317273|NCT01793064|mHealth|mhealth
317274|NCT01793064|eHealth|ehealth
317275|NCT01793051|Myeloma|myeloma
317276|NCT01793051|Multiple Myeloma|multiple myeloma
317277|NCT01793051|MM|mm
317278|NCT01793051|Symptom Burden|symptom burden
317279|NCT01793051|Symptom reduction|symptom reduction
317280|NCT01793051|Maintenance therapy with lenalidomide|maintenance therapy with lenalidomide
317281|NCT01793051|Minocycline|minocycline
317282|NCT01793051|Dynacin|dynacin
317283|NCT01793051|Minocin|minocin
317284|NCT01793051|Minocin PAC|minocin pac
317285|NCT01793051|Myrac|myrac
317286|NCT01793051|Solodyn|solodyn
317287|NCT01793051|Placebo|placebo
317288|NCT01793051|Sugar pill|sugar pill
317289|NCT01793051|MD Anderson Symptom Inventory|md anderson symptom inventory
317290|NCT01793051|MDASI|mdasi
317291|NCT01793051|Questionnaires|questionnaires
317292|NCT01793051|Surveys|surveys
317293|NCT01793038|PCOS|pcos
317294|NCT01793038|clomiphene citrate resistant PCOS|clomiphene citrate resistant pcos
317295|NCT01793038|Aromatase inhibitors|aromatase inhibitors
317296|NCT01793025|leukemia|leukemia
317297|NCT01793025|myeloid|myeloid
317298|NCT01793025|acute|acute
317299|NCT01793025|acute myeloid leukemia|acute myeloid leukemia
317300|NCT01793025|allogeneic|allogeneic
317301|NCT01793025|transient chimerism|transient chimerism
317302|NCT01793025|cell therapy|cell therapy
317303|NCT01793025|immunotherapy|immunotherapy
317304|NCT01793012|therapeutic drug monitoring|therapeutic drug monitoring
317305|NCT01793012|antibiotics|antibiotics
317306|NCT01793012|inflammation parameters|inflammation parameters
317504|NCT01791946|cross eyed|cross eyed
317307|NCT01793012|critically ill patients|critically ill patients
317308|NCT01793012|septicaemia|septicaemia
317309|NCT01793012|intensive care unit|intensive care unit
317310|NCT01792999|Breast CT|breast ct
317311|NCT01792986|Diabetes|diabetes
317312|NCT01792986|Fasting|fasting
317313|NCT01792986|Pre-diabetes|pre-diabetes
317314|NCT01792986|Hemoglobin A1C|hemoglobin a1c
317315|NCT01792973|HIV|hiv
317316|NCT01792973|HPV|hpv
317317|NCT01792973|Women|women
317318|NCT01792973|Thailand|thailand
317319|NCT01792973|Antiretrovirals|antiretrovirals
317320|NCT01792973|Cervical cancer|cervical cancer
317321|NCT01792934|Debulking, cytoreduction, RFA, SABR, palliative chemotherapy|debulking, cytoreduction, rfa, sabr, palliative chemotherapy
317322|NCT01792921|Age 7-10 years old|age 7-10 years old
317323|NCT01792921|regular education system|regular education system
317324|NCT01792921|no moderate or severe neurological and/or psychiatric disorders|no moderate or severe neurological and/or psychiatric disorders
317325|NCT01792908|ankle lateral ligament|ankle lateral ligament
317326|NCT01792908|athletic tape|athletic tape
317327|NCT01792908|position sense|position sense
317328|NCT01792908|Proprioception|proprioception
317329|NCT01792895|Posterior Neck Pain|posterior neck pain
317330|NCT01792895|Cervical spine pain|cervical spine pain
317331|NCT01792895|Manual therapy|manual therapy
317332|NCT01792856|coaching|coaching
317333|NCT01792856|early psychosis|early psychosis
317334|NCT01792856|schizophrenia|schizophrenia
317335|NCT01792830|Coronary Artery Bypass Graft surgery|coronary artery bypass graft surgery
317336|NCT01792817|Cluster Headache|cluster headache
317337|NCT01792817|GammaCore|gammacore
317338|NCT01792817|vagal nerve stimulation|vagal nerve stimulation
317339|NCT01792817|nVNS|nvns
317340|NCT01792817|VNS|vns
317341|NCT01792817|non invasive|non invasive
317342|NCT01792817|vagus nerve stimulation|vagus nerve stimulation
317343|NCT01792804|Staphylococcus aureus|staphylococcus aureus
317344|NCT01792804|Bloodstream infection|bloodstream infection
317345|NCT01792804|Oral switch|oral switch
317346|NCT01792778|IV Catheters|iv catheters
317347|NCT01792778|Blood control|blood control
317348|NCT01792765|urolithiasis|urolithiasis
317349|NCT01792765|radiation free|radiation free
317350|NCT01792765|ultrasound guidance|ultrasound guidance
317351|NCT01792765|ureteroscopy|ureteroscopy
317352|NCT01792752|HIV/AIDS|hiv/aids
317353|NCT01792752|Drug Users|drug users
317354|NCT01792752|Puerto Rico|puerto rico
317355|NCT01792739|Probiotics|probiotics
317356|NCT01792739|Diarrhea|diarrhea
317357|NCT01792739|Intentive care units|intentive care units
317358|NCT01792726|breast cancer|breast cancer
317359|NCT01792726|radiotherapy|radiotherapy
317360|NCT01792726|TARGIT|targit
317361|NCT01792726|Intrabeam|intrabeam
317362|NCT01792713|Skin alterations|skin alterations
317363|NCT01792713|Atopic Dermatitis|atopic dermatitis
317364|NCT01792687|Metastatic castrate resistant prostate cancer (CRPC)|metastatic castrate resistant prostate cancer (crpc)
317365|NCT01792674|Education|education
317366|NCT01792674|Patient simulation|patient simulation
317367|NCT01792674|In situ simulation|in situ simulation
317368|NCT01792674|Stress|stress
317369|NCT01792661|Chronic Kidney Disease|chronic kidney disease
317370|NCT01792661|Electronic Health Record|electronic health record
317371|NCT01792661|Personal Health Record|personal health record
317372|NCT01792661|Chronic Kidney Disease registry|chronic kidney disease registry
317373|NCT01792661|Glomerular Filtration Rate|glomerular filtration rate
317374|NCT01792661|Patient Navigator|patient navigator
317375|NCT01792648|Almond|almond
317376|NCT01792648|Carbohydrate|carbohydrate
317377|NCT01792648|Diet|diet
317378|NCT01792648|Cholesterol|cholesterol
317379|NCT01792635|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
317380|NCT01792635|Pharmacodynamics|pharmacodynamics
317381|NCT01792635|Safety & Tolerability|safety & tolerability
317382|NCT01792622|Instrument Development|instrument development
317383|NCT01792622|Patient Reported Outcomes|patient reported outcomes
317384|NCT01792622|Pulmonary Arterial Hypertension.|pulmonary arterial hypertension.
317385|NCT01792609|Scoliosis|scoliosis
317386|NCT01792609|Cobb Angle|cobb angle
317387|NCT01792609|Screw Density|screw density
317388|NCT01792609|Outcomes Measures|outcomes measures
317389|NCT01792583|pregnancy|pregnancy
317390|NCT01792570|HIV-1|hiv-1
317391|NCT01792570|darunavir|darunavir
317392|NCT01792570|rilpivirine|rilpivirine
317393|NCT01792570|strategic study|strategic study
317394|NCT01792557|Pilonidal sinus|pilonidal sinus
317395|NCT01792557|Crystallized phenol|crystallized phenol
317396|NCT01792557|Limberg Flap|limberg flap
317397|NCT01792557|Modified Limberg Flap|modified limberg flap
317398|NCT01792557|Karydakis|karydakis
317399|NCT01792557|Recurrence|recurrence
317400|NCT01792557|Complications|complications
317401|NCT01792557|Recovery duration|recovery duration
317402|NCT01792557|Time to return to work|time to return to work
317403|NCT01792531|children|children
317404|NCT01792531|obesity|obesity
317405|NCT01792531|treatment|treatment
317406|NCT01792531|family|family
317407|NCT01792492|Thyroid Neoplasms|thyroid neoplasms
317505|NCT01791933|LBP|lbp
317408|NCT01792492|Optical Devices|optical devices
317409|NCT01792492|Spectrum Analysis|spectrum analysis
317410|NCT01792492|Thyroid diseases|thyroid diseases
317411|NCT01792479|NSCLC|nsclc
317412|NCT01792479|lung cancer|lung cancer
317413|NCT01792466|difficult biliary cannulation|difficult biliary cannulation
317414|NCT01792453|Gastrointestinal physiology|gastrointestinal physiology
317415|NCT01792453|MRI|mri
317416|NCT01792453|Small bowel water volumes|small bowel water volumes
317417|NCT01792453|Gastric volumes|gastric volumes
317418|NCT01792401|Critical illness|critical illness
317419|NCT01792401|Dietary supplements|dietary supplements
317420|NCT01792401|Gastrointestinal tract/physio-pathology|gastrointestinal tract/physio-pathology
317421|NCT01792388|Crohn's Disease|crohn's disease
317422|NCT01792388|Vitamin D|vitamin d
317423|NCT01792388|Intestinal Permeability|intestinal permeability
317424|NCT01792388|Tara Raftery|tara raftery
317425|NCT01792375|Cervical ripening|cervical ripening
317426|NCT01792375|Dinoprostone|dinoprostone
317427|NCT01792375|Labor induction|labor induction
317428|NCT01792375|Membrane sweeping|membrane sweeping
317429|NCT01792375|Nulliparous women|nulliparous women
317430|NCT01792375|Trial|trial
317431|NCT01792362|Anti-mullerian hormone (AMH) level, poly cystic ovarian syndrome obese infertility weight loss diet|anti-mullerian hormone (amh) level, poly cystic ovarian syndrome obese infertility weight loss diet
317432|NCT01792336|Repetitive TMS (rTMS)|repetitive tms (rtms)
317433|NCT01792336|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
317434|NCT01792336|Motor Cortex|motor cortex
317435|NCT01792336|Focal Hand Dystonia|focal hand dystonia
317436|NCT01792336|Facilitation|facilitation
317437|NCT01792323|insulin pump therapy|insulin pump therapy
317438|NCT01792323|insulin bolus|insulin bolus
317439|NCT01792323|rapid acting insulin|rapid acting insulin
317440|NCT01792323|insulin lispro|insulin lispro
317441|NCT01792323|pharmacodynamics|pharmacodynamics
317442|NCT01792323|pharmacokinetics|pharmacokinetics
317443|NCT01792323|glucose clamp|glucose clamp
317444|NCT01792310|Glioma|glioma
317445|NCT01792310|Solid Tumours|solid tumours
317446|NCT01792310|Minerval|minerval
317447|NCT01792297|Sarcopenia|sarcopenia
317448|NCT01792297|Osteoporosis|osteoporosis
317449|NCT01792297|Cognition|cognition
317450|NCT01792297|Inflammation|inflammation
317451|NCT01792271|COPD|copd
317452|NCT01792271|Chronic Bronchitis|chronic bronchitis
317453|NCT01792271|Hypertonic Saline|hypertonic saline
317454|NCT01792258|Percutaneous tracheostomy|percutaneous tracheostomy
317455|NCT01792258|Intensive Care Unit|intensive care unit
317456|NCT01792258|Ineffective Airway Clearance|ineffective airway clearance
317457|NCT01792258|Weaning failure|weaning failure
317458|NCT01792245|narrow band UVB; PUVA; psoriasis; eczema; hand|narrow band uvb; puva; psoriasis; eczema; hand
317459|NCT01792232|Diesel exhaust|diesel exhaust
317460|NCT01792232|Air pollution|air pollution
317461|NCT01792232|Airway responsiveness|airway responsiveness
317462|NCT01792232|Allergies|allergies
317463|NCT01792219|interprofessional learning|interprofessional learning
317464|NCT01792219|interprofessional collaboration|interprofessional collaboration
317465|NCT01792219|residents|residents
317466|NCT01792219|nursing homes|nursing homes
317467|NCT01792206|Stage 3 chronic kidney disease (CKD)|stage 3 chronic kidney disease (ckd)
317468|NCT01792206|Stage 4 chronic kidney disease (CKD)|stage 4 chronic kidney disease (ckd)
317469|NCT01792206|CKD|ckd
317470|NCT01792180|Gait speed|gait speed
317471|NCT01792180|Mobility|mobility
317472|NCT01792180|Falls|falls
317473|NCT01792180|Fall risk|fall risk
317474|NCT01792180|Self-management|self-management
317475|NCT01792180|Mental wellbeing|mental wellbeing
317476|NCT01792180|Elderly|elderly
317477|NCT01792115|Fatty Liver|fatty liver
317478|NCT01792115|Alpha-Tocopherol|alpha-tocopherol
317479|NCT01792115|Vitamin E|vitamin e
317480|NCT01792115|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
317481|NCT01792102|Multiple Myeloma|multiple myeloma
317482|NCT01792102|Carfilzomib|carfilzomib
317483|NCT01792102|Krypolis|krypolis
317484|NCT01792102|60 minute infusion|60 minute infusion
317485|NCT01792089|de novo lipogenesis|de novo lipogenesis
317486|NCT01792089|fructose|fructose
317487|NCT01792089|roux-en-Y gastric bypass|roux-en-y gastric bypass
317488|NCT01792089|post-prandial triglycerides|post-prandial triglycerides
317489|NCT01792050|IDO|ido
317490|NCT01792050|IDO Inhibitor|ido inhibitor
317491|NCT01792050|Metastatic Breast Cancer|metastatic breast cancer
317617|NCT01791374|Gastric Cancer|gastric cancer
317492|NCT01792011|Elective living donor liver transplantation|elective living donor liver transplantation
317493|NCT01791985|Breast Cancer|breast cancer
317494|NCT01791985|AZD4547|azd4547
317495|NCT01791985|Safety Run-In|safety run-in
317496|NCT01791985|FGFR1|fgfr1
317497|NCT01791985|ER positive breast cancer|er positive breast cancer
317498|NCT01791985|Single arm phase IIa study|single arm phase iia study
317499|NCT01791972|Exercise-Induced Bronchoconstriction (EIB)|exercise-induced bronchoconstriction (eib)
317500|NCT01791972|Spiromax®|spiromax®
317501|NCT01791972|Albuterol sulfate|albuterol sulfate
317502|NCT01791946|lazy eye|lazy eye
317503|NCT01791946|cross eye|cross eye
317506|NCT01791933|Neck pain|neck pain
317507|NCT01791933|Integrative package|integrative package
317508|NCT01791933|CAM|cam
317509|NCT01791868|Generalized convulsive status epilepticus|generalized convulsive status epilepticus
317510|NCT01791868|Sodium valproate|sodium valproate
317511|NCT01791868|Refractory status epilepticus|refractory status epilepticus
317512|NCT01791868|Mortality|mortality
317513|NCT01791868|Epilepsy|epilepsy
317514|NCT01791868|Intensive Care Unit|intensive care unit
317515|NCT01791868|Neurological sequela|neurological sequela
317516|NCT01791868|Quality of life|quality of life
317517|NCT01791868|Adult|adult
317518|NCT01791855|Subjects with Renal Impairment|subjects with renal impairment
317519|NCT01791855|healthy|healthy
317520|NCT01791842|fibrous dysplasia of bone|fibrous dysplasia of bone
317521|NCT01791842|tocilizumab|tocilizumab
317522|NCT01791842|McCune-Albright syndrome|mccune-albright syndrome
317523|NCT01791829|Luminal A|luminal a
317524|NCT01791829|Ipsilateral Breast Tumour Recurrence|ipsilateral breast tumour recurrence
317525|NCT01791816|Vasovagal Syncope|vasovagal syncope
317526|NCT01791816|Postural Tachycardia Syndrome|postural tachycardia syndrome
317527|NCT01791816|Orthostatic Intolerance|orthostatic intolerance
317528|NCT01791816|Nitric Oxide (NO)|nitric oxide (no)
317529|NCT01791816|Orthostatic Stress|orthostatic stress
317530|NCT01791816|L-Ng-monomethyl Arginine (L-NMMA)|l-ng-monomethyl arginine (l-nmma)
317531|NCT01791816|Phenylephrine|phenylephrine
317532|NCT01791816|Sodium Nitroprusside|sodium nitroprusside
317533|NCT01791803|Smoking cessation|smoking cessation
317534|NCT01791803|Tobacco abstinence|tobacco abstinence
317535|NCT01791803|hypnotherapy|hypnotherapy
317536|NCT01791803|Nicotine replacement therapy|nicotine replacement therapy
317537|NCT01791790|old Subjects|old subjects
317538|NCT01791790|Controls|controls
317539|NCT01791790|brain stimulation|brain stimulation
317540|NCT01791790|tSOS|tsos
317541|NCT01791790|tDCS|tdcs
317542|NCT01791790|sleep|sleep
317543|NCT01791790|memory|memory
317544|NCT01791790|memory consolidation|memory consolidation
317545|NCT01791777|fidelity|fidelity
317546|NCT01791777|implementation science|implementation science
317547|NCT01791777|competence|competence
317548|NCT01791777|training|training
317549|NCT01791777|coaching|coaching
317550|NCT01791738|Total Hip Arthroplasty (THA)|total hip arthroplasty (tha)
317551|NCT01791738|Patient-Specific Instruments|patient-specific instruments
317552|NCT01791738|Acetabular Cup Placement|acetabular cup placement
317553|NCT01791738|Accuracy|accuracy
317554|NCT01791699|atrial fibrillation|atrial fibrillation
317555|NCT01791699|paroxysmal|paroxysmal
317556|NCT01791699|persistent|persistent
317557|NCT01791699|ablation|ablation
317558|NCT01791699|pulmonary vein isolation|pulmonary vein isolation
317559|NCT01791699|recurrence|recurrence
317560|NCT01791686|Dense Deposit Disease|dense deposit disease
317561|NCT01791686|DDD|ddd
317562|NCT01791673|Glaucoma|glaucoma
317563|NCT01791673|Cyclocoagulation|cyclocoagulation
317564|NCT01791673|HIFU - High Intensity Focused Ultrasound|hifu - high intensity focused ultrasound
317565|NCT01791673|Ciliary Body|ciliary body
317566|NCT01791647|Polycystic ovary syndrome|polycystic ovary syndrome
317567|NCT01791647|myoinositol|myoinositol
317568|NCT01791647|metformin|metformin
317569|NCT01791647|glucose-insulinemic metabolism|glucose-insulinemic metabolism
317570|NCT01791647|menstrual pattern|menstrual pattern
317571|NCT01791647|insulin-lowering therapies|insulin-lowering therapies
317572|NCT01791621|Irritable Bowel Syndrome|irritable bowel syndrome
317573|NCT01791621|Elimination diet|elimination diet
317574|NCT01791621|Food allergies|food allergies
317575|NCT01791608|Child, Preschool|child, preschool
317576|NCT01791608|Dietary Zinc|dietary zinc
317577|NCT01791608|Zinc sulfate|zinc sulfate
317578|NCT01791608|zinc-glycine chelate|zinc-glycine chelate
317579|NCT01791595|Phase I|phase i
317580|NCT01791595|Cancer|cancer
317581|NCT01791595|Solid Tumours|solid tumours
317582|NCT01791595|Prostate Cancer|prostate cancer
317583|NCT01791595|Gastric Cancer|gastric cancer
317584|NCT01791595|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
317585|NCT01791595|Monocarboxylate Transporter 1 Inhibitor|monocarboxylate transporter 1 inhibitor
317586|NCT01791595|lactate|lactate
317587|NCT01791556|HIV|hiv
317588|NCT01791556|AIDS|aids
317589|NCT01791556|Kenya|kenya
317590|NCT01791556|viral load|viral load
317591|NCT01791556|Antiretroviral therapy|antiretroviral therapy
317592|NCT01791556|randomized clinical trial|randomized clinical trial
317593|NCT01791556|ART monitoring|art monitoring
317594|NCT01791556|treatment failure|treatment failure
317595|NCT01791556|HIV resistance|hiv resistance
317596|NCT01791543|ventricular tachycardia|ventricular tachycardia
317597|NCT01791543|ablation|ablation
317598|NCT01791543|ventricular arrhythmia|ventricular arrhythmia
317599|NCT01791530|VAT|vat
317600|NCT01791530|VAP|vap
317601|NCT01791530|Transition from VAT to VAP|transition from vat to vap
317602|NCT01791504|Abdominoplasty|abdominoplasty
317603|NCT01791478|-Metastatic breast cancer, PI3K inhibitor, Endocrine therapy|-metastatic breast cancer, pi3k inhibitor, endocrine therapy
317604|NCT01791465|HIV|hiv
317605|NCT01791465|Diabetes|diabetes
317606|NCT01791400|Metoclopramide|metoclopramide
317607|NCT01791400|Sumatriptan|sumatriptan
317608|NCT01791400|migraine|migraine
317609|NCT01791400|headache|headache
317610|NCT01791387|Renal cell|renal cell
317611|NCT01791387|Kidney|kidney
317612|NCT01791387|Cancer|cancer
317613|NCT01791387|Metastatic carcinoma|metastatic carcinoma
317614|NCT01791374|Advanced Solid Tumors|advanced solid tumors
317615|NCT01791374|Advanced or Metastatic Gastric Cancer|advanced or metastatic gastric cancer
317616|NCT01791374|Advanced or Metastatic GEJ|advanced or metastatic gej
317618|NCT01791361|Metastatic colorectal cancer|metastatic colorectal cancer
317619|NCT01791335|Glottis|glottis
317620|NCT01791335|Respiratory Muscles|respiratory muscles
317621|NCT01791335|Upper airway|upper airway
317622|NCT01791335|Noninvasive ventilation|noninvasive ventilation
317623|NCT01791309|Vemurafenib|vemurafenib
317624|NCT01791309|Panitumumab|panitumumab
317625|NCT01791309|V600E BRAF mutation|v600e braf mutation
317626|NCT01791309|colon|colon
317627|NCT01791309|12-221|12-221
317628|NCT01791296|sedation|sedation
317629|NCT01791296|sleep|sleep
317630|NCT01791296|delirium|delirium
317631|NCT01791296|critical illness|critical illness
317632|NCT01791296|sub-syndromal delirium|sub-syndromal delirium
317633|NCT01791296|intensive care|intensive care
317634|NCT01791283|Left ventricular stroke volume|left ventricular stroke volume
317635|NCT01791283|Arterial waveform analysis|arterial waveform analysis
317636|NCT01791283|Esofageal doppler|esofageal doppler
317637|NCT01791283|Ultrasound|ultrasound
317638|NCT01791283|Cardiac magnetic Imaging|cardiac magnetic imaging
317639|NCT01791283|Limits of agreement|limits of agreement
317640|NCT01791270|Obstructive Sleep Apnea|obstructive sleep apnea
317641|NCT01791270|Hypertension|hypertension
317642|NCT01791270|β1 Subunit of Maxi-k+Channel|β1 subunit of maxi-k+channel
317643|NCT01791270|Cardiovascular Risk|cardiovascular risk
317644|NCT01791257|delayed|delayed
317645|NCT01791257|cerebral|cerebral
317646|NCT01791257|ischemia|ischemia
317647|NCT01791257|microrna|microrna
317648|NCT01791257|cerebrospinal fluid|cerebrospinal fluid
317649|NCT01791257|subarachnoid|subarachnoid
317650|NCT01791257|hemorrhage|hemorrhage
317651|NCT01791244|Multiple Sclerosis|multiple sclerosis
317652|NCT01791244|Relapsing-Remitting|relapsing-remitting
317653|NCT01791244|Rebif|rebif
317654|NCT01791244|RebiSmart|rebismart
317655|NCT01791244|Patient support program|patient support program
317656|NCT01791231|Healthy|healthy
317657|NCT01791231|Male|male
317658|NCT01791231|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
317659|NCT01791231|Radiolabeled 14C-canagliflozin|radiolabeled 14c-canagliflozin
317660|NCT01791231|Absorption|absorption
317661|NCT01791231|Metabolism|metabolism
317662|NCT01791231|Excretion|excretion
317663|NCT01791231|Radioactivity|radioactivity
317664|NCT01791218|Pulmonary vein isolation|pulmonary vein isolation
317665|NCT01791218|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
317666|NCT01791218|Quality of life|quality of life
317667|NCT01791192|Uveitis, Fingolimod, Phase II, Visual Acuity, Vitreous Haze, OCT|uveitis, fingolimod, phase ii, visual acuity, vitreous haze, oct
317668|NCT01791114|Insulin sensitivity|insulin sensitivity
317669|NCT01791114|Diabetes Prevention|diabetes prevention
317670|NCT01791114|Obesity|obesity
317671|NCT01791114|Brown adipose tissue|brown adipose tissue
317672|NCT01791101|Thrombocytopenia|thrombocytopenia
317673|NCT01791101|Eltrombopag|eltrombopag
317674|NCT01791075|DSAEK|dsaek
317675|NCT01791075|Tan Endoglide|tan endoglide
317676|NCT01791075|Endosaver/Endoserter|endosaver/endoserter
317677|NCT01791062|cartilage tissue engineering|cartilage tissue engineering
317678|NCT01791062|hyaluronan|hyaluronan
317679|NCT01791062|hyaluronic acid|hyaluronic acid
317680|NCT01791049|Gram-positive|gram-positive
317681|NCT01791049|Infections|infections
317682|NCT01791049|Bacterial infections|bacterial infections
317683|NCT01791036|Adductor canal block|adductor canal block
317684|NCT01791036|Femoral Nerve Block|femoral nerve block
317685|NCT01791023|Depression|depression
317686|NCT01791023|Physical exercise|physical exercise
317687|NCT01791023|Stress|stress
317688|NCT01791010|Breathing exercises|breathing exercises
317689|NCT01791010|Aged|aged
317690|NCT01790997|DLBS1033|dlbs1033
317691|NCT01790997|Lumbrokinase|lumbrokinase
317692|NCT01790997|Acute ischemic stroke|acute ischemic stroke
317693|NCT01790997|Bleeding profile|bleeding profile
317694|NCT01790997|Clinical outcome|clinical outcome
317695|NCT01790997|Aspirin|aspirin
317696|NCT01790997|Clopidogrel|clopidogrel
317697|NCT01790984|Dietary extrinsic sugars, atherogenic lipoprotein phenotype, lipoprotein kinetics, fatty liver|dietary extrinsic sugars, atherogenic lipoprotein phenotype, lipoprotein kinetics, fatty liver
317698|NCT01790971|Obstructive sleep apnea|obstructive sleep apnea
317699|NCT01790971|Spinal morphine|spinal morphine
317700|NCT01790932|Metastatic|metastatic
317701|NCT01790932|Triple Negative|triple negative
317702|NCT01790919|Depression, Adults|depression, adults
317703|NCT01790906|Chronic Heart Failure|chronic heart failure
317704|NCT01790906|Renal Sympathetic Denervation|renal sympathetic denervation
317908|NCT01789684|HBOC|hboc
317705|NCT01790893|Histoplasmosis|histoplasmosis
317706|NCT01790880|Aphasia|aphasia
317707|NCT01790880|Stroke|stroke
317708|NCT01790880|Speech Rehabilitation|speech rehabilitation
317709|NCT01790854|prasugrel|prasugrel
317710|NCT01790854|antiplatelet|antiplatelet
317711|NCT01790854|Acute Coronary Syndrome|acute coronary syndrome
317712|NCT01790815|Acute Malnutrition|acute malnutrition
317713|NCT01790815|Mid Upper Arm Circumference|mid upper arm circumference
317714|NCT01790815|Screening|screening
317715|NCT01790802|laser treatment, high risk, early AMD|laser treatment, high risk, early amd
317716|NCT01790776|urethrography|urethrography
317717|NCT01790763|Burn|burn
317718|NCT01790763|Second-degree|second-degree
317719|NCT01790750|PDA|pda
317720|NCT01790750|Echo|echo
317721|NCT01790750|PES|pes
317722|NCT01790750|Handheld echo system|handheld echo system
317723|NCT01790737|myeloma, stem cell mobilization, autologous stem cell transplantation|myeloma, stem cell mobilization, autologous stem cell transplantation
317724|NCT01790737|induction treatment, maintenance treatment|induction treatment, maintenance treatment
317725|NCT01790711|Gut bacteria|gut bacteria
317726|NCT01790711|Bacteria|bacteria
317727|NCT01790711|Fecal transplant|fecal transplant
317728|NCT01790711|Bacteriotherapy|bacteriotherapy
317729|NCT01790698|Necrotizing fasciitis|necrotizing fasciitis
317730|NCT01790698|Streptococcus pyogenes|streptococcus pyogenes
317731|NCT01790698|Staphylococcus aureus|staphylococcus aureus
317732|NCT01790698|Immunopathogenesis|immunopathogenesis
317733|NCT01790672|Antioxidants|antioxidants
317734|NCT01790672|Central Nervous System Agents|central nervous system agents
317735|NCT01790672|Wine|wine
317736|NCT01790659|leishmaniasis|leishmaniasis
317737|NCT01790659|cutaneous leishmaniasis|cutaneous leishmaniasis
317738|NCT01790659|Leishmania panamensis|leishmania panamensis
317739|NCT01790659|L panamensis|l panamensis
317740|NCT01790659|Paromomycin|paromomycin
317741|NCT01790659|Paromomycin/Gentamicin|paromomycin/gentamicin
317742|NCT01790633|rapid test|rapid test
317743|NCT01790633|screening|screening
317744|NCT01790633|ELISA|elisa
317745|NCT01790633|hepatitis B virus|hepatitis b virus
317746|NCT01790633|hepatitis C virus|hepatitis c virus
317747|NCT01790633|human immunodeficiency virus|human immunodeficiency virus
317748|NCT01790633|access to care|access to care
317749|NCT01790620|Severe sepsis|severe sepsis
317750|NCT01790620|Septic shock|septic shock
317751|NCT01790620|Acute renal failure|acute renal failure
317752|NCT01790620|Acute kidney injury|acute kidney injury
317753|NCT01790620|Continuous renal replacement therapies CRRT|continuous renal replacement therapies crrt
317754|NCT01790607|Adult healthy subjects will be matched with individual subjects by age (± 5 years, gender, and BMI (± 15%)|adult healthy subjects will be matched with individual subjects by age (± 5 years, gender, and bmi (± 15%)
317755|NCT01790594|transplantation|transplantation
317756|NCT01790594|kidney|kidney
317757|NCT01790594|pancreas|pancreas
317758|NCT01790594|immunosuppression|immunosuppression
317759|NCT01790594|calcineurin inhibitor (CNI)|calcineurin inhibitor (cni)
317760|NCT01790581|Chronic Ankle Instability|chronic ankle instability
317761|NCT01790555|Postsurgical|postsurgical
317762|NCT01790555|Pain|pain
317763|NCT01790555|THC|thc
317764|NCT01790555|Sensitization|sensitization
317765|NCT01790542|Iron|iron
317766|NCT01790542|Intestinal inflammation|intestinal inflammation
317767|NCT01790542|ROS|ros
317768|NCT01790516|Head and neck cancer|head and neck cancer
317769|NCT01790516|genetic testing|genetic testing
317770|NCT01790516|cisplatin|cisplatin
317771|NCT01790516|erbitux|erbitux
317772|NCT01790516|radiation therapy|radiation therapy
317773|NCT01790503|glioblastoma|glioblastoma
317774|NCT01790503|GBM|gbm
317775|NCT01790477|Tonsillectomy|tonsillectomy
317776|NCT01790477|Acupuncture|acupuncture
317777|NCT01790464|Glossopharyngeal nerve block|glossopharyngeal nerve block
317778|NCT01790464|Airway anesthesia|airway anesthesia
317779|NCT01790464|Awake intubation|awake intubation
317780|NCT01790451|focal therapy|focal therapy
317781|NCT01790451|irreversible electroporation|irreversible electroporation
317782|NCT01790451|prostate cancer|prostate cancer
317783|NCT01790412|pregnancy, exercise, gestational diabetes|pregnancy, exercise, gestational diabetes
317784|NCT01790399|SENTINEL NODE|sentinel node
317785|NCT01790386|hemostasis|hemostasis
317786|NCT01790386|thromboelastography|thromboelastography
317787|NCT01790386|coagulation|coagulation
317788|NCT01790386|TEG|teg
317789|NCT01790373|Suubi|suubi
317790|NCT01790373|Adolescents|adolescents
317791|NCT01790373|Poverty|poverty
317792|NCT01790373|Economic empowerment interventions|economic empowerment interventions
317793|NCT01790373|Adherence to HIV antiretroviral therapy|adherence to hiv antiretroviral therapy
317794|NCT01790373|Wisepill|wisepill
317795|NCT01790373|HIV/AIDS infected Children|hiv/aids infected children
317796|NCT01790373|Medical event monitoring system|medical event monitoring system
317797|NCT01790373|Uganda|uganda
317798|NCT01790360|MSM|msm
317799|NCT01790360|HIV|hiv
317800|NCT01790360|Substance Abuse|substance abuse
317801|NCT01790360|Sexual Behavior|sexual behavior
317802|NCT01790347|Exercise|exercise
317803|NCT01790347|Aerobic|aerobic
317804|NCT01790347|Resistance training|resistance training
317805|NCT01790347|Pregnancy|pregnancy
317806|NCT01790347|Maternal weight gain|maternal weight gain
317807|NCT01790347|IOM recommendations|iom recommendations
317808|NCT01790295|Myelofibrosis|myelofibrosis
317809|NCT01790295|Stem cell transplant|stem cell transplant
317810|NCT01790295|Ruxolitinib|ruxolitinib
317811|NCT01790282|luteal support|luteal support
317812|NCT01790282|high responder|high responder
317813|NCT01790282|ICSI|icsi
317814|NCT01790282|ivf|ivf
317815|NCT01790282|cycle outcome|cycle outcome
317816|NCT01790269|Relapsing-Remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
317817|NCT01790269|NK cells|nk cells
317818|NCT01790269|Fingolimod|fingolimod
317819|NCT01790204|mutant p53|mutant p53
317820|NCT01790204|watercress|watercress
317821|NCT01790204|Phenethyl isothyocyanate|phenethyl isothyocyanate
317822|NCT01790204|oral cells of smokers|oral cells of smokers
317823|NCT01790191|Children|children
317824|NCT01790191|Eating behaviour|eating behaviour
317825|NCT01790191|Intake|intake
317826|NCT01790191|Liking|liking
317827|NCT01790191|Conditioned liking|conditioned liking
317828|NCT01790191|Flavour|flavour
317829|NCT01790191|Nutrient|nutrient
317830|NCT01790191|Vegetable|vegetable
317831|NCT01790165|Onychomycosis|onychomycosis
317832|NCT01790165|Open Label|open label
317833|NCT01790165|PK|pk
317834|NCT01790126|Men with Biochemically Relapsed Hormone Sensitive Prostate Cancer|men with biochemically relapsed hormone sensitive prostate cancer
317835|NCT01790074|cervicogenic headache|cervicogenic headache
317836|NCT01790074|trigger point|trigger point
317837|NCT01790074|sternocleidomastoid|sternocleidomastoid
317838|NCT01790074|manual therapy|manual therapy
317839|NCT01790061|Gut bacteria|gut bacteria
317840|NCT01790061|Gut flora|gut flora
317841|NCT01790061|Bacteriotherapy|bacteriotherapy
317842|NCT01790061|Fecal Microbiota Transplantation|fecal microbiota transplantation
317843|NCT01790061|Inflammatory bowel disease|inflammatory bowel disease
317844|NCT01790061|Ulcerative colitis|ulcerative colitis
317845|NCT01790048|MAM|mam
317846|NCT01790009|ADME|adme
317847|NCT01790009|Flavanols|flavanols
317848|NCT01790009|Age|age
317849|NCT01790009|Pharmacokinetics|pharmacokinetics
317850|NCT01789996|6 minute walk test|6 minute walk test
317851|NCT01789996|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
317852|NCT01789996|pulmonary arterial hypertension|pulmonary arterial hypertension
317853|NCT01789983|Physical Activity|physical activity
317854|NCT01789983|Chemotherapy|chemotherapy
317855|NCT01789983|Elderly|elderly
317856|NCT01789983|Geriatric|geriatric
317857|NCT01789983|Walking|walking
317858|NCT01789983|Geriatric Assessment|geriatric assessment
317859|NCT01789983|Geriatric Oncology|geriatric oncology
317860|NCT01789970|chronic low back pain|chronic low back pain
317861|NCT01789970|hydrocodone bitartrate|hydrocodone bitartrate
317862|NCT01789970|opioids|opioids
317863|NCT01789944|Childhood Obesity|childhood obesity
317864|NCT01789918|Hypertension|hypertension
317865|NCT01789918|Blood pressure|blood pressure
317866|NCT01789918|Renal denervation|renal denervation
317867|NCT01789905|Tygacil|tygacil
317868|NCT01789905|Tigecycline|tigecycline
317869|NCT01789905|Post marketing surveillance|post marketing surveillance
317870|NCT01789905|Japanese|japanese
317871|NCT01789905|Infection|infection
317872|NCT01789879|Levonorgestrel|levonorgestrel
317873|NCT01789879|Efavirenz|efavirenz
317874|NCT01789879|Nevirapine|nevirapine
317875|NCT01789879|Pharmacokinetics|pharmacokinetics
317877|NCT01789866|lutein|lutein
317878|NCT01789866|cognitive development|cognitive development
317879|NCT01789866|fMRI|fmri
317880|NCT01789853|stroke, rehabilitation, gait training|stroke, rehabilitation, gait training
317881|NCT01789840|BPH|bph
317882|NCT01789840|Prostate|prostate
317883|NCT01789840|Prostatic Hyperplasia|prostatic hyperplasia
317884|NCT01789840|enlarged prostate|enlarged prostate
317885|NCT01789840|LUTS|luts
317886|NCT01789840|urinary retention|urinary retention
317887|NCT01789814|Percutaneous Coronary Intervention|percutaneous coronary intervention
317888|NCT01789814|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
317889|NCT01789814|bivalirudin|bivalirudin
317890|NCT01789762|Platelet transfusions|platelet transfusions
317891|NCT01789762|Pathogen reduction|pathogen reduction
317892|NCT01789762|Haemorrhagic episodes|haemorrhagic episodes
317893|NCT01789749|snare tip soft coagulation|snare tip soft coagulation
317894|NCT01789749|endoscopic mucosal resection|endoscopic mucosal resection
317895|NCT01789749|adenoma recurrence|adenoma recurrence
317896|NCT01789749|adenoma|adenoma
317897|NCT01789749|colonoscopy|colonoscopy
317898|NCT01789736|Glaucoma|glaucoma
317899|NCT01789736|Ocular hypertension|ocular hypertension
317900|NCT01789736|AR-12286|ar-12286
317901|NCT01789736|Travoprost|travoprost
317902|NCT01789710|smoking|smoking
317903|NCT01789710|homelessness|homelessness
317904|NCT01789710|contingency management|contingency management
317905|NCT01789684|cluster|cluster
317906|NCT01789684|genetic counseling|genetic counseling
317907|NCT01789684|breast cancer|breast cancer
317909|NCT01789684|provider intervention|provider intervention
317910|NCT01789671|Childhood Obesity|childhood obesity
317911|NCT01789658|Oral Mucositis|oral mucositis
317912|NCT01789658|Children|children
317913|NCT01789658|Cryotherapy|cryotherapy
317914|NCT01789658|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
317915|NCT01789645|Carpal tunnel|carpal tunnel
317916|NCT01789645|Physical therapy|physical therapy
317917|NCT01789645|Surgery|surgery
317918|NCT01789645|Efficacy|efficacy
317919|NCT01789606|Self-selection and actual use/compliance trial.|self-selection and actual use/compliance trial.
317920|NCT01789580|Experimental study, moderators, online gambling,|experimental study, moderators, online gambling,
317921|NCT01789580|problem gambling prevention|problem gambling prevention
317922|NCT01789554|Out of hospital cardiac arrest|out of hospital cardiac arrest
317923|NCT01789554|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
317924|NCT01789554|Bystander CPR|bystander cpr
317925|NCT01789554|Mobile phone positioning system|mobile phone positioning system
317926|NCT01789528|Phase I,|phase i,
317927|NCT01789528|open label,|open label,
317928|NCT01789528|CAZ-AVI,|caz-avi,
317929|NCT01789528|CXL,|cxl,
317930|NCT01789528|healthy volunteers,|healthy volunteers,
317931|NCT01789528|intestinal flora.|intestinal flora.
317932|NCT01789502|self-expandable metal stent; plastic stent|self-expandable metal stent; plastic stent
317933|NCT01789476|pain|pain
317934|NCT01789476|acute pain|acute pain
317935|NCT01789476|kappa agonis|kappa agonis
317936|NCT01789476|opioid analgesia|opioid analgesia
317937|NCT01789476|bunionectomy|bunionectomy
317938|NCT01789476|peripheral nervous system agents|peripheral nervous system agents
317939|NCT01789476|physiological effects of drugs|physiological effects of drugs
317940|NCT01789476|surgery|surgery
317941|NCT01789476|post-operative|post-operative
317942|NCT01789476|post-operative complications|post-operative complications
317943|NCT01789450|sensitivity|sensitivity
317944|NCT01789450|section of periareolar dermis|section of periareolar dermis
317945|NCT01789450|breast reduction|breast reduction
317946|NCT01789437|retinal vein occlusion|retinal vein occlusion
317947|NCT01789437|systemic hypertension|systemic hypertension
317948|NCT01789437|arteriolar diameter|arteriolar diameter
317949|NCT01789385|Deep brain stimulation|deep brain stimulation
317950|NCT01789385|Parkinson|parkinson
317951|NCT01789372|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
317952|NCT01789372|yoga|yoga
317953|NCT01789372|quality of life|quality of life
317954|NCT01789372|blood pressure|blood pressure
317955|NCT01789372|heart rate|heart rate
317956|NCT01789372|heart rate variability|heart rate variability
317957|NCT01789359|anthocyanin|anthocyanin
317958|NCT01789359|bioavailability|bioavailability
317959|NCT01789359|urine|urine
317960|NCT01789359|long-term|long-term
317961|NCT01789346|Scar|scar
317962|NCT01789346|Scars|scars
317963|NCT01789346|Surgical Scar|surgical scar
317964|NCT01789346|Surgical Scars|surgical scars
317965|NCT01789346|Cicatrix|cicatrix
317966|NCT01789346|Hypertrophic Cicatrix|hypertrophic cicatrix
317967|NCT01789346|Keloid|keloid
317968|NCT01789346|Hypertrophic Scar|hypertrophic scar
317969|NCT01789346|Surgical Incision|surgical incision
317970|NCT01789346|Scarring|scarring
317971|NCT01789346|Abdominoplasty|abdominoplasty
317972|NCT01789346|Tummy Tuck|tummy tuck
317973|NCT01789346|Augmentation Mammoplasty|augmentation mammoplasty
317974|NCT01789346|Breast Augmentation|breast augmentation
317975|NCT01789346|Thyroidectomy|thyroidectomy
317976|NCT01789333|Keratoconus|keratoconus
317977|NCT01789333|Ectasia|ectasia
317978|NCT01789333|UVA light|uva light
317979|NCT01789333|riboflavin|riboflavin
317980|NCT01789333|post-LASIK|post-lasik
317981|NCT01789333|irregular astigmatism|irregular astigmatism
317982|NCT01789320|uveitis|uveitis
317983|NCT01789320|intermediate uveitis|intermediate uveitis
317984|NCT01789320|posterior uveitis|posterior uveitis
317985|NCT01789320|panuveitis|panuveitis
317986|NCT01789320|noninfectious uveitis|noninfectious uveitis
317987|NCT01789320|microneedle|microneedle
317988|NCT01789320|suprachoroidal space|suprachoroidal space
317989|NCT01789320|SCS|scs
317990|NCT01789320|inflammation|inflammation
317991|NCT01789320|ocular inflammatory conditions|ocular inflammatory conditions
317992|NCT01789320|triamcinolone acetonide|triamcinolone acetonide
317993|NCT01789320|TA|ta
317994|NCT01789320|Triesence|triesence
317995|NCT01789320|injection|injection
317996|NCT01789320|IVT|ivt
317997|NCT01789320|intravitreal|intravitreal
317998|NCT01789320|corticosteroid|corticosteroid
317999|NCT01789320|sympathetic ophthalmia|sympathetic ophthalmia
318000|NCT01789320|temporal arteritis|temporal arteritis
318001|NCT01789320|vitreous haze|vitreous haze
318002|NCT01789294|lymphoid nodular hyperplasia|lymphoid nodular hyperplasia
318003|NCT01789294|food allergy|food allergy
318004|NCT01789281|Neoplasms, Carcinoid tumor, Neuroendocrine tumor|neoplasms, carcinoid tumor, neuroendocrine tumor
318005|NCT01789268|acute|acute
318006|NCT01789268|adaptive cellular immune phenotypes|adaptive cellular immune phenotypes
318007|NCT01789268|infants|infants
318008|NCT01789268|Lymphocyte|lymphocyte
318009|NCT01789268|premature|premature
318010|NCT01789268|respiratory viral infections|respiratory viral infections
318011|NCT01789229|Breast cancer|breast cancer
318012|NCT01789229|Ovarian cancer|ovarian cancer
318013|NCT01789229|Endometrium carcinoma|endometrium carcinoma
318014|NCT01789229|Cervix carcinoma,|cervix carcinoma,
318015|NCT01789229|Mamma carcinoma,|mamma carcinoma,
318016|NCT01789229|Prostata carcinoma|prostata carcinoma
318017|NCT01789229|Colon carcinoma|colon carcinoma
318018|NCT01789229|Rectal carcinoma|rectal carcinoma
318019|NCT01789229|Bronchus carcinoma|bronchus carcinoma
318020|NCT01789229|NSCLC (non small cell lung cancer) & SCLC (small cell lung cancer)|nsclc (non small cell lung cancer) & sclc (small cell lung cancer)
318021|NCT01789229|Prostate carcinoma|prostate carcinoma
318022|NCT01789216|Pilon fractures|pilon fractures
318023|NCT01789216|Calcaneus fractures|calcaneus fractures
318024|NCT01789216|Acute pain|acute pain
318025|NCT01789216|Chronic pain|chronic pain
318026|NCT01789216|Isolated|isolated
318027|NCT01789216|unilateral|unilateral
318028|NCT01789216|Grade I|grade i
318029|NCT01789216|Grade II|grade ii
318030|NCT01789216|open|open
318031|NCT01789216|closed|closed
318032|NCT01789203|BK infection|bk infection
318033|NCT01789203|BK viremia|bk viremia
318034|NCT01789203|BK nephropathy|bk nephropathy
318035|NCT01789203|polyomavirus|polyomavirus
318036|NCT01789203|fluoroquinolone|fluoroquinolone
318037|NCT01789203|ciprofloxacin|ciprofloxacin
318038|NCT01789190|Honeymoon|honeymoon
318039|NCT01789190|Type 1 diabetes|type 1 diabetes
318040|NCT01789177|Spirometry|spirometry
318041|NCT01789177|Postoperative Care|postoperative care
318042|NCT01789164|TBI|tbi
318043|NCT01789164|fNIRS|fnirs
318044|NCT01789164|hypercapnea|hypercapnea
318045|NCT01789164|Cerebrovascular reactivity|cerebrovascular reactivity
318046|NCT01789151|arthritis|arthritis
318047|NCT01789151|nuclear imaging|nuclear imaging
318048|NCT01789151|rheumatoid|rheumatoid
318049|NCT01789151|ankylosing spondylitis|ankylosing spondylitis
318050|NCT01789151|glucosamine|glucosamine
318051|NCT01789138|Antiretroviral Therapy|antiretroviral therapy
318052|NCT01789138|Adherence|adherence
318053|NCT01789138|Intervention|intervention
318054|NCT01789125|anxiety|anxiety
318055|NCT01789125|stress|stress
318056|NCT01789125|smoking|smoking
318057|NCT01789125|cessation|cessation
318058|NCT01789099|Lung cancer|lung cancer
318059|NCT01789099|Peptide vaccine|peptide vaccine
318060|NCT01789073|Postoperative|postoperative
318061|NCT01789073|Complications|complications
318062|NCT01789073|Elective|elective
318063|NCT01789073|Surgery|surgery
318064|NCT01789073|GI surgery|gi surgery
318065|NCT01789073|Immunonutrition|immunonutrition
318066|NCT01789073|Immune-enhancing|immune-enhancing
318067|NCT01789073|Immune-modulating|immune-modulating
318068|NCT01789073|Nutrition|nutrition
318069|NCT01789073|Pancreatic cancer|pancreatic cancer
318070|NCT01789073|Postoperative complications and length of hospital stay after major gastrointestinal (GI) elective surgery.|postoperative complications and length of hospital stay after major gastrointestinal (gi) elective surgery.
318071|NCT01789047|Parkinson's disease|parkinson's disease
318072|NCT01789047|dyskinesia|dyskinesia
318073|NCT01789047|Indonesia|indonesia
318074|NCT01789047|amantadine|amantadine
318075|NCT01789021|blood glucose monitoring systems|blood glucose monitoring systems
318076|NCT01789021|ISO 15197|iso 15197
318077|NCT01789021|system accuracy|system accuracy
318078|NCT01789008|Transient elastography|transient elastography
318079|NCT01789008|Alcoholic liver disease|alcoholic liver disease
318080|NCT01789008|liver fibrosis|liver fibrosis
318081|NCT01788982|Thyroid Cancer|thyroid cancer
318082|NCT01788982|Medullary thyroid cancer (MTC)|medullary thyroid cancer (mtc)
318083|NCT01788982|Differentiated thyroid cancer (DTC)|differentiated thyroid cancer (dtc)
318084|NCT01788969|Gait training|gait training
318085|NCT01788969|Lexapro|lexapro
318086|NCT01788969|Tizanidine|tizanidine
318087|NCT01788956|venous oximeter|venous oximeter
318088|NCT01788956|CO-Oximeter|co-oximeter
318089|NCT01788956|ICU Patients|icu patients
318090|NCT01788956|Sepsis|sepsis
318091|NCT01788956|non-invasive device|non-invasive device
318092|NCT01788943|positron emission tomography|positron emission tomography
318093|NCT01788943|nicotine receptor|nicotine receptor
318094|NCT01788917|n-3 LC-PUFA, vegetarians, fatty acids, blood lipids|n-3 lc-pufa, vegetarians, fatty acids, blood lipids
318095|NCT01788904|Acute mesenteric ischemia|acute mesenteric ischemia
318096|NCT01788904|Percutaneous endovascular revascularization|percutaneous endovascular revascularization
318097|NCT01788904|Intestinal plasma fatty acid binding protein (i-FABP)|intestinal plasma fatty acid binding protein (i-fabp)
318098|NCT01788904|Bowel necrosis|bowel necrosis
318099|NCT01788891|longitudinal observational cohort study|longitudinal observational cohort study
318100|NCT01788891|multicenter|multicenter
318101|NCT01788891|pediatrics|pediatrics
318102|NCT01788891|Asian|asian
318103|NCT01788891|treatment failure|treatment failure
318104|NCT01788891|renal status|renal status
318105|NCT01788891|toxicities|toxicities
318106|NCT01788891|therapeutic drug monitoring (TDM)|therapeutic drug monitoring (tdm)
318107|NCT01788891|drug levels in blood and hair|drug levels in blood and hair
318108|NCT01788878|socio-professional future|socio-professional future
318109|NCT01788865|covered Metal stent|covered metal stent
318110|NCT01788865|ureteral obstruction|ureteral obstruction
318111|NCT01788852|HPV|hpv
318112|NCT01788852|HIV|hiv
318113|NCT01788852|cervical/anal dysplasia|cervical/anal dysplasia
318114|NCT01788852|intraepithelial neoplasia|intraepithelial neoplasia
318115|NCT01788852|E6/E7 biomarker|e6/e7 biomarker
318116|NCT01788852|perinatally HIV-infected adolescents|perinatally hiv-infected adolescents
318117|NCT01788852|behaviorally HIV-infected adolescents|behaviorally hiv-infected adolescents
318118|NCT01788852|anal and pap smear|anal and pap smear
318119|NCT01788839|Sexual and Reproductive Health|sexual and reproductive health
318120|NCT01788839|premenopausal|premenopausal
318121|NCT01788839|postmenopausal|postmenopausal
318122|NCT01788839|12-249|12-249
318123|NCT01788839|Fertility|fertility
318124|NCT01788826|Ventral hernia|ventral hernia
318125|NCT01788826|surgical meshes|surgical meshes
318126|NCT01788826|polypropylenes|polypropylenes
318127|NCT01788813|Repeat Dose Safety|repeat dose safety
318128|NCT01788813|Allergic Asthma|allergic asthma
318129|NCT01788813|Effect on Allergen Reactivity|effect on allergen reactivity
318130|NCT01788813|Allergic Rhinitis|allergic rhinitis
318131|NCT01788813|TLR7 Agonist|tlr7 agonist
318132|NCT01788813|Pharmacodynamics|pharmacodynamics
318133|NCT01788800|Panic disorder|panic disorder
318134|NCT01788800|Physical activity|physical activity
318135|NCT01788787|Cancer Prevention|cancer prevention
318136|NCT01788787|Tobacco Use Cessation|tobacco use cessation
318137|NCT01788787|Ask Advise Connect|ask advise connect
318138|NCT01788787|AAC|aac
318139|NCT01788787|Smoking Cessation Treatment|smoking cessation treatment
318140|NCT01788787|Texas Quitline|texas quitline
318141|NCT01788787|Saliva sample|saliva sample
318142|NCT01788787|Telephone Counseling|telephone counseling
318143|NCT01788787|Nicotine replacement|nicotine replacement
318144|NCT01788787|Interviews|interviews
318145|NCT01788774|Pharmacokinetics|pharmacokinetics
318146|NCT01788774|Safety|safety
318147|NCT01788774|Risperidone ISM®|risperidone ism®
318148|NCT01788774|Intramuscular|intramuscular
318149|NCT01788774|Schizophrenia|schizophrenia
318150|NCT01788761|Probiotics|probiotics
318151|NCT01788761|Feeding Tolerance|feeding tolerance
318152|NCT01788761|Extremely Low Birthweight Infants|extremely low birthweight infants
318153|NCT01788748|fractional|fractional
318154|NCT01788748|bipolar|bipolar
318155|NCT01788748|radiofrequency|radiofrequency
318156|NCT01788748|striae|striae
318157|NCT01788748|infrared|infrared
318158|NCT01788748|combined|combined
318159|NCT01788735|unexplained infertility|unexplained infertility
318160|NCT01788735|asthma|asthma
318161|NCT01788735|allergy|allergy
318162|NCT01788709|colonoscopy|colonoscopy
318163|NCT01788709|preparation|preparation
318164|NCT01788696|Parkinsonism|parkinsonism
318165|NCT01788696|Idiopathic Parkinson Disease|idiopathic parkinson disease
318166|NCT01788683|Rotator Cuff|rotator cuff
318167|NCT01788683|Rotator Cuff Tear|rotator cuff tear
318168|NCT01788683|Supraspinatus Tear|supraspinatus tear
318169|NCT01788670|Antioxidants, Central Nervous System Agents|antioxidants, central nervous system agents
318170|NCT01788657|Depression|depression
318171|NCT01788657|Internet|internet
318172|NCT01788657|Cognitive Behavior Therapy|cognitive behavior therapy
318173|NCT01788644|Child adiposity|child adiposity
318174|NCT01788644|Infancy|infancy
318175|NCT01788644|Motor activity|motor activity
318176|NCT01788644|Feeding behavior|feeding behavior
318177|NCT01788644|Sleep|sleep
318178|NCT01788644|Stress, Physiological|stress, physiological
318179|NCT01788618|Cognitive functions|cognitive functions
318180|NCT01788618|Quality of life|quality of life
318181|NCT01788618|Cancer|cancer
318182|NCT01788605|hematologic malignancies|hematologic malignancies
318183|NCT01788605|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
318184|NCT01788605|ramosetron|ramosetron
318185|NCT01788605|emesis|emesis
318186|NCT01788592|coronary artery disease|coronary artery disease
318187|NCT01788592|drug eluting stent|drug eluting stent
318188|NCT01788579|Intimate Partner Violence (IPV)|intimate partner violence (ipv)
318189|NCT01788579|Drug Abuse|drug abuse
318190|NCT01788579|Criminal Justice|criminal justice
318191|NCT01788553|remission|remission
318192|NCT01788553|generalized anxiety disorder|generalized anxiety disorder
318193|NCT01788540|Recurrent miscarriage|recurrent miscarriage
318194|NCT01788540|Implantation failure|implantation failure
318195|NCT01788540|Intralipid|intralipid
318196|NCT01788540|ICSI / IVF failure|icsi / ivf failure
318197|NCT01788527|Diabetes|diabetes
318198|NCT01788527|Type 1|type 1
318199|NCT01788527|CGM|cgm
318200|NCT01788527|Continuous Glucose Monitor|continuous glucose monitor
318201|NCT01788527|HGM|hgm
318202|NCT01788527|HbA1c|hba1c
318203|NCT01788488|procalcitonin|procalcitonin
318204|NCT01788488|antimicrobial stewardship|antimicrobial stewardship
318205|NCT01788488|pneumonia|pneumonia
318206|NCT01788475|Diabetic Macular Edema|diabetic macular edema
318207|NCT01788475|DME|dme
318208|NCT01788475|Pars Plana Vitrectomy|pars plana vitrectomy
318209|NCT01788462|Tesamorelin|tesamorelin
318210|NCT01788462|Egrifta|egrifta
318211|NCT01788462|HIV|hiv
318212|NCT01788462|Lipodystrophy|lipodystrophy
318213|NCT01788462|Sleep Apnea|sleep apnea
318214|NCT01788449|Antibiotic Bacterial Resistance|antibiotic bacterial resistance
318215|NCT01788436|Schizophrenia|schizophrenia
318216|NCT01788436|Young healthy volunteers|young healthy volunteers
318217|NCT01788436|Elderly healthy volunteers|elderly healthy volunteers
318218|NCT01788436|Learning performance|learning performance
318219|NCT01788423|presbycusis|presbycusis
318220|NCT01788423|hearing aids|hearing aids
318221|NCT01788410|Cryoablation|cryoablation
318222|NCT01788410|Nerves|nerves
318223|NCT01788410|Facet joint|facet joint
318224|NCT01788410|Pain|pain
318225|NCT01788410|Neuralgia|neuralgia
318226|NCT01788410|Neuropathy|neuropathy
318227|NCT01788410|Image-guided|image-guided
318228|NCT01788397|physical disabilities|physical disabilities
318229|NCT01788397|rehabilitation|rehabilitation
318230|NCT01788384|acne|acne
318231|NCT01788384|Clindamycin Phosphate/Benzoyl Peroxide|clindamycin phosphate/benzoyl peroxide
318232|NCT01788384|Acanya|acanya
318233|NCT01788384|Mild to severe acne vulgaris|mild to severe acne vulgaris
318234|NCT01788358|Drug combination|drug combination
318235|NCT01788358|Nifedipine GITS|nifedipine gits
318236|NCT01788358|Candesartan Cilexetil|candesartan cilexetil
318237|NCT01788358|Hypertension|hypertension
318238|NCT01788358|Combination therapy|combination therapy
318239|NCT01788345|non-invasion ventilation|non-invasion ventilation
318240|NCT01788345|Boussignac|boussignac
318241|NCT01788332|NSCLC|nsclc
318242|NCT01788332|non-small cell|non-small cell
318243|NCT01788332|lung cancer|lung cancer
318244|NCT01788319|laser trabeculoplasty|laser trabeculoplasty
318245|NCT01788319|glaucoma|glaucoma
318246|NCT01788306|Elevated risk|elevated risk
318247|NCT01788306|opioid overdose|opioid overdose
318248|NCT01788293|Fluid management|fluid management
318249|NCT01788293|Pleth Variability Index (PVI)|pleth variability index (pvi)
318250|NCT01788293|monitoring|monitoring
318251|NCT01788293|high-risk surgery|high-risk surgery
318252|NCT01788267|Cystic Fibrosis|cystic fibrosis
318253|NCT01788267|High-Resolution peripheral Quantitative Computed Tomography|high-resolution peripheral quantitative computed tomography
318254|NCT01788267|Bone Mass Density|bone mass density
318255|NCT01788254|pharmacokinetic/genetic|pharmacokinetic/genetic
318256|NCT01788254|Cyp450 polymorphisms|cyp450 polymorphisms
318257|NCT01788254|Noninvasive functional characterization of liver heart and kidneys using MRI|noninvasive functional characterization of liver heart and kidneys using mri
318258|NCT01788241|coronary artery disease|coronary artery disease
318259|NCT01788241|Atherosclerosis|atherosclerosis
318260|NCT01788241|Coronary Stenosis|coronary stenosis
318261|NCT01788241|Cardiovascular Diseases|cardiovascular diseases
318262|NCT01788241|Non-significant coronary artery disease|non-significant coronary artery disease
318263|NCT01788241|Mild Stenosis|mild stenosis
318264|NCT01788241|Vascular Irregularities|vascular irregularities
318265|NCT01788241|Psychosocial factors|psychosocial factors
318266|NCT01788241|Personality|personality
318267|NCT01788241|Type D personality|type d personality
318268|NCT01788241|Hostility|hostility
318269|NCT01788241|Depression|depression
318270|NCT01788241|Anxiety|anxiety
318271|NCT01788241|Fatigue|fatigue
318272|NCT01788241|Social Support|social support
318273|NCT01788241|Socioeconomic Status|socioeconomic status
318274|NCT01788241|Patient Reported Outcomes|patient reported outcomes
318275|NCT01788241|Patient Perceived Symptoms|patient perceived symptoms
318276|NCT01788241|Health Status|health status
318277|NCT01788241|Quality of Life|quality of life
318278|NCT01788241|Chest pain|chest pain
318279|NCT01788241|Cardiac risk factors|cardiac risk factors
318280|NCT01788241|Metabolic Syndrome|metabolic syndrome
318281|NCT01788241|BMI|bmi
318282|NCT01788241|Obesity|obesity
318283|NCT01788241|Waist Circumference|waist circumference
318284|NCT01788241|Lifestyle|lifestyle
318285|NCT01788241|Smoking|smoking
318286|NCT01788241|Alcohol use|alcohol use
318287|NCT01788241|Activity|activity
318288|NCT01788241|Hypertension|hypertension
318289|NCT01788241|Diabetes|diabetes
318290|NCT01788241|Familial Cardiovascular Disease|familial cardiovascular disease
318291|NCT01788241|Coronary angiography|coronary angiography
318292|NCT01788241|Computed Tomography|computed tomography
318293|NCT01788228|Vaccine|vaccine
318294|NCT01788228|Occupational exposure|occupational exposure
318295|NCT01788228|Influenza|influenza
318296|NCT01788228|H5N1|h5n1
318297|NCT01788215|Polycystic Ovarian Syndrome|polycystic ovarian syndrome
318298|NCT01788215|Irregular Menstrual Cycles|irregular menstrual cycles
318299|NCT01788215|Androgen Excess in Women|androgen excess in women
318300|NCT01788202|cocaine and general anesthesia|cocaine and general anesthesia
318301|NCT01788189|Lymphoma|lymphoma
318302|NCT01788189|CD20|cd20
318303|NCT01788189|Relapse|relapse
318304|NCT01788189|Lenalidomide|lenalidomide
318305|NCT01788176|Complex Regional Pain Syndromes|complex regional pain syndromes
318306|NCT01788176|drug therapy|drug therapy
318307|NCT01788176|zoledronic acid|zoledronic acid
318308|NCT01788163|EGFR|egfr
318309|NCT01788163|aNSCLC|ansclc
318310|NCT01788163|mutation status|mutation status
318311|NCT01788163|diagnostic study|diagnostic study
318312|NCT01788163|Russia|russia
318313|NCT01788163|China|china
318314|NCT01788163|Asia|asia
318315|NCT01788137|T-cell lymphoma,DFS,OS|t-cell lymphoma,dfs,os
318316|NCT01788124|Speculum|speculum
318317|NCT01788124|Metal|metal
318318|NCT01788124|Plastic|plastic
318319|NCT01788124|Visual Analoge Scale|visual analoge scale
318320|NCT01788124|Discomfort|discomfort
318321|NCT01788085|GERD|gerd
318322|NCT01788072|Autism Spectrum Disorders|autism spectrum disorders
318323|NCT01788072|Oxytocin|oxytocin
318324|NCT01788072|Adults|adults
318325|NCT01788059|nonunion|nonunion
318326|NCT01788059|mesenchymal stem cell|mesenchymal stem cell
318327|NCT01788059|long bone|long bone
318328|NCT01788046|Secondary Hyperparathyroidism (SHPT), chronic kidney disease (CKD), hemodialysis, parathyroid hormone (PTH), hypocalcemia, bone and mineral metabolism|secondary hyperparathyroidism (shpt), chronic kidney disease (ckd), hemodialysis, parathyroid hormone (pth), hypocalcemia, bone and mineral metabolism
318329|NCT01788007|Actinic Keratosis|actinic keratosis
318330|NCT01788007|Imiquimod Topical Cream 3.75%|imiquimod topical cream 3.75%
318331|NCT01788007|Zyclara® (imiquimod) Topical Cream 3.75%|zyclara® (imiquimod) topical cream 3.75%
318332|NCT01787968|Congenital transmission|congenital transmission
318333|NCT01787968|Trypanosoma cruzi|trypanosoma cruzi
318334|NCT01787968|Chagas disease|chagas disease
318335|NCT01787955|Pylorus preserving pancreaticoduodenectomy(PPPD), Delayed gastric emptying syndrome(DGE), Braun anastomosis|pylorus preserving pancreaticoduodenectomy(pppd), delayed gastric emptying syndrome(dge), braun anastomosis
318336|NCT01787942|Lipid thickness|lipid thickness
318337|NCT01787942|Blepharoplasty|blepharoplasty
318338|NCT01787942|Tear break up time|tear break up time
318339|NCT01787942|Corneal staining|corneal staining
318340|NCT01787916|type 1 diabetes|type 1 diabetes
318341|NCT01787916|overweight|overweight
318342|NCT01787916|insulin|insulin
318343|NCT01787916|liraglutide|liraglutide
318344|NCT01787903|Type 1 diabetes mellitus|type 1 diabetes mellitus
318345|NCT01787903|Hypoglycemia unawareness|hypoglycemia unawareness
318346|NCT01787903|Real-time continuous glucose monitoring|real-time continuous glucose monitoring
318347|NCT01787903|Glucose control|glucose control
318348|NCT01787877|Cerebrovascular Accident, Inflammatory biomarkers|cerebrovascular accident, inflammatory biomarkers
318349|NCT01787864|Barrett's Esophagus|barrett's esophagus
318350|NCT01787864|Intestinal metaplasia|intestinal metaplasia
318351|NCT01787864|Intramucosal Adenocarcinoma|intramucosal adenocarcinoma
318352|NCT01787864|Gastric Cardia|gastric cardia
318353|NCT01787864|High Cardia Dysplasia|high cardia dysplasia
318354|NCT01787864|Radiofrequency ablation (RFA)|radiofrequency ablation (rfa)
318355|NCT01787851|Heart failure|heart failure
318356|NCT01787851|Anaplerosis|anaplerosis
318357|NCT01787851|Medium-chain fatty acid|medium-chain fatty acid
318358|NCT01787838|Pneumococcal vaccination rates, ambulatory settings|pneumococcal vaccination rates, ambulatory settings
318359|NCT01787825|intestinal disease|intestinal disease
318360|NCT01787825|inflammatory bowel disease|inflammatory bowel disease
318361|NCT01787825|crohn disease|crohn disease
318362|NCT01787825|ulcer|ulcer
318363|NCT01787825|celiac disease|celiac disease
318364|NCT01787825|angioectasia|angioectasia
318365|NCT01787825|polyp|polyp
318366|NCT01787799|Drug-eluting stents|drug-eluting stents
318367|NCT01787786|Crohn's Disease|crohn's disease
318368|NCT01787786|Ulcerative Colitis|ulcerative colitis
318369|NCT01787786|Optimal Use of infliximab|optimal use of infliximab
318370|NCT01787773|Inferior Vena Cava Filter|inferior vena cava filter
318371|NCT01787773|Vena Cava Filters|vena cava filters
318372|NCT01787747|Pharmacokinetics|pharmacokinetics
318373|NCT01787747|Healthy Volunteers|healthy volunteers
318374|NCT01787747|dextromethorphan with quinidine|dextromethorphan with quinidine
318375|NCT01787747|deuterated dextromethorphan|deuterated dextromethorphan
318377|NCT01787721|Ankle joint|ankle joint
318378|NCT01787721|Manipulation, Chiropractic|manipulation, chiropractic
318379|NCT01787708|Vitiligo|vitiligo
318380|NCT01787708|red|red
318381|NCT01787708|laser|laser
318382|NCT01787708|light|light
318383|NCT01787695|Vitiligo|vitiligo
318384|NCT01787695|UVA1|uva1
318385|NCT01787695|Phototherapy|phototherapy
318386|NCT01787682|CHF|chf
318387|NCT01787682|Protein digestion|protein digestion
318388|NCT01787682|Fat digestion|fat digestion
318389|NCT01787682|Gut function|gut function
318390|NCT01787682|Glucose absorption|glucose absorption
318391|NCT01787682|Muscle function|muscle function
318392|NCT01787669|diabetic macular oedema|diabetic macular oedema
318393|NCT01787669|diabetic macular edema|diabetic macular edema
318394|NCT01787669|diabetic retinopathy|diabetic retinopathy
318395|NCT01787669|dexamethasone|dexamethasone
318396|NCT01787669|Ozurdex|ozurdex
318397|NCT01787669|Avastin|avastin
318398|NCT01787669|bevacizumab|bevacizumab
318399|NCT01787669|DME|dme
318400|NCT01787669|DMO|dmo
318401|NCT01787643|height-adjustable desk|height-adjustable desk
318402|NCT01787643|office workers|office workers
318403|NCT01787643|sitting occupations|sitting occupations
318404|NCT01787643|energy expenditure|energy expenditure
318405|NCT01787643|BMI|bmi
318406|NCT01787643|Weight|weight
318407|NCT01787643|Lower fat diet|lower fat diet
318408|NCT01787630|Prostatic cancer|prostatic cancer
318409|NCT01787630|Radiotherapy|radiotherapy
318410|NCT01787630|Hyaluronic acid|hyaluronic acid
318411|NCT01787617|Exercise Training|exercise training
318412|NCT01787617|Strength Training|strength training
318413|NCT01787617|African American Men|african american men
318414|NCT01787617|Insulin Resistance|insulin resistance
318415|NCT01787604|Valve-sparing|valve-sparing
318416|NCT01787604|Valve repair|valve repair
318417|NCT01787591|Vitamin E|vitamin e
318418|NCT01787591|Metabolic syndrome|metabolic syndrome
318419|NCT01787591|Liver disease|liver disease
318420|NCT01787591|Non-alcoholic liver steatohepatitis|non-alcoholic liver steatohepatitis
318421|NCT01787591|Fatty liver|fatty liver
318422|NCT01787591|Dairy consumption|dairy consumption
318423|NCT01787578|X-linked adrenoleukodystrophy|x-linked adrenoleukodystrophy
318424|NCT01787578|adrenomyeloneuropathy|adrenomyeloneuropathy
318425|NCT01787578|sobetirome|sobetirome
318426|NCT01787578|thyroid|thyroid
318427|NCT01787578|thyromimetic|thyromimetic
318428|NCT01787565|non-interventional|non-interventional
318429|NCT01787565|clinical|clinical
318430|NCT01787565|investigation|investigation
318431|NCT01787565|low|low
318432|NCT01787565|back|back
318433|NCT01787565|pain|pain
318434|NCT01787565|painPREMIER|painpremier
318435|NCT01787552|Dose escalation|dose escalation
318436|NCT01787552|Maximum Tolerated Dose|maximum tolerated dose
318437|NCT01787552|MTD|mtd
318438|NCT01787552|Safety Expansion|safety expansion
318439|NCT01787552|Safety|safety
318440|NCT01787552|Efficacy|efficacy
318441|NCT01787552|Myelofibrosis|myelofibrosis
318442|NCT01787552|Post-polycythemia vera myelofbrosis (Post PV-PMF)|post-polycythemia vera myelofbrosis (post pv-pmf)
318443|NCT01787552|Post essential thrombocythemia myelofibrosis (Post ET-MF)|post essential thrombocythemia myelofibrosis (post et-mf)
318444|NCT01787552|Primary myelofibrosis (PMF)|primary myelofibrosis (pmf)
318445|NCT01787552|Intermediate risk myelofibrosis|intermediate risk myelofibrosis
318446|NCT01787552|High risk myelofibrosis|high risk myelofibrosis
318447|NCT01787552|Combination Treatment|combination treatment
318448|NCT01787552|Hedgehog Signaling Pathway|hedgehog signaling pathway
318449|NCT01787552|Smoothened inhibitor|smoothened inhibitor
318450|NCT01787552|JAK inhibitor|jak inhibitor
318451|NCT01787539|gastric cancer|gastric cancer
318452|NCT01787539|perioperative chemotherapy|perioperative chemotherapy
318453|NCT01787539|combined modality therapy|combined modality therapy
318454|NCT01787539|gastrectomy|gastrectomy
318455|NCT01787526|iron depletion|iron depletion
318456|NCT01787526|donor safety|donor safety
318457|NCT01787526|blood donation|blood donation
318458|NCT01787526|transfusion medicine|transfusion medicine
318459|NCT01787526|iron deficiency|iron deficiency
318460|NCT01787526|intravenous iron|intravenous iron
318461|NCT01787526|fatigue|fatigue
318462|NCT01787526|restless legs syndrome|restless legs syndrome
318463|NCT01787526|anemia|anemia
318464|NCT01787500|Advanced Cancers|advanced cancers
318465|NCT01787500|Advanced Solid Cancers|advanced solid cancers
318466|NCT01787500|BRAF V600 Mutant Advanced Solid Malignancies|braf v600 mutant advanced solid malignancies
318467|NCT01787500|Metastatic|metastatic
318468|NCT01787500|Unresectable|unresectable
318469|NCT01787500|BRAF mutant, KRAS wild type colorectal cancer|braf mutant, kras wild type colorectal cancer
318470|NCT01787500|BRAF mutant, KRAS wild type solid tumor cancers|braf mutant, kras wild type solid tumor cancers
318471|NCT01787500|Vemurafenib|vemurafenib
318472|NCT01787500|PLX4032|plx4032
318473|NCT01787500|RO5185426|ro5185426
318474|NCT01787500|Cetuximab|cetuximab
318475|NCT01787500|C225|c225
318476|NCT01787500|Erbitux|erbitux
318477|NCT01787500|IMC-C225|imc-c225
318478|NCT01787500|Irinotecan|irinotecan
318479|NCT01787500|CPT-11|cpt-11
318480|NCT01787500|Camptosar|camptosar
318481|NCT01787487|Leukemia|leukemia
318482|NCT01787487|Myelofibrosis|myelofibrosis
318483|NCT01787487|Myelodysplastic syndrome|myelodysplastic syndrome
318484|NCT01787487|Myeloproliferative neoplasm|myeloproliferative neoplasm
318485|NCT01787487|Ruxolitinib|ruxolitinib
318486|NCT01787487|RUX|rux
318487|NCT01787487|Jakafi|jakafi
318488|NCT01787487|INCB018424|incb018424
318489|NCT01787487|INC424|inc424
318490|NCT01787487|Azacitidine|azacitidine
318491|NCT01787487|AZA|aza
318492|NCT01787487|5-Azacitidine|5-azacitidine
318493|NCT01787487|5-aza|5-aza
318494|NCT01787487|Vidaza|vidaza
318495|NCT01787487|5-AZC|5-azc
318496|NCT01787487|AZA-CR|aza-cr
318497|NCT01787487|Ladakamycin|ladakamycin
318498|NCT01787487|NSC-102816|nsc-102816
318499|NCT01787474|Leukemia|leukemia
318500|NCT01787474|Acute Myeloid Leukemia|acute myeloid leukemia
318501|NCT01787474|Blood And Marrow Transplantation|blood and marrow transplantation
318502|NCT01787474|Natural killer cells|natural killer cells
318503|NCT01787474|NK|nk
318504|NCT01787474|mbIL21-expanded haploidentical NK cells|mbil21-expanded haploidentical nk cells
318505|NCT01787474|G-CSF|g-csf
318506|NCT01787474|Filgrastim|filgrastim
318507|NCT01787474|Neupogen|neupogen
318508|NCT01787474|Fludarabine monophosphate|fludarabine monophosphate
318509|NCT01787474|Fludarabine Phosphate|fludarabine phosphate
318510|NCT01787474|Fludara|fludara
318511|NCT01787474|Cytarabine|cytarabine
318512|NCT01787474|Ara-C|ara-c
318513|NCT01787474|Cytosar|cytosar
318514|NCT01787474|DepoCyt|depocyt
318515|NCT01787474|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
318516|NCT01787461|Trial assessing effects of an oral dietary supplement on overall facial appearance among healthy women with photodamaged skin.|trial assessing effects of an oral dietary supplement on overall facial appearance among healthy women with photodamaged skin.
318517|NCT01787448|repeat insult patch test|repeat insult patch test
318518|NCT01787435|Asthma,|asthma,
318519|NCT01787435|acid-suppressing drugs,|acid-suppressing drugs,
318520|NCT01787435|pregnancy,|pregnancy,
318521|NCT01787435|epidemiology|epidemiology
318522|NCT01787422|Telemedicine|telemedicine
318523|NCT01787383|Actinic Keratosis|actinic keratosis
318524|NCT01787383|Ingenol mebutate gel|ingenol mebutate gel
318525|NCT01787370|coronary artery disease, endothelial dysfunction|coronary artery disease, endothelial dysfunction
318526|NCT01787357|Healthy|healthy
318527|NCT01787357|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
318528|NCT01787357|Pharmacokinetics|pharmacokinetics
318529|NCT01787357|Moxifloxacin|moxifloxacin
318530|NCT01787357|Electrocardiogram Parameters|electrocardiogram parameters
318531|NCT01787357|QT/QTc Interval|qt/qtc interval
318532|NCT01787357|Therapeutic dose|therapeutic dose
318533|NCT01787357|Supra-Therapeutic dose|supra-therapeutic dose
318534|NCT01787344|Other Infantile Cerebral Palsy|other infantile cerebral palsy
318535|NCT01787305|microbiome|microbiome
318536|NCT01787305|commensals|commensals
318537|NCT01787305|autoantibodies|autoantibodies
318538|NCT01787305|autoreactive T cells|autoreactive t cells
318539|NCT01787292|Exercise|exercise
318540|NCT01787292|Magnetic Resonance Imaging|magnetic resonance imaging
318541|NCT01787292|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
318542|NCT01787292|Aging|aging
318543|NCT01787214|glucose variability|glucose variability
318544|NCT01787214|glycemia|glycemia
318545|NCT01787214|type-2 diabetes|type-2 diabetes
318546|NCT01787175|Medication Therapy Management|medication therapy management
318547|NCT01787175|Clinical Decision Support Systems|clinical decision support systems
318548|NCT01787175|Medical Informatics|medical informatics
318549|NCT01787175|Patient Care Management|patient care management
318550|NCT01787175|United States Department of Veterans Affairs|united states department of veterans affairs
318551|NCT01787162|Myeloproliferative disorders|myeloproliferative disorders
318552|NCT01787162|pulmonary hypertension|pulmonary hypertension
318553|NCT01787162|pulmonary vascular diseases|pulmonary vascular diseases
318554|NCT01787149|ENIA11|enia11
318555|NCT01787149|DMARDs|dmards
318556|NCT01787149|RA|ra
318557|NCT01787149|TNF|tnf
318558|NCT01787110|Acute coronary syndrome|acute coronary syndrome
318559|NCT01787110|Acute myocardial infarction|acute myocardial infarction
318560|NCT01787110|Non ST-segment Myocardial Infarction|non st-segment myocardial infarction
318561|NCT01787110|ST-segment Myocardial Infarction|st-segment myocardial infarction
318562|NCT01787110|STEMI|stemi
318563|NCT01787110|NSTEMI|nstemi
318564|NCT01787110|Oxygen|oxygen
318565|NCT01787110|Unstable angina|unstable angina
318566|NCT01787110|Randomised trial|randomised trial
318567|NCT01787110|CMR|cmr
318568|NCT01787110|Mortality|mortality
318569|NCT01787110|RCRT|rcrt
318570|NCT01787110|RRCT|rrct
318571|NCT01787084|Aortic Stenosis|aortic stenosis
318572|NCT01787084|TAVR|tavr
318573|NCT01787071|fluids|fluids
318574|NCT01787071|crtically ill patients|crtically ill patients
318575|NCT01787071|functional hemodynamics|functional hemodynamics
318576|NCT01787071|cvp|cvp
318577|NCT01787058|WASH|wash
318578|NCT01787058|schoolchildren|schoolchildren
318579|NCT01787058|absenteeism|absenteeism
318580|NCT01787045|SEPSIS|sepsis
318581|NCT01787006|non resectable|non resectable
318582|NCT01787006|locally advanced|locally advanced
318583|NCT01787006|Cetuximab|cetuximab
318584|NCT01787006|radiation|radiation
318585|NCT01786967|overactive bladder|overactive bladder
318586|NCT01786967|urge urinary incontinence|urge urinary incontinence
318587|NCT01786967|pharmacogenetics|pharmacogenetics
318588|NCT01786954|vitreoretinal surgery|vitreoretinal surgery
318589|NCT01786954|intraocular pressure|intraocular pressure
318590|NCT01786954|applanation|applanation
318591|NCT01786954|rebound|rebound
318592|NCT01786954|tonometry|tonometry
318593|NCT01786941|Branched-chain Amino Acids|branched-chain amino acids
318594|NCT01786941|Insulin Sensitivity|insulin sensitivity
318595|NCT01786941|Exercise|exercise
318596|NCT01786941|Leucine|leucine
318597|NCT01786928|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
318598|NCT01786928|exacerbation|exacerbation
318599|NCT01786928|resistance training|resistance training
318600|NCT01786928|muscle force|muscle force
318601|NCT01786902|growth hormone|growth hormone
318602|NCT01786876|AME|ame
318603|NCT01786876|Radiolabelled|radiolabelled
318604|NCT01786850|Locally advanced Pancreatic Cancer|locally advanced pancreatic cancer
318896|NCT01785615|women|women
318605|NCT01786850|Noninvasive treatment|noninvasive treatment
318606|NCT01786850|High Intensity focused ultrasound|high intensity focused ultrasound
318607|NCT01786850|Magnetic Resonance|magnetic resonance
318608|NCT01786837|constipation|constipation
318609|NCT01786837|gastric emptying|gastric emptying
318610|NCT01786824|contrast induced nephropathy|contrast induced nephropathy
318611|NCT01786824|hydration strategy|hydration strategy
318612|NCT01786824|L-carnitine|l-carnitine
318613|NCT01786798|Transvaginal sonography|transvaginal sonography
318614|NCT01786798|Endometrial thickness|endometrial thickness
318615|NCT01786798|Endometrial pattern|endometrial pattern
318616|NCT01786798|Abnormal uterine bleeding|abnormal uterine bleeding
318617|NCT01786798|Endometrial hyperplasia|endometrial hyperplasia
318618|NCT01786798|Endometrial cancer|endometrial cancer
318619|NCT01786772|arthroscopic partial meniscectomy|arthroscopic partial meniscectomy
318620|NCT01786772|meniscus|meniscus
318621|NCT01786772|quadriceps strength|quadriceps strength
318622|NCT01786772|quadriceps voluntary activation|quadriceps voluntary activation
318623|NCT01786772|cryotherapy|cryotherapy
318624|NCT01786772|compression|compression
318625|NCT01786772|vasopneumatic compression|vasopneumatic compression
318626|NCT01786772|intermittent pneumatic compression|intermittent pneumatic compression
318627|NCT01786759|lipids|lipids
318628|NCT01786759|preterm infants|preterm infants
318629|NCT01786759|parenteral nutrition|parenteral nutrition
318630|NCT01786759|liver function|liver function
318631|NCT01786746|depression|depression
318632|NCT01786746|cognitive behavioral therapy|cognitive behavioral therapy
318633|NCT01786746|culture|culture
318634|NCT01786746|Chinese Americans|chinese americans
318635|NCT01786746|psychotherapy|psychotherapy
318636|NCT01786733|Acute Inpatient Psychiatry|acute inpatient psychiatry
318637|NCT01786733|Continuity of Care|continuity of care
318638|NCT01786733|Behavioral Activation|behavioral activation
318639|NCT01786733|Depression|depression
318640|NCT01786720|COPD|copd
318641|NCT01786720|Triple Therapy|triple therapy
318642|NCT01786720|ICS|ics
318643|NCT01786720|LABA|laba
318644|NCT01786720|LAMA|lama
318645|NCT01786707|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
318646|NCT01786707|Hyperbaric oxygen therapy (HOT)|hyperbaric oxygen therapy (hot)
318647|NCT01786707|Autologous Bone Marrow-Derived Buffy Coat|autologous bone marrow-derived buffy coat
318648|NCT01786707|Stem cells (SC)|stem cells (sc)
318649|NCT01786694|rectum|rectum
318650|NCT01786694|microdialysis|microdialysis
318651|NCT01786694|quality of life|quality of life
318652|NCT01786681|Morbid obesity|morbid obesity
318653|NCT01786681|Bariatric Surgery|bariatric surgery
318654|NCT01786681|Pulmonary Atelectasis|pulmonary atelectasis
318655|NCT01786681|Spirometry|spirometry
318656|NCT01786681|Continuous Positive Airway Pressure|continuous positive airway pressure
318657|NCT01786681|Physical Therapy Specialty|physical therapy specialty
318658|NCT01786668|Ankylosing Spondylitis|ankylosing spondylitis
318659|NCT01786668|Spondylitis|spondylitis
318660|NCT01786668|Ankylosing|ankylosing
318661|NCT01786668|Spondyloarthritis|spondyloarthritis
318662|NCT01786668|Spondyloarthropathy|spondyloarthropathy
318663|NCT01786668|Oral preparation|oral preparation
318664|NCT01786655|local anesthetic|local anesthetic
318665|NCT01786655|neosaxitoxin|neosaxitoxin
318666|NCT01786655|neoSTX|neostx
318667|NCT01786655|bupivacaine|bupivacaine
318668|NCT01786655|safety|safety
318669|NCT01786655|phase 1|phase 1
318670|NCT01786655|pharmacokinetic|pharmacokinetic
318671|NCT01786577|Neuroimaging Biomarkers|neuroimaging biomarkers
318672|NCT01786577|Cognitive Decline in Elderly|cognitive decline in elderly
318673|NCT01786577|Memory, Thinking problems for Older Adults|memory, thinking problems for older adults
318674|NCT01786577|Executive Decline|executive decline
318675|NCT01786577|Post-operative cognitive change|post-operative cognitive change
318676|NCT01786564|diabetes|diabetes
318677|NCT01786564|sleep|sleep
318678|NCT01786525|Live Donor Kidney Transplantation|live donor kidney transplantation
318679|NCT01786525|LDKT|ldkt
318680|NCT01786525|African American|african american
318681|NCT01786525|Disparity|disparity
318682|NCT01786525|Education|education
318683|NCT01786525|Patient Support|patient support
318684|NCT01786512|Pharmacokinetics|pharmacokinetics
318685|NCT01786512|Omecamtiv mecarbil|omecamtiv mecarbil
318686|NCT01786512|AMG 423|amg 423
318687|NCT01786512|Double-blind|double-blind
318688|NCT01786512|Randomized|randomized
318689|NCT01786512|Placebo-controlled|placebo-controlled
318690|NCT01786512|Oral forumlation|oral forumlation
318691|NCT01786512|CK-1827452|ck-1827452
318692|NCT01786512|Cardiac myosin activator|cardiac myosin activator
318693|NCT01786499|Burnout|burnout
318694|NCT01786499|Stress|stress
318695|NCT01786499|Provider|provider
318696|NCT01786499|Relaxation Response|relaxation response
318697|NCT01786434|colonoscopy|colonoscopy
318698|NCT01786434|pain|pain
318699|NCT01786421|Ethanol|ethanol
318700|NCT01786421|Lipemia|lipemia
318701|NCT01786421|Postprandial|postprandial
318702|NCT01786421|Triglyceride|triglyceride
318703|NCT01786395|UF-021|uf-021
318704|NCT01786395|unoprostone|unoprostone
318705|NCT01786395|rp|rp
318706|NCT01786369|Schizophrenia|schizophrenia
318707|NCT01786369|Psychotic Disorders|psychotic disorders
318708|NCT01786369|Bipolar Disorder|bipolar disorder
318709|NCT01786369|Antipsychotic Agents|antipsychotic agents
318710|NCT01786369|Drug Monitoring|drug monitoring
318711|NCT01786356|posterior capsule opacification|posterior capsule opacification
318712|NCT01786356|PCO|pco
318713|NCT01786356|after cataract|after cataract
318714|NCT01786356|intraocular lens|intraocular lens
318715|NCT01786343|Leukemia|leukemia
318716|NCT01786343|Acute myeloid leukemia|acute myeloid leukemia
318717|NCT01786343|AML|aml
318718|NCT01786343|Response rates|response rates
318719|NCT01786343|Decitabine|decitabine
318720|NCT01786343|Dacogen|dacogen
318721|NCT01786317|Fecal incontinence, ano-rectal manometry|fecal incontinence, ano-rectal manometry
318722|NCT01786304|Fecal incontinence, sacral nerve stimulation|fecal incontinence, sacral nerve stimulation
318723|NCT01786291|obstructive sleep apnea|obstructive sleep apnea
318724|NCT01786291|continuous positive airway pressure|continuous positive airway pressure
318725|NCT01786291|cardiopulmonary exercise test|cardiopulmonary exercise test
318726|NCT01786291|VE/VCO2|ve/vco2
318727|NCT01786278|adenocarcinoma|adenocarcinoma
318728|NCT01786278|esophago-gastric junction|esophago-gastric junction
318729|NCT01786278|dysphagia|dysphagia
318730|NCT01786278|brachytherapy|brachytherapy
318731|NCT01786278|endoscopic stenting|endoscopic stenting
318732|NCT01786265|Prostate Cancer|prostate cancer
318733|NCT01786265|PSA Progression After Prostatectomy and/or Radiotherapy|psa progression after prostatectomy and/or radiotherapy
318734|NCT01786265|Prostate specific antigen|prostate specific antigen
318735|NCT01786265|PSA|psa
318736|NCT01786265|Luteinizing-hormone-releasing hormone|luteinizing-hormone-releasing hormone
318737|NCT01786265|LHRH|lhrh
318738|NCT01786265|Finite maximal androgen ablation|finite maximal androgen ablation
318739|NCT01786265|Lupron|lupron
318740|NCT01786265|Leuprolide Acetate|leuprolide acetate
318741|NCT01786265|Lupron Depot|lupron depot
318742|NCT01786265|Zoladex|zoladex
318743|NCT01786265|Goserelin|goserelin
318744|NCT01786265|Degarelix|degarelix
318745|NCT01786265|Abiraterone Acetate|abiraterone acetate
318746|NCT01786265|Zytiga|zytiga
318747|NCT01786265|Prednisone|prednisone
318748|NCT01786252|embryo|embryo
318749|NCT01786252|implantation|implantation
318750|NCT01786252|blastocyst|blastocyst
318751|NCT01786252|in vitro fertilization|in vitro fertilization
318752|NCT01786252|human chorionic gonadotropin|human chorionic gonadotropin
318753|NCT01786239|Adolescence|adolescence
318754|NCT01786239|Adult|adult
318755|NCT01786239|Antipsychotic Agents|antipsychotic agents
318756|NCT01786239|Female|female
318757|NCT01786239|Human|human
318758|NCT01786239|Male|male
318759|NCT01786239|Risperidone|risperidone
318760|NCT01786239|Omega-3|omega-3
318761|NCT01786239|Schizophrenia|schizophrenia
318762|NCT01786239|Schizophreniform|schizophreniform
318763|NCT01786239|Schizoaffective|schizoaffective
318764|NCT01786239|Schizophrenia -- *drug therapy|schizophrenia -- *drug therapy
318765|NCT01786226|leiomyoma, fibroid, mifepristone, antiprogestins|leiomyoma, fibroid, mifepristone, antiprogestins
318766|NCT01786213|adenoma detection rate, colonoscopy, trainee, learning curve|adenoma detection rate, colonoscopy, trainee, learning curve
318767|NCT01786200|colon|colon
318768|NCT01786200|cancer|cancer
318769|NCT01786200|NSAID|nsaid
318770|NCT01786200|inflammation|inflammation
318771|NCT01786187|Lung Cancer|lung cancer
318772|NCT01786187|Symptoms|symptoms
318774|NCT01786174|Gilenya|gilenya
318775|NCT01786174|Fingolimod|fingolimod
318776|NCT01786148|HIV/AIDS|hiv/aids
318777|NCT01786148|Adherence|adherence
318778|NCT01786148|Self-management|self-management
318779|NCT01786148|Antiretroviral therapy|antiretroviral therapy
318780|NCT01786135|Antibodies, Monoclonal|antibodies, monoclonal
318781|NCT01786135|Antibody-Drug Conjugate|antibody-drug conjugate
318782|NCT01786135|Antigens, CD19|antigens, cd19
318783|NCT01786135|B-Lineage Lymphoblastic Lymphoma|b-lineage lymphoblastic lymphoma
318784|NCT01786135|Burkitt Lymphoma|burkitt lymphoma
318785|NCT01786135|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
318786|NCT01786135|Mantle Cell Lymphoma|mantle cell lymphoma
318787|NCT01786135|B-Cell Lymphoma|b-cell lymphoma
318788|NCT01786135|Drug Therapy|drug therapy
318789|NCT01786135|Monomethylauristatin F|monomethylauristatin f
318790|NCT01786135|Follicular Lymphoma Grade 3|follicular lymphoma grade 3
318791|NCT01786122|physical exercise|physical exercise
318792|NCT01786122|Health Related Quality of Life|health related quality of life
318793|NCT01786122|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
318794|NCT01786122|digestive system neoplasms|digestive system neoplasms
318795|NCT01786122|breast neoplasms|breast neoplasms
318796|NCT01786109|anandamide|anandamide
318797|NCT01786109|cannabinoid|cannabinoid
318798|NCT01786109|fatty acid amide hydrolase|fatty acid amide hydrolase
318799|NCT01786109|gastric|gastric
318800|NCT01786109|motility|motility
318801|NCT01786109|small bowel|small bowel
318802|NCT01786109|sensory|sensory
318803|NCT01786109|motor|motor
318804|NCT01786096|Burkitt Lymphoma|burkitt lymphoma
318805|NCT01786096|Antibodies, Monoclonal|antibodies, monoclonal
318806|NCT01786096|Antibody-Drug Conjugate|antibody-drug conjugate
318807|NCT01786096|B-Lineage Acute Lymphoblastic Leukemia|b-lineage acute lymphoblastic leukemia
318808|NCT01786096|B-Lineage Lymphoblastic Lymphoma|b-lineage lymphoblastic lymphoma
318809|NCT01786096|Burkitt Leukemia|burkitt leukemia
318810|NCT01786096|Monomethylauristatin F|monomethylauristatin f
318811|NCT01786096|Antigens, CD19|antigens, cd19
318812|NCT01786096|Drug Therapy|drug therapy
318813|NCT01786083|family caregivers|family caregivers
318814|NCT01786083|dependency|dependency
318815|NCT01786083|Problem Solving Technique|problem solving technique
318816|NCT01786083|home based nursing|home based nursing
318817|NCT01786044|patient education|patient education
318818|NCT01786044|primary health care|primary health care
318819|NCT01786018|Non Hodgkin lymphomas|non hodgkin lymphomas
318820|NCT01786018|Allogeneic Transplantation|allogeneic transplantation
318821|NCT01786018|Thiotepa|thiotepa
318822|NCT01786018|Busulfan|busulfan
318823|NCT01786018|Fludarabin|fludarabin
318824|NCT01785992|Oestrogen receptor|oestrogen receptor
318825|NCT01785992|Locally advanced|locally advanced
318826|NCT01785992|Metastatic|metastatic
318827|NCT01785992|Breast cancer|breast cancer
318828|NCT01785992|Sulfatase inhibitor|sulfatase inhibitor
318829|NCT01785966|Critical care|critical care
318830|NCT01785966|quality improvement|quality improvement
318831|NCT01785966|checklist|checklist
318832|NCT01785940|Interscalene Block|interscalene block
318833|NCT01785940|Perineural catheter|perineural catheter
318834|NCT01785940|Ropivacaine|ropivacaine
318835|NCT01785940|Postoperative pain|postoperative pain
318836|NCT01785940|Home regional|home regional
318837|NCT01785927|Antituberculosis|antituberculosis
318838|NCT01785927|Dry powder aerosols|dry powder aerosols
318839|NCT01785927|Inhalation|inhalation
318840|NCT01785901|asthma|asthma
318841|NCT01785901|control rate|control rate
318842|NCT01785901|budesonide/formoterol|budesonide/formoterol
318843|NCT01785901|Non-Interventional study|non-interventional study
318844|NCT01785888|EGFR,|egfr,
318845|NCT01785888|aNSCLC,|ansclc,
318846|NCT01785888|mutation status,|mutation status,
318847|NCT01785888|diagnostic study,|diagnostic study,
318848|NCT01785888|Europe,|europe,
318849|NCT01785888|Japan|japan
318850|NCT01785875|Secondary Hyperparathyroidism (SHPT), chronic kidney disease (CKD), hemodialysis, parathyroid hormone (PTH), hypocalcemia, bone and mineral metabolism|secondary hyperparathyroidism (shpt), chronic kidney disease (ckd), hemodialysis, parathyroid hormone (pth), hypocalcemia, bone and mineral metabolism
318851|NCT01785862|sore throat pain|sore throat pain
318852|NCT01785862|tonsillopharyngitis|tonsillopharyngitis
318853|NCT01785862|upper respiratory tract infection|upper respiratory tract infection
318854|NCT01785849|Secondary Hyperparathyroidism (SHPT), chronic kidney disease (CKD), hemodialysis, parathyroid hormone (PTH), hypocalcemia, bone and mineral metabolism|secondary hyperparathyroidism (shpt), chronic kidney disease (ckd), hemodialysis, parathyroid hormone (pth), hypocalcemia, bone and mineral metabolism
318855|NCT01785823|analgesia|analgesia
318856|NCT01785823|fentanyl|fentanyl
318857|NCT01785823|total intravenous anesthesia|total intravenous anesthesia
318858|NCT01785758|complications, renal;|complications, renal;
318859|NCT01785758|kidney, failure;|kidney, failure;
318860|NCT01785758|neuromuscular block, antagonism;|neuromuscular block, antagonism;
318861|NCT01785758|neuromuscular block, rocuronium;|neuromuscular block, rocuronium;
318862|NCT01785758|safety, drug|safety, drug
318863|NCT01785758|sugammadex|sugammadex
318864|NCT01785745|conservative treatment|conservative treatment
318865|NCT01785745|shoulder|shoulder
318866|NCT01785745|neurocognitive therapeutic exercise|neurocognitive therapeutic exercise
318867|NCT01785745|traditional therapeutic exercise|traditional therapeutic exercise
318868|NCT01785745|pain|pain
318869|NCT01785719|Weight Loss|weight loss
318870|NCT01785719|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
318871|NCT01785719|Ovarian Follicle Development|ovarian follicle development
318872|NCT01785719|Metabolism|metabolism
318873|NCT01785693|Nerve block|nerve block
318874|NCT01785693|Femoropopliteal bypass|femoropopliteal bypass
318875|NCT01785693|Postoperative analgesia|postoperative analgesia
318876|NCT01785693|Peripheral circulation|peripheral circulation
318877|NCT01785693|Levobupivacaine|levobupivacaine
318878|NCT01785693|Clonidine|clonidine
318879|NCT01785693|Pain|pain
318880|NCT01785680|MAM|mam
318881|NCT01785680|SAM|sam
318882|NCT01785654|Reventilation collapse|reventilation collapse
318883|NCT01785654|Rate of reventilation collapse|rate of reventilation collapse
318884|NCT01785654|Risk factor of reventilation collapse|risk factor of reventilation collapse
318885|NCT01785654|Hemodynamic profile of reventilation collapse|hemodynamic profile of reventilation collapse
318886|NCT01785654|Biologic approach of reventilation collapse|biologic approach of reventilation collapse
318887|NCT01785641|peritoneal dialysis|peritoneal dialysis
318888|NCT01785641|peritonitis|peritonitis
318889|NCT01785628|Parkinson's disease|parkinson's disease
318890|NCT01785628|dementia|dementia
318891|NCT01785628|NMDA|nmda
318892|NCT01785628|event related potential|event related potential
318893|NCT01785628|Bereitschaftspotential|bereitschaftspotential
318894|NCT01785615|metabolic syndrome|metabolic syndrome
318895|NCT01785615|atorvastatin|atorvastatin
318897|NCT01785602|Atopic eczema|atopic eczema
318898|NCT01785602|Skin Diseases|skin diseases
318899|NCT01785589|coronary artery disease|coronary artery disease
318900|NCT01785589|cardiac nuclear medicine|cardiac nuclear medicine
318901|NCT01785589|myocardial perfusion imaging|myocardial perfusion imaging
318902|NCT01785589|invasive coronary angiography|invasive coronary angiography
318903|NCT01785576|couples|couples
318904|NCT01785576|head and neck cancer|head and neck cancer
318905|NCT01785576|oncology|oncology
318906|NCT01785576|spousal support|spousal support
318907|NCT01785563|NAVA|nava
318908|NCT01785563|NIV-NAVA|niv-nava
318909|NCT01785563|VLBW|vlbw
318910|NCT01785563|electrical activity of the diaphragm|electrical activity of the diaphragm
318911|NCT01785563|neural trigger, mechanical ventilation|neural trigger, mechanical ventilation
318912|NCT01785563|respiratory distress syndrome|respiratory distress syndrome
318913|NCT01785537|e-cigarette smoking|e-cigarette smoking
318914|NCT01785537|cigarette smoking|cigarette smoking
318915|NCT01785537|cardiovascular disease|cardiovascular disease
318916|NCT01785537|hospitalization|hospitalization
318917|NCT01785537|chronic obstructive pulmonary diseases|chronic obstructive pulmonary diseases
318918|NCT01785537|observational study|observational study
318919|NCT01785537|efficacy|efficacy
318920|NCT01785537|safety|safety
318921|NCT01785524|Cardiovascular Diseases|cardiovascular diseases
318922|NCT01785524|Vascular Diseases|vascular diseases
318923|NCT01785524|Arterial Occlusive Diseases|arterial occlusive diseases
318924|NCT01785524|Diabetes|diabetes
318925|NCT01785524|Exercise|exercise
318926|NCT01785524|Functional Capacity|functional capacity
318927|NCT01785511|hypertension|hypertension
318928|NCT01785511|UV radiation|uv radiation
318929|NCT01785511|coronary flow reserve|coronary flow reserve
318930|NCT01785511|nitric oxide|nitric oxide
318931|NCT01785498|children|children
318932|NCT01785498|quality of life|quality of life
318933|NCT01785498|physical activity|physical activity
318934|NCT01785498|healthy lifestyle|healthy lifestyle
318935|NCT01785485|Integrative medicine|integrative medicine
318936|NCT01785485|primary care|primary care
318937|NCT01785485|cost-effectiveness|cost-effectiveness
318938|NCT01785472|Essential hypertension|essential hypertension
318939|NCT01785472|LCZ696|lcz696
318940|NCT01785459|headache|headache
318941|NCT01785459|migraine|migraine
318942|NCT01785459|bupivacaine|bupivacaine
318943|NCT01785446|Dexmedetomidine|dexmedetomidine
318944|NCT01785446|Cisatracurion infusion|cisatracurion infusion
318945|NCT01785446|Sufentanil|sufentanil
318946|NCT01785446|Recovery Index|recovery index
318947|NCT01785446|Closed loop computer control system|closed loop computer control system
318948|NCT01785433|COPD, pharmacokinetics, tiotropium|copd, pharmacokinetics, tiotropium
318949|NCT01785420|Pre-operative Trastuzumab Protocol|pre-operative trastuzumab protocol
318950|NCT01785407|Iron bio availability|iron bio availability
318951|NCT01785407|Hepcidin|hepcidin
318952|NCT01785407|Iron absorption|iron absorption
318953|NCT01785394|pollinosis|pollinosis
318954|NCT01785394|sublingual immunotherapy|sublingual immunotherapy
318955|NCT01785394|exhaled breath temperature|exhaled breath temperature
318956|NCT01785381|Osteoporosis, hip fracture, fractures, Bone density|osteoporosis, hip fracture, fractures, bone density
318957|NCT01785368|guidelines|guidelines
318958|NCT01785368|referral guidelines|referral guidelines
318959|NCT01785368|exam delays|exam delays
318960|NCT01785368|exam relevance|exam relevance
318961|NCT01785355|periodontal disease|periodontal disease
318962|NCT01785355|CKD|ckd
318963|NCT01785355|nutrition|nutrition
318964|NCT01785355|inflammation|inflammation
318965|NCT01785355|anemia response to ESA|anemia response to esa
318966|NCT01785355|quality of life|quality of life
318967|NCT01785355|hemodialysis|hemodialysis
318968|NCT01785316|Perfusion Cancer Chemotherapy, Regional|perfusion cancer chemotherapy, regional
318969|NCT01785303|CBT|cbt
318970|NCT01785303|CPAP|cpap
318971|NCT01785303|Multidisciplinary Treatment|multidisciplinary treatment
318972|NCT01785303|Combination treatment|combination treatment
318973|NCT01785290|Delirium|delirium
318974|NCT01785290|Survival|survival
318975|NCT01785290|Side-effects|side-effects
318976|NCT01785290|QoL|qol
318977|NCT01785277|Spinal Cord Independence Measure|spinal cord independence measure
318978|NCT01785277|SCIM|scim
318979|NCT01785277|Spinal cord injury|spinal cord injury
318980|NCT01785277|Traumatic spine injury|traumatic spine injury
318981|NCT01785264|Achilles|achilles
318982|NCT01785264|Tendon|tendon
318983|NCT01785264|Rupture|rupture
318984|NCT01785264|Acute|acute
318985|NCT01785264|Treatment|treatment
318986|NCT01785264|Outcome measure|outcome measure
318987|NCT01785251|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
318988|NCT01785251|NMES|nmes
318989|NCT01785251|Deep vein thrombosis|deep vein thrombosis
318990|NCT01785251|DVT|dvt
318991|NCT01785251|total hip arthroplasty|total hip arthroplasty
318992|NCT01785251|lower limb hemodynamics|lower limb hemodynamics
318993|NCT01785238|preterm infants|preterm infants
318994|NCT01785238|acute renal failure|acute renal failure
318995|NCT01785238|nephronic reduction|nephronic reduction
318996|NCT01785199|apnea-hypopnea index|apnea-hypopnea index
318997|NCT01785199|obstructive sleep apnea|obstructive sleep apnea
318998|NCT01785199|body posture|body posture
318999|NCT01785199|ultra-wideband|ultra-wideband
319000|NCT01785186|TB|tb
319001|NCT01785186|Tuberculosis|tuberculosis
319002|NCT01785186|MAMS - Multiple-arm, multiple-stage|mams - multiple-arm, multiple-stage
319003|NCT01785186|Pulmonary|pulmonary
319004|NCT01785186|SQ109|sq109
319005|NCT01785186|High dose rifampicin|high dose rifampicin
319006|NCT01785186|moxifloxacin|moxifloxacin
319007|NCT01785173|Endoscopes|endoscopes
319008|NCT01785173|Esophago-gastro-duodenoscopy|esophago-gastro-duodenoscopy
319009|NCT01785173|Transnasal endoscopy|transnasal endoscopy
319010|NCT01785173|Nasal anesthesia|nasal anesthesia
319011|NCT01785147|Tobacco addition|tobacco addition
319012|NCT01785134|Obesity|obesity
319013|NCT01785134|Bariatric Surgery|bariatric surgery
319014|NCT01785134|Insulin Sensitivity|insulin sensitivity
319015|NCT01785108|Diamyd|diamyd
319016|NCT01785108|Diabetes|diabetes
319017|NCT01785108|Juvenile Diabetes|juvenile diabetes
319018|NCT01785108|Diabetes type 1|diabetes type 1
319019|NCT01785108|Autoimmune Diabetes|autoimmune diabetes
319020|NCT01785108|Insulin dependent Diabetes|insulin dependent diabetes
319021|NCT01785108|Type 1 diabetes|type 1 diabetes
319022|NCT01785108|Type 1 diabetes mellitus|type 1 diabetes mellitus
319023|NCT01785108|rhGAD65|rhgad65
319024|NCT01785108|GAD|gad
319025|NCT01785108|GAD65|gad65
319026|NCT01785108|GAD-alum|gad-alum
319027|NCT01785108|Diabetes Mellitus|diabetes mellitus
319028|NCT01785108|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
319029|NCT01785108|Glucose Metabolism Disorders|glucose metabolism disorders
319030|NCT01785108|Metabolic Diseases|metabolic diseases
319031|NCT01785108|Vitamin D|vitamin d
319032|NCT01785108|Ibuprofen|ibuprofen
319033|NCT01785082|13-C-Methacetin|13-c-methacetin
319034|NCT01785082|partial liver resection|partial liver resection
319035|NCT01785082|liver function tests|liver function tests
319036|NCT01785056|Systemic Sclerosis|systemic sclerosis
319037|NCT01785056|Diffuse Scleroderma|diffuse scleroderma
319038|NCT01785056|SSc|ssc
319039|NCT01785043|DIABETES Mellitus Type 2|diabetes mellitus type 2
319040|NCT01785043|Difficult control|difficult control
319041|NCT01785017|critical|critical
319042|NCT01785017|asthma|asthma
319043|NCT01785017|children|children
319044|NCT01785004|Adiposity|adiposity
319045|NCT01785004|Body composition|body composition
319046|NCT01785004|Vitamin D|vitamin d
319047|NCT01785004|Adipokines|adipokines
319048|NCT01785004|Omega-3 fatty acid|omega-3 fatty acid
319049|NCT01784991|Pain|pain
319050|NCT01784991|Opioids|opioids
319051|NCT01784991|Hydromorphone|hydromorphone
319052|NCT01784991|regimen|regimen
319053|NCT01784978|cancer|cancer
319054|NCT01784978|renal|renal
319055|NCT01784978|metastatic|metastatic
319056|NCT01784978|clear|clear
319057|NCT01784978|cell|cell
319058|NCT01784978|Sunitinib|sunitinib
319059|NCT01784978|Everolimus|everolimus
319060|NCT01784978|Alternating|alternating
319061|NCT01784939|hereditary hemochromatosis C282Y homozygous|hereditary hemochromatosis c282y homozygous
319062|NCT01784939|Iron Reabsorption Index (IRI)|iron reabsorption index (iri)
319063|NCT01784939|Hepcidin / ferritin (H / F) ratio|hepcidin / ferritin (h / f) ratio
319064|NCT01784926|cataract surgery|cataract surgery
319065|NCT01784926|scleral suturing|scleral suturing
319066|NCT01784926|Verisyse|verisyse
319067|NCT01784926|Late in-the-bag IOL dislocation|late in-the-bag iol dislocation
319068|NCT01784913|Prostate|prostate
319069|NCT01784913|cancer|cancer
319070|NCT01784913|vaccine|vaccine
319071|NCT01784874|Rabies|rabies
319072|NCT01784874|Human Diploid Cell Vaccine|human diploid cell vaccine
319073|NCT01784874|Imovax® Rabies|imovax® rabies
319074|NCT01784848|high blood pressure|high blood pressure
319075|NCT01784848|hypertension|hypertension
319076|NCT01784848|bariatric surgery|bariatric surgery
319077|NCT01784848|Laparoscopic Roux-en-Y gastric bypass (LRYGB)|laparoscopic roux-en-y gastric bypass (lrygb)
319078|NCT01784848|obesity|obesity
319079|NCT01784835|Osteopathic manipulative treatment|osteopathic manipulative treatment
319080|NCT01784835|neonatology|neonatology
319081|NCT01784835|neonatal care|neonatal care
319082|NCT01784835|prematurity|prematurity
319083|NCT01784835|complementary and alternative medicine|complementary and alternative medicine
319084|NCT01784835|length of stay|length of stay
319085|NCT01784822|Ventral hernia|ventral hernia
319086|NCT01784822|Graft repair|graft repair
319087|NCT01784809|HIV|hiv
319088|NCT01784809|STIs|stis
319089|NCT01784809|Condom Use|condom use
319090|NCT01784809|Criminal Justice|criminal justice
319091|NCT01784809|Drug Use|drug use
319092|NCT01784796|cardiovascular disease|cardiovascular disease
319093|NCT01784796|women's health|women's health
319094|NCT01784796|psychological stress|psychological stress
319095|NCT01784796|Veterans|veterans
319096|NCT01784796|stroke|stroke
319097|NCT01784783|HIV transmission|hiv transmission
319098|NCT01784783|PMTCT|pmtct
319099|NCT01784783|Discordancy|discordancy
319100|NCT01784783|Home-based testing|home-based testing
319101|NCT01784783|Couple counseling|couple counseling
319102|NCT01784783|Couple testing|couple testing
319103|NCT01784783|Facility delivery|facility delivery
319104|NCT01784783|Exclusive breastfeeding|exclusive breastfeeding
319105|NCT01784783|Family planning|family planning
319106|NCT01784783|Postpartum contraceptives|postpartum contraceptives
319107|NCT01784783|Linkage to care|linkage to care
319108|NCT01784783|ART initiation|art initiation
319109|NCT01784770|Legionnaires' disease|legionnaires' disease
319110|NCT01784770|Legionella pneumophila|legionella pneumophila
319111|NCT01784770|Zithromax|zithromax
319112|NCT01784770|Zithromac|zithromac
319113|NCT01784770|Japanese|japanese
319114|NCT01784770|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
319115|NCT01784744|Autism|autism
319116|NCT01784744|ASD|asd
319117|NCT01784744|Aspergers|aspergers
319118|NCT01784744|Autism Spectrum Disorder|autism spectrum disorder
319119|NCT01784692|Immulina|immulina
319120|NCT01784692|Elderly|elderly
319121|NCT01784692|Immune|immune
319122|NCT01784679|Hereditary Inclusion Body Myopathy|hereditary inclusion body myopathy
319123|NCT01784679|GNE Myopathy|gne myopathy
319124|NCT01784679|Nonaka Disease|nonaka disease
319125|NCT01784679|Quadriceps Sparing Myopathy|quadriceps sparing myopathy
319126|NCT01784679|distal myopathy with rimmed vacuoles|distal myopathy with rimmed vacuoles
319127|NCT01784679|ultragenyx|ultragenyx
319128|NCT01784679|rare disease|rare disease
319129|NCT01784666|Bipolar Disorder|bipolar disorder
319130|NCT01784666|Depression|depression
319131|NCT01784666|Lithium|lithium
319132|NCT01784666|Valproate|valproate
319133|NCT01784666|Isradipine|isradipine
319134|NCT01784653|Substance abuse|substance abuse
319135|NCT01784653|Drug abuse|drug abuse
319136|NCT01784653|Alcohol abuse|alcohol abuse
319137|NCT01784653|Tobacco|tobacco
319138|NCT01784653|Adolescent|adolescent
319139|NCT01784627|substance use|substance use
319140|NCT01784627|alcohol abuse|alcohol abuse
319141|NCT01784627|cannabis abuse|cannabis abuse
319142|NCT01784627|nicotine dependence|nicotine dependence
319143|NCT01784627|adolescents|adolescents
319144|NCT01784601|Interscalene block|interscalene block
319145|NCT01784601|Hemidiaphragm palsy|hemidiaphragm palsy
319146|NCT01784575|Quality of care|quality of care
319147|NCT01784575|Pediatric|pediatric
319148|NCT01784575|Pregnancy|pregnancy
319149|NCT01784575|Low-income|low-income
319150|NCT01784575|Low literacy|low literacy
319151|NCT01784562|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
319152|NCT01784549|NSCL|nscl
319153|NCT01784549|biomarkers|biomarkers
319154|NCT01784549|Customized Neoadjuvant Therapy|customized neoadjuvant therapy
319155|NCT01784523|antiphospholipid autoantibodies|antiphospholipid autoantibodies
319156|NCT01784523|antiphospholipid positive|antiphospholipid positive
319157|NCT01784497|Health Related Quality of Life (HRQL)|health related quality of life (hrql)
319158|NCT01784497|Living Donor Liver Transplantation(LDLT)|living donor liver transplantation(ldlt)
319159|NCT01784471|Foot Symptoms|foot symptoms
319160|NCT01784471|Diabetes|diabetes
319161|NCT01784471|Peripheral Vascular Disease|peripheral vascular disease
319162|NCT01784471|Magic Foot shoe|magic foot shoe
319163|NCT01784458|severe sepsis|severe sepsis
319164|NCT01784458|intra-abdominal hypertension|intra-abdominal hypertension
319165|NCT01784458|intra-abdominal pressure|intra-abdominal pressure
319166|NCT01784445|Endoscopic Retrograde Cholangiopancreatography,|endoscopic retrograde cholangiopancreatography,
319167|NCT01784432|low-level laser therapy|low-level laser therapy
319168|NCT01784432|muscle performance|muscle performance
319169|NCT01784432|strength training|strength training
319170|NCT01784432|gene expression|gene expression
319171|NCT01784432|microarrays|microarrays
319172|NCT01784419|Cystic fibrosis|cystic fibrosis
319173|NCT01784419|Ivacaftor|ivacaftor
319174|NCT01784419|Genotype|genotype
319175|NCT01784419|Phenotype|phenotype
319176|NCT01784419|Sweat chloride|sweat chloride
319177|NCT01784419|Pancreatic sufficient|pancreatic sufficient
319178|NCT01784406|Self-management intervention|self-management intervention
319179|NCT01784406|Psychosocial care|psychosocial care
319180|NCT01784406|Autonomy-supportive|autonomy-supportive
319181|NCT01784406|Gynaecological cancer survivors|gynaecological cancer survivors
319182|NCT01784406|Guided self-Determination|guided self-determination
319183|NCT01784367|Hypercapnia|hypercapnia
319184|NCT01784367|noninvasive ventilation|noninvasive ventilation
319185|NCT01784367|acute respiratory failure|acute respiratory failure
319186|NCT01784367|endotracheal intubation|endotracheal intubation
319187|NCT01784367|invasive mechanical ventilation|invasive mechanical ventilation
319188|NCT01784341|Bipolar, Circadian, Melatonin|bipolar, circadian, melatonin
319189|NCT01784328|Peristeen Bowel Irrigation System|peristeen bowel irrigation system
319190|NCT01784328|Cauda Equina Syndrome|cauda equina syndrome
319191|NCT01784328|Lower Motor Neuron Neurogenic Bowel|lower motor neuron neurogenic bowel
319192|NCT01784315|The presence of parasites in the blood|the presence of parasites in the blood
319193|NCT01784289|Interleukin 7|interleukin 7
319194|NCT01784289|adipose tissue|adipose tissue
319195|NCT01784276|Children|children
319196|NCT01784276|Autism Spectrum Disorders|autism spectrum disorders
319197|NCT01784276|Electronic Screen Media|electronic screen media
319198|NCT01784276|Dental fear|dental fear
319199|NCT01784263|Intervention|intervention
319200|NCT01784263|Autism|autism
319201|NCT01784263|Treatment sensitivity|treatment sensitivity
319202|NCT01784263|School aged|school aged
319203|NCT01784263|Cognitive behavioral therapy|cognitive behavioral therapy
319204|NCT01784250|Clonidine|clonidine
319205|NCT01784250|Propranolol|propranolol
319206|NCT01784250|Third molar|third molar
319207|NCT01784250|Anxiety|anxiety
319208|NCT01784237|Endoscopes|endoscopes
319209|NCT01784237|Esophago-gastro-duodenoscopy|esophago-gastro-duodenoscopy
319210|NCT01784237|Transnasal endoscopy|transnasal endoscopy
319211|NCT01784237|Anterior meatoscopy|anterior meatoscopy
319212|NCT01784198|pregnancy|pregnancy
319213|NCT01784198|protein requirements|protein requirements
319214|NCT01784198|Indicator Amino acid oxidation|indicator amino acid oxidation
319215|NCT01784198|Stable isotopes|stable isotopes
319216|NCT01784185|EBUS guided transbronchial needle aspiration (EBUS-TBNA)|ebus guided transbronchial needle aspiration (ebus-tbna)
319217|NCT01784185|virtual bronchoscopy (VB)|virtual bronchoscopy (vb)
319218|NCT01784185|VB guided transbronchial needle aspiration VB-TBNA)|vb guided transbronchial needle aspiration vb-tbna)
319219|NCT01784185|mediastinal sampling|mediastinal sampling
319220|NCT01784185|transbronchial needle aspiration (TBNA)|transbronchial needle aspiration (tbna)
319221|NCT01784172|efficacy|efficacy
319222|NCT01784172|safety|safety
319223|NCT01784172|electroacupuncture|electroacupuncture
319224|NCT01784172|simple female stress urinary incontinence|simple female stress urinary incontinence
319225|NCT01784133|rosacea|rosacea
319226|NCT01784120|breast cancer|breast cancer
319227|NCT01784120|doxorubicin|doxorubicin
319228|NCT01784120|genexol-PM|genexol-pm
319229|NCT01784120|paclitaxel|paclitaxel
319230|NCT01784107|SCLC|sclc
319231|NCT01784107|belotecan|belotecan
319232|NCT01784107|Ifosfamide|ifosfamide
319233|NCT01784081|palliative care|palliative care
319234|NCT01784081|decision aid|decision aid
319235|NCT01784068|Ph+ CML-CP|ph+ cml-cp
319236|NCT01784068|chronic phase|chronic phase
319237|NCT01784068|nilotinib treatment|nilotinib treatment
319238|NCT01784068|2 years treatment|2 years treatment
319239|NCT01784068|MR 4.5|mr 4.5
319240|NCT01784068|Loss of MR 4|loss of mr 4
319241|NCT01784068|Loss of MMR|loss of mmr
319242|NCT01784055|NeoChord|neochord
319243|NCT01784055|DS1000|ds1000
319244|NCT01784055|Mitral Valve|mitral valve
319245|NCT01784055|Mitral Valve Regurgitation|mitral valve regurgitation
319246|NCT01784055|MR|mr
319247|NCT01784055|Mitral Valve Repair|mitral valve repair
319248|NCT01784055|Mitral Valve Prolapse|mitral valve prolapse
319249|NCT01784055|Artificial Chordae|artificial chordae
319250|NCT01784042|breast cancer|breast cancer
319251|NCT01784042|omega-3 fatty acids|omega-3 fatty acids
319252|NCT01784029|adolescents|adolescents
319253|NCT01784029|minority|minority
319254|NCT01783964|Elacytarabine|elacytarabine
319255|NCT01783964|pharmacokinetic|pharmacokinetic
319256|NCT01783964|Microdose|microdose
319257|NCT01783964|Mass Balance Recovery|mass balance recovery
319258|NCT01783951|Gastric cancer|gastric cancer
319259|NCT01783951|S-1|s-1
319260|NCT01783951|DC-CIK|dc-cik
319261|NCT01783951|T cell|t cell
319262|NCT01783912|Smoking|smoking
319263|NCT01783912|Nicotine Dependence|nicotine dependence
319264|NCT01783912|Mental Disorders|mental disorders
319265|NCT01783886|Diabetic Macular Edema|diabetic macular edema
319266|NCT01783886|DME|dme
319267|NCT01783886|VEGF Trap-Eye|vegf trap-eye
319268|NCT01783886|best-corrected visual acuity (BCVA)|best-corrected visual acuity (bcva)
319269|NCT01783860|Azithromycin|azithromycin
319270|NCT01783860|Doxycycline|doxycycline
319271|NCT01783860|Posterior Blepharitis|posterior blepharitis
319272|NCT01783847|Erythropoietin|erythropoietin
319273|NCT01783847|Traumatic Optic Neuropathy|traumatic optic neuropathy
319274|NCT01783847|Visual function|visual function
319275|NCT01783834|Pemetrexed|pemetrexed
319276|NCT01783834|Gefitinib|gefitinib
319277|NCT01783834|iressa|iressa
319278|NCT01783834|alimta|alimta
319279|NCT01783821|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
319280|NCT01783808|COPD|copd
319281|NCT01783808|Physical capacity|physical capacity
319282|NCT01783808|Physical activity|physical activity
319283|NCT01783808|Inflammatory markers|inflammatory markers
319284|NCT01783808|Health related quality of life|health related quality of life
319285|NCT01783795|Dent|dent
319286|NCT01783795|Dents|dents
319287|NCT01783795|Dent Disease|dent disease
319288|NCT01783795|Dent genetic testing|dent genetic testing
319289|NCT01783795|CLCN5|clcn5
319290|NCT01783795|OCRL1|ocrl1
319291|NCT01783795|Genetic testing for Dent Disease|genetic testing for dent disease
319292|NCT01783795|Hereditary study for Dent Disease|hereditary study for dent disease
319293|NCT01783782|Capsule Endoscopy|capsule endoscopy
319294|NCT01783782|colon cleansing|colon cleansing
319295|NCT01783782|children|children
319296|NCT01783782|age 2 -18 years|age 2 -18 years
319297|NCT01783769|neurosurgery|neurosurgery
319298|NCT01783769|operating room personnel|operating room personnel
319299|NCT01783769|sterile procedures|sterile procedures
319300|NCT01783769|infection|infection
319301|NCT01783769|Conditions requiring surgery|conditions requiring surgery
319302|NCT01783743|Trichiasis|trichiasis
319303|NCT01783743|Trachoma|trachoma
319304|NCT01783743|Mass treatment|mass treatment
319305|NCT01783730|Rheumatoid arthritis|rheumatoid arthritis
319306|NCT01783704|hip fracture|hip fracture
319307|NCT01783704|randomized controlled trial|randomized controlled trial
319308|NCT01783704|exercise|exercise
319309|NCT01783691|Sickle cell disease|sickle cell disease
319310|NCT01783652|Adolescent depression|adolescent depression
319311|NCT01783652|internet intervention|internet intervention
319312|NCT01783639|Carotid|carotid
319313|NCT01783639|Carotid artery stenting|carotid artery stenting
319314|NCT01783639|Stent|stent
319315|NCT01783639|Embolic protection|embolic protection
319316|NCT01783639|Atherosclerotic Disease|atherosclerotic disease
319317|NCT01783600|Peripheral Arterial Disease|peripheral arterial disease
319318|NCT01783600|Infrapopliteal lesions|infrapopliteal lesions
319319|NCT01783600|balloon catheter|balloon catheter
319320|NCT01783574|Depression|depression
319321|NCT01783574|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
319322|NCT01783561|caffeine|caffeine
319323|NCT01783561|intubation|intubation
319324|NCT01783561|hemodynamic|hemodynamic
319325|NCT01783548|allergic rhinitis|allergic rhinitis
319326|NCT01783548|pediatric subjects|pediatric subjects
319327|NCT01783548|BDP nasal aerosol|bdp nasal aerosol
319328|NCT01783535|intraocular retinoblastoma|intraocular retinoblastoma
319329|NCT01783509|GENETICALLY CONFIRMED limb girdle muscular dystrophy|genetically confirmed limb girdle muscular dystrophy
319330|NCT01783483|CABG|cabg
319331|NCT01783483|Valve replacement|valve replacement
319332|NCT01783483|sternal closure|sternal closure
319333|NCT01783483|midline sternotomy|midline sternotomy
319334|NCT01783483|sternal plates|sternal plates
319335|NCT01783470|adipose tissue, brown|adipose tissue, brown
319336|NCT01783470|obesity|obesity
319337|NCT01783470|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists
319338|NCT01783470|thermogenesis|thermogenesis
319339|NCT01783470|metabolism|metabolism
319340|NCT01783457|First psychotic episode|first psychotic episode
319341|NCT01783457|Individual psychoeducation|individual psychoeducation
319342|NCT01783457|Telemedicine|telemedicine
319343|NCT01783457|BDNF|bdnf
319344|NCT01783457|Oxidative stress|oxidative stress
319345|NCT01783444|Estrogen receptor positive, locally advanced, metastatic breast cancer|estrogen receptor positive, locally advanced, metastatic breast cancer
319346|NCT01783418|mindfulness-based meditation|mindfulness-based meditation
319347|NCT01783418|pediatric cancer|pediatric cancer
319348|NCT01783418|adolescence|adolescence
319349|NCT01783418|quality of life|quality of life
319350|NCT01783418|sleep|sleep
319351|NCT01783418|affect|affect
319352|NCT01783418|health psychology|health psychology
319353|NCT01783405|LDLR mutation|ldlr mutation
319354|NCT01783405|Statin|statin
319355|NCT01783405|Cardiovascular disease|cardiovascular disease
319356|NCT01783392|overactive bladder|overactive bladder
319357|NCT01783392|transcutaneous posterior tibial nerve stimulation|transcutaneous posterior tibial nerve stimulation
319358|NCT01783392|placebo PTNS|placebo ptns
319359|NCT01783379|invasive fungal infection|invasive fungal infection
319360|NCT01783379|micafungin|micafungin
319361|NCT01783379|intensive care|intensive care
319362|NCT01783379|pharmacokinetics|pharmacokinetics
319363|NCT01783366|nasogastric tube, tube exchange catheter|nasogastric tube, tube exchange catheter
319364|NCT01783353|Recalcitrant cutaneous warts|recalcitrant cutaneous warts
319365|NCT01783353|verruca|verruca
319366|NCT01783340|Malaria|malaria
319367|NCT01783340|P falciparum|p falciparum
319368|NCT01783340|Chloroquine|chloroquine
319369|NCT01783340|Azithromycin|azithromycin
319370|NCT01783340|Immunization|immunization
319497|NCT01782781|Therapeutic Uses|therapeutic uses
319371|NCT01783327|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
319372|NCT01783327|Self care|self care
319373|NCT01783327|Coping skills|coping skills
319374|NCT01783327|Adolescent|adolescent
319375|NCT01783327|Internet|internet
319376|NCT01783327|Intervention Studies|intervention studies
319377|NCT01783327|Chronic Disease|chronic disease
319378|NCT01783314|hepatic fibrosis|hepatic fibrosis
319379|NCT01783314|Eovist|eovist
319380|NCT01783314|gadoxetate disodium|gadoxetate disodium
319381|NCT01783314|biomarker|biomarker
319382|NCT01783314|liver biopsy|liver biopsy
319383|NCT01783314|liver function|liver function
319385|NCT01783314|Hepatitis C|hepatitis c
319386|NCT01783301|follicle stimulating hormone|follicle stimulating hormone
319387|NCT01783301|ovarian stimulation|ovarian stimulation
319388|NCT01783301|antimullerian hormone|antimullerian hormone
319389|NCT01783301|antral follicle count|antral follicle count
319390|NCT01783301|assisted reproductive technologies|assisted reproductive technologies
319391|NCT01783288|Postural tachycardia syndrome|postural tachycardia syndrome
319392|NCT01783288|orthostatic intolerance|orthostatic intolerance
319393|NCT01783288|orthostatic tachycardia|orthostatic tachycardia
319394|NCT01783288|POTS|pots
319395|NCT01783275|Obesity|obesity
319396|NCT01783275|Type 2 diabetes|type 2 diabetes
319397|NCT01783275|Liver|liver
319398|NCT01783236|VATS|vats
319399|NCT01783236|thoracic surgery|thoracic surgery
319400|NCT01783236|acetaminophen|acetaminophen
319401|NCT01783236|ofirmev|ofirmev
319402|NCT01783236|lung surgery|lung surgery
319403|NCT01783236|thoracoscopic|thoracoscopic
319404|NCT01783236|intravenous acetaminophen|intravenous acetaminophen
319405|NCT01783158|head and neck carcinoma|head and neck carcinoma
319406|NCT01783158|chromoendoscopy|chromoendoscopy
319407|NCT01783158|Lugol's solution|lugol's solution
319408|NCT01783158|esophageal carcinoma|esophageal carcinoma
319409|NCT01783158|synchronous tumors|synchronous tumors
319410|NCT01783158|deglutition|deglutition
319411|NCT01783158|deglutition disorders|deglutition disorders
319412|NCT01783158|Newly diagnosed HNSCC|newly diagnosed hnscc
319413|NCT01783145|survivorship care|survivorship care
319414|NCT01783145|testicular cancer|testicular cancer
319415|NCT01783145|shared care model|shared care model
319416|NCT01783119|Ulcerative Colitis|ulcerative colitis
319417|NCT01783119|Aloe Vera|aloe vera
319418|NCT01783106|Crohn's|crohn's
319419|NCT01783106|antibiotics|antibiotics
319420|NCT01783106|hydroxychloroquine|hydroxychloroquine
319421|NCT01783106|ciprofloxacin|ciprofloxacin
319422|NCT01783106|doxycycline|doxycycline
319423|NCT01783080|Chronic depression|chronic depression
319424|NCT01783080|Dysthymic disorder|dysthymic disorder
319425|NCT01783080|Double Depression|double depression
319426|NCT01783080|Behavioral Activation therapy|behavioral activation therapy
319427|NCT01783080|Work impairment|work impairment
319428|NCT01783080|Unemployment|unemployment
319429|NCT01783067|Biofortification|biofortification
319430|NCT01783067|Pearl millet|pearl millet
319431|NCT01783067|Iron absorption|iron absorption
319432|NCT01783067|Zinc absorption|zinc absorption
319433|NCT01783054|NEOADJUVANT GEMCITABINE AND ABRAXANE CHEMOTHERAPY|neoadjuvant gemcitabine and abraxane chemotherapy
319434|NCT01783054|SURGERY|surgery
319435|NCT01783054|RESECTABLE ADENOCARCINOMA OF THE PANCREAS|resectable adenocarcinoma of the pancreas
319436|NCT01783041|Prematurity|prematurity
319437|NCT01783041|Carnitine supplementation|carnitine supplementation
319438|NCT01783041|Neonatal Intensive Care|neonatal intensive care
319439|NCT01783041|MRI|mri
319440|NCT01783041|Amplitude-integrated EEG|amplitude-integrated eeg
319441|NCT01783041|NICU Network Neurobehavioral Scale|nicu network neurobehavioral scale
319442|NCT01783041|Bayley Scale of Infant Development III|bayley scale of infant development iii
319443|NCT01783028|asthma|asthma
319444|NCT01783015|Rheumatoid arthritis|rheumatoid arthritis
319445|NCT01783015|etanercept|etanercept
319446|NCT01783015|methotrexate|methotrexate
319447|NCT01783015|infliximab|infliximab
319448|NCT01783015|adalimumab|adalimumab
319449|NCT01783015|anti-drug antibody|anti-drug antibody
319450|NCT01782989|geographic atrophy|geographic atrophy
319451|NCT01782989|non-exudative age-related macular degeneration|non-exudative age-related macular degeneration
319452|NCT01782989|macular degeneration|macular degeneration
319453|NCT01782989|dry macular degeneration|dry macular degeneration
319454|NCT01782989|dry AMD|dry amd
319455|NCT01782976|Glioblastoma|glioblastoma
319456|NCT01782976|GBM|gbm
319457|NCT01782976|Intracranial glioblastoma|intracranial glioblastoma
319458|NCT01782976|Recurrent|recurrent
319459|NCT01782976|MD Anderson Symptom Inventory for Brain Tumors|md anderson symptom inventory for brain tumors
319460|NCT01782976|MDASI-BT|mdasi-bt
319461|NCT01782976|Questionnaire|questionnaire
319462|NCT01782976|Survey|survey
319463|NCT01782963|Newly diagnosed|newly diagnosed
319464|NCT01782950|HIV|hiv
319465|NCT01782950|Tuberculosis|tuberculosis
319466|NCT01782950|Antituberculosis drugs|antituberculosis drugs
319467|NCT01782911|Androgen|androgen
319468|NCT01782911|IVF|ivf
319469|NCT01782911|Resveratrol|resveratrol
319470|NCT01782911|PCOS.|pcos.
319471|NCT01782898|Anesthesia|anesthesia
319472|NCT01782898|MEDOC neuro sensory analyzer|medoc neuro sensory analyzer
319473|NCT01782898|Pain|pain
319474|NCT01782898|Quality of recovery|quality of recovery
319475|NCT01782885|Osteoarthritis|osteoarthritis
319476|NCT01782885|Platelet-Rich Plasma|platelet-rich plasma
319477|NCT01782885|Intra-articular|intra-articular
319478|NCT01782885|Injection|injection
319479|NCT01782807|Ovarian function|ovarian function
319480|NCT01782807|Hysterectomy|hysterectomy
319481|NCT01782807|Salpingectomy|salpingectomy
319482|NCT01782807|Anti mullerian hormone|anti mullerian hormone
319483|NCT01782794|Vaccination|vaccination
319484|NCT01782794|Acceptability|acceptability
319485|NCT01782794|General population|general population
319486|NCT01782794|Hepatitis B|hepatitis b
319487|NCT01782794|Vaccine coverage|vaccine coverage
319488|NCT01782781|Analgesia|analgesia
319489|NCT01782781|Local infiltration analgesia|local infiltration analgesia
319490|NCT01782781|Pain, relief|pain, relief
319491|NCT01782781|Pain, Postoperative|pain, postoperative
319492|NCT01782781|Ropivacaine|ropivacaine
319493|NCT01782781|Ketorolac|ketorolac
319494|NCT01782781|Epinephrine|epinephrine
319989|NCT01780467|Dopamine|dopamine
319495|NCT01782781|Adrenergic Agonists|adrenergic agonists
319496|NCT01782781|Sympathomimetics|sympathomimetics
319498|NCT01782781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
319499|NCT01782781|Analgesics, Non-Narcotic|analgesics, non-narcotic
319500|NCT01782781|Analgesics|analgesics
319501|NCT01782781|Opioids|opioids
319502|NCT01782781|Morphine|morphine
319503|NCT01782781|Pain|pain
319504|NCT01782781|Postoperative Complications|postoperative complications
319505|NCT01782781|Physiological Effects of Drugs|physiological effects of drugs
319506|NCT01782781|Anesthetics, Local|anesthetics, local
319507|NCT01782781|Anesthetics|anesthetics
319508|NCT01782768|Neural respiratory drive in different level of NPPV|neural respiratory drive in different level of nppv
319509|NCT01782755|Probiotics|probiotics
319510|NCT01782755|Ventilator Associated Pneumonia (VAP)|ventilator associated pneumonia (vap)
319511|NCT01782755|Infection|infection
319512|NCT01782755|Antibiotic-Associated Diarrhea|antibiotic-associated diarrhea
319513|NCT01782755|C-Difficile|c-difficile
319514|NCT01782742|Mild to Moderate Alzheimer's Disease|mild to moderate alzheimer's disease
319515|NCT01782729|Dermatitis, Atopic|dermatitis, atopic
319516|NCT01782729|Tacrolimus|tacrolimus
319517|NCT01782716|Mortality|mortality
319518|NCT01782716|Length|length
319519|NCT01782716|hospitalization|hospitalization
319520|NCT01782716|cardiac surgery|cardiac surgery
319521|NCT01782716|patients|patients
319522|NCT01782703|Atopic Dermatitis|atopic dermatitis
319523|NCT01782703|Filaggrin|filaggrin
319524|NCT01782703|Biomarkers|biomarkers
319525|NCT01782703|Eczema|eczema
319526|NCT01782664|PASI|pasi
319527|NCT01782664|DLQI|dlqi
319528|NCT01782664|GSK2586184|gsk2586184
319529|NCT01782664|plaque-type psoriasis|plaque-type psoriasis
319531|NCT01782664|inflammatory gene transcription|inflammatory gene transcription
319532|NCT01782664|JAK-1 inhibitor|jak-1 inhibitor
319533|NCT01782664|serum neopterin|serum neopterin
319534|NCT01782664|skin biopsy|skin biopsy
319535|NCT01782664|ACR response criteria|acr response criteria
319536|NCT01782664|VAS itch score|vas itch score
319537|NCT01782651|HER2 positive|her2 positive
319538|NCT01782651|Breast Cancer|breast cancer
319539|NCT01782651|treatment patterns|treatment patterns
319540|NCT01782638|Parkinson's disease|parkinson's disease
319541|NCT01782638|Deep brain stimulation|deep brain stimulation
319542|NCT01782638|Gait|gait
319543|NCT01782638|Freezing|freezing
319544|NCT01782638|Electrode placements|electrode placements
319545|NCT01782625|diving|diving
319546|NCT01782625|cognitive impairment|cognitive impairment
319547|NCT01782625|nitrogen narcosis|nitrogen narcosis
319548|NCT01782625|narcosis|narcosis
319549|NCT01782625|end tidal carbon dioxide|end tidal carbon dioxide
319550|NCT01782625|arterial carbon dioxide|arterial carbon dioxide
319551|NCT01782625|immersion|immersion
319552|NCT01782612|Balanced Anesthesia|balanced anesthesia
319553|NCT01782612|Nerve Block|nerve block
319554|NCT01782612|Postoperative Recovery|postoperative recovery
319555|NCT01782612|Delirium|delirium
319556|NCT01782612|Postoperative Complications|postoperative complications
319557|NCT01782612|Stress|stress
319558|NCT01782612|Inflammation|inflammation
319559|NCT01782586|kidney transplant|kidney transplant
319560|NCT01782586|gene expression markers|gene expression markers
319561|NCT01782586|renal allograft function|renal allograft function
319562|NCT01782573|pre - disinfection scrubbing solution|pre - disinfection scrubbing solution
319563|NCT01782573|surgical site culture|surgical site culture
319564|NCT01782573|surgical site infection|surgical site infection
319565|NCT01782573|liver tumors|liver tumors
319566|NCT01782573|hepatectomy|hepatectomy
319567|NCT01782573|chlorhexidine gluconate|chlorhexidine gluconate
319568|NCT01782560|Laryngomalacia|laryngomalacia
319569|NCT01782560|Acid-reflux|acid-reflux
319570|NCT01782547|diabetes mellitus|diabetes mellitus
319571|NCT01782547|adolescents|adolescents
319572|NCT01782521|Bracket failure rate|bracket failure rate
319573|NCT01782521|Orthodontic bonding|orthodontic bonding
319574|NCT01782521|Primer|primer
319575|NCT01782508|melanoma,adjuvant therapy,kit mutated melanoma|melanoma,adjuvant therapy,kit mutated melanoma
319576|NCT01782495|Hepatitis C Genotype 4|hepatitis c genotype 4
319577|NCT01782495|Chronic Hepatitis|chronic hepatitis
319578|NCT01782495|Interferon-Free|interferon-free
319579|NCT01782495|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
319580|NCT01782495|Renal Transplant|renal transplant
319581|NCT01782495|Liver Transplant|liver transplant
319582|NCT01782495|Hepatitis C Genotype 1|hepatitis c genotype 1
319583|NCT01782482|Color contact lenses|color contact lenses
319584|NCT01782482|Refractive error|refractive error
319585|NCT01782482|Myopia|myopia
319586|NCT01782469|Synovitis|synovitis
319587|NCT01782469|Rheumatoid Arthritis|rheumatoid arthritis
319588|NCT01782443|Progressive|progressive
319589|NCT01782443|Metastatic|metastatic
319590|NCT01782430|Preoxygenation|preoxygenation
319591|NCT01782430|Intubation|intubation
319592|NCT01782417|osteoarthritis|osteoarthritis
319593|NCT01782417|Hispanic|hispanic
319594|NCT01782417|behavior|behavior
319595|NCT01782417|intervention|intervention
319596|NCT01782417|Spanish|spanish
319597|NCT01782391|mild cognitive impairment|mild cognitive impairment
319598|NCT01782391|dementia|dementia
319599|NCT01782391|MCI|mci
319600|NCT01782391|brain stimulation|brain stimulation
319601|NCT01782391|tSOS|tsos
319602|NCT01782391|tDCS|tdcs
319603|NCT01782391|sleep|sleep
319604|NCT01782391|memory|memory
319605|NCT01782391|memory consolidation|memory consolidation
319606|NCT01782378|Persian Gulf Syndrome|persian gulf syndrome
319607|NCT01782378|Veterans Health|veterans health
319608|NCT01782378|Executive Function|executive function
319609|NCT01782378|Memory|memory
319610|NCT01782378|Attention|attention
319611|NCT01782378|Cognition|cognition
319612|NCT01782378|Laser Therapy, Low-Level|laser therapy, low-level
319613|NCT01782378|Phototherapy|phototherapy
319614|NCT01782378|Light Therapy|light therapy
319615|NCT01782378|Depression|depression
319616|NCT01782365|mild cognitive impairment|mild cognitive impairment
319617|NCT01782365|dementia|dementia
319618|NCT01782365|MCI|mci
319619|NCT01782365|brain stimulation|brain stimulation
319620|NCT01782365|tSOS|tsos
319621|NCT01782365|tDCS|tdcs
319622|NCT01782365|sleep|sleep
319623|NCT01782365|nap|nap
319624|NCT01782365|daytime sleep|daytime sleep
319625|NCT01782365|memory|memory
319626|NCT01782365|memory consolidation|memory consolidation
319627|NCT01782352|age-related macular degeneration|age-related macular degeneration
319628|NCT01782352|incidence|incidence
319629|NCT01782352|progression|progression
319630|NCT01782326|COPD, QVA149, FLAME( EFfect of Indacaterol Glycopyronium Vs Fluticasone salmeterol on COPD Exacerbations)|copd, qva149, flame( effect of indacaterol glycopyronium vs fluticasone salmeterol on copd exacerbations)
319631|NCT01782287|Neoplasm Metastasis|neoplasm metastasis
319632|NCT01782287|Brain metastasis|brain metastasis
319633|NCT01782287|Lung cancer|lung cancer
319634|NCT01782274|Neoplasm Metastasis|neoplasm metastasis
319635|NCT01782274|Brain metastasis|brain metastasis
319636|NCT01782274|Breast cancer|breast cancer
319637|NCT01782261|autoimmune disease|autoimmune disease
319638|NCT01782261|diabetes type 1|diabetes type 1
319639|NCT01782261|incretin effect|incretin effect
319640|NCT01782222|Parkinson's Disease|parkinson's disease
319641|NCT01782222|Rotigotine|rotigotine
319642|NCT01782222|Apathy|apathy
319643|NCT01782222|Nonmotor|nonmotor
319644|NCT01782222|Motor|motor
319645|NCT01782222|Neupro|neupro
319646|NCT01782209|BK virus viremia|bk virus viremia
319647|NCT01782209|renal transplant|renal transplant
319648|NCT01782209|other viral pathogens|other viral pathogens
319649|NCT01782183|sore throat|sore throat
319650|NCT01782183|thermal camera photo|thermal camera photo
319651|NCT01782183|normal tonsils and pharynx|normal tonsils and pharynx
319652|NCT01782183|redness of tonsils and/or pharynx|redness of tonsils and/or pharynx
319653|NCT01782183|exudates on tonsils|exudates on tonsils
319654|NCT01782183|petechiae of the palate|petechiae of the palate
319655|NCT01782170|Gingivitis|gingivitis
319656|NCT01782170|Biomarkers|biomarkers
319657|NCT01782170|Biological Markers of Inflammation|biological markers of inflammation
319658|NCT01782157|dementia|dementia
319659|NCT01782144|Obesity|obesity
319660|NCT01782144|Foot pain|foot pain
319661|NCT01782105|weight gain|weight gain
319662|NCT01782105|healthy lifestyle|healthy lifestyle
319663|NCT01782105|gestational diabetes|gestational diabetes
319664|NCT01782105|adipokins|adipokins
319665|NCT01782105|glycemic regulation|glycemic regulation
319666|NCT01782092|diabetes|diabetes
319667|NCT01782079|Lactobacillus brevis|lactobacillus brevis
319668|NCT01782079|Oral health|oral health
319669|NCT01782079|Bacterial adhesion|bacterial adhesion
319670|NCT01782040|Premenstrual syndrome|premenstrual syndrome
319671|NCT01782040|Physical distress|physical distress
319672|NCT01782040|Behavioral changes|behavioral changes
319673|NCT01782027|healthy controls|healthy controls
319674|NCT01782027|Tangier Disease|tangier disease
319675|NCT01782027|Adenosine triphosphate-binding cassette transporter 1 (ABCA1)|adenosine triphosphate-binding cassette transporter 1 (abca1)
319676|NCT01782027|apoA-I|apoa-i
319677|NCT01782027|LCAT deficiency|lcat deficiency
319678|NCT01782027|Scavenger receptor BI (SRBI) deficiency|scavenger receptor bi (srbi) deficiency
319679|NCT01782027|CETP deficiency|cetp deficiency
319680|NCT01782014|Screening colonoscopy|screening colonoscopy
319681|NCT01782014|Water method|water method
319682|NCT01782014|Carbon dioxide method|carbon dioxide method
319683|NCT01782014|Air method|air method
319684|NCT01782014|Water versus carbon dioxide versus air insufflation colonoscopy|water versus carbon dioxide versus air insufflation colonoscopy
319685|NCT01782014|Adenoma Detection Rate|adenoma detection rate
319686|NCT01782014|Pain Scores in colonoscopy|pain scores in colonoscopy
319687|NCT01782001|Vitamin A|vitamin a
319688|NCT01782001|Zinc|zinc
319689|NCT01782001|Malaria|malaria
319690|NCT01782001|Morbidity|morbidity
319691|NCT01782001|MRDR|mrdr
319692|NCT01781988|lung cancer|lung cancer
319693|NCT01781988|gemcitabine|gemcitabine
319694|NCT01781988|carboplatin|carboplatin
319695|NCT01781988|pemetrexed|pemetrexed
319696|NCT01781949|HIV infection|hiv infection
319697|NCT01781949|Targeted screening|targeted screening
319698|NCT01781949|Nontargeted screening|nontargeted screening
319699|NCT01781949|Emergency department|emergency department
319700|NCT01781949|Urgent care|urgent care
319701|NCT01781949|Effectiveness|effectiveness
319702|NCT01781923|Cognitive remediation|cognitive remediation
319703|NCT01781923|Social Cognition|social cognition
319704|NCT01781910|branched chain amino acids, exercise, delayed onset muscle soreness|branched chain amino acids, exercise, delayed onset muscle soreness
319705|NCT01781897|acupuncture|acupuncture
319706|NCT01781897|electro-acupuncture|electro-acupuncture
319707|NCT01781871|Pneumococcal vaccination|pneumococcal vaccination
319708|NCT01781871|immunogenicity|immunogenicity
319709|NCT01781871|solid organ transplant|solid organ transplant
319710|NCT01781858|Pulmonary embolism|pulmonary embolism
319711|NCT01781858|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
319712|NCT01781858|Venous thromboembolism|venous thromboembolism
319713|NCT01781793|dyspnea, exercise endurance, lung disease|dyspnea, exercise endurance, lung disease
319714|NCT01781780|Obesity|obesity
319715|NCT01781780|Weight Loss|weight loss
319716|NCT01781780|Breakfast|breakfast
319717|NCT01781767|UCP2|ucp2
319718|NCT01781767|Thyroid function|thyroid function
319719|NCT01781767|Thyroid carcinoma|thyroid carcinoma
319720|NCT01781754|Glycemic control|glycemic control
319721|NCT01781754|Metabolic control|metabolic control
319722|NCT01781754|Oxidative stress|oxidative stress
319723|NCT01781754|Diabetes|diabetes
319724|NCT01781728|recurrent|recurrent
319725|NCT01781728|unresectable|unresectable
319726|NCT01781728|residual|residual
319727|NCT01781728|stereotactic body radiation therapy (SBRT)|stereotactic body radiation therapy (sbrt)
319728|NCT01781728|palliative management|palliative management
319729|NCT01781715|STEMI, Multivessel Coronary Artery Disease, Primary PCI, multivessel stenting, zotarolimus-eluting stent|stemi, multivessel coronary artery disease, primary pci, multivessel stenting, zotarolimus-eluting stent
319730|NCT01781689|cortical activation|cortical activation
319731|NCT01781689|motor function|motor function
319732|NCT01781689|activity of daily living|activity of daily living
319733|NCT01781650|Warm Water Infusion colonoscopy|warm water infusion colonoscopy
319734|NCT01781650|Water Immersion colonoscopy|water immersion colonoscopy
319735|NCT01781650|Water Exchange colonoscopy|water exchange colonoscopy
319736|NCT01781650|Painless unsedated colonoscopy|painless unsedated colonoscopy
319737|NCT01781650|Adenoma detection rate|adenoma detection rate
319738|NCT01781650|Adenoma resection rate|adenoma resection rate
319739|NCT01781637|Xolair|xolair
319740|NCT01781637|omalizumab|omalizumab
319741|NCT01781637|peanut|peanut
319742|NCT01781637|oral desensitization|oral desensitization
319743|NCT01781611|lupus|lupus
319744|NCT01781611|dipyridamole|dipyridamole
319745|NCT01781598|Total knee arthroplasty|total knee arthroplasty
319746|NCT01781598|Patient specific instruments|patient specific instruments
319747|NCT01781598|Patient matched cutting blocks|patient matched cutting blocks
319748|NCT01781598|Alignment|alignment
319749|NCT01781598|Learning curve|learning curve
319750|NCT01781598|VISIONAIRE|visionaire
319751|NCT01781585|Sustained low-efficiency dialysis;|sustained low-efficiency dialysis;
319752|NCT01781585|Continuous venovenous hemofiltration;|continuous venovenous hemofiltration;
319753|NCT01781585|hemodynamic stability,|hemodynamic stability,
319754|NCT01781585|Intracranial pressure|intracranial pressure
319755|NCT01781546|drug eluting balloon|drug eluting balloon
319756|NCT01781546|bare metal stent|bare metal stent
319757|NCT01781546|coronary artery disease|coronary artery disease
319758|NCT01781546|acute coronary syndrome|acute coronary syndrome
319759|NCT01781546|percutaneous coronary intervention|percutaneous coronary intervention
319760|NCT01781546|DEB|deb
319761|NCT01781546|BMS|bms
319762|NCT01781520|Pancreatic Cancer|pancreatic cancer
319763|NCT01781520|S1|s1
319764|NCT01781520|DC-CIK|dc-cik
319765|NCT01781507|Asthma|asthma
319766|NCT01781507|Allergic rhinitis|allergic rhinitis
319767|NCT01781507|Cetirizine|cetirizine
319768|NCT01781507|Impulse oscillometry|impulse oscillometry
319769|NCT01781481|Psychosocial Stress and Adjustment|psychosocial stress and adjustment
319770|NCT01781481|Pediatric Chronic Illness|pediatric chronic illness
319771|NCT01781481|Decision-support tool|decision-support tool
319772|NCT01781481|Integrated Health Care|integrated health care
319773|NCT01781481|Case Complexity|case complexity
319774|NCT01781442|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
319775|NCT01781416|cardiovascular risk|cardiovascular risk
319776|NCT01781416|SCORE|score
319777|NCT01781416|cardiovascular primary prevention|cardiovascular primary prevention
319778|NCT01781416|risk factors|risk factors
319779|NCT01781403|Temozolomide|temozolomide
319780|NCT01781403|capecitabine|capecitabine
319781|NCT01781403|rectal cancer|rectal cancer
319782|NCT01781390|Acute Myocardial Infarction|acute myocardial infarction
319783|NCT01781390|STEMI|stemi
319784|NCT01781390|Heart Attack|heart attack
319785|NCT01781390|AMI|ami
319786|NCT01781390|Stem Cells|stem cells
319787|NCT01781377|NAUSEA|nausea
319788|NCT01781377|VOMITING|vomiting
319789|NCT01781377|CESAREAN SECTION|cesarean section
319790|NCT01781377|PREVENTION|prevention
319791|NCT01781377|PROPOFOL|propofol
319792|NCT01781364|Brain Oscillations|brain oscillations
319793|NCT01781364|Cognitive Performance|cognitive performance
319794|NCT01781325|musculoskeletal, physical therapy|musculoskeletal, physical therapy
319795|NCT01781299|Breast Cancer|breast cancer
319796|NCT01781299|Mastectomy|mastectomy
319797|NCT01781299|Immediate reconstruction|immediate reconstruction
319798|NCT01781286|Obesity|obesity
319799|NCT01781286|Snacking|snacking
319800|NCT01781286|Appetite|appetite
319801|NCT01781286|Protein|protein
319802|NCT01781286|Soy|soy
319803|NCT01781286|Reward driven eating|reward driven eating
319804|NCT01781286|Satiety|satiety
319805|NCT01781273|impaired driving|impaired driving
319806|NCT01781260|Prone position|prone position
319807|NCT01781260|Cardiac output|cardiac output
319808|NCT01781260|Liver Circulation|liver circulation
319809|NCT01781247|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
319810|NCT01781247|Myocardial Infarction|myocardial infarction
319811|NCT01781247|Psychotherapy|psychotherapy
319812|NCT01781247|Preventive Therapy|preventive therapy
319813|NCT01781247|Randomized Controlled Trial|randomized controlled trial
319814|NCT01781247|Cardiovascular Diseases|cardiovascular diseases
319815|NCT01781247|Psychological Stress|psychological stress
319816|NCT01781247|Biomarkers|biomarkers
319817|NCT01781195|Advagraf|advagraf
319818|NCT01781195|MELD-score|meld-score
319819|NCT01781195|Na-MELD-score|na-meld-score
319820|NCT01781195|liver function|liver function
319821|NCT01781195|LiMAx-test|limax-test
319822|NCT01781195|infection rate|infection rate
319823|NCT01781195|HLA-DR status|hla-dr status
319824|NCT01781195|immunostatus|immunostatus
319825|NCT01781169|Vitamin D,|vitamin d,
319826|NCT01781169|Oral supplementation,|oral supplementation,
319827|NCT01781169|Obese males|obese males
319828|NCT01781156|phosphorus|phosphorus
319829|NCT01781156|hemodialysis|hemodialysis
319830|NCT01781156|cardiac biomarkers|cardiac biomarkers
319831|NCT01781117|Benign prostatic obstruction (BPO)|benign prostatic obstruction (bpo)
319832|NCT01781117|Detrusor overactivity (DO)|detrusor overactivity (do)
319833|NCT01781117|Urinary nerve growth factor (NGF)|urinary nerve growth factor (ngf)
319834|NCT01781104|constipation gastric emptying gastrointestinal motility ghrelin|constipation gastric emptying gastrointestinal motility ghrelin
319835|NCT01781078|Single chamber pacing|single chamber pacing
319836|NCT01781078|Dual chamber pacing|dual chamber pacing
319837|NCT01781078|MRI|mri
319838|NCT01781078|MR scans|mr scans
319839|NCT01781052|Iloprost Compliance|iloprost compliance
319840|NCT01781039|"hair cell"|"hair cell"
319841|NCT01781039|"hearing aid"|"hearing aid"
319842|NCT01781039|"hearing loss"|"hearing loss"
319843|NCT01781039|"auditory nerve"|"auditory nerve"
319844|NCT01781039|synaptopathy|synaptopathy
319845|NCT01781026|B-raf V600E|b-raf v600e
319846|NCT01781026|V600K mutation|v600k mutation
319847|NCT01781026|metastatic melanoma|metastatic melanoma
319848|NCT01781013|Depression screening|depression screening
319849|NCT01781013|Depression monitoring|depression monitoring
319850|NCT01781013|Chronic illness|chronic illness
319851|NCT01781013|Behavioral health|behavioral health
319852|NCT01781013|Care management|care management
319853|NCT01781013|Automatic telephone assessment|automatic telephone assessment
319854|NCT01781013|Clinical decision support|clinical decision support
319855|NCT01781013|Suicide alert|suicide alert
319856|NCT01781000|Cognitive Training|cognitive training
319857|NCT01781000|Neuroplasticity|neuroplasticity
319858|NCT01781000|MEG|meg
319859|NCT01781000|MATRICS|matrics
319860|NCT01780987|DVT|dvt
319861|NCT01780987|PE|pe
319862|NCT01780987|VTE|vte
319863|NCT01780974|Hypertension|hypertension
319864|NCT01780974|Vascular Risk|vascular risk
319865|NCT01780974|Alzheimer's Risk|alzheimer's risk
319866|NCT01780974|fish oil|fish oil
319867|NCT01780974|Lipoic acid|lipoic acid
319868|NCT01780961|Esophageal Cancer|esophageal cancer
319869|NCT01780961|ESBX|esbx
319870|NCT01780948|Drug Interaction|drug interaction
319871|NCT01780948|Pharmacokinetics|pharmacokinetics
319872|NCT01780948|Everolimus|everolimus
319873|NCT01780948|Atorvastatin|atorvastatin
319874|NCT01780922|Inflammation|inflammation
319875|NCT01780922|Oxidative Stress|oxidative stress
319876|NCT01780922|Vaccinium macrocarpon|vaccinium macrocarpon
319877|NCT01780896|Topographical Memory|topographical memory
319878|NCT01780896|Non-Topographical Memory|non-topographical memory
319879|NCT01780896|Vestibular Function|vestibular function
319880|NCT01780896|Alzheimer's Disease|alzheimer's disease
319881|NCT01780883|melatonin|melatonin
319882|NCT01780883|childhood autism|childhood autism
319883|NCT01780883|6-Sulphatoxymelatonin|6-sulphatoxymelatonin
319884|NCT01780883|autistic disorder|autistic disorder
319885|NCT01780883|dose-effect relation|dose-effect relation
319886|NCT01780870|Overweight|overweight
319887|NCT01780870|Obesity|obesity
319888|NCT01780870|Obese|obese
319889|NCT01780870|Weight loss|weight loss
319890|NCT01780857|palmoplantar pustulosis|palmoplantar pustulosis
319891|NCT01780857|psoriasis|psoriasis
319892|NCT01780844|Kidney Transplantation|kidney transplantation
319990|NCT01780467|Parkinson's disease|parkinson's disease
319893|NCT01780844|de novo Kidney Transplantation|de novo kidney transplantation
319894|NCT01780844|ASKP1240|askp1240
319895|NCT01780818|Warm Water Infusion colonoscopy|warm water infusion colonoscopy
319896|NCT01780818|Water Immersion colonoscopy|water immersion colonoscopy
319897|NCT01780818|Water Exchange colonoscopy|water exchange colonoscopy
319898|NCT01780818|Painless unsedated colonoscopy|painless unsedated colonoscopy
319899|NCT01780818|Adenoma detection rate|adenoma detection rate
319900|NCT01780818|Adenoma resection rate|adenoma resection rate
319901|NCT01780792|multiple sclerosis|multiple sclerosis
319902|NCT01780792|mobility|mobility
319903|NCT01780792|cognition|cognition
319904|NCT01780792|neuroplasticity|neuroplasticity
319905|NCT01780792|videogame play|videogame play
319906|NCT01780779|Diffusion weighted MRI|diffusion weighted mri
319907|NCT01780779|Patient outcome assessment|patient outcome assessment
319908|NCT01780779|Treatment response|treatment response
319909|NCT01780779|Histopathology|histopathology
319910|NCT01780766|Whole body MRI|whole body mri
319911|NCT01780766|Multiple myeloma|multiple myeloma
319912|NCT01780766|Diffusion Weighted MRI|diffusion weighted mri
319913|NCT01780766|Whole body scan|whole body scan
319914|NCT01780753|Primaquine|primaquine
319915|NCT01780753|Vivax malaria|vivax malaria
319916|NCT01780753|G6PD|g6pd
319917|NCT01780740|Bypass Surgery, Coronary Artery|bypass surgery, coronary artery
319918|NCT01780740|Atrial fibrillation|atrial fibrillation
319919|NCT01780740|Ischaemia-reperfusion injury|ischaemia-reperfusion injury
319920|NCT01780740|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
319921|NCT01780740|Statins, HMG-CoA|statins, hmg-coa
319922|NCT01780727|echocardiography|echocardiography
319923|NCT01780727|hemodynamic management|hemodynamic management
319924|NCT01780714|smoking|smoking
319925|NCT01780714|cigarette|cigarette
319926|NCT01780714|exposure|exposure
319927|NCT01780714|biomarker|biomarker
319928|NCT01780714|human smoking topography (HST)|human smoking topography (hst)
319929|NCT01780714|modified risk tobacco product (MRTP)|modified risk tobacco product (mrtp)
319930|NCT01780714|THS 2.1|ths 2.1
319931|NCT01780701|prostate cancer aggressiveness|prostate cancer aggressiveness
319932|NCT01780701|magnetic resonance imaging|magnetic resonance imaging
319933|NCT01780701|fatty acid synthase|fatty acid synthase
319934|NCT01780688|Modified risk tobacco product (MRTP)|modified risk tobacco product (mrtp)
319935|NCT01780688|Smoking|smoking
319936|NCT01780688|Nicotine profile|nicotine profile
319937|NCT01780675|Prophylactic Cranial Irradiation|prophylactic cranial irradiation
319938|NCT01780675|Hippocampal Avoidance Prophylactic Cranial Irradiation|hippocampal avoidance prophylactic cranial irradiation
319939|NCT01780649|IMSI|imsi
319940|NCT01780649|ICSI|icsi
319941|NCT01780649|ART Assisted reproductive technology|art assisted reproductive technology
319942|NCT01780649|Spermatozoa|spermatozoa
319943|NCT01780649|male infertility|male infertility
319944|NCT01780649|vacuoles|vacuoles
319945|NCT01780636|Non relaxing puborectalis syndrome|non relaxing puborectalis syndrome
319946|NCT01780636|Botulinum toxin A|botulinum toxin a
319947|NCT01780636|Botox|botox
319948|NCT01780636|Constipation|constipation
319949|NCT01780623|fatigue|fatigue
319950|NCT01780623|sleep|sleep
319951|NCT01780623|quality of life|quality of life
319952|NCT01780623|light|light
319953|NCT01780623|cancer|cancer
319954|NCT01780610|endometrium preparation protocols|endometrium preparation protocols
319955|NCT01780610|frozen-thawed embryo transfer|frozen-thawed embryo transfer
319956|NCT01780610|irregular cycle|irregular cycle
319957|NCT01780610|randomized controlled trial|randomized controlled trial
319958|NCT01780597|Heart transplantation|heart transplantation
319959|NCT01780597|Ev Vivo Perfusion|ev vivo perfusion
319960|NCT01780597|Cardiac function|cardiac function
319961|NCT01780584|congenital heart surgery, thyroid hormones|congenital heart surgery, thyroid hormones
319962|NCT01780571|Obesity|obesity
319963|NCT01780571|general anaesthesia|general anaesthesia
319964|NCT01780571|preoxygenation|preoxygenation
319965|NCT01780571|atelectasis|atelectasis
319966|NCT01780558|endometrium preparation protocols|endometrium preparation protocols
319967|NCT01780558|frozen-thawed embryo transfer|frozen-thawed embryo transfer
319968|NCT01780558|natural cycles|natural cycles
319969|NCT01780558|hormone replacement therapy cycles|hormone replacement therapy cycles
319970|NCT01780558|randomized controlled trial|randomized controlled trial
319971|NCT01780545|OGX-427|ogx-427
319972|NCT01780545|Docetaxel|docetaxel
319973|NCT01780519|Alzheimer's disease (AD)|alzheimer's disease (ad)
319974|NCT01780506|HIV|hiv
319975|NCT01780506|Treatment Naive|treatment naive
319976|NCT01780506|HIV 1 Infected|hiv 1 infected
319977|NCT01780506|Female|female
319978|NCT01780506|Women|women
319979|NCT01780493|Nipple|nipple
319980|NCT01780493|Technique|technique
319981|NCT01780493|Ureter|ureter
319982|NCT01780493|Vesicoureteral Reflux|vesicoureteral reflux
319983|NCT01780480|Ischemic Stroke|ischemic stroke
319984|NCT01780480|Convalescence|convalescence
319985|NCT01780480|Randomized Controlled Trial|randomized controlled trial
319986|NCT01780480|Pilot Study|pilot study
319987|NCT01780480|Traditional Chinese Medicine|traditional chinese medicine
319988|NCT01780467|Loss aversion|loss aversion
319991|NCT01780454|End Stage Renal Disease|end stage renal disease
319992|NCT01780454|Renal Transplant|renal transplant
319993|NCT01780454|Bone Marrow Transplant|bone marrow transplant
319994|NCT01780454|Tolerance|tolerance
319995|NCT01780454|Chimerism|chimerism
319996|NCT01780454|ESRD|esrd
319997|NCT01780441|Tuberous Sclerosis Complex|tuberous sclerosis complex
319998|NCT01780441|TSC|tsc
319999|NCT01780441|Autism|autism
320000|NCT01780441|ASD|asd
320001|NCT01780441|Biomarkers|biomarkers
320002|NCT01780441|Infants|infants
320003|NCT01780428|Pain|pain
320004|NCT01780428|Nausea|nausea
320005|NCT01780428|Vomiting|vomiting
320006|NCT01780415|Blastocoele fluid|blastocoele fluid
320007|NCT01780415|Human DNA|human dna
320008|NCT01780415|molecular diagnosis|molecular diagnosis
320009|NCT01780402|feeding difficulty|feeding difficulty
320010|NCT01780402|eating difficulty|eating difficulty
320011|NCT01780402|dementia|dementia
320012|NCT01780402|nursing home|nursing home
320013|NCT01780402|careful hand feeding|careful hand feeding
320014|NCT01780389|Knee|knee
320015|NCT01780389|Pain|pain
320016|NCT01780389|Osteoarthritis|osteoarthritis
320017|NCT01780376|whole-body vibration|whole-body vibration
320018|NCT01780376|latency|latency
320019|NCT01780376|reflex response|reflex response
320020|NCT01780376|muscle|muscle
320021|NCT01780337|Oxytocin|oxytocin
320022|NCT01780337|Arrhythmia|arrhythmia
320023|NCT01780298|COPD|copd
320024|NCT01780298|Biomarkers|biomarkers
320025|NCT01780298|Cigarette Smoke|cigarette smoke
320026|NCT01780298|Lung Inflammation|lung inflammation
320027|NCT01780298|FEV|fev
320028|NCT01780298|Sputum|sputum
320029|NCT01780285|Hiatal hernia|hiatal hernia
320030|NCT01780285|Gastro-oesophageal reflux disease|gastro-oesophageal reflux disease
320031|NCT01780285|Laparoscopic hiatal repair|laparoscopic hiatal repair
320032|NCT01780285|Laparoscopic anti-reflux surgery|laparoscopic anti-reflux surgery
320033|NCT01780285|Partially absorbable lightweight mesh|partially absorbable lightweight mesh
320034|NCT01780285|Polytetrafluoroethylene|polytetrafluoroethylene
320035|NCT01780285|PTFE|ptfe
320036|NCT01780285|Nitinol|nitinol
320037|NCT01780285|Nitinol-framed lightweight PTFE mesh|nitinol-framed lightweight ptfe mesh
320038|NCT01780259|Healthy|healthy
320039|NCT01780259|Esketamine|esketamine
320040|NCT01780259|Pharmacokinetics|pharmacokinetics
320041|NCT01780259|Intranasal|intranasal
320042|NCT01780246|Spinal Muscular Atrophy|spinal muscular atrophy
320043|NCT01780246|SMA|sma
320044|NCT01780246|SMN|smn
320045|NCT01780246|SMNRx|smnrx
320046|NCT01780246|ISIS-SMNRx|isis-smnrx
320047|NCT01780246|ISIS 396443|isis 396443
320048|NCT01780220|abiraterone|abiraterone
320049|NCT01780220|biochemically-relapsing|biochemically-relapsing
320050|NCT01780220|prostate adenocarcinoma|prostate adenocarcinoma
320051|NCT01780181|lung cancer|lung cancer
320052|NCT01780181|traditional Chinese medicine|traditional chinese medicine
320053|NCT01780168|Inborn Error of Metabolism|inborn error of metabolism
320054|NCT01780168|Metabolism|metabolism
320055|NCT01780168|UCD|ucd
320056|NCT01780168|Immunity|immunity
320057|NCT01780168|Nutrition|nutrition
320058|NCT01780168|Mitochondrial Disease|mitochondrial disease
320059|NCT01780155|Oxidative Stress|oxidative stress
320060|NCT01780155|Hyperoxia|hyperoxia
320061|NCT01780155|Brochopulmonary Dysplasia|brochopulmonary dysplasia
320062|NCT01780155|Retinopathy of Prematurity|retinopathy of prematurity
320063|NCT01780155|Very Low Birth Rate|very low birth rate
320064|NCT01780142|Airflow Obstruction|airflow obstruction
320065|NCT01780142|Airflow Inflammation|airflow inflammation
320066|NCT01780142|Corticosteroid Resistance|corticosteroid resistance
320067|NCT01780142|Exacerbations|exacerbations
320068|NCT01780142|Quality of Life|quality of life
320069|NCT01780116|schizophrenia|schizophrenia
320070|NCT01780116|adherence therapy|adherence therapy
320071|NCT01780116|medication|medication
320072|NCT01780116|randomized controlled trial|randomized controlled trial
320073|NCT01780116|cost-effectiveness|cost-effectiveness
320074|NCT01780090|autism|autism
320075|NCT01780090|prosody|prosody
320076|NCT01780090|speech|speech
320077|NCT01780090|autism spectrum disorder|autism spectrum disorder
320078|NCT01780077|Scar|scar
320079|NCT01780077|Scar prevention|scar prevention
320080|NCT01780077|Fibrosis|fibrosis
320081|NCT01780051|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
320082|NCT01780051|Pharmacokinetics|pharmacokinetics
320083|NCT01780038|Cigarette Smoking|cigarette smoking
320084|NCT01780038|Nicotine Dependence|nicotine dependence
320085|NCT01780038|Smoking Abstinence|smoking abstinence
320086|NCT01780038|Health Literacy|health literacy
320087|NCT01780038|Genetic Predisposition Testing|genetic predisposition testing
320088|NCT01780038|Heredity|heredity
320089|NCT01780025|Hearing|hearing
320090|NCT01780025|Thresholds|thresholds
320091|NCT01780025|Coupling to the inner ear|coupling to the inner ear
320092|NCT01780012|osteoporosis|osteoporosis
320093|NCT01780012|fragility fracture|fragility fracture
320094|NCT01780012|secondary prevention|secondary prevention
320095|NCT01779999|central venous catheters|central venous catheters
320096|NCT01779999|thrombosis|thrombosis
320097|NCT01779999|secondary prevention|secondary prevention
320098|NCT01779973|Skype|skype
320099|NCT01779973|compliance|compliance
320100|NCT01779973|remote dosing|remote dosing
320101|NCT01779973|suboxone|suboxone
320102|NCT01779973|opiate|opiate
320103|NCT01779973|opiates|opiates
320104|NCT01779973|heroin|heroin
320105|NCT01779973|oxycontin|oxycontin
320106|NCT01779973|Philadelphia|philadelphia
320107|NCT01779960|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
320108|NCT01779960|Motor activity|motor activity
320109|NCT01779960|Climatologic station|climatologic station
320110|NCT01779908|Vitamin D supplementation|vitamin d supplementation
320111|NCT01779908|Insulin resistance|insulin resistance
320112|NCT01779895|Dust mite|dust mite
320113|NCT01779895|Perennial allergic rhinitis|perennial allergic rhinitis
320114|NCT01779869|PET MR myocardial perfusion imaging|pet mr myocardial perfusion imaging
320115|NCT01779856|End Stage Renal Disease, Hemodialysis, Arrhythmia, Reveal ICM|end stage renal disease, hemodialysis, arrhythmia, reveal icm
320116|NCT01779843|Newly diagnosed|newly diagnosed
320117|NCT01779804|foot , ankle, injury|foot , ankle, injury
320118|NCT01779791|Lymphoma|lymphoma
320119|NCT01779791|Refractory follicular lymphoma|refractory follicular lymphoma
320120|NCT01779791|Chemoimmunotherapy-resistant follicular lymphoma|chemoimmunotherapy-resistant follicular lymphoma
320121|NCT01779791|PCI-32765|pci-32765
320122|NCT01779791|Ibrutinib|ibrutinib
320123|NCT01779791|IMBRUVICA|imbruvica
320125|NCT01779765|Diarrhea|diarrhea
320126|NCT01779765|Constipation|constipation
320127|NCT01779765|Fibers|fibers
320128|NCT01779739|vaginal prolapse|vaginal prolapse
320129|NCT01779739|sexual function|sexual function
320130|NCT01779739|sexual dysfunction|sexual dysfunction
320131|NCT01779739|prolapse surgery|prolapse surgery
320132|NCT01779726|Organization|organization
320133|NCT01779726|of fast track|of fast track
320134|NCT01779713|Aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
320135|NCT01779713|Vasospasm|vasospasm
320136|NCT01779713|Transcriptomic|transcriptomic
320137|NCT01779713|Case-Control Study|case-control study
320138|NCT01779700|psychosis|psychosis
320139|NCT01779700|schizophrenia|schizophrenia
320140|NCT01779700|cognition|cognition
320141|NCT01779700|fingolimod|fingolimod
320142|NCT01779687|pharmacokinetic|pharmacokinetic
320143|NCT01779687|interaction|interaction
320144|NCT01779687|cholesterol|cholesterol
320145|NCT01779687|raltegravir|raltegravir
320146|NCT01779687|atorvastatin|atorvastatin
320147|NCT01779661|Neurodevelopment, Infant-Aquatics, Prematurity|neurodevelopment, infant-aquatics, prematurity
320148|NCT01779648|deep vein thrombosis|deep vein thrombosis
320149|NCT01779648|intermittent pneumatic compression|intermittent pneumatic compression
320150|NCT01779648|venous hemodynamics|venous hemodynamics
320151|NCT01779635|Heparin-grafted membrane|heparin-grafted membrane
320152|NCT01779635|Circuit lifespan|circuit lifespan
320153|NCT01779635|Continuous renal replacement therapy|continuous renal replacement therapy
320154|NCT01779635|Anticoagulation free|anticoagulation free
320155|NCT01779635|Bleeding risk|bleeding risk
320156|NCT01779635|Acute kidney injury|acute kidney injury
320157|NCT01779635|Critical illness|critical illness
320158|NCT01779622|mixed meal¨|mixed meal¨
320159|NCT01779622|insulin|insulin
320160|NCT01779622|glucagon|glucagon
320161|NCT01779622|GIP|gip
320162|NCT01779622|GLP-1|glp-1
320163|NCT01779596|diabetes|diabetes
320164|NCT01779596|endothelial function|endothelial function
320165|NCT01779596|exercise|exercise
320166|NCT01779596|blood flow|blood flow
320167|NCT01779596|bosentan|bosentan
320168|NCT01779583|Advanced gastric cancer|advanced gastric cancer
320169|NCT01779570|Influenza|influenza
320170|NCT01779570|Macrolide|macrolide
320171|NCT01779570|Anti-inflammatory|anti-inflammatory
320172|NCT01779557|CAPD|capd
320173|NCT01779557|efficacy|efficacy
320174|NCT01779557|safety|safety
320175|NCT01779557|survival rate|survival rate
320176|NCT01779544|rehabilitation,surgery,brief intervention, exercises|rehabilitation,surgery,brief intervention, exercises
320177|NCT01779531|HER2-negative Luminal B breast cancer|her2-negative luminal b breast cancer
320178|NCT01779518|HCV|hcv
320179|NCT01779518|Sustained Virologic Response|sustained virologic response
320180|NCT01779518|Direct Acting Antiviral|direct acting antiviral
320181|NCT01779518|GS-7977|gs-7977
320182|NCT01779518|Pegylated interferon|pegylated interferon
320183|NCT01779518|Ribavirin|ribavirin
320184|NCT01779518|Open Label|open label
320185|NCT01779518|Sofosbuvir|sofosbuvir
320186|NCT01779518|Liver transplant|liver transplant
320187|NCT01779518|Hepatitis|hepatitis
320188|NCT01779518|Hepatitis, Chronic|hepatitis, chronic
320189|NCT01779518|Hepatitis C|hepatitis c
320190|NCT01779518|Hepatitis C, Chronic|hepatitis c, chronic
320191|NCT01779518|Liver Diseases|liver diseases
320192|NCT01779518|Digestive System Diseases|digestive system diseases
320193|NCT01779518|Hepatitis, Viral, Human|hepatitis, viral, human
320194|NCT01779518|Virus Diseases|virus diseases
320195|NCT01779518|Enterovirus Infections|enterovirus infections
320388|NCT01778712|Menopause|menopause
320196|NCT01779518|Picornaviridae Infections|picornaviridae infections
320197|NCT01779518|RNA Virus Infections|rna virus infections
320198|NCT01779518|Flaviviridae Infections|flaviviridae infections
320199|NCT01779518|Antiviral Agents|antiviral agents
320200|NCT01779518|Anti-Infective Agents|anti-infective agents
320201|NCT01779518|Therapeutic Uses|therapeutic uses
320202|NCT01779518|Pharmacologic Actions|pharmacologic actions
320203|NCT01779518|Antimetabolites|antimetabolites
320204|NCT01779518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
320205|NCT01779492|Oxycodone, controlled release formulation|oxycodone, controlled release formulation
320206|NCT01779479|German Breast Group|german breast group
320207|NCT01779479|GBG Forschungs GmbH|gbg forschungs gmbh
320208|NCT01779479|GBG|gbg
320209|NCT01779479|GBG 74|gbg 74
320210|NCT01779479|Genevieve|genevieve
320211|NCT01779479|Breast Cancer|breast cancer
320212|NCT01779479|Primary Breast Cancer|primary breast cancer
320213|NCT01779479|Cabazitaxel|cabazitaxel
320214|NCT01779479|Paclitaxel|paclitaxel
320215|NCT01779479|neo-adjuvant|neo-adjuvant
320216|NCT01779479|triple negative|triple negative
320217|NCT01779479|luminal B|luminal b
320218|NCT01779453|Atorvastatin|atorvastatin
320219|NCT01779453|Drug-drug interaction|drug-drug interaction
320220|NCT01779453|Combination therapy|combination therapy
320221|NCT01779440|Mental Illness|mental illness
320222|NCT01779440|Tobacco Smoking|tobacco smoking
320223|NCT01779440|Young Adults|young adults
320224|NCT01779440|Treatment Engagement|treatment engagement
320225|NCT01779440|Motivational Intervention|motivational intervention
320226|NCT01779427|traumatic brain injury (TBI)|traumatic brain injury (tbi)
320227|NCT01779427|intracranial edema|intracranial edema
320228|NCT01779427|brain edema|brain edema
320229|NCT01779427|craniocerebral trauma|craniocerebral trauma
320230|NCT01779427|head injury|head injury
320231|NCT01779427|brain hemorrhage, traumatic|brain hemorrhage, traumatic
320232|NCT01779427|subdural hematoma|subdural hematoma
320233|NCT01779427|brain concussion|brain concussion
320234|NCT01779427|head injuries, closed|head injuries, closed
320235|NCT01779427|epidural hematoma|epidural hematoma
320236|NCT01779427|extra-axial hemorrhage|extra-axial hemorrhage
320237|NCT01779427|cortical contusion|cortical contusion
320238|NCT01779427|wounds and injuries|wounds and injuries
320239|NCT01779427|disorders of environmental origin|disorders of environmental origin
320240|NCT01779427|trauma, nervous system|trauma, nervous system
320241|NCT01779427|brain injuries|brain injuries
320242|NCT01779427|attention deficit hyperactivity disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
320243|NCT01779427|attention|attention
320244|NCT01779414|Suicide Ideation|suicide ideation
320245|NCT01779401|PCI|pci
320246|NCT01779401|platelet function monitoring|platelet function monitoring
320247|NCT01779401|Thrombelastography|thrombelastography
320248|NCT01779401|clopidogrel|clopidogrel
320249|NCT01779401|cilostazol|cilostazol
320250|NCT01779401|in-stent thrombosis|in-stent thrombosis
320251|NCT01779388|Lung nodule|lung nodule
320252|NCT01779388|PET scanner|pet scanner
320253|NCT01779388|Bronchoscopy|bronchoscopy
320254|NCT01779388|Electromagnetic navigation|electromagnetic navigation
320255|NCT01779375|Children|children
320256|NCT01779375|Pediatric|pediatric
320257|NCT01779349|benign prostatic hyperplasia (BPH)|benign prostatic hyperplasia (bph)
320258|NCT01779349|acoustic vibration|acoustic vibration
320259|NCT01779336|Advanced Refractory Solid Tumors|advanced refractory solid tumors
320260|NCT01779323|SUI|sui
320261|NCT01779323|stress urinary incontinence|stress urinary incontinence
320262|NCT01779323|male|male
320263|NCT01779323|transobturator sling|transobturator sling
320264|NCT01779297|new integrative weaning indexes|new integrative weaning indexes
320265|NCT01779297|mechanical ventilation|mechanical ventilation
320266|NCT01779297|ICU|icu
320267|NCT01779284|glaucoma|glaucoma
320268|NCT01779284|fixed combinations|fixed combinations
320269|NCT01779284|24-hour monitoring|24-hour monitoring
320270|NCT01779271|Pelubi|pelubi
320271|NCT01779271|Pelubiprofen|pelubiprofen
320272|NCT01779271|Loxoprofen|loxoprofen
320273|NCT01779271|Anti-pyretic|anti-pyretic
320274|NCT01779271|Fever|fever
320275|NCT01779258|xerosis|xerosis
320276|NCT01779258|dry skin|dry skin
320277|NCT01779258|dermatitis|dermatitis
320278|NCT01779258|eczema|eczema
320279|NCT01779258|emollient|emollient
320280|NCT01779258|corticosteroid|corticosteroid
320281|NCT01779258|flare|flare
320282|NCT01779232|endometriosis|endometriosis
320283|NCT01779232|ivf|ivf
320284|NCT01779232|ovarian reserve|ovarian reserve
320285|NCT01779232|danazol|danazol
320286|NCT01779219|intraoperative magnetic resonance|intraoperative magnetic resonance
320287|NCT01779219|stereotactic biopsy|stereotactic biopsy
320288|NCT01779219|brain tumor|brain tumor
320289|NCT01779219|frameless stereotaxy|frameless stereotaxy
320290|NCT01779219|image-guided neurosurgery|image-guided neurosurgery
320291|NCT01779193|group B streptococcus|group b streptococcus
320292|NCT01779193|pregnancy|pregnancy
320293|NCT01779193|probiotics|probiotics
320294|NCT01779180|Vitamin A supplementation|vitamin a supplementation
320589|NCT01777776|LEE011|lee011
320295|NCT01779180|BCG vaccination|bcg vaccination
320296|NCT01779180|diphtheria-tetanus-pertussis vaccination|diphtheria-tetanus-pertussis vaccination
320297|NCT01779180|measles vaccination|measles vaccination
320298|NCT01779180|atopy|atopy
320299|NCT01779167|WM|wm
320300|NCT01779154|eosinophilic esophagitis|eosinophilic esophagitis
320301|NCT01779154|eosinophilic gastritis|eosinophilic gastritis
320302|NCT01779154|eosinophilic enteritis|eosinophilic enteritis
320303|NCT01779154|eosinophilic colitis|eosinophilic colitis
320304|NCT01779141|Type 1 Diabetes Mellitus - T1DM|type 1 diabetes mellitus - t1dm
320305|NCT01779141|Pregnancy|pregnancy
320306|NCT01779141|Insulin Pump|insulin pump
320307|NCT01779141|Glucose Sensor|glucose sensor
320308|NCT01779141|Continuous Subcutaneous Insulin Infusion - CSII|continuous subcutaneous insulin infusion - csii
320309|NCT01779141|Sensor Augmented Pump - SAP|sensor augmented pump - sap
320310|NCT01779141|Continuous Glucose Monitoring - CGM|continuous glucose monitoring - cgm
320311|NCT01779115|Registry,Diabetes,Health Maintenance Organization|registry,diabetes,health maintenance organization
320312|NCT01779089|diabetic nephropathy|diabetic nephropathy
320313|NCT01779089|diabetic kidney disease|diabetic kidney disease
320314|NCT01779089|minocycline|minocycline
320315|NCT01779089|proteinuria|proteinuria
320316|NCT01779089|albuminuria|albuminuria
320317|NCT01779063|lymphedema|lymphedema
320318|NCT01779063|self-care|self-care
320319|NCT01779063|breast cancer|breast cancer
320320|NCT01779024|Addiction|addiction
320321|NCT01779024|Alcohol|alcohol
320322|NCT01779024|Alcohol Clamp|alcohol clamp
320323|NCT01778998|incision|incision
320324|NCT01778998|pre-cut|pre-cut
320325|NCT01778998|wound architecture|wound architecture
320326|NCT01778998|OCT|oct
320327|NCT01778985|Pelvic organ prolapse|pelvic organ prolapse
320328|NCT01778985|Menopause|menopause
320329|NCT01778985|Estrogen|estrogen
320330|NCT01778985|Premarin|premarin
320331|NCT01778972|Fall prevention|fall prevention
320332|NCT01778972|Home exercise|home exercise
320333|NCT01778972|Strength training|strength training
320334|NCT01778972|Balance training|balance training
320335|NCT01778946|Nicotine|nicotine
320336|NCT01778946|Down Syndrome|down syndrome
320337|NCT01778946|Mild Cognitive Impairment|mild cognitive impairment
320338|NCT01778946|Event Related Potential|event related potential
320339|NCT01778946|Memory|memory
320340|NCT01778946|Attention|attention
320341|NCT01778946|Trisomy 21|trisomy 21
320342|NCT01778946|Neuroprotection|neuroprotection
320343|NCT01778946|Cognitive Enhancement|cognitive enhancement
320344|NCT01778946|Alzheimer's Disease|alzheimer's disease
320345|NCT01778946|Dementia|dementia
320346|NCT01778946|APOE|apoe
320347|NCT01778933|Renal cell carcinoma|renal cell carcinoma
320348|NCT01778933|Renal nodules|renal nodules
320349|NCT01778907|Pharmacogenetics|pharmacogenetics
320350|NCT01778907|Depression|depression
320351|NCT01778907|Depressive Disorder|depressive disorder
320352|NCT01778907|Cytochrome P-450 CYP2D6|cytochrome p-450 cyp2d6
320353|NCT01778907|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic
320354|NCT01778907|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation
320355|NCT01778907|Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant|poor metabolizer due to cytochrome p450 cyp2d6 variant
320356|NCT01778907|Intermediate Metabolizer Due to Cytochrome P450 CYP2D6 Variant|intermediate metabolizer due to cytochrome p450 cyp2d6 variant
320357|NCT01778907|Ultrarapid Metabolizer Due to Cytochrome P450 CYP2D6 Variant|ultrarapid metabolizer due to cytochrome p450 cyp2d6 variant
320358|NCT01778907|Multicenter studies|multicenter studies
320359|NCT01778894|Diastolic Dysfunction, Diastolic Heart Failure, Diastolic|diastolic dysfunction, diastolic heart failure, diastolic
320360|NCT01778894|Echocardiography|echocardiography
320361|NCT01778881|Bruxism|bruxism
320362|NCT01778881|Physical therapy modalities|physical therapy modalities
320363|NCT01778881|Massage|massage
320364|NCT01778881|Muscle stretching exercises|muscle stretching exercises
320365|NCT01778881|Relaxation therapy|relaxation therapy
320366|NCT01778881|Imagination|imagination
320367|NCT01778855|stroke|stroke
320368|NCT01778855|hypothermia|hypothermia
320369|NCT01778855|thrombolysis|thrombolysis
320370|NCT01778855|imaging|imaging
320371|NCT01778855|collateral circulation|collateral circulation
320372|NCT01778855|recanalization|recanalization
320373|NCT01778855|reperfusion|reperfusion
320374|NCT01778842|antiplatelet effect|antiplatelet effect
320375|NCT01778842|prasugrel|prasugrel
320376|NCT01778842|clopidogrel|clopidogrel
320377|NCT01778842|acute coronary syndrome|acute coronary syndrome
320378|NCT01778816|Achilles tendon, muscle volume, Achilles tendon length, force, ATRS, Hannover, AOFAS|achilles tendon, muscle volume, achilles tendon length, force, atrs, hannover, aofas
320379|NCT01778777|rotator cuff tear arthropathy|rotator cuff tear arthropathy
320380|NCT01778777|inverse prosthesis|inverse prosthesis
320381|NCT01778777|safety|safety
320382|NCT01778777|universe reverse|universe reverse
320383|NCT01778751|Self-Management Support|self-management support
320384|NCT01778751|Depression|depression
320385|NCT01778751|Home Telehealth|home telehealth
320386|NCT01778725|Chorioamnionitis, S100B, Brain, Neuro-development|chorioamnionitis, s100b, brain, neuro-development
320387|NCT01778712|Multi-level intervention|multi-level intervention
320389|NCT01778712|Body composition|body composition
320390|NCT01778712|Abdominal adipose tissue|abdominal adipose tissue
320391|NCT01778712|Visceral adipose tissue|visceral adipose tissue
320392|NCT01778712|Perceived stress|perceived stress
320393|NCT01778712|Computed tomography|computed tomography
320394|NCT01778712|Dual energy X-ray absorptiometry|dual energy x-ray absorptiometry
320395|NCT01778699|Lactobacillus brevis CD2|lactobacillus brevis cd2
320396|NCT01778699|caries incidence|caries incidence
320397|NCT01778699|plaque-pH|plaque-ph
320398|NCT01778686|Positron Emission Tomography|positron emission tomography
320399|NCT01778686|Serotonin|serotonin
320400|NCT01778686|5-HT2A|5-ht2a
320401|NCT01778686|Radioligand|radioligand
320402|NCT01778660|Fecal Incontinence|fecal incontinence
320403|NCT01778660|Treatment options|treatment options
320404|NCT01778660|Patient Satisfaction|patient satisfaction
320405|NCT01778647|ADHD|adhd
320406|NCT01778647|Omega- 3 Fatty acids|omega- 3 fatty acids
320407|NCT01778647|CGI|cgi
320408|NCT01778647|Conners rating scale|conners rating scale
320409|NCT01778647|Stimulants|stimulants
320410|NCT01778634|Ureaplasma parvum|ureaplasma parvum
320411|NCT01778634|Ureaplasma urealyticum|ureaplasma urealyticum
320412|NCT01778634|prematurity|prematurity
320413|NCT01778634|bronchopulmonary dysplasia|bronchopulmonary dysplasia
320414|NCT01778634|azithromycin|azithromycin
320415|NCT01778621|Acupuncture|acupuncture
320416|NCT01778621|AMH|amh
320417|NCT01778621|Infertility|infertility
320418|NCT01778621|PCOS|pcos
320419|NCT01778621|Pregnancy rate|pregnancy rate
320420|NCT01778608|Sedation|sedation
320421|NCT01778595|Microbiome|microbiome
320422|NCT01778595|Feces|feces
320423|NCT01778595|Cancer Screening|cancer screening
320424|NCT01778582|Emotion|emotion
320425|NCT01778582|Informed Consent|informed consent
320426|NCT01778569|Psoriasis|psoriasis
320427|NCT01778569|Cardiovascular Risk Factors|cardiovascular risk factors
320428|NCT01778569|Inflammation|inflammation
320429|NCT01778569|Lipoproteins|lipoproteins
320430|NCT01778569|Metabolic Dysfunction|metabolic dysfunction
320431|NCT01778556|Lipodystrophy|lipodystrophy
320432|NCT01778556|Leptin|leptin
320433|NCT01778556|Energy Expenditure|energy expenditure
320434|NCT01778556|Diabetes|diabetes
320435|NCT01778556|Hypertriglyceridemia|hypertriglyceridemia
320436|NCT01778543|Coloboma|coloboma
320437|NCT01778530|Glioblastoma|glioblastoma
320438|NCT01778530|Anti-Angiogenesis|anti-angiogenesis
320439|NCT01778530|Radiotherapy|radiotherapy
320440|NCT01778530|Malignant Glioma|malignant glioma
320441|NCT01778530|Progression|progression
320442|NCT01778517|Psychogenic Movement Disorders|psychogenic movement disorders
320443|NCT01778504|Children and Adolescents|children and adolescents
320444|NCT01778504|Natural History Study|natural history study
320445|NCT01778504|Neurodevelopmental Disorders|neurodevelopmental disorders
320446|NCT01778504|Autism|autism
320447|NCT01778504|Obsessive Compulsive Disorder|obsessive compulsive disorder
320448|NCT01778491|Phenotype-Genotype correlation|phenotype-genotype correlation
320449|NCT01778491|Phenotype|phenotype
320450|NCT01778491|Phenotypes|phenotypes
320451|NCT01778491|Age Related Macular Degeneration|age related macular degeneration
320452|NCT01778478|Anxiety|anxiety
320453|NCT01778478|Depression|depression
320454|NCT01778478|Adolescents and Adults|adolescents and adults
320455|NCT01778478|Cancer Diagnosis|cancer diagnosis
320456|NCT01778465|Chronic Rhinosinusitis|chronic rhinosinusitis
320457|NCT01778465|Aspirin exacerbated respiratory disease|aspirin exacerbated respiratory disease
320458|NCT01778465|Asthma|asthma
320459|NCT01778465|Aspirin sensitivity|aspirin sensitivity
320460|NCT01778465|Salicylate|salicylate
320461|NCT01778452|Endometrial priming, genomic expression. Natural cycle. Antagonist GnRH.|endometrial priming, genomic expression. natural cycle. antagonist gnrh.
320462|NCT01778439|Phase 1|phase 1
320463|NCT01778439|Dose escalation|dose escalation
320464|NCT01778439|relapsed or refractory|relapsed or refractory
320465|NCT01778439|solid tumor|solid tumor
320466|NCT01778426|Chronic neuropathic pain syndrome|chronic neuropathic pain syndrome
320467|NCT01778426|Spinal Cord Stimulation|spinal cord stimulation
320468|NCT01778426|Painstim devices|painstim devices
320469|NCT01778426|Efficacy|efficacy
320470|NCT01778426|Safety|safety
320471|NCT01778400|Ultrasound|ultrasound
320472|NCT01778400|Radiofrequency|radiofrequency
320473|NCT01778400|Ethanol|ethanol
320474|NCT01778400|Predominantly cystic thyroid nodule|predominantly cystic thyroid nodule
320475|NCT01778400|Thyroid nodule|thyroid nodule
320476|NCT01778400|Thyroid|thyroid
320477|NCT01778374|Emergency Medicine|emergency medicine
320478|NCT01778374|Screening|screening
320479|NCT01778374|Point of care testing|point of care testing
320480|NCT01778374|Video assisted counseling|video assisted counseling
320481|NCT01778361|Human immunodeficiency virus|human immunodeficiency virus
320482|NCT01778361|low bone mineral density|low bone mineral density
320483|NCT01778361|osteopenia|osteopenia
320484|NCT01778361|osteoporosis|osteoporosis
320485|NCT01778361|fracture|fracture
320486|NCT01778348|Type 1 diabetes|type 1 diabetes
320487|NCT01778348|Closed-loop glucose control|closed-loop glucose control
320488|NCT01778348|Artificial Pancreas|artificial pancreas
320489|NCT01778348|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
320490|NCT01778348|Continuous glucose monitoring|continuous glucose monitoring
320491|NCT01778335|recanalization|recanalization
320492|NCT01778335|endovascular|endovascular
320493|NCT01778335|thrombectomy|thrombectomy
320494|NCT01778309|aseptic inflammation|aseptic inflammation
320495|NCT01778309|skeletal muscle function|skeletal muscle function
320496|NCT01778309|exercise|exercise
320497|NCT01778296|Dorsal branch of the digital nerve;|dorsal branch of the digital nerve;
320498|NCT01778296|dorsal digital artery;|dorsal digital artery;
320499|NCT01778296|dorsal digital island flap;|dorsal digital island flap;
320500|NCT01778296|neurocutaneous island flap.|neurocutaneous island flap.
320501|NCT01778270|pleural effusion|pleural effusion
320502|NCT01778270|pleural drainage|pleural drainage
320503|NCT01778270|thorax impedance|thorax impedance
320504|NCT01778270|respiration parameters|respiration parameters
320505|NCT01778270|heart sounds analysis|heart sounds analysis
320506|NCT01778257|Mate extracts|mate extracts
320507|NCT01778257|Obesity|obesity
320508|NCT01778257|abdominal fat|abdominal fat
320509|NCT01778244|schizophrenia; dyslipidemia|schizophrenia; dyslipidemia
320510|NCT01778231|Focus|focus
320511|NCT01778231|uptake|uptake
320512|NCT01778231|Lutein|lutein
320513|NCT01778231|Zeaxanthin|zeaxanthin
320514|NCT01778231|individuals|individuals
320515|NCT01778218|Coronary Artery Disease|coronary artery disease
320516|NCT01778218|CAD|cad
320517|NCT01778192|Bowel preparation|bowel preparation
320518|NCT01778192|Polyethylene glycol|polyethylene glycol
320519|NCT01778192|Sodium picosulphate|sodium picosulphate
320520|NCT01778179|Lentigines|lentigines
320521|NCT01778179|Cryotherapy|cryotherapy
320522|NCT01778179|hyperpigmentation|hyperpigmentation
320523|NCT01778166|Early enteral nutrition|early enteral nutrition
320524|NCT01778166|Laparoscopic gastrointestinal surgery|laparoscopic gastrointestinal surgery
320525|NCT01778166|Immuno-enhanced nutrition|immuno-enhanced nutrition
320526|NCT01778153|Fitness training|fitness training
320527|NCT01778153|Personal training|personal training
320528|NCT01778140|Clinical Decision Support Systems|clinical decision support systems
320529|NCT01778140|Contrast-induced nephropathy|contrast-induced nephropathy
320530|NCT01778127|Cancer Survivor|cancer survivor
320531|NCT01778127|Physical Activity|physical activity
320532|NCT01778127|Health Outcomes|health outcomes
320533|NCT01778127|Rewards-Based Intervention|rewards-based intervention
320534|NCT01778127|Cardiovascular Health|cardiovascular health
320535|NCT01778127|Musculoskeletal Health|musculoskeletal health
320536|NCT01778127|Exercise|exercise
320537|NCT01778114|Vitamin D2|vitamin d2
320538|NCT01778114|Vitamin D3|vitamin d3
320539|NCT01778114|Vitamin D|vitamin d
320540|NCT01778114|Orange Juice|orange juice
320541|NCT01778101|preterm infants|preterm infants
320542|NCT01778101|reflux|reflux
320543|NCT01778101|impedance|impedance
320544|NCT01778101|pH|ph
320545|NCT01778101|monitoring|monitoring
320546|NCT01778101|lansoprazole|lansoprazole
320547|NCT01778075|Healthy|healthy
320548|NCT01778075|Ultracet extended release (ER)|ultracet extended release (er)
320549|NCT01778075|Tramadol hydrochloride|tramadol hydrochloride
320550|NCT01778075|Acetaminophen|acetaminophen
320551|NCT01778075|Bioequivalence|bioequivalence
320552|NCT01778036|Neck movement|neck movement
320553|NCT01778036|motor control|motor control
320554|NCT01778036|disability|disability
320555|NCT01778036|psychological variables|psychological variables
320556|NCT01778036|Head Movements|head movements
320557|NCT01778036|Physical therapy|physical therapy
320558|NCT01778036|Fear avoidance|fear avoidance
320559|NCT01778036|Self Efficacy|self efficacy
320560|NCT01778036|Catastrophizing|catastrophizing
320561|NCT01778036|Fly test|fly test
320562|NCT01778036|Postural sway|postural sway
320563|NCT01778010|cocaine|cocaine
320564|NCT01778010|modafinil|modafinil
320565|NCT01778010|self-administration|self-administration
320566|NCT01778010|DRD4|drd4
320567|NCT01777906|nasal polyps|nasal polyps
320568|NCT01777906|nasal steriod sprays|nasal steriod sprays
320569|NCT01777893|Type-2 diabetes mellitus|type-2 diabetes mellitus
320570|NCT01777893|Obesity|obesity
320571|NCT01777893|High protein diet|high protein diet
320572|NCT01777893|Low GI|low gi
320573|NCT01777893|Physical activity|physical activity
320574|NCT01777815|NeoChord|neochord
320575|NCT01777815|DS1000|ds1000
320576|NCT01777815|Mitral Valve|mitral valve
320577|NCT01777815|Mitral Valve Regurgitation|mitral valve regurgitation
320578|NCT01777815|MR|mr
320579|NCT01777815|Mitral Valve Repair|mitral valve repair
320580|NCT01777815|Mitral Valve Prolapse|mitral valve prolapse
320581|NCT01777815|Artificial Chordae|artificial chordae
320582|NCT01777789|fMRI|fmri
320583|NCT01777789|Dementia|dementia
320584|NCT01777789|Alzheimer's disease|alzheimer's disease
320585|NCT01777789|functional neuroimaging|functional neuroimaging
320586|NCT01777789|Memory|memory
320587|NCT01777776|Open-label dose escalation|open-label dose escalation
320588|NCT01777776|BRAF inhibitor|braf inhibitor
320590|NCT01777776|CDK4/6|cdk4/6
320591|NCT01777776|LGX818|lgx818
320592|NCT01777776|RAF kinase inhibitor|raf kinase inhibitor
320593|NCT01777776|Metastatic melanoma|metastatic melanoma
320594|NCT01777776|BRAF|braf
320595|NCT01777776|V600|v600
320596|NCT01777750|Myocardial Infarction|myocardial infarction
320597|NCT01777750|Myocardial Reperfusion Injury|myocardial reperfusion injury
320598|NCT01777750|Reperfusion Injury|reperfusion injury
320599|NCT01777750|Anterior Wall Myocardial Infarction|anterior wall myocardial infarction
320600|NCT01777750|Inferior Wall Myocardial Infarction|inferior wall myocardial infarction
320601|NCT01777750|Pathologic Processes|pathologic processes
320602|NCT01777750|Myocardial Ischemia|myocardial ischemia
320603|NCT01777737|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
320604|NCT01777737|Trimethoprim-sulfamethoxazole|trimethoprim-sulfamethoxazole
320605|NCT01777737|Pneumocystis jiroveci|pneumocystis jiroveci
320606|NCT01777711|mental contrasting|mental contrasting
320607|NCT01777711|weight loss|weight loss
320608|NCT01777711|obese couples|obese couples
320609|NCT01777711|obesity|obesity
320610|NCT01777711|overweight|overweight
320611|NCT01777711|planning|planning
320612|NCT01777711|health|health
320613|NCT01777711|diet|diet
320614|NCT01777711|exercise|exercise
320615|NCT01777711|physical activity|physical activity
320616|NCT01777711|goal|goal
320617|NCT01777711|goal-setting|goal-setting
320618|NCT01777698|body composition|body composition
320619|NCT01777698|hepatocellular carcinoma|hepatocellular carcinoma
320620|NCT01777698|chemoembolization|chemoembolization
320621|NCT01777685|Sulpiride|sulpiride
321129|NCT01775449|Dysesthesia|dysesthesia
320622|NCT01777685|Therapeutic drug monitoring|therapeutic drug monitoring
320623|NCT01777685|Pharmacokinetics|pharmacokinetics
320624|NCT01777659|exercise|exercise
320625|NCT01777659|neuromodulation|neuromodulation
320626|NCT01777659|blood flow|blood flow
320627|NCT01777659|exercise capacity|exercise capacity
320628|NCT01777646|Mesenchymal Strmal Cells (MSC)|mesenchymal strmal cells (msc)
320629|NCT01777646|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
320630|NCT01777646|Neuroprotection|neuroprotection
320631|NCT01777646|Neurodegeneration|neurodegeneration
320632|NCT01777646|Stem cells|stem cells
320633|NCT01777594|hepatocellular carcinoma|hepatocellular carcinoma
320634|NCT01777594|HCC|hcc
320635|NCT01777594|liver|liver
320636|NCT01777594|liver cancer|liver cancer
320637|NCT01777594|sorafenib|sorafenib
320638|NCT01777581|sciatica radiculopathy lumbar disc lumbosacral disc|sciatica radiculopathy lumbar disc lumbosacral disc
320639|NCT01777555|Parkinson's Disease|parkinson's disease
320640|NCT01777555|Motor fluctuations|motor fluctuations
320641|NCT01777555|levodopa|levodopa
320642|NCT01777555|inhaled drugs|inhaled drugs
320643|NCT01777555|Off episodes|off episodes
320644|NCT01777542|Rett syndrome|rett syndrome
320645|NCT01777542|RTT|rtt
320646|NCT01777542|IGF-1|igf-1
320647|NCT01777542|autism spectrum disorder|autism spectrum disorder
320648|NCT01777529|Measles|measles
320649|NCT01777529|Mumps|mumps
320650|NCT01777529|Rubella|rubella
320651|NCT01777516|Platelet Aggregation|platelet aggregation
320652|NCT01777516|Cardiovascular Diseases|cardiovascular diseases
320653|NCT01777516|Salicylic Acid|salicylic acid
320654|NCT01777503|acute coronary syndrome|acute coronary syndrome
320655|NCT01777503|elderly|elderly
320656|NCT01777503|percutaneous revascularization|percutaneous revascularization
320657|NCT01777503|antiaggregant drugs|antiaggregant drugs
320658|NCT01777490|Caregivers - Not professionals|caregivers - not professionals
320659|NCT01777490|Frail Elderly|frail elderly
320660|NCT01777490|Long-term Care|long-term care
320661|NCT01777490|Quality of Life|quality of life
320662|NCT01777451|Whole Body Imaging|whole body imaging
320663|NCT01777451|Magnetic Resonance Imaging|magnetic resonance imaging
320664|NCT01777451|Neurofibromatosis 1|neurofibromatosis 1
320665|NCT01777451|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
320666|NCT01777451|Peripheral Nerve Sheath Tumors, Malignant|peripheral nerve sheath tumors, malignant
320667|NCT01777412|NMO|nmo
320668|NCT01777412|NMOSD|nmosd
320669|NCT01777412|NMO-IgG|nmo-igg
320670|NCT01777412|Aquaporin-4|aquaporin-4
320671|NCT01777412|AQP4|aqp4
320672|NCT01777412|anti-AQP4|anti-aqp4
320673|NCT01777386|scar|scar
320674|NCT01777386|contracture|contracture
320675|NCT01777386|perforator flap|perforator flap
320676|NCT01777386|preexpanded perforator flap|preexpanded perforator flap
320677|NCT01777386|perforator vessel|perforator vessel
320678|NCT01777386|artery diameter|artery diameter
320679|NCT01777373|conducting airway, bronchiolization|conducting airway, bronchiolization
320680|NCT01777360|severe|severe
320681|NCT01777360|uncontrolled|uncontrolled
320682|NCT01777347|Keywords provided by ASSISTANCE PUBLIQUE HOPITAUX DE PARIS:|keywords provided by assistance publique hopitaux de paris:
320683|NCT01777347|Acute Viral bronchiolitis|acute viral bronchiolitis
320684|NCT01777347|Hypertonic saline|hypertonic saline
320685|NCT01777347|Hospitalization|hospitalization
320686|NCT01777347|Infants|infants
320687|NCT01777347|Hospital admissions|hospital admissions
320688|NCT01777347|Additional relevant MeSH terms:|additional relevant mesh terms:
320689|NCT01777347|Bronchiolitis|bronchiolitis
320690|NCT01777347|Bronchiolitis, Viral|bronchiolitis, viral
320691|NCT01777347|Bronchial Diseases|bronchial diseases
320692|NCT01777347|Respiratory Tract Diseases|respiratory tract diseases
320693|NCT01777347|Lung Diseases, Obstructive|lung diseases, obstructive
320694|NCT01777347|Respiratory Tract Infections|respiratory tract infections
320695|NCT01777347|Virus Diseases|virus diseases
320696|NCT01777321|Herpes Zoster|herpes zoster
320697|NCT01777321|Intramuscular|intramuscular
320698|NCT01777321|Subcutaneous|subcutaneous
320699|NCT01777321|Safety|safety
320700|NCT01777321|≥50 years of age|≥50 years of age
320701|NCT01777321|Adults|adults
320702|NCT01777321|Immunogenicity|immunogenicity
320703|NCT01777321|Elderly|elderly
320704|NCT01777308|Immunogenicity|immunogenicity
320705|NCT01777308|Booster|booster
320706|NCT01777308|Healthy|healthy
320707|NCT01777308|Vaccine response|vaccine response
320708|NCT01777308|Safety|safety
320709|NCT01777308|Neisseria meningiditis|neisseria meningiditis
320710|NCT01777308|Antibody persistence|antibody persistence
320711|NCT01777308|Meningococcal conjugate vaccine|meningococcal conjugate vaccine
320712|NCT01777295|Adults|adults
320713|NCT01777295|Reactogenicity|reactogenicity
320714|NCT01777295|Naive|naive
320715|NCT01777295|Immune responses|immune responses
320716|NCT01777295|Read-outs|read-outs
320717|NCT01777295|Hepatitis B|hepatitis b
320718|NCT01777295|Healthy|healthy
320719|NCT01777282|albiglutide|albiglutide
320720|NCT01777282|Japanese|japanese
320721|NCT01777282|glucagon-like peptide-1|glucagon-like peptide-1
320722|NCT01777282|GSK716155|gsk716155
320723|NCT01777256|systemic lupus erythematosus|systemic lupus erythematosus
320724|NCT01777256|adaptive design|adaptive design
320725|NCT01777256|clinical safety and efficacy|clinical safety and efficacy
320726|NCT01777256|pharmacodynamics|pharmacodynamics
320727|NCT01777243|pharmacokinetic|pharmacokinetic
320728|NCT01777243|systemic amyloidosis|systemic amyloidosis
320729|NCT01777243|safety|safety
320730|NCT01777243|dose escalation|dose escalation
320731|NCT01777243|Carboxy Pyrrolidine Hexanoyl Pyrrolidine Carboxylate (CPHPC)|carboxy pyrrolidine hexanoyl pyrrolidine carboxylate (cphpc)
320732|NCT01777243|biomarker|biomarker
320733|NCT01777243|GSK2315698|gsk2315698
320734|NCT01777243|GSK2398852|gsk2398852
320735|NCT01777243|SAP|sap
320736|NCT01777243|pharmacodynamic|pharmacodynamic
320737|NCT01777243|co-administration|co-administration
320738|NCT01777243|intravenous|intravenous
320739|NCT01777217|Urination Disorder|urination disorder
320740|NCT01777217|Overactive Bladder|overactive bladder
320741|NCT01777217|Prostate Cancer Radiation|prostate cancer radiation
320742|NCT01777217|Vesicare|vesicare
320743|NCT01777204|Renal transplant, Gastrointestinal motility, Biomagnetism|renal transplant, gastrointestinal motility, biomagnetism
320744|NCT01777178|bicarbonate|bicarbonate
320745|NCT01777178|dialysis|dialysis
320746|NCT01777165|GFR|gfr
320747|NCT01777165|Acute Kidney Injury|acute kidney injury
320748|NCT01777165|High Risk cardiac surgery|high risk cardiac surgery
320749|NCT01777152|Antibodies, Monoclonal|antibodies, monoclonal
320750|NCT01777152|Antibody-Drug Conjugate|antibody-drug conjugate
320751|NCT01777152|Antigens, CD30|antigens, cd30
320752|NCT01777152|Drug Therapy|drug therapy
320753|NCT01777152|Hematologic Diseases|hematologic diseases
320754|NCT01777152|Lymphoma|lymphoma
320755|NCT01777152|Monomethyl auristatin E|monomethyl auristatin e
320756|NCT01777152|Lymphoma, T-Cell|lymphoma, t-cell
320757|NCT01777152|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
320758|NCT01777152|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
320759|NCT01777139|Retigabine|retigabine
320760|NCT01777139|Drug-Resistant|drug-resistant
320761|NCT01777139|Epilepsy|epilepsy
320762|NCT01777139|Partial-Onset Seizures|partial-onset seizures
320763|NCT01777139|Safety and Tolerability|safety and tolerability
320764|NCT01777139|Immediate Release|immediate release
320765|NCT01777139|Long-Term|long-term
320766|NCT01777139|Adjunctive Therapy|adjunctive therapy
320767|NCT01777139|Asian Subjects|asian subjects
320768|NCT01777139|Efficacy|efficacy
320769|NCT01777139|GW582892|gw582892
320770|NCT01777126|cystectomy|cystectomy
320771|NCT01777126|parenteral nutrition|parenteral nutrition
320772|NCT01777126|discharge|discharge
320773|NCT01777126|outcome|outcome
320774|NCT01777113|Chronic Stroke|chronic stroke
320775|NCT01777113|Gait|gait
320776|NCT01777113|Exercise|exercise
320777|NCT01777113|High intensity aerobic training|high intensity aerobic training
320778|NCT01777113|Strength training|strength training
320779|NCT01777113|Randomized controlled trial|randomized controlled trial
320780|NCT01777100|Postoperative pain|postoperative pain
320781|NCT01777100|Patient controlled analgesia|patient controlled analgesia
320782|NCT01777100|Hyperalgesia|hyperalgesia
320783|NCT01777100|Remifentanil|remifentanil
320784|NCT01777100|Sufentanil|sufentanil
320785|NCT01777100|Morphine|morphine
320786|NCT01777100|Abdominal surgery|abdominal surgery
320787|NCT01777100|Safety|safety
320788|NCT01777087|Pain|pain
320789|NCT01777087|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
320790|NCT01777074|Vaccination|vaccination
320791|NCT01777074|Acceptability|acceptability
320792|NCT01777074|Hepatitis B|hepatitis b
320793|NCT01777061|Prostate Cancer|prostate cancer
320794|NCT01777061|Recurrent Prostate Cancer|recurrent prostate cancer
320795|NCT01777061|PET Scan|pet scan
320796|NCT01777061|FDG-PET|fdg-pet
320797|NCT01777061|[11C]Acetate|[11c]acetate
320798|NCT01777061|C11-Acetate|c11-acetate
320799|NCT01777035|mechanical ventilation|mechanical ventilation
320800|NCT01777035|physical therapy|physical therapy
320801|NCT01777035|occupational therapy|occupational therapy
320802|NCT01777035|ICU acquired weakness|icu acquired weakness
320803|NCT01777035|critical illness myopathy|critical illness myopathy
320804|NCT01777022|Education, Stillbirth, Prevention, Management|education, stillbirth, prevention, management
320805|NCT01777009|Total Knee Replacement|total knee replacement
320806|NCT01777009|Patellar Eversion|patellar eversion
320807|NCT01777009|Surgical Exposure|surgical exposure
320808|NCT01777009|Outcomes|outcomes
320809|NCT01777009|Quadriceps Strength|quadriceps strength
320810|NCT01777009|Straight Leg Raise|straight leg raise
320811|NCT01777009|SF-36|sf-36
320812|NCT01776996|Expanded access, HIV, maraviroc|expanded access, hiv, maraviroc
320813|NCT01776970|Motor Neuron Disease|motor neuron disease
320814|NCT01776970|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
320815|NCT01776970|Cannabinoids|cannabinoids
320816|NCT01776970|Sativex|sativex
320817|NCT01776970|Spasticity|spasticity
320818|NCT01776957|Abortion rate|abortion rate
320819|NCT01776957|Intrauterine device|intrauterine device
320820|NCT01776944|Resting energy expenditure|resting energy expenditure
320821|NCT01776944|Handheld calorimeter|handheld calorimeter
320822|NCT01776944|Obese and overweight|obese and overweight
320823|NCT01776944|Pediatrics|pediatrics
320824|NCT01776931|Indicator Amino acid technique|indicator amino acid technique
320825|NCT01776931|Lysine requirements|lysine requirements
320826|NCT01776931|Pregnancy|pregnancy
320827|NCT01776931|Dietary protein|dietary protein
320828|NCT01776918|POLG1 Mutation|polg1 mutation
320829|NCT01776918|Phenylketonuria|phenylketonuria
320830|NCT01776905|Melanoma|melanoma
320831|NCT01776905|Cancer|cancer
320832|NCT01776892|Collagenase|collagenase
320833|NCT01776892|Needle aponeurotomy|needle aponeurotomy
320834|NCT01776866|Coronary Angiography|coronary angiography
320835|NCT01776866|Rotational Coronary Angiography|rotational coronary angiography
320836|NCT01776866|Contrast Media|contrast media
320837|NCT01776866|Radiation|radiation
320838|NCT01776866|Quantitative Coronary Angiography|quantitative coronary angiography
320839|NCT01776853|Irritable Bowel Syndrome|irritable bowel syndrome
320840|NCT01776853|Fructose|fructose
320841|NCT01776853|Fructans|fructans
320842|NCT01776853|MRI|mri
320843|NCT01776853|Fermentation|fermentation
320844|NCT01776853|Breath Tests|breath tests
320845|NCT01776853|Flatulence|flatulence
320846|NCT01776853|Abdominal Pain|abdominal pain
320847|NCT01776853|Diarrhoea|diarrhoea
320848|NCT01776840|Mantle cell lymphoma|mantle cell lymphoma
320849|NCT01776840|Ibrutinib|ibrutinib
320850|NCT01776840|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
320851|NCT01776840|Bendamustine hydrochloride|bendamustine hydrochloride
320852|NCT01776840|Rituximab|rituximab
320853|NCT01776827|GERD|gerd
320854|NCT01776827|Hiatal Hernia|hiatal hernia
320855|NCT01776827|Paraesophageal Hernia|paraesophageal hernia
320856|NCT01776827|Biologic Mesh|biologic mesh
320857|NCT01776814|Entecair|entecair
320858|NCT01776814|Tenofovir|tenofovir
320859|NCT01776801|intracranial baroreflex|intracranial baroreflex
320860|NCT01776762|Nutrition|nutrition
320861|NCT01776762|Rehabilitation|rehabilitation
320862|NCT01776762|Weightloss|weightloss
320863|NCT01776749|low back pain|low back pain
320864|NCT01776749|failed back surgery syndrome|failed back surgery syndrome
320865|NCT01776749|spinal cord stimulation|spinal cord stimulation
320866|NCT01776749|subcutaneous stimulation|subcutaneous stimulation
320867|NCT01776749|peripheral nerve field stimulation|peripheral nerve field stimulation
320868|NCT01776736|Scoliosis|scoliosis
320869|NCT01776736|Posture correction|posture correction
320870|NCT01776723|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
320871|NCT01776723|CMML|cmml
320872|NCT01776723|Leukemia|leukemia
321384|NCT01774383|Parkinson's disease|parkinson's disease
320873|NCT01776710|Intermittent claudication|intermittent claudication
320874|NCT01776710|Behavior therapy|behavior therapy
320875|NCT01776710|Walking|walking
320876|NCT01776710|Exercise|exercise
320877|NCT01776710|Patient education|patient education
320878|NCT01776710|Randomized controlled trial|randomized controlled trial
320879|NCT01776658|Ocular pain|ocular pain
320880|NCT01776658|Dry Eye Syndrome|dry eye syndrome
320881|NCT01776658|siRNA|sirna
320882|NCT01776658|RNAi|rnai
320883|NCT01776658|TRPV1|trpv1
320884|NCT01776619|Safety|safety
320885|NCT01776619|tolerability|tolerability
320886|NCT01776619|PK|pk
320887|NCT01776593|bladder capacity; bladder diary; bladder oversensitivity; lower urinary tract symptoms|bladder capacity; bladder diary; bladder oversensitivity; lower urinary tract symptoms
320888|NCT01776580|Pelvic organ prolapse|pelvic organ prolapse
320889|NCT01776580|lower urinary tract symptoms|lower urinary tract symptoms
320890|NCT01776580|sexual dysfunction|sexual dysfunction
320891|NCT01776567|coronary artery disease|coronary artery disease
320892|NCT01776567|stents|stents
320893|NCT01776567|optical imaging|optical imaging
320894|NCT01776554|Influenza, Pandemic, H5N1, Children|influenza, pandemic, h5n1, children
320895|NCT01776541|Influenza, Pandemic, H5N1, Adults|influenza, pandemic, h5n1, adults
320896|NCT01776515|Low back pain|low back pain
320897|NCT01776515|Wontran|wontran
320898|NCT01776515|Wontran SR Tab.|wontran sr tab.
320899|NCT01776515|Tramadol Hydrochloride/Acetaminophen|tramadol hydrochloride/acetaminophen
320900|NCT01776489|Food allergy|food allergy
320901|NCT01776489|Sphingosine-1-phosphate|sphingosine-1-phosphate
320902|NCT01776489|Biomarker|biomarker
320903|NCT01776489|Double-blind placebo-controlled food challenge|double-blind placebo-controlled food challenge
320904|NCT01776489|Anaphylaxis|anaphylaxis
320905|NCT01776476|glutamine dipeptide|glutamine dipeptide
320906|NCT01776476|randomized controlled trial|randomized controlled trial
320907|NCT01776476|insulin resistance|insulin resistance
320908|NCT01776476|critical illness|critical illness
320909|NCT01776476|trauma|trauma
320910|NCT01776463|Z-360|z-360
320911|NCT01776463|Japanese|japanese
320912|NCT01776463|pK|pk
320913|NCT01776450|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
320914|NCT01776424|Cardiovascular events|cardiovascular events
320915|NCT01776424|Rivaroxaban|rivaroxaban
320916|NCT01776424|Xarelto|xarelto
320917|NCT01776424|anticoagulant|anticoagulant
320918|NCT01776424|blood thinner|blood thinner
320919|NCT01776424|aspirin|aspirin
320920|NCT01776424|ASA|asa
320921|NCT01776424|CAD|cad
320922|NCT01776424|coronary disease|coronary disease
320923|NCT01776424|artery disease|artery disease
320924|NCT01776424|coronary artery bypass graft|coronary artery bypass graft
320925|NCT01776424|stroke|stroke
320926|NCT01776424|heart attack|heart attack
320927|NCT01776424|angina|angina
320928|NCT01776424|arterial vascular disease|arterial vascular disease
320929|NCT01776424|transient ischemic attack|transient ischemic attack
320930|NCT01776424|TIA|tia
320931|NCT01776424|heart disease|heart disease
320932|NCT01776398|COPD|copd
320933|NCT01776398|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
320934|NCT01776398|Lung disease|lung disease
320935|NCT01776398|Emphysema|emphysema
320936|NCT01776398|Smoking|smoking
320937|NCT01776398|Healthy Smoker|healthy smoker
320938|NCT01776398|Smoker|smoker
320939|NCT01776398|Non-smoker|non-smoker
320940|NCT01776385|[C08.785.640]|[c08.785.640]
320941|NCT01776385|(C08.528.778)|(c08.528.778)
320942|NCT01776385|[C19.642.713]|[c19.642.713]
320943|NCT01776385|mesothelium|mesothelium
320944|NCT01776372|Drainage|drainage
320945|NCT01776372|Chest tubes|chest tubes
320946|NCT01776372|Randomized Controlled Trial|randomized controlled trial
320947|NCT01776359|Muscle|muscle
320948|NCT01776359|Protein|protein
320949|NCT01776359|Diet|diet
320950|NCT01776359|Exercise|exercise
320951|NCT01776333|ICU|icu
320952|NCT01776320|Erectile Dysfunction|erectile dysfunction
320953|NCT01776320|Topical Alprostadil|topical alprostadil
320954|NCT01776307|BBI608|bbi608
320955|NCT01776294|Prehypertension|prehypertension
320956|NCT01776294|Prevalence|prevalence
320957|NCT01776294|Cardiovascular Risk Factors|cardiovascular risk factors
320958|NCT01776281|effects|effects
320959|NCT01776281|KMC|kmc
320960|NCT01776281|LBW|lbw
320961|NCT01776281|preterm|preterm
320962|NCT01776281|temperature|temperature
320963|NCT01776281|breastfeeding|breastfeeding
320964|NCT01776281|secondary hospitals|secondary hospitals
320965|NCT01776268|antimicrobial proteins|antimicrobial proteins
320966|NCT01776255|Obesity|obesity
320967|NCT01776255|Overweight|overweight
320968|NCT01776255|Lifestyle|lifestyle
320969|NCT01776255|American Indian|american indian
320970|NCT01776242|low back pain|low back pain
320971|NCT01776242|elderly|elderly
320972|NCT01776242|back pain|back pain
320973|NCT01776242|lumbar pain|lumbar pain
320974|NCT01776242|over 65|over 65
320975|NCT01776229|nightmare|nightmare
320976|NCT01776229|PTSD|ptsd
320977|NCT01776229|trauma|trauma
320978|NCT01776229|children|children
320979|NCT01776229|cognitive behavior therapy|cognitive behavior therapy
320980|NCT01776229|stress|stress
320981|NCT01776229|sleep|sleep
320982|NCT01776216|Endothelial function|endothelial function
320983|NCT01776216|Dairy|dairy
320984|NCT01776177|Allergic asthma|allergic asthma
320985|NCT01776177|Omalizumab therapy|omalizumab therapy
320986|NCT01776177|IgE profile|ige profile
320987|NCT01776164|Friedreich|friedreich
320988|NCT01776164|ataxia|ataxia
320989|NCT01776164|FRDA|frda
320990|NCT01776164|FA|fa
320991|NCT01776164|recessive|recessive
320992|NCT01776164|neurodegenerative|neurodegenerative
320993|NCT01776164|cerebellum|cerebellum
320994|NCT01776151|HIV|hiv
320995|NCT01776151|cardiovascular diseases|cardiovascular diseases
320996|NCT01776151|vascular stiffness|vascular stiffness
320997|NCT01776138|Elderly|elderly
320998|NCT01776138|Chemotherapy|chemotherapy
320999|NCT01776138|Cystectomy|cystectomy
321000|NCT01776138|Radical Cystectomy|radical cystectomy
321001|NCT01776138|University of North Carolina|university of north carolina
321002|NCT01776138|Cancer|cancer
321003|NCT01776138|Bladder Cancer|bladder cancer
321004|NCT01776138|Bladder|bladder
321005|NCT01776125|Neurofibromatosis Type One|neurofibromatosis type one
321006|NCT01776125|Scoliosis|scoliosis
321007|NCT01776112|schizophrenia|schizophrenia
321008|NCT01776112|negative symptoms|negative symptoms
321009|NCT01776112|cognitive deficits|cognitive deficits
321010|NCT01776112|synaptic plasticity|synaptic plasticity
321011|NCT01776099|type 2 diabetes|type 2 diabetes
321012|NCT01776099|nutrition|nutrition
321013|NCT01776099|fibers|fibers
321014|NCT01776073|Transplantation|transplantation
321015|NCT01776073|Healthcare Disparities|healthcare disparities
321016|NCT01776073|Quality Assurance|quality assurance
321017|NCT01776060|Primary Progressive Multiple Sclerosis|primary progressive multiple sclerosis
321018|NCT01776060|Multiple Sclerosis|multiple sclerosis
321019|NCT01776060|biomarker|biomarker
321020|NCT01776060|'omic|'omic
321021|NCT01776060|progression|progression
321022|NCT01776034|Self Care|self care
321023|NCT01776034|Exercise|exercise
321024|NCT01776034|Weight management|weight management
321025|NCT01776021|Urinary tract infection|urinary tract infection
321026|NCT01776021|Recurrent urinary tract infection|recurrent urinary tract infection
321027|NCT01776021|Cranberry|cranberry
321028|NCT01776021|Prevention|prevention
321029|NCT01776021|E-coli|e-coli
321030|NCT01775995|Chronic Pain|chronic pain
321031|NCT01775995|Low Back Pain|low back pain
321032|NCT01775982|French language validation|french language validation
321033|NCT01775982|The Confusion Assessment Method (CAM)|the confusion assessment method (cam)
321034|NCT01775943|Epidermal growth factor receptor|epidermal growth factor receptor
321035|NCT01775943|Mutation|mutation
321036|NCT01775943|Lung cancer|lung cancer
321037|NCT01775943|Drug sensitivity|drug sensitivity
321038|NCT01775930|Kidney Cancer|kidney cancer
321039|NCT01775930|Refractory Renal Cell Carcinoma|refractory renal cell carcinoma
321041|NCT01775930|Clear cell kidney cancer with metastatic disease|clear cell kidney cancer with metastatic disease
321042|NCT01775930|Carfilzomib|carfilzomib
321043|NCT01775891|pilsicainide|pilsicainide
321044|NCT01775891|class IC antiarrhythmic drug|class ic antiarrhythmic drug
321045|NCT01775891|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
321046|NCT01775891|catheter ablation|catheter ablation
321047|NCT01775878|Diabetes|diabetes
321048|NCT01775878|HbA1c|hba1c
321049|NCT01775878|Fructosamine|fructosamine
321050|NCT01775878|Blood Pressure|blood pressure
321051|NCT01775878|Telemonitoring|telemonitoring
321052|NCT01775865|aortic stiffness|aortic stiffness
321053|NCT01775865|endothelium-dependent dilation|endothelium-dependent dilation
321054|NCT01775865|vascular aging|vascular aging
321055|NCT01775865|oxidative stress|oxidative stress
321056|NCT01775865|inflammation|inflammation
321057|NCT01775865|nitric oxide|nitric oxide
321058|NCT01775865|nuclear factor kappa B|nuclear factor kappa b
321059|NCT01775852|Acceptance and Commitment Therapy (ACT)|acceptance and commitment therapy (act)
321060|NCT01775852|Depression|depression
321061|NCT01775852|Illness Management|illness management
321062|NCT01775852|Behavioral treatment|behavioral treatment
321063|NCT01775852|Impairment|impairment
321064|NCT01775826|physical activity|physical activity
321065|NCT01775826|sedentary behavior|sedentary behavior
321066|NCT01775826|accelerometer|accelerometer
321067|NCT01775826|GPS|gps
321068|NCT01775826|GIS|gis
321069|NCT01775826|machine learning|machine learning
321070|NCT01775813|Insulin resistance|insulin resistance
321071|NCT01775813|Puberty|puberty
321072|NCT01775813|Obesity|obesity
321073|NCT01775813|Hypogonadism|hypogonadism
321074|NCT01775813|Gonadal dysfunction|gonadal dysfunction
321075|NCT01775813|Metformin|metformin
321076|NCT01775787|smoking|smoking
321077|NCT01775774|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
321078|NCT01775774|Acute Lung Injury|acute lung injury
321079|NCT01775774|Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells|allogeneic bone marrow-derived human mesenchymal stem cells
321080|NCT01775761|Thorough QTc evaluation of tafamidis compared to the effects of moxifloxacin and placebo in healthy volunteers.|thorough qtc evaluation of tafamidis compared to the effects of moxifloxacin and placebo in healthy volunteers.
321081|NCT01775748|Grape juice|grape juice
321082|NCT01775735|headache|headache
321083|NCT01775735|pain|pain
321084|NCT01775735|chronic|chronic
321085|NCT01775709|middler ear infection|middler ear infection
321086|NCT01775696|Alzheimer's disease|alzheimer's disease
321087|NCT01775696|Pittsburgh binding Compound (PiB)|pittsburgh binding compound (pib)
321088|NCT01775696|Positron Emission Tomography (PET)|positron emission tomography (pet)
321089|NCT01775696|Inflammation|inflammation
321090|NCT01775696|Anti Abeta immune responses|anti abeta immune responses
321091|NCT01775696|Blood markers|blood markers
321092|NCT01775696|MRI|mri
321093|NCT01775683|homelessness|homelessness
321094|NCT01775670|Arthrosis|arthrosis
321095|NCT01775657|pulmonary air leak|pulmonary air leak
321096|NCT01775657|Thopaz|thopaz
321097|NCT01775657|digital|digital
321098|NCT01775657|analog|analog
321099|NCT01775657|randomized|randomized
321100|NCT01775618|Hemophilia A|hemophilia a
321101|NCT01775618|Factor VIII|factor viii
321102|NCT01775618|Prophylaxis|prophylaxis
321103|NCT01775618|Pediatric|pediatric
321104|NCT01775605|Subject|subject
321105|NCT01775592|P.f resistance|p.f resistance
321106|NCT01775553|Relapsed Multiple Myeloma|relapsed multiple myeloma
321107|NCT01775553|Refractory Multiple Myeloma|refractory multiple myeloma
321108|NCT01775553|High-Dose Carfilzomib|high-dose carfilzomib
321109|NCT01775553|Standard Dose Carfilzomib|standard dose carfilzomib
321110|NCT01775553|Carfilzomib|carfilzomib
321111|NCT01775540|Dry eye|dry eye
321112|NCT01775540|Artificial tears|artificial tears
321113|NCT01775540|Ocular surface inflammation|ocular surface inflammation
321114|NCT01775501|sorafenib|sorafenib
321115|NCT01775501|FOLFOX|folfox
321116|NCT01775488|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
321117|NCT01775488|BPH|bph
321118|NCT01775488|LUTS|luts
321119|NCT01775488|Vortx Rx|vortx rx
321120|NCT01775488|Histotripsy|histotripsy
321121|NCT01775462|Hypohidrotic Ectodermal Dysplasia|hypohidrotic ectodermal dysplasia
321122|NCT01775462|XLHED|xlhed
321123|NCT01775449|Anticancer drug;|anticancer drug;
321124|NCT01775449|Oxaliplatin;|oxaliplatin;
321125|NCT01775449|Digestive cancer system|digestive cancer system
321126|NCT01775449|Acute oxaliplatin-induced hypersensitivity|acute oxaliplatin-induced hypersensitivity
321127|NCT01775449|Hyperalgesia;|hyperalgesia;
321128|NCT01775449|Allodynia;|allodynia;
321130|NCT01775449|Polyamines depleted diet|polyamines depleted diet
321131|NCT01775436|palliative care|palliative care
321132|NCT01775436|HIV/AIDS|hiv/aids
321133|NCT01775436|quality of life|quality of life
321134|NCT01775436|adherence|adherence
321135|NCT01775436|spiritual|spiritual
321136|NCT01775436|threat appraisal|threat appraisal
321137|NCT01775436|treatment congruence|treatment congruence
321138|NCT01775436|treatment preferences|treatment preferences
321139|NCT01775436|dialysis|dialysis
321140|NCT01775436|hospitalization|hospitalization
321141|NCT01775436|communication|communication
321142|NCT01775436|family intervention|family intervention
321143|NCT01775436|Family Centered Advance Care Planning|family centered advance care planning
321144|NCT01775436|decision making|decision making
321145|NCT01775436|advance care planning|advance care planning
321146|NCT01775436|end of life|end of life
321147|NCT01775397|Clostridium|clostridium
321148|NCT01775397|Difficile|difficile
321149|NCT01775397|Infections|infections
321150|NCT01775397|Immunosuppression|immunosuppression
321151|NCT01775397|Fidaxomicin|fidaxomicin
321152|NCT01775397|Vancomycin|vancomycin
321153|NCT01775397|Efficacy|efficacy
321154|NCT01775397|Stem Cells|stem cells
321155|NCT01775397|Transplantation|transplantation
321156|NCT01775397|Adult|adult
321157|NCT01775397|Dificid|dificid
321158|NCT01775384|Inflammation|inflammation
321159|NCT01775384|Oxidative stress|oxidative stress
321160|NCT01775384|Immune dysfunction|immune dysfunction
321161|NCT01775384|Metabolomics.|metabolomics.
321162|NCT01775371|Pain|pain
321163|NCT01775371|Emergency|emergency
321164|NCT01775371|Analgesia|analgesia
321165|NCT01775371|ED patients|ed patients
321166|NCT01775371|acute pain|acute pain
321167|NCT01775371|IV opioid|iv opioid
321168|NCT01775345|Partial meniscectomy|partial meniscectomy
321169|NCT01775345|Physiotherapy|physiotherapy
321170|NCT01775345|Isokinetics|isokinetics
321171|NCT01775345|Cost-effectiveness|cost-effectiveness
321172|NCT01775319|Zinc|zinc
321173|NCT01775293|Non-absorbable polypropylene mesh|non-absorbable polypropylene mesh
321174|NCT01775293|WSRS|wsrs
321175|NCT01775293|Rhytidectomy|rhytidectomy
321176|NCT01775254|Colon Cancer|colon cancer
321177|NCT01775254|FOLFOX|folfox
321178|NCT01775254|Laparoscopic Colectomy|laparoscopic colectomy
321179|NCT01775254|Open Colectomy|open colectomy
321180|NCT01775254|Robotic Colectomy|robotic colectomy
321181|NCT01775254|Quality of Life|quality of life
321182|NCT01775254|Sexual Function|sexual function
321183|NCT01775254|Peripheral Neuropathy|peripheral neuropathy
321184|NCT01775254|Demands of Illness|demands of illness
321185|NCT01775254|Cancer Survivor|cancer survivor
321186|NCT01775228|Depression, peer support, recovery, health services|depression, peer support, recovery, health services
321187|NCT01775215|Left Ventricular Function|left ventricular function
321188|NCT01775215|Aortic Valve Replacement|aortic valve replacement
321189|NCT01775215|Late Gadolinium Enhancement|late gadolinium enhancement
321190|NCT01775215|Cardiac I123 MIBG|cardiac i123 mibg
321191|NCT01775215|Longitudinal Strain|longitudinal strain
321192|NCT01775215|Brain Natriuretic Peptide|brain natriuretic peptide
321193|NCT01775215|High Sensitivity Troponin I|high sensitivity troponin i
321194|NCT01775189|Relative abuse potential study|relative abuse potential study
321195|NCT01775189|Chronic pain|chronic pain
321196|NCT01775189|oxycodone|oxycodone
321197|NCT01775189|naltrexone|naltrexone
321198|NCT01775189|opioid-related disorders|opioid-related disorders
321199|NCT01775189|drug abusers|drug abusers
321200|NCT01775176|PCOS, Weight, Insulin Sensitivity, Reproductive Function|pcos, weight, insulin sensitivity, reproductive function
321201|NCT01775163|Energy|energy
321202|NCT01775163|Metabolism|metabolism
321203|NCT01775163|Weight Loss|weight loss
321204|NCT01775163|Exercise|exercise
321205|NCT01775150|mobile phone text messaging|mobile phone text messaging
321206|NCT01775150|maternality|maternality
321207|NCT01775150|infant|infant
321208|NCT01775150|death rate|death rate
321209|NCT01775137|CF, Open-label, TIP, phase IV, extension study|cf, open-label, tip, phase iv, extension study
321210|NCT01775124|Macular degeneration,|macular degeneration,
321211|NCT01775124|age-related macular degeneration (ARMD),|age-related macular degeneration (armd),
321212|NCT01775124|vision loss,|vision loss,
321213|NCT01775124|macula damage,|macula damage,
321214|NCT01775124|retina damage,|retina damage,
321215|NCT01775124|dry macular degeneration,|dry macular degeneration,
321216|NCT01775124|wet macular degeneration,|wet macular degeneration,
321217|NCT01775124|AMD|amd
321218|NCT01775111|strength training|strength training
321219|NCT01775111|protein supplementation|protein supplementation
321220|NCT01775111|sarcopenia|sarcopenia
321221|NCT01775098|Gout|gout
321222|NCT01775098|uric acid|uric acid
321223|NCT01775098|allopurinol|allopurinol
321224|NCT01775085|Interventions|interventions
321225|NCT01775085|Meaning-Centered Group (MCG)|meaning-centered group (mcg)
321226|NCT01775085|Discussion Group (DG)|discussion group (dg)
321227|NCT01775085|Modules|modules
321228|NCT01775085|Sessions|sessions
321229|NCT01775085|12-291|12-291
321230|NCT01775072|tissue|tissue
321231|NCT01775072|blood|blood
321232|NCT01775072|salvia|salvia
321233|NCT01775072|buccal swab|buccal swab
321234|NCT01775072|Genomic Profiling|genomic profiling
321235|NCT01775072|Solid Tumors|solid tumors
321236|NCT01775072|hematologic cancer|hematologic cancer
321237|NCT01775072|Clinical Assay|clinical assay
321238|NCT01775072|Research Assay|research assay
321239|NCT01775072|12-245|12-245
321240|NCT01775046|Valiant|valiant
321241|NCT01775046|Captivia|captivia
321242|NCT01775046|Stent Graft|stent graft
321243|NCT01775046|Thoracic|thoracic
321244|NCT01775046|Aortic|aortic
321245|NCT01775033|Pediatrics|pediatrics
321246|NCT01775033|Emergency medical services|emergency medical services
321247|NCT01775033|Emergency Treatment|emergency treatment
321248|NCT01775033|Telemedicine|telemedicine
321249|NCT01775007|Lens|lens
321250|NCT01775007|Cornea|cornea
321251|NCT01775007|Stiffness|stiffness
321252|NCT01775007|Brillouin Shift|brillouin shift
321253|NCT01775007|Young Modulus|young modulus
321254|NCT01774994|volunteers|volunteers
321255|NCT01774942|Diabetes Mellitus|diabetes mellitus
321256|NCT01774942|C-Reactive Protein|c-reactive protein
321257|NCT01774942|Dental Implants, Single-Tooth|dental implants, single-tooth
321258|NCT01774942|Dental Prosthesis, Implant-Supported|dental prosthesis, implant-supported
321259|NCT01774929|Osteoarthritis|osteoarthritis
321260|NCT01774929|Transdermal Therapeutic System (TTS)-fentanyl|transdermal therapeutic system (tts)-fentanyl
321261|NCT01774929|Durogesic|durogesic
321262|NCT01774903|Low Back Pain|low back pain
321263|NCT01774903|TTS-fentanyl|tts-fentanyl
321264|NCT01774903|Durogesic|durogesic
321265|NCT01774877|xinfeng capsule;|xinfeng capsule;
321266|NCT01774877|rheumatoid arthritis (RA);|rheumatoid arthritis (ra);
321267|NCT01774877|randomized;|randomized;
321268|NCT01774877|double-blind;|double-blind;
321269|NCT01774851|HER-2 Gene Amplification|her-2 gene amplification
321270|NCT01774851|Esophagus Cancer|esophagus cancer
321271|NCT01774851|Gastroesophageal Junction Cancer|gastroesophageal junction cancer
321272|NCT01774851|Stomach Cancer|stomach cancer
321273|NCT01774851|Her2 Positive|her2 positive
321274|NCT01774851|Her2+|her2+
321275|NCT01774851|Esophageal Cancer|esophageal cancer
321276|NCT01774851|Metastatic|metastatic
321277|NCT01774825|Irritable bowel syndrome|irritable bowel syndrome
321278|NCT01774825|IBS|ibs
321279|NCT01774812|vitamin D|vitamin d
321280|NCT01774812|hemodialysis|hemodialysis
321281|NCT01774812|sudden cardiac death|sudden cardiac death
321282|NCT01774812|heart rate variability|heart rate variability
321283|NCT01774812|cardiac autonomic tone|cardiac autonomic tone
321284|NCT01774799|advanced dementia|advanced dementia
321285|NCT01774799|advance care planning|advance care planning
321286|NCT01774799|nursing home|nursing home
321287|NCT01774760|18F-EF5|18f-ef5
321288|NCT01774760|PET/CT|pet/ct
321289|NCT01774760|Reproducibility|reproducibility
321290|NCT01774747|Pharmacokinetics|pharmacokinetics
321291|NCT01774734|Chronic neck pain|chronic neck pain
321292|NCT01774734|Neck strength exerciser|neck strength exerciser
321293|NCT01774734|Biofeedback|biofeedback
321294|NCT01774734|Physiotherapy|physiotherapy
321295|NCT01774734|Strengthening exercise|strengthening exercise
321296|NCT01774734|Randomized trials|randomized trials
321297|NCT01774721|first-line|first-line
321298|NCT01774721|locally advanced or metastatic|locally advanced or metastatic
321299|NCT01774721|non-small cell lung cancer|non-small cell lung cancer
321404|NCT01774240|DOS scale|dos scale
321300|NCT01774721|epidermal growth factor receptor|epidermal growth factor receptor
321301|NCT01774721|EGFR|egfr
321302|NCT01774721|Archer|archer
321303|NCT01774721|mutation|mutation
321304|NCT01774721|dacomitinib|dacomitinib
321305|NCT01774721|SFJ|sfj
321306|NCT01774721|PF-00299804|pf-00299804
321307|NCT01774695|IBS|ibs
321308|NCT01774695|physical activity|physical activity
321309|NCT01774695|exercise|exercise
321310|NCT01774682|obesity|obesity
321311|NCT01774682|surgery|surgery
321312|NCT01774669|ischemic stroke|ischemic stroke
321313|NCT01774669|hemorrhagic stroke|hemorrhagic stroke
321314|NCT01774669|upper limb|upper limb
321315|NCT01774669|virtual reality|virtual reality
321316|NCT01774669|physiotherapy|physiotherapy
321317|NCT01774669|occupational therapy|occupational therapy
321318|NCT01774656|heart-assist device|heart-assist device
321319|NCT01774643|Pancreatic cancer|pancreatic cancer
321320|NCT01774643|Liver metastases|liver metastases
321321|NCT01774643|Tumor tissue biopsy|tumor tissue biopsy
321322|NCT01774643|Blood samples|blood samples
321323|NCT01774643|Xenografts|xenografts
321324|NCT01774643|Murine|murine
321325|NCT01774643|Genomic profiling|genomic profiling
321326|NCT01774643|Circulating biomarkers|circulating biomarkers
321327|NCT01774630|Treatment, relapse, complete molecular response|treatment, relapse, complete molecular response
321328|NCT01774617|portal hypertension|portal hypertension
321329|NCT01774617|elastography|elastography
321330|NCT01774617|Hepatic venous pressure gradient measurement|hepatic venous pressure gradient measurement
321331|NCT01774604|Post ERCP acute pancreatitis|post ercp acute pancreatitis
321332|NCT01774604|Post Fine Needle Aspiration (FNA) acute pancreatitis|post fine needle aspiration (fna) acute pancreatitis
321333|NCT01774604|Indomethacin|indomethacin
321334|NCT01774604|Rectal Non Steroidal Anti-Inflammatory Drugs (NSAIDs)|rectal non steroidal anti-inflammatory drugs (nsaids)
321335|NCT01774591|Post Menopause|post menopause
321336|NCT01774591|Female|female
321337|NCT01774591|Obese|obese
321338|NCT01774578|Non-small Cell Lung Cancer|non-small cell lung cancer
321339|NCT01774578|Vaccine Therapy|vaccine therapy
321340|NCT01774578|Immunotherapy|immunotherapy
321341|NCT01774578|Second line therapy|second line therapy
321342|NCT01774578|Progressive|progressive
321343|NCT01774578|Relapsed|relapsed
321344|NCT01774565|Diabetes|diabetes
321345|NCT01774565|Insulin|insulin
321346|NCT01774565|Closed-Loop|closed-loop
321347|NCT01774565|Real-time CGM|real-time cgm
321348|NCT01774565|Subcutaneous insulin pump|subcutaneous insulin pump
321349|NCT01774565|Hospital|hospital
321350|NCT01774539|Fracture|fracture
321351|NCT01774539|Physeal injury|physeal injury
321352|NCT01774539|Diffusion MRI|diffusion mri
321353|NCT01774500|biomarkers|biomarkers
321354|NCT01774500|Emergency Department|emergency department
321355|NCT01774500|Seizures|seizures
321356|NCT01774500|epilepsy|epilepsy
321357|NCT01774500|S100b|s100b
321358|NCT01774500|copeptin|copeptin
321359|NCT01774487|Biliary Atresia|biliary atresia
321360|NCT01774487|Pentoxifylline|pentoxifylline
321361|NCT01774487|Trental|trental
321362|NCT01774487|Serum bilirubin|serum bilirubin
321363|NCT01774487|Conjugated bilirubin|conjugated bilirubin
321364|NCT01774487|Liver transplantation|liver transplantation
321365|NCT01774487|Fibrosis|fibrosis
321366|NCT01774474|Prevention|prevention
321367|NCT01774448|Dementia|dementia
321368|NCT01774448|Spouse Caregiver|spouse caregiver
321369|NCT01774448|Depression|depression
321370|NCT01774448|Mind Body Therapy|mind body therapy
321371|NCT01774448|Cognitive Therapy|cognitive therapy
321372|NCT01774448|Quality of Life|quality of life
321373|NCT01774448|Attention|attention
321374|NCT01774448|Memory|memory
321375|NCT01774435|Schizophrenia|schizophrenia
321376|NCT01774435|Schizophrenic|schizophrenic
321377|NCT01774435|Stable Schizophrenic|stable schizophrenic
321378|NCT01774422|Hypercapnia|hypercapnia
321379|NCT01774422|Respiratory Distress Syndrome|respiratory distress syndrome
321380|NCT01774422|Extracorporeal CO2 remover|extracorporeal co2 remover
321381|NCT01774422|Noninvasive ventilation|noninvasive ventilation
321382|NCT01774409|all advanced malignant tumor|all advanced malignant tumor
321383|NCT01774396|Hands Rejuvenation, fillers|hands rejuvenation, fillers
321385|NCT01774383|sub-thalamic nucleus|sub-thalamic nucleus
321386|NCT01774383|oscillation|oscillation
321387|NCT01774383|local field potential|local field potential
321388|NCT01774344|Regorafenib|regorafenib
321389|NCT01774344|BAY73-4506|bay73-4506
321390|NCT01774318|sleep-wake-cycles|sleep-wake-cycles
321391|NCT01774318|preterm infants|preterm infants
321393|NCT01774318|conventional EEG|conventional eeg
321394|NCT01774318|polysomnography|polysomnography
321395|NCT01774292|Impact of alkalized lidocaine on coughing at extubation|impact of alkalized lidocaine on coughing at extubation
321396|NCT01774266|Gastric Cancer|gastric cancer
321397|NCT01774266|DNA methylation|dna methylation
321398|NCT01774266|Reprimo|reprimo
321399|NCT01774266|cell-free DNA|cell-free dna
321400|NCT01774266|non-invasive|non-invasive
321401|NCT01774253|DIPG|dipg
321402|NCT01774240|Delirium|delirium
321403|NCT01774240|Cardiac surgery|cardiac surgery
321405|NCT01774227|Refractory glaucoma|refractory glaucoma
321406|NCT01774227|Transcleral cyclophotocoagulation (TSCPC)|transcleral cyclophotocoagulation (tscpc)
321407|NCT01774227|Dark iris|dark iris
321408|NCT01774227|Pops-titration|pops-titration
321409|NCT01774227|Slow-coagulation|slow-coagulation
321410|NCT01774227|Neovascular glaucoma|neovascular glaucoma
321411|NCT01774214|Resuscitation|resuscitation
321412|NCT01774214|Shock|shock
321413|NCT01774214|Fluid Therapy|fluid therapy
321414|NCT01774214|Pediatrics|pediatrics
321415|NCT01774201|Multiple sclerosis|multiple sclerosis
321416|NCT01774201|Self-assessment|self-assessment
321417|NCT01774201|Physical endurance|physical endurance
321418|NCT01774201|Respiratory function|respiratory function
321419|NCT01774201|Fatigue|fatigue
321420|NCT01774188|Enhanced Extracorporeal Counterpulsation|enhanced extracorporeal counterpulsation
321421|NCT01774188|intraocular pressure|intraocular pressure
321422|NCT01774188|Pen type tonometer|pen type tonometer
321423|NCT01774175|Bowel preparation|bowel preparation
321424|NCT01774175|PEG with ascorbic acid|peg with ascorbic acid
321425|NCT01774175|Picosulfate|picosulfate
321426|NCT01774162|Endoscopic Ultrasound|endoscopic ultrasound
321427|NCT01774162|Fine needle aspiration|fine needle aspiration
321428|NCT01774162|Fine needle biopsy|fine needle biopsy
321429|NCT01774162|ProCore|procore
321430|NCT01774136|community health workers|community health workers
321431|NCT01774136|HIV|hiv
321432|NCT01774136|PMTCT|pmtct
321433|NCT01774136|antenatal|antenatal
321434|NCT01774136|postnatal|postnatal
321435|NCT01774136|breastfeeding|breastfeeding
321436|NCT01774136|South Africa|south africa
321437|NCT01774110|stroke|stroke
321438|NCT01774110|gait|gait
321439|NCT01774110|acute|acute
321440|NCT01774097|Peripheral Artery Disease|peripheral artery disease
321441|NCT01774097|Intermittent Claudication|intermittent claudication
321442|NCT01774097|Autologous Stem Cells|autologous stem cells
321443|NCT01774097|ALDH cells|aldh cells
321444|NCT01774097|Claudicants|claudicants
321445|NCT01774097|PAD|pad
321446|NCT01774097|Peak Walking Time|peak walking time
321447|NCT01774097|MRI|mri
321448|NCT01774097|Vascular Flow|vascular flow
321449|NCT01774097|Anatomy|anatomy
321450|NCT01774097|Perfusion|perfusion
321451|NCT01774084|Insulin sensitivity|insulin sensitivity
321452|NCT01774084|Beta cell function|beta cell function
321453|NCT01774084|Carbohydrate preload|carbohydrate preload
321454|NCT01774084|Elective hip replacement|elective hip replacement
321455|NCT01774084|Double-blind randomized control study|double-blind randomized control study
321456|NCT01774071|89Zr-DFO-MSTP2109A|89zr-dfo-mstp2109a
321457|NCT01774071|tracer|tracer
321458|NCT01774071|pet scan|pet scan
321459|NCT01774071|12-178|12-178
321460|NCT01774058|blood flow volume|blood flow volume
321461|NCT01774058|ilomedin|ilomedin
321462|NCT01774058|measurement|measurement
321463|NCT01774058|intraarterial|intraarterial
321464|NCT01774058|neuropathy|neuropathy
321465|NCT01774045|Major depressive disorder|major depressive disorder
321466|NCT01774045|Depression|depression
321467|NCT01774019|Pancreatic|pancreatic
321468|NCT01774019|Periampullary Cancer|periampullary cancer
321469|NCT01774019|Preoperative Biliary Drainage|preoperative biliary drainage
321470|NCT01774019|Resectable|resectable
321471|NCT01774006|In vitro fertilization|in vitro fertilization
321472|NCT01774006|Embryo transfer|embryo transfer
321473|NCT01774006|Embryo culture|embryo culture
321474|NCT01774006|individual culture|individual culture
321475|NCT01774006|Group culture|group culture
321476|NCT01774006|embryo quality|embryo quality
321477|NCT01774006|Pregnancy rate|pregnancy rate
321478|NCT01774006|Implantation|implantation
321479|NCT01773993|Lyrica|lyrica
321480|NCT01773993|pregabalin|pregabalin
321481|NCT01773993|Good post marketing practice|good post marketing practice
321482|NCT01773993|Post Marketing Surveillance|post marketing surveillance
321483|NCT01773993|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
321484|NCT01773993|Fibromyalgia|fibromyalgia
321485|NCT01773967|Lactobacillus rhamnosus GG|lactobacillus rhamnosus gg
321486|NCT01773967|LGG|lgg
321487|NCT01773967|Probiotic|probiotic
321488|NCT01773967|Gastroenteritis|gastroenteritis
321489|NCT01773967|acute gastroenteritis|acute gastroenteritis
321490|NCT01773967|child|child
321491|NCT01773967|pediatric|pediatric
321492|NCT01773967|RCT|rct
321493|NCT01773954|amd|amd
321494|NCT01773954|age related macular degeneration|age related macular degeneration
321495|NCT01773954|macular degeneration|macular degeneration
321496|NCT01773954|neovascular|neovascular
321497|NCT01773928|Active immunization against influenza disease|active immunization against influenza disease
321498|NCT01773889|Epithelial Ovarian Cancer|epithelial ovarian cancer
321499|NCT01773889|FIGO (Int Federation of Gyn and Ob )Stage III or Stage IV|figo (int federation of gyn and ob )stage iii or stage iv
321500|NCT01773889|Extraovarian Peritoneal Cancer|extraovarian peritoneal cancer
321501|NCT01773889|Fallopian Tube Carcinoma Failing|fallopian tube carcinoma failing
321502|NCT01773876|survival without proven invasive candidiasis|survival without proven invasive candidiasis
321503|NCT01773876|effectiveness|effectiveness
321504|NCT01773876|micafungin versus placebo|micafungin versus placebo
321505|NCT01773876|pharmacokinetic|pharmacokinetic
321506|NCT01773876|pharmacodynamic|pharmacodynamic
321507|NCT01773876|tolerance|tolerance
321508|NCT01773863|Community-acquired pneumonia|community-acquired pneumonia
321509|NCT01773863|Acute myocardial infarction|acute myocardial infarction
321510|NCT01773863|Platelet activation|platelet activation
321511|NCT01773863|Coagulation abnormalities,|coagulation abnormalities,
321512|NCT01773863|Thrombosis|thrombosis
321513|NCT01773863|Isoprosantes|isoprosantes
321514|NCT01773863|NADPH oxidase|nadph oxidase
321515|NCT01773863|Major adverse cardiac and cerebrovascular events|major adverse cardiac and cerebrovascular events
321516|NCT01773850|breast cancer|breast cancer
321517|NCT01773837|asthenia|asthenia
321518|NCT01773837|advanced cancer|advanced cancer
321519|NCT01773837|randomized controlled trial|randomized controlled trial
321520|NCT01773824|antibiotic|antibiotic
321521|NCT01773824|prescription rate|prescription rate
321522|NCT01773811|Posttraumatic Stress Disorder (PTSD)|posttraumatic stress disorder (ptsd)
321523|NCT01773811|Narrative Writing|narrative writing
321524|NCT01773759|Immunizations|immunizations
321525|NCT01773759|Child care|child care
321526|NCT01773759|School health promotion|school health promotion
321527|NCT01773746|neonatal|neonatal
321528|NCT01773746|resuscitation|resuscitation
321529|NCT01773746|room air|room air
321530|NCT01773720|cardiac index|cardiac index
321531|NCT01773720|coronary artery bypass|coronary artery bypass
321532|NCT01773720|uncalibrated pulse contour analysis|uncalibrated pulse contour analysis
321533|NCT01773720|hemodynamic monitoring|hemodynamic monitoring
321534|NCT01773707|prevention of type 1 diabetes|prevention of type 1 diabetes
321535|NCT01773707|prevention of abnormal glucose tolerance|prevention of abnormal glucose tolerance
321536|NCT01773694|Post-operative management|post-operative management
321537|NCT01773694|Post-operative complications|post-operative complications
321538|NCT01773694|Post-operative treatment|post-operative treatment
321539|NCT01773694|water|water
321540|NCT01773694|skin|skin
321541|NCT01773694|Dermatologic Surgical Procedures|dermatologic surgical procedures
321542|NCT01773655|somatic|somatic
321543|NCT01773655|germline|germline
321544|NCT01773655|mutations|mutations
321545|NCT01773655|BAP1 (BRCA associated protein-1)|bap1 (brca associated protein-1)
321546|NCT01773655|12-235|12-235
321547|NCT01773642|pediatric HIV diagnosis disclosure|pediatric hiv diagnosis disclosure
321548|NCT01773642|cognitive behavioral intervention|cognitive behavioral intervention
321549|NCT01773642|Uganda|uganda
321550|NCT01773629|Depression|depression
321551|NCT01773629|Pregnancy|pregnancy
321552|NCT01773629|Postpartum|postpartum
321553|NCT01773629|Perinatal|perinatal
321554|NCT01773616|Systemic lupus erythematosus|systemic lupus erythematosus
321555|NCT01773616|Lupus|lupus
321556|NCT01773616|Nephritis|nephritis
321557|NCT01773603|Time-lapse|time-lapse
321558|NCT01773603|morphokinetics|morphokinetics
321559|NCT01773603|blastocyst transfer|blastocyst transfer
321560|NCT01773603|eSET|eset
321561|NCT01773577|EHR|ehr
321562|NCT01773577|VHR|vhr
321563|NCT01773577|Electronic Health Record|electronic health record
321564|NCT01773564|Dressings, Prevention,|dressings, prevention,
321565|NCT01773538|quality of life|quality of life
321566|NCT01773512|Intravascular ultrasound|intravascular ultrasound
321567|NCT01773512|Virtual histology|virtual histology
321568|NCT01773512|Optical coherence tomography|optical coherence tomography
321569|NCT01773512|Coronary atherosclerosis|coronary atherosclerosis
321570|NCT01773512|Statins|statins
321571|NCT01773512|Retinal imaging|retinal imaging
321572|NCT01773499|cellulitis|cellulitis
321573|NCT01773499|ultrasound|ultrasound
321574|NCT01773486|Obesity|obesity
321575|NCT01773486|Insulin Resistance|insulin resistance
321576|NCT01773486|Endothelial dysfunction|endothelial dysfunction
321577|NCT01773486|Blood pressure|blood pressure
321578|NCT01773460|everolimus progress exemestane|everolimus progress exemestane
321579|NCT01773460|treated with exemestane and everolimus|treated with exemestane and everolimus
321580|NCT01773460|progress under this treatment|progress under this treatment
321581|NCT01773395|Advanced|advanced
321582|NCT01773369|cerebral palsy|cerebral palsy
321583|NCT01773369|physical therapy|physical therapy
321584|NCT01773369|rehabilitation|rehabilitation
321585|NCT01773356|Obesity|obesity
321586|NCT01773356|Body Weight|body weight
321587|NCT01773356|Body Composition|body composition
321588|NCT01773356|Metabolism|metabolism
321589|NCT01773356|Resting Energy Expenditure|resting energy expenditure
321590|NCT01773343|skin texture, efficacy, adverse effects|skin texture, efficacy, adverse effects
321591|NCT01773330|high resolution manometry|high resolution manometry
321592|NCT01773330|provocative swallow|provocative swallow
321593|NCT01773330|impedence|impedence
321594|NCT01773304|Obesity|obesity
321595|NCT01773304|Adults|adults
321596|NCT01773304|Bone metabolism|bone metabolism
321597|NCT01773304|Metabolic profile|metabolic profile
321598|NCT01773304|Dairy protein|dairy protein
321599|NCT01773304|Meat protein|meat protein
321600|NCT01773291|Acupuncture; laser acupuncture; traumatic brain injury|acupuncture; laser acupuncture; traumatic brain injury
321601|NCT01773278|Antioxidant treatment|antioxidant treatment
321602|NCT01773278|Oxysterols|oxysterols
321603|NCT01773278|Cholesterol deficiency|cholesterol deficiency
321604|NCT01773278|Accumulation of 7-dehydrocholesterol|accumulation of 7-dehydrocholesterol
321605|NCT01773278|electroretinogram (ERG)|electroretinogram (erg)
321606|NCT01773278|Auditory Brainstem Response (ABR)|auditory brainstem response (abr)
321607|NCT01773252|RLS|rls
321608|NCT01773252|RTLS|rtls
321609|NCT01773252|PFO|pfo
321610|NCT01773252|ASD|asd
321611|NCT01773252|shunt|shunt
321612|NCT01773252|cardiac|cardiac
321613|NCT01773252|paradoxical thromboembolism|paradoxical thromboembolism
321614|NCT01773252|interventional cardiology|interventional cardiology
321615|NCT01773252|stroke|stroke
321616|NCT01773252|migraine|migraine
321617|NCT01773252|aura|aura
321618|NCT01773252|obstructive sleep apnea|obstructive sleep apnea
321619|NCT01773252|decompression illness|decompression illness
321620|NCT01773252|neurology|neurology
321621|NCT01773252|transesophageal echocardiography|transesophageal echocardiography
321622|NCT01773252|TEE|tee
321623|NCT01773252|transthoracic echocardiography|transthoracic echocardiography
321624|NCT01773252|TTE|tte
321625|NCT01773252|transcranial Doppler|transcranial doppler
321626|NCT01773252|ultrasound|ultrasound
321627|NCT01773252|TCD|tcd
321628|NCT01773252|power m Mode|power m mode
321629|NCT01773252|indocyanine green dye|indocyanine green dye
321630|NCT01773252|ICG|icg
321631|NCT01773252|Valsalva|valsalva
321632|NCT01773239|social cognition|social cognition
321633|NCT01773239|cognitive deficits|cognitive deficits
321634|NCT01773239|prodromal schizophrenia|prodromal schizophrenia
321635|NCT01773239|recent-onset schizophrenia|recent-onset schizophrenia
321636|NCT01773239|remediation|remediation
321637|NCT01773239|computer training|computer training
321638|NCT01773239|cognitive training exercises|cognitive training exercises
321639|NCT01773226|Autologous Protein Solution|autologous protein solution
321640|NCT01773226|APS|aps
321641|NCT01773226|Osteoarthritis|osteoarthritis
321642|NCT01773226|Injection|injection
321643|NCT01773213|Lower urinary tract|lower urinary tract
321644|NCT01773213|Bladder|bladder
321645|NCT01773213|Neuropathic bladder|neuropathic bladder
321646|NCT01773213|Overactive bladder|overactive bladder
321647|NCT01773200|endothelial progenitor cells|endothelial progenitor cells
321648|NCT01773200|aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
321649|NCT01773200|vasospasm|vasospasm
321650|NCT01773200|BNP|bnp
321651|NCT01773187|Myelofibrosis|myelofibrosis
321652|NCT01773187|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
321653|NCT01773187|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
321654|NCT01773187|Primary Myelofibrosis|primary myelofibrosis
321655|NCT01773187|Polycythemia|polycythemia
321656|NCT01773187|Polycythemia Vera|polycythemia vera
321657|NCT01773187|Thrombocythemia, Essential|thrombocythemia, essential
321658|NCT01773187|Thrombocythemia|thrombocythemia
321659|NCT01773187|Myeloproliferative Disorders|myeloproliferative disorders
321660|NCT01773187|Bone Marrow Disease|bone marrow disease
321661|NCT01773187|Hematologic Diseases|hematologic diseases
321662|NCT01773187|Blood Platelet Disorders|blood platelet disorders
321663|NCT01773187|Hemorrhagic Disorders|hemorrhagic disorders
321664|NCT01773187|Splenomegaly|splenomegaly
321665|NCT01773187|Pacritinib|pacritinib
321666|NCT01773187|MPN-SAF|mpn-saf
321667|NCT01773187|MPN-SAF TSS|mpn-saf tss
321668|NCT01773187|Anemia|anemia
321669|NCT01773187|Myeloproliferative|myeloproliferative
321670|NCT01773187|Myeloproliferative Neoplasm|myeloproliferative neoplasm
321671|NCT01773187|Spleen|spleen
321672|NCT01773187|Spleen volume|spleen volume
321673|NCT01773187|Thrombocytopenia|thrombocytopenia
321674|NCT01773187|SB1518|sb1518
321675|NCT01773161|Cerebral Palsy|cerebral palsy
321676|NCT01773161|Hip surgery|hip surgery
321677|NCT01773161|Quality of Life|quality of life
321678|NCT01773135|threatened preterm labor|threatened preterm labor
321679|NCT01773135|ACTH|acth
321680|NCT01773135|PTL|ptl
321681|NCT01773109|Male and female subjects 18 years of age and older|male and female subjects 18 years of age and older
321682|NCT01773109|metastatic or recurrent NSCLC|metastatic or recurrent nsclc
321683|NCT01773109|who have failed 2nd line therapy (with up to two prior cytotoxic regimens and one prior exposure to an oral TKI).|who have failed 2nd line therapy (with up to two prior cytotoxic regimens and one prior exposure to an oral tki).
321684|NCT01773096|opioid-induced|opioid-induced
321685|NCT01773083|Inhalation trauma|inhalation trauma
321686|NCT01773083|pulmonary coagulopathy|pulmonary coagulopathy
321687|NCT01773083|heparin nebulization|heparin nebulization
321688|NCT01773083|mechanical ventilation|mechanical ventilation
321689|NCT01773070|Chronic Hepatitis C|chronic hepatitis c
321690|NCT01773070|Hepatitis C virus|hepatitis c virus
321691|NCT01773070|Direct Acting Antiviral|direct acting antiviral
321692|NCT01773070|Sustained Virologic Response|sustained virologic response
321693|NCT01773070|Hepatitis C|hepatitis c
321694|NCT01773070|Persistence of treatment-emergent substitutions|persistence of treatment-emergent substitutions
321695|NCT01773057|Computerized Decision Support System|computerized decision support system
322083|NCT01771354|Volunteers|volunteers
321696|NCT01773057|Heart failure|heart failure
321697|NCT01773057|Effects on quality of care|effects on quality of care
321698|NCT01773057|Process of care|process of care
321699|NCT01773057|Patient outcomes|patient outcomes
321700|NCT01773031|Autoimmune pancreatitis|autoimmune pancreatitis
321701|NCT01773031|MR pancreatography|mr pancreatography
321702|NCT01773005|Anesthetics, Intravenous|anesthetics, intravenous
321703|NCT01772992|HIV couples adherence linkage to care viral suppression|hiv couples adherence linkage to care viral suppression
321704|NCT01772979|Trabectedin|trabectedin
321705|NCT01772979|BRCA1 and BRCA2|brca1 and brca2
321706|NCT01772979|BRCAness|brcaness
321707|NCT01772979|Ovarian cancer|ovarian cancer
321708|NCT01772966|neck|neck
321709|NCT01772966|pain|pain
321710|NCT01772966|chronic|chronic
321711|NCT01772966|manipulation|manipulation
321712|NCT01772966|control|control
321713|NCT01772966|randomized trial|randomized trial
321714|NCT01772953|AML|aml
321715|NCT01772953|MDS|mds
321716|NCT01772953|Treosulfan|treosulfan
321717|NCT01772940|First-line therapy|first-line therapy
321718|NCT01772940|Protease inhibitor|protease inhibitor
321719|NCT01772940|Non-Nucleoside Reverse transcriptase Inhibitor|non-nucleoside reverse transcriptase inhibitor
321720|NCT01772940|Resource-limited setting|resource-limited setting
321721|NCT01772927|parenteral nutrition|parenteral nutrition
321722|NCT01772927|Very low birth weight infants|very low birth weight infants
321723|NCT01772927|preterm infants|preterm infants
321724|NCT01772927|biochemical tolerance|biochemical tolerance
321725|NCT01772927|nutritional intake|nutritional intake
321726|NCT01772914|Copeptin|copeptin
321727|NCT01772914|eating|eating
321728|NCT01772914|glucose tolerance test|glucose tolerance test
321729|NCT01772914|mixed meal test|mixed meal test
321730|NCT01772914|physiological|physiological
321731|NCT01772901|influenza|influenza
321732|NCT01772901|influenza vaccines|influenza vaccines
321733|NCT01772901|infectious disease|infectious disease
321734|NCT01772901|pregnancy|pregnancy
321735|NCT01772875|urinary catheter|urinary catheter
321736|NCT01772875|UTI|uti
321737|NCT01772875|bladder lavage|bladder lavage
321738|NCT01772862|childhood|childhood
321739|NCT01772862|cancer|cancer
321740|NCT01772862|physical activity|physical activity
321741|NCT01772862|quality of life|quality of life
321742|NCT01772849|childhood|childhood
321743|NCT01772849|cancer|cancer
321744|NCT01772849|education|education
321745|NCT01772849|physical activity|physical activity
321746|NCT01772849|quality of life|quality of life
321747|NCT01772823|HIV, PrEP, FTC/TDF, Truvada®|hiv, prep, ftc/tdf, truvada®
321748|NCT01772810|Paralysis, spinal cord injury, chronic spinal cord injury, cspine injury, neck injury|paralysis, spinal cord injury, chronic spinal cord injury, cspine injury, neck injury
321749|NCT01772797|anaplastic lymphoma kinase, ALK-rearranged lung cancer, non-small cell lung cancer|anaplastic lymphoma kinase, alk-rearranged lung cancer, non-small cell lung cancer
321750|NCT01772784|subjects|subjects
321751|NCT01772771|Cancer|cancer
321752|NCT01772771|Molecular testing|molecular testing
321753|NCT01772771|Personalized Cancer Therapy Program|personalized cancer therapy program
321754|NCT01772771|Bladder|bladder
321755|NCT01772771|Bone|bone
321756|NCT01772771|Breast|breast
321757|NCT01772771|Cytology|cytology
321758|NCT01772771|Endocrine|endocrine
321759|NCT01772771|Gynecology|gynecology
321760|NCT01772771|Endocrine - Neoplasia|endocrine - neoplasia
321761|NCT01772771|genitourinary|genitourinary
321762|NCT01772771|Research Biorepository|research biorepository
321763|NCT01772771|Head and Neck|head and neck
321764|NCT01772771|Aerodigestive Tract|aerodigestive tract
321765|NCT01772771|Hematopathology|hematopathology
321766|NCT01772771|Human Cancer Genetics|human cancer genetics
321767|NCT01772771|Kidney|kidney
321768|NCT01772771|Leukemia|leukemia
321769|NCT01772771|Lower Gastrointestinal|lower gastrointestinal
321770|NCT01772771|Lymphoma|lymphoma
321771|NCT01772771|Melanoma|melanoma
321772|NCT01772771|Neurology|neurology
321773|NCT01772771|Brain|brain
321774|NCT01772771|Non-Melanoma Skin|non-melanoma skin
321775|NCT01772771|Pancreas|pancreas
321776|NCT01772771|Pediatrics|pediatrics
321777|NCT01772771|Prostate|prostate
321778|NCT01772771|Breast Cancer Patients, Serum|breast cancer patients, serum
321779|NCT01772771|Plasma|plasma
321780|NCT01772771|Soft Tissue Sarcoma|soft tissue sarcoma
321781|NCT01772771|Thoracic|thoracic
321782|NCT01772771|Lung|lung
321783|NCT01772771|S.P.O.R.E.|s.p.o.r.e.
321784|NCT01772771|Upper Gastrointestinal|upper gastrointestinal
321785|NCT01772758|CF, cystic fibrosis, exercise|cf, cystic fibrosis, exercise
321786|NCT01772745|single incision|single incision
321787|NCT01772745|cholecystectomy|cholecystectomy
321788|NCT01772745|laparoscopy|laparoscopy
321789|NCT01772732|Simotinib|simotinib
321790|NCT01772732|Non-small Cell Lung Cancer|non-small cell lung cancer
321791|NCT01772719|refractory multiple myeloma|refractory multiple myeloma
321792|NCT01772706|Head and neck cancer|head and neck cancer
321793|NCT01772706|Low level laser therapy|low level laser therapy
321794|NCT01772706|Mucositis induced by radiochemotherpy|mucositis induced by radiochemotherpy
322084|NCT01771354|Identify|identify
321795|NCT01772693|ExAblate Transcranial MRgFUS|exablate transcranial mrgfus
321796|NCT01772680|Thalassemia|thalassemia
321797|NCT01772680|Diabetes|diabetes
321798|NCT01772680|Zinc|zinc
321799|NCT01772680|Iron-Overload|iron-overload
321800|NCT01772667|pulmonary fibrosis|pulmonary fibrosis
321801|NCT01772667|interstitial lung disease|interstitial lung disease
321802|NCT01772667|pulmonary rehabilitation|pulmonary rehabilitation
321803|NCT01772667|exercise capacity|exercise capacity
321804|NCT01772667|physical activity|physical activity
321805|NCT01772667|quality of life|quality of life
321806|NCT01772654|Epilepsy|epilepsy
321807|NCT01772654|Arterial Spin Labeled MRI|arterial spin labeled mri
321808|NCT01772654|Brain lesions|brain lesions
321809|NCT01772654|Cerebral blood flow|cerebral blood flow
321810|NCT01772641|cigarette|cigarette
321811|NCT01772641|smoking|smoking
321812|NCT01772641|cessation|cessation
321813|NCT01772641|varenicline|varenicline
321814|NCT01772641|scheduled reduction|scheduled reduction
321815|NCT01772641|craving|craving
321816|NCT01772628|Communication|communication
321817|NCT01772628|Healthy sexual behaviour|healthy sexual behaviour
321818|NCT01772628|Sexual and reproductive health|sexual and reproductive health
321819|NCT01772628|Adolescents|adolescents
321820|NCT01772615|EcN, Nissle, Mutaflor, Ulcerative Colitis, antibiotics, Inflammatory Bowel Diseases|ecn, nissle, mutaflor, ulcerative colitis, antibiotics, inflammatory bowel diseases
321821|NCT01772602|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
321822|NCT01772602|Lou Gehrig's Disease|lou gehrig's disease
321823|NCT01772602|Motor Neuron Disease|motor neuron disease
321824|NCT01772576|Reliance|reliance
321825|NCT01772576|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
321826|NCT01772576|Cardiac Resynchronization Therapy - Defibrillator (CRT-D)|cardiac resynchronization therapy - defibrillator (crt-d)
321827|NCT01772550|CECT, catheter, contrast|cect, catheter, contrast
321828|NCT01772537|thoracoabdominal|thoracoabdominal
321829|NCT01772537|aneurysm|aneurysm
321830|NCT01772537|open|open
321831|NCT01772537|stent|stent
321832|NCT01772537|cardiopulmonary|cardiopulmonary
321833|NCT01772537|abdominal|abdominal
321834|NCT01772537|bypass|bypass
321835|NCT01772524|Migraine Disorders|migraine disorders
321836|NCT01772524|Phase 1|phase 1
321837|NCT01772524|ALD403|ald403
321838|NCT01772511|questionnaire|questionnaire
321839|NCT01772511|prior therapy|prior therapy
321840|NCT01772511|prior study volunteer|prior study volunteer
321841|NCT01772511|prior study patient|prior study patient
321842|NCT01772511|cancer|cancer
321843|NCT01772511|oncology|oncology
321844|NCT01772498|depression|depression
321845|NCT01772498|anxiety|anxiety
321846|NCT01772498|sleep|sleep
321847|NCT01772498|pain|pain
321848|NCT01772498|biofeedback|biofeedback
321849|NCT01772498|breathing|breathing
321850|NCT01772498|resonant|resonant
321851|NCT01772459|Scoliosis|scoliosis
321852|NCT01772459|Adolescents|adolescents
321853|NCT01772459|Questionnaire|questionnaire
321854|NCT01772459|Reliability|reliability
321855|NCT01772446|diabetes|diabetes
321856|NCT01772446|management|management
321857|NCT01772446|glycated hemoglobin|glycated hemoglobin
321858|NCT01772446|preventive activities|preventive activities
321859|NCT01772433|Low Back Pain|low back pain
321860|NCT01772433|Topical Olive Oil|topical olive oil
321861|NCT01772433|Phonophoresis|phonophoresis
321862|NCT01772407|Colon Cancer Surgery|colon cancer surgery
321863|NCT01772407|Laparoscopy|laparoscopy
321864|NCT01772407|Open surgery|open surgery
321865|NCT01772407|Costs|costs
321866|NCT01772407|Mortality|mortality
321867|NCT01772407|Morbidity|morbidity
321868|NCT01772407|Quality of life|quality of life
321869|NCT01772394|Anorexia Nervosa|anorexia nervosa
321870|NCT01772394|Cognitive remediation therapy|cognitive remediation therapy
321871|NCT01772394|Randomized clinical trial|randomized clinical trial
321872|NCT01772381|Dexamethasone, term, elective cesarean section|dexamethasone, term, elective cesarean section
321873|NCT01772368|Asthma|asthma
321874|NCT01772368|dry powder inhaler|dry powder inhaler
321875|NCT01772368|long-acting beta2-agonist|long-acting beta2-agonist
321876|NCT01772368|bronchodilation|bronchodilation
321877|NCT01772368|bronchodilator|bronchodilator
321878|NCT01772368|metered dose inhaler|metered dose inhaler
321879|NCT01772368|inhaled corticosteroid|inhaled corticosteroid
321880|NCT01772355|orbit; tumor; core biopsy|orbit; tumor; core biopsy
321881|NCT01772342|Sleep Fragmentation|sleep fragmentation
321882|NCT01772342|Quality of Life|quality of life
321883|NCT01772342|Air Filters|air filters
321884|NCT01772303|Pressure Ulcers, diabetic Ulcers, post operational wounds|pressure ulcers, diabetic ulcers, post operational wounds
321885|NCT01772277|Endoscopic dacryocystorhinostomy|endoscopic dacryocystorhinostomy
321886|NCT01772277|Mitomycin C|mitomycin c
321887|NCT01772251|Diabetes Mellitus|diabetes mellitus
321888|NCT01772251|Oral Insulin|oral insulin
321889|NCT01772238|Mexico|mexico
321890|NCT01772238|Respiratory infections|respiratory infections
321891|NCT01772238|Amoxicillin-Clavulanic Acid|amoxicillin-clavulanic acid
321892|NCT01772238|Bioequivalence|bioequivalence
322085|NCT01771354|Biomarkers|biomarkers
321893|NCT01772225|Observational Retrospective|observational retrospective
321894|NCT01772225|Health-related quality of life (HRQoL)|health-related quality of life (hrqol)
321895|NCT01772225|Patients|patients
321896|NCT01772225|Stage IB-IIIA|stage ib-iiia
321897|NCT01772225|Burden of Illness|burden of illness
321898|NCT01772225|Non-small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
321899|NCT01772212|Mexico|mexico
321900|NCT01772212|terbinafine|terbinafine
321901|NCT01772212|mycoses|mycoses
321902|NCT01772212|pharmacokinetics|pharmacokinetics
321903|NCT01772199|GSK239512|gsk239512
321904|NCT01772199|remyelination|remyelination
321905|NCT01772199|magnetic resonance imaging|magnetic resonance imaging
321906|NCT01772199|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
321907|NCT01772199|Histamine 3 Receptor Antagonist|histamine 3 receptor antagonist
321908|NCT01772199|magnetization transfer ratio|magnetization transfer ratio
321909|NCT01772186|Freezing of gait|freezing of gait
321910|NCT01772186|Parkinson's disease|parkinson's disease
321911|NCT01772186|Somatosensory stimulation|somatosensory stimulation
321912|NCT01772186|Fall prevention|fall prevention
321913|NCT01772173|diabetes|diabetes
321914|NCT01772173|computer|computer
321915|NCT01772173|retina|retina
321916|NCT01772173|vessel|vessel
321917|NCT01772173|analysis|analysis
321918|NCT01772160|Adults|adults
321919|NCT01772160|Italy|italy
321920|NCT01772160|Herpes Zoster|herpes zoster
321921|NCT01772160|Complications|complications
321922|NCT01772160|Quality of life|quality of life
321923|NCT01772160|Surveillance|surveillance
321924|NCT01772160|Burden|burden
321925|NCT01772160|Cost|cost
321926|NCT01772160|Incidence|incidence
321927|NCT01772121|HBV, HCV, chronic, India, observational study, prevalence,|hbv, hcv, chronic, india, observational study, prevalence,
321928|NCT01772121|genotypes, SNPs, viral hepatitis|genotypes, snps, viral hepatitis
321929|NCT01772108|Heart Valve Diseases|heart valve diseases
321930|NCT01772095|Donepezil (Dementis)|donepezil (dementis)
321931|NCT01772095|Elderly|elderly
321932|NCT01772069|systemic lupus erythematosus, disease activity, sleep, quality of life|systemic lupus erythematosus, disease activity, sleep, quality of life
321933|NCT01772056|Dermatitis, Atopic|dermatitis, atopic
321934|NCT01772056|Randomized Controlled Trial|randomized controlled trial
321935|NCT01772056|Child|child
321936|NCT01772056|Fluticasone|fluticasone
321937|NCT01772056|Preventive therapy|preventive therapy
321938|NCT01772043|muscular dystrophy|muscular dystrophy
321939|NCT01772043|tissue bank|tissue bank
321940|NCT01772030|Atrial Fibrillation|atrial fibrillation
321941|NCT01772030|Cryoballoon Ablation|cryoballoon ablation
321942|NCT01772017|Obstructive Sleep Apnea|obstructive sleep apnea
321944|NCT01772017|Snoring|snoring
321945|NCT01772017|Tongue Advancement Retainer Device|tongue advancement retainer device
321946|NCT01772004|Solid Tumors|solid tumors
321947|NCT01772004|MSB0010718C|msb0010718c
321948|NCT01772004|Phase 1|phase 1
321949|NCT01772004|Pharmacokinetic|pharmacokinetic
321950|NCT01772004|anti PD-L1|anti pd-l1
321951|NCT01772004|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
321952|NCT01772004|Metastatic breast cancer (MBC)|metastatic breast cancer (mbc)
321953|NCT01772004|Gastric and gastroesophageal junction (GEJ) cancer|gastric and gastroesophageal junction (gej) cancer
321954|NCT01772004|Ovarian cancer|ovarian cancer
321955|NCT01772004|Colorectal cancer (CRC)|colorectal cancer (crc)
321956|NCT01772004|Castrate-resistant prostate cancer (CRPC)|castrate-resistant prostate cancer (crpc)
321957|NCT01772004|Melanoma|melanoma
321958|NCT01772004|Urothelial carcinoma|urothelial carcinoma
321959|NCT01772004|Bladder cancer|bladder cancer
321960|NCT01772004|Head and neck squamous cell carcinoma (HNSCC)|head and neck squamous cell carcinoma (hnscc)
321961|NCT01772004|Renal cell carcinoma (RCC)|renal cell carcinoma (rcc)
321962|NCT01772004|Adrenocortical carcinoma (ACC)|adrenocortical carcinoma (acc)
321963|NCT01771991|fibrosis|fibrosis
321964|NCT01771991|radiation|radiation
321965|NCT01771991|neck|neck
321966|NCT01771991|cancer|cancer
321967|NCT01771991|Sodermix|sodermix
321968|NCT01771978|ischaemia-reperfusion injury|ischaemia-reperfusion injury
321969|NCT01771978|cardiac surgery|cardiac surgery
321970|NCT01771978|oxidative stress markers|oxidative stress markers
321971|NCT01771978|troponin|troponin
321972|NCT01771978|diltiazem|diltiazem
321973|NCT01771978|acetylcystein|acetylcystein
321974|NCT01771952|Patellofemoral Chondromalacia|patellofemoral chondromalacia
321975|NCT01771952|Anterior Knee Pain|anterior knee pain
321976|NCT01771952|Patellofemoral Pain Syndrome|patellofemoral pain syndrome
321977|NCT01771952|Synvisc-One|synvisc-one
321978|NCT01771952|Hyaluronic Acid|hyaluronic acid
321979|NCT01771939|Idiopathic epiretinal membranes|idiopathic epiretinal membranes
321980|NCT01771939|25-G surgery in idiopathic epiretinal membranes|25-g surgery in idiopathic epiretinal membranes
321981|NCT01771926|resistant starch|resistant starch
321982|NCT01771926|lifestyle intervention|lifestyle intervention
321983|NCT01771913|adipocytes|adipocytes
321984|NCT01771913|cell transplantations|cell transplantations
321985|NCT01771913|mesenchymal stem cell|mesenchymal stem cell
321986|NCT01771913|immunophenotyping|immunophenotyping
321987|NCT01771913|adipose tissue|adipose tissue
321988|NCT01771913|breast reconstruction|breast reconstruction
321989|NCT01771913|mammaplasty|mammaplasty
321990|NCT01771913|magnetic resonance imaging|magnetic resonance imaging
321991|NCT01771913|fat necrosis|fat necrosis
321992|NCT01771900|heart failure|heart failure
321993|NCT01771900|exercise|exercise
321994|NCT01771900|adherence to exercise|adherence to exercise
321995|NCT01771887|Diabetic Type2|diabetic type2
321996|NCT01771887|education|education
321997|NCT01771887|self-management behaviors|self-management behaviors
321998|NCT01771887|self-efficacy|self-efficacy
321999|NCT01771887|HbA1c|hba1c
322000|NCT01771874|MDMA|mdma
322001|NCT01771874|pharmacokinetics|pharmacokinetics
322002|NCT01771874|pharmacodynamics|pharmacodynamics
322003|NCT01771874|emotions|emotions
322004|NCT01771874|Mechanism of action of MDMA|mechanism of action of mdma
322005|NCT01771874|Interaction study|interaction study
322006|NCT01771874|Effect of MDMA and bupropion on emotions|effect of mdma and bupropion on emotions
322007|NCT01771848|Malaria|malaria
322008|NCT01771848|Plasmodium falciparum|plasmodium falciparum
322009|NCT01771835|diabetes mellitus|diabetes mellitus
322010|NCT01771835|retinal venous pressure|retinal venous pressure
322011|NCT01771835|endothelin-1|endothelin-1
322012|NCT01771822|cumulative irritancy patch test (CIPT)|cumulative irritancy patch test (cipt)
322013|NCT01771809|Anti-TNF Refractory|anti-tnf refractory
322014|NCT01771809|Active Ulcerative Colitis|active ulcerative colitis
322015|NCT01771809|Immunosuppressant Refractory|immunosuppressant refractory
322016|NCT01771796|Exercise; lung cancer; aerobic training, resistance training; respiratory muscle training|exercise; lung cancer; aerobic training, resistance training; respiratory muscle training
322017|NCT01771783|RAS-Peptide Profile|ras-peptide profile
322018|NCT01771783|Renin-Angiotensin-System|renin-angiotensin-system
322019|NCT01771783|Angiotensin-Converting-Enzyme-Inhibitor|angiotensin-converting-enzyme-inhibitor
322020|NCT01771783|Angiotensin-Receptor-Antagonist|angiotensin-receptor-antagonist
322021|NCT01771783|Renin-inhibitor|renin-inhibitor
322022|NCT01771770|retinal venous pressure (RVP)|retinal venous pressure (rvp)
322023|NCT01771770|chronically reduced ambient pressure|chronically reduced ambient pressure
322024|NCT01771770|oxygen partial pressure|oxygen partial pressure
322025|NCT01771770|mountain sickness|mountain sickness
322026|NCT01771757|retinal venous pressure|retinal venous pressure
322027|NCT01771757|reduced ambient pressure|reduced ambient pressure
322028|NCT01771757|oxygen partial pressure|oxygen partial pressure
322029|NCT01771757|short-term hypoxic changes|short-term hypoxic changes
322030|NCT01771705|Transplantation|transplantation
322031|NCT01771705|Kidney|kidney
322032|NCT01771705|calcineurin inhibitor|calcineurin inhibitor
322033|NCT01771705|NFAT|nfat
322034|NCT01771705|tacrolimus|tacrolimus
322035|NCT01771692|Orthodontics|orthodontics
322036|NCT01771679|Mesenchymal Stem Cells|mesenchymal stem cells
322037|NCT01771679|Bone Marrow Cells|bone marrow cells
322038|NCT01771679|Allogeneic Transplantation|allogeneic transplantation
322039|NCT01771679|Skin Wrinkling|skin wrinkling
322040|NCT01771679|Solar Aging of Skin|solar aging of skin
322041|NCT01771679|Intravenous Administration|intravenous administration
322042|NCT01771653|Hepatitis C infection|hepatitis c infection
322043|NCT01771653|Hepatitis C Virus|hepatitis c virus
322044|NCT01771653|HCV|hcv
322045|NCT01771640|ALS intrathecal injection bone marrow mesenchymal stem cell|als intrathecal injection bone marrow mesenchymal stem cell
322046|NCT01771614|Glucotoxicity|glucotoxicity
322047|NCT01771614|Exercise|exercise
322048|NCT01771614|Beta-cell function|beta-cell function
322049|NCT01771601|Near-infrared spectroscopy, cerebral oxygenation, term newborn, reproducibility,|near-infrared spectroscopy, cerebral oxygenation, term newborn, reproducibility,
322050|NCT01771562|HIV-1|hiv-1
322051|NCT01771562|Child|child
322052|NCT01771562|Adolescent|adolescent
322053|NCT01771562|Growth|growth
322054|NCT01771562|Lipodystrophy|lipodystrophy
322055|NCT01771562|ARV treatment|arv treatment
322056|NCT01771562|Senegal|senegal
322057|NCT01771549|Adriamycin|adriamycin
322058|NCT01771549|Trastuzumab|trastuzumab
322059|NCT01771549|Brain Natriuretic Peptide (BNP)|brain natriuretic peptide (bnp)
322060|NCT01771549|Troponin|troponin
322061|NCT01771523|thyroidectomy|thyroidectomy
322062|NCT01771523|drain use|drain use
322063|NCT01771497|Breast CT|breast ct
322064|NCT01771484|tachycardia|tachycardia
322065|NCT01771484|pots|pots
322066|NCT01771484|orthostatic intolerance|orthostatic intolerance
322067|NCT01771471|back pain|back pain
322068|NCT01771471|intervertebral disc|intervertebral disc
322069|NCT01771471|lumbar spine|lumbar spine
322070|NCT01771458|Metastatic/Reccurent|metastatic/reccurent
322071|NCT01771458|Solid Tumor|solid tumor
322072|NCT01771458|Refractory|refractory
322073|NCT01771458|Molecular profile|molecular profile
322074|NCT01771458|Targeted treatment|targeted treatment
322075|NCT01771445|IL-1|il-1
322076|NCT01771445|IL-6|il-6
322077|NCT01771445|Inflammation|inflammation
322078|NCT01771419|loop-tip|loop-tip
322079|NCT01771419|ERCP|ercp
322080|NCT01771419|cannulation of CBD|cannulation of cbd
322081|NCT01771393|arthroscanner|arthroscanner
322082|NCT01771393|cone-beam computed tomodensitometry|cone-beam computed tomodensitometry
322086|NCT01771354|Vaccine Safety|vaccine safety
322087|NCT01771341|NAVA|nava
322088|NCT01771341|post operative|post operative
322089|NCT01771328|Adrenal Hyperplasia, Congenital|adrenal hyperplasia, congenital
322090|NCT01771315|total knee arthroplasty|total knee arthroplasty
322091|NCT01771315|telephone follow-up|telephone follow-up
322092|NCT01771315|physical function|physical function
322093|NCT01771315|health related quality of life|health related quality of life
322094|NCT01771315|self-efficacy|self-efficacy
322095|NCT01771302|PRGF-Endoret|prgf-endoret
322096|NCT01771302|Bone graft|bone graft
322097|NCT01771302|Maxillary sinus|maxillary sinus
322098|NCT01771302|Vertical bone augmentation|vertical bone augmentation
322099|NCT01771289|Lung Cancer|lung cancer
322100|NCT01771276|POSE|pose
322101|NCT01771263|Anesthesia|anesthesia
322102|NCT01771263|Propofol|propofol
322103|NCT01771263|Remifentanil|remifentanil
322104|NCT01771263|NeuroSENSE|neurosense
322105|NCT01771237|HIV infection|hiv infection
322106|NCT01771224|Palmitoleic acid ulcerative colitis|palmitoleic acid ulcerative colitis
322107|NCT01771211|MCI|mci
322108|NCT01771211|Word-retrieval|word-retrieval
322109|NCT01771211|tDCS|tdcs
322110|NCT01771211|fMRI|fmri
322111|NCT01771198|Chronic rhinosinusitis|chronic rhinosinusitis
322112|NCT01771198|Refractory to treatment|refractory to treatment
322113|NCT01771198|SIMVASTATIN|simvastatin
322114|NCT01771185|Diabetes|diabetes
322115|NCT01771185|metabolic surgery|metabolic surgery
322116|NCT01771185|insulin resistance|insulin resistance
322117|NCT01771159|Spinal cord injury|spinal cord injury
322118|NCT01771159|Urinary dysfunction|urinary dysfunction
322119|NCT01771159|Bladder drainage|bladder drainage
322120|NCT01771146|Non-metastatic Pancreas Cancer|non-metastatic pancreas cancer
322121|NCT01771146|Pancreatic Cancer|pancreatic cancer
322122|NCT01771146|Cancer of Pancreas|cancer of pancreas
322123|NCT01771146|Adenocarcinoma of Pancreas|adenocarcinoma of pancreas
322124|NCT01771146|Neoadjuvant|neoadjuvant
322125|NCT01771133|Obesity|obesity
322126|NCT01771133|Maternal Welfare|maternal welfare
322127|NCT01771133|Child Welfare|child welfare
322128|NCT01771133|Nutritional Sciences|nutritional sciences
322129|NCT01771133|Clinical Trial|clinical trial
322130|NCT01771133|Pregnancy|pregnancy
322131|NCT01771133|Physical activity|physical activity
322132|NCT01771133|Fetal Development|fetal development
322133|NCT01771133|Metabolic Diseases|metabolic diseases
322134|NCT01771133|Life style|life style
322135|NCT01771133|Behavior and Behavior Mechanisms|behavior and behavior mechanisms
322136|NCT01771133|LIFE-Moms|life-moms
322137|NCT01771120|Asthma|asthma
322138|NCT01771120|Rhinitis|rhinitis
322139|NCT01771120|Control|control
322140|NCT01771120|Burden|burden
322141|NCT01771081|Longitudinal Studies,|longitudinal studies,
322142|NCT01771081|Observation|observation
322143|NCT01771081|Epidemiology|epidemiology
322144|NCT01771055|Trauma|trauma
322145|NCT01771055|Hypovolemia|hypovolemia
322146|NCT01771042|weight loss|weight loss
322147|NCT01771042|metabolic syndrome|metabolic syndrome
322148|NCT01771042|sympathetic nervous system|sympathetic nervous system
322149|NCT01771042|insulin resistance|insulin resistance
322150|NCT01771042|glucose tolerance|glucose tolerance
322151|NCT01771029|Procalcitonin|procalcitonin
322152|NCT01771029|Infection|infection
322153|NCT01771029|Point-of-Care|point-of-care
322154|NCT01771016|Emergency contraception|emergency contraception
322155|NCT01771016|Emergency hormonal contraception|emergency hormonal contraception
322156|NCT01771016|Community pharmacies|community pharmacies
322157|NCT01771016|Pharmaceutical care|pharmaceutical care
322158|NCT01771016|Time to access|time to access
322159|NCT01771016|Written assessments|written assessments
322160|NCT01771016|Switzerland|switzerland
322161|NCT01771003|Partial nephrectomy|partial nephrectomy
322162|NCT01771003|renal cell carcinoma|renal cell carcinoma
322163|NCT01771003|Renal Function|renal function
322164|NCT01771003|Remote ischemia preconditioning|remote ischemia preconditioning
322165|NCT01770990|depression|depression
322166|NCT01770990|telephone-based psychotherapy|telephone-based psychotherapy
322167|NCT01770990|cognitive-behavioral psychotherapy|cognitive-behavioral psychotherapy
322168|NCT01770990|manualized psychotherapy|manualized psychotherapy
322169|NCT01770990|telephone counseling|telephone counseling
322170|NCT01770990|telephone psychological treatment|telephone psychological treatment
322171|NCT01770990|telephone-administered therapy|telephone-administered therapy
322172|NCT01770990|low-intensity treatment|low-intensity treatment
322173|NCT01770990|motivational mail|motivational mail
322174|NCT01770990|reminder|reminder
322175|NCT01770990|letter|letter
322176|NCT01770977|Light-emitting diode therapy|light-emitting diode therapy
322177|NCT01770977|Muscle performance|muscle performance
322178|NCT01770977|Aerobic performance|aerobic performance
322179|NCT01770977|Lactate|lactate
322180|NCT01770977|Creatine kinase|creatine kinase
322181|NCT01770938|Light-emitting diode therapy|light-emitting diode therapy
322182|NCT01770938|Muscle performance|muscle performance
322183|NCT01770938|Gene expression|gene expression
322184|NCT01770938|Functional performance|functional performance
322185|NCT01770912|facial pain|facial pain
322186|NCT01770912|temporomandibular joint|temporomandibular joint
322187|NCT01770912|arthrocentesis|arthrocentesis
322188|NCT01770912|steroid|steroid
322189|NCT01770899|Montelukast|montelukast
322190|NCT01770899|Singulair|singulair
322191|NCT01770899|status asthmaticus|status asthmaticus
322192|NCT01770886|Drug Safety|drug safety
322193|NCT01770873|Youth|youth
322194|NCT01770873|Violence|violence
322195|NCT01770873|Assault-injured|assault-injured
322196|NCT01770873|Mentoring|mentoring
322197|NCT01770873|Emergency Room|emergency room
322198|NCT01770873|Urban|urban
322199|NCT01770860|Adhesive Bandages|adhesive bandages
322200|NCT01770860|Dermabrasion Wounds|dermabrasion wounds
322201|NCT01770821|sip drink|sip drink
322202|NCT01770821|protein|protein
322203|NCT01770821|muscle strength|muscle strength
322204|NCT01770821|6 minutes walking test|6 minutes walking test
322205|NCT01770808|Bloating|bloating
322206|NCT01770808|Flatulence|flatulence
322207|NCT01770808|Stomach discomfort|stomach discomfort
322208|NCT01770795|non-small cell lung cancer|non-small cell lung cancer
322209|NCT01770795|gemcitabine|gemcitabine
322210|NCT01770795|genexol-PM|genexol-pm
322211|NCT01770795|paclitaxel|paclitaxel
322212|NCT01770782|Palatal Expansion Technique|palatal expansion technique
322213|NCT01770782|Orthognathic Surgery|orthognathic surgery
322214|NCT01770782|Three Dimensional images|three dimensional images
322215|NCT01770769|Femoral Neck Fracture|femoral neck fracture
322216|NCT01770769|undisplaced|undisplaced
322217|NCT01770769|minimally displaced|minimally displaced
322218|NCT01770769|internal fixation|internal fixation
322219|NCT01770769|hemiarthroplasty|hemiarthroplasty
322220|NCT01770769|harris hip score|harris hip score
322221|NCT01770769|hospital cost|hospital cost
322222|NCT01770769|society cost|society cost
322223|NCT01770769|quality of life|quality of life
322224|NCT01770769|Timed Up and go test|timed up and go test
322225|NCT01770756|Hypertension|hypertension
322226|NCT01770756|High blood pressure|high blood pressure
322227|NCT01770756|Willpower|willpower
322228|NCT01770756|Self care|self care
322229|NCT01770743|post-exposure prophylaxis|post-exposure prophylaxis
322230|NCT01770743|toxin neutralization assay|toxin neutralization assay
322231|NCT01770730|urine LAM strip test|urine lam strip test
322232|NCT01770730|diagnostics|diagnostics
322233|NCT01770730|tuberculosis|tuberculosis
322234|NCT01770704|Bipolar disorder|bipolar disorder
322235|NCT01770704|Clinical management|clinical management
322236|NCT01770704|Clinical outcomes|clinical outcomes
322237|NCT01770678|Children|children
322238|NCT01770678|Cerebral Palsy|cerebral palsy
322239|NCT01770678|Randomised|randomised
322240|NCT01770678|Constraint Induced Movement Therapy|constraint induced movement therapy
322241|NCT01770652|Renal Impairment|renal impairment
322242|NCT01770652|Kidney Impairment|kidney impairment
322243|NCT01770652|Kidney Disease|kidney disease
322244|NCT01770652|Ferriprox|ferriprox
322245|NCT01770652|Deferiprone|deferiprone
322246|NCT01770652|DFP (deferiprone)|dfp (deferiprone)
322247|NCT01770652|L1|l1
322248|NCT01770639|charcot foot|charcot foot
322249|NCT01770639|charcot neuroarthropathy|charcot neuroarthropathy
322250|NCT01770639|midfoot arthrodesis|midfoot arthrodesis
322251|NCT01770639|midfoot fusion|midfoot fusion
322252|NCT01770613|Adult|adult
322253|NCT01770613|Allogeneic|allogeneic
322254|NCT01770613|Stem|stem
322255|NCT01770613|Cells|cells
322256|NCT01770613|Myocardial|myocardial
322257|NCT01770613|Infarction|infarction
322258|NCT01770600|Age 19 to 64|age 19 to 64
322259|NCT01770600|Medically stable|medically stable
322260|NCT01770600|No current or history of psychosis|no current or history of psychosis
322261|NCT01770600|No alcohol or benzodiazepine withdrawal|no alcohol or benzodiazepine withdrawal
322262|NCT01770587|Insomnia|insomnia
322263|NCT01770587|Sleep|sleep
322264|NCT01770587|Behavioral Medicine|behavioral medicine
322265|NCT01770587|Suicide|suicide
322266|NCT01770587|Suicidal Ideation|suicidal ideation
322267|NCT01770574|calcaneal lengthening|calcaneal lengthening
322268|NCT01770574|calcium ceramics|calcium ceramics
322269|NCT01770574|noninferiority|noninferiority
322270|NCT01770574|radiostereometric analysis|radiostereometric analysis
322271|NCT01770535|Ovarian cancer, paclitaxel|ovarian cancer, paclitaxel
322272|NCT01770522|Bodyweight|bodyweight
322273|NCT01770522|Physical Acivitiy|physical acivitiy
322274|NCT01770522|Diet|diet
322275|NCT01770522|Bodymass index|bodymass index
322276|NCT01770522|Pregnancy|pregnancy
322277|NCT01770522|Postnatal|postnatal
322278|NCT01770509|Chronic venous leg ulcers|chronic venous leg ulcers
322279|NCT01770509|Venous ulcer|venous ulcer
322280|NCT01770509|Stasis ulcer|stasis ulcer
322281|NCT01770509|Varicose ulcer|varicose ulcer
322282|NCT01770496|immunization|immunization
322283|NCT01770496|vaccination|vaccination
322284|NCT01770496|immunization information system|immunization information system
322285|NCT01770496|immunization registry|immunization registry
322286|NCT01770496|reminder / recall|reminder / recall
322287|NCT01770483|Nitazoxanide,|nitazoxanide,
322288|NCT01770483|Sustained viral response|sustained viral response
322289|NCT01770483|Type 2 DIABETICS|type 2 diabetics
322290|NCT01770470|serum phosphate|serum phosphate
322291|NCT01770470|chitosan|chitosan
322292|NCT01770470|kidney disease|kidney disease
322293|NCT01770470|salivary phosphate|salivary phosphate
322294|NCT01770457|ICU population|icu population
322295|NCT01770444|Acute coronary syndrome|acute coronary syndrome
322296|NCT01770444|Cardiac computed tomographic angiography|cardiac computed tomographic angiography
322297|NCT01770444|Radiation dose reduction|radiation dose reduction
322298|NCT01770444|Medical radiation exposure|medical radiation exposure
322299|NCT01770431|Huaier Granule;|huaier granule;
322300|NCT01770431|After radical hepatectomy;|after radical hepatectomy;
322301|NCT01770431|Prevention of Recurrence and Metastasis;|prevention of recurrence and metastasis;
322302|NCT01770431|Safety.|safety.
322303|NCT01770418|Non Small Cell Lung Cancer|non small cell lung cancer
322304|NCT01770418|Cancer|cancer
322305|NCT01770418|Lung|lung
322306|NCT01770418|Proton|proton
322307|NCT01770418|Radiation|radiation
322308|NCT01770405|endomicroscopy|endomicroscopy
322309|NCT01770405|needle-based|needle-based
322310|NCT01770405|pancreatic|pancreatic
322311|NCT01770405|cyst|cyst
322312|NCT01770405|mass|mass
322313|NCT01770405|EUSFNA|eusfna
322314|NCT01770379|Rheumatoid Arthritis, RA, IL-17 blocker, subcutaneous, self-injection, AIN457, AIN457F, secukinumab, anti-TNFα, pre-filled syringe|rheumatoid arthritis, ra, il-17 blocker, subcutaneous, self-injection, ain457, ain457f, secukinumab, anti-tnfα, pre-filled syringe
322315|NCT01770366|obesity|obesity
322316|NCT01770366|weight loss surgery|weight loss surgery
322317|NCT01770366|virtual support|virtual support
322318|NCT01770366|wireless devices|wireless devices
322319|NCT01770366|Internet|internet
322320|NCT01770353|solid tumors|solid tumors
322321|NCT01770353|Triple Negative Breast Cancer|triple negative breast cancer
322322|NCT01770353|Colorectal Cancer|colorectal cancer
322323|NCT01770353|MM-398|mm-398
322324|NCT01770353|nanoliposomal irinotecan|nanoliposomal irinotecan
322325|NCT01770353|Ferumoxytol|ferumoxytol
322326|NCT01770353|ER/PR positive Breast Cancer|er/pr positive breast cancer
322327|NCT01770353|Pancreatic Cancer|pancreatic cancer
322328|NCT01770353|Ovarian Cancer|ovarian cancer
322329|NCT01770353|Gastric Cancer|gastric cancer
322330|NCT01770353|Gastro-Esophageal Junction Adenocarcinoma|gastro-esophageal junction adenocarcinoma
322331|NCT01770353|Head and Neck Cancer|head and neck cancer
322332|NCT01770353|TNBC|tnbc
322333|NCT01770340|radical prostatectomy|radical prostatectomy
322334|NCT01770340|erectile function|erectile function
322335|NCT01770340|nerve grafting|nerve grafting
322336|NCT01770340|allogenic|allogenic
322337|NCT01770340|prostate cancer|prostate cancer
322338|NCT01770340|Allogenic nerve graft|allogenic nerve graft
322339|NCT01770340|Time required for nerve grafting|time required for nerve grafting
322340|NCT01770314|Opioid Pain Medication|opioid pain medication
322341|NCT01770314|Medication Safety|medication safety
322342|NCT01770314|Correct storage|correct storage
322343|NCT01770314|Correct disposal|correct disposal
322344|NCT01770314|Correct Use|correct use
322345|NCT01770288|Anerobic exercise|anerobic exercise
322346|NCT01770288|Pain|pain
322347|NCT01770288|Analgesia|analgesia
322348|NCT01770288|Diffuse Noxious Inhibitory Control (DNIC)|diffuse noxious inhibitory control (dnic)
322349|NCT01770288|psychological stress|psychological stress
322350|NCT01770275|esophagus|esophagus
322351|NCT01770249|dysphagia|dysphagia
322352|NCT01770210|hypercholesterolemia|hypercholesterolemia
322353|NCT01770210|atorvastatin|atorvastatin
322354|NCT01770210|cardiovascular events|cardiovascular events
322355|NCT01770197|China|china
322356|NCT01770197|Stroke|stroke
322357|NCT01770197|Thrombolytic therapy|thrombolytic therapy
322358|NCT01770184|Self-management|self-management
322359|NCT01770184|Rehabilitation|rehabilitation
322360|NCT01770184|Occupational Therapy|occupational therapy
322361|NCT01770171|endometrial cancer|endometrial cancer
322362|NCT01770171|recurrent endometrial cancer|recurrent endometrial cancer
322363|NCT01770171|bevacizumab|bevacizumab
322364|NCT01770158|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
322365|NCT01770158|Histamine Dihydrochloride|histamine dihydrochloride
322366|NCT01770158|Interleukin-2|interleukin-2
322367|NCT01770145|Motor symptoms|motor symptoms
322368|NCT01770145|Parkinson's Disease|parkinson's disease
322369|NCT01770145|Delayed Onset|delayed onset
322370|NCT01770145|Akinesia|akinesia
322371|NCT01770145|Hypomobility|hypomobility
322372|NCT01770145|Unified Parkinson Disease Rating Scale (UPDRS) motor scores|unified parkinson disease rating scale (updrs) motor scores
322373|NCT01770145|Dopamine agonist|dopamine agonist
322374|NCT01770145|Apomorphine|apomorphine
322375|NCT01770145|Apokyn|apokyn
322376|NCT01770145|Levodopa|levodopa
322377|NCT01770119|Measles|measles
322378|NCT01770119|Mumps|mumps
322379|NCT01770119|Rubella|rubella
322380|NCT01770119|Pediatric|pediatric
322381|NCT01770119|Solid-organ transplant|solid-organ transplant
322382|NCT01770119|serology|serology
322383|NCT01770119|vaccine|vaccine
322384|NCT01770106|Rheumatoid arthritis|rheumatoid arthritis
322385|NCT01770106|Bone density|bone density
322386|NCT01770106|Bone microarchitecture|bone microarchitecture
322387|NCT01770106|HR-pQCT|hr-pqct
322388|NCT01770067|Cardiac Resynchronization Therapy Devices|cardiac resynchronization therapy devices
322389|NCT01770054|metabolic syndrome|metabolic syndrome
322390|NCT01770054|diabetes mellitus|diabetes mellitus
322391|NCT01770028|Obesity|obesity
322392|NCT01770028|Pregnancy|pregnancy
322393|NCT01770028|Spouse|spouse
322394|NCT01770028|Weight loss|weight loss
322395|NCT01770028|Behavioral|behavioral
322396|NCT01770015|patient ventilated for at least five days|patient ventilated for at least five days
322397|NCT01769963|Advanced glycation end-products|advanced glycation end-products
322398|NCT01769963|chronic kidney disease|chronic kidney disease
322399|NCT01769963|nutrition|nutrition
322400|NCT01769963|inflammation|inflammation
322401|NCT01769963|insulin resistance|insulin resistance
322402|NCT01769963|endothelial function|endothelial function
322403|NCT01769950|Choline PET|choline pet
322404|NCT01769950|Choline PET-CT|choline pet-ct
322405|NCT01769950|Positron emission tomography|positron emission tomography
322406|NCT01769950|Prostate cancer|prostate cancer
322407|NCT01769937|Lupus|lupus
322408|NCT01769937|SLE|sle
322409|NCT01769937|ACTH|acth
322410|NCT01769937|Acthar|acthar
322411|NCT01769924|Kidney donors|kidney donors
322412|NCT01769924|Arterial stiffness|arterial stiffness
322413|NCT01769924|Blood pressure|blood pressure
322414|NCT01769924|Nephrectomy|nephrectomy
322415|NCT01769898|Bronchiectasis|bronchiectasis
322416|NCT01769898|Theophylline|theophylline
322417|NCT01769898|Therapeutic Uses|therapeutic uses
322418|NCT01769898|HDAC|hdac
322419|NCT01769898|HAT|hat
322420|NCT01769898|Random placebo study|random placebo study
322421|NCT01769898|ICS(inhaled corticosteroid)|ics(inhaled corticosteroid)
322422|NCT01769898|corticosteroid|corticosteroid
322423|NCT01769898|Inhaled corticosteroid|inhaled corticosteroid
322424|NCT01769859|Bipolar Disorder|bipolar disorder
322425|NCT01769859|Major Depressive Disorder|major depressive disorder
322426|NCT01769859|Genetics|genetics
322427|NCT01769833|HBsAg|hbsag
322428|NCT01769833|Chronic hepatitis B|chronic hepatitis b
322429|NCT01769833|PEGinterferon Alfa-2A|peginterferon alfa-2a
322430|NCT01769820|Heavy menstrual bleeding (HMB)|heavy menstrual bleeding (hmb)
322431|NCT01769820|Dexamethasone|dexamethasone
322432|NCT01769820|glucocorticoid|glucocorticoid
322433|NCT01769807|Sleep apnea|sleep apnea
322434|NCT01769807|CPAP treatment|cpap treatment
322435|NCT01769807|Plasma nitrate|plasma nitrate
322436|NCT01769807|Urinary norepinephrine|urinary norepinephrine
322437|NCT01769807|Blood pressure|blood pressure
322438|NCT01769794|Hand, Foot and Mouth Disease|hand, foot and mouth disease
322439|NCT01769794|Medicine, Chinese Traditional|medicine, chinese traditional
322440|NCT01769794|Enterovirus|enterovirus
322441|NCT01769794|Fever|fever
322442|NCT01769781|endometriosis recurrence|endometriosis recurrence
322443|NCT01769781|pelvic pain|pelvic pain
322444|NCT01769781|aromatase inhibitor|aromatase inhibitor
322445|NCT01769768|Adults, Hh (Hedgehog) pathway inhibitor, LDE225, Warfarin, Bupropion, advanced solid tumor, drug-drug interaction, pharmacokinetic|adults, hh (hedgehog) pathway inhibitor, lde225, warfarin, bupropion, advanced solid tumor, drug-drug interaction, pharmacokinetic
322446|NCT01769755|Crohn's disease|crohn's disease
322447|NCT01769755|Fistula|fistula
322448|NCT01769755|Diarrhea|diarrhea
322449|NCT01769755|Colon|colon
322450|NCT01769755|Stem cells|stem cells
322451|NCT01769742|Pneumonia|pneumonia
322452|NCT01769742|promotion of activity|promotion of activity
322453|NCT01769729|integrated primary care|integrated primary care
322454|NCT01769729|depression|depression
322455|NCT01769729|chronic low back pain|chronic low back pain
322456|NCT01769716|Global developmental delay|global developmental delay
322457|NCT01769716|Umbilical cord blood|umbilical cord blood
322458|NCT01769716|Rehabilitation|rehabilitation
322459|NCT01769690|PD|pd
322460|NCT01769690|Parkinson's Disease|parkinson's disease
322461|NCT01769690|DBS|dbs
322462|NCT01769690|deep brain stimulation|deep brain stimulation
322463|NCT01769677|Bioequivalence|bioequivalence
322464|NCT01769677|Hydrocodone bitartrate extended-release tablets|hydrocodone bitartrate extended-release tablets
322465|NCT01769664|Acne vulgaris|acne vulgaris
322466|NCT01769664|Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel|clindamycin 1%/benzoyl peroxide 5% topical gel
322467|NCT01769664|Duac® Topical Gel|duac® topical gel
322468|NCT01769651|drug user patients|drug user patients
322469|NCT01769651|addiction nurses|addiction nurses
322470|NCT01769651|overdose risk|overdose risk
322471|NCT01769638|Orally disintegrating Film|orally disintegrating film
322472|NCT01769638|Film Coated Tablet|film coated tablet
322473|NCT01769638|Sildenafil|sildenafil
322474|NCT01769638|Pharmacokinetics|pharmacokinetics
322475|NCT01769625|breast|breast
322476|NCT01769625|high risk women|high risk women
322477|NCT01769625|biomarkers|biomarkers
322478|NCT01769625|vitamin D|vitamin d
322479|NCT01769612|Leishmaniasis, Leishmania|leishmaniasis, leishmania
322480|NCT01769586|Sedation|sedation
322481|NCT01769586|Endoscopy|endoscopy
322482|NCT01769586|Diphenhydramine|diphenhydramine
322483|NCT01769586|Midazolam|midazolam
322484|NCT01769573|normal|normal
322485|NCT01769560|tailored intervention|tailored intervention
322486|NCT01769560|college aged students|college aged students
322487|NCT01769560|HPV|hpv
322488|NCT01769521|Glaucoma|glaucoma
322489|NCT01769521|IOP|iop
322490|NCT01769521|Blood pressure|blood pressure
322491|NCT01769521|ECG|ecg
322492|NCT01769508|Esophagogastric Adenocarcinoma|esophagogastric adenocarcinoma
322493|NCT01769508|5-Fluorouracil|5-fluorouracil
322494|NCT01769508|Oxaliplatin|oxaliplatin
322495|NCT01769508|Lapatinib|lapatinib
322496|NCT01769508|Radiation Therapy|radiation therapy
322497|NCT01769508|Surgery|surgery
322498|NCT01769495|Emergency department, Geriatrics, mortality, readmission rates.|emergency department, geriatrics, mortality, readmission rates.
322499|NCT01769495|Patients 75 years of age and older.|patients 75 years of age and older.
322500|NCT01769482|microvascular angina|microvascular angina
322501|NCT01769482|PDE-5 inhibitors|pde-5 inhibitors
322502|NCT01769482|Heart disease|heart disease
322503|NCT01769482|Ischemia|ischemia
322504|NCT01769482|Cardiac MRI|cardiac mri
322505|NCT01769469|Tenofovir|tenofovir
322506|NCT01769469|Emtricitabine|emtricitabine
322507|NCT01769469|Truvada|truvada
322508|NCT01769469|Renal, endocrine, bone changes|renal, endocrine, bone changes
322509|NCT01769469|HIV prevention|hiv prevention
322510|NCT01769469|PrEP|prep
322511|NCT01769456|HIV, PrEP, FTC/TDF, Truvada®|hiv, prep, ftc/tdf, truvada®
322512|NCT01769443|desensitization therapy|desensitization therapy
322513|NCT01769443|bortezomib (VELCADE®)|bortezomib (velcade®)
322514|NCT01769443|plasmapheresis|plasmapheresis
322515|NCT01769430|influenza virus|influenza virus
322516|NCT01769430|aerosol transmission|aerosol transmission
322517|NCT01769430|contact transmission|contact transmission
322518|NCT01769430|large droplet transmission|large droplet transmission
322519|NCT01769430|airborne infection|airborne infection
322520|NCT01769391|NSCLC|nsclc
322521|NCT01769365|Helicobacter pylori infection|helicobacter pylori infection
322522|NCT01769352|cystoid macular edema|cystoid macular edema
322523|NCT01769339|Vulvar Candidiasis|vulvar candidiasis
322524|NCT01769339|Miconazole|miconazole
322525|NCT01769339|Hydrocortisone|hydrocortisone
322526|NCT01769339|Daktacort Feminine Care Cream|daktacort feminine care cream
322527|NCT01769326|Stroke|stroke
322528|NCT01769313|Cataract|cataract
322529|NCT01769313|Laser-assisted|laser-assisted
322530|NCT01769313|Femtosecond|femtosecond
322531|NCT01769300|Clinical decision support|clinical decision support
322532|NCT01769300|Electronic health records|electronic health records
322533|NCT01769300|Electronic medical records|electronic medical records
322534|NCT01769300|Attention deficit-hyperactivity disorder|attention deficit-hyperactivity disorder
322535|NCT01769300|Primary care Pediatric research network|primary care pediatric research network
322536|NCT01769287|Atrial fibrillation|atrial fibrillation
322537|NCT01769287|Electrophysiological Assessment|electrophysiological assessment
322538|NCT01769287|12 months post-operatively|12 months post-operatively
322539|NCT01769287|High Intensity Ultrasound|high intensity ultrasound
322540|NCT01769261|quality of health care|quality of health care
322541|NCT01769261|continuity of patient care|continuity of patient care
322542|NCT01769261|adverse effects|adverse effects
322543|NCT01769261|outcome and process assessment (health care)|outcome and process assessment (health care)
322544|NCT01769248|EUS|eus
322545|NCT01769248|FNA|fna
322546|NCT01769248|FNB|fnb
322547|NCT01769235|Acne Vulgaris|acne vulgaris
322548|NCT01769235|Clindamycin Phosphate and Benzoyl Peroxide Gel|clindamycin phosphate and benzoyl peroxide gel
322549|NCT01769235|Acanya® Gel|acanya® gel
322550|NCT01769196|Idiopathic|idiopathic
322551|NCT01769196|Pulmonary|pulmonary
322552|NCT01769196|Fibrosis|fibrosis
322553|NCT01769196|IPF|ipf
322554|NCT01769183|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
322555|NCT01769170|CMV|cmv
322556|NCT01769170|Hematopoietic Stem Cell Transplant Recipients|hematopoietic stem cell transplant recipients
322557|NCT01769170|CMV seropositive|cmv seropositive
322558|NCT01769144|wound healing|wound healing
322559|NCT01769144|wound infection|wound infection
322560|NCT01769144|pain|pain
322561|NCT01769144|pruritus|pruritus
322562|NCT01769144|cicatrix|cicatrix
322563|NCT01769144|dressings|dressings
322564|NCT01769144|acticoat absorbent|acticoat absorbent
322565|NCT01769144|BCT|bct
322566|NCT01769144|KoCarbonAg|kocarbonag
322567|NCT01769131|cervix|cervix
322568|NCT01769131|Allis|allis
322569|NCT01769131|Tenaculum|tenaculum
322570|NCT01769131|gynecology|gynecology
322571|NCT01769118|Autonomic nervous system|autonomic nervous system
322572|NCT01769105|Meibomian Gland Dysfunction|meibomian gland dysfunction
322573|NCT01769105|Lipiflow|lipiflow
322574|NCT01769092|Epilepsy|epilepsy
322575|NCT01769092|Seizure|seizure
322576|NCT01769092|Fish Oil|fish oil
322577|NCT01769053|Acute Lung Injury|acute lung injury
322578|NCT01769053|Adult Respiratory Distress Syndrome|adult respiratory distress syndrome
322579|NCT01769053|Interactive Ventilatory Support|interactive ventilatory support
322580|NCT01769053|Positive-Pressure Respiration|positive-pressure respiration
322581|NCT01769053|Ventilator-Induced Lung Injury|ventilator-induced lung injury
322785|NCT01768286|Flaviviridae Infections|flaviviridae infections
322582|NCT01769040|Decompensated liver cirrhosis|decompensated liver cirrhosis
322583|NCT01769040|Ascites|ascites
322584|NCT01769040|Haemodynamics|haemodynamics
322585|NCT01769040|Small intestinal bacterial overgrowth|small intestinal bacterial overgrowth
322586|NCT01769040|Pathophysiology|pathophysiology
322587|NCT01769014|adherence|adherence
322588|NCT01769001|Fabry disease|fabry disease
322589|NCT01769001|Alpha galactosidase deficiency|alpha galactosidase deficiency
322590|NCT01769001|Metabolic storage disease|metabolic storage disease
322591|NCT01768975|Knee|knee
322592|NCT01768975|Osteoarthritis|osteoarthritis
322593|NCT01768975|OA|oa
322594|NCT01768975|Knee pain|knee pain
322595|NCT01768975|Moderate pain|moderate pain
322596|NCT01768975|Severe pain|severe pain
322597|NCT01768975|Inflammation|inflammation
322598|NCT01768975|Safety|safety
322599|NCT01768975|Efficacy|efficacy
322600|NCT01768975|Randomized|randomized
322601|NCT01768975|Topical|topical
322602|NCT01768975|Gel|gel
322603|NCT01768975|Olatec|olatec
322604|NCT01768975|OLT1177|olt1177
322605|NCT01768975|Joint Diseases|joint diseases
322606|NCT01768975|Musculoskeletal Diseases|musculoskeletal diseases
322607|NCT01768975|Rheumatic Diseases|rheumatic diseases
322608|NCT01768975|Arthritis|arthritis
322609|NCT01768975|Therapeutic|therapeutic
322610|NCT01768975|Analgesic|analgesic
322611|NCT01768962|Microbicides|microbicides
322612|NCT01768962|Tenofovir|tenofovir
322613|NCT01768962|Reduced-glycerin|reduced-glycerin
322614|NCT01768962|Vaginal use|vaginal use
322615|NCT01768962|Rectal use|rectal use
322616|NCT01768962|Pharmacokinetics|pharmacokinetics
322617|NCT01768949|Acute respiratory distress syndrome|acute respiratory distress syndrome
322618|NCT01768949|Echocardiography|echocardiography
322619|NCT01768949|Recruitment maneuver|recruitment maneuver
322620|NCT01768936|on-demand relaparotomy|on-demand relaparotomy
322621|NCT01768936|PCT|pct
322622|NCT01768936|procalcitonin|procalcitonin
322623|NCT01768936|peritonitis|peritonitis
322624|NCT01768936|sepsis|sepsis
322625|NCT01768936|focus index|focus index
322626|NCT01768923|Early Rheumatoid Arthritis|early rheumatoid arthritis
322627|NCT01768923|Arterial stiffness|arterial stiffness
322628|NCT01768923|SDAI remission group|sdai remission group
322629|NCT01768923|Minimal disease activity remission group|minimal disease activity remission group
322630|NCT01768910|lower urinary tract|lower urinary tract
322631|NCT01768910|bladder|bladder
322632|NCT01768910|supraspinal control|supraspinal control
322633|NCT01768910|neuroimaging|neuroimaging
322634|NCT01768910|functional magnetic resonance imaging|functional magnetic resonance imaging
322635|NCT01768910|diffusion tensor imaging|diffusion tensor imaging
322636|NCT01768910|functional connectivity|functional connectivity
322637|NCT01768910|neurogenic lower urinary tract dysfunction|neurogenic lower urinary tract dysfunction
322638|NCT01768910|overactive bladder|overactive bladder
322639|NCT01768910|multiple sclerosis|multiple sclerosis
322640|NCT01768910|spinal cord injury|spinal cord injury
322641|NCT01768884|Infants|infants
322642|NCT01768884|Bronchiolitis|bronchiolitis
322643|NCT01768884|NO|no
322644|NCT01768884|inhalation|inhalation
322645|NCT01768858|Arthritis|arthritis
322646|NCT01768858|Morbus Crohn|morbus crohn
322647|NCT01768858|Adherence|adherence
322648|NCT01768858|Spondylitis|spondylitis
322649|NCT01768858|Ulcerative colitis|ulcerative colitis
322650|NCT01768858|Monoclonals|monoclonals
322651|NCT01768858|Rheumatoid|rheumatoid
322652|NCT01768858|Antibodies|antibodies
322653|NCT01768858|Ankylosing|ankylosing
322654|NCT01768858|Plaque psoriasis|plaque psoriasis
322655|NCT01768858|Psoriatic|psoriatic
322656|NCT01768858|Crohn´s disease|crohn´s disease
322657|NCT01768858|Antirheumatic Agents|antirheumatic agents
322658|NCT01768845|Chronic myelogenous leukemia (CML)|chronic myelogenous leukemia (cml)
322659|NCT01768845|Acute myelogenous leukemia (AML)|acute myelogenous leukemia (aml)
322660|NCT01768845|Myelodysplastic syndrome|myelodysplastic syndrome
322661|NCT01768845|Multiple myeloma|multiple myeloma
322662|NCT01768845|Hodgkin lymphoma|hodgkin lymphoma
322663|NCT01768845|Non Hodgkin lymphoma|non hodgkin lymphoma
322664|NCT01768845|Chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
322665|NCT01768845|Acute lymphocytic leukemia (ALL)|acute lymphocytic leukemia (all)
322666|NCT01768845|Severe Aplastic Anemia|severe aplastic anemia
322667|NCT01768845|Cord Blood|cord blood
322668|NCT01768845|Umbilical cord blood transplantation|umbilical cord blood transplantation
322669|NCT01768845|UBC transplantation|ubc transplantation
322670|NCT01768832|Parkinson disease|parkinson disease
322671|NCT01768832|walking|walking
322672|NCT01768832|fMRI|fmri
322673|NCT01768832|exercise|exercise
322674|NCT01768832|dance|dance
322675|NCT01768832|treadmill|treadmill
322676|NCT01768819|aging|aging
322677|NCT01768819|exercise|exercise
322678|NCT01768819|muscle strength|muscle strength
322679|NCT01768819|physical activity|physical activity
322680|NCT01768806|Autism|autism
322681|NCT01768806|Autism Spectrum Disorder|autism spectrum disorder
322682|NCT01768806|PLAY and Language for Autistic Youngsters|play and language for autistic youngsters
322683|NCT01768806|Intensive Early Intervention|intensive early intervention
322684|NCT01768806|Parent Training|parent training
322685|NCT01768793|Obesity|obesity
322686|NCT01768793|Pregnancy|pregnancy
322687|NCT01768793|Body Weight Changes|body weight changes
322688|NCT01768793|Diet Therapy|diet therapy
322689|NCT01768780|spinal anesthesia|spinal anesthesia
322690|NCT01768780|peripheral nerve stimulator|peripheral nerve stimulator
322691|NCT01768780|sensory block level|sensory block level
322692|NCT01768754|Exercise testing|exercise testing
322693|NCT01768754|Functional status|functional status
322694|NCT01768754|Pulmonary rehabilitation|pulmonary rehabilitation
322695|NCT01768741|hepatocellular carcinoma|hepatocellular carcinoma
322696|NCT01768715|Alcoholic hepatitis|alcoholic hepatitis
322697|NCT01768715|Liver transplantation|liver transplantation
322698|NCT01768715|Survival|survival
322699|NCT01768715|Alcoholism|alcoholism
322700|NCT01768702|Chronic Heart Failure of Ischemic Origin|chronic heart failure of ischemic origin
322701|NCT01768689|adherence|adherence
322702|NCT01768689|chronic myeloid leukemia|chronic myeloid leukemia
322703|NCT01768689|tyrosine kinase inhibitors|tyrosine kinase inhibitors
322704|NCT01768676|healthy male|healthy male
322705|NCT01768650|traumatic brain injury|traumatic brain injury
322706|NCT01768650|chronic pain|chronic pain
322707|NCT01768650|headache|headache
322708|NCT01768650|Veteran|veteran
322709|NCT01768637|Chronic kidney disease|chronic kidney disease
322710|NCT01768637|Platelet function|platelet function
322711|NCT01768637|aspirin|aspirin
322712|NCT01768637|antiplatelet agent|antiplatelet agent
322713|NCT01768624|chronic kidney disease|chronic kidney disease
322714|NCT01768624|dialysis|dialysis
322715|NCT01768624|pre dialysis education|pre dialysis education
322716|NCT01768624|transplantation|transplantation
322717|NCT01768624|conservative care|conservative care
322718|NCT01768598|Wrist Fracture|wrist fracture
322719|NCT01768598|Adolescents|adolescents
322720|NCT01768598|Risk Taking Behaviour|risk taking behaviour
322721|NCT01768598|Bone Microstructure|bone microstructure
322722|NCT01768546|Diabetes Prevention Program|diabetes prevention program
322723|NCT01768546|obesity|obesity
322724|NCT01768546|activity|activity
322725|NCT01768546|diabetes|diabetes
322726|NCT01768533|pediatric|pediatric
322727|NCT01768533|obesity|obesity
322728|NCT01768533|prevention|prevention
322729|NCT01768533|health behaviors|health behaviors
322730|NCT01768533|guidelines|guidelines
322731|NCT01768481|Obesity|obesity
322732|NCT01768481|Dyslipidemia|dyslipidemia
322733|NCT01768481|Cholesterol|cholesterol
322734|NCT01768481|Intima media thickness|intima media thickness
322735|NCT01768468|LAYLA|layla
322736|NCT01768468|Non-inferiority|non-inferiority
322737|NCT01768468|100mm pain VAS|100mm pain vas
322738|NCT01768442|Head and neck cancer|head and neck cancer
322739|NCT01768403|Hypercholesterolemia|hypercholesterolemia
322740|NCT01768403|Cardiovascular disease|cardiovascular disease
322741|NCT01768403|Hypertension|hypertension
322742|NCT01768403|Coronary Heart disease|coronary heart disease
322743|NCT01768403|Peripheral Arterial disease|peripheral arterial disease
322744|NCT01768390|caries|caries
322745|NCT01768390|prevention|prevention
322746|NCT01768390|orthodontics|orthodontics
322747|NCT01768390|fixed appliances|fixed appliances
322748|NCT01768390|adolescents|adolescents
322749|NCT01768377|Awake intubation|awake intubation
322750|NCT01768377|Nerve block|nerve block
322751|NCT01768377|Sedation|sedation
322752|NCT01768377|Physician satisfaction|physician satisfaction
322753|NCT01768351|anemia|anemia
322754|NCT01768351|chronic kidney disease|chronic kidney disease
322755|NCT01768351|vitamin D|vitamin d
322756|NCT01768351|paricalcitol|paricalcitol
322757|NCT01768351|hyperparathyroidism|hyperparathyroidism
322758|NCT01768325|ProCore Needle|procore needle
322759|NCT01768299|abortion|abortion
322760|NCT01768299|medical abortion|medical abortion
322761|NCT01768299|mifepristone|mifepristone
322762|NCT01768299|misoprostol|misoprostol
322763|NCT01768286|HCV genotype 1 (GT-1)|hcv genotype 1 (gt-1)
322764|NCT01768286|HCV|hcv
322765|NCT01768286|Sustained Virologic Response|sustained virologic response
322766|NCT01768286|Direct Acting Antiviral|direct acting antiviral
322767|NCT01768286|Combination Therapy|combination therapy
322768|NCT01768286|GS-7977|gs-7977
322769|NCT01768286|GS-5885|gs-5885
322770|NCT01768286|Ribavirin|ribavirin
322771|NCT01768286|Open Label|open label
322772|NCT01768286|Sofosbuvir|sofosbuvir
322773|NCT01768286|Additional relevant MeSH terms:|additional relevant mesh terms:
322774|NCT01768286|Hepatitis|hepatitis
322775|NCT01768286|Hepatitis, Chronic|hepatitis, chronic
322776|NCT01768286|Hepatitis C|hepatitis c
322777|NCT01768286|Hepatitis C, Chronic|hepatitis c, chronic
322778|NCT01768286|Liver Diseases|liver diseases
322779|NCT01768286|Digestive System Diseases|digestive system diseases
322780|NCT01768286|Hepatitis, Viral, Human|hepatitis, viral, human
322781|NCT01768286|Virus Diseases|virus diseases
322782|NCT01768286|Enterovirus Infections|enterovirus infections
322783|NCT01768286|Picornaviridae Infections|picornaviridae infections
322784|NCT01768286|RNA Virus Infections|rna virus infections
322786|NCT01768286|Antiviral Agents|antiviral agents
322787|NCT01768286|Anti-Infective Agents|anti-infective agents
322788|NCT01768286|Therapeutic Uses|therapeutic uses
322789|NCT01768286|Pharmacologic Actions|pharmacologic actions
322790|NCT01768286|Antimetabolites|antimetabolites
322791|NCT01768286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
322792|NCT01768273|PA-824,|pa-824,
322793|NCT01768273|midazolam|midazolam
322794|NCT01768273|drug-drug interaction|drug-drug interaction
322795|NCT01768273|pharmacokinetics|pharmacokinetics
322796|NCT01768273|pretomanid|pretomanid
322797|NCT01768273|CL-006|cl-006
322798|NCT01768260|visual acuity|visual acuity
322799|NCT01768260|artery flow velocity|artery flow velocity
322800|NCT01768260|Enhanced External Counterpulsation|enhanced external counterpulsation
322801|NCT01768260|Ischemic|ischemic
322802|NCT01768260|Optic Neuropathy|optic neuropathy
322803|NCT01768247|endometrium|endometrium
322804|NCT01768247|thickness|thickness
322805|NCT01768247|pregnancy|pregnancy
322806|NCT01768247|HCG|hcg
322807|NCT01768247|frozen cycles|frozen cycles
322808|NCT01768234|cognition|cognition
322809|NCT01768234|hydration|hydration
322810|NCT01768234|schoolchildren|schoolchildren
322811|NCT01768221|Palliative Care|palliative care
322812|NCT01768221|Caregiver Outlook|caregiver outlook
322813|NCT01768195|Lymphoma|lymphoma
322814|NCT01768195|Hepatitis B Virus|hepatitis b virus
322815|NCT01768195|Therapeutic Uses|therapeutic uses
322816|NCT01768195|Antiviral Agents|antiviral agents
322817|NCT01768195|rituximab|rituximab
322818|NCT01768182|folic acid; folates; Vascular Reactivity; HIV|folic acid; folates; vascular reactivity; hiv
322819|NCT01768169|metabolic syndrome,|metabolic syndrome,
322820|NCT01768169|waist, blood pressure,|waist, blood pressure,
322821|NCT01768169|fasting plasma glucose,|fasting plasma glucose,
322822|NCT01768169|HDL cholesterol,|hdl cholesterol,
322823|NCT01768169|triglycerides|triglycerides
322824|NCT01768156|ovarian cancer|ovarian cancer
322825|NCT01768156|biomarker|biomarker
322826|NCT01768156|metastatic|metastatic
322827|NCT01768143|Propofol|propofol
322828|NCT01768143|Sedation|sedation
322829|NCT01768143|Endoscopy|endoscopy
322830|NCT01768143|nonanesthesiologist|nonanesthesiologist
322831|NCT01768104|upper gastrointestinal submucosal tumors|upper gastrointestinal submucosal tumors
322832|NCT01768104|SMTs|smts
322833|NCT01768104|Gastrointestinal stromal tumors|gastrointestinal stromal tumors
322834|NCT01768104|GISTs|gists
322835|NCT01768104|Leiomyoma|leiomyoma
322836|NCT01768104|Endoscopic submucosal tunnel dissection|endoscopic submucosal tunnel dissection
322837|NCT01768104|ESTD|estd
322838|NCT01768104|Submucosal tunneling endoscopic resection|submucosal tunneling endoscopic resection
322839|NCT01768104|STER|ster
322840|NCT01768104|Submucosal endoscopic tumor resection|submucosal endoscopic tumor resection
322841|NCT01768104|SET|set
322842|NCT01768091|Esophageal achalasia|esophageal achalasia
322843|NCT01768091|Peroral endoscopic myotomy|peroral endoscopic myotomy
322844|NCT01768091|POEM|poem
322845|NCT01768091|Pneumatic dilation|pneumatic dilation
322846|NCT01768065|NEPAP|nepap
322847|NCT01768065|CPAP|cpap
322848|NCT01768065|alternative|alternative
322849|NCT01768065|OSAS|osas
322850|NCT01768052|MDD, major depression, treatment-resistant|mdd, major depression, treatment-resistant
322851|NCT01768039|Multiple sclerosis|multiple sclerosis
322852|NCT01768039|Vitamin D|vitamin d
322853|NCT01768039|EDSS|edss
322854|NCT01768039|ARR|arr
322855|NCT01768026|Dystrophic Epidermolysis Bullosa|dystrophic epidermolysis bullosa
322856|NCT01768026|Type VII Collagen|type vii collagen
322857|NCT01768026|QOL Evaluation in Epidermolysis Bullosa|qol evaluation in epidermolysis bullosa
322858|NCT01768026|Instrument for Scoring Clinical Outcomes for Research of Epidermolysis Bullosa|instrument for scoring clinical outcomes for research of epidermolysis bullosa
322859|NCT01768026|Birmingham Epidermolysis Bullosa Severity Score|birmingham epidermolysis bullosa severity score
322860|NCT01768000|Psychosis|psychosis
322861|NCT01768000|Psychosis NOS|psychosis nos
322862|NCT01768000|Schizophrenia|schizophrenia
322863|NCT01768000|Schizoaffective Disorder|schizoaffective disorder
322864|NCT01768000|Bipolar Disorder|bipolar disorder
322865|NCT01767987|Acute Coronary Syndrome|acute coronary syndrome
322866|NCT01767987|ACS|acs
322867|NCT01767987|Percutaneous Coronary Intervention|percutaneous coronary intervention
322868|NCT01767987|PCI|pci
322869|NCT01767987|Ranolazine|ranolazine
322870|NCT01767987|Coronary Angiogram|coronary angiogram
322871|NCT01767987|Cardioprotectant|cardioprotectant
322872|NCT01767974|Non-Small Cell lung cancer|non-small cell lung cancer
322873|NCT01767948|Hepatic Impairment|hepatic impairment
322874|NCT01767948|PCI 32765|pci 32765
322875|NCT01767948|Metabolite PCI-45227|metabolite pci-45227
322876|NCT01767948|Pharmacokinetics|pharmacokinetics
322877|NCT01767922|Super-Oxyd-Dismutase|super-oxyd-dismutase
322878|NCT01767922|SOD|sod
322879|NCT01767922|melon juce|melon juce
322880|NCT01767922|perceived stress|perceived stress
322881|NCT01767909|Intranasal insulin|intranasal insulin
322882|NCT01767909|Alzheimer's disease|alzheimer's disease
322986|NCT01767441|sleeve gastrectomy|sleeve gastrectomy
322883|NCT01767909|Amnestic mild cognitive impairment|amnestic mild cognitive impairment
322884|NCT01767909|Dementia|dementia
322885|NCT01767909|Brain diseases|brain diseases
322886|NCT01767909|Memory problems|memory problems
322887|NCT01767909|Mental disorders|mental disorders
322888|NCT01767909|Cognitive disorders|cognitive disorders
322889|NCT01767896|Influenza vaccine|influenza vaccine
322890|NCT01767883|Chronic Kidney Disease|chronic kidney disease
322891|NCT01767883|CKD|ckd
322892|NCT01767883|TRANSLATE|translate
322893|NCT01767883|Practice Facilitation|practice facilitation
322894|NCT01767883|Practice-based research|practice-based research
322895|NCT01767883|CKD Guidelines|ckd guidelines
322896|NCT01767870|advanced colorectal adenoma|advanced colorectal adenoma
322897|NCT01767870|colonoscopy|colonoscopy
322898|NCT01767870|sigmoidoscopy|sigmoidoscopy
322899|NCT01767870|fecal immunochemical test|fecal immunochemical test
322900|NCT01767857|Pivotal|pivotal
322901|NCT01767857|Colorectal|colorectal
322902|NCT01767857|Survival|survival
322903|NCT01767857|Phase 3|phase 3
322904|NCT01767844|Rheumatoid Arthritis|rheumatoid arthritis
322905|NCT01767844|Arthritis|arthritis
322906|NCT01767844|Rheumatology|rheumatology
322907|NCT01767844|Creatine|creatine
322908|NCT01767831|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
322909|NCT01767831|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
322910|NCT01767831|Simulation-based Education|simulation-based education
322911|NCT01767818|Parkinson's Disease|parkinson's disease
322912|NCT01767792|Neurofibromatosis Type 2|neurofibromatosis type 2
322913|NCT01767792|Progressive Vestibular Schwannomas|progressive vestibular schwannomas
322914|NCT01767779|Epilepsy|epilepsy
322915|NCT01767779|TSC|tsc
322916|NCT01767779|Tuberous Sclerosis Complex|tuberous sclerosis complex
322917|NCT01767779|Infants|infants
322918|NCT01767779|Seizures|seizures
322919|NCT01767779|Biomarkers|biomarkers
322920|NCT01767779|EEG|eeg
322921|NCT01767753|Glaucoma|glaucoma
322922|NCT01767753|SLT|slt
322923|NCT01767740|Rotator Cuff Tear|rotator cuff tear
322924|NCT01767740|Supraspinatus Tear|supraspinatus tear
322925|NCT01767727|surgical flap;|surgical flap;
322926|NCT01767727|dorsal branch of the digital artery|dorsal branch of the digital artery
322927|NCT01767714|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
322928|NCT01767701|raltegravir|raltegravir
322929|NCT01767701|MS|ms
322930|NCT01767701|RRMS|rrms
322931|NCT01767701|Charcot Project|charcot project
322932|NCT01767688|Diabetes Mellitus|diabetes mellitus
322933|NCT01767688|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
322934|NCT01767688|Glucose Metabolism Disorders|glucose metabolism disorders
322935|NCT01767688|Metabolic Diseases|metabolic diseases
322936|NCT01767688|Endocrine System Diseases|endocrine system diseases
322937|NCT01767675|Secondary Cytoreductive Surgery|secondary cytoreductive surgery
322938|NCT01767675|Carboplatin|carboplatin
322939|NCT01767675|Hyperthermic Intraperitoneal Chemotherapy (HIPEC)|hyperthermic intraperitoneal chemotherapy (hipec)
322940|NCT01767675|12-275|12-275
322941|NCT01767662|TCV|tcv
322942|NCT01767649|Pregnancy|pregnancy
322943|NCT01767649|Remodelling|remodelling
322944|NCT01767649|Extracellular matrix|extracellular matrix
322945|NCT01767649|Biomarkers|biomarkers
322946|NCT01767597|rapid test|rapid test
322947|NCT01767597|screening|screening
322948|NCT01767597|ELISA|elisa
322949|NCT01767597|hepatitis B virus|hepatitis b virus
322950|NCT01767597|access to care|access to care
322951|NCT01767584|Pharmacokinetics|pharmacokinetics
322952|NCT01767584|Bioequivalence|bioequivalence
322953|NCT01767584|Mexico|mexico
322954|NCT01767584|Cephalexin|cephalexin
322955|NCT01767571|Mexico|mexico
322956|NCT01767571|Respiratory infections|respiratory infections
322957|NCT01767571|Bioequivalence|bioequivalence
322958|NCT01767571|Cepphalexin|cepphalexin
322959|NCT01767532|Cephalexin|cephalexin
322960|NCT01767532|Respiratory infections|respiratory infections
322961|NCT01767532|Mexico|mexico
322962|NCT01767532|Bioequivalence|bioequivalence
322963|NCT01767506|Trachoma|trachoma
322964|NCT01767506|Azithromycin|azithromycin
322965|NCT01767506|Mass treatment|mass treatment
322966|NCT01767493|Multiple sclerosis|multiple sclerosis
322967|NCT01767480|Intensive Robot Assisted Therapy|intensive robot assisted therapy
322968|NCT01767480|Subacute Stroke|subacute stroke
322969|NCT01767480|Brain Reorganization|brain reorganization
322970|NCT01767480|Sensory Motor|sensory motor
322971|NCT01767480|Physiological Marker|physiological marker
322972|NCT01767467|Immunogenicity|immunogenicity
322973|NCT01767467|Safety|safety
322974|NCT01767467|Herpes zoster|herpes zoster
322975|NCT01767467|Vaccination|vaccination
322976|NCT01767467|Haematologic malignancies|haematologic malignancies
322977|NCT01767454|BRAF V600E|braf v600e
322978|NCT01767454|Melanoma|melanoma
322979|NCT01767454|V600K|v600k
322980|NCT01767454|Trametinib|trametinib
322981|NCT01767454|Dabrafenib|dabrafenib
322982|NCT01767454|Ipilimumab|ipilimumab
322983|NCT01767441|bariatric surgery|bariatric surgery
322984|NCT01767441|gastric bypass|gastric bypass
322985|NCT01767441|gastric banding|gastric banding
322987|NCT01767441|weight loss|weight loss
322988|NCT01767441|Type 2 Diabetes mellitus|type 2 diabetes mellitus
322989|NCT01767441|GLP1|glp1
322990|NCT01767441|obesity|obesity
322991|NCT01767441|mixed meal test|mixed meal test
322992|NCT01767415|brain tumor|brain tumor
322993|NCT01767415|resection|resection
322994|NCT01767415|indigo carmine dye|indigo carmine dye
322995|NCT01767402|Safety|safety
322996|NCT01767402|Pneumococcal Infections|pneumococcal infections
322997|NCT01767402|Immunogenicity|immunogenicity
322998|NCT01767402|PhtD vaccine|phtd vaccine
322999|NCT01767402|Healthy adults|healthy adults
323000|NCT01767402|Reactogenicity|reactogenicity
323001|NCT01767389|utilization|utilization
323002|NCT01767389|acute pancreatitis|acute pancreatitis
323003|NCT01767389|Exenatide|exenatide
323004|NCT01767389|DPP-4 inhibitors|dpp-4 inhibitors
323005|NCT01767389|liraglutide|liraglutide
323006|NCT01767389|GLP-1 receptor agonist|glp-1 receptor agonist
323007|NCT01767389|adherence|adherence
323008|NCT01767376|Young adults|young adults
323009|NCT01767376|Adolescents|adolescents
323010|NCT01767376|Reactogenicity|reactogenicity
323011|NCT01767376|Diphtheria|diphtheria
323012|NCT01767376|pertussis|pertussis
323013|NCT01767376|Immunogenicity|immunogenicity
323014|NCT01767376|Tetanus|tetanus
323015|NCT01767376|Meningococcal vaccines|meningococcal vaccines
323016|NCT01767376|Safety|safety
323017|NCT01767376|Neisseria meningitidis|neisseria meningitidis
323018|NCT01767376|Healthy|healthy
323019|NCT01767363|5-alpha reductase inhibitor|5-alpha reductase inhibitor
323020|NCT01767363|benign prostatic hyperplasia treatment|benign prostatic hyperplasia treatment
323021|NCT01767363|Prostate cancer mortality|prostate cancer mortality
323022|NCT01767350|Pediatric transplantation|pediatric transplantation
323023|NCT01767350|Pharmacogenetics|pharmacogenetics
323024|NCT01767350|Pharmacokinetics|pharmacokinetics
323025|NCT01767350|Calcineurin inhibitors|calcineurin inhibitors
323026|NCT01767350|CYP3A|cyp3a
323027|NCT01767350|Pgp|pgp
323028|NCT01767337|microneedle-based delivery|microneedle-based delivery
323029|NCT01767337|hollow microneedle|hollow microneedle
323030|NCT01767337|intracutaneous|intracutaneous
323031|NCT01767337|drug delivery|drug delivery
323032|NCT01767324|microneedle-based array|microneedle-based array
323033|NCT01767324|hollow microneedle|hollow microneedle
323034|NCT01767324|intracutaneous|intracutaneous
323035|NCT01767324|drug delivery|drug delivery
323036|NCT01767324|vaccine delivery|vaccine delivery
323037|NCT01767311|Alzheimer's Disease|alzheimer's disease
323038|NCT01767311|BAN2401|ban2401
323039|NCT01767298|Fixed dose combination|fixed dose combination
323040|NCT01767298|Pharmacokinetics|pharmacokinetics
323041|NCT01767298|Valsartan|valsartan
323042|NCT01767298|Hydrochlorothiazide|hydrochlorothiazide
323043|NCT01767285|Etonogestrel Implant|etonogestrel implant
323044|NCT01767285|Implanon|implanon
323045|NCT01767285|Nexplanon|nexplanon
323046|NCT01767285|Long Acting Reversible Contraception|long acting reversible contraception
323047|NCT01767272|Fexofenadine|fexofenadine
323048|NCT01767272|Pharmacokinetics|pharmacokinetics
323049|NCT01767272|Bioavailability|bioavailability
323050|NCT01767272|Linearity|linearity
323051|NCT01767272|HPLC|hplc
323052|NCT01767272|Dose proportionality of fexofenadine in Egyptian volunteers|dose proportionality of fexofenadine in egyptian volunteers
323053|NCT01767259|Fixed dose combination|fixed dose combination
323054|NCT01767259|Pharmacokinetics|pharmacokinetics
323055|NCT01767259|Valsartan|valsartan
323056|NCT01767259|Hydrochlorothiazide|hydrochlorothiazide
323057|NCT01767233|Acute necrotizing pancreatitis|acute necrotizing pancreatitis
323058|NCT01767233|ERCP|ercp
323059|NCT01767233|Pancreatic stenting|pancreatic stenting
323060|NCT01767220|ventricular tachycardia|ventricular tachycardia
323061|NCT01767220|endocardial ablation|endocardial ablation
323062|NCT01767220|epicardial ablation|epicardial ablation
323063|NCT01767181|Light therapy|light therapy
323064|NCT01767181|physical exercise|physical exercise
323065|NCT01767181|night shift workers|night shift workers
323066|NCT01767181|genetic markers|genetic markers
323067|NCT01767181|PBMCs|pbmcs
323068|NCT01767142|Lipolysis|lipolysis
323069|NCT01767142|Cryolipolysis|cryolipolysis
323070|NCT01767142|Fat Reduction|fat reduction
323071|NCT01767129|levodopa|levodopa
323072|NCT01767129|dyskinesia|dyskinesia
323073|NCT01767129|parkinson's disease|parkinson's disease
323074|NCT01767129|AVP-923|avp-923
323075|NCT01767129|dextromethorphan|dextromethorphan
323076|NCT01767129|quinidine|quinidine
323077|NCT01767116|Interferon-Free|interferon-free
323078|NCT01767116|Hepatitis C Genotype 1b|hepatitis c genotype 1b
323079|NCT01767116|Chronic Hepatitis C|chronic hepatitis c
323080|NCT01767116|Hepatitis C Virus|hepatitis c virus
323081|NCT01767116|Hepatitis C|hepatitis c
323082|NCT01767116|Treatment-Naive|treatment-naive
323083|NCT01767116|Paritaprevir|paritaprevir
323084|NCT01767116|Ombitasvir|ombitasvir
323085|NCT01767116|Dasabuvir|dasabuvir
323086|NCT01767116|Viekira PAK|viekira pak
323087|NCT01767116|Ribavirin|ribavirin
323088|NCT01767103|Hepatic Impairment|hepatic impairment
323089|NCT01767103|Liver Impairment|liver impairment
323090|NCT01767103|Liver Disease|liver disease
323091|NCT01767103|Ferriprox®|ferriprox®
323092|NCT01767103|LI|li
323093|NCT01767103|DFP|dfp
323094|NCT01767103|Deferiprone|deferiprone
323095|NCT01767090|Endometriosis|endometriosis
323096|NCT01767090|ASP1707|asp1707
323097|NCT01767090|Pelvic pain|pelvic pain
323098|NCT01767090|Double-blind|double-blind
323099|NCT01767090|Placebo-controlled|placebo-controlled
323100|NCT01767090|Phase 2|phase 2
323101|NCT01767077|Saturated fat|saturated fat
323102|NCT01767077|Dairy products|dairy products
323103|NCT01767077|Milk fat globule membrane|milk fat globule membrane
323104|NCT01767077|Cholesterol|cholesterol
323105|NCT01767077|Butter|butter
323106|NCT01767077|Cream|cream
323107|NCT01767064|ARIs, antibiotics, public commitment, quality improvement|aris, antibiotics, public commitment, quality improvement
323108|NCT01767051|PCOS|pcos
323109|NCT01767051|Children|children
323110|NCT01767051|Cardiovascular|cardiovascular
323111|NCT01767051|Follow-up|follow-up
323112|NCT01767025|Influence|influence
323113|NCT01767025|oxytocin|oxytocin
323114|NCT01767025|automatic imitation|automatic imitation
323115|NCT01767025|behaviour|behaviour
323116|NCT01767025|volunteers|volunteers
323117|NCT01766999|pulse oximetry|pulse oximetry
323118|NCT01766999|tumescent anesthesia|tumescent anesthesia
323119|NCT01766960|Bile acids|bile acids
323120|NCT01766960|Pharmacokinetics|pharmacokinetics
323121|NCT01766947|Glaucoma|glaucoma
323122|NCT01766947|Deep sclerectomy|deep sclerectomy
323123|NCT01766934|Peripheral blood progenitor cell mobilization|peripheral blood progenitor cell mobilization
323124|NCT01766934|allogenic hematopoetic stem cell transplantation|allogenic hematopoetic stem cell transplantation
323125|NCT01766934|recombinant human granulocyte colony stimulating factor|recombinant human granulocyte colony stimulating factor
323126|NCT01766934|filgrastim|filgrastim
323127|NCT01766921|Influenza, Pandemic, H5N1, Elderly adults|influenza, pandemic, h5n1, elderly adults
323128|NCT01766908|Timing of Umbilical Cord clamping|timing of umbilical cord clamping
323129|NCT01766908|Cord Clamp 20 seconds|cord clamp 20 seconds
323130|NCT01766908|Cord Clamp 40 seconds|cord clamp 40 seconds
323131|NCT01766908|Cord Clamp 60 seconds|cord clamp 60 seconds
323132|NCT01766895|uremia|uremia
323133|NCT01766895|HBV|hbv
323134|NCT01766895|HCV|hcv
323135|NCT01766895|seroclearance|seroclearance
323136|NCT01766882|Hemodialysis|hemodialysis
323137|NCT01766882|Blood Pressure|blood pressure
323138|NCT01766882|Hydration Status|hydration status
323139|NCT01766882|Low-sodium diet|low-sodium diet
323140|NCT01766869|Prostate Cancer|prostate cancer
323141|NCT01766869|MRI/MRS|mri/mrs
323142|NCT01766856|perforation|perforation
323143|NCT01766856|tympanoplasty|tympanoplasty
323144|NCT01766856|myringoplasty|myringoplasty
323145|NCT01766856|Eustachian tube function|eustachian tube function
323146|NCT01766856|tympanostomy tube|tympanostomy tube
323147|NCT01766817|IPF|ipf
323148|NCT01766804|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
323149|NCT01766804|Bovine Colostrum|bovine colostrum
323150|NCT01766804|Inflammation|inflammation
323151|NCT01766804|Infection|infection
323152|NCT01766804|Toxicity|toxicity
323153|NCT01766791|resistance exercise|resistance exercise
323154|NCT01766791|muscle mass|muscle mass
323155|NCT01766791|abdominal fat|abdominal fat
323156|NCT01766791|strength|strength
323157|NCT01766791|Coronary Heart Disease (CHD)-risk|coronary heart disease (chd)-risk
323158|NCT01766791|myocardial mass|myocardial mass
323159|NCT01766778|type-2 diabetes mellitus, inadequately controlled Metformin|type-2 diabetes mellitus, inadequately controlled metformin
323160|NCT01766739|GL-ONC1|gl-onc1
323161|NCT01766739|pleural effusion|pleural effusion
323162|NCT01766739|12-169|12-169
323163|NCT01766726|HIV|hiv
323164|NCT01766726|Atherosclerosis|atherosclerosis
323165|NCT01766700|Obesity, weight loss, weight maintenance|obesity, weight loss, weight maintenance
323166|NCT01766687|Chronic Kidney Disease|chronic kidney disease
323167|NCT01766687|estimated glomerular filtration rate|estimated glomerular filtration rate
323168|NCT01766687|water intake|water intake
323169|NCT01766687|fluid intake|fluid intake
323170|NCT01766687|renal decline|renal decline
323171|NCT01766674|Kyphosis|kyphosis
323172|NCT01766648|Distal|distal
323173|NCT01766648|Femur|femur
323174|NCT01766648|Locking|locking
323175|NCT01766648|Screw|screw
323176|NCT01766648|Fracture|fracture
323177|NCT01766648|Healing|healing
323178|NCT01766622|Apoptosis|apoptosis
323179|NCT01766622|Pro-Apoptotic Effects|pro-apoptotic effects
323180|NCT01766622|PET Imaging|pet imaging
323181|NCT01766622|TL32711|tl32711
323182|NCT01766622|Relapsed Platinum Resistant or Refractory Epithelial Ovarian Cancer|relapsed platinum resistant or refractory epithelial ovarian cancer
323183|NCT01766609|Vitiligo; Intralesional; Triamcinolone acetonide|vitiligo; intralesional; triamcinolone acetonide
323184|NCT01766596|Ophthalmology|ophthalmology
323185|NCT01766596|Age-related ocular pathologies|age-related ocular pathologies
323186|NCT01766583|Open label, 3 + 3 dose escalation study followed by an expansion phase.|open label, 3 + 3 dose escalation study followed by an expansion phase.
323187|NCT01766570|insulin sensitivity,|insulin sensitivity,
323188|NCT01766570|glucose tolerance,|glucose tolerance,
323189|NCT01766570|inflammatory markers,|inflammatory markers,
323190|NCT01766570|lipid profile,|lipid profile,
323191|NCT01766570|oxidative stress,|oxidative stress,
323192|NCT01766570|pancreatic β-cell function|pancreatic β-cell function
323193|NCT01766557|Polycystic ovarian syndrome, sex hormones, ovarian function, women, fish protein, insulin sensitivity, glucose tolerance, β-cell function, inflammation|polycystic ovarian syndrome, sex hormones, ovarian function, women, fish protein, insulin sensitivity, glucose tolerance, β-cell function, inflammation
323194|NCT01766544|asthma|asthma
323195|NCT01766544|COPD|copd
323196|NCT01766544|guidelines|guidelines
323197|NCT01766544|knowledge transfer|knowledge transfer
323198|NCT01766544|medical education|medical education
323199|NCT01766544|care gaps|care gaps
323200|NCT01766531|Bioelectrical impedance|bioelectrical impedance
323201|NCT01766531|Nutrition|nutrition
323202|NCT01766531|Phase angle|phase angle
323203|NCT01766531|ICU patients|icu patients
323204|NCT01766518|liver transplantation|liver transplantation
323205|NCT01766518|LT|lt
323206|NCT01766518|Mycophenolate mofetil|mycophenolate mofetil
323207|NCT01766518|MMF|mmf
323208|NCT01766505|hypertension, heart failure, candesartan, losartan|hypertension, heart failure, candesartan, losartan
323209|NCT01766492|prostate cancer|prostate cancer
323210|NCT01766492|CyberKnife|cyberknife
323211|NCT01766479|Colorectal cancer|colorectal cancer
323212|NCT01766479|colorectal neoplasia|colorectal neoplasia
323213|NCT01766479|CT colonography|ct colonography
323214|NCT01766479|advanced neoplasia|advanced neoplasia
323215|NCT01766479|colonoscopy|colonoscopy
323216|NCT01766479|family history|family history
323217|NCT01766453|South Asian|south asian
323218|NCT01766453|Cardiovascular|cardiovascular
323219|NCT01766453|Exercise|exercise
323220|NCT01766453|Obesity|obesity
323221|NCT01766453|Visceral Adipose Tissue|visceral adipose tissue
323222|NCT01766401|Generalized Anxiety Disorder|generalized anxiety disorder
323223|NCT01766401|GAD|gad
323224|NCT01766375|idarubicin|idarubicin
323225|NCT01766375|busulfan|busulfan
323226|NCT01766375|cyclophosphamide|cyclophosphamide
323227|NCT01766375|pretreatment|pretreatment
323228|NCT01766375|high-risk acute myeloid leukemia patient|high-risk acute myeloid leukemia patient
323229|NCT01766349|Esophageal cancer|esophageal cancer
323230|NCT01766349|Respiratory muscle strength|respiratory muscle strength
323231|NCT01766349|Pulmonary function testing|pulmonary function testing
323232|NCT01766349|Functional exercise capacity|functional exercise capacity
323233|NCT01766336|Agitation|agitation
323234|NCT01766336|Aggression|aggression
323235|NCT01766336|AD patients|ad patients
323236|NCT01766323|Morphine|morphine
323237|NCT01766323|Palliation|palliation
323238|NCT01766323|Cancer|cancer
323239|NCT01766323|Hospice|hospice
323240|NCT01766323|Sleepiness|sleepiness
323241|NCT01766323|Modafinil|modafinil
323242|NCT01766310|Folic acid|folic acid
323243|NCT01766310|Folate|folate
323244|NCT01766310|Homocysteine|homocysteine
323245|NCT01766310|Obese|obese
323246|NCT01766310|Children|children
323247|NCT01766297|Breast Cancer|breast cancer
323248|NCT01766297|Proton|proton
323249|NCT01766297|Radiation|radiation
323250|NCT01766284|Human Papillomavirus|human papillomavirus
323251|NCT01766284|Optical Coherence Tomography|optical coherence tomography
323252|NCT01766284|Imaging Systems|imaging systems
323253|NCT01766284|Cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
323254|NCT01766284|Cervical Cancer|cervical cancer
323255|NCT01766284|Cervical Dysplasia|cervical dysplasia
323256|NCT01766271|Coronary heart disease|coronary heart disease
323257|NCT01766271|cardiovascular disease|cardiovascular disease
323258|NCT01766271|risk|risk
323259|NCT01766258|Parkinson's Disease|parkinson's disease
323260|NCT01766258|Motor-fluctuation|motor-fluctuation
323261|NCT01766258|Wearing-off|wearing-off
323262|NCT01766245|mm|mm
323263|NCT01766206|conjugate vaccine|conjugate vaccine
323264|NCT01766206|phase IV clinical trial|phase iv clinical trial
323265|NCT01766206|Neisseria meningitidis|neisseria meningitidis
323266|NCT01766193|Delivery, obstetric|delivery, obstetric
323267|NCT01766193|Obstetric Surgical Procedures|obstetric surgical procedures
323268|NCT01766193|Vacuum Extraction, Obstetrical|vacuum extraction, obstetrical
323269|NCT01766193|Cesarean Section|cesarean section
323270|NCT01766193|Obstetrical Forceps|obstetrical forceps
323271|NCT01766193|Epidemiology|epidemiology
323272|NCT01766193|Norway|norway
323273|NCT01766180|Memory|memory
323274|NCT01766180|Fruitflow|fruitflow
323275|NCT01766180|Resveratrol (resVida)|resveratrol (resvida)
323276|NCT01766180|Cerebral blood flow|cerebral blood flow
323277|NCT01766180|Cardiopulmonary exercise test|cardiopulmonary exercise test
323278|NCT01766180|Maximal VO2|maximal vo2
323279|NCT01766167|Genotype 2|genotype 2
323280|NCT01766154|tirofiban|tirofiban
323281|NCT01766154|pharmacokinetic|pharmacokinetic
323282|NCT01766154|renal insufficiency|renal insufficiency
323283|NCT01766154|Phase 1|phase 1
323284|NCT01766154|pharmacodynamic|pharmacodynamic
323285|NCT01766141|Spinal manipulation|spinal manipulation
323286|NCT01766141|Tumor necrosis factor|tumor necrosis factor
324261|NCT01761630|Asthma|asthma
323287|NCT01766141|Interleukin 1|interleukin 1
323288|NCT01766141|Interleukin 10|interleukin 10
323289|NCT01766141|Inflammatory cytokines|inflammatory cytokines
323290|NCT01766128|Parkinson disease|parkinson disease
323291|NCT01766128|Early stage|early stage
323292|NCT01766128|Zonisamide|zonisamide
323293|NCT01766128|UPDRS|updrs
323294|NCT01766115|HCV|hcv
323295|NCT01766115|needlestick|needlestick
323296|NCT01766115|occupational|occupational
323297|NCT01766115|transmission|transmission
323298|NCT01766115|health care worker|health care worker
323299|NCT01766115|telaprevir|telaprevir
323300|NCT01766102|Mammography|mammography
323301|NCT01766089|Caesarean delivery|caesarean delivery
323302|NCT01766089|severe pre-eclampsia|severe pre-eclampsia
323303|NCT01766089|remifentanil|remifentanil
323304|NCT01766089|dexmedetomidine|dexmedetomidine
323305|NCT01766089|cardiovascular response|cardiovascular response
323306|NCT01766076|immune activation|immune activation
323307|NCT01766076|antiretroviral therapy|antiretroviral therapy
323308|NCT01766076|atorvastatin|atorvastatin
323309|NCT01766076|immune exhaustion|immune exhaustion
323310|NCT01766076|adults|adults
323311|NCT01766076|Africa|africa
323312|NCT01766063|Multiple Sclerosis|multiple sclerosis
323313|NCT01766063|Sleep|sleep
323314|NCT01766063|Quality of life|quality of life
323315|NCT01766063|Observational study|observational study
323316|NCT01766037|obesity|obesity
323317|NCT01766037|obese|obese
323318|NCT01766037|weight loss|weight loss
323319|NCT01766024|interferon beta-1a|interferon beta-1a
323320|NCT01766024|pharmacokinetics|pharmacokinetics
323321|NCT01766024|pharmacodynamics|pharmacodynamics
323322|NCT01766024|volunteers|volunteers
323323|NCT01765998|Crohn's disease, endothelial progenitor cells, probiotic|crohn's disease, endothelial progenitor cells, probiotic
323324|NCT01765985|palmoplantar|palmoplantar
323325|NCT01765959|Insomnia|insomnia
323326|NCT01765959|Auricular acupuncture|auricular acupuncture
323327|NCT01765959|CBT|cbt
323328|NCT01765946|Insulin resistance|insulin resistance
323329|NCT01765946|Prediabetes|prediabetes
323330|NCT01765946|Longevity genes|longevity genes
323331|NCT01765946|Inflammation|inflammation
323332|NCT01765946|Metformin|metformin
323333|NCT01765933|1,3-dimethylamylamine|1,3-dimethylamylamine
323334|NCT01765894|glucose homeostasis|glucose homeostasis
323335|NCT01765894|endogenous glucose production|endogenous glucose production
323336|NCT01765894|moderate exercise|moderate exercise
323337|NCT01765894|type 2 diabetes|type 2 diabetes
323338|NCT01765894|metformin|metformin
323339|NCT01765881|Induction of labor|induction of labor
323340|NCT01765881|cervical ripening|cervical ripening
323341|NCT01765881|misoprostol,|misoprostol,
323342|NCT01765881|prostaglandin|prostaglandin
323343|NCT01765881|cost-effectiveness|cost-effectiveness
323344|NCT01765868|Betrixaban|betrixaban
323345|NCT01765868|Healthy|healthy
323346|NCT01765868|Bioavailability|bioavailability
323347|NCT01765855|Betrixaban|betrixaban
323348|NCT01765855|Healthy|healthy
323349|NCT01765855|Mass Balance|mass balance
323350|NCT01765842|Lupus Nephritis|lupus nephritis
323351|NCT01765842|remission|remission
323352|NCT01765842|immunosuppressive treatment|immunosuppressive treatment
323353|NCT01765829|Non Affective Psychosis|non affective psychosis
323354|NCT01765829|First episode|first episode
323355|NCT01765829|Discontinuation scheme|discontinuation scheme
323356|NCT01765816|Exercise|exercise
323357|NCT01765816|Elderly|elderly
323358|NCT01765816|Blood volume|blood volume
323359|NCT01765816|Hemoglobin|hemoglobin
323360|NCT01765803|Mellaril|mellaril
323361|NCT01765803|Thioridazine|thioridazine
323362|NCT01765803|CD34+|cd34+
323363|NCT01765803|Stem cells|stem cells
323364|NCT01765803|Progenitor cells|progenitor cells
323365|NCT01765803|Peripheral blood|peripheral blood
323366|NCT01765803|mobilization|mobilization
323367|NCT01765803|circulation|circulation
323368|NCT01765777|Low back pain|low back pain
323369|NCT01765777|Lower back pain|lower back pain
323370|NCT01765777|Chronic back pain|chronic back pain
323371|NCT01765751|Cervical pain|cervical pain
323372|NCT01765751|Neck pain|neck pain
323373|NCT01765751|Arm pain|arm pain
323374|NCT01765738|PICC|picc
323375|NCT01765725|Chronic Fatigue Syndrome|chronic fatigue syndrome
323376|NCT01765725|Coping|coping
323377|NCT01765725|Patient education|patient education
323378|NCT01765712|PRP|prp
323379|NCT01765712|BPTB|bptb
323380|NCT01765712|VAS|vas
323381|NCT01765712|Anterior Knee Pain|anterior knee pain
323382|NCT01765673|Swallowing|swallowing
323383|NCT01765673|Stroke|stroke
323384|NCT01765673|Sensory stimulation|sensory stimulation
323385|NCT01765673|Home based therapy|home based therapy
323386|NCT01765673|Head and Neck Cancer|head and neck cancer
323387|NCT01765660|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
323388|NCT01765660|Mesenchymal Stem Cells|mesenchymal stem cells
323389|NCT01765660|Chronic Graft-versus-host disease|chronic graft-versus-host disease
323390|NCT01765647|Celiac disease|celiac disease
323391|NCT01765647|AGY|agy
323486|NCT01765166|Social Skill Training|social skill training
323392|NCT01765634|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
323393|NCT01765634|Mesenchymal Stem Cells|mesenchymal stem cells
323394|NCT01765634|Acute Graft-versus-host disease|acute graft-versus-host disease
323395|NCT01765621|health care expenditure|health care expenditure
323396|NCT01765621|drug drug interactions|drug drug interactions
323397|NCT01765621|electronic decision support systems|electronic decision support systems
323398|NCT01765621|pharmacogenetics|pharmacogenetics
323399|NCT01765621|Potential Reduction|potential reduction
323400|NCT01765608|Zonisamide|zonisamide
323401|NCT01765608|Zonegran|zonegran
323402|NCT01765608|Obstructive Sleep apnea|obstructive sleep apnea
323403|NCT01765608|Apnea|apnea
323404|NCT01765608|Respiration Disorders|respiration disorders
323405|NCT01765608|Sleep Disorders|sleep disorders
323406|NCT01765608|Obesity|obesity
323407|NCT01765608|Anti-Obesity Agents|anti-obesity agents
323408|NCT01765608|Carbonic Anhydrase|carbonic anhydrase
323409|NCT01765608|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors
323410|NCT01765608|Enzyme Inhibitors|enzyme inhibitors
323411|NCT01765608|Sulfonamides|sulfonamides
323412|NCT01765608|Therapeutic Uses|therapeutic uses
323413|NCT01765608|Pharmacologic Actions|pharmacologic actions
323414|NCT01765595|health care expenditure|health care expenditure
323415|NCT01765595|drug drug interactions|drug drug interactions
323416|NCT01765595|electronic decision support systems|electronic decision support systems
323417|NCT01765595|Potential reduction|potential reduction
323418|NCT01765530|Medical Devices|medical devices
323419|NCT01765530|Ventilator-Associated Pneumonia (VAP)|ventilator-associated pneumonia (vap)
323420|NCT01765530|Ventilator-Associated Events (VAE)|ventilator-associated events (vae)
323421|NCT01765530|Endotracheal Tube|endotracheal tube
323422|NCT01765530|Microbial Diversity|microbial diversity
323423|NCT01765530|Anti-Resistance|anti-resistance
323424|NCT01765530|Computed Tomography (CT)|computed tomography (ct)
323425|NCT01765517|Diabetes Mellitus|diabetes mellitus
323426|NCT01765504|Cardiac surgery; near infrared spectroscopy|cardiac surgery; near infrared spectroscopy
323427|NCT01765491|colonoscopy|colonoscopy
323428|NCT01765491|bowel preparation|bowel preparation
323429|NCT01765491|polyethylene glycol|polyethylene glycol
323430|NCT01765478|Rheumatoid Arthritis|rheumatoid arthritis
323431|NCT01765465|postcholecystectomy syndrome|postcholecystectomy syndrome
323432|NCT01765465|laparoscopic cholecystectomy|laparoscopic cholecystectomy
323433|NCT01765465|Rowachol|rowachol
323434|NCT01765439|bile acids|bile acids
323435|NCT01765439|metabolism|metabolism
323436|NCT01765439|probiotics|probiotics
323437|NCT01765426|Prophylactic vaccination|prophylactic vaccination
323438|NCT01765413|To identify|to identify
323439|NCT01765413|biomarkers|biomarkers
323440|NCT01765413|of vaccine safety|of vaccine safety
323441|NCT01765413|Volunteers|volunteers
323442|NCT01765400|Heart failure|heart failure
323443|NCT01765400|Antiplatelet therapy|antiplatelet therapy
323444|NCT01765400|Platelet aggregation|platelet aggregation
323445|NCT01765400|Clopidogrel|clopidogrel
323446|NCT01765400|Prasugrel|prasugrel
323447|NCT01765387|Spatherpy|spatherpy
323448|NCT01765387|Aerobic exercise|aerobic exercise
323449|NCT01765374|rituximab|rituximab
323450|NCT01765374|sonography|sonography
323451|NCT01765374|clinical response|clinical response
323452|NCT01765348|language impairment|language impairment
323453|NCT01765348|language disorders|language disorders
323454|NCT01765348|syntax treatment|syntax treatment
323455|NCT01765348|narrative-based treatment|narrative-based treatment
323456|NCT01765335|heart failure, BNP, NICaS system, readmition|heart failure, bnp, nicas system, readmition
323457|NCT01765309|Tissue expanders|tissue expanders
323458|NCT01765309|Botulinum toxin|botulinum toxin
323459|NCT01765309|Botox|botox
323460|NCT01765283|CN,|cn,
323461|NCT01765283|UCD|ucd
323462|NCT01765270|Diabetes|diabetes
323463|NCT01765270|Diabetes Mellitus|diabetes mellitus
323464|NCT01765270|Type 2 Diabetes|type 2 diabetes
323465|NCT01765270|Cardiovascular Disease|cardiovascular disease
323466|NCT01765270|Coronary Artery Bypass Surgery|coronary artery bypass surgery
323467|NCT01765257|Drug-naïve patients with Parkinson's disease|drug-naïve patients with parkinson's disease
323468|NCT01765257|Apathy|apathy
323469|NCT01765257|Rasagiline|rasagiline
323470|NCT01765244|Corneal trophic ulcers, limbal deficiency, cornea blindness|corneal trophic ulcers, limbal deficiency, cornea blindness
323471|NCT01765231|Lymphoma|lymphoma
323472|NCT01765231|Hepatitis B virus|hepatitis b virus
323473|NCT01765231|Therapeutic Uses|therapeutic uses
323474|NCT01765231|Antiviral Agents|antiviral agents
323475|NCT01765218|Hypoxic ischemic encephalopathy|hypoxic ischemic encephalopathy
323476|NCT01765218|HIE|hie
323477|NCT01765218|Perinatal depression|perinatal depression
323478|NCT01765218|Whole body cooling|whole body cooling
323479|NCT01765218|Therapeutic hypothermia|therapeutic hypothermia
323480|NCT01765205|congenital cardiovascular malformation|congenital cardiovascular malformation
323481|NCT01765205|newborn|newborn
323482|NCT01765192|Drug therapy|drug therapy
323483|NCT01765179|testosterone|testosterone
323484|NCT01765179|male hypogonadism|male hypogonadism
323485|NCT01765179|low testosterone|low testosterone
323773|NCT01763853|Crystalloid|crystalloid
323487|NCT01765166|Social Interaction|social interaction
323488|NCT01765166|Peer relations|peer relations
323489|NCT01765153|physical therapy|physical therapy
323490|NCT01765153|rehabilitation|rehabilitation
323491|NCT01765153|neuroplasticity|neuroplasticity
323492|NCT01765140|3,4 diaminopyridine (DAP)|3,4 diaminopyridine (dap)
323493|NCT01765101|knee osteoarthritis|knee osteoarthritis
323494|NCT01765101|therapeutic effect|therapeutic effect
323495|NCT01765101|insole|insole
323496|NCT01765088|High-grade glioma|high-grade glioma
323497|NCT01765088|chemotherapy|chemotherapy
323498|NCT01765088|Temozolomide|temozolomide
323499|NCT01765088|Interferon-alpha|interferon-alpha
323500|NCT01765075|Electrophysiological mapping|electrophysiological mapping
323501|NCT01765075|Multi-electrode catheter|multi-electrode catheter
323502|NCT01765062|Rapid maxillary expansion|rapid maxillary expansion
323503|NCT01765062|Cross bite|cross bite
323504|NCT01765062|Haas appliance|haas appliance
323505|NCT01765062|Lateral cephalograms|lateral cephalograms
323506|NCT01765049|breast density change|breast density change
323507|NCT01765049|endocrine therapy response|endocrine therapy response
323508|NCT01765049|aromatase inhibitor|aromatase inhibitor
323509|NCT01765036|contrast-enhanced endoscopic ultrasound|contrast-enhanced endoscopic ultrasound
323510|NCT01765036|pancreatic adenocarcinoma|pancreatic adenocarcinoma
323511|NCT01765010|Vitamin D|vitamin d
323512|NCT01765010|Serum sclerostin|serum sclerostin
323513|NCT01765010|Serum dickkopf1|serum dickkopf1
323514|NCT01764984|total knee arthroplasty|total knee arthroplasty
323515|NCT01764984|trabecular metal|trabecular metal
323516|NCT01764984|bone mineral density|bone mineral density
323517|NCT01764971|Chronic ITP, Cerebral dysfunction|chronic itp, cerebral dysfunction
323518|NCT01764958|mother-infant interaction|mother-infant interaction
323519|NCT01764958|general movements|general movements
323520|NCT01764958|preterm infants|preterm infants
323521|NCT01764893|Overactive Bladder|overactive bladder
323522|NCT01764880|Heparanase inhibitor|heparanase inhibitor
323523|NCT01764880|Multiple myeloma|multiple myeloma
323524|NCT01764867|major depressive disorder|major depressive disorder
323525|NCT01764867|algorithm guided treatment|algorithm guided treatment
323526|NCT01764867|treatment as usual|treatment as usual
323527|NCT01764867|escitalopram|escitalopram
323528|NCT01764867|mirtazapine|mirtazapine
323529|NCT01764867|transcranial magnetic stimulation (rTMS)|transcranial magnetic stimulation (rtms)
323530|NCT01764867|modified electroconvulsive therapy (mECT)|modified electroconvulsive therapy (mect)
323531|NCT01764867|remission|remission
323532|NCT01764867|relapse|relapse
323533|NCT01764867|quality of life|quality of life
323534|NCT01764854|Hemodialysis|hemodialysis
323535|NCT01764841|Ciprofloxacin|ciprofloxacin
323536|NCT01764841|Dry Powder for Inhalation|dry powder for inhalation
323537|NCT01764841|Exacerbation|exacerbation
323538|NCT01764841|Bronchiectasis|bronchiectasis
323539|NCT01764828|Phase I|phase i
323540|NCT01764828|Pharmacokinetics|pharmacokinetics
323541|NCT01764828|Safety measurements|safety measurements
323542|NCT01764802|Psychosexual Intervention|psychosexual intervention
323543|NCT01764802|Cancer|cancer
323544|NCT01764802|Gynecologic Cancer|gynecologic cancer
323545|NCT01764802|Breast Cancer|breast cancer
323546|NCT01764789|psychological intervention|psychological intervention
323547|NCT01764789|breast cancer|breast cancer
323548|NCT01764789|gynecologic cancer|gynecologic cancer
323549|NCT01764776|LDE225|lde225
323550|NCT01764776|Pharmacokinetics|pharmacokinetics
323551|NCT01764776|PK|pk
323552|NCT01764776|Postmenopausal women|postmenopausal women
323553|NCT01764776|normal hepatic function|normal hepatic function
323554|NCT01764776|mild hepatic impairment|mild hepatic impairment
323555|NCT01764776|moderate hepatic impairment|moderate hepatic impairment
323556|NCT01764776|severe hepatic impairment|severe hepatic impairment
323557|NCT01764750|Intrasite|intrasite
323558|NCT01764750|Antibiotic|antibiotic
323559|NCT01764750|Vancomycin|vancomycin
323560|NCT01764750|Infection|infection
323561|NCT01764750|Pharmacokinetics|pharmacokinetics
323562|NCT01764737|VX15/2503|vx15/2503
323563|NCT01764737|Semaphorin 4D|semaphorin 4d
323564|NCT01764737|SEMA4D|sema4d
323565|NCT01764737|CD100|cd100
323566|NCT01764737|safety|safety
323567|NCT01764737|tolerability|tolerability
323568|NCT01764737|pharmacokinetics|pharmacokinetics
323569|NCT01764737|immunogenicity|immunogenicity
323570|NCT01764737|multiple sclerosis|multiple sclerosis
323571|NCT01764737|monoclonal antibody|monoclonal antibody
323572|NCT01764724|Attitudes and understanding of sodium claims|attitudes and understanding of sodium claims
323573|NCT01764724|General canadian population|general canadian population
323574|NCT01764711|POTS|pots
323575|NCT01764698|anxiety disorders|anxiety disorders
323576|NCT01764698|substance use disorders|substance use disorders
323577|NCT01764698|treatment effectiveness|treatment effectiveness
323578|NCT01764698|cognitive behavioral therapy|cognitive behavioral therapy
323579|NCT01764672|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
323580|NCT01764672|Healthy Adults|healthy adults
323581|NCT01764672|Methylphenidate|methylphenidate
323582|NCT01764672|Functional connectivity|functional connectivity
323583|NCT01764672|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
323584|NCT01764659|4D-CT|4d-ct
323585|NCT01764659|Contrast Enhanced CT|contrast enhanced ct
323586|NCT01764659|Radiotherapy Simulation|radiotherapy simulation
323587|NCT01764646|Prostate cancer|prostate cancer
323588|NCT01764646|Radiation therapy|radiation therapy
323589|NCT01764633|High cholesterol|high cholesterol
323590|NCT01764633|Treatment for high cholesterol|treatment for high cholesterol
323591|NCT01764633|Lowering cholesterol|lowering cholesterol
323592|NCT01764633|Lowering high cholesterol|lowering high cholesterol
323593|NCT01764633|Hypercholesterolemia|hypercholesterolemia
323594|NCT01764620|shoulder|shoulder
323595|NCT01764620|muscle fatigue|muscle fatigue
323596|NCT01764620|kinematics|kinematics
323597|NCT01764620|athletes|athletes
323598|NCT01764607|Squamous|squamous
323599|NCT01764607|Renal|renal
323600|NCT01764607|Transplant|transplant
323601|NCT01764594|Lupus|lupus
323602|NCT01764594|SLE|sle
323603|NCT01764581|immune monitoring|immune monitoring
323604|NCT01764581|immune cell function ImmuKnow|immune cell function immuknow
323605|NCT01764581|randomized controlled trial|randomized controlled trial
323606|NCT01764581|immunosuppression management|immunosuppression management
323607|NCT01764581|infection|infection
323608|NCT01764581|rejection|rejection
323609|NCT01764581|liver transplantation|liver transplantation
323610|NCT01764581|Cylex|cylex
323611|NCT01764568|Metacognitive training|metacognitive training
323612|NCT01764568|Cognitive behavioral therapy|cognitive behavioral therapy
323613|NCT01764568|Clinical trial|clinical trial
323614|NCT01764568|Group intervention|group intervention
323615|NCT01764568|Group therapy|group therapy
323616|NCT01764568|Schizophrenia|schizophrenia
323617|NCT01764568|Psychosis|psychosis
323618|NCT01764568|Cognitive remediation|cognitive remediation
323619|NCT01764542|Ulcerative colitis|ulcerative colitis
323620|NCT01764542|dysplasia|dysplasia
323621|NCT01764542|risk factor|risk factor
323622|NCT01764542|surgery|surgery
323623|NCT01764516|zinc|zinc
323624|NCT01764516|selenium|selenium
323625|NCT01764516|serum|serum
323626|NCT01764516|epilepsy|epilepsy
323627|NCT01764516|antioxidants|antioxidants
323628|NCT01764503|ampullary tumors|ampullary tumors
323629|NCT01764503|endoscopic treatment|endoscopic treatment
323752|NCT01763892|TBI|tbi
323753|NCT01763892|Apolipoprotein E|apolipoprotein e
323754|NCT01763892|apo-E|apo-e
323630|NCT01764490|Bloodstream infections caused by multidrug-resistant Enterobacteriaceae, extended-spectrum β-lactamase-producers, carbapenemase-producing organisms|bloodstream infections caused by multidrug-resistant enterobacteriaceae, extended-spectrum β-lactamase-producers, carbapenemase-producing organisms
323631|NCT01764464|post laminectomy pain syndrome, failed back surgery syndrome|post laminectomy pain syndrome, failed back surgery syndrome
323632|NCT01764451|Hispanic|hispanic
323633|NCT01764425|P7435|p7435
323634|NCT01764425|Healthy,overweight and or obese subjects|healthy,overweight and or obese subjects
323635|NCT01764425|Single ascending dose|single ascending dose
323636|NCT01764425|Multiple ascending dose|multiple ascending dose
323637|NCT01764425|Pharmacokinetics|pharmacokinetics
323638|NCT01764412|Healthy women|healthy women
323639|NCT01764412|Menstrual cycle|menstrual cycle
323640|NCT01764412|Hepcidin|hepcidin
323641|NCT01764412|Seric iron|seric iron
323642|NCT01764399|cardiovascular risk factors|cardiovascular risk factors
323643|NCT01764386|obesity, overweight|obesity, overweight
323644|NCT01764373|Pain|pain
323645|NCT01764373|Fitness|fitness
323646|NCT01764373|Diabetes|diabetes
323647|NCT01764373|Aerobic Exercise|aerobic exercise
323648|NCT01764334|NonST elevation myocardial infarction (NSTEMI)|nonst elevation myocardial infarction (nstemi)
323649|NCT01764334|Fractional flow reserve (FFR)|fractional flow reserve (ffr)
323650|NCT01764334|Coronary angiogram|coronary angiogram
323651|NCT01764334|Diagnosis|diagnosis
323652|NCT01764334|Coronary revascularization|coronary revascularization
323653|NCT01764334|Prognosis|prognosis
323654|NCT01764334|Health economics|health economics
323655|NCT01764321|Certolizumab Pegol|certolizumab pegol
323656|NCT01764321|Cimzia®|cimzia®
323657|NCT01764321|TNF inhibitor|tnf inhibitor
323658|NCT01764321|DMARD|dmard
323659|NCT01764321|Rheumatoid Arthritis|rheumatoid arthritis
323660|NCT01764308|acne; omega-3; isotretinoin; placebo|acne; omega-3; isotretinoin; placebo
323661|NCT01764282|HIV|hiv
323662|NCT01764282|serodiscordant couples HIV sero-conversion|serodiscordant couples hiv sero-conversion
323663|NCT01764282|anti-retroviral therapy|anti-retroviral therapy
323664|NCT01764282|intervention|intervention
323665|NCT01764256|rotavirus|rotavirus
323666|NCT01764256|vaccine|vaccine
323667|NCT01764243|Alzheimer's Disease|alzheimer's disease
323668|NCT01764243|Nicotinic Acetylcholine Receptor Agonist|nicotinic acetylcholine receptor agonist
323669|NCT01764243|Cognitive function|cognitive function
323670|NCT01764243|Dementia|dementia
323671|NCT01764243|Central Nervous System Agents|central nervous system agents
323672|NCT01764230|Hodgkin lymphoma|hodgkin lymphoma
323673|NCT01764230|Hodgkin disease|hodgkin disease
323674|NCT01764217|Cervix Cancer|cervix cancer
323675|NCT01764217|SUV|suv
323676|NCT01764217|Radiotherapy|radiotherapy
323677|NCT01764217|Outcome Prediction|outcome prediction
323678|NCT01764217|Imaging|imaging
323679|NCT01764217|PET|pet
323680|NCT01764178|Pitavastatin|pitavastatin
323681|NCT01764178|Valsartan|valsartan
323682|NCT01764165|COPD|copd
323683|NCT01764165|Sleep|sleep
323684|NCT01764165|Supplemental oxygen|supplemental oxygen
323685|NCT01764165|Breathing mechanics|breathing mechanics
323686|NCT01764165|nasal insufflation|nasal insufflation
323687|NCT01764152|Prevention,|prevention,
323688|NCT01764152|influenza,|influenza,
323689|NCT01764152|adults hospitalized,|adults hospitalized,
323690|NCT01764152|vaccines,|vaccines,
323691|NCT01764152|Effectiveness|effectiveness
323692|NCT01764139|Minimal knee changes|minimal knee changes
323693|NCT01764126|Safety|safety
323694|NCT01764126|immunogenicity|immunogenicity
323695|NCT01764126|pneumococcal|pneumococcal
323696|NCT01764126|protein|protein
323697|NCT01764126|vaccine|vaccine
323698|NCT01764113|Obesity|obesity
323699|NCT01764113|Adolescence|adolescence
323700|NCT01764113|Mindful Eating|mindful eating
323701|NCT01764087|Stomach Neoplasms|stomach neoplasms
323702|NCT01764087|Breast Neoplasms|breast neoplasms
323703|NCT01764087|Carcinoma|carcinoma
323704|NCT01764087|Neoplasms|neoplasms
323705|NCT01764087|Paclitaxel|paclitaxel
323706|NCT01764087|Tubulin Modulators|tubulin modulators
323707|NCT01764087|Antimitotic Agents|antimitotic agents
323708|NCT01764087|Protein Kinase Inhibitors|protein kinase inhibitors
323709|NCT01764087|Enzyme Inhibitors|enzyme inhibitors
323710|NCT01764087|Pharmacologic Actions|pharmacologic actions
323711|NCT01764074|Bipolar Disorder|bipolar disorder
323712|NCT01764074|Sleep Intervention|sleep intervention
323713|NCT01764074|Suicide|suicide
323714|NCT01764074|Cognitive Behavioral Therapy|cognitive behavioral therapy
323715|NCT01764074|Sleep Quality|sleep quality
323716|NCT01764061|Red Cells|red cells
323717|NCT01764061|Blood donors|blood donors
323718|NCT01764048|pain management|pain management
323719|NCT01764048|cesarean section|cesarean section
323720|NCT01764035|Psychotherapy|psychotherapy
323721|NCT01764035|Bipolar Disorder|bipolar disorder
323722|NCT01764035|Sleep Problems|sleep problems
323723|NCT01764035|Insomnia|insomnia
323724|NCT01764035|Hypersomnia|hypersomnia
323725|NCT01764035|Mindfulness|mindfulness
323726|NCT01764035|Meditation|meditation
323727|NCT01764035|Sleep Disturbance|sleep disturbance
323728|NCT01764022|breast cancer|breast cancer
323729|NCT01764022|trastuzumab|trastuzumab
323730|NCT01764009|Advanced Melanoma|advanced melanoma
323731|NCT01764009|Metastatic Melanoma|metastatic melanoma
323732|NCT01764009|Melanoma Stage III and IV|melanoma stage iii and iv
323733|NCT01763996|Drug therapy|drug therapy
323734|NCT01763983|Multiple Sclerosis|multiple sclerosis
323735|NCT01763983|Stress, Psychological|stress, psychological
323736|NCT01763983|Psychological Stress|psychological stress
323737|NCT01763983|Emotional Stress|emotional stress
323738|NCT01763983|Cognitive Deficits|cognitive deficits
323739|NCT01763983|Cognitive Dysfunction|cognitive dysfunction
323740|NCT01763970|Stereotactic|stereotactic
323741|NCT01763970|Radiotherapy|radiotherapy
323742|NCT01763970|Hypofractionated|hypofractionated
323743|NCT01763944|diet|diet
323744|NCT01763944|prostate cancer|prostate cancer
323745|NCT01763944|carbohydrate|carbohydrate
323746|NCT01763944|lifestyle|lifestyle
323747|NCT01763931|Digoxin|digoxin
323748|NCT01763918|High cholesterol, Treatment for high cholesterol, Lowering cholesterol, Lowering high cholesterol, Hypercholesterolemia|high cholesterol, treatment for high cholesterol, lowering cholesterol, lowering high cholesterol, hypercholesterolemia
323749|NCT01763905|High Cholesterol, Treatment for high cholesterol, Lowering cholesterol, Lowering high cholesterol, Hypercholesterolemia|high cholesterol, treatment for high cholesterol, lowering cholesterol, lowering high cholesterol, hypercholesterolemia
323750|NCT01763892|Pediatric|pediatric
323751|NCT01763892|Traumatic Brain Injury|traumatic brain injury
323755|NCT01763892|Vasospasm|vasospasm
323756|NCT01763892|Genetics|genetics
323757|NCT01763892|Physiologic Mechanisms|physiologic mechanisms
323758|NCT01763892|Neurocognitive Outcomes|neurocognitive outcomes
323759|NCT01763892|Endothelin 1|endothelin 1
323760|NCT01763879|Thoracic surgery|thoracic surgery
323761|NCT01763879|one lung ventilation|one lung ventilation
323762|NCT01763879|pressure-controlled ventilation|pressure-controlled ventilation
323763|NCT01763879|volume-controlled ventilation|volume-controlled ventilation
323764|NCT01763879|right ventricular function|right ventricular function
323765|NCT01763866|High cholesterol, Treatment for high cholesterol, Lowering cholesterol, Lowering high cholesterol, Hypercholesterolemia|high cholesterol, treatment for high cholesterol, lowering cholesterol, lowering high cholesterol, hypercholesterolemia
323766|NCT01763853|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
323767|NCT01763853|Pulmonary edema|pulmonary edema
323768|NCT01763853|Alveolar fluid clearance|alveolar fluid clearance
323769|NCT01763853|Alveolar epithelial dysfunction|alveolar epithelial dysfunction
323770|NCT01763853|Receptor for advanced glycation end-products (RAGE)|receptor for advanced glycation end-products (rage)
323771|NCT01763853|Fluid resuscitation therapy|fluid resuscitation therapy
323772|NCT01763853|Hypovolemia|hypovolemia
323774|NCT01763853|Hydroxyethyl Starch|hydroxyethyl starch
323775|NCT01763853|Intensive care unit|intensive care unit
323776|NCT01763840|Pediatric Abdominal Trauma Ultrasound Contrast|pediatric abdominal trauma ultrasound contrast
323777|NCT01763827|High cholesterol, Treatment for high cholesterol, Lowering cholesterol, Lowering high cholesterol, Hypercholesterolemia|high cholesterol, treatment for high cholesterol, lowering cholesterol, lowering high cholesterol, hypercholesterolemia
323778|NCT01763801|chemo port|chemo port
323779|NCT01763801|intravenous electrocardiographic guidance|intravenous electrocardiographic guidance
323780|NCT01763801|P maximal wave|p maximal wave
323781|NCT01763801|P submaximal wave|p submaximal wave
323782|NCT01763801|catheter tip|catheter tip
323783|NCT01763775|weight|weight
323784|NCT01763775|total body water|total body water
323785|NCT01763775|body fat|body fat
323786|NCT01763775|muscle mass|muscle mass
323787|NCT01763775|bone mass|bone mass
323788|NCT01763762|Electrical pudendal nerve stimulation|electrical pudendal nerve stimulation
323789|NCT01763762|Pelvic floor muscle training|pelvic floor muscle training
323790|NCT01763762|Transvaginal electrical stimulation|transvaginal electrical stimulation
323791|NCT01763762|Stress urinary incontinence|stress urinary incontinence
323792|NCT01763762|Comparative study|comparative study
323793|NCT01763723|Intense pulsed light,|intense pulsed light,
323794|NCT01763723|UV-exposure,|uv-exposure,
323795|NCT01763723|skin type,|skin type,
323796|NCT01763723|safety,|safety,
323797|NCT01763723|pigment,|pigment,
323798|NCT01763723|home-use|home-use
323799|NCT01763723|subjects|subjects
323800|NCT01763710|Breast cancer|breast cancer
323801|NCT01763710|Neurotoxicity|neurotoxicity
323802|NCT01763697|Taste acuity|taste acuity
323803|NCT01763697|Feeding behavior|feeding behavior
323804|NCT01763697|opioid|opioid
323805|NCT01763697|Quantitative assessment|quantitative assessment
323806|NCT01763684|Osteoarthritis|osteoarthritis
323807|NCT01763684|Osteoarthritis, Knee|osteoarthritis, knee
323808|NCT01763684|Osteonecrosis|osteonecrosis
323809|NCT01763684|Arthritis|arthritis
323810|NCT01763684|Knee Arthritis|knee arthritis
323811|NCT01763684|Knee Replacement|knee replacement
323812|NCT01763671|Lung cancer|lung cancer
323813|NCT01763671|Paclitaxel bevacizumab|paclitaxel bevacizumab
323814|NCT01763658|ITP, antioxidant therapy, oxidant status|itp, antioxidant therapy, oxidant status
323815|NCT01763645|NSCLC|nsclc
323816|NCT01763645|bevacizumab|bevacizumab
323817|NCT01763645|pharmacokinetics|pharmacokinetics
323818|NCT01763632|Hyperbilirubinemia|hyperbilirubinemia
323819|NCT01763632|Neonatal|neonatal
323820|NCT01763632|Transcutaneous Bilirubin|transcutaneous bilirubin
323821|NCT01763619|Cervical DDD|cervical ddd
323822|NCT01763619|DDD|ddd
323823|NCT01763619|degenerative disc disease|degenerative disc disease
323824|NCT01763619|C3-C7|c3-c7
323825|NCT01763606|Enoxaparin|enoxaparin
323826|NCT01763606|Aspirin|aspirin
323827|NCT01763606|stroke|stroke
323828|NCT01763606|12-264|12-264
323829|NCT01763593|Patients having cataract|patients having cataract
323830|NCT01763580|Glomerulonephritis|glomerulonephritis
323831|NCT01763580|Tacrolimus|tacrolimus
323832|NCT01763580|Nephrotic syndrome|nephrotic syndrome
323833|NCT01763567|Medtronic|medtronic
323834|NCT01763567|Diabetes|diabetes
323835|NCT01763567|Hospital|hospital
323836|NCT01763567|Continuous Glucose Monitor|continuous glucose monitor
323837|NCT01763567|Intensive Care Unit|intensive care unit
323838|NCT01763554|Lu-177|lu-177
323839|NCT01763554|Lutetium-177|lutetium-177
323840|NCT01763554|DOTA-TATE|dota-tate
323841|NCT01763554|Neuroendocrine tumors|neuroendocrine tumors
323842|NCT01763554|radiopharmaceutical|radiopharmaceutical
323843|NCT01763541|Natriuretic Peptides|natriuretic peptides
323844|NCT01763528|body weight|body weight
323845|NCT01763528|Low-density-lipoprotein-type|low-density-lipoprotein-type
323846|NCT01763515|Joint Diseases|joint diseases
323847|NCT01763515|Arthritis|arthritis
323848|NCT01763515|Osteoarthritis|osteoarthritis
323849|NCT01763502|Cognitive development|cognitive development
323850|NCT01763502|Anemia|anemia
323851|NCT01763502|Preschool|preschool
323852|NCT01763502|Food transfers|food transfers
323853|NCT01763502|Cash transfers|cash transfers
323854|NCT01763502|Early childhood|early childhood
323855|NCT01763502|Nutrition|nutrition
323856|NCT01763489|randomized controlled trial|randomized controlled trial
323857|NCT01763489|applicability|applicability
323858|NCT01763489|ASSIST tool|assist tool
323859|NCT01763489|surgery|surgery
323860|NCT01763489|digestive cancer|digestive cancer
323861|NCT01763476|long infrapopliteal artery lesions|long infrapopliteal artery lesions
323862|NCT01763476|drug-coated balloon angioplasty|drug-coated balloon angioplasty
323863|NCT01763476|atherectomy|atherectomy
323864|NCT01763463|pneumonia requiring hospitalization|pneumonia requiring hospitalization
323865|NCT01763463|COPD|copd
323866|NCT01763463|long-acting bronchodilators (LABD)|long-acting bronchodilators (labd)
323867|NCT01763463|Inhaled Corticosteroids (ICS)|inhaled corticosteroids (ics)
323868|NCT01763450|Bevacizumab|bevacizumab
323869|NCT01763450|conversion therapy|conversion therapy
323870|NCT01763450|liver metastases|liver metastases
323871|NCT01763450|colorectal cancer|colorectal cancer
323872|NCT01763450|objective response rate|objective response rate
323873|NCT01763437|Chalazia|chalazia
323874|NCT01763437|Chalazion|chalazion
323875|NCT01763437|Meibomian gland dysfunction|meibomian gland dysfunction
323876|NCT01763437|Rosacea|rosacea
323877|NCT01763437|Ocular rosacea|ocular rosacea
323878|NCT01763411|Cataract|cataract
323879|NCT01763411|Vision|vision
323880|NCT01763411|Intraocular lens|intraocular lens
323881|NCT01763411|Multifocal|multifocal
323882|NCT01763411|Monofocal|monofocal
323883|NCT01763385|Erlotinib|erlotinib
323884|NCT01763385|brain radiotherapy|brain radiotherapy
323885|NCT01763385|NSCLC|nsclc
323886|NCT01763385|brain metastases|brain metastases
323887|NCT01763372|Arthroscopic|arthroscopic
323888|NCT01763372|Iliopsoas|iliopsoas
323889|NCT01763372|MRI|mri
323890|NCT01763359|acetabular fracture|acetabular fracture
323891|NCT01763359|pelvic fracture|pelvic fracture
323892|NCT01763359|hip adductor strength|hip adductor strength
323893|NCT01763359|obturator nerve palsy|obturator nerve palsy
323894|NCT01763359|modified Stoppa approach|modified stoppa approach
323895|NCT01763346|type 2 diabetes|type 2 diabetes
323896|NCT01763346|prediabetes|prediabetes
323897|NCT01763346|obesity|obesity
323898|NCT01763346|gastric banding|gastric banding
323899|NCT01763346|metformin|metformin
323900|NCT01763320|ischemic stroke|ischemic stroke
323901|NCT01763320|intracranial stenting|intracranial stenting
323902|NCT01763320|vascular risk factor management|vascular risk factor management
323903|NCT01763307|EGFRI|egfri
323904|NCT01763307|COLON CANCER|colon cancer
323905|NCT01763307|SKIN TOXICITY|skin toxicity
323906|NCT01763307|RECONVAL K1 cream|reconval k1 cream
323907|NCT01763294|multifocal refractory epilepsy|multifocal refractory epilepsy
323908|NCT01763294|tDCS|tdcs
323909|NCT01763294|neurostimulation|neurostimulation
323910|NCT01763294|seizures|seizures
323911|NCT01763268|Immunogenicity|immunogenicity
323912|NCT01763268|Reactogenicity|reactogenicity
323913|NCT01763268|Trivivac|trivivac
323914|NCT01763268|Measles|measles
323915|NCT01763268|Mump|mump
323916|NCT01763268|Rubella|rubella
323917|NCT01763255|cerebral palsy CD133 cells intrathecal injection|cerebral palsy cd133 cells intrathecal injection
323918|NCT01763242|CKD, Anaemia, Synchronization, Monthly dosing, Home Delivery|ckd, anaemia, synchronization, monthly dosing, home delivery
323919|NCT01763216|depressive symptoms|depressive symptoms
323920|NCT01763216|clinical depression|clinical depression
323921|NCT01763216|visual processing speed|visual processing speed
323922|NCT01763216|anxiety|anxiety
323923|NCT01763216|pain|pain
323924|NCT01763216|health-related quality of life|health-related quality of life
323925|NCT01763203|Self-management|self-management
323926|NCT01763203|Chronic Care Model|chronic care model
323927|NCT01763203|Community health worker|community health worker
323928|NCT01763177|nebulizer|nebulizer
323929|NCT01763177|oxygen|oxygen
323930|NCT01763177|post-operative sore throat|post-operative sore throat
323931|NCT01763164|Melanoma|melanoma
323932|NCT01763164|Cutaneous melanoma|cutaneous melanoma
323933|NCT01763164|Skin disease|skin disease
323934|NCT01763164|Skin cancer|skin cancer
323935|NCT01763164|Skin Neoplasms|skin neoplasms
323936|NCT01763164|Neoplasm Metastasis|neoplasm metastasis
323937|NCT01763151|cataract surgery, astigmatism, opposite clear corneal incision, toric IOL, IOL rotational stability|cataract surgery, astigmatism, opposite clear corneal incision, toric iol, iol rotational stability
323938|NCT01763125|Breast cancer|breast cancer
323939|NCT01763125|Ovarian cancer|ovarian cancer
323940|NCT01763125|Endometrium carcinoma|endometrium carcinoma
323941|NCT01763125|Cervix carcinoma,|cervix carcinoma,
323942|NCT01763125|Mamma carcinoma,|mamma carcinoma,
323943|NCT01763125|Prostata carcinoma|prostata carcinoma
323944|NCT01763125|Colon carcinoma|colon carcinoma
323945|NCT01763125|Rectal carcinoma|rectal carcinoma
323946|NCT01763125|Bronchus carcinoma|bronchus carcinoma
323947|NCT01763125|NSCLC & SCLC (Non Small Cell Lung Cancer & Small Cell Lung Cancer))|nsclc & sclc (non small cell lung cancer & small cell lung cancer))
323948|NCT01763125|Prostate carcinoma|prostate carcinoma
323949|NCT01763112|Influence of training with whole body vibration device|influence of training with whole body vibration device
323950|NCT01763099|Autologous Hematopoietic Stem Cell Transplantation|autologous hematopoietic stem cell transplantation
323951|NCT01763099|Mesenchymal Stem Cells|mesenchymal stem cells
323952|NCT01763099|Cord Blood|cord blood
323953|NCT01763099|Graft failure|graft failure
323954|NCT01763086|Poor Graft Function|poor graft function
323955|NCT01763086|Mesenchymal Stem Cells|mesenchymal stem cells
323956|NCT01763086|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
323957|NCT01763086|Third-party Donors|third-party donors
323958|NCT01763060|ards|ards
323959|NCT01763060|ecmo|ecmo
323960|NCT01763060|h1n1|h1n1
323961|NCT01763060|pandemics|pandemics
323962|NCT01763021|Healthy participants|healthy participants
323963|NCT01763021|PCI-32765|pci-32765
323964|NCT01763021|Rifampin|rifampin
323965|NCT01763021|PCI-45227|pci-45227
323966|NCT01763021|CYP3A4|cyp3a4
323967|NCT01763008|Pneumonia, Bacterial|pneumonia, bacterial
323968|NCT01763008|Nosocomial Infection|nosocomial infection
323969|NCT01763008|Intraabdominal Infections|intraabdominal infections
323970|NCT01763008|Urinary Tract Infection|urinary tract infection
323971|NCT01763008|Ventilator-associated pneumonia|ventilator-associated pneumonia
323972|NCT01763008|Doripenem|doripenem
323973|NCT01763008|Doribax|doribax
323974|NCT01763008|Filipino|filipino
323975|NCT01762995|Dolutegravir, pharmacokinetics, calcium, iron, drug interaction, healthy volunteers|dolutegravir, pharmacokinetics, calcium, iron, drug interaction, healthy volunteers
323976|NCT01762956|Pelvic floor|pelvic floor
323977|NCT01762956|Physical Therapy|physical therapy
323978|NCT01762956|Prostate cancer|prostate cancer
323979|NCT01762956|Radiotherapy|radiotherapy
323980|NCT01762956|Nuclear magnetic resonance|nuclear magnetic resonance
323981|NCT01762904|Antiseptics|antiseptics
323982|NCT01762904|Administration cutaneously|administration cutaneously
323983|NCT01762904|Anti-infecting agents, local|anti-infecting agents, local
323984|NCT01762891|Coumadin|coumadin
323985|NCT01762891|celecoxib|celecoxib
323986|NCT01762891|rofecoxib|rofecoxib
323987|NCT01762891|acetaminophen|acetaminophen
323988|NCT01762891|antiphospholipid syndrome and INR|antiphospholipid syndrome and inr
323989|NCT01762878|pharmacodynamics|pharmacodynamics
323990|NCT01762878|pharmacokinetics|pharmacokinetics
323991|NCT01762878|healthy volunteers|healthy volunteers
323992|NCT01762878|Pi3K-delta|pi3k-delta
323993|NCT01762878|GSK2269557|gsk2269557
323994|NCT01762878|safety|safety
323995|NCT01762878|dry powder inhaler|dry powder inhaler
323996|NCT01762865|acute bronchitis, bacteria, virus, clinical symoptoms|acute bronchitis, bacteria, virus, clinical symoptoms
323997|NCT01762852|Benlysta|benlysta
323998|NCT01762852|efficacy|efficacy
323999|NCT01762852|proteinuria|proteinuria
324000|NCT01762852|Idiopathic membranous nephropathy|idiopathic membranous nephropathy
324001|NCT01762852|GSK1550188|gsk1550188
324002|NCT01762852|anti-phospholipase A2 receptor antibodies|anti-phospholipase a2 receptor antibodies
324003|NCT01762852|safety|safety
324004|NCT01762852|placebo|placebo
324005|NCT01762852|BLyS|blys
324006|NCT01762852|belimumab|belimumab
324007|NCT01762852|Lymphostat-B|lymphostat-b
324008|NCT01762852|membrane attack complex|membrane attack complex
324009|NCT01762826|Inositol|inositol
324010|NCT01762826|GDM|gdm
324011|NCT01762813|Colon cancer|colon cancer
324012|NCT01762813|rectal cancer|rectal cancer
324013|NCT01762813|liver metastasis|liver metastasis
324014|NCT01762813|survival|survival
324015|NCT01762813|biomarker|biomarker
324016|NCT01762813|molecular profile|molecular profile
324017|NCT01762774|COPD|copd
324018|NCT01762774|forearm blood flow|forearm blood flow
324019|NCT01762774|soluble Epoxide Hydrolase inhibitor|soluble epoxide hydrolase inhibitor
324020|NCT01762761|eltrombopag|eltrombopag
324021|NCT01762761|TPO-R agonist|tpo-r agonist
324022|NCT01762761|Chronic ITP|chronic itp
324023|NCT01762748|Probiotic|probiotic
324024|NCT01762748|liver|liver
324025|NCT01762748|transplant|transplant
324026|NCT01762748|permeability|permeability
324027|NCT01762722|Spectroscopy, near infrared|spectroscopy, near infrared
324028|NCT01762722|Oximetry|oximetry
324029|NCT01762722|Hypoxemia|hypoxemia
324030|NCT01762722|Tissue oxygenation|tissue oxygenation
324031|NCT01762709|Video-assisted thoracoscopic surgery|video-assisted thoracoscopic surgery
324032|NCT01762709|one lung ventilation|one lung ventilation
324033|NCT01762709|low tidal volume|low tidal volume
324034|NCT01762709|acute lung injury|acute lung injury
324035|NCT01762709|lung water content|lung water content
324036|NCT01762696|marijuana|marijuana
324037|NCT01762696|intervention|intervention
324038|NCT01762696|adolescent, young adult|adolescent, young adult
324039|NCT01762696|primary care|primary care
324040|NCT01762696|mobile|mobile
324041|NCT01762683|pregnancy|pregnancy
324042|NCT01762683|obesity|obesity
324043|NCT01762683|differentiation|differentiation
324044|NCT01762670|Bacterial Vaginosis|bacterial vaginosis
324045|NCT01762670|BV|bv
324046|NCT01762657|Type 1 Diabetes|type 1 diabetes
324047|NCT01762657|Insulin Independence|insulin independence
324048|NCT01762657|Beta Regeneration|beta regeneration
324049|NCT01762657|Immune Tolerance Agent|immune tolerance agent
324050|NCT01762657|Lanzoprazole|lanzoprazole
324051|NCT01762657|Cyclosporine|cyclosporine
324052|NCT01762644|Type 1 Diabetes|type 1 diabetes
324053|NCT01762644|Insulin Independence|insulin independence
324054|NCT01762644|Beta Regeneration|beta regeneration
324055|NCT01762644|Immune Tolerance Agent|immune tolerance agent
324056|NCT01762644|Omeprazole|omeprazole
324057|NCT01762644|Cyclosporine|cyclosporine
324058|NCT01762618|Group Cognitive Behavior Therapy, Alzheimer's disease, Caregivers¡|group cognitive behavior therapy, alzheimer's disease, caregivers¡
324059|NCT01762579|Not-celiac wheat sensitivity|not-celiac wheat sensitivity
324060|NCT01762579|Gluten|gluten
324061|NCT01762579|esophagogastroduodenoscopy|esophagogastroduodenoscopy
324062|NCT01762579|Rectoscopy|rectoscopy
324063|NCT01762566|Not-celiac gluten (wheat) sensitivity|not-celiac gluten (wheat) sensitivity
324064|NCT01762566|Bioelectrical impedance analysis|bioelectrical impedance analysis
324065|NCT01762566|Bloating|bloating
324066|NCT01762566|Swelling|swelling
324067|NCT01762540|Protein breakdown|protein breakdown
324068|NCT01762540|Insulin resistance|insulin resistance
324069|NCT01762540|Glucose intolerance|glucose intolerance
324070|NCT01762540|Lipolysis|lipolysis
324071|NCT01762527|Adaptive radiotherapy|adaptive radiotherapy
324072|NCT01762527|Bladder cancer|bladder cancer
324073|NCT01762514|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
324074|NCT01762514|Amifostine|amifostine
324075|NCT01762514|Myelosuppression|myelosuppression
324076|NCT01762514|Xerostomia|xerostomia
324077|NCT01762514|Mucositis|mucositis
324078|NCT01762501|Hypertension|hypertension
324079|NCT01762488|Treatment Resistant Hypertension|treatment resistant hypertension
324080|NCT01762488|Renal Denervation|renal denervation
324081|NCT01762475|Magnetic resonance imaging|magnetic resonance imaging
324082|NCT01762475|Blood oxygen level dependent signal|blood oxygen level dependent signal
324083|NCT01762475|Hypercapnia|hypercapnia
324084|NCT01762475|Endothelial progenitor cells|endothelial progenitor cells
324085|NCT01762449|Scleroderma|scleroderma
324086|NCT01762449|interstitial lung disease|interstitial lung disease
324087|NCT01762410|Advanced refractory solid tumors|advanced refractory solid tumors
324088|NCT01762371|ACL|acl
324089|NCT01762371|Knee|knee
324090|NCT01762371|Ligament|ligament
324091|NCT01762371|Cruciate|cruciate
324092|NCT01762371|Anterior|anterior
324093|NCT01762358|ACL|acl
324094|NCT01762358|Ligament|ligament
324095|NCT01762358|Knee|knee
324096|NCT01762345|Stress urinary incontinence|stress urinary incontinence
324097|NCT01762345|SUI|sui
324098|NCT01762332|nociception|nociception
324099|NCT01762332|analgesia|analgesia
324100|NCT01762332|intraoperative monitoring|intraoperative monitoring
324101|NCT01762293|CRC|crc
324102|NCT01762293|Famitinib|famitinib
324103|NCT01762293|Phase II|phase ii
324104|NCT01762293|Colorectal Cancer|colorectal cancer
324105|NCT01762280|Famitinib|famitinib
324106|NCT01762280|Advanced Solid tumor|advanced solid tumor
324107|NCT01762280|Phase I|phase i
324108|NCT01762254|pain score|pain score
324109|NCT01762254|complication|complication
324110|NCT01762241|Prostate cancer|prostate cancer
324111|NCT01762241|Androgen deprivation therapy|androgen deprivation therapy
324112|NCT01762241|Exercise|exercise
324113|NCT01762241|Xbox|xbox
324114|NCT01762228|Oropharyngeal dysphagia|oropharyngeal dysphagia
324115|NCT01762228|Elderly|elderly
324116|NCT01762228|Transcutaneous electrical stimulation|transcutaneous electrical stimulation
324117|NCT01762228|TRPV1 agonist|trpv1 agonist
324118|NCT01762215|Epilepsy|epilepsy
324119|NCT01762215|Seizure|seizure
324120|NCT01762215|Veteran|veteran
324121|NCT01762202|CLL|cll
324122|NCT01762202|Fludarabine|fludarabine
324123|NCT01762202|Cyclophosphamide|cyclophosphamide
324124|NCT01762202|Ofatumumab|ofatumumab
324125|NCT01762189|Hyperbilirubinemia|hyperbilirubinemia
324126|NCT01762189|Neonatal|neonatal
324127|NCT01762189|Incidence|incidence
324128|NCT01762189|Risk factors|risk factors
324129|NCT01762176|Early Rheumatoid Arthritis|early rheumatoid arthritis
324130|NCT01762176|Usual care|usual care
324131|NCT01762176|Intensive Care|intensive care
324132|NCT01762176|Boolean criteria|boolean criteria
324133|NCT01762163|Ischemic Stroke,adaptive design, randomized, double-blind|ischemic stroke,adaptive design, randomized, double-blind
324134|NCT01762150|collected duct carcinoma|collected duct carcinoma
324135|NCT01762150|sorafenib|sorafenib
324136|NCT01762137|Aneurysm|aneurysm
324137|NCT01762137|Coiling|coiling
324138|NCT01762137|Flow Diversion|flow diversion
324139|NCT01762124|Pulmonary valve|pulmonary valve
324140|NCT01762124|Congenital heart disease|congenital heart disease
324141|NCT01762124|Transcatheter pulmonary valve|transcatheter pulmonary valve
324142|NCT01762124|Percutaneous pulmonary valve|percutaneous pulmonary valve
324143|NCT01762111|Anti-Mullerian Hormone|anti-mullerian hormone
324144|NCT01762111|In-Vitro fertilization|in-vitro fertilization
324145|NCT01762098|In vitro fertilization|in vitro fertilization
324146|NCT01762098|Hysteroscopy|hysteroscopy
324147|NCT01762098|Endometrial biopsy|endometrial biopsy
324148|NCT01762085|neuropathic diabetic foot ulcer|neuropathic diabetic foot ulcer
324149|NCT01762085|nerve decompression surgery|nerve decompression surgery
324150|NCT01762072|homocysteine-vitamin B12-fish oil-ferritin|homocysteine-vitamin b12-fish oil-ferritin
324151|NCT01762059|bionic pancreas|bionic pancreas
324152|NCT01762059|artificial pancreas|artificial pancreas
324153|NCT01762059|insulin|insulin
324154|NCT01762059|glucagon|glucagon
324155|NCT01762059|continuous glucose monitoring|continuous glucose monitoring
324156|NCT01762059|CGM|cgm
324157|NCT01762059|outpatient|outpatient
324158|NCT01762059|insulin pump|insulin pump
324159|NCT01762046|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
324160|NCT01762046|Pharmacogenetics|pharmacogenetics
324161|NCT01762046|Genetics|genetics
324162|NCT01762046|Obesity|obesity
324163|NCT01762033|Renal cell carcinoma|renal cell carcinoma
324164|NCT01762033|Renal cell cancer|renal cell cancer
324165|NCT01762033|ASONEP|asonep
324166|NCT01762033|Sonepcizumab|sonepcizumab
324167|NCT01762020|Women with Breast Cancer|women with breast cancer
324168|NCT01762020|Receiving Adjuvant Radiation Therapy|receiving adjuvant radiation therapy
324169|NCT01762007|hypospadias, bladder outlet obstruction, ultrasonography|hypospadias, bladder outlet obstruction, ultrasonography
324170|NCT01761994|nafamostat mesilate|nafamostat mesilate
324171|NCT01761994|heparin|heparin
324172|NCT01761994|continuous renal replacement therapy|continuous renal replacement therapy
324173|NCT01761981|Haemorrhagic Hereditary Telangiectasia|haemorrhagic hereditary telangiectasia
324174|NCT01761981|Rendu Osler Weber Syndrome|rendu osler weber syndrome
324175|NCT01761981|Osler Weber Rendu Syndrome|osler weber rendu syndrome
324176|NCT01761981|HHT|hht
324177|NCT01761968|chronic myeloproliferative neoplasms|chronic myeloproliferative neoplasms
324178|NCT01761968|Polycythemia Vera|polycythemia vera
324179|NCT01761968|Essential Thrombocythemia|essential thrombocythemia
324180|NCT01761968|Primary Myelofibrosis|primary myelofibrosis
324181|NCT01761968|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
324182|NCT01761968|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
324183|NCT01761968|Givinostat|givinostat
324184|NCT01761955|body weight|body weight
324185|NCT01761955|lipids|lipids
324186|NCT01761955|glucose|glucose
324187|NCT01761955|insulin|insulin
324188|NCT01761942|omega-3 fatty acids|omega-3 fatty acids
324189|NCT01761942|anorexia nervosa|anorexia nervosa
324190|NCT01761942|efficacy|efficacy
324191|NCT01761942|safety|safety
324192|NCT01761929|oligometastatic|oligometastatic
324193|NCT01761929|oligometastases|oligometastases
324194|NCT01761929|stereotactic body radiotherapy|stereotactic body radiotherapy
324195|NCT01761929|radiation therapy|radiation therapy
324196|NCT01761929|Oligometastasis|oligometastasis
324197|NCT01761929|Stereotactic ablative body|stereotactic ablative body
324198|NCT01761929|radiotherapy|radiotherapy
324199|NCT01761916|captopril, clonidine, pregnancy-induced hypertension,|captopril, clonidine, pregnancy-induced hypertension,
324200|NCT01761890|Chronic Myeloid Leukemia|chronic myeloid leukemia
324201|NCT01761890|Early phase|early phase
324202|NCT01761890|CML|cml
324203|NCT01761890|Dasatinib|dasatinib
324204|NCT01761877|breast cancer, nonsteroidal antiinflammatory drug , breast density, chemoprevention, aromatase inhibitors|breast cancer, nonsteroidal antiinflammatory drug , breast density, chemoprevention, aromatase inhibitors
324205|NCT01761851|Resting metabolic rate|resting metabolic rate
324206|NCT01761851|nutrition status|nutrition status
324207|NCT01761851|dietary intake|dietary intake
324208|NCT01761838|spinal manipulative therapy|spinal manipulative therapy
324209|NCT01761838|low back pain|low back pain
324210|NCT01761838|experimental pain|experimental pain
324211|NCT01761838|spinal stiffness|spinal stiffness
324212|NCT01761838|lumbar multifidus|lumbar multifidus
324213|NCT01761838|degeneration|degeneration
324214|NCT01761812|Prostate cancer|prostate cancer
324215|NCT01761812|MRI|mri
324216|NCT01761812|Elastography|elastography
324217|NCT01761812|Gadofosveset|gadofosveset
324218|NCT01761799|Influenza|influenza
324219|NCT01761799|Pertussis|pertussis
324220|NCT01761799|Vaccination|vaccination
324221|NCT01761786|Myocardial Infarction|myocardial infarction
324222|NCT01761786|Thrombosis|thrombosis
324223|NCT01761786|Acute Coronary Syndrome|acute coronary syndrome
324224|NCT01761786|Myocardial Ischemia|myocardial ischemia
324225|NCT01761786|Heart Diseases|heart diseases
324226|NCT01761786|Cardiovascular Diseases|cardiovascular diseases
324227|NCT01761786|Vascular Diseases|vascular diseases
324228|NCT01761786|Embolism and Thrombosis|embolism and thrombosis
324229|NCT01761786|Genetic Testing|genetic testing
324230|NCT01761786|Clopidogrel|clopidogrel
324231|NCT01761786|Prasugrel|prasugrel
324232|NCT01761786|Ticagrelor|ticagrelor
324233|NCT01761786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
324234|NCT01761786|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists
324235|NCT01761747|Squamous Cell Carcinoma|squamous cell carcinoma
324236|NCT01761734|Influenza vaccination|influenza vaccination
324237|NCT01761721|Endometrial cancer (MeSH)|endometrial cancer (mesh)
324238|NCT01761721|Robotics (MeSH)|robotics (mesh)
324239|NCT01761708|primary ventral hernia repair with mesh|primary ventral hernia repair with mesh
324240|NCT01761708|umbilical hernia repair|umbilical hernia repair
324241|NCT01761708|epigastric hernia repair|epigastric hernia repair
324242|NCT01761708|C-Qur V-patch|c-qur v-patch
324243|NCT01761708|Size tailored repair|size tailored repair
324244|NCT01761708|preperitoneal repair|preperitoneal repair
324245|NCT01761708|abdominal hernia|abdominal hernia
324246|NCT01761708|dual sided mesh|dual sided mesh
324247|NCT01761708|trocar-site hernia|trocar-site hernia
324248|NCT01761656|stable angina|stable angina
324249|NCT01761656|unstable angina|unstable angina
324250|NCT01761656|acute non-ST-segment elevation myocardial infarction|acute non-st-segment elevation myocardial infarction
324252|NCT01761656|perioperative myocardial infarction|perioperative myocardial infarction
324253|NCT01761656|major adverse cardiac events|major adverse cardiac events
324254|NCT01761643|PrEP|prep
324255|NCT01761643|Pre exposure Prophylaxis|pre exposure prophylaxis
324256|NCT01761643|Text Messaging|text messaging
324257|NCT01761643|Truvada|truvada
324258|NCT01761643|iTab|itab
324259|NCT01761643|CCTG|cctg
324260|NCT01761643|595|595
324262|NCT01761630|Severe Asthma|severe asthma
324263|NCT01761630|SARP|sarp
324264|NCT01761617|Yoga|yoga
324265|NCT01761617|Chronic Low Back Pain|chronic low back pain
324266|NCT01761617|CAM|cam
324267|NCT01761617|Complementary and Alternative Medicine|complementary and alternative medicine
324268|NCT01761617|Minorities|minorities
324269|NCT01761591|CAD|cad
324270|NCT01761591|PCI|pci
324271|NCT01761591|BMS|bms
324272|NCT01761591|Svelte|svelte
324273|NCT01761591|Acrobat|acrobat
324274|NCT01761591|direct stenting|direct stenting
324275|NCT01761591|RCT|rct
324276|NCT01761578|Bioresorbable|bioresorbable
324277|NCT01761578|Coronary|coronary
324278|NCT01761578|Stent|stent
324279|NCT01761578|Vascular Remodeling|vascular remodeling
324280|NCT01761578|Angioplasty|angioplasty
324281|NCT01761578|Coronary Artery Disease|coronary artery disease
324282|NCT01761552|in ASA 4 AND ASA 4E patients|in asa 4 and asa 4e patients
324283|NCT01761539|pancreatitis|pancreatitis
324284|NCT01761539|pancreatitis, alcoholic|pancreatitis, alcoholic
324285|NCT01761526|Rotigotine|rotigotine
324286|NCT01761526|Neupro|neupro
324287|NCT01761526|Japanese|japanese
324288|NCT01761526|Caucasian|caucasian
324289|NCT01761526|Male|male
324290|NCT01761526|Female|female
324291|NCT01761526|Single dose|single dose
324292|NCT01761526|Pharmacokinetics|pharmacokinetics
324293|NCT01761500|Non-Hodgkin's lymphoma;|non-hodgkin's lymphoma;
324294|NCT01761500|Childhood and adolescence;|childhood and adolescence;
324295|NCT01761500|Survival Rate|survival rate
324296|NCT01761474|Carbon dioxide insufflation|carbon dioxide insufflation
324297|NCT01761474|Air insufflatioin|air insufflatioin
324298|NCT01761474|ERCP|ercp
324299|NCT01761474|Sedation|sedation
324300|NCT01761448|Coronary Artery Disease|coronary artery disease
324301|NCT01761448|Cardiac rehabilitation program|cardiac rehabilitation program
324302|NCT01761448|telemedical homely rehabilitation|telemedical homely rehabilitation
324303|NCT01761448|guided exercise|guided exercise
324304|NCT01761448|ECG- vest|ecg- vest
324305|NCT01761435|Influenza|influenza
324306|NCT01761435|Solid Organ Transplant Recipients|solid organ transplant recipients
324307|NCT01761396|Anxiety|anxiety
324308|NCT01761396|Fear|fear
324309|NCT01761396|Worry|worry
324310|NCT01761396|Therapy|therapy
324311|NCT01761396|Cognitive behavioral therapy|cognitive behavioral therapy
324312|NCT01761383|Chronic Schizophrenia|chronic schizophrenia
324313|NCT01761383|Nintendo Wii|nintendo wii
324314|NCT01761383|Quality of Life|quality of life
324315|NCT01761370|Non alcoholic Steatohepatitis|non alcoholic steatohepatitis
324316|NCT01761370|Intra-gastric balloon|intra-gastric balloon
324317|NCT01761357|Aortic valve stenosis|aortic valve stenosis
324318|NCT01761357|Quality of life|quality of life
324319|NCT01761357|Burden co morbidities|burden co morbidities
324320|NCT01761357|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
324321|NCT01761357|Geriatric assessment|geriatric assessment
324322|NCT01761331|infant, colic, crying, acupuncture, stooling, sleep|infant, colic, crying, acupuncture, stooling, sleep
324323|NCT01761318|Diabetes mellitus type 2|diabetes mellitus type 2
324324|NCT01761318|Glucagon-Like Peptide 1|glucagon-like peptide 1
324325|NCT01761318|Magnetic Resonance Imaging|magnetic resonance imaging
324326|NCT01761318|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
324327|NCT01761318|Steatosis|steatosis
324328|NCT01761305|Idiopathic scoliosis|idiopathic scoliosis
324329|NCT01761305|Brace|brace
324330|NCT01761305|Scoliosis specific exercise|scoliosis specific exercise
324331|NCT01761305|Physical activity|physical activity
324332|NCT01761279|Colonic polyps|colonic polyps
324333|NCT01761266|Hepatocellular Carcinoma|hepatocellular carcinoma
324334|NCT01761266|Neoplasms|neoplasms
324335|NCT01761266|Cancer|cancer
324336|NCT01761253|comorbidity, multiple chronic conditions, Medicaid, prediction of cost|comorbidity, multiple chronic conditions, medicaid, prediction of cost
324337|NCT01761253|Predictive models, cost containment, managed care|predictive models, cost containment, managed care
324338|NCT01761227|Vascular dementia|vascular dementia
324339|NCT01761227|Fufangdanshen Tablets|fufangdanshen tablets
324340|NCT01761227|Randomized Controlled trial|randomized controlled trial
324341|NCT01761227|Chinese Medicine|chinese medicine
324342|NCT01761214|bacteriology, inflammation, bronchiectasis, exacerbation|bacteriology, inflammation, bronchiectasis, exacerbation
324343|NCT01761201|Prophylaxis|prophylaxis
324344|NCT01761201|Tuberculosis|tuberculosis
324345|NCT01761201|Transplant recipients|transplant recipients
324346|NCT01761201|Transplant waiting list|transplant waiting list
324347|NCT01761188|Persistent Atrial fibrillation;LA substrate;ablation;voltage mapping|persistent atrial fibrillation;la substrate;ablation;voltage mapping
324348|NCT01761149|remifentanil,|remifentanil,
324349|NCT01761149|opioid,|opioid,
324350|NCT01761149|hyperalgesia,|hyperalgesia,
324351|NCT01761149|visual analogue score|visual analogue score
324352|NCT01761149|thyroidectomy,|thyroidectomy,
324353|NCT01761123|Prevention of Influenza|prevention of influenza
324354|NCT01761110|Opioid dependence|opioid dependence
324355|NCT01761110|Injection drug use|injection drug use
324356|NCT01761110|Buprenorphine|buprenorphine
324357|NCT01761110|Opioid agonist treatment|opioid agonist treatment
324358|NCT01761110|Access to care|access to care
324359|NCT01761110|HIV risk behaviors|hiv risk behaviors
324360|NCT01761110|Opioids|opioids
324361|NCT01761097|Adenoma, polyp, colonoscopy.|adenoma, polyp, colonoscopy.
324362|NCT01761084|Osteoporosis|osteoporosis
324363|NCT01761084|Spine fracture|spine fracture
324364|NCT01761084|Vertebral fracture|vertebral fracture
324365|NCT01761084|Exercise Interventions|exercise interventions
324366|NCT01761084|Exercise|exercise
324367|NCT01761058|Asthma|asthma
324368|NCT01761058|Bronchial Diseases|bronchial diseases
324369|NCT01761058|Respiratory Tract Diseases|respiratory tract diseases
324370|NCT01761058|Lung Diseases, Obstructive|lung diseases, obstructive
324371|NCT01761058|Lung Diseases|lung diseases
324372|NCT01761058|Respiratory Hypersensitivity|respiratory hypersensitivity
324373|NCT01761058|Hypersensitivity, Immediate|hypersensitivity, immediate
324374|NCT01761058|Hypersensitivity|hypersensitivity
324375|NCT01761058|Immune System Disease|immune system disease
324376|NCT01761045|Monosodium L-Glutamate (MSG)|monosodium l-glutamate (msg)
324377|NCT01761045|Nucleic Acid (IMP)|nucleic acid (imp)
324378|NCT01761045|Satiety|satiety
324379|NCT01761045|Gastrointestinal Sensation|gastrointestinal sensation
324380|NCT01761045|Consommé Soups|consommé soups
324381|NCT01761045|Snack Intake|snack intake
324382|NCT01761032|Tanning|tanning
324383|NCT01761032|neuroimaging|neuroimaging
324384|NCT01761032|dopamine|dopamine
324385|NCT01761032|MRI|mri
324386|NCT01761032|SPECT|spect
324387|NCT01761019|psoriasis|psoriasis
324388|NCT01761019|Taclonex|taclonex
324389|NCT01761019|Acitretin|acitretin
324390|NCT01761019|Methotrexate|methotrexate
324391|NCT01761006|COPD|copd
324392|NCT01761006|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
324393|NCT01761006|Exhaled Nitric Oxide|exhaled nitric oxide
324394|NCT01761006|NIOX MINO|niox mino
324395|NCT01761006|Acute COPD exacerbation|acute copd exacerbation
324396|NCT01760993|Not Required|not required
324397|NCT01760980|Rate and extend of absorption of Exemestane|rate and extend of absorption of exemestane
324398|NCT01760967|Dexmedetomidine|dexmedetomidine
324399|NCT01760967|sepsis|sepsis
324400|NCT01760967|mortality|mortality
324401|NCT01760967|duration of mechanical ventilation|duration of mechanical ventilation
324402|NCT01760967|organ failure|organ failure
324403|NCT01760954|Gonadotropin-Releasing Hormone Antagonist|gonadotropin-releasing hormone antagonist
324404|NCT01760954|Non-Menstrual Pelvic Pain (NMPP)|non-menstrual pelvic pain (nmpp)
324405|NCT01760954|Dysmenorrhea (DYS)|dysmenorrhea (dys)
324406|NCT01760954|Endometriosis associated pain|endometriosis associated pain
324407|NCT01760954|Elagolix|elagolix
324408|NCT01760941|Urology|urology
324409|NCT01760941|Prostate|prostate
324410|NCT01760941|Breast|breast
324411|NCT01760941|Lung|lung
324412|NCT01760941|Chest|chest
324413|NCT01760915|asthma|asthma
324414|NCT01760915|severe|severe
324415|NCT01760902|Inflammation|inflammation
324416|NCT01760876|Optical Coherence Tomography|optical coherence tomography
324417|NCT01760876|Biofreedom Stent|biofreedom stent
324418|NCT01760863|Revision|revision
324419|NCT01760863|Knee|knee
324420|NCT01760863|Hip|hip
324421|NCT01760863|Arthroplasty|arthroplasty
324422|NCT01760863|Oral|oral
324423|NCT01760863|Antibiotics|antibiotics
324424|NCT01760863|Infection|infection
324425|NCT01760837|cow's milk allergy|cow's milk allergy
324426|NCT01760837|baked milk|baked milk
324427|NCT01760837|tolerance|tolerance
324428|NCT01760837|infants and children|infants and children
324429|NCT01760824|Sequential|sequential
324430|NCT01760824|Quadruple|quadruple
324431|NCT01760824|First|first
324432|NCT01760824|Line|line
324433|NCT01760824|Helicobacter|helicobacter
324434|NCT01760824|pylori|pylori
324435|NCT01760824|infection|infection
324436|NCT01760811|tongue|tongue
324437|NCT01760811|Squamous cell carcinoma|squamous cell carcinoma
324438|NCT01760811|locally advanced|locally advanced
324439|NCT01760811|cetuximab|cetuximab
324440|NCT01760798|osteoporosis|osteoporosis
324441|NCT01760798|Teriparatide|teriparatide
324442|NCT01760785|Veterans|veterans
324443|NCT01760785|Traumatic Brain Injury(TBI)|traumatic brain injury(tbi)
324444|NCT01760785|Alcoholism|alcoholism
324445|NCT01760772|heart disease|heart disease
324446|NCT01760772|GLP-1|glp-1
324447|NCT01760772|Exendin-9|exendin-9
324448|NCT01760772|postprandial lipids|postprandial lipids
324449|NCT01760759|HIV|hiv
324450|NCT01760759|Antiretroviral therapy adherence|antiretroviral therapy adherence
324451|NCT01760746|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
324452|NCT01760746|Vitrectomy|vitrectomy
324453|NCT01760746|Inflammatory Cytokines|inflammatory cytokines
324454|NCT01760707|Diabetes mellitus|diabetes mellitus
324455|NCT01760707|Peripheral neuropathy|peripheral neuropathy
324456|NCT01760707|Exercise|exercise
324457|NCT01760707|Balance performance|balance performance
324458|NCT01760694|Pancreatic|pancreatic
324459|NCT01760694|Pancreas|pancreas
324460|NCT01760694|Intraoperative Radiation Therapy|intraoperative radiation therapy
324557|NCT01760148|HCV|hcv
324461|NCT01760694|Chemotherapy|chemotherapy
324462|NCT01760668|Sex chromosome|sex chromosome
324463|NCT01760668|Turner Syndrome|turner syndrome
324464|NCT01760668|Marfan syndrome|marfan syndrome
324465|NCT01760668|Bicuspid aortic valve|bicuspid aortic valve
324466|NCT01760668|Aortic Aneurysm|aortic aneurysm
324467|NCT01760668|Epigenetics|epigenetics
324468|NCT01760668|Transcriptome|transcriptome
324469|NCT01760668|non-coding RNA|non-coding rna
324470|NCT01760668|Electron microscopy|electron microscopy
324471|NCT01760668|Proteomics|proteomics
324472|NCT01760642|metabolite profiles|metabolite profiles
324473|NCT01760642|pharmacokinetics|pharmacokinetics
324474|NCT01760642|CYP3A|cyp3a
324475|NCT01760642|metabolomics|metabolomics
324476|NCT01760629|Encephalopathy, Newborn, Low and Middle-income countries, Hypothermia|encephalopathy, newborn, low and middle-income countries, hypothermia
324477|NCT01760616|Huaier Granule;|huaier granule;
324478|NCT01760616|After non-radical hepatectomy;|after non-radical hepatectomy;
324479|NCT01760616|Prevention of Disease Progression of Hepatocarcinoma;|prevention of disease progression of hepatocarcinoma;
324480|NCT01760616|Safety.|safety.
324481|NCT01760603|pelvic organ prolapse|pelvic organ prolapse
324482|NCT01760590|neck pain|neck pain
324483|NCT01760590|cervical pain|cervical pain
324484|NCT01760590|pain pressure thresholds|pain pressure thresholds
324485|NCT01760590|pain catastrophizing|pain catastrophizing
324486|NCT01760577|osteoarthritis, botulinum toxin, hyaluronate|osteoarthritis, botulinum toxin, hyaluronate
324487|NCT01760564|Niemann-Pick disease type C|niemann-pick disease type c
324488|NCT01760564|miglustat|miglustat
324489|NCT01760551|Fracture|fracture
324490|NCT01760551|Trauma|trauma
324491|NCT01760551|impairment|impairment
324492|NCT01760538|Cardiac transplant recipients|cardiac transplant recipients
324493|NCT01760538|Heart rate variability|heart rate variability
324494|NCT01760538|Exercise training|exercise training
324495|NCT01760525|p53, solid tumor|p53, solid tumor
324496|NCT01760512|Gastric bypass|gastric bypass
324497|NCT01760512|Robot-assisted surgery|robot-assisted surgery
324498|NCT01760512|Conventional laparoscopy|conventional laparoscopy
324499|NCT01760512|Pain assessment|pain assessment
324500|NCT01760512|Health economics outcomes|health economics outcomes
324501|NCT01760499|skin|skin
324502|NCT01760499|metastatic|metastatic
324503|NCT01760473|opioid dependence|opioid dependence
324504|NCT01760434|scoliosis|scoliosis
324505|NCT01760434|long-term outcomes|long-term outcomes
324506|NCT01760434|sagittal plane|sagittal plane
324507|NCT01760434|quality of life|quality of life
324508|NCT01760434|curve progression|curve progression
324509|NCT01760434|pulmonary function|pulmonary function
324510|NCT01760382|Acute myocardial infarction|acute myocardial infarction
324511|NCT01760382|ST elevation myocardial infarction|st elevation myocardial infarction
324512|NCT01760382|primary PCI|primary pci
324513|NCT01760382|reperfusion therapy|reperfusion therapy
324514|NCT01760382|angioplasty|angioplasty
324515|NCT01760382|stent|stent
324516|NCT01760356|Liver transplantation|liver transplantation
324517|NCT01760356|Calcineurin inhibitors|calcineurin inhibitors
324518|NCT01760356|Pharmacodynamic biomarkers|pharmacodynamic biomarkers
324519|NCT01760356|Calcineurin pathway|calcineurin pathway
324520|NCT01760356|Tacrolimus|tacrolimus
324521|NCT01760356|interindividual variability|interindividual variability
324522|NCT01760304|COPD|copd
324523|NCT01760278|Time-lapse monitoring of embryos.|time-lapse monitoring of embryos.
324524|NCT01760278|Embryoscope|embryoscope
324525|NCT01760278|IVF-ET/ICSI|ivf-et/icsi
324526|NCT01760278|Cetrorelix|cetrorelix
324527|NCT01760278|Gonal-F|gonal-f
324528|NCT01760265|dysbetalipoproteinemia|dysbetalipoproteinemia
324529|NCT01760265|artery calcium score|artery calcium score
324530|NCT01760265|carotid intima media|carotid intima media
324531|NCT01760265|ankle brachial index|ankle brachial index
324532|NCT01760265|dysbetalipoproteinemic patients|dysbetalipoproteinemic patients
324533|NCT01760252|Pancreatic Cancer|pancreatic cancer
324534|NCT01760239|Adolescent Hypertension|adolescent hypertension
324535|NCT01760239|Adolescent Pre Hypertension|adolescent pre hypertension
324536|NCT01760239|Adolescent Pre Hypertension and Obesity|adolescent pre hypertension and obesity
324537|NCT01760226|DLBCL|dlbcl
324538|NCT01760226|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
324539|NCT01760226|dose adjusted|dose adjusted
324540|NCT01760226|EPOCH|epoch
324541|NCT01760226|Etoposide|etoposide
324542|NCT01760226|Doxorubicin|doxorubicin
324543|NCT01760226|Vincristine|vincristine
324544|NCT01760226|Cyclophosphamide|cyclophosphamide
324545|NCT01760226|Prednisone|prednisone
324546|NCT01760226|Rituximab|rituximab
324547|NCT01760200|Coronary angioplasty|coronary angioplasty
324548|NCT01760200|Coronary stent|coronary stent
324549|NCT01760200|paclitaxel drug-eluting stent|paclitaxel drug-eluting stent
324550|NCT01760200|drug eluting balloon|drug eluting balloon
324551|NCT01760174|Transversus abdominis plane catheter|transversus abdominis plane catheter
324552|NCT01760161|postoperative pain|postoperative pain
324553|NCT01760161|opioid consumption|opioid consumption
324554|NCT01760161|termanalgesia|termanalgesia
324555|NCT01760161|plasmaropivacain level|plasmaropivacain level
324556|NCT01760148|Hepatitis C Virus|hepatitis c virus
324558|NCT01760148|Interferon|interferon
324559|NCT01760148|Prediction|prediction
324560|NCT01760148|SVR|svr
324561|NCT01760148|Sustained Virus Response|sustained virus response
324562|NCT01760135|trauma|trauma
324563|NCT01760135|nutrition|nutrition
324564|NCT01760135|hyperglycemia|hyperglycemia
324565|NCT01760122|peginterferon|peginterferon
324566|NCT01760122|HBeAg Positive|hbeag positive
324567|NCT01760122|Chronic hepatitis B|chronic hepatitis b
324568|NCT01760109|Respiratory and urinary tract infections|respiratory and urinary tract infections
324569|NCT01760109|Piperacillin Sodium and Sulbactam Sodium for Injection (2:1)|piperacillin sodium and sulbactam sodium for injection (2:1)
324570|NCT01760109|Phase IV|phase iv
324571|NCT01760096|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
324572|NCT01760096|Anemia|anemia
324573|NCT01760096|Hematologic Diseases|hematologic diseases
324574|NCT01760096|bone marrow failure|bone marrow failure
324575|NCT01760096|Immunologic Factors|immunologic factors
324576|NCT01760096|Physiological Effects of Drugs|physiological effects of drugs
324577|NCT01760096|Levamisole|levamisole
324578|NCT01760096|cyclosporine A|cyclosporine a
324579|NCT01760070|cancer|cancer
324580|NCT01760070|endoscopy|endoscopy
324581|NCT01760070|endoscopic submucosal dissection|endoscopic submucosal dissection
324582|NCT01760044|tissue oxygenation|tissue oxygenation
324583|NCT01760044|perfusion status|perfusion status
324584|NCT01760031|preconditioning|preconditioning
324585|NCT01760031|contrast-induced acute kidney injury|contrast-induced acute kidney injury
324586|NCT01760031|renal faliure|renal faliure
324587|NCT01760018|desflurane, total intravenous anesthesia, QoR-40|desflurane, total intravenous anesthesia, qor-40
324588|NCT01760005|Alzheimer's|alzheimer's
324589|NCT01760005|Alzheimer's Disease|alzheimer's disease
324590|NCT01760005|Dementia|dementia
324591|NCT01760005|Mutation|mutation
324592|NCT01760005|Genetic Mutation|genetic mutation
324593|NCT01760005|Dominantly Inherited Alzheimer's Disease|dominantly inherited alzheimer's disease
324594|NCT01760005|Dominantly Inherited Alzheimer's Network|dominantly inherited alzheimer's network
324595|NCT01760005|Autosomal Dominant Alzheimer's Disease|autosomal dominant alzheimer's disease
324596|NCT01760005|Early Onset Alzheimer's Disease|early onset alzheimer's disease
324597|NCT01760005|DIAN|dian
324598|NCT01760005|DIAN-TU|dian-tu
324599|NCT01760005|DIAN TU|dian tu
324600|NCT01759992|Frail elderly|frail elderly
324601|NCT01759992|Muscle weakness|muscle weakness
324602|NCT01759992|Institutionalization|institutionalization
324603|NCT01759992|Respiratory muscle training|respiratory muscle training
324604|NCT01759979|Cholelithiasis, Common Bile Duct|cholelithiasis, common bile duct
324605|NCT01759979|Choledocholithiasis|choledocholithiasis
324606|NCT01759966|Heart transplantation|heart transplantation
324607|NCT01759966|Autonomic cardiovascular control|autonomic cardiovascular control
324608|NCT01759966|Acute rejection|acute rejection
324609|NCT01759966|Cardiac allograft vasculopathy|cardiac allograft vasculopathy
324610|NCT01759953|Diabetes Mellitus|diabetes mellitus
324611|NCT01759953|Insulin|insulin
324612|NCT01759953|Video Games|video games
324613|NCT01759953|Medical Education|medical education
324614|NCT01759953|Educational Technology|educational technology
324615|NCT01759953|Continuing Medical Education|continuing medical education
324616|NCT01759940|carotid|carotid
324617|NCT01759940|endarterectomy|endarterectomy
324618|NCT01759940|cervical block|cervical block
324619|NCT01759927|Physical activity counselor|physical activity counselor
324620|NCT01759927|Workplace intervention|workplace intervention
324621|NCT01759927|Active and healthy lifestyle|active and healthy lifestyle
324622|NCT01759901|hepatectomy|hepatectomy
324623|NCT01759901|vascular inflow occlusion|vascular inflow occlusion
324624|NCT01759862|kidney transplant|kidney transplant
324625|NCT01759862|Aminophylline|aminophylline
324626|NCT01759862|pediatric|pediatric
324627|NCT01759849|Asthma|asthma
324628|NCT01759849|β-chain signaling|β-chain signaling
324629|NCT01759849|allergen inhalation challenges|allergen inhalation challenges
324630|NCT01759849|sputum|sputum
324631|NCT01759849|bone marrow aspirate|bone marrow aspirate
324632|NCT01759849|blood collection|blood collection
324633|NCT01759849|-methacholine challenge|-methacholine challenge
324634|NCT01759836|Prostatectomy|prostatectomy
324635|NCT01759836|Statins|statins
324636|NCT01759810|Glioblastoma, recurrent glioblastoma|glioblastoma, recurrent glioblastoma
324637|NCT01759797|ALS bone marrow mesenchymal stem cell intravenous injection|als bone marrow mesenchymal stem cell intravenous injection
324638|NCT01759784|mesenchymal stem cell intraventricular injection ALS|mesenchymal stem cell intraventricular injection als
324639|NCT01759771|Prostate Cancer|prostate cancer
324640|NCT01759771|Vitamin D3|vitamin d3
324641|NCT01759771|Active surveillance|active surveillance
324642|NCT01759758|boxer's fracture|boxer's fracture
324643|NCT01759758|metacarpal neck fracture|metacarpal neck fracture
324644|NCT01759758|metacarpal fracture|metacarpal fracture
324645|NCT01759732|Aplastic anemia|aplastic anemia
324646|NCT01759732|T cell dose|t cell dose
324647|NCT01759732|CD3 depletion|cd3 depletion
324648|NCT01759732|Haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
324649|NCT01759719|platinum-chromium stents|platinum-chromium stents
324650|NCT01759719|concertina effect|concertina effect
324651|NCT01759719|stent deformation|stent deformation
324652|NCT01759719|everolimus eluting stents|everolimus eluting stents
324653|NCT01759719|stent lenght|stent lenght
324654|NCT01759693|Platelet activation|platelet activation
324655|NCT01759680|Risk of falls|risk of falls
324656|NCT01759680|Whole Body Vibration|whole body vibration
324657|NCT01759680|Nursing Home|nursing home
324658|NCT01759667|Diet-induced Thermogenesis;|diet-induced thermogenesis;
324659|NCT01759667|Respiratory Quotient;|respiratory quotient;
324660|NCT01759667|Roux-en-Y Gastric Bypass;|roux-en-y gastric bypass;
324661|NCT01759667|Energy Expenditure.|energy expenditure.
324662|NCT01759641|Dialysis|dialysis
324663|NCT01759641|Monitoring|monitoring
324664|NCT01759641|Cardiovascular stability|cardiovascular stability
324665|NCT01759641|biosignals|biosignals
324666|NCT01759628|Steatohepatitis,|steatohepatitis,
324667|NCT01759628|Helicobacter pylori,|helicobacter pylori,
324668|NCT01759628|Insulin resistance,|insulin resistance,
324669|NCT01759628|Alanine aminotransferase,|alanine aminotransferase,
324670|NCT01759628|Aspartate aminotransferase,|aspartate aminotransferase,
324671|NCT01759615|Preterm|preterm
324672|NCT01759615|SGA|sga
324673|NCT01759615|AREDF|aredf
324674|NCT01759615|Early feeding|early feeding
324675|NCT01759615|Late feeding|late feeding
324676|NCT01759615|Feed intolerence|feed intolerence
324677|NCT01759615|Necrotizing enterocolitis|necrotizing enterocolitis
324678|NCT01759602|Neuromyelitis optica|neuromyelitis optica
324679|NCT01759602|Devic's disease|devic's disease
324680|NCT01759602|NMO|nmo
324681|NCT01759602|Devic|devic
324682|NCT01759589|electroconvulsive therapy,sevoflurane,propofol,remifentanil|electroconvulsive therapy,sevoflurane,propofol,remifentanil
324683|NCT01759576|Renal Insufficiency|renal insufficiency
324684|NCT01759576|Healthy|healthy
324685|NCT01759576|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
324686|NCT01759576|Pharmacokinetics|pharmacokinetics
324687|NCT01759576|Pharmacodynamics|pharmacodynamics
324688|NCT01759576|Dialysis|dialysis
324689|NCT01759550|Gastric Procedures|gastric procedures
324690|NCT01759550|Force Triad|force triad
324691|NCT01759550|LigaSure Advance Pistol Grip|ligasure advance pistol grip
324692|NCT01759550|LigaSure Blunt Tip|ligasure blunt tip
324693|NCT01759524|local anaesthesia|local anaesthesia
324694|NCT01759524|analgesia|analgesia
324695|NCT01759524|bupivacaine|bupivacaine
324696|NCT01759524|lidocaine|lidocaine
324697|NCT01759524|clonidine|clonidine
324698|NCT01759524|sciatic nerve|sciatic nerve
324699|NCT01759524|saphenous nerve|saphenous nerve
324700|NCT01759511|Idiopathic|idiopathic
324701|NCT01759511|Pulmonary|pulmonary
324702|NCT01759511|Fibrosis|fibrosis
324703|NCT01759511|IPF|ipf
324704|NCT01759498|Inflammation|inflammation
324705|NCT01759498|Pain intensity|pain intensity
324706|NCT01759498|Flexibility|flexibility
324707|NCT01759498|RICE protocol|rice protocol
324708|NCT01759498|Swelling|swelling
324709|NCT01759485|Clozapine|clozapine
324710|NCT01759485|Schizophrenia|schizophrenia
324711|NCT01759485|Vitamin-D|vitamin-d
324712|NCT01759485|Treatment-resistant|treatment-resistant
324713|NCT01759472|leukotriene|leukotriene
324714|NCT01759472|leukotriene receptor antagonist|leukotriene receptor antagonist
324715|NCT01759420|Ondansetron|ondansetron
324716|NCT01759420|QT interval|qt interval
324717|NCT01759420|QTc|qtc
324718|NCT01759420|QT prolongation|qt prolongation
324719|NCT01759420|Drug induced QT prolongation|drug induced qt prolongation
324720|NCT01759381|Spinal Deformity|spinal deformity
324721|NCT01759381|Complex Spinal Surgery|complex spinal surgery
324722|NCT01759381|Negative Pressure Wound Therapy|negative pressure wound therapy
324723|NCT01759381|Post-Operative Infection|post-operative infection
324724|NCT01759368|self-care, heart failure, telemonitoring, health care utilization|self-care, heart failure, telemonitoring, health care utilization
324725|NCT01759342|Cystic fibrosis; pulmonary exacerbation, exercise|cystic fibrosis; pulmonary exacerbation, exercise
324726|NCT01759329|overweight|overweight
324727|NCT01759329|body weight|body weight
324728|NCT01759329|coffee|coffee
324729|NCT01759290|Angioplasty|angioplasty
324730|NCT01759290|Bioabsorbable|bioabsorbable
324731|NCT01759290|Bioresorbable|bioresorbable
324732|NCT01759290|BVS|bvs
324733|NCT01759290|Coronary Artery Endothelial Responsiveness|coronary artery endothelial responsiveness
324734|NCT01759290|Coronary Scaffold|coronary scaffold
324735|NCT01759290|Coronary Stent|coronary stent
324736|NCT01759264|Fecal Calprotectin|fecal calprotectin
324737|NCT01759264|Crohn's Disease|crohn's disease
324738|NCT01759264|Adalimumab|adalimumab
324739|NCT01759251|Meniere Disease|meniere disease
324740|NCT01759251|Betahistine Dihydrochloride|betahistine dihydrochloride
324741|NCT01759251|Vertigo|vertigo
324742|NCT01759238|colorectal cancer|colorectal cancer
324743|NCT01759238|metastases|metastases
324744|NCT01759238|non resectable|non resectable
324745|NCT01759238|chemoradiation|chemoradiation
324746|NCT01759225|Registry, Cardiovascular, CVD, Health Maintenance Organization|registry, cardiovascular, cvd, health maintenance organization
324747|NCT01759212|stem cell implantation|stem cell implantation
324748|NCT01759212|coronary artery disease|coronary artery disease
324749|NCT01759212|left ventricular assist device|left ventricular assist device
324750|NCT01759199|COPD|copd
324751|NCT01759199|ST6: The six minute Stepper Test|st6: the six minute stepper test
324752|NCT01759199|Conventional respiratory rehabilitation|conventional respiratory rehabilitation
324753|NCT01759199|Pulmonary rehabilitation|pulmonary rehabilitation
324754|NCT01759186|Asthma|asthma
324755|NCT01759186|Biomakers|biomakers
324756|NCT01759186|Phenotype|phenotype
324757|NCT01759173|Minor traumatic brain injury (TBI)|minor traumatic brain injury (tbi)
324758|NCT01759173|Concussion|concussion
324759|NCT01759160|Target control infusion|target control infusion
324760|NCT01759160|propofol|propofol
324761|NCT01759160|cardiac depression|cardiac depression
324762|NCT01759160|induction of anesthesia|induction of anesthesia
324763|NCT01759160|hemodynamics|hemodynamics
324764|NCT01759134|Premature neonate|premature neonate
324765|NCT01759134|Post-discharge|post-discharge
324766|NCT01759134|Formula|formula
324767|NCT01759121|severe non-proliferative diabetic retinopathy|severe non-proliferative diabetic retinopathy
324768|NCT01759121|subthreshold|subthreshold
324769|NCT01759121|panretinal photocoagulation|panretinal photocoagulation
324770|NCT01759121|PASCAL|pascal
324771|NCT01759121|endpoint management|endpoint management
324772|NCT01759108|xerostomia|xerostomia
324773|NCT01759108|rebamipide|rebamipide
324774|NCT01759108|efficacy|efficacy
324775|NCT01759108|safety|safety
324776|NCT01759095|adherence|adherence
324777|NCT01759095|electronic monitoring|electronic monitoring
324778|NCT01759095|primary care|primary care
324779|NCT01759095|community pharmacy|community pharmacy
324780|NCT01759095|multidrug blister pack|multidrug blister pack
324781|NCT01759095|pill box|pill box
324782|NCT01759056|Ulcerative colitis|ulcerative colitis
324783|NCT01759043|coronary artery disease|coronary artery disease
324784|NCT01759043|Myocardial Infarction|myocardial infarction
324785|NCT01759043|Radial Artery|radial artery
324786|NCT01759043|Catheters|catheters
324787|NCT01759030|rheumatoid arthritis, DMARDs|rheumatoid arthritis, dmards
324788|NCT01759030|rituximab|rituximab
324789|NCT01759030|biosimilar|biosimilar
324790|NCT01759030|interchangeability|interchangeability
324791|NCT01759017|Crohn's disease|crohn's disease
324792|NCT01759017|Inflammatory bowel disease|inflammatory bowel disease
324793|NCT01759017|IBD|ibd
324794|NCT01759017|Infliximab|infliximab
324795|NCT01759017|PET|pet
324796|NCT01759017|PET/CT|pet/ct
324797|NCT01759004|lipoedema|lipoedema
324798|NCT01759004|obesity|obesity
324799|NCT01758978|bioequivalence, hydrocodone bitartrate extended-release tablets|bioequivalence, hydrocodone bitartrate extended-release tablets
324800|NCT01758952|Peri-operative stroke|peri-operative stroke
324801|NCT01758952|incidence|incidence
324802|NCT01758952|risk factors|risk factors
324803|NCT01758952|prospective|prospective
324804|NCT01758939|Peg Interferon,|peg interferon,
324805|NCT01758939|Ribavirin,|ribavirin,
324806|NCT01758939|HCV,|hcv,
324807|NCT01758939|Genotype IV.|genotype iv.
324808|NCT01758926|Inflammatory Bowel Disease|inflammatory bowel disease
324809|NCT01758926|Confocal Laser Endomicroscopy|confocal laser endomicroscopy
324810|NCT01758913|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
324811|NCT01758913|patent ductus arteriosus|patent ductus arteriosus
324812|NCT01758913|prostaglandin|prostaglandin
324813|NCT01758913|Respiratory distress syndrome|respiratory distress syndrome
324814|NCT01758900|Single-Balloon Enteroscopy|single-balloon enteroscopy
324815|NCT01758874|Critical limb ischemia|critical limb ischemia
324816|NCT01758874|Phlebotomy|phlebotomy
324817|NCT01758874|Amputation|amputation
324818|NCT01758874|Rutherford classification Grade 3, Category 5 or 6|rutherford classification grade 3, category 5 or 6
324819|NCT01758874|Fontaine stage IV|fontaine stage iv
324820|NCT01758861|Erythropoietin|erythropoietin
324821|NCT01758861|acute kidney injury|acute kidney injury
324822|NCT01758861|valvular heart surgery|valvular heart surgery
324823|NCT01758848|overactive bladder|overactive bladder
324824|NCT01758848|pelvic floor muscles|pelvic floor muscles
324825|NCT01758848|deep abdominal muscles|deep abdominal muscles
324826|NCT01758835|ER-stress-test negative|er-stress-test negative
324827|NCT01758835|unimalleolar|unimalleolar
324828|NCT01758835|fibula|fibula
324829|NCT01758835|Weber-B fractures|weber-b fractures
324830|NCT01758822|meconium stained amniotic fluid|meconium stained amniotic fluid
324831|NCT01758822|endotracheal suction|endotracheal suction
324832|NCT01758822|non vigorous neonates|non vigorous neonates
324833|NCT01758809|Video Assisted Thoracic Surgery|video assisted thoracic surgery
324834|NCT01758809|Postoperative Pain|postoperative pain
324835|NCT01758809|Intravenous Patient Controlled Analgesia|intravenous patient controlled analgesia
324836|NCT01758809|Bupivacaine|bupivacaine
324837|NCT01758809|Major Pulmonary Resection|major pulmonary resection
324838|NCT01758809|Post Pulmonary Resection|post pulmonary resection
324839|NCT01758796|ER-stress positive|er-stress positive
324840|NCT01758796|Unimalleolar fibula fracture|unimalleolar fibula fracture
324841|NCT01758796|Operative vs non-operative treatment|operative vs non-operative treatment
324842|NCT01758770|osteoporosis|osteoporosis
324843|NCT01758770|osteoarthritis|osteoarthritis
325039|NCT01757951|Ankle|ankle
324844|NCT01758770|bone mineral density|bone mineral density
324845|NCT01758770|computed xray tomography|computed xray tomography
324846|NCT01758770|liver steatosis|liver steatosis
324847|NCT01758770|obesity|obesity
324848|NCT01758757|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
324849|NCT01758757|Vitrectomy|vitrectomy
324850|NCT01758744|COPD PH|copd ph
324851|NCT01758744|COPD associated Pulmonary Hypertension|copd associated pulmonary hypertension
324852|NCT01758744|COPD and Pulmonary Hypertension|copd and pulmonary hypertension
324853|NCT01758744|Disease|disease
324854|NCT01758731|Stage IVA-B Squamous Cell Carcinomas|stage iva-b squamous cell carcinomas
324855|NCT01758731|Head and Neck Cancer|head and neck cancer
324856|NCT01758731|Heavy drinking|heavy drinking
324857|NCT01758731|Smoking|smoking
324858|NCT01758718|Down's syndrome|down's syndrome
324859|NCT01758718|entropion|entropion
324860|NCT01758718|lid plasty|lid plasty
324861|NCT01758705|Psoriasis|psoriasis
324862|NCT01758705|Related to Health Quality of Life|related to health quality of life
324863|NCT01758705|Patient Reported Outcomes|patient reported outcomes
324864|NCT01758705|Venezuelan Patients|venezuelan patients
324865|NCT01758692|spinal cord injury|spinal cord injury
324866|NCT01758692|autonomic integrity|autonomic integrity
324867|NCT01758692|autonomic dysreflexia|autonomic dysreflexia
324868|NCT01758692|baroreceptor integrity|baroreceptor integrity
324869|NCT01758692|sympathetic integrity|sympathetic integrity
324870|NCT01758692|vagal integrity|vagal integrity
324871|NCT01758679|Iodine[131I] Metuximab Injection|iodine[131i] metuximab injection
324872|NCT01758653|CO poisoning|co poisoning
324873|NCT01758640|mechanical heart valve|mechanical heart valve
324874|NCT01758640|pregnancy|pregnancy
324875|NCT01758640|warfarin|warfarin
324876|NCT01758640|phenindione|phenindione
324877|NCT01758627|Peritoneal dialysis,|peritoneal dialysis,
324878|NCT01758627|chronic kidney disease,|chronic kidney disease,
324879|NCT01758627|refractory heart failure|refractory heart failure
324880|NCT01758614|carotid artery occlusion|carotid artery occlusion
324881|NCT01758614|middle cerebral artery occlusion|middle cerebral artery occlusion
324882|NCT01758614|EC-IC bypass surgery|ec-ic bypass surgery
324883|NCT01758614|stroke|stroke
324884|NCT01758601|white fish|white fish
324885|NCT01758601|Metabolic syndrome|metabolic syndrome
324886|NCT01758601|Cardiovascular risk|cardiovascular risk
324887|NCT01758588|Primary myelofibrosis|primary myelofibrosis
324888|NCT01758588|PMF|pmf
324889|NCT01758575|Patients|patients
324890|NCT01758549|pancreatitis|pancreatitis
324891|NCT01758549|cholangiopancreatography, endoscopic retrograde|cholangiopancreatography, endoscopic retrograde
324892|NCT01758549|hyperamylasemia|hyperamylasemia
324893|NCT01758536|ischemic stroke|ischemic stroke
324894|NCT01758536|neural function|neural function
324895|NCT01758536|life quality|life quality
324896|NCT01758523|neuroactive steroids|neuroactive steroids
324897|NCT01758510|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
324898|NCT01758510|ALS|als
324899|NCT01758510|Neurodegenerative disease|neurodegenerative disease
324900|NCT01758510|Motor Neuron Disease|motor neuron disease
324901|NCT01758510|Central Nervous System Disease|central nervous system disease
324902|NCT01758510|Neuromuscular Disease|neuromuscular disease
324903|NCT01758510|Bone marrow derived stem cell|bone marrow derived stem cell
324904|NCT01758510|stem cell therapy|stem cell therapy
324905|NCT01758510|intrathecal injection|intrathecal injection
324906|NCT01758497|Fascia Iliaca compartment block, Pain, Sensorial blockade|fascia iliaca compartment block, pain, sensorial blockade
324907|NCT01758484|Hematopoietic cell transplantation|hematopoietic cell transplantation
324908|NCT01758484|Supportive/palliative care|supportive/palliative care
324909|NCT01758471|Type 2 Diabetes|type 2 diabetes
324910|NCT01758471|gut microbiome|gut microbiome
324911|NCT01758471|incretin|incretin
324912|NCT01758471|Sulfonylurea|sulfonylurea
324913|NCT01758471|α-glucosidase inhibitor|α-glucosidase inhibitor
324914|NCT01758445|Breast|breast
324915|NCT01758445|Cancer|cancer
324916|NCT01758445|Radiation|radiation
324917|NCT01758445|Proton|proton
324918|NCT01758432|Healthy volunteers|healthy volunteers
324919|NCT01758419|post-RT|post-rt
324920|NCT01758419|myocardial perfusion images|myocardial perfusion images
324921|NCT01758406|Cardiac stem ce heart failure cardiac function intracoronary transplantation|cardiac stem ce heart failure cardiac function intracoronary transplantation
324922|NCT01758393|IgG4-related disease|igg4-related disease
324923|NCT01758393|IgG4-RD|igg4-rd
324924|NCT01758380|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
324925|NCT01758380|Ramadan|ramadan
324926|NCT01758380|Vildagliptin|vildagliptin
324927|NCT01758380|Hypoglycemia|hypoglycemia
324928|NCT01758367|demethylating agent|demethylating agent
324929|NCT01758367|immunogenicity|immunogenicity
324930|NCT01758367|decitabine(DAC)|decitabine(dac)
324931|NCT01758367|donor lymphocyte infusion(DLI)|donor lymphocyte infusion(dli)
324932|NCT01758367|AML|aml
324933|NCT01758354|Pompe disease|pompe disease
324934|NCT01758354|alpha glucosidase deficiency|alpha glucosidase deficiency
324935|NCT01758341|Malignant biliary obstruction|malignant biliary obstruction
324936|NCT01758341|Endoscopic radiofrequency ablation|endoscopic radiofrequency ablation
325040|NCT01757951|Fracture|fracture
324937|NCT01758341|Therapeutic endoscopy|therapeutic endoscopy
324938|NCT01758328|BUSULFAN|busulfan
324939|NCT01758328|FLUDARABINE|fludarabine
324940|NCT01758328|G-CSF|g-csf
324941|NCT01758328|MELPHALAN|melphalan
324942|NCT01758328|RABBIT ATG WT1|rabbit atg wt1
324943|NCT01758328|PEPTIDE SPECIFIC T CELLS|peptide specific t cells
324944|NCT01758328|12-175|12-175
324945|NCT01758315|Ambulatory|ambulatory
324946|NCT01758315|Outpatient|outpatient
324947|NCT01758315|Malpractice|malpractice
324948|NCT01758315|Quality Improvement|quality improvement
324949|NCT01758315|Patient Safety|patient safety
324950|NCT01758302|taste test|taste test
324951|NCT01758302|food consumption|food consumption
324952|NCT01758302|hunger|hunger
324953|NCT01758289|Venezuelan Patients|venezuelan patients
324954|NCT01758289|Depressive Symptoms|depressive symptoms
324955|NCT01758289|Health Related Quality of Life|health related quality of life
324956|NCT01758276|smoking, pregnancy|smoking, pregnancy
324957|NCT01758263|Hypertension|hypertension
324958|NCT01758263|Health Care Cost|health care cost
324959|NCT01758263|Monthly health care cost|monthly health care cost
324960|NCT01758250|Autoimmune diseases with cutaneous involvement|autoimmune diseases with cutaneous involvement
324961|NCT01758250|Systemic sclerosis|systemic sclerosis
324962|NCT01758250|Scleroderma|scleroderma
324963|NCT01758250|Morphea|morphea
324964|NCT01758250|Dermatomyositis|dermatomyositis
324965|NCT01758250|Cutaneous lupus|cutaneous lupus
324966|NCT01758250|Vasculitis|vasculitis
324967|NCT01758250|Sickle Cell Disease|sickle cell disease
324968|NCT01758250|Graft versus Host Disease|graft versus host disease
324969|NCT01758237|Laser Peripheral Iridotomy|laser peripheral iridotomy
324970|NCT01758237|Visual Dysphotopsia|visual dysphotopsia
324971|NCT01758237|Visual Disturbances|visual disturbances
324972|NCT01758237|Angle Closure Glaucoma|angle closure glaucoma
324973|NCT01758224|Multiple Sclerosis|multiple sclerosis
324974|NCT01758224|Functional Magnetic Stimulation|functional magnetic stimulation
324975|NCT01758224|Pulmonary Function|pulmonary function
324976|NCT01758211|Intracranial Arteriovenous Malformations|intracranial arteriovenous malformations
324977|NCT01758211|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
324978|NCT01758211|Neuronavigation|neuronavigation
324979|NCT01758185|Inactivated split influenza vaccine|inactivated split influenza vaccine
324980|NCT01758185|Immunogenicity|immunogenicity
324981|NCT01758185|Safety|safety
324982|NCT01758185|Consistence|consistence
324983|NCT01758172|pancreaticoduodenectomy|pancreaticoduodenectomy
324984|NCT01758172|postoperative patient|postoperative patient
324985|NCT01758172|colloid|colloid
324986|NCT01758172|albumin|albumin
324987|NCT01758172|hetastarch|hetastarch
324988|NCT01758146|Breast cancer|breast cancer
324989|NCT01758146|obesity|obesity
324990|NCT01758146|aromatase inhibitors|aromatase inhibitors
324991|NCT01758146|postmenopausal|postmenopausal
324992|NCT01758120|IgA nephropathy|iga nephropathy
324993|NCT01758120|Cyclophosphamide|cyclophosphamide
324994|NCT01758120|prednisone|prednisone
324995|NCT01758094|hypogonadism|hypogonadism
324996|NCT01758094|Retinol binding globulin 4|retinol binding globulin 4
324997|NCT01758094|Testosterone treatment|testosterone treatment
324998|NCT01758068|Preterms|preterms
324999|NCT01758068|Coconut Oil application|coconut oil application
325000|NCT01758068|Trans epidermal water loss|trans epidermal water loss
325001|NCT01758068|Weight gain|weight gain
325002|NCT01758055|Mesenchymal stem cell, emphysema, lung function|mesenchymal stem cell, emphysema, lung function
325003|NCT01758042|Kidney|kidney
325004|NCT01758042|Chronic Kidney Disease|chronic kidney disease
325005|NCT01758042|CKD|ckd
325006|NCT01758042|Bone Marrow|bone marrow
325007|NCT01758042|Bone Marrow Transplant|bone marrow transplant
325008|NCT01758042|BMT|bmt
325009|NCT01758042|Leukemia|leukemia
325010|NCT01758042|AML|aml
325011|NCT01758042|ALL|all
325012|NCT01758042|CML|cml
325013|NCT01758042|CLL|cll
325014|NCT01758042|MM|mm
325015|NCT01758042|NHL|nhl
325016|NCT01758042|MDS|mds
325017|NCT01758029|quality of life|quality of life
325018|NCT01758029|Testosterone Undecanoate|testosterone undecanoate
325019|NCT01758029|partner|partner
325020|NCT01758029|questionnaire|questionnaire
325021|NCT01758003|Physical Activity|physical activity
325022|NCT01758003|Sedentary Behaviour|sedentary behaviour
325023|NCT01758003|Healthy Volunteer|healthy volunteer
325024|NCT01758003|Quality of Life|quality of life
325025|NCT01758003|Exercise Capacity|exercise capacity
325026|NCT01758003|Transtheoretical Model|transtheoretical model
325027|NCT01757990|dental caries|dental caries
325028|NCT01757990|Stevioside|stevioside
325029|NCT01757990|Rebaudioside|rebaudioside
325030|NCT01757990|plaque pH|plaque ph
325031|NCT01757990|Streptococcus mutans|streptococcus mutans
325032|NCT01757977|Vivasight DL|vivasight dl
325033|NCT01757977|double lumen endotracheal tube|double lumen endotracheal tube
325034|NCT01757977|fiberoptic confirmation of tube position|fiberoptic confirmation of tube position
325035|NCT01757964|Crohns Disease|crohns disease
325036|NCT01757964|Ulcerative Colitis|ulcerative colitis
325037|NCT01757964|Inflammatory Bowel Disease|inflammatory bowel disease
325038|NCT01757964|IBD|ibd
325041|NCT01757951|medial malleolus|medial malleolus
325042|NCT01757951|Osteosynthesis|osteosynthesis
325043|NCT01757938|HIV|hiv
325044|NCT01757938|Prevention|prevention
325045|NCT01757938|Adult Male Circumcision|adult male circumcision
325046|NCT01757938|Uganda|uganda
325047|NCT01757938|Shang Ring|shang ring
325048|NCT01757925|activity|activity
325049|NCT01757925|gaming|gaming
325050|NCT01757925|obesity|obesity
325051|NCT01757925|Active Gaming|active gaming
325052|NCT01757925|Control|control
325053|NCT01757912|mechanical ventilation|mechanical ventilation
325054|NCT01757899|ALI|ali
325055|NCT01757899|Acute Lung Injury|acute lung injury
325056|NCT01757899|ARDS|ards
325057|NCT01757899|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
325058|NCT01757899|Pediatric Critical Care Medicine|pediatric critical care medicine
325059|NCT01757899|Inflammatory Response|inflammatory response
325060|NCT01757886|Myocardial infarction, Inflammation, Thrombus, Coronary angioplasty.|myocardial infarction, inflammation, thrombus, coronary angioplasty.
325061|NCT01757847|Binge-Eating Disorder|binge-eating disorder
325062|NCT01757847|Obesity|obesity
325063|NCT01757847|emotional eating|emotional eating
325064|NCT01757834|Thyroid Nodule|thyroid nodule
325065|NCT01757834|Thyroid Neoplasm|thyroid neoplasm
325066|NCT01757834|Differential Diagnosis|differential diagnosis
325067|NCT01757834|Elastography|elastography
325068|NCT01757834|Elasticity Imaging Technique|elasticity imaging technique
325069|NCT01757834|Sonoelastography|sonoelastography
325070|NCT01757821|Stroke|stroke
325071|NCT01757821|rTMS|rtms
325072|NCT01757821|TMS|tms
325073|NCT01757808|PAH|pah
325074|NCT01757808|Ranolazine|ranolazine
325075|NCT01757808|right ventricle|right ventricle
325076|NCT01757808|Safety|safety
325077|NCT01757808|cardiopulmonary exercise testing|cardiopulmonary exercise testing
325078|NCT01757795|acute ischemic stroke|acute ischemic stroke
325079|NCT01757795|ischemic stroke|ischemic stroke
325080|NCT01757795|stroke|stroke
325081|NCT01757769|Lower urinary tract symptoms|lower urinary tract symptoms
325082|NCT01757769|benign prostatic hyperplasia|benign prostatic hyperplasia
325083|NCT01757743|Heart Septal Defects, Atrial|heart septal defects, atrial
325084|NCT01757743|Oedema formation|oedema formation
325085|NCT01757717|radiation therapy|radiation therapy
325086|NCT01757717|HDR brachytherapy|hdr brachytherapy
325087|NCT01757717|Ir-192 high dose rate|ir-192 high dose rate
325088|NCT01757717|12-260|12-260
325089|NCT01757704|Cardiac de-airing|cardiac de-airing
325090|NCT01757704|Air emboli|air emboli
325091|NCT01757704|Trans-cranial Echo-Doppler|trans-cranial echo-doppler
325092|NCT01757704|Intraoperative Trans-esophageal Echocardiography|intraoperative trans-esophageal echocardiography
325093|NCT01757691|Acute demyelinating optic neuritis|acute demyelinating optic neuritis
325094|NCT01757691|Optic neuritis|optic neuritis
325095|NCT01757678|Coronary Artery Disease Computed Fractional Flow Reserve|coronary artery disease computed fractional flow reserve
325096|NCT01757665|Aortic valve replacement|aortic valve replacement
325097|NCT01757665|Mitral valve replacement|mitral valve replacement
325098|NCT01757626|Bone Marrow|bone marrow
325099|NCT01757626|Hu3F8|hu3f8
325100|NCT01757626|GM-CSF|gm-csf
325101|NCT01757626|12-230|12-230
325102|NCT01757587|Type 2 Diabetes|type 2 diabetes
325103|NCT01757587|Galvus|galvus
325104|NCT01757587|basal insulin|basal insulin
325105|NCT01757587|HbA1c|hba1c
325106|NCT01757574|CIDP- chronic inflammatory demyelinating neuropathy|cidp- chronic inflammatory demyelinating neuropathy
325107|NCT01757574|demyelinating neuropathy|demyelinating neuropathy
325108|NCT01757574|alemtuzumab|alemtuzumab
325109|NCT01757561|jugular bulb oxygen saturation|jugular bulb oxygen saturation
325110|NCT01757561|postoperative cognitive dysfunction|postoperative cognitive dysfunction
325111|NCT01757561|propofol|propofol
325112|NCT01757561|sevoflurane|sevoflurane
325113|NCT01757548|varicocele; male infertile;varicocelectomy|varicocele; male infertile;varicocelectomy
325114|NCT01757535|Maintenance therapy|maintenance therapy
325115|NCT01757535|AML|aml
325116|NCT01757535|Acute Myeloid Leukemia|acute myeloid leukemia
325117|NCT01757535|oral Azacitidine|oral azacitidine
325118|NCT01757535|best supportive care|best supportive care
325119|NCT01757535|complete remission|complete remission
325120|NCT01757509|Parkinson's disease|parkinson's disease
325121|NCT01757509|Set dancing|set dancing
325122|NCT01757496|Bronchiolitis|bronchiolitis
325123|NCT01757496|Respiratory Syncytial Virus|respiratory syncytial virus
325124|NCT01757496|Cough Assist|cough assist
325125|NCT01757496|Physiotherapy|physiotherapy
325126|NCT01757470|effectiveness of risk mitigation,|effectiveness of risk mitigation,
325127|NCT01757470|knowledge and understanding survey,|knowledge and understanding survey,
325128|NCT01757470|drug utilisation study,|drug utilisation study,
325129|NCT01757470|post marketing commitments|post marketing commitments
325130|NCT01757457|inflammation|inflammation
325131|NCT01757457|thrombosis|thrombosis
325132|NCT01757457|platelets|platelets
325133|NCT01757457|adhesion molecules|adhesion molecules
325134|NCT01757457|endothelium|endothelium
325135|NCT01757418|Sickle Cell Disease|sickle cell disease
325136|NCT01757418|Pain|pain
325137|NCT01757418|Immune Globulin|immune globulin
325138|NCT01757405|with Factor VIII (FVIII) or Factor IX (FIX) inhibitors|with factor viii (fviii) or factor ix (fix) inhibitors
325139|NCT01757392|Treatment|treatment
325140|NCT01757392|common wart lesions|common wart lesions
325141|NCT01757392|(verruca vulgaris)|(verruca vulgaris)
325142|NCT01757379|Short chain fatty acids|short chain fatty acids
325143|NCT01757379|Acetate|acetate
325144|NCT01757379|Propionate|propionate
325145|NCT01757379|Butyrate|butyrate
325146|NCT01757379|Bioavailability|bioavailability
325147|NCT01757314|arterial lines|arterial lines
325148|NCT01757301|Pain|pain
325149|NCT01757301|Depression|depression
325150|NCT01757301|Anxiety|anxiety
325151|NCT01757301|Musculoskeletal|musculoskeletal
325152|NCT01757301|Fibromyalgia|fibromyalgia
325153|NCT01757288|STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER|stage iiia/b nsclc / inoperable lung cancer
325154|NCT01757275|peptic ulcer bleeding|peptic ulcer bleeding
325155|NCT01757275|prevention of rebleeding|prevention of rebleeding
325156|NCT01757275|successful endoscopic haemostatic therapy|successful endoscopic haemostatic therapy
325157|NCT01757262|Coronary Heart Disease|coronary heart disease
325158|NCT01757236|Antibiotic|antibiotic
325159|NCT01757236|linezolid|linezolid
325160|NCT01757236|linezolid/rifampin|linezolid/rifampin
325161|NCT01757223|Diffuse Coronary Artery Disease (CAD)|diffuse coronary artery disease (cad)
325162|NCT01757210|Aprepitant|aprepitant
325163|NCT01757210|Pediatrics|pediatrics
325164|NCT01757210|Chemotherapy-induced nausea/vomiting|chemotherapy-induced nausea/vomiting
325165|NCT01757210|Survey|survey
325166|NCT01757184|Enzyme Replacement Therapy (ERT)|enzyme replacement therapy (ert)
325167|NCT01757184|Lysosomal Storage Disease|lysosomal storage disease
325168|NCT01757184|Late Onset Lysosomal Acid Lipase (LAL) Deficiency|late onset lysosomal acid lipase (lal) deficiency
325169|NCT01757184|Acid cholesteryl ester hydrolase deficiency, type 2|acid cholesteryl ester hydrolase deficiency, type 2
325170|NCT01757184|Acid lipase disease|acid lipase disease
325171|NCT01757184|Cholesterol ester hydrolase deficiency|cholesterol ester hydrolase deficiency
325172|NCT01757184|LAL Deficiency|lal deficiency
325173|NCT01757184|LIPA Deficiency|lipa deficiency
325174|NCT01757184|Wolman disease|wolman disease
325175|NCT01757171|Gastric Cancer|gastric cancer
325176|NCT01757158|lung cancer|lung cancer
325177|NCT01757158|lobectomy|lobectomy
325178|NCT01757158|local recurrence|local recurrence
325179|NCT01757145|Cord blood transplantation|cord blood transplantation
325180|NCT01757145|Eltrombopag|eltrombopag
325181|NCT01757145|Platelet engraftment|platelet engraftment
325182|NCT01757106|xenon anesthesia|xenon anesthesia
325183|NCT01757106|sevoflurane anesthesia|sevoflurane anesthesia
325184|NCT01757106|off-pump coronary artery bypass graft surgery|off-pump coronary artery bypass graft surgery
325185|NCT01757093|INDIRECT CALORIMETRY|indirect calorimetry
325186|NCT01757093|MECHANICAL VENTILATION|mechanical ventilation
325187|NCT01757093|WEANING VENTILATOR|weaning ventilator
325188|NCT01757093|AUTOMATIC TUBE COMPENSATION|automatic tube compensation
325189|NCT01757067|ablations|ablations
325190|NCT01757067|CHF|chf
325191|NCT01757067|PVC|pvc
325192|NCT01757054|probiotic|probiotic
325193|NCT01757054|LGG|lgg
325194|NCT01757054|BB-12|bb-12
325195|NCT01757054|fecal recovery|fecal recovery
325196|NCT01757054|healthy subjects|healthy subjects
325197|NCT01757041|Streptococcus agalactiae|streptococcus agalactiae
325198|NCT01757041|Maternal|maternal
325199|NCT01757041|Newborn|newborn
325200|NCT01757041|Africa|africa
325201|NCT01757028|Maternal and newborn health|maternal and newborn health
325202|NCT01757028|Africa|africa
325203|NCT01757015|COPD|copd
325204|NCT01757015|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
325205|NCT01757015|Moderate to severe airflow limitation|moderate to severe airflow limitation
325206|NCT01757015|GOLD spirometric classification 2 and 3|gold spirometric classification 2 and 3
325207|NCT01757015|GOLD group B and D|gold group b and d
325208|NCT01757015|NVA237|nva237
325209|NCT01757015|Salmeterol fluticasone propionate|salmeterol fluticasone propionate
325210|NCT01757002|Urban adolescents|urban adolescents
325211|NCT01757002|Acute asthma|acute asthma
325212|NCT01757002|Asthma|asthma
325213|NCT01757002|Computer tailoring|computer tailoring
325214|NCT01757002|Web-based intervention|web-based intervention
325215|NCT01757002|Puff City|puff city
325216|NCT01756950|Influenza|influenza
325217|NCT01756950|Virus|virus
325218|NCT01756950|Monoclonal|monoclonal
325219|NCT01756950|Antibody|antibody
325220|NCT01756950|Immunization|immunization
325221|NCT01756950|Treatment|treatment
325222|NCT01756937|osteoarthritis of the knee|osteoarthritis of the knee
325223|NCT01756924|prosthetic joint infection|prosthetic joint infection
325224|NCT01756924|hip arthroplasty|hip arthroplasty
325225|NCT01756924|MRSA|mrsa
325226|NCT01756924|knee arthroplasty|knee arthroplasty
325227|NCT01756911|MFM|mfm
325228|NCT01756911|Multilayer Flow Modulator|multilayer flow modulator
325229|NCT01756911|Multilayer stent|multilayer stent
325230|NCT01756911|Thoracoabdominal Aortic Aneurysm|thoracoabdominal aortic aneurysm
325231|NCT01756898|Atopic Dermatitis|atopic dermatitis
325232|NCT01756898|eczema|eczema
325233|NCT01756885|Smoking cessation|smoking cessation
325234|NCT01756885|Nicotine dependence|nicotine dependence
325235|NCT01756885|Varenicline|varenicline
325236|NCT01756885|Chantix|chantix
325237|NCT01756885|Cancer|cancer
325238|NCT01756872|infertility|infertility
325239|NCT01756872|Assisted reproductive technology|assisted reproductive technology
325240|NCT01756872|ovarian reserve|ovarian reserve
325241|NCT01756859|Portal hypertension|portal hypertension
325242|NCT01756859|HVPG|hvpg
325243|NCT01756859|MRI|mri
325244|NCT01756846|HEART score|heart score
325245|NCT01756846|risk score|risk score
325246|NCT01756846|impact|impact
325247|NCT01756846|chest pain|chest pain
325248|NCT01756833|abdominal|abdominal
325249|NCT01756833|aortic|aortic
325250|NCT01756833|aneurysm|aneurysm
325251|NCT01756820|Carpal Tunnel Syndrome|carpal tunnel syndrome
325252|NCT01756820|transverse ligament|transverse ligament
325253|NCT01756820|carpal tunnel release|carpal tunnel release
325254|NCT01756820|endoscopic|endoscopic
325255|NCT01756820|minimal invasive|minimal invasive
325256|NCT01756820|mini-open|mini-open
325257|NCT01756820|median nerve|median nerve
325258|NCT01756807|Optical Coherence Tomography|optical coherence tomography
325259|NCT01756807|Geneous Stent|geneous stent
325260|NCT01756807|Combo Stent|combo stent
325261|NCT01756794|Alcoholic hepatitis|alcoholic hepatitis
325262|NCT01756794|Liver transplantation|liver transplantation
325263|NCT01756794|Alcohol relapse|alcohol relapse
325264|NCT01756794|Alcoholic cirrhosis|alcoholic cirrhosis
325265|NCT01756781|PD-0332991|pd-0332991
325266|NCT01756781|Midazolam|midazolam
325267|NCT01756781|Drug-Drug Interaction Study|drug-drug interaction study
325268|NCT01756781|Healthy Adult Volunteer|healthy adult volunteer
325269|NCT01756768|Phase 1|phase 1
325270|NCT01756768|Mass Balance study|mass balance study
325271|NCT01756768|Radio-labeled dose|radio-labeled dose
325272|NCT01756768|PD-0332991|pd-0332991
325273|NCT01756755|Sepsis|sepsis
325274|NCT01756742|Pleural Effusion|pleural effusion
325275|NCT01756742|Respiratory physiotherapy|respiratory physiotherapy
325276|NCT01756742|Length of stay|length of stay
325277|NCT01756729|Brain tumor|brain tumor
325278|NCT01756729|Treatment|treatment
325279|NCT01756729|Minimal toxicity|minimal toxicity
325280|NCT01756729|GBM|gbm
325281|NCT01756729|Glioblastoma|glioblastoma
325282|NCT01756729|Recurrent|recurrent
325283|NCT01756729|TTFields|ttfields
325284|NCT01756716|Diabetic Nephropathy|diabetic nephropathy
325285|NCT01756703|Diabetic Nephropathy|diabetic nephropathy
325286|NCT01756690|respiratory distress syndrome, adult|respiratory distress syndrome, adult
325287|NCT01756690|blood component transfusion|blood component transfusion
325288|NCT01756690|gastrointestinal hemorrhage|gastrointestinal hemorrhage
325289|NCT01756690|blood coagulation|blood coagulation
325290|NCT01756651|Intranasal fentanyl|intranasal fentanyl
325291|NCT01756651|Cystoscopy|cystoscopy
325292|NCT01756638|Prostate cancer|prostate cancer
325293|NCT01756638|Abiraterone acetate|abiraterone acetate
325294|NCT01756638|JNJ-212082|jnj-212082
325295|NCT01756625|cetuximab|cetuximab
325296|NCT01756625|nicotine|nicotine
325297|NCT01756625|magnesium|magnesium
325298|NCT01756586|popliteal block|popliteal block
325299|NCT01756586|analgesia duration|analgesia duration
325300|NCT01756573|block duration|block duration
325301|NCT01756573|analgesia|analgesia
325302|NCT01756560|anterior cruciate ligament|anterior cruciate ligament
325303|NCT01756560|block duration|block duration
325304|NCT01756547|Nephrocalcinosis|nephrocalcinosis
325305|NCT01756547|Extreme premature|extreme premature
325306|NCT01756521|QT,|qt,
325307|NCT01756521|QTc,|qtc,
325308|NCT01756521|electrocardiogram,|electrocardiogram,
325309|NCT01756521|moxifloxacin|moxifloxacin
325310|NCT01756508|eculizumab|eculizumab
325311|NCT01756508|kidney transplantation|kidney transplantation
325312|NCT01756508|reperfusion|reperfusion
325313|NCT01756508|rejection|rejection
325314|NCT01756508|infection|infection
325315|NCT01756495|QTc,|qtc,
325316|NCT01756495|GW856553 .|gw856553 .
325317|NCT01756495|P38,|p38,
325318|NCT01756482|Respiratory|respiratory
325319|NCT01756482|Syncytial|syncytial
325320|NCT01756482|Virus|virus
325321|NCT01756482|Infections|infections
325322|NCT01756482|RSV|rsv
325323|NCT01756456|Keratitis|keratitis
325324|NCT01756456|Corneal Ulcer|corneal ulcer
325325|NCT01756443|sciatic nerve block|sciatic nerve block
325326|NCT01756443|ORIF lateral malleolus|orif lateral malleolus
325327|NCT01756443|sequential injection|sequential injection
325328|NCT01756443|premixed injection|premixed injection
325329|NCT01756443|local anaesthetics|local anaesthetics
325330|NCT01756430|Carvedilol SR|carvedilol sr
325331|NCT01756430|Carvedilol IR|carvedilol ir
325332|NCT01756430|Hypertension|hypertension
325333|NCT01756430|Essential Hypertension|essential hypertension
325334|NCT01756417|Healthy|healthy
325335|NCT01756417|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
325336|NCT01756417|Metformin|metformin
325337|NCT01756417|Pharmacokinetics|pharmacokinetics
325338|NCT01756417|Pharmacodynamics|pharmacodynamics
325339|NCT01756404|Healthy|healthy
326044|NCT01752920|ARQ 087|arq 087
325340|NCT01756404|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
325341|NCT01756404|Pharmacokinetics|pharmacokinetics
325342|NCT01756404|Pharmacodynamics|pharmacodynamics
325343|NCT01756404|Obesity|obesity
325344|NCT01756391|pediatric|pediatric
325345|NCT01756391|childhood|childhood
325346|NCT01756391|allergy|allergy
325347|NCT01756378|Mobilization with movement,knee osteoarthritis,|mobilization with movement,knee osteoarthritis,
325348|NCT01756352|FET|fet
325349|NCT01756352|Fluoroethyl tyrosine|fluoroethyl tyrosine
325350|NCT01756352|GBM|gbm
325351|NCT01756352|Response to treatment|response to treatment
325352|NCT01756352|Avastin|avastin
325353|NCT01756352|Brain Tumor|brain tumor
325354|NCT01756339|Pneumonia|pneumonia
325355|NCT01756339|CABP|cabp
325356|NCT01756339|CAP|cap
325357|NCT01756339|Macrolide|macrolide
325358|NCT01756326|Non-Union Fractures|non-union fractures
325359|NCT01756326|Impaired Healing|impaired healing
325360|NCT01756326|Fractures|fractures
325361|NCT01756326|Orthopedics|orthopedics
325362|NCT01756326|Bone|bone
325363|NCT01756326|Musculoskeletal Disorders|musculoskeletal disorders
325364|NCT01756300|Essential Hypertension|essential hypertension
325365|NCT01756300|Renal Denervation|renal denervation
325366|NCT01756300|Vascular Disease|vascular disease
325367|NCT01756300|Renal Catheter Ablation|renal catheter ablation
325368|NCT01756300|Primary Hypertension|primary hypertension
325369|NCT01756261|EYLEA|eylea
325370|NCT01756261|Age-Related Macular Degeneration|age-related macular degeneration
325371|NCT01756261|QOL|qol
325372|NCT01756248|EYLEA|eylea
325373|NCT01756248|Age-Related Macular Degeneration|age-related macular degeneration
325374|NCT01756235|Post-marketing observational study (PMOS) Protocol|post-marketing observational study (pmos) protocol
325375|NCT01756235|Rheumatoid Arthritis|rheumatoid arthritis
325376|NCT01756235|Physical Activity|physical activity
325377|NCT01756235|Adalimumab|adalimumab
325378|NCT01756235|Humira®|humira®
325379|NCT01756222|Bicuspid Aortic Valve Disease|bicuspid aortic valve disease
325380|NCT01756222|Bicuspid Aortic Valve|bicuspid aortic valve
325381|NCT01756222|BAV|bav
325382|NCT01756196|Spinal injection; Steroid; Systemic reaction; Complication; Side effect; Diabetes mellitus; Hypertension; Risk factor|spinal injection; steroid; systemic reaction; complication; side effect; diabetes mellitus; hypertension; risk factor
325383|NCT01756170|cervical cancer|cervical cancer
325384|NCT01756170|radiotherapy|radiotherapy
325385|NCT01756170|postoperative therapy|postoperative therapy
325386|NCT01756170|chemotherapy|chemotherapy
325387|NCT01756157|Crossover|crossover
325388|NCT01756157|Prevention|prevention
325389|NCT01756157|Hereditary Angioedema|hereditary angioedema
325390|NCT01756157|C1 esterase inhibitor|c1 esterase inhibitor
325391|NCT01756157|C1 inhibitor|c1 inhibitor
325392|NCT01756157|Subcutaneous|subcutaneous
325393|NCT01756157|Recombinant human hyaluronidase|recombinant human hyaluronidase
325394|NCT01756092|Breast Cancer|breast cancer
325395|NCT01756092|Lumpectomy|lumpectomy
325396|NCT01756092|Mastectomy, Segmental|mastectomy, segmental
325397|NCT01756066|Obesity|obesity
325398|NCT01756066|Weight loss program|weight loss program
325399|NCT01756066|incentives|incentives
325400|NCT01756053|Smoking|smoking
325401|NCT01756053|Tobacco|tobacco
325402|NCT01756040|intestinal permeability|intestinal permeability
325403|NCT01756040|preterm infants|preterm infants
325404|NCT01756040|dual sugar test|dual sugar test
325405|NCT01756027|Rosacea|rosacea
325406|NCT01756027|Ulthera System|ulthera system
325407|NCT01756027|Ultherapy™ Treatment|ultherapy™ treatment
325408|NCT01756027|Ulthera, Inc.|ulthera, inc.
325409|NCT01756027|Ultrasound treatment for the skin|ultrasound treatment for the skin
325410|NCT01755988|Telemedicine|telemedicine
325411|NCT01755988|Heart Failure|heart failure
325412|NCT01755988|Self care|self care
325413|NCT01755988|Quality of life|quality of life
325414|NCT01755988|Mortality|mortality
325415|NCT01755988|Hospitalization|hospitalization
325416|NCT01755975|LENALIDOMIDE (CC-5013)|lenalidomide (cc-5013)
325417|NCT01755975|Romidepsin (Istodax)|romidepsin (istodax)
325418|NCT01755975|12-170|12-170
325419|NCT01755962|diet|diet
325420|NCT01755962|obese|obese
325421|NCT01755962|overweight|overweight
325422|NCT01755962|exercise|exercise
325423|NCT01755962|resistance training|resistance training
325424|NCT01755962|nutrition|nutrition
325425|NCT01755962|glycemic load|glycemic load
325426|NCT01755962|body composition|body composition
325427|NCT01755962|weight training|weight training
325428|NCT01755962|lifestyle|lifestyle
325429|NCT01755949|atrial fibrillation|atrial fibrillation
325430|NCT01755949|catheter ablation|catheter ablation
325431|NCT01755949|colchicine|colchicine
325432|NCT01755949|c reactive protein|c reactive protein
325433|NCT01755949|CRP|crp
325434|NCT01755936|Aortic Stenosis|aortic stenosis
325435|NCT01755936|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
325436|NCT01755936|Late Gadolinium enhancement|late gadolinium enhancement
325437|NCT01755936|T1 mapping techniques|t1 mapping techniques
325438|NCT01755936|Replacement fibrosis|replacement fibrosis
325439|NCT01755936|Diffuse interstitial fibrosis|diffuse interstitial fibrosis
325440|NCT01755923|non-small cell lung cancer|non-small cell lung cancer
325441|NCT01755923|wild-type EGFR|wild-type egfr
325442|NCT01755923|gefitinib|gefitinib
325443|NCT01755923|docetaxel|docetaxel
325444|NCT01755923|second-line therapy|second-line therapy
325445|NCT01755910|Breast Surgery|breast surgery
325446|NCT01755910|Thoracic Paravertebral Block|thoracic paravertebral block
325447|NCT01755910|HRV|hrv
325448|NCT01755910|Autonomic Nervous System|autonomic nervous system
325449|NCT01755884|Wheat allergy|wheat allergy
325450|NCT01755884|Immunotherapy|immunotherapy
325451|NCT01755884|Desensitization|desensitization
325452|NCT01755884|Food allergy|food allergy
325453|NCT01755884|T cells|t cells
325454|NCT01755858|elamipretide|elamipretide
325455|NCT01755845|cervical cancer|cervical cancer
325456|NCT01755845|radiotherapy|radiotherapy
325457|NCT01755845|postoperative therapy|postoperative therapy
325458|NCT01755845|chemotherapy|chemotherapy
325459|NCT01755832|inflammatory rheumatic joint disease|inflammatory rheumatic joint disease
325460|NCT01755832|text message|text message
325461|NCT01755832|> 18 years|> 18 years
325462|NCT01755832|Norwegian speaking|norwegian speaking
325463|NCT01755806|Aortic annulus|aortic annulus
325464|NCT01755806|Aortic calcification|aortic calcification
325465|NCT01755806|Multislice computed tomography|multislice computed tomography
325466|NCT01755806|Cardiac cycle|cardiac cycle
325467|NCT01755767|MET diagnostic-high|met diagnostic-high
325468|NCT01755767|Unresectable|unresectable
325469|NCT01755767|Hepatocellular|hepatocellular
325470|NCT01755767|Carcinoma|carcinoma
325471|NCT01755767|c-Met inhibitor|c-met inhibitor
325472|NCT01755728|Paracetamol|paracetamol
325473|NCT01755728|Acetaminophen|acetaminophen
325474|NCT01755728|PDA|pda
325475|NCT01755728|Preterm infants|preterm infants
325476|NCT01755715|Abortion|abortion
325477|NCT01755715|Contraception|contraception
325478|NCT01755715|Intrauterine Devices|intrauterine devices
325479|NCT01755715|Intrauterine Device Expulsion|intrauterine device expulsion
325480|NCT01755702|caffeine|caffeine
325481|NCT01755702|paracetamol|paracetamol
325482|NCT01755702|tension headache|tension headache
325483|NCT01755689|pertussis|pertussis
325484|NCT01755689|Meningococcal meningitis|meningococcal meningitis
325485|NCT01755689|Meningococcal infections|meningococcal infections
325486|NCT01755689|HPV|hpv
325487|NCT01755689|Neisseria meningitidis|neisseria meningitidis
325488|NCT01755689|Vaccines, conjugate|vaccines, conjugate
325489|NCT01755689|tetanus|tetanus
325490|NCT01755689|diphtheria|diphtheria
325491|NCT01755689|Meningococcal vaccines|meningococcal vaccines
325492|NCT01755689|Immunogenicity|immunogenicity
325493|NCT01755663|CT coronary|ct coronary
325494|NCT01755663|Coronary arterial disease|coronary arterial disease
325495|NCT01755663|ivabradine|ivabradine
325496|NCT01755663|metoprolol|metoprolol
325497|NCT01755650|18F FPM|18f fpm
325498|NCT01755650|PET/CT|pet/ct
325499|NCT01755650|microdosing|microdosing
325500|NCT01755624|Non-Small Cell Lung Cancer|non-small cell lung cancer
325501|NCT01755624|NSCLC|nsclc
325502|NCT01755624|Brain metastases|brain metastases
325503|NCT01755624|Treatment|treatment
325504|NCT01755624|Minimal toxicity|minimal toxicity
325505|NCT01755624|TTFields|ttfields
325506|NCT01755624|TTF|ttf
325507|NCT01755624|Tumor Treating Fields|tumor treating fields
325508|NCT01755624|NovoCure|novocure
325509|NCT01755611|Minocycline|minocycline
325510|NCT01755611|Mexico|mexico
325511|NCT01755611|Acne|acne
325512|NCT01755611|bioequivalence|bioequivalence
325513|NCT01755598|Positive Interferon-γ release assay|positive interferon-γ release assay
325514|NCT01755598|Efficacy|efficacy
325515|NCT01755598|Adults|adults
325516|NCT01755598|Tuberculosis vaccine|tuberculosis vaccine
325517|NCT01755598|Endemic region|endemic region
325518|NCT01755585|Radiation therapy|radiation therapy
325519|NCT01755585|5-fluorouracil|5-fluorouracil
325520|NCT01755585|Cisplatin|cisplatin
325521|NCT01755585|Pharmacokinetics|pharmacokinetics
325522|NCT01755585|Matrix Metalloproteinase|matrix metalloproteinase
325523|NCT01755572|Type 2 Diabetes|type 2 diabetes
325524|NCT01755572|Hypertension|hypertension
325525|NCT01755572|Liraglutide|liraglutide
325526|NCT01755572|GLP-1|glp-1
325527|NCT01755559|malaria|malaria
325528|NCT01755559|artemisinin|artemisinin
325529|NCT01755559|artemisinin-based combination therapies|artemisinin-based combination therapies
325530|NCT01755559|Plasmodium falciparum|plasmodium falciparum
325531|NCT01755559|efficacy|efficacy
325532|NCT01755546|Chronic Pain|chronic pain
325533|NCT01755546|CLBP|clbp
325534|NCT01755546|Chronic Low Back Pain|chronic low back pain
325535|NCT01755546|Back Pain|back pain
325536|NCT01755546|Osteoarthritis|osteoarthritis
325537|NCT01755546|OA|oa
325538|NCT01755546|Neuropathic Pain|neuropathic pain
325539|NCT01755546|Nerve pain|nerve pain
325540|NCT01755546|Painful neuropathy|painful neuropathy
325541|NCT01755533|adolescent substance use|adolescent substance use
325542|NCT01755533|rural substance use|rural substance use
325543|NCT01755533|middle school prevention|middle school prevention
325544|NCT01755533|implementation processes|implementation processes
325545|NCT01755533|implementation quality|implementation quality
325546|NCT01755533|adaptation of prevention curricula|adaptation of prevention curricula
325547|NCT01755533|dissemination|dissemination
325548|NCT01755520|CABG|cabg
325549|NCT01755520|CAD|cad
325550|NCT01755520|antiplatelet drug|antiplatelet drug
325551|NCT01755520|Ticagrelor|ticagrelor
325552|NCT01755520|Aspirin|aspirin
325553|NCT01755507|PSC|psc
325554|NCT01755494|Type 2 diabetes, Saxagliptin, Metformin,Fixed dose combination tablet, Bioequivalence, pharmacokinetic, safety, tolerability|type 2 diabetes, saxagliptin, metformin,fixed dose combination tablet, bioequivalence, pharmacokinetic, safety, tolerability
325555|NCT01755468|beta-cell function, type 2 diabetes, intermittent insulin|beta-cell function, type 2 diabetes, intermittent insulin
325556|NCT01755455|Cystic fibrosis|cystic fibrosis
325557|NCT01755455|Iron|iron
325558|NCT01755455|Hepcidin|hepcidin
325559|NCT01755455|Anemia|anemia
325560|NCT01755455|Erythropoiesis|erythropoiesis
325561|NCT01755442|Ambulatory blood pressure|ambulatory blood pressure
325562|NCT01755442|Type 2 diabetes|type 2 diabetes
325563|NCT01755416|Type 1 diabetes|type 1 diabetes
325564|NCT01755416|closed loop|closed loop
325565|NCT01755416|artificial pancreas|artificial pancreas
325566|NCT01755416|insulin|insulin
325567|NCT01755416|victoza|victoza
325568|NCT01755416|liraglutide|liraglutide
325569|NCT01755338|cerebrospinal fluid|cerebrospinal fluid
325570|NCT01755338|inflammatory markers|inflammatory markers
325571|NCT01755338|heart surgery|heart surgery
325572|NCT01755338|neuronal damage|neuronal damage
325573|NCT01755338|blood brain barrier|blood brain barrier
325574|NCT01755299|Energy drinks|energy drinks
325575|NCT01755299|Wakefulness|wakefulness
325576|NCT01755299|Caffeine|caffeine
325577|NCT01755273|Pancreaticoduodenectomy|pancreaticoduodenectomy
325578|NCT01755273|Diabetes|diabetes
325579|NCT01755260|POPF|popf
325580|NCT01755260|pancreaticoduodenectomy|pancreaticoduodenectomy
325581|NCT01755260|enteral nutrition|enteral nutrition
325582|NCT01755260|parenteral nutrition|parenteral nutrition
325583|NCT01755247|acne|acne
325584|NCT01755234|Outpatient|outpatient
325585|NCT01755234|Surgery|surgery
325586|NCT01755234|Anesthesia|anesthesia
325587|NCT01755221|Laryngopharyngeal reflux (LPR)|laryngopharyngeal reflux (lpr)
325588|NCT01755221|Extraesophageal reflux|extraesophageal reflux
325589|NCT01755221|Reflux laryngitis|reflux laryngitis
325590|NCT01755221|Posterior laryngitis|posterior laryngitis
325591|NCT01755221|Proton pump inhibitor (PPI) medication|proton pump inhibitor (ppi) medication
325592|NCT01755221|Restech pH probe|restech ph probe
325593|NCT01755195|Dual Inhibitor of MET and VEGFR|dual inhibitor of met and vegfr
325594|NCT01755195|XL184|xl184
325595|NCT01755195|Metastatic Refractory|metastatic refractory
325596|NCT01755195|Soft Tissue Sarcoma|soft tissue sarcoma
325597|NCT01755195|Rare Heterogeneous Tumor|rare heterogeneous tumor
325598|NCT01755182|locoregional treatment|locoregional treatment
325599|NCT01755182|liver metastases|liver metastases
325600|NCT01755182|transarterial embolization|transarterial embolization
325601|NCT01755182|upfront treatment|upfront treatment
325602|NCT01755182|inoperable|inoperable
325603|NCT01755182|octreotide|octreotide
325604|NCT01755182|gastroenteropancreatic (GEP)primary|gastroenteropancreatic (gep)primary
325605|NCT01755182|pulmonary primary|pulmonary primary
325606|NCT01755182|primary unknown origin|primary unknown origin
325607|NCT01755182|systemic therapy|systemic therapy
325608|NCT01755169|Chronic pain|chronic pain
325609|NCT01755169|Child|child
325610|NCT01755169|Pediatric|pediatric
325611|NCT01755169|Ketamine|ketamine
325612|NCT01755130|Breast Cancer|breast cancer
325613|NCT01755130|LOUIS-3D|louis-3d
325614|NCT01755130|Breast Study|breast study
325615|NCT01755130|x-ray|x-ray
325616|NCT01755130|Multimode Laser Optoacoustic Ultrasonic Tomography System|multimode laser optoacoustic ultrasonic tomography system
325617|NCT01755130|Mass palpable or nonpalpable|mass palpable or nonpalpable
325618|NCT01755130|Breast lesions|breast lesions
325619|NCT01755130|Ductal carcinomas|ductal carcinomas
325620|NCT01755130|Lobular carcinomas|lobular carcinomas
325621|NCT01755130|Fibroadenomas|fibroadenomas
325622|NCT01755078|Phosphate binder|phosphate binder
325623|NCT01755065|laparoscopic surgery|laparoscopic surgery
325624|NCT01755065|teenager|teenager
325625|NCT01755052|Acute Myocardial Infarction|acute myocardial infarction
325626|NCT01755052|Geriatrics|geriatrics
325627|NCT01755052|Cardiology|cardiology
325628|NCT01755052|Aging|aging
325629|NCT01755052|Heart Attack|heart attack
325630|NCT01755052|Risk Factors|risk factors
325631|NCT01755052|Quality of Care|quality of care
325632|NCT01755052|Risk Models|risk models
325633|NCT01755026|Cesarean Delivery|cesarean delivery
325634|NCT01755026|Wound infection|wound infection
325635|NCT01755026|Obesity|obesity
325636|NCT01755026|Prophylactic antibiotics|prophylactic antibiotics
325637|NCT01755013|Cholangiocarcinoma|cholangiocarcinoma
325638|NCT01755013|Biliary Stricture|biliary stricture
325639|NCT01755013|Biliary obstruction|biliary obstruction
325640|NCT01755013|Bile Duct Cancer|bile duct cancer
325641|NCT01755013|PDT|pdt
325642|NCT01755013|Photodynamic Therapy|photodynamic therapy
325643|NCT01755013|Plastic optic Diffuser|plastic optic diffuser
325644|NCT01755013|Laser|laser
325645|NCT01754987|Vitamins|vitamins
325646|NCT01754987|Malignant Tumor, Tumour|malignant tumor, tumour
325647|NCT01754987|Integrative Medicine|integrative medicine
325648|NCT01754987|Complementary Medicine|complementary medicine
325649|NCT01754987|Alternative Medicine Antioxidants|alternative medicine antioxidants
325650|NCT01754987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
325651|NCT01754987|Pharmacologic Actions|pharmacologic actions
325652|NCT01754987|Protective Agents|protective agents
325653|NCT01754987|Physiological Effects of Drugs|physiological effects of drugs
325654|NCT01754987|Micronutrients|micronutrients
325655|NCT01754987|Growth Substances|growth substances
325656|NCT01754987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic
325657|NCT01754987|Antineoplastic Agents|antineoplastic agents
325658|NCT01754987|Therapeutic Uses|therapeutic uses
325659|NCT01754987|Radiation-Sensitizing Agents|radiation-sensitizing agents
325660|NCT01754987|Liver Cancer|liver cancer
325661|NCT01754948|asthma|asthma
325662|NCT01754948|reactive airway disease|reactive airway disease
325663|NCT01754948|cough|cough
325664|NCT01754948|air pollution|air pollution
325665|NCT01754948|nano particles|nano particles
325666|NCT01754922|exercise tolerance|exercise tolerance
325667|NCT01754922|Veterans|veterans
325668|NCT01754922|operation enduring freedom|operation enduring freedom
325669|NCT01754922|operation Iraqi freedom|operation iraqi freedom
325670|NCT01754909|lung cancer|lung cancer
325671|NCT01754909|radiation pneumonitis|radiation pneumonitis
325672|NCT01754909|mitigation|mitigation
325673|NCT01754909|enalapril|enalapril
325674|NCT01754909|placebo|placebo
325675|NCT01754896|colorectal cancer|colorectal cancer
325676|NCT01754896|fecal immunochemical test|fecal immunochemical test
325677|NCT01754896|fecal occult blood test|fecal occult blood test
325678|NCT01754896|screening|screening
325679|NCT01754883|Posttraumatic Stess Disorder|posttraumatic stess disorder
325680|NCT01754883|Lithium|lithium
325681|NCT01754870|CLL|cll
325682|NCT01754870|SLL|sll
325683|NCT01754857|Lymphoid Leukemia|lymphoid leukemia
325684|NCT01754857|Bendamustine|bendamustine
325685|NCT01754857|Rituximab|rituximab
325686|NCT01754857|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
325687|NCT01754844|Phase 1|phase 1
325688|NCT01754844|Healthy Volunteers|healthy volunteers
325689|NCT01754844|Single Ascending Dose (SAD)|single ascending dose (sad)
325690|NCT01754844|First Time in Man|first time in man
325691|NCT01754844|Pharmacokinetics|pharmacokinetics
325692|NCT01754844|Pharmacodynamics|pharmacodynamics
325693|NCT01754831|children|children
325694|NCT01754831|fluoride varnish|fluoride varnish
325695|NCT01754818|Pharmacokinetics|pharmacokinetics
325696|NCT01754818|volunteers|volunteers
325697|NCT01754805|ASP015K|asp015k
325698|NCT01754805|Rheumatoid Arthritis|rheumatoid arthritis
325699|NCT01754779|calcium phosphate|calcium phosphate
325700|NCT01754779|urolithiasis|urolithiasis
325701|NCT01754779|kidney stones|kidney stones
325702|NCT01754779|hypercalciuria|hypercalciuria
325703|NCT01754753|Mental well-being|mental well-being
325704|NCT01754753|Befriending|befriending
325705|NCT01754740|Xerostomia, Salivary flow, Burning Mouth Syndrome.|xerostomia, salivary flow, burning mouth syndrome.
325706|NCT01754727|Ankylosing Spondylitis|ankylosing spondylitis
325707|NCT01754727|Effectiveness|effectiveness
325708|NCT01754727|Post-marketing observational study (PMOS)|post-marketing observational study (pmos)
325709|NCT01754727|Adalimumab|adalimumab
325710|NCT01754727|Humira®|humira®
325711|NCT01754714|Steatohepatitis|steatohepatitis
325712|NCT01754662|Type 2 diabetes|type 2 diabetes
325713|NCT01754662|Cardiovascular risk|cardiovascular risk
325714|NCT01754662|Endothelial function|endothelial function
325715|NCT01754662|Insulin resistance|insulin resistance
325716|NCT01754662|Soy|soy
325717|NCT01754662|Isoflavones|isoflavones
325718|NCT01754662|Cocoa|cocoa
325719|NCT01754662|Diet|diet
325720|NCT01754649|intrauterine device|intrauterine device
325721|NCT01754649|insertion failure|insertion failure
325722|NCT01754636|Colorectal neoplasms|colorectal neoplasms
325723|NCT01754636|Elderly|elderly
325724|NCT01754636|Randomized clinical trials|randomized clinical trials
325725|NCT01754636|Inclusion.|inclusion.
325726|NCT01754623|Pancreas|pancreas
325727|NCT01754623|Pancreatic|pancreatic
325728|NCT01754623|Neoplasms|neoplasms
325729|NCT01754623|Stereotactic|stereotactic
325730|NCT01754623|Radiosurgery|radiosurgery
325731|NCT01754623|Borderline|borderline
325732|NCT01754623|Resectable|resectable
325733|NCT01754623|Gastrointestinal|gastrointestinal
325734|NCT01754623|Gemcitabine|gemcitabine
325735|NCT01754623|Capecitabine|capecitabine
325736|NCT01754623|Fluorouracil|fluorouracil
325737|NCT01754623|Docetaxel|docetaxel
325738|NCT01754623|SBRT|sbrt
325739|NCT01754623|GTX Chemotherapy|gtx chemotherapy
325740|NCT01754610|family trauma|family trauma
325741|NCT01754610|multi-family therapy|multi-family therapy
326149|NCT01752608|CBT|cbt
325742|NCT01754610|Posttraumatic Stress Disorder|posttraumatic stress disorder
325743|NCT01754610|poverty|poverty
325744|NCT01754597|Patients with breast cancer requiring surgical management with general anesthesia|patients with breast cancer requiring surgical management with general anesthesia
325745|NCT01754584|hyaluronan including concentrations|hyaluronan including concentrations
325746|NCT01754584|molecular weight|molecular weight
325747|NCT01754584|mucociliary differentiation|mucociliary differentiation
325748|NCT01754584|human respiratory epithelial cells|human respiratory epithelial cells
325749|NCT01754571|medication overuse headache|medication overuse headache
325750|NCT01754545|Infusions, Intravenous|infusions, intravenous
325751|NCT01754545|Plasma|plasma
325752|NCT01754545|ADAMTS-13 protein, human|adamts-13 protein, human
325753|NCT01754532|Schizophrenia|schizophrenia
325754|NCT01754532|Schizo-Affective Disorder|schizo-affective disorder
325755|NCT01754532|Stress|stress
325756|NCT01754532|Cortisol|cortisol
325757|NCT01754532|PANSS|panss
325758|NCT01754506|leg ulcers|leg ulcers
325759|NCT01754506|wounds|wounds
325760|NCT01754506|fish oil|fish oil
325761|NCT01754506|lipid mediators|lipid mediators
325762|NCT01754506|chronic venous stasis ulcers|chronic venous stasis ulcers
325763|NCT01754493|Major Depression|major depression
325764|NCT01754493|Irritable Bowel Syndrome|irritable bowel syndrome
325765|NCT01754493|Somatization|somatization
325766|NCT01754493|Cymbalta|cymbalta
325767|NCT01754493|Duloxetine|duloxetine
325768|NCT01754480|Fibrin Sealant|fibrin sealant
325769|NCT01754480|Parenchymous tissue open surgery|parenchymous tissue open surgery
325770|NCT01754480|Hepatic Resection|hepatic resection
325771|NCT01754480|Oxidized cellulose pads|oxidized cellulose pads
325772|NCT01754441|Spinal Muscular Atrophy|spinal muscular atrophy
325773|NCT01754441|SMA|sma
325774|NCT01754441|Motor Neuron Abnormalities|motor neuron abnormalities
325775|NCT01754428|Respiratory|respiratory
325776|NCT01754428|Syncytial|syncytial
325777|NCT01754428|Virus|virus
325778|NCT01754428|RSV|rsv
325779|NCT01754415|Aging|aging
325780|NCT01754415|Chronic illness|chronic illness
325781|NCT01754415|Resistance circuit training|resistance circuit training
325782|NCT01754402|Multiple Myeloma|multiple myeloma
325783|NCT01754376|Metastatic|metastatic
325784|NCT01754376|Unresectable|unresectable
325785|NCT01754376|V600E mutation|v600e mutation
325786|NCT01754363|Osteoarthritis|osteoarthritis
325787|NCT01754350|ketogenic diet|ketogenic diet
325788|NCT01754350|glioma|glioma
325789|NCT01754350|fasting|fasting
325790|NCT01754350|reirradiation|reirradiation
325791|NCT01754350|nutrition|nutrition
325792|NCT01754337|Type 1 diabetes|type 1 diabetes
325793|NCT01754337|Hypoglycemia|hypoglycemia
325794|NCT01754337|Insulin|insulin
325795|NCT01754337|Glucagon|glucagon
325796|NCT01754337|Closed-loop system|closed-loop system
325797|NCT01754337|Artificial pancreas|artificial pancreas
325798|NCT01754324|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
325799|NCT01754324|Pharmacokinetics|pharmacokinetics
325800|NCT01754324|Methadone|methadone
325801|NCT01754324|Neonate|neonate
325802|NCT01754324|Newborn|newborn
325803|NCT01754311|HTLV-I|htlv-i
325804|NCT01754298|osteochondritis dissecans (OCD)|osteochondritis dissecans (ocd)
325805|NCT01754298|juvenile osteochondritis dissecans (JOCD)|juvenile osteochondritis dissecans (jocd)
325806|NCT01754298|knee osteochondritis dissecans|knee osteochondritis dissecans
325807|NCT01754298|retro-articular drilling|retro-articular drilling
325808|NCT01754298|trans-articular drilling|trans-articular drilling
325809|NCT01754298|stable osteochondritis dissecans lesion|stable osteochondritis dissecans lesion
325810|NCT01754272|metastatic colorectal cancer|metastatic colorectal cancer
325811|NCT01754272|mCRC|mcrc
325812|NCT01754272|Aflibercept|aflibercept
325813|NCT01754272|FOLFIRI|folfiri
325814|NCT01754272|translational research|translational research
325815|NCT01754272|retrospective|retrospective
325816|NCT01754272|noninterventional|noninterventional
325817|NCT01754272|biomarkers|biomarkers
325818|NCT01754272|angiogenesis|angiogenesis
325819|NCT01754259|type 1 diabetes|type 1 diabetes
325820|NCT01754259|type 2 diabetes|type 2 diabetes
325821|NCT01754259|exertion angina|exertion angina
325822|NCT01754259|suspected CAD|suspected cad
325823|NCT01754259|known CAD|known cad
325824|NCT01754194|Gastric Sleeve|gastric sleeve
325825|NCT01754194|Gastric Bypass|gastric bypass
325826|NCT01754194|Roux en Y|roux en y
325827|NCT01754194|Morbid Obesity|morbid obesity
325828|NCT01754194|Laparoscopy|laparoscopy
325829|NCT01754181|Glycemic control algorithm|glycemic control algorithm
325830|NCT01754181|closed loop|closed loop
325831|NCT01754181|artificial pancreas|artificial pancreas
325832|NCT01754168|Parkinson disease|parkinson disease
325833|NCT01754168|Cognition|cognition
325834|NCT01754155|Vitamin E|vitamin e
325835|NCT01754155|Zimmer|zimmer
325836|NCT01754155|RSA|rsa
325837|NCT01754155|Radiostereometric Analysis|radiostereometric analysis
325838|NCT01754129|Caregiver|caregiver
325839|NCT01754129|Quality of Life|quality of life
325840|NCT01754129|Parkinson's Disease|parkinson's disease
325841|NCT01754116|healthy subjects|healthy subjects
325842|NCT01754116|GSK1265744 LAP|gsk1265744 lap
325843|NCT01754116|integrase inhibitor|integrase inhibitor
325844|NCT01754116|HIV-1 infection|hiv-1 infection
325845|NCT01754116|long acting retroviral|long acting retroviral
325846|NCT01754116|relative bioavailability|relative bioavailability
325847|NCT01754103|blind|blind
325848|NCT01754103|tactile stimulation|tactile stimulation
325849|NCT01754103|cross-modality|cross-modality
325850|NCT01754103|visual qualia|visual qualia
325851|NCT01754103|resting state MRI|resting state mri
325852|NCT01754103|functional connectivity|functional connectivity
325853|NCT01754103|neuroplasticity|neuroplasticity
325854|NCT01754090|alcohol|alcohol
325855|NCT01754090|online intervention|online intervention
325856|NCT01754090|hazardous drinking|hazardous drinking
325857|NCT01754090|harmful drinking|harmful drinking
325858|NCT01754090|early intervention|early intervention
325859|NCT01754090|behavior change intervention|behavior change intervention
325860|NCT01754077|Language|language
325861|NCT01754077|Behavior change|behavior change
325862|NCT01754077|Intervention|intervention
325863|NCT01754077|Home visiting|home visiting
325864|NCT01754077|Child language development|child language development
325865|NCT01754064|Bradycardia|bradycardia
325866|NCT01754064|Tachycardia|tachycardia
325867|NCT01754064|Arrhythimas|arrhythimas
325868|NCT01754064|ICD|icd
325869|NCT01754064|pacemaker|pacemaker
325870|NCT01754064|pacing lead|pacing lead
325871|NCT01754038|Patient Reported Outcomes|patient reported outcomes
325873|NCT01754038|Registry|registry
325874|NCT01754025|Gene Mutation|gene mutation
325875|NCT01754012|Nutrition|nutrition
325876|NCT01754012|Dietary intervention|dietary intervention
325877|NCT01754012|Aging|aging
325878|NCT01754012|Inflammation|inflammation
325879|NCT01754012|Elderly|elderly
325880|NCT01754012|Europe|europe
325881|NCT01753999|World Trade Center (WTC)|world trade center (wtc)
325882|NCT01753999|nasal symptoms|nasal symptoms
325883|NCT01753999|nasal inflammation|nasal inflammation
325884|NCT01753999|CPAP|cpap
325885|NCT01753973|Metabolic syndrome|metabolic syndrome
325886|NCT01753973|Renal transplantation|renal transplantation
325887|NCT01753895|Healthy Volunteers|healthy volunteers
325888|NCT01753882|Gait training|gait training
325889|NCT01753882|Lexapro|lexapro
325890|NCT01753882|Tizanidine|tizanidine
325891|NCT01753843|Preterm Birth|preterm birth
325892|NCT01753830|Double-blind|double-blind
325893|NCT01753830|Randomized|randomized
325894|NCT01753830|Intraarticular injection|intraarticular injection
325895|NCT01753830|Hyaluronic acid|hyaluronic acid
325896|NCT01753830|Placebo|placebo
325897|NCT01753830|Knee osteoarthritis|knee osteoarthritis
325898|NCT01753817|Coronary catheterization|coronary catheterization
325899|NCT01753817|Transradial patency|transradial patency
325900|NCT01753804|DMD|dmd
325901|NCT01753804|Myopathy|myopathy
325902|NCT01753804|Natural History|natural history
325903|NCT01753804|Muscular dystrophy|muscular dystrophy
325904|NCT01753804|Biomarkers|biomarkers
325905|NCT01753804|Muscle testing|muscle testing
325906|NCT01753778|Nerve Entrapment, Morton's neuroma, entrapment neuropathy|nerve entrapment, morton's neuroma, entrapment neuropathy
325907|NCT01753765|occipital neuralgia|occipital neuralgia
325908|NCT01753726|stretching, diaphragm, spinal movement, thoracic movement|stretching, diaphragm, spinal movement, thoracic movement
325909|NCT01753700|crossover|crossover
325910|NCT01753700|UHT milk|uht milk
325911|NCT01753700|Pasteurised milk|pasteurised milk
325912|NCT01753700|supplement|supplement
325913|NCT01753687|break up time|break up time
325914|NCT01753687|tear film thickness|tear film thickness
325915|NCT01753687|tear film osmolarity|tear film osmolarity
325916|NCT01753687|objective scattering index|objective scattering index
325917|NCT01753687|impression cytology|impression cytology
325918|NCT01753687|tear cytokines/chemokines|tear cytokines/chemokines
325919|NCT01753687|visual acuity|visual acuity
325920|NCT01753687|fluorescein staining|fluorescein staining
325921|NCT01753674|metabolic syndrome, insulin resistance, HDL cholesterol,|metabolic syndrome, insulin resistance, hdl cholesterol,
325922|NCT01753661|Hearing loss|hearing loss
325923|NCT01753661|Language|language
325924|NCT01753661|Behavior change|behavior change
325925|NCT01753661|Early Intervention|early intervention
325926|NCT01753661|Home visiting|home visiting
325927|NCT01753648|retinal blood flow|retinal blood flow
325928|NCT01753648|retinal blood velocity|retinal blood velocity
325929|NCT01753648|retinal oxygen saturation|retinal oxygen saturation
325930|NCT01753648|retinal vessel diameter|retinal vessel diameter
325931|NCT01753648|ocular perfusion pressure|ocular perfusion pressure
325932|NCT01753635|Baska mask|baska mask
325933|NCT01753635|LMA|lma
325934|NCT01753635|single use LMA device|single use lma device
325935|NCT01753635|laryngeal mask airway|laryngeal mask airway
325936|NCT01753635|supraglottic airway device|supraglottic airway device
325937|NCT01753622|Overweight, obese, pregnant, depression, outcomes|overweight, obese, pregnant, depression, outcomes
325938|NCT01753609|Over weight|over weight
325939|NCT01753609|Obesity|obesity
325940|NCT01753596|topical lubricants|topical lubricants
325941|NCT01753596|tear film thickness|tear film thickness
325942|NCT01753596|break up time|break up time
325943|NCT01753596|ocular surface disease index|ocular surface disease index
325944|NCT01753596|Schirmer I test|schirmer i test
325945|NCT01753583|optical coherence tomography|optical coherence tomography
325946|NCT01753583|corneal abrasion|corneal abrasion
325947|NCT01753583|corneal infiltrate|corneal infiltrate
325948|NCT01753570|Feron|feron
325949|NCT01753557|Pegasys|pegasys
325950|NCT01753531|Ultra Influenza A and B|ultra influenza a and b
325951|NCT01753531|Influenza Type A|influenza type a
325952|NCT01753531|Influenza Type B|influenza type b
325953|NCT01753531|Flu|flu
325954|NCT01753531|Sekisui Diagnostics|sekisui diagnostics
325955|NCT01753518|Subcuticular suture|subcuticular suture
325956|NCT01753518|Subcuticular staple|subcuticular staple
325957|NCT01753518|Skin closure|skin closure
325958|NCT01753518|Incision closure|incision closure
325959|NCT01753518|Wound|wound
325960|NCT01753505|multidetector coronary CT angiography, renal transplantation|multidetector coronary ct angiography, renal transplantation
325961|NCT01753492|Intraocular pressure|intraocular pressure
325962|NCT01753492|glaucoma|glaucoma
325963|NCT01753492|trabeculectomy|trabeculectomy
325964|NCT01753492|Ologen|ologen
325965|NCT01753479|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
325966|NCT01753453|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
325967|NCT01753453|Tumour cell mobilization|tumour cell mobilization
325968|NCT01753440|coronary artery disease|coronary artery disease
325969|NCT01753440|heart failure|heart failure
325970|NCT01753440|stem cells implantation|stem cells implantation
325971|NCT01753427|COPD,|copd,
325972|NCT01753427|symptoms,|symptoms,
325973|NCT01753427|Non-Interventional study,|non-interventional study,
325974|NCT01753414|Lung Cancer|lung cancer
325975|NCT01753401|SLE|sle
325976|NCT01753401|Lupus|lupus
325977|NCT01753375|Multiple Sclerosis|multiple sclerosis
325978|NCT01753375|Relapsing rate|relapsing rate
325979|NCT01753375|Expanded disability status scale|expanded disability status scale
325980|NCT01753375|Vitamin D3|vitamin d3
325981|NCT01753323|acute malaria, KAF156|acute malaria, kaf156
325982|NCT01753245|Anti-TNF drugs efficacy|anti-tnf drugs efficacy
325983|NCT01753245|Moderate-to-severe psoriasis vulgaris|moderate-to-severe psoriasis vulgaris
325984|NCT01753245|Gene polymorphism|gene polymorphism
325985|NCT01753232|DALI adsorber|dali adsorber
325986|NCT01753232|MONET lipoprotein filter|monet lipoprotein filter
325987|NCT01753193|Systemic Lupus Erythematosus|systemic lupus erythematosus
325988|NCT01753180|CTO|cto
325989|NCT01753180|PCI|pci
325990|NCT01753180|Angioplasty|angioplasty
325991|NCT01753154|Peritoneal Dialysis|peritoneal dialysis
325992|NCT01753154|Biocompatible dialysis solution|biocompatible dialysis solution
325993|NCT01753154|Hydration status|hydration status
325994|NCT01753154|Residual renal function|residual renal function
325995|NCT01753154|Body composition monitor|body composition monitor
325996|NCT01753154|Bioimpedance spectroscopy|bioimpedance spectroscopy
325997|NCT01753154|Cancer antigen 125|cancer antigen 125
325998|NCT01753141|Cognitive Behavioral Therapy|cognitive behavioral therapy
325999|NCT01753141|Smoking Cessation|smoking cessation
326000|NCT01753115|post-exposure prophylaxis|post-exposure prophylaxis
326001|NCT01753115|toxin neutralization assay|toxin neutralization assay
326002|NCT01753102|Estradiol|estradiol
326003|NCT01753102|Vulvar atrophy|vulvar atrophy
326004|NCT01753102|vaginal atrophy|vaginal atrophy
326005|NCT01753089|Metastatic|metastatic
326006|NCT01753076|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
326007|NCT01753076|efficacy|efficacy
326008|NCT01753076|ozanezumab|ozanezumab
326009|NCT01753076|safety|safety
326010|NCT01753063|Obesity|obesity
326011|NCT01753063|Children|children
326012|NCT01753063|Adolescents|adolescents
326013|NCT01753063|Attrition|attrition
326014|NCT01753037|Hyperandrogenism|hyperandrogenism
326015|NCT01753037|Inflammation|inflammation
326016|NCT01753037|Insulin sensitivity|insulin sensitivity
326017|NCT01753037|Body composition|body composition
326018|NCT01753024|exocrine pancreatic insufficiency|exocrine pancreatic insufficiency
326019|NCT01753024|fecal elastase-1|fecal elastase-1
326020|NCT01753024|amylase|amylase
326021|NCT01753024|lipase|lipase
326022|NCT01753024|critical illness|critical illness
326023|NCT01753024|enteral nutrition|enteral nutrition
326024|NCT01753024|malnutrition|malnutrition
326025|NCT01753024|sepsis|sepsis
326026|NCT01753024|diabetes|diabetes
326027|NCT01753024|hyperlactacidemia|hyperlactacidemia
326028|NCT01753024|hemodialysis|hemodialysis
326029|NCT01753024|mechanical ventilation|mechanical ventilation
326030|NCT01753011|Stress urinary Incontinence|stress urinary incontinence
326031|NCT01753011|Transobturator sling|transobturator sling
326032|NCT01753011|TOT|tot
326033|NCT01752998|pain|pain
326034|NCT01752998|depression|depression
326035|NCT01752998|substance use|substance use
326036|NCT01752972|Arsenic|arsenic
326037|NCT01752972|Keratosis|keratosis
326038|NCT01752972|Linoleic acid|linoleic acid
326039|NCT01752972|Palm|palm
326040|NCT01752972|Spirulina|spirulina
326041|NCT01752972|Vitamin E|vitamin e
326042|NCT01752972|Zinc|zinc
326043|NCT01752920|FGFR|fgfr
326045|NCT01752920|Targeted therapy|targeted therapy
326046|NCT01752920|Molecular therapy|molecular therapy
326047|NCT01752920|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
326048|NCT01752920|TKI|tki
326049|NCT01752920|Receptor tyrosine kinase|receptor tyrosine kinase
326050|NCT01752920|RTK|rtk
326051|NCT01752920|Biomarker|biomarker
326052|NCT01752920|Phase 1|phase 1
326053|NCT01752920|Phase I|phase i
326054|NCT01752920|Solid tumor|solid tumor
326055|NCT01752920|Liver Cancer|liver cancer
326056|NCT01752920|Hepatobiliary carcinoma|hepatobiliary carcinoma
326057|NCT01752920|Biliary tract cancer|biliary tract cancer
326058|NCT01752920|Cholangiocarcinoma|cholangiocarcinoma
326059|NCT01752920|Intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
326060|NCT01752920|FGFR inhibitor|fgfr inhibitor
326061|NCT01752920|Targeted FGFR kinase inhibitor|targeted fgfr kinase inhibitor
326062|NCT01752920|Pan-FGFR inhibitor|pan-fgfr inhibitor
326063|NCT01752920|Selective FGFR inhibitor|selective fgfr inhibitor
326064|NCT01752920|FGFR pathway|fgfr pathway
326065|NCT01752920|FGFR signaling|fgfr signaling
326066|NCT01752920|Fibroblast growth factor|fibroblast growth factor
326067|NCT01752920|FGFR1|fgfr1
326068|NCT01752920|FGFR2|fgfr2
326069|NCT01752920|FGFR3|fgfr3
326070|NCT01752920|FGFR4|fgfr4
326071|NCT01752920|FGF|fgf
326072|NCT01752920|FGF19|fgf19
326073|NCT01752920|FGF21|fgf21
326074|NCT01752920|FGF23|fgf23
326075|NCT01752920|FGFR mutation|fgfr mutation
326076|NCT01752920|FGFR gene fusion|fgfr gene fusion
326077|NCT01752920|FGFR gene translocation|fgfr gene translocation
326078|NCT01752920|FGFR genetic aberration|fgfr genetic aberration
326079|NCT01752920|FGFR2 fusion|fgfr2 fusion
326080|NCT01752920|FGFR2 translocation|fgfr2 translocation
326081|NCT01752920|Phase 1 Clinical Trial|phase 1 clinical trial
326082|NCT01752920|Phase I Clinical Trial|phase i clinical trial
326083|NCT01752920|Clinical oncology|clinical oncology
326084|NCT01752920|Tumor|tumor
326085|NCT01752920|Tumour|tumour
326086|NCT01752907|Breast cancer|breast cancer
326087|NCT01752907|Chemotherapy|chemotherapy
326088|NCT01752907|Pegfilgrastim|pegfilgrastim
326089|NCT01752907|Neulasta|neulasta
326090|NCT01752907|Bone Pain|bone pain
326091|NCT01752907|Education|education
326092|NCT01752881|Influenza|influenza
326093|NCT01752881|Vaccine|vaccine
326094|NCT01752881|Immunogenicity|immunogenicity
326095|NCT01752855|Rheumatoid Arthritis|rheumatoid arthritis
326096|NCT01752842|Diabetes|diabetes
326097|NCT01752842|Diabetic Cardiomyopathy|diabetic cardiomyopathy
326098|NCT01752842|Triglycerides|triglycerides
326099|NCT01752829|Obesity|obesity
326100|NCT01752829|gastric|gastric
326101|NCT01752829|banding|banding
326102|NCT01752829|Weight|weight
326103|NCT01752829|co-morbidities|co-morbidities
326104|NCT01752829|dilatation|dilatation
326105|NCT01752829|Excess weight loss|excess weight loss
326106|NCT01752829|adjustable gastric banding|adjustable gastric banding
326107|NCT01752816|endurance training,|endurance training,
326108|NCT01752816|strength training,|strength training,
326109|NCT01752816|aerobic capacity,|aerobic capacity,
326110|NCT01752816|muscle strenght|muscle strenght
326111|NCT01752816|physical capacity|physical capacity
326112|NCT01752790|Pediatric Crohn's disease|pediatric crohn's disease
326113|NCT01752790|Biologics|biologics
326114|NCT01752790|Immunomodulators|immunomodulators
326115|NCT01752790|Top-down|top-down
326116|NCT01752790|step-up|step-up
326117|NCT01752777|HIV/AIDS, HIV infectiousness, Medication adherence, Sexual risks reduction|hiv/aids, hiv infectiousness, medication adherence, sexual risks reduction
326118|NCT01752751|Neck cancer|neck cancer
326119|NCT01752751|Head cancer|head cancer
326120|NCT01752751|Lung cancer|lung cancer
326121|NCT01752725|supracervical hysterectomy|supracervical hysterectomy
326122|NCT01752725|vessel sealing|vessel sealing
326123|NCT01752725|bipolar electrocoagulation|bipolar electrocoagulation
326124|NCT01752712|Oxytocin|oxytocin
326125|NCT01752712|Social function|social function
326126|NCT01752712|CBSST|cbsst
326127|NCT01752699|neuropathic pain,|neuropathic pain,
326128|NCT01752699|post-herpetic neuralgia,|post-herpetic neuralgia,
326129|NCT01752699|methadone,|methadone,
326130|NCT01752686|Triple negative breast cancer|triple negative breast cancer
326131|NCT01752686|adjuvant chemotherapy|adjuvant chemotherapy
326132|NCT01752673|randomized controlled study|randomized controlled study
326133|NCT01752660|Exercise therapy|exercise therapy
326134|NCT01752660|Aerobic training|aerobic training
326135|NCT01752660|Endurance training|endurance training
326136|NCT01752647|lung cancer|lung cancer
326137|NCT01752647|screening|screening
326138|NCT01752647|low dose|low dose
326139|NCT01752647|computed tomography|computed tomography
326140|NCT01752634|Psoriatic arthritis, PsA, ACR, CASPAR, PASDAS|psoriatic arthritis, psa, acr, caspar, pasdas
326141|NCT01752621|Acromegaly|acromegaly
326142|NCT01752621|mortality|mortality
326143|NCT01752621|morbidity|morbidity
326144|NCT01752621|incidence|incidence
326145|NCT01752621|prevalence|prevalence
326146|NCT01752608|Depression|depression
326147|NCT01752608|Real-time|real-time
326148|NCT01752608|iPhone|iphone
326150|NCT01752608|Cognitive behavioral therapy|cognitive behavioral therapy
326151|NCT01752582|BuMA|buma
326152|NCT01752582|EXCEL|excel
326153|NCT01752582|OCT|oct
326154|NCT01752582|stent|stent
326155|NCT01752582|neointima formation|neointima formation
326156|NCT01752569|HIV|hiv
326157|NCT01752569|Kaposi's sarcoma|kaposi's sarcoma
326158|NCT01752569|Anti-retroviral therapy|anti-retroviral therapy
326159|NCT01752569|HAART|haart
326160|NCT01752569|AIDS|aids
326161|NCT01752556|Sleep apnea, Portable monitor,autoCPAP|sleep apnea, portable monitor,autocpap
326162|NCT01752543|Vasopressin|vasopressin
326163|NCT01752543|Exercise capacity|exercise capacity
326164|NCT01752543|Conivaptan|conivaptan
326165|NCT01752530|ADHD|adhd
326166|NCT01752517|small cell lung cancer|small cell lung cancer
326167|NCT01752517|chemotherapy|chemotherapy
326168|NCT01752517|vinorelbine|vinorelbine
326169|NCT01752517|ifosfamide|ifosfamide
326170|NCT01752517|third-line treatment|third-line treatment
326171|NCT01752504|HIV prevention|hiv prevention
326172|NCT01752504|HIV positive communities|hiv positive communities
326173|NCT01752491|Ascorbate|ascorbate
326174|NCT01752491|Ascorbic acid|ascorbic acid
326175|NCT01752491|Vitamin C|vitamin c
326176|NCT01752491|Radiation|radiation
326177|NCT01752491|Temozolomide|temozolomide
326178|NCT01752478|ptosis|ptosis
326179|NCT01752478|retina surgery|retina surgery
326180|NCT01752478|droopy eye lid|droopy eye lid
326181|NCT01752465|Health behaviour|health behaviour
326182|NCT01752465|Antipsychotic agents|antipsychotic agents
326183|NCT01752465|Adverse effects|adverse effects
326184|NCT01752465|Goals|goals
326185|NCT01752465|Life style|life style
326186|NCT01752439|Chronic Migraine|chronic migraine
326187|NCT01752439|Medication Overuse Headache|medication overuse headache
326188|NCT01752439|Refractory|refractory
326189|NCT01752439|transcranial direct current stimulation|transcranial direct current stimulation
326190|NCT01752426|Leukemia|leukemia
326191|NCT01752426|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
326192|NCT01752426|CLL|cll
326193|NCT01752426|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
326194|NCT01752426|SLL|sll
326195|NCT01752426|PCI-32765|pci-32765
326196|NCT01752426|Ibrutinib|ibrutinib
326197|NCT01752426|Btk inhibitor|btk inhibitor
326198|NCT01752426|Heavy water|heavy water
326199|NCT01752426|2H2O|2h2o
326200|NCT01752413|Iron depletion|iron depletion
326201|NCT01752413|blood donors|blood donors
326202|NCT01752413|iron replacement|iron replacement
326203|NCT01752400|Advanced|advanced
326204|NCT01752361|Gastrointestinal Motility|gastrointestinal motility
326205|NCT01752361|Inflammatory Bowel Disease|inflammatory bowel disease
326206|NCT01752361|Transit time|transit time
326207|NCT01752348|sepsis|sepsis
326208|NCT01752348|cytokine release|cytokine release
326209|NCT01752348|fever|fever
326210|NCT01752335|Rheumatoid Arthritis, tocilizumab, cardiovascular risk factors|rheumatoid arthritis, tocilizumab, cardiovascular risk factors
326211|NCT01752309|Early Rheumatoid arthritis|early rheumatoid arthritis
326212|NCT01752309|Rheumatoid arthritis|rheumatoid arthritis
326213|NCT01752309|Ultrasound|ultrasound
326214|NCT01752309|Predictive|predictive
326215|NCT01752309|Prognosis|prognosis
326216|NCT01752296|Morquio|morquio
326217|NCT01752296|Mucopolysaccharidosis IV|mucopolysaccharidosis iv
326218|NCT01752296|Psychological health|psychological health
326219|NCT01752283|Videoassited|videoassited
326220|NCT01752283|Thyroidectomy|thyroidectomy
326221|NCT01752283|Minimal invasive surgery|minimal invasive surgery
326222|NCT01752283|General anesthesia|general anesthesia
326223|NCT01752283|Hypnosis|hypnosis
326224|NCT01752257|Melanoma|melanoma
326225|NCT01752244|Obesity, vitamin D analogue, VDR, PPARg, PGC1a|obesity, vitamin d analogue, vdr, pparg, pgc1a
326226|NCT01752218|Femto-second Laser|femto-second laser
326227|NCT01752218|arcuate incision|arcuate incision
326228|NCT01752218|corneal astigmatism|corneal astigmatism
326229|NCT01752218|astigmatic keratotomy|astigmatic keratotomy
326230|NCT01752218|Cataract|cataract
326231|NCT01752205|Esophageal Squamous Carcinoma|esophageal squamous carcinoma
326232|NCT01752205|Erlotinib|erlotinib
326233|NCT01752205|Chemoradiotherapy|chemoradiotherapy
326234|NCT01752192|Rehabilitation|rehabilitation
326235|NCT01752192|Telemedicine|telemedicine
326236|NCT01752192|Heart patients|heart patients
326237|NCT01752192|Social media|social media
326238|NCT01752192|Organisational aspects|organisational aspects
326239|NCT01752179|Kinesio taping|kinesio taping
326240|NCT01752179|Piriformis syndrome|piriformis syndrome
326241|NCT01752179|Trigger point|trigger point
326242|NCT01752166|Candida|candida
326243|NCT01752166|Candidemia|candidemia
326244|NCT01752166|Blood culture|blood culture
326245|NCT01752166|Diagnostics|diagnostics
326246|NCT01752153|Focus|focus
326247|NCT01752153|immunomodulatory effect|immunomodulatory effect
326248|NCT01752153|of silymarin|of silymarin
326249|NCT01752153|on cell mediated immunity|on cell mediated immunity
326250|NCT01752153|Beta-Thalassemia|beta-thalassemia
326251|NCT01752153|major patients.|major patients.
326252|NCT01752140|Prostate cancer|prostate cancer
326253|NCT01752140|Prostate biopsy|prostate biopsy
326254|NCT01752140|Vienna nomogram|vienna nomogram
326255|NCT01752127|Drug-eluting stent|drug-eluting stent
326256|NCT01752127|diabetes|diabetes
326257|NCT01752127|small vessel disease|small vessel disease
326258|NCT01752114|Precancerous conditions|precancerous conditions
326259|NCT01752114|Carcinoma|carcinoma
326260|NCT01752101|Precancerous Conditions|precancerous conditions
326261|NCT01752101|Carcinoma|carcinoma
326262|NCT01752088|apularis, MRI clinical, results|apularis, mri clinical, results
326263|NCT01752075|Multiple myeloma|multiple myeloma
326264|NCT01752062|Chronic Myeloid Leukemia|chronic myeloid leukemia
326265|NCT01752062|CML|cml
326266|NCT01752062|Pregnancy|pregnancy
326267|NCT01752049|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
326268|NCT01752049|Anti-angiogenic Therapy|anti-angiogenic therapy
326269|NCT01752049|vascular malformations|vascular malformations
326270|NCT01752049|HHT|hht
326271|NCT01752036|stereotactic radiotherapy|stereotactic radiotherapy
326272|NCT01752036|SRS|srs
326273|NCT01751984|lipid-lowering drugs|lipid-lowering drugs
326274|NCT01751984|statin intolerance|statin intolerance
326275|NCT01751945|EmONC|emonc
326276|NCT01751945|Neonatal mortality|neonatal mortality
326277|NCT01751945|Perinatal mortality|perinatal mortality
326278|NCT01751919|CML|cml
326279|NCT01751919|GIST|gist
326280|NCT01751906|Absorb™ BVS|absorb™ bvs
326281|NCT01751906|Angioplasty|angioplasty
326282|NCT01751906|Bioabsorbable|bioabsorbable
326283|NCT01751906|BVS|bvs
326284|NCT01751906|Bioresorbable|bioresorbable
326285|NCT01751906|Coronary Artery Disease|coronary artery disease
326286|NCT01751906|Coronary Artery Endothelial Responsiveness|coronary artery endothelial responsiveness
326287|NCT01751906|Coronary artery restenosis|coronary artery restenosis
326288|NCT01751906|Coronary artery stenosis|coronary artery stenosis
326289|NCT01751906|Coronary scaffold|coronary scaffold
326290|NCT01751906|Coronary Stent|coronary stent
326291|NCT01751906|Drug eluting stents|drug eluting stents
326292|NCT01751906|Everolimus|everolimus
326293|NCT01751906|Myocardial ischemia|myocardial ischemia
326294|NCT01751906|Stent thrombosis|stent thrombosis
326295|NCT01751906|Stents|stents
326296|NCT01751893|Hand-foot syndrome|hand-foot syndrome
326297|NCT01751893|palmar-plantar erythrodysesthesia|palmar-plantar erythrodysesthesia
326298|NCT01751893|capecitabine|capecitabine
326299|NCT01751893|pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
326300|NCT01751893|henna|henna
326301|NCT01751880|Gastric cancer, minimally invasive gastrectomy, Physical activity intervention|gastric cancer, minimally invasive gastrectomy, physical activity intervention
326302|NCT01751867|Myelodysplastic Syndrome|myelodysplastic syndrome
326303|NCT01751867|Dacogen|dacogen
326304|NCT01751867|Oncology|oncology
326305|NCT01751867|Decitabine|decitabine
326306|NCT01751867|Bone marrow disorders|bone marrow disorders
326307|NCT01751854|pharmacology|pharmacology
326308|NCT01751854|rehabilitation|rehabilitation
326309|NCT01751854|locomotion|locomotion
326310|NCT01751828|Depression|depression
326311|NCT01751828|Major Depressive Disorder|major depressive disorder
326312|NCT01751802|Lesch Nyhan Disease|lesch nyhan disease
326313|NCT01751802|Self-Injury|self-injury
326314|NCT01751789|illicit opioid drug use|illicit opioid drug use
326315|NCT01751789|health service utilization|health service utilization
326316|NCT01751737|prostate|prostate
326317|NCT01751737|cancer|cancer
326318|NCT01751737|biopsy|biopsy
326319|NCT01751737|18F-choline|18f-choline
326320|NCT01751737|PET|pet
326321|NCT01751737|MRI|mri
326322|NCT01751724|Premature infants|premature infants
326323|NCT01751724|Caffeine|caffeine
326324|NCT01751724|Methylxanthines|methylxanthines
326325|NCT01751724|Mechanical ventilation|mechanical ventilation
326326|NCT01751724|Oxygen|oxygen
326327|NCT01751724|Weaning|weaning
326328|NCT01751724|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
326329|NCT01751698|Autism|autism
326330|NCT01751698|Minimally Verbal|minimally verbal
326331|NCT01751698|School Age|school age
326332|NCT01751685|kyphosis|kyphosis
326333|NCT01751672|SBIRT|sbirt
326334|NCT01751672|Substance Use|substance use
326335|NCT01751672|Screening|screening
326336|NCT01751672|Brief Intervention|brief intervention
326337|NCT01751672|Primary Care|primary care
326338|NCT01751633|Burst fractures|burst fractures
326339|NCT01751633|Thoracic or Lumbar Vertebrae/injuries [MeSH]|thoracic or lumbar vertebrae/injuries [mesh]
326340|NCT01751633|Thoracic or Lumbar Vertebrae/surgery [MeSH]|thoracic or lumbar vertebrae/surgery [mesh]
326341|NCT01751633|Spinal Fusion/methods [MeSH]|spinal fusion/methods [mesh]
326342|NCT01751633|Thoracolumbar fracture management|thoracolumbar fracture management
326343|NCT01751633|Quality of life|quality of life
326344|NCT01751633|Functional outcome|functional outcome
326345|NCT01751607|AF, catheter ablation, non-PV triggers, SNP|af, catheter ablation, non-pv triggers, snp
326346|NCT01751581|Obesity|obesity
326347|NCT01751581|Resting Metabolic Rate|resting metabolic rate
326348|NCT01751581|Sleep|sleep
326349|NCT01751581|Eating|eating
326350|NCT01751555|HBV co-infection ART TDF|hbv co-infection art tdf
326351|NCT01751529|renal malignancy|renal malignancy
326352|NCT01751529|Pilot Study|pilot study
326353|NCT01751529|LCCC 1219|lccc 1219
326354|NCT01751529|UNC Lineberger|unc lineberger
326355|NCT01751529|kidney cancer|kidney cancer
326356|NCT01751529|contrast-enhanced ultrasound|contrast-enhanced ultrasound
326357|NCT01751529|ultrasound|ultrasound
326358|NCT01751503|Foot drop deformity|foot drop deformity
326359|NCT01751503|gold standard treatment|gold standard treatment
326360|NCT01751503|Tibialis posterior tendon transfer|tibialis posterior tendon transfer
326361|NCT01751503|Interosseous route|interosseous route
326362|NCT01751503|Extramembranous or circumtibial route|extramembranous or circumtibial route
326363|NCT01751490|shoulder|shoulder
326364|NCT01751490|instability|instability
326365|NCT01751490|atraumatic|atraumatic
326366|NCT01751477|Very Low Birth Weight Infants|very low birth weight infants
326367|NCT01751477|Probiotics|probiotics
326368|NCT01751477|Necrotizing Enterocolitis|necrotizing enterocolitis
326369|NCT01751464|youth|youth
326370|NCT01751464|violence|violence
326371|NCT01751464|injury|injury
326372|NCT01751464|emergency department|emergency department
326373|NCT01751464|intervention|intervention
326374|NCT01751451|ABIRATERONE ACETATE (CB 7630)|abiraterone acetate (cb 7630)
326375|NCT01751451|DEGARELIX|degarelix
326376|NCT01751451|PREDNISONE|prednisone
326377|NCT01751451|12-187|12-187
326378|NCT01751438|Prostate cancer|prostate cancer
326379|NCT01751438|Prostate carcinoma|prostate carcinoma
326380|NCT01751438|Metastatic|metastatic
326381|NCT01751438|M1|m1
326382|NCT01751438|Best Systemic Therapy|best systemic therapy
326383|NCT01751438|BST|bst
326384|NCT01751438|Androgen deprivation therapy|androgen deprivation therapy
326385|NCT01751438|Bilateral orchiectomy|bilateral orchiectomy
326386|NCT01751438|Radiation|radiation
326387|NCT01751438|Radiation Therapy|radiation therapy
326388|NCT01751438|External beam radiation therapy|external beam radiation therapy
326389|NCT01751438|External-beam radiotherapy|external-beam radiotherapy
326390|NCT01751438|Xray therapy|xray therapy
326391|NCT01751438|XRT|xrt
326392|NCT01751438|Surgery|surgery
326393|NCT01751425|Leukemia|leukemia
326394|NCT01751425|Chronic Myeloid Leukemia|chronic myeloid leukemia
326395|NCT01751425|CML|cml
326396|NCT01751425|Minimal Residual Disease|minimal residual disease
326397|NCT01751425|Philadelphia chromosome|philadelphia chromosome
326398|NCT01751425|(Ph)-positive|(ph)-positive
326399|NCT01751425|BCR/ABL-positive|bcr/abl-positive
326400|NCT01751425|Ruxolitinib|ruxolitinib
326401|NCT01751425|Jakafi|jakafi
326402|NCT01751425|INCB018424|incb018424
326403|NCT01751425|INC424|inc424
326404|NCT01751425|TKI|tki
326405|NCT01751425|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
326406|NCT01751412|Hodgkin|hodgkin
326407|NCT01751412|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
326408|NCT01751412|Mediastinal|mediastinal
326409|NCT01751412|Adult Lymphoma|adult lymphoma
326410|NCT01751412|Pediatric Lymphoma|pediatric lymphoma
326411|NCT01751386|Addiction|addiction
326412|NCT01751386|Cue-Induced Craving|cue-induced craving
326413|NCT01751386|Craving|craving
326414|NCT01751386|Anxiety|anxiety
326415|NCT01751386|Alcohol Consumption|alcohol consumption
326416|NCT01751373|Botulinum Toxin|botulinum toxin
326417|NCT01751373|Rehabilitation|rehabilitation
326418|NCT01751373|Electromyography|electromyography
326419|NCT01751373|Electroencephalography|electroencephalography
326420|NCT01751373|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
326421|NCT01751347|Local anesthetics|local anesthetics
326422|NCT01751347|Elective hand surgeries|elective hand surgeries
326423|NCT01751334|Arthroplasty|arthroplasty
326424|NCT01751334|Replacement|replacement
326425|NCT01751334|Knee|knee
326426|NCT01751334|Rotational Alignment|rotational alignment
326427|NCT01751282|Stem Cells|stem cells
326428|NCT01751282|chronic wounds|chronic wounds
326429|NCT01751282|fibrin|fibrin
326430|NCT01751282|Bone marrow-derived mesenchymal stem cells|bone marrow-derived mesenchymal stem cells
326431|NCT01751256|Postcesarean Section|postcesarean section
326432|NCT01751256|Postoperative Pain|postoperative pain
326433|NCT01751256|Care, Postoperative|care, postoperative
326434|NCT01751256|Anesthesia, Local|anesthesia, local
326435|NCT01751256|Breast Feeding|breast feeding
326436|NCT01751256|Morphine|morphine
326437|NCT01751256|Pain Measurement|pain measurement
326438|NCT01751256|levobupivacaine|levobupivacaine
326439|NCT01751230|pregnancy|pregnancy
326440|NCT01751230|weight loss|weight loss
326441|NCT01751217|Substance Abuse|substance abuse
326442|NCT01751217|Adolescents|adolescents
326443|NCT01751217|Families|families
326444|NCT01751217|Functional Family Therapy|functional family therapy
326445|NCT01751217|Video|video
326446|NCT01751217|Teleconferencing|teleconferencing
326447|NCT01751217|Telemedicine|telemedicine
326448|NCT01751165|≥ 50 years of age|≥ 50 years of age
326449|NCT01751165|Herpes zoster|herpes zoster
326450|NCT01751165|Safety|safety
326451|NCT01751165|Immunogenicity|immunogenicity
326452|NCT01751165|Adults|adults
326453|NCT01751139|Endemic regions|endemic regions
326454|NCT01751139|Brazil|brazil
326455|NCT01751139|Incidence|incidence
326456|NCT01751139|Surveillance|surveillance
326457|NCT01751139|Dengue|dengue
326458|NCT01751126|vernal keratoconjunctivitis|vernal keratoconjunctivitis
326459|NCT01751126|ciclosporin|ciclosporin
326460|NCT01751126|cyclosporine|cyclosporine
326461|NCT01751087|abortion, induced|abortion, induced
326462|NCT01751074|Drug interaction, rosuvastatin, healthy volunteer, Lp-PLA2, atherosclerosis, darapladib, pharmacokinetics.|drug interaction, rosuvastatin, healthy volunteer, lp-pla2, atherosclerosis, darapladib, pharmacokinetics.
326463|NCT01751061|prolonged mechanical ventilation|prolonged mechanical ventilation
326464|NCT01751061|chronic critical illness|chronic critical illness
326465|NCT01751061|decision making|decision making
326466|NCT01751061|decision aid|decision aid
326467|NCT01751061|decisional support|decisional support
326468|NCT01751061|critical illness|critical illness
326469|NCT01751061|intensive care unit|intensive care unit
326470|NCT01751048|GLA-SE,LEISH-F3,leishmaniasis,MPL-SE,parent protocol,vaccine|gla-se,leish-f3,leishmaniasis,mpl-se,parent protocol,vaccine
326471|NCT01751022|heart failure|heart failure
326472|NCT01751022|cardiac pacing|cardiac pacing
326473|NCT01751022|cardiac resynchronization therapy|cardiac resynchronization therapy
326474|NCT01751022|left ventricular lead|left ventricular lead
326475|NCT01751009|vitamin A, complementary foods, malnutrition, children|vitamin a, complementary foods, malnutrition, children
326476|NCT01750983|Advanced Cancers|advanced cancers
326477|NCT01750983|Advanced Malignancies|advanced malignancies
326478|NCT01750983|Metastatic cancers|metastatic cancers
326479|NCT01750983|Ipilimumab|ipilimumab
326480|NCT01750983|Yervoy|yervoy
326481|NCT01750983|BMS-734016|bms-734016
326482|NCT01750983|MDX010|mdx010
326483|NCT01750983|Lenalidomide|lenalidomide
326484|NCT01750983|CC-5013|cc-5013
326485|NCT01750983|Revlimid|revlimid
326486|NCT01750944|Blood pressure site|blood pressure site
326487|NCT01750944|Good health|good health
326488|NCT01750944|Brachial blood pressure|brachial blood pressure
326489|NCT01750944|Ankle|ankle
326490|NCT01750944|Toe|toe
326491|NCT01750944|Walking test|walking test
326492|NCT01750944|Exercise|exercise
326493|NCT01750931|BE study of Meloxicam GSK 15mg|be study of meloxicam gsk 15mg
326494|NCT01750918|MEK inhibitor|mek inhibitor
326495|NCT01750918|anti-EGFR antibody|anti-egfr antibody
326496|NCT01750918|colorectal cancer|colorectal cancer
326497|NCT01750918|BRAF inhibitor|braf inhibitor
326498|NCT01750879|peanut|peanut
326499|NCT01750879|allergy|allergy
326500|NCT01750879|food|food
326501|NCT01750879|immunotherapy|immunotherapy
326502|NCT01750879|tolerance|tolerance
326503|NCT01750879|desensitization|desensitization
326504|NCT01750866|Prostrate Cancer|prostrate cancer
326505|NCT01750866|Castrate-resistant metastatic prostate cancer|castrate-resistant metastatic prostate cancer
326506|NCT01750866|Cabazitaxel|cabazitaxel
326507|NCT01750827|platelet function|platelet function
326508|NCT01750827|atherosclerosis,|atherosclerosis,
326509|NCT01750827|SB-659032|sb-659032
326510|NCT01750801|clinical trial|clinical trial
326511|NCT01750801|mouthwash|mouthwash
326512|NCT01750801|propolis|propolis
326513|NCT01750801|plaque|plaque
326514|NCT01750801|gingivitis|gingivitis
326515|NCT01750801|compliance|compliance
326516|NCT01750788|Stroke|stroke
326517|NCT01750788|Embolism|embolism
326518|NCT01750788|Atrial Fibrillation|atrial fibrillation
326519|NCT01750775|sinus bradycardia|sinus bradycardia
326520|NCT01750775|ventricular premature contraction|ventricular premature contraction
326521|NCT01750749|Venous ulcer|venous ulcer
326522|NCT01750749|Cell therapy|cell therapy
326523|NCT01750736|Augmented Exercise|augmented exercise
326524|NCT01750736|Cervicalgia|cervicalgia
326525|NCT01750736|Manual Therapy|manual therapy
326526|NCT01750736|Manipulation|manipulation
326527|NCT01750736|Quantitative Sensory|quantitative sensory
326528|NCT01750723|Acetazolamide|acetazolamide
326529|NCT01750723|Headache|headache
326530|NCT01750723|Migraine|migraine
326531|NCT01750710|Charcot-Marie-Tooth disease type 1A neuropathy|charcot-marie-tooth disease type 1a neuropathy
326532|NCT01750710|Isokinetic|isokinetic
326533|NCT01750710|Electromyography|electromyography
326534|NCT01750710|Walking|walking
326535|NCT01750684|Acute|acute
326536|NCT01750684|Traumatic|traumatic
326537|NCT01750684|SCI|sci
326538|NCT01750684|Spinal Cord Injury|spinal cord injury
326539|NCT01750671|ICU|icu
326540|NCT01750671|Body composition|body composition
326541|NCT01750671|Nutrition|nutrition
326542|NCT01750671|Survival|survival
326543|NCT01750671|Morbidity|morbidity
326544|NCT01750658|Biomarkers|biomarkers
326545|NCT01750658|Exacerbations|exacerbations
326546|NCT01750658|COPD|copd
326547|NCT01750593|radiofrequency|radiofrequency
326548|NCT01750593|thyroid|thyroid
326549|NCT01750593|nodule|nodule
326550|NCT01750567|Relapsed Chronic Lymphocytic Leukemia|relapsed chronic lymphocytic leukemia
326551|NCT01750567|untreated CLL patients|untreated cll patients
326552|NCT01750567|genomic deletion 11q|genomic deletion 11q
326553|NCT01750554|SpHb; hemoglobin monitoring;bupivacaine digital nerve block|sphb; hemoglobin monitoring;bupivacaine digital nerve block
326554|NCT01750515|Acupuncture|acupuncture
326555|NCT01750515|Hepatitis C (HCV)|hepatitis c (hcv)
326556|NCT01750489|COPD|copd
326557|NCT01750476|oral contraception|oral contraception
326558|NCT01750476|Depo-Provera|depo-provera
326559|NCT01750476|Mirena|mirena
326560|NCT01750463|Pediatric critically ill|pediatric critically ill
326561|NCT01750463|Masimo|masimo
326562|NCT01750463|hemoglobin|hemoglobin
326563|NCT01750463|monitoring|monitoring
326564|NCT01750463|UNC|unc
326565|NCT01750463|PICU|picu
326566|NCT01750450|Pressure Volume Area|pressure volume area
326567|NCT01750450|Pressure Flow Area|pressure flow area
326568|NCT01750450|Myocardial Work|myocardial work
326569|NCT01750437|NERD|nerd
326570|NCT01750424|Scar|scar
326571|NCT01750424|Fat Grafting|fat grafting
326572|NCT01750424|Adipose Grafting|adipose grafting
326573|NCT01750424|3-D imaging|3-d imaging
326574|NCT01750424|Manchester Scar Scale|manchester scar scale
326575|NCT01750411|Severe Asthma|severe asthma
326576|NCT01750411|SARP|sarp
326577|NCT01750398|Testosterone, Leuprolide, Goserelin|testosterone, leuprolide, goserelin
326578|NCT01750385|Esophageal Achalasia|esophageal achalasia
326579|NCT01750385|antibiotic prophylaxis|antibiotic prophylaxis
326580|NCT01750385|blood culture|blood culture
326581|NCT01750385|procalcitonin levels|procalcitonin levels
326582|NCT01750372|Artificial limbs|artificial limbs
326583|NCT01750372|Questionnaires|questionnaires
326584|NCT01750372|Mobility limitation|mobility limitation
326585|NCT01750359|antioxidants|antioxidants
326586|NCT01750359|curcumin|curcumin
326587|NCT01750359|depression|depression
326588|NCT01750346|Blepharospasm|blepharospasm
326589|NCT01750346|Treatment|treatment
326590|NCT01750346|Dystonia|dystonia
326591|NCT01750346|Acetyl-Hexapeptide|acetyl-hexapeptide
326592|NCT01750320|Breast CT|breast ct
326593|NCT01750320|Biopsy|biopsy
326594|NCT01750307|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
326595|NCT01750307|Essential fatty acids (EFAs)|essential fatty acids (efas)
326596|NCT01750307|Electroencephalography (EEG)|electroencephalography (eeg)
326597|NCT01750307|Event-related potential (ERP)|event-related potential (erp)
326598|NCT01750307|Omega 3|omega 3
326599|NCT01750307|Randomised Control Trial|randomised control trial
326600|NCT01750307|Fish oil|fish oil
326601|NCT01750307|Supplementation|supplementation
326602|NCT01750307|Reading|reading
326603|NCT01750307|Spelling|spelling
326604|NCT01750307|Behaviour|behaviour
326605|NCT01750307|Emotional lability|emotional lability
326606|NCT01750294|hypertension|hypertension
326607|NCT01750294|kidney disease|kidney disease
326608|NCT01750281|Mitogen-Activated Protein Kinase Kinase inhibitor|mitogen-activated protein kinase kinase inhibitor
326609|NCT01750281|Non Small Cell Lung Cancer|non small cell lung cancer
326610|NCT01750281|Metastatic|metastatic
326611|NCT01750281|Second line treatment for Non Small Cell Lung Cancer|second line treatment for non small cell lung cancer
326612|NCT01750268|TBI|tbi
326613|NCT01750268|hazardous and harmful alcohol use|hazardous and harmful alcohol use
326614|NCT01750268|veterans|veterans
326615|NCT01750268|co-occurring disorders|co-occurring disorders
326616|NCT01750268|pharmacotherapy|pharmacotherapy
326617|NCT01750255|Pharmaceutical care|pharmaceutical care
326618|NCT01750255|Pharmacotherapy follow-up|pharmacotherapy follow-up
326619|NCT01750255|Bipolar disorder|bipolar disorder
326620|NCT01750255|Pharmacy services|pharmacy services
326621|NCT01750203|Diabetic foot ulcers, venous leg ulcers, pressure sores, acute wounds|diabetic foot ulcers, venous leg ulcers, pressure sores, acute wounds
326622|NCT01750190|anemia|anemia
326623|NCT01750190|chronic kidney disease (CKD)|chronic kidney disease (ckd)
326624|NCT01750190|non-dialysis|non-dialysis
326625|NCT01750190|Hemoglobin (Hb)|hemoglobin (hb)
326626|NCT01750190|End-Stage Renal Disease|end-stage renal disease
326627|NCT01750190|erythropoeitin|erythropoeitin
326628|NCT01750190|ASP1517|asp1517
326629|NCT01750190|erythropoeisis stimulating-agent|erythropoeisis stimulating-agent
326630|NCT01750190|AZD9941|azd9941
326631|NCT01750164|Breast Cancer|breast cancer
326632|NCT01750125|Doppler|doppler
326633|NCT01750112|Pectus excavatum|pectus excavatum
326634|NCT01750112|funnel chest|funnel chest
326635|NCT01750112|sunken chest|sunken chest
326636|NCT01750099|Labor|labor
326637|NCT01750099|analgesia|analgesia
326638|NCT01750099|epidural|epidural
326639|NCT01750099|spinal|spinal
326640|NCT01750086|osteoporosis|osteoporosis
326641|NCT01750086|postmenopausal|postmenopausal
326642|NCT01750086|denosumab|denosumab
326643|NCT01750086|teriparatide|teriparatide
326644|NCT01750086|alendronate|alendronate
326645|NCT01750086|Forteo®|forteo®
326646|NCT01750086|Prolia®|prolia®
326647|NCT01750047|pain perception|pain perception
326648|NCT01750047|postoperative pain|postoperative pain
326649|NCT01750047|demography|demography
326650|NCT01750047|smoking|smoking
326651|NCT01750047|alcohol|alcohol
326652|NCT01750034|Burns|burns
326653|NCT01750034|Wounds and injuries|wounds and injuries
326654|NCT01750034|Bandages|bandages
326655|NCT01750008|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
326656|NCT01750008|Menorrhagia|menorrhagia
326657|NCT01750008|Heavy Bleeding|heavy bleeding
326658|NCT01750008|Myomas|myomas
326659|NCT01750008|Radiofrequency Ablation|radiofrequency ablation
326660|NCT01750008|RFA|rfa
326661|NCT01750008|Leiomyoma|leiomyoma
326662|NCT01750008|Fibroids|fibroids
326663|NCT01749995|Elderly cancer patients|elderly cancer patients
326664|NCT01749995|Screening tool|screening tool
326665|NCT01749995|Cognitive impairment|cognitive impairment
326666|NCT01749995|Freund Clock Drawing Test|freund clock drawing test
326667|NCT01749982|arsenic|arsenic
326668|NCT01749982|Bangladesh|bangladesh
326669|NCT01749982|choline|choline
326670|NCT01749982|betaine|betaine
326671|NCT01749982|methylation|methylation
326672|NCT01749956|Rectal Cancer|rectal cancer
326673|NCT01749956|Chemoradiation|chemoradiation
326674|NCT01749956|Aflibercept|aflibercept
326675|NCT01749956|Surgery|surgery
326676|NCT01749930|Intraocular pressure|intraocular pressure
326677|NCT01749917|Parkinson.|parkinson.
326678|NCT01749917|Dexterity.|dexterity.
326679|NCT01749917|Balance.|balance.
326680|NCT01749917|Exercises.|exercises.
326681|NCT01749904|Intraocular pressure|intraocular pressure
326682|NCT01749891|Age Related Wet Macular Degeneration|age related wet macular degeneration
326683|NCT01749813|Carbohydrate Specific Diet|carbohydrate specific diet
326684|NCT01749813|Crohn's Disease|crohn's disease
326685|NCT01749813|Immunomodulators|immunomodulators
326686|NCT01749800|TBI|tbi
326687|NCT01749800|Attention deficits|attention deficits
326688|NCT01749800|Upper extremity weakness|upper extremity weakness
326689|NCT01749787|arthritis|arthritis
326690|NCT01749787|rheumatoid|rheumatoid
326691|NCT01749787|methotrexate|methotrexate
326692|NCT01749787|leflunomide|leflunomide
326693|NCT01749774|Physical activity|physical activity
326694|NCT01749774|Testicular cancer|testicular cancer
326695|NCT01749774|Chemotherapy|chemotherapy
326696|NCT01749774|Feasibility|feasibility
326697|NCT01749761|IDH, intradialytic hypotension,|idh, intradialytic hypotension,
326698|NCT01749761|hypotension on hemodialysis,|hypotension on hemodialysis,
326699|NCT01749761|hemodialysis,|hemodialysis,
326700|NCT01749761|Blood pressure guided biofeedback|blood pressure guided biofeedback
326701|NCT01749748|Breast diseases|breast diseases
326702|NCT01749748|magnetic resonance spectroscopy|magnetic resonance spectroscopy
326703|NCT01749722|Colorectal Cancer|colorectal cancer
326704|NCT01749722|Polyp|polyp
326705|NCT01749722|Adenoma|adenoma
326706|NCT01749722|Detection Rate|detection rate
326707|NCT01749722|Colonoscopy|colonoscopy
326708|NCT01749722|NaviAid™ G-Eye procedure|naviaid™ g-eye procedure
326709|NCT01749722|NaviAid™ G-Eye system|naviaid™ g-eye system
326710|NCT01749722|G-Eye procedure|g-eye procedure
326711|NCT01749722|G-Eye system|g-eye system
326712|NCT01749709|Stroke|stroke
326713|NCT01749709|Recovery|recovery
326714|NCT01749709|Music|music
326715|NCT01749696|Pelvic organ prolapse|pelvic organ prolapse
326716|NCT01749696|Connective tissue|connective tissue
326717|NCT01749696|Elastin|elastin
326718|NCT01749696|Collagen|collagen
326719|NCT01749670|Autism Spectrum Disorder|autism spectrum disorder
326720|NCT01749670|Exosomal miRNA expression|exosomal mirna expression
326721|NCT01749657|biomechanics|biomechanics
326722|NCT01749657|outcomes|outcomes
326723|NCT01749657|foot|foot
326724|NCT01749657|orthotic device|orthotic device
326725|NCT01749644|Cystic Fibrosis, Chronic Pseudomonas Infection, Inhaled Tobramycin|cystic fibrosis, chronic pseudomonas infection, inhaled tobramycin
326726|NCT01749631|Patients suspected to have difficult intubation|patients suspected to have difficult intubation
326727|NCT01749631|Intratracheal intubation|intratracheal intubation
326728|NCT01749631|Difficult to intubate|difficult to intubate
326729|NCT01749618|Seronegative Inflammatory Arthritis|seronegative inflammatory arthritis
326730|NCT01749618|SpA|spa
326731|NCT01749618|PsA|psa
326732|NCT01749618|Randomized|randomized
326733|NCT01749618|Behavioural Change|behavioural change
326734|NCT01749592|hearing loss|hearing loss
326735|NCT01749592|cochlear implant|cochlear implant
326736|NCT01749592|PET|pet
326737|NCT01749592|EEG|eeg
326738|NCT01749592|MEG|meg
326739|NCT01749579|propofol|propofol
326740|NCT01749579|midazolam|midazolam
326741|NCT01749579|duration of recovery|duration of recovery
326742|NCT01749579|emergency procedure|emergency procedure
326743|NCT01749566|HIV/AIDS, preexposure prophylaxis, women's health|hiv/aids, preexposure prophylaxis, women's health
326744|NCT01749527|24-hour pad test|24-hour pad test
326745|NCT01749527|Activity|activity
326746|NCT01749527|Stress urinary incontinence|stress urinary incontinence
326747|NCT01749514|Myelodysplastic Syndrome|myelodysplastic syndrome
326748|NCT01749488|Dietitian|dietitian
326749|NCT01749488|Nutritional recommendations|nutritional recommendations
326750|NCT01749488|ICU nutrition|icu nutrition
326751|NCT01749462|chronic obstructive pulmonary disease,|chronic obstructive pulmonary disease,
326752|NCT01749462|COPD,|copd,
326753|NCT01749462|Oxis,|oxis,
326754|NCT01749449|high protein|high protein
326755|NCT01749449|high carbohydrate|high carbohydrate
326756|NCT01749449|meal frequency|meal frequency
326757|NCT01749449|abdominal body fat|abdominal body fat
326758|NCT01749449|postprandial thermogenesis|postprandial thermogenesis
326759|NCT01749436|Atelectasis|atelectasis
326760|NCT01749436|Pneumoperitoneum|pneumoperitoneum
326761|NCT01749436|Hypoxemia|hypoxemia
326762|NCT01749371|Alpha-Tocopherol|alpha-tocopherol
326763|NCT01749371|Inflammation|inflammation
326764|NCT01749371|Oxidative Stress|oxidative stress
326765|NCT01749371|Malondialdehyde|malondialdehyde
326766|NCT01749371|Isoprostanes|isoprostanes
326767|NCT01749371|Lung Dysfunction|lung dysfunction
326768|NCT01749371|Wound Healing|wound healing
326769|NCT01749358|stroke|stroke
326770|NCT01749358|hemiparesis|hemiparesis
326771|NCT01749358|physical therapy|physical therapy
326772|NCT01749358|occupational therapy|occupational therapy
326773|NCT01749358|neurorehabilitation|neurorehabilitation
326774|NCT01749358|patient focused|patient focused
326775|NCT01749358|motor learning|motor learning
326776|NCT01749358|motor control|motor control
326777|NCT01749358|skill acquisition|skill acquisition
326778|NCT01749358|skill training|skill training
326779|NCT01749358|motor recovery|motor recovery
326780|NCT01749358|task oriented training|task oriented training
326781|NCT01749358|task specific training|task specific training
326782|NCT01749358|arm function|arm function
326783|NCT01749358|hand function|hand function
326784|NCT01749358|upper extremity|upper extremity
326785|NCT01749358|arm therapy|arm therapy
326786|NCT01749358|physical rehabilitation|physical rehabilitation
326787|NCT01749358|arm rehabilitation|arm rehabilitation
326788|NCT01749358|motor function|motor function
326789|NCT01749332|blood draw|blood draw
326790|NCT01749332|Perihepatic Phlebotomy|perihepatic phlebotomy
326791|NCT01749332|12-236|12-236
326792|NCT01749319|baclofen, withdrawal, interuption, spasticity, pharmacokinetics, tolerability, intravenous, oral|baclofen, withdrawal, interuption, spasticity, pharmacokinetics, tolerability, intravenous, oral
326793|NCT01749306|epidermolysis bullosa, chronic wound, wound healing, dermal repair, fibroblasts, Dermagraft|epidermolysis bullosa, chronic wound, wound healing, dermal repair, fibroblasts, dermagraft
326794|NCT01749280|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
326795|NCT01749280|MRI|mri
326796|NCT01749280|USPIO|uspio
326797|NCT01749267|dentin remineralization|dentin remineralization
326798|NCT01749267|caries regression|caries regression
326799|NCT01749254|Culprit plaques|culprit plaques
326800|NCT01749254|Vulnerable Plaques|vulnerable plaques
326801|NCT01749254|PET|pet
326802|NCT01749254|calcification|calcification
326803|NCT01749254|inflammation|inflammation
326804|NCT01749228|Fed|fed
326805|NCT01749215|pharmacotherapy|pharmacotherapy
326806|NCT01749215|alcohol dependence|alcohol dependence
326807|NCT01749215|Veterans|veterans
326808|NCT01749202|Omega 3 fatty acids|omega 3 fatty acids
326809|NCT01749202|Omega 3 Index|omega 3 index
326810|NCT01749202|Stearidonic acid (SDA)|stearidonic acid (sda)
326811|NCT01749202|Red Blood Cells|red blood cells
326812|NCT01749202|Lipids|lipids
326813|NCT01749189|soy|soy
326814|NCT01749189|whey|whey
326815|NCT01749189|casein|casein
326816|NCT01749189|muscle|muscle
326817|NCT01749189|strength|strength
326818|NCT01749189|protein|protein
326819|NCT01749176|High risk Latino patients with diabetes|high risk latino patients with diabetes
326820|NCT01749137|Overweight|overweight
326821|NCT01749124|mental illness|mental illness
326822|NCT01749124|depression|depression
326823|NCT01749124|schizophrenia|schizophrenia
326824|NCT01749124|bipolar disorder|bipolar disorder
326825|NCT01749124|IVR|ivr
326826|NCT01749124|automated|automated
326827|NCT01749124|telephone|telephone
326828|NCT01749111|bone marrow transplantation|bone marrow transplantation
326829|NCT01749111|graft versus host disease|graft versus host disease
326830|NCT01749111|Acute myelogenous leukemia|acute myelogenous leukemia
326831|NCT01749111|Acute lymphoid leukemia|acute lymphoid leukemia
326832|NCT01749111|Myeloproliferative disease|myeloproliferative disease
326833|NCT01749111|Myelodysplastic syndrome|myelodysplastic syndrome
326834|NCT01749111|Chronic myeloid leukemia|chronic myeloid leukemia
326835|NCT01749111|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
326836|NCT01749098|PF-04958242|pf-04958242
326837|NCT01749098|ketamine|ketamine
326838|NCT01749098|cognition|cognition
326839|NCT01749098|healthy volunteers|healthy volunteers
326840|NCT01749085|PF-04449913|pf-04449913
326841|NCT01749085|Food Effect|food effect
326842|NCT01749085|Drug-drug interaction|drug-drug interaction
326843|NCT01749085|CYP3A4 inhibitor|cyp3a4 inhibitor
326844|NCT01749085|Pharmacokinetics|pharmacokinetics
326845|NCT01749072|non small cell lung cancer|non small cell lung cancer
326846|NCT01749072|chemotherapy|chemotherapy
326847|NCT01749072|gefitinib|gefitinib
326848|NCT01749072|vinorelbine|vinorelbine
326849|NCT01749072|ifosfamide|ifosfamide
326850|NCT01749046|Epileptic seizures, Partial seizures|epileptic seizures, partial seizures
326851|NCT01749033|Intubation|intubation
326852|NCT01749033|Airway|airway
326853|NCT01749033|Laryngeal Mask Airway|laryngeal mask airway
326854|NCT01749020|Diabetes type II, Insulin sensitivity|diabetes type ii, insulin sensitivity
326855|NCT01749007|Veterans|veterans
326856|NCT01749007|HIV|hiv
326857|NCT01749007|AIDS|aids
326858|NCT01749007|Cognitive Functioning|cognitive functioning
326859|NCT01749007|Suicide|suicide
326860|NCT01748994|Obesity|obesity
326861|NCT01748994|Fat distribution|fat distribution
326862|NCT01748994|Adipogenesis|adipogenesis
326863|NCT01748994|Adipocyte|adipocyte
326864|NCT01748994|Preadipocyte|preadipocyte
326865|NCT01748994|Ectopic fat|ectopic fat
326866|NCT01748981|Pulmonary function|pulmonary function
326867|NCT01748981|Maximal oxygen uptake|maximal oxygen uptake
326868|NCT01748981|Cardiorespiratory fitness|cardiorespiratory fitness
326869|NCT01748981|High-intensity training|high-intensity training
326870|NCT01748981|Surgery|surgery
326871|NCT01748968|Veterans|veterans
326872|NCT01748968|Human Immunodeficiency Virus Infection(HIV)/Acquired Immunodeficiency Syndrome (AIDS)|human immunodeficiency virus infection(hiv)/acquired immunodeficiency syndrome (aids)
326873|NCT01748968|Self-Directed Violence|self-directed violence
326874|NCT01748955|Major Depressive Disorder|major depressive disorder
326875|NCT01748955|MDD|mdd
326876|NCT01748955|Reward|reward
326877|NCT01748955|BOLD signal|bold signal
326878|NCT01748955|Suicide|suicide
326879|NCT01748929|Global Health|global health
326880|NCT01748929|Deworming|deworming
326881|NCT01748929|Postpartum|postpartum
326882|NCT01748929|Soil-Transmitted Helminths|soil-transmitted helminths
326883|NCT01748929|Pregnant Women|pregnant women
326884|NCT01748916|Papaya|papaya
326885|NCT01748916|Carrot|carrot
326886|NCT01748916|Tomato|tomato
326887|NCT01748916|Carotenoids|carotenoids
326888|NCT01748916|Lycopene|lycopene
326889|NCT01748916|Beta-carotene|beta-carotene
326890|NCT01748916|Beta-cryptoxanthin|beta-cryptoxanthin
326891|NCT01748903|intracranial aneurysm|intracranial aneurysm
326892|NCT01748903|cerebral aneurysm|cerebral aneurysm
326893|NCT01748903|packing density|packing density
326894|NCT01748903|Target Coils|target coils
326895|NCT01748903|aneurysm embolization|aneurysm embolization
326896|NCT01748877|shingles,|shingles,
326897|NCT01748877|neuropathic pain|neuropathic pain
326898|NCT01748877|post herpetic neuralgia|post herpetic neuralgia
326899|NCT01748877|sleep|sleep
326900|NCT01748864|Volunteers|volunteers
326901|NCT01748825|MK-1775|mk-1775
326902|NCT01748825|Refractory|refractory
326903|NCT01748825|Solid Tumors|solid tumors
326904|NCT01748825|Wee1 Inhibitor|wee1 inhibitor
326905|NCT01748825|Tyrosine Kinase|tyrosine kinase
326906|NCT01748812|Tumor Induced Osteomalacia|tumor induced osteomalacia
326907|NCT01748812|Hypophosphatemic Rickets|hypophosphatemic rickets
326908|NCT01748799|Cannabis dependence|cannabis dependence
326909|NCT01748799|Sativex|sativex
326910|NCT01748786|Fibromyalgia|fibromyalgia
326911|NCT01748786|Mindfulness|mindfulness
326912|NCT01748786|On-line intervention|on-line intervention
326913|NCT01748786|Chronic pain|chronic pain
326914|NCT01748760|Suicide Attempts|suicide attempts
326915|NCT01748760|Suicidal Ideation|suicidal ideation
326916|NCT01748734|Depression|depression
326917|NCT01748708|Magnetic seizure therapy|magnetic seizure therapy
326918|NCT01748708|Electroconvulsive therapy|electroconvulsive therapy
326919|NCT01748708|Treatment resistant depression|treatment resistant depression
326920|NCT01748708|Treatment resistance|treatment resistance
326921|NCT01748708|Randomized controlled trial|randomized controlled trial
326922|NCT01748695|Neuropathic pain|neuropathic pain
326923|NCT01748695|Spinal cord injury|spinal cord injury
326924|NCT01748682|Very low calorie diet|very low calorie diet
326925|NCT01748682|liquid diet|liquid diet
326926|NCT01748682|visceral fat|visceral fat
326927|NCT01748682|liver fat.|liver fat.
326928|NCT01748669|Arsenic|arsenic
326929|NCT01748669|Arsenicosis|arsenicosis
326930|NCT01748669|Garlic oil|garlic oil
326931|NCT01748669|Keratosis|keratosis
326932|NCT01748656|Noninvasive ventilation|noninvasive ventilation
326933|NCT01748656|Obesity Hypoventilation Syndrome|obesity hypoventilation syndrome
326934|NCT01748630|scoliosis, sedation, children, fentanyl consumption, pain|scoliosis, sedation, children, fentanyl consumption, pain
326935|NCT01748604|Lymphedema|lymphedema
326936|NCT01748604|Physical Therapies|physical therapies
326937|NCT01748604|Randomized controlled study|randomized controlled study
326938|NCT01748604|Decongestive lymphatic therapy|decongestive lymphatic therapy
326939|NCT01748604|Manual lymph drainage|manual lymph drainage
326940|NCT01748604|Intermittent pneumatic compression|intermittent pneumatic compression
326941|NCT01748604|Multilayer bandages|multilayer bandages
326942|NCT01748578|Healthy|healthy
326943|NCT01748578|Interleukin 1 Receptor Inhibitor|interleukin 1 receptor inhibitor
326944|NCT01748578|Dry Eye|dry eye
326945|NCT01748565|biomarkers|biomarkers
326946|NCT01748565|oxidative stress|oxidative stress
326947|NCT01748565|BPD|bpd
326948|NCT01748565|prematurity|prematurity
326949|NCT01748526|Healthy|healthy
326950|NCT01748526|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
326951|NCT01748526|Pharmacokinetics|pharmacokinetics
326952|NCT01748526|Pharmacodynamics|pharmacodynamics
326953|NCT01748526|Indian|indian
326954|NCT01748513|morbidly obese patients,|morbidly obese patients,
326955|NCT01748513|preoperative volume-challenge,|preoperative volume-challenge,
326956|NCT01748513|transthoracic echocardiography,|transthoracic echocardiography,
326957|NCT01748513|TTE,|tte,
326958|NCT01748513|rapid weight loss,|rapid weight loss,
326959|NCT01748513|venous return,|venous return,
326960|NCT01748513|bariatric surgery,|bariatric surgery,
326961|NCT01748513|left ventricular outflow tract,|left ventricular outflow tract,
326962|NCT01748513|stroke volume,|stroke volume,
326963|NCT01748513|diastolic function,|diastolic function,
326964|NCT01748513|hypervolemia,|hypervolemia,
326965|NCT01748513|hypovolemia|hypovolemia
326966|NCT01748500|metastatic|metastatic
326967|NCT01748461|intervention study in elderly (65+)|intervention study in elderly (65+)
326968|NCT01748461|cycle ergometer|cycle ergometer
326969|NCT01748461|physical activity|physical activity
326970|NCT01748461|physical fitness|physical fitness
326971|NCT01748461|assisted living facility|assisted living facility
326972|NCT01748448|Cutaneous malignant melanoma|cutaneous malignant melanoma
326973|NCT01748448|Vitamin D|vitamin d
326974|NCT01748448|Cholecalciferol|cholecalciferol
326975|NCT01748435|Neuropathic pain|neuropathic pain
326976|NCT01748435|Lower limb amputation|lower limb amputation
326977|NCT01748435|Pre-emptive analgesia|pre-emptive analgesia
326978|NCT01748422|Neuropathic pain|neuropathic pain
326979|NCT01748422|Arteriovenous fistulae|arteriovenous fistulae
326980|NCT01748422|End stage renal disease|end stage renal disease
326981|NCT01748409|Autonomic failure, Parkinson's disease, electrophysiological assessment, neuropathological assessment|autonomic failure, parkinson's disease, electrophysiological assessment, neuropathological assessment
326982|NCT01748396|FGF-23|fgf-23
326983|NCT01748396|Calcitriol|calcitriol
326984|NCT01748396|Calcium carbonate|calcium carbonate
326985|NCT01748396|CKD Stage 3|ckd stage 3
326986|NCT01748383|Bone marrow cells|bone marrow cells
326987|NCT01748383|Acute myocardial infarction|acute myocardial infarction
326988|NCT01748383|Transplantation of autologous mononuclear|transplantation of autologous mononuclear
326989|NCT01748383|Transplantation of autologous CD133 + cells|transplantation of autologous cd133 + cells
326990|NCT01748370|vitamin D|vitamin d
326991|NCT01748370|hypogonadism|hypogonadism
326992|NCT01748370|testosterone|testosterone
326993|NCT01748370|intervention|intervention
326994|NCT01748357|Tuberculosis|tuberculosis
326995|NCT01748357|Volatile organic compounds|volatile organic compounds
326996|NCT01748357|exhaled breath|exhaled breath
326997|NCT01748357|Siemens|siemens
326998|NCT01748331|Heart Failure|heart failure
326999|NCT01748331|Hyponatremia|hyponatremia
327000|NCT01748331|Fluid restriction|fluid restriction
327001|NCT01748318|Community acquired MRSA|community acquired mrsa
327002|NCT01748318|New Mexico Honey|new mexico honey
327003|NCT01748305|GDM|gdm
327004|NCT01748305|A1GDM|a1gdm
327005|NCT01748305|A2GDM|a2gdm
327006|NCT01748292|Age related|age related
327007|NCT01748292|Macular|macular
327008|NCT01748292|sub retinal fluid|sub retinal fluid
327009|NCT01748292|Age related Macular degeneration|age related macular degeneration
327010|NCT01748279|COPD|copd
327011|NCT01748279|Atorvastatin|atorvastatin
327012|NCT01748279|statins|statins
327013|NCT01748279|COPD treatment|copd treatment
327014|NCT01748279|microarrays|microarrays
327015|NCT01748266|StO2|sto2
327016|NCT01748266|microcirculation|microcirculation
327017|NCT01748266|NIRS|nirs
327018|NCT01748227|self-management|self-management
327019|NCT01748227|peer support|peer support
327020|NCT01748227|social support|social support
327021|NCT01748214|continuous positive airway pressure|continuous positive airway pressure
327022|NCT01748214|high flow nasal cannula|high flow nasal cannula
327023|NCT01748214|hearing outcomes|hearing outcomes
327024|NCT01748214|noise exposure|noise exposure
327025|NCT01748214|preterm infants|preterm infants
327026|NCT01748201|Osteoarthritis|osteoarthritis
327027|NCT01748201|Hemarthrosis|hemarthrosis
327028|NCT01748201|Hemophilia A|hemophilia a
327029|NCT01748201|Hemophilia B|hemophilia b
327030|NCT01748201|Viscosupplementation|viscosupplementation
327031|NCT01748188|Subacromial syndrome|subacromial syndrome
327032|NCT01748188|Dexketoprofen|dexketoprofen
327033|NCT01748188|Phonophoresis|phonophoresis
327034|NCT01748188|Iontophoresis|iontophoresis
327035|NCT01748188|Ultrasounds|ultrasounds
327036|NCT01748188|VAS|vas
327037|NCT01748188|DASH score|dash score
327038|NCT01748188|Constant score|constant score
327039|NCT01748175|Severe asthma|severe asthma
327040|NCT01748175|longitudinal study|longitudinal study
327041|NCT01748175|phenotypes|phenotypes
327042|NCT01748162|croup|croup
327043|NCT01748162|recurrent croup|recurrent croup
327044|NCT01748162|barky cough|barky cough
327045|NCT01748149|recurrent/refractory BRAFV600E-mutant gliomas|recurrent/refractory brafv600e-mutant gliomas
327046|NCT01748149|pediatrics|pediatrics
327047|NCT01748149|children|children
327048|NCT01748149|neo-adjuvant vemurafenib|neo-adjuvant vemurafenib
327049|NCT01748123|Pragmatic|pragmatic
327050|NCT01748123|Comparative Effectiveness|comparative effectiveness
327051|NCT01748110|quality of life|quality of life
327052|NCT01748110|erectile function|erectile function
327053|NCT01748097|infiltration|infiltration
327054|NCT01748097|extravasation|extravasation
327055|NCT01748097|sodium bicarbonate|sodium bicarbonate
327056|NCT01748097|capnography|capnography
327057|NCT01748097|end tidal carbon dioxide|end tidal carbon dioxide
327058|NCT01748097|chemotherapy|chemotherapy
327059|NCT01748084|Systemic sclerosis|systemic sclerosis
327060|NCT01748084|Arthritis|arthritis
327061|NCT01748084|B-cell therapy, Anti-CD20 therapy|b-cell therapy, anti-cd20 therapy
327062|NCT01748084|Quality of life|quality of life
327063|NCT01748084|Scleroderma|scleroderma
327064|NCT01748084|Lung fibrosis|lung fibrosis
327065|NCT01748084|Randomised controled trial|randomised controled trial
327066|NCT01748071|fentanyl|fentanyl
327067|NCT01748071|sufentanil|sufentanil
327068|NCT01748071|individual variation|individual variation
327069|NCT01748071|pain threshold|pain threshold
327070|NCT01748071|nacro-trend index|nacro-trend index
327071|NCT01748045|Inhaled Nitric Oxide|inhaled nitric oxide
327072|NCT01748045|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
327073|NCT01748045|Late Prematurity|late prematurity
327074|NCT01748045|Chronic Respiratory Morbidity|chronic respiratory morbidity
327075|NCT01748032|depression|depression
327076|NCT01748032|intervention studies|intervention studies
327077|NCT01748019|ST1968|st1968
327078|NCT01748019|Camptothecin|camptothecin
327079|NCT01748019|Solid tumors|solid tumors
327080|NCT01748019|Topoisomerase I|topoisomerase i
327081|NCT01747993|Urinary retention; urinary catheterization; alpha blocking agents; women; elder|urinary retention; urinary catheterization; alpha blocking agents; women; elder
327082|NCT01747980|Gaucher disease|gaucher disease
327083|NCT01747980|human glucocerebrosidase|human glucocerebrosidase
327084|NCT01747980|plant recombinant human glucocerebrosidase|plant recombinant human glucocerebrosidase
327085|NCT01747967|Antibodies|antibodies
327086|NCT01747967|Beta cells|beta cells
327087|NCT01747967|C-peptide|c-peptide
327088|NCT01747967|GAD|gad
327089|NCT01747967|Glucose|glucose
327090|NCT01747967|Glycemia|glycemia
327091|NCT01747967|Insulin|insulin
327092|NCT01747967|Meal test|meal test
327093|NCT01747967|Pancreas|pancreas
327094|NCT01747967|Proinsulin,|proinsulin,
327095|NCT01747967|T lymphocytes|t lymphocytes
327096|NCT01747954|Respiratory Insufficiency|respiratory insufficiency
327097|NCT01747954|Physiotherapy Techniques|physiotherapy techniques
327098|NCT01747954|Respiratory Mechanics|respiratory mechanics
327099|NCT01747928|usability study|usability study
327100|NCT01747915|Primary Generalized Tonic Clonic Seizures|primary generalized tonic clonic seizures
327101|NCT01747915|Epilepsy|epilepsy
327102|NCT01747915|Safety|safety
327103|NCT01747915|Efficacy|efficacy
327104|NCT01747915|Tolerability|tolerability
327105|NCT01747915|Pregabalin|pregabalin
327106|NCT01747915|Lyrica|lyrica
327107|NCT01747915|Adjunctive treatment|adjunctive treatment
327108|NCT01747915|Placebo Controlled|placebo controlled
327109|NCT01747915|Blinded|blinded
327110|NCT01747889|chest tube|chest tube
327111|NCT01747889|lung resection|lung resection
327112|NCT01747889|patient satisfaction|patient satisfaction
327113|NCT01747889|mobility|mobility
327114|NCT01747876|Phase 1|phase 1
327115|NCT01747876|pediatric|pediatric
327116|NCT01747876|CDK4/6 inhibitor|cdk4/6 inhibitor
327117|NCT01747876|dose escalation|dose escalation
327118|NCT01747876|malignant rhabdoid tumors|malignant rhabdoid tumors
327119|NCT01747876|MRT|mrt
327120|NCT01747876|neuroblastoma|neuroblastoma
327121|NCT01747863|Hypoxic Ischemic encephalopathy|hypoxic ischemic encephalopathy
327122|NCT01747837|Renal sympathetic denervation|renal sympathetic denervation
327123|NCT01747837|Renal catheter ablation|renal catheter ablation
327124|NCT01747837|Ventricular tachycardia|ventricular tachycardia
327125|NCT01747824|agitation|agitation
327126|NCT01747824|excited delirium|excited delirium
327127|NCT01747824|pain|pain
327128|NCT01747824|unexplained-in-custody-death|unexplained-in-custody-death
327129|NCT01747824|UICD|uicd
327130|NCT01747824|visual analog scale|visual analog scale
327131|NCT01747824|VAS|vas
327132|NCT01747824|altered mental status|altered mental status
327133|NCT01747824|AMS|ams
327261|NCT01747226|Bad Breath|bad breath
327134|NCT01747811|Mild traumatic brain injury|mild traumatic brain injury
327135|NCT01747811|Concussion|concussion
327136|NCT01747811|Sleep problems|sleep problems
327137|NCT01747811|brain imaging|brain imaging
327138|NCT01747811|functional magnetic resonance imaging (FMRI)|functional magnetic resonance imaging (fmri)
327139|NCT01747785|Heart failure|heart failure
327140|NCT01747785|HFpEF|hfpef
327141|NCT01747785|Dyspnea|dyspnea
327142|NCT01747785|Fatigue|fatigue
327143|NCT01747785|Shortness of Breath|shortness of breath
327144|NCT01747785|exercise|exercise
327145|NCT01747785|strain|strain
327146|NCT01747785|myocardial deformation|myocardial deformation
327147|NCT01747785|cardiac rehabilitation|cardiac rehabilitation
327148|NCT01747785|cardiac hemodynamics|cardiac hemodynamics
327149|NCT01747772|Non-focal Liver Disease|non-focal liver disease
327150|NCT01747772|Fibrosis|fibrosis
327151|NCT01747772|Shear Wave Sonoelastography|shear wave sonoelastography
327152|NCT01747772|Metavir Liver Fibrosis Grading|metavir liver fibrosis grading
327153|NCT01747759|• Knee osteoarthritis|• knee osteoarthritis
327154|NCT01747759|Total knee arthroplasty|total knee arthroplasty
327155|NCT01747759|Selfcare|selfcare
327156|NCT01747759|Booklet|booklet
327157|NCT01747759|Rehabilitation|rehabilitation
327158|NCT01747746|Rivaroxaban|rivaroxaban
327159|NCT01747746|Warfarin|warfarin
327160|NCT01747746|Anticoagulation|anticoagulation
327161|NCT01747746|Stroke|stroke
327162|NCT01747746|Thrombo-embolism|thrombo-embolism
327163|NCT01747746|Bleeding|bleeding
327164|NCT01747746|Atrial Fibrillation|atrial fibrillation
327165|NCT01747746|Cardioversion|cardioversion
327166|NCT01747733|Endoscopy|endoscopy
327167|NCT01747733|ERCP|ercp
327168|NCT01747733|PCS|pcs
327169|NCT01747733|Sedation|sedation
327170|NCT01747733|Bispectral index|bispectral index
327171|NCT01747720|breast cancer|breast cancer
327172|NCT01747720|mammographic breast density|mammographic breast density
327173|NCT01747720|vitamin D|vitamin d
327174|NCT01747720|prevention|prevention
327175|NCT01747720|randomized controlled trial|randomized controlled trial
327176|NCT01747707|gastric cancer|gastric cancer
327177|NCT01747707|gastroesophageal junction cancer|gastroesophageal junction cancer
327178|NCT01747707|chemotherapy|chemotherapy
327179|NCT01747707|docetaxel|docetaxel
327180|NCT01747707|cisplatin|cisplatin
327181|NCT01747707|S-1|s-1
327182|NCT01747694|COPD,Respiratory muscle training,Exercise tolerance|copd,respiratory muscle training,exercise tolerance
327183|NCT01747681|chondral defect|chondral defect
327184|NCT01747681|microfracture|microfracture
327185|NCT01747681|arthroscopy|arthroscopy
327186|NCT01747681|cartilage repair|cartilage repair
327187|NCT01747681|outcome study|outcome study
327188|NCT01747681|Lysholm score|lysholm score
327189|NCT01747668|Mother and Infant Pairs|mother and infant pairs
327190|NCT01747655|Early Observational Advanced|early observational advanced
327191|NCT01747655|Parkinson's Disease|parkinson's disease
327192|NCT01747642|Hepatocellular carcinoma|hepatocellular carcinoma
327193|NCT01747642|Oncoxin|oncoxin
327194|NCT01747642|Surafenib|surafenib
327195|NCT01747629|Asthma|asthma
327196|NCT01747629|dry powder inhaler|dry powder inhaler
327197|NCT01747629|short-acting beta2-agonist|short-acting beta2-agonist
327198|NCT01747629|SABA|saba
327199|NCT01747629|bronchoconstriction|bronchoconstriction
327200|NCT01747629|bronchodilation|bronchodilation
327201|NCT01747629|bronchodilator|bronchodilator
327202|NCT01747629|metered dose inhaler|metered dose inhaler
327203|NCT01747629|Albuterol Spiromax®|albuterol spiromax®
327204|NCT01747616|Chitosan-N-Acetylcysteine|chitosan-n-acetylcysteine
327205|NCT01747616|contact lenses|contact lenses
327206|NCT01747616|safety and tolerability|safety and tolerability
327207|NCT01747603|Late preterm infant|late preterm infant
327208|NCT01747603|Complications|complications
327209|NCT01747603|Hospital readmissions|hospital readmissions
327210|NCT01747603|Follow-up|follow-up
327211|NCT01747603|Pilot study|pilot study
327212|NCT01747577|Muscarine antagonist|muscarine antagonist
327213|NCT01747577|Prostatectomy|prostatectomy
327214|NCT01747577|Uroflowmetry|uroflowmetry
327215|NCT01747564|Pharmacokinetics|pharmacokinetics
327216|NCT01747564|Mirabegron|mirabegron
327217|NCT01747564|Phase 1|phase 1
327218|NCT01747564|YM178|ym178
327219|NCT01747551|Advanced|advanced
327220|NCT01747538|Uveitis|uveitis
327221|NCT01747538|Non-infectious Uveitis|non-infectious uveitis
327222|NCT01747538|Intermediate Uveitis|intermediate uveitis
327223|NCT01747538|Posterior Uveitis|posterior uveitis
327224|NCT01747538|Panuveitis|panuveitis
327225|NCT01747512|99mTc Pertechnetate|99mtc pertechnetate
327226|NCT01747512|thyroidectomy|thyroidectomy
327227|NCT01747512|thyroid neoplasms|thyroid neoplasms
327228|NCT01747473|Subjects|subjects
327229|NCT01747460|Subjects|subjects
327230|NCT01747408|subarachnoid hemorrhage|subarachnoid hemorrhage
327231|NCT01747395|Heart Failure|heart failure
327232|NCT01747395|Exercise and Physical Fitness|exercise and physical fitness
327233|NCT01747382|Treatment-resistant Hypertension|treatment-resistant hypertension
327234|NCT01747382|Chronic Kidney Disease|chronic kidney disease
327235|NCT01747382|Symplicity catheters|symplicity catheters
327236|NCT01747382|Renal denervation|renal denervation
327237|NCT01747369|surveillance study|surveillance study
327238|NCT01747369|prospective|prospective
327239|NCT01747369|observational|observational
327240|NCT01747369|health center-based|health center-based
327241|NCT01747369|pneumonia, bacterial|pneumonia, bacterial
327242|NCT01747369|pneumonia, viral|pneumonia, viral
327243|NCT01747369|meningitis, bacterial|meningitis, bacterial
327244|NCT01747369|Africa south of the Sahara|africa south of the sahara
327245|NCT01747343|Incontinence|incontinence
327246|NCT01747343|Enuresis|enuresis
327247|NCT01747330|cystic fibrosis|cystic fibrosis
327248|NCT01747317|FFR|ffr
327249|NCT01747317|fractional flow reserve|fractional flow reserve
327250|NCT01747317|CT|ct
327251|NCT01747317|Computed Tomography|computed tomography
327252|NCT01747304|Atypical Femur Fracture|atypical femur fracture
327253|NCT01747304|DXA|dxa
327254|NCT01747278|Pneumocystis carinii pneumonia|pneumocystis carinii pneumonia
327255|NCT01747278|prophylaxis|prophylaxis
327256|NCT01747278|trimethoprim/sulfamethoxazole|trimethoprim/sulfamethoxazole
327257|NCT01747239|Ovarian cancer|ovarian cancer
327258|NCT01747239|Platinum refractory|platinum refractory
327259|NCT01747226|Oral malodor|oral malodor
327260|NCT01747226|Halitosis|halitosis
327262|NCT01747226|Mouth rinses|mouth rinses
327263|NCT01747226|Mouthwashes|mouthwashes
327264|NCT01747226|Amine fluoride/Stannous fluoride|amine fluoride/stannous fluoride
327265|NCT01747226|Zinc ions|zinc ions
327266|NCT01747226|Chlorhexidine|chlorhexidine
327267|NCT01747213|Neurodegenerative|neurodegenerative
327268|NCT01747213|Cholinergic|cholinergic
327269|NCT01747213|Single Dose|single dose
327270|NCT01747213|Inhibitor|inhibitor
327271|NCT01747213|Tolerability|tolerability
327272|NCT01747200|Repetitive TMS (rTMS)|repetitive tms (rtms)
327273|NCT01747187|Septic shock|septic shock
327274|NCT01747187|Critical care|critical care
327275|NCT01747187|cardiac failure|cardiac failure
327276|NCT01747174|STEMI|stemi
327277|NCT01747174|Microvascular Obstruction|microvascular obstruction
327278|NCT01747174|No-reflow|no-reflow
327279|NCT01747174|Adenosine|adenosine
327280|NCT01747174|Sodium Nitroprusside|sodium nitroprusside
327281|NCT01747148|Antisense|antisense
327282|NCT01747148|Influenza|influenza
327283|NCT01747148|IV Injection|iv injection
327284|NCT01747148|RNA Based Therapeutic|rna based therapeutic
327285|NCT01747148|RNA Interference|rna interference
327286|NCT01747135|2-Hydroxypropyl-B-Cyclodextrin|2-hydroxypropyl-b-cyclodextrin
327287|NCT01747135|Niemann-Pick Disease, Type C1|niemann-pick disease, type c1
327288|NCT01747135|Neurodegeneration|neurodegeneration
327289|NCT01747122|epidurals|epidurals
327290|NCT01747122|wound catheters|wound catheters
327291|NCT01747122|liver resection|liver resection
327292|NCT01747122|liver surgery|liver surgery
327293|NCT01747109|Acute hypoxemic respiratory failure|acute hypoxemic respiratory failure
327294|NCT01747109|Preoxygenation|preoxygenation
327295|NCT01747109|Crash induction|crash induction
327296|NCT01747096|Gastroenteropancreatic Neuroendocrine Tumors|gastroenteropancreatic neuroendocrine tumors
327297|NCT01747096|immuno PET (iPET)|immuno pet (ipet)
327298|NCT01747096|Gallium (68-Ga)|gallium (68-ga)
327299|NCT01747096|DOTANOC|dotanoc
327300|NCT01747070|Electro Acupuncture|electro acupuncture
327301|NCT01747070|Knee Osteoarthritis|knee osteoarthritis
327302|NCT01747070|Chronic pain|chronic pain
327303|NCT01747070|Cortical Excitability|cortical excitability
327304|NCT01747044|Fibromyalgia|fibromyalgia
327305|NCT01747044|Diffuse Noxious Inhibitory Controls|diffuse noxious inhibitory controls
327306|NCT01747044|Milnacipran|milnacipran
327307|NCT01747031|iFR|ifr
327308|NCT01747031|FFR|ffr
327309|NCT01747031|instantaneous wave-free ratio|instantaneous wave-free ratio
327310|NCT01747031|fractional flow reserve|fractional flow reserve
327311|NCT01747018|Platelet-Rich Plasma|platelet-rich plasma
327312|NCT01747018|Knee pain|knee pain
327313|NCT01747018|osteoarthritis|osteoarthritis
327314|NCT01747018|degenerative chondropathy|degenerative chondropathy
327315|NCT01747018|Intraarticular injection|intraarticular injection
327316|NCT01747005|abdominal hysterectomy|abdominal hysterectomy
327317|NCT01747005|enhanced recovery after surgery|enhanced recovery after surgery
327318|NCT01747005|inflammatory response|inflammatory response
327319|NCT01747005|ERAS|eras
327320|NCT01747005|combined spinal-epidural anesthesia|combined spinal-epidural anesthesia
327321|NCT01746979|TH-302|th-302
327322|NCT01746979|Evofosfamide|evofosfamide
327323|NCT01746979|Pancreatic Cancer|pancreatic cancer
327324|NCT01746979|EMR200592-001|emr200592-001
327325|NCT01746966|gleno-humeral joint synovitis|gleno-humeral joint synovitis
327326|NCT01746966|anterior shoulder US|anterior shoulder us
327327|NCT01746966|rotator interval|rotator interval
327328|NCT01746940|Surgery|surgery
327329|NCT01746940|Surgeries|surgeries
327330|NCT01746940|Nasal|nasal
327331|NCT01746940|Cavities|cavities
327332|NCT01746940|Diagnosis|diagnosis
327333|NCT01746940|Diagnostic|diagnostic
327334|NCT01746940|Nose|nose
327335|NCT01746940|Rhinoplasty|rhinoplasty
327336|NCT01746940|Endoscopy|endoscopy
327337|NCT01746940|Bronchoscopy|bronchoscopy
327338|NCT01746927|cricoid pressure, glidescope|cricoid pressure, glidescope
327339|NCT01746901|Relative abuse potential study; oxycodone; nalteone; Opioid-related disorders; drug abusers|relative abuse potential study; oxycodone; nalteone; opioid-related disorders; drug abusers
327340|NCT01746901|Chronic pain|chronic pain
327341|NCT01746875|Angiogenesis inhibitors|angiogenesis inhibitors
327342|NCT01746875|Photochemotherapy|photochemotherapy
327343|NCT01746875|Vascular Endothelium Growth Factors|vascular endothelium growth factors
327344|NCT01746875|Aflibercept|aflibercept
327345|NCT01746862|Saizen®|saizen®
327346|NCT01746862|Recombinant human growth hormone (r-hGH)|recombinant human growth hormone (r-hgh)
327347|NCT01746862|Idiopathic short stature|idiopathic short stature
327348|NCT01746862|Height velocity|height velocity
327349|NCT01746862|Bone age|bone age
327350|NCT01746849|LUPRON DEPOT|lupron depot
327351|NCT01746849|PALIFERMIN|palifermin
327352|NCT01746849|12-077|12-077
327353|NCT01746836|Leukemia|leukemia
327354|NCT01746836|Chronic Myeloid Leukemia|chronic myeloid leukemia
327355|NCT01746836|CML|cml
327356|NCT01746836|Imatinib-resistant or intolerant|imatinib-resistant or intolerant
327357|NCT01746836|Imatinib failure|imatinib failure
327358|NCT01746836|Ph-positive (by cytogenetics or FISH)|ph-positive (by cytogenetics or fish)
327359|NCT01746836|BCR-ABL-positive (by PCR) CML in chronic phase|bcr-abl-positive (by pcr) cml in chronic phase
327360|NCT01746836|Ponatinib|ponatinib
327361|NCT01746836|AP24534|ap24534
327362|NCT01746823|Keratoconus|keratoconus
327363|NCT01746823|Proteomics|proteomics
327364|NCT01746810|Metastatic|metastatic
327365|NCT01746810|Lung Cancer|lung cancer
327366|NCT01746810|NSCLC|nsclc
327367|NCT01746797|infertility|infertility
327368|NCT01746797|depression|depression
327369|NCT01746797|IVF|ivf
327370|NCT01746797|IUI|iui
327371|NCT01746797|fertility treatment|fertility treatment
327372|NCT01746784|Cystic Fibrosis|cystic fibrosis
327373|NCT01746784|F508del-CFTR|f508del-cftr
327374|NCT01746784|N6022|n6022
327375|NCT01746784|S-Nitrosoglutathione|s-nitrosoglutathione
327376|NCT01746771|HM781-36B, Paclitaxel, Trastuzumab|hm781-36b, paclitaxel, trastuzumab
327377|NCT01746758|Reproductive health, mHealth, Cluster randomised trial|reproductive health, mhealth, cluster randomised trial
327378|NCT01746693|retinal vessel diameter|retinal vessel diameter
327379|NCT01746693|retinal oxygen saturation|retinal oxygen saturation
327380|NCT01746693|high resolution functional and anatomical imaging|high resolution functional and anatomical imaging
327381|NCT01746693|inner retinal function|inner retinal function
327382|NCT01746693|flicker response|flicker response
327383|NCT01746680|rheumatoid arthritis|rheumatoid arthritis
327384|NCT01746680|RA|ra
327385|NCT01746680|tacrolimus|tacrolimus
327386|NCT01746680|Disease Activity Score 28|disease activity score 28
327387|NCT01746680|EULAR|eular
327388|NCT01746667|Social Anxiety Disorder|social anxiety disorder
327389|NCT01746667|Social Phobia|social phobia
327390|NCT01746667|Virtual Reality|virtual reality
327391|NCT01746667|Exposure|exposure
327392|NCT01746654|S.aureus|s.aureus
327393|NCT01746654|Methicillin Resistant S.aureus (MRSA)|methicillin resistant s.aureus (mrsa)
327394|NCT01746654|Nasal carrier status|nasal carrier status
327395|NCT01746654|Prophylaxis|prophylaxis
327396|NCT01746641|Remifentanil|remifentanil
327397|NCT01746641|Propofol|propofol
327398|NCT01746641|Sedation|sedation
327399|NCT01746641|Endoscopy|endoscopy
327400|NCT01746641|Gastroenterology|gastroenterology
327401|NCT01746641|Target controlled infusion effect site|target controlled infusion effect site
327402|NCT01746628|type 0 myomata|type 0 myomata
327403|NCT01746628|type 1 myomata|type 1 myomata
327404|NCT01746628|type 2 myomata|type 2 myomata
327405|NCT01746628|bleeding|bleeding
327406|NCT01746628|hemorrhage|hemorrhage
327407|NCT01746628|hysteroscopy|hysteroscopy
327408|NCT01746628|FloSeal|floseal
327409|NCT01746615|branch retinal vein occlusion|branch retinal vein occlusion
327410|NCT01746615|dynamic vessel analyzer|dynamic vessel analyzer
327411|NCT01746615|fourier-domain OCT|fourier-domain oct
327412|NCT01746615|retinal oxygen saturation|retinal oxygen saturation
327413|NCT01746602|topical lubricants|topical lubricants
327414|NCT01746602|tear film thickness|tear film thickness
327415|NCT01746602|anti-glaucoma drugs|anti-glaucoma drugs
327416|NCT01746602|break up time|break up time
327417|NCT01746602|anti-glaucoma treatment|anti-glaucoma treatment
327418|NCT01746589|LASIK|lasik
327419|NCT01746576|volunteers|volunteers
327420|NCT01746563|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
327421|NCT01746563|Ranibizumab|ranibizumab
327422|NCT01746563|Panretinal Photocoagulation|panretinal photocoagulation
327423|NCT01746524|Arthroplasty|arthroplasty
327424|NCT01746524|Replacement|replacement
327425|NCT01746524|Knee|knee
327426|NCT01746511|glycerin suppositories|glycerin suppositories
327427|NCT01746511|glycerin shaves|glycerin shaves
327428|NCT01746511|neonatal hyperbilirubinemia|neonatal hyperbilirubinemia
327429|NCT01746511|idiopathic hyperbilirubinemia|idiopathic hyperbilirubinemia
327430|NCT01746511|jaundice|jaundice
327431|NCT01746511|neonatal jaundice|neonatal jaundice
327432|NCT01746511|prematurity|prematurity
327433|NCT01746498|Alzheimer disease|alzheimer disease
327434|NCT01746498|Direct current stimulation|direct current stimulation
327435|NCT01746498|cognitive function|cognitive function
327436|NCT01746498|memory|memory
327437|NCT01746485|Volunteers|volunteers
327438|NCT01746459|Sustainability of Innovations|sustainability of innovations
327439|NCT01746459|Knowledge Translation|knowledge translation
327440|NCT01746459|Gerontology|gerontology
327441|NCT01746459|Mobility|mobility
327442|NCT01746420|elbow|elbow
327443|NCT01746407|Emergency Department|emergency department
327444|NCT01746407|Infection|infection
327445|NCT01746407|Sepsis|sepsis
327446|NCT01746394|obesity|obesity
327447|NCT01746394|pregnant women|pregnant women
327448|NCT01746394|nutrition assessment|nutrition assessment
327449|NCT01746394|health behavior|health behavior
327450|NCT01746381|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
327451|NCT01746381|non-invasive ventilation|non-invasive ventilation
327452|NCT01746381|home ventilation|home ventilation
327453|NCT01746381|IVAPS|ivaps
327454|NCT01746381|neuromuscular diseases|neuromuscular diseases
327455|NCT01746368|advance directives|advance directives
327456|NCT01746355|atypical facial pain|atypical facial pain
327457|NCT01746355|atypical odontalgia|atypical odontalgia
328451|NCT01741922|aspirin|aspirin
327458|NCT01746355|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
327459|NCT01746355|neuropathic pain|neuropathic pain
327460|NCT01746355|chronic pain|chronic pain
327461|NCT01746355|assessment|assessment
327462|NCT01746329|Obesity, insulin resistance, muscle perfusion|obesity, insulin resistance, muscle perfusion
327463|NCT01746303|Working memory|working memory
327464|NCT01746303|Long-term memory|long-term memory
327465|NCT01746303|Neurocognition|neurocognition
327466|NCT01746303|Dietary supplementation|dietary supplementation
327467|NCT01746303|dementia|dementia
327468|NCT01746290|Cardiac Arrest, cardiopulmonary resuscitation, automated external defibrillators, smartphones|cardiac arrest, cardiopulmonary resuscitation, automated external defibrillators, smartphones
327469|NCT01746277|non small cell lung cancer|non small cell lung cancer
327470|NCT01746277|chemotherapy|chemotherapy
327471|NCT01746277|epidermal growth factor receptor tyrosine kinase inhibitor|epidermal growth factor receptor tyrosine kinase inhibitor
327472|NCT01746277|retreatment|retreatment
327473|NCT01746264|Obesity|obesity
327474|NCT01746264|Endothelial dysfunction|endothelial dysfunction
327475|NCT01746264|Vitamin D deficiency|vitamin d deficiency
327476|NCT01746251|EGFR mutation|egfr mutation
327477|NCT01746251|Resected|resected
327478|NCT01746238|soft tissue|soft tissue
327479|NCT01746238|high grade|high grade
327480|NCT01746225|Metastatic|metastatic
327481|NCT01746225|Breast|breast
327482|NCT01746225|Cancer|cancer
327483|NCT01746225|HER2-negative Stage IV|her2-negative stage iv
327484|NCT01746225|No previous chemotherapy|no previous chemotherapy
327485|NCT01746212|Degenerative Disc Disease|degenerative disc disease
327486|NCT01746212|InQu Bone Graft Extender and Substitute|inqu bone graft extender and substitute
327487|NCT01746212|Anterior Lumbar Interbody Fusion|anterior lumbar interbody fusion
327488|NCT01746212|Oswestry Disability Index|oswestry disability index
327489|NCT01746212|Visual Analog Scale|visual analog scale
327490|NCT01746212|Stand-alone ALIF|stand-alone alif
327491|NCT01746212|Bone Marrow Aspirate Concentrate|bone marrow aspirate concentrate
327492|NCT01746212|Fusion rate|fusion rate
327493|NCT01746212|Disc Height|disc height
327494|NCT01746212|Mean Optical Density|mean optical density
327495|NCT01746212|Integrated Optical Density|integrated optical density
327496|NCT01746173|T Cell lymphoma|t cell lymphoma
327497|NCT01746160|dental implant|dental implant
327498|NCT01746160|healing|healing
327499|NCT01746160|implant stability|implant stability
327500|NCT01746147|MDS|mds
327501|NCT01746147|AML|aml
327502|NCT01746147|allogeneic SCT|allogeneic sct
327503|NCT01746108|Pneumococcal infection|pneumococcal infection
327504|NCT01746108|Synflorix|synflorix
327505|NCT01746108|Children|children
327506|NCT01746108|Immunogenicity|immunogenicity
327507|NCT01746108|Safety|safety
327508|NCT01746095|Cystic Fibrosis|cystic fibrosis
327509|NCT01746095|MRSA|mrsa
327510|NCT01746095|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
327511|NCT01746095|Lung infection|lung infection
327512|NCT01746095|AeroVanc|aerovanc
327513|NCT01746095|Vancomycin|vancomycin
327514|NCT01746082|influenza, H3N2, H3N2v, vaccine, unadjuvanted, Parent Protocol|influenza, h3n2, h3n2v, vaccine, unadjuvanted, parent protocol
327515|NCT01746069|smoking|smoking
327516|NCT01746069|smoke cessation|smoke cessation
327517|NCT01746069|sms|sms
327518|NCT01746069|quit smoke|quit smoke
327519|NCT01746056|Warts|warts
327520|NCT01746056|Verruca|verruca
327521|NCT01746056|Heat patch|heat patch
327522|NCT01746043|Esophageal cancer|esophageal cancer
327523|NCT01746043|Chemotherapy|chemotherapy
327524|NCT01746043|Radiation therapy|radiation therapy
327525|NCT01746043|XRT|xrt
327526|NCT01746043|Chemoradiation|chemoradiation
327527|NCT01746043|CXRT|cxrt
327528|NCT01746043|Symptom Burden|symptom burden
327529|NCT01746043|Armodafinil|armodafinil
327530|NCT01746043|Nuvigil|nuvigil
327531|NCT01746043|Minocycline|minocycline
327532|NCT01746043|Dynacin|dynacin
327533|NCT01746043|Minocin|minocin
327534|NCT01746043|Minocin PAC|minocin pac
327535|NCT01746043|Myrac|myrac
327536|NCT01746043|Solodyn|solodyn
327537|NCT01746043|Placebo|placebo
327538|NCT01746043|Sugar pill|sugar pill
327539|NCT01746043|Questionnaires|questionnaires
327540|NCT01746043|Surveys|surveys
327541|NCT01745952|Epilepsies, Partial|epilepsies, partial
327542|NCT01745952|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
327543|NCT01745939|Back pain|back pain
327544|NCT01745913|Leukemia|leukemia
327545|NCT01745913|Lymphoma|lymphoma
327546|NCT01745900|Diabetes|diabetes
327547|NCT01745900|Gestational Diabetes|gestational diabetes
327548|NCT01745900|Female|female
327549|NCT01745887|Dry Eye Syndrome|dry eye syndrome
327550|NCT01745887|Interleukin 1 Receptor Inhibitor|interleukin 1 receptor inhibitor
327551|NCT01745874|Rectal cancer|rectal cancer
327552|NCT01745874|Whole-body MRI|whole-body mri
327553|NCT01745874|FDG-PET-CT|fdg-pet-ct
327554|NCT01745874|preoperative staging|preoperative staging
327555|NCT01745848|Roflumilast|roflumilast
327556|NCT01745848|COPD|copd
327557|NCT01745822|Hepatitis B|hepatitis b
327558|NCT01745822|Hepatitis B sAg|hepatitis b sag
327559|NCT01745822|Hepatitis B eAg|hepatitis b eag
327560|NCT01745822|pregnancy|pregnancy
327561|NCT01745796|Pseudomonas Aeruginosa|pseudomonas aeruginosa
327562|NCT01745796|Ventilated Acquired Pneumonia|ventilated acquired pneumonia
327563|NCT01745796|Transmission modes|transmission modes
327564|NCT01745718|prostate cancer|prostate cancer
327565|NCT01745718|targeted biopsies|targeted biopsies
327566|NCT01745718|cytological imprints|cytological imprints
327567|NCT01745718|histology|histology
327568|NCT01745705|Manipulation|manipulation
327569|NCT01745705|Balance|balance
327570|NCT01745705|Proprioception|proprioception
327571|NCT01745679|Ceftriaxone|ceftriaxone
327572|NCT01745679|Adverse drug effects|adverse drug effects
327573|NCT01745679|Therapeutic monitoring|therapeutic monitoring
327574|NCT01745679|Meningitis|meningitis
327575|NCT01745666|Long QT syndrome, stress tests|long qt syndrome, stress tests
327576|NCT01745640|Multiple myeloma|multiple myeloma
327577|NCT01745640|dexamethasone|dexamethasone
327578|NCT01745640|pomalidomide|pomalidomide
327579|NCT01745640|response|response
327580|NCT01745640|safety|safety
327581|NCT01745640|del 17p|del 17p
327582|NCT01745640|t 4-14|t 4-14
327583|NCT01745614|Bioequivalence|bioequivalence
327584|NCT01745614|Nimesulide|nimesulide
327585|NCT01745614|Pharmacokinetics|pharmacokinetics
327586|NCT01745614|Mexico|mexico
327587|NCT01745588|CC-4047(Pomalidomide)Pomalyst|cc-4047(pomalidomide)pomalyst
327588|NCT01745588|Clarithromycin|clarithromycin
327589|NCT01745588|Biaxin|biaxin
327590|NCT01745588|DEXAMETHASONE|dexamethasone
327591|NCT01745588|(ClaPD)|(clapd)
327592|NCT01745588|Stem cell|stem cell
327593|NCT01745588|12-138|12-138
327594|NCT01745575|Bioequivalence|bioequivalence
327595|NCT01745575|Alprazolam|alprazolam
327596|NCT01745575|Anxiety disorders|anxiety disorders
327597|NCT01745575|Mexico|mexico
327598|NCT01745562|Alprazolam|alprazolam
327599|NCT01745562|Anxiety disorders|anxiety disorders
327600|NCT01745562|Bioequivalence|bioequivalence
327601|NCT01745562|Mexico|mexico
327602|NCT01745549|diabetes|diabetes
327603|NCT01745549|insulin therapy|insulin therapy
327604|NCT01745549|needle|needle
327605|NCT01745536|Oocyte vitrification|oocyte vitrification
327606|NCT01745536|survival rate|survival rate
327607|NCT01745536|egg banking|egg banking
327608|NCT01745536|ovum donation|ovum donation
327609|NCT01745523|Oocyte vitrification|oocyte vitrification
327610|NCT01745523|survival rate|survival rate
327611|NCT01745523|egg banking|egg banking
327612|NCT01745523|ovum donation|ovum donation
327613|NCT01745510|docosahexaenoic acid|docosahexaenoic acid
327614|NCT01745510|n-3 fatty acids|n-3 fatty acids
327615|NCT01745510|necrotizing enterocolitis|necrotizing enterocolitis
327616|NCT01745510|preterm infants|preterm infants
327617|NCT01745497|Autism Spectrum Disorder|autism spectrum disorder
327618|NCT01745497|Insomnia|insomnia
327619|NCT01745484|SPECT|spect
327620|NCT01745484|Toxicity|toxicity
327621|NCT01745484|Non-small-cell lung cancer|non-small-cell lung cancer
327622|NCT01745484|Definitive Radiotherapy|definitive radiotherapy
327623|NCT01745484|Radiation pneumonitis|radiation pneumonitis
327624|NCT01745484|Randomized study|randomized study
327625|NCT01745471|Abdominal Adipose|abdominal adipose
327626|NCT01745471|Gluteal Adipose|gluteal adipose
327627|NCT01745471|Polycystic Ovary Syndrome|polycystic ovary syndrome
327628|NCT01745471|Obesity|obesity
327629|NCT01745471|Women|women
327630|NCT01745445|limited-stage small cell lung cancer|limited-stage small cell lung cancer
327631|NCT01745445|concurrent chemo-radiotherapy|concurrent chemo-radiotherapy
327632|NCT01745432|ADBLOCK|adblock
327633|NCT01745432|Adhesion Barrier System|adhesion barrier system
327634|NCT01745432|laparoscopic surgery|laparoscopic surgery
327635|NCT01745432|myomectomy|myomectomy
327636|NCT01745419|COPD|copd
327637|NCT01745419|Exacerbation|exacerbation
327638|NCT01745419|Haptoglobin|haptoglobin
327639|NCT01745393|Smoking Cessation|smoking cessation
327640|NCT01745393|Secondhand Smoke|secondhand smoke
327641|NCT01745393|Passive Smoking|passive smoking
327642|NCT01745393|Cotinine|cotinine
327643|NCT01745393|Nicotine Replacement Products|nicotine replacement products
327644|NCT01745380|operative|operative
327645|NCT01745380|dental procedure|dental procedure
327646|NCT01745367|Tivozanib hydrochloride|tivozanib hydrochloride
327647|NCT01745367|triple negative breast cancer|triple negative breast cancer
327648|NCT01745367|paclitaxel|paclitaxel
327649|NCT01745367|pharmacokinetics|pharmacokinetics
327650|NCT01745367|biomarkers|biomarkers
327651|NCT01745367|metastatic breast cancer|metastatic breast cancer
327652|NCT01745367|mBC|mbc
327653|NCT01745367|TNBC|tnbc
327654|NCT01745328|recurrent urinary tract infection|recurrent urinary tract infection
327655|NCT01745328|antibiotics|antibiotics
327656|NCT01745328|traditional chinese medicine|traditional chinese medicine
327657|NCT01745315|total laparoscopic hysterectomy|total laparoscopic hysterectomy
327658|NCT01745315|LigaSure|ligasure
327659|NCT01745315|EnSeal|enseal
327660|NCT01745315|Halo PKS Cutting forceps|halo pks cutting forceps
327661|NCT01745315|electrothermal bipolar vessel sealer|electrothermal bipolar vessel sealer
327662|NCT01745315|advanced bipolar device|advanced bipolar device
327663|NCT01745302|lung cancer|lung cancer
327664|NCT01745302|traditional Chinese medicine|traditional chinese medicine
327665|NCT01745302|EGFR-TKI|egfr-tki
327666|NCT01745289|Breast Cancer|breast cancer
327667|NCT01745289|Survival|survival
327668|NCT01745289|Recurrence|recurrence
327669|NCT01745276|Pin fixation|pin fixation
327670|NCT01745276|Osteotomy|osteotomy
327671|NCT01745276|hemicallotasis|hemicallotasis
327672|NCT01745250|lip|lip
327673|NCT01745250|fillers|fillers
327674|NCT01745250|Hyaluronic acid|hyaluronic acid
327675|NCT01745237|Sarcoidosis|sarcoidosis
327676|NCT01745237|Cardiac Magnetic Resonance|cardiac magnetic resonance
327677|NCT01745198|homocysteinemia|homocysteinemia
327678|NCT01745198|dementia|dementia
327679|NCT01745198|depression|depression
327680|NCT01745198|vitamin B12|vitamin b12
327681|NCT01745198|folate|folate
327682|NCT01745198|mild cognitive impairment|mild cognitive impairment
327683|NCT01745198|alzheimer's|alzheimer's
327684|NCT01745198|homocysteine|homocysteine
327685|NCT01745185|Fabry Disease|fabry disease
327686|NCT01745185|immunity|immunity
327687|NCT01745185|antibody|antibody
327688|NCT01745159|tacrolimus|tacrolimus
327689|NCT01745159|Protopic|protopic
327690|NCT01745159|pediatric|pediatric
327691|NCT01745159|atopic dermatitis|atopic dermatitis
327692|NCT01745159|China|china
327693|NCT01745146|traumatic brain injury|traumatic brain injury
327694|NCT01745146|TBI|tbi
327695|NCT01745146|head injury|head injury
327696|NCT01745146|brain injury|brain injury
327697|NCT01745146|Psych-educational treatment|psych-educational treatment
327698|NCT01745146|Anger|anger
327699|NCT01745146|irritability|irritability
327700|NCT01745146|anger management|anger management
327701|NCT01745133|Olux E foam|olux e foam
327702|NCT01745133|Sorilux foam|sorilux foam
327703|NCT01745120|gene therapy|gene therapy
327704|NCT01745120|beta thalassemia|beta thalassemia
327705|NCT01745120|hemoglobin|hemoglobin
327706|NCT01745120|anemia|anemia
327707|NCT01745120|CD34|cd34
327708|NCT01745107|T2-3N0M0 disease of esophageal neoplasm|t2-3n0m0 disease of esophageal neoplasm
327709|NCT01745107|postoperative radiotherapy|postoperative radiotherapy
327710|NCT01745107|intensity modulated radiation therapy|intensity modulated radiation therapy
327711|NCT01745107|survival|survival
327712|NCT01745094|mirabegron|mirabegron
327713|NCT01745094|solifenacin|solifenacin
327714|NCT01745068|fragility fracture|fragility fracture
327715|NCT01745068|osteoporosis|osteoporosis
327716|NCT01745068|fall prevention|fall prevention
327717|NCT01745068|integrated program|integrated program
327718|NCT01745068|interorganizational collaboration|interorganizational collaboration
327719|NCT01745068|Canada|canada
327720|NCT01745068|controlled clinical trial|controlled clinical trial
327721|NCT01745068|evaluation|evaluation
327722|NCT01745055|Pharmacokinetics|pharmacokinetics
327723|NCT01745055|oral JAK inhibitor|oral jak inhibitor
327724|NCT01745055|methotrexate (MTX)|methotrexate (mtx)
327725|NCT01745055|rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
327726|NCT01745042|Postmenopausal Women|postmenopausal women
327727|NCT01745042|Body Composition|body composition
327728|NCT01745042|Metabolic Syndrome|metabolic syndrome
327729|NCT01745042|Menopause Symptoms|menopause symptoms
327730|NCT01745029|Gastrointestinal Motility|gastrointestinal motility
327731|NCT01745029|Inflammatory Bowel Disease|inflammatory bowel disease
327732|NCT01745029|Transit time|transit time
327733|NCT01745016|dietary supplement|dietary supplement
327734|NCT01745016|carnosine|carnosine
327735|NCT01745003|Fibromyalgia|fibromyalgia
327736|NCT01744990|Nuts|nuts
327737|NCT01744990|allergy|allergy
327738|NCT01744990|Oral food challenge|oral food challenge
327739|NCT01744990|skin testing|skin testing
327740|NCT01744990|basophil activation tests|basophil activation tests
327741|NCT01744990|specific IgE's|specific ige's
327742|NCT01744964|apomorphine|apomorphine
327743|NCT01744964|dopamine transporter gene|dopamine transporter gene
327744|NCT01744964|SLC6A3|slc6a3
327745|NCT01744964|cold pressor test|cold pressor test
327746|NCT01744964|tolerance|tolerance
327747|NCT01744964|experimental pain|experimental pain
327748|NCT01744964|dopamine agonist|dopamine agonist
327749|NCT01744951|Adoption|adoption
327750|NCT01744951|Foster care|foster care
327751|NCT01744951|Substance abuse|substance abuse
327752|NCT01744951|Older children|older children
327753|NCT01744951|Mental health|mental health
327754|NCT01744938|Postoperative Complications,|postoperative complications,
327755|NCT01744938|mortality,|mortality,
327756|NCT01744938|length of Stay,|length of stay,
327757|NCT01744938|economics|economics
327758|NCT01744912|Lymphoma|lymphoma
327759|NCT01744912|monoclonal antibody|monoclonal antibody
327760|NCT01744912|immunomodulatory agent|immunomodulatory agent
327761|NCT01744912|ublituximab|ublituximab
327762|NCT01744912|lenalidomide|lenalidomide
327763|NCT01744899|Lumbosacral spine|lumbosacral spine
327764|NCT01744899|Nerve roots|nerve roots
327765|NCT01744899|Sitting|sitting
327766|NCT01744899|H-reflex|h-reflex
327767|NCT01744886|One-Lung Ventilation|one-lung ventilation
327768|NCT01744886|Thoracic Surgical Procedures|thoracic surgical procedures
327769|NCT01744886|Cardiac Surgical Procedures|cardiac surgical procedures
327770|NCT01744834|Reward-based learning|reward-based learning
327771|NCT01744834|Pavlovian-to-instrumental transfer|pavlovian-to-instrumental transfer
327772|NCT01744834|Functional imaging|functional imaging
327773|NCT01744834|alcohol use disorder risk|alcohol use disorder risk
327774|NCT01744821|High Risk|high risk
327775|NCT01744808|Healthy|healthy
327776|NCT01744808|Normal|normal
327777|NCT01744795|cardiac output|cardiac output
327778|NCT01744795|thermodilution|thermodilution
327779|NCT01744795|esophageal doppler|esophageal doppler
327780|NCT01744795|trending ability|trending ability
327781|NCT01744782|Nephropathic Cystinosis|nephropathic cystinosis
327782|NCT01744782|Cysteamine|cysteamine
327783|NCT01744782|Delayed-release Cysteamine|delayed-release cysteamine
327784|NCT01744782|CTNS Protein, Human|ctns protein, human
327785|NCT01744782|Orphan Disease|orphan disease
327786|NCT01744769|thyroid cancer|thyroid cancer
327787|NCT01744769|hypothyroidism|hypothyroidism
327788|NCT01744769|metabolic parameters|metabolic parameters
327789|NCT01744769|Hypothyroidism after levothyroxine withdrawal|hypothyroidism after levothyroxine withdrawal
327790|NCT01744756|Subconjunctival Bevacizumab|subconjunctival bevacizumab
327791|NCT01744756|Recurrent pterygium|recurrent pterygium
327792|NCT01744743|preconception|preconception
327793|NCT01744743|hypothyroidism|hypothyroidism
327794|NCT01744743|neurocognitive development|neurocognitive development
327795|NCT01744730|Bacterial infections|bacterial infections
327796|NCT01744730|Obesity|obesity
327797|NCT01744730|pharmacokinetics|pharmacokinetics
327798|NCT01744730|clindamycin|clindamycin
327799|NCT01744717|Pain|pain
327800|NCT01744717|mechanical ventilation|mechanical ventilation
327801|NCT01744717|uncommunicative|uncommunicative
327802|NCT01744717|Adult ICU patients pain|adult icu patients pain
327803|NCT01744704|Nerve Growth Factor|nerve growth factor
327804|NCT01744704|Ophthalmic Solutions|ophthalmic solutions
327805|NCT01744704|Eye Drops|eye drops
327806|NCT01744704|rh-NGF|rh-ngf
327807|NCT01744691|CLL|cll
327808|NCT01744691|SLL|sll
327809|NCT01744665|CML, chronic myeloid leukemia, stop, niotinib, discontinue, imatinib, switch, MR4.5, undetectable, bcr-abl|cml, chronic myeloid leukemia, stop, niotinib, discontinue, imatinib, switch, mr4.5, undetectable, bcr-abl
327810|NCT01744652|Advanced Cancers|advanced cancers
327811|NCT01744652|Advanced Malignancies|advanced malignancies
327812|NCT01744652|Unresectable|unresectable
327813|NCT01744652|Metastatic|metastatic
327814|NCT01744652|Crizotinib|crizotinib
327815|NCT01744652|PF-02341066|pf-02341066
327816|NCT01744652|Xalkori|xalkori
327817|NCT01744652|Dasatinib|dasatinib
327818|NCT01744652|BMS-354825|bms-354825
327819|NCT01744652|Sprycel|sprycel
327820|NCT01744639|Hepatocellular carcinoma|hepatocellular carcinoma
327821|NCT01744639|Radioablation|radioablation
327822|NCT01744626|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
327823|NCT01744626|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
327824|NCT01744613|Clopidogrel|clopidogrel
327825|NCT01744613|platelet inhibition|platelet inhibition
327826|NCT01744613|antiplatelet therapy|antiplatelet therapy
327827|NCT01744613|peripheral arterial disease|peripheral arterial disease
327828|NCT01744613|endovascular treatment|endovascular treatment
327829|NCT01744613|angioplasty|angioplasty
327830|NCT01744613|stenting|stenting
327831|NCT01744600|Dementia|dementia
327832|NCT01744600|Music Therapy|music therapy
327833|NCT01744587|EBV|ebv
327834|NCT01744587|EGCG|egcg
327835|NCT01744561|Exercise|exercise
327836|NCT01744561|Motivation|motivation
327837|NCT01744561|Feedback|feedback
327838|NCT01744561|web-based diary|web-based diary
327839|NCT01744561|pedometer|pedometer
327840|NCT01744535|smartphone|smartphone
327841|NCT01744535|smartphone app|smartphone app
327842|NCT01744535|smartphone application|smartphone application
327843|NCT01744535|obesity|obesity
327844|NCT01744535|overweight|overweight
327845|NCT01744535|self monitoring|self monitoring
327846|NCT01744496|Parkinson's Disease|parkinson's disease
327847|NCT01744496|Rotigotine|rotigotine
327848|NCT01744496|Chronic Pain|chronic pain
327849|NCT01744496|Nonmotor symptoms|nonmotor symptoms
327850|NCT01744483|pneumonia|pneumonia
327851|NCT01744483|endotracheal intubation|endotracheal intubation
327852|NCT01744470|Renal|renal
327853|NCT01744470|Transplantation|transplantation
327854|NCT01744470|Tacrolimus|tacrolimus
327855|NCT01744457|tear film osmolarity|tear film osmolarity
327856|NCT01744457|objective scattering index|objective scattering index
327857|NCT01744457|tear break up time|tear break up time
327858|NCT01744457|Schirmer I test|schirmer i test
327859|NCT01744418|ESRD|esrd
327860|NCT01744418|HEMODIALYSIS|hemodialysis
327861|NCT01744418|CHRONIC RENAL INSUFFICIENCY|chronic renal insufficiency
327862|NCT01744418|Renal Dialysis|renal dialysis
327863|NCT01744418|Hemodiafiltration|hemodiafiltration
327864|NCT01744418|Blood Vessel Prosthesis|blood vessel prosthesis
327865|NCT01744418|Tissue-Engineered Vascular Graft|tissue-engineered vascular graft
328452|NCT01741922|ASA|asa
327866|NCT01744418|Vascular Prosthesis Implantation|vascular prosthesis implantation
327867|NCT01744405|Chagas disease|chagas disease
327868|NCT01744405|lactation|lactation
327869|NCT01744405|breastmilk|breastmilk
327870|NCT01744405|postpartum period|postpartum period
327871|NCT01744405|infants|infants
327872|NCT01744405|pediatric clinical pharmacology|pediatric clinical pharmacology
327873|NCT01744405|developmental clinical pharmacology|developmental clinical pharmacology
327874|NCT01744405|parasitology|parasitology
327875|NCT01744405|trypanosoma cruzi|trypanosoma cruzi
327876|NCT01744405|nifurtimox|nifurtimox
327877|NCT01744353|newly diagnosed|newly diagnosed
327878|NCT01744353|advanced pancreatic cancer|advanced pancreatic cancer
327879|NCT01744353|pancreatic cancer|pancreatic cancer
327880|NCT01744353|metastatic pancreatic cancer|metastatic pancreatic cancer
327881|NCT01744353|pancreas|pancreas
327882|NCT01744340|Head and Neck|head and neck
327883|NCT01744340|Colon|colon
327884|NCT01744314|Elbow trauma,Heterotopic Ossification,Indomethacin, Prophylaxis|elbow trauma,heterotopic ossification,indomethacin, prophylaxis
327885|NCT01744301|Seizure|seizure
327886|NCT01744301|Acid-suppressing drugs|acid-suppressing drugs
327887|NCT01744301|Epidemiology|epidemiology
327888|NCT01744288|Phase 1 Safety ,|phase 1 safety ,
327889|NCT01744288|pharmacodynamic,|pharmacodynamic,
327890|NCT01744288|Ticagrelor,|ticagrelor,
327891|NCT01744288|Clopidogrel,|clopidogrel,
327892|NCT01744288|Platelets|platelets
327893|NCT01744275|Epilepsy|epilepsy
327894|NCT01744275|Omega 3 fatty acids|omega 3 fatty acids
327895|NCT01744262|intraocular pressure, total intravenous anesthesia, laparoscopic prostatectomy|intraocular pressure, total intravenous anesthesia, laparoscopic prostatectomy
327896|NCT01744249|Advanced neuroendocrine tumours of non-pancreatic origin|advanced neuroendocrine tumours of non-pancreatic origin
327897|NCT01744249|axitinib|axitinib
327898|NCT01744236|GLP-1 Receptor Agonists, DPP-4 inhibitors|glp-1 receptor agonists, dpp-4 inhibitors
327899|NCT01744223|iCaspase9|icaspase9
327900|NCT01744223|iCasp9|icasp9
327901|NCT01744223|Inducible Caspase|inducible caspase
327902|NCT01744223|AP1903|ap1903
327903|NCT01744223|Dimerizer drug|dimerizer drug
327904|NCT01744223|T depleted|t depleted
327905|NCT01744223|Suicide gene|suicide gene
327906|NCT01744223|CD-34 selection|cd-34 selection
327907|NCT01744223|haplotransplantation|haplotransplantation
327908|NCT01744223|Graft versus host disease|graft versus host disease
327909|NCT01744223|Allogenic transplantation|allogenic transplantation
327910|NCT01744197|Pain control|pain control
327911|NCT01744197|Needle stick pain|needle stick pain
327912|NCT01744197|Venipuncture pain|venipuncture pain
327913|NCT01744184|gastroscopy|gastroscopy
327914|NCT01744184|diagnostic|diagnostic
327915|NCT01744184|entonox|entonox
327916|NCT01744158|cerebral palsy|cerebral palsy
327917|NCT01744158|spasticity|spasticity
327918|NCT01744158|dystonia|dystonia
327919|NCT01744158|hypertonia|hypertonia
327920|NCT01744158|register|register
327921|NCT01744158|motor function|motor function
327922|NCT01744132|eye care utilization|eye care utilization
327923|NCT01744132|ophthalmology|ophthalmology
327924|NCT01744132|educational intervention|educational intervention
327925|NCT01744132|public health screening|public health screening
327926|NCT01744093|HIV|hiv
327927|NCT01744093|COPD|copd
327928|NCT01744093|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
327929|NCT01744093|Emphysema|emphysema
327930|NCT01744080|Rotator cuff|rotator cuff
327931|NCT01744067|Renal transplantation|renal transplantation
327932|NCT01744067|Interventional study|interventional study
327933|NCT01744067|Glomerular filtration rate|glomerular filtration rate
327934|NCT01744067|Renal function|renal function
327935|NCT01744067|Proteinuria|proteinuria
327936|NCT01744067|Cardiovascular risk markers|cardiovascular risk markers
327937|NCT01744067|Blood pressure|blood pressure
327938|NCT01744067|Flow mediated vasodilation|flow mediated vasodilation
327939|NCT01744067|Heart rate variability|heart rate variability
327940|NCT01744067|Pulse wave velocity|pulse wave velocity
327941|NCT01744067|Lipids|lipids
327942|NCT01744067|Blood glucose|blood glucose
327943|NCT01744067|Bone mineral density|bone mineral density
327944|NCT01744067|Body composition|body composition
327945|NCT01744067|Fat distribution|fat distribution
327946|NCT01744067|Body mass index|body mass index
327947|NCT01744067|Fatty acid composition|fatty acid composition
327948|NCT01744067|Tacrolimus pharmacokinetics|tacrolimus pharmacokinetics
327949|NCT01744067|Omega-3 fatty acids|omega-3 fatty acids
327950|NCT01744067|Marine n-3 fatty acids|marine n-3 fatty acids
327951|NCT01744067|Fatty acids|fatty acids
327952|NCT01744067|Gas chromatography|gas chromatography
327953|NCT01744067|Interstitial fibrosis|interstitial fibrosis
327954|NCT01744067|Inflammation|inflammation
327955|NCT01744041|depression|depression
327956|NCT01744041|pregnancy|pregnancy
327957|NCT01744041|postpartum|postpartum
327958|NCT01744041|psychotherapy|psychotherapy
327959|NCT01744028|COPD, remote patient monitoring, Hub, exacerbations, EXACT|copd, remote patient monitoring, hub, exacerbations, exact
327960|NCT01744015|Low back pain|low back pain
327961|NCT01744002|Shoulder, Impingement syndrome, Neck|shoulder, impingement syndrome, neck
327962|NCT01743976|neuropathic pain|neuropathic pain
327963|NCT01743976|diabetic neuropathy|diabetic neuropathy
327964|NCT01743976|neuropathic pain after back surgery|neuropathic pain after back surgery
327965|NCT01743963|efficacy|efficacy
327966|NCT01743963|glucocorticoid|glucocorticoid
327967|NCT01743950|Glioblastoma|glioblastoma
327968|NCT01743950|anaplastic glioma|anaplastic glioma
327969|NCT01743937|Ischemic preconditioning|ischemic preconditioning
327970|NCT01743937|Ticagrelor|ticagrelor
327971|NCT01743937|Antiplatelet therapy|antiplatelet therapy
327972|NCT01743937|Acute coronary syndrome|acute coronary syndrome
327973|NCT01743924|Broccoli; Isothiocyanates; Pharmacokinetics; Sulforaphane; Myrosinase|broccoli; isothiocyanates; pharmacokinetics; sulforaphane; myrosinase
327974|NCT01743911|Tadalafil|tadalafil
327975|NCT01743911|Resistant Hypertension|resistant hypertension
327976|NCT01743911|Left Ventricle Diastolic Dysfunction|left ventricle diastolic dysfunction
327977|NCT01743911|Brain natriuretic peptide|brain natriuretic peptide
327978|NCT01743885|Hemangioma|hemangioma
327979|NCT01743885|Beta-blocker|beta-blocker
327980|NCT01743885|Acebutolol|acebutolol
327981|NCT01743885|Propranolol|propranolol
327982|NCT01743885|Randomized controlled trial|randomized controlled trial
327983|NCT01743885|Infants|infants
327984|NCT01743872|Optical Coherence Tomography|optical coherence tomography
327985|NCT01743872|Contrast|contrast
327986|NCT01743872|Dextran|dextran
327987|NCT01743872|Carbon Dioxide|carbon dioxide
327988|NCT01743872|Imaging|imaging
327989|NCT01743872|Catheter|catheter
327990|NCT01743872|Lower Extremity Artery|lower extremity artery
327991|NCT01743859|Myeloid|myeloid
327992|NCT01743859|Leukemia|leukemia
327993|NCT01743807|Relapsed|relapsed
327994|NCT01743807|Minimal Residual Disease|minimal residual disease
327995|NCT01743807|MRD|mrd
327996|NCT01743807|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
327997|NCT01743807|Acute Myelogenous Leukemia|acute myelogenous leukemia
327998|NCT01743807|ALL|all
327999|NCT01743807|AML|aml
328000|NCT01743807|GNKG168|gnkg168
328001|NCT01743807|Pediatric|pediatric
328002|NCT01743807|Childhood|childhood
328003|NCT01743781|comprehensive eye examination|comprehensive eye examination
328004|NCT01743781|acceptance|acceptance
328005|NCT01743781|glaucoma|glaucoma
328006|NCT01743781|diabetic retinopathy|diabetic retinopathy
328007|NCT01743768|Antisense oligonucleotide|antisense oligonucleotide
328008|NCT01743768|Asthma|asthma
328009|NCT01743768|Healthy subjects|healthy subjects
328010|NCT01743768|Phase 1|phase 1
328011|NCT01743768|Transcription factor GATA-3|transcription factor gata-3
328012|NCT01743768|Oral inhalation|oral inhalation
328013|NCT01743755|Community-acquired pneumonia|community-acquired pneumonia
328014|NCT01743755|Dexamethasone|dexamethasone
328015|NCT01743755|Corticosteroid|corticosteroid
328016|NCT01743742|Oral vitamin E and vitamin C|oral vitamin e and vitamin c
328017|NCT01743729|SAR 1118|sar 1118
328018|NCT01743716|Major Depressive Disorder|major depressive disorder
328019|NCT01743716|MDD|mdd
328020|NCT01743716|depression|depression
328021|NCT01743716|adolescent|adolescent
328022|NCT01743703|traumatic injuries|traumatic injuries
328023|NCT01743703|Whole-body MRI|whole-body mri
328024|NCT01743703|Skeletal survey|skeletal survey
328025|NCT01743703|Children|children
328026|NCT01743703|Diagnostic|diagnostic
328027|NCT01743690|Probiotic|probiotic
328028|NCT01743690|Candida|candida
328029|NCT01743690|Oral Lichen Planus|oral lichen planus
328030|NCT01743677|TQT study|tqt study
328031|NCT01743677|CP-690,550|cp-690,550
328032|NCT01743664|Posttraumatic Stress Disorders|posttraumatic stress disorders
328033|NCT01743664|Multiple Sclerosis|multiple sclerosis
328034|NCT01743664|Eye Movement Desensitization Reprocessing|eye movement desensitization reprocessing
328035|NCT01743664|Psychotherapy|psychotherapy
328036|NCT01743664|Anxiety|anxiety
328037|NCT01743664|Depression|depression
328038|NCT01743664|Quality of Life|quality of life
328039|NCT01743651|spasticity|spasticity
328040|NCT01743651|multiple sclerosis|multiple sclerosis
328041|NCT01743651|arbaclofen|arbaclofen
328042|NCT01743612|healthy subject|healthy subject
328043|NCT01743612|hand blood flow|hand blood flow
328044|NCT01743612|laser speckle contrast imaging|laser speckle contrast imaging
328045|NCT01743586|Lung cancer|lung cancer
328046|NCT01743586|Chest physiotherapy|chest physiotherapy
328047|NCT01743586|Respiratory muscle strength|respiratory muscle strength
328048|NCT01743586|Dyspnea, Functional capacity|dyspnea, functional capacity
328049|NCT01743586|Quality of life|quality of life
328050|NCT01743560|Breast Neoplasms|breast neoplasms
328051|NCT01743560|Neoplasms|neoplasms
328052|NCT01743560|Breast diseases|breast diseases
328053|NCT01743560|Skin diseases|skin diseases
328054|NCT01743560|Exemestane|exemestane
328055|NCT01743560|Antibiotics, Antineoplastic|antibiotics, antineoplastic
328056|NCT01743560|Everolimus|everolimus
328057|NCT01743560|Antineoplastic Agents|antineoplastic agents
328058|NCT01743560|Therapeutic Uses|therapeutic uses
328059|NCT01743560|Pharmacologic Actions|pharmacologic actions
328060|NCT01743560|Immunosuppressive Agents|immunosuppressive agents
328061|NCT01743560|Physiological Effects of Drugs|physiological effects of drugs
328062|NCT01743560|Aromatase Inhibitors|aromatase inhibitors
328063|NCT01743560|Enzyme Inhibitors|enzyme inhibitors
328064|NCT01743560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
328065|NCT01743547|Women|women
328066|NCT01743547|Yoga|yoga
328067|NCT01743547|Ovarian Cancer|ovarian cancer
328068|NCT01743547|Lifestyle|lifestyle
328069|NCT01743521|Hepatitis C|hepatitis c
328070|NCT01743521|Individualised therapy|individualised therapy
328071|NCT01743521|Response-guided therapy|response-guided therapy
328072|NCT01743521|Telaprevir|telaprevir
328073|NCT01743521|PEG-IFN|peg-ifn
328074|NCT01743521|Ribavirin|ribavirin
328075|NCT01743521|Hepatitis|hepatitis
328076|NCT01743508|incomplete abortion|incomplete abortion
328077|NCT01743508|misoprostol treatment|misoprostol treatment
328078|NCT01743508|midwife|midwife
328079|NCT01743508|uganda|uganda
328080|NCT01743495|Medical Costs|medical costs
328081|NCT01743495|improved IADLs|improved iadls
328082|NCT01743495|and/or ADL's|and/or adl's
328083|NCT01743495|decreased nursing home admissions|decreased nursing home admissions
328084|NCT01743482|Testicular Cancer|testicular cancer
328085|NCT01743482|Germ Cell Tumors|germ cell tumors
328086|NCT01743482|Salvage Therapy|salvage therapy
328087|NCT01743482|Pazopanib|pazopanib
328088|NCT01743469|Advanced|advanced
328089|NCT01743469|Metastatic|metastatic
328090|NCT01743469|Hepatocellular cancer|hepatocellular cancer
328091|NCT01743469|Ovarian cancer|ovarian cancer
328092|NCT01743469|Renal cell cancer|renal cell cancer
328093|NCT01743469|Gastric carcinoma|gastric carcinoma
328094|NCT01743456|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
328095|NCT01743456|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
328096|NCT01743456|Postoperative cognitive improvement|postoperative cognitive improvement
328097|NCT01743456|Postoperative delirium|postoperative delirium
328098|NCT01743443|Corneal sensitivity|corneal sensitivity
328099|NCT01743443|Cross-linking|cross-linking
328100|NCT01743443|Keratoconus|keratoconus
328101|NCT01743430|telerehabilitation|telerehabilitation
328102|NCT01743430|stroke|stroke
328103|NCT01743430|Berg balance scale|berg balance scale
328104|NCT01743430|stroke impact scale|stroke impact scale
328105|NCT01743430|mobility|mobility
328106|NCT01743417|Cognitive rehabilitation|cognitive rehabilitation
328107|NCT01743417|malaria|malaria
328108|NCT01743417|neuropsychology|neuropsychology
328109|NCT01743417|attention|attention
328110|NCT01743417|working memory|working memory
328111|NCT01743404|atherosclerosis|atherosclerosis
328112|NCT01743404|inflammation|inflammation
328113|NCT01743404|intima-media thickness|intima-media thickness
328114|NCT01743391|IVF treatment|ivf treatment
328115|NCT01743391|Office-hysteroscopy|office-hysteroscopy
328116|NCT01743391|Endometrial biopsy|endometrial biopsy
328117|NCT01743352|Large arteries|large arteries
328118|NCT01743352|stiffness|stiffness
328119|NCT01743352|intima media thickness|intima media thickness
328120|NCT01743352|ultrasound imaging|ultrasound imaging
328121|NCT01743339|Randomized Controlled Trial|randomized controlled trial
328122|NCT01743339|Cognitive Therapy|cognitive therapy
328123|NCT01743339|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
328124|NCT01743339|Depression|depression
328125|NCT01743339|Sleep|sleep
328126|NCT01743326|Zygapophyseal Joint|zygapophyseal joint
328127|NCT01743313|glucose metabolism disorders|glucose metabolism disorders
328128|NCT01743313|metabolic syndrome|metabolic syndrome
328129|NCT01743313|joint replacement|joint replacement
328130|NCT01743313|osteoarthritis|osteoarthritis
328131|NCT01743300|sunitinib|sunitinib
328132|NCT01743300|pharmacokinetics|pharmacokinetics
328133|NCT01743300|phenotyping|phenotyping
328134|NCT01743300|interaction|interaction
328135|NCT01743287|osteoarthritis of the knee|osteoarthritis of the knee
328136|NCT01743274|acute coronary syndromes|acute coronary syndromes
328137|NCT01743274|non-ST elevation myocardial infarction|non-st elevation myocardial infarction
328138|NCT01743274|angioplasty|angioplasty
328139|NCT01743274|fractional flow reserve|fractional flow reserve
328140|NCT01743274|optical coherence tomography|optical coherence tomography
328141|NCT01743261|severe brain injury|severe brain injury
328142|NCT01743261|graded intensive rehabilitation|graded intensive rehabilitation
328143|NCT01743248|vestibular schwannoma|vestibular schwannoma
328144|NCT01743248|balance|balance
328145|NCT01743248|psychological factors|psychological factors
328146|NCT01743235|HSDD|hsdd
328147|NCT01743209|androgen antagonists|androgen antagonists
328148|NCT01743196|Folic acid|folic acid
328149|NCT01743196|Folate|folate
328150|NCT01743196|Pharmacokinetics|pharmacokinetics
328151|NCT01743196|Women of Child Bearing Age|women of child bearing age
328152|NCT01743183|hypertension|hypertension
328153|NCT01743170|Blood pressure control|blood pressure control
328154|NCT01743170|Hypertension|hypertension
328155|NCT01743170|Office blood pressure|office blood pressure
328156|NCT01743170|Self-measured blood pressure|self-measured blood pressure
328157|NCT01743170|Telemonitoring|telemonitoring
328158|NCT01743144|emergence agitation in children|emergence agitation in children
328159|NCT01743144|sevoflurane|sevoflurane
328160|NCT01743144|general anesthesia|general anesthesia
328161|NCT01743144|magnesium sulphate|magnesium sulphate
328162|NCT01743105|diaphragm movement|diaphragm movement
328163|NCT01743105|ultrasound|ultrasound
328164|NCT01743105|emergency room|emergency room
328165|NCT01743092|Pathological gambling|pathological gambling
328166|NCT01743092|treatment|treatment
328167|NCT01743092|online counselling|online counselling
328168|NCT01743092|webinar|webinar
328169|NCT01743092|workbook|workbook
328170|NCT01743079|Telbivudine|telbivudine
328171|NCT01743079|Lamivudine|lamivudine
328172|NCT01743079|safety|safety
328173|NCT01743079|efficacy|efficacy
328174|NCT01743079|pregnancy|pregnancy
328175|NCT01743066|Arsenic|arsenic
328176|NCT01743066|Arsenicosis|arsenicosis
328177|NCT01743066|Buccal cells|buccal cells
328178|NCT01743066|Serum|serum
328179|NCT01743066|Vitamin E|vitamin e
328180|NCT01743066|Cholesterol|cholesterol
328181|NCT01743040|Coronary Artery Disease|coronary artery disease
328182|NCT01743040|Nuclear Stress Test|nuclear stress test
328183|NCT01743040|CT Angiography|ct angiography
328184|NCT01743040|Angiography|angiography
328185|NCT01743027|Allergic conjunctivitis|allergic conjunctivitis
328186|NCT01743027|Olopatadine HCl solution|olopatadine hcl solution
328187|NCT01743027|Conjunctival Allergen Challenge|conjunctival allergen challenge
328188|NCT01743027|Itching eyes|itching eyes
328189|NCT01743027|Ocular allergies|ocular allergies
328190|NCT01743027|PATADAY|pataday
328191|NCT01743027|PATANOL|patanol
328192|NCT01743014|diabetes|diabetes
328193|NCT01743014|diabetic nephropathy|diabetic nephropathy
328194|NCT01743014|vascular inflammation|vascular inflammation
328195|NCT01743014|oxidative stress|oxidative stress
328196|NCT01743014|endothelial dysfunction|endothelial dysfunction
328197|NCT01743014|Asymmetric dimethylarginine|asymmetric dimethylarginine
328198|NCT01743014|High sensitivity CRP|high sensitivity crp
328199|NCT01743014|albumine to creatinine ratio|albumine to creatinine ratio
328200|NCT01743014|isoprostane|isoprostane
328201|NCT01743014|clopidogrel|clopidogrel
328202|NCT01743014|ramipril|ramipril
328203|NCT01743014|carotid intima media thickness|carotid intima media thickness
328204|NCT01743001|exercise capacity|exercise capacity
328205|NCT01743001|Eisenmenger Syndrome|eisenmenger syndrome
328206|NCT01742988|PI3K|pi3k
328207|NCT01742988|HDAC|hdac
328208|NCT01742988|Open-Label|open-label
328209|NCT01742988|Dose-Escalation|dose-escalation
328210|NCT01742962|Prostatectomy|prostatectomy
328211|NCT01742962|Prostate cancer|prostate cancer
328212|NCT01742962|Orgasm|orgasm
328213|NCT01742962|Urinary incontinence|urinary incontinence
328214|NCT01742962|Climacturia(orgasm related urinary incontinence)|climacturia(orgasm related urinary incontinence)
328215|NCT01742962|Penis|penis
328216|NCT01742962|Dysorgasmia (pain in relation to orgasm)|dysorgasmia (pain in relation to orgasm)
328217|NCT01742962|Pain|pain
328218|NCT01742962|Anorgasmia|anorgasmia
328219|NCT01742962|Penile shortening|penile shortening
328220|NCT01742962|Erectile dysfunction|erectile dysfunction
328221|NCT01742923|hypertension|hypertension
328222|NCT01742923|medication adherence|medication adherence
328223|NCT01742923|motivational interviewing|motivational interviewing
328224|NCT01742897|Osteoarthritis, Knee|osteoarthritis, knee
328225|NCT01742897|Transdermal therapeutic system (TTS) fentanyl|transdermal therapeutic system (tts) fentanyl
328226|NCT01742897|Durogesic|durogesic
328227|NCT01742884|Dry Eye Syndrome|dry eye syndrome
328228|NCT01742871|Antivitamin K|antivitamin k
328229|NCT01742871|Bleeding|bleeding
328230|NCT01742871|Haemorrhage|haemorrhage
328231|NCT01742871|Nutritional status|nutritional status
328232|NCT01742871|impedancemetry|impedancemetry
328233|NCT01742845|Ultrasound-guided|ultrasound-guided
328234|NCT01742845|regional anaesthesia|regional anaesthesia
328235|NCT01742845|Cervical block|cervical block
328236|NCT01742832|Vilazodone|vilazodone
328237|NCT01742832|Citalopram|citalopram
328238|NCT01742832|Major Depressive Disorder|major depressive disorder
328239|NCT01742819|Glaucoma, Optical Coherence Tomography, Progression|glaucoma, optical coherence tomography, progression
328240|NCT01742806|Gastric cancer|gastric cancer
328241|NCT01742806|Minimally invasive surgery|minimally invasive surgery
328242|NCT01742806|Distal gastrectomy|distal gastrectomy
328243|NCT01742806|Bio-absorbable Felt|bio-absorbable felt
328244|NCT01742793|relapsed /refractory Hodgkin lymphoma|relapsed /refractory hodgkin lymphoma
328245|NCT01742793|mature T-cell lymphoma|mature t-cell lymphoma
328246|NCT01742793|multiple myeloma|multiple myeloma
328247|NCT01742780|Intraosseous Vascular Access|intraosseous vascular access
328248|NCT01742780|IO Access|io access
328249|NCT01742780|IO Vascular Access|io vascular access
328250|NCT01742780|EZ-IO|ez-io
328251|NCT01742767|NSCLC; split dose Cisplatinum; Pemetrexed|nsclc; split dose cisplatinum; pemetrexed
328252|NCT01742741|Diabetes Mellitus, Type 1 (T1DM)|diabetes mellitus, type 1 (t1dm)
328253|NCT01742741|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
328254|NCT01742741|Artificial Pancreas (AP)|artificial pancreas (ap)
328255|NCT01742741|Insulin Pump|insulin pump
328256|NCT01742741|Closed Loop Control (CLC)|closed loop control (clc)
328761|NCT01740609|Phase 1|phase 1
328257|NCT01742741|Open Loop treatment|open loop treatment
328258|NCT01742741|Diabetes Assistant|diabetes assistant
328259|NCT01742741|DiAs|dias
328260|NCT01742728|oxidative stress, antioxidant, periodontitis, serum immunoglobulin G|oxidative stress, antioxidant, periodontitis, serum immunoglobulin g
328261|NCT01742728|antibody titer|antibody titer
328262|NCT01742715|ARDS|ards
328263|NCT01742715|Lung compliance|lung compliance
328264|NCT01742702|Blood pressure|blood pressure
328265|NCT01742702|Hypertension|hypertension
328266|NCT01742702|Arterial stiffness|arterial stiffness
328267|NCT01742702|Cardiac output|cardiac output
328268|NCT01742702|Vascular resistance|vascular resistance
328269|NCT01742702|Pulse wave reflection|pulse wave reflection
328270|NCT01742702|Head-up tilt|head-up tilt
328271|NCT01742689|Renal colic|renal colic
328272|NCT01742689|Pain|pain
328273|NCT01742689|Desmopressin|desmopressin
328274|NCT01742689|Urinary obstruction|urinary obstruction
328275|NCT01742689|Indomethacin|indomethacin
328276|NCT01742676|tacrolimus|tacrolimus
328277|NCT01742676|kidney|kidney
328278|NCT01742663|Diclofenac Sodium Gel 3%|diclofenac sodium gel 3%
328279|NCT01742663|Solaraze® (diclofenac sodium) Gel 3%|solaraze® (diclofenac sodium) gel 3%
328280|NCT01742663|Actinic Keratosis|actinic keratosis
328281|NCT01742650|ankle; fracture; syndesmosis;|ankle; fracture; syndesmosis;
328282|NCT01742637|Acne Vulgaris|acne vulgaris
328283|NCT01742637|Adapalene and Benzoyl Peroxide Gel 0.1%/2.5%|adapalene and benzoyl peroxide gel 0.1%/2.5%
328284|NCT01742637|Epiduo®|epiduo®
328285|NCT01742624|immunosuppressant|immunosuppressant
328286|NCT01742624|new-onset diabetes after kidney transplantation|new-onset diabetes after kidney transplantation
328287|NCT01742624|NODAT|nodat
328288|NCT01742611|CKD|ckd
328289|NCT01742611|Not on dialysis|not on dialysis
328290|NCT01742611|ASP1585|asp1585
328291|NCT01742611|Bixalomer|bixalomer
328292|NCT01742598|TAVI|tavi
328293|NCT01742598|TAVR|tavr
328294|NCT01742598|aortic stenosis|aortic stenosis
328295|NCT01742598|Transcatheter|transcatheter
328296|NCT01742598|valvular heart disease|valvular heart disease
328297|NCT01742598|aortic valve stenosis|aortic valve stenosis
328298|NCT01742598|aortic valve replacement|aortic valve replacement
328299|NCT01742598|transcatheter aortic valve implantation|transcatheter aortic valve implantation
328300|NCT01742585|CKD|ckd
328301|NCT01742585|Not on dialysis|not on dialysis
328302|NCT01742585|ASP1585|asp1585
328303|NCT01742585|Bixalomer|bixalomer
328304|NCT01742572|weight loss|weight loss
328305|NCT01742572|obesity|obesity
328306|NCT01742572|overweight|overweight
328307|NCT01742572|diet|diet
328308|NCT01742559|Treatment|treatment
328309|NCT01742546|myofascial pain syndrome|myofascial pain syndrome
328310|NCT01742546|therapeutic ultrasound|therapeutic ultrasound
328311|NCT01742546|combine therapy|combine therapy
328312|NCT01742533|Hormone Replacement Therapy，|hormone replacement therapy，
328313|NCT01742533|Premature Ovarian Failure，|premature ovarian failure，
328314|NCT01742533|Stem Cell Therapy|stem cell therapy
328315|NCT01742520|Preterm infant|preterm infant
328316|NCT01742520|pain|pain
328317|NCT01742520|neurodevelopment|neurodevelopment
328318|NCT01742507|Stent, OCT|stent, oct
328319|NCT01742494|Esophageal Achalasia,|esophageal achalasia,
328320|NCT01742494|Peroral endoscopic myotomy,|peroral endoscopic myotomy,
328321|NCT01742494|Water-jet assisted|water-jet assisted
328322|NCT01742481|childhood cancer survivors|childhood cancer survivors
328323|NCT01742481|long-term follow-up care|long-term follow-up care
328324|NCT01742481|health communication|health communication
328325|NCT01742481|ethnic/racial minorities|ethnic/racial minorities
328326|NCT01742481|longterm survivors|longterm survivors
328327|NCT01742468|n-3 LC-PUFA, DHA, rheumatoid arthritis|n-3 lc-pufa, dha, rheumatoid arthritis
328328|NCT01742455|Peripheral artery disease|peripheral artery disease
328329|NCT01742455|Arterial Occlusive Diseases|arterial occlusive diseases
328330|NCT01742455|Vascular Diseases|vascular diseases
328331|NCT01742455|Cardiovascular Diseases|cardiovascular diseases
328332|NCT01742455|Coronary Artery Disease|coronary artery disease
328333|NCT01742455|Myocardial Ischemia|myocardial ischemia
328334|NCT01742455|Arteriosclerosis|arteriosclerosis
328335|NCT01742455|Pathologic Processes|pathologic processes
328336|NCT01742442|Cancer|cancer
328337|NCT01742442|elderly OR older|elderly or older
328338|NCT01742442|chemotherapy|chemotherapy
328339|NCT01742442|geriatric assessment|geriatric assessment
328340|NCT01742429|Helicobacter pylori|helicobacter pylori
328341|NCT01742429|second line treatment|second line treatment
328342|NCT01742416|Arterial Cannulation|arterial cannulation
328343|NCT01742416|Ultrasound|ultrasound
328344|NCT01742416|Palpation Method|palpation method
328345|NCT01742416|Pediatrics|pediatrics
328346|NCT01742416|Cardiac Surgery|cardiac surgery
328347|NCT01742416|Craniotomies|craniotomies
328348|NCT01742416|Cranial Vault Surgery|cranial vault surgery
328349|NCT01742416|Abdominal Procedures|abdominal procedures
328350|NCT01742403|Prostate|prostate
328351|NCT01742403|IGRT|igrt
328352|NCT01742403|VMAT|vmat
328353|NCT01742390|schizophrenia|schizophrenia
328354|NCT01742390|risperidone|risperidone
328355|NCT01742390|paliperidone|paliperidone
328356|NCT01742390|aripiprazole|aripiprazole
328357|NCT01742377|GERD|gerd
328358|NCT01742377|Dyspepsia|dyspepsia
328359|NCT01742377|Ambulatory 24-hour Esophageal pH Monitoring|ambulatory 24-hour esophageal ph monitoring
328360|NCT01742377|Minimal change erosions|minimal change erosions
328361|NCT01742364|disposable syringe jet injector (DSJI)|disposable syringe jet injector (dsji)
328362|NCT01742364|DSJI|dsji
328363|NCT01742364|BCG|bcg
328364|NCT01742364|tuberculosis|tuberculosis
328365|NCT01742364|intradermal delivery|intradermal delivery
328366|NCT01742364|South Africa|south africa
328367|NCT01742338|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
328368|NCT01742338|COPD|copd
328369|NCT01742338|Chronic bronchitis|chronic bronchitis
328370|NCT01742338|emphysema|emphysema
328371|NCT01742338|Corticosteroids|corticosteroids
328372|NCT01742325|fatigue|fatigue
328373|NCT01742325|walking|walking
328374|NCT01742325|childhood cancer|childhood cancer
328375|NCT01742325|sleep disturbance|sleep disturbance
328376|NCT01742312|neoadjuvant chemotherapy|neoadjuvant chemotherapy
328377|NCT01742312|oesophageal cancer|oesophageal cancer
328378|NCT01742312|cardiorespiratory performance|cardiorespiratory performance
328379|NCT01742299|Glivec/Gleevec|glivec/gleevec
328380|NCT01742299|CML|cml
328381|NCT01742299|GIST|gist
328382|NCT01742299|Imatinib mesylate|imatinib mesylate
328383|NCT01742286|pediatric|pediatric
328384|NCT01742286|anaplastic lymphoma kinase|anaplastic lymphoma kinase
328385|NCT01742286|ALK|alk
328386|NCT01742286|ALK-activated tumors|alk-activated tumors
328387|NCT01742286|neuroblastoma|neuroblastoma
328388|NCT01742286|rhabdomyosarcoma|rhabdomyosarcoma
328389|NCT01742286|anaplastic large-cell lymphoma|anaplastic large-cell lymphoma
328390|NCT01742286|inflammatory myofibroblastic tumor|inflammatory myofibroblastic tumor
328391|NCT01742260|Cranioplasty|cranioplasty
328392|NCT01742260|Mesenchymal stromal cells|mesenchymal stromal cells
328393|NCT01742260|Bioceramic polymer|bioceramic polymer
328394|NCT01742247|Moisturizer, laser|moisturizer, laser
328395|NCT01742221|Safety and Tolerability, Cytokines, Acute Radiation Syndrome, Hematopoietic Syndrome, Radiation Countermeasure|safety and tolerability, cytokines, acute radiation syndrome, hematopoietic syndrome, radiation countermeasure
328396|NCT01742195|Endobronchial ultrasound|endobronchial ultrasound
328397|NCT01742195|Bronchoscopy|bronchoscopy
328398|NCT01742195|Patient satisfaction|patient satisfaction
328399|NCT01742182|Parkinson's Disease|parkinson's disease
328400|NCT01742182|Excessive Daytime Sleepiness|excessive daytime sleepiness
328401|NCT01742182|Circadian Rhythms|circadian rhythms
328402|NCT01742182|Light Therapy|light therapy
328403|NCT01742169|Colorectal Cancer Screening|colorectal cancer screening
328404|NCT01742169|Fecal Occult Blood Testing|fecal occult blood testing
328405|NCT01742156|CAD|cad
328406|NCT01742156|microangiopathy|microangiopathy
328407|NCT01742156|patients|patients
328408|NCT01742156|more likely|more likely
328409|NCT01742156|to have tortuosity|to have tortuosity
328410|NCT01742156|of conjunctival vessels|of conjunctival vessels
328411|NCT01742143|Quality of life|quality of life
328412|NCT01742143|cancer|cancer
328413|NCT01742143|12-223|12-223
328414|NCT01742130|Contrast-induced nephropathy|contrast-induced nephropathy
328415|NCT01742130|Contrast media|contrast media
328416|NCT01742130|Angiography|angiography
328417|NCT01742130|Coronary percutaneous intervention|coronary percutaneous intervention
328418|NCT01742117|percutaneous coronary intervention|percutaneous coronary intervention
328419|NCT01742117|angioplasty|angioplasty
328420|NCT01742104|glaucoma|glaucoma
328421|NCT01742104|primary open-angle glaucoma|primary open-angle glaucoma
328422|NCT01742104|observational study|observational study
328423|NCT01742104|quality of life|quality of life
328424|NCT01742091|Postmenopausal females|postmenopausal females
328425|NCT01742091|Volunteers|volunteers
328426|NCT01742078|Postmenopausal females|postmenopausal females
328427|NCT01742078|Volunteers|volunteers
328428|NCT01742065|Colorectal Cancer Screening|colorectal cancer screening
328429|NCT01742065|Cancer Screening|cancer screening
328430|NCT01742065|Pragmatic Trial|pragmatic trial
328431|NCT01742052|relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
328432|NCT01742052|RRMS|rrms
328433|NCT01742026|High risk aspergillosis infection patients|high risk aspergillosis infection patients
328434|NCT01742013|Chronic Fatigue|chronic fatigue
328435|NCT01742013|CFS|cfs
328436|NCT01742013|ICF|icf
328437|NCT01742013|human placenta|human placenta
328438|NCT01742000|postmenopause|postmenopause
328439|NCT01742000|phytoestrogen|phytoestrogen
328440|NCT01742000|atherosclerosis|atherosclerosis
328441|NCT01742000|intima-media thickness|intima-media thickness
328442|NCT01741974|perimenopause|perimenopause
328443|NCT01741974|phytoestrogen|phytoestrogen
328444|NCT01741974|atherosclerosis|atherosclerosis
328445|NCT01741974|intima-media thickness|intima-media thickness
328446|NCT01741961|uncontrolled glaucoma|uncontrolled glaucoma
328447|NCT01741961|glaucoma drainage device|glaucoma drainage device
328448|NCT01741948|Provoked vestibulodynia|provoked vestibulodynia
328449|NCT01741948|Hormonal contraceptives|hormonal contraceptives
328450|NCT01741922|Low dose|low dose
328453|NCT01741922|Hypertension|hypertension
328454|NCT01741922|blood pressure|blood pressure
328455|NCT01741909|azythromycin|azythromycin
328456|NCT01741909|community acquired pneumonia|community acquired pneumonia
328457|NCT01741909|intravenous|intravenous
328458|NCT01741909|oral|oral
328459|NCT01741883|Randomized Controlled Trial|randomized controlled trial
328460|NCT01741883|Patients´ Expectations|patients´ expectations
328461|NCT01741883|Breast Cancer|breast cancer
328462|NCT01741883|Adjuvant Endocrine Treatment|adjuvant endocrine treatment
328463|NCT01741883|Nocebo|nocebo
328464|NCT01741870|Nutritional supplement|nutritional supplement
328465|NCT01741870|Nutritional status|nutritional status
328466|NCT01741870|Physical functional activity|physical functional activity
328467|NCT01741870|Nursing home elderly|nursing home elderly
328468|NCT01741844|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
328469|NCT01741844|TMC125|tmc125
328470|NCT01741844|Etravirine|etravirine
328471|NCT01741844|Intelence|intelence
328472|NCT01741844|AIDS|aids
328473|NCT01741831|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
328474|NCT01741831|AIDS|aids
328475|NCT01741831|TMC114|tmc114
328476|NCT01741831|Darunavir|darunavir
328477|NCT01741831|Prezista|prezista
328478|NCT01741818|IVC|ivc
328479|NCT01741818|ultrasonography|ultrasonography
328480|NCT01741818|IVC collapsibility index|ivc collapsibility index
328481|NCT01741818|IVC diameter|ivc diameter
328482|NCT01741792|Relapsed DLBCL|relapsed dlbcl
328483|NCT01741792|Refractory DLBCL|refractory dlbcl
328484|NCT01741792|adult DLBCL|adult dlbcl
328485|NCT01741792|Lymphoma|lymphoma
328486|NCT01741792|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
328487|NCT01741792|Lymphatic diseases|lymphatic diseases
328488|NCT01741792|Lymphoproliferative disorders|lymphoproliferative disorders
328489|NCT01741792|bispecific antibody|bispecific antibody
328490|NCT01741792|anti-CD19|anti-cd19
328491|NCT01741792|Immunotherapeutic treatment|immunotherapeutic treatment
328492|NCT01741792|Immunoproliferative disorders|immunoproliferative disorders
328493|NCT01741779|whole body vibration training|whole body vibration training
328494|NCT01741779|hypocaloric diet|hypocaloric diet
328495|NCT01741779|prehypertension|prehypertension
328496|NCT01741779|hypertension|hypertension
328497|NCT01741779|obesity|obesity
328498|NCT01741779|arterial function|arterial function
328499|NCT01741779|arterial stiffness|arterial stiffness
328500|NCT01741779|pulse wave velocity|pulse wave velocity
328501|NCT01741779|autonomic function|autonomic function
328502|NCT01741779|endothelial function|endothelial function
328503|NCT01741779|adipocytokines|adipocytokines
328504|NCT01741766|prehypertension|prehypertension
328505|NCT01741766|hypertension|hypertension
328506|NCT01741766|obesity|obesity
328507|NCT01741766|stretching|stretching
328508|NCT01741766|arterial function|arterial function
328509|NCT01741766|arterial stiffness|arterial stiffness
328510|NCT01741766|pulse wave velocity|pulse wave velocity
328511|NCT01741766|autonomic function|autonomic function
328512|NCT01741766|endothelial function|endothelial function
328513|NCT01741753|Docetaxel Pretreated|docetaxel pretreated
328514|NCT01741753|Castrate Resistant|castrate resistant
328515|NCT01741753|Metastatic|metastatic
328516|NCT01741740|pain, hernia, chronic, discomfort, retrospective|pain, hernia, chronic, discomfort, retrospective
328517|NCT01741675|Questionnaires|questionnaires
328518|NCT01741675|Quality of Life|quality of life
328519|NCT01741675|Response rate|response rate
328520|NCT01741649|Surgical wound infection|surgical wound infection
328521|NCT01741649|Clorhexidine|clorhexidine
328522|NCT01741649|Povidone|povidone
328523|NCT01741610|Anaesthesia Spinal|anaesthesia spinal
328524|NCT01741610|Ephedrine|ephedrine
328525|NCT01741610|Fluid Therapy|fluid therapy
328526|NCT01741610|Hypotension|hypotension
328527|NCT01741558|Myocardial Ischemia|myocardial ischemia
328528|NCT01741558|Myocardial Infarction|myocardial infarction
328529|NCT01741558|Methotrexate|methotrexate
328530|NCT01741558|Inflammation|inflammation
328531|NCT01741558|Anti-Inflammatory Agents|anti-inflammatory agents
328532|NCT01741558|Inflammation Mediators|inflammation mediators
328533|NCT01741532|Pantothenate Kinase-associated Neurodegeneration|pantothenate kinase-associated neurodegeneration
328534|NCT01741532|PKAN|pkan
328535|NCT01741532|NBIA|nbia
328536|NCT01741532|Deferiprone|deferiprone
328537|NCT01741532|Ferriprox|ferriprox
328539|NCT01741519|PD|pd
328540|NCT01741519|landiolol|landiolol
328541|NCT01741519|esmolol|esmolol
328542|NCT01741519|healthy volunteers phase I study|healthy volunteers phase i study
328543|NCT01741506|Lung cancer|lung cancer
328544|NCT01741506|Surgery|surgery
328545|NCT01741506|Thromboembolism|thromboembolism
328546|NCT01741506|Bleeding|bleeding
328547|NCT01741493|Rheumatoid Arthritis|rheumatoid arthritis
328548|NCT01741493|Methotrexate|methotrexate
328549|NCT01741493|Tolerability|tolerability
328550|NCT01741493|Pharmacokinetics|pharmacokinetics
328551|NCT01741493|Safety|safety
328552|NCT01741493|Tofacitinib|tofacitinib
328553|NCT01741480|Outcomes|outcomes
328554|NCT01741480|Early warning systems|early warning systems
328555|NCT01741480|ICU transfer|icu transfer
328556|NCT01741454|Tolterodine|tolterodine
328557|NCT01741454|Tamsulosin|tamsulosin
328558|NCT01741454|Ureteral Obstruction|ureteral obstruction
328559|NCT01741441|Duodenogastroesophageal reflux|duodenogastroesophageal reflux
328560|NCT01741441|Weakly acidic reflux|weakly acidic reflux
328561|NCT01741441|Gastric emptying|gastric emptying
328562|NCT01741441|Laparoscopic fundoplication|laparoscopic fundoplication
328563|NCT01741428|CVD Risk score|cvd risk score
328564|NCT01741428|Physical activity|physical activity
328565|NCT01741428|Overweight|overweight
328566|NCT01741428|Cholesterol|cholesterol
328567|NCT01741428|LDL-Cholesterol|ldl-cholesterol
328568|NCT01741428|HDL-Cholesterol|hdl-cholesterol
328569|NCT01741428|Triglycerides|triglycerides
328570|NCT01741428|HbA1C|hba1c
328571|NCT01741428|Quality of life|quality of life
328572|NCT01741402|Control posture|control posture
328573|NCT01741402|Gait|gait
328574|NCT01741402|Virtual Reality|virtual reality
328575|NCT01741402|Elderly|elderly
328576|NCT01741389|Circadian variation, hemostasis, melatonin, tetraplegia|circadian variation, hemostasis, melatonin, tetraplegia
328577|NCT01741363|iFOBT|ifobt
328578|NCT01741363|one-day sample|one-day sample
328579|NCT01741363|two-day sample|two-day sample
328580|NCT01741363|Helicobacter pylori stool antigen|helicobacter pylori stool antigen
328581|NCT01741350|Methadone-maintenance|methadone-maintenance
328582|NCT01741350|HIV|hiv
328583|NCT01741350|Risk behavior|risk behavior
328584|NCT01741350|Injection drug use|injection drug use
328585|NCT01741350|Condom use|condom use
328586|NCT01741350|Health care participation|health care participation
328587|NCT01741350|Opioid replacement therapy|opioid replacement therapy
328588|NCT01741337|central sleep apneas syndrome|central sleep apneas syndrome
328589|NCT01741337|heart failure|heart failure
328590|NCT01741337|all coronary reperfusions|all coronary reperfusions
328591|NCT01741337|adaptive servo-ventilation treatment|adaptive servo-ventilation treatment
328592|NCT01741311|viral load|viral load
328593|NCT01741311|HIV|hiv
328594|NCT01741311|CD4|cd4
328595|NCT01741311|methadone maintenance|methadone maintenance
328596|NCT01741311|substance use|substance use
328597|NCT01741311|Antiretroviral therapy (ART)|antiretroviral therapy (art)
328598|NCT01741298|Metabolic syndrome|metabolic syndrome
328599|NCT01741285|Asthma|asthma
328600|NCT01741285|Adenosine|adenosine
328601|NCT01741285|Small airways|small airways
328602|NCT01741285|Smokers|smokers
328603|NCT01741285|Ex-smokers|ex-smokers
328604|NCT01741272|rotator cuff tear|rotator cuff tear
328605|NCT01741272|arthroscopically assisted|arthroscopically assisted
328606|NCT01741272|health related quality of life(HRQL)|health related quality of life(hrql)
328607|NCT01741272|functional outcome|functional outcome
328608|NCT01741259|analgesia|analgesia
328609|NCT01741259|meperidine|meperidine
328610|NCT01741259|epidural|epidural
328611|NCT01741246|Episodic migraine|episodic migraine
328612|NCT01741246|Chronic migraine|chronic migraine
328613|NCT01741246|Magnetic resonance imaging|magnetic resonance imaging
328614|NCT01741246|Positron emission tomography|positron emission tomography
328615|NCT01741233|SNPs|snps
328616|NCT01741233|vitamin D|vitamin d
328617|NCT01741233|Vitamin D status|vitamin d status
328618|NCT01741233|UVB irradiation|uvb irradiation
328619|NCT01741233|genetics|genetics
328620|NCT01741181|25(OH)Vitamin D|25(oh)vitamin d
328621|NCT01741181|Diabetes mellitus|diabetes mellitus
328622|NCT01741181|Endothelial Function|endothelial function
328623|NCT01741142|Major Depressive Disorder|major depressive disorder
328624|NCT01741129|Nasal CPAP|nasal cpap
328625|NCT01741129|Nasal IMV|nasal imv
328626|NCT01741129|Surfactant|surfactant
328627|NCT01741129|Preterm infants|preterm infants
328628|NCT01741116|castration-resistant prostate cancer|castration-resistant prostate cancer
328629|NCT01741116|TKI258|tki258
328630|NCT01741116|FGF23|fgf23
328631|NCT01741090|Autologous Mesenchymal stem cell|autologous mesenchymal stem cell
328632|NCT01741090|alcoholic liver cirrhosis|alcoholic liver cirrhosis
328633|NCT01741077|pregnancy|pregnancy
328634|NCT01741077|folic acid supplementation|folic acid supplementation
328635|NCT01741077|reproduction|reproduction
328636|NCT01741077|folate|folate
328637|NCT01741064|Secondary Hyperparathyroidism|secondary hyperparathyroidism
328638|NCT01741064|Renal Transplantation|renal transplantation
328639|NCT01741064|Myocardial Infarction|myocardial infarction
328640|NCT01741064|Fracture|fracture
328641|NCT01741064|Graft Failure|graft failure
328642|NCT01741051|Air pollution|air pollution
328643|NCT01741051|Particulate matter|particulate matter
328644|NCT01741051|Mongolia|mongolia
328645|NCT01741051|Pregnancy|pregnancy
328646|NCT01741051|Intrauterine growth restriction (IUGR)|intrauterine growth restriction (iugr)
328647|NCT01741051|Fetal growth|fetal growth
328648|NCT01741051|Birth weight|birth weight
328649|NCT01741051|Gestational age|gestational age
328650|NCT01741038|Cancer Vaccine|cancer vaccine
328651|NCT01741038|AlloStim®|allostim®
328652|NCT01741038|Immunovative|immunovative
328653|NCT01741038|Immunotherapy|immunotherapy
328654|NCT01741038|Allogeneic Cell Therapy|allogeneic cell therapy
328655|NCT01741038|Cryoablation|cryoablation
328656|NCT01741012|Lupus|lupus
328657|NCT01740986|Asthma|asthma
328658|NCT01740973|SILC|silc
328659|NCT01740973|lap. cholecystectomy|lap. cholecystectomy
328660|NCT01740973|trocar-site hernia|trocar-site hernia
328661|NCT01740960|delta-9-tetrahydrocannabinol|delta-9-tetrahydrocannabinol
328662|NCT01740960|THC|thc
328663|NCT01740960|Cannabis|cannabis
328664|NCT01740947|Selective decontamination of the digestive tract|selective decontamination of the digestive tract
328665|NCT01740947|anastomotic leakage|anastomotic leakage
328666|NCT01740947|colorectal cancer|colorectal cancer
328667|NCT01740934|rosacea|rosacea
328668|NCT01740934|anatabine|anatabine
328669|NCT01740934|Anatabloc|anatabloc
328670|NCT01740934|dermatology|dermatology
328671|NCT01740921|GLP-1 analogues|glp-1 analogues
328672|NCT01740921|microvascular|microvascular
328673|NCT01740921|inflammation|inflammation
328674|NCT01740921|fat tissue|fat tissue
328675|NCT01740921|clot structure|clot structure
328676|NCT01740908|hyperbaric oxygen|hyperbaric oxygen
328677|NCT01740908|stem cell|stem cell
328678|NCT01740882|incisional hernia|incisional hernia
328679|NCT01740882|mesh fixation|mesh fixation
328680|NCT01740882|absorbable tacks|absorbable tacks
328681|NCT01740869|autism|autism
328682|NCT01740869|autism spectrum|autism spectrum
328683|NCT01740869|stem cells|stem cells
328684|NCT01740869|children|children
328685|NCT01740856|cardiac catheterization|cardiac catheterization
328686|NCT01740856|safety|safety
328687|NCT01740856|nursing care|nursing care
328688|NCT01740856|rest|rest
328689|NCT01740856|Patients|patients
328690|NCT01740817|diabetes|diabetes
328691|NCT01740817|obesity|obesity
328692|NCT01740817|inflammation|inflammation
328693|NCT01740804|Circulating tumor cell|circulating tumor cell
328694|NCT01740804|Non-small cell lung cancer|non-small cell lung cancer
328695|NCT01740804|chemotherapy|chemotherapy
328696|NCT01740791|Hepatitis C|hepatitis c
328697|NCT01740791|HCV|hcv
328698|NCT01740791|Genotype 1|genotype 1
328699|NCT01740791|Genotype 2|genotype 2
328700|NCT01740791|Genotype 3|genotype 3
328701|NCT01740791|Genotype 4|genotype 4
328702|NCT01740791|Genotype 5|genotype 5
328703|NCT01740791|Genotype 6|genotype 6
328704|NCT01740791|Liver Disease|liver disease
328705|NCT01740778|Diabetes|diabetes
328706|NCT01740778|Medical Device|medical device
328707|NCT01740778|Lancing|lancing
328708|NCT01740752|anorexia nervosa|anorexia nervosa
328709|NCT01740752|eating disorder|eating disorder
328710|NCT01740752|couples|couples
328711|NCT01740752|relationships|relationships
328712|NCT01740752|couple therapy|couple therapy
328713|NCT01740739|Health Risk Appraisal|health risk appraisal
328714|NCT01740739|HCardiac Risk Factors|hcardiac risk factors
328715|NCT01740726|Depression|depression
328716|NCT01740726|Behavioral Activation|behavioral activation
328717|NCT01740726|Fluoxetine|fluoxetine
328718|NCT01740726|Prozac|prozac
328719|NCT01740726|Treatment|treatment
328720|NCT01740726|Therapy|therapy
328721|NCT01740726|Psychotherapy|psychotherapy
328722|NCT01740726|Antidepressant|antidepressant
328723|NCT01740726|Intervention|intervention
328724|NCT01740713|chronic iron overload|chronic iron overload
328725|NCT01740713|hereditary haemoglobinopathy|hereditary haemoglobinopathy
328726|NCT01740713|beta thalassaemia major|beta thalassaemia major
328727|NCT01740700|Abdominal aortic aneurysm|abdominal aortic aneurysm
328728|NCT01740700|Endovascular|endovascular
328729|NCT01740700|Fenestration|fenestration
328730|NCT01740700|Juxtarenal|juxtarenal
328731|NCT01740700|Off-the-shelf|off-the-shelf
328732|NCT01740700|Pararenal|pararenal
328733|NCT01740687|Endometrial Ablation|endometrial ablation
328734|NCT01740687|Permanent Sterilization|permanent sterilization
328735|NCT01740687|Essure|essure
328736|NCT01740687|NovaSure|novasure
328737|NCT01740687|Prevention of Pregnancy|prevention of pregnancy
328738|NCT01740674|internet data collection|internet data collection
328739|NCT01740674|longitudinal research|longitudinal research
328740|NCT01740674|cohort retention|cohort retention
328741|NCT01740648|MEK Inhibitor|mek inhibitor
328742|NCT01740648|Trametinib|trametinib
328743|NCT01740648|Rectal Cancers|rectal cancers
328744|NCT01740648|KRAS|kras
328745|NCT01740648|BRAF|braf
328746|NCT01740648|NRAS Mutant|nras mutant
328747|NCT01740648|Fluorouracil|fluorouracil
328748|NCT01740635|rehabilitation|rehabilitation
328749|NCT01740635|wheelchair|wheelchair
328750|NCT01740635|manual wheelchair|manual wheelchair
328751|NCT01740635|wheelchair users|wheelchair users
328752|NCT01740635|older adults|older adults
328753|NCT01740635|cognitive computer games|cognitive computer games
328754|NCT01740635|home-based training|home-based training
328755|NCT01740635|community mobility|community mobility
328756|NCT01740622|Injury|injury
328757|NCT01740622|Injury Prevention|injury prevention
328758|NCT01740622|Cincinnati Home Injury Prevention|cincinnati home injury prevention
328759|NCT01740622|Injury Hazards|injury hazards
328760|NCT01740622|Modifiable Injury Hazards|modifiable injury hazards
328762|NCT01740609|RN168|rn168
328763|NCT01740609|Healthy Volunteers|healthy volunteers
328764|NCT01740596|NYHA III|nyha iii
328765|NCT01740596|NYHA IV|nyha iv
328766|NCT01740596|ACC Stage C|acc stage c
328767|NCT01740596|Heart Failure|heart failure
328768|NCT01740596|Congestive Heart Failure|congestive heart failure
328769|NCT01740596|C-Pulse|c-pulse
328770|NCT01740596|Counterpulsation|counterpulsation
328771|NCT01740596|Heart Assist|heart assist
328772|NCT01740596|Sunshine Heart|sunshine heart
328773|NCT01740596|Left Heart Failure|left heart failure
328774|NCT01740583|mitral valve, regurgitation, annuloplasty|mitral valve, regurgitation, annuloplasty
328775|NCT01740570|Brain cancer|brain cancer
328776|NCT01740570|Malignant glioma|malignant glioma
328777|NCT01740570|Glioblastoma multiforme|glioblastoma multiforme
328778|NCT01740570|Gliosarcoma|gliosarcoma
328779|NCT01740570|Anaplastic astrocytoma|anaplastic astrocytoma
328780|NCT01740570|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
328781|NCT01740570|Anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
328782|NCT01740570|Cabazitaxel|cabazitaxel
328783|NCT01740570|Jevtana|jevtana
328784|NCT01740557|Melanoma|melanoma
328785|NCT01740557|Metastatic Melanoma|metastatic melanoma
328786|NCT01740557|Stage III in-transit, subcutaneous, or regional nodal disease|stage iii in-transit, subcutaneous, or regional nodal disease
328787|NCT01740557|Cytoxan|cytoxan
328788|NCT01740557|Cyclophosphamide|cyclophosphamide
328789|NCT01740557|Neosar|neosar
328790|NCT01740557|Mesna|mesna
328791|NCT01740557|Mesnex|mesnex
328792|NCT01740557|Fludarabine|fludarabine
328793|NCT01740557|Fludarabine Phosphate|fludarabine phosphate
328794|NCT01740557|Fludara|fludara
328795|NCT01740557|IL-2|il-2
328796|NCT01740557|Interleukin-2|interleukin-2
328797|NCT01740557|Aldesleukin|aldesleukin
328798|NCT01740557|Proleukin|proleukin
328799|NCT01740557|T-cells|t-cells
328800|NCT01740557|Autologous tumor infiltrating lymphocytes|autologous tumor infiltrating lymphocytes
328801|NCT01740557|TIL|til
328802|NCT01740557|CXCR2|cxcr2
328803|NCT01740531|S303 treated RBCs|s303 treated rbcs
328804|NCT01740505|energy cost of walking|energy cost of walking
328805|NCT01740505|energy metabolism|energy metabolism
328806|NCT01740505|aged|aged
328807|NCT01740505|older adult|older adult
328808|NCT01740505|exercise|exercise
328809|NCT01740505|gait|gait
328810|NCT01740505|walking|walking
328811|NCT01740505|aerobic|aerobic
328812|NCT01740505|motor skill|motor skill
328813|NCT01740492|Ketamine|ketamine
328814|NCT01740492|Acute pain|acute pain
328815|NCT01740492|Pain control|pain control
328816|NCT01740492|Pain|pain
328817|NCT01740479|STEMI|stemi
328818|NCT01740479|ticagrelor|ticagrelor
328819|NCT01740479|multi-vessel disease|multi-vessel disease
328820|NCT01740479|culprit lesion|culprit lesion
328821|NCT01740466|Prevalence|prevalence
328822|NCT01740466|Vision disorders|vision disorders
328823|NCT01740466|Eye diseases|eye diseases
328824|NCT01740466|Visual acuity|visual acuity
328825|NCT01740466|Primary health care|primary health care
328826|NCT01740440|Healthy females|healthy females
328827|NCT01740427|breast cancer|breast cancer
328828|NCT01740427|postmenopausal women|postmenopausal women
328829|NCT01740427|estrogen-receptor positive|estrogen-receptor positive
328830|NCT01740427|HER2 negative|her2 negative
328831|NCT01740427|locoregionally recurrent|locoregionally recurrent
328832|NCT01740427|metastatic|metastatic
328833|NCT01740427|Palbociclib (PD-0332991)|palbociclib (pd-0332991)
328834|NCT01740427|PALOMA-2|paloma-2
328835|NCT01740414|prescription opioid abuse|prescription opioid abuse
328836|NCT01740414|pain|pain
328837|NCT01740414|opioid withdrawal|opioid withdrawal
328838|NCT01740414|oxycodone|oxycodone
328839|NCT01740414|ibudilast|ibudilast
328840|NCT01740401|Melanoma|melanoma
328841|NCT01740401|Advanced Malignant Melanoma|advanced malignant melanoma
328842|NCT01740401|Anti CTLA4 Blockade|anti ctla4 blockade
328843|NCT01740401|Progression Free Survival|progression free survival
328844|NCT01740401|Interventional Therapy|interventional therapy
328845|NCT01740401|Phase II Clinical Trial|phase ii clinical trial
328846|NCT01740401|Immunotherapy|immunotherapy
328847|NCT01740401|T Cell Activation|t cell activation
328848|NCT01740362|CP-690|cp-690
328849|NCT01740362|550|550
328850|NCT01740362|pharmacokinetics|pharmacokinetics
328851|NCT01740362|renal impairment|renal impairment
328852|NCT01740323|Breast Cancer|breast cancer
328853|NCT01740323|Chemotherapy|chemotherapy
328854|NCT01740323|Radiotherapy|radiotherapy
328855|NCT01740323|NF-kB|nf-kb
328856|NCT01740323|DNA Binding|dna binding
328857|NCT01740323|Curcumin|curcumin
328858|NCT01740323|IL-6|il-6
328859|NCT01740323|TNF|tnf
328860|NCT01740323|sTNFR2|stnfr2
328861|NCT01740323|IL-1-ra|il-1-ra
328862|NCT01740323|Fatigue|fatigue
328863|NCT01740323|Cytokine|cytokine
328864|NCT01740310|pregnancy,|pregnancy,
328865|NCT01740310|vaccine acceptance,|vaccine acceptance,
328866|NCT01740310|vaccination,|vaccination,
328867|NCT01740310|influenza,|influenza,
328868|NCT01740310|pertussis,|pertussis,
328869|NCT01740310|Tdap,|tdap,
328870|NCT01740310|minority,|minority,
328871|NCT01740310|African-American|african-american
328872|NCT01740297|melanoma, talimogene laherparepvec, ipilimumab, metastatic melanoma, melanoma, immunotherapy, unresectable melanoma, oncolytic immunotherapy,|melanoma, talimogene laherparepvec, ipilimumab, metastatic melanoma, melanoma, immunotherapy, unresectable melanoma, oncolytic immunotherapy,
328873|NCT01740271|breast cancer|breast cancer
328874|NCT01740271|non-metastatic carcinoma of the breast chemotherapy|non-metastatic carcinoma of the breast chemotherapy
328875|NCT01740271|adjuvant therapy|adjuvant therapy
328876|NCT01740271|neoadjuvant|neoadjuvant
328877|NCT01740258|malignant glioma|malignant glioma
328878|NCT01740258|Grade 4 malignant glioma|grade 4 malignant glioma
328879|NCT01740258|glioblastoma|glioblastoma
328880|NCT01740258|gliosarcoma|gliosarcoma
328881|NCT01740258|adult brain tumor|adult brain tumor
328882|NCT01740245|Laser therapy|laser therapy
328883|NCT01740245|Cervical lesions|cervical lesions
328884|NCT01740245|Polyhexamethylene biguanide|polyhexamethylene biguanide
328885|NCT01740245|Chlorhexidine|chlorhexidine
328886|NCT01740219|Health promotion|health promotion
328887|NCT01740219|Religion and medicine|religion and medicine
328888|NCT01740219|Hispanic Americans|hispanic americans
328889|NCT01740219|Randomized controlled trial|randomized controlled trial
328890|NCT01740219|Program evaluation|program evaluation
328891|NCT01740219|Neoplasms/prevention & control|neoplasms/prevention & control
328892|NCT01740219|Mass screening|mass screening
328893|NCT01740219|Female|female
328894|NCT01740219|Male|male
328895|NCT01740219|Preventive Health Services/methods|preventive health services/methods
328896|NCT01740219|Adult|adult
328897|NCT01740219|Organizations|organizations
328898|NCT01740193|Pain|pain
328899|NCT01740193|Regional Anesthesia|regional anesthesia
328900|NCT01740193|ultrasound|ultrasound
328901|NCT01740193|transversus abdominis plane|transversus abdominis plane
328902|NCT01740193|herniorrhaphy|herniorrhaphy
328903|NCT01740193|pediatrics|pediatrics
328904|NCT01740167|prodrome|prodrome
328905|NCT01740167|mental illness|mental illness
328906|NCT01740167|health promotion|health promotion
328907|NCT01740167|lifestyle behavior|lifestyle behavior
328908|NCT01740141|Pain|pain
328909|NCT01740128|spinal cord injuries|spinal cord injuries
328910|NCT01740128|paraplegia|paraplegia
328911|NCT01740128|postural balance|postural balance
328912|NCT01740128|locomotor activity|locomotor activity
328913|NCT01740128|exercise therapy|exercise therapy
328914|NCT01740128|electromyography|electromyography
328915|NCT01740128|transcranial magnetic stimulation, single pulse|transcranial magnetic stimulation, single pulse
328916|NCT01740115|HIV|hiv
328917|NCT01740115|Alcohol Use|alcohol use
328918|NCT01740115|Bone Disease|bone disease
328919|NCT01740115|Bone Mineral Density|bone mineral density
328920|NCT01740115|Bone Microarchitecture|bone microarchitecture
328921|NCT01740115|Substance Dependence|substance dependence
328922|NCT01740102|Ischemic preconditioning|ischemic preconditioning
328923|NCT01740102|Coronary artery bypass|coronary artery bypass
328924|NCT01740102|Preoperative care|preoperative care
328925|NCT01740102|Postoperative period|postoperative period
328926|NCT01740089|Hepatitis C|hepatitis c
328927|NCT01740089|Cepeginterferon alfa|cepeginterferon alfa
328928|NCT01740089|Peginterferon|peginterferon
328929|NCT01740089|Treatment|treatment
328930|NCT01740076|isoflavones, hypertension, soy, diet, nutrition, women, inflammation, hot flashes|isoflavones, hypertension, soy, diet, nutrition, women, inflammation, hot flashes
328931|NCT01740037|Chronic care program|chronic care program
328932|NCT01740037|Nurse specialist|nurse specialist
328933|NCT01740037|Atrial Fibrillation guideline|atrial fibrillation guideline
328934|NCT01740024|Immunotherapy|immunotherapy
328935|NCT01740024|Subcutaneous immunotherapy|subcutaneous immunotherapy
328936|NCT01740024|Skin Prick Test|skin prick test
328937|NCT01740024|Dose Response Prick Test|dose response prick test
328938|NCT01739985|Postoperative|postoperative
328939|NCT01739985|Vomiting|vomiting
328940|NCT01739985|Children|children
328941|NCT01739985|Prophylaxis|prophylaxis
328942|NCT01739985|Droperidol|droperidol
328943|NCT01739985|Ondansetron|ondansetron
328944|NCT01739985|Dexamethasone|dexamethasone
328945|NCT01739972|Desiccated thyroid extract and levothyroxine|desiccated thyroid extract and levothyroxine
328946|NCT01739959|Necrotizing fasciitis|necrotizing fasciitis
328947|NCT01739959|Fournier's gangrene|fournier's gangrene
328948|NCT01739959|Cellulitis|cellulitis
328949|NCT01739959|Serum Lactate|serum lactate
328950|NCT01739933|Delirium|delirium
328951|NCT01739933|Delirium/coma-free days|delirium/coma-free days
328952|NCT01739933|Long term cognitive impairment|long term cognitive impairment
328953|NCT01739933|Sedation|sedation
328954|NCT01739933|Intensive care|intensive care
328955|NCT01739933|Mechanical Ventilation|mechanical ventilation
328956|NCT01739933|Dexmedetomidine|dexmedetomidine
328957|NCT01739933|Propofol|propofol
328958|NCT01739933|Coma-free days|coma-free days
328959|NCT01739933|Sepsis|sepsis
328960|NCT01739933|Organ dysfunction|organ dysfunction
328961|NCT01739933|Acute Respiratory Distress|acute respiratory distress
328962|NCT01739933|Markers of inflammation|markers of inflammation
328963|NCT01739920|Povidone-Iodine|povidone-iodine
328964|NCT01739920|Ophthalmic Solutions|ophthalmic solutions
328965|NCT01739920|Endophthalmitis|endophthalmitis
328966|NCT01739920|Preoperative procedures|preoperative procedures
328967|NCT01739907|Iron deficiency|iron deficiency
328968|NCT01739907|Menstruating women|menstruating women
328969|NCT01739907|Vitamin D|vitamin d
328970|NCT01739907|Functional food|functional food
328971|NCT01739894|Advanced gastric cancer|advanced gastric cancer
328972|NCT01739894|unresectable gastric cancer|unresectable gastric cancer
328973|NCT01739894|recurrent gastric cancer|recurrent gastric cancer
328974|NCT01739894|with peritoneal metastasis|with peritoneal metastasis
328975|NCT01739894|cancer cells on peritoneal cytology|cancer cells on peritoneal cytology
328976|NCT01739881|Exhaled breath condensate (EBC) method|exhaled breath condensate (ebc) method
328977|NCT01739881|Volatile Organic Compounds (VOCs)|volatile organic compounds (vocs)
328978|NCT01739881|Endobronchial Ultrasound (EBUS)|endobronchial ultrasound (ebus)
328979|NCT01739881|Confocal Endoscopy|confocal endoscopy
328980|NCT01739881|Exhaled alveolar gas|exhaled alveolar gas
328981|NCT01739868|Pre-diabetes|pre-diabetes
328982|NCT01739868|Type 2 diabetes|type 2 diabetes
328983|NCT01739868|Biomarkers|biomarkers
328984|NCT01739868|Diabetes risk score|diabetes risk score
328985|NCT01739842|Alcohol consumption|alcohol consumption
328986|NCT01739842|Kudzu extract|kudzu extract
328987|NCT01739842|Cerebral blood flow|cerebral blood flow
328988|NCT01739829|xenotransplantation|xenotransplantation
328989|NCT01739829|type 1 diabetes|type 1 diabetes
328990|NCT01739829|porcine islets|porcine islets
328991|NCT01739816|Compliance|compliance
328992|NCT01739816|Adherence|adherence
328993|NCT01739816|Polypharmacy|polypharmacy
328994|NCT01739816|Medicines use|medicines use
328995|NCT01739816|Medication review|medication review
328996|NCT01739816|Pharmaceutical care|pharmaceutical care
328997|NCT01739816|Primary care|primary care
328998|NCT01739816|Drug related problem|drug related problem
328999|NCT01739816|Patient safety|patient safety
329000|NCT01739803|Immunosuppressant therapy adherence|immunosuppressant therapy adherence
329001|NCT01739803|Quality of life|quality of life
329002|NCT01739803|Economic outcomes|economic outcomes
329003|NCT01739790|COPD|copd
329004|NCT01739790|Chronic Bronchitis|chronic bronchitis
329005|NCT01739790|N-acetylcysteine|n-acetylcysteine
329006|NCT01739777|Heart Failure|heart failure
329007|NCT01739777|Coronary Heart Disease|coronary heart disease
329008|NCT01739777|Adult Stem Cells|adult stem cells
329009|NCT01739777|Umbilical Progenitor Cells|umbilical progenitor cells
329010|NCT01739777|Umbilical Cord Stem Cells Allogenic|umbilical cord stem cells allogenic
329011|NCT01739777|Left Ventricular Function|left ventricular function
329012|NCT01739777|Intravenous Injection|intravenous injection
329013|NCT01739751|COPD|copd
329014|NCT01739751|Physical activity|physical activity
329015|NCT01739751|Pedometers|pedometers
329016|NCT01739751|steps|steps
329017|NCT01739751|non pharmacological treatment|non pharmacological treatment
329018|NCT01739751|rehabilitation|rehabilitation
329019|NCT01739751|exercise|exercise
329020|NCT01739738|peristalsis, kidney stones, hydronephrosis, ureteral stent|peristalsis, kidney stones, hydronephrosis, ureteral stent
329021|NCT01739725|kidney stones, ureteral stent, pain,|kidney stones, ureteral stent, pain,
329022|NCT01739712|Diabetes|diabetes
329023|NCT01739712|Sleep problems|sleep problems
329024|NCT01739712|School|school
329025|NCT01739712|Neurobehavioral|neurobehavioral
329026|NCT01739699|craniotomy|craniotomy
329027|NCT01739699|brain surgery|brain surgery
329028|NCT01739699|acetaminophen|acetaminophen
329029|NCT01739699|Tylenol|tylenol
329030|NCT01739686|Quality of Life|quality of life
329031|NCT01739686|Symptoms|symptoms
329032|NCT01739686|Palliative care|palliative care
329033|NCT01739686|Symptom management|symptom management
329034|NCT01739686|Disease management|disease management
329035|NCT01739686|Health delivery|health delivery
329036|NCT01739673|Infectious Keratitis|infectious keratitis
329037|NCT01739660|Chronic Kidney Disease Stage 5|chronic kidney disease stage 5
329038|NCT01739660|Hemodialysis|hemodialysis
329039|NCT01739660|pegloticase|pegloticase
329040|NCT01739647|AZD3293|azd3293
329041|NCT01739647|Healthy volunteers|healthy volunteers
329042|NCT01739647|Elderly volunteers|elderly volunteers
329043|NCT01739647|Phase 1|phase 1
329044|NCT01739647|Single Ascending Dose Study|single ascending dose study
329045|NCT01739634|Diarrhea|diarrhea
329046|NCT01739634|Medullary thyroid cancer|medullary thyroid cancer
329047|NCT01739608|CRC|crc
329048|NCT01739569|Diet treatment|diet treatment
329049|NCT01739569|Mental Health|mental health
329050|NCT01739569|Reaction time|reaction time
329051|NCT01739569|State of moods|state of moods
329052|NCT01739569|Working hours|working hours
329053|NCT01739569|Medical Hospital Staff|medical hospital staff
329054|NCT01739556|antiplatelet therapy|antiplatelet therapy
329055|NCT01739556|primary PCI|primary pci
329056|NCT01739556|modification|modification
329057|NCT01739517|Short bowel syndrome|short bowel syndrome
329058|NCT01739517|Cholestasis|cholestasis
329059|NCT01739517|Omegaven|omegaven
329159|NCT01738984|exercise|exercise
329060|NCT01739517|Parenteral nutrition-associated Liver Disease|parenteral nutrition-associated liver disease
329061|NCT01739504|Arthritis|arthritis
329062|NCT01739504|Joint pain|joint pain
329063|NCT01739504|Articular cartilage|articular cartilage
329064|NCT01739504|Mesenchymal stem cells|mesenchymal stem cells
329065|NCT01739504|Autologous|autologous
329066|NCT01739504|Adipose tissue|adipose tissue
329067|NCT01739491|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
329068|NCT01739491|Bendamustine hydrochloride|bendamustine hydrochloride
329069|NCT01739491|Leukemia|leukemia
329070|NCT01739491|Filipino|filipino
329071|NCT01739465|Cholangiocarcinoma|cholangiocarcinoma
329072|NCT01739465|Pathologic|pathologic
329073|NCT01739465|Digestive System|digestive system
329074|NCT01739465|Neoplasms|neoplasms
329075|NCT01739465|Neoplasms by Site|neoplasms by site
329076|NCT01739465|Digestive System Diseases|digestive system diseases
329077|NCT01739465|Bile Duct Diseases|bile duct diseases
329078|NCT01739465|Biliary Tract Diseases|biliary tract diseases
329079|NCT01739465|Pathological Conditions|pathological conditions
329080|NCT01739465|Constriction|constriction
329081|NCT01739465|Adenocarcinoma|adenocarcinoma
329082|NCT01739465|Carcinoma|carcinoma
329083|NCT01739452|Low-risk MDS|low-risk mds
329084|NCT01739452|myelodysplastic syndrome|myelodysplastic syndrome
329085|NCT01739452|retrospective|retrospective
329086|NCT01739426|LigaSure V (TM)|ligasure v (tm)
329087|NCT01739400|Eisenmenger Syndrome|eisenmenger syndrome
329088|NCT01739400|exercise capacity|exercise capacity
329089|NCT01739387|Flutiform®|flutiform®
329090|NCT01739387|Asthma|asthma
329091|NCT01739387|COPD|copd
329092|NCT01739374|pelvic floor reconstruction|pelvic floor reconstruction
329093|NCT01739374|mesh implants|mesh implants
329094|NCT01739335|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
329095|NCT01739335|Mifepristone|mifepristone
329096|NCT01739335|Veterans|veterans
329097|NCT01739335|Clinical Trial|clinical trial
329098|NCT01739322|skin prick test|skin prick test
329099|NCT01739322|inmunotherapy|inmunotherapy
329100|NCT01739322|standarization|standarization
329101|NCT01739309|Non- Hodgkins Lymphoma|non- hodgkins lymphoma
329102|NCT01739296|osteoarthritis|osteoarthritis
329103|NCT01739296|osteoarthritis, knee|osteoarthritis, knee
329104|NCT01739296|foot orthoses|foot orthoses
329105|NCT01739296|orthotic insoles|orthotic insoles
329106|NCT01739270|analgesia|analgesia
329107|NCT01739270|regional anesthesia|regional anesthesia
329108|NCT01739270|surgery|surgery
329109|NCT01739270|duration of analgesia|duration of analgesia
329110|NCT01739270|dexamethasone added to levobupivacaine compared to levobupivacaine alone|dexamethasone added to levobupivacaine compared to levobupivacaine alone
329111|NCT01739244|Glaucoma|glaucoma
329112|NCT01739244|Open Angle Glaucoma|open angle glaucoma
329113|NCT01739244|Ocular Hypertension|ocular hypertension
329114|NCT01739244|IOP|iop
329115|NCT01739244|RNAi|rnai
329116|NCT01739244|siRNA|sirna
329117|NCT01739244|beta inhibitor|beta inhibitor
329118|NCT01739205|Type 2 diabetes and depression|type 2 diabetes and depression
329119|NCT01739179|Ventricular peritoneal Shunt|ventricular peritoneal shunt
329120|NCT01739179|Shunt Complications|shunt complications
329121|NCT01739179|Shunt Failure|shunt failure
329122|NCT01739179|Hydrocephalus|hydrocephalus
329123|NCT01739166|Health Services Research|health services research
329124|NCT01739166|Quality Assurance|quality assurance
329125|NCT01739153|Dairy|dairy
329126|NCT01739153|Cheese|cheese
329127|NCT01739153|Blood lipid concentrations|blood lipid concentrations
329128|NCT01739153|Blood lipid sizes|blood lipid sizes
329129|NCT01739153|Fecal fat|fecal fat
329130|NCT01739153|Fat digestibility|fat digestibility
329131|NCT01739153|bile acids|bile acids
329132|NCT01739127|Antipsychotic agents|antipsychotic agents
329133|NCT01739127|Adverse effects|adverse effects
329134|NCT01739127|Magnetic Resonance Imaging|magnetic resonance imaging
329135|NCT01739114|Lung aeration|lung aeration
329136|NCT01739114|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
329137|NCT01739114|Positive Pressure Respiration|positive pressure respiration
329138|NCT01739114|Sustained Inflation|sustained inflation
329139|NCT01739114|Continuous Positive Airway Pressure|continuous positive airway pressure
329140|NCT01739088|Congenital heart disease|congenital heart disease
329141|NCT01739088|pediatrics|pediatrics
329142|NCT01739088|ischemia-reperfusion injury|ischemia-reperfusion injury
329143|NCT01739088|long term outcomes|long term outcomes
329144|NCT01739062|PSA test|psa test
329145|NCT01739062|Prostate cancer|prostate cancer
329146|NCT01739062|Genetic screening|genetic screening
329147|NCT01739036|Malaria|malaria
329148|NCT01739036|Vaccine|vaccine
329149|NCT01739036|Plasmodium|plasmodium
329150|NCT01739036|Falciparum|falciparum
329151|NCT01739023|paraplegia|paraplegia
329152|NCT01739023|cell therapy|cell therapy
329153|NCT01739023|Schwann cells|schwann cells
329154|NCT01739023|spinal cord injury|spinal cord injury
329155|NCT01738997|Benign|benign
329156|NCT01738997|Esophageal strictures|esophageal strictures
329157|NCT01738997|Esophagus|esophagus
329158|NCT01738997|Balloon Dilation|balloon dilation
329160|NCT01738984|video|video
329162|NCT01738984|mother|mother
329163|NCT01738984|infant|infant
329164|NCT01738971|emergency contraception|emergency contraception
329165|NCT01738971|community pharmacy|community pharmacy
329166|NCT01738958|Probiotic bacteria|probiotic bacteria
329167|NCT01738958|Caries dentalis|caries dentalis
329168|NCT01738958|QLF|qlf
329169|NCT01738932|endometriosis|endometriosis
329170|NCT01738932|mannan-binding lectin|mannan-binding lectin
329171|NCT01738932|immunology|immunology
329172|NCT01738893|Gabapentin|gabapentin
329173|NCT01738893|Bioequivalence|bioequivalence
329174|NCT01738893|Pharmacokinetics|pharmacokinetics
329175|NCT01738893|Mexico|mexico
329176|NCT01738867|Pharmacogenetics|pharmacogenetics
329177|NCT01738867|OPRM1|oprm1
329178|NCT01738867|Pharmacodynamics|pharmacodynamics
329179|NCT01738867|Addiction|addiction
329180|NCT01738867|mu opioid receptors|mu opioid receptors
329181|NCT01738854|laryngeal mask airway supreme|laryngeal mask airway supreme
329182|NCT01738854|airway sealing|airway sealing
329183|NCT01738854|intracuff pressure|intracuff pressure
329184|NCT01738841|Combined measles-mumps-rubella-varicella vaccine|combined measles-mumps-rubella-varicella vaccine
329185|NCT01738841|Priorix-Tetra™|priorix-tetra™
329186|NCT01738841|MMRV|mmrv
329187|NCT01738841|children|children
329188|NCT01738841|Post-marketing surveillance|post-marketing surveillance
329189|NCT01738841|Philippines|philippines
329190|NCT01738815|bladder cancer|bladder cancer
329191|NCT01738815|hematuria|hematuria
329192|NCT01738815|sodium valproate|sodium valproate
329193|NCT01738815|valproic acid|valproic acid
329194|NCT01738802|Type 2 Diabetes|type 2 diabetes
329195|NCT01738802|carotid intima medial thickness|carotid intima medial thickness
329196|NCT01738802|micronutrient|micronutrient
329197|NCT01738802|anti-oxidant|anti-oxidant
329198|NCT01738789|Adnexal masses|adnexal masses
329199|NCT01738789|Magnetic resonance imaging|magnetic resonance imaging
329200|NCT01738789|Ovarian tumor|ovarian tumor
329201|NCT01738776|hip fracture|hip fracture
329202|NCT01738776|risk factors|risk factors
329203|NCT01738776|vitamin K1|vitamin k1
329204|NCT01738776|vitamin D|vitamin d
329205|NCT01738776|bone turnover markers|bone turnover markers
329206|NCT01738776|osteocalcin|osteocalcin
329207|NCT01738776|undercarboxylated osteocalcin|undercarboxylated osteocalcin
329208|NCT01738776|bone specific alkaline phosphatase (BALP)|bone specific alkaline phosphatase (balp)
329209|NCT01738776|insulin like growth factor 1 (IGF1)|insulin like growth factor 1 (igf1)
329210|NCT01738776|parathyroid hormone (PTH)|parathyroid hormone (pth)
329211|NCT01738763|Glucose|glucose
329212|NCT01738763|Insulin|insulin
329213|NCT01738763|3-O-methyl-D-chiro-inositol|3-o-methyl-d-chiro-inositol
329214|NCT01738750|surgical choice|surgical choice
329215|NCT01738750|cost of care|cost of care
329216|NCT01738750|decision making|decision making
329217|NCT01738750|health care|health care
329218|NCT01738750|health care cost|health care cost
329219|NCT01738750|pediatric|pediatric
329220|NCT01738750|children|children
329221|NCT01738750|appendicitis|appendicitis
329222|NCT01738750|patient satisfaction|patient satisfaction
329223|NCT01738711|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
329224|NCT01738711|Cognitive behavioural therapy|cognitive behavioural therapy
329225|NCT01738711|Anxiety|anxiety
329226|NCT01738711|Quality of life|quality of life
329227|NCT01738685|Breast Cancer.|breast cancer.
329228|NCT01738685|Adjuvant Endocrine therapy.|adjuvant endocrine therapy.
329229|NCT01738672|Nitrous oxide|nitrous oxide
329230|NCT01738672|labor and delivery|labor and delivery
329231|NCT01738672|analgesia|analgesia
329232|NCT01738659|sodium ,diuretics, PCWP|sodium ,diuretics, pcwp
329233|NCT01738646|vorinostat|vorinostat
329234|NCT01738646|SAHA|saha
329235|NCT01738646|bevacizumab|bevacizumab
329236|NCT01738646|AVASTIN|avastin
329237|NCT01738646|malignant glioma|malignant glioma
329238|NCT01738646|GBM|gbm
329239|NCT01738646|glioblastoma multiforme|glioblastoma multiforme
329240|NCT01738646|brain tumor|brain tumor
329241|NCT01738633|Esophageal Cancer|esophageal cancer
329242|NCT01738633|Quality of Life|quality of life
329243|NCT01738620|esophageal cancer|esophageal cancer
329244|NCT01738620|sleep disturbance|sleep disturbance
329245|NCT01738620|quality of life|quality of life
329246|NCT01738607|fecal incontinence, dietary fiber|fecal incontinence, dietary fiber
329247|NCT01738581|focal hand dystonia (FHD)|focal hand dystonia (fhd)
329248|NCT01738581|repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
329249|NCT01738581|sensorimotor retraining|sensorimotor retraining
329250|NCT01738568|High intensity aerobic training|high intensity aerobic training
329251|NCT01738555|amdoxovir|amdoxovir
329252|NCT01738555|zidovudine|zidovudine
329253|NCT01738555|HIV|hiv
329254|NCT01738555|HAART|haart
329255|NCT01738555|antiretroviral|antiretroviral
329256|NCT01738542|Bosentan|bosentan
329257|NCT01738542|Peripheral Arterial Disease|peripheral arterial disease
329258|NCT01738529|confocal laser endomicroscopy|confocal laser endomicroscopy
329259|NCT01738529|Crohn´disease|crohn´disease
329363|NCT01738217|NIR Fluorescence|nir fluorescence
329658|NCT01737034|refeeding|refeeding
329260|NCT01738503|Opioid Dependence, Buprenorphine, Depot, SUBUTEX, RBP-6000|opioid dependence, buprenorphine, depot, subutex, rbp-6000
329261|NCT01738490|Bone anchored hearing aid|bone anchored hearing aid
329262|NCT01738490|Bone anchored implant|bone anchored implant
329263|NCT01738490|Implant stability|implant stability
329264|NCT01738490|Wide diameter implant|wide diameter implant
329265|NCT01738490|Linear incision|linear incision
329266|NCT01738490|Ponto|ponto
329267|NCT01738477|Booster|booster
329268|NCT01738477|Tdap|tdap
329269|NCT01738477|Immunogenicity|immunogenicity
329270|NCT01738477|Repeat dose|repeat dose
329271|NCT01738477|Safety|safety
329272|NCT01738477|BoostrixTM|boostrixtm
329273|NCT01738477|Persistence|persistence
329274|NCT01738464|Pelvic Pain|pelvic pain
329275|NCT01738464|Interstitial Cystitis|interstitial cystitis
329276|NCT01738464|Microbiome|microbiome
329277|NCT01738464|Prostatitis|prostatitis
329278|NCT01738464|Chronic|chronic
329279|NCT01738464|Depression|depression
329280|NCT01738451|ECG intervals and morphology|ecg intervals and morphology
329281|NCT01738451|BRAF-mutation positive tumor|braf-mutation positive tumor
329282|NCT01738451|Holter monitor|holter monitor
329283|NCT01738451|BRAF inhibitor|braf inhibitor
329284|NCT01738451|GSK2118436|gsk2118436
329285|NCT01738451|safety|safety
329286|NCT01738451|cancer|cancer
329287|NCT01738451|QTc|qtc
329288|NCT01738451|pharmacokinetics|pharmacokinetics
329289|NCT01738438|Metastatic|metastatic
329290|NCT01738438|Triple Negative|triple negative
329291|NCT01738438|Stage IV|stage iv
329292|NCT01738425|GIC-1001|gic-1001
329293|NCT01738425|opioid agonist|opioid agonist
329294|NCT01738425|sulfide|sulfide
329295|NCT01738425|colonoscopy|colonoscopy
329296|NCT01738425|gicare|gicare
329297|NCT01738425|Phase I|phase i
329298|NCT01738425|safety|safety
329299|NCT01738425|tolerability|tolerability
329300|NCT01738425|pharmacokinetics|pharmacokinetics
329301|NCT01738425|healthy subjects|healthy subjects
329302|NCT01738425|single ascending dose|single ascending dose
329303|NCT01738425|multiple ascending dose|multiple ascending dose
329304|NCT01738425|SAD|sad
329305|NCT01738425|MAD|mad
329306|NCT01738425|food effect|food effect
329307|NCT01738412|Stroke|stroke
329308|NCT01738399|Insulin resistance|insulin resistance
329309|NCT01738399|Coffee|coffee
329310|NCT01738399|Glucose metabolism|glucose metabolism
329311|NCT01738386|Adaptation|adaptation
329312|NCT01738386|Coping|coping
329313|NCT01738386|Presenile Dementia|presenile dementia
329314|NCT01738386|Caregiver Burden|caregiver burden
329315|NCT01738373|autologous stem cell transplantation|autologous stem cell transplantation
329316|NCT01738373|lymphoma|lymphoma
329317|NCT01738373|multiple myeloma|multiple myeloma
329318|NCT01738360|Arsenic trioxide|arsenic trioxide
329319|NCT01738360|Systemic Lupus|systemic lupus
329320|NCT01738360|clinically|clinically
329321|NCT01738360|biologically active|biologically active
329322|NCT01738334|Meditation|meditation
329323|NCT01738334|Cognition|cognition
329324|NCT01738334|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
329325|NCT01738308|Healing Touch|healing touch
329326|NCT01738308|Pediatrics|pediatrics
329327|NCT01738308|surgery|surgery
329328|NCT01738308|stress|stress
329329|NCT01738308|pain|pain
329330|NCT01738308|Pediatric Stress|pediatric stress
329331|NCT01738308|maladaptive behaviors|maladaptive behaviors
329332|NCT01738308|energy medicine|energy medicine
329333|NCT01738308|emergence delirium|emergence delirium
329334|NCT01738308|emergence agitation|emergence agitation
329335|NCT01738308|length of stay|length of stay
329336|NCT01738308|ease of wake up|ease of wake up
329337|NCT01738308|distress parents|distress parents
329338|NCT01738308|distress pediatric patients|distress pediatric patients
329339|NCT01738308|Pediatric Post-Traumatic Stress Disorder|pediatric post-traumatic stress disorder
329340|NCT01738295|acetylcholine|acetylcholine
329341|NCT01738295|cholinergic system|cholinergic system
329342|NCT01738295|visual perception|visual perception
329343|NCT01738295|visual attention|visual attention
329344|NCT01738295|multiple objects tracking|multiple objects tracking
329345|NCT01738295|perceptual learning|perceptual learning
329346|NCT01738295|vision training|vision training
329347|NCT01738282|baclofene|baclofene
329348|NCT01738282|Alcohol dependence|alcohol dependence
329349|NCT01738282|Maintenance of abstinence|maintenance of abstinence
329350|NCT01738269|Ovarian cancer, HE4, normal range|ovarian cancer, he4, normal range
329351|NCT01738256|Cognitive Behavior Therapy|cognitive behavior therapy
329352|NCT01738256|Acceptance Commitment Therapy|acceptance commitment therapy
329353|NCT01738256|Psychological Stress|psychological stress
329354|NCT01738256|Metabolic Syndrome|metabolic syndrome
329355|NCT01738256|Overweight|overweight
329356|NCT01738256|Life Style|life style
329357|NCT01738243|Thyroid|thyroid
329358|NCT01738243|Thyroid Eye Disease|thyroid eye disease
329359|NCT01738243|Thyroid Orbitopathy|thyroid orbitopathy
329360|NCT01738243|Eyelid Retraction|eyelid retraction
329361|NCT01738243|Upper Eyelid Retraction|upper eyelid retraction
329362|NCT01738217|Intra-operative imaging|intra-operative imaging
329364|NCT01738217|Liver surgery|liver surgery
329365|NCT01738217|Tumoral margins|tumoral margins
329366|NCT01738204|endometriosis|endometriosis
329367|NCT01738204|dysmenorrhea|dysmenorrhea
329368|NCT01738204|pelvic pain|pelvic pain
329369|NCT01738204|women's health|women's health
329370|NCT01738204|adolescence|adolescence
329371|NCT01738204|biorepository|biorepository
329372|NCT01738204|observational|observational
329373|NCT01738204|women|women
329374|NCT01738204|female|female
329375|NCT01738204|gynecology|gynecology
329376|NCT01738204|fertility|fertility
329377|NCT01738204|infertility|infertility
329378|NCT01738191|Parkinson's disease|parkinson's disease
329379|NCT01738165|Prospective|prospective
329380|NCT01738165|Multi-Center|multi-center
329381|NCT01738165|Pilot Study|pilot study
329382|NCT01738165|Single Arm|single arm
329383|NCT01738165|Safety|safety
329384|NCT01738165|Efficacy|efficacy
329385|NCT01738152|HYALOGYN VAGINAL GEL|hyalogyn vaginal gel
329386|NCT01738152|vaginal dryness|vaginal dryness
329387|NCT01738152|12-232|12-232
329388|NCT01738139|Advanced Cancers|advanced cancers
329389|NCT01738139|Advanced Malignancies|advanced malignancies
329390|NCT01738139|Metastatic|metastatic
329391|NCT01738139|Unresectable|unresectable
329392|NCT01738139|Ipilimumab|ipilimumab
329393|NCT01738139|Yervoy|yervoy
329394|NCT01738139|BMS-734016|bms-734016
329395|NCT01738139|MDX010|mdx010
329396|NCT01738139|Imatinib Mesylate|imatinib mesylate
329397|NCT01738139|Imatinib|imatinib
329398|NCT01738139|Gleevec|gleevec
329399|NCT01738139|STI 571|sti 571
329400|NCT01738139|NSC-716051|nsc-716051
329401|NCT01738126|cerebellum|cerebellum
329402|NCT01738126|fMRI|fmri
329403|NCT01738126|DTI|dti
329404|NCT01738126|pain|pain
329405|NCT01738126|heat|heat
329406|NCT01738126|noxious|noxious
329407|NCT01738126|aversion|aversion
329408|NCT01738126|unpleasantness|unpleasantness
329409|NCT01738126|anger|anger
329410|NCT01738126|aversive stimulus|aversive stimulus
329411|NCT01738126|motor|motor
329412|NCT01738126|human|human
329413|NCT01738126|image analysis|image analysis
329414|NCT01738126|perception|perception
329415|NCT01738126|central nervous system|central nervous system
329416|NCT01738126|sensory|sensory
329417|NCT01738126|somatosensory cortex|somatosensory cortex
329418|NCT01738126|trigeminal system|trigeminal system
329419|NCT01738126|white matter|white matter
329420|NCT01738113|Ilizarov|ilizarov
329421|NCT01738113|distraction osteogenesis|distraction osteogenesis
329422|NCT01738113|Muscle architecture|muscle architecture
329423|NCT01738113|muscle mechanics|muscle mechanics
329424|NCT01738113|Rehabilitation|rehabilitation
329425|NCT01738087|patients|patients
329426|NCT01738087|Adult|adult
329427|NCT01738074|rotavirus|rotavirus
329428|NCT01738074|trivalent genetic reassortment vaccine|trivalent genetic reassortment vaccine
329429|NCT01738074|Phase three clinical trials|phase three clinical trials
329430|NCT01738061|Older workers|older workers
329431|NCT01738061|Multidimensional intervention|multidimensional intervention
329432|NCT01738061|Worksite health promotion|worksite health promotion
329433|NCT01738061|Taiwan|taiwan
329434|NCT01738048|Pain|pain
329435|NCT01738048|Neuropathic pain|neuropathic pain
329436|NCT01738048|Chronic pain|chronic pain
329437|NCT01738035|IgA nephropathy|iga nephropathy
329438|NCT01738022|Sleep apnea|sleep apnea
329439|NCT01738022|Pathophysiology|pathophysiology
329440|NCT01738009|Sleep Apnea|sleep apnea
329441|NCT01738009|Pathophysiology|pathophysiology
329442|NCT01737983|cystic fibrosis|cystic fibrosis
329443|NCT01737983|probiotics|probiotics
329444|NCT01737983|Lactobacillus reuteri|lactobacillus reuteri
329445|NCT01737957|Proliferative Diabetic retinopathy|proliferative diabetic retinopathy
329446|NCT01737957|Pan-retinal photocoagulation|pan-retinal photocoagulation
329447|NCT01737944|methotrexate injection, subcutaneous, autoinjector|methotrexate injection, subcutaneous, autoinjector
329448|NCT01737931|SPM 962|spm 962
329449|NCT01737931|rotigotine|rotigotine
329450|NCT01737931|application site reaction|application site reaction
329451|NCT01737918|urge urinary incontinence, cesa, vasa, TOT, solifenacin|urge urinary incontinence, cesa, vasa, tot, solifenacin
329452|NCT01737905|Asthma|asthma
329453|NCT01737905|Safety|safety
329454|NCT01737905|Efficacy|efficacy
329455|NCT01737905|Epinephrine|epinephrine
329456|NCT01737905|Bronchodilator|bronchodilator
329457|NCT01737905|Metered dose inhaler|metered dose inhaler
329458|NCT01737892|Asthma|asthma
329459|NCT01737892|Pharmacokinetics|pharmacokinetics
329460|NCT01737892|Epinephrine|epinephrine
329461|NCT01737892|Bronchodilator|bronchodilator
329462|NCT01737892|Metered dose inhaler|metered dose inhaler
329463|NCT01737879|Anemia, Chronic Kidney Disease, End Stage Renal Disease, erythropoiesis-stimulating agents, Hemodialysis, Hemoglobin|anemia, chronic kidney disease, end stage renal disease, erythropoiesis-stimulating agents, hemodialysis, hemoglobin
329464|NCT01737866|Heart, Failure, Renal, Insufficiency, Cardiac, Kidney, Hemodialysis, Impairment, omecamtiv mecarbil, cardiac myosin activator, CK-1827452|heart, failure, renal, insufficiency, cardiac, kidney, hemodialysis, impairment, omecamtiv mecarbil, cardiac myosin activator, ck-1827452
329465|NCT01737853|Primary Open-Angle Glaucoma|primary open-angle glaucoma
329466|NCT01737853|Ocular Hypertension|ocular hypertension
329467|NCT01737853|Ganfort|ganfort
329468|NCT01737840|dyspepsia|dyspepsia
329469|NCT01737840|pantoprazole|pantoprazole
329470|NCT01737840|ranitidine|ranitidine
329471|NCT01737840|emergency department|emergency department
329472|NCT01737827|INC280, advanced hepatocellular carcinoma, c-MET pathway dysregulation|inc280, advanced hepatocellular carcinoma, c-met pathway dysregulation
329473|NCT01737814|sickle cell disease|sickle cell disease
329474|NCT01737814|vaso-occlusive crisis|vaso-occlusive crisis
329475|NCT01737801|Lung function|lung function
329476|NCT01737801|Physiotherapy|physiotherapy
329477|NCT01737788|Cervical cerclage|cervical cerclage
329478|NCT01737788|Uterine Cervical Incompetence|uterine cervical incompetence
329479|NCT01737775|diaphragmatic dysfunction|diaphragmatic dysfunction
329480|NCT01737775|ultrasonography|ultrasonography
329481|NCT01737775|respiratory distress|respiratory distress
329482|NCT01737775|abdominal surgery|abdominal surgery
329483|NCT01737775|Age|age
329484|NCT01737775|gender|gender
329485|NCT01737775|biometric|biometric
329486|NCT01737775|body mass index|body mass index
329487|NCT01737775|ASA score|asa score
329488|NCT01737775|smoking status|smoking status
329489|NCT01737775|history of respiratory disease|history of respiratory disease
329490|NCT01737762|Venous leg ulcer|venous leg ulcer
329491|NCT01737762|ulcer|ulcer
329492|NCT01737762|Venous stasis|venous stasis
329493|NCT01737762|compression|compression
329494|NCT01737762|venous|venous
329495|NCT01737762|venous stasis ulcer|venous stasis ulcer
329496|NCT01737762|vlu|vlu
329497|NCT01737762|wound|wound
329498|NCT01737762|varicose veins|varicose veins
329499|NCT01737762|venous insufficiency|venous insufficiency
329500|NCT01737762|dvt|dvt
329501|NCT01737762|deep vein thrombosis|deep vein thrombosis
329502|NCT01737749|Stroke|stroke
329503|NCT01737736|Stroke|stroke
329504|NCT01737723|Stroke|stroke
329505|NCT01737710|Influenza Vaccines|influenza vaccines
329506|NCT01737710|Dermatitis|dermatitis
329507|NCT01737710|Injections, Intradermal|injections, intradermal
329508|NCT01737710|Injections, Intramuscular|injections, intramuscular
329509|NCT01737710|Skin Diseases|skin diseases
329510|NCT01737710|Skin Diseases, Eczematous|skin diseases, eczematous
329511|NCT01737710|Hypersensitivity, Immediate|hypersensitivity, immediate
329512|NCT01737710|Hypersensitivity|hypersensitivity
329513|NCT01737710|Immune System Diseases|immune system diseases
329514|NCT01737710|Genetic Diseases, Inborn|genetic diseases, inborn
329515|NCT01737710|Skin Diseases, Genetic|skin diseases, genetic
329516|NCT01737671|Brain tumor|brain tumor
329517|NCT01737671|Malignant Fourth Ventricular Brain Tumors|malignant fourth ventricular brain tumors
329518|NCT01737671|Ependymoma involving brain|ependymoma involving brain
329519|NCT01737671|Ependymoma involving spine|ependymoma involving spine
329520|NCT01737671|Recurrent ependymoma involving brain and/or spine|recurrent ependymoma involving brain and/or spine
329521|NCT01737671|Recurrent atypical teratoid/rhabdoid tumor involving brain|recurrent atypical teratoid/rhabdoid tumor involving brain
329522|NCT01737671|Recurrent atypical teratoid/rhabdoid tumor involving spine|recurrent atypical teratoid/rhabdoid tumor involving spine
329523|NCT01737671|AT/RT|at/rt
329524|NCT01737671|Ommaya reservoir catheter|ommaya reservoir catheter
329525|NCT01737671|Methotrexate|methotrexate
329526|NCT01737671|Medulloblastoma|medulloblastoma
329527|NCT01737671|ATRT|atrt
329528|NCT01737671|Atypical teratoid rhabdoid tumor|atypical teratoid rhabdoid tumor
329529|NCT01737671|Ependymoma|ependymoma
329530|NCT01737671|Pediatric brain tumor|pediatric brain tumor
329531|NCT01737671|Intraventricular chemotherapy|intraventricular chemotherapy
329532|NCT01737632|Adolescents|adolescents
329533|NCT01737632|Residential Treatment|residential treatment
329534|NCT01737632|Outpatient Treatment|outpatient treatment
329535|NCT01737632|Substance Abuse|substance abuse
329536|NCT01737632|Delinquency|delinquency
329537|NCT01737632|Family Therapy|family therapy
329538|NCT01737632|Multidimensional Family therapy|multidimensional family therapy
329539|NCT01737619|Gynecologic cancer|gynecologic cancer
329540|NCT01737619|Endometrial Cancer|endometrial cancer
329541|NCT01737619|Lymph Nodes Metastasis|lymph nodes metastasis
329542|NCT01737619|Surgical Staging|surgical staging
329543|NCT01737619|False negative rate|false negative rate
329544|NCT01737619|Detection of positive lymph nodes|detection of positive lymph nodes
329545|NCT01737619|Histologically confirmed high grade endometrial cancer|histologically confirmed high grade endometrial cancer
329546|NCT01737619|Sentinel lymph node mapping|sentinel lymph node mapping
329547|NCT01737606|Cerebral pulsatility|cerebral pulsatility
329548|NCT01737606|Fast Cerebral Pulsatility Imaging or FCPI|fast cerebral pulsatility imaging or fcpi
329549|NCT01737606|MRI|mri
329550|NCT01737606|Arteriel Spin Labelling|arteriel spin labelling
329551|NCT01737606|Cognitive tasks|cognitive tasks
329552|NCT01737606|Aging|aging
329553|NCT01737593|acetaminophen|acetaminophen
329554|NCT01737593|emergence agitation|emergence agitation
329555|NCT01737593|children|children
329556|NCT01737593|sevoflurane|sevoflurane
329557|NCT01737580|influenza, human|influenza, human
329558|NCT01737580|influenza vaccines|influenza vaccines
329559|NCT01737580|older adults|older adults
329560|NCT01737580|immune response|immune response
329561|NCT01737554|Central venous access device|central venous access device
329562|NCT01737554|Catheter resistance monitoring|catheter resistance monitoring
329563|NCT01737541|Cerebrovascular Disorders|cerebrovascular disorders
329564|NCT01737541|Cardiovascular Diseases|cardiovascular diseases
329565|NCT01737541|Intracerebral Hemorrhage|intracerebral hemorrhage
329566|NCT01737541|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
329567|NCT01737541|Therapeutic Uses|therapeutic uses
329568|NCT01737528|severe symptomatic native aortic valve stenosis|severe symptomatic native aortic valve stenosis
329569|NCT01737528|inoperable or high risk for open aortic valve replacement|inoperable or high risk for open aortic valve replacement
329570|NCT01737476|age 18-65|age 18-65
329571|NCT01737463|Ampulla of Vater adenoma|ampulla of vater adenoma
329572|NCT01737450|Metastatic head and neck cancer|metastatic head and neck cancer
329573|NCT01737450|PI3K inhibitor|pi3k inhibitor
329574|NCT01737450|Recurrent head and meck cancer|recurrent head and meck cancer
329575|NCT01737450|Progressive head and neck cancer|progressive head and neck cancer
329576|NCT01737450|BKM120|bkm120
329577|NCT01737411|surgery, solifenacin, urge urinary incontinence|surgery, solifenacin, urge urinary incontinence
329578|NCT01737398|FAP|fap
329579|NCT01737398|Familial Amyloid Polyneuropathy|familial amyloid polyneuropathy
329580|NCT01737398|TTR|ttr
329581|NCT01737398|Transthyretin|transthyretin
329582|NCT01737398|Amyloidosis|amyloidosis
329583|NCT01737385|microcirculation|microcirculation
329584|NCT01737385|proximal humeral fractures|proximal humeral fractures
329585|NCT01737385|O2C|o2c
329586|NCT01737372|Multiple Sclerosis|multiple sclerosis
329587|NCT01737372|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
329588|NCT01737372|Clinically Isolated Syndrome|clinically isolated syndrome
329589|NCT01737359|amdoxovir|amdoxovir
329590|NCT01737359|zidovudine|zidovudine
329591|NCT01737359|tenofovir DF|tenofovir df
329592|NCT01737359|HIV|hiv
329593|NCT01737359|HAART|haart
329594|NCT01737359|antiretroviral|antiretroviral
329595|NCT01737346|glioblastoma, recurrent, refractory, CCNU, procarbazine|glioblastoma, recurrent, refractory, ccnu, procarbazine
329596|NCT01737320|gram negative bacteremia|gram negative bacteremia
329597|NCT01737320|Duration of antibiotic treatment|duration of antibiotic treatment
329598|NCT01737320|safety|safety
329599|NCT01737320|efficacy|efficacy
329600|NCT01737320|short-course|short-course
329601|NCT01737307|Fluoride Varnish|fluoride varnish
329602|NCT01737307|CPP-ACP paste|cpp-acp paste
329603|NCT01737307|Dry mouth|dry mouth
329604|NCT01737307|Burning sensation|burning sensation
329605|NCT01737307|Chemotherapy|chemotherapy
329606|NCT01737294|Phase IV|phase iv
329607|NCT01737294|Peripheral Neuropathic Pain|peripheral neuropathic pain
329608|NCT01737294|QUTENZA|qutenza
329609|NCT01737281|Smoking|smoking
329610|NCT01737281|Tobacco control|tobacco control
329611|NCT01737281|Counseling|counseling
329612|NCT01737281|mental health|mental health
329613|NCT01737268|patients|patients
329614|NCT01737268|Major depressive episode|major depressive episode
329615|NCT01737268|FK949E|fk949e
329616|NCT01737255|Li-Fraumeni Syndrome|li-fraumeni syndrome
329617|NCT01737255|Whole Body Magnetic Resonance Imaging|whole body magnetic resonance imaging
329618|NCT01737255|TP53|tp53
329619|NCT01737255|Psychological Impact|psychological impact
329620|NCT01737242|Prostate cancer|prostate cancer
329621|NCT01737242|PSA|psa
329622|NCT01737216|Aged|aged
329623|NCT01737216|patients|patients
329624|NCT01737203|Viagra|viagra
329625|NCT01737203|ODT|odt
329626|NCT01737203|bioquivalence|bioquivalence
329627|NCT01737190|esophageal pressure|esophageal pressure
329628|NCT01737190|ARDSnet protocol|ardsnet protocol
329629|NCT01737177|MCL|mcl
329630|NCT01737177|Mantle Cell Lymphoma|mantle cell lymphoma
329631|NCT01737177|RELAPSED-REFRACTORY|relapsed-refractory
329632|NCT01737164|Glucose|glucose
329633|NCT01737164|Lipid|lipid
329634|NCT01737164|Metabolism|metabolism
329635|NCT01737164|Non Diabetic|non diabetic
329636|NCT01737164|Healthy|healthy
329637|NCT01737138|Resistant hypertension|resistant hypertension
329638|NCT01737138|All-cause mortality|all-cause mortality
329639|NCT01737138|Renal function|renal function
329640|NCT01737112|Lung Cancer|lung cancer
329641|NCT01737112|integrin αvβ3 receptor|integrin αvβ3 receptor
329642|NCT01737112|99mTc-3PRGD2|99mtc-3prgd2
329643|NCT01737112|SPECT/CT|spect/ct
329644|NCT01737112|efficacy and safety|efficacy and safety
329645|NCT01737099|omega-3|omega-3
329646|NCT01737099|DHA|dha
329647|NCT01737099|triglycerides|triglycerides
329648|NCT01737099|lipids|lipids
329649|NCT01737099|cardiovascular|cardiovascular
329650|NCT01737099|hypertriglyceridemia|hypertriglyceridemia
329651|NCT01737073|chronic pain|chronic pain
329652|NCT01737073|opioid|opioid
329653|NCT01737073|cognitive behavior therapy|cognitive behavior therapy
329654|NCT01737060|Reversed prosthesis, Philos, Severe displaced|reversed prosthesis, philos, severe displaced
329655|NCT01737047|HIV|hiv
329656|NCT01737047|Ageing|ageing
329657|NCT01737034|partitioning of weight gain|partitioning of weight gain
329659|NCT01737034|catch-up fat phenomenon|catch-up fat phenomenon
329660|NCT01737034|glycemic index|glycemic index
329661|NCT01737021|PICU|picu
329662|NCT01737021|Critical illness|critical illness
329663|NCT01737021|Outcomes|outcomes
329664|NCT01737021|Mental health|mental health
329665|NCT01737021|Education|education
329666|NCT01737021|Randomized Controlled Trial (RCT)|randomized controlled trial (rct)
329667|NCT01737021|Pilot|pilot
329668|NCT01737021|Feasibility|feasibility
329669|NCT01737008|Head and neck|head and neck
329670|NCT01737008|Squamous cell carcinoma|squamous cell carcinoma
329671|NCT01737008|Phase 1|phase 1
329672|NCT01737008|Dacomitinib|dacomitinib
329673|NCT01737008|Radiation|radiation
329674|NCT01737008|Radiotherapy|radiotherapy
329675|NCT01737008|Chemotherapy|chemotherapy
329676|NCT01737008|Chemoradiation|chemoradiation
329677|NCT01737008|Chemoradiotherapy|chemoradiotherapy
329678|NCT01737008|Cisplatin|cisplatin
329679|NCT01737008|Pharmacokinetics|pharmacokinetics
329680|NCT01737008|Maximum tolerated dose|maximum tolerated dose
329681|NCT01737008|Safety|safety
329682|NCT01737008|Human epidermal growth factor receptor|human epidermal growth factor receptor
329683|NCT01737008|Previously Untreated|previously untreated
329684|NCT01737008|Local or Locally Advanced|local or locally advanced
329685|NCT01736995|Substance Abuse|substance abuse
329686|NCT01736995|Adolescents|adolescents
329687|NCT01736995|Families|families
329688|NCT01736995|Functional Family Therapy|functional family therapy
329689|NCT01736995|Cognitive Behavioral Therapy|cognitive behavioral therapy
329690|NCT01736995|Motivational Therapy|motivational therapy
329691|NCT01736995|Contingency Management|contingency management
329692|NCT01736982|Cigarette Smoking|cigarette smoking
329693|NCT01736982|Homeless|homeless
329694|NCT01736982|Contingency Management|contingency management
329695|NCT01736982|Smoking Cessation|smoking cessation
329696|NCT01736956|aortic stenosis|aortic stenosis
329697|NCT01736956|hypoplastic left heart syndrome|hypoplastic left heart syndrome
329698|NCT01736956|fetal aortic valvuloplasty|fetal aortic valvuloplasty
329699|NCT01736943|Bortezomib|bortezomib
329700|NCT01736943|Doxil|doxil
329701|NCT01736930|Type 1 Diabetes|type 1 diabetes
329702|NCT01736930|Hypoglycemia|hypoglycemia
329703|NCT01736930|Continuous Glucose Monitoring|continuous glucose monitoring
329704|NCT01736930|Pump Suspension|pump suspension
329705|NCT01736917|Fosaprepitant|fosaprepitant
329706|NCT01736917|5HT3 Receptor Antagonists|5ht3 receptor antagonists
329707|NCT01736917|Dexamethasone|dexamethasone
329708|NCT01736917|Germ Cell Tumors|germ cell tumors
329709|NCT01736917|Testis Cancer|testis cancer
329710|NCT01736917|Rescue Medications|rescue medications
329711|NCT01736904|advanced colorectal cancer|advanced colorectal cancer
329712|NCT01736904|FOLFIRI|folfiri
329713|NCT01736904|XELIRI|xeliri
329714|NCT01736891|Motor fluctuations|motor fluctuations
329715|NCT01736891|Parkinson´s Disease|parkinson´s disease
329716|NCT01736891|Rasagiline|rasagiline
329717|NCT01736878|Medullary Thyroid Carcinoma|medullary thyroid carcinoma
329718|NCT01736878|Sorafenib|sorafenib
329719|NCT01736878|Efficacy|efficacy
329720|NCT01736852|Premature Rupture of Membrane (Pregnancy)|premature rupture of membrane (pregnancy)
329721|NCT01736852|PROM|prom
329722|NCT01736852|Cervical Ripening|cervical ripening
329723|NCT01736852|Induced Labor|induced labor
329724|NCT01736826|plasma nucleosome concentration|plasma nucleosome concentration
329725|NCT01736826|plasma free DNA concentration|plasma free dna concentration
329726|NCT01736813|colorectal cancer|colorectal cancer
329727|NCT01736813|liver metastases|liver metastases
329728|NCT01736813|chemotherapy|chemotherapy
329729|NCT01736813|chemokine|chemokine
329730|NCT01736813|CCR5 inhibition|ccr5 inhibition
329731|NCT01736800|Temozolomide|temozolomide
329732|NCT01736800|Topotecan|topotecan
329733|NCT01736800|Central Nervous System Metastases|central nervous system metastases
329734|NCT01736800|Chemotherapy|chemotherapy
329735|NCT01736800|Brain Metastases|brain metastases
329736|NCT01736800|Solid Tumors|solid tumors
329737|NCT01736787|Cauliflower Mushroom extract|cauliflower mushroom extract
329738|NCT01736787|immunity|immunity
329739|NCT01736774|Manual therapy|manual therapy
329740|NCT01736774|Exercise|exercise
329741|NCT01736748|obesity|obesity
329742|NCT01736748|physical activity|physical activity
329743|NCT01736748|metabolism|metabolism
329744|NCT01736748|environment|environment
329745|NCT01736748|obese children, as defined by a body mass index > 95th percentile|obese children, as defined by a body mass index > 95th percentile
329746|NCT01736748|for age and sex|for age and sex
329747|NCT01736722|Laser Induced Thermal Therapy|laser induced thermal therapy
329748|NCT01736722|Metastatic cancer|metastatic cancer
329749|NCT01736722|Brain Tumor|brain tumor
329750|NCT01736722|Visualase|visualase
329751|NCT01736722|Treatment resistant|treatment resistant
329752|NCT01736722|Magnetic Resonance Thermal Imaging|magnetic resonance thermal imaging
329753|NCT01736722|Magnetic Imaging|magnetic imaging
329754|NCT01736709|2012-2013 trivalent seasonal influenza vaccine|2012-2013 trivalent seasonal influenza vaccine
329755|NCT01736709|immunogenicity,|immunogenicity,
329756|NCT01736709|safety|safety
329757|NCT01736696|Psoriasis|psoriasis
329758|NCT01736696|PASI|pasi
329759|NCT01736696|plaques|plaques
329760|NCT01736696|skin biopsy|skin biopsy
329761|NCT01736696|immunomodulation|immunomodulation
329762|NCT01736683|ACE-011|ace-011
329763|NCT01736683|anemia|anemia
329764|NCT01736683|dose-ranging|dose-ranging
329765|NCT01736683|intermediate-1 risk myelodysplastic syndromes|intermediate-1 risk myelodysplastic syndromes
329766|NCT01736683|low risk myelodysplastic syndromes (MDS)|low risk myelodysplastic syndromes (mds)
329767|NCT01736683|multicenter|multicenter
329768|NCT01736683|open-label|open-label
329769|NCT01736683|parallel|parallel
329770|NCT01736683|phase 2|phase 2
329771|NCT01736683|randomized|randomized
329772|NCT01736683|Sotatercept|sotatercept
329773|NCT01736683|Non-proliferative chronic myelomonocytic leukemia (CMML)|non-proliferative chronic myelomonocytic leukemia (cmml)
329774|NCT01736683|hemoglobin|hemoglobin
329775|NCT01736683|transfusions|transfusions
329776|NCT01736644|blood loss|blood loss
329777|NCT01736644|bipolar sealer|bipolar sealer
329778|NCT01736644|aquamantys|aquamantys
329779|NCT01736644|total knee replacement|total knee replacement
329780|NCT01736644|primary total knee arthroplasty|primary total knee arthroplasty
329781|NCT01736631|social phobia|social phobia
329782|NCT01736631|bipolar disorder|bipolar disorder
329783|NCT01736631|cognitive behavioural therapy|cognitive behavioural therapy
329784|NCT01736618|subcutaneous implantable defibrillator, post approval study, sudden cardiac arrest, Cameron Health defibrillator|subcutaneous implantable defibrillator, post approval study, sudden cardiac arrest, cameron health defibrillator
329785|NCT01736605|Massage|massage
329786|NCT01736605|Meditation|meditation
329787|NCT01736605|Breast Cancer|breast cancer
329788|NCT01736605|Breast Surgery|breast surgery
329789|NCT01736605|Breast Reconstruction|breast reconstruction
329790|NCT01736566|Primary Care|primary care
329791|NCT01736566|Cardiology|cardiology
329792|NCT01736566|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
329793|NCT01736566|Dilated Cardiomyopathy|dilated cardiomyopathy
329794|NCT01736566|Whole Genome Sequencing|whole genome sequencing
329795|NCT01736553|Spinal Muscular Atrophy (SMA) Biomarkers|spinal muscular atrophy (sma) biomarkers
329796|NCT01736553|Healthy controls|healthy controls
329797|NCT01736553|Infants|infants
329798|NCT01736540|iron overload, liver iron concentration (LIC), cardiac siderosis, transfusional siderosis, magnetic resonance imaging (MRI)|iron overload, liver iron concentration (lic), cardiac siderosis, transfusional siderosis, magnetic resonance imaging (mri)
329799|NCT01736514|xanthine oxidase inhibitor|xanthine oxidase inhibitor
329800|NCT01736514|Uric acid lowering drug|uric acid lowering drug
329801|NCT01736488|Hypertension|hypertension
329802|NCT01736488|Antihypertensive efficacy|antihypertensive efficacy
329803|NCT01736488|Neurohormonal markers|neurohormonal markers
329804|NCT01736488|Blood Pressure Response|blood pressure response
329805|NCT01736488|Exercise|exercise
329806|NCT01736462|Cornea|cornea
329807|NCT01736462|Endothelial cell density|endothelial cell density
329808|NCT01736449|pterygium|pterygium
329809|NCT01736449|bevacizumab|bevacizumab
329810|NCT01736449|recurrence of pterygium|recurrence of pterygium
329811|NCT01736436|MDS|mds
329812|NCT01736436|Myelodysplastic syndrome|myelodysplastic syndrome
329813|NCT01736436|Low and intermediate risk|low and intermediate risk
329814|NCT01736436|Transfusion-dependent patients|transfusion-dependent patients
329815|NCT01736436|Transfusion|transfusion
329816|NCT01736436|Anemia|anemia
329817|NCT01736423|YM060|ym060
329818|NCT01736423|Ramosetron|ramosetron
329819|NCT01736423|long term study|long term study
329820|NCT01736423|Diarrhea-predominant Irritable Bowel Syndrome|diarrhea-predominant irritable bowel syndrome
329821|NCT01736423|Female|female
329822|NCT01736397|CKD|ckd
329823|NCT01736397|Chronic Kidney Disease|chronic kidney disease
329824|NCT01736397|Phosphorus|phosphorus
329825|NCT01736397|Iron Deficiency|iron deficiency
329826|NCT01736397|Iron Deficiency Anemia|iron deficiency anemia
329827|NCT01736397|Elevated Phosphorus|elevated phosphorus
329828|NCT01736371|Sevoflurane|sevoflurane
329829|NCT01736371|Cisatracurium infusion consumption|cisatracurium infusion consumption
329830|NCT01736371|Closed loop computer control system|closed loop computer control system
329831|NCT01736371|Recovery Index|recovery index
329832|NCT01736358|Sprix|sprix
329833|NCT01736358|Intranasal ketoralac|intranasal ketoralac
329834|NCT01736358|Ketoralac|ketoralac
329835|NCT01736358|Urolithiasis|urolithiasis
329836|NCT01736358|Kidney stone|kidney stone
329837|NCT01736358|Uretal stone|uretal stone
329838|NCT01736358|Ureteroscopic removal of stones|ureteroscopic removal of stones
329839|NCT01736358|URS|urs
329840|NCT01736358|Pain management|pain management
329841|NCT01736358|Pain|pain
329842|NCT01736332|Methamphetamine|methamphetamine
329843|NCT01736332|Amphetamines|amphetamines
329844|NCT01736332|Opiates|opiates
329845|NCT01736332|Oral Opiates (poppy seeds)|oral opiates (poppy seeds)
329846|NCT01736332|Intranasal amphetamines|intranasal amphetamines
329847|NCT01736319|Artemisinin-based Combination Therapies|artemisinin-based combination therapies
329848|NCT01736319|Recrudescence|recrudescence
329849|NCT01736319|DHA-PPQ|dha-ppq
329850|NCT01736319|Parasite Clearance Rate|parasite clearance rate
329851|NCT01736306|Breast Cancer|breast cancer
329852|NCT01736306|Breast Milk|breast milk
329853|NCT01736306|Epigenetics|epigenetics
329854|NCT01736293|Retinal Degeneration|retinal degeneration
329855|NCT01736280|Symptoms|symptoms
329856|NCT01736280|Immunogenetics|immunogenetics
329857|NCT01736280|Digestive Disorders|digestive disorders
329858|NCT01736280|Gastrointestinal|gastrointestinal
329859|NCT01736267|Auditory Brainstem Implant|auditory brainstem implant
329860|NCT01736267|ABI|abi
329861|NCT01736267|Nucleus 24|nucleus 24
329862|NCT01736267|Deafness|deafness
329863|NCT01736267|Hearing loss|hearing loss
329864|NCT01736267|Non-tumor|non-tumor
329865|NCT01736267|Non-NF2|non-nf2
329866|NCT01736267|ABI541|abi541
329867|NCT01736228|xenotransplantation|xenotransplantation
329868|NCT01736228|type 1 diabetes|type 1 diabetes
329869|NCT01736228|porcine islets|porcine islets
329870|NCT01736215|Anemia - cancer related|anemia - cancer related
329871|NCT01736215|Eprex (Erythropoietin alfa)|eprex (erythropoietin alfa)
329872|NCT01736202|oral fat|oral fat
329873|NCT01736202|insulin sensitivity|insulin sensitivity
329874|NCT01736189|Rheumatoid arthritis|rheumatoid arthritis
329875|NCT01736176|Safety and efficacy|safety and efficacy
329876|NCT01736176|Advanced Parkinson's disease|advanced parkinson's disease
329877|NCT01736176|levodopa-carbidopa intestinal gel,|levodopa-carbidopa intestinal gel,
329878|NCT01736176|carbidopa|carbidopa
329879|NCT01736176|levodopa|levodopa
329880|NCT01736176|Non-Motor Symptom Scale|non-motor symptom scale
329881|NCT01736150|Hemodialysis|hemodialysis
329882|NCT01736137|Heart failure|heart failure
329883|NCT01736137|Autonomic Nervous System|autonomic nervous system
329884|NCT01736137|Heart rate|heart rate
329885|NCT01736137|Quality of life|quality of life
329886|NCT01736124|computerize cognitive training|computerize cognitive training
329887|NCT01736124|dementia|dementia
329888|NCT01736124|cognitive decline|cognitive decline
329889|NCT01736124|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
329890|NCT01736111|obesity|obesity
329891|NCT01736111|weight loss|weight loss
329892|NCT01736111|text message|text message
329893|NCT01736085|tobacco cessation|tobacco cessation
329894|NCT01736085|smoking cessation|smoking cessation
329895|NCT01736085|nicotine|nicotine
329896|NCT01736085|telephone counseling|telephone counseling
329897|NCT01736085|self-help|self-help
329898|NCT01736085|smoking abstinence|smoking abstinence
329899|NCT01736085|tobacco use disorder|tobacco use disorder
329900|NCT01736085|nicotine replacement therapy|nicotine replacement therapy
329901|NCT01736085|voucher|voucher
329902|NCT01736072|Rectal Cancer|rectal cancer
329903|NCT01736072|Colorectal Cancer|colorectal cancer
329904|NCT01736072|Laparoscopic Surgery|laparoscopic surgery
329905|NCT01736072|Robotic Surgery|robotic surgery
329906|NCT01736072|Robotic Assisted Laparoscopic Surgery|robotic assisted laparoscopic surgery
329907|NCT01736059|Stem cells|stem cells
329908|NCT01736059|intravitreal|intravitreal
329909|NCT01736059|bone marrow CD34+ cells|bone marrow cd34+ cells
329910|NCT01736059|retinal disease|retinal disease
329911|NCT01736059|clinical trial|clinical trial
329912|NCT01736059|autologous|autologous
329913|NCT01736046|CT Enterography|ct enterography
329914|NCT01736046|Crohn's Disease|crohn's disease
329915|NCT01736046|Inflammatory Bowel Disease|inflammatory bowel disease
329916|NCT01736033|Lower Urinary Tracts Symptoms|lower urinary tracts symptoms
329917|NCT01736033|5 alpha reductase inhibitor|5 alpha reductase inhibitor
329918|NCT01736033|Proscar|proscar
329919|NCT01736033|Finasteride|finasteride
329920|NCT01736033|alpha blocker|alpha blocker
329921|NCT01736033|Tamsulosin|tamsulosin
329922|NCT01736033|Harnal D|harnal d
329923|NCT01736007|alopecia areata child|alopecia areata child
329924|NCT01736007|scalp|scalp
329925|NCT01735994|Eating disorders|eating disorders
329926|NCT01735994|body image|body image
329927|NCT01735994|female athletes|female athletes
329928|NCT01735994|female athlete triad|female athlete triad
329929|NCT01735994|eating disorder prevention|eating disorder prevention
329930|NCT01735994|cluster randomization|cluster randomization
329931|NCT01735994|risk factors|risk factors
329932|NCT01735994|prevention|prevention
329933|NCT01735981|Huntington's Disease|huntington's disease
329934|NCT01735981|gait|gait
329935|NCT01735981|exercise|exercise
329936|NCT01735981|balance|balance
329937|NCT01735981|video game|video game
329938|NCT01735968|Imatinib mesylate|imatinib mesylate
329939|NCT01735968|BYL719|byl719
329940|NCT01735968|GIST|gist
329941|NCT01735955|Tasigna|tasigna
329942|NCT01735955|CML|cml
329943|NCT01735955|GIST|gist
329944|NCT01735955|nilotinib|nilotinib
329945|NCT01735890|Safety|safety
329946|NCT01735890|Pharmacokinetics|pharmacokinetics
329947|NCT01735877|Hemispatial neglect, Stroke|hemispatial neglect, stroke
329948|NCT01735864|Indigo naturalis extract in oil|indigo naturalis extract in oil
329949|NCT01735851|Thoracic epidural analgesia|thoracic epidural analgesia
329950|NCT01735851|Paravertebral block|paravertebral block
329951|NCT01735851|pain|pain
329952|NCT01735851|postoperative|postoperative
329953|NCT01735825|coronary artery disease|coronary artery disease
329954|NCT01735825|stent|stent
329955|NCT01735825|restenosis|restenosis
329956|NCT01735812|cryoablation|cryoablation
329957|NCT01735812|uterine fibroid|uterine fibroid
329958|NCT01735812|uterine myoma|uterine myoma
329959|NCT01735812|who completed her family planning|who completed her family planning
329960|NCT01735812|but wishes to preserve her uterus|but wishes to preserve her uterus
329961|NCT01735786|Endoscopic Hemostasis|endoscopic hemostasis
329962|NCT01735786|EndoClot Absorbable Polysaccharide Hemostat|endoclot absorbable polysaccharide hemostat
329963|NCT01735786|Colonic Polyps|colonic polyps
329964|NCT01735773|hemodialysis|hemodialysis
329965|NCT01735773|inflammation|inflammation
329966|NCT01735773|iron|iron
329967|NCT01735773|peritoneal dialysis|peritoneal dialysis
329968|NCT01735773|prohepcidin|prohepcidin
329969|NCT01735773|uremia|uremia
329970|NCT01735760|airway management|airway management
329971|NCT01735760|cricothyroid membrane|cricothyroid membrane
329972|NCT01735747|Lymphoma|lymphoma
329973|NCT01735734|Skin disease|skin disease
329974|NCT01735734|Capillary Malformation|capillary malformation
329975|NCT01735734|Laser therapy|laser therapy
329976|NCT01735721|Sinus Floor Augmentation|sinus floor augmentation
329977|NCT01735721|Bone Transplantation|bone transplantation
329978|NCT01735721|Bone Substitute|bone substitute
329979|NCT01735708|pain|pain
329980|NCT01735708|depression|depression
329981|NCT01735708|HIV|hiv
329982|NCT01735708|adherence|adherence
329983|NCT01735695|Meconium|meconium
329984|NCT01735695|concentration|concentration
329985|NCT01735695|level|level
329986|NCT01735682|older adults|older adults
329987|NCT01735682|exercise|exercise
329988|NCT01735682|balance|balance
329989|NCT01735682|gait|gait
329990|NCT01735682|fall|fall
329991|NCT01735682|rehabilitation|rehabilitation
329992|NCT01735682|vibration|vibration
329993|NCT01735682|muscle|muscle
329994|NCT01735669|Remifentanil|remifentanil
329995|NCT01735669|Breech presentation|breech presentation
329996|NCT01735669|Nitrous oxide|nitrous oxide
329997|NCT01735669|Pregnancy complications|pregnancy complications
329998|NCT01735669|Caesarean section|caesarean section
329999|NCT01735669|Fetal version|fetal version
330000|NCT01735656|Coronary heart disease;|coronary heart disease;
330001|NCT01735656|Percutaneous coronary intervention;|percutaneous coronary intervention;
330002|NCT01735656|Bifurcation lesion;|bifurcation lesion;
330003|NCT01735656|Double kissing culotte technique;|double kissing culotte technique;
330004|NCT01735656|clinical trial|clinical trial
330005|NCT01735643|type 2 diabetes mellitus|type 2 diabetes mellitus
330006|NCT01735643|physical activity|physical activity
330007|NCT01735643|lifestyle change|lifestyle change
330008|NCT01735643|motivation|motivation
330009|NCT01735643|patient empowerment|patient empowerment
330010|NCT01735630|Agitation|agitation
330011|NCT01735630|Aggression|aggression
330012|NCT01735630|patients|patients
330013|NCT01735617|congenital adrenal hyperplasia|congenital adrenal hyperplasia
330014|NCT01735617|glucocorticoids|glucocorticoids
330015|NCT01735617|cortisol|cortisol
330016|NCT01735617|adrenal|adrenal
330017|NCT01735591|Liver cirrhosis|liver cirrhosis
330018|NCT01735591|Liver transplantation|liver transplantation
330019|NCT01735591|Probiotics|probiotics
330020|NCT01735591|Mortality|mortality
330021|NCT01735591|Liver function|liver function
330022|NCT01735591|Infections|infections
330023|NCT01735578|splanchnic oxygen saturations|splanchnic oxygen saturations
330024|NCT01735565|NET formation|net formation
330025|NCT01735565|neutraphil extracellular traps|neutraphil extracellular traps
330026|NCT01735565|post-engraftment immune system|post-engraftment immune system
330027|NCT01735552|gut reperfusion injury|gut reperfusion injury
330028|NCT01735552|blood transfusions|blood transfusions
330029|NCT01735552|premature infants|premature infants
330030|NCT01735552|anemia|anemia
330031|NCT01735552|regional oxygen saturations|regional oxygen saturations
330032|NCT01735552|necrotizing enterocolitis|necrotizing enterocolitis
330033|NCT01735552|mesenteric oxygenation|mesenteric oxygenation
330034|NCT01735539|old age|old age
330035|NCT01735539|sarcopenia|sarcopenia
330036|NCT01735539|essential amino acid|essential amino acid
330037|NCT01735539|arginine|arginine
330038|NCT01735539|contrast enhanced ultrasound|contrast enhanced ultrasound
330039|NCT01735539|muscle microcirculation|muscle microcirculation
330040|NCT01735539|muscle protein synthesis|muscle protein synthesis
330041|NCT01735526|Allogeneic and autologous|allogeneic and autologous
330042|NCT01735526|hematopoietic stem-cell transplantation|hematopoietic stem-cell transplantation
330043|NCT01735526|Lung diffusing capacity|lung diffusing capacity
330044|NCT01735526|for nitric oxide|for nitric oxide
330045|NCT01735526|carbon monoxide|carbon monoxide
330046|NCT01735526|Lung tissue density|lung tissue density
330047|NCT01735526|microvascular damage|microvascular damage
330048|NCT01735513|transaortic TAVI or TAVR|transaortic tavi or tavr
330049|NCT01735513|embolic protection device|embolic protection device
330050|NCT01735513|EmbolX|embolx
330051|NCT01735513|efficacy|efficacy
330052|NCT01735513|during transaortic TAVI|during transaortic tavi
330151|NCT01735032|multimodal imaging|multimodal imaging
330152|NCT01735032|SEEG|seeg
330053|NCT01735513|reduce the incidence of new foci of restricted diffusion on diffusion-weighted MRI|reduce the incidence of new foci of restricted diffusion on diffusion-weighted mri
330054|NCT01735500|Prei-procedural|prei-procedural
330055|NCT01735500|Elevation|elevation
330056|NCT01735500|cardia Troponin T|cardia troponin t
330057|NCT01735500|in stable|in stable
330058|NCT01735500|unknown|unknown
330059|NCT01735474|manual therapy|manual therapy
330060|NCT01735474|respiratory disease|respiratory disease
330061|NCT01735474|thoracic movement|thoracic movement
330062|NCT01735448|smoking cessation|smoking cessation
330063|NCT01735448|tobacco|tobacco
330064|NCT01735448|addiction|addiction
330065|NCT01735448|Aboriginal|aboriginal
330066|NCT01735448|youth|youth
330067|NCT01735448|Indigenous|indigenous
330068|NCT01735448|pharmacological|pharmacological
330069|NCT01735448|focus group|focus group
330070|NCT01735448|interview|interview
330071|NCT01735435|geriatric patients|geriatric patients
330072|NCT01735435|nutritional support|nutritional support
330073|NCT01735422|Infertility|infertility
330074|NCT01735422|Ovulation induction|ovulation induction
330075|NCT01735422|Recombinant human Luteinizing Hormone (r-hLH)|recombinant human luteinizing hormone (r-hlh)
330076|NCT01735422|Urinary human Chorionic Gonadotrophin (u-hCG)|urinary human chorionic gonadotrophin (u-hcg)
330077|NCT01735422|Recombinant human Follicle Stimulating Hormone (Gonal-f®)|recombinant human follicle stimulating hormone (gonal-f®)
330078|NCT01735409|Advanced Nasopharyngeal Carcinoma|advanced nasopharyngeal carcinoma
330079|NCT01735409|Abraxane|abraxane
330080|NCT01735409|Cisplatin|cisplatin
330081|NCT01735409|Dose|dose
330082|NCT01735396|African American men|african american men
330083|NCT01735396|metastatic prostate cancer|metastatic prostate cancer
330084|NCT01735396|castration resistant|castration resistant
330085|NCT01735357|Eicosapentaenoic acid|eicosapentaenoic acid
330086|NCT01735357|Docosahexaenoic acid|docosahexaenoic acid
330087|NCT01735357|Cardiovascular risk|cardiovascular risk
330088|NCT01735357|Platelet function|platelet function
330089|NCT01735357|Endothelial function|endothelial function
330090|NCT01735357|Vascular function|vascular function
330091|NCT01735357|young males|young males
330092|NCT01735331|Vascular endothelial growth factor, Recurrent Pregnancy Loss|vascular endothelial growth factor, recurrent pregnancy loss
330093|NCT01735305|Coronary Artery Disease|coronary artery disease
330094|NCT01735305|antiplatelet therapy|antiplatelet therapy
330095|NCT01735292|Ventilation, timer|ventilation, timer
330096|NCT01735279|tobacco dependence|tobacco dependence
330097|NCT01735279|tobacco treatment|tobacco treatment
330098|NCT01735279|omega 3 series|omega 3 series
330099|NCT01735279|polyunsaturated fatty acids|polyunsaturated fatty acids
330100|NCT01735266|Colonoscopy|colonoscopy
330101|NCT01735253|metabolic surgery|metabolic surgery
330102|NCT01735253|gastric bypass|gastric bypass
330103|NCT01735253|duodenojejunal bypass|duodenojejunal bypass
330104|NCT01735253|type 2 DM|type 2 dm
330105|NCT01735240|Phase I,|phase i,
330106|NCT01735240|healthy volunteers,|healthy volunteers,
330107|NCT01735240|fixed-sequence,|fixed-sequence,
330108|NCT01735240|open-label,|open-label,
330109|NCT01735240|ketoconazole,|ketoconazole,
330110|NCT01735240|combination,|combination,
330111|NCT01735240|safety|safety
330112|NCT01735227|pantoprazole|pantoprazole
330113|NCT01735227|omeprazole|omeprazole
330114|NCT01735227|anti - platelet effect|anti - platelet effect
330115|NCT01735188|Natural history study|natural history study
330116|NCT01735175|biosimilars|biosimilars
330117|NCT01735175|Pegfilgrastim,|pegfilgrastim,
330118|NCT01735175|G-CSF,|g-csf,
330119|NCT01735175|neutropenia,|neutropenia,
330120|NCT01735175|breast cancer,|breast cancer,
330121|NCT01735175|myelosuppressive chemotherapy,|myelosuppressive chemotherapy,
330122|NCT01735175|supportive care|supportive care
330123|NCT01735175|granulocyte-colony-stimulating factor|granulocyte-colony-stimulating factor
330124|NCT01735162|Renal angina|renal angina
330126|NCT01735162|Pediatric Intensive Care|pediatric intensive care
330127|NCT01735123|infant formula|infant formula
330128|NCT01735123|diet|diet
330129|NCT01735123|diabetes mellitus, type 1|diabetes mellitus, type 1
330130|NCT01735123|autoimmunity|autoimmunity
330131|NCT01735097|Arsenic|arsenic
330132|NCT01735097|Keratosis|keratosis
330133|NCT01735097|Nigella sativa|nigella sativa
330134|NCT01735097|Palm|palm
330135|NCT01735097|Vitamin E|vitamin e
330136|NCT01735084|randomized controlled trial|randomized controlled trial
330137|NCT01735084|pneumococcal conjugate vaccines|pneumococcal conjugate vaccines
330138|NCT01735084|booster dose|booster dose
330139|NCT01735084|immunogenicity|immunogenicity
330140|NCT01735084|nasopharyngeal carriage|nasopharyngeal carriage
330141|NCT01735084|Australian Indigenous|australian indigenous
330142|NCT01735084|pediatric|pediatric
330143|NCT01735071|ovarian cancer|ovarian cancer
330144|NCT01735071|bevacizumab|bevacizumab
330145|NCT01735071|trabectedin|trabectedin
330146|NCT01735071|carboplatin|carboplatin
330147|NCT01735071|randomized trial|randomized trial
330148|NCT01735071|phase II|phase ii
330149|NCT01735032|focal epilepsy|focal epilepsy
330150|NCT01735032|pre-surgical evaluation|pre-surgical evaluation
330554|NCT01732926|rituximab|rituximab
330153|NCT01735019|EC95, effective concentration in 95% of subjects|ec95, effective concentration in 95% of subjects
330154|NCT01735006|Human Papillomavirus 16|human papillomavirus 16
330155|NCT01735006|Human Papillomavirus 18|human papillomavirus 18
330156|NCT01735006|vaccine|vaccine
330157|NCT01735006|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
330158|NCT01735006|cervical Cancer|cervical cancer
330159|NCT01735006|Vaginal intraepithelial neoplasia|vaginal intraepithelial neoplasia
330160|NCT01735006|Vulvar intraepithelial neoplasia|vulvar intraepithelial neoplasia
330161|NCT01734980|Endobronchial Ultrasound|endobronchial ultrasound
330162|NCT01734980|transbronchial needle aspiration|transbronchial needle aspiration
330163|NCT01734967|confocal laser endomicroscopy|confocal laser endomicroscopy
330164|NCT01734967|Pancreatic Neoplasms|pancreatic neoplasms
330165|NCT01734967|CHRONIC PANCREATITIS|chronic pancreatitis
330166|NCT01734967|Endoscopic ultrasound|endoscopic ultrasound
330167|NCT01734954|Nerve block|nerve block
330168|NCT01734954|Sciatic nerve|sciatic nerve
330169|NCT01734954|Ultrasonography|ultrasonography
330170|NCT01734954|Orthopedics|orthopedics
330171|NCT01734954|Hallux Valgus|hallux valgus
330172|NCT01734954|Amputation|amputation
330173|NCT01734954|Arthrodesis|arthrodesis
330174|NCT01734954|Arthroscopy|arthroscopy
330175|NCT01734954|Fracture fixation|fracture fixation
330176|NCT01734954|Osteotomy|osteotomy
330177|NCT01734954|Tendon transfer|tendon transfer
330178|NCT01734954|Tenodesis|tenodesis
330179|NCT01734954|Tenotomy|tenotomy
330180|NCT01734954|Orthopedic procedure|orthopedic procedure
330181|NCT01734941|Autism|autism
330182|NCT01734941|Trichuris Suis Ova|trichuris suis ova
330183|NCT01734941|Behavior|behavior
330184|NCT01734941|Irritability|irritability
330185|NCT01734928|Multiple Myeloma|multiple myeloma
330186|NCT01734928|Pomalidomide|pomalidomide
330187|NCT01734915|Advanced|advanced
330188|NCT01734915|EGFR mutation|egfr mutation
330189|NCT01734889|nitisinone|nitisinone
330190|NCT01734889|Orfadin|orfadin
330191|NCT01734889|suspension|suspension
330192|NCT01734889|taste|taste
330193|NCT01734889|acceptability|acceptability
330194|NCT01734876|Parkinson´s disease|parkinson´s disease
330195|NCT01734876|Pain|pain
330196|NCT01734876|Sleep|sleep
330197|NCT01734876|HPA axis function|hpa axis function
330198|NCT01734876|Health Related Quality of Life|health related quality of life
330199|NCT01734850|HIV-1|hiv-1
330200|NCT01734837|Laparoscopic appendectomy|laparoscopic appendectomy
330201|NCT01734837|appendical stump closure|appendical stump closure
330202|NCT01734824|bone marrow edema, denosumab, PTH 1-84|bone marrow edema, denosumab, pth 1-84
330203|NCT01734811|Vaccine|vaccine
330204|NCT01734811|Bronchospasm|bronchospasm
330205|NCT01734798|locally advanced bladder cancer|locally advanced bladder cancer
330206|NCT01734798|Postoperative radiotherapy|postoperative radiotherapy
330207|NCT01734798|Adjuvant chemotherapy|adjuvant chemotherapy
330208|NCT01734798|Radical Cystectomy|radical cystectomy
330209|NCT01734759|medication palatability|medication palatability
330210|NCT01734759|medication taste|medication taste
330211|NCT01734746|ovarian cancer|ovarian cancer
330212|NCT01734746|sentinel node|sentinel node
330213|NCT01734733|Parkinson's Disease|parkinson's disease
330214|NCT01734733|Xenotransplantation|xenotransplantation
330215|NCT01734733|choroid plexus|choroid plexus
330216|NCT01734707|atherosclerosis|atherosclerosis
330217|NCT01734707|regression|regression
330218|NCT01734707|Allicor|allicor
330219|NCT01734707|garlic|garlic
330220|NCT01734707|intima-media thickness|intima-media thickness
330221|NCT01734642|Medication errors, patients hospitalized, ADRs, adverse events|medication errors, patients hospitalized, adrs, adverse events
330222|NCT01734629|Coronary Disease|coronary disease
330223|NCT01734629|COPD|copd
330224|NCT01734629|Spirometry|spirometry
330225|NCT01734629|Coronary tomography|coronary tomography
330226|NCT01734616|Microvascular|microvascular
330227|NCT01734616|Muscle|muscle
330228|NCT01734616|Nutrition|nutrition
330229|NCT01734616|Exercise|exercise
330230|NCT01734616|Ageing|ageing
330231|NCT01734603|Assessment|assessment
330232|NCT01734603|Rehabilitation|rehabilitation
330233|NCT01734603|Walking Constant Test|walking constant test
330234|NCT01734603|Walking Graded test|walking graded test
330235|NCT01734603|Six minute Walking test|six minute walking test
330236|NCT01734603|Walking Distance|walking distance
330237|NCT01734590|Flour,|flour,
330238|NCT01734590|carbohydrate,|carbohydrate,
330239|NCT01734590|digestibility|digestibility
330240|NCT01734590|subjects|subjects
330241|NCT01734577|Back pain|back pain
330242|NCT01734551|Prenatal opiate exposure|prenatal opiate exposure
330243|NCT01734551|neonatal withdrawal|neonatal withdrawal
330244|NCT01734551|Pharmacologic treatment|pharmacologic treatment
330245|NCT01734525|candidemia|candidemia
330246|NCT01734525|intensive care unit|intensive care unit
330247|NCT01734525|1,3 beta-D-glucan|1,3 beta-d-glucan
330248|NCT01734512|pediatric recurrent progressive low-grade gliomas|pediatric recurrent progressive low-grade gliomas
330249|NCT01734512|pediatric progressive low-grade gliomas|pediatric progressive low-grade gliomas
330250|NCT01734512|everolimus|everolimus
330943|NCT01731132|HRQoL|hrqol
330251|NCT01734512|mTOR inhibition|mtor inhibition
330252|NCT01734499|Breast cancer|breast cancer
330253|NCT01734499|Survivorship|survivorship
330254|NCT01734499|Coping|coping
330255|NCT01734499|Quality of Life|quality of life
330256|NCT01734473|COPD|copd
330257|NCT01734473|Protein synthesis|protein synthesis
330258|NCT01734473|Protein breakdown|protein breakdown
330259|NCT01734473|Muscle wasting|muscle wasting
330260|NCT01734473|Leucine|leucine
330261|NCT01734473|Hydrolyzed|hydrolyzed
330262|NCT01734473|Casein protein|casein protein
330263|NCT01734473|Carbohydrates|carbohydrates
330264|NCT01734460|pregnancy, snoring, fetal growth|pregnancy, snoring, fetal growth
330265|NCT01734434|Health care access, Pregnant women|health care access, pregnant women
330266|NCT01734421|Smoking cessation|smoking cessation
330267|NCT01734421|Primary health care|primary health care
330268|NCT01734421|Young people|young people
330269|NCT01734421|Cellular phone|cellular phone
330270|NCT01734408|immunogenicity|immunogenicity
330271|NCT01734408|safety|safety
330272|NCT01734408|inactivated EV71 vaccine|inactivated ev71 vaccine
330273|NCT01734395|Alzheimer's disease|alzheimer's disease
330274|NCT01734395|Caregiver's Burden in Alzheimer's disease|caregiver's burden in alzheimer's disease
330275|NCT01734395|Galantamine|galantamine
330276|NCT01734395|Razadyne|razadyne
330277|NCT01734395|Reminyl|reminyl
330278|NCT01734369|Dermatomyositis|dermatomyositis
330279|NCT01734369|Inclusion Body Myositis|inclusion body myositis
330280|NCT01734369|Myositis|myositis
330281|NCT01734369|Polymyositis|polymyositis
330282|NCT01734369|Military|military
330283|NCT01734356|iPS|ips
330284|NCT01734356|fibroblast|fibroblast
330285|NCT01734356|arrhythmias|arrhythmias
330286|NCT01734356|valvulopathies|valvulopathies
330287|NCT01734356|electrophysiology|electrophysiology
330288|NCT01734356|genetics|genetics
330289|NCT01734343|posterior capsule opacification|posterior capsule opacification
330290|NCT01734343|PCO|pco
330291|NCT01734343|after cataract|after cataract
330292|NCT01734343|intraocular lens|intraocular lens
330293|NCT01734330|behavior cognitive therapy|behavior cognitive therapy
330294|NCT01734330|Smokers|smokers
330295|NCT01734330|randomized clinical trial|randomized clinical trial
330296|NCT01734304|vaccination|vaccination
330297|NCT01734304|postremission therapy|postremission therapy
330298|NCT01734304|acute myeloid leukemia|acute myeloid leukemia
330299|NCT01734304|dendritic cells|dendritic cells
330300|NCT01734291|Family psychoeducation|family psychoeducation
330301|NCT01734291|Major depressive disorder|major depressive disorder
330302|NCT01734291|Family burden|family burden
330303|NCT01734174|transesophageal and transthoracic echocardiogram|transesophageal and transthoracic echocardiogram
330304|NCT01734174|thermodilution|thermodilution
330305|NCT01734174|left ventricular volume|left ventricular volume
330306|NCT01734174|ejection volume|ejection volume
330307|NCT01734161|cesarean section|cesarean section
330308|NCT01734161|nausea|nausea
330309|NCT01734161|vomiting|vomiting
330310|NCT01734161|dexamethasone|dexamethasone
330311|NCT01734161|postoperative nausea and vomiting|postoperative nausea and vomiting
330312|NCT01734161|antiemetics|antiemetics
330313|NCT01734148|pediatric|pediatric
330314|NCT01734148|sleep difficulties in children|sleep difficulties in children
330315|NCT01734148|Sleep Education|sleep education
330316|NCT01734135|B type natriuretic peptide|b type natriuretic peptide
330317|NCT01734135|heart failure|heart failure
330318|NCT01734135|cardiac imaging|cardiac imaging
330319|NCT01734135|quality of care|quality of care
330320|NCT01734122|Stereotactic Radiosurgery|stereotactic radiosurgery
330321|NCT01734122|Essential Tremor|essential tremor
330322|NCT01734122|Parkinsonian Tremor|parkinsonian tremor
330323|NCT01734122|Quality of Life|quality of life
330324|NCT01734122|Severity of Tremor|severity of tremor
330325|NCT01734109|Negative Pressure Wound Therapy|negative pressure wound therapy
330326|NCT01734109|Irrigation Therapy|irrigation therapy
330327|NCT01734109|Pressure Ulcers|pressure ulcers
330328|NCT01734109|Sacral Ulcers|sacral ulcers
330329|NCT01734096|hypertension|hypertension
330330|NCT01734096|obesity|obesity
330331|NCT01734096|white coat hypertension|white coat hypertension
330332|NCT01734096|resistant hypertension|resistant hypertension
330333|NCT01734083|rehabilitation|rehabilitation
330334|NCT01734083|exercise|exercise
330335|NCT01734083|fall|fall
330336|NCT01734083|muscle|muscle
330337|NCT01734083|vibration|vibration
330338|NCT01734083|mobility|mobility
330339|NCT01734083|cognition|cognition
330340|NCT01734070|anthocyanins|anthocyanins
330341|NCT01734070|catechins|catechins
330342|NCT01734070|chlorogenic acid|chlorogenic acid
330343|NCT01734070|flavanol glycosides|flavanol glycosides
330344|NCT01734057|Recombinant Human Thrombopoietin|recombinant human thrombopoietin
330345|NCT01734057|rhTPO|rhtpo
330346|NCT01734057|Rituximab|rituximab
330347|NCT01734057|Dexamethasone|dexamethasone
330348|NCT01734044|Recombinant Human Thrombopoietin|recombinant human thrombopoietin
330349|NCT01734044|rhTPO|rhtpo
330350|NCT01734044|Dexamethasone|dexamethasone
330351|NCT01733953|Cardiovascular Disease|cardiovascular disease
330944|NCT01731132|IUD|iud
330352|NCT01733953|Childhood ALL|childhood all
330353|NCT01733953|Childhood NHL|childhood nhl
330354|NCT01733927|HIV screening|hiv screening
330355|NCT01733927|Rapid test for HIV|rapid test for hiv
330356|NCT01733914|shoulder pain|shoulder pain
330357|NCT01733914|acupuncture|acupuncture
330358|NCT01733901|Coronary heart disease|coronary heart disease
330359|NCT01733901|PCI|pci
330360|NCT01733901|Renal sympathetic denervation|renal sympathetic denervation
330361|NCT01733901|Hypertension|hypertension
330362|NCT01733901|Diabetes|diabetes
330363|NCT01733888|caries|caries
330364|NCT01733888|caries infiltration|caries infiltration
330365|NCT01733888|fluorosis treatment|fluorosis treatment
330366|NCT01733875|Safety|safety
330367|NCT01733875|Pharmacokinetics|pharmacokinetics
330368|NCT01733875|Food effect|food effect
330369|NCT01733875|Healthy subjects|healthy subjects
330370|NCT01733862|Impact|impact
330371|NCT01733862|Vaccination|vaccination
330372|NCT01733862|Hospitalizations|hospitalizations
330373|NCT01733862|Rotavirus gastroenteritis|rotavirus gastroenteritis
330374|NCT01733862|Japan|japan
330375|NCT01733849|Bulgaria|bulgaria
330376|NCT01733849|Primary care settings|primary care settings
330377|NCT01733849|Children|children
330378|NCT01733849|Latvia|latvia
330379|NCT01733849|Acute gastroenteritis|acute gastroenteritis
330380|NCT01733810|Esophagitis|esophagitis
330381|NCT01733810|Reflux esophagitis|reflux esophagitis
330382|NCT01733810|Gastroesophageal reflux disease|gastroesophageal reflux disease
330383|NCT01733810|Acid|acid
330384|NCT01733810|Inflammation|inflammation
330385|NCT01733810|Esophagus|esophagus
330386|NCT01733810|Cytokines|cytokines
330387|NCT01733810|Esophageal squamous cell|esophageal squamous cell
330388|NCT01733810|Reflux|reflux
330389|NCT01733810|Squamous epithelium|squamous epithelium
330390|NCT01733797|Trismus|trismus
330391|NCT01733797|Therabite|therabite
330392|NCT01733797|Wooden spatula|wooden spatula
330393|NCT01733797|Head and Neck cancer|head and neck cancer
330394|NCT01733784|Sleep Apnea|sleep apnea
330395|NCT01733784|Pathophysiology|pathophysiology
330396|NCT01733771|complementary medicine|complementary medicine
330397|NCT01733771|hospitalized|hospitalized
330398|NCT01733758|albiglutide|albiglutide
330399|NCT01733758|Japanese|japanese
330400|NCT01733758|GSK716155|gsk716155
330401|NCT01733758|Type 2 diabetes mellitus|type 2 diabetes mellitus
330402|NCT01733758|glucagon-like peptide 1|glucagon-like peptide 1
330403|NCT01733745|dry eye|dry eye
330404|NCT01733745|lipid deficiency|lipid deficiency
330405|NCT01733745|meibomian gland|meibomian gland
330407|NCT01733732|Lipid deficiency|lipid deficiency
330408|NCT01733732|Inflammatory markers|inflammatory markers
330409|NCT01733706|No Nicotine Electronic Cigarette|no nicotine electronic cigarette
330410|NCT01733706|Antismoke intervention|antismoke intervention
330411|NCT01733693|Buprenorphine|buprenorphine
330412|NCT01733693|Methadone|methadone
330413|NCT01733693|Cognition|cognition
330414|NCT01733680|ADHD|adhd
330415|NCT01733680|executive function|executive function
330416|NCT01733680|emotional self-regulation|emotional self-regulation
330417|NCT01733667|synechia|synechia
330418|NCT01733667|Fess|fess
330419|NCT01733667|sinus surgery|sinus surgery
330420|NCT01733654|depression|depression
330421|NCT01733654|major depressive disorder|major depressive disorder
330422|NCT01733628|Hypertension|hypertension
330423|NCT01733628|Bevacizumab Response Predictors|bevacizumab response predictors
330424|NCT01733628|Metastatic Breast Cancer|metastatic breast cancer
330425|NCT01733628|Metastatic Colon Cancer|metastatic colon cancer
330426|NCT01733615|Mucopolysaccharidosis Type IVA|mucopolysaccharidosis type iva
330427|NCT01733615|Mucopolysaccharidosis Type IV|mucopolysaccharidosis type iv
330428|NCT01733615|MPS Type IVA|mps type iva
330429|NCT01733615|MPS Type IV|mps type iv
330430|NCT01733615|Morquio Syndrome|morquio syndrome
330431|NCT01733615|Morquio Syndrome Type A|morquio syndrome type a
330432|NCT01733615|Urine biomarkers|urine biomarkers
330433|NCT01733589|Recombinant human endostatin|recombinant human endostatin
330434|NCT01733589|Non-small-Cell Lung Cancer|non-small-cell lung cancer
330435|NCT01733589|chemoradiotherapy|chemoradiotherapy
330436|NCT01733563|sugar sweetened beverages|sugar sweetened beverages
330437|NCT01733563|fructose|fructose
330438|NCT01733563|lipogenesis|lipogenesis
330439|NCT01733563|beta-oxidation|beta-oxidation
330440|NCT01733550|Intraocular Pressure|intraocular pressure
330441|NCT01733550|Tonometry, Ocular|tonometry, ocular
330442|NCT01733550|iCare|icare
330443|NCT01733537|traffic accidents, motorcycle, injury, conspicuity|traffic accidents, motorcycle, injury, conspicuity
330444|NCT01733524|adolescence|adolescence
330445|NCT01733524|self care|self care
330446|NCT01733485|Asthma|asthma
330447|NCT01733485|Electrophilic Fatty Acids|electrophilic fatty acids
330448|NCT01733485|Inflammation|inflammation
330449|NCT01733472|anaesthetic techniques|anaesthetic techniques
330450|NCT01733472|subarachnoid|subarachnoid
330451|NCT01733472|analgesia|analgesia
330452|NCT01733459|PCOS, DLBS3233, metformin,oral anti-hyperglycemic agent|pcos, dlbs3233, metformin,oral anti-hyperglycemic agent
331446|NCT01728870|Pediatric|pediatric
330453|NCT01733446|High frequency jet ventilation|high frequency jet ventilation
330454|NCT01733407|inherited neuropathies|inherited neuropathies
330455|NCT01733394|Epilepsy|epilepsy
330456|NCT01733394|Generic|generic
330457|NCT01733381|Barefoot running, minimally shod running, non-invasive measures of autonomic nervous system (ANS) functioning and mood state.|barefoot running, minimally shod running, non-invasive measures of autonomic nervous system (ans) functioning and mood state.
330458|NCT01733368|CRT|crt
330459|NCT01733368|Optimization|optimization
330460|NCT01733368|Responders|responders
330461|NCT01733329|Buccal Misoprostol|buccal misoprostol
330462|NCT01733329|Uterine Atony|uterine atony
330463|NCT01733329|Postpartum Hemorrhage|postpartum hemorrhage
330464|NCT01733316|Nephropathic Cystinosis|nephropathic cystinosis
330465|NCT01733316|Cysteamine|cysteamine
330466|NCT01733316|Delayed-Release Cysteamine|delayed-release cysteamine
330467|NCT01733316|Orphan Disease|orphan disease
330468|NCT01733316|CTNS Protein, Human|ctns protein, human
330469|NCT01733290|Botulinum Toxin A (BoNT-A)|botulinum toxin a (bont-a)
330470|NCT01733290|Dysfunctional voiding|dysfunctional voiding
330471|NCT01733277|Neuropathic pain|neuropathic pain
330472|NCT01733277|Knee osteoarthritis|knee osteoarthritis
330473|NCT01733277|MRI|mri
330474|NCT01733238|PNT2258|pnt2258
330475|NCT01733238|Lymphoma|lymphoma
330476|NCT01733238|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
330477|NCT01733238|NHL|nhl
330478|NCT01733212|Nausea|nausea
330479|NCT01733212|Vomiting|vomiting
330480|NCT01733212|Cesaraen|cesaraen
330481|NCT01733212|Ginger|ginger
330482|NCT01733212|cesarean section|cesarean section
330483|NCT01733199|Parkinson's disease|parkinson's disease
330484|NCT01733199|Behavioural addictions|behavioural addictions
330485|NCT01733199|Pathological gambling|pathological gambling
330486|NCT01733199|Dopamine agonist|dopamine agonist
330487|NCT01733199|Dopamine dysregulation syndrome|dopamine dysregulation syndrome
330488|NCT01733199|Pharmacokinetic|pharmacokinetic
330489|NCT01733199|Pramipexole|pramipexole
330490|NCT01733186|human umbilical cord blood-derived mesenchymal stem cells|human umbilical cord blood-derived mesenchymal stem cells
330491|NCT01733186|MSC|msc
330492|NCT01733186|cartilage lesion|cartilage lesion
330493|NCT01733186|cartilage defect|cartilage defect
330494|NCT01733186|degenerative arthritis|degenerative arthritis
330495|NCT01733186|stem cell implantation|stem cell implantation
330496|NCT01733173|mass in posterior fossa|mass in posterior fossa
330497|NCT01733173|benign|benign
330498|NCT01733173|malignant|malignant
330499|NCT01733173|surgical resection|surgical resection
330500|NCT01733173|MRI|mri
330501|NCT01733173|fMRI|fmri
330502|NCT01733173|DTI|dti
330503|NCT01733173|12-121|12-121
330504|NCT01733160|Atrial Fibrillation|atrial fibrillation
330505|NCT01733160|Stroke|stroke
330506|NCT01733160|Anticoagulants|anticoagulants
330507|NCT01733147|Barrett's esophagus|barrett's esophagus
330508|NCT01733147|Obesity|obesity
330509|NCT01733147|Omega-3 fatty acid|omega-3 fatty acid
330510|NCT01733134|acute heart failure|acute heart failure
330511|NCT01733134|emergency department|emergency department
330512|NCT01733134|copeptin|copeptin
330513|NCT01733134|adh antagonists|adh antagonists
330514|NCT01733108|Healthy|healthy
330515|NCT01733108|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
330516|NCT01733108|Pharmacokinetics|pharmacokinetics
330517|NCT01733108|Pharmacodynamics|pharmacodynamics
330518|NCT01733108|Glyburide (MICRONASE)|glyburide (micronase)
330519|NCT01733056|Dermatology|dermatology
330520|NCT01733056|Influenza Vaccine|influenza vaccine
330521|NCT01733030|PTSD|ptsd
330522|NCT01733017|heart failure|heart failure
330523|NCT01733017|nutrition therapy|nutrition therapy
330524|NCT01733017|symptoms|symptoms
330525|NCT01733017|quality of life|quality of life
330526|NCT01733017|lycopene|lycopene
330527|NCT01733017|omega-3 fatty acids|omega-3 fatty acids
330528|NCT01733004|Cancer|cancer
330529|NCT01733004|Hepatocellular Carcinoma|hepatocellular carcinoma
330530|NCT01733004|Oncology|oncology
330532|NCT01733004|ErbB3|erbb3
330533|NCT01733004|IGF-1R|igf-1r
330534|NCT01733004|Everolimus|everolimus
330535|NCT01733004|Gemcitabine|gemcitabine
330536|NCT01733004|Abraxane|abraxane
330537|NCT01732991|Prostatic Hypertrophy, Benign|prostatic hypertrophy, benign
330538|NCT01732991|Greenlight laser|greenlight laser
330539|NCT01732991|Prostatic photovaporization|prostatic photovaporization
330540|NCT01732991|Prostatic MRI|prostatic mri
330541|NCT01732991|Prostatic contrast-enhanced ultrasound|prostatic contrast-enhanced ultrasound
330542|NCT01732991|Urinary irritative signs|urinary irritative signs
330543|NCT01732991|Postoperative necrotic area|postoperative necrotic area
330544|NCT01732978|Crying record|crying record
330545|NCT01732978|Newborn|newborn
330546|NCT01732965|Vitiligo|vitiligo
330547|NCT01732965|Phototherapy|phototherapy
330548|NCT01732965|Photochemotherapy|photochemotherapy
330549|NCT01732952|the prevalence,lipid abnormalities,CV risks|the prevalence,lipid abnormalities,cv risks
330550|NCT01732926|iNHL|inhl
330551|NCT01732926|indolent NHL|indolent nhl
330552|NCT01732926|follicular lymphoma|follicular lymphoma
330553|NCT01732926|CAL-101|cal-101
330555|NCT01732926|bendamustine|bendamustine
330556|NCT01732926|small lymphocytic lymphoma|small lymphocytic lymphoma
330557|NCT01732926|lymphoplasmacytoid lymphoma|lymphoplasmacytoid lymphoma
330558|NCT01732926|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
330559|NCT01732926|LPL|lpl
330560|NCT01732926|WM|wm
330561|NCT01732926|Marginal zone lymphoma|marginal zone lymphoma
330562|NCT01732926|MZL|mzl
330563|NCT01732926|SLL|sll
330564|NCT01732926|FL|fl
330565|NCT01732926|GS-1101|gs-1101
330566|NCT01732926|PI3K inhibitor|pi3k inhibitor
330567|NCT01732926|idelalisib|idelalisib
330568|NCT01732913|iNHL|inhl
330569|NCT01732913|indolent NHL|indolent nhl
330570|NCT01732913|follicular lymphoma|follicular lymphoma
330571|NCT01732913|CAL-101|cal-101
330572|NCT01732913|Rituximab|rituximab
330573|NCT01732913|Small lymphocytic lymphoma|small lymphocytic lymphoma
330574|NCT01732913|lymphoplasmacytoid lymphoma|lymphoplasmacytoid lymphoma
330575|NCT01732913|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
330576|NCT01732913|LPL|lpl
330577|NCT01732913|WM|wm
330578|NCT01732913|Marginal zone lymphoma|marginal zone lymphoma
330579|NCT01732913|MZL|mzl
330580|NCT01732913|SLL|sll
330581|NCT01732913|FL|fl
330582|NCT01732913|GS-1101|gs-1101
330583|NCT01732913|idelalisib|idelalisib
330584|NCT01732900|In vitro fertilization|in vitro fertilization
330585|NCT01732900|Assisted reproduction|assisted reproduction
330586|NCT01732900|pregnancy outcome|pregnancy outcome
330587|NCT01732900|cumulus cells|cumulus cells
330588|NCT01732887|cochlear implants|cochlear implants
330589|NCT01732887|speech comprehension|speech comprehension
330590|NCT01732887|cognitive training|cognitive training
330591|NCT01732887|cognitive fitness|cognitive fitness
330592|NCT01732887|intervention|intervention
330593|NCT01732887|memory|memory
330594|NCT01732887|attention|attention
330595|NCT01732887|rehabilitation|rehabilitation
330596|NCT01732874|DHA|dha
330597|NCT01732874|Preterm infant|preterm infant
330598|NCT01732874|Inflammation|inflammation
330599|NCT01732874|Growth|growth
330600|NCT01732874|Developement|developement
330601|NCT01732861|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
330602|NCT01732861|Small Lymphocytic Leukemia|small lymphocytic leukemia
330603|NCT01732848|Volunteers|volunteers
330604|NCT01732835|Aortic Insufficiency (AI) Aortic Regurgitation (AR)|aortic insufficiency (ai) aortic regurgitation (ar)
330605|NCT01732822|Peripheral artery disease Atherothrombotic events Atherosclerosis|peripheral artery disease atherothrombotic events atherosclerosis
330606|NCT01732809|wrinkles|wrinkles
330607|NCT01732809|botulinum toxin|botulinum toxin
330608|NCT01732783|Wild-type RAS|wild-type ras
330609|NCT01732783|Metastatic Colorectal Cancer|metastatic colorectal cancer
330610|NCT01732783|Vectibix|vectibix
330611|NCT01732744|biofilm, castor bean, sodium hypochlorite, alkaline peroxide|biofilm, castor bean, sodium hypochlorite, alkaline peroxide
330612|NCT01732731|Cerebral palsy|cerebral palsy
330613|NCT01732731|treadmill training|treadmill training
330614|NCT01732718|sickle cell disease|sickle cell disease
330615|NCT01732718|endothelial function|endothelial function
330616|NCT01732718|albuminuria|albuminuria
330617|NCT01732718|atorvastatin|atorvastatin
330618|NCT01732718|soluble fms-like tyrosine kinase-1|soluble fms-like tyrosine kinase-1
330619|NCT01732705|Type 2 diabetes|type 2 diabetes
330620|NCT01732705|Insulin sensitivity|insulin sensitivity
330621|NCT01732705|High intensity interval training|high intensity interval training
330622|NCT01732692|Bowel preparation, MOVIPREP®|bowel preparation, moviprep®
330623|NCT01732679|stroke, rehabilitation, multidisciplinary, description|stroke, rehabilitation, multidisciplinary, description
330624|NCT01732666|Opioid-induced hyperalgesia (OIH)|opioid-induced hyperalgesia (oih)
330625|NCT01732653|virtual reality,|virtual reality,
330626|NCT01732653|falls,|falls,
330627|NCT01732653|elderly,|elderly,
330628|NCT01732653|Parkinson's disease,|parkinson's disease,
330629|NCT01732653|MCI|mci
330630|NCT01732640|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
330631|NCT01732627|Meningitis|meningitis
330632|NCT01732627|Meningococcal Meningitis|meningococcal meningitis
330633|NCT01732627|Menactra®|menactra®
330634|NCT01732627|Menomune® A/C/Y/W-135|menomune® a/c/y/w-135
330635|NCT01732614|Diabetic Macular Edema|diabetic macular edema
330636|NCT01732614|DME|dme
330637|NCT01732614|Laser|laser
330638|NCT01732614|Topcon|topcon
330639|NCT01732614|EndPoint Management|endpoint management
330640|NCT01732601|Suicide Attempt|suicide attempt
330641|NCT01732601|Suicidal Ideation|suicidal ideation
330642|NCT01732601|NSSI|nssi
330643|NCT01732601|Substance Use|substance use
330644|NCT01732588|Bioavailability|bioavailability
330645|NCT01732575|everyday activities|everyday activities
330646|NCT01732575|rehabilitation|rehabilitation
330647|NCT01732575|mental illness|mental illness
330648|NCT01732575|occupational therapy|occupational therapy
330649|NCT01732562|Primary Total Knee Arthroplasty|primary total knee arthroplasty
330650|NCT01732562|Patient Expectations|patient expectations
330651|NCT01732562|Patient Satisfaction|patient satisfaction
330652|NCT01732562|Patient Education|patient education
330653|NCT01732562|e-Learning|e-learning
330654|NCT01732523|Carotid stenosis|carotid stenosis
330655|NCT01732523|Vasa Vasorum|vasa vasorum
330656|NCT01732523|Ultrasonography|ultrasonography
330657|NCT01732497|Underarm Hair|underarm hair
330658|NCT01732497|Underarm Hair Reduction|underarm hair reduction
330659|NCT01732497|Axillary Hair|axillary hair
330660|NCT01732497|Axillary Hair Reduction|axillary hair reduction
330661|NCT01732497|Underarm Odor|underarm odor
330662|NCT01732497|Axillary Odor|axillary odor
330663|NCT01732471|EMR 700733_510, Genetic disorder, Phenylketonuria, phenylalanine, Kuvan, sapropterin dihydrochloride|emr 700733_510, genetic disorder, phenylketonuria, phenylalanine, kuvan, sapropterin dihydrochloride
330664|NCT01732419|Rehabilitation, exercise therapy, coronary artery disease|rehabilitation, exercise therapy, coronary artery disease
330665|NCT01732393|Quercetin|quercetin
330666|NCT01732393|Chemotherapy|chemotherapy
330667|NCT01732393|Mucositis|mucositis
330668|NCT01732393|Hematologic Malignancies|hematologic malignancies
330669|NCT01732367|Tenofovir|tenofovir
330670|NCT01732367|Lamivudine|lamivudine
330671|NCT01732367|Adefovir|adefovir
330672|NCT01732367|Chronic Hepatitis B|chronic hepatitis b
330673|NCT01732354|Hepatitis B virus, Tenofovir|hepatitis b virus, tenofovir
330674|NCT01732341|STEMI|stemi
330675|NCT01732341|BMS|bms
330676|NCT01732341|Self-expanding stent|self-expanding stent
330677|NCT01732315|Adolescent vaccination|adolescent vaccination
330678|NCT01732315|Immunization rates|immunization rates
330679|NCT01732315|Barriers to vaccination|barriers to vaccination
330680|NCT01732315|Attitudes|attitudes
330681|NCT01732315|Intentions|intentions
330682|NCT01732302|Drug Utilization Review|drug utilization review
330683|NCT01732302|Aged|aged
330684|NCT01732302|Aged, 80 and over|aged, 80 and over
330685|NCT01732302|Primary Health Care|primary health care
330686|NCT01732289|Age-related hearing loss|age-related hearing loss
330687|NCT01732289|Gene|gene
330688|NCT01732289|Single nucleotide polymorphism|single nucleotide polymorphism
330689|NCT01732289|environmental factors|environmental factors
330690|NCT01732276|Triple-negative breast cancer|triple-negative breast cancer
330691|NCT01732276|Epidermal growth factor receptor|epidermal growth factor receptor
330692|NCT01732276|Gefitinib|gefitinib
330693|NCT01732250|Gram-Negative Bacterial Infections|gram-negative bacterial infections
330694|NCT01732250|Resistant Bacteria|resistant bacteria
330695|NCT01732250|Drug Resistance, Bacterial|drug resistance, bacterial
330696|NCT01732250|Colistin|colistin
330697|NCT01732237|Healthy|healthy
330698|NCT01732237|JNJ-42396302|jnj-42396302
330699|NCT01732237|JNJ-42692507|jnj-42692507
330700|NCT01732237|JNJ-53773187|jnj-53773187
330701|NCT01732237|Pharmacokinetics|pharmacokinetics
330702|NCT01732211|Phase 2|phase 2
330703|NCT01732211|Randomized|randomized
330704|NCT01732211|Double Blind|double blind
330705|NCT01732211|Placebo Controlled|placebo controlled
330706|NCT01732211|Parallel|parallel
330707|NCT01732211|20 Week Safety|20 week safety
330708|NCT01732211|Tolerability|tolerability
330709|NCT01732211|and Efficacy Study|and efficacy study
330710|NCT01732185|Congenital lung malformation|congenital lung malformation
330711|NCT01732185|Congenital Cystic Adenomatoid Malformation|congenital cystic adenomatoid malformation
330712|NCT01732185|Cystic lung disease|cystic lung disease
330713|NCT01732172|Urethritis|urethritis
330714|NCT01732172|Prevalence of a chronic inflammatory male genital tract|prevalence of a chronic inflammatory male genital tract
330715|NCT01732159|Ambulatory surgery|ambulatory surgery
330716|NCT01732159|Checklist|checklist
330717|NCT01732159|Cancellation|cancellation
330718|NCT01732146|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
330719|NCT01732146|Term neonate|term neonate
330720|NCT01732146|Neuroprotection|neuroprotection
330721|NCT01732146|erythropoietin|erythropoietin
330722|NCT01732133|Hypotension|hypotension
330723|NCT01732133|Cesarean delivery|cesarean delivery
330724|NCT01732120|off-clamp|off-clamp
330725|NCT01732120|partial nephrectomy|partial nephrectomy
330726|NCT01732120|renal cancer treatment|renal cancer treatment
330727|NCT01732120|renal ischemia|renal ischemia
330728|NCT01732107|Dovitinib|dovitinib
330729|NCT01732107|FGFR3 Mutations|fgfr3 mutations
330730|NCT01732107|BCG-Refractory Urothelial Carcinoma|bcg-refractory urothelial carcinoma
330731|NCT01732094|Poor ovarian response|poor ovarian response
330732|NCT01732094|Poor ovarian responders|poor ovarian responders
330733|NCT01732094|Bologna criteria for poor ovarian response|bologna criteria for poor ovarian response
330734|NCT01732081|Hepatitis B|hepatitis b
330735|NCT01732068|Poor ovarian response|poor ovarian response
330736|NCT01732068|Poor ovarian responders|poor ovarian responders
330737|NCT01732068|Bologna criteria for poor ovarian response|bologna criteria for poor ovarian response
330738|NCT01732055|Pregnancy|pregnancy
330739|NCT01732055|Antenatal|antenatal
330740|NCT01732055|Major Depressive Disorder|major depressive disorder
330741|NCT01732055|Psychotherapy|psychotherapy
330742|NCT01732055|Antidepressant Medication|antidepressant medication
330743|NCT01732055|Partners|partners
330744|NCT01732055|Spouses|spouses
330745|NCT01732055|Interpersonal Psychotherapy|interpersonal psychotherapy
330746|NCT01732042|retinal venous pressure|retinal venous pressure
330747|NCT01732029|pulse oximeter|pulse oximeter
330748|NCT01732029|oxygen saturation|oxygen saturation
330749|NCT01732029|heart rate|heart rate
330750|NCT01732029|calibration|calibration
330751|NCT01732029|accuracy|accuracy
330752|NCT01732016|pulse oximeter|pulse oximeter
330753|NCT01732016|oxygen saturation|oxygen saturation
330754|NCT01732016|heart rate|heart rate
330755|NCT01732016|calibration|calibration
330756|NCT01732016|accuracy|accuracy
330757|NCT01732003|Omega-3|omega-3
330758|NCT01732003|Skeletal Muscle|skeletal muscle
330759|NCT01732003|Eicosapentaenoic acid|eicosapentaenoic acid
330760|NCT01732003|Docosahexaenoic acid|docosahexaenoic acid
330761|NCT01732003|Exercise|exercise
330762|NCT01732003|Membrane Composition|membrane composition
330763|NCT01732003|Lipid Metabolism|lipid metabolism
330764|NCT01731990|Peripheral artery disease|peripheral artery disease
330765|NCT01731990|Intermittent claudication|intermittent claudication
330766|NCT01731990|magnetic resonance imaging|magnetic resonance imaging
330767|NCT01731977|Psychotherapy, Psychotic disorders, Caregiver|psychotherapy, psychotic disorders, caregiver
330768|NCT01731964|Macular Degeneration|macular degeneration
330769|NCT01731964|Visual Impairment|visual impairment
330770|NCT01731964|Implantable Telescope|implantable telescope
330771|NCT01731951|Myelofibrosis|myelofibrosis
330772|NCT01731951|Myelodysplastic Syndromes|myelodysplastic syndromes
330773|NCT01731951|Myeloproliferative Neoplasm|myeloproliferative neoplasm
330774|NCT01731951|Imetelstat|imetelstat
330775|NCT01731951|GRN163L|grn163l
330776|NCT01731938|Fibrin Sealant|fibrin sealant
330777|NCT01731938|Soft tissue open surgery|soft tissue open surgery
330778|NCT01731938|Oxidized cellulose pads|oxidized cellulose pads
330779|NCT01731925|midgut carcinoid tumors|midgut carcinoid tumors
330780|NCT01731925|progressive|progressive
330781|NCT01731925|advanced|advanced
330782|NCT01731925|metastatic|metastatic
330783|NCT01731899|major depression|major depression
330784|NCT01731899|fibromyalgia|fibromyalgia
330785|NCT01731899|agomelatine|agomelatine
330786|NCT01731899|Becks' Depression Inventory (BDI)|becks' depression inventory (bdi)
330787|NCT01731899|Pittsburgh's Sleep Quality Index (PSQI)|pittsburgh's sleep quality index (psqi)
330788|NCT01731886|Stem cell transplant|stem cell transplant
330789|NCT01731886|plasma cell myeloma|plasma cell myeloma
330790|NCT01731886|multiple myeloma|multiple myeloma
330791|NCT01731873|postoperative pain|postoperative pain
330792|NCT01731873|children|children
330793|NCT01731873|pharmacogenetic|pharmacogenetic
330794|NCT01731873|opioid adverse effects|opioid adverse effects
330795|NCT01731873|respiratory depression|respiratory depression
330796|NCT01731873|analgesia|analgesia
330797|NCT01731873|genetic polymorphisms|genetic polymorphisms
330798|NCT01731860|PET/CT|pet/ct
330799|NCT01731860|Philips|philips
330800|NCT01731847|dysphagia,endoscopy, electrical stimulation,stroke|dysphagia,endoscopy, electrical stimulation,stroke
330801|NCT01731834|Pain|pain
330802|NCT01731834|Stress|stress
330803|NCT01731834|Physiotherapy|physiotherapy
330804|NCT01731834|Children|children
330805|NCT01731821|Pancreaticoduodenectomy|pancreaticoduodenectomy
330806|NCT01731821|Pancreaticojejunostomy|pancreaticojejunostomy
330807|NCT01731808|Nursing counseling|nursing counseling
330808|NCT01731808|diabetic foot|diabetic foot
330809|NCT01731795|acute respiratory distress syndrome, mechanical ventilation|acute respiratory distress syndrome, mechanical ventilation
330810|NCT01731782|colorectal surgery|colorectal surgery
330811|NCT01731769|Seroma Formation|seroma formation
330812|NCT01731769|Axillary Lymph Node Dissection|axillary lymph node dissection
330813|NCT01731769|Breast cancer|breast cancer
330814|NCT01731769|Early Vacuum Assisted Closure|early vacuum assisted closure
330815|NCT01731756|Palm|palm
330816|NCT01731756|Arsenic|arsenic
330817|NCT01731756|Keratosis|keratosis
330818|NCT01731756|Salicylic acid|salicylic acid
330819|NCT01731756|Azadirachta indica|azadirachta indica
330820|NCT01731756|Neem|neem
330821|NCT01731730|Postsurgical pain|postsurgical pain
330822|NCT01731730|Total knee arthroplasty|total knee arthroplasty
330823|NCT01731730|Total knee replacement|total knee replacement
330824|NCT01731717|depression|depression
330825|NCT01731717|stepped care|stepped care
330826|NCT01731717|evidence-based medicine|evidence-based medicine
330827|NCT01731717|health services research|health services research
330828|NCT01731717|psychotherapy|psychotherapy
330829|NCT01731717|complex intervention|complex intervention
330830|NCT01731717|guideline|guideline
330831|NCT01731704|5 or more brain metastases|5 or more brain metastases
330832|NCT01731704|proven diagnosis of a non-hematopoietic malignancy|proven diagnosis of a non-hematopoietic malignancy
330833|NCT01731704|non-small cell lung cancer or germ cell malignancy|non-small cell lung cancer or germ cell malignancy
330834|NCT01731665|Crohn's disease|crohn's disease
330835|NCT01731665|ulcerative colitis|ulcerative colitis
330836|NCT01731665|epidemiology|epidemiology
330837|NCT01731665|Korea|korea
330838|NCT01731652|bladder cancer|bladder cancer
330839|NCT01731652|carcinoma in situ|carcinoma in situ
330840|NCT01731652|non muscle invasive bladder cancer|non muscle invasive bladder cancer
330841|NCT01731587|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
330842|NCT01731587|exploratory study|exploratory study
330843|NCT01731587|L-BLP25|l-blp25
330844|NCT01731561|Granulomatosis with Polyangiitis|granulomatosis with polyangiitis
330845|NCT01731561|Microscopic polyangiitis|microscopic polyangiitis
330846|NCT01731561|Renal limited forms|renal limited forms
330847|NCT01731561|ANCA-associated vasculitis|anca-associated vasculitis
330848|NCT01731561|Rituximab|rituximab
330849|NCT01731535|osteoporosis, low trauma fracture, non-union fracture, delayed healing fracture, bisphosphonate|osteoporosis, low trauma fracture, non-union fracture, delayed healing fracture, bisphosphonate
330850|NCT01731509|congenital diaphragmatic hernia|congenital diaphragmatic hernia
330851|NCT01731509|fetoscopy|fetoscopy
330852|NCT01731509|fetal endoscopic tracheal occlusion|fetal endoscopic tracheal occlusion
330853|NCT01731509|pulmonary hypoplasia|pulmonary hypoplasia
330854|NCT01731509|fetal surgery|fetal surgery
330855|NCT01731509|fetal lung|fetal lung
330856|NCT01731496|Human Papillomavirus|human papillomavirus
330857|NCT01731483|virulence factors|virulence factors
330858|NCT01731457|ischemia, reperfusion, kidney, transplantation|ischemia, reperfusion, kidney, transplantation
330859|NCT01731444|blood loss|blood loss
330860|NCT01731444|burn|burn
330861|NCT01731444|hemostasis|hemostasis
330862|NCT01731431|Gestational Diabetes,|gestational diabetes,
330863|NCT01731431|Insulin,|insulin,
330864|NCT01731431|Glyburide,|glyburide,
330865|NCT01731431|Glycemia|glycemia
330866|NCT01731418|Post Traumatic Stress Disorder|post traumatic stress disorder
330867|NCT01731418|Depression|depression
330868|NCT01731418|Intimate Partner violence|intimate partner violence
330869|NCT01731418|Narrative Exposure Therapy|narrative exposure therapy
330870|NCT01731405|Medication Guides|medication guides
330871|NCT01731405|FDA|fda
330872|NCT01731405|Prototype|prototype
330873|NCT01731405|Format|format
330874|NCT01731392|Diarrhea|diarrhea
330875|NCT01731392|Children|children
330876|NCT01731392|Lactobacilli|lactobacilli
330877|NCT01731379|spectroscopy|spectroscopy
330878|NCT01731379|nerve|nerve
330879|NCT01731379|muscle|muscle
330880|NCT01731379|fat|fat
330881|NCT01731353|invasive fungal infection|invasive fungal infection
330882|NCT01731353|Web-based registry|web-based registry
330883|NCT01731340|Calcium Supplements|calcium supplements
330884|NCT01731340|Dairy Foods|dairy foods
330885|NCT01731340|Cardiovascular Diseases|cardiovascular diseases
330886|NCT01731340|Osteoporosis|osteoporosis
330887|NCT01731340|Postmenopause|postmenopause
330888|NCT01731340|Vitamin D|vitamin d
330889|NCT01731340|Micronutrients|micronutrients
330890|NCT01731340|Primary Prevention|primary prevention
330891|NCT01731340|Bone Health|bone health
330892|NCT01731327|Phase 1|phase 1
330893|NCT01731327|relative bioavailability|relative bioavailability
330894|NCT01731327|modified release|modified release
330895|NCT01731327|tofacitinib|tofacitinib
330896|NCT01731327|CP-690|cp-690
330897|NCT01731327|550|550
330898|NCT01731327|pharmacokinetic|pharmacokinetic
330899|NCT01731301|Chronic hepatitis C|chronic hepatitis c
330900|NCT01731301|HCV|hcv
330901|NCT01731301|End stage renal disease|end stage renal disease
330902|NCT01731301|ESRD|esrd
330903|NCT01731301|Boceprevir|boceprevir
330904|NCT01731301|Ribavirin|ribavirin
330905|NCT01731301|Peg-interferon|peg-interferon
330906|NCT01731301|Triple therapy|triple therapy
330907|NCT01731288|pregnancy|pregnancy
330908|NCT01731288|childbirth|childbirth
330909|NCT01731288|pain|pain
330910|NCT01731288|vulvodynia|vulvodynia
330911|NCT01731288|provoked vestibulodynia|provoked vestibulodynia
330912|NCT01731275|Healthy volunteers|healthy volunteers
330913|NCT01731275|immunogenicity|immunogenicity
330914|NCT01731275|anti-E6011 antibody|anti-e6011 antibody
330915|NCT01731262|Arthritis, Rheumatoid|arthritis, rheumatoid
330916|NCT01731262|Sonic hedgehog protein, human|sonic hedgehog protein, human
330917|NCT01731262|Neovascularization, Pathologic|neovascularization, pathologic
330918|NCT01731262|Synovitis|synovitis
330919|NCT01731249|Sublingual immunotherapy|sublingual immunotherapy
330920|NCT01731249|Birch pollen extract solution|birch pollen extract solution
330921|NCT01731249|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
330922|NCT01731236|Carnitine metabolism|carnitine metabolism
330923|NCT01731236|gut flora|gut flora
330924|NCT01731223|Insomnia|insomnia
330925|NCT01731223|Primary health care|primary health care
330926|NCT01731197|obesity, isolated soy protein, satiety, food intake|obesity, isolated soy protein, satiety, food intake
330927|NCT01731184|acute traumatic pain, pre-hospital setting, Midazolam|acute traumatic pain, pre-hospital setting, midazolam
330928|NCT01731171|mania|mania
330929|NCT01731171|manic episode|manic episode
330930|NCT01731171|mixed episode|mixed episode
330931|NCT01731171|bipolar disorder|bipolar disorder
330932|NCT01731171|schizoaffective disorder|schizoaffective disorder
330933|NCT01731171|probiotics|probiotics
330934|NCT01731171|probiotic supplement|probiotic supplement
330935|NCT01731171|relapse prevention|relapse prevention
330936|NCT01731171|new mood episode|new mood episode
330937|NCT01731171|re-hospitalization|re-hospitalization
330938|NCT01731145|Tremor|tremor
330939|NCT01731145|SNUMAP|snumap
330940|NCT01731145|accelerometry|accelerometry
330941|NCT01731145|gyroscope|gyroscope
330942|NCT01731145|clinical rating scale|clinical rating scale
330945|NCT01731132|Contraception|contraception
330946|NCT01731132|SEC-QoL|sec-qol
330947|NCT01731119|Latuda,lurasidone,antipsychotics,autism, mood, psychosis|latuda,lurasidone,antipsychotics,autism, mood, psychosis
330948|NCT01731093|aged|aged
330949|NCT01731093|health|health
330950|NCT01731093|brain|brain
330951|NCT01731054|lupus nephritis|lupus nephritis
330952|NCT01731054|normal healthy volunteer|normal healthy volunteer
330953|NCT01731054|MRI|mri
330954|NCT01731041|coronary disease, platelet function, platelet inhibitors|coronary disease, platelet function, platelet inhibitors
330955|NCT01731002|Glaucoma|glaucoma
330956|NCT01730989|menopause|menopause
330957|NCT01730989|Kupperman|kupperman
330958|NCT01730989|hot flushes|hot flushes
330959|NCT01730989|isoflavones|isoflavones
330960|NCT01730989|magnolia|magnolia
330961|NCT01730989|chaste tree|chaste tree
330962|NCT01730976|asthma, elderly, vitamin D|asthma, elderly, vitamin d
330963|NCT01730924|Atrial fibrillation|atrial fibrillation
330964|NCT01730924|Contact force|contact force
330965|NCT01730924|Ablation|ablation
330966|NCT01730911|Bleeding|bleeding
330967|NCT01730911|Cramping|cramping
330968|NCT01730911|Pregnancy with intrauterine device in place|pregnancy with intrauterine device in place
330969|NCT01730911|Intrauterine device expulsion|intrauterine device expulsion
330970|NCT01730911|Intrauterine device removal|intrauterine device removal
330971|NCT01730859|Balance exercise|balance exercise
330972|NCT01730859|Ankle|ankle
330973|NCT01730859|Postural stability|postural stability
330974|NCT01730859|Taping|taping
330975|NCT01730859|Biodex|biodex
330976|NCT01730846|smoking lapse behavior|smoking lapse behavior
330977|NCT01730846|smoking cessation|smoking cessation
330978|NCT01730846|doxazosin|doxazosin
330979|NCT01730846|medication effect on smoking lapse behavior|medication effect on smoking lapse behavior
330980|NCT01730846|medication effect on smoking cessation|medication effect on smoking cessation
330981|NCT01730846|stress|stress
330982|NCT01730807|Atrial Flutter|atrial flutter
330983|NCT01730807|Ablation|ablation
330984|NCT01730807|Type I Atrial Flutter|type i atrial flutter
330985|NCT01730807|Atrial Arrhythmia|atrial arrhythmia
330986|NCT01730794|Acute Respiratory Failure|acute respiratory failure
330987|NCT01730794|Mechanical Ventilation|mechanical ventilation
330988|NCT01730794|NAVA|nava
330989|NCT01730794|Lung protective ventilation|lung protective ventilation
330990|NCT01730794|invasive ventilation|invasive ventilation
330991|NCT01730794|noninvasive ventilation|noninvasive ventilation
330992|NCT01730781|Cannabis dependence|cannabis dependence
330993|NCT01730781|Brain Imaging|brain imaging
330994|NCT01730781|Schizophrenia|schizophrenia
330995|NCT01730768|schizophrenia, chronic stable schizophrenia, cognition, memory, visual learning, CogState|schizophrenia, chronic stable schizophrenia, cognition, memory, visual learning, cogstate
330996|NCT01730755|Polycythemia|polycythemia
330997|NCT01730716|Human spinal cord derived neural stem cell transplantation|human spinal cord derived neural stem cell transplantation
330998|NCT01730716|ALS|als
330999|NCT01730703|walking|walking
331000|NCT01730703|incentives|incentives
331001|NCT01730703|elderly|elderly
331002|NCT01730690|Bacterial meningitis in adults|bacterial meningitis in adults
331003|NCT01730690|determinants of in-hospital mortality|determinants of in-hospital mortality
331004|NCT01730677|Lapatinib|lapatinib
331005|NCT01730677|Vinorelbine|vinorelbine
331006|NCT01730664|ertapenem|ertapenem
331007|NCT01730664|tuberculosis|tuberculosis
331008|NCT01730664|pharmacokinetics|pharmacokinetics
331009|NCT01730651|cervical cancer with metastatic lymphadenopathies|cervical cancer with metastatic lymphadenopathies
331010|NCT01730638|thyroid,|thyroid,
331011|NCT01730638|endocrine tumour|endocrine tumour
331012|NCT01730638|Nuclear medicine,|nuclear medicine,
331013|NCT01730638|molecular imaging|molecular imaging
331014|NCT01730638|ImmunoTEP|immunotep
331015|NCT01730625|Attention bias modification treatment (ABMT)|attention bias modification treatment (abmt)
331016|NCT01730625|Attention biases|attention biases
331017|NCT01730625|Anxious children|anxious children
331018|NCT01730625|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
331019|NCT01730612|ImmunoTEP|immunotep
331020|NCT01730612|HER2 negative|her2 negative
331021|NCT01730612|Breast Cancer|breast cancer
331022|NCT01730586|Colorectal Cancer|colorectal cancer
331023|NCT01730586|Cancer of Gastrointestinal Tract|cancer of gastrointestinal tract
331024|NCT01730586|CIMP-high Colorectal Adenocarcinoma|cimp-high colorectal adenocarcinoma
331025|NCT01730586|Small Bowel Adenocarcinomas|small bowel adenocarcinomas
331026|NCT01730586|Colorectal|colorectal
331027|NCT01730586|Small bowel cancer|small bowel cancer
331028|NCT01730586|Abraxane|abraxane
331029|NCT01730586|Nab-Paclitaxel|nab-paclitaxel
331030|NCT01730586|Paclitaxel (Protein-Bound)|paclitaxel (protein-bound)
331031|NCT01730586|ABI-007|abi-007
331032|NCT01730573|interscalene|interscalene
331033|NCT01730573|suprascapular|suprascapular
331034|NCT01730573|axillary|axillary
331035|NCT01730547|Mesenchymal stem cells|mesenchymal stem cells
331036|NCT01730547|Multiple Sclerosis|multiple sclerosis
331037|NCT01730547|Autoimmune diseases|autoimmune diseases
331038|NCT01730534|Phase IIIb|phase iiib
331039|NCT01730534|T2DM|t2dm
331040|NCT01730534|cardiovascular events|cardiovascular events
331041|NCT01730495|Chronic fatigue syndrome|chronic fatigue syndrome
331042|NCT01730495|CFS|cfs
331043|NCT01730495|Myalgic Encephalomyelitis (ME)|myalgic encephalomyelitis (me)
331044|NCT01730495|CFS/ME|cfs/me
331045|NCT01730495|Tumor necrosis factor-alpha|tumor necrosis factor-alpha
331046|NCT01730495|TNF-alpha|tnf-alpha
331047|NCT01730495|Etanercept|etanercept
331048|NCT01730482|excretion|excretion
331049|NCT01730482|healthy volunteer|healthy volunteer
331050|NCT01730482|migalastat hydrochloride|migalastat hydrochloride
331051|NCT01730482|AT1001|at1001
331052|NCT01730482|pharmacokinetics|pharmacokinetics
331053|NCT01730482|Fabry disease|fabry disease
331054|NCT01730469|Pharmacokinetics|pharmacokinetics
331055|NCT01730469|GR181413|gr181413
331056|NCT01730469|Safety|safety
331057|NCT01730469|AT1001|at1001
331058|NCT01730469|Migalastat hydrochloride|migalastat hydrochloride
331059|NCT01730443|traumatic brain injury|traumatic brain injury
331060|NCT01730430|non-AD dementias|non-ad dementias
331061|NCT01730430|healthy elderly controls|healthy elderly controls
331062|NCT01730417|Phase 1|phase 1
331063|NCT01730417|no carrier added metaiodobenzylguanidine|no carrier added metaiodobenzylguanidine
331064|NCT01730417|radiation dosimetry|radiation dosimetry
331065|NCT01730378|Influenza vaccine|influenza vaccine
331066|NCT01730365|spectroscopy|spectroscopy
331067|NCT01730365|tumour|tumour
331068|NCT01730365|biopsy|biopsy
331069|NCT01730365|malignancy|malignancy
331070|NCT01730352|immune thrombocytopenic purpura|immune thrombocytopenic purpura
331071|NCT01730352|chronic immune thrombocytopenic purpura|chronic immune thrombocytopenic purpura
331072|NCT01730352|secondary immune thrombocytopenic purpura|secondary immune thrombocytopenic purpura
331073|NCT01730352|Helicobacter pylori infection|helicobacter pylori infection
331074|NCT01730352|Helicobacter pylori gastritis|helicobacter pylori gastritis
331075|NCT01730352|children|children
331076|NCT01730352|adolescents|adolescents
331077|NCT01730339|Skin scarring|skin scarring
331078|NCT01730339|cicatrix|cicatrix
331079|NCT01730339|breast scar|breast scar
331080|NCT01730339|hypertrophic scar|hypertrophic scar
331081|NCT01730326|Headache|headache
331082|NCT01730326|paracetamol|paracetamol
331083|NCT01730326|dexketoprofen|dexketoprofen
331084|NCT01730326|emergency department|emergency department
331085|NCT01730313|Nodding syndrome|nodding syndrome
331086|NCT01730287|Stepwise Excavation|stepwise excavation
331087|NCT01730287|Pulpal vitality|pulpal vitality
331088|NCT01730287|Deep caries lesions|deep caries lesions
331089|NCT01730287|Clinical symptoms|clinical symptoms
331090|NCT01730287|Radiographic evaluation|radiographic evaluation
331091|NCT01730261|Traumatic Brain Injury|traumatic brain injury
331092|NCT01730261|TBI|tbi
331093|NCT01730261|Executive Dysfunction|executive dysfunction
331094|NCT01730261|Emotional Regulation|emotional regulation
331095|NCT01730261|Problem Solving|problem solving
331096|NCT01730261|Self-regulation|self-regulation
331097|NCT01730261|Cognitive Rehabilitation|cognitive rehabilitation
331098|NCT01730261|Metacognitive Strategies|metacognitive strategies
331099|NCT01730261|Cognitive-behavioral therapy|cognitive-behavioral therapy
331100|NCT01730261|Online Therapy|online therapy
331101|NCT01730261|Group therapy|group therapy
331102|NCT01730261|Group videoconference|group videoconference
331103|NCT01730261|Telehealth|telehealth
331104|NCT01730261|Telerehabilitation|telerehabilitation
331105|NCT01730248|Myelofibrosis,|myelofibrosis,
331106|NCT01730248|PMF,|pmf,
331107|NCT01730248|PPV-MF,|ppv-mf,
331108|NCT01730248|PET-MF,|pet-mf,
331109|NCT01730248|Primary Myelofibrosis,|primary myelofibrosis,
331110|NCT01730248|Post-polycythemia vera myelofibrosis,|post-polycythemia vera myelofibrosis,
331111|NCT01730248|Post-essential thrombocythemia myelofibrosis|post-essential thrombocythemia myelofibrosis
331112|NCT01730222|pancreatic adenocarcinoma|pancreatic adenocarcinoma
331113|NCT01730222|stage III disease|stage iii disease
331114|NCT01730222|stage IV disease|stage iv disease
331115|NCT01730222|chemotherapy|chemotherapy
331116|NCT01730209|Tuberous Sclerosis Complex|tuberous sclerosis complex
331117|NCT01730209|TSC|tsc
331118|NCT01730209|Autism|autism
331119|NCT01730209|Learning problems|learning problems
331120|NCT01730209|Everolimus|everolimus
331121|NCT01730209|RAD001|rad001
331122|NCT01730209|Treatment|treatment
331123|NCT01730209|Cognition|cognition
331124|NCT01730209|Intellectual disability|intellectual disability
331125|NCT01730170|Epilepsy|epilepsy
331126|NCT01730170|Pregnancy|pregnancy
331127|NCT01730144|Nasal Spray Vaccine|nasal spray vaccine
331128|NCT01730144|Nasal Cells|nasal cells
331129|NCT01730131|Immune Reconstitution Syndrome|immune reconstitution syndrome
331130|NCT01730131|Human Immunodeficiency Virus|human immunodeficiency virus
331131|NCT01730131|Multiple Sclerosis|multiple sclerosis
331132|NCT01730118|Metastatic Solid Tumors|metastatic solid tumors
331133|NCT01730118|Human Epidermal Growth Factor Receptor 2 Expression (HER2/neu)|human epidermal growth factor receptor 2 expression (her2/neu)
331134|NCT01730118|Trastuzumab Exposure|trastuzumab exposure
331135|NCT01730118|Dendritic Cell Vaccine|dendritic cell vaccine
331136|NCT01730118|Breast Cancer|breast cancer
331137|NCT01730105|Adaptive Thermogenesis|adaptive thermogenesis
331138|NCT01730105|Adipose Tissue|adipose tissue
331139|NCT01730105|Body Composition|body composition
331140|NCT01730105|Body Weight Regulation|body weight regulation
331141|NCT01730105|Brown Adipose Tissue|brown adipose tissue
331142|NCT01730092|Vascular Inflammation|vascular inflammation
331143|NCT01730092|Microarray|microarray
331144|NCT01730092|Right Ventricular Function|right ventricular function
331145|NCT01730092|Endothelial Dysfunction|endothelial dysfunction
331146|NCT01730092|Magnetic Resonance Imaging|magnetic resonance imaging
331147|NCT01730079|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
331148|NCT01730079|Autism|autism
331149|NCT01730079|Near Infrared Spectroscopy|near infrared spectroscopy
331150|NCT01730079|Brain Activity|brain activity
331151|NCT01730066|Probiotics|probiotics
331152|NCT01730066|Pathogenic enteric bacteria|pathogenic enteric bacteria
331153|NCT01730066|Oropharyngeal flora|oropharyngeal flora
331154|NCT01730066|CRP|crp
331155|NCT01730066|WBC|wbc
331156|NCT01729949|Nutrition|nutrition
331157|NCT01729949|Polyphenols|polyphenols
331158|NCT01729949|Berries|berries
331159|NCT01729949|Overweight|overweight
331160|NCT01729949|Lipid Panels|lipid panels
331161|NCT01729936|Sitting time|sitting time
331162|NCT01729936|Overweight|overweight
331163|NCT01729936|Obese|obese
331164|NCT01729936|Primary Health Care|primary health care
331165|NCT01729910|overweight|overweight
331166|NCT01729910|obesity|obesity
331167|NCT01729910|rural|rural
331168|NCT01729910|primary care|primary care
331169|NCT01729897|gastroscopy|gastroscopy
331170|NCT01729897|sedation|sedation
331171|NCT01729897|etomidate|etomidate
331172|NCT01729871|Atrial Fibrillation|atrial fibrillation
331173|NCT01729871|Irregular heart beat|irregular heart beat
331174|NCT01729871|Catheter Ablation|catheter ablation
331175|NCT01729871|Rivaroxaban|rivaroxaban
331176|NCT01729793|TNFalpha|tnfalpha
331177|NCT01729793|IL6|il6
331178|NCT01729793|postprandial|postprandial
331179|NCT01729793|digestive|digestive
331180|NCT01729793|inflammation|inflammation
331181|NCT01729793|IL1beta|il1beta
331182|NCT01729793|CRP|crp
331183|NCT01729793|CBC|cbc
331184|NCT01729793|ESR|esr
331185|NCT01729780|EEG-NF|eeg-nf
331186|NCT01729780|Neurofeedback|neurofeedback
331187|NCT01729780|Prevention|prevention
331188|NCT01729780|ACS|acs
331189|NCT01729741|Drain or no drain|drain or no drain
331190|NCT01729741|Thyroid surgery|thyroid surgery
331191|NCT01729741|Randomized Trial|randomized trial
331192|NCT01729728|Tonsillectomy|tonsillectomy
331193|NCT01729728|Dental surgery|dental surgery
331194|NCT01729728|Ear surgery|ear surgery
331195|NCT01729728|Nose surgery|nose surgery
331196|NCT01729728|Throat surgery|throat surgery
331197|NCT01729715|Pediatric|pediatric
331198|NCT01729715|Insomnia|insomnia
331199|NCT01729702|1- Hypertrophic cardiomyopathy|1- hypertrophic cardiomyopathy
331200|NCT01729702|2- BNP|2- bnp
331201|NCT01729702|3- NT-proBNP|3- nt-probnp
331202|NCT01729702|4- Neurohormons|4- neurohormons
331203|NCT01729663|melanoma|melanoma
331204|NCT01729663|irradiated-allogeneic cells|irradiated-allogeneic cells
331205|NCT01729663|therapeutic vaccine|therapeutic vaccine
331206|NCT01729663|Interferon alpha 2-b|interferon alpha 2-b
331207|NCT01729650|Psychotic Disorders,|psychotic disorders,
331208|NCT01729650|Heart Diseases|heart diseases
331209|NCT01729637|Lung Transplantation|lung transplantation
331210|NCT01729637|Respiratory Mechanics|respiratory mechanics
331211|NCT01729637|Isolated lung perfusion|isolated lung perfusion
331212|NCT01729637|Ex-vivo lung perfusion|ex-vivo lung perfusion
331213|NCT01729637|Lung mechanics|lung mechanics
331214|NCT01729624|Wegener Granulomatosis|wegener granulomatosis
331215|NCT01729624|Microscopic Polyangiitis|microscopic polyangiitis
331216|NCT01729624|Churg-Strauss Syndrome|churg-strauss syndrome
331217|NCT01729624|Antibodies, Antineutrophil Cytoplasmic|antibodies, antineutrophil cytoplasmic
331218|NCT01729611|Scleroderma|scleroderma
331219|NCT01729611|Cirrhosis|cirrhosis
331220|NCT01729598|cognitively normal elderly population|cognitively normal elderly population
331221|NCT01729598|safety and tolerability|safety and tolerability
331222|NCT01729585|cystic fibrosis|cystic fibrosis
331223|NCT01729585|quality of life|quality of life
331224|NCT01729572|schizophrenia|schizophrenia
331225|NCT01729572|Schizoaffective Disorder|schizoaffective disorder
331226|NCT01729572|disease management|disease management
331227|NCT01729572|treatment|treatment
331228|NCT01729572|rehabilitation|rehabilitation
331229|NCT01729572|pharmacotherapy|pharmacotherapy
331230|NCT01729559|venous thromboembolic disease|venous thromboembolic disease
331231|NCT01729559|deep vein thrombosis|deep vein thrombosis
331232|NCT01729559|pulmonary embolism|pulmonary embolism
331233|NCT01729559|trauma|trauma
331234|NCT01729559|antithrombotic prophylaxis|antithrombotic prophylaxis
331235|NCT01729546|SMBG (self-monitoring of blood glucose)|smbg (self-monitoring of blood glucose)
331236|NCT01729546|POCT|poct
331237|NCT01729546|System Accuracy|system accuracy
331238|NCT01729533|ICSI|icsi
331239|NCT01729533|IMSI|imsi
331240|NCT01729533|Pregnancy|pregnancy
331241|NCT01729533|Sperm morphology|sperm morphology
331242|NCT01729533|Unexplained infertility|unexplained infertility
331243|NCT01729520|Total knee arthroplasty|total knee arthroplasty
331244|NCT01729520|Total knee replacement|total knee replacement
331245|NCT01729520|Strength training|strength training
331246|NCT01729520|Resistance training|resistance training
331247|NCT01729520|Physical therapy modalities|physical therapy modalities
331248|NCT01729520|Fatigue|fatigue
331249|NCT01729507|Smoking cessation|smoking cessation
331250|NCT01729507|Add on and smoking cessation|add on and smoking cessation
331251|NCT01729507|Therapy for tobacco dependence|therapy for tobacco dependence
331252|NCT01729507|Transcranial direct current stimulation|transcranial direct current stimulation
331253|NCT01729494|belatacept|belatacept
331254|NCT01729494|rabbit antithymocyte globulin|rabbit antithymocyte globulin
331255|NCT01729494|alemtuzumab|alemtuzumab
331256|NCT01729494|corticosteroid withdrawal|corticosteroid withdrawal
331257|NCT01729468|Low Dose Acetylsalicylic Acid|low dose acetylsalicylic acid
331258|NCT01729468|Prevention|prevention
331259|NCT01729468|Pre-eclampsia|pre-eclampsia
331260|NCT01729468|Intra-uterine Growth Restriction|intra-uterine growth restriction
331261|NCT01729468|Primiparous Women|primiparous women
331262|NCT01729468|Bilateral Uterine Artery Notches|bilateral uterine artery notches
331263|NCT01729468|First Quarter|first quarter
331264|NCT01729455|Belimumab|belimumab
331265|NCT01729455|Connective Tissue Diseases|connective tissue diseases
331266|NCT01729455|Lupus|lupus
331267|NCT01729455|Additional relevant MeSH terms:|additional relevant mesh terms:
331268|NCT01729455|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
331269|NCT01729455|Autoimmune Diseases|autoimmune diseases
331270|NCT01729455|SLE|sle
331271|NCT01729455|Systemic Lupus Erythematosus|systemic lupus erythematosus
331272|NCT01729455|Autoimmune Disease|autoimmune disease
331273|NCT01729455|Antibodies|antibodies
331274|NCT01729455|Immune System Diseases|immune system diseases
331275|NCT01729429|Papillomavirus Vaccines|papillomavirus vaccines
331276|NCT01729429|Intervention Studies|intervention studies
331277|NCT01729429|Health Services Research|health services research
331278|NCT01729429|Cancer of Cervix|cancer of cervix
331279|NCT01729416|colon|colon
331280|NCT01729416|cancer|cancer
331281|NCT01729416|screening|screening
331282|NCT01729416|water exchange|water exchange
331283|NCT01729416|air|air
331284|NCT01729416|method|method
331285|NCT01729416|polyp|polyp
331286|NCT01729416|adenoma|adenoma
331287|NCT01729416|detection|detection
331288|NCT01729416|rate|rate
331289|NCT01729416|sedation|sedation
331290|NCT01729416|time|time
331291|NCT01729416|procedure|procedure
331292|NCT01729390|Feeding behavior|feeding behavior
331293|NCT01729364|elective CABG|elective cabg
331294|NCT01729364|renal impairment|renal impairment
331295|NCT01729364|GFR|gfr
331296|NCT01729364|renal blood flow|renal blood flow
331297|NCT01729364|colloid|colloid
331298|NCT01729364|crystalloid|crystalloid
331299|NCT01729364|thermodilution technique|thermodilution technique
331300|NCT01729364|oxygen supply demand|oxygen supply demand
331301|NCT01729351|Primary Care|primary care
331302|NCT01729351|Particle size|particle size
331303|NCT01729351|beclomethasone dipropionate|beclomethasone dipropionate
331304|NCT01729351|Asthma Management|asthma management
331305|NCT01729351|Maintenance Therapy|maintenance therapy
331306|NCT01729351|Metered-Dose Inhaler|metered-dose inhaler
331307|NCT01729351|Smoking|smoking
331308|NCT01729325|Post-traumatic Stress disorder (PTSD)|post-traumatic stress disorder (ptsd)
331309|NCT01729325|Aggressive Behavior|aggressive behavior
331310|NCT01729325|Appetitive Aggression|appetitive aggression
331311|NCT01729325|Resilience|resilience
331312|NCT01729325|Preventive Narrative Exposure Therapy|preventive narrative exposure therapy
331313|NCT01729299|ghrelin|ghrelin
331314|NCT01729299|glucose control|glucose control
331315|NCT01729299|GLP-1|glp-1
331316|NCT01729299|Exendin (9-39)|exendin (9-39)
331317|NCT01729299|insulin|insulin
331318|NCT01729260|Glioblastoma|glioblastoma
331319|NCT01729260|mebendazole|mebendazole
331320|NCT01729260|temozolomide|temozolomide
331321|NCT01729247|Asthma|asthma
331322|NCT01729234|age related Endothelial Dysfunction|age related endothelial dysfunction
331323|NCT01729221|Hepatocellular carcinoma|hepatocellular carcinoma
331324|NCT01729221|Hepatitis C virus|hepatitis c virus
331325|NCT01729208|myopia progression|myopia progression
331326|NCT01729208|myopia control|myopia control
331327|NCT01729195|bioabsorbable implant|bioabsorbable implant
331328|NCT01729195|bone screw|bone screw
331329|NCT01729195|local antibiotic prophylaxis|local antibiotic prophylaxis
331330|NCT01729195|syndesmosis injury|syndesmosis injury
331331|NCT01729195|ankle fracture|ankle fracture
331332|NCT01729195|ciprofloxacin|ciprofloxacin
331333|NCT01729182|Low dose Aspirin(LDA)|low dose aspirin(lda)
331334|NCT01729182|Gastric ulcer or duodenal ulcer|gastric ulcer or duodenal ulcer
331335|NCT01729182|Nexium|nexium
331336|NCT01729169|Sarcoidosis|sarcoidosis
331337|NCT01729169|Cardiac sarcoidosis|cardiac sarcoidosis
331338|NCT01729169|18-FDG PET|18-fdg pet
331339|NCT01729169|68Ga-DOTANOC PET|68ga-dotanoc pet
331340|NCT01729156|Type 2 diabetes|type 2 diabetes
331341|NCT01729156|Hepatic fatty acid oxidation|hepatic fatty acid oxidation
331342|NCT01729156|Dyslipidemia|dyslipidemia
331343|NCT01729156|Metformin|metformin
331344|NCT01729143|black pepper|black pepper
331345|NCT01729143|metabolic chamber|metabolic chamber
331346|NCT01729143|respiratory chamber|respiratory chamber
331347|NCT01729117|Type 2 diabetes|type 2 diabetes
331348|NCT01729117|Obesity|obesity
331349|NCT01729117|Insulin|insulin
331350|NCT01729117|Hispanic|hispanic
331351|NCT01729117|Low-income|low-income
331352|NCT01729117|Meal replacement|meal replacement
331353|NCT01729104|Lymphoma|lymphoma
331354|NCT01729104|Mantle cell lymphoma|mantle cell lymphoma
331355|NCT01729104|MCL|mcl
331356|NCT01729104|Relapsed|relapsed
331357|NCT01729104|Refractory|refractory
331358|NCT01729104|Carfilzomib|carfilzomib
331359|NCT01729104|Rituximab|rituximab
331360|NCT01729104|Rituxan|rituxan
331361|NCT01729104|Lenalidomide|lenalidomide
331362|NCT01729104|CC-5013|cc-5013
331363|NCT01729104|Revlimid|revlimid
331364|NCT01729091|Myeloma|myeloma
331365|NCT01729091|Multiple myeloma|multiple myeloma
331366|NCT01729091|MM|mm
331367|NCT01729091|Umbilical cord blood|umbilical cord blood
331368|NCT01729091|UCB|ucb
331369|NCT01729091|Natural killer cells|natural killer cells
331370|NCT01729091|NK|nk
331371|NCT01729091|Autologous stem cell transplant|autologous stem cell transplant
331372|NCT01729091|Stem cell infusion|stem cell infusion
331373|NCT01729091|High dose chemotherapy|high dose chemotherapy
331374|NCT01729091|Lenalidomide|lenalidomide
331375|NCT01729091|CC-5013|cc-5013
331376|NCT01729091|Revlimid|revlimid
331377|NCT01729091|Melphalan|melphalan
331378|NCT01729091|Alkeran|alkeran
331379|NCT01729091|G-CSF|g-csf
331380|NCT01729091|Filgrastim|filgrastim
331381|NCT01729091|Neupogen|neupogen
331382|NCT01729091|Elotuzumab|elotuzumab
331383|NCT01729091|Dexamethasone|dexamethasone
331384|NCT01729091|Decadron|decadron
331385|NCT01729065|Spinal Accessory Nerve Palsy, Cranial Nerve XI, shoulder weakness, neck stiffness, head and neck cancer, neck dissection|spinal accessory nerve palsy, cranial nerve xi, shoulder weakness, neck stiffness, head and neck cancer, neck dissection
331386|NCT01729052|Acupuncture|acupuncture
331387|NCT01729052|Children|children
331388|NCT01729052|Postoperative nausea and vomiting|postoperative nausea and vomiting
331389|NCT01729052|Postoperative pain|postoperative pain
331390|NCT01729052|Parental attitudes|parental attitudes
331391|NCT01729052|Parental expectations|parental expectations
331392|NCT01729039|rehabilitation|rehabilitation
331393|NCT01729039|aged|aged
331394|NCT01729039|aged, 80 and over|aged, 80 and over
331395|NCT01729039|vestibular diseases|vestibular diseases
331396|NCT01729026|Veterans|veterans
331397|NCT01729026|Posttraumatic Stress Disorder|posttraumatic stress disorder
331398|NCT01729026|dog adoption|dog adoption
331399|NCT01729026|companion animal|companion animal
331400|NCT01729013|vitamin D|vitamin d
331401|NCT01729013|fat|fat
331402|NCT01729013|biopsy|biopsy
331403|NCT01729000|prematurity|prematurity
331404|NCT01729000|infection control|infection control
331405|NCT01729000|necrotizing entercolitis|necrotizing entercolitis
331406|NCT01728974|Obstructive Sleep Apnea|obstructive sleep apnea
331407|NCT01728974|Pathophysiology|pathophysiology
331408|NCT01728961|HIV 1|hiv 1
331409|NCT01728961|NVP|nvp
331410|NCT01728961|malaria|malaria
331411|NCT01728961|Children|children
331412|NCT01728961|Youth|youth
331413|NCT01728961|nevirapine|nevirapine
331414|NCT01728961|Coartem Dispersible|coartem dispersible
331415|NCT01728961|Artemether|artemether
331416|NCT01728961|Lumefantrine|lumefantrine
331417|NCT01728961|Pharmacokinetics|pharmacokinetics
331418|NCT01728948|Sorafenib|sorafenib
331419|NCT01728948|renal cell carcinoma(RCC)|renal cell carcinoma(rcc)
331420|NCT01728948|elderly|elderly
331421|NCT01728948|effectiveness|effectiveness
331422|NCT01728948|safety|safety
331423|NCT01728935|HBV|hbv
331424|NCT01728935|Tenofovir|tenofovir
331425|NCT01728935|HBV DNA|hbv dna
331426|NCT01728935|HBsAg|hbsag
331427|NCT01728935|Resistance|resistance
331428|NCT01728922|Clinically isolated syndrome|clinically isolated syndrome
331429|NCT01728922|Multiple sclerosis|multiple sclerosis
331430|NCT01728922|Vitamin D|vitamin d
331431|NCT01728922|Immune response|immune response
331432|NCT01728922|CD4 T cell subsets|cd4 t cell subsets
331433|NCT01728922|Cytokine|cytokine
331434|NCT01728909|Oxytocin|oxytocin
331435|NCT01728909|Syntocinon|syntocinon
331436|NCT01728909|Social Cognition|social cognition
331437|NCT01728909|Social Approach Behaviors|social approach behaviors
331438|NCT01728896|Acute pancreatitis, nutrition|acute pancreatitis, nutrition
331439|NCT01728883|Diabetic Retinopathy|diabetic retinopathy
331440|NCT01728883|Diabetic Macular Edema|diabetic macular edema
331441|NCT01728883|Macular Edema|macular edema
331442|NCT01728883|Maculopathy|maculopathy
331443|NCT01728883|home monitoring|home monitoring
331444|NCT01728883|shape discrimination hyperacuity|shape discrimination hyperacuity
331445|NCT01728883|Psychophysical Testing|psychophysical testing
331447|NCT01728870|Crohn's disease|crohn's disease
331448|NCT01728870|Mild to moderate Crohn's Disease|mild to moderate crohn's disease
331449|NCT01728870|Diet|diet
331450|NCT01728870|Enteral Nutrition|enteral nutrition
331451|NCT01728857|Lipolysis|lipolysis
331452|NCT01728857|Cryolipolysis|cryolipolysis
331453|NCT01728857|Fat Reduction|fat reduction
331454|NCT01728831|Red Cell Transfusion|red cell transfusion
331455|NCT01728831|Cerebral tissue oxygenation|cerebral tissue oxygenation
331456|NCT01728831|Traumatic brain injury|traumatic brain injury
331457|NCT01728805|Cutaneous T-Cell Lymphoma (CTCL)|cutaneous t-cell lymphoma (ctcl)
331458|NCT01728805|myocis fungoides (MF)|myocis fungoides (mf)
331459|NCT01728805|Sezary Syndrome (SS)|sezary syndrome (ss)
331460|NCT01728792|Prophylactic vaccination|prophylactic vaccination
331461|NCT01728766|Breast milk zinc transfer|breast milk zinc transfer
331462|NCT01728766|Bangladeshi infants|bangladeshi infants
331463|NCT01728766|appropriate-for-gestational-age|appropriate-for-gestational-age
331464|NCT01728766|small-for-gestational-age|small-for-gestational-age
331465|NCT01728766|plasma zinc|plasma zinc
331466|NCT01728740|Bioequivalence|bioequivalence
331467|NCT01728740|Acarbose|acarbose
331468|NCT01728740|Metformin|metformin
331469|NCT01728740|FDC|fdc
331470|NCT01728727|liver cirrhosis|liver cirrhosis
331471|NCT01728727|end stage liver disease|end stage liver disease
331472|NCT01728727|umbilical cord|umbilical cord
331473|NCT01728727|mesenchymal stem cells|mesenchymal stem cells
331474|NCT01728727|HBV|hbv
331475|NCT01728714|Diabetes; compliance|diabetes; compliance
331476|NCT01728701|Malaria|malaria
331477|NCT01728701|Plasmodium falciparum|plasmodium falciparum
331478|NCT01728701|PfSPZ Challenge|pfspz challenge
331479|NCT01728701|Chemoprophylaxis|chemoprophylaxis
331480|NCT01728701|PfSPZ-CVac|pfspz-cvac
331481|NCT01728688|liver cirrhosis|liver cirrhosis
331482|NCT01728688|stem cell|stem cell
331483|NCT01728688|peripheral blood|peripheral blood
331484|NCT01728688|autologous|autologous
331485|NCT01728688|HBV|hbv
331486|NCT01728688|end stage liver disease|end stage liver disease
331487|NCT01728675|Aging|aging
331488|NCT01728675|Skeletal muscle|skeletal muscle
331489|NCT01728675|Biomarkers|biomarkers
331490|NCT01728675|Adaptation|adaptation
331491|NCT01728662|emphysema|emphysema
331492|NCT01728662|lung volume reduction therapy|lung volume reduction therapy
331493|NCT01728649|Acute Ischemic Stroke|acute ischemic stroke
331494|NCT01728649|Mild Hypothermia|mild hypothermia
331495|NCT01728649|Stroke|stroke
331496|NCT01728649|Hypothermia|hypothermia
331497|NCT01728623|Thyroid cancer|thyroid cancer
331498|NCT01728610|irritable bowel syndrome|irritable bowel syndrome
331499|NCT01728610|probiotic|probiotic
331500|NCT01728610|pain|pain
331501|NCT01728610|bloating|bloating
331502|NCT01728610|diarrhoea|diarrhoea
331503|NCT01728610|constipation|constipation
331504|NCT01728597|no history of cardiovascular diseases|no history of cardiovascular diseases
331505|NCT01728571|COPD|copd
331506|NCT01728571|asthma|asthma
331507|NCT01728571|pulmonary function|pulmonary function
331508|NCT01728571|pneumonia|pneumonia
331509|NCT01728558|Sedation|sedation
331510|NCT01728558|Delirium|delirium
331511|NCT01728558|Goal Directed|goal directed
331512|NCT01728558|Dexmedetomidine|dexmedetomidine
331513|NCT01728558|Mortality|mortality
331514|NCT01728558|Mechanical ventilation|mechanical ventilation
331515|NCT01728558|Intensive care|intensive care
331516|NCT01728558|Critically Ill|critically ill
331517|NCT01728545|Cord blood registry|cord blood registry
331518|NCT01728545|Umbilical Cord Blood|umbilical cord blood
331519|NCT01728545|fetal blood|fetal blood
331520|NCT01728545|placenta|placenta
331521|NCT01728545|Placental Blood Stem Cell Transplantation|placental blood stem cell transplantation
331522|NCT01728545|hematopoietic progenitor cells|hematopoietic progenitor cells
331523|NCT01728545|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
331524|NCT01728545|cord blood unit total nucleated cell|cord blood unit total nucleated cell
331525|NCT01728545|TNC|tnc
331526|NCT01728545|CD34-positive(+) cell|cd34-positive(+) cell
331527|NCT01728545|human leukocyte antigen|human leukocyte antigen
331528|NCT01728545|HLA|hla
331529|NCT01728545|allogeneic transplantation|allogeneic transplantation
331530|NCT01728519|Allergy|allergy
331531|NCT01728519|Birch Pollen|birch pollen
331532|NCT01728519|Immunotherapy|immunotherapy
331533|NCT01728506|breast cancer survivor|breast cancer survivor
331534|NCT01728506|Weight loss|weight loss
331535|NCT01728506|Exercise|exercise
331536|NCT01728493|Prevalence|prevalence
331537|NCT01728493|Primary aldosteronism|primary aldosteronism
331538|NCT01728493|Organ damage|organ damage
331539|NCT01728493|Mineralocorticoid receptor antagonists|mineralocorticoid receptor antagonists
331540|NCT01728441|PAD|pad
331541|NCT01728441|stenting|stenting
331542|NCT01728441|angioplasty|angioplasty
331543|NCT01728428|hemifacial spasm|hemifacial spasm
331544|NCT01728428|observational study|observational study
331545|NCT01728428|clinical manifestation|clinical manifestation
331546|NCT01728428|treatment|treatment
331547|NCT01728428|Chinese|chinese
331548|NCT01728415|Exercise|exercise
331549|NCT01728415|Hemodialysis|hemodialysis
331550|NCT01728415|Physical therapy|physical therapy
331551|NCT01728415|high-intensity|high-intensity
331552|NCT01728389|allogenic stem cell transplantation|allogenic stem cell transplantation
331553|NCT01728389|peripheral blood stem cells|peripheral blood stem cells
331554|NCT01728389|intrabone|intrabone
331555|NCT01728389|intra-bone|intra-bone
331556|NCT01728389|leukemia|leukemia
331557|NCT01728389|lymphoma|lymphoma
331558|NCT01728363|Staphylococcal|staphylococcal
331559|NCT01728350|traumatic brain injury|traumatic brain injury
331560|NCT01728350|volunteering|volunteering
331561|NCT01728350|well being|well being
331562|NCT01728350|cortisol|cortisol
331563|NCT01728337|botulinum toxin,|botulinum toxin,
331564|NCT01728337|wrinkles|wrinkles
331565|NCT01728298|House Dust Mite|house dust mite
331566|NCT01728298|allergy|allergy
331567|NCT01728298|rhinitis|rhinitis
331568|NCT01728298|asthma|asthma
331569|NCT01728285|specific allergen immunotherapy|specific allergen immunotherapy
331570|NCT01728285|sublingual immunotherapy|sublingual immunotherapy
331571|NCT01728285|allergen tablets|allergen tablets
331572|NCT01728285|compliance|compliance
331573|NCT01728285|electronic compliance device|electronic compliance device
331574|NCT01728272|metoprolol, atrial fibrillation|metoprolol, atrial fibrillation
331575|NCT01728246|Osteoarthritis|osteoarthritis
331576|NCT01728246|Celecoxib|celecoxib
331577|NCT01728246|Tramadol|tramadol
331578|NCT01728246|Paracetamol|paracetamol
331579|NCT01728233|Molecular Targeted Therapy|molecular targeted therapy
331580|NCT01728233|Neoadjuvant therapy|neoadjuvant therapy
331581|NCT01728233|Dacomitinib|dacomitinib
331582|NCT01728220|Inhaled nitric oxide (iNO)|inhaled nitric oxide (ino)
331583|NCT01728220|Pulmonary hypertension (PH)|pulmonary hypertension (ph)
331584|NCT01728220|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
331585|NCT01728220|Long term oxygen therapy (LTOT)|long term oxygen therapy (ltot)
331586|NCT01728207|NHL|nhl
331587|NCT01728207|CLL|cll
331588|NCT01728207|follicular lymphoma|follicular lymphoma
331589|NCT01728207|mantle cell lymphoma|mantle cell lymphoma
331590|NCT01728207|marginal zone lymphoma|marginal zone lymphoma
331591|NCT01728207|chronic lymphocytic leukemia|chronic lymphocytic leukemia
331592|NCT01728207|small lymphocytic lymphoma|small lymphocytic lymphoma
331593|NCT01728194|Depression|depression
331594|NCT01728194|Depressive Disorder|depressive disorder
331595|NCT01728194|Behavioral Symptoms|behavioral symptoms
331596|NCT01728194|Mood Disorders|mood disorders
331597|NCT01728194|Mental Disorders|mental disorders
331598|NCT01728194|Escitalopram|escitalopram
331599|NCT01728194|Central Nervous System Agents|central nervous system agents
331600|NCT01728194|Therapeutic Uses|therapeutic uses
331601|NCT01728194|Pharmacologic Actions|pharmacologic actions
331602|NCT01728194|Physiological Effects of Drugs|physiological effects of drugs
331603|NCT01728194|Muscarinic Antagonists|muscarinic antagonists
331604|NCT01728194|Antidepressive Agents|antidepressive agents
331605|NCT01728194|Psychotropic Drugs|psychotropic drugs
331606|NCT01728194|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
331607|NCT01728194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors
331608|NCT01728194|Serotonin Agents|serotonin agents
331609|NCT01728194|Magnetic Resonance Imaging, Functional|magnetic resonance imaging, functional
331610|NCT01728194|fMRI|fmri
331611|NCT01728194|Magnetic Resonance Imaging|magnetic resonance imaging
331612|NCT01728168|lupin|lupin
331613|NCT01728168|peanut|peanut
331614|NCT01728168|soy|soy
331615|NCT01728168|pea|pea
331616|NCT01728168|legumes|legumes
331617|NCT01728168|cross-reactivity|cross-reactivity
331618|NCT01728168|sensitization|sensitization
331619|NCT01728168|atopy|atopy
331620|NCT01728155|NEUROBLASTOMA, LOW RISK, INTERMEDIATE RISK|neuroblastoma, low risk, intermediate risk
331621|NCT01728142|DANA|dana
331622|NCT01728142|ANAM|anam
331623|NCT01728142|Concussion|concussion
331624|NCT01728142|mild traumatic brain injury|mild traumatic brain injury
331625|NCT01728129|Concussion|concussion
331626|NCT01728129|Mild traumatic brain injury|mild traumatic brain injury
331627|NCT01728129|DANA|dana
331628|NCT01728129|MACE|mace
331629|NCT01728116|glycemic control, type 2 diabetes, device, obese|glycemic control, type 2 diabetes, device, obese
331630|NCT01728090|handwashing|handwashing
331631|NCT01728090|hand sanitizer|hand sanitizer
331632|NCT01728090|absenteeism|absenteeism
331633|NCT01728090|school age children|school age children
331634|NCT01728090|preschool children|preschool children
331635|NCT01728077|Brivaracetam|brivaracetam
331636|NCT01728077|Long-term Follow-up|long-term follow-up
331637|NCT01728077|Epilepsy|epilepsy
331638|NCT01728077|Partial Onset Seizures|partial onset seizures
331639|NCT01728077|Adjunctive treatment|adjunctive treatment
331640|NCT01728064|Friedreich's|friedreich's
331641|NCT01728064|Ataxia|ataxia
331642|NCT01728064|FRDA|frda
331643|NCT01728064|FA|fa
331644|NCT01728064|EPI-743|epi-743
331645|NCT01728064|Edison|edison
331646|NCT01728038|Bronchiolitis|bronchiolitis
331647|NCT01728038|Cough|cough
331648|NCT01728038|Ear Infection|ear infection
331649|NCT01728038|Respiratory Infection|respiratory infection
331650|NCT01728038|Wheezing|wheezing
331651|NCT01728025|Long QT syndrome|long qt syndrome
331652|NCT01728025|Ranolazine|ranolazine
331653|NCT01728012|Successful transplantation|successful transplantation
331654|NCT01728012|Long-term observation|long-term observation
331655|NCT01727999|TPO response|tpo response
331656|NCT01727999|ITP|itp
331657|NCT01727999|immune thrombocytopenia|immune thrombocytopenia
331658|NCT01727973|Graves' orbitopathy|graves' orbitopathy
331659|NCT01727973|Graves´ ophthalmopathy|graves´ ophthalmopathy
331660|NCT01727973|Thyroid eye disease|thyroid eye disease
331661|NCT01727973|Thyroid-associated ophthalmopathy|thyroid-associated ophthalmopathy
331662|NCT01727973|Doxycycline|doxycycline
331663|NCT01727973|EUGOGO|eugogo
331664|NCT01727973|CAS|cas
331665|NCT01727960|Education|education
331666|NCT01727960|Neck pain|neck pain
331667|NCT01727960|Shoulder pain|shoulder pain
331668|NCT01727960|Prevalence|prevalence
331669|NCT01727960|Associated factors|associated factors
331670|NCT01727960|Students|students
331671|NCT01727934|Antisense|antisense
331672|NCT01727934|miR-122 antagonist|mir-122 antagonist
331673|NCT01727934|host factor|host factor
331674|NCT01727934|Chronic hepatitis C|chronic hepatitis c
331675|NCT01727934|Hepatitis C|hepatitis c
331676|NCT01727921|ProCore FNA biopsy|procore fna biopsy
331677|NCT01727908|Familial Gastric Cancer Screening|familial gastric cancer screening
331678|NCT01727895|Betaglucan, immune modulation, immunoparalysis, immune suppression|betaglucan, immune modulation, immunoparalysis, immune suppression
331679|NCT01727882|Paroled offenders|paroled offenders
331680|NCT01727882|Interactive Voice Response|interactive voice response
331681|NCT01727882|Stress|stress
331682|NCT01727882|Mental symptoms|mental symptoms
331683|NCT01727882|Alcohol consumption|alcohol consumption
331684|NCT01727882|Substance use|substance use
331685|NCT01727856|rehabilitation|rehabilitation
331686|NCT01727856|physical therapy|physical therapy
331687|NCT01727856|telemedicine|telemedicine
331688|NCT01727843|fracture|fracture
331689|NCT01727843|hip|hip
331690|NCT01727843|tranexamic acid|tranexamic acid
331691|NCT01727843|topical|topical
331692|NCT01727817|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
331693|NCT01727817|Continuous Glucose Monitor|continuous glucose monitor
331694|NCT01727817|Artificial Pancreas|artificial pancreas
331695|NCT01727817|Insulin Pump|insulin pump
331696|NCT01727817|Closed Loop|closed loop
331697|NCT01727817|Open Loop|open loop
331698|NCT01727817|Diabetes Assistant|diabetes assistant
331699|NCT01727817|DiAs|dias
331700|NCT01727817|Cell Phone|cell phone
331701|NCT01727791|pharmacokinetic|pharmacokinetic
331702|NCT01727791|pregabalin|pregabalin
331703|NCT01727791|lactation|lactation
331704|NCT01727765|Asthma, inspiratory muscle training|asthma, inspiratory muscle training
331705|NCT01727739|Tibial tunnel widening|tibial tunnel widening
331706|NCT01727739|Interference screws|interference screws
331707|NCT01727726|OPC-34712|opc-34712
331708|NCT01727726|brexpiprazole|brexpiprazole
331709|NCT01727726|Major Depressive Disorder|major depressive disorder
331710|NCT01727726|Adjunctive Treatment|adjunctive treatment
331711|NCT01727713|Tourette Syndrome|tourette syndrome
331712|NCT01727713|Basal Ganglia Diseases|basal ganglia diseases
331713|NCT01727713|Brain Diseases|brain diseases
331714|NCT01727713|Central Nervous System Diseases|central nervous system diseases
331715|NCT01727713|Tic Disorders|tic disorders
331716|NCT01727713|Tics|tics
331717|NCT01727713|Movement Disorders|movement disorders
331718|NCT01727713|Mental Disorders|mental disorders
331719|NCT01727713|Aripiprazole|aripiprazole
331720|NCT01727700|Tourette Syndrome|tourette syndrome
331721|NCT01727700|Basal Ganglia Diseases|basal ganglia diseases
331722|NCT01727700|Brain Diseases|brain diseases
331723|NCT01727700|Central Nervous System Diseases|central nervous system diseases
331724|NCT01727700|Tic Disorders|tic disorders
331725|NCT01727700|Tics|tics
331726|NCT01727700|Movement Disorders|movement disorders
331727|NCT01727700|Mental Disorders|mental disorders
331728|NCT01727700|Aripiprazole|aripiprazole
331729|NCT01727687|To asses the training effects on traffic safety between normal and patients with Parkinson's disease|to asses the training effects on traffic safety between normal and patients with parkinson's disease
331730|NCT01727674|Depression|depression
331731|NCT01727674|experiences of communication|experiences of communication
331732|NCT01727661|diabetes mellitus|diabetes mellitus
331733|NCT01727661|cardiopulmonary fitness|cardiopulmonary fitness
331734|NCT01727661|lung function|lung function
331735|NCT01727661|muscular oxygenation|muscular oxygenation
331736|NCT01727648|Stroke rehabilitation|stroke rehabilitation
331737|NCT01727648|Comparative efficacy research|comparative efficacy research
331738|NCT01727648|Combined therapy|combined therapy
331739|NCT01727648|Robot-Assisted Therapy|robot-assisted therapy
331740|NCT01727648|Constraint-Induced Therapy|constraint-induced therapy
331741|NCT01727648|Kinematic analysis|kinematic analysis
331742|NCT01727635|Breast cancer, survivors, partners, group therapy|breast cancer, survivors, partners, group therapy
331743|NCT01727609|Preterm|preterm
331744|NCT01727609|Very low birth weight|very low birth weight
331745|NCT01727609|Feeding|feeding
331746|NCT01727609|Enteral|enteral
331747|NCT01727609|Milk|milk
331748|NCT01727609|Sepsis|sepsis
331749|NCT01727609|Necrotizing enterocolitis (NEC)|necrotizing enterocolitis (nec)
331750|NCT01727583|Healthy|healthy
331751|NCT01727570|Cancer|cancer
331752|NCT01727570|Colon|colon
331753|NCT01727570|Rectum|rectum
331754|NCT01727570|Surgery|surgery
331755|NCT01727557|Hemodialysis and AV fistula|hemodialysis and av fistula
331756|NCT01727544|superior semicircular canal|superior semicircular canal
331757|NCT01727544|non-vestibular dizziness|non-vestibular dizziness
331758|NCT01727544|vestibular dizziness|vestibular dizziness
331759|NCT01727531|chloroquine|chloroquine
331760|NCT01727531|WBRT|wbrt
331761|NCT01727531|survival|survival
331762|NCT01727531|brain metastasis|brain metastasis
331763|NCT01727531|radiotherapy|radiotherapy
331764|NCT01727531|SNPs|snps
331765|NCT01727531|gene coding|gene coding
331766|NCT01727531|immunoregulatory enzyme IDO2|immunoregulatory enzyme ido2
331767|NCT01727518|natural history|natural history
331768|NCT01727518|lung function|lung function
331769|NCT01727518|general population|general population
331770|NCT01727518|COPD|copd
331771|NCT01727505|hypoxemia|hypoxemia
331772|NCT01727505|desaturation|desaturation
331773|NCT01727505|mechanical ventilation|mechanical ventilation
331774|NCT01727505|preterm infants|preterm infants
331775|NCT01727505|volume guarantee ventilation|volume guarantee ventilation
331776|NCT01727492|prevention|prevention
331777|NCT01727492|noise-induced tinnitus|noise-induced tinnitus
331778|NCT01727492|noise-induced hearing loss|noise-induced hearing loss
331779|NCT01727492|young population|young population
331780|NCT01727479|Peak VO2 consumption|peak vo2 consumption
331781|NCT01727479|3km time trial|3km time trial
331782|NCT01727479|fatigue perception|fatigue perception
331783|NCT01727479|lactate|lactate
331784|NCT01727479|time to complete|time to complete
331785|NCT01727440|severe acne|severe acne
331786|NCT01727440|severe acne vulgaris|severe acne vulgaris
331787|NCT01727440|acne|acne
331788|NCT01727440|acne vulgaris|acne vulgaris
331789|NCT01727440|isotretinoin|isotretinoin
331790|NCT01727440|Accutane|accutane
331791|NCT01727440|Sortret|sortret
331792|NCT01727440|Amnesteem|amnesteem
331793|NCT01727440|Claravis|claravis
331794|NCT01727440|Clarus|clarus
331795|NCT01727440|Decutan|decutan
331796|NCT01727440|Isotane|isotane
331797|NCT01727440|Izotek|izotek
331798|NCT01727440|Oratane|oratane
331799|NCT01727440|Isotret|isotret
331800|NCT01727440|Roaccutane|roaccutane
331801|NCT01727427|Unsuspected|unsuspected
331802|NCT01727427|pulmonary embolism|pulmonary embolism
331803|NCT01727427|cancer|cancer
331804|NCT01727414|ADHD|adhd
331805|NCT01727414|Inattention|inattention
331806|NCT01727414|Methylphenidate|methylphenidate
331807|NCT01727414|Pharmacogenetics|pharmacogenetics
331808|NCT01727401|Fondaparinux|fondaparinux
331809|NCT01727401|medical patient|medical patient
331810|NCT01727401|vein thromboembolism|vein thromboembolism
331811|NCT01727401|prophylaxis|prophylaxis
331812|NCT01727401|thrombocytopenia|thrombocytopenia
331813|NCT01727388|rectal examination|rectal examination
331814|NCT01727388|colorectal cancer|colorectal cancer
331815|NCT01727375|delirium, light, ICU, sleep|delirium, light, icu, sleep
331816|NCT01727362|Breast Cancer|breast cancer
331817|NCT01727362|Acupuncture|acupuncture
331818|NCT01727362|Quality of Life|quality of life
331819|NCT01727258|Tooth Sensitivity|tooth sensitivity
331820|NCT01727232|ITP|itp
331821|NCT01727232|Rituximab|rituximab
331822|NCT01727232|Efficacy|efficacy
331823|NCT01727232|Anti-CD20|anti-cd20
331824|NCT01727232|Regimen|regimen
331825|NCT01727206|Erdheim-Chester disease|erdheim-chester disease
331826|NCT01727206|Tocilizumab|tocilizumab
331827|NCT01727206|Treatment|treatment
331828|NCT01727206|Phase II|phase ii
331829|NCT01727193|myasthenia gravis|myasthenia gravis
331830|NCT01727193|leflunomide|leflunomide
331831|NCT01727167|cardiac disease|cardiac disease
331832|NCT01727167|mitochondrial biogenesis|mitochondrial biogenesis
331833|NCT01727167|carbon monoxide|carbon monoxide
331834|NCT01727141|COPD, QVA149|copd, qva149
331835|NCT01727128|Hepatic impairment|hepatic impairment
331836|NCT01727128|Clinical pharmacology study|clinical pharmacology study
331837|NCT01727128|Volunteer study|volunteer study
331838|NCT01727063|Chronic ischemic heart disease|chronic ischemic heart disease
331839|NCT01727063|Coronary artery disease|coronary artery disease
331840|NCT01727063|Angina pectoris|angina pectoris
331841|NCT01727063|Myocardial ischemia|myocardial ischemia
331842|NCT01727063|Cardiac surgery|cardiac surgery
331843|NCT01727037|Emphysema|emphysema
331844|NCT01727037|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
331845|NCT01727037|COPD|copd
331846|NCT01727037|Bulla|bulla
331847|NCT01727037|Interventional bronchoscopy|interventional bronchoscopy
331848|NCT01727037|Lung volume reduction|lung volume reduction
331849|NCT01727024|Breezhaler|breezhaler
331850|NCT01727024|Respimat|respimat
331851|NCT01727024|Indacaterol|indacaterol
331852|NCT01727024|Tiotropium|tiotropium
331853|NCT01727011|Single fraction|single fraction
331854|NCT01727011|Elderly|elderly
331855|NCT01727011|Breast Irradiation|breast irradiation
331856|NCT01726959|methotrexate|methotrexate
331857|NCT01726946|Chronic Hepatitis C|chronic hepatitis c
331858|NCT01726946|HCV|hcv
331859|NCT01726946|CHC|chc
331860|NCT01726933|psoriasis, systemic treatment|psoriasis, systemic treatment
331861|NCT01726920|Migraine|migraine
331862|NCT01726920|Naratriptan|naratriptan
331863|NCT01726920|Naproxen|naproxen
331864|NCT01726907|submandibular gland|submandibular gland
331865|NCT01726907|robotic|robotic
331866|NCT01726907|endoscopic|endoscopic
331867|NCT01726907|face lift|face lift
331868|NCT01726907|hairline|hairline
331869|NCT01726894|Focal Therapy|focal therapy
331870|NCT01726881|chronic|chronic
331871|NCT01726881|Spinal Cord Injury patients|spinal cord injury patients
331872|NCT01726855|tendon repair|tendon repair
331873|NCT01726829|Type 1 Diabetes|type 1 diabetes
331874|NCT01726829|Artificial Pancreas|artificial pancreas
331875|NCT01726829|Closed Loop|closed loop
331876|NCT01726816|Diabetic nephropathy|diabetic nephropathy
331877|NCT01726816|Albumin creatinine ratio|albumin creatinine ratio
331878|NCT01726816|Probucol|probucol
331879|NCT01726803|Low Back Pain|low back pain
331880|NCT01726803|Primary Care|primary care
331881|NCT01726803|Physical Therapy|physical therapy
331882|NCT01726790|corneal endothelium|corneal endothelium
331883|NCT01726790|Bevacizumab|bevacizumab
331884|NCT01726790|Intravitreal injection|intravitreal injection
331885|NCT01726790|Confoscan|confoscan
331886|NCT01726777|Randomized controlled clinical trial|randomized controlled clinical trial
331887|NCT01726777|Diabetes|diabetes
331888|NCT01726777|Vitamin D|vitamin d
331889|NCT01726777|Oral glucose tolerance|oral glucose tolerance
331890|NCT01726777|Blood glucose|blood glucose
331891|NCT01726777|Insulin resistance|insulin resistance
331892|NCT01726751|Spinal cord stimulation|spinal cord stimulation
331893|NCT01726751|Irritable bowel syndrome|irritable bowel syndrome
331894|NCT01726751|Abdominal pain|abdominal pain
331895|NCT01726751|Diarrhea|diarrhea
331896|NCT01726738|Melanoma|melanoma
331897|NCT01726738|Stage III|stage iii
331898|NCT01726738|Stage IV|stage iv
331899|NCT01726738|Unresectable|unresectable
331900|NCT01726738|BRAF Mutant|braf mutant
331901|NCT01726738|Dabrafenib|dabrafenib
331902|NCT01726738|Trametinib|trametinib
331903|NCT01726738|Kinome|kinome
331904|NCT01726738|Resistance|resistance
331905|NCT01726738|Sequencing|sequencing
331906|NCT01726738|Mutations|mutations
331907|NCT01726738|Kinases|kinases
331908|NCT01726738|Mechanism|mechanism
331909|NCT01726725|hemifacial spasm|hemifacial spasm
331910|NCT01726725|microvascular decompression surgery|microvascular decompression surgery
331911|NCT01726725|desflurane|desflurane
331912|NCT01726712|Patient Care Management|patient care management
331913|NCT01726712|Primary Health Care|primary health care
331914|NCT01726712|HIV|hiv
331915|NCT01726712|Patient Acceptance of Health Care|patient acceptance of health care
331916|NCT01726686|Total Knee Arthroplasty|total knee arthroplasty
331917|NCT01726673|Stroke|stroke
331918|NCT01726673|Cerebrovascular Accident|cerebrovascular accident
331919|NCT01726673|Cerebral Stroke|cerebral stroke
331920|NCT01726673|CVA|cva
331921|NCT01726673|Robotic therapy|robotic therapy
331922|NCT01726673|Upper extremity recovery|upper extremity recovery
331923|NCT01726673|tDCS|tdcs
331924|NCT01726673|Non-invasive brain stimulation|non-invasive brain stimulation
331925|NCT01726660|Stroke|stroke
331926|NCT01726660|Cerebrovascular Accident|cerebrovascular accident
331927|NCT01726660|Cerebral stroke|cerebral stroke
331928|NCT01726660|CVA|cva
331929|NCT01726660|robotic therapy|robotic therapy
331930|NCT01726660|upper extremity recovery|upper extremity recovery
331931|NCT01726660|kinematic training|kinematic training
331932|NCT01726647|obese women|obese women
331933|NCT01726647|fat mass distribution|fat mass distribution
331934|NCT01726647|Metabolomic profiles|metabolomic profiles
331935|NCT01726634|upper limb|upper limb
331936|NCT01726634|functional test|functional test
331937|NCT01726634|elastic tape|elastic tape
331938|NCT01726595|critical care|critical care
331939|NCT01726595|severe sepsis|severe sepsis
331940|NCT01726595|microvascular function|microvascular function
331941|NCT01726595|ultrasound|ultrasound
331942|NCT01726582|pancreas|pancreas
331943|NCT01726582|adenocarcinoma|adenocarcinoma
331944|NCT01726582|molecular profile|molecular profile
331945|NCT01726582|molecular profiling|molecular profiling
331946|NCT01726582|pancreatic cancer|pancreatic cancer
331947|NCT01726582|pancreas cancer|pancreas cancer
331948|NCT01726582|cancer|cancer
331949|NCT01726582|molecular target|molecular target
331950|NCT01726582|pancreas head|pancreas head
331951|NCT01726582|pancreas neck|pancreas neck
331952|NCT01726582|pancreas uncinate|pancreas uncinate
331953|NCT01726582|pancreas body|pancreas body
331954|NCT01726582|pancreas tail|pancreas tail
331955|NCT01726569|glaucoma|glaucoma
331956|NCT01726569|educational intervention|educational intervention
331957|NCT01726569|post-operative satisfaction|post-operative satisfaction
331958|NCT01726569|knowledges|knowledges
331959|NCT01726556|Pleural effusion|pleural effusion
331960|NCT01726556|Semirigid thoracoscopy|semirigid thoracoscopy
331961|NCT01726556|Rigid thoracoscopy|rigid thoracoscopy
331962|NCT01726543|canaloplasty|canaloplasty
331963|NCT01726543|non-penetrating deep sclerectomy|non-penetrating deep sclerectomy
331964|NCT01726543|glaucoma|glaucoma
331965|NCT01726543|cataract|cataract
331966|NCT01726543|ophthalmology|ophthalmology
331967|NCT01726543|glaucoma surgery|glaucoma surgery
331968|NCT01726530|transdermal fentanyl patch, postoperative pain,|transdermal fentanyl patch, postoperative pain,
331969|NCT01726517|HCV genotype 1 (GT-1)|hcv genotype 1 (gt-1)
331970|NCT01726517|HCV|hcv
331971|NCT01726517|Sustained Virologic Response|sustained virologic response
331972|NCT01726517|Direct Acting Antiviral|direct acting antiviral
331973|NCT01726517|Combination Therapy|combination therapy
331974|NCT01726517|GS-7977|gs-7977
331975|NCT01726517|GS-5885|gs-5885
331976|NCT01726517|Ribavirin|ribavirin
331977|NCT01726517|Open Label|open label
331978|NCT01726517|Sofosbuvir|sofosbuvir
331979|NCT01726517|Treatment-Naïve|treatment-naïve
331980|NCT01726517|Protease Inhibitors|protease inhibitors
331981|NCT01726517|PI|pi
331982|NCT01726504|chronic functional constipation|chronic functional constipation
331983|NCT01726504|electro-acupuncture|electro-acupuncture
331984|NCT01726504|multi-center randomized controlled trial|multi-center randomized controlled trial
331985|NCT01726504|efficacy|efficacy
331986|NCT01726504|safety|safety
331987|NCT01726491|Insulin resistance|insulin resistance
331988|NCT01726491|Exercise|exercise
331989|NCT01726491|Type 2 diabetes mellitus|type 2 diabetes mellitus
331990|NCT01726491|Obesity|obesity
331991|NCT01726491|Epigenetic studies|epigenetic studies
331992|NCT01726478|Oxytocin|oxytocin
331993|NCT01726478|Uterine tone|uterine tone
331994|NCT01726478|Mulago Hospital|mulago hospital
331995|NCT01726478|Dose|dose
331996|NCT01726478|Side effects|side effects
331997|NCT01726465|N-Acetylcysteine|n-acetylcysteine
331998|NCT01726465|Methylprednisolone|methylprednisolone
331999|NCT01726465|Liver ischemia reperfusion injury|liver ischemia reperfusion injury
332000|NCT01726465|Pringle manoeuvre|pringle manoeuvre
332001|NCT01726465|Hepatic resection|hepatic resection
332002|NCT01726426|Chronic arsenic poisoning|chronic arsenic poisoning
332003|NCT01726426|Palmer arsenical keratosis|palmer arsenical keratosis
332004|NCT01726413|Diabetic neuropathy|diabetic neuropathy
332005|NCT01726400|Hepatitis C|hepatitis c
332006|NCT01726400|Interferon|interferon
332007|NCT01726400|Ribavirin|ribavirin
332008|NCT01726400|Hepcidin|hepcidin
332009|NCT01726400|Iron metabolism|iron metabolism
332010|NCT01726361|Multidimension Treatment Foster Care|multidimension treatment foster care
332011|NCT01726361|Adolescents|adolescents
332012|NCT01726361|Disadvantaged families|disadvantaged families
332013|NCT01726361|Out-of-home placement|out-of-home placement
332014|NCT01726361|Conduct Disorder|conduct disorder
332015|NCT01726361|Family program|family program
332016|NCT01726361|Denmark|denmark
332017|NCT01726361|Youth|youth
332018|NCT01726348|Human Immunodeficiency Virus-Type 1|human immunodeficiency virus-type 1
332019|NCT01726348|HIV-1|hiv-1
332020|NCT01726348|TMC114|tmc114
332021|NCT01726348|Darunavir|darunavir
332022|NCT01726348|Ritonavir|ritonavir
332023|NCT01726348|Filipino|filipino
332024|NCT01726335|Schizophrenia|schizophrenia
332025|NCT01726335|Risperidone|risperidone
332026|NCT01726335|Risperdal consta|risperdal consta
332027|NCT01726283|fruste keratoconus|fruste keratoconus
332028|NCT01726283|ectasia|ectasia
332029|NCT01726257|Infrarenal|infrarenal
332030|NCT01726257|Abdominal|abdominal
332031|NCT01726257|Aortic|aortic
332032|NCT01726257|Aneurysm|aneurysm
332033|NCT01726257|AAA|aaa
332034|NCT01726257|Endologix|endologix
332035|NCT01726257|EVAS|evas
332036|NCT01726257|EndoVascular|endovascular
332037|NCT01726257|Sealing|sealing
332038|NCT01726257|System|system
332039|NCT01726231|Laparoscopic access|laparoscopic access
332040|NCT01726231|Abdominal wall lifting|abdominal wall lifting
332041|NCT01726231|Direct trocar insertion|direct trocar insertion
332042|NCT01726231|Safety endoscopy|safety endoscopy
332043|NCT01726218|Stroke|stroke
332044|NCT01726218|Physical Medicine & Rehabilitation|physical medicine & rehabilitation
332045|NCT01726218|Neurology|neurology
332046|NCT01726218|Neurophysiology|neurophysiology
332047|NCT01726218|Neuroscience|neuroscience
332048|NCT01726218|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
332049|NCT01726179|caries infiltration|caries infiltration
332050|NCT01726179|caries arrest|caries arrest
332051|NCT01726179|dental anxiety|dental anxiety
332052|NCT01726179|dental stress|dental stress
332053|NCT01726166|Infant|infant
332054|NCT01726166|contamination rates|contamination rates
332055|NCT01726166|urinary catheterization|urinary catheterization
332056|NCT01726166|suprapubic aspiration|suprapubic aspiration
332057|NCT01726153|Condom Use|condom use
332058|NCT01726153|HIV+ gay males|hiv+ gay males
332059|NCT01726153|Intervention|intervention
332060|NCT01726153|Tailored|tailored
332061|NCT01726153|On-line|on-line
332062|NCT01726153|Internet|internet
332063|NCT01726153|Web-based|web-based
332064|NCT01726140|intubation|intubation
332065|NCT01726140|respiratory failure|respiratory failure
332066|NCT01726140|cardiac surgery|cardiac surgery
332067|NCT01726114|Diabetes|diabetes
332068|NCT01726114|Diabetes Mellitus|diabetes mellitus
332069|NCT01726114|continuous Glucose Monitor|continuous glucose monitor
332070|NCT01726088|Modafinil|modafinil
332071|NCT01726088|p50|p50
332072|NCT01726088|Attentional Bias|attentional bias
332073|NCT01726075|diabetic retinopathy|diabetic retinopathy
332074|NCT01726062|Motivational Incentives|motivational incentives
332075|NCT01726062|Motivational Interviewing|motivational interviewing
332076|NCT01726062|Secondhand Smoke|secondhand smoke
332077|NCT01726062|Neonatal Intensive Care Unit|neonatal intensive care unit
332078|NCT01726062|NICU|nicu
332079|NCT01726062|High respiratory risk infants|high respiratory risk infants
332080|NCT01726062|Low birth weight infants|low birth weight infants
332081|NCT01726062|Environmental Tobacco Smoke|environmental tobacco smoke
332082|NCT01726062|Smoking|smoking
332083|NCT01726062|Contingency management|contingency management
332084|NCT01726062|Infants|infants
332085|NCT01726062|Children|children
332086|NCT01726049|HFpEF|hfpef
332087|NCT01726049|PH|ph
332088|NCT01726036|neonatal circumcision|neonatal circumcision
332089|NCT01726036|neonatal surgical pain|neonatal surgical pain
332090|NCT01726036|Mogen|mogen
332091|NCT01726036|Gomco|gomco
332092|NCT01726023|Ceftazidime-avibactam,|ceftazidime-avibactam,
332093|NCT01726023|Metronidazole,|metronidazole,
332094|NCT01726023|Meropenem,|meropenem,
332095|NCT01726023|Anti-Bacterial Agents,|anti-bacterial agents,
332096|NCT01726023|Anti-Infective Agents,|anti-infective agents,
332097|NCT01726023|Therapeutic Uses,|therapeutic uses,
332098|NCT01726023|Pharmacologic Actions,|pharmacologic actions,
332099|NCT01726023|Physiological Effects of Drugs|physiological effects of drugs
332100|NCT01725997|acromioclavicular joint dislocation|acromioclavicular joint dislocation
332101|NCT01725997|ac joint dislocation|ac joint dislocation
332102|NCT01725997|acromioclavicular joint separation|acromioclavicular joint separation
332103|NCT01725997|hook plate|hook plate
332104|NCT01725997|Rockwood|rockwood
332105|NCT01725984|Male Incontinence|male incontinence
332106|NCT01725984|AdVance Male Sling|advance male sling
332107|NCT01725984|AdVance XP Male Sling|advance xp male sling
332108|NCT01725984|Male Sling|male sling
332109|NCT01725971|Silicosis|silicosis
332110|NCT01725971|forced oscillations|forced oscillations
332111|NCT01725971|respiratory mechanics|respiratory mechanics
332112|NCT01725945|DASH|dash
332113|NCT01725945|diet|diet
332114|NCT01725945|asthma|asthma
332115|NCT01725945|adults|adults
332116|NCT01725945|asthma control|asthma control
332117|NCT01725932|culture, depression, cognitive therapy, behaviour therapy,|culture, depression, cognitive therapy, behaviour therapy,
332118|NCT01725919|motor|motor
332119|NCT01725919|stroke|stroke
332120|NCT01725919|hemiparesis|hemiparesis
332121|NCT01725919|rehabilitation|rehabilitation
332122|NCT01725919|constraint induced movement therapy|constraint induced movement therapy
332123|NCT01725919|CI therapy|ci therapy
332124|NCT01725906|genotypic resistance guided therapy|genotypic resistance guided therapy
332125|NCT01725893|Claw Toe|claw toe
332126|NCT01725880|Spinal Cord Injury|spinal cord injury
332127|NCT01725880|HuCNS-SC cells|hucns-sc cells
332128|NCT01725880|Human Neural Stem Cells|human neural stem cells
332129|NCT01725880|Neural Stem Cells|neural stem cells
332130|NCT01725880|Stem Cells|stem cells
332131|NCT01725867|temporomandibular joint disorder|temporomandibular joint disorder
332132|NCT01725867|myofascial pain|myofascial pain
332133|NCT01725867|manual myofascial release|manual myofascial release
332134|NCT01725867|physical therapy|physical therapy
332135|NCT01725867|oral appliance|oral appliance
332136|NCT01725841|To determine the prevalence of ESBL-producing among Enterobacteriaceae isolates in Taiwan|to determine the prevalence of esbl-producing among enterobacteriaceae isolates in taiwan
332137|NCT01725841|To determine the susceptibility of ertapenem and other antimicrobial agents against Enterobacteriaceae isolates with and without expression of ESBLs|to determine the susceptibility of ertapenem and other antimicrobial agents against enterobacteriaceae isolates with and without expression of esbls
332138|NCT01725841|To determine the molecular typing of the Enterobacteriaceae isolates with expression of ESBLs|to determine the molecular typing of the enterobacteriaceae isolates with expression of esbls
332139|NCT01725841|To analyze the association between geographic area, hospital types against the antimicrobial susceptibility|to analyze the association between geographic area, hospital types against the antimicrobial susceptibility
332140|NCT01725828|Cricothyroid membrane|cricothyroid membrane
332141|NCT01725828|Ultrasound|ultrasound
332142|NCT01725828|Neck landmarks|neck landmarks
332143|NCT01725828|External palpation|external palpation
332144|NCT01725789|Acute isovolemic anemia after gastrectomy for gastric cancer|acute isovolemic anemia after gastrectomy for gastric cancer
332145|NCT01725776|Pulmonary hypertension|pulmonary hypertension
332146|NCT01725776|Cardiac surgery|cardiac surgery
332147|NCT01725776|Cardiopulmonary Bypass (CPB)|cardiopulmonary bypass (cpb)
332148|NCT01725750|Traumatic Brain Injury|traumatic brain injury
332149|NCT01725750|TBI|tbi
332150|NCT01725750|Fatigue|fatigue
332151|NCT01725750|Post-TBI Fatigue|post-tbi fatigue
332152|NCT01725750|PTBIF|ptbif
332153|NCT01725750|Depressed Mood|depressed mood
332154|NCT01725750|Excessive Daytime Sleepiness|excessive daytime sleepiness
332155|NCT01725750|Circadian Rhythm|circadian rhythm
332156|NCT01725750|Anxiety|anxiety
332157|NCT01725750|Cognitive Dysfunction|cognitive dysfunction
332158|NCT01725750|Intervention|intervention
332159|NCT01725750|Treatment|treatment
332160|NCT01725737|ADHD|adhd
332161|NCT01725737|GlyTI-M|glyti-m
332162|NCT01725724|Autologous blood transfusion|autologous blood transfusion
332163|NCT01725724|Allogeneic blood transfusion|allogeneic blood transfusion
332164|NCT01725724|Infection rate|infection rate
332165|NCT01725685|healthy volunteers|healthy volunteers
332166|NCT01725685|Umeclidinium|umeclidinium
332167|NCT01725685|tolerability|tolerability
332168|NCT01725685|Safety|safety
332169|NCT01725685|Fluticasone Furoate|fluticasone furoate
332170|NCT01725685|Pharmacokinetics|pharmacokinetics
332171|NCT01725672|healthy volunteers|healthy volunteers
332172|NCT01725672|Diabetes mellitus|diabetes mellitus
332173|NCT01725672|glimepiride|glimepiride
332174|NCT01725672|pharmacokinetics|pharmacokinetics
332175|NCT01725672|metformin|metformin
332176|NCT01725659|Stroke|stroke
332177|NCT01725659|electric stimulation|electric stimulation
332178|NCT01725659|robotics|robotics
332179|NCT01725659|motor learning|motor learning
332180|NCT01725646|Hypertriglyceridemia, omega-3-acid ethyl ester|hypertriglyceridemia, omega-3-acid ethyl ester
332181|NCT01725633|Stretching|stretching
332182|NCT01725633|Nonlinear Aerobic Training|nonlinear aerobic training
332183|NCT01725633|14-170|14-170
332184|NCT01725607|dexmedetomidine, thoracic epidural anesthesia|dexmedetomidine, thoracic epidural anesthesia
332185|NCT01725581|OSAT|osat
332186|NCT01725581|Pelvic Examination|pelvic examination
332187|NCT01725581|Validation|validation
332188|NCT01725581|Reliability|reliability
332189|NCT01725542|HCV-HIV Co-Infection|hcv-hiv co-infection
332190|NCT01725542|Quadruple therapy|quadruple therapy
332191|NCT01725542|null responder to a standard Pegylated interferon/Ribavirin regimen|null responder to a standard pegylated interferon/ribavirin regimen
332192|NCT01725529|Hepatitis C, Chronic|hepatitis c, chronic
332193|NCT01725529|TMC435|tmc435
332194|NCT01725529|Ribavirin|ribavirin
332195|NCT01725529|peginterferon-alpha (PegIFNα-2a)|peginterferon-alpha (pegifnα-2a)
332196|NCT01725503|creatine synthesis|creatine synthesis
332197|NCT01725490|chemoprevention, metformin, familial adenomatous polyposis|chemoprevention, metformin, familial adenomatous polyposis
332198|NCT01725464|thoracotomy|thoracotomy
332199|NCT01725464|oxygen saturation|oxygen saturation
332200|NCT01725464|postoperative|postoperative
332201|NCT01725438|Circulating Trophoblastic Cells|circulating trophoblastic cells
332202|NCT01725438|Non-Invasive Prenatal Diagnosis|non-invasive prenatal diagnosis
332203|NCT01725438|Genetic analysis|genetic analysis
332204|NCT01725438|Trisomy 21|trisomy 21
332205|NCT01725438|Down's Syndrome|down's syndrome
332206|NCT01725425|snack food (chips)|snack food (chips)
332207|NCT01725425|fruit (red grapes) consumed in each condition|fruit (red grapes) consumed in each condition
332208|NCT01725425|mood|mood
332209|NCT01725399|post-operative vomiting|post-operative vomiting
332210|NCT01725373|left main, stent,angioplasty|left main, stent,angioplasty
332211|NCT01725360|asthma|asthma
332212|NCT01725360|airway hyperresponsiveness|airway hyperresponsiveness
332213|NCT01725347|nutrition assessment|nutrition assessment
332214|NCT01725347|children|children
332215|NCT01725347|preschool|preschool
332216|NCT01725347|eating behavior|eating behavior
332217|NCT01725347|Head Start|head start
332218|NCT01725347|digital technology|digital technology
332219|NCT01725334|Schizophrenia|schizophrenia
332220|NCT01725334|Negative Symptoms|negative symptoms
332221|NCT01725334|Treatment Resistance|treatment resistance
332222|NCT01725334|Deep Brain Stimulation|deep brain stimulation
332223|NCT01725334|Electrical Stimulation|electrical stimulation
332224|NCT01725334|Mental Disorders|mental disorders
332225|NCT01725334|Brain Diseases|brain diseases
332226|NCT01725334|Neurologic Manifestations|neurologic manifestations
332227|NCT01725334|Signs and Symptoms|signs and symptoms
332228|NCT01725321|Colonoscopy|colonoscopy
332229|NCT01725321|colonic adenoma|colonic adenoma
332230|NCT01725321|serrated polyps|serrated polyps
332231|NCT01725308|FK949E|fk949e
332232|NCT01725308|Major depressive episode|major depressive episode
332233|NCT01725308|patients|patients
332234|NCT01725295|fibromyalgia treatment|fibromyalgia treatment
332235|NCT01725295|physical therapy|physical therapy
332236|NCT01725295|hydrotherapy|hydrotherapy
332237|NCT01725282|patients|patients
332238|NCT01725282|FK949E|fk949e
332239|NCT01725269|AIR001|air001
332240|NCT01725269|sodium nitrite|sodium nitrite
332241|NCT01725269|PAH|pah
332242|NCT01725269|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
332243|NCT01725269|inhaled sodium nitrite|inhaled sodium nitrite
332244|NCT01725256|AIR001|air001
332245|NCT01725256|sodium nitrite|sodium nitrite
332246|NCT01725256|PAH|pah
332247|NCT01725256|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
332248|NCT01725256|inhaled sodium nitrite|inhaled sodium nitrite
332249|NCT01725243|pregnancy|pregnancy
332250|NCT01725243|postpartum hemorrhage|postpartum hemorrhage
332251|NCT01725243|Cesarean delivery|cesarean delivery
332252|NCT01725243|carbetocin|carbetocin
332253|NCT01725243|failure to progress in labor|failure to progress in labor
332254|NCT01725230|Fostamatinib,|fostamatinib,
332255|NCT01725230|simvastatin,|simvastatin,
332256|NCT01725230|rosuvastatin,|rosuvastatin,
332257|NCT01725230|Phase I,|phase i,
332258|NCT01725230|Healthy Subjects,|healthy subjects,
332259|NCT01725230|Pharmacokinetics|pharmacokinetics
332260|NCT01725217|Meningitis|meningitis
332261|NCT01725217|children|children
332262|NCT01725217|adolescents|adolescents
332263|NCT01725217|adults|adults
332264|NCT01725217|MenACWY|menacwy
332265|NCT01725204|dasatinib|dasatinib
332266|NCT01725204|Protein Kinase Inhibitors|protein kinase inhibitors
332267|NCT01725204|pegylated IFN-alpha 2B|pegylated ifn-alpha 2b
332268|NCT01725204|Interferon-alpha|interferon-alpha
332269|NCT01725178|Mild Cognitive Impairment|mild cognitive impairment
332270|NCT01725178|Dementia|dementia
332271|NCT01725178|Memory disorders|memory disorders
332272|NCT01725178|Physical fitness|physical fitness
332273|NCT01725165|Lung cancer|lung cancer
332274|NCT01725165|Non-Small Cell Lung Cancer|non-small cell lung cancer
332275|NCT01725165|NSCLC|nsclc
332276|NCT01725165|Oligometastatic Disease|oligometastatic disease
332277|NCT01725165|Chemotherapy|chemotherapy
332278|NCT01725165|Surgical control|surgical control
332279|NCT01725165|primary and metastatic sites of disease|primary and metastatic sites of disease
332280|NCT01725165|Radiation therapy|radiation therapy
332281|NCT01725165|external beam radiation|external beam radiation
332282|NCT01725165|2D/conventional techniques|2d/conventional techniques
332283|NCT01725165|three-dimensional conformal therapy|three-dimensional conformal therapy
332284|NCT01725165|intensity modulated radiation therapy|intensity modulated radiation therapy
332285|NCT01725165|IMRT|imrt
332286|NCT01725165|stereotactic radiosurgery|stereotactic radiosurgery
332288|NCT01725165|proton beam therapy|proton beam therapy
332289|NCT01725165|PBT|pbt
332290|NCT01725152|fragile x syndrome|fragile x syndrome
332291|NCT01725152|ganaxolone|ganaxolone
332292|NCT01725152|anxiety|anxiety
332293|NCT01725152|attention|attention
332294|NCT01725152|pediatric|pediatric
332295|NCT01725126|metformin|metformin
332296|NCT01725126|diabetes|diabetes
332297|NCT01725126|obesity|obesity
332298|NCT01725126|liraglutide|liraglutide
332299|NCT01725100|GSK1120212|gsk1120212
332300|NCT01725100|DMSO content|dmso content
332301|NCT01725100|pharmacokinetics|pharmacokinetics
332302|NCT01725100|solid tumors|solid tumors
332303|NCT01725100|MEK inhibitor|mek inhibitor
332304|NCT01725100|dissolution|dissolution
332305|NCT01725100|trametinib|trametinib
332306|NCT01725100|relative bioavailability|relative bioavailability
332307|NCT01725074|Coronary Heart Disease, multimorbidity, primary care, case management, loneliness, depression, social support|coronary heart disease, multimorbidity, primary care, case management, loneliness, depression, social support
332308|NCT01725048|Major depressive disorder|major depressive disorder
332309|NCT01725048|Neoplasms|neoplasms
332310|NCT01725035|De Novo Lipogenesis|de novo lipogenesis
332311|NCT01725035|Fatty Liver|fatty liver
332312|NCT01725035|Hepatic Steatosis|hepatic steatosis
332313|NCT01725035|Gene variants|gene variants
332314|NCT01725022|stem cell transplant|stem cell transplant
332315|NCT01725022|bowel microbiota|bowel microbiota
332316|NCT01725022|home care|home care
332317|NCT01725009|Healthy volunteers|healthy volunteers
332318|NCT01725009|Japanese|japanese
332319|NCT01725009|Caucasian|caucasian
332320|NCT01724983|pain|pain
332321|NCT01724983|mood|mood
332322|NCT01724983|depression|depression
332323|NCT01724983|respiration|respiration
332324|NCT01724970|anesthesia|anesthesia
332325|NCT01724970|postanesthetic recovery|postanesthetic recovery
332326|NCT01724970|ventilation|ventilation
332327|NCT01724970|bariatric surgery|bariatric surgery
332328|NCT01724957|Fractional flow reserve,|fractional flow reserve,
332329|NCT01724957|coronary bifurcation stenosis,|coronary bifurcation stenosis,
332330|NCT01724957|intracoronary ECG,|intracoronary ecg,
332331|NCT01724957|coronary stent|coronary stent
332332|NCT01724957|Coronary bifurcation lesions|coronary bifurcation lesions
332333|NCT01724957|icECG|icecg
332334|NCT01724944|Interval debulking surgery|interval debulking surgery
332335|NCT01724944|IDS|ids
332336|NCT01724944|NACT|nact
332337|NCT01724944|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
332338|NCT01724944|Lymphadenectomy|lymphadenectomy
332339|NCT01724944|Ovarian cancer|ovarian cancer
332340|NCT01724931|antifolate|antifolate
332341|NCT01724931|antiinflammatory|antiinflammatory
332342|NCT01724931|autoimmune disease|autoimmune disease
332343|NCT01724931|hematological treatment|hematological treatment
332344|NCT01724931|rheumatic disease|rheumatic disease
332345|NCT01724931|folic acid antagonist|folic acid antagonist
332346|NCT01724931|enzyme inhibitor|enzyme inhibitor
332347|NCT01724918|IV lacosamide|iv lacosamide
332348|NCT01724918|focal epilepsy|focal epilepsy
332349|NCT01724918|EEG|eeg
332350|NCT01724918|EKG|ekg
332351|NCT01724905|Diet|diet
332352|NCT01724905|Obesity|obesity
332353|NCT01724905|Chronic disease|chronic disease
332354|NCT01724879|philadelphia chromosome|philadelphia chromosome
332355|NCT01724879|BCR-ABL|bcr-abl
332356|NCT01724879|ALL|all
332357|NCT01724879|acute lymphoblastic leukemia|acute lymphoblastic leukemia
332358|NCT01724879|dasatinib|dasatinib
332359|NCT01724879|Sprycel|sprycel
332360|NCT01724853|Carpometacarpal|carpometacarpal
332361|NCT01724853|osteoarthritis|osteoarthritis
332362|NCT01724853|outcome measures|outcome measures
332363|NCT01724827|Dental caries|dental caries
332364|NCT01724827|inlays|inlays
332365|NCT01724827|composite resins|composite resins
332366|NCT01724827|IPS-Empress ceramic|ips-empress ceramic
332367|NCT01724827|bicuspid|bicuspid
332368|NCT01724827|FDI dental restorations evaluation criteria|fdi dental restorations evaluation criteria
332369|NCT01724801|EGFR mutant|egfr mutant
332370|NCT01724775|complete mesocolic excision|complete mesocolic excision
332371|NCT01724775|colon cancer|colon cancer
332372|NCT01724775|efficacy|efficacy
332373|NCT01724775|safety|safety
332374|NCT01724762|Baths|baths
332375|NCT01724762|Anxiety|anxiety
332376|NCT01724762|Acute Coronary Syndrome|acute coronary syndrome
332377|NCT01724762|Education, Nursing|education, nursing
332378|NCT01724749|Atherosclerosis|atherosclerosis
332379|NCT01724749|Sodium-Fluoride|sodium-fluoride
332380|NCT01724749|18F-Sodium Fluoride|18f-sodium fluoride
332381|NCT01724749|18F-NaF|18f-naf
332382|NCT01724749|fluorodeoxyglucose|fluorodeoxyglucose
332383|NCT01724749|18F-FDG|18f-fdg
332384|NCT01724749|FDG|fdg
332385|NCT01724749|Positron emission tomography|positron emission tomography
332386|NCT01724749|PET|pet
332387|NCT01724736|microbiome|microbiome
332388|NCT01724736|prebiotic|prebiotic
332389|NCT01724736|cobiotic|cobiotic
332390|NCT01724736|NM504|nm504
332391|NCT01724736|GI microbiome|gi microbiome
332392|NCT01724723|hepatitis during anti-tuberculous treatment|hepatitis during anti-tuberculous treatment
332393|NCT01724723|tuberculosis|tuberculosis
332394|NCT01724723|hepatitis B virus|hepatitis b virus
332395|NCT01724723|viral load|viral load
332396|NCT01724723|entecavir|entecavir
332397|NCT01724697|liver cirrhosis|liver cirrhosis
332398|NCT01724697|end stage liver disease|end stage liver disease
332399|NCT01724697|HBV|hbv
332400|NCT01724697|autologous|autologous
332401|NCT01724697|stem cell|stem cell
332402|NCT01724697|bone morrow|bone morrow
332403|NCT01724671|MRSA|mrsa
332404|NCT01724671|Bacteremia|bacteremia
332405|NCT01724671|ABSSSI|absssi
332406|NCT01724671|Pneumonia|pneumonia
332407|NCT01724671|Vancomycin|vancomycin
332408|NCT01724671|Ceftaroline|ceftaroline
332409|NCT01724658|female sexual function|female sexual function
332410|NCT01724658|postmenopause|postmenopause
332411|NCT01724658|testosterone|testosterone
332412|NCT01724645|Korean Traditional diets|korean traditional diets
332413|NCT01724645|hypertension|hypertension
332414|NCT01724645|diabetes|diabetes
332415|NCT01724632|Overweight|overweight
332416|NCT01724632|Obesity|obesity
332417|NCT01724632|Weight Loss|weight loss
332418|NCT01724606|Whole Brain Radiotherapy (WBRT)|whole brain radiotherapy (wbrt)
332419|NCT01724606|Sorafenib (BAY 43-9006)|sorafenib (bay 43-9006)
332420|NCT01724606|12-046|12-046
332421|NCT01724593|functional recovery, critical illness, pediatrics|functional recovery, critical illness, pediatrics
332422|NCT01724567|Interval Training|interval training
332423|NCT01724567|Weight Loss|weight loss
332424|NCT01724567|Secondary Prevention|secondary prevention
332425|NCT01724567|Rehabilitation|rehabilitation
332426|NCT01724567|Cardiovascular Risk Factors|cardiovascular risk factors
332427|NCT01724528|Febuxostat, Tumor lysis syndrome, leukemia, lymphoma|febuxostat, tumor lysis syndrome, leukemia, lymphoma
332428|NCT01724515|insulin resistance|insulin resistance
332429|NCT01724502|insulin resistance|insulin resistance
332430|NCT01724463|Systemic Inflammatory Response Syndrome (SIRS)|systemic inflammatory response syndrome (sirs)
332431|NCT01724463|Sepsis|sepsis
332432|NCT01724463|Severe Sepsis|severe sepsis
332433|NCT01724463|Septic Shock|septic shock
332434|NCT01724463|Electronic Health Record|electronic health record
332435|NCT01724463|Health Screening|health screening
332436|NCT01724463|Goal Directed Therapy|goal directed therapy
332437|NCT01724463|Infant|infant
332438|NCT01724463|Child|child
332439|NCT01724463|Pediatric|pediatric
332440|NCT01724463|Adolescent|adolescent
332441|NCT01724463|Critical Illness|critical illness
332442|NCT01724463|Outcomes Research|outcomes research
332443|NCT01724463|Resource Utilization|resource utilization
332444|NCT01724450|Breast Cancer|breast cancer
332445|NCT01724450|Heart Failure|heart failure
332446|NCT01724450|Cardiotoxicity|cardiotoxicity
332447|NCT01724450|Biomarkers|biomarkers
332448|NCT01724411|Overweight and Obesity|overweight and obesity
332449|NCT01724411|Appetite|appetite
332450|NCT01724411|Gut hormones and obesity|gut hormones and obesity
332451|NCT01724411|Resistant Starch|resistant starch
332452|NCT01724411|Gut microbiota and obesity|gut microbiota and obesity
332453|NCT01724411|SmartPill|smartpill
332454|NCT01724398|mesenchymal stem cells|mesenchymal stem cells
332455|NCT01724398|plasma exchange|plasma exchange
332456|NCT01724398|liver failure|liver failure
332457|NCT01724398|hepatitis B virus|hepatitis b virus
332458|NCT01724385|bevacizumab,|bevacizumab,
332459|NCT01724385|proliferative diabetic retinopathy,|proliferative diabetic retinopathy,
332460|NCT01724385|vitreous hemorrhage,|vitreous hemorrhage,
332461|NCT01724359|Schizophrenia|schizophrenia
332462|NCT01724359|Paliperidone extended-release (ER)|paliperidone extended-release (er)
332463|NCT01724359|Antipsychotic agents|antipsychotic agents
332464|NCT01724346|CLL, SLL|cll, sll
332465|NCT01724333|EORTC QLQ-C30|eortc qlq-c30
332466|NCT01724333|Oral health|oral health
332467|NCT01724333|Quality of life|quality of life
332468|NCT01724333|Questionnaires|questionnaires
332469|NCT01724333|Patient reported|patient reported
332470|NCT01724333|outcomes|outcomes
332471|NCT01724320|solid tumors|solid tumors
332472|NCT01724320|first-in-man|first-in-man
332473|NCT01724320|phase I|phase i
332474|NCT01724320|cancer|cancer
332475|NCT01724320|galectin|galectin
332476|NCT01724281|lateral ventricles|lateral ventricles
332477|NCT01724281|Asymetry|asymetry
332478|NCT01724255|Caesarian section|caesarian section
332479|NCT01724255|Surgical Wound|surgical wound
332480|NCT01724242|Vaginal dryness|vaginal dryness
332481|NCT01724242|Breast Cancer|breast cancer
332482|NCT01724242|Urinary Incontinence|urinary incontinence
332483|NCT01724242|Quality of Life|quality of life
332484|NCT01724242|Sexual Satisfaction|sexual satisfaction
332485|NCT01724229|Incontinence-associated dermatitis|incontinence-associated dermatitis
332486|NCT01724229|Skin care regimen for moisture-associated conditions|skin care regimen for moisture-associated conditions
332487|NCT01724229|Perineal skin care|perineal skin care
332488|NCT01724229|Fungal infection in perineal area|fungal infection in perineal area
332489|NCT01724203|Probiotics for infants|probiotics for infants
332490|NCT01724203|Bacterial and viral infections in infants|bacterial and viral infections in infants
332491|NCT01724190|Type 1 Diabetes|type 1 diabetes
332492|NCT01724190|Vitamin D|vitamin d
332493|NCT01724190|Clinical Remission|clinical remission
332494|NCT01724177|Lenalidomide|lenalidomide
332495|NCT01724177|ATL|atl
332496|NCT01724177|ATLL|atll
332497|NCT01724138|deferasirox|deferasirox
332498|NCT01724125|serious mental illness|serious mental illness
332499|NCT01724099|Obesity|obesity
332500|NCT01724099|Herbal product|herbal product
332501|NCT01724099|Korean Medicine|korean medicine
332502|NCT01724086|Chronic hepatitis C|chronic hepatitis c
332503|NCT01724086|Chronic hepatitis C-infected patients|chronic hepatitis c-infected patients
332504|NCT01724086|TMC647055|tmc647055
332505|NCT01724086|TMC435|tmc435
332506|NCT01724086|Ritonavir|ritonavir
332507|NCT01724086|Ribavirin|ribavirin
332508|NCT01724086|Genotype 1a|genotype 1a
332509|NCT01724086|Genotype 1b|genotype 1b
332510|NCT01724086|GSK2336805|gsk2336805
332511|NCT01724073|food to food fortification strategy|food to food fortification strategy
332512|NCT01724073|leafy vegetable|leafy vegetable
332513|NCT01724073|iron|iron
332514|NCT01724073|zinc|zinc
332515|NCT01724073|vitamin A|vitamin a
332516|NCT01724073|growth|growth
332517|NCT01724047|Autism|autism
332518|NCT01724047|School Based Intervention|school based intervention
332519|NCT01724034|Weaning|weaning
332520|NCT01724034|Mechanical Ventilation|mechanical ventilation
332521|NCT01724034|Lung Ultrasound|lung ultrasound
332522|NCT01723995|nipple/injure|nipple/injure
332523|NCT01723995|breastfeeding|breastfeeding
332524|NCT01723995|pain|pain
332525|NCT01723995|laser|laser
332526|NCT01723956|Cervical Dysplasia|cervical dysplasia
332527|NCT01723956|Cin 2|cin 2
332528|NCT01723956|Cin 3|cin 3
332529|NCT01723956|HIV positive women|hiv positive women
332530|NCT01723956|South Africa|south africa
332531|NCT01723904|Rotigotine|rotigotine
332532|NCT01723904|Neupro|neupro
332533|NCT01723865|Heart failure|heart failure
332534|NCT01723865|Remote Monitoring|remote monitoring
332535|NCT01723865|ICD|icd
332536|NCT01723865|Follow-up|follow-up
332537|NCT01723852|Vitamin D|vitamin d
332538|NCT01723852|Infectious diseases|infectious diseases
332539|NCT01723852|cognitive development|cognitive development
332540|NCT01723852|Bone mineral density|bone mineral density
332541|NCT01723852|Immunoregulation|immunoregulation
332542|NCT01723852|Allergy|allergy
332543|NCT01723852|Growth|growth
332544|NCT01723839|CLL|cll
332545|NCT01723839|FCR|fcr
332546|NCT01723839|Rituximab|rituximab
332547|NCT01723839|Lenalidomide|lenalidomide
332548|NCT01723839|Cyclophosphamide|cyclophosphamide
332549|NCT01723813|Immunotherapy|immunotherapy
332550|NCT01723813|Tumor-specific peptides|tumor-specific peptides
332551|NCT01723813|GM-CT-01|gm-ct-01
332552|NCT01723761|air pollution|air pollution
332553|NCT01723761|pacemaker|pacemaker
332554|NCT01723761|ICD|icd
332555|NCT01723761|remote monitoring|remote monitoring
332556|NCT01723761|supraventricular arrhythmias|supraventricular arrhythmias
332557|NCT01723761|ventricular arrhythmias|ventricular arrhythmias
332558|NCT01723748|Acromegaly|acromegaly
332559|NCT01723748|Somatostatin treatment|somatostatin treatment
332560|NCT01723748|metabolic effect|metabolic effect
332561|NCT01723722|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
332562|NCT01723722|Methadone|methadone
332563|NCT01723722|Diluted Deodorized Tincture of Opium|diluted deodorized tincture of opium
332564|NCT01723722|dDTO|ddto
332565|NCT01723722|Phenobarbital|phenobarbital
332566|NCT01723709|multiple sclerosis|multiple sclerosis
332567|NCT01723709|immune response|immune response
332568|NCT01723709|genetic|genetic
332569|NCT01723709|progression|progression
332570|NCT01723709|relapse|relapse
332571|NCT01723709|biomarkers|biomarkers
332572|NCT01723709|disease|disease
332573|NCT01723709|proteomics|proteomics
332574|NCT01723709|genome|genome
332575|NCT01723709|gene|gene
332576|NCT01723696|In-utero smoke;|in-utero smoke;
332577|NCT01723696|Pulmonary function testing;|pulmonary function testing;
332578|NCT01723696|Wheeze;|wheeze;
332579|NCT01723696|Vitamin C;|vitamin c;
332580|NCT01723696|Forced expiratory flows|forced expiratory flows
332581|NCT01723683|Preterm infants|preterm infants
332582|NCT01723683|RDS|rds
332583|NCT01723683|Surfactant|surfactant
332584|NCT01723683|MISTCPAP|mistcpap
332585|NCT01723683|CPAP|cpap
332586|NCT01723657|Leukemia|leukemia
332587|NCT01723657|Myeloid|myeloid
332588|NCT01723657|Acute|acute
332589|NCT01723657|Young|young
332590|NCT01723657|CETLAM|cetlam
332591|NCT01723644|antibiotherapy, community acquired pneumonia, procalcitonin guided guidelines, clinical reassessment|antibiotherapy, community acquired pneumonia, procalcitonin guided guidelines, clinical reassessment
332592|NCT01723631|Multiple sclerosis|multiple sclerosis
332593|NCT01723631|TRAP|trap
332594|NCT01723631|TRAP-Myéline|trap-myéline
332595|NCT01723605|insitu repair|insitu repair
332596|NCT01723605|intestinal motility|intestinal motility
332597|NCT01723592|chemotherapy|chemotherapy
332598|NCT01723592|vaginal flora|vaginal flora
332599|NCT01723553|aphasia|aphasia
332600|NCT01723553|logopenic|logopenic
332601|NCT01723553|PCA|pca
332602|NCT01723553|LPA|lpa
332603|NCT01723540|Cholecystectomy,minilaparotomy,laparascopy,ultrasonic dissection|cholecystectomy,minilaparotomy,laparascopy,ultrasonic dissection
332604|NCT01723527|Cocaine|cocaine
332605|NCT01723527|Heroin|heroin
332606|NCT01723527|HIV|hiv
332607|NCT01723527|Contingency Management|contingency management
332608|NCT01723527|Incentives|incentives
332609|NCT01723527|Criminal Justice|criminal justice
332610|NCT01723527|Methadone|methadone
332611|NCT01723527|Buprenorphine|buprenorphine
332612|NCT01723527|Employment|employment
332613|NCT01723527|Job Training|job training
332614|NCT01723527|Wage Subsidies|wage subsidies
332615|NCT01723514|Migraine|migraine
332616|NCT01723501|chlorhexidine|chlorhexidine
332617|NCT01723501|sepsis|sepsis
332618|NCT01723501|neonatal|neonatal
332619|NCT01723501|whole-body skin cleansing|whole-body skin cleansing
332620|NCT01723488|AD|ad
332621|NCT01723475|Phase I|phase i
332622|NCT01723475|Dose Escalation|dose escalation
332623|NCT01723475|Prostate cancer|prostate cancer
332624|NCT01723475|Antibodies|antibodies
332625|NCT01723475|Bispecific T-cell Engager (BiTE)|bispecific t-cell engager (bite)
332626|NCT01723436|Decision fatigue|decision fatigue
332627|NCT01723423|breast cancer|breast cancer
332628|NCT01723423|evidence based medicine|evidence based medicine
332629|NCT01723423|reconstruction|reconstruction
332630|NCT01723423|mastectomy|mastectomy
332631|NCT01723423|outcomes|outcomes
332632|NCT01723423|quality of life|quality of life
332633|NCT01723384|methamphetamine|methamphetamine
332634|NCT01723384|alcohol|alcohol
332635|NCT01723384|HIV|hiv
332636|NCT01723384|sexual behavior|sexual behavior
332637|NCT01723371|Pulmonary Arterial Hypertension (PAH|pulmonary arterial hypertension (pah
332638|NCT01723371|Pediatrics|pediatrics
332639|NCT01723371|Right Heart Failure (RHF)|right heart failure (rhf)
332640|NCT01723371|Carvedilol|carvedilol
332641|NCT01723371|Beta-blockers|beta-blockers
332642|NCT01723358|pediatrics|pediatrics
332643|NCT01723358|dysphagia|dysphagia
332644|NCT01723345|elective percutaneous coronary intervention|elective percutaneous coronary intervention
332645|NCT01723345|omega 3 polyunsaturated fatty acids (PUFAs)|omega 3 polyunsaturated fatty acids (pufas)
332646|NCT01723345|short-term MACE|short-term mace
332647|NCT01723345|long-term MACE|long-term mace
332648|NCT01723332|Transition from pediatric to adult clinical care|transition from pediatric to adult clinical care
332649|NCT01723319|ADHD|adhd
332650|NCT01723319|TMS|tms
332651|NCT01723319|brain stimulation|brain stimulation
332652|NCT01723319|clinical improvement|clinical improvement
332653|NCT01723306|T cells|t cells
332654|NCT01723306|gene transfer|gene transfer
332655|NCT01723306|immunotherapy|immunotherapy
332656|NCT01723306|metastatic cancers|metastatic cancers
332657|NCT01723306|lung cancer|lung cancer
332658|NCT01723306|gastric cancer|gastric cancer
332659|NCT01723306|colorectal cancer|colorectal cancer
332660|NCT01723306|solid tumors|solid tumors
332661|NCT01723293|Fetal heart rate, pregnancy, fetus, cardiovascular system|fetal heart rate, pregnancy, fetus, cardiovascular system
332662|NCT01723267|IVF|ivf
332663|NCT01723267|3D ultrasound|3d ultrasound
332664|NCT01723267|SonoAVC|sonoavc
332665|NCT01723267|patients in IVF treatment|patients in ivf treatment
332666|NCT01723254|Vaccines|vaccines
332667|NCT01723254|Phase 1|phase 1
332668|NCT01723254|Allergic Rhinitis|allergic rhinitis
332669|NCT01723241|volunteers|volunteers
332670|NCT01723228|Parkinson's Disease|parkinson's disease
332671|NCT01723228|Cognition|cognition
332672|NCT01723228|Rasagiline|rasagiline
332673|NCT01723215|Attention bias modification|attention bias modification
332674|NCT01723215|resilience|resilience
332675|NCT01723215|combat|combat
332676|NCT01723215|PTSD|ptsd
332677|NCT01723215|Depression|depression
332678|NCT01723215|Anxiety|anxiety
332679|NCT01723202|BRAF|braf
332680|NCT01723202|BRAFi|brafi
332681|NCT01723202|thyroid cancer|thyroid cancer
332682|NCT01723202|thyroid carcinoma|thyroid carcinoma
332683|NCT01723189|central apnoeas|central apnoeas
332684|NCT01723189|stroke|stroke
332685|NCT01723176|goal-directed echocardiography|goal-directed echocardiography
332686|NCT01723176|cardiopulmonary failure|cardiopulmonary failure
332687|NCT01723176|critical care ultrasound|critical care ultrasound
332688|NCT01723163|veteran|veteran
332689|NCT01723163|smoking cessation|smoking cessation
332690|NCT01723150|Klebsiella pneumoniae|klebsiella pneumoniae
332691|NCT01723137|Pain|pain
332692|NCT01723137|Pain measurement|pain measurement
332693|NCT01723137|Visual analog scale|visual analog scale
332694|NCT01723137|Anxiety|anxiety
332695|NCT01723137|Stress|stress
332696|NCT01723137|Opioid|opioid
332697|NCT01723137|Emergency department|emergency department
332698|NCT01723137|Demographics|demographics
332699|NCT01723124|Dense breast tissue|dense breast tissue
332700|NCT01723124|breast cancer screening|breast cancer screening
332701|NCT01723124|molecular breast imaging|molecular breast imaging
332702|NCT01723124|breast cancer|breast cancer
332703|NCT01723124|breast|breast
332704|NCT01723111|hepcidin|hepcidin
332705|NCT01723111|ESA|esa
332706|NCT01723111|hemodialysis|hemodialysis
332707|NCT01723111|peritoneal dialysis|peritoneal dialysis
332708|NCT01723111|iron metabolism|iron metabolism
332709|NCT01723111|dialysis modality|dialysis modality
332710|NCT01723098|Pregnancy, cardiovascular system, physical exercise|pregnancy, cardiovascular system, physical exercise
332711|NCT01723085|Anti-Mullerian hormone|anti-mullerian hormone
332712|NCT01723085|Myomectomy|myomectomy
332713|NCT01723085|Laparotomy|laparotomy
332714|NCT01723072|Chronic spontanous urticaria, refractory CSU, Angioedema|chronic spontanous urticaria, refractory csu, angioedema
332715|NCT01723046|Upper extremity|upper extremity
332716|NCT01723046|Rehabilitation|rehabilitation
332717|NCT01723046|Robot assisted therapy|robot assisted therapy
332718|NCT01723046|Robotics|robotics
332719|NCT01723046|Devices|devices
332720|NCT01723046|Orthosis|orthosis
332721|NCT01723046|clinical outcome|clinical outcome
332722|NCT01723033|PTSD|ptsd
332723|NCT01723033|OCD|ocd
332724|NCT01723020|Solid Tumors|solid tumors
332725|NCT01723020|Multiple Myeloma|multiple myeloma
332726|NCT01723007|Weight loss|weight loss
332727|NCT01723007|cholesterol|cholesterol
332728|NCT01722968|Metastatic breast cancer|metastatic breast cancer
332729|NCT01722955|Prewarmed fluid|prewarmed fluid
332730|NCT01722955|monitored anesthesia care|monitored anesthesia care
332731|NCT01722955|core body temperature|core body temperature
332732|NCT01722955|anesthetic satisfaction|anesthetic satisfaction
332733|NCT01722942|Chagas cardiomyopathy|chagas cardiomyopathy
332734|NCT01722942|sudden cardiac death|sudden cardiac death
332735|NCT01722942|primary prevention of death|primary prevention of death
332736|NCT01722942|amiodarone|amiodarone
332737|NCT01722942|implantable cardioverter defibrillator|implantable cardioverter defibrillator
332738|NCT01722903|colorectal cancer|colorectal cancer
332739|NCT01722903|liver metastases|liver metastases
332740|NCT01722903|lung metastases|lung metastases
332741|NCT01722890|HER2-positive breast cancer|her2-positive breast cancer
332742|NCT01722890|durable complete response|durable complete response
332743|NCT01722890|cytogenetic characteristics|cytogenetic characteristics
332744|NCT01722890|molecular characteristics|molecular characteristics
332745|NCT01722890|trastuzumab|trastuzumab
332746|NCT01722877|Restenosis|restenosis
332747|NCT01722877|aspiration|aspiration
332748|NCT01722877|in-stent restenosis|in-stent restenosis
332749|NCT01722877|atherectomy|atherectomy
332750|NCT01722877|superficial femoral artery|superficial femoral artery
332751|NCT01722877|popliteal artery|popliteal artery
332752|NCT01722851|Breast Cancer|breast cancer
332753|NCT01722851|miRNAs|mirnas
332754|NCT01722851|Newly diagnosed|newly diagnosed
332755|NCT01722851|Recurrent|recurrent
332756|NCT01722838|Black MSM|black msm
332757|NCT01722838|HIV Prevention|hiv prevention
332758|NCT01722799|angioplasty|angioplasty
332759|NCT01722799|Percutaneous Transluminal Coronary Angioplasty|percutaneous transluminal coronary angioplasty
332760|NCT01722799|Drug elluting Balloon|drug elluting balloon
332761|NCT01722799|Coronary Balloon|coronary balloon
332762|NCT01722799|Dilatation|dilatation
332763|NCT01722786|severe bleeding|severe bleeding
332764|NCT01722786|dabigatran|dabigatran
332765|NCT01722786|rivaroxaban|rivaroxaban
332766|NCT01722786|apixaban|apixaban
332767|NCT01722786|edoxaban|edoxaban
332768|NCT01722786|PCC|pcc
332769|NCT01722786|aPCC|apcc
332770|NCT01722786|rVIIa|rviia
332771|NCT01722786|hemodialysis|hemodialysis
332772|NCT01722786|antidots|antidots
332773|NCT01722786|idarucizumab|idarucizumab
332774|NCT01722773|COPD|copd
332775|NCT01722760|Neonatal|neonatal
332776|NCT01722760|Preterm|preterm
332777|NCT01722760|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
332778|NCT01722760|Nasal Continuous Positive airway Pressure (CPAP)|nasal continuous positive airway pressure (cpap)
332779|NCT01722760|Oxygen|oxygen
332780|NCT01722760|Vitamin A|vitamin a
332781|NCT01722760|Vitamin D|vitamin d
332782|NCT01722760|Nitrogen oxide (NO)|nitrogen oxide (no)
332783|NCT01722760|Reference material|reference material
332784|NCT01722734|Malaria|malaria
332785|NCT01722734|ACTs|acts
332786|NCT01722708|Abnormal vaginal flora|abnormal vaginal flora
332787|NCT01722708|clindamycin Vs metronidazole|clindamycin vs metronidazole
332788|NCT01722708|High risk pregnancies for preterm labor|high risk pregnancies for preterm labor
332789|NCT01722708|Preterm labor|preterm labor
332790|NCT01722708|Late abortion|late abortion
332791|NCT01722708|bacterial vaginosis|bacterial vaginosis
332792|NCT01722682|Diabetes|diabetes
332793|NCT01722669|quercetin|quercetin
332794|NCT01722669|isoquercetin|isoquercetin
332795|NCT01722669|pharmacokinetic|pharmacokinetic
332796|NCT01722669|pharmacodynamic|pharmacodynamic
332797|NCT01722656|PED|ped
332798|NCT01722656|AMD|amd
332799|NCT01722656|CNV|cnv
332800|NCT01722630|dopamine|dopamine
332801|NCT01722630|laparoscopy|laparoscopy
332802|NCT01722630|fluid management|fluid management
332803|NCT01722578|Cirrhosis|cirrhosis
332804|NCT01722578|Encephalopathy|encephalopathy
332805|NCT01722578|L-ornithine L-aspartate|l-ornithine l-aspartate
332806|NCT01722565|Parastomal hernias|parastomal hernias
332807|NCT01722565|Tolerance of lightweight meshes|tolerance of lightweight meshes
332808|NCT01722565|laparoscopic abdominoperineal resection|laparoscopic abdominoperineal resection
332809|NCT01722552|HIV|hiv
332810|NCT01722552|AIDS|aids
332811|NCT01722552|antiretroviral therapy|antiretroviral therapy
332812|NCT01722552|adherence|adherence
332813|NCT01722552|China|china
332814|NCT01722539|intermittent|intermittent
332815|NCT01722539|preventive|preventive
332816|NCT01722539|treatment|treatment
332817|NCT01722539|malaria|malaria
332818|NCT01722539|soil transmitted helminths|soil transmitted helminths
332819|NCT01722539|schistosomiasis|schistosomiasis
332820|NCT01722539|schoolchildren|schoolchildren
332821|NCT01722526|Human acid sphingomyelinase deficiency|human acid sphingomyelinase deficiency
332822|NCT01722513|Contrast Induced Nephropathy|contrast induced nephropathy
332823|NCT01722500|International|international
332824|NCT01722500|Childhood|childhood
332825|NCT01722500|Obesity|obesity
332826|NCT01722500|ISCOLE|iscole
332827|NCT01722500|Pennington Biomedical Research Center|pennington biomedical research center
332828|NCT01722500|PBRC|pbrc
332829|NCT01722500|longitudinal|longitudinal
332830|NCT01722500|multinational|multinational
332831|NCT01722487|CLL, SLL|cll, sll
332832|NCT01722474|Pulse Wave Analysis|pulse wave analysis
332833|NCT01722474|Arterial Stiffness|arterial stiffness
332834|NCT01722461|Excessive underarm sweating|excessive underarm sweating
332835|NCT01722448|muscle|muscle
332836|NCT01722448|muscle dysfunction|muscle dysfunction
332837|NCT01722448|choline|choline
332838|NCT01722448|exercise|exercise
332839|NCT01722448|exertional rhabdomyolysis|exertional rhabdomyolysis
332840|NCT01722448|rhabdomyolysis|rhabdomyolysis
332841|NCT01722435|opioid dependence|opioid dependence
332842|NCT01722435|opiate substitution treatment|opiate substitution treatment
332843|NCT01722435|methadone|methadone
332844|NCT01722435|completion|completion
332845|NCT01722435|termination|termination
332846|NCT01722422|sepsis|sepsis
332847|NCT01722422|shock|shock
332848|NCT01722422|hyperoxia|hyperoxia
332849|NCT01722422|hypertonic saline|hypertonic saline
332850|NCT01722409|dexmedetomidine, endovascular coil embolization|dexmedetomidine, endovascular coil embolization
332851|NCT01722357|bariatric surgery|bariatric surgery
332852|NCT01722357|physical activity|physical activity
332853|NCT01722357|morbid obesity|morbid obesity
332854|NCT01722344|Severe mental illness|severe mental illness
332855|NCT01722344|Vocational rehabilitation|vocational rehabilitation
332856|NCT01722344|Supported employment|supported employment
332857|NCT01722344|Individual placement and support|individual placement and support
332858|NCT01722344|Cognitive remediation|cognitive remediation
332859|NCT01722344|Social skill training|social skill training
332860|NCT01722279|bariatric surgery|bariatric surgery
332861|NCT01722279|long-term outcomes|long-term outcomes
332862|NCT01722279|obesity|obesity
332863|NCT01722266|Liraglutide|liraglutide
332864|NCT01722266|Glucagon|glucagon
332865|NCT01722266|Systolic blood pressure|systolic blood pressure
332866|NCT01722266|Weight|weight
332867|NCT01722266|Carbohydrate intake|carbohydrate intake
332868|NCT01722266|Insulin dose|insulin dose
332869|NCT01722266|HbA1c|hba1c
332870|NCT01722266|Post-prandial glucagon|post-prandial glucagon
332871|NCT01722253|electroacupuncture|electroacupuncture
332872|NCT01722253|acupuncture|acupuncture
332873|NCT01722253|pain management|pain management
332874|NCT01722214|Psoriasis|psoriasis
332875|NCT01722214|Vascular Inflammation|vascular inflammation
332876|NCT01722214|Coronary Atherosclerosis|coronary atherosclerosis
332877|NCT01722214|Ascending aorta|ascending aorta
332878|NCT01722214|Pet scan|pet scan
332879|NCT01722214|MRI|mri
332880|NCT01722188|Optim|optim
332881|NCT01722188|Insulation|insulation
332882|NCT01722149|malignant pleural mesothelioma|malignant pleural mesothelioma
332883|NCT01722149|re-directed T cells|re-directed t cells
332884|NCT01722149|FAP|fap
332885|NCT01722149|fibroblast activation protein|fibroblast activation protein
332886|NCT01722149|CD8 positive T cells|cd8 positive t cells
332887|NCT01722149|pleural effusion|pleural effusion
332888|NCT01722123|Decision fatigue|decision fatigue
332889|NCT01722071|Oxytocin|oxytocin
332890|NCT01722071|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
332891|NCT01722071|Social|social
332892|NCT01722071|Motivation|motivation
332893|NCT01722058|peptide|peptide
332894|NCT01722058|colon|colon
332895|NCT01722058|flat lesions|flat lesions
332896|NCT01722045|AMD|amd
332897|NCT01722032|childhood obesity, early childhood, nutrition|childhood obesity, early childhood, nutrition
332898|NCT01722019|venous insufficiency|venous insufficiency
332899|NCT01722006|methamphetamine|methamphetamine
332900|NCT01722006|subjective|subjective
332901|NCT01722006|conditioning|conditioning
332902|NCT01722006|preference|preference
332903|NCT01721993|oral zoledronic acid|oral zoledronic acid
332904|NCT01721967|chest pain|chest pain
332905|NCT01721967|dyspnea|dyspnea
332906|NCT01721954|colon|colon
332907|NCT01721954|rectum|rectum
332908|NCT01721954|metastatic colorectal cancer|metastatic colorectal cancer
332909|NCT01721954|liver metastases|liver metastases
332910|NCT01721941|hepatocellular carcinoma|hepatocellular carcinoma
332911|NCT01721941|HCC|hcc
332912|NCT01721941|liver cancer|liver cancer
332913|NCT01721941|hepatoma|hepatoma
332914|NCT01721941|TACE|tace
332915|NCT01721941|transarterial chemoembolization|transarterial chemoembolization
332916|NCT01721941|TH302|th302
332917|NCT01721928|Acute kidney injury|acute kidney injury
332918|NCT01721928|Deep venous thrombosis|deep venous thrombosis
332919|NCT01721928|Dialysis|dialysis
332920|NCT01721928|Prophylaxis|prophylaxis
332921|NCT01721915|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
332922|NCT01721915|glucose metabolism|glucose metabolism
332923|NCT01721915|Vitamin D deficiency|vitamin d deficiency
332924|NCT01721915|vitamin D supplementation|vitamin d supplementation
332925|NCT01721915|pharmakogenetics|pharmakogenetics
332926|NCT01721915|women|women
332927|NCT01721863|Atrial Fibrillation|atrial fibrillation
332928|NCT01721863|Exercise Training|exercise training
332929|NCT01721863|Endothelial Function|endothelial function
332930|NCT01721863|Autonomic Nerve Modulation|autonomic nerve modulation
332931|NCT01721863|Exercise Capacity|exercise capacity
332932|NCT01721863|Quality of Life|quality of life
332933|NCT01721850|infant nutrition, infantile colic|infant nutrition, infantile colic
332934|NCT01721824|Supported employment|supported employment
332935|NCT01721824|Individual Placement and Support|individual placement and support
332936|NCT01721824|Workability|workability
332937|NCT01721824|Return to work|return to work
332938|NCT01721798|AE adverse event|ae adverse event
332939|NCT01721798|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
332940|NCT01721798|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
332941|NCT01721798|ART antiretroviral therapy|art antiretroviral therapy
332942|NCT01721798|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
332943|NCT01721798|DCF data collection forms|dcf data collection forms
332944|NCT01721798|DMC Data Monitoring Committee|dmc data monitoring committee
332945|NCT01721798|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
332946|NCT01721798|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
332947|NCT01721798|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
332948|NCT01721798|ICH International Conference of Harmonization|ich international conference of harmonization
332949|NCT01721798|IND Investigational New Drug Application|ind investigational new drug application
332950|NCT01721798|IRB Institutional Review Board|irb institutional review board
332951|NCT01721798|IU International units|iu international units
332952|NCT01721798|mg milligram(s)|mg milligram(s)
332953|NCT01721798|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
332954|NCT01721798|PCR polymerase chain reaction|pcr polymerase chain reaction
332955|NCT01721798|SAE serious adverse event|sae serious adverse event
332956|NCT01721798|µg microgram|µg microgram
332957|NCT01721798|ULN upper limit of the normal range|uln upper limit of the normal range
332958|NCT01721798|WB Western Blot|wb western blot
332959|NCT01721785|Nodal imaging|nodal imaging
332960|NCT01721785|Restaging|restaging
332961|NCT01721733|EPI743|epi743
332962|NCT01721733|Leigh syndrome|leigh syndrome
332963|NCT01721733|respiratory chain disease|respiratory chain disease
332964|NCT01721733|mitochondrial disorders|mitochondrial disorders
332965|NCT01721720|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
332966|NCT01721720|Behavioral Phenotype|behavioral phenotype
332967|NCT01721720|Brain Development|brain development
332968|NCT01721720|Complex Disease|complex disease
332969|NCT01721720|Social Networks|social networks
332970|NCT01721707|glaucoma|glaucoma
332971|NCT01721707|ocular hypertension|ocular hypertension
332972|NCT01721707|latanoprost|latanoprost
332973|NCT01721707|brinzolamide|brinzolamide
332974|NCT01721694|bacterial ocular inflammation|bacterial ocular inflammation
332975|NCT01721694|blepharitis|blepharitis
332976|NCT01721694|keratitis|keratitis
332977|NCT01721694|conjunctivitis|conjunctivitis
332978|NCT01721655|Spironolactone|spironolactone
332979|NCT01721655|Preterm Infants|preterm infants
332980|NCT01721655|Chronic Lung Disease|chronic lung disease
332981|NCT01721655|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
332982|NCT01721655|Electrolyte Supplementation|electrolyte supplementation
332983|NCT01721642|access|access
332984|NCT01721642|closure|closure
332985|NCT01721642|trans-apical|trans-apical
332986|NCT01721642|trans-catheter aortic valve implantation|trans-catheter aortic valve implantation
332987|NCT01721642|TAVI|tavi
332988|NCT01721642|trans-catheter aortic valve repair|trans-catheter aortic valve repair
332989|NCT01721642|TAVR|tavr
332990|NCT01721629|Nasal cpap weaning|nasal cpap weaning
332991|NCT01721629|Premature infants|premature infants
332992|NCT01721629|Respiratory distress syndrome|respiratory distress syndrome
332993|NCT01721629|Randomized controlled trial|randomized controlled trial
332994|NCT01721603|BRAFV600E melanoma patients|brafv600e melanoma patients
332995|NCT01721603|melanoma|melanoma
332996|NCT01721603|stereotactic radiosurgery|stereotactic radiosurgery
332997|NCT01721603|BRAFV600E melanoma brain metastases|brafv600e melanoma brain metastases
332998|NCT01721603|dabrafenib|dabrafenib
332999|NCT01721603|SRS|srs
333000|NCT01721590|high on-treatment platelet reactivity|high on-treatment platelet reactivity
333001|NCT01721590|Coronary Heart Disease|coronary heart disease
333002|NCT01721590|Tongxinluo|tongxinluo
333003|NCT01721577|glioblastoma|glioblastoma
333004|NCT01721577|gliosarcoma|gliosarcoma
333005|NCT01721577|anaplastic astrocytoma|anaplastic astrocytoma
333006|NCT01721577|anaplastic oligodendroglioma|anaplastic oligodendroglioma
333007|NCT01721577|anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
333008|NCT01721577|AXL1717|axl1717
333009|NCT01721577|IGF-1 receptor inhibitor|igf-1 receptor inhibitor
333010|NCT01721577|picropodophyllin|picropodophyllin
333011|NCT01721551|Dialysis fatigue,|dialysis fatigue,
333012|NCT01721551|exercise intolerance,|exercise intolerance,
333013|NCT01721551|muscle atrophy,|muscle atrophy,
333014|NCT01721551|cachexia,|cachexia,
333015|NCT01721551|disability,|disability,
333016|NCT01721551|Sleep disorders|sleep disorders
333017|NCT01721551|Depression|depression
333018|NCT01721551|Mental Fatigue,|mental fatigue,
333019|NCT01721551|Cognitive function|cognitive function
333020|NCT01721551|Physical Fatigue|physical fatigue
333021|NCT01721538|stroke|stroke
333022|NCT01721538|prevention|prevention
333023|NCT01721538|obesity|obesity
333024|NCT01721538|weight reduction|weight reduction
333025|NCT01721525|BIBW2992 (AFATINIB)|bibw2992 (afatinib)
333026|NCT01721525|CARBOPLATIN|carboplatin
333027|NCT01721525|RIBAVIRIN-ICN (VIRAZOLE)|ribavirin-icn (virazole)
333028|NCT01721525|TAXOL (PACLITAXEL)|taxol (paclitaxel)
333029|NCT01721525|OROPHARYNX|oropharynx
333030|NCT01721525|HPV associated|hpv associated
333031|NCT01721525|12-150|12-150
333032|NCT01721512|Prospective observational study|prospective observational study
333033|NCT01721512|Breast feeding|breast feeding
333034|NCT01721512|Infant formula|infant formula
333035|NCT01721512|Infant|infant
333036|NCT01721512|Indonesia|indonesia
333037|NCT01721499|Stress|stress
333038|NCT01721499|obesity|obesity
333039|NCT01721499|overeating|overeating
333040|NCT01721486|tonsillitis|tonsillitis
333041|NCT01721486|recurrent tonsillitis|recurrent tonsillitis
333042|NCT01721486|obstructed air passages|obstructed air passages
333043|NCT01721486|swallowing difficulties|swallowing difficulties
333044|NCT01721473|Tobacco|tobacco
333045|NCT01721473|Positron Emission Tomography|positron emission tomography
333046|NCT01721473|Marijuana|marijuana
333047|NCT01721473|Caffeine|caffeine
333048|NCT01721473|Menthol|menthol
333049|NCT01721460|SubThalamic Nucleus|subthalamic nucleus
333050|NCT01721460|Microelectrode recording|microelectrode recording
333051|NCT01721460|Deep Brain Stimulation Electrode implantation|deep brain stimulation electrode implantation
333052|NCT01721447|Atrial fibrillation|atrial fibrillation
333053|NCT01721447|stroke|stroke
333054|NCT01721447|TEE|tee
333055|NCT01721447|Left atrial thrombus|left atrial thrombus
333056|NCT01721434|levosimendan|levosimendan
333057|NCT01721434|diaphragm function|diaphragm function
333058|NCT01721434|mechanically ventilated patients|mechanically ventilated patients
333059|NCT01721434|neuro-mechanical efficiency|neuro-mechanical efficiency
333060|NCT01721421|haemodialysis|haemodialysis
333061|NCT01721421|Crossover|crossover
333062|NCT01721421|Treatment time|treatment time
333063|NCT01721421|nutritional status|nutritional status
333064|NCT01721395|Cough|cough
333065|NCT01721395|Nocturnal Cough|nocturnal cough
333066|NCT01721395|Agave|agave
333067|NCT01721395|Sleep Quality|sleep quality
333068|NCT01721395|Childhood cough|childhood cough
333069|NCT01721382|cystic fibrosis|cystic fibrosis
333070|NCT01721382|CF|cf
333071|NCT01721382|CFRD|cfrd
333072|NCT01721382|sitagliptin|sitagliptin
333073|NCT01721382|incretins|incretins
333074|NCT01721382|GLP1|glp1
333075|NCT01721382|GIP|gip
333076|NCT01721382|beta cell function|beta cell function
333077|NCT01721382|adolescents|adolescents
333078|NCT01721330|ADHD|adhd
333079|NCT01721330|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
333080|NCT01721330|Psychopharmacology|psychopharmacology
333081|NCT01721330|Psychiatry|psychiatry
333082|NCT01721330|Non-stimulant treatment|non-stimulant treatment
333083|NCT01721317|Ezogabine/Retigabine|ezogabine/retigabine
333084|NCT01721317|Adjunctive Treatment|adjunctive treatment
333085|NCT01721317|Safety|safety
333086|NCT01721317|Efficacy|efficacy
333087|NCT01721317|Epilepsy|epilepsy
333088|NCT01721317|Tolerability|tolerability
333089|NCT01721317|Immediate Release|immediate release
333090|NCT01721317|GW582892|gw582892
333091|NCT01721317|Dose-Optimization|dose-optimization
333092|NCT01721317|Partial-Onset Seizures|partial-onset seizures
333093|NCT01721304|decision making|decision making
333094|NCT01721304|abnormal uterine bleeding|abnormal uterine bleeding
333095|NCT01721304|adaptive conjoint analysis|adaptive conjoint analysis
333096|NCT01721304|satisfaction|satisfaction
333097|NCT01721304|regret|regret
333098|NCT01721291|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|chronic obstructive pulmonary disease
333099|NCT01721291|ASTHMA|asthma
333100|NCT01721291|SALBUTAMOL|salbutamol
333101|NCT01721291|ALBUTEROL|albuterol
333102|NCT01721291|VENTOLIN|ventolin
333103|NCT01721291|LUNG PHYSIOLOGY|lung physiology
333104|NCT01721291|LUNG DEPOSITION|lung deposition
333105|NCT01721291|INHALERS|inhalers
333106|NCT01721291|DRUG THERAPY|drug therapy
333107|NCT01721265|HCV|hcv
333108|NCT01721265|Hepatitis C|hepatitis c
333109|NCT01721265|IDX184|idx184
333110|NCT01721265|IDX719|idx719
333111|NCT01721252|non-small cell lung cancer|non-small cell lung cancer
333112|NCT01721252|Erlotinib|erlotinib
333113|NCT01721252|TarcevaTM|tarcevatm
333114|NCT01721252|proteomic signature|proteomic signature
333115|NCT01721239|ICU|icu
333116|NCT01721239|Follow-up consultations|follow-up consultations
333117|NCT01721239|Quality of life|quality of life
333118|NCT01721239|Sense Of Coherence|sense of coherence
333119|NCT01721239|RCT multicenter study|rct multicenter study
333120|NCT01721226|Linkage to HIV care following release from prison|linkage to hiv care following release from prison
333121|NCT01721226|Anti-retroviral therapy adherence after release from prison|anti-retroviral therapy adherence after release from prison
333122|NCT01721226|HIV loads after release from prison|hiv loads after release from prison
333123|NCT01721226|information technology and ART adherence|information technology and art adherence
333124|NCT01721226|information technology and linkage to HIV care|information technology and linkage to hiv care
333125|NCT01721213|Epilepsy|epilepsy
333126|NCT01721213|survey|survey
333127|NCT01721213|retigabine|retigabine
333128|NCT01721213|patient information leaflet|patient information leaflet
333129|NCT01721213|physician's guide|physician's guide
333130|NCT01721213|Trobalt™|trobalt™
333131|NCT01721200|Rheumatoid Arthritis|rheumatoid arthritis
333132|NCT01721200|web based interactive learning tool|web based interactive learning tool
333133|NCT01721187|fMRI|fmri
333134|NCT01721187|Satiety|satiety
333135|NCT01721187|Willingness to Pay|willingness to pay
333136|NCT01721187|Incentive Delay|incentive delay
333137|NCT01721187|Dietary Disinhibition|dietary disinhibition
333138|NCT01721174|Pancreatic cancer|pancreatic cancer
333139|NCT01721174|Cholangiocarcinoma|cholangiocarcinoma
333140|NCT01721174|Endoscopic radiofrequency ablation|endoscopic radiofrequency ablation
333141|NCT01721161|Optic Neuritis|optic neuritis
333142|NCT01721135|moxifloxacin|moxifloxacin
333143|NCT01721135|GSK2190915|gsk2190915
333144|NCT01721135|pharmacokinetics|pharmacokinetics
333145|NCT01721135|QTc|qtc
333146|NCT01721109|Adolescents|adolescents
333147|NCT01721109|HIV-1|hiv-1
333148|NCT01721109|HIV|hiv
333149|NCT01721109|Treatment Naive|treatment naive
333150|NCT01721096|Angioplasty|angioplasty
333151|NCT01721096|Drug eluting stents|drug eluting stents
333152|NCT01721096|Stents|stents
333153|NCT01721096|Real world|real world
333154|NCT01721083|intramuscular injection|intramuscular injection
333155|NCT01721083|bunch|bunch
333156|NCT01721083|z-track|z-track
333157|NCT01721070|Area under curve, time to maximum concentration|area under curve, time to maximum concentration
333158|NCT01721031|Catheter Related Bladder Discomfort|catheter related bladder discomfort
333159|NCT01721031|Dorsal Penile Nerve Block|dorsal penile nerve block
333160|NCT01721018|Oncolytic virus|oncolytic virus
333161|NCT01721018|HSV1716|hsv1716
333162|NCT01721018|Mesothelioma|mesothelioma
333163|NCT01721018|MPM|mpm
333164|NCT01721018|Woll|woll
333165|NCT01721018|Sheffield|sheffield
333166|NCT01721018|Weston Park|weston park
333167|NCT01721018|Virttu|virttu
333168|NCT01721018|Crusade|crusade
333169|NCT01721005|atrial fibrillation|atrial fibrillation
333170|NCT01721005|thromboembolism|thromboembolism
333171|NCT01721005|patient education|patient education
333172|NCT01720979|TBI|tbi
333173|NCT01720979|Traumatic Brain Injury|traumatic brain injury
333174|NCT01720979|Children|children
333175|NCT01720979|Prognosis|prognosis
333176|NCT01720979|Neurocognition|neurocognition
333177|NCT01720966|Adhesions|adhesions
333178|NCT01720966|laparoscopy|laparoscopy
333179|NCT01720966|laparotomy|laparotomy
333180|NCT01720966|liver resection|liver resection
333181|NCT01720966|colorectal malignancy|colorectal malignancy
333182|NCT01720953|Borderline Personality Disorder|borderline personality disorder
333183|NCT01720953|Mentalization Based Therapy|mentalization based therapy
333184|NCT01720953|DNA methylation|dna methylation
333185|NCT01720953|BDNF|bdnf
333186|NCT01720953|Cortisol|cortisol
333187|NCT01720953|Neuropsychology|neuropsychology
333188|NCT01720927|Acute Pharyngitis, GABHS|acute pharyngitis, gabhs
333189|NCT01720888|Autologous|autologous
333190|NCT01720888|Bone Marrow|bone marrow
333191|NCT01720888|Mesenchymal Stem Cells|mesenchymal stem cells
333192|NCT01720888|Ischemic Dilated Cardiomyopathy|ischemic dilated cardiomyopathy
333193|NCT01720862|migraine|migraine
333194|NCT01720862|episodic migraine|episodic migraine
333195|NCT01720862|chronic migraine|chronic migraine
333196|NCT01720862|obesity|obesity
333197|NCT01720862|non-obese|non-obese
333198|NCT01720823|Obstructive Sleep Apnea syndrome|obstructive sleep apnea syndrome
333199|NCT01720823|polysomnography|polysomnography
333200|NCT01720823|Home monitoring|home monitoring
333201|NCT01720797|Malocclusion|malocclusion
333202|NCT01720797|Accelerated tooth movement|accelerated tooth movement
333203|NCT01720797|Braces|braces
333204|NCT01720797|Orthodontic treatment|orthodontic treatment
333205|NCT01720797|Propel|propel
333206|NCT01720771|bacteriotherapy|bacteriotherapy
333207|NCT01720771|caries|caries
333208|NCT01720771|preschool children|preschool children
333209|NCT01720771|probiotics|probiotics
333210|NCT01720745|EUS|eus
333211|NCT01720745|FNA|fna
333212|NCT01720745|Wet suction|wet suction
333213|NCT01720745|Dry suction|dry suction
333214|NCT01720745|Solid lesions|solid lesions
333215|NCT01720719|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
333216|NCT01720719|Dyslipidemias|dyslipidemias
333217|NCT01720719|Diabetes Mellitus|diabetes mellitus
333218|NCT01720719|atorvastatin|atorvastatin
333219|NCT01720719|Vitamin E|vitamin e
333220|NCT01720706|Liver tumour|liver tumour
333221|NCT01720706|Kidney tumour|kidney tumour
333222|NCT01720706|Hepatectomy|hepatectomy
333223|NCT01720706|Nephrectomy|nephrectomy
333224|NCT01720706|Metastatic Colon Cancer|metastatic colon cancer
333225|NCT01720706|Renal Cell Carcinoma|renal cell carcinoma
333226|NCT01720693|partial nephrectomy|partial nephrectomy
333227|NCT01720693|hypoperfusion|hypoperfusion
333228|NCT01720693|renal function|renal function
333229|NCT01720680|COPD|copd
333230|NCT01720680|Functional Imaging|functional imaging
333231|NCT01720680|Patient Reported Outcome (PRO)|patient reported outcome (pro)
333232|NCT01720680|Lung Function|lung function
333233|NCT01720680|AlphaCore|alphacore
333234|NCT01720680|Computational Fluid Dynamics|computational fluid dynamics
333235|NCT01720667|Seizures|seizures
333236|NCT01720667|Neonates|neonates
333237|NCT01720667|Anticonvulsants|anticonvulsants
333238|NCT01720667|Treatment|treatment
333239|NCT01720667|Levetiracetam|levetiracetam
333240|NCT01720667|Phenobarbital|phenobarbital
333241|NCT01720654|Expedited Partner Therapy|expedited partner therapy
333242|NCT01720654|MSM|msm
333243|NCT01720654|Peru|peru
333244|NCT01720654|Gonorrhea|gonorrhea
333245|NCT01720654|Chlamydia|chlamydia
333246|NCT01720641|MSM|msm
333247|NCT01720641|Transgender Women|transgender women
333248|NCT01720641|Partner Notification|partner notification
333249|NCT01720641|Syphilis|syphilis
333250|NCT01720641|Peru|peru
333251|NCT01720628|Angiogenin, Behçet's disease, bFGF, VEGF|angiogenin, behçet's disease, bfgf, vegf
333252|NCT01720615|EEG|eeg
333253|NCT01720615|AEP|aep
333254|NCT01720615|Propofol|propofol
333255|NCT01720615|Sevoflurane|sevoflurane
333256|NCT01720615|Remifentanil|remifentanil
333257|NCT01720615|General anesthesia|general anesthesia
333258|NCT01720589|Obesity|obesity
333259|NCT01720589|Dietary fat|dietary fat
333260|NCT01720589|Energy expenditure|energy expenditure
333261|NCT01720589|Food intake|food intake
333262|NCT01720563|Cancer-related fatigue|cancer-related fatigue
333263|NCT01720563|astragalus polysaccharides|astragalus polysaccharides
333264|NCT01720563|concurrent chemoradiotherapy|concurrent chemoradiotherapy
333265|NCT01720563|squamous cell carcinoma of head and neck|squamous cell carcinoma of head and neck
333266|NCT01720550|Cancer-related fatigue|cancer-related fatigue
333267|NCT01720550|Palliative Treatment|palliative treatment
333268|NCT01720550|Astragalus polysaccharides|astragalus polysaccharides
333269|NCT01720537|High Cholesterol|high cholesterol
333270|NCT01720537|Dyslipidemia|dyslipidemia
333271|NCT01720524|persistent pulmonary hypertension|persistent pulmonary hypertension
333272|NCT01720524|newborn|newborn
333273|NCT01720524|neonates|neonates
333274|NCT01720524|iv sildenafil|iv sildenafil
333275|NCT01720524|hypoxic respiratory failure and at risk of persistent pulmonary hypertension of the newborn|hypoxic respiratory failure and at risk of persistent pulmonary hypertension of the newborn
333276|NCT01720472|Aging|aging
333277|NCT01720472|Healthy Aging|healthy aging
333278|NCT01720472|Physical Performance|physical performance
333279|NCT01720472|Physical Functioning|physical functioning
333280|NCT01720472|Cognitive Functioning|cognitive functioning
333281|NCT01720472|Fitness|fitness
333282|NCT01720472|Physical Activity|physical activity
333283|NCT01720433|laparoscopic pain prospective blinded trial|laparoscopic pain prospective blinded trial
333284|NCT01720420|edentulous|edentulous
333285|NCT01720420|maxilla|maxilla
333286|NCT01720420|mandible|mandible
333287|NCT01720420|dental implant|dental implant
333288|NCT01720420|bar|bar
333289|NCT01720420|overdenture|overdenture
333290|NCT01720420|Oral Health Impact Profile (OHIP)|oral health impact profile (ohip)
333291|NCT01720420|survival rate|survival rate
333292|NCT01720420|technical complications|technical complications
333293|NCT01720420|marginal bone level|marginal bone level
333294|NCT01720420|soft tissue|soft tissue
333295|NCT01720407|Dermatology/ Skin cancers/Lentigo maligna melanoma|dermatology/ skin cancers/lentigo maligna melanoma
333296|NCT01720381|monitoring|monitoring
333297|NCT01720381|blood glucose|blood glucose
333298|NCT01720381|intensive care unit|intensive care unit
333299|NCT01720368|IBD|ibd
333300|NCT01720368|Crohn's|crohn's
333301|NCT01720342|Medtronic Enable® aortic bioprosthesis|medtronic enable® aortic bioprosthesis
333302|NCT01720342|Aortic valve stenosis|aortic valve stenosis
333303|NCT01720342|Aortic valve insufficiency|aortic valve insufficiency
333304|NCT01720342|"Real world patients"|"real world patients"
333305|NCT01720316|Glycine|glycine
333306|NCT01720316|Glycine decarboxylase|glycine decarboxylase
333307|NCT01720316|Psychosis|psychosis
333308|NCT01720316|Mutation|mutation
333309|NCT01720277|Randomized Controlled Trial|randomized controlled trial
333310|NCT01720277|Influenza|influenza
333311|NCT01720277|Influenza vaccine|influenza vaccine
333312|NCT01720277|Flu Vaccine|flu vaccine
333313|NCT01720277|Fluzone|fluzone
333314|NCT01720277|HD Fluzone|hd fluzone
333315|NCT01720277|Nursing Homes|nursing homes
333316|NCT01720277|Hospitalization|hospitalization
333317|NCT01720277|Mortality|mortality
333318|NCT01720277|Health Care worker vaccination|health care worker vaccination
333319|NCT01720277|ADL decline|adl decline
333320|NCT01720277|Pilot|pilot
333321|NCT01720277|Effectiveness|effectiveness
333322|NCT01720251|allergic rhinitis|allergic rhinitis
333323|NCT01720251|birch pollen|birch pollen
333324|NCT01720251|immunotherapy|immunotherapy
333325|NCT01720238|Compensated Liver Cirrhosis|compensated liver cirrhosis
333326|NCT01720238|Early Antiviral Therapy|early antiviral therapy
333327|NCT01720238|Cost Effectiveness|cost effectiveness
333328|NCT01720225|Leukemia|leukemia
333329|NCT01720225|Myelodysplastic syndromes|myelodysplastic syndromes
333330|NCT01720225|MDS|mds
333331|NCT01720225|Low and Intermediate-1 Risk Disease|low and intermediate-1 risk disease
333332|NCT01720225|Decitabine|decitabine
333333|NCT01720225|DAC|dac
333334|NCT01720225|Dacogen|dacogen
333335|NCT01720225|Azacitidine|azacitidine
333336|NCT01720225|AZA|aza
333337|NCT01720225|5-azacytidine|5-azacytidine
333338|NCT01720225|5-aza|5-aza
333339|NCT01720225|Vidaza|vidaza
333340|NCT01720225|5-AZC|5-azc
333341|NCT01720225|AZA-CR|aza-cr
333342|NCT01720225|Ladakamycin|ladakamycin
333343|NCT01720225|NSC-102816|nsc-102816
333344|NCT01720212|YM178|ym178
333345|NCT01720212|Mirabegron|mirabegron
333346|NCT01720212|OCAS|ocas
333347|NCT01720212|Chinese Healthy Volunteers|chinese healthy volunteers
333348|NCT01720212|PK|pk
333349|NCT01720212|Safety|safety
333350|NCT01720199|universal prevention|universal prevention
333351|NCT01720199|primary prevention|primary prevention
333352|NCT01720199|health promotion|health promotion
333353|NCT01720199|wellbeing|wellbeing
333354|NCT01720199|smoking|smoking
333355|NCT01720199|alcohol|alcohol
333356|NCT01720199|diet|diet
333357|NCT01720199|physical activity|physical activity
333358|NCT01720199|emotional and social skills|emotional and social skills
333359|NCT01720186|Lung Cancer|lung cancer
333360|NCT01720186|PET/CT|pet/ct
333361|NCT01720186|FDG|fdg
333362|NCT01720186|Respiratory synchronization|respiratory synchronization
333363|NCT01720147|Fanconi Anemia|fanconi anemia
333364|NCT01720147|FA|fa
333365|NCT01720147|Quercetin|quercetin
333366|NCT01720043|multiple myeloma|multiple myeloma
333367|NCT01720030|Renal|renal
333368|NCT01720030|Acute Kidney Injury|acute kidney injury
333369|NCT01720030|AKI|aki
333370|NCT01720030|Levosimendan|levosimendan
333371|NCT01720030|Simdax|simdax
333372|NCT01720030|Renal perfusion|renal perfusion
333373|NCT01720030|Mortality|mortality
333374|NCT01720030|Renal flow|renal flow
333375|NCT01720017|Airtraq|airtraq
333376|NCT01720017|laryngoscope|laryngoscope
333377|NCT01720017|airway|airway
333378|NCT01720017|difficult|difficult
333379|NCT01720017|training|training
333380|NCT01720017|manikin|manikin
333381|NCT01720004|human labour|human labour
333382|NCT01720004|hands-and-knees positioning|hands-and-knees positioning
333383|NCT01720004|pilot trial|pilot trial
333384|NCT01719991|Primary care|primary care
333385|NCT01719991|Self-management|self-management
333386|NCT01719991|Self-support|self-support
333387|NCT01719991|Nurse case management|nurse case management
333388|NCT01719978|Local Anaesthetics|local anaesthetics
333389|NCT01719978|Mepivacaine|mepivacaine
333390|NCT01719978|hyaluronoglucosaminidase|hyaluronoglucosaminidase
333391|NCT01719978|Hemodynamic|hemodynamic
333392|NCT01719978|Electrocardiography and Dentistry.|electrocardiography and dentistry.
333393|NCT01719965|Community Advisory Board|community advisory board
333394|NCT01719965|Focus Group Discussion|focus group discussion
333395|NCT01719965|Interview|interview
333396|NCT01719965|Community Engagement|community engagement
333397|NCT01719965|Thailand|thailand
333398|NCT01719952|pregnancy|pregnancy
333399|NCT01719952|anaesthesia|anaesthesia
333400|NCT01719952|caesarean section|caesarean section
333401|NCT01719926|Colorectal|colorectal
333402|NCT01719926|Esophageal|esophageal
333403|NCT01719926|Indomethacin|indomethacin
333404|NCT01719926|PIFA|pifa
333405|NCT01719900|Dietary intervention|dietary intervention
333406|NCT01719900|Dietary fibre|dietary fibre
333407|NCT01719900|Obesity|obesity
333408|NCT01719900|Metabolic syndrome|metabolic syndrome
333409|NCT01719900|Weight loss|weight loss
333410|NCT01719900|Glucose regulation|glucose regulation
333411|NCT01719900|Pulse fibre|pulse fibre
333412|NCT01719887|humerus|humerus
333413|NCT01719887|humeral|humeral
333414|NCT01719887|shaft|shaft
333415|NCT01719887|diaphysis|diaphysis
333416|NCT01719887|fracture|fracture
333417|NCT01719887|RCT|rct
333418|NCT01719874|Influenza|influenza
333419|NCT01719874|monoclonal antibody|monoclonal antibody
333420|NCT01719848|Physical examinations, Percentage of glottic opening(POGO)|physical examinations, percentage of glottic opening(pogo)
333421|NCT01719835|T-Cell Lymphoma|t-cell lymphoma
333422|NCT01719835|Untreated|untreated
333423|NCT01719822|Treatment Outcome [E01.789.800]|treatment outcome [e01.789.800]
333424|NCT01719822|Rehabilitation [N02.421.784]|rehabilitation [n02.421.784]
333425|NCT01719822|Physical Fitness [I03.621]|physical fitness [i03.621]
333426|NCT01719822|Lung Diseases, Obstructive [C08.381.495]|lung diseases, obstructive [c08.381.495]
333427|NCT01719822|Pulmonary Disease, Chronic Obstructive [C08.381.495.389]|pulmonary disease, chronic obstructive [c08.381.495.389]
333428|NCT01719822|Bronchitis, Chronic [C08.381.495.389.500]|bronchitis, chronic [c08.381.495.389.500]
333429|NCT01719809|Glaucoma|glaucoma
333430|NCT01719809|Eye Drop|eye drop
333431|NCT01719809|Eye Drop Technique|eye drop technique
333432|NCT01719809|Training|training
333433|NCT01719809|Instilling Eye Drops|instilling eye drops
333434|NCT01719783|influenza|influenza
333435|NCT01719783|vaccine|vaccine
333436|NCT01719783|pandemic|pandemic
333437|NCT01719770|cardiac arrest|cardiac arrest
333438|NCT01719770|therapeutic hypothermia|therapeutic hypothermia
333439|NCT01719770|skeletal muscle paralysis|skeletal muscle paralysis
333440|NCT01719770|shivering|shivering
333441|NCT01719770|serum drug levels|serum drug levels
333442|NCT01719770|basal metabolism|basal metabolism
333443|NCT01719757|Targin, Cancer Pain|targin, cancer pain
333444|NCT01719744|ENMD-2076|enmd-2076
333445|NCT01719744|advanced|advanced
333446|NCT01719744|metastatic|metastatic
333447|NCT01719744|soft tissue sarcoma|soft tissue sarcoma
333448|NCT01719731|BPD|bpd
333449|NCT01719718|ventral hernia|ventral hernia
333450|NCT01719705|caesarean delivery|caesarean delivery
333451|NCT01719705|spinal anesthesia|spinal anesthesia
333452|NCT01719705|pregabalin|pregabalin
333453|NCT01719705|postoperative pain|postoperative pain
333454|NCT01719705|morphine|morphine
333455|NCT01719679|school located vaccine program|school located vaccine program
333456|NCT01719666|MPFL|mpfl
333457|NCT01719666|patella|patella
333458|NCT01719666|dislocation|dislocation
333459|NCT01719666|release|release
333460|NCT01719653|Colonoscopy|colonoscopy
333461|NCT01719653|Bowel Preparation|bowel preparation
333462|NCT01719653|MiraLAX|miralax
333463|NCT01719653|Gatorade|gatorade
333464|NCT01719653|PEG-3350|peg-3350
333465|NCT01719653|MoviPrep|moviprep
333466|NCT01719653|SUPREP|suprep
333467|NCT01719653|Chicago Bowel Preparation Scale|chicago bowel preparation scale
333468|NCT01719653|Boston Bowel Preparation Scale|boston bowel preparation scale
333469|NCT01719640|mesenchymal stem cells|mesenchymal stem cells
333470|NCT01719640|bone marrow mononeclear cells|bone marrow mononeclear cells
333471|NCT01719640|type 2 diabetes mellitus|type 2 diabetes mellitus
333472|NCT01719627|HIV, Maraviroc, PrEP, Ex vivo infection, rectal mucosa.|hiv, maraviroc, prep, ex vivo infection, rectal mucosa.
333473|NCT01719614|Healthy participants|healthy participants
333474|NCT01719614|Rilpivirine|rilpivirine
333475|NCT01719614|Metformin|metformin
333476|NCT01719614|Pharmacokinetics|pharmacokinetics
333575|NCT01719055|stimulation|stimulation
333477|NCT01719601|Moderate to severe acute non-cancer pain|moderate to severe acute non-cancer pain
333478|NCT01719601|Immediate release tapentadol hydrochloride|immediate release tapentadol hydrochloride
333479|NCT01719601|Tapentadol IR|tapentadol ir
333480|NCT01719601|Nucynta IR|nucynta ir
333481|NCT01719588|Moderate to severe chronic non-cancer pain|moderate to severe chronic non-cancer pain
333482|NCT01719588|Prolonged release tapentadol hydrochloride|prolonged release tapentadol hydrochloride
333483|NCT01719588|Tapentadol PR|tapentadol pr
333484|NCT01719588|Extended release tapentadol hydrochloride|extended release tapentadol hydrochloride
333485|NCT01719588|Nucynta PR|nucynta pr
333486|NCT01719549|Gastric Cancer|gastric cancer
333487|NCT01719549|Dovitinib|dovitinib
333488|NCT01719523|Tourette syndrome|tourette syndrome
333489|NCT01719523|Tics|tics
333490|NCT01719523|Tic Disorders|tic disorders
333491|NCT01719510|Group B Streptococcus,|group b streptococcus,
333492|NCT01719510|Vaginal screening|vaginal screening
333493|NCT01719510|Per partum antibiotic prophylaxis|per partum antibiotic prophylaxis
333494|NCT01719510|Meningitis|meningitis
333495|NCT01719510|Neonatal infection|neonatal infection
333496|NCT01719510|PCR|pcr
333497|NCT01719510|Streptococcus agalactiae.|streptococcus agalactiae.
333498|NCT01719445|Energy Intake|energy intake
333499|NCT01719432|Filgrastim|filgrastim
333500|NCT01719432|Obese|obese
333501|NCT01719432|Non-obese|non-obese
333502|NCT01719432|Pharmacokinetics|pharmacokinetics
333503|NCT01719406|Gestational diabetes|gestational diabetes
333504|NCT01719406|Exercise|exercise
333505|NCT01719406|Diet|diet
333506|NCT01719406|Fruits|fruits
333507|NCT01719406|Vegetables|vegetables
333508|NCT01719406|Whole grains|whole grains
333509|NCT01719406|pregnancy weight|pregnancy weight
333510|NCT01719393|Asthma|asthma
333511|NCT01719393|Pulse spectrum analysis|pulse spectrum analysis
333512|NCT01719393|lung function|lung function
333513|NCT01719393|exhaled nitric oxide|exhaled nitric oxide
333514|NCT01719393|metabolites|metabolites
333515|NCT01719393|exhaled breath condensate|exhaled breath condensate
333516|NCT01719380|Open-label dose escalation; BRAF inhibitor; LGX818; PI3K inhibitor; BYL719; EGFR; cetuximab; metastatic colorectal cancer; KRAS; BRAF; V600|open-label dose escalation; braf inhibitor; lgx818; pi3k inhibitor; byl719; egfr; cetuximab; metastatic colorectal cancer; kras; braf; v600
333517|NCT01719367|Baseline (pre-atenolol)|baseline (pre-atenolol)
333518|NCT01719367|Post-atenolol|post-atenolol
333519|NCT01719354|Community Mental Health Centers|community mental health centers
333520|NCT01719354|Norway|norway
333521|NCT01719354|Aftercare|aftercare
333522|NCT01719328|yoga,|yoga,
333523|NCT01719328|exercise|exercise
333524|NCT01719328|affect|affect
333525|NCT01719328|mind/body therapies|mind/body therapies
333526|NCT01719328|stress, psychological|stress, psychological
333527|NCT01719302|Soft tissue sarcoma|soft tissue sarcoma
333528|NCT01719302|gemcitabine|gemcitabine
333529|NCT01719302|docetaxel|docetaxel
333530|NCT01719302|pazopanib|pazopanib
333531|NCT01719289|depression|depression
333532|NCT01719289|problem solving|problem solving
333533|NCT01719263|emphysema|emphysema
333534|NCT01719263|InterVapor|intervapor
333535|NCT01719263|treatments|treatments
333536|NCT01719263|pulmonary rehabilitation|pulmonary rehabilitation
333537|NCT01719263|lung volume reduction|lung volume reduction
333538|NCT01719263|endoscopic lung volume reduction|endoscopic lung volume reduction
333539|NCT01719237|Onset|onset
333540|NCT01719237|Duration|duration
333541|NCT01719237|Upper Limb Block|upper limb block
333542|NCT01719237|Ultrasound guided supraclavicular block|ultrasound guided supraclavicular block
333543|NCT01719237|Ropivacaine|ropivacaine
333544|NCT01719237|Chloroprocaine|chloroprocaine
333545|NCT01719211|MVP, mitral valve|mvp, mitral valve
333546|NCT01719198|adenoma|adenoma
333547|NCT01719198|calprotectin|calprotectin
333548|NCT01719159|Progressive multiple sclerosis|progressive multiple sclerosis
333549|NCT01719159|Monoclonal antibodies|monoclonal antibodies
333550|NCT01719159|Mabthera|mabthera
333551|NCT01719159|Intrathecal treatment|intrathecal treatment
333552|NCT01719146|Anemia|anemia
333553|NCT01719146|Chronic Kidney Disease|chronic kidney disease
333554|NCT01719146|Erythropoiesis Stimulating Agents|erythropoiesis stimulating agents
333555|NCT01719146|Erythropoietin|erythropoietin
333556|NCT01719146|Iron|iron
333557|NCT01719146|Iron Deficiency|iron deficiency
333558|NCT01719133|allergy|allergy
333559|NCT01719133|birch|birch
333560|NCT01719120|Insomnia|insomnia
333561|NCT01719120|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
333562|NCT01719120|Internet-Based|internet-based
333563|NCT01719120|Self-Help|self-help
333564|NCT01719120|Randomized Controlled Trial|randomized controlled trial
333565|NCT01719107|Functional abdominal pain|functional abdominal pain
333566|NCT01719107|Probiotics|probiotics
333567|NCT01719107|Lactobacilus reuteri|lactobacilus reuteri
333568|NCT01719081|Sacroiliac Joint|sacroiliac joint
333569|NCT01719081|Ultrasound|ultrasound
333570|NCT01719081|Fluoroscopy|fluoroscopy
333571|NCT01719081|Chronic Pain|chronic pain
333572|NCT01719068|Mesothelioma|mesothelioma
333573|NCT01719068|Lung Cancer|lung cancer
333574|NCT01719068|Early Detection|early detection
333576|NCT01719055|implantable|implantable
333577|NCT01719055|pulse generator|pulse generator
333578|NCT01719055|back pain|back pain
333579|NCT01719055|chronic pain|chronic pain
333580|NCT01719055|leg pain|leg pain
333581|NCT01719029|continuous glucose monitoring|continuous glucose monitoring
333582|NCT01719029|gestational diabetes|gestational diabetes
333583|NCT01719029|diet therapy|diet therapy
333584|NCT01719016|Reversible ischemia|reversible ischemia
333585|NCT01719016|microvascular dysfunction|microvascular dysfunction
333586|NCT01718977|Intervention|intervention
333587|NCT01718977|Body Weight Supported Treadmill Training|body weight supported treadmill training
333588|NCT01718977|Arm Cycle Ergometry Training|arm cycle ergometry training
333589|NCT01718977|carotid-to-femoral pulse wave velocity|carotid-to-femoral pulse wave velocity
333590|NCT01718951|spondyloarthropathy|spondyloarthropathy
333591|NCT01718951|ankylosing spondylitis|ankylosing spondylitis
333592|NCT01718938|Gastroparesis|gastroparesis
333593|NCT01718938|Diabetic|diabetic
333594|NCT01718938|Idiopathic|idiopathic
333595|NCT01718938|Delayed gastric emptying|delayed gastric emptying
333596|NCT01718912|periodontal disease|periodontal disease
333597|NCT01718912|bleeding on probing|bleeding on probing
333598|NCT01718912|periodontal pockets|periodontal pockets
333599|NCT01718912|disabled|disabled
333600|NCT01718886|Obesity|obesity
333601|NCT01718886|Weight loss|weight loss
333602|NCT01718886|Weight control|weight control
333603|NCT01718886|Intragastric balloon|intragastric balloon
333604|NCT01718886|gastric balloon|gastric balloon
333605|NCT01718873|metastatic|metastatic
333606|NCT01718873|stage IV|stage iv
333607|NCT01718860|Cost Analysis|cost analysis
333608|NCT01718860|Postoperative Complications|postoperative complications
333609|NCT01718860|Length of Stay|length of stay
333610|NCT01718860|Intensive Care Units|intensive care units
333611|NCT01718847|EGFR Tyrosine Kinase Inhibitor|egfr tyrosine kinase inhibitor
333612|NCT01718847|Aquired resistance to EGFR TKI|aquired resistance to egfr tki
333613|NCT01718847|Pan-Her inhibitor|pan-her inhibitor
333614|NCT01718834|prophylactic vaccine|prophylactic vaccine
333615|NCT01718834|chronic HCV patients|chronic hcv patients
333616|NCT01718834|healthy risk volunteers|healthy risk volunteers
333617|NCT01718808|Metastatic Colorectal Cancer|metastatic colorectal cancer
333618|NCT01718808|KRAS|kras
333619|NCT01718808|BRAF|braf
333620|NCT01718808|Wild-type Metastatic|wild-type metastatic
333621|NCT01718808|Cetuximab|cetuximab
333622|NCT01718808|Capecitabine|capecitabine
333623|NCT01718808|Phase II Trial|phase ii trial
333624|NCT01718808|Elderly Patients|elderly patients
333625|NCT01718795|Airway|airway
333626|NCT01718795|Cardiac Arrest|cardiac arrest
333627|NCT01718795|CPR|cpr
333628|NCT01718795|Ventilation|ventilation
333629|NCT01718782|laryngeal mask, leakage pressure, ventilation|laryngeal mask, leakage pressure, ventilation
333630|NCT01718769|Nutritional assessment|nutritional assessment
333631|NCT01718769|children|children
333632|NCT01718769|malnutrition|malnutrition
333633|NCT01718756|Orthopaedic|orthopaedic
333634|NCT01718756|General anaesthesia|general anaesthesia
333635|NCT01718756|lornoxicam|lornoxicam
333636|NCT01718756|patient controlled analgesia|patient controlled analgesia
333637|NCT01718756|morphine consumption|morphine consumption
333638|NCT01718743|Myeloma|myeloma
333639|NCT01718743|Multiple Myeloma|multiple myeloma
333640|NCT01718743|MM|mm
333641|NCT01718743|Post Autologous Stem Cell Transplant|post autologous stem cell transplant
333642|NCT01718743|Lenalidomide|lenalidomide
333643|NCT01718743|CC-5013|cc-5013
333644|NCT01718743|Revlimid|revlimid
333645|NCT01718743|MLN9708|mln9708
333646|NCT01718743|Questionnaire|questionnaire
333647|NCT01718743|Survey|survey
333648|NCT01718730|TMS|tms
333649|NCT01718730|Adolescent|adolescent
333650|NCT01718730|Child|child
333651|NCT01718730|MDD|mdd
333652|NCT01718730|Major depressive disorder|major depressive disorder
333653|NCT01718730|Mild MDD|mild mdd
333654|NCT01718730|Mild depression|mild depression
333655|NCT01718730|SSRI|ssri
333656|NCT01718730|Motor cortex|motor cortex
333657|NCT01718730|Cortical excitability|cortical excitability
333658|NCT01718730|Cortical inhibition|cortical inhibition
333659|NCT01718730|Cortical silent period|cortical silent period
333660|NCT01718730|Motor threshold|motor threshold
333661|NCT01718730|Intracortical facilitation|intracortical facilitation
333662|NCT01718730|Intracortical inhibition|intracortical inhibition
333663|NCT01718730|gamma-aminobutyric acid (GABA)|gamma-aminobutyric acid (gaba)
333664|NCT01718730|Glutamate|glutamate
333665|NCT01718730|N-methyl-D-aspartate (NMDA)|n-methyl-d-aspartate (nmda)
333666|NCT01718730|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
333667|NCT01718730|MRS|mrs
333668|NCT01718717|Thoracotomy|thoracotomy
333669|NCT01718717|Thoracic epidural analgesia|thoracic epidural analgesia
333670|NCT01718717|Arrythmiogenesis|arrythmiogenesis
333671|NCT01718717|Atrial fibrillation|atrial fibrillation
333672|NCT01718717|Sympathetic outflow|sympathetic outflow
333673|NCT01718704|rehabilitation|rehabilitation
333674|NCT01718704|erectile dysfunction|erectile dysfunction
333675|NCT01718704|incontinence|incontinence
333676|NCT01718678|Multiple sclerosis|multiple sclerosis
333677|NCT01718678|Melatonin|melatonin
333678|NCT01718678|Fatigue|fatigue
333679|NCT01718678|Quality of life|quality of life
333680|NCT01718652|Healthy|healthy
333681|NCT01718652|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
333682|NCT01718652|Pharmacokinetics|pharmacokinetics
333683|NCT01718652|Cyclosporine|cyclosporine
333684|NCT01718600|carotid artery stenting|carotid artery stenting
333685|NCT01718600|neuropsychological testing|neuropsychological testing
333686|NCT01718600|microembolization|microembolization
333687|NCT01718600|MRI|mri
333688|NCT01718587|umbilical cord mesenchyma stem cell|umbilical cord mesenchyma stem cell
333689|NCT01718587|liver cirrhosis|liver cirrhosis
333690|NCT01718587|antiviral therapy|antiviral therapy
333691|NCT01718574|self-help book|self-help book
333692|NCT01718574|support service|support service
333693|NCT01718561|Airway assessment|airway assessment
333694|NCT01718561|Intubation|intubation
333695|NCT01718561|Mask ventilation|mask ventilation
333696|NCT01718535|Cyp2C19|cyp2c19
333697|NCT01718535|Genotyping|genotyping
333698|NCT01718535|Spartan|spartan
333699|NCT01718535|Comparison|comparison
333700|NCT01718535|Sequencing|sequencing
333701|NCT01718496|dyspnea|dyspnea
333702|NCT01718496|COPD|copd
333703|NCT01718496|exercise tolerance|exercise tolerance
333704|NCT01718496|opioids|opioids
333705|NCT01718496|morphine|morphine
333706|NCT01718496|single dose oral Morphine|single dose oral morphine
333707|NCT01718470|Systolic blood pressure|systolic blood pressure
333708|NCT01718470|Heart rate|heart rate
333709|NCT01718470|Laryngeal mask|laryngeal mask
333710|NCT01718470|Endotracheal tube|endotracheal tube
333711|NCT01718470|craniotomy|craniotomy
333712|NCT01718457|Endobarrier|endobarrier
333713|NCT01718457|Diabetes|diabetes
333714|NCT01718457|Obesity|obesity
333715|NCT01718457|Weight|weight
333716|NCT01718457|BMI|bmi
333717|NCT01718457|Lipid profile|lipid profile
333718|NCT01718457|fatty liver|fatty liver
333719|NCT01718457|gut peptides|gut peptides
333720|NCT01718457|HbA1c|hba1c
333721|NCT01718444|PCOS|pcos
333722|NCT01718444|Polycystic ovary syndrome|polycystic ovary syndrome
333723|NCT01718444|Infertility|infertility
333724|NCT01718444|Anovulation|anovulation
333725|NCT01718444|Clomiphene citrate|clomiphene citrate
333726|NCT01718444|Clomid|clomid
333727|NCT01718444|Progestin|progestin
333728|NCT01718444|Provera|provera
333729|NCT01718444|Progesterone|progesterone
333730|NCT01718444|Endometrial shedding|endometrial shedding
333731|NCT01718392|combined training|combined training
333732|NCT01718392|insulin resistance|insulin resistance
333733|NCT01718379|Myelodysplasia|myelodysplasia
333734|NCT01718340|PCOS|pcos
333735|NCT01718340|Hyper insulinaemia|hyper insulinaemia
333736|NCT01718340|metformin|metformin
333737|NCT01718340|recurrent abortion|recurrent abortion
333738|NCT01718327|Cholangiocarcinoma|cholangiocarcinoma
333739|NCT01718314|Hysteroscopy|hysteroscopy
333740|NCT01718314|Misoprostol|misoprostol
333741|NCT01718314|Lidocaine|lidocaine
333742|NCT01718314|Visual analogue score|visual analogue score
333743|NCT01718301|HCV|hcv
333744|NCT01718301|HIV|hiv
333745|NCT01718301|Coinfection|coinfection
333746|NCT01718288|PAD; iloprost; walking distance; cardiovascular events|pad; iloprost; walking distance; cardiovascular events
333747|NCT01718275|Appendicitis|appendicitis
333748|NCT01718275|Pediatrics|pediatrics
333749|NCT01718275|Children|children
333750|NCT01718275|Non-operative|non-operative
333751|NCT01718262|Ropivacaine Level|ropivacaine level
333752|NCT01718262|continuous peripheral nerve blocks.|continuous peripheral nerve blocks.
333753|NCT01718249|Deep Brain Stimulation (DBS)|deep brain stimulation (dbs)
333754|NCT01718249|Post-coma|post-coma
333755|NCT01718249|Consciousness|consciousness
333756|NCT01718249|Vegetative state|vegetative state
333757|NCT01718249|Minimally conscious state|minimally conscious state
333758|NCT01718236|caesarean section|caesarean section
333759|NCT01718236|rocuronium|rocuronium
333760|NCT01718236|sugammadex|sugammadex
333761|NCT01718210|GM-CSF|gm-csf
333762|NCT01718210|recurrent implantation failure|recurrent implantation failure
333763|NCT01718210|pregnancy rate|pregnancy rate
333764|NCT01718210|IVF|ivf
333765|NCT01718197|Severe Asthma|severe asthma
333766|NCT01718197|Bronchoscopy|bronchoscopy
333767|NCT01718184|sulcoflex|sulcoflex
333768|NCT01718184|toric|toric
333769|NCT01718184|corneal implantation|corneal implantation
333770|NCT01718171|Appendicitis|appendicitis
333771|NCT01718171|SIRS|sirs
333772|NCT01718171|C-reactive protein|c-reactive protein
333773|NCT01718132|Quality of the anaesthetic care in a PACU|quality of the anaesthetic care in a pacu
333774|NCT01718132|reduction of postoperative pain|reduction of postoperative pain
333775|NCT01718132|reduction of postoperative nausea and vomiting|reduction of postoperative nausea and vomiting
333776|NCT01718132|quality markers|quality markers
333777|NCT01718106|coronary artery disease|coronary artery disease
333778|NCT01718106|drug eluting stent|drug eluting stent
333779|NCT01718106|bioabsorbable polymer|bioabsorbable polymer
333873|NCT01717833|handgrip|handgrip
333780|NCT01718106|percutaneous coronary intervention|percutaneous coronary intervention
333781|NCT01718106|restenosis|restenosis
333782|NCT01718106|late thrombosis|late thrombosis
333783|NCT01718093|Adolescents|adolescents
333784|NCT01718080|Obese, Lean, Pubertal, Prepubertal, Glucose, Adolescents, Type 2 Diabetes|obese, lean, pubertal, prepubertal, glucose, adolescents, type 2 diabetes
333785|NCT01718067|Chest physiotherapy|chest physiotherapy
333786|NCT01718067|Rehabilitation|rehabilitation
333787|NCT01718067|Chronic respiratory diseases|chronic respiratory diseases
333788|NCT01718054|Vascular function|vascular function
333789|NCT01718054|Ready to use supplementary foods|ready to use supplementary foods
333790|NCT01718054|Chloroquine|chloroquine
333791|NCT01718054|Children|children
333792|NCT01718054|Growth|growth
333793|NCT01718054|Nitric Oxide|nitric oxide
333794|NCT01718041|Growth hormone|growth hormone
333795|NCT01718041|Growth hormone deficiency|growth hormone deficiency
333796|NCT01718041|Growth|growth
333797|NCT01718041|Pediatric growth hormone deficiency|pediatric growth hormone deficiency
333798|NCT01718041|Long acting growth hormone|long acting growth hormone
333799|NCT01718041|GHD|ghd
333800|NCT01718041|PGHD|pghd
333801|NCT01718041|VRS 317|vrs 317
333802|NCT01718041|Exten|exten
333803|NCT01718041|Versartis|versartis
333804|NCT01718028|Systane BALANCE|systane balance
333805|NCT01718028|Dry eye|dry eye
333806|NCT01718028|lipid deficiency|lipid deficiency
333807|NCT01718028|NITFBUT|nitfbut
333808|NCT01718015|Vascular Endothelial Growth Factor|vascular endothelial growth factor
334183|NCT01716611|arginine vasopressin|arginine vasopressin
333809|NCT01718015|Brain-Derived Neurothropic Factor|brain-derived neurothropic factor
333810|NCT01718015|Diabetes Mellitus|diabetes mellitus
333811|NCT01718015|CD-163|cd-163
333812|NCT01718015|Cerebrospinal fluid|cerebrospinal fluid
333813|NCT01718015|Peripheral Nervous System Diseases|peripheral nervous system diseases
333814|NCT01718015|Mass spectrometry|mass spectrometry
333815|NCT01718002|Nursing|nursing
333816|NCT01718002|Simulation|simulation
333817|NCT01718002|Education|education
333818|NCT01717989|Dialysis|dialysis
333819|NCT01717989|Prospective Payment System|prospective payment system
333820|NCT01717989|Center for Medicare and Medicaide Services|center for medicare and medicaide services
333821|NCT01717989|End Stage Renal Disease|end stage renal disease
333822|NCT01717989|Concomitant Medications Dosage /Treatment patterns|concomitant medications dosage /treatment patterns
333823|NCT01717976|emergency department use|emergency department use
333824|NCT01717976|Veterans|veterans
333825|NCT01717950|Human Hookworm|human hookworm
333826|NCT01717950|Necator americanus|necator americanus
333827|NCT01717950|Hookworm|hookworm
333828|NCT01717950|Hookworm Disease|hookworm disease
333829|NCT01717950|Iron-deficiency anemia|iron-deficiency anemia
333830|NCT01717950|Soil-transmitted helminth infection|soil-transmitted helminth infection
333831|NCT01717950|Neglected Tropical Disease|neglected tropical disease
333832|NCT01717950|Na-APR-1|na-apr-1
333833|NCT01717937|retinovascular disease|retinovascular disease
333834|NCT01717937|imaging|imaging
333835|NCT01717937|fluorescein angiography|fluorescein angiography
333836|NCT01717937|FA|fa
333837|NCT01717937|angiography|angiography
333838|NCT01717937|optical coherence tomography|optical coherence tomography
333839|NCT01717937|OCT|oct
333840|NCT01717937|phase variance|phase variance
333841|NCT01717937|comparison|comparison
333842|NCT01717937|age-related macular degeneration|age-related macular degeneration
333843|NCT01717937|diabetic retinopathy|diabetic retinopathy
333844|NCT01717937|hypertensive retinopathy|hypertensive retinopathy
333845|NCT01717937|retinal vein occlusion|retinal vein occlusion
333846|NCT01717937|retinal artery occlusion|retinal artery occlusion
333847|NCT01717924|Signet ring cell|signet ring cell
333848|NCT01717924|gastric adenocarcinoma|gastric adenocarcinoma
333849|NCT01717924|peri-operative chemotherapy|peri-operative chemotherapy
333850|NCT01717924|surgery|surgery
333851|NCT01717911|Newly diagnosed type 2 diabetes|newly diagnosed type 2 diabetes
333852|NCT01717911|Insulin, metformin, sitagliptin|insulin, metformin, sitagliptin
333853|NCT01717911|beta-cell function, glycemic control|beta-cell function, glycemic control
333854|NCT01717898|Castrate-resistant prostate cancer|castrate-resistant prostate cancer
333855|NCT01717885|Pharmacokinetics|pharmacokinetics
333856|NCT01717885|Antimalarial|antimalarial
333857|NCT01717885|HIV|hiv
333858|NCT01717885|Antiretrovirals|antiretrovirals
333859|NCT01717885|Childhood development|childhood development
333860|NCT01717885|Pregnancy|pregnancy
333861|NCT01717872|glottis, laryngoscopy, laryngoscope blade|glottis, laryngoscopy, laryngoscope blade
333862|NCT01717859|Rheumatoid Arthritis|rheumatoid arthritis
333863|NCT01717846|Apoptosos|apoptosos
333864|NCT01717846|Rheumatoid Arthritis|rheumatoid arthritis
333865|NCT01717846|T cells, B cells|t cells, b cells
333866|NCT01717846|DAS28|das28
333867|NCT01717846|Clinical Disease activity Index|clinical disease activity index
333868|NCT01717846|CDAI|cdai
333869|NCT01717833|ICU acquired weakness|icu acquired weakness
333870|NCT01717833|Critical illness polyneuromyopathy|critical illness polyneuromyopathy
333871|NCT01717833|post ICU rehabilitation|post icu rehabilitation
333872|NCT01717833|neuromuscular electrical rehabilitation|neuromuscular electrical rehabilitation
333874|NCT01717820|Obesity|obesity
333875|NCT01717820|Postmenopausal women|postmenopausal women
333876|NCT01717820|Body composition|body composition
333877|NCT01717820|Resveratrol|resveratrol
333878|NCT01717820|Inflammatory biomarkers|inflammatory biomarkers
333879|NCT01717820|Bone formation|bone formation
333880|NCT01717820|Adipose metabolism|adipose metabolism
333881|NCT01717807|epithelial growth factor receptors|epithelial growth factor receptors
333882|NCT01717807|lung cancer|lung cancer
333883|NCT01717807|advanced tumor of pancrease|advanced tumor of pancrease
333884|NCT01717807|erlotinib|erlotinib
333885|NCT01717807|C11-Erlotinib PET/CT|c11-erlotinib pet/ct
333886|NCT01717794|operative time|operative time
333887|NCT01717794|laparoscopy|laparoscopy
333888|NCT01717794|total hysterectomy|total hysterectomy
333889|NCT01717794|pelvic lymphadenectomy|pelvic lymphadenectomy
333890|NCT01717794|endometrial cancer|endometrial cancer
333891|NCT01717794|Thunderbeat|thunderbeat
333892|NCT01717781|operative time|operative time
333893|NCT01717781|laparoscopy|laparoscopy
333894|NCT01717781|radical hysterectomy|radical hysterectomy
333895|NCT01717781|pelvic lymphadenectomy|pelvic lymphadenectomy
333896|NCT01717781|cervical cancer|cervical cancer
333897|NCT01717781|thunderbeat|thunderbeat
333898|NCT01717768|hypogonadism|hypogonadism
333899|NCT01717768|Gonadal Disorders|gonadal disorders
333900|NCT01717768|Endocrine System Diseases|endocrine system diseases
333901|NCT01717768|Testosterone|testosterone
333902|NCT01717768|Testosterone enanthate|testosterone enanthate
333903|NCT01717768|Testosterone undecanoate|testosterone undecanoate
333904|NCT01717768|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate
333905|NCT01717768|Methyltestosterone|methyltestosterone
333906|NCT01717768|Androgens|androgens
333907|NCT01717768|Hormones|hormones
333908|NCT01717768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
333909|NCT01717768|Physiological Effects of Drugs|physiological effects of drugs
333910|NCT01717768|Pharmacologic Actions|pharmacologic actions
333911|NCT01717768|Therapeutic Uses|therapeutic uses
333912|NCT01717768|Anabolic Agents|anabolic agents
333913|NCT01717755|basilar|basilar
333914|NCT01717755|stroke|stroke
333915|NCT01717755|mechanical|mechanical
333916|NCT01717755|thrombolysis|thrombolysis
333917|NCT01717755|intra-arterial|intra-arterial
333918|NCT01717755|trombectomy|trombectomy
333919|NCT01717742|Randomized controlled trial|randomized controlled trial
333920|NCT01717742|Pleural Empyema|pleural empyema
333921|NCT01717742|tPA|tpa
333922|NCT01717742|DNase|dnase
333923|NCT01717729|HCC, RFA, Iodine-125, Recurrence|hcc, rfa, iodine-125, recurrence
333924|NCT01717716|boys|boys
333925|NCT01717716|obesity|obesity
333926|NCT01717716|glucose|glucose
333927|NCT01717716|sucrose|sucrose
333928|NCT01717716|high-fructose corn syrup-55|high-fructose corn syrup-55
333929|NCT01717703|prevention|prevention
333930|NCT01717690|MRSA|mrsa
333931|NCT01717690|chlorhexidine|chlorhexidine
333932|NCT01717664|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
333933|NCT01717664|MAP|map
333934|NCT01717664|antibiotic|antibiotic
333935|NCT01717664|Interferon beta 1-a|interferon beta 1-a
333936|NCT01717664|MS|ms
333937|NCT01717664|MRI|mri
333938|NCT01717664|EDSS|edss
333939|NCT01717664|relapse rate|relapse rate
333940|NCT01717651|Atrophy|atrophy
333941|NCT01717651|Muscle wasting|muscle wasting
333942|NCT01717651|Sepsis|sepsis
333943|NCT01717638|Meningococcal disease, vaccines, children, persistence|meningococcal disease, vaccines, children, persistence
333944|NCT01717625|montelukast|montelukast
333945|NCT01717625|BPD|bpd
333946|NCT01717625|singulair|singulair
333947|NCT01717625|prematurity|prematurity
333948|NCT01717612|gastric varices, thrombin, histoacryl|gastric varices, thrombin, histoacryl
333949|NCT01717599|Post ERCP pancreatitis|post ercp pancreatitis
333950|NCT01717599|Diclofenac|diclofenac
333951|NCT01717599|NSAID|nsaid
333952|NCT01717586|preeclampsia|preeclampsia
333953|NCT01717586|pravastatin|pravastatin
333954|NCT01717586|Pravachol®|pravachol®
333955|NCT01717586|statin|statin
333956|NCT01717586|high-risk pregnancy|high-risk pregnancy
333957|NCT01717586|safety|safety
333958|NCT01717586|fetal morbidity and mortality|fetal morbidity and mortality
333959|NCT01717586|maternal morbidity and mortality|maternal morbidity and mortality
333960|NCT01717586|neonatal mortality|neonatal mortality
333961|NCT01717586|premature delivery|premature delivery
333962|NCT01717586|preemie|preemie
333963|NCT01717573|STEMI|stemi
333964|NCT01717573|No-reflow|no-reflow
333965|NCT01717573|Primary percutaneous intervention|primary percutaneous intervention
333966|NCT01717573|Deferred stenting|deferred stenting
333967|NCT01717560|chronic hepatitis C|chronic hepatitis c
333968|NCT01717560|illicit drug use|illicit drug use
333969|NCT01717560|Substance-Related Disorders|substance-related disorders
333970|NCT01717560|multidisciplinary care|multidisciplinary care
333971|NCT01717560|integrated care|integrated care
333972|NCT01717560|mental health care|mental health care
333973|NCT01717560|intensive case management|intensive case management
333974|NCT01717547|Veterans|veterans
333975|NCT01717547|Yoga|yoga
333976|NCT01717547|Stress|stress
333977|NCT01717534|Diarrhea|diarrhea
333978|NCT01717534|Children|children
333979|NCT01717534|Heat-treated lactobacilli|heat-treated lactobacilli
333980|NCT01717521|hysterectomy|hysterectomy
333981|NCT01717521|gynecological abdominal surgery|gynecological abdominal surgery
333982|NCT01717508|MDD|mdd
333983|NCT01717508|depression|depression
333984|NCT01717508|major depressive disorder|major depressive disorder
333985|NCT01717508|adolescent|adolescent
333986|NCT01717495|Pacemaker|pacemaker
333987|NCT01717495|Implantable-cardioverter defibrillator|implantable-cardioverter defibrillator
333988|NCT01717495|Cardiac Pacing, Artificial/adverse effects|cardiac pacing, artificial/adverse effects
333989|NCT01717495|Venous thrombosis|venous thrombosis
333990|NCT01717495|Pulmonary embolism|pulmonary embolism
333991|NCT01717495|Phlebography|phlebography
333992|NCT01717495|Biological markers|biological markers
333993|NCT01717495|Computed tomography angiography|computed tomography angiography
333994|NCT01717482|Bronchoscopy|bronchoscopy
333995|NCT01717482|Metformin|metformin
333996|NCT01717469|Pacemaker|pacemaker
333997|NCT01717469|Pacemaker implantation|pacemaker implantation
333998|NCT01717469|Coronary sinus|coronary sinus
333999|NCT01717469|Ventricular dysfunction|ventricular dysfunction
334000|NCT01717469|Right ventricular pacing|right ventricular pacing
334001|NCT01717469|Left ventricular pacing|left ventricular pacing
334002|NCT01717456|Fecal incontinence|fecal incontinence
334003|NCT01717456|Frail elders|frail elders
334004|NCT01717456|Home health care|home health care
334005|NCT01717456|Nurse|nurse
334006|NCT01717456|Patient education|patient education
334007|NCT01717443|Human Papillomavirus|human papillomavirus
334008|NCT01717443|Renal transplantation|renal transplantation
334009|NCT01717430|Injections, epidural|injections, epidural
334010|NCT01717430|Injections, intra-articular|injections, intra-articular
334011|NCT01717430|Chronic pain|chronic pain
334012|NCT01717430|Neck pain|neck pain
334013|NCT01717430|Back pain|back pain
334014|NCT01717430|Low back pain|low back pain
334015|NCT01717430|Sciatica|sciatica
334016|NCT01717430|Sacroiliac joint|sacroiliac joint
334017|NCT01717430|Corticosteroids|corticosteroids
334018|NCT01717430|Dexamethasone|dexamethasone
334019|NCT01717430|Adrenocorticotropic hormone|adrenocorticotropic hormone
334020|NCT01717430|Adrenal insufficiency|adrenal insufficiency
334021|NCT01717430|Hemoglobin A, glycosylated|hemoglobin a, glycosylated
334022|NCT01717417|impacted canine|impacted canine
334023|NCT01717417|miniscrew|miniscrew
334024|NCT01717417|cone beam|cone beam
334025|NCT01717404|IBS|ibs
334026|NCT01717391|radiotherapy|radiotherapy
334027|NCT01717391|Positron-Emission Tomography and Computed Tomography|positron-emission tomography and computed tomography
334028|NCT01717391|chemotherapy|chemotherapy
334029|NCT01717391|bone marrow|bone marrow
334030|NCT01717378|Patient Recruitment|patient recruitment
334031|NCT01717378|Research Subject Recruitment|research subject recruitment
334032|NCT01717378|Research Subject Selection|research subject selection
334033|NCT01717378|Selection of Subjects|selection of subjects
334034|NCT01717378|Health Surveys|health surveys
334035|NCT01717378|Health Questionnaires|health questionnaires
334036|NCT01717378|Health Interviews|health interviews
334037|NCT01717365|SCOPE|scope
334038|NCT01717352|Weight loss|weight loss
334039|NCT01717274|Functional Endoscopic Sinus Surgery|functional endoscopic sinus surgery
334040|NCT01717274|Hot water irrigation|hot water irrigation
334041|NCT01717261|breast cancer|breast cancer
334042|NCT01717261|early breast cancer|early breast cancer
334043|NCT01717261|partial breast irradiation|partial breast irradiation
334044|NCT01717261|preoperative radiation|preoperative radiation
334045|NCT01717222|Lignocaine|lignocaine
334046|NCT01717222|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
334047|NCT01717222|Pain relief|pain relief
334048|NCT01717209|heart failure|heart failure
334049|NCT01717209|hypertension, pulmonary|hypertension, pulmonary
334050|NCT01717209|heart failure, right-sided|heart failure, right-sided
334051|NCT01717209|heart-assist devices|heart-assist devices
334052|NCT01717209|Heart Transplantation|heart transplantation
334053|NCT01717196|sample adequacy|sample adequacy
334054|NCT01717196|diagnostic accuracy|diagnostic accuracy
334055|NCT01717196|complications|complications
334056|NCT01717183|Patient|patient
334057|NCT01717170|Non-infectious Uveitis, Tocilizumab|non-infectious uveitis, tocilizumab
334058|NCT01717157|Healthy|healthy
334059|NCT01717157|Fentanyl|fentanyl
334060|NCT01717157|Transdermal patch|transdermal patch
334061|NCT01717157|DUROGESIC|durogesic
334062|NCT01717144|therapeutic education|therapeutic education
334063|NCT01717144|Parkinson's disease|parkinson's disease
334064|NCT01717144|quality of life|quality of life
334065|NCT01717131|Invasive breast cancer|invasive breast cancer
334066|NCT01717118|Evaluation|evaluation
334067|NCT01717118|Immunogenicity|immunogenicity
334068|NCT01717118|Levels|levels
334069|NCT01717118|Women|women
334070|NCT01717118|HPV|hpv
334071|NCT01717118|Vaccine|vaccine
334072|NCT01717118|Mexico|mexico
334073|NCT01717105|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
335171|NCT01712191|NUsurface|nusurface
334074|NCT01717105|Epidermal growth factor receptor (EGFR) positive mutation|epidermal growth factor receptor (egfr) positive mutation
334075|NCT01717066|Hepatocellular Carcinoma|hepatocellular carcinoma
334076|NCT01717066|ginsenoside Rg3|ginsenoside rg3
334077|NCT01717040|Bipolar Disorder|bipolar disorder
334078|NCT01717040|Insulin Resistance|insulin resistance
334079|NCT01717027|pharmacokinetics|pharmacokinetics
334080|NCT01717027|bioavailability|bioavailability
334081|NCT01717027|oxycodone|oxycodone
334082|NCT01717027|management of moderate to severe pain|management of moderate to severe pain
334083|NCT01717014|rectal cancer|rectal cancer
334084|NCT01717014|stapler|stapler
334085|NCT01717001|kinematics|kinematics
334086|NCT01717001|knee joint|knee joint
334087|NCT01716988|Micafungin|micafungin
334088|NCT01716988|pharmacokinetics|pharmacokinetics
334089|NCT01716988|invasive candidiasis|invasive candidiasis
334090|NCT01716988|intensive care|intensive care
334091|NCT01716975|Schizophrenia|schizophrenia
334092|NCT01716975|Cognition|cognition
334093|NCT01716975|Cognition Impairment|cognition impairment
334094|NCT01716975|Alpha-7 nAChR|alpha-7 nachr
334095|NCT01716962|Acute respiratory distress syndrome, Fluid responsiveness, Pulse pressure variation|acute respiratory distress syndrome, fluid responsiveness, pulse pressure variation
334096|NCT01716962|Pleth variability index, Passive leg raising test|pleth variability index, passive leg raising test
334097|NCT01716949|rectal cancer|rectal cancer
334098|NCT01716949|recurrent rectal cancer|recurrent rectal cancer
334099|NCT01716949|hyperthermia|hyperthermia
334100|NCT01716949|radiation|radiation
334101|NCT01716949|chemoradiation|chemoradiation
334102|NCT01716949|5-FU|5-fu
334103|NCT01716949|capecitabine|capecitabine
334104|NCT01716949|oxaliplatin|oxaliplatin
334105|NCT01716936|Thoracic Insufficiency Syndrome|thoracic insufficiency syndrome
334106|NCT01716936|Early Onset Spinal Deformity|early onset spinal deformity
334107|NCT01716884|STEMI|stemi
334108|NCT01716884|reperfution|reperfution
334109|NCT01716884|primary PCI|primary pci
334110|NCT01716858|Schizophrenia|schizophrenia
334111|NCT01716858|Sulforaphane|sulforaphane
334112|NCT01716858|Psychosis|psychosis
334113|NCT01716858|Cognition|cognition
334114|NCT01716858|Oxidative stress|oxidative stress
334115|NCT01716858|Antioxidant|antioxidant
334116|NCT01716858|Anti-inflammatory|anti-inflammatory
334117|NCT01716845|autism|autism
334118|NCT01716845|autism spectrum disorders|autism spectrum disorders
334119|NCT01716845|RNA|rna
334120|NCT01716845|gene expression|gene expression
334121|NCT01716845|developmental delay|developmental delay
334122|NCT01716819|Heart failure, abdominal obesity, RAAS|heart failure, abdominal obesity, raas
334123|NCT01716806|Antibody-Drug Conjugate|antibody-drug conjugate
334124|NCT01716806|Antibodies, Monoclonal|antibodies, monoclonal
334125|NCT01716806|Hematologic Diseases|hematologic diseases
334126|NCT01716806|Hodgkin Disease|hodgkin disease
334127|NCT01716806|Antigens, CD30|antigens, cd30
334128|NCT01716806|Lymphoma|lymphoma
334129|NCT01716806|monomethylauristatin E|monomethylauristatin e
334130|NCT01716806|Drug Therapy|drug therapy
334131|NCT01716793|Primary AML|primary aml
334132|NCT01716793|Risk-adapted treatment|risk-adapted treatment
334133|NCT01716793|Hematopoietic transplantation|hematopoietic transplantation
334134|NCT01716793|CD34+ cell selection|cd34+ cell selection
334135|NCT01716767|Carpal tunnel syndrome|carpal tunnel syndrome
334136|NCT01716767|hand pain|hand pain
334137|NCT01716767|wrist pain|wrist pain
334138|NCT01716767|arm pain|arm pain
334139|NCT01716767|topical menthol|topical menthol
334140|NCT01716754|asthma|asthma
334141|NCT01716754|asthma control|asthma control
334142|NCT01716754|allergy|allergy
334143|NCT01716754|atopic|atopic
334144|NCT01716754|IgE|ige
334145|NCT01716754|double-blind|double-blind
334146|NCT01716754|placebo|placebo
334147|NCT01716754|omalizumab|omalizumab
334148|NCT01716741|Gaucher disease|gaucher disease
334149|NCT01716741|lysosomal storage disorder|lysosomal storage disorder
334150|NCT01716741|metabolic disease|metabolic disease
334151|NCT01716741|medical records review|medical records review
334152|NCT01716728|Lysosomal Acid Lipase Deficiency|lysosomal acid lipase deficiency
334153|NCT01716728|Cholesterol Ester Storage Disease|cholesterol ester storage disease
334154|NCT01716728|Wolman Disease|wolman disease
334155|NCT01716728|Lysosomal Storage Disorder|lysosomal storage disorder
334156|NCT01716728|Metabolic Disease|metabolic disease
334157|NCT01716728|Recessive Inheritance|recessive inheritance
334158|NCT01716702|Prostate Cancer|prostate cancer
334159|NCT01716702|Psychosocial Intervention|psychosocial intervention
334160|NCT01716702|Sexual Rehabilitation|sexual rehabilitation
334161|NCT01716702|Online Intervention|online intervention
334162|NCT01716663|Symptomatic paroxysmal|symptomatic paroxysmal
334163|NCT01716663|Atrial fibrillation|atrial fibrillation
334164|NCT01716663|Observational|observational
334165|NCT01716663|Acute procedural outcomes|acute procedural outcomes
334166|NCT01716663|Ablation|ablation
334167|NCT01716650|ankle|ankle
334168|NCT01716650|saphenous nerve block|saphenous nerve block
334169|NCT01716637|Alzheimer's Disease|alzheimer's disease
334170|NCT01716637|Dementia|dementia
334171|NCT01716637|Cognitive decline|cognitive decline
334172|NCT01716637|Cognitive disorder|cognitive disorder
334173|NCT01716637|Degenerative brain disease|degenerative brain disease
334174|NCT01716637|Cognitive impairment|cognitive impairment
334175|NCT01716637|Memory loss|memory loss
334176|NCT01716637|TNF-alpha|tnf-alpha
334177|NCT01716624|Pediatric|pediatric
334178|NCT01716611|liver cirrhosis|liver cirrhosis
334179|NCT01716611|hyponatemia|hyponatemia
334180|NCT01716611|ascites|ascites
334181|NCT01716611|vaptans|vaptans
334182|NCT01716611|antidiuretic hormon|antidiuretic hormon
334184|NCT01716598|COPD|copd
334185|NCT01716598|TLD Therapy|tld therapy
334186|NCT01716598|Targeted Lung Denervation Therapy|targeted lung denervation therapy
334188|NCT01716598|Innovative Pulmonary Solutions, Inc.|innovative pulmonary solutions, inc.
334189|NCT01716598|Holaira, Inc.|holaira, inc.
334190|NCT01716585|Hepatitis C Virus|hepatitis c virus
334191|NCT01716585|Hepatitis C Genotype 1|hepatitis c genotype 1
334192|NCT01716585|Hepatitis C|hepatitis c
334193|NCT01716585|Treatment-Naïve|treatment-naïve
334194|NCT01716585|Interferon-Free|interferon-free
334195|NCT01716585|Chronic Hepatitis C|chronic hepatitis c
334196|NCT01716585|Viekira Pak|viekira pak
334197|NCT01716585|ombitasvir|ombitasvir
334198|NCT01716585|paritaprevir|paritaprevir
334199|NCT01716585|dasabuvir|dasabuvir
334200|NCT01716572|Upper gastrointestinal bleeding|upper gastrointestinal bleeding
334201|NCT01716572|Endoscopy|endoscopy
334202|NCT01716572|Erythromycin|erythromycin
334203|NCT01716572|Gastric lavage|gastric lavage
334204|NCT01716546|Advanced cancer of the stomach|advanced cancer of the stomach
334205|NCT01716546|Chemotherapy - naive patients|chemotherapy - naive patients
334206|NCT01716546|DCF|dcf
334207|NCT01716533|Serological|serological
334208|NCT01716533|Adults|adults
334209|NCT01716533|Clostridium difficile|clostridium difficile
334210|NCT01716533|Adult CDI patients|adult cdi patients
334211|NCT01716520|long-acting muscarinic antagonist|long-acting muscarinic antagonist
334212|NCT01716520|long-acting beta-agonist|long-acting beta-agonist
334213|NCT01716520|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
334214|NCT01716520|vilanterol|vilanterol
334215|NCT01716520|umeclidinium|umeclidinium
334216|NCT01716507|RRD|rrd
334217|NCT01716507|Rhegmatogenous|rhegmatogenous
334218|NCT01716507|Retinal|retinal
334219|NCT01716507|Detachment|detachment
334220|NCT01716507|PPV|ppv
334221|NCT01716507|Pars Plana Vitrectomy|pars plana vitrectomy
334222|NCT01716507|Gauge|gauge
334223|NCT01716494|asthma|asthma
334224|NCT01716481|Stroke|stroke
334225|NCT01716481|Mesenchymal stem cells|mesenchymal stem cells
334226|NCT01716481|Stem cells|stem cells
334227|NCT01716481|Neurogenesis|neurogenesis
334228|NCT01716468|Ketogenic Diet, Advanced Cancer, Neoplasm|ketogenic diet, advanced cancer, neoplasm
334229|NCT01716468|Low carbohydrate|low carbohydrate
334230|NCT01716442|rituximab|rituximab
334231|NCT01716442|nephrotic|nephrotic
334232|NCT01716442|refractory|refractory
334233|NCT01716429|vegetarian|vegetarian
334234|NCT01716429|vegan|vegan
334235|NCT01716429|low calorie|low calorie
334236|NCT01716429|weight Loss|weight loss
334237|NCT01716429|infertility|infertility
334238|NCT01716429|PCOS|pcos
334239|NCT01716403|C hepatitis, telaprevir concentration, ribavirin oncentration, anemia|c hepatitis, telaprevir concentration, ribavirin oncentration, anemia
334240|NCT01716377|Neck Pain|neck pain
334241|NCT01716377|Musculoskeletal pain|musculoskeletal pain
334242|NCT01716377|Venlafaxine|venlafaxine
334243|NCT01716351|Randomized Clinical Control Trial|randomized clinical control trial
334244|NCT01716351|Complementary and Alternative Medicine|complementary and alternative medicine
334245|NCT01716351|Yoga|yoga
334246|NCT01716351|Electrophysiology|electrophysiology
334247|NCT01716351|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
334248|NCT01716351|Psychosocial|psychosocial
334249|NCT01716351|Anxiety|anxiety
334250|NCT01716351|Self-Compassion|self-compassion
334251|NCT01716351|Anti-Tachycardia Pacing Events|anti-tachycardia pacing events
334252|NCT01716338|glyburide|glyburide
334253|NCT01716338|glybenclamide|glybenclamide
334254|NCT01716338|hypoglycemia|hypoglycemia
334255|NCT01716312|Safety Of Omalizumab In Patients With SLE|safety of omalizumab in patients with sle
334256|NCT01716312|Systemic Lupus Erythematosus|systemic lupus erythematosus
334257|NCT01716299|HIV|hiv
334258|NCT01716299|Diagnostics|diagnostics
334259|NCT01716247|Mammography (CESM)|mammography (cesm)
334260|NCT01716247|MRI|mri
334261|NCT01716247|Breast screening|breast screening
334262|NCT01716247|12-214|12-214
334263|NCT01716208|Fresh Frozen Plasma|fresh frozen plasma
334264|NCT01716208|Complement|complement
334265|NCT01716208|Monoclonal Antibody|monoclonal antibody
334266|NCT01716195|Human Papillomavirus|human papillomavirus
334267|NCT01716195|HPV|hpv
334268|NCT01716143|atrial fibrillation|atrial fibrillation
334269|NCT01716143|catheter ablation|catheter ablation
334270|NCT01716143|Mapping|mapping
334271|NCT01716130|Fluzone Intradermal vaccine|fluzone intradermal vaccine
334272|NCT01716117|Large aneurysm|large aneurysm
334273|NCT01716117|Giant aneurysm|giant aneurysm
334274|NCT01716117|Wide neck aneurysm|wide neck aneurysm
335172|NCT01712191|Meniscus|meniscus
334275|NCT01716091|focus of study is postoperative enfectious morbidity and postoperative GİS functionally recovery|focus of study is postoperative enfectious morbidity and postoperative gis functionally recovery
334276|NCT01716078|Brachial Plexus|brachial plexus
334277|NCT01716078|Nerve Block|nerve block
334278|NCT01716078|Nerve Conduction|nerve conduction
334279|NCT01716065|Anesthesia, Circulating tumor cells|anesthesia, circulating tumor cells
334280|NCT01716052|Mammogram|mammogram
334281|NCT01716052|Ibuprofen|ibuprofen
334282|NCT01716052|Pain management|pain management
334283|NCT01716039|Moderately to severely active Ulcerative Colitis|moderately to severely active ulcerative colitis
334284|NCT01716026|high myopia|high myopia
334285|NCT01716026|choroidal neovascularization|choroidal neovascularization
334286|NCT01716000|vaginal gel|vaginal gel
334287|NCT01716000|vaginal coating|vaginal coating
334288|NCT01716000|sensory perceptions|sensory perceptions
334289|NCT01715987|Hepatitis B|hepatitis b
334290|NCT01715987|Antiviral|antiviral
334291|NCT01715987|Tubular dysfunction|tubular dysfunction
334292|NCT01715987|Entecavir|entecavir
334293|NCT01715987|Tenofovir|tenofovir
334294|NCT01715974|G-CSF, IVF failure,pregnancy|g-csf, ivf failure,pregnancy
334295|NCT01715961|70 years old|70 years old
334296|NCT01715961|DLBCL|dlbcl
334297|NCT01715961|Rituximab-CHOP|rituximab-chop
334298|NCT01715961|Sarcopenia|sarcopenia
334299|NCT01715948|CROS hearing aid|cros hearing aid
334300|NCT01715948|Bone-anchored hearing device|bone-anchored hearing device
334301|NCT01715935|Clear cells renal carcinoma|clear cells renal carcinoma
334302|NCT01715935|everolimus|everolimus
334303|NCT01715935|neo-adjuvant treatment|neo-adjuvant treatment
334304|NCT01715922|Cryptococcal meningitis|cryptococcal meningitis
334305|NCT01715922|HIV Infections|hiv infections
334306|NCT01715922|Oral treatment|oral treatment
334307|NCT01715922|High dose of fluconazole|high dose of fluconazole
334308|NCT01715922|Flucytosine|flucytosine
334309|NCT01715922|Burundi|burundi
334310|NCT01715922|Ivory Coast|ivory coast
334311|NCT01715896|Rheumatoid Arthritis|rheumatoid arthritis
334312|NCT01715896|Golimumab|golimumab
334313|NCT01715896|Mavrilimumab|mavrilimumab
334314|NCT01715883|Lung transplant|lung transplant
334315|NCT01715883|Pulmonary Graft Dysfunction|pulmonary graft dysfunction
334316|NCT01715883|Sodium Nitrite|sodium nitrite
334317|NCT01715870|Age related macular degeneration|age related macular degeneration
334318|NCT01715870|Food habits|food habits
334319|NCT01715870|Life style|life style
334320|NCT01715870|Risk factors|risk factors
334321|NCT01715870|questionnaire|questionnaire
334322|NCT01715857|Economics, Pharmaceutical|economics, pharmaceutical
334323|NCT01715857|Physician's Practice Patterns|physician's practice patterns
334324|NCT01715857|Chinese|chinese
334325|NCT01715857|Sevoflurane|sevoflurane
334326|NCT01715844|L-citrulline|l-citrulline
334327|NCT01715844|ADMA|adma
334328|NCT01715844|Asthma|asthma
334329|NCT01715844|Obesity|obesity
334330|NCT01715805|MDD|mdd
334331|NCT01715805|Major Depressive Disorder|major depressive disorder
334332|NCT01715792|Solid organ transplant rejection|solid organ transplant rejection
334333|NCT01715792|United Kingdom|united kingdom
334334|NCT01715792|Influenza|influenza
334335|NCT01715792|H1N1|h1n1
334336|NCT01715792|Pandemrix™|pandemrix™
334337|NCT01715779|Liver transplantation|liver transplantation
334338|NCT01715779|ENABLE|enable
334339|NCT01715779|observational|observational
334340|NCT01715779|mortality|mortality
334341|NCT01715779|Thromboembolic Events|thromboembolic events
334342|NCT01715779|Hepatic decompensation|hepatic decompensation
334343|NCT01715779|Long-Term follow-up|long-term follow-up
334344|NCT01715779|TEE|tee
334345|NCT01715766|Proteomics study|proteomics study
334346|NCT01715766|biomarker study of pain|biomarker study of pain
334347|NCT01715753|Function|function
334348|NCT01715753|Muscle mass|muscle mass
334349|NCT01715740|Chinese herbal medicine|chinese herbal medicine
334350|NCT01715740|Urticaria|urticaria
334351|NCT01715740|Antipruritics|antipruritics
334352|NCT01715740|Phase III clinical trial|phase iii clinical trial
334353|NCT01715727|diffusion kurtosis imaging|diffusion kurtosis imaging
334354|NCT01715727|parkinson disease|parkinson disease
334355|NCT01715727|parkinsonism|parkinsonism
334356|NCT01715727|diagnosis|diagnosis
334357|NCT01715727|differential diagnosis|differential diagnosis
334358|NCT01715714|Coronary Artery Disease|coronary artery disease
334359|NCT01715714|Statins|statins
334360|NCT01715714|Coronary Artery Bypass Grafting|coronary artery bypass grafting
334361|NCT01715714|Cardiac Surgery|cardiac surgery
334362|NCT01715675|asthma|asthma
334363|NCT01715675|allergy|allergy
334364|NCT01715675|sitostanol|sitostanol
334365|NCT01715675|cytokines|cytokines
334366|NCT01715675|Th1|th1
334367|NCT01715675|Treg|treg
334368|NCT01715675|antibodies|antibodies
334369|NCT01715675|IgE|ige
334370|NCT01715675|vaccination|vaccination
334371|NCT01715662|rehabilitation|rehabilitation
334372|NCT01715662|lower limb amputation|lower limb amputation
334373|NCT01715662|unilateral transtibial amputation|unilateral transtibial amputation
334374|NCT01715662|unilateral transfemoral amputation|unilateral transfemoral amputation
335173|NCT01712191|Knee|knee
334375|NCT01715662|older adults|older adults
334376|NCT01715662|cognitive computer games|cognitive computer games
334377|NCT01715662|home-based training|home-based training
334378|NCT01715662|Nintendo Wii|nintendo wii
334379|NCT01715662|virtual reality|virtual reality
334380|NCT01715649|Type 2 diabetes|type 2 diabetes
334381|NCT01715649|self-management|self-management
334382|NCT01715649|remote patient monitoring|remote patient monitoring
334383|NCT01715623|polymorphism|polymorphism
334384|NCT01715623|serum Ig|serum ig
334385|NCT01715597|uterine leiomyoma|uterine leiomyoma
334386|NCT01715597|laparoscopic myomectomy|laparoscopic myomectomy
334387|NCT01715597|intraoperative blood loss|intraoperative blood loss
334388|NCT01715597|ascorbic acid|ascorbic acid
334389|NCT01715584|Hypertension|hypertension
334390|NCT01715584|Sevoflurane|sevoflurane
334391|NCT01715584|Inhaled Anesthetic|inhaled anesthetic
334392|NCT01715584|Angiotensin Converting Enzyme Inhibitor|angiotensin converting enzyme inhibitor
334393|NCT01715584|Angiotensin II Receptor Blocking Agent|angiotensin ii receptor blocking agent
334394|NCT01715571|erectile dysfunction|erectile dysfunction
334395|NCT01715571|vibratory stimulation|vibratory stimulation
334396|NCT01715571|viberect|viberect
334397|NCT01715545|day-3 poor quality embryo|day-3 poor quality embryo
334398|NCT01715545|vitrification|vitrification
334399|NCT01715545|clinical outcome|clinical outcome
334400|NCT01715532|Huachansu|huachansu
334401|NCT01715532|Na+/K+-ATPase α3|na+/k+-atpase α3
334402|NCT01715532|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
334403|NCT01715532|randomized controlled trial|randomized controlled trial
334404|NCT01715519|Vilazodone|vilazodone
334405|NCT01715519|PTSD|ptsd
334406|NCT01715519|Depression|depression
334407|NCT01715506|Dementia|dementia
334408|NCT01715506|Resident|resident
334409|NCT01715506|Nursinghome|nursinghome
334410|NCT01715506|Use of restraint|use of restraint
334411|NCT01715506|Agitation|agitation
334412|NCT01715493|COPD|copd
334413|NCT01715493|Asthma|asthma
334414|NCT01715493|Lysozyme Hydrochloride|lysozyme hydrochloride
334415|NCT01715480|broccoli sprout|broccoli sprout
334416|NCT01715480|sickle cell|sickle cell
334417|NCT01715480|NRF2|nrf2
334418|NCT01715467|Dupuytren|dupuytren
334419|NCT01715467|Contracture|contracture
334420|NCT01715467|Auxilium|auxilium
334421|NCT01715467|XIAFLEX|xiaflex
334422|NCT01715441|Metastatic colorectal cancer patients|metastatic colorectal cancer patients
334423|NCT01715441|KRAS mutation|kras mutation
334424|NCT01715441|Sorafenib|sorafenib
334425|NCT01715428|diabetes, cardiovascular risk|diabetes, cardiovascular risk
334426|NCT01715415|Hepatitis C|hepatitis c
334427|NCT01715415|Treatment-Experienced|treatment-experienced
334428|NCT01715415|Null responder|null responder
334429|NCT01715415|Partial Responder|partial responder
334430|NCT01715415|Chronic Hepatitis|chronic hepatitis
334431|NCT01715415|Hepatitis C Genotype 1|hepatitis c genotype 1
334432|NCT01715415|Interferon-Free|interferon-free
334433|NCT01715415|Hepatitis C Virus|hepatitis c virus
334434|NCT01715415|Relapser|relapser
334435|NCT01715415|Non responder|non responder
334436|NCT01715415|Viekira Pak|viekira pak
334437|NCT01715415|ombitasvir|ombitasvir
334438|NCT01715415|ribavirin|ribavirin
334439|NCT01715415|ritonavir|ritonavir
334440|NCT01715415|paritaprevir|paritaprevir
334441|NCT01715415|dasabuvir|dasabuvir
334442|NCT01715402|liver tumor|liver tumor
334443|NCT01715402|carcinoma|carcinoma
334444|NCT01715402|cholangiocarcinoma|cholangiocarcinoma
334445|NCT01715402|metastasis|metastasis
334446|NCT01715389|Asthma|asthma
334447|NCT01715389|Goals|goals
334448|NCT01715389|Shared Decision Making|shared decision making
334449|NCT01715389|Patient Portal|patient portal
334450|NCT01715389|Electronic Medical Record|electronic medical record
334451|NCT01715376|traditional chinese medicine|traditional chinese medicine
334452|NCT01715376|complementary therapies|complementary therapies
334453|NCT01715376|traditional chinese medicine syndrome scale|traditional chinese medicine syndrome scale
334454|NCT01715350|Alzheimer's Disease|alzheimer's disease
334455|NCT01715337|muscle fibre|muscle fibre
334456|NCT01715337|capillary|capillary
334457|NCT01715337|rehabilitation|rehabilitation
334458|NCT01715337|exercise training|exercise training
334459|NCT01715324|In vitro fertilization|in vitro fertilization
334460|NCT01715324|Antagonist protocol|antagonist protocol
334461|NCT01715324|Growth Hormone|growth hormone
334462|NCT01715311|COPD|copd
334463|NCT01715311|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
334464|NCT01715311|indacaterol|indacaterol
334465|NCT01715311|tiotropium|tiotropium
334466|NCT01715298|Anticholinergic|anticholinergic
334467|NCT01715298|Antimuscarinic|antimuscarinic
334468|NCT01715298|Chronic Obstructive Airway Disease|chronic obstructive airway disease
334469|NCT01715298|Chronic Obstructive Lung Disease|chronic obstructive lung disease
334470|NCT01715298|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
334471|NCT01715298|COPD|copd
334472|NCT01715298|LAMA|lama
334473|NCT01715298|Lung Disease|lung disease
334474|NCT01715298|Lung Diseases, Obstructive|lung diseases, obstructive
334475|NCT01715298|Lung Function|lung function
334476|NCT01715298|Muscarinic receptor antagonist|muscarinic receptor antagonist
334477|NCT01715298|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
334478|NCT01715298|Respiratory Tract Diseases|respiratory tract diseases
334479|NCT01715285|Prostate neoplasms|prostate neoplasms
334480|NCT01715285|Prostate cancer|prostate cancer
334481|NCT01715285|Metastatic prostate cancer|metastatic prostate cancer
334482|NCT01715285|Abiraterone acetate|abiraterone acetate
334483|NCT01715285|ZYTIGA|zytiga
334484|NCT01715285|Prednisone|prednisone
334485|NCT01715285|Androgen deprivation therapy|androgen deprivation therapy
334486|NCT01715259|Renal insufficiency|renal insufficiency
334487|NCT01715259|Renal impairment|renal impairment
334488|NCT01715259|End-stage renal disease|end-stage renal disease
334489|NCT01715259|Abiraterone acetate|abiraterone acetate
334490|NCT01715259|Pharmacokinetics|pharmacokinetics
334491|NCT01715246|healthy babbies|healthy babbies
334492|NCT01715246|infant formula|infant formula
334493|NCT01715246|growth|growth
334495|NCT01715220|Nitroglycerin|nitroglycerin
334496|NCT01715220|Biliary Colic|biliary colic
334497|NCT01715220|Cholelithiasis|cholelithiasis
334498|NCT01715220|Abdominal Pain.|abdominal pain.
334499|NCT01715194|OSAS|osas
334500|NCT01715194|CPAP|cpap
334501|NCT01715194|Adherence|adherence
334502|NCT01715194|Telemedicine|telemedicine
334503|NCT01715168|Doxil generic|doxil generic
334504|NCT01715168|Caelyx generic|caelyx generic
334505|NCT01715168|generic treatment|generic treatment
334506|NCT01715168|ovarian cancer|ovarian cancer
334507|NCT01715168|ovary|ovary
334508|NCT01715168|progressed|progressed
334509|NCT01715168|recurred cancer|recurred cancer
334510|NCT01715168|platinum based therapy|platinum based therapy
334511|NCT01715155|Metastatic Breast Cancer,|metastatic breast cancer,
334512|NCT01715155|retrospective study,|retrospective study,
334513|NCT01715155|disease progression,|disease progression,
334514|NCT01715155|clinical management|clinical management
334515|NCT01715142|Pancreatic cancer|pancreatic cancer
334516|NCT01715142|Nab-paclitaxel|nab-paclitaxel
334517|NCT01715142|Gemcitabine|gemcitabine
334518|NCT01715142|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
334519|NCT01715116|Cardiac arrhythmias|cardiac arrhythmias
334520|NCT01715116|Implantable Cardioverter-Defibrillator|implantable cardioverter-defibrillator
334521|NCT01715116|Patient Safety|patient safety
334522|NCT01715116|Quality of life|quality of life
334523|NCT01715103|HIV infection|hiv infection
334524|NCT01715103|mucosa|mucosa
334525|NCT01715103|immunological parameters|immunological parameters
334526|NCT01715103|genital sampling|genital sampling
334527|NCT01715103|healthy women volunteers|healthy women volunteers
334528|NCT01715077|melanoma|melanoma
334529|NCT01715077|stage IV|stage iv
334530|NCT01715077|stage III|stage iii
334531|NCT01715077|unresectable|unresectable
334532|NCT01715064|Prostate Cancer|prostate cancer
334533|NCT01715064|Exercise|exercise
334534|NCT01715064|Cortical Inhibition|cortical inhibition
334535|NCT01715064|Cortical Silent Period|cortical silent period
334536|NCT01715064|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
334537|NCT01715051|cocaine|cocaine
334538|NCT01715051|D-serine|d-serine
334539|NCT01715051|Drug dependence|drug dependence
334540|NCT01715038|malnutrition|malnutrition
334541|NCT01715038|stunting|stunting
334542|NCT01715038|LNS|lns
334543|NCT01715038|micronutrient powder|micronutrient powder
334544|NCT01715038|hemoglobin|hemoglobin
334545|NCT01715025|measured|measured
334546|NCT01715025|heavy menstrual bleeding|heavy menstrual bleeding
334547|NCT01715025|combined oral contraceptive|combined oral contraceptive
334548|NCT01715025|alkaline haematin method|alkaline haematin method
334549|NCT01715012|Burn|burn
334550|NCT01715012|Diabetes|diabetes
334551|NCT01715012|Skin graft|skin graft
334552|NCT01715012|Donor site|donor site
334553|NCT01714999|olecranon|olecranon
334554|NCT01714999|prepatellar|prepatellar
334555|NCT01714999|bursa|bursa
334556|NCT01714999|trauma|trauma
334557|NCT01714999|laceration|laceration
334558|NCT01714999|bursectomy|bursectomy
334559|NCT01714999|bursa reconstruction|bursa reconstruction
334560|NCT01714986|Diabetes mellitus|diabetes mellitus
334561|NCT01714986|Depression|depression
334562|NCT01714986|Anxiety|anxiety
334563|NCT01714986|Alexithymia|alexithymia
334564|NCT01714986|Self Image|self image
334565|NCT01714986|HbA1c|hba1c
334566|NCT01714986|Psychoeducation|psychoeducation
334567|NCT01714934|IDIOPATHIC PULMONARY FIBROSIS|idiopathic pulmonary fibrosis
334568|NCT01714934|MICROASPIRATION|microaspiration
334569|NCT01714908|NSCLC|nsclc
334570|NCT01714908|EGFR mutation|egfr mutation
334571|NCT01714908|unresectable|unresectable
334572|NCT01714908|erlotinib|erlotinib
334573|NCT01714908|concurrent radiotherapy|concurrent radiotherapy
334574|NCT01714895|Interstitial glucose dynamics|interstitial glucose dynamics
334575|NCT01714895|Accuracy of continuous glucose monitoring under hypoglycemia|accuracy of continuous glucose monitoring under hypoglycemia
334576|NCT01714895|Glucose clamp|glucose clamp
334577|NCT01714882|Infertility|infertility
334578|NCT01714882|In Vitro Fertilization (IVF)|in vitro fertilization (ivf)
334579|NCT01714882|Stress Management|stress management
334580|NCT01714882|Stress Reduction|stress reduction
334581|NCT01714869|Swedish massage|swedish massage
334582|NCT01714869|massage|massage
334583|NCT01714869|osteoarthritis|osteoarthritis
334584|NCT01714869|knee|knee
334585|NCT01714843|ASP0456|asp0456
334586|NCT01714843|constipation|constipation
334587|NCT01714843|irritable bowel syndrome (IBS)|irritable bowel syndrome (ibs)
334588|NCT01714843|linaclotide|linaclotide
334589|NCT01714804|Bone Morphogenetic Protein (BMP)|bone morphogenetic protein (bmp)
334590|NCT01714804|Demineralized bone matrix (DBM)|demineralized bone matrix (dbm)
334591|NCT01714804|Fusion rates|fusion rates
334592|NCT01714804|Interbody fusion|interbody fusion
334593|NCT01714804|Lumbar spine|lumbar spine
334594|NCT01714804|Transverse lumbar interbody fusion (TLIF)|transverse lumbar interbody fusion (tlif)
334595|NCT01714804|Patient reported outcomes|patient reported outcomes
334596|NCT01714804|Posterolateral lumbar fusion (PLF)|posterolateral lumbar fusion (plf)
334597|NCT01714791|Coronary Artery Bypass Graft|coronary artery bypass graft
334598|NCT01714791|Osteopathic Medicine|osteopathic medicine
334599|NCT01714791|Vital Capacity|vital capacity
334600|NCT01714791|Quality of Life|quality of life
334601|NCT01714791|Cardiac rehabilitation|cardiac rehabilitation
334602|NCT01714765|Metastatic Clear Cell Renal Cancer Dovitinib Everolimus Cohort Maximum administered dose maximum tolerated dose|metastatic clear cell renal cancer dovitinib everolimus cohort maximum administered dose maximum tolerated dose
334603|NCT01714752|Diagnosis|diagnosis
334604|NCT01714752|Left ventricular end diastolic pressure (LVEDP)|left ventricular end diastolic pressure (lvedp)
334605|NCT01714752|Exercise echocardiography|exercise echocardiography
334606|NCT01714752|Left atrial remodeling|left atrial remodeling
334607|NCT01714726|MEDI2070|medi2070
334608|NCT01714726|inflammatory bowel disease|inflammatory bowel disease
334609|NCT01714726|moderate to severe Crohn's disease|moderate to severe crohn's disease
334610|NCT01714713|Schizophrenia|schizophrenia
334611|NCT01714713|Cognition|cognition
334612|NCT01714713|Cognition Impairment|cognition impairment
334613|NCT01714713|Alpha-7 nAChR|alpha-7 nachr
334614|NCT01714700|protein|protein
334615|NCT01714700|resistance exercise ghrelin|resistance exercise ghrelin
334616|NCT01714700|overweight|overweight
334617|NCT01714674|cardiac troponin T|cardiac troponin t
334618|NCT01714674|cTnT|ctnt
334619|NCT01714674|exercise|exercise
334620|NCT01714674|dietary nitrate|dietary nitrate
334621|NCT01714661|Schizophrenia|schizophrenia
334622|NCT01714661|Cognition|cognition
334623|NCT01714661|Cognition Impairment|cognition impairment
334624|NCT01714661|Alpha-7 nAChR|alpha-7 nachr
334625|NCT01714648|OVULATION INDUCTION|ovulation induction
334626|NCT01714635|cataract|cataract
334627|NCT01714635|IOL|iol
334628|NCT01714635|intraocular lens|intraocular lens
334629|NCT01714622|metabolic syndrome|metabolic syndrome
334630|NCT01714622|insulin resistance|insulin resistance
334631|NCT01714622|gastric cancer|gastric cancer
334632|NCT01714609|portal hypertension|portal hypertension
334633|NCT01714609|sorafenib|sorafenib
334634|NCT01714596|Oral Antibiotic|oral antibiotic
334635|NCT01714596|Intravenous Antibiotic|intravenous antibiotic
334636|NCT01714596|Wound infection|wound infection
334637|NCT01714596|Randomized Controlled Trial|randomized controlled trial
334638|NCT01714583|Mechanical ventilation|mechanical ventilation
334639|NCT01714583|ARDS|ards
334640|NCT01714583|acute lung injury|acute lung injury
334641|NCT01714583|cardiac function|cardiac function
334642|NCT01714583|cardiac index|cardiac index
334643|NCT01714583|heart-lung interaction|heart-lung interaction
334644|NCT01714531|Mild TBI|mild tbi
334645|NCT01714518|Interstitial Lung Disease|interstitial lung disease
334646|NCT01714518|Diagnosis|diagnosis
334647|NCT01714518|Cryobiopsy|cryobiopsy
334648|NCT01714518|Video-assisted thoracic surgery|video-assisted thoracic surgery
334649|NCT01714518|Lung biopsy|lung biopsy
334650|NCT01714505|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
334651|NCT01714505|Continuous Glucose Monitor|continuous glucose monitor
334652|NCT01714505|Artificial Pancreas|artificial pancreas
334653|NCT01714505|Insulin Pump|insulin pump
334654|NCT01714505|Closed Loop control|closed loop control
334655|NCT01714505|Open Loop treatment|open loop treatment
334656|NCT01714492|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
334657|NCT01714492|in vivo mechanics|in vivo mechanics
334658|NCT01714492|kinematics|kinematics
334659|NCT01714492|fluoroscopy|fluoroscopy
334660|NCT01714440|genomics of kidney transplantation|genomics of kidney transplantation
334661|NCT01714440|genetic variation|genetic variation
334662|NCT01714440|recipient genotypes|recipient genotypes
334663|NCT01714440|donor genotypes|donor genotypes
334664|NCT01714414|HIV|hiv
334665|NCT01714414|Fozivudine|fozivudine
334666|NCT01714414|Zidovudine|zidovudine
334667|NCT01714414|FATI|fati
334668|NCT01714388|remifentanil|remifentanil
334669|NCT01714388|heart rate|heart rate
334670|NCT01714388|autonomic nervous system|autonomic nervous system
334671|NCT01714388|heart rate variability|heart rate variability
334672|NCT01714388|autonomic nervous activity|autonomic nervous activity
335174|NCT01712191|KOOS|koos
334673|NCT01714388|vagotonic effect|vagotonic effect
334674|NCT01714388|single dose|single dose
334675|NCT01714362|oculocardiac effect|oculocardiac effect
334676|NCT01714362|bradycardia|bradycardia
334677|NCT01714362|HRV|hrv
334678|NCT01714349|Spinal cord injury|spinal cord injury
334679|NCT01714349|nerve transfer|nerve transfer
334680|NCT01714349|tetraplegia|tetraplegia
334681|NCT01714349|quadriplegia|quadriplegia
334682|NCT01714336|Arbeitsgemeinschaft für Osteosynthesefragen (AO) fracture|arbeitsgemeinschaft für osteosynthesefragen (ao) fracture
334683|NCT01714336|Orthopaedic Trauma Association (OTA) fracture|orthopaedic trauma association (ota) fracture
334684|NCT01714323|Cigarette smoking|cigarette smoking
334685|NCT01714323|Tobacco smoking|tobacco smoking
334686|NCT01714323|Tobacco use disorder|tobacco use disorder
334687|NCT01714310|severe mood dysregulation|severe mood dysregulation
334688|NCT01714310|irritability|irritability
334689|NCT01714310|lisdexamfetamine|lisdexamfetamine
334690|NCT01714310|fluoxetine|fluoxetine
334691|NCT01714310|newly recognized syndrome|newly recognized syndrome
334692|NCT01714297|cemented total hip arthroplasty|cemented total hip arthroplasty
334693|NCT01714297|blood loss|blood loss
334694|NCT01714297|wound discharge|wound discharge
334695|NCT01714297|thromboprophylaxis|thromboprophylaxis
334696|NCT01714297|biomarkers|biomarkers
334697|NCT01714284|psoriasis|psoriasis
334698|NCT01714258|cardiac output|cardiac output
334699|NCT01714258|fick method|fick method
334700|NCT01714258|thermodilution|thermodilution
334701|NCT01714245|Eczema|eczema
334702|NCT01714245|Atopic Dermatitis|atopic dermatitis
334703|NCT01714245|Compromised Skin|compromised skin
334704|NCT01714245|Inflamed Skin|inflamed skin
334705|NCT01714219|prostatic neoplasms|prostatic neoplasms
334706|NCT01714219|prostatectomy|prostatectomy
334707|NCT01714219|robotics|robotics
334708|NCT01714219|urinary incontinence|urinary incontinence
334709|NCT01714206|Healthy|healthy
334710|NCT01714206|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
334711|NCT01714206|Pharmacokinetics|pharmacokinetics
334712|NCT01714206|Digoxin (LANOXIN)|digoxin (lanoxin)
334713|NCT01714193|Healthy|healthy
334714|NCT01714193|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
334715|NCT01714193|Pharmacokinetics|pharmacokinetics
334716|NCT01714193|Contraceptives, Oral|contraceptives, oral
334717|NCT01714193|Ethinyl Estradiol|ethinyl estradiol
334718|NCT01714193|Levonorgestrel|levonorgestrel
334719|NCT01714193|LEVORA|levora
334720|NCT01714180|Acyclovir|acyclovir
334721|NCT01714180|Pharmacokinetics|pharmacokinetics
334722|NCT01714180|Obese|obese
334723|NCT01714180|Non-obese|non-obese
334724|NCT01714180|Weight|weight
334725|NCT01714180|Distribution|distribution
334726|NCT01714180|Clearance|clearance
334727|NCT01714167|Chronic|chronic
334728|NCT01714167|Ischemic Stroke|ischemic stroke
334729|NCT01714167|Intracerebral Hemorrhage|intracerebral hemorrhage
334730|NCT01714167|Bone Marrow Mesenchymal Stem Cell|bone marrow mesenchymal stem cell
334731|NCT01714141|Technology based intervention|technology based intervention
334732|NCT01714141|Emerging adults|emerging adults
334733|NCT01714141|African Americans|african americans
334734|NCT01714141|Asthma|asthma
334735|NCT01714141|Controller medications|controller medications
334736|NCT01714141|Motivational intervention|motivational intervention
334737|NCT01714128|NCI protocol #8762|nci protocol #8762
334738|NCT01714128|Estrogen receptor positive breast cancer|estrogen receptor positive breast cancer
334739|NCT01714128|recurrent breast cancer|recurrent breast cancer
334740|NCT01714128|stage IV breast cancer|stage iv breast cancer
334741|NCT01714102|Obesity|obesity
334742|NCT01714102|Insulin resistance|insulin resistance
334743|NCT01714102|Metabolic syndrome|metabolic syndrome
334744|NCT01714102|Pre-diabetes|pre-diabetes
334745|NCT01714089|Relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
334746|NCT01714089|RR-MS|rr-ms
334747|NCT01714063|pediatric|pediatric
334748|NCT01714063|asthma|asthma
334749|NCT01714063|metered dose inhaler|metered dose inhaler
334750|NCT01714063|valved holding chamber|valved holding chamber
334751|NCT01714063|pMDI|pmdi
334752|NCT01714063|VHC|vhc
334753|NCT01714050|seasonal affective disorder|seasonal affective disorder
334754|NCT01714050|winter depression|winter depression
334755|NCT01714050|cognitive-behavioral therapy|cognitive-behavioral therapy
334756|NCT01714050|light therapy|light therapy
334757|NCT01714037|Safety|safety
334758|NCT01714037|Efficacy|efficacy
334759|NCT01714037|HSP90|hsp90
334760|NCT01714037|Debio 0932|debio 0932
334761|NCT01714037|Standard of care treatment, NSCLC|standard of care treatment, nsclc
334762|NCT01714024|Dental|dental
334763|NCT01714024|Implant|implant
334764|NCT01714024|UNC Dental School|unc dental school
334765|NCT01714024|Trabecular Metal|trabecular metal
334766|NCT01714024|Titanium|titanium
334767|NCT01714024|Healthy Volunteers|healthy volunteers
334768|NCT01714024|Diabetic|diabetic
334769|NCT01714024|Osteopenic|osteopenic
334770|NCT01714024|Bone Inductive Properties|bone inductive properties
334771|NCT01714024|Osseous Healing|osseous healing
334772|NCT01714024|GO Health|go health
334773|NCT01714024|Offenbacher|offenbacher
334774|NCT01714024|Zimmer Dental, Inc.|zimmer dental, inc.
334775|NCT01714011|Randomized|randomized
334776|NCT01714011|Controlled|controlled
334777|NCT01714011|Trial|trial
334778|NCT01714011|Safety|safety
334779|NCT01714011|Efficacy|efficacy
334780|NCT01714011|Aripiprazole|aripiprazole
334781|NCT01714011|Ziprasidone|ziprasidone
334782|NCT01714011|Metabolic Syndrome|metabolic syndrome
334783|NCT01713998|Ulthera® System|ulthera® system
334784|NCT01713998|Ultherapy™ Treatment|ultherapy™ treatment
334785|NCT01713998|Ulthera, Inc.|ulthera, inc.
334786|NCT01713998|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
334787|NCT01713985|Ulthera® System|ulthera® system
334788|NCT01713985|Ultherapy™ Treatment|ultherapy™ treatment
334789|NCT01713985|Ulthera, Inc.|ulthera, inc.
334790|NCT01713985|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
334791|NCT01713972|BRAFi|brafi
334792|NCT01713972|BRAF-mutated|braf-mutated
334793|NCT01713959|Underarm sweating|underarm sweating
334794|NCT01713946|TSC seizures,|tsc seizures,
334795|NCT01713946|TSC epilepsy,|tsc epilepsy,
334796|NCT01713946|mTOR inhibitor,|mtor inhibitor,
334797|NCT01713946|RAD001,|rad001,
334798|NCT01713946|Everolimus|everolimus
334799|NCT01713933|Ulthera® System|ulthera® system
334800|NCT01713933|Ultherapy™ treatment|ultherapy™ treatment
334801|NCT01713933|Ulthera, Inc.|ulthera, inc.
334802|NCT01713907|Ultherapy™ treatment|ultherapy™ treatment
334803|NCT01713907|Ulthera® System|ulthera® system
334804|NCT01713907|Ulthera, Inc.|ulthera, inc.
334805|NCT01713907|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
334806|NCT01713894|Counseling|counseling
334807|NCT01713894|Limits of viability|limits of viability
334808|NCT01713881|Polyp|polyp
334809|NCT01713881|colonoscopy|colonoscopy
334810|NCT01713881|surveillance|surveillance
334811|NCT01713868|Breastfeeding|breastfeeding
334812|NCT01713868|Safe Sleep|safe sleep
334813|NCT01713868|Messaging|messaging
334814|NCT01713868|Social Media|social media
334815|NCT01713855|ITP|itp
334816|NCT01713855|Rituximab|rituximab
334817|NCT01713855|Vaccine|vaccine
334818|NCT01713855|Immune Reconstitution|immune reconstitution
334819|NCT01713842|Tocilizumab|tocilizumab
334820|NCT01713842|Polymyalgia Rheumatica|polymyalgia rheumatica
334821|NCT01713842|Glucocorticotherapy|glucocorticotherapy
334822|NCT01713842|PMR-AS|pmr-as
334823|NCT01713829|cranberry|cranberry
334824|NCT01713829|gamma delta T cell|gamma delta t cell
334825|NCT01713829|improvement in immune cell function in healthy humans|improvement in immune cell function in healthy humans
334826|NCT01713829|proliferation|proliferation
334827|NCT01713816|Glutathione|glutathione
334828|NCT01713816|Ascorbate|ascorbate
334829|NCT01713816|Alzheimer's disease|alzheimer's disease
334830|NCT01713816|Aging|aging
334831|NCT01713816|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
334832|NCT01713790|physical functional performance|physical functional performance
334833|NCT01713790|postural balance|postural balance
334834|NCT01713790|reaction time|reaction time
334835|NCT01713790|mobility|mobility
334836|NCT01713790|muscle strength|muscle strength
334837|NCT01713790|cognition|cognition
334838|NCT01713777|Seizures|seizures
334839|NCT01713764|diabetes|diabetes
334840|NCT01713764|obesity|obesity
334841|NCT01713764|mindful eating|mindful eating
334842|NCT01713764|positive affect|positive affect
334843|NCT01713764|low carbohydrate|low carbohydrate
334844|NCT01713764|diet|diet
334845|NCT01713751|Surgical site infection|surgical site infection
334846|NCT01713751|Cesarean section|cesarean section
334847|NCT01713738|ITP|itp
334848|NCT01713738|rituximab|rituximab
334849|NCT01713738|bleeding score|bleeding score
334850|NCT01713738|platelet count|platelet count
334851|NCT01713738|health-related quality of life|health-related quality of life
334852|NCT01713738|HRQL|hrql
334853|NCT01713725|Chronic urticaria|chronic urticaria
334854|NCT01713725|Chronic spontaneous urticaria|chronic spontaneous urticaria
334855|NCT01713725|Autoimmune and non autoimmune urticaria|autoimmune and non autoimmune urticaria
334856|NCT01713725|UAS7|uas7
334857|NCT01713712|Pregnancy|pregnancy
334858|NCT01713712|Obesity|obesity
334859|NCT01713712|Nutrition therapy|nutrition therapy
334860|NCT01713699|CTC, cytology, meningeal carcinomatosis, leptomeningeal metastases|ctc, cytology, meningeal carcinomatosis, leptomeningeal metastases
334861|NCT01713686|Ulthera® System|ulthera® system
334862|NCT01713686|Ultherapy™ Treatment|ultherapy™ treatment
334863|NCT01713686|Ulthera, Inc.|ulthera, inc.
334864|NCT01713686|Micro-focused Ultrasound with Visualization (MFU-V)|micro-focused ultrasound with visualization (mfu-v)
334865|NCT01713673|Hyperhidrosis|hyperhidrosis
334866|NCT01713673|Axillary sweating|axillary sweating
334867|NCT01713673|Ulthera® System|ulthera® system
334868|NCT01713673|Ultherapy™ Treatment|ultherapy™ treatment
334869|NCT01713673|Ulthera, Inc.|ulthera, inc.
334870|NCT01713660|Cataract surgery|cataract surgery
334871|NCT01713660|Femtosecond laser|femtosecond laser
334872|NCT01713660|Corneal incisions|corneal incisions
334873|NCT01713647|Bio-equivalence, crossover|bio-equivalence, crossover
334874|NCT01713634|Bone resorption|bone resorption
334875|NCT01713634|Diet|diet
334876|NCT01713621|P. falciparum|p. falciparum
334877|NCT01713621|malaria|malaria
334878|NCT01713608|malaria|malaria
334879|NCT01713608|dose escalation|dose escalation
334880|NCT01713608|safety|safety
334881|NCT01713608|tolerability|tolerability
334882|NCT01713608|maximum tolerated dose|maximum tolerated dose
334883|NCT01713595|Acute Lung Injury|acute lung injury
334884|NCT01713595|Mechanical Ventilation|mechanical ventilation
334885|NCT01713569|Ulthera® System|ulthera® system
334886|NCT01713569|Ultherapy™ Treatment|ultherapy™ treatment
334887|NCT01713569|Ulthera, Inc.|ulthera, inc.
334888|NCT01713569|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
334889|NCT01713556|PTSD, Propranolol|ptsd, propranolol
334890|NCT01713543|falls|falls
334891|NCT01713517|Mosquito Control|mosquito control
334892|NCT01713517|Insecticide Resistance|insecticide resistance
334893|NCT01713491|brain ischemia|brain ischemia
334894|NCT01713491|thrombolytic therapy|thrombolytic therapy
334895|NCT01713491|Impaired cognition|impaired cognition
334896|NCT01713491|dementia|dementia
334897|NCT01713478|hepatic cirrhosis|hepatic cirrhosis
334898|NCT01713478|subclinical myocardial dysfunction|subclinical myocardial dysfunction
334899|NCT01713478|echocardiography|echocardiography
334900|NCT01713478|specific biomarkers|specific biomarkers
334901|NCT01713478|vascular assessment|vascular assessment
334902|NCT01713465|Diabetes|diabetes
334903|NCT01713465|Hypertension|hypertension
334904|NCT01713465|Hypercholesterolemia|hypercholesterolemia
334905|NCT01713465|Obesity|obesity
334906|NCT01713452|Surgical Stomas|surgical stomas
334907|NCT01713452|ileostomy|ileostomy
334908|NCT01713452|surgical site infection|surgical site infection
334909|NCT01713439|Relapsed/Refractory Neuroblastoma|relapsed/refractory neuroblastoma
334910|NCT01713439|Retroviral vector injections|retroviral vector injections
334911|NCT01713439|Allogeneic neuroblastoma cells|allogeneic neuroblastoma cells
334912|NCT01713439|Lymphotactin|lymphotactin
334913|NCT01713439|Interleukin-2 (IL-2)|interleukin-2 (il-2)
334914|NCT01713426|Post herpetic neuralgia|post herpetic neuralgia
334915|NCT01713426|Qutenza|qutenza
334916|NCT01713426|NGX-4010|ngx-4010
334917|NCT01713426|Peripheral Neuropathic Pain|peripheral neuropathic pain
334918|NCT01713426|Pregabalin|pregabalin
334919|NCT01713413|Oxymizer|oxymizer
334920|NCT01713413|endurance time|endurance time
334921|NCT01713413|exercise test|exercise test
334922|NCT01713413|nasal cannula|nasal cannula
334923|NCT01713413|COPD|copd
334924|NCT01713413|ILD|ild
334925|NCT01713413|oxygenation|oxygenation
334926|NCT01713400|Acute Graft vs. Host Disease (aGVHD)|acute graft vs. host disease (agvhd)
334927|NCT01713400|Graft vs. Host Disease (GVHD)|graft vs. host disease (gvhd)
334928|NCT01713387|adjuvant chemotherapy|adjuvant chemotherapy
334929|NCT01713374|endothelial function|endothelial function
334930|NCT01713374|sympathetic nervous system|sympathetic nervous system
334931|NCT01713361|total knee arthroplasty|total knee arthroplasty
334932|NCT01713361|Prophylaxis|prophylaxis
334933|NCT01713348|CGM|cgm
334934|NCT01713348|MDI|mdi
334935|NCT01713322|parent education|parent education
334936|NCT01713322|pain management|pain management
334937|NCT01713322|immunization|immunization
334938|NCT01713322|infant|infant
334939|NCT01713309|Filgrastim|filgrastim
334940|NCT01713309|G-CSF|g-csf
334941|NCT01713309|Heparin-binding protein|heparin-binding protein
334942|NCT01713309|critically ill|critically ill
334943|NCT01713309|acute respiratory failure|acute respiratory failure
334944|NCT01713296|SCLC|sclc
334945|NCT01713296|2nd Line|2nd line
334946|NCT01713296|Relapsed or Refractory|relapsed or refractory
334947|NCT01713270|Hypertension|hypertension
334948|NCT01713270|Atrial Fibrillation|atrial fibrillation
334949|NCT01713270|Arrhythmias, Cardiac|arrhythmias, cardiac
334950|NCT01713270|Heart Diseases|heart diseases
334951|NCT01713257|Critically ill patients|critically ill patients
334952|NCT01713244|Hepatocellular Carcinoma|hepatocellular carcinoma
334953|NCT01713244|Radiofrequency Ablation|radiofrequency ablation
334954|NCT01713244|Hepatectomy|hepatectomy
334955|NCT01713244|Recurrence|recurrence
334956|NCT01713231|osteogenesis imperfecta|osteogenesis imperfecta
334957|NCT01713231|high-dose vitamin D|high-dose vitamin d
334958|NCT01713231|bone density|bone density
334959|NCT01713231|muscle function|muscle function
334960|NCT01713218|Pancreas|pancreas
334961|NCT01713218|Cancer|cancer
334962|NCT01713218|Hedgehog inhibitor|hedgehog inhibitor
334963|NCT01713218|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
334964|NCT01713218|Dynamic imaging|dynamic imaging
334965|NCT01713205|trauma ; sepsis; Multiple Organ Dysfunction Syndrome; Prediction; risk|trauma ; sepsis; multiple organ dysfunction syndrome; prediction; risk
334966|NCT01713153|postpartum hemorrhage|postpartum hemorrhage
334967|NCT01713153|prevention|prevention
334968|NCT01713153|misoprostol|misoprostol
334969|NCT01713153|Uniject|uniject
334970|NCT01713153|oxytocin|oxytocin
334971|NCT01713140|strength training|strength training
334972|NCT01713140|resistance training|resistance training
334973|NCT01713140|fatigue|fatigue
334974|NCT01713140|knee extension|knee extension
334975|NCT01713140|total knee arthroplasty|total knee arthroplasty
334976|NCT01713140|total knee replacement|total knee replacement
334977|NCT01713140|electromyography|electromyography
334978|NCT01713140|physical therapy modalities|physical therapy modalities
334979|NCT01713101|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
334980|NCT01713101|Peptic Ulcer Hemorrhage|peptic ulcer hemorrhage
334981|NCT01713101|Hematemesis|hematemesis
334982|NCT01713101|Melena|melena
334983|NCT01713101|Tranexamic acid|tranexamic acid
334984|NCT01713088|multisystemic therapy, RCT, young offenders, U.K.|multisystemic therapy, rct, young offenders, u.k.
334985|NCT01713075|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
334986|NCT01713075|Symbicort|symbicort
334987|NCT01713075|long-term use|long-term use
334988|NCT01713049|FLT PET|flt pet
334989|NCT01713049|breast neoplasms|breast neoplasms
334990|NCT01713049|mammography|mammography
334991|NCT01713049|breast ultrasound|breast ultrasound
334992|NCT01713036|Mass balance, bioavailability, cancer, 14C|mass balance, bioavailability, cancer, 14c
334993|NCT01713023|type 1 diabetes|type 1 diabetes
334994|NCT01713023|fructose|fructose
334995|NCT01713023|glucose|glucose
334996|NCT01713023|TAS1R2|tas1r2
334997|NCT01713023|oxidative stress|oxidative stress
334998|NCT01713010|Keywords provided by Atlantic Health System:|keywords provided by atlantic health system:
334999|NCT01713010|Rapid Shallow Breathing Index|rapid shallow breathing index
335000|NCT01713010|Mechanical Ventilation|mechanical ventilation
335001|NCT01713010|Additional relevant MeSH terms:|additional relevant mesh terms:
335002|NCT01713010|Respiration Disorders|respiration disorders
335003|NCT01713010|Traumatic Brain Injury|traumatic brain injury
335004|NCT01713010|Weaning Failure|weaning failure
335005|NCT01713010|Mechanical ventilation complication|mechanical ventilation complication
335006|NCT01712997|Treatment of|treatment of
335007|NCT01712984|Influenza|influenza
335008|NCT01712984|Fluzone® Intradermal vaccine|fluzone® intradermal vaccine
335009|NCT01712984|Influenza Virus Vaccine USP Quadrivalent|influenza virus vaccine usp quadrivalent
335010|NCT01712984|Influenza Virus Vaccine USP Trivalent Types A and B|influenza virus vaccine usp trivalent types a and b
335011|NCT01712971|surgery|surgery
335012|NCT01712971|pancreas|pancreas
335013|NCT01712971|tumour|tumour
335014|NCT01712971|blood loss|blood loss
335015|NCT01712958|CRC miRNA|crc mirna
335016|NCT01712945|Alemtuzumab|alemtuzumab
335017|NCT01712945|Palifermin|palifermin
335018|NCT01712945|Reconstitution|reconstitution
335019|NCT01712945|Thymus|thymus
335020|NCT01712919|Locoregionally advanced nasopharyngeal carcinoma|locoregionally advanced nasopharyngeal carcinoma
335021|NCT01712919|cetuximab|cetuximab
335022|NCT01712919|chemoradiation|chemoradiation
335023|NCT01712893|breast cancer|breast cancer
335024|NCT01712893|adjuvant therapy|adjuvant therapy
335025|NCT01712893|Ovarian suppression|ovarian suppression
335026|NCT01712854|COPD|copd
335027|NCT01712854|Chronic Obstructive Lung Disease|chronic obstructive lung disease
335028|NCT01712854|Long acting beta agonist|long acting beta agonist
335029|NCT01712841|Dry AMD|dry amd
335030|NCT01712841|Age-related macular degeneration|age-related macular degeneration
335031|NCT01712841|Optical coherenece tomography|optical coherenece tomography
335032|NCT01712841|Imaging|imaging
335033|NCT01712841|Blood flow|blood flow
335034|NCT01712828|Lenalidomide,|lenalidomide,
335035|NCT01712828|Revlimid,|revlimid,
335036|NCT01712828|pharmacokinetics,|pharmacokinetics,
335037|NCT01712828|healthy male subjects|healthy male subjects
335038|NCT01712789|Multiple Myeloma|multiple myeloma
335039|NCT01712789|Relapsed Multiple Myeloma|relapsed multiple myeloma
335040|NCT01712789|Relapsed and refractory Multiple Myeloma|relapsed and refractory multiple myeloma
335041|NCT01712789|Pomalidomide|pomalidomide
335042|NCT01712789|Dexamethasone|dexamethasone
335043|NCT01712776|Vapocoolant|vapocoolant
335044|NCT01712763|Endometriosis|endometriosis
335045|NCT01712763|long acting GnRH antagonist|long acting gnrh antagonist
335046|NCT01712763|Degarelix|degarelix
335047|NCT01712763|Recurrence|recurrence
335048|NCT01712763|Pelvic Pain|pelvic pain
335049|NCT01712750|Regional tissue oximetry|regional tissue oximetry
335050|NCT01712750|Cardiopulmonary bypass|cardiopulmonary bypass
335051|NCT01712750|Cardiac surgical procedures|cardiac surgical procedures
335052|NCT01712737|raisins, grapes, snacks, appetite, food intake|raisins, grapes, snacks, appetite, food intake
335053|NCT01712724|exercise therapy|exercise therapy
335054|NCT01712724|rehabilitation|rehabilitation
335055|NCT01712711|Steatohepatitis,|steatohepatitis,
335056|NCT01712711|Helicobacter pylori,|helicobacter pylori,
335057|NCT01712711|Insulin resistance,|insulin resistance,
335058|NCT01712711|Alanine aminotransferase,|alanine aminotransferase,
335059|NCT01712711|Aspartate aminotransferase,|aspartate aminotransferase,
335060|NCT01712698|trauma|trauma
335061|NCT01712698|spinal cord injury|spinal cord injury
335062|NCT01712698|cervical spine|cervical spine
335063|NCT01712685|Kidney Neoplasm|kidney neoplasm
335064|NCT01712685|RCC|rcc
335065|NCT01712685|Biodistribution of 18F-VM4-037|biodistribution of 18f-vm4-037
335066|NCT01712685|CAIX Staining|caix staining
335067|NCT01712685|Tumor Angiogenesis|tumor angiogenesis
335068|NCT01712672|Dental Plaque|dental plaque
335069|NCT01712672|Biofilm|biofilm
335070|NCT01712672|Bacterial Interactions|bacterial interactions
335071|NCT01712672|Receptor Polysaccharide|receptor polysaccharide
335072|NCT01712672|Oral Streptococci|oral streptococci
335073|NCT01712659|JAK 1/2|jak 1/2
335074|NCT01712659|Human T-Cell Lymphotropic Virus 1|human t-cell lymphotropic virus 1
335075|NCT01712659|HTLV-1|htlv-1
335076|NCT01712659|Janus Kinase Inhibitor|janus kinase inhibitor
335077|NCT01712646|Oxytocin|oxytocin
335078|NCT01712646|Childhood Onset Schizophrenia|childhood onset schizophrenia
335079|NCT01712646|Double Blind|double blind
335080|NCT01712633|fMRI|fmri
335081|NCT01712633|Brain Perfusion|brain perfusion
335082|NCT01712620|Microarray|microarray
335083|NCT01712620|Magnetic Resonance Imaging|magnetic resonance imaging
335084|NCT01712620|Mineralocorticoid Receptor Antagonist|mineralocorticoid receptor antagonist
335085|NCT01712620|Neurohormonal Axis|neurohormonal axis
335086|NCT01712620|Vascular Inflammation|vascular inflammation
335087|NCT01712620|Pulmonary Hypertension|pulmonary hypertension
335088|NCT01712620|Cardiovascular Disease|cardiovascular disease
335089|NCT01712620|Vascular Disease|vascular disease
335090|NCT01712607|laparoscopy|laparoscopy
335091|NCT01712607|surgery|surgery
335092|NCT01712607|warm-up|warm-up
335093|NCT01712607|preoperative|preoperative
335094|NCT01712607|surgical skills|surgical skills
335095|NCT01712594|United Kingdom Overnight closed loop|united kingdom overnight closed loop
335096|NCT01712581|normal myocardial T1, T2 and T2* values|normal myocardial t1, t2 and t2* values
335097|NCT01712555|Anophthalmic orbits|anophthalmic orbits
335098|NCT01712555|autologous fat|autologous fat
335099|NCT01712555|platelet rich plasma|platelet rich plasma
335100|NCT01712555|orbital atrophy|orbital atrophy
335101|NCT01712555|anophthalmos|anophthalmos
335102|NCT01712555|cannula|cannula
335103|NCT01712529|Systemic lupus erythematosus|systemic lupus erythematosus
335104|NCT01712529|endothelium|endothelium
335105|NCT01712529|exercise|exercise
335106|NCT01712516|COPD, QVA149|copd, qva149
335107|NCT01712503|Cataract|cataract
335108|NCT01712503|Astigmatism|astigmatism
335109|NCT01712503|Toric|toric
335110|NCT01712503|Phacoemulsification|phacoemulsification
335111|NCT01712503|Intraocular lens|intraocular lens
335112|NCT01712490|Hodgkin Lymphoma|hodgkin lymphoma
335113|NCT01712490|Hodgkins Lymphoma|hodgkins lymphoma
335114|NCT01712490|Antibody, Monoclonal|antibody, monoclonal
335115|NCT01712490|Antibody-Drug Conjugate|antibody-drug conjugate
335116|NCT01712490|Antigens, CD-30|antigens, cd-30
335117|NCT01712490|Immunotherapy|immunotherapy
335118|NCT01712490|Lymphoma|lymphoma
335119|NCT01712490|Lymphoma, Classical|lymphoma, classical
335120|NCT01712490|ECHELON-1|echelon-1
335121|NCT01712451|adiposity|adiposity
335122|NCT01712438|Previously untreated patients|previously untreated patients
335123|NCT01712425|vaccine|vaccine
335124|NCT01712425|recently HIV-1 infected individuals|recently hiv-1 infected individuals
335125|NCT01712373|Multiple sclerosis|multiple sclerosis
335126|NCT01712373|Ginseng|ginseng
335127|NCT01712373|Fatigue|fatigue
335128|NCT01712373|Quality of life|quality of life
335129|NCT01712360|Tinea Pedis|tinea pedis
335130|NCT01712360|Tinea Cruris|tinea cruris
335131|NCT01712360|Athlete foot|athlete foot
335132|NCT01712360|Jock itch|jock itch
335133|NCT01712321|Social Anxiety Disorder|social anxiety disorder
335134|NCT01712321|Social Anxiety|social anxiety
335135|NCT01712321|Social Phobia|social phobia
335136|NCT01712321|SAD|sad
335137|NCT01712308|Leukemia|leukemia
335138|NCT01712308|Myeloproliferative Neoplasm|myeloproliferative neoplasm
335139|NCT01712308|MPN|mpn
335140|NCT01712308|Associated Myelofibrosis|associated myelofibrosis
335141|NCT01712308|Anemia|anemia
335142|NCT01712308|Sotatercept|sotatercept
335143|NCT01712308|ACE-011|ace-011
335144|NCT01712295|Warts|warts
335145|NCT01712295|salicylic acid|salicylic acid
335146|NCT01712295|ethyl pyruvate|ethyl pyruvate
335147|NCT01712282|Physical Activity|physical activity
335148|NCT01712282|Accelerometer|accelerometer
335149|NCT01712256|CD4|cd4
335150|NCT01712256|Clinical trial|clinical trial
335151|NCT01712256|Human immunodeficiency virus-1 (HIV-1)|human immunodeficiency virus-1 (hiv-1)
335152|NCT01712256|HIV|hiv
335153|NCT01712256|Immunomodulary|immunomodulary
335154|NCT01712256|Infection|infection
335155|NCT01712256|Phase II|phase ii
335156|NCT01712256|Re-boost|re-boost
335157|NCT01712256|Vaccine|vaccine
335158|NCT01712256|Vacc-4x|vacc-4x
335159|NCT01712230|hormone therapy|hormone therapy
335160|NCT01712230|obesity|obesity
335161|NCT01712230|menopause|menopause
335162|NCT01712230|disease /disorder proneness /risk|disease /disorder proneness /risk
335163|NCT01712230|insulin sensitivity /resistance|insulin sensitivity /resistance
335164|NCT01712230|metabolic syndrome|metabolic syndrome
335165|NCT01712230|women's health|women's health
335166|NCT01712217|Non-small cell lung cancer|non-small cell lung cancer
335167|NCT01712204|Prophylaxis of Acute Gout Flares|prophylaxis of acute gout flares
335168|NCT01712204|Urate-Lowering Therapy|urate-lowering therapy
335169|NCT01712204|Hyperuricemia|hyperuricemia
335170|NCT01712204|Gouty arthritis|gouty arthritis
335175|NCT01712178|Pharmacodynamic,Pharmacokinetic|pharmacodynamic,pharmacokinetic
335176|NCT01712165|Folic acid supplement|folic acid supplement
335177|NCT01712165|Neural tube defect-affected pregnancy|neural tube defect-affected pregnancy
335178|NCT01712165|Homocysteine concentration|homocysteine concentration
335179|NCT01712165|Plasma Folate concentration|plasma folate concentration
335180|NCT01712165|Plasma vitamin B12 concentration|plasma vitamin b12 concentration
335181|NCT01712152|Duchenne muscular dystrophy|duchenne muscular dystrophy
335182|NCT01712152|carrier|carrier
335183|NCT01712152|cardiac MRI|cardiac mri
335184|NCT01712152|myocardial fibrosis|myocardial fibrosis
335185|NCT01712152|female|female
335186|NCT01712087|spasticity|spasticity
335187|NCT01712087|muscle spasticity|muscle spasticity
335188|NCT01712087|muscle rigidity|muscle rigidity
335189|NCT01712087|motor neuron disease|motor neuron disease
335190|NCT01712087|hyperreflexia|hyperreflexia
335191|NCT01712074|Randomized|randomized
335192|NCT01712074|Double Blind|double blind
335193|NCT01712074|Safety and Efficacy|safety and efficacy
335194|NCT01712061|Diabetic nephropathy|diabetic nephropathy
335195|NCT01712061|type 2 diabetes|type 2 diabetes
335196|NCT01712061|albuminuria|albuminuria
335197|NCT01712061|chemokine antagonist|chemokine antagonist
335198|NCT01712035|Wet AMD|wet amd
335199|NCT01712035|Age-related macular degeneration|age-related macular degeneration
335200|NCT01712035|Optical coherenece tomography|optical coherenece tomography
335201|NCT01712035|Imaging|imaging
335202|NCT01712035|Blood flow|blood flow
335203|NCT01712009|Breast cancer|breast cancer
335204|NCT01712009|Chemotherapy|chemotherapy
335205|NCT01712009|Neulasta|neulasta
335206|NCT01712009|Pegfilgrastim|pegfilgrastim
335207|NCT01712009|Naproxen|naproxen
335208|NCT01712009|Loratadine|loratadine
335209|NCT01712009|Non-steroidal antiinflammatory drug (NSAID)|non-steroidal antiinflammatory drug (nsaid)
335210|NCT01712009|Anti-histamine|anti-histamine
335211|NCT01712009|Bone Pain|bone pain
335212|NCT01711996|hydronephrosis|hydronephrosis
335213|NCT01711996|biopsy|biopsy
335214|NCT01711996|biomarker|biomarker
335215|NCT01711957|Complications|complications
335216|NCT01711957|Mortality|mortality
335217|NCT01711957|Liver transplantation|liver transplantation
335218|NCT01711957|Platelet count|platelet count
335219|NCT01711957|Survival|survival
335220|NCT01711944|childhood cancer|childhood cancer
335221|NCT01711944|Internet communication|internet communication
335222|NCT01711944|parents|parents
335223|NCT01711944|caregivers|caregivers
335224|NCT01711944|problem solving|problem solving
335225|NCT01711931|percutaneous coronary intervention|percutaneous coronary intervention
335226|NCT01711931|bioresorbable vascular scaffold stents|bioresorbable vascular scaffold stents
335227|NCT01711931|everolimus|everolimus
335228|NCT01711931|biolimus|biolimus
335229|NCT01711918|gastroparesis|gastroparesis
335230|NCT01711918|domperidone|domperidone
335231|NCT01711918|nausea|nausea
335232|NCT01711918|vomiting|vomiting
335233|NCT01711892|Prostatic Neoplasms|prostatic neoplasms
335234|NCT01711892|Prostate Cancer|prostate cancer
335235|NCT01711892|Exercise|exercise
335236|NCT01711892|Soccer|soccer
335237|NCT01711892|Androgen Deprivation Therapy|androgen deprivation therapy
335238|NCT01711892|Body Composition|body composition
335239|NCT01711892|Cardiovascular fitness|cardiovascular fitness
335240|NCT01711892|Bone Health|bone health
335241|NCT01711892|Health Related Quality of Life|health related quality of life
335242|NCT01711866|Rotigotine|rotigotine
335243|NCT01711866|Neupro|neupro
335244|NCT01711866|Switch|switch
335245|NCT01711866|Dopamine agonists|dopamine agonists
335246|NCT01711840|Bronchial asthma|bronchial asthma
335247|NCT01711840|Symbicort Turbuhaler|symbicort turbuhaler
335248|NCT01711827|isavuconazole|isavuconazole
335249|NCT01711827|prednisone|prednisone
335250|NCT01711827|prednisolone|prednisolone
335251|NCT01711827|BAL8557|bal8557
335252|NCT01711827|healthy volunteers|healthy volunteers
335253|NCT01711814|Rheumatoid Arthritis|rheumatoid arthritis
335254|NCT01711814|ASP015K|asp015k
335255|NCT01711788|Hematopoietic stem cells|hematopoietic stem cells
335256|NCT01711788|Umbilical cord blood transplantation|umbilical cord blood transplantation
335257|NCT01711788|Intrabone infusion|intrabone infusion
335258|NCT01711788|Platelet recovery|platelet recovery
335259|NCT01711788|Neutrophil recovery|neutrophil recovery
335260|NCT01711788|Pediatric patients|pediatric patients
335261|NCT01711736|Immunogenicity|immunogenicity
335262|NCT01711736|Children|children
335263|NCT01711736|Safety|safety
335264|NCT01711736|Seasonal influenza|seasonal influenza
335265|NCT01711736|Fluarix|fluarix
335266|NCT01711723|darapladib|darapladib
335267|NCT01711723|Lp-PLA2- inhibitor|lp-pla2- inhibitor
335268|NCT01711723|healthy volunteer|healthy volunteer
335269|NCT01711723|renal impairment|renal impairment
335270|NCT01711723|pharmacokinetics|pharmacokinetics
335271|NCT01711710|Breast cancer|breast cancer
335272|NCT01711710|reconstruction|reconstruction
335273|NCT01711710|augmentation|augmentation
335274|NCT01711710|cohesive silicone gel|cohesive silicone gel
335275|NCT01711710|breast implant|breast implant
335276|NCT01711710|rupture|rupture
335277|NCT01711710|capsular contracture|capsular contracture
335278|NCT01711684|Neoplasm Metastasis|neoplasm metastasis
335279|NCT01711684|Melanoma|melanoma
335280|NCT01711645|Acellular|acellular
335281|NCT01711645|Adacel®|adacel®
335282|NCT01711645|Diptheria toxoids|diptheria toxoids
335283|NCT01711645|Pertussis|pertussis
335284|NCT01711645|postpartum|postpartum
335285|NCT01711645|Tdap|tdap
335286|NCT01711645|Tetanus|tetanus
335287|NCT01711645|women|women
335288|NCT01711632|VEMURAFENIB|vemurafenib
335289|NCT01711632|BRAF Inhibitor|braf inhibitor
335290|NCT01711632|12-200|12-200
335291|NCT01711632|Zelboraf™|zelboraf™
335292|NCT01711606|Fragile-X Syndrome|fragile-x syndrome
335293|NCT01711606|registry|registry
335294|NCT01711606|non-interventional trial|non-interventional trial
335295|NCT01711606|patient-related outcome study|patient-related outcome study
335296|NCT01711606|drug utilization|drug utilization
335297|NCT01711606|effectiveness|effectiveness
335298|NCT01711606|treatment patterns|treatment patterns
335299|NCT01711606|patient characteristics under real life conditions|patient characteristics under real life conditions
335300|NCT01711606|quality of life|quality of life
335301|NCT01711606|economics|economics
335302|NCT01711593|Asthma|asthma
335303|NCT01711593|Allergic|allergic
335304|NCT01711593|Inflammation|inflammation
335305|NCT01711593|Airway|airway
335306|NCT01711593|Challenge|challenge
335307|NCT01711593|Chemokines|chemokines
335308|NCT01711593|Tolerization|tolerization
335309|NCT01711580|Recurrent glioma|recurrent glioma
335310|NCT01711580|Quality of life|quality of life
335311|NCT01711580|Glioblastoma multiforme|glioblastoma multiforme
335312|NCT01711580|Anaplastic glioma|anaplastic glioma
335313|NCT01711580|Cognition|cognition
335314|NCT01711580|Re-irradiation|re-irradiation
335315|NCT01711567|Chronic Hepatitis B|chronic hepatitis b
335316|NCT01711567|TENOFOVIR|tenofovir
335317|NCT01711567|ENTECAVIR|entecavir
335318|NCT01711567|PARTIAL RESPONDER|partial responder
335319|NCT01711502|metastatic breast cancer,|metastatic breast cancer,
335320|NCT01711502|epidemiology,|epidemiology,
335321|NCT01711502|retrospective cohort|retrospective cohort
335322|NCT01711489|isavuconazole|isavuconazole
335323|NCT01711489|mycophenolate mofetil (MMF)|mycophenolate mofetil (mmf)
335324|NCT01711489|BAL8557|bal8557
335325|NCT01711489|BAL4815|bal4815
335326|NCT01711489|healthy volunteers|healthy volunteers
335327|NCT01711489|Mycophenolic acid (MPA)|mycophenolic acid (mpa)
335328|NCT01711489|Phenolic glucuronide of MPA (MPAG)|phenolic glucuronide of mpa (mpag)
335329|NCT01711489|CellCept|cellcept
335330|NCT01711476|PCOS|pcos
335331|NCT01711476|Bdiet|bdiet
335332|NCT01711476|Ddiet|ddiet
335333|NCT01711476|OGTT|ogtt
335334|NCT01711463|Pharmacodynamics|pharmacodynamics
335335|NCT01711463|Fluticasone furoate (FF)|fluticasone furoate (ff)
335336|NCT01711463|novel dry powder device|novel dry powder device
335337|NCT01711463|Safety and tolerability|safety and tolerability
335338|NCT01711463|vilanterol(VI)|vilanterol(vi)
335339|NCT01711463|Healthy Chinese subjects|healthy chinese subjects
335340|NCT01711463|Pharmacokinetics|pharmacokinetics
335341|NCT01711437|colonoscopy|colonoscopy
335342|NCT01711437|colon cleansing|colon cleansing
335343|NCT01711437|children|children
335344|NCT01711437|age 2 -18 years|age 2 -18 years
335345|NCT01711411|HIV prevention|hiv prevention
335346|NCT01711411|PrePex|prepex
335347|NCT01711411|voluntary medical male circumcision|voluntary medical male circumcision
335348|NCT01711411|non-surgical|non-surgical
335349|NCT01711411|medical device|medical device
335350|NCT01711411|wound healing|wound healing
335351|NCT01711411|Kenya|kenya
335352|NCT01711398|solid tumor|solid tumor
335353|NCT01711398|peptide|peptide
335354|NCT01711385|Oral Health|oral health
335355|NCT01711385|Prediabetes|prediabetes
335356|NCT01711385|Diabetes|diabetes
335357|NCT01711385|Periodontitis|periodontitis
335358|NCT01711385|Early Identification|early identification
335359|NCT01711385|Prevention|prevention
335360|NCT01711372|ADHD|adhd
335361|NCT01711320|Omeprazole|omeprazole
335362|NCT01711320|Metformin|metformin
335363|NCT01711307|Achilles|achilles
335364|NCT01711307|Rupture|rupture
335365|NCT01711294|Pancreatic Cystic Lesions|pancreatic cystic lesions
335366|NCT01711294|PCL|pcl
335367|NCT01711294|EUS-FNA|eus-fna
335368|NCT01711281|Heart Failure|heart failure
335369|NCT01711281|Implantable Cardioverter-Defibrillator|implantable cardioverter-defibrillator
335370|NCT01711281|Intracardiac Impedance Measurement|intracardiac impedance measurement
335371|NCT01711281|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
335372|NCT01711281|Home Monitoring|home monitoring
335373|NCT01711281|Reverse Remodeling|reverse remodeling
335374|NCT01711268|Sunitinib|sunitinib
335375|NCT01711268|Renal Cell Carcinoma|renal cell carcinoma
335376|NCT01711268|Therapeutic Drug Monitoring|therapeutic drug monitoring
335377|NCT01711268|Pharmacokinetic|pharmacokinetic
335378|NCT01711268|Treatment toxicity|treatment toxicity
335379|NCT01711255|Multiple sclerosis|multiple sclerosis
335380|NCT01711255|Coagulation|coagulation
335381|NCT01711255|Alternative Medicine|alternative medicine
335382|NCT01711255|Clotting|clotting
335383|NCT01711255|Complementary Medicine|complementary medicine
335384|NCT01711255|Inflammation|inflammation
335385|NCT01711242|gastric cancer|gastric cancer
335386|NCT01711242|radiotherapy|radiotherapy
335387|NCT01711242|postoperative therapy|postoperative therapy
335388|NCT01711242|chemotherapy|chemotherapy
335389|NCT01711229|oral acetaminophen|oral acetaminophen
335390|NCT01711229|IV acetaminophen|iv acetaminophen
335391|NCT01711229|Ofirmev|ofirmev
335392|NCT01711229|equianalgesic|equianalgesic
335393|NCT01711229|arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
335394|NCT01711216|Dydrogesterone|dydrogesterone
335395|NCT01711216|Irregular Menstrual Cycle|irregular menstrual cycle
335396|NCT01711216|Progestins|progestins
335397|NCT01711203|Spondylolysis|spondylolysis
335398|NCT01711203|Spondylolisthesis|spondylolisthesis
335399|NCT01711203|Rehabilitation|rehabilitation
335400|NCT01711203|Physical Therapy|physical therapy
335401|NCT01711203|Children|children
335402|NCT01711190|glaucoma|glaucoma
335403|NCT01711190|trabeculectomy|trabeculectomy
335404|NCT01711190|astigmatism|astigmatism
335405|NCT01711190|intraocular pressure|intraocular pressure
335406|NCT01711177|primary open angle glaucoma|primary open angle glaucoma
335407|NCT01711177|retinal oximetry|retinal oximetry
335408|NCT01711164|HCV|hcv
335409|NCT01711164|T regulatory cells (Tregs)|t regulatory cells (tregs)
335410|NCT01711164|FGL2|fgl2
335411|NCT01711151|ILD|ild
335412|NCT01711138|Physical Activity|physical activity
335413|NCT01711138|Physical Fitness|physical fitness
335414|NCT01711138|Transportation|transportation
335415|NCT01711138|Environment Design|environment design
335416|NCT01711138|Child|child
335417|NCT01711138|Adolescent|adolescent
335418|NCT01711086|asthma|asthma
335419|NCT01711086|dry powder inhaler|dry powder inhaler
335420|NCT01711047|catheter ablation|catheter ablation
335421|NCT01711047|atrial fibrillation|atrial fibrillation
335422|NCT01711047|pulmonary vein isolation|pulmonary vein isolation
335423|NCT01711047|linear ablation|linear ablation
335424|NCT01711047|CFAE ablation|cfae ablation
335425|NCT01711034|Solid tumors|solid tumors
335426|NCT01711021|ADHD|adhd
335427|NCT01711008|Breakfast size|breakfast size
335428|NCT01711008|Exercise|exercise
335429|NCT01711008|Cognitive performance|cognitive performance
335430|NCT01711008|Mood|mood
335431|NCT01711008|Appetite|appetite
335432|NCT01711008|Active women|active women
335433|NCT01710956|concurrent chemoradiation in patients with limited disease small cell lung cancer|concurrent chemoradiation in patients with limited disease small cell lung cancer
335434|NCT01710943|Web-based CBT|web-based cbt
335435|NCT01710943|PTSD|ptsd
335436|NCT01710943|Alcohol Misuse|alcohol misuse
335437|NCT01710943|Substance Misuse|substance misuse
335438|NCT01710943|Integrated Primary Care|integrated primary care
335439|NCT01710943|OEF/OIF Veterans|oef/oif veterans
335440|NCT01710930|Allergic Broncho-Pulmonary Aspergillosis|allergic broncho-pulmonary aspergillosis
335441|NCT01710917|Chronic pain|chronic pain
335442|NCT01710917|Severe pain|severe pain
335443|NCT01710917|Oxycodon|oxycodon
335444|NCT01710917|Naloxon|naloxon
335445|NCT01710917|Opioid-induced constipation|opioid-induced constipation
335446|NCT01710917|Opioid|opioid
335447|NCT01710917|Quality of life|quality of life
335448|NCT01710917|Laxative|laxative
335449|NCT01710917|Analgesic rescue medication|analgesic rescue medication
335450|NCT01710904|Chronic pain|chronic pain
335451|NCT01710904|Severe pain|severe pain
335452|NCT01710904|Oxycodone|oxycodone
335453|NCT01710904|Naloxone|naloxone
335454|NCT01710904|Opioid-induced constipation|opioid-induced constipation
335455|NCT01710904|Opioid|opioid
335456|NCT01710904|Quality of life|quality of life
335457|NCT01710904|Laxative|laxative
335458|NCT01710904|Analgesic rescue medication|analgesic rescue medication
335459|NCT01710891|endotracheal intubation|endotracheal intubation
335460|NCT01710891|direct laryngoscopy|direct laryngoscopy
335461|NCT01710891|video laryngoscopy|video laryngoscopy
335462|NCT01710865|Caries prevention|caries prevention
335463|NCT01710865|pit and fissure sealants|pit and fissure sealants
335464|NCT01710852|Atrial Fibrillation|atrial fibrillation
335465|NCT01710852|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
335466|NCT01710852|AF|af
335467|NCT01710839|CRVO|crvo
335468|NCT01710839|BRVO|brvo
335469|NCT01710839|HRVO|hrvo
335470|NCT01710839|Macular edema|macular edema
335471|NCT01710839|vein occlusion|vein occlusion
335472|NCT01710813|pompe disease|pompe disease
335473|NCT01710813|alglucosidase alfa|alglucosidase alfa
335474|NCT01710813|anaphylaxis|anaphylaxis
335475|NCT01710813|severe cutaneous|severe cutaneous
335476|NCT01710813|systemic immune complex-mediated reactions|systemic immune complex-mediated reactions
335477|NCT01710800|impedance|impedance
335478|NCT01710800|reflux|reflux
335479|NCT01710800|GERD|gerd
335480|NCT01710787|operative|operative
335481|NCT01710787|dental procedure|dental procedure
335482|NCT01710774|Diabetic Foot|diabetic foot
335483|NCT01710774|Diabetes Mellitus|diabetes mellitus
335484|NCT01710774|Foot Ulcer|foot ulcer
335485|NCT01710774|Wound Healing|wound healing
335486|NCT01710774|Delivery of Health Care|delivery of health care
335487|NCT01710774|Depression|depression
335488|NCT01710774|sequela|sequela
335489|NCT01710774|Sick Leave|sick leave
335490|NCT01710774|Quality of Life|quality of life
335491|NCT01710774|Amputation|amputation
335492|NCT01710761|nitric oxide|nitric oxide
335493|NCT01710761|cycling performance|cycling performance
335494|NCT01710761|lactate|lactate
335495|NCT01710761|VO2|vo2
335496|NCT01710748|Percutaneous coronary intervention|percutaneous coronary intervention
335497|NCT01710748|Drug eluting stent|drug eluting stent
335498|NCT01710748|Neointimal hyperplasia|neointimal hyperplasia
335499|NCT01710748|Diabetes Mellitus|diabetes mellitus
335500|NCT01710735|TP|tp
335501|NCT01710735|Myofascial pain|myofascial pain
335502|NCT01710709|Aripiprazole, Intramuscular (IM) Depot, Bipolar|aripiprazole, intramuscular (im) depot, bipolar
335503|NCT01710683|Discectomy|discectomy
335504|NCT01710683|1st postoperative day|1st postoperative day
335505|NCT01710683|Intensive exercise training|intensive exercise training
335506|NCT01710683|Randomized controlled trial|randomized controlled trial
335507|NCT01710670|Brivaracetam|brivaracetam
335508|NCT01710670|Ethanol|ethanol
335509|NCT01710670|Pharmacodynamics|pharmacodynamics
335510|NCT01710670|Pharmacokinetic|pharmacokinetic
335511|NCT01710670|Interaction|interaction
335512|NCT01710657|Lacosamide|lacosamide
335513|NCT01710657|Epilepsy|epilepsy
335514|NCT01710657|Partial Onset Seizures|partial onset seizures
335515|NCT01710631|Sleep|sleep
335516|NCT01710618|Protein Expression of Sciatic Nerve|protein expression of sciatic nerve
335517|NCT01710618|traumatized sciatic nerve|traumatized sciatic nerve
335518|NCT01710605|Circulating tumor cells|circulating tumor cells
335519|NCT01710605|Breast Cancer|breast cancer
335520|NCT01710605|Hormone-receptors positive|hormone-receptors positive
335521|NCT01710579|Primary esophageal achalasia|primary esophageal achalasia
335522|NCT01710579|endoscopic myotomy|endoscopic myotomy
335523|NCT01710579|high resolution manometry|high resolution manometry
335524|NCT01710566|Postpartum hemorrhage|postpartum hemorrhage
335525|NCT01710566|prevention|prevention
335526|NCT01710566|oxytocin|oxytocin
335527|NCT01710566|misoprostol|misoprostol
335528|NCT01710566|Uniject|uniject
335529|NCT01710566|community|community
335530|NCT01710527|Healthy Volunteers|healthy volunteers
335531|NCT01710488|COPD exacerbation|copd exacerbation
335532|NCT01710488|fluoroquinolones,|fluoroquinolones,
335533|NCT01710449|Lung Transplant|lung transplant
335534|NCT01710423|Obesity|obesity
335535|NCT01710423|Nutrition|nutrition
335536|NCT01710423|Home Food Preparation|home food preparation
335537|NCT01710423|Peer Mentoring|peer mentoring
335538|NCT01710423|Early Head Start|early head start
335539|NCT01710423|Cooking|cooking
335540|NCT01710423|Diet|diet
335541|NCT01710410|transcranial direct current stimulation|transcranial direct current stimulation
335542|NCT01710410|nicotine dependence|nicotine dependence
335543|NCT01710410|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
335544|NCT01710410|nicotine replacement therapy|nicotine replacement therapy
335545|NCT01710410|nicotine patch|nicotine patch
335546|NCT01710410|addiction|addiction
335547|NCT01710410|smoking cessation|smoking cessation
335548|NCT01710410|neuroplasticity|neuroplasticity
335549|NCT01710397|Antiretroviral therapy|antiretroviral therapy
335550|NCT01710397|South Africa|south africa
335551|NCT01710384|late preterm, betamethasone,|late preterm, betamethasone,
335552|NCT01710332|Persistent|persistent
335553|NCT01710332|Central|central
335554|NCT01710332|Serous|serous
335555|NCT01710332|Chorioretinopathy|chorioretinopathy
335556|NCT01710332|Regeneron|regeneron
335557|NCT01710332|CSR|csr
335558|NCT01710332|CSCR|cscr
335559|NCT01710319|Immunoregulation|immunoregulation
335560|NCT01710319|Natural Killer Cells|natural killer cells
335561|NCT01710306|Women|women
335562|NCT01710306|Veterans|veterans
335563|NCT01710306|PTSD|ptsd
335564|NCT01710293|Electronic Health Records|electronic health records
335565|NCT01710293|Diagnostic Delay|diagnostic delay
335566|NCT01710293|Triggers|triggers
335567|NCT01710280|Lipemia|lipemia
335568|NCT01710280|Vascular function|vascular function
335569|NCT01710280|Blood pressure|blood pressure
335570|NCT01710254|MRI|mri
335571|NCT01710254|Atrial Fibrillation|atrial fibrillation
335572|NCT01710228|MS|ms
335573|NCT01710228|Natalizumab|natalizumab
335574|NCT01710228|copaxone|copaxone
335575|NCT01710215|Colorectal Neoplasms|colorectal neoplasms
335576|NCT01710215|Colorectal Cancer|colorectal cancer
335577|NCT01710215|Colon Cancer|colon cancer
335578|NCT01710215|Mass Screening|mass screening
335579|NCT01710215|Health Services Research|health services research
335580|NCT01710215|Comparative Effectiveness Research|comparative effectiveness research
335581|NCT01710202|Hydrocortisone|hydrocortisone
335582|NCT01710202|Cortisol|cortisol
335583|NCT01710202|Testosterone|testosterone
335584|NCT01710202|Stress|stress
335585|NCT01710202|Serotonin|serotonin
335586|NCT01710202|5-HTTLPR|5-httlpr
335587|NCT01710202|Amygdala|amygdala
335588|NCT01710202|Depression|depression
335589|NCT01710189|Tick-Borne Encephalitis Virus|tick-borne encephalitis virus
335590|NCT01710163|Lithium Carbonate|lithium carbonate
335591|NCT01710163|Lithium|lithium
335592|NCT01710163|Central Nervous System Agents|central nervous system agents
335593|NCT01710163|Therapeutic Uses|therapeutic uses
335594|NCT01710163|Pharmacologic Actions|pharmacologic actions
335595|NCT01710163|Enzyme Inhibitors|enzyme inhibitors
335596|NCT01710163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
335597|NCT01710163|Neurotransmitter Agents|neurotransmitter agents
335598|NCT01710163|Physiological Effects of Drugs|physiological effects of drugs
335599|NCT01710163|Antimanic Agents|antimanic agents
335600|NCT01710163|Tranquilizing Agents|tranquilizing agents
335601|NCT01710163|Central Nervous System Depressants|central nervous system depressants
335602|NCT01710163|Psychotropic Drugs|psychotropic drugs
335603|NCT01710163|Sensory System Agents|sensory system agents
335604|NCT01710163|Antipsychotic Agents|antipsychotic agents
335605|NCT01710163|Antidepressive Agents|antidepressive agents
335606|NCT01710150|typical aflutter (AFLT)|typical aflutter (aflt)
335607|NCT01710150|CTI ablation|cti ablation
335608|NCT01710150|Atrial Fibrillation (AF)|atrial fibrillation (af)
335609|NCT01710150|PVI|pvi
335610|NCT01710137|Smoking cessation|smoking cessation
335611|NCT01710137|Nicotine dependence|nicotine dependence
335612|NCT01710137|Varenicline|varenicline
335613|NCT01710137|Chantix|chantix
335614|NCT01710137|HIV|hiv
335615|NCT01710137|AIDS|aids
335616|NCT01710124|grocery purchases|grocery purchases
335617|NCT01710124|financial incentives|financial incentives
335618|NCT01710124|obesogenic home food environment|obesogenic home food environment
335619|NCT01710111|Human challenge model|human challenge model
335620|NCT01710111|Quarantine study|quarantine study
335621|NCT01710111|Influenza virus|influenza virus
335622|NCT01710111|Modes of transmission|modes of transmission
335623|NCT01710111|Droplet spray|droplet spray
335624|NCT01710111|Droplet nuclei|droplet nuclei
335625|NCT01710111|Secondary attack rate|secondary attack rate
335626|NCT01710111|Face shield|face shield
335627|NCT01710111|Hand hygiene|hand hygiene
335628|NCT01710111|Fomites|fomites
335629|NCT01710111|Environmental deposition|environmental deposition
335630|NCT01710111|Environmental dispersion|environmental dispersion
335631|NCT01710098|testosterone|testosterone
335632|NCT01710098|S3-Adherence|s3-adherence
335633|NCT01710098|Quality of Life|quality of life
335634|NCT01710085|Diffusion weighted MRI|diffusion weighted mri
335635|NCT01710085|Curative surgery|curative surgery
335636|NCT01710085|Recurrence|recurrence
335637|NCT01710072|aneurysm, inflammation, MRI|aneurysm, inflammation, mri
335638|NCT01710059|Health Status Disparities|health status disparities
335639|NCT01710059|Minority Health|minority health
335640|NCT01710059|Pediatrics|pediatrics
335641|NCT01710059|Behavioral Intervention|behavioral intervention
335642|NCT01710059|Cellular Phone|cellular phone
335643|NCT01710059|Peer Group|peer group
335644|NCT01710046|plaque psoriasis|plaque psoriasis
335645|NCT01710046|tofacitinib|tofacitinib
335646|NCT01710046|biopsy|biopsy
335647|NCT01710046|Janus Kinase|janus kinase
335648|NCT01710046|randomized placebo controlled clinical trial|randomized placebo controlled clinical trial
335649|NCT01710046|psoriasis vulgaris|psoriasis vulgaris
335650|NCT01710033|CP-690,550|cp-690,550
335651|NCT01710033|kidney transplant|kidney transplant
335652|NCT01710020|CP-690|cp-690
335653|NCT01710020|550|550
335654|NCT01710020|pharmacokinetics|pharmacokinetics
335655|NCT01710020|end-stage renal disease|end-stage renal disease
335656|NCT01710007|HMG-CoA reductase inhibitors|hmg-coa reductase inhibitors
335657|NCT01709994|cardiovascular events|cardiovascular events
335658|NCT01709994|chronic kidney disease|chronic kidney disease
335659|NCT01709994|bleedings|bleedings
335660|NCT01709994|progression|progression
335661|NCT01709994|antiinflammatory effects|antiinflammatory effects
335662|NCT01709968|Nocturnal Leg Cramps|nocturnal leg cramps
335663|NCT01709968|Quality of life|quality of life
335664|NCT01709968|Quality of sleep|quality of sleep
335665|NCT01709955|Obesity|obesity
335666|NCT01709955|Overweight|overweight
335667|NCT01709955|Glucomannan|glucomannan
335668|NCT01709942|GnRH antagonist|gnrh antagonist
335669|NCT01709942|PCOS|pcos
335670|NCT01709942|OHSS|ohss
335671|NCT01709942|COH|coh
335672|NCT01709942|IVF|ivf
335673|NCT01709916|Glaucoma|glaucoma
335674|NCT01709916|intra ocular pressure|intra ocular pressure
335675|NCT01709916|diurnal fluctuations|diurnal fluctuations
335676|NCT01709903|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
335677|NCT01709877|Multiport laparoscopy|multiport laparoscopy
335678|NCT01709877|Single Port Laparoscopy|single port laparoscopy
335679|NCT01709877|Symptomatic Gallstones|symptomatic gallstones
335680|NCT01709864|Anticholinergic|anticholinergic
335681|NCT01709864|Antimuscarinic|antimuscarinic
335682|NCT01709864|Chronic Obstructive Airway Disease|chronic obstructive airway disease
335683|NCT01709864|Chronic Obstructive Lung Disease|chronic obstructive lung disease
335684|NCT01709864|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
335685|NCT01709864|COPD|copd
335686|NCT01709864|LAMA|lama
335687|NCT01709864|Lung Disease|lung disease
335688|NCT01709864|Lung Diseases, Obstructive|lung diseases, obstructive
335689|NCT01709864|Lung Function|lung function
335690|NCT01709864|Muscarinic receptor antagonist|muscarinic receptor antagonist
335691|NCT01709864|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
335692|NCT01709864|Respiratory Tract Diseases|respiratory tract diseases
335693|NCT01709851|Type 1 diabetes|type 1 diabetes
335694|NCT01709851|Intravascular continuous glucose monitoring|intravascular continuous glucose monitoring
335695|NCT01709851|Subcutaneous continuous glucose monitoring|subcutaneous continuous glucose monitoring
335826|NCT01709175|Quality of Life|quality of life
335696|NCT01709838|Non-transfusion dependent thalassemia, NTDT|non-transfusion dependent thalassemia, ntdt
335697|NCT01709825|probiotics|probiotics
335698|NCT01709825|cold|cold
335699|NCT01709825|flu|flu
335700|NCT01709825|immune function|immune function
335701|NCT01709825|microbiota|microbiota
335702|NCT01709799|Cognitive Training|cognitive training
335703|NCT01709799|Aging|aging
335704|NCT01709799|Seniors|seniors
335705|NCT01709786|Hemorrhage|hemorrhage
335706|NCT01709786|Hemoglobin|hemoglobin
335707|NCT01709786|Non-invasive monitoring|non-invasive monitoring
335708|NCT01709786|Medical device accuracy|medical device accuracy
335709|NCT01709760|ENIA11|enia11
335710|NCT01709760|MTX|mtx
335711|NCT01709760|RA|ra
335712|NCT01709760|TNF|tnf
335713|NCT01709747|Hydromorphone Hydrochloride|hydromorphone hydrochloride
335714|NCT01709747|Hydromorphone|hydromorphone
335715|NCT01709747|Pain|pain
335716|NCT01709747|Chronic Pain|chronic pain
335717|NCT01709747|Implantable Pump|implantable pump
335718|NCT01709747|Pump|pump
335719|NCT01709747|Intrathecal|intrathecal
335720|NCT01709734|prostate cancer CRPC|prostate cancer crpc
335721|NCT01709721|Hydromorphone|hydromorphone
335722|NCT01709721|Hydromorphone Hydrochloride|hydromorphone hydrochloride
335723|NCT01709721|Pain Management|pain management
335724|NCT01709721|Non-narcotic analgesics|non-narcotic analgesics
335725|NCT01709708|Migraine|migraine
335726|NCT01709708|Headache|headache
335727|NCT01709708|Chronic Migraine|chronic migraine
335728|NCT01709708|Marcaine|marcaine
335729|NCT01709708|Tx360|tx360
335730|NCT01709695|Intuniv|intuniv
335731|NCT01709695|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
335732|NCT01709695|fMRI|fmri
335733|NCT01709682|atrial fibrillation|atrial fibrillation
335734|NCT01709682|arrhythmias|arrhythmias
335735|NCT01709682|anti-arrhythmic agents|anti-arrhythmic agents
335736|NCT01709669|acute coronary syndrome|acute coronary syndrome
335737|NCT01709669|gratitude|gratitude
335738|NCT01709669|health behavior|health behavior
335739|NCT01709669|myocardial infarction|myocardial infarction
335740|NCT01709669|unstable angina|unstable angina
335741|NCT01709617|carbohydrate, glycogen, glucose|carbohydrate, glycogen, glucose
335742|NCT01709604|acute paraquat poisoning|acute paraquat poisoning
335743|NCT01709604|hemoperfusion|hemoperfusion
335744|NCT01709604|continuous blood purification|continuous blood purification
335745|NCT01709591|intrapartum pain management, epidural|intrapartum pain management, epidural
335746|NCT01709565|Sepsis|sepsis
335747|NCT01709565|Lactic acid|lactic acid
335748|NCT01709565|Shock|shock
335749|NCT01709565|Resuscitation|resuscitation
335750|NCT01709539|Cancer diagnosis center|cancer diagnosis center
335751|NCT01709539|Time to diagnosis|time to diagnosis
335752|NCT01709539|Survival|survival
335753|NCT01709539|Health economics|health economics
335754|NCT01709539|Biomarkers|biomarkers
335755|NCT01709526|Psychosocial functioning|psychosocial functioning
335756|NCT01709526|Cognitive performance of inpatients|cognitive performance of inpatients
335757|NCT01709526|Psychiatric diseases|psychiatric diseases
335758|NCT01709487|HIPEC|hipec
335759|NCT01709487|ovarian carcinoma|ovarian carcinoma
335760|NCT01709487|Bordet|bordet
335761|NCT01709474|SLE|sle
335762|NCT01709474|Vitamin D3|vitamin d3
335763|NCT01709474|Vitamin D deficiency|vitamin d deficiency
335764|NCT01709474|IFN alpha expression|ifn alpha expression
335765|NCT01709448|Neoplasms, Squamous Cell|neoplasms, squamous cell
335766|NCT01709448|Papillomavirus Infections|papillomavirus infections
335767|NCT01709448|HIV|hiv
335768|NCT01709422|Propofol|propofol
335769|NCT01709422|Midazolam|midazolam
335770|NCT01709422|Meperidine|meperidine
335771|NCT01709409|Prematurity|prematurity
335772|NCT01709383|Aphasia|aphasia
335773|NCT01709383|Stroke|stroke
335774|NCT01709383|Transcranial Direct Current Stimulation|transcranial direct current stimulation
335775|NCT01709383|Neuroplasticity|neuroplasticity
335776|NCT01709357|manual therapy|manual therapy
335777|NCT01709357|trigger point|trigger point
335778|NCT01709357|range of motion|range of motion
335779|NCT01709357|pain threshold|pain threshold
335780|NCT01709357|pain perception|pain perception
335781|NCT01709292|Thyroid Cancer|thyroid cancer
335782|NCT01709292|ERK|erk
335783|NCT01709292|Extracellular-signal-regulated kinase|extracellular-signal-regulated kinase
335784|NCT01709292|Biomarkers|biomarkers
335785|NCT01709292|Papillary thyroid cancer|papillary thyroid cancer
335786|NCT01709292|PTC|ptc
335787|NCT01709292|BRAF mutated|braf mutated
335788|NCT01709292|Vemurafenib|vemurafenib
335789|NCT01709292|PLX4032|plx4032
335790|NCT01709292|RO5185426|ro5185426
335791|NCT01709292|Zelboraf™|zelboraf™
335792|NCT01709279|Ischemic heart failure|ischemic heart failure
335793|NCT01709279|Myocardial regeneration|myocardial regeneration
335794|NCT01709279|ADRC|adrc
335795|NCT01709253|hpofractionation study using proton beam therapy|hpofractionation study using proton beam therapy
335796|NCT01709240|Chitosan|chitosan
335797|NCT01709240|Plasma|plasma
335798|NCT01709240|Incision Closure|incision closure
335799|NCT01709227|Acute kidney injury|acute kidney injury
335800|NCT01709227|AKI|aki
335801|NCT01709227|cardiopulmonary bypass|cardiopulmonary bypass
335802|NCT01709214|Osteoarthritis|osteoarthritis
335803|NCT01709214|Knee|knee
335804|NCT01709214|Pain|pain
335805|NCT01709214|Chronic|chronic
335806|NCT01709214|OA|oa
335807|NCT01709214|Arthritis|arthritis
335808|NCT01709201|Alcohol abuse|alcohol abuse
335809|NCT01709201|Drug abuse|drug abuse
335810|NCT01709201|Diabetes Mellitus|diabetes mellitus
335811|NCT01709201|Persistent Asthma|persistent asthma
335812|NCT01709201|Juvenile Arthritis|juvenile arthritis
335813|NCT01709201|Ulcerative Colitis|ulcerative colitis
335814|NCT01709188|Musical Dual Task Training|musical dual task training
335815|NCT01709188|dementia|dementia
335816|NCT01709188|attention control|attention control
335817|NCT01709188|dual task cost|dual task cost
335818|NCT01709188|gait stability|gait stability
335819|NCT01709175|Cancer|cancer
335820|NCT01709175|Breast Cancer|breast cancer
335821|NCT01709175|Gynecologic Cancer|gynecologic cancer
335822|NCT01709175|Strength Training|strength training
335823|NCT01709175|Exercise|exercise
335824|NCT01709175|Physical Activity|physical activity
335825|NCT01709175|Fatigue|fatigue
335827|NCT01709175|Strength|strength
335828|NCT01709175|Fitness|fitness
335829|NCT01709175|Cancer Survivor|cancer survivor
335830|NCT01709175|Survivor|survivor
335831|NCT01709123|Diabetes Mellitus, Juvenile Onset|diabetes mellitus, juvenile onset
335832|NCT01709123|Cardiovascular Diseases|cardiovascular diseases
335833|NCT01709123|Hyperglycemia|hyperglycemia
335834|NCT01709123|Hyperketonemia|hyperketonemia
335835|NCT01709110|Bone Loss|bone loss
335836|NCT01709110|Vertebral fractures|vertebral fractures
335837|NCT01709097|Adherence|adherence
335838|NCT01709097|Compliance|compliance
335839|NCT01709097|Kidney Transplant Recipient|kidney transplant recipient
335840|NCT01709097|An electronic drug dispenser|an electronic drug dispenser
335841|NCT01709097|The Portal|the portal
335842|NCT01709084|Human immunodeficiency virus-type 1 infection|human immunodeficiency virus-type 1 infection
335843|NCT01709084|HIV-1|hiv-1
335844|NCT01709084|Infectious diseases|infectious diseases
335845|NCT01709084|Ribonucleic acid|ribonucleic acid
335846|NCT01709084|RNA|rna
335847|NCT01709084|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
335848|NCT01709084|Emtricitabine|emtricitabine
335849|NCT01709084|Rilpivirine|rilpivirine
335850|NCT01709084|Efavirenz|efavirenz
335851|NCT01709084|Edurant|edurant
335852|NCT01709084|TMC278|tmc278
335853|NCT01709084|R278474|r278474
335854|NCT01709084|Fixed dose combination|fixed dose combination
335855|NCT01709071|Vaccination|vaccination
335856|NCT01709071|Inactivated poliomyelitis vaccine|inactivated poliomyelitis vaccine
335857|NCT01709071|poliomyelitis|poliomyelitis
335858|NCT01709071|Sabin strains|sabin strains
335859|NCT01709058|Back Pain|back pain
335860|NCT01709058|Therapeutics|therapeutics
335861|NCT01709058|Aged|aged
335862|NCT01709058|Injections, Intramuscular|injections, intramuscular
335863|NCT01709058|Oxygen|oxygen
335864|NCT01709058|Ozone|ozone
335865|NCT01709058|Geriatric Assessment|geriatric assessment
335866|NCT01709058|Trace Elements|trace elements
335867|NCT01709058|Oxidative stress|oxidative stress
335868|NCT01709045|Endarterectomy, Carotid|endarterectomy, carotid
335869|NCT01709045|Carotid Arteries|carotid arteries
335870|NCT01709032|Thalassemia|thalassemia
335871|NCT01709032|Chelation|chelation
335872|NCT01709032|Transfusion|transfusion
335873|NCT01709032|Safety|safety
335874|NCT01709006|Head and neck cancer|head and neck cancer
335875|NCT01708980|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
335876|NCT01708980|Electromyography|electromyography
335877|NCT01708980|Resistance training|resistance training
335878|NCT01708980|Physical Therapy Modalities|physical therapy modalities
335879|NCT01708967|transnasal endoscopy|transnasal endoscopy
335880|NCT01708967|pretreatment method|pretreatment method
335881|NCT01708954|erlotinib|erlotinib
335882|NCT01708954|cabozantinib|cabozantinib
335883|NCT01708954|non-small cell lung cancer|non-small cell lung cancer
335884|NCT01708928|Ulthera® System|ulthera® system
335885|NCT01708928|Ultherapy™ Treatment|ultherapy™ treatment
335886|NCT01708928|Ulthera, Inc.|ulthera, inc.
335887|NCT01708928|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
336691|NCT01705574|HIV|hiv
335888|NCT01708876|uncomplicated|uncomplicated
335889|NCT01708876|plasmodium|plasmodium
335890|NCT01708876|knowlesi|knowlesi
335891|NCT01708876|malaria|malaria
335892|NCT01708876|infection|infection
335893|NCT01708863|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
335894|NCT01708863|Stage II palliative surgery|stage ii palliative surgery
335895|NCT01708863|Glenn procedure|glenn procedure
335896|NCT01708863|Congenital heart defect|congenital heart defect
335897|NCT01708863|Congenital heart disease|congenital heart disease
335898|NCT01708863|Underdeveloped left ventricle|underdeveloped left ventricle
335899|NCT01708837|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
335900|NCT01708837|Bispectral index|bispectral index
335901|NCT01708824|colorectal cancer|colorectal cancer
335902|NCT01708824|cancer survivor|cancer survivor
335903|NCT01708824|western pattern diet|western pattern diet
335904|NCT01708824|physical activity|physical activity
335905|NCT01708824|behavioral intervention|behavioral intervention
335906|NCT01708824|acceptability|acceptability
335907|NCT01708824|feasibility|feasibility
335908|NCT01708824|randomized controlled trial|randomized controlled trial
335909|NCT01708824|compliance|compliance
335910|NCT01708811|Contractility|contractility
335911|NCT01708811|human|human
335912|NCT01708811|myometrium|myometrium
335913|NCT01708811|hyponatraemia|hyponatraemia
335914|NCT01708798|Diastolic heart failure|diastolic heart failure
335915|NCT01708785|obesity|obesity
335916|NCT01708785|overweight|overweight
335917|NCT01708785|overweight children|overweight children
335918|NCT01708785|overweight parents|overweight parents
335919|NCT01708785|overeating|overeating
335920|NCT01708785|eating in the absence of hunger|eating in the absence of hunger
335921|NCT01708785|families with overweight child|families with overweight child
335922|NCT01708785|body mass index|body mass index
335923|NCT01708785|BMI|bmi
335924|NCT01708785|weight|weight
335925|NCT01708785|childhood obesity|childhood obesity
335926|NCT01708785|treatment|treatment
335927|NCT01708785|cue exposure treatment|cue exposure treatment
335928|NCT01708785|cravings|cravings
335929|NCT01708785|habituation to food cues|habituation to food cues
335930|NCT01708785|psychophysiological response to food cues|psychophysiological response to food cues
335931|NCT01708785|intervention|intervention
335932|NCT01708785|experiments|experiments
335933|NCT01708785|family based treatment|family based treatment
335934|NCT01708785|behavioral treatment|behavioral treatment
335935|NCT01708772|TNF alpha|tnf alpha
335936|NCT01708772|SOFA score|sofa score
335937|NCT01708759|Serum Il-8|serum il-8
335938|NCT01708759|IL8 polymorphism|il8 polymorphism
335939|NCT01708759|critically ill patients|critically ill patients
335940|NCT01708733|HCV carrier|hcv carrier
335941|NCT01708733|Chinese herbal medicine|chinese herbal medicine
335942|NCT01708733|Liver function|liver function
335943|NCT01708733|HCV RNA titer|hcv rna titer
335944|NCT01708720|Vaccination|vaccination
335945|NCT01708720|Inactivated Poliomyelitis Vaccine|inactivated poliomyelitis vaccine
335946|NCT01708720|Polio|polio
335947|NCT01708720|Sabin|sabin
335948|NCT01708681|Seafood|seafood
335949|NCT01708681|Meat|meat
335950|NCT01708681|Egg|egg
335951|NCT01708681|Milk|milk
335952|NCT01708681|Postprandial lipid metabolism|postprandial lipid metabolism
336076|NCT01708226|OCD|ocd
335953|NCT01708681|Postprandial glucose metabolism|postprandial glucose metabolism
335954|NCT01708681|Triglycerides|triglycerides
335955|NCT01708681|Cholesterol|cholesterol
335956|NCT01708681|Postprandial incretins|postprandial incretins
335957|NCT01708681|Postprandial hormones|postprandial hormones
335958|NCT01708668|Fever|fever
335959|NCT01708668|Patient controlled epidural analgesia|patient controlled epidural analgesia
335960|NCT01708668|Labor analgesia|labor analgesia
335961|NCT01708668|Epidural analgesia|epidural analgesia
335962|NCT01708668|Combined spinal-epidural analgesia|combined spinal-epidural analgesia
335963|NCT01708655|Cystic Fibrosis|cystic fibrosis
335964|NCT01708655|Sweat Evaporimeter|sweat evaporimeter
335965|NCT01708629|psoriasis, brodalumab, AMG 827|psoriasis, brodalumab, amg 827
335966|NCT01708603|psoriasis, brodalumab, AMG 827|psoriasis, brodalumab, amg 827
335967|NCT01708590|psoriasis, brodalumab (AMG 827)|psoriasis, brodalumab (amg 827)
335968|NCT01708577|heart rate|heart rate
335969|NCT01708577|sweating|sweating
335970|NCT01708577|respiration|respiration
335971|NCT01708577|acceleration of body movement|acceleration of body movement
335972|NCT01708577|heart activity.|heart activity.
335973|NCT01708551|Hyperhidrosis|hyperhidrosis
335974|NCT01708551|Axillary sweating|axillary sweating
335975|NCT01708551|Ulthera® System|ulthera® system
335976|NCT01708551|Ultherapy™ Treatment|ultherapy™ treatment
335977|NCT01708551|Ulthera, Inc.|ulthera, inc.
335978|NCT01708538|keratoconus, corneal collagen crosslinking, riboflavin, corneal ectasia|keratoconus, corneal collagen crosslinking, riboflavin, corneal ectasia
335979|NCT01708525|Ulthera® System|ulthera® system
335980|NCT01708525|Ultherapy® Treatment|ultherapy® treatment
335981|NCT01708525|Ulthera, Inc.|ulthera, inc.
335982|NCT01708525|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
335983|NCT01708512|Ulthera® System|ulthera® system
337098|NCT01703988|ISIS 396443|isis 396443
335984|NCT01708512|Ultherapy™ Treatment|ultherapy™ treatment
335985|NCT01708512|Ulthera, Inc.|ulthera, inc.
335986|NCT01708512|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
335987|NCT01708499|Ulthera® System|ulthera® system
335988|NCT01708499|Ultherapy™ Treatment|ultherapy™ treatment
335989|NCT01708499|Ulthera, Inc.|ulthera, inc.
335990|NCT01708499|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
335991|NCT01708486|asthma|asthma
335992|NCT01708486|Dry Powder Inhalers|dry powder inhalers
335993|NCT01708486|FSI-10 questionnaire|fsi-10 questionnaire
335994|NCT01708460|Ulthera® System|ulthera® system
335995|NCT01708460|Ultherapy™ Treatment|ultherapy™ treatment
335996|NCT01708460|Ulthera, Inc.|ulthera, inc.
335997|NCT01708460|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
335998|NCT01708434|Skin laxity|skin laxity
335999|NCT01708434|Knees|knees
336000|NCT01708408|biorepository|biorepository
336001|NCT01708408|biobank|biobank
336002|NCT01708408|registry|registry
336003|NCT01708408|community|community
336004|NCT01708408|biospecimens|biospecimens
336005|NCT01708408|volunteers|volunteers
336006|NCT01708408|chronic disease|chronic disease
336007|NCT01708408|longitudinal|longitudinal
336008|NCT01708408|blood|blood
336009|NCT01708408|electronic health records|electronic health records
336010|NCT01708408|follow-up|follow-up
336011|NCT01708395|Ulcerative colitis|ulcerative colitis
336012|NCT01708382|Ulthera® System|ulthera® system
336013|NCT01708382|Ultherapy™ Treatment|ultherapy™ treatment
336014|NCT01708382|Ulthera, Inc.|ulthera, inc.
336015|NCT01708382|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
336016|NCT01708369|human carboxylesterase-1|human carboxylesterase-1
336017|NCT01708369|human carboxylesterase-2|human carboxylesterase-2
336018|NCT01708369|alcohol|alcohol
336019|NCT01708369|pharmacokinetics|pharmacokinetics
336020|NCT01708356|Air Pollution|air pollution
336021|NCT01708356|Particulate Matter|particulate matter
336022|NCT01708356|Exercise|exercise
336023|NCT01708356|Respiratory Rate|respiratory rate
336024|NCT01708356|Inflammation|inflammation
336025|NCT01708356|Oxidative Stress|oxidative stress
336026|NCT01708356|Plethysmography|plethysmography
336027|NCT01708343|Myofascial Pain Syndrome,|myofascial pain syndrome,
336028|NCT01708343|intramuscular stimulation,|intramuscular stimulation,
336029|NCT01708343|acupuncture,|acupuncture,
336030|NCT01708343|sleep quality,|sleep quality,
336031|NCT01708343|pain threshold.|pain threshold.
336032|NCT01708330|manual vacuum aspiration|manual vacuum aspiration
336033|NCT01708330|missed abortion|missed abortion
336034|NCT01708330|incomplete abortion|incomplete abortion
336035|NCT01708330|nonviable pregnancy|nonviable pregnancy
336036|NCT01708330|topical lidocaine|topical lidocaine
336037|NCT01708317|ACASI|acasi
336038|NCT01708317|Gonorrhea|gonorrhea
336039|NCT01708317|Chlamydia|chlamydia
336040|NCT01708317|Emergency Department|emergency department
336041|NCT01708317|Youth|youth
336042|NCT01708317|Adolescents|adolescents
336043|NCT01708317|Computer|computer
336044|NCT01708317|Questionnaire|questionnaire
336045|NCT01708304|Dementia|dementia
336046|NCT01708304|Alzheimer's Disease|alzheimer's disease
336047|NCT01708304|Exercise|exercise
336048|NCT01708304|Caregiver|caregiver
336049|NCT01708304|Behavior modification|behavior modification
336050|NCT01708291|youth|youth
336051|NCT01708291|Stress|stress
336052|NCT01708291|mindfulness|mindfulness
336053|NCT01708291|foster care|foster care
336054|NCT01708291|stress reduction|stress reduction
336055|NCT01708291|high risk teens|high risk teens
336056|NCT01708278|COPD|copd
336057|NCT01708278|Emphysema|emphysema
336058|NCT01708278|chronic bronchitis|chronic bronchitis
336059|NCT01708278|Quercetin|quercetin
336060|NCT01708278|flavonoids|flavonoids
336061|NCT01708265|Mitral Valve Insufficiency|mitral valve insufficiency
336062|NCT01708265|Mitral Valve Regurgitation|mitral valve regurgitation
336063|NCT01708265|Asymptomatic Mitral Valve Regurgitation|asymptomatic mitral valve regurgitation
336064|NCT01708265|Asymptomatic Mitral Valve Insufficiency|asymptomatic mitral valve insufficiency
336065|NCT01708265|Mitral Valve Repair|mitral valve repair
336066|NCT01708265|Watchful Waiting|watchful waiting
336067|NCT01708252|Ulthera® System|ulthera® system
336068|NCT01708252|Ultherapy™ Treatment|ultherapy™ treatment
336069|NCT01708252|Ulthera, Inc.|ulthera, inc.
336070|NCT01708252|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
336071|NCT01708239|Pregnancy|pregnancy
336072|NCT01708239|Deep vein thrombosis|deep vein thrombosis
336073|NCT01708239|Clinical probability|clinical probability
336074|NCT01708239|D-Dimer|d-dimer
336075|NCT01708239|Compression ultrasonography|compression ultrasonography
336077|NCT01708226|obsessive compulsive disorder|obsessive compulsive disorder
336078|NCT01708226|children|children
336079|NCT01708213|soft tissue|soft tissue
336080|NCT01708213|augmentation|augmentation
336081|NCT01708213|correction|correction
336082|NCT01708213|wrinkles|wrinkles
336083|NCT01708200|Memory|memory
336084|NCT01708200|Intervention|intervention
336085|NCT01708200|Computerized|computerized
336086|NCT01708200|Psychoeducational|psychoeducational
336087|NCT01708200|Mental Illness|mental illness
336088|NCT01708187|Peroneal tendon|peroneal tendon
336089|NCT01708174|medulloblastoma,|medulloblastoma,
336090|NCT01708174|relapsed,|relapsed,
336091|NCT01708174|pediatric,|pediatric,
336092|NCT01708174|children,|children,
336093|NCT01708174|adults,|adults,
336094|NCT01708174|Hh pathway inhibitor,|hh pathway inhibitor,
336095|NCT01708174|LDE225|lde225
336096|NCT01708161|PIK3CA mutation|pik3ca mutation
336097|NCT01708161|advanced solid tumor|advanced solid tumor
336098|NCT01708161|breast cancer|breast cancer
336099|NCT01708161|ovarian cancer|ovarian cancer
336100|NCT01708161|cancers with a mass|cancers with a mass
336101|NCT01708161|bulky tumor|bulky tumor
336102|NCT01708161|nodule|nodule
336103|NCT01708161|lump|lump
336104|NCT01708161|advanced cancer|advanced cancer
336105|NCT01708161|advanced solid malignancies|advanced solid malignancies
336106|NCT01708122|Intranasal fentanyl|intranasal fentanyl
336107|NCT01708122|Cystoscopy|cystoscopy
336108|NCT01708070|asthma|asthma
336109|NCT01708070|depression|depression
336110|NCT01708070|anxiety|anxiety
336111|NCT01708057|COPD|copd
336112|NCT01708057|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
336113|NCT01708044|Pramlintide,|pramlintide,
336114|NCT01708044|insulin,|insulin,
336115|NCT01708044|type 1 diabetes,|type 1 diabetes,
336116|NCT01708044|reduction in postprandial glucose,|reduction in postprandial glucose,
336117|NCT01708044|pramlintide:insulin dose-ratio|pramlintide:insulin dose-ratio
336118|NCT01708018|Pregnancy|pregnancy
336119|NCT01708018|Stress, Psychological|stress, psychological
336120|NCT01708018|Low Back Pain|low back pain
336121|NCT01708018|Breech Presentation|breech presentation
336122|NCT01708018|Relaxation|relaxation
336123|NCT01708018|Hydrotherapy|hydrotherapy
336124|NCT01708018|Acupressure|acupressure
336125|NCT01708018|WATSU|watsu
336126|NCT01708005|Mild Cognitive Impairment|mild cognitive impairment
336127|NCT01708005|Vitamin D|vitamin d
336128|NCT01708005|Cholecalciferol|cholecalciferol
336129|NCT01708005|Lecitone®Se-Vitamin D3|lecitone®se-vitamin d3
336130|NCT01707979|Near infrared light|near infrared light
336131|NCT01707979|Diabetic neuropathy|diabetic neuropathy
336132|NCT01707979|Sensory neuropathy|sensory neuropathy
336133|NCT01707979|Autonomic neuropathy|autonomic neuropathy
336134|NCT01707979|Vagus|vagus
336135|NCT01707979|Sudomotor function|sudomotor function
336136|NCT01707979|Monofilament|monofilament
336137|NCT01707979|Impedance|impedance
336138|NCT01707966|adenocarcinoma of the prostate|adenocarcinoma of the prostate
336139|NCT01707966|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
336140|NCT01707966|maintenance therapy|maintenance therapy
336141|NCT01707966|orteronel|orteronel
336142|NCT01707966|TAK-700|tak-700
336143|NCT01707927|EOA|eoa
336144|NCT01707914|oxidative stress|oxidative stress
336145|NCT01707914|dyslipidemia|dyslipidemia
336146|NCT01707914|inflammation|inflammation
336147|NCT01707901|GERD|gerd
336148|NCT01707862|Intravenous leiomyomatosis|intravenous leiomyomatosis
336149|NCT01707862|Surgery|surgery
336150|NCT01707862|Smooth muscle tumor|smooth muscle tumor
336151|NCT01707849|Hepatitis C|hepatitis c
336152|NCT01707849|Liver Fibrosis|liver fibrosis
336153|NCT01707849|m-TOR inhibitors|m-tor inhibitors
336154|NCT01707810|Liver transplatation|liver transplatation
336155|NCT01707797|dental caries|dental caries
336156|NCT01707797|high risk|high risk
336157|NCT01707797|dental cavities|dental cavities
336158|NCT01707797|children dental care|children dental care
336159|NCT01707784|Pregnancy|pregnancy
336160|NCT01707784|Stress|stress
336161|NCT01707784|Anxiety|anxiety
336162|NCT01707784|Cortisol|cortisol
336163|NCT01707784|Copeptin|copeptin
336164|NCT01707784|Gestational diabetes|gestational diabetes
336165|NCT01707758|pancreatic cancer|pancreatic cancer
336166|NCT01707758|nanoparticle|nanoparticle
336167|NCT01707758|proteases|proteases
336168|NCT01707758|cell survival|cell survival
336169|NCT01707758|tumor progression|tumor progression
336170|NCT01707758|angiogenesis|angiogenesis
336171|NCT01707758|tissue remodeling/invasion|tissue remodeling/invasion
336172|NCT01707732|Obesity|obesity
336173|NCT01707732|thromboprophylaxis|thromboprophylaxis
336174|NCT01707732|Enoxaparin|enoxaparin
336175|NCT01707719|Alzheimer's disease|alzheimer's disease
336176|NCT01707719|Oxidative stress|oxidative stress
336177|NCT01707719|HPA axis|hpa axis
336178|NCT01707706|Insomnia|insomnia
336179|NCT01707706|Depression|depression
336180|NCT01707706|Electroacupuncture|electroacupuncture
336181|NCT01707706|Acupuncture|acupuncture
336182|NCT01707706|Randomized Clinical Trial|randomized clinical trial
336183|NCT01707706|Traditional Chinese Medicine|traditional chinese medicine
336184|NCT01707693|physical activity|physical activity
336185|NCT01707693|prevention|prevention
336186|NCT01707693|coronary heart disease|coronary heart disease
336187|NCT01707693|women|women
336188|NCT01707680|weaning|weaning
337487|NCT01702285|HDAC|hdac
336189|NCT01707680|mechanical ventilation|mechanical ventilation
336190|NCT01707680|dexmedetomidine|dexmedetomidine
336191|NCT01707680|propofol|propofol
336192|NCT01707680|midazolam|midazolam
336193|NCT01707654|defect;|defect;
336194|NCT01707654|dorsal branch of the proper digital nerve;|dorsal branch of the proper digital nerve;
336195|NCT01707654|proper digital nerve;|proper digital nerve;
336196|NCT01707654|finger sensory reconstruction.|finger sensory reconstruction.
336197|NCT01707628|NHL|nhl
336198|NCT01707628|influenza vaccination|influenza vaccination
336199|NCT01707628|rituximab|rituximab
336200|NCT01707615|proanthocyanidin,atherosclerosis, carotid plaque|proanthocyanidin,atherosclerosis, carotid plaque
336201|NCT01707602|Intradermal|intradermal
336202|NCT01707602|transcutaneous|transcutaneous
336203|NCT01707602|influenza|influenza
336204|NCT01707602|routes of vaccination|routes of vaccination
336205|NCT01707602|T cell responses|t cell responses
336206|NCT01707602|humoral responses|humoral responses
336207|NCT01707602|skin|skin
336208|NCT01707602|clinical trial|clinical trial
336209|NCT01707602|Novel application of influenza vaccine|novel application of influenza vaccine
336210|NCT01707602|Transcutaneous vaccination(hair follicular targeting)|transcutaneous vaccination(hair follicular targeting)
336211|NCT01707602|Intradermal vaccination(micro-needle)|intradermal vaccination(micro-needle)
336212|NCT01707589|monitoring|monitoring
336213|NCT01707589|heart rate|heart rate
336214|NCT01707589|respiration rate|respiration rate
336215|NCT01707589|temperature|temperature
336216|NCT01707589|motion|motion
336217|NCT01707589|noninvasive|noninvasive
336218|NCT01707589|physiologic parameters|physiologic parameters
336219|NCT01707589|NICU|nicu
336220|NCT01707576|Follow-Up Studies|follow-up studies
336221|NCT01707576|Adolescent|adolescent
336222|NCT01707576|Depressive Disorder, Major/diagnosis|depressive disorder, major/diagnosis
336223|NCT01707576|Attempted/prevention & control|attempted/prevention & control
336224|NCT01707576|Self-report questionnaire|self-report questionnaire
336225|NCT01707576|emmergency department|emmergency department
336226|NCT01707576|parental perception|parental perception
336227|NCT01707576|Emergency|emergency
336228|NCT01707563|Marfan syndrome|marfan syndrome
336229|NCT01707563|Variability|variability
336230|NCT01707563|Fibrillin 1|fibrillin 1
336231|NCT01707563|clinical expression|clinical expression
336232|NCT01707537|OCV|ocv
336233|NCT01707537|cholera|cholera
336234|NCT01707511|Arterial carbondioxide pressure|arterial carbondioxide pressure
336235|NCT01707511|Colon surgery|colon surgery
336236|NCT01707511|End-tidal carbondioxide|end-tidal carbondioxide
336237|NCT01707511|Laparoscopic Trendelenburg|laparoscopic trendelenburg
336238|NCT01707498|BCI|bci
336239|NCT01707498|TETRAPLEGIA|tetraplegia
336240|NCT01707498|COMMUNICATION|communication
336241|NCT01707498|P300|p300
336242|NCT01707498|ASSISTIVE TECHNOLOGIE|assistive technologie
336243|NCT01707485|Antibiotics|antibiotics
336244|NCT01707472|Liver Fibrosis|liver fibrosis
336245|NCT01707472|Fibrosis|fibrosis
336246|NCT01707472|HIV|hiv
336247|NCT01707472|HCV|hcv
336248|NCT01707472|GS-6624|gs-6624
336249|NCT01707472|Hepatitis|hepatitis
336250|NCT01707472|Hepatitis C|hepatitis c
336251|NCT01707459|platelet function|platelet function
336252|NCT01707459|perioperative complications|perioperative complications
336253|NCT01707459|major adverse cardiac events (MACE)|major adverse cardiac events (mace)
336254|NCT01707459|thromboelastography|thromboelastography
336255|NCT01707459|polymorphism analysis|polymorphism analysis
336256|NCT01707459|coronary stents|coronary stents
336257|NCT01707459|non-cardiac surgery|non-cardiac surgery
336258|NCT01707446|Cardiac surgery|cardiac surgery
336259|NCT01707446|Delirium|delirium
336260|NCT01707446|Cerebral Oximetry|cerebral oximetry
336261|NCT01707433|spondyloepiphyseal dysplasia|spondyloepiphyseal dysplasia
336262|NCT01707433|multiple epiphyseal dysplasia|multiple epiphyseal dysplasia
336263|NCT01707433|bilateral Legg Calve Perthes|bilateral legg calve perthes
336264|NCT01707433|bilateral proximal femoral epiphyseal dysplasia|bilateral proximal femoral epiphyseal dysplasia
336265|NCT01707433|GALNS|galns
336266|NCT01707420|pediatric pain|pediatric pain
336267|NCT01707420|post operative pain|post operative pain
336268|NCT01707420|opioids|opioids
336269|NCT01707420|emergence agitation|emergence agitation
336270|NCT01707420|preoperative anxiety|preoperative anxiety
336271|NCT01707420|pharmacogenomics|pharmacogenomics
336272|NCT01707407|CC-4047|cc-4047
336273|NCT01707407|Pomalidomide|pomalidomide
336274|NCT01707407|Ketoconazole|ketoconazole
336275|NCT01707407|Fluvoxamine|fluvoxamine
336276|NCT01707407|Carbamazepine|carbamazepine
336277|NCT01707407|DDI|ddi
336278|NCT01707407|safety|safety
336279|NCT01707407|tolerability|tolerability
336280|NCT01707407|pharmacokinetic|pharmacokinetic
336281|NCT01707368|Psoriasis|psoriasis
336282|NCT01707368|Psoriasis vulgaris|psoriasis vulgaris
336283|NCT01707368|Plaque Psoriasis|plaque psoriasis
336284|NCT01707368|Daivobet® Gel|daivobet® gel
336285|NCT01707368|Germany|germany
336286|NCT01707355|education, knowledge, poster, dental trauma|education, knowledge, poster, dental trauma
336287|NCT01707342|Healthy male participants|healthy male participants
337488|NCT01702285|Her2|her2
336288|NCT01707342|Absolute bioavailability|absolute bioavailability
336289|NCT01707342|Bioavailability|bioavailability
336290|NCT01707342|Pharmacokinetics|pharmacokinetics
336291|NCT01707342|Simeprevir|simeprevir
336292|NCT01707342|TMC435|tmc435
336293|NCT01707342|[3H]-TMC435|[3h]-tmc435
336294|NCT01707342|Hepatitis C virus|hepatitis c virus
336295|NCT01707342|HCV|hcv
336296|NCT01707316|Healthy|healthy
336297|NCT01707316|JNJ-28431754|jnj-28431754
336298|NCT01707316|Canagliflozin|canagliflozin
336299|NCT01707316|Pharmacokinetics|pharmacokinetics
336300|NCT01707316|Pharmacodynamics|pharmacodynamics
336301|NCT01707303|ICU|icu
336302|NCT01707303|Critical Care|critical care
336303|NCT01707303|Intensive Care|intensive care
336304|NCT01707303|Critical Illness|critical illness
336305|NCT01707303|Acute Respiratory Failure|acute respiratory failure
336306|NCT01707303|Mechanical Ventilation|mechanical ventilation
336307|NCT01707303|Physical Therapy|physical therapy
336308|NCT01707303|Strength|strength
336309|NCT01707303|Functional Status|functional status
336310|NCT01707303|Short Physical Performance Battery|short physical performance battery
336311|NCT01707277|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
336312|NCT01707277|Inspiratory muscle training|inspiratory muscle training
336313|NCT01707277|Exercise capacity|exercise capacity
336314|NCT01707264|AL amyloidosis|al amyloidosis
336315|NCT01707264|Primary amyloidosis|primary amyloidosis
336316|NCT01707251|Obesity, Morbid|obesity, morbid
336317|NCT01707251|Bariatric Surgery|bariatric surgery
336318|NCT01707251|Laparoscopy|laparoscopy
336319|NCT01707251|Intravenous Ibuprofen|intravenous ibuprofen
336320|NCT01707251|Analgesia|analgesia
336321|NCT01707251|Morphine|morphine
336322|NCT01707225|GI Bleeding|gi bleeding
336323|NCT01707225|Gastrointestinal bleeding|gastrointestinal bleeding
336324|NCT01707225|LVAD|lvad
336325|NCT01707212|parent education|parent education
336326|NCT01707212|pain management|pain management
336327|NCT01707212|immunization|immunization
336328|NCT01707212|infant|infant
336329|NCT01707199|P. falciparum|p. falciparum
336330|NCT01707199|Sulphadoxine-pyrimethamine|sulphadoxine-pyrimethamine
336331|NCT01707199|Artesunate|artesunate
336332|NCT01707199|Artemisinin Combination Therapy (ACT)|artemisinin combination therapy (act)
336333|NCT01707173|SIDS|sids
336334|NCT01707121|morbidity|morbidity
336335|NCT01707121|sick-leave|sick-leave
336336|NCT01707121|hospital stay|hospital stay
336337|NCT01707108|dental implants|dental implants
336338|NCT01707108|bone loss|bone loss
336339|NCT01707095|Electrosurgery|electrosurgery
336340|NCT01707095|Radiofrequency energy|radiofrequency energy
336341|NCT01707095|Monopolar instruments|monopolar instruments
336342|NCT01707095|Capacitive coupling|capacitive coupling
336343|NCT01707095|Thermal injury|thermal injury
336344|NCT01707095|Surgical complications|surgical complications
336345|NCT01707056|levothyroxine|levothyroxine
336346|NCT01707056|synthroid|synthroid
336347|NCT01707056|coffee|coffee
336348|NCT01707056|absorption|absorption
336349|NCT01707056|tea|tea
336350|NCT01707056|thyroid carcinoma|thyroid carcinoma
336351|NCT01707043|plaque psoriasis|plaque psoriasis
336352|NCT01707043|taclonex|taclonex
336353|NCT01707043|crossover|crossover
336354|NCT01707030|clinical trial|clinical trial
336355|NCT01707030|veteran|veteran
336356|NCT01707030|substance use disorder|substance use disorder
336357|NCT01706978|rotator cuff tear|rotator cuff tear
336358|NCT01706952|Endoscopic sinus surgery|endoscopic sinus surgery
336359|NCT01706952|Bleeding|bleeding
336360|NCT01706952|Topical Vasocontriction|topical vasocontriction
336361|NCT01706952|Cocaine|cocaine
336362|NCT01706952|Adrenaline|adrenaline
336363|NCT01706939|Reduced radiotherapy|reduced radiotherapy
336364|NCT01706939|Randomization, Phase III|randomization, phase iii
336365|NCT01706939|Reduced radiation therapy|reduced radiation therapy
336366|NCT01706939|head and neck|head and neck
336367|NCT01706939|oropharynx|oropharynx
336368|NCT01706939|unknown primary (cervical lymph nodes)|unknown primary (cervical lymph nodes)
336369|NCT01706939|nasopharynx primary|nasopharynx primary
336370|NCT01706939|HPV|hpv
336371|NCT01706939|p16|p16
336372|NCT01706926|Rheumatoid Arthritis|rheumatoid arthritis
336373|NCT01706926|Mavrilimumab|mavrilimumab
336374|NCT01706926|CAM-3001|cam-3001
336375|NCT01706887|Nedd4-2|nedd4-2
336376|NCT01706887|blood pressure|blood pressure
336377|NCT01706887|polymorphism|polymorphism
336378|NCT01706887|salt intake|salt intake
336379|NCT01706887|between 18 and 35 years old|between 18 and 35 years old
336380|NCT01706887|BMI between 18 and 28 Kg per m2|bmi between 18 and 28 kg per m2
336381|NCT01706887|no active disease|no active disease
336382|NCT01706887|no alcool or drug abuse or smoke|no alcool or drug abuse or smoke
336383|NCT01706874|Rheumatoid arthritis|rheumatoid arthritis
336384|NCT01706874|P.gingivalis|p.gingivalis
336385|NCT01706874|Periodontal disease|periodontal disease
336386|NCT01706874|Plaque control|plaque control
336387|NCT01706874|Prophylaxis|prophylaxis
336388|NCT01706874|Oral hygiene instruction|oral hygiene instruction
336389|NCT01706835|solid tumor|solid tumor
336390|NCT01706835|aldoxorubicin|aldoxorubicin
336391|NCT01706835|phase 1|phase 1
336392|NCT01706835|pharmacokinetic|pharmacokinetic
336393|NCT01706835|INNO-206|inno-206
336394|NCT01706796|Pain|pain
336395|NCT01706744|Hospital Readmissions|hospital readmissions
336396|NCT01706744|Community Health Services|community health services
336397|NCT01706744|Preventive Health Services|preventive health services
336398|NCT01706744|Norway|norway
336399|NCT01706731|Buddhist monks|buddhist monks
336400|NCT01706731|CBT|cbt
336401|NCT01706731|elderly|elderly
336402|NCT01706731|depression|depression
336403|NCT01706718|Beetroot|beetroot
336404|NCT01706718|Blood pressure|blood pressure
336405|NCT01706718|Vascular function|vascular function
336406|NCT01706705|Cervical Cancer|cervical cancer
336407|NCT01706705|Radiation therapy|radiation therapy
336408|NCT01706705|XRT|xrt
336409|NCT01706705|External beam therapy|external beam therapy
336410|NCT01706705|Brachytherapy|brachytherapy
336411|NCT01706705|Intracavitary brachytherapy|intracavitary brachytherapy
336412|NCT01706705|ICBT|icbt
336413|NCT01706705|MRI compatible intracavitary applicators|mri compatible intracavitary applicators
336414|NCT01706705|Computed tomography|computed tomography
336415|NCT01706705|CT|ct
336416|NCT01706705|Magnetic resonance imaging|magnetic resonance imaging
336417|NCT01706705|MRI|mri
336418|NCT01706705|MRI compatible applicators|mri compatible applicators
336419|NCT01706705|3D image guided treatment planning|3d image guided treatment planning
336420|NCT01706705|2D treatment planning|2d treatment planning
336421|NCT01706692|Methotrexate|methotrexate
336422|NCT01706692|Acitretin|acitretin
336423|NCT01706692|Cyclosporine A|cyclosporine a
336424|NCT01706692|Systemic PUVA|systemic puva
336425|NCT01706692|Infliximab|infliximab
336426|NCT01706692|Adalimumab|adalimumab
336427|NCT01706692|Etanercept|etanercept
336428|NCT01706692|Ustekinumab|ustekinumab
336429|NCT01706692|Fumaric acids|fumaric acids
336430|NCT01706692|Psoriasis|psoriasis
336431|NCT01706692|Psoriatic arthritis|psoriatic arthritis
336432|NCT01706692|Skin disease|skin disease
336433|NCT01706679|Healthy volunteers|healthy volunteers
336434|NCT01706666|Maintenance|maintenance
336435|NCT01706666|Consolidation|consolidation
336436|NCT01706653|Polyphenol|polyphenol
336437|NCT01706653|Fruit|fruit
336438|NCT01706653|Metabolic|metabolic
336439|NCT01706653|Healthy|healthy
336440|NCT01706627|cancer|cancer
336441|NCT01706627|melatonin|melatonin
336442|NCT01706627|adjuvant therapy|adjuvant therapy
336443|NCT01706627|quality of life|quality of life
336444|NCT01706627|survival|survival
336445|NCT01706627|adverse events|adverse events
336446|NCT01706627|oxidative stress|oxidative stress
336447|NCT01706588|diclofenac, postsurgical pain, oral surgery|diclofenac, postsurgical pain, oral surgery
336448|NCT01706562|Neutropenia|neutropenia
336449|NCT01706562|Hematologic malignancy|hematologic malignancy
336450|NCT01706562|Itraconazole|itraconazole
336451|NCT01706562|Fungal infection|fungal infection
336452|NCT01706562|Antifungal agent|antifungal agent
336453|NCT01706562|Neutropenic fever|neutropenic fever
336454|NCT01706549|Chronic pain|chronic pain
336455|NCT01706549|Hysterectomy|hysterectomy
336456|NCT01706549|Quality of life|quality of life
336457|NCT01706523|Autism Spectrum Disorders|autism spectrum disorders
336458|NCT01706523|Autism|autism
336459|NCT01706523|Asperger|asperger
336583|NCT01706055|Multiple Sclerosis (MS)|multiple sclerosis (ms)
336460|NCT01706523|Pervasive Developmental Disorder - Not otherwise specified|pervasive developmental disorder - not otherwise specified
336461|NCT01706510|Clopidogrel|clopidogrel
336462|NCT01706510|Ticagrelor|ticagrelor
336463|NCT01706510|Coronary Artery Disease|coronary artery disease
336464|NCT01706510|Myocardial Ischemia|myocardial ischemia
336465|NCT01706510|Coronary Disease|coronary disease
336466|NCT01706510|Heart Diseases|heart diseases
336467|NCT01706510|Cardiovascular Diseases|cardiovascular diseases
336468|NCT01706510|Arteriosclerosis|arteriosclerosis
336469|NCT01706510|Arterial Occlusive Diseases|arterial occlusive diseases
336470|NCT01706510|Vascular Diseases|vascular diseases
336471|NCT01706510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
336472|NCT01706510|Hematologic Agents|hematologic agents
336473|NCT01706510|Therapeutic Uses|therapeutic uses
336474|NCT01706510|Pharmacologic Actions|pharmacologic actions
336475|NCT01706510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists
336476|NCT01706510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists
336477|NCT01706510|Purinergic Antagonists|purinergic antagonists
336478|NCT01706510|Purinergic Agents|purinergic agents
336479|NCT01706510|Physiological Effects of Drugs|physiological effects of drugs
336480|NCT01706497|cerebral tissue oxygen saturation|cerebral tissue oxygen saturation
336481|NCT01706497|congenital cardiac surgery|congenital cardiac surgery
336482|NCT01706497|pediatric intensive care unit|pediatric intensive care unit
336483|NCT01706497|Near Infra-Red Spectroscopy|near infra-red spectroscopy
336484|NCT01706497|early warning monitor|early warning monitor
336485|NCT01706497|outcome prediction|outcome prediction
336486|NCT01706484|randomized clinical trial|randomized clinical trial
336487|NCT01706484|chronic rhinosinusitis|chronic rhinosinusitis
336488|NCT01706484|herbal extract BNO 1016|herbal extract bno 1016
336489|NCT01706484|exacerbation|exacerbation
336490|NCT01706484|pharmacoeconomic|pharmacoeconomic
336491|NCT01706484|quality of life|quality of life
336492|NCT01706471|verLowCNI|verlowcni
336493|NCT01706458|Vaccine|vaccine
336494|NCT01706458|pTVG-HP|ptvg-hp
336495|NCT01706458|Prostate Cancer|prostate cancer
336496|NCT01706458|Castrate Resistant|castrate resistant
336497|NCT01706445|cystic fibrosis|cystic fibrosis
336498|NCT01706445|exercise|exercise
336499|NCT01706445|children|children
336500|NCT01706445|cardiorespiratory fitness|cardiorespiratory fitness
336501|NCT01706445|muscle strength|muscle strength
336502|NCT01706445|pulmonary function|pulmonary function
336503|NCT01706445|quality of life|quality of life
336504|NCT01706419|vitamin A|vitamin a
336505|NCT01706419|iron|iron
336506|NCT01706419|zinc|zinc
336507|NCT01706419|school children|school children
336508|NCT01706419|fortified rice|fortified rice
336509|NCT01706419|morbidity|morbidity
336510|NCT01706419|growth|growth
336511|NCT01706406|female sexual arousal|female sexual arousal
336512|NCT01706406|female sexual desire|female sexual desire
336513|NCT01706406|psychoeducational intervention|psychoeducational intervention
336514|NCT01706393|probiotics|probiotics
336515|NCT01706393|intestinal microbiome|intestinal microbiome
336516|NCT01706393|radiotherapy|radiotherapy
336517|NCT01706380|Substance use disorders|substance use disorders
336518|NCT01706380|Adolescents|adolescents
336519|NCT01706380|Retention|retention
336520|NCT01706380|Mobile telephone|mobile telephone
336521|NCT01706380|Follow-up|follow-up
336522|NCT01706380|Interactive voice response|interactive voice response
336523|NCT01706367|Clostridium difficile|clostridium difficile
336524|NCT01706367|vaccine|vaccine
336525|NCT01706354|end stage renal disease|end stage renal disease
336526|NCT01706354|vascular access|vascular access
336527|NCT01706354|regional anaesthesia|regional anaesthesia
336528|NCT01706341|cesarean section|cesarean section
336529|NCT01706341|intravenous fluid|intravenous fluid
336530|NCT01706341|a glucose-containing solution|a glucose-containing solution
336531|NCT01706341|fetal hypoglycemia|fetal hypoglycemia
336532|NCT01706341|neonatal hypoglycemia|neonatal hypoglycemia
336533|NCT01706328|Vilanterol (VI)|vilanterol (vi)
336534|NCT01706328|Novel Dry Powder Inhaler (NDPI)|novel dry powder inhaler (ndpi)
336535|NCT01706328|FEV1|fev1
336536|NCT01706328|Fluticasone Furoate (FF)|fluticasone furoate (ff)
336537|NCT01706328|COPD|copd
336538|NCT01706302|General Practice Research Database|general practice research database
336539|NCT01706302|Burden of Disease|burden of disease
336540|NCT01706302|Clinical Practice Research Datalink|clinical practice research datalink
336541|NCT01706302|Hospital Episode Statistics|hospital episode statistics
336542|NCT01706302|Office of National Statistics|office of national statistics
336543|NCT01706302|RSV|rsv
336544|NCT01706289|diabetes|diabetes
336545|NCT01706289|cardiovascular autonomic neuropathy|cardiovascular autonomic neuropathy
336546|NCT01706289|VAP 1|vap 1
336547|NCT01706237|Myopia|myopia
336548|NCT01706237|LASIK|lasik
336549|NCT01706224|Pertussis antibodies|pertussis antibodies
336550|NCT01706224|Bordetella pertussis|bordetella pertussis
336551|NCT01706224|sero-prevalence|sero-prevalence
336552|NCT01706224|Healthcare professionals (HCP)|healthcare professionals (hcp)
336553|NCT01706224|Spain|spain
336554|NCT01706211|non insulin dependent diabetes mellitus, rosiglitazone|non insulin dependent diabetes mellitus, rosiglitazone
336555|NCT01706198|respiratory|respiratory
336556|NCT01706198|adult|adult
336557|NCT01706198|asthma|asthma
336558|NCT01706185|Patients|patients
336559|NCT01706185|Tumor antigens|tumor antigens
336560|NCT01706185|Bladder cancer|bladder cancer
336561|NCT01706172|TMD|tmd
336562|NCT01706172|temporomandibular|temporomandibular
336563|NCT01706172|dextrose|dextrose
336564|NCT01706172|prolotherapy|prolotherapy
336565|NCT01706146|atrial fibrillation|atrial fibrillation
336566|NCT01706146|reveal xt|reveal xt
336567|NCT01706146|oral anticoagulation|oral anticoagulation
336568|NCT01706146|dabigatran|dabigatran
336569|NCT01706146|rivaroxaban|rivaroxaban
336570|NCT01706146|apixaban|apixaban
336571|NCT01706133|Frailty, emergency services, elderly|frailty, emergency services, elderly
336572|NCT01706120|prognostic factors|prognostic factors
336573|NCT01706120|biologic factors|biologic factors
336574|NCT01706120|clinical factors|clinical factors
336575|NCT01706120|routine clinical practice|routine clinical practice
336576|NCT01706107|Quality of life|quality of life
336577|NCT01706094|stroke|stroke
336578|NCT01706094|head position|head position
336579|NCT01706081|acupuncture|acupuncture
336580|NCT01706068|acute ECG changes|acute ecg changes
336581|NCT01706068|acute illness of gallbladder|acute illness of gallbladder
336582|NCT01706068|acute illness of biliary tract|acute illness of biliary tract
336584|NCT01706055|Interferon|interferon
336585|NCT01706003|Migraine|migraine
336586|NCT01706003|Headaches|headaches
336587|NCT01706003|Telemedicine|telemedicine
336588|NCT01705990|HIV|hiv
336589|NCT01705990|AIDS|aids
336590|NCT01705990|HIV vaccine|hiv vaccine
336591|NCT01705990|HIV prevention|hiv prevention
336592|NCT01705977|Antibodies|antibodies
336593|NCT01705977|Lupus|lupus
336594|NCT01705977|SLE|sle
336595|NCT01705977|Systemic Lupus Erythematosus|systemic lupus erythematosus
336596|NCT01705977|Autoimmune Disease|autoimmune disease
336597|NCT01705977|Belimumab|belimumab
336598|NCT01705964|Status asthmaticus|status asthmaticus
336599|NCT01705964|Asthma exacerbation|asthma exacerbation
336600|NCT01705964|Epinephrine|epinephrine
336601|NCT01705964|Adjunctive therapy|adjunctive therapy
336602|NCT01705951|Smoking|smoking
336603|NCT01705951|Insulin resistance|insulin resistance
336604|NCT01705951|Metabolic Syndrome|metabolic syndrome
336605|NCT01705951|Endothelial Function|endothelial function
336606|NCT01705951|Smoking Cessation|smoking cessation
336607|NCT01705951|Resistance Training|resistance training
336608|NCT01705951|Nicotine Replacement|nicotine replacement
336609|NCT01705951|Exercise|exercise
336610|NCT01705951|Cardiovascular Disease|cardiovascular disease
336611|NCT01705951|Arterial Stiffness|arterial stiffness
336612|NCT01705951|Body Composition|body composition
336613|NCT01705912|fall|fall
336614|NCT01705912|prevention|prevention
336615|NCT01705899|Type 1 Diabetes|type 1 diabetes
336616|NCT01705899|Islet transplant|islet transplant
336617|NCT01705899|Kidney transplant|kidney transplant
336618|NCT01705886|Osteoarthritis|osteoarthritis
336619|NCT01705886|Joint Disease|joint disease
336620|NCT01705886|Arthritis|arthritis
336621|NCT01705886|Musculoskeletal Disease|musculoskeletal disease
336622|NCT01705873|HIV|hiv
336623|NCT01705873|cardiovascular|cardiovascular
336624|NCT01705873|risk|risk
336625|NCT01705873|mortality|mortality
336626|NCT01705860|Collagen, collagenase, scar|collagen, collagenase, scar
336627|NCT01705847|chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
336628|NCT01705847|non-Hodgkin lymphoma (NHL)|non-hodgkin lymphoma (nhl)
336629|NCT01705847|Hodgkin lymphoma (HL)|hodgkin lymphoma (hl)
336630|NCT01705847|indolent non-Hodgkin lymphoma (iNHL)|indolent non-hodgkin lymphoma (inhl)
336631|NCT01705847|diffuse large B-cell lymphoma-activated B-cell (DLBCL-ABC)|diffuse large b-cell lymphoma-activated b-cell (dlbcl-abc)
336632|NCT01705847|DLBCL-germinal center B-cell (GCB)|dlbcl-germinal center b-cell (gcb)
336633|NCT01705847|mantle cell lymphoma (MCL)|mantle cell lymphoma (mcl)
336634|NCT01705847|GS-9820|gs-9820
336635|NCT01705847|phosphatidylinositol 3-kinase (PI3K)|phosphatidylinositol 3-kinase (pi3k)
336636|NCT01705834|Arthritis|arthritis
336637|NCT01705834|Stiffness|stiffness
336638|NCT01705834|Range of movement|range of movement
336639|NCT01705834|Goniometry|goniometry
336640|NCT01705834|Digital|digital
336641|NCT01705834|Dataglove|dataglove
336642|NCT01705834|Outcome|outcome
336643|NCT01705821|Skull base|skull base
336644|NCT01705821|Pituitary|pituitary
336645|NCT01705821|Robotics|robotics
336646|NCT01705821|Endonasal surgery|endonasal surgery
336647|NCT01705821|Sinus surgery|sinus surgery
336648|NCT01705769|treatment|treatment
336649|NCT01705769|severe acute malnutrition|severe acute malnutrition
336650|NCT01705756|Colchicine|colchicine
336651|NCT01705756|Anakinra|anakinra
336652|NCT01705756|Colchicine resistance|colchicine resistance
336653|NCT01705756|Familial Mediterranean fever|familial mediterranean fever
336654|NCT01705743|anaesthesia|anaesthesia
336655|NCT01705743|middle aged|middle aged
336656|NCT01705743|minimal alveolar concentration|minimal alveolar concentration
336657|NCT01705743|sevoflurane|sevoflurane
336658|NCT01705743|nitrous oxide|nitrous oxide
336659|NCT01705743|isoelectric EEG|isoelectric eeg
336660|NCT01705678|Males|males
336661|NCT01705678|Metabolic syndrome|metabolic syndrome
336662|NCT01705678|Otherwise healthy|otherwise healthy
336663|NCT01705652|nexrutine|nexrutine
336664|NCT01705652|prostate cancer|prostate cancer
336665|NCT01705639|diabetes|diabetes
336666|NCT01705639|melatonin|melatonin
336667|NCT01705639|glucose tolerance|glucose tolerance
336668|NCT01705639|sleep|sleep
336669|NCT01705626|Peripheral Nervous System Diseases|peripheral nervous system diseases
336670|NCT01705626|Neuromuscular Diseases|neuromuscular diseases
336671|NCT01705626|Nervous System Diseases|nervous system diseases
336672|NCT01705626|Metabolism, Inborn Errors|metabolism, inborn errors
336673|NCT01705626|Genetic Diseases, Inborn|genetic diseases, inborn
336674|NCT01705613|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
336675|NCT01705613|ADHD|adhd
336676|NCT01705613|Methylphenidate Immediate-release|methylphenidate immediate-release
336677|NCT01705613|Cost-effectiveness|cost-effectiveness
336678|NCT01705613|Cost-utility|cost-utility
336679|NCT01705613|QALYs|qalys
336680|NCT01705600|Central Sensitization|central sensitization
336681|NCT01705600|Low Back Pain|low back pain
336682|NCT01705600|Pain|pain
336683|NCT01705600|Pain Catastrophizing|pain catastrophizing
336684|NCT01705600|Brence|brence
336685|NCT01705587|osteoporosis|osteoporosis
336686|NCT01705587|atypical femoral fractures|atypical femoral fractures
336687|NCT01705587|prior bisphosphonate treatment|prior bisphosphonate treatment
336688|NCT01705587|postmenopausal women|postmenopausal women
336689|NCT01705587|bone loss|bone loss
336690|NCT01705574|HIV-1|hiv-1
336692|NCT01705574|Treatment-Naive|treatment-naive
336693|NCT01705574|Women|women
336694|NCT01705574|WAVES|waves
336695|NCT01705561|fertility|fertility
336696|NCT01705561|chemotherapy|chemotherapy
336697|NCT01705561|breast cancer|breast cancer
336698|NCT01705561|latin american women|latin american women
336699|NCT01705561|pre menopausal|pre menopausal
336700|NCT01705548|Brain metastasis|brain metastasis
336701|NCT01705535|Fecal incontinence|fecal incontinence
336702|NCT01705535|Pelvic floor muscle exercises|pelvic floor muscle exercises
336703|NCT01705535|Physiotherapy|physiotherapy
336704|NCT01705522|IBD|ibd
336705|NCT01705522|ulcerative colitis|ulcerative colitis
336706|NCT01705522|Crohn's disease|crohn's disease
336707|NCT01705522|NAFLD|nafld
336708|NCT01705522|biomarkers|biomarkers
336709|NCT01705522|vitamin D|vitamin d
336710|NCT01705509|The Effects of Ranolazine on CPET Parameters in Ischemic|the effects of ranolazine on cpet parameters in ischemic
336711|NCT01705509|Cardiomyopathy Patients|cardiomyopathy patients
336712|NCT01705496|Phase II|phase ii
336713|NCT01705496|FIAU|fiau
336714|NCT01705496|Fialuridine|fialuridine
336715|NCT01705496|Prosthetic|prosthetic
336716|NCT01705496|Joint|joint
336717|NCT01705496|Infection|infection
336718|NCT01705496|PET-CT|pet-ct
336719|NCT01705483|ASP9853|asp9853
336720|NCT01705483|Docetaxel|docetaxel
336721|NCT01705483|Paclitaxel|paclitaxel
336722|NCT01705470|Furosemide|furosemide
336723|NCT01705470|Anemia|anemia
336724|NCT01705470|LV dysfunction|lv dysfunction
336725|NCT01705470|blood transfusion|blood transfusion
336726|NCT01705457|multiple sclerosis|multiple sclerosis
336727|NCT01705457|Vitamin A|vitamin a
336728|NCT01705457|retinoic acid receptor|retinoic acid receptor
336729|NCT01705457|retinoic x receptor|retinoic x receptor
336730|NCT01705444|Urinary retention|urinary retention
336731|NCT01705444|Foley catheter|foley catheter
336732|NCT01705444|The Spanner|the spanner
336733|NCT01705444|Quality of life|quality of life
336734|NCT01705431|Emotional Disturbance|emotional disturbance
336735|NCT01705431|Behavioral Disturbance|behavioral disturbance
336736|NCT01705431|EBD|ebd
336737|NCT01705431|Middle School|middle school
336738|NCT01705431|Special Education|special education
336739|NCT01705431|School Psychology|school psychology
336740|NCT01705418|Parkinson disease|parkinson disease
336741|NCT01705418|Deep brain stimulation|deep brain stimulation
336742|NCT01705418|behavior and psychiatric symptoms improvement|behavior and psychiatric symptoms improvement
336743|NCT01705405|cancer|cancer
336744|NCT01705405|prostate|prostate
336745|NCT01705379|Neisseria meningitidis, conjugate vaccine, phase IV clinical trial|neisseria meningitidis, conjugate vaccine, phase iv clinical trial
336746|NCT01705366|Osteoarthritis|osteoarthritis
336747|NCT01705366|Joint Disease|joint disease
336748|NCT01705366|Arthritis|arthritis
336749|NCT01705366|Musculoskeletal Disease|musculoskeletal disease
336750|NCT01705353|Stroke|stroke
336751|NCT01705353|Cerebrovascular Accident|cerebrovascular accident
336752|NCT01705353|HMGB-1|hmgb-1
336753|NCT01705353|cytokines|cytokines
336754|NCT01705353|functional recovery|functional recovery
336755|NCT01705353|inflammation|inflammation
336756|NCT01705353|immune response|immune response
336757|NCT01705327|Parkinson's|parkinson's
336758|NCT01705327|Biomarkers|biomarkers
336759|NCT01705327|Neurodegenerative disorder|neurodegenerative disorder
336760|NCT01705314|human influenza children|human influenza children
336761|NCT01705288|laparotomy|laparotomy
336762|NCT01705288|hysterectomy|hysterectomy
336763|NCT01705262|compliance|compliance
336764|NCT01705262|Bowel preparations|bowel preparations
336765|NCT01705262|Moviprep|moviprep
336766|NCT01705262|Phosphoral|phosphoral
336767|NCT01705223|prophylactic|prophylactic
336768|NCT01705223|vaccine|vaccine
336769|NCT01705184|Stop and go|stop and go
336770|NCT01705184|Non-small cell lung cancer|non-small cell lung cancer
336771|NCT01705184|Non-squamous|non-squamous
336772|NCT01705184|Bevacizumab|bevacizumab
336773|NCT01705171|IBS|ibs
336774|NCT01705171|fructose intolerance|fructose intolerance
336775|NCT01705171|GLUT 5|glut 5
336776|NCT01705171|GLUT 2|glut 2
336777|NCT01705158|ovarian cancer in relapse|ovarian cancer in relapse
336778|NCT01705158|sensitive in platin|sensitive in platin
336779|NCT01705145|Cystic Fibrosis|cystic fibrosis
336780|NCT01705119|Mechanically Ventilated|mechanically ventilated
336781|NCT01705119|Critical Care|critical care
336782|NCT01705093|strawberry, cardiovascular, obesity, adolescent|strawberry, cardiovascular, obesity, adolescent
336783|NCT01705080|Renal Denervation|renal denervation
336784|NCT01705080|Renal artery|renal artery
336785|NCT01705067|Osteoarthritis, Degenerative Knee Disease, TKA|osteoarthritis, degenerative knee disease, tka
336786|NCT01705054|Angina|angina
336787|NCT01705054|Stable ischemic heart disease|stable ischemic heart disease
336788|NCT01705054|Quality of Life|quality of life
336789|NCT01705054|Seattle Angina Questionnaire (SAQ)|seattle angina questionnaire (saq)
336790|NCT01705015|exercise|exercise
336791|NCT01705002|phase 1|phase 1
336792|NCT01705002|dose escalating|dose escalating
336793|NCT01705002|prodrug|prodrug
336794|NCT01705002|mitomycin C|mitomycin c
336795|NCT01705002|Capecitabine|capecitabine
336796|NCT01704989|Glaucoma, SLT|glaucoma, slt
336797|NCT01704963|Recurrent mature B-cell neoplasms|recurrent mature b-cell neoplasms
336798|NCT01704963|B-cell malignancies|b-cell malignancies
336799|NCT01704963|Bruton's Tyrosine Kinase (Btk) Inhibitor|bruton's tyrosine kinase (btk) inhibitor
336800|NCT01704963|PCI-32765|pci-32765
336801|NCT01704963|Tumor|tumor
336802|NCT01704963|Pharmacokinetics|pharmacokinetics
336803|NCT01704963|Japanese|japanese
336804|NCT01704937|Fecal Microbiota Transplant|fecal microbiota transplant
336805|NCT01704937|Clostridium difficile|clostridium difficile
336806|NCT01704937|Diarrhea|diarrhea
336807|NCT01704924|Prevena|prevena
336808|NCT01704924|negative pressure wound therapy|negative pressure wound therapy
336809|NCT01704924|Incisional wound vac|incisional wound vac
336810|NCT01704911|Transradial|transradial
336811|NCT01704911|Transfemoral|transfemoral
336812|NCT01704911|Coronary Intervention|coronary intervention
336813|NCT01704898|efavirenz|efavirenz
336814|NCT01704898|bioequivalence|bioequivalence
336815|NCT01704898|fasting|fasting
336816|NCT01704898|healthy volunteers|healthy volunteers
336817|NCT01704885|Childhood Cancer|childhood cancer
336818|NCT01704885|Sibling Play intervention|sibling play intervention
336819|NCT01704885|Sibling Behavioral Intervention|sibling behavioral intervention
336820|NCT01704885|Siblings of Cancer Patients|siblings of cancer patients
336821|NCT01704872|Neuroblastoma|neuroblastoma
336822|NCT01704872|Refractory neuroblastoma|refractory neuroblastoma
336823|NCT01704872|ch14.18/CHO|ch14.18/cho
336824|NCT01704859|fracture|fracture
336825|NCT01704833|Psychosis|psychosis
336826|NCT01704833|Paranoia|paranoia
336827|NCT01704833|Cognitive Behavioral Therapy|cognitive behavioral therapy
336828|NCT01704833|Delusions|delusions
336829|NCT01704833|Group Therapy|group therapy
336830|NCT01704820|Colon Polyps|colon polyps
336831|NCT01704820|Colon Cancer screening|colon cancer screening
336832|NCT01704820|Colonoscopy|colonoscopy
336833|NCT01704807|Low Back Pain|low back pain
336834|NCT01704807|Chronic|chronic
336835|NCT01704807|Orthotic Device|orthotic device
336836|NCT01704807|Applied Kinesiology|applied kinesiology
336837|NCT01704807|Manual Muscle Testing|manual muscle testing
336838|NCT01704807|Chiropractic|chiropractic
336839|NCT01704794|Sickle Cell Anemia|sickle cell anemia
336840|NCT01704794|Quality of Life|quality of life
336841|NCT01704794|Antioxidant|antioxidant
336842|NCT01704794|Anti inflammatory|anti inflammatory
336843|NCT01704794|Sorghum bicolor|sorghum bicolor
336844|NCT01704781|CD4|cd4
336845|NCT01704781|Clinical trial|clinical trial
336846|NCT01704781|Dose escalation assessment lenalidomide|dose escalation assessment lenalidomide
336847|NCT01704781|Human immunodeficiency virus-1 (HIV-1)|human immunodeficiency virus-1 (hiv-1)
336848|NCT01704781|HIV|hiv
336849|NCT01704781|Immunomodulatory|immunomodulatory
336850|NCT01704781|Infection|infection
336851|NCT01704781|Lenalidomide|lenalidomide
336852|NCT01704781|Phase I/II|phase i/ii
336853|NCT01704781|Vaccine|vaccine
336854|NCT01704781|Vacc-4x|vacc-4x
336855|NCT01704768|Randomized Controlled Trial|randomized controlled trial
336856|NCT01704768|School-Based Intervention|school-based intervention
336857|NCT01704755|Cirrhosis|cirrhosis
336858|NCT01704755|Hepatitis C|hepatitis c
336859|NCT01704755|Child Pugh A|child pugh a
336860|NCT01704755|Compensated Cirrhosis|compensated cirrhosis
336861|NCT01704755|Hepatitis C Genotype 1|hepatitis c genotype 1
336862|NCT01704755|Cirrhotic|cirrhotic
336863|NCT01704755|Chronic Hepatitis C|chronic hepatitis c
336864|NCT01704755|Hepatitis C Virus|hepatitis c virus
336865|NCT01704755|ombitasvir|ombitasvir
336866|NCT01704755|paritaprevir|paritaprevir
336867|NCT01704755|dasabuvir|dasabuvir
336868|NCT01704755|Interferon-Free|interferon-free
336869|NCT01704755|Viekira Pak|viekira pak
336870|NCT01704742|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
336871|NCT01704742|Hodgkin's Lymphoma|hodgkin's lymphoma
336872|NCT01704742|Kenya|kenya
336873|NCT01704742|Epstein Barr Virus (EBV)|epstein barr virus (ebv)
336874|NCT01704742|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
336875|NCT01704742|Kaposi's Sarcoma Herpes Virus (KSHV)|kaposi's sarcoma herpes virus (kshv)
336876|NCT01704729|Myopia|myopia
336877|NCT01704729|Focus groups|focus groups
336878|NCT01704729|refraction|refraction
336879|NCT01704729|Glasses|glasses
336880|NCT01704729|spectacles|spectacles
336881|NCT01704716|neuroblastoma|neuroblastoma
336882|NCT01704716|immunotherapy|immunotherapy
336883|NCT01704716|MAT|mat
336884|NCT01704716|antibody treatment|antibody treatment
336885|NCT01704703|colorectal cancer|colorectal cancer
336886|NCT01704703|FOLFIRI|folfiri
336887|NCT01704703|Panitumumab|panitumumab
336888|NCT01704703|KRAS, PIK3Ca,BRAF and NRAS genes|kras, pik3ca,braf and nras genes
336889|NCT01704703|highly sensitive techniques|highly sensitive techniques
336890|NCT01704690|Esophageal cancer|esophageal cancer
336891|NCT01704690|Chemotherapy|chemotherapy
336892|NCT01704690|Efficacy|efficacy
336893|NCT01704690|Toxicity|toxicity
336894|NCT01704677|Chronic low back pain|chronic low back pain
336895|NCT01704677|Degenerated disc|degenerated disc
336896|NCT01704677|Total disc replacement|total disc replacement
336897|NCT01704677|Multidisciplinary rehabilitation|multidisciplinary rehabilitation
336898|NCT01704677|Long term results|long term results
336899|NCT01704664|malnutrition,|malnutrition,
336900|NCT01704664|perioperative artificial nutrition,|perioperative artificial nutrition,
336901|NCT01704664|immunonutrition,|immunonutrition,
336902|NCT01704664|gastrectomy,|gastrectomy,
336903|NCT01704664|lymphocytes,|lymphocytes,
336904|NCT01704664|interleukin,|interleukin,
336905|NCT01704664|blood platelets,|blood platelets,
336906|NCT01704664|phagocytic and bactericidal activity of blood platelets|phagocytic and bactericidal activity of blood platelets
336907|NCT01704651|Ovary|ovary
336908|NCT01704651|Ovarian|ovarian
336909|NCT01704651|Fallopian|fallopian
336910|NCT01704651|Peritoneal|peritoneal
336911|NCT01704651|Cancer|cancer
336912|NCT01704651|Gynecological|gynecological
336913|NCT01704651|Female|female
336914|NCT01704625|pain|pain
336915|NCT01704625|headache|headache
336916|NCT01704612|local anesthetic|local anesthetic
336917|NCT01704612|sciatic|sciatic
336918|NCT01704612|diabetes|diabetes
336919|NCT01704612|block|block
336920|NCT01704612|duration|duration
336921|NCT01704599|Psoriasis|psoriasis
336922|NCT01704599|Adalimumab|adalimumab
336923|NCT01704599|B vitamins|b vitamins
336924|NCT01704599|Homocysteine|homocysteine
336925|NCT01704599|Folic acid|folic acid
336926|NCT01704599|Cyanocobalamin|cyanocobalamin
336927|NCT01704599|Pyridoxine|pyridoxine
336928|NCT01704599|Vitamin B6|vitamin b6
336929|NCT01704599|Vitamin B9|vitamin b9
336930|NCT01704599|Vitamin B12|vitamin b12
336931|NCT01704586|Differentiated thyroid carcinoma|differentiated thyroid carcinoma
336932|NCT01704586|PET/CT|pet/ct
336933|NCT01704586|Radioiodine Remnant Ablation|radioiodine remnant ablation
336934|NCT01704586|I-124|i-124
336935|NCT01704586|Quality of life|quality of life
336936|NCT01704573|PET Scan|pet scan
336937|NCT01704547|Breast cancer|breast cancer
336938|NCT01704547|Lumpectomy|lumpectomy
336939|NCT01704547|Breast Irradiation|breast irradiation
336940|NCT01704534|Hidradenitis suppurativa|hidradenitis suppurativa
336941|NCT01704534|Acne ectopica|acne ectopica
336942|NCT01704534|Inverse acne|inverse acne
336943|NCT01704534|Ustekinumab|ustekinumab
336944|NCT01704534|Stelara|stelara
336945|NCT01704521|Hepatitis C|hepatitis c
336946|NCT01704521|HCV|hcv
336947|NCT01704521|Hemophilia|hemophilia
336948|NCT01704508|Falciparum malaria|falciparum malaria
336949|NCT01704508|children|children
336950|NCT01704508|treatment|treatment
336951|NCT01704495|Uncontrolled Asthma,|uncontrolled asthma,
336952|NCT01704495|Exacerbation,|exacerbation,
336953|NCT01704495|Safety|safety
336954|NCT01704469|Opioid induced hyperalgesia|opioid induced hyperalgesia
336955|NCT01704456|provoked vestibulodynia|provoked vestibulodynia
336956|NCT01704456|dyspareunia|dyspareunia
336957|NCT01704456|vulvodynia|vulvodynia
336958|NCT01704456|mindfulness|mindfulness
336959|NCT01704456|cognitive behavioural therapy|cognitive behavioural therapy
336960|NCT01704443|provoked vestibulodynia|provoked vestibulodynia
336961|NCT01704443|dyspareunia|dyspareunia
336962|NCT01704443|vulvodynia|vulvodynia
336963|NCT01704443|mindfulness|mindfulness
336964|NCT01704443|cognitive behavioural therapy|cognitive behavioural therapy
336965|NCT01704430|Cardiac surgery|cardiac surgery
336966|NCT01704430|Cardiac bypass|cardiac bypass
336967|NCT01704430|Intensive Care|intensive care
336968|NCT01704430|Nosocomial infection|nosocomial infection
336969|NCT01704430|Glutamine|glutamine
336970|NCT01704430|Randomized trial|randomized trial
336971|NCT01704404|Long acting muscarinic antagonist|long acting muscarinic antagonist
336972|NCT01704404|Chronic Bronchitis|chronic bronchitis
336973|NCT01704404|Emphysema|emphysema
336974|NCT01704404|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
336976|NCT01704352|Cognitive Behavioral Therapy|cognitive behavioral therapy
336977|NCT01704352|CBT-I|cbt-i
336978|NCT01704339|End stage renal failure|end stage renal failure
336979|NCT01704339|Neuropathic pain|neuropathic pain
336980|NCT01704339|Critical digital ischaemia|critical digital ischaemia
336981|NCT01704326|Deuce|deuce
336982|NCT01704326|Journey Deuce|journey deuce
336983|NCT01704326|Knee pain|knee pain
336984|NCT01704326|Osteoarthritis|osteoarthritis
336985|NCT01704326|Bicompartmental|bicompartmental
336986|NCT01704326|Femoral|femoral
336987|NCT01704326|Medial|medial
336988|NCT01704313|Vascular access|vascular access
336989|NCT01704313|Haemodialysis|haemodialysis
336990|NCT01704313|Suturing technique|suturing technique
336991|NCT01704300|Abdominal aortic aneurysm|abdominal aortic aneurysm
336992|NCT01704300|Acute Myocardial Infarction|acute myocardial infarction
336993|NCT01704300|Coronary heart disease not otherwise specified|coronary heart disease not otherwise specified
336994|NCT01704300|Haemorrhagic stroke|haemorrhagic stroke
336995|NCT01704300|Heart failure|heart failure
336996|NCT01704300|Ischaemic stroke|ischaemic stroke
336997|NCT01704300|Peripheral arterial disease|peripheral arterial disease
336998|NCT01704300|Stable angina|stable angina
337489|NCT01702285|Open-Label|open-label
336999|NCT01704300|Unheralded coronary death|unheralded coronary death
337000|NCT01704300|Unstable angina|unstable angina
337001|NCT01704300|Ventricular arrhythmias, cardiac arrest and sudden cardiac death|ventricular arrhythmias, cardiac arrest and sudden cardiac death
337002|NCT01704300|Transient Ischemic Attack|transient ischemic attack
337003|NCT01704287|PD-1|pd-1
337004|NCT01704287|PD1|pd1
337005|NCT01704287|PD-L1|pd-l1
337006|NCT01704287|PDL1|pdl1
337007|NCT01704274|biochemical|biochemical
337008|NCT01704274|recurrence|recurrence
337009|NCT01704274|prostate|prostate
337010|NCT01704274|cancer|cancer
337011|NCT01704274|active|active
337012|NCT01704274|surveillence|surveillence
337013|NCT01704248|eye drops self-instillation|eye drops self-instillation
337014|NCT01704235|screening|screening
337015|NCT01704222|Children|children
337016|NCT01704222|nursery|nursery
337017|NCT01704222|CMV|cmv
337018|NCT01704222|Infection|infection
337019|NCT01704183|relapse-remitting multiple sclerosis|relapse-remitting multiple sclerosis
337020|NCT01704183|heart rate variability|heart rate variability
337021|NCT01704183|fingolimod|fingolimod
337022|NCT01704183|cardiac autonomic regulation|cardiac autonomic regulation
337023|NCT01704157|Osteoarthritis|osteoarthritis
337024|NCT01704157|knee|knee
337025|NCT01704157|chronic pain|chronic pain
337026|NCT01704144|Efavirenz|efavirenz
337027|NCT01704144|rifampin|rifampin
337028|NCT01704144|Pharmacokinetics|pharmacokinetics
337029|NCT01704144|Drug-drug interactions|drug-drug interactions
337030|NCT01704144|Drug-gene interactions|drug-gene interactions
337031|NCT01704144|Children|children
337032|NCT01704131|Levosimendan|levosimendan
337033|NCT01704131|Children|children
337034|NCT01704131|Pharmacokinetics|pharmacokinetics
337035|NCT01704118|I-gel|i-gel
337036|NCT01704118|ProSeal laryngeal mask|proseal laryngeal mask
337037|NCT01704118|small infants|small infants
337038|NCT01704118|neonates|neonates
337039|NCT01704105|Chlorine water treatment|chlorine water treatment
337040|NCT01704105|Point-of-use water treatment|point-of-use water treatment
337041|NCT01704105|Household water treatment with safe storage|household water treatment with safe storage
337042|NCT01704105|Handwashing with soap|handwashing with soap
337043|NCT01704105|Hand hygiene|hand hygiene
337044|NCT01704105|Latrines|latrines
337045|NCT01704105|Water|water
337046|NCT01704105|Sanitation|sanitation
337047|NCT01704105|Handwashing|handwashing
337048|NCT01704105|Breast Feeding|breast feeding
337049|NCT01704105|Complementary Feeding|complementary feeding
337050|NCT01704105|Micronutrients|micronutrients
337051|NCT01704105|Malnutrition|malnutrition
337052|NCT01704105|Nutrition Disorders|nutrition disorders
337053|NCT01704105|Diarrhea|diarrhea
337054|NCT01704105|Child Development|child development
337055|NCT01704105|Child potties|child potties
337056|NCT01704105|Point-of-use fortification|point-of-use fortification
337057|NCT01704105|Lipid-based nutrient supplement|lipid-based nutrient supplement
337058|NCT01704105|Exclusive breastfeeding|exclusive breastfeeding
337059|NCT01704105|Environmental enteropathy|environmental enteropathy
337060|NCT01704105|Tropical enteropathy|tropical enteropathy
337061|NCT01704105|Gut function|gut function
337062|NCT01704105|Intestinal parasitic infection|intestinal parasitic infection
337063|NCT01704105|Soil transmitted helminths|soil transmitted helminths
337064|NCT01704105|Intestinal protozoans|intestinal protozoans
337065|NCT01704105|Antibody response|antibody response
337066|NCT01704079|Parathyroid Diseases|parathyroid diseases
337067|NCT01704079|Renal Insufficiency|renal insufficiency
337068|NCT01704079|Kidney Failure, Chronic|kidney failure, chronic
337069|NCT01704079|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
337070|NCT01704079|Vitamin D|vitamin d
337071|NCT01704079|Hyperparathyroidism|hyperparathyroidism
337072|NCT01704079|Kidney Diseases|kidney diseases
337073|NCT01704079|Kidney Failure|kidney failure
337074|NCT01704079|Renal Insufficiency, Chronic|renal insufficiency, chronic
337075|NCT01704066|ARDS|ards
337076|NCT01704066|Chest radiograph|chest radiograph
337077|NCT01704066|Berlin Definition|berlin definition
337078|NCT01704066|Inter-observer agreement|inter-observer agreement
337079|NCT01704053|New Oral Anticoagulants|new oral anticoagulants
337080|NCT01704053|Dabigatran|dabigatran
337081|NCT01704053|Rivaroxaban|rivaroxaban
337082|NCT01704053|Thrombelastometry/-graphy (ROTEM, TEG)|thrombelastometry/-graphy (rotem, teg)
337083|NCT01704053|Multiple Platelet Function Analyzer (Multiplate)|multiple platelet function analyzer (multiplate)
337084|NCT01704040|Healthy volunteers and asthma|healthy volunteers and asthma
337085|NCT01704040|CNTO 3157|cnto 3157
337086|NCT01704040|Rhinovirus|rhinovirus
337087|NCT01704027|Localized|localized
337088|NCT01704027|High risk|high risk
337089|NCT01704014|occurrence of|occurrence of
337090|NCT01704001|ART-123|art-123
337091|NCT01704001|Disseminated Intravascular Coagulation|disseminated intravascular coagulation
337092|NCT01704001|Pharmacokinetics|pharmacokinetics
337093|NCT01703988|Spinal Muscular Atrophy|spinal muscular atrophy
337094|NCT01703988|SMA|sma
337095|NCT01703988|SMN|smn
337096|NCT01703988|SMNRx|smnrx
337097|NCT01703988|ISIS-SMNRx|isis-smnrx
337099|NCT01703975|Simulation efficiency|simulation efficiency
337100|NCT01703975|Collaborative learning|collaborative learning
337101|NCT01703962|Glioma|glioma
337102|NCT01703962|IDH1|idh1
337103|NCT01703962|Spectroscopy|spectroscopy
337104|NCT01703962|Plasma|plasma
337105|NCT01703936|economic intervention|economic intervention
337106|NCT01703936|ex-combatant|ex-combatant
337107|NCT01703936|agriculture|agriculture
337108|NCT01703936|life skills|life skills
337109|NCT01703910|Genomic expression profile in tumor samples|genomic expression profile in tumor samples
337110|NCT01703910|Adult patients|adult patients
337111|NCT01703910|metastatic disease status and progression after two lines of systemic therapy|metastatic disease status and progression after two lines of systemic therapy
337112|NCT01703897|gastric by-pass surgery|gastric by-pass surgery
337113|NCT01703884|Malria diagnosis|malria diagnosis
337114|NCT01703884|Malaria prevention in pregnancy|malaria prevention in pregnancy
337115|NCT01703884|ANC services improvement|anc services improvement
337116|NCT01703832|acute stress reaction|acute stress reaction
337117|NCT01703832|stress|stress
337118|NCT01703832|stress perception|stress perception
337119|NCT01703832|physiological stress response|physiological stress response
337120|NCT01703832|Neurexan|neurexan
337121|NCT01703819|acute stress reaction|acute stress reaction
337122|NCT01703819|stress|stress
337123|NCT01703819|stress perception|stress perception
337124|NCT01703819|physiological stress response|physiological stress response
337125|NCT01703819|Neurexan|neurexan
337126|NCT01703806|Mitral regurgitation|mitral regurgitation
337127|NCT01703806|Mitral valve repair|mitral valve repair
337128|NCT01703806|Watchful waiting|watchful waiting
337129|NCT01703767|patient satisfaction|patient satisfaction
337130|NCT01703767|Gulf War 1 Veteran|gulf war 1 veteran
337131|NCT01703767|Desert Storm Veteran|desert storm veteran
337132|NCT01703754|Genetically Modified Organism|genetically modified organism
337133|NCT01703754|Metastatic Breast Cancer|metastatic breast cancer
337134|NCT01703754|Recurrent Breast Cancer|recurrent breast cancer
337135|NCT01703754|Breast Cancer|breast cancer
337136|NCT01703754|Palifosfamide|palifosfamide
337137|NCT01703754|INXN1001|inxn1001
337138|NCT01703754|INXN2001|inxn2001
337139|NCT01703754|Adenoviral vector|adenoviral vector
337140|NCT01703715|Hydration|hydration
337141|NCT01703715|Elderly patients|elderly patients
337142|NCT01703715|Age 65 years and over|age 65 years and over
337143|NCT01703715|Admitted acutely to medical admissions ward|admitted acutely to medical admissions ward
337144|NCT01703689|Quality indicators|quality indicators
337145|NCT01703689|quality of care|quality of care
337146|NCT01703689|nursing home|nursing home
337147|NCT01703689|long-term care unit|long-term care unit
337148|NCT01703689|nursing home organisation|nursing home organisation
337149|NCT01703689|nursing home structure|nursing home structure
337150|NCT01703689|disability|disability
337151|NCT01703689|dependence|dependence
337152|NCT01703689|functional decline|functional decline
337153|NCT01703689|functional impairment|functional impairment
337154|NCT01703689|older adults|older adults
337155|NCT01703689|elderly|elderly
337156|NCT01703689|audit and feedback|audit and feedback
337157|NCT01703689|cooperative work|cooperative work
337158|NCT01703689|geriatrician|geriatrician
337159|NCT01703689|medication|medication
337160|NCT01703689|hospitalisation|hospitalisation
337161|NCT01703689|comorbidity|comorbidity
337162|NCT01703676|Hypogonadism, Klinefelter Syndrome, Cardiovascular Risk, Epigenetics, Methylation of Genes|hypogonadism, klinefelter syndrome, cardiovascular risk, epigenetics, methylation of genes
337163|NCT01703676|Cardiovascular risk factors|cardiovascular risk factors
337164|NCT01703676|Gonadal status|gonadal status
337165|NCT01703676|Gene expression|gene expression
337166|NCT01703676|Methylation|methylation
337167|NCT01703663|Stroke|stroke
337168|NCT01703663|Sleep Apnea|sleep apnea
337169|NCT01703650|CT|ct
337170|NCT01703650|pancreas adenocarcinoma|pancreas adenocarcinoma
337171|NCT01703650|RECIST|recist
337172|NCT01703650|perfusion|perfusion
337173|NCT01703637|Sitagliptin|sitagliptin
337174|NCT01703637|Vildagliptin|vildagliptin
337175|NCT01703637|Saxagliptin|saxagliptin
337176|NCT01703637|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
337177|NCT01703624|glycopyrronium bromide|glycopyrronium bromide
337178|NCT01703624|glycopyrrolate|glycopyrrolate
337179|NCT01703624|oral inhalation|oral inhalation
337180|NCT01703624|COPD|copd
337181|NCT01703624|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
337182|NCT01703624|lung function|lung function
337183|NCT01703624|pharmacokinetics|pharmacokinetics
337184|NCT01703624|tolerability|tolerability
337185|NCT01703624|safety|safety
337186|NCT01703624|cross-over|cross-over
337187|NCT01703624|single-dose|single-dose
337188|NCT01703624|dose-ranging|dose-ranging
337189|NCT01703611|Nutrition|nutrition
337190|NCT01703611|Medical Nutrition Therapy|medical nutrition therapy
337191|NCT01703611|Diabetes Mellitus|diabetes mellitus
337192|NCT01703611|Nutrition outcomes|nutrition outcomes
337193|NCT01703611|Evidence Based Guidelines|evidence based guidelines
337194|NCT01703598|Parkinson's disease|parkinson's disease
337195|NCT01703598|Deep Brain Stimulation|deep brain stimulation
337196|NCT01703585|genomic analysis|genomic analysis
337197|NCT01703585|genome|genome
337198|NCT01703585|tumor|tumor
337199|NCT01703585|tissue|tissue
337200|NCT01703585|archival|archival
337201|NCT01703585|biopsy|biopsy
337202|NCT01703585|core needle|core needle
337203|NCT01703585|fine needle|fine needle
337204|NCT01703585|DNA|dna
337205|NCT01703585|gene|gene
337206|NCT01703585|expression|expression
337207|NCT01703585|sequencing|sequencing
337208|NCT01703572|Phase 1|phase 1
337209|NCT01703572|Dose escalation|dose escalation
337210|NCT01703572|relapsed or refractory|relapsed or refractory
337211|NCT01703572|lymphoid malignancies|lymphoid malignancies
337212|NCT01703559|Glare|glare
337213|NCT01703559|Starburst|starburst
337214|NCT01703559|Halos|halos
337215|NCT01703559|Reduced contrast sensitivity|reduced contrast sensitivity
337216|NCT01703546|Morbid Obesity|morbid obesity
337217|NCT01703546|Weight Loss Surgery|weight loss surgery
337218|NCT01703546|Laparoscopic Adjustable Gastric Band|laparoscopic adjustable gastric band
337219|NCT01703546|Laparoscopic Gastric Plication|laparoscopic gastric plication
337220|NCT01703546|Imbrication|imbrication
337221|NCT01703533|Autism|autism
337222|NCT01703533|Rett's Syndrome|rett's syndrome
337223|NCT01703533|Rett Disorder|rett disorder
337224|NCT01703533|Rett's Disorder|rett's disorder
337225|NCT01703533|Ataxia|ataxia
337226|NCT01703520|Males breast cancer|males breast cancer
337227|NCT01703520|Finasteride|finasteride
337228|NCT01703520|PROSCAR®|proscar®
337229|NCT01703520|PROPECIA®|propecia®
337230|NCT01703494|C. difficile|c. difficile
337231|NCT01703494|fecal transplant|fecal transplant
337232|NCT01703494|stool transplant|stool transplant
337233|NCT01703494|fecal flora reconstitution|fecal flora reconstitution
337234|NCT01703494|fecal microbiota transplant|fecal microbiota transplant
337235|NCT01703494|FMT|fmt
337236|NCT01703481|Tumor|tumor
337237|NCT01703481|Fibroblast Growth Factor Receptor (FGFR)|fibroblast growth factor receptor (fgfr)
337238|NCT01703481|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
337239|NCT01703481|Small Cell Lung Cancer (SCLC)|small cell lung cancer (sclc)
337240|NCT01703481|JNJ-42756493|jnj-42756493
337241|NCT01703455|Salivary gland cancer metastatic disease recurrent disease clinical trial|salivary gland cancer metastatic disease recurrent disease clinical trial
337242|NCT01703429|Multiple Sclerosis|multiple sclerosis
337243|NCT01703429|MS|ms
337244|NCT01703429|Complementary and Alternative|complementary and alternative
337245|NCT01703429|CAM|cam
337246|NCT01703416|COPD|copd
337247|NCT01703416|GOLD group C and D|gold group c and d
337248|NCT01703416|CDLM questionnaire|cdlm questionnaire
337249|NCT01703416|visual scale - physician evaluation|visual scale - physician evaluation
337250|NCT01703403|physical therapy|physical therapy
337251|NCT01703403|treated at NTUH and received rehabilitation at the PTC in recent ten years.|treated at ntuh and received rehabilitation at the ptc in recent ten years.
337252|NCT01703390|metastatic colorectal cancer|metastatic colorectal cancer
337253|NCT01703390|mCRC|mcrc
337254|NCT01703390|ERCC-1|ercc-1
337255|NCT01703390|ERCC1|ercc1
337256|NCT01703390|AGMT|agmt
337257|NCT01703364|CLL|cll
337258|NCT01703364|Lenalidomide|lenalidomide
337259|NCT01703364|Revlimid|revlimid
337260|NCT01703364|AGMT|agmt
337261|NCT01703364|T cell|t cell
337262|NCT01703351|pain control, VATS|pain control, vats
337263|NCT01703338|assessment model|assessment model
337264|NCT01703338|biomechanical changes|biomechanical changes
337265|NCT01703338|functional activities|functional activities
337266|NCT01703338|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
337267|NCT01703338|causal relationship|causal relationship
337268|NCT01703338|core muscles activation pattern|core muscles activation pattern
337269|NCT01703338|pathological changes|pathological changes
337270|NCT01703338|early rehabilitation|early rehabilitation
337271|NCT01703338|core stability exercise|core stability exercise
337272|NCT01703338|minimally invasive lumbar spinal fusion surgery|minimally invasive lumbar spinal fusion surgery
337273|NCT01703325|Psoriatic nails|psoriatic nails
337274|NCT01703325|Triamcinolone injection|triamcinolone injection
337275|NCT01703325|clobetasol propionate|clobetasol propionate
337276|NCT01703312|Allergies, asthma, IgE|allergies, asthma, ige
337277|NCT01703299|imipenem|imipenem
337278|NCT01703299|ertapenem|ertapenem
337279|NCT01703299|resistance|resistance
337280|NCT01703299|commensal flora|commensal flora
337281|NCT01703273|Extreme Obesity Keywords: obesity, adiposity, psychosocial, healthcare, co-morbidities, low key intervention, quality of life|extreme obesity keywords: obesity, adiposity, psychosocial, healthcare, co-morbidities, low key intervention, quality of life
337282|NCT01703260|Drug therapy|drug therapy
337283|NCT01703247|Arrhythmias|arrhythmias
337284|NCT01703247|Ablation|ablation
337285|NCT01703234|FGF-23 , ramipril, endothelial dysfunction|fgf-23 , ramipril, endothelial dysfunction
337286|NCT01703195|Vaginal Cancer|vaginal cancer
337287|NCT01703195|Malignancies involving the vagina|malignancies involving the vagina
337288|NCT01703195|Middle third and the distal third of the vagina|middle third and the distal third of the vagina
337289|NCT01703195|Pre and post radiation therapy|pre and post radiation therapy
337490|NCT01702285|Dose-Escalation|dose-escalation
337290|NCT01703195|Diffusion weighted magnetic resonance imaging|diffusion weighted magnetic resonance imaging
337291|NCT01703195|DWMR|dwmr
337292|NCT01703195|Magnetic resonance imaging|magnetic resonance imaging
337293|NCT01703195|MRI|mri
337294|NCT01703195|Tumor involvement|tumor involvement
337295|NCT01703195|Response to radiation therapy|response to radiation therapy
337296|NCT01703195|XRT|xrt
337297|NCT01703182|transcutaneous oximetry|transcutaneous oximetry
337298|NCT01703182|transcutaneous carbon dioxide|transcutaneous carbon dioxide
337299|NCT01703182|leg amputation|leg amputation
337300|NCT01703182|wound healing failure|wound healing failure
337301|NCT01703182|amputation revision|amputation revision
337302|NCT01703169|severe aplastic anemia|severe aplastic anemia
337303|NCT01703169|very severe aplastic anemia|very severe aplastic anemia
337304|NCT01703169|moderate aplastic anemia|moderate aplastic anemia
337305|NCT01703169|bleeding|bleeding
337306|NCT01703156|Low Risk ACS, Acute Coronary Syndrome, Stress Testing, Non-Stress Testing|low risk acs, acute coronary syndrome, stress testing, non-stress testing
337307|NCT01703130|ISPB|ispb
337308|NCT01703130|Brachial Plexus Block|brachial plexus block
337309|NCT01703130|Anesthesia|anesthesia
337310|NCT01703130|Pain Management|pain management
337311|NCT01703130|Surgery|surgery
337312|NCT01703117|Alzheimer's Disease|alzheimer's disease
337313|NCT01703117|Dementia|dementia
337314|NCT01703104|Sorghum bicolor|sorghum bicolor
337315|NCT01703104|sickle cell anaemia|sickle cell anaemia
337316|NCT01703104|haematological parameters|haematological parameters
337317|NCT01703065|Prostate cancer|prostate cancer
337318|NCT01703065|Bone metastases|bone metastases
337319|NCT01703039|Major Depression|major depression
337320|NCT01703039|Major Depressive Disorder|major depressive disorder
337321|NCT01703039|Depression|depression
337322|NCT01703039|Riluzole|riluzole
337323|NCT01703039|Glutamate|glutamate
337324|NCT01703039|Sertraline|sertraline
337325|NCT01703013|Demonstrate that DEFA4 is a reliable biomarker for the prediction of adrenal insufficiency|demonstrate that defa4 is a reliable biomarker for the prediction of adrenal insufficiency
337326|NCT01703000|drug eluting coronary stent|drug eluting coronary stent
337327|NCT01702987|ubiquinol (coenzyme Q10)|ubiquinol (coenzyme q10)
337328|NCT01702974|HIV|hiv
337329|NCT01702974|cholecalciferol|cholecalciferol
337330|NCT01702974|sodium phenylbutyrate|sodium phenylbutyrate
337331|NCT01702974|antimicrobial peptides|antimicrobial peptides
337332|NCT01702974|immune response|immune response
337333|NCT01702974|inflammation|inflammation
337334|NCT01702961|Lymphoma|lymphoma
337335|NCT01702961|Hodgkin's Disease|hodgkin's disease
337336|NCT01702948|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
337337|NCT01702948|Nicotine|nicotine
337338|NCT01702948|Repetitive TMS (rTMS)|repetitive tms (rtms)
337339|NCT01702948|fMRI|fmri
337340|NCT01702935|Ovarian Failure|ovarian failure
337341|NCT01702935|Premature Ovarian Failure|premature ovarian failure
337342|NCT01702935|Infertility|infertility
337343|NCT01702935|Primary Ovarian Insufficiency|primary ovarian insufficiency
337344|NCT01702935|Stem Cells|stem cells
337345|NCT01702922|Stress|stress
337346|NCT01702922|Marriage|marriage
337347|NCT01702922|Dyadic Coping|dyadic coping
337348|NCT01702922|Mother|mother
337349|NCT01702922|Father|father
337350|NCT01702909|Metastatic Renal Cell|metastatic renal cell
337351|NCT01702909|Metastatic Kidney Cancer|metastatic kidney cancer
337352|NCT01702896|Metastatic Melanoma|metastatic melanoma
337353|NCT01702883|prescriptions|prescriptions
337354|NCT01702883|hypertension|hypertension
337355|NCT01702883|high cholesterol|high cholesterol
337356|NCT01702883|diabetes|diabetes
337357|NCT01702883|depression|depression
337358|NCT01702883|adherence|adherence
337359|NCT01702870|Magnetic resonance imaging|magnetic resonance imaging
337360|NCT01702857|Dengue|dengue
337361|NCT01702857|Dengue fever|dengue fever
337362|NCT01702857|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
337363|NCT01702857|Flavivirus|flavivirus
337364|NCT01702844|Nab paclitaxel|nab paclitaxel
337365|NCT01702844|Abraxane|abraxane
337366|NCT01702844|First Line|first line
337367|NCT01702844|Non small cell lung cancer|non small cell lung cancer
337368|NCT01702844|NSCLC|nsclc
337369|NCT01702844|Phase II|phase ii
337370|NCT01702844|Non-Randomized|non-randomized
337371|NCT01702844|Elderly|elderly
337372|NCT01702844|Lineberger|lineberger
337373|NCT01702844|UNC|unc
337374|NCT01702844|LCCC 1210|lccc 1210
337375|NCT01702831|Newly Diagnosed multiple myeloma|newly diagnosed multiple myeloma
337376|NCT01702818|Hypoactive Sexual Desire Disorder|hypoactive sexual desire disorder
337377|NCT01702818|HSDD|hsdd
337378|NCT01702818|Cortisol|cortisol
337379|NCT01702818|DHEA|dhea
337380|NCT01702818|Stress Hormones|stress hormones
337381|NCT01702818|Sexual Desire|sexual desire
337382|NCT01702818|Mood|mood
337383|NCT01702818|Sexual Function|sexual function
337384|NCT01702818|Childhood Maltreatment|childhood maltreatment
337385|NCT01702818|Childhood Abuse|childhood abuse
337386|NCT01702805|NICHD Neonatal Research Network|nichd neonatal research network
337387|NCT01702805|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
337388|NCT01702805|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
337389|NCT01702805|Transfusions|transfusions
337390|NCT01702792|Immunotherapy, cancer vaccine, glioblastoma, hybridoma|immunotherapy, cancer vaccine, glioblastoma, hybridoma
337391|NCT01702779|Weaning from mechanical ventilation|weaning from mechanical ventilation
337392|NCT01702779|Lung ultrasound|lung ultrasound
337393|NCT01702779|Oxygen inhalation therapy|oxygen inhalation therapy
337394|NCT01702740|Cutaneous lupus erythematosus|cutaneous lupus erythematosus
337395|NCT01702740|Systemic lupus erythematosus|systemic lupus erythematosus
337396|NCT01702740|Lupus erythematosus|lupus erythematosus
337397|NCT01702740|Human anti-IL 6 monoclonal antibody|human anti-il 6 monoclonal antibody
337398|NCT01702740|Sirukumab|sirukumab
337399|NCT01702727|Amblyopia|amblyopia
337400|NCT01702727|I-BiT TM|i-bit tm
337401|NCT01702727|Interactive games|interactive games
337402|NCT01702727|Binocular|binocular
337403|NCT01702675|Safety|safety
337404|NCT01702675|Pharmacokinetics|pharmacokinetics
337405|NCT01702675|Tolerability|tolerability
337406|NCT01702675|Healthy men|healthy men
337407|NCT01702636|Intracerebral Hemorrhage|intracerebral hemorrhage
337408|NCT01702636|ICH|ich
337409|NCT01702636|Stroke|stroke
337410|NCT01702636|Cerebrovascular Disorders|cerebrovascular disorders
337411|NCT01702636|Brain Diseases|brain diseases
337412|NCT01702636|Central Nervous System Diseases|central nervous system diseases
337413|NCT01702636|Nervous System Diseases|nervous system diseases
337414|NCT01702636|Vascular Diseases|vascular diseases
337415|NCT01702636|Cardiovascular Diseases|cardiovascular diseases
337416|NCT01702636|Tranexamic Acid|tranexamic acid
337417|NCT01702636|Antifibrinolytic Agents|antifibrinolytic agents
337418|NCT01702636|Fibrin Modulating Agents|fibrin modulating agents
337419|NCT01702636|Pharmacologic Actions|pharmacologic actions
337420|NCT01702636|Cardiovascular Agents|cardiovascular agents
337421|NCT01702636|Therapeutic Uses|therapeutic uses
337422|NCT01702636|Hematologic Agents|hematologic agents
337423|NCT01702636|Hemostatics|hemostatics
337424|NCT01702636|Contrast Media|contrast media
337425|NCT01702636|Angiography|angiography
337426|NCT01702636|Cerebral Angiography|cerebral angiography
337427|NCT01702636|Tomography, X-Ray Computed|tomography, x-ray computed
337428|NCT01702584|stent|stent
337429|NCT01702584|intracranial aneurysm|intracranial aneurysm
337430|NCT01702584|embolization|embolization
337431|NCT01702584|adverse event|adverse event
337432|NCT01702532|provoked craving|provoked craving
337433|NCT01702506|Dacomitinib|dacomitinib
337434|NCT01702506|PF-00299804|pf-00299804
337435|NCT01702506|fed|fed
337436|NCT01702506|fasted|fasted
337437|NCT01702506|antacid|antacid
337438|NCT01702506|relative Bioavailability|relative bioavailability
337439|NCT01702493|SRT2104|srt2104
337440|NCT01702493|Modified Release|modified release
337441|NCT01702493|Bioavailability|bioavailability
337442|NCT01702493|Crossover|crossover
337443|NCT01702480|Consumer Healthcare|consumer healthcare
337444|NCT01702480|Ketones|ketones
337445|NCT01702480|Medium Chain Triglycerides|medium chain triglycerides
337446|NCT01702480|Age related cognitive decline|age related cognitive decline
337447|NCT01702480|GSK Nutrition|gsk nutrition
337448|NCT01702467|Lp-PLA2|lp-pla2
337449|NCT01702467|Alzheimer's disease|alzheimer's disease
337450|NCT01702454|GSK Biologicals quadrivalent influenza vaccine|gsk biologicals quadrivalent influenza vaccine
337451|NCT01702454|Influenza|influenza
337452|NCT01702454|Children|children
337453|NCT01702454|Safety|safety
337454|NCT01702454|Immunogenicity|immunogenicity
337455|NCT01702428|Safety|safety
337456|NCT01702428|Consistency study|consistency study
337457|NCT01702428|Measles, mumps and rubella diseases|measles, mumps and rubella diseases
337458|NCT01702428|Healthy children|healthy children
337459|NCT01702428|Immunogenicity|immunogenicity
337460|NCT01702415|Cystic fibrosis|cystic fibrosis
337461|NCT01702415|Bone density|bone density
337462|NCT01702402|intervention|intervention
337463|NCT01702389|opioid induced hyperalgesia|opioid induced hyperalgesia
337464|NCT01702389|Pain|pain
337465|NCT01702389|Postoperative pain|postoperative pain
337466|NCT01702389|Hyperalgesia|hyperalgesia
337467|NCT01702363|Chronic Obstructive Pulmonary Disease (COPD), GSK573719, Pharmacogenetics|chronic obstructive pulmonary disease (copd), gsk573719, pharmacogenetics
337468|NCT01702350|Healthy Subjects|healthy subjects
337469|NCT01702350|Relative Bioavailability|relative bioavailability
337470|NCT01702350|Pharmacokinetics|pharmacokinetics
337471|NCT01702350|Elderly Subjects|elderly subjects
337472|NCT01702337|Gardasil|gardasil
337473|NCT01702337|Prevalence-model|prevalence-model
337474|NCT01702337|Cervarix|cervarix
337475|NCT01702337|economic|economic
337476|NCT01702337|health|health
337477|NCT01702324|Psoriasis Vulgaris|psoriasis vulgaris
337478|NCT01702324|Plaque|plaque
337479|NCT01702324|Topical|topical
337480|NCT01702324|Treatment|treatment
337481|NCT01702311|Diabetes|diabetes
337482|NCT01702311|Point of care testing|point of care testing
337483|NCT01702311|Hypoglycemia|hypoglycemia
337484|NCT01702311|Basal bolus insulin|basal bolus insulin
337485|NCT01702285|Advanced Solid Tumors|advanced solid tumors
337486|NCT01702285|EGFR|egfr
337491|NCT01702246|sickle cell disease|sickle cell disease
337492|NCT01702246|statins|statins
337493|NCT01702246|vaso-occlusive pain|vaso-occlusive pain
337494|NCT01702246|inflammation|inflammation
337495|NCT01702246|biomarkers|biomarkers
337496|NCT01702220|Generalized Anxiety Disorder|generalized anxiety disorder
337497|NCT01702220|Geriatric|geriatric
337498|NCT01702207|Prograf®|prograf®
337499|NCT01702207|Advagraf®|advagraf®
337500|NCT01702207|tacrolimus|tacrolimus
337501|NCT01702207|kidney transplant|kidney transplant
337502|NCT01702207|renal transplant|renal transplant
337503|NCT01702207|cardiovascular risk|cardiovascular risk
337504|NCT01702207|Framingham Risk|framingham risk
337505|NCT01702207|Reynolds Risk|reynolds risk
337506|NCT01702207|immunosuppression|immunosuppression
337507|NCT01702194|OIC|oic
337508|NCT01702194|Opioid Induced Constipation|opioid induced constipation
337509|NCT01702194|Constipation|constipation
337510|NCT01702181|Atopic Dermatitis, Eczema|atopic dermatitis, eczema
337511|NCT01702168|PTSD|ptsd
337512|NCT01702168|EBT|ebt
337513|NCT01702168|EST|est
337514|NCT01702168|Community|community
337515|NCT01702168|Latino|latino
337516|NCT01702142|Addiction Treatment|addiction treatment
337517|NCT01702129|EGFR|egfr
337518|NCT01702129|liposomes|liposomes
337519|NCT01702129|immunoliposomes|immunoliposomes
337520|NCT01702116|rectal adenocarcinoma|rectal adenocarcinoma
337521|NCT01702116|Standard APR|standard apr
337522|NCT01702116|Extralevator APR|extralevator apr
337523|NCT01702090|HIV-1|hiv-1
337524|NCT01702090|TMC114|tmc114
337525|NCT01702090|Darunavir|darunavir
337526|NCT01702090|PREZISTA|prezista
337527|NCT01702090|Ritonavir|ritonavir
337528|NCT01702090|Antiretrovirals|antiretrovirals
337529|NCT01702090|Early access|early access
337530|NCT01702090|Early treatment|early treatment
337531|NCT01702090|Treatment naive|treatment naive
337532|NCT01702077|neurofeedback|neurofeedback
337533|NCT01702077|biofeedback|biofeedback
337534|NCT01702077|real-time fMRI|real-time fmri
337535|NCT01702077|rt-fMRI|rt-fmri
337536|NCT01702077|functional connectivity|functional connectivity
337537|NCT01702077|fMRI|fmri
337538|NCT01702064|CML|cml
337539|NCT01702064|CP-CML|cp-cml
337540|NCT01702064|Chronic Phase-CML (CP-CML)|chronic phase-cml (cp-cml)
337541|NCT01702064|chronic myeloid leukemia|chronic myeloid leukemia
337542|NCT01702051|Pancreatogenic diabetes|pancreatogenic diabetes
337543|NCT01702051|Autologou Islet Transplantation|autologou islet transplantation
337544|NCT01702051|Pancreas|pancreas
337545|NCT01702051|Pancreatectomy|pancreatectomy
337546|NCT01702025|Hypoxia|hypoxia
337547|NCT01702025|Altitude|altitude
337548|NCT01702025|Exercise|exercise
337549|NCT01702012|Diabetes-Obesity|diabetes-obesity
337550|NCT01701999|Botulism Vaccine|botulism vaccine
337551|NCT01701986|Lymphoma|lymphoma
337552|NCT01701986|Aggressive lymphomas|aggressive lymphomas
337553|NCT01701986|Allogeneic stem-cell transplant|allogeneic stem-cell transplant
337554|NCT01701986|alloSCT|allosct
337555|NCT01701986|Refractory B-cell|refractory b-cell
337556|NCT01701986|T-cell|t-cell
337557|NCT01701986|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
337558|NCT01701986|Hodgkin's lymphoma|hodgkin's lymphoma
337559|NCT01701986|Gemcitabine|gemcitabine
337560|NCT01701986|Gemcitabine Hydrochloride|gemcitabine hydrochloride
337561|NCT01701986|Gemzar|gemzar
337562|NCT01701986|Clofarabine|clofarabine
337563|NCT01701986|Clofarex|clofarex
337564|NCT01701986|Clolar|clolar
337565|NCT01701986|Busulfan|busulfan
337566|NCT01701986|Busulfex|busulfex
337567|NCT01701986|Myleran|myleran
337568|NCT01701986|Anti-Thymocyte Globulin|anti-thymocyte globulin
337569|NCT01701986|ATG|atg
337570|NCT01701986|Thymoglobulin|thymoglobulin
337571|NCT01701986|Rituximab|rituximab
337572|NCT01701986|Rituxan|rituxan
337573|NCT01701986|Filgrastim|filgrastim
337574|NCT01701986|G-CSF|g-csf
337575|NCT01701986|Neupogen|neupogen
337576|NCT01701986|Tacrolimus|tacrolimus
337577|NCT01701986|Prograf|prograf
337578|NCT01701986|Mycophenolate Mofetil|mycophenolate mofetil
337579|NCT01701986|MMF|mmf
337580|NCT01701986|CellCept|cellcept
337581|NCT01701973|obesity|obesity
337582|NCT01701973|growth hormone|growth hormone
337583|NCT01701947|Factor XI deficiency|factor xi deficiency
337584|NCT01701947|EAP|eap
337585|NCT01701947|postpartum hemorrhage|postpartum hemorrhage
337586|NCT01701947|surgery|surgery
337587|NCT01701947|delivery|delivery
337588|NCT01701947|Child birth|child birth
337589|NCT01701934|COPD|copd
337590|NCT01701934|Intrabdominal adiposity|intrabdominal adiposity
337591|NCT01701934|Body composition|body composition
337592|NCT01701934|Triglycerides|triglycerides
337593|NCT01701934|Cholesterol|cholesterol
337594|NCT01701921|cardiac surgery|cardiac surgery
337595|NCT01701921|pregabalin|pregabalin
337596|NCT01701921|postoperative pain|postoperative pain
337597|NCT01701908|PPCs|ppcs
337598|NCT01701908|abdominal surgery|abdominal surgery
337599|NCT01701908|postoperative infections|postoperative infections
337600|NCT01701908|postoperative residual curarization|postoperative residual curarization
337601|NCT01701908|tracheal re-intubation|tracheal re-intubation
337602|NCT01701908|mortality|mortality
337603|NCT01701908|ICU stay|icu stay
337604|NCT01701895|Complera|complera
337605|NCT01701895|short-term|short-term
337606|NCT01701895|long-term|long-term
337607|NCT01701895|compliance|compliance
337608|NCT01701895|caloric|caloric
337609|NCT01701895|intake|intake
337611|NCT01701895|positive|positive
337612|NCT01701895|women|women
337613|NCT01701856|relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
337614|NCT01701856|natalizumab|natalizumab
337615|NCT01701856|de-escalation|de-escalation
337616|NCT01701856|interferon beta-1b|interferon beta-1b
337617|NCT01701830|omentin-1|omentin-1
337618|NCT01701830|carotid atherosclerosis|carotid atherosclerosis
337619|NCT01701830|kidney disease|kidney disease
337620|NCT01701817|Atrial Fibrillation|atrial fibrillation
337621|NCT01701817|Irregular heart beat|irregular heart beat
337622|NCT01701804|Failed Back Surgery Syndrome|failed back surgery syndrome
337623|NCT01701791|Depression|depression
337624|NCT01701791|Primary care|primary care
337625|NCT01701791|Computerized decision support system|computerized decision support system
337626|NCT01701791|General practitioner|general practitioner
337627|NCT01701778|Dexmedetomidine|dexmedetomidine
337628|NCT01701778|Postoperative pain reaction|postoperative pain reaction
337629|NCT01701778|anesthesia|anesthesia
337630|NCT01701778|children|children
337631|NCT01701765|Severe mental disorders|severe mental disorders
337632|NCT01701765|Discharge|discharge
337633|NCT01701765|Outcome evaluation|outcome evaluation
337634|NCT01701752|Influenza A|influenza a
337635|NCT01701726|Essential Hypertension|essential hypertension
337636|NCT01701726|Acupuncture|acupuncture
337637|NCT01701726|Specificity|specificity
337638|NCT01701726|Acupoints effect|acupoints effect
337639|NCT01701726|randomized controlled trials|randomized controlled trials
337640|NCT01701713|TDCS|tdcs
337641|NCT01701713|STROKE|stroke
337642|NCT01701713|APHASIA|aphasia
337643|NCT01701713|NAMING|naming
337644|NCT01701700|portable electronic magnifiers|portable electronic magnifiers
337645|NCT01701687|Cirrhosis|cirrhosis
337646|NCT01701687|Alcoholic liver disease|alcoholic liver disease
337647|NCT01701687|Decompensated liver cirrhosis|decompensated liver cirrhosis
337648|NCT01701687|Hazardous alcohol|hazardous alcohol
337649|NCT01701674|skin cancer|skin cancer
337650|NCT01701661|venous surgery|venous surgery
337651|NCT01701661|compression therapy|compression therapy
337652|NCT01701648|Vitiligo, amniotic membrane, malanocytes, C02 laser.|vitiligo, amniotic membrane, malanocytes, c02 laser.
337653|NCT01701635|Disclosure|disclosure
337654|NCT01701635|HIV-infected children|hiv-infected children
337655|NCT01701635|Resource-limited settings|resource-limited settings
337656|NCT01701622|Blood Pressure|blood pressure
337657|NCT01701622|Gout|gout
337658|NCT01701622|allopurinol|allopurinol
337659|NCT01701622|febuxostat|febuxostat
337660|NCT01701622|uric acid|uric acid
337661|NCT01701609|early-onset schizophrenia|early-onset schizophrenia
337662|NCT01701609|adolescents|adolescents
337663|NCT01701609|cognition|cognition
337664|NCT01701609|cognitive remediation therapy|cognitive remediation therapy
337665|NCT01701596|Rotational atherectomy|rotational atherectomy
337666|NCT01701596|Coronary dissection|coronary dissection
337667|NCT01701596|Percutaneous coronary intervention|percutaneous coronary intervention
337668|NCT01701596|Calcification|calcification
337669|NCT01701583|Chronic Idiopathic Urticaria|chronic idiopathic urticaria
337670|NCT01701583|CIU|ciu
337671|NCT01701583|Urticaria|urticaria
337672|NCT01701583|Chronic Hives|chronic hives
337673|NCT01701583|Xolair|xolair
337674|NCT01701570|Type 2 Diabetes|type 2 diabetes
337675|NCT01701570|Exercise|exercise
337676|NCT01701570|Rate of Perceived Exertion|rate of perceived exertion
337677|NCT01701557|Ketoacidosis Fluids|ketoacidosis fluids
337678|NCT01701518|Ozurdex|ozurdex
337679|NCT01701518|Dexamethasone|dexamethasone
337680|NCT01701518|Epiretinal membrane|epiretinal membrane
337681|NCT01701518|Macular edema|macular edema
337682|NCT01701505|operative|operative
337683|NCT01701505|dental procedure|dental procedure
337684|NCT01701492|pediatric|pediatric
337685|NCT01701492|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
337686|NCT01701492|allogeneic bone marrow transplantation|allogeneic bone marrow transplantation
337687|NCT01701479|Neuroblastoma|neuroblastoma
337688|NCT01701479|Refractory neuroblastoma|refractory neuroblastoma
337689|NCT01701479|Relapsed neuroblastoma|relapsed neuroblastoma
337690|NCT01701479|ch14.18/CHO|ch14.18/cho
337691|NCT01701479|Aldesleukin (IL-2)|aldesleukin (il-2)
337692|NCT01701466|Patients|patients
337693|NCT01701466|with|with
337694|NCT01701453|duration of DAPT|duration of dapt
337695|NCT01701427|Hyperalgesia|hyperalgesia
337696|NCT01701427|Persistent pain|persistent pain
337697|NCT01701427|deep pain|deep pain
337698|NCT01701427|electrical stimulation|electrical stimulation
337699|NCT01701427|groin hernia|groin hernia
337700|NCT01701414|Femur|femur
337701|NCT01701414|Hip|hip
337702|NCT01701414|Fracture|fracture
337703|NCT01701414|Femoral neck|femoral neck
337704|NCT01701414|Femoral head|femoral head
337705|NCT01701401|HCV genotype 1 (GT-1)|hcv genotype 1 (gt-1)
337706|NCT01701401|HCV|hcv
337707|NCT01701401|Sustained Virologic Response|sustained virologic response
337708|NCT01701401|Direct Acting Antiviral|direct acting antiviral
337709|NCT01701401|Combination Therapy|combination therapy
337710|NCT01701401|GS-7977|gs-7977
337711|NCT01701401|GS-5885|gs-5885
337712|NCT01701401|Ribavirin|ribavirin
337713|NCT01701401|Open Label|open label
337714|NCT01701401|Sofosbuvir|sofosbuvir
337715|NCT01701401|Additional relevant MeSH terms:|additional relevant mesh terms:
337716|NCT01701401|Hepatitis|hepatitis
337717|NCT01701401|Hepatitis, Chronic|hepatitis, chronic
337718|NCT01701401|Hepatitis C|hepatitis c
337719|NCT01701401|Hepatitis C, Chronic|hepatitis c, chronic
337720|NCT01701401|Liver Diseases|liver diseases
337721|NCT01701401|Digestive System Diseases|digestive system diseases
337722|NCT01701401|Hepatitis, Viral, Human|hepatitis, viral, human
337723|NCT01701401|Virus Diseases|virus diseases
337724|NCT01701401|Enterovirus Infections|enterovirus infections
337725|NCT01701401|Picornaviridae Infections|picornaviridae infections
337726|NCT01701401|RNA Virus Infections|rna virus infections
337727|NCT01701401|Flaviviridae Infections|flaviviridae infections
337728|NCT01701401|Antiviral Agents|antiviral agents
337729|NCT01701401|Anti-Infective Agents|anti-infective agents
337730|NCT01701401|Therapeutic Uses|therapeutic uses
337731|NCT01701401|Pharmacologic Actions|pharmacologic actions
337732|NCT01701401|Antimetabolites|antimetabolites
337733|NCT01701401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
337734|NCT01701388|Ekso|ekso
337735|NCT01701388|Exoskeleton|exoskeleton
337736|NCT01701388|Spinal Cord Injury|spinal cord injury
337737|NCT01701388|Motor Complete Incomplete|motor complete incomplete
337738|NCT01701362|post-traumatic peripheral neuropathic pain|post-traumatic peripheral neuropathic pain
337739|NCT01701349|ATC|atc
337740|NCT01701349|Anaplastic Thyroid Cancer|anaplastic thyroid cancer
337741|NCT01701349|Stage IVC Anaplastic Thyroid Cancer|stage ivc anaplastic thyroid cancer
337742|NCT01701349|Thyroid Cancer|thyroid cancer
337743|NCT01701349|Head and Neck Tumors|head and neck tumors
337744|NCT01701336|Hepatitis|hepatitis
337745|NCT01701336|Hepatitis C|hepatitis c
337746|NCT01701336|HCV|hcv
337747|NCT01701336|vaccine|vaccine
337748|NCT01701336|adenovirus|adenovirus
337749|NCT01701336|MVA|mva
337750|NCT01701336|T cells|t cells
337751|NCT01701336|ELISpot|elispot
337752|NCT01701310|Adenocarcinoma|adenocarcinoma
337753|NCT01701310|Anemia|anemia
337754|NCT01701310|Blood Transfusion|blood transfusion
337755|NCT01701310|Colorectal surgery|colorectal surgery
337756|NCT01701310|Preoperative care|preoperative care
337757|NCT01701310|Perioperative care|perioperative care
337758|NCT01701310|Postoperative care|postoperative care
337759|NCT01701310|Iron|iron
337760|NCT01701310|Hematinics|hematinics
337761|NCT01701310|Hepcidin|hepcidin
337762|NCT01701310|Quality of life|quality of life
337763|NCT01701310|Postoperative complications|postoperative complications
337764|NCT01701297|Cirrhosis, ascites, infection|cirrhosis, ascites, infection
337765|NCT01701284|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
337766|NCT01701284|Cancer Survivors|cancer survivors
337767|NCT01701284|Depression|depression
337768|NCT01701284|Anxiety|anxiety
337769|NCT01701271|Baldness|baldness
337770|NCT01701271|Androgenetic Alopecia|androgenetic alopecia
337771|NCT01701271|Alopecia|alopecia
337772|NCT01701258|Depression|depression
337773|NCT01701258|Childhood Sexual Abuse|childhood sexual abuse
337774|NCT01701258|Dopamine|dopamine
337775|NCT01701258|MRI|mri
337776|NCT01701258|PET|pet
337777|NCT01701258|ERP|erp
337778|NCT01701258|Stress|stress
337779|NCT01701258|Reward|reward
337780|NCT01701258|Childhood trauma|childhood trauma
337781|NCT01701258|Amisulpride|amisulpride
337782|NCT01701245|vagus nerve stimulation|vagus nerve stimulation
337783|NCT01701245|vagal nerve stimulation|vagal nerve stimulation
337784|NCT01701245|nVNS|nvns
337785|NCT01701245|VNS|vns
337786|NCT01701245|cluster headache|cluster headache
337787|NCT01701245|chronic|chronic
337788|NCT01701245|non invasive|non invasive
337789|NCT01701245|gammacore|gammacore
337790|NCT01701232|lymphoma, non-Hodgkin's|lymphoma, non-hodgkin's
337791|NCT01701219|Staphylococcus aureus bacteremia|staphylococcus aureus bacteremia
337792|NCT01701219|Methicillin-resistant Staphylococcus aureus bacteremia|methicillin-resistant staphylococcus aureus bacteremia
337793|NCT01701219|MRSA bacteremia|mrsa bacteremia
337794|NCT01701219|Blood|blood
337795|NCT01701219|Adult|adult
337796|NCT01701219|Infections|infections
337797|NCT01701219|Blood Culture|blood culture
337798|NCT01701206|HIV|hiv
337799|NCT01701206|social networking|social networking
337800|NCT01701206|at-risk populations|at-risk populations
337801|NCT01701206|sexual risk behaviors|sexual risk behaviors
337802|NCT01701180|Male Volunteers|male volunteers
337803|NCT01701154|Pompe respiratory|pompe respiratory
337804|NCT01701141|Positron Emission Tomography (PET)|positron emission tomography (pet)
337805|NCT01701141|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
337806|NCT01701141|reward|reward
337807|NCT01701141|stress|stress
337808|NCT01701141|learning|learning
337809|NCT01701141|Major Depressive Disorder|major depressive disorder
337810|NCT01701141|Anhedonia|anhedonia
337811|NCT01701128|Physical activity, treadmill training, rehabilitation|physical activity, treadmill training, rehabilitation
337812|NCT01701115|Interscalene Block|interscalene block
337813|NCT01701076|Relapsed / refractory multiple myeloma|relapsed / refractory multiple myeloma
337814|NCT01701076|2nd line treatment|2nd line treatment
337815|NCT01701050|circulating tumor cells|circulating tumor cells
337816|NCT01701050|CTC|ctc
337817|NCT01701050|metastatic breast cancer|metastatic breast cancer
337818|NCT01701050|endocrine therapy|endocrine therapy
337819|NCT01701050|hormone therapy|hormone therapy
337820|NCT01701037|Melanoma, B-RAF, biomarkers, targeted therapy, resistance|melanoma, b-raf, biomarkers, targeted therapy, resistance
337821|NCT01701024|Acne|acne
337822|NCT01701011|coping|coping
337823|NCT01701011|intervention|intervention
337824|NCT01701011|waiting-period|waiting-period
337825|NCT01700985|psoriasis|psoriasis
337826|NCT01700985|plaque psoriasis|plaque psoriasis
337827|NCT01700985|122-0551|122-0551
337828|NCT01700985|steroid|steroid
337829|NCT01700959|Melatonin|melatonin
337830|NCT01700959|Neurocognitive impairment|neurocognitive impairment
337831|NCT01700959|Sleep disturbance|sleep disturbance
337832|NCT01700959|Childhood cancer survivors|childhood cancer survivors
337833|NCT01700946|leukemia|leukemia
337834|NCT01700946|lymphoma|lymphoma
337835|NCT01700946|Non-Hodgkins|non-hodgkins
337836|NCT01700933|Exercise therapy|exercise therapy
337837|NCT01700920|Osteonecrosis of the femoral head|osteonecrosis of the femoral head
337838|NCT01700920|Stem Cell|stem cell
337839|NCT01700920|Mesenchymal Stem Cells|mesenchymal stem cells
337840|NCT01700920|Femoral Head|femoral head
337841|NCT01700907|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
337842|NCT01700907|elderly patients|elderly patients
337843|NCT01700907|long surgery|long surgery
337844|NCT01700894|Physical Activity|physical activity
337845|NCT01700894|African American|african american
337846|NCT01700894|Adherence|adherence
337847|NCT01700881|Rheumatoid Arthritis, Diet, Fat-Restricted, Diet, Vegetarian|rheumatoid arthritis, diet, fat-restricted, diet, vegetarian
337848|NCT01700868|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
337849|NCT01700868|Diet, Vegetarian|diet, vegetarian
337850|NCT01700868|Diet, Fat-Restricted|diet, fat-restricted
337851|NCT01700868|Glycemic Index|glycemic index
337852|NCT01700855|Electroacupuncture|electroacupuncture
337853|NCT01700855|Analgesia|analgesia
337854|NCT01700855|Anesthesia|anesthesia
337855|NCT01700855|Nasal septoplasty|nasal septoplasty
337856|NCT01700855|Mammaplasty|mammaplasty
337857|NCT01700842|ceftaroline, infection, CAPB, CAP, ABSSSI, cSSTI|ceftaroline, infection, capb, cap, absssi, cssti
337858|NCT01700829|Ketamine|ketamine
337859|NCT01700829|Midazolam|midazolam
337860|NCT01700829|Major Depressive Disorder|major depressive disorder
337861|NCT01700829|Suicidal ideation|suicidal ideation
337862|NCT01700829|Suicide|suicide
337863|NCT01700829|Depression|depression
337864|NCT01700829|Treatment|treatment
337865|NCT01700829|Ketamine Treatment|ketamine treatment
337866|NCT01700816|Delirium|delirium
337867|NCT01700816|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
337868|NCT01700816|Bone marrow transplantation|bone marrow transplantation
337869|NCT01700816|Bright Light Therapy|bright light therapy
337870|NCT01700803|Betadine|betadine
337871|NCT01700803|Povidine Iodine|povidine iodine
337872|NCT01700803|Hand scrubbing|hand scrubbing
337873|NCT01700803|Cesarean section wound infections|cesarean section wound infections
337874|NCT01700803|post cesarean section|post cesarean section
337876|NCT01700790|AIDS|aids
337877|NCT01700790|Tuberculosis|tuberculosis
337878|NCT01700790|Rifampin|rifampin
337879|NCT01700790|Lopinavir|lopinavir
337880|NCT01700790|Pharmacokinetic|pharmacokinetic
337881|NCT01700777|bimanual training|bimanual training
337882|NCT01700777|lower limb|lower limb
337883|NCT01700777|intensive rehabilitation|intensive rehabilitation
337884|NCT01700777|regular rehabilitation|regular rehabilitation
337885|NCT01700777|hemiplegia|hemiplegia
337886|NCT01700725|Gulf War Illness|gulf war illness
337887|NCT01700725|xylitol|xylitol
337888|NCT01700725|nasal irrigation|nasal irrigation
337889|NCT01700725|Desert Storm|desert storm
337890|NCT01700725|Persian Gulf Conflicts|persian gulf conflicts
337891|NCT01700725|neti pot|neti pot
337892|NCT01700725|cytokines|cytokines
337893|NCT01700725|nasal mucus|nasal mucus
337894|NCT01700725|inflammatory mediator|inflammatory mediator
337895|NCT01700725|lactoferrin|lactoferrin
337896|NCT01700725|lysozyme|lysozyme
337897|NCT01700712|Caries, probiotic bacteria|caries, probiotic bacteria
337898|NCT01700699|thyroid cancer|thyroid cancer
337899|NCT01700699|tyrosine kinase inhibitors|tyrosine kinase inhibitors
337900|NCT01700699|BRAF|braf
337901|NCT01700699|Sorafenib|sorafenib
337902|NCT01700699|Pazopanib|pazopanib
337903|NCT01700699|Sunitinib|sunitinib
337904|NCT01700699|Cabozantinib|cabozantinib
338103|NCT01699672|information|information
337905|NCT01700673|maintenance treatment|maintenance treatment
337906|NCT01700673|stem cell transplant|stem cell transplant
337907|NCT01700673|cytarabine-based chemotherapy|cytarabine-based chemotherapy
337908|NCT01700647|Larynx cancer|larynx cancer
337909|NCT01700647|Volatile organic compounds|volatile organic compounds
337910|NCT01700647|Diagnosis|diagnosis
337911|NCT01700647|Bronchoscopy|bronchoscopy
337912|NCT01700647|Cancer staging|cancer staging
337913|NCT01700634|fMRI, BOLD, pressure stimuli|fmri, bold, pressure stimuli
337914|NCT01700621|rotavirus|rotavirus
337915|NCT01700582|lung cancer|lung cancer
337916|NCT01700582|biomarkers|biomarkers
337917|NCT01700582|EGFR|egfr
337918|NCT01700582|KRAS|kras
337919|NCT01700582|ALK|alk
337920|NCT01700582|HER2|her2
337921|NCT01700582|PI3K|pi3k
337922|NCT01700582|BRAF|braf
337923|NCT01700569|high-grade|high-grade
337924|NCT01700569|glioma|glioma
337925|NCT01700569|epigenetic|epigenetic
337926|NCT01700556|Alzheimer Disease|alzheimer disease
337927|NCT01700556|Family Caregiver|family caregiver
337928|NCT01700556|Caregiver Burden|caregiver burden
337929|NCT01700556|Home Care Services|home care services
337930|NCT01700556|Assistive Technologies|assistive technologies
337931|NCT01700543|Stemless shoulder implant|stemless shoulder implant
337932|NCT01700543|Osteoarthritis|osteoarthritis
337933|NCT01700543|Rheumatoid Arthritis|rheumatoid arthritis
337934|NCT01700543|Hemi Shoulder Arthroplasty|hemi shoulder arthroplasty
337935|NCT01700543|Total Shoulder Arthroplasty|total shoulder arthroplasty
337936|NCT01700543|Prospective|prospective
337937|NCT01700543|Multi-center|multi-center
337938|NCT01700543|Europe|europe
337939|NCT01700543|Non-Controlled|non-controlled
337940|NCT01700543|Good Bone Stock|good bone stock
337941|NCT01700530|mitochondria|mitochondria
337942|NCT01700530|fitness|fitness
337943|NCT01700530|statins|statins
337944|NCT01700530|cholesterol|cholesterol
337945|NCT01700530|metabolic syndrome|metabolic syndrome
337946|NCT01700517|total knee arthroplasty, analgesia, ultrasonography|total knee arthroplasty, analgesia, ultrasonography
337947|NCT01700504|Axillary drainage volume|axillary drainage volume
337948|NCT01700504|Lavage with gentamicin solution|lavage with gentamicin solution
337949|NCT01700491|Paravertebral Catheter|paravertebral catheter
337950|NCT01700491|Epidural Catheter|epidural catheter
337951|NCT01700491|Analgesia|analgesia
337952|NCT01700491|Hypotension|hypotension
337953|NCT01700491|Analgesia,Epidural|analgesia,epidural
337954|NCT01700491|Analgesia,Paravertebral|analgesia,paravertebral
337955|NCT01700478|Myomectomy|myomectomy
337956|NCT01700465|Hemodialysis|hemodialysis
337957|NCT01700465|Hemodynamics|hemodynamics
337958|NCT01700452|Lung cancer|lung cancer
337959|NCT01700452|Pulmonary nodules|pulmonary nodules
337960|NCT01700452|FISH Test|fish test
337961|NCT01700439|Aortic valve|aortic valve
337962|NCT01700439|Heart valve|heart valve
337963|NCT01700439|Tissue valve|tissue valve
337964|NCT01700439|Bioprosthesis|bioprosthesis
337965|NCT01700439|Valve disorder|valve disorder
337966|NCT01700439|Valve disease|valve disease
337967|NCT01700439|Cardiac surgery|cardiac surgery
337968|NCT01700439|Less invasive cardiac surgery|less invasive cardiac surgery
337969|NCT01700439|Aortic valve stenosis|aortic valve stenosis
337970|NCT01700439|Aortic valve regurgitation|aortic valve regurgitation
337971|NCT01700439|Bovine pericardium|bovine pericardium
337972|NCT01700426|Iron Deficiency|iron deficiency
337973|NCT01700426|Iron Deficiency Anemia|iron deficiency anemia
337974|NCT01700413|acute|acute
337975|NCT01700413|myeloid|myeloid
337976|NCT01700413|leukemia|leukemia
337977|NCT01700413|CETLAM|cetlam
337978|NCT01700413|Idarubicin|idarubicin
337979|NCT01700400|Lung Cancer|lung cancer
337980|NCT01700400|Non Small Cell Lung Cancer|non small cell lung cancer
337981|NCT01700400|Advanced Lung Cancer|advanced lung cancer
337982|NCT01700387|Migraine|migraine
337983|NCT01700387|Chronic Migraine|chronic migraine
337984|NCT01700387|Cognitive Efficiency|cognitive efficiency
337985|NCT01700387|Pilot Study|pilot study
337986|NCT01700387|Long Term Effect|long term effect
337987|NCT01700374|pregnancy|pregnancy
337988|NCT01700374|stress, psychological|stress, psychological
337989|NCT01700374|stress, physiological|stress, physiological
337990|NCT01700374|maternal-fetal relations|maternal-fetal relations
337991|NCT01700361|sexual arousal|sexual arousal
337992|NCT01700361|pelvic floor sEMG|pelvic floor semg
337993|NCT01700348|moderate gingivitis|moderate gingivitis
337994|NCT01700322|Coronary artery disease|coronary artery disease
337995|NCT01700322|coronary stenting|coronary stenting
337996|NCT01700322|platelet aggregation|platelet aggregation
337997|NCT01700309|Obesity prevention; Adolescent; Physical activity; Health counselling|obesity prevention; adolescent; physical activity; health counselling
337998|NCT01700283|Colorectal Cancer、Fatigue、Muscle strength、Metabolomics|colorectal cancer、fatigue、muscle strength、metabolomics
337999|NCT01700257|Lung cancer screening|lung cancer screening
338000|NCT01700257|Smokers or former smokers|smokers or former smokers
338001|NCT01700257|Family history of lung cancer|family history of lung cancer
338002|NCT01700231|hepatorenal syndrome, liver regeneration, liver dysfunction|hepatorenal syndrome, liver regeneration, liver dysfunction
338003|NCT01700218|telemonitoring|telemonitoring
338004|NCT01700205|Formula Feeding|formula feeding
338005|NCT01700205|Mother|mother
338006|NCT01700205|Moms|moms
338007|NCT01700205|Infants|infants
338008|NCT01700205|Babies|babies
338009|NCT01700205|Baby|baby
338010|NCT01700205|growth|growth
338011|NCT01700205|energy balance|energy balance
338012|NCT01700166|Autologous|autologous
338013|NCT01700166|Cord Blood|cord blood
338014|NCT01700166|Stem Cells|stem cells
338015|NCT01700166|Pediatric stroke|pediatric stroke
338016|NCT01700166|Children with ischemic stroke|children with ischemic stroke
338017|NCT01700166|Cerebral Palsy|cerebral palsy
338018|NCT01700166|Perinatal AIS|perinatal ais
338019|NCT01700153|Robotic-assisted therapy|robotic-assisted therapy
338020|NCT01700153|cerebral palsy|cerebral palsy
338021|NCT01700153|ICF|icf
338022|NCT01700127|immune response|immune response
338023|NCT01700127|infants|infants
338024|NCT01700127|rotavirus vaccine|rotavirus vaccine
338025|NCT01700114|Pigmented Skin Lesions|pigmented skin lesions
338026|NCT01700114|Dermatology|dermatology
338027|NCT01700114|Skin Cancer|skin cancer
338028|NCT01700114|Melanoma|melanoma
338029|NCT01700114|MelaFind|melafind
338030|NCT01700088|hypoxemia|hypoxemia
338031|NCT01700088|Post Pulmonary Resection|post pulmonary resection
338032|NCT01700075|atherosclerosis, development of concept, weight loss therapy|atherosclerosis, development of concept, weight loss therapy
338033|NCT01700062|medium-calorie|medium-calorie
338034|NCT01700062|standard calorie|standard calorie
338035|NCT01700062|parenteral nutrition|parenteral nutrition
338036|NCT01700049|advanced BCC|advanced bcc
338037|NCT01700049|high risk|high risk
338038|NCT01700049|locally advanced|locally advanced
338039|NCT01700023|acute heart failure|acute heart failure
338040|NCT01700010|Urothelial|urothelial
338041|NCT01700010|Bladder|bladder
338042|NCT01700010|Cancer|cancer
338043|NCT01699997|Schizophrenia|schizophrenia
338044|NCT01699997|Oxytocin|oxytocin
338045|NCT01699997|RCT|rct
338046|NCT01699984|Cognitive impairment.|cognitive impairment.
338047|NCT01699984|Geriatrics.|geriatrics.
338048|NCT01699984|Hospital admission.|hospital admission.
338049|NCT01699984|Hospital discharge.|hospital discharge.
338050|NCT01699958|Problem solving therapy|problem solving therapy
338051|NCT01699958|Behavior change|behavior change
338052|NCT01699945|Verbal autopsies|verbal autopsies
338053|NCT01699945|Maternal deaths|maternal deaths
338054|NCT01699945|Still births|still births
338055|NCT01699919|perioperative lignocaine infusion|perioperative lignocaine infusion
338056|NCT01699919|elective open abdominal surgeries|elective open abdominal surgeries
338057|NCT01699919|postoperative pain|postoperative pain
338058|NCT01699906|Obesity|obesity
338059|NCT01699880|tracheal intubation|tracheal intubation
338060|NCT01699880|preoxygenation|preoxygenation
338061|NCT01699880|desaturation|desaturation
338062|NCT01699880|hypoxemia|hypoxemia
338063|NCT01699880|oxygen therapy|oxygen therapy
338064|NCT01699880|high flow nasal cannula oxygen therapy|high flow nasal cannula oxygen therapy
338065|NCT01699867|lumpectomy|lumpectomy
338066|NCT01699867|breast cancer|breast cancer
338067|NCT01699867|optical coherence tomography|optical coherence tomography
338068|NCT01699867|tumor margin|tumor margin
338069|NCT01699867|imaging|imaging
338070|NCT01699828|buspirone|buspirone
338071|NCT01699828|smoking cessation|smoking cessation
338072|NCT01699828|dopamine|dopamine
338073|NCT01699828|PET imaging|pet imaging
338074|NCT01699828|[11C]-(+)-PHNO|[11c]-(+)-phno
338075|NCT01699815|acetaminophen|acetaminophen
338076|NCT01699815|timing|timing
338077|NCT01699815|arthroplasty|arthroplasty
338078|NCT01699789|Community Partnered Participatory Research|community partnered participatory research
338079|NCT01699789|Community Engagement|community engagement
338080|NCT01699789|Implementation|implementation
338081|NCT01699789|Community Based Participatory Research|community based participatory research
338082|NCT01699789|Quality Improvement|quality improvement
338083|NCT01699789|Evidence Based Practice|evidence based practice
338084|NCT01699789|Patient Centered Outcomes Research|patient centered outcomes research
338085|NCT01699776|Digoxin|digoxin
338086|NCT01699776|Ivabradine|ivabradine
338087|NCT01699776|with atrial fibrillation.|with atrial fibrillation.
338088|NCT01699750|contact lenses|contact lenses
338089|NCT01699750|contact lens solution|contact lens solution
338090|NCT01699750|myopia|myopia
338091|NCT01699750|astigmatism|astigmatism
338092|NCT01699737|Diabetes|diabetes
338093|NCT01699724|JZoloft|jzoloft
338094|NCT01699724|Sertraline hydrochloride|sertraline hydrochloride
338095|NCT01699724|ODT|odt
338096|NCT01699724|bioequivalence|bioequivalence
338218|NCT01699243|epidural|epidural
338097|NCT01699711|APP function (amyloid precursor protein, cognitive stimulation, alzheimer disease. program|app function (amyloid precursor protein, cognitive stimulation, alzheimer disease. program
338098|NCT01699698|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
338099|NCT01699685|Moderate to severe COPD patients are included|moderate to severe copd patients are included
338100|NCT01699685|NVA|nva
338101|NCT01699685|QAB|qab
338102|NCT01699672|Patient education|patient education
338104|NCT01699672|communication|communication
338105|NCT01699659|Allergic Rhinitis|allergic rhinitis
338106|NCT01699659|Allergen Immunotherapy|allergen immunotherapy
338107|NCT01699646|Intrapartum fetal surveillance|intrapartum fetal surveillance
338108|NCT01699646|CTG|ctg
338109|NCT01699646|cardiotocography|cardiotocography
338110|NCT01699646|STAN|stan
338111|NCT01699646|ST-Analysis|st-analysis
338112|NCT01699646|metabolic acidosis in umbilical artery|metabolic acidosis in umbilical artery
338113|NCT01699646|operative delivery|operative delivery
338114|NCT01699633|Drug-drug interactions|drug-drug interactions
338115|NCT01699633|Drug-gene interactions|drug-gene interactions
338116|NCT01699633|Nevirapine|nevirapine
338117|NCT01699633|Rifampicin|rifampicin
338118|NCT01699633|children|children
338119|NCT01699620|Bone anchored hearing aid|bone anchored hearing aid
338120|NCT01699620|Soft tissue healing|soft tissue healing
338121|NCT01699620|Implant stability|implant stability
338122|NCT01699620|Linear incision|linear incision
338123|NCT01699620|Dermatome technique|dermatome technique
338124|NCT01699620|Hearing Aids|hearing aids
338125|NCT01699620|Implants, Artificial|implants, artificial
338126|NCT01699620|Surgical Procedures, Operative|surgical procedures, operative
338127|NCT01699607|Cigarette Smokers|cigarette smokers
338128|NCT01699607|Healthy Non Smokers|healthy non smokers
338129|NCT01699607|Amphetamine|amphetamine
338130|NCT01699607|PET|pet
338131|NCT01699607|Controls|controls
338132|NCT01699594|asthma|asthma
338133|NCT01699594|allergies|allergies
338134|NCT01699594|mannitol|mannitol
338135|NCT01699594|methacholine|methacholine
338136|NCT01699581|Hodgkin's Lymphoma|hodgkin's lymphoma
338137|NCT01699581|Multiple Myeloma|multiple myeloma
338138|NCT01699581|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
338139|NCT01699568|dental implant stability|dental implant stability
338140|NCT01699568|dental implant surface treatment|dental implant surface treatment
338141|NCT01699568|resonance frequence analysis|resonance frequence analysis
338142|NCT01699555|Multiple sclerosis|multiple sclerosis
338143|NCT01699555|GNbAC1|gnbac1
338144|NCT01699555|Monoclonal antibody|monoclonal antibody
338145|NCT01699555|Multiple Sclerosis Associated Retrovirus (MSRV)|multiple sclerosis associated retrovirus (msrv)
338146|NCT01699542|Refractory Anastomotic esophageal strictures|refractory anastomotic esophageal strictures
338147|NCT01699516|allogeneic transplantation; intestinal graft-vs.-host disease; contrast enhanced ultrasound sonography|allogeneic transplantation; intestinal graft-vs.-host disease; contrast enhanced ultrasound sonography
338148|NCT01699503|Dementia|dementia
338149|NCT01699503|Alzheimer's Disease|alzheimer's disease
338150|NCT01699503|Mild Cognitive Impairment|mild cognitive impairment
338151|NCT01699503|Screening|screening
338152|NCT01699490|Major Depressive Disorder|major depressive disorder
338153|NCT01699490|Antidepressants|antidepressants
338154|NCT01699490|Insulin|insulin
338155|NCT01699490|Fluoxetine|fluoxetine
338156|NCT01699477|FUS|fus
338157|NCT01699477|focused ultrasound|focused ultrasound
338158|NCT01699477|functional brain disorders|functional brain disorders
338159|NCT01699477|neuropathic pain|neuropathic pain
338160|NCT01699477|movement disorders|movement disorders
338161|NCT01699464|Glaucoma|glaucoma
338162|NCT01699438|Irritable Bowel Syndrome|irritable bowel syndrome
338163|NCT01699438|Inflammation|inflammation
338164|NCT01699438|Mesalazine|mesalazine
338165|NCT01699425|Stress urinary incontinence.|stress urinary incontinence.
338166|NCT01699425|Suburethral sling.|suburethral sling.
338167|NCT01699425|Single-incision suburethral sling.|single-incision suburethral sling.
338168|NCT01699425|Ajust.|ajust.
338169|NCT01699425|Transobturator tape.|transobturator tape.
338170|NCT01699412|Bone Marrow Transplantation|bone marrow transplantation
338171|NCT01699412|Graft vs Host Disease|graft vs host disease
338172|NCT01699412|Oral Manifestations|oral manifestations
338173|NCT01699399|colonoscopy|colonoscopy
338174|NCT01699399|pain|pain
338175|NCT01699399|sedation|sedation
338176|NCT01699399|water|water
338177|NCT01699360|Kidney Transplantation|kidney transplantation
338178|NCT01699360|Immunosuppressive Agents|immunosuppressive agents
338179|NCT01699360|Hydrocortisone|hydrocortisone
338180|NCT01699360|Cortisone|cortisone
338181|NCT01699347|OK432, CYSTIC MALFORMATION|ok432, cystic malformation
338182|NCT01699334|Whiplash injuries|whiplash injuries
338183|NCT01699334|patient education|patient education
338184|NCT01699334|illness perceptions|illness perceptions
338185|NCT01699334|RCT|rct
338186|NCT01699334|motor vehicle accidents|motor vehicle accidents
338187|NCT01699321|physical activity|physical activity
338188|NCT01699321|barbershop|barbershop
338189|NCT01699321|cancer prevention|cancer prevention
338190|NCT01699321|exercise|exercise
338191|NCT01699321|men's health|men's health
338192|NCT01699321|African American men|african american men
338193|NCT01699308|Traumatic Brain Injury|traumatic brain injury
338194|NCT01699308|Growth Hormone|growth hormone
338195|NCT01699308|Neuroimaging|neuroimaging
338196|NCT01699295|academic achievement|academic achievement
338197|NCT01699295|elementary school|elementary school
338198|NCT01699295|physical activity|physical activity
338199|NCT01699295|exercise|exercise
338200|NCT01699282|oral anticoagulant|oral anticoagulant
338201|NCT01699282|in the long term (> 12 months)|in the long term (> 12 months)
338202|NCT01699269|High grade brain tumor|high grade brain tumor
338203|NCT01699269|Glioma|glioma
338204|NCT01699269|Glioblastoma Multiform|glioblastoma multiform
338205|NCT01699269|Brain Cancer|brain cancer
338206|NCT01699269|Diffusion-Weighted Magnetic Resonance Imaging|diffusion-weighted magnetic resonance imaging
338207|NCT01699269|High order diffusion tensor|high order diffusion tensor
338208|NCT01699269|Imaging guided biopsy|imaging guided biopsy
338209|NCT01699269|Histopathologic evaluation|histopathologic evaluation
338210|NCT01699269|Infiltration percentage|infiltration percentage
338211|NCT01699256|General Practice|general practice
338212|NCT01699256|Low Back Pain|low back pain
338213|NCT01699256|Guideline|guideline
338214|NCT01699256|Health Plan Implementation|health plan implementation
338215|NCT01699256|Referral and Consultation|referral and consultation
338216|NCT01699243|pregnancy|pregnancy
338217|NCT01699243|labor|labor
338219|NCT01699243|fetal intervention|fetal intervention
338220|NCT01699230|Elective cardiac surgery|elective cardiac surgery
338221|NCT01699230|with sternotomy and|with sternotomy and
338222|NCT01699230|cardiopulmonary bypass|cardiopulmonary bypass
338223|NCT01699230|for coronary artery|for coronary artery
338224|NCT01699230|bypass graft.|bypass graft.
338225|NCT01699217|Chronic Myeloid Leukaemia|chronic myeloid leukaemia
338226|NCT01699217|Philadelphia positive|philadelphia positive
338227|NCT01699217|BCR-ABL positive|bcr-abl positive
338228|NCT01699204|Air pollution|air pollution
338229|NCT01699204|Diesel exhaust|diesel exhaust
338230|NCT01699204|Airway responsiveness|airway responsiveness
338231|NCT01699204|Asthma|asthma
338232|NCT01699204|Anti-oxidant|anti-oxidant
338233|NCT01699191|Irritable Bowel Syndrome|irritable bowel syndrome
338234|NCT01699191|Celiac Desease|celiac desease
338235|NCT01699191|Probiotic|probiotic
338236|NCT01699191|Lactobacillus plantarum|lactobacillus plantarum
338237|NCT01699191|Bifidobacterium breve|bifidobacterium breve
338238|NCT01699191|Lactobacillus casei|lactobacillus casei
338239|NCT01699191|Bifidobacterium animalis|bifidobacterium animalis
338240|NCT01699165|rhinitis|rhinitis
338241|NCT01699165|allergic|allergic
338242|NCT01699165|seasonal|seasonal
338243|NCT01699165|double blind|double blind
338244|NCT01699165|doubleblind|doubleblind
338245|NCT01699165|randomized|randomized
338246|NCT01699165|randomised|randomised
338247|NCT01699165|placebo|placebo
338248|NCT01699165|crossover|crossover
338249|NCT01699165|clinical|clinical
338250|NCT01699165|nasal|nasal
338251|NCT01699165|filter|filter
338252|NCT01699165|controlled|controlled
338253|NCT01699165|trial|trial
338254|NCT01699165|hayfever|hayfever
338255|NCT01699165|hay|hay
338256|NCT01699165|fever|fever
338257|NCT01699165|efficacy|efficacy
338258|NCT01699165|safety|safety
338259|NCT01699165|prevention|prevention
338260|NCT01699165|adult|adult
338261|NCT01699165|grass|grass
338262|NCT01699165|pollen|pollen
338263|NCT01699165|symptom|symptom
338264|NCT01699165|Total nasal symptom score|total nasal symptom score
338265|NCT01699165|acoustic rhinometry|acoustic rhinometry
338266|NCT01699152|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
338267|NCT01699152|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
338268|NCT01699139|supine position|supine position
338269|NCT01699126|Obstructive Sleep Apnea|obstructive sleep apnea
338270|NCT01699126|CPAP|cpap
338271|NCT01699126|Endothelium dysfunction|endothelium dysfunction
338272|NCT01699126|Hypertension|hypertension
338273|NCT01699113|YF476|yf476
338274|NCT01699113|gastrin receptor antagonist|gastrin receptor antagonist
338275|NCT01699113|gastric pH|gastric ph
338276|NCT01699113|gastrin|gastrin
338277|NCT01699113|rabeprazole|rabeprazole
338278|NCT01699113|proton-pump inhibitor|proton-pump inhibitor
338279|NCT01699113|gastric function|gastric function
338280|NCT01699113|healthy subjects|healthy subjects
338281|NCT01699100|offloading|offloading
338282|NCT01699100|plantar pressure|plantar pressure
338283|NCT01699100|insole|insole
338284|NCT01699100|foot ulcer|foot ulcer
338285|NCT01699087|PRK|prk
338286|NCT01699087|myopia|myopia
338287|NCT01699087|astigmatism|astigmatism
338288|NCT01699074|Korean White Ginseng|korean white ginseng
338289|NCT01699074|Type 2 diabetes|type 2 diabetes
338290|NCT01699074|Metabolic syndrome|metabolic syndrome
338291|NCT01699048|multivessel PCI,MIDCAB,CABG|multivessel pci,midcab,cabg
338292|NCT01699048|Hybrid coronary revascularization|hybrid coronary revascularization
338293|NCT01699035|stroke|stroke
338294|NCT01699035|work|work
338295|NCT01699035|vocational rehabilitation|vocational rehabilitation
338296|NCT01699022|Contraceptive|contraceptive
338297|NCT01699022|Injectable|injectable
338298|NCT01699009|Migraines, diet, vegan, vegetarian, plant-based|migraines, diet, vegan, vegetarian, plant-based
338299|NCT01698996|abscess|abscess
338300|NCT01698996|packing|packing
338301|NCT01698996|emergency medicine|emergency medicine
338302|NCT01698996|wound care|wound care
338303|NCT01698996|incision and drainage|incision and drainage
338304|NCT01698970|Probiotic|probiotic
338305|NCT01698970|capsules|capsules
338306|NCT01698970|Crohn's disease|crohn's disease
338307|NCT01698970|recurrent endoscopic ileo-colonic lesions|recurrent endoscopic ileo-colonic lesions
338308|NCT01698957|Pregnant women|pregnant women
338309|NCT01698957|Uterine Artery Doppler Velocimetry|uterine artery doppler velocimetry
338310|NCT01698918|metastatic breast cancer, locally advanced breast cancer, HER2-, ER+, everolimus, Afinitor|metastatic breast cancer, locally advanced breast cancer, her2-, er+, everolimus, afinitor
338311|NCT01698905|Phase II, single arm, open label, nilotinib, treatment-free remission, MR4.5, confirmed loss of MR4, loss of MMR, Ph+ CML-CP|phase ii, single arm, open label, nilotinib, treatment-free remission, mr4.5, confirmed loss of mr4, loss of mmr, ph+ cml-cp
338312|NCT01698892|I.V. sedation, midazolam, bronchoscopy|i.v. sedation, midazolam, bronchoscopy
338313|NCT01698866|Low grade lymphoma|low grade lymphoma
338314|NCT01698866|follicular lymphoma|follicular lymphoma
338315|NCT01698866|indolent lymphoproliferative disorders|indolent lymphoproliferative disorders
338316|NCT01698866|Vaccin GenHevac B Pasteur|vaccin genhevac b pasteur
338317|NCT01698840|Vitamin D|vitamin d
338318|NCT01698840|Transitional Formula|transitional formula
338319|NCT01698827|gastrostomy|gastrostomy
338320|NCT01698827|tube|tube
338321|NCT01698827|endoscopic|endoscopic
338322|NCT01698827|replacement|replacement
338323|NCT01698827|tube rupture|tube rupture
338324|NCT01698827|durability|durability
338325|NCT01698827|tube loss|tube loss
338326|NCT01698827|balloon rupture|balloon rupture
338327|NCT01698814|ocular safety|ocular safety
338328|NCT01698814|allergic conjunctivitis|allergic conjunctivitis
338329|NCT01698801|Lenalidomide|lenalidomide
338330|NCT01698801|dexamethasone|dexamethasone
338331|NCT01698801|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
338332|NCT01698788|diabetic macular edema|diabetic macular edema
338333|NCT01698788|taut posterior hyaloid membrane|taut posterior hyaloid membrane
338334|NCT01698788|ozurdex|ozurdex
338335|NCT01698762|Musculoskeletal Diseases|musculoskeletal diseases
338336|NCT01698762|Osteoarthritis|osteoarthritis
338337|NCT01698762|OA|oa
338338|NCT01698762|Rheumatoid Arthritis|rheumatoid arthritis
338339|NCT01698762|RA|ra
338340|NCT01698762|Osteoporosis|osteoporosis
338341|NCT01698762|OP|op
338342|NCT01698762|Multimedia Patient Decision Aids|multimedia patient decision aids
338343|NCT01698762|MM-PtDAs|mm-ptdas
338344|NCT01698762|DVD|dvd
338345|NCT01698762|Comparative Effectiveness Research Summary Guide|comparative effectiveness research summary guide
338347|NCT01698762|Booklet|booklet
338348|NCT01698762|Questionnaires|questionnaires
338349|NCT01698762|Surveys|surveys
338350|NCT01698749|Ozurdex|ozurdex
338351|NCT01698749|Diabetic macular edema|diabetic macular edema
338352|NCT01698749|Central macular thickness|central macular thickness
338353|NCT01698736|ABO isoagglutinins|abo isoagglutinins
338354|NCT01698736|ABO incompatible transplantation|abo incompatible transplantation
338355|NCT01698736|immunoadsorption|immunoadsorption
338356|NCT01698736|membrane filtration|membrane filtration
338357|NCT01698736|plasmapheresis|plasmapheresis
338358|NCT01698723|ACLF|aclf
338359|NCT01698723|HEV|hev
338360|NCT01698723|Ribavirin|ribavirin
338361|NCT01698710|Premalignant|premalignant
338362|NCT01698710|Malignant|malignant
338363|NCT01698684|ED|ed
338364|NCT01698645|quality of life|quality of life
338365|NCT01698645|PecFent|pecfent
338366|NCT01698645|Lazanda|lazanda
338367|NCT01698645|fentanyl|fentanyl
338368|NCT01698645|intranasal|intranasal
338369|NCT01698645|breakthrough cancer pain|breakthrough cancer pain
338370|NCT01698632|Adnexal masses|adnexal masses
338371|NCT01698632|Ovarian cysts|ovarian cysts
338372|NCT01698632|Ovarian tumors|ovarian tumors
338373|NCT01698606|childhood obesity|childhood obesity
338374|NCT01698606|multidisciplinary|multidisciplinary
338375|NCT01698606|preschool children|preschool children
338376|NCT01698606|community-based|community-based
338377|NCT01698606|lifestyle intervention|lifestyle intervention
338378|NCT01698606|family-centered|family-centered
338379|NCT01698593|Bupivacaine|bupivacaine
338380|NCT01698593|digital nerve block|digital nerve block
338381|NCT01698593|epinephrine|epinephrine
338382|NCT01698593|duration of action|duration of action
338383|NCT01698593|pain|pain
338384|NCT01698593|touch|touch
338385|NCT01698593|pressure|pressure
338386|NCT01698593|temperature|temperature
338387|NCT01698580|accidental falls|accidental falls
338388|NCT01698580|aged|aged
338389|NCT01698580|aged, 80 and over|aged, 80 and over
338390|NCT01698580|prevention and control|prevention and control
338391|NCT01698567|Infants|infants
338392|NCT01698567|Cardiopulmonary bypass|cardiopulmonary bypass
338393|NCT01698567|anticoaglution|anticoaglution
338394|NCT01698541|Renal|renal
338395|NCT01698541|Transplantation|transplantation
338396|NCT01698541|Elderly|elderly
338397|NCT01698528|Diabetes|diabetes
338398|NCT01698528|diabetes technologies|diabetes technologies
338399|NCT01698528|telemedicine|telemedicine
338400|NCT01698502|Incretin|incretin
338401|NCT01698502|Training|training
338402|NCT01698502|Glucagon like peptide|glucagon like peptide
338505|NCT01698021|Unstable angina|unstable angina
338403|NCT01698502|glucose dependent insulinotropic peptide|glucose dependent insulinotropic peptide
338404|NCT01698502|Gut|gut
338405|NCT01698502|Exercise|exercise
338406|NCT01698502|Insulin|insulin
338407|NCT01698502|Focus:|focus:
338408|NCT01698502|Gut hormone|gut hormone
338409|NCT01698502|adaptations|adaptations
338410|NCT01698476|pulmonary TB|pulmonary tb
338411|NCT01698476|cholecalciferol|cholecalciferol
338412|NCT01698476|sodium phenylbutyrate|sodium phenylbutyrate
338413|NCT01698476|antimicrobial peptides|antimicrobial peptides
338414|NCT01698476|immune response|immune response
338415|NCT01698463|Falls, Fractures, Osteoporosis, Frailty, Older Adults.|falls, fractures, osteoporosis, frailty, older adults.
338416|NCT01698450|FUS|fus
338417|NCT01698450|focused ultrasound|focused ultrasound
338418|NCT01698450|functional brain disorder|functional brain disorder
338419|NCT01698450|neuropathic pain|neuropathic pain
338420|NCT01698450|movement disorders|movement disorders
338421|NCT01698450|malignant brain tumors|malignant brain tumors
338422|NCT01698437|FUS|fus
338423|NCT01698437|focused ultrasound|focused ultrasound
338424|NCT01698437|functional brain disorders|functional brain disorders
338425|NCT01698437|neuropathic pain|neuropathic pain
338426|NCT01698437|movement disorders|movement disorders
338427|NCT01698437|malignant of brain tumors|malignant of brain tumors
338428|NCT01698411|hypertension|hypertension
338429|NCT01698411|sleep|sleep
338430|NCT01698411|insomnia|insomnia
338431|NCT01698372|Cardiac surgery.|cardiac surgery.
338432|NCT01698372|Wound healing.|wound healing.
338433|NCT01698372|Leg wound infection.|leg wound infection.
338434|NCT01698372|Wound care.|wound care.
338435|NCT01698346|Pertussis|pertussis
338436|NCT01698346|Infants|infants
338437|NCT01698346|Vaccination|vaccination
338438|NCT01698346|Pregnancy|pregnancy
338439|NCT01698333|122-0551|122-0551
338440|NCT01698333|steroid|steroid
338441|NCT01698333|HPA|hpa
338442|NCT01698307|Crohn's Disease|crohn's disease
338443|NCT01698307|Deep Remission|deep remission
338444|NCT01698307|Complications|complications
338445|NCT01698294|gut microbiome|gut microbiome
338446|NCT01698294|hormones|hormones
338447|NCT01698294|women|women
338448|NCT01698294|race|race
338449|NCT01698294|phytoestrogens|phytoestrogens
338450|NCT01698255|Depression|depression
338451|NCT01698255|Geriatrics|geriatrics
338452|NCT01698242|Heart failure|heart failure
338453|NCT01698242|Self-Management|self-management
338454|NCT01698242|Behavioral Clinical Trial|behavioral clinical trial
338455|NCT01698229|Cerebrospinal fluid|cerebrospinal fluid
338456|NCT01698229|Lumbar puncture|lumbar puncture
338457|NCT01698229|Spinal tap|spinal tap
338458|NCT01698229|Late infantile neuronal ceroid lipofuscinosis|late infantile neuronal ceroid lipofuscinosis
338459|NCT01698229|Batten disease|batten disease
338460|NCT01698216|Paliperidone|paliperidone
338461|NCT01698216|Palmitate|palmitate
338462|NCT01698216|switching|switching
338463|NCT01698216|schizophrenia|schizophrenia
338464|NCT01698216|subjective well-being|subjective well-being
338465|NCT01698177|Influenza|influenza
338466|NCT01698177|Cancer|cancer
338467|NCT01698177|Vaccination|vaccination
338468|NCT01698177|Immune response to influenza vaccination|immune response to influenza vaccination
338469|NCT01698164|lipid profiles|lipid profiles
338470|NCT01698164|coronary heart disease|coronary heart disease
338471|NCT01698164|menopausal syndrome|menopausal syndrome
338472|NCT01698164|MMSE|mmse
338473|NCT01698164|MENQOL|menqol
338474|NCT01698164|HAD|had
338475|NCT01698151|Chronic obstructive Pulmonary Disease|chronic obstructive pulmonary disease
338476|NCT01698151|COPD|copd
338477|NCT01698138|Spinal cord injury|spinal cord injury
338478|NCT01698138|Neurogenic overactive bladder|neurogenic overactive bladder
338479|NCT01698138|Onabotulinum toxin A|onabotulinum toxin a
338480|NCT01698138|Prevention|prevention
338481|NCT01698138|Botulinum Toxins, Type A|botulinum toxins, type a
338482|NCT01698125|Delirium|delirium
338483|NCT01698125|Autonomic cardiovascular control|autonomic cardiovascular control
338484|NCT01698125|Abdominal surgery|abdominal surgery
338485|NCT01698125|Tilt-test|tilt-test
338486|NCT01698086|Multiple Sclerosis|multiple sclerosis
338487|NCT01698086|Balance|balance
338488|NCT01698086|Fatigue|fatigue
338489|NCT01698086|Eye movement|eye movement
338490|NCT01698073|Teen pregnancy prevention|teen pregnancy prevention
338491|NCT01698073|American Indian|american indian
338492|NCT01698073|Group-randomized trial|group-randomized trial
338493|NCT01698060|Prevention of Avian Influenza|prevention of avian influenza
338494|NCT01698047|Depressive symptoms|depressive symptoms
338495|NCT01698047|sub-threshold depression|sub-threshold depression
338496|NCT01698047|resiliency|resiliency
338497|NCT01698047|Health Promotion|health promotion
338498|NCT01698047|minority health|minority health
338499|NCT01698034|volunteering|volunteering
338500|NCT01698034|cardiovascular health|cardiovascular health
338501|NCT01698021|Creatine Kinase, MB form|creatine kinase, mb form
338502|NCT01698021|Troponin|troponin
338503|NCT01698021|Acute coronary syndrome|acute coronary syndrome
338504|NCT01698021|myocardial infarction|myocardial infarction
338506|NCT01697995|right ventricle|right ventricle
338507|NCT01697995|radiotracer uptake|radiotracer uptake
338508|NCT01697995|Myocardial Perfusion Imaging|myocardial perfusion imaging
338509|NCT01697995|balanced ischemia|balanced ischemia
338510|NCT01697982|pilot study|pilot study
338511|NCT01697982|psychosocial intervention|psychosocial intervention
338512|NCT01697982|advanced cancer|advanced cancer
338513|NCT01697969|allergic conjunctivitis|allergic conjunctivitis
338514|NCT01697969|Pataday|pataday
338515|NCT01697969|Olopatadine|olopatadine
338516|NCT01697956|Pediatric Subjects|pediatric subjects
338517|NCT01697943|Gastric Malignant Tumor|gastric malignant tumor
338518|NCT01697943|Total Gastrectomy|total gastrectomy
338519|NCT01697943|Reconstruction|reconstruction
338520|NCT01697930|PET Imaging|pet imaging
338521|NCT01697930|18F] 4-L-Fluoroglutam (2S,4R)|18f] 4-l-fluoroglutam (2s,4r)
338522|NCT01697930|12-168|12-168
338523|NCT01697917|Adenocarcinoma of Esophagogastric Junction|adenocarcinoma of esophagogastric junction
338524|NCT01697917|Total Gastrectomy|total gastrectomy
338525|NCT01697917|Proximal Gastrectomy|proximal gastrectomy
338526|NCT01697891|Radiation Treatment|radiation treatment
338527|NCT01697891|Head and Neck Cancer|head and neck cancer
338528|NCT01697891|Dysphagia|dysphagia
338529|NCT01697878|obstructive sleep apnea|obstructive sleep apnea
338530|NCT01697878|obesity|obesity
338531|NCT01697878|respiratory function|respiratory function
338532|NCT01697878|weight loss surgery|weight loss surgery
338533|NCT01697865|Reverse total shoulder|reverse total shoulder
338534|NCT01697852|vector control|vector control
338535|NCT01697852|LLIN|llin
338536|NCT01697852|IRS|irs
338537|NCT01697826|Clindamycin|clindamycin
338538|NCT01697826|Clotrimazole|clotrimazole
338539|NCT01697826|Vaginal formulation|vaginal formulation
338540|NCT01697826|Bacterial vaginosis|bacterial vaginosis
338541|NCT01697826|Candidiasis|candidiasis
338542|NCT01697826|Trichomoniasis|trichomoniasis
338543|NCT01697826|Mixed vaginitis|mixed vaginitis
338544|NCT01697826|Infective vaginitis|infective vaginitis
338545|NCT01697787|Treatment, diagnosis|treatment, diagnosis
338546|NCT01697761|Crohn's disease,acupuncture,moxibustion,inflammation factors|crohn's disease,acupuncture,moxibustion,inflammation factors
338547|NCT01697722|Primary care|primary care
338548|NCT01697722|Asthma management|asthma management
338549|NCT01697722|Inhaled corticosteroids|inhaled corticosteroids
338550|NCT01697722|Extra-fine hydrofluoroalkane|extra-fine hydrofluoroalkane
338551|NCT01697722|Long-acting beta-agonist|long-acting beta-agonist
338552|NCT01697722|Fixed-dose combination therapy|fixed-dose combination therapy
338553|NCT01697709|cannabis|cannabis
338554|NCT01697709|marijuana|marijuana
338555|NCT01697709|pharmacotherapy|pharmacotherapy
338556|NCT01697696|COPD, NVA237, QAB149, glycopyrronium bromide|copd, nva237, qab149, glycopyrronium bromide
338557|NCT01697605|Phase I, open-label, dose escalation, BGJ398, Japanese, Asian, FGF-R|phase i, open-label, dose escalation, bgj398, japanese, asian, fgf-r
338558|NCT01697566|Gynecology|gynecology
338559|NCT01697566|Endometrial Cancer Chemoprevention|endometrial cancer chemoprevention
338560|NCT01697566|Obese|obese
338561|NCT01697566|Body Mass Index (BMI) >/= 35 kg.m2|body mass index (bmi) >/= 35 kg.m2
338562|NCT01697566|Post-menopausal|post-menopausal
338563|NCT01697566|Hyperinsulinemia|hyperinsulinemia
338564|NCT01697566|Metformin|metformin
338565|NCT01697566|Placebo|placebo
338566|NCT01697566|Sugar pill|sugar pill
338567|NCT01697566|Lifestyle intervention|lifestyle intervention
338568|NCT01697566|Diet|diet
338569|NCT01697566|Exercise|exercise
338570|NCT01697514|recurrent medulloblastoma|recurrent medulloblastoma
338571|NCT01697397|Irritable bowel syndrome|irritable bowel syndrome
338572|NCT01697397|IBS|ibs
338573|NCT01697397|Gastrointestinal pain|gastrointestinal pain
338574|NCT01697397|Gastrointestinal functional disorder|gastrointestinal functional disorder
338575|NCT01697384|prostate cancer, PSA|prostate cancer, psa
338576|NCT01697358|FBSS|fbss
338577|NCT01697358|post laminectomy syndrome|post laminectomy syndrome
338578|NCT01697358|SCS|scs
338579|NCT01697358|RCT|rct
338580|NCT01697358|back pain|back pain
338581|NCT01697345|Vaginal Testosterone|vaginal testosterone
338582|NCT01697345|Vaginal atrophy|vaginal atrophy
338583|NCT01697345|Female Sexual Dysfunction|female sexual dysfunction
338584|NCT01697345|Aromatase Inhibitors|aromatase inhibitors
338585|NCT01697332|COPD|copd
338586|NCT01697319|Mucopolysaccharidosis IVA Type A|mucopolysaccharidosis iva type a
338587|NCT01697319|MPS IVA Type A|mps iva type a
338588|NCT01697319|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
338589|NCT01697319|MPS IVA|mps iva
338590|NCT01697319|Morquio A Syndrome|morquio a syndrome
338591|NCT01697319|Lysosomal Storage Disorder|lysosomal storage disorder
338592|NCT01697319|LSD|lsd
338593|NCT01697319|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
338594|NCT01697319|N-acetylgalactosamine-6-sulfate|n-acetylgalactosamine-6-sulfate
338595|NCT01697319|sulfatase|sulfatase
338596|NCT01697319|galactose-6-sulfatase|galactose-6-sulfatase
338598|NCT01697319|enzyme replacement therapy|enzyme replacement therapy
338599|NCT01697319|ERT|ert
338600|NCT01697319|MOR-006|mor-006
338601|NCT01697319|CPET|cpet
338602|NCT01697319|Limited ambulation|limited ambulation
338603|NCT01697319|Grip/ Pinch|grip/ pinch
338604|NCT01697306|non muscle invasive bladder cancer|non muscle invasive bladder cancer
338605|NCT01697280|Polio supplementary immunization activities|polio supplementary immunization activities
338606|NCT01697280|Routine EPI vaccine|routine epi vaccine
338607|NCT01697280|Integration of polio NID and routine EPI|integration of polio nid and routine epi
338608|NCT01697267|vasculitis|vasculitis
338609|NCT01697267|ANCA vasculitis|anca vasculitis
338610|NCT01697267|microscopic polyangiitis|microscopic polyangiitis
338611|NCT01697267|granulomatosis|granulomatosis
338612|NCT01697267|Wegener's|wegener's
338613|NCT01697267|AAV|aav
338614|NCT01697267|vasculitides|vasculitides
338615|NCT01697241|Exercise Therapy|exercise therapy
338616|NCT01697241|Education|education
338617|NCT01697241|Osteoarthritis|osteoarthritis
338618|NCT01697241|Hip|hip
338619|NCT01697241|Hip replacement|hip replacement
338620|NCT01697228|Diabetes|diabetes
338621|NCT01697228|Vitamin D|vitamin d
338622|NCT01697228|Proinflammatory markers|proinflammatory markers
338623|NCT01697189|professional drivers|professional drivers
338624|NCT01697189|sleepiness|sleepiness
338625|NCT01697189|stress|stress
338626|NCT01697189|safe driving|safe driving
338627|NCT01697189|training|training
338628|NCT01697163|De Novo Resistance|de novo resistance
338629|NCT01697163|Iressa|iressa
338630|NCT01697163|EGFR mutation|egfr mutation
338631|NCT01697163|lung cancer|lung cancer
338632|NCT01697150|Type 1 diabetes mellitus|type 1 diabetes mellitus
338633|NCT01697150|closed loop artificial pancreas|closed loop artificial pancreas
338634|NCT01697124|Physical activity|physical activity
338635|NCT01697124|children|children
338636|NCT01697124|Head Start|head start
338637|NCT01697124|SPARK-EC|spark-ec
338638|NCT01697111|YAZ|yaz
338639|NCT01697111|Flexible regimen|flexible regimen
338640|NCT01697111|Drospirenone|drospirenone
338641|NCT01697111|Ethinylestradiol Betadex|ethinylestradiol betadex
338642|NCT01697111|Endometriosis|endometriosis
338643|NCT01697111|Dienogest|dienogest
338644|NCT01697111|Japanese Patients|japanese patients
338645|NCT01697098|Dexamethasone|dexamethasone
338646|NCT01697098|preterm labour|preterm labour
338647|NCT01697098|respiratory distress|respiratory distress
338648|NCT01697085|sea buckthorn|sea buckthorn
338649|NCT01697085|mucous membrane|mucous membrane
338650|NCT01697085|dryness|dryness
338651|NCT01697085|metabolic syndrome|metabolic syndrome
338652|NCT01697085|vaginal atrophy|vaginal atrophy
338653|NCT01697072|Gastric Cancer|gastric cancer
338654|NCT01697072|First Line Treatment Gastroesophageal Junction (GEJ)|first line treatment gastroesophageal junction (gej)
338655|NCT01697072|Gastroesophageal Junction Cancer (GEJ)|gastroesophageal junction cancer (gej)
338656|NCT01697072|GEJ Cancer|gej cancer
338657|NCT01697059|appendicitis|appendicitis
338658|NCT01697046|peri-exposure|peri-exposure
338659|NCT01697046|chemoprophylaxis|chemoprophylaxis
338660|NCT01696942|Crohn's disease|crohn's disease
338661|NCT01696942|certolizumab|certolizumab
338662|NCT01696942|mesalamine|mesalamine
338663|NCT01696942|recurrence|recurrence
338664|NCT01696929|tocilizumab|tocilizumab
338665|NCT01696929|safety|safety
338666|NCT01696929|tolerability|tolerability
338667|NCT01696929|efficacy|efficacy
338668|NCT01696929|schizophrenia|schizophrenia
338669|NCT01696929|improvement|improvement
338670|NCT01696929|cognition|cognition
338671|NCT01696929|psychotic symptoms|psychotic symptoms
338672|NCT01696929|baseline IL-6 levels|baseline il-6 levels
338673|NCT01696916|COPD|copd
338674|NCT01696916|carbon dioxide|carbon dioxide
338675|NCT01696916|6-minute walking test|6-minute walking test
338676|NCT01696903|Postoperative pancreatic fistula|postoperative pancreatic fistula
338677|NCT01696903|Pancreatic texture|pancreatic texture
338678|NCT01696903|Pancreatic duct diameter|pancreatic duct diameter
338679|NCT01696903|Pancreatic consistency|pancreatic consistency
338680|NCT01696903|Pancreaticoduodenectomy|pancreaticoduodenectomy
338681|NCT01696890|chronic heart failure|chronic heart failure
338682|NCT01696890|telemonitoring|telemonitoring
338683|NCT01696890|first line practitioners|first line practitioners
338684|NCT01696890|integrated approach|integrated approach
338685|NCT01696890|efficacy|efficacy
338686|NCT01696838|Crohn's disease|crohn's disease
338687|NCT01696838|acupuncture|acupuncture
338688|NCT01696838|moxibustion|moxibustion
338689|NCT01696838|fMRI|fmri
338690|NCT01696838|Gut|gut
338691|NCT01696812|electrodeposition|electrodeposition
338692|NCT01696812|Subthalamic Nucleus|subthalamic nucleus
338693|NCT01696812|Deep Brain Stimulation|deep brain stimulation
338694|NCT01696812|Parkinson Disease|parkinson disease
338695|NCT01696773|tomato|tomato
338696|NCT01696773|tangerine tomato|tangerine tomato
338697|NCT01696773|carotenoids|carotenoids
338698|NCT01696773|lycopene|lycopene
338699|NCT01696773|flavonoids|flavonoids
338700|NCT01696747|gastroparesis|gastroparesis
338701|NCT01696747|idiopathic gastroparesis|idiopathic gastroparesis
338702|NCT01696747|diabetic gastroparesis|diabetic gastroparesis
338703|NCT01696747|post-Nissen gastroparesis|post-nissen gastroparesis
338704|NCT01696734|Gastrointestinal diseases|gastrointestinal diseases
338705|NCT01696734|GI|gi
338706|NCT01696734|Compassionate use|compassionate use
338707|NCT01696734|GI motility disorders|gi motility disorders
338708|NCT01696734|GI disorders|gi disorders
338709|NCT01696734|Gastroparesis|gastroparesis
338710|NCT01696734|Gastroesophageal reflux disease|gastroesophageal reflux disease
338711|NCT01696734|GERD|gerd
338712|NCT01696734|Chronic nausea and vomiting|chronic nausea and vomiting
338713|NCT01696734|Questionnaires|questionnaires
338714|NCT01696734|Surveys|surveys
338715|NCT01696734|Phone calls|phone calls
338716|NCT01696734|Domperidone|domperidone
338717|NCT01696721|Proton Therapy|proton therapy
338718|NCT01696721|Pediatrics|pediatrics
338719|NCT01696721|Radiation Oncology|radiation oncology
338720|NCT01696682|minimally invasive esophagectomy|minimally invasive esophagectomy
338721|NCT01696682|anastomotic leakage|anastomotic leakage
338722|NCT01696682|gastric conduit|gastric conduit
338723|NCT01696669|Ewing's Sarcoma|ewing's sarcoma
338724|NCT01696669|P6 protocol MSKCC|p6 protocol mskcc
338725|NCT01696669|Gemcitabine|gemcitabine
338726|NCT01696669|Docetaxel|docetaxel
338727|NCT01696656|Gastrointestinal drugs|gastrointestinal drugs
338728|NCT01696656|Antibiotics|antibiotics
338729|NCT01696656|Vitamins|vitamins
338730|NCT01696656|Minerals|minerals
338731|NCT01696656|Intestinal insufficiency|intestinal insufficiency
338732|NCT01696656|Short Bowel syndrome|short bowel syndrome
338733|NCT01696656|Adjuvant therapy|adjuvant therapy
338734|NCT01696656|Antacids|antacids
338735|NCT01696656|Gastrointestinal motility modifiers|gastrointestinal motility modifiers
338736|NCT01696656|Micronutrients|micronutrients
338737|NCT01696643|Opioid|opioid
338738|NCT01696643|Constipation|constipation
338739|NCT01696643|Chronic|chronic
338740|NCT01696643|Pain|pain
338741|NCT01696630|anesthesia, epidural anagesia, colorectal surgery, xenon, hemodynamic change|anesthesia, epidural anagesia, colorectal surgery, xenon, hemodynamic change
338742|NCT01696604|safety|safety
338743|NCT01696604|pharmacokinetics|pharmacokinetics
338744|NCT01696604|FTIH|ftih
338745|NCT01696604|SARM|sarm
338746|NCT01696591|Alzheimer, Mesenchymal Stem Cells, Umbilical Cord Blood|alzheimer, mesenchymal stem cells, umbilical cord blood
338747|NCT01696578|PTSD|ptsd
338748|NCT01696578|Depression|depression
338749|NCT01696578|Anxiety|anxiety
338750|NCT01696578|Chronic pain|chronic pain
338751|NCT01696578|Anger|anger
338752|NCT01696578|Heart rate variability|heart rate variability
338753|NCT01696578|Disability|disability
338754|NCT01696565|myelosuppression|myelosuppression
338755|NCT01696565|chemotherapy|chemotherapy
338756|NCT01696565|Astragalus membranaceus|astragalus membranaceus
338757|NCT01696565|hematopoietic response|hematopoietic response
338758|NCT01696552|Gonarthritis|gonarthritis
338759|NCT01696552|TKR|tkr
338760|NCT01696552|Conventional|conventional
338761|NCT01696552|Positioning Guides|positioning guides
338762|NCT01696552|PSPG|pspg
338763|NCT01696552|CT Perth|ct perth
338764|NCT01696539|Prostate Cancer|prostate cancer
338765|NCT01696526|vitamin D|vitamin d
338766|NCT01696526|bioeffiency|bioeffiency
338767|NCT01696526|vitamin d fortified fish|vitamin d fortified fish
338768|NCT01696500|IVIG in Stevens-Johnson syndrome|ivig in stevens-johnson syndrome
338769|NCT01696500|Toxic Epidermal Necrolysis|toxic epidermal necrolysis
338770|NCT01696500|Patients with Stevens-Johnson syndrome|patients with stevens-johnson syndrome
338771|NCT01696500|Toxic Epidermal Necrolysis unresponsive to corticosteroids|toxic epidermal necrolysis unresponsive to corticosteroids
338772|NCT01696487|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
338773|NCT01696487|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
338774|NCT01696487|NAFLD|nafld
338775|NCT01696487|NASH|nash
338776|NCT01696474|Refractory cold agglutinin disease|refractory cold agglutinin disease
338777|NCT01696474|Bortezomib|bortezomib
338778|NCT01696474|blood-transfusion|blood-transfusion
338779|NCT01696448|Appetite Suppression|appetite suppression
338780|NCT01696448|CAR-191|car-191
338781|NCT01696435|Depression|depression
338782|NCT01696435|Depressive Symptoms|depressive symptoms
338783|NCT01696435|Mood|mood
338784|NCT01696435|Geriatric|geriatric
338785|NCT01696435|Prevention|prevention
338786|NCT01696422|Dengue|dengue
338787|NCT01696422|tetravalent attenuated Vaccine|tetravalent attenuated vaccine
338788|NCT01696422|Healthy adults|healthy adults
338789|NCT01696396|IBD, Crohn's Disease|ibd, crohn's disease
338790|NCT01696383|Intraocular Pressure (IOP)|intraocular pressure (iop)
338791|NCT01696383|Glaucoma|glaucoma
338792|NCT01696383|Ocular hypertension|ocular hypertension
338793|NCT01696383|DuoTrav|duotrav
338794|NCT01696383|Prostaglandin analogue|prostaglandin analogue
338795|NCT01696383|Beta-blocker|beta-blocker
338796|NCT01696370|Trimetazidine|trimetazidine
338797|NCT01696357|Asthma|asthma
338798|NCT01696357|Adolescents|adolescents
338799|NCT01696357|Self-monitoring|self-monitoring
338800|NCT01696357|Quality of life|quality of life
338801|NCT01696357|Biomedical device|biomedical device
338802|NCT01696357|Symptom monitoring|symptom monitoring
338803|NCT01696357|Self-management|self-management
338804|NCT01696344|LSPAF|lspaf
338805|NCT01696344|AF termination|af termination
338806|NCT01696344|PVAI|pvai
338807|NCT01696344|nonPV triggers|nonpv triggers
338808|NCT01696344|Long-standing persistent|long-standing persistent
338809|NCT01696305|Thyroid disease|thyroid disease
338810|NCT01696305|Hyalobarrier|hyalobarrier
338811|NCT01696305|Thyroidectomy|thyroidectomy
338812|NCT01696305|anti-adhesive effect|anti-adhesive effect
338813|NCT01696240|Pulmonary Hypertension|pulmonary hypertension
338814|NCT01696240|Exercise Capacity|exercise capacity
338815|NCT01696240|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
338816|NCT01696240|Udenafil (Zydena)|udenafil (zydena)
338817|NCT01696240|Phosphodiesterase Type 5 Inhibitors|phosphodiesterase type 5 inhibitors
338818|NCT01696227|Nissle 1917|nissle 1917
338819|NCT01696227|Probiotic|probiotic
338820|NCT01696227|Uropathogen|uropathogen
338821|NCT01696214|asthma,smokers|asthma,smokers
338822|NCT01696201|Pregnancy, outcomes, depression, mood, physical exercise|pregnancy, outcomes, depression, mood, physical exercise
338823|NCT01696188|Interscalene|interscalene
338824|NCT01696188|nerve block|nerve block
338825|NCT01696188|nerve catheter|nerve catheter
338826|NCT01696188|in-plane|in-plane
338827|NCT01696188|out-of-plane|out-of-plane
338828|NCT01696188|anterolateral approach|anterolateral approach
338829|NCT01696188|posterior approach|posterior approach
338830|NCT01696188|shoulder surgery|shoulder surgery
338831|NCT01696175|ScvO2|scvo2
338832|NCT01696175|venous|venous
338833|NCT01696175|oxymetry|oxymetry
338834|NCT01696175|lactate|lactate
338835|NCT01696175|children|children
338836|NCT01696175|PICU|picu
338837|NCT01696175|Admission parameters of shock|admission parameters of shock
338838|NCT01696162|Knee pain|knee pain
338839|NCT01696162|Anterior knee pain|anterior knee pain
338840|NCT01696162|Patellofemoral|patellofemoral
338841|NCT01696162|Patellofemoral syndrome|patellofemoral syndrome
338842|NCT01696162|Runners knee|runners knee
338843|NCT01696149|TENS, sympathetic skin response, skin temperature|tens, sympathetic skin response, skin temperature
338844|NCT01696136|Ablation|ablation
338845|NCT01696136|Multi-electrode catheter|multi-electrode catheter
338846|NCT01696136|Single-tip catheter|single-tip catheter
338847|NCT01696136|Holter|holter
338848|NCT01696123|Alzheimer disease|alzheimer disease
338849|NCT01696123|Cholinesterase inhibitors|cholinesterase inhibitors
338850|NCT01696123|MLC601|mlc601
338851|NCT01696123|NeuroAiD|neuroaid
338852|NCT01696123|neuroprotection|neuroprotection
338853|NCT01696123|neuroregeneration|neuroregeneration
338854|NCT01696110|Bivalirudin|bivalirudin
338855|NCT01696110|Acute myocardial infarction|acute myocardial infarction
338856|NCT01696110|percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
338857|NCT01696084|AML|aml
338858|NCT01696084|Acute Myeloid Leukemia|acute myeloid leukemia
338859|NCT01696084|high risk AML|high risk aml
338860|NCT01696084|secondary AML|secondary aml
338861|NCT01696084|AML in elderly|aml in elderly
338862|NCT01696032|Ovarian Cancer|ovarian cancer
338863|NCT01696019|magnetic resonance imaging|magnetic resonance imaging
338864|NCT01696019|cognition|cognition
338865|NCT01696019|Tai Chi|tai chi
338866|NCT01696019|physical exercise|physical exercise
338867|NCT01696019|mental exercise|mental exercise
338868|NCT01696019|intervention trial|intervention trial
338869|NCT01696019|prevention|prevention
338870|NCT01696019|dementia|dementia
338871|NCT01696019|Alzheimer disease|alzheimer disease
338872|NCT01696019|mild cognitive impairment|mild cognitive impairment
338873|NCT01696006|perfusion computed tomography|perfusion computed tomography
338874|NCT01696006|coronary artery disease|coronary artery disease
338875|NCT01695993|Nausea|nausea
338876|NCT01695993|Quality of life|quality of life
338877|NCT01695993|Chemotherapy|chemotherapy
338878|NCT01695993|Expectancy|expectancy
338879|NCT01695980|adenotonsillectomy|adenotonsillectomy
338880|NCT01695967|nasal obstruction|nasal obstruction
338881|NCT01695954|HIV|hiv
338882|NCT01695954|Hyperlipidemia|hyperlipidemia
338883|NCT01695954|Pharmacokinetics|pharmacokinetics
338884|NCT01695954|Statins|statins
338885|NCT01695954|Darunavir|darunavir
338886|NCT01695954|Efavirenz|efavirenz
338887|NCT01695954|Pitavastatin|pitavastatin
338888|NCT01695928|Velocity|velocity
338889|NCT01695928|Location|location
338890|NCT01695928|Periodontal status|periodontal status
338891|NCT01695915|constipation|constipation
338892|NCT01695915|children|children
338893|NCT01695915|healthy|healthy
338894|NCT01695915|rectal diameter|rectal diameter
338895|NCT01695863|Miralax with gatorade and dulcolax|miralax with gatorade and dulcolax
338896|NCT01695863|Movi pre|movi pre
338897|NCT01695863|Patient satisfaction and efficacy|patient satisfaction and efficacy
338898|NCT01695850|Randomized controlled trial|randomized controlled trial
338899|NCT01695850|Drugs,Chinese Herbal|drugs,chinese herbal
338900|NCT01695850|Constipation/drug therapy|constipation/drug therapy
338901|NCT01695837|Diet counseling|diet counseling
338902|NCT01695837|primary care|primary care
338903|NCT01695824|catheter ablation|catheter ablation
338904|NCT01695811|Keratoconus, PKP, femtosecond laser assisted keratoplasty|keratoconus, pkp, femtosecond laser assisted keratoplasty
338905|NCT01695798|poliomyelitis|poliomyelitis
338906|NCT01695798|oral polio vaccine|oral polio vaccine
338907|NCT01695798|OPV|opv
338908|NCT01695798|seroconversion|seroconversion
338909|NCT01695798|mucosal immunity|mucosal immunity
338910|NCT01695798|malnutrition|malnutrition
338911|NCT01695798|IPV|ipv
338912|NCT01695798|Inactivated polio vaccine|inactivated polio vaccine
338913|NCT01695798|Pakistan|pakistan
338914|NCT01695759|Anemia Secondary|anemia secondary
338915|NCT01695759|Chronic Kidney Disease|chronic kidney disease
338916|NCT01695720|Knee Injuries|knee injuries
338917|NCT01695720|Meniscus Injuries|meniscus injuries
338918|NCT01695720|Articular Cartilage Injuries|articular cartilage injuries
338919|NCT01695720|Orthopaedic Diagnostic|orthopaedic diagnostic
338920|NCT01695720|Magnetic Resonance Imaging|magnetic resonance imaging
338921|NCT01695707|atopic dermatitis|atopic dermatitis
338922|NCT01695707|eczema|eczema
338923|NCT01695681|Quality of life|quality of life
338924|NCT01695681|Celiac Disease/diet therapy|celiac disease/diet therapy
338925|NCT01695681|Celiac Disease/diagnosis|celiac disease/diagnosis
338926|NCT01695681|Prospective Studies|prospective studies
338927|NCT01695668|Graft versus Host Disease (GVHD)|graft versus host disease (gvhd)
338928|NCT01695668|dry eyes|dry eyes
338929|NCT01695668|Bone marrow transplant (BMT)|bone marrow transplant (bmt)
338930|NCT01695668|Restasis|restasis
338931|NCT01695668|Lotemax|lotemax
338932|NCT01695642|lasik, intralase, microkeratome|lasik, intralase, microkeratome
338933|NCT01695603|Brain injury|brain injury
338934|NCT01695603|Controlled ventilation|controlled ventilation
338935|NCT01695603|Intellivent|intellivent
338936|NCT01695603|Capnia control|capnia control
338937|NCT01695590|Myeloma|myeloma
338938|NCT01695590|PRLX93936|prlx93936
338939|NCT01695577|Traumatic brain injury|traumatic brain injury
338940|NCT01695577|Dizziness|dizziness
338941|NCT01695577|Vestibular rehabilitation|vestibular rehabilitation
338942|NCT01695577|Balance rehabilitation|balance rehabilitation
338943|NCT01695564|atrial enlargement|atrial enlargement
338944|NCT01695564|left atrial appendage|left atrial appendage
338945|NCT01695551|Radiofrequency ablation|radiofrequency ablation
338946|NCT01695551|fast heart rhythm|fast heart rhythm
338947|NCT01695551|ventricle|ventricle
338948|NCT01695551|catheter ablation|catheter ablation
338949|NCT01695551|ablation|ablation
338950|NCT01695538|Yoga|yoga
338951|NCT01695538|atrial tachycardia|atrial tachycardia
338952|NCT01695525|Neurocardiogenic Syncope|neurocardiogenic syncope
338953|NCT01695525|Yoga|yoga
338954|NCT01695486|BIS|bis
338955|NCT01695486|Comfort|comfort
338956|NCT01695486|open muscle biopsy|open muscle biopsy
338957|NCT01695473|Prostate cancer|prostate cancer
338958|NCT01695473|High-risk prostate cancer|high-risk prostate cancer
338959|NCT01695473|Radical prostatectomy|radical prostatectomy
338960|NCT01695473|BKM120|bkm120
338961|NCT01695460|Migraine|migraine
338962|NCT01695460|Vitamin D|vitamin d
338963|NCT01695434|multiple sclerosis|multiple sclerosis
338964|NCT01695434|MRI|mri
338965|NCT01695434|Copaxone|copaxone
338966|NCT01695434|healthy controls|healthy controls
338967|NCT01695434|glatiramer acetate|glatiramer acetate
338968|NCT01695421|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
338969|NCT01695421|Oxygen Consumption|oxygen consumption
338970|NCT01695421|Heart Failure|heart failure
338971|NCT01695408|Drug Treatment|drug treatment
338972|NCT01695408|Treatment pathways|treatment pathways
338973|NCT01695408|Clinical routine|clinical routine
338974|NCT01695408|Registry|registry
338975|NCT01695408|Outcomes|outcomes
338976|NCT01695408|Survival|survival
338977|NCT01695408|Patient-related outcomes|patient-related outcomes
338978|NCT01695408|Quality of life|quality of life
338979|NCT01695408|Steroids|steroids
338980|NCT01695408|Azathioprine|azathioprine
338981|NCT01695408|N-Acetylcysteine|n-acetylcysteine
338982|NCT01695408|Pirfenidone|pirfenidone
338983|NCT01695408|Tyrosine kinase inhibitors|tyrosine kinase inhibitors
338984|NCT01695408|Nintedanib|nintedanib
338985|NCT01695408|multicenter|multicenter
338986|NCT01695408|Germany|germany
338987|NCT01695408|Safety|safety
338988|NCT01695408|Adverse event|adverse event
338989|NCT01695395|intellectual disability|intellectual disability
338990|NCT01695395|mental disorder|mental disorder
338991|NCT01695395|dual diagnosis|dual diagnosis
338992|NCT01695395|provision|provision
338993|NCT01695395|needs assessment|needs assessment
338994|NCT01695395|quality of life|quality of life
338995|NCT01695382|Cancer|cancer
338996|NCT01695382|Palliative Care|palliative care
338997|NCT01695382|Patient Navigation|patient navigation
338998|NCT01695356|Melasma|melasma
338999|NCT01695356|sunscreens|sunscreens
339000|NCT01695356|visible light|visible light
339001|NCT01695356|ultraviolet light|ultraviolet light
339002|NCT01695343|Cystic Fibrosis|cystic fibrosis
339003|NCT01695343|Pseudomonas aeruginosa (Pa)|pseudomonas aeruginosa (pa)
339004|NCT01695343|CF|cf
339005|NCT01695330|Multiple Myeloma|multiple myeloma
339006|NCT01695330|Relapsed|relapsed
339007|NCT01695330|Refractory|refractory
339008|NCT01695330|Bortezomib|bortezomib
339498|NCT01693289|letrozole|letrozole
339009|NCT01695330|Subcutaneous|subcutaneous
339010|NCT01695330|Oncotherapeutics|oncotherapeutics
339011|NCT01695317|Migraine|migraine
339012|NCT01695317|Preventive medication|preventive medication
339013|NCT01695304|Cryptosporidiosis|cryptosporidiosis
339014|NCT01695304|Waterborne disease|waterborne disease
339015|NCT01695304|Diarrheal disease|diarrheal disease
339016|NCT01695304|Ceramic water filters|ceramic water filters
339017|NCT01695304|infants|infants
339018|NCT01695304|young children|young children
339019|NCT01695304|drinking water|drinking water
339020|NCT01695304|Kenya|kenya
339021|NCT01695291|Obsessive compulsive disorder|obsessive compulsive disorder
339022|NCT01695278|motivational interviewing|motivational interviewing
339023|NCT01695278|telephone counseling|telephone counseling
339024|NCT01695278|medical education|medical education
339025|NCT01695278|diabetes self management|diabetes self management
339026|NCT01695265|Airflow Obstruction|airflow obstruction
339027|NCT01695226|Celecoxib|celecoxib
339028|NCT01695226|Clinical trial, Phase II|clinical trial, phase ii
339029|NCT01695226|Oligonucleotide Array Sequence Analysis|oligonucleotide array sequence analysis
339030|NCT01695213|uncemented hip|uncemented hip
339031|NCT01695213|bone remodeling|bone remodeling
339032|NCT01695213|DEXA|dexa
339033|NCT01695213|clinical evaluation|clinical evaluation
339034|NCT01695187|Herpes, Herpes Labialis, nanoemulsion, NanoBio, NB-001|herpes, herpes labialis, nanoemulsion, nanobio, nb-001
339035|NCT01695174|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
339036|NCT01695174|Xifaxan|xifaxan
339037|NCT01695161|Mucopolysaccharidosis|mucopolysaccharidosis
339038|NCT01695161|Fabry disease|fabry disease
339039|NCT01695148|beta-carotene biofortified maize|beta-carotene biofortified maize
339040|NCT01695148|micronutrients|micronutrients
339041|NCT01695148|vitamin A|vitamin a
339042|NCT01695148|serum retinol|serum retinol
339043|NCT01695148|dark adaptation|dark adaptation
339044|NCT01695135|Prostate neoplasms|prostate neoplasms
339045|NCT01695135|Prostate cancer|prostate cancer
339046|NCT01695135|Metastatic castration resistant prostate cancer|metastatic castration resistant prostate cancer
339047|NCT01695135|Abiraterone acetate|abiraterone acetate
339048|NCT01695135|JNJ-212082|jnj-212082
339049|NCT01695122|Head and Neck Cancer|head and neck cancer
339050|NCT01695122|Oropharyngeal cancer|oropharyngeal cancer
339051|NCT01695122|Oral cavity cancer|oral cavity cancer
339052|NCT01695122|Chemoradiation|chemoradiation
339053|NCT01695122|valproic acid|valproic acid
339054|NCT01695122|histone deacetylase|histone deacetylase
339055|NCT01695109|GLP1|glp1
339056|NCT01695109|obesity|obesity
339057|NCT01695109|fMRI|fmri
339058|NCT01695109|ghrelin|ghrelin
339059|NCT01695083|Non alcoholic steatohepatitis|non alcoholic steatohepatitis
339060|NCT01695083|Liver fibrosis,Steatosis|liver fibrosis,steatosis
339061|NCT01695083|Liver inflammation|liver inflammation
339062|NCT01695083|Morbid obesity|morbid obesity
339063|NCT01695083|Non invasive tests|non invasive tests
339064|NCT01695031|Urban adolescents|urban adolescents
339065|NCT01695031|Acute asthma|acute asthma
339066|NCT01695031|Emergency department|emergency department
339067|NCT01695031|Computer tailoring|computer tailoring
339068|NCT01695031|Web-based intervention|web-based intervention
339069|NCT01695018|oral epithelial dysplasia|oral epithelial dysplasia
339070|NCT01695018|p16 methylation|p16 methylation
339071|NCT01695018|diagnostic reagents|diagnostic reagents
339072|NCT01695018|early diagnosis|early diagnosis
339073|NCT01694992|Stroke|stroke
339074|NCT01694992|Early Ambulation|early ambulation
339075|NCT01694992|Rehabilitation|rehabilitation
339076|NCT01694992|Physical Therapy|physical therapy
339077|NCT01694992|Randomized controlled trial|randomized controlled trial
339078|NCT01694979|Pelvic floor|pelvic floor
339079|NCT01694979|Rehabilitation|rehabilitation
339080|NCT01694979|Respiration|respiration
339081|NCT01694979|Urinary incontinence|urinary incontinence
339082|NCT01694953|MNGIE|mngie
339083|NCT01694953|Mitochondrial|mitochondrial
339084|NCT01694953|Mitochondrial Neurogastrointestinal encephalopathy|mitochondrial neurogastrointestinal encephalopathy
339085|NCT01694940|mitochondrial disorders|mitochondrial disorders
339086|NCT01694940|Mito Disease|mito disease
339087|NCT01694940|Mitochondria|mitochondria
339088|NCT01694940|Mitochondrial disease|mitochondrial disease
339089|NCT01694940|Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke (MELAS) Syndrome|mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke (melas) syndrome
339090|NCT01694940|Myoclonic Epilepsy with Ragged Red Fibers (MERRF)|myoclonic epilepsy with ragged red fibers (merrf)
339091|NCT01694940|Leber Hereditary Optic Neuropathy (LHON)|leber hereditary optic neuropathy (lhon)
339092|NCT01694940|Leigh Syndrome|leigh syndrome
339093|NCT01694940|Neuropathy, ataxia, and retinitis pigmentosa (NARP)|neuropathy, ataxia, and retinitis pigmentosa (narp)
339094|NCT01694940|Kearns Sayre syndrome|kearns sayre syndrome
339095|NCT01694940|Alpers Huttenlocher|alpers huttenlocher
339096|NCT01694940|Pearson|pearson
339097|NCT01694940|Mitochondrial Neurogastrointestinal Encephalopathy (MNGIE)|mitochondrial neurogastrointestinal encephalopathy (mngie)
339098|NCT01694940|Barth Syndrome|barth syndrome
339099|NCT01694940|Coenzyme Q (CoQ) Deficiency|coenzyme q (coq) deficiency
339195|NCT01694537|euglobulin clot lysis time|euglobulin clot lysis time
339100|NCT01694940|Chronic progressive external ophthalmoplegia (CPEO)|chronic progressive external ophthalmoplegia (cpeo)
339101|NCT01694940|DAD|dad
339102|NCT01694940|Diabetes and Deafness|diabetes and deafness
339103|NCT01694940|Encephalopathy|encephalopathy
339104|NCT01694940|Encephalomyopathy|encephalomyopathy
339105|NCT01694940|Familial Bilateral Striatal Necrosis (FBSN)|familial bilateral striatal necrosis (fbsn)
339106|NCT01694940|Hepatocerebral Disease|hepatocerebral disease
339107|NCT01694940|Leukoencephalopathy|leukoencephalopathy
339108|NCT01694940|Maternally Inherited Leigh Syndrome (MILS)|maternally inherited leigh syndrome (mils)
339109|NCT01694940|Complex I Deficiency|complex i deficiency
339110|NCT01694940|Complex II Deficiency|complex ii deficiency
339111|NCT01694940|Complex III Deficiency|complex iii deficiency
339112|NCT01694940|Complex IV Deficiency|complex iv deficiency
339113|NCT01694940|Complex V Deficiency|complex v deficiency
339114|NCT01694940|mitochondrial DNA depletion syndrome|mitochondrial dna depletion syndrome
339115|NCT01694940|mtDNA depletion syndrome|mtdna depletion syndrome
339116|NCT01694927|Mesenchymal stem cell|mesenchymal stem cell
339117|NCT01694927|Spinal cord injury|spinal cord injury
339118|NCT01694914|Corneal Transplantation|corneal transplantation
339119|NCT01694914|corneal organ culture medium|corneal organ culture medium
339120|NCT01694914|free animal compound medium|free animal compound medium
339121|NCT01694888|Students practice, Lecture; Nursing records; Nursing education; Midwifery|students practice, lecture; nursing records; nursing education; midwifery
339122|NCT01694875|cervix cancer|cervix cancer
339123|NCT01694875|HPV|hpv
339124|NCT01694875|APTIMA|aptima
339125|NCT01694862|quasi experimental|quasi experimental
339126|NCT01694862|evaluation|evaluation
339127|NCT01694862|intervention|intervention
339128|NCT01694862|service integration|service integration
339129|NCT01694862|cost analysis|cost analysis
339130|NCT01694862|HIV|hiv
339131|NCT01694862|FP|fp
339132|NCT01694862|PNC|pnc
339133|NCT01694862|Sub-Saharan Africa|sub-saharan africa
339134|NCT01694849|PPARs|ppars
339135|NCT01694849|NASH|nash
339136|NCT01694849|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
339137|NCT01694849|Liver Diseases|liver diseases
339138|NCT01694849|Fibrosis|fibrosis
339139|NCT01694836|Allergic rhinitis|allergic rhinitis
339140|NCT01694836|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
339141|NCT01694836|Allergy induced asthma|allergy induced asthma
339142|NCT01694836|Birch (Betula alba)|birch (betula alba)
339143|NCT01694836|Hayfever|hayfever
339144|NCT01694836|Immunotherapy|immunotherapy
339145|NCT01694823|Cartilage repair|cartilage repair
339146|NCT01694823|Cartilage defects|cartilage defects
339147|NCT01694823|cell sheet|cell sheet
339148|NCT01694823|Autologous chondrocyte implantation|autologous chondrocyte implantation
339149|NCT01694810|acne vulgaris|acne vulgaris
339150|NCT01694758|Benchmarking could improve quality of patient care|benchmarking could improve quality of patient care
339151|NCT01694758|ESC and ATP III Guidelines|esc and atp iii guidelines
339152|NCT01694745|Newborns|newborns
339153|NCT01694745|Premature|premature
339154|NCT01694745|Pain|pain
339155|NCT01694745|Pain assessment|pain assessment
339156|NCT01694745|Endotracheal Intubation|endotracheal intubation
339157|NCT01694745|Analgesia|analgesia
339158|NCT01694745|Sedation|sedation
339159|NCT01694745|Longterm effects of pain|longterm effects of pain
339160|NCT01694745|Epidemiology|epidemiology
339161|NCT01694732|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
339162|NCT01694732|Varenicline|varenicline
339163|NCT01694732|Smoking cessation|smoking cessation
339164|NCT01694719|Depression|depression
339165|NCT01694719|Major Depressive Disorder|major depressive disorder
339166|NCT01694719|Behavioral Activation|behavioral activation
339167|NCT01694719|Cognitive Training|cognitive training
339168|NCT01694680|AMD|amd
339169|NCT01694680|Lutein|lutein
339170|NCT01694680|Visual function|visual function
339171|NCT01694680|Early signs of AMD|early signs of amd
339172|NCT01694680|AREDS-category 2|areds-category 2
339173|NCT01694641|time lapse monitoring|time lapse monitoring
339174|NCT01694641|blastocyst|blastocyst
339175|NCT01694641|single embryo transfer|single embryo transfer
339176|NCT01694641|clinical pregnancy|clinical pregnancy
339177|NCT01694641|implantation rate|implantation rate
339178|NCT01694615|Lung Transplantation|lung transplantation
339179|NCT01694615|Acute Rejection|acute rejection
339180|NCT01694602|Cachexia|cachexia
339181|NCT01694602|Sarcopenia|sarcopenia
339182|NCT01694602|De Novo|de novo
339183|NCT01694602|Deuterated|deuterated
339184|NCT01694589|pancreatic cancer|pancreatic cancer
339185|NCT01694589|resectable pancreatic cancer|resectable pancreatic cancer
339186|NCT01694576|Nasopharyngeal carcinoma staged N2-3M0|nasopharyngeal carcinoma staged n2-3m0
339187|NCT01694576|Adjuvant chemotherapy|adjuvant chemotherapy
339188|NCT01694563|Atrial Fibrillation|atrial fibrillation
339189|NCT01694550|pacemaker|pacemaker
339190|NCT01694550|ICD / CRTD|icd / crtd
339191|NCT01694550|corrected QT-interval|corrected qt-interval
339192|NCT01694537|lumbrokinase|lumbrokinase
339193|NCT01694537|fibrinolytic|fibrinolytic
339194|NCT01694537|plasmin-antiplasmin complex|plasmin-antiplasmin complex
339497|NCT01693289|Metformin|metformin
339196|NCT01694537|platelet aggregation|platelet aggregation
339197|NCT01694511|Endoscopy, Gastrointestinal|endoscopy, gastrointestinal
339198|NCT01694485|Ulcerative Colitis, IBD|ulcerative colitis, ibd
339199|NCT01694459|angioplasty|angioplasty
339200|NCT01694459|heparin|heparin
339201|NCT01694459|trial|trial
339202|NCT01694446|Intestinal lipoprotein|intestinal lipoprotein
339203|NCT01694446|Apo B48 and apoB100|apo b48 and apob100
339204|NCT01694446|Pancreatic clamp|pancreatic clamp
339205|NCT01694407|Prevention|prevention
339206|NCT01694394|atrial fibrillation|atrial fibrillation
339207|NCT01694394|implantable cardiac monitor|implantable cardiac monitor
339208|NCT01694394|left atrial enlargement|left atrial enlargement
339209|NCT01694394|CHA2DS2 VASc Score|cha2ds2 vasc score
339210|NCT01694394|cardiovascular risk|cardiovascular risk
339211|NCT01694381|Acute Ischemic Stroke|acute ischemic stroke
339212|NCT01694381|TS01|ts01
339213|NCT01694381|Mutant pro-urokinase|mutant pro-urokinase
339214|NCT01694381|M5|m5
339215|NCT01694381|C1 inhibitor|c1 inhibitor
339216|NCT01694381|Safety|safety
339217|NCT01694381|Stroke|stroke
339218|NCT01694381|Tolerability|tolerability
339219|NCT01694381|Ischemia|ischemia
339220|NCT01694381|Cerebral Infarction|cerebral infarction
339221|NCT01694381|Cerebrovascular Disorders|cerebrovascular disorders
339222|NCT01694381|Vascular Diseases|vascular diseases
339223|NCT01694381|Cardiovascular Diseases|cardiovascular diseases
339224|NCT01694381|Brain Infarction|brain infarction
339225|NCT01694381|Brain Ischemia|brain ischemia
339226|NCT01694381|Fibrinolytic Agents|fibrinolytic agents
339227|NCT01694381|Thrombolytic Agents|thrombolytic agents
339228|NCT01694381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
339229|NCT01694381|Pharmacologic Actions|pharmacologic actions
339230|NCT01694381|Cardiovascular Agents|cardiovascular agents
339231|NCT01694381|Therapeutic Uses|therapeutic uses
339232|NCT01694381|Hematologic Agents|hematologic agents
339233|NCT01694368|Near infrared spectroscopy; lipid core; vulnerable plaque|near infrared spectroscopy; lipid core; vulnerable plaque
339234|NCT01694329|Streptococcus pneumoniae|streptococcus pneumoniae
339235|NCT01694329|Pneumococcal Conjugate Vaccines|pneumococcal conjugate vaccines
339236|NCT01694329|Immunization|immunization
339237|NCT01694329|Otitis media|otitis media
339238|NCT01694316|Computerized neurobehavioral intervention|computerized neurobehavioral intervention
339239|NCT01694277|Gastrointestinal Stromal Tumour|gastrointestinal stromal tumour
339240|NCT01694277|GIST|gist
339241|NCT01694277|non-resectable|non-resectable
339242|NCT01694277|metastatic|metastatic
339243|NCT01694277|second line treatment|second line treatment
339244|NCT01694277|resistance to imatinib|resistance to imatinib
339245|NCT01694264|HBV surface antigen|hbv surface antigen
339246|NCT01694264|Anti-HBc positive|anti-hbc positive
339247|NCT01694264|Anti-TNFα Treatment|anti-tnfα treatment
339248|NCT01694264|Reactivation|reactivation
339249|NCT01694251|mitral valve area|mitral valve area
339250|NCT01694251|pressure half time|pressure half time
339251|NCT01694251|3 dimensional transesophageal echocardiography|3 dimensional transesophageal echocardiography
339252|NCT01694251|computed tomography|computed tomography
339253|NCT01694238|Colostomy|colostomy
339254|NCT01694238|Surgical technique|surgical technique
339255|NCT01694225|Breast cancer|breast cancer
339256|NCT01694225|Anti-estrogen therapy|anti-estrogen therapy
339257|NCT01694212|Macular edema|macular edema
339258|NCT01694212|Cataract|cataract
339259|NCT01694212|Diabetic retinopathy|diabetic retinopathy
339260|NCT01694212|Anti-inflammatory agents,Non-steroidal|anti-inflammatory agents,non-steroidal
339261|NCT01694199|Pulsed Radiofrequency Energy (PRFE)|pulsed radiofrequency energy (prfe)
339262|NCT01694199|Pain|pain
339263|NCT01694199|Postsurgical|postsurgical
339264|NCT01694199|Opioids|opioids
339265|NCT01694199|Pain relief|pain relief
339266|NCT01694199|Medical device|medical device
339267|NCT01694199|Endorphins|endorphins
339268|NCT01694173|Type 2 diabetes mellitus, F18-FDG labelled stem cells|type 2 diabetes mellitus, f18-fdg labelled stem cells
339269|NCT01694160|kidney transplant patients|kidney transplant patients
339270|NCT01694160|Albuminuria|albuminuria
339271|NCT01694147|relationship|relationship
339272|NCT01694147|endothelial injury|endothelial injury
339273|NCT01694147|vascular permeability|vascular permeability
339274|NCT01694147|severe sepsis related ALI/ARDS|severe sepsis related ali/ards
339275|NCT01694134|Discopathy|discopathy
339276|NCT01694134|Modic I|modic i
339277|NCT01694134|Corticoids|corticoids
339278|NCT01694134|Local Anaesthetic|local anaesthetic
339279|NCT01694134|Intradiscal injection|intradiscal injection
339280|NCT01694121|HIV prevention|hiv prevention
339281|NCT01694121|African American men|african american men
339282|NCT01694121|evaluation study|evaluation study
339283|NCT01694095|Geographic atrophy, prognosis, risk factors, natural history|geographic atrophy, prognosis, risk factors, natural history
339284|NCT01694082|brief intervention|brief intervention
339285|NCT01694082|web-based interventions|web-based interventions
339286|NCT01694082|computer-based interventions|computer-based interventions
339287|NCT01694082|harm reduction|harm reduction
339288|NCT01694082|young adult|young adult
339289|NCT01694082|college student|college student
339290|NCT01694069|piperacillin|piperacillin
339291|NCT01694069|tazobactam|tazobactam
339292|NCT01694069|pseudomonas aeruginosa|pseudomonas aeruginosa
339293|NCT01694069|cystic fibrosis|cystic fibrosis
339294|NCT01694069|pulmonary exacerbation|pulmonary exacerbation
339295|NCT01694069|continuous infusion|continuous infusion
339296|NCT01694069|beta lactam|beta lactam
339297|NCT01694030|Attachment security priming|attachment security priming
339298|NCT01694030|depressed mood|depressed mood
339299|NCT01694017|HIV,treatment,cost effectiveness,drug toxicity,QOL,costs|hiv,treatment,cost effectiveness,drug toxicity,qol,costs
339300|NCT01694004|Nutrient absorption|nutrient absorption
339301|NCT01694004|Duodenal feeding tube|duodenal feeding tube
339302|NCT01694004|Gut-brain-gut axis|gut-brain-gut axis
339303|NCT01693978|PTSD|ptsd
339304|NCT01693978|Prolonged Exposure|prolonged exposure
339305|NCT01693978|Comorbidity|comorbidity
339306|NCT01693978|Treatment|treatment
339307|NCT01693978|Methadone Maintenance|methadone maintenance
339308|NCT01693978|Substance Use Disorder|substance use disorder
339309|NCT01693939|Lasik|lasik
339310|NCT01693939|Myopia|myopia
339311|NCT01693939|Femtosecond Laser|femtosecond laser
339312|NCT01693926|Obesity|obesity
339313|NCT01693926|Children|children
339314|NCT01693926|Physical activity|physical activity
339315|NCT01693926|Stress|stress
339316|NCT01693926|Snacking|snacking
339317|NCT01693900|joint replacement|joint replacement
339318|NCT01693900|total hip replacement|total hip replacement
339319|NCT01693900|regional pain block|regional pain block
339320|NCT01693900|ultrasound guidance|ultrasound guidance
339321|NCT01693900|fascia iliaca compartment block|fascia iliaca compartment block
339322|NCT01693887|IFI|ifi
339323|NCT01693887|empirical therapy|empirical therapy
339324|NCT01693887|preemptive therapy|preemptive therapy
339325|NCT01693887|Itraconazole|itraconazole
339326|NCT01693874|anxiety|anxiety
339327|NCT01693874|depression|depression
339328|NCT01693874|cognition|cognition
339329|NCT01693874|MBSR|mbsr
339330|NCT01693874|mindfulness|mindfulness
339331|NCT01693874|stress|stress
339332|NCT01693874|elderly|elderly
339333|NCT01693861|Colorectal|colorectal
339334|NCT01693861|Cancer|cancer
339335|NCT01693861|Metastatic|metastatic
339336|NCT01693861|Chronotherapy|chronotherapy
339337|NCT01693861|Urine|urine
339338|NCT01693861|Nucleosides|nucleosides
339339|NCT01693861|Chemotherapy|chemotherapy
339340|NCT01693861|Treated with chemotherapy|treated with chemotherapy
339341|NCT01693848|Colorectal|colorectal
339342|NCT01693848|Cancer|cancer
339343|NCT01693848|Metastatic|metastatic
339344|NCT01693848|Control|control
339345|NCT01693848|Urine|urine
339346|NCT01693848|Nucleosides|nucleosides
339347|NCT01693848|Surgery|surgery
339348|NCT01693848|General anesthesia|general anesthesia
339349|NCT01693848|Scheduled for surgery|scheduled for surgery
339350|NCT01693835|Colorectal|colorectal
339351|NCT01693835|Cancer|cancer
339352|NCT01693835|Metastatic|metastatic
339353|NCT01693835|Healthy|healthy
339354|NCT01693835|Control|control
339355|NCT01693835|Circadian|circadian
339356|NCT01693835|Urine|urine
339357|NCT01693835|Nucleosides|nucleosides
339358|NCT01693822|metastatic renal cell carcinoma|metastatic renal cell carcinoma
339359|NCT01693822|predominant clear cell histology|predominant clear cell histology
339360|NCT01693822|Unsuitable for nephrectomy|unsuitable for nephrectomy
339361|NCT01693822|unsuitable for 'watch and wait' policy|unsuitable for 'watch and wait' policy
339362|NCT01693809|Caffeine|caffeine
339363|NCT01693809|Vestibular Evoked Myogenic Potentials|vestibular evoked myogenic potentials
339364|NCT01693809|dizziness|dizziness
339365|NCT01693809|vertigo|vertigo
339366|NCT01693809|tinnitus|tinnitus
339367|NCT01693770|Bone Metastasis|bone metastasis
339368|NCT01693770|Pain Palliation|pain palliation
339369|NCT01693770|High Intensity Focused Ultrasound|high intensity focused ultrasound
339370|NCT01693757|Anterior Cruciate Ligament|anterior cruciate ligament
339371|NCT01693757|Hamstrings versus patellar tendon|hamstrings versus patellar tendon
339372|NCT01693757|Hop test|hop test
339373|NCT01693757|Return to sports|return to sports
339374|NCT01693744|Pseudoexfoliation, chronic kidney disease|pseudoexfoliation, chronic kidney disease
339375|NCT01693731|Breast cancer|breast cancer
339376|NCT01693731|Periodontal Diseases|periodontal diseases
339377|NCT01693731|Aromatase Inhibitors|aromatase inhibitors
339378|NCT01693731|Oral Health Related Quality of Life|oral health related quality of life
339379|NCT01693718|cancer|cancer
339380|NCT01693718|advanced|advanced
339381|NCT01693718|oral cavity|oral cavity
339382|NCT01693718|larynx|larynx
339383|NCT01693705|Tracheostomy|tracheostomy
339384|NCT01693692|Fibromyalgia|fibromyalgia
339385|NCT01693679|Tebivudine eGFR non-Tebivudine|tebivudine egfr non-tebivudine
339386|NCT01693666|Pregnancy|pregnancy
339387|NCT01693666|Obesity|obesity
339388|NCT01693666|Weight gain|weight gain
339389|NCT01693666|Obstetric complications|obstetric complications
339390|NCT01693666|Lifestyle intervention|lifestyle intervention
339391|NCT01693653|Behcet's syndrome|behcet's syndrome
339392|NCT01693653|oral ulcers|oral ulcers
339393|NCT01693640|Behcet's|behcet's
339394|NCT01693614|Diffuse large B-cell lymphoma, Mantle cell lymphoma, Follicular lymphoma, PI3K inhibitor, Non-Hodgkin lymphoma, NHL|diffuse large b-cell lymphoma, mantle cell lymphoma, follicular lymphoma, pi3k inhibitor, non-hodgkin lymphoma, nhl
339395|NCT01693601|Myelofibrosis|myelofibrosis
339396|NCT01693601|Panobinostat|panobinostat
339397|NCT01693601|Ruxolitinib|ruxolitinib
339398|NCT01693588|Pain|pain
339399|NCT01693588|Postoperative Pain|postoperative pain
339400|NCT01693588|Surgical Pain|surgical pain
339401|NCT01693588|Neurosurgical Pain|neurosurgical pain
339402|NCT01693575|Small pupil cataract surgery|small pupil cataract surgery
339403|NCT01693575|Intraoperative floppy iris syndrome (IFIS)|intraoperative floppy iris syndrome (ifis)
339404|NCT01693562|Advanced solid tumors|advanced solid tumors
339405|NCT01693549|HER-2 negative|her-2 negative
339406|NCT01693549|Metastatic breast adenocarcinoma|metastatic breast adenocarcinoma
339407|NCT01693536|Elderly|elderly
339408|NCT01693536|Sodium reduction|sodium reduction
339409|NCT01693536|Fitness increase|fitness increase
339410|NCT01693536|Primary Care|primary care
339411|NCT01693523|Pancreatic Cancer|pancreatic cancer
339412|NCT01693523|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
339413|NCT01693523|Locally advanced|locally advanced
339414|NCT01693523|Metastatic disease|metastatic disease
339415|NCT01693523|Symptom reduction|symptom reduction
339416|NCT01693523|Minocycline|minocycline
339417|NCT01693523|Dynacin|dynacin
339418|NCT01693523|Minocin|minocin
339419|NCT01693523|Minocin PAC|minocin pac
339420|NCT01693523|Myrac|myrac
339421|NCT01693523|Solodyn|solodyn
339422|NCT01693523|Placebo|placebo
339423|NCT01693523|Sugar Pill|sugar pill
339424|NCT01693523|Questionnaires|questionnaires
339425|NCT01693523|Surveys|surveys
339426|NCT01693510|Excess gestational weight gain (GWG)|excess gestational weight gain (gwg)
339427|NCT01693510|Obesity|obesity
339428|NCT01693510|Type 2 diabetes|type 2 diabetes
339429|NCT01693510|Elevated fats in the blood|elevated fats in the blood
339430|NCT01693510|High blood pressure|high blood pressure
339431|NCT01693497|Posttraumatic Stress Disorder|posttraumatic stress disorder
339432|NCT01693497|PTSD|ptsd
339433|NCT01693497|psychotherapy|psychotherapy
339434|NCT01693497|randomized trial|randomized trial
339435|NCT01693497|gestalt|gestalt
339436|NCT01693484|Calcaneus|calcaneus
339437|NCT01693484|Fracture|fracture
339438|NCT01693484|Indocyanine Green|indocyanine green
339439|NCT01693484|Angiography|angiography
339440|NCT01693484|Open Reduction and Internal Fixation|open reduction and internal fixation
339441|NCT01693471|asthma|asthma
339442|NCT01693471|SF-36|sf-36
339443|NCT01693471|HRQOL|hrqol
339444|NCT01693458|HIV|hiv
339445|NCT01693458|prevention|prevention
339446|NCT01693458|HIV-positive|hiv-positive
339447|NCT01693458|education|education
339448|NCT01693445|Gastrointestinal neoplasms|gastrointestinal neoplasms
339449|NCT01693445|Oxaliplatin|oxaliplatin
339450|NCT01693445|Irinotecan|irinotecan
339451|NCT01693445|S-1|s-1
339452|NCT01693432|Esophageal neoplasms|esophageal neoplasms
339453|NCT01693432|Docetaxel|docetaxel
339454|NCT01693432|S-1|s-1
339455|NCT01693419|pancreas neoplasm|pancreas neoplasm
339456|NCT01693419|gemcitabine|gemcitabine
339457|NCT01693419|erlotinib|erlotinib
339458|NCT01693419|S-1|s-1
339459|NCT01693406|human milk|human milk
339460|NCT01693406|infant growth|infant growth
339461|NCT01693406|obesity|obesity
339462|NCT01693406|diabetes|diabetes
339463|NCT01693406|breastfeeding|breastfeeding
339464|NCT01693393|primary Sjogren´s Syndrome|primary sjogren´s syndrome
339465|NCT01693393|Cyclosporine|cyclosporine
339466|NCT01693380|Influenza|influenza
339467|NCT01693380|Vaccination|vaccination
339468|NCT01693380|Vaccines|vaccines
339469|NCT01693380|Schoolchildren|schoolchildren
339470|NCT01693380|Effectiveness|effectiveness
339471|NCT01693380|Intervention studies|intervention studies
339472|NCT01693380|Adolescents|adolescents
339473|NCT01693380|Laboratory Confirmed Influenza|laboratory confirmed influenza
339474|NCT01693367|Femoral fracture|femoral fracture
339475|NCT01693367|Periprosthetic fracture|periprosthetic fracture
339476|NCT01693367|Fracture fixation, internal|fracture fixation, internal
339477|NCT01693367|Distal femur fractures|distal femur fractures
339478|NCT01693367|Dynamic Locking Screw|dynamic locking screw
339479|NCT01693367|WOMAC|womac
339480|NCT01693354|dialysis|dialysis
339481|NCT01693354|mortality|mortality
339482|NCT01693354|cardiovascular stability|cardiovascular stability
339483|NCT01693354|inflammation|inflammation
339484|NCT01693354|quality of life|quality of life
339485|NCT01693341|Chronic stroke patients|chronic stroke patients
339486|NCT01693341|Stroke rehabilitation|stroke rehabilitation
339487|NCT01693341|Caregiver|caregiver
339488|NCT01693341|Caregiver-mediated intervention|caregiver-mediated intervention
339489|NCT01693328|quality of life|quality of life
339490|NCT01693328|PecFent|pecfent
339491|NCT01693328|Lazanda|lazanda
339492|NCT01693328|fentanyl|fentanyl
339493|NCT01693328|intranasal|intranasal
339494|NCT01693328|breakthrough cancer pain|breakthrough cancer pain
339495|NCT01693302|Blood Glucose|blood glucose
339496|NCT01693302|Meal insulin|meal insulin
339499|NCT01693289|ovarian drilling|ovarian drilling
339500|NCT01693289|clomiphene resistance|clomiphene resistance
339501|NCT01693289|polycystic ovary.|polycystic ovary.
339502|NCT01693276|pancreatic cancer|pancreatic cancer
339503|NCT01693263|end stage renal disease (ESRD)|end stage renal disease (esrd)
339504|NCT01693263|brachiocephalic fistula (BCF)|brachiocephalic fistula (bcf)
339505|NCT01693263|cephalic arch stenosis (CAS)|cephalic arch stenosis (cas)
339506|NCT01693263|dialysis|dialysis
339507|NCT01693250|technology|technology
339508|NCT01693250|healthy weight management|healthy weight management
339509|NCT01693250|primary care setting|primary care setting
339510|NCT01693224|Tests, Diagnostic|tests, diagnostic
339511|NCT01693224|Mycobacterium tuberculosis|mycobacterium tuberculosis
339512|NCT01693224|Mycobacterium tuberculosis antigens|mycobacterium tuberculosis antigens
339514|NCT01693224|Tuberculosis|tuberculosis
339515|NCT01693224|Tuberculosis, Pulmonary|tuberculosis, pulmonary
339516|NCT01693224|Tuberculosis, Miliary|tuberculosis, miliary
339517|NCT01693224|Lipoarabinomannan|lipoarabinomannan
339518|NCT01693211|femtosecond laser|femtosecond laser
339519|NCT01693211|cataract|cataract
339520|NCT01693211|control study|control study
339521|NCT01693211|prospective|prospective
339522|NCT01693198|allergy|allergy
339523|NCT01693198|cyanobacteria|cyanobacteria
339524|NCT01693198|sweet water swimming|sweet water swimming
339525|NCT01693185|colonoscopy|colonoscopy
339526|NCT01693185|remifentanil|remifentanil
339527|NCT01693185|midazolam|midazolam
339528|NCT01693185|meperidine|meperidine
339529|NCT01693172|exercise|exercise
339530|NCT01693172|neoplasm|neoplasm
339531|NCT01693159|Painful cetuximab-induced rhagades|painful cetuximab-induced rhagades
339532|NCT01693159|Radioimmunotherapy|radioimmunotherapy
339533|NCT01693159|Head and neck cancer|head and neck cancer
339534|NCT01693146|Oxygen|oxygen
339535|NCT01693146|High Flow|high flow
339536|NCT01693146|COPD|copd
339537|NCT01693146|Hypercapnia|hypercapnia
339538|NCT01693120|ablation|ablation
339539|NCT01693120|atrial fibrillation|atrial fibrillation
339540|NCT01693120|Radio frequency|radio frequency
339541|NCT01693107|Atrial Fibrillation|atrial fibrillation
339542|NCT01693107|Catheter Ablation|catheter ablation
339543|NCT01693107|Electrophysiology|electrophysiology
339544|NCT01693107|Cardiac Arrhythmias|cardiac arrhythmias
339545|NCT01693081|Parkinson's disease|parkinson's disease
339546|NCT01693081|inhaled apomorphine|inhaled apomorphine
339547|NCT01693081|"convert off to on"|"convert off to on"
339548|NCT01693068|Cutaneous Melanoma|cutaneous melanoma
339549|NCT01693068|Dacarbazine|dacarbazine
339550|NCT01693068|Pimasertib|pimasertib
339551|NCT01693068|N-Ras|n-ras
339552|NCT01693055|orbital Computed Tomography|orbital computed tomography
339553|NCT01693055|baggy eyelids|baggy eyelids
339554|NCT01693055|orbital fat prolapse|orbital fat prolapse
339555|NCT01693055|UltheraTM|ultheratm
339556|NCT01693055|high intensity focused ultrasound|high intensity focused ultrasound
339557|NCT01693042|heart failure|heart failure
339558|NCT01693042|old myocardial infarction|old myocardial infarction
339559|NCT01693042|bone marrow-derived mononuclear cells|bone marrow-derived mononuclear cells
339560|NCT01693042|chronic|chronic
339561|NCT01693042|ischemic|ischemic
339562|NCT01693029|erythropoietin alfa|erythropoietin alfa
339563|NCT01693029|CKD 5d|ckd 5d
339564|NCT01693016|non-invasive Hb measurement in children|non-invasive hb measurement in children
339565|NCT01693003|COPD|copd
339566|NCT01692990|Appetite|appetite
339567|NCT01692990|Fish oil|fish oil
339568|NCT01692990|Long-chain n-3 fatty acids|long-chain n-3 fatty acids
339569|NCT01692912|Psoriatic Arthritis|psoriatic arthritis
339570|NCT01692912|Randomized|randomized
339571|NCT01692912|Single blind|single blind
339572|NCT01692912|Treat to target|treat to target
339573|NCT01692899|Retention Rates|retention rates
339574|NCT01692899|of Adalimumab|of adalimumab
339575|NCT01692899|Etanercept and Infliximab|etanercept and infliximab
339576|NCT01692899|as First and Second-Line Biotherapy|as first and second-line biotherapy
339577|NCT01692899|in Patients with Rheumatoid Arthritis|in patients with rheumatoid arthritis
339578|NCT01692899|in Daily Practice.|in daily practice.
339579|NCT01692899|TNF inhibitors|tnf inhibitors
339580|NCT01692899|biotherapy|biotherapy
339581|NCT01692899|retrospective study|retrospective study
339582|NCT01692886|13vPnC|13vpnc
339583|NCT01692886|7vPnC|7vpnc
339584|NCT01692886|Healthy subjects|healthy subjects
339585|NCT01692886|China|china
339586|NCT01692873|pancreatic tumor|pancreatic tumor
339587|NCT01692860|the impact of a higher dairy-based protein diet in|the impact of a higher dairy-based protein diet in
339588|NCT01692860|combination with energy restriction on muscle health,|combination with energy restriction on muscle health,
339589|NCT01692860|metabolic health (including blood pressure) in overweight|metabolic health (including blood pressure) in overweight
339590|NCT01692860|and obese, middle aged adults|and obese, middle aged adults
339591|NCT01692847|patient deterioration|patient deterioration
339592|NCT01692847|rapid response teams|rapid response teams
339593|NCT01692847|acute care teams|acute care teams
339594|NCT01692847|early warning scoring|early warning scoring
339595|NCT01692834|bioequivalence|bioequivalence
339596|NCT01692834|pharmacokinetics|pharmacokinetics
339597|NCT01692834|tolerability|tolerability
339598|NCT01692834|safety|safety
339599|NCT01692834|ciclosporin|ciclosporin
339600|NCT01692834|cyclosporine|cyclosporine
339601|NCT01692834|cyclosporine A|cyclosporine a
339602|NCT01692834|Sandimmune|sandimmune
339603|NCT01692834|Sandimmun|sandimmun
339604|NCT01692834|CicloMulsion|ciclomulsion
339605|NCT01692834|NeuroSTAT|neurostat
339606|NCT01692821|retinal oxygen saturation|retinal oxygen saturation
339607|NCT01692821|retinal blood flow|retinal blood flow
339608|NCT01692821|hyperoxia|hyperoxia
339609|NCT01692821|hypoxia|hypoxia
339610|NCT01692808|Crohn|crohn
339611|NCT01692808|vitamin D|vitamin d
339612|NCT01692808|remission|remission
339613|NCT01692808|inflammation|inflammation
339614|NCT01692808|tolerance|tolerance
339615|NCT01692795|Myocardial infarction|myocardial infarction
339616|NCT01692795|Antiplatelets|antiplatelets
339617|NCT01692795|Lipid lowering agents|lipid lowering agents
339618|NCT01692795|ACE inhibitors|ace inhibitors
339619|NCT01692795|Angiotensin Receptor Blockers|angiotensin receptor blockers
339620|NCT01692795|Beta blockers|beta blockers
339621|NCT01692795|Blood pressure lowering drugs|blood pressure lowering drugs
339622|NCT01692782|ADHD|adhd
339623|NCT01692782|Attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
339624|NCT01692769|Trauma|trauma
339625|NCT01692769|Pediatric|pediatric
339626|NCT01692769|Intravenous Fluid|intravenous fluid
339627|NCT01692769|Normal Saline|normal saline
339628|NCT01692769|Ringer's Lactate|ringer's lactate
339629|NCT01692743|Telemedicine|telemedicine
339630|NCT01692743|Inflammatory bowel disease|inflammatory bowel disease
339631|NCT01692743|Crohn's disease|crohn's disease
339632|NCT01692743|Ulcerative colitis|ulcerative colitis
339633|NCT01692743|Quality of life|quality of life
339634|NCT01692743|Health care utilization|health care utilization
339635|NCT01692730|Smoking Cessation|smoking cessation
339636|NCT01692730|Web Assisted Tobacco Intervention|web assisted tobacco intervention
339637|NCT01692691|Melanoma Metastatic|melanoma metastatic
339638|NCT01692678|Advanced or Metastatic liposarcoma or leiomyosarcoma|advanced or metastatic liposarcoma or leiomyosarcoma
339639|NCT01692678|Sarcoma|sarcoma
339640|NCT01692678|L-sarcoma|l-sarcoma
339641|NCT01692678|Liposarcoma|liposarcoma
339642|NCT01692678|Leiomyosarcoma|leiomyosarcoma
339643|NCT01692678|Trabectedin|trabectedin
339644|NCT01692678|Dacarbazine|dacarbazine
339645|NCT01692678|Yondelis|yondelis
339646|NCT01692678|Chinese patients|chinese patients
339647|NCT01692678|Overall survival|overall survival
339648|NCT01692678|Pharmacokinetics|pharmacokinetics
339649|NCT01692665|meibomian gland dysfunction|meibomian gland dysfunction
339650|NCT01692665|keratometric value|keratometric value
339651|NCT01692665|ocular aberration|ocular aberration
339652|NCT01692626|Cetuximab rash|cetuximab rash
339653|NCT01692626|Erbitux rash|erbitux rash
339654|NCT01692626|Rash|rash
339655|NCT01692626|Pimecrolimus|pimecrolimus
339656|NCT01692626|1% Topical pimecrolimus cream|1% topical pimecrolimus cream
339657|NCT01692600|Late oral radiation toxicity|late oral radiation toxicity
339658|NCT01692600|head and neck cancer patients|head and neck cancer patients
339659|NCT01692600|optical coherence tomography|optical coherence tomography
339660|NCT01692600|subsurface imaging|subsurface imaging
339661|NCT01692600|mirometer-resolution imaging|mirometer-resolution imaging
339662|NCT01692600|vascular imaging|vascular imaging
339663|NCT01692600|Doppler optical coherence tomography|doppler optical coherence tomography
339664|NCT01692600|speckle variance optical coherence tomography|speckle variance optical coherence tomography
339665|NCT01692587|PSA|psa
339666|NCT01692587|protein|protein
339667|NCT01692587|prostate|prostate
339668|NCT01692574|depression and obesity treatment|depression and obesity treatment
339669|NCT01692561|Dysautonomia|dysautonomia
339670|NCT01692561|Postural orthostatic tachycardic hypotension|postural orthostatic tachycardic hypotension
339671|NCT01692561|Neurocardiogenic vasovagal syncope|neurocardiogenic vasovagal syncope
339672|NCT01692509|Non invasive ventilation|non invasive ventilation
339673|NCT01692509|Respiratory failure|respiratory failure
339674|NCT01692509|Respiratory comfort|respiratory comfort
339675|NCT01692496|Advanced|advanced
339676|NCT01692496|Metastatic|metastatic
339677|NCT01692496|Liposarcoma|liposarcoma
339678|NCT01692496|Pazopanib|pazopanib
339679|NCT01692483|Prostate neoplasms|prostate neoplasms
339680|NCT01692483|Prostate cancer|prostate cancer
339681|NCT01692483|Castration resistant prostate cancer|castration resistant prostate cancer
339682|NCT01692483|Hormone refractory prostate cancer|hormone refractory prostate cancer
339683|NCT01692483|Abiraterone acetate|abiraterone acetate
339684|NCT01692483|Taxane|taxane
339685|NCT01692470|Human immunodeficiency virus type 1 (HIV-1) infection|human immunodeficiency virus type 1 (hiv-1) infection
339686|NCT01692470|HIV-1|hiv-1
339687|NCT01692470|Anti-retroviral naive|anti-retroviral naive
339688|NCT01692470|ARV|arv
339689|NCT01692470|Filipino patients|filipino patients
339690|NCT01692470|Rilpivirine hydrochloride|rilpivirine hydrochloride
339691|NCT01692470|Edurant|edurant
339791|NCT01692171|Subjects|subjects
339692|NCT01692457|Rheumatoid Arthritis|rheumatoid arthritis
339693|NCT01692457|Psoriatic Arthritis|psoriatic arthritis
339694|NCT01692457|Ankylosing Spondylitis|ankylosing spondylitis
339695|NCT01692457|Arthritis|arthritis
339696|NCT01692457|Spondylitis|spondylitis
339697|NCT01692457|Joint pain|joint pain
339698|NCT01692457|CNTO148|cnto148
339699|NCT01692457|Golimumab|golimumab
339700|NCT01692457|Simponi|simponi
339701|NCT01692457|Filipino|filipino
339702|NCT01692457|Post-Marketing|post-marketing
339703|NCT01692457|Surveillance|surveillance
339704|NCT01692444|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
339705|NCT01692444|Fibrosis|fibrosis
339706|NCT01692444|Fibroblast|fibroblast
339707|NCT01692444|Lung attenuation|lung attenuation
339708|NCT01692444|Pletysmography|pletysmography
339709|NCT01692418|Anaemia|anaemia
339710|NCT01692418|Blood transfusion|blood transfusion
339711|NCT01692418|Surgery|surgery
339712|NCT01692418|Iron|iron
339713|NCT01692418|Ferric carboxymaltose|ferric carboxymaltose
339714|NCT01692392|Pectus carinatum|pectus carinatum
339715|NCT01692392|Quality of life|quality of life
339716|NCT01692392|Pain, postoperative|pain, postoperative
339717|NCT01692392|Somatosensory disorders|somatosensory disorders
339718|NCT01692379|Acute ischemic stroke|acute ischemic stroke
339719|NCT01692379|endovascular treatment|endovascular treatment
339720|NCT01692379|clinical trial|clinical trial
339721|NCT01692353|Flow mediated dilation|flow mediated dilation
339722|NCT01692353|Carotid intima-media thickness|carotid intima-media thickness
339723|NCT01692353|Ankle-brachial index|ankle-brachial index
339724|NCT01692353|Smokeless tobacco|smokeless tobacco
339725|NCT01692353|Biological markers|biological markers
339726|NCT01692353|Nicotine|nicotine
339727|NCT01692353|Tobacco-specific nitrosamines|tobacco-specific nitrosamines
339728|NCT01692353|Polycyclic aromatic hydrocarbons|polycyclic aromatic hydrocarbons
339729|NCT01692353|Aromatic amines|aromatic amines
339730|NCT01692353|Mercapturic acid metabolites|mercapturic acid metabolites
339731|NCT01692353|Cholesterol|cholesterol
339732|NCT01692353|Blood lipids|blood lipids
339733|NCT01692353|Oxidative stress|oxidative stress
339734|NCT01692353|Inflammation|inflammation
339735|NCT01692353|Cytokines|cytokines
339736|NCT01692340|tomato|tomato
339737|NCT01692340|prostate cancer|prostate cancer
339738|NCT01692340|metabolism|metabolism
339739|NCT01692327|glucose intolerance (20)|glucose intolerance (20)
339740|NCT01692327|Control (20)|control (20)
339741|NCT01692314|Endothelial function|endothelial function
339742|NCT01692314|Microvascular reactivity|microvascular reactivity
339743|NCT01692314|Obesity|obesity
339744|NCT01692314|Adolescents|adolescents
339745|NCT01692301|hypertension, elderly, central aortic pulse pressure, central pulse pressure, pulse wave velocity|hypertension, elderly, central aortic pulse pressure, central pulse pressure, pulse wave velocity
339746|NCT01692262|Metastatic Castrate-Resistant Prostate Cancer (mCRPC),|metastatic castrate-resistant prostate cancer (mcrpc),
339747|NCT01692262|adenocarcinoma of the prostate,|adenocarcinoma of the prostate,
339748|NCT01692262|prostate cancer,|prostate cancer,
339749|NCT01692262|progressive disease,|progressive disease,
339750|NCT01692262|advanced disease.|advanced disease.
339751|NCT01692249|chronic shoulder pain|chronic shoulder pain
339752|NCT01692249|rotator cuff tendinopathy|rotator cuff tendinopathy
339753|NCT01692249|sap therapy|sap therapy
339754|NCT01692249|balneotherapy|balneotherapy
339755|NCT01692236|MRI|mri
339756|NCT01692236|HIV|hiv
339757|NCT01692236|Neurocognitive Disorders|neurocognitive disorders
339758|NCT01692236|Major Depression|major depression
339759|NCT01692236|Vasculopathy|vasculopathy
339760|NCT01692223|Personal genomics|personal genomics
339761|NCT01692223|Genome Sequencing Results|genome sequencing results
339762|NCT01692223|12-167|12-167
339763|NCT01692210|Breast Cancer|breast cancer
339764|NCT01692210|Dexmedetomidine|dexmedetomidine
339765|NCT01692210|Unilateral mastectomy|unilateral mastectomy
339766|NCT01692210|Blood sample collections|blood sample collections
339767|NCT01692210|Immune system|immune system
339768|NCT01692210|White blood cell levels|white blood cell levels
339769|NCT01692197|Leukemia|leukemia
339770|NCT01692197|Acute Myeloid Leukemia|acute myeloid leukemia
339771|NCT01692197|Acute Myelogenous Leukemia|acute myelogenous leukemia
339772|NCT01692197|AML|aml
339773|NCT01692197|Relapsed or Refractory|relapsed or refractory
339774|NCT01692197|High-Risk Myelodysplastic Syndromes|high-risk myelodysplastic syndromes
339775|NCT01692197|HRMDS|hrmds
339776|NCT01692197|E7070|e7070
339777|NCT01692197|Idarubicin|idarubicin
339778|NCT01692197|Idamycin|idamycin
339779|NCT01692197|Cytarabine|cytarabine
339780|NCT01692197|ARA-C|ara-c
339781|NCT01692197|Cytosar|cytosar
339782|NCT01692197|DepoCyt|depocyt
339783|NCT01692197|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
339784|NCT01692197|Dexamethasone|dexamethasone
339785|NCT01692197|Decadron|decadron
339786|NCT01692184|AVL-292|avl-292
339787|NCT01692184|Safety|safety
339788|NCT01692184|Pharmacokinetics|pharmacokinetics
339789|NCT01692184|Pharmacodynamics|pharmacodynamics
339790|NCT01692184|Pharmacology, Clinical|pharmacology, clinical
339792|NCT01692158|subjects|subjects
339793|NCT01692145|Dry eye syndromes|dry eye syndromes
339794|NCT01692145|Corneal diseases|corneal diseases
339795|NCT01692145|Conjunctival diseases|conjunctival diseases
339796|NCT01692132|Chronic Constipation|chronic constipation
339797|NCT01692132|Prucalopride|prucalopride
339798|NCT01692132|Post Marketing Surveillance|post marketing surveillance
339799|NCT01692119|chronic heart failure|chronic heart failure
339800|NCT01692119|medication adherence|medication adherence
339801|NCT01692119|pharmacy|pharmacy
339802|NCT01692119|interdisciplinary care|interdisciplinary care
339803|NCT01692119|randomized controlled trial|randomized controlled trial
339804|NCT01692119|mortality|mortality
339805|NCT01692119|hospitalization|hospitalization
339806|NCT01692106|Heller myotomy|heller myotomy
339807|NCT01692093|SCORAD|scorad
339808|NCT01692093|Atopic dermatits|atopic dermatits
339809|NCT01692093|Skin health|skin health
339810|NCT01692067|Rape|rape
339811|NCT01692067|Women|women
339812|NCT01692067|Military|military
339813|NCT01692067|Veterans|veterans
339814|NCT01692067|Post-traumatic Stress Disorder|post-traumatic stress disorder
339815|NCT01692067|Traumatic Brain Injury|traumatic brain injury
339816|NCT01692041|asthma|asthma
339817|NCT01692041|children|children
339818|NCT01692028|vitamin D|vitamin d
339819|NCT01692028|Associational study|associational study
339820|NCT01691976|Mild cognitive impairment|mild cognitive impairment
339821|NCT01691976|Androgen deprivation therapy|androgen deprivation therapy
339822|NCT01691963|Epiglottis|epiglottis
339823|NCT01691963|Intubation|intubation
339824|NCT01691963|Laryngoscopy|laryngoscopy
339825|NCT01691950|Trauma|trauma
339826|NCT01691950|Limb reconstruction|limb reconstruction
339827|NCT01691950|Amputation|amputation
339828|NCT01691950|Functional outcome|functional outcome
339829|NCT01691950|Sensing|sensing
339830|NCT01691937|Thoracic paravertebral block|thoracic paravertebral block
339831|NCT01691937|Postoperative pain|postoperative pain
339832|NCT01691937|Right lobe hepatectomy|right lobe hepatectomy
339833|NCT01691937|Patient controlled analgesia|patient controlled analgesia
339834|NCT01691924|Adenosine A2a receptor antagonist|adenosine a2a receptor antagonist
339835|NCT01691924|adenosine receptor modulator|adenosine receptor modulator
339836|NCT01691924|Cancer|cancer
339837|NCT01691911|Vascular disease|vascular disease
339838|NCT01691911|Open aortic aneurysm repair|open aortic aneurysm repair
339839|NCT01691911|Endovascular aneurysm repair|endovascular aneurysm repair
339840|NCT01691911|Carotid endartrectomy|carotid endartrectomy
339841|NCT01691911|Lower limb surgical revascularisation|lower limb surgical revascularisation
339842|NCT01691911|Major lower limb amputation|major lower limb amputation
339843|NCT01691859|extension study|extension study
339969|NCT01691326|Influenza virus vaccine|influenza virus vaccine
339844|NCT01691859|Severe refractory asthma|severe refractory asthma
339845|NCT01691859|safety|safety
339846|NCT01691859|SB-240563|sb-240563
339847|NCT01691859|mepolizumab|mepolizumab
339848|NCT01691859|eosinophils|eosinophils
339849|NCT01691833|Vitamin D|vitamin d
339850|NCT01691833|nonunion|nonunion
339851|NCT01691833|long bone fracture|long bone fracture
339852|NCT01691833|hypovitaminosis D|hypovitaminosis d
339853|NCT01691820|Adolescent females|adolescent females
339854|NCT01691820|Cytomegalovirus (CMV)|cytomegalovirus (cmv)
339855|NCT01691807|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
339856|NCT01691807|drug-drug interaction|drug-drug interaction
339857|NCT01691807|ofatumumab|ofatumumab
339858|NCT01691807|bendamustine|bendamustine
339859|NCT01691781|Hyperparathyroidism|hyperparathyroidism
339860|NCT01691781|Renin-angiotensin-aldosterone system|renin-angiotensin-aldosterone system
339861|NCT01691781|ACE inhibitors|ace inhibitors
339862|NCT01691768|microbicides|microbicides
339863|NCT01691768|women|women
339864|NCT01691768|HIV prevention|hiv prevention
339865|NCT01691768|PrEP|prep
339866|NCT01691768|Tenofovir gel|tenofovir gel
339867|NCT01691742|Postoperative constipation|postoperative constipation
339868|NCT01691742|Urogynecologic Surgery|urogynecologic surgery
339869|NCT01691742|MiraLax|miralax
339870|NCT01691742|Docusate Sodium|docusate sodium
339871|NCT01691716|Achilles tendinopathy|achilles tendinopathy
339872|NCT01691716|Tendoactive|tendoactive
339873|NCT01691716|Eccentric training|eccentric training
339874|NCT01691703|Fiber Optic Technology/methods|fiber optic technology/methods
339875|NCT01691703|Intubation, Intratracheal/methods|intubation, intratracheal/methods
339876|NCT01691703|Laryngoscopy/methods|laryngoscopy/methods
339877|NCT01691664|Esophageal Cancer|esophageal cancer
339878|NCT01691664|DC-CIK|dc-cik
339879|NCT01691664|immunotherapy|immunotherapy
339880|NCT01691664|cellular therapy|cellular therapy
339881|NCT01691664|radiation therapy|radiation therapy
339882|NCT01691651|Keratoconus|keratoconus
339883|NCT01691651|Tetanus toxin|tetanus toxin
339884|NCT01691625|Locally advanced esophageal carcinoma|locally advanced esophageal carcinoma
339885|NCT01691625|DC-CIK|dc-cik
339886|NCT01691625|Immunotherapy|immunotherapy
339887|NCT01691612|Role of Pin-1 enzyme in Asthma|role of pin-1 enzyme in asthma
339888|NCT01691599|Infection|infection
342305|NCT01681004|si joint|si joint
339889|NCT01691599|Open tibia fractures|open tibia fractures
339890|NCT01691599|Closed tibia fractures|closed tibia fractures
339891|NCT01691599|Wound infection|wound infection
339892|NCT01691586|implantable defibrillators|implantable defibrillators
339893|NCT01691586|remote patient monitoring|remote patient monitoring
339894|NCT01691586|patient-reported outcomes|patient-reported outcomes
339895|NCT01691586|cost-effectiveness|cost-effectiveness
339896|NCT01691573|ablation|ablation
339897|NCT01691573|procedure|procedure
339898|NCT01691573|pediatric|pediatric
339899|NCT01691573|european|european
339900|NCT01691573|cardiac|cardiac
339901|NCT01691573|arrhythmias|arrhythmias
339902|NCT01691573|registry|registry
339903|NCT01691573|observational|observational
339904|NCT01691573|prospective|prospective
339905|NCT01691573|catheter|catheter
339906|NCT01691573|cryoablation|cryoablation
339907|NCT01691573|atrioventricular|atrioventricular
339908|NCT01691547|GW642444 (Vilanterol)|gw642444 (vilanterol)
339909|NCT01691547|pharmacokinetics|pharmacokinetics
339910|NCT01691547|pharmacodynamics|pharmacodynamics
339911|NCT01691547|GSK573719 (Umeclidinium)|gsk573719 (umeclidinium)
339912|NCT01691547|healthy subjects|healthy subjects
339913|NCT01691547|GW685698 (Fluticasone Furoate)|gw685698 (fluticasone furoate)
339914|NCT01691534|Tuberculosis|tuberculosis
339915|NCT01691534|EBA|eba
339916|NCT01691534|PA824|pa824
339917|NCT01691534|pretomanid|pretomanid
339918|NCT01691534|TMC207|tmc207
339919|NCT01691521|safety|safety
339920|NCT01691521|SB-240563|sb-240563
339921|NCT01691521|efficacy|efficacy
339922|NCT01691521|placebo|placebo
339923|NCT01691521|eosinophils|eosinophils
339924|NCT01691521|mepolizumab|mepolizumab
339925|NCT01691521|Severe refractory asthma|severe refractory asthma
339926|NCT01691508|Safety|safety
339927|NCT01691508|Steroid Reduction|steroid reduction
339928|NCT01691508|Efficacy|efficacy
339929|NCT01691508|SB-240563|sb-240563
339930|NCT01691508|Eosinophils|eosinophils
339931|NCT01691508|Quality of Life|quality of life
339932|NCT01691508|Mepolizumab|mepolizumab
339933|NCT01691508|Severe Refractory Asthma|severe refractory asthma
339934|NCT01691495|Physician Adherence|physician adherence
339935|NCT01691495|superficial vein thrombosis|superficial vein thrombosis
339936|NCT01691495|Fondaparinux|fondaparinux
339937|NCT01691469|Bioequivalence|bioequivalence
339938|NCT01691469|Montelukast Sodium|montelukast sodium
339939|NCT01691469|crossover|crossover
339940|NCT01691456|Bioequivalence|bioequivalence
339941|NCT01691456|Montelukast Sodium|montelukast sodium
339942|NCT01691456|crossover|crossover
339943|NCT01691404|Flavonoids|flavonoids
339944|NCT01691404|Quercetin|quercetin
339945|NCT01691404|Epicatechin|epicatechin
339946|NCT01691404|Vascular function|vascular function
339947|NCT01691404|Blood pressure|blood pressure
339948|NCT01691404|Endothelial function|endothelial function
339949|NCT01691391|Advanced CRC|advanced crc
339950|NCT01691378|Veterans|veterans
339951|NCT01691378|Window to Hope|window to hope
339952|NCT01691378|Cognitive Behavioral Therapy|cognitive behavioral therapy
339953|NCT01691378|Traumatic Brain Injury|traumatic brain injury
339954|NCT01691378|Hopelessness|hopelessness
339955|NCT01691378|Suicide|suicide
339956|NCT01691365|Antioxidant|antioxidant
339957|NCT01691365|vitamins|vitamins
339958|NCT01691365|Diet|diet
339959|NCT01691352|Wound infection|wound infection
339960|NCT01691352|Ostomy reversal|ostomy reversal
339961|NCT01691339|Influenza|influenza
339962|NCT01691339|Influenza virus vaccine|influenza virus vaccine
339963|NCT01691339|Fluzone® (Influenza Virus Vaccine) 2012-2013 Formulation|fluzone® (influenza virus vaccine) 2012-2013 formulation
339964|NCT01691339|Fluzone® High-Dose (Influenza Virus Vaccine) 2012-2013 Formulation|fluzone® high-dose (influenza virus vaccine) 2012-2013 formulation
339965|NCT01691339|Trivalent Inactivated Influenza Vaccine|trivalent inactivated influenza vaccine
339966|NCT01691339|Fluzone® Intradermal (Influenza Virus Vaccine) 2012-2013 Formulation|fluzone® intradermal (influenza virus vaccine) 2012-2013 formulation
339967|NCT01691326|Influenza|influenza
339968|NCT01691326|Fluzone® (Influenza Virus Vaccine) 2012-2013 Formulation|fluzone® (influenza virus vaccine) 2012-2013 formulation
339970|NCT01691326|Trivalent Inactivated Influenza Vaccine|trivalent inactivated influenza vaccine
339971|NCT01691313|vanoxerine|vanoxerine
339972|NCT01691313|atrial fibrillation|atrial fibrillation
339973|NCT01691313|atrial flutter|atrial flutter
339974|NCT01691313|a-fib|a-fib
339975|NCT01691300|C11-acetate PET/CT|c11-acetate pet/ct
339976|NCT01691300|Multiple myeloma|multiple myeloma
339977|NCT01691300|Pretreatment staging|pretreatment staging
339978|NCT01691300|Response assessment|response assessment
339979|NCT01691287|Type 1 Diabetes|type 1 diabetes
339980|NCT01691287|Metabolic Control|metabolic control
339981|NCT01691287|Quality of Life|quality of life
339982|NCT01691274|Epilepsy|epilepsy
339983|NCT01691274|Phase 1|phase 1
339984|NCT01691274|Multiple Dose|multiple dose
339985|NCT01691274|Safety|safety
339986|NCT01691274|Pharmacokinetics|pharmacokinetics
339987|NCT01691274|Toleration|toleration
339988|NCT01691248|Clostridium difficile|clostridium difficile
340294|NCT01689935|Photodynamic Therapy|photodynamic therapy
339989|NCT01691248|Clostridium difficile-Associated Diarrhea|clostridium difficile-associated diarrhea
339990|NCT01691248|Prophylaxis|prophylaxis
339991|NCT01691248|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
339992|NCT01691235|SIMpill|simpill
339993|NCT01691235|HCV|hcv
339994|NCT01691235|Chronic Hepatitis C Virus|chronic hepatitis c virus
339995|NCT01691222|Bedside percutaneous tracheostomy|bedside percutaneous tracheostomy
339996|NCT01691222|Intensive Care Unit|intensive care unit
339997|NCT01691222|Dedicated Double-lumen tube|dedicated double-lumen tube
339998|NCT01691222|Ineffective Airway Clearance|ineffective airway clearance
339999|NCT01691222|weaning failure|weaning failure
340000|NCT01691209|Phoenix|phoenix
340001|NCT01691209|Hydrocortison|hydrocortison
340002|NCT01691209|mild atopic dermatitis|mild atopic dermatitis
340003|NCT01691209|efficacy|efficacy
340004|NCT01691209|safety|safety
340005|NCT01691196|Obesity|obesity
340006|NCT01691196|Peritoneal dialysis|peritoneal dialysis
340007|NCT01691196|Inflammation|inflammation
340008|NCT01691196|Macrophages|macrophages
340009|NCT01691196|Innate immunity|innate immunity
340010|NCT01691183|Hertel|hertel
340011|NCT01691183|exophthalmometer|exophthalmometer
340012|NCT01691183|proptosis|proptosis
340013|NCT01691183|eye disease|eye disease
340014|NCT01691170|Pattelofemoral pain syndrome|pattelofemoral pain syndrome
340015|NCT01691170|Stretching|stretching
340016|NCT01691170|Strengthening|strengthening
340017|NCT01691157|Subacromial impingement syndrome|subacromial impingement syndrome
340018|NCT01691157|Rotator cuff|rotator cuff
340019|NCT01691157|Exercise|exercise
340020|NCT01691157|Physiotherapy|physiotherapy
340021|NCT01691144|cancer|cancer
340022|NCT01691144|gynecological|gynecological
340023|NCT01691144|expectations|expectations
340024|NCT01691144|satisfaction|satisfaction
340025|NCT01691144|cooperation|cooperation
340026|NCT01691131|Physical activity in daily life|physical activity in daily life
340027|NCT01691131|Balance|balance
340028|NCT01691131|COPD|copd
340029|NCT01691131|Exercise training|exercise training
340030|NCT01691118|Hypertension|hypertension
340031|NCT01691118|Angiotensin Receptor Blocker|angiotensin receptor blocker
340032|NCT01691118|Diastolic Dysfunction|diastolic dysfunction
340033|NCT01691105|Tobacco Use Cessation|tobacco use cessation
340034|NCT01691105|Smoking Cessation|smoking cessation
340035|NCT01691105|Nicotine Replacement Therapy|nicotine replacement therapy
340036|NCT01691105|Hospitalized Smokers|hospitalized smokers
340037|NCT01691092|Depression|depression
340038|NCT01691092|Ketamine|ketamine
340039|NCT01691092|PET|pet
340040|NCT01691092|PTSD|ptsd
340041|NCT01691053|End stage renal disease|end stage renal disease
340042|NCT01691053|Hemodialysis|hemodialysis
340043|NCT01691053|Spironolactone|spironolactone
340044|NCT01691053|Left ventricular hypertrophy|left ventricular hypertrophy
340045|NCT01691040|Hepcidin|hepcidin
340046|NCT01691040|Iron|iron
340047|NCT01691040|Anemia of Chronic Disease|anemia of chronic disease
340048|NCT01691040|Anemia|anemia
340049|NCT01691040|Cancer|cancer
340050|NCT01691040|Interleukin-6|interleukin-6
340051|NCT01691040|Iron restriction|iron restriction
340052|NCT01691040|Lymphoma|lymphoma
340053|NCT01691040|CLL|cll
340054|NCT01691040|Multiple Myeloma|multiple myeloma
340055|NCT01691040|Hodgkin|hodgkin
340056|NCT01691040|anti-hepcidin|anti-hepcidin
340057|NCT01691027|scotoma, central|scotoma, central
340058|NCT01691027|visual motor coordination|visual motor coordination
340059|NCT01690988|Delirium|delirium
340060|NCT01690988|ketamine|ketamine
340061|NCT01690988|surgery|surgery
340062|NCT01690988|neurological complications|neurological complications
340063|NCT01690962|diabetic neuropathy, diet, vegan, vegetarian|diabetic neuropathy, diet, vegan, vegetarian
340064|NCT01690949|inflammation|inflammation
340065|NCT01690949|COPD|copd
340066|NCT01690949|respiratory disease|respiratory disease
340067|NCT01690949|healthy volunteers|healthy volunteers
340068|NCT01690936|Almonds|almonds
340069|NCT01690936|Body weight|body weight
340070|NCT01690936|Snacking|snacking
340071|NCT01690910|Ventilator|ventilator
340072|NCT01690910|Mobility Limitations|mobility limitations
340073|NCT01690910|Critical Care|critical care
340074|NCT01690910|Rifton Gait Trainer|rifton gait trainer
340075|NCT01690897|Female sexual desire|female sexual desire
340076|NCT01690897|Psychoeducational intervention|psychoeducational intervention
340077|NCT01690897|Mindfulness|mindfulness
340078|NCT01690884|Adenosine|adenosine
340079|NCT01690884|Ticagrelor|ticagrelor
340080|NCT01690884|Microdialysis|microdialysis
340081|NCT01690871|Malignant PEComa|malignant pecoma
340082|NCT01690871|Angiomyolipoma|angiomyolipoma
340083|NCT01690871|Tuberous Sclerosis Complex|tuberous sclerosis complex
340084|NCT01690871|Pi3kinase /m-tor inhibitors|pi3kinase /m-tor inhibitors
340085|NCT01690858|Foetal loss|foetal loss
340086|NCT01690858|complement|complement
340087|NCT01690858|antiangiogenic factors|antiangiogenic factors
340088|NCT01690858|Repeated fetal losses|repeated fetal losses
340089|NCT01690832|Contrast induced acute kidney injury|contrast induced acute kidney injury
341203|NCT01685684|Opioid|opioid
340090|NCT01690819|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
340091|NCT01690819|Acute Brain Injury|acute brain injury
340092|NCT01690793|ASTHMA|asthma
340093|NCT01690793|ACUTE EXACERBATION OF ASTHMA|acute exacerbation of asthma
340094|NCT01690780|fracture|fracture
340095|NCT01690780|pediatric|pediatric
340096|NCT01690780|oral morphine|oral morphine
340097|NCT01690780|ibuprofen|ibuprofen
340098|NCT01690767|Urethral catheterization|urethral catheterization
340099|NCT01690767|Lidocaine|lidocaine
340100|NCT01690754|SMS|sms
340101|NCT01690754|tuberculosis|tuberculosis
340102|NCT01690754|impact evaluation|impact evaluation
340103|NCT01690741|Cancer|cancer
340104|NCT01690741|Malignancy|malignancy
340105|NCT01690741|Solid tumors|solid tumors
340106|NCT01690728|Obesity|obesity
340107|NCT01690728|Gastric bypass|gastric bypass
340108|NCT01690715|Hepatocellular Carcinoma|hepatocellular carcinoma
340109|NCT01690715|Thrombosis|thrombosis
340110|NCT01690715|Portal Vein Invasion|portal vein invasion
340111|NCT01690702|breast cancer|breast cancer
340112|NCT01690702|tailored|tailored
340113|NCT01690702|high-risk|high-risk
340114|NCT01690676|FMD|fmd
340115|NCT01690676|epicatechin|epicatechin
340116|NCT01690676|apple polyphenol|apple polyphenol
340117|NCT01690676|borderline hypertension|borderline hypertension
340118|NCT01690650|Preterm|preterm
340119|NCT01690650|Newborn|newborn
340120|NCT01690650|Neonate|neonate
340121|NCT01690650|Cerebral oxygenation|cerebral oxygenation
340122|NCT01690650|Oxygen|oxygen
340123|NCT01690637|Oseltamivir|oseltamivir
340124|NCT01690637|Tamiflu|tamiflu
340125|NCT01690611|Balance Training|balance training
340126|NCT01690611|Walking|walking
340127|NCT01690611|Falls|falls
340128|NCT01690598|Epithelial ovarian cancer|epithelial ovarian cancer
340129|NCT01690598|BRCA mutation|brca mutation
340130|NCT01690598|Platinum resistant|platinum resistant
340131|NCT01690598|Platinum sensitive|platinum sensitive
340132|NCT01690598|Relapsed ovarian cancer|relapsed ovarian cancer
340133|NCT01690572|drug eluting balloon|drug eluting balloon
340134|NCT01690572|constrictive remodeling|constrictive remodeling
340135|NCT01690559|Ciprofloxacin|ciprofloxacin
340136|NCT01690559|sepsis|sepsis
340137|NCT01690559|infection|infection
340138|NCT01690559|pneumonia|pneumonia
340139|NCT01690559|peritonitis|peritonitis
340140|NCT01690559|cholecystitis|cholecystitis
340141|NCT01690559|cholangitis|cholangitis
340142|NCT01690559|anthrax|anthrax
340143|NCT01690546|Opioid Addiction|opioid addiction
340144|NCT01690546|Addiction|addiction
340145|NCT01690546|Drug Dependence|drug dependence
340146|NCT01690533|Avelox|avelox
340147|NCT01690533|Laryngopharyngitis|laryngopharyngitis
340148|NCT01690533|Tonsillitis|tonsillitis
340149|NCT01690533|Bronchitis acute|bronchitis acute
340150|NCT01690533|Pneumonia|pneumonia
340151|NCT01690533|Secondary infection in chronic respiratory diseases Sinusitis|secondary infection in chronic respiratory diseases sinusitis
340152|NCT01690507|demethylating agent|demethylating agent
340153|NCT01690507|immunogenicity|immunogenicity
340154|NCT01690494|STI|sti
340155|NCT01690494|sexually transmitted infection|sexually transmitted infection
340156|NCT01690494|HIV|hiv
340157|NCT01690494|criminal justice|criminal justice
340158|NCT01690494|probation|probation
340159|NCT01690494|couples|couples
340160|NCT01690494|drug use|drug use
340161|NCT01690442|HIV|hiv
340162|NCT01690442|AIDS|aids
340163|NCT01690442|Prevention|prevention
340164|NCT01690429|Arousal detection|arousal detection
340165|NCT01690429|Pulse Wave Amplitude|pulse wave amplitude
340166|NCT01690429|Obstructive Sleep Apnea|obstructive sleep apnea
340167|NCT01690429|Daytime sleepiness|daytime sleepiness
340168|NCT01690429|Cardiorespiratory risk|cardiorespiratory risk
340169|NCT01690377|Dendritic Cells|dendritic cells
340170|NCT01690364|Motor evoked potential monitoring|motor evoked potential monitoring
340171|NCT01690364|General Anesthesia|general anesthesia
340172|NCT01690364|Neurosurgery|neurosurgery
340173|NCT01690364|Cisatracurium|cisatracurium
340174|NCT01690364|Vecuronium|vecuronium
340175|NCT01690338|TOFr (train of four ratio)|tofr (train of four ratio)
340176|NCT01690338|airway extubation|airway extubation
340177|NCT01690338|PACU (postanesthesia care unit)|pacu (postanesthesia care unit)
340178|NCT01690338|PORC (postoperative residual curarization)|porc (postoperative residual curarization)
340179|NCT01690325|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
340180|NCT01690325|Neoadjuvant cytotoxic-antiangiogenic therapy|neoadjuvant cytotoxic-antiangiogenic therapy
340181|NCT01690325|Bevacizumab|bevacizumab
340182|NCT01690325|PET|pet
340183|NCT01690312|Humans|humans
340184|NCT01690312|Cardiovascular Disease|cardiovascular disease
340185|NCT01690312|Statins|statins
340186|NCT01690312|Fish Oil|fish oil
340187|NCT01690312|DHA|dha
340188|NCT01690312|EPA|epa
340189|NCT01690312|High-DHA|high-dha
340190|NCT01690312|Triglycerides|triglycerides
340191|NCT01690312|Total cholesterol [TC]|total cholesterol [tc]
340192|NCT01690312|Lipoproteins|lipoproteins
340193|NCT01690312|High-density lipoprotein [HDL2, HDL3]|high-density lipoprotein [hdl2, hdl3]
340194|NCT01690312|Low-density lipoprotein [LDL1+2+3+4]|low-density lipoprotein [ldl1+2+3+4]
340195|NCT01690312|Lipoprotein A [Lp(a)]|lipoprotein a [lp(a)]
340196|NCT01690312|Intermediate-density lipoprotein (IDL)|intermediate-density lipoprotein (idl)
340197|NCT01690312|Very low-density lipoprotein (VLDL1+2, VLDL3)|very low-density lipoprotein (vldl1+2, vldl3)
340198|NCT01690312|Remnant Lipoproteins|remnant lipoproteins
340199|NCT01690312|High-sensitivity C-Reactive Protein [hs-CRP]|high-sensitivity c-reactive protein [hs-crp]
340200|NCT01690312|Homocysteine|homocysteine
340201|NCT01690312|Essential Fatty Acid Profile|essential fatty acid profile
340202|NCT01690312|Apolipoprotein B|apolipoprotein b
340203|NCT01690312|Apolipoprotein A-1|apolipoprotein a-1
340204|NCT01690312|Glucose|glucose
340205|NCT01690312|Insulin|insulin
340206|NCT01690312|Fasted|fasted
340207|NCT01690312|Post-Prandial|post-prandial
340208|NCT01690299|Psoriasis|psoriasis
340209|NCT01690299|arthritis|arthritis
340210|NCT01690299|psoriatic|psoriatic
340211|NCT01690299|palmoplantar|palmoplantar
340212|NCT01690299|scalp|scalp
340213|NCT01690299|psoriasis pill|psoriasis pill
340214|NCT01690299|psoriasis tablet|psoriasis tablet
340215|NCT01690299|plaque psoriasis|plaque psoriasis
340216|NCT01690299|plaque type psoriasis|plaque type psoriasis
340217|NCT01690299|moderate to severe plaque type psoriasis|moderate to severe plaque type psoriasis
340218|NCT01690299|psoriatic arthritis|psoriatic arthritis
340219|NCT01690286|Healthy|healthy
340220|NCT01690286|Ketoconazole|ketoconazole
340221|NCT01690286|JNJ-38518168|jnj-38518168
340222|NCT01690286|Pharmacokinetics|pharmacokinetics
340223|NCT01690273|exercise|exercise
340224|NCT01690273|mobility|mobility
340225|NCT01690273|strengthening|strengthening
340226|NCT01690273|physiotherapy|physiotherapy
340227|NCT01690260|Bone|bone
340228|NCT01690260|Morphogenetic|morphogenetic
340229|NCT01690260|Protein|protein
340230|NCT01690260|Ilizarow|ilizarow
340231|NCT01690260|Autologous|autologous
340232|NCT01690260|Osteoarthritis|osteoarthritis
340233|NCT01690247|mesenchymal stem cells|mesenchymal stem cells
340234|NCT01690247|liver transplantation|liver transplantation
340235|NCT01690247|clinical trial|clinical trial
340236|NCT01690247|rejection|rejection
340237|NCT01690234|Low back pain|low back pain
340238|NCT01690234|Return to work|return to work
340239|NCT01690234|Sickness absence|sickness absence
340240|NCT01690234|Rehabilitation|rehabilitation
340241|NCT01690234|Multidisciplinary intervention|multidisciplinary intervention
340242|NCT01690221|Anal|anal
340243|NCT01690221|Fissure|fissure
340244|NCT01690221|Pain|pain
340245|NCT01690208|Diabetes|diabetes
340246|NCT01690208|Structure Care|structure care
340247|NCT01690182|Gastrointestinal physiology|gastrointestinal physiology
340248|NCT01690182|MRI|mri
340249|NCT01690182|gastric volumes|gastric volumes
340250|NCT01690182|satiety|satiety
340251|NCT01690156|In-plane|in-plane
340252|NCT01690156|Ultrasound-guided regional anesthesia performance|ultrasound-guided regional anesthesia performance
340253|NCT01690156|Probe position|probe position
340254|NCT01690156|Needle visualization|needle visualization
340255|NCT01690130|nicotine|nicotine
340256|NCT01690130|craving|craving
340257|NCT01690130|smoking|smoking
340258|NCT01690130|TMS|tms
340259|NCT01690130|prefrontal cortex|prefrontal cortex
340260|NCT01690117|family caregiver|family caregiver
340261|NCT01690117|dementia|dementia
340262|NCT01690117|intervention|intervention
340263|NCT01690117|implementation|implementation
340264|NCT01690104|rifampicin|rifampicin
340265|NCT01690104|pregnane X receptor|pregnane x receptor
340266|NCT01690104|blood pressure|blood pressure
340267|NCT01690091|chronic heart failure|chronic heart failure
340268|NCT01690091|type 2 diabetes|type 2 diabetes
340269|NCT01690091|metformin|metformin
340270|NCT01690091|insulin resistance|insulin resistance
340271|NCT01690078|Airway modeling|airway modeling
340272|NCT01690078|Pierre Robin Sequence or PRS|pierre robin sequence or prs
340273|NCT01690078|Micrognathia|micrognathia
340274|NCT01690078|Subglottic Stenosis or SGS|subglottic stenosis or sgs
340275|NCT01690065|chronic myeloid leukemia|chronic myeloid leukemia
340276|NCT01690065|myeloid blastic phase|myeloid blastic phase
340277|NCT01690065|bcr-abl(+) acute myeloid leukemia|bcr-abl(+) acute myeloid leukemia
340278|NCT01690065|nilotinib|nilotinib
340279|NCT01690052|dry mouth|dry mouth
340280|NCT01690039|renal tubular acidosis|renal tubular acidosis
340281|NCT01690039|V-ATPase|v-atpase
340282|NCT01690039|kidney stones|kidney stones
340283|NCT01689974|Metastatic Melanoma|metastatic melanoma
340284|NCT01689974|Radiation Therapy|radiation therapy
340285|NCT01689974|Immunology|immunology
340286|NCT01689974|Abscopal|abscopal
340287|NCT01689961|Nutrition|nutrition
340288|NCT01689961|Physical activity|physical activity
340289|NCT01689961|Gestational weight gain|gestational weight gain
340290|NCT01689961|Pregnancy outcomes|pregnancy outcomes
340291|NCT01689961|Birth|birth
340292|NCT01689948|Home care, rehabilitation therapy, Alzheimer's disease|home care, rehabilitation therapy, alzheimer's disease
340293|NCT01689935|Acne vulgaris|acne vulgaris
341204|NCT01685684|Oxycodone|oxycodone
340295|NCT01689935|Side-effects|side-effects
340296|NCT01689935|Pain|pain
340297|NCT01689909|Insomnia|insomnia
340298|NCT01689909|Depression|depression
340299|NCT01689909|Suicidal ideation|suicidal ideation
340300|NCT01689909|Zolpidem CR|zolpidem cr
340301|NCT01689909|Placebo|placebo
340302|NCT01689896|Hypogonadism|hypogonadism
340303|NCT01689896|Low testosterone|low testosterone
340304|NCT01689896|Pain|pain
340305|NCT01689883|stroke|stroke
340306|NCT01689883|electrical stimulation|electrical stimulation
340307|NCT01689870|OX40|ox40
340308|NCT01689870|Anti-OX40|anti-ox40
340309|NCT01689870|Ipilimumab|ipilimumab
340310|NCT01689870|Melanoma|melanoma
340311|NCT01689857|hypertropic scar, Vancouver scar scale, silicon gel sheet|hypertropic scar, vancouver scar scale, silicon gel sheet
340312|NCT01689844|controlled high blood pressure|controlled high blood pressure
340313|NCT01689818|insomnia, elderly, exercise training|insomnia, elderly, exercise training
340314|NCT01689805|Atopic dermatitis|atopic dermatitis
340315|NCT01689805|Filaggrin|filaggrin
340316|NCT01689779|vitamin D|vitamin d
340317|NCT01689779|surgery|surgery
340318|NCT01689779|acute stress|acute stress
340319|NCT01689766|Renal Cell|renal cell
340320|NCT01689753|Renal dialyse|renal dialyse
340321|NCT01689753|Catheter, indwelling|catheter, indwelling
340322|NCT01689753|Catheter-related infection|catheter-related infection
340323|NCT01689740|MDMA|mdma
340324|NCT01689740|Posttraumatic stress disorder|posttraumatic stress disorder
340325|NCT01689740|PTSD|ptsd
340326|NCT01689740|Israel|israel
340327|NCT01689740|psychotherapy|psychotherapy
340328|NCT01689727|Pituitary Tumors|pituitary tumors
340329|NCT01689714|Ovarian Carcinoma|ovarian carcinoma
340330|NCT01689714|Recurrent Endometrial Carcinoma|recurrent endometrial carcinoma
340331|NCT01689701|Erosive Gastritis|erosive gastritis
340332|NCT01689701|Hizikia Fusiformis|hizikia fusiformis
340333|NCT01689675|musculoskeletal|musculoskeletal
340334|NCT01689675|pain|pain
340335|NCT01689675|pain management|pain management
340336|NCT01689675|computer based intervention|computer based intervention
340337|NCT01689662|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
340338|NCT01689649|Epilepsy|epilepsy
340339|NCT01689649|Seizures|seizures
340340|NCT01689649|Topiramate|topiramate
340341|NCT01689649|Anti-epileptic drug|anti-epileptic drug
340342|NCT01689649|Nervous disorder|nervous disorder
340343|NCT01689636|Ovarian Cancer|ovarian cancer
340344|NCT01689623|Healthy participants|healthy participants
340345|NCT01689623|TMC435|tmc435
340346|NCT01689623|HMG-CoA reductase inhibitors|hmg-coa reductase inhibitors
340347|NCT01689623|Atorvastatin|atorvastatin
340348|NCT01689623|Simvastatin|simvastatin
340349|NCT01689623|Pharmacokinetic interaction|pharmacokinetic interaction
340350|NCT01689610|Nab-Paclitaxel|nab-paclitaxel
340351|NCT01689610|Abraxane|abraxane
340352|NCT01689610|Nabucco|nabucco
340353|NCT01689610|safety|safety
340354|NCT01689610|breast cancer|breast cancer
340355|NCT01689610|daily routine|daily routine
340356|NCT01689610|peripheral neuropathy|peripheral neuropathy
340357|NCT01689610|iOMEDICO|iomedico
340358|NCT01689584|BRCA1|brca1
340359|NCT01689584|BRCA2|brca2
340360|NCT01689584|VUS|vus
340361|NCT01689584|co-segregation|co-segregation
340362|NCT01689584|genetic counseling|genetic counseling
340363|NCT01689584|PALB2|palb2
340364|NCT01689571|PDE4 inhibitor|pde4 inhibitor
340365|NCT01689571|Allergen Challenge|allergen challenge
340366|NCT01689571|Asthma|asthma
340367|NCT01689558|nasopharynx cancer,Image department of nose pharynx ministry|nasopharynx cancer,image department of nose pharynx ministry
340368|NCT01689545|HIV|hiv
340369|NCT01689545|drug abuse|drug abuse
340370|NCT01689545|social stigma|social stigma
340371|NCT01689545|Vietnam|vietnam
340372|NCT01689532|Active Rheumatoid Arthritis Unresponsive to Methotrexate or Sulfasalazine|active rheumatoid arthritis unresponsive to methotrexate or sulfasalazine
340373|NCT01689532|Sirukumab|sirukumab
340374|NCT01689532|Human Anti-IL-6 Monoclonal Antibody|human anti-il-6 monoclonal antibody
340375|NCT01689519|Zelboraf|zelboraf
340376|NCT01689519|vemurafenib|vemurafenib
340377|NCT01689519|RG7204|rg7204
340378|NCT01689519|PLX4032|plx4032
340379|NCT01689519|Genentech MEK inhibitor|genentech mek inhibitor
340380|NCT01689519|Genentech BRAF inhibitor|genentech braf inhibitor
340381|NCT01689519|Roche MEK inhibitor|roche mek inhibitor
340382|NCT01689519|Roche BRAF inhibitor|roche braf inhibitor
340383|NCT01689519|RO5185426|ro5185426
340384|NCT01689519|metastatic melanoma|metastatic melanoma
340385|NCT01689519|BRAF positive melanoma|braf positive melanoma
340386|NCT01689519|BRAF mutant melanoma|braf mutant melanoma
340387|NCT01689519|advanced melanoma|advanced melanoma
340388|NCT01689519|Genentech RAF inhibitor|genentech raf inhibitor
340389|NCT01689519|Roche RAF inhibitor|roche raf inhibitor
340390|NCT01689519|BRAF V600E kinase inhibitor|braf v600e kinase inhibitor
340391|NCT01689519|Oncogenic BRAF inhibitor|oncogenic braf inhibitor
340392|NCT01689519|BRAF kinase inhibitor|braf kinase inhibitor
340393|NCT01689519|GDC-0973|gdc-0973
340394|NCT01689519|XL518|xl518
340395|NCT01689519|melanoma|melanoma
341205|NCT01685684|DETERx|deterx
340396|NCT01689480|Muscular Dystrophy|muscular dystrophy
340397|NCT01689480|Facioscapulohumeral|facioscapulohumeral
340398|NCT01689480|Physical training|physical training
340399|NCT01689480|Exercise|exercise
340400|NCT01689454|IVF|ivf
340401|NCT01689454|embryo culture|embryo culture
340402|NCT01689454|Ongoing pregnancy rate|ongoing pregnancy rate
340403|NCT01689454|Ongoing implantation rate|ongoing implantation rate
340404|NCT01689454|Miscarriage|miscarriage
340405|NCT01689428|IVF|ivf
340406|NCT01689428|Embryo culture|embryo culture
340407|NCT01689428|Ongoing Pregnancy rate|ongoing pregnancy rate
340408|NCT01689428|Ongoing Implantation rate|ongoing implantation rate
340409|NCT01689428|Miscarriage|miscarriage
340410|NCT01689415|Renal nerve denervation|renal nerve denervation
340411|NCT01689389|Schizophrenia|schizophrenia
340412|NCT01689389|Bipolar episodes|bipolar episodes
340413|NCT01689389|France|france
340414|NCT01689389|Xeroquel|xeroquel
340415|NCT01689389|Real-life|real-life
340416|NCT01689363|hyaluronidase|hyaluronidase
340417|NCT01689363|enzymes with tissue spreading activity|enzymes with tissue spreading activity
340418|NCT01689363|allergic reaction|allergic reaction
340419|NCT01689363|intradermal skin testing|intradermal skin testing
340420|NCT01689350|Cyclophosphamide|cyclophosphamide
340421|NCT01689350|genotype-based therapy|genotype-based therapy
340422|NCT01689350|prospective study|prospective study
340423|NCT01689337|Microfracture surgery|microfracture surgery
340424|NCT01689337|Cartilage repair|cartilage repair
340425|NCT01689337|Knee surgery|knee surgery
340426|NCT01689324|Pertussis|pertussis
340427|NCT01689324|Tetanus|tetanus
340428|NCT01689324|Diphtheria|diphtheria
340429|NCT01689324|Acellular pertussis|acellular pertussis
340430|NCT01689324|ADACEL®|adacel®
340431|NCT01689324|Tdap vaccine|tdap vaccine
340432|NCT01689311|Uterine contraction|uterine contraction
340433|NCT01689311|Dose response|dose response
340434|NCT01689311|Non-laboring|non-laboring
340435|NCT01689311|Laboring|laboring
340436|NCT01689311|Laboring with oxytocin augmentation|laboring with oxytocin augmentation
340437|NCT01689311|Oxytocin|oxytocin
340438|NCT01689311|Ergonovine|ergonovine
340439|NCT01689311|Prostaglandin F2alpha|prostaglandin f2alpha
340440|NCT01689311|Misoprostol|misoprostol
340441|NCT01689298|Uterine contraction|uterine contraction
340442|NCT01689298|Dose response|dose response
340443|NCT01689298|Oxytocin pretreatment|oxytocin pretreatment
340444|NCT01689298|Oxytocin|oxytocin
340445|NCT01689298|Carbetocin|carbetocin
340446|NCT01689285|bioequivalence|bioequivalence
340447|NCT01689285|pharmacokinetics|pharmacokinetics
340448|NCT01689285|valacyclovir|valacyclovir
340449|NCT01689285|paediatric formulation|paediatric formulation
340450|NCT01689272|Kidney transplantation,functional status,survival.|kidney transplantation,functional status,survival.
340451|NCT01689246|Alzheimer's Disease|alzheimer's disease
340452|NCT01689246|Alzheimer Disease|alzheimer disease
340453|NCT01689246|TRx0237|trx0237
340454|NCT01689246|AD|ad
340455|NCT01689246|Neurodegenerative Diseases|neurodegenerative diseases
340456|NCT01689246|Dementia|dementia
340457|NCT01689246|Brain Diseases|brain diseases
340458|NCT01689233|Alzheimer's Disease|alzheimer's disease
340459|NCT01689233|Alzheimer Disease|alzheimer disease
340460|NCT01689233|TRx0237|trx0237
340461|NCT01689233|AD|ad
340462|NCT01689233|Neurodegenerative Diseases|neurodegenerative diseases
340463|NCT01689233|Dementia|dementia
340464|NCT01689233|Brain Diseases|brain diseases
340465|NCT01689207|Phase I, Safety, tolerability, healthy.|phase i, safety, tolerability, healthy.
340466|NCT01689155|Meningitis|meningitis
340467|NCT01689155|Meningococcal Infection|meningococcal infection
340468|NCT01689155|Menactra®|menactra®
340469|NCT01689103|Alcohol use disorders|alcohol use disorders
340470|NCT01689103|Treatment|treatment
340471|NCT01689103|Outpatient|outpatient
340472|NCT01689103|Therapeutic alliance|therapeutic alliance
340473|NCT01689051|Type 2 diabetes|type 2 diabetes
340474|NCT01689051|Blod pressure|blod pressure
340475|NCT01689051|Glucagon-like peptide-1|glucagon-like peptide-1
340476|NCT01689051|Human physiology|human physiology
340477|NCT01689051|Blood flow|blood flow
340478|NCT01688999|Kidney Cancer|kidney cancer
340479|NCT01688999|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
340480|NCT01688999|Bladder Cancer|bladder cancer
340481|NCT01688986|Complex Disease|complex disease
340482|NCT01688986|DNA Biorepository|dna biorepository
340483|NCT01688986|Genotype-Phenotype Correlation|genotype-phenotype correlation
340484|NCT01688986|Genetics|genetics
340485|NCT01688986|Environmental Factors|environmental factors
340486|NCT01688947|Pain|pain
340487|NCT01688947|Neuralgia, Postherpetic|neuralgia, postherpetic
340488|NCT01688934|Pain|pain
340489|NCT01688934|Osteoarthritis|osteoarthritis
340490|NCT01688934|Knee|knee
340491|NCT01688921|Injections, Jet|injections, jet
340492|NCT01688921|Influenza Vaccines|influenza vaccines
340493|NCT01688908|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
340494|NCT01688908|Endoscopic Screening|endoscopic screening
340495|NCT01688908|Efficacy|efficacy
340496|NCT01688908|Cost-utility|cost-utility
341913|NCT01682668|akinesia|akinesia
340497|NCT01688908|High risk region|high risk region
340498|NCT01688908|China|china
340499|NCT01688895|erythropoietic|erythropoietic
340500|NCT01688895|protoporphyria|protoporphyria
340501|NCT01688895|cutaneous|cutaneous
340502|NCT01688895|porphyria|porphyria
340503|NCT01688882|bullous pemphigoid|bullous pemphigoid
340504|NCT01688882|QGE031|qge031
340505|NCT01688869|brain concussion|brain concussion
340506|NCT01688856|hand|hand
340507|NCT01688856|arm|arm
340508|NCT01688856|stroke|stroke
340509|NCT01688856|hemiplegia|hemiplegia
340510|NCT01688856|electrical stimulation|electrical stimulation
340511|NCT01688856|recovery|recovery
340512|NCT01688856|rehabilitation|rehabilitation
340513|NCT01688843|bradycardia|bradycardia
340514|NCT01688843|sinus node dysfunction|sinus node dysfunction
340515|NCT01688817|Colorectal Neoplasms|colorectal neoplasms
340516|NCT01688817|Colonoscopy|colonoscopy
340517|NCT01688817|Early Detection of Cancer|early detection of cancer
340518|NCT01688817|Patient Selection|patient selection
340519|NCT01688817|Patient Participation|patient participation
340520|NCT01688817|Physicians, Primary Care|physicians, primary care
340521|NCT01688817|Conscious Sedation|conscious sedation
340522|NCT01688804|Sedentary behavior|sedentary behavior
340523|NCT01688804|Physical activity|physical activity
340524|NCT01688804|Obesity|obesity
340525|NCT01688804|Mobile health|mobile health
340526|NCT01688804|Smartphone|smartphone
340527|NCT01688778|Type 2 diabetes|type 2 diabetes
340528|NCT01688778|Quality of life|quality of life
340529|NCT01688778|Lifestyle intervention|lifestyle intervention
340530|NCT01688778|Telemedicine|telemedicine
340531|NCT01688778|Videoconference|videoconference
340532|NCT01688765|Schizophrenia|schizophrenia
340533|NCT01688765|Schizoaffective disorder|schizoaffective disorder
340534|NCT01688765|Bipolar disorder|bipolar disorder
340535|NCT01688739|Migraine|migraine
340536|NCT01688726|Dry eye|dry eye
340537|NCT01688726|Ocular surface|ocular surface
340538|NCT01688726|Vision complaint|vision complaint
340539|NCT01688726|Tear film stability|tear film stability
340540|NCT01688726|Time controlled functional visual acuity|time controlled functional visual acuity
340541|NCT01688726|Tear film kinetics|tear film kinetics
340542|NCT01688700|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
340543|NCT01688700|neoadjuvant therapy|neoadjuvant therapy
340544|NCT01688700|Nimotuzumab|nimotuzumab
340545|NCT01688648|Coronary artery bypass graft|coronary artery bypass graft
340546|NCT01688648|dexmedetomidine|dexmedetomidine
340547|NCT01688648|lidocaine|lidocaine
340548|NCT01688648|myocardial injury|myocardial injury
340549|NCT01688648|arrhythmia|arrhythmia
340550|NCT01688648|blood electrolyte balance|blood electrolyte balance
340551|NCT01688635|Volunteers|volunteers
340552|NCT01688596|Local|local
340553|NCT01688596|Anesthesia|anesthesia
340554|NCT01688596|Pain|pain
340555|NCT01688596|Laparoscopic hysterectomy|laparoscopic hysterectomy
340556|NCT01688596|Trocar site|trocar site
340557|NCT01688596|Port site|port site
340558|NCT01688583|Chronic pain|chronic pain
340559|NCT01688583|Chronic non-cancer pain|chronic non-cancer pain
340560|NCT01688583|Fentanyl matrix|fentanyl matrix
340561|NCT01688583|Transdermal system|transdermal system
340562|NCT01688570|neuromuscular fatigue|neuromuscular fatigue
340563|NCT01688570|motor impairment|motor impairment
340564|NCT01688557|narrow band imaging|narrow band imaging
340565|NCT01688557|dual focus|dual focus
340566|NCT01688557|responsive insertion technique|responsive insertion technique
340567|NCT01688557|scope guide|scope guide
340568|NCT01688557|colonoscopy|colonoscopy
340569|NCT01688557|colorectal cancer screening|colorectal cancer screening
340570|NCT01688544|Ilaprazole|ilaprazole
340571|NCT01688544|Intragastric pH|intragastric ph
340572|NCT01688544|Serum Gastrin|serum gastrin
340573|NCT01688544|Pharmacokinetics|pharmacokinetics
340574|NCT01688518|Evaluation|evaluation
340575|NCT01688518|Depth and Duration|depth and duration
340576|NCT01688518|Anesthesia|anesthesia
340577|NCT01688505|cerebral small vessel diseases|cerebral small vessel diseases
340578|NCT01688505|cognitive impairment|cognitive impairment
340579|NCT01688505|Blood pressure variability|blood pressure variability
340580|NCT01688492|MDX-010 (Ipilimumab)|mdx-010 (ipilimumab)
340581|NCT01688492|ABIRATERONE ACETATE (CB 7630)|abiraterone acetate (cb 7630)
340582|NCT01688492|PREDNISONE|prednisone
340583|NCT01688492|Immunotherapy-naïve|immunotherapy-naïve
340584|NCT01688492|castration resistant prostate cancer (CRPC)|castration resistant prostate cancer (crpc)
340585|NCT01688492|12-120|12-120
340586|NCT01688479|Postoperative radiotherapy|postoperative radiotherapy
340587|NCT01688479|breast cancer|breast cancer
340588|NCT01688466|Immune Modulatory|immune modulatory
340589|NCT01688466|Systemic Absorption|systemic absorption
340590|NCT01688466|Oral Agent|oral agent
340591|NCT01688453|overweight/obesity|overweight/obesity
340592|NCT01688453|adolescence|adolescence
340593|NCT01688453|care management|care management
340594|NCT01688440|Endotracheal Cares|endotracheal cares
340595|NCT01688440|Neonate|neonate
340596|NCT01688440|TAC's|tac's
340597|NCT01688440|Endotracheal Suctioning|endotracheal suctioning
340598|NCT01688440|Tracheal Aspirate Culture|tracheal aspirate culture
340599|NCT01688440|Oral Cares|oral cares
340600|NCT01688440|Neonate oxygen Therapy|neonate oxygen therapy
340601|NCT01688401|diffuse intrinsic pontine glioma (DIPG)|diffuse intrinsic pontine glioma (dipg)
340602|NCT01688401|intra-arterial chemotherapy|intra-arterial chemotherapy
340603|NCT01688401|angiography|angiography
340604|NCT01688388|Breast Cancer|breast cancer
340605|NCT01688388|Carcinoma|carcinoma
340606|NCT01688388|Radiotherapy|radiotherapy
340607|NCT01688388|Intraoperative Radiotherapy|intraoperative radiotherapy
340608|NCT01688388|IORT|iort
340609|NCT01688375|obstructive jaundice|obstructive jaundice
340610|NCT01688375|ursodeoxycholic acid|ursodeoxycholic acid
340611|NCT01688362|Prospective Randomized Controlled Double Blinded Trial|prospective randomized controlled double blinded trial
340612|NCT01688362|Rotator Cuff Tear|rotator cuff tear
340613|NCT01688362|Platelet Rich Plasma|platelet rich plasma
340614|NCT01688362|Corticosteroid|corticosteroid
340615|NCT01688362|Ultrasound|ultrasound
340616|NCT01688349|Glucocorticoids|glucocorticoids
340617|NCT01688349|adipose tissue|adipose tissue
340618|NCT01688349|Cushing|cushing
340619|NCT01688349|lipodystrophy|lipodystrophy
340620|NCT01688349|11 beta-HSD1|11 beta-hsd1
340621|NCT01688336|Pancreatic|pancreatic
340622|NCT01688336|Phase II|phase ii
340623|NCT01688336|FOLFIRINOX|folfirinox
340624|NCT01688336|Unresectable|unresectable
340625|NCT01688336|Regimen|regimen
340626|NCT01688336|First-line|first-line
340627|NCT01688336|Resectable|resectable
340628|NCT01688336|Borderline|borderline
340629|NCT01688336|Oxaliplatin|oxaliplatin
340630|NCT01688336|Leucovorin|leucovorin
340631|NCT01688336|Irinotecan|irinotecan
340632|NCT01688336|5FU|5fu
340633|NCT01688336|Lineberger|lineberger
340634|NCT01688336|University of North Carolina|university of north carolina
340635|NCT01688323|Geriatrics|geriatrics
340636|NCT01688323|Oncology|oncology
340637|NCT01688323|Biological Markers|biological markers
340638|NCT01688323|Survey Instruments|survey instruments
340639|NCT01688323|p16|p16
340640|NCT01688323|Geriatric Oncology|geriatric oncology
340641|NCT01688323|Biological Markers of Aging|biological markers of aging
340642|NCT01688323|Symptom Assessment|symptom assessment
340643|NCT01688323|Cancer|cancer
340644|NCT01688323|Older Persons|older persons
340645|NCT01688323|Head and Neck Cancer|head and neck cancer
340646|NCT01688310|Gomco clamp instrument|gomco clamp instrument
340647|NCT01688310|Tissue adhesive|tissue adhesive
340648|NCT01688310|Open surgical circumcision|open surgical circumcision
340649|NCT01688310|Minimally-invasive circumcision|minimally-invasive circumcision
340650|NCT01688297|Influenza|influenza
340651|NCT01688297|H1N1|h1n1
340652|NCT01688297|flu|flu
340653|NCT01688297|seasonal|seasonal
340654|NCT01688284|uterine natural killer cells|uterine natural killer cells
340655|NCT01688284|recurrent miscarriages|recurrent miscarriages
340656|NCT01688284|alloimmunity|alloimmunity
340657|NCT01688271|simulation|simulation
340658|NCT01688271|ultrasound|ultrasound
340659|NCT01688271|perineural infusion|perineural infusion
340660|NCT01688271|continuous peripheral nerve block|continuous peripheral nerve block
340661|NCT01688245|young adults|young adults
340662|NCT01688245|alcohol consumption|alcohol consumption
340663|NCT01688245|mobile health|mobile health
340664|NCT01688245|text message|text message
340665|NCT01688232|colorectal cancer|colorectal cancer
340666|NCT01688232|tumor resection|tumor resection
340667|NCT01688232|immunoscore|immunoscore
340668|NCT01688232|lymphocytic density|lymphocytic density
340669|NCT01688232|CD3|cd3
340670|NCT01688232|CD8|cd8
340671|NCT01688232|CD45RO|cd45ro
340672|NCT01688232|biopsy|biopsy
340673|NCT01688232|genetic feature of the tumor|genetic feature of the tumor
340674|NCT01688232|relapse|relapse
340675|NCT01688232|immunohistochemistry|immunohistochemistry
340676|NCT01688232|image analysis software|image analysis software
340677|NCT01688219|SAPHO syndrome|sapho syndrome
340678|NCT01688219|Innate immunity|innate immunity
340679|NCT01688219|TNF alpha|tnf alpha
340680|NCT01688219|Polymorphonuclear neutrophils|polymorphonuclear neutrophils
340681|NCT01688219|Propionibacterium acnes|propionibacterium acnes
340682|NCT01688219|Interleukin-8|interleukin-8
340683|NCT01688180|bronchiectasis|bronchiectasis
340684|NCT01688180|depression|depression
340685|NCT01688180|anxiety|anxiety
340686|NCT01688167|HIV|hiv
340687|NCT01688167|Male circumcision|male circumcision
340688|NCT01688167|Sexual risk reduction|sexual risk reduction
340689|NCT01688167|Stages of change|stages of change
340690|NCT01688141|CKD|ckd
340691|NCT01688128|Mild cognitive impairment|mild cognitive impairment
340692|NCT01688128|Cognitive rehabilitation|cognitive rehabilitation
340693|NCT01688128|Cognitive therapy|cognitive therapy
340694|NCT01688128|Spaced retrieval Training|spaced retrieval training
340695|NCT01688128|Alzheimer's disease|alzheimer's disease
340696|NCT01688128|Memory enhancement|memory enhancement
340697|NCT01688128|U-healthcare|u-healthcare
340698|NCT01688089|volunteer|volunteer
340699|NCT01688089|study|study
340700|NCT01688063|Skin Elasticity|skin elasticity
340701|NCT01688063|Scar Elasticity|scar elasticity
340702|NCT01688063|Cutometer|cutometer
340703|NCT01688063|Dermal Torque Meter|dermal torque meter
340704|NCT01688050|Blunt thoracic aortic injury|blunt thoracic aortic injury
340705|NCT01688050|Transection|transection
340706|NCT01688050|Endovascular graft|endovascular graft
340707|NCT01688024|mitomycin C|mitomycin c
340708|NCT01688011|Myelodysplastic Syndromes|myelodysplastic syndromes
340709|NCT01688011|MDS|mds
340710|NCT01688011|Acute Myeloid Leukemia|acute myeloid leukemia
340711|NCT01688011|AML|aml
340712|NCT01688011|Registry|registry
340713|NCT01688011|Connect®|connect®
340714|NCT01687972|cesarean section|cesarean section
340715|NCT01687972|insorb staples|insorb staples
340716|NCT01687972|absorbable staples|absorbable staples
340717|NCT01687972|transverse skin incision|transverse skin incision
340718|NCT01687959|cholelithiasis|cholelithiasis
340719|NCT01687959|laparoscopic cholecystectomy|laparoscopic cholecystectomy
340720|NCT01687959|endoscopic sphincterotomy|endoscopic sphincterotomy
340721|NCT01687959|choledocholithiasis|choledocholithiasis
340722|NCT01687946|Biology of Fibrosis|biology of fibrosis
340723|NCT01687933|Labor pain|labor pain
340724|NCT01687933|Virtual reality|virtual reality
340725|NCT01687933|the first stage of labor|the first stage of labor
340726|NCT01687933|Pain relief|pain relief
340727|NCT01687933|Simulator|simulator
340728|NCT01687920|Cardiac disorders|cardiac disorders
340729|NCT01687907|fear of childbirth|fear of childbirth
340730|NCT01687907|outcome of delivery|outcome of delivery
340731|NCT01687907|music|music
340732|NCT01687907|mother-baby relationship|mother-baby relationship
340733|NCT01687894|cerebral oxygen saturation|cerebral oxygen saturation
340734|NCT01687894|beach chair position|beach chair position
340735|NCT01687894|hemodynamic|hemodynamic
340736|NCT01687894|jugular venous oximetry|jugular venous oximetry
340737|NCT01687881|Chiropractic|chiropractic
340738|NCT01687881|Manipulative therapy|manipulative therapy
340739|NCT01687881|Cervicogenic headache|cervicogenic headache
340740|NCT01687855|Obstructive Sleep|obstructive sleep
340741|NCT01687855|Apnoea|apnoea
340742|NCT01687855|tongue|tongue
340743|NCT01687855|alteration|alteration
340744|NCT01687829|Macular Holes|macular holes
340745|NCT01687829|Internal limiting membrane|internal limiting membrane
340746|NCT01687829|peeling|peeling
340747|NCT01687829|Surgery|surgery
340748|NCT01687816|Influenza-Like-Illness|influenza-like-illness
340749|NCT01687816|nasal swabs|nasal swabs
340750|NCT01687816|Detection of influenza|detection of influenza
340751|NCT01687816|sensitivity of detection assays|sensitivity of detection assays
340752|NCT01687803|Obesity|obesity
340753|NCT01687803|Sedentary lifestyle|sedentary lifestyle
340754|NCT01687803|Body weight|body weight
340755|NCT01687803|Physical fitness|physical fitness
340756|NCT01687790|molecular breast imaging|molecular breast imaging
340757|NCT01687790|breast disease|breast disease
340758|NCT01687790|breast biopsy|breast biopsy
340759|NCT01687777|Supraspinatus tendon|supraspinatus tendon
340760|NCT01687777|Mesenchymal stem cells|mesenchymal stem cells
340761|NCT01687777|OrthADAPT|orthadapt
340762|NCT01687777|Rotator cuff|rotator cuff
340763|NCT01687764|Generalized Anxiety Disorder (GAD)|generalized anxiety disorder (gad)
340764|NCT01687764|Separation Anxiety Disorder (SeAD)|separation anxiety disorder (sead)
340765|NCT01687764|Social Anxiety Disorder (SoAD)|social anxiety disorder (soad)
340766|NCT01687751|feasibility studies|feasibility studies
340767|NCT01687751|conscious sedation/|conscious sedation/
340768|NCT01687751|dexmedetomidine/|dexmedetomidine/
340769|NCT01687751|midazolam/|midazolam/
340770|NCT01687751|infusions, subcutaneous/|infusions, subcutaneous/
340771|NCT01687751|palliative care/|palliative care/
340772|NCT01687751|terminal care/|terminal care/
340773|NCT01687751|terminally ill/|terminally ill/
340774|NCT01687751|neoplasms/|neoplasms/
340775|NCT01687751|treatment outcome|treatment outcome
340776|NCT01687751|Precedex|precedex
340777|NCT01687751|"end of life"|"end of life"
340778|NCT01687751|Dying|dying
340779|NCT01687751|Advanced cancer|advanced cancer
340780|NCT01687751|mood/delirium/delirious|mood/delirium/delirious
340781|NCT01687738|non small cell lung cancer|non small cell lung cancer
340782|NCT01687738|health disparities|health disparities
340783|NCT01687712|IVF|ivf
340784|NCT01687712|In vitro fertilization|in vitro fertilization
340785|NCT01687712|Controlled ovarian stimulation|controlled ovarian stimulation
340786|NCT01687712|Follitropin|follitropin
340787|NCT01687712|AFOLIA|afolia
340788|NCT01687712|Finox|finox
340789|NCT01687699|cardiovascular event|cardiovascular event
340790|NCT01687699|hemodialysis|hemodialysis
340791|NCT01687699|spironolactone|spironolactone
340792|NCT01687673|Advanced HCC|advanced hcc
340793|NCT01687673|Temsirolimus|temsirolimus
340794|NCT01687673|TORISEL|torisel
340795|NCT01687673|Sorafenib|sorafenib
340796|NCT01687660|acupuncture|acupuncture
340797|NCT01687660|migraine prophylaxis|migraine prophylaxis
340798|NCT01687647|Lung cancer screening|lung cancer screening
340799|NCT01687647|Asbestos exposed workers|asbestos exposed workers
340800|NCT01687647|Sputum analysis|sputum analysis
342009|NCT01682382|genetics|genetics
340801|NCT01687647|Automated cytometry|automated cytometry
340802|NCT01687647|Predictive biomarkers|predictive biomarkers
340803|NCT01687634|pregnancy|pregnancy
340804|NCT01687634|home healthcare visits|home healthcare visits
340805|NCT01687634|breast feeding|breast feeding
340806|NCT01687634|nutrition|nutrition
340807|NCT01687634|community health workers|community health workers
340808|NCT01687621|Omphalitis|omphalitis
340809|NCT01687621|Neonate|neonate
340810|NCT01687621|Zambia|zambia
340811|NCT01687621|Neonatal mortality|neonatal mortality
340812|NCT01687621|Umbilical cord infection|umbilical cord infection
340813|NCT01687608|Hemophilia B|hemophilia b
340814|NCT01687608|factor IX deficiency|factor ix deficiency
340815|NCT01687608|gene therapy|gene therapy
340816|NCT01687595|herpes simplex virus type 2,|herpes simplex virus type 2,
340817|NCT01687595|genital herpes|genital herpes
340818|NCT01687582|type 2 diabetes|type 2 diabetes
340819|NCT01687582|psoriasis|psoriasis
340820|NCT01687582|exenatide|exenatide
340821|NCT01687582|liraglutide|liraglutide
340822|NCT01687569|Glycaemic Response|glycaemic response
340823|NCT01687556|EGCG|egcg
340824|NCT01687556|green tea|green tea
340825|NCT01687543|Clostridium difficile|clostridium difficile
340826|NCT01687543|WBC|wbc
340827|NCT01687543|CRP|crp
340828|NCT01687543|Lactate|lactate
340829|NCT01687543|Urea|urea
340830|NCT01687543|Creatinine|creatinine
340831|NCT01687517|sarcoidosis|sarcoidosis
340832|NCT01687517|healthy volunteers|healthy volunteers
340833|NCT01687504|pharmacokinetics|pharmacokinetics
340834|NCT01687504|children|children
340835|NCT01687504|HIV|hiv
340836|NCT01687504|Tuberculosis|tuberculosis
340837|NCT01687504|Pharmacogenetics|pharmacogenetics
340838|NCT01687491|Enoxaparin|enoxaparin
340839|NCT01687491|Acute Coronary Syndrome|acute coronary syndrome
340840|NCT01687491|Factor X|factor x
340841|NCT01687465|glaucoma|glaucoma
340842|NCT01687465|laser|laser
340843|NCT01687465|SLT|slt
340844|NCT01687465|ALT|alt
340845|NCT01687374|proximal humeral fracture|proximal humeral fracture
340846|NCT01687335|chemotherapy|chemotherapy
340847|NCT01687322|quality of life|quality of life
340848|NCT01687322|functioning|functioning
340849|NCT01687296|PEF|pef
340850|NCT01687296|inhaled|inhaled
340851|NCT01687296|Fluticasone Propionate|fluticasone propionate
340852|NCT01687296|safety|safety
340853|NCT01687296|prednisone|prednisone
340854|NCT01687296|acute exacerbation|acute exacerbation
340855|NCT01687296|asthma|asthma
340856|NCT01687296|efficacy|efficacy
340857|NCT01687283|fluticasone propionate inhalation solution|fluticasone propionate inhalation solution
340858|NCT01687283|budesonide suspension for inhalation|budesonide suspension for inhalation
340859|NCT01687283|efficacy|efficacy
340860|NCT01687283|severe persistent asthma|severe persistent asthma
340861|NCT01687283|pharmacokinetics|pharmacokinetics
340862|NCT01687283|safety|safety
340863|NCT01687244|BCG Refractory or Relapsed Superficial Bladder Cancer|bcg refractory or relapsed superficial bladder cancer
340864|NCT01687244|rAd-IFN|rad-ifn
340865|NCT01687244|Syn3|syn3
340866|NCT01687244|Intravesical|intravesical
340867|NCT01687244|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
340868|NCT01687244|superficial non-muscle invasive tumor|superficial non-muscle invasive tumor
340869|NCT01687244|Interferon alpha2b|interferon alpha2b
340870|NCT01687244|INSTILADRIN|instiladrin
340871|NCT01687231|Neutropenic Diet, Non-Neutropenic Diet, Allogeneic SCT|neutropenic diet, non-neutropenic diet, allogeneic sct
340872|NCT01687192|Seroconversion|seroconversion
340873|NCT01687192|Immunosuppressed treatment|immunosuppressed treatment
340874|NCT01687192|HPV vaccination|hpv vaccination
340875|NCT01687192|Immunogenicity|immunogenicity
340876|NCT01687179|LAM|lam
340877|NCT01687179|TSC|tsc
340878|NCT01687179|lymphangioleiomyomatosis|lymphangioleiomyomatosis
340879|NCT01687166|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
340880|NCT01687166|Cardiac Arrhythmias|cardiac arrhythmias
340881|NCT01687166|Heart Disease|heart disease
340882|NCT01687166|Cardiovascular Disease|cardiovascular disease
340883|NCT01687166|Radiofrequency Ablation|radiofrequency ablation
340884|NCT01687153|traumatic brain injury (TBI)|traumatic brain injury (tbi)
340885|NCT01687153|post traumatic stress disorder (PTSD)|post traumatic stress disorder (ptsd)
340886|NCT01687153|Alzheimer's disease (AD)|alzheimer's disease (ad)
340887|NCT01687153|mild cognitive impairment (MCI)|mild cognitive impairment (mci)
340888|NCT01687153|dementia|dementia
340889|NCT01687153|biomarkers|biomarkers
340890|NCT01687153|amyloid|amyloid
340891|NCT01687153|neuroimaging|neuroimaging
340892|NCT01687153|cognition disorder|cognition disorder
340893|NCT01687153|tau|tau
340894|NCT01687127|folic acid|folic acid
340895|NCT01687127|folate|folate
340896|NCT01687127|5-methyltetrahydrofolate|5-methyltetrahydrofolate
340897|NCT01687127|supplements|supplements
340898|NCT01687127|women|women
340899|NCT01687127|one-carbon metabolism|one-carbon metabolism
340900|NCT01687127|methionine|methionine
340901|NCT01687127|DNA methylation|dna methylation
340902|NCT01687127|in vivo kinetics|in vivo kinetics
342109|NCT01681849|PTSD|ptsd
340903|NCT01687114|compliance, proanthocyanidin, phenoic acids, cranberry|compliance, proanthocyanidin, phenoic acids, cranberry
340904|NCT01687101|acute migraine|acute migraine
340905|NCT01687101|acute migraine treatment|acute migraine treatment
340906|NCT01687101|topical treatment|topical treatment
340907|NCT01687075|coronary angioplasty|coronary angioplasty
340908|NCT01687075|de novo lesion|de novo lesion
340909|NCT01687062|NaFeEDTA|nafeedta
340910|NCT01687062|phytate|phytate
340911|NCT01687062|injera|injera
340912|NCT01687062|iron absorption|iron absorption
340913|NCT01687049|nonmetastatic|nonmetastatic
340914|NCT01687049|localized|localized
340915|NCT01687049|prostate|prostate
340916|NCT01687049|active surveillance|active surveillance
340917|NCT01687036|Atrial fibrillation|atrial fibrillation
340918|NCT01687036|Cryoablation|cryoablation
340919|NCT01687023|Tai Chi|tai chi
340920|NCT01687023|Wearable sensors|wearable sensors
340921|NCT01687023|Movement|movement
340922|NCT01687010|CRP, PCT, IL-6, Diagnosis, Prediction|crp, pct, il-6, diagnosis, prediction
340923|NCT01686997|Bariatric surgery|bariatric surgery
340924|NCT01686997|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
340925|NCT01686958|Prostate Cancer|prostate cancer
340926|NCT01686958|High intensity transurethral ultrasound ablation|high intensity transurethral ultrasound ablation
340927|NCT01686958|MRI-guided|mri-guided
340928|NCT01686958|Minimally invasive|minimally invasive
340929|NCT01686958|Real-time temperature feedback control|real-time temperature feedback control
340930|NCT01686932|vildagliptin|vildagliptin
340931|NCT01686932|sitagliptin|sitagliptin
340932|NCT01686932|continuous glucose monitoring (CGM)|continuous glucose monitoring (cgm)
340933|NCT01686932|glycemic fluctuations|glycemic fluctuations
340934|NCT01686932|MAGE|mage
340935|NCT01686932|impact of hypoglycemia on heart function (cardiac dysfuction measured via ECG)|impact of hypoglycemia on heart function (cardiac dysfuction measured via ecg)
340936|NCT01686932|difference in glycemic profile of vildagliptin compared to sitagliptin|difference in glycemic profile of vildagliptin compared to sitagliptin
340937|NCT01686919|Gastric bypass|gastric bypass
340938|NCT01686919|Questionnaires|questionnaires
340939|NCT01686919|Diet|diet
340940|NCT01686919|Milk|milk
340941|NCT01686906|Keratoconus|keratoconus
340942|NCT01686906|Bowman layer|bowman layer
340943|NCT01686893|Oxygen, Insufflation, COPD, High Flow Treatment|oxygen, insufflation, copd, high flow treatment
340944|NCT01686880|Hepatocellular Carcinoma|hepatocellular carcinoma
340945|NCT01686880|Liver Cirrhosis|liver cirrhosis
340946|NCT01686880|radioembolization|radioembolization
340947|NCT01686880|SIRT|sirt
340948|NCT01686880|TARE|tare
340949|NCT01686880|Sirspheres|sirspheres
340950|NCT01686880|neoadjuvant|neoadjuvant
340951|NCT01686880|liver cancer|liver cancer
340952|NCT01686867|improved cookstove|improved cookstove
340953|NCT01686867|ventilated cookstove|ventilated cookstove
340954|NCT01686867|behavior change|behavior change
340955|NCT01686867|adoption|adoption
340956|NCT01686867|indoor air pollution|indoor air pollution
340957|NCT01686867|DLCO|dlco
340958|NCT01686867|spirometry|spirometry
340959|NCT01686867|biomass fuel|biomass fuel
340960|NCT01686854|cognitive-behavioral approach|cognitive-behavioral approach
340961|NCT01686854|obesity treatment|obesity treatment
340962|NCT01686841|Lipolysis|lipolysis
340963|NCT01686841|Cryolipolysis|cryolipolysis
340964|NCT01686841|Fat Reduction|fat reduction
340965|NCT01686828|insulin|insulin
340966|NCT01686828|androgens|androgens
340967|NCT01686828|insulin resistance|insulin resistance
340968|NCT01686828|testosterone|testosterone
340969|NCT01686828|estradiol|estradiol
340970|NCT01686828|obesity|obesity
340971|NCT01686815|metabolic side effects|metabolic side effects
340972|NCT01686815|atypical antipsychotics|atypical antipsychotics
340973|NCT01686815|FSIVGTT|fsivgtt
340974|NCT01686802|oral morphine|oral morphine
340975|NCT01686802|ibuprofen|ibuprofen
340976|NCT01686802|post-operative pain|post-operative pain
340977|NCT01686776|Plasma albumine|plasma albumine
340978|NCT01686776|Plasma volume|plasma volume
340979|NCT01686776|Transcapillary escape rate|transcapillary escape rate
340980|NCT01686776|Inflammation|inflammation
340981|NCT01686776|Circulation|circulation
340982|NCT01686750|HIV|hiv
340983|NCT01686750|injection drug use|injection drug use
340984|NCT01686750|men who have sex with men|men who have sex with men
340985|NCT01686750|voluntary counselling and testing|voluntary counselling and testing
340986|NCT01686750|risk reduction|risk reduction
340987|NCT01686750|sexually transmitted infections|sexually transmitted infections
340988|NCT01686750|community viral load|community viral load
340989|NCT01686750|antiretroviral therapy|antiretroviral therapy
340990|NCT01686724|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
340991|NCT01686724|Psychosocial Intervention|psychosocial intervention
340992|NCT01686724|Behavioral Intervention|behavioral intervention
340993|NCT01686724|School-home collaborative intervention|school-home collaborative intervention
340994|NCT01686698|cirrhosis, VSL#3, cognitive function, falls, quality of life|cirrhosis, vsl#3, cognitive function, falls, quality of life
340995|NCT01686685|ASD|asd
340996|NCT01686685|autism|autism
340997|NCT01686685|prematurity|prematurity
340998|NCT01686685|oxygen-dependant gene activation|oxygen-dependant gene activation
340999|NCT01686685|CXCR4|cxcr4
341000|NCT01686685|Language delay|language delay
341001|NCT01686685|Cognitive delay|cognitive delay
341002|NCT01686672|Cystic Fibrosis|cystic fibrosis
341003|NCT01686672|Behavioral Intervention|behavioral intervention
341004|NCT01686672|Children|children
341005|NCT01686659|Transfusion|transfusion
341006|NCT01686659|Continuous Hemoglobin Monitoring|continuous hemoglobin monitoring
341007|NCT01686659|SpHb|sphb
341008|NCT01686646|alertness|alertness
341009|NCT01686633|asthma|asthma
341010|NCT01686633|pharmacogenetics|pharmacogenetics
341011|NCT01686633|adult|adult
341012|NCT01686633|vilanterol|vilanterol
341013|NCT01686633|adolescents|adolescents
341014|NCT01686633|fluticasone furoate|fluticasone furoate
341015|NCT01686620|Mealtime insulin|mealtime insulin
341016|NCT01686620|Ultra-rapid acting insulin|ultra-rapid acting insulin
341017|NCT01686620|Prandial insulin|prandial insulin
341018|NCT01686607|Hepatic toxicity|hepatic toxicity
341019|NCT01686607|Renal toxicity|renal toxicity
341020|NCT01686607|Micafungin|micafungin
341021|NCT01686607|Hepatocellular carcinoma|hepatocellular carcinoma
341022|NCT01686607|Antifungals (parenteral)|antifungals (parenteral)
341023|NCT01686594|Mycosis fungoides|mycosis fungoides
341024|NCT01686594|Psoralen and UVA (PUVA)|psoralen and uva (puva)
341025|NCT01686594|Photochemotherapy|photochemotherapy
341026|NCT01686594|Maintenance treatment|maintenance treatment
341027|NCT01686594|Immune function|immune function
341028|NCT01686542|atrial fibrillation|atrial fibrillation
341029|NCT01686529|Pterygium|pterygium
341030|NCT01686529|bevacizumab|bevacizumab
341031|NCT01686529|autoconjunctival graft|autoconjunctival graft
341032|NCT01686516|age|age
341033|NCT01686516|microstructure|microstructure
341034|NCT01686516|diffusion MRI|diffusion mri
341035|NCT01686490|AICD|aicd
341036|NCT01686490|focus groups|focus groups
341037|NCT01686490|cognitive-behavioral video/workbook training|cognitive-behavioral video/workbook training
341038|NCT01686490|pre-implant concern/distress about upcoming AICD|pre-implant concern/distress about upcoming aicd
341039|NCT01686464|magnetic|magnetic
341040|NCT01686464|oxygen|oxygen
341041|NCT01686464|Bell's Palsy|bell's palsy
341042|NCT01686464|acupuncture|acupuncture
341043|NCT01686438|cost effectiveness|cost effectiveness
341044|NCT01686438|patient satisfaction|patient satisfaction
341045|NCT01686425|Cholestasis|cholestasis
341046|NCT01686425|Malignancy|malignancy
341047|NCT01686425|ERCP|ercp
341048|NCT01686425|PTC|ptc
341049|NCT01686425|EUS-BD|eus-bd
341050|NCT01686412|Breast Cancer|breast cancer
341051|NCT01686412|Hepatocellular carcinoma|hepatocellular carcinoma
341052|NCT01686399|Sustainable diet|sustainable diet
341053|NCT01686399|Health promotion|health promotion
341054|NCT01686399|Obesity|obesity
341055|NCT01686386|Relapsed|relapsed
341056|NCT01686386|Multiple Myeloma|multiple myeloma
341057|NCT01686386|Lenalidomide|lenalidomide
341058|NCT01686386|Bendamustine|bendamustine
341059|NCT01686373|Aphasia|aphasia
341060|NCT01686373|Brain|brain
341061|NCT01686373|Stimulation|stimulation
341062|NCT01686373|Communication|communication
341063|NCT01686373|Stoke|stoke
341064|NCT01686373|Post|post
341065|NCT01686373|Phase II Clinical Trial|phase ii clinical trial
341066|NCT01686373|Treatment|treatment
341067|NCT01686373|tDCS|tdcs
341068|NCT01686373|Fridriksson|fridriksson
341069|NCT01686347|epidural analgesia|epidural analgesia
341070|NCT01686347|fetal cardiac rythm|fetal cardiac rythm
341071|NCT01686347|ropivacaine|ropivacaine
341072|NCT01686347|sufentanil|sufentanil
341073|NCT01686334|in complete remission|in complete remission
341074|NCT01686334|Adult (>18 years) at very high risk of relapse|adult (>18 years) at very high risk of relapse
341075|NCT01686321|elderly patients|elderly patients
341076|NCT01686321|bendamustine|bendamustine
341077|NCT01686308|cataract|cataract
341078|NCT01686308|circadian rhythm|circadian rhythm
341079|NCT01686308|pupillometry|pupillometry
341080|NCT01686308|blue light transmission|blue light transmission
341081|NCT01686308|questionnaire|questionnaire
341082|NCT01686308|sleep|sleep
341083|NCT01686295|androgenetic alopecia|androgenetic alopecia
341084|NCT01686295|Baldness|baldness
341085|NCT01686282|Blood pressure|blood pressure
341086|NCT01686282|Arterial Stiffness|arterial stiffness
341087|NCT01686282|Blueberry Supplementation|blueberry supplementation
341088|NCT01686282|Aortic Blood Pressure|aortic blood pressure
341089|NCT01686282|Hypertension|hypertension
341090|NCT01686282|Postmenopausal|postmenopausal
341091|NCT01686282|Pulse Wave Velocity|pulse wave velocity
341092|NCT01686269|Endothelial progenitor cell|endothelial progenitor cell
341093|NCT01686269|coronary artery bypass|coronary artery bypass
341094|NCT01686256|Ovarian Cancer|ovarian cancer
341095|NCT01686256|Endometrial Cancer|endometrial cancer
341096|NCT01686243|epidural|epidural
341097|NCT01686230|acupuncture|acupuncture
341098|NCT01686230|Angina|angina
341099|NCT01686230|Stable Angina Pectoris|stable angina pectoris
341100|NCT01686217|ASP015K Extended Release|asp015k extended release
341101|NCT01686217|ASP015K Immediate Release|asp015k immediate release
341102|NCT01686217|Food Effect|food effect
341103|NCT01686217|Healthy Volunteers|healthy volunteers
341104|NCT01686204|Yogurt|yogurt
341105|NCT01686204|Intestine|intestine
341106|NCT01686204|Inflammation|inflammation
341107|NCT01686204|Obese|obese
341108|NCT01686191|heart transplantation|heart transplantation
341109|NCT01686191|chronic renal insufficiency|chronic renal insufficiency
341110|NCT01686191|pharmacogenomics|pharmacogenomics
341111|NCT01686191|cyclosporine|cyclosporine
341112|NCT01686191|tacrolimus|tacrolimus
341113|NCT01686178|Smoking|smoking
341114|NCT01686178|Smoking Cessation|smoking cessation
341115|NCT01686178|Tobacco Use Cessation|tobacco use cessation
341116|NCT01686178|Social Networks|social networks
341117|NCT01686178|Social Control, Informal|social control, informal
341118|NCT01686139|Diabetic mellitus|diabetic mellitus
341119|NCT01686139|Diabetic foot ulcers|diabetic foot ulcers
341120|NCT01686139|Ischemic Limb|ischemic limb
341121|NCT01686126|endometrial hyperplasia|endometrial hyperplasia
341122|NCT01686126|endometrial adenocarcinoma|endometrial adenocarcinoma
341123|NCT01686126|Gynecological Cancer|gynecological cancer
341124|NCT01686113|Taste|taste
341125|NCT01686113|Fat Taste|fat taste
341126|NCT01686113|Threshold Testing|threshold testing
341127|NCT01686100|Coronary artery bypass grafting|coronary artery bypass grafting
341128|NCT01686100|Saphenous vein grafts|saphenous vein grafts
341129|NCT01686074|Motor control|motor control
341130|NCT01686074|walking|walking
341131|NCT01686074|physical activity|physical activity
341132|NCT01686074|Muscle activity|muscle activity
341133|NCT01686022|Grass|grass
341134|NCT01686022|Major allergen|major allergen
341135|NCT01686022|cross-reactivity|cross-reactivity
341136|NCT01686009|pain|pain
341137|NCT01686009|analgesia|analgesia
341138|NCT01686009|ketamine|ketamine
341139|NCT01686009|intranasal|intranasal
341140|NCT01686009|emergency|emergency
341141|NCT01685996|tobacco|tobacco
341142|NCT01685996|smoking cessation|smoking cessation
341143|NCT01685996|nicotine|nicotine
341144|NCT01685996|cigarettes|cigarettes
341145|NCT01685996|nicotine withdrawal|nicotine withdrawal
341146|NCT01685983|Prostate Cancer|prostate cancer
341147|NCT01685983|Metastatic-castration resistant prostate cancer|metastatic-castration resistant prostate cancer
341148|NCT01685983|Prostate specific antigen|prostate specific antigen
341149|NCT01685983|Abiraterone acetate|abiraterone acetate
341150|NCT01685983|JNJ-212082|jnj-212082
341151|NCT01685983|Abiraterone|abiraterone
341152|NCT01685983|Prednisolone|prednisolone
341153|NCT01685983|Androgen Deprivation|androgen deprivation
341154|NCT01685983|Docetaxel-based chemotherapy|docetaxel-based chemotherapy
341155|NCT01685970|Bowel preparation|bowel preparation
341156|NCT01685970|colonoscopy|colonoscopy
341157|NCT01685970|polyethylene glycol|polyethylene glycol
341158|NCT01685970|picosulfate|picosulfate
341159|NCT01685957|Weight loss|weight loss
341160|NCT01685957|Dietary intervention|dietary intervention
341161|NCT01685957|Self-help book|self-help book
341162|NCT01685957|Cooking|cooking
341163|NCT01685957|Dietitian|dietitian
341164|NCT01685957|Dietary therapy|dietary therapy
341165|NCT01685931|Schizophrenia|schizophrenia
341166|NCT01685931|Paliperidone Palmitate|paliperidone palmitate
341167|NCT01685931|Oral Antipsychotics|oral antipsychotics
341168|NCT01685931|Invega Sustenna|invega sustenna
341169|NCT01685918|Rheumatoid arthritis|rheumatoid arthritis
341170|NCT01685918|aged|aged
341171|NCT01685905|rheumatic disease, latent tuberculosis|rheumatic disease, latent tuberculosis
341172|NCT01685879|postprandial glycemic response|postprandial glycemic response
341173|NCT01685879|postprandial insulin response|postprandial insulin response
341174|NCT01685879|rice|rice
341175|NCT01685879|appetite|appetite
341176|NCT01685879|hunger|hunger
341177|NCT01685866|anesthesia|anesthesia
341178|NCT01685866|venous access|venous access
341179|NCT01685840|Heart Failure|heart failure
341180|NCT01685814|multiple myeloma|multiple myeloma
341181|NCT01685814|autologous stem cell transplant|autologous stem cell transplant
341182|NCT01685814|allogeneic stem cell transplant|allogeneic stem cell transplant
341183|NCT01685814|lenalidomide|lenalidomide
341184|NCT01685814|bortezomib|bortezomib
341185|NCT01685775|Gallbladder|gallbladder
341186|NCT01685775|cholecystectomy|cholecystectomy
341187|NCT01685775|NOTES|notes
341188|NCT01685775|natural orifice transluminal endoscopic surgery|natural orifice transluminal endoscopic surgery
341189|NCT01685775|gallstone|gallstone
341190|NCT01685762|Endometrial hyperplasia|endometrial hyperplasia
341191|NCT01685762|Uterus|uterus
341192|NCT01685762|Pilot|pilot
341193|NCT01685762|Metformin|metformin
341194|NCT01685723|Cancer patients|cancer patients
341195|NCT01685723|Smoking cessation|smoking cessation
341196|NCT01685723|Risk communication|risk communication
341197|NCT01685710|Arteriovenous fistula|arteriovenous fistula
341198|NCT01685710|Patency|patency
341199|NCT01685710|GTN patch|gtn patch
341200|NCT01685684|Low back pain|low back pain
341201|NCT01685684|Chronic back pain|chronic back pain
341202|NCT01685684|Back pain|back pain
341206|NCT01685684|Chronic pain|chronic pain
341207|NCT01685684|Chronic low back pain|chronic low back pain
341208|NCT01685684|CLBP|clbp
341209|NCT01685684|Xtampza|xtampza
341210|NCT01685671|CKD-11101|ckd-11101
341211|NCT01685671|NESP|nesp
341212|NCT01685671|Darbepoetin alfa|darbepoetin alfa
341213|NCT01685671|Anemia|anemia
341214|NCT01685671|subcutaneous|subcutaneous
341215|NCT01685671|Pharmacokinetics|pharmacokinetics
341216|NCT01685671|Phase 1|phase 1
341217|NCT01685632|intra peritonal chemo hyperthermia|intra peritonal chemo hyperthermia
341218|NCT01685632|peritoneal carcinomatosis|peritoneal carcinomatosis
341219|NCT01685632|colorectal cancer|colorectal cancer
341220|NCT01685632|ovarian cancer|ovarian cancer
341221|NCT01685619|AML|aml
341222|NCT01685619|Acute Myeloid Leukemia|acute myeloid leukemia
341223|NCT01685619|MDS|mds
341224|NCT01685619|Myelodysplastic Syndrome|myelodysplastic syndrome
341225|NCT01685619|Prognostic|prognostic
341226|NCT01685619|Economic|economic
341227|NCT01685606|Leukemia|leukemia
341228|NCT01685606|Lymphoma|lymphoma
341229|NCT01685606|Mantle cell|mantle cell
341230|NCT01685606|DLBCL|dlbcl
341231|NCT01685606|DLBC|dlbc
341232|NCT01685606|Diffuse large B cell|diffuse large b cell
341233|NCT01685606|T cell|t cell
341234|NCT01685606|AML|aml
341235|NCT01685606|ALL|all
341236|NCT01685593|abdominal binder|abdominal binder
341237|NCT01685580|primary lung cancer|primary lung cancer
341238|NCT01685580|lobectomy|lobectomy
341239|NCT01685580|pneumonectomy|pneumonectomy
341240|NCT01685580|non-invasive ventilation|non-invasive ventilation
341241|NCT01685567|carotid artery disease|carotid artery disease
341242|NCT01685567|reverse flow|reverse flow
341243|NCT01685554|perfusion|perfusion
341244|NCT01685554|cardiopulmonary bypass|cardiopulmonary bypass
341245|NCT01685554|hypothermia|hypothermia
341246|NCT01685554|cerebral oxygenation|cerebral oxygenation
341247|NCT01685528|Anxiety|anxiety
341248|NCT01685528|Depression|depression
341249|NCT01685528|Geriatric|geriatric
341250|NCT01685528|Veteran|veteran
341251|NCT01685502|Glucobay OD|glucobay od
341252|NCT01685502|Diabetes Mellitus|diabetes mellitus
341253|NCT01685489|Prostate|prostate
341254|NCT01685489|Neoplasm|neoplasm
341255|NCT01685489|Adenocarcinoma|adenocarcinoma
341256|NCT01685489|Cancer|cancer
341257|NCT01685489|Metastatic|metastatic
341258|NCT01685489|Castrate resistant|castrate resistant
341259|NCT01685489|Docetaxel|docetaxel
341260|NCT01685489|PSK|psk
341261|NCT01685489|Krestin|krestin
341262|NCT01685489|Trametes versicolor|trametes versicolor
341263|NCT01685489|Safety|safety
341264|NCT01685489|Maximum tolerated dose|maximum tolerated dose
341265|NCT01685489|Mushroom|mushroom
341266|NCT01685489|Natural|natural
341267|NCT01685489|Immunotherapy|immunotherapy
341268|NCT01685476|Cochlear microphonic potential|cochlear microphonic potential
341269|NCT01685476|non invasive method|non invasive method
341270|NCT01685476|indirect monitoring|indirect monitoring
341271|NCT01685476|intracranial pressure|intracranial pressure
341272|NCT01685463|methamphetamine, craving, TMS, cortical excitability, prefrontal cortex|methamphetamine, craving, tms, cortical excitability, prefrontal cortex
341273|NCT01685450|Cochlear microphonic potential|cochlear microphonic potential
341274|NCT01685450|non invasive method|non invasive method
341275|NCT01685450|indirect measurement|indirect measurement
341276|NCT01685450|intracranial pressure|intracranial pressure
341277|NCT01685450|adults|adults
341278|NCT01685437|Peyronie's disease, penile plaque, penile curvature|peyronie's disease, penile plaque, penile curvature
341279|NCT01685424|Etoricoxib|etoricoxib
341280|NCT01685424|ARCOXIA|arcoxia
341281|NCT01685424|Osteoarthritis|osteoarthritis
341282|NCT01685424|Rheumatoid Arthritis|rheumatoid arthritis
341283|NCT01685424|Ankylosing Spondylitis|ankylosing spondylitis
341284|NCT01685424|Gout|gout
341285|NCT01685424|Arthritis|arthritis
341286|NCT01685385|Dyspnoea|dyspnoea
341287|NCT01685385|BNP|bnp
341288|NCT01685385|Chronic heart failure|chronic heart failure
341289|NCT01685385|congestive heart failure|congestive heart failure
341290|NCT01685346|advanced (stage IV) non-small cell lung cancer (NSCLC)|advanced (stage iv) non-small cell lung cancer (nsclc)
341291|NCT01685346|biofeedback-mediated stress management (BFSM)|biofeedback-mediated stress management (bfsm)
341292|NCT01685333|subject|subject
341293|NCT01685320|Force|force
341294|NCT01685320|Pressure|pressure
341295|NCT01685320|Intubation|intubation
341296|NCT01685320|laryngoscopy|laryngoscopy
341297|NCT01685307|ileal digestibility|ileal digestibility
341298|NCT01685307|metabolism|metabolism
341299|NCT01685307|stable isotopes|stable isotopes
341300|NCT01685294|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
341301|NCT01685294|Suicidality|suicidality
341302|NCT01685294|Incarcerated Populations|incarcerated populations
341303|NCT01685294|Prisons|prisons
341304|NCT01685294|Interpersonal Psychotherapy (IPT)|interpersonal psychotherapy (ipt)
341305|NCT01685281|ADHD , Inattention|adhd , inattention
341306|NCT01685268|Prostate Cancer|prostate cancer
341307|NCT01685255|FIGO Stage III or IV EOC|figo stage iii or iv eoc
341308|NCT01685255|PPC FTC|ppc ftc
341309|NCT01685255|increasing CA 125|increasing ca 125
341310|NCT01685216|VPRIV|vpriv
341311|NCT01685216|velaglucerase alfa|velaglucerase alfa
341312|NCT01685203|Hepatitis C Virus|hepatitis c virus
341313|NCT01685203|Ribavirin-Free|ribavirin-free
341314|NCT01685203|Hepatitis C Genotype 1|hepatitis c genotype 1
341315|NCT01685203|Hepatitis C|hepatitis c
341316|NCT01685203|Interferon-Free|interferon-free
341317|NCT01685203|Chronic Hepatitis C|chronic hepatitis c
341318|NCT01685203|Compensated cirrhosis|compensated cirrhosis
341319|NCT01685203|Hepatitis C Genotype 4|hepatitis c genotype 4
341320|NCT01685203|Paritaprevir|paritaprevir
341321|NCT01685203|Ombitasvir|ombitasvir
341322|NCT01685203|Ritonavir|ritonavir
341323|NCT01685203|Ribavirin|ribavirin
341324|NCT01685177|Morbid obesity|morbid obesity
341325|NCT01685177|Sleeve gastrectomy|sleeve gastrectomy
341326|NCT01685177|Duodenal Switch|duodenal switch
341327|NCT01685177|SADI-S|sadi-s
341328|NCT01685164|nulliparous|nulliparous
341329|NCT01685164|IUD|iud
341330|NCT01685164|IUS|ius
341331|NCT01685164|insertion|insertion
341332|NCT01685164|expulsion|expulsion
341333|NCT01685151|Drug therapy|drug therapy
341334|NCT01685138|Non-Small Cell Lung Cancer, ALK, LDK378|non-small cell lung cancer, alk, ldk378
341335|NCT01685112|adults|adults
341336|NCT01685112|ECMO|ecmo
341337|NCT01685099|diagnosis, inflammation-associated markers, pleural effusion, tuberculosis, tuberculous pleurisy|diagnosis, inflammation-associated markers, pleural effusion, tuberculosis, tuberculous pleurisy
341338|NCT01685086|latent tuberculosis infection, tuberculosis, chronic kidney disease, peritoneal dialysis, hemodialysis|latent tuberculosis infection, tuberculosis, chronic kidney disease, peritoneal dialysis, hemodialysis
341339|NCT01685073|marijuana|marijuana
341340|NCT01685073|cannabis|cannabis
341341|NCT01685073|treatment|treatment
341342|NCT01685073|insomnia|insomnia
341343|NCT01685073|relapse|relapse
341344|NCT01685060|Non-Small Cell Lung Cancer|non-small cell lung cancer
341345|NCT01685060|NSCLC|nsclc
341346|NCT01685060|ALK|alk
341347|NCT01685060|LDK378|ldk378
341348|NCT01685060|Ceritinib|ceritinib
341349|NCT01685047|Coronary Artery Disease|coronary artery disease
341350|NCT01685047|Ventricular Arrhythmias|ventricular arrhythmias
341351|NCT01685047|ST Segment Changes|st segment changes
341352|NCT01685034|Eosinophilic esophagitis|eosinophilic esophagitis
341353|NCT01685034|Environmental allergens|environmental allergens
341354|NCT01685034|Allergy immunotherapy|allergy immunotherapy
341355|NCT01685034|Tolerance|tolerance
341356|NCT01685034|Allergic rhinitis|allergic rhinitis
341357|NCT01685034|Asthma|asthma
341358|NCT01685034|Seasonal variation|seasonal variation
341359|NCT01685021|B-ALL|b-all
341360|NCT01685021|CD19|cd19
341361|NCT01685021|MOR208|mor208
341362|NCT01685021|MOR00208|mor00208
341363|NCT01685021|Xmab5574|xmab5574
341364|NCT01685021|B-cell acute lymphoblastic leukemia|b-cell acute lymphoblastic leukemia
341365|NCT01685021|Fc-optimized Anti-CD19 Antibody|fc-optimized anti-cd19 antibody
341366|NCT01685008|NHL|nhl
341367|NCT01685008|CD19|cd19
341368|NCT01685008|MOR208|mor208
341369|NCT01685008|MOR00208|mor00208
341370|NCT01685008|Xmab5574|xmab5574
341371|NCT01685008|B-Cell Non-Hodgkin´s Lymphoma|b-cell non-hodgkin´s lymphoma
341372|NCT01685008|Fc-optimized Anti-CD19 Antibody|fc-optimized anti-cd19 antibody
341373|NCT01684982|Primary PCI|primary pci
341374|NCT01684982|Drug Eluting Stent|drug eluting stent
341375|NCT01684969|Nausea|nausea
341376|NCT01684969|vomiting|vomiting
341377|NCT01684969|gastrointestinal symptoms|gastrointestinal symptoms
341378|NCT01684969|palliative care|palliative care
341379|NCT01684956|intradermal|intradermal
341380|NCT01684956|pharmacokinetics|pharmacokinetics
341381|NCT01684956|microneedle|microneedle
341382|NCT01684956|insulin|insulin
341383|NCT01684956|glucagon|glucagon
341384|NCT01684943|Pharmacokinetics|pharmacokinetics
341385|NCT01684930|Cardiovascular Diseases|cardiovascular diseases
341386|NCT01684930|Vascular Diseases|vascular diseases
341387|NCT01684930|Arterial Occlusive Diseases|arterial occlusive diseases
341388|NCT01684930|Exercise|exercise
341389|NCT01684930|Functional Capacity|functional capacity
341390|NCT01684852|dry eye, sicca, HA, Hyaluronic Acid, ectoin, ectoine, bitop|dry eye, sicca, ha, hyaluronic acid, ectoin, ectoine, bitop
341391|NCT01684839|Painful digital neuroma|painful digital neuroma
341392|NCT01684839|nerve defect|nerve defect
341393|NCT01684839|dorsal branch of the digital nerve|dorsal branch of the digital nerve
341394|NCT01684839|digital nerve|digital nerve
341395|NCT01684839|pedicled nerve flap|pedicled nerve flap
341396|NCT01684839|Pain Disorder Associated with Psychological and Physical Factors|pain disorder associated with psychological and physical factors
341397|NCT01684826|X-rays|x-rays
341398|NCT01684826|Image processing|image processing
341399|NCT01684826|Cardiovascular procedure|cardiovascular procedure
341400|NCT01684813|Diabetes mellitus.|diabetes mellitus.
341401|NCT01684813|Acute coronary syndrome.|acute coronary syndrome.
341402|NCT01684813|Percutaneous coronary intervention.|percutaneous coronary intervention.
341403|NCT01684787|chronic hepatitis C|chronic hepatitis c
341404|NCT01684787|normal ALT|normal alt
341405|NCT01684787|HIV/HCV patients|hiv/hcv patients
341406|NCT01684761|Multicenter Study|multicenter study
341407|NCT01684761|Randomized Controlled Trial|randomized controlled trial
341408|NCT01684761|Individualized Medicine|individualized medicine
341409|NCT01684761|Immunotherapy|immunotherapy
341410|NCT01684761|Myelin Proteins|myelin proteins
341411|NCT01684761|Biological Agents|biological agents
341412|NCT01684748|angiotensin II|angiotensin ii
341413|NCT01684748|obesity|obesity
341414|NCT01684748|diabetes|diabetes
341415|NCT01684735|diffusion-weighted magnetic resonance imaging|diffusion-weighted magnetic resonance imaging
341416|NCT01684722|vitamin D3|vitamin d3
341417|NCT01684722|omega-3 fatty acids|omega-3 fatty acids
341418|NCT01684722|fish oil|fish oil
341419|NCT01684722|diabetes|diabetes
341420|NCT01684722|kidney disease|kidney disease
341421|NCT01684722|albuminuria|albuminuria
341422|NCT01684722|urine albumin excretion|urine albumin excretion
341423|NCT01684722|glomerular filtration rate|glomerular filtration rate
341424|NCT01684722|diabetic kidney disease|diabetic kidney disease
341425|NCT01684709|Type 2 Diabetes|type 2 diabetes
341426|NCT01684709|Informal Caregivers|informal caregivers
341427|NCT01684709|Self Care|self care
341428|NCT01684709|Quality of Life|quality of life
341429|NCT01684709|Health Information Technology|health information technology
341430|NCT01684696|Lung cancer|lung cancer
341431|NCT01684696|stigma|stigma
341432|NCT01684696|virtual intervention|virtual intervention
341433|NCT01684696|mHealth|mhealth
341434|NCT01684683|Bronchiectasis|bronchiectasis
341435|NCT01684683|Theophylline|theophylline
341436|NCT01684683|Therapeutic Uses|therapeutic uses
341437|NCT01684683|HDAC|hdac
341438|NCT01684683|HAT|hat
341439|NCT01684683|Random placebo study|random placebo study
341440|NCT01684657|Stuttering|stuttering
341441|NCT01684644|ADHD|adhd
341442|NCT01684644|Parent Training|parent training
341443|NCT01684644|RCT|rct
341444|NCT01684644|Preschool|preschool
341445|NCT01684618|Preterm|preterm
341446|NCT01684618|Neonate|neonate
341447|NCT01684618|Newborn|newborn
341448|NCT01684618|Cerebral oxygenation|cerebral oxygenation
341449|NCT01684618|CPAP|cpap
341450|NCT01684605|CKD-11101|ckd-11101
341451|NCT01684605|NESP|nesp
341452|NCT01684605|Darbepoetin alfa|darbepoetin alfa
341453|NCT01684605|Anemia|anemia
341454|NCT01684605|intravenous|intravenous
341455|NCT01684605|Pharmacokinetics|pharmacokinetics
341456|NCT01684605|Phase 1|phase 1
341457|NCT01684592|smoking cessation|smoking cessation
341458|NCT01684592|relapse prevention|relapse prevention
341459|NCT01684592|pregnancy|pregnancy
341460|NCT01684592|postpartum|postpartum
341461|NCT01684579|Breast Cancer|breast cancer
341462|NCT01684579|African-American Women|african-american women
341463|NCT01684579|Aerobic Exercise|aerobic exercise
341464|NCT01684553|Eating speed|eating speed
341465|NCT01684553|energy intake|energy intake
341466|NCT01684540|sinusitis, rhinosinusitis, ectoin, ectoine, bitop, SNS, SNS01|sinusitis, rhinosinusitis, ectoin, ectoine, bitop, sns, sns01
341467|NCT01684514|confocal laser endomicroscopy|confocal laser endomicroscopy
341468|NCT01684514|inflammatory bowel disease|inflammatory bowel disease
341469|NCT01684514|colitis, ulcerative|colitis, ulcerative
341470|NCT01684501|prosthesis|prosthesis
341471|NCT01684501|amputees|amputees
341472|NCT01684501|gait|gait
341473|NCT01684488|Depression/therapy;|depression/therapy;
341474|NCT01684488|Developing Countries;|developing countries;
341475|NCT01684488|Interpersonal Relations;|interpersonal relations;
341476|NCT01684488|Life Change Events;|life change events;
341477|NCT01684488|Psychotherapy, Group;|psychotherapy, group;
341478|NCT01684488|Resilience, Psychological;|resilience, psychological;
341479|NCT01684488|Sierra Leone;|sierra leone;
341480|NCT01684488|Survivors/psychology;|survivors/psychology;
341481|NCT01684488|Social Adjustment;|social adjustment;
341482|NCT01684488|Social Behavior;|social behavior;
341483|NCT01684488|War|war
341484|NCT01684475|Novel Treatment Parkinson's disease|novel treatment parkinson's disease
341485|NCT01684462|Acute Ischemic Stroke|acute ischemic stroke
341486|NCT01684462|Albumin|albumin
341487|NCT01684449|Soft tissue sarcoma|soft tissue sarcoma
341488|NCT01684449|Gemcitabine|gemcitabine
341489|NCT01684449|Rapamycin|rapamycin
341490|NCT01684449|Sirolimus|sirolimus
341491|NCT01684449|mTOR inhibitor|mtor inhibitor
341492|NCT01684449|Molecular biomarkers|molecular biomarkers
341493|NCT01684410|Cystic Fibrosis|cystic fibrosis
341494|NCT01684410|Alpha1-proteinase inhibitor|alpha1-proteinase inhibitor
341495|NCT01684410|Alpha1-antitrypsin|alpha1-antitrypsin
341496|NCT01684384|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
341497|NCT01684384|COPD|copd
341498|NCT01684384|Exacerbation|exacerbation
341499|NCT01684384|Functional Respiratory Imaging|functional respiratory imaging
341500|NCT01684384|High Resolution Computed Tomography|high resolution computed tomography
341501|NCT01684384|HRCT scan|hrct scan
341502|NCT01684384|Patient Reported Outcome|patient reported outcome
341504|NCT01684384|Computational Fluid Dynamic|computational fluid dynamic
341505|NCT01684384|CFD|cfd
341506|NCT01684384|Lung function parameters|lung function parameters
341507|NCT01684371|Osteoarthritis|osteoarthritis
341508|NCT01684371|Osteoarthritic pain|osteoarthritic pain
341509|NCT01684371|Arthritic pain|arthritic pain
341510|NCT01684371|Arthritis|arthritis
341511|NCT01684371|joint inflammation|joint inflammation
341512|NCT01684371|Arthralgia|arthralgia
341513|NCT01684358|Prostate-specific antigen|prostate-specific antigen
341514|NCT01684358|Contraceptive implant|contraceptive implant
341515|NCT01684358|Biological marker|biological marker
341516|NCT01684358|Condoms|condoms
341517|NCT01684358|Women|women
341518|NCT01684345|Uveitis|uveitis
341519|NCT01684345|Non-infectious Uveitis|non-infectious uveitis
341520|NCT01684345|Intermediate Uveitis|intermediate uveitis
341521|NCT01684345|Posterior Uveitis|posterior uveitis
341522|NCT01684345|Panuveitis|panuveitis
341523|NCT01684332|Antioxidant|antioxidant
341524|NCT01684332|glucose metabolism|glucose metabolism
341525|NCT01684332|jam|jam
341526|NCT01684332|polyphenols|polyphenols
341527|NCT01684332|postprandial|postprandial
341528|NCT01684332|strawberry|strawberry
341529|NCT01684319|Constipation|constipation
341530|NCT01684319|Gastroeosphageal reflux|gastroeosphageal reflux
341531|NCT01684319|Colics|colics
341532|NCT01684306|RsfMRI, brain plasticity, cognitive enhancer|rsfmri, brain plasticity, cognitive enhancer
341533|NCT01684293|Cocaine|cocaine
341534|NCT01684293|Cognitive Impairment|cognitive impairment
341535|NCT01684293|Cognitive Rehabilitation|cognitive rehabilitation
341536|NCT01684280|abdominal adipose tissue; microRNA|abdominal adipose tissue; microrna
341537|NCT01684267|Stroke|stroke
341538|NCT01684267|Gait|gait
341539|NCT01684267|Rehabilitation|rehabilitation
341540|NCT01684254|Cerebral Palsy|cerebral palsy
341541|NCT01684254|Home monitoring|home monitoring
341542|NCT01684254|Gait|gait
341543|NCT01684254|Sensorized Shoe|sensorized shoe
341544|NCT01684241|Biontech|biontech
341545|NCT01684241|Biontech RNA Pharmaceuticals GmbH|biontech rna pharmaceuticals gmbh
341546|NCT01684241|Biontech RNA|biontech rna
341547|NCT01684241|MERIT|merit
341548|NCT01684241|RNA|rna
341549|NCT01684241|Immuno Therapy|immuno therapy
341550|NCT01684241|RB_0001-01|rb_0001-01
341551|NCT01684241|Ribological|ribological
341552|NCT01684241|Melanoma|melanoma
341553|NCT01684241|RBL001|rbl001
341554|NCT01684241|RBL002|rbl002
341555|NCT01684241|cancer vaccine|cancer vaccine
341556|NCT01684228|End stage renal disease|end stage renal disease
341557|NCT01684228|hemodialysis|hemodialysis
341558|NCT01684228|breath test|breath test
341559|NCT01684228|volatile organic compound|volatile organic compound
341560|NCT01684228|dialysis adequacy|dialysis adequacy
341561|NCT01684215|Phase 1/2|phase 1/2
341562|NCT01684215|PD-0332991|pd-0332991
341563|NCT01684215|palbociclib|palbociclib
341564|NCT01684215|Cyclin Dependent Kinase 4/6 inhibitor|cyclin dependent kinase 4/6 inhibitor
341565|NCT01684215|Japanese|japanese
341566|NCT01684215|solid tumors|solid tumors
341567|NCT01684215|breast cancer|breast cancer
341568|NCT01684215|A5481010|a5481010
341569|NCT01684176|Stroke|stroke
341570|NCT01684176|Ischemic Attack, Transient|ischemic attack, transient
341571|NCT01684176|Medication adherence|medication adherence
341572|NCT01684176|Motivational interviewing|motivational interviewing
341573|NCT01684176|Stroke prevention|stroke prevention
341574|NCT01684163|depression|depression
341575|NCT01684163|MDD|mdd
341576|NCT01684163|GLYX-13|glyx-13
341577|NCT01684163|HDRS-17|hdrs-17
341578|NCT01684163|HAMD-17|hamd-17
341579|NCT01684150|Leukemia|leukemia
341580|NCT01684150|Advanced hematologic malignancies|advanced hematologic malignancies
341581|NCT01684150|Epizyme|epizyme
341582|NCT01684150|Phase 1|phase 1
341583|NCT01684150|Mixed Lineage Leukemia (MLL)|mixed lineage leukemia (mll)
341584|NCT01684137|Food supplements|food supplements
341585|NCT01684137|Asthma bronchiale|asthma bronchiale
341586|NCT01684124|oxygen|oxygen
341587|NCT01684124|critical illness|critical illness
341588|NCT01684124|mechanical ventilation|mechanical ventilation
341589|NCT01684111|Non Small Cell Lung Cancer - Stage IV|non small cell lung cancer - stage iv
341590|NCT01684111|NSCLC Stage IV|nsclc stage iv
341591|NCT01684098|recurrent or metastatic cancer|recurrent or metastatic cancer
341592|NCT01684098|head and neck cancer|head and neck cancer
341593|NCT01684098|pancreas cancer|pancreas cancer
341594|NCT01684098|bladder cancer|bladder cancer
341595|NCT01684098|testicular cancer|testicular cancer
341596|NCT01684085|sleep deprivation, PTSD,prevention|sleep deprivation, ptsd,prevention
341597|NCT01684072|varicella vaccine|varicella vaccine
341598|NCT01684072|gelatin|gelatin
341599|NCT01684046|multi-purpose solution|multi-purpose solution
341600|NCT01684046|silicone hydrogel|silicone hydrogel
341601|NCT01684046|contact lenses|contact lenses
341602|NCT01684046|comfort|comfort
341603|NCT01684046|Opti-Free|opti-free
341604|NCT01684046|RevitaLens|revitalens
341605|NCT01684033|multi-purpose solution|multi-purpose solution
341606|NCT01684033|silicone hydrogel|silicone hydrogel
341607|NCT01684033|contact lenses|contact lenses
341608|NCT01684033|comfort|comfort
341609|NCT01684033|Opti-Free|opti-free
341610|NCT01684033|Biotrue|biotrue
341611|NCT01684020|rhinoplasty|rhinoplasty
341612|NCT01684020|external rhinoplasty|external rhinoplasty
341613|NCT01684020|open rhinoplasty|open rhinoplasty
341614|NCT01684020|nose job|nose job
341615|NCT01684007|Intraocular lens|intraocular lens
341616|NCT01684007|Multifocal intraocular lens (MIOL)|multifocal intraocular lens (miol)
341617|NCT01683994|Angiogenesis Inhibitors|angiogenesis inhibitors
341618|NCT01683994|Small Molecules|small molecules
341619|NCT01683994|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
341620|NCT01683981|Idiopathic Pulmonary Arterial Hypertension|idiopathic pulmonary arterial hypertension
341621|NCT01683981|Eisenmenger Syndrome|eisenmenger syndrome
341622|NCT01683981|Exercise Capacity|exercise capacity
341623|NCT01683981|Quality of Life|quality of life
341624|NCT01683955|Tranexamic Acid|tranexamic acid
341625|NCT01683955|Blood transfusion|blood transfusion
341626|NCT01683955|Total hip arthroplasty|total hip arthroplasty
341627|NCT01683942|cup disc ratio measurement|cup disc ratio measurement
341628|NCT01683942|digital stereo optic disc images|digital stereo optic disc images
341629|NCT01683929|Obesity|obesity
341630|NCT01683929|Overweight|overweight
341631|NCT01683929|Sugar consumption|sugar consumption
341632|NCT01683929|Metabolic syndrome|metabolic syndrome
341633|NCT01683929|Artificially sweetened foods and beverages|artificially sweetened foods and beverages
341634|NCT01683916|spinal cord injury|spinal cord injury
341635|NCT01683916|stress hormone|stress hormone
341636|NCT01683916|surgery|surgery
341637|NCT01683916|bispectral index value|bispectral index value
341638|NCT01683916|volatile anesthetic|volatile anesthetic
341639|NCT01683903|heart failure|heart failure
341640|NCT01683903|cardiac rehabilitation|cardiac rehabilitation
341641|NCT01683903|myocardial infarction|myocardial infarction
341642|NCT01683890|Bladder symptoms|bladder symptoms
341643|NCT01683890|Sexual function|sexual function
341644|NCT01683890|Quality of life|quality of life
341645|NCT01683890|Simple hysterectomy|simple hysterectomy
341646|NCT01683851|pediatric|pediatric
341647|NCT01683851|conscious sedation|conscious sedation
341648|NCT01683851|mouthpiece|mouthpiece
341649|NCT01683851|airway|airway
341650|NCT01683851|isolite system|isolite system
341651|NCT01683838|spinal cord injury|spinal cord injury
341652|NCT01683838|muscle spasticity|muscle spasticity
341653|NCT01683825|Amyloidosis|amyloidosis
341654|NCT01683825|Cardiac|cardiac
341655|NCT01683825|Heart|heart
341656|NCT01683825|Imaging|imaging
341657|NCT01683825|Diagnosis|diagnosis
341658|NCT01683799|Osteoarthritis|osteoarthritis
341659|NCT01683799|Insomnia|insomnia
341660|NCT01683799|Chronic pain|chronic pain
341661|NCT01683799|Cognitive Behavioral Therapy for Insomnia|cognitive behavioral therapy for insomnia
341662|NCT01683799|Inflammation|inflammation
341663|NCT01683799|Inflammatory cytokines|inflammatory cytokines
341664|NCT01683773|Tuberculosis|tuberculosis
341665|NCT01683773|Phase I|phase i
341666|NCT01683773|MVA85A|mva85a
341667|NCT01683773|AERAS-402|aeras-402
341668|NCT01683760|Fluconazole|fluconazole
341669|NCT01683747|sepsis|sepsis
341670|NCT01683747|shock|shock
341671|NCT01683747|placebo controlled|placebo controlled
341672|NCT01683747|double blinded|double blinded
341673|NCT01683747|interventional|interventional
341674|NCT01683708|sepsis|sepsis
341675|NCT01683708|jaundice|jaundice
341676|NCT01683708|symbiotic|symbiotic
341677|NCT01683708|translocation|translocation
341678|NCT01683708|abdominal collection|abdominal collection
341679|NCT01683708|morbidity|morbidity
341680|NCT01683695|Lupus Arthritis, Systemic Lupus Erythematosus, AMG 557, Lupus|lupus arthritis, systemic lupus erythematosus, amg 557, lupus
341681|NCT01683682|Non-Small Lung Cancer|non-small lung cancer
341682|NCT01683682|NSCLC Stage IV|nsclc stage iv
341683|NCT01683669|ALI|ali
341684|NCT01683669|ARDS|ards
341685|NCT01683669|Noisy pressure support ventilation|noisy pressure support ventilation
341686|NCT01683656|HIV|hiv
341687|NCT01683656|Atherosclerosis|atherosclerosis
341688|NCT01683656|Niacin/laropiprant|niacin/laropiprant
341689|NCT01683656|HDL|hdl
341690|NCT01683630|Influenza|influenza
341691|NCT01683630|Influenza type A|influenza type a
341692|NCT01683630|Influenza type B|influenza type b
341693|NCT01683630|hospitalization|hospitalization
341694|NCT01683630|Manitoba|manitoba
341695|NCT01683630|Canada|canada
341696|NCT01683617|Psychological stress|psychological stress
341697|NCT01683591|Acute stroke|acute stroke
341698|NCT01683591|Dysphagia|dysphagia
341699|NCT01683591|High-resolution manometry|high-resolution manometry
341700|NCT01683578|mechanical ventilation|mechanical ventilation
341701|NCT01683578|lung function|lung function
341702|NCT01683578|abdominal surgery, open|abdominal surgery, open
341703|NCT01683578|systemic inflammation|systemic inflammation
341704|NCT01683552|ITCH|itch
341705|NCT01683539|Schizophrenia|schizophrenia
341706|NCT01683539|Chronic Mental Disorder|chronic mental disorder
341707|NCT01683539|Employment|employment
341708|NCT01683539|Cognitive remediation|cognitive remediation
341709|NCT01683539|Vocational rehabilitation|vocational rehabilitation
341710|NCT01683539|Brain-derived Neurotrophic Factor (BDNF)|brain-derived neurotrophic factor (bdnf)
341711|NCT01683526|Urgent endotrachel intubation|urgent endotrachel intubation
341712|NCT01683526|Direct laryngoscopy|direct laryngoscopy
341713|NCT01683526|Video laryngoscopy|video laryngoscopy
341714|NCT01683526|Glidescope|glidescope
341715|NCT01683526|Critical Care|critical care
341716|NCT01683513|OHSS|ohss
341717|NCT01683513|mataphase II oocytes (MII)|mataphase ii oocytes (mii)
341718|NCT01683513|good quality embryo's|good quality embryo's
341719|NCT01683513|pregnancy|pregnancy
341720|NCT01683474|aortic valve stenosis|aortic valve stenosis
341721|NCT01683474|Calcification|calcification
341722|NCT01683474|TAVI|tavi
341723|NCT01683474|aortic valve Prosthesis|aortic valve prosthesis
341724|NCT01683461|HIV|hiv
341725|NCT01683461|AIDS|aids
341726|NCT01683448|Perioperative medications|perioperative medications
341727|NCT01683448|cardiac surgery|cardiac surgery
341728|NCT01683448|outcomes|outcomes
341729|NCT01683396|Erosive Osteoarthritis|erosive osteoarthritis
341730|NCT01683396|Osteoarthritis|osteoarthritis
341731|NCT01683396|Osteoarthritis of the Hand|osteoarthritis of the hand
341732|NCT01683383|Hypoxic ischemic encephalopathy|hypoxic ischemic encephalopathy
341733|NCT01683383|Therapeutic hypothermia|therapeutic hypothermia
341734|NCT01683383|Whole body cooling|whole body cooling
341735|NCT01683383|Transport cooling|transport cooling
341736|NCT01683357|Liver Metastases|liver metastases
341737|NCT01683357|Surgery|surgery
341738|NCT01683357|Intraoperative Ultrasound|intraoperative ultrasound
341739|NCT01683331|Kidney transplant|kidney transplant
341740|NCT01683331|New onset diabetes|new onset diabetes
341741|NCT01683331|Prevention|prevention
341742|NCT01683331|Insulin|insulin
341743|NCT01683305|biomarker,|biomarker,
341744|NCT01683305|NAF|naf
341745|NCT01683305|Subjects|subjects
341746|NCT01683292|apomorphine|apomorphine
341747|NCT01683292|inhaled|inhaled
341748|NCT01683292|motor fluctuations|motor fluctuations
341749|NCT01683279|pediatric|pediatric
341750|NCT01683279|acute lymphoblastic leukemia|acute lymphoblastic leukemia
341751|NCT01683279|CD19|cd19
341752|NCT01683279|Chimeric Antigen Receptor|chimeric antigen receptor
341753|NCT01683240|cholangiography|cholangiography
341754|NCT01683240|cholangioscopy|cholangioscopy
341755|NCT01683240|mother-baby|mother-baby
341756|NCT01683240|cholangioscope|cholangioscope
341757|NCT01683240|Frimberger cholangioscope|frimberger cholangioscope
341758|NCT01683240|short access cholangioscopy|short access cholangioscopy
341759|NCT01683240|ERCP|ercp
341760|NCT01683240|gallstone therapy|gallstone therapy
341761|NCT01683227|drug use; emergency department; brief intervention|drug use; emergency department; brief intervention
341762|NCT01683201|Total hip replacement|total hip replacement
341763|NCT01683201|Functional exercise class|functional exercise class
341764|NCT01683201|Randomised controlled trial|randomised controlled trial
341765|NCT01683188|melanoma|melanoma
341766|NCT01683188|skin cancer|skin cancer
341767|NCT01683188|Stage IV|stage iv
341768|NCT01683175|Erlotinib|erlotinib
341769|NCT01683175|adjuvant therapy|adjuvant therapy
341770|NCT01683175|radical operation|radical operation
341771|NCT01683175|IIIA NSCLC|iiia nsclc
341772|NCT01683175|EGFR mutation|egfr mutation
341773|NCT01683162|parenteral nutrition|parenteral nutrition
341774|NCT01683162|lipid emulsion|lipid emulsion
341775|NCT01683162|olive oil|olive oil
341776|NCT01683162|liver function|liver function
341777|NCT01683162|fatty acid|fatty acid
341778|NCT01683162|clinical outcomes|clinical outcomes
341779|NCT01683149|Refractory|refractory
341780|NCT01683149|Relapsed|relapsed
341781|NCT01683149|Recurrent|recurrent
341782|NCT01683149|Pediatric|pediatric
341783|NCT01683149|Malignancy|malignancy
341784|NCT01683123|Allogeneic HSCT|allogeneic hsct
341785|NCT01683123|Busulfan|busulfan
341786|NCT01683123|Fludarabina|fludarabina
341787|NCT01683084|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
341789|NCT01683084|telmisartan|telmisartan
341790|NCT01683071|Total knee arthroplasty|total knee arthroplasty
341791|NCT01683071|Analgesia|analgesia
341792|NCT01683071|Pain management|pain management
341793|NCT01683058|Schizophrenia|schizophrenia
341794|NCT01683045|non-paroxysmal atrial fibrillation|non-paroxysmal atrial fibrillation
341795|NCT01683045|persistent atrial fibrillation|persistent atrial fibrillation
341796|NCT01683045|atrial fibrillation|atrial fibrillation
341797|NCT01683045|heart palpitations|heart palpitations
341798|NCT01683045|irregular heart beat|irregular heart beat
341799|NCT01683045|temperature-controlled radiofrequency ablation|temperature-controlled radiofrequency ablation
341800|NCT01683045|radiofrequency energy|radiofrequency energy
341801|NCT01683045|TCRF energy|tcrf energy
341802|NCT01683045|RF energy|rf energy
341803|NCT01683045|epicardial and endocardial lesions|epicardial and endocardial lesions
341804|NCT01683045|concomitant heart surgery|concomitant heart surgery
341805|NCT01683045|surgical ablation|surgical ablation
341806|NCT01683019|Depression|depression
341807|NCT01683019|magnetic field|magnetic field
341808|NCT01683019|alpha frequency|alpha frequency
341809|NCT01683019|EEG|eeg
341810|NCT01683019|NeoSync EEG Synchronization Therapy|neosync eeg synchronization therapy
341811|NCT01682993|corneal cross linking|corneal cross linking
341812|NCT01682993|topography guided excimer laser|topography guided excimer laser
341813|NCT01682993|Keratoconus|keratoconus
341814|NCT01682993|Pellucid marginal degeneration|pellucid marginal degeneration
341815|NCT01682993|Post Excimer ectasia|post excimer ectasia
341816|NCT01682980|Osteoarthritis|osteoarthritis
341817|NCT01682980|Pain|pain
341818|NCT01682980|Exercise|exercise
341819|NCT01682980|Function|function
341820|NCT01682980|Cartilage quality|cartilage quality
341821|NCT01682967|Parturients|parturients
341822|NCT01682967|Analgesia, epidural|analgesia, epidural
341823|NCT01682967|Headache, post-dural puncture|headache, post-dural puncture
341824|NCT01682954|lifestyle risk reduction|lifestyle risk reduction
341825|NCT01682941|soy, isoflavones, functional food, prostate cancer|soy, isoflavones, functional food, prostate cancer
341826|NCT01682928|Oligohydramnios|oligohydramnios
341827|NCT01682928|Hydrotherapy|hydrotherapy
341828|NCT01682928|Pregnancy|pregnancy
341829|NCT01682915|ADHD|adhd
341830|NCT01682915|endophenotype|endophenotype
341831|NCT01682915|executive function|executive function
341832|NCT01682915|diffusion spectrum imaging|diffusion spectrum imaging
341833|NCT01682915|resting-state fMRI|resting-state fmri
341834|NCT01682915|frontostriatal and frontoparietal circuitries|frontostriatal and frontoparietal circuitries
341835|NCT01682915|DAT1|dat1
341836|NCT01682876|Prevention of meningococcal disease, children, vaccine|prevention of meningococcal disease, children, vaccine
341837|NCT01682863|COPD, QAB149, QVA149, indacaterol maleate, gylcopyrronium bromide|copd, qab149, qva149, indacaterol maleate, gylcopyrronium bromide
341838|NCT01682850|COPD|copd
341839|NCT01682850|Chronic Obstructive Lung Disease|chronic obstructive lung disease
341840|NCT01682850|lung cancer|lung cancer
341841|NCT01682850|emphysema|emphysema
341842|NCT01682850|Pulmonary Rehabilitation|pulmonary rehabilitation
341843|NCT01682824|Central Nervous System|central nervous system
341844|NCT01682824|CNS|cns
341845|NCT01682824|CNS tumor|cns tumor
341846|NCT01682824|Adolescent or Young Adult|adolescent or young adult
341847|NCT01682824|AYA|aya
341848|NCT01682824|Survivors|survivors
341849|NCT01682824|Eating Questionnaire-Ecological Momentary Assessment|eating questionnaire-ecological momentary assessment
341850|NCT01682824|EQ-EMA|eq-ema
341851|NCT01682824|Cognitive restraint|cognitive restraint
341852|NCT01682824|CR|cr
341853|NCT01682824|Uncontrollable eating|uncontrollable eating
341854|NCT01682824|UE|ue
341855|NCT01682824|Three Factor Eating Questionnaire-R18v2|three factor eating questionnaire-r18v2
341856|NCT01682824|TFEQ-R18v2|tfeq-r18v2
341857|NCT01682824|Web-based questionnaire|web-based questionnaire
341858|NCT01682824|Multifactor Screener|multifactor screener
341859|NCT01682785|Major depressive disorder|major depressive disorder
341860|NCT01682785|Metabolic syndrome|metabolic syndrome
341861|NCT01682785|Thyroid dysfunction|thyroid dysfunction
341862|NCT01682785|incidence|incidence
341863|NCT01682772|Olaparib|olaparib
341864|NCT01682772|Adenocarcinoma|adenocarcinoma
341865|NCT01682772|Prostate|prostate
341866|NCT01682759|diabetes|diabetes
341867|NCT01682746|Brain Tumor|brain tumor
341868|NCT01682746|Photodynamic Therapy|photodynamic therapy
341869|NCT01682746|Photochemotherapy|photochemotherapy
341870|NCT01682746|Astrocytoma|astrocytoma
341871|NCT01682746|Pilocytic Astrocytoma|pilocytic astrocytoma
341872|NCT01682746|Low grade Astrocytoma|low grade astrocytoma
341873|NCT01682746|Anaplastic Astrocytoma|anaplastic astrocytoma
341874|NCT01682746|Glioblastoma|glioblastoma
341876|NCT01682746|Chordoma|chordoma
341877|NCT01682746|Germinoma|germinoma
341878|NCT01682746|Germ Cell Tumor|germ cell tumor
341879|NCT01682746|Non-germinaoma|non-germinaoma
341880|NCT01682746|CNS Lymphoma|cns lymphoma
341881|NCT01682746|Craniopharyngioma|craniopharyngioma
341882|NCT01682746|Brain Stem Glioma|brain stem glioma
341883|NCT01682746|Ependymoma|ependymoma
341884|NCT01682746|Mixed Glioma|mixed glioma
341885|NCT01682746|Optic Nerve Glioma|optic nerve glioma
341886|NCT01682746|Subependymoma|subependymoma
341887|NCT01682746|Medulloblastoma|medulloblastoma
341888|NCT01682746|Meningioma|meningioma
341889|NCT01682746|Metastatic Brain Tumors|metastatic brain tumors
341890|NCT01682746|Oligodendroglioma|oligodendroglioma
341891|NCT01682746|Pituitary Tumors|pituitary tumors
341892|NCT01682746|Primitive Neuroectodermal|primitive neuroectodermal
341893|NCT01682746|PNET|pnet
341894|NCT01682746|Desmoplastic Neuroepithelial Tumor|desmoplastic neuroepithelial tumor
341895|NCT01682746|DNET|dnet
341896|NCT01682733|Obesity|obesity
341897|NCT01682733|Weight loss|weight loss
341898|NCT01682733|Gastric reduction (volume)|gastric reduction (volume)
341899|NCT01682733|BMI 30-40|bmi 30-40
341900|NCT01682720|HCV|hcv
341901|NCT01682720|Genotype 2|genotype 2
341902|NCT01682720|Genotype 3|genotype 3
341903|NCT01682707|intubation|intubation
341904|NCT01682707|coronary disease|coronary disease
341905|NCT01682707|hemodynamic response|hemodynamic response
341906|NCT01682707|anesthesia with tracheal intubation|anesthesia with tracheal intubation
341907|NCT01682707|assessment of hemodynamic response|assessment of hemodynamic response
341908|NCT01682681|Epilepsy|epilepsy
341909|NCT01682681|Topiramate|topiramate
341910|NCT01682681|Topmax|topmax
341911|NCT01682668|parkinson's disease|parkinson's disease
341912|NCT01682668|subthalamic nucleus|subthalamic nucleus
341914|NCT01682668|gait initiation|gait initiation
341915|NCT01682668|neuronal activity|neuronal activity
341916|NCT01682668|before STN stimulation|before stn stimulation
341917|NCT01682668|with STN stimulation|with stn stimulation
341918|NCT01682668|functional MRI|functional mri
341919|NCT01682642|endometriosis|endometriosis
341920|NCT01682642|pregnancy|pregnancy
341921|NCT01682642|In Vitro Fertilization (IVF)/Intra Cytoplastic Sperm Injection (ICSI)|in vitro fertilization (ivf)/intra cytoplastic sperm injection (icsi)
341922|NCT01682642|peritoneal implants|peritoneal implants
341923|NCT01682642|embryo quality|embryo quality
341924|NCT01682629|Pediatric|pediatric
341925|NCT01682629|Cardiac|cardiac
341926|NCT01682629|Arrest|arrest
341927|NCT01682629|Simulation|simulation
341928|NCT01682629|Debriefing|debriefing
341929|NCT01682629|Realism|realism
341930|NCT01682616|Safety|safety
341931|NCT01682616|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
341932|NCT01682616|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
341933|NCT01682616|Rituximab|rituximab
341934|NCT01682616|Tolerability|tolerability
341935|NCT01682616|Pharmacokinetics|pharmacokinetics
341936|NCT01682616|ABT-199|abt-199
341937|NCT01682616|Cancer|cancer
341938|NCT01682616|Preliminary|preliminary
341939|NCT01682616|Efficacy|efficacy
341940|NCT01682616|Maximum Tolerated Dose|maximum tolerated dose
341941|NCT01682616|Venetoclax|venetoclax
341942|NCT01682603|Nerve growth factor|nerve growth factor
341943|NCT01682603|P2X3 receptor|p2x3 receptor
341944|NCT01682603|Transient Receptor Potential Vanilloid 1 (TRPV-1) receptor|transient receptor potential vanilloid 1 (trpv-1) receptor
341945|NCT01682603|Bladder function|bladder function
341946|NCT01682603|Glomerular filtration rate|glomerular filtration rate
341947|NCT01682603|Detrusor overactivity|detrusor overactivity
341948|NCT01682603|Spinal cord injury|spinal cord injury
341949|NCT01682590|septic shock; acute renal failure; renal remplacement therapy; mortality; intensive care; critical care; acute kidney injury|septic shock; acute renal failure; renal remplacement therapy; mortality; intensive care; critical care; acute kidney injury
341950|NCT01682577|Perindopril|perindopril
341951|NCT01682577|Perindoprilat|perindoprilat
341952|NCT01682577|Bioequivalence|bioequivalence
341953|NCT01682577|Pharmacokinetic|pharmacokinetic
341954|NCT01682577|Angiotensin-converting enzyme inhibitor|angiotensin-converting enzyme inhibitor
341955|NCT01682564|Candemore|candemore
341956|NCT01682564|Atacand|atacand
341957|NCT01682564|Candesartan cilexetil|candesartan cilexetil
341958|NCT01682564|Primary Hypertension|primary hypertension
341959|NCT01682564|Congestive Hypertension|congestive hypertension
341960|NCT01682551|High altitude illness|high altitude illness
341961|NCT01682551|Chinese medicine body constitution|chinese medicine body constitution
341962|NCT01682551|Chinese Medicine|chinese medicine
341963|NCT01682551|High altitude medicine|high altitude medicine
341964|NCT01682551|Mountain trekking|mountain trekking
341965|NCT01682538|Orfadin|orfadin
341966|NCT01682538|Nitisinone|nitisinone
341967|NCT01682538|Bioequivalence|bioequivalence
341968|NCT01682538|Bioavailability|bioavailability
341969|NCT01682525|Fertility preservation|fertility preservation
341970|NCT01682525|Ovarian Tissue|ovarian tissue
341971|NCT01682525|Cryopreservation|cryopreservation
341972|NCT01682525|Assisted Reproductive Technology|assisted reproductive technology
341973|NCT01682499|neuropathy|neuropathy
341974|NCT01682499|taxane|taxane
341975|NCT01682499|paclitaxel|paclitaxel
341976|NCT01682499|calcium|calcium
341977|NCT01682499|magnesium|magnesium
341978|NCT01682499|prevention|prevention
341979|NCT01682486|Medical device|medical device
341980|NCT01682486|Endotracheal Tube(s), ETT|endotracheal tube(s), ett
341981|NCT01682486|Bactiguard Coated ETT|bactiguard coated ett
341982|NCT01682486|Tolerability|tolerability
341983|NCT01682486|Safety|safety
341984|NCT01682486|Performance|performance
341985|NCT01682486|Bacterial colonization on ETT surface|bacterial colonization on ett surface
341986|NCT01682486|Hospital Acquired Infections, HAI|hospital acquired infections, hai
341987|NCT01682486|Ventilator Associated Pneumonia, VAP|ventilator associated pneumonia, vap
341988|NCT01682473|PI3K inhibitor|pi3k inhibitor
341989|NCT01682473|clinical trial|clinical trial
341990|NCT01682447|COPD|copd
341991|NCT01682447|Cognitive Dysfunction|cognitive dysfunction
341992|NCT01682447|Pulmonary Rehabilitation|pulmonary rehabilitation
341993|NCT01682447|Quality of life|quality of life
341994|NCT01682447|Cognitive rehabilitation|cognitive rehabilitation
341995|NCT01682408|R406,|r406,
341996|NCT01682408|Fostamatinib,|fostamatinib,
341997|NCT01682408|Phase I,|phase i,
341998|NCT01682408|Healthy Subjects,|healthy subjects,
341999|NCT01682408|Pharmacokinetics,|pharmacokinetics,
342000|NCT01682408|Fed/Fasted|fed/fasted
342001|NCT01682395|Intestinal volvulus|intestinal volvulus
342002|NCT01682395|Colon, sigmoid|colon, sigmoid
342003|NCT01682395|Anastomosis, surgical|anastomosis, surgical
342004|NCT01682395|Anastomotic leak|anastomotic leak
342005|NCT01682395|Malawi|malawi
342006|NCT01682395|Developing Country|developing country
342007|NCT01682382|age-related macular degeneration|age-related macular degeneration
342008|NCT01682382|choroidal neovascular age-related macular degeneration|choroidal neovascular age-related macular degeneration
342010|NCT01682382|macular pigment optical density (MPOD)|macular pigment optical density (mpod)
342011|NCT01682356|heart failure|heart failure
342012|NCT01682356|hypertension, pulmonary|hypertension, pulmonary
342013|NCT01682356|oxygen consumption|oxygen consumption
342014|NCT01682356|exercise tolerance|exercise tolerance
342015|NCT01682317|eating frequency|eating frequency
342016|NCT01682304|preeclampsia|preeclampsia
342017|NCT01682304|hypertension|hypertension
342018|NCT01682304|blood pressure|blood pressure
342019|NCT01682304|pregnancy induced hypertension|pregnancy induced hypertension
342020|NCT01682304|chronic hypertension|chronic hypertension
342021|NCT01682291|Prehypertension|prehypertension
342022|NCT01682291|Life-style modifications|life-style modifications
342023|NCT01682291|Dietary supplementation|dietary supplementation
342024|NCT01682278|Health complaints|health complaints
342025|NCT01682278|Amalgam|amalgam
342026|NCT01682278|Mercury|mercury
342027|NCT01682278|Plasma|plasma
342028|NCT01682278|Cytokine|cytokine
342029|NCT01682226|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
342030|NCT01682226|CYCLOSPORINE|cyclosporine
342031|NCT01682226|FLUDARABINE|fludarabine
342032|NCT01682226|G-CSF|g-csf
342033|NCT01682226|MYCOPHENOLATE MOFETIL (MMF)|mycophenolate mofetil (mmf)
342034|NCT01682226|Cord Blood Transplantation|cord blood transplantation
342035|NCT01682226|CliniMACS|clinimacs
342036|NCT01682226|12-153|12-153
342037|NCT01682213|Dabrafenib|dabrafenib
342038|NCT01682213|(GSK2118436)|(gsk2118436)
342039|NCT01682213|BRAFV600E/K|brafv600e/k
342040|NCT01682213|Resected AJCC Stage IIIC|resected ajcc stage iiic
342041|NCT01682213|12-124|12-124
342042|NCT01682200|moderate|moderate
342043|NCT01682200|facial acne|facial acne
342044|NCT01682200|acne vulgaris|acne vulgaris
342045|NCT01682161|Schizophrenia|schizophrenia
342046|NCT01682161|Paliperidone Palmitate|paliperidone palmitate
342047|NCT01682161|Invega Sustenna|invega sustenna
342048|NCT01682161|Antipsychotics|antipsychotics
342049|NCT01682161|Atypical antipsychotics|atypical antipsychotics
342050|NCT01682161|Medication Satisfaction and Adherence|medication satisfaction and adherence
342051|NCT01682122|Blood Pressure|blood pressure
342052|NCT01682122|Pediatrics|pediatrics
342053|NCT01682122|Infant, Newborn|infant, newborn
342054|NCT01682122|Cardiology|cardiology
342055|NCT01682109|prophylaxis|prophylaxis
342056|NCT01682109|herpes zoster|herpes zoster
342057|NCT01682109|herpes simplex|herpes simplex
342058|NCT01682109|valacyclovir|valacyclovir
342059|NCT01682109|palatability|palatability
342060|NCT01682109|paediatric|paediatric
342061|NCT01682096|Chest pain|chest pain
342062|NCT01682096|Emergency room|emergency room
342063|NCT01682096|Acute coronary syndrome|acute coronary syndrome
342064|NCT01682096|Computed tomography coronary angiography|computed tomography coronary angiography
342065|NCT01682096|Stress echocardiography|stress echocardiography
342066|NCT01682083|MEK inhibitor|mek inhibitor
342067|NCT01682083|trametinib|trametinib
342068|NCT01682083|Oncology|oncology
342069|NCT01682083|adjuvant melanoma|adjuvant melanoma
342070|NCT01682083|dabrafenib|dabrafenib
342071|NCT01682083|dabrafenib and trametinib combination therapy|dabrafenib and trametinib combination therapy
342072|NCT01682083|BRAF mutation-positive melanoma|braf mutation-positive melanoma
342073|NCT01682083|BRAF inhibitor|braf inhibitor
342074|NCT01682070|Sublingual immunotherapy|sublingual immunotherapy
342075|NCT01682070|Dose range finding|dose range finding
342076|NCT01682070|Dose tolerability|dose tolerability
342077|NCT01682070|grass pollen|grass pollen
342078|NCT01682070|Allergic rhinitis/rhinoconjunctivitis|allergic rhinitis/rhinoconjunctivitis
342079|NCT01682070|Safety|safety
342080|NCT01682070|Immunogenicity|immunogenicity
342081|NCT01682057|High Blood Pressure|high blood pressure
342082|NCT01682057|Hypertension|hypertension
342083|NCT01682057|Resistant Hypertension|resistant hypertension
342084|NCT01682018|emphysema|emphysema
342085|NCT01682018|lung transplantation|lung transplantation
342086|NCT01682005|Cost|cost
342087|NCT01682005|Children|children
342088|NCT01682005|Rotavirus|rotavirus
342089|NCT01682005|Rotavirus vaccination|rotavirus vaccination
342090|NCT01682005|Clinical|clinical
342091|NCT01681992|Safety|safety
342092|NCT01681992|Measles, mumps and rubella diseases|measles, mumps and rubella diseases
342093|NCT01681992|Immunogenicity|immunogenicity
342094|NCT01681979|fluticasone propionate|fluticasone propionate
342095|NCT01681979|asthma|asthma
342096|NCT01681979|pregnancy|pregnancy
342097|NCT01681979|major congenital malformations|major congenital malformations
342098|NCT01681927|idiopathic edema nocturia|idiopathic edema nocturia
342099|NCT01681914|adult HIV positive patients|adult hiv positive patients
342100|NCT01681875|Biomarkers of exposure|biomarkers of exposure
342101|NCT01681875|Compensatory smoking|compensatory smoking
342102|NCT01681875|Nicotine dependence|nicotine dependence
342103|NCT01681875|Reduced nicotine cigarettes|reduced nicotine cigarettes
342104|NCT01681875|Tobacco withdrawal|tobacco withdrawal
342105|NCT01681862|Hypertension|hypertension
342106|NCT01681862|African American|african american
342107|NCT01681862|Personal Health Record|personal health record
342108|NCT01681862|Faith-based Organizations|faith-based organizations
342110|NCT01681849|childhood abuse|childhood abuse
342111|NCT01681823|Prostate Cancer|prostate cancer
342112|NCT01681823|Prostatic Neoplasms|prostatic neoplasms
342113|NCT01681823|Prostate Specific Antigen|prostate specific antigen
342114|NCT01681823|Modified Citrus Pectin|modified citrus pectin
342115|NCT01681823|PectaSol-C|pectasol-c
342116|NCT01681823|Biochemical Relapse|biochemical relapse
342117|NCT01681797|fluorescent angiography|fluorescent angiography
342118|NCT01681797|reconstructive surgery|reconstructive surgery
342119|NCT01681797|perforator flap|perforator flap
342120|NCT01681784|lower urinary tract symptoms|lower urinary tract symptoms
342121|NCT01681784|biomarkers|biomarkers
342122|NCT01681784|urodynamic studies|urodynamic studies
342123|NCT01681758|cardiac surgery|cardiac surgery
342124|NCT01681758|Pulse pressure variation|pulse pressure variation
342125|NCT01681758|intravenous fluids|intravenous fluids
342126|NCT01681732|Asthma|asthma
342127|NCT01681732|child|child
342128|NCT01681732|pediatric|pediatric
342129|NCT01681719|VO2|vo2
342130|NCT01681719|VCO2|vco2
342131|NCT01681719|VE/VO2|ve/vo2
342132|NCT01681719|heart rate|heart rate
342133|NCT01681706|HIV|hiv
342134|NCT01681706|Indicator disease|indicator disease
342135|NCT01681654|Head/Neck Cancer|head/neck cancer
342136|NCT01681654|Exercise|exercise
342137|NCT01681654|Progressive Strength Training|progressive strength training
342138|NCT01681654|Quality of Life|quality of life
342139|NCT01681654|Cancer|cancer
342140|NCT01681654|Randomized Controlled Trial|randomized controlled trial
342141|NCT01681654|Nutrition|nutrition
342142|NCT01681654|Lifestyle Intervention|lifestyle intervention
342143|NCT01681641|Patients|patients
342144|NCT01681641|Nursing|nursing
342145|NCT01681641|Parkinsons disease|parkinsons disease
342146|NCT01681641|Deep Brain Stimulation|deep brain stimulation
342147|NCT01681641|Spouses|spouses
342148|NCT01681628|Thought Field Therapy.|thought field therapy.
342149|NCT01681628|Post-traumatic stress disorder.|post-traumatic stress disorder.
342150|NCT01681628|Post-traumatic stress disorder check list for Civilians.|post-traumatic stress disorder check list for civilians.
342151|NCT01681628|Uganda|uganda
342152|NCT01681628|Ugandan therapists.|ugandan therapists.
342153|NCT01681628|Community treatment.|community treatment.
342154|NCT01681615|Challenge test for Aspirin Hypersensitivity|challenge test for aspirin hypersensitivity
342155|NCT01681615|Challenge test for Acetylsalicylic Hypersensitivity|challenge test for acetylsalicylic hypersensitivity
342156|NCT01681602|Alzheimer Disease|alzheimer disease
342157|NCT01681602|Exercise|exercise
342158|NCT01681602|Cognition|cognition
342159|NCT01681602|Quality of life|quality of life
342160|NCT01681602|Cardiovascular fitness|cardiovascular fitness
342161|NCT01681602|Behavioural or psychological symptoms|behavioural or psychological symptoms
342162|NCT01681602|Physical fitness|physical fitness
342163|NCT01681589|TBI|tbi
342164|NCT01681589|Traumatic Brain Injury|traumatic brain injury
342165|NCT01681589|Rehabilitation|rehabilitation
342166|NCT01681589|Therapy|therapy
342167|NCT01681576|hypertension, salt sensitivity, valsartan, LCZ696|hypertension, salt sensitivity, valsartan, lcz696
342168|NCT01681537|Relapsed|relapsed
342169|NCT01681537|Refractory|refractory
342170|NCT01681524|Flurpiridaz F18 Injection|flurpiridaz f18 injection
342171|NCT01681524|Positron Emission Tomography Myocardial Perfusion Imaging|positron emission tomography myocardial perfusion imaging
342172|NCT01681524|Single Positron Emission Computed Tomography|single positron emission computed tomography
342173|NCT01681524|Coronary Artery Disease|coronary artery disease
342174|NCT01681524|Myocardia Ischemia|myocardia ischemia
342175|NCT01681524|Coronary Disease|coronary disease
342176|NCT01681524|Heart Diseases|heart diseases
342177|NCT01681524|Cardiovascular Diseases|cardiovascular diseases
342178|NCT01681524|Arteriosclerosis|arteriosclerosis
342179|NCT01681524|Arterial Occlusive Diseases|arterial occlusive diseases
342180|NCT01681524|Vascular Diseases|vascular diseases
342181|NCT01681511|Catheter Associated Urinary Tract Infections|catheter associated urinary tract infections
342182|NCT01681511|CAUTI|cauti
342183|NCT01681498|pregnant|pregnant
342184|NCT01681498|fetal ecg|fetal ecg
342185|NCT01681498|ecg|ecg
342186|NCT01681485|Traditional Chinese medicine|traditional chinese medicine
342187|NCT01681485|Non small cell lung cancer|non small cell lung cancer
342188|NCT01681485|Surgery|surgery
342189|NCT01681485|Chemotherapy|chemotherapy
342190|NCT01681485|Radiation therapy|radiation therapy
342191|NCT01681472|Colon cancer|colon cancer
342192|NCT01681472|5,10-methylenetetrahydrofolate|5,10-methylenetetrahydrofolate
342193|NCT01681472|Rectal Neoplasms|rectal neoplasms
342194|NCT01681472|Colorectal Neoplasms|colorectal neoplasms
342195|NCT01681472|Intestinal Neoplasms|intestinal neoplasms
342196|NCT01681472|Gastrointestinal Neoplasms|gastrointestinal neoplasms
342197|NCT01681472|Digestive System Neoplasms|digestive system neoplasms
342198|NCT01681472|Gastrointestinal Diseases|gastrointestinal diseases
342199|NCT01681472|Therapeutic Uses|therapeutic uses
342200|NCT01681472|Pharmacokinetics|pharmacokinetics
342201|NCT01681472|Pharmacodynamics|pharmacodynamics
342202|NCT01681459|Free fatty acid|free fatty acid
342203|NCT01681459|Triglyceride|triglyceride
342204|NCT01681459|Gastric emptying|gastric emptying
342205|NCT01681459|Satiety hormones|satiety hormones
342206|NCT01681459|Appetite|appetite
342207|NCT01681459|Severe obesity|severe obesity
342208|NCT01681446|hepatocellular carcinoma|hepatocellular carcinoma
342209|NCT01681446|interferon-alpha|interferon-alpha
342210|NCT01681446|miR-26|mir-26
342211|NCT01681433|OGX-427|ogx-427
342212|NCT01681433|Abiraterone Acetate|abiraterone acetate
342213|NCT01681420|HIV counseling|hiv counseling
342214|NCT01681420|Blood donor HIV testing|blood donor hiv testing
342215|NCT01681420|Brazil|brazil
342216|NCT01681420|Blood banks|blood banks
342217|NCT01681420|Blood donors|blood donors
342218|NCT01681407|Depression|depression
342219|NCT01681407|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors
342220|NCT01681407|MicroRNAs|micrornas
342221|NCT01681407|Proteome|proteome
342222|NCT01681368|NF-Kappa B Pathway|nf-kappa b pathway
342223|NCT01681368|Response Biomarkers|response biomarkers
342224|NCT01681368|Progression-Free Survival|progression-free survival
342225|NCT01681368|Pharmacokinetics|pharmacokinetics
342226|NCT01681368|Pharmacodynamics|pharmacodynamics
342227|NCT01681355|Healthy, term, Asian infants|healthy, term, asian infants
342228|NCT01681355|Infant formula|infant formula
342229|NCT01681342|stade Ib to IV cervix cancer|stade ib to iv cervix cancer
342230|NCT01681342|ambulatory high dose rate brachytherapy|ambulatory high dose rate brachytherapy
342231|NCT01681329|Cognitive-behavioral therapy|cognitive-behavioral therapy
342232|NCT01681329|Interpretation modification training|interpretation modification training
342233|NCT01681329|Randomized clinical trial|randomized clinical trial
342234|NCT01681329|Adults|adults
342235|NCT01681316|Chronic Stable Angina|chronic stable angina
342236|NCT01681316|Randomized Controlled Trial|randomized controlled trial
342237|NCT01681316|Traditional Chinese Medicine|traditional chinese medicine
342238|NCT01681264|Pain|pain
342239|NCT01681264|Pain Management|pain management
342240|NCT01681264|Back pain|back pain
342241|NCT01681264|Neck pain|neck pain
342242|NCT01681238|perioperative fluid optimization|perioperative fluid optimization
342243|NCT01681238|goal-directed therapy|goal-directed therapy
342244|NCT01681238|elderly|elderly
342245|NCT01681238|high-risk surgery|high-risk surgery
342246|NCT01681225|ARDS|ards
342247|NCT01681225|mechanical ventilation|mechanical ventilation
342248|NCT01681225|ALI|ali
342249|NCT01681225|esophageal pressure|esophageal pressure
342250|NCT01681199|statin|statin
342251|NCT01681199|atherosclerosis|atherosclerosis
342252|NCT01681199|Coronary heart disease|coronary heart disease
342253|NCT01681199|OPN|opn
342254|NCT01681199|OPG|opg
342255|NCT01681173|Nutritional support|nutritional support
342256|NCT01681173|Diet therapy|diet therapy
342257|NCT01681173|Diabetes prevention|diabetes prevention
342258|NCT01681173|Insoluble fiber|insoluble fiber
342259|NCT01681173|Healthy life style|healthy life style
342260|NCT01681173|Weight loss|weight loss
342261|NCT01681160|MAGGOT THERAPY|maggot therapy
342262|NCT01681160|DIABETIC FOOT|diabetic foot
342263|NCT01681160|NURSING CARE|nursing care
342264|NCT01681160|DRESSING|dressing
342265|NCT01681147|Gestational Diabetes|gestational diabetes
342266|NCT01681147|postpartum|postpartum
342267|NCT01681147|nutrition|nutrition
342268|NCT01681147|exercise|exercise
342269|NCT01681134|tacrolimus|tacrolimus
342270|NCT01681134|Advagraf®|advagraf®
342271|NCT01681134|Prograf®|prograf®
342272|NCT01681134|Glomerular Filtration Rate|glomerular filtration rate
342273|NCT01681134|Effective Renal Plasma Flow|effective renal plasma flow
342274|NCT01681134|Pharmacokinetics|pharmacokinetics
342275|NCT01681134|Pharmacodynamics|pharmacodynamics
342276|NCT01681095|Physiological Effects of Drugs|physiological effects of drugs
342277|NCT01681095|Cardiovascular Agents|cardiovascular agents
342278|NCT01681095|Therapeutic Uses|therapeutic uses
342279|NCT01681095|Pharmacologic Actions|pharmacologic actions
342280|NCT01681095|Mannitol|mannitol
342281|NCT01681095|Cardiac Surgery|cardiac surgery
342282|NCT01681095|Cardioplegic Solutions|cardioplegic solutions
342283|NCT01681095|HTK solution|htk solution
342284|NCT01681095|Myocardial protection|myocardial protection
342285|NCT01681095|Coronary Artery Disease|coronary artery disease
342286|NCT01681095|Myocardial Ischemia|myocardial ischemia
342287|NCT01681095|Coronary Disease|coronary disease
342288|NCT01681095|Heart Diseases|heart diseases
342289|NCT01681056|autosuggestion|autosuggestion
342290|NCT01681056|quality of life|quality of life
342291|NCT01681056|geriatric|geriatric
342292|NCT01681056|serum cortisol|serum cortisol
342293|NCT01681056|Interferon gamma|interferon gamma
342294|NCT01681056|interleukin-2|interleukin-2
342295|NCT01681056|interleukin-6|interleukin-6
342296|NCT01681056|neuroplasticity|neuroplasticity
342297|NCT01681043|Sleep|sleep
342298|NCT01681017|Perinatal Mortality|perinatal mortality
342299|NCT01681017|Asphyxia|asphyxia
342300|NCT01681017|Stillbirth|stillbirth
342301|NCT01681017|Neonatal Death|neonatal death
342302|NCT01681017|Resuscitation|resuscitation
342303|NCT01681017|Helping Babies Breathe|helping babies breathe
342304|NCT01681017|among births greater than one thousand five hundred grams|among births greater than one thousand five hundred grams
342306|NCT01681004|si joint pain|si joint pain
342307|NCT01681004|si joint injury|si joint injury
342308|NCT01681004|si joint treatment|si joint treatment
342309|NCT01681004|si joint injections|si joint injections
342310|NCT01681004|si joint inflammation|si joint inflammation
342311|NCT01681004|si joint problems|si joint problems
342312|NCT01681004|si joint symptoms|si joint symptoms
342313|NCT01681004|hypermobile si joint|hypermobile si joint
342314|NCT01681004|si joint arthritis|si joint arthritis
342315|NCT01681004|si joint pain treatment|si joint pain treatment
342316|NCT01681004|inflamed si joint|inflamed si joint
342317|NCT01681004|si joint sclerosis|si joint sclerosis
342318|NCT01681004|locked si joint|locked si joint
342319|NCT01681004|si joint injuries|si joint injuries
342320|NCT01681004|si joint disease|si joint disease
342321|NCT01681004|si joint infection|si joint infection
342322|NCT01681004|sacroiliac joint pelvic pain|sacroiliac joint pelvic pain
342323|NCT01681004|sacroiliac joint arthritis treatment|sacroiliac joint arthritis treatment
342324|NCT01680965|Graft vs. Host Disease|graft vs. host disease
342325|NCT01680965|GVHD|gvhd
342326|NCT01680965|chronic graft versus host disease (cGVHD)|chronic graft versus host disease (cgvhd)
342327|NCT01680965|Allogeneic Transplant|allogeneic transplant
342328|NCT01680965|Ofatumumab|ofatumumab
342329|NCT01680952|RECORD study|record study
342330|NCT01680939|Pediatrics|pediatrics
342331|NCT01680939|Obstructive Sleep Apnea|obstructive sleep apnea
342332|NCT01680939|Adenotonsillectomy|adenotonsillectomy
342333|NCT01680939|Analgesia|analgesia
342334|NCT01680926|type 2 diabetes mellitus|type 2 diabetes mellitus
342335|NCT01680926|insulin|insulin
342336|NCT01680926|hbA1c|hba1c
342337|NCT01680926|body weight|body weight
342338|NCT01680900|menopause|menopause
342339|NCT01680900|hot flashes|hot flashes
342340|NCT01680900|vilazodone|vilazodone
342341|NCT01680887|Cocaine dependence|cocaine dependence
342342|NCT01680874|Clostridium difficile|clostridium difficile
342343|NCT01680874|Diarrhea|diarrhea
342344|NCT01680874|Infection|infection
342345|NCT01680874|Lactobacilli|lactobacilli
342346|NCT01680874|Bifidobacteria|bifidobacteria
342347|NCT01680874|Lactobacillus acidophilus|lactobacillus acidophilus
342348|NCT01680874|Lactobacillus paracasei|lactobacillus paracasei
342349|NCT01680874|Bifidobacterium lactis|bifidobacterium lactis
342350|NCT01680874|Yogurt|yogurt
342351|NCT01680874|Probiotics|probiotics
342352|NCT01680861|Kidney transplant patients|kidney transplant patients
342353|NCT01680848|Dental caries,|dental caries,
342354|NCT01680848|Caries diagnosis,|caries diagnosis,
342355|NCT01680848|Caries treatment,|caries treatment,
342356|NCT01680848|Caries risk,|caries risk,
342357|NCT01680848|Practice pattern,|practice pattern,
342358|NCT01680848|Clinical epidemiology,|clinical epidemiology,
342359|NCT01680848|Dental Practice-Based Research Network|dental practice-based research network
342360|NCT01680822|Nontuberculous, Atypical, Mycobacterial|nontuberculous, atypical, mycobacterial
342361|NCT01680809|Venous insufficiency|venous insufficiency
342362|NCT01680809|Venous stasis ulcerations|venous stasis ulcerations
342363|NCT01680809|Compression stockings|compression stockings
342364|NCT01680809|Compression stocking compliance|compression stocking compliance
342365|NCT01680796|Multiple Myeloma|multiple myeloma
342366|NCT01680796|Relapsed Multiple Myeloma|relapsed multiple myeloma
342367|NCT01680796|Refractory Multiple Myeloma|refractory multiple myeloma
342368|NCT01680783|noninvasive ventilation|noninvasive ventilation
342369|NCT01680783|acute hypoxemic respiratory failure|acute hypoxemic respiratory failure
342370|NCT01680783|Acute respiratory distress syndrome|acute respiratory distress syndrome
342371|NCT01680783|shock|shock
342372|NCT01680770|shock|shock
342373|NCT01680770|transthoracic echocardiography|transthoracic echocardiography
342374|NCT01680770|critical care|critical care
342375|NCT01680757|Left Atrial Appendage|left atrial appendage
342376|NCT01680757|LARIAT|lariat
342377|NCT01680757|atrial fibrillation|atrial fibrillation
342378|NCT01680757|contraindication to oral anticoagulation therapy|contraindication to oral anticoagulation therapy
342379|NCT01680744|Transplantation|transplantation
342380|NCT01680744|Terminal creatinine|terminal creatinine
342381|NCT01680744|Renal function|renal function
342382|NCT01680744|GFR|gfr
342383|NCT01680731|Pelvic floor injury|pelvic floor injury
342384|NCT01680731|Levator ani muscle|levator ani muscle
342385|NCT01680718|oxytocin|oxytocin
342386|NCT01680718|vasopressin|vasopressin
342387|NCT01680718|intranasal administration|intranasal administration
342388|NCT01680718|healthy sample|healthy sample
342389|NCT01680705|Chronic Rhinosinusitis|chronic rhinosinusitis
342390|NCT01680705|Endoscopic Sinus Surgery|endoscopic sinus surgery
342391|NCT01680705|Sinonasal saline irrigation|sinonasal saline irrigation
342392|NCT01680705|Frequency|frequency
342393|NCT01680705|Postoperative|postoperative
342394|NCT01680705|High Volume|high volume
342395|NCT01680705|Randomized Control Trial|randomized control trial
342396|NCT01680705|Single Blinded|single blinded
342397|NCT01680705|Prospective Study|prospective study
342398|NCT01680705|Quality of Life|quality of life
342399|NCT01680705|Endoscopic Sinus Score|endoscopic sinus score
342400|NCT01680692|Analgesia TKA|analgesia tka
342695|NCT01679236|MBSR|mbsr
342401|NCT01680692|Total knee arthroplasty|total knee arthroplasty
342402|NCT01680692|Continuous femoral catheter|continuous femoral catheter
342403|NCT01680692|Continuous tibial catheter|continuous tibial catheter
342404|NCT01680692|Single shot sciatic|single shot sciatic
342405|NCT01680679|Influenza|influenza
342406|NCT01680679|India|india
342407|NCT01680679|Children|children
342408|NCT01680679|Trivalent Influenza Vaccine (TIV)|trivalent influenza vaccine (tiv)
342409|NCT01680679|Inactivated poliovirus vaccine (IPV)|inactivated poliovirus vaccine (ipv)
342410|NCT01680679|Direct influenza vaccine effectiveness|direct influenza vaccine effectiveness
342411|NCT01680679|Total influenza vaccine effectiveness|total influenza vaccine effectiveness
342412|NCT01680679|Indirect influenza vaccine effectiveness|indirect influenza vaccine effectiveness
342413|NCT01680640|non alcoholic fatty liver disease|non alcoholic fatty liver disease
342414|NCT01680640|NAFLD|nafld
342415|NCT01680640|synbiotic|synbiotic
342416|NCT01680640|gut microbiota|gut microbiota
342417|NCT01680640|intervention|intervention
342418|NCT01680640|RCT|rct
342419|NCT01680640|biomarkers|biomarkers
342420|NCT01680588|Alzheimer|alzheimer
342421|NCT01680575|Neutropenia|neutropenia
342422|NCT01680575|Paclitaxel|paclitaxel
342423|NCT01680575|Carboplatin|carboplatin
342424|NCT01680575|Epithelial ovarian cancer|epithelial ovarian cancer
342425|NCT01680562|in-vivo skin imaging|in-vivo skin imaging
342426|NCT01680562|non-invasive non-melanoma skin cancer diagnostics|non-invasive non-melanoma skin cancer diagnostics
342427|NCT01680523|cervical cancer|cervical cancer
342428|NCT01680523|bulky early-stage|bulky early-stage
342429|NCT01680523|locally advanced|locally advanced
342430|NCT01680523|radical hysterectomy|radical hysterectomy
342431|NCT01680523|concurrent chemoradiation therapy|concurrent chemoradiation therapy
342432|NCT01680484|non-stress test|non-stress test
342433|NCT01680471|emergence agitation|emergence agitation
342434|NCT01680471|midazolam|midazolam
342435|NCT01680471|sevoflurane|sevoflurane
342436|NCT01680471|strabismus|strabismus
342437|NCT01680458|antifungal treatment|antifungal treatment
342438|NCT01680458|prophylaxis|prophylaxis
342439|NCT01680458|administration|administration
342440|NCT01680458|Japanese|japanese
342441|NCT01680458|infants|infants
342442|NCT01680458|fluconazole|fluconazole
342443|NCT01680458|Diflucan|diflucan
342444|NCT01680458|Regulatory Post Marketing Commitment Plan.|regulatory post marketing commitment plan.
342445|NCT01680445|osteoarthritis, arthritis|osteoarthritis, arthritis
342446|NCT01680432|constipation|constipation
342447|NCT01680432|probiotics|probiotics
342448|NCT01680432|bifidobacterium|bifidobacterium
342449|NCT01680432|cheese|cheese
342450|NCT01680419|Veterans|veterans
342451|NCT01680419|Reintegration|reintegration
342452|NCT01680419|Resilience|resilience
342453|NCT01680419|Marital|marital
342454|NCT01680419|Spouse|spouse
342455|NCT01680419|Behavioral intervention|behavioral intervention
342456|NCT01680419|PTSD|ptsd
342457|NCT01680419|Integrative therapies|integrative therapies
342458|NCT01680419|Complementary therapies|complementary therapies
342459|NCT01680419|Massage|massage
342460|NCT01680419|Meditation|meditation
342461|NCT01680419|Mindfulness|mindfulness
342462|NCT01680419|Compassion|compassion
342463|NCT01680419|Mental health|mental health
342464|NCT01680406|Plasmodium vivax|plasmodium vivax
342465|NCT01680406|malaria|malaria
342466|NCT01680406|Ethiopia|ethiopia
342467|NCT01680406|Sub-Saharan Africa|sub-saharan africa
342468|NCT01680406|primaquine|primaquine
342469|NCT01680406|artemether lumefantrine|artemether lumefantrine
342470|NCT01680406|chloroquine|chloroquine
342471|NCT01680380|sleep apnea|sleep apnea
342472|NCT01680380|snoring|snoring
342473|NCT01680315|Satiety,|satiety,
342474|NCT01680315|satiation,|satiation,
342475|NCT01680315|anticipation,|anticipation,
342476|NCT01680315|food intake|food intake
342477|NCT01680302|Atrial fibrillation|atrial fibrillation
342478|NCT01680302|Prevention|prevention
342479|NCT01680302|Exercise|exercise
342480|NCT01680289|Dentin bonding agents|dentin bonding agents
342481|NCT01680289|Composite restorations|composite restorations
342482|NCT01680289|Dental restoration failure|dental restoration failure
342483|NCT01680276|intellectual disability|intellectual disability
342484|NCT01680276|developmental disability|developmental disability
342485|NCT01680276|challenging behaviour|challenging behaviour
342486|NCT01680276|behavioural intervention|behavioural intervention
342487|NCT01680276|training|training
342488|NCT01680263|Kinesiotaping|kinesiotaping
342489|NCT01680263|pes anserinus tendino-bursitis|pes anserinus tendino-bursitis
342490|NCT01680263|nonsteroidal anti-inflammatory drugs|nonsteroidal anti-inflammatory drugs
342491|NCT01680263|physical therapy|physical therapy
342492|NCT01680250|Total liver volume|total liver volume
342493|NCT01680250|Liver cyst|liver cyst
342494|NCT01680237|cognitive behavior therapy|cognitive behavior therapy
342495|NCT01680237|exposure in-vivo|exposure in-vivo
342496|NCT01680237|panic disorder with agoraphobia|panic disorder with agoraphobia
342497|NCT01680224|Obesity|obesity
342498|NCT01680224|Weight Gain|weight gain
342499|NCT01680224|Dissonance|dissonance
342799|NCT01678781|Diarrhea|diarrhea
342500|NCT01680224|College,University Students|college,university students
342501|NCT01680224|Eating Disorders|eating disorders
342502|NCT01680224|Obesity Prevention|obesity prevention
342503|NCT01680224|Selective Prevention|selective prevention
342504|NCT01680224|Effectiveness|effectiveness
342505|NCT01680211|Blood Sugar,|blood sugar,
342506|NCT01680211|Lipoproteins,|lipoproteins,
342507|NCT01680211|Salacia,|salacia,
342508|NCT01680211|Sesame,|sesame,
342509|NCT01680211|Prediabetes,|prediabetes,
342510|NCT01680211|Hyperlipidemia,|hyperlipidemia,
342511|NCT01680211|Herbal supplement|herbal supplement
342512|NCT01680198|Vitamin D|vitamin d
342513|NCT01680198|Paracalcitol|paracalcitol
342514|NCT01680198|Chronic kidney disease|chronic kidney disease
342515|NCT01680198|Endothelial dysfunction|endothelial dysfunction
342516|NCT01680198|Flow mediated vasodilation|flow mediated vasodilation
342517|NCT01680185|Hyperglycemia|hyperglycemia
342518|NCT01680185|NODAT|nodat
342519|NCT01680185|Insulin pump|insulin pump
342520|NCT01680185|Semiclosed loop|semiclosed loop
342521|NCT01680172|cancer|cancer
342522|NCT01680172|depression|depression
342523|NCT01680172|anxiety|anxiety
342524|NCT01680172|palliative care|palliative care
342525|NCT01680159|Infliximab|infliximab
342526|NCT01680159|REMICADE|remicade
342527|NCT01680159|TA-650|ta-650
342528|NCT01680159|psoriasis|psoriasis
342529|NCT01680107|d-cycloserine, cognitive-behaviour therapy, panic disorder|d-cycloserine, cognitive-behaviour therapy, panic disorder
342530|NCT01680094|HIV Infection|hiv infection
342531|NCT01680094|Panobinostat|panobinostat
342532|NCT01680094|Lentivirus Infections|lentivirus infections
342533|NCT01680094|Retroviridae Infections|retroviridae infections
342534|NCT01680094|RNA Virus Infections|rna virus infections
342535|NCT01680094|Virus Diseases|virus diseases
342536|NCT01680094|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
342537|NCT01680094|Sexually Transmitted Diseases|sexually transmitted diseases
342538|NCT01680094|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
342539|NCT01680094|Immune System Diseases|immune system diseases
342540|NCT01680094|Histone Deacetylase Inhibitors|histone deacetylase inhibitors
342541|NCT01680094|Therapeutic Uses|therapeutic uses
342542|NCT01680068|Macular hole|macular hole
342543|NCT01680068|Vitreoretinal surgery|vitreoretinal surgery
342544|NCT01680068|Macular surgery|macular surgery
342545|NCT01680068|Air tamponade|air tamponade
342546|NCT01680042|inflammatory halo|inflammatory halo
342547|NCT01680042|VAS|vas
342548|NCT01680016|Rabies virus, postexposure, vaccine schedule, children, older adults|rabies virus, postexposure, vaccine schedule, children, older adults
342549|NCT01679964|HIV infection|hiv infection
342550|NCT01679964|Raltegravir|raltegravir
342551|NCT01679964|Adverse event|adverse event
342552|NCT01679964|Life quality|life quality
342553|NCT01679951|Rheumatoid arthritis|rheumatoid arthritis
342554|NCT01679951|Swollen and tender joints|swollen and tender joints
342555|NCT01679951|Methotrexate|methotrexate
342556|NCT01679951|Immunology|immunology
342557|NCT01679951|Dose range finding study|dose range finding study
342558|NCT01679938|obesity prevention|obesity prevention
342559|NCT01679938|cluster-randomized controlled trial|cluster-randomized controlled trial
342560|NCT01679938|preschool-aged children|preschool-aged children
342561|NCT01679925|Early puberty|early puberty
342562|NCT01679925|Psychosocial impact|psychosocial impact
342563|NCT01679925|Qualitative assessment|qualitative assessment
342564|NCT01679912|Hereditary angioedema|hereditary angioedema
342565|NCT01679912|Emergency Medical Service|emergency medical service
342566|NCT01679912|Health care coast|health care coast
342567|NCT01679912|Telephone|telephone
342568|NCT01679899|diabetes|diabetes
342569|NCT01679899|type 2 diabetes mellitus|type 2 diabetes mellitus
342570|NCT01679899|osteopenia|osteopenia
342571|NCT01679899|osteoporosis|osteoporosis
342572|NCT01679899|glycemic variability|glycemic variability
342573|NCT01679899|bone markers|bone markers
342574|NCT01679899|osteocalcin|osteocalcin
342575|NCT01679899|NTX|ntx
342576|NCT01679899|CTX|ctx
342577|NCT01679899|BALP|balp
342578|NCT01679886|Position emission tomography;|position emission tomography;
342579|NCT01679886|Rubidium;|rubidium;
342580|NCT01679886|Women;|women;
342581|NCT01679886|Overweighted patients|overweighted patients
342582|NCT01679873|confidence|confidence
342583|NCT01679873|funding sources|funding sources
342584|NCT01679873|conflicts of interests|conflicts of interests
342585|NCT01679873|general practitioner|general practitioner
342586|NCT01679847|Elemene|elemene
342587|NCT01679847|pharmacokinetics|pharmacokinetics
342588|NCT01679847|Blood-brain barrier|blood-brain barrier
342589|NCT01679821|Temporomandibular disorders.|temporomandibular disorders.
342590|NCT01679821|Dental prosthesis.|dental prosthesis.
342591|NCT01679821|Dental students|dental students
342592|NCT01679808|copd|copd
342593|NCT01679808|airway obstruction|airway obstruction
342594|NCT01679808|Tracheobronchomalacia|tracheobronchomalacia
342595|NCT01679795|hormone replacement therapy; Dopplervelocimetry; Flow-mediated dilation; menopause; tibolone|hormone replacement therapy; dopplervelocimetry; flow-mediated dilation; menopause; tibolone
343206|NCT01677104|Exenatide|exenatide
342596|NCT01679782|COPD, nervous system, peripheral muscle dysfunction|copd, nervous system, peripheral muscle dysfunction
342597|NCT01679756|Colorectal cancer|colorectal cancer
342598|NCT01679756|Laparoscopic right hemicolectomy|laparoscopic right hemicolectomy
342599|NCT01679756|Intracorporeal anastomosis|intracorporeal anastomosis
342600|NCT01679743|Metastatic Breast Cancer|metastatic breast cancer
342601|NCT01679743|Metastatic Lung Cancer|metastatic lung cancer
342602|NCT01679743|Monoclonal Antibody|monoclonal antibody
342603|NCT01679743|18FLT|18flt
342604|NCT01679743|Surgery|surgery
342605|NCT01679717|Osteoarthritis|osteoarthritis
342606|NCT01679717|CMC1-joint|cmc1-joint
342607|NCT01679717|Postoperative therapy|postoperative therapy
342608|NCT01679717|Interposition arthroplasty of the thumb|interposition arthroplasty of the thumb
342609|NCT01679717|Occupational therapy|occupational therapy
342610|NCT01679652|Essential hypertension|essential hypertension
342611|NCT01679652|Nitric oxide|nitric oxide
342612|NCT01679652|Nebivolol|nebivolol
342613|NCT01679652|Fractional excretion of sodium|fractional excretion of sodium
342614|NCT01679626|cricoid pressure (CP)|cricoid pressure (cp)
342615|NCT01679626|backward upward rightward pressure (BURP)|backward upward rightward pressure (burp)
342616|NCT01679626|AP-rima distances|ap-rima distances
342617|NCT01679626|Glottic area|glottic area
342618|NCT01679626|Extralaryngeal manoeuvres|extralaryngeal manoeuvres
342619|NCT01679600|Rehabilitation|rehabilitation
342620|NCT01679600|Robotics-assisted Treadmill Exercise|robotics-assisted treadmill exercise
342621|NCT01679600|Aerobic Capacity|aerobic capacity
342622|NCT01679600|Exercise Testing|exercise testing
342624|NCT01679561|implantation failure|implantation failure
342625|NCT01679561|recurrent abortion|recurrent abortion
342626|NCT01679561|intralipid|intralipid
342627|NCT01679535|Infant nutrition disorder|infant nutrition disorder
342628|NCT01679535|Child nutrition disorders|child nutrition disorders
342629|NCT01679535|Malnutrition|malnutrition
342630|NCT01679535|Protein-energy malnutrition|protein-energy malnutrition
342631|NCT01679522|endometrial cancer|endometrial cancer
342632|NCT01679522|laparoscopic surgical staging|laparoscopic surgical staging
342633|NCT01679522|single-port|single-port
342634|NCT01679522|four-port|four-port
342635|NCT01679496|LDL-cholesterol|ldl-cholesterol
342636|NCT01679470|cancer|cancer
342637|NCT01679470|lung|lung
342638|NCT01679470|laser|laser
342639|NCT01679470|ablation|ablation
342640|NCT01679470|airway obstruction|airway obstruction
342641|NCT01679444|MRS|mrs
342642|NCT01679444|Heavy dose drinkers|heavy dose drinkers
342643|NCT01679444|Alcohol|alcohol
342644|NCT01679444|NIAAA|niaaa
342645|NCT01679431|Aortic Stenosis|aortic stenosis
342646|NCT01679431|Obesity, Abdominal|obesity, abdominal
342647|NCT01679431|Metabolic Syndrome X|metabolic syndrome x
342648|NCT01679431|Insulin Resistance|insulin resistance
342649|NCT01679431|Echocardiography, Doppler|echocardiography, doppler
342650|NCT01679431|Multidetector Computed Tomography|multidetector computed tomography
342651|NCT01679431|Magnetic Resonance Imaging|magnetic resonance imaging
342652|NCT01679418|PONV|ponv
342653|NCT01679418|thyroid|thyroid
342654|NCT01679418|surgery|surgery
342655|NCT01679418|nausea and vomiting|nausea and vomiting
342656|NCT01679418|postoperative|postoperative
342657|NCT01679405|metastatic biliary tract cancer|metastatic biliary tract cancer
342658|NCT01679392|Transversus abdominis plane block|transversus abdominis plane block
342659|NCT01679392|Ultrasound guided nerve block|ultrasound guided nerve block
342660|NCT01679379|Cesarean Section|cesarean section
342661|NCT01679379|Obese Women|obese women
342662|NCT01679379|Surgical Site Infection|surgical site infection
342663|NCT01679353|inguinal hernia, caudal analgesia, magnesium|inguinal hernia, caudal analgesia, magnesium
342664|NCT01679340|Gastric cancer|gastric cancer
342665|NCT01679340|D2 surgery|d2 surgery
342666|NCT01679340|S-1|s-1
342667|NCT01679340|Oxaliplatin|oxaliplatin
342668|NCT01679340|cisplatin|cisplatin
342669|NCT01679314|COPD|copd
342670|NCT01679314|vagus nerve stimulation|vagus nerve stimulation
342671|NCT01679314|vagal nerve stimulation|vagal nerve stimulation
342672|NCT01679314|nVNS|nvns
342673|NCT01679314|VNS|vns
342674|NCT01679314|non invasive|non invasive
342675|NCT01679314|gammacore|gammacore
342676|NCT01679301|oxygen|oxygen
342677|NCT01679288|Hand-Held ultrasonography|hand-held ultrasonography
342678|NCT01679288|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
342679|NCT01679288|Abdominal Aortic Atherosclerosis|abdominal aortic atherosclerosis
342680|NCT01679288|Cardiovascular risk|cardiovascular risk
342681|NCT01679288|Primary Health Care|primary health care
342682|NCT01679275|Heart Defects, congenital|heart defects, congenital
342683|NCT01679275|Patient Monitoring|patient monitoring
342684|NCT01679275|Infant, Newborn|infant, newborn
342685|NCT01679275|Physiology|physiology
342686|NCT01679249|extracellular fluid volume|extracellular fluid volume
342687|NCT01679249|hypotension|hypotension
342688|NCT01679249|hemodialysis|hemodialysis
342689|NCT01679236|Smoking|smoking
342690|NCT01679236|Smoking cessation|smoking cessation
342691|NCT01679236|Nicotine|nicotine
342692|NCT01679236|Tobacco|tobacco
342693|NCT01679236|Mindfulness|mindfulness
342694|NCT01679236|Meditation|meditation
342696|NCT01679236|Mindfulness Training|mindfulness training
342697|NCT01679236|Behavioral Intervention|behavioral intervention
342698|NCT01679236|Alcohol|alcohol
342699|NCT01679236|Young Adults|young adults
342700|NCT01679223|Breast reconstruction|breast reconstruction
342701|NCT01679223|Hydroxyproline concentration|hydroxyproline concentration
342702|NCT01679223|neoangiogenesis|neoangiogenesis
342703|NCT01679223|collagen deposition|collagen deposition
342704|NCT01679197|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
342705|NCT01679197|NAFLD|nafld
342706|NCT01679197|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
342707|NCT01679197|NASH|nash
342708|NCT01679197|Lipodystrophy|lipodystrophy
342709|NCT01679197|Leptin|leptin
342710|NCT01679197|Metreleptin|metreleptin
342711|NCT01679197|Hypertriglyceridemia|hypertriglyceridemia
342712|NCT01679197|Diabetes mellitus|diabetes mellitus
342713|NCT01679171|Elderly|elderly
342714|NCT01679171|Intensive care unit|intensive care unit
342715|NCT01679171|Outcome|outcome
342716|NCT01679171|Comprehensive geriatric assessment|comprehensive geriatric assessment
342717|NCT01679158|Using POSE as a treatment for Obesity|using pose as a treatment for obesity
342718|NCT01679145|Reward- based learning|reward- based learning
342719|NCT01679145|Pavlovian-to-instrumental transfer|pavlovian-to-instrumental transfer
342720|NCT01679145|Functional imaging|functional imaging
342721|NCT01679145|Relapse risk|relapse risk
342722|NCT01679132|Hypertension|hypertension
342723|NCT01679132|High Blood Pressure|high blood pressure
342724|NCT01679132|Blood Pressure|blood pressure
342725|NCT01679132|Cardiovascular Disease|cardiovascular disease
342726|NCT01679132|Resistant Hypertension|resistant hypertension
342727|NCT01679119|Diffuse large b cell lymphoma|diffuse large b cell lymphoma
342728|NCT01679119|Inotuzumab Ozogamicin|inotuzumab ozogamicin
342729|NCT01679119|Gemcitabine|gemcitabine
342730|NCT01679119|Rituximab|rituximab
342731|NCT01679119|Cyclophosphamide|cyclophosphamide
342732|NCT01679119|Vincristine|vincristine
342733|NCT01679119|Prednisolone|prednisolone
342734|NCT01679106|renal transplant|renal transplant
342735|NCT01679106|flank incision|flank incision
342736|NCT01679093|postoperative analgesia|postoperative analgesia
342737|NCT01679093|paracetamol|paracetamol
342738|NCT01679093|5-HT3 antagonist|5-ht3 antagonist
342739|NCT01679093|ondansetron|ondansetron
342740|NCT01679093|PainMatcher|painmatcher
342741|NCT01679080|Drug therapy|drug therapy
342742|NCT01679080|Adult|adult
342743|NCT01679067|HIV|hiv
342744|NCT01679067|GALT|galt
342745|NCT01679054|Neoplasm|neoplasm
342746|NCT01679054|Gastric Cancer|gastric cancer
342747|NCT01679054|Cost|cost
342748|NCT01679028|T89 Safety in Healthy Japanese population|t89 safety in healthy japanese population
342749|NCT01679015|Burning|burning
342750|NCT01679015|Dryness|dryness
342751|NCT01679015|Itching|itching
342752|NCT01679015|Blurry Vision|blurry vision
342753|NCT01679002|Epilepsy|epilepsy
342754|NCT01679002|Oxcarbazepine|oxcarbazepine
342755|NCT01679002|Eslicarbazepine Acetate|eslicarbazepine acetate
342756|NCT01679002|BIA 2-093|bia 2-093
342757|NCT01678989|Bipolar disorder|bipolar disorder
342758|NCT01678989|Children|children
342759|NCT01678989|Cranial MRI|cranial mri
342760|NCT01678976|Eslicarbazepine acetate|eslicarbazepine acetate
342761|NCT01678976|Epilepsy|epilepsy
342762|NCT01678976|Oxcarbazepine|oxcarbazepine
342763|NCT01678963|Neovascular AMD|neovascular amd
342764|NCT01678963|Wet AMD|wet amd
342765|NCT01678963|AMD|amd
342766|NCT01678963|Age related macular degeneration|age related macular degeneration
342767|NCT01678950|Cardiac output monitoring|cardiac output monitoring
342768|NCT01678950|Echocardiography|echocardiography
342769|NCT01678950|Pulse contour system|pulse contour system
342770|NCT01678937|Immunosuppression|immunosuppression
342771|NCT01678911|Pelvic Pain|pelvic pain
342772|NCT01678911|Chronic Pelvic Pain|chronic pelvic pain
342773|NCT01678911|Irritable Bowel Syndrome|irritable bowel syndrome
342774|NCT01678911|IBS|ibs
342775|NCT01678911|Ulcerative Colitis|ulcerative colitis
342776|NCT01678911|UC|uc
342777|NCT01678911|Interstitial Cystitis|interstitial cystitis
342778|NCT01678911|IC|ic
342779|NCT01678911|Prostatitis|prostatitis
342780|NCT01678911|Pain|pain
342781|NCT01678898|Fabry disease|fabry disease
342782|NCT01678898|Alpha galactosidase deficiency|alpha galactosidase deficiency
342783|NCT01678898|Metabolic storage disease|metabolic storage disease
342784|NCT01678859|infertility|infertility
342785|NCT01678859|cervical|cervical
342786|NCT01678859|mucus|mucus
342787|NCT01678859|sperm|sperm
342788|NCT01678859|interaction|interaction
342789|NCT01678846|corporal punishment|corporal punishment
342790|NCT01678846|violence|violence
342791|NCT01678846|education|education
342792|NCT01678846|depression|depression
342793|NCT01678846|anxiety|anxiety
342794|NCT01678846|conduct disorder|conduct disorder
342795|NCT01678833|Drug Abuse/Dependence|drug abuse/dependence
342796|NCT01678794|Chronic heart failure (CHF)|chronic heart failure (chf)
342797|NCT01678794|cardiac and renal dysfunction|cardiac and renal dysfunction
342798|NCT01678781|Abdominal pain|abdominal pain
342800|NCT01678781|Mebeverine hydrochloride|mebeverine hydrochloride
342801|NCT01678781|Constipation|constipation
342802|NCT01678781|Pinaverium bromide|pinaverium bromide
342803|NCT01678781|Irritable bowel syndrome|irritable bowel syndrome
342804|NCT01678781|Bloating|bloating
342805|NCT01678781|Quality of life|quality of life
342806|NCT01678755|schizophrenia|schizophrenia
342807|NCT01678742|Diet|diet
342808|NCT01678742|Incretins|incretins
342809|NCT01678742|Gastrointestinal Hormones|gastrointestinal hormones
342810|NCT01678742|Fish Proteins|fish proteins
342811|NCT01678729|refractive surgery|refractive surgery
342812|NCT01678729|pupil|pupil
342813|NCT01678729|Pupil size|pupil size
342814|NCT01678716|Anemia|anemia
342815|NCT01678716|Breastfeeding|breastfeeding
342816|NCT01678716|Complementary feeding|complementary feeding
342817|NCT01678716|Stunting|stunting
342818|NCT01678716|Wasting|wasting
342819|NCT01678716|Underweight|underweight
342820|NCT01678716|Micronutrient powder|micronutrient powder
342821|NCT01678716|Behavior change counseling|behavior change counseling
342822|NCT01678716|Frontline health worker|frontline health worker
342823|NCT01678703|late abortion|late abortion
342824|NCT01678703|laminaria|laminaria
342825|NCT01678703|Misoprostol|misoprostol
342826|NCT01678703|Cervical preparation|cervical preparation
342827|NCT01678677|non-typeable Haemophilus influenzae|non-typeable haemophilus influenzae
342828|NCT01678677|immunogenicity|immunogenicity
342829|NCT01678677|reactogenicity|reactogenicity
342830|NCT01678677|safety|safety
342831|NCT01678664|cancer|cancer
342832|NCT01678664|neuroendocrine tumors|neuroendocrine tumors
342833|NCT01678664|gastrointestinal tract|gastrointestinal tract
342834|NCT01678664|metastases|metastases
342835|NCT01678664|liver|liver
342836|NCT01678664|hepatic|hepatic
342837|NCT01678651|time-lapse, FSH, kinetics|time-lapse, fsh, kinetics
342838|NCT01678638|inguinal hernia|inguinal hernia
342839|NCT01678638|premature infants|premature infants
342840|NCT01678638|anesthesia safety|anesthesia safety
342841|NCT01678638|neurodevelopmental outcome|neurodevelopmental outcome
342842|NCT01678638|preterm infants|preterm infants
342843|NCT01678638|neonatal prematurity|neonatal prematurity
342844|NCT01678625|Residual neuromuscular blockade|residual neuromuscular blockade
342845|NCT01678625|Train-of-four|train-of-four
342846|NCT01678625|Acceleromyography|acceleromyography
342847|NCT01678625|Electromyography|electromyography
342848|NCT01678612|Copper|copper
342849|NCT01678612|Health-Acquired Infections|health-acquired infections
342850|NCT01678612|Bacterial Load|bacterial load
342851|NCT01678612|Intensive Care Units, Pediatric|intensive care units, pediatric
342852|NCT01678599|Chagas Disease|chagas disease
342853|NCT01678599|PCR|pcr
342854|NCT01678599|diagnosis|diagnosis
342855|NCT01678586|Pain|pain
342856|NCT01678586|Pain management|pain management
342857|NCT01678573|Healthy|healthy
342858|NCT01678573|Pharmacokinetics|pharmacokinetics
342859|NCT01678573|Abiraterone acetate|abiraterone acetate
342860|NCT01678573|Abiraterone|abiraterone
342861|NCT01678573|JNJ-212082|jnj-212082
342862|NCT01678573|Zytiga|zytiga
342863|NCT01678573|Chinese|chinese
342864|NCT01678573|Fasted|fasted
342865|NCT01678560|Obstructive sleep apnea PAP adherence efficacy economics|obstructive sleep apnea pap adherence efficacy economics
342866|NCT01678547|Stroke|stroke
342867|NCT01678547|Robot|robot
342868|NCT01678547|Treatment|treatment
342869|NCT01678547|Rehabilitation|rehabilitation
342870|NCT01678534|Cerebral infarction|cerebral infarction
342871|NCT01678534|Cellular therapy|cellular therapy
342872|NCT01678521|Hypercholesterolemia|hypercholesterolemia
342873|NCT01678521|LDL-apheresis|ldl-apheresis
342874|NCT01678521|Coronary artery disease|coronary artery disease
342875|NCT01678521|PTX3|ptx3
342876|NCT01678521|CRP|crp
342877|NCT01678521|IL6|il6
342878|NCT01678521|IL10|il10
342879|NCT01678482|Acne, LED, blue light|acne, led, blue light
342880|NCT01678456|Atrial Fibrillation|atrial fibrillation
342881|NCT01678456|Critical Event Committee|critical event committee
342882|NCT01678456|Serious adverse events|serious adverse events
342883|NCT01678456|Thromboembolic complications|thromboembolic complications
342884|NCT01678456|Cardiac and noncardiac complications|cardiac and noncardiac complications
342885|NCT01678456|Bleeding complications|bleeding complications
342886|NCT01678456|Acute heart failure|acute heart failure
342887|NCT01678456|Syncope|syncope
342888|NCT01678456|Resuscitation|resuscitation
342889|NCT01678430|Chronic Lymphocytic Leukaemia|chronic lymphocytic leukaemia
342890|NCT01678430|Less fit|less fit
342891|NCT01678430|CD20 antibody|cd20 antibody
342892|NCT01678430|Ofatumumab|ofatumumab
342893|NCT01678430|Chlorambucil|chlorambucil
342894|NCT01678430|Bendamustine|bendamustine
342895|NCT01678378|Adolescent|adolescent
342896|NCT01678378|Intervention|intervention
342897|NCT01678378|Female|female
342898|NCT01678378|Male|male
342899|NCT01678378|Interpersonal Relations|interpersonal relations
342900|NCT01678378|School Health Services|school health services
342901|NCT01678378|Community-Based Participatory Research|community-based participatory research
343207|NCT01677104|Liraglutide|liraglutide
342902|NCT01678378|Randomized Controlled Trial|randomized controlled trial
342903|NCT01678378|Health Care Provider|health care provider
342904|NCT01678378|Training Program|training program
342905|NCT01678378|Harm Reduction|harm reduction
342906|NCT01678378|Prevention|prevention
342907|NCT01678378|Reproductive Coercion|reproductive coercion
342908|NCT01678378|Tech-Based Abuse|tech-based abuse
342909|NCT01678378|Social Environment|social environment
342910|NCT01678378|Sexual Partners|sexual partners
342911|NCT01678365|complicated appendicitis|complicated appendicitis
342912|NCT01678365|Children|children
342913|NCT01678365|conservative therapy|conservative therapy
342914|NCT01678365|Study population: Children 1 month - 14 years with Complicated appendicitis|study population: children 1 month - 14 years with complicated appendicitis
342915|NCT01678365|Type of the study: prospective, open randomized|type of the study: prospective, open randomized
342916|NCT01678352|Glioma|glioma
342917|NCT01678352|Vaccine|vaccine
342918|NCT01678352|Immunotherapy|immunotherapy
342919|NCT01678352|WHO Grade II|who grade ii
342920|NCT01678339|ACS|acs
342921|NCT01678339|AMI|ami
342922|NCT01678326|Diseases Classified Elsewhere|diseases classified elsewhere
342923|NCT01678313|Benign prostatic hyperplasia (BPH)|benign prostatic hyperplasia (bph)
342924|NCT01678313|Lower urinary tract symptoms (LUTS)|lower urinary tract symptoms (luts)
342925|NCT01678313|Prostatic specific antigen (PSA)|prostatic specific antigen (psa)
342926|NCT01678313|Cyclooxygenase-2 (COX-2)|cyclooxygenase-2 (cox-2)
342927|NCT01678300|Ulcerative Colitis|ulcerative colitis
342928|NCT01678287|ASP1941|asp1941
342929|NCT01678274|Turner Syndrome|turner syndrome
342930|NCT01678274|Aortic Aneurysm|aortic aneurysm
342931|NCT01678274|Ischemic heart disease|ischemic heart disease
342932|NCT01678274|Hypertension|hypertension
342933|NCT01678274|Congenital Heart Defect|congenital heart defect
342934|NCT01678274|Pulse Wave Velocity|pulse wave velocity
342935|NCT01678274|Augmentation Index|augmentation index
342936|NCT01678274|Central Blood Pressure|central blood pressure
342937|NCT01678274|Agatston Score|agatston score
342938|NCT01678274|Segment involvement score|segment involvement score
342939|NCT01678261|Sex chromosome|sex chromosome
342940|NCT01678261|Turner Syndrome|turner syndrome
342941|NCT01678261|Klinefelter Syndrome|klinefelter syndrome
342942|NCT01678261|Triple X Syndrome|triple x syndrome
342943|NCT01678261|47 XYY syndrome|47 xyy syndrome
342944|NCT01678261|Aortic Aneurysm|aortic aneurysm
342945|NCT01678261|Epigenetics|epigenetics
342946|NCT01678261|Transcriptome|transcriptome
342947|NCT01678261|non-coding RNA|non-coding rna
342948|NCT01678235|diabetes|diabetes
342949|NCT01678235|insulin pump|insulin pump
342950|NCT01678235|glulisine|glulisine
342951|NCT01678235|aspart|aspart
342952|NCT01678235|glycemic index|glycemic index
342953|NCT01678222|Lymphocyte|lymphocyte
342954|NCT01678222|Cyclooxygenase 2|cyclooxygenase 2
342955|NCT01678222|Eicosanoid|eicosanoid
342956|NCT01678222|Prostaglandin|prostaglandin
342957|NCT01678209|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
342958|NCT01678209|Stimulant|stimulant
342959|NCT01678209|Non-stimulant|non-stimulant
342960|NCT01678209|Drug|drug
342961|NCT01678209|Methylphenidate|methylphenidate
342962|NCT01678209|Atomoxetine|atomoxetine
342963|NCT01678209|Strattera|strattera
342964|NCT01678209|Concerta|concerta
342965|NCT01678209|MACRO|macro
342966|NCT01678209|Medication|medication
342967|NCT01678209|Treatment|treatment
342968|NCT01678209|Youth|youth
342969|NCT01678209|Adolescent|adolescent
342970|NCT01678209|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
342971|NCT01678209|Brain scan|brain scan
342972|NCT01678209|Imaging|imaging
342973|NCT01678209|Response inhibition|response inhibition
342974|NCT01678209|Inattentive|inattentive
342975|NCT01678209|Hyperactive|hyperactive
342976|NCT01678209|Combined|combined
342977|NCT01678209|Medication Treatment|medication treatment
342978|NCT01678209|Brain Imaging|brain imaging
342979|NCT01678196|Family Members|family members
342980|NCT01678196|Community Outreach|community outreach
342981|NCT01678196|Internet|internet
342982|NCT01678170|blood-oxygen functional imaging technology|blood-oxygen functional imaging technology
342983|NCT01678170|diagnosis|diagnosis
342984|NCT01678157|Esophageal Hernia|esophageal hernia
342985|NCT01678157|Hernia, Esophageal|hernia, esophageal
342986|NCT01678157|Hernia, Paraesophageal|hernia, paraesophageal
342987|NCT01678157|Hiatal Hernia|hiatal hernia
342988|NCT01678157|Paraesophageal Hiatal Hernia|paraesophageal hiatal hernia
342989|NCT01678157|Sliding Esophageal Hernia|sliding esophageal hernia
342990|NCT01678157|Sliding Hiatal Hernia|sliding hiatal hernia
342991|NCT01678144|mitral valve|mitral valve
342992|NCT01678144|mitral surgery|mitral surgery
342993|NCT01678144|mitral repair|mitral repair
342994|NCT01678144|mitral annuloplasty|mitral annuloplasty
342995|NCT01678118|Patient Navigation|patient navigation
342996|NCT01678118|Tobacco dependent|tobacco dependent
342997|NCT01678118|smoking|smoking
342998|NCT01678118|Cessation|cessation
342999|NCT01678118|11-028|11-028
343000|NCT01678105|Recurrent Adenoid Cystic Carcinoma of the Salivary Glands|recurrent adenoid cystic carcinoma of the salivary glands
343001|NCT01678105|Metastatic Adenoid Cystic Carcinoma of the Salivary Glands|metastatic adenoid cystic carcinoma of the salivary glands
343002|NCT01678105|Salivary Gland Cancers|salivary gland cancers
343003|NCT01678105|ACC|acc
343004|NCT01678105|Dovitinib|dovitinib
343005|NCT01678105|TKI258|tki258
343006|NCT01678105|RTK Inhibitor|rtk inhibitor
343007|NCT01678079|Pregnancy|pregnancy
343008|NCT01678079|Micronutrient Powder|micronutrient powder
343009|NCT01678079|Calcium|calcium
343010|NCT01678079|Iron|iron
343011|NCT01678079|Bangladesh|bangladesh
343012|NCT01678066|Noninvasive cardiac output.|noninvasive cardiac output.
343013|NCT01678066|Pediatrics.|pediatrics.
343014|NCT01678053|Botulinum Toxins, Type A|botulinum toxins, type a
343015|NCT01678040|Ventricular Volume|ventricular volume
343016|NCT01678040|Cardiac Magnetic Resonance|cardiac magnetic resonance
343017|NCT01678040|Echocardiogram|echocardiogram
343018|NCT01678027|Stomach neoplasm|stomach neoplasm
343019|NCT01678027|Helicobacter pylori|helicobacter pylori
343020|NCT01678014|Anorexia|anorexia
343021|NCT01678014|DBS|dbs
343022|NCT01678014|Capsulotomy|capsulotomy
343023|NCT01678014|Signs and Symptoms|signs and symptoms
343024|NCT01678001|plantar fascia|plantar fascia
343025|NCT01678001|plantar fascitis|plantar fascitis
343026|NCT01678001|botulinum toxin|botulinum toxin
343027|NCT01678001|Xeomin|xeomin
343028|NCT01677988|NEOADJUVANT FOLFIRINOX CHEMOTHERAPY|neoadjuvant folfirinox chemotherapy
343029|NCT01677988|LOCALIZED PANCREATIC HEAD ADENOCARCINOMA|localized pancreatic head adenocarcinoma
343030|NCT01677988|RADIATION THERAPY|radiation therapy
343031|NCT01677962|locally advanced, unresectable pancreatic adenocarcinoma|locally advanced, unresectable pancreatic adenocarcinoma
343032|NCT01677962|Poly ICLC|poly iclc
343033|NCT01677962|dendritic cells|dendritic cells
343034|NCT01677936|diabetes|diabetes
343035|NCT01677936|blood pressure|blood pressure
343036|NCT01677936|lipid|lipid
343037|NCT01677936|waist circumference|waist circumference
343038|NCT01677936|BMI|bmi
343039|NCT01677923|weight|weight
343040|NCT01677923|body mass index|body mass index
343041|NCT01677923|lipid profile|lipid profile
343042|NCT01677923|glucose profile|glucose profile
343043|NCT01677845|Localized Prostate Cancer|localized prostate cancer
343044|NCT01677845|Radiation|radiation
343045|NCT01677806|Percutaneous vertebroplasty|percutaneous vertebroplasty
343046|NCT01677741|Children and Adolescents|children and adolescents
343047|NCT01677741|BRAF|braf
343048|NCT01677741|dabrafenib|dabrafenib
343049|NCT01677741|dose escalation|dose escalation
343050|NCT01677741|BRF116013|brf116013
343051|NCT01677741|V600-mutation positive|v600-mutation positive
343052|NCT01677741|BRF|brf
343053|NCT01677728|colorectal liver metastases|colorectal liver metastases
343054|NCT01677728|chemotherapy|chemotherapy
343055|NCT01677728|cetuximab|cetuximab
343056|NCT01677728|bevacizumab|bevacizumab
343057|NCT01677689|oral temperature|oral temperature
343058|NCT01677689|respiratory symptom|respiratory symptom
343059|NCT01677689|cough|cough
343060|NCT01677689|nasal obstruction|nasal obstruction
343061|NCT01677689|sore throat|sore throat
343062|NCT01677689|fever|fever
343063|NCT01677676|Influenza A|influenza a
343064|NCT01677663|autism|autism
343065|NCT01677663|clinical phenotypes|clinical phenotypes
343066|NCT01677663|neuropsychology|neuropsychology
343067|NCT01677663|imaging endophenotypes|imaging endophenotypes
343068|NCT01677663|family-based cohort|family-based cohort
343069|NCT01677663|knoutout mice|knoutout mice
343070|NCT01677650|Spinal Fusion|spinal fusion
343071|NCT01677650|Opioid Analgesia|opioid analgesia
343072|NCT01677637|osteopenia, postmenopausal|osteopenia, postmenopausal
343073|NCT01677624|Hypervascular tumor|hypervascular tumor
343074|NCT01677624|arteriovenous malformation|arteriovenous malformation
343075|NCT01677624|arterial embolization|arterial embolization
343076|NCT01677611|Resveratrol|resveratrol
343077|NCT01677611|SIRT1|sirt1
343078|NCT01677611|AMPK|ampk
343079|NCT01677598|Plaque Psoriasis|plaque psoriasis
343080|NCT01677598|Ustekinumab|ustekinumab
343081|NCT01677598|CNTO 1275|cnto 1275
343082|NCT01677598|Asia-Pacific|asia-pacific
343083|NCT01677546|diabetes|diabetes
343084|NCT01677546|insulin pump|insulin pump
343085|NCT01677546|bolus calculator|bolus calculator
343086|NCT01677546|Contour Link|contour link
343087|NCT01677533|Panel management|panel management
343088|NCT01677533|Clinical microsystems|clinical microsystems
343089|NCT01677533|Hypertension management|hypertension management
343090|NCT01677533|Smoking cessation|smoking cessation
343091|NCT01677533|Continuing medical education|continuing medical education
343092|NCT01677533|Quality improvement,|quality improvement,
343093|NCT01677533|Population health|population health
343094|NCT01677520|adipose-derived stem cells|adipose-derived stem cells
343095|NCT01677520|viable ADSCs|viable adscs
343096|NCT01677520|apoptosis|apoptosis
343097|NCT01677520|necrosis|necrosis
343098|NCT01677520|cryopreservation|cryopreservation
343099|NCT01677507|glaucoma|glaucoma
343100|NCT01677507|aqueous humor dynamics|aqueous humor dynamics
343101|NCT01677507|intraocular pressure|intraocular pressure
343208|NCT01677104|Linagliptin|linagliptin
343102|NCT01677468|Hepatocellular carcinoma|hepatocellular carcinoma
343103|NCT01677468|Transarterial chemoembolization|transarterial chemoembolization
343104|NCT01677455|Hsp90 inhibitor|hsp90 inhibitor
343105|NCT01677455|ganetespib|ganetespib
343106|NCT01677455|STA 9090|sta 9090
343107|NCT01677442|nonintubated|nonintubated
343108|NCT01677442|anaesthesia|anaesthesia
343109|NCT01677442|VATS|vats
343110|NCT01677429|panic disorder|panic disorder
343111|NCT01677429|balance impairment|balance impairment
343112|NCT01677429|virtual reality|virtual reality
343113|NCT01677416|Rheumatoid arthritis|rheumatoid arthritis
343114|NCT01677416|Ultrasonography|ultrasonography
343115|NCT01677416|Synovitis|synovitis
343116|NCT01677416|Foot joints|foot joints
343117|NCT01677403|Bronchiectasis|bronchiectasis
343118|NCT01677403|Tobramycin|tobramycin
343119|NCT01677403|nebulised|nebulised
343120|NCT01677390|Antibody-Drug Conjugate|antibody-drug conjugate
343121|NCT01677390|monomethylauristatin F|monomethylauristatin f
343122|NCT01677390|Carcinoma, Renal Cell|carcinoma, renal cell
343123|NCT01677390|Antigens, CD70|antigens, cd70
343124|NCT01677390|Drug Therapy|drug therapy
343125|NCT01677377|Schizophrenia|schizophrenia
343126|NCT01677377|Schizophrenic|schizophrenic
343127|NCT01677377|Schizophrenias|schizophrenias
343128|NCT01677364|induction of labour|induction of labour
343129|NCT01677364|heart disease patients|heart disease patients
343130|NCT01677351|clonidine|clonidine
343131|NCT01677351|cataract surgery|cataract surgery
343132|NCT01677351|arrythmia|arrythmia
343133|NCT01677351|anesthesic medication|anesthesic medication
343134|NCT01677286|AL Amyloidosis|al amyloidosis
343135|NCT01677286|Primary Amyloidosis|primary amyloidosis
343136|NCT01677286|Hereditary Amyloidosis|hereditary amyloidosis
343137|NCT01677286|Familial Amyloidosis|familial amyloidosis
343138|NCT01677286|SSA Amyloidosis|ssa amyloidosis
343139|NCT01677286|Senile Systemic Amyloidosis|senile systemic amyloidosis
343140|NCT01677286|AA Amyloidosis|aa amyloidosis
343141|NCT01677286|Secondary Amyloidosis|secondary amyloidosis
343142|NCT01677286|Localized Amyloidosis|localized amyloidosis
343143|NCT01677286|Systemic Amyloidosis|systemic amyloidosis
343144|NCT01677273|Respiratory chambers|respiratory chambers
343145|NCT01677273|Energy expenditure|energy expenditure
343146|NCT01677273|Appetite|appetite
343147|NCT01677273|Dairy proteins|dairy proteins
343148|NCT01677273|Diet induced thermogenesis|diet induced thermogenesis
343149|NCT01677273|Obesity|obesity
343150|NCT01677260|Biguanide|biguanide
343151|NCT01677260|anti-hyperglycaemic|anti-hyperglycaemic
343152|NCT01677260|bioavailability|bioavailability
343153|NCT01677260|bioequivalence|bioequivalence
343154|NCT01677260|metformin|metformin
343155|NCT01677260|pharmacokinetics|pharmacokinetics
343156|NCT01677247|sulphonylurea|sulphonylurea
343157|NCT01677247|anti-hyperglycaemic|anti-hyperglycaemic
343158|NCT01677247|bioavailability|bioavailability
343159|NCT01677247|bioequivalence|bioequivalence
343160|NCT01677247|glimepiride|glimepiride
343161|NCT01677247|pharmacokinetics|pharmacokinetics
343162|NCT01677234|Blood pressure|blood pressure
343163|NCT01677221|acne|acne
343164|NCT01677221|inflammatory acne|inflammatory acne
343165|NCT01677221|intense pulsed light|intense pulsed light
343166|NCT01677208|Acute Ischemic Stroke|acute ischemic stroke
343167|NCT01677208|Randomized Controlled Trial|randomized controlled trial
343168|NCT01677208|Traditional Chinese Medicine|traditional chinese medicine
343169|NCT01677195|Mycotoxins|mycotoxins
343170|NCT01677195|Aflatoxin|aflatoxin
343171|NCT01677195|Fumonisin|fumonisin
343172|NCT01677195|Aflatoxicosis|aflatoxicosis
343173|NCT01677195|Dietary|dietary
343174|NCT01677195|Cancer|cancer
343175|NCT01677182|Drug therapy|drug therapy
343176|NCT01677156|ASGES|asges
343177|NCT01677156|Corus CAD|corus cad
343178|NCT01677156|Age/Sex/Gene Expression Score|age/sex/gene expression score
343179|NCT01677156|Gene Expression|gene expression
343180|NCT01677156|GES|ges
343181|NCT01677156|CAD|cad
343182|NCT01677156|CVD|cvd
343183|NCT01677156|CHD|chd
343184|NCT01677156|Precision Medicine|precision medicine
343185|NCT01677156|Clinical Utility|clinical utility
343186|NCT01677156|Registry|registry
343187|NCT01677156|Coronary Artery Disease|coronary artery disease
343188|NCT01677156|Angina Pectoris|angina pectoris
343189|NCT01677156|Chest Pain|chest pain
343190|NCT01677156|Cardiovascular Disease|cardiovascular disease
343191|NCT01677156|Coronary Heart Disease|coronary heart disease
343192|NCT01677156|PRESET|preset
343193|NCT01677143|Local anesthetic|local anesthetic
343194|NCT01677143|Preemptive analgesia|preemptive analgesia
343195|NCT01677143|Postoperative pain|postoperative pain
343196|NCT01677143|Laparoscopy|laparoscopy
343197|NCT01677143|Gynecological surgery|gynecological surgery
343198|NCT01677143|Day-case surgery|day-case surgery
343199|NCT01677130|Clinical efficacy|clinical efficacy
343200|NCT01677130|safety|safety
343201|NCT01677130|of HFOV treatment|of hfov treatment
343202|NCT01677130|of patients|of patients
343203|NCT01677104|GLP-1|glp-1
343204|NCT01677104|DPP-IV inhibitor|dpp-iv inhibitor
343205|NCT01677104|microcirculation|microcirculation
343209|NCT01677091|Balance,Hemiplegia,Cervical vibration,Prism adaptation,Rehabilitation|balance,hemiplegia,cervical vibration,prism adaptation,rehabilitation
343210|NCT01677078|Major depressive disorder|major depressive disorder
343211|NCT01677078|rTMS|rtms
343212|NCT01677078|Neuronavigation|neuronavigation
343213|NCT01677065|Bioavailability|bioavailability
343214|NCT01677065|Oxycodone|oxycodone
343215|NCT01677065|Healthy Volunteers|healthy volunteers
343216|NCT01677039|Bioavailability|bioavailability
343217|NCT01677039|oxycodone|oxycodone
343218|NCT01677039|ethanol interaction|ethanol interaction
343219|NCT01677039|healthy volunteers|healthy volunteers
343220|NCT01677013|Type 2; diabetes mellitus; stem cell; safety; efficacy|type 2; diabetes mellitus; stem cell; safety; efficacy
343221|NCT01677000|bone infection|bone infection
343222|NCT01677000|staphylococcus aureus|staphylococcus aureus
343223|NCT01677000|registry|registry
343224|NCT01676987|Asthma|asthma
343225|NCT01676987|Budesonide|budesonide
343226|NCT01676987|Adrenergic beta-2 receptor agonists.|adrenergic beta-2 receptor agonists.
343227|NCT01676974|Drug Resistance, Microbial|drug resistance, microbial
343228|NCT01676974|Enterobacteriaceae|enterobacteriaceae
343229|NCT01676974|ESBL|esbl
343230|NCT01676974|Carbapenemase|carbapenemase
343231|NCT01676974|Travel|travel
343232|NCT01676948|SJIA|sjia
343233|NCT01676948|Systemic Juvenile Idiopathic Arthritis|systemic juvenile idiopathic arthritis
343234|NCT01676948|children|children
343235|NCT01676948|systemic autoinflammatory disease, ACZ885, canakinumab|systemic autoinflammatory disease, acz885, canakinumab
343236|NCT01676948|human monoclonal anti-interleukin-1β (IL-1 β) antibody|human monoclonal anti-interleukin-1β (il-1 β) antibody
343237|NCT01676948|hildhood immunizations vaccinations|hildhood immunizations vaccinations
343238|NCT01676909|self-management|self-management
343239|NCT01676896|children|children
343240|NCT01676896|asthma|asthma
343241|NCT01676896|quality of life|quality of life
343242|NCT01676896|self-management|self-management
343243|NCT01676883|Body constitution|body constitution
343244|NCT01676883|Anthropometry|anthropometry
343245|NCT01676883|Electric impedance|electric impedance
343246|NCT01676870|exercise training|exercise training
343247|NCT01676870|exercise therapy|exercise therapy
343248|NCT01676870|physical fitness|physical fitness
343249|NCT01676870|risk factors|risk factors
343250|NCT01676857|chronic pain, prostatitis, pelvic pain|chronic pain, prostatitis, pelvic pain
343251|NCT01676844|Phosphorus|phosphorus
343252|NCT01676844|Phosphate|phosphate
343253|NCT01676844|Hypophosphataemia|hypophosphataemia
343254|NCT01676844|Osteopenia|osteopenia
343255|NCT01676844|Prematurity|prematurity
343256|NCT01676805|Developing Novel Treatment Approaches|developing novel treatment approaches
343257|NCT01676805|Developing Therapeutic Agents|developing therapeutic agents
343258|NCT01676805|Analysis of Genetic and Genomic Biology|analysis of genetic and genomic biology
343259|NCT01676805|New Prognostic and Diagnostic Models|new prognostic and diagnostic models
343260|NCT01676805|Analysis of Cellular and Molecular Biology|analysis of cellular and molecular biology
343261|NCT01676792|condyloma acuminate|condyloma acuminate
343262|NCT01676792|ano-genital warts|ano-genital warts
343263|NCT01676792|genital warts|genital warts
343264|NCT01676792|cutaneous condyloma|cutaneous condyloma
343265|NCT01676792|Vulva pre-cancerous lesions|vulva pre-cancerous lesions
343266|NCT01676792|Vulvar Intraepitheral Neoplasia|vulvar intraepitheral neoplasia
343267|NCT01676792|VIN|vin
343268|NCT01676792|EGW|egw
343269|NCT01676779|melanoma|melanoma
343270|NCT01676779|no evidence of disease|no evidence of disease
343271|NCT01676779|resection|resection
343272|NCT01676779|macro-metastases|macro-metastases
343273|NCT01676766|Stargardt Disease|stargardt disease
343274|NCT01676766|Macular degeneration|macular degeneration
343275|NCT01676766|Retinal dystrophy|retinal dystrophy
343276|NCT01676740|hematinic therapy|hematinic therapy
343277|NCT01676740|blood transfusion|blood transfusion
343278|NCT01676740|joint replacement|joint replacement
343279|NCT01676727|Transcatheter Aortic valve Implantation|transcatheter aortic valve implantation
343280|NCT01676727|Heart Valve Diseases|heart valve diseases
343281|NCT01676727|Cardiovascular Diseases|cardiovascular diseases
343282|NCT01676714|Dovitinib|dovitinib
343283|NCT01676714|Fibroblast Growth Factor Receptor Biomarkers|fibroblast growth factor receptor biomarkers
343284|NCT01676714|Anti-Vascular Endothelial Growth Factor Therapy|anti-vascular endothelial growth factor therapy
343285|NCT01676688|alpha-1 antitrypsin|alpha-1 antitrypsin
343286|NCT01676688|deficiency|deficiency
343287|NCT01676688|Alfalastin|alfalastin
343288|NCT01676688|safety|safety
343289|NCT01676675|whole virus|whole virus
343290|NCT01676675|inactivated|inactivated
343291|NCT01676675|influenza|influenza
343292|NCT01676675|H5N1 vaccine|h5n1 vaccine
343293|NCT01676675|safety|safety
343294|NCT01676675|immunogenicity|immunogenicity
343295|NCT01676662|Urinary Incontinence|urinary incontinence
343296|NCT01676662|Urinary Incontinence, Stress|urinary incontinence, stress
343297|NCT01676662|Urination Disorders|urination disorders
343298|NCT01676662|Urologic Diseases|urologic diseases
343299|NCT01676662|Urological Manifestations|urological manifestations
343300|NCT01676662|Signs and Symptoms|signs and symptoms
343301|NCT01676636|Pregnancy|pregnancy
343302|NCT01676636|Calcium|calcium
343303|NCT01676636|Supplements|supplements
343304|NCT01676623|Child nutrition|child nutrition
343305|NCT01676623|Stunting|stunting
343306|NCT01676623|Exclusive breastfeeding|exclusive breastfeeding
343307|NCT01676623|Complementary feeding|complementary feeding
343308|NCT01676623|Social franchise|social franchise
343309|NCT01676623|Mass media|mass media
343310|NCT01676623|Counseling|counseling
343311|NCT01676623|Facility-based|facility-based
343312|NCT01676610|Pulse Oximetry|pulse oximetry
343313|NCT01676610|Pediatrics|pediatrics
343314|NCT01676610|Pakistan|pakistan
343315|NCT01676610|Hypoxemia|hypoxemia
343316|NCT01676610|Neonatal Sepsis|neonatal sepsis
343317|NCT01676610|Pneumonia|pneumonia
343318|NCT01676558|diffuse large B cell lymphoma|diffuse large b cell lymphoma
343319|NCT01676558|radioimmunotherapy|radioimmunotherapy
343320|NCT01676558|131I-rituximab|131i-rituximab
343321|NCT01676532|School Board Health Center|school board health center
343322|NCT01676532|Pediatrics|pediatrics
343323|NCT01676506|Wet AMD|wet amd
343324|NCT01676506|genetic polymorphisms|genetic polymorphisms
343325|NCT01676506|Ranibizumab|ranibizumab
343326|NCT01676480|Prostate cancer|prostate cancer
343327|NCT01676480|ADT|adt
343328|NCT01676480|Endurance training|endurance training
343329|NCT01676454|Vasopressin|vasopressin
343330|NCT01676454|Trauma|trauma
343331|NCT01676454|Injury|injury
343332|NCT01676441|spinal cord injury|spinal cord injury
343333|NCT01676441|mesenchymal stem cell|mesenchymal stem cell
343334|NCT01676428|Kidney|kidney
343335|NCT01676428|Renal|renal
343336|NCT01676428|Radiotherapy|radiotherapy
343337|NCT01676428|Stereotactic|stereotactic
343338|NCT01676428|Cancer|cancer
343339|NCT01676415|Sinus disease|sinus disease
343340|NCT01676415|Sinonasal complaints|sinonasal complaints
343341|NCT01676415|Chronic sinusitis|chronic sinusitis
343342|NCT01676415|Nasal polyps|nasal polyps
343343|NCT01676415|Chronic rhinosinusitis without nasal polyps|chronic rhinosinusitis without nasal polyps
343344|NCT01676415|Glucocorticoids|glucocorticoids
343345|NCT01676415|Prednisone|prednisone
343346|NCT01676415|Topical mometasone|topical mometasone
343347|NCT01676415|Anti-inflammatory agents|anti-inflammatory agents
343348|NCT01676402|Influenza A (H1)|influenza a (h1)
343349|NCT01676402|Influenza A (H3)|influenza a (h3)
343350|NCT01676402|Influenza B|influenza b
343351|NCT01676402|DNA Vaccine|dna vaccine
343352|NCT01676402|Trivalent Inactivated Vaccine (TIV)|trivalent inactivated vaccine (tiv)
343353|NCT01676402|Healthy Adults|healthy adults
343354|NCT01676402|Intradermal (ID)|intradermal (id)
343355|NCT01676389|Autism Spectrum Disorders|autism spectrum disorders
343356|NCT01676376|CABG|cabg
343357|NCT01676376|SVG|svg
343358|NCT01676376|nitinol mesh|nitinol mesh
343359|NCT01676376|external saphenous vein graft support|external saphenous vein graft support
343360|NCT01676363|diflunisal|diflunisal
343361|NCT01676363|anti-inflammatory agents, non-steroidal|anti-inflammatory agents, non-steroidal
343362|NCT01676363|antiviral agents|antiviral agents
343363|NCT01676350|Intraosseous (IO) vascular access|intraosseous (io) vascular access
343364|NCT01676337|Text messaging|text messaging
343365|NCT01676337|Clinic appointment attendance|clinic appointment attendance
343366|NCT01676337|Emergency department|emergency department
343367|NCT01676337|Primary care|primary care
343368|NCT01676324|Fecal Calprotectin|fecal calprotectin
343369|NCT01676311|cognition|cognition
343370|NCT01676311|seizures|seizures
343371|NCT01676311|electroencephalography|electroencephalography
343372|NCT01676311|transcranial magnetic stimulation|transcranial magnetic stimulation
343373|NCT01676311|huperzine|huperzine
343374|NCT01676311|chinese club moss|chinese club moss
343375|NCT01676298|Cyp2C19|cyp2c19
343376|NCT01676298|Genotyping|genotyping
343377|NCT01676298|Spartan|spartan
343378|NCT01676298|Reproducibility|reproducibility
343379|NCT01676285|Cirrhosis|cirrhosis
343380|NCT01676285|cirrhotic cardiomyopathy|cirrhotic cardiomyopathy
343381|NCT01676285|cardiac remodeling|cardiac remodeling
343382|NCT01676285|cardiomyopathy|cardiomyopathy
343383|NCT01676285|metoprolol succinate|metoprolol succinate
343384|NCT01676285|betablockers|betablockers
343385|NCT01676259|siRNA|sirna
343386|NCT01676259|RNA interference (RNAi)|rna interference (rnai)
343387|NCT01676259|Cancer|cancer
343388|NCT01676259|Pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
343389|NCT01676259|Locally Advanced Pancreatic cancer|locally advanced pancreatic cancer
343390|NCT01676259|Solid tumor|solid tumor
343391|NCT01676259|Non operable pancreatic ductal adenocarcinoma|non operable pancreatic ductal adenocarcinoma
343392|NCT01676207|coronary collateral circulation|coronary collateral circulation
343393|NCT01676207|extracardiac coronary collaterals|extracardiac coronary collaterals
343394|NCT01676207|coronary artery disease|coronary artery disease
343395|NCT01676207|coronary circulation|coronary circulation
343396|NCT01676207|internal mammary artery|internal mammary artery
343397|NCT01676194|Transarterial Chemoembolization|transarterial chemoembolization
343398|NCT01676194|Liver transplantation|liver transplantation
343399|NCT01676194|Hepatocellular carcinoma|hepatocellular carcinoma
343498|NCT01675674|Mucopolysaccharidoses|mucopolysaccharidoses
343400|NCT01676181|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
343401|NCT01676181|Children|children
343402|NCT01676181|Polysomnography|polysomnography
343403|NCT01676181|Surgery|surgery
343404|NCT01676181|Coblation|coblation
343405|NCT01676181|Tonsils|tonsils
343406|NCT01676181|Tonsillectomy|tonsillectomy
343407|NCT01676155|Tuberculosis, latent tuberculosis infection, apoptosis, predictor|tuberculosis, latent tuberculosis infection, apoptosis, predictor
343408|NCT01676129|temporomandibular joint disorders|temporomandibular joint disorders
343409|NCT01676129|nocipoint|nocipoint
343410|NCT01676129|physical therapy|physical therapy
343411|NCT01676103|Parkinson's Disease (PD)|parkinson's disease (pd)
343412|NCT01676103|Orthostatic hypotension (OH)|orthostatic hypotension (oh)
343413|NCT01676077|LGMD2B|lgmd2b
343414|NCT01676077|Miyoshi Myopathy|miyoshi myopathy
343415|NCT01676077|Dysferlin|dysferlin
343416|NCT01676077|Dysferlinopathy|dysferlinopathy
343417|NCT01676077|Limb Girdle muscular dystrophy type 2b|limb girdle muscular dystrophy type 2b
343418|NCT01676077|Muscular Dystrophy|muscular dystrophy
343419|NCT01676064|intraocular pressure|intraocular pressure
343420|NCT01676064|perioperative fluid|perioperative fluid
343421|NCT01676064|trendelenburg position|trendelenburg position
343422|NCT01676064|laparoscopic gynecologic surgery|laparoscopic gynecologic surgery
343423|NCT01676038|Total Knee Replacement, Computer-Assisted Surgery|total knee replacement, computer-assisted surgery
343424|NCT01676025|pheochromocytoma|pheochromocytoma
343425|NCT01676025|aldosteronism|aldosteronism
343426|NCT01676025|cushing's syndrome|cushing's syndrome
343427|NCT01676025|adrenal incidentaloma|adrenal incidentaloma
343428|NCT01676025|Conn's syndrome|conn's syndrome
343429|NCT01675999|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
343430|NCT01675999|Locally advanced malignant neoplasm|locally advanced malignant neoplasm
343431|NCT01675999|colon cancer|colon cancer
343432|NCT01675973|Ranolazine|ranolazine
343433|NCT01675973|renal impairment|renal impairment
343434|NCT01675960|chronic irritability|chronic irritability
343435|NCT01675960|chronic pain|chronic pain
343436|NCT01675960|Neurologically impaired|neurologically impaired
343437|NCT01675960|gabapentin|gabapentin
343438|NCT01675921|Asthma|asthma
343439|NCT01675921|Facebook|facebook
343440|NCT01675921|teenagers|teenagers
343442|NCT01675895|Hyperbaric Levobupivacaine|hyperbaric levobupivacaine
343443|NCT01675895|İntrathecal|intrathecal
343444|NCT01675895|Lidocaine|lidocaine
343445|NCT01675895|TUR-P|tur-p
343446|NCT01675882|Food allergy|food allergy
343447|NCT01675882|Immediate hypersensitivity|immediate hypersensitivity
343448|NCT01675882|Whole peanut extract|whole peanut extract
343449|NCT01675882|Allergenic product|allergenic product
343450|NCT01675882|Specific Immunotherapy|specific immunotherapy
343451|NCT01675882|Epicutaneous Immunotherapy (EPIT)|epicutaneous immunotherapy (epit)
343452|NCT01675869|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
343453|NCT01675869|Executive function|executive function
343454|NCT01675869|Preschooler|preschooler
343455|NCT01675869|Metacognition|metacognition
343456|NCT01675856|Glasgow-Blatchford score|glasgow-blatchford score
343457|NCT01675856|Gastrointestinal bleeding|gastrointestinal bleeding
343458|NCT01675843|Infertility|infertility
343459|NCT01675843|PCOS|pcos
343460|NCT01675843|IUI|iui
343461|NCT01675817|heparin rebound|heparin rebound
343462|NCT01675817|protamine|protamine
343463|NCT01675817|cardiopulmonary bypass|cardiopulmonary bypass
343464|NCT01675817|cardiac surgery|cardiac surgery
343465|NCT01675817|anti-Xa|anti-xa
343466|NCT01675817|anti-IIa|anti-iia
343467|NCT01675804|ADHD|adhd
343468|NCT01675778|hydromorphone|hydromorphone
343469|NCT01675778|acute pain|acute pain
343470|NCT01675778|emergency department|emergency department
343471|NCT01675765|Cancer|cancer
343472|NCT01675765|Cancer vaccine|cancer vaccine
343473|NCT01675765|Listeria monocytogenes|listeria monocytogenes
343474|NCT01675765|Listeria-based vaccines|listeria-based vaccines
343475|NCT01675765|Pemetrexed|pemetrexed
343476|NCT01675765|Cisplatin|cisplatin
343477|NCT01675765|T regulatory cells|t regulatory cells
343478|NCT01675765|Mesothelin|mesothelin
343479|NCT01675765|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
343480|NCT01675765|Chemotherapy|chemotherapy
343481|NCT01675765|Standard of care|standard of care
343482|NCT01675765|Naive|naive
343483|NCT01675765|Front-line|front-line
343484|NCT01675765|Immunotherapy|immunotherapy
343485|NCT01675765|MPM|mpm
343486|NCT01675752|colonoscopy, narrow-band imaging|colonoscopy, narrow-band imaging
343487|NCT01675739|colonoscopy|colonoscopy
343488|NCT01675739|bowel preparation|bowel preparation
343489|NCT01675739|short message service|short message service
343490|NCT01675713|Lifestyle|lifestyle
343491|NCT01675713|Physical activity|physical activity
343492|NCT01675700|Myofascial pain|myofascial pain
343493|NCT01675700|Trigger point|trigger point
343494|NCT01675700|Nitroglycerin|nitroglycerin
343495|NCT01675687|dietary habits and obesity|dietary habits and obesity
343496|NCT01675687|exercise habits and obesity|exercise habits and obesity
343497|NCT01675687|cognition and obesity|cognition and obesity
343499|NCT01675674|Prevalence|prevalence
343500|NCT01675674|Pediatric|pediatric
343501|NCT01675674|Rheumatology|rheumatology
343502|NCT01675674|Mucopolysaccharidosis I|mucopolysaccharidosis i
343503|NCT01675674|Mucopolysaccharidosis II|mucopolysaccharidosis ii
343504|NCT01675674|Mucopolysaccharidosis IV|mucopolysaccharidosis iv
343505|NCT01675674|Mucopolysaccharidosis VI|mucopolysaccharidosis vi
343506|NCT01675648|Opiate dependent|opiate dependent
343507|NCT01675648|inpatient detoxification|inpatient detoxification
343508|NCT01675622|Cancer Pain|cancer pain
343509|NCT01675596|Aortic Stenosis|aortic stenosis
343510|NCT01675596|Transfemoral|transfemoral
343511|NCT01675596|Transcatheter Heart Valve|transcatheter heart valve
343512|NCT01675583|Diabetic Wounds|diabetic wounds
343513|NCT01675583|Hyperbaric Oxygen|hyperbaric oxygen
343514|NCT01675583|Laser Speckle Imaging|laser speckle imaging
343515|NCT01675583|Hyperbaric Oxygenation|hyperbaric oxygenation
343516|NCT01675570|RX-10045|rx-10045
343517|NCT01675570|Dry Eye Disease|dry eye disease
343518|NCT01675557|chronic kidney disease|chronic kidney disease
343519|NCT01675544|Heart failure|heart failure
343520|NCT01675531|Targin|targin
343521|NCT01675531|Chemotherapy Induced Peripheral Neuropathy (CIPN)|chemotherapy induced peripheral neuropathy (cipn)
343522|NCT01675518|Plasma concentration|plasma concentration
343523|NCT01675518|ASP7991|asp7991
343524|NCT01675518|food effect|food effect
343525|NCT01675518|PTH (parathyroid hormone)|pth (parathyroid hormone)
343526|NCT01675492|Astigmatism|astigmatism
343527|NCT01675492|refractive|refractive
343528|NCT01675492|error|error
343529|NCT01675492|LASIK|lasik
343530|NCT01675479|refractive|refractive
343531|NCT01675479|errors|errors
343532|NCT01675466|non-specific abdominal pain|non-specific abdominal pain
343533|NCT01675466|undifferentiated abdominal pain|undifferentiated abdominal pain
343534|NCT01675466|appendicitis|appendicitis
343535|NCT01675466|appendicectomy|appendicectomy
343536|NCT01675466|appendectomy|appendectomy
343537|NCT01675466|surgery|surgery
343538|NCT01675466|laparoscopy|laparoscopy
343539|NCT01675466|antibiotics|antibiotics
343540|NCT01675466|randomised controlled trial|randomised controlled trial
343541|NCT01675466|randomized controlled trial|randomized controlled trial
343542|NCT01675466|controlled clinical trial|controlled clinical trial
343543|NCT01675466|randomised|randomised
343544|NCT01675466|placebo|placebo
343545|NCT01675453|Organ dysfunction|organ dysfunction
343546|NCT01675453|Hypertonic solution|hypertonic solution
343547|NCT01675453|Extravascular water|extravascular water
343548|NCT01675453|Cardiopulmonary Bypass|cardiopulmonary bypass
343549|NCT01675414|ASD|asd
343550|NCT01675414|autism|autism
343551|NCT01675414|gastrointestinal|gastrointestinal
343552|NCT01675414|gastrointestinal conditions in children with ASD|gastrointestinal conditions in children with asd
343553|NCT01675401|Body Weight|body weight
343554|NCT01675401|Obesity|obesity
343555|NCT01675401|Weight Loss|weight loss
343556|NCT01675401|Vascular Function Markers|vascular function markers
343557|NCT01675388|Neonatal hypoxemic respiratory failure|neonatal hypoxemic respiratory failure
343558|NCT01675388|Extra Corporeal Membrane Oxygenation|extra corporeal membrane oxygenation
343559|NCT01675388|Neurodevelopmental outcomes|neurodevelopmental outcomes
343560|NCT01675388|Neuroimaging|neuroimaging
343561|NCT01675362|Extracorporeal shockwave lithotripsy (ESWL)|extracorporeal shockwave lithotripsy (eswl)
343562|NCT01675362|Kidney calculi|kidney calculi
343563|NCT01675362|Renal protection|renal protection
343564|NCT01675362|Antioxidants|antioxidants
343565|NCT01675362|Calcium channel blockers|calcium channel blockers
343566|NCT01675362|Angiotensin receptor blockers|angiotensin receptor blockers
343567|NCT01675349|Standardization|standardization
343568|NCT01675349|Immunotherapy|immunotherapy
343569|NCT01675349|Skin prick test|skin prick test
343570|NCT01675323|Restless Legs Syndrome|restless legs syndrome
343571|NCT01675323|RLS|rls
343572|NCT01675310|obesity, polycystic ovary syndrome, gestational diabetes|obesity, polycystic ovary syndrome, gestational diabetes
343573|NCT01675297|Risedronate, cholecalciferol, BMD|risedronate, cholecalciferol, bmd
343574|NCT01675284|Avian Influenza|avian influenza
343575|NCT01675284|Influenza A Virus Subtype H5N1|influenza a virus subtype h5n1
343576|NCT01675284|Inactivated H5N1 Influenza Virion Vaccine|inactivated h5n1 influenza virion vaccine
343577|NCT01675284|Phase I|phase i
343578|NCT01675284|Preventive H5N1 vaccination|preventive h5n1 vaccination
343579|NCT01675271|gestational diabetes|gestational diabetes
343580|NCT01675271|inflammation|inflammation
343581|NCT01675271|autonomic nervous system|autonomic nervous system
343582|NCT01675245|Multiple Myeloma|multiple myeloma
343583|NCT01675245|Cancer|cancer
343584|NCT01675245|Velcade|velcade
343585|NCT01675245|Bortezomib|bortezomib
343586|NCT01675245|Chinese patients|chinese patients
343587|NCT01675232|Atopic dermatitis|atopic dermatitis
343588|NCT01675232|Topical corticosteroid|topical corticosteroid
343589|NCT01675232|Pediatric|pediatric
343590|NCT01675232|Eczema|eczema
343591|NCT01675219|bladder cancer|bladder cancer
343592|NCT01675219|recurrence|recurrence
343593|NCT01675219|photodynamic diagnosis|photodynamic diagnosis
343594|NCT01675219|PDD|pdd
343595|NCT01675219|cost analysis|cost analysis
343596|NCT01675206|Vascular calcification|vascular calcification
343597|NCT01675206|Hemodialysis|hemodialysis
343598|NCT01675206|Matrix Gla Protein|matrix gla protein
343599|NCT01675206|Vitamin K2|vitamin k2
343600|NCT01675193|Amblyopia|amblyopia
343601|NCT01675193|Vision-Screening|vision-screening
343602|NCT01675180|pregnancy, oral health, attitude, awareness, streptococcus mutans, lactobacilli, oxidative stress|pregnancy, oral health, attitude, awareness, streptococcus mutans, lactobacilli, oxidative stress
343603|NCT01675167|CLBP|clbp
343604|NCT01675167|Chronic Low Back Pain|chronic low back pain
343605|NCT01675167|Chronic Pain|chronic pain
343606|NCT01675167|Back Pain|back pain
343607|NCT01675154|hypertriglyceridemia|hypertriglyceridemia
343608|NCT01675141|NK Cell Function|nk cell function
343609|NCT01675141|Immunomodulatory Drugs|immunomodulatory drugs
343610|NCT01675141|T Cell Activity|t cell activity
343611|NCT01675141|Immune Stimulatory Effects|immune stimulatory effects
343612|NCT01675141|Extended Dosing|extended dosing
343613|NCT01675128|Human Eukaryotic Translation Initiation Factor 4E (eIF4E) protein|human eukaryotic translation initiation factor 4e (eif4e) protein
343614|NCT01675128|Refractory|refractory
343615|NCT01675128|Oncogene|oncogene
343616|NCT01675128|Maximum Tolerated Dose|maximum tolerated dose
343617|NCT01675128|Safety|safety
343618|NCT01675115|Ischemic stroke|ischemic stroke
343619|NCT01675115|Traditional Chinese Medication|traditional chinese medication
343620|NCT01675115|Aspirin|aspirin
343621|NCT01675102|del 17p|del 17p
343622|NCT01675102|chronic lymphocytic leukemia|chronic lymphocytic leukemia
343623|NCT01675102|cll|cll
343624|NCT01675102|mutation|mutation
343625|NCT01675102|p53|p53
343626|NCT01675089|bone disease|bone disease
343627|NCT01675089|kidney transplantation|kidney transplantation
343628|NCT01675089|bisphosphonates|bisphosphonates
343629|NCT01675076|Hematoma|hematoma
343630|NCT01675076|novel oral anti-coagulant (NOAC)|novel oral anti-coagulant (noac)
343631|NCT01675076|Device surgery|device surgery
343632|NCT01675037|hypothalamic|hypothalamic
343633|NCT01675037|pituitary,|pituitary,
343634|NCT01675037|endoscopic third ventriculostomy|endoscopic third ventriculostomy
343635|NCT01675037|hydrocephalus|hydrocephalus
343636|NCT01675024|Neupro, Pharmacokinetics, healthy Chinese subjects|neupro, pharmacokinetics, healthy chinese subjects
343637|NCT01674998|REM Sleep Behavior Disorder|rem sleep behavior disorder
343638|NCT01674998|RBD|rbd
343639|NCT01674998|Dream|dream
343640|NCT01674998|Dreams|dreams
343641|NCT01674985|Decitabine|decitabine
343642|NCT01674985|microtransplantation|microtransplantation
343643|NCT01674985|myelodysplastic syndromes|myelodysplastic syndromes
343644|NCT01674985|chemotherapy|chemotherapy
343645|NCT01674972|NAFLD|nafld
343646|NCT01674972|NASH|nash
343647|NCT01674972|GLP-1|glp-1
343648|NCT01674959|gastric cancer|gastric cancer
343649|NCT01674959|radiation|radiation
343650|NCT01674959|chemotherapy|chemotherapy
343651|NCT01674946|GI-physiology|gi-physiology
343652|NCT01674946|CDCA|cdca
343653|NCT01674946|bile acids|bile acids
343654|NCT01674946|TGR5|tgr5
343655|NCT01674946|satiation peptides|satiation peptides
343656|NCT01674933|dental|dental
343657|NCT01674933|prevention|prevention
343658|NCT01674933|caries|caries
343659|NCT01674933|oral|oral
343660|NCT01674933|children|children
343661|NCT01674920|Pediatric obesity|pediatric obesity
343662|NCT01674920|resiliency|resiliency
343663|NCT01674920|physical activity|physical activity
343664|NCT01674920|dietary patterns|dietary patterns
343665|NCT01674920|children|children
343666|NCT01674881|Mindfulness|mindfulness
343667|NCT01674881|breast cancer|breast cancer
343668|NCT01674881|chronic pain|chronic pain
343669|NCT01674881|mediators|mediators
343670|NCT01674881|distress|distress
343671|NCT01674881|Breast cancer survivors|breast cancer survivors
343672|NCT01674881|Effectiveness of MBCT on chronic pain|effectiveness of mbct on chronic pain
343673|NCT01674881|Potential mediators and moderators|potential mediators and moderators
343674|NCT01674881|Effectiveness of MBCT on psychological symptoms|effectiveness of mbct on psychological symptoms
343675|NCT01674868|stroke|stroke
343676|NCT01674868|recovery|recovery
343677|NCT01674868|fluoxetine|fluoxetine
343678|NCT01674868|aphasia|aphasia
343679|NCT01674868|neglect|neglect
343680|NCT01674868|motor|motor
343681|NCT01674855|PEG-G-CSF|peg-g-csf
343682|NCT01674842|Triple negative|triple negative
343683|NCT01674842|Stage II|stage ii
343684|NCT01674842|Stage III|stage iii
343685|NCT01674803|drug-eluting stent|drug-eluting stent
343686|NCT01674803|zotarolimus|zotarolimus
343687|NCT01674803|everolimus|everolimus
343688|NCT01674803|sirolimus|sirolimus
343689|NCT01674803|all comers population|all comers population
343690|NCT01674803|target vessel failure|target vessel failure
343691|NCT01674803|coronary artery disease|coronary artery disease
343692|NCT01674803|durable polymer|durable polymer
343693|NCT01674803|biodegradable polymer|biodegradable polymer
343694|NCT01674777|ASP1941|asp1941
343695|NCT01674777|Food effect|food effect
343696|NCT01674777|Pharmacokinetics|pharmacokinetics
343697|NCT01674751|pre-ordering|pre-ordering
343698|NCT01674751|healthy eating|healthy eating
343699|NCT01674751|mindfulness|mindfulness
343700|NCT01674751|incentives|incentives
343701|NCT01674751|employees|employees
343702|NCT01674738|Non Small Cell Lung Cancer|non small cell lung cancer
343703|NCT01674738|NSCLC Stage IV|nsclc stage iv
343704|NCT01674738|Non-Squamous Advanced Non-Small-Cell Lung-Cancer (Stage IV)|non-squamous advanced non-small-cell lung-cancer (stage iv)
343705|NCT01674725|Hepatitis C virus|hepatitis c virus
343706|NCT01674725|Hepatitis C Genotype 1|hepatitis c genotype 1
343707|NCT01674725|Hepatitis C|hepatitis c
343708|NCT01674725|Interferon-Free|interferon-free
343709|NCT01674725|Chronic Hepatitis C|chronic hepatitis c
343710|NCT01674725|Ombitasvir|ombitasvir
343711|NCT01674725|Ribavirin|ribavirin
343712|NCT01674725|Viekira PAK|viekira pak
343713|NCT01674725|Dasabuvir|dasabuvir
343714|NCT01674725|Paritaprevir|paritaprevir
343715|NCT01674712|Fibrates|fibrates
343716|NCT01674712|Dyslipidemia|dyslipidemia
343717|NCT01674686|Vasospasm|vasospasm
343718|NCT01674686|Sarpogrelate|sarpogrelate
343719|NCT01674686|Statin|statin
343720|NCT01674673|panic disorder|panic disorder
343721|NCT01674673|SSRIs pharmacotherapy|ssris pharmacotherapy
343722|NCT01674673|Cognitive Behavioral therapy|cognitive behavioral therapy
343723|NCT01674660|hemodialysis|hemodialysis
343724|NCT01674660|blood pressure variability|blood pressure variability
343725|NCT01674660|volume status|volume status
343726|NCT01674647|rivaroxaban|rivaroxaban
343727|NCT01674647|oral anticoagulant|oral anticoagulant
343728|NCT01674647|nonvalvular atrial fibrillation|nonvalvular atrial fibrillation
343729|NCT01674647|cardioversion|cardioversion
343730|NCT01674647|stroke|stroke
343731|NCT01674647|transient ischemic attack|transient ischemic attack
343732|NCT01674647|thromboembolism|thromboembolism
343733|NCT01674647|cardiovascular event|cardiovascular event
343734|NCT01674634|XIAFLEX|xiaflex
343735|NCT01674634|XIAPEX|xiapex
343736|NCT01674634|Dupuytren's disease|dupuytren's disease
343737|NCT01674634|contracture|contracture
343738|NCT01674621|BA058|ba058
343739|NCT01674621|Abaloparatide-SC|abaloparatide-sc
343740|NCT01674621|abaloparatide|abaloparatide
343741|NCT01674621|Abaloparatide-TD|abaloparatide-td
343742|NCT01674621|Osteo|osteo
343743|NCT01674621|Osteoporosis|osteoporosis
343744|NCT01674621|Transdermal|transdermal
343745|NCT01674621|Patch|patch
343746|NCT01674608|intensive care|intensive care
343747|NCT01674608|mobilization|mobilization
343748|NCT01674608|rehabilitation|rehabilitation
343749|NCT01674608|critical care|critical care
343750|NCT01674595|Olea sensitization|olea sensitization
343752|NCT01674582|Brain tumors|brain tumors
343753|NCT01674582|Brain metastases|brain metastases
343754|NCT01674582|MRI|mri
343755|NCT01674582|Cognitive measurement|cognitive measurement
343756|NCT01674582|Neuropsychological evaluation|neuropsychological evaluation
343757|NCT01674582|DW-MRI|dw-mri
343758|NCT01674582|P-MRI|p-mri
343759|NCT01674582|MRS|mrs
343760|NCT01674569|VEGF|vegf
343761|NCT01674569|PDGF|pdgf
343762|NCT01674569|AMD|amd
343763|NCT01674556|pancreatic|pancreatic
343764|NCT01674556|cancer|cancer
343765|NCT01674556|adenocarcinoma|adenocarcinoma
343766|NCT01674556|Ultrasound|ultrasound
343767|NCT01674556|CEUS|ceus
343768|NCT01674543|Physical exercise|physical exercise
343769|NCT01674543|Schizophrenia|schizophrenia
343770|NCT01674543|symptoms|symptoms
343771|NCT01674543|IGF-1|igf-1
343772|NCT01674517|Bioequivalence|bioequivalence
343773|NCT01674517|Montelukast Sodium|montelukast sodium
343774|NCT01674517|crossover|crossover
343775|NCT01674504|Bioequivalence|bioequivalence
343776|NCT01674504|Montelukast Sodium|montelukast sodium
343777|NCT01674504|crossover|crossover
343778|NCT01674478|NEC, SBS, enterostomy, fish oil, Microlipid, Intralipid,|nec, sbs, enterostomy, fish oil, microlipid, intralipid,
343779|NCT01674478|enteral fat|enteral fat
343780|NCT01674465|Kidney fibrosis|kidney fibrosis
343781|NCT01674465|Kidney hypoxia|kidney hypoxia
343782|NCT01674465|Calcineurin inhibitors|calcineurin inhibitors
343783|NCT01674452|Stroke|stroke
343784|NCT01674452|Exercise and Physical Fitness|exercise and physical fitness
343785|NCT01674439|Adipose-derived regenerative cells|adipose-derived regenerative cells
343786|NCT01674439|Cell therapy|cell therapy
343787|NCT01674439|Autologous fat transfer|autologous fat transfer
343788|NCT01674439|Tissue engineering|tissue engineering
343789|NCT01674439|Craniofacial microsomia|craniofacial microsomia
343790|NCT01674426|functional hypothalamic amenorrhea|functional hypothalamic amenorrhea
343791|NCT01674426|stress induced anovulation|stress induced anovulation
343792|NCT01674413|Crohn's Disease|crohn's disease
343793|NCT01674413|Crohn's|crohn's
343794|NCT01674413|Crohns|crohns
343795|NCT01674413|Inflammatory Bowel Disease|inflammatory bowel disease
343796|NCT01674413|IBD|ibd
343797|NCT01674413|Humira|humira
343798|NCT01674413|Adalimumab|adalimumab
343799|NCT01674413|Adalimumab injection|adalimumab injection
343800|NCT01674413|Higgins|higgins
343801|NCT01674413|Calprotectin|calprotectin
343802|NCT01674413|biomarkers|biomarkers
343803|NCT01674413|Gastroenterology|gastroenterology
343804|NCT01674413|University of Michigan|university of michigan
343805|NCT01674413|U of M|u of m
343806|NCT01674387|electroacupuncture therapy|electroacupuncture therapy
343807|NCT01674387|neck pain|neck pain
343808|NCT01674387|McGill Pain Questionnaire|mcgill pain questionnaire
343809|NCT01674387|Acupuncture Therapy|acupuncture therapy
343810|NCT01674387|Electroacupuncture|electroacupuncture
343811|NCT01674387|Meridians|meridians
343812|NCT01674348|Diabetes Mellitus|diabetes mellitus
343813|NCT01674335|Fibromyalgia|fibromyalgia
343814|NCT01674335|Chronic pain|chronic pain
343815|NCT01674335|Chronic fatigue|chronic fatigue
343816|NCT01674335|Activity pacing|activity pacing
343817|NCT01674335|Operant learning|operant learning
343818|NCT01674335|Energy conservation|energy conservation
343819|NCT01674335|Treatment|treatment
343820|NCT01674335|Intervention|intervention
343821|NCT01674335|Biopsychosocial factors|biopsychosocial factors
343822|NCT01674335|Coping|coping
343823|NCT01674335|Mood|mood
343824|NCT01674335|Quality of life|quality of life
343825|NCT01674322|Healthy participants|healthy participants
343826|NCT01674322|Ibrutinib|ibrutinib
343827|NCT01674322|PCI-32765|pci-32765
343828|NCT01674322|B-cell malignancies|b-cell malignancies
343829|NCT01674322|CYP3A4|cyp3a4
343830|NCT01674296|Body Weight/physiology*|body weight/physiology*
343831|NCT01674296|Diet*/statistics & numerical data|diet*/statistics & numerical data
343832|NCT01674296|Diet*/trends|diet*/trends
343833|NCT01674296|Exercise/physiology*|exercise/physiology*
343834|NCT01674296|Female|female
343835|NCT01674296|Humans|humans
343836|NCT01674296|Longitudinal Studies|longitudinal studies
343837|NCT01674296|Middle Aged|middle aged
343838|NCT01674296|Obesity/epidemiology*|obesity/epidemiology*
343839|NCT01674296|Seasons*|seasons*
343840|NCT01674296|Time Factors|time factors
343841|NCT01674257|Atherosclerosis|atherosclerosis
343842|NCT01674257|Stroke|stroke
343843|NCT01674257|Positron-emission tomography|positron-emission tomography
343844|NCT01674257|Ferumoxytol|ferumoxytol
343845|NCT01674257|Magnetic resonance imaging|magnetic resonance imaging
343846|NCT01674257|Genetics|genetics
343847|NCT01674257|Calcification|calcification
343848|NCT01674257|Inflammation|inflammation
343849|NCT01674257|Flurodeoxyglucose F18|flurodeoxyglucose f18
343850|NCT01674257|Radiopharmaceuticals|radiopharmaceuticals
343851|NCT01674218|tuberculosis, safety, PA-824, QTc interval, moxifloxacin, healthy volunteers, crossover|tuberculosis, safety, pa-824, qtc interval, moxifloxacin, healthy volunteers, crossover
343852|NCT01674179|Fibromyalgia|fibromyalgia
343853|NCT01674179|qEEG|qeeg
343854|NCT01674179|Sleep|sleep
343855|NCT01674179|Pain|pain
343856|NCT01674153|Intra-dialytic exercise|intra-dialytic exercise
343857|NCT01674153|Toxin removal|toxin removal
343858|NCT01674153|Hemodiafiltration|hemodiafiltration
343859|NCT01674153|Inter-compartmental resistance|inter-compartmental resistance
343860|NCT01674153|Cardiac output|cardiac output
343861|NCT01674140|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
343862|NCT01674140|HER2-negative breast cancer|her2-negative breast cancer
343863|NCT01674140|stage IA breast cancer|stage ia breast cancer
343864|NCT01674140|stage IB breast cancer|stage ib breast cancer
343865|NCT01674140|stage II breast cancer|stage ii breast cancer
343866|NCT01674140|stage IIIA breast cancer|stage iiia breast cancer
343867|NCT01674140|stage IIIB breast cancer|stage iiib breast cancer
343868|NCT01674140|stage IIIC breast cancer|stage iiic breast cancer
343869|NCT01674140|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
343870|NCT01674140|male breast cancer|male breast cancer
343871|NCT01674114|Cesarean Section|cesarean section
343872|NCT01674114|Anesthetics, Local|anesthetics, local
343873|NCT01674101|Lower extremity malignancy|lower extremity malignancy
343874|NCT01674088|Irritable Bowel Syndrome|irritable bowel syndrome
343875|NCT01674088|breath testing|breath testing
343876|NCT01674088|carbon-13|carbon-13
343877|NCT01674075|safety|safety
343878|NCT01674075|J-Tip Delivery System|j-tip delivery system
343879|NCT01674075|pharmacokinetic profile|pharmacokinetic profile
343880|NCT01674049|nutrition|nutrition
343881|NCT01674049|nutrient|nutrient
343882|NCT01674049|timing|timing
343883|NCT01674049|diabetes|diabetes
343884|NCT01674049|family history|family history
343885|NCT01674049|dairy|dairy
343886|NCT01673971|hemangioma|hemangioma
343887|NCT01673958|Eccentric exercise|eccentric exercise
343888|NCT01673958|Aging|aging
343889|NCT01673958|Heart failure|heart failure
343890|NCT01673958|Muscle strength loss|muscle strength loss
343891|NCT01673958|Sarcopenia|sarcopenia
343892|NCT01673945|EUS-FNA, Forward viewing EUS scope, accuracy, Curvilinear EUS scope|eus-fna, forward viewing eus scope, accuracy, curvilinear eus scope
343893|NCT01673932|stroke|stroke
343894|NCT01673932|chronic stroke|chronic stroke
343895|NCT01673932|ischemic stroke|ischemic stroke
343896|NCT01673932|umbilical cord blood|umbilical cord blood
343897|NCT01673932|mononuclear cell|mononuclear cell
343898|NCT01673932|transplant|transplant
343899|NCT01673906|positron-emission tomography|positron-emission tomography
343900|NCT01673906|neuroendocrine tumors|neuroendocrine tumors
343901|NCT01673906|endosonography|endosonography
344410|NCT01671787|GS-7340|gs-7340
343902|NCT01673906|tomography, X-ray computed|tomography, x-ray computed
343903|NCT01673906|biopsy, fine needle|biopsy, fine needle
343904|NCT01673906|sensitivity and sensibility|sensitivity and sensibility
343905|NCT01673893|ClearWay|clearway
343906|NCT01673893|Glycoprotein|glycoprotein
343907|NCT01673893|Primary Coronary Intervention|primary coronary intervention
343908|NCT01673893|Abciximab|abciximab
343909|NCT01673893|ST Elevation Myocardial Infarction|st elevation myocardial infarction
343910|NCT01673893|Non-ST Elevation Myocardial Infarction|non-st elevation myocardial infarction
343911|NCT01673893|STEMI|stemi
343912|NCT01673893|NSTEMI|nstemi
343913|NCT01673893|Medicare|medicare
343914|NCT01673893|Medicaid|medicaid
343915|NCT01673893|Registry|registry
343916|NCT01673893|catheterization|catheterization
343917|NCT01673893|readmission|readmission
343918|NCT01673893|Acute Coronary Syndrome|acute coronary syndrome
343919|NCT01673893|ClearwayRx Catheter|clearwayrx catheter
343920|NCT01673841|bypass grafting|bypass grafting
343921|NCT01673828|Brain Injuries|brain injuries
343922|NCT01673828|Pregnanolone|pregnanolone
343923|NCT01673828|Epilepsy|epilepsy
343924|NCT01673815|optic disk|optic disk
343925|NCT01673815|fundoscopy|fundoscopy
343926|NCT01673815|pediatric|pediatric
343927|NCT01673815|clinical examination|clinical examination
343928|NCT01673802|Cholangiocarcinoma|cholangiocarcinoma
343929|NCT01673789|Stem Cell Educator|stem cell educator
343930|NCT01673789|Cord blood stem cells|cord blood stem cells
343931|NCT01673789|Immune modulation|immune modulation
343932|NCT01673789|Alopecia Areata|alopecia areata
343933|NCT01673776|Proximal femoral fracture|proximal femoral fracture
343934|NCT01673776|multimodal intervention|multimodal intervention
343935|NCT01673776|goal directed therapy (GDT)|goal directed therapy (gdt)
343936|NCT01673776|hemodynamic intervention|hemodynamic intervention
343937|NCT01673776|outcome|outcome
343938|NCT01673763|ERCP|ercp
343939|NCT01673763|endoscopy|endoscopy
343940|NCT01673763|pancreatitis|pancreatitis
343941|NCT01673750|Adolescents|adolescents
343942|NCT01673750|Body Image|body image
343943|NCT01673698|obesity|obesity
343944|NCT01673698|weight loss|weight loss
343945|NCT01673685|COPD|copd
343946|NCT01673685|Oxygen cylinder|oxygen cylinder
343947|NCT01673685|Portable oxygen cylinder|portable oxygen cylinder
343948|NCT01673685|Battery powered delivery device|battery powered delivery device
343949|NCT01673685|mobility|mobility
343950|NCT01673685|dyspnoea|dyspnoea
343951|NCT01673685|Quality of Life|quality of life
343952|NCT01673685|Cost effectiveness|cost effectiveness
343953|NCT01673646|SOM230, Pasireotide, acromegaly, Phase II|som230, pasireotide, acromegaly, phase ii
343954|NCT01673594|ADHD|adhd
343955|NCT01673594|Naltrexone|naltrexone
343956|NCT01673594|SODAS MPH|sodas mph
343957|NCT01673594|Stimulant-Induced Euphoria|stimulant-induced euphoria
343958|NCT01673594|Substance Abuse|substance abuse
343959|NCT01673594|Adults|adults
343960|NCT01673581|Low Risk|low risk
343961|NCT01673555|GSK1278863|gsk1278863
343962|NCT01673555|Pulmonary artery pressure|pulmonary artery pressure
343963|NCT01673529|Pruritus|pruritus
343964|NCT01673529|TRPV1|trpv1
343965|NCT01673529|Cowhage|cowhage
343966|NCT01673529|Atopic Dermatitis|atopic dermatitis
343967|NCT01673529|Capsaicin|capsaicin
343968|NCT01673529|Itch|itch
343969|NCT01673529|Histamine|histamine
343970|NCT01673529|healthy volunteers|healthy volunteers
343971|NCT01673529|SB705498|sb705498
343972|NCT01673529|Clinical|clinical
343973|NCT01673516|Renal sympathetic denervation|renal sympathetic denervation
343974|NCT01673516|Impedance cardiography|impedance cardiography
343975|NCT01673503|Myopia|myopia
343976|NCT01673503|refractive surgery|refractive surgery
343977|NCT01673503|all femtosecond laser|all femtosecond laser
343978|NCT01673503|ReLEx flex|relex flex
343979|NCT01673503|ReLEx smile|relex smile
343980|NCT01673490|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
343981|NCT01673490|dutasteride and tamsulosin|dutasteride and tamsulosin
343982|NCT01673464|mild Traumatic Brain Injury|mild traumatic brain injury
343983|NCT01673464|mTBI|mtbi
343984|NCT01673464|Concussion|concussion
343985|NCT01673451|insomnia|insomnia
343986|NCT01673438|solid tumor|solid tumor
343987|NCT01673438|aldoxorubicin|aldoxorubicin
343988|NCT01673438|phase 1|phase 1
343989|NCT01673438|INNO-206|inno-206
343990|NCT01673438|doxorubicin|doxorubicin
343991|NCT01673425|Influenza|influenza
343992|NCT01673425|Influenza Vaccines|influenza vaccines
343993|NCT01673425|Vaccines, Attenuated|vaccines, attenuated
343994|NCT01673425|Immunity, Mucosal|immunity, mucosal
343995|NCT01673412|venous leg ulcer healing prognostic factors|venous leg ulcer healing prognostic factors
343996|NCT01673399|repeated implantation failure (RIF)|repeated implantation failure (rif)
343997|NCT01673399|atosiban|atosiban
343998|NCT01673399|pregnancy|pregnancy
343999|NCT01673386|Tivozanib hydrochloride|tivozanib hydrochloride
344000|NCT01673386|renal cell carcinoma|renal cell carcinoma
344001|NCT01673386|subject preference|subject preference
344002|NCT01673386|quality of life|quality of life
344003|NCT01673373|Renal Artery Stenosis|renal artery stenosis
344004|NCT01673373|Renal Artery Obstruction|renal artery obstruction
344005|NCT01673373|Renovascular Hypertension|renovascular hypertension
344006|NCT01673373|Resistant Hypertension|resistant hypertension
344007|NCT01673373|Renal Revascularization|renal revascularization
344008|NCT01673373|Atherosclerotic Renal Artery Stenosis|atherosclerotic renal artery stenosis
344009|NCT01673373|ARAS (Atherosclerotic Renal Artery Stenosis)|aras (atherosclerotic renal artery stenosis)
344010|NCT01673373|RAS (Renal Artery Stenosis)|ras (renal artery stenosis)
344011|NCT01673373|Uncontrolled hypertension|uncontrolled hypertension
344012|NCT01673373|Hypertension|hypertension
344013|NCT01673373|systolic blood pressure|systolic blood pressure
344014|NCT01673373|blood pressure|blood pressure
344015|NCT01673360|vaginal repair|vaginal repair
344016|NCT01673360|urinary slings|urinary slings
344017|NCT01673360|POP|pop
344018|NCT01673360|SUI|sui
344019|NCT01673360|prolapse|prolapse
344020|NCT01673360|incontinence|incontinence
344021|NCT01673347|allograft|allograft
344022|NCT01673347|great toe|great toe
344023|NCT01673334|Pancreas Tumor EUS FNA Core Biopsy Procore FNB|pancreas tumor eus fna core biopsy procore fnb
344024|NCT01673321|Yogurt|yogurt
344025|NCT01673321|Milk|milk
344026|NCT01673321|Protein|protein
344027|NCT01673321|Food intake|food intake
344028|NCT01673321|Appetite|appetite
344029|NCT01673321|Glucose|glucose
344030|NCT01673321|Insulin|insulin
344031|NCT01673295|Lupus Nephritis|lupus nephritis
344032|NCT01673295|Rituximab|rituximab
344033|NCT01673282|Lacosamide|lacosamide
344034|NCT01673282|Vimpat|vimpat
344035|NCT01673282|Focal Epilepsy|focal epilepsy
344036|NCT01673282|Drug Load|drug load
344037|NCT01673282|AED|aed
344038|NCT01673282|SP1065|sp1065
344039|NCT01673269|ERCP|ercp
344040|NCT01673269|Direct cholangioscopic examination of the common bile duct|direct cholangioscopic examination of the common bile duct
344041|NCT01673269|Choledocholithiasis|choledocholithiasis
344042|NCT01673269|Cholangiocarcinoma|cholangiocarcinoma
344043|NCT01673269|Benign stricture of common bile duct|benign stricture of common bile duct
344044|NCT01673243|Smoking cessation|smoking cessation
344045|NCT01673243|Household smoking bans|household smoking bans
344046|NCT01673243|Cancer|cancer
344047|NCT01673243|Sickle cell disease|sickle cell disease
344048|NCT01673204|surrogate marker,|surrogate marker,
344049|NCT01673204|circulating soluble TNF receptor,|circulating soluble tnf receptor,
344050|NCT01673204|diabetic nephropathy|diabetic nephropathy
344051|NCT01673178|Type 2 diabetes|type 2 diabetes
344052|NCT01673178|safety|safety
344053|NCT01673178|multiple dose|multiple dose
344054|NCT01673178|intravenous|intravenous
344055|NCT01673152|Obesity|obesity
344056|NCT01673152|Overweight|overweight
344057|NCT01673152|Satiety|satiety
344058|NCT01673152|Oligofructose|oligofructose
344059|NCT01673152|Prebiotic|prebiotic
344060|NCT01673139|Atrial fibrillation|atrial fibrillation
344061|NCT01673139|Exercise|exercise
344062|NCT01673126|vegetative state|vegetative state
344063|NCT01673126|minimally conscious state|minimally conscious state
344064|NCT01673126|disorders of consciousness|disorders of consciousness
344065|NCT01673126|transcranial direct current stimulation|transcranial direct current stimulation
344066|NCT01673113|cryolipolysis, sensory nerve function, Zeltiq|cryolipolysis, sensory nerve function, zeltiq
344067|NCT01673100|physical activity|physical activity
344068|NCT01673100|percutaneous coronary intervention|percutaneous coronary intervention
344069|NCT01673100|heart disease|heart disease
344070|NCT01673087|stress biology|stress biology
344071|NCT01673087|cortisol|cortisol
344072|NCT01673087|adrenocorticotropin|adrenocorticotropin
344073|NCT01673087|salivary biomarkers|salivary biomarkers
344074|NCT01673061|Abscess|abscess
344075|NCT01673061|Boils|boils
344076|NCT01673061|Anesthetics, Local|anesthetics, local
344077|NCT01673061|Lidocaine|lidocaine
344078|NCT01673061|Vapocoolant|vapocoolant
344079|NCT01673061|1,1,1,3,3-Pentafluoropropane|1,1,1,3,3-pentafluoropropane
344080|NCT01673061|1,1,1,2-Tetrafluoroethane|1,1,1,2-tetrafluoroethane
344081|NCT01673048|Elastic stable intramedullary nailing|elastic stable intramedullary nailing
344082|NCT01673048|biomechanical testing|biomechanical testing
344083|NCT01673048|fracture|fracture
344084|NCT01673048|femur|femur
344085|NCT01673048|treatment|treatment
344086|NCT01673048|children|children
344087|NCT01673048|adolescents|adolescents
344088|NCT01673009|Gleevec|gleevec
344089|NCT01672996|Use in Abdominal|use in abdominal
344090|NCT01672996|Contrast Enhanced|contrast enhanced
344091|NCT01672996|Computed Tomography|computed tomography
344092|NCT01672996|Optimize concentration|optimize concentration
344093|NCT01672996|dosage of Ioforminol Injection|dosage of ioforminol injection
344094|NCT01672983|Japanese|japanese
344095|NCT01672983|Hepatitis C|hepatitis c
344096|NCT01672983|Genotype 2|genotype 2
344097|NCT01672983|Genotype 1b|genotype 1b
344098|NCT01672983|paritaprevir|paritaprevir
344099|NCT01672983|ombitasvir|ombitasvir
344100|NCT01672983|ritonavir|ritonavir
344101|NCT01672983|VIEKIRAX Combination Tablets|viekirax combination tablets
344102|NCT01672944|Biological specimen banks|biological specimen banks
344103|NCT01672944|Health education|health education
344104|NCT01672944|Tissue banks|tissue banks
344105|NCT01672944|Health care survey|health care survey
344106|NCT01672944|Tissue|tissue
344107|NCT01672918|PET/CT|pet/ct
344108|NCT01672918|Lymphoma|lymphoma
344109|NCT01672918|Lymphadenopathy|lymphadenopathy
344110|NCT01672918|ALPS|alps
344111|NCT01672905|recurrent prostate cancer|recurrent prostate cancer
344112|NCT01672905|stage I prostate cancer|stage i prostate cancer
344113|NCT01672905|stage IIA prostate cancer|stage iia prostate cancer
344114|NCT01672905|stage IIB prostate cancer|stage iib prostate cancer
344115|NCT01672905|stage III prostate cancer|stage iii prostate cancer
344116|NCT01672892|gastrointestinal complications|gastrointestinal complications
344117|NCT01672892|perioperative/postoperative complications|perioperative/postoperative complications
344118|NCT01672892|radiation toxicity|radiation toxicity
344119|NCT01672892|urinary complications|urinary complications
344120|NCT01672892|urinary tract toxicity|urinary tract toxicity
344121|NCT01672892|endometrial clear cell carcinoma|endometrial clear cell carcinoma
344122|NCT01672892|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
344123|NCT01672892|stage IA endometrial carcinoma|stage ia endometrial carcinoma
344124|NCT01672892|stage IB endometrial carcinoma|stage ib endometrial carcinoma
344125|NCT01672892|stage II endometrial carcinoma|stage ii endometrial carcinoma
344126|NCT01672892|stage IIIA endometrial carcinoma|stage iiia endometrial carcinoma
344127|NCT01672892|stage IIIB endometrial carcinoma|stage iiib endometrial carcinoma
344128|NCT01672892|stage IIIC endometrial carcinoma|stage iiic endometrial carcinoma
344129|NCT01672892|endometrial adenocarcinoma|endometrial adenocarcinoma
344130|NCT01672892|cervical adenocarcinoma|cervical adenocarcinoma
344131|NCT01672892|stage IB cervical cancer|stage ib cervical cancer
344132|NCT01672892|stage IIA cervical cancer|stage iia cervical cancer
344133|NCT01672892|stage IIB cervical cancer|stage iib cervical cancer
344134|NCT01672879|NASH|nash
344135|NCT01672879|cirrhosis|cirrhosis
344136|NCT01672879|Compensated Liver disease|compensated liver disease
344137|NCT01672879|Monoclonal antibody|monoclonal antibody
344138|NCT01672879|LOXL2|loxl2
344139|NCT01672879|Simtuzumab|simtuzumab
344140|NCT01672879|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
344141|NCT01672879|Hepatic venous pressure gradient|hepatic venous pressure gradient
344142|NCT01672879|HVPG|hvpg
344143|NCT01672879|NAFLD|nafld
344144|NCT01672879|MRE|mre
344145|NCT01672879|Liver biopsy|liver biopsy
344146|NCT01672866|NASH|nash
344147|NCT01672866|non cirrhotic|non cirrhotic
344148|NCT01672866|Monoclonal antibody|monoclonal antibody
344149|NCT01672866|LOXL2|loxl2
344150|NCT01672866|Simtuzumab|simtuzumab
344151|NCT01672866|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
344152|NCT01672866|NAFLD|nafld
344153|NCT01672866|Liver biopsy|liver biopsy
344154|NCT01672866|MRE|mre
344155|NCT01672853|PSC|psc
344156|NCT01672853|Sclerosis|sclerosis
344157|NCT01672853|Monoclonal antibody|monoclonal antibody
344158|NCT01672853|LOXL2|loxl2
344159|NCT01672853|Simtuzumab|simtuzumab
344160|NCT01672853|Primary sclerosing cholangitis|primary sclerosing cholangitis
344161|NCT01672853|Liver fibrosis|liver fibrosis
344162|NCT01672853|Liver disease|liver disease
344163|NCT01672853|MRCP|mrcp
344164|NCT01672853|MRE|mre
344165|NCT01672853|Liver biopsy|liver biopsy
344166|NCT01672840|Stage 1 Hypertension|stage 1 hypertension
344167|NCT01672840|cocoa consumption|cocoa consumption
344168|NCT01672840|Blood pressure|blood pressure
344169|NCT01672840|Endothelial function|endothelial function
344170|NCT01672840|arterial stiffness|arterial stiffness
344171|NCT01672827|Alzheimer's Disease|alzheimer's disease
344172|NCT01672827|Mild Cognitive Impairment|mild cognitive impairment
344173|NCT01672827|Positron Emission Tomography (PET)|positron emission tomography (pet)
344174|NCT01672827|PET Images|pet images
344175|NCT01672814|Keratoconus|keratoconus
344176|NCT01672814|Collagen Crosslinking|collagen crosslinking
344177|NCT01672814|Riboflavin|riboflavin
344178|NCT01672814|Microwave|microwave
344179|NCT01672814|Keraflex|keraflex
344180|NCT01672775|Renal Cell Carcinoma|renal cell carcinoma
344181|NCT01672775|AGS-16C3F|ags-16c3f
344182|NCT01672775|Pharmacokinetics of AGS-16C3F|pharmacokinetics of ags-16c3f
344183|NCT01672762|diabetes mellitus|diabetes mellitus
344184|NCT01672762|serum Insulin|serum insulin
344185|NCT01672762|blood glucose|blood glucose
344186|NCT01672762|glucose excretion|glucose excretion
344187|NCT01672762|hypoglycemic agents|hypoglycemic agents
344188|NCT01672762|ipragliflozin|ipragliflozin
344189|NCT01672749|Scoliosis [MESH]|scoliosis [mesh]
344190|NCT01672749|Pediatrics [MESH]|pediatrics [mesh]
344191|NCT01672749|Early onset|early onset
344192|NCT01672749|Growth guidance|growth guidance
344193|NCT01672749|Growing rod|growing rod
344194|NCT01672749|Trolley|trolley
344195|NCT01672749|Dual growing rod technique|dual growing rod technique
344196|NCT01672736|Relapsed or relapse/refractory Multiple Myeloma|relapsed or relapse/refractory multiple myeloma
344197|NCT01672723|opioids|opioids
344198|NCT01672723|social connection|social connection
344199|NCT01672710|Hubbard detoxification|hubbard detoxification
344200|NCT01672710|Exercise|exercise
344201|NCT01672710|Sauna therapy|sauna therapy
344202|NCT01672710|Niacin|niacin
344203|NCT01672697|anal incontinence|anal incontinence
344204|NCT01672697|genital trauma|genital trauma
344205|NCT01672697|physical therapy|physical therapy
344206|NCT01672697|anal manometry|anal manometry
344207|NCT01672684|quality of life|quality of life
344208|NCT01672658|TBI,|tbi,
344209|NCT01672658|vestibular|vestibular
344210|NCT01672645|Smoking cessation|smoking cessation
344211|NCT01672645|vaccine|vaccine
344212|NCT01672645|Phase 1|phase 1
344213|NCT01672619|craniosynostoses|craniosynostoses
344214|NCT01672619|Osteogenesis Distraction|osteogenesis distraction
344215|NCT01672619|craniotomy|craniotomy
344216|NCT01672593|Autologous platelet rich fibrin glue;|autologous platelet rich fibrin glue;
344217|NCT01672593|Enterocutaneous fistulas;|enterocutaneous fistulas;
344218|NCT01672593|Single low output GI fistulas;|single low output gi fistulas;
344219|NCT01672580|social networks|social networks
344220|NCT01672580|nutrition|nutrition
344221|NCT01672580|vitamins|vitamins
344222|NCT01672580|chlorine|chlorine
344223|NCT01672567|Coronary Artery Disease|coronary artery disease
344224|NCT01672567|Egg Consumption|egg consumption
344225|NCT01672567|Endothelial Function|endothelial function
344226|NCT01672554|Schizophrenia|schizophrenia
344227|NCT01672554|Anxiety disorder|anxiety disorder
344228|NCT01672541|dating violence|dating violence
344229|NCT01672541|healthy relationship behaviors|healthy relationship behaviors
344230|NCT01672528|Patient Reported Outcome Measures|patient reported outcome measures
344231|NCT01672528|PROMs|proms
344232|NCT01672528|Cardiac arrhythmia|cardiac arrhythmia
344233|NCT01672528|Cardiac ablation|cardiac ablation
344234|NCT01672502|sleep|sleep
344235|NCT01672502|firefighter|firefighter
344236|NCT01672502|fire|fire
344237|NCT01672502|apnea|apnea
344238|NCT01672502|insomnia|insomnia
344239|NCT01672502|shift|shift
344240|NCT01672502|narcolepsy|narcolepsy
344241|NCT01672502|restless leg|restless leg
344242|NCT01672502|rls|rls
344243|NCT01672502|fatigue|fatigue
344244|NCT01672502|Optalert|optalert
344245|NCT01672502|actigraph|actigraph
344246|NCT01672502|actigraphy|actigraphy
344247|NCT01672502|actiwatch|actiwatch
344248|NCT01672502|safety|safety
344249|NCT01672502|sleepiness|sleepiness
344250|NCT01672502|sleepy|sleepy
344251|NCT01672502|work|work
344252|NCT01672502|hours|hours
344253|NCT01672502|FEMA|fema
344254|NCT01672502|drowsy|drowsy
344255|NCT01672489|Drowsy|drowsy
344256|NCT01672489|Drive|drive
344257|NCT01672489|Driving|driving
344258|NCT01672489|Shift Work Disorder|shift work disorder
344259|NCT01672489|SWD|swd
344260|NCT01672489|EEG|eeg
344261|NCT01672489|ECG|ecg
344262|NCT01672489|Actiwatch|actiwatch
344263|NCT01672489|Diary|diary
344264|NCT01672489|Bioharness|bioharness
344265|NCT01672489|Q-Sensor|q-sensor
344266|NCT01672489|Q Sensor|q sensor
344267|NCT01672489|Liberty Mutual|liberty mutual
344268|NCT01672489|sleep|sleep
344269|NCT01672489|impaired|impaired
344270|NCT01672489|Optalert|optalert
344271|NCT01672489|tracker|tracker
344272|NCT01672489|vehicle|vehicle
344273|NCT01672489|questionnaire|questionnaire
344274|NCT01672489|survey|survey
344275|NCT01672476|Fimasartan|fimasartan
344276|NCT01672450|Histologically or cytologically proven melanoma; Stages III-IV; accessible cutaneous, subcutaneous, and/or nodal lesions; ECOG performance status 0 to 2|histologically or cytologically proven melanoma; stages iii-iv; accessible cutaneous, subcutaneous, and/or nodal lesions; ecog performance status 0 to 2
344277|NCT01672437|Birth and parent preparation|birth and parent preparation
344278|NCT01672437|Parenting stress|parenting stress
344279|NCT01672437|Depression|depression
344280|NCT01672437|self-efficacy|self-efficacy
344281|NCT01672437|social network and support|social network and support
344282|NCT01672424|NPO|npo
344283|NCT01672424|Gastric Emptying|gastric emptying
344284|NCT01672424|Ice Chips|ice chips
344285|NCT01672424|Protein Drink|protein drink
344286|NCT01672424|Ultrasound|ultrasound
344287|NCT01672411|prostate cancer, PSA, markers, diagnosis, prognosis, pro-PSA|prostate cancer, psa, markers, diagnosis, prognosis, pro-psa
344288|NCT01672398|CarePartner|carepartner
344289|NCT01672398|informal caregiver|informal caregiver
344290|NCT01672398|interactive voice response|interactive voice response
344291|NCT01672398|transition|transition
344292|NCT01672398|post-discharge|post-discharge
344293|NCT01672398|chronic illness|chronic illness
344294|NCT01672398|readmission|readmission
344295|NCT01672398|self-care|self-care
344296|NCT01672385|CarePartner|carepartner
344297|NCT01672385|informal caregiver|informal caregiver
344298|NCT01672385|interactive voice response|interactive voice response
344299|NCT01672385|transition|transition
344300|NCT01672385|post-discharge|post-discharge
344301|NCT01672385|chronic illness|chronic illness
344302|NCT01672385|readmission|readmission
344303|NCT01672385|self-care|self-care
344304|NCT01672359|cognitive functioning|cognitive functioning
344305|NCT01672359|immune function|immune function
344306|NCT01672359|cytokines|cytokines
344307|NCT01672359|growth factors|growth factors
344308|NCT01672359|quality of life|quality of life
344309|NCT01672359|dietary supplementation|dietary supplementation
344310|NCT01672359|Ginkgo biloba|ginkgo biloba
344311|NCT01672359|Improvement of cognitive function|improvement of cognitive function
344312|NCT01672346|PAF|paf
344313|NCT01672320|Robotic|robotic
344314|NCT01672320|Arthroplasty|arthroplasty
344315|NCT01672320|Total Hip Arthroplasty|total hip arthroplasty
344316|NCT01672320|Cup Positioning|cup positioning
344317|NCT01672320|Outcomes|outcomes
344318|NCT01672307|hypotrichosis of eyebrows|hypotrichosis of eyebrows
344319|NCT01672307|thinning eyebrows|thinning eyebrows
344320|NCT01672307|minoxidil|minoxidil
344321|NCT01672307|placebo|placebo
344322|NCT01672307|randomized|randomized
344323|NCT01672294|caregiver|caregiver
344324|NCT01672294|end of life|end of life
344325|NCT01672294|self-disclosure|self-disclosure
344326|NCT01672268|cardiac computed tomography|cardiac computed tomography
344327|NCT01672268|Transcatheter Aortic Valve Implantation|transcatheter aortic valve implantation
344328|NCT01672268|safety and efficacy|safety and efficacy
344329|NCT01672255|exercise|exercise
344330|NCT01672255|diabetes|diabetes
344331|NCT01672255|SSRIs|ssris
344332|NCT01672216|Exercise Therapy|exercise therapy
344333|NCT01672216|Biofeedback (Psychology)|biofeedback (psychology)
344334|NCT01672216|Adult|adult
344335|NCT01672216|Chronic Obstipation/*therapy|chronic obstipation/*therapy
344336|NCT01672216|EMG - Biofeedback|emg - biofeedback
344337|NCT01672216|EMG - Triggered Stimulation|emg - triggered stimulation
344338|NCT01672216|Augmented biofeedback|augmented biofeedback
344339|NCT01672177|Geriatrics|geriatrics
344340|NCT01672177|Aged|aged
344341|NCT01672177|Aging|aging
344342|NCT01672177|Chronic disease|chronic disease
344343|NCT01672177|Self management|self management
344344|NCT01672164|proteogenomic biomarker panels|proteogenomic biomarker panels
344345|NCT01672151|Refractory Immune Thrombocytopenic Purpura|refractory immune thrombocytopenic purpura
344346|NCT01672151|rapamycin|rapamycin
344347|NCT01672151|regulatory T cells|regulatory t cells
344348|NCT01672138|PVAI|pvai
344349|NCT01672138|CFAE|cfae
344350|NCT01672138|NPAF|npaf
344351|NCT01672112|analgesic efficacy|analgesic efficacy
344352|NCT01672112|oral codeine|oral codeine
344353|NCT01672112|oral oxycodone|oral oxycodone
344354|NCT01672112|postcraniotomy|postcraniotomy
344355|NCT01672099|vitamin K2|vitamin k2
344356|NCT01672099|menaquinone-7|menaquinone-7
344357|NCT01672099|vascular health|vascular health
344358|NCT01672073|pressure|pressure
344359|NCT01672073|waveform|waveform
344360|NCT01672073|arterial|arterial
344361|NCT01672047|The 25(OH) vitamin D level|the 25(oh) vitamin d level
344362|NCT01672047|The 1.25(OH) vitamin D level|the 1.25(oh) vitamin d level
344363|NCT01672047|The intact PTH level|the intact pth level
344364|NCT01672047|The calcification score of coronary artery|the calcification score of coronary artery
344365|NCT01672047|The microalbuminuria level|the microalbuminuria level
344366|NCT01672021|Breast Cancer|breast cancer
344367|NCT01672021|MRI PET-CT|mri pet-ct
344368|NCT01672008|NOX-100|nox-100
344369|NCT01671995|Heart failure|heart failure
344370|NCT01671995|Quality of life|quality of life
344371|NCT01671969|determine effects of diet on renal and other parameters|determine effects of diet on renal and other parameters
344372|NCT01671956|IBD|ibd
344373|NCT01671956|UC|uc
344374|NCT01671956|Colitis|colitis
344375|NCT01671956|Ulcerative Colitis|ulcerative colitis
344376|NCT01671943|small malignant invasive breast tumors|small malignant invasive breast tumors
344377|NCT01671917|Total knee arthroplasty|total knee arthroplasty
344378|NCT01671917|Total knee replacement|total knee replacement
344379|NCT01671917|Knee osteoarthritis|knee osteoarthritis
344380|NCT01671917|Education|education
344381|NCT01671917|Exercise|exercise
344382|NCT01671917|Handicap|handicap
344383|NCT01671917|Function|function
344384|NCT01671917|Cost-effectiveness|cost-effectiveness
344385|NCT01671917|Cost-utility|cost-utility
344386|NCT01671917|Quality of life|quality of life
344387|NCT01671891|rectal cancer|rectal cancer
344388|NCT01671891|circulating tumor cells|circulating tumor cells
344389|NCT01671891|predict responses|predict responses
344390|NCT01671865|FSHD|fshd
344391|NCT01671865|magnetic resonance imaging|magnetic resonance imaging
344392|NCT01671865|magnetic resonance spectroscopy|magnetic resonance spectroscopy
344393|NCT01671826|Multiple Myeloma|multiple myeloma
344394|NCT01671826|Autologous Stem Cell Transplantation|autologous stem cell transplantation
344395|NCT01671826|Elderly Patients|elderly patients
344396|NCT01671813|positive|positive
344397|NCT01671813|diffuse|diffuse
344398|NCT01671813|B-Cell|b-cell
344399|NCT01671813|elderly|elderly
344400|NCT01671813|EBV|ebv
344401|NCT01671813|DLBCL|dlbcl
344402|NCT01671813|malignant|malignant
344403|NCT01671813|pilot|pilot
344404|NCT01671800|Hyperhidrosis|hyperhidrosis
344405|NCT01671800|Botulinum Toxin|botulinum toxin
344406|NCT01671800|Amputation|amputation
344407|NCT01671800|Phantom limb pain|phantom limb pain
344408|NCT01671787|Hepatitis B|hepatitis b
344409|NCT01671787|HBV|hbv
344411|NCT01671787|TDF|tdf
344412|NCT01671787|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
344413|NCT01671787|Gilead|gilead
344414|NCT01671787|Viread|viread
344415|NCT01671761|Healthy|healthy
344416|NCT01671761|Control|control
344417|NCT01671748|Venous Leg Ulcer|venous leg ulcer
344418|NCT01671748|Varicose Ulcer|varicose ulcer
344419|NCT01671748|Chronic ulcer|chronic ulcer
344420|NCT01671748|Chronic wound|chronic wound
344421|NCT01671748|Ultrasound therapy|ultrasound therapy
344422|NCT01671748|MIST device|mist device
344423|NCT01671748|Wound healing|wound healing
344424|NCT01671748|Low frequency non contact ultrasound|low frequency non contact ultrasound
344425|NCT01671735|prevention|prevention
344426|NCT01671735|diabetes|diabetes
344427|NCT01671722|Bioequivalence|bioequivalence
344428|NCT01671722|Montelukast Sodium|montelukast sodium
344429|NCT01671722|crossover|crossover
344430|NCT01671709|Bioequivalence|bioequivalence
344431|NCT01671709|Montelukast Sodium|montelukast sodium
344432|NCT01671709|crossover|crossover
344433|NCT01671683|rectal cancer|rectal cancer
344434|NCT01671683|neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
344435|NCT01671683|Capecitabine|capecitabine
344436|NCT01671670|Functional dyspepsia|functional dyspepsia
344437|NCT01671670|postprandial distress syndrome|postprandial distress syndrome
344438|NCT01671657|In vitro fertilization|in vitro fertilization
344439|NCT01671657|Assisted reproductive therapy|assisted reproductive therapy
344440|NCT01671657|Time-lapse image recording|time-lapse image recording
344441|NCT01671657|Image analysis software|image analysis software
344442|NCT01671644|In vitro fertilization|in vitro fertilization
344443|NCT01671644|Assisted reproductive therapy|assisted reproductive therapy
344444|NCT01671644|Time-lapse image recording|time-lapse image recording
344445|NCT01671644|Image analysis software|image analysis software
344446|NCT01671618|Aortic dissection|aortic dissection
344447|NCT01671618|Aortic dilation|aortic dilation
344448|NCT01671618|Aortic Aneurysm|aortic aneurysm
344449|NCT01671618|ultrasound|ultrasound
344450|NCT01671618|point-of-care|point-of-care
344451|NCT01671618|echocardiography|echocardiography
344452|NCT01671592|Cancer|cancer
344453|NCT01671592|colorectal|colorectal
344454|NCT01671592|tumor|tumor
344455|NCT01671592|neoplasms|neoplasms
344456|NCT01671592|carcinoma|carcinoma
344457|NCT01671592|vaccine|vaccine
344458|NCT01671566|Congenital Heart defect|congenital heart defect
344459|NCT01671566|Exercise and Physical fitness|exercise and physical fitness
344460|NCT01671566|Rehabilitation|rehabilitation
344461|NCT01671566|Quality of life|quality of life
344462|NCT01671566|Behaviour|behaviour
344463|NCT01671540|COPD|copd
344464|NCT01671540|IPV|ipv
344465|NCT01671527|Deep Brain Stimulation|deep brain stimulation
344466|NCT01671527|DBS|dbs
344467|NCT01671527|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
344468|NCT01671527|TMS|tms
344469|NCT01671527|Cervical Dystonia|cervical dystonia
344470|NCT01671527|Dystonia|dystonia
344471|NCT01671527|Control|control
344472|NCT01671527|Healthy|healthy
344473|NCT01671514|mitochondrial biogenesis|mitochondrial biogenesis
344474|NCT01671514|skeletal muscle|skeletal muscle
344475|NCT01671514|epicatechin|epicatechin
344476|NCT01671501|HIV|hiv
344477|NCT01671501|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
344478|NCT01671501|Alcoholism|alcoholism
344479|NCT01671501|Alcoholic Intoxication|alcoholic intoxication
344480|NCT01671501|Substance-Related Disorders|substance-related disorders
344481|NCT01671501|Intervention Studies|intervention studies
344482|NCT01671501|Primary Health Care|primary health care
344483|NCT01671501|therapy|therapy
344484|NCT01671501|prevention & control|prevention & control
344485|NCT01671488|Anal Cancer|anal cancer
344486|NCT01671488|Mitomycin|mitomycin
344487|NCT01671488|5-Fluorouracil|5-fluorouracil
344488|NCT01671488|5-FU|5-fu
344489|NCT01671488|IMRT|imrt
344490|NCT01671488|ADXS11-001|adxs11-001
344491|NCT01671475|Altered Mental Status|altered mental status
344492|NCT01671475|Non-convulsive seizure|non-convulsive seizure
344493|NCT01671475|Electroencephalography|electroencephalography
344494|NCT01671462|HPV|hpv
344495|NCT01671462|Cervical Cancer|cervical cancer
344496|NCT01671462|Cervical Neoplasms|cervical neoplasms
344497|NCT01671449|Gastric cancer|gastric cancer
344498|NCT01671449|S-1|s-1
344499|NCT01671449|Cisplatin|cisplatin
344500|NCT01671449|Oxaliplatin|oxaliplatin
344501|NCT01671436|Depression|depression
344502|NCT01671436|Guided Imagery|guided imagery
344503|NCT01671436|Psychotherapy|psychotherapy
344504|NCT01671436|Meditation|meditation
344505|NCT01671423|Cellulitis|cellulitis
344506|NCT01671423|Skin infection|skin infection
344507|NCT01671423|Prednisone|prednisone
344508|NCT01671423|Steroid|steroid
344509|NCT01671423|Anti-inflammatory|anti-inflammatory
344510|NCT01671410|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
344511|NCT01671410|buprenorphine|buprenorphine
344512|NCT01671410|morphine|morphine
344513|NCT01671410|benzodiazepine|benzodiazepine
344514|NCT01671397|Obesity|obesity
344515|NCT01671397|weight loss|weight loss
344516|NCT01671397|sleep hygiene|sleep hygiene
344517|NCT01671397|diet|diet
344518|NCT01671397|exercise|exercise
344519|NCT01671384|Valproate|valproate
344520|NCT01671384|levocarnitine|levocarnitine
344521|NCT01671384|SMA|sma
344522|NCT01671384|physiotherapy|physiotherapy
344523|NCT01671384|placebo|placebo
344524|NCT01671371|syncope|syncope
344525|NCT01671371|point of care|point of care
344526|NCT01671371|ultrasound|ultrasound
344527|NCT01671371|echocardiography|echocardiography
344528|NCT01671358|MRSA|mrsa
344529|NCT01671358|Contamination|contamination
344530|NCT01671358|Isolation|isolation
344531|NCT01671332|Carcinoma, non small cell lung|carcinoma, non small cell lung
344532|NCT01671332|Second line|second line
344533|NCT01671332|Third line|third line
344534|NCT01671319|breast cancer|breast cancer
344535|NCT01671319|female|female
344536|NCT01671319|women|women
344537|NCT01671319|adjuvant|adjuvant
344538|NCT01671306|Coronary collaterals|coronary collaterals
344539|NCT01671306|diabetes mellitus|diabetes mellitus
344540|NCT01671306|monocyte subsets|monocyte subsets
344541|NCT01671280|pneumonia|pneumonia
344542|NCT01671280|pelvic inflammatory disease|pelvic inflammatory disease
344543|NCT01671280|Zithromax|zithromax
344544|NCT01671280|Zithromac|zithromac
344545|NCT01671280|Japanese|japanese
344546|NCT01671280|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
344547|NCT01671228|dialysis|dialysis
344548|NCT01671228|chronic kidney failure|chronic kidney failure
344549|NCT01671228|informed choice|informed choice
344550|NCT01671228|patient decision making|patient decision making
344551|NCT01671228|decision aid|decision aid
344552|NCT01671215|endometrium|endometrium
344553|NCT01671215|myometrium|myometrium
344554|NCT01671215|fibroids|fibroids
344555|NCT01671215|uterine malformations|uterine malformations
344556|NCT01671176|Wide diameter implant|wide diameter implant
344557|NCT01671176|ISQ|isq
344558|NCT01671176|Ponto|ponto
344559|NCT01671176|Bone anchored implant|bone anchored implant
344560|NCT01671163|Cancer|cancer
344561|NCT01671163|Radiation therapy|radiation therapy
344562|NCT01671163|Fiducial markers|fiducial markers
344563|NCT01671150|inflammation|inflammation
344564|NCT01671150|depression|depression
344565|NCT01671150|social cognition|social cognition
344566|NCT01671150|neural activity|neural activity
344567|NCT01671137|Lactobacillus GG|lactobacillus gg
344568|NCT01671137|Functional Abdominal Pain|functional abdominal pain
344569|NCT01671137|Children|children
344570|NCT01671137|Acute|acute
344571|NCT01671137|Gastroenteritis|gastroenteritis
344572|NCT01671124|TG|tg
344573|NCT01671124|TC|tc
344574|NCT01671124|HDL|hdl
344575|NCT01671124|LDL|ldl
344576|NCT01671124|Albumin|albumin
344577|NCT01671124|Hemoglobin|hemoglobin
344578|NCT01671124|Hematocrit|hematocrit
344579|NCT01671124|Uric acid|uric acid
344580|NCT01671124|Sodium|sodium
344581|NCT01671124|Potassium|potassium
344582|NCT01671124|Calcium|calcium
344583|NCT01671098|nitric oxide|nitric oxide
344584|NCT01671098|sinuplasty|sinuplasty
344585|NCT01671072|Chondrocyte cells|chondrocyte cells
344586|NCT01671072|Osteoarthritis|osteoarthritis
344587|NCT01671072|Gene therapy|gene therapy
344588|NCT01671033|Panic disorder|panic disorder
344589|NCT01671033|cognitive behavior therapy|cognitive behavior therapy
344590|NCT01671033|Internet|internet
344591|NCT01671020|fimasartan|fimasartan
344592|NCT01671020|absolute bioavailability|absolute bioavailability
344593|NCT01670994|cancer|cancer
344594|NCT01670994|immunotherapy|immunotherapy
344595|NCT01670994|immunochemotherapy|immunochemotherapy
344596|NCT01670994|targeted|targeted
344597|NCT01670994|metastatic|metastatic
344598|NCT01670994|interleukin-2|interleukin-2
344599|NCT01670994|antitumor|antitumor
344600|NCT01670994|TCR|tcr
344601|NCT01670994|T-cell receptor|t-cell receptor
344602|NCT01670994|p53|p53
344603|NCT01670994|p53 gene|p53 gene
344604|NCT01670994|p53 tumor supressor protein|p53 tumor supressor protein
344605|NCT01670994|HLA-A2 positive|hla-a2 positive
344606|NCT01670994|HLA-A*0201/p53 aa264-272|hla-a*0201/p53 aa264-272
344607|NCT01670994|HLA complex|hla complex
344608|NCT01670994|multiple myeloma|multiple myeloma
344609|NCT01670994|IFN-γ and TNF-α|ifn-γ and tnf-α
344610|NCT01670994|refractory|refractory
344611|NCT01670994|relapsed|relapsed
344612|NCT01670981|Ischemic dilated cardiomyopathy|ischemic dilated cardiomyopathy
344613|NCT01670981|Heart failure|heart failure
344614|NCT01670981|ixCELL|ixcell
344615|NCT01670981|ixCELL DCM|ixcell dcm
344616|NCT01670981|IDCM|idcm
344617|NCT01670981|DCM|dcm
344618|NCT01670981|stem cells|stem cells
344619|NCT01670981|MSC|msc
344620|NCT01670981|cell therapy|cell therapy
344621|NCT01670955|Anemia|anemia
344622|NCT01670955|preoperative|preoperative
344623|NCT01670955|gynecological patients|gynecological patients
344624|NCT01670955|Sorghum bicolor|sorghum bicolor
344625|NCT01670955|Packed Cells Volume|packed cells volume
344626|NCT01670942|pneumothorax|pneumothorax
344627|NCT01670942|trauma|trauma
344628|NCT01670942|commercial air travel|commercial air travel
344629|NCT01670929|recurrent miscarriages|recurrent miscarriages
344630|NCT01670929|progesterone|progesterone
344631|NCT01670916|Necrotizing enterocolitis|necrotizing enterocolitis
344632|NCT01670916|Probiotics|probiotics
344633|NCT01670916|Preterm|preterm
344634|NCT01670916|Infant|infant
344635|NCT01670890|temozolomide(TMZ)|temozolomide(tmz)
344636|NCT01670890|cisplatin(CDDP)|cisplatin(cddp)
344637|NCT01670890|recurrent malignant gliomas|recurrent malignant gliomas
344638|NCT01670851|eLAPE,|elape,
344639|NCT01670851|perineum,|perineum,
344640|NCT01670851|pelvic floor reconstruction|pelvic floor reconstruction
344641|NCT01670838|subarachnoid haemorrhage|subarachnoid haemorrhage
344642|NCT01670838|cardiopulmonary complications|cardiopulmonary complications
344643|NCT01670825|Occipital neuralgia|occipital neuralgia
344898|NCT01669681|Severe asthma|severe asthma
344644|NCT01670825|corticosteroid injection|corticosteroid injection
344645|NCT01670825|pulsed radiofrequency|pulsed radiofrequency
344646|NCT01670812|chronic lymphocytic leukemia|chronic lymphocytic leukemia
344647|NCT01670812|ultra-high risk|ultra-high risk
344648|NCT01670812|fresh frozen plasma|fresh frozen plasma
344649|NCT01670812|methylprednisolone|methylprednisolone
344650|NCT01670812|rituximab|rituximab
344651|NCT01670799|Ketorolac|ketorolac
344652|NCT01670799|Bioavailability|bioavailability
344653|NCT01670799|Pain|pain
344654|NCT01670760|Deep Tissue Temperature|deep tissue temperature
344655|NCT01670760|Zero Heat Flux Thermometry|zero heat flux thermometry
344656|NCT01670760|Thermometry|thermometry
344657|NCT01670760|Core Temperature|core temperature
344658|NCT01670708|Substance Use|substance use
344659|NCT01670708|Illicit Drug Use|illicit drug use
344660|NCT01670708|Criminal Behavior|criminal behavior
344661|NCT01670695|IgG4-related disease|igg4-related disease
344662|NCT01670695|IgG4-RD|igg4-rd
344663|NCT01670682|Stage III|stage iii
344664|NCT01670643|AMD|amd
344665|NCT01670643|vision rehabilitation|vision rehabilitation
344666|NCT01670643|video camera magnifier|video camera magnifier
344667|NCT01670643|IVI|ivi
344668|NCT01670643|DASS|dass
344669|NCT01670630|speculum|speculum
344670|NCT01670630|vagina|vagina
344671|NCT01670630|cervix|cervix
344672|NCT01670630|examination|examination
344673|NCT01670578|P.R.P.|p.r.p.
344674|NCT01670578|viscosupplementation|viscosupplementation
344675|NCT01670578|double-blind randomized|double-blind randomized
344676|NCT01670578|intra-articular injections|intra-articular injections
344677|NCT01670578|knee degenerative pathology|knee degenerative pathology
344678|NCT01670578|early osteoarthritis|early osteoarthritis
344679|NCT01670565|Diffuse cutaneous systemic sclerosis|diffuse cutaneous systemic sclerosis
344680|NCT01670565|Early Diffuse cutaneous systemic sclerosis|early diffuse cutaneous systemic sclerosis
344681|NCT01670539|Lung Cancer|lung cancer
344682|NCT01670539|Telemonitoring|telemonitoring
344683|NCT01670539|Rural|rural
344684|NCT01670539|Nursing|nursing
344685|NCT01670526|Traumatic Brain Injury|traumatic brain injury
344686|NCT01670526|Cognitive Impairment|cognitive impairment
344687|NCT01670526|Rivastigmine|rivastigmine
344688|NCT01670526|Pharmacologic Actions|pharmacologic actions
344689|NCT01670526|TBI|tbi
344690|NCT01670526|Memory|memory
344691|NCT01670526|Cholinesterase Inhibitors|cholinesterase inhibitors
344692|NCT01670526|Cognition|cognition
344693|NCT01670526|Head Trauma|head trauma
344694|NCT01670513|Psoriasis|psoriasis
344695|NCT01670500|germline mutation|germline mutation
344696|NCT01670500|BRCA1 mutation|brca1 mutation
344697|NCT01670500|BRCA2 mutation|brca2 mutation
344698|NCT01670487|Vapocoolant|vapocoolant
344699|NCT01670474|Temporary hemodialysis catheters|temporary hemodialysis catheters
344700|NCT01670474|Non-cuffed hemodialysis catheters|non-cuffed hemodialysis catheters
344701|NCT01670474|Thrombolysis|thrombolysis
344702|NCT01670474|rt-PA|rt-pa
344703|NCT01670474|Thrombosis|thrombosis
344704|NCT01670474|Lifespan|lifespan
344705|NCT01670474|Blood flow rate|blood flow rate
344706|NCT01670474|Catheter related bacteriemia|catheter related bacteriemia
344707|NCT01670461|advance care planning, palliative care, pediatric|advance care planning, palliative care, pediatric
344708|NCT01670448|Postoperative pain|postoperative pain
344709|NCT01670448|Chronic pain prevention|chronic pain prevention
344710|NCT01670448|Regional anesthesia|regional anesthesia
344711|NCT01670448|Mastectomy|mastectomy
344712|NCT01670435|Ciprofloxacin|ciprofloxacin
344713|NCT01670435|sepsis|sepsis
344714|NCT01670435|infection|infection
344715|NCT01670435|pneumonia|pneumonia
344716|NCT01670435|peritonitis|peritonitis
344717|NCT01670435|cholecystitis|cholecystitis
344718|NCT01670435|cholangitis|cholangitis
344719|NCT01670435|anthrax|anthrax
344720|NCT01670422|CSOJ|csoj
344721|NCT01670422|recurrence|recurrence
344722|NCT01670422|life-threatening complications|life-threatening complications
344723|NCT01670422|risk factors|risk factors
344724|NCT01670409|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
344725|NCT01670409|SMART|smart
344726|NCT01670409|IMRT|imrt
344727|NCT01670409|Chemotherapy|chemotherapy
344728|NCT01670396|coronary stent implant|coronary stent implant
344729|NCT01670396|polymorphism|polymorphism
344730|NCT01670396|G protein|g protein
344731|NCT01670396|drug-eluting stent|drug-eluting stent
344732|NCT01670396|restenosis|restenosis
344733|NCT01670383|Cardiac Arrest|cardiac arrest
344734|NCT01670383|Sepsis|sepsis
344735|NCT01670383|Biological Markers|biological markers
344736|NCT01670383|Anti-Inflammation Agents|anti-inflammation agents
344737|NCT01670383|Antioxidants|antioxidants
344738|NCT01670370|Rituximab|rituximab
344739|NCT01670370|Gemcitabine|gemcitabine
344740|NCT01670370|Oxaliplatin|oxaliplatin
344741|NCT01670370|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
344742|NCT01670357|Dry Eye Syndrome|dry eye syndrome
344743|NCT01670318|Chronic total occlusion|chronic total occlusion
344744|NCT01670318|Bifurcation lesion|bifurcation lesion
344745|NCT01670318|Left main trunk lesion|left main trunk lesion
344746|NCT01670318|Small vessel disease|small vessel disease
344747|NCT01670318|Multi vessel disease|multi vessel disease
344748|NCT01670292|Low Back Pain|low back pain
344749|NCT01670279|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
344750|NCT01670266|ONO-9054|ono-9054
344751|NCT01670266|ocular hypertension|ocular hypertension
344752|NCT01670266|OHT|oht
344753|NCT01670266|Open angle-glaucoma|open angle-glaucoma
344754|NCT01670266|OAG|oag
344755|NCT01670266|Glaucoma|glaucoma
344756|NCT01670266|Eye diseases|eye diseases
344757|NCT01670240|IPAA|ipaa
344758|NCT01670240|Pouchitis|pouchitis
344759|NCT01670240|Ulcerative colitis|ulcerative colitis
344760|NCT01670240|Pouch|pouch
344761|NCT01670240|Adalimumab|adalimumab
344762|NCT01670240|Humira|humira
344763|NCT01670227|EARLY CHILDHOOD|early childhood
344764|NCT01670227|UNIVERSAL PREVENTION|universal prevention
344765|NCT01670214|RM|rm
344766|NCT01670214|R-CM|r-cm
344767|NCT01670214|based on ICHD-2 criteria|based on ichd-2 criteria
344768|NCT01670188|Pneumatic sequential compression device (SCD)|pneumatic sequential compression device (scd)
344769|NCT01670188|Peripherally Inserted Central Catheters (PICC)|peripherally inserted central catheters (picc)
344770|NCT01670175|Histologic verification of solid tumor, including lymphomas|histologic verification of solid tumor, including lymphomas
344771|NCT01670175|Original diagnosis or relapse|original diagnosis or relapse
344772|NCT01670162|Pigment Epithelium of Eye|pigment epithelium of eye
344773|NCT01670162|Wet macular degeneration|wet macular degeneration
344774|NCT01670162|Macular degeneration|macular degeneration
344775|NCT01670149|Clostridium difficile|clostridium difficile
344776|NCT01670149|Diarrhoea|diarrhoea
344777|NCT01670149|Rifaximin|rifaximin
344778|NCT01670136|sildenafil|sildenafil
344779|NCT01670136|preterm infants|preterm infants
344780|NCT01670136|persistent pulmonary hypertension of the newborn|persistent pulmonary hypertension of the newborn
344781|NCT01670123|Mobile phone|mobile phone
344782|NCT01670123|electronic intervention|electronic intervention
344783|NCT01670123|behavioral intervention|behavioral intervention
344784|NCT01670123|telehealth|telehealth
344785|NCT01670123|bipolar disorder|bipolar disorder
344786|NCT01670110|Polycystic Liver Disease|polycystic liver disease
344787|NCT01670110|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
344788|NCT01670110|Autosomal dominant polycystic liver disease|autosomal dominant polycystic liver disease
344789|NCT01670110|Somatostatin analogs|somatostatin analogs
344790|NCT01670110|Pasireotide LAR|pasireotide lar
344791|NCT01670110|SOM230|som230
344792|NCT01670097|Advanced Cancers|advanced cancers
344793|NCT01670097|Hematologic Disorder|hematologic disorder
344794|NCT01670097|Solid Tumors|solid tumors
344795|NCT01670097|Dyspnea|dyspnea
344796|NCT01670097|Difficulty breathing|difficulty breathing
344797|NCT01670097|Shortness of breath|shortness of breath
344798|NCT01670097|Dexamethasone|dexamethasone
344799|NCT01670097|Decadron|decadron
344800|NCT01670097|Placebo|placebo
344801|NCT01670097|Sugar pill|sugar pill
344802|NCT01670097|Questionnaires|questionnaires
344803|NCT01670097|Surveys|surveys
344804|NCT01670097|Spirometer|spirometer
344805|NCT01670097|Phone calls|phone calls
344806|NCT01670071|Schizophrenia|schizophrenia
344807|NCT01670071|Paliperidone|paliperidone
344808|NCT01670071|Risperidone|risperidone
344809|NCT01670071|Paliperidone extended-release (ER)|paliperidone extended-release (er)
344810|NCT01670071|Risperidone immediate-release (IR)|risperidone immediate-release (ir)
344811|NCT01670019|Depression|depression
344812|NCT01670019|Antidepressant|antidepressant
344813|NCT01670019|Antipsychotic|antipsychotic
344814|NCT01669993|Outcomes|outcomes
344815|NCT01669993|Quality improvement|quality improvement
344816|NCT01669993|Patient Safety|patient safety
344817|NCT01669993|PACU|pacu
344818|NCT01669993|Complications|complications
344819|NCT01669993|Adverse events|adverse events
344820|NCT01669993|Respiratory arrest|respiratory arrest
344821|NCT01669993|Pain|pain
344822|NCT01669993|PONV|ponv
344823|NCT01669993|Age|age
344824|NCT01669993|Neonate|neonate
344825|NCT01669993|Infant|infant
344826|NCT01669993|Child|child
344827|NCT01669993|Ambulatory|ambulatory
344828|NCT01669993|Inpatient|inpatient
344829|NCT01669993|General Anesthesia|general anesthesia
344830|NCT01669993|Otolaryngology|otolaryngology
344831|NCT01669993|Tonsillectomy|tonsillectomy
344832|NCT01669993|Obstructive sleep apnea|obstructive sleep apnea
344833|NCT01669980|Infections|infections
344834|NCT01669980|Pediatrics|pediatrics
344835|NCT01669980|Teflaro|teflaro
344836|NCT01669980|Ceftriaxone|ceftriaxone
344837|NCT01669980|cephalosporin|cephalosporin
344838|NCT01669980|Vancomycin|vancomycin
344839|NCT01669980|Clindamycin|clindamycin
344840|NCT01669980|Amoxicillin Clavulanate|amoxicillin clavulanate
344841|NCT01669980|Linezolid|linezolid
344842|NCT01669980|MRSA|mrsa
344843|NCT01669980|pneumonia|pneumonia
344844|NCT01669954|HIV|hiv
344845|NCT01669954|Bone mineral density|bone mineral density
344846|NCT01669954|Osteoporosis|osteoporosis
344847|NCT01669954|Vitamin D|vitamin d
344848|NCT01669954|Fractures|fractures
344849|NCT01669941|Pregnancy|pregnancy
344850|NCT01669941|Plasmodium|plasmodium
344851|NCT01669941|Malaria|malaria
344852|NCT01669941|Prevention|prevention
344853|NCT01669941|Kenya|kenya
344854|NCT01669941|Piperaquine|piperaquine
344855|NCT01669941|Dihydroartemisinin-Piperaquine|dihydroartemisinin-piperaquine
344856|NCT01669941|Sulfadoxine Pyrimethamine|sulfadoxine pyrimethamine
344857|NCT01669876|Randomized|randomized
344858|NCT01669876|Double-Blind|double-blind
344859|NCT01669876|Dietary Supplements|dietary supplements
344860|NCT01669863|ARDS|ards
344861|NCT01669850|Chronic kidney disease|chronic kidney disease
344862|NCT01669850|Arteriovenous fistula|arteriovenous fistula
344863|NCT01669850|Surgical anastomosis|surgical anastomosis
344864|NCT01669850|Complications|complications
344865|NCT01669850|Patency|patency
344866|NCT01669850|Dialysis access|dialysis access
344867|NCT01669837|Inguinal hernia|inguinal hernia
344868|NCT01669837|Laparoscopy|laparoscopy
344869|NCT01669837|Surgical tissue glue|surgical tissue glue
344870|NCT01669811|Refractory Reflux Esophagitis,|refractory reflux esophagitis,
344871|NCT01669811|Japanese,|japanese,
344872|NCT01669811|Nexium,|nexium,
344873|NCT01669811|twice daily,|twice daily,
344874|NCT01669811|oral administration|oral administration
344875|NCT01669798|Recurrent epithelial ovarian carcinoma|recurrent epithelial ovarian carcinoma
344876|NCT01669798|Persistent epithelial ovarian carcinoma|persistent epithelial ovarian carcinoma
344877|NCT01669798|Bevacizumab resistant epithelial ovarian carcinoma|bevacizumab resistant epithelial ovarian carcinoma
344878|NCT01669746|Androgenetic Alopecia|androgenetic alopecia
344879|NCT01669746|Male Pattern Baldness|male pattern baldness
344880|NCT01669746|Female Pattern Baldness|female pattern baldness
344881|NCT01669746|Hair Loss|hair loss
344882|NCT01669746|Baldness|baldness
344883|NCT01669733|Breast Surgery|breast surgery
344884|NCT01669733|Breast Biopsy|breast biopsy
344885|NCT01669733|Music Therapy|music therapy
344886|NCT01669720|Metastatic|metastatic
344887|NCT01669720|Colorectal|colorectal
344888|NCT01669720|Colorectal Cancer|colorectal cancer
344889|NCT01669720|Resected or Ablated Metastatic Colorectal Cancer|resected or ablated metastatic colorectal cancer
344890|NCT01669707|Endostar|endostar
344891|NCT01669707|advanced Non-small cell lung cancer|advanced non-small cell lung cancer
344892|NCT01669707|Continued Pumping into vein|continued pumping into vein
344893|NCT01669707|Gemcitabine|gemcitabine
344894|NCT01669707|Carboplatin|carboplatin
344895|NCT01669694|Pelvic Pain|pelvic pain
344896|NCT01669694|Pelvic Floor Physical Therapy|pelvic floor physical therapy
344897|NCT01669694|Biomarkers|biomarkers
344899|NCT01669681|Medical economic|medical economic
344900|NCT01669681|care|care
344901|NCT01669681|Cost efficiency|cost efficiency
344902|NCT01669681|CPAM|cpam
344903|NCT01669681|EQ5D|eq5d
344904|NCT01669642|ketamine sedation|ketamine sedation
344905|NCT01669642|pediatric|pediatric
344906|NCT01669642|abscess drainage|abscess drainage
344907|NCT01669642|fracture reduction|fracture reduction
344908|NCT01669616|Type 2 Diabetes|type 2 diabetes
344909|NCT01669616|Adults 18 years and older|adults 18 years and older
344910|NCT01669603|Common cold|common cold
344911|NCT01669577|predictors|predictors
344912|NCT01669577|trauma|trauma
344913|NCT01669577|mortality|mortality
344914|NCT01669564|Quality of Life|quality of life
344915|NCT01669564|Tobacco Use Cessation|tobacco use cessation
344916|NCT01669564|Physical Activity|physical activity
344917|NCT01669538|Galantamine|galantamine
344918|NCT01669538|Nicotine Bitartrate|nicotine bitartrate
344919|NCT01669538|Nicotine Tartrate|nicotine tartrate
344920|NCT01669538|Nicotine dependence|nicotine dependence
344921|NCT01669538|Tobacco Dependence|tobacco dependence
344922|NCT01669512|Malaria vaccine|malaria vaccine
344923|NCT01669512|Matrix M|matrix m
344924|NCT01669499|Bone metastases, radiotherapy, dexamethasone, pain flare|bone metastases, radiotherapy, dexamethasone, pain flare
344925|NCT01669486|Pain|pain
344926|NCT01669486|ICU|icu
344927|NCT01669486|Mechanical ventilation|mechanical ventilation
344928|NCT01669486|CPOT|cpot
344929|NCT01669486|BPS|bps
344930|NCT01669473|Diabetes|diabetes
344931|NCT01669447|dmri, mnvc, lucentis|dmri, mnvc, lucentis
344932|NCT01669434|Perioperative Period|perioperative period
344933|NCT01669421|Alpha 1|alpha 1
344934|NCT01669408|ischemic stroke|ischemic stroke
344935|NCT01669408|hemorrhagic stroke|hemorrhagic stroke
344936|NCT01669408|prehospital cooling|prehospital cooling
344937|NCT01669408|induction of cooling|induction of cooling
344938|NCT01669408|ambulance|ambulance
344939|NCT01669408|emergency room|emergency room
344940|NCT01669408|cold infusions|cold infusions
344941|NCT01669408|hypothermia|hypothermia
344942|NCT01669408|normothermia|normothermia
344943|NCT01669395|Severe heart failure|severe heart failure
344944|NCT01669395|Homebased rehabilitation|homebased rehabilitation
344945|NCT01669395|Physical exercise|physical exercise
344946|NCT01669395|Activities of daily living|activities of daily living
344947|NCT01669395|Intersectoral Cooperation|intersectoral cooperation
344948|NCT01669382|AngioSeal, ExoSeal, PCI, puncture site|angioseal, exoseal, pci, puncture site
344949|NCT01669369|Lithium Carbonate|lithium carbonate
344950|NCT01669369|Chemotherapy|chemotherapy
344951|NCT01669369|prognosis|prognosis
344952|NCT01669356|malnutrition|malnutrition
344953|NCT01669356|parenteral supplement|parenteral supplement
344954|NCT01669356|rest metabolic rate|rest metabolic rate
344955|NCT01669356|postoperative complications|postoperative complications
344956|NCT01669343|Aromatase Inhibitors|aromatase inhibitors
344957|NCT01669330|Gastroesophageal Reflux|gastroesophageal reflux
344958|NCT01669330|Fundoplication|fundoplication
344959|NCT01669330|Surgical Procedures|surgical procedures
344960|NCT01669317|Cherry Juice Pilot|cherry juice pilot
344961|NCT01669304|migraine variant|migraine variant
344962|NCT01669304|chronic dizziness|chronic dizziness
344963|NCT01669304|pharmacologic dissection|pharmacologic dissection
344964|NCT01669278|sheath|sheath
344965|NCT01669278|flexible|flexible
344966|NCT01669278|endoscopy|endoscopy
344967|NCT01669278|otolaryngology|otolaryngology
344968|NCT01669278|office|office
344969|NCT01669265|Breast cancer|breast cancer
344970|NCT01669265|OSNA|osna
344971|NCT01669265|sentinel lymph node|sentinel lymph node
344972|NCT01669252|Breast cancer|breast cancer
344973|NCT01669252|Eribulin|eribulin
344974|NCT01669252|Neoadjuvant|neoadjuvant
344975|NCT01669252|PAM50|pam50
344976|NCT01669252|Triple-negative|triple-negative
344977|NCT01669252|Luminal A|luminal a
344978|NCT01669252|Luminal B|luminal b
344979|NCT01669239|Breast Cancer|breast cancer
344980|NCT01669239|HER2 positive|her2 positive
344981|NCT01669239|Neoadjuvant|neoadjuvant
344982|NCT01669239|Liposomal doxorubicin|liposomal doxorubicin
344983|NCT01669239|Paclitaxel|paclitaxel
344984|NCT01669239|Trastuzumab|trastuzumab
344985|NCT01669239|Pertuzumab|pertuzumab
344986|NCT01669239|Safety|safety
344987|NCT01669226|Ovarian Cancer|ovarian cancer
344988|NCT01669226|intraperitoneal chemotherapy|intraperitoneal chemotherapy
344989|NCT01669213|5-HT3 receptor antagonist|5-ht3 receptor antagonist
344990|NCT01669213|hypotension|hypotension
344991|NCT01669213|spinal anesthesia|spinal anesthesia
344992|NCT01669174|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
344993|NCT01669174|COPD; cachexia; muscle wasting|copd; cachexia; muscle wasting
344994|NCT01669161|Upper|upper
344995|NCT01669161|Limb|limb
344996|NCT01669161|Deficits|deficits
344997|NCT01669161|Rehabilitation|rehabilitation
344998|NCT01669161|VNS|vns
344999|NCT01669148|breast cancer|breast cancer
345000|NCT01669148|imaging|imaging
345001|NCT01669135|cerebral oximetry|cerebral oximetry
345002|NCT01669135|cesarean delivery|cesarean delivery
345003|NCT01669109|Yoga|yoga
345004|NCT01669109|Colorectal Neoplasms|colorectal neoplasms
345005|NCT01669109|Quality of Life|quality of life
345006|NCT01669109|Randomized Controlled Trial|randomized controlled trial
345007|NCT01669096|adults|adults
345008|NCT01669096|healthy|healthy
345009|NCT01669096|Tuberculosis vaccine|tuberculosis vaccine
345010|NCT01669096|mRNA expression|mrna expression
345011|NCT01669096|HIV negative|hiv negative
345012|NCT01669083|Oxytocin Antagonist|oxytocin antagonist
345013|NCT01669083|Embryo/Blastocyst Implantation|embryo/blastocyst implantation
345014|NCT01669070|bioavailability|bioavailability
345015|NCT01669070|Fluticasone Furoate|fluticasone furoate
345016|NCT01669070|pharmacokinetics|pharmacokinetics
345017|NCT01669070|dose proportionality|dose proportionality
345018|NCT01669057|Congenital heart disease|congenital heart disease
345019|NCT01669057|DNA variation|dna variation
345020|NCT01669057|methylation|methylation
345021|NCT01669057|risk factors|risk factors
345022|NCT01669057|supplements|supplements
345023|NCT01669031|automated perimetry|automated perimetry
345024|NCT01669031|visual fields|visual fields
345025|NCT01669031|reliability|reliability
345026|NCT01669031|vision tests/standards|vision tests/standards
345027|NCT01669031|randomized controlled trial|randomized controlled trial
345028|NCT01669031|false positive reactions|false positive reactions
345029|NCT01669031|false negative reactions|false negative reactions
345030|NCT01669031|fixation, ocular|fixation, ocular
345031|NCT01669031|mean deviation|mean deviation
345032|NCT01669031|variability|variability
345033|NCT01669031|program|program
345034|NCT01669031|software|software
345035|NCT01669031|glaucoma/diagnosis|glaucoma/diagnosis
345036|NCT01669031|visual field tests/methods|visual field tests/methods
345037|NCT01669031|aged|aged
345038|NCT01669031|humans|humans
345039|NCT01669031|female|female
345040|NCT01669031|male|male
345041|NCT01669031|prospective studies|prospective studies
345042|NCT01669031|reproducibility of results|reproducibility of results
345043|NCT01669005|neutropenia|neutropenia
345044|NCT01669005|multiplex PCR|multiplex pcr
345045|NCT01669005|infection|infection
345046|NCT01668992|Parenting|parenting
345047|NCT01668992|Discipline|discipline
345048|NCT01668992|Family interventions|family interventions
345049|NCT01668992|Thailand|thailand
345050|NCT01668992|Migration|migration
345051|NCT01668953|Lateral Epicondylitis|lateral epicondylitis
345052|NCT01668953|Tennis Elbow|tennis elbow
345053|NCT01668953|Platelet Rich Plasma|platelet rich plasma
345054|NCT01668953|Whole Blood|whole blood
345055|NCT01668953|Tendon Fenestration|tendon fenestration
345056|NCT01668940|Morning Sickness|morning sickness
345057|NCT01668940|Lillipops Iced Soothies|lillipops iced soothies
345058|NCT01668940|Pregnancy|pregnancy
345059|NCT01668940|Obstetrics|obstetrics
345060|NCT01668914|Breast Cancer|breast cancer
345061|NCT01668914|Clinically Axillary Node -Positive|clinically axillary node -positive
345062|NCT01668914|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
345063|NCT01668914|Internal Mammary|internal mammary
345064|NCT01668901|warfarin|warfarin
345065|NCT01668901|aspirin|aspirin
345066|NCT01668875|head down postural drainage|head down postural drainage
345067|NCT01668849|Plant exosomes|plant exosomes
345068|NCT01668849|Grape exosomes|grape exosomes
345069|NCT01668849|Grape extract|grape extract
345070|NCT01668849|Oral mucositis|oral mucositis
345071|NCT01668849|Head and Neck Cancer|head and neck cancer
345072|NCT01668849|Immune response|immune response
345073|NCT01668836|sirtuin|sirtuin
345074|NCT01668836|atherosclerosis|atherosclerosis
345075|NCT01668836|longevity|longevity
345076|NCT01668836|calorie restriction|calorie restriction
345077|NCT01668836|resveratrol|resveratrol
345078|NCT01668836|vascular reactivity|vascular reactivity
345079|NCT01668810|prescription|prescription
345080|NCT01668810|schizophrenia|schizophrenia
345081|NCT01668810|depression|depression
345082|NCT01668810|bipolar disorder|bipolar disorder
345083|NCT01668771|Self-Affirmation|self-affirmation
345084|NCT01668771|Affect|affect
345085|NCT01668771|Alcohol|alcohol
345086|NCT01668758|Near Infrared Spectroscopy|near infrared spectroscopy
345087|NCT01668758|Traumatic Brain Injury|traumatic brain injury
345088|NCT01668745|Child mortality|child mortality
345089|NCT01668745|Measles vaccine|measles vaccine
345090|NCT01668745|Non-specific effects|non-specific effects
345091|NCT01668693|Endometrial receptivity|endometrial receptivity
345092|NCT01668693|recurrent implantation failure|recurrent implantation failure
345093|NCT01668693|predictor tool|predictor tool
345094|NCT01668693|ERA|era
345095|NCT01668693|customized microarray|customized microarray
345096|NCT01668693|personalized embryo transfer|personalized embryo transfer
345097|NCT01668680|Metronomic Chemotherapy|metronomic chemotherapy
345098|NCT01668680|Anti-Angiogenic|anti-angiogenic
345099|NCT01668680|Maintenance Treatment|maintenance treatment
345100|NCT01668680|Colorectal Cancer Metastatic|colorectal cancer metastatic
345101|NCT01668667|gabapentin enacarbil|gabapentin enacarbil
345102|NCT01668667|Horizant|horizant
345103|NCT01668654|Epilepsy|epilepsy
345104|NCT01668654|Partial Onset epilepsy|partial onset epilepsy
345105|NCT01668654|Lennox-Gastaut Syndrome|lennox-gastaut syndrome
345106|NCT01668654|Open-label extension study|open-label extension study
345107|NCT01668641|Methotrexate insufficient responders|methotrexate insufficient responders
345108|NCT01668628|quality of life|quality of life
345109|NCT01668628|depression|depression
345110|NCT01668628|BCM (body composition minitor)|bcm (body composition minitor)
345111|NCT01668628|hydrational status|hydrational status
345112|NCT01668615|idiopathicthrombocytopenic purpura|idiopathicthrombocytopenic purpura
345113|NCT01668615|all-trans retinoic acid|all-trans retinoic acid
345114|NCT01668615|regulory T cells|regulory t cells
345115|NCT01668576|mesenchymal stem cells|mesenchymal stem cells
345116|NCT01668576|Lung transplantation|lung transplantation
345117|NCT01668563|Aneurysm|aneurysm
345118|NCT01668563|Intracranial Aneurysm|intracranial aneurysm
345119|NCT01668563|Vascular Diseases|vascular diseases
345120|NCT01668563|Cardiovascular Diseases|cardiovascular diseases
345121|NCT01668563|Intracranial Arterial Diseases|intracranial arterial diseases
345122|NCT01668563|Cerebrovascular Disorders|cerebrovascular disorders
345123|NCT01668563|Brain Diseases|brain diseases
345124|NCT01668563|Central Nervous System Diseases|central nervous system diseases
345125|NCT01668563|Nervous System Diseases|nervous system diseases
345126|NCT01668550|Phase I|phase i
345127|NCT01668550|Src/Abl inhibitor|src/abl inhibitor
345128|NCT01668550|Solid Tumours|solid tumours
345129|NCT01668550|Cancer|cancer
345130|NCT01668511|Immunogenicity|immunogenicity
345131|NCT01668511|Safety|safety
345132|NCT01668511|Tolerability|tolerability
345133|NCT01668511|Osteoarthritis|osteoarthritis
345134|NCT01668511|Pharmacokinetics|pharmacokinetics
345135|NCT01668498|Can preemptive treatment of panitumumab mediated skin|can preemptive treatment of panitumumab mediated skin
345136|NCT01668498|toxicity with oral doxycycline be replaced by local treatment with erythromycin?|toxicity with oral doxycycline be replaced by local treatment with erythromycin?
345137|NCT01668498|Panitumumab|panitumumab
345138|NCT01668485|Type 1 diabetes mellitus|type 1 diabetes mellitus
345139|NCT01668485|hypoglycemia counterregulation,|hypoglycemia counterregulation,
345140|NCT01668485|pancreatic islet transplantation|pancreatic islet transplantation
345141|NCT01668472|Pregnant|pregnant
345142|NCT01668472|leaking fluid|leaking fluid
345143|NCT01668459|Transitional cell carcinoma|transitional cell carcinoma
345144|NCT01668459|Bladder cancer|bladder cancer
345145|NCT01668459|Cancer|cancer
345146|NCT01668459|Oncology|oncology
345147|NCT01668459|Cabazitaxel|cabazitaxel
345148|NCT01668446|Sildenafil|sildenafil
345149|NCT01668446|Endometrial thickness|endometrial thickness
345150|NCT01668446|Frozen embryo transfer|frozen embryo transfer
345151|NCT01668446|ultrasonographic endometrial thickness|ultrasonographic endometrial thickness
345152|NCT01668446|endometrial pattern|endometrial pattern
345153|NCT01668446|Implantation rate|implantation rate
345154|NCT01668446|chemical pregnancy rate|chemical pregnancy rate
345155|NCT01668433|G6PD|g6pd
345156|NCT01668433|Primaquine|primaquine
345157|NCT01668433|Methylene blue|methylene blue
345158|NCT01668420|thermal stimulation|thermal stimulation
345159|NCT01668420|lower extremity|lower extremity
345160|NCT01668420|temperature|temperature
345161|NCT01668420|efficacy|efficacy
345162|NCT01668407|Parkinson's disease|parkinson's disease
345164|NCT01668407|Robot|robot
345165|NCT01668407|Gait rehabilitation|gait rehabilitation
345166|NCT01668381|hepatocellular carcinoma|hepatocellular carcinoma
345167|NCT01668381|Catheter Ablation|catheter ablation
345168|NCT01668381|T-Lymphocytes, Regulatory|t-lymphocytes, regulatory
345169|NCT01668381|IL-10|il-10
345170|NCT01668381|TGF-β|tgf-β
345171|NCT01668381|IFN-γ|ifn-γ
345172|NCT01668368|ARDS|ards
345173|NCT01668368|Esophageal pressure|esophageal pressure
345174|NCT01668368|pleural pressure|pleural pressure
345175|NCT01668368|pulmonary compliance|pulmonary compliance
345176|NCT01668355|Delivery of Healthcare|delivery of healthcare
345177|NCT01668355|Health Services Research|health services research
345178|NCT01668355|Integrated Healthcare Systems|integrated healthcare systems
345179|NCT01668355|Healthcare Quality, Access, and Evaluation|healthcare quality, access, and evaluation
345180|NCT01668355|Primary Care|primary care
345181|NCT01668355|Quality Improvement|quality improvement
345182|NCT01668355|Psychotic Disorders|psychotic disorders
345183|NCT01668355|Medical Home|medical home
345184|NCT01668355|Psychiatry|psychiatry
345185|NCT01668355|Patient Care Management|patient care management
345186|NCT01668355|Nursing Care Management|nursing care management
345187|NCT01668355|Treatment Costs|treatment costs
345188|NCT01668329|Septic shock|septic shock
345189|NCT01668329|Inflammatory process|inflammatory process
345190|NCT01668329|Cytokines|cytokines
345191|NCT01668329|Hormonal response|hormonal response
345192|NCT01668329|Oxydative stress|oxydative stress
345193|NCT01668316|Overweight|overweight
345194|NCT01668316|Obese|obese
345195|NCT01668316|Postpartum|postpartum
345196|NCT01668316|Weight loss|weight loss
345197|NCT01668316|Inflammation|inflammation
345198|NCT01668316|Obesity|obesity
345199|NCT01668316|Cardiovascular|cardiovascular
345200|NCT01668303|juvenile drug court|juvenile drug court
345201|NCT01668303|adolescents|adolescents
345202|NCT01668303|substance abuse|substance abuse
345203|NCT01668303|delinquency|delinquency
345204|NCT01668303|family therapy|family therapy
345205|NCT01668303|multidimensional family therapy|multidimensional family therapy
345206|NCT01668290|Coronary Artery Disease|coronary artery disease
345207|NCT01668290|Stress Echocardiography|stress echocardiography
345208|NCT01668290|Single Photon Emission Computed Tomography|single photon emission computed tomography
345209|NCT01668290|Cardiac Computed Tomographic Angiography|cardiac computed tomographic angiography
345210|NCT01668290|outcomes|outcomes
345211|NCT01668277|Pulmonary Hypertensive Crisis|pulmonary hypertensive crisis
345212|NCT01668277|Pediatrics|pediatrics
345213|NCT01668277|Hypertonic Saline|hypertonic saline
345214|NCT01668264|Pediatrics|pediatrics
345215|NCT01668264|Congenital Heart Disease|congenital heart disease
345216|NCT01668264|Diastolic Function|diastolic function
345217|NCT01668264|Echocardiograph|echocardiograph
345218|NCT01668264|MRI|mri
345219|NCT01668251|Turner syndrome|turner syndrome
345220|NCT01668251|Diagnosis, prenatal|diagnosis, prenatal
345221|NCT01668238|Thyroid tumor|thyroid tumor
345222|NCT01668238|Breast tumor|breast tumor
345223|NCT01668238|Fourier Transform Infrared Spectrometry|fourier transform infrared spectrometry
345224|NCT01668238|Tumor Diagnosis|tumor diagnosis
345225|NCT01668186|Peroxisome biogenesis disorders|peroxisome biogenesis disorders
345226|NCT01668186|PBD|pbd
345227|NCT01668186|Zellweger spectrum|zellweger spectrum
345228|NCT01668186|Rhizomelic chondrodysplasia punctata|rhizomelic chondrodysplasia punctata
345229|NCT01668186|RCDP|rcdp
345230|NCT01668173|HSP90 Inhibitor|hsp90 inhibitor
345231|NCT01668173|AUY922|auy922
345232|NCT01668173|12-076|12-076
345233|NCT01668160|clinical outcomes|clinical outcomes
345234|NCT01668160|radiographic outcomes|radiographic outcomes
345235|NCT01668160|total hip arthroplasty|total hip arthroplasty
345236|NCT01668160|survivorship|survivorship
345237|NCT01668147|PET Imaging|pet imaging
345238|NCT01668147|Efavirenz|efavirenz
345239|NCT01668147|Ritonavior|ritonavior
345240|NCT01668147|[11C] desmethyl-loperamide|[11c] desmethyl-loperamide
345241|NCT01668147|Healthy volunteers|healthy volunteers
345242|NCT01668108|carcinoma|carcinoma
345243|NCT01668108|breast cancer|breast cancer
345244|NCT01668108|non-small cell lung cancer|non-small cell lung cancer
345245|NCT01668108|ovarial cancer|ovarial cancer
345246|NCT01668108|ambulant chemotherapy|ambulant chemotherapy
345247|NCT01668108|treatment cycles|treatment cycles
345248|NCT01668108|Paclitaxel|paclitaxel
345249|NCT01668108|Paclitaxel onkovis|paclitaxel onkovis
345250|NCT01668108|Quantity of Paclitaxel|quantity of paclitaxel
345251|NCT01668108|Packaging Sizes|packaging sizes
345252|NCT01668082|Patients with newly identified brain mass|patients with newly identified brain mass
345253|NCT01668069|nausea|nausea
345254|NCT01668069|vomiting|vomiting
345255|NCT01668069|pregnancy|pregnancy
345256|NCT01668069|ondansetron|ondansetron
345257|NCT01668069|doxylamine|doxylamine
345258|NCT01668069|vitamin B6|vitamin b6
345259|NCT01668069|pyridoxine|pyridoxine
345260|NCT01668056|in vitro fertilization|in vitro fertilization
345261|NCT01668056|ovarian stimulation|ovarian stimulation
345262|NCT01668056|follicular waves|follicular waves
345263|NCT01668056|luteal phase|luteal phase
345264|NCT01668043|HIV-1|hiv-1
345265|NCT01668043|CD4|cd4
345266|NCT01668043|antibody|antibody
345267|NCT01668043|immunotherapy|immunotherapy
345268|NCT01668030|Facial|facial
345269|NCT01668030|Partial thickness|partial thickness
345270|NCT01668017|Advanced solid tumors|advanced solid tumors
345271|NCT01668017|Hepatocellular carcinoma|hepatocellular carcinoma
345272|NCT01668017|cancer, liver|cancer, liver
345273|NCT01667991|Colonization|colonization
345274|NCT01667991|infection|infection
345275|NCT01667991|multidrug-resistant bacteria|multidrug-resistant bacteria
345276|NCT01667991|guideline|guideline
345277|NCT01667978|contraception|contraception
345278|NCT01667978|mini pill|mini pill
345279|NCT01667978|norethindrone|norethindrone
345280|NCT01667978|atazanavir|atazanavir
345281|NCT01667978|ritonavir|ritonavir
345282|NCT01667978|norvir|norvir
345283|NCT01667978|reyataz|reyataz
345284|NCT01667978|pregnancy prevent|pregnancy prevent
345285|NCT01667978|birth control|birth control
345287|NCT01667978|AIDS|aids
345288|NCT01667978|antiviral|antiviral
345289|NCT01667978|antiretroviral|antiretroviral
345290|NCT01667965|palliative radiation|palliative radiation
345291|NCT01667965|12-172|12-172
345292|NCT01667952|Family History Questionnaire (FHQ)|family history questionnaire (fhq)
345293|NCT01667952|Blood sample|blood sample
345294|NCT01667952|Salvia sample|salvia sample
345295|NCT01667952|12-145|12-145
345296|NCT01667939|adequacy|adequacy
345297|NCT01667939|diet|diet
345298|NCT01667939|pregnancy|pregnancy
345299|NCT01667913|Hip Fracture|hip fracture
345300|NCT01667913|6-minutes walking test|6-minutes walking test
345301|NCT01667913|Reliability|reliability
345302|NCT01667887|Far Cortical Locking|far cortical locking
345303|NCT01667887|Distal Femur Fracture|distal femur fracture
345304|NCT01667887|Locking Plate|locking plate
345305|NCT01667887|MotionLoc|motionloc
345306|NCT01667887|Fracture Fixation|fracture fixation
345307|NCT01667874|Randomized controlled trial|randomized controlled trial
345308|NCT01667874|early joint infection|early joint infection
345309|NCT01667874|gentamicin impregnated sponges|gentamicin impregnated sponges
345310|NCT01667861|Glaucoma|glaucoma
345311|NCT01667861|Wind instruments|wind instruments
345312|NCT01667848|pain|pain
345313|NCT01667835|yoga|yoga
345314|NCT01667835|postmenopausal, sedentary South Asian women|postmenopausal, sedentary south asian women
345315|NCT01667796|Multiple sclerosis|multiple sclerosis
345316|NCT01667796|Healthy controls|healthy controls
345317|NCT01667796|Pharmacokinetics|pharmacokinetics
345318|NCT01667796|Vitamin D|vitamin d
345319|NCT01667783|Obesity|obesity
345320|NCT01667783|Diabetes|diabetes
345321|NCT01667757|coronary atherosclerosis|coronary atherosclerosis
345322|NCT01667757|drug eluting stent|drug eluting stent
345323|NCT01667757|intravascular ultrasound|intravascular ultrasound
345324|NCT01667757|fractional flow reserve|fractional flow reserve
345325|NCT01667744|Angina|angina
345326|NCT01667744|Acute Coronary Syndrome|acute coronary syndrome
345327|NCT01667744|Emotional Distress|emotional distress
345328|NCT01667744|Citalopram|citalopram
345329|NCT01667744|Health Care Utilization|health care utilization
345330|NCT01667731|Hepatitis C|hepatitis c
345331|NCT01667731|Chronic|chronic
345332|NCT01667731|HCV|hcv
345333|NCT01667731|HIV|hiv
345334|NCT01667731|Human Immunodeficiency Virus|human immunodeficiency virus
345335|NCT01667731|Co-Infected|co-infected
345336|NCT01667718|eradication|eradication
345337|NCT01667718|helicobacter pylori|helicobacter pylori
345338|NCT01667718|bismuth|bismuth
345339|NCT01667705|Stress|stress
345340|NCT01667705|Anxiety|anxiety
345341|NCT01667705|Skyceiling|skyceiling
345342|NCT01667705|Nature|nature
345343|NCT01667692|H-pylori|h-pylori
345344|NCT01667692|eradication|eradication
345345|NCT01667692|azithromycin|azithromycin
345346|NCT01667692|clarithromycin|clarithromycin
345347|NCT01667679|Migraine|migraine
345348|NCT01667679|Headaches|headaches
345349|NCT01667679|Sumatriptan|sumatriptan
345350|NCT01667666|trauma|trauma
345351|NCT01667666|acute lung injury|acute lung injury
345352|NCT01667666|adult respiratory distress syndrome|adult respiratory distress syndrome
345353|NCT01667640|Brain metastases|brain metastases
345354|NCT01667640|radiation|radiation
345355|NCT01667640|sector|sector
345356|NCT01667640|singular|singular
345357|NCT01667640|solitary|solitary
345358|NCT01667640|neurocognition|neurocognition
345359|NCT01667627|IBS|ibs
345360|NCT01667627|Probiotic|probiotic
345361|NCT01667627|hs-CRP|hs-crp
345362|NCT01667627|Cholinergic status|cholinergic status
345363|NCT01667627|Micro-inflammation|micro-inflammation
345364|NCT01667601|mindfulness-based program|mindfulness-based program
345365|NCT01667601|Psychoeducation|psychoeducation
345366|NCT01667601|schizophrenia|schizophrenia
345367|NCT01667601|Chinese|chinese
345368|NCT01667601|outpatients|outpatients
345369|NCT01667588|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
345370|NCT01667588|Pediatrics|pediatrics
345371|NCT01667588|Sleep Disorders|sleep disorders
345372|NCT01667549|Breastfeeding|breastfeeding
345373|NCT01667549|Flavor learning|flavor learning
345374|NCT01667549|Mother|mother
345375|NCT01667549|Moms|moms
345376|NCT01667549|Infants|infants
345377|NCT01667549|Babies|babies
345378|NCT01667549|Baby|baby
345379|NCT01667549|Food Habits|food habits
345380|NCT01667549|Fruits|fruits
345381|NCT01667549|Vegetables|vegetables
345382|NCT01667536|PROSTATE CANCER|prostate cancer
345383|NCT01667536|HIGH-RISK|high-risk
345384|NCT01667536|PROSTATECTOMY SURGERY|prostatectomy surgery
345385|NCT01667536|NEWLY DIAGNOSED|newly diagnosed
345386|NCT01667523|capsaicin|capsaicin
345387|NCT01667523|cinnamaldehyde|cinnamaldehyde
345388|NCT01667510|Prehypertension|prehypertension
345389|NCT01667510|anti oxidation|anti oxidation
345390|NCT01667510|lycopene|lycopene
345391|NCT01667497|Cognitive fatigue|cognitive fatigue
345392|NCT01667497|multiple sclerosis|multiple sclerosis
345393|NCT01667484|Cognitive Impairment|cognitive impairment
345394|NCT01667484|Multiple Sclerosis|multiple sclerosis
345395|NCT01667484|Processing Speed|processing speed
345396|NCT01667484|Treatment|treatment
345397|NCT01667445|total knee arthroplasty|total knee arthroplasty
345398|NCT01667445|epimorph|epimorph
345399|NCT01667445|analgesia|analgesia
345400|NCT01667406|kisspeptin|kisspeptin
345401|NCT01667406|infertility|infertility
345402|NCT01667406|in vitro fertilisation|in vitro fertilisation
345403|NCT01667354|Parental Childhood Vaccine Hesitancy|parental childhood vaccine hesitancy
345404|NCT01667341|HSV|hsv
345405|NCT01667341|Herpes|herpes
345406|NCT01667341|genital infection|genital infection
345407|NCT01667341|vaccine|vaccine
345408|NCT01667328|Anxiety|anxiety
345409|NCT01667328|Presurgical anxiety|presurgical anxiety
345410|NCT01667328|Breast Cancer|breast cancer
345411|NCT01667302|NK/T-cell lymphoma|nk/t-cell lymphoma
345412|NCT01667302|Radiotherapy|radiotherapy
345413|NCT01667302|Adjuvant chemotherapy|adjuvant chemotherapy
345414|NCT01667289|NK/T-cell lymphoma|nk/t-cell lymphoma
345415|NCT01667289|Methotrexate|methotrexate
345416|NCT01667289|Radiotherapy|radiotherapy
345417|NCT01667289|Concurrent chemoradiation|concurrent chemoradiation
345418|NCT01667276|AE adverse event|ae adverse event
345419|NCT01667276|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
345420|NCT01667276|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
345421|NCT01667276|ART antiretroviral therapy|art antiretroviral therapy
345422|NCT01667276|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
345423|NCT01667276|DCF data collection forms|dcf data collection forms
345424|NCT01667276|DMC Data Monitoring Committee|dmc data monitoring committee
345425|NCT01667276|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
345426|NCT01667276|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
345427|NCT01667276|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
345428|NCT01667276|ICH International Conference of Harmonisation|ich international conference of harmonisation
345429|NCT01667276|IND Investigational New Drug Application|ind investigational new drug application
345430|NCT01667276|IRB Institutional Review Board|irb institutional review board
345431|NCT01667276|IU international units|iu international units
345432|NCT01667276|mg milligram(s)|mg milligram(s)
345433|NCT01667276|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
345434|NCT01667276|PCR polymerase chain reaction|pcr polymerase chain reaction
345435|NCT01667276|SAE serious adverse event|sae serious adverse event
345436|NCT01667276|µg microgram|µg microgram
345627|NCT01666405|Bowel Incontinence|bowel incontinence
345437|NCT01667276|ULN upper limit of the normal range|uln upper limit of the normal range
345438|NCT01667276|WB Western Blot|wb western blot
345439|NCT01667263|All-trans retinoic acid|all-trans retinoic acid
345440|NCT01667263|primary immune thrombocytopenia|primary immune thrombocytopenia
345441|NCT01667263|corticosteroid-resistant|corticosteroid-resistant
345442|NCT01667263|refractory|refractory
345443|NCT01667263|danazol|danazol
345444|NCT01667250|vagus nerve stimulation|vagus nerve stimulation
345445|NCT01667250|vagal nerve stimulation|vagal nerve stimulation
345446|NCT01667250|nVNS|nvns
345447|NCT01667250|VNS|vns
345448|NCT01667250|chronic migraine|chronic migraine
345449|NCT01667250|migraine|migraine
345450|NCT01667250|non invasive|non invasive
345451|NCT01667250|gammacore|gammacore
345452|NCT01667237|Pulmonary rehabilitation program|pulmonary rehabilitation program
345453|NCT01667237|Lung cancer|lung cancer
345454|NCT01667237|Lung resection surgery|lung resection surgery
345455|NCT01667237|Home-based|home-based
345456|NCT01667224|Actiponin|actiponin
345457|NCT01667224|Obesity|obesity
345458|NCT01667224|Abdominal fat|abdominal fat
345459|NCT01667211|Advanced uterine cervical cancer|advanced uterine cervical cancer
345460|NCT01667185|pediatric|pediatric
345461|NCT01667185|diabetes mellitus|diabetes mellitus
345462|NCT01667159|Depression|depression
345463|NCT01667159|Alcohol Use|alcohol use
345464|NCT01667159|Outpatient Therapy|outpatient therapy
345465|NCT01667133|Leukemia|leukemia
345466|NCT01667133|Leukemia, Myeloid|leukemia, myeloid
345467|NCT01667133|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
345468|NCT01667133|Neoplasms by Histologic Type|neoplasms by histologic type
345469|NCT01667133|Neoplasms|neoplasms
345470|NCT01667133|Lymphoproliferative Disorders|lymphoproliferative disorders
345471|NCT01667133|Lymphatic Diseases|lymphatic diseases
345472|NCT01667133|Immunoproliferative Disorders|immunoproliferative disorders
345473|NCT01667133|Immune System Diseases|immune system diseases
345474|NCT01667133|Myeloproliferative Disorders|myeloproliferative disorders
345475|NCT01667133|Bone Marrow Diseases|bone marrow diseases
345476|NCT01667133|Hematologic Diseases|hematologic diseases
345477|NCT01667120|Ketorolac|ketorolac
345478|NCT01667120|postoperative pain|postoperative pain
345479|NCT01667120|bleeding events|bleeding events
345480|NCT01667094|Pulmonary exacerbation|pulmonary exacerbation
345481|NCT01667094|Continuous infusion|continuous infusion
345482|NCT01667094|Antipseudomonal beta-lactams|antipseudomonal beta-lactams
345483|NCT01667068|Cardiac Diseases|cardiac diseases
345484|NCT01667068|HIV-Infection|hiv-infection
345485|NCT01667068|AIDS|aids
345486|NCT01667068|Antiretroviral Therapy|antiretroviral therapy
345487|NCT01667068|Cardiovascular Medication|cardiovascular medication
345488|NCT01667068|Risk Factors|risk factors
345489|NCT01667068|coronary heart disease|coronary heart disease
345490|NCT01667068|heart failure|heart failure
345491|NCT01667068|metabolic syndrome|metabolic syndrome
345492|NCT01667055|drug allergy|drug allergy
345493|NCT01667055|drug hypersensitivity|drug hypersensitivity
345494|NCT01667055|beta-lactam allergy|beta-lactam allergy
345495|NCT01667055|penicillin allergy|penicillin allergy
345496|NCT01667055|adverse drug reaction|adverse drug reaction
345497|NCT01667042|Scleroderma Lung|scleroderma lung
345498|NCT01667042|Gastroesophageal Reflux|gastroesophageal reflux
345499|NCT01667042|Microaspiration|microaspiration
345500|NCT01667042|Cough|cough
345501|NCT01667016|International|international
345502|NCT01667016|Multicenter|multicenter
345503|NCT01667016|Observational registry|observational registry
345504|NCT01667016|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
345505|NCT01667016|Stenting|stenting
345506|NCT01667016|Treatment of Coronary Artery Disease|treatment of coronary artery disease
345507|NCT01667016|Coronary revascularization|coronary revascularization
345508|NCT01667016|Percutaneous Coronary Intervention|percutaneous coronary intervention
345509|NCT01667016|STEMI|stemi
345510|NCT01667016|NSTEMI|nstemi
345511|NCT01667016|Ischemia|ischemia
345512|NCT01667016|Angina|angina
345513|NCT01667016|Subgroups|subgroups
345514|NCT01667016|Acute Myocardial Infarction|acute myocardial infarction
345515|NCT01667016|Diabetes|diabetes
345516|NCT01667016|Small Vessels|small vessels
345517|NCT01667016|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
345518|NCT01667003|International|international
345519|NCT01667003|Multicenter|multicenter
345520|NCT01667003|Observational registry|observational registry
345521|NCT01667003|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
345522|NCT01667003|Stenting|stenting
345523|NCT01667003|Treatment of Coronary Artery Disease|treatment of coronary artery disease
345524|NCT01667003|Coronary revascularization|coronary revascularization
345525|NCT01667003|Percutaneous Coronary Intervention|percutaneous coronary intervention
345526|NCT01667003|STEMI|stemi
345527|NCT01667003|NSTEMI|nstemi
345528|NCT01667003|Ischemia|ischemia
345529|NCT01667003|Angina|angina
345530|NCT01667003|Subgroups|subgroups
345531|NCT01667003|Acute Myocardial Infarction|acute myocardial infarction
345532|NCT01667003|Diabetes|diabetes
345533|NCT01667003|Small Vessels|small vessels
345534|NCT01666990|Tripterygium wilfordii Hook F (TwHF)|tripterygium wilfordii hook f (twhf)
345536|NCT01666990|CD4|cd4
345537|NCT01666990|immune over-activation|immune over-activation
345538|NCT01666964|Traumatic brain injury|traumatic brain injury
345539|NCT01666964|hypopituitarism|hypopituitarism
345540|NCT01666938|Diabetes Mellitus|diabetes mellitus
345541|NCT01666938|Telephone|telephone
345542|NCT01666938|Physical activity|physical activity
345543|NCT01666912|adolescence|adolescence
345544|NCT01666912|contraception|contraception
345545|NCT01666912|postpartum|postpartum
345546|NCT01666912|rapid repeat pregnancy|rapid repeat pregnancy
345547|NCT01666873|osteoarthritis|osteoarthritis
345548|NCT01666860|anterior lumbar interbody fusion|anterior lumbar interbody fusion
345549|NCT01666847|Umbilical Cord Milking|umbilical cord milking
345550|NCT01666847|Extremely Low Birth Weight Infant (ELBW)|extremely low birth weight infant (elbw)
345551|NCT01666834|mechanical ventilation, ARDS, Ventilator strategy, outcome|mechanical ventilation, ards, ventilator strategy, outcome
345552|NCT01666821|macular degeneration; choroidal neovascularization|macular degeneration; choroidal neovascularization
345553|NCT01666782|Influenza vaccine|influenza vaccine
345554|NCT01666782|Oncology|oncology
345555|NCT01666782|Chemotherapy|chemotherapy
345556|NCT01666769|Extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
345557|NCT01666769|ECMO|ecmo
345558|NCT01666769|Extracorporeal life support|extracorporeal life support
345559|NCT01666769|Micafungin|micafungin
345560|NCT01666769|Mycamine|mycamine
345561|NCT01666769|Pharmacokinetics|pharmacokinetics
345562|NCT01666743|Community-Acquired Pneumonia|community-acquired pneumonia
345563|NCT01666743|Lung|lung
345564|NCT01666743|Adult|adult
345565|NCT01666743|Infections|infections
345566|NCT01666691|Obese|obese
345567|NCT01666691|Obesity|obesity
345568|NCT01666691|Overweight|overweight
345569|NCT01666691|Weight loss|weight loss
345570|NCT01666691|Weight reduction|weight reduction
345571|NCT01666691|Beloranib|beloranib
345572|NCT01666678|Bioequivalence|bioequivalence
345573|NCT01666665|Burn|burn
345574|NCT01666652|Dengue|dengue
345575|NCT01666652|Dengue fever|dengue fever
345576|NCT01666652|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
345577|NCT01666652|Flavivirus|flavivirus
345578|NCT01666626|crohn's disease|crohn's disease
345579|NCT01666626|ultrasound|ultrasound
345580|NCT01666626|intestinal fibrosis|intestinal fibrosis
345581|NCT01666626|shear wave imaging|shear wave imaging
345582|NCT01666626|acoustic radiation force impulse|acoustic radiation force impulse
345583|NCT01666613|Phase I, Healthy volunteers, pharmacokinetics|phase i, healthy volunteers, pharmacokinetics
345584|NCT01666613|Bioavailability|bioavailability
345585|NCT01666613|AUC|auc
345586|NCT01666548|haemolytic uraemic syndrome|haemolytic uraemic syndrome
345587|NCT01666548|complications of HUS|complications of hus
345588|NCT01666548|renal replacement treatment|renal replacement treatment
345589|NCT01666548|renal function outcome|renal function outcome
345590|NCT01666548|neuropsychological sequelae|neuropsychological sequelae
345591|NCT01666548|psychological adjustment|psychological adjustment
345592|NCT01666548|quality of life|quality of life
345593|NCT01666535|Influenza vaccine|influenza vaccine
345594|NCT01666535|Immune response|immune response
345595|NCT01666535|Remicade (infliximab)|remicade (infliximab)
345596|NCT01666535|Inflammatory bowel disease|inflammatory bowel disease
345597|NCT01666522|sarcopenia|sarcopenia
345598|NCT01666522|osteopenia/osteoporosis|osteopenia/osteoporosis
345599|NCT01666522|older adults|older adults
345600|NCT01666522|vitamin D supplementation|vitamin d supplementation
345601|NCT01666522|physical activity|physical activity
345602|NCT01666496|Adolescent|adolescent
345603|NCT01666496|risk|risk
345604|NCT01666496|HIV|hiv
345605|NCT01666496|video games|video games
345606|NCT01666483|hysterectomy|hysterectomy
345607|NCT01666483|single-port|single-port
345608|NCT01666483|micro-laparoscopy|micro-laparoscopy
345609|NCT01666470|Quality of life|quality of life
345610|NCT01666457|Supporting Oral Feeding in Fragile Infants (SOFFI)|supporting oral feeding in fragile infants (soffi)
345611|NCT01666457|Infant Oral Feeding|infant oral feeding
345612|NCT01666457|Infant Growth|infant growth
345613|NCT01666457|Preterm infant oral feeding|preterm infant oral feeding
345614|NCT01666457|Preterm infant growth|preterm infant growth
345615|NCT01666457|Neonatal Intensive Care Unit (NICU)|neonatal intensive care unit (nicu)
345616|NCT01666444|recurrent epithelial ovarian cancer|recurrent epithelial ovarian cancer
345617|NCT01666444|recurrent fallopian tube cancer|recurrent fallopian tube cancer
345618|NCT01666444|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
345619|NCT01666444|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
345620|NCT01666444|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
345621|NCT01666444|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
345622|NCT01666444|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
345623|NCT01666444|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
345624|NCT01666444|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
345625|NCT01666444|Brenner tumor|brenner tumor
345626|NCT01666405|Fecal Incontinence|fecal incontinence
345832|NCT01665482|C-peptide|c-peptide
345628|NCT01666392|Omega-3 fatty acid|omega-3 fatty acid
345629|NCT01666392|Fish oil|fish oil
345630|NCT01666392|Muscle mass|muscle mass
345631|NCT01666392|Muscle strength|muscle strength
345632|NCT01666392|Older adults|older adults
345633|NCT01666392|Circulating inflammatory cytokines|circulating inflammatory cytokines
345634|NCT01666392|Skeletal muscle mass|skeletal muscle mass
345635|NCT01666392|Upper body strength|upper body strength
345636|NCT01666392|Lower body strength|lower body strength
345637|NCT01666379|Hallux valgus|hallux valgus
345638|NCT01666379|Forefoot|forefoot
345639|NCT01666379|transdermal fentanyl|transdermal fentanyl
345640|NCT01666340|Exercise|exercise
345641|NCT01666340|Elderly|elderly
345642|NCT01666340|Mortality|mortality
345643|NCT01666340|Morbidity|morbidity
345644|NCT01666340|Prognosis|prognosis
345645|NCT01666340|Longevity|longevity
345646|NCT01666327|Crohn's Disease|crohn's disease
345647|NCT01666327|Ulcerative Colitis|ulcerative colitis
345648|NCT01666314|castrate resistant prostate cancer,|castrate resistant prostate cancer,
345649|NCT01666314|CRPC,|crpc,
345650|NCT01666314|orteronel,|orteronel,
345651|NCT01666314|TAK-700|tak-700
345652|NCT01666301|Erythropoietin stimulating agents|erythropoietin stimulating agents
345653|NCT01666301|Hemoglobin|hemoglobin
345654|NCT01666301|Reticulocytes|reticulocytes
345655|NCT01666301|Variability|variability
345656|NCT01666262|FLU|flu
345657|NCT01666262|H1N1|h1n1
345658|NCT01666262|GPO|gpo
345659|NCT01666262|PLAIV|plaiv
345660|NCT01666249|FMH; anti-Rh; efficacy|fmh; anti-rh; efficacy
345661|NCT01666236|Age-Related Macular Degeneration|age-related macular degeneration
345662|NCT01666236|Pigment Epithelial Detachment|pigment epithelial detachment
345663|NCT01666236|Polypoidal Choroidal Vasculopathy|polypoidal choroidal vasculopathy
345664|NCT01666223|Type 2 diabetes|type 2 diabetes
345665|NCT01666223|GLP-1|glp-1
345666|NCT01666223|Bile acid|bile acid
345667|NCT01666223|TGR-5|tgr-5
345668|NCT01666197|Acute Joint Pain|acute joint pain
345669|NCT01666184|Biomarkers study|biomarkers study
345670|NCT01666171|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
345671|NCT01666171|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
345672|NCT01666171|stage IB breast cancer|stage ib breast cancer
345673|NCT01666171|stage II breast cancer|stage ii breast cancer
345674|NCT01666171|stage IIIA breast cancer|stage iiia breast cancer
345675|NCT01666171|stage IIIC breast cancer|stage iiic breast cancer
345676|NCT01666145|Hepatocellular Cancer|hepatocellular cancer
345677|NCT01666145|Hepatocellular Carcinoma|hepatocellular carcinoma
345678|NCT01666145|Hepatoma|hepatoma
345679|NCT01666145|Liver Cancer, Adult|liver cancer, adult
345680|NCT01666145|Liver Cell Carcinoma, Adult|liver cell carcinoma, adult
345681|NCT01666132|LVEF < 40%|lvef < 40%
345682|NCT01666119|Opioid dependence|opioid dependence
345683|NCT01666119|Suboxone|suboxone
345684|NCT01666119|addiction|addiction
345685|NCT01666119|BEMA Buprenorphine NX|bema buprenorphine nx
345686|NCT01666119|oral transmucosal|oral transmucosal
345687|NCT01666093|peripheral artery disease|peripheral artery disease
345688|NCT01666093|endovascular procedure|endovascular procedure
345689|NCT01666093|non-healing ulcer|non-healing ulcer
345690|NCT01666080|second stem cell transplant|second stem cell transplant
345691|NCT01666080|donor hematopoietic engraftment|donor hematopoietic engraftment
345692|NCT01666080|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
345693|NCT01666080|inherited metabolic disorder|inherited metabolic disorder
345694|NCT01666067|insulin resistance|insulin resistance
345695|NCT01666054|Weaning|weaning
345696|NCT01666054|mechanical ventilation|mechanical ventilation
345697|NCT01666054|Proportional Assist Ventilation|proportional assist ventilation
345698|NCT01666041|insulin resistance|insulin resistance
345699|NCT01666028|Type 1 Diabetes|type 1 diabetes
345700|NCT01666028|Closed Loop glucose control|closed loop glucose control
345701|NCT01666028|Artificial Pancreas|artificial pancreas
345702|NCT01666028|CSII|csii
345703|NCT01666028|CGM|cgm
345704|NCT01666015|pediatric|pediatric
345705|NCT01666015|exercise|exercise
345706|NCT01666015|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
345707|NCT01666015|cancer|cancer
345708|NCT01666015|quality of life|quality of life
345709|NCT01666015|immune system|immune system
345710|NCT01666015|physical activity levels|physical activity levels
345711|NCT01665937|liver cancer|liver cancer
345712|NCT01665937|advanced liver cancer|advanced liver cancer
345713|NCT01665937|advanced hepatocellular cancer|advanced hepatocellular cancer
345714|NCT01665911|Caries|caries
345715|NCT01665898|cold biopsy forceps|cold biopsy forceps
345716|NCT01665898|cold snare biopsy|cold snare biopsy
345717|NCT01665885|hypothermia|hypothermia
345718|NCT01665885|induction of hypothermia|induction of hypothermia
345719|NCT01665885|non invasive cooling|non invasive cooling
345720|NCT01665885|external cooling|external cooling
345721|NCT01665885|surface cooling|surface cooling
345722|NCT01665885|endovascular cooling|endovascular cooling
345723|NCT01665885|cooling catheter|cooling catheter
345724|NCT01665885|stroke|stroke
345725|NCT01665885|shivering|shivering
345726|NCT01665885|neuro monitoring|neuro monitoring
345727|NCT01665885|coagulation|coagulation
345728|NCT01665872|Mothers|mothers
345729|NCT01665872|Depression|depression
345730|NCT01665872|Stress|stress
345731|NCT01665872|Trauma|trauma
345732|NCT01665872|Public Housing|public housing
345733|NCT01665859|readmission|readmission
345734|NCT01665859|recurrence|recurrence
345735|NCT01665859|umbilical|umbilical
345736|NCT01665859|epigastric|epigastric
345737|NCT01665859|hernia|hernia
345738|NCT01665859|outcome|outcome
345739|NCT01665859|morbidity|morbidity
345740|NCT01665846|HIV associated neurocognitive disorders|hiv associated neurocognitive disorders
345741|NCT01665846|MRI|mri
345742|NCT01665846|Ferumoxytol|ferumoxytol
345743|NCT01665833|Angina|angina
345744|NCT01665833|SYNTAX|syntax
345745|NCT01665833|Coronary|coronary
345746|NCT01665833|PCI|pci
345747|NCT01665833|CABG|cabg
345748|NCT01665820|chest|chest
345749|NCT01665820|pathology|pathology
345750|NCT01665807|influenza|influenza
345751|NCT01665807|vaccine|vaccine
345752|NCT01665807|administration|administration
345753|NCT01665781|Hemoglobin|hemoglobin
345754|NCT01665781|Erythropoietin|erythropoietin
345755|NCT01665781|Acute Mountain sickness|acute mountain sickness
345756|NCT01665742|Obesity|obesity
345757|NCT01665742|Chronic inflammation|chronic inflammation
345758|NCT01665742|Anti-inflammatory dietary intervention|anti-inflammatory dietary intervention
345759|NCT01665742|Genetic susceptibility|genetic susceptibility
345760|NCT01665729|etiology|etiology
345761|NCT01665729|pathogenesis|pathogenesis
345762|NCT01665729|minor ischaemic stroke|minor ischaemic stroke
345763|NCT01665729|types|types
345764|NCT01665729|intervention|intervention
345765|NCT01665703|[18F]|[18f]
345766|NCT01665703|Fluorodeoxyglucose Positron Emission Tomography-Magnetic Resonance Imaging|fluorodeoxyglucose positron emission tomography-magnetic resonance imaging
345767|NCT01665703|FDG-PET-MRI|fdg-pet-mri
345768|NCT01665703|Renal Cell Carcinoma|renal cell carcinoma
345769|NCT01665703|Pilot Study|pilot study
345770|NCT01665703|LCCC 1213|lccc 1213
345771|NCT01665703|UNC Lineberger|unc lineberger
345772|NCT01665690|patient delivered partner therapy|patient delivered partner therapy
345773|NCT01665690|expedited partner therapy|expedited partner therapy
345774|NCT01665690|partner notification|partner notification
345775|NCT01665690|gonorrhea|gonorrhea
345776|NCT01665690|chlamydia|chlamydia
345777|NCT01665677|Graft vs Host Disease|graft vs host disease
345778|NCT01665677|GVHD|gvhd
345779|NCT01665677|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
345780|NCT01665677|HSCT|hsct
345781|NCT01665677|Atorvastatin|atorvastatin
345782|NCT01665664|Indirect calorimetry|indirect calorimetry
345783|NCT01665664|hypocaloric feeding|hypocaloric feeding
345784|NCT01665638|Healthy|healthy
345785|NCT01665638|Clearance|clearance
345786|NCT01665638|Canagliflozin|canagliflozin
345787|NCT01665638|JNJ-28431754|jnj-28431754
345788|NCT01665638|Placebo|placebo
345789|NCT01665638|Somatostatin|somatostatin
345790|NCT01665638|C-peptide|c-peptide
345791|NCT01665625|Pancreatic cancer|pancreatic cancer
345792|NCT01665625|Intra-arterial infusion|intra-arterial infusion
345793|NCT01665625|Gemcitabine|gemcitabine
345794|NCT01665612|Contact lens|contact lens
345795|NCT01665612|Care solution|care solution
345796|NCT01665612|MPDS|mpds
345797|NCT01665612|comfort|comfort
345798|NCT01665586|dexmedetomidine|dexmedetomidine
345799|NCT01665586|sedation in elderly patient|sedation in elderly patient
345800|NCT01665586|spinal anesthesia|spinal anesthesia
345801|NCT01665573|Fear Conditioning|fear conditioning
345802|NCT01665573|Cannabinoids|cannabinoids
345803|NCT01665573|Fear Response|fear response
345804|NCT01665560|smoking|smoking
345805|NCT01665560|fMRI|fmri
345806|NCT01665560|odors|odors
345807|NCT01665560|taste|taste
345808|NCT01665547|clomiphene resistant|clomiphene resistant
345809|NCT01665547|pcos|pcos
345810|NCT01665547|induction of ovulation|induction of ovulation
345811|NCT01665547|l-carnitine|l-carnitine
345812|NCT01665534|hypertension|hypertension
345813|NCT01665534|inflammation|inflammation
345814|NCT01665534|salt intake|salt intake
345815|NCT01665521|Acute Coronary Syndrome|acute coronary syndrome
345816|NCT01665521|Chest pain|chest pain
345817|NCT01665521|Risk Stratification|risk stratification
345818|NCT01665521|HEART Pathway|heart pathway
345819|NCT01665521|Emergency Department|emergency department
345820|NCT01665508|angina|angina
345821|NCT01665508|cardiopulmonary testing|cardiopulmonary testing
345822|NCT01665508|metabolomics|metabolomics
345823|NCT01665508|nebivolol|nebivolol
345824|NCT01665495|pericardial effusion|pericardial effusion
345825|NCT01665495|cardiac tamponade|cardiac tamponade
345826|NCT01665495|pericardiocentesis|pericardiocentesis
345827|NCT01665495|pericardial drainage|pericardial drainage
345828|NCT01665495|prevention|prevention
345829|NCT01665482|Inflammation|inflammation
345830|NCT01665482|Insulin sensitivity|insulin sensitivity
345831|NCT01665482|Interleukin-6 (IL-6)|interleukin-6 (il-6)
345833|NCT01665482|Saturated fatty acid (SFA)|saturated fatty acid (sfa)
345834|NCT01665482|Monounsaturated fatty acid (MUFA)|monounsaturated fatty acid (mufa)
345835|NCT01665482|Carbohydrate (CARB)|carbohydrate (carb)
345836|NCT01665469|anti oxidation|anti oxidation
345837|NCT01665469|lycopene|lycopene
345838|NCT01665469|Ox-LDL|ox-ldl
345839|NCT01665456|complications|complications
345840|NCT01665417|Icotinib|icotinib
345841|NCT01665417|EGFR positive mutation|egfr positive mutation
345842|NCT01665417|First-line treatment|first-line treatment
345843|NCT01665417|Maintenance treatment|maintenance treatment
345844|NCT01665378|prepregnancy|prepregnancy
345845|NCT01665378|micronutrient|micronutrient
345846|NCT01665378|supplementation|supplementation
345847|NCT01665378|maternal|maternal
345848|NCT01665378|child|child
345849|NCT01665378|health|health
345850|NCT01665365|Myocardial infarction|myocardial infarction
345851|NCT01665365|Remote ischemic conditioning|remote ischemic conditioning
345852|NCT01665365|Clinical outcome|clinical outcome
345853|NCT01665339|preload|preload
345854|NCT01665339|anthropometric measures|anthropometric measures
345855|NCT01665339|cardiovascular risk factors|cardiovascular risk factors
345856|NCT01665326|Pompe disease|pompe disease
345857|NCT01665326|Glycogen Storage Disease Type II|glycogen storage disease type ii
345858|NCT01665326|Acid Maltase Deficiency|acid maltase deficiency
345859|NCT01665326|CRIM Status|crim status
345860|NCT01665326|Acid Alpha-Glucosidase Deficiency|acid alpha-glucosidase deficiency
345861|NCT01665326|Alglucosidase alfa|alglucosidase alfa
345862|NCT01665326|Myozyme|myozyme
345863|NCT01665326|Enzyme replacement therapy|enzyme replacement therapy
345864|NCT01665326|Immune Tolerance Induction|immune tolerance induction
345865|NCT01665313|attention|attention
345866|NCT01665300|myocardial deformation imaging|myocardial deformation imaging
345867|NCT01665300|Trastuzumab|trastuzumab
345868|NCT01665287|Cerebral Oximetry|cerebral oximetry
345869|NCT01665287|Near infrared spectroscopy|near infrared spectroscopy
345870|NCT01665287|Fullterm|fullterm
345871|NCT01665287|Infant|infant
345872|NCT01665274|xelox|xelox
345873|NCT01665274|advanced gastric cancer|advanced gastric cancer
345874|NCT01665261|Congenital heart disease|congenital heart disease
345875|NCT01665261|Newborn|newborn
345876|NCT01665261|Pulse oximetry|pulse oximetry
345877|NCT01665261|Screening|screening
345878|NCT01665248|18-F Sodium Fluoride|18-f sodium fluoride
345879|NCT01665248|Acute coronary syndrome|acute coronary syndrome
345880|NCT01665248|Stable Angina|stable angina
345881|NCT01665196|IgG4-related disease|igg4-related disease
345882|NCT01665196|IgG4-RD|igg4-rd
345883|NCT01665196|18F-FDG|18f-fdg
345884|NCT01665196|PET/CT|pet/ct
345885|NCT01665183|argininosuccinate synthetase|argininosuccinate synthetase
345886|NCT01665183|arginine|arginine
345887|NCT01665183|arginine deiminase|arginine deiminase
345888|NCT01665170|Pascoflair|pascoflair
345889|NCT01665170|tsst|tsst
345890|NCT01665170|passiflora incarnata|passiflora incarnata
345891|NCT01665170|non smoking male|non smoking male
345892|NCT01665170|and female volunteers|and female volunteers
345893|NCT01665157|Diet Control before Colonoscopy|diet control before colonoscopy
345894|NCT01665144|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
345895|NCT01665118|Radio frequency|radio frequency
345896|NCT01665118|thigh|thigh
345897|NCT01665118|circumference|circumference
345898|NCT01665118|reduction|reduction
345899|NCT01665105|Pulse Rate Variability|pulse rate variability
345900|NCT01665105|Skin Blood Flow|skin blood flow
345901|NCT01665105|Skin Temperature|skin temperature
345902|NCT01665105|Electroacupuncture|electroacupuncture
345903|NCT01665105|Zusanli|zusanli
345904|NCT01665105|Yanglingquan|yanglingquan
345905|NCT01665079|anaesthetics iv|anaesthetics iv
345906|NCT01665079|propofol|propofol
345907|NCT01665079|pharmacokinetics|pharmacokinetics
345908|NCT01665079|pharmacodynamic|pharmacodynamic
345909|NCT01665053|Drug-Eluting Stents|drug-eluting stents
345910|NCT01665040|neurostimulation|neurostimulation
345911|NCT01665040|spinal cord stimulation|spinal cord stimulation
345912|NCT01665040|peripheral nerve stimulation|peripheral nerve stimulation
345913|NCT01665027|caesarean section,|caesarean section,
345914|NCT01665027|vacuum,|vacuum,
345915|NCT01665027|fetal head extraction,|fetal head extraction,
345916|NCT01665027|maternal complication,|maternal complication,
345917|NCT01665027|fetal complication|fetal complication
345918|NCT01665014|autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
345919|NCT01665014|total marrow irradiation|total marrow irradiation
345920|NCT01665014|melphalan|melphalan
345921|NCT01665014|multiple myeloma|multiple myeloma
345922|NCT01665001|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
345923|NCT01665001|Induction|induction
345924|NCT01665001|Consolidation|consolidation
345925|NCT01665001|Minimal residual disease|minimal residual disease
345926|NCT01665001|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
345927|NCT01664975|Peripheral T-cell lymphoma;chemotherapy;|peripheral t-cell lymphoma;chemotherapy;
345928|NCT01664975|RR;PFS;OS|rr;pfs;os
345929|NCT01664936|18F-FDG PET/CT scan|18f-fdg pet/ct scan
345930|NCT01664936|131I therapy|131i therapy
345931|NCT01664936|Cerenkov Luminescence Imaging|cerenkov luminescence imaging
345932|NCT01664936|12-050|12-050
345933|NCT01664936|Lymphoma|lymphoma
345934|NCT01664936|Leukemia|leukemia
345935|NCT01664936|Metastatic Lymph Nodes|metastatic lymph nodes
345936|NCT01664923|prostate cancer|prostate cancer
345937|NCT01664923|enzalutamide|enzalutamide
345938|NCT01664923|MDV3100|mdv3100
345939|NCT01664910|Lymphoma|lymphoma
345940|NCT01664910|CD22 Positive-Lymphoid Malignancies|cd22 positive-lymphoid malignancies
345941|NCT01664910|Leukemia|leukemia
345942|NCT01664910|Allogeneic stem cell transplant|allogeneic stem cell transplant
345943|NCT01664910|CMC-544|cmc-544
345944|NCT01664910|Inotuzumab Ozogamicin|inotuzumab ozogamicin
345945|NCT01664910|Fludarabine|fludarabine
345946|NCT01664910|Fludarabine Phosphate|fludarabine phosphate
345947|NCT01664910|Fludara|fludara
345948|NCT01664910|Bendamustine|bendamustine
345949|NCT01664910|Bendamustine Hydrochloride|bendamustine hydrochloride
345950|NCT01664910|Bendamustine HCL|bendamustine hcl
345951|NCT01664910|CEP-18083|cep-18083
345952|NCT01664910|SDX105|sdx105
345953|NCT01664910|Treanda|treanda
345954|NCT01664910|G-CSF|g-csf
345955|NCT01664910|Filgrastim|filgrastim
345956|NCT01664910|Neupogen|neupogen
345957|NCT01664910|Methotrexate|methotrexate
345958|NCT01664910|Rituximab|rituximab
345959|NCT01664910|Rituxan|rituxan
345960|NCT01664910|Thymoglobulin|thymoglobulin
345961|NCT01664910|ATG|atg
345962|NCT01664910|Antithymocyte Globulin|antithymocyte globulin
345963|NCT01664910|Tacrolimus|tacrolimus
345964|NCT01664910|Prograf|prograf
345965|NCT01664897|Leukemia|leukemia
345966|NCT01664897|Acute myeloid leukemia|acute myeloid leukemia
345967|NCT01664897|AML|aml
345968|NCT01664897|refractory|refractory
345969|NCT01664897|relapsed|relapsed
345970|NCT01664897|Erlotinib|erlotinib
345971|NCT01664897|Erlotinib Hydrochloride|erlotinib hydrochloride
345972|NCT01664897|OSI-774|osi-774
345973|NCT01664897|CP358774|cp358774
345974|NCT01664897|Tarceva|tarceva
345975|NCT01664884|INTERNALIZED STIGMA|internalized stigma
345976|NCT01664884|INSIGHT|insight
345977|NCT01664884|SOCIAL ADEQUACY|social adequacy
345978|NCT01664884|BIPOLAR DISORDER|bipolar disorder
345979|NCT01664884|SCHIZOPHRENIA|schizophrenia
345980|NCT01664858|Coronary Heart Disease|coronary heart disease
345981|NCT01664858|Ischaemic Heart Disease|ischaemic heart disease
345982|NCT01664858|Angina|angina
345983|NCT01664858|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
345984|NCT01664845|hepatitis c|hepatitis c
345985|NCT01664845|metformin|metformin
345986|NCT01664845|pegylated interferon|pegylated interferon
345987|NCT01664832|Premature Infants|premature infants
345988|NCT01664832|snychronized ventilation|snychronized ventilation
345989|NCT01664832|non-invasive ventilation|non-invasive ventilation
345990|NCT01664832|RDS|rds
345991|NCT01664806|Electrosurgery|electrosurgery
345992|NCT01664806|Radiofrequency energy|radiofrequency energy
345993|NCT01664806|Monopolar instruments|monopolar instruments
345994|NCT01664806|Capacitive coupling|capacitive coupling
345995|NCT01664806|Thermal injury|thermal injury
345996|NCT01664806|Surgical complications|surgical complications
345997|NCT01664793|influenza|influenza
345998|NCT01664793|vaccination|vaccination
345999|NCT01664793|strategies|strategies
346000|NCT01664793|children/adolescents|children/adolescents
346001|NCT01664780|standard|standard
346002|NCT01664780|values|values
346003|NCT01664780|share|share
346004|NCT01664780|wave velocity|wave velocity
346005|NCT01664780|in ARFI imaging|in arfi imaging
346006|NCT01664767|COPD|copd
346007|NCT01664767|Thermal water|thermal water
346008|NCT01664767|Oxidative stress|oxidative stress
346009|NCT01664767|Inflammation|inflammation
346010|NCT01664741|Nicotine dependence|nicotine dependence
346011|NCT01664741|cigarette|cigarette
346012|NCT01664741|smoking|smoking
346013|NCT01664741|nicotine replacement therapy|nicotine replacement therapy
346014|NCT01664741|positron emission tomography|positron emission tomography
346015|NCT01664728|Prostate neoplasms|prostate neoplasms
346016|NCT01664728|Hormone refractory prostate cancer|hormone refractory prostate cancer
346017|NCT01664728|Castration resistant prostate cancer|castration resistant prostate cancer
346018|NCT01664728|Castration refractory prostate cancer|castration refractory prostate cancer
346019|NCT01664728|Abiraterone acetate|abiraterone acetate
346020|NCT01664728|CB7630|cb7630
346021|NCT01664715|Overweight|overweight
346022|NCT01664715|Obesity|obesity
346023|NCT01664715|Exercise|exercise
346024|NCT01664715|Weight Loss|weight loss
346025|NCT01664702|Dairy|dairy
346026|NCT01664702|obesity|obesity
346027|NCT01664676|liraglutide|liraglutide
346028|NCT01664676|victoza|victoza
346029|NCT01664676|GLP-1|glp-1
346030|NCT01664676|kidney|kidney
346031|NCT01664676|diabetes|diabetes
346032|NCT01664676|renal|renal
346033|NCT01664676|diabetic nephropathy|diabetic nephropathy
346034|NCT01664663|Radiotherapy|radiotherapy
346035|NCT01664663|Dose escalation|dose escalation
346532|NCT01662193|vitamin D3|vitamin d3
346036|NCT01664663|Normal tissue constraints|normal tissue constraints
346037|NCT01664663|Locally advanced disease|locally advanced disease
346038|NCT01664663|Good performance status|good performance status
346039|NCT01664650|menopause|menopause
346040|NCT01664650|pre-diabetes|pre-diabetes
346041|NCT01664637|diabetic gastroparesis|diabetic gastroparesis
346042|NCT01664637|delayed gastric emptying|delayed gastric emptying
346043|NCT01664637|gastroparesis|gastroparesis
346044|NCT01664637|diabetes mellitus, Type 1|diabetes mellitus, type 1
346045|NCT01664637|diabetes mellitus, Type 2|diabetes mellitus, type 2
346046|NCT01664624|Drug Therapy|drug therapy
346047|NCT01664611|Remote Ischaemic Conditioning|remote ischaemic conditioning
346048|NCT01664611|Remodeling|remodeling
346049|NCT01664611|Heart Failure|heart failure
346050|NCT01664611|Myocardial Infarction|myocardial infarction
346051|NCT01664611|Ischaemia/Reperfusion Injury|ischaemia/reperfusion injury
346052|NCT01664611|successful primary percutaneous coronary intervention following a first STEMI|successful primary percutaneous coronary intervention following a first stemi
346053|NCT01664585|headache|headache
346054|NCT01664585|women|women
346055|NCT01664585|exercise|exercise
346056|NCT01664585|fear avoidance|fear avoidance
346057|NCT01664585|physical activity|physical activity
346058|NCT01664572|laser Doppler flowmetry, skin blood flow|laser doppler flowmetry, skin blood flow
346059|NCT01664559|intrauterine device|intrauterine device
346060|NCT01664559|ketorolac|ketorolac
346061|NCT01664559|toradol|toradol
346062|NCT01664559|mirena|mirena
346063|NCT01664559|paragard|paragard
346064|NCT01664559|pain control|pain control
346065|NCT01664520|Subarachnoid hemorrhage|subarachnoid hemorrhage
346066|NCT01664520|Dexmedetomidine|dexmedetomidine
346067|NCT01664520|Autoregulation|autoregulation
346068|NCT01664520|Intracranial pressure|intracranial pressure
346069|NCT01664520|Cerebral oxygenation|cerebral oxygenation
346070|NCT01664507|croup, dose, epinephrine|croup, dose, epinephrine
346071|NCT01664273|electroporation|electroporation
346072|NCT01664273|gen electrotransfer|gen electrotransfer
346073|NCT01664273|muscle|muscle
346074|NCT01664273|plasmid AMEP|plasmid amep
346075|NCT01664260|Posttraumatic Stress Disorder|posttraumatic stress disorder
346076|NCT01664260|N-acetylcysteine|n-acetylcysteine
346077|NCT01664260|Magnetic Resonance Imaging|magnetic resonance imaging
346078|NCT01664234|infants with cleft palate|infants with cleft palate
346079|NCT01664234|Pierre Robin|pierre robin
346080|NCT01664234|Treacher Collins|treacher collins
346081|NCT01664234|trisomy 21|trisomy 21
346082|NCT01664221|subject|subject
346083|NCT01664195|subjects|subjects
346084|NCT01664169|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
346085|NCT01664169|recurrent pancreatic cancer|recurrent pancreatic cancer
346086|NCT01664169|stage III pancreatic cancer|stage iii pancreatic cancer
346087|NCT01664169|stage IV pancreatic cancer|stage iv pancreatic cancer
346088|NCT01664169|stage IIB pancreatic cancer|stage iib pancreatic cancer
346089|NCT01664156|Cold hypersensitivity|cold hypersensitivity
346090|NCT01664156|Korean red ginseng|korean red ginseng
346091|NCT01664156|Infrared thermography|infrared thermography
346092|NCT01664156|Cold stress test|cold stress test
346093|NCT01664156|Distal-dorsal difference|distal-dorsal difference
346094|NCT01664091|tissue expander|tissue expander
346095|NCT01664091|acellular dermal matrix|acellular dermal matrix
346096|NCT01664078|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
346097|NCT01664065|Patient Safety|patient safety
346098|NCT01664065|Tolerability|tolerability
346099|NCT01664065|Pharmacokinetics|pharmacokinetics
346100|NCT01664039|Glaucoma|glaucoma
346101|NCT01664039|Ocular hypertension|ocular hypertension
346102|NCT01664000|Tumors|tumors
346103|NCT01664000|carcinoma|carcinoma
346104|NCT01664000|apoptosis|apoptosis
346105|NCT01664000|p53|p53
346106|NCT01664000|p21|p21
346107|NCT01664000|Caspase3|caspase3
346108|NCT01664000|PARP|parp
346109|NCT01664000|MDM2|mdm2
346110|NCT01664000|PUMA|puma
346111|NCT01663974|Bipolar Disorders|bipolar disorders
346112|NCT01663974|Sub-syndromal symptoms|sub-syndromal symptoms
346113|NCT01663974|Acute depressive episode|acute depressive episode
346114|NCT01663974|Symptomatic remission|symptomatic remission
346115|NCT01663974|Functioning remission|functioning remission
346116|NCT01663961|Phase I|phase i
346117|NCT01663961|Pharmacokinetics|pharmacokinetics
346118|NCT01663961|YM178 Oral Controlled Absorption System (OCAS)|ym178 oral controlled absorption system (ocas)
346119|NCT01663961|Digoxin (Lanoxin)|digoxin (lanoxin)
346120|NCT01663961|DDI (Drug-drug interaction)|ddi (drug-drug interaction)
346121|NCT01663961|Open-label|open-label
346122|NCT01663961|Steady-state|steady-state
346123|NCT01663961|subjects|subjects
346124|NCT01663948|Plastic bronchitis|plastic bronchitis
346125|NCT01663948|PB|pb
346126|NCT01663935|levodopa|levodopa
346127|NCT01663935|Albinism|albinism
346128|NCT01663935|dopamine|dopamine
346129|NCT01663935|oculocutaneous albinism|oculocutaneous albinism
346130|NCT01663935|vision|vision
346131|NCT01663935|retina function|retina function
346132|NCT01663909|Pain|pain
346133|NCT01663909|Scoliosis|scoliosis
346134|NCT01663909|Rehabilitation|rehabilitation
346135|NCT01663909|Cognitive-behavioral interventions|cognitive-behavioral interventions
346136|NCT01663909|Adolescents|adolescents
346137|NCT01663883|Blood flow autoregulation|blood flow autoregulation
346138|NCT01663883|optic nerve head blood flow|optic nerve head blood flow
346139|NCT01663883|isometric exercise|isometric exercise
346140|NCT01663883|Autoregulation|autoregulation
346141|NCT01663883|ocular physiology|ocular physiology
346142|NCT01663870|Cancer Prevention|cancer prevention
346143|NCT01663870|Breast cancer survivors|breast cancer survivors
346144|NCT01663870|Cancer survivorship clinic|cancer survivorship clinic
346145|NCT01663870|eHealth technology|ehealth technology
346146|NCT01663870|Internet|internet
346147|NCT01663870|HealthATM website|healthatm website
346148|NCT01663870|Questionnaire|questionnaire
346149|NCT01663870|Clinic stakeholders|clinic stakeholders
346150|NCT01663870|Clinic nurses|clinic nurses
346151|NCT01663870|Physicians|physicians
346152|NCT01663870|Case managers|case managers
346153|NCT01663870|Oncology patient navigators|oncology patient navigators
346154|NCT01663870|Audio recorded interviews|audio recorded interviews
346155|NCT01663844|Cognitive behavior therapy|cognitive behavior therapy
346156|NCT01663844|Internet treatment|internet treatment
346157|NCT01663844|Self-help treatment|self-help treatment
346158|NCT01663844|Insomnia|insomnia
346159|NCT01663844|Depression|depression
346160|NCT01663844|ICBT|icbt
346161|NCT01663844|CBT-i|cbt-i
346162|NCT01663844|CBT-d|cbt-d
346163|NCT01663831|Outdoor Malaria Transmission|outdoor malaria transmission
346164|NCT01663831|Anopheles|anopheles
346165|NCT01663831|Topical repellent|topical repellent
346166|NCT01663831|Early biting vector|early biting vector
346167|NCT01663831|Long Lasting Insecticidal Net (LLIN)|long lasting insecticidal net (llin)
346168|NCT01663831|Cambodia|cambodia
346169|NCT01663805|Extended Criteria Donor|extended criteria donor
346170|NCT01663805|Delayed Graft Function|delayed graft function
346171|NCT01663805|DGF|dgf
346172|NCT01663805|Deceased donors aged ≥ 60 years|deceased donors aged ≥ 60 years
346173|NCT01663805|aged between 50 and 59 years|aged between 50 and 59 years
346174|NCT01663805|history of systemic hypertension|history of systemic hypertension
346175|NCT01663805|terminal creatinine levels > 1.5 mg/dL|terminal creatinine levels > 1.5 mg/dl
346176|NCT01663805|death by a cerebrovascular accident|death by a cerebrovascular accident
346177|NCT01663792|urokinase receptor|urokinase receptor
346178|NCT01663792|protein expression|protein expression
346179|NCT01663792|seaweed (Undaria pinnatifida)|seaweed (undaria pinnatifida)
346180|NCT01663766|GVHD (acute or chronic)|gvhd (acute or chronic)
346181|NCT01663766|acute myeloid or lymphoblastic leukemia (AML or ALL)|acute myeloid or lymphoblastic leukemia (aml or all)
346182|NCT01663766|myelodysplastic syndrome|myelodysplastic syndrome
346183|NCT01663766|Chronic myelogenous leukemia (CML)|chronic myelogenous leukemia (cml)
346184|NCT01663766|Multiple Myeloma (MM)|multiple myeloma (mm)
346185|NCT01663766|Non-Hodgekin lymphoma (NHL-both follicular & diffuse large cell)|non-hodgekin lymphoma (nhl-both follicular & diffuse large cell)
346186|NCT01663766|Chronic lymphocytic leukemia or small lymphocytic leukemia (CLL or SLL)|chronic lymphocytic leukemia or small lymphocytic leukemia (cll or sll)
346187|NCT01663753|2-fluoro-2-deoxy-d-glucose-positron emission tomography|2-fluoro-2-deoxy-d-glucose-positron emission tomography
346188|NCT01663753|Positron emission tomography|positron emission tomography
346189|NCT01663753|Magnetic resonance imaging|magnetic resonance imaging
346190|NCT01663753|Diffusion weighted MRI|diffusion weighted mri
346191|NCT01663753|Squamous-cell cervical carcinoma|squamous-cell cervical carcinoma
346192|NCT01663753|Sensitivity|sensitivity
346193|NCT01663714|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
346194|NCT01663714|tositumomab and iodine I 131 tositumomab|tositumomab and iodine i 131 tositumomab
346195|NCT01663714|Bexxar|bexxar
346196|NCT01663714|cycolophosphamide, vacristine, and pednisone|cycolophosphamide, vacristine, and pednisone
346197|NCT01663701|Sepsis|sepsis
346198|NCT01663701|Severe sepsis|severe sepsis
346199|NCT01663701|Tuberculosis|tuberculosis
346200|NCT01663701|Bundle|bundle
346201|NCT01663701|Zambia|zambia
346202|NCT01663675|Down syndrome|down syndrome
346203|NCT01663649|Depression|depression
346204|NCT01663649|Online-Therapy|online-therapy
346205|NCT01663649|Deprexis|deprexis
346206|NCT01663649|Self-help|self-help
346207|NCT01663636|vaccines|vaccines
346208|NCT01663636|SMS|sms
346209|NCT01663636|mobile phones|mobile phones
346210|NCT01663623|Wegener's Granulomatosis|wegener's granulomatosis
346211|NCT01663623|anti-MPO|anti-mpo
346212|NCT01663623|WG|wg
346213|NCT01663623|Belimumab|belimumab
346214|NCT01663623|GPA|gpa
346215|NCT01663623|anti-proteinase 3|anti-proteinase 3
346216|NCT01663623|anti-neutrophil cytoplasmic antibody|anti-neutrophil cytoplasmic antibody
346217|NCT01663623|anti-myeloperoxidase|anti-myeloperoxidase
346218|NCT01663623|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
346219|NCT01663623|Vasculitis|vasculitis
346220|NCT01663623|Autoimmune Diseases|autoimmune diseases
346221|NCT01663623|Microscopic Polyangiitis|microscopic polyangiitis
346222|NCT01663623|anti-PR3|anti-pr3
346223|NCT01663623|ANCA|anca
346224|NCT01663623|MPA|mpa
346225|NCT01663623|Systemic Vasculitis|systemic vasculitis
346226|NCT01663584|Spinal Muscular Atrophy (SMA)|spinal muscular atrophy (sma)
346227|NCT01663584|Carrier Screening|carrier screening
346228|NCT01663584|Genetic Testing|genetic testing
346229|NCT01663558|anal dysplasia|anal dysplasia
346230|NCT01663558|HPV|hpv
346231|NCT01663558|HIV|hiv
346232|NCT01663558|MSM|msm
346233|NCT01663545|Epilepsy|epilepsy
346234|NCT01663545|Epileptic Focus|epileptic focus
346235|NCT01663545|Inflammation|inflammation
346236|NCT01663545|P-Glycoprotein|p-glycoprotein
346237|NCT01663545|PET Imaging|pet imaging
346238|NCT01663532|Schizophrenia|schizophrenia
346239|NCT01663519|Diabetic foot|diabetic foot
346240|NCT01663519|Offloading|offloading
346241|NCT01663519|Prevention|prevention
346242|NCT01663519|Orthotics|orthotics
346243|NCT01663467|tinnitus|tinnitus
346244|NCT01663467|smartphone|smartphone
346245|NCT01663467|Web|web
346246|NCT01663441|Chemotherapy|chemotherapy
346247|NCT01663441|Thrombocytopenia|thrombocytopenia
346248|NCT01663441|Interleukin-11|interleukin-11
346249|NCT01663441|Platelet|platelet
346250|NCT01663428|birth related brachial plexus injury|birth related brachial plexus injury
346251|NCT01663428|brachial plexus|brachial plexus
346252|NCT01663428|splint|splint
346253|NCT01663415|MDV3100|mdv3100
346254|NCT01663415|prostate|prostate
346255|NCT01663415|cancer|cancer
346256|NCT01663415|enzalutamide|enzalutamide
346257|NCT01663389|mass balance|mass balance
346258|NCT01663389|radiolabel|radiolabel
346259|NCT01663389|oral|oral
346260|NCT01663389|IV|iv
346261|NCT01663389|GSK1322322|gsk1322322
346262|NCT01663389|healthy volunteer|healthy volunteer
346263|NCT01663389|antibiotic|antibiotic
346264|NCT01663363|refractive|refractive
346265|NCT01663363|LASIK|lasik
346266|NCT01663337|Posttraumatic Stress Disorder|posttraumatic stress disorder
346267|NCT01663337|PTSD|ptsd
346268|NCT01663337|Alcohol Abuse|alcohol abuse
346269|NCT01663337|Alcohol Dependance|alcohol dependance
346270|NCT01663337|Alcoholism|alcoholism
346271|NCT01663337|Comorbid|comorbid
346272|NCT01663337|Relapse Prevention (RP)|relapse prevention (rp)
346273|NCT01663337|Cognitive Processing Therapy (CPT)|cognitive processing therapy (cpt)
346274|NCT01663324|Tinnitus|tinnitus
346275|NCT01663324|chronic subjective Tinnitus|chronic subjective tinnitus
346276|NCT01663324|transcranial magnetic stimulation|transcranial magnetic stimulation
346277|NCT01663324|rTMS|rtms
346278|NCT01663324|hearing disorders|hearing disorders
346279|NCT01663311|rTMS|rtms
346280|NCT01663311|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
346281|NCT01663311|chronic tinnitus|chronic tinnitus
346282|NCT01663311|subjective tinnitus|subjective tinnitus
346283|NCT01663311|double cone coil|double cone coil
346284|NCT01663298|DNA methylation|dna methylation
346285|NCT01663298|FGF2|fgf2
346286|NCT01663298|Wound healing|wound healing
346287|NCT01663298|Smoking|smoking
346288|NCT01663298|Diabetes|diabetes
346289|NCT01663298|Implant|implant
346290|NCT01663285|Urothelial|urothelial
346291|NCT01663285|Bladder|bladder
346292|NCT01663285|Cancer|cancer
346293|NCT01663272|oncology|oncology
346294|NCT01663272|pancrease|pancrease
346295|NCT01663233|Essential hypertension|essential hypertension
346296|NCT01663233|High blood pressure|high blood pressure
346297|NCT01663220|type 2 diabetes|type 2 diabetes
346298|NCT01663220|beta cell function|beta cell function
346299|NCT01663220|meal tolerance test|meal tolerance test
346300|NCT01663220|maximum stimulation test|maximum stimulation test
346301|NCT01663220|method standardization|method standardization
346302|NCT01663220|insulin secretion|insulin secretion
346303|NCT01663220|prediabetes|prediabetes
346304|NCT01663220|insulin sensitivity|insulin sensitivity
346305|NCT01663207|type 2 diabetes|type 2 diabetes
346306|NCT01663207|beta cell function|beta cell function
346307|NCT01663207|meal tolerance test|meal tolerance test
346308|NCT01663207|maximum stimulation test|maximum stimulation test
346309|NCT01663207|method standardization|method standardization
346310|NCT01663207|insulin secretion|insulin secretion
346311|NCT01663207|prediabetes|prediabetes
346312|NCT01663207|insulin sensitivity|insulin sensitivity
346313|NCT01663194|N/L ratio, STEMI, primary PCI, Long-term mortality|n/l ratio, stemi, primary pci, long-term mortality
346314|NCT01663168|HIV|hiv
346315|NCT01663168|Tuberculosis|tuberculosis
346316|NCT01663168|Rifabutin|rifabutin
346317|NCT01663168|HIV Protease Inhibitors|hiv protease inhibitors
346318|NCT01663168|EARNEST trial|earnest trial
346319|NCT01663168|Randomized Controlled Trial|randomized controlled trial
346320|NCT01663168|Pilot Projects|pilot projects
346321|NCT01663168|Second-line ART|second-line art
346322|NCT01663168|Drug Toxicity|drug toxicity
346323|NCT01663168|Pharmacokinetics|pharmacokinetics
346324|NCT01663168|Drug Interactions|drug interactions
346325|NCT01663155|lung cancer|lung cancer
346326|NCT01663155|chest x-ray|chest x-ray
346327|NCT01663155|CT scan|ct scan
346328|NCT01663155|computer aided detection (CAD)|computer aided detection (cad)
346329|NCT01663155|screening|screening
346330|NCT01663155|smokers|smokers
346331|NCT01663142|Crohn's disease|crohn's disease
346332|NCT01663142|gastrointestinal tract|gastrointestinal tract
346333|NCT01663129|Children|children
346334|NCT01663129|Osteoporosis|osteoporosis
346335|NCT01663129|Vertebral Compression Fractures|vertebral compression fractures
346336|NCT01663129|Chronic Illness|chronic illness
346337|NCT01663129|Glucocorticoids|glucocorticoids
346338|NCT01663129|Bone Fragility|bone fragility
346339|NCT01663116|Rheumatoid arthritis|rheumatoid arthritis
346340|NCT01663116|Expanded adipose derived allogeneic adult stem cells (eASCs)|expanded adipose derived allogeneic adult stem cells (eascs)
346341|NCT01663103|Interleukin-1|interleukin-1
346342|NCT01663103|Endothelium, Vascular|endothelium, vascular
346343|NCT01663103|Vascular Stiffness|vascular stiffness
346344|NCT01663103|Oxidative Stress|oxidative stress
346345|NCT01663103|Inflammation|inflammation
346346|NCT01663103|Endothelial cells|endothelial cells
346347|NCT01663090|Newly diagnosed|newly diagnosed
346348|NCT01663077|Clozapine|clozapine
346349|NCT01663077|Schizophrenia|schizophrenia
346350|NCT01663077|Remissia|remissia
346351|NCT01663077|polymorphism|polymorphism
346352|NCT01663064|Abdominal aortic aneurysm|abdominal aortic aneurysm
346353|NCT01663064|Endovascular|endovascular
346354|NCT01663064|Fenestration|fenestration
346355|NCT01663064|Juxtarenal|juxtarenal
346356|NCT01663064|Off-the-shelf|off-the-shelf
346357|NCT01663064|Pararenal|pararenal
346358|NCT01663038|Clopidogrel|clopidogrel
346359|NCT01663038|Aspirin|aspirin
346360|NCT01663038|Combination|combination
346361|NCT01663038|Pharmacokinetics|pharmacokinetics
346362|NCT01663038|Phase 1|phase 1
346363|NCT01663025|Randomised controlled trial|randomised controlled trial
346364|NCT01663025|Pain|pain
346365|NCT01663025|Anxiety|anxiety
346366|NCT01663025|Ambulatory surgery|ambulatory surgery
346367|NCT01663025|Hand massage|hand massage
346368|NCT01663025|Local anaesthetic|local anaesthetic
346369|NCT01662973|Primary Biliary Cirrhosis|primary biliary cirrhosis
346370|NCT01662973|Mesenchymal Stem Cells|mesenchymal stem cells
346371|NCT01662973|Serum alkaline phosphatase|serum alkaline phosphatase
346372|NCT01662973|Serum Bilirubin|serum bilirubin
346373|NCT01662960|stroke|stroke
346374|NCT01662960|hemiparesis|hemiparesis
346375|NCT01662960|arm movement|arm movement
346376|NCT01662960|sensory functioning|sensory functioning
346377|NCT01662947|blood pressure|blood pressure
346378|NCT01662934|dysmenorrhea|dysmenorrhea
346379|NCT01662934|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
346380|NCT01662934|heat therapy|heat therapy
346381|NCT01662921|bolus treatment|bolus treatment
346382|NCT01662895|Brain hemorrhage|brain hemorrhage
346383|NCT01662895|Cerebral Hemorrhage|cerebral hemorrhage
346384|NCT01662895|Deferoxamine|deferoxamine
346385|NCT01662895|Hi-DEF Trial|hi-def trial
346386|NCT01662856|Vascular Surgery|vascular surgery
346387|NCT01662856|Fibrin Sealant|fibrin sealant
346388|NCT01662856|Polytetrafluoroethylene (PTFE) grafts|polytetrafluoroethylene (ptfe) grafts
346389|NCT01662843|Dyspnea|dyspnea
346390|NCT01662843|Ultrasonography|ultrasonography
346391|NCT01662843|Emergencies|emergencies
346392|NCT01662843|Critical Care|critical care
346393|NCT01662830|Obesity|obesity
346394|NCT01662830|Meal replacements|meal replacements
346395|NCT01662804|INTERLEUKIN 2|interleukin 2
346396|NCT01662804|MAB 3F8|mab 3f8
346397|NCT01662804|GD2-positive tumor|gd2-positive tumor
346398|NCT01662804|12-116|12-116
346399|NCT01662791|Parkinson's Disease|parkinson's disease
346400|NCT01662791|Small Bowel Bacterial Overgrowth|small bowel bacterial overgrowth
346401|NCT01662791|Weight Loss|weight loss
346402|NCT01662791|Gastrointestinal|gastrointestinal
346403|NCT01662791|Rifaximin|rifaximin
346404|NCT01662778|Monodisperse aerosols|monodisperse aerosols
346405|NCT01662778|Asthmatics|asthmatics
346406|NCT01662778|Pharmacokinetics|pharmacokinetics
346407|NCT01662778|AMP Challenge|amp challenge
346656|NCT01661595|Phosphodiesterase (PDE)|phosphodiesterase (pde)
346408|NCT01662778|Multiple Breath Nitrogen Washout|multiple breath nitrogen washout
346409|NCT01662765|Umbilical pilonidal sinus|umbilical pilonidal sinus
346410|NCT01662765|Treatment|treatment
346411|NCT01662765|Surgery|surgery
346412|NCT01662765|Conservative|conservative
346413|NCT01662765|Investigational treatment|investigational treatment
346414|NCT01662765|After care|after care
346415|NCT01662752|Early colonic cancer|early colonic cancer
346416|NCT01662752|Sentinel lymph node mapping|sentinel lymph node mapping
346417|NCT01662752|Sentinel lymph node biopsy|sentinel lymph node biopsy
346418|NCT01662752|Near infrared imaging|near infrared imaging
346419|NCT01662752|Indocyanine green|indocyanine green
346420|NCT01662752|Laparoscopic|laparoscopic
346421|NCT01662739|Population-Based Cancer Registry|population-based cancer registry
346422|NCT01662739|Stomach|stomach
346423|NCT01662739|Epidemiology|epidemiology
346424|NCT01662739|Risk Factor|risk factor
346425|NCT01662739|Biomolecular Features|biomolecular features
346426|NCT01662713|skin cancer|skin cancer
346427|NCT01662713|optical imaging|optical imaging
346428|NCT01662713|optical coherence tomography|optical coherence tomography
346429|NCT01662713|optical frequency domain imaging|optical frequency domain imaging
346430|NCT01662700|P. vivax infection|p. vivax infection
346431|NCT01662700|Artesunate|artesunate
346432|NCT01662700|Chloroquine|chloroquine
346433|NCT01662700|Primaquine|primaquine
346434|NCT01662661|Healthy participants|healthy participants
346435|NCT01662661|Hepatitis C|hepatitis c
346436|NCT01662661|Relative bioavailability|relative bioavailability
346437|NCT01662661|Bioavailability|bioavailability
346438|NCT01662661|Pharmacokinetics|pharmacokinetics
346439|NCT01662661|JNJ-47910382|jnj-47910382
346440|NCT01662648|Schizophrenia|schizophrenia
346441|NCT01662648|Paliperidone|paliperidone
346442|NCT01662648|Paliperidone extended-release (ER)|paliperidone extended-release (er)
346443|NCT01662635|Non-small cell lung cancer.|non-small cell lung cancer.
346444|NCT01662635|Diagnosis,|diagnosis,
346445|NCT01662635|Adenocarcinoma,|adenocarcinoma,
346446|NCT01662635|ALK,|alk,
346447|NCT01662635|FISH,|fish,
346448|NCT01662635|IHC|ihc
346449|NCT01662635|RT-qPCR|rt-qpcr
346450|NCT01662622|anaesthesia|anaesthesia
346451|NCT01662622|middle aged|middle aged
346452|NCT01662622|minimal alveolar concentration|minimal alveolar concentration
346453|NCT01662622|sevoflurane|sevoflurane
346454|NCT01662622|isoelectric EEG|isoelectric eeg
346455|NCT01662609|pancreas|pancreas
346456|NCT01662609|high-risk|high-risk
346457|NCT01662596|Risk factors,|risk factors,
346458|NCT01662596|prenatal diagnosis,|prenatal diagnosis,
346459|NCT01662596|fetal malformations|fetal malformations
346460|NCT01662583|Influenza|influenza
346461|NCT01662583|text message|text message
346462|NCT01662583|vaccination|vaccination
346463|NCT01662570|Pediatric Obesity|pediatric obesity
346464|NCT01662570|Child Overweight|child overweight
346465|NCT01662557|Pediatric Obesity|pediatric obesity
346466|NCT01662544|Infants|infants
346467|NCT01662544|Bronchiolitis|bronchiolitis
346468|NCT01662544|Hypoxia|hypoxia
346469|NCT01662544|Emergency Department|emergency department
346470|NCT01662544|Length of Stay|length of stay
346471|NCT01662544|Pediatrics|pediatrics
346472|NCT01662466|testosterone|testosterone
346473|NCT01662466|DHEA|dhea
346474|NCT01662466|IVF|ivf
346475|NCT01662466|egg quality|egg quality
346476|NCT01662466|pregnancy rates|pregnancy rates
346477|NCT01662453|epilepsy|epilepsy
346478|NCT01662453|seizures|seizures
346479|NCT01662453|mortality|mortality
346480|NCT01662453|sudep|sudep
346481|NCT01662453|risk factors|risk factors
346482|NCT01662440|Rabies|rabies
346483|NCT01662440|JE|je
346484|NCT01662440|accelerated schedule|accelerated schedule
346485|NCT01662427|Quality of life|quality of life
346486|NCT01662427|Noctural Parkinson's Disease Symptoms|noctural parkinson's disease symptoms
346487|NCT01662401|children|children
346488|NCT01662401|laparoscopic appendectomy|laparoscopic appendectomy
346489|NCT01662401|iliohypogastric nerve block|iliohypogastric nerve block
346490|NCT01662401|rectus sheath nerve block|rectus sheath nerve block
346491|NCT01662401|ilioinguinal nerve block|ilioinguinal nerve block
346492|NCT01662388|proximal caries, composite restoration, proximal contact|proximal caries, composite restoration, proximal contact
346493|NCT01662362|Chagas Disease|chagas disease
346494|NCT01662362|Trypanosoma cruzi|trypanosoma cruzi
346495|NCT01662362|American trypanosomiasis|american trypanosomiasis
346496|NCT01662362|South American trypanosomiasis|south american trypanosomiasis
346497|NCT01662362|kissing bugs|kissing bugs
346498|NCT01662362|reduviid bugs|reduviid bugs
346499|NCT01662336|Human Immunodeficiency Virus infection|human immunodeficiency virus infection
346500|NCT01662323|Heart failure, general practitioner, medical therapy, quality of live|heart failure, general practitioner, medical therapy, quality of live
346501|NCT01662310|Schizophrenia|schizophrenia
346502|NCT01662310|Paliperidone|paliperidone
346503|NCT01662310|Paliperidone Extended-Release|paliperidone extended-release
346504|NCT01662297|Quetiapine|quetiapine
346505|NCT01662297|Trazodone|trazodone
346506|NCT01662297|Insomnia|insomnia
346507|NCT01662297|Dual Diagnosis|dual diagnosis
346508|NCT01662271|obesity|obesity
346509|NCT01662271|adiposity|adiposity
346510|NCT01662271|psychosocial|psychosocial
346511|NCT01662271|healthcare|healthcare
346512|NCT01662271|co-morbidities|co-morbidities
346513|NCT01662271|youth with extreme obesity|youth with extreme obesity
346514|NCT01662271|weight loss|weight loss
346515|NCT01662258|Community-acquired pneumonia|community-acquired pneumonia
346516|NCT01662258|Targeted strategy|targeted strategy
346517|NCT01662258|Empiric therapy|empiric therapy
346518|NCT01662232|Green tea|green tea
346519|NCT01662232|EGCG|egcg
346520|NCT01662232|Cardiovascular diseases|cardiovascular diseases
346521|NCT01662232|Endothelial function|endothelial function
346522|NCT01662232|Flow-mediated dilation|flow-mediated dilation
346523|NCT01662219|superficial cervical plexus block|superficial cervical plexus block
346524|NCT01662219|quality of recovery|quality of recovery
346525|NCT01662206|adults|adults
346526|NCT01662206|probiotics|probiotics
346527|NCT01662206|immune function|immune function
346528|NCT01662206|microbiota|microbiota
346529|NCT01662206|digestive health|digestive health
346530|NCT01662193|Cholecalciferol|cholecalciferol
346531|NCT01662193|Calciol|calciol
346533|NCT01662193|Diabetes Mellitus|diabetes mellitus
346534|NCT01662193|Diabetes Mellitus Type 2|diabetes mellitus type 2
346535|NCT01662193|glucose metabolism disorders|glucose metabolism disorders
346536|NCT01662193|ergocalciferol|ergocalciferol
346537|NCT01662193|calcium|calcium
346538|NCT01662193|adipicytokines|adipicytokines
346539|NCT01662193|inflammatory biomarkers|inflammatory biomarkers
346540|NCT01662180|subfertility, IUI, rec FSH, FSH, E2, AMH|subfertility, iui, rec fsh, fsh, e2, amh
346541|NCT01662141|Cardiac output|cardiac output
346542|NCT01662141|Perivascular Probe|perivascular probe
346543|NCT01662128|Breast Cancer|breast cancer
346544|NCT01662115|ILEUS|ileus
346545|NCT01662089|Female pattern hair loss|female pattern hair loss
346546|NCT01662076|Cancer|cancer
346547|NCT01662076|Fatigue|fatigue
346548|NCT01662076|Chemotherapy|chemotherapy
346549|NCT01662076|Pediatrics|pediatrics
346550|NCT01662076|Homeopathy|homeopathy
346551|NCT01662050|MCL|mcl
346552|NCT01662050|Mantle Cell Lymphoma|mantle cell lymphoma
346553|NCT01662050|Older|older
346554|NCT01662037|Pulmonary vascular resistance|pulmonary vascular resistance
346555|NCT01662037|Heart defects, Congenital|heart defects, congenital
346556|NCT01662037|Receptors, endothelin|receptors, endothelin
346557|NCT01662037|Bosentan|bosentan
346558|NCT01662024|Obesity|obesity
346559|NCT01662024|BMI|bmi
346560|NCT01662024|Weight loss|weight loss
346561|NCT01662024|Gastric restriction|gastric restriction
346562|NCT01662024|Bariatrics|bariatrics
346563|NCT01662011|patient-ventilator interaction|patient-ventilator interaction
346564|NCT01662011|neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
346565|NCT01662011|diaphragm electrical activity|diaphragm electrical activity
346566|NCT01662011|pressure support ventilation|pressure support ventilation
346567|NCT01661998|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
346568|NCT01661998|Spinal Deformity|spinal deformity
346569|NCT01661998|Treatment Outcomes|treatment outcomes
346570|NCT01661985|Mycoplasma genitalium|mycoplasma genitalium
346571|NCT01661985|Chlamydia trachomatis|chlamydia trachomatis
346572|NCT01661985|Treatment|treatment
346573|NCT01661985|Antibiotic resistance|antibiotic resistance
346574|NCT01661972|colorectal cancer|colorectal cancer
346575|NCT01661972|all solid tumors|all solid tumors
346576|NCT01661972|metastatic|metastatic
346577|NCT01661972|refractory|refractory
346578|NCT01661972|advanced solid tumors|advanced solid tumors
346579|NCT01661959|Scoliosis|scoliosis
346580|NCT01661959|Multi-center Database Registry|multi-center database registry
346581|NCT01661959|Spinal Deformity|spinal deformity
346582|NCT01661959|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
346583|NCT01661946|vascular endothelial growth factor|vascular endothelial growth factor
346584|NCT01661946|macular edema|macular edema
346585|NCT01661946|diabetic retinopathy|diabetic retinopathy
346586|NCT01661933|celiac disease|celiac disease
346587|NCT01661933|hookworm|hookworm
346588|NCT01661933|probiotic|probiotic
346589|NCT01661920|Community Acquired Pneumonia.|community acquired pneumonia.
346590|NCT01661920|Treatment duration|treatment duration
346591|NCT01661907|Elderly|elderly
346592|NCT01661907|Anesthesia and postoperative analgesia|anesthesia and postoperative analgesia
346593|NCT01661907|Postoperative period|postoperative period
346594|NCT01661907|Delirium|delirium
346595|NCT01661907|Postoperative complications|postoperative complications
346596|NCT01661881|Newly diagnosed|newly diagnosed
346597|NCT01661868|BRCA1 mutation|brca1 mutation
346598|NCT01661868|BRCA2 mutation|brca2 mutation
346599|NCT01661855|Autism Spectrum Disorders|autism spectrum disorders
346600|NCT01661842|Autoimmune Hepatitis|autoimmune hepatitis
346601|NCT01661842|Mesenchymal stem cells|mesenchymal stem cells
346602|NCT01661842|serum albumin|serum albumin
346603|NCT01661842|serum Tbil|serum tbil
346604|NCT01661842|serum immunoglobulin G(IgG)|serum immunoglobulin g(igg)
346605|NCT01661816|breast cancer|breast cancer
346606|NCT01661816|everyday issues|everyday issues
346607|NCT01661816|couple|couple
346608|NCT01661803|bupivacaine|bupivacaine
346609|NCT01661803|clonidine|clonidine
346610|NCT01661803|pediatric spinal|pediatric spinal
346611|NCT01661803|efficacy|efficacy
346612|NCT01661803|duration|duration
346613|NCT01661803|quality|quality
346614|NCT01661803|side effects|side effects
346615|NCT01661803|intrathecal bupivacaine alone|intrathecal bupivacaine alone
346616|NCT01661803|bupivacaine plus clonidine|bupivacaine plus clonidine
346617|NCT01661790|Bevacizumab;|bevacizumab;
346618|NCT01661790|non-small cell lung cancer;|non-small cell lung cancer;
346619|NCT01661790|malignant pleural effusion;|malignant pleural effusion;
346620|NCT01661790|intrapleural administration|intrapleural administration
346621|NCT01661777|Eustachian tube dysfunction|eustachian tube dysfunction
346622|NCT01661777|Endolymphatic hydrops|endolymphatic hydrops
346623|NCT01661777|Diuretic|diuretic
346624|NCT01661777|Low salt diet|low salt diet
346625|NCT01661777|Myringotomy|myringotomy
346626|NCT01661777|Pressure equalization tube|pressure equalization tube
346627|NCT01661777|Ear tube|ear tube
346628|NCT01661777|Ear fullness|ear fullness
346629|NCT01661777|Ear pressure|ear pressure
346630|NCT01661777|Allergy|allergy
346631|NCT01661777|Nasal steroid|nasal steroid
346632|NCT01661777|Antihistamine|antihistamine
346633|NCT01661764|Colorectal Neoplasm|colorectal neoplasm
346634|NCT01661751|Group ACYW135 Meninigococcal Polysaccharide Vaccine|group acyw135 meninigococcal polysaccharide vaccine
346635|NCT01661738|Group ACYW135 Meninigococcal Polysaccharide Vaccine|group acyw135 meninigococcal polysaccharide vaccine
346636|NCT01661725|Group ACYW135 Meningococcal Polysaccharide Vaccine|group acyw135 meningococcal polysaccharide vaccine
346637|NCT01661712|obstructive sleep apnoea,|obstructive sleep apnoea,
346638|NCT01661712|continuous transcutaneous electrical stimulation|continuous transcutaneous electrical stimulation
346639|NCT01661699|Obstructive Sleep Apnea|obstructive sleep apnea
346640|NCT01661686|esophageal cancer|esophageal cancer
346641|NCT01661686|esophageal stenosis|esophageal stenosis
346642|NCT01661686|stent|stent
346643|NCT01661686|endoscopy|endoscopy
346644|NCT01661634|Acute decompensated heart failure|acute decompensated heart failure
346645|NCT01661621|Lower urinary tract symptoms (LUTS)|lower urinary tract symptoms (luts)
346646|NCT01661621|International Prostate Symptom Score (IPSS)|international prostate symptom score (ipss)
346647|NCT01661621|Antimuscarinics|antimuscarinics
346648|NCT01661621|α-blockers|α-blockers
346649|NCT01661608|Gastric Restriction|gastric restriction
346650|NCT01661595|Fatigue|fatigue
346651|NCT01661595|Fatigability|fatigability
346652|NCT01661595|Surface Electromyography (sEMG)|surface electromyography (semg)
346653|NCT01661595|cyclic guanosine monophosphate (cGMP)|cyclic guanosine monophosphate (cgmp)
346654|NCT01661595|Nitric Oxide (NO)|nitric oxide (no)
346655|NCT01661595|NO-cGMP|no-cgmp
346657|NCT01661595|Sildenafil|sildenafil
346658|NCT01661595|Tadalafil|tadalafil
346659|NCT01661595|Isotope|isotope
346660|NCT01661595|Infusion|infusion
346661|NCT01661595|Anabolism|anabolism
346662|NCT01661595|Upregulation|upregulation
346663|NCT01661595|Accelerometer|accelerometer
346664|NCT01661595|Placebo|placebo
346665|NCT01661595|Nitrosylation|nitrosylation
346666|NCT01661582|Air Pollution|air pollution
346667|NCT01661582|Myocardial Ischaemia|myocardial ischaemia
346668|NCT01661582|Coronary Blood Flow|coronary blood flow
346669|NCT01661582|Diesel Exhaust|diesel exhaust
346670|NCT01661582|Troponin|troponin
346671|NCT01661582|Electrocardiography|electrocardiography
346672|NCT01661569|Mindfulness|mindfulness
346673|NCT01661569|meditation|meditation
346674|NCT01661569|stress|stress
346675|NCT01661569|well-being|well-being
346676|NCT01661569|work stress|work stress
346677|NCT01661569|blood pressure|blood pressure
346678|NCT01661569|cortisol|cortisol
346679|NCT01661556|Melasma, miconazole, hydroquinone|melasma, miconazole, hydroquinone
346680|NCT01661530|asthma|asthma
346681|NCT01661530|pregnancy|pregnancy
346682|NCT01661530|diet|diet
346683|NCT01661530|vitamin E|vitamin e
346684|NCT01661517|substance use treatment|substance use treatment
346685|NCT01661439|Recurrent miscarriages|recurrent miscarriages
346686|NCT01661439|recurrent pregnancy loss|recurrent pregnancy loss
346687|NCT01661439|aps|aps
346688|NCT01661439|anti coagulants in pregnancy|anti coagulants in pregnancy
346689|NCT01661426|Adults|adults
346690|NCT01661426|Weight loss|weight loss
346691|NCT01661426|Diet|diet
346692|NCT01661426|Insulin Resistance|insulin resistance
346693|NCT01661426|Fatty acid composition|fatty acid composition
346694|NCT01661413|Acute Leukemia|acute leukemia
346695|NCT01661413|Pediatrics|pediatrics
346696|NCT01661413|Intrathecal methotrexate|intrathecal methotrexate
346697|NCT01661413|Chemotherapy|chemotherapy
346698|NCT01661413|Nausea|nausea
346699|NCT01661413|Vomiting|vomiting
346700|NCT01661400|Glioma includes ependymoma and medulloblastoma|glioma includes ependymoma and medulloblastoma
346701|NCT01661387|Adrenal insufficiency|adrenal insufficiency
346702|NCT01661387|DuoCort|duocort
346703|NCT01661387|Congenital adrenal hyperplasia (CAH)|congenital adrenal hyperplasia (cah)
346704|NCT01661387|Modified release|modified release
346705|NCT01661387|Hydrocortisone|hydrocortisone
346706|NCT01661361|vancomycin|vancomycin
346707|NCT01661361|levels|levels
346708|NCT01661361|central venous port device|central venous port device
346709|NCT01661361|peripherally obtained levels|peripherally obtained levels
346710|NCT01661361|dose adjustments|dose adjustments
346711|NCT01661361|TDM|tdm
346712|NCT01661348|Cesarian section|cesarian section
346713|NCT01661348|Pregnancy|pregnancy
346714|NCT01661348|Incision management|incision management
346715|NCT01661335|Nausea|nausea
346716|NCT01661335|Vomiting|vomiting
346717|NCT01661335|Children|children
346718|NCT01661335|Aprepitant|aprepitant
346719|NCT01661335|Emend®|emend®
346720|NCT01661322|Acute ischaemic stroke|acute ischaemic stroke
346721|NCT01661322|TIA|tia
346722|NCT01661309|Hyperhomocysteinemia|hyperhomocysteinemia
346723|NCT01661309|Methylcobalamin|methylcobalamin
346724|NCT01661309|Cardiovascular disease|cardiovascular disease
346725|NCT01661309|Plasma total homocysteine|plasma total homocysteine
346726|NCT01661309|Vegetarians|vegetarians
346727|NCT01661296|cutaneous leishmaniasis, heat therapy, antimony|cutaneous leishmaniasis, heat therapy, antimony
346728|NCT01661283|MPNST|mpnst
346729|NCT01661283|malignant peripheral nerve sheath tumors|malignant peripheral nerve sheath tumors
346730|NCT01661283|RAD001|rad001
346731|NCT01661283|Everolimus|everolimus
346732|NCT01661283|Bevacizumab|bevacizumab
346733|NCT01661283|Sarcoma|sarcoma
346734|NCT01661283|Avastin|avastin
346735|NCT01661283|mTOR inhibitor|mtor inhibitor
346736|NCT01661257|Crohn's disease|crohn's disease
346737|NCT01661257|Infliximab|infliximab
346738|NCT01661257|T-cell immunoglobulin- and mucin-domain-containing molecule 3 (TIM-3)|t-cell immunoglobulin- and mucin-domain-containing molecule 3 (tim-3)
346739|NCT01661231|Vascular intervention|vascular intervention
346740|NCT01661231|Endovascular|endovascular
346741|NCT01661231|Peripheral stent|peripheral stent
346742|NCT01661218|catheters|catheters
346743|NCT01661218|Central Venous|central venous
346744|NCT01661218|complications|complications
346745|NCT01661218|cancer|cancer
346746|NCT01661205|Persistent AF|persistent af
346747|NCT01661205|Longstanding Persistent AF|longstanding persistent af
346748|NCT01661205|Ablation|ablation
346749|NCT01661205|catheter ablation|catheter ablation
346750|NCT01661192|Type 1 Diabetes|type 1 diabetes
346751|NCT01661192|newly diagnosed|newly diagnosed
346752|NCT01661192|Beta cell preservation|beta cell preservation
346753|NCT01661179|Medullary Thyroid Carcinoma|medullary thyroid carcinoma
346754|NCT01661179|Medullary Thyroid Cancer|medullary thyroid cancer
346755|NCT01661179|Vandetanib|vandetanib
346756|NCT01661166|Male adult subjects|male adult subjects
346757|NCT01661166|aged 30-90 years|aged 30-90 years
346758|NCT01661166|RARP|rarp
346759|NCT01661166|AUA symptom score greater than 7 will be included|aua symptom score greater than 7 will be included
346760|NCT01661114|Gemcitabine, Infusional 5-Fluorouracil,Cisplatin|gemcitabine, infusional 5-fluorouracil,cisplatin
346761|NCT01661114|Advanced Pancreatic and Biliary Cancers|advanced pancreatic and biliary cancers
346762|NCT01661114|untreated & previously treated pancreatic & biliary cancer.|untreated & previously treated pancreatic & biliary cancer.
346763|NCT01661101|Perioperative myocardial infarction|perioperative myocardial infarction
346764|NCT01661101|Myocardial injury|myocardial injury
346765|NCT01661101|noncardiac surgery|noncardiac surgery
346766|NCT01661088|Neoadjuvant FOLFIRINOX|neoadjuvant folfirinox
346767|NCT01661088|FDR-Gemcitabine|fdr-gemcitabine
346768|NCT01661088|Concurrent|concurrent
346769|NCT01661088|IMRT|imrt
346770|NCT01661088|Borderline Resectable Pancreatic Cancer|borderline resectable pancreatic cancer
346771|NCT01661075|mTBI|mtbi
346772|NCT01661075|concussion|concussion
346773|NCT01661075|mild traumatic brain injury|mild traumatic brain injury
346774|NCT01661075|athlete|athlete
346775|NCT01661075|college|college
346776|NCT01661075|football|football
346777|NCT01661075|soccer|soccer
346778|NCT01661036|Cognitive Testing|cognitive testing
346779|NCT01661036|Survey|survey
346780|NCT01661036|Interview|interview
346781|NCT01661023|Breast Cancer|breast cancer
346782|NCT01661023|Epidemiology|epidemiology
346783|NCT01661010|Infertility|infertility
346784|NCT01661010|Male Factor Infertility|male factor infertility
346785|NCT01661010|Female Factor Infertility|female factor infertility
346786|NCT01661010|Unexplained Infertility|unexplained infertility
346787|NCT01661010|Sex Chromosome|sex chromosome
346788|NCT01661010|Klinefelter Syndrome|klinefelter syndrome
346789|NCT01661010|Turner's Syndrome|turner's syndrome
346790|NCT01661010|XXY|xxy
346791|NCT01661010|Y Chromosome Deletion|y chromosome deletion
346792|NCT01661010|Aneuploidy|aneuploidy
346793|NCT01660997|Proteasome Inhibitor|proteasome inhibitor
346794|NCT01660997|Induction Combination Therapy|induction combination therapy
346795|NCT01660997|Maintenance Strategy|maintenance strategy
346796|NCT01660997|Potent Anti-Myeloma Effect|potent anti-myeloma effect
346797|NCT01660997|Precursor Disease|precursor disease
346798|NCT01660984|Thyroid Tumor|thyroid tumor
346799|NCT01660984|Multiple Endocrine Neoplasia 2|multiple endocrine neoplasia 2
346800|NCT01660984|Pheochromocytoma|pheochromocytoma
346801|NCT01660984|RET Mutations|ret mutations
346802|NCT01660958|Micronutrient Deficiencies|micronutrient deficiencies
346803|NCT01660958|Early Child Development|early child development
346804|NCT01660958|Infant Growth|infant growth
346805|NCT01660958|Iron Deficiency|iron deficiency
346806|NCT01660945|statins, insulin resistance|statins, insulin resistance
346807|NCT01660932|insulin resistance|insulin resistance
346808|NCT01660919|insulin resistance|insulin resistance
346809|NCT01660893|operative|operative
346810|NCT01660893|dental procedure|dental procedure
346811|NCT01660867|hospital admission within 7 days of 3% NaCl nebulizer vs dexamethasone|hospital admission within 7 days of 3% nacl nebulizer vs dexamethasone
346812|NCT01660854|Plasmodium|plasmodium
346813|NCT01660854|falciparum|falciparum
346814|NCT01660854|malaria|malaria
346815|NCT01660854|heterologous|heterologous
346816|NCT01660854|immunity|immunity
346817|NCT01660841|Magnetic resonance imaging|magnetic resonance imaging
346818|NCT01660841|central nervous system|central nervous system
346819|NCT01660841|contrast media|contrast media
346820|NCT01660841|gadobutrol|gadobutrol
346821|NCT01660828|Exercise induced (high sensitive) troponin release|exercise induced (high sensitive) troponin release
346822|NCT01660828|Ischemia reperfusion injury|ischemia reperfusion injury
346823|NCT01660828|Remote ischemic preconditioning|remote ischemic preconditioning
346824|NCT01660789|Obesity|obesity
346825|NCT01660789|Diabetes|diabetes
346826|NCT01660789|Physical activity|physical activity
346827|NCT01660776|diffuse large B-cell lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
346828|NCT01660776|Hodgkin lymphoma|hodgkin lymphoma
346829|NCT01660776|metastatic breast cancer.|metastatic breast cancer.
346830|NCT01660776|non-small cell lung cancer|non-small cell lung cancer
346831|NCT01660750|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
346832|NCT01660750|transplant eligible multiple myeloma|transplant eligible multiple myeloma
346833|NCT01660737|Hay fever|hay fever
346834|NCT01660737|Pascallerg|pascallerg
346835|NCT01660711|neoadjuvant|neoadjuvant
346836|NCT01660711|chemotherapy|chemotherapy
346837|NCT01660711|resectable|resectable
346838|NCT01660711|adjuvant|adjuvant
346839|NCT01660711|pancreas|pancreas
346840|NCT01660711|cancer|cancer
346841|NCT01660711|adenocarcinoma|adenocarcinoma
346842|NCT01660711|surgery|surgery
346843|NCT01660685|Weight loss|weight loss
346844|NCT01660685|Web-based|web-based
346845|NCT01660685|Journaling|journaling
346846|NCT01660685|Body Mass Index between 27 and 45|body mass index between 27 and 45
346847|NCT01660659|Indoor air pollution|indoor air pollution
346848|NCT01660659|pneumococcal carriage|pneumococcal carriage
346849|NCT01660646|Tuberculosis case finding|tuberculosis case finding
346850|NCT01660633|Multiple Myeloma|multiple myeloma
346851|NCT01660633|High-Dose Melphalan|high-dose melphalan
346852|NCT01660633|Propylene Glycol-Free|propylene glycol-free
346853|NCT01660633|Autologous Stem Cell Transplantation|autologous stem cell transplantation
346854|NCT01660633|Captisol|captisol
346855|NCT01660620|betaxolol/ retinopathy of prematurity|betaxolol/ retinopathy of prematurity
346856|NCT01660594|coronary disease|coronary disease
346857|NCT01660594|tomography, x-ray computed|tomography, x-ray computed
346858|NCT01660594|calcium|calcium
346859|NCT01660594|exercise test|exercise test
346860|NCT01660581|CD133+|cd133+
346861|NCT01660581|stem cells|stem cells
346862|NCT01660581|Coronary Artery Disease|coronary artery disease
346863|NCT01660581|Stable Angina Pectoris|stable angina pectoris
346864|NCT01660555|Microbiota|microbiota
346865|NCT01660555|HITChip|hitchip
346866|NCT01660555|biopsies|biopsies
346867|NCT01660555|colon|colon
346868|NCT01660555|protected biopsies|protected biopsies
346869|NCT01660529|Subjects with metastatic breast cancer who have failed at least one standard|subjects with metastatic breast cancer who have failed at least one standard
346870|NCT01660529|of care regimen|of care regimen
346871|NCT01660516|Camellia sinensis|camellia sinensis
346872|NCT01660516|flavonoids|flavonoids
346873|NCT01660516|cardiovascular risk|cardiovascular risk
346874|NCT01660516|flow mediated dilation|flow mediated dilation
346875|NCT01660503|Calcium absorption|calcium absorption
346876|NCT01660503|Osteoporosis|osteoporosis
346877|NCT01660503|Bone Health|bone health
346878|NCT01660503|Adolescent|adolescent
346879|NCT01660490|Radiographic Image Enhancement,|radiographic image enhancement,
346880|NCT01660490|Intraoperative Care|intraoperative care
346881|NCT01660490|Femoral Fractures|femoral fractures
346882|NCT01660490|Femoral Neck Fractures|femoral neck fractures
346883|NCT01660490|Hip Fractures, Internal Fixators|hip fractures, internal fixators
346884|NCT01660490|Fracture Fixation Internal|fracture fixation internal
346885|NCT01660490|Fracture Fixation Intramedullary|fracture fixation intramedullary
346886|NCT01660490|Fractures Bone|fractures bone
346887|NCT01660477|Isavuconazole|isavuconazole
346888|NCT01660477|Lopinavir/ritonavir|lopinavir/ritonavir
346889|NCT01660477|Healthy Volunteers|healthy volunteers
346890|NCT01660477|BAL8557|bal8557
346891|NCT01660477|Kaletra ®|kaletra ®
346892|NCT01660464|Program evaluation|program evaluation
346893|NCT01660464|ADHD|adhd
346894|NCT01660451|Clinical trial, phase II|clinical trial, phase ii
346895|NCT01660451|Phosphatidylinositol 3-Kinase|phosphatidylinositol 3-kinase
346896|NCT01660451|Class I, Non-Hodgkin's lymphoma|class i, non-hodgkin's lymphoma
346897|NCT01660438|Stress urinary incontinence|stress urinary incontinence
346898|NCT01660438|Suburethral sling|suburethral sling
346899|NCT01660425|Attention deficit-/hyperactivity disorder|attention deficit-/hyperactivity disorder
346900|NCT01660425|parenting enhancement training|parenting enhancement training
346901|NCT01660425|guided self-help|guided self-help
346902|NCT01660425|methylphenidate|methylphenidate
346903|NCT01660412|Pain|pain
346904|NCT01660412|Alkalinization|alkalinization
346905|NCT01660412|Technetium 99m Sulfur Colloid|technetium 99m sulfur colloid
346906|NCT01660412|sentinel lymphoscintigraphy?|sentinel lymphoscintigraphy?
346907|NCT01660399|salvage chemotherapy|salvage chemotherapy
346908|NCT01660399|advanced squamous cell lung cancer|advanced squamous cell lung cancer
346909|NCT01660399|Boanmycin|boanmycin
346910|NCT01660386|Type 2 Diabetes|type 2 diabetes
346911|NCT01660386|Dpp-4 inhibitor|dpp-4 inhibitor
346912|NCT01660386|Sulfonylurea|sulfonylurea
346913|NCT01660386|beta cell function|beta cell function
346914|NCT01660373|ticagrelor|ticagrelor
346915|NCT01660373|tirofiban|tirofiban
346916|NCT01660373|glycoprotein IIa/IIIa inhibitors|glycoprotein iia/iiia inhibitors
346917|NCT01660373|P2Y12 blockers|p2y12 blockers
346918|NCT01660373|acute coronary syndrome|acute coronary syndrome
347215|NCT01658670|exercise|exercise
346919|NCT01660360|Tanibirumab Phase I trial|tanibirumab phase i trial
346920|NCT01660334|Systemic Mycosis|systemic mycosis
346921|NCT01660334|Scedosporium infection|scedosporium infection
346922|NCT01660334|Scedosporisis|scedosporisis
346923|NCT01660334|Japanese|japanese
346924|NCT01660334|voriconazole|voriconazole
346925|NCT01660334|VFEND|vfend
346926|NCT01660334|Regulatory Post Marketing Commitment Plan.|regulatory post marketing commitment plan.
346927|NCT01660321|Pediculosis capitis|pediculosis capitis
346928|NCT01660321|Head Lice|head lice
346929|NCT01660295|Severe renal insufficiency certoparin|severe renal insufficiency certoparin
346930|NCT01660295|Severe renal insufficiency|severe renal insufficiency
346931|NCT01660243|Pruritus|pruritus
346932|NCT01660243|Renal dialysis|renal dialysis
346933|NCT01660243|Receptors, Opioid, kappa|receptors, opioid, kappa
346934|NCT01660243|Sleep Disorders|sleep disorders
346935|NCT01660243|Quality of Life|quality of life
346936|NCT01660230|APC, 3K3A, 3K3A-APC, volunteer, healthy|apc, 3k3a, 3k3a-apc, volunteer, healthy
346937|NCT01660217|atopic dermatitis|atopic dermatitis
346938|NCT01660217|eczema action plan|eczema action plan
346939|NCT01660217|patient education|patient education
346940|NCT01660217|written handout|written handout
346941|NCT01660217|investigator's global assessment|investigator's global assessment
346942|NCT01660217|randomized controlled trial|randomized controlled trial
346943|NCT01660204|pneumonia, anti-bacterial agents, (cost)efficacy|pneumonia, anti-bacterial agents, (cost)efficacy
346944|NCT01660191|LDL, HDL|ldl, hdl
346945|NCT01660178|newborns|newborns
346946|NCT01660178|intensive care unit|intensive care unit
346947|NCT01660178|early stimulation|early stimulation
346948|NCT01660165|Nutritional status|nutritional status
346949|NCT01660165|Mental Health|mental health
346950|NCT01660165|Omega-3|omega-3
346951|NCT01660165|Pregnancy|pregnancy
346952|NCT01660165|Postpartum depression|postpartum depression
346953|NCT01660152|male erectile disorder|male erectile disorder
346954|NCT01660152|prostate cancer|prostate cancer
346955|NCT01660152|Laparoscopic prostatectomy|laparoscopic prostatectomy
346956|NCT01660126|Aged|aged
346957|NCT01660126|Cardiovascular disease|cardiovascular disease
346958|NCT01660126|Levothyroxine|levothyroxine
346959|NCT01660126|Randomised controlled trial|randomised controlled trial
346960|NCT01660126|Quality of life|quality of life
346961|NCT01660126|Subclinical hypothyroidism|subclinical hypothyroidism
346962|NCT01660100|Atrial fibrillation ablation|atrial fibrillation ablation
346963|NCT01660087|Exhaled breath condensate (EBC) method|exhaled breath condensate (ebc) method
346964|NCT01660087|Volatile Organic Compounds (VOCs)|volatile organic compounds (vocs)
346965|NCT01660087|Endobronchial Ultrasound (EBUS)|endobronchial ultrasound (ebus)
346966|NCT01660087|Confocal Endoscopy|confocal endoscopy
346967|NCT01660087|Exhaled alveolar gas|exhaled alveolar gas
346968|NCT01660074|glycemic index, resistant starch, glycemic response|glycemic index, resistant starch, glycemic response
346969|NCT01660061|Antiphospholipid syndrome|antiphospholipid syndrome
346970|NCT01660061|Antiphospholipid antibodies|antiphospholipid antibodies
346971|NCT01660061|Vitamin-K antagonists|vitamin-k antagonists
346972|NCT01660061|International normalized ratio|international normalized ratio
346973|NCT01660061|Chromogenic factor X|chromogenic factor x
346974|NCT01660048|Laparoscopic total extraperitoneal Inguinal hernia repair|laparoscopic total extraperitoneal inguinal hernia repair
346975|NCT01660022|Healthy|healthy
346976|NCT01660022|Volunteers|volunteers
346977|NCT01660009|Endothelial Function|endothelial function
346978|NCT01660009|Hypoglycemia|hypoglycemia
346979|NCT01660009|Mitochondria|mitochondria
346980|NCT01659996|Meningitis|meningitis
346981|NCT01659996|Meningococcal Infection|meningococcal infection
346982|NCT01659996|Diphtheria|diphtheria
346983|NCT01659996|Pertussis|pertussis
346984|NCT01659996|Menactra®|menactra®
346985|NCT01659996|Pentacel®|pentacel®
346986|NCT01659983|complicated appendicitis|complicated appendicitis
346987|NCT01659983|wound closure|wound closure
346988|NCT01659983|infection|infection
346989|NCT01659957|Alcoholism|alcoholism
346990|NCT01659957|Couples|couples
346991|NCT01659944|Drug-drug interaction|drug-drug interaction
346992|NCT01659879|Parents|parents
346993|NCT01659879|Caregivers|caregivers
346994|NCT01659879|Anxiety|anxiety
346995|NCT01659879|Consumer satisfaction|consumer satisfaction
346996|NCT01659866|Infection|infection
346997|NCT01659866|Antibiotic resistance|antibiotic resistance
346998|NCT01659866|Prostate biopsy|prostate biopsy
346999|NCT01659840|laser,|laser,
347000|NCT01659840|quality of life,|quality of life,
347001|NCT01659840|orofacial pain|orofacial pain
347002|NCT01659814|Major Depressive Disorder|major depressive disorder
347003|NCT01659814|Anhedonia|anhedonia
347004|NCT01659814|Dopamine|dopamine
347005|NCT01659814|Electroencephalography (EEG)|electroencephalography (eeg)
347006|NCT01659814|Positron Emission Tomography (PET)|positron emission tomography (pet)
347007|NCT01659814|Reward|reward
347008|NCT01659801|cataract|cataract
347009|NCT01659801|cataract surgery|cataract surgery
347010|NCT01659801|intaocular lens|intaocular lens
347011|NCT01659801|toric lens|toric lens
347012|NCT01659788|Advanced Reproductive Age|advanced reproductive age
347216|NCT01658670|adherence|adherence
347013|NCT01659788|poor ovarian response|poor ovarian response
347014|NCT01659788|Mitochondrial dysfunction|mitochondrial dysfunction
347015|NCT01659788|Mitochondrial nutrients|mitochondrial nutrients
347016|NCT01659788|Coenzyme Q10|coenzyme q10
347017|NCT01659788|Electron transfer chain|electron transfer chain
347018|NCT01659762|inflammatory bowel disease|inflammatory bowel disease
347019|NCT01659762|Crohn's disease|crohn's disease
347020|NCT01659749|Genetics|genetics
347021|NCT01659749|Metabolic|metabolic
347022|NCT01659749|Nutrition|nutrition
347023|NCT01659749|Maternal PKU|maternal pku
347024|NCT01659749|Phenylketonuria (PKU)|phenylketonuria (pku)
347025|NCT01659723|Radio therapy|radio therapy
347026|NCT01659723|STRI|stri
347027|NCT01659723|Urinary bladder|urinary bladder
347028|NCT01659723|Hyperbaric Oxygen|hyperbaric oxygen
347029|NCT01659697|lifestyle|lifestyle
347030|NCT01659697|diabetes prevention|diabetes prevention
347031|NCT01659697|BMI|bmi
347032|NCT01659697|physical activity|physical activity
347033|NCT01659684|congenital CMV infection|congenital cmv infection
347034|NCT01659684|standard immunoglobulins|standard immunoglobulins
347035|NCT01659684|immunoglobulin therapy|immunoglobulin therapy
347036|NCT01659684|IgG CMV avidity index|igg cmv avidity index
347037|NCT01659684|Cytomegalovirus|cytomegalovirus
347038|NCT01659658|MLN9708|mln9708
347039|NCT01659658|Amyloidosis|amyloidosis
347040|NCT01659658|Light Chain|light chain
347041|NCT01659658|IXAZOMIB|ixazomib
347042|NCT01659658|Tourmaline AL1|tourmaline al1
347043|NCT01659658|Drug Therapy|drug therapy
347044|NCT01659606|dyskeratosis congenita|dyskeratosis congenita
347045|NCT01659606|bone marrow failure|bone marrow failure
347046|NCT01659606|aplastic anemia|aplastic anemia
347047|NCT01659606|bone marrow transplantation|bone marrow transplantation
347048|NCT01659606|reduced intensity conditioning|reduced intensity conditioning
347049|NCT01659606|campath|campath
347050|NCT01659606|fludarabine|fludarabine
347051|NCT01659606|telomere|telomere
347052|NCT01659593|cognitive disorders|cognitive disorders
347053|NCT01659593|multiple sclerosis|multiple sclerosis
347054|NCT01659593|neuropsychology|neuropsychology
347055|NCT01659580|Angina Pectoris Treatment Prevention|angina pectoris treatment prevention
347056|NCT01659554|Primary peritoneal|primary peritoneal
347057|NCT01659541|spinal cord injury|spinal cord injury
347058|NCT01659541|paralysis|paralysis
347059|NCT01659541|cough|cough
347060|NCT01659541|cervical spinal cord injury|cervical spinal cord injury
347061|NCT01659541|thoracic spinal cord injury|thoracic spinal cord injury
347062|NCT01659528|Penis|penis
347063|NCT01659528|Micropenis|micropenis
347064|NCT01659528|Nomograms|nomograms
347065|NCT01659528|Ultrasound|ultrasound
347066|NCT01659528|Fetus|fetus
347067|NCT01659502|Patients|patients
347068|NCT01659489|adnexal torsion|adnexal torsion
347069|NCT01659489|laparoscopy|laparoscopy
347070|NCT01659476|methacholine|methacholine
347071|NCT01659476|deep inspiration|deep inspiration
347072|NCT01659476|bronchoprotective effect|bronchoprotective effect
347073|NCT01659476|bronchodilating effect|bronchodilating effect
347074|NCT01659463|CARIES INFILTRATION|caries infiltration
347075|NCT01659463|CARIES LESION|caries lesion
347076|NCT01659463|INFILTRANT|infiltrant
347077|NCT01659450|overweight|overweight
347078|NCT01659450|obesity|obesity
347079|NCT01659450|low energy dense|low energy dense
347080|NCT01659437|M. ulcerans|m. ulcerans
347081|NCT01659437|Buruli ulcer|buruli ulcer
347082|NCT01659437|drug trial|drug trial
347083|NCT01659437|clarithromycin|clarithromycin
347084|NCT01659424|Rectal cancer|rectal cancer
347085|NCT01659411|Congenital Heart Disease|congenital heart disease
347086|NCT01659411|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
347087|NCT01659398|Alzheimer's Disease|alzheimer's disease
347088|NCT01659398|cerebral blood flow|cerebral blood flow
347089|NCT01659398|ophthalmic blood flow|ophthalmic blood flow
347090|NCT01659398|blood viscosity|blood viscosity
347091|NCT01659372|temporomandibular disorder|temporomandibular disorder
347092|NCT01659372|myofascial pain syndrome|myofascial pain syndrome
347093|NCT01659333|Peritoneal, Dialysis|peritoneal, dialysis
347094|NCT01659307|Acute Lung Injury|acute lung injury
347095|NCT01659307|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
347096|NCT01659307|Aspirin|aspirin
347097|NCT01659294|Type 2 diabetes|type 2 diabetes
347098|NCT01659294|outcomes|outcomes
347099|NCT01659294|case management|case management
347100|NCT01659281|Artesunate|artesunate
347101|NCT01659281|Mefloquine|mefloquine
347102|NCT01659281|Plasmodium Falciparum|plasmodium falciparum
347103|NCT01659281|Thailand|thailand
347104|NCT01659281|Uncomplicated Plasmodium Falciparum malaria|uncomplicated plasmodium falciparum malaria
347105|NCT01659268|teaching|teaching
347106|NCT01659268|patient simulation|patient simulation
347107|NCT01659268|laryngeal masks|laryngeal masks
347108|NCT01659268|baccalaureate nursing education|baccalaureate nursing education
347109|NCT01659268|teaching strategies|teaching strategies
347110|NCT01659268|simulation|simulation
347111|NCT01659242|Rheumatoid arthritis|rheumatoid arthritis
347112|NCT01659242|Ultrasound|ultrasound
347113|NCT01659242|Magnetic Resonance Imaging|magnetic resonance imaging
347114|NCT01659229|knee osteoarthritis|knee osteoarthritis
347115|NCT01659216|Electrical Pudendal Nerve Stimulation|electrical pudendal nerve stimulation
347116|NCT01659216|Urgency-Frequency Syndrome|urgency-frequency syndrome
347117|NCT01659216|long-term efficacy|long-term efficacy
347118|NCT01659203|extraskeletal chondrosarcoma|extraskeletal chondrosarcoma
347119|NCT01659164|Cognitive Behavioral Therapy|cognitive behavioral therapy
347120|NCT01659164|Dialectical Behavioral Therapy|dialectical behavioral therapy
347121|NCT01659164|Group Treatment|group treatment
347122|NCT01659164|ADHD|adhd
347123|NCT01659151|metastatic|metastatic
347124|NCT01659151|melanoma|melanoma
347125|NCT01659151|cell transfer|cell transfer
347126|NCT01659151|ACT|act
347127|NCT01659151|T-cell|t-cell
347128|NCT01659151|immunotherapy|immunotherapy
347129|NCT01659151|antibodies|antibodies
347130|NCT01659151|lymphocytes|lymphocytes
347131|NCT01659112|core stabilization, upper extremity, kinetic chain, movement|core stabilization, upper extremity, kinetic chain, movement
347132|NCT01659099|DLBCL|dlbcl
347133|NCT01659099|aa-IPI > or equal to 1|aa-ipi > or equal to 1
347134|NCT01659099|Diagnosis|diagnosis
347135|NCT01659099|18 to 60 years|18 to 60 years
347136|NCT01659099|Lymphoma|lymphoma
347137|NCT01659086|Influenza|influenza
347138|NCT01659086|Immunogenicity|immunogenicity
347139|NCT01659086|H9N2|h9n2
347140|NCT01659086|Safety|safety
347141|NCT01659073|Caloric Vestibular Stimulation|caloric vestibular stimulation
347142|NCT01659073|Functional Imaging|functional imaging
347143|NCT01659060|Cacao|cacao
347144|NCT01659060|Chocolate|chocolate
347145|NCT01659060|Theobromine|theobromine
347146|NCT01659060|Flavonoids|flavonoids
347147|NCT01659060|Pregnant women|pregnant women
347148|NCT01659060|Hypertension pregnancy-induced|hypertension pregnancy-induced
347149|NCT01659060|Pre-eclampsia|pre-eclampsia
347150|NCT01659060|Epicatechin|epicatechin
347151|NCT01659047|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
347152|NCT01659047|CLL|cll
347153|NCT01659047|CAL-101|cal-101
347154|NCT01659047|Ofatumumab|ofatumumab
347155|NCT01659034|Anti-platelet therapy|anti-platelet therapy
347157|NCT01659021|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
347158|NCT01659021|GS-1101|gs-1101
347159|NCT01659021|CAL-101|cal-101
347160|NCT01659021|Ofatumumab|ofatumumab
347161|NCT01659008|acute cyclical heavy menstrual bleeding|acute cyclical heavy menstrual bleeding
347162|NCT01658995|Implanon|implanon
347163|NCT01658995|Etonogestrel subdermal implant|etonogestrel subdermal implant
347164|NCT01658995|Nexplanon|nexplanon
347165|NCT01658995|Contraception|contraception
347166|NCT01658995|Irregular Bleeding|irregular bleeding
347167|NCT01658995|Menometrorrhagia|menometrorrhagia
347168|NCT01658956|GCSF|gcsf
347169|NCT01658956|Chemotherapy|chemotherapy
347170|NCT01658956|Breast cancer|breast cancer
347171|NCT01658956|Prophylaxis|prophylaxis
347172|NCT01658917|Tissue Acquisition|tissue acquisition
347173|NCT01658904|Autologous Transplant|autologous transplant
347174|NCT01658904|Proteasome Inhibitor|proteasome inhibitor
347175|NCT01658904|Melphalan|melphalan
347176|NCT01658904|Filgrastim|filgrastim
347177|NCT01658839|pediatric glaucoma|pediatric glaucoma
347178|NCT01658839|pediatric ocular hypertension|pediatric ocular hypertension
347179|NCT01658839|travoprost|travoprost
347180|NCT01658826|AIC316|aic316
347181|NCT01658826|Viral shedding|viral shedding
347182|NCT01658813|Metastatic Gastrointestinal|metastatic gastrointestinal
347183|NCT01658813|Metastatic Kidney|metastatic kidney
347184|NCT01658813|Metastatic Lung|metastatic lung
347185|NCT01658800|H5N1 Influenza|h5n1 influenza
347186|NCT01658800|H5N1 Influenza vaccine|h5n1 influenza vaccine
347187|NCT01658787|Aorta|aorta
347188|NCT01658761|Myopic traction maculopathy|myopic traction maculopathy
347189|NCT01658761|vitrectomy|vitrectomy
347190|NCT01658761|internal limiting membrane|internal limiting membrane
347191|NCT01658761|Retrospective, case control study|retrospective, case control study
347192|NCT01658748|Pilot Study|pilot study
347193|NCT01658748|Longitudinal Study|longitudinal study
347194|NCT01658748|Amygdaloid Body|amygdaloid body
347195|NCT01658748|Insula of Reil|insula of reil
347196|NCT01658748|Cortex, prefrontal|cortex, prefrontal
347197|NCT01658748|Stimulation, Deep Brain|stimulation, deep brain
347198|NCT01658748|Chronic Post Traumatic Stress Disorder|chronic post traumatic stress disorder
347199|NCT01658748|Combat Stress Disorder|combat stress disorder
347200|NCT01658748|Social Adjustments|social adjustments
347201|NCT01658748|Positron-Emission Tomography, Computed Tomography|positron-emission tomography, computed tomography
347202|NCT01658735|Chronic low back pain|chronic low back pain
347203|NCT01658735|Electrotherapy|electrotherapy
347204|NCT01658735|H-Wave|h-wave
347205|NCT01658735|H wave|h wave
347206|NCT01658735|TENS|tens
347207|NCT01658735|Trial|trial
347208|NCT01658683|Coronary Artery Disease|coronary artery disease
347209|NCT01658683|Cardiac Rehabilitation|cardiac rehabilitation
347210|NCT01658683|Exercise Maintenance|exercise maintenance
347211|NCT01658683|Facilitator|facilitator
347212|NCT01658683|Managed Home Exercise|managed home exercise
347213|NCT01658683|Community Based Exercise|community based exercise
347214|NCT01658670|Heart failure|heart failure
347217|NCT01658670|quality of life|quality of life
347218|NCT01658644|Patient satisfaction|patient satisfaction
347219|NCT01658644|Memory recall|memory recall
347220|NCT01658644|Patient-clinician communication|patient-clinician communication
347221|NCT01658644|health communication|health communication
347222|NCT01658644|clinical care team recall|clinical care team recall
347223|NCT01658644|hospital quality of care|hospital quality of care
347224|NCT01658618|Venous leg ulcer|venous leg ulcer
347225|NCT01658618|ulcer|ulcer
347226|NCT01658618|venous stasis|venous stasis
347227|NCT01658618|compression|compression
347228|NCT01658618|venous|venous
347229|NCT01658618|venous stasis ulcer|venous stasis ulcer
347230|NCT01658618|vlu|vlu
347231|NCT01658618|hp802-247-09-029|hp802-247-09-029
347232|NCT01658605|GSK1605786|gsk1605786
347233|NCT01658605|ulcerative colitis|ulcerative colitis
347234|NCT01658605|CCR9 antagonist|ccr9 antagonist
347235|NCT01658605|proof of concept|proof of concept
347236|NCT01658592|Alcohol Addiction;|alcohol addiction;
347237|NCT01658592|Deep Brain Stimulation;|deep brain stimulation;
347238|NCT01658592|Nucleus Accumbens;|nucleus accumbens;
347239|NCT01658592|Ventral Anterior Internal capsule;|ventral anterior internal capsule;
347240|NCT01658553|solid tumors|solid tumors
347241|NCT01658540|Drug Eluting Balloon (DEB) technology|drug eluting balloon (deb) technology
347242|NCT01658540|long SFA lesions disease|long sfa lesions disease
347243|NCT01658527|metastatic|metastatic
347244|NCT01658527|prostate cancer|prostate cancer
347245|NCT01658488|Iron deficiency anemia|iron deficiency anemia
347246|NCT01658488|rice|rice
347247|NCT01658475|IgG titer|igg titer
347248|NCT01658475|periodontopathic bacteria|periodontopathic bacteria
347249|NCT01658462|locally recurrent or metastatic breast cancer|locally recurrent or metastatic breast cancer
347250|NCT01658462|Docetaxel|docetaxel
347251|NCT01658462|Nintedanib|nintedanib
347252|NCT01658436|advanced pancreatic neuroendocrine tumor|advanced pancreatic neuroendocrine tumor
347253|NCT01658436|BEZ235|bez235
347254|NCT01658436|pNET|pnet
347255|NCT01658423|pubic hair|pubic hair
347256|NCT01658423|sprint velocity|sprint velocity
347257|NCT01658423|vertical jump height|vertical jump height
347258|NCT01658423|body composition|body composition
347259|NCT01658423|maximal voluntary torque|maximal voluntary torque
347260|NCT01658410|Coronary artery disease|coronary artery disease
347261|NCT01658410|bypass grafting|bypass grafting
347262|NCT01658397|Healthy subjects|healthy subjects
347263|NCT01658397|Fasting|fasting
347264|NCT01658397|Weight loss|weight loss
347265|NCT01658371|HIV|hiv
347266|NCT01658358|ErbB receptor|erbb receptor
347267|NCT01658358|tyrosine kinase inhibitor|tyrosine kinase inhibitor
347268|NCT01658358|Anthracycline|anthracycline
347269|NCT01658345|aortic stenosis|aortic stenosis
347270|NCT01658345|asymptomatic|asymptomatic
347271|NCT01658345|microvascular dysfunction|microvascular dysfunction
347272|NCT01658345|Cardiac MRI|cardiac mri
347273|NCT01658332|lung cancer|lung cancer
347274|NCT01658332|circulating tumor cells|circulating tumor cells
347275|NCT01658332|prospective|prospective
347276|NCT01658332|monocentrique trial|monocentrique trial
347277|NCT01658306|remote ischemic preconditioning|remote ischemic preconditioning
347278|NCT01658306|random-controlled|random-controlled
347279|NCT01658306|double blind|double blind
347280|NCT01658306|RIPC|ripc
347281|NCT01658293|stroke|stroke
347282|NCT01658293|follow up|follow up
347283|NCT01658293|upper limb|upper limb
347284|NCT01658293|rehabilitation|rehabilitation
347285|NCT01658280|transbronchial needle aspiration|transbronchial needle aspiration
347286|NCT01658280|ultrasound guided transbronchial needle aspiration|ultrasound guided transbronchial needle aspiration
347287|NCT01658280|sensitivity|sensitivity
347288|NCT01658280|hilar/mediastinal adenopathy|hilar/mediastinal adenopathy
347289|NCT01658254|Clinical trials|clinical trials
347290|NCT01658254|Basic results|basic results
347291|NCT01658254|Registry|registry
347292|NCT01658228|Depression|depression
347293|NCT01658228|Dysthymia|dysthymia
347294|NCT01658228|Cognitive Impairment|cognitive impairment
347295|NCT01658228|Cognitive Decline|cognitive decline
347296|NCT01658228|Memory|memory
347297|NCT01658215|Smoking cessation|smoking cessation
347298|NCT01658215|Nicotine|nicotine
347299|NCT01658215|Tobacco Use Disorder|tobacco use disorder
347300|NCT01658215|Central Nervous System Agents|central nervous system agents
347301|NCT01658202|Smoking cessation|smoking cessation
347302|NCT01658202|Nicotine|nicotine
347303|NCT01658202|Tobacco Use Disorder|tobacco use disorder
347304|NCT01658202|Central Nervous System Agents|central nervous system agents
347305|NCT01658176|Estrogen receptor positive|estrogen receptor positive
347306|NCT01658176|Her-2 negative|her-2 negative
347307|NCT01658176|advanced breast cancer|advanced breast cancer
347308|NCT01658176|Breast Cancer|breast cancer
347309|NCT01658163|abdominoplasty,|abdominoplasty,
347310|NCT01658163|skin closure, dressings|skin closure, dressings
347311|NCT01658150|Cognition|cognition
347312|NCT01658150|Schizophrenia|schizophrenia
347313|NCT01658150|Schizoaffective disorder|schizoaffective disorder
347314|NCT01658137|diet|diet
347315|NCT01658137|dietary pattern|dietary pattern
347316|NCT01658137|gene|gene
347317|NCT01658137|gene expression|gene expression
347318|NCT01658137|epigenomics|epigenomics
347319|NCT01658137|diet-gene interaction|diet-gene interaction
347320|NCT01658137|inflammation|inflammation
347321|NCT01658137|9p21|9p21
347322|NCT01658137|fruits|fruits
347323|NCT01658137|vegetables|vegetables
347324|NCT01658124|haemorrhage,antifibrinolytic, clinical trial,|haemorrhage,antifibrinolytic, clinical trial,
347325|NCT01658111|Stroke|stroke
347326|NCT01658111|Robots|robots
347327|NCT01658111|EEG|eeg
347328|NCT01658111|EMG|emg
347329|NCT01658098|postpartum|postpartum
347330|NCT01658098|depression|depression
347331|NCT01658098|edinburgh postpartum depression scale|edinburgh postpartum depression scale
347332|NCT01658098|mexican population|mexican population
347333|NCT01658085|Thyroidectomy|thyroidectomy
347334|NCT01658085|Multinodular goiter|multinodular goiter
347335|NCT01658085|Harmonic Focus|harmonic focus
347336|NCT01658085|budget impact|budget impact
347337|NCT01658085|Harmonic scalpel|harmonic scalpel
347338|NCT01658072|Total Hip Arthroplasty|total hip arthroplasty
347339|NCT01658072|Total Hip Replacement|total hip replacement
347340|NCT01658046|COPD|copd
347341|NCT01658046|exercise|exercise
347342|NCT01658046|neuromuscular electrical stimulation|neuromuscular electrical stimulation
347343|NCT01658033|Metastatic Breast Cancer, Her-2 negative Breast Cancer|metastatic breast cancer, her-2 negative breast cancer
347344|NCT01658033|Avastin, FOLFOX regimen|avastin, folfox regimen
347345|NCT01658020|Acute exacerbation of Chronic obstructive pulmonary disease|acute exacerbation of chronic obstructive pulmonary disease
347346|NCT01658020|Acute Exacerbation|acute exacerbation
347347|NCT01658020|Chronic obstructive pulmonary disease(COPD)|chronic obstructive pulmonary disease(copd)
347348|NCT01658020|Zabofloxacin|zabofloxacin
347349|NCT01658020|Moxifloxacin|moxifloxacin
347350|NCT01657994|cerebral palsy|cerebral palsy
347351|NCT01657994|gait training|gait training
347352|NCT01657994|robotic|robotic
347353|NCT01657994|functional electrical stimulation|functional electrical stimulation
347354|NCT01657981|Pharmacokinetics|pharmacokinetics
347355|NCT01657981|Phase 1|phase 1
347356|NCT01657981|14C-labeled|14c-labeled
347357|NCT01657968|Acute tonsillitis|acute tonsillitis
347358|NCT01657968|Procalcitonin|procalcitonin
347359|NCT01657968|Streptococcal antigen test|streptococcal antigen test
347360|NCT01657968|Centor Criteria|centor criteria
347361|NCT01657968|Infection marker|infection marker
347362|NCT01657942|MRgFUS|mrgfus
347363|NCT01657942|Prostate|prostate
347364|NCT01657942|Intermediate Risk Prostate Lesions|intermediate risk prostate lesions
347365|NCT01657942|Focal Prostate treatment|focal prostate treatment
347366|NCT01657942|InSightec|insightec
347367|NCT01657942|ExAblate|exablate
347368|NCT01657942|Non-invasive|non-invasive
347369|NCT01657942|Prostate cancer|prostate cancer
347370|NCT01657942|Gleason 7|gleason 7
347371|NCT01657929|Influenza|influenza
347372|NCT01657929|Avian|avian
347373|NCT01657929|H5N1|h5n1
347374|NCT01657929|H5-VLP|h5-vlp
347375|NCT01657929|GLA|gla
347376|NCT01657929|GLA-AF|gla-af
347377|NCT01657916|mid-urethral sling|mid-urethral sling
347378|NCT01657916|Align urethral support system|align urethral support system
347379|NCT01657916|tension free vaginal tape|tension free vaginal tape
347380|NCT01657916|cough stress test|cough stress test
347381|NCT01657916|pelvic exam|pelvic exam
347382|NCT01657916|PFDI-20|pfdi-20
347383|NCT01657916|PFIQ|pfiq
347384|NCT01657916|SSQ|ssq
347385|NCT01657916|Urinary retention|urinary retention
347386|NCT01657916|mesh erosion|mesh erosion
347387|NCT01657916|urodynamics|urodynamics
347388|NCT01657890|isavuconazole|isavuconazole
347389|NCT01657890|BAL8557|bal8557
347390|NCT01657864|Aseptic Meningitis|aseptic meningitis
347391|NCT01657864|Epidemiology|epidemiology
347392|NCT01657864|Bipolar Disorder|bipolar disorder
347393|NCT01657864|Lamotrigine|lamotrigine
347394|NCT01657864|Epilepsy|epilepsy
347395|NCT01657838|Isavuconazole|isavuconazole
347396|NCT01657838|Ketoconazole|ketoconazole
347397|NCT01657838|Healthy Volunteers|healthy volunteers
347398|NCT01657838|BAL8557|bal8557
347399|NCT01657838|BAL4815|bal4815
347400|NCT01657825|isavuconazole|isavuconazole
347401|NCT01657825|warfarin|warfarin
347402|NCT01657825|Healthy Volunteers|healthy volunteers
347403|NCT01657825|BAL8557|bal8557
347404|NCT01657825|Coumadin|coumadin
347405|NCT01657812|dexmedetomidine|dexmedetomidine
347406|NCT01657812|Epidural Anesthesia|epidural anesthesia
347407|NCT01657812|stress response|stress response
347408|NCT01657812|anesthesia recovery|anesthesia recovery
347409|NCT01657786|ondanstron|ondanstron
347410|NCT01657786|gene polymorphism|gene polymorphism
347411|NCT01657786|postoperative nausea and vomiting|postoperative nausea and vomiting
347412|NCT01657786|laparoscopic surgery under general anesthesia|laparoscopic surgery under general anesthesia
347413|NCT01657760|craving|craving
347414|NCT01657760|dopamine|dopamine
347415|NCT01657760|citalopram|citalopram
347416|NCT01657760|ssri|ssri
347417|NCT01657747|Ovarian carcinoma|ovarian carcinoma
347418|NCT01657747|Staging|staging
347624|NCT01656863|Dehydration|dehydration
347419|NCT01657747|Early treatment follow-up|early treatment follow-up
347420|NCT01657747|Identifying tumor recurrence|identifying tumor recurrence
347421|NCT01657747|Whole body diffusion-weighted MRI|whole body diffusion-weighted mri
347422|NCT01657734|therapy-induced inflammatory response with|therapy-induced inflammatory response with
347423|NCT01657734|magnetic resonance imaging|magnetic resonance imaging
347424|NCT01657695|HCC|hcc
347425|NCT01657695|Computed tomography|computed tomography
347426|NCT01657695|Gene expression|gene expression
347427|NCT01657695|Fractional growth|fractional growth
347428|NCT01657682|FLT3|flt3
347429|NCT01657682|Crenolanib|crenolanib
347430|NCT01657682|Acute|acute
347431|NCT01657682|Myeloid|myeloid
347432|NCT01657682|AML|aml
347433|NCT01657669|Choroidal neovascularization due to AMD|choroidal neovascularization due to amd
347434|NCT01657643|Health related quality of life|health related quality of life
347435|NCT01657643|Functional Status|functional status
347436|NCT01657630|Insulin Pump Therapy|insulin pump therapy
347437|NCT01657630|Type 1 Diabetes|type 1 diabetes
347438|NCT01657630|Treatment Satisfaction|treatment satisfaction
347439|NCT01657604|CML|cml
347440|NCT01657604|Tasigna|tasigna
347441|NCT01657604|Nilotinib|nilotinib
347442|NCT01657604|Interferon|interferon
347443|NCT01657591|skin cancer|skin cancer
347444|NCT01657591|unresectable|unresectable
347445|NCT01657591|BRAF|braf
347446|NCT01657578|neonates|neonates
347447|NCT01657578|reflux disease|reflux disease
347448|NCT01657578|population pharmacokinetics, omeprazole|population pharmacokinetics, omeprazole
347449|NCT01657565|LOS|los
347450|NCT01657565|Ileus|ileus
347451|NCT01657565|Fever|fever
347452|NCT01657565|reoperation|reoperation
347453|NCT01657552|Drug interaction|drug interaction
347454|NCT01657552|INCIVEK (telaprevir),|incivek (telaprevir),
347455|NCT01657552|SB-497115 (eltrombopag)|sb-497115 (eltrombopag)
347456|NCT01657552|Pharmacokinetics|pharmacokinetics
347457|NCT01657552|Thrombocytopenia|thrombocytopenia
347458|NCT01657552|VICTRELIS (boceprevir)|victrelis (boceprevir)
347459|NCT01657526|Healthy adults|healthy adults
347460|NCT01657526|Safety|safety
347461|NCT01657526|Reactogenicity|reactogenicity
347462|NCT01657526|Immunogenicity|immunogenicity
347463|NCT01657526|Non-typeable H. Influenzae (NTHi)|non-typeable h. influenzae (nthi)
347464|NCT01657513|psoriasis|psoriasis
347465|NCT01657513|treatment failure|treatment failure
347466|NCT01657513|tnf-alfa|tnf-alfa
347467|NCT01657500|endothelial keratoplasty|endothelial keratoplasty
347468|NCT01657487|COPD|copd
347469|NCT01657487|Fluticasone/Salmeterol|fluticasone/salmeterol
347470|NCT01657487|high dose|high dose
347471|NCT01657448|Symptom of Dysuria|symptom of dysuria
347472|NCT01657435|Total hip replacement|total hip replacement
347473|NCT01657435|Total hip arthroplasty|total hip arthroplasty
347474|NCT01657435|Hip joint replacement|hip joint replacement
347475|NCT01657435|Hip prosthesis replacement|hip prosthesis replacement
347476|NCT01657422|Nutrition|nutrition
347477|NCT01657422|Physical Activity|physical activity
347478|NCT01657422|Adolescents|adolescents
347479|NCT01657409|botulinum toxin|botulinum toxin
347480|NCT01657409|detrusor overactivity|detrusor overactivity
347481|NCT01657396|Oral Care|oral care
347482|NCT01657396|Oral Hygiene|oral hygiene
347483|NCT01657396|Intensive Care|intensive care
347484|NCT01657396|Mechanical Ventilation|mechanical ventilation
347485|NCT01657396|Chlorhexidine|chlorhexidine
347486|NCT01657331|Hodgkin Lymphoma|hodgkin lymphoma
347487|NCT01657331|Hodgkin Disease|hodgkin disease
347488|NCT01657331|Hodgkin's Disease|hodgkin's disease
347489|NCT01657331|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
347490|NCT01657331|ALCL|alcl
347491|NCT01657331|SGN+Benda|sgn+benda
347492|NCT01657331|Bendamustine|bendamustine
347493|NCT01657331|Brentuximab Vedotin|brentuximab vedotin
347494|NCT01657318|diabetic foot|diabetic foot
347495|NCT01657318|leg ulcer|leg ulcer
347496|NCT01657305|Split-Thickness Skin Graft (STSG) donor site|split-thickness skin graft (stsg) donor site
347497|NCT01657305|Split-thickness skin graft|split-thickness skin graft
347498|NCT01657305|STSG|stsg
347499|NCT01657305|Wound healing|wound healing
347500|NCT01657305|Skin grafting|skin grafting
347501|NCT01657305|Superficial wound|superficial wound
347502|NCT01657305|Partial-thickness wound|partial-thickness wound
347503|NCT01657305|Time to wound closure|time to wound closure
347504|NCT01657292|Wound healing|wound healing
347505|NCT01657292|Burn wound|burn wound
347506|NCT01657292|Superficial partial-thickness burn wound|superficial partial-thickness burn wound
347507|NCT01657292|Grade 2a burn wounds|grade 2a burn wounds
347508|NCT01657292|Time to wound closure|time to wound closure
347509|NCT01657279|stroke|stroke
347510|NCT01657279|risk score|risk score
347511|NCT01657279|iScore|iscore
347512|NCT01657279|outcomes|outcomes
347513|NCT01657279|mortality|mortality
347514|NCT01657279|disability|disability
347515|NCT01657279|institutionalization|institutionalization
347516|NCT01657227|diabetes|diabetes
347517|NCT01657227|self-management|self-management
347518|NCT01657227|lifestyle|lifestyle
347519|NCT01657227|diet|diet
347520|NCT01657227|physical exercise|physical exercise
347521|NCT01657227|computer-assisted decision support systems|computer-assisted decision support systems
347522|NCT01657188|Heart failure, congestive|heart failure, congestive
347523|NCT01657188|Sleep apnea syndromes|sleep apnea syndromes
347524|NCT01657188|Adaptive servoventilation|adaptive servoventilation
347525|NCT01657188|Prognosis|prognosis
347526|NCT01657188|Cheyne-Stokes respiration|cheyne-stokes respiration
347527|NCT01657175|Cancer|cancer
347528|NCT01657175|long-term follow-up|long-term follow-up
347529|NCT01657175|quality of life|quality of life
347530|NCT01657175|Surgery|surgery
347531|NCT01657175|Nursing|nursing
347532|NCT01657162|BA058|ba058
347533|NCT01657162|Abaloparatide-SC|abaloparatide-sc
347534|NCT01657162|abaloparatide|abaloparatide
347535|NCT01657162|ACTIVExtend|activextend
347536|NCT01657162|osteoporosis|osteoporosis
347537|NCT01657162|fracture|fracture
347538|NCT01657162|bone loss|bone loss
347539|NCT01657136|Inappropriate sinus tachycardia|inappropriate sinus tachycardia
347540|NCT01657136|ivabradine|ivabradine
347541|NCT01657136|beta blockers|beta blockers
347542|NCT01657123|exercise capacity|exercise capacity
347543|NCT01657123|Addison's disease|addison's disease
347544|NCT01657110|acne|acne
347545|NCT01657110|inflamed lesions|inflamed lesions
347546|NCT01657110|non-inflamed lesions|non-inflamed lesions
347547|NCT01657110|complementary medicine|complementary medicine
347548|NCT01657110|essential oil|essential oil
347549|NCT01657058|soluble fiber|soluble fiber
347550|NCT01657058|second meal effect|second meal effect
347551|NCT01657058|glycemia|glycemia
347552|NCT01657058|satiety|satiety
347553|NCT01657058|Individuals|individuals
347554|NCT01657045|Cicatrix|cicatrix
347555|NCT01657045|Wound healing|wound healing
347556|NCT01657032|diarrhea|diarrhea
347557|NCT01657032|probiotics|probiotics
347558|NCT01657032|diosmectite|diosmectite
347559|NCT01657006|Heart rate variability|heart rate variability
347560|NCT01657006|ischemic heart disease|ischemic heart disease
347561|NCT01657006|myocardial ischemia|myocardial ischemia
347562|NCT01656993|Aspirin|aspirin
347563|NCT01656993|ASA|asa
347564|NCT01656993|aortopulmonary shunt|aortopulmonary shunt
347565|NCT01656993|cavopulmonary shunt|cavopulmonary shunt
347566|NCT01656993|shunt|shunt
347567|NCT01656993|TEG|teg
347568|NCT01656993|Antiplatelet|antiplatelet
347569|NCT01656967|Laryngeal Mask Airway|laryngeal mask airway
347570|NCT01656967|LMA|lma
347571|NCT01656967|Intubation|intubation
347572|NCT01656967|AMBU|ambu
347573|NCT01656967|AScope|ascope
347574|NCT01656967|Aura-I|aura-i
347575|NCT01656967|Fastrach|fastrach
347576|NCT01656967|Fiberoptic|fiberoptic
347577|NCT01656967|Disposable Fiberoptic|disposable fiberoptic
347578|NCT01656967|Blind Intubation|blind intubation
347579|NCT01656967|Fiberoptic Intubation|fiberoptic intubation
347580|NCT01656954|stroke volume|stroke volume
347581|NCT01656954|cardiac output|cardiac output
347582|NCT01656954|pulse pressure variance|pulse pressure variance
347583|NCT01656954|stroke volume variance|stroke volume variance
347584|NCT01656954|passive leg raise|passive leg raise
347585|NCT01656954|fluid challenge|fluid challenge
347586|NCT01656954|central venous pressure|central venous pressure
347587|NCT01656941|neonate|neonate
347588|NCT01656941|congenital heart disease|congenital heart disease
347589|NCT01656941|single ventricle cardiac disease|single ventricle cardiac disease
347590|NCT01656941|hypoplastic left heart syndrome|hypoplastic left heart syndrome
347591|NCT01656941|hypoplastic right heart syndrome|hypoplastic right heart syndrome
347592|NCT01656941|d-Transposition of the Great Arteries|d-transposition of the great arteries
347593|NCT01656915|inflammation|inflammation
347594|NCT01656915|response|response
347595|NCT01656915|resilience|resilience
347596|NCT01656915|cytokines|cytokines
347597|NCT01656915|pre-diabetes|pre-diabetes
347598|NCT01656902|Autologous Chondrocyte Transplantation|autologous chondrocyte transplantation
347599|NCT01656902|NOVOCART 3D plus|novocart 3d plus
347600|NCT01656902|knee joint pain|knee joint pain
347601|NCT01656902|safety|safety
347602|NCT01656902|efficacy|efficacy
347603|NCT01656902|treatment|treatment
347604|NCT01656902|TETEC|tetec
347605|NCT01656902|cartilage|cartilage
347606|NCT01656902|ACT|act
347607|NCT01656902|cartilage repair|cartilage repair
347608|NCT01656902|tissue|tissue
347609|NCT01656902|MOCART|mocart
347610|NCT01656889|Venous leg ulcer|venous leg ulcer
347611|NCT01656889|ulcer|ulcer
347612|NCT01656889|venous stasis|venous stasis
347613|NCT01656889|compression|compression
347614|NCT01656889|venous|venous
347615|NCT01656889|venous stasis ulcer|venous stasis ulcer
347616|NCT01656889|vlu|vlu
347617|NCT01656876|Comparative effectiveness research|comparative effectiveness research
347618|NCT01656876|Mirror therapy|mirror therapy
347619|NCT01656876|Stroke rehabilitation|stroke rehabilitation
347620|NCT01656876|Clinical evaluation|clinical evaluation
347621|NCT01656876|Kinematic analysis|kinematic analysis
347622|NCT01656876|Mesh glove|mesh glove
347623|NCT01656876|Combined therapy|combined therapy
347625|NCT01656850|hyperglycemia|hyperglycemia
347626|NCT01656850|hyperinsulinemia|hyperinsulinemia
347627|NCT01656837|Substance Abuse|substance abuse
347628|NCT01656837|Child Maltreatment|child maltreatment
347629|NCT01656837|Multisystemic Therapy|multisystemic therapy
347630|NCT01656837|Child Trauma|child trauma
347631|NCT01656824|Bv8/PK-2|bv8/pk-2
347632|NCT01656824|MDSC Myeloid Derived Suppressor Cells|mdsc myeloid derived suppressor cells
347633|NCT01656824|BMDC Bone Marrow Derived Cells|bmdc bone marrow derived cells
347634|NCT01656824|Angiogenesis|angiogenesis
347635|NCT01656824|Pancreatic Cancer|pancreatic cancer
347636|NCT01656785|stroke|stroke
347637|NCT01656785|cerebrovascular disease|cerebrovascular disease
347638|NCT01656785|angiogenesis imaging|angiogenesis imaging
347639|NCT01656785|68Ga-BNOTA-PRGD2|68ga-bnota-prgd2
347640|NCT01656785|PET/CT|pet/ct
347641|NCT01656772|magnetic navigation|magnetic navigation
347642|NCT01656772|robotic control|robotic control
347643|NCT01656772|RMT ThermoCool catheter|rmt thermocool catheter
347644|NCT01656759|Blood Loss|blood loss
347645|NCT01656759|Hemoglobin|hemoglobin
347646|NCT01656759|Hematocrit|hematocrit
347647|NCT01656759|Blood Transfusions|blood transfusions
347648|NCT01656746|Colorectal Disease|colorectal disease
347649|NCT01656746|SILS|sils
347650|NCT01656746|colorectal surgery|colorectal surgery
347651|NCT01656733|Smoking Cessation|smoking cessation
347652|NCT01656733|Pregnancy|pregnancy
347653|NCT01656733|Nicotrol Inhaler|nicotrol inhaler
347654|NCT01656733|Placebo Inhaler|placebo inhaler
347655|NCT01656733|Nicotine Inhaler|nicotine inhaler
347656|NCT01656720|Faecal Incontinence|faecal incontinence
347657|NCT01656720|Suppository|suppository
347658|NCT01656720|Wexner score|wexner score
347659|NCT01656707|Adolescents|adolescents
347660|NCT01656707|Substance Use Disorders|substance use disorders
347661|NCT01656694|Osteoarthritis|osteoarthritis
347662|NCT01656694|Knee|knee
347663|NCT01656694|Replacement|replacement
347664|NCT01656694|Unicompartmental|unicompartmental
347665|NCT01656694|DePuy|depuy
347666|NCT01656694|Sigma HP|sigma hp
347667|NCT01656668|Chronic|chronic
347668|NCT01656668|Acute|acute
347669|NCT01656668|Persistent|persistent
347670|NCT01656668|Longterm|longterm
347671|NCT01656668|Cough|cough
347672|NCT01656655|ptsd, parenting|ptsd, parenting
347673|NCT01656642|PD-L1|pd-l1
347674|NCT01656642|PD-1|pd-1
347675|NCT01656642|PDL1|pdl1
347676|NCT01656642|antiPD-L1|antipd-l1
347677|NCT01656642|MPDL3280A|mpdl3280a
347678|NCT01656642|Melanoma|melanoma
347679|NCT01656642|BRAF|braf
347680|NCT01656642|MPDL320A|mpdl320a
347681|NCT01656616|Pharmacoeconomics|pharmacoeconomics
347682|NCT01656616|Cost effectiveness|cost effectiveness
347683|NCT01656616|Cyanide|cyanide
347684|NCT01656616|Fire|fire
347685|NCT01656616|Emergency Medical Services|emergency medical services
347686|NCT01656616|Smoke Inhalation|smoke inhalation
347687|NCT01656603|cord blood|cord blood
347688|NCT01656603|transplantation|transplantation
347689|NCT01656603|stem cells|stem cells
347690|NCT01656603|adverse event|adverse event
347691|NCT01656590|Pompe disease|pompe disease
347692|NCT01656590|Acid Maltase Deficiency|acid maltase deficiency
347693|NCT01656577|CRF1 antagonist|crf1 antagonist
347694|NCT01656577|Stress|stress
347695|NCT01656577|Eating Behavior|eating behavior
347696|NCT01656577|Food Craving|food craving
347697|NCT01656564|HIV|hiv
347698|NCT01656564|Pediatric|pediatric
347699|NCT01656564|ART|art
347700|NCT01656564|Longitudinal|longitudinal
347701|NCT01656564|Outcomes|outcomes
347702|NCT01656551|elderly|elderly
347703|NCT01656551|chemotherapy|chemotherapy
347704|NCT01656512|ALL|all
347705|NCT01656512|zoledronic acid|zoledronic acid
347706|NCT01656512|Osteoporosis|osteoporosis
347707|NCT01656486|Pancreas|pancreas
347708|NCT01656486|Pancreatic fistula|pancreatic fistula
347709|NCT01656486|Stereotactic radiation|stereotactic radiation
347710|NCT01656473|Concurrent Disorders|concurrent disorders
347711|NCT01656473|Adolescents|adolescents
347712|NCT01656473|Motivational Interviewing|motivational interviewing
347713|NCT01656473|Dialectical Behaviour Therapy|dialectical behaviour therapy
347714|NCT01656473|Caregiver Burden|caregiver burden
347715|NCT01656460|Lung Cancer|lung cancer
347716|NCT01656447|Scleroderma|scleroderma
347717|NCT01656447|Scleroderma Registry|scleroderma registry
347718|NCT01656447|Hospital for Special Surgery Scleroderma|hospital for special surgery scleroderma
347719|NCT01656434|Combined Oral Contraceptives|combined oral contraceptives
347720|NCT01656382|ABLC|ablc
347721|NCT01656382|cryptococcosis|cryptococcosis
347722|NCT01656369|Delorme operation,incontinence|delorme operation,incontinence
347723|NCT01656356|Avian Flu|avian flu
347724|NCT01656356|H5N2|h5n2
347725|NCT01656330|Healthy|healthy
347726|NCT01656330|Rivaroxaban|rivaroxaban
347727|NCT01656330|JNJ-39039039|jnj-39039039
347728|NCT01656330|BAY59-7939|bay59-7939
347729|NCT01656330|Prothrombin Complex Concentrate (PCC)|prothrombin complex concentrate (pcc)
347730|NCT01656317|SAH|sah
347731|NCT01656317|Early rehabilitation|early rehabilitation
347732|NCT01656317|Mobilisation|mobilisation
347733|NCT01656278|Arthritis, Rheumatoid/drug therapy|arthritis, rheumatoid/drug therapy
347734|NCT01656278|Arthritis, Rheumatoid/pathology|arthritis, rheumatoid/pathology
347735|NCT01656278|Disease Progression|disease progression
347736|NCT01656278|Longitudinal Studies|longitudinal studies
347737|NCT01656278|Prospective Studies|prospective studies
347738|NCT01656278|Imaging, Magnetic Resonance|imaging, magnetic resonance
347739|NCT01656278|Remission Induction|remission induction
347740|NCT01656278|Synovitis/immunology|synovitis/immunology
347741|NCT01656278|Synovitis/pathology|synovitis/pathology
347742|NCT01656278|Wrist Joint/pathology|wrist joint/pathology
347743|NCT01656278|Wrist Joint/physiopathology|wrist joint/physiopathology
347744|NCT01656252|Acute Leukemia|acute leukemia
347745|NCT01656252|Complete Remission|complete remission
347746|NCT01656252|Consolidation|consolidation
347747|NCT01656252|Consolidation Chemotherapy|consolidation chemotherapy
347748|NCT01656252|Cytarabine|cytarabine
347749|NCT01656252|Eltrombopag|eltrombopag
347750|NCT01656252|Leukemia|leukemia
347751|NCT01656252|Thrombocytopenia|thrombocytopenia
347752|NCT01656252|Thrombopoietin|thrombopoietin
347753|NCT01656239|VA106483, fedovapagon, Nocturia, males, nocturnal voids, anti-diuretic|va106483, fedovapagon, nocturia, males, nocturnal voids, anti-diuretic
347754|NCT01656226|Actinic Keratosis|actinic keratosis
347755|NCT01656226|AK|ak
347756|NCT01656213|Stroke|stroke
347757|NCT01656213|End Stage Renal Disease|end stage renal disease
347758|NCT01656213|Recovery|recovery
347759|NCT01656213|Haemodialysis|haemodialysis
347760|NCT01656200|Japanese encephalitis|japanese encephalitis
347761|NCT01656200|Japanese encephalitis vaccine|japanese encephalitis vaccine
347762|NCT01656200|T lymphocyte|t lymphocyte
347763|NCT01656200|Immune response|immune response
347764|NCT01656187|memantine|memantine
347765|NCT01656187|cognition|cognition
347766|NCT01656187|corticosteroid|corticosteroid
347767|NCT01656187|prednisone|prednisone
347768|NCT01656187|memory|memory
347769|NCT01656187|hippocampus|hippocampus
347770|NCT01656148|Multiple sclerosis|multiple sclerosis
347771|NCT01656148|Walking disablility|walking disablility
347772|NCT01656148|Mobility|mobility
347773|NCT01656148|Six Spot Step Test|six spot step test
347774|NCT01656148|Outcome measures|outcome measures
347775|NCT01656148|Fampridine-SR|fampridine-sr
347776|NCT01656148|Fampyra|fampyra
347777|NCT01656135|gold standard treatment|gold standard treatment
347778|NCT01656135|immune monitoring|immune monitoring
347779|NCT01656135|acute rejection|acute rejection
347780|NCT01656135|graft rejection|graft rejection
347781|NCT01656135|living-donor|living-donor
347782|NCT01656135|renal transplantation|renal transplantation
347783|NCT01656135|kidney transplantation|kidney transplantation
347784|NCT01656122|pharmacokinetic paramters|pharmacokinetic paramters
347785|NCT01656122|abacavir|abacavir
347786|NCT01656122|lamuvidine|lamuvidine
347787|NCT01656122|HIV-infected children|hiv-infected children
347788|NCT01656109|pharmacokinetics|pharmacokinetics
347789|NCT01656109|atazanavir/ritonavir|atazanavir/ritonavir
347790|NCT01656109|HIV-infected children|hiv-infected children
347791|NCT01656083|Mobile phone text messaging (SM)|mobile phone text messaging (sm)
347792|NCT01656083|Varenicline|varenicline
347793|NCT01656083|The compliance|the compliance
347794|NCT01656083|The abstinence rate|the abstinence rate
347796|NCT01656070|children|children
347797|NCT01656070|adolescents|adolescents
347798|NCT01656070|Vitamin D|vitamin d
347799|NCT01656070|immunity|immunity
347800|NCT01656070|T cell phenotype|t cell phenotype
347801|NCT01656057|Bile acids|bile acids
347802|NCT01656057|Gall bladder emptying|gall bladder emptying
347803|NCT01656057|Human|human
347804|NCT01656057|Glucagon like peptide 1|glucagon like peptide 1
347805|NCT01656057|GLP-1|glp-1
347806|NCT01656031|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
347807|NCT01656031|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
347808|NCT01656031|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
347809|NCT01656031|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
347810|NCT01656031|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
347811|NCT01656031|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
347812|NCT01656031|adult acute basophilic leukemia|adult acute basophilic leukemia
347813|NCT01656031|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
347814|NCT01656031|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
347815|NCT01656031|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
347816|NCT01656031|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
347817|NCT01656031|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
347818|NCT01656031|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
347819|NCT01656031|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
347820|NCT01656031|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
347821|NCT01656031|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
347822|NCT01656031|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
347823|NCT01656018|Healthy|healthy
347824|NCT01656018|TMC278|tmc278
347825|NCT01656018|Human Immunodeficiency Virus Type 1|human immunodeficiency virus type 1
347826|NCT01656018|HIV-1|hiv-1
347827|NCT01656018|Pharmacokinetics|pharmacokinetics
347828|NCT01656018|Ex-vivo pharmacodynamics|ex-vivo pharmacodynamics
347829|NCT01656005|COPD|copd
347830|NCT01656005|Beta blockers|beta blockers
347831|NCT01656005|Cardioselective|cardioselective
347832|NCT01656005|Non-cardioselective|non-cardioselective
347833|NCT01656005|Impulse oscillometry|impulse oscillometry
347834|NCT01655992|capecitabine|capecitabine
347835|NCT01655992|Tegafur，Gimeracil and Oteracil Potassium Capsules|tegafur，gimeracil and oteracil potassium capsules
347836|NCT01655966|chronic hepatitis c|chronic hepatitis c
347837|NCT01655966|hcv|hcv
347838|NCT01655966|vitamin d|vitamin d
347839|NCT01655927|Neoplasms|neoplasms
347840|NCT01655927|Tranexamic Acid|tranexamic acid
347841|NCT01655927|Brain Tumors|brain tumors
347842|NCT01655901|Active video games|active video games
347843|NCT01655901|Food intake|food intake
347844|NCT01655901|Energy balance|energy balance
347845|NCT01655901|Adolescents|adolescents
347846|NCT01655888|Tremelimumab|tremelimumab
347847|NCT01655888|anti-CTLA-4 monoclonal antibody|anti-ctla-4 monoclonal antibody
347848|NCT01655888|malignant mesothelioma|malignant mesothelioma
347849|NCT01655875|Allogeneic Blood and Marrow Transplantation|allogeneic blood and marrow transplantation
347850|NCT01655823|Pain|pain
347851|NCT01655823|Puffer fish|puffer fish
347852|NCT01655823|Tetrodotoxin|tetrodotoxin
347853|NCT01655823|TTX|ttx
347854|NCT01655823|Neuropathy|neuropathy
347855|NCT01655823|Chemotherapy|chemotherapy
347856|NCT01655823|WEX Pharmaceuticals|wex pharmaceuticals
347857|NCT01655797|insomnia|insomnia
347858|NCT01655797|cognitive behavior therapy|cognitive behavior therapy
347859|NCT01655797|primary care|primary care
347860|NCT01655784|aneurysm|aneurysm
347861|NCT01655784|intracranial aneurysm|intracranial aneurysm
347862|NCT01655784|cerebral aneurysm|cerebral aneurysm
347863|NCT01655784|intracranial embolization|intracranial embolization
347864|NCT01655784|aneurysm embolization|aneurysm embolization
347865|NCT01655784|intracranial coil|intracranial coil
347866|NCT01655784|eighteen coils|eighteen coils
347867|NCT01655784|bare platinum coils|bare platinum coils
347868|NCT01655784|GDC Coil|gdc coil
347869|NCT01655784|Target Coil|target coil
347870|NCT01655771|Opioid induced constipation|opioid induced constipation
347871|NCT01655771|Constipation|constipation
347872|NCT01655758|glaucoma|glaucoma
347873|NCT01655758|24-hour IOP|24-hour iop
347874|NCT01655758|outflow drugs|outflow drugs
347875|NCT01655758|inflow drugs|inflow drugs
347876|NCT01655745|[18F]|[18f]
347877|NCT01655745|FDG Positron Emission Tomography-Magnetic Resonance Imaging|fdg positron emission tomography-magnetic resonance imaging
347878|NCT01655745|FDG-PET-MRI|fdg-pet-mri
347879|NCT01655745|Muscle-Invasive Bladder Cancer|muscle-invasive bladder cancer
347880|NCT01655745|Pilot Study|pilot study
347881|NCT01655745|LCCC 1209|lccc 1209
347882|NCT01655745|UNC Lineberger|unc lineberger
347883|NCT01655745|MDCT|mdct
347884|NCT01655732|Pregnancy|pregnancy
347885|NCT01655706|major depression|major depression
347886|NCT01655706|major depressive disorder|major depressive disorder
347887|NCT01655706|biomarkers|biomarkers
347888|NCT01655706|escitalopram|escitalopram
347889|NCT01655706|aripiprazole|aripiprazole
347890|NCT01655706|MDD|mdd
347891|NCT01655706|neuroimaging|neuroimaging
347892|NCT01655706|proteomic|proteomic
347893|NCT01655706|genomics|genomics
347894|NCT01655693|Intermediate/advanced hepatocellular carcinoma|intermediate/advanced hepatocellular carcinoma
347895|NCT01655693|After failure or intolerance to Sorafenib.|after failure or intolerance to sorafenib.
347896|NCT01655680|Schizophrenia|schizophrenia
347897|NCT01655667|Diagnosis|diagnosis
347898|NCT01655667|Primary Care|primary care
347899|NCT01655667|Comorbidities|comorbidities
347900|NCT01655667|Healthcare utilisation|healthcare utilisation
347901|NCT01655654|Hypertension|hypertension
347902|NCT01655654|Acute hospital staff|acute hospital staff
347903|NCT01655654|Exercise|exercise
347904|NCT01655654|Diet|diet
347905|NCT01655641|Blood transfusion|blood transfusion
347906|NCT01655641|Bleeding|bleeding
347907|NCT01655641|Major Gastro-intestinal surgery|major gastro-intestinal surgery
347908|NCT01655641|Tranexamic Acid|tranexamic acid
347909|NCT01655628|nasopharyngeal carcinoma|nasopharyngeal carcinoma
347910|NCT01655628|metastasis|metastasis
347911|NCT01655628|gemcitabine|gemcitabine
347912|NCT01655628|CIK cells|cik cells
347913|NCT01655615|Adolescent cognitive development|adolescent cognitive development
347914|NCT01655615|mental disorders|mental disorders
347915|NCT01655615|Mood disorders|mood disorders
347916|NCT01655615|Alcohol-Related disorders|alcohol-related disorders
347917|NCT01655615|Mental disorders diagnosed in childhood|mental disorders diagnosed in childhood
347918|NCT01655615|Substance related disorders|substance related disorders
347919|NCT01655602|Trichophytic closure|trichophytic closure
347920|NCT01655602|hair transplantation|hair transplantation
347921|NCT01655602|donor site|donor site
347922|NCT01655602|Androgenetic alopecia|androgenetic alopecia
347923|NCT01655576|drainage|drainage
347924|NCT01655576|pregnancy|pregnancy
347925|NCT01655576|active management|active management
347926|NCT01655576|postpartum hemorrhage|postpartum hemorrhage
347927|NCT01655563|Transplant|transplant
347928|NCT01655563|Pediatrics|pediatrics
347929|NCT01655563|Tacrolimus|tacrolimus
347930|NCT01655563|Prograf|prograf
347931|NCT01655537|fibromyalgia|fibromyalgia
347932|NCT01655537|cognitive dysfunction|cognitive dysfunction
347933|NCT01655524|Regadenoson|regadenoson
347934|NCT01655524|Aminophylline|aminophylline
347935|NCT01655524|ASSUAGE|assuage
347936|NCT01655524|Myocardial Perfusion Imaging (MPI)|myocardial perfusion imaging (mpi)
347937|NCT01655511|Pharmacokinetic|pharmacokinetic
347938|NCT01655511|pharmacodynamic|pharmacodynamic
347939|NCT01655498|fecal incontinence|fecal incontinence
347940|NCT01655498|bowel control|bowel control
347941|NCT01655485|child anxiety|child anxiety
347942|NCT01655485|challenging behaviors|challenging behaviors
347943|NCT01655485|time|time
347944|NCT01655485|Parent anxiety|parent anxiety
347945|NCT01655472|schizophrenia|schizophrenia
347946|NCT01655472|imaging|imaging
347947|NCT01655459|ultrasound, LMA, fiberoptic bronchoscopy|ultrasound, lma, fiberoptic bronchoscopy
347948|NCT01655446|Comparative effectiveness research|comparative effectiveness research
347949|NCT01655446|Robotic rehabilitation|robotic rehabilitation
347950|NCT01655446|Mirror therapy|mirror therapy
347951|NCT01655446|Functional electrical therapy|functional electrical therapy
347952|NCT01655446|Combined therapy|combined therapy
347953|NCT01655446|Stroke rehabilitation|stroke rehabilitation
347954|NCT01655446|Translational science|translational science
347955|NCT01655433|ST-elevation MI|st-elevation mi
347956|NCT01655433|Hypothermia|hypothermia
347957|NCT01655420|Myopia|myopia
347958|NCT01655420|Hyperopia|hyperopia
347959|NCT01655420|Astigmatism|astigmatism
347960|NCT01655420|Patient-reported outcomes|patient-reported outcomes
347961|NCT01655420|Patient satisfaction|patient satisfaction
347962|NCT01655420|Refractive Error|refractive error
347963|NCT01655420|Emmetropia|emmetropia
347964|NCT01655420|Dry eyes|dry eyes
347965|NCT01655420|Glare|glare
347966|NCT01655420|Halos|halos
347967|NCT01655420|Patient expectations|patient expectations
347968|NCT01655407|Split-thickness Autograft|split-thickness autograft
347969|NCT01655407|Engraftment|engraftment
347970|NCT01655407|Wound Closure|wound closure
347971|NCT01655407|Engineered Skin Substitute|engineered skin substitute
347972|NCT01655407|ESS-W|ess-w
347973|NCT01655407|Cultured Skin Substitutes|cultured skin substitutes
347974|NCT01655407|Burn|burn
347975|NCT01655342|pulpotomy|pulpotomy
347976|NCT01655342|primary teeth|primary teeth
347977|NCT01655342|Biodentine®|biodentine®
347978|NCT01655342|formocresol|formocresol
347979|NCT01655329|Image Processing|image processing
347980|NCT01655329|tubes|tubes
347981|NCT01655329|lines|lines
347982|NCT01655329|catheters|catheters
347983|NCT01655329|wires|wires
347984|NCT01655329|Bedside|bedside
347985|NCT01655329|chest|chest
347986|NCT01655329|radiographs|radiographs
347987|NCT01655264|Stroke|stroke
347988|NCT01655264|Tele-health|tele-health
347989|NCT01655264|Rehabilitation|rehabilitation
347990|NCT01655264|Intervention|intervention
347991|NCT01655264|Gesture recognition system|gesture recognition system
347992|NCT01655251|children|children
347993|NCT01655251|fever|fever
347994|NCT01655251|emergency department|emergency department
347995|NCT01655225|Advanced Breast Cancer|advanced breast cancer
347996|NCT01655225|Advanced Lung Cancer|advanced lung cancer
347997|NCT01655225|Mesothelioma|mesothelioma
347998|NCT01655225|Lymphoma|lymphoma
347999|NCT01655212|Cytomegalovirus|cytomegalovirus
348000|NCT01655212|Congenital infection|congenital infection
348001|NCT01655212|Sensorineural hearing loss|sensorineural hearing loss
348002|NCT01655212|Randomized controlled trial|randomized controlled trial
348003|NCT01655212|Valganciclovir|valganciclovir
348004|NCT01655199|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
348005|NCT01655199|Lung function|lung function
348006|NCT01655199|Exertional dyspnea|exertional dyspnea
348007|NCT01655199|Exercise capacity|exercise capacity
348008|NCT01655199|Pulmonary function|pulmonary function
348009|NCT01655199|Pleural pressures|pleural pressures
348010|NCT01655186|Chronic Kidney Disease|chronic kidney disease
348011|NCT01655186|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
348012|NCT01655173|Asperger syndrome|asperger syndrome
348013|NCT01655173|Autistic disorder|autistic disorder
348014|NCT01655173|Adult|adult
348015|NCT01655173|Psychotherapy|psychotherapy
348016|NCT01655160|Stroke rehabilitation|stroke rehabilitation
348017|NCT01655160|Mirror therapy|mirror therapy
348018|NCT01655160|Functional performance|functional performance
348019|NCT01655160|Kinematic analysis|kinematic analysis
348020|NCT01655160|Functional magnetic resonance image|functional magnetic resonance image
348021|NCT01655160|Motor recovery|motor recovery
348022|NCT01655147|Healthy|healthy
348023|NCT01655147|Pharmacokinetics|pharmacokinetics
348024|NCT01655147|Abiraterone acetate|abiraterone acetate
348025|NCT01655147|Abiraterone|abiraterone
348026|NCT01655147|JNJ-589485|jnj-589485
348027|NCT01655147|JNJ-212082|jnj-212082
348028|NCT01655147|Zytiga|zytiga
348029|NCT01655147|Rifampicin|rifampicin
348030|NCT01655147|Rifadin|rifadin
348031|NCT01655147|CYP3A4 inducer|cyp3a4 inducer
348032|NCT01655134|Heart Failure|heart failure
348033|NCT01655134|Telemonitoring systems for congestive HF|telemonitoring systems for congestive hf
348034|NCT01655134|Biomarkers|biomarkers
348035|NCT01655108|Androgenetic Alopecia|androgenetic alopecia
348036|NCT01655108|Mesotherapy|mesotherapy
348037|NCT01655108|Minoxidil|minoxidil
348038|NCT01655108|Trichogram|trichogram
348039|NCT01655095|Colon capsule|colon capsule
348040|NCT01655095|Picosalax|picosalax
348041|NCT01655095|PEG|peg
348042|NCT01655095|Prucalopride|prucalopride
348043|NCT01655082|Smoking cessation|smoking cessation
348044|NCT01655082|Nicotine|nicotine
348045|NCT01655082|Tobacco Use Disorder|tobacco use disorder
348046|NCT01655082|Central Nervous System Agents|central nervous system agents
348047|NCT01655069|Overactive bladder (OAB)|overactive bladder (oab)
348048|NCT01655069|Solifenacin succinate suspension|solifenacin succinate suspension
348049|NCT01655069|Phase 3|phase 3
348050|NCT01655069|Pediatric|pediatric
348051|NCT01655056|Pharmacokinetics|pharmacokinetics
348052|NCT01655056|Pharmacodynamics|pharmacodynamics
348053|NCT01655056|Phase 1|phase 1
348054|NCT01655056|YM150|ym150
348055|NCT01655056|Dose-escalating|dose-escalating
348056|NCT01655056|Ethnicity|ethnicity
348057|NCT01655056|Caucasian|caucasian
348058|NCT01655056|Japanese|japanese
348059|NCT01655043|Magnetic Resonance Imaging|magnetic resonance imaging
348060|NCT01655043|regadenoson|regadenoson
348061|NCT01655017|Obesity|obesity
348062|NCT01655017|adipose tissue fibrosis|adipose tissue fibrosis
348063|NCT01655017|Adipose tissue inflammation|adipose tissue inflammation
348064|NCT01655017|Low grade systemic inflammation|low grade systemic inflammation
348065|NCT01655017|non invasive device|non invasive device
348066|NCT01655017|Bariatric surgery|bariatric surgery
348067|NCT01655004|hormone receptor positive|hormone receptor positive
348068|NCT01655004|breast cancer|breast cancer
348069|NCT01654939|HIV|hiv
348070|NCT01654939|hepatitis C|hepatitis c
348071|NCT01654926|Feasibility of using the FlexFlowTM ultrafiltration pump in a non hospital environment|feasibility of using the flexflowtm ultrafiltration pump in a non hospital environment
348072|NCT01654913|hemoglobin determination|hemoglobin determination
348073|NCT01654913|oxygen|oxygen
348074|NCT01654887|Comparative Effectiveness|comparative effectiveness
348075|NCT01654887|Lung Ultrasound versus Chest X-ray|lung ultrasound versus chest x-ray
348076|NCT01654887|Pneumonia|pneumonia
348077|NCT01654887|Emergency Department|emergency department
348078|NCT01654848|liver transplantation|liver transplantation
348079|NCT01654848|thrombocytes|thrombocytes
348080|NCT01654848|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
348081|NCT01654848|multivariate analysis of associated factors of HIT 2 after OLT|multivariate analysis of associated factors of hit 2 after olt
348082|NCT01654848|laboratory investigations of HIT-antibodies|laboratory investigations of hit-antibodies
348083|NCT01654822|HPV|hpv
348084|NCT01654822|cervix|cervix
348085|NCT01654796|Depression|depression
348086|NCT01654796|Treatment Resistant Depression|treatment resistant depression
348087|NCT01654783|5-ASA, ulcerative colitis, active, remission, adherence|5-asa, ulcerative colitis, active, remission, adherence
348088|NCT01654770|VCE, DBE,OGIB|vce, dbe,ogib
348089|NCT01654770|consecutive|consecutive
348090|NCT01654770|patients|patients
348091|NCT01654731|PBC|pbc
348092|NCT01654731|Bezafibrate|bezafibrate
348093|NCT01654692|metastatic melanoma|metastatic melanoma
348094|NCT01654692|Ipilimumab|ipilimumab
348095|NCT01654679|wound infection|wound infection
348096|NCT01654679|surgery|surgery
348097|NCT01654679|surgical wound infection rate|surgical wound infection rate
348098|NCT01654679|wound healing|wound healing
348099|NCT01654666|Remote ischemic preconditioning|remote ischemic preconditioning
348100|NCT01654666|Stroke secondary prevention|stroke secondary prevention
348101|NCT01654666|Carotid artery stenting|carotid artery stenting
348102|NCT01654666|Carotid stenosis|carotid stenosis
348103|NCT01654666|Inflammation|inflammation
348104|NCT01654653|Heart disease|heart disease
348105|NCT01654653|cardiac surgery|cardiac surgery
348106|NCT01654653|CABG|cabg
348107|NCT01654653|Totilac|totilac
348108|NCT01654653|Voluven|voluven
348109|NCT01654653|6% HES|6% hes
348110|NCT01654640|schizophrenia|schizophrenia
348111|NCT01654640|obesity|obesity
348112|NCT01654640|clozapine|clozapine
348113|NCT01654640|metformin|metformin
348114|NCT01654627|Guided Tissue Regeneration|guided tissue regeneration
348115|NCT01654627|Dental Implants|dental implants
348116|NCT01654627|Membrane, Synthetic|membrane, synthetic
348117|NCT01654614|Keratoconus match index|keratoconus match index
348118|NCT01654614|keratoconus probability index|keratoconus probability index
348119|NCT01654614|ocular response analyzer|ocular response analyzer
348120|NCT01654614|Pentacam|pentacam
348421|NCT01653327|oral|oral
348121|NCT01654614|forme fruste keratoconus|forme fruste keratoconus
348122|NCT01654601|Schizophrenia|schizophrenia
348123|NCT01654588|BRONCHIAL CHALLANGE TEST, ASTHMA, METACHLINE, ADENOSINE|bronchial challange test, asthma, metachline, adenosine
348124|NCT01654575|Methotrexate|methotrexate
348125|NCT01654575|Knee Osteoarthritis|knee osteoarthritis
348126|NCT01654575|Synovitis|synovitis
348127|NCT01654575|Pain reduction|pain reduction
348128|NCT01654575|Function scores|function scores
348129|NCT01654549|Steatohepatitis,|steatohepatitis,
348130|NCT01654549|Helicobacter pylori,|helicobacter pylori,
348131|NCT01654549|Insulin resistance,|insulin resistance,
348132|NCT01654549|Alanine aminotransferase,|alanine aminotransferase,
348133|NCT01654549|Aspartate aminotransferase,|aspartate aminotransferase,
348134|NCT01654536|PAR|par
348135|NCT01654523|Trichotillomania|trichotillomania
348136|NCT01654497|Brain|brain
348137|NCT01654497|Glioma|glioma
348138|NCT01654497|glioblastoma|glioblastoma
348139|NCT01654497|metastases|metastases
348140|NCT01654497|cancer|cancer
348141|NCT01654497|ETS2101|ets2101
348142|NCT01654497|leptomeningeal|leptomeningeal
348143|NCT01654497|astrocytoma|astrocytoma
348144|NCT01654497|oligodendroglioma|oligodendroglioma
348145|NCT01654497|meningioma|meningioma
348146|NCT01654471|Walking Impairment Questionnaire|walking impairment questionnaire
348147|NCT01654471|Peripheral arterial occlusive disease|peripheral arterial occlusive disease
348148|NCT01654471|Korean version|korean version
348149|NCT01654458|Sexual Dysfunctions, Psychological|sexual dysfunctions, psychological
348150|NCT01654458|Psychotherapy, Group|psychotherapy, group
348151|NCT01654458|Genital Neoplasms, Female|genital neoplasms, female
348152|NCT01654458|Endometrial Neoplasms|endometrial neoplasms
348153|NCT01654458|Fallopian Tube Neoplasms|fallopian tube neoplasms
348154|NCT01654458|Ovarian Neoplasms|ovarian neoplasms
348155|NCT01654458|Urogenital Neoplasms|urogenital neoplasms
348156|NCT01654458|Uterine Cervical Neoplasms|uterine cervical neoplasms
348157|NCT01654458|Uterine Neoplasms|uterine neoplasms
348158|NCT01654458|Vaginal Neoplasms|vaginal neoplasms
348159|NCT01654458|Vulvar Neoplasms|vulvar neoplasms
348160|NCT01654445|Minor stroke|minor stroke
348161|NCT01654419|sliding jig|sliding jig
348162|NCT01654419|Class II malocclusion|class ii malocclusion
348163|NCT01654419|Distalization mechanics|distalization mechanics
348164|NCT01654419|Intermaxillary elastics|intermaxillary elastics
348165|NCT01654406|Cesarian scar|cesarian scar
348166|NCT01654406|Fractional CO2 laser|fractional co2 laser
348167|NCT01654393|Triage nurse|triage nurse
348168|NCT01654393|Ottawa ankle rules|ottawa ankle rules
348169|NCT01654354|Qualitative Evaluation of abdominal CT image using 4 point scale: Excellent(4)/ Good(3) / Fair(2) / Unacceptable(1)|qualitative evaluation of abdominal ct image using 4 point scale: excellent(4)/ good(3) / fair(2) / unacceptable(1)
348170|NCT01654328|contrast media|contrast media
348171|NCT01654328|kidney injury|kidney injury
348172|NCT01654328|hydration|hydration
348173|NCT01654315|RTP Only Group|rtp only group
348174|NCT01654315|Myomo Only Group|myomo only group
348175|NCT01654315|Myom0 + RTP Group|myom0 + rtp group
348176|NCT01654289|respiratory tract infections|respiratory tract infections
348177|NCT01654289|common cold|common cold
348178|NCT01654289|exercise|exercise
348179|NCT01654289|influenza|influenza
348180|NCT01654289|meditation|meditation
348181|NCT01654263|13-valent|13-valent
348182|NCT01654263|23-valent|23-valent
348183|NCT01654263|elderly|elderly
348184|NCT01654263|parent protocol|parent protocol
348185|NCT01654263|Pneumococcal infections|pneumococcal infections
348186|NCT01654263|vaccine|vaccine
348187|NCT01654250|ADHD|adhd
348188|NCT01654250|methylphenidate extended-release|methylphenidate extended-release
348189|NCT01654237|work|work
348190|NCT01654237|WMSD|wmsd
348191|NCT01654237|prevalence|prevalence
348192|NCT01654237|occupational risks|occupational risks
348193|NCT01654237|industry|industry
348194|NCT01654237|questionnaires|questionnaires
348195|NCT01654237|musculoskeletal pain|musculoskeletal pain
348196|NCT01654237|lifestyle|lifestyle
348197|NCT01654224|Influenza in Long Term Care Setting|influenza in long term care setting
348198|NCT01654224|High dose Inactivated influenza vaccine|high dose inactivated influenza vaccine
348199|NCT01654224|Standard dose inactivated influenza vaccine|standard dose inactivated influenza vaccine
348200|NCT01654172|Diabetes|diabetes
348201|NCT01654172|peripheral neuropathy|peripheral neuropathy
348202|NCT01654172|Cocoa flavanols|cocoa flavanols
348203|NCT01654159|intraocular lenses|intraocular lenses
348204|NCT01654159|evaluation|evaluation
348205|NCT01654159|cataract|cataract
348206|NCT01654146|Ovarian cancer|ovarian cancer
348207|NCT01654146|Epithelial ovarian carcinoma|epithelial ovarian carcinoma
348208|NCT01654146|Fallopian tube carcinoma|fallopian tube carcinoma
348209|NCT01654146|Primary serous peritoneal carcinoma|primary serous peritoneal carcinoma
348210|NCT01654146|Gynaecological carcinoma|gynaecological carcinoma
348211|NCT01654146|Randomised controlled trial|randomised controlled trial
348212|NCT01654133|Aortic Aneurysm, abdominal|aortic aneurysm, abdominal
348213|NCT01654120|insulin|insulin
348214|NCT01654120|Type II Diabetes|type ii diabetes
348215|NCT01654120|liraglutide|liraglutide
348216|NCT01654120|Glucagon-Like Peptide 1|glucagon-like peptide 1
348217|NCT01654107|tobacco|tobacco
348218|NCT01654107|smoking cessation|smoking cessation
348219|NCT01654107|nicotine dependence|nicotine dependence
348220|NCT01654081|Lung Cancer|lung cancer
348221|NCT01654081|POSITIVE NON SMALL CELL CARCINOMA|positive non small cell carcinoma
348222|NCT01654081|ISG15|isg15
348223|NCT01654081|IRINOTECAN|irinotecan
348224|NCT01654068|Female Breast Cancer|female breast cancer
348225|NCT01654068|Kidney Cancer|kidney cancer
348226|NCT01654068|Lung Cancer|lung cancer
348227|NCT01654068|Prostate Cancer|prostate cancer
348228|NCT01654068|Vertebral metastasis|vertebral metastasis
348229|NCT01654055|Morphine|morphine
348230|NCT01654055|Adverse events|adverse events
348231|NCT01654055|Predictive factors|predictive factors
348232|NCT01654042|anticoagulation|anticoagulation
348233|NCT01654042|warfarin|warfarin
348234|NCT01654042|monitoring|monitoring
348235|NCT01654042|bleeding|bleeding
348236|NCT01654042|thromboembolism|thromboembolism
348237|NCT01654029|Stroke|stroke
348238|NCT01654029|Communication impairments|communication impairments
348239|NCT01654029|Nurse-patient communication|nurse-patient communication
348240|NCT01654029|Patient-centred care|patient-centred care
348241|NCT01654016|varicose veins|varicose veins
348242|NCT01654016|inflammation|inflammation
348243|NCT01654003|Goal-directed therapy|goal-directed therapy
348244|NCT01654003|severe sepsis|severe sepsis
348245|NCT01654003|emergency surgery|emergency surgery
348246|NCT01654003|vasopressor|vasopressor
348247|NCT01654003|dynamic flow-related parameters|dynamic flow-related parameters
348248|NCT01653977|Hypovolemic shock|hypovolemic shock
348249|NCT01653977|trauma|trauma
348250|NCT01653977|emergency|emergency
348251|NCT01653977|surgery|surgery
348252|NCT01653977|GDT|gdt
348253|NCT01653977|Picco|picco
348254|NCT01653964|suspicious|suspicious
348255|NCT01653964|lesion|lesion
348256|NCT01653964|breast|breast
348257|NCT01653964|cancer|cancer
348258|NCT01653964|screening|screening
348259|NCT01653964|mammogram|mammogram
348260|NCT01653964|negative|negative
348261|NCT01653938|CHF|chf
348262|NCT01653925|Prostatic Neoplasms|prostatic neoplasms
348263|NCT01653925|Low grade prostate cancer|low grade prostate cancer
348264|NCT01653912|cancer|cancer
348265|NCT01653912|ovarian|ovarian
348266|NCT01653912|platinum-resistant|platinum-resistant
348267|NCT01653899|Type I Diabetes|type i diabetes
348268|NCT01653886|Palatability|palatability
348269|NCT01653886|Taste|taste
348270|NCT01653873|fracture|fracture
348271|NCT01653873|vertebral column|vertebral column
348272|NCT01653873|osteoporosis|osteoporosis
348273|NCT01653873|predictor|predictor
348274|NCT01653873|vertebroplasty|vertebroplasty
348275|NCT01653860|Behavior therapy|behavior therapy
348276|NCT01653860|Group therapy|group therapy
348277|NCT01653847|transplant|transplant
348278|NCT01653847|kidney|kidney
348279|NCT01653847|renal disease|renal disease
348280|NCT01653834|lymphopenia|lymphopenia
348281|NCT01653821|carotid body|carotid body
348282|NCT01653821|heart failure|heart failure
348283|NCT01653821|chemoreceptor|chemoreceptor
348284|NCT01653821|hypersensitivity|hypersensitivity
348285|NCT01653808|CKD dialysis|ckd dialysis
348286|NCT01653808|hemodialysis|hemodialysis
348287|NCT01653808|hemodiafiltration|hemodiafiltration
348288|NCT01653808|Elisio dialyzer|elisio dialyzer
348289|NCT01653808|efficacy|efficacy
348290|NCT01653808|biocompatibility|biocompatibility
348291|NCT01653782|LPB|lpb
348292|NCT01653782|RCT|rct
348293|NCT01653782|Intervention study|intervention study
348294|NCT01653782|Cost effectiveness|cost effectiveness
348295|NCT01653782|Yoga|yoga
348296|NCT01653782|evidence based|evidence based
348297|NCT01653782|advice to stay active|advice to stay active
348298|NCT01653782|exercise training|exercise training
348299|NCT01653769|CoSeal|coseal
348300|NCT01653769|Surgical bleeding|surgical bleeding
348301|NCT01653769|hemostasis|hemostasis
348302|NCT01653769|Aortic anastamoses|aortic anastamoses
348303|NCT01653769|bleeding|bleeding
348304|NCT01653769|Cardiac surgery|cardiac surgery
348305|NCT01653769|Aneurysms|aneurysms
348306|NCT01653769|Aortic Dissection|aortic dissection
348307|NCT01653756|Asthma|asthma
348308|NCT01653756|Allergen Challenge|allergen challenge
348309|NCT01653743|Japanese|japanese
348310|NCT01653730|portable oxygen concentrator|portable oxygen concentrator
348311|NCT01653730|6-minute walk test|6-minute walk test
348312|NCT01653730|chronic obstructive lung disease|chronic obstructive lung disease
348313|NCT01653730|pulmonary fibrosis|pulmonary fibrosis
348314|NCT01653730|long term oxygen therapy|long term oxygen therapy
348315|NCT01653717|Advanced Cancers|advanced cancers
348316|NCT01653717|Leukemia|leukemia
348317|NCT01653717|B-cell Chronic Lymphocytic Leukemia|b-cell chronic lymphocytic leukemia
348318|NCT01653717|B-CLL|b-cll
348319|NCT01653717|CD19 positivity|cd19 positivity
348320|NCT01653717|CD19-specific T cells|cd19-specific t cells
348321|NCT01653717|T-Cell Infusion|t-cell infusion
348322|NCT01653717|Gene Transfer|gene transfer
348323|NCT01653717|Leukapheresis|leukapheresis
348324|NCT01653717|Fludarabine|fludarabine
348325|NCT01653717|Fludarabine Phosphate|fludarabine phosphate
348326|NCT01653717|Fludara|fludara
348327|NCT01653717|Cyclophosphamide|cyclophosphamide
348328|NCT01653717|Cytoxan|cytoxan
348329|NCT01653717|Neosar|neosar
348330|NCT01653691|Pediatric|pediatric
348331|NCT01653691|Burns|burns
348332|NCT01653691|Scars|scars
348333|NCT01653691|Pulse Dye laser|pulse dye laser
348334|NCT01653678|vitamin D-3|vitamin d-3
348335|NCT01653678|omega-3 fatty acids|omega-3 fatty acids
348336|NCT01653678|fish oil|fish oil
348337|NCT01653678|hypertension|hypertension
348338|NCT01653678|blood pressure|blood pressure
348339|NCT01653652|grass pollen|grass pollen
348340|NCT01653652|allergic rhinitis|allergic rhinitis
348341|NCT01653652|TNSS|tnss
348342|NCT01653652|miniRQLQ|minirqlq
348343|NCT01653639|BAY14-2222|bay14-2222
348344|NCT01653639|Pharmacokinetics|pharmacokinetics
348345|NCT01653613|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
348346|NCT01653613|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
348347|NCT01653613|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
348348|NCT01653613|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
348349|NCT01653600|peripheral arterial disease|peripheral arterial disease
348350|NCT01653600|atherosclerosis|atherosclerosis
348351|NCT01653600|nitinol|nitinol
348352|NCT01653600|stents|stents
348353|NCT01653587|Transradial Approach|transradial approach
348354|NCT01653587|Transfemoral Approach|transfemoral approach
348355|NCT01653587|Vascular Closure Device|vascular closure device
348356|NCT01653574|Famitinib Malate|famitinib malate
348357|NCT01653574|Metastatic Breast Cancer|metastatic breast cancer
348358|NCT01653574|HER-2 negative|her-2 negative
348359|NCT01653561|Metastatic breast cancer|metastatic breast cancer
348360|NCT01653561|Apatinib|apatinib
348361|NCT01653561|non-triple-negative|non-triple-negative
348362|NCT01653548|emotion dysregulation|emotion dysregulation
348363|NCT01653548|borderline personality disorder|borderline personality disorder
348364|NCT01653548|anxiety|anxiety
348365|NCT01653548|depression|depression
348366|NCT01653548|negative emotions|negative emotions
348367|NCT01653548|outpatient interventions for negative emotions|outpatient interventions for negative emotions
348368|NCT01653548|psychological distress|psychological distress
348369|NCT01653548|emotion regulation problems|emotion regulation problems
348370|NCT01653535|Prevention|prevention
348371|NCT01653535|Health Service Use|health service use
348372|NCT01653535|Behavioral Intervention|behavioral intervention
348373|NCT01653535|Conduct Problems|conduct problems
348374|NCT01653535|Anti-Social Behavior|anti-social behavior
348375|NCT01653509|cold sore|cold sore
348376|NCT01653496|Gastric cancer|gastric cancer
348377|NCT01653496|Perioperative care|perioperative care
348378|NCT01653496|Enhanced recovery after surgery|enhanced recovery after surgery
348379|NCT01653496|Multimodal rehabilitation|multimodal rehabilitation
348380|NCT01653496|Fast track surgery|fast track surgery
348381|NCT01653496|Gastrectomy|gastrectomy
348382|NCT01653483|Asthma|asthma
348383|NCT01653483|Umeclidinium|umeclidinium
348384|NCT01653483|Adolescent|adolescent
348385|NCT01653483|Pharmacokinetics|pharmacokinetics
348386|NCT01653457|Fibromyalgia|fibromyalgia
348387|NCT01653457|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
348388|NCT01653457|Memantine|memantine
348389|NCT01653457|electroencephalic cordance|electroencephalic cordance
348390|NCT01653405|anticoagulants|anticoagulants
348391|NCT01653405|pharmacists|pharmacists
348392|NCT01653405|quality improvement|quality improvement
348393|NCT01653405|quality of health care|quality of health care
348394|NCT01653392|Maternal Mortality|maternal mortality
348395|NCT01653392|Obstetric Labor, Premature|obstetric labor, premature
348396|NCT01653392|Eclampsia|eclampsia
348397|NCT01653392|Pre-Eclampsia|pre-eclampsia
348398|NCT01653392|Abortion, Spontaneous|abortion, spontaneous
348399|NCT01653392|Diabetes, Gestational|diabetes, gestational
348400|NCT01653392|Pregnancy, Ectopic|pregnancy, ectopic
348401|NCT01653392|Hydatidiform Mole|hydatidiform mole
348402|NCT01653392|Fetal death|fetal death
348403|NCT01653392|Live birth|live birth
348404|NCT01653392|Still birth|still birth
348405|NCT01653392|Premature Birth|premature birth
348406|NCT01653392|Sex ratio|sex ratio
348407|NCT01653392|Birth weight|birth weight
348408|NCT01653366|Breast Cancer|breast cancer
348409|NCT01653353|nursing home|nursing home
348410|NCT01653353|vitamin D supplements|vitamin d supplements
348411|NCT01653353|calcium supplements|calcium supplements
348412|NCT01653353|guideline adherence|guideline adherence
348413|NCT01653340|Refractory Chronic Migraine|refractory chronic migraine
348414|NCT01653340|Medically Intractable Chronic Migraine|medically intractable chronic migraine
348415|NCT01653340|High Frequency Spinal Cord Stimulator|high frequency spinal cord stimulator
348416|NCT01653327|mucositis|mucositis
348417|NCT01653327|head and neck|head and neck
348418|NCT01653327|cancer|cancer
348419|NCT01653327|radiation therapy|radiation therapy
348420|NCT01653327|chemoradiation|chemoradiation
348422|NCT01653327|pain|pain
348423|NCT01653275|Mediterranean Diet|mediterranean diet
348424|NCT01653275|Bone turnover|bone turnover
348425|NCT01653275|postmenopausal women|postmenopausal women
348426|NCT01653262|Brivaracetam|brivaracetam
348427|NCT01653262|Levetiracetam|levetiracetam
348428|NCT01653262|Epilepsy|epilepsy
348429|NCT01653262|Nonpsychotic behavior|nonpsychotic behavior
348430|NCT01653249|human papillomavirus (HPV)|human papillomavirus (hpv)
348431|NCT01653249|vaccine|vaccine
348432|NCT01653249|treatment|treatment
348433|NCT01653210|Insulin Pump|insulin pump
348434|NCT01653210|Continuous Glucose Monitor|continuous glucose monitor
348435|NCT01653210|Premenopausal women|premenopausal women
348436|NCT01653184|AMD|amd
348437|NCT01653184|Vision loss|vision loss
348438|NCT01653184|omega-3|omega-3
348439|NCT01653184|supplement|supplement
348440|NCT01653184|age related macular degeneration|age related macular degeneration
348441|NCT01653171|Acetylcysteine, Simethicone, Stomach Neoplasms|acetylcysteine, simethicone, stomach neoplasms
348442|NCT01653158|non-hematologic cancer|non-hematologic cancer
348443|NCT01653158|advanced solid tumors|advanced solid tumors
348444|NCT01653158|prostrate cancer|prostrate cancer
348445|NCT01653145|Appetite|appetite
348446|NCT01653145|Satiety|satiety
348447|NCT01653132|PD|pd
348448|NCT01653119|Acute coronary syndrome|acute coronary syndrome
348449|NCT01653119|Diabetes mellitus|diabetes mellitus
348450|NCT01653119|Statins|statins
348451|NCT01653119|High loading dose|high loading dose
348452|NCT01653119|Recurrent events|recurrent events
348453|NCT01653106|cryotherapy|cryotherapy
348454|NCT01653106|Melphalan|melphalan
348455|NCT01653106|Mucositis|mucositis
348456|NCT01653080|Solid Tumor|solid tumor
348457|NCT01653080|Eye|eye
348458|NCT01653080|Orbit|orbit
348459|NCT01653067|Non Hodgkin´s Lymphoma|non hodgkin´s lymphoma
348460|NCT01653067|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
348461|NCT01653067|Aggressive Lymphoma|aggressive lymphoma
348462|NCT01653067|Aggressive Non Hodgkin´s Lymphoma|aggressive non hodgkin´s lymphoma
348463|NCT01653067|NHL|nhl
348464|NCT01653067|aNHL|anhl
348465|NCT01653067|Temsirolimus|temsirolimus
348466|NCT01653067|Torisel|torisel
348467|NCT01653067|Relapsed Non Hodgkin´s Lymphoma|relapsed non hodgkin´s lymphoma
348468|NCT01653067|Relapsed Diffuse Large B-Cell Lymphoma|relapsed diffuse large b-cell lymphoma
348469|NCT01653067|aggressive NHL|aggressive nhl
348470|NCT01653067|B-NHL|b-nhl
348471|NCT01653067|aggressive B-NHL|aggressive b-nhl
348472|NCT01653041|immunosuppression, identical HLA, kidney transplantation, everolimus|immunosuppression, identical hla, kidney transplantation, everolimus
348473|NCT01653002|Lung cancer|lung cancer
348474|NCT01653002|EBUS-TBNA|ebus-tbna
348475|NCT01653002|Epigenetics|epigenetics
348476|NCT01653002|shox2 protein, human|shox2 protein, human
348477|NCT01652989|weight loss|weight loss
348478|NCT01652989|weight loss maintenance|weight loss maintenance
348479|NCT01652989|community based participatory research|community based participatory research
348480|NCT01652989|overweight|overweight
348481|NCT01652976|Metastatic|metastatic
348482|NCT01652976|Pancreatic Cancer|pancreatic cancer
348483|NCT01652976|Adenocarcinoma|adenocarcinoma
348484|NCT01652950|Physical activity|physical activity
348485|NCT01652950|health-insured|health-insured
348486|NCT01652950|Financial Incentives|financial incentives
348487|NCT01652950|Benefits design|benefits design
348488|NCT01652937|Rheumatoid Arthritis|rheumatoid arthritis
348489|NCT01652937|DMARD-IR|dmard-ir
348490|NCT01652924|mechanical ventilation|mechanical ventilation
348491|NCT01652924|manual ventilation|manual ventilation
348492|NCT01652911|Islet Transplantation|islet transplantation
348493|NCT01652911|Cell Pouch|cell pouch
348494|NCT01652898|PK|pk
348495|NCT01652885|atopic dermatitis|atopic dermatitis
348496|NCT01652872|anemia|anemia
348497|NCT01652872|chronic kidney disease|chronic kidney disease
348498|NCT01652872|kidney disease|kidney disease
348499|NCT01652872|renal failure|renal failure
348500|NCT01652833|Metastatic Colorectal Cancer|metastatic colorectal cancer
348501|NCT01652820|LUNG|lung
348502|NCT01652820|DOCETAXEL|docetaxel
348503|NCT01652820|GEMCITABINE|gemcitabine
348504|NCT01652820|CARBOPLATIN|carboplatin
348505|NCT01652820|RADIOTHERAPY|radiotherapy
348506|NCT01652781|myelodysplastic syndrome|myelodysplastic syndrome
348507|NCT01652781|azacitidine|azacitidine
348508|NCT01652781|dosing schedule|dosing schedule
348509|NCT01652768|Malignant Brain Tumors|malignant brain tumors
348510|NCT01652768|Malignant Glioma|malignant glioma
348511|NCT01652768|High-grade Gliomas|high-grade gliomas
348512|NCT01652768|Oncology|oncology
348513|NCT01652768|Cancer|cancer
348514|NCT01652768|Patient Caregiver|patient caregiver
348515|NCT01652768|Caregiver Stress, Anxiety, Depression|caregiver stress, anxiety, depression
348516|NCT01652768|Palliative Care Intervention|palliative care intervention
348517|NCT01652755|cystatin C,acute kidney injury,|cystatin c,acute kidney injury,
348518|NCT01652729|Diabetes, Type 2, exenatide, Sitagliptin|diabetes, type 2, exenatide, sitagliptin
348519|NCT01652703|Japanese, hypercholesterolemia, high risk for cardiovascular events|japanese, hypercholesterolemia, high risk for cardiovascular events
348520|NCT01652677|navigation transcranial magnetic stimulation|navigation transcranial magnetic stimulation
348521|NCT01652677|stroke rehabilitation|stroke rehabilitation
348522|NCT01652651|Learning Disorders|learning disorders
348523|NCT01652638|subjects|subjects
348524|NCT01652625|Yunnan Baiyao|yunnan baiyao
348525|NCT01652625|recurrent aphthous stomatitis|recurrent aphthous stomatitis
348526|NCT01652625|clinical trial|clinical trial
348527|NCT01652612|positive end expiratory pressure|positive end expiratory pressure
348528|NCT01652599|Eltrombopag|eltrombopag
348529|NCT01652599|Dexamethasone|dexamethasone
348530|NCT01652599|High-dose|high-dose
348531|NCT01652599|ITP|itp
348532|NCT01652586|cardiac ablation|cardiac ablation
348533|NCT01652573|X linked hypophosphatemia|x linked hypophosphatemia
348534|NCT01652573|calcitonin|calcitonin
348535|NCT01652573|FGF twenty three|fgf twenty three
348536|NCT01652560|bevacizumab|bevacizumab
348537|NCT01652560|neoadjuvant chemotherapy|neoadjuvant chemotherapy
348538|NCT01652560|HER2-negative breast cancer|her2-negative breast cancer
348539|NCT01652547|Melanoma|melanoma
348540|NCT01652547|Merkel cell carcinoma|merkel cell carcinoma
348541|NCT01652547|Metastatic skin cancer|metastatic skin cancer
348542|NCT01652534|Freezing of gait|freezing of gait
348543|NCT01652534|gait dysfunction|gait dysfunction
348544|NCT01652521|lung compliance|lung compliance
348545|NCT01652521|pleural effusion|pleural effusion
348546|NCT01652521|esophageal pressure|esophageal pressure
348547|NCT01652508|smoking cessation|smoking cessation
348548|NCT01652508|Acceptance and Commitment Therapy|acceptance and commitment therapy
348549|NCT01652508|primary care setting|primary care setting
348550|NCT01652508|randomised controlled trial|randomised controlled trial
348551|NCT01652495|rotatory cuff calcific tendonitis|rotatory cuff calcific tendonitis
348552|NCT01652495|corticosteroids|corticosteroids
348553|NCT01652495|US guided percutaneous treatment|us guided percutaneous treatment
348554|NCT01652495|methylprednisolone|methylprednisolone
348555|NCT01652495|triamcinolone|triamcinolone
348556|NCT01652495|hypothalamus pituitary adrenal axis|hypothalamus pituitary adrenal axis
348557|NCT01652469|squamous cell|squamous cell
348558|NCT01652469|NSCLC|nsclc
348559|NCT01652469|TKI|tki
348560|NCT01652469|Erlotinib|erlotinib
348561|NCT01652469|Docetaxel|docetaxel
348562|NCT01652469|VeriStrat|veristrat
348563|NCT01652469|protein signature|protein signature
348564|NCT01652456|addiction support|addiction support
348565|NCT01652456|addiction specialist|addiction specialist
348566|NCT01652456|lung cancer|lung cancer
348567|NCT01652456|head and neck cancer|head and neck cancer
348568|NCT01652443|OEF/OIF Veterans|oef/oif veterans
348569|NCT01652443|Relationships|relationships
348570|NCT01652430|PTSD|ptsd
348571|NCT01652430|Suicidal ideation|suicidal ideation
348572|NCT01652430|Cognitive processes|cognitive processes
348573|NCT01652417|Methylprednisolone|methylprednisolone
348574|NCT01652417|prednisone|prednisone
348575|NCT01652417|renal sarcoidosis treatment|renal sarcoidosis treatment
348576|NCT01652404|ICU|icu
348577|NCT01652404|sepsis|sepsis
348578|NCT01652404|antibiotic therapy|antibiotic therapy
348579|NCT01652404|procalcitonin|procalcitonin
348580|NCT01652378|cocaine addiction|cocaine addiction
348581|NCT01652378|neuroimaging|neuroimaging
348582|NCT01652378|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
348583|NCT01652365|Malaria Diagnosis|malaria diagnosis
348584|NCT01652365|Rapid Diagnostic Tests|rapid diagnostic tests
348585|NCT01652365|RDTs|rdts
348586|NCT01652365|Private Sector|private sector
348587|NCT01652365|Retail Sector|retail sector
348588|NCT01652365|Drug Shops|drug shops
348589|NCT01652352|Disabled|disabled
348590|NCT01652352|Disability|disability
348591|NCT01652352|Power wheelchair|power wheelchair
348592|NCT01652352|Wheelchair|wheelchair
348593|NCT01652352|Wheelchair mounted robotic arm|wheelchair mounted robotic arm
348594|NCT01652352|WMRA|wmra
348595|NCT01652352|Assistive|assistive
348596|NCT01652352|Assistive robot|assistive robot
348597|NCT01652352|Assistive robotics|assistive robotics
348598|NCT01652352|Rehabilitation robot|rehabilitation robot
348599|NCT01652352|Rehabilitation engineering|rehabilitation engineering
348600|NCT01652352|Rehabilitation robotics|rehabilitation robotics
348601|NCT01652300|Oral health|oral health
348602|NCT01652300|education|education
348603|NCT01652300|knowledge|knowledge
348604|NCT01652300|attitude|attitude
348605|NCT01652300|performance|performance
348606|NCT01652274|Child Passenger Safety|child passenger safety
348607|NCT01652274|Parental perception of vulnerability|parental perception of vulnerability
348608|NCT01652274|Neonatology|neonatology
348609|NCT01652274|Newborn|newborn
348610|NCT01652261|advanced stage|advanced stage
348611|NCT01652248|Heart failure|heart failure
348612|NCT01652248|Pacemaker|pacemaker
348613|NCT01652248|cardiac resynchronization therapy|cardiac resynchronization therapy
348614|NCT01652235|Abdominal aortic aneurysm|abdominal aortic aneurysm
348615|NCT01652235|Endovascular|endovascular
348616|NCT01652235|Fenestration|fenestration
348617|NCT01652235|Juxtarenal|juxtarenal
348618|NCT01652235|Off-the-shelf|off-the-shelf
348619|NCT01652235|Pararenal|pararenal
348620|NCT01652222|Alzheimer|alzheimer
348621|NCT01652222|caregiver|caregiver
348622|NCT01652222|dementia|dementia
348623|NCT01652222|social support|social support
348624|NCT01652222|Montessori|montessori
348625|NCT01652222|Therapeutic game|therapeutic game
348626|NCT01652196|colorectal cancer|colorectal cancer
348627|NCT01652196|rectal cancer|rectal cancer
348628|NCT01652196|FOLFOX|folfox
348629|NCT01652196|Aflibercept|aflibercept
348630|NCT01652183|Intravenous paracetamol|intravenous paracetamol
348631|NCT01652183|catheter related bladder discomfort|catheter related bladder discomfort
348632|NCT01652183|urologic surgery|urologic surgery
348633|NCT01652157|prospective|prospective
348634|NCT01652157|pancreatic insufficiency|pancreatic insufficiency
348635|NCT01652157|fibrosing colonopathy|fibrosing colonopathy
348636|NCT01652157|observational|observational
348637|NCT01652157|pancreatic enzyme replacement therapy|pancreatic enzyme replacement therapy
348638|NCT01652131|general anesthesia|general anesthesia
348639|NCT01652131|volume kinetics|volume kinetics
348640|NCT01652118|bronchopulmonary dysplasia|bronchopulmonary dysplasia
348641|NCT01652118|clarithromycin|clarithromycin
348642|NCT01652118|preterm babies|preterm babies
348643|NCT01652105|Gastric bypass|gastric bypass
348644|NCT01652105|Preoperative diet|preoperative diet
348645|NCT01652105|Prodimed|prodimed
348646|NCT01652092|immunodeficiency disorder|immunodeficiency disorder
348647|NCT01652092|histiocytic disorder|histiocytic disorder
348648|NCT01652079|Epithelial|epithelial
348649|NCT01652079|Primary|primary
348650|NCT01652053|InterCushion|intercushion
348651|NCT01652040|Spinal Cord Injury|spinal cord injury
348652|NCT01652040|Rehabilitation|rehabilitation
348653|NCT01652040|Electrical Stimulation|electrical stimulation
348654|NCT01652040|Testosterone|testosterone
348655|NCT01652040|Body Composition|body composition
348656|NCT01652040|Lipid and Glucose profile|lipid and glucose profile
348657|NCT01652040|Ectopic Adiposity|ectopic adiposity
348658|NCT01652027|FVIII inhibitors|fviii inhibitors
348659|NCT01652014|Transplantation|transplantation
348660|NCT01652014|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
348661|NCT01652001|Xerostomia|xerostomia
348662|NCT01652001|Antidepressant agents|antidepressant agents
348663|NCT01652001|Antihypertensive agents|antihypertensive agents
348664|NCT01651988|ketamine|ketamine
348665|NCT01651988|propofol anesthesia|propofol anesthesia
348666|NCT01651975|Dysphagia|dysphagia
348667|NCT01651975|Thickening liquid|thickening liquid
348668|NCT01651975|Thickening agent|thickening agent
348669|NCT01651975|Fluoroscopic swallow study|fluoroscopic swallow study
348670|NCT01651975|Aspiration|aspiration
348671|NCT01651975|History of dysphagia|history of dysphagia
348673|NCT01651975|Age > 18|age > 18
348674|NCT01651975|comprehensive DSS|comprehensive dss
348675|NCT01651975|informed consent|informed consent
348676|NCT01651962|Labor Pain|labor pain
348677|NCT01651962|Analgesia, Epidural|analgesia, epidural
348678|NCT01651923|subjects|subjects
348679|NCT01651910|Cancer Pain|cancer pain
348680|NCT01651910|Breakthrough Pain|breakthrough pain
348681|NCT01651910|Unmet Needs|unmet needs
348682|NCT01651910|Supportive care needs|supportive care needs
348683|NCT01651897|delirium|delirium
348684|NCT01651897|emergency department|emergency department
348685|NCT01651897|natural course|natural course
348686|NCT01651897|outcomes|outcomes
348687|NCT01651897|elderly|elderly
348688|NCT01651884|Stroke|stroke
348689|NCT01651884|Anomia|anomia
348690|NCT01651871|Agents, anti allergic|agents, anti allergic
348691|NCT01651871|Nasal congestion|nasal congestion
348692|NCT01651871|Sneezing|sneezing
348693|NCT01651871|Nasal discharge|nasal discharge
348694|NCT01651871|D prostanoid (DP) receptor antagonist|d prostanoid (dp) receptor antagonist
348695|NCT01651832|Colorectal Neoplasms/*drug therapy/*secondary|colorectal neoplasms/*drug therapy/*secondary
348696|NCT01651832|Health Services Accessibility|health services accessibility
348697|NCT01651832|Humans|humans
348698|NCT01651832|Supportive Care Needs|supportive care needs
348699|NCT01651832|Psychooncology|psychooncology
348700|NCT01651832|Rural Population|rural population
348701|NCT01651832|Primary Health Care/*methods|primary health care/*methods
348702|NCT01651832|Treatment Outcome|treatment outcome
348703|NCT01651832|Socioeconomic Factors|socioeconomic factors
348704|NCT01651832|Quality Assurance, Health Care|quality assurance, health care
348705|NCT01651832|Quality of Life|quality of life
348706|NCT01651832|Adult|adult
348707|NCT01651832|Aged|aged
348708|NCT01651832|Aged, 80 and over|aged, 80 and over
348709|NCT01651819|HTLV-1|htlv-1
348710|NCT01651819|neurogenic bladder|neurogenic bladder
348711|NCT01651819|physical therapy|physical therapy
348712|NCT01651819|Tropical Spastic Paraparesis|tropical spastic paraparesis
348713|NCT01651806|Blood loss|blood loss
348714|NCT01651806|transfusion rates|transfusion rates
348715|NCT01651806|complications|complications
348716|NCT01651793|cacao|cacao
348717|NCT01651793|theobromine|theobromine
348718|NCT01651793|flavanols|flavanols
348719|NCT01651793|caffeine|caffeine
348720|NCT01651793|sustained attention|sustained attention
348721|NCT01651793|vigilance|vigilance
348722|NCT01651793|vigor|vigor
348723|NCT01651793|vitality|vitality
348724|NCT01651793|energy|energy
348725|NCT01651793|fatigue|fatigue
348726|NCT01651780|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
348727|NCT01651780|Aortic valve replacement|aortic valve replacement
348728|NCT01651780|Severe aortic stenosis|severe aortic stenosis
348729|NCT01651767|Chronic hepatitis C virus infection|chronic hepatitis c virus infection
348730|NCT01651767|JNJ-47910382|jnj-47910382
348731|NCT01651767|Pharmacokinetics|pharmacokinetics
348732|NCT01651767|Caucasian genotype-1|caucasian genotype-1
348733|NCT01651767|Non-structural protein 5A (NS5A) inhibitor|non-structural protein 5a (ns5a) inhibitor
348734|NCT01651741|Intestinal Microbiota|intestinal microbiota
348735|NCT01651741|Probiotics|probiotics
348736|NCT01651741|Seaweed|seaweed
348737|NCT01651741|Healthy Subject|healthy subject
348738|NCT01651728|Simvastatin|simvastatin
348739|NCT01651728|Pneumonia|pneumonia
348740|NCT01651728|Elderly|elderly
348741|NCT01651728|TNF-α|tnf-α
348742|NCT01651728|IFN-ϒ|ifn-ϒ
348743|NCT01651728|PAI-1|pai-1
348744|NCT01651728|CRP|crp
348745|NCT01651702|Arrhythmia|arrhythmia
348746|NCT01651702|Electroanatomical mapping|electroanatomical mapping
348747|NCT01651689|Scalp biopsy|scalp biopsy
348748|NCT01651689|Hair count|hair count
348749|NCT01651689|Vertical section|vertical section
348750|NCT01651689|Horizontal section|horizontal section
348751|NCT01651689|Thais|thais
348752|NCT01651676|VQ11 questionnaire|vq11 questionnaire
348753|NCT01651676|COPD|copd
348754|NCT01651676|LBD|lbd
348755|NCT01651663|Influenza|influenza
348756|NCT01651650|Asthma|asthma
348757|NCT01651650|PIF|pif
348758|NCT01651637|Respiratory Distress syndrome|respiratory distress syndrome
348759|NCT01651637|Complications of prematurity|complications of prematurity
348760|NCT01651624|Colorectal Cancer|colorectal cancer
348761|NCT01651624|Screening|screening
348762|NCT01651624|Fecal Occult Blood Test|fecal occult blood test
348763|NCT01651624|CT Colonography|ct colonography
348764|NCT01651624|Virtual Colonoscopy|virtual colonoscopy
348765|NCT01651624|Colonoscopy|colonoscopy
348766|NCT01651611|Tobacco Cessation|tobacco cessation
348767|NCT01651611|Public Housing|public housing
348768|NCT01651611|Community Health Workers|community health workers
348769|NCT01651611|Motivational Interviewing|motivational interviewing
348770|NCT01651611|Patient centered|patient centered
348771|NCT01651611|Low-income|low-income
348772|NCT01651611|Tobacco Treatment Advocates|tobacco treatment advocates
348773|NCT01651611|Social Epidemiology|social epidemiology
348774|NCT01651611|Smoking cessation predictors|smoking cessation predictors
348775|NCT01651611|Behavioral Intervention|behavioral intervention
348776|NCT01651611|Non-pharmacologic|non-pharmacologic
348777|NCT01651585|viral disease|viral disease
348778|NCT01651585|cytomegalovirus infection|cytomegalovirus infection
348779|NCT01651585|is the first cause|is the first cause
348780|NCT01651585|of congenital|of congenital
348781|NCT01651585|neurological handicap|neurological handicap
348782|NCT01651585|of infectious origin.|of infectious origin.
348783|NCT01651572|Postoperative residual curarization|postoperative residual curarization
348784|NCT01651572|Residual neuromuscular block|residual neuromuscular block
348785|NCT01651572|Complications|complications
348786|NCT01651572|Postoperative|postoperative
348787|NCT01651572|Neuromuscular function|neuromuscular function
348788|NCT01651572|Neuromuscular block|neuromuscular block
348789|NCT01651559|modified PASI|modified pasi
348790|NCT01651559|narrow band UVB phototherapy|narrow band uvb phototherapy
348791|NCT01651559|Dead Sea Minerals|dead sea minerals
348792|NCT01651559|Skin auto-Fluorescence|skin auto-fluorescence
348793|NCT01651559|Skin wash samples|skin wash samples
348794|NCT01651546|Clean Intermittent Self Catheterization|clean intermittent self catheterization
348795|NCT01651546|acceptance|acceptance
348796|NCT01651546|test|test
348797|NCT01651533|Mental practice group|mental practice group
348798|NCT01651533|Active control group|active control group
348799|NCT01651520|Neurodegeneration|neurodegeneration
348800|NCT01651520|Disability|disability
348801|NCT01651520|Cognition|cognition
348802|NCT01651520|Prognosis|prognosis
348803|NCT01651507|Pulmonary Langerhans cell histiocytosis|pulmonary langerhans cell histiocytosis
348804|NCT01651494|DAS181|das181
348805|NCT01651494|Influenza|influenza
348806|NCT01651494|inhalation|inhalation
348807|NCT01651494|inpatient clinic|inpatient clinic
348808|NCT01651494|Multi-Dose|multi-dose
348809|NCT01651494|recombinant neuraminidase|recombinant neuraminidase
348810|NCT01651481|Rhinitis|rhinitis
348811|NCT01651468|mild bleeding disorder|mild bleeding disorder
348812|NCT01651455|Cystic Fibrosis|cystic fibrosis
348813|NCT01651455|Pseudomonas Aeruginosa|pseudomonas aeruginosa
348814|NCT01651429|Sleep Deprivation|sleep deprivation
348815|NCT01651416|Home management of malaria|home management of malaria
348816|NCT01651416|Seasonal malaria chemoprevention|seasonal malaria chemoprevention
348817|NCT01651403|Hepatitis|hepatitis
348818|NCT01651403|Hepatitis B|hepatitis b
348819|NCT01651403|HBV|hbv
348820|NCT01651390|Restenosis|restenosis
348821|NCT01651390|Drug coated balloon|drug coated balloon
348822|NCT01651390|Drug eluting stent|drug eluting stent
348823|NCT01651390|Paclitaxel|paclitaxel
348824|NCT01651390|Sirolimus|sirolimus
348825|NCT01651377|Pramipexole|pramipexole
348826|NCT01651377|Mirapex|mirapex
348827|NCT01651377|Cocaine|cocaine
348828|NCT01651364|Cocaine|cocaine
348829|NCT01651364|Cabergoline|cabergoline
348830|NCT01651351|for this study|for this study
348831|NCT01651351|volunteers|volunteers
348832|NCT01651351|Focus|focus
348833|NCT01651351|Condition:|condition:
348834|NCT01651338|Acupuncture|acupuncture
348835|NCT01651338|quality of life|quality of life
348836|NCT01651325|Isavuconazole|isavuconazole
348837|NCT01651325|dextromethorphan|dextromethorphan
348838|NCT01651325|dextrorphan|dextrorphan
348839|NCT01651325|DXM|dxm
348840|NCT01651325|Healthy Volunteers|healthy volunteers
348841|NCT01651325|BAL4815|bal4815
348842|NCT01651312|Radioactivity|radioactivity
348843|NCT01651312|Excretion rate|excretion rate
348844|NCT01651312|Human subjects|human subjects
348845|NCT01651312|Pharmacokinetics|pharmacokinetics
348846|NCT01651312|YM178|ym178
348847|NCT01651312|Radio-labeled|radio-labeled
348848|NCT01651312|Phase 1|phase 1
348849|NCT01651299|copperhead snake envenomation|copperhead snake envenomation
348850|NCT01651286|General anesthesia|general anesthesia
348851|NCT01651286|Positive-pressure ventilation|positive-pressure ventilation
348852|NCT01651286|Masks|masks
348853|NCT01651247|Toddlers|toddlers
348854|NCT01651247|Retrospective|retrospective
348855|NCT01651247|Porcine circovirus type 1 (PCV-1)|porcine circovirus type 1 (pcv-1)
348856|NCT01651247|Infants|infants
348857|NCT01651247|Laboratory evaluations|laboratory evaluations
348858|NCT01651247|IPV|ipv
348859|NCT01651221|gustatory response|gustatory response
348860|NCT01651221|olfactory response|olfactory response
348861|NCT01651208|Coronary stents|coronary stents
348862|NCT01651208|Medication adherence|medication adherence
348863|NCT01651208|Antiplatelet medications|antiplatelet medications
348864|NCT01651208|Motivational Interviewing|motivational interviewing
348865|NCT01651182|Blood transfusion|blood transfusion
348866|NCT01651182|Blood loss|blood loss
348867|NCT01651182|Postoperative complications|postoperative complications
348868|NCT01651182|Outcome|outcome
348869|NCT01651169|Paired Transcranial Magnetic Stimulation|paired transcranial magnetic stimulation
348870|NCT01651169|Methamphetamine abuse, ADHD, Methylphenidate|methamphetamine abuse, adhd, methylphenidate
348871|NCT01651169|We study the effect of Methamphetamine abuse on Intracortical Inhibition, in ADHD patients, treated with Methylphenidate.|we study the effect of methamphetamine abuse on intracortical inhibition, in adhd patients, treated with methylphenidate.
348872|NCT01651130|pregnancy|pregnancy
348873|NCT01651130|postpartum hemorrhage|postpartum hemorrhage
348874|NCT01651130|Cesarean delivery|cesarean delivery
348875|NCT01651130|carbetocin|carbetocin
348876|NCT01651117|Diabetes Mellitus|diabetes mellitus
348877|NCT01651117|Mentors|mentors
348878|NCT01651117|Glucose control|glucose control
348879|NCT01651117|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
348880|NCT01651117|Randomized Controlled Trial|randomized controlled trial
348881|NCT01651117|Veterans|veterans
348882|NCT01651104|Influenza, Trivalent, Adjuvanted, Adjuvant, MF59, MF-59, Fluad, Seasonal|influenza, trivalent, adjuvanted, adjuvant, mf59, mf-59, fluad, seasonal
348883|NCT01651078|Metastatic Brain Tumors|metastatic brain tumors
348884|NCT01651078|Progression|progression
348885|NCT01651078|Radiation Necrosis|radiation necrosis
348886|NCT01651078|Quality of Life|quality of life
348887|NCT01651052|Aortic valve replacement/regurgitation|aortic valve replacement/regurgitation
348888|NCT01651039|Panobinostat|panobinostat
348889|NCT01651039|Lenalidomide|lenalidomide
348890|NCT01651039|Dexamethasone|dexamethasone
348891|NCT01651000|Parathyroid Diseases|parathyroid diseases
348892|NCT01651000|Renal Insufficiency|renal insufficiency
348893|NCT01651000|Kidney Failure, Chronic|kidney failure, chronic
348894|NCT01651000|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
348895|NCT01651000|Vitamin D|vitamin d
348896|NCT01651000|Hyperparathyroidism|hyperparathyroidism
348897|NCT01651000|Kidney Diseases|kidney diseases
348898|NCT01651000|Kidney Failure|kidney failure
348899|NCT01651000|Renal Insufficiency, Chronic|renal insufficiency, chronic
348900|NCT01650987|carcinoma|carcinoma
348901|NCT01650987|uterus|uterus
348902|NCT01650987|Not metastatic|not metastatic
348903|NCT01650974|high flow nasal oxygen therapy|high flow nasal oxygen therapy
348904|NCT01650974|diagnostic bronchoscopy|diagnostic bronchoscopy
348905|NCT01650948|age-related macular degeneration|age-related macular degeneration
348906|NCT01650948|AMD|amd
348907|NCT01650935|Nephrolithiasis|nephrolithiasis
348908|NCT01650935|Recurrent stone former|recurrent stone former
348909|NCT01650935|DASH|dash
348910|NCT01650935|Urine oxalate|urine oxalate
348911|NCT01650935|Urine calcium oxalate supersaturation|urine calcium oxalate supersaturation
348912|NCT01650896|Delirium|delirium
348913|NCT01650896|Dementia|dementia
348914|NCT01650896|Instrumental activities of daily living|instrumental activities of daily living
348915|NCT01650883|Vitamin D3|vitamin d3
348916|NCT01650883|Vitamin D 25 OH|vitamin d 25 oh
348917|NCT01650870|Cathartics|cathartics
348918|NCT01650870|Laxatives|laxatives
348919|NCT01650870|Lactulose|lactulose
348920|NCT01650870|Gastrointestinal Agents|gastrointestinal agents
348921|NCT01650870|Therapeutic Uses|therapeutic uses
348922|NCT01650870|Pharmacologic Actions|pharmacologic actions
348923|NCT01650857|Pulmonary hypertension|pulmonary hypertension
348924|NCT01650857|Rehabilitation|rehabilitation
348925|NCT01650857|Exercise capacity|exercise capacity
348926|NCT01650857|Body composition|body composition
348927|NCT01650857|Health related Quality of Life|health related quality of life
348928|NCT01650831|Helicobacter Pylori|helicobacter pylori
348929|NCT01650831|13C Urea Breath Test|13c urea breath test
348930|NCT01650831|BreathID|breathid
348931|NCT01650818|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
348932|NCT01650818|Aerobic training|aerobic training
348933|NCT01650818|Peak oxygen consumption|peak oxygen consumption
348934|NCT01650818|Quality of life|quality of life
348935|NCT01650805|Leukemia|leukemia
348936|NCT01650805|Leukemia, Myeloid|leukemia, myeloid
348937|NCT01650805|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
348938|NCT01650805|Neoplasms by Histologic Type|neoplasms by histologic type
348939|NCT01650805|Neoplasms|neoplasms
348940|NCT01650805|Lymphoproliferative Disorders|lymphoproliferative disorders
348941|NCT01650805|Lymphatic Diseases|lymphatic diseases
348942|NCT01650805|Immunoproliferative Disorders|immunoproliferative disorders
348943|NCT01650805|Immune System Diseases|immune system diseases
348944|NCT01650805|Myeloproliferative Disorders|myeloproliferative disorders
348945|NCT01650805|Bone Marrow Diseases|bone marrow diseases
348946|NCT01650805|Hematologic Diseases|hematologic diseases
348947|NCT01650792|Chagas disease|chagas disease
348948|NCT01650792|Heart failure|heart failure
348949|NCT01650792|Stroke|stroke
348950|NCT01650792|Dementia|dementia
348951|NCT01650779|alpha-galactosidase A|alpha-galactosidase a
348952|NCT01650779|a-GAL|a-gal
348953|NCT01650779|Fabry|fabry
348954|NCT01650779|GL-3|gl-3
348955|NCT01650779|Fabrazyme|fabrazyme
348956|NCT01650701|follicular lymphoma|follicular lymphoma
348957|NCT01650701|non-hodgkins follicular lymphoma|non-hodgkins follicular lymphoma
348958|NCT01650701|treatment for follicular lymphoma|treatment for follicular lymphoma
348959|NCT01650701|rituximab treatment|rituximab treatment
348960|NCT01650701|rituximab and lenalidomide treatment|rituximab and lenalidomide treatment
348961|NCT01650688|Epiblepharon, general anesthesia, positional change|epiblepharon, general anesthesia, positional change
348962|NCT01650675|pregnancy|pregnancy
348963|NCT01650675|screening|screening
348964|NCT01650675|motivation|motivation
348965|NCT01650662|Acute Myocardial Infarction|acute myocardial infarction
348966|NCT01650662|Cyclosporine A|cyclosporine a
348967|NCT01650662|Reperfusion|reperfusion
348968|NCT01650662|Clinical Trial|clinical trial
348969|NCT01650649|lofexidine|lofexidine
348970|NCT01650649|methadone|methadone
348971|NCT01650649|interaction|interaction
348972|NCT01650649|pharmacodynamic|pharmacodynamic
348973|NCT01650649|ECG|ecg
348974|NCT01650649|QTc|qtc
348975|NCT01650636|Videophone-delivered stress management intervention|videophone-delivered stress management intervention
348976|NCT01650636|Chronic fatigue syndrome|chronic fatigue syndrome
348977|NCT01650636|Symptoms|symptoms
348978|NCT01650636|Neuroimmune processes|neuroimmune processes
348979|NCT01650636|Psychosocial|psychosocial
348980|NCT01650623|Parkinson´s Disease|parkinson´s disease
348981|NCT01650623|Rehabilitation|rehabilitation
348982|NCT01650623|Cognition|cognition
348983|NCT01650610|Parkinson´s Disease|parkinson´s disease
348984|NCT01650610|Rehabilitation|rehabilitation
348985|NCT01650610|Cognition|cognition
348986|NCT01650597|Healthy volunteers|healthy volunteers
348987|NCT01650597|Pharmacokinetics|pharmacokinetics
348988|NCT01650597|Free fatty amides|free fatty amides
348989|NCT01650558|Malaria|malaria
348990|NCT01650558|HIV|hiv
348991|NCT01650558|Prophylaxis|prophylaxis
348992|NCT01650558|Antiretroviral therapy|antiretroviral therapy
348993|NCT01650545|case-control study|case-control study
348994|NCT01650545|aerosolized liposomal cyclosporine A|aerosolized liposomal cyclosporine a
348995|NCT01650545|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
348996|NCT01650545|Lung Transplantation|lung transplantation
348997|NCT01650545|Lung function|lung function
348998|NCT01650519|knee surgery, arthroscopy; orthopaedic, orthopedic surgery|knee surgery, arthroscopy; orthopaedic, orthopedic surgery
348999|NCT01650506|Triple Negative|triple negative
349000|NCT01650506|Basal-like|basal-like
349001|NCT01650493|remineralization|remineralization
349002|NCT01650493|demineralzation|demineralzation
349003|NCT01650493|in situ|in situ
349004|NCT01650493|dentrifice|dentrifice
349005|NCT01650480|COPD|copd
349006|NCT01650480|holistic|holistic
349007|NCT01650480|pilot|pilot
349008|NCT01650480|intervention|intervention
349009|NCT01650467|abl polymorphisms|abl polymorphisms
349010|NCT01650454|Alzheimer|alzheimer
349011|NCT01650454|Sleep|sleep
349012|NCT01650454|Somnolence|somnolence
349013|NCT01650441|Asthma|asthma
349014|NCT01650441|NEXThaler®|nexthaler®
349015|NCT01650441|Formoterol|formoterol
349016|NCT01650441|Beclomethasone Dipropionate|beclomethasone dipropionate
349017|NCT01650441|Computational Fluid Dynamics|computational fluid dynamics
349018|NCT01650441|Functional Imaging|functional imaging
349019|NCT01650441|Central and Peripheral Airways|central and peripheral airways
349020|NCT01650441|Asthma Control Test (ACT™)|asthma control test (act™)
349021|NCT01650441|Asthma Control Questionnaire (ACQ)|asthma control questionnaire (acq)
349022|NCT01650428|Rectal Cancer|rectal cancer
349023|NCT01650428|Bevacizumab|bevacizumab
349024|NCT01650428|Neoadjuvant|neoadjuvant
349025|NCT01650428|Chemotherapy|chemotherapy
349026|NCT01650428|Randomised|randomised
349027|NCT01650415|Cerebral Palsy|cerebral palsy
349028|NCT01650415|Erythropoietin|erythropoietin
349029|NCT01650415|Rehabilitation|rehabilitation
349030|NCT01650402|Hypertension, systolic|hypertension, systolic
349031|NCT01650402|Elderly (> or equal to 75 years)|elderly (> or equal to 75 years)
349032|NCT01650402|Cerebrovascular disease|cerebrovascular disease
349033|NCT01650389|Tuberculosis|tuberculosis
349034|NCT01650389|HIV|hiv
349035|NCT01650389|BCG|bcg
349036|NCT01650389|Infant|infant
349037|NCT01650376|Ovarian Neoplasms|ovarian neoplasms
349038|NCT01650376|Cancer of the Ovary|cancer of the ovary
349039|NCT01650376|Ovarian Cancer|ovarian cancer
349040|NCT01650376|Uterine Neoplasms|uterine neoplasms
349041|NCT01650376|Cancer of the Uterus|cancer of the uterus
349042|NCT01650376|Uterine Cancer|uterine cancer
349043|NCT01650376|Olaparib|olaparib
349044|NCT01650376|AZD2281|azd2281
349045|NCT01650376|Carboplatin|carboplatin
349046|NCT01650376|Paclitaxel|paclitaxel
349047|NCT01650376|Relapsed|relapsed
349048|NCT01650363|Complementary and alternative medicine|complementary and alternative medicine
349049|NCT01650363|Post operative recovery|post operative recovery
349050|NCT01650363|Cardio- thoracic surgery|cardio- thoracic surgery
349051|NCT01650350|Melanoma|melanoma
349052|NCT01650350|Prostate Cancer|prostate cancer
349053|NCT01650350|Renal Cancer|renal cancer
349054|NCT01650324|DBPR108|dbpr108
349055|NCT01650324|DPP4|dpp4
349056|NCT01650324|Diabetes|diabetes
349057|NCT01650324|GLP-1|glp-1
349058|NCT01650324|Incretins|incretins
349059|NCT01650311|IBD, CD, UC, Serotonin, 5-HT|ibd, cd, uc, serotonin, 5-ht
349060|NCT01650285|Prostate Cancer|prostate cancer
349061|NCT01650285|Radical prostatectomy|radical prostatectomy
349062|NCT01650207|electroacupuncture|electroacupuncture
349063|NCT01650207|TENS|tens
349064|NCT01650207|shoulder disorder|shoulder disorder
349065|NCT01650207|hemiplegia|hemiplegia
349066|NCT01650194|abiraterone acetate|abiraterone acetate
349067|NCT01650194|prednisone|prednisone
349068|NCT01650194|enzalutamide|enzalutamide
349069|NCT01650194|cancer|cancer
349070|NCT01650194|prostate|prostate
349071|NCT01650194|MDV3100|mdv3100
349072|NCT01650181|nafld, nash, fatty liver|nafld, nash, fatty liver
349073|NCT01650168|NOMAC-E2|nomac-e2
349074|NCT01650168|Nomegestrol acetate|nomegestrol acetate
349075|NCT01650168|Estradiol|estradiol
349076|NCT01650168|Levonorgestrel|levonorgestrel
349077|NCT01650168|Safety|safety
349078|NCT01650142|Neurofibromatosis 1|neurofibromatosis 1
349079|NCT01650142|Phenotype|phenotype
349080|NCT01650142|Modifiers|modifiers
349081|NCT01650116|hypovolemia|hypovolemia
349082|NCT01650116|renal hypoperfusion|renal hypoperfusion
349083|NCT01650116|liver transplantation|liver transplantation
349084|NCT01650116|sodium|sodium
349085|NCT01650116|chloride|chloride
349086|NCT01650116|PuCO2|puco2
349087|NCT01650116|ScvO2|scvo2
349088|NCT01650116|PiCCO|picco
349089|NCT01650116|O2-delivery|o2-delivery
349090|NCT01650116|hemodynamic indexes|hemodynamic indexes
349091|NCT01650103|hypovolemia|hypovolemia
349092|NCT01650103|renal hypoperfusion|renal hypoperfusion
349093|NCT01650103|major surgery|major surgery
349094|NCT01650103|sodium|sodium
349095|NCT01650103|potassium|potassium
349096|NCT01650103|chloride|chloride
349097|NCT01650103|ScvO2|scvo2
349098|NCT01650103|hemodynamic indexes|hemodynamic indexes
349099|NCT01650090|Pulmonary relapse|pulmonary relapse
349100|NCT01650090|Osteosarcoma|osteosarcoma
349101|NCT01650090|Lung metastases|lung metastases
349102|NCT01650090|Pediatric osteosarcoma|pediatric osteosarcoma
349103|NCT01650090|Inhaled chemotherapy|inhaled chemotherapy
349104|NCT01650090|Inhaled Lipid Cisplatin|inhaled lipid cisplatin
349105|NCT01650077|Soft tissue sarcoma|soft tissue sarcoma
349106|NCT01650077|Yondelis|yondelis
349107|NCT01650077|Intolerance to doxorubicin/ifosfamide|intolerance to doxorubicin/ifosfamide
349108|NCT01650077|CHOI criteria|choi criteria
349109|NCT01650064|Hip fracture|hip fracture
349110|NCT01650064|Mortality|mortality
349111|NCT01650038|faecal transplantation|faecal transplantation
349112|NCT01650038|ulcerative colitis|ulcerative colitis
349113|NCT01650038|inflammatory bowel disease|inflammatory bowel disease
349114|NCT01650025|probiotic, obesity, BMI, metabolic profile, metabolomics|probiotic, obesity, bmi, metabolic profile, metabolomics
349115|NCT01649999|Rheumatoid Arthritis|rheumatoid arthritis
349116|NCT01649999|ASP015K|asp015k
349117|NCT01649986|Hyperlipidemia|hyperlipidemia
349118|NCT01649986|Non-pharmacologic prevention|non-pharmacologic prevention
349119|NCT01649960|Aging|aging
349120|NCT01649960|Biomarkers|biomarkers
349121|NCT01649960|CAD|cad
349122|NCT01649947|Lung cancer|lung cancer
349123|NCT01649947|Non-small cell lung cancer|non-small cell lung cancer
349124|NCT01649947|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
349125|NCT01649947|Recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
349126|NCT01649934|Appointments and Schedules|appointments and schedules
349127|NCT01649921|Sepsis|sepsis
349128|NCT01649921|SIRS|sirs
349129|NCT01649921|Septic shock|septic shock
349130|NCT01649921|Immunoparalysis|immunoparalysis
349131|NCT01649921|Interferon-gamma|interferon-gamma
349132|NCT01649895|Obsessive-compulsive disorder|obsessive-compulsive disorder
349133|NCT01649895|internet|internet
349134|NCT01649895|cognitive-behaviour therapy|cognitive-behaviour therapy
349135|NCT01649895|D-Cycloserine|d-cycloserine
349136|NCT01649882|endotracheal tube position|endotracheal tube position
349137|NCT01649882|intubation|intubation
349138|NCT01649869|CMV|cmv
349139|NCT01649869|Cytomegalovirus|cytomegalovirus
349140|NCT01649869|Hearing Loss|hearing loss
349141|NCT01649869|Infants|infants
349142|NCT01649869|Valganciclovir|valganciclovir
349143|NCT01649843|Peroral endoscopic myotomy|peroral endoscopic myotomy
349144|NCT01649843|Esophageal Achalasia|esophageal achalasia
349145|NCT01649830|low-grade glioma|low-grade glioma
349146|NCT01649830|radiotherapy|radiotherapy
349147|NCT01649830|chemotherapy|chemotherapy
349148|NCT01649765|SLE Flare Index|sle flare index
349149|NCT01649765|SRI|sri
349150|NCT01649765|belimumab|belimumab
349151|NCT01649765|efficacy|efficacy
349152|NCT01649765|safety|safety
349153|NCT01649765|B lymphocyte|b lymphocyte
349154|NCT01649765|BLyS|blys
349155|NCT01649765|SELENA SLEDAI|selena sledai
349156|NCT01649765|BILAG|bilag
349157|NCT01649765|Lupus|lupus
349158|NCT01649765|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
349159|NCT01649765|PGA|pga
349160|NCT01649765|Pharmacokinetics|pharmacokinetics
349161|NCT01649765|placebo|placebo
349162|NCT01649765|PRINTO|printo
349163|NCT01649752|Stem cells|stem cells
349164|NCT01649752|Uterine cavity|uterine cavity
349165|NCT01649752|Implantation|implantation
349166|NCT01649752|ICSI|icsi
349167|NCT01649739|PAH|pah
349168|NCT01649713|Fluval AB|fluval ab
349169|NCT01649713|influenza|influenza
349170|NCT01649713|vaccine|vaccine
349171|NCT01649713|immunization|immunization
349172|NCT01649713|infections|infections
349173|NCT01649661|MRI|mri
349174|NCT01649661|12-125|12-125
349175|NCT01649661|premenopausal women|premenopausal women
349176|NCT01649661|postmenopausal women|postmenopausal women
349177|NCT01649661|questionnaire|questionnaire
349178|NCT01649648|Hypoxic ischemic encephalopathy|hypoxic ischemic encephalopathy
349179|NCT01649648|Autologous cord blood|autologous cord blood
349180|NCT01649622|Leukemia|leukemia
349181|NCT01649622|Lymphoma|lymphoma
349182|NCT01649622|Acute Lymphoblastic Leukemia/Lymphoma|acute lymphoblastic leukemia/lymphoma
349183|NCT01649622|ALL|all
349184|NCT01649622|Relapsed or primary refractory B-cell/T-cell|relapsed or primary refractory b-cell/t-cell
349185|NCT01649622|Bendamustine|bendamustine
349186|NCT01649622|Bendamustine Hydrochloride|bendamustine hydrochloride
349187|NCT01649622|Bendamustine HCL|bendamustine hcl
349188|NCT01649622|CEP-18083|cep-18083
349189|NCT01649622|SDX-105|sdx-105
349190|NCT01649622|Treanda|treanda
349191|NCT01649609|BK Viremia|bk viremia
349192|NCT01649609|BK Nephropathy|bk nephropathy
349193|NCT01649609|mTOR inhibitor|mtor inhibitor
349194|NCT01649609|renal transplant|renal transplant
349195|NCT01649557|Schizophrenia|schizophrenia
349196|NCT01649544|Mitral valvulopathy|mitral valvulopathy
349197|NCT01649544|Atrial Fibrillation|atrial fibrillation
349198|NCT01649544|Amiodarone|amiodarone
349199|NCT01649544|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
349200|NCT01649544|Chronic Atrial Fibrillation|chronic atrial fibrillation
349201|NCT01649544|Ultrasound Technique|ultrasound technique
349202|NCT01649492|diclofenac|diclofenac
349203|NCT01649492|CYP2C9|cyp2c9
349204|NCT01649492|bromelain|bromelain
349205|NCT01649492|pineapple juice|pineapple juice
349206|NCT01649479|Obstetrical antiphospholipid syndrome|obstetrical antiphospholipid syndrome
349207|NCT01649479|Thrombophilia|thrombophilia
349208|NCT01649466|Type 2 diabetes mellitus, diabetes|type 2 diabetes mellitus, diabetes
349209|NCT01649453|Neoplasms|neoplasms
349210|NCT01649453|Neoplasm Metastasis|neoplasm metastasis
349211|NCT01649453|Neoplastic Processes|neoplastic processes
349212|NCT01649453|Pathologic Processes|pathologic processes
349213|NCT01649440|Metabolomics|metabolomics
349214|NCT01649440|serum|serum
349215|NCT01649440|sepsis|sepsis
349216|NCT01649440|biomarkers|biomarkers
349217|NCT01649427|Pharmacokinetics Study|pharmacokinetics study
349218|NCT01649427|Tacroliums|tacroliums
349219|NCT01649427|GFR|gfr
349220|NCT01649427|kdney|kdney
349221|NCT01649401|nebulizer|nebulizer
349222|NCT01649401|PARI LC Spring SP|pari lc spring sp
349223|NCT01649388|Kidney transplant|kidney transplant
349224|NCT01649388|Delayed tolerance|delayed tolerance
349225|NCT01649388|Marrow/enriched hematopoetic stem cell transplant|marrow/enriched hematopoetic stem cell transplant
349226|NCT01649375|Ankylosing spondylitis|ankylosing spondylitis
349227|NCT01649375|AS|as
349228|NCT01649375|Chronic inflammatory disease|chronic inflammatory disease
349229|NCT01649375|Inflammatory back pain|inflammatory back pain
349230|NCT01649375|Secukinumab|secukinumab
349231|NCT01649375|Prefilled syringe (PFS)|prefilled syringe (pfs)
349232|NCT01649375|Subcutaneous injection|subcutaneous injection
349233|NCT01649375|AIN457|ain457
349234|NCT01649375|AIN457F|ain457f
349235|NCT01649375|AIN457F2310|ain457f2310
349236|NCT01649362|preterm infant|preterm infant
349237|NCT01649362|feeding difficulties|feeding difficulties
349238|NCT01649362|prefeeding oral stimulation|prefeeding oral stimulation
349239|NCT01649310|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
349240|NCT01649310|Muscle strenght|muscle strenght
349241|NCT01649310|Aged|aged
349242|NCT01649245|Chronic hepatitis C|chronic hepatitis c
349243|NCT01649245|Egyptian patients|egyptian patients
349244|NCT01649245|pegylated interferon|pegylated interferon
349245|NCT01649245|Ribavirin|ribavirin
349246|NCT01649245|Reiferon retard|reiferon retard
349247|NCT01649232|tdcs|tdcs
349248|NCT01649232|tms|tms
349249|NCT01649232|qeeg|qeeg
349250|NCT01649232|neuroplasticity|neuroplasticity
349251|NCT01649232|brain networks|brain networks
349252|NCT01649232|add|add
349253|NCT01649232|adhs|adhs
349254|NCT01649219|Prediabetes, objectively measured exercise, glucose and lipid metabolism, dose response, muscle metabolism.|prediabetes, objectively measured exercise, glucose and lipid metabolism, dose response, muscle metabolism.
349255|NCT01649206|Thyroid Nodule|thyroid nodule
349256|NCT01649206|Radiofrequency Thermal Ablation|radiofrequency thermal ablation
349257|NCT01649206|Pressure symptoms|pressure symptoms
349258|NCT01649206|Hyperthyroidism|hyperthyroidism
349259|NCT01649193|Rehabilitation [E02.831]|rehabilitation [e02.831]
349260|NCT01649193|Exercise [G11.427.394.380]|exercise [g11.427.394.380]
349261|NCT01649193|Health Education [I02.233.332]|health education [i02.233.332]
349262|NCT01649193|[C08]|[c08]
349263|NCT01649193|[C08.381]|[c08.381]
349264|NCT01649180|RCC|rcc
349265|NCT01649180|Clear Cell Renal Cell Carcinoma|clear cell renal cell carcinoma
349266|NCT01649180|ccRCC|ccrcc
349267|NCT01649180|Metastatic RCC|metastatic rcc
349268|NCT01649180|Recurrent RCC|recurrent rcc
349269|NCT01649180|Kidney Cancer|kidney cancer
349270|NCT01649180|Kidney Neoplasms|kidney neoplasms
349271|NCT01649180|Axitinib|axitinib
349272|NCT01649180|AG-013736|ag-013736
349273|NCT01649180|Tyrosine Kinase Inhibition|tyrosine kinase inhibition
349274|NCT01649180|TKI|tki
349275|NCT01649167|body mass index|body mass index
349276|NCT01649167|gestational diabetes|gestational diabetes
349277|NCT01649167|leptin|leptin
349278|NCT01649167|obesity|obesity
349279|NCT01649167|pregnancy.|pregnancy.
349280|NCT01649141|posttraumatic stress disorder|posttraumatic stress disorder
349281|NCT01649141|trauma-focused cognitive behavioral therapy|trauma-focused cognitive behavioral therapy
349282|NCT01649141|trauma|trauma
349283|NCT01649141|child abuse|child abuse
349284|NCT01649128|preeclampsia|preeclampsia
349285|NCT01649115|obesity|obesity
349286|NCT01649115|overweight|overweight
349287|NCT01649115|childhood obesity|childhood obesity
349288|NCT01649115|prevention|prevention
349289|NCT01649115|Z score|z score
349290|NCT01649115|weight for length|weight for length
349291|NCT01649115|WFL|wfl
349292|NCT01649115|body mass index|body mass index
349293|NCT01649115|BMI|bmi
349294|NCT01649115|prenatal|prenatal
349295|NCT01649115|maternal|maternal
349296|NCT01649115|nutrition education|nutrition education
349297|NCT01649115|health education|health education
349298|NCT01649115|health literacy|health literacy
349299|NCT01649115|health numeracy|health numeracy
349300|NCT01649115|passport|passport
349301|NCT01649115|healthy lifestyles|healthy lifestyles
349302|NCT01649115|growth|growth
349303|NCT01649115|growth chart|growth chart
349304|NCT01649102|Chronic hemodialysis|chronic hemodialysis
349305|NCT01649102|Tunneled cuffed catheter|tunneled cuffed catheter
349306|NCT01649102|Catheter-related bloodstream infection|catheter-related bloodstream infection
349307|NCT01649102|Mechanical catheter dysfunction|mechanical catheter dysfunction
349308|NCT01649102|impact of catheter design on outcome|impact of catheter design on outcome
349309|NCT01649063|Uterine contraction;|uterine contraction;
349310|NCT01649063|Shape; Frequency;|shape; frequency;
349311|NCT01649063|First stage labor;|first stage labor;
349312|NCT01649063|Fall|fall
349313|NCT01649063|Rise ratio.|rise ratio.
349314|NCT01649050|Spasticity|spasticity
349315|NCT01649050|Multiple Sclerosis|multiple sclerosis
349316|NCT01649024|Tremelimumab|tremelimumab
349317|NCT01649024|Malignant Mesothelioma|malignant mesothelioma
349318|NCT01649024|anti-CTLA-4 mAb|anti-ctla-4 mab
349319|NCT01649011|Oswestry Disability Index|oswestry disability index
349320|NCT01649011|ODI|odi
349321|NCT01649011|Roland Morris Disability Questionnaire|roland morris disability questionnaire
349322|NCT01649011|RMDQ|rmdq
349323|NCT01648998|Mineralocorticoid receptor|mineralocorticoid receptor
349324|NCT01648998|Fludrocortisone|fludrocortisone
349325|NCT01648998|Information Processing|information processing
349326|NCT01648998|Cognition|cognition
349327|NCT01648998|Depression|depression
349328|NCT01648946|Strategies of transfusion|strategies of transfusion
349329|NCT01648946|Red blood cells|red blood cells
349330|NCT01648946|Liberal|liberal
349331|NCT01648946|Restrictive|restrictive
349332|NCT01648946|Oncologic critically ill patients|oncologic critically ill patients
349333|NCT01648933|sarcoidosis|sarcoidosis
349334|NCT01648933|heart|heart
349335|NCT01648933|Rubidium|rubidium
349336|NCT01648933|PET|pet
349337|NCT01648920|Asthma|asthma
349338|NCT01648920|Suspected but undiagnosed asthma|suspected but undiagnosed asthma
349339|NCT01648907|DESIR|desir
349340|NCT01648907|SPONDYLARTHRITIS|spondylarthritis
349341|NCT01648907|EARLY INFLAMMATORY RACHIIALGIA|early inflammatory rachiialgia
349342|NCT01648907|BACK PAIN|back pain
349343|NCT01648894|Rectal cancer|rectal cancer
349344|NCT01648894|radiochemotherapy|radiochemotherapy
349345|NCT01648894|complete pathological response|complete pathological response
349346|NCT01648868|TMSAutism|tmsautism
349347|NCT01648868|Eye-tracking|eye-tracking
349348|NCT01648868|Social perception|social perception
349349|NCT01648868|Social cognition|social cognition
349350|NCT01648855|Circulating antiangiogenic factors|circulating antiangiogenic factors
349351|NCT01648855|Preeclampsia|preeclampsia
349352|NCT01648855|Developing lung|developing lung
349353|NCT01648855|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
349354|NCT01648842|Preeclampsia|preeclampsia
349355|NCT01648842|Vitamin D deficiency|vitamin d deficiency
349356|NCT01648842|Pregnancy|pregnancy
349357|NCT01648842|First trimester|first trimester
349358|NCT01648777|Pneumonia|pneumonia
349359|NCT01648777|Postoperative infection|postoperative infection
349360|NCT01648777|Cardiac surgery|cardiac surgery
349361|NCT01648777|Multiperforated catheter|multiperforated catheter
349362|NCT01648777|Analgesia|analgesia
349363|NCT01648751|Pelvic organ prolapse|pelvic organ prolapse
349364|NCT01648751|Pelvic floor physical therapy|pelvic floor physical therapy
349365|NCT01648751|Vaginal estrogen|vaginal estrogen
349366|NCT01648751|Placebo|placebo
349367|NCT01648738|Subacute low back pain|subacute low back pain
349368|NCT01648738|Chronic low back pain|chronic low back pain
349369|NCT01648738|Low back pain|low back pain
349370|NCT01648738|Disability|disability
349371|NCT01648738|Education|education
349372|NCT01648738|Exercise|exercise
349373|NCT01648738|Spa therapy|spa therapy
349374|NCT01648738|Physiotherapy|physiotherapy
349375|NCT01648738|Multidisciplinary|multidisciplinary
349376|NCT01648738|Cost-effectiveness|cost-effectiveness
349377|NCT01648738|Sick leave|sick leave
349378|NCT01648725|Hypnosis|hypnosis
349379|NCT01648725|Anesthesia|anesthesia
349380|NCT01648725|Propofol|propofol
349381|NCT01648725|Closed-loop|closed-loop
349382|NCT01648712|extracorporeal circuit, platelet function|extracorporeal circuit, platelet function
349383|NCT01648699|Pain|pain
349384|NCT01648699|Cancer|cancer
349385|NCT01648699|Osmotic Release Oral System|osmotic release oral system
349386|NCT01648699|OROS Hydromorphone|oros hydromorphone
349387|NCT01648699|Jurnista|jurnista
349388|NCT01648686|Alendronate|alendronate
349389|NCT01648686|Dental extraction|dental extraction
349390|NCT01648686|Bone healing|bone healing
349391|NCT01648686|postmenopausal women|postmenopausal women
349392|NCT01648686|dental radiography|dental radiography
349393|NCT01648673|Coronary Artery Disease|coronary artery disease
349394|NCT01648673|Cardiac Rehabilitation|cardiac rehabilitation
349395|NCT01648634|Nebivolol|nebivolol
349396|NCT01648634|beta-blockade treatment|beta-blockade treatment
349397|NCT01648621|COPD|copd
349398|NCT01648621|case management|case management
349399|NCT01648595|Fentanyl|fentanyl
349400|NCT01648595|analgesia|analgesia
349401|NCT01648595|duration of the active phase|duration of the active phase
349402|NCT01648595|pain severity|pain severity
349403|NCT01648556|Purpura thrombopenic|purpura thrombopenic
349404|NCT01648556|Medullary cytogenetics|medullary cytogenetics
349405|NCT01648556|Myelodysplasic syndrome|myelodysplasic syndrome
349406|NCT01648556|bone marrow biopsy|bone marrow biopsy
349407|NCT01648517|on-small cell lung carcinoma|on-small cell lung carcinoma
349408|NCT01648517|chemotherapy naive patient|chemotherapy naive patient
349409|NCT01648504|Colonoscopy|colonoscopy
349410|NCT01648504|Screening colonoscopy|screening colonoscopy
349411|NCT01648504|Electronic education|electronic education
349412|NCT01648504|Ipad|ipad
349413|NCT01648504|Patient education|patient education
349414|NCT01648478|IRAP|irap
349415|NCT01648478|insulin sensitivity marker|insulin sensitivity marker
349416|NCT01648465|metastatic|metastatic
349417|NCT01648465|unresectable|unresectable
349418|NCT01648465|well or moderately differentiated|well or moderately differentiated
349419|NCT01648465|advanced|advanced
349420|NCT01648452|Achromatopsia|achromatopsia
349421|NCT01648452|Ciliary Neurotrophic Factor|ciliary neurotrophic factor
349422|NCT01648452|CNTF|cntf
349423|NCT01648322|Breast Cancer|breast cancer
349424|NCT01648322|Taxotere Chemotherapy|taxotere chemotherapy
349425|NCT01648322|Neulasta|neulasta
349426|NCT01648322|efficacy and safety|efficacy and safety
349427|NCT01648322|single cycle doses of F-627|single cycle doses of f-627
349428|NCT01648322|pegfilgrastim|pegfilgrastim
349429|NCT01648309|aortic stenosis|aortic stenosis
349430|NCT01648309|TAVI|tavi
349431|NCT01648309|neuropsychological|neuropsychological
349432|NCT01648309|cognitive|cognitive
349433|NCT01648309|candidates for TAVI|candidates for tavi
349434|NCT01648296|Heart Failure|heart failure
349435|NCT01648296|Obesity|obesity
349436|NCT01648296|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
349437|NCT01648296|Health Normal Volunteer Subjects|health normal volunteer subjects
349438|NCT01648283|methadone polymorphisms|methadone polymorphisms
349439|NCT01648270|buprenorphine concentration-effect (miosis) relationship|buprenorphine concentration-effect (miosis) relationship
349440|NCT01648257|healthy subjects|healthy subjects
349441|NCT01648257|relative bioavailability|relative bioavailability
349442|NCT01648257|HIV|hiv
349443|NCT01648257|GSK1265744|gsk1265744
349444|NCT01648244|DM, T2DM, Diabetes|dm, t2dm, diabetes
349445|NCT01648231|Healthy Volunteer|healthy volunteer
349446|NCT01648218|glucocorticoid|glucocorticoid
349447|NCT01648218|diabetes mellitus|diabetes mellitus
349448|NCT01648218|post-transplant|post-transplant
349449|NCT01648218|insulin|insulin
349450|NCT01648205|ranolazine|ranolazine
349451|NCT01648205|clinical trial|clinical trial
349452|NCT01648179|GSK1322322, relative bioavailability, healthy subjects, open label, food effect, weight effect|gsk1322322, relative bioavailability, healthy subjects, open label, food effect, weight effect
349453|NCT01648166|trace|trace
349454|NCT01648166|element|element
349455|NCT01648166|lung|lung
349456|NCT01648166|cancer|cancer
349457|NCT01648166|Appalachia|appalachia
349458|NCT01648153|Efficacy|efficacy
349459|NCT01648153|Obese|obese
349460|NCT01648153|T2DM|t2dm
349461|NCT01648153|IL-18|il-18
349462|NCT01648153|Monoclonal antibody (mAb)|monoclonal antibody (mab)
349463|NCT01648140|Genotype 4|genotype 4
349464|NCT01648140|GSK2336805|gsk2336805
349465|NCT01648140|pegylated interferon|pegylated interferon
349466|NCT01648140|telaprevir|telaprevir
349467|NCT01648140|Genotype 1|genotype 1
349468|NCT01648140|chronic hepatitis C|chronic hepatitis c
349469|NCT01648140|ribavirin|ribavirin
349470|NCT01648140|NS5A inhibitor|ns5a inhibitor
349471|NCT01648140|hepatitis C virus (HCV) infection|hepatitis c virus (hcv) infection
349472|NCT01648127|Ceftaroline|ceftaroline
349473|NCT01648127|Pharmacokinetics|pharmacokinetics
349474|NCT01648127|Obesity|obesity
349475|NCT01648114|breastfeeding|breastfeeding
349476|NCT01648114|pregnancy|pregnancy
349477|NCT01648114|antenatal|antenatal
349478|NCT01648114|exclusive breastfeeding|exclusive breastfeeding
349479|NCT01648114|education|education
349480|NCT01648101|Retigabine IR|retigabine ir
349481|NCT01648101|Asian Subjects|asian subjects
349482|NCT01648101|Adjunctive Therapy|adjunctive therapy
349483|NCT01648101|Efficacy|efficacy
349484|NCT01648101|Drug-Resistant|drug-resistant
349485|NCT01648101|Safety & tolerability|safety & tolerability
349486|NCT01648101|Partial-Onset Seizures|partial-onset seizures
349487|NCT01648101|Epilepsy|epilepsy
349488|NCT01648088|staphylococcus aureus|staphylococcus aureus
349489|NCT01648088|prosthetic joint implantation|prosthetic joint implantation
349490|NCT01648075|caries|caries
349491|NCT01648075|probiotics|probiotics
349492|NCT01648075|lactobacilli|lactobacilli
349493|NCT01648062|Sleep|sleep
349494|NCT01648062|self-regulation|self-regulation
349495|NCT01648062|Implementation intentions|implementation intentions
349496|NCT01648062|intervention|intervention
349497|NCT01648062|mental simulation|mental simulation
349498|NCT01648023|LC Bead|lc bead
349499|NCT01648023|Irinotecan|irinotecan
349500|NCT01648023|ONCOZENE BEAD|oncozene bead
349501|NCT01648010|Non Muscle Invasive Bladder Cancer|non muscle invasive bladder cancer
349502|NCT01648010|Carcinoma of urinary bladder, invasive|carcinoma of urinary bladder, invasive
349503|NCT01648010|Intravesical instillation|intravesical instillation
349504|NCT01648010|Mitomycin C|mitomycin c
349505|NCT01648010|Hydrogel|hydrogel
349506|NCT01648010|Reverse thermal gelation|reverse thermal gelation
349507|NCT01648010|Drug retention|drug retention
349508|NCT01648010|radical cystectomy|radical cystectomy
349509|NCT01647997|bacterial lipopolysaccharides|bacterial lipopolysaccharides
349510|NCT01647997|hyperlactatemia|hyperlactatemia
349511|NCT01647997|muscle lactate|muscle lactate
349512|NCT01647984|Arrhythmias|arrhythmias
349513|NCT01647984|Life quality|life quality
349514|NCT01647971|Lymphoma|lymphoma
349515|NCT01647971|Rituxan|rituxan
349516|NCT01647971|Relapsed|relapsed
349517|NCT01647971|Refractory|refractory
349518|NCT01647958|TEMPO|tempo
349519|NCT01647958|TIF|tif
349520|NCT01647958|Transoral Incisionless Fundoplication|transoral incisionless fundoplication
349521|NCT01647958|EsophyX System|esophyx system
349522|NCT01647958|refractory symptoms|refractory symptoms
349523|NCT01647958|proton pump inhibitors|proton pump inhibitors
349524|NCT01647958|EndoGastric Solutions|endogastric solutions
349525|NCT01647958|EGS|egs
349526|NCT01647958|Acid Reflux|acid reflux
349527|NCT01647958|Heartburn|heartburn
349528|NCT01647958|Regurgitation|regurgitation
349529|NCT01647945|PAH WHO group 1|pah who group 1
349530|NCT01647932|Heart Failure|heart failure
349531|NCT01647932|Diuretics|diuretics
349532|NCT01647932|Diuretic resistance|diuretic resistance
349533|NCT01647919|Cognition|cognition
349534|NCT01647919|Attention|attention
349535|NCT01647919|Memory|memory
349536|NCT01647919|Mood|mood
349537|NCT01647867|Met fragments expression|met fragments expression
349538|NCT01647854|emergency medical service|emergency medical service
349539|NCT01647854|telemedicine|telemedicine
349540|NCT01647854|teleconsultation|teleconsultation
349541|NCT01647854|safety|safety
349542|NCT01647828|Newly diagnosed Stage IV Pancreatic Cancer|newly diagnosed stage iv pancreatic cancer
349543|NCT01647815|Axillary vein ultrasound|axillary vein ultrasound
349544|NCT01647815|Subclavian vein ultrasound|subclavian vein ultrasound
349545|NCT01647802|standing devices|standing devices
349546|NCT01647802|transfer devices|transfer devices
349547|NCT01647789|prostate cancer, castration resistant,|prostate cancer, castration resistant,
349548|NCT01647776|Colon Neoplasia|colon neoplasia
349549|NCT01647776|Colorectal carcinoma|colorectal carcinoma
349550|NCT01647776|colon cancer|colon cancer
349551|NCT01647776|colon polyp|colon polyp
349552|NCT01647776|colonoscopy|colonoscopy
349553|NCT01647776|sDNA test|sdna test
349554|NCT01647776|FIT tests (fecal immunochemical test)|fit tests (fecal immunochemical test)
349555|NCT01647776|relating colon neoplasia to obesity, type 2 diabetes|relating colon neoplasia to obesity, type 2 diabetes
349556|NCT01647776|colonoscopy and pathology confirmed advanced adenomas|colonoscopy and pathology confirmed advanced adenomas
349557|NCT01647763|Hemorrhoids|hemorrhoids
349558|NCT01647737|Xerostomia|xerostomia
349559|NCT01647737|Sjogren syndrome|sjogren syndrome
349560|NCT01647737|dry mouth|dry mouth
349561|NCT01647724|cervical cancer|cervical cancer
349562|NCT01647724|prevention|prevention
349563|NCT01647724|screening|screening
349564|NCT01647698|Parkinson Disease|parkinson disease
349565|NCT01647698|near transfer|near transfer
349566|NCT01647698|far transfer|far transfer
349567|NCT01647698|working memory|working memory
349568|NCT01647698|fluid intelligence|fluid intelligence
349569|NCT01647698|cognitive training|cognitive training
349570|NCT01647698|dual n-back|dual n-back
349571|NCT01647685|Vesselwall inflammation|vesselwall inflammation
349572|NCT01647685|liposomal prednisolone|liposomal prednisolone
349573|NCT01647659|MEK inhibitor GSK1120212|mek inhibitor gsk1120212
349574|NCT01647659|pharmacokinetics|pharmacokinetics
349575|NCT01647659|powder for oral solution|powder for oral solution
349576|NCT01647659|Solid Tumors|solid tumors
349577|NCT01647659|pediatric formulation|pediatric formulation
349578|NCT01647646|asthma|asthma
349579|NCT01647646|SMART|smart
349580|NCT01647646|fixed dose|fixed dose
349581|NCT01647633|rhinitis|rhinitis
349582|NCT01647633|stuffy nose|stuffy nose
349583|NCT01647633|congestion|congestion
349584|NCT01647633|Sneezing|sneezing
349585|NCT01647607|Breast Cancer|breast cancer
349586|NCT01647607|Young Women|young women
349587|NCT01647607|Fertility|fertility
349588|NCT01647607|Physical Activity|physical activity
349589|NCT01647607|Survivorship|survivorship
349590|NCT01647594|Breast cancer|breast cancer
349591|NCT01647594|Young women|young women
349592|NCT01647594|Fertility|fertility
349593|NCT01647594|Physical activity|physical activity
349594|NCT01647594|Survivorship|survivorship
349595|NCT01647581|hemoclip|hemoclip
349596|NCT01647581|colonoscopy|colonoscopy
349597|NCT01647581|post-polypectomy bleed|post-polypectomy bleed
349598|NCT01647555|Cetuximab|cetuximab
349599|NCT01647555|radiotherapy|radiotherapy
349600|NCT01647555|epidermoid head and neck cancer|epidermoid head and neck cancer
349601|NCT01647542|Drug therapy|drug therapy
349602|NCT01647529|Cytomegalovirus|cytomegalovirus
349603|NCT01647529|uveitis|uveitis
349604|NCT01647529|endotheliitis|endotheliitis
349605|NCT01647529|ganciclovir|ganciclovir
349606|NCT01647503|parathyroid gland|parathyroid gland
349607|NCT01647503|primary hyperparathyroidism|primary hyperparathyroidism
349608|NCT01647503|proteins|proteins
349609|NCT01647477|non treated cancer|non treated cancer
349610|NCT01647477|oral cavity|oral cavity
349611|NCT01647477|oropharynx|oropharynx
349612|NCT01647477|hypopharynx|hypopharynx
349613|NCT01647477|larynx|larynx
349614|NCT01647477|first consultation|first consultation
349615|NCT01647438|South Asians|south asians
349616|NCT01647438|Diabetes|diabetes
349617|NCT01647438|Physical Activity|physical activity
349618|NCT01647438|Coronary Heart Disease|coronary heart disease
349619|NCT01647438|Lifestyle|lifestyle
349620|NCT01647425|head and neck cancer|head and neck cancer
349621|NCT01647425|lung cancer|lung cancer
349622|NCT01647425|tobacco use disorder|tobacco use disorder
349623|NCT01647425|alcoholism|alcoholism
349624|NCT01647412|Crohn's disease|crohn's disease
349625|NCT01647412|Inflammatory Bowel Disease|inflammatory bowel disease
349626|NCT01647412|Growth Hormone|growth hormone
349627|NCT01647412|Nutraceuticals|nutraceuticals
349628|NCT01647399|Obesity|obesity
349629|NCT01647399|Asthma|asthma
349630|NCT01647399|Vitamin D|vitamin d
349631|NCT01647399|Allergy|allergy
349632|NCT01647399|Genetic|genetic
349633|NCT01647399|Childhood|childhood
349634|NCT01647399|Pediatric|pediatric
349635|NCT01647399|cohort|cohort
349636|NCT01647399|observational|observational
349637|NCT01647399|prospective|prospective
349638|NCT01647399|molecular|molecular
349639|NCT01647373|retinal detachment|retinal detachment
349640|NCT01647373|scleral buckle|scleral buckle
349641|NCT01647373|silicone sponge|silicone sponge
349642|NCT01647373|axial length|axial length
349643|NCT01647373|surgery included silicone sponge scleral buckling|surgery included silicone sponge scleral buckling
349644|NCT01647373|retina currently attached|retina currently attached
349645|NCT01647373|at least 6 months after surgery|at least 6 months after surgery
349646|NCT01647360|Metrorrhagia|metrorrhagia
349647|NCT01647360|Menorrhagia|menorrhagia
349648|NCT01647347|bacteria|bacteria
349649|NCT01647347|bacteremia|bacteremia
349650|NCT01647347|PVP-iodine|pvp-iodine
349651|NCT01647347|periodontitis|periodontitis
349652|NCT01647321|SPMS|spms
349653|NCT01647295|visual exploration|visual exploration
349654|NCT01647295|pupil size|pupil size
349655|NCT01647295|social interactions|social interactions
349656|NCT01647295|faces|faces
349657|NCT01647295|human motion|human motion
349658|NCT01647256|Bioavailability|bioavailability
349659|NCT01647256|Fed|fed
349660|NCT01647256|Fasting|fasting
349661|NCT01647243|Knee osteoarthritis|knee osteoarthritis
349662|NCT01647243|Total knee arthroplasty|total knee arthroplasty
349663|NCT01647243|Preoperative training|preoperative training
349664|NCT01647243|Strength training|strength training
349665|NCT01647230|Anaesthesia, spinal|anaesthesia, spinal
349666|NCT01647230|Cerebral oximetry|cerebral oximetry
349667|NCT01647230|Blood pressure|blood pressure
349668|NCT01647230|Heart rate|heart rate
349669|NCT01647230|Cognitive Symptom|cognitive symptom
349670|NCT01647217|Blepharitis|blepharitis
349671|NCT01647217|Demodex|demodex
349672|NCT01647217|Mites|mites
349673|NCT01647217|Tea Tree oil|tea tree oil
349674|NCT01647217|Terpinen|terpinen
349675|NCT01647204|Nutrition|nutrition
349676|NCT01647204|older|older
349677|NCT01647204|hospital|hospital
349678|NCT01647204|volunteer|volunteer
349679|NCT01647191|HCV，|hcv，
349680|NCT01647191|drug users，|drug users，
349681|NCT01647191|intervention|intervention
349682|NCT01647165|Maintenance Strategy|maintenance strategy
349683|NCT01647165|Plasma Cell Neoplasm|plasma cell neoplasm
349684|NCT01647165|Proteasome Inhibitor|proteasome inhibitor
349685|NCT01647165|Immunomodulatory Drugs|immunomodulatory drugs
349686|NCT01647165|Novel Therapy|novel therapy
349687|NCT01647152|Uveitis|uveitis
349688|NCT01647152|Ustekinumab|ustekinumab
349689|NCT01647152|IL 12/23|il 12/23
349690|NCT01647152|Stelara|stelara
349691|NCT01646866|autism|autism
349692|NCT01646866|siblings|siblings
349693|NCT01646866|genetic test|genetic test
349694|NCT01646866|screening|screening
349695|NCT01646840|PF-04958242|pf-04958242
349696|NCT01646840|bioequivalence|bioequivalence
349697|NCT01646840|pharmacokinetics|pharmacokinetics
349698|NCT01646840|Schizophrenia|schizophrenia
349699|NCT01646827|Schizophrenia, extended release antipsychotic|schizophrenia, extended release antipsychotic
349700|NCT01646814|Healthy volunteer|healthy volunteer
349701|NCT01646814|comparison of incidence of|comparison of incidence of
349702|NCT01646814|treatment groups.|treatment groups.
349703|NCT01646775|opioid|opioid
349704|NCT01646775|malignancy|malignancy
349705|NCT01646775|epidural|epidural
349706|NCT01646749|Energy intake|energy intake
349707|NCT01646749|Beef protein|beef protein
349708|NCT01646749|Satiety|satiety
349709|NCT01646749|Protein leverage hypothesis|protein leverage hypothesis
349710|NCT01646736|Lupus Nephritis|lupus nephritis
349711|NCT01646736|Cyclophosphamide|cyclophosphamide
349712|NCT01646736|Tripterygium|tripterygium
349713|NCT01646710|Tool|tool
349714|NCT01646710|FBR|fbr
349715|NCT01646710|Advocacy|advocacy
349716|NCT01646710|Development of a tool|development of a tool
349717|NCT01646710|advocacy materials|advocacy materials
349718|NCT01646697|pancreatic cancer|pancreatic cancer
349719|NCT01646697|adenocarcinoma|adenocarcinoma
349720|NCT01646697|pancreatic resection|pancreatic resection
349721|NCT01646684|Prostate cancer, pasireotide LAR, castration resistant prostatate cancer, CRPC, SOM230 LAR|prostate cancer, pasireotide lar, castration resistant prostatate cancer, crpc, som230 lar
349722|NCT01646671|Hypertension, Severe, LCZ696|hypertension, severe, lcz696
349723|NCT01646645|CMVpp65 specific T-cells|cmvpp65 specific t-cells
349724|NCT01646645|Stem Cell Transplantation|stem cell transplantation
349725|NCT01646645|12-086|12-086
349726|NCT01646632|institutionalized ADL fitness care-dependency|institutionalized adl fitness care-dependency
349727|NCT01646619|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
349728|NCT01646619|Therapeutic Hypothermia|therapeutic hypothermia
349729|NCT01646619|Therapeutic Hypothermia plus Adjuvant Therapy|therapeutic hypothermia plus adjuvant therapy
349730|NCT01646619|Cooling|cooling
349731|NCT01646606|Bronchiolitis|bronchiolitis
349732|NCT01646606|Length of stay|length of stay
349733|NCT01646606|Pilot Projects|pilot projects
349734|NCT01646606|Oxygen saturation monitoring|oxygen saturation monitoring
349735|NCT01646580|dermatomycoses, tinea, candidiasis, children|dermatomycoses, tinea, candidiasis, children
349736|NCT01646567|psoriasis|psoriasis
349737|NCT01646554|Liver metastases|liver metastases
349738|NCT01646554|Colorectal Cancer|colorectal cancer
349739|NCT01646554|KRAS mutated|kras mutated
349740|NCT01646554|FOLFOX|folfox
349741|NCT01646554|Aflibercept|aflibercept
349742|NCT01646554|Randomized|randomized
349743|NCT01646554|Phase II-III|phase ii-iii
349744|NCT01646554|Perioperative treatment|perioperative treatment
349745|NCT01646554|Adjuvant|adjuvant
349746|NCT01646554|Neo-adjuvant|neo-adjuvant
349747|NCT01646554|Surgery|surgery
349748|NCT01646554|Progression Free Survival|progression free survival
349749|NCT01646528|Gastric Intestinal Metaplasia|gastric intestinal metaplasia
349750|NCT01646528|Confocal Laser Endomicroscopy|confocal laser endomicroscopy
349751|NCT01646515|systolic heart failure|systolic heart failure
349752|NCT01646515|udenafil|udenafil
349753|NCT01646515|exercise capacity|exercise capacity
349754|NCT01646502|chronic wound|chronic wound
349755|NCT01646502|treatment|treatment
349756|NCT01646502|biofilms|biofilms
349757|NCT01646502|venous insufficiency|venous insufficiency
349758|NCT01646502|Esp|esp
349759|NCT01646489|Antisense|antisense
349760|NCT01646489|miR-122 antagonist|mir-122 antagonist
349761|NCT01646489|Safety in healthy volunteers|safety in healthy volunteers
349762|NCT01646489|Hepatitis C|hepatitis c
349763|NCT01646463|mindfulness|mindfulness
349764|NCT01646463|stress|stress
349765|NCT01646463|coping|coping
349766|NCT01646463|emotion|emotion
349767|NCT01646463|depression|depression
349768|NCT01646463|group medical visits|group medical visits
349769|NCT01646463|prenatal healthcare|prenatal healthcare
349770|NCT01646463|preterm birth|preterm birth
349771|NCT01646463|birth weight|birth weight
349772|NCT01646463|postpartum depression|postpartum depression
349773|NCT01646463|cortisol|cortisol
349774|NCT01646463|neuroendocrine function|neuroendocrine function
349775|NCT01646463|blood pressure|blood pressure
349776|NCT01646463|health disparities|health disparities
349777|NCT01646450|NSCLC|nsclc
349778|NCT01646450|EGFR Mutation|egfr mutation
349779|NCT01646450|Elder patients|elder patients
349780|NCT01646424|COPD,|copd,
349781|NCT01646424|Patient satisfaction,|patient satisfaction,
349782|NCT01646424|fix combination,|fix combination,
349783|NCT01646424|NIS Turkey,|nis turkey,
349784|NCT01646424|turbuhaler,|turbuhaler,
349785|NCT01646424|FSI-10|fsi-10
349786|NCT01646411|cytomegalovirus (CMV) IgM &IgG|cytomegalovirus (cmv) igm &igg
349787|NCT01646411|Lyme|lyme
349788|NCT01646411|Toxoplasma|toxoplasma
349789|NCT01646411|Rubella|rubella
349790|NCT01646411|Rubeola IgM|rubeola igm
349791|NCT01646411|Rocky mountain Spotted Fever IgM|rocky mountain spotted fever igm
349792|NCT01646411|Ebv IgM|ebv igm
349793|NCT01646411|Herpes|herpes
349794|NCT01646411|Babesia|babesia
349795|NCT01646411|Measles|measles
349796|NCT01646411|Tetanus|tetanus
349797|NCT01646411|Mumps|mumps
349798|NCT01646411|Mycoplasma|mycoplasma
349799|NCT01646411|Legionella|legionella
349800|NCT01646411|Giardia|giardia
349801|NCT01646411|Syphilis|syphilis
349802|NCT01646411|Bordetella Pertussis|bordetella pertussis
349803|NCT01646411|H Pylori|h pylori
349804|NCT01646411|Antibody Titre|antibody titre
349805|NCT01646411|Elevated IgG|elevated igg
349806|NCT01646411|Abnormal IgM|abnormal igm
349807|NCT01646411|SLE|sle
349808|NCT01646398|13VPNC|13vpnc
349809|NCT01646398|23VPS|23vps
349810|NCT01646385|observational|observational
349811|NCT01646385|non-interventional|non-interventional
349812|NCT01646385|cohort|cohort
349813|NCT01646385|retrospective|retrospective
349814|NCT01646385|register|register
349815|NCT01646385|rheumatoid arthritis|rheumatoid arthritis
349816|NCT01646372|Medical Education|medical education
349817|NCT01646372|Cognitive Aid|cognitive aid
349818|NCT01646372|Crisis Resource Management|crisis resource management
349819|NCT01646372|Advanced Cardiac Life Support|advanced cardiac life support
349820|NCT01646372|Skills Retention|skills retention
349821|NCT01646346|Breast Cancer|breast cancer
349822|NCT01646346|Radiation for Breast Cancer|radiation for breast cancer
349823|NCT01646333|Parkinson Disease|parkinson disease
349824|NCT01646333|Mild Cognitive Impairment|mild cognitive impairment
349825|NCT01646333|Cognition|cognition
349826|NCT01646333|Executive Function|executive function
349827|NCT01646333|Learning|learning
349828|NCT01646333|Memory|memory
349829|NCT01646333|Problem Solving|problem solving
349830|NCT01646294|Pharmacokinetics|pharmacokinetics
349831|NCT01646294|Phase I|phase i
349832|NCT01646294|YM178|ym178
349833|NCT01646294|Modified release (Oral Controlled Absorption System (OCAS))|modified release (oral controlled absorption system (ocas))
349834|NCT01646294|Immediate release (IR)|immediate release (ir)
349835|NCT01646294|Fasted conditions|fasted conditions
349836|NCT01646294|Fed conditions|fed conditions
349837|NCT01646281|Atrial fibrillation|atrial fibrillation
349838|NCT01646281|Vernakalant|vernakalant
349839|NCT01646281|Flecainide|flecainide
349840|NCT01646281|Echocardiography|echocardiography
349841|NCT01646268|Rotigotine|rotigotine
349842|NCT01646268|Neupro phase 3|neupro phase 3
349843|NCT01646268|Early phase|early phase
349844|NCT01646268|Idiopathic Parkinson's Disease|idiopathic parkinson's disease
349845|NCT01646255|Rotigotine|rotigotine
349846|NCT01646255|Neupro phase 3|neupro phase 3
349847|NCT01646255|Advanced-stage|advanced-stage
349848|NCT01646255|Idiopathic Parkinson's Disease|idiopathic parkinson's disease
349849|NCT01646229|Hemoperfusion|hemoperfusion
349850|NCT01646229|Polymyxin-B|polymyxin-b
349851|NCT01646229|Emergency abdominal surgery|emergency abdominal surgery
349852|NCT01646229|Sepsis|sepsis
349853|NCT01646229|Endotoxin|endotoxin
349854|NCT01646216|stroke|stroke
349855|NCT01646216|treadmill|treadmill
349856|NCT01646216|walking|walking
349857|NCT01646216|hemiparesis|hemiparesis
349858|NCT01646216|training|training
349859|NCT01646203|Advanced Solid Tumors|advanced solid tumors
349860|NCT01646190|Fast-track|fast-track
349861|NCT01646190|multimodal perioperative care|multimodal perioperative care
349862|NCT01646190|enhanced recovery|enhanced recovery
349863|NCT01646190|colorectal surgery|colorectal surgery
349864|NCT01646190|elderly patients|elderly patients
349865|NCT01646190|seniors|seniors
349866|NCT01646164|Dill seed|dill seed
349867|NCT01646164|Pattern of uterus contractions|pattern of uterus contractions
349868|NCT01646164|Active phase of labor|active phase of labor
349869|NCT01646138|H1N1|h1n1
349870|NCT01646138|Influenza|influenza
349871|NCT01646138|Human|human
349872|NCT01646138|Challenge Study|challenge study
349873|NCT01646138|Healthy Volunteer|healthy volunteer
349874|NCT01646125|Non-small cell lung carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
349875|NCT01646125|treatment of lung cancer after first metastasis|treatment of lung cancer after first metastasis
349876|NCT01646125|lung cancer|lung cancer
349877|NCT01646125|lung adenocarcinoma|lung adenocarcinoma
349878|NCT01646125|Squamous cell lung carcinoma|squamous cell lung carcinoma
349879|NCT01646125|Large-cell lung carcinoma|large-cell lung carcinoma
349880|NCT01646125|Non small cell lung carcinoma|non small cell lung carcinoma
349881|NCT01646125|Non small cell lung cancer|non small cell lung cancer
349882|NCT01646125|Non-small cell lung cancer|non-small cell lung cancer
349883|NCT01646125|NSCLC|nsclc
349884|NCT01646125|Large cell lung carcinoma|large cell lung carcinoma
349885|NCT01646125|Large cell lung cancer|large cell lung cancer
349886|NCT01646125|HSP90|hsp90
349887|NCT01646125|AUY922|auy922
349888|NCT01646125|Pemetrexed|pemetrexed
349889|NCT01646125|Docetaxel|docetaxel
349890|NCT01646125|EGFR TKI|egfr tki
349891|NCT01646125|EGFR mutations|egfr mutations
349892|NCT01646112|Uncertainty|uncertainty
349893|NCT01646112|HNPCC|hnpcc
349894|NCT01646112|Lynch Syndrome|lynch syndrome
349895|NCT01646112|Genetic Tests|genetic tests
349896|NCT01646099|Kidney transplant|kidney transplant
349897|NCT01646099|Renal transplant|renal transplant
349898|NCT01646099|Sun protection|sun protection
349899|NCT01646099|Skin cancer|skin cancer
349900|NCT01646086|Weight Loss|weight loss
349901|NCT01646086|Self-Weighing|self-weighing
349902|NCT01646086|Weight Tracking|weight tracking
349903|NCT01646073|Plaque Psoriasis|plaque psoriasis
349904|NCT01646073|Psoriasis|psoriasis
349905|NCT01646073|Placebo Controlled|placebo controlled
349906|NCT01646073|Skin Disease|skin disease
349907|NCT01646073|Double Blind|double blind
349908|NCT01646060|blood|blood
349909|NCT01646060|loss|loss
349910|NCT01646060|healthy|healthy
349911|NCT01646060|volume|volume
349912|NCT01646060|To evaluate the ability of the Zynex BVM to non-invasively detect blood loss in healthy subjects during a blood draw.|to evaluate the ability of the zynex bvm to non-invasively detect blood loss in healthy subjects during a blood draw.
349913|NCT01646047|diabetes|diabetes
349914|NCT01646047|diabetic retinopathy|diabetic retinopathy
349915|NCT01646047|nutritional supplements|nutritional supplements
349916|NCT01646047|visual function|visual function
349917|NCT01646047|macular pigment|macular pigment
349918|NCT01646047|macular threshold sensitivity|macular threshold sensitivity
349919|NCT01646047|contrast sensitivity|contrast sensitivity
349920|NCT01646047|color vision|color vision
349921|NCT01646047|optical coherence tomography|optical coherence tomography
349922|NCT01646034|oligo metastatic|oligo metastatic
349923|NCT01646034|HRD deficiency|hrd deficiency
349924|NCT01646021|Mantle cell lymphoma|mantle cell lymphoma
349925|NCT01646021|Relapsed mantle cell lymphoma|relapsed mantle cell lymphoma
349926|NCT01646021|Refractory mantle cell lymphoma|refractory mantle cell lymphoma
349927|NCT01646021|Ibrutinib|ibrutinib
349928|NCT01646021|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
349929|NCT01646021|Temsirolimus|temsirolimus
349930|NCT01645956|obesity|obesity
349931|NCT01645956|exercise|exercise
349932|NCT01645956|energy intake|energy intake
349933|NCT01645956|physical activity|physical activity
350034|NCT01645332|oral anti-hyperglycemic agent|oral anti-hyperglycemic agent
349934|NCT01645943|Non-ST-elevation acute myocardial infarction|non-st-elevation acute myocardial infarction
349935|NCT01645943|Comorbidities|comorbidities
349936|NCT01645930|Relapsed multiple myeloma,|relapsed multiple myeloma,
349937|NCT01645930|Refractory multiple myeloma,|refractory multiple myeloma,
349938|NCT01645930|MLN9708,|mln9708,
349939|NCT01645930|Proteasome inhibitor|proteasome inhibitor
349940|NCT01645917|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
349941|NCT01645904|Hereditary Diseases|hereditary diseases
349942|NCT01645904|Genetic|genetic
349943|NCT01645904|Lynch syndrome|lynch syndrome
349944|NCT01645904|Positive or indeterminate test results for Lynch syndrome|positive or indeterminate test results for lynch syndrome
349945|NCT01645904|Social media|social media
349946|NCT01645904|Internet-based program|internet-based program
349947|NCT01645904|Questionnaire|questionnaire
349948|NCT01645904|Survey|survey
349949|NCT01645904|My Family Garden website|my family garden website
349950|NCT01645904|Interview|interview
349951|NCT01645904|Focus group|focus group
349952|NCT01645904|Website Analysis and MeasureMent Inventory|website analysis and measurement inventory
349953|NCT01645904|WAMMI|wammi
349954|NCT01645891|Diabetic Foot Ulcer|diabetic foot ulcer
349955|NCT01645878|Primiparous Mothers|primiparous mothers
349956|NCT01645878|self-efficacy,|self-efficacy,
349957|NCT01645878|hands off,|hands off,
349958|NCT01645878|hands on ,|hands on ,
349959|NCT01645878|social cognitive theory|social cognitive theory
349960|NCT01645865|HIV|hiv
349961|NCT01645865|AIDS|aids
349962|NCT01645865|PMTCT|pmtct
349963|NCT01645865|Mobile Phone|mobile phone
349964|NCT01645865|SMS|sms
349965|NCT01645839|Leptomeningeal metastasis|leptomeningeal metastasis
349966|NCT01645839|Intrathecal chemotherapy|intrathecal chemotherapy
349967|NCT01645839|Depocyte|depocyte
349968|NCT01645800|Lysozyme hydrochloride|lysozyme hydrochloride
349969|NCT01645800|COPD|copd
349970|NCT01645787|Spinal Muscular Atrophy|spinal muscular atrophy
349971|NCT01645787|4-aminopyridine|4-aminopyridine
349972|NCT01645787|dalfampridine|dalfampridine
349973|NCT01645787|Ampyra|ampyra
349974|NCT01645774|subcutaneous injection heparin|subcutaneous injection heparin
349975|NCT01645774|injection duration|injection duration
349976|NCT01645774|bruising pain|bruising pain
349977|NCT01645774|decrease pain|decrease pain
349978|NCT01645774|decrease bruising|decrease bruising
349979|NCT01645761|Helicobacter pylori eradication|helicobacter pylori eradication
349980|NCT01645761|Peptic ulcer|peptic ulcer
349981|NCT01645748|head and neck cancer|head and neck cancer
349982|NCT01645748|docetaxel|docetaxel
349983|NCT01645748|cisplatin|cisplatin
349984|NCT01645748|S-1|s-1
349985|NCT01645735|Infections|infections
349986|NCT01645735|Teflaro|teflaro
349987|NCT01645735|cephalosporin|cephalosporin
349988|NCT01645735|Ceftaroline|ceftaroline
349989|NCT01645735|antibiotics|antibiotics
349990|NCT01645735|pneumonia|pneumonia
349991|NCT01645722|Fat Grafts|fat grafts
349992|NCT01645722|Autogenous Fat Transfers (AFT)|autogenous fat transfers (aft)
349993|NCT01645722|Wounded warriors|wounded warriors
349994|NCT01645722|Amputation pain|amputation pain
349995|NCT01645696|Diabetes|diabetes
349996|NCT01645696|Type 1 Diabetes|type 1 diabetes
349997|NCT01645696|Continuous glucose monitoring|continuous glucose monitoring
349998|NCT01645696|Blood glucose|blood glucose
349999|NCT01645696|Blood glucose sensor|blood glucose sensor
350000|NCT01645696|Glucose Binding Protein (GBP)|glucose binding protein (gbp)
350001|NCT01645566|cardiopulmonary resuscitation|cardiopulmonary resuscitation
350002|NCT01645566|stress|stress
350003|NCT01645566|intervention|intervention
350004|NCT01645475|enuresis|enuresis
350005|NCT01645449|Bioequivalence|bioequivalence
350006|NCT01645449|Atorvastatin calcium|atorvastatin calcium
350007|NCT01645449|crossover|crossover
350008|NCT01645436|randomized controlled trial|randomized controlled trial
350009|NCT01645436|in-hospital exercise|in-hospital exercise
350010|NCT01645436|children|children
350011|NCT01645436|cancer|cancer
350012|NCT01645423|Bioequivalence|bioequivalence
350013|NCT01645423|Atorvastatin calcium|atorvastatin calcium
350014|NCT01645423|crossover|crossover
350015|NCT01645410|Bioequivalence|bioequivalence
350016|NCT01645410|Atorvastatin calcium|atorvastatin calcium
350017|NCT01645410|crossover|crossover
350018|NCT01645397|Asthma|asthma
350019|NCT01645397|Deep inhalation|deep inhalation
350020|NCT01645397|Exhaled nitric oxide|exhaled nitric oxide
350021|NCT01645384|Bioequivalence|bioequivalence
350022|NCT01645384|Atorvastatin calcium|atorvastatin calcium
350023|NCT01645384|crossover|crossover
350024|NCT01645371|opioid-induced constipation|opioid-induced constipation
350025|NCT01645358|COPD|copd
350026|NCT01645358|NIV|niv
350027|NCT01645358|Acute Hypercapnic Respiratory Failure|acute hypercapnic respiratory failure
350028|NCT01645358|COPD patients with hypercapnic respiratory failure|copd patients with hypercapnic respiratory failure
350029|NCT01645345|wrinkles|wrinkles
350030|NCT01645345|acne scars|acne scars
350031|NCT01645332|DLBS3233|dlbs3233
350032|NCT01645332|new onset|new onset
350033|NCT01645332|type-2-diabetes mellitus|type-2-diabetes mellitus
350035|NCT01645280|Active rheumatoid arthritis|active rheumatoid arthritis
350036|NCT01645280|Ustekinumab|ustekinumab
350037|NCT01645280|STELARA|stelara
350038|NCT01645280|CNTO 1959|cnto 1959
350039|NCT01645254|healthy volunteers|healthy volunteers
350040|NCT01645254|pharmacokinetics|pharmacokinetics
350041|NCT01645254|malaria|malaria
350042|NCT01645254|Argemone mexicana|argemone mexicana
350043|NCT01645241|Ovarian stimulation|ovarian stimulation
350044|NCT01645241|Luteal phase|luteal phase
350045|NCT01645241|Egg donors|egg donors
350046|NCT01645241|Fertility preservation|fertility preservation
350047|NCT01645202|Aortic stenosis|aortic stenosis
350048|NCT01645202|TAVI|tavi
350049|NCT01645202|Device success|device success
350050|NCT01645202|Aortic regurgitation|aortic regurgitation
350051|NCT01645189|Hunter syndrome|hunter syndrome
350052|NCT01645189|idursulfase-beta|idursulfase-beta
350053|NCT01645189|Hunterase|hunterase
350054|NCT01645189|GC1111|gc1111
350055|NCT01645176|OA|oa
350056|NCT01645176|Knee|knee
350057|NCT01645163|mHealth|mhealth
350058|NCT01645163|Complementary feeding|complementary feeding
350059|NCT01645163|ICDS|icds
350060|NCT01645150|physical activity|physical activity
350061|NCT01645150|exercise|exercise
350062|NCT01645150|training|training
350063|NCT01645150|fatigue|fatigue
350064|NCT01645150|cancer|cancer
350065|NCT01645150|TKI|tki
350066|NCT01645150|tyrosine kinase inhibitor|tyrosine kinase inhibitor
350067|NCT01645137|prematurity|prematurity
350068|NCT01645137|OMT|omt
350069|NCT01645137|complementary and alternative medicine|complementary and alternative medicine
350070|NCT01645137|neonates|neonates
350071|NCT01645137|length of stay|length of stay
350072|NCT01645124|Polycythemia|polycythemia
350073|NCT01645124|Hematocrit|hematocrit
350074|NCT01645124|Thrombosis|thrombosis
350075|NCT01645085|R406|r406
350076|NCT01645085|Fostamatinib|fostamatinib
350077|NCT01645085|Phase I|phase i
350078|NCT01645085|Healthy Subjects|healthy subjects
350079|NCT01645085|Pharmacokinetics|pharmacokinetics
350080|NCT01645085|Bioequivalence|bioequivalence
350081|NCT01645072|Drug refractory epilepsy|drug refractory epilepsy
350082|NCT01645072|Dietary therapy|dietary therapy
350083|NCT01645072|ketogenic diet|ketogenic diet
350084|NCT01645072|childhood epilepsy|childhood epilepsy
350085|NCT01645033|Cognitive Behavioral Therapy|cognitive behavioral therapy
350086|NCT01645033|computer|computer
350087|NCT01645020|absorbable mesh|absorbable mesh
350088|NCT01645020|Partially absorbed Mesh|partially absorbed mesh
350089|NCT01645020|Prolift|prolift
350090|NCT01645020|Prolift + M|prolift + m
350091|NCT01645020|mesh related complications|mesh related complications
350092|NCT01645007|Hepatitis B|hepatitis b
350093|NCT01645007|Prevalence|prevalence
350094|NCT01645007|HBsAg|hbsag
350095|NCT01645007|Vaccination|vaccination
350096|NCT01645007|Galilee|galilee
350097|NCT01644968|metastatic carcinoma|metastatic carcinoma
350098|NCT01644968|lymphoma|lymphoma
350099|NCT01644968|sarcoma|sarcoma
350100|NCT01644968|anti-OX40|anti-ox40
350101|NCT01644955|Gliomas|gliomas
350102|NCT01644955|Carboplatin|carboplatin
350103|NCT01644942|Obese|obese
350104|NCT01644942|insulin sensitive|insulin sensitive
350105|NCT01644942|insulin resistant|insulin resistant
350106|NCT01644942|myotubes|myotubes
350107|NCT01644942|lipid accumulation|lipid accumulation
350108|NCT01644929|hemiparesis|hemiparesis
350109|NCT01644929|bihemispheric transcranial direct current stimulation|bihemispheric transcranial direct current stimulation
350110|NCT01644929|ischemic stroke|ischemic stroke
350111|NCT01644929|subacute|subacute
350112|NCT01644929|rehabilitation|rehabilitation
350113|NCT01644929|physiotherapy|physiotherapy
350114|NCT01644929|ergotherapy|ergotherapy
350115|NCT01644916|COPD|copd
350116|NCT01644916|Integrated care|integrated care
350117|NCT01644916|IPCL|ipcl
350118|NCT01644890|NK105, Paclitaxel, Breast cancer, Micelle|nk105, paclitaxel, breast cancer, micelle
350119|NCT01644851|veterans|veterans
350120|NCT01644851|neuropsychology|neuropsychology
350121|NCT01644851|neuroimaging|neuroimaging
350122|NCT01644851|attention|attention
350123|NCT01644851|working memory|working memory
350124|NCT01644851|inhibition|inhibition
350125|NCT01644851|magnetic resonance imaging, functional|magnetic resonance imaging, functional
350126|NCT01644851|trauma|trauma
350127|NCT01644851|stress|stress
350128|NCT01644851|anxiety|anxiety
350129|NCT01644851|emotion|emotion
350130|NCT01644851|prefrontal cortex|prefrontal cortex
350131|NCT01644838|Hyoscine,|hyoscine,
350132|NCT01644838|Promethazine,|promethazine,
350133|NCT01644838|The first stage of labor,|the first stage of labor,
350134|NCT01644838|Labor pain|labor pain
350135|NCT01644825|platinum resistant|platinum resistant
350136|NCT01644825|platinum refractory|platinum refractory
350137|NCT01644799|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
350138|NCT01644799|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
350139|NCT01644799|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
350140|NCT01644786|head and neck|head and neck
350141|NCT01644786|HNSCC|hnscc
350142|NCT01644786|orophaynx|orophaynx
350143|NCT01644786|hypopharynx|hypopharynx
350144|NCT01644786|larynx|larynx
350145|NCT01644786|nasopharynx|nasopharynx
350146|NCT01644786|oral cavity|oral cavity
350147|NCT01644786|prospective study|prospective study
350148|NCT01644786|predictive models for HNSCC|predictive models for hnscc
350149|NCT01644786|genomic analyses|genomic analyses
350150|NCT01644786|outcome prediction|outcome prediction
350151|NCT01644760|Diaphragmatic excursion|diaphragmatic excursion
350152|NCT01644760|normality|normality
350153|NCT01644747|Resistant Depression|resistant depression
350154|NCT01644747|Moods disorders|moods disorders
350155|NCT01644747|Unipolar depression|unipolar depression
350156|NCT01644747|Bipolar disorder|bipolar disorder
350157|NCT01644747|tDCS|tdcs
350158|NCT01644721|Child mortality|child mortality
350159|NCT01644721|Measles vaccine|measles vaccine
350160|NCT01644721|Non-specific effects|non-specific effects
350161|NCT01644708|Obesity|obesity
350162|NCT01644708|Overweight|overweight
350163|NCT01644708|Individual empowerment|individual empowerment
350164|NCT01644708|Physical parameters|physical parameters
350165|NCT01644708|Self esteem|self esteem
350166|NCT01644695|BARS|bars
350167|NCT01644695|Bony Anchoring Reinforcement System|bony anchoring reinforcement system
350168|NCT01644695|Hernia|hernia
350169|NCT01644695|Incisional|incisional
350170|NCT01644695|Recurrent|recurrent
350171|NCT01644695|abdominal wall reconstruction|abdominal wall reconstruction
350172|NCT01644695|abdominal wall defect|abdominal wall defect
350173|NCT01644695|mesh|mesh
350174|NCT01644695|component separation|component separation
350175|NCT01644682|Visceral leishmaniasis|visceral leishmaniasis
350176|NCT01644682|insecticide|insecticide
350177|NCT01644682|wall lining|wall lining
350178|NCT01644682|KO TAB123|ko tab123
350179|NCT01644682|Household|household
350180|NCT01644682|Kala-azar endemic area|kala-azar endemic area
350181|NCT01644656|portal hypertension|portal hypertension
350182|NCT01644656|cirrhosis|cirrhosis
350183|NCT01644656|ARFI|arfi
350184|NCT01644656|diagnostic study|diagnostic study
350185|NCT01644643|Ceftazidime,|ceftazidime,
350186|NCT01644643|avibactam,|avibactam,
350187|NCT01644643|metronidazone,|metronidazone,
350188|NCT01644643|Anti-Infectives|anti-infectives
350189|NCT01644604|Hypertension|hypertension
350190|NCT01644604|Vascular Diseases|vascular diseases
350191|NCT01644604|Cardiovascular Diseases|cardiovascular diseases
350192|NCT01644604|Renal denervation|renal denervation
350193|NCT01644591|Melanoma|melanoma
350194|NCT01644591|Malignant melanoma|malignant melanoma
350195|NCT01644591|Brain Metastases|brain metastases
350196|NCT01644591|Stereotactic Radiosurgery|stereotactic radiosurgery
350197|NCT01644591|SRS|srs
350198|NCT01644591|XRT|xrt
350199|NCT01644591|Questionnaires|questionnaires
350200|NCT01644591|Surveys|surveys
350201|NCT01644578|MRI|mri
350202|NCT01644578|real-time imaging|real-time imaging
350203|NCT01644578|workflow|workflow
350204|NCT01644552|aniridia|aniridia
350205|NCT01644552|positive angle kappa|positive angle kappa
350206|NCT01644539|Satiation|satiation
350207|NCT01644539|Brain activation|brain activation
350208|NCT01644539|Gut peptides|gut peptides
350209|NCT01644526|dialysis|dialysis
350210|NCT01644526|vascular access|vascular access
350211|NCT01644526|arteriovenous grafts|arteriovenous grafts
350212|NCT01644526|valve system|valve system
350213|NCT01644513|Age Related Macular Degeneration|age related macular degeneration
350214|NCT01644513|Choroidal Neovascular|choroidal neovascular
350215|NCT01644513|anti-VEGF Therapy|anti-vegf therapy
350216|NCT01644409|OAB|oab
350217|NCT01644409|Overactive bladder|overactive bladder
350218|NCT01644409|Urgency|urgency
350219|NCT01644409|Incontinence|incontinence
350220|NCT01644396|Moderate to Severe Plaque Psoriasis|moderate to severe plaque psoriasis
350221|NCT01644383|meaning of life|meaning of life
350222|NCT01644383|logotherapy|logotherapy
350223|NCT01644383|HIV-infected teenagers|hiv-infected teenagers
350224|NCT01644383|adherence|adherence
350225|NCT01644370|HIV-infected children|hiv-infected children
350226|NCT01644370|T cell response|t cell response
350227|NCT01644370|asthma|asthma
350228|NCT01644292|Mobility Impairment|mobility impairment
350229|NCT01644292|Manual Wheelchair|manual wheelchair
350230|NCT01644292|Older Adults|older adults
350231|NCT01644279|aging|aging
350232|NCT01644279|sarcopenia|sarcopenia
350233|NCT01644279|mitochondria|mitochondria
350234|NCT01644279|skeletal muscle|skeletal muscle
350235|NCT01644279|apoptosis|apoptosis
350236|NCT01644253|chronic lymphocytic leukemia|chronic lymphocytic leukemia
350237|NCT01644253|CLL|cll
350238|NCT01644253|previously untreated chronic lymphocytic leukemia|previously untreated chronic lymphocytic leukemia
350239|NCT01644253|peripheral T-cell lymphoma|peripheral t-cell lymphoma
350240|NCT01644253|PTCL|ptcl
350241|NCT01644227|Hip surgery|hip surgery
350242|NCT01644227|dual mobility cup|dual mobility cup
350243|NCT01644227|dislocation|dislocation
350244|NCT01644227|total hip arthroplasty|total hip arthroplasty
351734|NCT01637493|Pegylation|pegylation
350245|NCT01644214|Pelvic organ prolapse|pelvic organ prolapse
350246|NCT01644214|Pessary|pessary
350247|NCT01644162|Non-Invasive Positive-Pressure Ventilation|non-invasive positive-pressure ventilation
350248|NCT01644162|Disease Exacerbation|disease exacerbation
350249|NCT01644162|Respiratory Failure|respiratory failure
350250|NCT01644149|Jet Injector|jet injector
350251|NCT01644149|Stratis®|stratis®
350252|NCT01644149|PharmaJet|pharmajet
350253|NCT01644149|Jet Injection|jet injection
350254|NCT01644123|Spasticity|spasticity
350255|NCT01644123|Diagnostic Algorithm|diagnostic algorithm
350256|NCT01644097|Quality of Life|quality of life
350257|NCT01644084|albumin|albumin
350258|NCT01644084|hydroxyethyl starch 130/0.4|hydroxyethyl starch 130/0.4
350259|NCT01644084|cardiopulmonary bypass|cardiopulmonary bypass
350260|NCT01644071|violent video games|violent video games
350261|NCT01644071|serotonergic system|serotonergic system
350262|NCT01644058|immediate-loading|immediate-loading
350263|NCT01644058|patient-based outcomes|patient-based outcomes
350264|NCT01644045|Asthma|asthma
350265|NCT01644045|COPD|copd
350266|NCT01644045|emergency medical service|emergency medical service
350267|NCT01644045|teleconsultation|teleconsultation
350268|NCT01644045|telemedicine|telemedicine
350269|NCT01644032|telemedicine|telemedicine
350270|NCT01644032|teleconsultation|teleconsultation
350271|NCT01644032|analgesia|analgesia
350272|NCT01644032|emergency|emergency
350273|NCT01644032|prehospital|prehospital
350274|NCT01644019|stroke|stroke
350275|NCT01644019|teleconsultation|teleconsultation
350276|NCT01644019|telemedicine|telemedicine
350277|NCT01644019|emergency medical service|emergency medical service
350278|NCT01644006|acute coronary syndrome|acute coronary syndrome
350279|NCT01644006|telemedicine|telemedicine
350280|NCT01644006|teleconsultation|teleconsultation
350281|NCT01644006|emergency medical service|emergency medical service
350282|NCT01643993|IVF|ivf
350283|NCT01643993|embryo|embryo
350284|NCT01643967|Ozone|ozone
350285|NCT01643967|Sunflower oil|sunflower oil
350286|NCT01643967|diabetes Mellitus|diabetes mellitus
350287|NCT01643954|prostatectomy|prostatectomy
350288|NCT01643954|surgery|surgery
350289|NCT01643954|prostate cancer|prostate cancer
350290|NCT01643941|Staphylococcus aureus|staphylococcus aureus
350291|NCT01643941|vaccine|vaccine
350292|NCT01643941|Staphylococcal infection|staphylococcal infection
350293|NCT01643928|extension trial|extension trial
350294|NCT01643928|rheumatoid arthritis|rheumatoid arthritis
350295|NCT01643928|rituximab|rituximab
350296|NCT01643915|Audiovisual distraction|audiovisual distraction
350297|NCT01643915|Pediatric dentistry|pediatric dentistry
350298|NCT01643902|Stroke|stroke
350299|NCT01643902|Wake up|wake up
350300|NCT01643902|IV tPA|iv tpa
350301|NCT01643902|Thrombolytic|thrombolytic
350302|NCT01643889|Healthy|healthy
350303|NCT01643889|Domperidone|domperidone
350304|NCT01643889|Cardiac Repolarization|cardiac repolarization
350305|NCT01643876|Denture stomatitis|denture stomatitis
350306|NCT01643876|Denture Plaque|denture plaque
350307|NCT01643876|Oral Candidiasis|oral candidiasis
350308|NCT01643876|Oral Hygiene|oral hygiene
350309|NCT01643850|Pigmented Villonodular Synovitis|pigmented villonodular synovitis
350310|NCT01643850|PVNS|pvns
350311|NCT01643850|Giant cell tumor of the tendon sheath|giant cell tumor of the tendon sheath
350312|NCT01643850|GCCTS|gccts
350313|NCT01643850|Tenosynovial giant cell tumor (localized or diffused type)|tenosynovial giant cell tumor (localized or diffused type)
350314|NCT01643850|GCTS|gcts
350315|NCT01643850|MCS110|mcs110
350316|NCT01643837|Mastalgia|mastalgia
350317|NCT01643837|Breast Pain|breast pain
350318|NCT01643837|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
350319|NCT01643837|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
350320|NCT01643811|early gastric cancer, diabetes, hypertension|early gastric cancer, diabetes, hypertension
350321|NCT01643785|therapeutic efficacy endonase addictive effect|therapeutic efficacy endonase addictive effect
350322|NCT01643759|osteoarthritis disorders|osteoarthritis disorders
350323|NCT01643733|Angioplasty|angioplasty
350324|NCT01643707|Sick Sinus Syndrome|sick sinus syndrome
350325|NCT01643707|Bradycardia|bradycardia
350326|NCT01643616|Sciatic Nerve|sciatic nerve
350327|NCT01643616|Ultrasound|ultrasound
350328|NCT01643616|Anesthesia, Regional|anesthesia, regional
350329|NCT01643616|Orthopedic Surgery|orthopedic surgery
350330|NCT01643603|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
350331|NCT01643603|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
350332|NCT01643603|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
350333|NCT01643603|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
350334|NCT01643603|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
350335|NCT01643603|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
350336|NCT01643603|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
350337|NCT01643603|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
351735|NCT01637493|G-CSF|g-csf
350338|NCT01643603|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
350339|NCT01643603|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
350340|NCT01643603|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
350341|NCT01643603|anaplastic large cell lymphoma|anaplastic large cell lymphoma
350342|NCT01643603|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
350343|NCT01643603|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
350344|NCT01643603|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
350345|NCT01643603|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
350346|NCT01643603|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
350347|NCT01643603|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
350348|NCT01643603|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
350349|NCT01643603|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
350350|NCT01643603|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
350351|NCT01643603|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
350352|NCT01643603|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
350353|NCT01643603|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
350354|NCT01643603|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
350355|NCT01643603|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
350356|NCT01643603|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
350357|NCT01643603|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
350358|NCT01643603|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
350359|NCT01643603|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
350360|NCT01643603|hepatosplenic T-cell lymphoma|hepatosplenic t-cell lymphoma
350361|NCT01643603|intraocular lymphoma|intraocular lymphoma
350362|NCT01643603|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
350363|NCT01643603|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
350364|NCT01643603|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
350365|NCT01643603|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
350366|NCT01643603|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
350367|NCT01643603|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
350368|NCT01643603|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
350369|NCT01643603|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
350370|NCT01643603|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
350371|NCT01643603|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
350372|NCT01643603|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
350373|NCT01643603|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
350374|NCT01643603|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
350375|NCT01643603|noncutaneous extranodal lymphoma|noncutaneous extranodal lymphoma
350376|NCT01643603|peripheral T-cell lymphoma|peripheral t-cell lymphoma
350377|NCT01643603|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
350378|NCT01643603|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
350379|NCT01643603|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
350380|NCT01643603|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
350381|NCT01643603|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
350382|NCT01643603|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
350383|NCT01643603|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
350384|NCT01643603|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
350385|NCT01643603|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
350386|NCT01643603|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
350387|NCT01643603|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
350388|NCT01643603|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
350389|NCT01643603|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
350390|NCT01643603|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
350391|NCT01643603|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
350392|NCT01643603|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
350393|NCT01643603|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
350394|NCT01643603|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
350395|NCT01643603|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
350396|NCT01643603|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
350662|NCT01642680|Metabolic syndrome|metabolic syndrome
350397|NCT01643603|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
350398|NCT01643603|refractory hairy cell leukemia|refractory hairy cell leukemia
350399|NCT01643603|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
350400|NCT01643603|small intestine lymphoma|small intestine lymphoma
350401|NCT01643603|splenic marginal zone lymphoma|splenic marginal zone lymphoma
350402|NCT01643603|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
350403|NCT01643603|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
350404|NCT01643603|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
350405|NCT01643603|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
350406|NCT01643603|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
350407|NCT01643603|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
350515|NCT01643382|delayed draft function|delayed draft function
350408|NCT01643603|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
350409|NCT01643603|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
350410|NCT01643603|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
350411|NCT01643603|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
350412|NCT01643603|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
350413|NCT01643603|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
350414|NCT01643603|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
350415|NCT01643603|stage I mantle cell lymphoma|stage i mantle cell lymphoma
350416|NCT01643603|stage I marginal zone lymphoma|stage i marginal zone lymphoma
350417|NCT01643603|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
350418|NCT01643603|stage IA mycosis fungoides/Sezary syndrome|stage ia mycosis fungoides/sezary syndrome
350419|NCT01643603|stage IB mycosis fungoides/Sezary syndrome|stage ib mycosis fungoides/sezary syndrome
350420|NCT01643603|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
350421|NCT01643603|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
350422|NCT01643603|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
350423|NCT01643603|stage IIA mycosis fungoides/Sezary syndrome|stage iia mycosis fungoides/sezary syndrome
350424|NCT01643603|stage IIB mycosis fungoides/Sezary syndrome|stage iib mycosis fungoides/sezary syndrome
350425|NCT01643603|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
350426|NCT01643603|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
350427|NCT01643603|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
350428|NCT01643603|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
350429|NCT01643603|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
350430|NCT01643603|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
350431|NCT01643603|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
350432|NCT01643603|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
350433|NCT01643603|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
350434|NCT01643603|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
350435|NCT01643603|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
350436|NCT01643603|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
350437|NCT01643603|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
350438|NCT01643603|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
350439|NCT01643603|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
350440|NCT01643603|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
350441|NCT01643603|stage IIIA mycosis fungoides/Sezary syndrome|stage iiia mycosis fungoides/sezary syndrome
350442|NCT01643603|stage IIIB mycosis fungoides/Sezary syndrome|stage iiib mycosis fungoides/sezary syndrome
350443|NCT01643603|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
350444|NCT01643603|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
350445|NCT01643603|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
350446|NCT01643603|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
350447|NCT01643603|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
350448|NCT01643603|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
350449|NCT01643603|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
350450|NCT01643603|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
350451|NCT01643603|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
350452|NCT01643603|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
350453|NCT01643603|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
350454|NCT01643603|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
350455|NCT01643603|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
350456|NCT01643603|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
350457|NCT01643603|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
350458|NCT01643603|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
350459|NCT01643603|stage IVA mycosis fungoides/Sezary syndrome|stage iva mycosis fungoides/sezary syndrome
350460|NCT01643603|stage IVB mycosis fungoides/Sezary syndrome|stage ivb mycosis fungoides/sezary syndrome
350765|NCT01642199|weight loss|weight loss
350461|NCT01643603|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
350462|NCT01643603|testicular lymphoma|testicular lymphoma
350463|NCT01643603|Waldenström macroglobulinemia|waldenström macroglobulinemia
350464|NCT01643577|Idiopathic|idiopathic
350465|NCT01643577|gastroparesis|gastroparesis
350466|NCT01643577|delayed gastric emptying|delayed gastric emptying
350467|NCT01643577|nausea|nausea
350468|NCT01643577|vomiting|vomiting
350469|NCT01643577|abdominal pain|abdominal pain
350470|NCT01643577|bloating|bloating
350471|NCT01643564|Transplant|transplant
350472|NCT01643564|Cytokines|cytokines
350473|NCT01643564|Graft Dysfunction|graft dysfunction
350474|NCT01643551|Heart Failure|heart failure
350475|NCT01643551|Left Ventricular Assist Device|left ventricular assist device
350476|NCT01643551|Reperfusion Injury|reperfusion injury
350477|NCT01643551|Neuron Specific Enolase|neuron specific enolase
350478|NCT01643538|physical activity|physical activity
350479|NCT01643538|adults age 65 and older|adults age 65 and older
350480|NCT01643538|financial incentives|financial incentives
350481|NCT01643525|Ischemic Stroke|ischemic stroke
350482|NCT01643486|peritoneal dialysis|peritoneal dialysis
350483|NCT01643486|phosphate|phosphate
350484|NCT01643486|iTouch|itouch
350485|NCT01643473|Hypertension|hypertension
350486|NCT01643473|Latinos|latinos
350487|NCT01643473|Medication Adherence|medication adherence
350488|NCT01643473|Blood Pressure Control|blood pressure control
350489|NCT01643473|Patient-centered|patient-centered
350490|NCT01643473|Black|black
350491|NCT01643460|Intraductal papillary mucinous neoplasms (IPMNs)|intraductal papillary mucinous neoplasms (ipmns)
350492|NCT01643460|Mucinous cystadenomas [MCN])|mucinous cystadenomas [mcn])
350493|NCT01643460|Invasive IPMNs or mucinous cystadenocarcinomas) tumors|invasive ipmns or mucinous cystadenocarcinomas) tumors
350494|NCT01643447|Hepatocellular Carcinoma|hepatocellular carcinoma
350495|NCT01643447|Ulinastatin|ulinastatin
350496|NCT01643447|Hepatic Failure|hepatic failure
350497|NCT01643434|Resistant Hypertension|resistant hypertension
350498|NCT01643408|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
350499|NCT01643408|Lymphoblastic Lymphoma|lymphoblastic lymphoma
350500|NCT01643408|Erwinaze|erwinaze
350501|NCT01643408|asparaginase|asparaginase
350502|NCT01643408|Eusa Pharma|eusa pharma
350503|NCT01643408|Pharmacokinetic study|pharmacokinetic study
350504|NCT01643408|NSAA|nsaa
350505|NCT01643395|Trauma|trauma
350506|NCT01643395|vertebral|vertebral
350507|NCT01643395|compression fracture|compression fracture
350508|NCT01643395|spinal|spinal
350509|NCT01643395|acute|acute
350510|NCT01643395|vertebroplasty|vertebroplasty
350511|NCT01643395|conservative treatment|conservative treatment
350512|NCT01643382|diabetes|diabetes
350513|NCT01643382|kidney transplant|kidney transplant
350514|NCT01643382|end stage renal disease|end stage renal disease
350516|NCT01643369|meditation|meditation
350517|NCT01643369|compassion|compassion
350518|NCT01643369|inflammation|inflammation
350519|NCT01643369|immune system|immune system
350520|NCT01643356|weight|weight
350521|NCT01643356|pregnancy|pregnancy
350522|NCT01643356|behavioral intervention|behavioral intervention
350523|NCT01643356|obesity|obesity
350524|NCT01643343|autism spectrum disorders|autism spectrum disorders
350525|NCT01643343|autism|autism
350526|NCT01643343|joint attention|joint attention
350527|NCT01643343|imitation|imitation
350528|NCT01643343|fluency|fluency
350529|NCT01643330|Cardiomegaly|cardiomegaly
350530|NCT01643330|Heart Diseases|heart diseases
350531|NCT01643330|Cardiovascular Diseases|cardiovascular diseases
350532|NCT01643304|Menorrhagia|menorrhagia
350533|NCT01643304|Heavy menstrual bleeding|heavy menstrual bleeding
350534|NCT01643304|Uterine Hemorrhage|uterine hemorrhage
350535|NCT01643304|Menstruation Disturbancies|menstruation disturbancies
350536|NCT01643252|Corneal Ectasia|corneal ectasia
350537|NCT01643252|Refractive surgery|refractive surgery
350538|NCT01643252|Cross-Linking|cross-linking
350539|NCT01643239|Modified constraint-induced therapy|modified constraint-induced therapy
350540|NCT01643239|Children with cerebral palsy|children with cerebral palsy
350541|NCT01643239|Kinematic analysis|kinematic analysis
350542|NCT01643239|Group therapy|group therapy
350543|NCT01643200|Erectile Dysfunction|erectile dysfunction
350544|NCT01643200|Male|male
350545|NCT01643200|Zotarolimus|zotarolimus
350546|NCT01643200|Stent|stent
350547|NCT01643200|Stenosis|stenosis
350548|NCT01643200|Erection|erection
350549|NCT01643200|PDE5 Inhibitors|pde5 inhibitors
350550|NCT01643148|biomarker|biomarker
350551|NCT01643148|BMI|bmi
350552|NCT01643148|breast cancer|breast cancer
350553|NCT01643148|CA-15-3|ca-15-3
350554|NCT01643148|leptin|leptin
350555|NCT01643135|tranexamic acid|tranexamic acid
350556|NCT01643135|bleeding|bleeding
350557|NCT01643135|blood transfusion|blood transfusion
350558|NCT01643135|spine surgery|spine surgery
350559|NCT01643122|Endometriosis, Validation study|endometriosis, validation study
350560|NCT01643109|Cerebral Palsy|cerebral palsy
350561|NCT01643109|Hemiplegia|hemiplegia
350562|NCT01643109|Constraint Induced Movement Therapy|constraint induced movement therapy
350563|NCT01643096|Zataria multiflora Boiss Sumac TEF temperament|zataria multiflora boiss sumac tef temperament
350564|NCT01643083|Post-prandial distress syndrome|post-prandial distress syndrome
350565|NCT01643070|Rectal cancer|rectal cancer
350566|NCT01643070|Liver metastases|liver metastases
350567|NCT01643070|Capecitabine|capecitabine
350568|NCT01643070|Oxaliplatin|oxaliplatin
350569|NCT01643057|Apnea|apnea
350570|NCT01643057|Prematurity|prematurity
350571|NCT01643057|Biomarkers|biomarkers
350572|NCT01643057|Stochastic Resonance|stochastic resonance
350573|NCT01643057|Neonatal|neonatal
350574|NCT01643044|pregnancy|pregnancy
350575|NCT01643044|screening|screening
350576|NCT01643044|motivation|motivation
350577|NCT01643031|Diabetes|diabetes
350578|NCT01643031|Platelets aggregation inhibitors|platelets aggregation inhibitors
350579|NCT01643031|Platelet function tests|platelet function tests
350580|NCT01643018|cystic echinococcosis|cystic echinococcosis
350581|NCT01643018|liver cyst hydatique|liver cyst hydatique
350582|NCT01643018|treatment|treatment
350583|NCT01643018|surgery|surgery
350584|NCT01643018|laparoscopy|laparoscopy
350585|NCT01643005|HIV|hiv
350586|NCT01642992|Coronary bifurcation lesion|coronary bifurcation lesion
350587|NCT01642992|Drug-eluting stent|drug-eluting stent
350588|NCT01642979|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
350589|NCT01642979|Anemia|anemia
350590|NCT01642979|Hematologic Diseases|hematologic diseases
350591|NCT01642979|bone marrow failure|bone marrow failure
350592|NCT01642979|Immunologic Factors|immunologic factors
350593|NCT01642979|Physiological Effects of Drugs|physiological effects of drugs
350594|NCT01642979|Levamisole|levamisole
350595|NCT01642979|cyclosporine A|cyclosporine a
350596|NCT01642966|ticagrelor|ticagrelor
350597|NCT01642966|doppler echocardiography|doppler echocardiography
350598|NCT01642953|Gastric cancer surgery|gastric cancer surgery
350599|NCT01642953|Early oral feeding|early oral feeding
350600|NCT01642953|Fast track surgery|fast track surgery
350601|NCT01642927|LVAD|lvad
350602|NCT01642927|IABP|iabp
350603|NCT01642927|Heart Failure|heart failure
350604|NCT01642927|Thrombosis|thrombosis
350605|NCT01642927|Hemorrhage|hemorrhage
350606|NCT01642914|Chronic Constipation|chronic constipation
350607|NCT01642914|Abdominal Bloating|abdominal bloating
350608|NCT01642914|Linaclotide|linaclotide
350609|NCT01642901|spinal cord injury|spinal cord injury
350610|NCT01642901|bone mineral density|bone mineral density
350611|NCT01642875|Periampullary tumor|periampullary tumor
350612|NCT01642875|Chronic pancreatitis|chronic pancreatitis
350613|NCT01642875|Pancreatoduodenectomy|pancreatoduodenectomy
350614|NCT01642875|Oral Nutrition|oral nutrition
350615|NCT01642875|Enteral Nutrition|enteral nutrition
350616|NCT01642849|high protein diet|high protein diet
350617|NCT01642849|high carbohydrate diet|high carbohydrate diet
350618|NCT01642849|weight loss|weight loss
350619|NCT01642849|oxidative stress|oxidative stress
350620|NCT01642849|inflammation|inflammation
350621|NCT01642849|cardiovascular risk factors|cardiovascular risk factors
350622|NCT01642823|retinoblastoma|retinoblastoma
350623|NCT01642810|Online treatment for Fibromyalgia Syndrome|online treatment for fibromyalgia syndrome
350624|NCT01642810|Acceptance-based behavioural treatment|acceptance-based behavioural treatment
350625|NCT01642797|confocal laser endomicroscopy|confocal laser endomicroscopy
350626|NCT01642797|gastric intestinal metaplasia|gastric intestinal metaplasia
350627|NCT01642797|gastric intraepithelial neoplasia|gastric intraepithelial neoplasia
350628|NCT01642797|gastric carcinoma|gastric carcinoma
350629|NCT01642784|STEMI|stemi
350630|NCT01642784|NSTEMI|nstemi
350631|NCT01642784|revascularization|revascularization
350632|NCT01642784|stents|stents
350633|NCT01642771|Triple-negative Breast Cancer|triple-negative breast cancer
350634|NCT01642771|Post-operative adjuvant Chemotherapy|post-operative adjuvant chemotherapy
350635|NCT01642771|Docetaxel|docetaxel
350636|NCT01642771|Capecitabine|capecitabine
350637|NCT01642771|Epirubicin|epirubicin
350638|NCT01642771|Cyclophosphamide|cyclophosphamide
350639|NCT01642771|Fluorouracil|fluorouracil
350640|NCT01642758|Thalassemia intermedia|thalassemia intermedia
350641|NCT01642758|Fetal hemoglobin|fetal hemoglobin
350642|NCT01642758|Hemoglobin|hemoglobin
350643|NCT01642732|Prostate|prostate
350644|NCT01642732|Cancer|cancer
350645|NCT01642732|Everolimus|everolimus
350646|NCT01642732|Radiation|radiation
350647|NCT01642719|Sleep disturbance|sleep disturbance
350648|NCT01642719|Aging|aging
350649|NCT01642719|Sleep restriction|sleep restriction
350650|NCT01642719|Health status|health status
350651|NCT01642719|Glucose tolerance|glucose tolerance
350652|NCT01642719|Inflammation|inflammation
350653|NCT01642706|Regulatory B cells|regulatory b cells
350654|NCT01642706|Rheumatoid arthritis|rheumatoid arthritis
350655|NCT01642706|Biomarker|biomarker
350656|NCT01642693|root resorption|root resorption
350657|NCT01642693|low-power laser|low-power laser
350658|NCT01642693|orthodontic tooth movement|orthodontic tooth movement
350659|NCT01642693|pulp changes|pulp changes
350660|NCT01642680|Physical activity program|physical activity program
350661|NCT01642680|Chemotherapy|chemotherapy
350663|NCT01642680|Reducing cardiovascular risk factors|reducing cardiovascular risk factors
350664|NCT01642680|low physical activity level|low physical activity level
350665|NCT01642628|Mirror|mirror
350666|NCT01642628|Body Image|body image
350667|NCT01642628|Mastectomy|mastectomy
350668|NCT01642615|Drug therapy|drug therapy
350669|NCT01642602|Drug Therapy|drug therapy
350670|NCT01642589|Meningitis|meningitis
350671|NCT01642589|Meningococcal disease|meningococcal disease
350672|NCT01642589|Menactra®|menactra®
350673|NCT01642589|Adacel®|adacel®
350674|NCT01642576|obesity|obesity
350675|NCT01642576|men|men
350676|NCT01642576|sexual function|sexual function
350677|NCT01642576|urinary tract symptoms|urinary tract symptoms
350678|NCT01642576|endothelial function|endothelial function
350679|NCT01642576|inflammation|inflammation
350680|NCT01642576|quality of life|quality of life
350681|NCT01642563|Platelet transfusion|platelet transfusion
350682|NCT01642563|Leukemia|leukemia
350683|NCT01642563|Transfusion transmissible infections|transfusion transmissible infections
350684|NCT01642563|Chemotherapy|chemotherapy
350685|NCT01642563|Allogeneic hemopoietic stem cell transplant|allogeneic hemopoietic stem cell transplant
350686|NCT01642550|Anorexia nervosa|anorexia nervosa
350687|NCT01642550|Anorexia|anorexia
350688|NCT01642550|Eating disorders|eating disorders
350689|NCT01642524|resuscitation|resuscitation
350690|NCT01642511|Breast Cancer|breast cancer
350691|NCT01642511|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
350692|NCT01642511|Internal Mammary|internal mammary
350693|NCT01642511|Lymphoscintigraphy|lymphoscintigraphy
350694|NCT01642498|High Blood Pressure|high blood pressure
350695|NCT01642498|Hypertension|hypertension
350696|NCT01642498|Resistant Hypertension|resistant hypertension
350697|NCT01642485|Insulin clamp|insulin clamp
350698|NCT01642485|Glucose clamp|glucose clamp
350699|NCT01642485|Moxifloxacin|moxifloxacin
350700|NCT01642485|Fed|fed
350701|NCT01642485|Fasted|fasted
350702|NCT01642485|QT/QTC interval|qt/qtc interval
350703|NCT01642485|TQT|tqt
350704|NCT01642485|ECG|ecg
350705|NCT01642485|Meal effects|meal effects
350706|NCT01642485|C Peptide|c peptide
350707|NCT01642485|Japanese Caucasian bridging|japanese caucasian bridging
350708|NCT01642485|TQT bridging|tqt bridging
350709|NCT01642485|FDA standard breakfast|fda standard breakfast
350710|NCT01642485|Adaptive study design|adaptive study design
350711|NCT01642459|arteriovenous fistula|arteriovenous fistula
350712|NCT01642459|hemodialysis|hemodialysis
350713|NCT01642459|aneurysm|aneurysm
350714|NCT01642459|vascular stenosis|vascular stenosis
350715|NCT01642459|cannulation|cannulation
350716|NCT01642446|precise hepatectomy|precise hepatectomy
350717|NCT01642446|hepatocellular carcinoma|hepatocellular carcinoma
350718|NCT01642446|cirrhotic|cirrhotic
350719|NCT01642446|portal hypertension|portal hypertension
350720|NCT01642446|safety|safety
350721|NCT01642446|combined interventional treatment|combined interventional treatment
350722|NCT01642394|Diabetes Mellitus|diabetes mellitus
350723|NCT01642394|Chronic Disease|chronic disease
350724|NCT01642394|Education|education
350725|NCT01642394|Primary Care|primary care
350726|NCT01642394|Self care|self care
350727|NCT01642394|Self Management|self management
350728|NCT01642381|Drinking|drinking
350729|NCT01642381|Alcohol Problems|alcohol problems
350730|NCT01642381|Alcoholism|alcoholism
350731|NCT01642381|Moderation-Oriented Treatment|moderation-oriented treatment
350732|NCT01642381|Controlled Drinking|controlled drinking
350733|NCT01642381|Reduced Drinking|reduced drinking
350734|NCT01642381|Heavy Drinking|heavy drinking
350735|NCT01642381|Problematic Drinking|problematic drinking
350736|NCT01642381|Non-Abstinence-based Drinking|non-abstinence-based drinking
350737|NCT01642368|Omega-3 fatty acids|omega-3 fatty acids
350738|NCT01642368|Omega-3 to omega-6 ratio|omega-3 to omega-6 ratio
350739|NCT01642368|Cognitive response|cognitive response
350740|NCT01642368|Physical performance|physical performance
350741|NCT01642329|Myocardial Infarction|myocardial infarction
350742|NCT01642329|Angina, Unstable|angina, unstable
350743|NCT01642316|washback, reading comprehension|washback, reading comprehension
350744|NCT01642303|vodcasting,listening,language education|vodcasting,listening,language education
350745|NCT01642277|Overactive Bladder|overactive bladder
350746|NCT01642277|OAB|oab
350747|NCT01642277|Urinary Tract Infection|urinary tract infection
350748|NCT01642277|UTI|uti
350749|NCT01642277|Microbiome|microbiome
350750|NCT01642277|Bacteria|bacteria
350751|NCT01642277|Solifenacin|solifenacin
350752|NCT01642277|16S rRNA sequence|16s rrna sequence
350753|NCT01642264|Tobacco Cessation|tobacco cessation
350754|NCT01642264|Continuing Education|continuing education
350755|NCT01642264|Pediatric|pediatric
350756|NCT01642264|Respiratory Therapist|respiratory therapist
350757|NCT01642264|Nurse|nurse
350758|NCT01642238|Antiplatelet|antiplatelet
350759|NCT01642238|ticagrelor|ticagrelor
350760|NCT01642238|clopidogrel|clopidogrel
350761|NCT01642238|bivalirudin|bivalirudin
350762|NCT01642238|thrombosis|thrombosis
350763|NCT01642212|EoE|eoe
350764|NCT01642199|obesity|obesity
350766|NCT01642199|lay health coach|lay health coach
350767|NCT01642199|peer coach|peer coach
350768|NCT01642199|mentor coach|mentor coach
350894|NCT01641562|PREDICTIVE MODELS|predictive models
350769|NCT01642199|reduced intensity weight loss program|reduced intensity weight loss program
350770|NCT01642186|LETROZOLE|letrozole
350771|NCT01642186|LUPRON DEPOT|lupron depot
350772|NCT01642186|RAD001 (EVEROLIMUS)|rad001 (everolimus)
350773|NCT01642186|11-211|11-211
350774|NCT01642147|Cerebral blood flow|cerebral blood flow
350775|NCT01642147|Transcranial Doppler|transcranial doppler
350776|NCT01642147|Emergence from general anesthesia|emergence from general anesthesia
350777|NCT01642134|Antiplatelet|antiplatelet
350778|NCT01642134|Anticoagulation|anticoagulation
350779|NCT01642056|Fibroblasts|fibroblasts
350780|NCT01642056|Mitochondria|mitochondria
350781|NCT01642056|Energy|energy
350782|NCT01642056|Redox|redox
350783|NCT01642056|Metabolic Disease|metabolic disease
350784|NCT01642043|greater trochanteric pain syndrome|greater trochanteric pain syndrome
350785|NCT01642043|trochanteric bursitis|trochanteric bursitis
350786|NCT01642043|lateral hip pain|lateral hip pain
350787|NCT01642030|Quantitative sensory testing|quantitative sensory testing
350788|NCT01642030|Cold pressor test|cold pressor test
350789|NCT01642030|Opioid dependence|opioid dependence
350790|NCT01642030|Methadone maintenance|methadone maintenance
350791|NCT01642030|Buprenorphine maintenance|buprenorphine maintenance
350792|NCT01642030|Abuse liability|abuse liability
350793|NCT01642030|Diffuse Noxious Inhibitory Controls (DNIC)|diffuse noxious inhibitory controls (dnic)
350794|NCT01642030|Temporal Summation|temporal summation
350795|NCT01642017|Phase I, Pazopanib, Frail elderly patients, Pharmacokinetics|phase i, pazopanib, frail elderly patients, pharmacokinetics
350796|NCT01641991|Bacillus anthracis, anthrax, vaccine, BioThrax®, dose-sparing|bacillus anthracis, anthrax, vaccine, biothrax®, dose-sparing
350797|NCT01641913|Eosinophilic Esophagitis|eosinophilic esophagitis
350798|NCT01641900|sleep|sleep
350799|NCT01641900|memory|memory
350800|NCT01641900|schizophrenia|schizophrenia
350801|NCT01641900|eszopiclone|eszopiclone
350802|NCT01641887|GERD|gerd
350803|NCT01641887|Heartburn|heartburn
350804|NCT01641887|Decision Aid|decision aid
350805|NCT01641874|Knee|knee
350806|NCT01641874|Osteoarthritis|osteoarthritis
350807|NCT01641874|McKenzie system|mckenzie system
350808|NCT01641874|Exercise|exercise
350809|NCT01641874|Mechanical Diagnosis and Therapy|mechanical diagnosis and therapy
350810|NCT01641874|Directional preference|directional preference
350811|NCT01641861|Chemo-mechanical caries removal|chemo-mechanical caries removal
350812|NCT01641861|Papacarie®|papacarie®
350813|NCT01641848|Total Ankle Arthroplasty|total ankle arthroplasty
350814|NCT01641809|HIV -1|hiv -1
350815|NCT01641809|GSK1265744|gsk1265744
350816|NCT01641809|maintenance phase|maintenance phase
350817|NCT01641809|dose selection|dose selection
350818|NCT01641796|Cutaneous Leishmaniasis|cutaneous leishmaniasis
350820|NCT01641796|Lesion|lesion
350821|NCT01641796|Topical|topical
350822|NCT01641796|Treatment|treatment
350823|NCT01641796|Cream|cream
350824|NCT01641796|Expanded Access|expanded access
350825|NCT01641783|advanced|advanced
350826|NCT01641783|paclitaxel|paclitaxel
350827|NCT01641783|capecitabine|capecitabine
350828|NCT01641783|first line therapy|first line therapy
350829|NCT01641757|hemodialysis|hemodialysis
350830|NCT01641757|periodontitis|periodontitis
350831|NCT01641744|Parent Child Relationship|parent child relationship
350832|NCT01641744|Maltreatment|maltreatment
350833|NCT01641744|Risk Behaviors|risk behaviors
350834|NCT01641744|Social and Emotional Development|social and emotional development
350835|NCT01641744|Violence and Abuse|violence and abuse
350836|NCT01641744|Policy|policy
350837|NCT01641731|cow's milk protein allergy|cow's milk protein allergy
350838|NCT01641731|oral tolerance induction|oral tolerance induction
350839|NCT01641718|Hernia, Inguinal|hernia, inguinal
350840|NCT01641705|rheumatoid arthritis|rheumatoid arthritis
350841|NCT01641705|respiratory mechanics|respiratory mechanics
350842|NCT01641705|time of disease|time of disease
350843|NCT01641692|Asthma|asthma
350844|NCT01641692|Pharmacokinetics|pharmacokinetics
350845|NCT01641692|GSK573719|gsk573719
350846|NCT01641692|Adults|adults
350847|NCT01641692|Pharmacogenetics|pharmacogenetics
350848|NCT01641679|Recurrent differentiated thyroid cancer|recurrent differentiated thyroid cancer
350849|NCT01641679|I124-PET/CT|i124-pet/ct
350850|NCT01641679|FDG-PET/CT|fdg-pet/ct
350851|NCT01641653|Nondiabetics undergoing hernia repair.|nondiabetics undergoing hernia repair.
350852|NCT01641640|HCV genotype 1 (GT-1)|hcv genotype 1 (gt-1)
350853|NCT01641640|HCV genotype 4 (GT-4)|hcv genotype 4 (gt-4)
350854|NCT01641640|HCV genotype 5 (GT-5)|hcv genotype 5 (gt-5)
350855|NCT01641640|HCV genotype 6 (GT-6)|hcv genotype 6 (gt-6)
350856|NCT01641640|HCV|hcv
350857|NCT01641640|Sustained Virologic Response|sustained virologic response
350858|NCT01641640|Direct Acting Antiviral|direct acting antiviral
350859|NCT01641640|Combination Therapy|combination therapy
350860|NCT01641640|Treatment-Naïve|treatment-naïve
350861|NCT01641640|GS-7977|gs-7977
350862|NCT01641640|Ribavirin|ribavirin
350863|NCT01641640|RBV|rbv
350864|NCT01641640|Peginterferon Alfa 2a|peginterferon alfa 2a
350865|NCT01641640|PEG|peg
350866|NCT01641627|knee arthritis|knee arthritis
350867|NCT01641627|muscle atrophy|muscle atrophy
350868|NCT01641627|proprioceptive stimulation|proprioceptive stimulation
350869|NCT01641627|vibrations|vibrations
350870|NCT01641614|Mitral valve|mitral valve
350871|NCT01641614|valve replacement|valve replacement
350872|NCT01641614|arrested heart|arrested heart
350873|NCT01641614|beating heart|beating heart
350874|NCT01641601|Induction of labor|induction of labor
350875|NCT01641601|Outpatient cervical ripening|outpatient cervical ripening
350876|NCT01641588|cognitive executive function|cognitive executive function
350877|NCT01641588|posture|posture
350878|NCT01641588|cognitive performance|cognitive performance
350879|NCT01641588|heart rate|heart rate
350880|NCT01641588|eeg|eeg
350881|NCT01641575|CO-1.01|co-1.01
350882|NCT01641575|CO-101|co-101
350883|NCT01641575|gemcitabine elaidate|gemcitabine elaidate
350884|NCT01641575|hENT1|hent1
350885|NCT01641575|nucleoside equilibrative transporter|nucleoside equilibrative transporter
350886|NCT01641575|solid tumor|solid tumor
350887|NCT01641575|non-small-cell lung cancer|non-small-cell lung cancer
350888|NCT01641575|NSCLC|nsclc
350889|NCT01641575|lung cancer|lung cancer
350890|NCT01641562|BREAST CANCER,|breast cancer,
350891|NCT01641562|TAXANES,|taxanes,
350892|NCT01641562|SUBCLINICAL CARDIAC DYSFUNCTION ,|subclinical cardiac dysfunction ,
350893|NCT01641562|DIAGNOSTIC TOOLS,|diagnostic tools,
350895|NCT01641549|Prosthetic valve thrombosis|prosthetic valve thrombosis
350896|NCT01641549|Fibrinolytic therapy|fibrinolytic therapy
350897|NCT01641549|Emergency surgery|emergency surgery
350898|NCT01641536|Hepatitis, Chronic|hepatitis, chronic
350899|NCT01641536|Virus Diseases|virus diseases
350900|NCT01641536|DNA Virus Infections|dna virus infections
350901|NCT01641536|Hepatitis B|hepatitis b
350902|NCT01641536|Liver|liver
350903|NCT01641536|Chronic Disease|chronic disease
350904|NCT01641536|HBV|hbv
350905|NCT01641523|Cranioplasty prosthesis|cranioplasty prosthesis
350906|NCT01641523|Hydroxyapatite|hydroxyapatite
350907|NCT01641523|PolyMethylMethacrylate|polymethylmethacrylate
350908|NCT01641523|Autologous Bone|autologous bone
350909|NCT01641510|reduced-function CYP2C19 allele|reduced-function cyp2c19 allele
350910|NCT01641510|high platelet reactivity|high platelet reactivity
350911|NCT01641510|clopidogrel|clopidogrel
350912|NCT01641510|prasugrel|prasugrel
350913|NCT01641497|endometrial cancer|endometrial cancer
350914|NCT01641497|IMRT|imrt
350915|NCT01641497|age over 70|age over 70
350916|NCT01641471|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
350917|NCT01641471|Transcutaneous Electrical Nerve Stimulation (TENS)|transcutaneous electrical nerve stimulation (tens)
350918|NCT01641471|Pain|pain
350919|NCT01641471|Function|function
350920|NCT01641471|Knee Osteoarthritis|knee osteoarthritis
350921|NCT01641458|Genotyping|genotyping
350922|NCT01641458|Area-under-the concentration-time curve|area-under-the concentration-time curve
350923|NCT01641458|Toxicity|toxicity
350924|NCT01641458|5-fluorouracil|5-fluorouracil
350925|NCT01641458|Capecitabine|capecitabine
350926|NCT01641419|Pain|pain
350927|NCT01641419|Ropivacaine|ropivacaine
350928|NCT01641419|sciatic block|sciatic block
350929|NCT01641419|dexamethasone|dexamethasone
350930|NCT01641406|NAC Protocol|nac protocol
350931|NCT01641406|NAC and Oncotype Guided Hormonal therapy for breast cancer|nac and oncotype guided hormonal therapy for breast cancer
350932|NCT01641406|Neoadjuvant and Oncotype|neoadjuvant and oncotype
350933|NCT01641406|NAC CCAM 1101|nac ccam 1101
350934|NCT01641393|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
350935|NCT01641393|Cystic Fibrosis|cystic fibrosis
350936|NCT01641393|Pancreatic Insufficiency|pancreatic insufficiency
350937|NCT01641380|Depoprovera|depoprovera
350938|NCT01641380|Contraception|contraception
350939|NCT01641380|Appointment adherence/attendance|appointment adherence/attendance
350940|NCT01641380|Pregnancy Prevention|pregnancy prevention
350941|NCT01641354|Hemiepiphysiodesis|hemiepiphysiodesis
350942|NCT01641341|Irritable Bowel Syndrome|irritable bowel syndrome
350943|NCT01641341|Genova Diagnostics kit|genova diagnostics kit
350944|NCT01641341|Stool test|stool test
350945|NCT01641341|Rome III|rome iii
350946|NCT01641341|Practice-based research|practice-based research
350947|NCT01641341|treatable parasite|treatable parasite
350948|NCT01641341|Pancreatic insufficiency|pancreatic insufficiency
350949|NCT01641341|Bowel dysbiosis|bowel dysbiosis
350950|NCT01641341|High levels of inflammation, C. difficile, or H. pylori|high levels of inflammation, c. difficile, or h. pylori
350951|NCT01641328|Mild Cognitive Impairment|mild cognitive impairment
350952|NCT01641328|MCI|mci
350953|NCT01641328|Meditation|meditation
350954|NCT01641328|Mindfulness|mindfulness
350955|NCT01641328|Cognitive Activation|cognitive activation
350956|NCT01641328|Cognitive Training|cognitive training
350957|NCT01641328|Tai Chi|tai chi
350958|NCT01641315|rabies|rabies
350959|NCT01641315|rabies immunoglobulin|rabies immunoglobulin
350960|NCT01641289|Falciparum malaria|falciparum malaria
350961|NCT01641289|Paracetamol|paracetamol
350962|NCT01641289|Renal function|renal function
350963|NCT01641289|Oxidative stress|oxidative stress
350964|NCT01641276|biofeedback response|biofeedback response
350965|NCT01641263|Depression Prevention|depression prevention
350966|NCT01641263|Sleep Disturbances|sleep disturbances
350967|NCT01641263|Inflammatory Markers|inflammatory markers
350968|NCT01641263|Treatments for Sleep Problems|treatments for sleep problems
350969|NCT01641224|Irritable bowel syndrome,|irritable bowel syndrome,
350970|NCT01641224|Pinaverium|pinaverium
350971|NCT01641224|Herbal medication for IBS,|herbal medication for ibs,
350972|NCT01641224|Tong Xie Yao Fang (Formula for pain and diarrhea)|tong xie yao fang (formula for pain and diarrhea)
350973|NCT01641198|Dental implants, bone healing, fixed dental prostheses, implant surface|dental implants, bone healing, fixed dental prostheses, implant surface
350974|NCT01641185|prostate|prostate
350975|NCT01641185|IPI|ipi
350976|NCT01641185|hypofractionation|hypofractionation
350977|NCT01641185|carbon ions|carbon ions
350978|NCT01641185|proton|proton
350979|NCT01641172|taste|taste
350980|NCT01641172|smell|smell
350981|NCT01641172|cancer|cancer
350982|NCT01641172|nutrition|nutrition
350983|NCT01641159|Cocaine|cocaine
350984|NCT01641159|Crack|crack
350985|NCT01641159|Buspirone|buspirone
350986|NCT01641159|Relapse Prevention|relapse prevention
350987|NCT01641146|HIV risk reduction|hiv risk reduction
350988|NCT01641146|Stress reduction|stress reduction
350989|NCT01641146|Trauma reduction|trauma reduction
350990|NCT01641146|PTSD|ptsd
350991|NCT01641133|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
350992|NCT01641133|Synflorix™|synflorix™
350993|NCT01641133|Prevenar 13™|prevenar 13™
350994|NCT01641133|Pneumococcal diseases|pneumococcal diseases
350995|NCT01641120|Multiple Sclerosis|multiple sclerosis
350996|NCT01641120|Intramuscular Injections|intramuscular injections
350997|NCT01641120|Relapsing Remitting|relapsing remitting
350998|NCT01641107|Ph+|ph+
350999|NCT01641107|BCR-ABL+|bcr-abl+
351000|NCT01641107|ALL|all
351001|NCT01641107|Ponatinib|ponatinib
351002|NCT01641107|stem cell transplantation|stem cell transplantation
351003|NCT01641094|Hepatitis C|hepatitis c
351004|NCT01641094|Liver|liver
351005|NCT01641094|Immunology|immunology
351006|NCT01641094|Genotype 1|genotype 1
351007|NCT01641094|Treatment|treatment
351008|NCT01641094|Chronic|chronic
351009|NCT01641094|RNA Virus Infections|rna virus infections
351010|NCT01641094|Ribavirin|ribavirin
351011|NCT01641094|Peginterferon alfa-2a|peginterferon alfa-2a
351012|NCT01641094|Protease Inhibitors|protease inhibitors
351013|NCT01641094|Telaprevir|telaprevir
351014|NCT01641068|Memory|memory
351015|NCT01641068|Attention|attention
351016|NCT01641068|Chemo-brain|chemo-brain
351017|NCT01641068|Survivor|survivor
351018|NCT01641068|Treatment|treatment
351019|NCT01641042|Meningococcal vaccines|meningococcal vaccines
351020|NCT01641042|Vaccines, conjugate|vaccines, conjugate
351021|NCT01641042|Neisseria meningitidis|neisseria meningitidis
351022|NCT01641042|Immunocompromised patient|immunocompromised patient
351023|NCT01641016|short cycle therapy|short cycle therapy
351024|NCT01641016|young people|young people
351025|NCT01641016|HIV|hiv
351026|NCT01641003|cancer stem cells|cancer stem cells
351027|NCT01640990|Healthy male volunteers, intravenous infusion, GW328267X, dose escalation,|healthy male volunteers, intravenous infusion, gw328267x, dose escalation,
351028|NCT01640977|Open PLIF|open plif
351029|NCT01640977|MAS PLIF|mas plif
351030|NCT01640977|Lumbar spine|lumbar spine
351031|NCT01640964|Portal hypertension, cirrhosis, TIPSS, MRI, MRA, portal pressure, portal pressure gradient|portal hypertension, cirrhosis, tipss, mri, mra, portal pressure, portal pressure gradient
351032|NCT01640951|Psoriasis|psoriasis
351033|NCT01640951|Plaque|plaque
351034|NCT01640951|Inflammatory skin disease|inflammatory skin disease
351035|NCT01640951|Scaly patches|scaly patches
351036|NCT01640951|AIN457|ain457
351037|NCT01640951|Secukinumab|secukinumab
351038|NCT01640951|Moderate to Severe Plaque-type Psoriasis|moderate to severe plaque-type psoriasis
351039|NCT01640925|nosocomial infection|nosocomial infection
351040|NCT01640925|hospital acquired infection|hospital acquired infection
351041|NCT01640925|chlorhexidine|chlorhexidine
351042|NCT01640925|pneumonia, ventilator-associated|pneumonia, ventilator-associated
351043|NCT01640925|catheter-related infections|catheter-related infections
351044|NCT01640925|urinary tract infections, catheter-related|urinary tract infections, catheter-related
351045|NCT01640925|surgical site infection|surgical site infection
351046|NCT01640912|Scar|scar
351047|NCT01640912|Scar prevention|scar prevention
351048|NCT01640912|Fibrosis|fibrosis
351049|NCT01640899|Orthotic Devices|orthotic devices
351050|NCT01640899|Activities of Daily Living|activities of daily living
351051|NCT01640899|Pain Measurement|pain measurement
351052|NCT01640899|Lower Extremity|lower extremity
351053|NCT01640899|Foot|foot
351054|NCT01640899|Personal Satisfaction|personal satisfaction
351055|NCT01640886|Staphylococcus aureus|staphylococcus aureus
351056|NCT01640886|methicillin resistant|methicillin resistant
351057|NCT01640886|MRSA|mrsa
351058|NCT01640886|MSSA|mssa
351059|NCT01640886|Blood Culture|blood culture
351060|NCT01640886|Diagnostic|diagnostic
351061|NCT01640873|Type 2 Diabetes|type 2 diabetes
351062|NCT01640860|docetaxel|docetaxel
351063|NCT01640860|cisplatin|cisplatin
351064|NCT01640860|combined modality therapy|combined modality therapy
351065|NCT01640847|Painful bone metastases|painful bone metastases
351066|NCT01640847|Bone Cancer|bone cancer
351067|NCT01640847|Bone Cancer Pain|bone cancer pain
351068|NCT01640847|Patients with|patients with
351069|NCT01640821|Health-At-Every-Size intervention|health-at-every-size intervention
351070|NCT01640782|adenocarcinoma of the stomach|adenocarcinoma of the stomach
351071|NCT01640782|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
351072|NCT01640769|Cardiomyopathy|cardiomyopathy
351073|NCT01640769|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
351074|NCT01640756|Glaucoma Implant|glaucoma implant
351075|NCT01640756|Trabeculectomy|trabeculectomy
351076|NCT01640756|POAG|poag
351077|NCT01640743|Kidney transplantation|kidney transplantation
351078|NCT01640743|Regulatory T cells|regulatory t cells
351079|NCT01640743|Tolerance|tolerance
351080|NCT01640743|Tacrolimus|tacrolimus
351081|NCT01640743|Rejection|rejection
351082|NCT01640691|pandemic influenza|pandemic influenza
351083|NCT01640691|pandemic influenza vaccine|pandemic influenza vaccine
351084|NCT01640691|Influenza|influenza
351085|NCT01640691|Orthomyxoviruses|orthomyxoviruses
351086|NCT01640691|A/H5N1|a/h5n1
351087|NCT01640665|histologically|histologically
351088|NCT01640665|unresectable|unresectable
351089|NCT01640665|metastatic|metastatic
351090|NCT01640665|Phase 1|phase 1
351091|NCT01640665|Breast Cancer|breast cancer
351092|NCT01640665|GI Tumors|gi tumors
351093|NCT01640665|Sorafenib|sorafenib
351094|NCT01640665|Capecitabine|capecitabine
351095|NCT01640639|left ventricular function|left ventricular function
351096|NCT01640626|Health Education|health education
351097|NCT01640626|Soil-transmitted helminthiasis|soil-transmitted helminthiasis
351098|NCT01640626|Ascaris|ascaris
351099|NCT01640626|Trichuris|trichuris
351100|NCT01640626|Hookworm|hookworm
351101|NCT01640626|Prevention and control|prevention and control
351102|NCT01640613|carotid endarterectomy|carotid endarterectomy
351103|NCT01640613|regional anaesthesia|regional anaesthesia
351104|NCT01640613|ultrasound guided block|ultrasound guided block
351105|NCT01640600|To determine whether 4-8 year-old children exposed to nicotine or antidepressants in utero have more behavioral problems.|to determine whether 4-8 year-old children exposed to nicotine or antidepressants in utero have more behavioral problems.
351106|NCT01640600|To determine whether 4-8 year-old children exposed to nicotine or antidepressants in utero have more cognitive problems.|to determine whether 4-8 year-old children exposed to nicotine or antidepressants in utero have more cognitive problems.
351107|NCT01640600|To determine whether 4-8 year-old children exposed to nicotine or antidepressants in utero have poorer motor development.|to determine whether 4-8 year-old children exposed to nicotine or antidepressants in utero have poorer motor development.
351108|NCT01640587|Uncomplicated falciparum infection|uncomplicated falciparum infection
351109|NCT01640587|Mefloquine-artesunate|mefloquine-artesunate
351110|NCT01640587|Dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
351111|NCT01640574|Vivax|vivax
351112|NCT01640574|Chloroquine|chloroquine
351113|NCT01640574|Primaquine|primaquine
351114|NCT01640574|Dihydroartemisinin-Piperaquine|dihydroartemisinin-piperaquine
351115|NCT01640561|HIV affected|hiv affected
351116|NCT01640561|Child Neurodevelopment|child neurodevelopment
351117|NCT01640561|Low and Middle Income Country|low and middle income country
351118|NCT01640535|PAR|par
351119|NCT01640522|Hepatocellular carcinoma|hepatocellular carcinoma
351120|NCT01640522|Cholangio carcinoma|cholangio carcinoma
351121|NCT01640522|Primary Liver Cancer|primary liver cancer
351122|NCT01640522|Bile Duct CancerPancreatic Cancer|bile duct cancerpancreatic cancer
351123|NCT01640522|Gallbladder Cancer|gallbladder cancer
351124|NCT01640522|Colorectal Carcinoma|colorectal carcinoma
351125|NCT01640522|Other Primary Cancers with Liver Metastases|other primary cancers with liver metastases
351126|NCT01640509|Radiotherapy, Targeted|radiotherapy, targeted
351127|NCT01640496|Ulcerative Colitis|ulcerative colitis
351128|NCT01640496|Inflammatory Bowel disease|inflammatory bowel disease
351129|NCT01640496|IBD|ibd
351130|NCT01640496|Vitamin D|vitamin d
351131|NCT01640470|assistive technology|assistive technology
351132|NCT01640470|environmental modification|environmental modification
351133|NCT01640470|caregiver|caregiver
351134|NCT01640470|client-centred|client-centred
351135|NCT01640457|degenerative disc|degenerative disc
351136|NCT01640457|herniated disc|herniated disc
351137|NCT01640457|sequestrectomy|sequestrectomy
351138|NCT01640457|Autologous Disc Chondrocyte Transplantation|autologous disc chondrocyte transplantation
351139|NCT01640457|nucleotomy|nucleotomy
351140|NCT01640457|safety|safety
351141|NCT01640457|efficacy|efficacy
351142|NCT01640457|treatment|treatment
351143|NCT01640457|lumbar spine|lumbar spine
351144|NCT01640457|low back pain|low back pain
351145|NCT01640457|adjacent degenerative disc|adjacent degenerative disc
351146|NCT01640457|black disc|black disc
351147|NCT01640457|NOVOCART|novocart
351148|NCT01640444|colorectal carcinoma|colorectal carcinoma
351149|NCT01640444|BRAF and PIK3K|braf and pik3k
351150|NCT01640444|FOLFIRI -Bevacizumab -Cetuximab|folfiri -bevacizumab -cetuximab
351151|NCT01640444|circulating tumor cells|circulating tumor cells
351152|NCT01640431|lumbar disc herniation|lumbar disc herniation
351153|NCT01640431|clinical trial|clinical trial
351154|NCT01640431|exercise therapy|exercise therapy
351155|NCT01640431|TENS|tens
351156|NCT01640418|pressure ulcer|pressure ulcer
351157|NCT01640418|dressing|dressing
351158|NCT01640418|prevention|prevention
351159|NCT01640418|higher risk patients|higher risk patients
351160|NCT01640405|colorectal cancer|colorectal cancer
351161|NCT01640405|FOLFOX|folfox
351162|NCT01640405|Bevacizumab|bevacizumab
351163|NCT01640405|FOLFOXIRI|folfoxiri
351164|NCT01640405|circulating tumor cell|circulating tumor cell
351165|NCT01640392|Gay men|gay men
351166|NCT01640392|African American males|african american males
351167|NCT01640392|Unprotected anal sex|unprotected anal sex
351168|NCT01640392|HIV risk|hiv risk
351169|NCT01640392|behavioral intervention|behavioral intervention
351170|NCT01640392|group-level intervention|group-level intervention
351171|NCT01640379|Pelvic Inflammatory Disease (PID)|pelvic inflammatory disease (pid)
351172|NCT01640379|Community Health Nursing|community health nursing
351173|NCT01640379|Text Messaging|text messaging
351174|NCT01640379|mobile health (mhealth)|mobile health (mhealth)
351175|NCT01640379|Adolescents|adolescents
351176|NCT01640366|surgical incision|surgical incision
351177|NCT01640366|reduction mammoplasty|reduction mammoplasty
351178|NCT01640366|healing complications|healing complications
351179|NCT01640366|negative pressure wound therapy|negative pressure wound therapy
351180|NCT01640353|si joint|si joint
351181|NCT01640353|si joint pain|si joint pain
351182|NCT01640353|si joint injury|si joint injury
351183|NCT01640353|si joint treatment|si joint treatment
351184|NCT01640353|si joint injections|si joint injections
351185|NCT01640353|si joint inflammation|si joint inflammation
351186|NCT01640353|si joint problems|si joint problems
351187|NCT01640353|si joint symptoms|si joint symptoms
351188|NCT01640353|hypermobile si joint|hypermobile si joint
351189|NCT01640353|si joint arthritis|si joint arthritis
351190|NCT01640353|si joint pain treatment|si joint pain treatment
351191|NCT01640353|inflamed si joint|inflamed si joint
351192|NCT01640353|si joint sclerosis|si joint sclerosis
351193|NCT01640353|locked si joint|locked si joint
351194|NCT01640353|si joint injuries|si joint injuries
351195|NCT01640353|si joint disease|si joint disease
351196|NCT01640353|si joint infection|si joint infection
351197|NCT01640353|sacroiliac joint pelvic pain|sacroiliac joint pelvic pain
351198|NCT01640353|sacroiliac joint arthritis treatment|sacroiliac joint arthritis treatment
351199|NCT01640340|ondansetron|ondansetron
351200|NCT01640340|palonosetron|palonosetron
351201|NCT01640340|emetogenic chemotherapy|emetogenic chemotherapy
351202|NCT01640340|HEC|hec
351203|NCT01640327|Interpandemic influenza|interpandemic influenza
351204|NCT01640327|Adult|adult
351205|NCT01640327|Elderly|elderly
351206|NCT01640327|Safety|safety
351207|NCT01640327|Tolerability|tolerability
351208|NCT01640327|Immunology|immunology
351209|NCT01640314|Influenza|influenza
351210|NCT01640314|Adults|adults
351211|NCT01640314|Elderly|elderly
351212|NCT01640314|Immunology|immunology
351213|NCT01640314|Safety|safety
351214|NCT01640288|COPD|copd
351215|NCT01640288|Pulmonary Function Testing|pulmonary function testing
351216|NCT01640288|MRI|mri
351217|NCT01640288|Normal Lung Function|normal lung function
351218|NCT01640288|Current Smoker|current smoker
351219|NCT01640288|Non Smoker|non smoker
351220|NCT01640288|Ex Smoker|ex smoker
351221|NCT01640275|General Anesthesia|general anesthesia
351222|NCT01640275|Alzheimers Disease|alzheimers disease
351223|NCT01640275|Cognitive decline|cognitive decline
351224|NCT01640262|prostate biopsy|prostate biopsy
351225|NCT01640262|prostate cancer|prostate cancer
351226|NCT01640262|Magnetic Resonance Imaging|magnetic resonance imaging
351227|NCT01640262|Neoplasm Staging|neoplasm staging
351228|NCT01640236|Ocular flare|ocular flare
351229|NCT01640197|Cognitive performance|cognitive performance
351230|NCT01640197|Cerebral blood flow|cerebral blood flow
351231|NCT01640197|Subjective sleep|subjective sleep
351232|NCT01640197|Subjective mood|subjective mood
351233|NCT01640197|Subjective health|subjective health
351234|NCT01640184|hyperparathyroidism|hyperparathyroidism
351235|NCT01640184|vitamin D|vitamin d
351236|NCT01640184|ultrasonic ablation|ultrasonic ablation
351237|NCT01640184|surgery|surgery
351238|NCT01640171|anesthesia|anesthesia
351239|NCT01640171|pain|pain
351240|NCT01640171|intravitreal|intravitreal
351241|NCT01640171|anti-vegf|anti-vegf
351242|NCT01640158|mild Traumatic Brain Injury|mild traumatic brain injury
351243|NCT01640158|Cognitive remediation|cognitive remediation
351244|NCT01640158|computer|computer
351245|NCT01640119|metabolic acidosis|metabolic acidosis
351246|NCT01640119|renal death|renal death
351247|NCT01640106|Language|language
351248|NCT01640106|Fatty acids|fatty acids
351249|NCT01640106|Nutrition|nutrition
351250|NCT01640106|Developmental delay|developmental delay
351251|NCT01640093|Healthy participants|healthy participants
351252|NCT01640093|Bioavailability|bioavailability
351253|NCT01640093|Pharmacokinetics|pharmacokinetics
351254|NCT01640093|Abiraterone acetate|abiraterone acetate
351255|NCT01640093|Abiraterone|abiraterone
351256|NCT01640080|Major depressive disorder|major depressive disorder
351257|NCT01640080|Treatment resistant depression|treatment resistant depression
351258|NCT01640080|Depression|depression
351259|NCT01640080|Esketamine|esketamine
351260|NCT01640067|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
351261|NCT01640067|motor neuron disease|motor neuron disease
351262|NCT01640067|stem cells|stem cells
351263|NCT01640067|safety|safety
351264|NCT01640067|ALS-FRS-Functional scale R and FVC (%) variation|als-frs-functional scale r and fvc (%) variation
351265|NCT01640067|Survival analysis|survival analysis
351266|NCT01640067|Changes in quality of life scales|changes in quality of life scales
351267|NCT01640054|Rheumatoid Arthritis|rheumatoid arthritis
351268|NCT01640015|Blood pressure|blood pressure
351269|NCT01640015|eating episode|eating episode
351270|NCT01640015|eating frequency|eating frequency
351271|NCT01640015|insulin sensitivity|insulin sensitivity
351272|NCT01640002|overactive bladder|overactive bladder
351273|NCT01640002|HTLV-1|htlv-1
351274|NCT01640002|Propantheline|propantheline
351275|NCT01640002|anticholinergic|anticholinergic
351276|NCT01639989|Doppler, Pregnancy|doppler, pregnancy
351277|NCT01639976|Missed abortion, early pregnancy loss.|missed abortion, early pregnancy loss.
351278|NCT01639950|Self-Report|self-report
351279|NCT01639950|Survey Scale|survey scale
351280|NCT01639950|Validate|validate
351281|NCT01639950|Pain Severity|pain severity
351282|NCT01639950|Reliability|reliability
351283|NCT01639937|Cardiac MRI|cardiac mri
351284|NCT01639937|Congestive Heart Failure|congestive heart failure
351285|NCT01639937|Cardiac Fibrosis|cardiac fibrosis
351286|NCT01639937|Late Gadolinium Enhancement|late gadolinium enhancement
351287|NCT01639924|Small Bowel Disease|small bowel disease
351288|NCT01639924|Digestive Disease|digestive disease
351289|NCT01639924|Gastrointestinal Disease|gastrointestinal disease
351290|NCT01639924|Lower GI Disease|lower gi disease
351291|NCT01639911|malignant solid tumor|malignant solid tumor
351292|NCT01639911|advanced non-hematologic|advanced non-hematologic
351293|NCT01639898|POEMS|poems
351294|NCT01639898|VEGF|vegf
351295|NCT01639898|Free light|free light
351296|NCT01639898|lenalidomide|lenalidomide
351297|NCT01639898|dexamethasone|dexamethasone
351298|NCT01639885|p53 overexpression|p53 overexpression
351299|NCT01639885|platinum-resistant|platinum-resistant
351300|NCT01639872|Schizophrenia|schizophrenia
351301|NCT01639872|Cannabis Abuse|cannabis abuse
351302|NCT01639872|Cannabis Dependence|cannabis dependence
351303|NCT01639872|Dual Diagnosis|dual diagnosis
351304|NCT01639872|Clozapine|clozapine
351305|NCT01639872|Risperidone|risperidone
351306|NCT01639859|prostate cancer|prostate cancer
351307|NCT01639859|elastography|elastography
351308|NCT01639859|elasticity|elasticity
351309|NCT01639820|Cervical cancer|cervical cancer
351310|NCT01639820|early stage carcinoma|early stage carcinoma
351311|NCT01639820|FIGO IA1 IA2 IB1 IIA|figo ia1 ia2 ib1 iia
351312|NCT01639820|sentinel lymph node biopsy|sentinel lymph node biopsy
351313|NCT01639820|pelvic lymphadenectomy|pelvic lymphadenectomy
351314|NCT01639820|Surgery of uterine cervical carcinoma|surgery of uterine cervical carcinoma
351315|NCT01639820|medico economic impact|medico economic impact
351316|NCT01639820|quality of life|quality of life
351317|NCT01639807|Open Angle Glaucoma or Ocular hypertension|open angle glaucoma or ocular hypertension
351318|NCT01639794|LUTS (Lower Urinary Tract Symptoms)|luts (lower urinary tract symptoms)
351319|NCT01639794|Overactive Bladder (OAB)Vesitirim|overactive bladder (oab)vesitirim
351320|NCT01639794|Solifenacin|solifenacin
351321|NCT01639794|Anti-muscarinic treatment|anti-muscarinic treatment
351322|NCT01639794|Cholinergic receptor antagonist|cholinergic receptor antagonist
351323|NCT01639794|Storage Symptom improvement|storage symptom improvement
351324|NCT01639781|flavanols|flavanols
351325|NCT01639781|age related cardiovascular effects|age related cardiovascular effects
351326|NCT01639768|Sublingual immunotherapy|sublingual immunotherapy
351327|NCT01639768|Dose range finding|dose range finding
351328|NCT01639768|Dose tolerability|dose tolerability
351329|NCT01639768|Birch pollen|birch pollen
351330|NCT01639768|Allergic rhinitis/rhinoconjunctivitis|allergic rhinitis/rhinoconjunctivitis
351331|NCT01639768|Safety|safety
351332|NCT01639768|Immunogenicity|immunogenicity
351333|NCT01639729|pharmacokinetics|pharmacokinetics
351334|NCT01639729|area under curve|area under curve
351335|NCT01639729|time to maximum concentration|time to maximum concentration
351336|NCT01639716|Survey, interleukin status|survey, interleukin status
351337|NCT01639703|CT perfusion|ct perfusion
351338|NCT01639703|Hepatocellular Carcinoma|hepatocellular carcinoma
351339|NCT01639703|Xenetix|xenetix
351340|NCT01639703|Contrast agent|contrast agent
351341|NCT01639690|BUSULFAN|busulfan
351342|NCT01639690|G-CSF|g-csf
351343|NCT01639690|CliniMACS-CD34 Reagent System|clinimacs-cd34 reagent system
351344|NCT01639690|Blood transfusion|blood transfusion
351345|NCT01639690|10-164|10-164
351439|NCT01639183|compliance|compliance
351440|NCT01639183|power toothbrushing|power toothbrushing
351932|NCT01636609|Cytosar|cytosar
351346|NCT01639690|Autologous CD34+ cells transduced with TNS9.3.55, a lentiviral vector encoding the human β-globin gene|autologous cd34+ cells transduced with tns9.3.55, a lentiviral vector encoding the human β-globin gene
351347|NCT01639677|Obesity|obesity
351348|NCT01639677|weight loss|weight loss
351349|NCT01639677|surgery|surgery
351350|NCT01639677|gastric bypass|gastric bypass
351351|NCT01639677|VBG|vbg
351352|NCT01639651|Physical Therapy|physical therapy
351353|NCT01639651|Glenohumeral Internal Rotation Deficits|glenohumeral internal rotation deficits
351354|NCT01639651|Joint Mobilization|joint mobilization
351355|NCT01639651|Posterior capsule|posterior capsule
351356|NCT01639651|Capsular contracture|capsular contracture
351357|NCT01639638|Recurrent and non-recurrent genital condyloma|recurrent and non-recurrent genital condyloma
351358|NCT01639612|Stem Cell|stem cell
351359|NCT01639612|Grade IV Malignant Glioma|grade iv malignant glioma
351360|NCT01639599|non-smoker|non-smoker
351361|NCT01639599|female|female
351362|NCT01639599|IV PCA|iv pca
351363|NCT01639599|patient-controlled analgesia|patient-controlled analgesia
351364|NCT01639573|Patients with Scleroderma|patients with scleroderma
351365|NCT01639560|smoking|smoking
351366|NCT01639560|tobacco dependence|tobacco dependence
351367|NCT01639560|nicotine dependence|nicotine dependence
351368|NCT01639547|PEGASYS® PLUS RIBAVIRIN|pegasys® plus ribavirin
351369|NCT01639534|Biomarkers of ischemia|biomarkers of ischemia
351370|NCT01639534|Carotid Stenting procedure|carotid stenting procedure
351371|NCT01639534|Levels Xanthine Hypoxanthine and Inosine|levels xanthine hypoxanthine and inosine
351372|NCT01639534|peripheral blood|peripheral blood
351373|NCT01639508|Lung|lung
351374|NCT01639508|XL184 (CABOZANTINIB)|xl184 (cabozantinib)
351375|NCT01639508|KIF5B/RET Positive|kif5b/ret positive
351376|NCT01639508|RET Fusion Positive|ret fusion positive
351377|NCT01639508|12-097|12-097
351378|NCT01639508|Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity|genotypes: ros1 or ntrk fusions or increased met or axl activity
351379|NCT01639495|Drug refractory|drug refractory
351380|NCT01639495|Atrial fibrillation|atrial fibrillation
351381|NCT01639495|Antiarrhythmic drug failure|antiarrhythmic drug failure
351382|NCT01639495|Atrial tachyarrhythmias|atrial tachyarrhythmias
351383|NCT01639469|Parkinson Disease|parkinson disease
351384|NCT01639469|Quality of Life|quality of life
351385|NCT01639469|Exercise Therapy|exercise therapy
351386|NCT01639456|acute myelogenous leukemia|acute myelogenous leukemia
351387|NCT01639443|quality improvement|quality improvement
351388|NCT01639443|Organization and Administration|organization and administration
351389|NCT01639443|Costs and cost analysis|costs and cost analysis
351390|NCT01639443|Patient satisfaction|patient satisfaction
351391|NCT01639443|Health plan implementation|health plan implementation
351392|NCT01639404|Cerebral Palsy|cerebral palsy
351393|NCT01639404|Umbilical Cord Blood|umbilical cord blood
351394|NCT01639404|Rehabilitation|rehabilitation
351395|NCT01639365|Ventricular tachycardia|ventricular tachycardia
351396|NCT01639365|Catheter ablation|catheter ablation
351397|NCT01639365|Tissue contact|tissue contact
351398|NCT01639352|Hepatocellular Carcinoma|hepatocellular carcinoma
351400|NCT01639352|SOM230|som230
351401|NCT01639352|Pasireotide LAR|pasireotide lar
351402|NCT01639339|Antibodies|antibodies
351403|NCT01639339|Systemic Lupus Erythematosus|systemic lupus erythematosus
351404|NCT01639339|Autoimmune Disease|autoimmune disease
351405|NCT01639339|Glomerulonephritis|glomerulonephritis
351406|NCT01639339|Belimumab|belimumab
351407|NCT01639339|Lupus|lupus
351408|NCT01639339|Nephritis|nephritis
351409|NCT01639339|Kidney Diseases|kidney diseases
351410|NCT01639339|SLE|sle
351411|NCT01639300|Relapsing Forms of Multiple Sclerosis|relapsing forms of multiple sclerosis
351412|NCT01639300|Progressive Forms of Multiple Sclerosis|progressive forms of multiple sclerosis
351413|NCT01639300|GNbAC1|gnbac1
351414|NCT01639300|Monoclonal antibody|monoclonal antibody
351415|NCT01639300|Multiple Sclerosis Associated Retrovirus (MSRV)|multiple sclerosis associated retrovirus (msrv)
351416|NCT01639261|steroid-refractory|steroid-refractory
351417|NCT01639261|bronchiolitis obliterans|bronchiolitis obliterans
351418|NCT01639261|allogeneic stem cell transplantation|allogeneic stem cell transplantation
351419|NCT01639261|interferon gamma|interferon gamma
351420|NCT01639248|Breast Cancer|breast cancer
351421|NCT01639235|Secondhand Smoke|secondhand smoke
351422|NCT01639235|Flight Attendants|flight attendants
351423|NCT01639235|Lung function|lung function
351424|NCT01639235|Cardiac function|cardiac function
351425|NCT01639235|Reproductive health|reproductive health
351426|NCT01639222|Drug therapy|drug therapy
351427|NCT01639222|Increase in calcium urinary excretion and PTH decrease in serum|increase in calcium urinary excretion and pth decrease in serum
351428|NCT01639209|Retinal detachment|retinal detachment
351429|NCT01639209|Pneumatic retinopexy|pneumatic retinopexy
351430|NCT01639209|Vitrectomy|vitrectomy
351431|NCT01639196|Chronic pain|chronic pain
351432|NCT01639196|Psychological adjustment|psychological adjustment
351433|NCT01639196|Writing|writing
351434|NCT01639196|Brief intervention|brief intervention
351435|NCT01639196|Online|online
351436|NCT01639196|Internet interventions|internet interventions
351437|NCT01639183|oral inflammation|oral inflammation
351438|NCT01639183|systemic inflammation|systemic inflammation
351441|NCT01639183|nursing home residents|nursing home residents
351442|NCT01639170|Pneumoperitoneum|pneumoperitoneum
351443|NCT01639170|Free air|free air
351444|NCT01639170|Surgery|surgery
351445|NCT01639170|Perforation|perforation
351446|NCT01639170|Radiograph|radiograph
351447|NCT01639144|Infection|infection
351448|NCT01639144|delayed wound healing|delayed wound healing
351449|NCT01639144|platelet-rich plasma|platelet-rich plasma
351450|NCT01639131|Gemcitabine|gemcitabine
351451|NCT01639131|Docetaxel|docetaxel
351452|NCT01639131|Filgrastim|filgrastim
351453|NCT01639131|Pegfilgrastim|pegfilgrastim
351454|NCT01639118|primary ventral hernia repair with mesh|primary ventral hernia repair with mesh
351455|NCT01639118|umbilical hernia repair|umbilical hernia repair
351456|NCT01639118|epigastric hernia repair|epigastric hernia repair
351457|NCT01639118|C-Qur V-patch|c-qur v-patch
351458|NCT01639118|Size tailored repair|size tailored repair
351459|NCT01639118|preperitoneal repair|preperitoneal repair
351460|NCT01639118|abdominal hernia|abdominal hernia
351461|NCT01639118|dual sided mesh|dual sided mesh
351462|NCT01639092|Resistance of Entecavir|resistance of entecavir
351463|NCT01639079|cigarette smoking behavior|cigarette smoking behavior
351464|NCT01639079|smoking cessation|smoking cessation
351465|NCT01639079|Latino smoking cessation|latino smoking cessation
351466|NCT01639066|Resistance of Adefovir|resistance of adefovir
351467|NCT01639053|Breast Augmentation|breast augmentation
351468|NCT01639053|Breast Reconstruction|breast reconstruction
351469|NCT01639053|Breast Revision|breast revision
351470|NCT01639053|Silicone breast implants|silicone breast implants
351471|NCT01639001|Crizotinib|crizotinib
351472|NCT01639001|ALK positive|alk positive
351473|NCT01639001|ALK|alk
351474|NCT01639001|Anaplastic Lymphoma Kinase|anaplastic lymphoma kinase
351475|NCT01639001|NSCLC|nsclc
351476|NCT01639001|Non-Small Cell Lung Cancer|non-small cell lung cancer
351477|NCT01639001|Frontline|frontline
351478|NCT01639001|1L|1l
351479|NCT01639001|Previously Untreated|previously untreated
351480|NCT01639001|East Asian|east asian
351481|NCT01639001|Non-Squamous|non-squamous
351482|NCT01638962|Exercise Therapy|exercise therapy
351483|NCT01638962|Gait|gait
351484|NCT01638962|Joint load|joint load
351485|NCT01638962|Knee Joint|knee joint
351486|NCT01638962|Middle Aged|middle aged
351487|NCT01638962|Osteoarthritis, Knee/therapy|osteoarthritis, knee/therapy
351488|NCT01638962|Pain Management|pain management
351489|NCT01638949|Alzheimer's disease|alzheimer's disease
351490|NCT01638949|MCI|mci
351491|NCT01638949|genetic|genetic
351492|NCT01638949|AV45-PET|av45-pet
351493|NCT01638936|Combination|combination
351494|NCT01638936|Multiple Myeloma|multiple myeloma
351495|NCT01638923|Heavy Menstrual Bleeding|heavy menstrual bleeding
351496|NCT01638923|Efficacy|efficacy
351497|NCT01638923|Safety|safety
351498|NCT01638923|Oral contraceptive|oral contraceptive
351499|NCT01638923|Estradiol valerate|estradiol valerate
351500|NCT01638923|Dienogest|dienogest
351501|NCT01638910|Efficacy|efficacy
351502|NCT01638910|Safety|safety
351503|NCT01638910|oral contraception|oral contraception
351504|NCT01638910|estradiol valerate|estradiol valerate
351505|NCT01638910|dienogest|dienogest
351506|NCT01638897|ICD|icd
351507|NCT01638897|CRTD|crtd
351508|NCT01638897|DF4|df4
351509|NCT01638884|Prospective Memory|prospective memory
351510|NCT01638884|Healthy Aging|healthy aging
351511|NCT01638884|Alzheimer Disease|alzheimer disease
351512|NCT01638884|Brain Imaging|brain imaging
351513|NCT01638832|NASH; coronary artery disease|nash; coronary artery disease
351514|NCT01638806|Acute Coronary Syndrome|acute coronary syndrome
351515|NCT01638806|Myocardial infarction|myocardial infarction
351516|NCT01638806|Angioplasty|angioplasty
351517|NCT01638806|Prehospital emergency care|prehospital emergency care
351518|NCT01638806|Biological markers|biological markers
351519|NCT01638806|Troponin|troponin
351520|NCT01638806|Point-of-Care systems|point-of-care systems
351521|NCT01638767|In Vitro Fertilization long protocol|in vitro fertilization long protocol
351522|NCT01638767|NuvaRing|nuvaring
351523|NCT01638767|Marvelon|marvelon
351524|NCT01638767|In vitro fertilization|in vitro fertilization
351525|NCT01638715|Rheumatoid Arthritis|rheumatoid arthritis
351526|NCT01638715|Biologic therapies|biologic therapies
351527|NCT01638715|Biomarker|biomarker
351528|NCT01638715|Mode of Action|mode of action
351529|NCT01638702|Catheterisation, Central Venous|catheterisation, central venous
351530|NCT01638702|Catheters, Indwelling|catheters, indwelling
351531|NCT01638689|Mechanism of Action of escitalopram|mechanism of action of escitalopram
351532|NCT01638676|Unresectable melanoma|unresectable melanoma
351533|NCT01638676|Stage IIIC and Stage IV BRAFV600E+ Melanoma|stage iiic and stage iv brafv600e+ melanoma
351534|NCT01638663|Tolvaptan|tolvaptan
351535|NCT01638663|L-NMMA|l-nmma
351536|NCT01638663|Healthy subjects|healthy subjects
351537|NCT01638663|Nephrology|nephrology
351538|NCT01638663|Cardiology|cardiology
351539|NCT01638624|Propofol|propofol
351540|NCT01638624|antioxidant capacity|antioxidant capacity
351541|NCT01638624|total knee arthroplasty|total knee arthroplasty
351542|NCT01638624|Propofol,antioxidant|propofol,antioxidant
351543|NCT01638611|Healthy male volunteers|healthy male volunteers
351544|NCT01638572|Neuroblastoma|neuroblastoma
351545|NCT01638572|B4GALNT3|b4galnt3
351546|NCT01638572|Prognosis|prognosis
351547|NCT01638559|liver transplant|liver transplant
351548|NCT01638559|allograft function|allograft function
351549|NCT01638559|anti-rejection|anti-rejection
351550|NCT01638559|immunosuppression withdrawal|immunosuppression withdrawal
351551|NCT01638520|Immune Therapy|immune therapy
351552|NCT01638520|Interleukin 4|interleukin 4
351553|NCT01638520|monoclonal antibody|monoclonal antibody
351554|NCT01638507|TARGET LESION REVASCULARIZATION (TLR)|target lesion revascularization (tlr)
351555|NCT01638507|TARGET VESSEL REVASCULARIZATION (TVR)|target vessel revascularization (tvr)
351556|NCT01638507|Coronary Artery Disease|coronary artery disease
351557|NCT01638507|MYOCARDIAL INFARCTION (MI)|myocardial infarction (mi)
351558|NCT01638507|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
351559|NCT01638507|STENT THROMBOSIS|stent thrombosis
351560|NCT01638507|TARGET LESION FAILURE (TLF)|target lesion failure (tlf)
351561|NCT01638494|25-Hydroxyvitamin D|25-hydroxyvitamin d
351562|NCT01638494|dietary counseling|dietary counseling
351563|NCT01638494|pediatrics|pediatrics
351564|NCT01638494|allergy|allergy
351565|NCT01638494|bone metabolism|bone metabolism
351566|NCT01638468|Pulmonary Embolism|pulmonary embolism
351567|NCT01638468|Acute Pulmonary Embolism|acute pulmonary embolism
351568|NCT01638468|Sub-massive Pulmonary Embolism|sub-massive pulmonary embolism
351569|NCT01638468|Massive Pulmonary Embolism|massive pulmonary embolism
351570|NCT01638468|Pulmonary Thromboembolism|pulmonary thromboembolism
351571|NCT01638442|Male subjects, healthy|male subjects, healthy
351572|NCT01638403|narcolepsy|narcolepsy
351573|NCT01638403|excessive daytime sleepiness|excessive daytime sleepiness
351574|NCT01638403|cataplexy|cataplexy
351575|NCT01638377|Back on Track|back on track
351576|NCT01638377|convicted drinking drivers|convicted drinking drivers
351577|NCT01638377|naltrexone|naltrexone
351578|NCT01638377|alcohol dependence|alcohol dependence
351579|NCT01638351|Diabetes mellitus|diabetes mellitus
351580|NCT01638351|Resistance exercise|resistance exercise
351581|NCT01638351|Elderly|elderly
351582|NCT01638351|Skeletal muscle dysfunction|skeletal muscle dysfunction
351583|NCT01638351|Metabolomics|metabolomics
351584|NCT01638338|Alcohol|alcohol
351585|NCT01638338|Risky drinking|risky drinking
351586|NCT01638338|Web site|web site
351587|NCT01638338|Primary Care|primary care
351588|NCT01638338|General Practice|general practice
351589|NCT01638338|Local Community|local community
351590|NCT01638338|Mayors|mayors
351591|NCT01638312|HIV, fructose|hiv, fructose
351592|NCT01638299|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
351593|NCT01638299|Artificial Pancreas|artificial pancreas
351594|NCT01638273|Pregabalin, GLARS|pregabalin, glars
351595|NCT01638260|NEAT|neat
351596|NCT01638260|liraglutide|liraglutide
351597|NCT01638260|glycemic control|glycemic control
351598|NCT01638247|Male breast cancer|male breast cancer
351599|NCT01638247|neoadjuvant, adjuvant or metastatic situation|neoadjuvant, adjuvant or metastatic situation
351600|NCT01638247|anti-hormonal therapy|anti-hormonal therapy
351601|NCT01638234|atopic dermatitis|atopic dermatitis
351602|NCT01638234|eczema|eczema
351603|NCT01638182|phylloquinone,|phylloquinone,
351604|NCT01638182|menaquinone-7|menaquinone-7
351605|NCT01638182|vitamin K-status|vitamin k-status
351606|NCT01638182|efficacy|efficacy
351607|NCT01638156|Aortic stenosis|aortic stenosis
351608|NCT01638143|vitamin K2|vitamin k2
351609|NCT01638143|menaquinone-7|menaquinone-7
351610|NCT01638143|bioavailability|bioavailability
351611|NCT01638091|Narrow band imaging|narrow band imaging
351612|NCT01638091|Screening colonoscopy|screening colonoscopy
351613|NCT01638091|Histology|histology
351614|NCT01638078|coronary restenosis|coronary restenosis
351615|NCT01638065|vein identification|vein identification
351616|NCT01638065|vascular access|vascular access
351617|NCT01638052|Tympanomastoid Surgery|tympanomastoid surgery
351618|NCT01638052|Cochlear Implant|cochlear implant
351619|NCT01638052|Mastoidectomy|mastoidectomy
351620|NCT01638052|Cholesteatoma|cholesteatoma
351621|NCT01638052|Pediatrics|pediatrics
351622|NCT01638052|Clonidine|clonidine
351623|NCT01638052|Bupivacaine|bupivacaine
351624|NCT01638052|Greater Auricular Nerve Block|greater auricular nerve block
351625|NCT01638052|Regional Anesthesia|regional anesthesia
351626|NCT01638026|Gnrh agonist|gnrh agonist
351627|NCT01638013|Rheumatoid Arthritis|rheumatoid arthritis
351628|NCT01638013|ASP015K|asp015k
351629|NCT01638000|Vesitrim|vesitrim
351630|NCT01638000|Frequency|frequency
351631|NCT01638000|Urgency|urgency
351632|NCT01638000|Urgency incontinence|urgency incontinence
351633|NCT01638000|Urinary incontinence|urinary incontinence
351634|NCT01638000|Overactive Bladder (OAB)|overactive bladder (oab)
351635|NCT01638000|Micturition|micturition
351636|NCT01638000|Mirabegron|mirabegron
351637|NCT01638000|YM178|ym178
351638|NCT01638000|Vesicare|vesicare
351639|NCT01638000|Solifenacin|solifenacin
351640|NCT01637987|Peripheral intravenous catheter|peripheral intravenous catheter
351641|NCT01637987|Vein visualization|vein visualization
351642|NCT01637987|Transillumination|transillumination
351643|NCT01637987|Near infrared light|near infrared light
351644|NCT01637948|Chinese medicine|chinese medicine
351645|NCT01637948|gingivitis|gingivitis
351646|NCT01637948|cytokine|cytokine
351647|NCT01637948|microbial|microbial
351648|NCT01637935|Drug therapy|drug therapy
351649|NCT01637909|Prehypertension, Hypertension|prehypertension, hypertension
351650|NCT01637883|benzydamine HCl|benzydamine hcl
351651|NCT01637883|endotracheal tube|endotracheal tube
351652|NCT01637883|postoperative sore throat|postoperative sore throat
351653|NCT01637870|Cesarean delivery|cesarean delivery
351654|NCT01637870|Postpartum infection|postpartum infection
351655|NCT01637870|Wound complications|wound complications
351656|NCT01637870|Wound seroma|wound seroma
351657|NCT01637870|Wound separation|wound separation
351658|NCT01637870|Wound infection|wound infection
351659|NCT01637870|Negative pressure|negative pressure
351660|NCT01637857|foof hypersensitivity|foof hypersensitivity
351661|NCT01637857|anal fissures|anal fissures
351662|NCT01637857|ano-rectal manometry|ano-rectal manometry
351663|NCT01637844|Pregnant women|pregnant women
351664|NCT01637844|HBsAg positive|hbsag positive
351665|NCT01637844|HBeAg positive|hbeag positive
351666|NCT01637844|Telbivudine|telbivudine
351667|NCT01637831|Obstructive Sleep Apnea|obstructive sleep apnea
351668|NCT01637831|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
351669|NCT01637818|Inguinal hernia repair|inguinal hernia repair
351670|NCT01637818|long-term follow-up|long-term follow-up
351671|NCT01637818|Surgical technique|surgical technique
351672|NCT01637792|peritoneal dialysis|peritoneal dialysis
351673|NCT01637792|dose|dose
351674|NCT01637792|residual kidney function|residual kidney function
351675|NCT01637792|technique survival|technique survival
351676|NCT01637792|patient survival|patient survival
351677|NCT01637792|peritonitis|peritonitis
351678|NCT01637779|randomized controlled trial|randomized controlled trial
351679|NCT01637779|parent education|parent education
351680|NCT01637779|pain management|pain management
351681|NCT01637779|infant|infant
351682|NCT01637779|immunization|immunization
351683|NCT01637766|Spinal Metastases|spinal metastases
351684|NCT01637766|Spinal Metastatic Disease|spinal metastatic disease
351685|NCT01637766|Cord Compression|cord compression
351686|NCT01637766|Intra-arterial Chemotherapy|intra-arterial chemotherapy
351687|NCT01637766|Spinal Tumors|spinal tumors
351688|NCT01637740|myopia|myopia
351689|NCT01637740|pseudoexfoliation syndrome|pseudoexfoliation syndrome
351690|NCT01637740|optical low coherence reflectometry|optical low coherence reflectometry
351691|NCT01637740|ocular optical components|ocular optical components
351692|NCT01637740|cataract|cataract
351693|NCT01637727|Long term effects of gestational diabetes mellitus in a population of parous women|long term effects of gestational diabetes mellitus in a population of parous women
351694|NCT01637727|Gestational diabetes mellitus- GDM is defined as glucose intolerance diagnosed during pregnancy and not present shortly after birth|gestational diabetes mellitus- gdm is defined as glucose intolerance diagnosed during pregnancy and not present shortly after birth
351695|NCT01637701|benign prostatic hypertrophy|benign prostatic hypertrophy
351696|NCT01637701|bipolar transurethral resection of the prostate|bipolar transurethral resection of the prostate
351697|NCT01637701|plasmakinetic enucleation of the prostate|plasmakinetic enucleation of the prostate
351698|NCT01637688|cow milk allergy|cow milk allergy
351699|NCT01637688|amino acid formula|amino acid formula
351700|NCT01637675|sodium tanshinone IIA sulfonate|sodium tanshinone iia sulfonate
351701|NCT01637675|pulmonary hypertension|pulmonary hypertension
351702|NCT01637649|dysphagia,diaphragm, ultrasonography, inspiration, expiration,|dysphagia,diaphragm, ultrasonography, inspiration, expiration,
351703|NCT01637636|rifampin,|rifampin,
351704|NCT01637636|ketoconazole,|ketoconazole,
351705|NCT01637636|CYP3A4,|cyp3a4,
351706|NCT01637636|tasimelteon,|tasimelteon,
351707|NCT01637636|VEC-162|vec-162
351708|NCT01637636|Pharmacokinetics|pharmacokinetics
351709|NCT01637623|Hypertension|hypertension
351710|NCT01637623|High Blood Pressure|high blood pressure
351711|NCT01637623|Sleep Apnea|sleep apnea
351712|NCT01637623|Obstructive Sleep Apnea|obstructive sleep apnea
351713|NCT01637623|OSA|osa
351714|NCT01637610|placental alpha microglobulin-1|placental alpha microglobulin-1
351715|NCT01637610|AmniSure|amnisure
351716|NCT01637610|preterm|preterm
351717|NCT01637610|rupture of fetal membranes|rupture of fetal membranes
351718|NCT01637597|Non-small cell lung cancer(NSCLC)|non-small cell lung cancer(nsclc)
351719|NCT01637571|GERD|gerd
351720|NCT01637571|NCCP|nccp
351721|NCT01637571|chest pain|chest pain
351722|NCT01637571|reflux|reflux
351723|NCT01637571|GERD related non-cardiac chest pain|gerd related non-cardiac chest pain
351724|NCT01637545|facial bones|facial bones
351725|NCT01637545|Post operative nasea vomiting|post operative nasea vomiting
351726|NCT01637545|fractures|fractures
351727|NCT01637545|reduction|reduction
351728|NCT01637519|kidney stones|kidney stones
351729|NCT01637519|ureteral stones|ureteral stones
351730|NCT01637519|stent|stent
351731|NCT01637506|urine|urine
351732|NCT01637506|stool|stool
351733|NCT01637506|kidney stones|kidney stones
351736|NCT01637493|Pharmacokinetics|pharmacokinetics
351737|NCT01637493|Pharmacodynamics|pharmacodynamics
351738|NCT01637467|critical illness|critical illness
351739|NCT01637467|myopathy|myopathy
351740|NCT01637467|electrical muscle stimulation|electrical muscle stimulation
351741|NCT01637454|noradrenaline terlipressin type 2 HRS|noradrenaline terlipressin type 2 hrs
351742|NCT01637441|bladder prolapse (cystocele)|bladder prolapse (cystocele)
351743|NCT01637441|Pelvic organ prolapse repair|pelvic organ prolapse repair
351744|NCT01637441|coelioscopic|coelioscopic
351745|NCT01637441|prosthetic surgery|prosthetic surgery
351746|NCT01637441|vaginal approach|vaginal approach
351747|NCT01637441|Randomized study|randomized study
351748|NCT01637441|laparoscopic sacropexy|laparoscopic sacropexy
351749|NCT01637441|vaginal mesh surgery|vaginal mesh surgery
351750|NCT01637441|Stage II|stage ii
351751|NCT01637441|Clavien Dindo|clavien dindo
351752|NCT01637415|alcohol withdrawal syndrome|alcohol withdrawal syndrome
351753|NCT01637415|prediction|prediction
351754|NCT01637415|severity|severity
351755|NCT01637415|alcohol use disorder|alcohol use disorder
351756|NCT01637415|complicated alcohol withdrawal|complicated alcohol withdrawal
351757|NCT01637415|alcohol withdrawal seizures|alcohol withdrawal seizures
351758|NCT01637415|delirium tremens|delirium tremens
351759|NCT01637415|PAWSS|pawss
351760|NCT01637402|CRPC|crpc
351761|NCT01637402|prostate|prostate
351762|NCT01637402|cancer|cancer
351763|NCT01637376|Lung neoplasms|lung neoplasms
351764|NCT01637376|Non Small cell lung carcinoma|non small cell lung carcinoma
351765|NCT01637376|Non small cell lung cancer|non small cell lung cancer
351766|NCT01637376|Large cell carcinoma|large cell carcinoma
351767|NCT01637376|squamous cell carcinoma|squamous cell carcinoma
351768|NCT01637376|adenocarcinoma|adenocarcinoma
351769|NCT01637363|Psychoeducation|psychoeducation
351770|NCT01637363|Stress|stress
351771|NCT01637363|Sickness absence|sickness absence
351772|NCT01637363|Psychiatric symptoms|psychiatric symptoms
351773|NCT01637363|Locus of control|locus of control
351774|NCT01637363|Self reported health|self reported health
351775|NCT01637324|To assess VCT and linkage into care|to assess vct and linkage into care
351776|NCT01637324|nPEP|npep
351777|NCT01637324|STIs|stis
351778|NCT01637324|anal dysplasia/cancer|anal dysplasia/cancer
351779|NCT01637324|hyperlipidemia|hyperlipidemia
351780|NCT01637324|diabetes|diabetes
351781|NCT01637324|Proportion of first-time MSM clients attending multidisciplinary services who undergo HIV testing|proportion of first-time msm clients attending multidisciplinary services who undergo hiv testing
351782|NCT01637324|Proportion of MSM clients who have repeated HIV testing during the first six months after the first negative HIV test|proportion of msm clients who have repeated hiv testing during the first six months after the first negative hiv test
351783|NCT01637324|Proportion of HIV-positive MSM who receive HIV care within three months after HIV diagnosis or enrolment|proportion of hiv-positive msm who receive hiv care within three months after hiv diagnosis or enrolment
351784|NCT01637324|Proportion of HIV-positive MSM who still remain in HIV care at six months after enrollment|proportion of hiv-positive msm who still remain in hiv care at six months after enrollment
351785|NCT01637311|Peroral endoscopic myotomy|peroral endoscopic myotomy
351786|NCT01637311|Heller myotomy|heller myotomy
351787|NCT01637311|persistent/recurrent achalasia.|persistent/recurrent achalasia.
351788|NCT01637298|Histological HGAIN|histological hgain
351789|NCT01637298|detected biomarkers|detected biomarkers
351790|NCT01637298|MSM population|msm population
351791|NCT01637298|HPV subtypes|hpv subtypes
351792|NCT01637298|AIN study|ain study
351793|NCT01637298|HIV-positive and HIV-negative MSM|hiv-positive and hiv-negative msm
351794|NCT01637298|anal cytology and biomarkers|anal cytology and biomarkers
351795|NCT01637298|likelihood of AIN development at month 12 and yearly thereafter|likelihood of ain development at month 12 and yearly thereafter
351796|NCT01637272|Dumping syndrome|dumping syndrome
351797|NCT01637272|SOM230|som230
351798|NCT01637272|pasireotide LAR|pasireotide lar
351799|NCT01637259|proteinuria|proteinuria
351800|NCT01637259|HIV|hiv
351801|NCT01637233|HIV-1 infection|hiv-1 infection
351802|NCT01637233|neurocognitive function|neurocognitive function
351803|NCT01637233|switch study|switch study
351804|NCT01637220|Anaphylaxis|anaphylaxis
351805|NCT01637220|Neutrophils|neutrophils
351806|NCT01637220|Platelet activating factor|platelet activating factor
351807|NCT01637220|Neutrophil Extracellular Traps (NETs)|neutrophil extracellular traps (nets)
351808|NCT01637168|Disorders of cognitive function|disorders of cognitive function
351809|NCT01637155|Cholecalciferol|cholecalciferol
351810|NCT01637129|Childhood stroke|childhood stroke
351811|NCT01637129|Perinatal stroke|perinatal stroke
351812|NCT01637129|Pediatric stroke|pediatric stroke
351813|NCT01637129|Presumed perinatal stroke|presumed perinatal stroke
351814|NCT01637129|Children who have hemiparesis|children who have hemiparesis
351815|NCT01637103|Cancer|cancer
351816|NCT01637103|Depression|depression
351817|NCT01637103|Anxiety|anxiety
351818|NCT01637103|Fatigue|fatigue
351819|NCT01637103|Sleep|sleep
351820|NCT01637103|Quality of life|quality of life
351821|NCT01637103|Cognitive therapy|cognitive therapy
351822|NCT01637103|Bright light therapy|bright light therapy
351823|NCT01637064|Myositis|myositis
351933|NCT01636609|DepoCyt|depocyt
351824|NCT01637064|Acthar treatment|acthar treatment
351825|NCT01637038|ischemia/reperfusion injury|ischemia/reperfusion injury
351826|NCT01637038|remote ischemic postconditioning|remote ischemic postconditioning
351827|NCT01637012|ALEX|alex
351828|NCT01637012|coronary stent|coronary stent
351829|NCT01637012|cobalt-chromium|cobalt-chromium
351830|NCT01637012|sirolimus|sirolimus
351831|NCT01637012|OCT|oct
351832|NCT01636999|Sedara|sedara
351833|NCT01636999|Nitrous Oxide|nitrous oxide
351834|NCT01636999|Butorphanol|butorphanol
351835|NCT01636999|Visual Analog Scale|visual analog scale
351836|NCT01636986|myopia|myopia
351837|NCT01636986|contact lenses|contact lenses
351838|NCT01636986|dry eyes|dry eyes
351839|NCT01636986|comfort|comfort
351840|NCT01636986|replacement|replacement
351841|NCT01636973|Lung cancer|lung cancer
351842|NCT01636947|chemotherapy|chemotherapy
351843|NCT01636947|nausea|nausea
351844|NCT01636947|vomiting|vomiting
351845|NCT01636947|emetogenic|emetogenic
351846|NCT01636947|cancer|cancer
351847|NCT01636947|antiemetics|antiemetics
351848|NCT01636947|tumor|tumor
351849|NCT01636934|Lung Cancer|lung cancer
351850|NCT01636934|Non Small Cell Lung Cancer|non small cell lung cancer
351851|NCT01636934|NSCLC|nsclc
351852|NCT01636934|Symptom Burden|symptom burden
351853|NCT01636934|Chemoradiation|chemoradiation
351854|NCT01636934|CXRT|cxrt
351855|NCT01636934|Minocycline|minocycline
351856|NCT01636934|Dynacin|dynacin
351857|NCT01636934|Minocin|minocin
351858|NCT01636934|Minocin PAC|minocin pac
351859|NCT01636934|Myrac|myrac
351860|NCT01636934|Solodyn|solodyn
351861|NCT01636934|Placebo|placebo
351862|NCT01636934|Sugar Pill|sugar pill
351863|NCT01636934|Questionnaires|questionnaires
351864|NCT01636934|Surveys|surveys
351865|NCT01636921|Non-Small Cell Lung Cancer|non-small cell lung cancer
351866|NCT01636921|Lung Cancer|lung cancer
351867|NCT01636921|NSCLC|nsclc
351868|NCT01636921|Radiation Therapy|radiation therapy
351869|NCT01636921|Sorafenib|sorafenib
351870|NCT01636921|BAY 43-9006|bay 43-9006
351871|NCT01636921|Thoracic Radiation|thoracic radiation
351872|NCT01636895|malaria|malaria
351873|NCT01636895|pregnancy|pregnancy
351874|NCT01636895|prevention|prevention
351875|NCT01636895|treatment|treatment
351876|NCT01636895|molecular markers|molecular markers
351877|NCT01636882|Melanoma|melanoma
351878|NCT01636882|CALM|calm
351879|NCT01636869|bupivacaine level|bupivacaine level
351880|NCT01636869|periarticular block|periarticular block
351881|NCT01636869|total knee arthroplasty|total knee arthroplasty
351882|NCT01636856|oropharyngeal exercises, obstructive sleep apnea, speech therapy, magnetic resonance, PCRIT, negative expiratory pressure, snore|oropharyngeal exercises, obstructive sleep apnea, speech therapy, magnetic resonance, pcrit, negative expiratory pressure, snore
351883|NCT01636830|Toothbrushing|toothbrushing
351884|NCT01636830|gingival recession|gingival recession
351885|NCT01636804|Quicksite|quicksite
351886|NCT01636804|Quickflex|quickflex
351887|NCT01636804|St. Jude Medical|st. jude medical
351888|NCT01636778|Thrombocytopenia|thrombocytopenia
351889|NCT01636778|Hepatitis C, chronic|hepatitis c, chronic
351890|NCT01636739|Intussusceptions|intussusceptions
351891|NCT01636739|Special Drug Use Investigation|special drug use investigation
351892|NCT01636739|Rotavirus|rotavirus
351893|NCT01636726|COPD|copd
351894|NCT01636726|AMI|ami
351895|NCT01636726|Asthma|asthma
351896|NCT01636726|LABAs|labas
351897|NCT01636700|Tramadol infiltration|tramadol infiltration
351898|NCT01636700|Analgesic effect|analgesic effect
351899|NCT01636700|Serum IL-6|serum il-6
351900|NCT01636687|Psoriasis|psoriasis
351901|NCT01636687|Moderate to Severe Plaque-type Psoriasis|moderate to severe plaque-type psoriasis
351902|NCT01636674|positron emission tomography|positron emission tomography
351903|NCT01636674|computed tomography|computed tomography
351904|NCT01636674|fluordeoxyglucose|fluordeoxyglucose
351905|NCT01636674|colon cancer|colon cancer
351906|NCT01636674|cancer|cancer
351907|NCT01636674|staging|staging
351908|NCT01636674|imaging|imaging
351909|NCT01636648|Aortic Valve Replacement|aortic valve replacement
351910|NCT01636648|Aortic Valve Bioprosthesis|aortic valve bioprosthesis
351911|NCT01636622|Advanced Cancers|advanced cancers
351912|NCT01636622|Advanced Malignancy|advanced malignancy
351913|NCT01636622|BRAF Mutation|braf mutation
351914|NCT01636622|Advanced solid tumor|advanced solid tumor
351915|NCT01636622|Lymphoma|lymphoma
351916|NCT01636622|Vemurafenib|vemurafenib
351917|NCT01636622|PLX4032|plx4032
351918|NCT01636622|RO5185426|ro5185426
351919|NCT01636622|Carboplatin|carboplatin
351920|NCT01636622|Paraplatin|paraplatin
351921|NCT01636622|Paclitaxel|paclitaxel
351922|NCT01636622|Taxol|taxol
351923|NCT01636609|Leukemia|leukemia
351924|NCT01636609|Acute Myeloid Leukemia|acute myeloid leukemia
351925|NCT01636609|AML|aml
351926|NCT01636609|Myelodysplastic Syndromes|myelodysplastic syndromes
351927|NCT01636609|MDS|mds
351928|NCT01636609|Relapsed|relapsed
351929|NCT01636609|Refractory|refractory
351930|NCT01636609|Cytarabine|cytarabine
351931|NCT01636609|ARA-C|ara-c
351934|NCT01636609|Cytosine Arabinosine|cytosine arabinosine
351935|NCT01636609|5-Azacytidine|5-azacytidine
351936|NCT01636609|Azacitidine|azacitidine
351937|NCT01636609|5-aza|5-aza
351938|NCT01636609|Vidaza|vidaza
351939|NCT01636609|5-AZC|5-azc
351940|NCT01636609|AZA-CR|aza-cr
351941|NCT01636609|Ladakamycin|ladakamycin
351942|NCT01636609|NSC-102816|nsc-102816
351943|NCT01636609|Tosedostat|tosedostat
351944|NCT01636596|Alzheimer's Disease|alzheimer's disease
351945|NCT01636596|Mild Cognitive Impairment|mild cognitive impairment
351946|NCT01636596|Insulin|insulin
351947|NCT01636596|Pulsatile|pulsatile
351948|NCT01636583|zinc|zinc
351949|NCT01636583|absorption|absorption
351950|NCT01636583|bio-availability|bio-availability
351951|NCT01636583|aqueous zinc|aqueous zinc
351952|NCT01636583|zinc deficiency|zinc deficiency
351953|NCT01636583|zinc fortification|zinc fortification
351954|NCT01636570|Vitamin D|vitamin d
351955|NCT01636570|Cholecalciferol|cholecalciferol
351956|NCT01636570|Heart Failure|heart failure
351957|NCT01636570|Congestive heart failure|congestive heart failure
351958|NCT01636570|Cardiomyopathy|cardiomyopathy
351959|NCT01636570|Strength|strength
351960|NCT01636570|Parathyroid Hormone|parathyroid hormone
351961|NCT01636570|Calcium|calcium
351962|NCT01636570|Quality of Life|quality of life
351963|NCT01636570|C reactive protein|c reactive protein
351964|NCT01636570|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
351965|NCT01636570|Prognosis|prognosis
351966|NCT01636557|Rheumatoid arthritis|rheumatoid arthritis
351967|NCT01636557|sirukumab|sirukumab
351968|NCT01636557|CNTO 136|cnto 136
351969|NCT01636557|CYP450 enzyme|cyp450 enzyme
351970|NCT01636557|anti-interleukin-6 monoclonal antibody|anti-interleukin-6 monoclonal antibody
351971|NCT01636466|Chronic allograft failure|chronic allograft failure
351972|NCT01636466|Kidney Transplantation|kidney transplantation
351973|NCT01636453|wide-neck|wide-neck
351974|NCT01636453|saccular|saccular
351975|NCT01636453|intracranial aneurysms|intracranial aneurysms
351976|NCT01636453|ICA|ica
351977|NCT01636453|Stent assisted coiling|stent assisted coiling
351978|NCT01636453|Liberty Stent|liberty stent
351979|NCT01636440|Conditioned Pain Modulation|conditioned pain modulation
351980|NCT01636427|myocardial infarction|myocardial infarction
351981|NCT01636427|coronary angiography|coronary angiography
351982|NCT01636427|STEMI|stemi
351983|NCT01636427|NSTEMI|nstemi
351984|NCT01636414|Total joint arthroplasty, blood loss|total joint arthroplasty, blood loss
351985|NCT01636388|Relapsed Hodgkins Lymphoma|relapsed hodgkins lymphoma
351986|NCT01636388|Refractory Hodgkins Lymphoma|refractory hodgkins lymphoma
351987|NCT01636388|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
351988|NCT01636388|Adoptive Immunotherapy|adoptive immunotherapy
351989|NCT01636388|Cellular Therapy|cellular therapy
351990|NCT01636388|Cytotoxic T cell lymphocytes|cytotoxic t cell lymphocytes
351991|NCT01636362|Partial-thickness second degree burns|partial-thickness second degree burns
351992|NCT01636362|Mepitel Ag|mepitel ag
351993|NCT01636362|Silver dressing|silver dressing
351994|NCT01636349|Type 2 diabetes|type 2 diabetes
351995|NCT01636349|hypertension|hypertension
351996|NCT01636349|obesity|obesity
351997|NCT01636349|metabolic syndrome|metabolic syndrome
351998|NCT01636297|Parkinson's disease|parkinson's disease
351999|NCT01636297|Exercise|exercise
352000|NCT01636284|Liver Cancer|liver cancer
352001|NCT01636284|HCC|hcc
352002|NCT01636284|first line HCC|first line hcc
352003|NCT01636284|Pexa-Vec|pexa-vec
352004|NCT01636284|JX-594|jx-594
352005|NCT01636271|CV Risk|cv risk
352006|NCT01636271|Cardiovascular Disease|cardiovascular disease
352007|NCT01636271|Atherosclerosis|atherosclerosis
352008|NCT01636271|Acute coronary syndrome|acute coronary syndrome
352009|NCT01636258|Prediabetes|prediabetes
352010|NCT01636258|Overweight|overweight
352011|NCT01636258|African American|african american
352012|NCT01636258|Women|women
352013|NCT01636258|Cooking|cooking
352014|NCT01636258|Nutrition|nutrition
352015|NCT01636258|Exercise|exercise
352016|NCT01636258|Stress Management|stress management
352017|NCT01636245|71 vaccine|71 vaccine
352018|NCT01636245|HFMD|hfmd
352019|NCT01636245|consistency of three consecutive lots|consistency of three consecutive lots
352020|NCT01636245|immunogenicity|immunogenicity
352021|NCT01636232|Vitamin D|vitamin d
352022|NCT01636232|infection|infection
352023|NCT01636232|disease severity|disease severity
352024|NCT01636232|mortality|mortality
352025|NCT01636232|critically ill|critically ill
352026|NCT01636232|sepsis|sepsis
352027|NCT01636219|Spirometry,|spirometry,
352028|NCT01636219|Cough|cough
352029|NCT01636193|Rotavirus|rotavirus
352030|NCT01636193|Rotarix|rotarix
352031|NCT01636193|Drug Use Investigation|drug use investigation
352032|NCT01636193|Safety|safety
352033|NCT01636180|STEMI|stemi
352034|NCT01636180|NSTEMI|nstemi
352035|NCT01636180|clopidogrel|clopidogrel
352036|NCT01636180|Areplex|areplex
352037|NCT01636180|REL-0609|rel-0609
352038|NCT01636154|fire-heat syndrome|fire-heat syndrome
352821|NCT01632384|Drug free|drug free
352039|NCT01636154|blood stasis syndrome|blood stasis syndrome
352040|NCT01636154|method of clearing heat|method of clearing heat
352041|NCT01636154|method of promoting blood circulation|method of promoting blood circulation
352042|NCT01636154|medicinal fractions-based herbal combinations|medicinal fractions-based herbal combinations
352043|NCT01636141|Safety|safety
352044|NCT01636141|Tolerability|tolerability
352045|NCT01636141|Pharmacokinetics|pharmacokinetics
352046|NCT01636141|Dose escalation|dose escalation
352047|NCT01636141|Randomized|randomized
352048|NCT01636141|Healthy volunteers|healthy volunteers
352049|NCT01636141|Topical|topical
352050|NCT01636141|OLT1177|olt1177
352051|NCT01636141|Olatec|olatec
352052|NCT01636141|Pain|pain
352053|NCT01636141|Inflammation|inflammation
352054|NCT01636128|Urinary|urinary
352055|NCT01636128|biomarkers|biomarkers
352056|NCT01636128|DFMO|dfmo
352057|NCT01636128|sulindac|sulindac
352058|NCT01636102|Influenza|influenza
352059|NCT01636102|Adults|adults
352060|NCT01636102|Elderly|elderly
352061|NCT01636102|Immunology|immunology
352062|NCT01636102|Safety|safety
352063|NCT01636089|intensive care unit|intensive care unit
352064|NCT01636076|COPD|copd
352065|NCT01636063|Induced Abortion|induced abortion
352066|NCT01636063|Abortion Techniques|abortion techniques
352067|NCT01636063|Mifepristone|mifepristone
352068|NCT01636063|Misoprostol|misoprostol
352069|NCT01636063|Initial Cervical Dilation|initial cervical dilation
352070|NCT01636050|squat exercise|squat exercise
352071|NCT01636037|schizophrenia|schizophrenia
352072|NCT01636037|negative symptoms|negative symptoms
352073|NCT01636037|deficit syndrome|deficit syndrome
352074|NCT01636037|SANS|sans
352075|NCT01636037|Sinemet|sinemet
352076|NCT01636037|L-dopa|l-dopa
352077|NCT01636037|levodopa|levodopa
352078|NCT01636037|carbidopa|carbidopa
352079|NCT01636037|augmentation|augmentation
352080|NCT01636037|antipsychotics|antipsychotics
352081|NCT01636024|Phase 1,|phase 1,
352082|NCT01636024|healthy volunteers,|healthy volunteers,
352083|NCT01636024|safety,|safety,
352084|NCT01636024|tolerability,|tolerability,
352085|NCT01636024|pharmacokinetics,|pharmacokinetics,
352086|NCT01636024|pharmacodynamics,|pharmacodynamics,
352087|NCT01636024|single ascending dose study,|single ascending dose study,
352088|NCT01636024|multiple|multiple
352089|NCT01636011|Parkinson's Disease|parkinson's disease
352090|NCT01636011|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
352091|NCT01636011|Speech|speech
352092|NCT01636011|Pulmonary Function|pulmonary function
352093|NCT01635998|renal sympathetic denervation|renal sympathetic denervation
352094|NCT01635998|renal catheter ablation|renal catheter ablation
352095|NCT01635998|hypertension|hypertension
352096|NCT01635985|Phase I, Healthy male volunteers, pharmacokinetics|phase i, healthy male volunteers, pharmacokinetics
352097|NCT01635972|Isavuconazole|isavuconazole
352098|NCT01635972|Bupropion|bupropion
352099|NCT01635972|Bupropion hydrochloride|bupropion hydrochloride
352100|NCT01635972|Healthy Volunteers|healthy volunteers
352101|NCT01635972|BAL8557|bal8557
352102|NCT01635972|BAL4815|bal4815
352103|NCT01635972|BAL8728|bal8728
352104|NCT01635959|upper gastro-intestinal symptoms, GERD|upper gastro-intestinal symptoms, gerd
352105|NCT01635946|Isavuconazole|isavuconazole
352106|NCT01635946|Atorvastatin|atorvastatin
352107|NCT01635946|Healthy Volunteers|healthy volunteers
352108|NCT01635946|BAL8557|bal8557
352109|NCT01635946|BAL4815|bal4815
352110|NCT01635946|BAL8728|bal8728
352111|NCT01635933|contact lenses|contact lenses
352112|NCT01635933|color contact lenses|color contact lenses
352113|NCT01635933|myopia|myopia
352114|NCT01635920|contact lenses|contact lenses
352115|NCT01635920|color contact lenses|color contact lenses
352116|NCT01635920|myopia|myopia
352117|NCT01635894|female pelvic floor condition|female pelvic floor condition
352118|NCT01635894|pelvic floor training|pelvic floor training
352119|NCT01635894|supervised pelvic floor training|supervised pelvic floor training
352120|NCT01635894|practice nurse|practice nurse
352121|NCT01635894|nurse specialist|nurse specialist
352122|NCT01635842|Patient|patient
352123|NCT01635842|information leaflet|information leaflet
352124|NCT01635842|informed consent|informed consent
352125|NCT01635842|awareness|awareness
352126|NCT01635829|Healthy participants|healthy participants
352127|NCT01635829|Hepatitis C virus|hepatitis c virus
352128|NCT01635829|Telaprevir|telaprevir
352129|NCT01635829|Phenytoin|phenytoin
352130|NCT01635829|Carbamazepine|carbamazepine
352131|NCT01635829|HCV|hcv
352132|NCT01635829|Interaction|interaction
352133|NCT01635816|Immunogenicity|immunogenicity
352134|NCT01635816|SA 14-14-2 JE vaccine|sa 14-14-2 je vaccine
352135|NCT01635816|Bangladesh|bangladesh
352136|NCT01635803|bevacizumab|bevacizumab
352137|NCT01635803|ranibizumab|ranibizumab
352138|NCT01635803|retinal vein occlusions|retinal vein occlusions
352139|NCT01635803|randomized clinical trial|randomized clinical trial
352140|NCT01635803|Macular edema|macular edema
352141|NCT01635790|bevacizumab|bevacizumab
352142|NCT01635790|ranibizumab|ranibizumab
352822|NCT01632384|MRI|mri
352143|NCT01635790|diabetic macular edema|diabetic macular edema
352144|NCT01635790|randomized clinical trial|randomized clinical trial
352145|NCT01635777|PKDL|pkdl
352146|NCT01635777|miltefosine|miltefosine
352147|NCT01635764|hidradenitis suppurativa|hidradenitis suppurativa
352148|NCT01635764|open-label|open-label
352149|NCT01635764|acne inversa|acne inversa
352150|NCT01635764|PIONEER (OPEN-LABEL EXTENSION)|pioneer (open-label extension)
352151|NCT01635764|adalimumab|adalimumab
352152|NCT01635764|HS|hs
352153|NCT01635764|acne|acne
352154|NCT01635764|tumor necrosis factor|tumor necrosis factor
352155|NCT01635764|abscess|abscess
352156|NCT01635764|inflammatory nodule|inflammatory nodule
352157|NCT01635751|Pregabalin|pregabalin
352158|NCT01635751|GLARS|glars
352159|NCT01635738|Probiotics|probiotics
352160|NCT01635738|Lactobacillus paracasei GMNL-133|lactobacillus paracasei gmnl-133
352161|NCT01635738|Lactobacillus fermentum GM-090|lactobacillus fermentum gm-090
352162|NCT01635738|Atopic dermatitis|atopic dermatitis
352163|NCT01635738|Asthma|asthma
352164|NCT01635738|Lactobacillus paracasei|lactobacillus paracasei
352165|NCT01635738|Lactobacillus fermentum|lactobacillus fermentum
352166|NCT01635738|efficacy and safety|efficacy and safety
352167|NCT01635725|colonoscopy|colonoscopy
352168|NCT01635725|bowel cleanliness|bowel cleanliness
352169|NCT01635725|bowel rating scale|bowel rating scale
352170|NCT01635712|Hematological Malignancy|hematological malignancy
352171|NCT01635712|Hsp90|hsp90
352172|NCT01635699|DNA oxidation|dna oxidation
352173|NCT01635699|obstructive sleep apnea|obstructive sleep apnea
352174|NCT01635699|lipid peroxidation|lipid peroxidation
352175|NCT01635699|oxidative stresses|oxidative stresses
352176|NCT01635673|Exercise|exercise
352177|NCT01635673|Latino|latino
352178|NCT01635673|Hispanic|hispanic
352179|NCT01635673|Boys|boys
352180|NCT01635660|Out-of-hospital|out-of-hospital
352181|NCT01635660|airway management|airway management
352182|NCT01635660|intubation|intubation
352183|NCT01635660|video laryngoscope|video laryngoscope
352184|NCT01635634|Fibromyalgia|fibromyalgia
352185|NCT01635634|Cupping|cupping
352186|NCT01635621|Olokizumab|olokizumab
352187|NCT01635621|OKZ|okz
352188|NCT01635621|CDP6038|cdp6038
352189|NCT01635621|Crohn's Disease|crohn's disease
352190|NCT01635621|CDAI|cdai
352191|NCT01635621|IBDQ|ibdq
352192|NCT01635608|Pharmacokinetics|pharmacokinetics
352193|NCT01635608|Talinolol|talinolol
352194|NCT01635608|Amoxicillin|amoxicillin
352195|NCT01635608|Acetaminophen|acetaminophen
352196|NCT01635608|Magnetic Resonance Imaging|magnetic resonance imaging
352197|NCT01635582|Hand exercises|hand exercises
352198|NCT01635582|Hand function|hand function
352199|NCT01635582|Computer based exercises|computer based exercises
352200|NCT01635582|Therapeutic gaming|therapeutic gaming
352201|NCT01635569|Obsessive-compulsive disorder|obsessive-compulsive disorder
352202|NCT01635569|Pediatric|pediatric
352203|NCT01635569|Group-based|group-based
352204|NCT01635569|Cognitive-behavioural therapy|cognitive-behavioural therapy
352205|NCT01635556|borderline personality disorder|borderline personality disorder
352206|NCT01635556|dialectical behavior therapy|dialectical behavior therapy
352207|NCT01635556|psychological treatment|psychological treatment
352208|NCT01635517|Diuretics|diuretics
352209|NCT01635517|Vasopressins|vasopressins
352210|NCT01635517|Sodium|sodium
352211|NCT01635504|HIV lipoatrophy|hiv lipoatrophy
352212|NCT01635504|masseter hypertrophy|masseter hypertrophy
352213|NCT01635504|parotid enlargement|parotid enlargement
352214|NCT01635504|botulinum toxin|botulinum toxin
352215|NCT01635491|Gastrointestinal Motility|gastrointestinal motility
352216|NCT01635491|Transit time|transit time
352217|NCT01635426|Aspirin|aspirin
352218|NCT01635426|Clopidogrel|clopidogrel
352219|NCT01635426|Unexplained recurrent pregnancy loss|unexplained recurrent pregnancy loss
352220|NCT01635426|Uterine artery pulsatility index|uterine artery pulsatility index
352221|NCT01635400|Irinotecan|irinotecan
352222|NCT01635400|UGT1A1 Gene Polymorphisms|ugt1a1 gene polymorphisms
352223|NCT01635400|Small Cell Carcinoma of Lung|small cell carcinoma of lung
352224|NCT01635348|gait speed|gait speed
352225|NCT01635348|cognitive processing speed|cognitive processing speed
352226|NCT01635335|HIV prevention|hiv prevention
352227|NCT01635335|adolescents|adolescents
352228|NCT01635335|Latinos|latinos
352229|NCT01635335|Hispanics|hispanics
352230|NCT01635335|family|family
352231|NCT01635335|health promotion|health promotion
352232|NCT01635335|disease prevention|disease prevention
352233|NCT01635335|family communication|family communication
352234|NCT01635335|parental supervision|parental supervision
352235|NCT01635322|deformity|deformity
352236|NCT01635322|adult|adult
352237|NCT01635322|lumbar|lumbar
352238|NCT01635322|thoraco-lumbar|thoraco-lumbar
352239|NCT01635322|Sagittal vertebral Alignement (SVA)|sagittal vertebral alignement (sva)
352240|NCT01635322|Oswestry Disability Index (ODI)|oswestry disability index (odi)
352241|NCT01635257|pulmonary embolism diagnosis|pulmonary embolism diagnosis
352242|NCT01635257|ultrasound|ultrasound
352243|NCT01635244|Aortic valve prosthesis|aortic valve prosthesis
353016|NCT01631487|Healthy|healthy
352244|NCT01635244|Aortic valve hemodynamics|aortic valve hemodynamics
352245|NCT01635244|Prosthesis-patient mismatch|prosthesis-patient mismatch
352246|NCT01635244|Left ventricular diastolic function|left ventricular diastolic function
352247|NCT01635244|Left ventricular remodeling|left ventricular remodeling
352248|NCT01635231|Nephrology|nephrology
352249|NCT01635231|sodium-channels|sodium-channels
352250|NCT01635231|water-channels|water-channels
352251|NCT01635231|BCM|bcm
352252|NCT01635231|central blood pressure|central blood pressure
352253|NCT01635218|Depression|depression
352254|NCT01635218|Perimenopause|perimenopause
352255|NCT01635218|Postmenopause|postmenopause
352256|NCT01635218|Homeopathy|homeopathy
352257|NCT01635205|Paraspinous block|paraspinous block
352258|NCT01635205|Non-responsive chronic pelvic pain|non-responsive chronic pelvic pain
352259|NCT01635192|renin|renin
352260|NCT01635192|angiotensin|angiotensin
352261|NCT01635192|probiotic|probiotic
352262|NCT01635192|glucose absorption|glucose absorption
352263|NCT01635192|intestinal|intestinal
352264|NCT01635179|Videolaryngoscopy|videolaryngoscopy
352265|NCT01635179|Bronchial Aspiration|bronchial aspiration
352266|NCT01635179|Hypoxia|hypoxia
352267|NCT01635166|Arthroplasty|arthroplasty
352268|NCT01635166|Replacement|replacement
352269|NCT01635166|Hip|hip
352270|NCT01635166|Cementless|cementless
352271|NCT01635166|Ceramic on Ceramic|ceramic on ceramic
352272|NCT01635153|HIV|hiv
352273|NCT01635153|Tuberculosis|tuberculosis
352274|NCT01635153|Nutrition|nutrition
352275|NCT01635140|DIPG|dipg
352276|NCT01635140|Hypofractionated Radiotherapy|hypofractionated radiotherapy
352277|NCT01635140|Radiotherapy|radiotherapy
352278|NCT01635140|Median survival|median survival
352279|NCT01635101|Moderate to severe acute pain following surgery or trauma|moderate to severe acute pain following surgery or trauma
352280|NCT01635088|Asthma|asthma
352281|NCT01635088|FEV1 and IOS change after mometasone for asthma|fev1 and ios change after mometasone for asthma
352282|NCT01635075|psychiatric|psychiatric
352283|NCT01635075|comorbidity|comorbidity
352284|NCT01635075|craving|craving
352285|NCT01635075|tobacco|tobacco
352286|NCT01635049|in vitro fertilization|in vitro fertilization
352287|NCT01635049|assisted reproduction techniques|assisted reproduction techniques
352288|NCT01635049|noninvasive imaging of embryos|noninvasive imaging of embryos
352289|NCT01635049|time lapse imaging of embryos|time lapse imaging of embryos
352290|NCT01635049|traditional morphological grading of embryos|traditional morphological grading of embryos
352291|NCT01635049|prediction of blastocysts|prediction of blastocysts
352292|NCT01635049|infertility|infertility
352293|NCT01635049|preimplantation genetic diagnosis|preimplantation genetic diagnosis
352294|NCT01635049|comprehensive chromosome screening|comprehensive chromosome screening
352295|NCT01635036|in vitro fertilization|in vitro fertilization
352296|NCT01635036|assisted reproduction techniques|assisted reproduction techniques
352297|NCT01635036|noninvasive imaging of embryos|noninvasive imaging of embryos
352298|NCT01635036|time lapse imaging of embryos|time lapse imaging of embryos
352299|NCT01635036|traditional morphological grading of embryos|traditional morphological grading of embryos
352300|NCT01635036|prediction of blastocyst formation|prediction of blastocyst formation
352301|NCT01635036|infertility|infertility
352302|NCT01635036|male factor female factor|male factor female factor
352303|NCT01635036|embryo viability|embryo viability
352304|NCT01635023|Phase I|phase i
352305|NCT01635023|healthy volunteers|healthy volunteers
352306|NCT01635023|AZD6244|azd6244
352307|NCT01635023|pharmacokinetics|pharmacokinetics
352308|NCT01635023|AUC|auc
352309|NCT01635023|Cmax|cmax
352310|NCT01635023|tmax|tmax
352311|NCT01635023|AUC(0-t)|auc(0-t)
352312|NCT01635010|obstructive sleep apnea|obstructive sleep apnea
352313|NCT01635010|inflammation|inflammation
352314|NCT01635010|oxidative stress|oxidative stress
352315|NCT01635010|arterial stiffness|arterial stiffness
352316|NCT01634997|Screening for Type 2 Diabetes|screening for type 2 diabetes
352317|NCT01634984|expression of CDK5RAP2|expression of cdk5rap2
352318|NCT01634971|Postoperative pancreatic fistula(POPF);|postoperative pancreatic fistula(popf);
352319|NCT01634971|Postpancreatectomy hemorrhage(PPH);|postpancreatectomy hemorrhage(pph);
352320|NCT01634971|Delayed gastric emptying (DGE);|delayed gastric emptying (dge);
352321|NCT01634971|Bile leakage after pancreatic surgery;|bile leakage after pancreatic surgery;
352322|NCT01634971|Anastomotic leakage|anastomotic leakage
352323|NCT01634958|Allergic Rhinitis|allergic rhinitis
352324|NCT01634958|Hayfever|hayfever
352325|NCT01634958|Immunotherapy|immunotherapy
352326|NCT01634958|Dose-Finding-Study|dose-finding-study
352327|NCT01634945|anemia|anemia
352328|NCT01634945|malaria|malaria
352329|NCT01634945|malnutrition|malnutrition
352330|NCT01634945|iron fortification|iron fortification
352331|NCT01634945|intermittent preventive treatment|intermittent preventive treatment
352332|NCT01634945|subsaharan africa|subsaharan africa
352333|NCT01634945|ivory coast|ivory coast
352334|NCT01634945|young children|young children
352335|NCT01634932|Iron deficiency|iron deficiency
352336|NCT01634932|Biofortification|biofortification
352337|NCT01634932|Pearl Millet|pearl millet
352338|NCT01634932|Benin|benin
352339|NCT01634919|Chronic hepatitis C|chronic hepatitis c
352340|NCT01634919|Liver fibrosis|liver fibrosis
352341|NCT01634919|ARFI(Acoustic radiation force impulse)|arfi(acoustic radiation force impulse)
352342|NCT01634906|Apolipoprotein B, erythrocytes, statins|apolipoprotein b, erythrocytes, statins
352343|NCT01634893|Refractory or Relapsed Solid Tumors|refractory or relapsed solid tumors
352344|NCT01634880|Salivary Gland Malignancies|salivary gland malignancies
352345|NCT01634880|Panitumumab|panitumumab
352346|NCT01634880|Postoperative|postoperative
352347|NCT01634880|Radiotherapy|radiotherapy
352348|NCT01634841|walnuts|walnuts
352349|NCT01634841|age related cognitive decline|age related cognitive decline
352350|NCT01634841|age related macular degeneration|age related macular degeneration
352351|NCT01634841|healthy elderly subjects|healthy elderly subjects
352352|NCT01634802|Clinical Decision Support Systems|clinical decision support systems
352353|NCT01634802|Electronic Medical Record|electronic medical record
352354|NCT01634802|Resource constrained countries|resource constrained countries
352355|NCT01634802|HIV|hiv
352356|NCT01634789|bioavailability|bioavailability
352357|NCT01634763|Phase I, open-label, dose escalation, oral LDK378, Japanese patients with tumors characterized by ALK genetic alterations|phase i, open-label, dose escalation, oral ldk378, japanese patients with tumors characterized by alk genetic alterations
352358|NCT01634750|N-Acetyl-D-mannosamine (ManNAc)|n-acetyl-d-mannosamine (mannac)
352359|NCT01634750|HIBM|hibm
352360|NCT01634750|GNE Myopathy|gne myopathy
352361|NCT01634737|shellfish|shellfish
352362|NCT01634737|tropomyosin|tropomyosin
352363|NCT01634737|mites|mites
352364|NCT01634737|food allergy|food allergy
352365|NCT01634724|GnRH agonist withdrawal|gnrh agonist withdrawal
352366|NCT01634724|OHSS|ohss
352367|NCT01634724|E2|e2
352368|NCT01634724|VEGF|vegf
352369|NCT01634711|ACL|acl
352370|NCT01634711|Anterior Cruciate Ligament|anterior cruciate ligament
352371|NCT01634711|Ligament|ligament
352372|NCT01634711|Resorbable polymer|resorbable polymer
352373|NCT01634711|Knee ligament|knee ligament
352374|NCT01634698|chronic liver disease|chronic liver disease
352375|NCT01634698|cirrhosis|cirrhosis
352376|NCT01634698|vitamin A|vitamin a
352377|NCT01634698|RDR test|rdr test
352378|NCT01634698|retinol-binding protein|retinol-binding protein
352379|NCT01634685|Rectal cancer|rectal cancer
352380|NCT01634685|Bavituximab|bavituximab
352381|NCT01634685|Capecitabine|capecitabine
352382|NCT01634685|Radiation Therapy|radiation therapy
352383|NCT01634672|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
352384|NCT01634672|peritoneal dialysis|peritoneal dialysis
352385|NCT01634672|hemodialysis|hemodialysis
352386|NCT01634659|contact lenses|contact lenses
352387|NCT01634659|myopia|myopia
352388|NCT01634646|Observational study|observational study
352389|NCT01634633|Endometrial nerve fibres|endometrial nerve fibres
352390|NCT01634620|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
352391|NCT01634620|Chronic Obstructive Airways Disease|chronic obstructive airways disease
352392|NCT01634620|Chronic Bronchitis|chronic bronchitis
352393|NCT01634620|Chronic Emphysema|chronic emphysema
352394|NCT01634620|Asthma|asthma
352395|NCT01634607|osteopenia|osteopenia
352396|NCT01634607|vitamin D deficiency|vitamin d deficiency
352397|NCT01634607|HIV-infected patients|hiv-infected patients
352398|NCT01634607|bone health|bone health
352399|NCT01634607|Bone mineral density (BMD)|bone mineral density (bmd)
352400|NCT01634607|HIV-uninfected patients|hiv-uninfected patients
352401|NCT01634607|effects of TDF on the patients' bone|effects of tdf on the patients' bone
352402|NCT01634594|Deliberate hypotension, QTc, Tp-e, heart rate variability|deliberate hypotension, qtc, tp-e, heart rate variability
352403|NCT01634555|Advanced Malignant Solid Tumors|advanced malignant solid tumors
352404|NCT01634516|Diet|diet
352405|NCT01634516|Pregnant|pregnant
352406|NCT01634503|3+3 design|3+3 design
352407|NCT01634503|Phase 1|phase 1
352408|NCT01634503|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
352409|NCT01634503|Adult|adult
352410|NCT01634503|Safety|safety
352411|NCT01634503|Dose Finding|dose finding
352412|NCT01634490|cow's milk allergy|cow's milk allergy
352413|NCT01634490|formulas|formulas
352414|NCT01634490|probiotics|probiotics
352415|NCT01634477|morbidity|morbidity
352416|NCT01634477|mortality|mortality
352417|NCT01634477|HIV-infected patients|hiv-infected patients
352418|NCT01634477|prospective cohort study|prospective cohort study
352419|NCT01634477|highly active antiretroviral therapy (HAART)|highly active antiretroviral therapy (haart)
352420|NCT01634477|opportunistic infections|opportunistic infections
352421|NCT01634477|Non HIV-related illness|non hiv-related illness
352422|NCT01634477|cardiovascular disease (CVD)|cardiovascular disease (cvd)
352423|NCT01634477|HIV negative patients|hiv negative patients
352424|NCT01634477|Thai HIV-infected patients|thai hiv-infected patients
352425|NCT01634451|Sedation|sedation
352426|NCT01634451|Quality|quality
352427|NCT01634438|coronary angiography|coronary angiography
352428|NCT01634425|NSTEMI|nstemi
352429|NCT01634425|Point of Care Biomarkers|point of care biomarkers
352430|NCT01634334|Secondhand smoke|secondhand smoke
352431|NCT01634295|CKD-828|ckd-828
352432|NCT01634295|Hypertension|hypertension
352433|NCT01634295|Stage 2 Hypertension|stage 2 hypertension
352434|NCT01634295|S-Amlodipine|s-amlodipine
352435|NCT01634295|Telmisartan|telmisartan
352436|NCT01634269|Valvular Heart Disease|valvular heart disease
352437|NCT01634269|Severe Aortic Stenosis|severe aortic stenosis
352438|NCT01634269|Aortic Valve Replacement|aortic valve replacement
352439|NCT01634243|SPM 962|spm 962
352440|NCT01634243|rotigotine|rotigotine
352441|NCT01634243|Parkinson's disease|parkinson's disease
352442|NCT01634204|weight reduction|weight reduction
352443|NCT01634204|web-based intervention|web-based intervention
352444|NCT01634204|cost-effective|cost-effective
352445|NCT01634204|overweight|overweight
352446|NCT01634204|obesity|obesity
352447|NCT01634204|cardiovascular risk|cardiovascular risk
352448|NCT01634191|Apremilast|apremilast
352449|NCT01634191|pharmacokinetic|pharmacokinetic
352450|NCT01634191|safety|safety
352451|NCT01634191|Pharmacokinetics and safety in healthy volunteer subjects|pharmacokinetics and safety in healthy volunteer subjects
352452|NCT01634178|Apremilast,|apremilast,
352453|NCT01634178|pharmacokinetic|pharmacokinetic
352454|NCT01634178|safety|safety
352455|NCT01634178|Safety and pharmacokinetics in healthy volunteer subjects|safety and pharmacokinetics in healthy volunteer subjects
352456|NCT01634126|Colon|colon
352457|NCT01634126|Rectal|rectal
352458|NCT01634126|Cancer|cancer
352459|NCT01634126|Screening|screening
352461|NCT01634126|Fecal|fecal
352462|NCT01634061|Castration-resistant prostate cancer, abiraterone acetate, BEZ235, BKM120, dose escalation, abiraterone acetate failure|castration-resistant prostate cancer, abiraterone acetate, bez235, bkm120, dose escalation, abiraterone acetate failure
352463|NCT01634048|high protein diet|high protein diet
352464|NCT01634048|meal replacements|meal replacements
352465|NCT01634048|low calorie diet|low calorie diet
352466|NCT01634048|intra hepatocellular lipid|intra hepatocellular lipid
352467|NCT01634035|glycated hemoglobin|glycated hemoglobin
352468|NCT01634035|mean plasma glucose|mean plasma glucose
352469|NCT01634022|Acupuncture|acupuncture
352470|NCT01634022|Antidepressant|antidepressant
352471|NCT01634022|Monotherapy|monotherapy
352472|NCT01634022|Depression|depression
352473|NCT01634022|Alternative treatments|alternative treatments
352474|NCT01634009|Severe acute malnutrition|severe acute malnutrition
352475|NCT01634009|Ready to use therapeutic food|ready to use therapeutic food
352476|NCT01634009|Soy protein|soy protein
352477|NCT01634009|Community based management|community based management
352478|NCT01634009|Efficacy|efficacy
352479|NCT01634009|Management of Children with SAM in Bangladesh|management of children with sam in bangladesh
352480|NCT01633996|Acupuncture|acupuncture
352481|NCT01633996|Antidepressant|antidepressant
352482|NCT01633996|Augmentation|augmentation
352483|NCT01633996|Depression|depression
352484|NCT01633983|Central Serous Chorioretinopathy|central serous chorioretinopathy
352485|NCT01633983|Methotrexate|methotrexate
352486|NCT01633957|anticoagulation|anticoagulation
352487|NCT01633957|bleeding|bleeding
352488|NCT01633957|CYP2C9|cyp2c9
352489|NCT01633957|CYP4F2|cyp4f2
352490|NCT01633957|VKORC1|vkorc1
352491|NCT01633957|warfarin dosing|warfarin dosing
352492|NCT01633957|Heart Valve Diseases|heart valve diseases
352493|NCT01633957|pharmacogenomics|pharmacogenomics
352494|NCT01633944|CLBP|clbp
352495|NCT01633944|Chronic Low Back Pain|chronic low back pain
352496|NCT01633944|Chronic Pain|chronic pain
352497|NCT01633944|Back Pain|back pain
352498|NCT01633918|intervention|intervention
352499|NCT01633918|health education|health education
352500|NCT01633918|physical activity|physical activity
352501|NCT01633918|sedentary behavior|sedentary behavior
352502|NCT01633918|health promotion|health promotion
352503|NCT01633918|evaluation|evaluation
352504|NCT01633918|RE-AIM|re-aim
352505|NCT01633905|alcohol-dependence|alcohol-dependence
352506|NCT01633905|event-related potentials|event-related potentials
352507|NCT01633905|emotion|emotion
352508|NCT01633905|crossmodal|crossmodal
352509|NCT01633905|peripheral processing|peripheral processing
352510|NCT01633892|Craniomaxillofacial (CMF)|craniomaxillofacial (cmf)
352511|NCT01633892|Battle-injured (BI)|battle-injured (bi)
352512|NCT01633892|Facial Trauma|facial trauma
352513|NCT01633892|Fat Grafts|fat grafts
352514|NCT01633892|Autogenous Fat Transfers (AFT)|autogenous fat transfers (aft)
352515|NCT01633892|Wounded warriors|wounded warriors
352516|NCT01633892|Adipose Tissue|adipose tissue
352517|NCT01633879|parenting, prevention, HIV/AIDS, adolescents, Latino|parenting, prevention, hiv/aids, adolescents, latino
352518|NCT01633866|Magnetic Resonance Imaging|magnetic resonance imaging
352519|NCT01633853|chronic kidney disease mineral and bone disorder|chronic kidney disease mineral and bone disorder
352520|NCT01633853|vitamin D2|vitamin d2
352521|NCT01633853|parathyroid hormone|parathyroid hormone
352522|NCT01633840|double-blind placebo-controlled food challenges|double-blind placebo-controlled food challenges
352523|NCT01633840|food allergy|food allergy
352524|NCT01633840|food hypersensitivity|food hypersensitivity
352525|NCT01633840|triangle test|triangle test
352526|NCT01633840|validated recipes|validated recipes
352527|NCT01633814|Physiological Processes|physiological processes
352528|NCT01633814|Exercise|exercise
352529|NCT01633814|Hormone replacement therapy|hormone replacement therapy
353406|NCT01629602|defect;|defect;
352530|NCT01633775|Refractory primary open angle glaucoma|refractory primary open angle glaucoma
352531|NCT01633775|trabeculectomy|trabeculectomy
352532|NCT01633775|ahmed valve implant|ahmed valve implant
352533|NCT01633749|Influenza|influenza
352534|NCT01633749|Vaccine|vaccine
352535|NCT01633749|CHMP criteria|chmp criteria
352536|NCT01633736|single blinded|single blinded
352537|NCT01633736|randomised|randomised
352538|NCT01633736|controlled|controlled
352539|NCT01633736|physiotherapy|physiotherapy
352540|NCT01633736|children|children
352541|NCT01633736|cerebral palsy|cerebral palsy
352542|NCT01633710|Ankle brachial pressure index|ankle brachial pressure index
352543|NCT01633710|Colour duplex ultrasound|colour duplex ultrasound
352544|NCT01633710|Diabetes|diabetes
352545|NCT01633710|Photoplethysmography|photoplethysmography
352546|NCT01633697|emphysema|emphysema
352547|NCT01633697|chronic bronchitis|chronic bronchitis
352548|NCT01633684|diabetes mellitus|diabetes mellitus
352549|NCT01633684|bone|bone
352550|NCT01633671|Misadventures to Patients During Surgical and Medical Care|misadventures to patients during surgical and medical care
352551|NCT01633671|Pulmonary Embolism Without Acute Cor Pulmonale|pulmonary embolism without acute cor pulmonale
352552|NCT01633671|Pulmonary Embolism Without Mention of Acute Cor Pulmonale|pulmonary embolism without mention of acute cor pulmonale
352553|NCT01633658|vitamin D|vitamin d
352554|NCT01633632|Smoking cessation|smoking cessation
352555|NCT01633632|Yoga|yoga
352556|NCT01633632|Cognitive behavioral therapy|cognitive behavioral therapy
352557|NCT01633619|Prosthetic Joint Infection|prosthetic joint infection
352558|NCT01633606|severity of illness|severity of illness
352559|NCT01633606|scoring|scoring
352560|NCT01633606|medium care|medium care
352561|NCT01633606|intensive care|intensive care
352562|NCT01633606|staffing|staffing
352563|NCT01633580|ICSI|icsi
352564|NCT01633580|GnRH antagonist|gnrh antagonist
352565|NCT01633580|corifollitropin alfa|corifollitropin alfa
352566|NCT01633567|Smoking Cessation|smoking cessation
352567|NCT01633567|Cigarette Smoking|cigarette smoking
352568|NCT01633567|Tobacco|tobacco
352569|NCT01633567|LGBT|lgbt
352570|NCT01633567|LGBTQ|lgbtq
352571|NCT01633554|ST-2, IL-33, prediction, fibrosis, hepatitis B|st-2, il-33, prediction, fibrosis, hepatitis b
352572|NCT01633528|low dose aspirin endometrial thickness pregnancy rate ICSI IVF embryo transfer|low dose aspirin endometrial thickness pregnancy rate icsi ivf embryo transfer
352573|NCT01633515|Basal cell carcinoma (BCC)|basal cell carcinoma (bcc)
352574|NCT01633515|Cryotherapy|cryotherapy
352575|NCT01633515|Cryosurgery|cryosurgery
352576|NCT01633476|CMV|cmv
352577|NCT01633476|ANCA associated vasculitis|anca associated vasculitis
352578|NCT01633476|CD4+CD28- T-cells|cd4+cd28- t-cells
352579|NCT01633476|Valaciclovir|valaciclovir
352580|NCT01633463|EMERGENCY CANCER PAIN, ASSESSMENT, TREATMENT ADEQUACY.|emergency cancer pain, assessment, treatment adequacy.
352581|NCT01633437|tyramine|tyramine
352582|NCT01633437|MAOI|maoi
352583|NCT01633437|cheese effect|cheese effect
352584|NCT01633437|depression|depression
352585|NCT01633398|Heart Failure|heart failure
352586|NCT01633398|HF|hf
352587|NCT01633385|bronchial inflammation|bronchial inflammation
352588|NCT01633385|Bronchiolitis obliterans|bronchiolitis obliterans
352589|NCT01633385|Sputum|sputum
352590|NCT01633385|Blood|blood
352591|NCT01633385|Inflammation|inflammation
352592|NCT01633385|adaptive immune system|adaptive immune system
352593|NCT01633385|innate immune system|innate immune system
352594|NCT01633372|Primary Myelofibrosis|primary myelofibrosis
352595|NCT01633372|PMF|pmf
352596|NCT01633372|Post Polycythemia Vera Fibrosis|post polycythemia vera fibrosis
352597|NCT01633372|PPV-MF|ppv-mf
352598|NCT01633372|Post Essential Thrombocythemia Myelofibrosis|post essential thrombocythemia myelofibrosis
352599|NCT01633372|PET-MF|pet-mf
352600|NCT01633333|Colonoscopy|colonoscopy
352601|NCT01633333|Colorectal cancer|colorectal cancer
352602|NCT01633333|Colorectal adenomas|colorectal adenomas
352603|NCT01633333|Pain|pain
352604|NCT01633320|Analgesia/Nociception index|analgesia/nociception index
352605|NCT01633307|education|education
352606|NCT01633307|intravenous infusion|intravenous infusion
352607|NCT01633294|premature rupture of membranes|premature rupture of membranes
352608|NCT01633294|term pregnancy|term pregnancy
352609|NCT01633294|chorioamnionitis|chorioamnionitis
352610|NCT01633294|endometritis|endometritis
352611|NCT01633294|neonatal sepsis|neonatal sepsis
352612|NCT01633294|antibiotic prophylaxis|antibiotic prophylaxis
352613|NCT01633281|peripheral neuropathy|peripheral neuropathy
352614|NCT01633281|acupuncture|acupuncture
352615|NCT01633281|Bortezomib|bortezomib
352616|NCT01633281|Thalidomide|thalidomide
352617|NCT01633268|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
352618|NCT01633268|Traumatic Brain Injury|traumatic brain injury
352619|NCT01633255|Anti-Angiogenic|anti-angiogenic
352620|NCT01633255|Dynamic Contrast Enhanced Magnetic Resonance Imaging|dynamic contrast enhanced magnetic resonance imaging
352621|NCT01633255|PET/CT Imaging Studies|pet/ct imaging studies
352622|NCT01633242|MRI|mri
352623|NCT01633242|Muscular Dystrophy|muscular dystrophy
352624|NCT01633242|Cardiac|cardiac
352625|NCT01633242|Myocardium|myocardium
354814|NCT01623531|Fibrinogen|fibrinogen
352626|NCT01633242|Intramyocardial fat|intramyocardial fat
352627|NCT01633229|Immune Suppression|immune suppression
352628|NCT01633229|BMSC|bmsc
352629|NCT01633229|GVHD|gvhd
352630|NCT01633229|Marrow Failure|marrow failure
352631|NCT01633229|Regimen Related Toxicity|regimen related toxicity
352632|NCT01633229|Graft-Versus-Host Disease|graft-versus-host disease
352633|NCT01633216|poliovirus,|poliovirus,
352634|NCT01633216|trivalent oral polio vaccine,|trivalent oral polio vaccine,
352635|NCT01633216|bivalent oral polio vaccine,|bivalent oral polio vaccine,
352636|NCT01633216|monovalent oral polio vaccine|monovalent oral polio vaccine
352637|NCT01633203|gastric cancer|gastric cancer
352638|NCT01633203|combination chemotherapy|combination chemotherapy
352639|NCT01633203|HER-2 gene|her-2 gene
352640|NCT01633203|quality of life|quality of life
352641|NCT01633190|Surveillance|surveillance
352642|NCT01633190|Rotavirus|rotavirus
352643|NCT01633190|Gastroenteritis|gastroenteritis
352644|NCT01633177|vitamin D|vitamin d
352645|NCT01633177|omega-3 fatty acids|omega-3 fatty acids
352646|NCT01633177|Type 2 diabetes|type 2 diabetes
352647|NCT01633177|Oral glucose tolerance test (OGTT)|oral glucose tolerance test (ogtt)
352648|NCT01633177|Insulin sensitivity|insulin sensitivity
352649|NCT01633177|Beta-cell function|beta-cell function
352650|NCT01633164|Spinal Cord Injury|spinal cord injury
352651|NCT01633164|Self-Efficacy|self-efficacy
352652|NCT01633164|Life Satisfaction|life satisfaction
352653|NCT01633164|Community Participation|community participation
352654|NCT01633138|cognitive remediation therapy|cognitive remediation therapy
352655|NCT01633138|substance abuse treatment|substance abuse treatment
352656|NCT01633125|Group music therapy|group music therapy
352657|NCT01633125|prisoners|prisoners
352658|NCT01633125|Anxiety|anxiety
352659|NCT01633125|Depression|depression
352660|NCT01633125|Self-esteem|self-esteem
352661|NCT01633099|decitabine|decitabine
352662|NCT01633099|acute myeloid leukemia|acute myeloid leukemia
352663|NCT01633099|elderly patient|elderly patient
352664|NCT01633060|BKM120|bkm120
352665|NCT01633060|fulvestrant|fulvestrant
352666|NCT01633060|breast cancer|breast cancer
352667|NCT01633060|metastatic|metastatic
352668|NCT01633060|locally advanced|locally advanced
352669|NCT01633060|AI treated|ai treated
352670|NCT01633060|mTOR inhibitor|mtor inhibitor
352671|NCT01633060|PI3K|pi3k
352672|NCT01633060|PIK3CA|pik3ca
352673|NCT01633060|PTEN|pten
352674|NCT01633060|HER2-|her2-
352675|NCT01633060|HR+|hr+
352676|NCT01633047|Anterior Cruciate Ligament|anterior cruciate ligament
352677|NCT01633047|Electric Stimulation Therapy|electric stimulation therapy
352678|NCT01633034|intervertebral disc degeneration|intervertebral disc degeneration
352679|NCT01633034|back pain|back pain
352680|NCT01633034|spine surgery|spine surgery
352681|NCT01633021|Family Study|family study
352682|NCT01633021|Social Networks|social networks
352683|NCT01633021|Diabetes|diabetes
352684|NCT01633008|Modified Brief Pain Inventory|modified brief pain inventory
352685|NCT01633008|Quality of Life|quality of life
352686|NCT01633008|Pain-Related Coping|pain-related coping
352687|NCT01633008|Pain-Related Anxiety|pain-related anxiety
352688|NCT01633008|Depression|depression
352689|NCT01632982|opioid abuse|opioid abuse
352690|NCT01632982|substance abuse|substance abuse
352691|NCT01632982|methadone maintenance treatment|methadone maintenance treatment
352692|NCT01632982|mobile technology|mobile technology
352693|NCT01632982|technology-based intervention|technology-based intervention
352694|NCT01632982|behavioral intervention|behavioral intervention
352695|NCT01632982|psychosocial treatment|psychosocial treatment
352696|NCT01632969|12-136|12-136
352697|NCT01632956|Support Groups|support groups
352698|NCT01632956|Breast cancer|breast cancer
352699|NCT01632956|Mandarin speaking|mandarin speaking
352700|NCT01632956|12-105|12-105
352701|NCT01632943|Uncontrolled Hypertension|uncontrolled hypertension
352702|NCT01632930|diagnosis|diagnosis
352703|NCT01632930|prostate cancer|prostate cancer
352704|NCT01632930|urine|urine
352705|NCT01632930|medical economics|medical economics
352706|NCT01632917|Healthy volunteers|healthy volunteers
352707|NCT01632904|Polycythemia Vera|polycythemia vera
352708|NCT01632904|PV|pv
352709|NCT01632878|Secondary prevention post MI|secondary prevention post mi
352710|NCT01632865|occlusion|occlusion
352711|NCT01632865|recanalization|recanalization
352712|NCT01632865|stenting|stenting
352713|NCT01632839|PISQ-R|pisq-r
352714|NCT01632839|new sexuality questionnaire|new sexuality questionnaire
352715|NCT01632826|Relapsed|relapsed
352716|NCT01632826|refractory multiple myeloma|refractory multiple myeloma
352717|NCT01632826|pomalidomide|pomalidomide
352718|NCT01632813|neurocognitive testing|neurocognitive testing
352719|NCT01632813|critical illness|critical illness
352720|NCT01632813|executive function|executive function
352721|NCT01632813|intelligence|intelligence
352722|NCT01632800|Magnetic fields discomfort|magnetic fields discomfort
352723|NCT01632787|Anxiety|anxiety
352724|NCT01632787|Binocular|binocular
352725|NCT01632787|Chronic Headache|chronic headache
352726|NCT01632787|Dizziness|dizziness
355127|NCT01621958|plasticity|plasticity
352727|NCT01632787|Vertical Heterophoria|vertical heterophoria
352728|NCT01632787|Vision Dysfunction|vision dysfunction
352729|NCT01632761|anemia|anemia
352730|NCT01632761|vitamin D3|vitamin d3
352731|NCT01632761|omega-3 fatty acids|omega-3 fatty acids
352732|NCT01632761|fish oil|fish oil
352733|NCT01632761|primary prevention|primary prevention
352734|NCT01632735|Continuing Care|continuing care
352735|NCT01632735|Youth Substance Abuse|youth substance abuse
352736|NCT01632735|Recovery Support|recovery support
352737|NCT01632735|Mobile Texting|mobile texting
352738|NCT01632722|colorectal cancer, liver metastasis, bevacizumab, perioperative/postoperative chemotherapy|colorectal cancer, liver metastasis, bevacizumab, perioperative/postoperative chemotherapy
352739|NCT01632696|Antibodies, Monoclonal|antibodies, monoclonal
352740|NCT01632696|Biologics|biologics
352741|NCT01632696|F(ab')2|f(ab')2
352742|NCT01632696|Positron-emission tomography (PET)|positron-emission tomography (pet)
352743|NCT01632696|Phosphatidylserine (PS)|phosphatidylserine (ps)
352744|NCT01632696|Solid Tumors|solid tumors
352745|NCT01632696|Tumor Imaging|tumor imaging
352746|NCT01632683|difficult airway|difficult airway
352747|NCT01632683|video laryngoscopy|video laryngoscopy
352748|NCT01632670|music|music
352749|NCT01632670|cardiac catheterization|cardiac catheterization
352750|NCT01632670|endothelial function|endothelial function
352751|NCT01632631|suitable for endovascular exclusion|suitable for endovascular exclusion
352752|NCT01632605|ADPKD|adpkd
352753|NCT01632605|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
352754|NCT01632605|Sirolimus|sirolimus
352755|NCT01632605|Rapamune|rapamune
352756|NCT01632605|Polycystic liver disease|polycystic liver disease
352757|NCT01632605|Rapamycin|rapamycin
352758|NCT01632605|Mammalian target of rapamycin|mammalian target of rapamycin
352759|NCT01632605|m-TOR|m-tor
352760|NCT01632605|m-TOR inhibition|m-tor inhibition
352761|NCT01632553|Observation|observation
352762|NCT01632553|Domestic Violence|domestic violence
352763|NCT01632553|Partner Abuse|partner abuse
352764|NCT01632553|Spousal Abuse|spousal abuse
352765|NCT01632553|Battered Women|battered women
352766|NCT01632553|Abused Women|abused women
352767|NCT01632553|Cortisol|cortisol
352768|NCT01632553|Mental Health|mental health
352769|NCT01632553|Depression|depression
352770|NCT01632553|Anxiety|anxiety
352771|NCT01632553|Posttraumatic Stress Disorders|posttraumatic stress disorders
352772|NCT01632527|Age-Related Macular Degeneration|age-related macular degeneration
352773|NCT01632527|Dry AMD with GA|dry amd with ga
352774|NCT01632527|Geographic Atrophy of Age-Related Macular Degeneration|geographic atrophy of age-related macular degeneration
352775|NCT01632527|Stem Cell Transplantation|stem cell transplantation
352776|NCT01632527|Stem Cell transplant|stem cell transplant
352777|NCT01632527|Stem cells for AMD|stem cells for amd
352778|NCT01632527|Human neural stem cells|human neural stem cells
352779|NCT01632527|multipotent stem cells|multipotent stem cells
352780|NCT01632527|Macular Degeneration|macular degeneration
352781|NCT01632527|Dry AMD|dry amd
352782|NCT01632527|Human central nervous system stemcells|human central nervous system stemcells
352783|NCT01632527|dry age-related macular degeneration|dry age-related macular degeneration
352784|NCT01632514|hypocalcemia|hypocalcemia
352785|NCT01632514|vitamin D deficiency|vitamin d deficiency
352786|NCT01632514|cholecalciferol|cholecalciferol
352787|NCT01632514|thyroidectomy|thyroidectomy
352788|NCT01632488|Irritable Bowel Syndrome|irritable bowel syndrome
352789|NCT01632488|Inflammatory Bowel Disease|inflammatory bowel disease
352790|NCT01632488|Confocal Laser Endomicroscopy|confocal laser endomicroscopy
352791|NCT01632475|Human umbilical cord blood-derived mesenchymal stem cells|human umbilical cord blood-derived mesenchymal stem cells
352792|NCT01632475|Premature infants|premature infants
352793|NCT01632475|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
352794|NCT01632475|Lung injury|lung injury
352795|NCT01632475|Lung diseases|lung diseases
352796|NCT01632475|Hyperplasia|hyperplasia
352797|NCT01632475|Ventilator-induced lung injury|ventilator-induced lung injury
352798|NCT01632475|Respiratory lung diseases|respiratory lung diseases
352799|NCT01632475|Pathologic Processes|pathologic processes
352800|NCT01632475|Infant, Premature, Diseases|infant, premature, diseases
352801|NCT01632475|Infant, Newborn, Diseases|infant, newborn, diseases
352802|NCT01632462|Crohn's disease|crohn's disease
352803|NCT01632462|VSL#3|vsl#3
352804|NCT01632462|probiotics|probiotics
352805|NCT01632462|metabolic profile|metabolic profile
352806|NCT01632449|bioequivalence|bioequivalence
352807|NCT01632436|Hepatic impairment|hepatic impairment
352808|NCT01632436|Metastatic Cancer|metastatic cancer
352809|NCT01632410|autonomic nerve system|autonomic nerve system
352810|NCT01632410|post stroke|post stroke
352811|NCT01632410|focus of study: to describe the autonomic nerve system function post stroke|focus of study: to describe the autonomic nerve system function post stroke
352812|NCT01632410|autonomic nervous system|autonomic nervous system
352813|NCT01632397|PrEP|prep
352815|NCT01632397|Adherence|adherence
352816|NCT01632397|MSM|msm
352817|NCT01632397|Men having sex with men|men having sex with men
352818|NCT01632384|Smoker|smoker
352819|NCT01632384|Non-Smoker|non-smoker
352820|NCT01632384|Healthy|healthy
352823|NCT01632371|In-stent Restenosis|in-stent restenosis
352824|NCT01632371|Drug Eluting Stent|drug eluting stent
352825|NCT01632371|Paclitaxel Coated Balloon|paclitaxel coated balloon
352826|NCT01632371|Scoring Balloon|scoring balloon
352827|NCT01632371|Cutting Balloon|cutting balloon
352828|NCT01632371|Angiographic follow-up|angiographic follow-up
352829|NCT01632371|Optical coherence tomography (OCT)|optical coherence tomography (oct)
352830|NCT01632358|safety|safety
352831|NCT01632358|tolerability|tolerability
352832|NCT01632358|pharmacokinetics|pharmacokinetics
352833|NCT01632280|Obesity|obesity
352834|NCT01632280|Gastric Banding|gastric banding
352835|NCT01632280|Transcranial Direct Current Stimulation|transcranial direct current stimulation
352836|NCT01632241|Systemic Lupus Erythematosus|systemic lupus erythematosus
352837|NCT01632241|African Continental Ancestry Group|african continental ancestry group
352838|NCT01632241|Autoimmune Disease|autoimmune disease
352839|NCT01632241|Antibodies|antibodies
352840|NCT01632241|Minority Groups|minority groups
352841|NCT01632241|Black Race|black race
352842|NCT01632241|African Americans|african americans
352843|NCT01632241|SLE|sle
352844|NCT01632241|Belimumab|belimumab
352845|NCT01632241|Lupus|lupus
352846|NCT01632215|gabapentine|gabapentine
352847|NCT01632215|postoperative pain|postoperative pain
352848|NCT01632202|submucosal myomas|submucosal myomas
352849|NCT01632202|intrauterine adhesions|intrauterine adhesions
352850|NCT01632202|hysteroscopic myomectomy|hysteroscopic myomectomy
352851|NCT01632202|seprafilm|seprafilm
352852|NCT01632189|Varenicline|varenicline
352853|NCT01632189|PET imaging|pet imaging
352854|NCT01632189|[11C]-(+)-PHNO PET|[11c]-(+)-phno pet
352855|NCT01632189|neuroimaging in smokers|neuroimaging in smokers
352856|NCT01632176|dating abuse|dating abuse
352857|NCT01632176|dating violence|dating violence
352858|NCT01632176|domestic violence|domestic violence
352859|NCT01632176|sexual violence|sexual violence
352860|NCT01632176|sexual assault|sexual assault
352861|NCT01632176|youth violence|youth violence
352862|NCT01632176|underage alcohol use|underage alcohol use
352863|NCT01632176|alcohol use|alcohol use
352864|NCT01632098|psychosocial|psychosocial
352865|NCT01632098|healthcare|healthcare
352866|NCT01632098|co-morbidities|co-morbidities
352867|NCT01632098|extremely obese adolescents|extremely obese adolescents
352868|NCT01632059|ADMA|adma
352869|NCT01632059|DDAH II|ddah ii
352870|NCT01632059|SAPS|saps
352871|NCT01632059|SOFA|sofa
352872|NCT01632059|Sepsis|sepsis
352873|NCT01632059|Procalcitonin|procalcitonin
352874|NCT01632059|ICU|icu
352875|NCT01632059|mortality|mortality
352876|NCT01632059|length of stay|length of stay
352877|NCT01632046|peritoneal dialysis|peritoneal dialysis
352878|NCT01632046|bicarbonate/lactate buffer|bicarbonate/lactate buffer
352879|NCT01632046|peritoneal transport capacity|peritoneal transport capacity
352880|NCT01632046|ultrafiltration|ultrafiltration
352881|NCT01632046|children|children
352882|NCT01632033|Peripheral artery disease|peripheral artery disease
352883|NCT01632033|claudication|claudication
352884|NCT01632033|walking|walking
352885|NCT01632033|questionnaire|questionnaire
352886|NCT01632020|colorectal tumor|colorectal tumor
352887|NCT01632020|colorectal cancer|colorectal cancer
352888|NCT01632020|colorectal carcinoma|colorectal carcinoma
352889|NCT01632020|neoplasms, colorectal|neoplasms, colorectal
352890|NCT01632020|Metformin|metformin
352891|NCT01631994|metoclopramide video capsule endoscopy gastric transit time|metoclopramide video capsule endoscopy gastric transit time
352892|NCT01631955|Acute cystitis|acute cystitis
352893|NCT01631955|Antibiotics|antibiotics
352894|NCT01631955|Quality of life|quality of life
352895|NCT01631929|Diabetes|diabetes
352896|NCT01631929|Ketoacidosis|ketoacidosis
352897|NCT01631929|Children|children
352898|NCT01631916|community-acquired pneumonia|community-acquired pneumonia
352899|NCT01631916|children|children
352900|NCT01631916|respiratory infections|respiratory infections
352901|NCT01631864|Hypertension, obesity, insulin sensitivity, lipolysis, LCZ696|hypertension, obesity, insulin sensitivity, lipolysis, lcz696
352902|NCT01631851|Autism|autism
352903|NCT01631851|Irritability|irritability
352904|NCT01631851|Disruptive Behavior|disruptive behavior
352905|NCT01631851|Aggression|aggression
352906|NCT01631851|Behavior Therapy|behavior therapy
352907|NCT01631851|Cognitive Behavioral Therapy|cognitive behavioral therapy
352908|NCT01631838|Tocotrienols|tocotrienols
352909|NCT01631838|Platelet aggregation|platelet aggregation
352910|NCT01631838|Metabolic syndrome|metabolic syndrome
352911|NCT01631838|Platelet activation|platelet activation
352912|NCT01631838|Thrombosis|thrombosis
352913|NCT01631825|SPM 962|spm 962
352914|NCT01631825|rotigotine|rotigotine
352915|NCT01631825|Parkinson's disease|parkinson's disease
352916|NCT01631825|concomitant use of L-dopa|concomitant use of l-dopa
352917|NCT01631812|SPM 962|spm 962
352918|NCT01631812|rotigotine|rotigotine
352919|NCT01631812|Parkinson's disease|parkinson's disease
352920|NCT01631812|concomitant use of L-dopa|concomitant use of l-dopa
352921|NCT01631799|epidural anesthesia|epidural anesthesia
352922|NCT01631799|femoral block|femoral block
355334|NCT01621113|Walking|walking
352923|NCT01631799|patient control analgesia|patient control analgesia
352924|NCT01631786|Ovaries|ovaries
352925|NCT01631786|Imaging|imaging
352926|NCT01631786|Ultrasonography|ultrasonography
352927|NCT01631786|Synchrotron|synchrotron
352928|NCT01631786|Histology|histology
352929|NCT01631773|Aspirin-exacerbated respiratory disease|aspirin-exacerbated respiratory disease
352930|NCT01631773|Nasal polyp|nasal polyp
352931|NCT01631760|Asthma|asthma
352932|NCT01631760|Asthma Exacerbations|asthma exacerbations
352933|NCT01631747|Pregnancy|pregnancy
352934|NCT01631747|Weight gain|weight gain
352935|NCT01631747|Obesity|obesity
352936|NCT01631747|Pregnancy and weight gain|pregnancy and weight gain
352937|NCT01631721|adolescent couple decision-making|adolescent couple decision-making
352938|NCT01631721|parenting practices|parenting practices
352939|NCT01631721|sexual risk behavior|sexual risk behavior
352940|NCT01631708|Hereditary haemochromatosis|hereditary haemochromatosis
352941|NCT01631708|Moderate iron overload|moderate iron overload
352942|NCT01631708|Serum ferritin|serum ferritin
352943|NCT01631708|Treatment|treatment
352944|NCT01631682|Posttraumatic Stress Disorder|posttraumatic stress disorder
352945|NCT01631682|PTSD|ptsd
352946|NCT01631682|Anxiety|anxiety
352947|NCT01631682|Fear of spiders|fear of spiders
352948|NCT01631682|Reconsolidation|reconsolidation
352949|NCT01631682|Reconsolidation blockade|reconsolidation blockade
352950|NCT01631669|Ossification|ossification
352951|NCT01631669|Heterotopic Ossification|heterotopic ossification
352952|NCT01631656|Rosacea, Laser, Finacea Gel, Azelaic Acid,|rosacea, laser, finacea gel, azelaic acid,
352953|NCT01631643|Blood glucose monitor|blood glucose monitor
352954|NCT01631643|Pattern management|pattern management
352955|NCT01631643|Pattern guide|pattern guide
352956|NCT01631643|Education|education
352957|NCT01631630|Alcohol|alcohol
352958|NCT01631630|Alcohol Dependence|alcohol dependence
352959|NCT01631630|Alcohol Use|alcohol use
352960|NCT01631630|Nicotine Dependence|nicotine dependence
352961|NCT01631630|Nicotine|nicotine
352962|NCT01631617|Investigator-Blinded|investigator-blinded
352963|NCT01631617|Skin Biopsy|skin biopsy
352964|NCT01631617|Randomized|randomized
352965|NCT01631617|Antibiotics|antibiotics
352966|NCT01631617|Topical|topical
352967|NCT01631604|risk of falling|risk of falling
352968|NCT01631604|gait patterns|gait patterns
352969|NCT01631604|muscle activity|muscle activity
352970|NCT01631604|fall prevention|fall prevention
352971|NCT01631604|motor impairment|motor impairment
352972|NCT01631578|mitochondrial injection|mitochondrial injection
352973|NCT01631565|Palliative Care|palliative care
352974|NCT01631565|Survival|survival
352975|NCT01631565|Quality of life|quality of life
352976|NCT01631552|Colorectal (CRC)|colorectal (crc)
352977|NCT01631552|Gastric adenocarcinoma (GC)|gastric adenocarcinoma (gc)
352978|NCT01631552|Esophageal cancer (EC)|esophageal cancer (ec)
352979|NCT01631552|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
352980|NCT01631552|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
352981|NCT01631552|Small cell lung cancer (SCLC)|small cell lung cancer (sclc)
352982|NCT01631552|Ovarian epithelial cancer (OEC)|ovarian epithelial cancer (oec)
352983|NCT01631552|Triple-negative breast cancer (TNBC)|triple-negative breast cancer (tnbc)
352984|NCT01631552|Hormone-refractory prostate cancer (HRPC)|hormone-refractory prostate cancer (hrpc)
352985|NCT01631552|Pancreatic ductal adenocarcinoma (PDC)|pancreatic ductal adenocarcinoma (pdc)
352986|NCT01631552|Head and neck cancers- squamous cell (SCCHN)|head and neck cancers- squamous cell (scchn)
352987|NCT01631552|Renal cell cancer -clear cell (RCC)|renal cell cancer -clear cell (rcc)
352988|NCT01631552|Bladder cancer|bladder cancer
352989|NCT01631552|Endometrial Cancer|endometrial cancer
352990|NCT01631552|Cervical Cancer|cervical cancer
352991|NCT01631552|Breast cancer|breast cancer
352992|NCT01631552|Metastatic non-triple negative breast cancer|metastatic non-triple negative breast cancer
352993|NCT01631552|Glioblastoma multiforme|glioblastoma multiforme
352994|NCT01631552|Follicular thyroid cancer|follicular thyroid cancer
352995|NCT01631539|chemoembolization|chemoembolization
352996|NCT01631539|DC Bead™|dc bead™
352997|NCT01631539|Irinotecan|irinotecan
352998|NCT01631539|Cetuximab|cetuximab
352999|NCT01631539|5FU/LV|5fu/lv
353000|NCT01631539|KRAS|kras
353001|NCT01631539|metastatic colorectal cancer|metastatic colorectal cancer
353002|NCT01631526|Lung cancer|lung cancer
353003|NCT01631526|vitamin D|vitamin d
353004|NCT01631526|pharmacokinetics|pharmacokinetics
353005|NCT01631513|Chronic Low Back Pain|chronic low back pain
353006|NCT01631513|Osteoarthritis Pain In The Hip or Knee|osteoarthritis pain in the hip or knee
353007|NCT01631513|Oxycodone|oxycodone
353008|NCT01631513|Morphine, Hydrocodone|morphine, hydrocodone
353009|NCT01631513|Tapentadol|tapentadol
353010|NCT01631513|NUCYNTA ER|nucynta er
353011|NCT01631500|Integrative medicine|integrative medicine
353012|NCT01631500|Acupuncture|acupuncture
353013|NCT01631500|Minor mental health problems|minor mental health problems
353014|NCT01631500|Medically unexplained symptoms|medically unexplained symptoms
353015|NCT01631500|Minor mental health problems (e.g. minor depression and anxiety) and Medically unexplained symptoms (e.g. IBS, fibromyalgia, etc)|minor mental health problems (e.g. minor depression and anxiety) and medically unexplained symptoms (e.g. ibs, fibromyalgia, etc)
353017|NCT01631487|JNJ-39439335|jnj-39439335
353018|NCT01631487|Japanese|japanese
353019|NCT01631487|Caucasian|caucasian
353020|NCT01631487|Male|male
353021|NCT01631474|Intrepid|intrepid
353022|NCT01631474|acne|acne
353023|NCT01631474|antiandrogen|antiandrogen
353024|NCT01631461|pain|pain
353025|NCT01631461|breast feeding|breast feeding
353026|NCT01631461|yeast|yeast
353027|NCT01631461|candida albicance|candida albicance
353028|NCT01631461|staphylococcus aureus|staphylococcus aureus
353029|NCT01631461|Signs and symptoms|signs and symptoms
353030|NCT01631448|Fibrin sealant|fibrin sealant
353031|NCT01631448|renal transplantation|renal transplantation
353032|NCT01631448|surgical complication|surgical complication
353033|NCT01631435|All subjects will have evidence of active symptoms associated with Crohn's disease|all subjects will have evidence of active symptoms associated with crohn's disease
353034|NCT01631409|clinical research|clinical research
353035|NCT01631409|coronary heart disease|coronary heart disease
353036|NCT01631409|cardiac shock wave therapy|cardiac shock wave therapy
353037|NCT01631409|ischemic heart disease|ischemic heart disease
353038|NCT01631409|myocardial revascularization|myocardial revascularization
353039|NCT01631409|observational research|observational research
353040|NCT01631409|prospective research|prospective research
353041|NCT01631396|Morbid obesity|morbid obesity
353042|NCT01631396|Bariatric Surgery|bariatric surgery
353043|NCT01631396|Neuromuscular block reversal|neuromuscular block reversal
353044|NCT01631383|Cocaine Use|cocaine use
353045|NCT01631305|Euthyroid Sick Syndromes|euthyroid sick syndromes
353046|NCT01631305|Thyroxine|thyroxine
353047|NCT01631305|Intensive care|intensive care
353048|NCT01631279|NSCLC|nsclc
353049|NCT01631279|non-small cell lung cancer|non-small cell lung cancer
353050|NCT01631279|non-squamous, non-small cell lung cancer|non-squamous, non-small cell lung cancer
353051|NCT01631279|solid tumors|solid tumors
353052|NCT01631279|lung cancer|lung cancer
353053|NCT01631240|Sodium|sodium
353054|NCT01631240|Potassium|potassium
353055|NCT01631240|Iodine|iodine
353056|NCT01631240|Creatinine|creatinine
353057|NCT01631214|Osteoporosis, Osteoporosis-postmenopausal, Bone Diseases-Metabolic, Bone Diseases, Musculoskeletal Diseases|osteoporosis, osteoporosis-postmenopausal, bone diseases-metabolic, bone diseases, musculoskeletal diseases
353058|NCT01631201|Chlamydia|chlamydia
353059|NCT01631188|Minimally Invasive Surgery|minimally invasive surgery
353060|NCT01631188|Port Access Surgery|port access surgery
353061|NCT01631188|Heart|heart
353062|NCT01631188|Pacing|pacing
353063|NCT01631188|Wire|wire
353064|NCT01631188|MICS|mics
353065|NCT01631188|Cardiac Bypass|cardiac bypass
353066|NCT01631188|Epicardial pacing|epicardial pacing
353067|NCT01631188|pacing catheter|pacing catheter
353068|NCT01631188|pacing wire|pacing wire
353069|NCT01631188|pacing swan|pacing swan
353070|NCT01631188|pacing pulmonary catheter|pacing pulmonary catheter
353071|NCT01631188|Pulmonary Endovent|pulmonary endovent
353072|NCT01631188|Catheter|catheter
353073|NCT01631188|Aortic Valve Surgery|aortic valve surgery
353074|NCT01631188|Edwards Lifesciences|edwards lifesciences
353075|NCT01631175|sarcoma|sarcoma
353076|NCT01631175|distress|distress
353077|NCT01631175|tumor|tumor
353078|NCT01631175|quality of life|quality of life
353079|NCT01631175|cancer|cancer
353080|NCT01631162|Asthma|asthma
353081|NCT01631162|COPD|copd
353082|NCT01631149|urology|urology
353083|NCT01631149|muscle relaxation|muscle relaxation
353084|NCT01631149|laparoscopy|laparoscopy
353085|NCT01631149|anesthesia|anesthesia
353086|NCT01631149|rocuronium|rocuronium
353087|NCT01631136|Non Small Cell Lung Cancer|non small cell lung cancer
353088|NCT01631136|IFCT|ifct
353089|NCT01631136|Maintenance|maintenance
353090|NCT01631136|Switch|switch
353091|NCT01631123|Twins|twins
353092|NCT01631123|High carbohydrat diet|high carbohydrat diet
353093|NCT01631123|High fat diet|high fat diet
353094|NCT01631123|Isocaloric|isocaloric
353095|NCT01631123|Nutrigenomics|nutrigenomics
353096|NCT01631110|Influenza|influenza
353097|NCT01631110|Virus|virus
353098|NCT01631110|Vaccination|vaccination
353099|NCT01631110|Inflexal V|inflexal v
353100|NCT01631084|Diabetes|diabetes
353101|NCT01631084|Structured care|structured care
353102|NCT01631071|Influenza|influenza
353103|NCT01631071|Virus|virus
353104|NCT01631071|Vaccination|vaccination
353105|NCT01631071|Virosomal influenza vaccine|virosomal influenza vaccine
353106|NCT01631058|kidney transplantation|kidney transplantation
353107|NCT01631058|chronic renal failure|chronic renal failure
353108|NCT01631058|immunosuppressive therapy|immunosuppressive therapy
353109|NCT01631058|elderly|elderly
353110|NCT01631058|pharmacokinetic|pharmacokinetic
353111|NCT01631058|tacrolimus|tacrolimus
353112|NCT01631058|everolimus|everolimus
353113|NCT01631058|mycophenolate sodium|mycophenolate sodium
353114|NCT01631058|serious adverse events|serious adverse events
353115|NCT01631058|biopsy|biopsy
353116|NCT01631058|Cystatin C|cystatin c
353117|NCT01631058|metabolic effects|metabolic effects
353118|NCT01631058|Left Ventricular Mass (LVM)|left ventricular mass (lvm)
353119|NCT01631058|Left Ventricle Ejection Fraction|left ventricle ejection fraction
353120|NCT01631045|Obesity|obesity
353121|NCT01631032|Allergic rhinitis|allergic rhinitis
353122|NCT01631032|Chinese herbal products|chinese herbal products
353123|NCT01631032|Qi deficiency|qi deficiency
353124|NCT01631019|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
353125|NCT01631019|Pulmonary Rehabilitation|pulmonary rehabilitation
353126|NCT01631019|Mobile phone|mobile phone
353127|NCT01631019|Biomarker|biomarker
353128|NCT01631006|CPAP|cpap
353129|NCT01631006|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
353130|NCT01631006|Blood Pressure|blood pressure
353131|NCT01631006|The focus of the present study is to evaluate the acute hemodynamic effects of CPAP in patients with non-obstructive and obstructive hypertrophic cardiomyopathy|the focus of the present study is to evaluate the acute hemodynamic effects of cpap in patients with non-obstructive and obstructive hypertrophic cardiomyopathy
353132|NCT01630993|umbilical cord milking|umbilical cord milking
353133|NCT01630993|umbilical cord stripping|umbilical cord stripping
353134|NCT01630993|umbilical cord clamping|umbilical cord clamping
353135|NCT01630993|placental transfusion|placental transfusion
353136|NCT01630993|placental residual blood volume|placental residual blood volume
353137|NCT01630980|Systematic review and meta-analysis|systematic review and meta-analysis
353138|NCT01630980|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
353139|NCT01630980|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
353140|NCT01630980|Clinical practice guidelines|clinical practice guidelines
353141|NCT01630980|Clinical trials|clinical trials
353142|NCT01630980|Tree nuts|tree nuts
353143|NCT01630980|Cardiometabolic risk factors|cardiometabolic risk factors
353144|NCT01630980|Triglycerides|triglycerides
353145|NCT01630980|Cholesterol|cholesterol
353146|NCT01630980|Glycemic control|glycemic control
353147|NCT01630980|Insulin resistance|insulin resistance
353148|NCT01630980|Body weight|body weight
353149|NCT01630980|Blood pressure|blood pressure
353150|NCT01630967|castrate resistance|castrate resistance
353151|NCT01630967|PSA progression|psa progression
353152|NCT01630967|LHRH antagonism|lhrh antagonism
353153|NCT01630954|Hydatidiform mole|hydatidiform mole
353154|NCT01630954|Molar pregnancy|molar pregnancy
353155|NCT01630954|H Mole|h mole
353156|NCT01630954|GTN|gtn
353157|NCT01630954|GTD|gtd
353158|NCT01630941|Osteoarthritis of the hip|osteoarthritis of the hip
353159|NCT01630941|Uncemented Total Hip Arthroplasty|uncemented total hip arthroplasty
353160|NCT01630941|DXA|dxa
353161|NCT01630941|BMD|bmd
353162|NCT01630941|PET|pet
353163|NCT01630941|CT|ct
353164|NCT01630941|Biochemical bone markers|biochemical bone markers
353165|NCT01630928|Renal denervation|renal denervation
353166|NCT01630928|Resistant Hypertension|resistant hypertension
353167|NCT01630928|Cardiovascular disease|cardiovascular disease
353168|NCT01630928|Diabetes|diabetes
353169|NCT01630928|Quality of LIfe|quality of life
353170|NCT01630889|Kidney|kidney
353171|NCT01630889|ESRD|esrd
353172|NCT01630889|End Stage Renal Disease|end stage renal disease
353173|NCT01630889|Anemia|anemia
353174|NCT01630889|Oral anemia treatment|oral anemia treatment
353175|NCT01630889|Hemoglobin levels|hemoglobin levels
353176|NCT01630889|Hemodialysis|hemodialysis
353177|NCT01630889|CKD|ckd
353178|NCT01630889|Chronic Kidney Disease|chronic kidney disease
353179|NCT01630889|Peritoneal|peritoneal
353180|NCT01630889|HD|hd
353181|NCT01630889|PD|pd
353182|NCT01630889|Hb|hb
353183|NCT01630889|Erythropoietin|erythropoietin
353184|NCT01630889|Blood count|blood count
353185|NCT01630876|Epiretinal membrane|epiretinal membrane
353186|NCT01630876|triamcinolone acetonide|triamcinolone acetonide
353187|NCT01630863|Central serous chorioretinopathy|central serous chorioretinopathy
353188|NCT01630863|photodynamic therapy|photodynamic therapy
353189|NCT01630863|safe and effective dose|safe and effective dose
353190|NCT01630824|education program|education program
353191|NCT01630824|kidney transplantation|kidney transplantation
353192|NCT01630824|renal transplantation|renal transplantation
353193|NCT01630824|evaluation|evaluation
353194|NCT01630811|Adults|adults
353195|NCT01630798|barrett's esophgus|barrett's esophgus
353196|NCT01630798|High grade dysplasia|high grade dysplasia
353197|NCT01630798|Esophageal adenocarcinoma|esophageal adenocarcinoma
353198|NCT01630772|women with preeclampsia|women with preeclampsia
353199|NCT01630772|physical therapy|physical therapy
353200|NCT01630772|maternal-fetal hemodynamics|maternal-fetal hemodynamics
353201|NCT01630772|perinatal outcomes|perinatal outcomes
353202|NCT01630759|Gestational diabetes|gestational diabetes
353203|NCT01630759|telemonitoring|telemonitoring
353204|NCT01630759|telehealth|telehealth
353205|NCT01630759|feasibility study|feasibility study
353206|NCT01630733|Metastatic|metastatic
353207|NCT01630733|Stage IV|stage iv
353208|NCT01630733|Advanced|advanced
353209|NCT01630733|lung cancer|lung cancer
353210|NCT01630720|ascorbic acid|ascorbic acid
353211|NCT01630720|cholecalciferol|cholecalciferol
353212|NCT01630720|vitamin C|vitamin c
353213|NCT01630720|vitamin D|vitamin d
353214|NCT01630720|hypovitaminosis|hypovitaminosis
353215|NCT01630720|mood|mood
353216|NCT01630720|distress|distress
353217|NCT01630694|Difficult airway management|difficult airway management
353218|NCT01630694|anesthesia|anesthesia
353219|NCT01630694|difficult intubation|difficult intubation
353220|NCT01630629|Lactation|lactation
353221|NCT01630629|Weaning|weaning
353222|NCT01630629|Bone Density|bone density
353223|NCT01630629|Endocrine|endocrine
353224|NCT01630629|Physiological Properties|physiological properties
353225|NCT01630629|Bone Metabolism|bone metabolism
353226|NCT01630590|Prostate Cancer|prostate cancer
353227|NCT01630590|Metastatic Prostate Cancer|metastatic prostate cancer
353228|NCT01630590|Prostate adenocarcinoma|prostate adenocarcinoma
353229|NCT01630590|Androgen-Dependent Prostate Cancer|androgen-dependent prostate cancer
353230|NCT01630590|Cabozantinib|cabozantinib
353231|NCT01630590|XL 184|xl 184
353232|NCT01630590|Androgen Ablation|androgen ablation
353233|NCT01630577|acute circulatory failure|acute circulatory failure
353234|NCT01630577|hemodynamic stability|hemodynamic stability
353235|NCT01630577|hypovolemia|hypovolemia
353236|NCT01630564|Blood And Marrow Transplantation|blood and marrow transplantation
353237|NCT01630564|Leukemia|leukemia
353238|NCT01630564|Lymphoma|lymphoma
353239|NCT01630564|Myeloproliferative Diseases|myeloproliferative diseases
353240|NCT01630564|Relapsed hematological malignancies|relapsed hematological malignancies
353241|NCT01630564|Post-Transplant Relapsed Patients|post-transplant relapsed patients
353242|NCT01630564|Cord Blood Lymphocyte Infusion|cord blood lymphocyte infusion
353243|NCT01630564|Ex Vivo Expanded Donor Cord Blood T-Lymphocyte Infusion|ex vivo expanded donor cord blood t-lymphocyte infusion
353244|NCT01630551|tears|tears
353245|NCT01630551|dry eyes|dry eyes
353246|NCT01630551|ocular surface disease|ocular surface disease
353247|NCT01630538|Transplantation|transplantation
353248|NCT01630525|Alzheimer's disease|alzheimer's disease
353249|NCT01630525|neurodegenerative signs|neurodegenerative signs
353250|NCT01630499|Cancer|cancer
353251|NCT01630499|Breast cancer|breast cancer
353252|NCT01630499|Breast cancer prevention|breast cancer prevention
353253|NCT01630499|Breast cancer recurrence|breast cancer recurrence
353254|NCT01630499|Weight loss|weight loss
353255|NCT01630499|Weight management|weight management
353256|NCT01630499|Overweight|overweight
353257|NCT01630499|Obesity|obesity
353258|NCT01630486|renal progression|renal progression
353259|NCT01630486|mortality|mortality
353260|NCT01630486|complications|complications
353261|NCT01630486|risk factors|risk factors
353262|NCT01630486|role of biochemical parameters|role of biochemical parameters
353263|NCT01630486|genetic influence|genetic influence
353264|NCT01630473|Tooth crowding|tooth crowding
353265|NCT01630473|Teeth malpositions|teeth malpositions
353266|NCT01630473|corticotomy|corticotomy
353267|NCT01630473|orthodontics|orthodontics
353268|NCT01630473|tooth movement|tooth movement
353269|NCT01630473|periodontal parameters|periodontal parameters
353270|NCT01630460|Craniometaphyseal dysplasia|craniometaphyseal dysplasia
353271|NCT01630460|bone|bone
353272|NCT01630460|hyperostosis|hyperostosis
353273|NCT01630460|osteoblast|osteoblast
353274|NCT01630460|osteoclast|osteoclast
353275|NCT01630447|cherubism|cherubism
353276|NCT01630447|bone|bone
353277|NCT01630447|autoinflammatory disorder|autoinflammatory disorder
353278|NCT01630447|osteoblast|osteoblast
353279|NCT01630447|osteoclast|osteoclast
353280|NCT01630447|mandible|mandible
353281|NCT01630447|maxilla|maxilla
353282|NCT01630421|Aplasia cutis congenita|aplasia cutis congenita
353283|NCT01630421|bone|bone
353284|NCT01630421|osteoblast|osteoblast
353285|NCT01630421|osteoclast|osteoclast
353286|NCT01630421|skin|skin
353287|NCT01630408|Preserved ejection fraction|preserved ejection fraction
353288|NCT01630408|Left ventricular hypertrophy|left ventricular hypertrophy
353289|NCT01630408|Activated vitamin D|activated vitamin d
353290|NCT01630408|Cardiac lusitropic effect|cardiac lusitropic effect
353291|NCT01630408|Hospitalizations|hospitalizations
353292|NCT01630356|Secondhand Smoke|secondhand smoke
353293|NCT01630356|Nicotine|nicotine
353294|NCT01630356|Indoor Air Pollution|indoor air pollution
353295|NCT01630343|Geriatric hip fracture|geriatric hip fracture
353296|NCT01630343|pain management|pain management
353297|NCT01630304|telecommunications|telecommunications
353298|NCT01630304|Africa|africa
353299|NCT01630304|randomized controlled trial|randomized controlled trial
353300|NCT01630278|Prematurity|prematurity
353301|NCT01630278|patent ductus arteriosus|patent ductus arteriosus
353302|NCT01630278|ibuprofen|ibuprofen
353303|NCT01630265|Discharge Instructions|discharge instructions
353304|NCT01630265|Video Discharge Instructions|video discharge instructions
353305|NCT01630265|Video|video
353306|NCT01630265|Emergency Department Discharge Instructions|emergency department discharge instructions
353307|NCT01630265|ED Discharge|ed discharge
353308|NCT01630226|BRCA1|brca1
353309|NCT01630226|pathological complete response|pathological complete response
353310|NCT01630226|neoadjuvant chemotherapy|neoadjuvant chemotherapy
353311|NCT01630213|Vitamin D3|vitamin d3
353312|NCT01630213|Left ventricular mass|left ventricular mass
353313|NCT01630213|Echocardiography|echocardiography
353407|NCT01629602|dorsal branch of the proper digital nerve;|dorsal branch of the proper digital nerve;
353314|NCT01630213|Left ventricular systolic and diastolic function|left ventricular systolic and diastolic function
353315|NCT01630200|COPD|copd
353316|NCT01630200|comorbidity|comorbidity
353317|NCT01630200|arterial stiffness|arterial stiffness
353318|NCT01630200|roflumilast|roflumilast
353319|NCT01630187|Carbetocin|carbetocin
353320|NCT01630187|Uterotonic drug|uterotonic drug
353321|NCT01630187|elective cesarean section|elective cesarean section
353322|NCT01630174|IMRT,Pemetrexed,Cisplatin , Esophageal Cancer|imrt,pemetrexed,cisplatin , esophageal cancer
353323|NCT01630161|relapse|relapse
353324|NCT01630161|prevention|prevention
353325|NCT01630161|smoking|smoking
353326|NCT01630161|habit|habit
353327|NCT01630161|Forever Free|forever free
353328|NCT01630148|Thromboprophylaxis|thromboprophylaxis
353329|NCT01630148|Bemiparin|bemiparin
353330|NCT01630148|Low Molecular Weight Heparin|low molecular weight heparin
353331|NCT01630148|Major Gynaecological Surgeries|major gynaecological surgeries
353332|NCT01630148|Benign Gynaecological Surgeries|benign gynaecological surgeries
353333|NCT01630122|Trans-thoracic Needle Biopsy (TNB)|trans-thoracic needle biopsy (tnb)
353334|NCT01630122|Endobronchial Ultrasound Guided Transbronchial Needle Aspiration (EBUS-TBNA)|endobronchial ultrasound guided transbronchial needle aspiration (ebus-tbna)
353335|NCT01630122|Trans-esophageal Ultrasound Scanning with FNA (EUS-FNA)|trans-esophageal ultrasound scanning with fna (eus-fna)
353336|NCT01630070|Critical limb ischemia|critical limb ischemia
353337|NCT01630070|Rest pain|rest pain
353338|NCT01630070|Minor tissue loss|minor tissue loss
353339|NCT01630070|Below the knee|below the knee
353340|NCT01630031|atrial fibrillation|atrial fibrillation
353341|NCT01630031|paroxysmal|paroxysmal
353342|NCT01630031|contact force|contact force
353343|NCT01630031|radiofrequency|radiofrequency
353344|NCT01630031|catheter ablation|catheter ablation
353345|NCT01630031|pulmonary vein isolation|pulmonary vein isolation
353346|NCT01630031|recurrence|recurrence
353347|NCT01630031|follow-up|follow-up
353348|NCT01630018|Epithelial Ovarian Cancer|epithelial ovarian cancer
353349|NCT01630018|Belotecan|belotecan
353350|NCT01630018|Topotecan|topotecan
353351|NCT01629992|Vomiting|vomiting
353352|NCT01629992|Nausea|nausea
353353|NCT01629992|Postoperative pain|postoperative pain
353354|NCT01629992|Feeling|feeling
353355|NCT01629966|Generalized Anxiety Disorder|generalized anxiety disorder
353356|NCT01629966|GAD|gad
353357|NCT01629940|X-linked Hypohidrotic Ectodermal Dysplasia|x-linked hypohidrotic ectodermal dysplasia
353358|NCT01629940|Hypohidrotic Ectodermal Dysplasia|hypohidrotic ectodermal dysplasia
353359|NCT01629940|XLHED|xlhed
353360|NCT01629940|HED|hed
353361|NCT01629927|X-linked hypohidrotic ectodermal dysplasia|x-linked hypohidrotic ectodermal dysplasia
353362|NCT01629927|Hypohidrotic ectodermal dysplasia|hypohidrotic ectodermal dysplasia
353363|NCT01629927|HED|hed
353364|NCT01629927|XLHED|xlhed
353365|NCT01629914|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
353366|NCT01629914|executive functioning|executive functioning
353367|NCT01629914|mindfulness meditation|mindfulness meditation
353368|NCT01629914|magnetic resonance imaging|magnetic resonance imaging
353369|NCT01629914|healthy|healthy
353370|NCT01629901|Healthy volunteer|healthy volunteer
353371|NCT01629888|Plant sterol|plant sterol
353372|NCT01629888|Hypercholesterolemia|hypercholesterolemia
353373|NCT01629888|dairy|dairy
353374|NCT01629810|Motion platform at appropriate settings.|motion platform at appropriate settings.
353375|NCT01629810|Relief of pain.|relief of pain.
353376|NCT01629810|Improvement in quality of life, cognition, and mood.|improvement in quality of life, cognition, and mood.
353377|NCT01629810|Effects of WBPA on cognition, mood, behavior, and functioning.|effects of wbpa on cognition, mood, behavior, and functioning.
353378|NCT01629810|Dose response effect .|dose response effect .
353379|NCT01629810|Gather data for long-term (2 year) study|gather data for long-term (2 year) study
353380|NCT01629745|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
353381|NCT01629745|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
353382|NCT01629693|contact lenses|contact lenses
353383|NCT01629693|myopia|myopia
353384|NCT01629693|astigmatism|astigmatism
353385|NCT01629680|moxaverine|moxaverine
353386|NCT01629680|ocular blood flow|ocular blood flow
353387|NCT01629654|Poststroke fatigue|poststroke fatigue
353388|NCT01629654|Health promotion|health promotion
353389|NCT01629654|Patient education|patient education
353390|NCT01629641|goniometry|goniometry
353391|NCT01629641|outcome measures|outcome measures
353392|NCT01629641|shoulder assessment|shoulder assessment
353393|NCT01629628|Crohn Disease|crohn disease
353394|NCT01629628|Colitis Granulomatous|colitis granulomatous
353395|NCT01629628|Crohn's Disease|crohn's disease
353396|NCT01629628|Enteritis Regional|enteritis regional
353397|NCT01629628|Ileitis Regional|ileitis regional
353398|NCT01629628|Ileitis Terminal|ileitis terminal
353399|NCT01629628|Ileocolitis|ileocolitis
353400|NCT01629615|breast cancer|breast cancer
353401|NCT01629615|metastatic|metastatic
353402|NCT01629615|triple negative breast cancer|triple negative breast cancer
353403|NCT01629615|BKM120|bkm120
353404|NCT01629615|SOLTI|solti
353405|NCT01629615|PI3K inhibitor|pi3k inhibitor
353408|NCT01629602|proper digital nerve;|proper digital nerve;
353409|NCT01629602|vascularized nerve graft|vascularized nerve graft
353410|NCT01629589|Adacel® vaccine|adacel® vaccine
353411|NCT01629589|Tetanus|tetanus
353412|NCT01629589|Diphtheria|diphtheria
353413|NCT01629589|whooping cough|whooping cough
353414|NCT01629589|Pertussis|pertussis
353415|NCT01629589|BOOSTRIX® vaccine|boostrix® vaccine
353416|NCT01629537|Post Traumatic Stress Disorder|post traumatic stress disorder
353417|NCT01629511|Leukemia|leukemia
353418|NCT01629511|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
353420|NCT01629511|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
353421|NCT01629511|HCT|hct
353422|NCT01629511|Methotrexate|methotrexate
353423|NCT01629511|Filgrastim|filgrastim
353424|NCT01629511|G-CSF|g-csf
353425|NCT01629511|Neupogen|neupogen
353426|NCT01629511|Tacrolimus|tacrolimus
353427|NCT01629511|Prograf|prograf
353428|NCT01629511|Busulfan|busulfan
353429|NCT01629511|Busulfex|busulfex
353430|NCT01629511|Myleran|myleran
353431|NCT01629511|Clofarabine|clofarabine
353432|NCT01629511|Clofarex|clofarex
353433|NCT01629511|Clolar|clolar
353434|NCT01629511|Gemcitabine|gemcitabine
353435|NCT01629511|Gemcitabine Hydrochloride|gemcitabine hydrochloride
353436|NCT01629511|Gemzar|gemzar
353437|NCT01629511|Thymoglobulin|thymoglobulin
353438|NCT01629511|ATG|atg
353439|NCT01629511|Antithymocyte Globulin|antithymocyte globulin
353440|NCT01629498|Lung cancer|lung cancer
353441|NCT01629498|Non-small cell lung cancer|non-small cell lung cancer
353442|NCT01629498|NSCLC|nsclc
353443|NCT01629498|Image-guided intensity-modulated scanning beam proton therapy|image-guided intensity-modulated scanning beam proton therapy
353444|NCT01629498|IMPT|impt
353445|NCT01629498|Simultaneous integrated boost|simultaneous integrated boost
353446|NCT01629498|SIB|sib
353447|NCT01629498|Gross tumor volume|gross tumor volume
353448|NCT01629498|GTV|gtv
353449|NCT01629498|Chemotherapy|chemotherapy
353450|NCT01629498|Questionnaire|questionnaire
353451|NCT01629498|Survey|survey
353452|NCT01629485|Mastery Learning|mastery learning
353453|NCT01629485|Surgical Education|surgical education
353454|NCT01629485|Laparoscopic Hernia Repair|laparoscopic hernia repair
353455|NCT01629485|Part vs Whole Task|part vs whole task
353456|NCT01629485|Contextual Interference|contextual interference
353457|NCT01629485|laparoscopy|laparoscopy
353458|NCT01629485|training|training
353459|NCT01629485|curriculum|curriculum
353460|NCT01629472|Gender norms|gender norms
353461|NCT01629472|Financial Autonomy|financial autonomy
353462|NCT01629472|Economic Well-being|economic well-being
353463|NCT01629459|exercise|exercise
353464|NCT01629459|strength|strength
353465|NCT01629459|training|training
353466|NCT01629459|barth syndrome|barth syndrome
353467|NCT01629459|mitochondria|mitochondria
353468|NCT01629459|amino acid|amino acid
353469|NCT01629459|protein|protein
353470|NCT01629446|Phase 1|phase 1
353471|NCT01629446|Normal healthy volunteers|normal healthy volunteers
353472|NCT01629446|Mass Balance|mass balance
353473|NCT01629433|idiopathic detrusor overactivity|idiopathic detrusor overactivity
353474|NCT01629433|neurogenic dysfunction|neurogenic dysfunction
353475|NCT01629433|onabotulinumtoxinA|onabotulinumtoxina
353476|NCT01629420|Gonadotropin-Releasing Hormone (GnRH) antagonist|gonadotropin-releasing hormone (gnrh) antagonist
353477|NCT01629381|knee arthroscopy|knee arthroscopy
353478|NCT01629381|venous thromboembolism|venous thromboembolism
353479|NCT01629381|prevention|prevention
353480|NCT01629355|Auditory Brainstem Response|auditory brainstem response
353481|NCT01629355|ABR|abr
353482|NCT01629355|SD-BERA|sd-bera
353483|NCT01629329|Headache|headache
353484|NCT01629329|prochlorperazine|prochlorperazine
353485|NCT01629329|excedrin migraine|excedrin migraine
353486|NCT01629329|treatment efficacy|treatment efficacy
353487|NCT01629329|pain scores|pain scores
353488|NCT01629316|HIV|hiv
353489|NCT01629316|prisoners|prisoners
353490|NCT01629316|test|test
353491|NCT01629316|treat|treat
353492|NCT01629316|link coordination|link coordination
353493|NCT01629316|retain|retain
353494|NCT01629316|behavioral|behavioral
353495|NCT01629316|intervention|intervention
353496|NCT01629316|text reminders|text reminders
353497|NCT01629316|motivational interviewing|motivational interviewing
353498|NCT01629316|medication adherence|medication adherence
353499|NCT01629303|constipation|constipation
353500|NCT01629303|sacral nerve modulation|sacral nerve modulation
353501|NCT01629277|Closed-loop insulin delivery|closed-loop insulin delivery
353502|NCT01629277|Non-compliant behaviours during adolescence|non-compliant behaviours during adolescence
353503|NCT01629264|Cornea|cornea
353504|NCT01629264|biomechanics|biomechanics
353505|NCT01629264|pregnancy|pregnancy
353506|NCT01629264|keratoconus|keratoconus
353507|NCT01629264|refractive surgery|refractive surgery
353508|NCT01629251|Closed-loop insulin delivery|closed-loop insulin delivery
353509|NCT01629251|Post-prandial hypoglycaemia|post-prandial hypoglycaemia
353510|NCT01629251|Meal insulin dosing|meal insulin dosing
353511|NCT01629238|cardiovascular risk|cardiovascular risk
353512|NCT01629238|dairy enriched product with plant sterols|dairy enriched product with plant sterols
353513|NCT01629238|general practitioners|general practitioners
353514|NCT01629238|adults followed by general practitioners|adults followed by general practitioners
353515|NCT01629225|men and women|men and women
353516|NCT01629225|in southwestern Han Chinese|in southwestern han chinese
353517|NCT01629186|CPR|cpr
353518|NCT01629186|flexible bronchoscope|flexible bronchoscope
353519|NCT01629186|resuscitation|resuscitation
353520|NCT01629186|ventilation|ventilation
353521|NCT01629173|plantar pressure|plantar pressure
353522|NCT01629173|metatarsalgia|metatarsalgia
353523|NCT01629173|insole|insole
353524|NCT01629147|Constipation|constipation
353525|NCT01629108|Normative Data|normative data
353526|NCT01629108|Vestibular|vestibular
353527|NCT01629108|Auditory|auditory
353528|NCT01629108|Healthy Volunteers|healthy volunteers
353529|NCT01629108|Hearing|hearing
353530|NCT01629095|Fatty Liver|fatty liver
353531|NCT01629095|Liver Transplant|liver transplant
353532|NCT01629095|Non-Alcoholic Steato-Hepatitis|non-alcoholic steato-hepatitis
353533|NCT01629095|Steatosis|steatosis
353534|NCT01629095|Cirrhosis|cirrhosis
353535|NCT01629095|Cryptogenic Cirrhosis|cryptogenic cirrhosis
353536|NCT01629095|Liver Failure|liver failure
353537|NCT01629095|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
353538|NCT01629082|Myelodysplastic Syndromes|myelodysplastic syndromes
353539|NCT01629082|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
353540|NCT01629082|Chronic Myelomonocytic Leukemia (CMML)|chronic myelomonocytic leukemia (cmml)
353541|NCT01629069|stress|stress
353542|NCT01629069|mindfulness|mindfulness
353543|NCT01629069|coping|coping
353544|NCT01629056|atrial fibrillation|atrial fibrillation
353545|NCT01629056|ablation|ablation
353546|NCT01629056|contact|contact
353547|NCT01629043|Parkinson's|parkinson's
353548|NCT01629043|Quality of Care|quality of care
353549|NCT01629043|Improvement|improvement
353550|NCT01629043|Mobility|mobility
353551|NCT01629043|Cognition|cognition
353552|NCT01629043|Caregiver burden|caregiver burden
353553|NCT01629043|Center difference|center difference
353554|NCT01629030|sternal wound infection|sternal wound infection
353555|NCT01629030|coronary artery bypass graft|coronary artery bypass graft
353556|NCT01629030|risk factor|risk factor
353557|NCT01629004|colorectal cancer|colorectal cancer
353558|NCT01629004|screening|screening
353559|NCT01629004|fecal occult blood testing|fecal occult blood testing
353560|NCT01629004|mailed invitation|mailed invitation
353561|NCT01628991|Behavioral Intervention Program|behavioral intervention program
353562|NCT01628991|Vaginal Cones|vaginal cones
353563|NCT01628991|Stress Urinary Incontinence|stress urinary incontinence
353564|NCT01628991|treatment|treatment
353565|NCT01628991|Women|women
353566|NCT01628978|depth of endotracheal tube placement|depth of endotracheal tube placement
353567|NCT01628978|endotracheal intubation|endotracheal intubation
353568|NCT01628978|endobronchial intubation|endobronchial intubation
353569|NCT01628965|SPM 962|spm 962
353570|NCT01628965|rotigotine|rotigotine
353571|NCT01628965|Parkinson's disease|parkinson's disease
353572|NCT01628965|monotherapy|monotherapy
353573|NCT01628939|low back pain|low back pain
353574|NCT01628939|facet joint pain|facet joint pain
353575|NCT01628913|Pancreatic|pancreatic
353576|NCT01628913|Neuroendocrine tumors|neuroendocrine tumors
353577|NCT01628913|PNET|pnet
353578|NCT01628913|BEZ235|bez235
353579|NCT01628913|Everolimus|everolimus
353580|NCT01628900|pyelonephritis|pyelonephritis
353581|NCT01628900|Infection|infection
353582|NCT01628900|Antibiotic treatment|antibiotic treatment
353583|NCT01628887|Breast Cancer|breast cancer
353584|NCT01628874|Lumbar Puncture|lumbar puncture
353585|NCT01628874|J-Tip|j-tip
353586|NCT01628874|Jet injection|jet injection
353587|NCT01628874|Local Analgesia|local analgesia
353588|NCT01628861|occupation|occupation
353589|NCT01628861|work|work
353590|NCT01628861|sitting|sitting
353591|NCT01628861|sedentary behaviour|sedentary behaviour
353592|NCT01628861|office worker|office worker
353593|NCT01628861|adult|adult
353594|NCT01628861|education|education
353595|NCT01628861|point-of-choice prompt|point-of-choice prompt
353596|NCT01628848|SPM 962|spm 962
353597|NCT01628848|rotigotine|rotigotine
353598|NCT01628848|Parkinson's disease|parkinson's disease
353599|NCT01628848|concomitant use of L-dopa|concomitant use of l-dopa
353600|NCT01628835|overweight|overweight
353601|NCT01628835|pregnancy|pregnancy
353602|NCT01628835|diet counselling|diet counselling
353603|NCT01628835|glycemic|glycemic
353604|NCT01628822|Fibromyalgia|fibromyalgia
353605|NCT01628822|Relaxation|relaxation
353606|NCT01628822|Improving the quality of life|improving the quality of life
353607|NCT01628809|MBSR|mbsr
353608|NCT01628809|mindfulness|mindfulness
353609|NCT01628809|stress|stress
353610|NCT01628783|Depression|depression
353611|NCT01628783|emotional processing|emotional processing
353612|NCT01628783|fMRI|fmri
353613|NCT01628783|autobiographic memory|autobiographic memory
353614|NCT01628783|moderator of treatment response|moderator of treatment response
353615|NCT01628783|mediator of treatment response|mediator of treatment response
353616|NCT01628770|iron|iron
353617|NCT01628770|monofer|monofer
353618|NCT01628770|Pakistan|pakistan
353619|NCT01628731|loop diuretics|loop diuretics
353620|NCT01628731|fluid balance|fluid balance
353621|NCT01628731|urine output|urine output
353622|NCT01628731|acute renal dysfunction|acute renal dysfunction
353623|NCT01628718|OEF/OIF|oef/oif
353624|NCT01628718|Veterans|veterans
353625|NCT01628718|Psychotherapy|psychotherapy
353626|NCT01628718|PTSD|ptsd
353627|NCT01628705|Green tea|green tea
353628|NCT01628705|oxLDL|oxldl
353629|NCT01628705|fat mass|fat mass
353630|NCT01628679|provoked|provoked
353631|NCT01628679|vulvar|vulvar
353632|NCT01628679|vestibulodynia|vestibulodynia
353633|NCT01628679|vestibulitis|vestibulitis
353634|NCT01628666|Arrhythmia|arrhythmia
353635|NCT01628666|Device Procedure|device procedure
353636|NCT01628666|Antibiotics|antibiotics
353637|NCT01628666|Infection|infection
353638|NCT01628666|Cluster|cluster
353639|NCT01628653|Mild cognitive impairment|mild cognitive impairment
353640|NCT01628653|Cognitive rehabilitation|cognitive rehabilitation
353641|NCT01628653|Cognitive therapy|cognitive therapy
353642|NCT01628653|Spaced retrieval Training|spaced retrieval training
353643|NCT01628653|Alzheimer's disease|alzheimer's disease
353644|NCT01628653|Memory enhancement|memory enhancement
353645|NCT01628653|U-healthcare|u-healthcare
353646|NCT01628627|Diabetic Neuropathy, Painful|diabetic neuropathy, painful
353647|NCT01628575|periodontally accelerated orthodontics PAO|periodontally accelerated orthodontics pao
353648|NCT01628562|Remifentanil|remifentanil
353649|NCT01628562|Esmolol|esmolol
353650|NCT01628562|Intracranial surgery|intracranial surgery
353651|NCT01628562|Heart rate|heart rate
353652|NCT01628562|Blood pressure|blood pressure
353653|NCT01628549|acne|acne
353654|NCT01628536|Black Cohosh|black cohosh
353655|NCT01628536|Ductal Carcinoma in situ|ductal carcinoma in situ
353656|NCT01628536|Breast Cancer|breast cancer
353657|NCT01628523|Respiratory failure|respiratory failure
353658|NCT01628523|Mechanical ventilation|mechanical ventilation
353659|NCT01628523|Acute lung injury|acute lung injury
353660|NCT01628510|preterm|preterm
353661|NCT01628471|Phase I b : advanced solid malignancy|phase i b : advanced solid malignancy
353662|NCT01628471|Phase II a: stage III b or IV, Non Small Cell Lung Cancer|phase ii a: stage iii b or iv, non small cell lung cancer
353663|NCT01628458|Pancreatic cancer|pancreatic cancer
353664|NCT01628458|locally advanced|locally advanced
353665|NCT01628458|irresectable|irresectable
353666|NCT01628458|Radiofrequency|radiofrequency
353667|NCT01628458|RFA|rfa
353668|NCT01628445|Diabetes|diabetes
353669|NCT01628445|Insulin|insulin
353670|NCT01628419|Health promotion|health promotion
353671|NCT01628419|Intervention|intervention
353672|NCT01628419|Workplace|workplace
353673|NCT01628419|Exercise program|exercise program
353674|NCT01628380|HIPEC|hipec
353675|NCT01628380|Ovarian Cancer|ovarian cancer
353676|NCT01628380|Cytoreductive Surgery|cytoreductive surgery
353677|NCT01628354|Choroidal neovascularization|choroidal neovascularization
353678|NCT01628354|Lucentis|lucentis
353679|NCT01628328|colonic stenting|colonic stenting
353680|NCT01628328|colorectal cancer obstruction|colorectal cancer obstruction
353681|NCT01628328|circulating tumor cell|circulating tumor cell
353682|NCT01628315|Multiple Sclerosis|multiple sclerosis
353683|NCT01628315|ASA|asa
353684|NCT01628315|MRI|mri
353685|NCT01628315|Lesion activity|lesion activity
353686|NCT01628302|Hypertension,plasma renin activity,salt consumption|hypertension,plasma renin activity,salt consumption
353687|NCT01628289|diabetic retinopathy|diabetic retinopathy
353688|NCT01628289|screening|screening
353689|NCT01628289|co-payment|co-payment
353690|NCT01628289|health service|health service
353691|NCT01628276|Multiple Sclerosis|multiple sclerosis
353692|NCT01628276|MRI Scans|mri scans
353693|NCT01628263|PICU|picu
353694|NCT01628263|Follow up|follow up
353695|NCT01628263|PTSD|ptsd
353696|NCT01628224|Task saturation|task saturation
353697|NCT01628211|hyperthermic chemotherapy|hyperthermic chemotherapy
353698|NCT01628211|intraperitoneal chemotherapy|intraperitoneal chemotherapy
353699|NCT01628211|second-look laparoscopy|second-look laparoscopy
353700|NCT01628211|peritoneal carcinosis|peritoneal carcinosis
353701|NCT01628211|mucinous colorectal cancer|mucinous colorectal cancer
353702|NCT01628198|Hypertension|hypertension
353703|NCT01628198|renal denervation|renal denervation
353704|NCT01628198|renal ablation|renal ablation
353705|NCT01628198|uncontrolled high blood pressure|uncontrolled high blood pressure
353706|NCT01628172|renal sympathetic denervation|renal sympathetic denervation
353707|NCT01628172|renal catheter ablation|renal catheter ablation
353708|NCT01628172|hypertension|hypertension
353709|NCT01628146|Presbyopia|presbyopia
353710|NCT01628146|hyperopia|hyperopia
353711|NCT01628146|Supracor|supracor
353712|NCT01628146|contrast sensitivity|contrast sensitivity
353713|NCT01628133|Transfusion|transfusion
353714|NCT01628133|Neonate|neonate
353715|NCT01628133|Infant, Very Low Birth Weight|infant, very low birth weight
353716|NCT01628133|Patent Ductus Arteriosus|patent ductus arteriosus
353717|NCT01628133|Packed Red Blood Cell|packed red blood cell
353718|NCT01628120|Chronic renal failure|chronic renal failure
353719|NCT01628120|Hemodialysis|hemodialysis
353720|NCT01628107|Chronic renal failure|chronic renal failure
353721|NCT01628107|hemodialysis|hemodialysis
353722|NCT01628081|psoriasis|psoriasis
353723|NCT01628081|Alga Dunaliella Bardawil|alga dunaliella bardawil
353724|NCT01628068|Left atrial appendage occlusion|left atrial appendage occlusion
353725|NCT01628068|gastrointestinal bleeding|gastrointestinal bleeding
353726|NCT01628055|IVIg|ivig
353727|NCT01628055|Acute Ischemic Stroke|acute ischemic stroke
353728|NCT01628055|Stroke|stroke
353729|NCT01628055|CVA|cva
353730|NCT01628055|Cerebrovascular Accident|cerebrovascular accident
353731|NCT01628029|Advanced Cancers|advanced cancers
353732|NCT01628029|Metastatic|metastatic
353733|NCT01628029|Locally advanced|locally advanced
353734|NCT01628029|Sleep disturbance|sleep disturbance
353735|NCT01628029|Sleep problems|sleep problems
353736|NCT01628029|Litebook|litebook
353737|NCT01628029|Melatonin|melatonin
353738|NCT01628029|Methylphenidate|methylphenidate
353739|NCT01628029|Methylphenidate hydrochloride|methylphenidate hydrochloride
353740|NCT01628029|Ritalin|ritalin
353741|NCT01628029|Concerta|concerta
353742|NCT01628029|Placebo|placebo
353743|NCT01628029|Supportive counseling|supportive counseling
353744|NCT01628029|Questionnaires|questionnaires
353745|NCT01628029|Study Diaries|study diaries
353746|NCT01628016|depression|depression
353747|NCT01628016|attention|attention
353748|NCT01628016|training|training
353749|NCT01628016|modification|modification
353750|NCT01628003|Traumatic Brain Injury|traumatic brain injury
353751|NCT01628003|long-term outcome|long-term outcome
353752|NCT01628003|Brain Reserves|brain reserves
353753|NCT01628003|Cognitive Reserves|cognitive reserves
353754|NCT01628003|Emotional Reserves|emotional reserves
353755|NCT01628003|Patients 1 year or more after Moderate or Severe Traumatic Brain Injury|patients 1 year or more after moderate or severe traumatic brain injury
353756|NCT01627990|cytotoxic chemotherapy|cytotoxic chemotherapy
353757|NCT01627990|G-CSF|g-csf
353758|NCT01627990|Solid tumour|solid tumour
353759|NCT01627990|Malignant haematological tumour|malignant haematological tumour
353760|NCT01627977|chromovitrectomy|chromovitrectomy
353761|NCT01627977|epiretinal membrane|epiretinal membrane
353762|NCT01627964|Heart Wall Motion Function|heart wall motion function
353763|NCT01627951|Plasmodium falciparum|plasmodium falciparum
353764|NCT01627951|malaria|malaria
353765|NCT01627938|Multiple Sclerosis|multiple sclerosis
353766|NCT01627938|MS|ms
353767|NCT01627938|Mitoxantrone|mitoxantrone
353768|NCT01627938|Dexrazoxane|dexrazoxane
353769|NCT01627938|Cardioxane|cardioxane
353770|NCT01627938|cardiotoxicity|cardiotoxicity
353771|NCT01627938|cardiac toxicity|cardiac toxicity
353772|NCT01627938|cardiotoxic side effects|cardiotoxic side effects
353773|NCT01627938|cardiac MRI|cardiac mri
353774|NCT01627938|cranial MRI|cranial mri
353775|NCT01627938|LVEF|lvef
353776|NCT01627938|neurological outcome|neurological outcome
353777|NCT01627925|nasal positive airway pressure|nasal positive airway pressure
353778|NCT01627925|upper airway obstruction|upper airway obstruction
353779|NCT01627925|mask ventilation|mask ventilation
353780|NCT01627912|wine|wine
353781|NCT01627912|inflammation|inflammation
353782|NCT01627912|oxidative stress|oxidative stress
353783|NCT01627912|randomized control trial|randomized control trial
353784|NCT01627912|postprandial intervention|postprandial intervention
353785|NCT01627912|platelet aggregation|platelet aggregation
353786|NCT01627912|haemostasis|haemostasis
353787|NCT01627912|robola|robola
353788|NCT01627912|cabernet sauvignon|cabernet sauvignon
353789|NCT01627912|alcohol|alcohol
353790|NCT01627912|PAF metabolism|paf metabolism
353791|NCT01627899|Blood glucose monitor|blood glucose monitor
353792|NCT01627899|Pattern management|pattern management
353793|NCT01627899|Pattern guide|pattern guide
353794|NCT01627899|Education|education
353795|NCT01627886|Bioequivalence|bioequivalence
353796|NCT01627886|Ibandronate Sodium|ibandronate sodium
353797|NCT01627886|crossover|crossover
353798|NCT01627873|Major abdominal surgery|major abdominal surgery
353799|NCT01627873|analgesic method|analgesic method
353800|NCT01627873|Fentanyl|fentanyl
353801|NCT01627873|Remifentanyl|remifentanyl
353802|NCT01627873|Postoperative cognitive disorder|postoperative cognitive disorder
353803|NCT01627873|Pro and anti inflammatory cytokines|pro and anti inflammatory cytokines
353804|NCT01627860|Epilepsy|epilepsy
353805|NCT01627860|Topiramate|topiramate
353806|NCT01627860|Neuro-surgical patients|neuro-surgical patients
353807|NCT01627860|Nervous disorder|nervous disorder
353808|NCT01627860|Seizures|seizures
353809|NCT01627847|Bioequivalence|bioequivalence
353810|NCT01627847|Ropinirole Hydrochloride|ropinirole hydrochloride
353811|NCT01627847|crossover|crossover
353812|NCT01627834|Bioequivalence|bioequivalence
353813|NCT01627834|Ropinirole Hydrochloride|ropinirole hydrochloride
353814|NCT01627834|crossover|crossover
353815|NCT01627821|Heart Failure|heart failure
353816|NCT01627808|intraoperative monitoring|intraoperative monitoring
353817|NCT01627808|fluid management|fluid management
353818|NCT01627795|Malignant Mesothelioma|malignant mesothelioma
353819|NCT01627795|Cancer|cancer
353820|NCT01627795|Anti cancer agents|anti cancer agents
353821|NCT01627782|Major depressive disorder|major depressive disorder
353822|NCT01627782|Treatment-resistant depression|treatment-resistant depression
353823|NCT01627782|Ketamine|ketamine
353824|NCT01627769|scars|scars
353825|NCT01627769|blisters|blisters
353826|NCT01627769|second degree burns|second degree burns
353827|NCT01627769|cryosurgery|cryosurgery
353828|NCT01627769|keloid scars|keloid scars
353829|NCT01627769|hypertrophic scars|hypertrophic scars
353830|NCT01627756|Thoracic Surgery|thoracic surgery
353831|NCT01627756|Endotoxins|endotoxins
353832|NCT01627756|Respiration, Artificial|respiration, artificial
353833|NCT01627756|Immune System|immune system
353834|NCT01627743|CDLM|cdlm
353835|NCT01627743|visual scale - physician evaluation|visual scale - physician evaluation
353836|NCT01627743|COPD|copd
353837|NCT01627743|GOLD group C and D|gold group c and d
353838|NCT01627717|maraviroc|maraviroc
353839|NCT01627717|boceprevir|boceprevir
353840|NCT01627717|HIV|hiv
353841|NCT01627717|HCV|hcv
353842|NCT01627717|drug interaction|drug interaction
353843|NCT01627717|pharmacokinetics|pharmacokinetics
353844|NCT01627704|PET/CT,fluoroestradiol (18F)|pet/ct,fluoroestradiol (18f)
353845|NCT01627704|breast cancer|breast cancer
353846|NCT01627704|metastatic|metastatic
353847|NCT01627704|prediction of response|prediction of response
353848|NCT01627704|hormone therapy|hormone therapy
353849|NCT01627678|HIV-1, Vacc-C5|hiv-1, vacc-c5
353850|NCT01627665|dabigatran|dabigatran
353851|NCT01627665|rivaroxaban|rivaroxaban
353852|NCT01627665|PKC|pkc
353853|NCT01627665|PKD|pkd
353854|NCT01627665|p-glycoprotein|p-glycoprotein
353855|NCT01627665|polymorphism|polymorphism
353856|NCT01627652|hypoxia|hypoxia
353857|NCT01627626|xerostomia|xerostomia
353858|NCT01627626|pilocarpine mouthwash|pilocarpine mouthwash
353859|NCT01627626|minor salivary gland secretion|minor salivary gland secretion
353860|NCT01627600|stroke|stroke
353861|NCT01627600|myocardial infarction|myocardial infarction
353862|NCT01627600|cardiovascular health|cardiovascular health
353863|NCT01627600|population study|population study
353864|NCT01627587|preterm labor|preterm labor
353865|NCT01627574|Pregnancy|pregnancy
353866|NCT01627574|STI prevention|sti prevention
353867|NCT01627574|adolescents|adolescents
353868|NCT01627574|probation|probation
353869|NCT01627561|Immune response|immune response
353870|NCT01627561|Human papillomavirus|human papillomavirus
353871|NCT01627561|HPV vaccine|hpv vaccine
353872|NCT01627561|Safety|safety
353873|NCT01627548|PTSD|ptsd
353874|NCT01627548|Couples|couples
353875|NCT01627548|Combat Veteran|combat veteran
353876|NCT01627548|Warfighter|warfighter
353877|NCT01627548|OEF|oef
353878|NCT01627548|OIF|oif
353879|NCT01627548|OND|ond
353880|NCT01627548|Structured Approach Therapy|structured approach therapy
353881|NCT01627548|Trauma|trauma
353882|NCT01627535|Brain Tumor|brain tumor
353883|NCT01627509|continuous glucose monitoring system|continuous glucose monitoring system
353884|NCT01627509|hypoglycemia|hypoglycemia
353885|NCT01627509|insulin regimen|insulin regimen
353886|NCT01627509|basal bolus therapy|basal bolus therapy
353887|NCT01627509|modern premixed insulin|modern premixed insulin
353888|NCT01627509|diabetes control|diabetes control
353889|NCT01627496|malnutrition|malnutrition
353890|NCT01627496|elderly care|elderly care
353891|NCT01627496|quality of life|quality of life
353892|NCT01627496|hospital|hospital
353893|NCT01627483|elderly|elderly
353894|NCT01627483|hip fracture|hip fracture
353895|NCT01627483|osteoporosis|osteoporosis
353896|NCT01627483|fall risk|fall risk
353897|NCT01627483|medication review|medication review
353898|NCT01627470|non-invasive arterial pressure|non-invasive arterial pressure
353899|NCT01627470|emergency|emergency
353900|NCT01627470|intensive care|intensive care
353901|NCT01627457|Coronary Artery Disease|coronary artery disease
353902|NCT01627457|Guided Exercise System including ECG Vest with vital signs sensors and PDA|guided exercise system including ecg vest with vital signs sensors and pda
353903|NCT01627457|Validation Telemedical Device in regard to accuracy and safety of data|validation telemedical device in regard to accuracy and safety of data
353904|NCT01627457|Homely Rehabilitation|homely rehabilitation
353905|NCT01627457|Practicability and technical problems at home|practicability and technical problems at home
353906|NCT01627444|Acupuncture|acupuncture
353907|NCT01627444|Anxiety|anxiety
353908|NCT01627444|Human Milk|human milk
353909|NCT01627444|Very low birth weight infants|very low birth weight infants
353910|NCT01627444|Mother of very low birth weight infants|mother of very low birth weight infants
353911|NCT01627431|PAD|pad
353912|NCT01627431|Peripheral revascularization|peripheral revascularization
353913|NCT01627431|Antiplatelet therapy|antiplatelet therapy
353914|NCT01627431|Residual platelet activity|residual platelet activity
353915|NCT01627418|COPD|copd
353916|NCT01627418|CORD|cord
353917|NCT01627418|COAD|coad
353918|NCT01627379|nonresectable|nonresectable
353919|NCT01627379|advanced|advanced
353920|NCT01627379|metastatic esophageal squamous cell cancer|metastatic esophageal squamous cell cancer
353921|NCT01627379|Panitumumab|panitumumab
353922|NCT01627353|Hysterectomy|hysterectomy
353923|NCT01627353|Pain Prevention|pain prevention
353924|NCT01627353|Wound Infiltration|wound infiltration
353925|NCT01627340|hepatitis B|hepatitis b
353926|NCT01627340|adults|adults
353927|NCT01627340|Type 2 diabetes mellitus|type 2 diabetes mellitus
353928|NCT01627340|Engerix™-B|engerix™-b
353929|NCT01627327|Cardiovascular event|cardiovascular event
353930|NCT01627327|Cardiovascular disease|cardiovascular disease
353931|NCT01627275|Naive T Cell Depletion|naive t cell depletion
353932|NCT01627275|Donor Lymphocyte Infusion|donor lymphocyte infusion
353933|NCT01627275|Allogeneic Hematopoietic Stem Cell Transplant|allogeneic hematopoietic stem cell transplant
353934|NCT01627262|diverticular disease|diverticular disease
353935|NCT01627262|colonic diverticulosis|colonic diverticulosis
353936|NCT01627262|mesalamine|mesalamine
353937|NCT01627262|placebo|placebo
353938|NCT01627262|randomized|randomized
353939|NCT01627249|Diabetic Macular Edema|diabetic macular edema
353940|NCT01627249|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
353941|NCT01627223|Spontaneous Severe Acute Exacerbation of Chronic Hepatitis B|spontaneous severe acute exacerbation of chronic hepatitis b
353942|NCT01627223|Lamivudine (Zeffix®)|lamivudine (zeffix®)
353943|NCT01627223|Entecavir (Baraclude®)|entecavir (baraclude®)
353944|NCT01627210|Diabetes Mellitus|diabetes mellitus
353945|NCT01627197|Effects of Chemotherapy|effects of chemotherapy
353946|NCT01627197|intraarterial chemotherapy|intraarterial chemotherapy
353947|NCT01627145|overactive bladder syndrome|overactive bladder syndrome
353948|NCT01627145|derusor overactivity|derusor overactivity
353949|NCT01627145|urodynamic studies|urodynamic studies
353950|NCT01627145|bladder oversensitivity|bladder oversensitivity
353951|NCT01627119|CTGF|ctgf
353952|NCT01627119|Peritoneal metastasis|peritoneal metastasis
353953|NCT01627093|Head and Neck Cancer|head and neck cancer
353954|NCT01627093|Head and Neck Malignancies|head and neck malignancies
353955|NCT01627093|Chart Review|chart review
353956|NCT01627093|Proton Radiation Therapy|proton radiation therapy
353957|NCT01627080|Esophagus|esophagus
353958|NCT01627080|Esophageal Cancer|esophageal cancer
353959|NCT01627080|Radiation therapy|radiation therapy
353960|NCT01627080|RT|rt
353961|NCT01627080|Chemotherapy|chemotherapy
353962|NCT01627080|Mid thoracic tumor|mid thoracic tumor
353963|NCT01627080|Distal esophageal tumor|distal esophageal tumor
353964|NCT01627080|Gastroesophageal junction tumor|gastroesophageal junction tumor
353965|NCT01627080|Cardiac biomarkers|cardiac biomarkers
353966|NCT01627067|Breast Cancer|breast cancer
353967|NCT01627067|Hormone Receptor Positive Metastatic Breast Cancer|hormone receptor positive metastatic breast cancer
353968|NCT01627067|Hormone-sensitive|hormone-sensitive
353969|NCT01627067|Postmenopausal|postmenopausal
353970|NCT01627067|Body Mass Index|body mass index
353971|NCT01627067|BMI|bmi
353972|NCT01627067|Everolimus|everolimus
353973|NCT01627067|Afinitor|afinitor
353974|NCT01627067|RAD001|rad001
353975|NCT01627067|Exemestane|exemestane
353976|NCT01627067|Aromasin|aromasin
353977|NCT01627067|Metformin|metformin
353978|NCT01627028|Thai traditional massage|thai traditional massage
353979|NCT01627028|Bone formation|bone formation
353980|NCT01627028|Bone resorption|bone resorption
353981|NCT01627015|Fully formula fed|fully formula fed
353982|NCT01627002|Phase 1|phase 1
353983|NCT01627002|First in Human|first in human
353984|NCT01627002|Healthy Volunteers|healthy volunteers
353985|NCT01627002|Lipopolysaccharide Challenge|lipopolysaccharide challenge
353986|NCT01626976|safety|safety
353987|NCT01626976|tolerability|tolerability
353988|NCT01626976|pharmacokinetics|pharmacokinetics
353989|NCT01626976|oral|oral
353990|NCT01626976|single ascending dose|single ascending dose
353991|NCT01626976|placebo-controlled|placebo-controlled
353992|NCT01626976|healthy subjects|healthy subjects
353993|NCT01626963|single-port access|single-port access
353994|NCT01626963|laparoscopic surgery|laparoscopic surgery
353995|NCT01626963|surgical trauma|surgical trauma
353996|NCT01626950|Breast cancer|breast cancer
353997|NCT01626950|living conditions|living conditions
353998|NCT01626950|social fragility|social fragility
353999|NCT01626937|Acute respiratory failure|acute respiratory failure
354000|NCT01626937|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
354001|NCT01626937|Non invasive ventilation|non invasive ventilation
354002|NCT01626937|Out of hospital|out of hospital
354003|NCT01626924|Perinatal Asphyxia|perinatal asphyxia
354004|NCT01626924|Neonatal encephalopathy|neonatal encephalopathy
354005|NCT01626924|Oxygen shortage at birth|oxygen shortage at birth
354006|NCT01626924|Antenatal asphyxia|antenatal asphyxia
354007|NCT01626924|hypoxia-ischaemia|hypoxia-ischaemia
354008|NCT01626924|birth asphyxia|birth asphyxia
354009|NCT01626924|asphyxia neonatorum|asphyxia neonatorum
354010|NCT01626911|severe acute pancreatitis;|severe acute pancreatitis;
354011|NCT01626911|continuous regional arterial infusion;|continuous regional arterial infusion;
354115|NCT01626326|smoking|smoking
354012|NCT01626911|low molecular weight heparin|low molecular weight heparin
354013|NCT01626885|Schizophrenia|schizophrenia
354014|NCT01626885|Antipsychotic Agents|antipsychotic agents
354015|NCT01626885|Mental Disorder|mental disorder
354016|NCT01626885|Psychotropic Drugs|psychotropic drugs
354017|NCT01626885|Dopamine Agents|dopamine agents
354018|NCT01626885|Central Nervous System Agents|central nervous system agents
354019|NCT01626872|Schizophrenia|schizophrenia
354020|NCT01626872|Antipsychotic Agents|antipsychotic agents
354021|NCT01626872|Mental Disorder|mental disorder
354022|NCT01626872|Psychotropic Drugs|psychotropic drugs
354023|NCT01626872|Dopamine Agents|dopamine agents
354024|NCT01626872|Risperidone|risperidone
354025|NCT01626872|Central Nervous System Agents|central nervous system agents
354026|NCT01626859|Schizophrenia|schizophrenia
354027|NCT01626859|Antipsychotic Agents|antipsychotic agents
354028|NCT01626859|Mental Disorder|mental disorder
354029|NCT01626859|Psychotropic Drugs|psychotropic drugs
354030|NCT01626859|Dopamine Agents|dopamine agents
354031|NCT01626859|Central Nervous System Agents|central nervous system agents
354032|NCT01626846|Neurofibromatosis|neurofibromatosis
354033|NCT01626833|anorexia nervosa|anorexia nervosa
354035|NCT01626833|Growth velocity|growth velocity
354036|NCT01626820|Immunogenicity|immunogenicity
354037|NCT01626820|Influenza|influenza
354038|NCT01626820|Safety|safety
354039|NCT01626820|Adults|adults
354040|NCT01626820|Fluviral|fluviral
354041|NCT01626807|Safe Routes to School|safe routes to school
354042|NCT01626807|Walking School Bus|walking school bus
354043|NCT01626807|Cluster Randomized Controlled Trial|cluster randomized controlled trial
354044|NCT01626807|Physical Activity|physical activity
354045|NCT01626807|Obesity|obesity
354046|NCT01626807|Overweight|overweight
354047|NCT01626755|Phantom limb pain|phantom limb pain
354048|NCT01626755|Chronic pain|chronic pain
354049|NCT01626755|Amputation|amputation
354050|NCT01626755|Peripheral vascular disease|peripheral vascular disease
354051|NCT01626729|Food Labeling|food labeling
354052|NCT01626677|Umbilical Cord Blood|umbilical cord blood
354053|NCT01626677|Mesenchymal Stem Cells|mesenchymal stem cells
354054|NCT01626677|Cartilage injury|cartilage injury
354055|NCT01626677|Osteoarthritis|osteoarthritis
354056|NCT01626664|Adult T cell Leukemia-Lymphoma (ATL)|adult t cell leukemia-lymphoma (atl)
354057|NCT01626651|Healthy|healthy
354058|NCT01626651|Ketoconazole|ketoconazole
354059|NCT01626651|Ibrutinib|ibrutinib
354060|NCT01626638|Patients with malignant and pre-malignant pharyngo laryngeal tumors|patients with malignant and pre-malignant pharyngo laryngeal tumors
354061|NCT01626625|nonunion|nonunion
354062|NCT01626625|stem cells|stem cells
354063|NCT01626625|autograft|autograft
354064|NCT01626625|hydroxyapatite|hydroxyapatite
354065|NCT01626599|ECG|ecg
354066|NCT01626599|Accelerometer|accelerometer
354067|NCT01626599|Device|device
354068|NCT01626586|Youth|youth
354069|NCT01626586|Family|family
354070|NCT01626586|Group Therapy|group therapy
354071|NCT01626586|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
354072|NCT01626586|Self-Management|self-management
354073|NCT01626573|Rheumatoid Arthritis|rheumatoid arthritis
354074|NCT01626573|RA|ra
354075|NCT01626573|Active|active
354076|NCT01626547|symptomatic anameia|symptomatic anameia
354077|NCT01626508|breast milk|breast milk
354078|NCT01626508|breast-milk bank|breast-milk bank
354079|NCT01626508|plasma profile|plasma profile
354080|NCT01626508|essential fatty acids|essential fatty acids
354081|NCT01626495|Biological: CART19|biological: cart19
354082|NCT01626443|PCOS|pcos
354083|NCT01626443|Metabolic disorders|metabolic disorders
354084|NCT01626443|Ovarian functionality|ovarian functionality
354085|NCT01626443|Myo-inositol|myo-inositol
354086|NCT01626443|D-chiro-inositol|d-chiro-inositol
354087|NCT01626430|Gamma delta TRF|gamma delta trf
354088|NCT01626430|Insulin sensitivity|insulin sensitivity
354089|NCT01626430|Postprandial lipaemia|postprandial lipaemia
354090|NCT01626430|Inflammatory markers|inflammatory markers
354091|NCT01626430|NF-κB|nf-κb
354092|NCT01626417|Stroke|stroke
354093|NCT01626417|Tibion|tibion
354094|NCT01626417|Bionics|bionics
354095|NCT01626417|Rehab|rehab
354096|NCT01626417|Therapy|therapy
354097|NCT01626417|Robotics|robotics
354098|NCT01626417|Intention|intention
354099|NCT01626404|Thoratec Corporation|thoratec corporation
354100|NCT01626391|Alzheimer's Disease|alzheimer's disease
354101|NCT01626391|TRx0237|trx0237
354102|NCT01626391|Safety Study|safety study
354103|NCT01626391|AD|ad
354104|NCT01626378|Behavioral Variant Frontotemporal Dementia|behavioral variant frontotemporal dementia
354105|NCT01626378|bvFTD|bvftd
354106|NCT01626378|Frontotemporal Dementia|frontotemporal dementia
354107|NCT01626365|double-lumen tube|double-lumen tube
354108|NCT01626365|intubation|intubation
354109|NCT01626365|thermosoftening|thermosoftening
354110|NCT01626352|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
354111|NCT01626352|Ofatumumab|ofatumumab
354112|NCT01626352|Bendamustine|bendamustine
354113|NCT01626339|Anti vascular endothelial growth factor|anti vascular endothelial growth factor
354114|NCT01626339|retinal vessels|retinal vessels
354116|NCT01626326|smoking cessation|smoking cessation
354117|NCT01626326|mobile app|mobile app
354118|NCT01626313|Veteran families|veteran families
354119|NCT01626313|OEF|oef
354120|NCT01626313|OIF|oif
354121|NCT01626313|OND|ond
354122|NCT01626313|Resiliency|resiliency
354123|NCT01626313|Psycho educational training|psycho educational training
354124|NCT01626313|Stress|stress
354125|NCT01626313|Military|military
354126|NCT01626287|perineal|perineal
354127|NCT01626287|postpartum|postpartum
354128|NCT01626287|pain|pain
354129|NCT01626287|treatment|treatment
354130|NCT01626287|ice and black tea|ice and black tea
354131|NCT01626287|maternal satisfaction|maternal satisfaction
354132|NCT01626274|Polysomnography|polysomnography
354133|NCT01626274|Long term vital signs monitoring|long term vital signs monitoring
354134|NCT01626274|In-ear sensor system|in-ear sensor system
354135|NCT01626274|Photoplethysmographic micro-optic device|photoplethysmographic micro-optic device
354136|NCT01626274|High wearing comfort|high wearing comfort
354137|NCT01626248|Immunological|immunological
354138|NCT01626248|biomarkers|biomarkers
354139|NCT01626248|observational|observational
354140|NCT01626248|RRMS|rrms
354141|NCT01626248|Relapsing|relapsing
354142|NCT01626248|Remitting Multiple Sclerosis|remitting multiple sclerosis
354143|NCT01626235|pain control|pain control
354144|NCT01626235|fractures|fractures
354145|NCT01626235|sprains|sprains
354146|NCT01626235|strains|strains
354147|NCT01626235|dysmenorrhea|dysmenorrhea
354148|NCT01626235|kidney stones|kidney stones
354149|NCT01626235|gouty arthritis|gouty arthritis
354150|NCT01626235|opioids|opioids
354151|NCT01626235|NSDAIDs|nsdaids
354152|NCT01626235|Emergency Department|emergency department
354153|NCT01626235|patient reported outcomes|patient reported outcomes
354154|NCT01626222|Postmenopausal|postmenopausal
354155|NCT01626222|Estrogen Receptor Positive|estrogen receptor positive
354156|NCT01626222|HER2 negative|her2 negative
354157|NCT01626222|Locally Advanced|locally advanced
354158|NCT01626222|Metastatic Breast Cancer|metastatic breast cancer
354159|NCT01626222|Everolimus (RAD001)|everolimus (rad001)
354160|NCT01626222|Exemestane|exemestane
354161|NCT01626209|Breast cancer, NSCLC, SCCHN, esophageal cancer|breast cancer, nsclc, scchn, esophageal cancer
354162|NCT01626183|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
354163|NCT01626183|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
354164|NCT01626144|Exemestane|exemestane
354165|NCT01626144|Metabolism|metabolism
354166|NCT01626144|Metabolizing enzyme genotype|metabolizing enzyme genotype
354167|NCT01626144|Breast cancer|breast cancer
354168|NCT01626131|combat disorders|combat disorders
354169|NCT01626131|exercise therapy|exercise therapy
354170|NCT01626105|Hemophilia A|hemophilia a
354171|NCT01626105|Factor VIII|factor viii
354172|NCT01626105|Inhibitors|inhibitors
354173|NCT01626105|Immunogenicity|immunogenicity
354174|NCT01626105|Pharmacogenetics|pharmacogenetics
354175|NCT01626105|Mutation|mutation
354176|NCT01626105|Nonsynonymous Single Nucleotide Polymorphisms|nonsynonymous single nucleotide polymorphisms
354177|NCT01626105|Class II Human Leukocyte Antigens|class ii human leukocyte antigens
354178|NCT01626092|bone marrow transplantation|bone marrow transplantation
354179|NCT01626092|reduced intensity conditioning|reduced intensity conditioning
354180|NCT01626092|Adrenoleukodystrophy|adrenoleukodystrophy
354181|NCT01626092|Metachromatic Leukodystrophy|metachromatic leukodystrophy
354182|NCT01626092|Globoid Cell Leukodystrophy|globoid cell leukodystrophy
354183|NCT01626092|Wolman's disease|wolman's disease
354184|NCT01626092|GM1 gangliosidosis|gm1 gangliosidosis
354185|NCT01626092|Tay Sachs disease|tay sachs disease
354186|NCT01626092|Sanfilippo syndrome|sanfilippo syndrome
354187|NCT01626092|Sandhoff disease|sandhoff disease
354188|NCT01626092|inherited metabolic|inherited metabolic
354189|NCT01626092|I-cell disease|i-cell disease
354190|NCT01626092|mucolipidosis II|mucolipidosis ii
354191|NCT01626079|Functional Mitral Regurgitation|functional mitral regurgitation
354192|NCT01626079|Mitral Valve Regurgitation|mitral valve regurgitation
354193|NCT01626079|Symptomatic Heart Failure|symptomatic heart failure
354194|NCT01626079|Functional MR|functional mr
354195|NCT01626079|MitraClip|mitraclip
354196|NCT01626079|Mitral Valve Insufficiency|mitral valve insufficiency
354197|NCT01626079|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
354198|NCT01626079|COAPT CAS|coapt cas
354199|NCT01626079|COAPT Continued Access Study|coapt continued access study
354200|NCT01626079|MitraClip NT|mitraclip nt
354201|NCT01626053|psychological|psychological
354202|NCT01626053|intervention|intervention
354203|NCT01626053|stages of change|stages of change
354204|NCT01626053|motivational interviewing|motivational interviewing
354205|NCT01626053|coping skills|coping skills
354206|NCT01626053|HbA1C|hba1c
354207|NCT01626053|psychological testing|psychological testing
354208|NCT01626053|integrated care|integrated care
354209|NCT01626053|behavioral health|behavioral health
354210|NCT01626027|Coronary Heart Disease|coronary heart disease
354211|NCT01626027|Depression|depression
354212|NCT01626027|Health Care Services|health care services
354213|NCT01626014|Stage III ovarian cancer|stage iii ovarian cancer
354214|NCT01626014|Stage IV ovarian cancer|stage iv ovarian cancer
354215|NCT01626014|recurrent ovarian cancer|recurrent ovarian cancer
354216|NCT01626014|primary peritoneal cancer|primary peritoneal cancer
354217|NCT01626014|fallopian tube cancer|fallopian tube cancer
354218|NCT01626001|Esophagus Cancer|esophagus cancer
354219|NCT01626001|Lung Cancer|lung cancer
354220|NCT01626001|4-dimensional computed tomography|4-dimensional computed tomography
354221|NCT01626001|4D CT|4d ct
354222|NCT01625975|Growth modulation|growth modulation
354223|NCT01625975|Eight plate|eight plate
354224|NCT01625975|Leg length discrepancy|leg length discrepancy
354225|NCT01625975|Varus/valgus deformities|varus/valgus deformities
354226|NCT01625975|Pediatric|pediatric
354227|NCT01625962|PTSD|ptsd
354228|NCT01625962|mTBI|mtbi
354229|NCT01625962|mild TBI|mild tbi
354230|NCT01625962|extracranial injury|extracranial injury
354231|NCT01625962|ECI|eci
354232|NCT01625962|Brain Indices|brain indices
354233|NCT01625949|myocardial infarction|myocardial infarction
354234|NCT01625936|metastatic|metastatic
354235|NCT01625936|locally advanced|locally advanced
354236|NCT01625936|unresectable|unresectable
354237|NCT01625923|Gastroparesis|gastroparesis
354238|NCT01625923|Idiopathic|idiopathic
354239|NCT01625923|Olanzapine|olanzapine
354240|NCT01625910|Childhood obesity treatment|childhood obesity treatment
354241|NCT01625910|Motivational interviewing|motivational interviewing
354242|NCT01625897|Schizophrenia|schizophrenia
354243|NCT01625897|Antipsychotic Agents|antipsychotic agents
354244|NCT01625897|Mental Disorder|mental disorder
354245|NCT01625897|Psychotropic Drugs|psychotropic drugs
354246|NCT01625897|Dopamine Agents|dopamine agents
354247|NCT01625897|Risperidone|risperidone
354248|NCT01625897|Central Nervous System Agents|central nervous system agents
354249|NCT01625884|Statin|statin
354250|NCT01625884|Hypercholesterolemia|hypercholesterolemia
354251|NCT01625871|malaria|malaria
354252|NCT01625871|vivax|vivax
354253|NCT01625871|artemether/lumefantrine|artemether/lumefantrine
354255|NCT01625858|LMA Supreme|lma supreme
354256|NCT01625845|Major Depressive Disorder|major depressive disorder
354257|NCT01625845|Depression|depression
354258|NCT01625845|Depressive Symptoms|depressive symptoms
354259|NCT01625845|Cardiovascular Disease (CVD)|cardiovascular disease (cvd)
354260|NCT01625845|Coronary Artery Disease (CAD)|coronary artery disease (cad)
354261|NCT01625845|Heart Disease|heart disease
354262|NCT01625845|Endothelial Function|endothelial function
354263|NCT01625845|Inflammation|inflammation
354264|NCT01625832|intermittent coronary sinus occlusion|intermittent coronary sinus occlusion
354265|NCT01625832|collateral flow index|collateral flow index
354266|NCT01625832|collateral circulation|collateral circulation
354267|NCT01625832|coronary artery occlusion|coronary artery occlusion
354268|NCT01625819|Tai Chi|tai chi
354269|NCT01625793|Hepatitis C|hepatitis c
354270|NCT01625793|interferon|interferon
354271|NCT01625793|stress|stress
354272|NCT01625793|social behavior|social behavior
354273|NCT01625767|Nicotine|nicotine
354274|NCT01625767|Smoking|smoking
354275|NCT01625767|Adolescent|adolescent
354276|NCT01625767|Tobacco|tobacco
354277|NCT01625754|Ceramides|ceramides
354278|NCT01625754|Lipids|lipids
354279|NCT01625728|Voice|voice
354280|NCT01625728|aerodynamics|aerodynamics
354281|NCT01625728|acoustics|acoustics
354282|NCT01625715|peanut allergy|peanut allergy
354283|NCT01625702|no-prior chemotherapy|no-prior chemotherapy
354284|NCT01625689|Influenza vaccines|influenza vaccines
354285|NCT01625689|Influenza, Human|influenza, human
354286|NCT01625689|Live Attenuated Influenza Vaccine|live attenuated influenza vaccine
354287|NCT01625676|Aphasia|aphasia
354288|NCT01625676|Rehabilitation of Speech and Language Disorders|rehabilitation of speech and language disorders
354289|NCT01625663|barth syndrome|barth syndrome
354290|NCT01625663|heart failure|heart failure
354291|NCT01625663|mitochondria|mitochondria
354292|NCT01625663|metabolism|metabolism
354293|NCT01625663|amino acid|amino acid
354294|NCT01625650|Rheumatoid Arthritis|rheumatoid arthritis
354295|NCT01625650|Registry|registry
354296|NCT01625650|RA|ra
354297|NCT01625650|Biologic|biologic
354298|NCT01625650|Medications|medications
354299|NCT01625650|Rheumatology|rheumatology
354300|NCT01625637|Nicotine|nicotine
354301|NCT01625637|Smoking|smoking
354302|NCT01625637|Adolescent|adolescent
354303|NCT01625637|Tobacco|tobacco
354304|NCT01625611|Alcohol|alcohol
354305|NCT01625611|Drinking|drinking
354306|NCT01625611|Drinkers|drinkers
354307|NCT01625611|Alcohol Drinking|alcohol drinking
354308|NCT01625611|Naltrexone|naltrexone
354309|NCT01625611|Alcohol Dependence|alcohol dependence
354310|NCT01625611|Alcohol Abuse|alcohol abuse
354311|NCT01625611|Alcohol-Related Disorders|alcohol-related disorders
354312|NCT01625611|Ethanol|ethanol
354313|NCT01625611|Alcoholism|alcoholism
354314|NCT01625598|Nonproliferative diabetic retinopathy|nonproliferative diabetic retinopathy
354315|NCT01625598|diabetic macular edema|diabetic macular edema
354412|NCT01625234|NSCLC|nsclc
354316|NCT01625598|proliferative diabetic retinopathy|proliferative diabetic retinopathy
354317|NCT01625598|ophthalmologists|ophthalmologists
354318|NCT01625598|dilated eye exam|dilated eye exam
354319|NCT01625585|Push-and-Pull Enteroscopy|push-and-pull enteroscopy
354320|NCT01625585|Single-Balloon-Enteroscopy|single-balloon-enteroscopy
354321|NCT01625572|general anaesthesia|general anaesthesia
354322|NCT01625572|epidural catheter|epidural catheter
354323|NCT01625572|intravenous pain therapy|intravenous pain therapy
354324|NCT01625546|Major Depressive Disorder|major depressive disorder
354325|NCT01625546|Whole Body Hyperthermia|whole body hyperthermia
354326|NCT01625533|Coronary Angiography|coronary angiography
354327|NCT01625533|Rotational Coronary Angiography|rotational coronary angiography
354328|NCT01625533|Contrast media|contrast media
354329|NCT01625533|Radiation|radiation
354330|NCT01625520|Progressive metastatic|progressive metastatic
354331|NCT01625520|postoperative persistent|postoperative persistent
354332|NCT01625468|Secondhand smoke exposure|secondhand smoke exposure
354333|NCT01625468|Smoke-free homes|smoke-free homes
354334|NCT01625468|Smoke-free home bans|smoke-free home bans
354335|NCT01625455|Sezary Syndrome|sezary syndrome
354336|NCT01625455|Pruritus|pruritus
354337|NCT01625455|Aprepitant|aprepitant
354338|NCT01625455|Neurokinin-1|neurokinin-1
354339|NCT01625442|Metabolic syndrome|metabolic syndrome
354340|NCT01625442|hypercholesterolemia|hypercholesterolemia
354341|NCT01625442|hypertriglyceridemia|hypertriglyceridemia
354342|NCT01625442|hyperglycemia|hyperglycemia
354343|NCT01625416|Posttraumatic Stress Disorder|posttraumatic stress disorder
354344|NCT01625416|Depression|depression
354345|NCT01625416|Suicide|suicide
354346|NCT01625416|Traumatic Brain Injury|traumatic brain injury
354347|NCT01625416|Alcohol Use|alcohol use
354348|NCT01625416|Drug Use|drug use
354349|NCT01625416|Information Technology|information technology
354350|NCT01625403|Recombinant BNP|recombinant bnp
354351|NCT01625403|Diuretics|diuretics
354352|NCT01625403|Acute decompensated heart failure|acute decompensated heart failure
354353|NCT01625403|Acute renal injury|acute renal injury
354354|NCT01625403|Heart function|heart function
354355|NCT01625403|Renal function|renal function
354356|NCT01625390|hemophilia, haemophilia, inhibitor, FVIIa, Factor VII activated, bypassing|hemophilia, haemophilia, inhibitor, fviia, factor vii activated, bypassing
354357|NCT01625377|Everolimus,|everolimus,
354358|NCT01625377|liver transplantation,|liver transplantation,
354359|NCT01625377|early introduction,|early introduction,
354360|NCT01625377|renal function|renal function
354361|NCT01625364|Health Education|health education
354362|NCT01625364|Health Counseling|health counseling
354363|NCT01625364|Patient Education|patient education
354364|NCT01625338|HCV genotype 2 (GT-2)|hcv genotype 2 (gt-2)
354365|NCT01625338|HCV genotype 3 (GT-3)|hcv genotype 3 (gt-3)
354366|NCT01625338|HCV|hcv
354367|NCT01625338|Sustained Virologic Response|sustained virologic response
354368|NCT01625338|Direct Acting Antiviral|direct acting antiviral
354369|NCT01625338|Combination Therapy|combination therapy
354370|NCT01625338|GS-7977|gs-7977
354371|NCT01625338|Ribavirin|ribavirin
354372|NCT01625338|Open Label|open label
354373|NCT01625325|obesity, adiposity, psychosocial, healthcare, co-morbidities, low key intervention, quality of life|obesity, adiposity, psychosocial, healthcare, co-morbidities, low key intervention, quality of life
354374|NCT01625299|intestinal permeability|intestinal permeability
354375|NCT01625299|diet|diet
354376|NCT01625299|gluten|gluten
354377|NCT01625299|dairy|dairy
354378|NCT01625286|advanced breast cancer,|advanced breast cancer,
354379|NCT01625286|metastatic breast cancer,|metastatic breast cancer,
354380|NCT01625286|ER+ve breast cancer,|er+ve breast cancer,
354381|NCT01625286|Estrogen receptor positive breast cancer,|estrogen receptor positive breast cancer,
354382|NCT01625286|PIK3CA mutated advanced or metastatic breast cancer|pik3ca mutated advanced or metastatic breast cancer
354383|NCT01625286|AKT inhibitor|akt inhibitor
354384|NCT01625273|F19|f19
354385|NCT01625273|Lactobacillus paracasei paracasei|lactobacillus paracasei paracasei
354386|NCT01625260|cancer|cancer
354387|NCT01625260|immunotherapy|immunotherapy
354388|NCT01625260|targeted|targeted
354389|NCT01625260|non-muscle invasive|non-muscle invasive
354390|NCT01625260|interleukin-2|interleukin-2
354391|NCT01625260|antitumor|antitumor
354392|NCT01625260|TCR|tcr
354393|NCT01625260|T-cell receptor|t-cell receptor
354394|NCT01625260|p53|p53
354395|NCT01625260|p53 gene|p53 gene
354396|NCT01625260|p53 tumor supressor protein|p53 tumor supressor protein
354397|NCT01625260|urothelial cancer|urothelial cancer
354398|NCT01625260|bladder cancer|bladder cancer
354399|NCT01625260|HLA-A2 positive|hla-a2 positive
354400|NCT01625260|HLA-A*0201/p53 aa264-272|hla-a*0201/p53 aa264-272
354401|NCT01625260|HLA complex|hla complex
354402|NCT01625260|refractory|refractory
354403|NCT01625260|relapsed|relapsed
354404|NCT01625260|BCG|bcg
354405|NCT01625260|multi-focal|multi-focal
354406|NCT01625260|carcinoma in situ|carcinoma in situ
354407|NCT01625260|transitional cell carcinoma|transitional cell carcinoma
354408|NCT01625260|gemcitabine|gemcitabine
354409|NCT01625234|Cancer|cancer
354410|NCT01625234|Tumors|tumors
354411|NCT01625234|ALK|alk
354413|NCT01625234|Advanced Malignancies|advanced malignancies
354414|NCT01625234|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
354415|NCT01625234|Inflammatory Myofibroblastic Tumors|inflammatory myofibroblastic tumors
354416|NCT01625221|FENIX|fenix
354417|NCT01625182|chronic inflammatory demyelinating polyradiculoneuropathy, CIDP, FTY720, fingolimod.|chronic inflammatory demyelinating polyradiculoneuropathy, cidp, fty720, fingolimod.
354418|NCT01625169|Pharmacokinetics|pharmacokinetics
354419|NCT01625169|HIV|hiv
354420|NCT01625169|Breast milk|breast milk
354421|NCT01625130|sulforaphane|sulforaphane
354422|NCT01625130|ozone|ozone
354423|NCT01625130|airway inflammation|airway inflammation
354424|NCT01625130|broccoli sprouts|broccoli sprouts
354425|NCT01625130|NRF2|nrf2
354426|NCT01625130|controls|controls
354427|NCT01625117|Treatment of ex-combatants|treatment of ex-combatants
354428|NCT01625117|Narrative Exposure Therapy for ex-combatants|narrative exposure therapy for ex-combatants
354429|NCT01625117|Appetitive Aggression|appetitive aggression
354430|NCT01625117|Posttraumatic Stress Disorder|posttraumatic stress disorder
354431|NCT01625104|Myocardial Infarction|myocardial infarction
354432|NCT01625104|Time to Treatment|time to treatment
354433|NCT01625104|Door to Balloon Time|door to balloon time
354434|NCT01625091|HIV|hiv
354435|NCT01625091|women|women
354436|NCT01625091|drinking|drinking
354437|NCT01625091|Naltrexone|naltrexone
354438|NCT01625078|Baska Mask|baska mask
354439|NCT01625078|Supraglottic airway device|supraglottic airway device
354440|NCT01625078|Children|children
354441|NCT01625078|Pediatric|pediatric
354442|NCT01625065|medication compliance|medication compliance
354443|NCT01625065|adherence|adherence
354444|NCT01625065|toxicological analyzes|toxicological analyzes
354445|NCT01625065|GC-MS|gc-ms
354446|NCT01625065|HPLC|hplc
354447|NCT01625065|pain patients|pain patients
354448|NCT01625065|opioid misuse|opioid misuse
354449|NCT01625065|patients with current pain|patients with current pain
354450|NCT01625052|mask size|mask size
354451|NCT01625052|Baska mask|baska mask
354452|NCT01625052|supraglottic airway|supraglottic airway
354453|NCT01625052|airway management|airway management
354454|NCT01625039|Occupational health|occupational health
354455|NCT01625039|cognitive behavioural therapy|cognitive behavioural therapy
354456|NCT01625039|physiotherapy|physiotherapy
354457|NCT01625039|physical activity|physical activity
354458|NCT01625026|Morbidly obesity|morbidly obesity
354459|NCT01625026|Gastric bypass|gastric bypass
354460|NCT01625026|Cholecystolithiasis|cholecystolithiasis
354461|NCT01625013|osteoarthritis|osteoarthritis
354462|NCT01625013|viscosupplementation|viscosupplementation
354463|NCT01625013|Active|active
354464|NCT01625013|Knee|knee
354465|NCT01625013|Synvisc-One|synvisc-one
354466|NCT01625000|Schizophrenia|schizophrenia
354467|NCT01625000|Antipsychotic Agents|antipsychotic agents
354468|NCT01625000|Acute Schizophrenia|acute schizophrenia
354469|NCT01625000|Mental Disorder|mental disorder
354470|NCT01625000|Psychotropic Drugs|psychotropic drugs
354471|NCT01625000|Dopamine Agents|dopamine agents
354472|NCT01625000|Risperidone|risperidone
354473|NCT01625000|Central Nervous System Agents|central nervous system agents
354474|NCT01624987|Treatment of ex-combatants|treatment of ex-combatants
354475|NCT01624987|FORNET for ex-combatants|fornet for ex-combatants
354476|NCT01624987|Appetitive Aggression|appetitive aggression
354477|NCT01624987|Post-traumatic Stress Disorder|post-traumatic stress disorder
354478|NCT01624961|Controlled human malaria infection (CHMI)|controlled human malaria infection (chmi)
354479|NCT01624961|Malaria challenge|malaria challenge
354480|NCT01624961|Plasmodium falciparum|plasmodium falciparum
354481|NCT01624961|PfSPZ Challenge|pfspz challenge
354482|NCT01624948|BK virus|bk virus
354483|NCT01624948|Kidney Transplantation|kidney transplantation
354484|NCT01624948|Immunologic Monitoring|immunologic monitoring
354485|NCT01624935|PTSD|ptsd
354486|NCT01624935|earthquake|earthquake
354487|NCT01624935|disaster|disaster
354488|NCT01624935|global mental health|global mental health
354489|NCT01624935|disaster mental health|disaster mental health
354490|NCT01624935|depression|depression
354491|NCT01624870|Aortic Valve Stenonis|aortic valve stenonis
354492|NCT01624870|Valvular Heart Disease|valvular heart disease
354493|NCT01624870|Transcatheter Aortic Valve Implantation|transcatheter aortic valve implantation
354494|NCT01624844|ultrasound|ultrasound
354495|NCT01624831|Psychosis|psychosis
354496|NCT01624831|schizophrenia|schizophrenia
354497|NCT01624831|schizoaffective disorder|schizoaffective disorder
354498|NCT01624831|Bipolar disorder with psychotic features|bipolar disorder with psychotic features
354499|NCT01624831|Major depression with psychotic features|major depression with psychotic features
354500|NCT01624831|Psychosis NOS|psychosis nos
354501|NCT01624831|Social Cognition|social cognition
354502|NCT01624818|coping|coping
354503|NCT01624818|physical activity|physical activity
354504|NCT01624818|psychosocial|psychosocial
354505|NCT01624818|children|children
354506|NCT01624818|heart disease|heart disease
354507|NCT01624818|habilitation|habilitation
354508|NCT01624805|Leukemia|leukemia
354509|NCT01624805|Aplastic Anemia|aplastic anemia
354511|NCT01624805|Low/Int-1 Risk Myelodysplastic Syndrome|low/int-1 risk myelodysplastic syndrome
354512|NCT01624805|MDS|mds
354513|NCT01624805|hATG|hatg
354514|NCT01624805|Horse Antithymocyte Globulin|horse antithymocyte globulin
354515|NCT01624805|ATG|atg
354516|NCT01624805|Antithymocyte Globulin|antithymocyte globulin
354517|NCT01624805|Thymoglobulin|thymoglobulin
354518|NCT01624805|Cyclosporine|cyclosporine
354519|NCT01624805|Sandimmune|sandimmune
354520|NCT01624805|CYA|cya
354521|NCT01624805|Cyclosporin A|cyclosporin a
354522|NCT01624805|Methylprednisone|methylprednisone
354523|NCT01624805|Methylprednisolone|methylprednisolone
354524|NCT01624805|Depo-Medrol|depo-medrol
354525|NCT01624805|Medrol|medrol
354526|NCT01624805|Solu-Medrol|solu-medrol
354527|NCT01624805|pegfilgrastim|pegfilgrastim
354528|NCT01624805|Neulasta|neulasta
354529|NCT01624805|PEG-G-CSF|peg-g-csf
354530|NCT01624805|Filgrastim|filgrastim
354531|NCT01624805|C-CSF|c-csf
354532|NCT01624805|Neupogen|neupogen
354533|NCT01624792|Protein metabolism|protein metabolism
354534|NCT01624792|casein protein|casein protein
354535|NCT01624792|EPA|epa
354536|NCT01624792|Fish oil|fish oil
354537|NCT01624779|autologous adipose tissue|autologous adipose tissue
354538|NCT01624766|Advanced Cancers|advanced cancers
354539|NCT01624766|Advanced Malignancies|advanced malignancies
354540|NCT01624766|Metastatic Cancers|metastatic cancers
354541|NCT01624766|Everolimus|everolimus
354542|NCT01624766|Afinitor|afinitor
354543|NCT01624766|RAD001|rad001
354544|NCT01624766|Anakinra|anakinra
354545|NCT01624766|Kineret|kineret
354546|NCT01624766|Denosumab|denosumab
354547|NCT01624766|AMG 162|amg 162
354548|NCT01624753|interstitial lung disease|interstitial lung disease
354549|NCT01624753|interstitial pneumonia|interstitial pneumonia
354550|NCT01624753|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
354551|NCT01624727|Coronary heart disease|coronary heart disease
354552|NCT01624727|metabolic syndrome|metabolic syndrome
354553|NCT01624727|CT angiography|ct angiography
354554|NCT01624714|Treatment Refractory|treatment refractory
354555|NCT01624701|Cord blood|cord blood
354556|NCT01624701|unrelated donor|unrelated donor
354557|NCT01624701|allogeneic|allogeneic
354558|NCT01624701|cell dose|cell dose
354559|NCT01624688|Tattoo|tattoo
354560|NCT01624688|Tattoo Removal|tattoo removal
354561|NCT01624675|Autistic disorder in children and adolescents|autistic disorder in children and adolescents
354562|NCT01624675|Risperidone (R064766)|risperidone (r064766)
354563|NCT01624675|Children|children
354564|NCT01624675|Adolescents|adolescents
354565|NCT01624675|Irritability|irritability
354566|NCT01624675|Autistic disorder|autistic disorder
354567|NCT01624649|Attention-deficit hyperactivity disorder|attention-deficit hyperactivity disorder
354568|NCT01624649|Developmental disorder|developmental disorder
354569|NCT01624649|Atomoxetine|atomoxetine
354570|NCT01624649|Methylphenidate|methylphenidate
354571|NCT01624649|Psychiatric disorder|psychiatric disorder
354572|NCT01624636|AMD|amd
354573|NCT01624636|Age-related Macular Degeneration|age-related macular degeneration
354574|NCT01624636|Wet AMD|wet amd
354575|NCT01624636|Neovascular AMD|neovascular amd
354576|NCT01624623|radiation|radiation
354577|NCT01624623|Calypso|calypso
354578|NCT01624623|prostatectomy|prostatectomy
354579|NCT01624610|Irritable bowel syndrome|irritable bowel syndrome
354580|NCT01624610|Diarrhea|diarrhea
354581|NCT01624610|abdominal pain|abdominal pain
354582|NCT01624610|diet|diet
354583|NCT01624610|nutrition|nutrition
354584|NCT01624597|Road traffic safety|road traffic safety
354585|NCT01624584|child|child
354586|NCT01624584|anxiety|anxiety
354587|NCT01624584|CBT|cbt
354588|NCT01624558|malignant hyperthermia|malignant hyperthermia
354589|NCT01624545|chronic subdural hematoma|chronic subdural hematoma
354590|NCT01624545|burr hole trepanation|burr hole trepanation
354591|NCT01624545|radiologic follow-up|radiologic follow-up
354592|NCT01624545|outcome|outcome
354593|NCT01624545|recurrence|recurrence
354594|NCT01624532|Anthrax vaccine|anthrax vaccine
354595|NCT01624519|Arterial Lactate|arterial lactate
354596|NCT01624519|Central Venous Lactate|central venous lactate
354597|NCT01624519|Peripheral Venous Lactate|peripheral venous lactate
354598|NCT01624506|GERD|gerd
354599|NCT01624506|Fundoplication|fundoplication
354600|NCT01624506|Magnetic Sphincter Augmentation|magnetic sphincter augmentation
354601|NCT01624493|Vascular Disrupting Agents|vascular disrupting agents
354602|NCT01624493|BNC105P|bnc105p
354603|NCT01624493|Partially platinum sensitive|partially platinum sensitive
354604|NCT01624480|Pediatric Narcolepsy|pediatric narcolepsy
354605|NCT01624467|Advanced Solid Tumors|advanced solid tumors
354606|NCT01624454|colonoscopy|colonoscopy
354607|NCT01624454|bowel cleansing|bowel cleansing
354608|NCT01624428|Tobacco|tobacco
354609|NCT01624428|Adolescent|adolescent
354610|NCT01624428|Nicotine|nicotine
354611|NCT01624428|Magnetic Resonance Imaging|magnetic resonance imaging
354612|NCT01624428|Varenicline|varenicline
354613|NCT01624389|[18F]AV-45 PET amyloid binding imaging|[18f]av-45 pet amyloid binding imaging
354614|NCT01624389|Alzheimer's disease|alzheimer's disease
354615|NCT01624376|non-invasive management|non-invasive management
354616|NCT01624376|Fistula|fistula
354617|NCT01624376|Crohn's Disease|crohn's disease
354618|NCT01624376|local administration|local administration
354619|NCT01624376|non-invasive|non-invasive
354620|NCT01624363|Pancreatic cysts incidentally found during EUS|pancreatic cysts incidentally found during eus
354621|NCT01624350|Anorectal Fistulas|anorectal fistulas
354622|NCT01624337|Plasmodium falciparum|plasmodium falciparum
354623|NCT01624337|Plasmodium vivax|plasmodium vivax
354624|NCT01624324|aminoglycoside|aminoglycoside
354625|NCT01624324|KIM-1|kim-1
354626|NCT01624324|DPOAE|dpoae
354627|NCT01624324|nephrotoxicity|nephrotoxicity
354628|NCT01624324|ototoxicity|ototoxicity
354629|NCT01624311|High ammonia level|high ammonia level
354630|NCT01624311|Hyperammonemia|hyperammonemia
354631|NCT01624311|Poor suck|poor suck
354632|NCT01624311|Lethargy|lethargy
354633|NCT01624311|Coma|coma
354634|NCT01624311|Encephalopathy|encephalopathy
354635|NCT01624311|Seizures|seizures
354636|NCT01624311|Brain edema|brain edema
354637|NCT01624311|Urea Cycle Disorder|urea cycle disorder
354638|NCT01624311|Ornithine Transcarbamylase Deficiency|ornithine transcarbamylase deficiency
354639|NCT01624311|Carbamoyl Phosphate Synthetase Deficiency|carbamoyl phosphate synthetase deficiency
354640|NCT01624311|Citrullinemia|citrullinemia
354641|NCT01624311|Argininosuccinic Aciduria|argininosuccinic aciduria
354642|NCT01624311|Organic Acidemia|organic acidemia
354643|NCT01624311|Propionic Aciduria|propionic aciduria
354644|NCT01624311|Methylmalonic Aciduria|methylmalonic aciduria
354645|NCT01624311|Isovaleric Aciduria|isovaleric aciduria
354646|NCT01624298|Randomized controlled trial|randomized controlled trial
354647|NCT01624298|Traumatized youth|traumatized youth
354648|NCT01624298|HIV risk|hiv risk
354649|NCT01624272|Physical Therapy|physical therapy
354650|NCT01624272|Respiratory Muscle Training|respiratory muscle training
354651|NCT01624272|Elderly|elderly
354652|NCT01624220|Spinal tumor|spinal tumor
354653|NCT01624220|Tumor of the mid or lower spine|tumor of the mid or lower spine
354654|NCT01624220|Non-small cell lung cancer|non-small cell lung cancer
354655|NCT01624220|Breast cancer|breast cancer
354656|NCT01624220|Prostate cancer|prostate cancer
354657|NCT01624220|Renal cell cancer|renal cell cancer
354658|NCT01624220|Melanoma|melanoma
354659|NCT01624220|Gastrointestinal cancer|gastrointestinal cancer
354660|NCT01624220|Sarcoma|sarcoma
354661|NCT01624220|Thyroid cancer|thyroid cancer
354662|NCT01624220|Head and neck primary cancer|head and neck primary cancer
354663|NCT01624220|Carcinoma of unknown primary|carcinoma of unknown primary
354664|NCT01624220|Fiducial markers|fiducial markers
354665|NCT01624220|Gold seed markers|gold seed markers
354666|NCT01624220|Spinal stereotactic body radiation therapy|spinal stereotactic body radiation therapy
354667|NCT01624220|Spinal SBRT|spinal sbrt
354668|NCT01624220|Stereotactic Radiotherapy|stereotactic radiotherapy
354669|NCT01624207|Atorva|atorva
354670|NCT01624207|generic|generic
354671|NCT01624207|atorvastatin|atorvastatin
354672|NCT01624207|hypercholesterolemia|hypercholesterolemia
354673|NCT01624181|ion mobility spectrometry|ion mobility spectrometry
354674|NCT01624181|hospital-acquired pneumonia|hospital-acquired pneumonia
354675|NCT01624181|microbiological investigation|microbiological investigation
354676|NCT01624181|intensive care|intensive care
354677|NCT01624168|anxiety|anxiety
354678|NCT01624168|sleep quality|sleep quality
354679|NCT01624168|tai chi chuan|tai chi chuan
354680|NCT01624168|young adults|young adults
354681|NCT01624155|teratogens|teratogens
354682|NCT01624155|contraception|contraception
354683|NCT01624155|electronic medical record|electronic medical record
354684|NCT01624142|Hypercholesterolemia|hypercholesterolemia
354685|NCT01624142|Elevated Cholesterol|elevated cholesterol
354686|NCT01624142|High Cholesterol|high cholesterol
354687|NCT01624142|Homozygous Familial Hypercholesterolemia|homozygous familial hypercholesterolemia
354688|NCT01624142|PCSK9 mutations|pcsk9 mutations
354689|NCT01624142|Severe Familial Hypercholesterolemia|severe familial hypercholesterolemia
354690|NCT01624103|Arm Injuries|arm injuries
354691|NCT01624103|Wounds and Injuries|wounds and injuries
354692|NCT01624103|Lidocaine|lidocaine
354693|NCT01624103|Levobupivacaine|levobupivacaine
354694|NCT01624103|Bupivacaine|bupivacaine
354695|NCT01624103|Anesthetics|anesthetics
354696|NCT01624103|Central Nervous System Depressants|central nervous system depressants
354697|NCT01624103|Physiological Effects of Drugs|physiological effects of drugs
354698|NCT01624090|Cancer Stem Cell|cancer stem cell
354699|NCT01624090|Thoracic Malignancies|thoracic malignancies
354700|NCT01624090|Mythramycin Treatment|mythramycin treatment
354701|NCT01624090|Lung Tumors|lung tumors
354702|NCT01624090|Metastatic Lung Tumors|metastatic lung tumors
354703|NCT01624077|Regulatory T cells|regulatory t cells
354704|NCT01624077|Liver Transplantation|liver transplantation
354705|NCT01624077|Rejection|rejection
354706|NCT01624077|Tolerance|tolerance
354707|NCT01624077|Cell tolerance|cell tolerance
354708|NCT01624077|Survival|survival
354709|NCT01624064|Renal Insufficiency, Chronic|renal insufficiency, chronic
354710|NCT01624064|Uncertain aetiology|uncertain aetiology
354711|NCT01624064|ACEI|acei
354712|NCT01624051|cisplatin based chemotherapy|cisplatin based chemotherapy
354713|NCT01624051|non-small cell lung cancer|non-small cell lung cancer
354714|NCT01624051|lean body mass|lean body mass
354715|NCT01624051|sarcopenia|sarcopenia
354716|NCT01624038|Hydroxyurea|hydroxyurea
354717|NCT01624038|Erythropoitin therapy|erythropoitin therapy
354718|NCT01624038|Thalassemia intermedia|thalassemia intermedia
354719|NCT01624025|AGC, second-line, docetaxel, epirubicin|agc, second-line, docetaxel, epirubicin
354720|NCT01624012|NIV NAVA|niv nava
354721|NCT01624012|non-invasive ventilation|non-invasive ventilation
354722|NCT01623973|hemiparetic|hemiparetic
354723|NCT01623973|cognitive|cognitive
354724|NCT01623973|balance|balance
354725|NCT01623960|severe haemophilia|severe haemophilia
354726|NCT01623960|quality of life|quality of life
354727|NCT01623947|glutamine|glutamine
354728|NCT01623947|cycling performance|cycling performance
354729|NCT01623947|mental function|mental function
354730|NCT01623934|Gestational diabetes|gestational diabetes
354731|NCT01623934|Adiponectin|adiponectin
354732|NCT01623934|Leptin|leptin
354733|NCT01623934|Single Nucleotides Polymorphisms|single nucleotides polymorphisms
354734|NCT01623934|Insulin resistance|insulin resistance
354735|NCT01623921|Lung|lung
354736|NCT01623921|Contusion|contusion
354737|NCT01623921|Injury|injury
354738|NCT01623921|Cyclooxygenase|cyclooxygenase
354739|NCT01623921|Statin|statin
354740|NCT01623908|Breast neoplasms|breast neoplasms
354741|NCT01623908|Zoledronate|zoledronate
354742|NCT01623908|Bone loss|bone loss
354743|NCT01623882|Diabetes Mellitus|diabetes mellitus
354744|NCT01623882|Wounds|wounds
354745|NCT01623882|Ulcers|ulcers
354746|NCT01623843|FAI|fai
354747|NCT01623843|randomized|randomized
354748|NCT01623843|hip arthroscopy|hip arthroscopy
354749|NCT01623843|lavage|lavage
354750|NCT01623843|osteochondroplasty|osteochondroplasty
354751|NCT01623830|reconsolidation|reconsolidation
354752|NCT01623830|fear of flying|fear of flying
354753|NCT01623830|virtual reality|virtual reality
354754|NCT01623830|virtual reality exposure therapy|virtual reality exposure therapy
354755|NCT01623804|Ultrasound therapy|ultrasound therapy
354756|NCT01623804|Tibiofemoral joint, medial|tibiofemoral joint, medial
354757|NCT01623804|Nonsurgical|nonsurgical
354758|NCT01623791|Pre-eclampsia|pre-eclampsia
354759|NCT01623791|Proteinuria|proteinuria
354760|NCT01623791|Protein - creatinine ratio|protein - creatinine ratio
354761|NCT01623791|Dipstick proteinuria|dipstick proteinuria
354762|NCT01623791|Severity of disease|severity of disease
354763|NCT01623778|HBeAg seroconversion|hbeag seroconversion
354764|NCT01623778|Peginterferon alfa-2a|peginterferon alfa-2a
354765|NCT01623778|chronic hepatitis B(CHB|chronic hepatitis b(chb
354766|NCT01623778|Optimal therapy|optimal therapy
354767|NCT01623778|Response guild treatment(RGT);|response guild treatment(rgt);
354768|NCT01623765|Endobronchial ultrasound, lung cancer|endobronchial ultrasound, lung cancer
354769|NCT01623739|Dental implants|dental implants
354770|NCT01623739|Esthetic score|esthetic score
354771|NCT01623739|Immediate implants|immediate implants
354772|NCT01623739|Early placement|early placement
354773|NCT01623726|Transcranial Direct Current Stimulation|transcranial direct current stimulation
354774|NCT01623726|Schizophrenia|schizophrenia
354775|NCT01623713|schizophrenia|schizophrenia
354776|NCT01623713|iloperidone|iloperidone
354777|NCT01623713|Risperidone|risperidone
354778|NCT01623713|Efficacy|efficacy
354779|NCT01623713|Safety|safety
354780|NCT01623700|clopidogrel|clopidogrel
354781|NCT01623700|aspirin|aspirin
354782|NCT01623700|percutaneous coronary intervention|percutaneous coronary intervention
354783|NCT01623700|coronary stenting|coronary stenting
354784|NCT01623700|antiplatelet|antiplatelet
354785|NCT01623687|total hip arthroplasty|total hip arthroplasty
354786|NCT01623687|bone metabolism|bone metabolism
354787|NCT01623687|mineralisation|mineralisation
354788|NCT01623674|Sleep deprivation in surgeons during night shifts and the effect on performance.|sleep deprivation in surgeons during night shifts and the effect on performance.
354789|NCT01623661|Nephrology|nephrology
354790|NCT01623661|chronic kidney disease|chronic kidney disease
354791|NCT01623661|sodium-channels|sodium-channels
354792|NCT01623661|water-channels|water-channels
354793|NCT01623661|BCM|bcm
354794|NCT01623648|whey protein|whey protein
354795|NCT01623648|hunger|hunger
354796|NCT01623609|Phase 1|phase 1
354797|NCT01623609|Healthy volunteers|healthy volunteers
354798|NCT01623609|Naloxegol|naloxegol
354799|NCT01623609|Bioequivalence|bioequivalence
354800|NCT01623583|lidocaine|lidocaine
354801|NCT01623583|tetracaine|tetracaine
354802|NCT01623583|Renal dialysis|renal dialysis
354803|NCT01623570|Luteinizing Hormone|luteinizing hormone
354804|NCT01623570|Hypogonadotropic Hypogonadism|hypogonadotropic hypogonadism
354805|NCT01623570|Ovulation Induction|ovulation induction
354806|NCT01623570|Chorionic Gonadotropin|chorionic gonadotropin
354807|NCT01623557|Malaria|malaria
354808|NCT01623557|Vaccine|vaccine
354809|NCT01623557|Plasmodium|plasmodium
354810|NCT01623557|falciparum|falciparum
354811|NCT01623544|Asthma|asthma
354812|NCT01623544|Comparative Effectiveness|comparative effectiveness
354813|NCT01623544|Symbicort|symbicort
354815|NCT01623531|cardiac surgery|cardiac surgery
354816|NCT01623531|high risk|high risk
354817|NCT01623531|cardiopulmonary bypass|cardiopulmonary bypass
354818|NCT01623531|bleeding|bleeding
354819|NCT01623531|blood transfusion|blood transfusion
354820|NCT01623505|Smoking Cessation|smoking cessation
354821|NCT01623505|Psychiatric Illness|psychiatric illness
354822|NCT01623505|Pharmacotherapy|pharmacotherapy
354823|NCT01623492|Eisenmenger|eisenmenger
354824|NCT01623466|PK and Safety|pk and safety
354825|NCT01623453|crohn's disease|crohn's disease
354826|NCT01623453|fistula|fistula
354827|NCT01623453|complex|complex
354828|NCT01623427|pediatric|pediatric
354829|NCT01623427|laparoscopy|laparoscopy
354830|NCT01623427|vacuum|vacuum
354831|NCT01623427|dressing|dressing
354832|NCT01623362|Dentifrices|dentifrices
354833|NCT01623362|Dental Caries|dental caries
354834|NCT01623362|Fluorides|fluorides
354835|NCT01623362|Nails|nails
354836|NCT01623362|pH|ph
354837|NCT01623349|Recurrent|recurrent
354838|NCT01623349|High Grade|high grade
354839|NCT01623349|Serous|serous
354840|NCT01623349|Triple Negative|triple negative
354841|NCT01623336|HEPATITIS|hepatitis
354842|NCT01623336|HEPATITIS C|hepatitis c
354843|NCT01623336|PEGINTERFERON|peginterferon
354844|NCT01623336|BIOEQUIVALENCE|bioequivalence
354845|NCT01623336|TREATMENT|treatment
354846|NCT01623297|Laparoscopy|laparoscopy
354847|NCT01623297|Surgery|surgery
354848|NCT01623297|Acute Phase Reaction|acute phase reaction
354849|NCT01623297|Aged|aged
354850|NCT01623297|Aged 80 and over|aged 80 and over
354851|NCT01623297|Confusion|confusion
354852|NCT01623297|Inflammation|inflammation
354853|NCT01623297|Delirium|delirium
354854|NCT01623284|aphasia|aphasia
354855|NCT01623284|apraxia of speech|apraxia of speech
354856|NCT01623284|language|language
354857|NCT01623271|CRPS I|crps i
354858|NCT01623232|vaccine|vaccine
354859|NCT01623232|influenzavirus A|influenzavirus a
354860|NCT01623232|influenzavirus B|influenzavirus b
354861|NCT01623232|adjuvant|adjuvant
354862|NCT01623219|PTSD|ptsd
354863|NCT01623219|trauma|trauma
354864|NCT01623219|combat trauma|combat trauma
354865|NCT01623219|veterans|veterans
354866|NCT01623219|telemedicine|telemedicine
354867|NCT01623219|prolonged exposure|prolonged exposure
354868|NCT01623193|Cardioplegia|cardioplegia
354869|NCT01623193|Blood transfusion|blood transfusion
354870|NCT01623193|Cardiac function|cardiac function
354871|NCT01623193|Myocardial edema|myocardial edema
354872|NCT01623193|Coronary artery disease|coronary artery disease
354873|NCT01623193|Valve disease|valve disease
354874|NCT01623180|DES|des
354875|NCT01623180|coronary stent|coronary stent
354876|NCT01623180|bare metal stent|bare metal stent
354877|NCT01623180|high bleeding|high bleeding
354878|NCT01623180|MI|mi
354879|NCT01623180|angina|angina
354880|NCT01623167|T-cells|t-cells
354881|NCT01623167|Immunosuppression|immunosuppression
354882|NCT01623167|Hematopoesis|hematopoesis
354883|NCT01623167|Autoimmunity|autoimmunity
354884|NCT01623167|Thrombocytopenia|thrombocytopenia
354885|NCT01623154|Helicobacter pylori|helicobacter pylori
354886|NCT01623141|CRPS|crps
354887|NCT01623141|TPBS|tpbs
354888|NCT01623141|Pressure pain thresholds|pressure pain thresholds
354889|NCT01623141|limb pain of other origin|limb pain of other origin
354890|NCT01623128|Breastfeeding initiation|breastfeeding initiation
354891|NCT01623128|Breastfeeding duration|breastfeeding duration
354892|NCT01623128|WIC|wic
354893|NCT01623128|Video education|video education
354894|NCT01623128|Breastfeeding rates|breastfeeding rates
354895|NCT01623115|PCSK9|pcsk9
354896|NCT01623102|Bevacizumab|bevacizumab
354897|NCT01623102|gemcitabine|gemcitabine
354898|NCT01623102|cisplatin|cisplatin
354899|NCT01623102|EGFR wild-type|egfr wild-type
354900|NCT01623089|severe asthma, phenotype, data|severe asthma, phenotype, data
354901|NCT01623076|Neuromyelitis Optica|neuromyelitis optica
354902|NCT01623076|Neuromyelitis Optica Spectrum Disorder|neuromyelitis optica spectrum disorder
354903|NCT01623076|Transverse Myelitis|transverse myelitis
354904|NCT01623076|Optic Neuritis|optic neuritis
354905|NCT01623076|Biorepository|biorepository
354906|NCT01623063|endometrium|endometrium
354907|NCT01623063|infertility|infertility
354908|NCT01623063|uterus|uterus
354909|NCT01623063|histeroscopy|histeroscopy
354910|NCT01623037|Lipolysis|lipolysis
354911|NCT01623037|Cryolipolysis|cryolipolysis
354912|NCT01623037|Fat Reduction|fat reduction
354913|NCT01623011|Shoulder|shoulder
354914|NCT01623011|Sub-acromial|sub-acromial
354915|NCT01623011|Rotator Cuff|rotator cuff
354916|NCT01623011|Impingement|impingement
354917|NCT01622998|Pharmacotherapy|pharmacotherapy
354918|NCT01622998|Titration|titration
354919|NCT01622998|Smoking Cessation|smoking cessation
354920|NCT01622959|emergency departement|emergency departement
354921|NCT01622959|acute pain|acute pain
354922|NCT01622959|acupuncture|acupuncture
354923|NCT01622959|morphine|morphine
354924|NCT01622946|total hip arthroplasty|total hip arthroplasty
354925|NCT01622946|tranexamic acid|tranexamic acid
354926|NCT01622946|postoperative blood loss|postoperative blood loss
354927|NCT01622933|melanoma|melanoma
354928|NCT01622933|recurrent|recurrent
354929|NCT01622933|metastatic|metastatic
354930|NCT01622920|enamel erosion|enamel erosion
354931|NCT01622920|ultrasound|ultrasound
354932|NCT01622920|reproducibility|reproducibility
354933|NCT01622920|human central incisor|human central incisor
354934|NCT01622920|reliability|reliability
354935|NCT01622907|Catheter ablation, radiofrequency|catheter ablation, radiofrequency
354936|NCT01622907|Epicardially applied radiofrequency ablation|epicardially applied radiofrequency ablation
354937|NCT01622907|Minimally invasive surgical approach|minimally invasive surgical approach
354938|NCT01622894|Alzheimer genetics|alzheimer genetics
354939|NCT01622855|Rape|rape
354940|NCT01622855|Secondary prevention|secondary prevention
354941|NCT01622855|Intervention|intervention
354942|NCT01622842|Impedance|impedance
354943|NCT01622842|Electrical|electrical
354944|NCT01622842|Tissue|tissue
354945|NCT01622842|Excitation frequency|excitation frequency
354946|NCT01622842|arterial distension|arterial distension
354947|NCT01622842|distension wave form|distension wave form
354948|NCT01622777|Rosuvastatin|rosuvastatin
354949|NCT01622777|Diabetic polyneuropathy|diabetic polyneuropathy
354950|NCT01622777|Nerve conduction|nerve conduction
354951|NCT01622777|Oxidative stress|oxidative stress
354952|NCT01622777|Nerve growth factor|nerve growth factor
354953|NCT01622764|RO5323441|ro5323441
354954|NCT01622764|bevacizumab|bevacizumab
354955|NCT01622764|PET imaging|pet imaging
354956|NCT01622764|recurrent glioblastoma|recurrent glioblastoma
354957|NCT01622751|REM sleep|rem sleep
354958|NCT01622751|Adiponectin|adiponectin
354959|NCT01622751|Prader-Willi syndrome|prader-willi syndrome
354960|NCT01622725|ventral hernia|ventral hernia
354961|NCT01622712|inguinal hernia|inguinal hernia
354962|NCT01622699|Jaundice|jaundice
354963|NCT01622699|Neonatal Jaundice|neonatal jaundice
354964|NCT01622699|Hyperbilirubinemia|hyperbilirubinemia
354965|NCT01622699|Transcutaneous bilirubin measurement|transcutaneous bilirubin measurement
354966|NCT01622699|Transcutaneous bilirubinometry|transcutaneous bilirubinometry
354967|NCT01622699|jaundice meter|jaundice meter
354968|NCT01622699|Visual assessment of bilirubin|visual assessment of bilirubin
354969|NCT01622699|Newborn|newborn
354970|NCT01622686|Prescription Labels|prescription labels
354971|NCT01622686|Low Health Literacy|low health literacy
354972|NCT01622686|Limited English Proficiency|limited english proficiency
354973|NCT01622686|Spanish|spanish
354974|NCT01622660|URETER|ureter
354975|NCT01622660|URINARY BLADDER|urinary bladder
354976|NCT01622660|renal pelvis|renal pelvis
354977|NCT01622660|GEMCITABINE|gemcitabine
354978|NCT01622660|GW786034 (PAZOPANIB)|gw786034 (pazopanib)
354979|NCT01622660|11-191|11-191
354980|NCT01622647|NCPAP|ncpap
354981|NCT01622634|cardiovascular disease|cardiovascular disease
354982|NCT01622634|diabetes mellitus|diabetes mellitus
354983|NCT01622621|Lung|lung
354984|NCT01622621|Cancer|cancer
354985|NCT01622608|Adolescent vaccination|adolescent vaccination
354986|NCT01622608|Immunization rates|immunization rates
354987|NCT01622608|Informational kiosk|informational kiosk
354988|NCT01622608|Tailored health messaging|tailored health messaging
354989|NCT01622608|Barriers to vaccination|barriers to vaccination
354990|NCT01622608|Attitudes|attitudes
354991|NCT01622608|Intentions|intentions
354992|NCT01622595|Aspergillosis|aspergillosis
354993|NCT01622595|Candidemia|candidemia
354994|NCT01622595|Candidiasis|candidiasis
354995|NCT01622595|C. Difficile|c. difficile
354996|NCT01622595|cytomegalovirus|cytomegalovirus
354997|NCT01622595|respiratory syncytial virus (RSV)|respiratory syncytial virus (rsv)
354998|NCT01622595|Influenza|influenza
354999|NCT01622595|CONS|cons
355000|NCT01622582|Multiple Myeloma, Engraftment syndrome|multiple myeloma, engraftment syndrome
355001|NCT01622556|Chronic Myeloid Leukemia|chronic myeloid leukemia
355002|NCT01622556|Acute Myeloid Leukemia|acute myeloid leukemia
355003|NCT01622556|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
355004|NCT01622556|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
355005|NCT01622556|Hodgkin's Disease|hodgkin's disease
355006|NCT01622556|Myelodysplastic Syndromes|myelodysplastic syndromes
355007|NCT01622556|Myeloproliferative Disorder|myeloproliferative disorder
355008|NCT01622504|Intranasal|intranasal
355009|NCT01622504|nasal spray|nasal spray
355010|NCT01622504|opioid|opioid
355011|NCT01622504|overdose|overdose
355012|NCT01622491|H1N1|h1n1
355013|NCT01622491|pandemic|pandemic
355014|NCT01622491|influenza|influenza
355015|NCT01622491|pneumonia|pneumonia
355016|NCT01622491|vaccine|vaccine
355017|NCT01622491|effectiveness|effectiveness
355018|NCT01622491|Manitoba|manitoba
355019|NCT01622491|Canada|canada
355020|NCT01622478|sentinel lymph node biopsy|sentinel lymph node biopsy
355021|NCT01622478|neoadjuvant chemotherapy|neoadjuvant chemotherapy
355022|NCT01622478|breast cancer|breast cancer
355023|NCT01622478|locally advanced breast cancer|locally advanced breast cancer
355024|NCT01622478|positive axillary lymph node|positive axillary lymph node
355025|NCT01622478|negative conversion|negative conversion
355026|NCT01622465|Hip arthroplasty|hip arthroplasty
355027|NCT01622465|Aged|aged
355028|NCT01622465|Rehabilitation|rehabilitation
355029|NCT01622465|Exercise therapy|exercise therapy
355030|NCT01622452|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
355031|NCT01622452|Cognitive decline|cognitive decline
355032|NCT01622452|Valve surgery|valve surgery
355033|NCT01622452|Cardiac surgery|cardiac surgery
355034|NCT01622452|Diffusion Tensor Imaging|diffusion tensor imaging
355035|NCT01622452|Brain Morphometry|brain morphometry
355036|NCT01622452|1H-Magnetic Resonance Spectroscopy|1h-magnetic resonance spectroscopy
355037|NCT01622439|Lymphoma|lymphoma
355038|NCT01622439|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
355039|NCT01622439|Valproate|valproate
355040|NCT01622439|R-CHOP|r-chop
355041|NCT01622439|CD 20|cd 20
355042|NCT01622413|lumbar spine|lumbar spine
355043|NCT01622413|herniated disc|herniated disc
355044|NCT01622413|slipped disc|slipped disc
355045|NCT01622413|disc herniation|disc herniation
355046|NCT01622413|discectomy|discectomy
355047|NCT01622413|nucleotomy|nucleotomy
355048|NCT01622413|disc surgery|disc surgery
355049|NCT01622413|endoscopy|endoscopy
355050|NCT01622413|spine|spine
355051|NCT01622400|Cardiovascular risk, Therapeutic education, General practice|cardiovascular risk, therapeutic education, general practice
355052|NCT01622387|Coronary artery bypass surgery|coronary artery bypass surgery
355053|NCT01622387|Arteries|arteries
355054|NCT01622387|Veins|veins
355055|NCT01622387|Conduits|conduits
355056|NCT01622374|Music|music
355057|NCT01622374|dental anxiety|dental anxiety
355058|NCT01622374|"music for the mind"|"music for the mind"
355059|NCT01622374|mozart|mozart
355060|NCT01622374|iranian traditional music|iranian traditional music
355061|NCT01622361|Neoadjuvant|neoadjuvant
355062|NCT01622361|endocrine therapy|endocrine therapy
355063|NCT01622361|premenopausal|premenopausal
355064|NCT01622361|hormone responsive|hormone responsive
355065|NCT01622361|HER2 negative|her2 negative
355066|NCT01622361|lymph node positive|lymph node positive
355067|NCT01622348|Psoriasis|psoriasis
355068|NCT01622348|Plaque Psoriasis|plaque psoriasis
355069|NCT01622309|Oxidative Stress|oxidative stress
355070|NCT01622309|Obesity|obesity
355071|NCT01622309|Solanum melongena|solanum melongena
355072|NCT01622218|Medical clown|medical clown
355073|NCT01622192|Probing|probing
355074|NCT01622192|manual probe|manual probe
355075|NCT01622192|automated probe|automated probe
355076|NCT01622192|Periodontal disease|periodontal disease
355077|NCT01622179|surgery|surgery
355078|NCT01622179|suture method|suture method
355079|NCT01622179|blood supply|blood supply
355080|NCT01622140|T-SPOT.TB|t-spot.tb
355081|NCT01622140|QuantiFERON-TB Gold In-Tube|quantiferon-tb gold in-tube
355082|NCT01622140|Latent tuberculosis infection|latent tuberculosis infection
355083|NCT01622140|Tuberculin skin test|tuberculin skin test
355084|NCT01622140|Discordance|discordance
355085|NCT01622140|Predictive value|predictive value
355086|NCT01622140|Tuberculosis disease development|tuberculosis disease development
355087|NCT01622114|Obesity|obesity
355088|NCT01622114|Weight reduction|weight reduction
355089|NCT01622114|premenopausal Women|premenopausal women
355090|NCT01622114|Menstrual cycle|menstrual cycle
355091|NCT01622114|quality of life|quality of life
355092|NCT01622114|food cravings|food cravings
355093|NCT01622101|Energy expenditure|energy expenditure
355094|NCT01622101|Appetite|appetite
355095|NCT01622101|Bioactive herbal compounds|bioactive herbal compounds
355096|NCT01622101|blood pressure|blood pressure
355097|NCT01622088|ALS, Motor Neuron Disease, Amyotrophic Lateral Sclerosis|als, motor neuron disease, amyotrophic lateral sclerosis
355098|NCT01622062|Rabies|rabies
355099|NCT01622062|Verorab®|verorab®
355100|NCT01622062|Favirab®|favirab®
355101|NCT01622036|Malnutrition|malnutrition
355102|NCT01622036|pre-cachexia|pre-cachexia
355103|NCT01622036|cancer|cancer
355104|NCT01622036|cachexia|cachexia
355105|NCT01622036|MNA|mna
355106|NCT01622036|weight loss|weight loss
355107|NCT01622023|insemination|insemination
355108|NCT01622023|donor sperm|donor sperm
355109|NCT01622023|natural cycle|natural cycle
355110|NCT01622010|Heart Failure|heart failure
355111|NCT01622010|Patient Education as Topic|patient education as topic
355112|NCT01622010|Physical Therapy Specialty|physical therapy specialty
355113|NCT01621997|peritoneal dialysis|peritoneal dialysis
355114|NCT01621997|retraining|retraining
355115|NCT01621997|peritonitis|peritonitis
355116|NCT01621984|Cerebral palsy|cerebral palsy
355117|NCT01621984|brain injury|brain injury
355118|NCT01621984|spinal cord injuries|spinal cord injuries
355119|NCT01621984|muscular disease|muscular disease
355120|NCT01621971|inhaled milrinone|inhaled milrinone
355121|NCT01621971|pulmonary hypertension|pulmonary hypertension
355122|NCT01621971|mitral regurgitation|mitral regurgitation
355123|NCT01621971|mitral valve surgery|mitral valve surgery
355124|NCT01621958|balance loss|balance loss
355125|NCT01621958|dynamic stability|dynamic stability
355126|NCT01621958|motor learning|motor learning
355128|NCT01621945|Neisseria meningitidis B:14, P1-7, 16|neisseria meningitidis b:14, p1-7, 16
355129|NCT01621945|Serum bactericidal activity|serum bactericidal activity
355130|NCT01621945|OMV vaccine|omv vaccine
355131|NCT01621932|Anterior approach|anterior approach
355132|NCT01621906|Breast|breast
355133|NCT01621906|brain metastases|brain metastases
355134|NCT01621906|18F-FLT-PET Imaging|18f-flt-pet imaging
355135|NCT01621906|FLT(3'DEOXY-3'FLUOROTHYMIDINE)|flt(3'deoxy-3'fluorothymidine)
355136|NCT01621906|MR Imaging|mr imaging
355137|NCT01621906|12-039|12-039
355138|NCT01621893|bone marrow edema|bone marrow edema
355139|NCT01621893|bone marrow defects|bone marrow defects
355393|NCT01620814|diagnostic hysteroscopy|diagnostic hysteroscopy
355140|NCT01621880|radiation-induced brain necrosis|radiation-induced brain necrosis
355141|NCT01621880|nasopharyngeal carcinoma|nasopharyngeal carcinoma
355142|NCT01621880|Bevacizumab|bevacizumab
355143|NCT01621880|Methylprednisolone|methylprednisolone
355144|NCT01621867|Cystic fibrosis|cystic fibrosis
355145|NCT01621867|Gene therapy|gene therapy
355146|NCT01621867|CFTR gene|cftr gene
355147|NCT01621867|Gene expression|gene expression
355148|NCT01621867|Non-viral|non-viral
355149|NCT01621867|Multi dose|multi dose
355150|NCT01621854|cancer|cancer
355151|NCT01621854|nucleoside analogue|nucleoside analogue
355152|NCT01621854|advanced solid tumours|advanced solid tumours
355153|NCT01621828|pre-operative anxiety|pre-operative anxiety
355154|NCT01621828|multimedia information|multimedia information
355155|NCT01621828|operating theatre|operating theatre
355156|NCT01621815|ADHD|adhd
355157|NCT01621815|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
355158|NCT01621815|Conduct|conduct
355159|NCT01621815|Depression|depression
355160|NCT01621815|Anxiety|anxiety
355161|NCT01621815|PDD|pdd
355162|NCT01621815|Pervasive Developmental Disorders|pervasive developmental disorders
355163|NCT01621802|Safety|safety
355164|NCT01621802|Measles, mumps and rubella diseases|measles, mumps and rubella diseases
355165|NCT01621802|Immunogenicity|immunogenicity
355166|NCT01621789|lutein|lutein
355167|NCT01621789|zeaxanthin|zeaxanthin
355168|NCT01621789|trypan blue|trypan blue
355169|NCT01621789|dye|dye
355170|NCT01621776|post-prandial hyperglycemia|post-prandial hyperglycemia
355171|NCT01621737|oxytocin|oxytocin
355172|NCT01621724|Gene therapy|gene therapy
355173|NCT01621724|WT1 TCR|wt1 tcr
355174|NCT01621724|AML|aml
355175|NCT01621724|CML|cml
355176|NCT01621711|substance abuse|substance abuse
355177|NCT01621711|Substance Dependence|substance dependence
355178|NCT01621711|Substance, addiction|substance, addiction
355179|NCT01621711|Alcohol Abuse|alcohol abuse
355180|NCT01621711|prevention and control|prevention and control
355181|NCT01621711|preventative health services|preventative health services
355182|NCT01621711|patient centered care|patient centered care
355183|NCT01621698|VATS|vats
355184|NCT01621698|Paravertebral blocks.|paravertebral blocks.
355185|NCT01621698|Thoracoscopic surgery.|thoracoscopic surgery.
355186|NCT01621698|Analgesia.|analgesia.
355187|NCT01621685|Capsaicin|capsaicin
355188|NCT01621685|Cough|cough
355189|NCT01621685|Cough reflex|cough reflex
355190|NCT01621685|Inhalation agents|inhalation agents
355191|NCT01621685|Inhalation challenge|inhalation challenge
355192|NCT01621685|TRPV1 receptor|trpv1 receptor
355193|NCT01621672|Revlimid|revlimid
355194|NCT01621672|progression free|progression free
355195|NCT01621672|Lenalidomide|lenalidomide
355196|NCT01621659|multidisciplinary team|multidisciplinary team
355197|NCT01621659|exercise|exercise
355198|NCT01621659|nutrition|nutrition
355199|NCT01621659|cardiology|cardiology
355200|NCT01621659|physiotherapy|physiotherapy
355201|NCT01621659|imaging|imaging
355202|NCT01621646|lutein|lutein
355203|NCT01621646|eggs|eggs
355204|NCT01621646|mild cognitive impairment|mild cognitive impairment
355205|NCT01621646|elderly|elderly
355206|NCT01621633|hepatic impairment|hepatic impairment
355207|NCT01621607|fMRI|fmri
355208|NCT01621607|Monoamines|monoamines
355209|NCT01621607|Environment|environment
355210|NCT01621607|Genes|genes
355211|NCT01621607|Reward Learning|reward learning
355212|NCT01621594|Cardiac|cardiac
355213|NCT01621594|Computed Tomography|computed tomography
355214|NCT01621594|Radiation Reduction|radiation reduction
355215|NCT01621594|Iterative Reconstruction|iterative reconstruction
355216|NCT01621581|Gene Therapy|gene therapy
355217|NCT01621581|Parkinson's Disease|parkinson's disease
355218|NCT01621581|Convection-Ehanced Delivery|convection-ehanced delivery
355219|NCT01621581|Viral Vector|viral vector
355220|NCT01621568|VEGF|vegf
355221|NCT01621568|Anti-Angiogenesis|anti-angiogenesis
355222|NCT01621568|Targeted Agent|targeted agent
355223|NCT01621555|shoulder surgery|shoulder surgery
355224|NCT01621555|Pain sensitivity|pain sensitivity
355225|NCT01621555|Rowe score|rowe score
355226|NCT01621555|Constant Score|constant score
355227|NCT01621555|Surgical Outcome|surgical outcome
355228|NCT01621555|Postoperative pain|postoperative pain
355229|NCT01621542|Cancer|cancer
355230|NCT01621542|Vaccine|vaccine
355231|NCT01621542|Oncology|oncology
355232|NCT01621542|Malignancies|malignancies
355233|NCT01621542|Wilms' Tumor|wilms' tumor
355234|NCT01621542|WT1|wt1
355235|NCT01621542|Ovarian|ovarian
355236|NCT01621542|Glioblastoma [GBM]|glioblastoma [gbm]
355237|NCT01621542|Acute myeloid leukemia [AML]|acute myeloid leukemia [aml]
355238|NCT01621529|Positron-Emission Tomography|positron-emission tomography
355239|NCT01621529|PET Scan|pet scan
355240|NCT01621529|FDG|fdg
355241|NCT01621529|SUV|suv
355242|NCT01621529|Invasive Breast cancer|invasive breast cancer
355243|NCT01621529|Surgery compare|surgery compare
355244|NCT01621529|Tumor measurement|tumor measurement
355245|NCT01621516|Beta-cell function|beta-cell function
355246|NCT01621516|Liver/small bowel transplant|liver/small bowel transplant
355247|NCT01621516|Donor pancreas|donor pancreas
355248|NCT01621516|Diabetes|diabetes
355249|NCT01621516|Long-term immunesuppression|long-term immunesuppression
355250|NCT01621477|Hematologic malignancy|hematologic malignancy
355251|NCT01621477|Hematopoietic cell transplant|hematopoietic cell transplant
355252|NCT01621464|Neuromediated syncope|neuromediated syncope
355253|NCT01621464|Tilt test|tilt test
355254|NCT01621464|Pacemaker|pacemaker
355255|NCT01621464|CLS sensor|cls sensor
355256|NCT01621438|coronary artery|coronary artery
355257|NCT01621438|atherosclerosis|atherosclerosis
355258|NCT01621438|angina pectoris|angina pectoris
355259|NCT01621425|breast cancer|breast cancer
355260|NCT01621425|prostate carcinoma|prostate carcinoma
355261|NCT01621425|docetaxel|docetaxel
355262|NCT01621425|lean body mass|lean body mass
355263|NCT01621425|Body Surface Area|body surface area
355264|NCT01621425|body weight|body weight
355265|NCT01621425|dexascan|dexascan
355266|NCT01621412|Medication Adherence|medication adherence
355267|NCT01621412|HIV infection|hiv infection
355268|NCT01621412|Disclosure|disclosure
355269|NCT01621373|neonatology|neonatology
355270|NCT01621373|intratracheal intubation|intratracheal intubation
355271|NCT01621373|propofol|propofol
355272|NCT01621360|Randomized controlled trial|randomized controlled trial
355273|NCT01621360|Intention to treat|intention to treat
355274|NCT01621347|HIV|hiv
355275|NCT01621347|Pregnancy|pregnancy
355276|NCT01621347|Postpartum|postpartum
355277|NCT01621347|Women|women
355278|NCT01621347|Medication Adherence|medication adherence
355279|NCT01621308|Diabetes Mellitus type 1|diabetes mellitus type 1
355280|NCT01621308|Intraperitoneal insulin administration|intraperitoneal insulin administration
355281|NCT01621308|Subcutaneous insulin administration|subcutaneous insulin administration
355282|NCT01621308|Continuous intraperitoneal insulin infusion|continuous intraperitoneal insulin infusion
355283|NCT01621282|journal club|journal club
355284|NCT01621269|Multiple Sclerosis|multiple sclerosis
355285|NCT01621269|MS|ms
355286|NCT01621269|Fingolimod|fingolimod
355287|NCT01621269|Gilenya|gilenya
355288|NCT01621269|Neutralizing Antibodies|neutralizing antibodies
355289|NCT01621269|NAb|nab
355290|NCT01621243|necuparanib|necuparanib
355291|NCT01621243|gemcitabine|gemcitabine
355292|NCT01621243|heparin|heparin
355293|NCT01621243|low molecular weight heparin|low molecular weight heparin
355294|NCT01621243|nab-Paclitaxel|nab-paclitaxel
355295|NCT01621230|Bupivacaine|bupivacaine
355296|NCT01621230|Fentanyl|fentanyl
355297|NCT01621230|Epidural|epidural
355298|NCT01621230|Second Stage of Labor|second stage of labor
355299|NCT01621230|Randomized Controlled Trial|randomized controlled trial
355300|NCT01621217|Anal cancer|anal cancer
355301|NCT01621217|Locally advanced anal cancer|locally advanced anal cancer
355302|NCT01621217|Cetuximab|cetuximab
355303|NCT01621217|5-fluoruracil|5-fluoruracil
355304|NCT01621217|Mitomycin C|mitomycin c
355305|NCT01621217|Radiotherapy|radiotherapy
355306|NCT01621204|Thrombocytopenia|thrombocytopenia
355307|NCT01621204|ITP|itp
355308|NCT01621204|Platelets|platelets
355309|NCT01621204|Bleeding|bleeding
355310|NCT01621204|Immune|immune
355311|NCT01621204|Eltrombopag|eltrombopag
355312|NCT01621204|IVIG|ivig
355313|NCT01621165|treatment of bipolar, mania|treatment of bipolar, mania
355314|NCT01621165|double-blind, placebo-controlled study|double-blind, placebo-controlled study
355315|NCT01621165|drug intervention|drug intervention
355316|NCT01621165|add-on study|add-on study
355317|NCT01621165|prazosin|prazosin
355318|NCT01621165|alpha-1 adrenergic antagonist|alpha-1 adrenergic antagonist
355319|NCT01621152|Acute renal failure|acute renal failure
355320|NCT01621152|acute kidney injury|acute kidney injury
355321|NCT01621152|electronic surveillance|electronic surveillance
355322|NCT01621152|AKI|aki
355323|NCT01621152|sniffer|sniffer
355324|NCT01621152|AKIN|akin
355325|NCT01621152|improvement in the process of care and outcomes|improvement in the process of care and outcomes
355326|NCT01621126|Shoulder instability|shoulder instability
355327|NCT01621126|Latarjet procedure|latarjet procedure
355328|NCT01621126|Nerve injury|nerve injury
355329|NCT01621113|Spinal Cord Injuries|spinal cord injuries
355330|NCT01621113|4-Aminopyridine|4-aminopyridine
355331|NCT01621113|Physical Therapy Modalities|physical therapy modalities
355332|NCT01621113|Randomized Controlled Trial|randomized controlled trial
355333|NCT01621113|Rehabilitation|rehabilitation
355335|NCT01621100|Cancer pain|cancer pain
355336|NCT01621100|OROS|oros
355337|NCT01621100|Osmotic release oral system|osmotic release oral system
355338|NCT01621100|Hydromorphone|hydromorphone
355339|NCT01621100|Painkiller|painkiller
355340|NCT01621100|Opioid analgesic|opioid analgesic
355341|NCT01621100|Korean patients|korean patients
355342|NCT01621061|high altitude illness|high altitude illness
355343|NCT01621061|pulmonary hypertension|pulmonary hypertension
355344|NCT01621061|sleep apnea|sleep apnea
355345|NCT01621061|hypoxia|hypoxia
355346|NCT01621048|Head and Neck Neoplasmsr|head and neck neoplasmsr
355347|NCT01621048|Radiotherapy|radiotherapy
355348|NCT01621048|Xerostomia|xerostomia
355349|NCT01621048|Deglutition Disorders|deglutition disorders
355350|NCT01621022|smoking cessation|smoking cessation
355351|NCT01621022|tobacco dependence|tobacco dependence
355352|NCT01621009|smoking cessation medications|smoking cessation medications
355353|NCT01621009|smoking cessation counseling|smoking cessation counseling
355354|NCT01620996|preintervention and postintervention cohort longitudinal prospective study|preintervention and postintervention cohort longitudinal prospective study
355355|NCT01620983|arthroplasty|arthroplasty
355356|NCT01620983|pain|pain
355357|NCT01620970|Transitional Cell Carcinoma|transitional cell carcinoma
355358|NCT01620970|Metastatic disease|metastatic disease
355359|NCT01620970|Bladder tumors, Recurrent|bladder tumors, recurrent
355360|NCT01620970|Angiogenesis|angiogenesis
355361|NCT01620970|PF03446962|pf03446962
355362|NCT01620970|Transforming growth factor beta|transforming growth factor beta
355363|NCT01620970|Activin receptor like kinase 1|activin receptor like kinase 1
355364|NCT01620970|Monoclonal Antibody|monoclonal antibody
355365|NCT01620970|Locally advanced or metastatic disease|locally advanced or metastatic disease
355366|NCT01620970|Failure of one platinum-based chemotherapy|failure of one platinum-based chemotherapy
355367|NCT01620970|Measurable disease|measurable disease
355368|NCT01620957|Default-mode network|default-mode network
355369|NCT01620957|Difussion tensor imaging|difussion tensor imaging
355370|NCT01620957|Cortical thickness|cortical thickness
355371|NCT01620957|Coma|coma
355372|NCT01620957|Vegetative state|vegetative state
355373|NCT01620957|Minimally conscious state|minimally conscious state
355374|NCT01620957|Neural correlate of consciousness|neural correlate of consciousness
355375|NCT01620892|unicondylar knee arthroplasty|unicondylar knee arthroplasty
355376|NCT01620892|partial knee replacement|partial knee replacement
355377|NCT01620866|EMDR|emdr
355378|NCT01620866|bipolar disorder|bipolar disorder
355379|NCT01620866|trauma|trauma
355380|NCT01620866|subsyndromal symptoms|subsyndromal symptoms
355381|NCT01620866|PTSD|ptsd
355382|NCT01620853|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
355383|NCT01620853|ALK probe|alk probe
355384|NCT01620853|FISH|fish
355385|NCT01620853|Chromosomal aberrations|chromosomal aberrations
355386|NCT01620840|oral administration of Lacosamide is not possible or adequate|oral administration of lacosamide is not possible or adequate
355387|NCT01620827|follow up|follow up
355388|NCT01620827|cell phone|cell phone
355389|NCT01620827|hospital landline|hospital landline
355390|NCT01620814|misoprostol|misoprostol
355391|NCT01620814|dinoprostone|dinoprostone
355392|NCT01620814|cervical ripening|cervical ripening
355395|NCT01620801|AAV8|aav8
355396|NCT01620801|Adeno-associated virus|adeno-associated virus
355397|NCT01620801|Adeno-associated viral vectors|adeno-associated viral vectors
355398|NCT01620801|Hemophilia|hemophilia
355399|NCT01620801|Hemophilia B|hemophilia b
355400|NCT01620801|Severe hemophilia B|severe hemophilia b
355401|NCT01620801|Factor IX deficiency|factor ix deficiency
355402|NCT01620801|Factor IX|factor ix
355403|NCT01620801|FIX|fix
355404|NCT01620762|Cat allergy|cat allergy
355405|NCT01620762|Rhinoconjunctivitis|rhinoconjunctivitis
355406|NCT01620749|melanoma metastatic diagnosis|melanoma metastatic diagnosis
355407|NCT01620736|Raltegravir|raltegravir
355408|NCT01620736|HTLV|htlv
355409|NCT01620736|Integrase|integrase
355410|NCT01620723|Breastfeeding|breastfeeding
355411|NCT01620723|Breastfeeding self efficacy|breastfeeding self efficacy
355412|NCT01620710|prostatectomy|prostatectomy
355413|NCT01620658|Occupational Exposure to Radiation|occupational exposure to radiation
355414|NCT01620632|laparoscopy assisted ERCP|laparoscopy assisted ercp
355415|NCT01620632|altered gastric anatomy|altered gastric anatomy
355416|NCT01620619|Shoulder|shoulder
355417|NCT01620619|Bankart|bankart
355418|NCT01620619|Anterior Instability|anterior instability
355419|NCT01620619|Rotator Cuff|rotator cuff
355420|NCT01620606|FAP|fap
355421|NCT01620606|RAP|rap
355422|NCT01620606|Abdominal Pain|abdominal pain
355423|NCT01620606|IBS|ibs
355424|NCT01620593|Prostate Cancer|prostate cancer
355425|NCT01620593|Metformin|metformin
355426|NCT01620593|Castration therapy|castration therapy
355427|NCT01620580|sleep disturbance|sleep disturbance
355428|NCT01620580|tiredness|tiredness
355429|NCT01620580|itching & numbness|itching & numbness
355430|NCT01620567|lutein|lutein
355431|NCT01620567|avocados|avocados
355432|NCT01620567|chickpeas|chickpeas
355433|NCT01620567|potatoes|potatoes
355434|NCT01620567|elderly|elderly
355435|NCT01620554|Sleep disorder|sleep disorder
355436|NCT01620554|Obstructive Sleep Apnoea|obstructive sleep apnoea
355437|NCT01620554|Excessive Daytime Sleepiness|excessive daytime sleepiness
355438|NCT01620528|Gonadotropin-Releasing Hormone Antagonist|gonadotropin-releasing hormone antagonist
355439|NCT01620528|Endometriosis associated pain|endometriosis associated pain
355440|NCT01620528|Dysmenorrhea (DYS)|dysmenorrhea (dys)
355441|NCT01620528|Non-Menstrual Pelvic Pain (NMPP)|non-menstrual pelvic pain (nmpp)
355442|NCT01620528|Elagolix|elagolix
355443|NCT01620515|Prostate|prostate
355444|NCT01620515|Prostate Cancer|prostate cancer
355445|NCT01620515|Localized Prostate Cancer|localized prostate cancer
355446|NCT01620515|T1c Prostate Cancer|t1c prostate cancer
355447|NCT01620515|Focal Therapy|focal therapy
355448|NCT01620515|NX-1207|nx-1207
355449|NCT01620411|Active Duty|active duty
355450|NCT01620411|Comprehensive Medical Management|comprehensive medical management
355451|NCT01620411|Spinal Cord Stimulator|spinal cord stimulator
355452|NCT01620411|Veteran|veteran
355453|NCT01620411|sustained|sustained
355454|NCT01620411|military|military
355455|NCT01620398|cardiovascular diseases|cardiovascular diseases
355456|NCT01620398|secondary prevention|secondary prevention
355457|NCT01620398|diet|diet
355458|NCT01620385|Cochlear implants|cochlear implants
355459|NCT01620359|Breast cancer|breast cancer
355460|NCT01620359|Breast tumor|breast tumor
355461|NCT01620359|stage 1 disease|stage 1 disease
355462|NCT01620359|T1 M0 N0|t1 m0 n0
355463|NCT01620346|advanced maternal age|advanced maternal age
355464|NCT01620346|infertility|infertility
355465|NCT01620346|IMSI|imsi
355466|NCT01620346|ICSI|icsi
355467|NCT01620346|implantation|implantation
355468|NCT01620320|Left main coronary artery|left main coronary artery
355469|NCT01620320|Coronary artery disease|coronary artery disease
355470|NCT01620320|Stress echography|stress echography
355471|NCT01620320|Intrastent stenosis|intrastent stenosis
355472|NCT01620307|H1N1 patients with severe hypoxemia requiring ventilator support|h1n1 patients with severe hypoxemia requiring ventilator support
355473|NCT01620294|surgical site infection|surgical site infection
355474|NCT01620294|elective colorectal surgery|elective colorectal surgery
355475|NCT01620294|level of surgical site infection|level of surgical site infection
355476|NCT01620294|complication of surgical site infection|complication of surgical site infection
355477|NCT01620294|type of changed bandage|type of changed bandage
355478|NCT01620294|frequency of bandage changing|frequency of bandage changing
355479|NCT01620281|Back Pain|back pain
355480|NCT01620268|leflunomide|leflunomide
355481|NCT01620268|orotic acid|orotic acid
355482|NCT01620268|Polyoma BK Viruria|polyoma bk viruria
355483|NCT01620268|Polyoma BK Viremia|polyoma bk viremia
355484|NCT01620268|Polyoma BK Nephropathy|polyoma bk nephropathy
355485|NCT01620268|Renal Allograft Rejection|renal allograft rejection
355486|NCT01620242|recurrent or metastatic head and neck cancer|recurrent or metastatic head and neck cancer
355487|NCT01620242|cabazitaxel|cabazitaxel
355488|NCT01620203|Premature infants|premature infants
355489|NCT01620203|Intracranial hemorrhage|intracranial hemorrhage
355490|NCT01620203|Intraventricular hemorrhage|intraventricular hemorrhage
355491|NCT01620203|Cerebral oxygenation|cerebral oxygenation
355492|NCT01620203|Brain function|brain function
355493|NCT01620203|Cerebral perfusion|cerebral perfusion
355494|NCT01620177|Cannabis|cannabis
355495|NCT01620177|Marijuana|marijuana
355496|NCT01620177|Marihuana|marihuana
355497|NCT01620177|Alcohol|alcohol
355498|NCT01620177|Driving|driving
355499|NCT01620164|three-dimensional vision|three-dimensional vision
355500|NCT01620164|Parkinson|parkinson
355501|NCT01620151|Post-operative pain|post-operative pain
355502|NCT01620151|Wound bleeding requiring exploration|wound bleeding requiring exploration
355503|NCT01620151|PTH|pth
355504|NCT01620151|RLN complication|rln complication
355505|NCT01620151|Hypocalcaemia complication|hypocalcaemia complication
355506|NCT01620138|Non-functioning pituitary adenomas|non-functioning pituitary adenomas
355507|NCT01620138|Prolactinomas|prolactinomas
355508|NCT01620138|Cabergoline|cabergoline
355509|NCT01620138|Pasireotide|pasireotide
355510|NCT01620138|somatostatin receptors|somatostatin receptors
355511|NCT01620138|Dopamine receptors|dopamine receptors
355512|NCT01620125|Lactobacillus|lactobacillus
355513|NCT01620125|Gut microbiota|gut microbiota
355514|NCT01620125|Diabetes mellitus|diabetes mellitus
355515|NCT01620112|brachial plexus|brachial plexus
355516|NCT01620112|lidocaine|lidocaine
355517|NCT01620112|alfa 2 adrenergic receptor clonidine|alfa 2 adrenergic receptor clonidine
355518|NCT01620112|orthopedic procedure|orthopedic procedure
355519|NCT01620099|Asthma|asthma
355520|NCT01620099|Cigarette smoke|cigarette smoke
355521|NCT01620099|Small airways|small airways
355522|NCT01620099|Lung function|lung function
355523|NCT01620099|Asthma control|asthma control
355524|NCT01620086|Schizophrenia|schizophrenia
355525|NCT01620086|Auditory hallucinations (AH)|auditory hallucinations (ah)
355526|NCT01620086|Phantom sound perception|phantom sound perception
355527|NCT01620086|repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
355636|NCT01619722|Hyperphenylalaninemia|hyperphenylalaninemia
355528|NCT01620086|Percent habituation in the P50 amplitude with 250 ms ISI|percent habituation in the p50 amplitude with 250 ms isi
355529|NCT01620073|Male partner|male partner
355530|NCT01620073|HIV counseling and testing|hiv counseling and testing
355531|NCT01620073|Home based|home based
355532|NCT01620073|Pregnancy|pregnancy
355533|NCT01620060|Schizophrenia|schizophrenia
355534|NCT01620060|autism|autism
355535|NCT01620060|bipolar|bipolar
355536|NCT01620060|Lurasidone|lurasidone
355537|NCT01620060|Latuda|latuda
355538|NCT01620047|Regional Anesthesia|regional anesthesia
355539|NCT01620047|Post-operative pain management|post-operative pain management
355540|NCT01620047|Femoral Nerve Block|femoral nerve block
355541|NCT01620047|Total Knee Replacement|total knee replacement
355542|NCT01620021|wearable sensors|wearable sensors
355543|NCT01620021|kinematics|kinematics
355544|NCT01620021|gait|gait
355545|NCT01620008|cord clamping (delayed or immediate)|cord clamping (delayed or immediate)
355546|NCT01620008|Myelin content|myelin content
355547|NCT01620008|Ferritin|ferritin
355548|NCT01619995|urge incontinence|urge incontinence
355549|NCT01619956|dental implants|dental implants
355550|NCT01619956|osteotome sinus floor elevation|osteotome sinus floor elevation
355551|NCT01619956|survival rate|survival rate
355552|NCT01619956|sinus grafting|sinus grafting
355553|NCT01619956|bone remodeling|bone remodeling
355554|NCT01619956|RCT|rct
355555|NCT01619956|radiographic analysis|radiographic analysis
355556|NCT01619943|Minor head injury|minor head injury
355557|NCT01619943|CT scan|ct scan
355558|NCT01619943|Canadian CT Head Rules|canadian ct head rules
355559|NCT01619943|The New Orleans Criteria|the new orleans criteria
355560|NCT01619930|Depression|depression
355561|NCT01619930|Behavioral activation|behavioral activation
355562|NCT01619917|burn|burn
355563|NCT01619917|scar|scar
355564|NCT01619917|laser|laser
355565|NCT01619917|fractional|fractional
355566|NCT01619917|vascular|vascular
355567|NCT01619904|Pancreas Transplantation|pancreas transplantation
355568|NCT01619904|Goal-directed therapy|goal-directed therapy
355569|NCT01619904|Outcomes|outcomes
355570|NCT01619904|Immunometric|immunometric
355571|NCT01619878|plasmodium|plasmodium
355572|NCT01619878|P. falciparum|p. falciparum
355573|NCT01619878|malaria|malaria
355574|NCT01619878|infant|infant
355575|NCT01619878|neonate|neonate
355576|NCT01619865|GA-68|ga-68
355577|NCT01619865|Gallium 68|gallium 68
355578|NCT01619865|GA-68 PET|ga-68 pet
355579|NCT01619852|Surgery|surgery
355580|NCT01619852|Breast|breast
355581|NCT01619852|Pain|pain
355582|NCT01619852|Chronic Pain|chronic pain
355583|NCT01619852|Lidocaine|lidocaine
355584|NCT01619852|Anesthesia|anesthesia
355585|NCT01619852|Gynecologic|gynecologic
355586|NCT01619852|Urologic|urologic
355587|NCT01619839|Nektar|nektar
355588|NCT01619839|NKTR-181|nktr-181
355589|NCT01619826|physical activity|physical activity
355590|NCT01619826|fitness|fitness
355591|NCT01619826|brain health|brain health
355592|NCT01619826|cognition|cognition
355593|NCT01619826|scholastic achievement|scholastic achievement
355594|NCT01619826|preadolescent children|preadolescent children
355595|NCT01619800|Chronotropic Incompetence|chronotropic incompetence
355596|NCT01619800|Pacemaker|pacemaker
355597|NCT01619800|Mount Sinai School of Medicine|mount sinai school of medicine
355598|NCT01619774|Melanoma|melanoma
355599|NCT01619774|Metastatic melanoma|metastatic melanoma
355600|NCT01619774|Refractory or Resistant to BRAF Inhibitor|refractory or resistant to braf inhibitor
355601|NCT01619774|Advanced melanoma|advanced melanoma
355602|NCT01619774|GSK2118436|gsk2118436
355603|NCT01619774|GSK1120212|gsk1120212
355604|NCT01619761|Leukemia|leukemia
355605|NCT01619761|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
355606|NCT01619761|CLL|cll
355607|NCT01619761|Cord blood|cord blood
355608|NCT01619761|CB|cb
355609|NCT01619761|Umbilical cord blood|umbilical cord blood
355610|NCT01619761|UCB|ucb
355611|NCT01619761|Natural killer cells|natural killer cells
355612|NCT01619761|NK|nk
355613|NCT01619761|Graft versus host disease|graft versus host disease
355614|NCT01619761|GVHD|gvhd
355615|NCT01619761|Lenalidomide|lenalidomide
355616|NCT01619761|CC-5013|cc-5013
355617|NCT01619761|Revlimid|revlimid
355618|NCT01619761|Fludarabine|fludarabine
355619|NCT01619761|Fludarabine Phosphate|fludarabine phosphate
355620|NCT01619761|Fludara|fludara
355621|NCT01619761|Melphalan|melphalan
355622|NCT01619761|Alkeran|alkeran
355623|NCT01619761|Rituximab|rituximab
355624|NCT01619761|Rituxan|rituxan
355625|NCT01619735|Kidney Calculi|kidney calculi
355626|NCT01619735|Kidney Stones|kidney stones
355627|NCT01619735|Nephrolithiasis|nephrolithiasis
355628|NCT01619735|Renal Stones|renal stones
355629|NCT01619722|PKU|pku
355630|NCT01619722|Osteoporosis|osteoporosis
355631|NCT01619722|HMP|hmp
355632|NCT01619722|Life quality|life quality
355633|NCT01619722|Neuropsychological|neuropsychological
355634|NCT01619722|Nutritial evaluation|nutritial evaluation
355635|NCT01619722|Phenylketonuria|phenylketonuria
355637|NCT01619709|Intracerebral Hemorrhage|intracerebral hemorrhage
355638|NCT01619709|Cerebral Amyloid angiopathy|cerebral amyloid angiopathy
355639|NCT01619709|Amyloid imaging|amyloid imaging
355640|NCT01619709|18F-AV-45|18f-av-45
355641|NCT01619696|chemotherapy|chemotherapy
355642|NCT01619696|rectal adenocarcinoma|rectal adenocarcinoma
355643|NCT01619696|proctectomy|proctectomy
355644|NCT01619696|Fmiso TEP|fmiso tep
355645|NCT01619696|MRI|mri
355646|NCT01619657|Cystic Fibrosis|cystic fibrosis
355647|NCT01619657|Hypertonic Saline|hypertonic saline
355648|NCT01619657|Infant|infant
355649|NCT01619657|Newborn|newborn
355650|NCT01619657|Prevention|prevention
355651|NCT01619644|RTS|rts
355652|NCT01619644|Rubinstein Taybi|rubinstein taybi
355653|NCT01619644|explorative phase 2|explorative phase 2
355654|NCT01619644|clinical approach|clinical approach
355655|NCT01619644|biological approach|biological approach
355656|NCT01619644|motor skills|motor skills
355657|NCT01619631|Depression|depression
355658|NCT01619631|Tai Chi|tai chi
355659|NCT01619631|Alternative medicine|alternative medicine
355660|NCT01619631|Mind body medicine|mind body medicine
355661|NCT01619618|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
355662|NCT01619618|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
355663|NCT01619618|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
355664|NCT01619618|stage IVA squamous cell carcinoma of the larynx|stage iva squamous cell carcinoma of the larynx
355665|NCT01619618|stage IVB squamous cell carcinoma of the larynx|stage ivb squamous cell carcinoma of the larynx
355666|NCT01619618|stage IVC squamous cell carcinoma of the larynx|stage ivc squamous cell carcinoma of the larynx
355667|NCT01619618|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
355668|NCT01619618|stage IVA squamous cell carcinoma of the lip and oral cavity|stage iva squamous cell carcinoma of the lip and oral cavity
355669|NCT01619618|stage IVB squamous cell carcinoma of the lip and oral cavity|stage ivb squamous cell carcinoma of the lip and oral cavity
355670|NCT01619618|stage IVC squamous cell carcinoma of the lip and oral cavity|stage ivc squamous cell carcinoma of the lip and oral cavity
355671|NCT01619618|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
355672|NCT01619618|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
355673|NCT01619618|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
355674|NCT01619618|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
355675|NCT01619618|stage IVA squamous cell carcinoma of the oropharynx|stage iva squamous cell carcinoma of the oropharynx
355676|NCT01619618|stage IVB squamous cell carcinoma of the oropharynx|stage ivb squamous cell carcinoma of the oropharynx
355677|NCT01619618|stage IVC squamous cell carcinoma of the oropharynx|stage ivc squamous cell carcinoma of the oropharynx
355678|NCT01619618|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
355679|NCT01619618|stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iva squamous cell carcinoma of the paranasal sinus and nasal cavity
355680|NCT01619618|stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivb squamous cell carcinoma of the paranasal sinus and nasal cavity
355681|NCT01619618|stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivc squamous cell carcinoma of the paranasal sinus and nasal cavity
355682|NCT01619618|recurrent salivary gland cancer|recurrent salivary gland cancer
355683|NCT01619618|stage IVA salivary gland cancer|stage iva salivary gland cancer
355684|NCT01619618|stage IVB salivary gland cancer|stage ivb salivary gland cancer
355685|NCT01619618|stage IVC salivary gland cancer|stage ivc salivary gland cancer
355686|NCT01619605|tryptases|tryptases
355687|NCT01619605|anaphylaxis|anaphylaxis
355688|NCT01619605|shrimp allergy|shrimp allergy
355689|NCT01619592|patients|patients
355690|NCT01619592|adaptable|adaptable
355691|NCT01619592|insulin|insulin
355692|NCT01619592|schemes|schemes
355693|NCT01619579|Fibromyalgia|fibromyalgia
355694|NCT01619579|Pain|pain
355695|NCT01619579|Non-Invasive|non-invasive
355696|NCT01619579|Arthritis|arthritis
355697|NCT01619579|Rheumatoid Disease|rheumatoid disease
355698|NCT01619566|Fibromyalgia|fibromyalgia
355699|NCT01619566|Duloxetine|duloxetine
355700|NCT01619566|Cymbalta|cymbalta
355701|NCT01619566|Pain|pain
355702|NCT01619566|Peripheral Nerve|peripheral nerve
355703|NCT01619566|Biopsy|biopsy
355704|NCT01619566|Predictive|predictive
355705|NCT01619553|keloid|keloid
355706|NCT01619553|fibrosis|fibrosis
355707|NCT01619553|wound healing|wound healing
355708|NCT01619553|scar|scar
355709|NCT01619540|COPD|copd
355710|NCT01619540|Left Ventricular Failure|left ventricular failure
355711|NCT01619540|Valsalva Manoeuver|valsalva manoeuver
355712|NCT01619527|Healthy participants|healthy participants
355713|NCT01619527|Darunavir|darunavir
355714|NCT01619527|Cobicistat|cobicistat
355715|NCT01619527|Bioequivalence|bioequivalence
355716|NCT01619527|Fixed dose combination|fixed dose combination
355717|NCT01619527|Pharmacokinetics|pharmacokinetics
355718|NCT01619527|Human immunodeficiency virus|human immunodeficiency virus
355719|NCT01619527|Protease inhibitor|protease inhibitor
355720|NCT01619488|Lap-Band|lap-band
355721|NCT01619488|morbid obesity|morbid obesity
355722|NCT01619488|adolescents|adolescents
355723|NCT01619475|Living Donor|living donor
355724|NCT01619475|Liver Transplantation|liver transplantation
355725|NCT01619475|Quality of Life|quality of life
355726|NCT01619475|Biosamples|biosamples
355727|NCT01619475|Liver Recipient|liver recipient
355728|NCT01619462|pneumococcal|pneumococcal
355729|NCT01619462|vaccine|vaccine
355730|NCT01619462|papua new guinea|papua new guinea
355731|NCT01619449|Acute Kidney Injury|acute kidney injury
355732|NCT01619449|Continuous Renal Replacement Therapy|continuous renal replacement therapy
355733|NCT01619449|Liver Transplant|liver transplant
355734|NCT01619423|Metastatic colorectal cancer|metastatic colorectal cancer
355735|NCT01619423|stage IV|stage iv
355736|NCT01619423|FOLFOX6|folfox6
355737|NCT01619423|Chemotherapy|chemotherapy
355738|NCT01619423|PledOx|pledox
355739|NCT01619423|Mangafodipir|mangafodipir
355740|NCT01619423|Febrile neutropenia|febrile neutropenia
355741|NCT01619423|Oxidative stress|oxidative stress
355742|NCT01619423|Antioxidant|antioxidant
355743|NCT01619423|neutropenia|neutropenia
355744|NCT01619423|neuropathy|neuropathy
355745|NCT01619397|Condom|condom
355746|NCT01619397|Medical Device|medical device
355747|NCT01619384|posttraumatic stress|posttraumatic stress
355748|NCT01619384|irritable bowel|irritable bowel
355749|NCT01619371|breast pump|breast pump
355750|NCT01619371|engorgement|engorgement
355751|NCT01619371|lactation|lactation
355752|NCT01619332|Healthy volunteers,|healthy volunteers,
355753|NCT01619332|Diabetes|diabetes
355754|NCT01619332|Glucose|glucose
355755|NCT01619332|Pharmacokinetics|pharmacokinetics
355756|NCT01619319|schizophrenia prodrome|schizophrenia prodrome
355757|NCT01619319|clinical high risk of psychosis|clinical high risk of psychosis
355758|NCT01619293|CCT|cct
355759|NCT01619293|brain|brain
355760|NCT01619293|trauma|trauma
355761|NCT01619293|injury|injury
355762|NCT01619280|Acute Lung Injury|acute lung injury
355763|NCT01619280|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
355764|NCT01619280|Sodium Nitroprusside|sodium nitroprusside
355765|NCT01619280|adult|adult
355766|NCT01619280|Safety|safety
355767|NCT01619280|Dose Finding|dose finding
355768|NCT01619280|Phase 1|phase 1
355769|NCT01619280|3 + 3 design|3 + 3 design
355770|NCT01619280|Nebulizers and Vaporizers|nebulizers and vaporizers
355771|NCT01619280|High-Frequency Ventilation|high-frequency ventilation
355772|NCT01619280|nitric oxide|nitric oxide
355773|NCT01619280|lung injury|lung injury
355774|NCT01619280|Pulmonary Gas Exchange|pulmonary gas exchange
355775|NCT01619280|Pulmonary Alveoli|pulmonary alveoli
355776|NCT01619267|pacemaker defibrillator infection|pacemaker defibrillator infection
355777|NCT01619254|Intestinal parasitic infections|intestinal parasitic infections
355778|NCT01619254|Anaemia|anaemia
355779|NCT01619254|School-aged children|school-aged children
355780|NCT01619254|Hand washing and nail clipping|hand washing and nail clipping
355781|NCT01619241|lung cancer|lung cancer
355782|NCT01619241|F-18 FLT PET/CT|f-18 flt pet/ct
355783|NCT01619228|premature infant|premature infant
355784|NCT01619228|neonate|neonate
355785|NCT01619228|skin maturation|skin maturation
355786|NCT01619228|stratum corneum maturation|stratum corneum maturation
355787|NCT01619228|ontogeny of neonatal skin maturation|ontogeny of neonatal skin maturation
355788|NCT01619228|sunflower oil|sunflower oil
355789|NCT01619228|effect of Vitamin B3 on premature skin maturation|effect of vitamin b3 on premature skin maturation
355790|NCT01619228|skin acidity|skin acidity
355791|NCT01619228|stratum corneum barrier integrity|stratum corneum barrier integrity
355792|NCT01619228|stratum corneum lipid composition|stratum corneum lipid composition
355793|NCT01619228|stratum corneum biomarkers|stratum corneum biomarkers
355794|NCT01619228|stratum corneum cytokines|stratum corneum cytokines
355795|NCT01619228|stratum corneum structural proteins|stratum corneum structural proteins
355796|NCT01619202|accident prevention|accident prevention
355797|NCT01619202|Adolescent|adolescent
355798|NCT01619202|examination, automobile driver|examination, automobile driver
355799|NCT01619202|Driving simulator|driving simulator
355800|NCT01619202|Young drivers|young drivers
355801|NCT01619202|Driving education|driving education
355802|NCT01619189|Cell therapy|cell therapy
355803|NCT01619189|Limbal deficiency|limbal deficiency
355804|NCT01619189|Limbal stem cell|limbal stem cell
355805|NCT01619189|Transplantation|transplantation
355806|NCT01619176|Rheumatoid Arthritis|rheumatoid arthritis
355807|NCT01619176|blood|blood
355808|NCT01619176|gut intestinal microbiome|gut intestinal microbiome
355809|NCT01619163|Prednisolone,|prednisolone,
355810|NCT01619163|pain,|pain,
355811|NCT01619163|inflammation,|inflammation,
355812|NCT01619163|mobility|mobility
355813|NCT01619163|Function|function
355814|NCT01619150|knee|knee
355815|NCT01619150|osteoarthritis|osteoarthritis
355816|NCT01619150|central sensitization|central sensitization
355817|NCT01619150|mechanical detection|mechanical detection
355818|NCT01619150|pain threshold|pain threshold
355819|NCT01619150|quantitative sensory testing|quantitative sensory testing
355820|NCT01619150|pain biomarkers|pain biomarkers
355821|NCT01619150|COX-2 inhibitors|cox-2 inhibitors
355822|NCT01619150|etoricoxib.|etoricoxib.
355823|NCT01619137|ununion wound|ununion wound
355824|NCT01619137|soap|soap
355825|NCT01619137|irrigation|irrigation
355826|NCT01619137|Povidone-iodine|povidone-iodine
355827|NCT01619137|normal salin|normal salin
355828|NCT01619124|osteonecrosis|osteonecrosis
355829|NCT01619124|children|children
355830|NCT01619124|pediatric|pediatric
355831|NCT01619124|acute lymphoblastic leukaemia|acute lymphoblastic leukaemia
355832|NCT01619124|lymphoblastic lymphoma|lymphoblastic lymphoma
355833|NCT01619111|metastatic breast cancer|metastatic breast cancer
355834|NCT01619111|circulating tumor cells|circulating tumor cells
355835|NCT01619111|lapatinib|lapatinib
355836|NCT01619098|Hospital readmission|hospital readmission
355837|NCT01619098|Care transition|care transition
355838|NCT01619098|Discharge-transfer intervention|discharge-transfer intervention
355839|NCT01619098|Community health worker|community health worker
355840|NCT01619098|Patient Navigatgor|patient navigatgor
355841|NCT01619072|postpartum hemorrhage|postpartum hemorrhage
355842|NCT01619072|treatment|treatment
355843|NCT01619072|misoprostol|misoprostol
355844|NCT01619072|home births|home births
355845|NCT01619046|GreenGene™F, Previously Treated Patients|greengene™f, previously treated patients
355846|NCT01619033|Renal impairment|renal impairment
355847|NCT01619020|Healthy|healthy
355848|NCT01619020|Colon|colon
355849|NCT01619007|Treatment of Venous Thromboembolism|treatment of venous thromboembolism
355850|NCT01619007|Thromboembolism|thromboembolism
355851|NCT01619007|Venous Thromboembolism|venous thromboembolism
355852|NCT01619007|Embolism and Thrombosis|embolism and thrombosis
355853|NCT01619007|Vascular Diseases|vascular diseases
355854|NCT01619007|Cardiovascular Diseases|cardiovascular diseases
355855|NCT01619007|Thrombosis|thrombosis
355856|NCT01618994|Robotic Simulator|robotic simulator
355857|NCT01618994|EBL|ebl
355858|NCT01618994|Robotic Surgeons|robotic surgeons
355859|NCT01618994|Intuitive Surgical|intuitive surgical
355860|NCT01618994|simulation modules|simulation modules
355861|NCT01618994|benchmarks|benchmarks
355862|NCT01618994|Morristown Protocol|morristown protocol
355863|NCT01618994|Study Surgeons|study surgeons
355864|NCT01618994|Control Surgeons|control surgeons
355865|NCT01618994|Expert Surgeons|expert surgeons
355866|NCT01618994|dual-console daVinci system|dual-console davinci system
355867|NCT01618994|blinded skill assessment|blinded skill assessment
355868|NCT01618981|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
355869|NCT01618981|atrial dyssynchrony syndrome|atrial dyssynchrony syndrome
355870|NCT01618981|left atrio-ventricular asynchrony|left atrio-ventricular asynchrony
355871|NCT01618981|pacemaker|pacemaker
355872|NCT01618981|left atrial pacing therapy|left atrial pacing therapy
355873|NCT01618929|Food allergy|food allergy
355874|NCT01618929|Asthma|asthma
355875|NCT01618929|Children|children
355876|NCT01618929|Montelukast|montelukast
355877|NCT01618929|Inflammation|inflammation
355878|NCT01618903|Keppra Levetiracetam intravenous|keppra levetiracetam intravenous
355879|NCT01618903|Oral tablets|oral tablets
355880|NCT01618903|Bioequivalence|bioequivalence
355881|NCT01618903|Pharmacokinetics|pharmacokinetics
355882|NCT01618903|Safety|safety
355883|NCT01618903|Chinese healthy volunteers|chinese healthy volunteers
355884|NCT01618890|Prevention|prevention
355885|NCT01618890|Esophageal variceal bleeding|esophageal variceal bleeding
355886|NCT01618890|Hepatic Venous Pressure Gradient|hepatic venous pressure gradient
355887|NCT01618890|Betablocker therapy|betablocker therapy
355888|NCT01618877|Keppra Levetiracetam intravenous|keppra levetiracetam intravenous
355889|NCT01618877|Multiple dose|multiple dose
355890|NCT01618877|Safety|safety
355891|NCT01618877|Pharmacokinetics|pharmacokinetics
355892|NCT01618877|Chinese healthy volunteers|chinese healthy volunteers
355893|NCT01618851|prostate cancer|prostate cancer
355894|NCT01618838|prostate cancer|prostate cancer
355895|NCT01618812|Artificial bone graft|artificial bone graft
355896|NCT01618812|Hydroxyapatite|hydroxyapatite
355897|NCT01618812|Children|children
355898|NCT01618812|Osteotomy|osteotomy
355899|NCT01618812|Pes plano valgus|pes plano valgus
355900|NCT01618812|Flatfeet|flatfeet
355901|NCT01618786|Falls|falls
355902|NCT01618786|Fall injuries|fall injuries
355903|NCT01618786|Bone fracture|bone fracture
355904|NCT01618786|Hip fracture|hip fracture
355905|NCT01618786|Skull fracture|skull fracture
355906|NCT01618786|Wounds|wounds
355907|NCT01618786|Closed head injury|closed head injury
355908|NCT01618786|Traumatic brain injury|traumatic brain injury
355909|NCT01618786|Concussion|concussion
355910|NCT01618786|Spinal cord injury|spinal cord injury
355911|NCT01618786|Trauma|trauma
355912|NCT01618786|Older adults|older adults
355913|NCT01618786|Long-term care|long-term care
355914|NCT01618786|Compliant flooring|compliant flooring
355915|NCT01618786|Safety floors|safety floors
355916|NCT01618786|Balance|balance
355917|NCT01618786|Injury biomechanics|injury biomechanics
355918|NCT01618786|Biomedical engineering|biomedical engineering
355919|NCT01618786|Environmental hazards|environmental hazards
355920|NCT01618786|Environmental interventions|environmental interventions
355921|NCT01618786|Fall prevention|fall prevention
355922|NCT01618786|Gerontology|gerontology
355923|NCT01618773|acne|acne
355924|NCT01618773|Epiduo|epiduo
355925|NCT01618773|adapalene/ benzoyl peroxide|adapalene/ benzoyl peroxide
355926|NCT01618734|Immune Thrombocytopenia|immune thrombocytopenia
355927|NCT01618734|Thrombopoietin receptor agonist|thrombopoietin receptor agonist
355928|NCT01618721|Chronic obstructive lung disease;|chronic obstructive lung disease;
355929|NCT01618721|Interstitial lung disease;|interstitial lung disease;
355930|NCT01618721|Ultrasound Doppler;|ultrasound doppler;
355931|NCT01618721|Lung disease diagnosis;|lung disease diagnosis;
355932|NCT01618695|Partial-onset Seizures|partial-onset seizures
355933|NCT01618695|partial seizures|partial seizures
355934|NCT01618695|seizure|seizure
355935|NCT01618695|epilepsy|epilepsy
355936|NCT01618682|hand transplant|hand transplant
355937|NCT01618682|hand replant|hand replant
355938|NCT01618669|Coronary Artery Disease (CAD)|coronary artery disease (cad)
355939|NCT01618669|regadenoson|regadenoson
355940|NCT01618669|pharmacologic stress|pharmacologic stress
355941|NCT01618643|Barrett's|barrett's
355942|NCT01618643|High grade dysplasia|high grade dysplasia
355943|NCT01618643|HGD|hgd
355944|NCT01618643|IMC|imc
355945|NCT01618643|Intramucosal cancer|intramucosal cancer
355946|NCT01618643|Acetic acid|acetic acid
355947|NCT01618643|Chromoendoscopy|chromoendoscopy
355948|NCT01618630|burn injury|burn injury
355949|NCT01618630|children|children
355950|NCT01618630|nutrition|nutrition
355951|NCT01618630|lipid metabolism|lipid metabolism
355952|NCT01618630|insulin sensitivity|insulin sensitivity
355953|NCT01618630|amino acids|amino acids
355954|NCT01618630|stable isotopes|stable isotopes
355955|NCT01618617|Constipation|constipation
355956|NCT01618617|Probiotic|probiotic
355957|NCT01618617|Randomized Controlled Trial|randomized controlled trial
355958|NCT01618604|Conditioned Pain Modulation|conditioned pain modulation
355959|NCT01618604|Quantitative Sensory Testing|quantitative sensory testing
355960|NCT01618604|duration|duration
355961|NCT01618604|correlation|correlation
355962|NCT01618591|diarrhea|diarrhea
355963|NCT01618591|travelers' diarrhea|travelers' diarrhea
355964|NCT01618591|watery diarrhea|watery diarrhea
355965|NCT01618591|enteric illness|enteric illness
355966|NCT01618591|dysentery|dysentery
355967|NCT01618591|gastrointestinal|gastrointestinal
355968|NCT01618578|rubber hand illusion|rubber hand illusion
355969|NCT01618578|CRPS|crps
355970|NCT01618578|body image|body image
355971|NCT01618578|body ownership|body ownership
355972|NCT01618565|shoulder dystocia|shoulder dystocia
355973|NCT01618565|training|training
355974|NCT01618565|To assess the effectiveness of hands-on training versus expert demonstration|to assess the effectiveness of hands-on training versus expert demonstration
355975|NCT01618552|Chronic disease|chronic disease
355976|NCT01618552|Cluster randomization|cluster randomization
355977|NCT01618552|Comorbidity|comorbidity
355978|NCT01618552|Depression|depression
355979|NCT01618552|Diabetes|diabetes
355980|NCT01618552|Medical history taking|medical history taking
355981|NCT01618552|Office visits|office visits
355982|NCT01618552|Patient acceptance of health care|patient acceptance of health care
355983|NCT01618552|Patient compliance|patient compliance
355984|NCT01618552|Patient simulation|patient simulation
355985|NCT01618552|Physician patient relations|physician patient relations
355986|NCT01618552|Primary health care|primary health care
355987|NCT01618552|Randomized controlled trials|randomized controlled trials
355988|NCT01618552|Self care|self care
355989|NCT01618552|Self efficacy|self efficacy
355990|NCT01618539|Total intravenous anesthesia, Bispectral Index Score|total intravenous anesthesia, bispectral index score
355991|NCT01618526|Dietary fibers|dietary fibers
355992|NCT01618526|Butyrate|butyrate
355993|NCT01618526|Short Chain Fatty Acids|short chain fatty acids
355994|NCT01618526|Colon|colon
355995|NCT01618526|Metabolic Syndrome|metabolic syndrome
355996|NCT01618513|Acromegaly|acromegaly
355997|NCT01618513|Somatostatin analogs|somatostatin analogs
355998|NCT01618513|Treatment|treatment
355999|NCT01618500|Normal Pressure Hydrocephalus|normal pressure hydrocephalus
356000|NCT01618500|Neuropsychological Test|neuropsychological test
356001|NCT01618500|Assessment of cognitive disorders/dementia|assessment of cognitive disorders/dementia
356002|NCT01618500|Neuropsychological assessment|neuropsychological assessment
356003|NCT01618487|tennis elbow|tennis elbow
356004|NCT01618487|lateral epicondylitis|lateral epicondylitis
356005|NCT01618474|gastric cancer|gastric cancer
356006|NCT01618474|adjuvant chemotherapy|adjuvant chemotherapy
356007|NCT01618461|Prescription drug information|prescription drug information
356008|NCT01618461|Medication management|medication management
356009|NCT01618435|Fusion surgery|fusion surgery
356010|NCT01618435|Degenerative olisthesis|degenerative olisthesis
356011|NCT01618435|i-FACTOR|i-factor
356012|NCT01618435|ODI|odi
356013|NCT01618435|Spinal stenosis|spinal stenosis
356014|NCT01618422|DOTS plus|dots plus
356015|NCT01618422|DOTS|dots
356120|NCT01618058|HIV Infections|hiv infections
356016|NCT01618422|multidrug resistant tuberculosis (MDR TB)|multidrug resistant tuberculosis (mdr tb)
356017|NCT01618409|PictureRx|picturerx
356018|NCT01618409|Health Literacy|health literacy
356019|NCT01618409|Limited English Proficiency|limited english proficiency
356020|NCT01618409|Latinos|latinos
356021|NCT01618409|Spanish|spanish
356022|NCT01618396|Microcirculation|microcirculation
356023|NCT01618396|Hypnotics and Sedatives,|hypnotics and sedatives,
356024|NCT01618396|Propofol,|propofol,
356025|NCT01618396|Midazolam|midazolam
356026|NCT01618383|Parkinson's disease|parkinson's disease
356027|NCT01618383|gut|gut
356028|NCT01618383|colon|colon
356029|NCT01618383|biopsies|biopsies
356030|NCT01618383|LRRK2|lrrk2
356031|NCT01618370|Radium 223|radium 223
356032|NCT01618370|Alpharadin|alpharadin
356033|NCT01618370|Prostate Cancer|prostate cancer
356034|NCT01618370|Bone metastases|bone metastases
356035|NCT01618370|Castrate resistant prostate cancer|castrate resistant prostate cancer
356036|NCT01618370|Hormone refractory prostate cancer|hormone refractory prostate cancer
356037|NCT01618357|Veliparib|veliparib
356038|NCT01618357|ABT-888|abt-888
356039|NCT01618357|Radiation|radiation
356040|NCT01618357|POPI|popi
356041|NCT01618344|neoplasms|neoplasms
356042|NCT01618344|adolescent|adolescent
356043|NCT01618344|young adult|young adult
356044|NCT01618344|medication adherence|medication adherence
356045|NCT01618331|FSHD|fshd
356046|NCT01618331|Endurance exercise|endurance exercise
356047|NCT01618331|Protein supplementation|protein supplementation
356048|NCT01618331|Placebo RCT|placebo rct
356049|NCT01618318|Asthma|asthma
356050|NCT01618318|Allergy|allergy
356051|NCT01618318|Diagnosis|diagnosis
356052|NCT01618318|Correlation study|correlation study
356053|NCT01618292|pelvic organ prolapse|pelvic organ prolapse
356054|NCT01618292|constipation|constipation
356055|NCT01618292|bowel dysfunction|bowel dysfunction
356056|NCT01618292|irritable bowel syndrome (IBS)|irritable bowel syndrome (ibs)
356057|NCT01618292|CRADI-8|cradi-8
356058|NCT01618292|CRAIQ-7|craiq-7
356059|NCT01618292|splinting with defecation|splinting with defecation
356060|NCT01618292|excessive straining|excessive straining
356061|NCT01618292|bowel movements|bowel movements
356062|NCT01618292|fecal incontinence|fecal incontinence
356063|NCT01618292|bowel symptoms|bowel symptoms
356064|NCT01618279|tryptase|tryptase
356065|NCT01618279|coronary|coronary
356066|NCT01618279|stemi|stemi
356067|NCT01618279|nstemi|nstemi
356068|NCT01618253|Transarterial Chemoembolization|transarterial chemoembolization
356069|NCT01618253|TACE|tace
356070|NCT01618253|Sorafenib Tosylate|sorafenib tosylate
356071|NCT01618253|Sorafenib|sorafenib
356072|NCT01618253|Nexavar|nexavar
356073|NCT01618253|External Beam Radiation Therapy|external beam radiation therapy
356074|NCT01618253|Radiation Therapy|radiation therapy
356075|NCT01618253|Radiotherapy|radiotherapy
356076|NCT01618253|Radiation|radiation
356077|NCT01618240|FEES|fees
356078|NCT01618240|PAS|pas
356079|NCT01618240|VPSR|vpsr
356080|NCT01618240|MRC|mrc
356081|NCT01618201|Inflammation|inflammation
356082|NCT01618201|Migraine|migraine
356083|NCT01618201|Headache|headache
356084|NCT01618175|Bronchiolitis, Viral|bronchiolitis, viral
356085|NCT01618175|Home oxygen therapy|home oxygen therapy
356086|NCT01618175|Home Nursing|home nursing
356087|NCT01618175|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
356088|NCT01618175|bronchiolitis severity score|bronchiolitis severity score
356089|NCT01618149|osteoarthritis|osteoarthritis
356090|NCT01618149|periprosthetic bone loss|periprosthetic bone loss
356091|NCT01618149|dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
356092|NCT01618136|PARP inhibitors|parp inhibitors
356093|NCT01618136|Malignant Solid Tumour|malignant solid tumour
356094|NCT01618136|ovarian cancer|ovarian cancer
356095|NCT01618136|triple negative breast cancer|triple negative breast cancer
356096|NCT01618136|advanced melanoma|advanced melanoma
356097|NCT01618123|Endothelial function|endothelial function
356098|NCT01618123|Coronary disease|coronary disease
356099|NCT01618123|Atherosclerosis|atherosclerosis
356100|NCT01618123|Chest pain|chest pain
356101|NCT01618110|ADHD|adhd
356102|NCT01618110|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
356103|NCT01618110|TMS|tms
356104|NCT01618110|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
356105|NCT01618097|Osteoarthritis|osteoarthritis
356106|NCT01618097|Decision Aids|decision aids
356107|NCT01618097|Health Literacy|health literacy
356108|NCT01618084|hipreplacement|hipreplacement
356109|NCT01618084|uncemented|uncemented
356110|NCT01618084|migration|migration
356111|NCT01618084|boneremodeling|boneremodeling
356112|NCT01618071|n-3 PUFA|n-3 pufa
356113|NCT01618071|Endothelial cells|endothelial cells
356114|NCT01618071|Nitric oxide|nitric oxide
356115|NCT01618071|Oxidative stress|oxidative stress
356116|NCT01618071|Blood pressure|blood pressure
356117|NCT01618071|Vasodilation|vasodilation
356118|NCT01618071|Lipemia|lipemia
356119|NCT01618071|Unsaturated dietary fats|unsaturated dietary fats
356121|NCT01618058|Anti-HIV Agents|anti-hiv agents
356122|NCT01618058|HIV-1|hiv-1
356123|NCT01618045|Diabetes|diabetes
356124|NCT01618045|FPP|fpp
356125|NCT01618045|fermented papaya preparation|fermented papaya preparation
356126|NCT01618019|n-3 PUFA|n-3 pufa
356127|NCT01618019|rheumatoid arthritis|rheumatoid arthritis
356128|NCT01618019|inflammation|inflammation
356129|NCT01618019|eicosanoids|eicosanoids
356130|NCT01618019|bone turnover markers|bone turnover markers
356131|NCT01617993|in vitro fertilization|in vitro fertilization
356132|NCT01617993|assisted reproduction|assisted reproduction
356133|NCT01617993|noninvasive imaging of embryos|noninvasive imaging of embryos
356134|NCT01617993|time lapse imaging of embryos|time lapse imaging of embryos
356135|NCT01617993|traditional morphological grading of embryos|traditional morphological grading of embryos
356136|NCT01617993|prediction of blastocysts|prediction of blastocysts
356137|NCT01617993|infertility|infertility
356138|NCT01617993|Genital Diseases, Male|genital diseases, male
356139|NCT01617993|Genital Diseases, Female|genital diseases, female
356140|NCT01617980|Hypoxia imaging|hypoxia imaging
356141|NCT01617980|FMISO-PET|fmiso-pet
356142|NCT01617980|functional MRI|functional mri
356143|NCT01617980|Intensity modulated radiation therapy|intensity modulated radiation therapy
356144|NCT01617967|RNAi therapeutic|rnai therapeutic
356145|NCT01617941|non-chronic migraine, migraine prevention|non-chronic migraine, migraine prevention
356146|NCT01617902|Hyperbilirubinemia|hyperbilirubinemia
356147|NCT01617902|cardiac|cardiac
356148|NCT01617902|surgery|surgery
356149|NCT01617902|aorta|aorta
356150|NCT01617902|prognosis|prognosis
356151|NCT01617876|Stomach Neoplasms|stomach neoplasms
356152|NCT01617876|early gastric cancer|early gastric cancer
356153|NCT01617876|magnifying endoscopy|magnifying endoscopy
356154|NCT01617876|narrow band imaging|narrow band imaging
356155|NCT01617876|acetic acid|acetic acid
356156|NCT01617876|indigocarmine|indigocarmine
356157|NCT01617837|Postoperative nausea and vomiting|postoperative nausea and vomiting
356158|NCT01617837|P6 acupressure|p6 acupressure
356159|NCT01617837|Craniotomy.|craniotomy.
356160|NCT01617824|Diabetes|diabetes
356161|NCT01617824|Kidney|kidney
356162|NCT01617824|Inflammation|inflammation
356163|NCT01617824|Metabolism|metabolism
356164|NCT01617772|Non-alcoholic steatohepatitis, Atorvastatin, L-Carnitine|non-alcoholic steatohepatitis, atorvastatin, l-carnitine
356165|NCT01617746|Asthma|asthma
356166|NCT01617746|Endothelin|endothelin
356167|NCT01617746|Airway hyperreactivity|airway hyperreactivity
356168|NCT01617720|mitral|mitral
356169|NCT01617720|valve|valve
356170|NCT01617720|annuloplasty|annuloplasty
356171|NCT01617720|mitral regurgitation|mitral regurgitation
356172|NCT01617707|sedation|sedation
356173|NCT01617707|endoscopy|endoscopy
356174|NCT01617707|midazolam|midazolam
356175|NCT01617707|propofol|propofol
356176|NCT01617707|chronic alcoholics|chronic alcoholics
356177|NCT01617694|dexmedetomidine|dexmedetomidine
356178|NCT01617694|remifentanil|remifentanil
356179|NCT01617694|target-controlled infusion|target-controlled infusion
356180|NCT01617681|Hypertension; CKD; Pediatric|hypertension; ckd; pediatric
356181|NCT01617668|Breast cancer,|breast cancer,
356182|NCT01617668|LCL161,|lcl161,
356183|NCT01617668|paclitaxel,|paclitaxel,
356184|NCT01617668|neoadjuvant,|neoadjuvant,
356185|NCT01617668|triple negative breast cancer|triple negative breast cancer
356186|NCT01617642|Porphyria|porphyria
356187|NCT01617642|Inflammation|inflammation
356188|NCT01617642|Diet|diet
356189|NCT01617642|Iron status|iron status
356190|NCT01617629|Cvac|cvac
356191|NCT01617603|diabetes type 2|diabetes type 2
356192|NCT01617603|insulin resistance|insulin resistance
356193|NCT01617603|glycaemic control|glycaemic control
356194|NCT01617603|Endothelial function|endothelial function
356195|NCT01617603|Cocoa Polyphenols|cocoa polyphenols
356196|NCT01617590|RA|ra
356197|NCT01617590|Leflunomide|leflunomide
356198|NCT01617590|Methotrexate|methotrexate
356199|NCT01617577|G-CSF|g-csf
356200|NCT01617577|granulocyte colony stimulating factor|granulocyte colony stimulating factor
356201|NCT01617577|Filgrastim|filgrastim
356202|NCT01617564|medical abortion|medical abortion
356203|NCT01617564|second trimester|second trimester
356204|NCT01617564|para cervical blockage|para cervical blockage
356205|NCT01617564|pain management|pain management
356206|NCT01617551|Essential hypertension|essential hypertension
356207|NCT01617551|Nitric oxide|nitric oxide
356208|NCT01617551|Renal denervation|renal denervation
356209|NCT01617551|Sodium|sodium
356210|NCT01617551|GFR|gfr
356211|NCT01617538|atherosclerosis|atherosclerosis
356212|NCT01617538|stenosis|stenosis
356213|NCT01617538|statin therapy|statin therapy
356214|NCT01617538|Signs and Symptoms|signs and symptoms
356215|NCT01617538|Circulatory; Change|circulatory; change
356216|NCT01617499|physical activity|physical activity
356217|NCT01617499|pedometer|pedometer
356218|NCT01617499|worksite|worksite
356219|NCT01617499|wellness|wellness
356220|NCT01617499|cardiovascular|cardiovascular
356221|NCT01617499|lifestyle program|lifestyle program
356325|NCT01617070|Dopamine|dopamine
356222|NCT01617460|Autistic Disorder, children and adolescents|autistic disorder, children and adolescents
356223|NCT01617460|aripiprazole|aripiprazole
356224|NCT01617460|Long-term safety study|long-term safety study
356225|NCT01617460|children and adolescents|children and adolescents
356226|NCT01617447|Autistic Disorder, children and adolescents|autistic disorder, children and adolescents
356227|NCT01617447|Aripiprazole|aripiprazole
356228|NCT01617447|Double-blind|double-blind
356229|NCT01617447|Randomized|randomized
356230|NCT01617447|children and adolescents|children and adolescents
356231|NCT01617421|Yoga|yoga
356232|NCT01617421|Arthritis|arthritis
356233|NCT01617408|Theta Burst Stimulation|theta burst stimulation
356234|NCT01617408|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
356235|NCT01617408|Visual Cortex|visual cortex
356236|NCT01617408|Visual Processing|visual processing
356237|NCT01617395|Multiple Sclerosis|multiple sclerosis
356238|NCT01617395|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
356239|NCT01617382|HIPEC|hipec
356240|NCT01617382|Hyperthermic (heated) chemotherapy after debulking|hyperthermic (heated) chemotherapy after debulking
356241|NCT01617356|TMD|tmd
356242|NCT01617356|temporomandibular|temporomandibular
356243|NCT01617356|dextrose|dextrose
356244|NCT01617356|prolotherapy|prolotherapy
356245|NCT01617330|Particulate matter|particulate matter
356246|NCT01617330|Air pollution|air pollution
356247|NCT01617330|Diesel exhaust|diesel exhaust
356248|NCT01617330|Allergic rhinitis|allergic rhinitis
356249|NCT01617317|H1N1 2009|h1n1 2009
356250|NCT01617317|hyperimmune IVIG|hyperimmune ivig
356251|NCT01617317|mortality|mortality
356252|NCT01617317|length of stay|length of stay
356253|NCT01617317|viral load|viral load
356254|NCT01617317|cytokine|cytokine
356255|NCT01617304|advanced glycation end products|advanced glycation end products
356256|NCT01617304|insulin sensitivity|insulin sensitivity
356257|NCT01617304|obesity|obesity
356258|NCT01617304|inflammation|inflammation
356259|NCT01617304|metabolomics|metabolomics
356260|NCT01617304|appetite|appetite
356261|NCT01617304|CVD|cvd
356262|NCT01617291|Pre-hospital hypothermia|pre-hospital hypothermia
356263|NCT01617291|Induced therapeutic hypothermia|induced therapeutic hypothermia
356264|NCT01617291|Cardiac arrest|cardiac arrest
356265|NCT01617278|Colonoscopy|colonoscopy
356266|NCT01617278|I Scan|i scan
356267|NCT01617278|High definition white light|high definition white light
356268|NCT01617278|Adenomas|adenomas
356269|NCT01617265|intensive care|intensive care
356270|NCT01617265|mechanical ventilation|mechanical ventilation
356271|NCT01617265|sedatives|sedatives
356272|NCT01617265|morphinics|morphinics
356273|NCT01617265|oversedation|oversedation
356274|NCT01617265|mortality|mortality
356275|NCT01617265|midazolam|midazolam
356276|NCT01617265|propofol|propofol
356277|NCT01617265|pain|pain
356278|NCT01617265|agitation|agitation
356279|NCT01617252|Cardiac surgery|cardiac surgery
356280|NCT01617252|Acute respiratory failure|acute respiratory failure
356281|NCT01617252|High flow oxygen therapy|high flow oxygen therapy
356282|NCT01617239|Influenza|influenza
356283|NCT01617239|Vaccination|vaccination
356284|NCT01617239|Virosomal influenza vaccine|virosomal influenza vaccine
356285|NCT01617213|Multiple Myeloma|multiple myeloma
356286|NCT01617174|prostate|prostate
356287|NCT01617174|pain assessment|pain assessment
356288|NCT01617174|12-110|12-110
356289|NCT01617161|Low Risk|low risk
356290|NCT01617161|Intermediate Risk|intermediate risk
356291|NCT01617148|Exudative Macular Degeneration|exudative macular degeneration
356292|NCT01617148|Aflibercept|aflibercept
356293|NCT01617135|Parkinson's disease|parkinson's disease
356294|NCT01617135|Motor fluctuations|motor fluctuations
356295|NCT01617135|levodopa|levodopa
356296|NCT01617135|inhaled drugs|inhaled drugs
356297|NCT01617135|"Motor fluctuation (off episodes)"|"motor fluctuation (off episodes)"
356298|NCT01617122|PID|pid
356299|NCT01617122|PIDD|pidd
356300|NCT01617122|antibody deficiency|antibody deficiency
356301|NCT01617122|CVID|cvid
356302|NCT01617122|recurrent infections|recurrent infections
356303|NCT01617109|Vitamin D|vitamin d
356304|NCT01617109|Calcium|calcium
356305|NCT01617109|Parathyroid hormone|parathyroid hormone
356306|NCT01617109|Bone|bone
356307|NCT01617109|Bone formation|bone formation
356308|NCT01617109|Bone resorption|bone resorption
356309|NCT01617109|Micronutrients|micronutrients
356310|NCT01617109|Trace Elements|trace elements
356311|NCT01617096|HIV Infections|hiv infections
356312|NCT01617096|Anti-HIV agents|anti-hiv agents
356313|NCT01617096|HIV-1|hiv-1
356314|NCT01617083|PANS|pans
356315|NCT01617083|PANDAS|pandas
356316|NCT01617083|OCD|ocd
356317|NCT01617083|Tics|tics
356318|NCT01617083|Azithromycin|azithromycin
356319|NCT01617083|Antibiotic Treatment|antibiotic treatment
356320|NCT01617070|Tetrahydrobiopterin|tetrahydrobiopterin
356321|NCT01617070|Kuvan|kuvan
356322|NCT01617070|Phenylketonuria (PKU)|phenylketonuria (pku)
356323|NCT01617070|Large Neutral Amino Acids|large neutral amino acids
356324|NCT01617070|Serotonin|serotonin
356326|NCT01617070|Melatonin|melatonin
356327|NCT01617057|otosclerosis|otosclerosis
356328|NCT01617057|inner ear|inner ear
356329|NCT01617057|tiludronic acid|tiludronic acid
356330|NCT01617044|Iron|iron
356331|NCT01617044|Deficiency|deficiency
356332|NCT01617044|Restless|restless
356333|NCT01617044|Leg|leg
356334|NCT01617031|aspirin|aspirin
356335|NCT01617031|diabetes mellitus|diabetes mellitus
356336|NCT01617031|coronary artery disease|coronary artery disease
356337|NCT01617018|Psoriasis; Biological therapy; Methotrexate; Cyclosporine|psoriasis; biological therapy; methotrexate; cyclosporine
356338|NCT01616979|Off-pump coronary artery bypass surgery|off-pump coronary artery bypass surgery
356339|NCT01616979|Transesophageal echocardiography|transesophageal echocardiography
356340|NCT01616966|hoarseness|hoarseness
356341|NCT01616966|sore throat|sore throat
356342|NCT01616966|vocal cord injuries|vocal cord injuries
356343|NCT01616953|dental implants|dental implants
356344|NCT01616940|HIV/AIDS|hiv/aids
356345|NCT01616940|Peer support|peer support
356346|NCT01616927|ADPKD|adpkd
356347|NCT01616927|lanreotide|lanreotide
356348|NCT01616927|polycystic kidney|polycystic kidney
356349|NCT01616927|polycystic liver|polycystic liver
356350|NCT01616914|delirium|delirium
356351|NCT01616914|outcome|outcome
356352|NCT01616901|Obese|obese
356353|NCT01616901|Intensive Care|intensive care
356354|NCT01616901|Respiratory weaning|respiratory weaning
356355|NCT01616901|Spontaneous Breathing trial|spontaneous breathing trial
356356|NCT01616901|Work of breathing|work of breathing
356357|NCT01616888|drug eluting balloon with paclitaxel|drug eluting balloon with paclitaxel
356358|NCT01616888|in stent restenosis|in stent restenosis
356359|NCT01616888|femoropopliteal arteries|femoropopliteal arteries
356360|NCT01616888|angioplasty|angioplasty
356361|NCT01616875|Bladder cancer|bladder cancer
356362|NCT01616875|Transitional cell carcinoma|transitional cell carcinoma
356363|NCT01616875|Urothelial cancer|urothelial cancer
356364|NCT01616875|Cisplatin|cisplatin
356365|NCT01616875|Cabazitaxel|cabazitaxel
356366|NCT01616875|Chemotherapy|chemotherapy
356367|NCT01616875|Neo adjuvant chemotherapy|neo adjuvant chemotherapy
356368|NCT01616862|Pseudomonas aeruginosa|pseudomonas aeruginosa
356369|NCT01616862|cystic fibrosis|cystic fibrosis
356370|NCT01616823|Human immunodeficiency virus (HIV) positive women|human immunodeficiency virus (hiv) positive women
356371|NCT01616810|urinary tract|urinary tract
356372|NCT01616784|Adult|adult
356373|NCT01616784|Diabetes Mellitus|diabetes mellitus
356374|NCT01616784|Type 1|type 1
356375|NCT01616784|Humans|humans
356376|NCT01616784|Hypoglycemic Agents|hypoglycemic agents
356377|NCT01616784|Administration and Dosage|administration and dosage
356378|NCT01616784|Insulin|insulin
356379|NCT01616784|Self Care|self care
356380|NCT01616784|Health Education|health education
356381|NCT01616784|Insulin Infusion Systems|insulin infusion systems
356382|NCT01616784|Randomised controlled trial|randomised controlled trial
356383|NCT01616784|Patient Education as Topic|patient education as topic
356384|NCT01616784|Hemoglobin A|hemoglobin a
356385|NCT01616784|Glycosylated|glycosylated
356386|NCT01616771|laryngoscopes|laryngoscopes
356387|NCT01616745|NTM Lung disease|ntm lung disease
356388|NCT01616745|NTM Lung disease patients enrolled in SNUH|ntm lung disease patients enrolled in snuh
356389|NCT01616693|rotavirus|rotavirus
356390|NCT01616693|polio|polio
356391|NCT01616693|zinc supplement|zinc supplement
356392|NCT01616693|probiotic supplement|probiotic supplement
356393|NCT01616693|rotavirus vaccine shedding|rotavirus vaccine shedding
356394|NCT01616667|Controlled Clinical Trial|controlled clinical trial
356395|NCT01616667|Operative Surgical Procedures|operative surgical procedures
356396|NCT01616667|Treatment Outcome|treatment outcome
356397|NCT01616667|Pain Measurement|pain measurement
356398|NCT01616667|Quality of Life|quality of life
356399|NCT01616667|Questionnaires/standards|questionnaires/standards
356400|NCT01616667|Activities of Daily Living|activities of daily living
356401|NCT01616667|Biomechanics|biomechanics
356402|NCT01616667|Gait*|gait*
356403|NCT01616667|Hip Joint/physiology*|hip joint/physiology*
356404|NCT01616667|Hip Joint/surgery*|hip joint/surgery*
356405|NCT01616667|Recovery of Function/physiology|recovery of function/physiology
356406|NCT01616641|rheumatoid arthritis|rheumatoid arthritis
356407|NCT01616641|bite force|bite force
356408|NCT01616641|grip strenght|grip strenght
356409|NCT01616641|oral health|oral health
356410|NCT01616641|quality of life|quality of life
356411|NCT01616628|Incentives|incentives
356412|NCT01616628|Fruit|fruit
356413|NCT01616628|Vegetables|vegetables
356414|NCT01616602|patients|patients
356415|NCT01616602|presenting|presenting
356416|NCT01616602|elective|elective
356417|NCT01616602|colonoscopy.|colonoscopy.
356418|NCT01616589|Fragile X syndrome|fragile x syndrome
356419|NCT01616589|Fragile X full mutation|fragile x full mutation
356420|NCT01616589|Fragile X premutation|fragile x premutation
356421|NCT01616589|Fragile X intermediate|fragile x intermediate
356422|NCT01616589|CGG repeat length|cgg repeat length
356423|NCT01616576|cochlear implant|cochlear implant
356424|NCT01616576|adults|adults
356921|NCT01614366|amlodipine|amlodipine
356425|NCT01616576|HiResolution™|hiresolution™
356426|NCT01616576|Fidelity 120™|fidelity 120™
356427|NCT01616576|listening benefits|listening benefits
356428|NCT01616576|noise|noise
356429|NCT01616576|cochlear implant benefit|cochlear implant benefit
356430|NCT01616563|central obesity|central obesity
356431|NCT01616563|abdominal obesity|abdominal obesity
356432|NCT01616563|hypertension|hypertension
356433|NCT01616563|cardiovascular disease|cardiovascular disease
356434|NCT01616563|high cholesterol|high cholesterol
356435|NCT01616563|high triglycerides|high triglycerides
356436|NCT01616563|insulin resistance|insulin resistance
356437|NCT01616563|diabetes mellitus|diabetes mellitus
356438|NCT01616550|analgesia|analgesia
356439|NCT01616550|thoracic surgery|thoracic surgery
356440|NCT01616537|solid tumors|solid tumors
356441|NCT01616537|hematological malignancy|hematological malignancy
356442|NCT01616472|hypertension|hypertension
356443|NCT01616472|avascular necrosis|avascular necrosis
356444|NCT01616472|systemic lupus erythematosus|systemic lupus erythematosus
356445|NCT01616472|osteoporosis|osteoporosis
356446|NCT01616472|Steroid|steroid
356447|NCT01616472|diabetes|diabetes
356448|NCT01616472|cataracts|cataracts
356449|NCT01616459|Streptococcus pneumoniae|streptococcus pneumoniae
356450|NCT01616459|Haemophilus influenzae|haemophilus influenzae
356451|NCT01616459|Pneumococcal vaccine|pneumococcal vaccine
356452|NCT01616459|Infants|infants
356453|NCT01616459|Safety|safety
356454|NCT01616459|Immunogenicity|immunogenicity
356455|NCT01616446|cyclosporin|cyclosporin
356456|NCT01616446|nephrotic syndrome|nephrotic syndrome
356457|NCT01616446|pharmacokinetics|pharmacokinetics
356458|NCT01616446|children|children
356459|NCT01616433|Arthritis|arthritis
356460|NCT01616433|Preventive Behaviors|preventive behaviors
356461|NCT01616420|prevention|prevention
356462|NCT01616420|treatment|treatment
356463|NCT01616420|cost-effectiveness|cost-effectiveness
356464|NCT01616420|assisted partner notification services|assisted partner notification services
356465|NCT01616420|Kenya|kenya
356466|NCT01616420|linkage to HIV care|linkage to hiv care
356467|NCT01616420|case-finding|case-finding
356468|NCT01616407|Effects of psychostimulants on emotion recognition and empathy|effects of psychostimulants on emotion recognition and empathy
356469|NCT01616355|denture, complete;|denture, complete;
356470|NCT01616355|sodium hypochlorite;|sodium hypochlorite;
356471|NCT01616355|disinfection;|disinfection;
356472|NCT01616355|surface roughness;|surface roughness;
356473|NCT01616355|color stability.|color stability.
356474|NCT01616329|alloimmunization|alloimmunization
356475|NCT01616329|RBC|rbc
356476|NCT01616329|clinicalfactors|clinicalfactors
356477|NCT01616329|Risk|risk
356478|NCT01616303|ovarian|ovarian
356479|NCT01616303|cancer|cancer
356480|NCT01616303|neoplasm|neoplasm
356481|NCT01616303|adenocarcinoma|adenocarcinoma
356482|NCT01616303|CA125|ca125
356483|NCT01616290|peripheral artery disease|peripheral artery disease
356484|NCT01616290|PAD|pad
356485|NCT01616290|claudication|claudication
356486|NCT01616290|angioplasty|angioplasty
356487|NCT01616290|percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
356488|NCT01616290|PTA|pta
356489|NCT01616290|superficial femoral artery|superficial femoral artery
356490|NCT01616290|SFA|sfa
356491|NCT01616290|popliteal artery|popliteal artery
356492|NCT01616290|PA|pa
356493|NCT01616290|PRT-201|prt-201
356494|NCT01616290|restenosis|restenosis
356495|NCT01616290|vonapanitase|vonapanitase
356496|NCT01616264|Tuberculosis|tuberculosis
356497|NCT01616264|Pleural Effusion|pleural effusion
356498|NCT01616264|Computed Tomography|computed tomography
356499|NCT01616251|Protein sources|protein sources
356500|NCT01616251|Appetite|appetite
356501|NCT01616251|Dietary fibers|dietary fibers
356502|NCT01616251|Meat|meat
356503|NCT01616251|Egg|egg
356504|NCT01616251|Legumes|legumes
356505|NCT01616225|Infertility|infertility
356506|NCT01616225|Poor Responder|poor responder
356507|NCT01616225|In Vitro Fertilization|in vitro fertilization
356508|NCT01616225|Growth Hormone|growth hormone
356509|NCT01616212|Teens|teens
356510|NCT01616212|Parenting|parenting
356511|NCT01616212|Substance Abuse|substance abuse
356512|NCT01616212|Treatment Efficacy|treatment efficacy
356513|NCT01616199|PX-866|px-866
356514|NCT01616199|BRAF-mutant cancers|braf-mutant cancers
356515|NCT01616199|Advanced melanoma|advanced melanoma
356516|NCT01616199|BRAF inhibitor|braf inhibitor
356517|NCT01616199|Vemurafenib|vemurafenib
356518|NCT01616199|Zelboraf|zelboraf
356519|NCT01616199|PI-3K inhibitor|pi-3k inhibitor
356520|NCT01616186|Renal Cell Carcinoma|renal cell carcinoma
356521|NCT01616173|Nerve Block|nerve block
356522|NCT01616173|Anesthesia Recovery Period|anesthesia recovery period
356523|NCT01616160|Nasal polyps|nasal polyps
356524|NCT01616147|Intensive Lifestyle Intervention|intensive lifestyle intervention
356525|NCT01616134|overweight,|overweight,
356526|NCT01616134|ginseng|ginseng
356527|NCT01616108|strabismus|strabismus
356528|NCT01616108|diplopia|diplopia
356529|NCT01616095|Growth hormone deficiency|growth hormone deficiency
356530|NCT01616095|hrGH therapy|hrgh therapy
356531|NCT01616095|metabolic health|metabolic health
356532|NCT01616095|adipose tissue metabolism|adipose tissue metabolism
356533|NCT01616095|adipose tissue inflammation|adipose tissue inflammation
356534|NCT01616095|adipokines|adipokines
356535|NCT01616082|fatty acid oxidation|fatty acid oxidation
356536|NCT01616082|Proton magnetic resonance spectroscopy|proton magnetic resonance spectroscopy
356537|NCT01616069|CABG|cabg
356538|NCT01616069|Echocardiography|echocardiography
356539|NCT01616069|Heart Failure|heart failure
356540|NCT01616069|Heart Function|heart function
356541|NCT01616056|Chronic graft-versus-host disease|chronic graft-versus-host disease
356542|NCT01616056|eye|eye
356543|NCT01616043|scar quality|scar quality
356544|NCT01616030|Hip fractures|hip fractures
356545|NCT01616030|Strength training|strength training
356546|NCT01616017|Cardiac output|cardiac output
356547|NCT01616017|ultrasound dilution|ultrasound dilution
356548|NCT01616017|thermodilution|thermodilution
356549|NCT01615965|prostate cancer|prostate cancer
356550|NCT01615965|lymph node|lymph node
356551|NCT01615965|micrometastasis|micrometastasis
356552|NCT01615952|Supraclavicular Block|supraclavicular block
356553|NCT01615939|Sciatic Nerve Block|sciatic nerve block
356554|NCT01615939|Continuous Nerve Block|continuous nerve block
356555|NCT01615926|dyspnea|dyspnea
356556|NCT01615926|shortness of breath|shortness of breath
356557|NCT01615926|respiratory rate|respiratory rate
356558|NCT01615926|orthopnea|orthopnea
356559|NCT01615913|onychomycosis|onychomycosis
356560|NCT01615913|terbinafine|terbinafine
356561|NCT01615913|ketoconazole|ketoconazole
356562|NCT01615913|transdermal topical therapy|transdermal topical therapy
356563|NCT01615900|Renal graft|renal graft
356564|NCT01615900|Teleconsultation|teleconsultation
356565|NCT01615900|Kidney transplant failure score|kidney transplant failure score
356566|NCT01615848|polycystic Ovary syndrome (PCOS)|polycystic ovary syndrome (pcos)
356567|NCT01615848|diet|diet
356568|NCT01615848|mediterranean diet|mediterranean diet
356569|NCT01615848|high protein diet|high protein diet
356570|NCT01615822|Malaria|malaria
356571|NCT01615822|PK|pk
356572|NCT01615822|OZ439|oz439
356573|NCT01615822|Mefloquine|mefloquine
356574|NCT01615822|Healthy Volunteers|healthy volunteers
356575|NCT01615809|Invasive pulmonary aspergillosis|invasive pulmonary aspergillosis
356576|NCT01615809|IFI|ifi
356577|NCT01615809|Leukaemia|leukaemia
356578|NCT01615809|Leukemia|leukemia
356579|NCT01615809|Pediatric|pediatric
356580|NCT01615809|Paediatrics|paediatrics
356581|NCT01615809|Amphotericin B|amphotericin b
356582|NCT01615809|Aspergillosis|aspergillosis
356583|NCT01615809|Pulmonary Aspergillosis|pulmonary aspergillosis
356584|NCT01615809|Invasive Aspergillosis|invasive aspergillosis
356585|NCT01615809|Antifungal agents|antifungal agents
356586|NCT01615809|Fungal infections|fungal infections
356587|NCT01615809|Invasive Fungal Infection|invasive fungal infection
356588|NCT01615796|GSK2140944|gsk2140944
356589|NCT01615796|antibiotics|antibiotics
356590|NCT01615796|first time in human|first time in human
356591|NCT01615796|pharmacokinetics|pharmacokinetics
356592|NCT01615796|intravenous|intravenous
356593|NCT01615796|safety|safety
356594|NCT01615796|absolute bioavailability|absolute bioavailability
356595|NCT01615796|Bacterial Type II|bacterial type ii
356596|NCT01615796|tolerability|tolerability
356597|NCT01615796|infection|infection
356598|NCT01615783|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
356599|NCT01615783|Costs|costs
356600|NCT01615783|Resource utilization|resource utilization
356601|NCT01615783|Medicaid|medicaid
356602|NCT01615757|AML|aml
356603|NCT01615757|Acute Myeloid Leukemia|acute myeloid leukemia
356604|NCT01615757|Cytarabine dose|cytarabine dose
356605|NCT01615757|Ara-c dose|ara-c dose
356606|NCT01615757|Consolidation|consolidation
356607|NCT01615744|calcaneal fractures|calcaneal fractures
356608|NCT01615744|surgical treatment|surgical treatment
356609|NCT01615744|conservative treatment|conservative treatment
356610|NCT01615744|VAS scoring|vas scoring
356611|NCT01615744|SF-36|sf-36
356612|NCT01615744|AOFAS|aofas
356613|NCT01615744|Olerud-Molander score|olerud-molander score
356614|NCT01615744|outcome|outcome
356615|NCT01615731|Mifepristone|mifepristone
356616|NCT01615731|Induced Abortion|induced abortion
356617|NCT01615731|Dilation and Evacuation|dilation and evacuation
356618|NCT01615731|Cervical preparation|cervical preparation
356619|NCT01615731|Osmotic dilators|osmotic dilators
356620|NCT01615718|noninvasive stimulation|noninvasive stimulation
356621|NCT01615718|motor function|motor function
356622|NCT01615718|transcranial stimulation|transcranial stimulation
356623|NCT01615718|transcranial ultrasound|transcranial ultrasound
356624|NCT01615718|brain stimulation|brain stimulation
356625|NCT01615705|Postphlebitic Syndrome|postphlebitic syndrome
356626|NCT01615705|Post-Thrombotic Syndrome|post-thrombotic syndrome
356627|NCT01615705|Biomarkers|biomarkers
356628|NCT01615705|Markers of Inflammation|markers of inflammation
356629|NCT01615705|Genetic Thrombophilia|genetic thrombophilia
356630|NCT01615705|Coagulation Activation|coagulation activation
356631|NCT01615692|Elastic Stockings|elastic stockings
356632|NCT01615692|Stockings, Compression|stockings, compression
356633|NCT01615692|Randomized Controlled Trials|randomized controlled trials
356634|NCT01615692|Quality of Life|quality of life
356635|NCT01615679|Non-interventional study|non-interventional study
356636|NCT01615679|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
356637|NCT01615679|ADHD|adhd
356638|NCT01615666|Alzheimer's disease|alzheimer's disease
356639|NCT01615666|Mild Cognitive Impairment|mild cognitive impairment
356640|NCT01615666|Frontotemporal dementia|frontotemporal dementia
356641|NCT01615666|fMRI|fmri
356642|NCT01615666|functional neuroimaging|functional neuroimaging
356643|NCT01615666|Memory|memory
356644|NCT01615653|Pancreatic cancer|pancreatic cancer
356645|NCT01615653|Pancreas cancer|pancreas cancer
356646|NCT01615653|Pain|pain
356647|NCT01615653|Celiac Plexus|celiac plexus
356648|NCT01615653|Neurolysis|neurolysis
356649|NCT01615640|Osteosarcoma|osteosarcoma
356650|NCT01615640|Response of chemotherapy|response of chemotherapy
356651|NCT01615640|Dynamic contrast medium examination|dynamic contrast medium examination
356652|NCT01615640|Diffusion-weighted MR imaging|diffusion-weighted mr imaging
356653|NCT01615627|Subcutaneous Treprostinil|subcutaneous treprostinil
356654|NCT01615614|Rilpivirine|rilpivirine
356655|NCT01615614|Rifabutin|rifabutin
356656|NCT01615614|Pharmacokinetics|pharmacokinetics
356657|NCT01615614|Healthy participants|healthy participants
356658|NCT01615601|Human Immunodeficiency Virus|human immunodeficiency virus
356659|NCT01615601|HIV|hiv
356660|NCT01615601|HIV-1|hiv-1
356661|NCT01615601|HIV type 1|hiv type 1
356662|NCT01615601|Darunavir|darunavir
356663|NCT01615601|PREZISTA|prezista
356664|NCT01615601|Etravirine|etravirine
356665|NCT01615601|INTELENCE|intelence
356666|NCT01615601|HIV symptom Distress Module|hiv symptom distress module
356667|NCT01615601|HIV-SDM|hiv-sdm
356668|NCT01615601|Antiretroviral therapy|antiretroviral therapy
356669|NCT01615601|HIV Symptom Index (HSI),|hiv symptom index (hsi),
356670|NCT01615588|manuka honey|manuka honey
356671|NCT01615588|glycaemic index|glycaemic index
356672|NCT01615588|blood glucose control|blood glucose control
356673|NCT01615588|individuals|individuals
356674|NCT01615588|current disease|current disease
356675|NCT01615588|medication use|medication use
356676|NCT01615562|Polycystic Ovary Syndrome|polycystic ovary syndrome
356677|NCT01615562|PCOS|pcos
356678|NCT01615562|Infertility|infertility
356679|NCT01615549|Cholecystectomy|cholecystectomy
356680|NCT01615549|Virtual reality device|virtual reality device
356681|NCT01615549|Training|training
356682|NCT01615536|chronic rhinosinusitis|chronic rhinosinusitis
356683|NCT01615536|canine fossa trephine|canine fossa trephine
356684|NCT01615536|canine fossa puncture|canine fossa puncture
356685|NCT01615523|Executive functions|executive functions
356686|NCT01615497|cognitive behavior therapy|cognitive behavior therapy
356687|NCT01615497|computer assisted instruction|computer assisted instruction
356688|NCT01615497|alcohol abuse therapy|alcohol abuse therapy
356689|NCT01615497|educational resource design and development|educational resource design and development
356690|NCT01615484|Lung Transplant|lung transplant
356691|NCT01615484|Emphysema|emphysema
356692|NCT01615484|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
356693|NCT01615484|Cystic Fibrosis|cystic fibrosis
356694|NCT01615484|Pulmonary Fibrosis|pulmonary fibrosis
356695|NCT01615484|Bronchiectasis|bronchiectasis
356696|NCT01615484|Sarcoidosis|sarcoidosis
356697|NCT01615484|Pulmonary Hypertension|pulmonary hypertension
356698|NCT01615484|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
356699|NCT01615471|Obesity|obesity
356700|NCT01615471|Lifestyle Intervention|lifestyle intervention
356701|NCT01615471|Group treatment|group treatment
356702|NCT01615471|Internet Intervention|internet intervention
356703|NCT01615458|Care Management|care management
356704|NCT01615458|Implementation|implementation
356705|NCT01615458|Intervention|intervention
356706|NCT01615458|Mood Disorders|mood disorders
356707|NCT01615380|smoking cessation|smoking cessation
356708|NCT01615380|Aerobic Exercise|aerobic exercise
356709|NCT01615380|Women|women
356710|NCT01615380|YMCA|ymca
356711|NCT01615367|Bipolar disorder|bipolar disorder
356712|NCT01615367|Nutrition|nutrition
356713|NCT01615367|Exercise|exercise
356714|NCT01615367|Symptoms|symptoms
356715|NCT01615367|Functioning|functioning
356716|NCT01615341|Kidney transplantation|kidney transplantation
356717|NCT01615341|Subclinical Viral Infection|subclinical viral infection
356718|NCT01615341|Renal Allograft Injury|renal allograft injury
356719|NCT01615328|anterior cervical discectomy and fusion|anterior cervical discectomy and fusion
356720|NCT01615328|bone graft substitute|bone graft substitute
356721|NCT01615328|PEEK cage|peek cage
356722|NCT01615328|hydroxyapatite|hydroxyapatite
356723|NCT01615328|demineralized bone matrix|demineralized bone matrix
356724|NCT01615328|b-tricalcium phosphate|b-tricalcium phosphate
356725|NCT01615328|Bonion|bonion
356726|NCT01615328|Cervios ChronOs|cervios chronos
356727|NCT01615315|aspirin|aspirin
356728|NCT01615315|screening|screening
356729|NCT01615315|microscopic hematuria|microscopic hematuria
356730|NCT01615302|Rectal Fistula|rectal fistula
356731|NCT01615302|Peri-anal Fistula|peri-anal fistula
356732|NCT01615302|Platelet-Rich Plasma|platelet-rich plasma
356733|NCT01615302|Mucosa advancement flap|mucosa advancement flap
356734|NCT01615276|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
356735|NCT01615276|Ageing|ageing
356736|NCT01615276|Protein ingestion|protein ingestion
356737|NCT01615263|Video-assisted thoracoscopic surgery (VATS)|video-assisted thoracoscopic surgery (vats)
356738|NCT01615263|One lung ventilation|one lung ventilation
356739|NCT01615263|Bronchial blocker|bronchial blocker
356740|NCT01615263|Lung collapse|lung collapse
356741|NCT01615263|Double lumen tube|double lumen tube
356742|NCT01615224|missed abortion|missed abortion
356743|NCT01615224|miscarriage|miscarriage
356744|NCT01615211|Abortion|abortion
356745|NCT01615211|medical abortion|medical abortion
356746|NCT01615211|termination of pregnancy|termination of pregnancy
356747|NCT01615211|Mifepristone|mifepristone
356748|NCT01615211|misoprostol|misoprostol
356749|NCT01615211|letrozole|letrozole
356750|NCT01615211|trilostane|trilostane
356751|NCT01615211|femara|femara
356752|NCT01615211|Modrenal|modrenal
356753|NCT01615198|Hypertension, blood pressure, LCZ696, dual inhibitor, neprilysin, NEP inhibition, vasopeptidase, ARNi, angiotensin receptor|hypertension, blood pressure, lcz696, dual inhibitor, neprilysin, nep inhibition, vasopeptidase, arni, angiotensin receptor
356754|NCT01615185|schizophrenia|schizophrenia
356755|NCT01615185|amisulpride|amisulpride
356756|NCT01615185|sulpiride|sulpiride
356757|NCT01615185|antipsychotic combination|antipsychotic combination
356758|NCT01615159|Sodium|sodium
356759|NCT01615159|Diet|diet
356760|NCT01615159|Urinary sodium excretion|urinary sodium excretion
356761|NCT01615159|Feeding study|feeding study
356762|NCT01615159|Diet maintenance|diet maintenance
356763|NCT01615146|Myelodysplasia|myelodysplasia
356764|NCT01615146|Leukemia|leukemia
356765|NCT01615146|Thrombocytopenia|thrombocytopenia
356766|NCT01615146|Platelet|platelet
356767|NCT01615146|transfusions|transfusions
356768|NCT01615146|Outpatient|outpatient
356769|NCT01615081|Malt extract|malt extract
356770|NCT01615081|carbohydrate|carbohydrate
356771|NCT01615081|glucose response|glucose response
356772|NCT01615081|insulin response|insulin response
356773|NCT01615081|Appetite|appetite
356774|NCT01615081|Appetite regulating hormones|appetite regulating hormones
356775|NCT01615055|Chemotherapy|chemotherapy
356776|NCT01615055|Cognitive|cognitive
356777|NCT01615055|Prozac|prozac
356778|NCT01615055|Fluoxetine|fluoxetine
356779|NCT01615055|FDG|fdg
356780|NCT01615055|PET|pet
356781|NCT01615042|Acute Leukemia|acute leukemia
356782|NCT01615042|Bone Marrow Transplant|bone marrow transplant
356783|NCT01615042|High Dose Lenalidomide|high dose lenalidomide
356784|NCT01615029|Multiple Myeloma|multiple myeloma
356785|NCT01615029|Daratumumab|daratumumab
356786|NCT01615029|Lenalidomide|lenalidomide
356787|NCT01615029|Dexamethasone|dexamethasone
356788|NCT01615029|Dose-escalation|dose-escalation
356789|NCT01615029|Relapsed multiple myeloma|relapsed multiple myeloma
356790|NCT01615029|Relapsed and refractory multiple myeloma|relapsed and refractory multiple myeloma
356791|NCT01615016|Preterm infant|preterm infant
356792|NCT01615016|Surfactant application|surfactant application
356793|NCT01615016|Respiratory Distress Syndrome|respiratory distress syndrome
356794|NCT01615016|Minimally invasive Surfactant Application|minimally invasive surfactant application
356795|NCT01615016|INSURE (Intubate-Surfactant-Extubate)|insure (intubate-surfactant-extubate)
356796|NCT01615003|MicroRNA|microrna
356797|NCT01615003|coronary heart disease|coronary heart disease
356798|NCT01615003|unstable angina|unstable angina
356799|NCT01615003|blood stasis syndrome|blood stasis syndrome
356800|NCT01615003|Xuesaitong soft capsule|xuesaitong soft capsule
356801|NCT01614977|nontuberculous mycobacteria|nontuberculous mycobacteria
356802|NCT01614977|corticosteroids|corticosteroids
356803|NCT01614977|children|children
356804|NCT01614977|lymphadeniti|lymphadeniti
356805|NCT01614977|Therapeutic intervention in immunocompetent children with nontuberculous mycobacterial lymphadenitis.|therapeutic intervention in immunocompetent children with nontuberculous mycobacterial lymphadenitis.
356806|NCT01614964|Plasmodium falciparum|plasmodium falciparum
356807|NCT01614964|pharmacokinetics|pharmacokinetics
356808|NCT01614964|antimalarials (antimalarial drugs)|antimalarials (antimalarial drugs)
356809|NCT01614964|chloroquine (chloroquine-resistant)|chloroquine (chloroquine-resistant)
356810|NCT01614964|QT (QTc) interval|qt (qtc) interval
356811|NCT01614938|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
356812|NCT01614938|Locally advanced|locally advanced
356813|NCT01614938|Cetuximab|cetuximab
356814|NCT01614938|Weekly cisplatin chemotherapy|weekly cisplatin chemotherapy
356815|NCT01614938|Intensity-modulated radiotherapy|intensity-modulated radiotherapy
356816|NCT01614886|Rivastigmine, Alzheimer's disease, Transdermal patch|rivastigmine, alzheimer's disease, transdermal patch
356817|NCT01614873|Breathing Pattern|breathing pattern
356818|NCT01614873|Mechanical Ventilation|mechanical ventilation
356819|NCT01614873|Pressure support ventilation|pressure support ventilation
356922|NCT01614366|DMTA07|dmta07
356820|NCT01614873|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
356821|NCT01614860|Aldosterone|aldosterone
356822|NCT01614860|Echocardiography|echocardiography
356823|NCT01614860|Neurohormones|neurohormones
356824|NCT01614847|dry eye|dry eye
356825|NCT01614847|artificial tears|artificial tears
356826|NCT01614847|tear osmolarity|tear osmolarity
356827|NCT01614847|residence time|residence time
356828|NCT01614834|urticaria|urticaria
356829|NCT01614834|disease control|disease control
356830|NCT01614834|severity|severity
356831|NCT01614834|test|test
356832|NCT01614821|Relapsed|relapsed
356833|NCT01614821|Refractory|refractory
356834|NCT01614743|Rosacea|rosacea
356835|NCT01614730|EMS|ems
356836|NCT01614730|Modified Device|modified device
356837|NCT01614717|Hypertrophic Obstructive Cardiomyopathy|hypertrophic obstructive cardiomyopathy
356838|NCT01614717|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
356839|NCT01614704|Breast cancer|breast cancer
356840|NCT01614704|Fertility|fertility
356841|NCT01614678|myopia|myopia
356842|NCT01614665|Transplant|transplant
356843|NCT01614665|Prograf|prograf
356844|NCT01614665|Heart|heart
356845|NCT01614665|Advagraf|advagraf
356846|NCT01614665|Tacrolimus|tacrolimus
356847|NCT01614665|Immunosuppression|immunosuppression
356848|NCT01614665|Kidney|kidney
356849|NCT01614665|Liver|liver
356850|NCT01614665|Pharmacokinetic|pharmacokinetic
356851|NCT01614665|Pediatric|pediatric
356852|NCT01614652|Congestive Heart Failure Due to LV Systolic Dysfunction|congestive heart failure due to lv systolic dysfunction
356853|NCT01614639|Acupuncture|acupuncture
356854|NCT01614639|fMRI|fmri
356855|NCT01614639|CLBP|clbp
356856|NCT01614639|Pain|pain
356857|NCT01614639|Low Back Pain|low back pain
356858|NCT01614639|Back Pain|back pain
356859|NCT01614626|HIV|hiv
356860|NCT01614626|Alcohol Use|alcohol use
356861|NCT01614626|Microbial Translocation|microbial translocation
356862|NCT01614626|Inflammation|inflammation
356863|NCT01614626|Altered Coagulation|altered coagulation
356864|NCT01614626|Russia|russia
356865|NCT01614600|contact lens|contact lens
356866|NCT01614600|dry eye syndrome|dry eye syndrome
356867|NCT01614600|symptomatic|symptomatic
356868|NCT01614600|daily disposable|daily disposable
356869|NCT01614600|myopia|myopia
356870|NCT01614587|pelvic organ prolapse|pelvic organ prolapse
356871|NCT01614587|recurrence of pelvic organ prolapse|recurrence of pelvic organ prolapse
356872|NCT01614587|genetic predisposition|genetic predisposition
356873|NCT01614587|SNP microarray analysis|snp microarray analysis
356874|NCT01614587|pelvic floor|pelvic floor
356875|NCT01614587|genetic factors|genetic factors
356876|NCT01614587|adequate prolapse repair|adequate prolapse repair
356877|NCT01614587|polymorphisms|polymorphisms
356878|NCT01614587|surgical failure|surgical failure
356879|NCT01614587|reoperation|reoperation
356880|NCT01614587|DNA|dna
356881|NCT01614587|buccal swabs|buccal swabs
356882|NCT01614587|TaqMan SNP allelic discriminiation assays|taqman snp allelic discriminiation assays
356883|NCT01614587|duplex real-time PCR|duplex real-time pcr
356884|NCT01614587|genome-wide SNP microarrays|genome-wide snp microarrays
356885|NCT01614587|next-generation sequencing|next-generation sequencing
356886|NCT01614561|Hypercholesterolemia|hypercholesterolemia
356887|NCT01614561|Lipid lowering drugs|lipid lowering drugs
356888|NCT01614561|Cholesterol level in blood|cholesterol level in blood
356889|NCT01614561|Target cholesterol levels guidelines for the management of high blood cholesterol|target cholesterol levels guidelines for the management of high blood cholesterol
356890|NCT01614548|Prostatic Neoplasms|prostatic neoplasms
356891|NCT01614548|Prostate Cancer|prostate cancer
356892|NCT01614548|Disease Management|disease management
356893|NCT01614548|Rural|rural
356894|NCT01614548|Urban|urban
356895|NCT01614522|Metastatic gastro-oesophageal carcinoma|metastatic gastro-oesophageal carcinoma
356896|NCT01614522|Recurrent gastro-oesophageal carcinoma|recurrent gastro-oesophageal carcinoma
356897|NCT01614522|Gastric cancer|gastric cancer
356898|NCT01614522|HER-1|her-1
356899|NCT01614522|HER-2|her-2
356900|NCT01614509|branch retinal vein occlusion|branch retinal vein occlusion
356901|NCT01614509|bevacizumab|bevacizumab
356902|NCT01614509|triamcinolone acetonide|triamcinolone acetonide
356903|NCT01614483|Vitamin A deficiency|vitamin a deficiency
356904|NCT01614483|Biofortification|biofortification
356905|NCT01614483|Cassava|cassava
356906|NCT01614483|B-carotene|b-carotene
356907|NCT01614483|School children|school children
356908|NCT01614483|Kenya|kenya
356909|NCT01614431|renal function|renal function
356910|NCT01614431|before and after N acetyl cysteine|before and after n acetyl cysteine
356911|NCT01614431|Cystinosis patients|cystinosis patients
356912|NCT01614405|PBC|pbc
356913|NCT01614392|Resistance Exercise|resistance exercise
356914|NCT01614392|Physical Activity|physical activity
356915|NCT01614392|Mobility disability|mobility disability
356916|NCT01614392|Physical function|physical function
356917|NCT01614392|Muscle Strength|muscle strength
356918|NCT01614392|Older Adults|older adults
356919|NCT01614392|Mobility-Limited|mobility-limited
356920|NCT01614392|Peak power and strength|peak power and strength
356923|NCT01614366|hypertension|hypertension
356924|NCT01614353|Multiple Chronic Conditions|multiple chronic conditions
356925|NCT01614353|Older Adults|older adults
356926|NCT01614353|New Prescription|new prescription
356927|NCT01614340|Home care|home care
356928|NCT01614340|Cognitive-Behavioral techniques|cognitive-behavioral techniques
356929|NCT01614340|Physical Therapy|physical therapy
356930|NCT01614340|Pain|pain
356931|NCT01614340|Older Adults|older adults
356932|NCT01614327|Diabetes Type One|diabetes type one
356933|NCT01614327|Diabetes Type Two|diabetes type two
356934|NCT01614327|PreDiabetes|prediabetes
356935|NCT01614327|Retinal Screening|retinal screening
356936|NCT01614327|RiskAnalyzer|riskanalyzer
356937|NCT01614327|Retinal Imaging|retinal imaging
356938|NCT01614327|Algorithm|algorithm
356939|NCT01614327|Diabetic Retinopathy|diabetic retinopathy
356940|NCT01614327|Microaneurysms|microaneurysms
356941|NCT01614327|Neovascularization|neovascularization
356942|NCT01614327|Intraretinal microvascular abnormalities|intraretinal microvascular abnormalities
356943|NCT01614314|Preceptorship, simulation, nursing, catheters|preceptorship, simulation, nursing, catheters
356944|NCT01614301|advanced Melanoma|advanced melanoma
356945|NCT01614288|HTO|hto
356946|NCT01614288|Arthroscopy|arthroscopy
356947|NCT01614288|Quality-of-Life|quality-of-life
356948|NCT01614288|Gait Analysis|gait analysis
356949|NCT01614275|Autism|autism
356950|NCT01614275|Early Intervention|early intervention
356951|NCT01614275|Parent Training|parent training
356952|NCT01614275|EIBI|eibi
356953|NCT01614275|Applied Behavior Analysis|applied behavior analysis
356954|NCT01614249|Omega-3|omega-3
356955|NCT01614249|EPA|epa
356956|NCT01614249|Depression|depression
356957|NCT01614249|HIV infected|hiv infected
356958|NCT01614249|Pregnant women|pregnant women
356959|NCT01614236|pregabalin|pregabalin
356960|NCT01614236|analgesia|analgesia
356961|NCT01614236|postoperative pain|postoperative pain
356962|NCT01614236|orthopedic oncology patients|orthopedic oncology patients
356963|NCT01614223|Plantar fasciitis|plantar fasciitis
356964|NCT01614223|Autologous Conditioned Plasma|autologous conditioned plasma
356965|NCT01614197|Relapse|relapse
356966|NCT01614197|Lymphoblastic|lymphoblastic
356967|NCT01614197|Leukemia|leukemia
356968|NCT01614197|Refractory|refractory
356969|NCT01614197|Temsirolimus|temsirolimus
356970|NCT01614197|Acute|acute
356971|NCT01614197|Childhood|childhood
356972|NCT01614197|Pediatric|pediatric
356973|NCT01614197|ALL|all
356974|NCT01614197|NHL|nhl
356975|NCT01614197|LL|ll
356976|NCT01614197|PTL|ptl
356977|NCT01614171|osteoporosis pseudoglioma|osteoporosis pseudoglioma
356978|NCT01614171|OPPG|oppg
356979|NCT01614171|growth hormone|growth hormone
356980|NCT01614171|osteoporosis|osteoporosis
356981|NCT01614158|N-AION|n-aion
356982|NCT01614158|perimetry|perimetry
356983|NCT01614158|visual field loss|visual field loss
356984|NCT01614158|Mean Defect|mean defect
356985|NCT01614158|Total Loss Volume|total loss volume
356986|NCT01614158|D-BCVA|d-bcva
356987|NCT01614158|RAPD|rapd
356988|NCT01614158|retinal nerve fibre thickness/volume|retinal nerve fibre thickness/volume
356989|NCT01614158|optic nerve head|optic nerve head
356990|NCT01614132|medulloblastoma|medulloblastoma
356991|NCT01614132|CNS|cns
356992|NCT01614132|malignant neoplasm|malignant neoplasm
356993|NCT01614132|NOA|noa
356994|NCT01614132|neuroectodermal tumor|neuroectodermal tumor
356995|NCT01614132|Vincristin|vincristin
356996|NCT01614132|CCNU|ccnu
356997|NCT01614132|Cisplatin|cisplatin
356998|NCT01614119|Cerebral|cerebral
356999|NCT01614119|Oxygenation|oxygenation
357000|NCT01614119|Performance|performance
357001|NCT01614119|Exercise|exercise
357002|NCT01614106|HIV/AIDS|hiv/aids
357003|NCT01614106|Drug Users|drug users
357004|NCT01614106|Crack-Cocaine Use|crack-cocaine use
357005|NCT01614106|HIV Primary Care|hiv primary care
357006|NCT01614093|Schizophrenia|schizophrenia
357007|NCT01614093|Appetite|appetite
357008|NCT01614093|Oxytocin|oxytocin
357009|NCT01614080|Stroke|stroke
357010|NCT01614080|Ischemic stroke|ischemic stroke
357011|NCT01614080|thrombolysis|thrombolysis
357012|NCT01614080|toxicity of t-PA|toxicity of t-pa
357013|NCT01614067|DOR|dor
357014|NCT01614067|Infertility|infertility
357015|NCT01614067|IVF|ivf
357016|NCT01614067|ART|art
357017|NCT01614067|GnRHa|gnrha
357018|NCT01614067|GnRH Antagonist Protocol|gnrh antagonist protocol
357019|NCT01614067|Ganirelix|ganirelix
357020|NCT01614054|Smoking cessation|smoking cessation
357021|NCT01614054|Nicotine replacement therapy|nicotine replacement therapy
357022|NCT01614054|NRT|nrt
357023|NCT01614054|Inpatient|inpatient
357024|NCT01614054|General Medicine|general medicine
357025|NCT01614041|Generalized Anxiety Disorder|generalized anxiety disorder
357026|NCT01614015|Recording|recording
357027|NCT01614015|Supervision|supervision
357028|NCT01614015|Observation|observation
357029|NCT01614002|carcinoma|carcinoma
357030|NCT01614002|breast cancer|breast cancer
357629|NCT01611012|Phenotype|phenotype
357031|NCT01614002|non-small cell lung cancer|non-small cell lung cancer
357032|NCT01614002|prostata cancer|prostata cancer
357033|NCT01614002|adenocarcinoma of the stomach|adenocarcinoma of the stomach
357034|NCT01614002|squamous cell carcinoma of the head and neck region|squamous cell carcinoma of the head and neck region
357035|NCT01614002|ambulant chemotherapy|ambulant chemotherapy
357036|NCT01614002|treatment cycles|treatment cycles
357037|NCT01614002|Docetaxel|docetaxel
357038|NCT01614002|Doce onkovis|doce onkovis
357039|NCT01614002|Quantity of Docetaxel|quantity of docetaxel
357040|NCT01614002|Packaging Sizes|packaging sizes
357041|NCT01613989|Hip arthroplasty|hip arthroplasty
357042|NCT01613989|navigation|navigation
357043|NCT01613976|Myelodysplastic Syndromes|myelodysplastic syndromes
357045|NCT01613976|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
357046|NCT01613976|CMML|cmml
357047|NCT01613976|Acute Myeloid Leukemia|acute myeloid leukemia
357048|NCT01613976|AML|aml
357049|NCT01613976|Panobinostat|panobinostat
357050|NCT01613976|LBH589|lbh589
357051|NCT01613976|5-Aza|5-aza
357052|NCT01613976|Azacitidine|azacitidine
357053|NCT01613963|Uveitis|uveitis
357054|NCT01613963|Scleritis|scleritis
357055|NCT01613950|gastric cancer advanced gastric or metastatic gastric cancer PI3K PIK3CA mutation Her2 amplification HSP90 inhibitor PI3K inhibitor PIK3CA amplification|gastric cancer advanced gastric or metastatic gastric cancer pi3k pik3ca mutation her2 amplification hsp90 inhibitor pi3k inhibitor pik3ca amplification
357056|NCT01613937|Latinas|latinas
357057|NCT01613937|Gestational Diabetes|gestational diabetes
357058|NCT01613937|Prevention|prevention
357059|NCT01613911|Epilepsy|epilepsy
357060|NCT01613911|Invasive monitoring|invasive monitoring
357061|NCT01613911|Human sensory perception|human sensory perception
357062|NCT01613898|Cerebrotendinous xanthomatosis (CTX),|cerebrotendinous xanthomatosis (ctx),
357063|NCT01613898|lipoprotein,atherosclerosis,|lipoprotein,atherosclerosis,
357064|NCT01613898|carotid artery intima-media thickness (cIMT).|carotid artery intima-media thickness (cimt).
357065|NCT01613833|Alpha2 macroglobulin|alpha2 macroglobulin
357066|NCT01613833|Osteoarthritis|osteoarthritis
357067|NCT01613833|plasma and synovium|plasma and synovium
357068|NCT01613807|gestational diabetes mellitus|gestational diabetes mellitus
357069|NCT01613807|insulin analogues in pregnancy|insulin analogues in pregnancy
357070|NCT01613794|Deep vein thrombosis|deep vein thrombosis
357071|NCT01613794|Pulmonary embolism|pulmonary embolism
357072|NCT01613794|Rosuvastatin treatment|rosuvastatin treatment
357073|NCT01613794|Pharmacologic actions|pharmacologic actions
357074|NCT01613781|hemifacial spasm|hemifacial spasm
357075|NCT01613781|microvascular decompression|microvascular decompression
357076|NCT01613781|neuromuscular blockade|neuromuscular blockade
357077|NCT01613781|electromyography|electromyography
357078|NCT01613755|Effect Dipyridamole on pharmacokinetics of metformin|effect dipyridamole on pharmacokinetics of metformin
357079|NCT01613729|Dyslipidemia|dyslipidemia
357080|NCT01613729|Rosuvastatin|rosuvastatin
357081|NCT01613729|Efficacy|efficacy
357082|NCT01613729|Safety|safety
357083|NCT01613716|Diabetes|diabetes
357084|NCT01613716|Macular Edema|macular edema
357085|NCT01613716|Epiretinal Membrane|epiretinal membrane
357086|NCT01613716|Vitrectomy|vitrectomy
357087|NCT01613703|ONO-2952|ono-2952
357088|NCT01613703|Healthy adult subjects|healthy adult subjects
357089|NCT01613703|single doe|single doe
357090|NCT01613703|PET study|pet study
357091|NCT01613703|Safety|safety
357092|NCT01613703|Tolerability|tolerability
357093|NCT01613690|Renal impairment|renal impairment
357094|NCT01613690|NVA237|nva237
357095|NCT01613690|Pharmacokinetics|pharmacokinetics
357096|NCT01613677|advanced cervical cancer, BKM 120, progression free survival|advanced cervical cancer, bkm 120, progression free survival
357097|NCT01613664|obesity|obesity
357098|NCT01613664|surgical management|surgical management
357099|NCT01613664|sleeve gastrectomy|sleeve gastrectomy
357100|NCT01613638|congenital malformation|congenital malformation
357101|NCT01613638|pollutants|pollutants
357102|NCT01613586|Interstitial Cystitis|interstitial cystitis
357103|NCT01613586|Bladder Pain Syndrome|bladder pain syndrome
357104|NCT01613586|Painful Bladder Syndrome|painful bladder syndrome
357105|NCT01613586|ASP3652|asp3652
357106|NCT01613573|pegylated Somatropin|pegylated somatropin
357107|NCT01613573|PEG-GH|peg-gh
357108|NCT01613573|Phase 1 study|phase 1 study
357109|NCT01613573|Pharmacokinetics|pharmacokinetics
357110|NCT01613534|chronic radiation proctopathy|chronic radiation proctopathy
357111|NCT01613534|argon plasma coagulation|argon plasma coagulation
357112|NCT01613534|sucralfate|sucralfate
357113|NCT01613521|DCE-MRI|dce-mri
357114|NCT01613521|18F-FMISO PET|18f-fmiso pet
357115|NCT01613521|11-174|11-174
357116|NCT01613495|obesity|obesity
357117|NCT01613469|fluorouracil|fluorouracil
357118|NCT01613469|leucovorin|leucovorin
357119|NCT01613469|radiotherapy|radiotherapy
357120|NCT01613469|neoadjuvant therapy|neoadjuvant therapy
357121|NCT01613443|Dabigatran, Rivaroxaban, Point of Care-testing|dabigatran, rivaroxaban, point of care-testing
357122|NCT01613417|Have confirmed or are highly suspected of brain disease|have confirmed or are highly suspected of brain disease
357123|NCT01613404|Chronic kidney disease|chronic kidney disease
357630|NCT01611012|Sputum|sputum
357124|NCT01613404|Hemodialysis|hemodialysis
357125|NCT01613404|Eprex|eprex
357126|NCT01613404|Aranesp|aranesp
357127|NCT01613404|ESA|esa
357128|NCT01613404|Anemia|anemia
357129|NCT01613391|Visfatin|visfatin
357130|NCT01613391|Resistin|resistin
357131|NCT01613391|Apelin|apelin
357132|NCT01613391|roux-en-y gastric bypass|roux-en-y gastric bypass
357133|NCT01613391|laparoscopic adjustable gastric banding|laparoscopic adjustable gastric banding
357134|NCT01613391|morbid obesity|morbid obesity
357135|NCT01613352|Early breast cancer surgery|early breast cancer surgery
357136|NCT01613352|Psychosocial wellbeing|psychosocial wellbeing
357137|NCT01613352|Ambulatory surgery|ambulatory surgery
357138|NCT01613339|stroke|stroke
357139|NCT01613339|postural control|postural control
357140|NCT01613339|body awareness therapy|body awareness therapy
357141|NCT01613326|COPD|copd
357142|NCT01613313|Lipoma|lipoma
357143|NCT01613313|Fatty Tumor|fatty tumor
357144|NCT01613300|hodgkin|hodgkin
357145|NCT01613300|disease|disease
357146|NCT01613300|ofatumumab|ofatumumab
357147|NCT01613287|Pulmonary Hypertension|pulmonary hypertension
357148|NCT01613287|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
357149|NCT01613287|TheraSorb|therasorb
357150|NCT01613287|immunoadsorption|immunoadsorption
357151|NCT01613274|colon resection|colon resection
357152|NCT01613261|TAK-733,|tak-733,
357153|NCT01613261|alisertib,|alisertib,
357154|NCT01613261|MLN8237,|mln8237,
357155|NCT01613261|Oral MEK Inhibitor,|oral mek inhibitor,
357156|NCT01613261|Oral Aurora A Kinase Inhibitor|oral aurora a kinase inhibitor
357157|NCT01613235|subarachnoid hemorrhage|subarachnoid hemorrhage
357158|NCT01613235|ischemia|ischemia
357159|NCT01613235|vasospasm|vasospasm
357160|NCT01613235|CT|ct
357161|NCT01613235|perfusion|perfusion
357162|NCT01613235|induced hypertension|induced hypertension
357163|NCT01613235|delayed cerebral ischemia|delayed cerebral ischemia
357164|NCT01613209|Hypertension|hypertension
357165|NCT01613209|ABPM|abpm
357166|NCT01613209|office blood pressure|office blood pressure
357167|NCT01613209|olmesartan|olmesartan
357168|NCT01613209|amlodipine|amlodipine
357169|NCT01613209|fixed combination|fixed combination
357170|NCT01613209|time of intake|time of intake
357171|NCT01613196|Extrapulmonary tuberculosis|extrapulmonary tuberculosis
357172|NCT01613196|FDG-TEP|fdg-tep
357173|NCT01613196|cohorts|cohorts
357174|NCT01613170|Overactive Bladder|overactive bladder
357175|NCT01613170|Vaginal Estrogen|vaginal estrogen
357176|NCT01613170|Anticholinergics|anticholinergics
357177|NCT01613170|Antimuscarinics|antimuscarinics
357178|NCT01613157|pharmacokinetics|pharmacokinetics
357179|NCT01613157|HIV infected women|hiv infected women
357180|NCT01613118|Primary FSGS|primary fsgs
357181|NCT01613118|Nephrotic syndrome|nephrotic syndrome
357182|NCT01613118|Steroid Resistant|steroid resistant
357183|NCT01613105|Diabetes Mellitus|diabetes mellitus
357184|NCT01613105|Type-2|type-2
357185|NCT01613105|Acarbose|acarbose
357186|NCT01613105|Drug Therapy|drug therapy
357187|NCT01613105|Combination|combination
357188|NCT01613092|Arrhythmia|arrhythmia
357189|NCT01613092|Device Procedure|device procedure
357190|NCT01613092|High risk patients|high risk patients
357191|NCT01613092|Antibiotics|antibiotics
357192|NCT01613092|Infection|infection
357193|NCT01613092|Cluster|cluster
357194|NCT01613079|Rheumatoid Arthritis|rheumatoid arthritis
357195|NCT01613079|Methotrexate|methotrexate
357196|NCT01613079|Tripterygium|tripterygium
357197|NCT01613066|Haematological malignancies|haematological malignancies
357198|NCT01613066|Allogeneic Cord Blood transplantation|allogeneic cord blood transplantation
357199|NCT01613066|Intrabone|intrabone
357200|NCT01613053|Gastrointestinal Stromal Tumor, GIST|gastrointestinal stromal tumor, gist
357201|NCT01613014|Alcohol|alcohol
357202|NCT01613014|Alcohol Dependence|alcohol dependence
357203|NCT01613014|Alcohol Abuse|alcohol abuse
357204|NCT01613014|Alcohol Use Disorders|alcohol use disorders
357205|NCT01613014|Alcoholism|alcoholism
357206|NCT01612988|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
357207|NCT01612988|relapse|relapse
357208|NCT01612988|Bendamustine|bendamustine
357209|NCT01612988|Ofatumumab|ofatumumab
357210|NCT01612988|Méthylprednisolone|méthylprednisolone
357211|NCT01612975|Chest tubes|chest tubes
357212|NCT01612975|Length of stay|length of stay
357213|NCT01612975|Pleural effusion|pleural effusion
357214|NCT01612975|Lung resection|lung resection
357215|NCT01612975|Post-operative|post-operative
357216|NCT01612975|Lung cancer|lung cancer
357217|NCT01612949|endotracheal intubation|endotracheal intubation
357218|NCT01612949|facial structure|facial structure
357219|NCT01612949|Mallampati score|mallampati score
357220|NCT01612949|computerized facial analysis|computerized facial analysis
357221|NCT01612936|Asthma|asthma
357222|NCT01612936|Allergic|allergic
357223|NCT01612936|Inflammation|inflammation
357224|NCT01612936|Constriction|constriction
357225|NCT01612936|Airway|airway
357226|NCT01612936|Challenge|challenge
357227|NCT01612936|Chemokines|chemokines
357228|NCT01612923|abortion|abortion
357229|NCT01612923|medical abortion|medical abortion
357230|NCT01612910|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
357231|NCT01612910|HER2-negative breast cancer|her2-negative breast cancer
357232|NCT01612910|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
357233|NCT01612910|recurrent breast cancer|recurrent breast cancer
357234|NCT01612910|stage II breast cancer|stage ii breast cancer
357235|NCT01612910|stage IIIA breast cancer|stage iiia breast cancer
357236|NCT01612910|stage IIIB breast cancer|stage iiib breast cancer
357237|NCT01612910|stage IIIC breast cancer|stage iiic breast cancer
357238|NCT01612910|triple-negative breast cancer|triple-negative breast cancer
357239|NCT01612897|autism|autism
357240|NCT01612897|well child care|well child care
357241|NCT01612897|screening|screening
357242|NCT01612897|computer|computer
357243|NCT01612897|reminders|reminders
357244|NCT01612871|Breast cancer,|breast cancer,
357245|NCT01612871|hormonotherapy,|hormonotherapy,
357246|NCT01612871|miRNAs,|mirnas,
357247|NCT01612871|biomarkers|biomarkers
357248|NCT01612871|hormone therapy|hormone therapy
357249|NCT01612858|Lipodystrophy|lipodystrophy
357250|NCT01612858|Insulin resistance|insulin resistance
357251|NCT01612858|HIV infection|hiv infection
357252|NCT01612845|rotator cuff|rotator cuff
357253|NCT01612845|shoulder|shoulder
357254|NCT01612845|platelet rich plasma|platelet rich plasma
357255|NCT01612845|fibrin|fibrin
357256|NCT01612793|COPD|copd
357257|NCT01612780|Sinusitis|sinusitis
357258|NCT01612780|Sinus balloon dilation patients|sinus balloon dilation patients
357259|NCT01612767|de novo coronary lesions|de novo coronary lesions
357260|NCT01612767|restenotic coronary lesions|restenotic coronary lesions
357261|NCT01612767|coronary arteries|coronary arteries
357262|NCT01612754|Reduction of noise pollution|reduction of noise pollution
357263|NCT01612754|Specifically enforced workplace rules|specifically enforced workplace rules
357264|NCT01612754|Stress|stress
357265|NCT01612754|Sound Ears (TM)|sound ears (tm)
357266|NCT01612754|Error|error
357267|NCT01612741|Diabetes Mellitus, Type-2|diabetes mellitus, type-2
357268|NCT01612741|Acarbose|acarbose
357269|NCT01612741|Drug Therapy|drug therapy
357270|NCT01612741|Combination|combination
357271|NCT01612728|Aromatase Inhibitors|aromatase inhibitors
357272|NCT01612715|Asthma, allergen challenge, T cells, Fel d 1.|asthma, allergen challenge, t cells, fel d 1.
357273|NCT01612702|postoperative nausea and vomiting|postoperative nausea and vomiting
357274|NCT01612702|postoperative pain|postoperative pain
357275|NCT01612689|Accelerometer|accelerometer
357276|NCT01612689|EMU|emu
357277|NCT01612689|Ambulatory|ambulatory
357278|NCT01612689|ECG|ecg
357279|NCT01612689|Heart rate|heart rate
357280|NCT01612663|Knee pain|knee pain
357281|NCT01612663|Acupuncture|acupuncture
357282|NCT01612663|Sham acupuncture|sham acupuncture
357283|NCT01612650|breast cancer|breast cancer
357284|NCT01612650|surveillance|surveillance
357285|NCT01612650|diagnosis|diagnosis
357286|NCT01612650|2D mammography|2d mammography
357287|NCT01612650|3D mammography|3d mammography
357288|NCT01612637|Pelvic organ prolapse|pelvic organ prolapse
357289|NCT01612637|Pelvic floor muscle training|pelvic floor muscle training
357290|NCT01612637|Prolapse symptoms|prolapse symptoms
357291|NCT01612637|Pelvic organ prolapse quantification system|pelvic organ prolapse quantification system
357292|NCT01612637|Ultrasonography|ultrasonography
357293|NCT01612637|Predictors|predictors
357294|NCT01612520|type 2 Diabetes Mellitus|type 2 diabetes mellitus
357295|NCT01612520|telenursing|telenursing
357296|NCT01612520|RCT|rct
357297|NCT01612520|economic analysis|economic analysis
357298|NCT01612507|Phase 1|phase 1
357299|NCT01612507|healthy volunteers|healthy volunteers
357300|NCT01612507|Parallel Group Study|parallel group study
357301|NCT01612507|ceftaroline fosamil different doses|ceftaroline fosamil different doses
357302|NCT01612507|safety|safety
357303|NCT01612507|Cmax|cmax
357304|NCT01612507|tmax|tmax
357305|NCT01612507|AUC|auc
357306|NCT01612481|soft tissue sarcoma|soft tissue sarcoma
357307|NCT01612481|lung metastasis|lung metastasis
357308|NCT01612481|surveillance|surveillance
357309|NCT01612468|Diabetes|diabetes
357310|NCT01612468|Liraglutide|liraglutide
357311|NCT01612468|Hypoglycaemia|hypoglycaemia
357312|NCT01612468|Hyperglycaemia|hyperglycaemia
357313|NCT01612468|CIMT|cimt
357314|NCT01612468|PWV|pwv
357315|NCT01612468|Food preference|food preference
357316|NCT01612468|Blood pressure|blood pressure
357317|NCT01612455|HIV|hiv
357318|NCT01612455|drug addiction|drug addiction
357319|NCT01612455|Russia|russia
357320|NCT01612455|case management|case management
357321|NCT01612442|complementary feeding|complementary feeding
357322|NCT01612442|mothers|mothers
357323|NCT01612442|6-24 months children|6-24 months children
357324|NCT01612442|community health volunteers|community health volunteers
357325|NCT01612442|nutrition education|nutrition education
357326|NCT01612442|agricultural education|agricultural education
357327|NCT01612429|Carbamylation|carbamylation
357328|NCT01612429|Albumin|albumin
357329|NCT01612429|Protein structure|protein structure
357330|NCT01612429|Kidney disease|kidney disease
357331|NCT01612416|Ganglion Cell complex, Retinal Nerve Fiber Layer,Glaucoma|ganglion cell complex, retinal nerve fiber layer,glaucoma
357332|NCT01612403|zinc binding protein|zinc binding protein
357333|NCT01612390|postpartum hemorrhage|postpartum hemorrhage
357334|NCT01612377|Moderate to Severe|moderate to severe
357335|NCT01612364|CRPS I|crps i
357336|NCT01612351|Head and neck cancer|head and neck cancer
357337|NCT01612351|Squamous Cell Carcinoma|squamous cell carcinoma
357338|NCT01612351|Phase II|phase ii
357339|NCT01612351|Transoral Surgery|transoral surgery
357340|NCT01612351|Induction Chemotherapy|induction chemotherapy
357341|NCT01612351|Carboplatin|carboplatin
357342|NCT01612351|Paclitaxel|paclitaxel
357343|NCT01612351|Lapatinib|lapatinib
357344|NCT01612338|breast cancer|breast cancer
357345|NCT01612338|young age of onset|young age of onset
357346|NCT01612338|family history|family history
357347|NCT01612338|screening interventions|screening interventions
357348|NCT01612338|family support|family support
357349|NCT01612325|liver tumors|liver tumors
357350|NCT01612312|Non-ST-elevation myocardial infarction|non-st-elevation myocardial infarction
357351|NCT01612312|thrombectomy|thrombectomy
357352|NCT01612312|magnetic resonance imaging|magnetic resonance imaging
357353|NCT01612312|microvascular obstruction|microvascular obstruction
357354|NCT01612286|Recombinant human endostatin|recombinant human endostatin
357355|NCT01612286|nasopharyngeal carcinoma|nasopharyngeal carcinoma
357356|NCT01612286|chemotherapy|chemotherapy
357357|NCT01612273|Vasospastic syndrome|vasospastic syndrome
357358|NCT01612273|Vascular dysregulation|vascular dysregulation
357359|NCT01612260|heart failure|heart failure
357360|NCT01612260|ventricular premature complex|ventricular premature complex
357361|NCT01612260|Shensong Yangxin capsule|shensong yangxin capsule
357362|NCT01612247|Breast Cancer|breast cancer
357363|NCT01612247|Neoadjuvant therapy|neoadjuvant therapy
357364|NCT01612234|humans|humans
357365|NCT01612234|lean|lean
357366|NCT01612234|obese|obese
357367|NCT01612234|saturated fat|saturated fat
357368|NCT01612234|monounsaturated fat|monounsaturated fat
357369|NCT01612234|insulin sensitivity|insulin sensitivity
357370|NCT01612234|inflammation|inflammation
357371|NCT01612234|oxidant stress|oxidant stress
357372|NCT01612195|anal fistula|anal fistula
357373|NCT01612195|anal continence|anal continence
357374|NCT01612195|health-related quality of life|health-related quality of life
357375|NCT01612182|end-stage renal disease|end-stage renal disease
357376|NCT01612182|renal replacement therapy|renal replacement therapy
357377|NCT01612169|HIV patients|hiv patients
357378|NCT01612169|Hospitalized patients|hospitalized patients
357379|NCT01612169|Substance Users|substance users
357380|NCT01612169|Drug Users|drug users
357381|NCT01612156|Urodynamic testing|urodynamic testing
357382|NCT01612156|pelvic floor examination|pelvic floor examination
357383|NCT01612156|Lidocaine gel|lidocaine gel
357384|NCT01612156|Surgical lubricant|surgical lubricant
357385|NCT01612156|Pain|pain
357386|NCT01612156|Embarrassment|embarrassment
357387|NCT01612117|renal failure|renal failure
357388|NCT01612117|cardiology|cardiology
357389|NCT01612117|contrast-induced nephropathy|contrast-induced nephropathy
357390|NCT01612104|Post Traumatic Stress Disorder|post traumatic stress disorder
357391|NCT01612104|Anxiety symptoms|anxiety symptoms
357392|NCT01612104|Depressive symptoms|depressive symptoms
357393|NCT01612104|Externalizing behavior|externalizing behavior
357394|NCT01612104|Reduced quality of life|reduced quality of life
357395|NCT01612091|Expert System|expert system
357396|NCT01612091|Intensive Care|intensive care
357397|NCT01612091|Telemedicine|telemedicine
357398|NCT01612091|Equipment Design|equipment design
357399|NCT01612065|Office hysteroscopy|office hysteroscopy
357400|NCT01612065|Cervical priming|cervical priming
357401|NCT01612065|Misoprostol|misoprostol
357402|NCT01612052|Vascular Surgery|vascular surgery
357403|NCT01612039|ulcerative colitis|ulcerative colitis
357404|NCT01612013|N-acetylcysteine|n-acetylcysteine
357405|NCT01612013|angiography|angiography
357406|NCT01612013|contrast medium|contrast medium
357407|NCT01612013|contrast-induced nephropathy|contrast-induced nephropathy
357408|NCT01612013|sodium bicarbonate|sodium bicarbonate
357409|NCT01612000|Influenza|influenza
357410|NCT01611974|CMV|cmv
357411|NCT01611974|cytomegalovirus|cytomegalovirus
357412|NCT01611974|resistant|resistant
357413|NCT01611974|refractory|refractory
357414|NCT01611974|transplant|transplant
357415|NCT01611974|treatment|treatment
357416|NCT01611961|Docetaxel|docetaxel
357417|NCT01611961|Lipid Microsphere|lipid microsphere
357418|NCT01611961|Neoplasms|neoplasms
357419|NCT01611961|Antineoplastic Agents|antineoplastic agents
357420|NCT01611961|Pharmacologic Actions|pharmacologic actions
357421|NCT01611961|Therapeutic Uses|therapeutic uses
357422|NCT01611935|trauma|trauma
357423|NCT01611935|shock|shock
357424|NCT01611935|vasopressin|vasopressin
357425|NCT01611935|blood transfusion|blood transfusion
357426|NCT01611922|eye|eye
357427|NCT01611922|eyelid|eyelid
357428|NCT01611922|contact lenses|contact lenses
357429|NCT01611922|dry eye disease|dry eye disease
357430|NCT01611909|p-menthane-3,8-diol oil extract|p-menthane-3,8-diol oil extract
357431|NCT01611909|topical therapy|topical therapy
357432|NCT01611896|Graves' hyperthyroidism|graves' hyperthyroidism
357433|NCT01611896|Graves' disease|graves' disease
357434|NCT01611896|Selenium|selenium
357435|NCT01611896|Quality of Life|quality of life
357436|NCT01611896|ThyPRO|thypro
357437|NCT01611896|Autoimmunity|autoimmunity
357438|NCT01611870|COPD|copd
357439|NCT01611857|Advanced solid tumors|advanced solid tumors
357440|NCT01611857|First-Line Metastatic GE cancer|first-line metastatic ge cancer
357441|NCT01611857|c-Met Inhibitor|c-met inhibitor
357442|NCT01611857|Tivantinib|tivantinib
357443|NCT01611857|FOLFOX|folfox
357444|NCT01611844|delayed-type hypersensitivity reaction to tuberculin intradermal injection|delayed-type hypersensitivity reaction to tuberculin intradermal injection
357445|NCT01611844|tuberculosis skin test|tuberculosis skin test
357446|NCT01611844|BD micro-needle|bd micro-needle
357447|NCT01611844|medical device|medical device
357448|NCT01611844|spectroscopy|spectroscopy
357449|NCT01611831|fibromyalgia|fibromyalgia
357450|NCT01611831|Acceptation & Commitment Therapy|acceptation & commitment therapy
357451|NCT01611831|randomized controlled trial|randomized controlled trial
357452|NCT01611818|Depression|depression
357453|NCT01611818|Computer-delivered psychotherapy|computer-delivered psychotherapy
357454|NCT01611818|Randomized-controlled trial|randomized-controlled trial
357455|NCT01611792|Stabilization exercise|stabilization exercise
357456|NCT01611792|Strength and conditioning exercise|strength and conditioning exercise
357457|NCT01611792|Physical therapy|physical therapy
357458|NCT01611792|Rehabilitation|rehabilitation
357459|NCT01611779|obstructive sleep apnea|obstructive sleep apnea
357460|NCT01611779|tongue suspension|tongue suspension
357461|NCT01611766|secondary cytoreductive surgery|secondary cytoreductive surgery
357462|NCT01611766|Ovarian Cancer|ovarian cancer
357463|NCT01611766|surgery|surgery
357464|NCT01611766|recurrence|recurrence
357465|NCT01611753|Shock, Septic|shock, septic
357466|NCT01611753|Erythrocyte Transfusion|erythrocyte transfusion
357467|NCT01611753|Ischemia|ischemia
357468|NCT01611740|Preterm infant|preterm infant
357469|NCT01611740|Bacterial infection|bacterial infection
357470|NCT01611740|Diagnosis of proven or suspected bacterial infection|diagnosis of proven or suspected bacterial infection
357471|NCT01611727|BRCA1|brca1
357472|NCT01611727|survival|survival
357473|NCT01611727|metastatic disease|metastatic disease
357474|NCT01611727|cisplatin|cisplatin
357475|NCT01611714|Racial/ethnic disparities|racial/ethnic disparities
357476|NCT01611714|Imaging|imaging
357477|NCT01611714|Emergency|emergency
357478|NCT01611714|Headache|headache
357479|NCT01611675|Metastatic|metastatic
357480|NCT01611675|Unresectable|unresectable
357481|NCT01611675|Clearly progressive|clearly progressive
357482|NCT01611675|BRAF mutation|braf mutation
357483|NCT01611649|infant formula|infant formula
357484|NCT01611649|dairy lipids|dairy lipids
357485|NCT01611649|omega-3|omega-3
357486|NCT01611636|allergy|allergy
357487|NCT01611636|autoimmune diseases|autoimmune diseases
357488|NCT01611636|rheumatic diseases|rheumatic diseases
357489|NCT01611623|Solid tumor malignancy|solid tumor malignancy
357490|NCT01611623|Hsp90|hsp90
357491|NCT01611610|outcome measures|outcome measures
357492|NCT01611610|spinal muscular atrophy|spinal muscular atrophy
357493|NCT01611597|accelerometry|accelerometry
357494|NCT01611597|neuromuscular disease|neuromuscular disease
357495|NCT01611584|ALA|ala
357496|NCT01611584|Florescence|florescence
357497|NCT01611584|Lung cancer|lung cancer
357498|NCT01611571|osteoporosis|osteoporosis
357499|NCT01611571|male|male
357500|NCT01611545|Pharmacogenomics|pharmacogenomics
357501|NCT01611545|Pharmacogenetics|pharmacogenetics
357502|NCT01611545|Clopidogrel|clopidogrel
357503|NCT01611545|Plavix|plavix
357504|NCT01611532|Acute pancreatitis|acute pancreatitis
357505|NCT01611532|Intraabdominal pressure|intraabdominal pressure
357506|NCT01611532|Critical illness|critical illness
357507|NCT01611519|urinary bladder|urinary bladder
357508|NCT01611519|urinary catheterization|urinary catheterization
357509|NCT01611519|epidural analgesia|epidural analgesia
357510|NCT01611519|catheters, indwelling|catheters, indwelling
357511|NCT01611493|Dental Implants|dental implants
357512|NCT01611493|Jaw, Edentulous, Partially/rehabilitation|jaw, edentulous, partially/rehabilitation
357513|NCT01611493|Jaw, Edentulous, Partially/surgery|jaw, edentulous, partially/surgery
357514|NCT01611493|randomised Clinical Trials|randomised clinical trials
357515|NCT01611493|Humans|humans
357516|NCT01611467|CC-223|cc-223
357517|NCT01611467|safety|safety
357518|NCT01611467|tolerability|tolerability
357519|NCT01611467|pharmacokinetic|pharmacokinetic
357520|NCT01611467|AME (Absorption, Metabolism, and Excretion)|ame (absorption, metabolism, and excretion)
357521|NCT01611467|FE (Food Effect)|fe (food effect)
357522|NCT01611454|Occupational Exposure to Radiation|occupational exposure to radiation
357523|NCT01611441|Osteoarthritis of the knee|osteoarthritis of the knee
357524|NCT01611441|Biomarkers|biomarkers
357525|NCT01611428|Ipragliflozin|ipragliflozin
357526|NCT01611428|Healthy|healthy
357527|NCT01611428|Absolute Bioavailability|absolute bioavailability
357528|NCT01611428|Pharmacokinetics|pharmacokinetics
357529|NCT01611415|Phase 1|phase 1
357530|NCT01611415|Ipragliflozin|ipragliflozin
357531|NCT01611415|Furosemide|furosemide
357532|NCT01611415|Pharmacokinetics|pharmacokinetics
357533|NCT01611415|Pharmacodynamics|pharmacodynamics
357534|NCT01611402|Tuberculosis|tuberculosis
357535|NCT01611402|HIV Infection|hiv infection
357536|NCT01611402|Transcriptional Signature|transcriptional signature
357537|NCT01611402|IRIS|iris
357538|NCT01611376|impedance cardiography|impedance cardiography
357539|NCT01611376|Flotrac/Vigileo|flotrac/vigileo
357540|NCT01611376|cardiac output|cardiac output
357541|NCT01611363|Ipragliflozin|ipragliflozin
357542|NCT01611363|Phase 1|phase 1
357543|NCT01611363|Healthy|healthy
357544|NCT01611363|Diabetes Mellitus|diabetes mellitus
357545|NCT01611363|Pharmacokinetics|pharmacokinetics
357546|NCT01611363|Pharmacodynamics|pharmacodynamics
357547|NCT01611350|Indoor Air Pollution|indoor air pollution
357548|NCT01611350|Marketing Methods for Increasing Technology Adoption|marketing methods for increasing technology adoption
357549|NCT01611350|Optimal Contracts for Technology Adoption|optimal contracts for technology adoption
357550|NCT01611337|schizophrenia, insight|schizophrenia, insight
357551|NCT01611324|Varicose Veins|varicose veins
357552|NCT01611324|Phlebectomy|phlebectomy
357553|NCT01611324|Local Anesthesia|local anesthesia
357554|NCT01611298|allogeneic stem cell transplant|allogeneic stem cell transplant
357555|NCT01611298|malignant diseases|malignant diseases
357556|NCT01611298|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
357557|NCT01611298|acute myelogenous leukemia|acute myelogenous leukemia
357558|NCT01611298|Chronic myelogenous leukemia|chronic myelogenous leukemia
357559|NCT01611298|myelodysplastic syndrome|myelodysplastic syndrome
357560|NCT01611298|Hodgkin lymphoma|hodgkin lymphoma
357561|NCT01611298|non-Hodgkin lymphoma|non-hodgkin lymphoma
357562|NCT01611298|myeloproliferative disorder|myeloproliferative disorder
357563|NCT01611298|non-malignant disease|non-malignant disease
357564|NCT01611285|UPHOLD|uphold
357565|NCT01611285|robotic surgery|robotic surgery
357566|NCT01611285|decision analysis|decision analysis
357568|NCT01611285|decision node|decision node
357569|NCT01611285|outcome node|outcome node
357570|NCT01611272|Unstable angina|unstable angina
357571|NCT01611259|MALT Lymphoma|malt lymphoma
357572|NCT01611259|Lenalidomide|lenalidomide
357573|NCT01611259|Rituximab|rituximab
357574|NCT01611259|AGMT|agmt
357575|NCT01611233|metal on metal|metal on metal
357576|NCT01611233|hip replacement|hip replacement
357577|NCT01611233|ASR|asr
357578|NCT01611233|DePuy|depuy
357579|NCT01611220|Anorexia Nervosa|anorexia nervosa
357580|NCT01611220|Relapse prevention|relapse prevention
357581|NCT01611220|Cognitive Dissonance|cognitive dissonance
357582|NCT01611220|Inpatient treatment|inpatient treatment
357583|NCT01611220|Cognitive behavior therapy|cognitive behavior therapy
357584|NCT01611207|wound healing impairments,|wound healing impairments,
357585|NCT01611207|negative pressure wound therapy,|negative pressure wound therapy,
357586|NCT01611207|health services research,|health services research,
357587|NCT01611207|germany|germany
357588|NCT01611194|HBO2|hbo2
357589|NCT01611194|HBOT|hbot
357590|NCT01611194|mTBI|mtbi
357591|NCT01611194|Brain injury|brain injury
357592|NCT01611194|PCS|pcs
357593|NCT01611194|PTSD|ptsd
357594|NCT01611194|hyperbaric oxygen|hyperbaric oxygen
357595|NCT01611181|Iron supplementation|iron supplementation
357596|NCT01611181|Iron deficiency|iron deficiency
357597|NCT01611181|Hip arthroplasty|hip arthroplasty
357598|NCT01611181|Knee arthroplasty|knee arthroplasty
357599|NCT01611142|Monoclonal antibody|monoclonal antibody
357600|NCT01611142|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
357601|NCT01611142|cancer|cancer
357602|NCT01611142|hematologic malignancy|hematologic malignancy
357603|NCT01611129|Disability Evaluation|disability evaluation
357604|NCT01611103|Cognitive Enhancement|cognitive enhancement
357605|NCT01611103|tDCS|tdcs
357606|NCT01611103|stimulation|stimulation
357607|NCT01611103|elderly|elderly
357608|NCT01611103|older adults|older adults
357609|NCT01611090|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
357610|NCT01611090|Small lymphocytic lymphoma|small lymphocytic lymphoma
357611|NCT01611090|Relapsed or refractory chronic lymphocytic leukemia|relapsed or refractory chronic lymphocytic leukemia
357612|NCT01611090|Relapsed or refractory small lymphocytic lymphoma|relapsed or refractory small lymphocytic lymphoma
357613|NCT01611090|Ibrutinib|ibrutinib
357614|NCT01611090|PCI-32765|pci-32765
357615|NCT01611090|JNJ-54179060|jnj-54179060
357616|NCT01611090|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
357617|NCT01611090|Bendamustine|bendamustine
357618|NCT01611090|Rituximab|rituximab
357619|NCT01611064|Hand|hand
357620|NCT01611064|Surgery|surgery
357621|NCT01611064|Tourniquet|tourniquet
357622|NCT01611064|Pain|pain
357623|NCT01611064|Oxygen|oxygen
357624|NCT01611051|breast cancer|breast cancer
357625|NCT01611051|neutropenia|neutropenia
357626|NCT01611051|febrile neutropenia|febrile neutropenia
357627|NCT01611012|Asthma|asthma
357628|NCT01611012|Inflammation|inflammation
357631|NCT01610986|Fructose|fructose
357632|NCT01610986|Exercise|exercise
357633|NCT01610986|Lactic acid|lactic acid
357634|NCT01610986|Monocarboxylic Acid Transporters|monocarboxylic acid transporters
357635|NCT01610973|Fuch's dystrophy|fuch's dystrophy
357636|NCT01610973|Corneal graft|corneal graft
357637|NCT01610960|Non invasive ventilation|non invasive ventilation
357638|NCT01610960|Helmet|helmet
357639|NCT01610960|NEXT Helmet|next helmet
357640|NCT01610960|Work of breathing|work of breathing
357641|NCT01610960|Intensive care|intensive care
357642|NCT01610947|Spondyloarthritis|spondyloarthritis
357643|NCT01610947|Anti-TNF|anti-tnf
357644|NCT01610947|Adalimumab|adalimumab
357645|NCT01610947|Etanercept|etanercept
357646|NCT01610947|Infliximab|infliximab
357647|NCT01610934|MODY|mody
357648|NCT01610934|Monogenic diabetes|monogenic diabetes
357649|NCT01610934|Non-autoimmune diabetes|non-autoimmune diabetes
357650|NCT01610934|MODY3|mody3
357651|NCT01610921|asthma|asthma
357652|NCT01610921|small airways disease|small airways disease
357653|NCT01610921|inflammation|inflammation
357654|NCT01610921|provocation|provocation
357655|NCT01610921|adenosine|adenosine
357656|NCT01610908|Adolescent|adolescent
357657|NCT01610908|Idiopathic|idiopathic
357658|NCT01610908|Scoliosis|scoliosis
357659|NCT01610908|Schroth|schroth
357660|NCT01610908|Exercises|exercises
357661|NCT01610908|Conservative treatment|conservative treatment
357662|NCT01610895|Colonoscopy|colonoscopy
357663|NCT01610895|low fibre diet|low fibre diet
357664|NCT01610895|clear fluids|clear fluids
357665|NCT01610895|Bowel Preparation|bowel preparation
357666|NCT01610869|Recurrence|recurrence
357667|NCT01610869|Ovarian Neoplasms|ovarian neoplasms
357668|NCT01610869|Ovarian Diseases|ovarian diseases
357669|NCT01610869|Fallopian Tube Neoplasms|fallopian tube neoplasms
357670|NCT01610869|Neoplasms|neoplasms
357671|NCT01610869|Carcinoma|carcinoma
357672|NCT01610869|Neoplasms by site|neoplasms by site
357673|NCT01610856|bowel preparation|bowel preparation
357674|NCT01610856|bowel purgative|bowel purgative
357675|NCT01610856|bowel cleansing|bowel cleansing
357676|NCT01610856|colonoscopy|colonoscopy
357677|NCT01610843|Sarcoidosis|sarcoidosis
357678|NCT01610843|WISE|wise
357679|NCT01610843|Sarcoid Study|sarcoid study
357680|NCT01610843|Worldwide Sarcoidosis Research Study|worldwide sarcoidosis research study
357681|NCT01610830|Purpura, Schoenlein-Henoch|purpura, schoenlein-henoch
357682|NCT01610830|adults|adults
357683|NCT01610830|children|children
357684|NCT01610830|pronostic factors|pronostic factors
357685|NCT01610817|Patient information and active participation|patient information and active participation
357686|NCT01610817|Patient safety|patient safety
357687|NCT01610817|Health education|health education
357688|NCT01610817|Adverse drug event|adverse drug event
357689|NCT01610817|Primary care|primary care
357690|NCT01610817|Antihypertensive drugs|antihypertensive drugs
357691|NCT01610765|HSV|hsv
357692|NCT01610765|pharmacokinetics|pharmacokinetics
357693|NCT01610765|herpes|herpes
357694|NCT01610765|neonates|neonates
357695|NCT01610752|Pregnancy|pregnancy
357696|NCT01610752|Gestational weight gain|gestational weight gain
357697|NCT01610726|colon|colon
357698|NCT01610726|rectum|rectum
357699|NCT01610726|recovery|recovery
357700|NCT01610726|surgery|surgery
357701|NCT01610674|Diabetes mellitus|diabetes mellitus
357702|NCT01610674|Surgery|surgery
357703|NCT01610674|Implementation|implementation
357704|NCT01610674|Quality of care|quality of care
357705|NCT01610674|Quality indicators|quality indicators
357706|NCT01610661|carbohydrate|carbohydrate
357707|NCT01610661|inflammation|inflammation
357708|NCT01610661|glucose homeostasis|glucose homeostasis
357709|NCT01610661|gene expression|gene expression
357710|NCT01610648|OSA|osa
357711|NCT01610648|metabolic syndrome|metabolic syndrome
357712|NCT01610648|Apnea-hypopnea index|apnea-hypopnea index
357713|NCT01610648|Oxygen desaturation index|oxygen desaturation index
357714|NCT01610635|RCT|rct
357715|NCT01610635|blood donation frequency|blood donation frequency
357716|NCT01610635|quality of life|quality of life
357717|NCT01610635|iron deficiency|iron deficiency
357718|NCT01610622|Cardiac Output|cardiac output
357719|NCT01610622|Blood volumes|blood volumes
357720|NCT01610622|Neonates|neonates
357721|NCT01610609|Statin treatment|statin treatment
357722|NCT01610609|Cardiovascular disease|cardiovascular disease
357723|NCT01610609|High cholesterol|high cholesterol
357724|NCT01610609|Care management|care management
357725|NCT01610596|Psoriasis|psoriasis
357726|NCT01610596|Skin Diseases|skin diseases
357727|NCT01610596|Halobetasol|halobetasol
357728|NCT01610596|Vasoconstrictor Agents|vasoconstrictor agents
357729|NCT01610596|Therapeutic Uses|therapeutic uses
357730|NCT01610596|Pharmacologic Actions|pharmacologic actions
357731|NCT01610596|Anti-Inflammatory Agents|anti-inflammatory agents
357732|NCT01610596|Physiological Effects of Drugs|physiological effects of drugs
357733|NCT01610583|Genetic Literacy|genetic literacy
357734|NCT01610583|Latino|latino
357735|NCT01610570|Dose Limiting Toxicity|dose limiting toxicity
357736|NCT01610570|Maximum Tolerated Dose|maximum tolerated dose
357737|NCT01610570|Radiographic Response|radiographic response
357738|NCT01610570|Time to Progression|time to progression
357739|NCT01610570|Bone Tumors|bone tumors
357740|NCT01610557|Diabetic Macular Edema|diabetic macular edema
357741|NCT01610557|Ranibizumab|ranibizumab
357742|NCT01610557|Bevacizumab|bevacizumab
357743|NCT01610544|Thymoma|thymoma
357744|NCT01610544|Insulin Growth Factor|insulin growth factor
357745|NCT01610544|Cell Proliferation|cell proliferation
357746|NCT01610544|Non Small Cell Lung Cancer|non small cell lung cancer
357747|NCT01610544|PET/CT Imaging Sessions|pet/ct imaging sessions
357748|NCT01610531|Cohort|cohort
357749|NCT01610531|Melanoma|melanoma
357750|NCT01610531|targeted screening|targeted screening
357751|NCT01610531|risks function|risks function
357752|NCT01610531|cost effectiveness|cost effectiveness
357753|NCT01610518|postprandial blood glucose|postprandial blood glucose
357754|NCT01610518|dietary fiber|dietary fiber
357755|NCT01610518|beta-glucan|beta-glucan
357756|NCT01610505|Knee Osteoarthritis|knee osteoarthritis
357757|NCT01610505|Knee pain|knee pain
357758|NCT01610505|Arthritis|arthritis
357759|NCT01610505|KineSpring|kinespring
357760|NCT01610505|High Tibial Osteotomy|high tibial osteotomy
357761|NCT01610492|IMGN|imgn
357762|NCT01610492|anti-PLA2R antibodies|anti-pla2r antibodies
357763|NCT01610492|pharmacokinetics|pharmacokinetics
357764|NCT01610492|belimumab|belimumab
357765|NCT01610492|Benlysta|benlysta
357766|NCT01610492|Idiopathic Membranous Glomerulonephropathy|idiopathic membranous glomerulonephropathy
357767|NCT01610492|safety|safety
357768|NCT01610492|GSK1550188|gsk1550188
357769|NCT01610492|Lymphostat-B|lymphostat-b
357770|NCT01610492|membrane attack complex|membrane attack complex
357771|NCT01610466|Education|education
357772|NCT01610466|Simulation|simulation
357773|NCT01610466|Technical skills training|technical skills training
357774|NCT01610466|Laparoscopy|laparoscopy
357775|NCT01610466|Bariatric Surgery|bariatric surgery
357776|NCT01610453|prolonged labor|prolonged labor
357777|NCT01610453|cesarean section|cesarean section
357778|NCT01610453|duration of labor|duration of labor
357779|NCT01610440|Duchenne muscular dystrophy|duchenne muscular dystrophy
357780|NCT01610440|Human Umbilical Cord Mesenchymal Stem Cells|human umbilical cord mesenchymal stem cells
357781|NCT01610427|CMI|cmi
357782|NCT01610427|HIV|hiv
357783|NCT01610427|Antiretroviral therapy-naïve|antiretroviral therapy-naïve
357784|NCT01610414|Observer-blind|observer-blind
357785|NCT01610414|Efficacy|efficacy
357786|NCT01610414|Immunogenicity|immunogenicity
357787|NCT01610414|Vaccination|vaccination
357788|NCT01610414|Safety|safety
357789|NCT01610414|Adult autologous haematopoietic cell transplant recipients|adult autologous haematopoietic cell transplant recipients
357790|NCT01610414|Herpes Zoster|herpes zoster
357791|NCT01610388|healthy subjects|healthy subjects
357792|NCT01610388|double-blind|double-blind
357793|NCT01610388|FTIH|ftih
357794|NCT01610388|dose-escalation|dose-escalation
357795|NCT01610388|absolute bioavailability|absolute bioavailability
357796|NCT01610388|GSK1322322|gsk1322322
357797|NCT01610388|BAL|bal
357798|NCT01610375|Endometrial cancer|endometrial cancer
357799|NCT01610362|rabies|rabies
357800|NCT01610362|immunoglobulin|immunoglobulin
357801|NCT01610362|dosage|dosage
357802|NCT01610336|EGFR|egfr
357803|NCT01610336|c-MET|c-met
357804|NCT01610336|Lung cancer|lung cancer
357805|NCT01610336|Gefitinib|gefitinib
357806|NCT01610336|Erlotinib|erlotinib
357807|NCT01610323|Pregnancy|pregnancy
357808|NCT01610323|Obesity|obesity
357809|NCT01610323|Physical activity|physical activity
357810|NCT01610323|Cardiorespiratory fitness|cardiorespiratory fitness
357811|NCT01610323|Muscular Fitness|muscular fitness
357812|NCT01610323|Weight gain|weight gain
357813|NCT01610323|Fetal growth|fetal growth
357814|NCT01610310|SC|sc
357815|NCT01610310|PEG|peg
357816|NCT01610310|Inteferon|inteferon
357817|NCT01610310|PK|pk
357818|NCT01610310|Subcutaneous|subcutaneous
357819|NCT01610310|PEGylated|pegylated
357820|NCT01610310|Autoinjector|autoinjector
357821|NCT01610310|Injectable|injectable
357822|NCT01610310|MS|ms
357823|NCT01610297|hematopoietic stem cell transplantation, beta-thalassemia major, deferasirox, iron overload|hematopoietic stem cell transplantation, beta-thalassemia major, deferasirox, iron overload
357824|NCT01610284|Breast cancer|breast cancer
357825|NCT01610284|Hormone receptor positive|hormone receptor positive
357826|NCT01610284|HER2-negative|her2-negative
357827|NCT01610284|Metastatic|metastatic
357828|NCT01610284|Locally advanced|locally advanced
357829|NCT01610284|PI3K|pi3k
357830|NCT01610284|Fulvestrant|fulvestrant
357831|NCT01610284|Refractory|refractory
357832|NCT01610284|Aromatase inhibitor|aromatase inhibitor
357833|NCT01610271|Prevention|prevention
357834|NCT01610271|Surgical Site Infection|surgical site infection
357835|NCT01610271|Air Barrier System|air barrier system
357836|NCT01610271|Implant Infection|implant infection
357837|NCT01610258|pregnancy, chorioamnionitis, PPROM, Treg|pregnancy, chorioamnionitis, pprom, treg
357838|NCT01610245|Influenza|influenza
357839|NCT01610232|Infrared LED|infrared led
357840|NCT01610232|Treadmill Training|treadmill training
357841|NCT01610232|Strength Muscle|strength muscle
357842|NCT01610232|Fatigue Muscle|fatigue muscle
357843|NCT01610232|Aerobic Capacity|aerobic capacity
357844|NCT01610232|Cellulite|cellulite
357845|NCT01610232|Osteoporosis|osteoporosis
357846|NCT01610206|recurrent|recurrent
357847|NCT01610206|persistent|persistent
357848|NCT01610193|Pancreatic Stone Protein|pancreatic stone protein
357849|NCT01610193|Abdominal pain|abdominal pain
357850|NCT01610193|Acute appendicitis|acute appendicitis
357851|NCT01610193|Alvarado score|alvarado score
357852|NCT01610193|Appendectomy|appendectomy
357853|NCT01610193|Sensitivity and specificity|sensitivity and specificity
357854|NCT01610180|Eltrombopag|eltrombopag
357855|NCT01610180|ITP|itp
357856|NCT01610180|LPD|lpd
357857|NCT01610180|leukemia|leukemia
357858|NCT01610180|Immune ThrombocytoPenia|immune thrombocytopenia
357859|NCT01610154|glucagon|glucagon
357860|NCT01610154|dipeptidyl peptidase-4 inhibitor|dipeptidyl peptidase-4 inhibitor
357861|NCT01610141|warfarin metabolism|warfarin metabolism
357862|NCT01610141|pharmacogenetics|pharmacogenetics
357863|NCT01610141|CYP2C9|cyp2c9
357864|NCT01610141|genotyping|genotyping
357865|NCT01610141|VKORC1|vkorc1
357866|NCT01610141|CYP4F2|cyp4f2
357867|NCT01610141|anticoagulation|anticoagulation
357868|NCT01610141|atrial fibrillation|atrial fibrillation
357869|NCT01610141|deep vein thrombosis|deep vein thrombosis
357870|NCT01610141|pulmonary embolism|pulmonary embolism
357871|NCT01610141|Artificial Heart Valve|artificial heart valve
357872|NCT01610128|urticaria, patient reported outcome|urticaria, patient reported outcome
357873|NCT01610115|Pregnancy|pregnancy
357874|NCT01610102|clinical follow-up|clinical follow-up
357875|NCT01610102|up to 7 years|up to 7 years
357876|NCT01610102|all patients enrolled in the main study|all patients enrolled in the main study
357877|NCT01610089|citrullinemia|citrullinemia
357878|NCT01610089|argininosuccinate synthetase deficiency|argininosuccinate synthetase deficiency
357879|NCT01610089|nitric oxide|nitric oxide
357880|NCT01610089|urea|urea
357881|NCT01610076|Code Status|code status
357882|NCT01610076|Do not resuscitate (DNR)|do not resuscitate (dnr)
357883|NCT01610076|Do not intubate (DNI)|do not intubate (dni)
357884|NCT01610076|CPR|cpr
357885|NCT01610076|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
357886|NCT01610076|video|video
357887|NCT01610076|advanced directives|advanced directives
357888|NCT01610063|Algorithm|algorithm
357889|NCT01610063|Depression|depression
357890|NCT01610063|Assurex|assurex
357891|NCT01610063|GeneSight|genesight
357892|NCT01610050|castration-resistant prostate cancer, advanced breast cancer|castration-resistant prostate cancer, advanced breast cancer
357893|NCT01610037|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
357894|NCT01610037|COPD|copd
357895|NCT01610037|QVA149|qva149
357896|NCT01610037|QAB149|qab149
357897|NCT01610037|NVA237|nva237
357898|NCT01610037|Indacaterol maleate|indacaterol maleate
357899|NCT01610037|Glycopyronnium bromide|glycopyronnium bromide
357900|NCT01610011|Schizophrenia|schizophrenia
357901|NCT01610011|Psychotic Disorders|psychotic disorders
357902|NCT01610011|N-methyl-D-aspartate receptor|n-methyl-d-aspartate receptor
357903|NCT01610011|Glycine augmentation|glycine augmentation
357904|NCT01610011|Glycine|glycine
357905|NCT01610011|Glycine Pharmacodynamics|glycine pharmacodynamics
357906|NCT01610011|Glycine Bioavailability|glycine bioavailability
357907|NCT01610011|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
357908|NCT01610011|Glycine Decarboxylase|glycine decarboxylase
357909|NCT01610011|Glycine Decarboxylase Mutation|glycine decarboxylase mutation
357910|NCT01609998|Influenza A (H1)|influenza a (h1)
357911|NCT01609998|Influenza A (H3)|influenza a (h3)
357912|NCT01609998|Influenza B|influenza b
357913|NCT01609998|DNA Vaccine|dna vaccine
357914|NCT01609998|Trivalent Inactivated Vaccine (TIV)|trivalent inactivated vaccine (tiv)
357915|NCT01609998|Healthy Adolescents|healthy adolescents
357916|NCT01609998|Healthy Children|healthy children
357917|NCT01609985|Cardiac Resynchronization Therapy Defibrillator (CRT-D) Devices|cardiac resynchronization therapy defibrillator (crt-d) devices
357918|NCT01609972|Back pain|back pain
357919|NCT01609972|Spinal Cord Stimulation|spinal cord stimulation
357920|NCT01609959|Hypertension|hypertension
357921|NCT01609959|Angiotensin II Receptor Blocker|angiotensin ii receptor blocker
357922|NCT01609959|Azilsartan|azilsartan
357923|NCT01609959|Valsartan|valsartan
357924|NCT01609946|presenting for FNAB or surgery|presenting for fnab or surgery
357925|NCT01609933|Hepatitis C|hepatitis c
357926|NCT01609933|Hepatitis C Genotype 1|hepatitis c genotype 1
357927|NCT01609933|Chronic Hepatitis C|chronic hepatitis c
357928|NCT01609933|HCV|hcv
357929|NCT01609920|MRI|mri
357930|NCT01609920|lymph node metastases|lymph node metastases
357931|NCT01609920|breast cancer|breast cancer
357932|NCT01609920|gadofosveset|gadofosveset
357933|NCT01609907|Drug interaction|drug interaction
357934|NCT01609907|YH14700|yh14700
357935|NCT01609907|Rosuvastatin|rosuvastatin
357936|NCT01609907|Valsartan|valsartan
357937|NCT01609907|Yuhan|yuhan
358869|NCT01606254|JNS010|jns010
357938|NCT01609894|Postnatal development|postnatal development
357939|NCT01609894|Breast milk fortification|breast milk fortification
357940|NCT01609894|Composition of breast milk|composition of breast milk
357941|NCT01609881|Inflammation|inflammation
357942|NCT01609868|premature infant feeding protein|premature infant feeding protein
357943|NCT01609855|Adenoma Detection Rate|adenoma detection rate
357944|NCT01609855|Anti-spasmotic drug|anti-spasmotic drug
357945|NCT01609842|Acute Coronary Syndrome|acute coronary syndrome
357946|NCT01609842|adherence|adherence
357947|NCT01609816|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
357948|NCT01609816|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
357949|NCT01609816|anaplastic large cell lymphoma|anaplastic large cell lymphoma
357950|NCT01609816|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
357951|NCT01609816|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
357952|NCT01609816|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
357953|NCT01609816|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
357954|NCT01609816|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
357955|NCT01609816|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
357956|NCT01609816|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
357957|NCT01609816|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
357958|NCT01609816|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
357959|NCT01609816|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
357960|NCT01609816|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
357961|NCT01609816|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
357962|NCT01609816|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
357963|NCT01609816|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
357964|NCT01609816|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
357965|NCT01609816|hepatosplenic T-cell lymphoma|hepatosplenic t-cell lymphoma
357966|NCT01609816|intraocular lymphoma|intraocular lymphoma
357967|NCT01609816|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
357968|NCT01609816|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
357969|NCT01609816|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
357970|NCT01609816|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
357971|NCT01609816|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
357972|NCT01609816|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
357973|NCT01609816|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
357974|NCT01609816|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
357975|NCT01609816|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
357976|NCT01609816|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
357977|NCT01609816|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
357978|NCT01609816|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
357979|NCT01609816|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
357980|NCT01609816|noncutaneous extranodal lymphoma|noncutaneous extranodal lymphoma
357981|NCT01609816|peripheral T-cell lymphoma|peripheral t-cell lymphoma
357982|NCT01609816|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
357983|NCT01609816|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
357984|NCT01609816|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
357985|NCT01609816|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
357986|NCT01609816|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
357987|NCT01609816|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
357988|NCT01609816|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
357989|NCT01609816|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
357990|NCT01609816|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
357991|NCT01609816|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
357992|NCT01609816|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
357993|NCT01609816|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
357994|NCT01609816|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
357995|NCT01609816|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
357996|NCT01609816|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
357997|NCT01609816|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
357998|NCT01609816|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
357999|NCT01609816|refractory hairy cell leukemia|refractory hairy cell leukemia
358000|NCT01609816|refractory multiple myeloma|refractory multiple myeloma
358001|NCT01609816|small intestine lymphoma|small intestine lymphoma
358002|NCT01609816|splenic marginal zone lymphoma|splenic marginal zone lymphoma
358003|NCT01609816|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
358004|NCT01609816|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
358005|NCT01609816|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
358006|NCT01609816|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
358007|NCT01609816|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
358008|NCT01609816|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
358009|NCT01609816|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
358010|NCT01609816|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
358119|NCT01609504|Rectal cancer|rectal cancer
358011|NCT01609816|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
358012|NCT01609816|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
358013|NCT01609816|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
358014|NCT01609816|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
358015|NCT01609816|stage I mantle cell lymphoma|stage i mantle cell lymphoma
358016|NCT01609816|stage I marginal zone lymphoma|stage i marginal zone lymphoma
358017|NCT01609816|stage I multiple myeloma|stage i multiple myeloma
358018|NCT01609816|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
358019|NCT01609816|stage IA mycosis fungoides/Sezary syndrome|stage ia mycosis fungoides/sezary syndrome
358020|NCT01609816|stage IB mycosis fungoides/Sezary syndrome|stage ib mycosis fungoides/sezary syndrome
358021|NCT01609816|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
358022|NCT01609816|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
358023|NCT01609816|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
358024|NCT01609816|stage II multiple myeloma|stage ii multiple myeloma
358025|NCT01609816|stage IIA mycosis fungoides/Sezary syndrome|stage iia mycosis fungoides/sezary syndrome
358026|NCT01609816|stage IIB mycosis fungoides/Sezary syndrome|stage iib mycosis fungoides/sezary syndrome
358027|NCT01609816|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
358028|NCT01609816|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
358029|NCT01609816|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
358030|NCT01609816|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
358031|NCT01609816|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
358032|NCT01609816|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
358033|NCT01609816|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
358034|NCT01609816|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
358035|NCT01609816|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
358036|NCT01609816|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
358037|NCT01609816|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
358038|NCT01609816|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
358039|NCT01609816|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
358040|NCT01609816|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
358041|NCT01609816|stage III multiple myeloma|stage iii multiple myeloma
358042|NCT01609816|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
358043|NCT01609816|stage IIIA mycosis fungoides/Sezary syndrome|stage iiia mycosis fungoides/sezary syndrome
358044|NCT01609816|stage IIIB mycosis fungoides/Sezary syndrome|stage iiib mycosis fungoides/sezary syndrome
358045|NCT01609816|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
358046|NCT01609816|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
358047|NCT01609816|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
358048|NCT01609816|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
358049|NCT01609816|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
358050|NCT01609816|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
358051|NCT01609816|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
358052|NCT01609816|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
358053|NCT01609816|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
358054|NCT01609816|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
358055|NCT01609816|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
358056|NCT01609816|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
358057|NCT01609816|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
358058|NCT01609816|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
358059|NCT01609816|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
358060|NCT01609816|stage IVA mycosis fungoides/Sezary syndrome|stage iva mycosis fungoides/sezary syndrome
358061|NCT01609816|stage IVB mycosis fungoides/Sezary syndrome|stage ivb mycosis fungoides/sezary syndrome
358062|NCT01609816|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
358063|NCT01609816|testicular lymphoma|testicular lymphoma
358064|NCT01609816|Waldenström macroglobulinemia|waldenström macroglobulinemia
358065|NCT01609751|probiotic|probiotic
358066|NCT01609751|lactobacillus|lactobacillus
358067|NCT01609751|colonic diseases|colonic diseases
358068|NCT01609751|dietary fibre|dietary fibre
358069|NCT01609738|Cardiac pacing|cardiac pacing
358070|NCT01609738|Left ventricular septal pacing|left ventricular septal pacing
358071|NCT01609738|Feasibility and safety|feasibility and safety
358072|NCT01609738|Lead stability|lead stability
358073|NCT01609738|Hemodynamics|hemodynamics
358074|NCT01609738|Left ventricular dyssynchrony|left ventricular dyssynchrony
358075|NCT01609738|Pacing for heart failure|pacing for heart failure
358076|NCT01609738|Cardiac resynchronization therapy|cardiac resynchronization therapy
358077|NCT01609725|Coronary artery disease|coronary artery disease
358078|NCT01609725|C reactive protein|c reactive protein
358079|NCT01609725|Periodontitis|periodontitis
358080|NCT01609725|Periodontal therapy|periodontal therapy
358081|NCT01609725|Flow-mediated dilation|flow-mediated dilation
358082|NCT01609712|Improvement of lung function (FEV1, PEF)|improvement of lung function (fev1, pef)
358083|NCT01609712|Visual Analog Scale|visual analog scale
358084|NCT01609712|Oswestry Disability Index|oswestry disability index
358085|NCT01609712|Radiographs pre and post Op|radiographs pre and post op
358086|NCT01609699|body circumference|body circumference
358087|NCT01609699|Non-Invasive Reduction|non-invasive reduction
358088|NCT01609686|cardiac surgery|cardiac surgery
358089|NCT01609686|renal dysfunction|renal dysfunction
358090|NCT01609686|pharmacokinetics|pharmacokinetics
358091|NCT01609686|tranexamic acid|tranexamic acid
358092|NCT01609673|Immunosuppression|immunosuppression
358093|NCT01609673|Chronic Kidney Disease|chronic kidney disease
358094|NCT01609673|Renal Transplant|renal transplant
358095|NCT01609660|probiotics|probiotics
358096|NCT01609660|cytokine|cytokine
358097|NCT01609660|short chain fatty acids|short chain fatty acids
358098|NCT01609660|complications|complications
358099|NCT01609660|colorectal surgery|colorectal surgery
358100|NCT01609647|High plate reactivity unit after loading dose of clopidogrel|high plate reactivity unit after loading dose of clopidogrel
358101|NCT01609634|Healthy|healthy
358102|NCT01609634|Term infants|term infants
358103|NCT01609634|Growth|growth
358104|NCT01609634|Body composition|body composition
358105|NCT01609595|Thalassemia|thalassemia
358106|NCT01609595|Anemia|anemia
358107|NCT01609595|Fetal hemoglobin|fetal hemoglobin
358108|NCT01609582|Drug therapy|drug therapy
358109|NCT01609556|FOLR solid tumors|folr solid tumors
358110|NCT01609530|verruca vulgaris|verruca vulgaris
358111|NCT01609530|hands|hands
358112|NCT01609530|feet|feet
358113|NCT01609530|Nd:YAG|nd:yag
358114|NCT01609530|laser|laser
358115|NCT01609530|cryotherapy|cryotherapy
358116|NCT01609517|Spinal anesthesia|spinal anesthesia
358117|NCT01609517|determinant|determinant
358118|NCT01609517|duration|duration
358120|NCT01609504|Radiochemotherapy|radiochemotherapy
358121|NCT01609504|Transanal Endoscopic Microsurgery|transanal endoscopic microsurgery
358122|NCT01609504|Laparoscopic Resection|laparoscopic resection
358123|NCT01609478|asthma|asthma
358124|NCT01609465|CAD|cad
358125|NCT01609465|stable angina|stable angina
358126|NCT01609465|STEMI|stemi
358127|NCT01609465|NSTEMI|nstemi
358128|NCT01609465|CVD|cvd
358129|NCT01609465|secondary prevention|secondary prevention
358130|NCT01609452|Immune Thrombocytopenic Purpura|immune thrombocytopenic purpura
358131|NCT01609452|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
358132|NCT01609452|Chronic ITP|chronic itp
358133|NCT01609439|Permanent|permanent
358134|NCT01609439|temporary|temporary
358135|NCT01609439|hypocalcemia|hypocalcemia
358136|NCT01609426|Proteinuria|proteinuria
358137|NCT01609426|idiopathic|idiopathic
358138|NCT01609426|nephrotic syndrome|nephrotic syndrome
358139|NCT01609426|herpesvirus|herpesvirus
358140|NCT01609426|epidemiology|epidemiology
358141|NCT01609426|immune response|immune response
358142|NCT01609426|interferon|interferon
358143|NCT01609426|steroid dependency|steroid dependency
358144|NCT01609426|nephrotic disease: Idiopathic nephrotic syndrome|nephrotic disease: idiopathic nephrotic syndrome
358145|NCT01609387|Vitamine|vitamine
358146|NCT01609387|mineral|mineral
358147|NCT01609387|obese patients|obese patients
358148|NCT01609387|Vitamine en mineral shortage in obese patients|vitamine en mineral shortage in obese patients
358149|NCT01609374|Spinal Kinetics|spinal kinetics
358150|NCT01609374|artificial cervical disc|artificial cervical disc
358151|NCT01609374|cervical radiculopathy|cervical radiculopathy
358152|NCT01609374|ACDF|acdf
358153|NCT01609374|neck pain|neck pain
358154|NCT01609374|cervical spine|cervical spine
358155|NCT01609374|degenerative disc disease|degenerative disc disease
358156|NCT01609361|Rehabilitation program|rehabilitation program
358157|NCT01609361|Fast track surgery|fast track surgery
358158|NCT01609361|Laparoscopic colorectal resection|laparoscopic colorectal resection
358159|NCT01609361|Colorectal cancer|colorectal cancer
358160|NCT01609361|Morbidity|morbidity
358161|NCT01609348|Depression|depression
358162|NCT01609348|Alzheimer's Disease|alzheimer's disease
358163|NCT01609322|fear of falling|fear of falling
358164|NCT01609322|agoraphobia|agoraphobia
358165|NCT01609309|Stomach Neoplasms|stomach neoplasms
358166|NCT01609309|Laparoscopy|laparoscopy
358167|NCT01609296|Peripheral Arterial Disease|peripheral arterial disease
358168|NCT01609296|Drug coated balloon|drug coated balloon
358169|NCT01609296|Superficial Femoral Artery|superficial femoral artery
358170|NCT01609296|Popliteal Femoral Artery|popliteal femoral artery
358171|NCT01609296|Atherosclerosis|atherosclerosis
358172|NCT01609244|Sleep apnea|sleep apnea
358173|NCT01609244|central sleep apnea|central sleep apnea
358174|NCT01609244|bilevel|bilevel
358175|NCT01609244|servoventilation|servoventilation
358176|NCT01609244|CPAP|cpap
358177|NCT01609192|sickle-cell anemia|sickle-cell anemia
358178|NCT01609192|spermatogenesis|spermatogenesis
358179|NCT01609192|hydroxyurea|hydroxyurea
358180|NCT01609166|Hand-foot Syndrome|hand-foot syndrome
358181|NCT01609166|capecitabine|capecitabine
358182|NCT01609166|allopurinol|allopurinol
358183|NCT01609153|schizophrenia|schizophrenia
358184|NCT01609153|amisulpride|amisulpride
358185|NCT01609153|olanzapine|olanzapine
358186|NCT01609153|polypharmacy|polypharmacy
358187|NCT01609140|Hyperlipidemia|hyperlipidemia
358188|NCT01609140|Dyslipidemia|dyslipidemia
358189|NCT01609114|phenomena and mechanism of RT-PK|phenomena and mechanism of rt-pk
358190|NCT01609114|fact for different anticancer drugs|fact for different anticancer drugs
358191|NCT01609114|different part in human|different part in human
358192|NCT01609101|Videolaryngoscopy|videolaryngoscopy
358193|NCT01609101|Palatopharyngeal distance|palatopharyngeal distance
358194|NCT01609101|Trauma|trauma
358195|NCT01609088|endothelium|endothelium
358196|NCT01609088|diabetes mellitus|diabetes mellitus
358197|NCT01609088|oxidative stress|oxidative stress
358198|NCT01609062|Mucopolysaccharidosis IVA Type A|mucopolysaccharidosis iva type a
358199|NCT01609062|MPS IVA Type A|mps iva type a
358200|NCT01609062|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
358201|NCT01609062|MPS IVA|mps iva
358202|NCT01609062|Morquio A Syndrome|morquio a syndrome
358203|NCT01609062|Lysosomal Storage Disorder|lysosomal storage disorder
358204|NCT01609062|LSD|lsd
358205|NCT01609062|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
358206|NCT01609062|N-acetylgalactosamine-6-sulfate|n-acetylgalactosamine-6-sulfate
358207|NCT01609062|sulfatase|sulfatase
358208|NCT01609062|galactose-6-sulfatase|galactose-6-sulfatase
358209|NCT01609062|GALNS|galns
358210|NCT01609062|enzyme replacement therapy|enzyme replacement therapy
358211|NCT01609062|ERT|ert
358212|NCT01609062|MOR-008|mor-008
358213|NCT01609062|CPET|cpet
358214|NCT01609062|MST|mst
358215|NCT01609062|muscle strength test|muscle strength test
358216|NCT01609062|physiological effect|physiological effect
358217|NCT01608984|remote ischemic preconditioning|remote ischemic preconditioning
358218|NCT01608984|coronary artery bypass grafting|coronary artery bypass grafting
358219|NCT01608984|myocardial injury|myocardial injury
358220|NCT01608971|Protamine|protamine
358221|NCT01608971|heparin level|heparin level
358222|NCT01608971|haemostasis|haemostasis
358223|NCT01608971|thromboelastometry|thromboelastometry
358224|NCT01608971|cardiac surgery|cardiac surgery
358225|NCT01608971|Patients undergoing cardiac surgery|patients undergoing cardiac surgery
358226|NCT01608958|Postpartum hemorrhage|postpartum hemorrhage
358227|NCT01608958|Oxytocin|oxytocin
358228|NCT01608958|Third stage of labor|third stage of labor
358229|NCT01608958|Hemoglobin|hemoglobin
358230|NCT01608958|Prevention|prevention
358231|NCT01608958|Intravenous|intravenous
358232|NCT01608958|Intramuscular|intramuscular
358233|NCT01608945|steroid|steroid
358234|NCT01608945|liver function|liver function
358235|NCT01608945|prognosis|prognosis
358236|NCT01608906|venous thrombosis|venous thrombosis
358237|NCT01608906|heparin|heparin
358238|NCT01608906|pulmonary embolism|pulmonary embolism
358239|NCT01608906|ICU|icu
358240|NCT01608867|Phase 1|phase 1
358241|NCT01608867|dose escalation|dose escalation
358242|NCT01608867|histologically confirmed|histologically confirmed
358243|NCT01608867|malignancy|malignancy
358244|NCT01608867|metastatic|metastatic
358245|NCT01608854|surgical site infection|surgical site infection
358246|NCT01608854|spinal surgery|spinal surgery
358247|NCT01608854|prophylactic antibiotics|prophylactic antibiotics
358248|NCT01608854|postoperative spinal drains|postoperative spinal drains
358249|NCT01608815|Salmonella infections|salmonella infections
358250|NCT01608815|Typhoid fever|typhoid fever
358251|NCT01608815|Bacterial infections|bacterial infections
358252|NCT01608815|Typhoid vaccine|typhoid vaccine
358253|NCT01608802|HIV|hiv
358254|NCT01608802|Antiretroviral therapy|antiretroviral therapy
358255|NCT01608802|Palliative care|palliative care
358256|NCT01608802|Pain|pain
358257|NCT01608789|Male sling|male sling
358258|NCT01608789|Stress Urinary Incontinence|stress urinary incontinence
358259|NCT01608789|Urination Disorders|urination disorders
358260|NCT01608789|Urologic Diseases|urologic diseases
358261|NCT01608724|Type 2 DM|type 2 dm
358262|NCT01608711|Gemcitabine|gemcitabine
358263|NCT01608711|ASP6182|asp6182
358264|NCT01608711|AGS-1C4D4|ags-1c4d4
358265|NCT01608711|Pancreatic Cancer|pancreatic cancer
358266|NCT01608698|chlormadinone acetate|chlormadinone acetate
358267|NCT01608698|drospirenone|drospirenone
358268|NCT01608698|contraceptive pills|contraceptive pills
358269|NCT01608685|Tuberculosis|tuberculosis
358270|NCT01608685|Latent tuberculosis infection|latent tuberculosis infection
358271|NCT01608685|Immunosuppression|immunosuppression
358272|NCT01608685|Renal transplant recipient|renal transplant recipient
358273|NCT01608646|S-1|s-1
358274|NCT01608646|Oxaliplatin|oxaliplatin
358275|NCT01608646|Dihydropyrimidine Dehydrogenase|dihydropyrimidine dehydrogenase
358276|NCT01608620|Systematic review and meta-analysis|systematic review and meta-analysis
358277|NCT01608620|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
358278|NCT01608620|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
358279|NCT01608620|Clinical practice guidelines|clinical practice guidelines
358280|NCT01608620|Clinical trials|clinical trials
358281|NCT01608620|Dietary sugars|dietary sugars
358282|NCT01608620|Fructose|fructose
358283|NCT01608620|High fructose corn syrup|high fructose corn syrup
358284|NCT01608620|Fruit|fruit
358285|NCT01608620|Isocaloric|isocaloric
358286|NCT01608620|Hypercaloric|hypercaloric
358287|NCT01608620|Cardiometabolic risk factors|cardiometabolic risk factors
358288|NCT01608620|Triglycerides|triglycerides
358289|NCT01608620|Cholesterol|cholesterol
358290|NCT01608620|Glycemic control|glycemic control
358291|NCT01608620|Insulin resistance|insulin resistance
358292|NCT01608620|Body weight|body weight
358293|NCT01608620|Uric acid|uric acid
358294|NCT01608620|Blood pressure|blood pressure
358295|NCT01608607|Systematic review and meta-analysis|systematic review and meta-analysis
358296|NCT01608607|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
358297|NCT01608607|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
358298|NCT01608607|Clinical practice guidelines|clinical practice guidelines
358299|NCT01608607|Clinical trials|clinical trials
358300|NCT01608607|Dietary sugars|dietary sugars
358301|NCT01608607|Fructose|fructose
358302|NCT01608607|High fructose corn syrup|high fructose corn syrup
358303|NCT01608607|sucrose|sucrose
358304|NCT01608607|Isocaloric|isocaloric
358305|NCT01608607|Hypercaloric|hypercaloric
358306|NCT01608607|Glycemic control|glycemic control
358307|NCT01608607|Insulin resistance|insulin resistance
358308|NCT01608607|Body weight|body weight
358309|NCT01608607|body mass index|body mass index
358310|NCT01608607|waist circumference|waist circumference
358311|NCT01608581|prevention|prevention
358312|NCT01608581|burn|burn
358313|NCT01608581|adult|adult
358314|NCT01608581|health promotion|health promotion
358315|NCT01608581|evaluation|evaluation
358316|NCT01608581|media|media
358317|NCT01608568|Sutures|sutures
358318|NCT01608568|Pelvic Organ Prolapse|pelvic organ prolapse
358319|NCT01608568|Sacrocolpopexy|sacrocolpopexy
358320|NCT01608568|Robotic Assisted Laparoscopy|robotic assisted laparoscopy
358321|NCT01608555|cystic fibrosis|cystic fibrosis
358322|NCT01608555|bacterial load|bacterial load
358323|NCT01608555|inhaled tobramycin|inhaled tobramycin
358324|NCT01608542|fostamatinib|fostamatinib
358325|NCT01608542|FosD|fosd
358326|NCT01608542|Japanese Healthy volunteers|japanese healthy volunteers
358327|NCT01608542|Phase 1|phase 1
358328|NCT01608542|Single and Multiple Dose Study|single and multiple dose study
358329|NCT01608529|Restriction device ventilatory nasal flow|restriction device ventilatory nasal flow
358330|NCT01608529|oronasal breathing|oronasal breathing
358331|NCT01608529|nasal breathing.|nasal breathing.
358332|NCT01608516|PET/CT|pet/ct
358333|NCT01608516|68Ga-NODAGA-RGD|68ga-nodaga-rgd
358334|NCT01608516|18F-FDG|18f-fdg
358335|NCT01608516|MRI|mri
358336|NCT01608516|US ultrasound|us ultrasound
358337|NCT01608516|inflammatory atheromatous plaque|inflammatory atheromatous plaque
358338|NCT01608516|endarterectomy|endarterectomy
358339|NCT01608503|subclavian vein|subclavian vein
358340|NCT01608503|ultrasound|ultrasound
358341|NCT01608503|distance between the subclavian vein and the lung|distance between the subclavian vein and the lung
358342|NCT01608490|COPD|copd
358343|NCT01608490|RePneu|repneu
358344|NCT01608477|Heart transplantation|heart transplantation
358345|NCT01608477|Medication adherence|medication adherence
358346|NCT01608477|Behavior system factor|behavior system factor
358347|NCT01608464|Randomized trial,|randomized trial,
358348|NCT01608464|Pre-operative chemo-RT with CDDP and 5-FU|pre-operative chemo-rt with cddp and 5-fu
358349|NCT01608464|Multicenter study|multicenter study
358350|NCT01608438|Body-machine interface|body-machine interface
358351|NCT01608438|Customization|customization
358352|NCT01608438|Upper-body motion|upper-body motion
358353|NCT01608438|Motor learning|motor learning
358354|NCT01608438|Assistive Devices|assistive devices
358355|NCT01608438|Wheelchair|wheelchair
358356|NCT01608438|Computer keyboard|computer keyboard
358357|NCT01608425|diabetic foot ulcer|diabetic foot ulcer
358358|NCT01608425|ulcer monitoring|ulcer monitoring
358359|NCT01608425|telemedicine consultations|telemedicine consultations
358360|NCT01608425|cross-sectoral collaboration|cross-sectoral collaboration
358361|NCT01608412|renal transplantation|renal transplantation
358362|NCT01608412|everolimus|everolimus
358363|NCT01608412|tacrolimus|tacrolimus
358364|NCT01608412|molecular evaluation|molecular evaluation
358365|NCT01608399|major depressive disorder|major depressive disorder
358366|NCT01608399|psychotherapy|psychotherapy
358367|NCT01608399|metacognitive therapy|metacognitive therapy
358368|NCT01608386|Anterior approach|anterior approach
358369|NCT01608386|infrahepatic inferior vena cava clamping|infrahepatic inferior vena cava clamping
358370|NCT01608386|hepatic resection|hepatic resection
358371|NCT01608373|Pain|pain
358372|NCT01608373|Lidocaine|lidocaine
358373|NCT01608373|Intravenous|intravenous
358374|NCT01608373|Intraperitoneum|intraperitoneum
358375|NCT01608373|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
358376|NCT01608360|Pain|pain
358377|NCT01608360|Lidocaine|lidocaine
358378|NCT01608360|Intravenous|intravenous
358379|NCT01608360|Thyroidectomy|thyroidectomy
358380|NCT01608347|LMWH|lmwh
358381|NCT01608347|enoxaparin|enoxaparin
358382|NCT01608347|recurrent miscarriage|recurrent miscarriage
358383|NCT01608347|continuing fetal viability beyond 20 weeks gestation|continuing fetal viability beyond 20 weeks gestation
358384|NCT01608321|Chronic Pain|chronic pain
358385|NCT01608321|Gulf War Illness|gulf war illness
358386|NCT01608321|Gulf War Syndrome|gulf war syndrome
358387|NCT01608321|Fibromyalgia|fibromyalgia
358388|NCT01608321|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
358389|NCT01608321|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
358390|NCT01608321|Veterans|veterans
358391|NCT01608308|Chronic Sinusitis|chronic sinusitis
358392|NCT01608308|Pain Relief|pain relief
358393|NCT01608308|Post-Operative Opioid Requirement|post-operative opioid requirement
358394|NCT01608308|IV Acetaminophen|iv acetaminophen
358395|NCT01608308|Functional Endoscopic Sinus Surgery|functional endoscopic sinus surgery
358396|NCT01608308|FESS|fess
358397|NCT01608295|depressed|depressed
358398|NCT01608295|geriatric|geriatric
358399|NCT01608295|older adults|older adults
358400|NCT01608295|antidepressants|antidepressants
358401|NCT01608295|depression|depression
358402|NCT01608295|anxious|anxious
358403|NCT01608295|major depressive disorder|major depressive disorder
358404|NCT01608295|MDD|mdd
358405|NCT01608282|Osteoarthritis|osteoarthritis
358406|NCT01608282|Arthritis|arthritis
358407|NCT01608282|Knee|knee
358408|NCT01608282|Exercise|exercise
358409|NCT01608282|Physical Activity|physical activity
358410|NCT01608282|Web-based|web-based
358411|NCT01608256|mild cognitive impairment|mild cognitive impairment
358412|NCT01608256|Automobile Driving|automobile driving
358413|NCT01608256|cognitive aspects|cognitive aspects
358414|NCT01608217|Behavioural disturbances|behavioural disturbances
358415|NCT01608217|Pain|pain
358416|NCT01608217|Dementia|dementia
358417|NCT01608217|Alzheimer's dementia|alzheimer's dementia
358418|NCT01608217|Vascular dementia|vascular dementia
358419|NCT01608217|THC|thc
358420|NCT01608217|Cannabis|cannabis
358421|NCT01608204|Pharmacokinetics|pharmacokinetics
358422|NCT01608204|Busulfan|busulfan
358423|NCT01608204|Polymorphism|polymorphism
358424|NCT01608204|GST|gst
358425|NCT01608204|MDR-1(p-Glycoprotein)|mdr-1(p-glycoprotein)
358426|NCT01608204|Acute Myeloid Leukemia adult patients|acute myeloid leukemia adult patients
358427|NCT01608178|Pediatric Neurotransmitter Disorders|pediatric neurotransmitter disorders
358428|NCT01608178|Succinic Semialdehyde Dehydrogenase|succinic semialdehyde dehydrogenase
358429|NCT01608178|GABA|gaba
358430|NCT01608178|Epilepsy|epilepsy
358431|NCT01608165|Small renal cancer mass|small renal cancer mass
358432|NCT01608152|Leukemia|leukemia
358433|NCT01608152|Lymphoma|lymphoma
358434|NCT01608152|Game mechanics|game mechanics
358435|NCT01608152|Stem cell transplant survivors|stem cell transplant survivors
358436|NCT01608152|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
358437|NCT01608152|HSCT|hsct
358438|NCT01608152|Internet-based|internet-based
358439|NCT01608152|Interactive and personalized intervention|interactive and personalized intervention
358440|NCT01608152|Questionnaires|questionnaires
358441|NCT01608152|Focus groups|focus groups
358442|NCT01608152|Interviews|interviews
358443|NCT01608139|Advanced Cancers|advanced cancers
358444|NCT01608139|Advanced Solid Tumors|advanced solid tumors
358445|NCT01608139|Curcumin|curcumin
358446|NCT01608139|Sorafenib|sorafenib
358447|NCT01608139|Nexavar|nexavar
358448|NCT01608139|Bay 43-9006|bay 43-9006
358449|NCT01608139|Vorinostat|vorinostat
358450|NCT01608139|SAHA|saha
358451|NCT01608139|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
358452|NCT01608139|MSK-390|msk-390
358453|NCT01608139|Zolinza|zolinza
358454|NCT01608126|Ultrasound|ultrasound
358455|NCT01608126|Cervical Plexus|cervical plexus
358456|NCT01608126|Anesthesia, Conduction|anesthesia, conduction
358457|NCT01608126|Surgical Procedures, Elective|surgical procedures, elective
358458|NCT01608126|Atherectomy|atherectomy
358459|NCT01608113|neovascular AMD|neovascular amd
358460|NCT01608113|Optical coherence tomography|optical coherence tomography
358461|NCT01608113|reading acuity|reading acuity
358462|NCT01608113|contrast sensitivity|contrast sensitivity
358463|NCT01608074|BRCA1|brca1
358464|NCT01608074|BRCA2|brca2
358465|NCT01608074|Prophylactic surgery|prophylactic surgery
358466|NCT01608074|Salpingectomy|salpingectomy
358467|NCT01608074|Fimbriectomy|fimbriectomy
358468|NCT01608061|Mild probable Alzheimer's Disease|mild probable alzheimer's disease
358469|NCT01608048|In-vitro Fertilization|in-vitro fertilization
358470|NCT01608048|transcutaneous electrical acupoint stimulation|transcutaneous electrical acupoint stimulation
358471|NCT01608035|sciatic catheter|sciatic catheter
358472|NCT01608035|stump catheter|stump catheter
358473|NCT01608035|below knee amputation|below knee amputation
358474|NCT01608009|platinum resistant|platinum resistant
358475|NCT01608009|ovarian cancer|ovarian cancer
358476|NCT01607996|Epidural anesthesia|epidural anesthesia
358477|NCT01607996|pancreatic perfusion|pancreatic perfusion
358478|NCT01607996|pancreatic necrosectomy|pancreatic necrosectomy
358479|NCT01607983|nitric oxide|nitric oxide
358480|NCT01607983|ventricular-arterial coupling|ventricular-arterial coupling
358481|NCT01607983|congenital heart disease|congenital heart disease
358482|NCT01607970|Oxytocin|oxytocin
358483|NCT01607970|Startle|startle
358484|NCT01607970|moral dilemma|moral dilemma
358485|NCT01607970|oxytocin receptor gene|oxytocin receptor gene
358486|NCT01607957|Refractory, metastatic colorectal cancer|refractory, metastatic colorectal cancer
358487|NCT01607931|Exercise|exercise
358488|NCT01607931|Physical activity|physical activity
358489|NCT01607931|Type 2 diabetes|type 2 diabetes
358490|NCT01607931|Obesity|obesity
358491|NCT01607931|Incretin effect|incretin effect
358492|NCT01607931|GLP-1|glp-1
358493|NCT01607931|GIP|gip
358494|NCT01607931|Insulin secretion|insulin secretion
358495|NCT01607931|Glucagon|glucagon
358496|NCT01607931|Beta-cell function|beta-cell function
358497|NCT01607931|Disposition Index|disposition index
358498|NCT01607918|H pylori, eradication|h pylori, eradication
358499|NCT01607905|Selinexor|selinexor
358500|NCT01607905|KPT-330|kpt-330
358501|NCT01607905|Squamous Cell Carcinoma|squamous cell carcinoma
358502|NCT01607905|Glioblastoma multiforme|glioblastoma multiforme
358503|NCT01607905|Adenocarcinoma|adenocarcinoma
358504|NCT01607905|Melanoma|melanoma
358505|NCT01607892|Selinexor|selinexor
358506|NCT01607892|KPT-330|kpt-330
358507|NCT01607892|Multiple Myeloma|multiple myeloma
358508|NCT01607892|non-Hodgkin Lymphoma|non-hodgkin lymphoma
358509|NCT01607892|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
358510|NCT01607892|Waldenström's macroglobulinemia|waldenström's macroglobulinemia
358511|NCT01607892|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
358512|NCT01607892|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
358513|NCT01607892|Chronic Myelocytic Leukemia|chronic myelocytic leukemia
358514|NCT01607892|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
358515|NCT01607879|Prostate Cancer|prostate cancer
358517|NCT01607879|Androgen Deprivation Therapy|androgen deprivation therapy
358518|NCT01607879|Elderly|elderly
358519|NCT01607879|Geriatric|geriatric
358520|NCT01607879|Nutritional supplementation|nutritional supplementation
358521|NCT01607840|Schizophrenia|schizophrenia
358522|NCT01607840|Cognitive Improvement|cognitive improvement
358523|NCT01607840|tDCS|tdcs
358524|NCT01607840|stimulation|stimulation
358525|NCT01607827|polypectomy|polypectomy
358526|NCT01607827|colonoscopy|colonoscopy
358527|NCT01607827|polyp miss rate|polyp miss rate
358528|NCT01607827|surveillance|surveillance
358529|NCT01607827|colorectal cancer|colorectal cancer
358530|NCT01607814|cirrhosis|cirrhosis
358531|NCT01607814|oxidative stress|oxidative stress
358532|NCT01607814|NADPH oxidase|nadph oxidase
358533|NCT01607814|isoprostanes|isoprostanes
358534|NCT01607814|PUFA balance|pufa balance
358535|NCT01607814|platelet activation|platelet activation
358536|NCT01607814|coagulation abnormalities|coagulation abnormalities
358537|NCT01607801|umbilical hernia repair|umbilical hernia repair
358538|NCT01607801|recurrence|recurrence
358539|NCT01607801|choice of suture|choice of suture
358540|NCT01607801|mesh|mesh
358541|NCT01607801|mesh/non-mesh|mesh/non-mesh
358542|NCT01607788|Selection criteria|selection criteria
358543|NCT01607788|Liver transplantation|liver transplantation
358544|NCT01607788|Hepatocellular carcinoma|hepatocellular carcinoma
358545|NCT01607762|Healthy|healthy
358546|NCT01607762|Antipsychotics|antipsychotics
358547|NCT01607762|Aripiprazole|aripiprazole
358548|NCT01607762|Paliperidone|paliperidone
358549|NCT01607762|Risperidone|risperidone
358550|NCT01607762|Quetiapine|quetiapine
358551|NCT01607762|Olanzapine|olanzapine
358552|NCT01607749|Asthma Control|asthma control
358553|NCT01607749|Quality of life|quality of life
358554|NCT01607749|Children|children
358555|NCT01607749|Asthma education|asthma education
358556|NCT01607736|falls|falls
358557|NCT01607736|walking|walking
358558|NCT01607736|healthy older individuals|healthy older individuals
358559|NCT01607736|virtual gait training|virtual gait training
358560|NCT01607723|Sleep pattern|sleep pattern
358561|NCT01607723|Mechanical ventilation|mechanical ventilation
358562|NCT01607723|weaning|weaning
358563|NCT01607723|Intensive Care|intensive care
358564|NCT01607723|NAVA (Neurally Adjusted Ventilatory Assist)|nava (neurally adjusted ventilatory assist)
358565|NCT01607723|PAV+ (Proportional Assist Ventilation Plus)|pav+ (proportional assist ventilation plus)
358566|NCT01607710|fMRI|fmri
358567|NCT01607710|Generalized Anxiety Disorder|generalized anxiety disorder
358568|NCT01607697|Parkinson's Disease|parkinson's disease
358569|NCT01607671|Ischemic|ischemic
358570|NCT01607671|Optic Neuropathy|optic neuropathy
358571|NCT01607671|Non-Arteritic Anterior Ischemic Optic Neuropathy|non-arteritic anterior ischemic optic neuropathy
358572|NCT01607671|NAION|naion
358573|NCT01607671|Ischemic Optic Neuropathy|ischemic optic neuropathy
358574|NCT01607671|Intraocular Pressure|intraocular pressure
358575|NCT01607658|Testosterone|testosterone
358576|NCT01607632|posttraumatic stress|posttraumatic stress
358577|NCT01607632|depression|depression
358578|NCT01607619|CRP|crp
358579|NCT01607593|Retrospective|retrospective
358580|NCT01607593|Sertraline|sertraline
358581|NCT01607593|Posttraumatic stress disorder|posttraumatic stress disorder
358582|NCT01607554|Lung|lung
358583|NCT01607554|non small cell|non small cell
358584|NCT01607554|NSCLC|nsclc
358585|NCT01607554|Irinotecan|irinotecan
358586|NCT01607541|HIV/AIDS|hiv/aids
358587|NCT01607541|vulnerable populations|vulnerable populations
358588|NCT01607541|heterosexuals at high risk|heterosexuals at high risk
358589|NCT01607541|peer-driven intervention|peer-driven intervention
358590|NCT01607541|tailored intervention|tailored intervention
358591|NCT01607541|African-American|african-american
358592|NCT01607541|Latino/Hispanic|latino/hispanic
358593|NCT01607541|Seek, test, treat, and retain (STTR)|seek, test, treat, and retain (sttr)
358594|NCT01607515|Pulmonary hypertension|pulmonary hypertension
358595|NCT01607515|Cardiac index|cardiac index
358596|NCT01607515|impedance cardiography|impedance cardiography
358597|NCT01607502|Pulmonary hypertension|pulmonary hypertension
358598|NCT01607502|database|database
358599|NCT01607502|biomarker|biomarker
358600|NCT01607489|Early diagnosis of pulmonary arterial hypertension|early diagnosis of pulmonary arterial hypertension
358601|NCT01607489|dynamic dual-energy computed tomography|dynamic dual-energy computed tomography
358602|NCT01607463|pain|pain
358603|NCT01607463|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
358604|NCT01607450|Type 2 diabetes mellitus|type 2 diabetes mellitus
358605|NCT01607450|lean healthy control|lean healthy control
358606|NCT01607424|cognitive rehabilitation|cognitive rehabilitation
358607|NCT01607424|schizophrenia|schizophrenia
358608|NCT01607398|Japan|japan
358609|NCT01607398|COPD|copd
358610|NCT01607398|CAT|cat
358611|NCT01607398|placebo|placebo
358612|NCT01607398|serum|serum
358613|NCT01607398|Adoair250|adoair250
358614|NCT01607398|anti-inflammatory|anti-inflammatory
358615|NCT01607398|sputum|sputum
358616|NCT01607385|pharmacokinetic|pharmacokinetic
358617|NCT01607385|intestinal bile acid transporter inhibitor|intestinal bile acid transporter inhibitor
358618|NCT01607385|GSK2330672|gsk2330672
358619|NCT01607385|pharmacodynamic|pharmacodynamic
358620|NCT01607385|GSK1614235|gsk1614235
358621|NCT01607385|dose escalation|dose escalation
358622|NCT01607372|TLR7 agonist, Respiratory Allergies, Allergic Rhinitis, Mild Allergic Asthma, Repeat Dose Safety, Reduction of Allergic Reactivity|tlr7 agonist, respiratory allergies, allergic rhinitis, mild allergic asthma, repeat dose safety, reduction of allergic reactivity
358623|NCT01607359|atrial fibrillation|atrial fibrillation
358624|NCT01607359|catheter ablation|catheter ablation
358625|NCT01607359|dabigatran|dabigatran
358626|NCT01607359|warfarin|warfarin
358627|NCT01607359|oral anticoagulation|oral anticoagulation
358628|NCT01607346|Urinary Retention|urinary retention
358629|NCT01607333|Antiepileptics|antiepileptics
358630|NCT01607333|suicidality|suicidality
358631|NCT01607320|PCOS|pcos
358632|NCT01607320|Infertility|infertility
358633|NCT01607320|Anovulation|anovulation
358634|NCT01607307|daikenchuto|daikenchuto
358635|NCT01607307|postoperative ileus|postoperative ileus
358636|NCT01607307|pancreaticoduodenectomy|pancreaticoduodenectomy
358637|NCT01607281|anatomical landmark|anatomical landmark
358638|NCT01607281|internal jugular vein canulation|internal jugular vein canulation
358639|NCT01607268|autonomic failure|autonomic failure
358640|NCT01607268|mangenetic resonance|mangenetic resonance
358641|NCT01607268|neurochemistry|neurochemistry
358642|NCT01607268|neurotransmitter|neurotransmitter
358643|NCT01607268|glutamate|glutamate
358644|NCT01607255|adenoma detection|adenoma detection
358645|NCT01607255|screening colonoscopy|screening colonoscopy
358646|NCT01607255|water exchange method|water exchange method
358647|NCT01607255|chromoendoscopy|chromoendoscopy
358648|NCT01607242|total thyroidectomy|total thyroidectomy
358649|NCT01607242|voice handicap index|voice handicap index
358650|NCT01607242|swallowing disorders|swallowing disorders
358651|NCT01607242|thyroid surgery|thyroid surgery
358652|NCT01607242|voice disorders|voice disorders
358653|NCT01607229|multi-frequency|multi-frequency
358654|NCT01607229|bioelectrical impedance|bioelectrical impedance
358655|NCT01607229|body composition|body composition
358656|NCT01607229|hydration|hydration
358657|NCT01607216|Prematurity|prematurity
358658|NCT01607216|Respiratory Illness|respiratory illness
358659|NCT01607216|Lung Function|lung function
358660|NCT01607216|Lung Disease|lung disease
358661|NCT01607203|ovarian hyper stimulation syndrome (OHSS)|ovarian hyper stimulation syndrome (ohss)
358662|NCT01607203|metaphase II oocytes (MII)|metaphase ii oocytes (mii)
358663|NCT01607203|good quality embryo's|good quality embryo's
358664|NCT01607203|implantation|implantation
358665|NCT01607203|pregnancy|pregnancy
358666|NCT01607190|type 2 diabetes mellitus|type 2 diabetes mellitus
358667|NCT01607190|nonproliferative diabetic retinopathy|nonproliferative diabetic retinopathy
358668|NCT01607164|Mood management|mood management
358669|NCT01607164|self-help|self-help
358670|NCT01607164|depression|depression
358671|NCT01607164|prevention|prevention
358672|NCT01607164|cognitive behavioral|cognitive behavioral
358673|NCT01607151|hypothermia|hypothermia
358674|NCT01607151|normothermia|normothermia
358675|NCT01607151|hyperthermia|hyperthermia
358676|NCT01607138|laryngectomy|laryngectomy
358677|NCT01607138|swallowing disturbances|swallowing disturbances
358678|NCT01607138|speech disturbances|speech disturbances
358679|NCT01607138|speech intelligibility|speech intelligibility
358680|NCT01607138|voice prothesis|voice prothesis
358681|NCT01607112|Influenza|influenza
358682|NCT01607112|Healthy|healthy
358683|NCT01607112|Immunogenicity|immunogenicity
358684|NCT01607112|Elderly|elderly
358685|NCT01607112|Safety|safety
358686|NCT01607112|Adults|adults
358687|NCT01607099|colonoscopy|colonoscopy
358688|NCT01607099|bowel cleansing|bowel cleansing
358689|NCT01607099|bowel cleanness|bowel cleanness
358690|NCT01607099|efficiency|efficiency
358691|NCT01607099|compatibility|compatibility
358692|NCT01607086|Lamotrigine|lamotrigine
358693|NCT01607086|placebo|placebo
358694|NCT01607086|properties|properties
358695|NCT01607086|characteristics|characteristics
358696|NCT01607073|Dravet|dravet
358697|NCT01607073|seizures|seizures
358698|NCT01607073|verapamil|verapamil
358699|NCT01607060|Critically ill patients|critically ill patients
358700|NCT01607060|intestinal failure|intestinal failure
358701|NCT01607047|leptospirosis|leptospirosis
358702|NCT01607047|qPCR|qpcr
358703|NCT01607047|cohort|cohort
358704|NCT01607047|french west indies|french west indies
358705|NCT01607047|blood sample collection|blood sample collection
358706|NCT01607047|pronostic|pronostic
358707|NCT01607047|diagnosis|diagnosis
358708|NCT01607021|Chronic hepatitis C|chronic hepatitis c
358709|NCT01607021|interleukin 28|interleukin 28
358710|NCT01607021|Children|children
358711|NCT01606995|Stroke|stroke
358712|NCT01606995|Embolism|embolism
358713|NCT01606995|Atrial fibrillation|atrial fibrillation
358714|NCT01606982|prostate|prostate
358715|NCT01606982|MDV3100|mdv3100
358716|NCT01606982|cancer|cancer
358717|NCT01606969|Dexmedetomidine|dexmedetomidine
358718|NCT01606969|epinephrine|epinephrine
358719|NCT01606969|lidocaine|lidocaine
358720|NCT01606969|scalp infiltration|scalp infiltration
358721|NCT01606969|craniotomy|craniotomy
358722|NCT01606943|Aortic dissection|aortic dissection
358723|NCT01606943|Risk factor|risk factor
358724|NCT01606943|Feature|feature
358725|NCT01606943|Management|management
358726|NCT01606943|Outcome|outcome
358727|NCT01606930|Patient Satisfaction|patient satisfaction
358728|NCT01606930|Patient Doctor Communication|patient doctor communication
358729|NCT01606930|Shared Decision Making|shared decision making
358730|NCT01606930|Patient Activation|patient activation
358731|NCT01606891|preschooler obesity prevention|preschooler obesity prevention
358732|NCT01606891|community home visiting parents|community home visiting parents
358733|NCT01606891|preschooler excess BMI gain|preschooler excess bmi gain
358734|NCT01606891|multi-setting/component intervention|multi-setting/component intervention
358735|NCT01606852|sedation|sedation
358736|NCT01606852|mechanical ventilation|mechanical ventilation
358737|NCT01606852|anxiety|anxiety
358738|NCT01606852|respiratory failure|respiratory failure
358739|NCT01606826|Severe|severe
358740|NCT01606787|Kidney|kidney
358741|NCT01606787|MANNITOL|mannitol
358742|NCT01606787|PLACEBO|placebo
358743|NCT01606787|Partial Nephrectomy|partial nephrectomy
358744|NCT01606787|12-079|12-079
358745|NCT01606761|Arthritis, Rheumatoid|arthritis, rheumatoid
358746|NCT01606761|Active rheumatoid arthritis despite anti-TNF-alpha therapy|active rheumatoid arthritis despite anti-tnf-alpha therapy
358747|NCT01606761|Sirukumab|sirukumab
358748|NCT01606761|Human Anti-IL-6 monoclonal antibody|human anti-il-6 monoclonal antibody
358749|NCT01606748|Advanced Malignant Solid Tumors|advanced malignant solid tumors
358750|NCT01606748|Solid Cancers|solid cancers
358751|NCT01606748|Non-small Cell Lung Cancer|non-small cell lung cancer
358752|NCT01606748|NSCLC|nsclc
358753|NCT01606748|Breast Cancer|breast cancer
358754|NCT01606735|cataract surgery|cataract surgery
358755|NCT01606735|ocular inflammation|ocular inflammation
358756|NCT01606722|Antiretroviral therapy|antiretroviral therapy
358757|NCT01606722|Boosted-Darunavir monotherapy|boosted-darunavir monotherapy
358758|NCT01606722|Resistance|resistance
358759|NCT01606722|Proviral DNA-HIV|proviral dna-hiv
358760|NCT01606709|GnRHa trigger|gnrha trigger
358761|NCT01606709|endometrial gene profile|endometrial gene profile
358762|NCT01606709|quality of life|quality of life
358764|NCT01606696|cardiac rehabilitation|cardiac rehabilitation
358765|NCT01606696|fitness|fitness
359577|NCT01603095|dwarfism|dwarfism
358766|NCT01606683|Acidified milk|acidified milk
358767|NCT01606683|Beta-palmitate|beta-palmitate
358768|NCT01606683|Bifidobacteria|bifidobacteria
358769|NCT01606683|Breastfeeding|breastfeeding
358770|NCT01606683|Infant formula|infant formula
358771|NCT01606683|Galacto-oligosaccharides|galacto-oligosaccharides
358772|NCT01606683|Growth|growth
358773|NCT01606683|Infants|infants
358774|NCT01606683|Metabolomics|metabolomics
358775|NCT01606683|Prebiotics|prebiotics
358776|NCT01606670|Rotigotine|rotigotine
358777|NCT01606670|Neupro®|neupro®
358778|NCT01606657|I&D|i&d
358779|NCT01606657|Abscess|abscess
358780|NCT01606657|Irrigation|irrigation
358781|NCT01606657|Cutaneous Abscess|cutaneous abscess
358782|NCT01606644|radiation sequelae|radiation sequelae
358783|NCT01606644|hyperbaric oxygen|hyperbaric oxygen
358784|NCT01606631|severe sepsis|severe sepsis
358785|NCT01606631|toxic shock|toxic shock
358786|NCT01606618|Self-esteem|self-esteem
358787|NCT01606618|Spina Bifida|spina bifida
358788|NCT01606618|Spinal cord injury|spinal cord injury
358789|NCT01606605|Lymphoma|lymphoma
358790|NCT01606605|Prognosis|prognosis
358791|NCT01606605|Relapse|relapse
358792|NCT01606605|Gene|gene
358793|NCT01606605|microRNA|microrna
358794|NCT01606579|Leukemia|leukemia
358795|NCT01606579|acute myeloid leukemia|acute myeloid leukemia
358796|NCT01606579|AML|aml
358797|NCT01606579|chronic myeloid leukemia|chronic myeloid leukemia
358798|NCT01606579|CML|cml
358799|NCT01606579|MDS|mds
358800|NCT01606579|myelodysplastic syndrome|myelodysplastic syndrome
358801|NCT01606579|myeloproliferative neoplasia|myeloproliferative neoplasia
358802|NCT01606579|MPN|mpn
358803|NCT01606566|Recurrent|recurrent
358804|NCT01606566|Head and Neck|head and neck
358805|NCT01606566|Neoplasms|neoplasms
358806|NCT01606566|Squamous Cell Carcinoma|squamous cell carcinoma
358807|NCT01606566|Amphinex|amphinex
358808|NCT01606566|Cancer|cancer
358809|NCT01606566|Photodynamic therapy|photodynamic therapy
358810|NCT01606566|Chemotherapy|chemotherapy
358811|NCT01606566|Bleomycin|bleomycin
358812|NCT01606553|chronic heart failure|chronic heart failure
358813|NCT01606553|respiratory muscle weakness|respiratory muscle weakness
358814|NCT01606553|inspiratory muscle training|inspiratory muscle training
358815|NCT01606540|Colles fracture|colles fracture
358816|NCT01606540|Non-steroid antiinflammatory drugs|non-steroid antiinflammatory drugs
358817|NCT01606540|Bone healing|bone healing
358818|NCT01606527|Spectrum of Altitude-associated acute mountain sickness|spectrum of altitude-associated acute mountain sickness
358819|NCT01606527|hypoxia|hypoxia
358820|NCT01606527|high altitude headache|high altitude headache
358821|NCT01606527|high altitude cerebral edemat is.....|high altitude cerebral edemat is.....
358822|NCT01606488|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
358823|NCT01606488|Postoperative Cognitive Decline|postoperative cognitive decline
358824|NCT01606488|POCD|pocd
358825|NCT01606488|Alzheimer's disease|alzheimer's disease
358826|NCT01606488|Florbetapir F 18 (18F-AV-45)|florbetapir f 18 (18f-av-45)
358827|NCT01606475|Islet transplant|islet transplant
358828|NCT01606475|Diabetes Mellitus|diabetes mellitus
358829|NCT01606475|Hypoglycemia|hypoglycemia
358830|NCT01606462|oxytocin|oxytocin
358831|NCT01606462|social cognition|social cognition
358832|NCT01606462|fMRI|fmri
358833|NCT01606462|oxytocin receptor gene|oxytocin receptor gene
358834|NCT01606449|Gastroesophageal reflux diseases|gastroesophageal reflux diseases
358835|NCT01606449|Hiatal Hernia|hiatal hernia
358836|NCT01606449|Paraesophageal Hernia|paraesophageal hernia
358837|NCT01606358|Ovarian Cancer|ovarian cancer
358838|NCT01606358|Patient with ovarian cancer|patient with ovarian cancer
358839|NCT01606345|Upper Tract Urothelial Carcinoma|upper tract urothelial carcinoma
358840|NCT01606345|UTUC|utuc
358841|NCT01606345|Kidney|kidney
358842|NCT01606345|Cancer|cancer
358843|NCT01606345|Renal|renal
358844|NCT01606319|Asthma|asthma
358845|NCT01606319|Wheezing|wheezing
358846|NCT01606319|Ibuprofen|ibuprofen
358847|NCT01606319|Acetaminophen|acetaminophen
358848|NCT01606319|exacerbations|exacerbations
358849|NCT01606319|pain|pain
358850|NCT01606319|fever|fever
358851|NCT01606306|Asthma|asthma
358852|NCT01606306|Wheezing|wheezing
358853|NCT01606306|Fluticasone|fluticasone
358854|NCT01606306|Montelukast|montelukast
358855|NCT01606306|Preschool-age|preschool-age
358856|NCT01606293|Small cell carcinomas of the cervix|small cell carcinomas of the cervix
358857|NCT01606293|Large cell carcinomas of the cervix|large cell carcinomas of the cervix
358858|NCT01606293|Online surveys|online surveys
358859|NCT01606293|Electronic surveys|electronic surveys
358860|NCT01606293|Questionnaires|questionnaires
358861|NCT01606293|Facebook|facebook
358862|NCT01606293|Social networking support groups|social networking support groups
358863|NCT01606280|Amyloidosis|amyloidosis
358864|NCT01606267|Integrated Community Case Management|integrated community case management
358865|NCT01606267|Pneumonia|pneumonia
358866|NCT01606267|Ethiopia|ethiopia
358867|NCT01606254|Schizophrenia|schizophrenia
358868|NCT01606254|Paliperidone Palmitate|paliperidone palmitate
358870|NCT01606228|Schizophrenia|schizophrenia
358871|NCT01606228|Paliperidone ER|paliperidone er
358872|NCT01606228|Treatment naive patients|treatment naive patients
358873|NCT01606228|Newly diagnosed patients|newly diagnosed patients
358874|NCT01606215|multiple sclerosis|multiple sclerosis
358875|NCT01606215|mesenchymal stem cells|mesenchymal stem cells
358876|NCT01606215|bone marrow|bone marrow
358877|NCT01606215|rapidly evolving|rapidly evolving
358878|NCT01606150|neonate|neonate
358879|NCT01606150|late preterm|late preterm
358880|NCT01606150|lumbar puncture|lumbar puncture
358881|NCT01606150|analgesia|analgesia
358882|NCT01606150|pain|pain
358883|NCT01606150|lidocaine|lidocaine
358884|NCT01606098|Surgery|surgery
358885|NCT01606098|Chemotherapy|chemotherapy
358886|NCT01606085|Diabetes|diabetes
358887|NCT01606085|Heart Failure|heart failure
358888|NCT01606085|Quality of Life|quality of life
358889|NCT01606085|Self Care|self care
358890|NCT01606072|DDAVP|ddavp
358891|NCT01606033|stress|stress
358892|NCT01606033|Life quality|life quality
358893|NCT01606033|adjustment strategy|adjustment strategy
358894|NCT01606033|receiving an antitumor treatment|receiving an antitumor treatment
358895|NCT01606033|within a clinical trial (case)|within a clinical trial (case)
358896|NCT01606033|according to a standard treatment (control)|according to a standard treatment (control)
358897|NCT01606020|effects of sleep deprivation|effects of sleep deprivation
358898|NCT01606020|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
358899|NCT01606020|male, healthy volunteers|male, healthy volunteers
358900|NCT01605981|Nilotinib|nilotinib
358901|NCT01605981|CML patients|cml patients
358902|NCT01605981|accelerated phase|accelerated phase
358903|NCT01605968|Obstetrics|obstetrics
358904|NCT01605968|Gynecology|gynecology
358905|NCT01605968|Wound healing|wound healing
358906|NCT01605955|SPO2|spo2
358907|NCT01605929|Anesthetics, local/administration & dosage|anesthetics, local/administration & dosage
358908|NCT01605929|Brachial Plexus/ultrasonography|brachial plexus/ultrasonography
358909|NCT01605929|Humans|humans
358910|NCT01605929|Nerve Block/methods|nerve block/methods
358911|NCT01605929|Upper Extremity/surgery|upper extremity/surgery
358912|NCT01605929|Catheters, Indwelling|catheters, indwelling
358913|NCT01605929|Anesthesia, Conduction/methods|anesthesia, conduction/methods
358914|NCT01605929|Analgesia/methods|analgesia/methods
358915|NCT01605929|Nerve Block/adverse effects|nerve block/adverse effects
358916|NCT01605916|Cancer,|cancer,
358917|NCT01605916|Tumour,|tumour,
358918|NCT01605916|Metastatic,|metastatic,
358919|NCT01605916|Lung cancer,|lung cancer,
358920|NCT01605916|Non-Small Cell Lung Cancer|non-small cell lung cancer
358921|NCT01605903|Tonsillectomy|tonsillectomy
358922|NCT01605903|adenoidectomy|adenoidectomy
358923|NCT01605903|bleeding|bleeding
358924|NCT01605903|bleeding rates|bleeding rates
358925|NCT01605903|Tonsillectomy with and without adenoidectomy|tonsillectomy with and without adenoidectomy
358926|NCT01605890|HIV-2|hiv-2
358927|NCT01605877|Cataracts|cataracts
358928|NCT01605877|Intraocular lens|intraocular lens
358929|NCT01605877|Multifocal|multifocal
358930|NCT01605877|Presbyopia|presbyopia
358931|NCT01605864|pneumonia|pneumonia
358932|NCT01605864|community acquired bacterial pneumonia|community acquired bacterial pneumonia
358933|NCT01605864|CAP|cap
358934|NCT01605864|CABP|cabp
358935|NCT01605864|bacterial pneumonia|bacterial pneumonia
358936|NCT01605851|PFO|pfo
358937|NCT01605851|closure|closure
358938|NCT01605838|TBI|tbi
358939|NCT01605812|IOL;|iol;
358940|NCT01605812|capsule；|capsule；
358941|NCT01605812|PCO;|pco;
358942|NCT01605812|OCT|oct
358943|NCT01605799|PTSD|ptsd
358944|NCT01605799|Mental Health|mental health
358945|NCT01605799|War|war
358946|NCT01605799|Veterans|veterans
358947|NCT01605786|Malaria|malaria
358948|NCT01605786|Plasmodium falciparum|plasmodium falciparum
358949|NCT01605786|vaccine|vaccine
358950|NCT01605786|ADCI|adci
358951|NCT01605786|sporozoite challenge|sporozoite challenge
358952|NCT01605786|pre-erythrocytic|pre-erythrocytic
358953|NCT01605786|erythrocytic|erythrocytic
358954|NCT01605760|immunotherapy|immunotherapy
358955|NCT01605760|elderly|elderly
358956|NCT01605734|hepatocellular carcinoma|hepatocellular carcinoma
358957|NCT01605734|transarterial chemoembolization|transarterial chemoembolization
358958|NCT01605734|sorafenib|sorafenib
358959|NCT01605721|Everolimus|everolimus
358960|NCT01605721|XIENCE PRIME|xience prime
358961|NCT01605721|Drug eluting stent|drug eluting stent
358962|NCT01605708|Itching|itching
358963|NCT01605695|reference range|reference range
358964|NCT01605695|plasma|plasma
358965|NCT01605695|inducible nitric oxide synthase|inducible nitric oxide synthase
358966|NCT01605695|iNOS|inos
358967|NCT01605695|healthy adults|healthy adults
358968|NCT01605682|effect of different berry doses on mood and cognition|effect of different berry doses on mood and cognition
358969|NCT01605682|adults|adults
358970|NCT01605669|Auscultation|auscultation
358971|NCT01605669|Aortic stenosis|aortic stenosis
358972|NCT01605669|computer assisted auscultation|computer assisted auscultation
358973|NCT01605669|Aortic Stenosis Acceleration Index|aortic stenosis acceleration index
358974|NCT01605656|Cancer Prevention|cancer prevention
358975|NCT01605656|Cervix|cervix
358976|NCT01605656|Questionnaires|questionnaires
358977|NCT01605656|Focus groups|focus groups
358978|NCT01605656|Surveys|surveys
358979|NCT01605656|Interviews|interviews
358980|NCT01605643|cancer|cancer
358981|NCT01605643|tobacco use|tobacco use
358982|NCT01605643|pregnancy|pregnancy
358983|NCT01605604|mindfulness EQ adolescents|mindfulness eq adolescents
358984|NCT01605591|left-side double lumen bronchial tube|left-side double lumen bronchial tube
358985|NCT01605591|bending type|bending type
358986|NCT01605591|GlideScope videolaryngoscope|glidescope videolaryngoscope
358987|NCT01605552|Depression|depression
358988|NCT01605552|Depressive Symptoms|depressive symptoms
358989|NCT01605552|Cardiovascular Disease (CVD)|cardiovascular disease (cvd)
358990|NCT01605552|Coronary Artery Disease (CAD)|coronary artery disease (cad)
358991|NCT01605552|Heart Disease|heart disease
358992|NCT01605513|recombinant interferon, tolerated, effective|recombinant interferon, tolerated, effective
358993|NCT01605500|ICD|icd
358994|NCT01605474|foley catheter|foley catheter
358995|NCT01605474|foley bulb|foley bulb
358996|NCT01605474|induction of labor|induction of labor
358997|NCT01605474|labor|labor
358998|NCT01605448|Mild Cognitive Impairment|mild cognitive impairment
358999|NCT01605448|Alzheimer's disease|alzheimer's disease
359000|NCT01605448|Meditation|meditation
359001|NCT01605448|Default Mode Network|default mode network
359002|NCT01605422|Systematic review and meta-analysis|systematic review and meta-analysis
359003|NCT01605422|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
359004|NCT01605422|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
359005|NCT01605422|Clinical practice guidelines|clinical practice guidelines
359006|NCT01605422|Clinical trials|clinical trials
359007|NCT01605422|Dietary pulses|dietary pulses
359008|NCT01605422|legumes|legumes
359009|NCT01605422|Beans, peas, chickpeas, lentils|beans, peas, chickpeas, lentils
359010|NCT01605422|glycemic index|glycemic index
359011|NCT01605422|postprandial glycemia|postprandial glycemia
359012|NCT01605422|insulin resistance|insulin resistance
359013|NCT01605422|body weight|body weight
359014|NCT01605422|appetite|appetite
359015|NCT01605422|food intake regulation|food intake regulation
359016|NCT01605422|satiety|satiety
359017|NCT01605422|satiation|satiation
359018|NCT01605409|Refractory cardiac arrest|refractory cardiac arrest
359019|NCT01605409|Emergency cardiopulmonary bypass|emergency cardiopulmonary bypass
359020|NCT01605409|Extracorporeal life support in cardiac arrest|extracorporeal life support in cardiac arrest
359021|NCT01605383|Avascular Necrosis of Femur Head|avascular necrosis of femur head
359022|NCT01605383|Osteonecrosis of the hip|osteonecrosis of the hip
359023|NCT01605383|Osteonecrosis of the femoral head|osteonecrosis of the femoral head
359024|NCT01605383|Mesenchymal Stem Cells|mesenchymal stem cells
359025|NCT01605383|Bone marrow|bone marrow
359026|NCT01605383|Tissue engineering|tissue engineering
359027|NCT01605383|Bone Diseases|bone diseases
359028|NCT01605383|Musculoskeletal Diseases|musculoskeletal diseases
359029|NCT01605370|Hypertension, Left Ventricular Mass|hypertension, left ventricular mass
359030|NCT01605357|Brain Injuries|brain injuries
359031|NCT01605357|Hematoma, subdural|hematoma, subdural
359032|NCT01605357|Decompressive Craniectomy|decompressive craniectomy
359033|NCT01605357|Saline solution, hypertonic|saline solution, hypertonic
359034|NCT01605357|Hypernatremia|hypernatremia
359035|NCT01605357|Intracranial hemorrhages|intracranial hemorrhages
359036|NCT01605357|Head Injuries, closed|head injuries, closed
359037|NCT01605357|Intracranial pressure|intracranial pressure
359038|NCT01605357|Brain edema|brain edema
359039|NCT01605357|Critical care|critical care
359040|NCT01605357|Brain Diseases|brain diseases
359041|NCT01605357|Central Nervous System Diseases|central nervous system diseases
359042|NCT01605357|Nervous System Diseases|nervous system diseases
359043|NCT01605357|Wounds and Injuries|wounds and injuries
359044|NCT01605357|Physiological Effects of Drugs|physiological effects of drugs
359045|NCT01605357|Pharmacologic Actions|pharmacologic actions
359046|NCT01605344|Advanced colon cancer|advanced colon cancer
359047|NCT01605344|Advanced rectal cancer|advanced rectal cancer
359048|NCT01605344|Metastatic colon cancer|metastatic colon cancer
359049|NCT01605344|Metastatic rectal cancer|metastatic rectal cancer
359050|NCT01605344|Lipitor|lipitor
359051|NCT01605344|Atorvastatin|atorvastatin
359052|NCT01605344|FOLFIRI|folfiri
359053|NCT01605331|Adults|adults
359054|NCT01605331|GH deficiency|gh deficiency
359055|NCT01605318|metastatic colorectal cancer|metastatic colorectal cancer
359056|NCT01605318|colon cancer|colon cancer
359057|NCT01605318|rectal cancer|rectal cancer
359058|NCT01605318|previously treated|previously treated
359059|NCT01605292|Transradial catheterization|transradial catheterization
359060|NCT01605292|Ultrasound|ultrasound
359061|NCT01605292|Radial artery|radial artery
359062|NCT01605279|Low superior vena cava flow|low superior vena cava flow
359063|NCT01605279|Functional echocardiography|functional echocardiography
359064|NCT01605266|pediatric|pediatric
359065|NCT01605266|kidney disease|kidney disease
359066|NCT01605266|minimal change disease|minimal change disease
359067|NCT01605266|focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
359068|NCT01605266|nephrotic syndrome|nephrotic syndrome
359069|NCT01605253|Post-traumatic stress disorder|post-traumatic stress disorder
359070|NCT01605253|sleep disturbance|sleep disturbance
359071|NCT01605253|insomnia|insomnia
359072|NCT01605253|cytokines|cytokines
359073|NCT01605253|anxiety|anxiety
359074|NCT01605253|traumatic event|traumatic event
359075|NCT01605253|memory|memory
359076|NCT01605240|Fracture pain|fracture pain
359077|NCT01605240|Fracture reduction|fracture reduction
359078|NCT01605240|Analgesia|analgesia
359079|NCT01605240|Acetaminophen|acetaminophen
359080|NCT01605240|Ibuprofen|ibuprofen
359081|NCT01605240|Codeine|codeine
359082|NCT01605240|Pediatric|pediatric
359083|NCT01605240|Fracture Pain Analgesia in Pediatric population|fracture pain analgesia in pediatric population
359084|NCT01605227|prostate cancer|prostate cancer
359085|NCT01605227|castration resistant prostate cancer|castration resistant prostate cancer
359086|NCT01605227|bone pain|bone pain
359087|NCT01605227|CRPC|crpc
359088|NCT01605214|Extravascular Lung Water|extravascular lung water
359089|NCT01605214|Transpulmonary Thermodilution|transpulmonary thermodilution
359090|NCT01605214|Primary Graft Dysfunction|primary graft dysfunction
359091|NCT01605214|Ischemia Reperfusion Injury|ischemia reperfusion injury
359092|NCT01605201|Chondral lesions in the knee after traumatic injury|chondral lesions in the knee after traumatic injury
359093|NCT01605175|Inflammatory Bowel Disease|inflammatory bowel disease
359094|NCT01605175|Predictors Mucosal Healing|predictors mucosal healing
359095|NCT01605149|Diabetes|diabetes
359096|NCT01605136|Erythropoietic Protoporphyria|erythropoietic protoporphyria
359097|NCT01605136|EPP|epp
359098|NCT01605136|Afamelanotide|afamelanotide
359099|NCT01605123|endothelial function|endothelial function
359100|NCT01605123|children|children
359101|NCT01605123|obesity|obesity
359102|NCT01605123|cardiovascular dysfunction|cardiovascular dysfunction
359103|NCT01605123|carotid intima media thickness|carotid intima media thickness
359104|NCT01605123|blood pressure|blood pressure
359105|NCT01605123|oral glucose tolerance test|oral glucose tolerance test
359106|NCT01605110|blepharoplasty|blepharoplasty
359107|NCT01605110|hyperbaric|hyperbaric
359108|NCT01605110|oxygen|oxygen
359109|NCT01605110|ecchymosis|ecchymosis
359110|NCT01605110|edema|edema
359111|NCT01605110|wound|wound
359112|NCT01605110|healing|healing
359113|NCT01605097|prostate neoplasms|prostate neoplasms
359114|NCT01605097|interstitial radiation|interstitial radiation
359115|NCT01605097|High dose rate prostate brachytherapy|high dose rate prostate brachytherapy
359116|NCT01605097|dose escalation|dose escalation
359117|NCT01605071|menopause|menopause
359118|NCT01605071|estrogen|estrogen
359119|NCT01605071|insulin sensitivity|insulin sensitivity
359120|NCT01605071|estrogen receptors|estrogen receptors
359121|NCT01605045|Cardiac catheterization|cardiac catheterization
359122|NCT01605045|Radiation|radiation
359123|NCT01605019|Ventricular Assist Devices|ventricular assist devices
359124|NCT01605019|Heart assist pumps|heart assist pumps
359125|NCT01605019|heart pumps|heart pumps
359126|NCT01605019|sealant agents|sealant agents
359127|NCT01605006|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
359128|NCT01605006|ALS|als
359129|NCT01605006|motor neuron disease|motor neuron disease
359130|NCT01605006|diaphragm|diaphragm
359131|NCT01605006|diaphragm pacing|diaphragm pacing
359132|NCT01605006|diaphragmatic pacing|diaphragmatic pacing
359133|NCT01605006|phrenic pacing|phrenic pacing
359134|NCT01605006|phrenic nerve|phrenic nerve
359135|NCT01605006|phrenic nerve stimulation|phrenic nerve stimulation
359136|NCT01605006|NeuRx DPS|neurx dps
359137|NCT01605006|DPS|dps
359138|NCT01605006|chronic hypoventilation|chronic hypoventilation
359139|NCT01605006|respiration|respiration
359140|NCT01605006|ventilation|ventilation
359141|NCT01605006|breathing|breathing
359142|NCT01605006|Humanitarian Device Exemption|humanitarian device exemption
359143|NCT01605006|HDE|hde
359144|NCT01605006|post-approval study|post-approval study
359145|NCT01604993|Dietary Nitrates|dietary nitrates
359146|NCT01604993|Arterial Stiffness|arterial stiffness
359147|NCT01604993|Vascular|vascular
359148|NCT01604993|Blood pressure|blood pressure
359149|NCT01604954|Food labeling|food labeling
359150|NCT01604928|Overactive Bladder|overactive bladder
359151|NCT01604928|YM178|ym178
359152|NCT01604928|Mirabegron|mirabegron
359153|NCT01604928|Frequency|frequency
359154|NCT01604928|Urinary urge incontinence|urinary urge incontinence
359155|NCT01604928|Urgency|urgency
359156|NCT01604928|Urinary incontinence|urinary incontinence
359157|NCT01604928|Micturition|micturition
359158|NCT01604902|Psoriasis mRNA and miRNA|psoriasis mrna and mirna
359159|NCT01604889|Melanoma, Skin Cancer, Oncology|melanoma, skin cancer, oncology
359160|NCT01604876|Parkinson's disease|parkinson's disease
359161|NCT01604876|depression|depression
359162|NCT01604876|light therapy|light therapy
359163|NCT01604876|sleeping problems|sleeping problems
359164|NCT01604863|Solid Tumors|solid tumors
359165|NCT01604863|Cancer|cancer
359166|NCT01604863|Lung Cancer|lung cancer
359985|NCT01601223|LAS VEGAS|las vegas
359167|NCT01604863|Prostate Cancer|prostate cancer
359168|NCT01604863|Mesothelioma|mesothelioma
359169|NCT01604863|Small Cell lung Cancer|small cell lung cancer
359170|NCT01604850|HCV genotype 2 (GT-2)|hcv genotype 2 (gt-2)
359171|NCT01604850|HCV genotype 3 (GT-3)|hcv genotype 3 (gt-3)
359172|NCT01604850|HCV|hcv
359173|NCT01604850|Sustained Virologic Response|sustained virologic response
359174|NCT01604850|Direct Acting Antiviral|direct acting antiviral
359175|NCT01604850|Combination Therapy|combination therapy
359176|NCT01604850|Treatment Experienced|treatment experienced
359177|NCT01604850|GS-7977|gs-7977
359178|NCT01604850|Ribavirin|ribavirin
359179|NCT01604837|superior hypogastric plexus block|superior hypogastric plexus block
359180|NCT01604837|pelvic malignancy|pelvic malignancy
359181|NCT01604837|chronic pelvic pain|chronic pelvic pain
359182|NCT01604798|proteomics|proteomics
359183|NCT01604798|serum peptides|serum peptides
359184|NCT01604798|colorectal cancer|colorectal cancer
359185|NCT01604798|MALDI-TOF MS|maldi-tof ms
359186|NCT01604785|Migraine Headache|migraine headache
359187|NCT01604785|Pediatric|pediatric
359188|NCT01604759|Mouth Neoplasms|mouth neoplasms
359189|NCT01604759|Mouth Diseases|mouth diseases
359190|NCT01604733|Multi-Center Survey|multi-center survey
359191|NCT01604733|patients currently on lipid-lowering pharmacological treatment|patients currently on lipid-lowering pharmacological treatment
359192|NCT01604733|level of Control of Hypercholesterolemia in Egypt|level of control of hypercholesterolemia in egypt
359193|NCT01604720|sample size|sample size
359194|NCT01604720|liver disease|liver disease
359195|NCT01604707|stress|stress
359196|NCT01604707|anxiety|anxiety
359197|NCT01604707|depression|depression
359198|NCT01604707|quality of life|quality of life
359199|NCT01604694|Abdominoplasty|abdominoplasty
359200|NCT01604694|Transversus Abdominis Plane (TAP) Block|transversus abdominis plane (tap) block
359201|NCT01604694|levobupivacaine|levobupivacaine
359202|NCT01604694|Placebo|placebo
359203|NCT01604681|Linseed Oil|linseed oil
359204|NCT01604681|Oxidative Stress|oxidative stress
359205|NCT01604681|Polymorphism, Genetic|polymorphism, genetic
359206|NCT01604681|Cardiovascular Diseases|cardiovascular diseases
359207|NCT01604655|Chest pain|chest pain
359208|NCT01604655|shortness of breath|shortness of breath
359209|NCT01604655|suspected acute coronary syndrome|suspected acute coronary syndrome
359210|NCT01604655|stress testing|stress testing
359211|NCT01604655|coronary computed tomography angiography|coronary computed tomography angiography
359212|NCT01604629|Spondylarthropathies|spondylarthropathies
359213|NCT01604629|Persistent clinical remission with anti-TNF therapy|persistent clinical remission with anti-tnf therapy
359214|NCT01604629|Standardized protocol for dose reduction anti-TNF therapy|standardized protocol for dose reduction anti-tnf therapy
359215|NCT01604590|Glioblastoma|glioblastoma
359216|NCT01604590|Imaging Biomarkers|imaging biomarkers
359217|NCT01604590|Bevacizumab|bevacizumab
359218|NCT01604590|MRI|mri
359219|NCT01604577|health literacy|health literacy
359220|NCT01604577|health numeracy|health numeracy
359221|NCT01604564|Registry|registry
359222|NCT01604564|Colitis Ulcerosa (CU)|colitis ulcerosa (cu)
359223|NCT01604564|Familial Adenomatous Polyposis(FAP)|familial adenomatous polyposis(fap)
359224|NCT01604564|IPAA|ipaa
359225|NCT01604512|Brain tumor|brain tumor
359226|NCT01604512|MRI Perfusion|mri perfusion
359227|NCT01604512|FDG PET/CT|fdg pet/ct
359228|NCT01604512|12-067|12-067
359229|NCT01604499|Healthy eating|healthy eating
359230|NCT01604499|Incentives|incentives
359231|NCT01604499|Feedback|feedback
359232|NCT01604486|Myocardial infarction|myocardial infarction
359233|NCT01604486|Ischaemic preconditioning|ischaemic preconditioning
359234|NCT01604486|Myocardial Ischaemia National Audit Project|myocardial ischaemia national audit project
359235|NCT01604486|General Practice Research Database|general practice research database
359236|NCT01604486|Hospital Episode Statistics|hospital episode statistics
359237|NCT01604486|Office for National Statistics|office for national statistics
359238|NCT01604473|Chronic Kidney Disease|chronic kidney disease
359239|NCT01604473|CKD|ckd
359240|NCT01604473|ESRD|esrd
359241|NCT01604473|AV Fistula|av fistula
359242|NCT01604473|Arterio-venous fistula|arterio-venous fistula
359243|NCT01604473|hemodialysis|hemodialysis
359244|NCT01604460|Hypothermia|hypothermia
359245|NCT01604460|Newborn|newborn
359246|NCT01604460|Plastic bag|plastic bag
359247|NCT01604460|Resuscitation|resuscitation
359248|NCT01604447|Hypothermia|hypothermia
359249|NCT01604447|Newborn|newborn
359250|NCT01604447|Incubator|incubator
359251|NCT01604447|Plastic bag|plastic bag
359252|NCT01604447|Normothermia|normothermia
359253|NCT01604434|Hypothermia|hypothermia
359254|NCT01604434|Low birth Weight|low birth weight
359255|NCT01604434|Newborn|newborn
359256|NCT01604434|Incubator|incubator
359257|NCT01604434|Plastic bag|plastic bag
359258|NCT01604421|Hypothermia|hypothermia
359259|NCT01604421|Low birth weight|low birth weight
359260|NCT01604421|Newborn|newborn
359261|NCT01604421|Plastic bag|plastic bag
359262|NCT01604421|Thermoregulation|thermoregulation
359263|NCT01604395|GHD|ghd
359264|NCT01604395|TS|ts
359265|NCT01604395|CRF|crf
359266|NCT01604395|SGA|sga
359267|NCT01604395|ISS|iss
359268|NCT01604382|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
359269|NCT01604369|Atrial flutter|atrial flutter
359270|NCT01604369|Cryoablation|cryoablation
359271|NCT01604369|Cavotricuspid isthmus|cavotricuspid isthmus
359272|NCT01604369|Visual analogue scale|visual analogue scale
359273|NCT01604356|retinitis pigmentosa|retinitis pigmentosa
359274|NCT01604343|Active rheumatoid arthritis despite disease-modifying antirheumatic drug therapy|active rheumatoid arthritis despite disease-modifying antirheumatic drug therapy
359275|NCT01604343|Sirukumab|sirukumab
359276|NCT01604343|Human Anti-IL-6 monoclonal antibody|human anti-il-6 monoclonal antibody
359277|NCT01604330|High dose baclofen|high dose baclofen
359278|NCT01604330|Alcoholism|alcoholism
359279|NCT01604330|Abstinence|abstinence
359280|NCT01604330|Low risk consumption|low risk consumption
359281|NCT01604330|Craving|craving
359282|NCT01604317|Hypothermia|hypothermia
359283|NCT01604317|Low birth Weight|low birth weight
359284|NCT01604317|Newborn|newborn
359285|NCT01604317|Resuscitation|resuscitation
359286|NCT01604317|Plastic bag|plastic bag
359287|NCT01604304|stone|stone
359288|NCT01604304|calculi|calculi
359289|NCT01604304|kidney|kidney
359290|NCT01604304|renal treatment|renal treatment
359291|NCT01604304|flexible ureteroscopy|flexible ureteroscopy
359292|NCT01604304|extracoporeal shockwave lithotripsy|extracoporeal shockwave lithotripsy
359293|NCT01604304|retrograde intra renal surgery|retrograde intra renal surgery
359294|NCT01604278|Indacaterol|indacaterol
359295|NCT01604278|Glycopyrronium Bromide|glycopyrronium bromide
359296|NCT01604278|COPD|copd
359297|NCT01604278|bronchodilation|bronchodilation
359298|NCT01604239|Osteoarthritis|osteoarthritis
359299|NCT01604239|Shinbaro|shinbaro
359300|NCT01604239|Herbal drug|herbal drug
359301|NCT01604226|total intravenous anesthesia|total intravenous anesthesia
359302|NCT01604226|Bispectral index monitoring|bispectral index monitoring
359303|NCT01604226|propofol|propofol
359304|NCT01604226|remifentanil|remifentanil
359305|NCT01604213|Type 2 diabetes mellitus|type 2 diabetes mellitus
359306|NCT01604213|vildagliptin|vildagliptin
359307|NCT01604213|metformin|metformin
359308|NCT01604213|atherosclerosis|atherosclerosis
359309|NCT01604213|inflammation|inflammation
359310|NCT01604213|interleukin-6|interleukin-6
359311|NCT01604213|TNF|tnf
359312|NCT01604213|atherothrombosis|atherothrombosis
359313|NCT01604213|adiponectin|adiponectin
359314|NCT01604213|MMP-9|mmp-9
359315|NCT01604213|hs-CRP|hs-crp
359316|NCT01604200|hypertension|hypertension
359317|NCT01604200|dentistry|dentistry
359318|NCT01604200|blood pressure|blood pressure
359319|NCT01604200|measurement|measurement
359320|NCT01604200|screening|screening
359321|NCT01604200|qualitative research|qualitative research
359322|NCT01604187|sublingual fentanyl|sublingual fentanyl
359323|NCT01604187|pain in coloscopy|pain in coloscopy
359324|NCT01604187|The efficacy and safety of fentanyl transmucosal tablet to placebo in patients having colonoscopy.|the efficacy and safety of fentanyl transmucosal tablet to placebo in patients having colonoscopy.
359325|NCT01604174|knee|knee
359326|NCT01604174|osteoarthritis|osteoarthritis
359327|NCT01604174|arthroplasty|arthroplasty
359328|NCT01604174|rehabilitation|rehabilitation
359329|NCT01604148|Holmium Laser Enucleation of Prostate|holmium laser enucleation of prostate
359330|NCT01604135|Collagen crosslinking|collagen crosslinking
359331|NCT01604135|Keratoconus|keratoconus
359332|NCT01604122|Survey|survey
359333|NCT01604122|burden of illness|burden of illness
359334|NCT01604122|caregivers|caregivers
359335|NCT01604122|TTR-FAP|ttr-fap
359336|NCT01604122|TTR-CM|ttr-cm
359337|NCT01604122|familial amyloid polyneuropathy|familial amyloid polyneuropathy
359338|NCT01604122|observational|observational
359339|NCT01604122|transthyretin familial amyloidosis|transthyretin familial amyloidosis
359340|NCT01604109|Caries detection/diagnosis/prevention|caries detection/diagnosis/prevention
359341|NCT01604109|Preventive Dentistry|preventive dentistry
359342|NCT01604109|Casien Phosphopeptide|casien phosphopeptide
359343|NCT01604109|Remineralization|remineralization
359344|NCT01604109|Clinical trial|clinical trial
359345|NCT01604096|Information|information
359346|NCT01604096|campaign|campaign
359347|NCT01604096|antibiotics|antibiotics
359348|NCT01604096|bacterial resistance|bacterial resistance
359349|NCT01604096|primary care|primary care
359350|NCT01604083|transfusion|transfusion
359351|NCT01604083|packed red blood cells (PRBC)|packed red blood cells (prbc)
359352|NCT01604083|Transfusion Practice|transfusion practice
359353|NCT01604083|Transfusion habits|transfusion habits
359354|NCT01604083|Outcome|outcome
359355|NCT01604083|elective surgery|elective surgery
359356|NCT01604083|ETPOS|etpos
359357|NCT01604083|ESA|esa
359358|NCT01604083|European Society of Anaesthesiology|european society of anaesthesiology
359359|NCT01604070|Hammertoe deformity|hammertoe deformity
359360|NCT01604070|podiatry|podiatry
359361|NCT01604031|B-CLL|b-cll
359362|NCT01604031|vaccine|vaccine
359363|NCT01604031|Lenalidomide|lenalidomide
359364|NCT01604031|CTL|ctl
359365|NCT01604018|Cat Allergy|cat allergy
359366|NCT01604018|Rhinoconjunctivitis|rhinoconjunctivitis
359367|NCT01604005|Mesothelioma|mesothelioma
359368|NCT01604005|radiotherapy|radiotherapy
359369|NCT01604005|prophylactic irradiation of tracts|prophylactic irradiation of tracts
359370|NCT01603992|Cannabis|cannabis
359371|NCT01603992|Craving|craving
359372|NCT01603992|Questionnaire|questionnaire
359373|NCT01603992|Non-Treatment|non-treatment
359374|NCT01603992|Drug Use|drug use
359375|NCT01603979|AV203|av203
359376|NCT01603979|Solid Tumors|solid tumors
359377|NCT01603979|ERBB3|erbb3
359378|NCT01603979|Monoclonal Antibody|monoclonal antibody
359379|NCT01603979|HER3|her3
359380|NCT01603966|platelet|platelet
359381|NCT01603966|aggregation|aggregation
359382|NCT01603966|aspirin|aspirin
359383|NCT01603966|inhibition|inhibition
359384|NCT01603966|reactivity|reactivity
359385|NCT01603940|Hypertension|hypertension
359386|NCT01603940|Diabetes Mellitus|diabetes mellitus
359387|NCT01603940|Vascular stiffness|vascular stiffness
359388|NCT01603940|Endothelial function|endothelial function
359389|NCT01603914|burns, catheter related bacteremia,|burns, catheter related bacteremia,
359390|NCT01603914|infection, central venous catheter,|infection, central venous catheter,
359391|NCT01603914|catheter-related bloodstream, adult critically ill patients|catheter-related bloodstream, adult critically ill patients
359392|NCT01603888|children with heart disease|children with heart disease
359393|NCT01603888|infants|infants
359394|NCT01603888|healthy newborns|healthy newborns
359395|NCT01603875|CPRV|cprv
359396|NCT01603875|SPEEDA|speeda
359397|NCT01603875|intradermal|intradermal
359398|NCT01603875|pre-exposure|pre-exposure
359399|NCT01603875|booster|booster
359400|NCT01603849|Prophylactic Cranial Irradiation|prophylactic cranial irradiation
359401|NCT01603849|Lung Cancer|lung cancer
359402|NCT01603849|Non Small Cell Lung Cancer|non small cell lung cancer
359403|NCT01603849|Carcinoembryonic Antigen|carcinoembryonic antigen
359404|NCT01603836|Lumbar spine|lumbar spine
359405|NCT01603836|Posterolateral fusion|posterolateral fusion
359406|NCT01603836|Allograft|allograft
359407|NCT01603836|Bone marrow concentrate|bone marrow concentrate
359408|NCT01603836|Mesenchymal stem cells|mesenchymal stem cells
359409|NCT01603836|Fusion rate|fusion rate
359410|NCT01603784|exercise|exercise
359411|NCT01603784|cognition|cognition
359412|NCT01603784|memory|memory
359413|NCT01603784|adult|adult
359414|NCT01603771|Adult|adult
359415|NCT01603771|Exercise|exercise
359416|NCT01603771|Cognition|cognition
359417|NCT01603771|MRI|mri
359418|NCT01603758|Cholesterol|cholesterol
359419|NCT01603758|Spectrometry, mass|spectrometry, mass
359420|NCT01603758|Deuterium|deuterium
359421|NCT01603758|Kinetics|kinetics
359422|NCT01603758|Cholesterol absorption|cholesterol absorption
359423|NCT01603758|Coronary Heart Disease|coronary heart disease
359424|NCT01603732|Strep exposure and heart defects|strep exposure and heart defects
359425|NCT01603719|infant formula|infant formula
359426|NCT01603719|prebiotics|prebiotics
359427|NCT01603719|beta-palmitate|beta-palmitate
359428|NCT01603719|stool flora|stool flora
359429|NCT01603719|bifidogenic|bifidogenic
359430|NCT01603563|Stepped Care|stepped care
359431|NCT01603563|Trauma-Focused Cognitive Behavioral Therapy|trauma-focused cognitive behavioral therapy
359432|NCT01603563|Preschool children|preschool children
359433|NCT01603550|energy restriction|energy restriction
359434|NCT01603550|sleep deprivation|sleep deprivation
359435|NCT01603550|cognitive performance|cognitive performance
359436|NCT01603550|brain function|brain function
359437|NCT01603537|Traumatic injuries|traumatic injuries
359438|NCT01603537|Prehospital Trauma Life Support|prehospital trauma life support
359439|NCT01603537|Traffic accidents|traffic accidents
359440|NCT01603524|Ottawa Model for Smoking Cessation|ottawa model for smoking cessation
359441|NCT01603524|Primary Care|primary care
359442|NCT01603511|rewarming|rewarming
359443|NCT01603511|core cooling|core cooling
359444|NCT01603511|afterdrop|afterdrop
359445|NCT01603511|pre-hospital treatment|pre-hospital treatment
359446|NCT01603511|hypothermia|hypothermia
359447|NCT01603498|pain measurement,|pain measurement,
359448|NCT01603498|edema,|edema,
359449|NCT01603498|trismus|trismus
359450|NCT01603407|prednisone|prednisone
359451|NCT01603407|deflazacort|deflazacort
359452|NCT01603407|muscular dystrophy|muscular dystrophy
359453|NCT01603407|neuromuscular disease|neuromuscular disease
359454|NCT01603407|multi-center|multi-center
359455|NCT01603823|vitrectomy|vitrectomy
359456|NCT01603823|cataract|cataract
359457|NCT01603823|macular edema|macular edema
359458|NCT01603810|Basal cell carcinoma|basal cell carcinoma
359459|NCT01603810|Optical Coherence Tomography|optical coherence tomography
359460|NCT01603797|internetdelivered CBT|internetdelivered cbt
359461|NCT01603797|chronic pain|chronic pain
359462|NCT01603797|acceptance and commitment therapy|acceptance and commitment therapy
359463|NCT01603797|mindfulness|mindfulness
359464|NCT01603797|guided self help|guided self help
359465|NCT01603745|PCOS|pcos
359466|NCT01603706|Heart failure|heart failure
359467|NCT01603706|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
359468|NCT01603706|CRT|crt
359469|NCT01603706|Radial strain echocardiography|radial strain echocardiography
359470|NCT01603706|Ischemic cardiomyopathy|ischemic cardiomyopathy
359471|NCT01603693|Guided bone regeneration|guided bone regeneration
359472|NCT01603693|Bio Oss|bio oss
359473|NCT01603693|BondBone|bondbone
359474|NCT01603693|computerized tomography|computerized tomography
359475|NCT01603693|histological examination|histological examination
359476|NCT01603680|Ultrasonography|ultrasonography
359477|NCT01603680|Block nerve|block nerve
359478|NCT01603680|Anaesthesia|anaesthesia
359479|NCT01603680|Carpal tunnel syndrome|carpal tunnel syndrome
359480|NCT01603654|Colon preparation|colon preparation
359481|NCT01603654|Colonoscopy|colonoscopy
359482|NCT01603654|Polyethylene glycol|polyethylene glycol
359483|NCT01603654|Sodium Picosulphate|sodium picosulphate
359484|NCT01603589|coronary artery disease|coronary artery disease
359485|NCT01603589|coronary artery bypass grafting|coronary artery bypass grafting
359486|NCT01603589|cardiopulmonary bypass|cardiopulmonary bypass
359487|NCT01603589|minimal extracorporeal circulation|minimal extracorporeal circulation
359488|NCT01603485|Bioavailability|bioavailability
359489|NCT01603485|Pharmacokinetics|pharmacokinetics
359490|NCT01603485|Lersivirine|lersivirine
359491|NCT01603485|Modified-release|modified-release
359492|NCT01603472|pediatric|pediatric
359493|NCT01603472|parenteral nutrition|parenteral nutrition
359494|NCT01603472|bone disease|bone disease
359495|NCT01603472|long-term PN|long-term pn
359496|NCT01603446|pediatric|pediatric
359497|NCT01603446|MELAS|melas
359498|NCT01603446|mechanism of action of L-arginine|mechanism of action of l-arginine
359499|NCT01603420|prostate|prostate
359500|NCT01603420|cancer|cancer
359501|NCT01603420|radiation|radiation
359502|NCT01603420|proton|proton
359503|NCT01603420|chemotherapy|chemotherapy
359504|NCT01603420|high risk|high risk
359505|NCT01603368|Probiotics|probiotics
359506|NCT01603368|Lactobacillus reuteri|lactobacillus reuteri
359507|NCT01603368|Prematures|prematures
359508|NCT01603368|Enteral feeding|enteral feeding
359509|NCT01603368|Motility|motility
359510|NCT01603368|Necrotizing enterocolitis|necrotizing enterocolitis
359511|NCT01603368|Sepsis|sepsis
359512|NCT01603368|Weight|weight
359513|NCT01603355|JIA|jia
359514|NCT01603329|medication adherence|medication adherence
359515|NCT01603329|diabetes|diabetes
359516|NCT01603329|hypertension|hypertension
359517|NCT01603329|cholesterol|cholesterol
359518|NCT01603329|statins|statins
359519|NCT01603316|Food pantry|food pantry
359520|NCT01603316|Food voucher|food voucher
359521|NCT01603316|Grocery delivery|grocery delivery
359522|NCT01603316|12-099|12-099
359523|NCT01603303|Breast Cancer|breast cancer
359524|NCT01603303|Localized breast cancer|localized breast cancer
359525|NCT01603303|Postmenopausal women|postmenopausal women
359526|NCT01603303|Aromatase inhibitor|aromatase inhibitor
359527|NCT01603303|AI|ai
359528|NCT01603303|Questionnaires|questionnaires
359529|NCT01603303|Surveys|surveys
359530|NCT01603303|Luvena|luvena
359531|NCT01603303|Internet based website|internet based website
359532|NCT01603303|Phone counseling|phone counseling
359533|NCT01603303|Water-based vaginal lubricant|water-based vaginal lubricant
359534|NCT01603303|Hyalo-Gyn|hyalo-gyn
359535|NCT01603290|Acute leukemia,|acute leukemia,
359536|NCT01603290|Chemotherapy,|chemotherapy,
359537|NCT01603290|Cancer-Related Fatigue,|cancer-related fatigue,
359538|NCT01603290|Physical Fitness|physical fitness
359539|NCT01603277|Asthma|asthma
359540|NCT01603277|GM-CSF|gm-csf
359541|NCT01603277|Moderate-to-Severe Asthma|moderate-to-severe asthma
359542|NCT01603264|Bioequivalence|bioequivalence
359543|NCT01603264|Biosimilarity|biosimilarity
359544|NCT01603264|Similarity|similarity
359545|NCT01603264|PK|pk
359546|NCT01603264|Phase I|phase i
359547|NCT01603264|Trastuzumab|trastuzumab
359548|NCT01603264|Healthy Male Volunteers|healthy male volunteers
359549|NCT01603264|Single-dose|single-dose
359550|NCT01603264|HER-2|her-2
359551|NCT01603264|Oncology|oncology
359552|NCT01603251|transmission|transmission
359553|NCT01603251|anopheles|anopheles
359554|NCT01603225|Autism|autism
359555|NCT01603225|tDCS|tdcs
359556|NCT01603212|Melanoma|melanoma
359557|NCT01603212|Metastatic melanoma|metastatic melanoma
359558|NCT01603212|Advanced melanoma|advanced melanoma
359559|NCT01603212|Vemurafenib|vemurafenib
359560|NCT01603212|PLX4032|plx4032
359561|NCT01603212|RO5185426|ro5185426
359562|NCT01603212|IL-2|il-2
359563|NCT01603212|Interleukin-2|interleukin-2
359564|NCT01603212|Aldesleukin|aldesleukin
359565|NCT01603212|Proleukin|proleukin
359566|NCT01603212|Interferon Alfa-2b|interferon alfa-2b
359567|NCT01603212|Intron A|intron a
359568|NCT01603160|Sickle Cell Disease|sickle cell disease
359569|NCT01603160|Emergency Department|emergency department
359570|NCT01603160|Quality Improvement|quality improvement
359571|NCT01603147|methamphetamine|methamphetamine
359572|NCT01603147|monoclonal antibody|monoclonal antibody
359573|NCT01603121|lisofylline|lisofylline
359574|NCT01603108|Liver Transplant Recipient|liver transplant recipient
359575|NCT01603108|Recurrent Fibrosis|recurrent fibrosis
359576|NCT01603095|Achondroplasia|achondroplasia
359578|NCT01603069|Parkinson's disease|parkinson's disease
359579|NCT01603069|Safety|safety
359580|NCT01603069|Tolerability|tolerability
359581|NCT01603056|House dust mite induced allergic rhinitis.|house dust mite induced allergic rhinitis.
359582|NCT01603043|Geographic Atrophy|geographic atrophy
359583|NCT01603043|Age-Related Macular Degeneration|age-related macular degeneration
359584|NCT01603043|Intravitreal injection|intravitreal injection
359585|NCT01603030|Moxifloxacin|moxifloxacin
359586|NCT01603030|Prednisolone|prednisolone
359587|NCT01603030|LASIK|lasik
359588|NCT01603017|Magnetic Resonance Therapy|magnetic resonance therapy
359589|NCT01603017|Osteoarthrosis|osteoarthrosis
359590|NCT01603017|Osteoarthritis|osteoarthritis
359591|NCT01603004|MRI|mri
359592|NCT01603004|CT|ct
359593|NCT01603004|12-058|12-058
359594|NCT01602991|Obesity|obesity
359595|NCT01602991|Endoscopy|endoscopy
359596|NCT01602991|Nasopharyngoesophagogastroscopy|nasopharyngoesophagogastroscopy
359597|NCT01602991|Bariatric Surgery|bariatric surgery
359598|NCT01602991|Gastric Bypass Surgery|gastric bypass surgery
359599|NCT01602965|obesity|obesity
359600|NCT01602965|counselling|counselling
359601|NCT01602965|weight loss|weight loss
359602|NCT01602952|Radotinib|radotinib
359603|NCT01602952|CML-CP, AP|cml-cp, ap
359604|NCT01602939|Mast cell|mast cell
359605|NCT01602939|Mastocytosis|mastocytosis
359606|NCT01602939|Mast cell disease|mast cell disease
359607|NCT01602926|hallux valgus|hallux valgus
359608|NCT01602913|Pravastatin|pravastatin
359609|NCT01602913|Adverse Events|adverse events
359610|NCT01602913|Type II Diabetes Mellitus|type ii diabetes mellitus
359611|NCT01602913|Incidence|incidence
359612|NCT01602913|Paroxetine|paroxetine
359613|NCT01602887|BA/BE|ba/be
359614|NCT01602887|PK|pk
359615|NCT01602887|PD-0332991|pd-0332991
359616|NCT01602887|PF-05089326|pf-05089326
359617|NCT01602887|Breast Cancer|breast cancer
359618|NCT01602874|children|children
359619|NCT01602874|pediatry|pediatry
359620|NCT01602874|pneumonia|pneumonia
359621|NCT01602874|intra-abdominal|intra-abdominal
359622|NCT01602874|infection|infection
359623|NCT01602861|Fibrosis|fibrosis
359624|NCT01602861|calcineurin inhibitor|calcineurin inhibitor
359625|NCT01602861|kidney transplant|kidney transplant
359626|NCT01602861|chronic rejection|chronic rejection
359627|NCT01602848|Medicaid|medicaid
359628|NCT01602848|frequent users|frequent users
359629|NCT01602848|heavy users|heavy users
359630|NCT01602848|high risk|high risk
359631|NCT01602848|high cost|high cost
359632|NCT01602848|intervention to improve care and reduce Medicaid expenditures|intervention to improve care and reduce medicaid expenditures
359633|NCT01602835|Alport syndrome|alport syndrome
359634|NCT01602835|proteinuria|proteinuria
359635|NCT01602835|glomerular disease|glomerular disease
359636|NCT01602835|hereditary nephropathy|hereditary nephropathy
359637|NCT01602835|nephropathy|nephropathy
359638|NCT01602822|HIV Prevention|hiv prevention
359639|NCT01602822|NPEP|npep
359640|NCT01602822|PEP|pep
359641|NCT01602809|Perfusion|perfusion
359642|NCT01602809|Microvessels|microvessels
359643|NCT01602809|Ultrasound|ultrasound
359644|NCT01602809|Sickle Cell Disease|sickle cell disease
359645|NCT01602783|Radical Prostatectomy|radical prostatectomy
359646|NCT01602770|Oral contraceptives|oral contraceptives
359647|NCT01602770|Adverse events|adverse events
359648|NCT01602770|Safety profile|safety profile
359649|NCT01602770|Contraceptive Agents|contraceptive agents
359650|NCT01602744|STOPP screening tool|stopp screening tool
359651|NCT01602744|START screening tool|start screening tool
359652|NCT01602744|MIP-medication inappropriate prescription|mip-medication inappropriate prescription
359653|NCT01602744|PIM-Potentially inappropriate medication|pim-potentially inappropriate medication
359654|NCT01602731|medication adherence|medication adherence
359655|NCT01602718|physical activity|physical activity
359656|NCT01602718|physical performance|physical performance
359657|NCT01602718|ESRD|esrd
359658|NCT01602718|home dialysis|home dialysis
359659|NCT01602705|Feedback (NOT MESH)|feedback (not mesh)
359660|NCT01602705|Medication errors|medication errors
359661|NCT01602705|Medication review|medication review
359662|NCT01602705|Inappropriate medication|inappropriate medication
359663|NCT01602705|Randomised controlled trial|randomised controlled trial
359664|NCT01602705|Primary Health Care|primary health care
359665|NCT01602705|Family Practice|family practice
359666|NCT01602692|Pain, postoperative|pain, postoperative
359667|NCT01602692|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
359668|NCT01602692|Patient Readmission|patient readmission
359669|NCT01602692|Time to Discharge|time to discharge
359670|NCT01602640|sedation|sedation
359671|NCT01602640|critical care|critical care
359672|NCT01602640|morphine|morphine
359673|NCT01602640|fentanyl|fentanyl
359674|NCT01602640|analgesic based sedation|analgesic based sedation
359675|NCT01602601|Hunter syndrome, immunogenicity, antibodies|hunter syndrome, immunogenicity, antibodies
359676|NCT01602575|IBS, FMRI, MBSR|ibs, fmri, mbsr
359677|NCT01602562|Herpes simplex infection|herpes simplex infection
359678|NCT01602562|valaciclovir|valaciclovir
359679|NCT01602562|herpes simplex virus|herpes simplex virus
359680|NCT01602562|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
359681|NCT01602536|twitter|twitter
359682|NCT01602536|quit smoking|quit smoking
359683|NCT01602536|smoking cessation|smoking cessation
359684|NCT01602536|social media|social media
359685|NCT01602536|peer support|peer support
359686|NCT01602523|Emphysema|emphysema
359687|NCT01602523|COPD|copd
359688|NCT01602523|Sleep|sleep
359689|NCT01602497|Borderline personality disorder|borderline personality disorder
359690|NCT01602497|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
359691|NCT01602471|Endarterectomy|endarterectomy
359692|NCT01602471|K5-C200|k5-c200
359693|NCT01602471|RGD-K5|rgd-k5
359694|NCT01602471|angiogenesis|angiogenesis
359695|NCT01602471|Carotid CT Angiogram|carotid ct angiogram
359696|NCT01602458|Preventative Scar Management|preventative scar management
359697|NCT01602458|Skin Grafts|skin grafts
359698|NCT01602458|Silicone Therapy|silicone therapy
359699|NCT01602458|Silicone Pressure Garment Therapy|silicone pressure garment therapy
359700|NCT01602445|Venous Thrombosis|venous thrombosis
359701|NCT01602445|Coagulation factors|coagulation factors
359702|NCT01602445|Cancer|cancer
359703|NCT01602445|Blood|blood
359704|NCT01602432|Venous Thrombosis|venous thrombosis
359705|NCT01602432|Cancer|cancer
359706|NCT01602432|Coagulation factors|coagulation factors
359707|NCT01602432|Blood|blood
359708|NCT01602406|Advanced HER2-positive Breast cancer or Gastric cancer|advanced her2-positive breast cancer or gastric cancer
359709|NCT01602380|hormone receptor positive breast cancer|hormone receptor positive breast cancer
359710|NCT01602380|endocrine|endocrine
359711|NCT01602380|no hormone therapy|no hormone therapy
359712|NCT01602380|hormone|hormone
359713|NCT01602380|breast|breast
359714|NCT01602380|cancer|cancer
359715|NCT01602380|neoplasm|neoplasm
359716|NCT01602380|metastatic|metastatic
359717|NCT01602380|tumour|tumour
359718|NCT01602354|Endotoxin Activity Assay|endotoxin activity assay
359719|NCT01602354|Gram negative|gram negative
359720|NCT01602354|Septic Shock|septic shock
359721|NCT01602354|EAA|eaa
359722|NCT01602341|atopic dermatitis|atopic dermatitis
359723|NCT01602328|Acute Kidney Injury|acute kidney injury
359724|NCT01602328|Acute renal failure|acute renal failure
359725|NCT01602328|Human mesenchymal stem cells|human mesenchymal stem cells
359726|NCT01602328|Allogeneic stem cells|allogeneic stem cells
359727|NCT01602315|BYL719|byl719
359728|NCT01602315|PI3K inhibitor|pi3k inhibitor
359729|NCT01602315|PIK3CA|pik3ca
359730|NCT01602315|cetuximab|cetuximab
359731|NCT01602315|EGFR|egfr
359732|NCT01602315|HNSCC|hnscc
359733|NCT01602315|RM HNSCC|rm hnscc
359734|NCT01602315|platinum-based chemotherapy|platinum-based chemotherapy
359735|NCT01602315|(RM HNSCC) patients|(rm hnscc) patients
359736|NCT01602315|resistant or ineligible/intolerant to platinum-based chemotherapy|resistant or ineligible/intolerant to platinum-based chemotherapy
359737|NCT01602315|swallowing dysfunction|swallowing dysfunction
359738|NCT01602315|G-tube|g-tube
359739|NCT01602315|alpelisib|alpelisib
359740|NCT01602302|rheumatoid arthritis|rheumatoid arthritis
359741|NCT01602302|ultrasound|ultrasound
359742|NCT01602302|remission|remission
359743|NCT01602302|biological DMARD|biological dmard
359744|NCT01602276|Parkinson's disease|parkinson's disease
359745|NCT01602276|Lewy body dementia|lewy body dementia
359746|NCT01602276|Korsakoff's syndrome|korsakoff's syndrome
359747|NCT01602276|Subcortical Dementia|subcortical dementia
359748|NCT01602276|Huntington's Disease|huntington's disease
359749|NCT01602263|Normal cognitive function|normal cognitive function
359750|NCT01602263|Aphasia|aphasia
359751|NCT01602263|Autism|autism
359752|NCT01602263|Schizophrenia|schizophrenia
359753|NCT01602250|Anesthetics, local|anesthetics, local
359754|NCT01602250|Toxicity|toxicity
359755|NCT01602250|Adverse effects|adverse effects
359756|NCT01602211|stem cell transplant|stem cell transplant
359757|NCT01602211|cancer survivors|cancer survivors
359758|NCT01602211|internet|internet
359759|NCT01602211|social media|social media
359760|NCT01602211|distress|distress
359761|NCT01602211|health care adherence|health care adherence
359762|NCT01602185|NMDA (N-Methyl-D-Aspartate) antagonists|nmda (n-methyl-d-aspartate) antagonists
359763|NCT01602185|ketamine|ketamine
359764|NCT01602185|memantine|memantine
359765|NCT01602185|dextromethorphan|dextromethorphan
359766|NCT01602185|Neuropathic pain|neuropathic pain
359767|NCT01602172|alcohol consumption|alcohol consumption
359768|NCT01602172|inpatients|inpatients
359769|NCT01602172|risk reduction behavior|risk reduction behavior
359770|NCT01602172|counseling|counseling
359771|NCT01602172|nurses|nurses
359772|NCT01602172|brief intervention|brief intervention
359773|NCT01602159|Claudication|claudication
359774|NCT01602159|SFA|sfa
359775|NCT01602159|Open Bypass|open bypass
359776|NCT01602159|Angioplasty|angioplasty
359777|NCT01602159|Stenting|stenting
359778|NCT01602146|ultramarathon central fatigue,|ultramarathon central fatigue,
359779|NCT01602133|venous puncture|venous puncture
360082|NCT01600885|Ketamine|ketamine
359780|NCT01602133|seldinger technique|seldinger technique
359781|NCT01602133|ultrasound guidance|ultrasound guidance
359782|NCT01602107|Stress|stress
359783|NCT01602107|Urinary|urinary
359784|NCT01602107|Incontinence|incontinence
359785|NCT01602107|Pelvic|pelvic
359786|NCT01602107|Physiotherapy|physiotherapy
359787|NCT01602094|measles|measles
359788|NCT01602094|antibody|antibody
359789|NCT01602094|prevalence|prevalence
359790|NCT01602094|predictors|predictors
359791|NCT01602094|Donor of National Blood Centre, The Thai Red Cross Society who age 18-30 years old|donor of national blood centre, the thai red cross society who age 18-30 years old
359792|NCT01602094|Measles antibody levels|measles antibody levels
359793|NCT01602094|Predictors of adequate measles antibody levels and inadequate measles antibody levels|predictors of adequate measles antibody levels and inadequate measles antibody levels
359794|NCT01602081|Anal fistula|anal fistula
359795|NCT01602081|Ligation of the intersphincteric fistula tract|ligation of the intersphincteric fistula tract
359796|NCT01602081|LIFT|lift
359797|NCT01602081|Tissue graft|tissue graft
359798|NCT01602068|Iontophoresis|iontophoresis
359799|NCT01602068|Cataract Surgery|cataract surgery
359800|NCT01602068|Ophthalmology|ophthalmology
359801|NCT01602068|Posterior Chamber Intraocular Lens Implant|posterior chamber intraocular lens implant
359802|NCT01602042|essential tremor|essential tremor
359803|NCT01602042|motion sensors|motion sensors
359804|NCT01602042|tremor|tremor
359805|NCT01602029|Anti inflammatory|anti inflammatory
359806|NCT01602029|Schizophrenia|schizophrenia
359807|NCT01602029|Simvastatin|simvastatin
359808|NCT01602029|Ondansetron|ondansetron
359809|NCT01602016|ASD|asd
359810|NCT01602016|PDD-NOS|pdd-nos
359811|NCT01601977|COPD|copd
359812|NCT01601977|Respiratory failure|respiratory failure
359813|NCT01601977|NIV|niv
359814|NCT01601977|OSA|osa
359815|NCT01601964|VEGF, ectopic pregnancy.|vegf, ectopic pregnancy.
359816|NCT01601951|Osteoarthritis|osteoarthritis
359817|NCT01601951|Stem Cell Injections|stem cell injections
359818|NCT01601951|Bone Marrow|bone marrow
359819|NCT01601951|Autologous|autologous
359820|NCT01601938|Sepsis|sepsis
359821|NCT01601938|Shock, Septic|shock, septic
359822|NCT01601938|Selenium|selenium
359823|NCT01601938|Survival|survival
359824|NCT01601912|Whiplash Injuries|whiplash injuries
359825|NCT01601912|Chronic Pain|chronic pain
359826|NCT01601912|Exercise|exercise
359827|NCT01601912|Cognition|cognition
359828|NCT01601899|trial|trial
359829|NCT01601899|stavudine|stavudine
359830|NCT01601899|tenofovir|tenofovir
359831|NCT01601899|mitochondria|mitochondria
359832|NCT01601899|insulin resistance|insulin resistance
359833|NCT01601899|lipids|lipids
359834|NCT01601899|HOMA|homa
359835|NCT01601886|Intubation, Intratracheal|intubation, intratracheal
359836|NCT01601886|Continuous Positive Airway Pressure|continuous positive airway pressure
359837|NCT01601886|Historical Cohort Studies|historical cohort studies
359838|NCT01601886|Clinical Trial|clinical trial
359839|NCT01601873|Arteriovenous graft|arteriovenous graft
359840|NCT01601873|Propaten|propaten
359841|NCT01601873|Heparin-bonded|heparin-bonded
359842|NCT01601873|hemodialysis vascular access|hemodialysis vascular access
359843|NCT01601873|Surgical|surgical
359844|NCT01601873|Arteriovenous Shunt|arteriovenous shunt
359845|NCT01601860|Labor|labor
359846|NCT01601860|vaginal delivery|vaginal delivery
359847|NCT01601860|pain|pain
359848|NCT01601834|Phase 1|phase 1
359849|NCT01601834|Single Dose|single dose
359850|NCT01601834|Pharmacokinetics|pharmacokinetics
359851|NCT01601834|Safety|safety
359852|NCT01601834|Toleration|toleration
359853|NCT01601795|Cardioprotection|cardioprotection
359854|NCT01601769|Cervical preinvasive disease|cervical preinvasive disease
359855|NCT01601769|Colposcopy|colposcopy
359856|NCT01601769|Exocolposcopy|exocolposcopy
359857|NCT01601769|Leep|leep
359858|NCT01601756|revision knee arthroplasty|revision knee arthroplasty
359859|NCT01601756|navigation|navigation
359860|NCT01601756|joint line|joint line
359861|NCT01601743|Cocaine|cocaine
359862|NCT01601743|Exercise|exercise
359863|NCT01601730|Cocaine|cocaine
359864|NCT01601730|Modafinil|modafinil
359865|NCT01601730|Escitalopram|escitalopram
359866|NCT01601717|RTI-336|rti-336
359867|NCT01601717|Methamphetamine|methamphetamine
359868|NCT01601704|Body Weight|body weight
359869|NCT01601704|Bupropion|bupropion
359870|NCT01601704|Cardiovascular Diseases|cardiovascular diseases
359871|NCT01601704|Diabetes Mellitus|diabetes mellitus
359872|NCT01601704|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
359873|NCT01601704|Endocrine System Diseases|endocrine system diseases
359874|NCT01601704|Glucose Metabolism Disorders|glucose metabolism disorders
359875|NCT01601704|Heart Diseases|heart diseases
359876|NCT01601704|Metabolic Diseases|metabolic diseases
359877|NCT01601704|Narcotic Antagonists|narcotic antagonists
359878|NCT01601704|Naltrexone|naltrexone
359879|NCT01601704|Nutrition Disorders|nutrition disorders
359880|NCT01601704|Obesity|obesity
359881|NCT01601704|Overnutrition|overnutrition
359882|NCT01601704|Overweight|overweight
359883|NCT01601691|prostate cancer|prostate cancer
359884|NCT01601691|brachytherapy|brachytherapy
359885|NCT01601691|spacer|spacer
359886|NCT01601691|side effect|side effect
359887|NCT01601678|Achalasia|achalasia
359888|NCT01601678|Heller Myotomy|heller myotomy
359889|NCT01601678|Dysphagia|dysphagia
359890|NCT01601678|Peroral Endoscopic Myotomy|peroral endoscopic myotomy
359891|NCT01601665|Intraocular lens|intraocular lens
359892|NCT01601665|Cataracts|cataracts
359893|NCT01601665|Astigmatism|astigmatism
359894|NCT01601665|Toric|toric
359895|NCT01601652|cholestasis|cholestasis
359896|NCT01601652|PNAC|pnac
359897|NCT01601652|Parenteral Nutrition Associated Cholestasis|parenteral nutrition associated cholestasis
359898|NCT01601652|PNALD|pnald
359899|NCT01601652|Parenteral Nutrition Associated Liver Disease|parenteral nutrition associated liver disease
359900|NCT01601639|Gastric Antral Vascular Ectasia|gastric antral vascular ectasia
359901|NCT01601639|Argon plasma Coagulation|argon plasma coagulation
359902|NCT01601639|Endoscopic Band Ligation|endoscopic band ligation
359903|NCT01601639|GAVE|gave
359904|NCT01601587|Introductory Seminar|introductory seminar
359905|NCT01601587|Waiting list|waiting list
359906|NCT01601587|Community Mental Health Centre|community mental health centre
359907|NCT01601574|Type 2 diabetes|type 2 diabetes
359908|NCT01601574|HbA1c|hba1c
359909|NCT01601574|Overweight|overweight
359910|NCT01601574|Obesity|obesity
359911|NCT01601561|Insulin|insulin
359912|NCT01601561|Protein metabolism|protein metabolism
359913|NCT01601561|Stress response|stress response
359914|NCT01601483|AMD|amd
359915|NCT01601483|Dry AMD|dry amd
359916|NCT01601483|Nonexudative AMD|nonexudative amd
359917|NCT01601483|MC-1101|mc-1101
359918|NCT01601470|LCZ696, sildenafil, pharmacokinetics, mild to moderate hypertension|lcz696, sildenafil, pharmacokinetics, mild to moderate hypertension
359919|NCT01601444|To assess pleural effusion by measuring internal thoracic impedance|to assess pleural effusion by measuring internal thoracic impedance
359920|NCT01601431|Screening colonoscopy|screening colonoscopy
359921|NCT01601418|YF476|yf476
359922|NCT01601418|gastrin receptor antagonist|gastrin receptor antagonist
359923|NCT01601418|pentagastrin|pentagastrin
359924|NCT01601418|gastric acid|gastric acid
359925|NCT01601418|healthy subjects|healthy subjects
359926|NCT01601405|YF476|yf476
359927|NCT01601405|gastrin receptor antagonist|gastrin receptor antagonist
359928|NCT01601405|gastrin|gastrin
359929|NCT01601405|gastric aspiration|gastric aspiration
359930|NCT01601405|healthy subjects|healthy subjects
359931|NCT01601392|Ischemic stroke|ischemic stroke
359932|NCT01601392|direct current stimulation|direct current stimulation
359933|NCT01601392|motor threshold|motor threshold
359934|NCT01601392|National institutes of Health Stroke Scale|national institutes of health stroke scale
359935|NCT01601392|Barthel index scale|barthel index scale
359936|NCT01601392|Measurement of motor power improvement|measurement of motor power improvement
359937|NCT01601379|Observational|observational
359938|NCT01601379|GERD|gerd
359939|NCT01601379|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
359940|NCT01601379|Gastro-oesophageal Reflux|gastro-oesophageal reflux
359941|NCT01601379|Heartburn|heartburn
359942|NCT01601366|Adenomyosis|adenomyosis
359943|NCT01601366|Intrauterine levonorgestrel|intrauterine levonorgestrel
359944|NCT01601366|Dysmenorrhea|dysmenorrhea
359945|NCT01601366|Oral contraceptives|oral contraceptives
359946|NCT01601366|Uterus|uterus
359947|NCT01601353|Erectile Dysfunction|erectile dysfunction
359948|NCT01601327|hypogonadism|hypogonadism
359949|NCT01601327|treatment|treatment
359950|NCT01601327|testis volume|testis volume
359951|NCT01601301|Limb|limb
359952|NCT01601301|Lengthening|lengthening
359953|NCT01601301|PRECICE|precice
359954|NCT01601301|Ellipse|ellipse
359955|NCT01601301|Technologies|technologies
359956|NCT01601301|Distraction|distraction
359957|NCT01601301|Osteogenesis|osteogenesis
359958|NCT01601301|Femur|femur
359959|NCT01601301|Tibia|tibia
359960|NCT01601301|Intramedullary|intramedullary
359961|NCT01601301|Nail|nail
359962|NCT01601301|Device|device
359963|NCT01601301|Medical|medical
359964|NCT01601301|Orthopedic|orthopedic
359965|NCT01601301|Implant|implant
359966|NCT01601288|obstructive lung disease|obstructive lung disease
359967|NCT01601288|restrictive lung disease|restrictive lung disease
359968|NCT01601288|cough|cough
359969|NCT01601288|dyspnea|dyspnea
359970|NCT01601275|tuberculosis|tuberculosis
359971|NCT01601262|ED|ed
359972|NCT01601262|LI-ESWT|li-eswt
359973|NCT01601249|IVF, embryo selection, polarized light|ivf, embryo selection, polarized light
359974|NCT01601236|H.P. Acthar Gel|h.p. acthar gel
359975|NCT01601236|Acthar|acthar
359976|NCT01601236|diabetic nephropathy|diabetic nephropathy
359977|NCT01601236|proteinuria|proteinuria
359978|NCT01601236|nephrotic syndrome|nephrotic syndrome
359979|NCT01601223|Ventilatory Management|ventilatory management
359980|NCT01601223|Mechanical Ventilation|mechanical ventilation
359981|NCT01601223|Post Operative pulmonary complications|post operative pulmonary complications
359982|NCT01601223|Intra-operative complications|intra-operative complications
359983|NCT01601223|General Anesthesia|general anesthesia
359984|NCT01601223|Surgery|surgery
359986|NCT01601223|ESA (European Society of Anaesthesiology)|esa (european society of anaesthesiology)
359987|NCT01601223|European Society of Anaesthesiology|european society of anaesthesiology
359988|NCT01601197|immunization|immunization
359989|NCT01601197|pain management|pain management
359990|NCT01601197|infants|infants
359991|NCT01601197|tactile stimulation|tactile stimulation
359992|NCT01601184|medulloblastoma|medulloblastoma
359993|NCT01601184|sonic hedgehog pathway|sonic hedgehog pathway
359994|NCT01601184|vismodegib|vismodegib
359995|NCT01601171|GnRH deficiency|gnrh deficiency
359996|NCT01601171|hypogonadism|hypogonadism
359997|NCT01601171|anosmia|anosmia
359998|NCT01601171|infertility|infertility
359999|NCT01601171|cleft lip|cleft lip
360000|NCT01601171|cleft palate|cleft palate
360001|NCT01601171|cryptorchidism|cryptorchidism
360002|NCT01601171|microphallus|microphallus
360003|NCT01601158|Global developmental delay|global developmental delay
360004|NCT01601158|Umbilical cord blood|umbilical cord blood
360005|NCT01601158|Rehabilitation|rehabilitation
360006|NCT01601145|Lactobacillus Brevis CD2|lactobacillus brevis cd2
360007|NCT01601145|schoolchildren|schoolchildren
360008|NCT01601145|dental caries|dental caries
360009|NCT01601145|Gingivatis|gingivatis
360010|NCT01601132|pharmacokinetics|pharmacokinetics
360011|NCT01601132|colchicine|colchicine
360012|NCT01601132|theophylline|theophylline
360013|NCT01601119|Multiple Sclerosis|multiple sclerosis
360014|NCT01601119|Patient reported outcome|patient reported outcome
360015|NCT01601119|Patient reported experience|patient reported experience
360016|NCT01601106|Atherosclerosis, inflammation|atherosclerosis, inflammation
360139|NCT01600690|Stem cells|stem cells
360017|NCT01601093|Respiratory and urinary tract infections|respiratory and urinary tract infections
360018|NCT01601093|Ceftazidime and Sulbactam Sodium for Injection (2:1)|ceftazidime and sulbactam sodium for injection (2:1)
360019|NCT01601093|Phase Ⅱ|phase ⅱ
360020|NCT01601080|Adherence|adherence
360021|NCT01601080|Multiple Sclerosis|multiple sclerosis
360022|NCT01601067|posttraumatic stress disorder|posttraumatic stress disorder
360023|NCT01601067|psychotherapy|psychotherapy
360024|NCT01601067|alcoholism|alcoholism
360025|NCT01601054|spine|spine
360026|NCT01601054|deformity|deformity
360027|NCT01601054|instrumentation|instrumentation
360028|NCT01601054|ALIF|alif
360029|NCT01601041|Urinary Tract Infection|urinary tract infection
360030|NCT01601041|Bacteriuria|bacteriuria
360031|NCT01601041|Pyuria|pyuria
360032|NCT01601041|Prostatitis|prostatitis
360033|NCT01601041|Intermittent Catheterization|intermittent catheterization
360034|NCT01601041|Spinal Cord Injuries|spinal cord injuries
360035|NCT01601041|Residual Urine|residual urine
360036|NCT01601028|Autoimmune Diseases|autoimmune diseases
360037|NCT01601028|Sjogren's Syndrome|sjogren's syndrome
360038|NCT01601028|Hydroxychloroquine|hydroxychloroquine
360039|NCT01601015|Tension-type headache, Effectiveness, Manual therapy|tension-type headache, effectiveness, manual therapy
360040|NCT01601002|Mirtazapine|mirtazapine
360041|NCT01600989|shock septic|shock septic
360042|NCT01600989|monocytes|monocytes
360043|NCT01600989|lymphocytes|lymphocytes
360044|NCT01600989|mitochondria|mitochondria
360045|NCT01600989|interleukins|interleukins
360046|NCT01600989|Tumor Necrosis Factor-alpha|tumor necrosis factor-alpha
360047|NCT01600989|Hypoxia-Inducible Factor 1, alpha Subunit|hypoxia-inducible factor 1, alpha subunit
360048|NCT01600976|Hepatic impairment|hepatic impairment
360049|NCT01600976|Hepatitis C|hepatitis c
360050|NCT01600976|Telaprevir|telaprevir
360051|NCT01600976|VX-950|vx-950
360052|NCT01600976|Pharmacokinetics|pharmacokinetics
360053|NCT01600976|Safety|safety
360054|NCT01600976|Unbound plasma concentrations|unbound plasma concentrations
360055|NCT01600976|Child-Pugh score|child-pugh score
360056|NCT01600963|Multi-drug resistant tuberculosis|multi-drug resistant tuberculosis
360057|NCT01600963|Pre-extensively drug resistant tuberculosis|pre-extensively drug resistant tuberculosis
360058|NCT01600963|TMC207|tmc207
360059|NCT01600963|Background regimen|background regimen
360060|NCT01600937|diabetes mellitus|diabetes mellitus
360061|NCT01600937|diabetes education|diabetes education
360062|NCT01600937|behavioral therapy|behavioral therapy
360063|NCT01600937|behavior modification|behavior modification
360064|NCT01600937|physical activity|physical activity
360065|NCT01600937|supervised exercise|supervised exercise
360066|NCT01600937|physical fitness|physical fitness
360067|NCT01600937|HbA1c|hba1c
360068|NCT01600937|modifiable cardiovascular risk factors|modifiable cardiovascular risk factors
360069|NCT01600937|quality of life|quality of life
360070|NCT01600924|diabetes mellitus|diabetes mellitus
360071|NCT01600924|muscle strength|muscle strength
360072|NCT01600924|bone strength|bone strength
360073|NCT01600924|cardiovascular risk factors|cardiovascular risk factors
360074|NCT01600924|diabetic complications|diabetic complications
360075|NCT01600911|metabolomics|metabolomics
360076|NCT01600911|nutri-metabolomics|nutri-metabolomics
360077|NCT01600911|plant food|plant food
360078|NCT01600911|blood pressure|blood pressure
360079|NCT01600898|Asymptomatic carriers of a BMPR2 mutation|asymptomatic carriers of a bmpr2 mutation
360080|NCT01600898|follow up study|follow up study
360081|NCT01600885|Guanfacine|guanfacine
360083|NCT01600885|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
360084|NCT01600885|Prefrontal Cortex Activity|prefrontal cortex activity
360085|NCT01600885|Receptors, N-Methyl-D-Aspartate|receptors, n-methyl-d-aspartate
360086|NCT01600885|Receptors, Adrenergic, alpha-2|receptors, adrenergic, alpha-2
360087|NCT01600885|Memory, Short-Term|memory, short-term
360088|NCT01600885|Schizophrenia|schizophrenia
360089|NCT01600872|EDCs|edcs
360090|NCT01600872|PCOS|pcos
360091|NCT01600872|TAS|tas
360092|NCT01600872|TOS|tos
360093|NCT01600872|ROS|ros
360094|NCT01600872|Oxidative Stress, Endocrine-Disrupting Chemicals, Polycystic Ovary syndrome|oxidative stress, endocrine-disrupting chemicals, polycystic ovary syndrome
360095|NCT01600846|Pharmacogenetic testing|pharmacogenetic testing
360096|NCT01600846|pharmacokinetics|pharmacokinetics
360097|NCT01600846|Pharmacogenomics|pharmacogenomics
360098|NCT01600846|genetics|genetics
360099|NCT01600846|pharmacy|pharmacy
360100|NCT01600846|drug response|drug response
360101|NCT01600833|PCOS|pcos
360102|NCT01600833|Ferritin|ferritin
360103|NCT01600833|Homocysteine|homocysteine
360104|NCT01600833|Insulin Resistance|insulin resistance
360105|NCT01600833|Metabolic Syndrome|metabolic syndrome
360106|NCT01600820|Plant sterol|plant sterol
360107|NCT01600820|Hypercholesterolemia|hypercholesterolemia
360108|NCT01600820|diet|diet
360109|NCT01600820|dairy|dairy
360110|NCT01600820|LDL-C|ldl-c
360111|NCT01600820|Mildly hypercholesterolemic subjects|mildly hypercholesterolemic subjects
360112|NCT01600807|Metastatic|metastatic
360113|NCT01600807|Pancreas|pancreas
360114|NCT01600807|Cancer|cancer
360115|NCT01600807|Adenocarcinoma|adenocarcinoma
360116|NCT01600794|In Vitro Fertilization (IVF)|in vitro fertilization (ivf)
360117|NCT01600794|androgens|androgens
360118|NCT01600794|ovary function|ovary function
360119|NCT01600794|This study include the patients who are evaluated by the doctors and are sure to process the In Vitro Fertilization cycle.|this study include the patients who are evaluated by the doctors and are sure to process the in vitro fertilization cycle.
360120|NCT01600781|Improve the nutritional status|improve the nutritional status
360121|NCT01600781|QOL|qol
360122|NCT01600781|children|children
360123|NCT01600781|enhance immune response|enhance immune response
360124|NCT01600781|induction chemotherapy|induction chemotherapy
360125|NCT01600781|fewer side effects|fewer side effects
360126|NCT01600768|focus of study|focus of study
360127|NCT01600755|Cell Therapy|cell therapy
360128|NCT01600755|Autologous Cell Transplantation|autologous cell transplantation
360129|NCT01600755|Muscle-derived Cell|muscle-derived cell
360130|NCT01600755|Anal Incontinence|anal incontinence
360131|NCT01600755|Rectal Diseases|rectal diseases
360132|NCT01600755|Intestinal Diseases|intestinal diseases
360133|NCT01600755|Gastrointestinal Diseases|gastrointestinal diseases
360134|NCT01600755|Urinary Incontinence|urinary incontinence
360135|NCT01600703|Intestinal lipoprotein|intestinal lipoprotein
360136|NCT01600703|Apolipoprotein B48 and apolipoprotein B100|apolipoprotein b48 and apolipoprotein b100
360137|NCT01600703|Pancreatic clamp|pancreatic clamp
360138|NCT01600703|DPPIV inhibitor|dppiv inhibitor
360140|NCT01600690|Regeneration|regeneration
360141|NCT01600690|Inflammation|inflammation
360142|NCT01600677|Experimental; Computerized medication delivery unit|experimental; computerized medication delivery unit
360143|NCT01600664|Type 1 diabetes|type 1 diabetes
360144|NCT01600664|"My Diabetic friend"|"my diabetic friend"
360145|NCT01600664|interactive computer game|interactive computer game
360146|NCT01600651|Receptor for advanced glycation end products (RAGE)|receptor for advanced glycation end products (rage)
360147|NCT01600651|Soluble RAGE (sRAGE)|soluble rage (srage)
360148|NCT01600651|Recruitment Maneuver|recruitment maneuver
360149|NCT01600651|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
360150|NCT01600651|Alveolar epithelium|alveolar epithelium
360151|NCT01600651|Electrical Impedance Tomography|electrical impedance tomography
360152|NCT01600651|Mechanical ventilation|mechanical ventilation
360153|NCT01600651|Intensive Care Unit (ICU)|intensive care unit (icu)
360154|NCT01600638|Lipolysis|lipolysis
360155|NCT01600638|Cryolipolysis|cryolipolysis
360156|NCT01600638|Fat Reduction|fat reduction
360157|NCT01600625|meibomian gland dysfunction|meibomian gland dysfunction
360158|NCT01600625|inflammatory tear cytokine|inflammatory tear cytokine
360159|NCT01600625|minocycline|minocycline
360160|NCT01600612|postpartum hemorrhage, oxytocin, carbetocin, misopristol|postpartum hemorrhage, oxytocin, carbetocin, misopristol
360161|NCT01600586|Neonatal Intensive Care Unit (NICU)|neonatal intensive care unit (nicu)
360162|NCT01600586|Music therapy|music therapy
360163|NCT01600586|Premature infant|premature infant
360164|NCT01600586|Oral feeds|oral feeds
360165|NCT01600586|Non-Nutritive Sucking|non-nutritive sucking
360166|NCT01600586|Suck rate|suck rate
360167|NCT01600586|Suck efficiency|suck efficiency
360168|NCT01600586|Contingent music|contingent music
360169|NCT01600586|Mother's voice|mother's voice
360170|NCT01600573|ovarian cancer|ovarian cancer
360171|NCT01600534|gestational diabetes|gestational diabetes
360172|NCT01600508|stoma care|stoma care
360173|NCT01600508|videoconference|videoconference
360174|NCT01600508|costs|costs
360175|NCT01600508|quality of life|quality of life
360176|NCT01600495|pain|pain
360177|NCT01600495|electric stimulation|electric stimulation
360178|NCT01600495|nervous|nervous
360179|NCT01600495|transcutaneous|transcutaneous
360180|NCT01600495|humanized childbirth|humanized childbirth
360181|NCT01600482|Hemostasis.|hemostasis.
360182|NCT01600482|Percutaneous coronary interventions.|percutaneous coronary interventions.
360183|NCT01600482|Closure Device|closure device
360184|NCT01600469|Alzheimer's disease|alzheimer's disease
360185|NCT01600469|mild cognitive impairment|mild cognitive impairment
360186|NCT01600469|NMDA|nmda
360187|NCT01600456|PTSD|ptsd
360188|NCT01600456|Antidepressants|antidepressants
360189|NCT01600456|Cognitive behavior therapy|cognitive behavior therapy
360190|NCT01600430|Vitamin D|vitamin d
360191|NCT01600430|Newborn|newborn
360192|NCT01600430|Preterm|preterm
360193|NCT01600430|Supplementation|supplementation
360194|NCT01600430|Respiratory|respiratory
360195|NCT01600417|low back pain|low back pain
360196|NCT01600417|spine|spine
360197|NCT01600417|lumbar spine|lumbar spine
360198|NCT01600417|lumbar instability|lumbar instability
360199|NCT01600417|radiology|radiology
360200|NCT01600417|functional radiology|functional radiology
360201|NCT01600404|Mild Cognitive Impairment|mild cognitive impairment
360202|NCT01600404|Muscarinic Antagonists|muscarinic antagonists
360203|NCT01600404|Spinal Cord Injuries|spinal cord injuries
360204|NCT01600404|Urinary Bladder, Neurogenic|urinary bladder, neurogenic
360205|NCT01600404|Urinary Bladder, Overactive|urinary bladder, overactive
360206|NCT01600404|Overactive Detrusor|overactive detrusor
360207|NCT01600391|Stroke|stroke
360208|NCT01600391|Visual cues|visual cues
360209|NCT01600391|Gait rehabilitation|gait rehabilitation
360210|NCT01600391|Walking adaptability|walking adaptability
360211|NCT01600391|Turning|turning
360212|NCT01600391|Overground walking|overground walking
360213|NCT01600391|Treadmill training|treadmill training
360214|NCT01600378|diffuse parenchymal lung disease|diffuse parenchymal lung disease
360215|NCT01600378|interstitial lung disease|interstitial lung disease
360216|NCT01600378|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
360217|NCT01600365|Conjunctivitis|conjunctivitis
360218|NCT01600365|adenovirus.|adenovirus.
360219|NCT01600352|interstitial lung disease|interstitial lung disease
360220|NCT01600352|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
360221|NCT01600313|rice bran oil|rice bran oil
360222|NCT01600313|diet|diet
360223|NCT01600313|cardiovascular disease|cardiovascular disease
360224|NCT01600313|low density lipoprotein|low density lipoprotein
360225|NCT01600313|total cholesterol|total cholesterol
360226|NCT01600300|Age-related macular degeneration|age-related macular degeneration
360227|NCT01600300|electrical stimulation|electrical stimulation
360228|NCT01600300|randomized|randomized
360229|NCT01600300|double blind|double blind
360230|NCT01600287|bispectral index|bispectral index
360231|NCT01600287|propofol|propofol
360232|NCT01600287|paediatric cardiac surgery|paediatric cardiac surgery
360233|NCT01600287|closed loop anaesthesia delivery system|closed loop anaesthesia delivery system
360234|NCT01600261|without eye disease|without eye disease
360235|NCT01600248|Chronic Pain|chronic pain
360236|NCT01600248|Military|military
360237|NCT01600248|Veteran|veteran
360238|NCT01600248|Online|online
360239|NCT01600248|Acceptance|acceptance
360240|NCT01600235|Stroke, ischemic|stroke, ischemic
360241|NCT01600235|Progression|progression
360242|NCT01600235|Induced-hypertension|induced-hypertension
360243|NCT01600235|Phenylephrine|phenylephrine
360244|NCT01600209|Cancer|cancer
360245|NCT01600209|Colorectal Cancer|colorectal cancer
360246|NCT01600209|Neoplasm|neoplasm
360247|NCT01600209|Colorectal Neoplasm|colorectal neoplasm
360248|NCT01600209|Intestinal Neoplasms|intestinal neoplasms
360249|NCT01600209|Gastrointestinal Neoplasms|gastrointestinal neoplasms
360250|NCT01600209|Digestive System Neoplasms|digestive system neoplasms
360251|NCT01600209|Neoplasms by Site|neoplasms by site
360252|NCT01600209|Neoplasms|neoplasms
360253|NCT01600209|Digestive System Diseases|digestive system diseases
360254|NCT01600209|Gastrointestinal Diseases|gastrointestinal diseases
360255|NCT01600209|Colonic Diseases|colonic diseases
360256|NCT01600209|Intestinal Diseases|intestinal diseases
360257|NCT01600209|Rectal Diseases|rectal diseases
360258|NCT01600196|Hepatectomy|hepatectomy
360259|NCT01600196|Thrombectomy|thrombectomy
360260|NCT01600196|Hepatocellular carcinoma|hepatocellular carcinoma
360261|NCT01600196|Portal vein tumor thrombus|portal vein tumor thrombus
360262|NCT01600183|MTA|mta
360263|NCT01600183|metatarsus|metatarsus
360264|NCT01600183|Metatarsus Adductus, also known as Metatarsus Varus|metatarsus adductus, also known as metatarsus varus
360265|NCT01600170|HIV|hiv
360266|NCT01600170|monocytes|monocytes
360267|NCT01600170|CD16+|cd16+
360268|NCT01600170|statins|statins
360269|NCT01600170|mcp1|mcp1
360270|NCT01600170|inflammation|inflammation
360271|NCT01600144|data mammography|data mammography
360272|NCT01600118|tooth mobility|tooth mobility
360273|NCT01600118|periodontal status|periodontal status
360274|NCT01600118|irregularity index|irregularity index
360275|NCT01600118|pulpal blood flow|pulpal blood flow
360276|NCT01600105|liver fibrosis|liver fibrosis
360277|NCT01600105|liver cirrhosis|liver cirrhosis
360278|NCT01600105|chronic hepatitis|chronic hepatitis
360279|NCT01600105|magnetic resonance imaging|magnetic resonance imaging
360280|NCT01600079|Varicella-zoster vaccine|varicella-zoster vaccine
360281|NCT01600079|herpes zoster|herpes zoster
360282|NCT01600079|shingles|shingles
360283|NCT01600079|Varicella-zoster virus|varicella-zoster virus
360284|NCT01600079|postherpetic neuralgia|postherpetic neuralgia
360285|NCT01600079|Herpesviridae Infections|herpesviridae infections
360286|NCT01600079|DNA Virus Infections|dna virus infections
360287|NCT01600079|Virus Diseases|virus diseases
360288|NCT01600053|Chronic|chronic
360289|NCT01600053|Lymphocytic|lymphocytic
360290|NCT01600053|Leukemia|leukemia
360291|NCT01600040|metastatic|metastatic
360292|NCT01600027|Fascia iliaca block|fascia iliaca block
360293|NCT01600027|dexmetomidine|dexmetomidine
360294|NCT01600027|fracture femur|fracture femur
360295|NCT01600027|α2 agonist|α2 agonist
360296|NCT01600001|Chronic Idiopathic Constipation (CIC)|chronic idiopathic constipation (cic)
360297|NCT01600001|Constipation|constipation
360298|NCT01600001|Functional gastrointestinal disorders|functional gastrointestinal disorders
360299|NCT01599975|HAND|hand
360300|NCT01599975|HIV Associated Neurocognitive Disorder|hiv associated neurocognitive disorder
360301|NCT01599975|Methylphenidate|methylphenidate
360302|NCT01599975|HIV Dementia|hiv dementia
360303|NCT01599949|Mantle cell lymphoma|mantle cell lymphoma
360304|NCT01599949|Ibrutinib|ibrutinib
360305|NCT01599949|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
360306|NCT01599949|Rituximab|rituximab
360307|NCT01599949|Bortezomib|bortezomib
360308|NCT01599936|scorpion sting|scorpion sting
360309|NCT01599936|envenomation|envenomation
360310|NCT01599936|Anascorp|anascorp
360311|NCT01599923|scorpion|scorpion
360312|NCT01599923|envenomation|envenomation
360313|NCT01599923|Alacramyn|alacramyn
360314|NCT01599910|Scribes|scribes
360315|NCT01599910|Physician Productivity|physician productivity
360316|NCT01599910|Electronic Documentation|electronic documentation
360317|NCT01599897|Tuberculosis|tuberculosis
360318|NCT01599897|TB|tb
360319|NCT01599897|Pulmonary|pulmonary
360320|NCT01599897|Vaccine|vaccine
360321|NCT01599884|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
360322|NCT01599884|Chronic bronchitis|chronic bronchitis
360323|NCT01599884|N-acetylcysteine|n-acetylcysteine
360324|NCT01599871|COPD|copd
360325|NCT01599858|YF476|yf476
360326|NCT01599858|gastrin receptor antagonist|gastrin receptor antagonist
360327|NCT01599858|gastric pH|gastric ph
360328|NCT01599858|healthy subjects|healthy subjects
360329|NCT01599858|omeprazole|omeprazole
360330|NCT01599845|Lung|lung
360331|NCT01599845|Alveoli|alveoli
360332|NCT01599845|Nanoparticles|nanoparticles
360333|NCT01599845|Particulate matter|particulate matter
360334|NCT01599845|Exhaled breath condensate|exhaled breath condensate
360335|NCT01599845|Induced sputum|induced sputum
360336|NCT01599845|Forced expiratory volume|forced expiratory volume
360337|NCT01599845|Force vital capacity|force vital capacity
360338|NCT01599806|Ceftazidime, Avibactam, Doripenem, Ciprofloxacin, sulfamethoxazole/trimethoprim, Anti-Infective Agents, Complicated Urinary Tract Infection,Acute Pyelonephritis|ceftazidime, avibactam, doripenem, ciprofloxacin, sulfamethoxazole/trimethoprim, anti-infective agents, complicated urinary tract infection,acute pyelonephritis
360339|NCT01599793|castrate resistant prostate cancer|castrate resistant prostate cancer
360340|NCT01599793|CRPC|crpc
360341|NCT01599793|cabozantinib|cabozantinib
360342|NCT01599793|XL184|xl184
360343|NCT01599780|preterm|preterm
360344|NCT01599780|premature|premature
360345|NCT01599780|prematurity|prematurity
360346|NCT01599780|children|children
360347|NCT01599780|child|child
360348|NCT01599780|kid|kid
360349|NCT01599780|toddler|toddler
360350|NCT01599780|infant|infant
360351|NCT01599780|baby|baby
360352|NCT01599780|language|language
360353|NCT01599780|development|development
360354|NCT01599780|skills|skills
360355|NCT01599780|listening|listening
360356|NCT01599780|talking|talking
360357|NCT01599780|communication|communication
360358|NCT01599780|speech|speech
360359|NCT01599780|processing|processing
360360|NCT01599767|transcranial stimulation|transcranial stimulation
360361|NCT01599767|direct current|direct current
360362|NCT01599754|renal cell carcinoma|renal cell carcinoma
360363|NCT01599754|axitinib|axitinib
360364|NCT01599754|tyrosine kinase inhibitor|tyrosine kinase inhibitor
360365|NCT01599741|X-rays|x-rays
360366|NCT01599741|Endovascular angiography|endovascular angiography
360367|NCT01599741|Image processing|image processing
360368|NCT01599728|Urocortin 2|urocortin 2
360369|NCT01599728|Urocortin 3|urocortin 3
360370|NCT01599728|Forearm venous occlusion plethysmography|forearm venous occlusion plethysmography
360371|NCT01599728|Heart failure|heart failure
360372|NCT01599728|Endothelium|endothelium
360373|NCT01599728|Substance P|substance p
360374|NCT01599715|Urinary Incontinence|urinary incontinence
360375|NCT01599715|Weak bladder|weak bladder
360667|NCT01598662|expulsion|expulsion
360376|NCT01599715|Frequent urination|frequent urination
360377|NCT01599715|Overactive bladder|overactive bladder
360378|NCT01599715|Urine leakage|urine leakage
360379|NCT01599715|Stress incontinence|stress incontinence
360380|NCT01599715|Urge Incontinence|urge incontinence
360381|NCT01599715|Pelvic Floor weakness|pelvic floor weakness
360382|NCT01599715|Pelvic Floor Muscle Exercises|pelvic floor muscle exercises
360383|NCT01599715|Kegel exercises|kegel exercises
360384|NCT01599715|Self-Care|self-care
360385|NCT01599702|IBD|ibd
360386|NCT01599702|IDA|ida
360387|NCT01599702|Subjects|subjects
360388|NCT01599702|diagnosis|diagnosis
360389|NCT01599689|Delirium|delirium
360390|NCT01599689|Delirium, Dementia, Amnestic, Cognitive Disorders|delirium, dementia, amnestic, cognitive disorders
360391|NCT01599689|Confusion|confusion
360392|NCT01599689|Neurobehavioral Manifestations|neurobehavioral manifestations
360393|NCT01599689|Neurologic Manifestations|neurologic manifestations
360394|NCT01599689|Nervous System Diseases|nervous system diseases
360395|NCT01599689|Signs and Symptoms|signs and symptoms
360396|NCT01599689|Mental Disorders|mental disorders
360397|NCT01599689|Cardiac Surgery|cardiac surgery
360398|NCT01599689|Mirrors|mirrors
360399|NCT01599676|Citrulline|citrulline
360400|NCT01599676|protein-energy malnutrition|protein-energy malnutrition
360401|NCT01599676|amino acids|amino acids
360402|NCT01599676|muscle strength|muscle strength
360403|NCT01599676|resistance training|resistance training
360404|NCT01599663|Pain management|pain management
360405|NCT01599663|Pain assessment|pain assessment
360406|NCT01599663|Intensive care unit|intensive care unit
360407|NCT01599663|Adult|adult
360408|NCT01599650|Macular Edema, Branch Retinal Vein Occlusion, visual impairment|macular edema, branch retinal vein occlusion, visual impairment
360409|NCT01599637|Chronic idiopathic urticaria|chronic idiopathic urticaria
360411|NCT01599637|Xolair|xolair
360412|NCT01599637|IGE025|ige025
360413|NCT01599637|FcεRI|fcεri
360414|NCT01599637|IgE|ige
360415|NCT01599624|Resilience|resilience
360416|NCT01599624|Perceived stress|perceived stress
360417|NCT01599624|PTSD symptoms|ptsd symptoms
360418|NCT01599624|Depression|depression
360419|NCT01599624|Anxiety|anxiety
360420|NCT01599624|Sleep quality|sleep quality
360421|NCT01599624|United States Navy service members|united states navy service members
360422|NCT01599611|Neonatal hyperbilirubinemia|neonatal hyperbilirubinemia
360423|NCT01599611|Follow-up|follow-up
360424|NCT01599611|Motor development|motor development
360425|NCT01599611|Hearing|hearing
360426|NCT01599611|Executive function|executive function
360427|NCT01599598|perceived stress|perceived stress
360428|NCT01599598|depression|depression
360429|NCT01599598|anxiety|anxiety
360430|NCT01599598|posttraumatic stress disorder|posttraumatic stress disorder
360431|NCT01599598|military|military
360432|NCT01599598|school|school
360433|NCT01599598|training environment|training environment
360434|NCT01599598|heart rate variability|heart rate variability
360435|NCT01599598|progressive muscle relaxation|progressive muscle relaxation
360436|NCT01599598|psychophysiological coherence|psychophysiological coherence
360437|NCT01599598|coherence advantage|coherence advantage
360438|NCT01599598|stress reduction|stress reduction
360439|NCT01599598|stress regulation|stress regulation
360440|NCT01599598|independent duty corpsmen|independent duty corpsmen
360441|NCT01599585|Depression|depression
360442|NCT01599585|Behavioral Activation|behavioral activation
360443|NCT01599585|Tele-medicine|tele-medicine
360444|NCT01599572|zinc supplementation|zinc supplementation
360445|NCT01599572|serum zinc concentration|serum zinc concentration
360446|NCT01599572|lymphocyte proliferation|lymphocyte proliferation
360447|NCT01599559|previously|previously
360448|NCT01599559|untreated|untreated
360449|NCT01599546|Preterm|preterm
360450|NCT01599546|Full term|full term
360451|NCT01599546|Reading|reading
360452|NCT01599546|Dyslexia|dyslexia
360453|NCT01599546|Brain|brain
360454|NCT01599546|Diffusion tensor imaging|diffusion tensor imaging
360455|NCT01599520|cancer|cancer
360456|NCT01599520|stress|stress
360457|NCT01599520|stress management|stress management
360458|NCT01599520|Latinas|latinas
360459|NCT01599520|Hispanics|hispanics
360460|NCT01599507|Anemia|anemia
360461|NCT01599507|Renal|renal
360462|NCT01599481|Common mental illness|common mental illness
360463|NCT01599481|Supported Employment|supported employment
360464|NCT01599481|Anxiety|anxiety
360465|NCT01599481|Depression|depression
360466|NCT01599481|Sickness absence|sickness absence
360467|NCT01599468|post partum hemorrhage|post partum hemorrhage
360468|NCT01599468|transfusion|transfusion
360469|NCT01599468|tranexamic acid|tranexamic acid
360470|NCT01599455|pediatric spinal cord injury|pediatric spinal cord injury
360471|NCT01599455|blood pressure|blood pressure
360472|NCT01599455|heart rate|heart rate
360473|NCT01599455|baseline|baseline
360474|NCT01599429|AML / LMA|aml / lma
360475|NCT01599416|Oral Probiotics|oral probiotics
360476|NCT01599416|HPV DNA Index Test|hpv dna index test
360477|NCT01599416|Vaginal infection|vaginal infection
360478|NCT01599403|Rib Fracture|rib fracture
360479|NCT01599403|Intercostal Nerve Block|intercostal nerve block
360480|NCT01599403|Paravertebral Nerve Block|paravertebral nerve block
360481|NCT01599390|United States|united states
360482|NCT01599390|Burden of Disease|burden of disease
360483|NCT01599390|Influenza|influenza
360484|NCT01599364|HIV infection|hiv infection
360485|NCT01599364|Atazanavir|atazanavir
360486|NCT01599364|Lamivudine|lamivudine
360487|NCT01599364|Ritonavir|ritonavir
360488|NCT01599364|virological suppression|virological suppression
360489|NCT01599364|non-inferiority|non-inferiority
360490|NCT01599364|Combined antiretroviral therapy|combined antiretroviral therapy
360491|NCT01599351|Radiation exposure|radiation exposure
360492|NCT01599351|ERCP|ercp
360493|NCT01599338|Liraglutide|liraglutide
360494|NCT01599338|GLP-1 analogue|glp-1 analogue
360495|NCT01599338|Food preference|food preference
360496|NCT01599338|Gustative perception|gustative perception
360497|NCT01599338|Liking|liking
360498|NCT01599338|wanting|wanting
360499|NCT01599338|T2DM|t2dm
360500|NCT01599338|body mass composition|body mass composition
360501|NCT01599338|leptin|leptin
360502|NCT01599338|ghrelin|ghrelin
360503|NCT01599312|Videolaryngoscopy|videolaryngoscopy
360504|NCT01599312|Forces|forces
360505|NCT01599312|Teeth|teeth
360506|NCT01599299|ultrasound|ultrasound
360507|NCT01599299|left and right jugular vein|left and right jugular vein
360508|NCT01599299|comparison|comparison
360509|NCT01599286|Hyperammonia|hyperammonia
360510|NCT01599286|Propionic Acidemia (PA)|propionic acidemia (pa)
360511|NCT01599286|Methylmalonic Acidemia (MMA)|methylmalonic acidemia (mma)
360512|NCT01599286|Late-Onset CPS1 Deficiency (CPSD)|late-onset cps1 deficiency (cpsd)
360513|NCT01599286|Late-Onset Ornithine Transcarbamylase Deficiency (OTCD)|late-onset ornithine transcarbamylase deficiency (otcd)
360514|NCT01599286|Carbaglu|carbaglu
360515|NCT01599273|thyroid-associated ophthalmopathy|thyroid-associated ophthalmopathy
360516|NCT01599273|triamcinolone|triamcinolone
360517|NCT01599273|retraction|retraction
360518|NCT01599273|swelling|swelling
360519|NCT01599247|Suicide|suicide
360520|NCT01599247|Optimism|optimism
360521|NCT01599247|Hopelessness|hopelessness
360522|NCT01599221|Femoral fractures|femoral fractures
360523|NCT01599221|Nail|nail
360524|NCT01599221|Implant|implant
360525|NCT01599221|Elderly|elderly
360526|NCT01599221|Orthopaedics|orthopaedics
360527|NCT01599195|carotid stenosis|carotid stenosis
360528|NCT01599195|femoral artery ischemia|femoral artery ischemia
360529|NCT01599195|carotid bruit asymptomatic|carotid bruit asymptomatic
360530|NCT01599195|carotid murmur|carotid murmur
360531|NCT01599169|Burnout syndrome|burnout syndrome
360532|NCT01599169|Depression work-related|depression work-related
360533|NCT01599169|Food supplement|food supplement
360534|NCT01599156|Chronic constipation|chronic constipation
360535|NCT01599156|Reflexology|reflexology
360536|NCT01599156|Complementary medicine|complementary medicine
360537|NCT01599143|Mindfulness|mindfulness
360538|NCT01599143|Pain Disorder (Chronic physical or mental health complaints:|pain disorder (chronic physical or mental health complaints:
360539|NCT01599143|Fibromyalgia; Migraines; Back Pain; etc)|fibromyalgia; migraines; back pain; etc)
360540|NCT01599143|Anxiety Disorder/Anxiety State|anxiety disorder/anxiety state
360541|NCT01599130|Hepatitis B|hepatitis b
360542|NCT01599130|sequential peg-interferon-2a to entecavir|sequential peg-interferon-2a to entecavir
360543|NCT01599117|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
360544|NCT01599117|Diastolic Heart Failure|diastolic heart failure
360545|NCT01599117|Exercise Capacity|exercise capacity
360546|NCT01599117|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
360547|NCT01599117|Udenafil (Zydena)|udenafil (zydena)
360548|NCT01599117|Phosphodiesterase Type 5 Inhibitors|phosphodiesterase type 5 inhibitors
360549|NCT01599104|Essential hypertension|essential hypertension
360550|NCT01599104|LCZ696|lcz696
360551|NCT01599091|Fibroblasts|fibroblasts
360552|NCT01599091|Periodontal ligament|periodontal ligament
360553|NCT01599091|Gingiva|gingiva
360554|NCT01599091|Porphyromonas gingivalis|porphyromonas gingivalis
360555|NCT01599091|Chronic periodontitis|chronic periodontitis
360556|NCT01599091|( patients undergoing tooth extraction will be asked permission to use extracted tooth and gingiva for periodontal disease basic research)|( patients undergoing tooth extraction will be asked permission to use extracted tooth and gingiva for periodontal disease basic research)
360557|NCT01599078|Restenosis|restenosis
360558|NCT01599078|Angioplasty|angioplasty
360559|NCT01599078|Stent|stent
360560|NCT01599078|Atherectomy|atherectomy
360561|NCT01599078|Femoral Artery|femoral artery
360562|NCT01599078|Popliteal Artery|popliteal artery
360563|NCT01599078|Paclitaxel|paclitaxel
360564|NCT01599065|ICD|icd
360565|NCT01599065|internal cardioverter defibrillator|internal cardioverter defibrillator
360566|NCT01599065|electrocautery|electrocautery
360567|NCT01599052|Social Cognition|social cognition
360568|NCT01599052|Theory of Mind|theory of mind
360569|NCT01599052|Emotion Recognition|emotion recognition
360570|NCT01599052|Social competence|social competence
360571|NCT01599052|Brain Tumour|brain tumour
360572|NCT01599039|early diagnostics|early diagnostics
360573|NCT01599039|lymphedema|lymphedema
360965|NCT01597362|trocars|trocars
360574|NCT01599039|breast cancer|breast cancer
360575|NCT01599039|breast cancer related lymphedema|breast cancer related lymphedema
360576|NCT01599039|measuring methods|measuring methods
360577|NCT01599039|inverse water volumetry|inverse water volumetry
360578|NCT01599039|prevention|prevention
360579|NCT01599026|cardiology|cardiology
360580|NCT01599026|fetus of diabetic mother|fetus of diabetic mother
360581|NCT01599013|urothelial carcinoma|urothelial carcinoma
360582|NCT01599013|bladder cancer|bladder cancer
360583|NCT01599013|vinflunine|vinflunine
360584|NCT01599013|transitional cell carcinoma|transitional cell carcinoma
360585|NCT01599013|advanced or metastatic|advanced or metastatic
360586|NCT01599013|unfit|unfit
360587|NCT01599013|ineligible to cisplatin|ineligible to cisplatin
360588|NCT01599013|renal impairment|renal impairment
360589|NCT01599013|renal insufficiency|renal insufficiency
360590|NCT01599013|urologic neoplasms|urologic neoplasms
360591|NCT01599013|urogenital neoplasm|urogenital neoplasm
360592|NCT01599013|urinary neoplasms|urinary neoplasms
360593|NCT01599013|cisplatin|cisplatin
360594|NCT01599013|tubulin inhibitors|tubulin inhibitors
360595|NCT01599000|malaria|malaria
360596|NCT01599000|Plasmodium|plasmodium
360597|NCT01599000|Papua New Guinea|papua new guinea
360598|NCT01599000|artemether/lumefantrine|artemether/lumefantrine
360599|NCT01598987|Paediatric liver transplantation|paediatric liver transplantation
360600|NCT01598987|Everolimus|everolimus
360601|NCT01598987|Reduced calcineurin inhibitor|reduced calcineurin inhibitor
360602|NCT01598987|Cyclosporine, tacrolimus|cyclosporine, tacrolimus
360603|NCT01598987|Renal function|renal function
360604|NCT01598987|Composite efficacy endpoint (treated biopsy proven acute rejection death, graft loss)|composite efficacy endpoint (treated biopsy proven acute rejection death, graft loss)
360605|NCT01598987|Liver transplant|liver transplant
360606|NCT01598974|Lower Back Pain|lower back pain
360607|NCT01598974|Acupuncture|acupuncture
360608|NCT01598948|hypercholesterolemia|hypercholesterolemia
360609|NCT01598948|apheresis|apheresis
360610|NCT01598948|coronary heart disease|coronary heart disease
360611|NCT01598948|cerebrovascular disease|cerebrovascular disease
360612|NCT01598948|peripheral arterial disease|peripheral arterial disease
360613|NCT01598922|Depression|depression
360614|NCT01598922|Internet Cognitive Behavioral Therapy|internet cognitive behavioral therapy
360615|NCT01598922|fMRI|fmri
360616|NCT01598922|Neuroimaging|neuroimaging
360617|NCT01598909|blepharoplasty|blepharoplasty
360618|NCT01598909|arnica|arnica
360619|NCT01598909|homeopathy|homeopathy
360620|NCT01598896|Cannabis Dependence|cannabis dependence
360621|NCT01598896|Marijuana Dependence|marijuana dependence
360622|NCT01598896|Cannabis Use Disorders|cannabis use disorders
360623|NCT01598896|Cannabis Withdrawal|cannabis withdrawal
360624|NCT01598896|Dronabinol|dronabinol
360625|NCT01598896|Clonidine|clonidine
360626|NCT01598896|Schizophrenia|schizophrenia
360627|NCT01598870|Spontaneous bacterial peritonitis.|spontaneous bacterial peritonitis.
360628|NCT01598857|granulomatosis with polyangiitis|granulomatosis with polyangiitis
360629|NCT01598857|microscopic polyangiitis|microscopic polyangiitis
360630|NCT01598857|anti-neutrophil cytoplasmic antibodies|anti-neutrophil cytoplasmic antibodies
360631|NCT01598857|ANCA-associated vasculitis|anca-associated vasculitis
360632|NCT01598857|Wegener Granulomatosis|wegener granulomatosis
360633|NCT01598831|sepsis|sepsis
360634|NCT01598818|Vision Nearsighted|vision nearsighted
360635|NCT01598818|Vision Farsighted|vision farsighted
360885|NCT01597661|pregnancy|pregnancy
360636|NCT01598805|venous thromboembolism/prevention & control|venous thromboembolism/prevention & control
360637|NCT01598779|genital warts|genital warts
360638|NCT01598779|HPV types|hpv types
360639|NCT01598779|Sexually Transmitted Diseases|sexually transmitted diseases
360640|NCT01598779|Skin Diseases, Viral|skin diseases, viral
360641|NCT01598779|Tumor Virus Infections|tumor virus infections
360642|NCT01598779|Skin Diseases, Infectious|skin diseases, infectious
360643|NCT01598779|Skin Diseases|skin diseases
360644|NCT01598779|Papillomavirus Infections|papillomavirus infections
360645|NCT01598779|DNA Virus Infections|dna virus infections
360646|NCT01598779|Virus Diseases|virus diseases
360647|NCT01598779|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
360648|NCT01598727|parathyroid surgery|parathyroid surgery
360649|NCT01598701|Acetaminophen|acetaminophen
360650|NCT01598701|Intravenous Acetaminophen|intravenous acetaminophen
360651|NCT01598701|Opioid Requirement|opioid requirement
360652|NCT01598701|Pain|pain
360653|NCT01598701|Post-Operative Pain|post-operative pain
360654|NCT01598701|Craniotomy|craniotomy
360655|NCT01598701|Post-Craniotomy Pain|post-craniotomy pain
360656|NCT01598688|Bone marrow transplantation|bone marrow transplantation
360657|NCT01598688|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
360658|NCT01598688|Medication management|medication management
360659|NCT01598688|Nursing care|nursing care
360660|NCT01598675|stroke|stroke
360661|NCT01598675|Gait|gait
360662|NCT01598675|walking|walking
360663|NCT01598662|IUD placement|iud placement
360664|NCT01598662|contraception|contraception
360665|NCT01598662|postpartum|postpartum
360666|NCT01598662|intrauterine device|intrauterine device
360668|NCT01598649|Dietary protein|dietary protein
360669|NCT01598649|Lupin protein|lupin protein
360670|NCT01598649|Cholesterol metabolism|cholesterol metabolism
360671|NCT01598649|Protein metabolism|protein metabolism
360672|NCT01598649|Hypercholesterolemia|hypercholesterolemia
360673|NCT01598649|Protein-enriched foods|protein-enriched foods
360674|NCT01598584|Mirtazapine|mirtazapine
360675|NCT01598584|gemcitabine|gemcitabine
360676|NCT01598584|placebo|placebo
360678|NCT01598584|pancreatic cancer|pancreatic cancer
360679|NCT01598571|Phase 1|phase 1
360680|NCT01598571|Healthy male volunteers|healthy male volunteers
360681|NCT01598571|pharmacokinetics|pharmacokinetics
360682|NCT01598571|fostamatinib|fostamatinib
360683|NCT01598571|Bioavailability|bioavailability
360684|NCT01598571|R406 plasma AUC and Cmax|r406 plasma auc and cmax
360685|NCT01598571|R406 plasma AUC0-t|r406 plasma auc0-t
360686|NCT01598571|t1/2λz|t1/2λz
360687|NCT01598571|tmax|tmax
360688|NCT01598532|mild traumatic brain injury|mild traumatic brain injury
360689|NCT01598532|mild TBI|mild tbi
360690|NCT01598532|mTBI|mtbi
360691|NCT01598519|school-based|school-based
360692|NCT01598519|adolescent suicide|adolescent suicide
360693|NCT01598519|intervention|intervention
360694|NCT01598519|screening|screening
360695|NCT01598493|Burns|burns
360696|NCT01598493|Wound Healing|wound healing
360697|NCT01598480|Burns|burns
360698|NCT01598480|Wound Healing|wound healing
360699|NCT01598467|pelvic organ prolapse|pelvic organ prolapse
360700|NCT01598467|POP|pop
360701|NCT01598467|sacrocolpopexy|sacrocolpopexy
360702|NCT01598467|sacrohysteropexy|sacrohysteropexy
360703|NCT01598467|promontofixation|promontofixation
360704|NCT01598467|colpopexy|colpopexy
360705|NCT01598467|robotic surgery|robotic surgery
360706|NCT01598467|surgical complications|surgical complications
360707|NCT01598467|mesh|mesh
360708|NCT01598467|prolapse repair|prolapse repair
360709|NCT01598441|pulmonary hypertension, pulmonary hypertensive crisis|pulmonary hypertension, pulmonary hypertensive crisis
360710|NCT01598428|age related cataract|age related cataract
360711|NCT01598428|phacoemulsification|phacoemulsification
360712|NCT01598428|anterior capsule polishing|anterior capsule polishing
360713|NCT01598428|optical coherence tomography|optical coherence tomography
360714|NCT01598428|anterior chamber depth|anterior chamber depth
360715|NCT01598402|LAHNC|lahnc
360716|NCT01598402|Locally Advanced Head and Neck Cancer|locally advanced head and neck cancer
360717|NCT01598376|entropion|entropion
360718|NCT01598376|suture|suture
360719|NCT01598376|granuloma|granuloma
360720|NCT01598376|tissue reaction|tissue reaction
360721|NCT01598350|Gait|gait
360722|NCT01598350|Orthoses|orthoses
360723|NCT01598350|Down syndrome|down syndrome
360724|NCT01598324|magnetic resonance imaging|magnetic resonance imaging
360725|NCT01598324|magnetic resonance spectroscopy|magnetic resonance spectroscopy
360726|NCT01598324|depression|depression
360727|NCT01598324|escitalopram|escitalopram
360728|NCT01598324|selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
360729|NCT01598324|treatment-resistant depression|treatment-resistant depression
360730|NCT01598324|ziprasidone|ziprasidone
360731|NCT01598311|CDAD|cdad
360732|NCT01598311|Clostridium difficile Associated Diarrhea|clostridium difficile associated diarrhea
360733|NCT01598311|CDI|cdi
360734|NCT01598311|Clostridium difficile Infection|clostridium difficile infection
360735|NCT01598311|Diarrhea|diarrhea
360736|NCT01598298|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
360737|NCT01598298|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
360738|NCT01598298|stage IA breast cancer|stage ia breast cancer
360739|NCT01598298|stage IB breast cancer|stage ib breast cancer
360740|NCT01598298|stage II breast cancer|stage ii breast cancer
360741|NCT01598298|stage IIIA breast cancer|stage iiia breast cancer
360742|NCT01598298|stage IIIB breast cancer|stage iiib breast cancer
360743|NCT01598298|stage IIIC breast cancer|stage iiic breast cancer
360744|NCT01598298|pain|pain
360745|NCT01598298|musculoskeletal complications|musculoskeletal complications
360746|NCT01598285|Genome-Wide|genome-wide
360747|NCT01598285|GWAS|gwas
360748|NCT01598285|microRNA|microrna
360749|NCT01598285|miRNA|mirna
360750|NCT01598285|Bevacizumab Response Predictors|bevacizumab response predictors
360751|NCT01598285|Metastatic Breast Cancer|metastatic breast cancer
360752|NCT01598272|Ginseng|ginseng
360753|NCT01598272|Cordyceps|cordyceps
360754|NCT01598272|Pomegranate|pomegranate
360755|NCT01598272|Red Orange|red orange
360756|NCT01598272|Grape Seed|grape seed
360757|NCT01598272|Broccoli Seed|broccoli seed
360758|NCT01598246|Extubation failures|extubation failures
360759|NCT01598246|Sedation|sedation
360760|NCT01598220|schizophrenia|schizophrenia
360761|NCT01598220|cognitive remediation therapy|cognitive remediation therapy
360762|NCT01598220|cognition|cognition
360763|NCT01598220|quality of life|quality of life
360764|NCT01598194|solid pancreatic mass lesions|solid pancreatic mass lesions
360765|NCT01598194|22-gauge core biopsy needle|22-gauge core biopsy needle
360766|NCT01598194|reverse bevel design|reverse bevel design
360966|NCT01597362|veress|veress
360767|NCT01598194|endoscopic ultrasound|endoscopic ultrasound
360768|NCT01598194|EUS|eus
360769|NCT01598194|guided|guided
360770|NCT01598194|fine needle aspiration|fine needle aspiration
360771|NCT01598194|FNA|fna
360772|NCT01598168|rivaroxaban|rivaroxaban
360773|NCT01598168|treatment|treatment
360774|NCT01598168|venous thromboembolism|venous thromboembolism
360775|NCT01598168|arterial thromboembolism|arterial thromboembolism
360776|NCT01598168|thrombocytopenia|thrombocytopenia
360777|NCT01598155|dental biofilm|dental biofilm
360778|NCT01598155|periodontitis|periodontitis
360779|NCT01598155|maintenance|maintenance
360780|NCT01598155|randomized clinical trial|randomized clinical trial
360781|NCT01598155|biomarkers|biomarkers
360782|NCT01598155|bacterias|bacterias
360783|NCT01598155|gingival crevicular fluid|gingival crevicular fluid
360784|NCT01598142|Endoscopic retrograde cholangiopancreatography (ERCP)|endoscopic retrograde cholangiopancreatography (ercp)
360785|NCT01598142|Guidewires|guidewires
360786|NCT01598142|Cannulation|cannulation
360787|NCT01598142|Single-operator|single-operator
360788|NCT01598142|C-Hook|c-hook
360789|NCT01598129|Phase I|phase i
360790|NCT01598129|Dose escalation|dose escalation
360791|NCT01598129|oncolytic virus|oncolytic virus
360792|NCT01598103|Neurogenic detrusor overactivity|neurogenic detrusor overactivity
360793|NCT01598103|spinal cord lesions|spinal cord lesions
360794|NCT01598103|spinal cord injury|spinal cord injury
360795|NCT01598077|Breast cancer, gastric cancer, squamous cell carcinoma of head and neck, esophageal squamous cell carcinoma|breast cancer, gastric cancer, squamous cell carcinoma of head and neck, esophageal squamous cell carcinoma
360796|NCT01598077|Breast cancer|breast cancer
360797|NCT01598077|Gastric cancer|gastric cancer
360798|NCT01598077|Squamous cell carcinoma of head and neck|squamous cell carcinoma of head and neck
360799|NCT01598077|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
360800|NCT01598051|Xarelto|xarelto
360801|NCT01598051|SPAF|spaf
360802|NCT01598051|QOL|qol
360803|NCT01598038|cancer|cancer
360804|NCT01598038|renal|renal
360805|NCT01598038|Afinitor|afinitor
360806|NCT01598038|pharmacokinetics|pharmacokinetics
360807|NCT01598025|ANTITHYMOCYTE GLOBULIN:ATG|antithymocyte globulin:atg
360808|NCT01598025|FLUDARABINE|fludarabine
360809|NCT01598025|THI0TEPA|thi0tepa
360810|NCT01598025|CliniMACS-CD34 Reagent System|clinimacs-cd34 reagent system
360811|NCT01598025|12-053|12-053
360812|NCT01598012|Ayurved Siriraj Prasaplai|ayurved siriraj prasaplai
360813|NCT01598012|primary dysmenorrhea|primary dysmenorrhea
360814|NCT01597986|isavuconazole|isavuconazole
360815|NCT01597986|ethinyl estradiol|ethinyl estradiol
360816|NCT01597986|norethindrone|norethindrone
360817|NCT01597986|contraceptive|contraceptive
360818|NCT01597986|Healthy Volunteers|healthy volunteers
360819|NCT01597986|BAL8557|bal8557
360820|NCT01597986|BAL4815|bal4815
360821|NCT01597934|Chronic hepatitis B|chronic hepatitis b
360822|NCT01597934|Partial virologic response|partial virologic response
360823|NCT01597934|YMDD mutation|ymdd mutation
360824|NCT01597921|Breast conserving surgery|breast conserving surgery
360825|NCT01597921|Radiation dermatitis|radiation dermatitis
360826|NCT01597908|BRAF inhibitor|braf inhibitor
360827|NCT01597908|Metastatic Melanoma|metastatic melanoma
360828|NCT01597908|Cancer|cancer
360829|NCT01597908|MEK inhibitor|mek inhibitor
360830|NCT01597895|maraviroc|maraviroc
360831|NCT01597895|boceprevir|boceprevir
360832|NCT01597895|telaprevir|telaprevir
360833|NCT01597895|drug interaction|drug interaction
360834|NCT01597895|pharmacokinetics|pharmacokinetics
360835|NCT01597895|HIV|hiv
360836|NCT01597882|case management|case management
360837|NCT01597882|long term conditions|long term conditions
360838|NCT01597882|aged sixty five and over|aged sixty five and over
360839|NCT01597843|education|education
360840|NCT01597843|self care|self care
360841|NCT01597843|peer group|peer group
360842|NCT01597843|Computers|computers
360843|NCT01597843|Attitude to computers|attitude to computers
360844|NCT01597830|knee|knee
360845|NCT01597830|osteoarthritis|osteoarthritis
360846|NCT01597830|loading|loading
360847|NCT01597817|Atopic dermatitis|atopic dermatitis
360848|NCT01597817|Eczema|eczema
360849|NCT01597817|Textiles|textiles
360850|NCT01597791|Urinary Retention|urinary retention
360851|NCT01597791|Urinary Catheter|urinary catheter
360852|NCT01597791|Bacteriuria|bacteriuria
360853|NCT01597778|Haplo identical transplant|haplo identical transplant
360854|NCT01597778|Cord blood transplant|cord blood transplant
360855|NCT01597778|Reduced intensity conditioning regimen|reduced intensity conditioning regimen
360856|NCT01597778|Lymphoma|lymphoma
360857|NCT01597778|Leukemia|leukemia
360858|NCT01597765|Thalassemia|thalassemia
360859|NCT01597765|Oxidative stress|oxidative stress
360860|NCT01597765|antioxidant cocktail|antioxidant cocktail
360861|NCT01597752|Immunotherapy|immunotherapy
360862|NCT01597752|Skin prick test|skin prick test
360863|NCT01597752|Standardization|standardization
360864|NCT01597752|Blomia tropicalis|blomia tropicalis
360865|NCT01597739|Active rheumatoid arthritis despite disease-modifying antirheumatic drug therapy|active rheumatoid arthritis despite disease-modifying antirheumatic drug therapy
360866|NCT01597739|Disease-modifying antirheumatic drugs|disease-modifying antirheumatic drugs
360867|NCT01597726|Abortion, Induced|abortion, induced
360868|NCT01597726|Laminaria|laminaria
360869|NCT01597726|Misoprostol|misoprostol
360870|NCT01597726|Pregnancy Trimester, Second|pregnancy trimester, second
360871|NCT01597687|pertussis infection|pertussis infection
360872|NCT01597687|Prevalence|prevalence
360873|NCT01597687|health economic burden|health economic burden
360874|NCT01597687|prolonged cough|prolonged cough
360875|NCT01597674|YF476|yf476
360876|NCT01597674|gastrin receptor antagonist|gastrin receptor antagonist
360877|NCT01597674|gastric pH|gastric ph
360878|NCT01597674|gastrin|gastrin
360879|NCT01597674|healthy subjects|healthy subjects
360880|NCT01597661|first trimester|first trimester
360881|NCT01597661|left outflow tract obstruction|left outflow tract obstruction
360882|NCT01597661|Bupropion|bupropion
360883|NCT01597661|cardiovascular malformation|cardiovascular malformation
360884|NCT01597661|antidepressants|antidepressants
360886|NCT01597661|cardiovascular defect|cardiovascular defect
360887|NCT01597661|congenital malformation|congenital malformation
360888|NCT01597648|Combivir™, HIV, bioequivalence, Combined Formulated Tablet, Combined Formulated Tablet, HIV, bioequivalence, Combivir, Selzentry™, Celsentri™, lamivudine, zidov|combivir™, hiv, bioequivalence, combined formulated tablet, combined formulated tablet, hiv, bioequivalence, combivir, selzentry™, celsentri™, lamivudine, zidov
360889|NCT01597635|rhACE2|rhace2
360890|NCT01597635|Acute Respiratory Distress Syndrome (ARDS)|acute respiratory distress syndrome (ards)
360891|NCT01597635|Acute Lung Injury|acute lung injury
360892|NCT01597635|GSK2586881|gsk2586881
360893|NCT01597635|critical care|critical care
360894|NCT01597622|SELENA|selena
360895|NCT01597622|belimumab|belimumab
360896|NCT01597622|Lupus|lupus
360897|NCT01597622|systemic lupus erythematosus|systemic lupus erythematosus
360898|NCT01597622|PGA|pga
360899|NCT01597622|BLys|blys
360900|NCT01597622|SLE Flare Index|sle flare index
360901|NCT01597622|continuation|continuation
360902|NCT01597622|phase III|phase iii
360903|NCT01597622|BILAG|bilag
360904|NCT01597622|extension|extension
360905|NCT01597622|efficacy|efficacy
360906|NCT01597622|SRI|sri
360907|NCT01597622|B cell|b cell
360908|NCT01597622|SLEDAI|sledai
360909|NCT01597622|safety|safety
360910|NCT01597622|Asia|asia
360911|NCT01597622|B lymphocyte|b lymphocyte
360912|NCT01597557|Atrial Fibrillation|atrial fibrillation
360913|NCT01597557|Electrical Cardioversion|electrical cardioversion
360914|NCT01597557|Magnesium Sulfate|magnesium sulfate
360915|NCT01597544|Voiding dysfunction|voiding dysfunction
360916|NCT01597544|bladder catheter|bladder catheter
360917|NCT01597544|prolapse surgery|prolapse surgery
360918|NCT01597544|patient satisfaction|patient satisfaction
360919|NCT01597531|Liraglutide|liraglutide
360920|NCT01597531|Orlistat|orlistat
360921|NCT01597518|Riluzole|riluzole
360922|NCT01597518|spinal cord injury|spinal cord injury
360923|NCT01597518|treatment|treatment
360924|NCT01597505|CDAD|cdad
360925|NCT01597505|Clostridium difficile Associated Diarrhea|clostridium difficile associated diarrhea
360926|NCT01597505|CDI|cdi
360927|NCT01597505|Clostridium difficile Infection|clostridium difficile infection
360928|NCT01597505|Diarrhea|diarrhea
360929|NCT01597492|Antibodies|antibodies
360930|NCT01597492|Vaccines|vaccines
360931|NCT01597492|SLE|sle
360932|NCT01597492|Immune System Diseases|immune system diseases
360933|NCT01597492|Biological Therapy|biological therapy
360934|NCT01597492|Autoimmune Diseases|autoimmune diseases
360935|NCT01597492|Pneumococcal Vaccines|pneumococcal vaccines
360936|NCT01597492|Lupus|lupus
360937|NCT01597492|Immunoglobulins|immunoglobulins
360938|NCT01597492|Vaccination|vaccination
360939|NCT01597492|Belimumab|belimumab
360940|NCT01597492|Biological Agents|biological agents
360941|NCT01597492|Immunization|immunization
360942|NCT01597479|Ultrasound guided distal peripheral nerve blocks|ultrasound guided distal peripheral nerve blocks
360943|NCT01597453|Young ischemic stroke|young ischemic stroke
360944|NCT01597453|Families|families
360945|NCT01597453|Long-term follow-up|long-term follow-up
360946|NCT01597440|Propionic acidemia (PA)|propionic acidemia (pa)
360947|NCT01597440|Methylmalonic acidemia (MMA)|methylmalonic acidemia (mma)
360948|NCT01597440|Carbaglu NCG|carbaglu ncg
360949|NCT01597440|Hyperammonia|hyperammonia
360950|NCT01597427|Clonidine|clonidine
360951|NCT01597427|Hypertension Pulmonary|hypertension pulmonary
360952|NCT01597427|Cardiac Surgical Procedures|cardiac surgical procedures
360953|NCT01597401|Antisickling Agents|antisickling agents
360954|NCT01597388|Estrogen receptor positive|estrogen receptor positive
360955|NCT01597388|Advanced metastatic breast cancer|advanced metastatic breast cancer
360956|NCT01597388|Estrogen receptor positive advanced metastatic breast cancer|estrogen receptor positive advanced metastatic breast cancer
360957|NCT01597375|Aspirin|aspirin
360958|NCT01597375|Prasugrel|prasugrel
360959|NCT01597375|Asthma|asthma
360960|NCT01597375|AERD|aerd
360961|NCT01597375|Aspirin challenge|aspirin challenge
360962|NCT01597375|Aspirin desensitization|aspirin desensitization
360963|NCT01597375|Aspirin induced asthma|aspirin induced asthma
360964|NCT01597362|laparoscopy|laparoscopy
360967|NCT01597362|open|open
360968|NCT01597362|direct|direct
360969|NCT01597336|abscess|abscess
360970|NCT01597336|tPA|tpa
360971|NCT01597323|Wrinkle Reduction|wrinkle reduction
360972|NCT01597323|Skin Resurfacing|skin resurfacing
360973|NCT01597323|Skin Texture Improvement|skin texture improvement
360974|NCT01597284|Oral therapies|oral therapies
360975|NCT01597284|Cancer|cancer
360976|NCT01597284|cognitive function|cognitive function
360977|NCT01597284|compliance|compliance
360978|NCT01597258|Safety|safety
360979|NCT01597258|All cases surveillance in Japan|all cases surveillance in japan
360980|NCT01597258|ALK-positive unresectable advanced and/or recurrent non-small cell lung cancer|alk-positive unresectable advanced and/or recurrent non-small cell lung cancer
360981|NCT01597232|Transfusion trigger|transfusion trigger
360982|NCT01597232|Hemoglobin level|hemoglobin level
360983|NCT01597219|Haploidentical transplant|haploidentical transplant
360984|NCT01597219|Haematological malignancy|haematological malignancy
360985|NCT01597219|Myeloablative|myeloablative
360986|NCT01597219|Reduced intensity|reduced intensity
360987|NCT01597206|randomized controlled trial|randomized controlled trial
360988|NCT01597206|intervention|intervention
360989|NCT01597206|posterior reduced dental arch|posterior reduced dental arch
360990|NCT01597206|patient satisfaction|patient satisfaction
360991|NCT01597206|sequential sampling|sequential sampling
360992|NCT01597193|enzalutamide|enzalutamide
360993|NCT01597193|MDV3100|mdv3100
360994|NCT01597193|breast cancer|breast cancer
360995|NCT01597180|contraception|contraception
360996|NCT01597180|HIV|hiv
360997|NCT01597180|pharmacokinetics|pharmacokinetics
360998|NCT01597180|pharmacodynamics|pharmacodynamics
360999|NCT01597167|mild moderate treatment-resistant depression|mild moderate treatment-resistant depression
361000|NCT01597167|magnesium sulfate|magnesium sulfate
361001|NCT01597154|Adolescent|adolescent
361002|NCT01597154|Type 2 Diabetes|type 2 diabetes
361003|NCT01597154|Peer mentorship|peer mentorship
361004|NCT01597141|Prodromal|prodromal
361005|NCT01597141|Schizophrenia|schizophrenia
361006|NCT01597141|Psychosis|psychosis
361007|NCT01597141|Family psychoeducation|family psychoeducation
361008|NCT01597141|Assertive community treatment|assertive community treatment
361009|NCT01597141|Supported employment|supported employment
361010|NCT01597141|Supported education|supported education
361011|NCT01597128|Hernia|hernia
361012|NCT01597128|human tissue|human tissue
361013|NCT01597128|mesh|mesh
361014|NCT01597115|duplex study|duplex study
361015|NCT01597115|hemodialysis access|hemodialysis access
361016|NCT01597115|maturation rate|maturation rate
361017|NCT01597115|endovascular intervention|endovascular intervention
361018|NCT01597102|encephalopathy, hepatic|encephalopathy, hepatic
361019|NCT01597102|autoregulation, cerebrovascular|autoregulation, cerebrovascular
361020|NCT01597102|liver failure|liver failure
361021|NCT01597102|liver transplantation|liver transplantation
361022|NCT01597089|Specificity|specificity
361023|NCT01597089|Bronchoalveolar Lavage|bronchoalveolar lavage
361024|NCT01597089|Film Array Assay|film array assay
361025|NCT01597089|Nasopharyngeal Swab|nasopharyngeal swab
361026|NCT01597089|Sensitivity|sensitivity
361027|NCT01597076|Morinda citrifolia|morinda citrifolia
361028|NCT01597076|noni|noni
361029|NCT01597076|advanced glycation end products|advanced glycation end products
361030|NCT01597076|oxidative stress|oxidative stress
361031|NCT01597076|quality of life|quality of life
361032|NCT01597076|metabolic syndrome|metabolic syndrome
361033|NCT01597076|safety|safety
361034|NCT01597050|Discoid Lupus Erythematosus|discoid lupus erythematosus
361035|NCT01597050|Systemic Lupus Erythematosus|systemic lupus erythematosus
361036|NCT01597037|Aphasia|aphasia
361037|NCT01597037|Speech Rehabilitation|speech rehabilitation
361038|NCT01597024|appetite|appetite
361039|NCT01597024|food|food
361040|NCT01597024|gut|gut
361041|NCT01597024|brain|brain
361042|NCT01597024|satiety|satiety
361043|NCT01597024|hunger|hunger
361044|NCT01597024|gut hormones|gut hormones
361045|NCT01597011|Hernia, Inguinal|hernia, inguinal
361046|NCT01597011|Hernia repair|hernia repair
361047|NCT01597011|Fibrin Tissue Adhesive|fibrin tissue adhesive
361048|NCT01597011|Tisseel|tisseel
361049|NCT01597011|Tissucol|tissucol
361050|NCT01597011|Recurrence|recurrence
361051|NCT01597011|Chronic Pain|chronic pain
361052|NCT01597011|Dysejaculation|dysejaculation
361053|NCT01596998|anesthesia, conduction|anesthesia, conduction
361054|NCT01596998|transversus abdominis plane block|transversus abdominis plane block
361055|NCT01596998|Vasoconstrictor Agents|vasoconstrictor agents
361056|NCT01596998|Ultrasonography|ultrasonography
361057|NCT01596985|Endometrioma|endometrioma
361058|NCT01596985|Endometriosis|endometriosis
361059|NCT01596985|Cystectomy|cystectomy
361060|NCT01596985|Ablation|ablation
361061|NCT01596985|Plasma energy|plasma energy
361062|NCT01596959|atrial flutter|atrial flutter
361063|NCT01596959|ablation|ablation
361064|NCT01596959|irrigation|irrigation
361065|NCT01596959|contact|contact
361066|NCT01596959|ECI|eci
361067|NCT01596946|contact tracing|contact tracing
361068|NCT01596946|home sampling|home sampling
361069|NCT01596946|cluster randomisation|cluster randomisation
361070|NCT01596933|head and neck cancer|head and neck cancer
361071|NCT01596933|omega-3 fatty acid supplementation|omega-3 fatty acid supplementation
361072|NCT01596933|echium oil|echium oil
361073|NCT01596933|weight loss|weight loss
361074|NCT01596933|cancer cachexia|cancer cachexia
361075|NCT01596933|body composition|body composition
361076|NCT01596933|biomarker|biomarker
361077|NCT01596933|quality of life|quality of life
361078|NCT01596920|Chronic DFUs|chronic dfus
361079|NCT01596920|Diabetic Foot Ulcers|diabetic foot ulcers
361080|NCT01596907|resting energy expenditure|resting energy expenditure
361081|NCT01596907|fat free mass|fat free mass
361082|NCT01596907|lean body mass|lean body mass
361083|NCT01596907|bariatric surgery|bariatric surgery
361084|NCT01596907|morbid obesity|morbid obesity
361085|NCT01596907|ephedrine|ephedrine
361086|NCT01596907|caffeine|caffeine
361087|NCT01596907|Low metabolic rate|low metabolic rate
361088|NCT01596907|Low lean body mass|low lean body mass
361089|NCT01596907|Weight loss rate|weight loss rate
361090|NCT01596894|Pediatric|pediatric
361091|NCT01596894|Crohn's disease|crohn's disease
361092|NCT01596894|Azithromycin|azithromycin
361093|NCT01596894|Metronidazole|metronidazole
361094|NCT01596894|Mild to moderate Crohn's Disease|mild to moderate crohn's disease
361095|NCT01596881|Multiple sclerosis|multiple sclerosis
361096|NCT01596881|Blood flow|blood flow
361097|NCT01596881|Optical Coherence Tomography|optical coherence tomography
361098|NCT01596881|Imaging|imaging
361099|NCT01596868|Advanced Nasopharyngeal Carcinoma|advanced nasopharyngeal carcinoma
361100|NCT01596868|treatment|treatment
361101|NCT01596868|Northwest China|northwest china
361102|NCT01596855|Anemia|anemia
361103|NCT01596855|Renal|renal
361104|NCT01596842|Omega-3 fatty acid|omega-3 fatty acid
361105|NCT01596842|vitamin D|vitamin d
361106|NCT01596842|ergocalciferol|ergocalciferol
361107|NCT01596842|hemodialysis|hemodialysis
361108|NCT01596829|antibiotic|antibiotic
361109|NCT01596829|probiotic|probiotic
361110|NCT01596829|antibiotic-associated diarrhoea|antibiotic-associated diarrhoea
361111|NCT01596829|faecal microbiota|faecal microbiota
361112|NCT01596816|prostate cancer|prostate cancer
361113|NCT01596803|FSHD|fshd
361114|NCT01596803|Antioxidants|antioxidants
361115|NCT01596803|Oxidative stress|oxidative stress
361116|NCT01596803|Muscle function|muscle function
361117|NCT01596803|Quality of life|quality of life
361118|NCT01596803|Activity|activity
361119|NCT01596803|(FSHD;4q35)|(fshd;4q35)
361120|NCT01596790|Bevacizumab|bevacizumab
361121|NCT01596790|Circulating tumor cells|circulating tumor cells
361122|NCT01596790|Treatment efficiency|treatment efficiency
361123|NCT01596777|Loperamide-induced obstipation|loperamide-induced obstipation
361124|NCT01596777|Methylnaltrexone|methylnaltrexone
361125|NCT01596777|oro-cecal transit time|oro-cecal transit time
361126|NCT01596777|whole gut transit time|whole gut transit time
361127|NCT01596777|Pharmacokinetics|pharmacokinetics
361128|NCT01596764|whole-gut transit time|whole-gut transit time
361129|NCT01596764|oro-cecal transit time|oro-cecal transit time
361130|NCT01596764|colon transit time|colon transit time
361131|NCT01596764|loperamide-induced obstipation|loperamide-induced obstipation
361132|NCT01596764|pharmacokinetics|pharmacokinetics
361133|NCT01596764|Methylnaltrexone|methylnaltrexone
361134|NCT01596764|Naloxone|naloxone
361135|NCT01596751|metastatic|metastatic
361136|NCT01596751|breast|breast
361137|NCT01596751|cancer|cancer
361138|NCT01596751|triple|triple
361139|NCT01596751|negative|negative
361140|NCT01596751|PLX|plx
361141|NCT01596751|Eribulin|eribulin
361142|NCT01596738|Coronary Artery Disease|coronary artery disease
361143|NCT01596738|Coronary Artery Bypass Graft|coronary artery bypass graft
361144|NCT01596738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
361145|NCT01596738|Tranexamic Acid|tranexamic acid
361146|NCT01596712|Allergy,|allergy,
361147|NCT01596712|Asthma,|asthma,
361148|NCT01596712|Atopic dermatitis,|atopic dermatitis,
361149|NCT01596712|Japanese,|japanese,
361150|NCT01596712|QGE031,|qge031,
361151|NCT01596712|IgE|ige
361152|NCT01596699|conditioning|conditioning
361153|NCT01596699|allogeneic|allogeneic
361154|NCT01596699|hematopoietic|hematopoietic
361155|NCT01596699|cell|cell
361156|NCT01596699|transplantation|transplantation
361157|NCT01596699|HCT|hct
361158|NCT01596660|Tap block|tap block
361159|NCT01596660|laparoscopic hysterectomy|laparoscopic hysterectomy
361160|NCT01596660|pain|pain
361161|NCT01596647|cancer, tumors, phase I, drug-drug interaction, pharmacokinetic, probe drug, caffeine, diclofenac, omeprazole, midazolam, CYP1A2, CYP2C9, CYP2C19, CYP3A4|cancer, tumors, phase i, drug-drug interaction, pharmacokinetic, probe drug, caffeine, diclofenac, omeprazole, midazolam, cyp1a2, cyp2c9, cyp2c19, cyp3a4
361162|NCT01596621|Bendamustine hydrochloride|bendamustine hydrochloride
361163|NCT01596621|CEP-18083|cep-18083
361164|NCT01596621|Treanda®|treanda®
361165|NCT01596621|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
361166|NCT01596608|Magnetic seizure therapy|magnetic seizure therapy
361167|NCT01596608|Treatment resistance|treatment resistance
361360|NCT01595867|snorting|snorting
361168|NCT01596608|Open-label trial|open-label trial
361169|NCT01596608|Treatment resistant depression|treatment resistant depression
361170|NCT01596608|Treatment resistant schizophrenia|treatment resistant schizophrenia
361171|NCT01596608|Treatment resistant obsessive-compulsive disorder|treatment resistant obsessive-compulsive disorder
361172|NCT01596595|ICD|icd
361173|NCT01596595|CRT-D|crt-d
361174|NCT01596595|Defibrillation lead|defibrillation lead
361175|NCT01596582|Colorectal cancer screening|colorectal cancer screening
361176|NCT01596582|Shared decision-making|shared decision-making
361177|NCT01596582|Patient preferences|patient preferences
361178|NCT01596582|Risk assessment|risk assessment
361179|NCT01596582|Advanced colorectal neoplasia|advanced colorectal neoplasia
361180|NCT01596569|Blast Traumatic Brain Injury|blast traumatic brain injury
361181|NCT01596569|Cognitive Rehabilitation|cognitive rehabilitation
361182|NCT01596569|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
361183|NCT01596569|Combined Treatment|combined treatment
361184|NCT01596556|smoking|smoking
361185|NCT01596556|exercise|exercise
361186|NCT01596556|heat tolerance|heat tolerance
361187|NCT01596556|heat stroke|heat stroke
361188|NCT01596543|sleep|sleep
361189|NCT01596543|HTT|htt
361190|NCT01596543|heat illness|heat illness
361191|NCT01596530|Breast Neoplasm|breast neoplasm
361192|NCT01596530|Breast Cancer|breast cancer
361193|NCT01596530|Breast Tumour|breast tumour
361194|NCT01596530|Cancer of Breast|cancer of breast
361195|NCT01596530|Cancer of the Breast|cancer of the breast
361196|NCT01596491|peripheral nerve injury|peripheral nerve injury
361197|NCT01596491|postherpetic neuralgia|postherpetic neuralgia
361198|NCT01596491|PNI|pni
361199|NCT01596491|PHN|phn
361200|NCT01596491|Capsaicin|capsaicin
361201|NCT01596491|QST|qst
361202|NCT01596491|quantitative sensory testing|quantitative sensory testing
361203|NCT01596491|sensory profile|sensory profile
361204|NCT01596491|neuropathic pain|neuropathic pain
361205|NCT01596478|Gambling|gambling
361206|NCT01596478|Pathological Gambling|pathological gambling
361207|NCT01596439|Healthy women|healthy women
361208|NCT01596439|consisting of a friend or relative of the patient|consisting of a friend or relative of the patient
361209|NCT01596426|CINV|cinv
361210|NCT01596413|CINV|cinv
361211|NCT01596400|CINV|cinv
361212|NCT01596387|anaesthetics iv|anaesthetics iv
361213|NCT01596387|propofol|propofol
361214|NCT01596387|pharmacokinetics|pharmacokinetics
361215|NCT01596387|pharmacodynamic|pharmacodynamic
361216|NCT01596348|Exercise|exercise
361217|NCT01596348|Barriers|barriers
361218|NCT01596348|Benefits|benefits
361219|NCT01596348|Preferences|preferences
361220|NCT01596348|Stages of change|stages of change
361221|NCT01596335|Infliximab|infliximab
361222|NCT01596335|REMICADE|remicade
361223|NCT01596335|TA-650|ta-650
361224|NCT01596335|intravenous immunoglobulin|intravenous immunoglobulin
361225|NCT01596335|Kawasaki disease|kawasaki disease
361226|NCT01596335|IVIG|ivig
361227|NCT01596322|HIV/AIDS in resource limited setting|hiv/aids in resource limited setting
361228|NCT01596322|HIV treatment outcomes in resource limited setting|hiv treatment outcomes in resource limited setting
361229|NCT01596322|Adherence to HIV treatment in resource limited setting|adherence to hiv treatment in resource limited setting
361230|NCT01596322|ART resistance in resource limited setting|art resistance in resource limited setting
361231|NCT01596309|cardiovascular risk|cardiovascular risk
361232|NCT01596309|Elderly population|elderly population
361233|NCT01596309|cocoa extract|cocoa extract
361234|NCT01596309|overweight and obesity|overweight and obesity
361235|NCT01596309|Glycemic profile|glycemic profile
361236|NCT01596309|lipid profile|lipid profile
361237|NCT01596309|antioxidant status|antioxidant status
361238|NCT01596309|inflammatory state|inflammatory state
361239|NCT01596309|Cardiovascular Risk factors in elder population|cardiovascular risk factors in elder population
361240|NCT01596296|labor induction|labor induction
361241|NCT01596296|transcervical foley catheter|transcervical foley catheter
361242|NCT01596296|dinoprostone|dinoprostone
361243|NCT01596296|parous women|parous women
361244|NCT01596283|Perioperative Fluid Management|perioperative fluid management
361245|NCT01596283|liver resection|liver resection
361246|NCT01596283|12-056|12-056
361247|NCT01596257|CliniMACS-CD34 Reagent System|clinimacs-cd34 reagent system
361248|NCT01596257|Acute Leukemia|acute leukemia
361249|NCT01596257|Myelodysplastic syndrome|myelodysplastic syndrome
361250|NCT01596257|Non Hodgkins Lymphoma|non hodgkins lymphoma
361251|NCT01596257|Hodgkins Disease|hodgkins disease
361252|NCT01596257|Multiple Myeloma|multiple myeloma
361253|NCT01596257|12-016|12-016
361254|NCT01596244|Diabetes Mellitus, Type II|diabetes mellitus, type ii
361255|NCT01596244|Disease management|disease management
361256|NCT01596244|Chronic disease|chronic disease
361257|NCT01596244|Prevention and control|prevention and control
361258|NCT01596244|Education|education
361259|NCT01596231|Alcohol consumption|alcohol consumption
361260|NCT01596231|Kudzu extract|kudzu extract
361261|NCT01596218|Steroid Refractory|steroid refractory
361262|NCT01596218|Acute|acute
361263|NCT01596205|cognitive therapy|cognitive therapy
361652|NCT01594554|ITPA|itpa
361264|NCT01596192|allogeneic transplantation, GVHD|allogeneic transplantation, gvhd
361265|NCT01596192|Patients with acute GVHD after allogeneic hematopoietic cell transplantation|patients with acute gvhd after allogeneic hematopoietic cell transplantation
361266|NCT01596179|treatment adherence|treatment adherence
361267|NCT01596179|fatigue|fatigue
361268|NCT01596179|symptom management|symptom management
361269|NCT01596166|migraine|migraine
361270|NCT01596166|pediatric|pediatric
361271|NCT01596166|childhood|childhood
361272|NCT01596166|emergency department|emergency department
361273|NCT01596166|ketorolac|ketorolac
361274|NCT01596166|metoclopramide|metoclopramide
361275|NCT01596166|intravenous|intravenous
361276|NCT01596140|Vemurafenib|vemurafenib
361277|NCT01596140|Everolimus|everolimus
361278|NCT01596140|Afinitor|afinitor
361279|NCT01596140|RAD001|rad001
361280|NCT01596140|temsirolimus|temsirolimus
361281|NCT01596140|BRAF gene mutation|braf gene mutation
361282|NCT01596140|solid tumor|solid tumor
361283|NCT01596140|relapsed BRAF mutation positive malignant melanoma|relapsed braf mutation positive malignant melanoma
361284|NCT01596140|refractory BRAF mutation positive malignant melanoma|refractory braf mutation positive malignant melanoma
361285|NCT01596127|relapsed CD20+ lymphoid malignancies|relapsed cd20+ lymphoid malignancies
361286|NCT01596127|refractory CD20+ lymphoid malignancies|refractory cd20+ lymphoid malignancies
361287|NCT01596127|Rituximab|rituximab
361288|NCT01596127|Intrathecal Rituximab|intrathecal rituximab
361289|NCT01596127|CNS|cns
361290|NCT01596127|Leptomeningeal disease|leptomeningeal disease
361291|NCT01596127|LMD|lmd
361292|NCT01596127|central nervous system disease|central nervous system disease
361293|NCT01596127|Relapsed lymphoid malignancies|relapsed lymphoid malignancies
361294|NCT01596127|refractory lymphoid malignancies|refractory lymphoid malignancies
361295|NCT01596127|CNS leukemia|cns leukemia
361296|NCT01596127|intrathecal chemotherapy|intrathecal chemotherapy
361297|NCT01596127|cerebrospinal fluid|cerebrospinal fluid
361298|NCT01596127|CSF|csf
361299|NCT01596127|lumbar puncture|lumbar puncture
361300|NCT01596127|LP|lp
361301|NCT01596114|TKI|tki
361302|NCT01596114|CML|cml
361303|NCT01596114|Stopping|stopping
361304|NCT01596114|chronic phase|chronic phase
361305|NCT01596114|in remission|in remission
361306|NCT01596088|Extravasation|extravasation
361307|NCT01596088|Anthracyclines|anthracyclines
361308|NCT01596075|Cannabidiol|cannabidiol
361309|NCT01596075|GVHD|gvhd
361310|NCT01596075|Allogeneic transplantation|allogeneic transplantation
361311|NCT01596062|Basiliximab|basiliximab
361312|NCT01596062|renal transplantation|renal transplantation
361313|NCT01596062|CNI-free|cni-free
361314|NCT01596062|everolimus|everolimus
361315|NCT01596036|cardiac rehabilitation|cardiac rehabilitation
361316|NCT01596036|referral|referral
361317|NCT01596036|enrollment|enrollment
361318|NCT01596036|timing|timing
361319|NCT01596023|COPD|copd
361320|NCT01595997|safety tolerability and immunogenicity of two different doses of DLX105 applied intra-dermally into psoriatic lesion of mild-to-moderate psoriatic patients|safety tolerability and immunogenicity of two different doses of dlx105 applied intra-dermally into psoriatic lesion of mild-to-moderate psoriatic patients
361321|NCT01595984|kidney|kidney
361322|NCT01595984|transplantation|transplantation
361323|NCT01595984|graft|graft
361324|NCT01595984|creatinin|creatinin
361325|NCT01595971|Asthma|asthma
361326|NCT01595971|Continuing education|continuing education
361327|NCT01595971|Primary health care|primary health care
361328|NCT01595958|Cardiac arrest|cardiac arrest
361329|NCT01595958|heart arrest|heart arrest
361330|NCT01595958|cyclosporine A|cyclosporine a
361331|NCT01595958|post cardiac arrest syndrome|post cardiac arrest syndrome
361332|NCT01595958|protective agent|protective agent
361333|NCT01595958|multiple organ failure|multiple organ failure
361334|NCT01595958|mitochondrial permeability transition pore|mitochondrial permeability transition pore
361335|NCT01595958|mitochondria|mitochondria
361336|NCT01595958|cardio-pulmonary resuscitation|cardio-pulmonary resuscitation
361337|NCT01595958|cardioprotection|cardioprotection
361338|NCT01595958|ischemia reperfusion|ischemia reperfusion
361339|NCT01595958|postconditioning|postconditioning
361340|NCT01595945|Caloric restriction|caloric restriction
361341|NCT01595945|Obesity|obesity
361342|NCT01595945|Gastric bypass|gastric bypass
361343|NCT01595945|Resting metabolic rate|resting metabolic rate
361344|NCT01595932|irritable bowel syndrome (IBS)|irritable bowel syndrome (ibs)
361345|NCT01595932|bloating|bloating
361346|NCT01595932|abdominal distension|abdominal distension
361347|NCT01595932|flatulence|flatulence
361348|NCT01595932|α-Galactosidase|α-galactosidase
361349|NCT01595906|Helmet|helmet
361350|NCT01595906|Heat Tolerance Test|heat tolerance test
361351|NCT01595906|ventilation System|ventilation system
361352|NCT01595893|Polymorphic light eruption|polymorphic light eruption
361353|NCT01595893|Vitamin D3|vitamin d3
361354|NCT01595893|Photo provocation|photo provocation
361355|NCT01595893|Immune function|immune function
361356|NCT01595867|abuse liability|abuse liability
361357|NCT01595867|abuse potential|abuse potential
361358|NCT01595867|morphine|morphine
361359|NCT01595867|intranasal administration|intranasal administration
361361|NCT01595867|opioid abuse|opioid abuse
361362|NCT01595867|pharmacodynamic|pharmacodynamic
361363|NCT01595867|recreational drug use|recreational drug use
361364|NCT01595841|hemodialysis|hemodialysis
361365|NCT01595841|stenosis|stenosis
361366|NCT01595841|angioplasty|angioplasty
361367|NCT01595841|sirolimus|sirolimus
361368|NCT01595815|Fertilization failure, calcium ionophore, SrCl2|fertilization failure, calcium ionophore, srcl2
361369|NCT01595802|Cerebral vasospasm|cerebral vasospasm
361370|NCT01595789|Coronary Artery Disease|coronary artery disease
361371|NCT01595789|Diabetes Mellitus|diabetes mellitus
361372|NCT01595789|Left ventricular ejection fraction|left ventricular ejection fraction
361373|NCT01595789|Beta-cell function|beta-cell function
361374|NCT01595776|CLI, PAD, Buerger disease|cli, pad, buerger disease
361375|NCT01595763|Deep vein thrombosis|deep vein thrombosis
361376|NCT01595763|Primary care|primary care
361377|NCT01595763|Diagnosis|diagnosis
361378|NCT01595763|Clinical model|clinical model
361379|NCT01595750|Post-bronchodilator FEV1<70% reference|post-bronchodilator fev1<70% reference
361380|NCT01595750|Chronic bronchitis|chronic bronchitis
361381|NCT01595750|Presence of estavlished CVD,|presence of estavlished cvd,
361382|NCT01595750|CVD equivalent or diabetes mellitus|cvd equivalent or diabetes mellitus
361383|NCT01595724|Non-interventional study|non-interventional study
361384|NCT01595724|Endometriosis,|endometriosis,
361385|NCT01595724|Quality of life|quality of life
361386|NCT01595698|Physical exercise|physical exercise
361388|NCT01595698|Schizophrenia|schizophrenia
361389|NCT01595698|neuroplasticity|neuroplasticity
361390|NCT01595685|HBeAg-positive|hbeag-positive
361391|NCT01595672|severe acute pancreatitis|severe acute pancreatitis
361392|NCT01595672|organ failure|organ failure
361393|NCT01595672|multiple organ dysfunction syndrome|multiple organ dysfunction syndrome
361394|NCT01595672|systemic complications|systemic complications
361395|NCT01595672|continuous veno-venous hemofiltration|continuous veno-venous hemofiltration
361396|NCT01595672|blood purification|blood purification
361397|NCT01595672|continuous renal replacement therapy|continuous renal replacement therapy
361398|NCT01595659|Risk|risk
361399|NCT01595659|Young drivers|young drivers
361400|NCT01595659|Alcohol|alcohol
361401|NCT01595659|Passengers|passengers
361402|NCT01595659|Gender|gender
361403|NCT01595646|Memory|memory
361404|NCT01595646|Intranasal insulin|intranasal insulin
361405|NCT01595646|Alzheimer's disease|alzheimer's disease
361406|NCT01595646|Mild Cognitive Impairment|mild cognitive impairment
361407|NCT01595633|nucleoside analogue|nucleoside analogue
361408|NCT01595633|adefovir|adefovir
361409|NCT01595633|tenofovir|tenofovir
361410|NCT01595633|hepatitis B|hepatitis b
361411|NCT01595620|Cannabis|cannabis
361412|NCT01595620|THC|thc
361413|NCT01595620|Pain|pain
361414|NCT01595594|Periodontal Diseases|periodontal diseases
361415|NCT01595594|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
361416|NCT01595594|hemoglobin A1c protein|hemoglobin a1c protein
361417|NCT01595581|Testosterone|testosterone
361418|NCT01595581|ACL Reconstruction|acl reconstruction
361419|NCT01595581|Clinical outcomes|clinical outcomes
361420|NCT01595581|Lean mass|lean mass
361421|NCT01595581|Strength|strength
361422|NCT01595581|Muscle atrophy|muscle atrophy
361423|NCT01595568|Adolescents|adolescents
361424|NCT01595568|Dual Diagnosis|dual diagnosis
361425|NCT01595568|Mental Disorders|mental disorders
361426|NCT01595568|Substance Use Problems|substance use problems
361427|NCT01595568|Prevention|prevention
361428|NCT01595555|stress|stress
361429|NCT01595555|relaxation|relaxation
361430|NCT01595555|mindfulness|mindfulness
361431|NCT01595555|web-based|web-based
361432|NCT01595555|online|online
361433|NCT01595555|social media|social media
361434|NCT01595555|discussion board|discussion board
361435|NCT01595529|antibiotic therapy|antibiotic therapy
361436|NCT01595529|antimicrobial resistance|antimicrobial resistance
361437|NCT01595529|children|children
361438|NCT01595529|E.coli|e.coli
361439|NCT01595529|K.pneumoniae|k.pneumoniae
361440|NCT01595529|parent study|parent study
361441|NCT01595529|SCOUT Study|scout study
361442|NCT01595529|spectrum stool bacteria|spectrum stool bacteria
361443|NCT01595529|stool culture|stool culture
361444|NCT01595529|urinary tract infections|urinary tract infections
361445|NCT01595503|Schizophrenia, auditory hallucination|schizophrenia, auditory hallucination
361446|NCT01595451|Acupuncture|acupuncture
361447|NCT01595451|Back Pain|back pain
361448|NCT01595451|Lower Back Pain|lower back pain
361449|NCT01595451|Brigham and Women's Hospital|brigham and women's hospital
361450|NCT01595451|Massachusetts General Hospital|massachusetts general hospital
361451|NCT01595451|Effects of Acupuncture|effects of acupuncture
361452|NCT01595438|Ceftazidime, Avibactam, Doripenem, Ciprofloxacin, sulfamethoxazole/trimethoprim, Anti-Infective Agents, Complicated Urinary Tract Infection,Acute Pyelonephritis|ceftazidime, avibactam, doripenem, ciprofloxacin, sulfamethoxazole/trimethoprim, anti-infective agents, complicated urinary tract infection,acute pyelonephritis
361453|NCT01595425|Bioequivalence,|bioequivalence,
361454|NCT01595425|pharmacokinetics,|pharmacokinetics,
361455|NCT01595425|safety,|safety,
361456|NCT01595425|esomeprazole,|esomeprazole,
361457|NCT01595425|Japanese,|japanese,
361458|NCT01595425|healthy subject,|healthy subject,
361459|NCT01595425|homo-EM|homo-em
361460|NCT01595412|Laparoscopic surgery|laparoscopic surgery
361461|NCT01595412|Colorectal Surgery|colorectal surgery
361462|NCT01595412|Quality of Life|quality of life
361463|NCT01595412|Rectal Prolapse|rectal prolapse
361464|NCT01595412|Anorectal Physiology|anorectal physiology
361465|NCT01595399|bradycardia|bradycardia
361466|NCT01595399|hypoxemia|hypoxemia
361467|NCT01595399|intubation|intubation
361468|NCT01595399|premedication|premedication
361469|NCT01595373|Ghrelin|ghrelin
361470|NCT01595373|Microdialysis|microdialysis
361471|NCT01595373|Controls|controls
361472|NCT01595373|Metabolic effects of ghrelin|metabolic effects of ghrelin
361473|NCT01595360|TT-173|tt-173
361474|NCT01595360|Topical Hemostatics|topical hemostatics
361475|NCT01595360|Hemostasis|hemostasis
361476|NCT01595347|Pressure Ulcer|pressure ulcer
361477|NCT01595347|Primary Prevention|primary prevention
361478|NCT01595347|Fatty Acids|fatty acids
361479|NCT01595347|Vegetable Fats|vegetable fats
361480|NCT01595347|Olive oil|olive oil
361481|NCT01595347|"Pressure Ulcer[prevention and control][Mesh]"|"pressure ulcer[prevention and control][mesh]"
361482|NCT01595334|IVF-ET|ivf-et
361483|NCT01595334|ICSI|icsi
361484|NCT01595334|Gonadotrophins|gonadotrophins
361485|NCT01595334|rFSH|rfsh
361486|NCT01595334|rLH|rlh
361487|NCT01595334|Cetrorelix|cetrorelix
361488|NCT01595334|Leuprolide acetate|leuprolide acetate
361489|NCT01595321|Adjuvant therapy|adjuvant therapy
361490|NCT01595321|Immunotherapy|immunotherapy
361491|NCT01595321|Cytoxan|cytoxan
361492|NCT01595321|Cyclophosphamide|cyclophosphamide
361493|NCT01595321|Pancreatic Vaccine|pancreatic vaccine
361494|NCT01595321|Stereotactic radiation therapy|stereotactic radiation therapy
361495|NCT01595321|SBRT|sbrt
361496|NCT01595321|FOLFIRINOX|folfirinox
361497|NCT01595308|Male infertility|male infertility
361498|NCT01595295|CMML|cmml
361499|NCT01595295|MDS|mds
361500|NCT01595295|AML|aml
361501|NCT01595295|registry|registry
361502|NCT01595295|Vidaza|vidaza
361503|NCT01595282|pain|pain
361504|NCT01595282|suction curettage|suction curettage
361505|NCT01595269|Diabetes|diabetes
361506|NCT01595269|eHealth|ehealth
361507|NCT01595269|Type 2 Diabetes|type 2 diabetes
361508|NCT01595269|Education|education
361509|NCT01595269|Calgary Health Region|calgary health region
361510|NCT01595256|colorectal cancer,fatigue,6-minute walking test|colorectal cancer,fatigue,6-minute walking test
361511|NCT01595243|hepatocellular carcinoma|hepatocellular carcinoma
361512|NCT01595243|Needs|needs
361513|NCT01595243|Telephone consultation|telephone consultation
361514|NCT01595230|Internal Hernias|internal hernias
361515|NCT01595230|Clips|clips
361516|NCT01595230|Gastric Bypass|gastric bypass
361517|NCT01595230|Avoid|avoid
361518|NCT01595217|Biliary Tract Neoplasm|biliary tract neoplasm
361519|NCT01595217|Cholangiocarcinoma|cholangiocarcinoma
361520|NCT01595217|Diffusion magnetic resonance imaging|diffusion magnetic resonance imaging
361521|NCT01595217|Magnetic resonance imaging|magnetic resonance imaging
361522|NCT01595217|Magnetic resonance Cholangiopancreatography|magnetic resonance cholangiopancreatography
361523|NCT01595204|Cancer of Ovary, laparoscopy, operability , score.|cancer of ovary, laparoscopy, operability , score.
361524|NCT01595178|smoking|smoking
361525|NCT01595178|drinking|drinking
361526|NCT01595178|SBIRT|sbirt
361527|NCT01595178|BNI|bni
361528|NCT01595178|counseling intervention|counseling intervention
361529|NCT01595178|emergency department|emergency department
361530|NCT01595178|adults|adults
361531|NCT01595165|laparoscopic cholecystectomy|laparoscopic cholecystectomy
361532|NCT01595165|ultrasound|ultrasound
361533|NCT01595165|transversus abdominis plane block|transversus abdominis plane block
361534|NCT01595152|Urgency, urgency incontinence,USIQ|urgency, urgency incontinence,usiq
361535|NCT01595100|Waist circumference|waist circumference
361536|NCT01595100|Visceral adipose tissue|visceral adipose tissue
361537|NCT01595100|Intra-abdominal fat|intra-abdominal fat
361538|NCT01595100|Pediatrics|pediatrics
361539|NCT01595087|CRPC|crpc
361540|NCT01595035|Day surgery|day surgery
361541|NCT01595035|Orthopedic surgery|orthopedic surgery
361542|NCT01595035|Breast reconstruction surgery|breast reconstruction surgery
361543|NCT01594996|Seroquel XR|seroquel xr
361544|NCT01594996|Quetiapine XR|quetiapine xr
361545|NCT01594996|Drug utilization|drug utilization
361546|NCT01594996|Major depressive disorder (MDD)|major depressive disorder (mdd)
361547|NCT01594983|hypertriglyceridemia|hypertriglyceridemia
361548|NCT01594983|Non familial Chylocmicronemia Syndrome (non-FCS)|non familial chylocmicronemia syndrome (non-fcs)
361549|NCT01594957|LCQ908,|lcq908,
361550|NCT01594957|Hepatic Impairment,|hepatic impairment,
361551|NCT01594957|Pharmacokinetics|pharmacokinetics
361552|NCT01594931|malaria|malaria
361553|NCT01594931|antimalarial|antimalarial
361554|NCT01594931|artemisinin based combination therapy|artemisinin based combination therapy
361555|NCT01594918|metastatic|metastatic
361556|NCT01594918|CRPC|crpc
361557|NCT01594918|prostate|prostate
361558|NCT01594918|CAMP|camp
361559|NCT01594905|To explore|to explore
361560|NCT01594905|adequate management|adequate management
361561|NCT01594905|CHB|chb
361562|NCT01594905|Multidrug resistance|multidrug resistance
361563|NCT01594892|Spinal metastases|spinal metastases
361564|NCT01594892|Vertebral metastases|vertebral metastases
361565|NCT01594892|Radiosurgery|radiosurgery
361566|NCT01594892|Radiotherapy|radiotherapy
361567|NCT01594892|Stereotactic body radiotherapy|stereotactic body radiotherapy
361568|NCT01594892|Pain|pain
361569|NCT01594879|Endometrial cancer|endometrial cancer
361570|NCT01594879|LNG-IUS|lng-ius
361571|NCT01594879|oral MPA|oral mpa
361572|NCT01594866|Major depressive disorder, remission, escitalopram|major depressive disorder, remission, escitalopram
361573|NCT01594853|exercise|exercise
361574|NCT01594853|women|women
361575|NCT01594853|training|training
361576|NCT01594853|rehabilitation|rehabilitation
361577|NCT01594853|leukodystrophy|leukodystrophy
361578|NCT01594840|language development|language development
361579|NCT01594840|parental interaction|parental interaction
361580|NCT01594827|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
361581|NCT01594827|Vancomycin|vancomycin
361582|NCT01594814|AVNRT|avnrt
361583|NCT01594814|AVRT|avrt
361584|NCT01594814|WPW|wpw
361585|NCT01594801|DM|dm
361586|NCT01594801|insulin|insulin
361587|NCT01594801|injections|injections
361588|NCT01594762|Diabetic Foot Ulcer Infection|diabetic foot ulcer infection
361589|NCT01594749|NK-1 Receptor Antagonist, CINV, Emesis, MEC|nk-1 receptor antagonist, cinv, emesis, mec
361590|NCT01594684|restenosis|restenosis
361591|NCT01594684|stent|stent
361592|NCT01594684|drug eltuing balloon|drug eltuing balloon
361593|NCT01594684|peripheral arterial disease|peripheral arterial disease
361594|NCT01594671|primary knee arthroplasty|primary knee arthroplasty
361595|NCT01594671|tranexamic acid|tranexamic acid
361596|NCT01594671|topical|topical
361597|NCT01594658|Ultrasound-guided foam sclerotherapy; chronic venous ulcers|ultrasound-guided foam sclerotherapy; chronic venous ulcers
361598|NCT01594632|AE adverse event|ae adverse event
361599|NCT01594632|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
361600|NCT01594632|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
361601|NCT01594632|ART antiretroviral therapy|art antiretroviral therapy
361602|NCT01594632|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
361603|NCT01594632|DCF data collection forms|dcf data collection forms
361604|NCT01594632|DMC Data Monitoring Committee|dmc data monitoring committee
361605|NCT01594632|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
361606|NCT01594632|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
361607|NCT01594632|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
361608|NCT01594632|ICH International Conference of Harmonization|ich international conference of harmonization
361609|NCT01594632|IND Investigational New Drug Application|ind investigational new drug application
361610|NCT01594632|IRB Institutional Review Board|irb institutional review board
361611|NCT01594632|IU International units|iu international units
361612|NCT01594632|mg milligram(s)|mg milligram(s)
361613|NCT01594632|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
361614|NCT01594632|PCR polymerase chain reaction|pcr polymerase chain reaction
361615|NCT01594632|SAE serious adverse event|sae serious adverse event
361616|NCT01594632|µg microgram|µg microgram
361617|NCT01594632|ULN upper limit of the normal range|uln upper limit of the normal range
361618|NCT01594632|WB Western Blot|wb western blot
361619|NCT01594619|Phase 1|phase 1
361620|NCT01594619|Healthy male and female volunteers|healthy male and female volunteers
361621|NCT01594619|Drug-drug interaction|drug-drug interaction
361622|NCT01594619|Pharmacokinetics|pharmacokinetics
361623|NCT01594619|Naloxegol|naloxegol
361624|NCT01594606|Animal-assisted intervention|animal-assisted intervention
361625|NCT01594606|adjudicated adolescents|adjudicated adolescents
361626|NCT01594606|empathy|empathy
361627|NCT01594593|prostate cancer|prostate cancer
361628|NCT01594593|behavioral|behavioral
361629|NCT01594593|acceptance and commitment therapy|acceptance and commitment therapy
361630|NCT01594593|distress|distress
361631|NCT01594567|Systematic review and meta-analysis|systematic review and meta-analysis
361632|NCT01594567|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
361633|NCT01594567|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
361634|NCT01594567|Clinical practice guidelines|clinical practice guidelines
361635|NCT01594567|Clinical trials|clinical trials
361636|NCT01594567|Dietary pulses|dietary pulses
361637|NCT01594567|legumes|legumes
361638|NCT01594567|Beans, peas, chickpeas, lentils|beans, peas, chickpeas, lentils
361639|NCT01594567|Cardiometabolic risk factors|cardiometabolic risk factors
361640|NCT01594567|Triglycerides|triglycerides
361641|NCT01594567|Cholesterol|cholesterol
361642|NCT01594567|Glycemic control|glycemic control
361643|NCT01594567|Insulin resistance|insulin resistance
361644|NCT01594567|Body weight|body weight
361645|NCT01594567|Uric acid|uric acid
361646|NCT01594567|Blood pressure|blood pressure
361647|NCT01594554|HCV viral genotypes|hcv viral genotypes
361648|NCT01594554|host genotypes|host genotypes
361649|NCT01594554|IL28B|il28b
361650|NCT01594554|Outcome|outcome
361651|NCT01594554|Follow-Up|follow-up
361654|NCT01594554|China|china
361655|NCT01594541|hyperhomocysteinemia|hyperhomocysteinemia
361656|NCT01594541|dementia|dementia
361657|NCT01594541|depression|depression
361658|NCT01594541|vitamin B12|vitamin b12
361659|NCT01594541|mild cognitive impairment|mild cognitive impairment
361660|NCT01594541|alzheimer's|alzheimer's
361661|NCT01594528|schizophrenia|schizophrenia
361662|NCT01594528|major depression|major depression
361663|NCT01594528|pain|pain
361664|NCT01594528|behavior|behavior
361665|NCT01594502|prostate cancer|prostate cancer
361666|NCT01594502|dutasteride|dutasteride
361667|NCT01594476|Postpartum|postpartum
361668|NCT01594476|Contraception|contraception
361669|NCT01594476|Intrauterine device|intrauterine device
361670|NCT01594476|Intrauterine system|intrauterine system
361671|NCT01594476|Mirena|mirena
361672|NCT01594476|Paragard|paragard
361673|NCT01594476|Uterine involution|uterine involution
361674|NCT01594463|Intrauterine growth restriction|intrauterine growth restriction
361675|NCT01594463|Screening|screening
361676|NCT01594463|Ultrasound|ultrasound
361677|NCT01594463|Perinatal morbidity|perinatal morbidity
361678|NCT01594463|Maternal complications|maternal complications
361679|NCT01594450|incisional ventral hernia|incisional ventral hernia
361680|NCT01594450|infected field|infected field
361681|NCT01594450|biological mesh|biological mesh
361682|NCT01594437|Cytomegalovirus|cytomegalovirus
361683|NCT01594437|Monoclonal antibody|monoclonal antibody
361684|NCT01594424|Donor-Specific Anti-HLA Antibodies|donor-specific anti-hla antibodies
361685|NCT01594424|Kidney Transplantation|kidney transplantation
361686|NCT01594411|Corus CAD|corus cad
361687|NCT01594411|ASGES|asges
361688|NCT01594411|Age/Sex/Gene Expression Score|age/sex/gene expression score
361689|NCT01594411|Gene Expression|gene expression
361690|NCT01594411|GES|ges
361691|NCT01594411|CAD|cad
361692|NCT01594411|CVD|cvd
361693|NCT01594411|CHD|chd
361694|NCT01594411|Clinical Utility|clinical utility
361695|NCT01594411|Precision Medicine|precision medicine
361696|NCT01594411|Primary care|primary care
361697|NCT01594411|Coronary Artery Disease|coronary artery disease
361698|NCT01594411|Angina Pectoris|angina pectoris
361699|NCT01594411|Chest Pain|chest pain
361700|NCT01594411|Cardiovascular Disease|cardiovascular disease
361701|NCT01594411|Coronary Heart Disease|coronary heart disease
361702|NCT01594411|IMPACT|impact
361703|NCT01594411|IMPACT-PCP|impact-pcp
361704|NCT01594398|carcinoma,non small cell lung|carcinoma,non small cell lung
361705|NCT01594398|lung diseases|lung diseases
361706|NCT01594398|lung neoplasms|lung neoplasms
361707|NCT01594398|Respiratory|respiratory
361708|NCT01594398|Carcinoma, Bronchogenic|carcinoma, bronchogenic
361709|NCT01594398|Bronchial Neoplasms|bronchial neoplasms
361710|NCT01594398|Respiratory Tract Neoplasms|respiratory tract neoplasms
361711|NCT01594398|Thoracic Neoplasms|thoracic neoplasms
361712|NCT01594398|Neoplasms by Site|neoplasms by site
361713|NCT01594398|Respiratory Tract Diseases|respiratory tract diseases
361714|NCT01594398|Erlotinib|erlotinib
361715|NCT01594398|Protein Kinase Inhibitors|protein kinase inhibitors
361716|NCT01594398|Breast Neoplasms|breast neoplasms
361717|NCT01594398|Neoplasms|neoplasms
361718|NCT01594398|Breast Diseases|breast diseases
361719|NCT01594398|Exemestane|exemestane
361720|NCT01594398|Aromatase Inhibitors|aromatase inhibitors
361721|NCT01594385|Open Abdomen|open abdomen
361722|NCT01594385|Damage Control|damage control
361723|NCT01594385|Trauma|trauma
361724|NCT01594385|Wound healing|wound healing
361725|NCT01594385|Gun shot wounds|gun shot wounds
361726|NCT01594385|Stab wounds|stab wounds
361727|NCT01594385|Automobile accidents|automobile accidents
361728|NCT01594385|Wounds and Injury|wounds and injury
361729|NCT01594372|Uterine Prolapse|uterine prolapse
361730|NCT01594372|Laparoscopy|laparoscopy
361731|NCT01594372|Hysterectomy, vaginal|hysterectomy, vaginal
361732|NCT01594359|Ferritin|ferritin
361733|NCT01594346|Vitamin E|vitamin e
361734|NCT01594346|alpha-tocopherol|alpha-tocopherol
361735|NCT01594346|cognitive decline|cognitive decline
361736|NCT01594346|Down syndrome|down syndrome
361737|NCT01594346|Aging|aging
361738|NCT01594346|Dementia|dementia
361739|NCT01594333|Myocardial Infarction|myocardial infarction
361740|NCT01594333|Stroke|stroke
361741|NCT01594333|Cardiovascular death|cardiovascular death
361742|NCT01594333|Type 2 Diabetes|type 2 diabetes
361743|NCT01594333|Metabolic Syndrome|metabolic syndrome
361744|NCT01594333|Cardiovascular Inflammation|cardiovascular inflammation
361745|NCT01594333|Atherothrombosis|atherothrombosis
361746|NCT01594307|BP|bp
361747|NCT01594294|CLEAR CARE®|clear care®
361748|NCT01594294|AOSEPT® Plus|aosept® plus
361749|NCT01594294|ReNu MultiPlus®|renu multiplus®
361750|NCT01594294|silicone hydrogel|silicone hydrogel
361751|NCT01594294|hydrogel|hydrogel
361752|NCT01594294|ACUVUE® 2®|acuvue® 2®
361753|NCT01594294|AIR OPTIX® AQUA|air optix® aqua
361754|NCT01594294|eyelid response|eyelid response
361755|NCT01594294|wettability|wettability
361756|NCT01594294|contamination|contamination
361757|NCT01594294|contact lenses|contact lenses
361758|NCT01594281|Panretinal photocoagulation|panretinal photocoagulation
361759|NCT01594281|Ranibizumab|ranibizumab
361760|NCT01594268|kidney transplant|kidney transplant
361761|NCT01594268|Certican|certican
361762|NCT01594255|Healthy volunteer|healthy volunteer
361763|NCT01594255|QT intervals|qt intervals
361764|NCT01594255|ECG|ecg
361765|NCT01594255|QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs|qt/qtc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs
361766|NCT01594242|multiple myeloma|multiple myeloma
361767|NCT01594242|bortezomib|bortezomib
361768|NCT01594242|proteasome inhibitor|proteasome inhibitor
361769|NCT01594229|Pharmacokinetics|pharmacokinetics
361770|NCT01594229|Maximum Tolerated Dose|maximum tolerated dose
361771|NCT01594229|Safety|safety
361772|NCT01594229|Bendamustine|bendamustine
361773|NCT01594229|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
361774|NCT01594229|Rituximab|rituximab
361775|NCT01594229|ABT-199|abt-199
361776|NCT01594229|Cancer|cancer
361777|NCT01594229|Preliminary Efficacy|preliminary efficacy
361778|NCT01594216|Postmenopausal female|postmenopausal female
361779|NCT01594203|Soft Tissue Sarcoma|soft tissue sarcoma
361780|NCT01594203|Pazopanib|pazopanib
361781|NCT01594203|F18-FDG PET/CT|f18-fdg pet/ct
361782|NCT01594177|DAFNE|dafne
361783|NCT01594177|GBG 70|gbg 70
361784|NCT01594177|GBG|gbg
361785|NCT01594177|German Breast Group|german breast group
361786|NCT01594177|GBG Forschungs GmbH|gbg forschungs gmbh
361787|NCT01594177|Afatinib|afatinib
361788|NCT01594177|neo-adjuvant|neo-adjuvant
361789|NCT01594177|HER-2 positive breast cancer|her-2 positive breast cancer
361790|NCT01594177|BIBW 2992|bibw 2992
361791|NCT01594177|1200.159|1200.159
361792|NCT01594164|High Resolution Computed Tomography|high resolution computed tomography
361793|NCT01594164|Cone Beam Computed Tomography|cone beam computed tomography
361794|NCT01594164|upper airway|upper airway
361795|NCT01594164|geometry|geometry
361796|NCT01594151|asthma|asthma
361797|NCT01594151|controlled|controlled
361798|NCT01594151|Cone Beam Computed Tomography|cone beam computed tomography
361799|NCT01594151|upper airway|upper airway
361800|NCT01594151|paediatric|paediatric
361801|NCT01594112|Remote monitoring|remote monitoring
361802|NCT01594112|Home monitoring|home monitoring
361803|NCT01594112|Defibrillators, Implantable cardioverter-defibrillator|defibrillators, implantable cardioverter-defibrillator
361804|NCT01594112|Shock|shock
361805|NCT01594112|Inappropriate diagnoses and Therapies|inappropriate diagnoses and therapies
361806|NCT01594112|Corrective actions|corrective actions
361807|NCT01594112|ID recurrences|id recurrences
361808|NCT01594112|Medical reaction time|medical reaction time
361809|NCT01594099|cervical cancer|cervical cancer
361810|NCT01594099|elderly women|elderly women
361811|NCT01594099|concurrent chemotherapy|concurrent chemotherapy
361812|NCT01594086|green tea|green tea
361813|NCT01594086|aging|aging
361814|NCT01594086|atherosclerosis|atherosclerosis
361815|NCT01594086|homocysteine|homocysteine
361816|NCT01594086|cognitive impairment|cognitive impairment
361817|NCT01594073|implantable defibrillator|implantable defibrillator
361818|NCT01594073|ventricular arrhythmias|ventricular arrhythmias
361819|NCT01594073|cardiac death|cardiac death
361820|NCT01594047|hyperalgesia|hyperalgesia
361821|NCT01594047|Patient controlled analgesia|patient controlled analgesia
361822|NCT01594047|morphine|morphine
361823|NCT01594047|methadone|methadone
361824|NCT01594047|ketamine|ketamine
361825|NCT01594021|propofol|propofol
361826|NCT01594021|anesthesia, induction|anesthesia, induction
361827|NCT01594021|hypotension|hypotension
361828|NCT01594021|cardiac output|cardiac output
361829|NCT01594008|Toll like receptors|toll like receptors
361830|NCT01594008|Inflammation|inflammation
361831|NCT01594008|Anthocyanins|anthocyanins
361832|NCT01594008|Blueberries|blueberries
361833|NCT01593995|Erlotinib|erlotinib
361834|NCT01593995|Skin side effect|skin side effect
361835|NCT01593995|EGF ointment|egf ointment
361836|NCT01593982|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
361837|NCT01593982|Cocaine Dependence|cocaine dependence
361838|NCT01593982|Cocaine Addicts|cocaine addicts
361839|NCT01593982|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
361840|NCT01593982|Cognitive Function|cognitive function
361841|NCT01593969|Essential Fatty Acid|essential fatty acid
361842|NCT01593969|Seed oil|seed oil
361843|NCT01593969|Fish oil|fish oil
361844|NCT01593969|Dietary deficiency|dietary deficiency
361845|NCT01593943|contraception|contraception
361846|NCT01593943|india|india
361847|NCT01593943|rural|rural
361848|NCT01593930|Pulp Anesthesia|pulp anesthesia
361849|NCT01593930|Articaine|articaine
361850|NCT01593930|Lidocaine|lidocaine
361851|NCT01593917|Aortic valve|aortic valve
361852|NCT01593917|Heart valve|heart valve
361853|NCT01593917|Tissue valve|tissue valve
361854|NCT01593917|Bioprosthesis|bioprosthesis
361855|NCT01593904|CCSVI, Flow, Perfusion in MS|ccsvi, flow, perfusion in ms
361856|NCT01593891|IVUS, CCSVI|ivus, ccsvi
361857|NCT01593865|Coronary Artery Bypass Grafting|coronary artery bypass grafting
361858|NCT01593865|Mammary Artery Grafts|mammary artery grafts
361859|NCT01593865|Bilateral Mammary Artery Grafting|bilateral mammary artery grafting
361860|NCT01593865|Clinical Outcomes|clinical outcomes
361861|NCT01593852|X-rays|x-rays
361862|NCT01593852|Cardiac Electrophysiology|cardiac electrophysiology
361863|NCT01593852|Image Processing, Computer-Assisted|image processing, computer-assisted
361864|NCT01593852|Catheter Ablation|catheter ablation
361865|NCT01593813|Pronator quadratus|pronator quadratus
361866|NCT01593813|distal radius fracture|distal radius fracture
361867|NCT01593813|volar plating|volar plating
361868|NCT01593800|Probiotics|probiotics
361869|NCT01593800|Lactose|lactose
361870|NCT01593787|Hypertension|hypertension
361871|NCT01593787|Renal dysfunction|renal dysfunction
361872|NCT01593787|LCZ696|lcz696
361873|NCT01593774|Melatonin|melatonin
361874|NCT01593774|Olanzapine|olanzapine
361875|NCT01593774|Metabolic side effects|metabolic side effects
361876|NCT01593774|Psychosis|psychosis
361877|NCT01593774|Hyperlipidemia|hyperlipidemia
361878|NCT01593774|Hyperglycemia|hyperglycemia
361879|NCT01593774|Weight gain|weight gain
361880|NCT01593774|Diabetes|diabetes
361881|NCT01593761|cABSSSI|cabsssi
361882|NCT01593761|MRSA|mrsa
361883|NCT01593748|Sarcoma|sarcoma
361884|NCT01593748|Soft Tissue Sarcoma|soft tissue sarcoma
361885|NCT01593722|Loa loa|loa loa
361886|NCT01593722|Immune Response|immune response
361887|NCT01593722|Therapy|therapy
361888|NCT01593709|Healthy Volunteers|healthy volunteers
361889|NCT01593696|CD 19 Expressing B Cells|cd 19 expressing b cells
361890|NCT01593696|B Cell Lymphoma|b cell lymphoma
361891|NCT01593696|ALL|all
361892|NCT01593696|Anti-CD19 Chimeric Antigen Receptor|anti-cd19 chimeric antigen receptor
361893|NCT01593696|Adoptive Immunotherapy|adoptive immunotherapy
361894|NCT01593683|Oncology service|oncology service
361895|NCT01593683|Nursing staff|nursing staff
361896|NCT01593683|Psychosocial intervention|psychosocial intervention
361897|NCT01593683|Coping skills|coping skills
361898|NCT01593670|high risk myelodysplastic syndrome|high risk myelodysplastic syndrome
361899|NCT01593670|natural killer cells|natural killer cells
361900|NCT01593644|Dipyridamole/adenosine combination given intravenously|dipyridamole/adenosine combination given intravenously
361901|NCT01593644|slow bolus and low doses|slow bolus and low doses
361902|NCT01593644|coronary flow reserve assessment|coronary flow reserve assessment
361903|NCT01593644|transthoracic echodoppler|transthoracic echodoppler
361904|NCT01593644|Patients|patients
361905|NCT01593644|stable|stable
361906|NCT01593631|lactose malabsorption|lactose malabsorption
361907|NCT01593631|lactose intolerance|lactose intolerance
361908|NCT01593631|lactose digestion|lactose digestion
361909|NCT01593631|lactose maldigestion|lactose maldigestion
361910|NCT01593631|acid lactase|acid lactase
361911|NCT01593631|yoghurt bacteria|yoghurt bacteria
361912|NCT01593618|cancer survivor|cancer survivor
361913|NCT01593605|Impaired glucose tolerance, pre-diabetes,glycemic control,|impaired glucose tolerance, pre-diabetes,glycemic control,
361914|NCT01593605|supplements|supplements
361915|NCT01593592|Helicobacter pylori|helicobacter pylori
361916|NCT01593592|Lactobacillus reuteri|lactobacillus reuteri
361917|NCT01593592|dyspeptic patients|dyspeptic patients
361918|NCT01593592|eradication|eradication
361919|NCT01593579|melanoma|melanoma
361920|NCT01593579|autonomic failure|autonomic failure
361921|NCT01593579|hypotension|hypotension
361922|NCT01593579|akt therapy|akt therapy
361923|NCT01593566|femoral nerve block|femoral nerve block
361924|NCT01593553|Screening|screening
361925|NCT01593553|Stroke prevention|stroke prevention
361926|NCT01593553|Cost effectiveness|cost effectiveness
361927|NCT01593527|Frequent flares|frequent flares
361928|NCT01593527|Frequent attacks|frequent attacks
361929|NCT01593527|gout|gout
361930|NCT01593527|gouty arthritis|gouty arthritis
361931|NCT01593527|Chronic kidney disease|chronic kidney disease
361932|NCT01593527|renal impairment|renal impairment
361933|NCT01593527|Anti-interleukin-1β monoclonal antibody|anti-interleukin-1β monoclonal antibody
361934|NCT01593527|anti-inflammatory therapy|anti-inflammatory therapy
361935|NCT01593514|Vaccines|vaccines
361936|NCT01593514|Meningitis|meningitis
361937|NCT01593514|Meningococcal|meningococcal
361938|NCT01593501|vitamin D|vitamin d
361939|NCT01593501|cholecalciferol|cholecalciferol
361940|NCT01593501|bone mineral density|bone mineral density
361941|NCT01593501|Magnesium deficiency|magnesium deficiency
361942|NCT01593501|Calcium metabolism disorders|calcium metabolism disorders
361943|NCT01593488|recurrent|recurrent
361944|NCT01593488|CNS disease|cns disease
361945|NCT01593488|intrathecal therapy|intrathecal therapy
361946|NCT01593436|insomnia,menopause, polysomnography, mindfulness|insomnia,menopause, polysomnography, mindfulness
361947|NCT01593410|Efficacy/Safety|efficacy/safety
361948|NCT01593410|Lenalidomide and Low-Dose Dexamethasone|lenalidomide and low-dose dexamethasone
361949|NCT01593410|Chinese Subjects|chinese subjects
361950|NCT01593410|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
361951|NCT01593397|Obesity|obesity
361952|NCT01593397|Insulin Resistance|insulin resistance
361953|NCT01593384|Breast Cancer|breast cancer
362156|NCT01592760|air-Q|air-q
361954|NCT01593384|Digital Breast Tomosynthesis (DBT)|digital breast tomosynthesis (dbt)
361955|NCT01593384|Digital Mammography (DM)|digital mammography (dm)
361956|NCT01593371|Adipokines|adipokines
361957|NCT01593371|leptin|leptin
361958|NCT01593371|chemerin|chemerin
361959|NCT01593371|omentin|omentin
361960|NCT01593371|metformin|metformin
361961|NCT01593371|type 2 diabetes mellitus|type 2 diabetes mellitus
361962|NCT01593358|CCSVI|ccsvi
361963|NCT01593345|Elderly|elderly
361964|NCT01593345|mobility limitations|mobility limitations
361965|NCT01593345|self-management|self-management
361966|NCT01593345|exercise|exercise
361967|NCT01593332|Rituximab|rituximab
361968|NCT01593332|Rheumatoid arthritis|rheumatoid arthritis
361969|NCT01593332|Biologics|biologics
361970|NCT01593332|Anti-tumour necrosis factor|anti-tumour necrosis factor
361971|NCT01593332|Disease-modifying anti-rheumatic drugs|disease-modifying anti-rheumatic drugs
361972|NCT01593332|DAS28|das28
361973|NCT01593332|European League Against Rheumatism response|european league against rheumatism response
361974|NCT01593293|Elderly patients|elderly patients
361975|NCT01593293|Non-squamous Non-small Cell Lung Cancer|non-squamous non-small cell lung cancer
361976|NCT01593293|Pemetrexed|pemetrexed
361977|NCT01593293|Carboplatin|carboplatin
361978|NCT01593280|anesthesia|anesthesia
361979|NCT01593280|regional anesthetic techniques: transversus abdominis plane block,|regional anesthetic techniques: transversus abdominis plane block,
361980|NCT01593280|pain, postoperative|pain, postoperative
361981|NCT01593280|surgery, cesarean section|surgery, cesarean section
361982|NCT01593280|quality of recovery|quality of recovery
361983|NCT01593267|intracranial aneurysm|intracranial aneurysm
361984|NCT01593267|subarachnoid hemorrhage|subarachnoid hemorrhage
361985|NCT01593267|randomized trial|randomized trial
361986|NCT01593267|coil embolization|coil embolization
361987|NCT01593267|clip occlusion|clip occlusion
361988|NCT01593267|vascular disorders|vascular disorders
361989|NCT01593241|Seminoma IIA/B|seminoma iia/b
361990|NCT01593241|Carboplatin|carboplatin
361991|NCT01593241|RT|rt
361992|NCT01593215|genetics|genetics
361993|NCT01593215|type 2 diabetes|type 2 diabetes
361994|NCT01593215|insulin secretion|insulin secretion
361995|NCT01593189|developmental disabilities|developmental disabilities
361996|NCT01593189|school readiness|school readiness
361997|NCT01593189|literacy|literacy
361998|NCT01593189|social emotional skills|social emotional skills
361999|NCT01593189|self regulation|self regulation
362000|NCT01593189|caregiver involvement|caregiver involvement
362001|NCT01593176|Femur|femur
362002|NCT01593176|Fracture|fracture
362003|NCT01593176|Radiostereometric Analysis|radiostereometric analysis
362004|NCT01593163|Functional echocardiography|functional echocardiography
362005|NCT01593163|power Doppler cranial ultrasonography|power doppler cranial ultrasonography
362006|NCT01593163|N-terminal probrain natriuretic peptide|n-terminal probrain natriuretic peptide
362007|NCT01593163|Patent ductus arteriosus|patent ductus arteriosus
362008|NCT01593150|Atrial Fibrillation|atrial fibrillation
362009|NCT01593150|TEE|tee
362010|NCT01593150|Early versus late DC cardioversion.|early versus late dc cardioversion.
362011|NCT01593124|Vaginal innate immune and inflammatory responses|vaginal innate immune and inflammatory responses
362012|NCT01593111|Allergies|allergies
362013|NCT01593111|Asthma|asthma
362014|NCT01593111|Environmental|environmental
362015|NCT01593111|NYC|nyc
362016|NCT01593111|Manhattan|manhattan
362017|NCT01593111|Harlem|harlem
362018|NCT01593111|Bronx|bronx
362019|NCT01593111|Brooklyn|brooklyn
362020|NCT01593111|Breathing|breathing
362021|NCT01593111|eNO|eno
362022|NCT01593111|IgE|ige
362023|NCT01593111|Allergens|allergens
362024|NCT01593111|Cockroach|cockroach
362025|NCT01593111|Dust mites|dust mites
362026|NCT01593111|Pets|pets
362027|NCT01593098|siblings|siblings
362028|NCT01593098|advanced neoplasm|advanced neoplasm
362029|NCT01593098|mRNA|mrna
362030|NCT01593098|TaqMan microRNA expression assays|taqman microrna expression assays
362031|NCT01593085|palliative cares|palliative cares
362032|NCT01593085|cancer|cancer
362033|NCT01593085|suicide risk|suicide risk
362034|NCT01593072|Multiple Ascending Dose (MAD)|multiple ascending dose (mad)
362035|NCT01593072|Ebola Virus|ebola virus
362036|NCT01593072|Post Exposure Prophylaxis|post exposure prophylaxis
362037|NCT01593072|EHF|ehf
362038|NCT01593059|International|international
362039|NCT01593059|Multicenter|multicenter
362040|NCT01593059|Observational registry|observational registry
362041|NCT01593059|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
362042|NCT01593059|Stenting|stenting
362043|NCT01593059|Treatment of Coronary Artery Disease|treatment of coronary artery disease
362044|NCT01593059|Coronary revascularization|coronary revascularization
362045|NCT01593059|Percutaneous Coronary Intervention|percutaneous coronary intervention
362046|NCT01593059|STEMI|stemi
362047|NCT01593059|NSTEMI|nstemi
362048|NCT01593059|Ischemia|ischemia
362049|NCT01593059|Angina|angina
362050|NCT01593059|Subgroups|subgroups
362051|NCT01593059|Acute Myocardial Infarction|acute myocardial infarction
362052|NCT01593059|Diabetes|diabetes
362053|NCT01593059|Small Vessels|small vessels
362054|NCT01593059|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
362055|NCT01593046|GSK1265744 LAP|gsk1265744 lap
362056|NCT01593046|integrase inhibitor|integrase inhibitor
362057|NCT01593046|healthy subjects|healthy subjects
362058|NCT01593046|TMC278 LA|tmc278 la
362059|NCT01593046|GSK1265744LAP|gsk1265744lap
362060|NCT01593046|long acting retroviral|long acting retroviral
362061|NCT01593046|HIV-1 infection|hiv-1 infection
362062|NCT01593020|Breast cancer|breast cancer
362063|NCT01593020|Early Stage Breast Cancer Not Overexpressing HER-2|early stage breast cancer not overexpressing her-2
362064|NCT01593020|Primary invasive adenocarcinoma of the breast|primary invasive adenocarcinoma of the breast
362065|NCT01593020|Paclitaxel|paclitaxel
362066|NCT01593020|Taxol|taxol
362067|NCT01593020|Eribulin|eribulin
362068|NCT01593020|E7389|e7389
362069|NCT01593020|5-Fluorouracil|5-fluorouracil
362070|NCT01593020|5-FU|5-fu
362071|NCT01593020|Adrucil|adrucil
362072|NCT01593020|Efudex|efudex
362073|NCT01593020|Epirubicin|epirubicin
362074|NCT01593020|Ellence|ellence
362075|NCT01593020|Cyclophosphamide|cyclophosphamide
362076|NCT01593020|Cytoxan|cytoxan
362077|NCT01593020|Neosar|neosar
362078|NCT01593020|Doxorubicin|doxorubicin
362079|NCT01593020|Doxorubicin hydrochloride|doxorubicin hydrochloride
362080|NCT01593020|Adriamycin PFS|adriamycin pfs
362081|NCT01593020|Adriamycin RDF|adriamycin rdf
362082|NCT01593020|Adriamycin|adriamycin
362083|NCT01593020|Rubex|rubex
362084|NCT01593007|Heart failure|heart failure
362085|NCT01593007|respiratory muscles|respiratory muscles
362086|NCT01593007|optoelectronic plethysmography|optoelectronic plethysmography
362087|NCT01592994|HIV|hiv
362088|NCT01592994|condom use|condom use
362089|NCT01592994|India|india
362090|NCT01592994|women|women
362091|NCT01592981|Waldenstrom's macroglobulinaemia|waldenstrom's macroglobulinaemia
362092|NCT01592981|bortezomib|bortezomib
362093|NCT01592981|cyclophosphamide|cyclophosphamide
362094|NCT01592981|rituximab|rituximab
362095|NCT01592968|Brain Neoplasms|brain neoplasms
362096|NCT01592968|Non-melanoma brain metastases|non-melanoma brain metastases
362097|NCT01592968|Stereotactic radiosurgery|stereotactic radiosurgery
362098|NCT01592968|SRS|srs
362099|NCT01592968|Whole brain radiation therapy|whole brain radiation therapy
362100|NCT01592968|WBRT|wbrt
362101|NCT01592955|Glaucoma|glaucoma
362102|NCT01592955|Cyclocoagulation|cyclocoagulation
362103|NCT01592955|HIFU High Intensity Focused Ultrasound|hifu high intensity focused ultrasound
362104|NCT01592942|inguinal hernia|inguinal hernia
362105|NCT01592942|mesh fixation|mesh fixation
362106|NCT01592942|glue|glue
362107|NCT01592942|Lichtenstein|lichtenstein
362108|NCT01592929|Functional Respiratory Imaging|functional respiratory imaging
362109|NCT01592929|Magnetic Resonance Imaging|magnetic resonance imaging
362110|NCT01592929|MRI|mri
362111|NCT01592929|Pharyngometry|pharyngometry
362112|NCT01592929|Upper Airway|upper airway
362113|NCT01592929|Mouthpiece of Inhaler|mouthpiece of inhaler
362114|NCT01592929|Cone Beam Computed Tomography|cone beam computed tomography
362115|NCT01592929|CBCT|cbct
362116|NCT01592929|Computed Tomography|computed tomography
362117|NCT01592929|CT|ct
362118|NCT01592916|Fibromyalgia|fibromyalgia
362119|NCT01592916|Pain|pain
362120|NCT01592916|Women|women
362121|NCT01592916|Exercise|exercise
362122|NCT01592916|IGF1|igf1
362123|NCT01592903|Uterine fibroids|uterine fibroids
362124|NCT01592903|somatic stem cell|somatic stem cell
362125|NCT01592903|Side Population|side population
362126|NCT01592877|UWB|uwb
362127|NCT01592877|non-contact|non-contact
362128|NCT01592877|patient monitor|patient monitor
362129|NCT01592838|Belgium|belgium
362130|NCT01592838|Quality of hospital care|quality of hospital care
362131|NCT01592838|Rotavirus vaccination|rotavirus vaccination
362132|NCT01592825|Breast Cancer|breast cancer
362133|NCT01592825|Prognostic factor|prognostic factor
362134|NCT01592825|uPA/PA-1|upa/pa-1
362135|NCT01592825|cohort|cohort
362136|NCT01592799|Influenza|influenza
362137|NCT01592799|Children|children
362138|NCT01592799|Hospitalizations|hospitalizations
362139|NCT01592799|Spain|spain
362140|NCT01592799|Burden|burden
362141|NCT01592786|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
362142|NCT01592786|Autism|autism
362143|NCT01592786|Autistic Disorder|autistic disorder
362144|NCT01592786|Asperger's Disorder|asperger's disorder
362145|NCT01592786|Asperger's|asperger's
362146|NCT01592786|Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)|pervasive developmental disorder not otherwise specified (pdd-nos)
362147|NCT01592786|Memantine|memantine
362148|NCT01592786|Pediatric Disorder|pediatric disorder
362149|NCT01592773|Autistic Disorder|autistic disorder
362150|NCT01592773|Asperger's Disorder|asperger's disorder
362151|NCT01592773|Asperger's|asperger's
362152|NCT01592773|Pediatric Autism|pediatric autism
362153|NCT01592773|Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)|pervasive developmental disorder not otherwise specified (pdd-nos)
362154|NCT01592773|Pervasive Child Development Disorder|pervasive child development disorder
362155|NCT01592760|air-Q SP|air-q sp
362157|NCT01592760|i-gel|i-gel
362158|NCT01592760|supraglottic airway device|supraglottic airway device
362159|NCT01592760|laryngeal mask airway|laryngeal mask airway
362160|NCT01592747|Asperger's|asperger's
362161|NCT01592747|Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)|pervasive developmental disorder not otherwise specified (pdd-nos)
362162|NCT01592747|Memantine|memantine
362163|NCT01592747|Pervasive Child Development Disorder|pervasive child development disorder
362164|NCT01592747|Pediatric Disorder|pediatric disorder
362165|NCT01592747|Randomized Controlled Trial|randomized controlled trial
362166|NCT01592734|chronic constipation|chronic constipation
362167|NCT01592734|faecal impaction|faecal impaction
362168|NCT01592734|PEG-only laxative|peg-only laxative
362169|NCT01592721|Carcinoma|carcinoma
362170|NCT01592721|Squamous cell carcinoma|squamous cell carcinoma
362171|NCT01592721|Head and neck neoplasms|head and neck neoplasms
362172|NCT01592721|Cetuximab|cetuximab
362173|NCT01592708|orthognathic surgery|orthognathic surgery
362174|NCT01592708|maxillary osteotomy|maxillary osteotomy
362175|NCT01592708|post operative nausea vomiting|post operative nausea vomiting
362176|NCT01592708|post discharge nausea vomiting|post discharge nausea vomiting
362177|NCT01592708|anesthesia|anesthesia
362178|NCT01592695|Nicotine dependence|nicotine dependence
362179|NCT01592695|Smoking cessation|smoking cessation
362180|NCT01592695|Telehealth|telehealth
362181|NCT01592695|Alcohol use|alcohol use
362182|NCT01592695|Depression|depression
362183|NCT01592695|Body weight|body weight
362184|NCT01592682|tobacco|tobacco
362185|NCT01592682|secondhand smoke|secondhand smoke
362186|NCT01592682|Chinese|chinese
362187|NCT01592682|NNAL|nnal
362188|NCT01592669|Passive leg raising, blood pressure, heart rate|passive leg raising, blood pressure, heart rate
362189|NCT01592656|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
362190|NCT01592656|GOLD stages II, III and IV|gold stages ii, iii and iv
362191|NCT01592656|Computed Tomography scan|computed tomography scan
362192|NCT01592656|Functional Respiratory Imaging|functional respiratory imaging
362193|NCT01592656|Non-Invasive Ventilation|non-invasive ventilation
362194|NCT01592656|Arterial Blood Gas|arterial blood gas
362195|NCT01592656|Hypercapnic|hypercapnic
362196|NCT01592656|Health Related Quality of Life|health related quality of life
362197|NCT01592656|Lung compliance|lung compliance
362198|NCT01592643|Corneal shield|corneal shield
362199|NCT01592643|PRK|prk
362200|NCT01592643|Myopia|myopia
362201|NCT01592643|Pain|pain
362202|NCT01592643|Vision|vision
362203|NCT01592617|cancer vaccine|cancer vaccine
362204|NCT01592617|HLA-A*24:02|hla-a*24:02
362205|NCT01592617|lung cancer|lung cancer
362206|NCT01592617|CTL|ctl
362207|NCT01592604|fracture|fracture
362208|NCT01592604|fifth metatarsal|fifth metatarsal
362209|NCT01592604|functioanl outcome|functioanl outcome
362210|NCT01592578|gastroesophgeal variceal bleeding|gastroesophgeal variceal bleeding
362211|NCT01592578|liver cirrhosis|liver cirrhosis
362212|NCT01592578|portal hypertension|portal hypertension
362213|NCT01592552|Alzheimer's Disease|alzheimer's disease
362214|NCT01592552|Multiple Sclerosis|multiple sclerosis
362215|NCT01592552|Parkinson's Disease|parkinson's disease
362216|NCT01592552|Huntington's Disease|huntington's disease
362217|NCT01592552|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
362218|NCT01592539|Type 1 Diabetes|type 1 diabetes
362219|NCT01592539|Bone|bone
362220|NCT01592526|Systemic inflammatory response.|systemic inflammatory response.
362221|NCT01592526|Autonomic nervous regulation.|autonomic nervous regulation.
362222|NCT01592526|Cholinergic antiinflammatory pathway|cholinergic antiinflammatory pathway
362223|NCT01592500|GHD|ghd
362224|NCT01592500|r-hGH|r-hgh
362225|NCT01592500|Long-acting|long-acting
362226|NCT01592474|Multiple Sclerosis|multiple sclerosis
362227|NCT01592474|Avonex|avonex
362228|NCT01592474|Brain atrophy|brain atrophy
362229|NCT01592474|MRI|mri
362230|NCT01592474|Interferon-beta 1a|interferon-beta 1a
362231|NCT01592474|IFN Beta 1-a|ifn beta 1-a
362232|NCT01592474|Clinically isolated syndrome|clinically isolated syndrome
362233|NCT01592474|CIS|cis
362234|NCT01592461|Substance abuse treatment outcomes|substance abuse treatment outcomes
362235|NCT01592461|Opioid dependence|opioid dependence
362236|NCT01592461|Suboxone|suboxone
362237|NCT01592461|Methadone|methadone
362238|NCT01592448|Acetaminophen|acetaminophen
362239|NCT01592448|Patient Safety|patient safety
362240|NCT01592448|Health Literacy|health literacy
362241|NCT01592422|Small cell lung cancer|small cell lung cancer
362242|NCT01592422|Maintenance therapy|maintenance therapy
362243|NCT01592422|Immunotherapy|immunotherapy
362244|NCT01592422|Autologous cytokine-induced killer cell|autologous cytokine-induced killer cell
362245|NCT01592409|cannabis impaired driving|cannabis impaired driving
362246|NCT01592409|driving simulation|driving simulation
362247|NCT01592409|acute psychopharmacologic effects of cannabis|acute psychopharmacologic effects of cannabis
362248|NCT01592409|residual effects of cannabis|residual effects of cannabis
362249|NCT01592409|young drivers|young drivers
362250|NCT01592396|Tralokinumab|tralokinumab
362251|NCT01592396|CAT-354|cat-354
362252|NCT01592396|Asthma|asthma
362253|NCT01592357|cardiac rehabilitation|cardiac rehabilitation
362254|NCT01592357|gait speed|gait speed
362255|NCT01592357|mind body exercise|mind body exercise
362256|NCT01592357|tai chi|tai chi
362257|NCT01592357|cardiac disease|cardiac disease
362258|NCT01592357|frail elderly|frail elderly
362259|NCT01592344|Chronic pain|chronic pain
362260|NCT01592344|peripheral nerve|peripheral nerve
362261|NCT01592344|neuralgia|neuralgia
362262|NCT01592344|somatosensory nervous system|somatosensory nervous system
362263|NCT01592266|FLT|flt
362264|NCT01592266|PET|pet
362265|NCT01592266|bone marrow|bone marrow
362266|NCT01592266|AML|aml
362267|NCT01592240|PF-04950615|pf-04950615
362268|NCT01592240|RN316|rn316
362269|NCT01592227|healthy volunteer|healthy volunteer
362270|NCT01592227|pharmacokinetics|pharmacokinetics
362271|NCT01592227|paracetamol|paracetamol
362272|NCT01592214|Staphylococcus aureus, nasal decolonization, XF-73, gel formulation|staphylococcus aureus, nasal decolonization, xf-73, gel formulation
362273|NCT01592201|Schizophrenia|schizophrenia
362274|NCT01592201|Paliperidone ER|paliperidone er
362275|NCT01592201|Antipsychotics|antipsychotics
362276|NCT01592201|Mental disorder|mental disorder
362277|NCT01592201|Comparative study|comparative study
362278|NCT01592188|meditation, inflammation, children, attention|meditation, inflammation, children, attention
362279|NCT01592149|Appetite|appetite
362280|NCT01592136|Ponatinib|ponatinib
362281|NCT01592136|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
362282|NCT01592123|anxiety|anxiety
362283|NCT01592123|septal surgery|septal surgery
362284|NCT01592123|septum deviation|septum deviation
362285|NCT01592123|sleep|sleep
362286|NCT01592110|Schizophrenia|schizophrenia
362287|NCT01592097|Multiple Sclerosis|multiple sclerosis
362288|NCT01592097|MS|ms
362289|NCT01592097|Autoimmune|autoimmune
362290|NCT01592084|lipid lowering therapy|lipid lowering therapy
362291|NCT01592084|survival|survival
362292|NCT01592084|ALSFRS|alsfrs
362293|NCT01592084|age|age
362294|NCT01592084|BMI|bmi
362295|NCT01592084|weight|weight
362296|NCT01592071|food sensitivity|food sensitivity
362297|NCT01592071|IgG|igg
362298|NCT01592071|obesity|obesity
362299|NCT01592071|overweight|overweight
362300|NCT01592071|body composition|body composition
362301|NCT01592071|reactive foods|reactive foods
362302|NCT01592058|weight change|weight change
362303|NCT01592058|contraception|contraception
362304|NCT01592058|birth control|birth control
362305|NCT01592058|progestin|progestin
362306|NCT01592058|progestin only|progestin only
362307|NCT01592058|weight gain|weight gain
362308|NCT01592058|depo|depo
362309|NCT01592058|Depo Provera|depo provera
362310|NCT01592058|DMPA|dmpa
362311|NCT01592058|IUD|iud
362312|NCT01592058|IUC|iuc
362313|NCT01592058|Mirena|mirena
362314|NCT01592058|Paragard|paragard
362315|NCT01592058|Implanon|implanon
362316|NCT01592058|implant|implant
362317|NCT01592032|Antibiotic-lock technique.|antibiotic-lock technique.
362318|NCT01592032|In vivo antimicrobial concentration.|in vivo antimicrobial concentration.
362319|NCT01592032|Antimicrobial bioactivity.|antimicrobial bioactivity.
362320|NCT01592006|hepatitis C virus|hepatitis c virus
362321|NCT01592006|liver transplant recipient|liver transplant recipient
362322|NCT01591993|Sensitive skin|sensitive skin
362323|NCT01591993|Lactic acid test|lactic acid test
362324|NCT01591993|Transepidermal water loss|transepidermal water loss
362325|NCT01591993|Colorimetry|colorimetry
362326|NCT01591993|Capacitance|capacitance
362327|NCT01591980|post-craniotomy pain|post-craniotomy pain
362328|NCT01591980|pregabalin|pregabalin
362329|NCT01591980|chronic post-craniotomy headache|chronic post-craniotomy headache
362330|NCT01591980|Craniotomy|craniotomy
362331|NCT01591967|Chiropractic|chiropractic
362332|NCT01591967|Blood pressure|blood pressure
362333|NCT01591967|Pulse Rate|pulse rate
362334|NCT01591967|Thoracic|thoracic
362335|NCT01591941|ACL, Knee , Injury,|acl, knee , injury,
362336|NCT01591928|Pediatrics|pediatrics
362337|NCT01591928|Congenital heart disease|congenital heart disease
362338|NCT01591928|Heterotaxy syndrome|heterotaxy syndrome
362339|NCT01591928|Intestinal malrotation|intestinal malrotation
362340|NCT01591915|Breast cancer, Mindfulness Based Stress Reduction, RCT, mood, cooping, health related quality of life|breast cancer, mindfulness based stress reduction, rct, mood, cooping, health related quality of life
362341|NCT01591876|exercise|exercise
362342|NCT01591876|kidney disease|kidney disease
362343|NCT01591876|vascular function|vascular function
362344|NCT01591876|haemodialysis|haemodialysis
362345|NCT01591863|Clostridium difficile-associated diarrhea|clostridium difficile-associated diarrhea
362346|NCT01591863|CDAD|cdad
362347|NCT01591863|Pediatric|pediatric
362348|NCT01591798|Rectal cancer|rectal cancer
362349|NCT01591798|Robotic surgery|robotic surgery
362350|NCT01591798|Laparoscopic surgery|laparoscopic surgery
362351|NCT01591785|Hand|hand
362352|NCT01591785|Foot|foot
362353|NCT01591785|Eczema|eczema
362354|NCT01591785|Atopic Dermatitis|atopic dermatitis
362355|NCT01591772|FALLOPIAN TUBE|fallopian tube
362356|NCT01591772|OVARY|ovary
362357|NCT01591772|PERITONEUM|peritoneum
362358|NCT01591772|Quality of Life|quality of life
362359|NCT01591772|structural MRI|structural mri
362360|NCT01591772|functional MRI|functional mri
362361|NCT01591772|neuropsychological assessment|neuropsychological assessment
362362|NCT01591772|12-075|12-075
362363|NCT01591759|citicoline|citicoline
362364|NCT01591759|cognitive function|cognitive function
362365|NCT01591759|function magnetic resonance imaging|function magnetic resonance imaging
362366|NCT01591759|magnetic resonance spectroscopy|magnetic resonance spectroscopy
362367|NCT01591759|diffusion tensor imaging|diffusion tensor imaging
362368|NCT01591746|Mastectomy|mastectomy
362369|NCT01591746|Mammaplasty|mammaplasty
362370|NCT01591746|Breast reconstruction|breast reconstruction
362371|NCT01591746|Tissue expansion|tissue expansion
362372|NCT01591746|Botulinum toxins, Type A|botulinum toxins, type a
362373|NCT01591746|Quality of Life|quality of life
362374|NCT01591746|Acellular dermal matrix|acellular dermal matrix
362375|NCT01591733|Borderline resectable|borderline resectable
362376|NCT01591707|autism spectrum disorders|autism spectrum disorders
362377|NCT01591707|school|school
362378|NCT01591707|language|language
362379|NCT01591707|social|social
362380|NCT01591694|child trauma|child trauma
362381|NCT01591694|maltreatment|maltreatment
362382|NCT01591694|physical abuse|physical abuse
362383|NCT01591694|sexual abuse|sexual abuse
362384|NCT01591694|emotional abuse|emotional abuse
362385|NCT01591694|abandonment|abandonment
362386|NCT01591694|domestic violence|domestic violence
362387|NCT01591694|community violence|community violence
362388|NCT01591681|Type 1 Diabetes|type 1 diabetes
362389|NCT01591681|Hypoglycemia|hypoglycemia
362390|NCT01591681|Continuous Glucose Monitoring|continuous glucose monitoring
362391|NCT01591681|Pump Suspension|pump suspension
362392|NCT01591668|Hepatitis|hepatitis
362393|NCT01591668|Hepatitis C|hepatitis c
362394|NCT01591668|Chronic HCV|chronic hcv
362395|NCT01591668|HCV|hcv
362396|NCT01591668|Treatment Naive|treatment naive
362397|NCT01591668|Gilead|gilead
362398|NCT01591668|GS-9620|gs-9620
362399|NCT01591642|physical activity|physical activity
362400|NCT01591642|functional fitness|functional fitness
362401|NCT01591642|quality of life|quality of life
362402|NCT01591629|Cannabis|cannabis
362403|NCT01591629|Marijuana|marijuana
362404|NCT01591629|Naloxone|naloxone
362405|NCT01591629|THC|thc
362406|NCT01591629|Psychotic Disorders|psychotic disorders
362407|NCT01591590|Colorectal Cancer|colorectal cancer
362408|NCT01591590|Cancer|cancer
362409|NCT01591590|Colon Cancer|colon cancer
362410|NCT01591590|Rectal Cancer|rectal cancer
362411|NCT01591590|PET|pet
362412|NCT01591590|PET-CT|pet-ct
362413|NCT01591590|MRI|mri
362414|NCT01591590|Diffusion MRI|diffusion mri
362415|NCT01591590|Apparent Diffusion Coefficient|apparent diffusion coefficient
362416|NCT01591590|ADC|adc
362417|NCT01591590|Metabolic Progression Index|metabolic progression index
362418|NCT01591564|interpersonal psychotherapy|interpersonal psychotherapy
362419|NCT01591564|severe mood dysregulation|severe mood dysregulation
362420|NCT01591538|Prevalence|prevalence
362421|NCT01591538|MDRGNB|mdrgnb
362422|NCT01591538|Acquisition|acquisition
362423|NCT01591538|Middle stay|middle stay
362424|NCT01591538|Endemic area|endemic area
362425|NCT01591525|Type II Diabetes|type ii diabetes
362426|NCT01591525|Minorities|minorities
362427|NCT01591525|Diabetes Mellitus|diabetes mellitus
362428|NCT01591525|Community based screening|community based screening
362429|NCT01591512|Small Cell Lung Cancer|small cell lung cancer
362430|NCT01591512|SCLC|sclc
362431|NCT01591512|Lung Cancer|lung cancer
362432|NCT01591512|Subjects diagnosed with SCLC who will undergo treatment|subjects diagnosed with sclc who will undergo treatment
362433|NCT01591486|Helicobacter pylori (Hp)|helicobacter pylori (hp)
362434|NCT01591486|ASA users|asa users
362435|NCT01591486|peptic ulcer bleeding|peptic ulcer bleeding
362436|NCT01591486|cohorts|cohorts
362437|NCT01591473|Influenza|influenza
362438|NCT01591473|Ampligen|ampligen
362439|NCT01591473|Poly I:Poly C12U|poly i:poly c12u
362440|NCT01591473|Rintatolimod|rintatolimod
362441|NCT01591473|FluMist|flumist
362442|NCT01591408|EEG biofeedback|eeg biofeedback
362443|NCT01591408|neurofeedback|neurofeedback
362444|NCT01591408|therapy|therapy
362445|NCT01591408|adjunct|adjunct
362446|NCT01591395|inguinal hernia|inguinal hernia
362447|NCT01591395|laparoscopy|laparoscopy
362448|NCT01591395|laparoendoscopic single-site surgery|laparoendoscopic single-site surgery
362449|NCT01591382|Ketamine|ketamine
362450|NCT01591382|Postoperative pain|postoperative pain
362451|NCT01591382|Opioid dependent patients|opioid dependent patients
362452|NCT01591382|Acute pain control|acute pain control
362453|NCT01591356|Advanced Cancers|advanced cancers
362454|NCT01591356|Advanced solid tumors|advanced solid tumors
362455|NCT01591356|siRNA/EphA2|sirna/epha2
362456|NCT01591343|Specific immunotherapy|specific immunotherapy
362457|NCT01591343|Allergic rhinitis|allergic rhinitis
362458|NCT01591343|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
362459|NCT01591343|Asthma|asthma
362460|NCT01591304|Ulthera® System|ulthera® system
362461|NCT01591304|Ultherapy™ Treatment|ultherapy™ treatment
362462|NCT01591304|Ulthera, Inc.|ulthera, inc.
362463|NCT01591291|alcohol dependence|alcohol dependence
362464|NCT01591291|alcohol addiction|alcohol addiction
362465|NCT01591265|Compensatory dental extraction|compensatory dental extraction
362466|NCT01591265|Children 7-11 years old|children 7-11 years old
362467|NCT01591252|HIV|hiv
362468|NCT01591252|Bone mineral density|bone mineral density
362469|NCT01591252|bone turnover|bone turnover
362470|NCT01591252|fracture|fracture
362471|NCT01591252|inflammation|inflammation
362472|NCT01591239|Adolescent|adolescent
362473|NCT01591239|Parent|parent
362474|NCT01591239|Substance Abuse|substance abuse
362475|NCT01591239|Parent Training|parent training
362476|NCT01591239|Addiction|addiction
362477|NCT01591239|Family Intervention|family intervention
362478|NCT01591239|Brief Intervention|brief intervention
362479|NCT01591239|Home Intervention|home intervention
362480|NCT01591226|caffeine|caffeine
362481|NCT01591226|sodium citrate|sodium citrate
362482|NCT01591226|exercise performance|exercise performance
362483|NCT01591226|wheelchair athletes|wheelchair athletes
362484|NCT01591226|1500m|1500m
362485|NCT01591213|Cancer education|cancer education
362486|NCT01591213|Prevention education|prevention education
362487|NCT01591213|Volunteers|volunteers
362488|NCT01591200|Alcoholic|alcoholic
362489|NCT01591200|Liver|liver
362490|NCT01591200|Cirrhosis|cirrhosis
362491|NCT01591200|Stem|stem
362492|NCT01591200|Cells|cells
362493|NCT01591187|Text messaging|text messaging
362494|NCT01591187|Secondhand smoke exposure|secondhand smoke exposure
362495|NCT01591174|Functional Dyspepsia|functional dyspepsia
362496|NCT01591174|Postprandial Distress Syndrome|postprandial distress syndrome
362497|NCT01591174|ghrelin|ghrelin
362498|NCT01591174|C-13 acetate|c-13 acetate
362499|NCT01591148|Pharmacokinetics|pharmacokinetics
362500|NCT01591148|Pharmacodynamics|pharmacodynamics
362501|NCT01591135|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
362502|NCT01591135|chemoradiotherapy|chemoradiotherapy
362503|NCT01591122|Prostate cancer|prostate cancer
362504|NCT01591122|Metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
362505|NCT01591122|Abiraterone acetate|abiraterone acetate
362506|NCT01591122|Prednisone|prednisone
362507|NCT01591122|Zytiga|zytiga
362508|NCT01591096|Stroke|stroke
362509|NCT01591096|Childhood|childhood
362510|NCT01591096|Thrombolysis|thrombolysis
362511|NCT01591083|Peptic ulcer rebleeding, double dose of esomeprazole|peptic ulcer rebleeding, double dose of esomeprazole
362512|NCT01591070|Facial seborrhoeic dermatitis, tacrolimus|facial seborrhoeic dermatitis, tacrolimus
362513|NCT01591057|fruit|fruit
362514|NCT01591057|vegetables|vegetables
362515|NCT01591057|biomarkers|biomarkers
362516|NCT01591057|randomised controlled feeding study|randomised controlled feeding study
362517|NCT01591057|Fruit and vegetable intake biomarkers in healthy adults|fruit and vegetable intake biomarkers in healthy adults
362518|NCT01591031|laryngeal injuries|laryngeal injuries
362519|NCT01591031|vocal cord injuries|vocal cord injuries
362520|NCT01591031|hoarseness|hoarseness
362521|NCT01591031|sore throat|sore throat
362522|NCT01591018|sonolysis, brain infarction, prevention, cardiac surgery|sonolysis, brain infarction, prevention, cardiac surgery
362523|NCT01591005|sonolysis|sonolysis
362524|NCT01591005|carotid|carotid
362525|NCT01591005|endarterectomy|endarterectomy
362526|NCT01591005|stenting|stenting
362527|NCT01590992|Somatoform disorder|somatoform disorder
362528|NCT01590992|Functional Somatic Syndrome|functional somatic syndrome
362529|NCT01590992|Functional Somatic Symptoms|functional somatic symptoms
362530|NCT01590992|Somatic Symptom Disorder|somatic symptom disorder
362531|NCT01590992|globus sensation|globus sensation
362532|NCT01590992|globus pharynges|globus pharynges
362533|NCT01590992|globus hystericus|globus hystericus
362534|NCT01590979|Atrial Fibrillation New Onset|atrial fibrillation new onset
362535|NCT01590979|Ranolazine|ranolazine
362536|NCT01590979|CABG|cabg
362537|NCT01590979|valve repair/replacement|valve repair/replacement
362538|NCT01590979|Cardiac Surgery|cardiac surgery
362539|NCT01590966|spondyloarthritis|spondyloarthritis
362540|NCT01590966|Rheumatoid arthritis|rheumatoid arthritis
362541|NCT01590927|pelvic floor|pelvic floor
362542|NCT01590927|ultrasonography|ultrasonography
362543|NCT01590914|Roux-en-Y Bariatric surgery,|roux-en-y bariatric surgery,
362544|NCT01590914|Gastric banding,|gastric banding,
362545|NCT01590914|fMRI,|fmri,
362546|NCT01590914|food cues|food cues
362547|NCT01590901|Pharmacokinetics|pharmacokinetics
362548|NCT01590901|Probucol|probucol
362549|NCT01590901|healthy male subjects|healthy male subjects
362550|NCT01590875|atrial fibrillation|atrial fibrillation
362551|NCT01590875|ablation|ablation
362552|NCT01590875|pulmonary veins|pulmonary veins
362553|NCT01590875|adenosine|adenosine
362554|NCT01590862|Obesessive Compulsive Disorder|obesessive compulsive disorder
362555|NCT01590862|Major Depressive Disorder|major depressive disorder
362556|NCT01590862|Deep Brain Stimulation|deep brain stimulation
362557|NCT01590849|contraceptive agents|contraceptive agents
362558|NCT01590849|autonomic nervous system|autonomic nervous system
362559|NCT01590849|blood pressure|blood pressure
362560|NCT01590849|risk|risk
362561|NCT01590823|pharmacokinetics|pharmacokinetics
362562|NCT01590784|Depression|depression
362563|NCT01590784|Schizophrenia|schizophrenia
362564|NCT01590758|Diabetic Foot Ulcer Infection|diabetic foot ulcer infection
362565|NCT01590745|Ultrasound therapy|ultrasound therapy
362566|NCT01590745|Nerve Conduction studies|nerve conduction studies
362567|NCT01590745|Boston and Levine Questionnaire|boston and levine questionnaire
362568|NCT01590745|Neutral Angle Wrist Splint|neutral angle wrist splint
362569|NCT01590745|Canterbury CTS scale|canterbury cts scale
362570|NCT01590732|Lymphoma|lymphoma
362571|NCT01590732|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
362572|NCT01590732|PTCL|ptcl
362573|NCT01590732|Relapsed or refractory T-Cell Lymphoma|relapsed or refractory t-cell lymphoma
362575|NCT01590732|Peripheral TCL-NOS|peripheral tcl-nos
362576|NCT01590732|Angioimmunoblastic TCL|angioimmunoblastic tcl
362577|NCT01590732|Anaplastic large cell lymphoma|anaplastic large cell lymphoma
362578|NCT01590732|Hepatosplenic TCL|hepatosplenic tcl
362579|NCT01590732|Enteropathy-associated TCL|enteropathy-associated tcl
362580|NCT01590732|Romidepsin|romidepsin
362581|NCT01590732|Istodax|istodax
362582|NCT01590732|Depsipeptide|depsipeptide
362583|NCT01590732|FK228|fk228
362584|NCT01590732|Etoposide|etoposide
362585|NCT01590732|VePesid|vepesid
362586|NCT01590732|Carboplatin|carboplatin
362587|NCT01590732|Paraplatin|paraplatin
362588|NCT01590732|Mesna|mesna
362589|NCT01590732|Mesnex|mesnex
362590|NCT01590706|Genotype-Phenotype Association|genotype-phenotype association
362591|NCT01590706|Aged|aged
362592|NCT01590706|Middle Aged|middle aged
362593|NCT01590706|Mild Cognitive Impairment|mild cognitive impairment
362594|NCT01590706|Heart Rate Control|heart rate control
362595|NCT01590706|Biomarkers|biomarkers
362596|NCT01590693|Gait|gait
362597|NCT01590667|Fat excretion|fat excretion
362598|NCT01590654|Hepatitis|hepatitis
362599|NCT01590654|Hepatitis B|hepatitis b
362600|NCT01590654|Hepatitis B Virus|hepatitis b virus
362601|NCT01590654|HBV|hbv
362602|NCT01590654|GS-9620|gs-9620
362603|NCT01590654|Toll-like receptor (TLR)-7 Agonist|toll-like receptor (tlr)-7 agonist
362604|NCT01590641|Hepatitis|hepatitis
362605|NCT01590641|Hepatitis B|hepatitis b
362606|NCT01590641|Hepatitis B Virus|hepatitis b virus
362607|NCT01590641|HBV|hbv
362608|NCT01590641|GS-9620|gs-9620
362609|NCT01590641|Toll-like receptor (TLR)-7 Agonist|toll-like receptor (tlr)-7 agonist
362610|NCT01590628|Sickle Cell Disease & Thalassemia|sickle cell disease & thalassemia
362611|NCT01590628|Genetic disorder|genetic disorder
362612|NCT01590615|Hepatitis|hepatitis
362613|NCT01590615|Hepatitis B|hepatitis b
362614|NCT01590615|HBV|hbv
362615|NCT01590615|OLT|olt
362616|NCT01590615|MELD|meld
362617|NCT01590615|Renal Safety|renal safety
362618|NCT01590615|Liver Transplant|liver transplant
362619|NCT01590602|Huntington's Disease|huntington's disease
362620|NCT01590602|European Huntington's Disease Network|european huntington's disease network
362621|NCT01590602|Juvenile HD|juvenile hd
362622|NCT01590602|EHDN|ehdn
362623|NCT01590602|REGISTRY|registry
362624|NCT01590589|Huntington Disease|huntington disease
362625|NCT01590589|European HD Network|european hd network
362626|NCT01590589|Cohort|cohort
362627|NCT01590589|REGISTRY|registry
362628|NCT01590589|EHDN|ehdn
362629|NCT01590576|women|women
362630|NCT01590550|Pediatric hemodialysis|pediatric hemodialysis
362631|NCT01590550|Anticoagulation|anticoagulation
362632|NCT01590537|non-interventional|non-interventional
362633|NCT01590537|Mirena|mirena
362634|NCT01590537|Contraception|contraception
362635|NCT01590537|Russian Federation|russian federation
362636|NCT01590524|Parent|parent
362637|NCT01590524|childhood cancer|childhood cancer
362638|NCT01590524|Complementary and Alternative|complementary and alternative
362639|NCT01590511|mini fluid challenge|mini fluid challenge
362640|NCT01590511|subaortic velocity time integral|subaortic velocity time integral
362641|NCT01590498|Adenocarcinoma|adenocarcinoma
362642|NCT01590498|Prostatic Neoplasms|prostatic neoplasms
362643|NCT01590498|Carcinoma|carcinoma
362644|NCT01590498|Prostatic Diseases|prostatic diseases
362645|NCT01590485|pain|pain
362646|NCT01590485|root canal therapy|root canal therapy
362647|NCT01590472|Genetics of Mesothelioma|genetics of mesothelioma
362648|NCT01590472|Mesothelioma Consortium|mesothelioma consortium
362649|NCT01590472|GWAS|gwas
362650|NCT01590472|Asbestos|asbestos
362651|NCT01590446|Achondroplasia|achondroplasia
362652|NCT01590433|Obesity|obesity
362653|NCT01590433|Overweight|overweight
362654|NCT01590433|Exenatide|exenatide
362655|NCT01590433|Diet|diet
362656|NCT01590433|Women|women
362657|NCT01590420|OSA|osa
362658|NCT01590420|Sleep|sleep
362659|NCT01590420|CPAP|cpap
362660|NCT01590420|Cost|cost
362661|NCT01590394|obstruction|obstruction
362662|NCT01590394|bile duct|bile duct
362663|NCT01590394|malignant|malignant
362664|NCT01590342|Pulmonary embolism|pulmonary embolism
362665|NCT01590342|Right ventricular dysfunction|right ventricular dysfunction
362666|NCT01590342|Prognosis|prognosis
362667|NCT01590342|Inflammation|inflammation
362668|NCT01590329|Skin surgery|skin surgery
362669|NCT01590329|Micrografting|micrografting
362670|NCT01590329|Hypo-pigmentation|hypo-pigmentation
362671|NCT01590316|Brain Injuries|brain injuries
362672|NCT01590316|Infant, Premature|infant, premature
362673|NCT01590316|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
362674|NCT01590316|Randomized Controlled Trial|randomized controlled trial
362675|NCT01590303|severe sepsis|severe sepsis
362676|NCT01590264|tinnitus|tinnitus
362677|NCT01590264|bimodal stimulation|bimodal stimulation
362678|NCT01590264|rTMS|rtms
362679|NCT01590264|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
362680|NCT01590251|Pain|pain
362681|NCT01590251|Addiction|addiction
362682|NCT01590251|Buprenorphine|buprenorphine
362683|NCT01590251|Counseling|counseling
362684|NCT01590251|Methadone|methadone
362685|NCT01590251|Yoga|yoga
362686|NCT01590238|alopecia|alopecia
362687|NCT01590186|Pain|pain
362688|NCT01590186|Front foot|front foot
362689|NCT01590186|Flat foot|flat foot
362690|NCT01590186|Metatarsalgia|metatarsalgia
362691|NCT01590173|Low molecular weight heparin|low molecular weight heparin
362692|NCT01590173|Prednisolone|prednisolone
362693|NCT01590173|Glucocorticoids|glucocorticoids
362694|NCT01590173|Recurrent implantation failure|recurrent implantation failure
362695|NCT01590173|Pregnancy rate|pregnancy rate
362696|NCT01590134|volunteers|volunteers
362697|NCT01590134|Pilot study|pilot study
362698|NCT01590134|There are no pre registration evaluations.|there are no pre registration evaluations.
362699|NCT01590134|Inclusion criteria: to be a healthy, consenting volunteer not currently receiving iron supplements.|inclusion criteria: to be a healthy, consenting volunteer not currently receiving iron supplements.
362700|NCT01590134|Exclusion criteria: 1) Needle phobia; 2) Currently receiving iron supplements; 3) Unable to provide informed consent|exclusion criteria: 1) needle phobia; 2) currently receiving iron supplements; 3) unable to provide informed consent
362701|NCT01590121|Previous flight by aeroplane|previous flight by aeroplane
362702|NCT01590108|Idiopathic Pulmonary Arterial Hypertension|idiopathic pulmonary arterial hypertension
362703|NCT01590108|IPAH|ipah
362704|NCT01590108|Apelin|apelin
362705|NCT01590108|APJ receptor|apj receptor
362706|NCT01590095|Chlorine water treatment|chlorine water treatment
362707|NCT01590095|Point-of-use water treatment|point-of-use water treatment
362708|NCT01590095|Household water treatment with safe storage|household water treatment with safe storage
362709|NCT01590095|Hand washing with soap|hand washing with soap
362710|NCT01590095|Hand hygiene|hand hygiene
362711|NCT01590095|Latrines|latrines
362712|NCT01590095|Child potties|child potties
362713|NCT01590095|Point-of-use fortification|point-of-use fortification
362714|NCT01590095|Lipid-based nutrient supplement|lipid-based nutrient supplement
362715|NCT01590095|Environmental enteropathy|environmental enteropathy
362716|NCT01590095|Tropical enteropathy|tropical enteropathy
362717|NCT01590095|Gut function|gut function
362718|NCT01590095|Intestinal parasitic infection|intestinal parasitic infection
362719|NCT01590095|Soil transmitted helminths|soil transmitted helminths
362720|NCT01590095|Intestinal protozoans|intestinal protozoans
362721|NCT01590095|Antibody response|antibody response
362722|NCT01590095|Water|water
362723|NCT01590095|Sanitation|sanitation
362724|NCT01590095|Hand washing|hand washing
362725|NCT01590095|Breast Feeding|breast feeding
362726|NCT01590095|Complementary Feeding|complementary feeding
362727|NCT01590095|Micronutrients|micronutrients
362728|NCT01590095|Malnutrition|malnutrition
362729|NCT01590095|Nutrition Disorders|nutrition disorders
362730|NCT01590095|Diarrhea|diarrhea
362731|NCT01590095|Child Development|child development
362732|NCT01590082|Melanoma|melanoma
362733|NCT01590082|Metastatic Melanoma|metastatic melanoma
362734|NCT01590082|Advanced melanoma|advanced melanoma
362735|NCT01590082|Doxycycline|doxycycline
362736|NCT01590082|Ipilimumab|ipilimumab
362737|NCT01590082|Yervoy|yervoy
362738|NCT01590082|MDX010|mdx010
362739|NCT01590082|BMS-734016|bms-734016
362740|NCT01590082|Temozolomide|temozolomide
362741|NCT01590082|Temodar|temodar
362742|NCT01590069|Sarcoma|sarcoma
362743|NCT01590069|Solid Tumors|solid tumors
362744|NCT01590069|Pulmonary Metastases|pulmonary metastases
362745|NCT01590069|Lung metastases|lung metastases
362746|NCT01590069|Osteosarcomas|osteosarcomas
362747|NCT01590069|Ewing sarcoma|ewing sarcoma
362748|NCT01590069|IL-2|il-2
362749|NCT01590069|Interleukin-2|interleukin-2
362750|NCT01590069|Aldesleukin|aldesleukin
362751|NCT01590069|Proleukin|proleukin
362752|NCT01590069|Aerosol IL-2|aerosol il-2
362753|NCT01590069|Spirometry|spirometry
362754|NCT01590069|Nebulizer|nebulizer
362755|NCT01590069|Pulse oximeter|pulse oximeter
362756|NCT01590056|Mapping limbic areas of the STN|mapping limbic areas of the stn
362757|NCT01590056|neuronal responses to stimuli during surgery|neuronal responses to stimuli during surgery
362758|NCT01590017|stage IB cervical cancer|stage ib cervical cancer
362759|NCT01590017|stage IIA cervical cancer|stage iia cervical cancer
362760|NCT01590017|stage IIB cervical cancer|stage iib cervical cancer
362761|NCT01590017|stage III cervical cancer|stage iii cervical cancer
362762|NCT01590017|stage IVA cervical cancer|stage iva cervical cancer
362763|NCT01590017|cervical adenocarcinoma|cervical adenocarcinoma
362764|NCT01590017|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
362765|NCT01590017|cervical squamous cell carcinoma|cervical squamous cell carcinoma
362766|NCT01590017|HIV infection|hiv infection
362767|NCT01590004|LumbarCool system|lumbarcool system
362768|NCT01590004|Cooled radiofrequency medial ablation|cooled radiofrequency medial ablation
362769|NCT01590004|Cooled-RF neurotomy|cooled-rf neurotomy
362770|NCT01589991|toothpastes|toothpastes
362771|NCT01589991|bioavailability|bioavailability
362772|NCT01589991|sodium fluoride|sodium fluoride
362773|NCT01589991|monofluorphosphate|monofluorphosphate
362774|NCT01589991|low-fluoride|low-fluoride
362775|NCT01589978|drug-eluting stent|drug-eluting stent
362776|NCT01589978|DES|des
362777|NCT01589978|atherosclerosis|atherosclerosis
362778|NCT01589978|everolimus|everolimus
362779|NCT01589965|HIV/AIDS|hiv/aids
362780|NCT01589965|STIs|stis
362781|NCT01589965|Lottery|lottery
362782|NCT01589952|Pegalyted interferon|pegalyted interferon
362783|NCT01589952|Entecavir|entecavir
362784|NCT01589939|Reduced Planning Target Volume|reduced planning target volume
362785|NCT01589939|radiation therapy|radiation therapy
362786|NCT01589939|Calypso|calypso
362787|NCT01589913|Implantable Cardioverter Defibrillators|implantable cardioverter defibrillators
362788|NCT01589913|Heart Failure|heart failure
362789|NCT01589913|Anxiety|anxiety
362790|NCT01589913|Depression|depression
362791|NCT01589913|Quality of Life|quality of life
362792|NCT01589913|Remote Care|remote care
362793|NCT01589913|Prevention|prevention
362794|NCT01589900|colorectal cancer|colorectal cancer
362795|NCT01589900|invasion|invasion
362796|NCT01589900|metastasis|metastasis
362797|NCT01589900|IHC|ihc
362798|NCT01589874|hepcidin|hepcidin
362799|NCT01589874|anemia|anemia
362800|NCT01589874|acute inflammation|acute inflammation
362801|NCT01589874|IL-6|il-6
362802|NCT01589874|cytokines|cytokines
362803|NCT01589848|vWD|vwd
362804|NCT01589809|Congenital, familial and genetic disorders|congenital, familial and genetic disorders
362805|NCT01589809|Nervous System Diseases|nervous system diseases
362806|NCT01589796|anesthesia|anesthesia
362807|NCT01589796|regional anesthetic techniques: transversus abdominis plane block, ilioinguinal nerve block, iliohypogastric nerve block|regional anesthetic techniques: transversus abdominis plane block, ilioinguinal nerve block, iliohypogastric nerve block
362808|NCT01589796|surgery, inguinal herniorrhaphy|surgery, inguinal herniorrhaphy
362809|NCT01589796|pain, postoperative|pain, postoperative
362810|NCT01589796|surgery, inguinal hernia repair|surgery, inguinal hernia repair
362811|NCT01589783|Pregnancy|pregnancy
362812|NCT01589783|Vitamin D|vitamin d
362813|NCT01589770|rheumatoid arthritis|rheumatoid arthritis
362814|NCT01589770|inflammation|inflammation
362815|NCT01589757|"glycaemic index"|"glycaemic index"
362816|NCT01589757|"glycemic index"|"glycemic index"
362817|NCT01589757|hyperglycaemia|hyperglycaemia
362818|NCT01589757|hyperglycemia|hyperglycemia
362819|NCT01589757|pregnancy|pregnancy
362820|NCT01589757|"dietary intervention"|"dietary intervention"
362821|NCT01589757|"education evaluation"|"education evaluation"
362822|NCT01589757|antioxidant|antioxidant
362823|NCT01589757|"Impaired Glucose Tolerance of Pregnancy"|"impaired glucose tolerance of pregnancy"
362824|NCT01589757|"Gestational Diabetes Mellitus"|"gestational diabetes mellitus"
362825|NCT01589757|"Breast Milk"|"breast milk"
362826|NCT01589744|medical device|medical device
362827|NCT01589731|Allergenicity|allergenicity
362828|NCT01589731|Cow's milk allergy|cow's milk allergy
362829|NCT01589731|Leukocyte adherence inhibition test|leukocyte adherence inhibition test
362830|NCT01589731|Polymerization|polymerization
362831|NCT01589718|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
362832|NCT01589718|Tractional Retinal Detachment|tractional retinal detachment
362833|NCT01589718|Vitreous Hemorrhage|vitreous hemorrhage
362834|NCT01589705|Uric acid|uric acid
362835|NCT01589705|polycystic kidney disease|polycystic kidney disease
362836|NCT01589692|WRIST|wrist
362837|NCT01589692|Distal Radius Fracture|distal radius fracture
362838|NCT01589692|DRF|drf
362839|NCT01589692|elderly|elderly
362840|NCT01589692|internal fixation|internal fixation
362841|NCT01589692|VLPS|vlps
362842|NCT01589692|External Fixation|external fixation
362843|NCT01589692|Multi center randomized trial|multi center randomized trial
362844|NCT01589666|Entegrion|entegrion
362845|NCT01589666|Spray-dried Solvent/Detergent Plasma|spray-dried solvent/detergent plasma
362846|NCT01589666|Fresh Frozen Plasma|fresh frozen plasma
362847|NCT01589666|Transfusion|transfusion
362848|NCT01589666|Resuscitation|resuscitation
362849|NCT01589666|Hemorrhage|hemorrhage
362850|NCT01589666|Coagulopathy|coagulopathy
362851|NCT01589627|distal radius fracture|distal radius fracture
362852|NCT01589627|wrist contracture|wrist contracture
362853|NCT01589627|dynasplint|dynasplint
362854|NCT01589601|Congestive Heart Failure|congestive heart failure
362855|NCT01589601|Heart Failure|heart failure
362856|NCT01589601|Palliative Care|palliative care
362857|NCT01589601|Palliative Medicine|palliative medicine
362858|NCT01589588|acute treatment|acute treatment
362859|NCT01589575|Intensive Care Unit|intensive care unit
362860|NCT01589549|Acute graft versus host disease|acute graft versus host disease
362861|NCT01589549|Bone marrow transplantation|bone marrow transplantation
362862|NCT01589549|Mesenchymal stromal cells|mesenchymal stromal cells
362863|NCT01589536|psychocardiological|psychocardiological
362864|NCT01589536|interval intervention|interval intervention
362865|NCT01589536|disability pension|disability pension
362866|NCT01589536|risk profile|risk profile
362867|NCT01589536|mental comorbidity|mental comorbidity
362868|NCT01589484|Tomography|tomography
362869|NCT01589484|Urinary Lithiasis|urinary lithiasis
362870|NCT01589484|Kidney Calculi|kidney calculi
362871|NCT01589471|Low anterior resection syndrome|low anterior resection syndrome
362872|NCT01589471|Botulinum toxin A|botulinum toxin a
362873|NCT01589471|Quality of life|quality of life
362874|NCT01589471|Incontinence|incontinence
362875|NCT01589471|Rectal cancer|rectal cancer
362876|NCT01589471|Anorectal manometry|anorectal manometry
362877|NCT01589458|toothpastes|toothpastes
362878|NCT01589458|saliva|saliva
362879|NCT01589458|dental caries|dental caries
362880|NCT01589458|fluoride|fluoride
362881|NCT01589445|Bangladesh|bangladesh
362882|NCT01589445|T2DM|t2dm
362883|NCT01589445|Pioglitazone|pioglitazone
362884|NCT01589445|Metformin|metformin
362885|NCT01589445|Insulin secretion and Sensitivity|insulin secretion and sensitivity
362886|NCT01589432|Diabetic peripheral neuropathy|diabetic peripheral neuropathy
362887|NCT01589419|DLT|dlt
362888|NCT01589419|radiation|radiation
362889|NCT01589419|veliparib|veliparib
362890|NCT01589419|locally advanced rectal cancer|locally advanced rectal cancer
362891|NCT01589419|ABT-888|abt-888
362892|NCT01589419|capecitabine|capecitabine
362893|NCT01589419|MTD|mtd
362894|NCT01589419|PARP|parp
362895|NCT01589406|Gynaecological Cancer|gynaecological cancer
362896|NCT01589406|Quality of Life|quality of life
362897|NCT01589406|Sexuality|sexuality
362898|NCT01589393|Trauma|trauma
362899|NCT01589393|Thromboprophylaxis|thromboprophylaxis
362900|NCT01589393|Intracranial haemorrhage|intracranial haemorrhage
362901|NCT01589393|Deep vein Thrombosis|deep vein thrombosis
362902|NCT01589380|Aortic stenosis|aortic stenosis
362903|NCT01589380|Exercise performance|exercise performance
362904|NCT01589380|cardiopulmonary exercise test|cardiopulmonary exercise test
362905|NCT01589380|fimasartan|fimasartan
362906|NCT01589367|neoadjuvant endocrine therapy|neoadjuvant endocrine therapy
362907|NCT01589367|metformin|metformin
362908|NCT01589367|postmenopausal breast cancer|postmenopausal breast cancer
362909|NCT01589328|pancreatic cancer|pancreatic cancer
362910|NCT01589328|biliary tract cancer|biliary tract cancer
362911|NCT01589328|cancer pain|cancer pain
362912|NCT01589328|depression|depression
362913|NCT01589315|ECT|ect
362914|NCT01589315|FEAST|feast
362915|NCT01589315|brain stimulation|brain stimulation
362916|NCT01589315|depression|depression
362917|NCT01589302|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
362918|NCT01589302|CLL|cll
362919|NCT01589302|SLL|sll
362920|NCT01589302|B-PLL|b-pll
362921|NCT01589289|Diagnostic research|diagnostic research
362922|NCT01589289|Rapid diagnostic tests|rapid diagnostic tests
362923|NCT01589289|Neurological disorders|neurological disorders
362924|NCT01589289|Neglected Tropical Diseases|neglected tropical diseases
362925|NCT01589289|Developing countries|developing countries
362926|NCT01589263|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
362927|NCT01589263|Lower Urinary Track Symptoms|lower urinary track symptoms
362928|NCT01589263|BPH|bph
362929|NCT01589263|LUTS|luts
362930|NCT01589237|Familial Chylomicronemia Syndrome (FCS) (HLP type I)|familial chylomicronemia syndrome (fcs) (hlp type i)
362931|NCT01589237|LCQ908|lcq908
362932|NCT01589211|smoking|smoking
362933|NCT01589211|cessation|cessation
362934|NCT01589211|intervention|intervention
362935|NCT01589211|brief|brief
362936|NCT01589198|Asthma|asthma
362937|NCT01589185|Pneumonia|pneumonia
362938|NCT01589185|Monoclonal antibody|monoclonal antibody
362939|NCT01589185|Staphylococcus aureus|staphylococcus aureus
362940|NCT01589146|colon-rectal cancer|colon-rectal cancer
362941|NCT01589146|heparin|heparin
362942|NCT01589146|prophylaxis|prophylaxis
362943|NCT01589146|laparoscopy|laparoscopy
362944|NCT01589133|Irregular antibody screening|irregular antibody screening
362945|NCT01589120|CHF|chf
362946|NCT01589120|video decision aid|video decision aid
362947|NCT01589094|CISPLATIN|cisplatin
362948|NCT01589094|GEMCITABINE|gemcitabine
362949|NCT01589094|GM-CSF|gm-csf
362950|NCT01589094|radical cystectomy|radical cystectomy
362951|NCT01589094|12-071|12-071
362952|NCT01589003|low GI milk mood behaviour cognitive function children|low gi milk mood behaviour cognitive function children
362953|NCT01588964|HIPEC|hipec
362954|NCT01588964|ovarian cancer|ovarian cancer
362955|NCT01588964|recurrence|recurrence
362956|NCT01588938|radiation therapy|radiation therapy
362957|NCT01588938|Calypso|calypso
362958|NCT01588925|Cochlear implantation|cochlear implantation
362959|NCT01588925|Dexamethasone|dexamethasone
362960|NCT01588925|Acid, Hyaluronic|acid, hyaluronic
363460|NCT01586533|mesalazine|mesalazine
362961|NCT01588912|chronic hepatitis B|chronic hepatitis b
362962|NCT01588912|HBeAg positive|hbeag positive
362963|NCT01588912|telbivudine|telbivudine
362964|NCT01588912|tenofovir|tenofovir
362965|NCT01588912|entecavir|entecavir
362966|NCT01588912|roadmap|roadmap
362967|NCT01588899|Uterine Leiomyomas|uterine leiomyomas
362968|NCT01588899|Fibroids|fibroids
362969|NCT01588899|HIFU|hifu
362970|NCT01588899|Ablation|ablation
362971|NCT01588899|High Intensity Focused Ultrasound|high intensity focused ultrasound
362972|NCT01588886|Proton pump inhibitors|proton pump inhibitors
362973|NCT01588886|Pneumonia|pneumonia
362974|NCT01588886|Retrospective cohort study|retrospective cohort study
362975|NCT01588873|Oral contraceptive pill|oral contraceptive pill
362976|NCT01588873|Hormonal contraceptive ring|hormonal contraceptive ring
362977|NCT01588873|Polycystic ovary syndrome|polycystic ovary syndrome
362978|NCT01588847|perioperative immunoediting|perioperative immunoediting
362979|NCT01588847|potential predictive biomarkers|potential predictive biomarkers
362980|NCT01588847|lymph node dissection|lymph node dissection
362981|NCT01588821|Metastatic|metastatic
362982|NCT01588821|Refractory|refractory
362983|NCT01588821|Relapsed|relapsed
362984|NCT01588808|Immobilization|immobilization
362985|NCT01588808|Protein supplementation|protein supplementation
362986|NCT01588795|Diabetic nephropathy|diabetic nephropathy
362987|NCT01588795|renal denervation|renal denervation
362988|NCT01588795|nephroprotection|nephroprotection
362989|NCT01588795|Renal failure|renal failure
362990|NCT01588795|Renal injury|renal injury
362991|NCT01588795|End stage renal disease|end stage renal disease
362992|NCT01588782|Healthy volunteers|healthy volunteers
362993|NCT01588782|Pharmacology|pharmacology
362994|NCT01588782|Pharmacokinetics|pharmacokinetics
362995|NCT01588782|Pharmacodynamics|pharmacodynamics
362996|NCT01588782|Drug-drug interactions|drug-drug interactions
362997|NCT01588782|CYP3A4|cyp3a4
362998|NCT01588782|Abiraterone acetate|abiraterone acetate
362999|NCT01588782|JNJ-589485|jnj-589485
363000|NCT01588782|JNJ-212082|jnj-212082
363001|NCT01588782|Ketoconazole|ketoconazole
363002|NCT01588769|Glioblastoma Multiforme|glioblastoma multiforme
363003|NCT01588769|Brain cancer|brain cancer
363004|NCT01588769|Immunotherapy|immunotherapy
363005|NCT01588769|Cell based therapy|cell based therapy
363006|NCT01588769|Autologous cell based therapy|autologous cell based therapy
363007|NCT01588769|Adoptive immunotherapy|adoptive immunotherapy
363008|NCT01588769|Cytotoxic T cells|cytotoxic t cells
363009|NCT01588769|Natural Killer cells|natural killer cells
363010|NCT01588756|Chronic kidney disease|chronic kidney disease
363011|NCT01588756|GFR|gfr
363012|NCT01588756|Inulin|inulin
363013|NCT01588756|51Cr-EDTA|51cr-edta
363014|NCT01588756|ASDKP-NH2|asdkp-nh2
363015|NCT01588756|Healthy male 18-35 yrs old, non smokers, non allergic|healthy male 18-35 yrs old, non smokers, non allergic
363016|NCT01588756|Or Male/female 18-80 yrs old with chronic Kidney disease|or male/female 18-80 yrs old with chronic kidney disease
363017|NCT01588730|PF|pf
363018|NCT01588730|Dynasplint|dynasplint
363019|NCT01588730|ADFD|adfd
363020|NCT01588730|AFD|afd
363021|NCT01588730|Plantar Fasciitis|plantar fasciitis
363022|NCT01588730|plantar Fasciopathy|plantar fasciopathy
363023|NCT01588717|Hyperhydrosis|hyperhydrosis
363024|NCT01588717|Excessive Sweating|excessive sweating
363025|NCT01588717|Sweating|sweating
363026|NCT01588717|Depression|depression
363027|NCT01588717|Antidepressant|antidepressant
363028|NCT01588704|lung cancer|lung cancer
363029|NCT01588704|lung adenocarcinoma|lung adenocarcinoma
363030|NCT01588704|bevacizumab|bevacizumab
363031|NCT01588704|adjuvant chemotherapy|adjuvant chemotherapy
363032|NCT01588704|surgical resection rate|surgical resection rate
363033|NCT01588704|safety|safety
363034|NCT01588704|feasibility|feasibility
363035|NCT01588691|Traumatic Brain Injury|traumatic brain injury
363036|NCT01588678|endometrial|endometrial
363037|NCT01588678|prostate|prostate
363038|NCT01588678|breast|breast
363039|NCT01588678|gastric|gastric
363040|NCT01588678|cervical|cervical
363041|NCT01588678|ovarian|ovarian
363042|NCT01588678|neuroendocrine cancers|neuroendocrine cancers
363043|NCT01588678|soft-tissue sarcoma|soft-tissue sarcoma
363044|NCT01588678|squamous cell NSCLC|squamous cell nsclc
363045|NCT01588678|renal cell carcinoma|renal cell carcinoma
363046|NCT01588678|non-Hodgkin lymphoma|non-hodgkin lymphoma
363047|NCT01588665|pregnancy|pregnancy
363048|NCT01588665|stable isotopes|stable isotopes
363049|NCT01588665|red blood cell catabolism|red blood cell catabolism
363050|NCT01588639|Recombinant human insulin|recombinant human insulin
363051|NCT01588639|T2DM|t2dm
363052|NCT01588639|Safety|safety
363053|NCT01588639|Efficacy|efficacy
363054|NCT01588626|Healthy volunteer|healthy volunteer
363055|NCT01588626|Japanese males|japanese males
363056|NCT01588626|PK study|pk study
363057|NCT01588600|food intake, satiety, fiber|food intake, satiety, fiber
363058|NCT01588548|Advanced solid malignancies|advanced solid malignancies
363059|NCT01588548|Malignant lymphoma|malignant lymphoma
363060|NCT01588535|pain|pain
363061|NCT01588535|pain measurement|pain measurement
363062|NCT01588535|ear, middle|ear, middle
363063|NCT01588535|otitis media|otitis media
363064|NCT01588522|alopecia|alopecia
363065|NCT01588509|AMG 785, bone mineral density, alendronate|amg 785, bone mineral density, alendronate
363066|NCT01588496|hypercholesterolemia|hypercholesterolemia
363067|NCT01588496|familial hypercholesterolemia|familial hypercholesterolemia
363068|NCT01588496|homozygous familial hypercholesterolemia|homozygous familial hypercholesterolemia
363069|NCT01588470|diastolic function|diastolic function
363070|NCT01588470|mitochondria|mitochondria
363071|NCT01588470|pioglitazone|pioglitazone
363072|NCT01588470|pericardial fat|pericardial fat
363073|NCT01588444|tooth extraction|tooth extraction
363074|NCT01588444|bone grafting|bone grafting
363075|NCT01588431|Locally advanced head and neck cancer|locally advanced head and neck cancer
363076|NCT01588431|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
363077|NCT01588418|Impaired glucose tolerance (IGT)|impaired glucose tolerance (igt)
363078|NCT01588418|Diabetes|diabetes
363079|NCT01588405|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
363080|NCT01588405|UT-15C SR|ut-15c sr
363081|NCT01588405|PAH|pah
363082|NCT01588392|Physical activity|physical activity
363083|NCT01588392|preschoolers|preschoolers
363084|NCT01588353|AK160, collagenase clostridium histolyticum|ak160, collagenase clostridium histolyticum
363085|NCT01588314|Fabry disease|fabry disease
363086|NCT01588314|neuropathic pain|neuropathic pain
363087|NCT01588314|gabapentin|gabapentin
363088|NCT01588301|Cervical Cancer Screening|cervical cancer screening
363089|NCT01588301|Human Papillomavirus (HPV)|human papillomavirus (hpv)
363090|NCT01588301|Self-collected vaginal sample|self-collected vaginal sample
363091|NCT01588301|Cervical Smear|cervical smear
363092|NCT01588288|Diagnosis|diagnosis
363093|NCT01588288|Galectin 3|galectin 3
363094|NCT01588288|Puncture|puncture
363095|NCT01588288|Goiter, nodular|goiter, nodular
363096|NCT01588288|Surgery|surgery
363097|NCT01588275|cost-effectiveness|cost-effectiveness
363098|NCT01588275|effectiveness|effectiveness
363099|NCT01588275|treatment|treatment
363100|NCT01588275|CPAP|cpap
363101|NCT01588275|MRA|mra
363102|NCT01588275|compliance|compliance
363103|NCT01588210|caries|caries
363104|NCT01588210|sealant|sealant
363105|NCT01588210|fluoride|fluoride
363106|NCT01588210|prevention|prevention
363107|NCT01588210|community dentistry|community dentistry
363108|NCT01588197|Pain|pain
363109|NCT01588197|fMRI|fmri
363110|NCT01588197|real time|real time
363111|NCT01588171|Deep vein thrombosis|deep vein thrombosis
363112|NCT01588171|Pulmonary embolism|pulmonary embolism
363113|NCT01588171|Low molecular weight heparin|low molecular weight heparin
363114|NCT01588171|Enoxaparin|enoxaparin
363115|NCT01588171|Bemiparin|bemiparin
363116|NCT01588158|carpal tunnel syndrome|carpal tunnel syndrome
363117|NCT01588158|Tylenol|tylenol
363118|NCT01588158|Vicodin|vicodin
363119|NCT01588158|pain|pain
363120|NCT01588145|NSCLC|nsclc
363121|NCT01588145|HM61713|hm61713
363122|NCT01588145|EGFR-TKI|egfr-tki
363123|NCT01588145|Phase II|phase ii
363124|NCT01588145|olmutinib|olmutinib
363125|NCT01588041|Microscope mounted SDOCT|microscope mounted sdoct
363126|NCT01587976|Health related quality of life|health related quality of life
363127|NCT01587976|Colorectal liver metastasis|colorectal liver metastasis
363128|NCT01587976|surveillance|surveillance
363129|NCT01587963|hypovolemic or septic|hypovolemic or septic
363130|NCT01587950|dentinal sensitivity|dentinal sensitivity
363131|NCT01587950|potassium nitrate|potassium nitrate
363132|NCT01587950|dental pain|dental pain
363133|NCT01587937|Antibiotic stewardship.|antibiotic stewardship.
363134|NCT01587937|Clostridium difficile infection.|clostridium difficile infection.
363135|NCT01587937|Antibiotic resistance.|antibiotic resistance.
363136|NCT01587924|Renal Impairment|renal impairment
363137|NCT01587924|Anemia|anemia
363138|NCT01587924|pharmacokinetics|pharmacokinetics
363139|NCT01587924|hemodialysis|hemodialysis
363140|NCT01587924|Chronic kidney disease|chronic kidney disease
363141|NCT01587924|GSK1278863|gsk1278863
363142|NCT01587924|hemoglobin|hemoglobin
363143|NCT01587924|Prolyl hydroxylase inhibitor|prolyl hydroxylase inhibitor
363144|NCT01587924|recombinant human erythropoietin|recombinant human erythropoietin
363145|NCT01587924|erythropoiesis stimulating agents|erythropoiesis stimulating agents
363146|NCT01587924|Dialysis, Renal|dialysis, renal
363147|NCT01587911|Satiety|satiety
363148|NCT01587911|Food intake regulation|food intake regulation
363149|NCT01587911|Appetite regulation|appetite regulation
363150|NCT01587911|Dairy Protein|dairy protein
363151|NCT01587898|Anemia|anemia
363152|NCT01587898|Prolyl hydroxylase inhibitor|prolyl hydroxylase inhibitor
363153|NCT01587898|Hemoglobin|hemoglobin
363154|NCT01587898|Chronic kidney disease|chronic kidney disease
363155|NCT01587898|pharmacokinetics|pharmacokinetics
363156|NCT01587898|recombinant human erythropoietin|recombinant human erythropoietin
363157|NCT01587898|GSK1278863|gsk1278863
363158|NCT01587885|Frequent Heartburn|frequent heartburn
363159|NCT01587885|Omeprazole|omeprazole
363160|NCT01587885|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination
363161|NCT01587885|Gastrointestinal Agents|gastrointestinal agents
363162|NCT01587885|Therapeutic Uses|therapeutic uses
363163|NCT01587885|Pharmacologic Actions|pharmacologic actions
363164|NCT01587885|Enzyme Inhibitors|enzyme inhibitors
363165|NCT01587885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
363166|NCT01587885|Proton Pump Inhibitors|proton pump inhibitors
363167|NCT01587872|Colonoscopy|colonoscopy
363168|NCT01587872|Colorectal cancer|colorectal cancer
363169|NCT01587872|Screening colonoscopy|screening colonoscopy
363170|NCT01587859|esophagus|esophagus
363171|NCT01587859|gastro-esophageal reflux disease|gastro-esophageal reflux disease
363172|NCT01587859|type II-IV hiatal hernia|type ii-iv hiatal hernia
363173|NCT01587859|esophageal surgery|esophageal surgery
363174|NCT01587859|minimally invasive surgery|minimally invasive surgery
363175|NCT01587846|abdominal pain, constipation, Lactobacillus reuteri|abdominal pain, constipation, lactobacillus reuteri
363176|NCT01587833|Benzodiazepines|benzodiazepines
363177|NCT01587833|hip/femur fracture|hip/femur fracture
363178|NCT01587820|cisplatin|cisplatin
363179|NCT01587820|RADPLAT|radplat
363180|NCT01587820|intra-arterial chemotherapy|intra-arterial chemotherapy
363181|NCT01587820|head and neck cancer|head and neck cancer
363182|NCT01587807|Infection, Quality of Life, lung injury|infection, quality of life, lung injury
363183|NCT01587794|Rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
363184|NCT01587794|thickness of retinal layer|thickness of retinal layer
363185|NCT01587794|outer nuclear layer|outer nuclear layer
363186|NCT01587794|photoreceptor layer|photoreceptor layer
363187|NCT01587781|Pharmacokinetics of enoxaparin|pharmacokinetics of enoxaparin
363188|NCT01587768|Acute liver injury|acute liver injury
363189|NCT01587768|antibiotics|antibiotics
363190|NCT01587742|Calcium channel blockers|calcium channel blockers
363191|NCT01587742|cancer|cancer
363192|NCT01587729|Hip/femur fracture|hip/femur fracture
363193|NCT01587729|antidepressants|antidepressants
363194|NCT01587716|Safety and tolerability, pharmacokinetics, cough, voltage gated sodium channels (VGSC), anaesthesia|safety and tolerability, pharmacokinetics, cough, voltage gated sodium channels (vgsc), anaesthesia
363195|NCT01587703|BRD3|brd3
363196|NCT01587703|GSK525762|gsk525762
363197|NCT01587703|NUT Midline Carcinoma|nut midline carcinoma
363198|NCT01587703|MYCN-amplified Solid Tumor|mycn-amplified solid tumor
363199|NCT01587703|BRD4|brd4
363200|NCT01587703|BET inhibitor|bet inhibitor
363201|NCT01587703|bromodomains|bromodomains
363202|NCT01587703|NMC|nmc
363203|NCT01587703|Colorectal C ancer|colorectal c ancer
363204|NCT01587703|Small Cell Lung Cancer|small cell lung cancer
363205|NCT01587703|Multiple Myeloma|multiple myeloma
363206|NCT01587703|Neuroblastoma|neuroblastoma
363207|NCT01587703|Oncology|oncology
363208|NCT01587677|Tuberculosis|tuberculosis
363209|NCT01587664|Swallowing disorders|swallowing disorders
363210|NCT01587664|Aspiration|aspiration
363211|NCT01587651|CAD|cad
363212|NCT01587651|prasugrel|prasugrel
363213|NCT01587651|ticagrelor|ticagrelor
363214|NCT01587651|antiplatelet|antiplatelet
363215|NCT01587651|thienopyridine|thienopyridine
363216|NCT01587651|P2Y12 Inhibitors|p2y12 inhibitors
363217|NCT01587638|new-onset diabetes|new-onset diabetes
363218|NCT01587638|carvedilol|carvedilol
363219|NCT01587638|claims analysis|claims analysis
363220|NCT01587638|beta-blocker|beta-blocker
363221|NCT01587638|Diabetes Mellitus|diabetes mellitus
363222|NCT01587625|Delayed labour|delayed labour
363223|NCT01587625|dystocia|dystocia
363224|NCT01587625|oxytocin augmentation|oxytocin augmentation
363225|NCT01587625|primiparous women|primiparous women
363226|NCT01587625|childbirth|childbirth
363227|NCT01587625|childbirth experience|childbirth experience
363228|NCT01587625|progress|progress
363229|NCT01587612|Pain|pain
363230|NCT01587612|Foot|foot
363231|NCT01587599|pharmaceutical care|pharmaceutical care
363232|NCT01587599|drug-related problems|drug-related problems
363233|NCT01587599|elderly|elderly
363234|NCT01587599|Pharmaceutical care of elderly patients with diabetes|pharmaceutical care of elderly patients with diabetes
363235|NCT01587586|Hepatitis C, Chronic|hepatitis c, chronic
363236|NCT01587586|Interferon-alpha|interferon-alpha
363237|NCT01587586|Hepatitis C Virus|hepatitis c virus
363238|NCT01587573|salivary biomarkers|salivary biomarkers
363239|NCT01587560|Shoulder|shoulder
363240|NCT01587560|Arthroplasty|arthroplasty
363241|NCT01587560|Pyrocarbon|pyrocarbon
363242|NCT01587560|Randomized controlled trial|randomized controlled trial
363243|NCT01587560|Shoulder resurfacing|shoulder resurfacing
363244|NCT01587547|ART|art
363245|NCT01587547|IVF|ivf
363246|NCT01587547|ICSI|icsi
363247|NCT01587547|embryo selection|embryo selection
363248|NCT01587534|Unresectable Pancreatic cancer|unresectable pancreatic cancer
363249|NCT01587521|Metabolic syndrome|metabolic syndrome
363250|NCT01587521|Prevalence|prevalence
363251|NCT01587521|Quality of life|quality of life
363252|NCT01587521|Depression|depression
363253|NCT01587521|Antipsychotics|antipsychotics
363254|NCT01587482|Superficial femoral artery|superficial femoral artery
363255|NCT01587482|endovascular|endovascular
363256|NCT01587482|Drug eluting balloon|drug eluting balloon
363257|NCT01587482|Paclitaxel|paclitaxel
363258|NCT01587456|Osteoporosis|osteoporosis
363259|NCT01587430|acute myeloid leukemia|acute myeloid leukemia
363260|NCT01587430|anthracyclines|anthracyclines
363261|NCT01587430|high dose cytarabine|high dose cytarabine
363262|NCT01587430|maintenance|maintenance
363263|NCT01587404|Atrial Fibrillation|atrial fibrillation
363264|NCT01587404|Electrogram|electrogram
363265|NCT01587404|Ablation|ablation
363266|NCT01587404|Contact Force|contact force
363267|NCT01587378|miscarriage|miscarriage
363268|NCT01587378|preterm birth|preterm birth
363269|NCT01587378|prevention|prevention
363270|NCT01587326|cytokine, depression, escitalopram|cytokine, depression, escitalopram
363271|NCT01587313|hydralazine|hydralazine
363272|NCT01587313|isosorbide|isosorbide
363273|NCT01587313|bidil|bidil
363274|NCT01587313|volunteers|volunteers
363275|NCT01587313|pharmacokinetic profile|pharmacokinetic profile
363276|NCT01587287|Anterior corneal power|anterior corneal power
363277|NCT01587287|Placido topographer|placido topographer
363278|NCT01587287|Scheimpﬂug|scheimpﬂug
363279|NCT01587287|Precision|precision
363280|NCT01587287|Agreement|agreement
363281|NCT01587274|low back pain|low back pain
363282|NCT01587261|Burns|burns
363283|NCT01587261|Vitamin C|vitamin c
363284|NCT01587261|Thermal Injury|thermal injury
363285|NCT01587261|Fluid Resuscitation|fluid resuscitation
363286|NCT01587248|Breast cancer,|breast cancer,
363287|NCT01587248|Harmonic scalpel,|harmonic scalpel,
363288|NCT01587248|Electrocautery,|electrocautery,
363289|NCT01587248|Modified Radical Mastectomy,|modified radical mastectomy,
363290|NCT01587248|Randomized Controlled Trial|randomized controlled trial
363291|NCT01587209|decompression|decompression
363292|NCT01587209|intravascular bubbles|intravascular bubbles
363293|NCT01587209|neutrophil activation|neutrophil activation
363294|NCT01587196|prescription opiates/medications|prescription opiates/medications
363295|NCT01587196|vivitrol|vivitrol
363296|NCT01587196|brain imaging|brain imaging
363297|NCT01587183|Running|running
363298|NCT01587183|Blood pressure|blood pressure
363299|NCT01587170|spasticity|spasticity
363300|NCT01587170|spinal cord injury|spinal cord injury
363301|NCT01587170|zolmitriptan|zolmitriptan
363302|NCT01587144|GBM|gbm
363303|NCT01587131|Universal Influenza|universal influenza
363304|NCT01587131|Intradermal DNA-Based Vaccine|intradermal dna-based vaccine
363305|NCT01587131|Senior|senior
363306|NCT01587131|Electroporation|electroporation
363307|NCT01587131|H1|h1
363308|NCT01587131|Influenza|influenza
363309|NCT01587131|FVH1|fvh1
363310|NCT01587118|PTSD|ptsd
363311|NCT01587118|Posttraumatic Stress Disorder|posttraumatic stress disorder
363312|NCT01587118|Asenapine|asenapine
363313|NCT01587118|Adjunctive|adjunctive
363314|NCT01587118|antidepressant|antidepressant
363315|NCT01587118|neuroleptic|neuroleptic
363316|NCT01587092|walking|walking
363317|NCT01587092|physical activity|physical activity
363318|NCT01587092|sedentary behavior|sedentary behavior
363319|NCT01587092|workplace|workplace
363320|NCT01587079|COPD|copd
363321|NCT01587027|Altitude Sickness|altitude sickness
363322|NCT01587027|High Altitude Sickness|high altitude sickness
363323|NCT01587001|Sarcoidosis|sarcoidosis
363324|NCT01587001|oxidative stress|oxidative stress
363325|NCT01587001|anti-oxidant|anti-oxidant
363326|NCT01586988|HIV|hiv
363327|NCT01586988|Parenting|parenting
363328|NCT01586988|self-care|self-care
363329|NCT01586988|disclosure|disclosure
363330|NCT01586988|medication adherence|medication adherence
363331|NCT01586988|mother|mother
363332|NCT01586988|child|child
363333|NCT01586988|adolescent|adolescent
363334|NCT01586962|paracetamol|paracetamol
363335|NCT01586962|pseudoephedrine|pseudoephedrine
363336|NCT01586962|syrup|syrup
363337|NCT01586962|upper respiratory tract infection|upper respiratory tract infection
363338|NCT01586949|well-being|well-being
363339|NCT01586949|web-based intervention|web-based intervention
363340|NCT01586949|social networks|social networks
363341|NCT01586923|Anemia|anemia
363342|NCT01586923|Transfusion|transfusion
363343|NCT01586923|RBC storage age|rbc storage age
363344|NCT01586923|Tissue oxygenation|tissue oxygenation
363345|NCT01586923|Malaria|malaria
363346|NCT01586897|health information technology|health information technology
363347|NCT01586897|primary care|primary care
363348|NCT01586897|visit-independent|visit-independent
363349|NCT01586897|medication monitoring|medication monitoring
363350|NCT01586884|LV Pacing|lv pacing
363351|NCT01586884|LV Lead Placement|lv lead placement
363352|NCT01586884|LV Pacing Site|lv pacing site
363353|NCT01586884|CRT Device Placement|crt device placement
363354|NCT01586871|MPS I|mps i
363355|NCT01586871|MPS II|mps ii
363356|NCT01586871|MPS VI|mps vi
363357|NCT01586871|Mucopolysaccharidoses|mucopolysaccharidoses
363358|NCT01586858|Vasculitis|vasculitis
363359|NCT01586858|ANCA|anca
363360|NCT01586858|Rituximab|rituximab
363361|NCT01586858|Small vessel vasculitis|small vessel vasculitis
363362|NCT01586845|Randomized Controlled Trials|randomized controlled trials
363363|NCT01586845|Immunosuppression|immunosuppression
363364|NCT01586845|Adult|adult
363365|NCT01586845|Kidney Transplantation|kidney transplantation
363366|NCT01586845|Treatment Outcome|treatment outcome
363367|NCT01586832|Hospital Supplies|hospital supplies
363368|NCT01586832|Stocking of Supplies|stocking of supplies
363369|NCT01586806|Dexamethasone|dexamethasone
363370|NCT01586806|Glucocorticoids|glucocorticoids
363371|NCT01586806|Physiological Effects of Drugs|physiological effects of drugs
363372|NCT01586806|Therapeutic Uses|therapeutic uses
363373|NCT01586806|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
363374|NCT01586806|Regional Anesthesia, nerve block|regional anesthesia, nerve block
363375|NCT01586806|Ultrasonic Imaging|ultrasonic imaging
363376|NCT01586806|Post-Operative Complications: muscle weakness, pain, nausea and vomiting|post-operative complications: muscle weakness, pain, nausea and vomiting
363377|NCT01586806|Dexamethasone (as local anesthetic additive)|dexamethasone (as local anesthetic additive)
363378|NCT01586793|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
363379|NCT01586793|Bipolar depression|bipolar depression
363380|NCT01586793|Randomized trial|randomized trial
363381|NCT01586793|rTMS|rtms
363382|NCT01586793|Neuromodulation|neuromodulation
363383|NCT01586780|Whey protein|whey protein
363384|NCT01586780|Soy protein|soy protein
363385|NCT01586780|Insulinogenic amino acids|insulinogenic amino acids
363386|NCT01586780|Incretins|incretins
363387|NCT01586780|Glycaemia|glycaemia
363388|NCT01586780|Insulinaemia|insulinaemia
363389|NCT01586767|Nasal cavity|nasal cavity
363390|NCT01586767|Salivary gland tumors|salivary gland tumors
363391|NCT01586767|Hard palate|hard palate
363392|NCT01586767|Sinus|sinus
363393|NCT01586767|Soft Palate|soft palate
363394|NCT01586767|Lacrimal Apparatus|lacrimal apparatus
363395|NCT01586754|metabolic syndrome|metabolic syndrome
363397|NCT01586754|endothelial damage|endothelial damage
363398|NCT01586754|homocysteine|homocysteine
363399|NCT01586754|microalbumin|microalbumin
363400|NCT01586754|carotis intima-media thickness|carotis intima-media thickness
363401|NCT01586728|Cystic fibrosis|cystic fibrosis
363402|NCT01586728|oxygen therapy|oxygen therapy
363403|NCT01586728|sleep|sleep
363404|NCT01586715|Extremely complex perianal fistula|extremely complex perianal fistula
363405|NCT01586715|Adipose Derived Stem Cells|adipose derived stem cells
363406|NCT01586702|Stroke, TIA, secondary prevention, support program, multifactorial intervention|stroke, tia, secondary prevention, support program, multifactorial intervention
363407|NCT01586689|Oxford House|oxford house
363408|NCT01586689|recovery|recovery
363409|NCT01586689|substance abuse|substance abuse
363410|NCT01586689|alcohol abuse|alcohol abuse
363411|NCT01586689|addiction|addiction
363412|NCT01586676|supervision|supervision
363413|NCT01586676|motivational interviewing|motivational interviewing
363414|NCT01586676|substance abuse|substance abuse
363415|NCT01586676|dissemination|dissemination
363416|NCT01586663|Diffuse Systemic Sclerosis|diffuse systemic sclerosis
363417|NCT01586663|Hand|hand
363418|NCT01586663|Range of motion|range of motion
363419|NCT01586663|Splint|splint
363420|NCT01586650|ankylosing spondylitis|ankylosing spondylitis
363421|NCT01586650|aerobic exercise|aerobic exercise
363422|NCT01586637|Fibromyalgia|fibromyalgia
363423|NCT01586637|Art Therapy|art therapy
363424|NCT01586637|Pain|pain
363425|NCT01586637|Quality of life|quality of life
363426|NCT01586637|Body Image|body image
363427|NCT01586624|Phase I|phase i
363428|NCT01586624|Drug evaluation|drug evaluation
363429|NCT01586624|Oncology|oncology
363430|NCT01586624|Vandetanib|vandetanib
363431|NCT01586624|Selumetinib|selumetinib
363432|NCT01586624|Dose escalation|dose escalation
363433|NCT01586624|Clinical trial|clinical trial
363434|NCT01586624|Vascular Endothelial Growth Factor(VEGFR) inhibitor|vascular endothelial growth factor(vegfr) inhibitor
363435|NCT01586624|Epidermal Growth Factor Receptor(EGFR)inhibitor|epidermal growth factor receptor(egfr)inhibitor
363436|NCT01586624|Mitogen Activated Kinase (MEK) inhibitor|mitogen activated kinase (mek) inhibitor
363437|NCT01586624|Non small cell lung cancer|non small cell lung cancer
363438|NCT01586598|Mandibular Nerve|mandibular nerve
363439|NCT01586598|Orthognathic Surgery|orthognathic surgery
363440|NCT01586598|Sagittal Split Osteotomy|sagittal split osteotomy
363441|NCT01586598|Sensory Retraining|sensory retraining
363442|NCT01586572|Polio virus type 1,2,3|polio virus type 1,2,3
363443|NCT01586572|Poliovaccine-Oral|poliovaccine-oral
363444|NCT01586572|Poliovaccine|poliovaccine
363445|NCT01586572|Trivalent Oral Polio vaccine|trivalent oral polio vaccine
363446|NCT01586572|Monovalent oral polio vaccine|monovalent oral polio vaccine
363447|NCT01586572|Bivalent Oral polio vaccine|bivalent oral polio vaccine
363448|NCT01586546|Mind-body|mind-body
363449|NCT01586546|Psychosocial|psychosocial
363450|NCT01586546|Meditation|meditation
363451|NCT01586546|Breathing Exercises|breathing exercises
363452|NCT01586546|Guided Imagery|guided imagery
363453|NCT01586546|Visualization|visualization
363454|NCT01586533|ulcerative colitis|ulcerative colitis
363455|NCT01586533|UC|uc
363456|NCT01586533|left-sided ulcerative colitis|left-sided ulcerative colitis
363457|NCT01586533|distal ulcerative colitis|distal ulcerative colitis
363458|NCT01586533|Zoenasa|zoenasa
363459|NCT01586533|mesalamine|mesalamine
363461|NCT01586533|5-ASA|5-asa
363462|NCT01586533|5-aminosalicylic acid|5-aminosalicylic acid
363463|NCT01586533|N-acetylcysteine|n-acetylcysteine
363464|NCT01586533|acetylcysteine|acetylcysteine
363465|NCT01586533|NAC|nac
363466|NCT01586533|enema|enema
363467|NCT01586533|rectal gel|rectal gel
363468|NCT01586520|thyroid cancer, papillary, follicular, proteomics, genetic markers|thyroid cancer, papillary, follicular, proteomics, genetic markers
363469|NCT01586507|Pain|pain
363470|NCT01586507|ULTRAM ER|ultram er
363471|NCT01586507|Tramadol hydrochloride|tramadol hydrochloride
363472|NCT01586507|Adolescents|adolescents
363473|NCT01586494|Pain|pain
363474|NCT01586494|ULTRAM ER|ultram er
363475|NCT01586494|Tramadol hydrochloride|tramadol hydrochloride
363476|NCT01586494|Children|children
363477|NCT01586481|Diabetic foot ulcer|diabetic foot ulcer
363478|NCT01586481|Off loading|off loading
363479|NCT01586481|Compliance|compliance
363480|NCT01586481|Healing duration|healing duration
363481|NCT01586481|Amputation rate|amputation rate
363482|NCT01586455|umbilical cord blood|umbilical cord blood
363483|NCT01586455|stem cell transplantation|stem cell transplantation
363484|NCT01586455|placental stem cell|placental stem cell
363485|NCT01586455|inborn errors of metabolism|inborn errors of metabolism
363486|NCT01586455|marrow failure|marrow failure
363487|NCT01586455|Severe Combined Immunodeficiency Disease|severe combined immunodeficiency disease
363488|NCT01586455|AML|aml
363489|NCT01586455|ALL|all
363490|NCT01586455|MDS|mds
363491|NCT01586429|comparing the analgesic efficacy of ultrasound-guided nerve block catheter compared with epidural analgesia|comparing the analgesic efficacy of ultrasound-guided nerve block catheter compared with epidural analgesia
363492|NCT01586416|Colonic neoplasms|colonic neoplasms
363493|NCT01586416|Older adults|older adults
363494|NCT01586416|Psychosocial Intervention|psychosocial intervention
363495|NCT01586416|Chemotherapy adherence|chemotherapy adherence
363496|NCT01586403|Melanoma|melanoma
363497|NCT01586403|Gene Therapy|gene therapy
363498|NCT01586403|Adoptive T-Cell Transfer|adoptive t-cell transfer
363499|NCT01586403|IL-2|il-2
363500|NCT01586390|Ankle Sprain|ankle sprain
363501|NCT01586390|Ankle Distortion|ankle distortion
363502|NCT01586390|Functional treatment|functional treatment
363503|NCT01586390|Brace treatment|brace treatment
363504|NCT01586377|Complex regional pain syndrome|complex regional pain syndrome
363505|NCT01586377|Near Infrared Spectroscopy|near infrared spectroscopy
363506|NCT01586377|Vascular Occlusion Test|vascular occlusion test
363507|NCT01586364|Menopausal symptoms|menopausal symptoms
363508|NCT01586364|Vulvar and vaginal atrophy in menopausal women|vulvar and vaginal atrophy in menopausal women
363509|NCT01586364|Vaginal atrophy|vaginal atrophy
363510|NCT01586364|Urogenital atrophy|urogenital atrophy
363511|NCT01586351|Rotator cuff tears|rotator cuff tears
363512|NCT01586351|ACP|acp
363513|NCT01586351|DX Reinforcement Matrix|dx reinforcement matrix
363514|NCT01586325|Chronic hepatitis C infection|chronic hepatitis c infection
363515|NCT01586325|Asian genotype 1 chronic hepatitis C infection|asian genotype 1 chronic hepatitis c infection
363516|NCT01586325|JNJ-47910382|jnj-47910382
363517|NCT01586325|Non-structural protein 5A (NS5A) inhibitor|non-structural protein 5a (ns5a) inhibitor
363518|NCT01586312|Knee degenerative disease|knee degenerative disease
363519|NCT01586312|osteoarthritis|osteoarthritis
363520|NCT01586312|gonarthrosis|gonarthrosis
363521|NCT01586312|stem cell|stem cell
363522|NCT01586312|cellular therapy|cellular therapy
363523|NCT01586312|regenerative therapy|regenerative therapy
363524|NCT01586312|Mesenchymal stem cells|mesenchymal stem cells
363525|NCT01586312|Bone marrow|bone marrow
363526|NCT01586312|musculoskeletal Diseases|musculoskeletal diseases
363527|NCT01586312|Mesenchymal Stromal Cells (allogenic)|mesenchymal stromal cells (allogenic)
363528|NCT01586299|pleuropneumonia children|pleuropneumonia children
363529|NCT01586299|non steroidal anti inflammatory drugs|non steroidal anti inflammatory drugs
363530|NCT01586299|pleural effusion|pleural effusion
363531|NCT01586299|severe pneumonia|severe pneumonia
363532|NCT01586286|Levator Myalgia|levator myalgia
363533|NCT01586286|Pelvic Pain|pelvic pain
363534|NCT01586286|Vaginismus|vaginismus
363535|NCT01586286|Myofascial pain syndromes|myofascial pain syndromes
363536|NCT01586260|Neuroblastoma in remission|neuroblastoma in remission
363537|NCT01586260|Relapsed Neuroblastoma|relapsed neuroblastoma
363538|NCT01586260|Refractory Neuroblastoma|refractory neuroblastoma
363539|NCT01586234|Fuchs' endothelial dystrophy|fuchs' endothelial dystrophy
363540|NCT01586234|DSAEK|dsaek
363541|NCT01586234|Descemet's stripping automated endothelial keratoplasty|descemet's stripping automated endothelial keratoplasty
363542|NCT01586221|Rehabilitation|rehabilitation
363543|NCT01586221|Fingers|fingers
363544|NCT01586221|Grasp|grasp
363545|NCT01586221|Strength|strength
363546|NCT01586221|Brain Function|brain function
363547|NCT01586221|Physiopathology|physiopathology
363548|NCT01586221|Functional Laterality|functional laterality
363549|NCT01586221|Psychomotor Performance|psychomotor performance
363550|NCT01586221|Biomechanis|biomechanis
363551|NCT01586221|Touch|touch
363552|NCT01586221|Music Therapy|music therapy
363553|NCT01586221|Weight-Bearing|weight-bearing
363554|NCT01586208|refractory status epilepticus|refractory status epilepticus
363555|NCT01586208|valproic acid|valproic acid
363556|NCT01586208|phenytoin|phenytoin
363557|NCT01586208|benzodiazepines|benzodiazepines
363558|NCT01586208|Valproic acid initial dosage in status treatment|valproic acid initial dosage in status treatment
363559|NCT01586182|poor prognosis|poor prognosis
363560|NCT01586169|Albendazole|albendazole
363561|NCT01586169|Ivermectin|ivermectin
363562|NCT01586169|Azithromycin|azithromycin
363563|NCT01586169|Lymphatic filariasis|lymphatic filariasis
363564|NCT01586169|Trachoma|trachoma
363565|NCT01586169|Safety|safety
363566|NCT01586143|Paracetamol by permucosal route,|paracetamol by permucosal route,
363567|NCT01586143|Paracetamol by intraveinous route,|paracetamol by intraveinous route,
363568|NCT01586143|Pain.|pain.
363569|NCT01586143|Patient with minor trauma of lower limb and/or superior limb (sprains, muscle contusions, …).|patient with minor trauma of lower limb and/or superior limb (sprains, muscle contusions, …).
363570|NCT01586130|Knee Osteoarthritis|knee osteoarthritis
363571|NCT01586130|Exercise|exercise
363572|NCT01586130|Isokinetic|isokinetic
363573|NCT01586130|Muscle strength|muscle strength
363574|NCT01586130|Rehabilitation|rehabilitation
363575|NCT01586117|rectal cancer|rectal cancer
363576|NCT01586117|amifostine|amifostine
363577|NCT01586117|pre-operative chemo-radiation|pre-operative chemo-radiation
363578|NCT01586065|type 1 diabetes|type 1 diabetes
363579|NCT01586065|adolescents|adolescents
363580|NCT01586065|poor control|poor control
363581|NCT01586065|CGM|cgm
363582|NCT01586052|Cerebral Palsy|cerebral palsy
363583|NCT01586052|Erythropoietin|erythropoietin
363584|NCT01586052|Rehabilitation|rehabilitation
363585|NCT01586039|Melatonin|melatonin
363586|NCT01586039|Sleep|sleep
363587|NCT01586039|Light|light
363588|NCT01586039|Alertness|alertness
363589|NCT01586039|Circadian Rhythms|circadian rhythms
363590|NCT01586026|Ports|ports
363591|NCT01586026|Catheters|catheters
363592|NCT01586026|Distal Valved Catheters|distal valved catheters
363593|NCT01586026|Maintenance Flush|maintenance flush
363594|NCT01586026|subjects|subjects
363595|NCT01586026|routine maintenance flushes|routine maintenance flushes
363596|NCT01586013|propofol|propofol
363597|NCT01586013|pharmacodynamic|pharmacodynamic
363598|NCT01586013|age|age
363599|NCT01586013|ke0|ke0
363600|NCT01586000|vaginal ring|vaginal ring
363601|NCT01585974|Renal Cell Carcinoma|renal cell carcinoma
363602|NCT01585974|TKI|tki
363603|NCT01585974|Turkey|turkey
363604|NCT01585974|Observational|observational
363605|NCT01585961|Symptomatic paroxysmal|symptomatic paroxysmal
363606|NCT01585961|Atrial fibrillation|atrial fibrillation
363607|NCT01585961|Observational|observational
363608|NCT01585961|Acute procedural outcomes|acute procedural outcomes
363609|NCT01585961|Ablation|ablation
363610|NCT01585961|Drug refractory|drug refractory
363611|NCT01585961|Arrhythmia Recurrent|arrhythmia recurrent
363612|NCT01585961|Symptomatic|symptomatic
363613|NCT01585935|Infant, Extremely Low Birth Weight|infant, extremely low birth weight
363614|NCT01585935|Parenteral Nutrition|parenteral nutrition
363615|NCT01585935|Fish Oils|fish oils
363616|NCT01585935|Cholestasis|cholestasis
363617|NCT01585935|Psychomotor Disorders, Developmental|psychomotor disorders, developmental
363618|NCT01585922|noninvasive positive pressure ventilation|noninvasive positive pressure ventilation
363619|NCT01585896|Hoarding|hoarding
363620|NCT01585896|Compulsive Hoarding|compulsive hoarding
363621|NCT01585896|Self-Help|self-help
363622|NCT01585883|Lung cancer|lung cancer
363623|NCT01585883|Breathlessness|breathlessness
363624|NCT01585883|Self-management|self-management
363625|NCT01585870|Safety|safety
363626|NCT01585870|Tolerability|tolerability
363627|NCT01585870|Pharmacokinetics|pharmacokinetics
363628|NCT01585870|Clinical benefit|clinical benefit
363629|NCT01585870|Sorafenib|sorafenib
363630|NCT01585870|Eribulin|eribulin
363631|NCT01585870|advanced metastatic solid tumors|advanced metastatic solid tumors
363632|NCT01585844|sleep apnea|sleep apnea
363633|NCT01585844|pregnancy|pregnancy
363634|NCT01585844|obesity|obesity
363635|NCT01585831|Klinefelter syndrome|klinefelter syndrome
363636|NCT01585831|XXY syndrome|xxy syndrome
363637|NCT01585831|Sex Chromosome Abnormality|sex chromosome abnormality
363638|NCT01585831|Testosterone replacement therapy|testosterone replacement therapy
363639|NCT01585818|Glycemic Index|glycemic index
363640|NCT01585818|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
363641|NCT01585818|Diet|diet
363642|NCT01585818|Glucose Variability|glucose variability
363643|NCT01585818|Metabolic Response|metabolic response
363644|NCT01585818|Glucose Response|glucose response
363645|NCT01585766|MAb, B cell, depletion, RMS|mab, b cell, depletion, rms
363646|NCT01585753|cardiovascular function|cardiovascular function
363647|NCT01585753|maraviroc|maraviroc
363648|NCT01585740|Hyperchloraemic metabolic acidosis|hyperchloraemic metabolic acidosis
363649|NCT01585740|Neonatal acidosis|neonatal acidosis
363650|NCT01585740|Neonatal hyperchloraemia|neonatal hyperchloraemia
363651|NCT01585740|Base excess|base excess
363652|NCT01585740|Metabolic acidosis|metabolic acidosis
363653|NCT01585740|Caesarean section|caesarean section
363654|NCT01585740|Normal saline|normal saline
363655|NCT01585740|Ringer's Lactate|ringer's lactate
363656|NCT01585740|Postoperative morbidity|postoperative morbidity
363657|NCT01585727|Rectal cancer|rectal cancer
363658|NCT01585727|total mesorectal excision|total mesorectal excision
363659|NCT01585727|pelvic autonomic nerve preservation|pelvic autonomic nerve preservation
363660|NCT01585727|neurostimulation|neurostimulation
363661|NCT01585727|urogenital function|urogenital function
363662|NCT01585727|quality of life|quality of life
363663|NCT01585701|Phase I|phase i
363664|NCT01585701|Oncology|oncology
363665|NCT01585701|AGC Kinase inhibitor|agc kinase inhibitor
363666|NCT01585701|Protein Kinase inhibitor|protein kinase inhibitor
363667|NCT01585701|Clinical Trial|clinical trial
363668|NCT01585701|Multiple protein kinases|multiple protein kinases
363669|NCT01585688|NHL|nhl
363670|NCT01585688|CLL|cll
363671|NCT01585675|Lung Cancer|lung cancer
363672|NCT01585662|EUS|eus
363673|NCT01585662|pancreatic pseudocyst|pancreatic pseudocyst
363674|NCT01585662|drainage|drainage
363675|NCT01585636|SQ109|sq109
363676|NCT01585636|Tuberculosis|tuberculosis
363677|NCT01585610|smoking|smoking
363678|NCT01585610|smoking cessation|smoking cessation
363679|NCT01585610|disabled persons|disabled persons
363680|NCT01585610|behavioral research|behavioral research
363681|NCT01585597|Ischemic Stoke|ischemic stoke
363682|NCT01585597|Endovascular Reperfusion|endovascular reperfusion
363683|NCT01585597|Reperfusion Injury|reperfusion injury
363684|NCT01585597|Mild hypothermia|mild hypothermia
363685|NCT01585584|Boceprevir|boceprevir
363686|NCT01585584|Hepatitis C Genotype 3|hepatitis c genotype 3
363687|NCT01585571|Balance|balance
363688|NCT01585571|Posture|posture
363689|NCT01585571|Virtual Environment|virtual environment
363690|NCT01585571|Cerebral Palsy|cerebral palsy
363691|NCT01585571|Adults|adults
363692|NCT01585558|Menopausal symptoms|menopausal symptoms
363693|NCT01585558|Urogenital atrophy|urogenital atrophy
363694|NCT01585558|Vulvar and vaginal atrophy in menopausal women|vulvar and vaginal atrophy in menopausal women
363695|NCT01585558|Vaginal atrophy|vaginal atrophy
363696|NCT01585545|CT|ct
363697|NCT01585545|PET CT|pet ct
363698|NCT01585545|MRI|mri
363699|NCT01585545|cancer genomics|cancer genomics
363700|NCT01585545|Radiomics|radiomics
363701|NCT01585545|Radiogenomics|radiogenomics
363702|NCT01585532|Tuberculosis|tuberculosis
363703|NCT01585532|Urine|urine
363704|NCT01585532|Nucleic acid|nucleic acid
363705|NCT01585532|Alere|alere
363706|NCT01585532|Borstel|borstel
363707|NCT01585519|High Epicatechin Apples|high epicatechin apples
363708|NCT01585519|Low Epicatechin Apples|low epicatechin apples
363709|NCT01585519|Apple Extract|apple extract
363710|NCT01585519|Apple Granules|apple granules
363711|NCT01585519|Blood Pressure|blood pressure
363712|NCT01585519|Cholesterol|cholesterol
363713|NCT01585493|Lifestyle|lifestyle
363714|NCT01585493|Smoking|smoking
363715|NCT01585493|Dietary|dietary
363716|NCT01585493|Exercise|exercise
363717|NCT01585480|Obesity|obesity
363718|NCT01585480|Weight Gain Prevention|weight gain prevention
363719|NCT01585480|Workplace|workplace
363720|NCT01585480|Intervention|intervention
363721|NCT01585480|Diet|diet
363722|NCT01585480|Exercise|exercise
363723|NCT01585467|Anterior Shoulder Dislocation|anterior shoulder dislocation
363724|NCT01585467|Shoulder Dislocation|shoulder dislocation
363725|NCT01585467|Shoulder Pain|shoulder pain
363726|NCT01585467|Shoulder Deformity|shoulder deformity
363727|NCT01585454|Pregnancy|pregnancy
363728|NCT01585454|Diabetes Mellitus|diabetes mellitus
363729|NCT01585454|Weight Gain|weight gain
363730|NCT01585454|Diabetes|diabetes
363731|NCT01585441|Finasteride|finasteride
363732|NCT01585441|Central Serous Chorioretinopathy|central serous chorioretinopathy
363733|NCT01585428|Immunotherapy|immunotherapy
363734|NCT01585428|HPV-Associated Cancers|hpv-associated cancers
363735|NCT01585428|Cervical Cancer|cervical cancer
363736|NCT01585428|Oropharyngeal Cancer|oropharyngeal cancer
363737|NCT01585428|HPV Infection|hpv infection
363738|NCT01585415|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
363739|NCT01585415|Immunotherapy|immunotherapy
363740|NCT01585415|Adoptive Cell Therapy|adoptive cell therapy
363741|NCT01585415|B Raf Inhibitor|b raf inhibitor
363742|NCT01585402|NT5E|nt5e
363743|NCT01585402|Biphosphonates|biphosphonates
363744|NCT01585402|Vascular Calcifications|vascular calcifications
363745|NCT01585402|Joint Capsule Calcifications|joint capsule calcifications
363746|NCT01585402|Inherited Disease|inherited disease
363747|NCT01585389|adult brain tumor|adult brain tumor
363748|NCT01585389|childhood brain tumor|childhood brain tumor
363749|NCT01585376|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
363750|NCT01585376|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
363751|NCT01585350|melanoma|melanoma
363752|NCT01585350|peptide vaccine|peptide vaccine
363753|NCT01585350|polyICLC|polyiclc
363754|NCT01585350|lipopolysaccharide (LPS)|lipopolysaccharide (lps)
363755|NCT01585350|immunotherapy|immunotherapy
363756|NCT01585311|Subarachnoid Hemorrhage (SAH)|subarachnoid hemorrhage (sah)
363757|NCT01585311|tachycardia|tachycardia
363758|NCT01585311|Outcome|outcome
363759|NCT01585298|Multiple Sclerosis|multiple sclerosis
363760|NCT01585298|MS|ms
363761|NCT01585298|Fingolimod|fingolimod
363762|NCT01585298|Gilenya|gilenya
363763|NCT01585298|ECG|ecg
363764|NCT01585298|Bradyarrythmia|bradyarrythmia
363765|NCT01585298|conduction abnormalities|conduction abnormalities
363766|NCT01585298|first dose observation|first dose observation
363767|NCT01585285|Coronary artery bypass grafting|coronary artery bypass grafting
363768|NCT01585285|Left internal mammary artery|left internal mammary artery
363769|NCT01585285|Composite grafting|composite grafting
363770|NCT01585285|Multislice Spiral Computed Tomography Scanner|multislice spiral computed tomography scanner
363771|NCT01585285|Graft patency assessment|graft patency assessment
363772|NCT01585272|Alzheimer's dementia, AD|alzheimer's dementia, ad
363773|NCT01585259|anti-platelet;|anti-platelet;
363774|NCT01585259|safety;|safety;
363775|NCT01585259|efficacy|efficacy
363776|NCT01585246|Prostate Cancer|prostate cancer
363777|NCT01585246|Radiation Therapy|radiation therapy
363778|NCT01585246|Quality of Life|quality of life
363779|NCT01585246|Symptom Management|symptom management
363780|NCT01585233|Moderate Psoriasis|moderate psoriasis
363781|NCT01585233|Severe Psoriasis|severe psoriasis
363782|NCT01585233|Skin disease|skin disease
363783|NCT01585233|ASKP1240|askp1240
363784|NCT01585233|CD40 antigen|cd40 antigen
363785|NCT01585233|Anti-CD40 monoclonal antibody|anti-cd40 monoclonal antibody
363786|NCT01585220|WSRS|wsrs
363787|NCT01585220|GAIS|gais
363788|NCT01585220|HA filler|ha filler
363789|NCT01585220|filler|filler
363790|NCT01585207|Tourette's Disorder|tourette's disorder
363791|NCT01585207|vigabatrin|vigabatrin
363792|NCT01585194|Melanoma|melanoma
363793|NCT01585194|History of Uveal Melanoma|history of uveal melanoma
363794|NCT01585194|Metastatic|metastatic
363795|NCT01585194|Ipilimumab|ipilimumab
363796|NCT01585194|Yervoy|yervoy
363797|NCT01585194|BMS-734016|bms-734016
363798|NCT01585194|MDX010|mdx010
363799|NCT01585194|Nivolumab|nivolumab
363800|NCT01585194|BMS-936558|bms-936558
363801|NCT01585194|Opdivo|opdivo
363802|NCT01585181|Vaccine, Bacterial disease condition, Cholera|vaccine, bacterial disease condition, cholera
363803|NCT01585168|Reward Circuitry|reward circuitry
363804|NCT01585168|Impulsivity|impulsivity
363805|NCT01585168|Family History of Alcoholism|family history of alcoholism
363806|NCT01585168|NMDA/DA Interactions|nmda/da interactions
363807|NCT01585155|Infliximab|infliximab
363808|NCT01585155|REMICADE|remicade
363809|NCT01585155|TA-650|ta-650
363810|NCT01585090|Ankle positions|ankle positions
363811|NCT01585090|pelvic floor muscles strength|pelvic floor muscles strength
363812|NCT01585090|relaxation of pelvic floor muscles syndrome|relaxation of pelvic floor muscles syndrome
363813|NCT01585090|doing strengthening exercises of pelvic floor muscles|doing strengthening exercises of pelvic floor muscles
363814|NCT01585077|Plasmodium vivax|plasmodium vivax
363815|NCT01585077|Malaria|malaria
363816|NCT01585077|Challenge|challenge
363817|NCT01585077|Anopheles albimanus|anopheles albimanus
363818|NCT01585064|Rheumatoid Arthritis (RA)|rheumatoid arthritis (ra)
363819|NCT01585064|Anti-TNF therapy|anti-tnf therapy
363820|NCT01585064|Adalimumab|adalimumab
363821|NCT01585064|Disease activity|disease activity
363822|NCT01585064|Treating to target|treating to target
363823|NCT01585051|vitamin D|vitamin d
363824|NCT01585051|blood pressure|blood pressure
363825|NCT01585051|typ 2 diabetes mellitus|typ 2 diabetes mellitus
363826|NCT01585051|blood glucose|blood glucose
363827|NCT01585051|HbA1c|hba1c
363828|NCT01585038|endothelium|endothelium
363829|NCT01585038|inflammation|inflammation
363830|NCT01585038|oxidative stress|oxidative stress
363831|NCT01585038|HIV-1|hiv-1
363832|NCT01585025|Primary bile acid malabsorption|primary bile acid malabsorption
363833|NCT01585025|Secondary bile acid malabsorption|secondary bile acid malabsorption
363834|NCT01585025|Chronic diarrhoea|chronic diarrhoea
363835|NCT01585025|Obeticholic acid|obeticholic acid
363836|NCT01585025|SeHCAT|sehcat
363837|NCT01585025|FXR|fxr
363838|NCT01585025|FGF19|fgf19
363839|NCT01585012|Cervical cap insemination|cervical cap insemination
363840|NCT01585012|Collection condom|collection condom
363841|NCT01585012|Instructions for Use|instructions for use
363842|NCT01585012|Safety during intercourse|safety during intercourse
363843|NCT01585012|Acceptability of the cervical cap with condom sheath|acceptability of the cervical cap with condom sheath
363844|NCT01585012|slip|slip
363845|NCT01585012|break|break
363846|NCT01585012|ease of conversion|ease of conversion
363847|NCT01585012|adequate sample collection|adequate sample collection
363848|NCT01584947|Oral pain|oral pain
363849|NCT01584947|Local anesthetic|local anesthetic
363850|NCT01584947|Bupivacaine hydrochloride|bupivacaine hydrochloride
363851|NCT01584934|fatigue|fatigue
363852|NCT01584934|sleep quality|sleep quality
363853|NCT01584934|Chronic, disabling, unexplained fatigue with at least 4 minor criteria for CFS, according to the 1994 Fukuda case definition|chronic, disabling, unexplained fatigue with at least 4 minor criteria for cfs, according to the 1994 fukuda case definition
363854|NCT01584921|Erythropoietin|erythropoietin
364052|NCT01584141|Lymphoma|lymphoma
363855|NCT01584921|Glomerular filtration rate|glomerular filtration rate
363856|NCT01584921|Tubular reabsorption|tubular reabsorption
363857|NCT01584921|Renal function|renal function
363858|NCT01584921|Renal perfusion|renal perfusion
363859|NCT01584908|kidney transplant recipients|kidney transplant recipients
363860|NCT01584882|Clinical decision support (CDS)|clinical decision support (cds)
363861|NCT01584882|Tobacco|tobacco
363862|NCT01584882|Behavioral|behavioral
363863|NCT01584882|Dental hygienist|dental hygienist
363864|NCT01584882|Dentist|dentist
363865|NCT01584882|Smoking|smoking
363866|NCT01584882|Electronic health record|electronic health record
363867|NCT01584869|GI-bleeding|gi-bleeding
363868|NCT01584869|capsule endoscopy|capsule endoscopy
363869|NCT01584843|Neuromuscular Agents|neuromuscular agents
363870|NCT01584843|Strabismus|strabismus
363871|NCT01584843|Botulinum Toxin Type A|botulinum toxin type a
363872|NCT01584830|Regorafenib|regorafenib
363873|NCT01584830|Colorectal|colorectal
363874|NCT01584830|Metastatic|metastatic
363875|NCT01584817|colonoscopy|colonoscopy
363876|NCT01584817|bowel preparation|bowel preparation
363877|NCT01584817|education|education
363878|NCT01584804|Su Huang antitussive capsule|su huang antitussive capsule
363879|NCT01584804|Cough variant asthma|cough variant asthma
363880|NCT01584804|Placebo|placebo
363881|NCT01584791|CAD|cad
363882|NCT01584791|PCI|pci
363883|NCT01584791|Percutaneous Coronary Intervention|percutaneous coronary intervention
363884|NCT01584778|Behçet's disease|behçet's disease
363885|NCT01584778|Eosinophil cationic protein|eosinophil cationic protein
363886|NCT01584778|Eosinophils|eosinophils
363887|NCT01584765|liver injury|liver injury
363888|NCT01584765|Rechallenge|rechallenge
363889|NCT01584765|Kaiser Permanente California|kaiser permanente california
363890|NCT01584739|Safety|safety
363891|NCT01584739|tolerability|tolerability
363892|NCT01584739|healthy|healthy
363893|NCT01584739|COPD (chronic obstructive pulmonary disease)|copd (chronic obstructive pulmonary disease)
363894|NCT01584739|pharmacokinetic|pharmacokinetic
363895|NCT01584739|pharmacodynamic|pharmacodynamic
363896|NCT01584739|inhaled|inhaled
363897|NCT01584726|magnesium|magnesium
363898|NCT01584726|nebulization|nebulization
363899|NCT01584726|asthma|asthma
363900|NCT01584726|sulfate|sulfate
363901|NCT01584726|children|children
363902|NCT01584726|pediatric|pediatric
363903|NCT01584713|Enterocutaneous fistula|enterocutaneous fistula
363904|NCT01584713|Adipose Derived Stem Cells|adipose derived stem cells
363905|NCT01584700|NYHA class III or IV|nyha class iii or iv
363906|NCT01584700|Maximal medical therapy|maximal medical therapy
363907|NCT01584700|Not eligible for CRT|not eligible for crt
363908|NCT01584687|asthma|asthma
363909|NCT01584687|difficult-to-control asthma|difficult-to-control asthma
363910|NCT01584687|mRNA expression|mrna expression
363911|NCT01584687|biomarker|biomarker
363912|NCT01584687|real time PCR|real time pcr
363913|NCT01584687|ACT|act
363914|NCT01584687|ACQ|acq
363915|NCT01584648|Randomized study|randomized study
363916|NCT01584648|combination therapy|combination therapy
363917|NCT01584648|BRAF inhibitor|braf inhibitor
363918|NCT01584648|GSK1120212|gsk1120212
363919|NCT01584648|BRAF V600E/K mutation-positive cutaneous melanoma|braf v600e/k mutation-positive cutaneous melanoma
363920|NCT01584648|trametinib|trametinib
363921|NCT01584648|GSK2118436|gsk2118436
363922|NCT01584648|MEK inhibitor|mek inhibitor
363923|NCT01584648|Phase III|phase iii
363924|NCT01584648|dabrafenib|dabrafenib
363925|NCT01584635|Less invasive treatment for Achalasia|less invasive treatment for achalasia
363926|NCT01584609|ischemic stroke|ischemic stroke
363927|NCT01584609|large vessel occlusion|large vessel occlusion
363928|NCT01584609|mechanical thrombectomy|mechanical thrombectomy
363929|NCT01584609|revascularization|revascularization
363930|NCT01584609|Penumbra System|penumbra system
363931|NCT01584609|Separator 3D|separator 3d
363932|NCT01584596|physical activity|physical activity
363933|NCT01584596|dietary|dietary
363934|NCT01584596|adults|adults
363935|NCT01584596|pedometer|pedometer
363936|NCT01584596|education|education
363937|NCT01584583|BP|bp
363938|NCT01584570|dexmedetomidine|dexmedetomidine
363939|NCT01584570|heart rate variability|heart rate variability
363940|NCT01584570|QTc interval|qtc interval
363941|NCT01584544|rectal neoplasms|rectal neoplasms
363942|NCT01584544|aged|aged
363943|NCT01584544|chemoradiotherapy|chemoradiotherapy
363944|NCT01584544|clinical trials, phase I|clinical trials, phase i
363945|NCT01584544|capecitabine|capecitabine
363946|NCT01584531|rigosertib sodium|rigosertib sodium
363947|NCT01584531|rigosertib|rigosertib
363948|NCT01584531|ON 01910.Na|on 01910.na
363949|NCT01584531|oral rigosertib|oral rigosertib
363950|NCT01584505|COPD|copd
363951|NCT01584479|periodontitis|periodontitis
363952|NCT01584466|Schizophrenia|schizophrenia
363953|NCT01584466|Substance Abuse|substance abuse
363954|NCT01584427|Dietary fibers|dietary fibers
363955|NCT01584427|Resistent Starch|resistent starch
363956|NCT01584427|Arabinoxylans|arabinoxylans
363957|NCT01584427|Postprandial lipaemia|postprandial lipaemia
363958|NCT01584427|Insulin sensitivity|insulin sensitivity
363959|NCT01584427|Body composition|body composition
363960|NCT01584427|Gene expression|gene expression
363961|NCT01584427|Metabolic rate|metabolic rate
363962|NCT01584427|Blood pressure|blood pressure
363963|NCT01584414|Zetiq CellDetect ® stain|zetiq celldetect ® stain
363964|NCT01584414|distinct red/purple color to the cytoplasm of neoplastic|distinct red/purple color to the cytoplasm of neoplastic
363965|NCT01584414|distinguishes green/blue stained non-neoplastic cells and tissues|distinguishes green/blue stained non-neoplastic cells and tissues
363966|NCT01584401|Body temperature|body temperature
363967|NCT01584401|Thermometers|thermometers
363968|NCT01584401|Non invasive|non invasive
363969|NCT01584401|Medisim's non invasive thermometers|medisim's non invasive thermometers
363970|NCT01584388|Type 1 autoimmune pancreatitis|type 1 autoimmune pancreatitis
363971|NCT01584388|IgG4-related sclerosing cholangitis|igg4-related sclerosing cholangitis
363972|NCT01584388|Chronic sclerosing sialadenitis|chronic sclerosing sialadenitis
363973|NCT01584388|Lacrimal glands|lacrimal glands
363974|NCT01584388|Orbital pseudotumor|orbital pseudotumor
363975|NCT01584388|IgG4-related tubulointerstitial nephritis|igg4-related tubulointerstitial nephritis
363976|NCT01584388|Lymphadenopathy|lymphadenopathy
363977|NCT01584388|Pachymeningitis|pachymeningitis
363978|NCT01584388|Aorta|aorta
363979|NCT01584388|Peri-aortitis|peri-aortitis
363980|NCT01584388|Retroperitoneal fibrosis|retroperitoneal fibrosis
363981|NCT01584388|Riedel's thyroiditis|riedel's thyroiditis
363982|NCT01584375|Intraventricular hemorrhage|intraventricular hemorrhage
363983|NCT01584375|Preterm infant|preterm infant
363984|NCT01584375|Midline head position|midline head position
363985|NCT01584375|Lateral head Position|lateral head position
363986|NCT01584362|Taenia solium|taenia solium
363987|NCT01584362|neurocysticercosis|neurocysticercosis
363988|NCT01584362|oxfendazole|oxfendazole
363989|NCT01584362|clinical trial, phase 1|clinical trial, phase 1
363990|NCT01584362|safety|safety
363991|NCT01584362|pharmacokinetics|pharmacokinetics
363992|NCT01584336|Gastric cancer, laparoscopy-assisted total gastrectomy|gastric cancer, laparoscopy-assisted total gastrectomy
363993|NCT01584323|Preterm premature rupture of membranes|preterm premature rupture of membranes
363994|NCT01584323|pomgranate|pomgranate
363995|NCT01584323|oxidative stress|oxidative stress
363996|NCT01584323|pregnant women with Preterm premature rupture of membranes|pregnant women with preterm premature rupture of membranes
363997|NCT01584310|Nutritional assessment|nutritional assessment
363998|NCT01584310|children|children
363999|NCT01584310|malnutrition|malnutrition
364000|NCT01584297|Granulosa Cell Tumour|granulosa cell tumour
364001|NCT01584284|Genelux|genelux
364002|NCT01584284|Genelux Corporation|genelux corporation
364003|NCT01584284|GL-ONC1|gl-onc1
364004|NCT01584284|Vaccinia|vaccinia
364005|NCT01584284|Vaccinia Virus|vaccinia virus
364006|NCT01584284|Oncolytic virus|oncolytic virus
364007|NCT01584284|Oncolytic Virotherapy|oncolytic virotherapy
364008|NCT01584284|Head and Neck Cancer|head and neck cancer
364009|NCT01584284|Squamous Cell Carcinoma|squamous cell carcinoma
364010|NCT01584271|AOE|aoe
364011|NCT01584271|Ear Comfort|ear comfort
364012|NCT01584271|Dex Otic|dex otic
364013|NCT01584271|Otidin|otidin
364014|NCT01584258|Prostate cancer|prostate cancer
364015|NCT01584258|Prostate adenocarcinoma|prostate adenocarcinoma
364016|NCT01584258|Early stage prostate cancer|early stage prostate cancer
364017|NCT01584258|Organ-confined prostate cancer|organ-confined prostate cancer
364018|NCT01584258|Low-risk prostate cancer|low-risk prostate cancer
364019|NCT01584258|Intermediate-risk prostate cancer|intermediate-risk prostate cancer
364020|NCT01584232|Glucagon-like peptide-1 (GLP-1)|glucagon-like peptide-1 (glp-1)
364021|NCT01584206|Sitosterolemia|sitosterolemia
364022|NCT01584206|Ezetimibe|ezetimibe
364023|NCT01584206|Plant sterol|plant sterol
364024|NCT01584206|Cholesterol|cholesterol
364025|NCT01584193|central venous access port|central venous access port
364026|NCT01584193|ultrasound-guided venous puncture|ultrasound-guided venous puncture
364027|NCT01584193|suclavian vein|suclavian vein
364028|NCT01584193|cephalic vein|cephalic vein
364029|NCT01584180|hypothermia|hypothermia
364030|NCT01584180|induction of hypothermia|induction of hypothermia
364031|NCT01584180|cold infusion|cold infusion
364032|NCT01584180|local neck cooling|local neck cooling
364033|NCT01584180|external cooling|external cooling
364034|NCT01584180|surface cooling|surface cooling
364035|NCT01584180|non invasive cooling|non invasive cooling
364036|NCT01584180|stroke|stroke
364037|NCT01584180|intracranial hemorrhage|intracranial hemorrhage
364038|NCT01584180|cerebrovascular disease|cerebrovascular disease
364039|NCT01584180|neuro intensive care|neuro intensive care
364040|NCT01584167|hypothermia|hypothermia
364041|NCT01584167|induction of hypothermia|induction of hypothermia
364042|NCT01584167|cold infusion|cold infusion
364043|NCT01584167|whole-body cooling|whole-body cooling
364044|NCT01584167|external cooling|external cooling
364045|NCT01584167|surface cooling|surface cooling
364046|NCT01584167|non invasive cooling|non invasive cooling
364047|NCT01584167|stroke|stroke
364048|NCT01584167|intracranial hemorrhage|intracranial hemorrhage
364049|NCT01584167|cerebrovascular disease|cerebrovascular disease
364050|NCT01584167|neuro intensive care|neuro intensive care
364051|NCT01584141|Leukemia|leukemia
364053|NCT01584141|Occupational Epidemiology|occupational epidemiology
364054|NCT01584141|Molecular Epidemiology|molecular epidemiology
364055|NCT01584141|Genetic Polymorphisms|genetic polymorphisms
364056|NCT01584115|Cancer.|cancer.
364057|NCT01584115|Melanoma.|melanoma.
364058|NCT01584115|Ovarian cancer.|ovarian cancer.
364059|NCT01584115|Lung cancer.|lung cancer.
364060|NCT01584115|NY-ESO-1.|ny-eso-1.
364061|NCT01584115|MPLA (monophosphoryl lipid A).|mpla (monophosphoryl lipid a).
364062|NCT01584115|Tumor antigen.|tumor antigen.
364063|NCT01584115|Bordetella pertussis.|bordetella pertussis.
364064|NCT01584102|Randomized controlled trial|randomized controlled trial
364065|NCT01584102|obesity|obesity
364066|NCT01584102|community-based participatory research|community-based participatory research
364067|NCT01584102|minority health|minority health
364068|NCT01584102|rural health|rural health
364069|NCT01584102|health promotion|health promotion
364070|NCT01584076|Amblyopia|amblyopia
364071|NCT01584076|Donepezil|donepezil
364072|NCT01584063|Mexican Americans|mexican americans
364073|NCT01584063|Pregnancy|pregnancy
364074|NCT01584063|Diabetes Mellitus Type 2|diabetes mellitus type 2
364075|NCT01584063|Prevention|prevention
364076|NCT01584063|Community health workers|community health workers
364077|NCT01584063|Community based participatory research|community based participatory research
364078|NCT01584063|Behavioral Intervention|behavioral intervention
364079|NCT01584063|Lifestyle Intervention|lifestyle intervention
364080|NCT01584037|Adenovirus|adenovirus
364081|NCT01584037|Adenovirus Type 4|adenovirus type 4
364082|NCT01584037|Adenovirus Type 7|adenovirus type 7
364083|NCT01584037|Adenovirus Type 4 and Type 7 Vaccine, Live, Oral|adenovirus type 4 and type 7 vaccine, live, oral
364084|NCT01584024|Dental caries|dental caries
364085|NCT01584024|Proximal surfaces|proximal surfaces
364086|NCT01584024|Posterior teeth|posterior teeth
364087|NCT01584024|Carious lesions|carious lesions
364088|NCT01584024|Tooth diseases|tooth diseases
364089|NCT01584024|Preventive therapy|preventive therapy
364090|NCT01584011|Taste|taste
364091|NCT01584011|Chorda tympani nerve|chorda tympani nerve
364092|NCT01583998|Major Depressive Disorder|major depressive disorder
364093|NCT01583998|MDD|mdd
364094|NCT01583998|Depression|depression
364095|NCT01583998|Measurement Based Care|measurement based care
364096|NCT01583998|MBC|mbc
364097|NCT01583998|electronic health records|electronic health records
364098|NCT01583998|EHR|ehr
364099|NCT01583998|electronic medical records|electronic medical records
364100|NCT01583998|EMR|emr
364101|NCT01583985|opioid analgesics|opioid analgesics
364102|NCT01583985|chronic pain|chronic pain
364103|NCT01583985|musculoskeletal pain|musculoskeletal pain
364104|NCT01583972|Vitamin A deficiency|vitamin a deficiency
364105|NCT01583972|Vitamin A|vitamin a
364106|NCT01583972|retinyl palmitate|retinyl palmitate
364107|NCT01583972|malnutrition|malnutrition
364108|NCT01583972|vaccine|vaccine
364109|NCT01583972|vaccination|vaccination
364110|NCT01583972|BCG|bcg
364111|NCT01583972|tuberculosis|tuberculosis
364112|NCT01583972|polio virus|polio virus
364113|NCT01583972|tetanus toxoid|tetanus toxoid
364114|NCT01583972|hepatitis B virus|hepatitis b virus
364115|NCT01583972|thymus|thymus
364116|NCT01583972|T lymphocyte|t lymphocyte
364117|NCT01583972|B lymphocyte|b lymphocyte
364118|NCT01583972|antibody|antibody
364119|NCT01583972|bacterial translocation|bacterial translocation
364120|NCT01583972|T-cell receptor excision circle|t-cell receptor excision circle
364121|NCT01583959|rheumatoid arthritis|rheumatoid arthritis
364122|NCT01583959|folic acid|folic acid
364123|NCT01583959|methotrexate|methotrexate
364124|NCT01583946|subjective well-being|subjective well-being
364125|NCT01583946|life transitions|life transitions
364126|NCT01583946|health-related quality of life|health-related quality of life
364127|NCT01583946|health|health
364128|NCT01583946|healthcare costs|healthcare costs
364129|NCT01583933|Dental stability|dental stability
364130|NCT01583933|Occlusal stability|occlusal stability
364131|NCT01583933|Retainers|retainers
364132|NCT01583920|prostatic neoplasms|prostatic neoplasms
364133|NCT01583920|brachytherapy|brachytherapy
364134|NCT01583920|salvage therapy|salvage therapy
364135|NCT01583920|recurrent prostate cancer|recurrent prostate cancer
364136|NCT01583907|cow's milk allergy|cow's milk allergy
364137|NCT01583881|Patients with diastolic heart failure and hypertension|patients with diastolic heart failure and hypertension
364138|NCT01583855|Remote catheter ablation|remote catheter ablation
364139|NCT01583855|Atrial fibrillation|atrial fibrillation
364140|NCT01583842|neuroblastoma|neuroblastoma
364141|NCT01583842|imaging|imaging
364142|NCT01583842|124I-MIBG|124i-mibg
364143|NCT01583842|131I-MIBG|131i-mibg
364144|NCT01583842|PET/CT|pet/ct
364145|NCT01583829|ADHD|adhd
364146|NCT01583829|neurofeedback|neurofeedback
364147|NCT01583829|biofeedback|biofeedback
364148|NCT01583829|computer attention training|computer attention training
364149|NCT01583816|Actinic Keratosis|actinic keratosis
364150|NCT01583816|Resiquimod|resiquimod
364151|NCT01583790|Laparoscopic Sleeve Gastrectomy|laparoscopic sleeve gastrectomy
364152|NCT01583790|Bariatric surgery|bariatric surgery
364153|NCT01583790|Morbid Obesity|morbid obesity
364154|NCT01583777|Belinostat|belinostat
364155|NCT01583751|pilonidal sinus|pilonidal sinus
364156|NCT01583751|new technique|new technique
364157|NCT01583751|videoendoscopic|videoendoscopic
364158|NCT01583725|Obesity|obesity
364159|NCT01583725|Bariatric surgery|bariatric surgery
364160|NCT01583725|Weight loss|weight loss
364161|NCT01583725|fMRI|fmri
364162|NCT01583725|gut peptides|gut peptides
364163|NCT01583712|Confocal laser endomicroscopy|confocal laser endomicroscopy
364164|NCT01583712|Small bowel imaging|small bowel imaging
364165|NCT01583712|Graft-versus-host disease|graft-versus-host disease
364166|NCT01583712|HSCT|hsct
364167|NCT01583699|MALT-lymphoma|malt-lymphoma
364168|NCT01583699|Confocal laser endomicroscopy|confocal laser endomicroscopy
364169|NCT01583699|Gastrointestinal endoscopy|gastrointestinal endoscopy
364170|NCT01583686|Metastatic Cancer|metastatic cancer
364171|NCT01583686|Immunotherapy|immunotherapy
364172|NCT01583686|Gene Therapy|gene therapy
364173|NCT01583686|Mesothelioma|mesothelioma
364174|NCT01583686|Pancreatic Cancer|pancreatic cancer
364175|NCT01583660|NSAIDs|nsaids
364176|NCT01583660|Anti-inflammatory|anti-inflammatory
364177|NCT01583660|elderly hip fracture|elderly hip fracture
364178|NCT01583660|mortality|mortality
364179|NCT01583608|Drug eluting stent|drug eluting stent
364180|NCT01583608|Bioabsorbable|bioabsorbable
364181|NCT01583608|Bioresorbable|bioresorbable
364182|NCT01583608|Coronary Stent|coronary stent
364183|NCT01583608|Scaffold|scaffold
364184|NCT01583608|Stents|stents
364185|NCT01583608|Angioplasty|angioplasty
364186|NCT01583608|Coronary Artery Disease|coronary artery disease
364187|NCT01583608|Stentthrombosis|stentthrombosis
364188|NCT01583595|Chronic Lung Disease|chronic lung disease
364189|NCT01583595|Exercise|exercise
364190|NCT01583595|Self-efficacy|self-efficacy
364191|NCT01583582|randomized double-blind placebo-controlled study|randomized double-blind placebo-controlled study
364192|NCT01583582|peptide concentrate|peptide concentrate
364193|NCT01583582|Coldwater Shrimp|coldwater shrimp
364194|NCT01583582|antihypertensive effect|antihypertensive effect
364195|NCT01583582|mild hypertension|mild hypertension
364196|NCT01583582|moderate hypertension|moderate hypertension
364197|NCT01583582|blood pressure|blood pressure
364198|NCT01583569|Complex Dynamic Systems|complex dynamic systems
364199|NCT01583569|Biomarkers|biomarkers
364200|NCT01583569|Mood Disorders|mood disorders
364201|NCT01583556|Adult|adult
364202|NCT01583556|English speaking|english speaking
364203|NCT01583556|Fractures|fractures
364204|NCT01583556|Excellent prognosis|excellent prognosis
364205|NCT01583556|Upper Extremity|upper extremity
364206|NCT01583543|Recurrent|recurrent
364207|NCT01583543|Metastatic|metastatic
364208|NCT01583530|Belimumab|belimumab
364209|NCT01583530|Injections, Subcutaneous|injections, subcutaneous
364210|NCT01583530|Drug Administration Routes|drug administration routes
364211|NCT01583530|Injections|injections
364212|NCT01583530|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
364213|NCT01583530|Lupus|lupus
364214|NCT01583530|SLE|sle
364215|NCT01583530|Systemic Lupus Erythematosus|systemic lupus erythematosus
364216|NCT01583530|Antibodies|antibodies
364217|NCT01583530|Autoimmune Disease|autoimmune disease
364218|NCT01583530|Biological Therapy|biological therapy
364219|NCT01583530|Immune System Diseases|immune system diseases
364220|NCT01583530|Pharmacokinetics|pharmacokinetics
364221|NCT01583530|Biological Availability|biological availability
364222|NCT01583517|Acute pancreatitis|acute pancreatitis
364223|NCT01583517|ERCP|ercp
364224|NCT01583517|Sphincterotomy|sphincterotomy
364225|NCT01583517|Manometry|manometry
364226|NCT01583517|Sphincter of Oddi dysfunction|sphincter of oddi dysfunction
364227|NCT01583504|Achilles|achilles
364228|NCT01583504|Tendinopathy|tendinopathy
364229|NCT01583504|Tendonitis|tendonitis
364230|NCT01583504|Injection|injection
364231|NCT01583491|platelet rich fibrin|platelet rich fibrin
364232|NCT01583491|mandibular third molar|mandibular third molar
364233|NCT01583491|periodontal problem|periodontal problem
364234|NCT01583478|incobotulinumtoxinA|incobotulinumtoxina
364235|NCT01583478|wrinkles|wrinkles
364236|NCT01583478|glabellar|glabellar
364237|NCT01583478|rhytids|rhytids
364238|NCT01583478|frown|frown
364239|NCT01583478|lines|lines
364240|NCT01583465|randomized controlled trial|randomized controlled trial
364241|NCT01583465|Blood loss, surgical|blood loss, surgical
364242|NCT01583465|Blood loss, postoperative|blood loss, postoperative
364243|NCT01583465|Wound healing|wound healing
364244|NCT01583452|Post operative ileus|post operative ileus
364245|NCT01583452|Gastrointestinal surgery|gastrointestinal surgery
364246|NCT01583452|Chewing gum|chewing gum
364247|NCT01583439|HIV Infections|hiv infections
364248|NCT01583439|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
364249|NCT01583439|Anti-HIV Agents|anti-hiv agents
364250|NCT01583439|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
364251|NCT01583439|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
364252|NCT01583439|Immune System Diseases|immune system diseases
364253|NCT01583439|Anti-Retroviral Agents|anti-retroviral agents
364254|NCT01583439|Antiviral Agents|antiviral agents
364255|NCT01583426|GeparSepto|geparsepto
364256|NCT01583426|GBG 69|gbg 69
364257|NCT01583426|GBG|gbg
364258|NCT01583426|German Breast Group|german breast group
364259|NCT01583426|neo-adjuvant|neo-adjuvant
364260|NCT01583426|GBG Forschungs GmbH|gbg forschungs gmbh
364261|NCT01583426|Tubular breast cancer stage II|tubular breast cancer stage ii
364262|NCT01583426|Mucinous breast cancer stage II|mucinous breast cancer stage ii
364263|NCT01583426|Invasive ductal breast cancer|invasive ductal breast cancer
364264|NCT01583426|Tubular breast cancer stage III|tubular breast cancer stage iii
364265|NCT01583426|HER-2 positive breast cancer|her-2 positive breast cancer
364266|NCT01583426|Inflammatory breast cancer|inflammatory breast cancer
364267|NCT01583413|Ventilator-associated pneumonia|ventilator-associated pneumonia
364268|NCT01583400|Depressive Disorder, Major|depressive disorder, major
364269|NCT01583400|Depressive Disorder, Minor|depressive disorder, minor
364270|NCT01583400|Dysthymic Disorder|dysthymic disorder
364271|NCT01583387|healthy adults|healthy adults
364272|NCT01583387|urinary adducts|urinary adducts
364273|NCT01583387|water intake|water intake
364274|NCT01583374|spondylitis|spondylitis
364275|NCT01583374|spondyloarthritis|spondyloarthritis
364276|NCT01583374|Spondyloarthropathy|spondyloarthropathy
364277|NCT01583374|Oral preparation|oral preparation
364278|NCT01583361|two arms|two arms
364279|NCT01583361|D2 lymphadenectomy|d2 lymphadenectomy
364280|NCT01583361|chemotherapy before and after surgery|chemotherapy before and after surgery
364281|NCT01583361|disease free survival|disease free survival
364282|NCT01583348|transvaginal|transvaginal
364283|NCT01583348|NOTES|notes
364284|NCT01583348|cholecystectomy|cholecystectomy
364285|NCT01583348|cholangiography|cholangiography
364286|NCT01583348|symptomatic gallstone disease|symptomatic gallstone disease
364287|NCT01583335|Overweight|overweight
364288|NCT01583335|Obesity|obesity
364289|NCT01583335|Predisposition|predisposition
364290|NCT01583335|Prevention|prevention
364291|NCT01583335|Diet|diet
364292|NCT01583335|Physical activity|physical activity
364293|NCT01583335|Sleep|sleep
364294|NCT01583335|Family stress|family stress
364295|NCT01583322|ovarian cancer|ovarian cancer
364296|NCT01583322|debulking surgery|debulking surgery
364297|NCT01583322|interval debulking|interval debulking
364298|NCT01583322|vargatef|vargatef
364299|NCT01583322|nintedanib|nintedanib
364300|NCT01583322|maintenance|maintenance
364301|NCT01583322|first line|first line
364302|NCT01583322|paclitaxel|paclitaxel
364303|NCT01583322|carboplatin|carboplatin
364304|NCT01583309|blood pressure|blood pressure
364305|NCT01583309|cardiovascular instability|cardiovascular instability
364306|NCT01583309|symptomatic hypotension|symptomatic hypotension
364307|NCT01583309|online hemofiltration|online hemofiltration
364308|NCT01583309|online hemodiafiltration|online hemodiafiltration
364309|NCT01583283|Multiple Myeloma|multiple myeloma
364310|NCT01583283|Relapsed|relapsed
364311|NCT01583283|Refractory|refractory
364312|NCT01583283|Histone deacetylase inhibitors|histone deacetylase inhibitors
364313|NCT01583283|Lenalidomide|lenalidomide
364314|NCT01583283|Revlimid|revlimid
364315|NCT01583283|Dexamethasone|dexamethasone
364316|NCT01583270|Arabinxylan|arabinxylan
364317|NCT01583270|Rye kernels|rye kernels
364318|NCT01583270|whole grain|whole grain
364319|NCT01583270|Dietary fibre|dietary fibre
364320|NCT01583270|Metabolic syndrome|metabolic syndrome
364321|NCT01583270|Glycemic response|glycemic response
364322|NCT01583270|Colon fermentation|colon fermentation
364323|NCT01583270|Second meal effekt|second meal effekt
364324|NCT01583270|Satiety|satiety
364325|NCT01583218|Phase III|phase iii
364326|NCT01583205|ALS|als
364327|NCT01583205|Coping Effectiveness Training|coping effectiveness training
364328|NCT01583205|Distress|distress
364329|NCT01583205|Care Giver|care giver
364330|NCT01583192|infection|infection
364331|NCT01583192|skin preparation|skin preparation
364332|NCT01583192|fore-foot surgery|fore-foot surgery
364333|NCT01583192|chloride-hexidine|chloride-hexidine
364334|NCT01583192|povidine-jodine|povidine-jodine
364335|NCT01583192|alcohol|alcohol
364336|NCT01583179|nerve block|nerve block
364337|NCT01583179|outpatient surgery|outpatient surgery
364338|NCT01583140|physical activity|physical activity
364339|NCT01583140|Latinas|latinas
364340|NCT01583127|Problem Behavior|problem behavior
364341|NCT01583114|dilated cardiomyopathy|dilated cardiomyopathy
364342|NCT01583114|heart failure|heart failure
364343|NCT01583114|genetics|genetics
364344|NCT01583114|mutation carrier|mutation carrier
364345|NCT01583114|ACE treatment|ace treatment
364346|NCT01583114|preclinical|preclinical
364347|NCT01583088|Amyotrophic lateral sclerosis,|amyotrophic lateral sclerosis,
364348|NCT01583088|Diaphragm|diaphragm
364349|NCT01583088|Mechanical ventilation|mechanical ventilation
364350|NCT01583088|Phrenic nerve stimulation|phrenic nerve stimulation
364351|NCT01583088|Respiratory insufficiency|respiratory insufficiency
364352|NCT01583062|Surgical Wound Infection|surgical wound infection
364353|NCT01583062|Facial Injuries|facial injuries
364354|NCT01583062|Orbital Fractures|orbital fractures
364355|NCT01583062|Zygomatic Fractures|zygomatic fractures
364356|NCT01583062|Mandibular Fractures|mandibular fractures
364357|NCT01583062|Jaw Injuries|jaw injuries
364358|NCT01583023|bipolar disorder|bipolar disorder
364359|NCT01583023|repetitive transcranial magnetic stimulation (rtms)|repetitive transcranial magnetic stimulation (rtms)
364360|NCT01583023|bupropion|bupropion
364361|NCT01583023|lithium a/o Epival|lithium a/o epival
364362|NCT01583010|ultrasound guided regional anaesthesia needle visualization|ultrasound guided regional anaesthesia needle visualization
364363|NCT01582997|BRAF|braf
364364|NCT01582997|Advance solid tumors|advance solid tumors
364365|NCT01582984|consent|consent
364366|NCT01582984|Patient Understanding|patient understanding
364367|NCT01582984|Knee Arthroplasty|knee arthroplasty
364368|NCT01582971|Breast Cancer|breast cancer
364369|NCT01582971|Reflexology|reflexology
364370|NCT01582971|Complementary|complementary
364371|NCT01582958|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
364372|NCT01582958|Pulmonary Function Tests|pulmonary function tests
364373|NCT01582958|Biochemical Alterations|biochemical alterations
364374|NCT01582945|Treatment resistant|treatment resistant
364375|NCT01582945|suicidal ideation|suicidal ideation
364376|NCT01582945|major depressive disorder|major depressive disorder
364377|NCT01582932|plaque psoriasis|plaque psoriasis
364378|NCT01582932|pediatric|pediatric
364379|NCT01582932|mild|mild
364380|NCT01582932|moderate|moderate
364381|NCT01582919|dementia|dementia
364382|NCT01582919|Alzheimer's Disease|alzheimer's disease
364383|NCT01582919|diagnostic|diagnostic
364384|NCT01582919|biomarkers|biomarkers
364385|NCT01582919|neuroimaging|neuroimaging
364386|NCT01582919|PET|pet
364387|NCT01582919|MRI|mri
364388|NCT01582919|mild cognitive impairment|mild cognitive impairment
364389|NCT01582893|inflammation|inflammation
364390|NCT01582893|dialysis|dialysis
364391|NCT01582880|Keratoprosthesis|keratoprosthesis
364392|NCT01582880|sterile cornea ulcer|sterile cornea ulcer
364393|NCT01582867|Hemodiafiltration|hemodiafiltration
364394|NCT01582867|Hemodialysis|hemodialysis
364395|NCT01582867|Sodium|sodium
364396|NCT01582867|Artis|artis
364397|NCT01582867|renal failure|renal failure
364398|NCT01582854|Post-Stroke Cognitive Impairment (PSCI)|post-stroke cognitive impairment (psci)
364399|NCT01582854|Stroke|stroke
364400|NCT01582854|Actovegin|actovegin
364401|NCT01582854|Cognition disorders|cognition disorders
364402|NCT01582841|Colon Cancer|colon cancer
364403|NCT01582841|Lynch Syndrome|lynch syndrome
364404|NCT01582841|Genetic Screening|genetic screening
364405|NCT01582828|atrial|atrial
364406|NCT01582828|fibrillation|fibrillation
364407|NCT01582828|pvi|pvi
364408|NCT01582828|vats|vats
364409|NCT01582828|ablation|ablation
364410|NCT01582828|hybrid|hybrid
364411|NCT01582815|Major Depressive Disorder|major depressive disorder
364412|NCT01582815|Depression|depression
364413|NCT01582815|Anxiety symptoms|anxiety symptoms
364414|NCT01582815|JNJ-40411813|jnj-40411813
364415|NCT01582763|Guillain-Barré syndrome|guillain-barré syndrome
364416|NCT01582763|Polyneuropathy|polyneuropathy
364417|NCT01582763|Autoimmune Diseases|autoimmune diseases
364418|NCT01582763|Immune System Diseases|immune system diseases
364419|NCT01582763|Neuromuscular Diseases|neuromuscular diseases
364420|NCT01582763|Outcome|outcome
364421|NCT01582763|Quality of life|quality of life
364422|NCT01582763|Disability|disability
364423|NCT01582763|Prognostic Determinants|prognostic determinants
364424|NCT01582763|Treatment|treatment
364425|NCT01582763|Immunoglobulins|immunoglobulins
364426|NCT01582763|Prognosis|prognosis
364427|NCT01582763|Infections|infections
364428|NCT01582763|Anti-ganglioside antibodies|anti-ganglioside antibodies
364429|NCT01582763|Genetic polymorphisms|genetic polymorphisms
364430|NCT01582763|Electrophysiology|electrophysiology
364431|NCT01582763|Cerebrospinal Fluid|cerebrospinal fluid
364432|NCT01582763|Serum|serum
364433|NCT01582750|endoscopic ultrasound|endoscopic ultrasound
364434|NCT01582750|pre-operative concurrent chemoradiotherapy|pre-operative concurrent chemoradiotherapy
364435|NCT01582737|Xarelto|xarelto
364436|NCT01582737|SPAF|spaf
364437|NCT01582724|Menstrual pain|menstrual pain
364438|NCT01582724|Primary dysmenorrhea|primary dysmenorrhea
364439|NCT01582724|Self-care acupressure|self-care acupressure
364440|NCT01582711|LTBI|ltbi
364441|NCT01582711|LTB|ltb
364442|NCT01582711|Latent TB|latent tb
364443|NCT01582711|TB infection|tb infection
364444|NCT01582685|Breast Cancer|breast cancer
364445|NCT01582685|Obesity|obesity
364446|NCT01582685|Exercise|exercise
364447|NCT01582685|Angiogenesis|angiogenesis
364448|NCT01582672|RCC|rcc
364449|NCT01582672|Kidney Cancer|kidney cancer
364450|NCT01582659|constipation|constipation
364451|NCT01582659|children|children
364452|NCT01582659|outpatient|outpatient
364453|NCT01582633|vaccine|vaccine
364454|NCT01582633|influenza|influenza
364455|NCT01582633|needle free jet injector|needle free jet injector
364456|NCT01582633|Intradermal|intradermal
364457|NCT01582633|sparing dose|sparing dose
364458|NCT01582620|Cerebrovascular disorders|cerebrovascular disorders
364459|NCT01582620|Telemedicine|telemedicine
364460|NCT01582620|remote consultation|remote consultation
364461|NCT01582620|rural|rural
364462|NCT01582620|thrombolysis therapy|thrombolysis therapy
364463|NCT01582620|plasminogen activators|plasminogen activators
364464|NCT01582620|stroke care|stroke care
364465|NCT01582620|stroke management|stroke management
364466|NCT01582594|1000 residual serum/plasma samples|1000 residual serum/plasma samples
364467|NCT01582594|anti-HCV seronegative or seropositive|anti-hcv seronegative or seropositive
364468|NCT01582581|mental health|mental health
364469|NCT01582581|depression|depression
364470|NCT01582581|behavioral health|behavioral health
364471|NCT01582581|cognitive behavioral therapy|cognitive behavioral therapy
364472|NCT01582581|CBT|cbt
364473|NCT01582581|computer-assisted psychotherapy|computer-assisted psychotherapy
364474|NCT01582555|mucolysis|mucolysis
364475|NCT01582555|QOL|qol
364476|NCT01582555|endoscopy|endoscopy
364477|NCT01582555|sinus surgery|sinus surgery
364478|NCT01582529|Developmental Outcomes|developmental outcomes
364479|NCT01582529|Psychosocial Outcomes|psychosocial outcomes
364480|NCT01582529|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
364481|NCT01582529|Congenital Heart Disease|congenital heart disease
364482|NCT01582516|brain tumor|brain tumor
364483|NCT01582516|virotherapy|virotherapy
364484|NCT01582516|glioblastoma|glioblastoma
364485|NCT01582516|replication competent adenovirus|replication competent adenovirus
364486|NCT01582490|Mammoplasty|mammoplasty
364487|NCT01582490|Postoperative pain|postoperative pain
364488|NCT01582490|Analgesia|analgesia
364489|NCT01582477|TAP, robot-assisted prostatectomy|tap, robot-assisted prostatectomy
364490|NCT01582464|Protective Headwear|protective headwear
364491|NCT01582464|Social Marketing|social marketing
364492|NCT01582464|Theory of Planned Behavior|theory of planned behavior
364493|NCT01582425|isavuconazole|isavuconazole
364494|NCT01582425|methadone|methadone
364495|NCT01582425|Healthy Volunteers|healthy volunteers
364496|NCT01582425|BAL8557|bal8557
364497|NCT01582412|Isavuconazole|isavuconazole
364498|NCT01582412|Digoxin|digoxin
364499|NCT01582412|Healthy Volunteers|healthy volunteers
364500|NCT01582412|BAL8557|bal8557
364501|NCT01582399|Healthy Volunteers|healthy volunteers
364502|NCT01582399|CD40 receptor occupancy|cd40 receptor occupancy
364503|NCT01582399|Co-stimulation blockade|co-stimulation blockade
364504|NCT01582399|CD40 antigen|cd40 antigen
364505|NCT01582399|Anti-CD40|anti-cd40
364506|NCT01582399|ASKP1240|askp1240
364507|NCT01582360|critical illness|critical illness
364508|NCT01582360|pharmacokinetics|pharmacokinetics
364509|NCT01582360|CRRT|crrt
364510|NCT01582360|CVVH|cvvh
364511|NCT01582360|CVVHD|cvvhd
364512|NCT01582360|CVVHDF|cvvhdf
364513|NCT01582360|antiinfectives|antiinfectives
364514|NCT01582360|antibiotics|antibiotics
364515|NCT01582360|minimum inhibitory concentration|minimum inhibitory concentration
364516|NCT01582360|bacterial killing|bacterial killing
364517|NCT01582360|pharmacodynamics|pharmacodynamics
364518|NCT01582360|PK/PD index|pk/pd index
364519|NCT01582347|Opioid dependence|opioid dependence
364520|NCT01582334|Growth disorders|growth disorders
364521|NCT01582334|Saizen|saizen
364522|NCT01582334|Easypod|easypod
364523|NCT01582334|Growth hormone|growth hormone
364524|NCT01582334|Pediatric subject|pediatric subject
364525|NCT01582321|vascular ultrasound|vascular ultrasound
364526|NCT01582321|flow cytometry|flow cytometry
364527|NCT01582321|platelet aggregation|platelet aggregation
364528|NCT01582295|Bone disease|bone disease
364529|NCT01582282|Type II NIDDM|type ii niddm
364530|NCT01582243|Diabetes Mellitus, type 2|diabetes mellitus, type 2
364531|NCT01582243|vildagliptin|vildagliptin
364532|NCT01582230|Type 2 diabetes mellitus|type 2 diabetes mellitus
364533|NCT01582230|Vildagliptin|vildagliptin
364534|NCT01582217|Bleeding|bleeding
364535|NCT01582217|Risk Score|risk score
364536|NCT01582217|Outcomes|outcomes
364537|NCT01582217|Prasugrel|prasugrel
364538|NCT01582204|clear cell carcinoma|clear cell carcinoma
364539|NCT01582204|Kidney|kidney
364540|NCT01582204|MAB-124I-CG250|mab-124i-cg250
364541|NCT01582204|PET scan|pet scan
364542|NCT01582204|CT scan|ct scan
364543|NCT01582204|sunitinib|sunitinib
364544|NCT01582204|pazopanib|pazopanib
364545|NCT01582204|11-134|11-134
364546|NCT01582191|Advanced Cancers|advanced cancers
364547|NCT01582191|Advanced solid cancer|advanced solid cancer
364548|NCT01582191|Metastatic cancer|metastatic cancer
364549|NCT01582191|Vandetanib|vandetanib
364550|NCT01582191|ZD 6474|zd 6474
364551|NCT01582191|Zactima|zactima
364552|NCT01582191|Caprelsa|caprelsa
364553|NCT01582191|Everolimus|everolimus
364554|NCT01582191|Afinitor|afinitor
364555|NCT01582191|RAD001|rad001
364556|NCT01582191|Multi-kinase Inhibitor|multi-kinase inhibitor
364557|NCT01582178|colonoscopy|colonoscopy
364558|NCT01582178|warm water immersion|warm water immersion
364559|NCT01582178|cool water immersion|cool water immersion
364560|NCT01582152|Brain Neoplasms|brain neoplasms
365665|NCT01577446|narrow QRS|narrow qrs
364561|NCT01582152|Central Nervous System Neoplasms|central nervous system neoplasms
364562|NCT01582152|Recurrent Glioblastoma|recurrent glioblastoma
364563|NCT01582152|Glioblastoma multiforme|glioblastoma multiforme
364564|NCT01582152|GBM|gbm
364565|NCT01582152|Gliosarcoma|gliosarcoma
364566|NCT01582152|TPI287|tpi287
364567|NCT01582152|Bevacizumab|bevacizumab
364568|NCT01582152|Avastin|avastin
364569|NCT01582152|Anti-VEGF Monoclonal Antibody|anti-vegf monoclonal antibody
364570|NCT01582152|rhuMAb-VEGF|rhumab-vegf
364571|NCT01582139|Artificial Pancreas Project|artificial pancreas project
364572|NCT01582139|AP Platform|ap platform
364573|NCT01582139|Insulin Pump|insulin pump
364574|NCT01582139|Continuous Glucose Monitor|continuous glucose monitor
364575|NCT01582139|Closed-Loop Control|closed-loop control
364576|NCT01582139|Control-to-Range|control-to-range
364577|NCT01582126|multiple sclerosis|multiple sclerosis
364578|NCT01582126|physical therapy|physical therapy
364579|NCT01582126|postural control|postural control
364580|NCT01582087|acute hepatic failure|acute hepatic failure
364581|NCT01582087|chronic hepatic failure|chronic hepatic failure
364582|NCT01582087|coma|coma
364583|NCT01582074|Ultrasound Tomography|ultrasound tomography
364584|NCT01582074|Tamoxifen|tamoxifen
364585|NCT01582074|Breast Cancer|breast cancer
364586|NCT01582074|Estrogen Receptor Positive|estrogen receptor positive
364587|NCT01582074|Breast Density|breast density
364588|NCT01582061|Cushing's disease|cushing's disease
364589|NCT01582061|Hormone disorder|hormone disorder
364590|NCT01582061|Cortisol|cortisol
364591|NCT01582061|Adrenocorticotropic hormone|adrenocorticotropic hormone
364592|NCT01582061|Pituitary tumor|pituitary tumor
364593|NCT01582061|SOM230|som230
364594|NCT01582061|adult|adult
364595|NCT01582035|Hepatitis C|hepatitis c
364596|NCT01582035|TMC647055HPC1005|tmc647055hpc1005
364597|NCT01582035|TMC647055|tmc647055
364598|NCT01582035|telaprevir|telaprevir
364599|NCT01581996|Chronic renal failure|chronic renal failure
364600|NCT01581996|End-stage renal disease|end-stage renal disease
364601|NCT01581996|Chronic peritoneal dialysis|chronic peritoneal dialysis
364602|NCT01581996|Serum phosphorus|serum phosphorus
364603|NCT01581996|Hyperphosphatemia|hyperphosphatemia
364604|NCT01581996|Phosphate binders|phosphate binders
364605|NCT01581996|Phosphate|phosphate
364606|NCT01581970|head and neck cancer|head and neck cancer
364607|NCT01581970|metastatic squamous cell cancer|metastatic squamous cell cancer
364608|NCT01581957|Enteral nutrition, critically ill patients|enteral nutrition, critically ill patients
364609|NCT01581944|myomectomy|myomectomy
364610|NCT01581944|GnRH|gnrh
364611|NCT01581944|blood loss|blood loss
364612|NCT01581905|Hysterectomy|hysterectomy
364613|NCT01581905|Laparoscopy|laparoscopy
364614|NCT01581905|Robotics|robotics
364615|NCT01581892|bone nonunion|bone nonunion
364616|NCT01581892|bone marrow|bone marrow
364617|NCT01581892|mononuclear|mononuclear
364618|NCT01581892|fracture|fracture
364619|NCT01581879|Bioequivalence|bioequivalence
364620|NCT01581879|Ziprasidone hydrochloride|ziprasidone hydrochloride
364621|NCT01581879|crossover|crossover
364622|NCT01581866|Bioequivalence|bioequivalence
364623|NCT01581866|Ziprasidone hydrochloride|ziprasidone hydrochloride
364624|NCT01581866|crossover|crossover
364625|NCT01581853|HIV|hiv
364626|NCT01581853|AIDS|aids
364627|NCT01581853|MONOTHERAPY|monotherapy
364628|NCT01581853|PILOT|pilot
364629|NCT01581853|LOPINAVIR/RITONAVIR|lopinavir/ritonavir
364630|NCT01581840|anus|anus
364631|NCT01581840|carcinoma|carcinoma
364632|NCT01581840|panitumumab|panitumumab
364633|NCT01581840|mitomycine|mitomycine
364634|NCT01581840|5Fu|5fu
364635|NCT01581840|radiotherapy|radiotherapy
364636|NCT01581827|Heart Failure|heart failure
364637|NCT01581827|BNP|bnp
364638|NCT01581827|NT-proBNP|nt-probnp
364639|NCT01581814|PCOS|pcos
364640|NCT01581801|gastric bypass|gastric bypass
364641|NCT01581801|sleeve gastrectomy|sleeve gastrectomy
364642|NCT01581801|reactive hypoglycemia|reactive hypoglycemia
364643|NCT01581788|Bioequivalence|bioequivalence
364644|NCT01581788|Divalproex Sodium|divalproex sodium
364645|NCT01581788|Crossover|crossover
364646|NCT01581775|Bioequivalence|bioequivalence
364647|NCT01581775|Divalproex Sodium|divalproex sodium
364648|NCT01581775|Crossover|crossover
364649|NCT01581762|EUS, FNA|eus, fna
364650|NCT01581749|low risk prostate cancer|low risk prostate cancer
364651|NCT01581749|intermediate risk prostate cancer|intermediate risk prostate cancer
364652|NCT01581749|stereotactic radiosurgery|stereotactic radiosurgery
364653|NCT01581736|insulin resistance|insulin resistance
364654|NCT01581736|mitochondria|mitochondria
364655|NCT01581723|urinary bladder tumor|urinary bladder tumor
364656|NCT01581723|monopolar TURBT|monopolar turbt
364657|NCT01581723|bipolar TURBT|bipolar turbt
364658|NCT01581710|Leukotriene Antagonists|leukotriene antagonists
364659|NCT01581710|Bronchodilator response|bronchodilator response
364660|NCT01581697|oat|oat
364661|NCT01581697|cholesterol|cholesterol
364662|NCT01581697|children|children
364663|NCT01581697|adolescent|adolescent
364664|NCT01581697|Level reduction of ceric cholesterol|level reduction of ceric cholesterol
364665|NCT01581645|Parkinson's disease|parkinson's disease
364666|NCT01581645|Parkinsonism|parkinsonism
364667|NCT01581645|Gait problems|gait problems
364668|NCT01581645|Freezing gait|freezing gait
364669|NCT01581632|atherosclerosis|atherosclerosis
364670|NCT01581632|endothelial dysfunction|endothelial dysfunction
364671|NCT01581632|coronary vasospasm|coronary vasospasm
364672|NCT01581619|Early Invasive N0|early invasive n0
364673|NCT01581619|Non-Invasive|non-invasive
364674|NCT01581606|Age Related Macular Degeneration|age related macular degeneration
364675|NCT01581606|Teleophthalmology|teleophthalmology
364676|NCT01581606|Screening|screening
364677|NCT01581606|Diagnosis|diagnosis
364678|NCT01581606|Timing|timing
364679|NCT01581606|Treatment|treatment
364680|NCT01581593|Primary Immunodeficiency|primary immunodeficiency
364681|NCT01581593|PID|pid
364682|NCT01581593|Agammaglobulinemia|agammaglobulinemia
364683|NCT01581593|Hypogammaglobulinemia|hypogammaglobulinemia
364684|NCT01581593|Antibody deficiency|antibody deficiency
364685|NCT01581580|Parkinson's Disease|parkinson's disease
364686|NCT01581580|Deep Brain Stimulation|deep brain stimulation
364687|NCT01581580|Neurophysiology|neurophysiology
364688|NCT01581580|Movement Disorder|movement disorder
364689|NCT01581580|Essential Tremor|essential tremor
364690|NCT01581580|Parkinson Disease|parkinson disease
364691|NCT01581567|Storage|storage
364692|NCT01581567|Repository|repository
364693|NCT01581567|Samples|samples
364694|NCT01581567|Data|data
364695|NCT01581554|Hepatitis B|hepatitis b
364696|NCT01581554|Treatment|treatment
364697|NCT01581554|Nucleoside/Nucleotide Analogue|nucleoside/nucleotide analogue
364698|NCT01581541|Targeted Therapy|targeted therapy
364699|NCT01581541|Solid Tumors|solid tumors
364700|NCT01581541|Lymphoma|lymphoma
364701|NCT01581541|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
364702|NCT01581541|Solid Tumor|solid tumor
364703|NCT01581528|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
364704|NCT01581528|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
364705|NCT01581528|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
364706|NCT01581528|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
364707|NCT01581502|Anticoagulation|anticoagulation
364708|NCT01581502|Recurrent stroke|recurrent stroke
364709|NCT01581502|Bleeding|bleeding
364710|NCT01581489|Cord clamping|cord clamping
364711|NCT01581489|iron deficiency|iron deficiency
364712|NCT01581489|Neurodevelopment|neurodevelopment
364713|NCT01581476|Adolescence|adolescence
364714|NCT01581463|pharmacokinetics of oral T3|pharmacokinetics of oral t3
364715|NCT01581450|Hyperalgesia and pain|hyperalgesia and pain
364716|NCT01581437|atrial fibrillation|atrial fibrillation
364717|NCT01581437|cardiac ablation|cardiac ablation
364718|NCT01581424|Fabry disease|fabry disease
364719|NCT01581424|kidney function|kidney function
364720|NCT01581424|kidney structure morphometry|kidney structure morphometry
364721|NCT01581424|Fabry kidney disease|fabry kidney disease
364722|NCT01581424|Podocytes|podocytes
364723|NCT01581411|central retinal vein occlusion|central retinal vein occlusion
364724|NCT01581411|macular edema|macular edema
364725|NCT01581411|vision loss|vision loss
364726|NCT01581411|rtelative afferent papillary defect|rtelative afferent papillary defect
364727|NCT01581398|Peginterferon|peginterferon
364728|NCT01581398|Pegasys|pegasys
364729|NCT01581398|Sustained virus response|sustained virus response
364730|NCT01581398|HCV|hcv
364731|NCT01581385|atherosclerosis|atherosclerosis
364732|NCT01581385|carotid artery|carotid artery
364733|NCT01581385|carotid endarterectomy|carotid endarterectomy
364734|NCT01581359|Endometriosis|endometriosis
364735|NCT01581359|GnRH treatment|gnrh treatment
364736|NCT01581359|Infertility|infertility
364737|NCT01581359|IVF|ivf
364738|NCT01581346|NSCLC|nsclc
364739|NCT01581346|exercise intervention|exercise intervention
364740|NCT01581346|quality of life|quality of life
364741|NCT01581333|febrile neutropenia|febrile neutropenia
364742|NCT01581333|antimicrobial treatment|antimicrobial treatment
364743|NCT01581333|procalcitonin|procalcitonin
364744|NCT01581307|liver|liver
364745|NCT01581307|pancreas|pancreas
364746|NCT01581307|chemotherapy|chemotherapy
364747|NCT01581307|radiotherapy|radiotherapy
364748|NCT01581294|Rheumatoid arthritis|rheumatoid arthritis
364749|NCT01581294|Psoriatic arthritis|psoriatic arthritis
364750|NCT01581294|Ankylosing spondylitis|ankylosing spondylitis
364751|NCT01581294|Spondyloarthritis|spondyloarthritis
364752|NCT01581281|Pediatric|pediatric
364753|NCT01581281|Children|children
364754|NCT01581281|Adolescent|adolescent
364755|NCT01581281|Headache|headache
364756|NCT01581281|Migraine|migraine
364757|NCT01581255|acute respiratory distress syndrome|acute respiratory distress syndrome
364758|NCT01581255|high frequency oscillation ventilation|high frequency oscillation ventilation
364759|NCT01581255|ventilator-induced lung injury|ventilator-induced lung injury
364760|NCT01581255|biomarkers|biomarkers
364761|NCT01581242|Clevudine and Adefovir dipivoxil|clevudine and adefovir dipivoxil
364762|NCT01581242|pharmacokinetic drug drug interaction|pharmacokinetic drug drug interaction
364763|NCT01581242|oral administration|oral administration
364764|NCT01581242|male subjects|male subjects
364765|NCT01581229|ALI;noninvasive positive pressure ventilation|ali;noninvasive positive pressure ventilation
364766|NCT01581216|Fatigue|fatigue
364767|NCT01581216|Palliative Care|palliative care
364768|NCT01581216|Exercise|exercise
364769|NCT01581190|Bananas|bananas
364770|NCT01581190|Exercise|exercise
364771|NCT01581190|Metabolomics|metabolomics
364772|NCT01581190|Oxidative stress|oxidative stress
364773|NCT01581190|Inflammation|inflammation
364774|NCT01581190|Immune function|immune function
364775|NCT01581177|asthma|asthma
364776|NCT01581177|mild-to-moderate persistent asthma|mild-to-moderate persistent asthma
364777|NCT01581177|mild asthma|mild asthma
364778|NCT01581177|moderate asthma|moderate asthma
364779|NCT01581177|persistent asthma|persistent asthma
364780|NCT01581164|blood|blood
364781|NCT01581164|hematopoietic|hematopoietic
364782|NCT01581164|stem|stem
364783|NCT01581164|cell|cell
364784|NCT01581164|transplant|transplant
364785|NCT01581164|vaccine|vaccine
364786|NCT01581164|vaccination|vaccination
364787|NCT01581164|recovery|recovery
364788|NCT01581164|immune|immune
364789|NCT01581164|system|system
364790|NCT01581151|retinal vein occlusion|retinal vein occlusion
364791|NCT01581151|ozurdex|ozurdex
364792|NCT01581151|lucentis|lucentis
364793|NCT01581151|BCVA|bcva
364794|NCT01581151|foveal thickness|foveal thickness
364795|NCT01581125|Inpatients|inpatients
364796|NCT01581125|Health Normalcy|health normalcy
364797|NCT01581125|circadian rhythm|circadian rhythm
364798|NCT01581099|Atherosclerosis|atherosclerosis
364799|NCT01581099|Cardiovascular risk factors|cardiovascular risk factors
364800|NCT01581099|Calorie restriction|calorie restriction
364801|NCT01581099|Bariatric Surgery|bariatric surgery
364802|NCT01581086|HIV|hiv
364803|NCT01581086|COPD|copd
364804|NCT01581086|Pulmonary disease|pulmonary disease
364805|NCT01581073|renal anemia|renal anemia
364806|NCT01581073|erythropoiesis stimulating agent|erythropoiesis stimulating agent
364807|NCT01581073|hemoglobin|hemoglobin
364808|NCT01581073|non-diabetes|non-diabetes
364809|NCT01581073|CKD|ckd
364810|NCT01581073|Chronic Kidney Disease patients without diabetes|chronic kidney disease patients without diabetes
364811|NCT01581047|amoxicillin|amoxicillin
364812|NCT01581047|clavulanic acid|clavulanic acid
364813|NCT01581047|cefuroxime|cefuroxime
364814|NCT01581047|Patients in the intensive care unit, with an infection which requires amoxicillin/clavulanic acid or cefuroxime|patients in the intensive care unit, with an infection which requires amoxicillin/clavulanic acid or cefuroxime
364815|NCT01581034|endothelial function|endothelial function
364816|NCT01581034|biomarkers|biomarkers
364817|NCT01581034|autonomic nervous system|autonomic nervous system
364818|NCT01581034|coronary artery disease|coronary artery disease
364819|NCT01581021|randomized|randomized
364820|NCT01581021|controlled|controlled
364821|NCT01581021|hooks|hooks
364822|NCT01581021|screws|screws
364823|NCT01581008|palliative care|palliative care
364824|NCT01581008|heart failure|heart failure
364825|NCT01581008|delivery of health care|delivery of health care
364826|NCT01580995|Chronic hepatitis C infection|chronic hepatitis c infection
364827|NCT01580982|Oncogenes|oncogenes
364828|NCT01580982|Lung and Other Thoracic Cancers|lung and other thoracic cancers
364829|NCT01580969|glioma|glioma
364830|NCT01580956|Acute respiratory failure|acute respiratory failure
364831|NCT01580956|Critical illness|critical illness
364832|NCT01580956|Mechanical ventilation|mechanical ventilation
364833|NCT01580956|Ventilation weaning|ventilation weaning
364834|NCT01580956|Intensive Care Unit|intensive care unit
364835|NCT01580956|Variable (NOISY) PSV|variable (noisy) psv
364836|NCT01580956|PSV|psv
364837|NCT01580943|Chlorhexidine|chlorhexidine
364838|NCT01580943|Cetyl pyridinium chloride|cetyl pyridinium chloride
364839|NCT01580943|Mouth rinse|mouth rinse
364840|NCT01580943|Antiplaque Efficacy|antiplaque efficacy
364841|NCT01580943|Self Efficacy|self efficacy
364842|NCT01580943|Taste Sweet|taste sweet
364843|NCT01580943|Side Effects|side effects
364844|NCT01580930|physical inactivity|physical inactivity
364845|NCT01580930|exercise training|exercise training
364846|NCT01580930|sedentary time|sedentary time
364847|NCT01580930|habitual physical activity|habitual physical activity
364848|NCT01580917|laser doppler anemometry|laser doppler anemometry
364849|NCT01580917|dynamic testing of tissue mechanical property|dynamic testing of tissue mechanical property
364850|NCT01580917|diabetic foot complications|diabetic foot complications
364851|NCT01580917|ulcer genesis|ulcer genesis
364852|NCT01580904|Pharmaceutical Care|pharmaceutical care
364853|NCT01580904|Diabetics patients|diabetics patients
364854|NCT01580904|Clinical trial|clinical trial
364855|NCT01580891|Naftifine HCl Cream 1%|naftifine hcl cream 1%
364856|NCT01580891|Naftin® (Naftifine HCl) Cream 1%|naftin® (naftifine hcl) cream 1%
364857|NCT01580891|Tinea Pedis|tinea pedis
364858|NCT01580891|Efficacy and safety|efficacy and safety
364859|NCT01580878|Butenafine Hydrochloride Cream, 1%|butenafine hydrochloride cream, 1%
364860|NCT01580878|Lotrimin Ultra® Cream, 1%|lotrimin ultra® cream, 1%
364861|NCT01580878|Interdigital Tinea Pedis|interdigital tinea pedis
364862|NCT01580878|Safety and Bioequivalence|safety and bioequivalence
364863|NCT01580865|Lupus nephritis|lupus nephritis
364864|NCT01580865|Tacrolimus|tacrolimus
364865|NCT01580865|Mycophenolate mofetil|mycophenolate mofetil
364866|NCT01580865|Complete remission|complete remission
364867|NCT01580839|ischemic stroke|ischemic stroke
364868|NCT01580839|ischemic penumbra|ischemic penumbra
364869|NCT01580839|magnetic resonance imaging|magnetic resonance imaging
364870|NCT01580839|MRI|mri
364871|NCT01580839|diffusion imaging|diffusion imaging
364872|NCT01580839|DWI|dwi
364873|NCT01580839|perfusion imaging|perfusion imaging
364874|NCT01580839|PWI|pwi
364875|NCT01580839|thrombolysis|thrombolysis
364876|NCT01580839|alteplase|alteplase
364877|NCT01580839|tPA|tpa
364878|NCT01580839|EPITHET|epithet
364879|NCT01580826|pasteurization|pasteurization
364880|NCT01580826|human milk|human milk
364881|NCT01580826|very low birth weight infants|very low birth weight infants
364882|NCT01580813|diabetes|diabetes
364883|NCT01580813|exercise|exercise
364884|NCT01580813|cardiovascular|cardiovascular
364885|NCT01580813|heart|heart
364886|NCT01580813|insulin sensitivity|insulin sensitivity
364887|NCT01580787|Parkinson´s disease|parkinson´s disease
364888|NCT01580787|Postural Balance|postural balance
364889|NCT01580787|virtual reality|virtual reality
364890|NCT01580735|NSCLC|nsclc
364891|NCT01580735|c-MET|c-met
364892|NCT01580735|EGFR mutation-positive|egfr mutation-positive
364893|NCT01580735|gefitinib|gefitinib
364894|NCT01580735|erlotinib|erlotinib
364895|NCT01580735|EGFR-TKI resistance|egfr-tki resistance
364896|NCT01580722|Anterior Cruciate Ligament,Early,Delay,Reconstruction|anterior cruciate ligament,early,delay,reconstruction
364897|NCT01580709|stricture|stricture
364898|NCT01580709|cholangiocarcinoma|cholangiocarcinoma
364899|NCT01580709|pancreatic adenocarcinoma|pancreatic adenocarcinoma
364900|NCT01580709|bile duct|bile duct
364901|NCT01580709|ERCP|ercp
364902|NCT01580696|Folate binding protein|folate binding protein
364903|NCT01580696|E39 vaccine|e39 vaccine
364904|NCT01580696|Stage I-IV ovarian cancer|stage i-iv ovarian cancer
364905|NCT01580696|Stage I-IV endometrial cancer|stage i-iv endometrial cancer
364906|NCT01580683|Atrial Fibrillation|atrial fibrillation
364907|NCT01580683|Ascorbic Acid|ascorbic acid
364908|NCT01580683|Thoracic Surgery|thoracic surgery
364909|NCT01580683|Cardiac Arrhythmias|cardiac arrhythmias
364910|NCT01580683|Cardiac Surgery|cardiac surgery
364911|NCT01580683|Vitamin C|vitamin c
364912|NCT01580683|Postoperative Complications|postoperative complications
364913|NCT01580683|Antioxidants|antioxidants
364914|NCT01580683|Inflammation|inflammation
364915|NCT01580670|Infliximab|infliximab
364916|NCT01580670|REMICADE|remicade
364917|NCT01580670|TA-650|ta-650
364918|NCT01580670|pediatric Crohn's disease|pediatric crohn's disease
364919|NCT01580657|HIV|hiv
364920|NCT01580657|Prevention|prevention
364921|NCT01580657|Methods|methods
364922|NCT01580657|Assessment reactivity|assessment reactivity
364923|NCT01580657|South Africa|south africa
364924|NCT01580657|Youth|youth
364925|NCT01580631|Narrow band imaging|narrow band imaging
364926|NCT01580631|Barrett's esophagus|barrett's esophagus
364927|NCT01580631|Gastroesophageal reflux disease|gastroesophageal reflux disease
364928|NCT01580618|pleural effusion|pleural effusion
364929|NCT01580618|malignancy|malignancy
364930|NCT01580618|loculated|loculated
364931|NCT01580579|Radiation pneumonitis|radiation pneumonitis
364932|NCT01580579|locally advanced lung cancer|locally advanced lung cancer
364933|NCT01580579|Respiratory function tests|respiratory function tests
364934|NCT01580566|Myocardial Infarction (MI)|myocardial infarction (mi)
364935|NCT01580566|Kidney function|kidney function
364936|NCT01580566|bio-markers|bio-markers
364937|NCT01580553|Heart failure|heart failure
364938|NCT01580553|L-carnitine|l-carnitine
364939|NCT01580553|injection|injection
364940|NCT01580553|safety|safety
364941|NCT01580553|efficacy|efficacy
364942|NCT01580527|postoperative artificial nutrition|postoperative artificial nutrition
364943|NCT01580527|parenteral nutrition|parenteral nutrition
364944|NCT01580527|enteral nutrition|enteral nutrition
364945|NCT01580527|postoperative complications|postoperative complications
364946|NCT01580527|cephalic pancreatoduodenectomy|cephalic pancreatoduodenectomy
364947|NCT01580514|myocardial infarction|myocardial infarction
364948|NCT01580514|percutaneous coronary intervention|percutaneous coronary intervention
364949|NCT01580514|exenatide|exenatide
364950|NCT01580514|reperfusion injury|reperfusion injury
364951|NCT01580514|cardiac magnetic resonance|cardiac magnetic resonance
364952|NCT01580475|glycemic control,|glycemic control,
364953|NCT01580475|exercise training,|exercise training,
364954|NCT01580475|detraining,|detraining,
364955|NCT01580475|retraining,|retraining,
364956|NCT01580475|body composition,|body composition,
364957|NCT01580475|strength and fitness|strength and fitness
364958|NCT01580462|continuous subcutaneous insulin infusion (CSII)|continuous subcutaneous insulin infusion (csii)
364959|NCT01580462|children|children
364960|NCT01580462|adolescent|adolescent
364961|NCT01580436|Tricuspid Valve Insufficiency|tricuspid valve insufficiency
366053|NCT01575990|UNC|unc
364962|NCT01580436|Cardiac Valve Annuloplasty|cardiac valve annuloplasty
364963|NCT01580436|Outcome Assessment (Health Care)|outcome assessment (health care)
364964|NCT01580423|dyspnea|dyspnea
364965|NCT01580397|Pancreatic cancer|pancreatic cancer
364966|NCT01580397|INNO-206|inno-206
364967|NCT01580397|Doxorubicin-EMCH|doxorubicin-emch
364968|NCT01580358|cancer|cancer
364969|NCT01580358|radiotherapy|radiotherapy
364970|NCT01580358|chemotherapy|chemotherapy
364971|NCT01580358|Traditional Chinese Medicine|traditional chinese medicine
364972|NCT01580358|Safety|safety
364973|NCT01580345|DHA|dha
364974|NCT01580345|Omega 3 fatty acid|omega 3 fatty acid
364975|NCT01580345|Decosa hexaenoic acid|decosa hexaenoic acid
364976|NCT01580345|Pregnancy|pregnancy
364977|NCT01580345|Newborn outcome|newborn outcome
364978|NCT01580345|Supplementation|supplementation
364979|NCT01580345|Birth size|birth size
364980|NCT01580345|gestational age|gestational age
364981|NCT01580345|India|india
364982|NCT01580345|Randomized controlled trial|randomized controlled trial
364983|NCT01580345|RCT|rct
364984|NCT01580332|biomarkers|biomarkers
364985|NCT01580332|lung cancer|lung cancer
364986|NCT01580332|solitary pulmonary nodules|solitary pulmonary nodules
364987|NCT01580332|SPN|spn
364988|NCT01580332|breath analysis|breath analysis
364989|NCT01580332|VOC|voc
364990|NCT01580332|volatile organic compounds|volatile organic compounds
364991|NCT01580332|sputum|sputum
364992|NCT01580332|auto-antibodies|auto-antibodies
364993|NCT01580319|obesity|obesity
364994|NCT01580319|cholesterol|cholesterol
364995|NCT01580319|cholesterol, LDL|cholesterol, ldl
364996|NCT01580319|cholesterol, HDL|cholesterol, hdl
364997|NCT01580319|blood glucose|blood glucose
364998|NCT01580319|Triglyceride|triglyceride
364999|NCT01580319|C-Reactive Protein - hs|c-reactive protein - hs
365000|NCT01580319|blood pressure|blood pressure
365001|NCT01580319|physical activity|physical activity
365002|NCT01580319|Sedentary Lifestyle|sedentary lifestyle
365003|NCT01580293|Hemophilia A, factor VIII, prophylaxis|hemophilia a, factor viii, prophylaxis
365004|NCT01580280|Cervicogenic|cervicogenic
365005|NCT01580280|Headache|headache
365006|NCT01580280|Neck Pain|neck pain
365007|NCT01580280|Manipulation|manipulation
365008|NCT01580280|Mobilization|mobilization
365009|NCT01580280|Exercise|exercise
365010|NCT01580267|Anemia in trauma|anemia in trauma
365011|NCT01580254|Latanoprost|latanoprost
365012|NCT01580254|IOP|iop
365013|NCT01580215|Valves|valves
365014|NCT01580215|Endobronchial|endobronchial
365015|NCT01580215|Endoscopic lung volume reduction|endoscopic lung volume reduction
365016|NCT01580215|Pulmonx|pulmonx
365017|NCT01580215|Zephyr|zephyr
365018|NCT01580215|Chartis|chartis
365019|NCT01580215|Emphysema|emphysema
365020|NCT01580215|COPD|copd
365021|NCT01580202|malignancy|malignancy
365022|NCT01580202|hepatitis B|hepatitis b
365023|NCT01580202|lamivudine|lamivudine
365024|NCT01580202|entecavir|entecavir
365025|NCT01580202|prophylaxis|prophylaxis
365026|NCT01580189|Lean tissue|lean tissue
365027|NCT01580189|Strength condition|strength condition
365028|NCT01580189|Protein|protein
365029|NCT01580189|Amino Acid|amino acid
365030|NCT01580163|the opioid dependence in rehabilitation phase|the opioid dependence in rehabilitation phase
365031|NCT01580163|community|community
365032|NCT01580150|Berries|berries
365033|NCT01580150|Starch|starch
365034|NCT01580150|Sucrose|sucrose
365035|NCT01580150|Glucose|glucose
365036|NCT01580150|Insulin|insulin
365037|NCT01580150|Postprandial|postprandial
365038|NCT01580137|acute respiratory tract infection|acute respiratory tract infection
365039|NCT01580137|common cold|common cold
365040|NCT01580137|acute bacterial rhinosinusitis|acute bacterial rhinosinusitis
365041|NCT01580137|adult|adult
365042|NCT01580137|conscript|conscript
365043|NCT01580111|Blood|blood
365044|NCT01580111|Storage|storage
365045|NCT01580111|Age|age
365046|NCT01580111|Transfusion|transfusion
365047|NCT01580111|Lactic acidosis|lactic acidosis
365048|NCT01580085|Sleep disordered breathing|sleep disordered breathing
365049|NCT01580085|gender|gender
365050|NCT01580085|hypercoagulability|hypercoagulability
365051|NCT01580046|Chronic Kidney Disease|chronic kidney disease
365052|NCT01580046|Coronary Angiography|coronary angiography
365053|NCT01580046|Contrast Media|contrast media
365054|NCT01580046|Percutaneous Coronary Intervention|percutaneous coronary intervention
365055|NCT01580046|Serum Creatinine|serum creatinine
365056|NCT01580046|Glomerular Filtration Rate|glomerular filtration rate
365057|NCT01580046|Iodixanol|iodixanol
365058|NCT01580046|Iopromide|iopromide
365059|NCT01580033|immunogenicity|immunogenicity
365060|NCT01580033|safety|safety
365061|NCT01580033|group A, C polysaccharide meningitis|group a, c polysaccharide meningitis
365062|NCT01580033|type b haemophilus Influenza|type b haemophilus influenza
365063|NCT01580020|Macular Degeneration|macular degeneration
365064|NCT01580020|Macular Edema|macular edema
365065|NCT01580020|Retinal Vein Occlusion|retinal vein occlusion
365066|NCT01580020|Choroidal Neovascularization|choroidal neovascularization
365067|NCT01580020|Signs and Symptoms|signs and symptoms
365068|NCT01580020|Retinal Degeneration|retinal degeneration
365069|NCT01580020|Retinal Diseases|retinal diseases
365070|NCT01580020|Eye Diseases|eye diseases
365071|NCT01580020|Venous Thrombosis Sensation Disorders|venous thrombosis sensation disorders
365072|NCT01580020|Dexamethasone acetate|dexamethasone acetate
365073|NCT01580020|Dexamethasone|dexamethasone
365074|NCT01580020|Dexamethasone 21-phosphate|dexamethasone 21-phosphate
365075|NCT01580020|BB 1101|bb 1101
365076|NCT01580020|Anti-Inflammatory Agents|anti-inflammatory agents
365077|NCT01580020|Therapeutic Uses|therapeutic uses
365078|NCT01580020|Vision, Low|vision, low
365079|NCT01580020|Signs|signs
365080|NCT01580020|Vision Disorders|vision disorders
365081|NCT01580007|tuberculosis|tuberculosis
365082|NCT01580007|phenylbutyrate|phenylbutyrate
365083|NCT01580007|vitamin D|vitamin d
365084|NCT01580007|cathelicidin|cathelicidin
365085|NCT01580007|antimicrobial peptide|antimicrobial peptide
365086|NCT01580007|in adults|in adults
365087|NCT01579994|adenocarcinoma|adenocarcinoma
365088|NCT01579994|Lung|lung
365089|NCT01579994|Metastatic|metastatic
365090|NCT01579994|Crizotinib|crizotinib
365091|NCT01579994|Ganetespib|ganetespib
365092|NCT01579994|STA-9090|sta-9090
365093|NCT01579994|ALK Positive Lung Cancers|alk positive lung cancers
365094|NCT01579994|12-015|12-015
365095|NCT01579981|RYGB|rygb
365096|NCT01579981|Bariatric Surgery|bariatric surgery
365097|NCT01579981|Glucagon-like-peptide 1|glucagon-like-peptide 1
365098|NCT01579942|EEG|eeg
365099|NCT01579942|Biomarker|biomarker
365100|NCT01579942|Major Depressive Disorder|major depressive disorder
365101|NCT01579942|Healthy Control|healthy control
365102|NCT01579929|Extensive Stage Small Cell Lung Cancer (ES-SCLC)|extensive stage small cell lung cancer (es-sclc)
365103|NCT01579929|CISPLATIN|cisplatin
365104|NCT01579929|ETOPOSIDE (VP-16)|etoposide (vp-16)
365105|NCT01579929|LDE-225|lde-225
365106|NCT01579929|STAR|star
365107|NCT01579929|Symptom Tracking and Reporting for Patients|symptom tracking and reporting for patients
365108|NCT01579929|11-206|11-206
365109|NCT01579916|Trivalent, Influenza, FluMist, Vaccine, Prevention|trivalent, influenza, flumist, vaccine, prevention
365110|NCT01579903|Hemophilia A|hemophilia a
365111|NCT01579903|moroctocog alfa (AF-CC)|moroctocog alfa (af-cc)
365112|NCT01579903|ReFacto AF|refacto af
365113|NCT01579903|dual-chamber syringe|dual-chamber syringe
365114|NCT01579903|bioavailability|bioavailability
365115|NCT01579877|Xerostomia|xerostomia
365116|NCT01579877|Yukmijihwang-tang|yukmijihwang-tang
365117|NCT01579877|Yin-Deficiency|yin-deficiency
365118|NCT01579877|Visual analogue scale|visual analogue scale
365119|NCT01579877|Dry mouth symptom questionnaire|dry mouth symptom questionnaire
365120|NCT01579812|Ovarian, Fallopian Tube, and Primary Peritoneal Cancer|ovarian, fallopian tube, and primary peritoneal cancer
365121|NCT01579786|post operative pain|post operative pain
365122|NCT01579786|acupuncture|acupuncture
365123|NCT01579760|radiation|radiation
365124|NCT01579760|retinopathy|retinopathy
365125|NCT01579760|macular edema|macular edema
365126|NCT01579760|anti-VEGF|anti-vegf
365127|NCT01579760|VEGF-Trap|vegf-trap
365128|NCT01579760|aflibercept|aflibercept
365129|NCT01579747|nerve stimulation|nerve stimulation
365130|NCT01579747|ultrasound|ultrasound
365131|NCT01579747|sciatic nerve block|sciatic nerve block
365132|NCT01579747|popliteal block|popliteal block
365133|NCT01579747|obese|obese
365134|NCT01579734|breast cancer chemoprevention postmenopause|breast cancer chemoprevention postmenopause
365135|NCT01579708|Diet|diet
365136|NCT01579708|Physical activity|physical activity
365137|NCT01579708|Knowledge|knowledge
365138|NCT01579708|Attitudes|attitudes
365139|NCT01579708|Habits|habits
365140|NCT01579708|Lifestyle|lifestyle
365141|NCT01579708|School-based|school-based
365142|NCT01579695|HIV with lipohypertrophy|hiv with lipohypertrophy
365143|NCT01579682|Eating Disorder|eating disorder
365144|NCT01579682|Anorexia Nervosa|anorexia nervosa
365145|NCT01579682|Eating Disorder Not Otherwise Specified|eating disorder not otherwise specified
365146|NCT01579682|Maudsley|maudsley
365147|NCT01579682|Family-Based Therapy|family-based therapy
365148|NCT01579682|FBT|fbt
365149|NCT01579682|Family Therapy|family therapy
365150|NCT01579669|Autism Spectrum Disorder|autism spectrum disorder
365151|NCT01579669|Primary Care Services|primary care services
365152|NCT01579669|Patient-Provider Communication|patient-provider communication
365153|NCT01579669|Adults|adults
365154|NCT01579643|cornea|cornea
365155|NCT01579643|opacity|opacity
365156|NCT01579643|congenital|congenital
365157|NCT01579630|NSCLC|nsclc
365158|NCT01579630|Nonsquamous|nonsquamous
365159|NCT01579630|Maintenance therapy|maintenance therapy
365160|NCT01579617|pregnancy|pregnancy
365161|NCT01579617|STI|sti
365162|NCT01579617|STD|std
365163|NCT01579604|Loss of upper extremities functions|loss of upper extremities functions
365164|NCT01579604|Nerve transfer|nerve transfer
365165|NCT01579578|Metastatic Gastric Cancer who progress following First Line Therapy and are Ineligible for Treatment with trastuzumab by HER2 Status|metastatic gastric cancer who progress following first line therapy and are ineligible for treatment with trastuzumab by her2 status
365166|NCT01579565|cataract|cataract
365167|NCT01579565|lens replacement|lens replacement
365168|NCT01579552|Questionnaires|questionnaires
365169|NCT01579552|telephone counseling session|telephone counseling session
365170|NCT01579552|10-104|10-104
365171|NCT01579552|Childhood Cancer Survivor Women Post Chest Radiation|childhood cancer survivor women post chest radiation
365172|NCT01579539|Methylprednisolone|methylprednisolone
365173|NCT01579539|Dry Eye Syndrome|dry eye syndrome
365174|NCT01579539|Tear Film|tear film
365175|NCT01579539|Thyroid-associated ophthalmopathy|thyroid-associated ophthalmopathy
365176|NCT01579526|Safety and Pharmacokinetics of FP01 in Healthy Volunteers|safety and pharmacokinetics of fp01 in healthy volunteers
365177|NCT01579513|Cardiopulmonary Bypass (CPB)|cardiopulmonary bypass (cpb)
365178|NCT01579513|System Inflammatory Response|system inflammatory response
365179|NCT01579513|inflammation|inflammation
365180|NCT01579513|Methylprednisolone|methylprednisolone
365181|NCT01579513|Neonates|neonates
365182|NCT01579513|Steroid|steroid
365183|NCT01579513|Cardiac Surgical Procedures|cardiac surgical procedures
365184|NCT01579513|Children|children
365185|NCT01579513|Infants|infants
365186|NCT01579513|Pediatrics|pediatrics
365187|NCT01579513|Glucocorticoid|glucocorticoid
365188|NCT01579513|Heart Disease|heart disease
365189|NCT01579513|Heart Defects, Congenital|heart defects, congenital
365190|NCT01579513|Cardiovascular Diseases|cardiovascular diseases
365191|NCT01579513|Cardiovascular Abnormalities|cardiovascular abnormalities
365192|NCT01579513|Corticosteroid|corticosteroid
365193|NCT01579513|methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate
365194|NCT01579513|Hormones|hormones
365195|NCT01579513|Physiological Effects of Drugs|physiological effects of drugs
365196|NCT01579513|Randomized Clinical Trial|randomized clinical trial
365197|NCT01579487|Lipolysis|lipolysis
365198|NCT01579487|Cryolipolysis|cryolipolysis
365199|NCT01579487|Fat Reduction|fat reduction
365200|NCT01579461|Pharmacokinetics|pharmacokinetics
365201|NCT01579461|mirabegron|mirabegron
365202|NCT01579461|hepatic impairment|hepatic impairment
365203|NCT01579461|Phase 1|phase 1
365204|NCT01579448|killed oral cholera vaccine|killed oral cholera vaccine
365205|NCT01579448|boosting vaccine regimen|boosting vaccine regimen
365206|NCT01579448|safety and immunogenicity|safety and immunogenicity
365207|NCT01579435|essential tremor|essential tremor
365208|NCT01579435|primary motor cortex|primary motor cortex
365209|NCT01579435|cerebellum|cerebellum
365210|NCT01579435|transcranial direct current stimulation|transcranial direct current stimulation
365211|NCT01579435|electrophysiology|electrophysiology
365212|NCT01579422|schizophrenia|schizophrenia
365213|NCT01579422|treatment|treatment
365214|NCT01579422|social cognition|social cognition
365215|NCT01579409|Nutrition|nutrition
365216|NCT01579409|Arterial stiffness|arterial stiffness
365217|NCT01579409|Endothelial dysfunction|endothelial dysfunction
365218|NCT01579409|Microcirculation|microcirculation
365219|NCT01579409|Cardiac autonomic system.|cardiac autonomic system.
365220|NCT01579396|septeX|septex
365221|NCT01579396|high cut-off|high cut-off
365222|NCT01579396|Thoracic Surgery|thoracic surgery
365223|NCT01579396|Renal Replacement Therapy|renal replacement therapy
365224|NCT01579383|Migraine Disorders|migraine disorders
365225|NCT01579383|Phase 1|phase 1
365226|NCT01579383|ALD403|ald403
365227|NCT01579370|healthcare associated infections|healthcare associated infections
365228|NCT01579370|multidrug resistant organisms|multidrug resistant organisms
365229|NCT01579370|methicillin resistant staphylococcus aureus|methicillin resistant staphylococcus aureus
365230|NCT01579370|vancomycin resistant enterococcus|vancomycin resistant enterococcus
365231|NCT01579370|clostridium difficile|clostridium difficile
365232|NCT01579370|acinetobacter|acinetobacter
365233|NCT01579357|colorectal carcinoma|colorectal carcinoma
365234|NCT01579357|K-ras wild type|k-ras wild type
365235|NCT01579357|Capecitabine|capecitabine
365236|NCT01579357|Cetuximab|cetuximab
365237|NCT01579357|Oxaliplatin|oxaliplatin
365238|NCT01579357|Pharmacokinetics|pharmacokinetics
365239|NCT01579357|exclude a possible influence of CETUX|exclude a possible influence of cetux
365240|NCT01579357|plasma disposition|plasma disposition
365241|NCT01579357|metabolic activation|metabolic activation
365242|NCT01579357|CCB|ccb
365243|NCT01579357|OxPt|oxpt
365244|NCT01579344|Iodine Radioisotopes|iodine radioisotopes
365245|NCT01579344|Nasolacrimal Duct|nasolacrimal duct
365246|NCT01579344|radiation effects|radiation effects
365247|NCT01579331|IOP|iop
365248|NCT01579331|Tonometry|tonometry
365249|NCT01579331|Pascal|pascal
365250|NCT01579331|Goldmann|goldmann
365251|NCT01579331|DCT|dct
365252|NCT01579331|Dynamic Contour|dynamic contour
365253|NCT01579279|Diabetic neuropathic pain|diabetic neuropathic pain
365254|NCT01579279|Active controlled phase 2 study|active controlled phase 2 study
365255|NCT01579266|Writer's Cramp|writer's cramp
365256|NCT01579266|Focal Hand Dystonia|focal hand dystonia
365257|NCT01579266|Writer Cramp|writer cramp
365258|NCT01579266|Dystonia|dystonia
365259|NCT01579253|Recurrent glioblastoma|recurrent glioblastoma
365260|NCT01579253|Radiotherapy|radiotherapy
365261|NCT01579253|PET-MRI|pet-mri
365262|NCT01579253|FET-PET|fet-pet
365263|NCT01579240|physical activity|physical activity
365264|NCT01579240|older adults|older adults
365265|NCT01579240|Internet|internet
365266|NCT01579240|sedentary|sedentary
365267|NCT01579240|multi-week|multi-week
365268|NCT01579240|internet intervention|internet intervention
365269|NCT01579227|Healthy participants|healthy participants
365270|NCT01579214|HIV|hiv
365271|NCT01579214|Africa south of the sahara|africa south of the sahara
365272|NCT01579214|Knowledge of results|knowledge of results
365273|NCT01579214|Communication barriers|communication barriers
365274|NCT01579214|Cellular Phones|cellular phones
365275|NCT01579201|Postpartum Hemorrhage|postpartum hemorrhage
365276|NCT01579201|Uterine Atony|uterine atony
365277|NCT01579201|Obstetric Anesthesia|obstetric anesthesia
365278|NCT01579201|Cesarean Section|cesarean section
365279|NCT01579201|Carbetocin|carbetocin
365280|NCT01579188|NSCLC|nsclc
365281|NCT01579162|Hepatitis|hepatitis
365282|NCT01579162|Fatty Liver|fatty liver
365283|NCT01579123|Laser atherectomy|laser atherectomy
365284|NCT01579123|Critical Limb Ischemia|critical limb ischemia
365285|NCT01579123|Angioplasty|angioplasty
365286|NCT01579110|autoimmune hemolytic anemia|autoimmune hemolytic anemia
365287|NCT01579110|hemolytic anemia|hemolytic anemia
365288|NCT01579110|Levamisole|levamisole
365289|NCT01579110|Treatment of autoimmune hemolytic anemia|treatment of autoimmune hemolytic anemia
365290|NCT01579110|warm antibody dependant autoimmune hemolytic anemia|warm antibody dependant autoimmune hemolytic anemia
365291|NCT01579097|(PN) Parenteral nutrition|(pn) parenteral nutrition
365292|NCT01579097|oral/enteral not possible|oral/enteral not possible
365293|NCT01579058|aortic stenosis|aortic stenosis
365294|NCT01579058|beta-blocker|beta-blocker
365295|NCT01579032|CKD,|ckd,
365296|NCT01578980|Artificial Pancreas|artificial pancreas
365297|NCT01578980|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
365298|NCT01578980|Control-to-Range|control-to-range
365299|NCT01578980|Closed-Loop Control|closed-loop control
365300|NCT01578980|Continuous Glucose Monitor|continuous glucose monitor
365301|NCT01578967|Hodgkin's lymphoma|hodgkin's lymphoma
365302|NCT01578967|Hodgkin lymphoma|hodgkin lymphoma
365303|NCT01578954|Leukemia|leukemia
365304|NCT01578954|Acute Myeloid Leukemia|acute myeloid leukemia
365305|NCT01578941|menstrual migraine|menstrual migraine
365306|NCT01578941|migraine|migraine
365307|NCT01578941|treximet|treximet
365308|NCT01578928|renal, impairment, endstage renal disease|renal, impairment, endstage renal disease
365309|NCT01578928|renal|renal
365310|NCT01578928|impairment|impairment
365311|NCT01578928|endstage renal disease|endstage renal disease
365312|NCT01578902|Prostatic Neoplasms|prostatic neoplasms
365313|NCT01578902|Radiotherapy|radiotherapy
365314|NCT01578902|Hypofractionation|hypofractionation
365315|NCT01578902|Low Risk Prostate Cancer|low risk prostate cancer
365316|NCT01578876|coronary artery disease|coronary artery disease
365317|NCT01578876|angina pectoris|angina pectoris
365318|NCT01578876|myocardial ischemia|myocardial ischemia
365319|NCT01578876|cardiac shock wave therapy|cardiac shock wave therapy
365320|NCT01578863|Childhood obesity|childhood obesity
365321|NCT01578863|Adolescence|adolescence
365322|NCT01578863|Predictors|predictors
365323|NCT01578863|Success|success
365324|NCT01578863|Intervention program|intervention program
365325|NCT01578850|rheumatoid arthritis|rheumatoid arthritis
365326|NCT01578850|etanercept|etanercept
365327|NCT01578850|methotrexate|methotrexate
365328|NCT01578850|DMARDs|dmards
365329|NCT01578824|Rickets|rickets
365330|NCT01578824|Vitamin D|vitamin d
365331|NCT01578824|airway hyperreactivity|airway hyperreactivity
365332|NCT01578824|Exhaled breath condensate|exhaled breath condensate
365333|NCT01578772|HIV|hiv
365334|NCT01578772|Flow-mediated dialation (FMD)|flow-mediated dialation (fmd)
365335|NCT01578772|Telmisartan|telmisartan
365336|NCT01578772|Cardiovascular disease (CVD)|cardiovascular disease (cvd)
365337|NCT01578772|HIV+ men and women age > 50 at risk for heart disease|hiv+ men and women age > 50 at risk for heart disease
365338|NCT01578759|ovarian function tests|ovarian function tests
365339|NCT01578746|Coxarthrosis|coxarthrosis
365340|NCT01578746|Hip arthroplasty|hip arthroplasty
365341|NCT01578746|Anterior approach|anterior approach
365342|NCT01578746|Direct lateral approach|direct lateral approach
365343|NCT01578746|Hardinge approach|hardinge approach
365344|NCT01578746|Smith-Petersen approach|smith-petersen approach
365345|NCT01578746|Osteoarthrosis|osteoarthrosis
365346|NCT01578733|protein requirement|protein requirement
365347|NCT01578733|female elderly|female elderly
365348|NCT01578733|healthy female subject's protein requirements|healthy female subject's protein requirements
365349|NCT01578707|Chronic|chronic
365350|NCT01578707|SLL|sll
365351|NCT01578707|CLL|cll
365352|NCT01578707|Ofatumumab|ofatumumab
365353|NCT01578707|ibrutinib|ibrutinib
365354|NCT01578707|RESONATE|resonate
365355|NCT01578707|Phase III|phase iii
365356|NCT01578707|Leukemia|leukemia
365357|NCT01578707|Lymphoma|lymphoma
365358|NCT01578681|bronchiectasis|bronchiectasis
365359|NCT01578681|respiratory therapy|respiratory therapy
365360|NCT01578681|airway clearance|airway clearance
365361|NCT01578668|lung adenocarcinoma|lung adenocarcinoma
365362|NCT01578668|brain metastases|brain metastases
365363|NCT01578668|erlotinib|erlotinib
365364|NCT01578668|pemetrexed|pemetrexed
365365|NCT01578655|custirsen sodium|custirsen sodium
365366|NCT01578655|prostate cancer|prostate cancer
365367|NCT01578655|metastatic castrate resistant prostate cancer|metastatic castrate resistant prostate cancer
365368|NCT01578655|overall survival|overall survival
365369|NCT01578642|GERD|gerd
365370|NCT01578642|LES Pressure|les pressure
365371|NCT01578642|Electrical Stimulation|electrical stimulation
365372|NCT01578629|stroke|stroke
365373|NCT01578629|ischemia|ischemia
365374|NCT01578629|TIA|tia
365375|NCT01578616|Coronary artery disease|coronary artery disease
365376|NCT01578616|Endothelial function|endothelial function
365377|NCT01578616|Optical coherence tomography|optical coherence tomography
365378|NCT01578616|Thin cap fibroatheroma|thin cap fibroatheroma
365379|NCT01578603|prevention & control|prevention & control
365380|NCT01578603|Xylitol|xylitol
365381|NCT01578603|casein phosphopeptide amorphous calcium phosphate complex|casein phosphopeptide amorphous calcium phosphate complex
365382|NCT01578603|Streptococcus mutans|streptococcus mutans
365383|NCT01578603|saliva|saliva
365384|NCT01578603|dental plaque|dental plaque
365385|NCT01578603|gingivitis|gingivitis
365386|NCT01578577|Medication Therapy Management|medication therapy management
365387|NCT01578577|Hypertension|hypertension
365388|NCT01578577|Health Literacy|health literacy
365389|NCT01578577|Medication Reconciliation|medication reconciliation
365390|NCT01578577|Medication Adherence|medication adherence
365391|NCT01578564|Cancer|cancer
365392|NCT01578564|Ovarian Cancer|ovarian cancer
365393|NCT01578564|TRPV6 Calcium channel|trpv6 calcium channel
365394|NCT01578551|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
365395|NCT01578551|Lung adenocarcinoma|lung adenocarcinoma
365396|NCT01578538|hernia, abdominal, strangulation, emergency, wall|hernia, abdominal, strangulation, emergency, wall
365397|NCT01578525|medication safety|medication safety
365398|NCT01578525|elderly|elderly
365399|NCT01578525|pharmaceutical care|pharmaceutical care
365400|NCT01578525|hospital readmission|hospital readmission
365401|NCT01578525|drug-related readmission|drug-related readmission
365402|NCT01578525|Health Services for the Aged|health services for the aged
365403|NCT01578499|brentuximab vedotin|brentuximab vedotin
365404|NCT01578499|ALCANZA|alcanza
365405|NCT01578486|Schizophrenia|schizophrenia
365406|NCT01578486|Cognition|cognition
365407|NCT01578486|Metabolism|metabolism
365408|NCT01578486|Antipsychotics|antipsychotics
365409|NCT01578486|Psychopathology|psychopathology
365410|NCT01578473|low testosterone|low testosterone
365411|NCT01578473|penile curvature|penile curvature
365412|NCT01578460|Pregnancy|pregnancy
365413|NCT01578460|Gestational Diabetes|gestational diabetes
365414|NCT01578460|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
365415|NCT01578460|Continuous Glucose Monitor|continuous glucose monitor
365416|NCT01578460|Glucose|glucose
365417|NCT01578447|injectable contraception|injectable contraception
365418|NCT01578447|acceptability|acceptability
365419|NCT01578447|intramuscular|intramuscular
365420|NCT01578447|subcutaneous|subcutaneous
365421|NCT01578434|Nutritional Rickets|nutritional rickets
365422|NCT01578434|Calcium|calcium
365423|NCT01578434|Vitamin D|vitamin d
365424|NCT01578408|Femoral neck fractures|femoral neck fractures
365425|NCT01578408|Uncemented|uncemented
365426|NCT01578408|Hydroxyapatite|hydroxyapatite
365427|NCT01578408|Coated|coated
365428|NCT01578408|Femoral|femoral
365429|NCT01578408|Stems|stems
365430|NCT01578408|Hip fractures|hip fractures
365431|NCT01578408|THA|tha
365432|NCT01578408|THR|thr
365433|NCT01578408|Cemented|cemented
365434|NCT01578408|Fat embolism|fat embolism
365435|NCT01578408|Cognition|cognition
365436|NCT01578408|Inflammatory response|inflammatory response
365437|NCT01578408|Mobilization|mobilization
365438|NCT01578382|Martorell hypertensive ischemic leg ulcer|martorell hypertensive ischemic leg ulcer
365439|NCT01578382|Calciphylaxis (calcific uremic arteriolopathy)|calciphylaxis (calcific uremic arteriolopathy)
365440|NCT01578382|Ischemic subcutaneous arteriolosclerosis|ischemic subcutaneous arteriolosclerosis
365441|NCT01578382|Hypertension|hypertension
365442|NCT01578382|Diabetes|diabetes
365443|NCT01578382|Medial calcinosis|medial calcinosis
365444|NCT01578382|Wound healing|wound healing
365445|NCT01578369|Urinary incontinence|urinary incontinence
365446|NCT01578369|Pregnancy|pregnancy
365447|NCT01578369|Pelvic floor muscle training|pelvic floor muscle training
365448|NCT01578356|Prostate cancer|prostate cancer
365449|NCT01578343|fludarabine|fludarabine
365450|NCT01578343|mitoxantrone|mitoxantrone
365451|NCT01578343|dexamethasone|dexamethasone
365452|NCT01578343|relapsed or refractory mantle cell lymphoma|relapsed or refractory mantle cell lymphoma
365453|NCT01578343|FND regimen|fnd regimen
365454|NCT01578343|vorinostat|vorinostat
365455|NCT01578343|autologous stem cell transplantation|autologous stem cell transplantation
365456|NCT01578330|Relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
365457|NCT01578330|Fingolimod|fingolimod
365458|NCT01578330|FTY720|fty720
365459|NCT01578317|H5N1 Vaccine|h5n1 vaccine
365460|NCT01578317|H5N1 Immunization|h5n1 immunization
365461|NCT01578317|AS03 Adjuvant|as03 adjuvant
365462|NCT01578317|Biologic Sample Collection|biologic sample collection
365463|NCT01578317|Laboratory Research Specimens|laboratory research specimens
365464|NCT01578317|Healthy Volunteer|healthy volunteer
365465|NCT01578317|HV|hv
365466|NCT01578304|Overactive bladder|overactive bladder
365467|NCT01578291|Play therapy|play therapy
365468|NCT01578291|Urinary tract infections|urinary tract infections
365469|NCT01578291|Children|children
365470|NCT01578291|Vesicoureteral reflux|vesicoureteral reflux
365471|NCT01578239|Neuroendocrine tumour|neuroendocrine tumour
365472|NCT01578239|177Lu-Dota0-Tyr3-octreotate|177lu-dota0-tyr3-octreotate
365473|NCT01578226|Cirrhosis|cirrhosis
365474|NCT01578226|Ascites|ascites
365475|NCT01578226|Decompensation|decompensation
365476|NCT01578226|Bacterial infection|bacterial infection
365477|NCT01578226|Sepsis|sepsis
365478|NCT01578226|Procalcitonin|procalcitonin
365479|NCT01578226|PCT|pct
365480|NCT01578200|CKD-MBD|ckd-mbd
365481|NCT01578200|phosphate-binder|phosphate-binder
365482|NCT01578200|vascular calcification|vascular calcification
365483|NCT01578200|mortality|mortality
365484|NCT01578200|dialysis|dialysis
365485|NCT01578200|Hemodialysis patients with hyperphosphatemia|hemodialysis patients with hyperphosphatemia
365486|NCT01578187|hair reduction|hair reduction
365487|NCT01578187|hair removal|hair removal
365488|NCT01578187|hair clearance|hair clearance
365489|NCT01578148|Cervical pain|cervical pain
365490|NCT01578148|Cervicalgia,|cervicalgia,
365491|NCT01578148|Cervicodynia|cervicodynia
365492|NCT01578148|Neck ache|neck ache
365493|NCT01578148|Neckache|neckache
365494|NCT01578148|Shoulder pain|shoulder pain
365495|NCT01578148|Shoulder impingement syndrome|shoulder impingement syndrome
365496|NCT01578122|post-thrombotic syndrome|post-thrombotic syndrome
365497|NCT01578122|prevention|prevention
365498|NCT01578122|deep vein thrombosis|deep vein thrombosis
365499|NCT01578122|elastic compression stockings|elastic compression stockings
365500|NCT01578122|compliance|compliance
365501|NCT01578122|quality of life|quality of life
365502|NCT01578096|Type 2 Diabetes|type 2 diabetes
365503|NCT01578083|Chemotherapy|chemotherapy
365504|NCT01578083|Breast Cancer|breast cancer
365505|NCT01578083|Cognitive Impairment|cognitive impairment
365506|NCT01578083|Chemo brain|chemo brain
365507|NCT01578070|Other and Unspecified Vaccines and Biological Substances Causing Adverse Effects in Therapeutic Use|other and unspecified vaccines and biological substances causing adverse effects in therapeutic use
365508|NCT01578057|alcohol|alcohol
365509|NCT01578044|Anti-coagulation|anti-coagulation
365510|NCT01578031|Sleep Apnea|sleep apnea
365511|NCT01578031|Obesity|obesity
365512|NCT01578018|lung cancer|lung cancer
365513|NCT01578018|smoking|smoking
365514|NCT01578005|acute coronary syndrome|acute coronary syndrome
365515|NCT01578005|IVUS|ivus
365516|NCT01578005|atherosclerotic plaque|atherosclerotic plaque
365517|NCT01577992|subjective pain|subjective pain
365518|NCT01577992|Multiple System Atrophy|multiple system atrophy
365519|NCT01577979|Vaccination|vaccination
365520|NCT01577979|Medical Home|medical home
365521|NCT01577979|Adolescents|adolescents
365522|NCT01577966|Patients with brain tumors associated with seizures|patients with brain tumors associated with seizures
365523|NCT01577953|Antisense oligonucleotide|antisense oligonucleotide
365524|NCT01577953|Asthma|asthma
365525|NCT01577953|Patients with asthma|patients with asthma
365526|NCT01577953|Phase 1b|phase 1b
365527|NCT01577953|Transcription factor GATA-3|transcription factor gata-3
365528|NCT01577953|Oral inhalation|oral inhalation
365529|NCT01577940|Transversus abdominis plane block|transversus abdominis plane block
365530|NCT01577940|postoperative pain|postoperative pain
365531|NCT01577940|Postoperative pain management|postoperative pain management
365532|NCT01577927|weaning|weaning
365533|NCT01577927|severe chronic diseases|severe chronic diseases
365534|NCT01577927|UTIR|utir
365535|NCT01577901|Pregnancy|pregnancy
365536|NCT01577862|ACINETOBACTER BAUMANNII|acinetobacter baumannii
365537|NCT01577862|COLISTIN|colistin
365538|NCT01577862|RIFAMPICIN|rifampicin
365539|NCT01577862|THERAPY|therapy
365540|NCT01577862|RESISTANCE|resistance
365541|NCT01577836|Radical prostatectomie|radical prostatectomie
365542|NCT01577836|Robotic assistance|robotic assistance
365543|NCT01577836|Laparotomy|laparotomy
365544|NCT01577810|NIRS|nirs
365545|NCT01577810|near infrared spectroscopy|near infrared spectroscopy
365546|NCT01577810|heart failure|heart failure
365547|NCT01577810|cardiac output|cardiac output
365548|NCT01577810|outpatient|outpatient
365549|NCT01577810|pediatric|pediatric
365550|NCT01577797|Methamphetamine|methamphetamine
365551|NCT01577797|Drug Abuse|drug abuse
365552|NCT01577797|Substance Abuse|substance abuse
365553|NCT01577797|Amphetamine|amphetamine
365554|NCT01577797|Dependence|dependence
365555|NCT01577797|Addiction|addiction
365556|NCT01577797|Craving|craving
365557|NCT01577797|Cognitive Behavioral Therapy|cognitive behavioral therapy
365558|NCT01577797|Text Messaging|text messaging
365559|NCT01577784|Advanced renal cell carcinoma|advanced renal cell carcinoma
365560|NCT01577784|second-line treatment with pazopanib|second-line treatment with pazopanib
365561|NCT01577784|first line of treatment with a Tyrosine Kinase Inhibitor|first line of treatment with a tyrosine kinase inhibitor
365562|NCT01577771|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
365563|NCT01577771|Immunogenicity|immunogenicity
365564|NCT01577771|Reactogenicity|reactogenicity
365565|NCT01577758|Phase 1,|phase 1,
365566|NCT01577758|Advanced gastrointestinal malignancies,|advanced gastrointestinal malignancies,
365567|NCT01577758|MLN0264,|mln0264,
365568|NCT01577758|Guanylyl Cyclase C(GCC),|guanylyl cyclase c(gcc),
365569|NCT01577758|Antibody Drug Conjugate(ADC)|antibody drug conjugate(adc)
365570|NCT01577745|Cancer|cancer
365571|NCT01577732|booster|booster
365572|NCT01577732|Infanrix-IPV+HibTM|infanrix-ipv+hibtm
365573|NCT01577732|DTPa-IPV/Hib|dtpa-ipv/hib
365574|NCT01577732|Vietnamese toddlers|vietnamese toddlers
365575|NCT01577719|Cardiovascular|cardiovascular
365576|NCT01577719|Prevention|prevention
365577|NCT01577719|Ethnicity|ethnicity
365578|NCT01577719|Culture|culture
365579|NCT01577719|Internet|internet
365580|NCT01577719|Text Message|text message
365581|NCT01577706|GABA|gaba
365582|NCT01577706|glutamate|glutamate
365583|NCT01577706|glutamine|glutamine
365584|NCT01577706|spectroscopy|spectroscopy
365585|NCT01577706|brain|brain
365586|NCT01577706|imaging|imaging
365587|NCT01577706|alprazolam|alprazolam
365588|NCT01577706|dextroamphetamine|dextroamphetamine
365589|NCT01577706|placebo|placebo
365590|NCT01577693|dutasteride|dutasteride
365591|NCT01577693|cross over study|cross over study
365592|NCT01577693|bioavailability|bioavailability
365593|NCT01577680|healthy subjects|healthy subjects
365594|NCT01577680|pharmacokinetics|pharmacokinetics
365595|NCT01577680|vilanterol|vilanterol
365596|NCT01577680|tolerability|tolerability
365597|NCT01577680|safety|safety
365598|NCT01577680|hepatic impairment|hepatic impairment
365599|NCT01577680|GW642444|gw642444
365600|NCT01577680|GSK573719|gsk573719
365601|NCT01577667|automation|automation
365602|NCT01577667|closed loop|closed loop
365603|NCT01577667|oxygenation|oxygenation
365604|NCT01577667|ventilation|ventilation
365605|NCT01577654|adenocarcinoma|adenocarcinoma
365606|NCT01577654|squamous|squamous
365607|NCT01577654|adenosquamous|adenosquamous
365608|NCT01577654|adenocarcinoma with other NSCLC variants|adenocarcinoma with other nsclc variants
365609|NCT01577654|EC145|ec145
365610|NCT01577654|EC20|ec20
365611|NCT01577654|Vintafolide|vintafolide
365612|NCT01577654|Etarfolatide|etarfolatide
365613|NCT01577628|Dermatitis|dermatitis
365614|NCT01577628|Eczema|eczema
365615|NCT01577628|Skin diseases|skin diseases
365616|NCT01577628|Skin barrier|skin barrier
365617|NCT01577628|Prevention|prevention
365618|NCT01577628|Infant|infant
365619|NCT01577628|Moisturizer|moisturizer
365620|NCT01577628|Emollient|emollient
365621|NCT01577628|Asthma|asthma
365622|NCT01577628|Food allergy|food allergy
365623|NCT01577628|Allergic rhinitis|allergic rhinitis
365624|NCT01577615|Preterm Infant|preterm infant
365625|NCT01577615|Neurobehavioral|neurobehavioral
365626|NCT01577615|Development|development
365627|NCT01577602|Medication reconciliation|medication reconciliation
365628|NCT01577602|Self report|self report
365629|NCT01577602|Electronic medical record medication list|electronic medical record medication list
365630|NCT01577589|Phase 1|phase 1
365631|NCT01577589|healthy volunteers|healthy volunteers
365632|NCT01577589|cross-over study|cross-over study
365633|NCT01577589|ceftaroline fosamil|ceftaroline fosamil
365634|NCT01577589|various infusion volumes|various infusion volumes
365635|NCT01577589|local tolerability|local tolerability
365636|NCT01577589|Cmax|cmax
365637|NCT01577589|tmax|tmax
365638|NCT01577589|AUC|auc
365639|NCT01577576|Athletes|athletes
365640|NCT01577576|Sedentary volunteers|sedentary volunteers
365641|NCT01577563|osteoarthritis (OA)|osteoarthritis (oa)
365642|NCT01577563|rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
365643|NCT01577563|ankylosing spondylitis (AS)|ankylosing spondylitis (as)
365644|NCT01577563|gastrointestinal risk factors|gastrointestinal risk factors
365645|NCT01577563|NSAIDs|nsaids
365646|NCT01577550|ABBV-066|abbv-066
365647|NCT01577550|BI 655066|bi 655066
365648|NCT01577550|risankizumab|risankizumab
365649|NCT01577537|SPL7013|spl7013
365650|NCT01577537|VivaGel|vivagel
365651|NCT01577537|bacterial vaginosis|bacterial vaginosis
365652|NCT01577537|BV|bv
365653|NCT01577511|invasive potential|invasive potential
365654|NCT01577511|molecular characterisation of circulating cells|molecular characterisation of circulating cells
365655|NCT01577498|Skeletal age|skeletal age
365656|NCT01577498|Chronological age|chronological age
365657|NCT01577498|Adolescent|adolescent
365658|NCT01577472|female infertility|female infertility
365659|NCT01577472|poor ovarian response|poor ovarian response
365660|NCT01577472|controlled ovarian hyperstimulation|controlled ovarian hyperstimulation
365661|NCT01577472|IVF|ivf
365662|NCT01577472|Antagonist protocol|antagonist protocol
365663|NCT01577446|CRT|crt
365664|NCT01577446|heart failure|heart failure
365666|NCT01577446|dyssynchrony|dyssynchrony
365667|NCT01577433|HeartMate II|heartmate ii
365668|NCT01577433|heart-assist device|heart-assist device
365669|NCT01577433|left ventricular assist device|left ventricular assist device
365670|NCT01577433|driveline infection|driveline infection
365671|NCT01577433|LVAD|lvad
365672|NCT01577433|HMII LVAS driveline|hmii lvas driveline
365673|NCT01577433|silicone portion|silicone portion
365674|NCT01577433|Thoratec Corporation|thoratec corporation
365675|NCT01577420|Reflexology|reflexology
365676|NCT01577420|Breast Cancer|breast cancer
365677|NCT01577420|Complementary|complementary
365678|NCT01577407|Dyspnea|dyspnea
365679|NCT01577407|Pain|pain
365680|NCT01577394|Alzheimer disease|alzheimer disease
365681|NCT01577394|Lewy Body Disease|lewy body disease
365682|NCT01577394|Cognitive Disorders|cognitive disorders
365683|NCT01577394|Neurodegenerative Diseases|neurodegenerative diseases
365684|NCT01577394|Differential diagnosis|differential diagnosis
365685|NCT01577394|Eye movement|eye movement
365686|NCT01577381|Phase 2|phase 2
365687|NCT01577381|Advanced Dry Age-Related Macular Degeneration|advanced dry age-related macular degeneration
365688|NCT01577381|Geographic Atrophy|geographic atrophy
365689|NCT01577381|RN6G|rn6g
365690|NCT01577368|Pseudomonas|pseudomonas
365691|NCT01577368|Piperacillin|piperacillin
365692|NCT01577368|Beta-lactams|beta-lactams
365693|NCT01577368|Continuous infusion|continuous infusion
365694|NCT01577368|Intermittent infusion|intermittent infusion
365695|NCT01577368|Pharmacokinetics|pharmacokinetics
365696|NCT01577329|meditation|meditation
365697|NCT01577329|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
365698|NCT01577329|Mindfulness|mindfulness
365699|NCT01577329|Anxiety|anxiety
365700|NCT01577329|Breathing Patterns|breathing patterns
365701|NCT01577316|vaccination|vaccination
365702|NCT01577316|Influenza|influenza
365703|NCT01577316|Immunogenicity|immunogenicity
365704|NCT01577316|Safety|safety
365705|NCT01577303|social phobia|social phobia
365706|NCT01577303|social anxiety|social anxiety
365707|NCT01577303|cognitive bias modification|cognitive bias modification
365708|NCT01577290|Anxiety|anxiety
365709|NCT01577290|Depression|depression
365710|NCT01577290|Insomnia|insomnia
365711|NCT01577290|Mindfulness|mindfulness
365712|NCT01577290|Internet|internet
365713|NCT01577277|Metabolic Syndrome X|metabolic syndrome x
365714|NCT01577277|Fatty Acids, Omega-3|fatty acids, omega-3
365715|NCT01577277|Learning|learning
365716|NCT01577277|Attention|attention
365717|NCT01577277|Nutritional Status|nutritional status
365718|NCT01577277|Nutrition Assessments|nutrition assessments
365719|NCT01577277|Body Weight|body weight
365720|NCT01577277|Physical Activity|physical activity
365721|NCT01577277|Sleep|sleep
365722|NCT01577277|Child Nutrition Sciences|child nutrition sciences
365723|NCT01577264|Certolizumab Pegol|certolizumab pegol
365724|NCT01577264|Cimzia|cimzia
365725|NCT01577238|SPL7013|spl7013
365726|NCT01577238|VivaGel|vivagel
365727|NCT01577238|bacterial vaginosis|bacterial vaginosis
365728|NCT01577238|BV|bv
365729|NCT01577225|Clean surgery|clean surgery
365730|NCT01577212|stage III NSCLC|stage iii nsclc
365731|NCT01577212|(chemo)radiotherapy|(chemo)radiotherapy
365732|NCT01577212|individualized dose-escalation|individualized dose-escalation
365733|NCT01577199|IVF|ivf
365734|NCT01577199|poor responder|poor responder
365735|NCT01577199|low ovarian reserve|low ovarian reserve
365736|NCT01577199|ART|art
365737|NCT01577199|ovarian stimulation|ovarian stimulation
365738|NCT01577199|IVF protocols|ivf protocols
365739|NCT01577186|Schizophrenia|schizophrenia
365740|NCT01577186|Paliperidone Extended Release|paliperidone extended release
365741|NCT01577160|Schizophrenia|schizophrenia
365742|NCT01577160|Paliperidone Extended Release (ER)|paliperidone extended release (er)
365743|NCT01577147|pregnancy|pregnancy
365744|NCT01577134|multimorbidity|multimorbidity
365745|NCT01577134|autonomy|autonomy
365746|NCT01577134|older adults|older adults
365747|NCT01577134|physical activity|physical activity
365748|NCT01577134|intervention|intervention
365749|NCT01577134|behavior change|behavior change
365750|NCT01577121|Preterm labor|preterm labor
365751|NCT01577108|31-32 Weeks of Gestation Completed|31-32 weeks of gestation completed
365752|NCT01577108|Group B Streptococcal Infection|group b streptococcal infection
365753|NCT01577108|Streptococcus Group B Infection of the Infant|streptococcus group b infection of the infant
365754|NCT01577095|electroacupuncture|electroacupuncture
365755|NCT01577095|rosiglitazone|rosiglitazone
365756|NCT01577095|plasma glucose|plasma glucose
365757|NCT01577095|insulin resistance|insulin resistance
365758|NCT01577095|free fatty acid|free fatty acid
365759|NCT01577082|Adults, not adequately controlled, pre-dose morning PEF|adults, not adequately controlled, pre-dose morning pef
365760|NCT01577069|Hepatitis C|hepatitis c
365761|NCT01577069|Direct Antiviral agent (DAA)|direct antiviral agent (daa)
365762|NCT01577069|Ultra-deep pyrosequencing|ultra-deep pyrosequencing
365763|NCT01577069|Single polynucleotide polymorphisms|single polynucleotide polymorphisms
365764|NCT01577069|Treatment-resistant mutants|treatment-resistant mutants
366054|NCT01575938|HIV infection|hiv infection
365765|NCT01577069|Hepatitis C Virus Protease Inhibitor|hepatitis c virus protease inhibitor
365766|NCT01577056|Familial hypercholesterolaemia|familial hypercholesterolaemia
365767|NCT01577056|Postprandial dyslipidaemia|postprandial dyslipidaemia
365768|NCT01577056|Fish oil treatment|fish oil treatment
365769|NCT01577056|Cardiovascular disease|cardiovascular disease
365770|NCT01577043|acute diarrhea|acute diarrhea
365771|NCT01577043|Racecadotril|racecadotril
365772|NCT01577043|children|children
365773|NCT01577017|ovulation induction, clomiphene citrate, letrozole|ovulation induction, clomiphene citrate, letrozole
365774|NCT01576978|LUMBAR BACK pain|lumbar back pain
365775|NCT01576978|PELVIC PAIN|pelvic pain
365776|NCT01576978|PREGNANCY|pregnancy
365777|NCT01576978|HATHA YOGA|hatha yoga
365778|NCT01576965|Laparoscopic hysterectomy,laparoscopic sacrocolpopexy,bowel prep|laparoscopic hysterectomy,laparoscopic sacrocolpopexy,bowel prep
365779|NCT01576926|Sleep apnea, obstructive|sleep apnea, obstructive
365780|NCT01576926|Deglutition Disorders|deglutition disorders
365781|NCT01576913|exercise testing|exercise testing
365782|NCT01576913|music|music
365783|NCT01576913|VO2 max|vo2 max
365784|NCT01576900|behavior therapy|behavior therapy
365785|NCT01576900|nocturia|nocturia
365786|NCT01576900|polyuria|polyuria
365787|NCT01576874|nicotine dependence|nicotine dependence
365788|NCT01576874|hormones|hormones
365789|NCT01576848|muscle metabolism|muscle metabolism
365790|NCT01576848|intrinsically labeled protein|intrinsically labeled protein
365791|NCT01576848|protein synthesis|protein synthesis
365792|NCT01576848|insulin|insulin
365793|NCT01576848|perfusion|perfusion
365794|NCT01576835|Non-contrast|non-contrast
365795|NCT01576822|Detoxification|detoxification
365796|NCT01576822|Sauna|sauna
365797|NCT01576809|Paracetamol|paracetamol
365798|NCT01576809|acetaminophen|acetaminophen
365799|NCT01576809|phenylephrine|phenylephrine
365800|NCT01576809|guaifenesin|guaifenesin
365801|NCT01576809|syrup|syrup
365802|NCT01576809|URTI|urti
365803|NCT01576809|productive cough|productive cough
365804|NCT01576796|Radiotherapy|radiotherapy
365805|NCT01576796|Fmiso|fmiso
365806|NCT01576796|FDG PETSCAN|fdg petscan
365807|NCT01576796|FMISO PETSCAN|fmiso petscan
365808|NCT01576796|complement dose|complement dose
365809|NCT01576796|lung cancer|lung cancer
365810|NCT01576796|NSCLC|nsclc
365811|NCT01576796|hypoxic lesion|hypoxic lesion
365812|NCT01576770|propofol|propofol
365813|NCT01576770|Pain|pain
365814|NCT01576770|Synera Patch|synera patch
365815|NCT01576770|Gebauer's Ethyl Chloride topical anesthetic|gebauer's ethyl chloride topical anesthetic
365816|NCT01576757|Stem cell therapy|stem cell therapy
365817|NCT01576744|HE4|he4
365818|NCT01576744|IVF|ivf
365819|NCT01576744|Biomarker|biomarker
365820|NCT01576744|Ovarian cancer|ovarian cancer
365821|NCT01576744|Infertility|infertility
365822|NCT01576731|HIV Infection|hiv infection
365823|NCT01576731|Postexposure prophylaxis|postexposure prophylaxis
365824|NCT01576718|Dose ranging|dose ranging
365825|NCT01576718|Fluticasone Propionate|fluticasone propionate
365826|NCT01576718|Dry Powder Inhaler (DPI)|dry powder inhaler (dpi)
365827|NCT01576718|High Dose ICS|high dose ics
365828|NCT01576718|Asthma|asthma
365829|NCT01576705|Down syndrome|down syndrome
365830|NCT01576705|Young children|young children
365831|NCT01576705|Psychomotor development|psychomotor development
365832|NCT01576705|Thyroid hormone|thyroid hormone
365833|NCT01576705|Folinic acid|folinic acid
365834|NCT01576705|Psychometric tests|psychometric tests
365835|NCT01576705|GMDS|gmds
365836|NCT01576705|Griffiths|griffiths
365837|NCT01576705|Genetic factors|genetic factors
365838|NCT01576705|Biochemical factors|biochemical factors
365839|NCT01576692|recurrent neuroblastoma|recurrent neuroblastoma
365840|NCT01576692|refractory neuroblastoma|refractory neuroblastoma
365841|NCT01576692|natural killer cells|natural killer cells
365842|NCT01576679|intra-abdominal|intra-abdominal
365843|NCT01576679|abscess|abscess
365844|NCT01576679|tPA|tpa
365845|NCT01576679|alteplase|alteplase
365846|NCT01576679|cathflo|cathflo
365847|NCT01576666|Dose escalation|dose escalation
365848|NCT01576666|Maximum Tolerated Dose|maximum tolerated dose
365849|NCT01576666|MTD|mtd
365850|NCT01576666|Safety Expansion|safety expansion
365851|NCT01576666|Safety|safety
365852|NCT01576666|Preliminary Efficacy|preliminary efficacy
365853|NCT01576666|Objective Response Rate|objective response rate
365854|NCT01576666|Early progression rate|early progression rate
365855|NCT01576666|PI3K activation|pi3k activation
365856|NCT01576666|Combination Treatment|combination treatment
365857|NCT01576666|Hedgehog Signaling Pathway|hedgehog signaling pathway
365858|NCT01576666|Smoothened inhibitor|smoothened inhibitor
365859|NCT01576666|Phosphoinositide-3' kinase|phosphoinositide-3' kinase
365860|NCT01576666|Phosphatase signaling pathway|phosphatase signaling pathway
365861|NCT01576666|Advanced solid tumors|advanced solid tumors
365862|NCT01576666|metastatic breast cancer|metastatic breast cancer
365863|NCT01576666|advanced pancreatic adenocarcinoma|advanced pancreatic adenocarcinoma
365864|NCT01576666|metastatic colorectal cancer|metastatic colorectal cancer
366334|NCT01574651|Formoterol|formoterol
365865|NCT01576666|recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
365866|NCT01576666|gastric cancer|gastric cancer
365867|NCT01576666|gastroesophageal junction cancer|gastroesophageal junction cancer
365868|NCT01576666|triple negative metastatic breast cancer|triple negative metastatic breast cancer
365869|NCT01576666|hormone receptor positive (ER+/PR+, and Her2-) metastatic breast cancer|hormone receptor positive (er+/pr+, and her2-) metastatic breast cancer
365870|NCT01576653|IFI|ifi
365871|NCT01576640|Nicotine Dependence|nicotine dependence
365872|NCT01576640|Smoking Cessation|smoking cessation
365873|NCT01576640|Relapse Prevention|relapse prevention
365874|NCT01576640|Cognitive Behavioral Therapy|cognitive behavioral therapy
365875|NCT01576640|Schizophrenia|schizophrenia
365876|NCT01576614|Comparing telephone VS RTP in SICU rounding practices|comparing telephone vs rtp in sicu rounding practices
365877|NCT01576601|pediatrics|pediatrics
365878|NCT01576601|acute pain|acute pain
365879|NCT01576601|neurosurgery|neurosurgery
365880|NCT01576601|Pediatric patients (0-18)|pediatric patients (0-18)
365881|NCT01576601|postoperative management|postoperative management
365882|NCT01576588|Chronic lymphocytic leukemia, relapsed, elderly or unfit patients, methylprednisolone, rituximab|chronic lymphocytic leukemia, relapsed, elderly or unfit patients, methylprednisolone, rituximab
365883|NCT01576575|to determine how people absorb and break down (metabolize) and eliminate buprenorphine and if CYP3A is involved.|to determine how people absorb and break down (metabolize) and eliminate buprenorphine and if cyp3a is involved.
365884|NCT01576562|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
365885|NCT01576562|Ventricular Assist Device|ventricular assist device
365886|NCT01576536|Myocardial infarction|myocardial infarction
365887|NCT01576536|Platelet aggregation|platelet aggregation
365888|NCT01576536|cold pressor test|cold pressor test
365889|NCT01576536|Genetics|genetics
365890|NCT01576497|EUS, EUS-FNA, Pancreatic masses|eus, eus-fna, pancreatic masses
365891|NCT01576471|T. suis ova|t. suis ova
365892|NCT01576471|Trichuris suis ova|trichuris suis ova
365893|NCT01576471|Inflammatory Bowel Disease|inflammatory bowel disease
365894|NCT01576471|TRUST-I|trust-i
365895|NCT01576471|TRUSTI|trusti
365896|NCT01576471|TRUST-1|trust-1
365897|NCT01576471|TRUST1|trust1
365898|NCT01576458|ursodeoxycholic acid|ursodeoxycholic acid
365899|NCT01576458|intrahepatic cholestasis|intrahepatic cholestasis
365900|NCT01576458|pregnancy|pregnancy
365901|NCT01576445|Total Knee Arthroplasty|total knee arthroplasty
365902|NCT01576445|function|function
365903|NCT01576432|Pain|pain
365904|NCT01576432|Breastfeeding|breastfeeding
365905|NCT01576432|Heel prick|heel prick
365906|NCT01576432|Sucrose|sucrose
365907|NCT01576432|Skin-to-skin contact|skin-to-skin contact
365908|NCT01576432|Newborn|newborn
365909|NCT01576419|PG201|pg201
365910|NCT01576419|Non-inferiority|non-inferiority
365911|NCT01576419|100mm pain VAS|100mm pain vas
365912|NCT01576406|crizotinib|crizotinib
365913|NCT01576406|xalkori|xalkori
365914|NCT01576406|PF-02341066|pf-02341066
365915|NCT01576406|hepatic impairment|hepatic impairment
365916|NCT01576406|pharmacokinetics|pharmacokinetics
365917|NCT01576406|advanced cancer|advanced cancer
365918|NCT01576393|substance abuse|substance abuse
365919|NCT01576393|treatment|treatment
365920|NCT01576393|families|families
365921|NCT01576380|Solid tumors|solid tumors
365922|NCT01576380|Advanced scirrhous gastric carcinoma|advanced scirrhous gastric carcinoma
365923|NCT01576380|Gastric Cancer|gastric cancer
365924|NCT01576380|Second-line or third-line treatment|second-line or third-line treatment
365925|NCT01576380|VEGF|vegf
365926|NCT01576380|FGFR|fgfr
365927|NCT01576380|Neoplasms|neoplasms
365928|NCT01576380|Gastric Neoplasms|gastric neoplasms
365929|NCT01576380|Cancer|cancer
365930|NCT01576380|Carcinoma|carcinoma
365931|NCT01576380|Gastric Diseases|gastric diseases
365932|NCT01576380|Female Genital Diseases|female genital diseases
365933|NCT01576380|Tumors|tumors
365934|NCT01576380|Oral Administration|oral administration
365935|NCT01576380|Capsules|capsules
365936|NCT01576380|TKI258|tki258
365937|NCT01576380|TKI-258|tki-258
365938|NCT01576380|TKI 258|tki 258
365939|NCT01576367|Cryopyrin-associated periodic syndromes (CAPS)|cryopyrin-associated periodic syndromes (caps)
365940|NCT01576367|Familial Cold Autoinflammatory Syndrome (FCAS)|familial cold autoinflammatory syndrome (fcas)
365941|NCT01576367|Muckle-Wells Syndrome (MWS)|muckle-wells syndrome (mws)
365942|NCT01576367|Neonatal Onset Multisystem Inflammatory Disease (NOMID)|neonatal onset multisystem inflammatory disease (nomid)
365943|NCT01576367|children, systemic autoinflammatory disease|children, systemic autoinflammatory disease
365944|NCT01576367|CIAS-1 gene|cias-1 gene
365945|NCT01576367|NALP-3|nalp-3
365946|NCT01576367|NLRP3|nlrp3
365947|NCT01576367|ACZ885|acz885
365948|NCT01576367|canakinumab|canakinumab
365949|NCT01576367|human monoclonal anti-human interleukin-1 antibody|human monoclonal anti-human interleukin-1 antibody
365950|NCT01576367|autosomal dominant|autosomal dominant
365951|NCT01576367|familial autoinflammatory syndrome|familial autoinflammatory syndrome
365952|NCT01576367|childhood immunizations vaccinations|childhood immunizations vaccinations
365953|NCT01576354|Multiple Sclerosis|multiple sclerosis
365954|NCT01576354|walking function|walking function
365955|NCT01576354|fampridine|fampridine
365956|NCT01576341|Epoetin alfa, ESA, HX575, CKD|epoetin alfa, esa, hx575, ckd
365957|NCT01576315|cystic fibrosis|cystic fibrosis
365958|NCT01576315|Aspergillus|aspergillus
365959|NCT01576315|itraconazole|itraconazole
365960|NCT01576315|voriconazole|voriconazole
365961|NCT01576302|Rumination|rumination
365962|NCT01576289|Esophagus|esophagus
365963|NCT01576289|Gastroesophageal reflux|gastroesophageal reflux
365964|NCT01576289|Reflux esophagitis|reflux esophagitis
365965|NCT01576289|Barrett's esophagus|barrett's esophagus
365966|NCT01576289|Stomach|stomach
365967|NCT01576289|Intestinal metaplasia stomach|intestinal metaplasia stomach
365968|NCT01576289|Helicobacter pylori infection|helicobacter pylori infection
365969|NCT01576289|Proton pump inhibitor|proton pump inhibitor
365970|NCT01576289|Duodenum|duodenum
365971|NCT01576289|Duodenal bulb|duodenal bulb
365972|NCT01576289|Celiac disease diagnosis|celiac disease diagnosis
365973|NCT01576263|Anaesthesia|anaesthesia
365974|NCT01576263|Infiltration|infiltration
365975|NCT01576263|Blood transfusion|blood transfusion
365976|NCT01576263|Autologous|autologous
365977|NCT01576263|Arthroplasty|arthroplasty
365978|NCT01576263|Replacement|replacement
365979|NCT01576263|Ropivacaine|ropivacaine
365980|NCT01576237|hemovigilance|hemovigilance
365981|NCT01576237|hemapheresis|hemapheresis
365982|NCT01576237|donor vigilance|donor vigilance
365983|NCT01576237|plasmapheresis|plasmapheresis
365984|NCT01576237|platelet apheresis|platelet apheresis
365985|NCT01576237|leukapheresis|leukapheresis
365986|NCT01576237|stem cell apheresis|stem cell apheresis
365987|NCT01576237|granulocyte apheresis|granulocyte apheresis
365988|NCT01576237|monocyte apheresis|monocyte apheresis
365989|NCT01576237|red cell apheresis|red cell apheresis
365990|NCT01576224|Volar locking plate osteosynthesis|volar locking plate osteosynthesis
365991|NCT01576224|Early mobilization|early mobilization
365992|NCT01576224|DASH|dash
365993|NCT01576211|Wilms tumor and other childhood kidney tumors|wilms tumor and other childhood kidney tumors
365994|NCT01576198|Wilms tumor and other childhood kidney tumors|wilms tumor and other childhood kidney tumors
365995|NCT01576159|Biochemical Marker|biochemical marker
365996|NCT01576159|Fitness Exercises|fitness exercises
365997|NCT01576159|Impact|impact
365998|NCT01576159|Articular Cartilage|articular cartilage
365999|NCT01576146|Clinical Trial, Phase 2|clinical trial, phase 2
366000|NCT01576146|Renal Dialysis|renal dialysis
366001|NCT01576146|Secondary Hyperparathyroidism|secondary hyperparathyroidism
366002|NCT01576146|Chronic kidney disease-mineral and bone disorder|chronic kidney disease-mineral and bone disorder
366003|NCT01576146|Parathyroid hormone|parathyroid hormone
366004|NCT01576133|Quality of Life|quality of life
366005|NCT01576120|Known, active Crohn's disease|known, active crohn's disease
366006|NCT01576120|Iieocolonic or colonic involvement|iieocolonic or colonic involvement
366007|NCT01576120|proven patency of the GI tract|proven patency of the gi tract
366008|NCT01576107|Different cancer entities|different cancer entities
366009|NCT01576094|congenital heart disease|congenital heart disease
366010|NCT01576081|bone density|bone density
366011|NCT01576081|weight bearing|weight bearing
366012|NCT01576081|muscle atrophy|muscle atrophy
366013|NCT01576081|vascular degeneration|vascular degeneration
366014|NCT01576081|gravitational loading|gravitational loading
366015|NCT01576081|muscular unloading|muscular unloading
366016|NCT01576068|COPD|copd
366017|NCT01576068|Pharmacy|pharmacy
366018|NCT01576068|Spirometry|spirometry
366019|NCT01576068|Case finding|case finding
366020|NCT01576055|Peripheral Arterial Disease|peripheral arterial disease
366021|NCT01576055|Superficial Femoral Artery|superficial femoral artery
366022|NCT01576055|Proximal Popliteal Artery|proximal popliteal artery
366023|NCT01576055|PAD|pad
366024|NCT01576055|SFA|sfa
366025|NCT01576055|PPA|ppa
366026|NCT01576055|Stent|stent
366027|NCT01576055|Gore|gore
366028|NCT01576055|Bare Metal Stent|bare metal stent
366029|NCT01576055|LifeStent|lifestent
366030|NCT01576055|atherosclerosis|atherosclerosis
366031|NCT01576055|Heparin|heparin
366032|NCT01576055|claudication|claudication
366033|NCT01576055|leg pain|leg pain
366034|NCT01576042|Ischemic heart disease|ischemic heart disease
366035|NCT01576042|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
366036|NCT01576042|Ventricular Tachycardia|ventricular tachycardia
366037|NCT01576042|Patient with Implantable Cardioverter Defibrillator (ICD)|patient with implantable cardioverter defibrillator (icd)
366038|NCT01576016|bradycardia|bradycardia
366039|NCT01576016|MRI scans|mri scans
366040|NCT01576003|Short Bowel Syndrome|short bowel syndrome
366041|NCT01576003|Necrotizing Entercolitis (NEC)|necrotizing entercolitis (nec)
366042|NCT01576003|Atresia|atresia
366043|NCT01576003|Parenteral Nutrition|parenteral nutrition
366044|NCT01576003|Biological Markers|biological markers
366045|NCT01576003|Growth|growth
366046|NCT01575990|Colon cancer screening|colon cancer screening
366047|NCT01575990|Decision support interventions|decision support interventions
366048|NCT01575990|Health status|health status
366049|NCT01575990|Patient-centered care|patient-centered care
366051|NCT01575990|Randomized controlled trial|randomized controlled trial
366052|NCT01575990|Double blind|double blind
366055|NCT01575925|Pomalidomide for multiple myeloma|pomalidomide for multiple myeloma
366056|NCT01575925|renal impairment|renal impairment
366057|NCT01575925|multiple myeloma patients with renal impairment|multiple myeloma patients with renal impairment
366058|NCT01575925|Pomalidomide for patients with renal impairment due to multiple myeloma|pomalidomide for patients with renal impairment due to multiple myeloma
366059|NCT01575925|Pomalidomide|pomalidomide
366060|NCT01575925|dexamethasone|dexamethasone
366061|NCT01575925|RRMM|rrmm
366062|NCT01575925|impaired renal function in multiple myeloma|impaired renal function in multiple myeloma
366063|NCT01575925|hemodialysis|hemodialysis
366064|NCT01575925|dialysis|dialysis
366065|NCT01575925|POM|pom
366066|NCT01575925|Pomalyst|pomalyst
366067|NCT01575925|MM|mm
366068|NCT01575925|severe renal impairment|severe renal impairment
366069|NCT01575925|CrCl ≤ 30 mL/min|crcl ≤ 30 ml/min
366070|NCT01575925|Creatinine less than 30|creatinine less than 30
366071|NCT01575925|clinical trial in subjects with multiple myeloma with renal impairement|clinical trial in subjects with multiple myeloma with renal impairement
366072|NCT01575912|Schizophrenia|schizophrenia
366073|NCT01575912|Major depression|major depression
366074|NCT01575912|Pain|pain
366075|NCT01575912|Past pain experience|past pain experience
366076|NCT01575899|Helicobacter pylori|helicobacter pylori
366077|NCT01575899|Levofloxacin|levofloxacin
366078|NCT01575899|Amoxicillin/clavulanate|amoxicillin/clavulanate
366079|NCT01575899|Rabeprazole|rabeprazole
366080|NCT01575899|Eastern Taiwan|eastern taiwan
366081|NCT01575886|clinician patient communication|clinician patient communication
366082|NCT01575886|smoking cessation|smoking cessation
366083|NCT01575886|weight management|weight management
366084|NCT01575886|primary care|primary care
366085|NCT01575886|health behavior change advice|health behavior change advice
366086|NCT01575873|GIOP, Glucocorticoid, osteporosis, denosumab, BMD, Bone Mineral Density|giop, glucocorticoid, osteporosis, denosumab, bmd, bone mineral density
366087|NCT01575860|biopsy-proven diagnosis|biopsy-proven diagnosis
366088|NCT01575860|completed at least 2 cycles of salvage chemotherapy|completed at least 2 cycles of salvage chemotherapy
366089|NCT01575860|showing PET positive residual lesions|showing pet positive residual lesions
366090|NCT01575847|Acetaminophen|acetaminophen
366091|NCT01575847|Acetaminophen Toxicity|acetaminophen toxicity
366092|NCT01575834|Osteoporosis, Osteoporosis-Postmenopausal, Bone Diseases-Metabolic, Bone Diseases, Musculoskeletal Diseases|osteoporosis, osteoporosis-postmenopausal, bone diseases-metabolic, bone diseases, musculoskeletal diseases
366093|NCT01575821|children, cough, honey|children, cough, honey
366094|NCT01575808|Symptomatic PAD|symptomatic pad
366095|NCT01575808|Stenosis|stenosis
366096|NCT01575808|Occlusion|occlusion
366097|NCT01575795|Ticagrelor|ticagrelor
366098|NCT01575795|ST elevation acute myocardial infarction|st elevation acute myocardial infarction
366099|NCT01575795|Platelet reactivity|platelet reactivity
366100|NCT01575782|small cell lung cancer|small cell lung cancer
366101|NCT01575782|stage I-III|stage i-iii
366102|NCT01575782|chloroquine|chloroquine
366103|NCT01575782|Phase I|phase i
366104|NCT01575730|Peritoneal carcinomatosis from colorectal or appendiceal origin|peritoneal carcinomatosis from colorectal or appendiceal origin
366105|NCT01575717|Vitamin D|vitamin d
366106|NCT01575717|hepatocellular carcinoma|hepatocellular carcinoma
366107|NCT01575717|liver neoplasms|liver neoplasms
366108|NCT01575717|liver transplantation|liver transplantation
366109|NCT01575704|Exercise|exercise
366110|NCT01575704|Hematopoetic cell transplantation|hematopoetic cell transplantation
366111|NCT01575704|Children|children
366112|NCT01575691|Combination Chemotherapy|combination chemotherapy
366113|NCT01575691|MDS|mds
366114|NCT01575691|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
366115|NCT01575691|AML|aml
366116|NCT01575691|Acute myelogenous leukemia|acute myelogenous leukemia
366117|NCT01575691|valproic acid|valproic acid
366118|NCT01575691|VPA|vpa
366119|NCT01575691|Depakene|depakene
366120|NCT01575691|5-azacytidine|5-azacytidine
366121|NCT01575691|5-aza|5-aza
366122|NCT01575691|Azacitidine|azacitidine
366123|NCT01575691|5-AZC|5-azc
366124|NCT01575691|Vidaza|vidaza
366125|NCT01575691|AZA-CR|aza-cr
366126|NCT01575691|Ladakamycin|ladakamycin
366127|NCT01575691|NSC-102816|nsc-102816
366128|NCT01575691|All-trans retinoic acid|all-trans retinoic acid
366129|NCT01575691|ATRA|atra
366130|NCT01575691|Tretinoin|tretinoin
366131|NCT01575691|Vesanoid|vesanoid
366132|NCT01575678|enuresis|enuresis
366133|NCT01575678|melatonin|melatonin
366134|NCT01575678|circadian rhythm|circadian rhythm
366135|NCT01575678|children|children
366136|NCT01575678|blood pressure|blood pressure
366137|NCT01575678|urine production|urine production
366138|NCT01575678|activity|activity
366139|NCT01575678|sleep|sleep
366140|NCT01575665|Hyperventilation|hyperventilation
366141|NCT01575665|Chronic Idiopathic Hyperventilation|chronic idiopathic hyperventilation
366142|NCT01575665|Dysfunctional Breathing|dysfunctional breathing
366143|NCT01575665|Respiratory Alkalosis|respiratory alkalosis
366144|NCT01575665|Respiratory Acidosis|respiratory acidosis
366145|NCT01575652|peritoneal dialysis|peritoneal dialysis
366146|NCT01575652|protein losses|protein losses
366147|NCT01575613|malaria|malaria
366148|NCT01575613|heterogeneity|heterogeneity
366149|NCT01575613|transmission|transmission
366150|NCT01575613|elimination|elimination
366151|NCT01575587|Pharmacology|pharmacology
366152|NCT01575587|Pharmacokinetics|pharmacokinetics
366153|NCT01575587|Pharmacodynamics|pharmacodynamics
366154|NCT01575587|Abiraterone acetate|abiraterone acetate
366155|NCT01575587|Food intake|food intake
366156|NCT01575587|Caucasion|caucasion
366157|NCT01575587|Japanese|japanese
366158|NCT01575587|Healthy|healthy
366159|NCT01575561|Lurasidone|lurasidone
366160|NCT01575561|Latuda|latuda
366161|NCT01575561|Bipolar Disorder|bipolar disorder
366162|NCT01575535|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
366163|NCT01575535|adult acute basophilic leukemia|adult acute basophilic leukemia
366164|NCT01575535|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
366165|NCT01575535|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
366166|NCT01575535|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
366167|NCT01575535|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
366168|NCT01575535|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
366169|NCT01575535|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
366170|NCT01575535|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
366171|NCT01575535|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
366172|NCT01575535|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
366173|NCT01575535|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
366174|NCT01575535|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
366175|NCT01575535|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
366176|NCT01575535|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
366177|NCT01575535|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
366178|NCT01575535|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
366179|NCT01575496|Tinnitus|tinnitus
366180|NCT01575496|Transcranial direct current stimulation|transcranial direct current stimulation
366181|NCT01575496|Transcranial magnetic stimulation|transcranial magnetic stimulation
366182|NCT01575470|Traumatic Brain Injury|traumatic brain injury
366183|NCT01575470|TBI|tbi
366184|NCT01575470|stem cells|stem cells
366185|NCT01575457|Adolescent Violence Prevention|adolescent violence prevention
366186|NCT01575444|Pap test|pap test
366187|NCT01575444|HPV testing|hpv testing
366188|NCT01575444|cervical cancer|cervical cancer
366189|NCT01575431|coronary artery disease|coronary artery disease
366190|NCT01575431|endothelial progenitor cells|endothelial progenitor cells
366191|NCT01575392|creatinine|creatinine
366192|NCT01575392|chronic kidney disease|chronic kidney disease
366193|NCT01575392|creatinine clearance|creatinine clearance
366194|NCT01575392|estimated glomerular filtration rate|estimated glomerular filtration rate
366195|NCT01575340|inflammatory markers|inflammatory markers
366196|NCT01575340|colorectal cancer|colorectal cancer
366197|NCT01575340|cytokines|cytokines
366198|NCT01575340|fish oil|fish oil
366199|NCT01575314|stapling device|stapling device
366200|NCT01575314|lobectomy|lobectomy
366201|NCT01575314|cost utility|cost utility
366202|NCT01575301|GLP-1R agonist|glp-1r agonist
366203|NCT01575301|biomarker|biomarker
366204|NCT01575288|arterial function|arterial function
366205|NCT01575288|cardiovascular|cardiovascular
366206|NCT01575288|aging|aging
366207|NCT01575288|endothelial function|endothelial function
366208|NCT01575288|arterial stiffness|arterial stiffness
366209|NCT01575288|vascular function|vascular function
366210|NCT01575288|Trehalose|trehalose
366211|NCT01575262|behaviour change|behaviour change
366212|NCT01575262|incentives|incentives
366213|NCT01575262|nudging|nudging
366214|NCT01575262|physical activity|physical activity
366215|NCT01575262|self-monitoring|self-monitoring
366216|NCT01575249|progression|progression
366217|NCT01575249|moderate aortic stenosis|moderate aortic stenosis
366218|NCT01575249|asymptomatic|asymptomatic
366219|NCT01575249|symptomatic|symptomatic
366220|NCT01575223|saline irrigation|saline irrigation
366221|NCT01575223|chronic rhinosinusitis|chronic rhinosinusitis
366222|NCT01575223|endoscopic sinus surgery|endoscopic sinus surgery
366223|NCT01575223|high volume saline irrigation|high volume saline irrigation
366224|NCT01575184|internal jugular vein cannulation|internal jugular vein cannulation
366225|NCT01575184|common carotid artery|common carotid artery
366226|NCT01575184|infants|infants
366227|NCT01575132|Parkinson's Disease|parkinson's disease
366228|NCT01575132|Stimulation, Deep Brain|stimulation, deep brain
366229|NCT01575132|Study, Follow-Up|study, follow-up
366230|NCT01575132|Adverse Effects|adverse effects
366231|NCT01575119|Cigarette smoker|cigarette smoker
366232|NCT01575119|Elective surgery|elective surgery
366233|NCT01575093|Healthy volunteers|healthy volunteers
366234|NCT01575067|BP|bp
366235|NCT01575041|sodium|sodium
366236|NCT01575041|salt|salt
366237|NCT01575041|potassium|potassium
366238|NCT01575041|blood pressure|blood pressure
366239|NCT01575041|flow-mediated dilatation|flow-mediated dilatation
366240|NCT01575041|endothelial function|endothelial function
366241|NCT01575041|renal function|renal function
366242|NCT01575041|controlled feeding study|controlled feeding study
366243|NCT01575041|dietary intervention|dietary intervention
366244|NCT01575028|Transversus abdominis plane block|transversus abdominis plane block
366245|NCT01575028|TAP block|tap block
366246|NCT01575028|Local anesthetic infiltration|local anesthetic infiltration
366247|NCT01575028|Appendectomy|appendectomy
366248|NCT01575028|Laparoscopic appendectomy|laparoscopic appendectomy
366249|NCT01575015|Liver transplantation (E04.210.650)|liver transplantation (e04.210.650)
366250|NCT01575015|Renal replacement therapy (E05.196.353)|renal replacement therapy (e05.196.353)
366251|NCT01575015|Intra-operative period (E04.614.374)|intra-operative period (e04.614.374)
366252|NCT01575015|Safety (N06.850.135.060.075)|safety (n06.850.135.060.075)
366253|NCT01575015|Efficacy|efficacy
366254|NCT01575002|transcranial stimulation|transcranial stimulation
366255|NCT01575002|direct current stimulation|direct current stimulation
366256|NCT01574989|direct current stimulation|direct current stimulation
366257|NCT01574989|magnetic stimulation|magnetic stimulation
366258|NCT01574989|transcranial stimulation|transcranial stimulation
366259|NCT01574976|ADHD|adhd
366260|NCT01574976|probabilistic|probabilistic
366261|NCT01574976|choice|choice
366262|NCT01574976|feedback|feedback
366263|NCT01574976|practice|practice
366264|NCT01574963|Coronary artery disease|coronary artery disease
366265|NCT01574963|OPG|opg
366266|NCT01574963|RANKL|rankl
366267|NCT01574963|bone disease|bone disease
366268|NCT01574950|Delirium|delirium
366269|NCT01574937|Castration Resistant|castration resistant
366270|NCT01574937|Post Chemotherapy|post chemotherapy
366271|NCT01574924|Personality change|personality change
366272|NCT01574924|Perfectionism|perfectionism
366273|NCT01574924|Coping|coping
366274|NCT01574924|Medical Specialty|medical specialty
366275|NCT01574924|Medical Residency|medical residency
366276|NCT01574911|volumetry 3D|volumetry 3d
366277|NCT01574911|Displacement of water|displacement of water
366278|NCT01574911|lymphoedema|lymphoedema
366279|NCT01574911|Venous chronic insufficiency|venous chronic insufficiency
366280|NCT01574898|Smoking cessation|smoking cessation
366281|NCT01574898|Nicotine|nicotine
366282|NCT01574898|Tobacco Use Disorder|tobacco use disorder
366283|NCT01574898|Central Nervous System Agents|central nervous system agents
366284|NCT01574885|sleep apnea|sleep apnea
366285|NCT01574885|adenotonsillar hypertrophy|adenotonsillar hypertrophy
366286|NCT01574885|salt|salt
366287|NCT01574885|sodium chloride|sodium chloride
366288|NCT01574872|psoriasis|psoriasis
366289|NCT01574872|salt|salt
366290|NCT01574872|sodium chloride|sodium chloride
366291|NCT01574859|central hypothyroidism|central hypothyroidism
366292|NCT01574859|hypopituitarism|hypopituitarism
366293|NCT01574859|levothyroxine replacement|levothyroxine replacement
366294|NCT01574859|lipids|lipids
366295|NCT01574859|body composition|body composition
366296|NCT01574820|prediabetes|prediabetes
366297|NCT01574820|coronary artery disease|coronary artery disease
366298|NCT01574820|insulin resistance|insulin resistance
366299|NCT01574820|glucose intolerance|glucose intolerance
366300|NCT01574807|mepivacaine|mepivacaine
366301|NCT01574807|lidocaine|lidocaine
366302|NCT01574807|inferior alveolar nerve block|inferior alveolar nerve block
366303|NCT01574807|pulpal anesthesia|pulpal anesthesia
366304|NCT01574807|pain of injection|pain of injection
366305|NCT01574807|mepivacaine/lidocaine|mepivacaine/lidocaine
366306|NCT01574807|lidocaine/lidocaine|lidocaine/lidocaine
366307|NCT01574781|Down syndrome|down syndrome
366308|NCT01574781|Trisomy 13|trisomy 13
366309|NCT01574781|Trisomy 18|trisomy 18
366310|NCT01574781|Microdeletions|microdeletions
366311|NCT01574781|Pregnancy|pregnancy
366312|NCT01574781|Non-invasive|non-invasive
366313|NCT01574755|gastric inlet patches|gastric inlet patches
366314|NCT01574755|argon plasma coagulation|argon plasma coagulation
366315|NCT01574755|globus sensations|globus sensations
366316|NCT01574729|p53 gene therapy|p53 gene therapy
366317|NCT01574729|non-small cell lung cancer|non-small cell lung cancer
366318|NCT01574729|post-surgery|post-surgery
366319|NCT01574729|chemotherapy|chemotherapy
366320|NCT01574703|smoking cessation|smoking cessation
366321|NCT01574703|psychiatric disease|psychiatric disease
366322|NCT01574703|cardiovascular events|cardiovascular events
366323|NCT01574690|central venous pressure|central venous pressure
366324|NCT01574690|right heart catheter (RHC)|right heart catheter (rhc)
366325|NCT01574690|non-invasive monitor|non-invasive monitor
366326|NCT01574690|physical exam of jugular venous pressure|physical exam of jugular venous pressure
366327|NCT01574690|heart failure (HF)|heart failure (hf)
366328|NCT01574677|Colorectal cancer|colorectal cancer
366329|NCT01574677|fecal immunochemical test|fecal immunochemical test
366330|NCT01574677|Septin 9|septin 9
366331|NCT01574677|screening|screening
366332|NCT01574651|QVA149|qva149
366333|NCT01574651|Health related quality of life|health related quality of life
366335|NCT01574651|Tiotropium|tiotropium
366336|NCT01574651|COPD|copd
366337|NCT01574612|Xerese|xerese
366338|NCT01574612|acyclovir hydrocortisone cream|acyclovir hydrocortisone cream
366339|NCT01574612|herpes labialis|herpes labialis
366340|NCT01574612|pediatric|pediatric
366341|NCT01574599|Stroke|stroke
366342|NCT01574599|weakness|weakness
366343|NCT01574599|rehabilitation|rehabilitation
366344|NCT01574599|chronic stroke|chronic stroke
366345|NCT01574586|True Bifurcation stenosis|true bifurcation stenosis
366346|NCT01574573|Obesity|obesity
366347|NCT01574573|GERD|gerd
366348|NCT01574573|Weight loss|weight loss
366349|NCT01574560|smoke-free|smoke-free
366350|NCT01574560|tobacco exposure|tobacco exposure
366351|NCT01574560|biomarker feedback|biomarker feedback
366352|NCT01574560|nicotine|nicotine
366353|NCT01574560|cotinine|cotinine
366354|NCT01574560|secondhand smoke|secondhand smoke
366355|NCT01574547|Cat Scratch Colon.|cat scratch colon.
366356|NCT01574547|Mucosal tears.|mucosal tears.
366357|NCT01574547|Mucosal erosion.|mucosal erosion.
366358|NCT01574547|Colonoscopy.|colonoscopy.
366359|NCT01574508|efficacy|efficacy
366360|NCT01574508|safety|safety
366361|NCT01574508|intensive insulin therapy|intensive insulin therapy
366362|NCT01574495|stroke|stroke
366363|NCT01574495|error augmentation|error augmentation
366364|NCT01574495|arm recovery|arm recovery
366365|NCT01574495|massed practice|massed practice
366366|NCT01574482|Plant sterol - Hypercholesterolemia - diet - dairy|plant sterol - hypercholesterolemia - diet - dairy
366367|NCT01574469|Plant sterol - Cholesterol absorption - diet - dairy - LDL|plant sterol - cholesterol absorption - diet - dairy - ldl
366368|NCT01574443|Epilepsy|epilepsy
366369|NCT01574417|Plant stanols|plant stanols
366370|NCT01574417|Gene expression profile|gene expression profile
366371|NCT01574417|Microbiota|microbiota
366372|NCT01574404|PGS,PGD, IVF, Polar Body Biopsy, FISH, Microarray analysis|pgs,pgd, ivf, polar body biopsy, fish, microarray analysis
366373|NCT01574378|Abdominoplasty|abdominoplasty
366374|NCT01574365|CKD patients with type 2 diabetes|ckd patients with type 2 diabetes
366375|NCT01574352|Children|children
366376|NCT01574352|Overweight|overweight
366377|NCT01574352|Obesity|obesity
366378|NCT01574352|BMI|bmi
366379|NCT01574352|Physical activity|physical activity
366380|NCT01574352|Cognitive function|cognitive function
366381|NCT01574352|Intervention study|intervention study
366382|NCT01574352|Randomized controlled trial|randomized controlled trial
366383|NCT01574352|Day camp|day camp
366384|NCT01574352|Risk factors|risk factors
366385|NCT01574339|GERD|gerd
366386|NCT01574339|LES Pressure|les pressure
366387|NCT01574339|Electrical Stimulation|electrical stimulation
366388|NCT01574326|Chronic Kidney Disease|chronic kidney disease
366389|NCT01574326|Pediatric|pediatric
366390|NCT01574326|Sevelamer Carbonate|sevelamer carbonate
366391|NCT01574326|Hyperphosphatemia|hyperphosphatemia
366392|NCT01574313|stellate ganglion block.|stellate ganglion block.
366393|NCT01574313|Meniere's disease.|meniere's disease.
366394|NCT01574313|electrocochleography.|electrocochleography.
366395|NCT01574313|vertigo.|vertigo.
366396|NCT01574313|hearing impairment.|hearing impairment.
366397|NCT01574300|Small Cell Lung Cancer (SCLC)|small cell lung cancer (sclc)
366398|NCT01574300|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
366399|NCT01574300|M1A or B NSCLC|m1a or b nsclc
366400|NCT01574261|Polycystic Ovary Syndrome|polycystic ovary syndrome
366401|NCT01574261|Cardiovascular risk|cardiovascular risk
366402|NCT01574261|Metabolic Syndrome|metabolic syndrome
366403|NCT01574248|ACE inhibitor|ace inhibitor
366404|NCT01574248|Angioedema|angioedema
366405|NCT01574248|Bradykinin|bradykinin
366406|NCT01574248|Swelling|swelling
366407|NCT01574222|Stages IIIB, IV, and recurrent NSCLC|stages iiib, iv, and recurrent nsclc
366408|NCT01574222|Carcinoma, Non-small cell lung|carcinoma, non-small cell lung
366409|NCT01574222|Lung Neoplasms|lung neoplasms
366410|NCT01574222|Carcinoma, Bronchogenic|carcinoma, bronchogenic
366411|NCT01574222|Thoracic Neoplasms|thoracic neoplasms
366412|NCT01574222|Neoplasms by Site|neoplasms by site
366413|NCT01574222|Neoplasms|neoplasms
366414|NCT01574222|Lung Diseases|lung diseases
366415|NCT01574209|Celiac disease|celiac disease
366416|NCT01574209|IBS|ibs
366417|NCT01574209|Intestinal barrier|intestinal barrier
366418|NCT01574209|Intestinal permeability|intestinal permeability
366419|NCT01574209|GI peptides|gi peptides
366420|NCT01574196|Childhood cancer|childhood cancer
366421|NCT01574196|Cancer|cancer
366422|NCT01574196|Sequels|sequels
366423|NCT01574196|Complications|complications
366424|NCT01574196|Chemotherapy|chemotherapy
366425|NCT01574196|Radiotherapy|radiotherapy
366426|NCT01574196|Surgery|surgery
366427|NCT01574196|Autonomic nervous system|autonomic nervous system
366428|NCT01574196|Parasympathetic Nervous System|parasympathetic nervous system
366429|NCT01574196|Sympathetic Nervous System|sympathetic nervous system
366430|NCT01574183|Marijuana|marijuana
366431|NCT01574183|Vilazodone|vilazodone
366432|NCT01574183|Contingency management|contingency management
366433|NCT01574183|Motivational enhancement therapy|motivational enhancement therapy
366434|NCT01574170|Breast cancer,|breast cancer,
366435|NCT01574170|Third line metastatic|third line metastatic
366436|NCT01574170|Chemotherapy,|chemotherapy,
366437|NCT01574170|Overall survival,|overall survival,
366438|NCT01574170|Quality of life.|quality of life.
366439|NCT01574144|Heart Failure|heart failure
366440|NCT01574131|Burn|burn
366441|NCT01574131|Fenofibrate|fenofibrate
366442|NCT01574131|PPAR alpha agonist|ppar alpha agonist
366443|NCT01574131|insulin sensitivity|insulin sensitivity
366444|NCT01574131|mitochondrial|mitochondrial
366445|NCT01574118|PTSD|ptsd
366446|NCT01574118|Posttraumatic Stress Disorder|posttraumatic stress disorder
366447|NCT01574118|Exposure Therapy|exposure therapy
366448|NCT01574118|Prolonged Exposure|prolonged exposure
366449|NCT01574118|Fear Memory Retrieval|fear memory retrieval
366450|NCT01574118|Compound extinction|compound extinction
366451|NCT01574118|Deepened extinction|deepened extinction
366452|NCT01574118|Psychotherapy|psychotherapy
366453|NCT01574105|Heparin Dose|heparin dose
366454|NCT01574105|Heparin Resistance|heparin resistance
366455|NCT01574105|Chest Tube Losses|chest tube losses
366456|NCT01574105|Transfusion Events|transfusion events
366457|NCT01574092|Pediatric|pediatric
366458|NCT01574092|Pediatrics|pediatrics
366459|NCT01574092|Gliomas|gliomas
366460|NCT01574092|Glioma|glioma
366461|NCT01574092|Brain tumor|brain tumor
366462|NCT01574092|Brain cancer|brain cancer
366463|NCT01574092|Cisplatin|cisplatin
366464|NCT01574092|Cisplatino|cisplatino
366465|NCT01574092|Irinotecan|irinotecan
366466|NCT01574092|Brain stem tumor|brain stem tumor
366467|NCT01574092|Brainstem gliomas|brainstem gliomas
366468|NCT01574092|Intrinsic brain stem tumor|intrinsic brain stem tumor
366469|NCT01574092|PAEDIATRIC HIGH GRADE GLIOMA|paediatric high grade glioma
366470|NCT01574092|Childhood brain stem glioma|childhood brain stem glioma
366471|NCT01574066|Community-acquired pneumonia|community-acquired pneumonia
366472|NCT01574066|Diagnosis|diagnosis
366473|NCT01574066|Emergency medicine|emergency medicine
366474|NCT01574066|Chest CT-scan|chest ct-scan
366475|NCT01574053|Huntington's Disease|huntington's disease
366476|NCT01574053|Huntington Disease|huntington disease
366477|NCT01574053|Juvenile Huntington's Disease|juvenile huntington's disease
366478|NCT01574053|Registry|registry
366479|NCT01574053|Cohort|cohort
366480|NCT01574053|CHDI|chdi
366481|NCT01574040|Lifestyle|lifestyle
366482|NCT01574040|Lifestyle modification|lifestyle modification
366483|NCT01574040|Behavior|behavior
366484|NCT01574040|Primary prevention|primary prevention
366485|NCT01574040|Healthy staff and visitors of an Academic Hospital|healthy staff and visitors of an academic hospital
366486|NCT01574027|Assess the efficacy of vitamin D for preventing colorectal cancer and identifying the populations likely (or unlikely) to benefit from vitamin D-based therapy.|assess the efficacy of vitamin d for preventing colorectal cancer and identifying the populations likely (or unlikely) to benefit from vitamin d-based therapy.
366487|NCT01574027|Evaluate the ability of Vitamin D3 (cholecalciferol) to reduce ACF's in humans.|evaluate the ability of vitamin d3 (cholecalciferol) to reduce acf's in humans.
366488|NCT01574014|Anxiety Disorder|anxiety disorder
366489|NCT01574014|Phobic Disorders|phobic disorders
366490|NCT01574001|ischemic stroke|ischemic stroke
366491|NCT01574001|smoking cessation|smoking cessation
366492|NCT01574001|antismoking interventions|antismoking interventions
366493|NCT01573988|Nutrition|nutrition
366494|NCT01573988|Eating frequency|eating frequency
366495|NCT01573988|Food intake|food intake
366496|NCT01573988|Eating behavior|eating behavior
366497|NCT01573988|Satiety|satiety
366498|NCT01573988|Ghrelin|ghrelin
366499|NCT01573975|Helicobacter pylori|helicobacter pylori
366500|NCT01573975|antibiotic resistance|antibiotic resistance
366501|NCT01573975|sequential therapy|sequential therapy
366502|NCT01573975|Taiwan|taiwan
366503|NCT01573962|Kidney Renal|kidney renal
366504|NCT01573949|Heart Failure|heart failure
366505|NCT01573949|Diabetes|diabetes
366506|NCT01573949|Pre-diabetes|pre-diabetes
366507|NCT01573949|Early type II diabetes|early type ii diabetes
366508|NCT01573949|Metformin|metformin
366509|NCT01573949|Pharmacotherapy with metformin for prevention of DM in HF patients with pre-diabetes (pre-DM) and glycemic control in HF patients with early type II DM|pharmacotherapy with metformin for prevention of dm in hf patients with pre-diabetes (pre-dm) and glycemic control in hf patients with early type ii dm
366510|NCT01573936|acquired brain injury|acquired brain injury
366511|NCT01573936|health-related quality of life|health-related quality of life
366512|NCT01573936|poliomyelitis survivor|poliomyelitis survivor
366513|NCT01573936|rehabilitation|rehabilitation
366514|NCT01573936|spinal cord injury|spinal cord injury
366515|NCT01573936|completed the WHOQOL-BREF|completed the whoqol-bref
366516|NCT01573923|Umbilical Mesenchymal Stem Cells; Liver cirrhosis|umbilical mesenchymal stem cells; liver cirrhosis
366517|NCT01573910|Bacterial conjunctivitis|bacterial conjunctivitis
366518|NCT01573910|Anti-infective|anti-infective
366519|NCT01573910|Antibiotics|antibiotics
366520|NCT01573897|Diabetes|diabetes
366521|NCT01573897|Sleep apnea|sleep apnea
366522|NCT01573897|Diabetic foot|diabetic foot
366523|NCT01573897|microcirculation|microcirculation
366524|NCT01573858|Infertility|infertility
366525|NCT01573858|Polycystic Ovary Syndrome|polycystic ovary syndrome
366718|NCT01573104|Diagnosis|diagnosis
366526|NCT01573858|Clomiphene citrate|clomiphene citrate
366527|NCT01573858|Acupuncture|acupuncture
366528|NCT01573845|child|child
366529|NCT01573845|communication|communication
366530|NCT01573845|diet|diet
366531|NCT01573845|food|food
366532|NCT01573845|health communication|health communication
366533|NCT01573845|nutrition|nutrition
366534|NCT01573845|parents|parents
366535|NCT01573845|primary schools|primary schools
366536|NCT01573845|school age population|school age population
366537|NCT01573845|school health|school health
366538|NCT01573819|repeat dose|repeat dose
366539|NCT01573819|PDE4|pde4
366540|NCT01573819|healthy volunteers|healthy volunteers
366541|NCT01573819|GSK356278|gsk356278
366542|NCT01573806|sepsis|sepsis
366543|NCT01573806|septic shock|septic shock
366544|NCT01573806|children|children
366545|NCT01573806|incretins|incretins
366546|NCT01573806|exenatide|exenatide
366547|NCT01573806|pharmacokinetics|pharmacokinetics
366548|NCT01573806|pharmacodynamics|pharmacodynamics
366549|NCT01573806|glucose homeostasis|glucose homeostasis
366550|NCT01573806|inflammation|inflammation
366551|NCT01573806|cytokines|cytokines
366552|NCT01573806|health-related quality of life|health-related quality of life
366553|NCT01573806|functional status|functional status
366554|NCT01573754|Porphyria, rare disease, orphan disease, iron metabolism|porphyria, rare disease, orphan disease, iron metabolism
366555|NCT01573741|depressive ketamine antidepressant|depressive ketamine antidepressant
366556|NCT01573728|Depression|depression
366557|NCT01573728|Biomarkers|biomarkers
366558|NCT01573728|Exercise|exercise
366559|NCT01573702|Non small cell lung cancer|non small cell lung cancer
366560|NCT01573702|EGFR mutant|egfr mutant
366561|NCT01573702|Phase II|phase ii
366562|NCT01573702|erlotinib|erlotinib
366563|NCT01573702|tarceva|tarceva
366564|NCT01573702|cyberknife|cyberknife
366565|NCT01573702|Lineberger|lineberger
366566|NCT01573689|bereaved children, mutual aid group, death, group intervention.|bereaved children, mutual aid group, death, group intervention.
366567|NCT01573676|bariatric surgery|bariatric surgery
366568|NCT01573676|sleep apnea|sleep apnea
366569|NCT01573676|overweight|overweight
366570|NCT01573663|Ambroxol|ambroxol
366571|NCT01573663|Levodropropizine|levodropropizine
366572|NCT01573663|Drug-drug interaction|drug-drug interaction
366573|NCT01573637|schizophrenia|schizophrenia
366574|NCT01573637|negative schizophrenia|negative schizophrenia
366575|NCT01573637|schizophrenia in post-menopausal women|schizophrenia in post-menopausal women
366576|NCT01573637|schizophrenia in women|schizophrenia in women
366577|NCT01573637|ralixifene|ralixifene
366578|NCT01573637|raloxifen|raloxifen
366579|NCT01573637|raloxifeno|raloxifeno
366580|NCT01573637|negative symptoms of schizophrenia|negative symptoms of schizophrenia
366581|NCT01573637|negative symptoms in schizophrenia|negative symptoms in schizophrenia
366582|NCT01573637|schizophrenia symptoms|schizophrenia symptoms
366583|NCT01573637|negative symptoms of psychosis|negative symptoms of psychosis
366584|NCT01573624|Fluticasone Furoate|fluticasone furoate
366585|NCT01573624|Vilanterol|vilanterol
366586|NCT01573624|Adults|adults
366587|NCT01573624|GSK573719|gsk573719
366588|NCT01573624|Asthma|asthma
366589|NCT01573611|mild cognitive impairment|mild cognitive impairment
366590|NCT01573611|dementia|dementia
366591|NCT01573611|positron emission tomography (PET)|positron emission tomography (pet)
366592|NCT01573611|F-18 Fluorodeoxyglucose (FDG)|f-18 fluorodeoxyglucose (fdg)
366593|NCT01573611|cerebral metabolism|cerebral metabolism
366594|NCT01573611|dietary supplement|dietary supplement
366595|NCT01573598|Major Depressive Disorder|major depressive disorder
366596|NCT01573598|Depression|depression
366597|NCT01573585|Physical Therapy|physical therapy
366598|NCT01573585|Exercise therapy|exercise therapy
366599|NCT01573559|Ambulatory adults with no apparent health conditions|ambulatory adults with no apparent health conditions
366600|NCT01573533|Treatment Resistant Idiopathic FSGS|treatment resistant idiopathic fsgs
366601|NCT01573533|Glomerulosclerosis|glomerulosclerosis
366602|NCT01573533|Proteinuria|proteinuria
366603|NCT01573533|Rituximab|rituximab
366604|NCT01573520|compliance|compliance
366605|NCT01573520|dialysis|dialysis
366606|NCT01573520|hyperparathyroidism|hyperparathyroidism
366607|NCT01573507|traumatic brain injury|traumatic brain injury
366608|NCT01573507|lactate|lactate
366609|NCT01573507|brain metabolism|brain metabolism
366610|NCT01573507|cerebral microdialysis|cerebral microdialysis
366611|NCT01573507|subarachnoid hemorrhage|subarachnoid hemorrhage
366612|NCT01573507|transcranial doppler|transcranial doppler
366613|NCT01573494|Cancer|cancer
366614|NCT01573494|Melanoma|melanoma
366615|NCT01573494|Circulating Tumor Cells|circulating tumor cells
366616|NCT01573481|WEANING|weaning
366617|NCT01573481|PRESSURE CONTROLLED CONTINOUS VENTILATION|pressure controlled continous ventilation
366618|NCT01573481|PRESSURE VENTILATION SUPPORT|pressure ventilation support
366619|NCT01573481|SLEEP|sleep
366620|NCT01573481|POLYGRAPHIC RECORD|polygraphic record
366621|NCT01573442|hot flashes|hot flashes
366622|NCT01573442|musculoskeletal complications|musculoskeletal complications
366623|NCT01573442|sexual dysfunction|sexual dysfunction
366624|NCT01573442|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
366625|NCT01573442|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
366626|NCT01573442|arthralgia|arthralgia
366627|NCT01573442|stage IA breast cancer|stage ia breast cancer
366628|NCT01573442|stage IB breast cancer|stage ib breast cancer
366629|NCT01573442|stage II breast cancer|stage ii breast cancer
366630|NCT01573442|stage IIIA breast cancer|stage iiia breast cancer
366631|NCT01573442|stage IIIB breast cancer|stage iiib breast cancer
366632|NCT01573442|stage IIIC breast cancer|stage iiic breast cancer
366633|NCT01573429|Biologic Sample Collection|biologic sample collection
366634|NCT01573429|Metabolism|metabolism
366635|NCT01573429|Healthy Volunteer|healthy volunteer
366636|NCT01573429|HV|hv
366637|NCT01573416|Alcohol|alcohol
366638|NCT01573416|Abuse|abuse
366639|NCT01573416|Drugs|drugs
366640|NCT01573416|Brief intervention|brief intervention
366641|NCT01573416|ASSIST|assist
366642|NCT01573403|Proton pump inhibitor (PPI)|proton pump inhibitor (ppi)
366643|NCT01573403|DLBS2411|dlbs2411
366644|NCT01573403|gastric pH|gastric ph
366645|NCT01573390|Non-invasive|non-invasive
366646|NCT01573390|tissue-oxygenation|tissue-oxygenation
366647|NCT01573390|hyperspectral|hyperspectral
366648|NCT01573390|CWC imaging system|cwc imaging system
366649|NCT01573377|polycystic ovary syndrome|polycystic ovary syndrome
366650|NCT01573377|insulin resistance|insulin resistance
366651|NCT01573364|Distal Airways|distal airways
366652|NCT01573364|Hyperinflation|hyperinflation
366653|NCT01573364|Reversibility|reversibility
366654|NCT01573338|Cyclin dependent kinases|cyclin dependent kinases
366655|NCT01573338|Drug therapy, combination|drug therapy, combination
366656|NCT01573338|Small cell lung carcinoma|small cell lung carcinoma
366657|NCT01573338|Etoposide|etoposide
366658|NCT01573338|Cisplatin|cisplatin
366659|NCT01573338|Carboplatin|carboplatin
366660|NCT01573325|Cirrhosis of the liver|cirrhosis of the liver
366661|NCT01573325|Pre-liver transplant Candidate|pre-liver transplant candidate
366662|NCT01573325|Depression|depression
366663|NCT01573325|Poor social support|poor social support
366664|NCT01573325|Liver disease symptoms|liver disease symptoms
366665|NCT01573325|Health releated quality of life|health releated quality of life
366666|NCT01573312|influenza, vaccine, H5N1, monovalent, adjuvant, ASO3|influenza, vaccine, h5n1, monovalent, adjuvant, aso3
366667|NCT01573299|Cerebral Infarction, Mobilization, Recovery|cerebral infarction, mobilization, recovery
366668|NCT01573286|Infant Nutrition Disorders|infant nutrition disorders
366669|NCT01573286|Childhood nutrition disorders|childhood nutrition disorders
366670|NCT01573286|malnutrition|malnutrition
366671|NCT01573286|post surgical syndromes|post surgical syndromes
366672|NCT01573286|necrotising enterocolitis|necrotising enterocolitis
366673|NCT01573286|intestinal atresia|intestinal atresia
366674|NCT01573286|gastroschisis|gastroschisis
366675|NCT01573273|cocaine|cocaine
366676|NCT01573273|substance abuse|substance abuse
366677|NCT01573273|drug abuse|drug abuse
366678|NCT01573273|cocaine dependence|cocaine dependence
366679|NCT01573273|drug addiction|drug addiction
366680|NCT01573260|Parkinson's Disease|parkinson's disease
366681|NCT01573260|Tango|tango
366682|NCT01573247|Acute myeloid leukemia|acute myeloid leukemia
366683|NCT01573247|Refractory Acute myeloid leukemia|refractory acute myeloid leukemia
366684|NCT01573247|FLT3 inhibitor|flt3 inhibitor
366685|NCT01573247|kinase inhibitor|kinase inhibitor
366686|NCT01573234|MySkin patch|myskin patch
366687|NCT01573234|Hydrogel bandage|hydrogel bandage
366688|NCT01573234|Occlusive dressing|occlusive dressing
366689|NCT01573208|Knee osteoarthritis|knee osteoarthritis
366690|NCT01573195|deescalation|deescalation
366691|NCT01573195|best practice alert|best practice alert
366692|NCT01573195|antimicrobial stewardship|antimicrobial stewardship
366693|NCT01573182|Zostavax|zostavax
366694|NCT01573182|Herpes Zoster|herpes zoster
366695|NCT01573182|VZV vaccination|vzv vaccination
366696|NCT01573182|Allogeneic haemopoietic stem cell transplantation|allogeneic haemopoietic stem cell transplantation
366697|NCT01573169|hemorrhagic stroke|hemorrhagic stroke
366698|NCT01573169|venous thromboembolism|venous thromboembolism
366699|NCT01573169|prevention|prevention
366700|NCT01573156|renal cancer|renal cancer
366701|NCT01573156|photodynamic therapy|photodynamic therapy
366702|NCT01573156|wst 11|wst 11
366703|NCT01573143|Surgical Procedures, Cardiac|surgical procedures, cardiac
366704|NCT01573143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
366705|NCT01573143|Rosuvastatin|rosuvastatin
366706|NCT01573143|Post operative atrial fibrillation|post operative atrial fibrillation
366707|NCT01573130|Depression|depression
366708|NCT01573130|Physical exercise|physical exercise
366709|NCT01573130|Internet|internet
366710|NCT01573117|hypothermia|hypothermia
366711|NCT01573117|induction of hypothermia|induction of hypothermia
366712|NCT01573117|cold infusion|cold infusion
366713|NCT01573117|nasopharyngeal cooling|nasopharyngeal cooling
366714|NCT01573117|stroke|stroke
366715|NCT01573117|intracranial hemorrhage|intracranial hemorrhage
366716|NCT01573117|cerebrovascular disease|cerebrovascular disease
366717|NCT01573117|neuro intensive care|neuro intensive care
366719|NCT01573104|Acute Kidney Injury|acute kidney injury
366720|NCT01573091|Cardiac resynchronization therapy|cardiac resynchronization therapy
366721|NCT01573091|Heart failure|heart failure
366722|NCT01573078|Crohn's disease|crohn's disease
366723|NCT01573078|IBS|ibs
366724|NCT01573078|Dissociation|dissociation
366725|NCT01573078|Emotional processing|emotional processing
366726|NCT01573065|alcohol consumption|alcohol consumption
366727|NCT01573065|sexual risk behaviors|sexual risk behaviors
366728|NCT01573065|young, unhealthy drinkers|young, unhealthy drinkers
366729|NCT01573039|Kidney transplantation|kidney transplantation
366730|NCT01573039|PCR quantitative|pcr quantitative
366731|NCT01573039|cytomegalovirus|cytomegalovirus
366732|NCT01573039|antigenemia|antigenemia
366733|NCT01573026|Dental Implants|dental implants
366734|NCT01573026|Dental Implantation|dental implantation
366735|NCT01573026|Osseointegration|osseointegration
366736|NCT01573013|iron deficiency|iron deficiency
366737|NCT01573013|Lead poisoning|lead poisoning
366738|NCT01573013|cognitive development|cognitive development
366739|NCT01573013|motor activity|motor activity
366740|NCT01573000|Bexxar|bexxar
366741|NCT01573000|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
366742|NCT01573000|Tositumomab|tositumomab
366743|NCT01573000|Anti-B1 Antibody|anti-b1 antibody
366744|NCT01573000|Radioimmunotherapy|radioimmunotherapy
366745|NCT01573000|Iodine I-131|iodine i-131
366746|NCT01573000|Iodine-131|iodine-131
366747|NCT01572987|Barrett's Esophagus|barrett's esophagus
366748|NCT01572987|Esophageal neoplasms|esophageal neoplasms
366749|NCT01572987|Radiofrequency ablation|radiofrequency ablation
366750|NCT01572987|Endoscopic mucosal resection|endoscopic mucosal resection
366751|NCT01572974|Barrett's esophagus|barrett's esophagus
366752|NCT01572974|Gastroesophageal reflux disease|gastroesophageal reflux disease
366753|NCT01572974|Quality of life|quality of life
366754|NCT01572961|Laser Doppler flowmetry, skin, microcirculation|laser doppler flowmetry, skin, microcirculation
366755|NCT01572935|childhood obesity prevalence|childhood obesity prevalence
366756|NCT01572922|Sickle cell disease|sickle cell disease
366757|NCT01572922|Thalassemia|thalassemia
366758|NCT01572922|Hemochromatosis|hemochromatosis
366759|NCT01572922|Cancer|cancer
366760|NCT01572909|Myocardial Reperfusion|myocardial reperfusion
366761|NCT01572909|Primary PCI|primary pci
366762|NCT01572909|Stenting for ST-segment Elevation Myocardial Infarction|stenting for st-segment elevation myocardial infarction
366763|NCT01572896|adoloescent|adoloescent
366764|NCT01572896|internet self-management|internet self-management
366765|NCT01572896|managing JIA|managing jia
366766|NCT01572883|adjuvant treatment with Radiotherapy and trastuzumab|adjuvant treatment with radiotherapy and trastuzumab
366767|NCT01572870|Chit1|chit1
366768|NCT01572870|Cystic Fibrosis|cystic fibrosis
366769|NCT01572870|Allergic Bronchopulmonary Aspergillosis (ABPA)|allergic bronchopulmonary aspergillosis (abpa)
366770|NCT01572870|Aspergillus|aspergillus
366771|NCT01572857|multiple myeloma|multiple myeloma
366772|NCT01572857|Proteinuria|proteinuria
366773|NCT01572857|Albuminuria|albuminuria
366774|NCT01572857|Urinary FLC|urinary flc
366775|NCT01572857|Urine creatinine|urine creatinine
366776|NCT01572844|Dermatomyositis|dermatomyositis
366777|NCT01572844|Superficial calcinosis|superficial calcinosis
366778|NCT01572844|Fractional carbon dioxide laser|fractional carbon dioxide laser
366779|NCT01572844|Sodium thiosulfate|sodium thiosulfate
366780|NCT01572831|antibiotic cessation rules|antibiotic cessation rules
366781|NCT01572831|procalcitonin|procalcitonin
366782|NCT01572831|infection|infection
366783|NCT01572831|critical care|critical care
366784|NCT01572818|Phlebotomy|phlebotomy
366785|NCT01572818|Insulin Resistance|insulin resistance
366786|NCT01572818|Iron Overload|iron overload
366787|NCT01572805|Post partum haemorrhage|post partum haemorrhage
366788|NCT01572805|Cesarean|cesarean
366789|NCT01572805|Pain|pain
366790|NCT01572792|COPD|copd
366791|NCT01572792|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
366792|NCT01572792|Chronic Bronchitis|chronic bronchitis
366793|NCT01572792|Emphysema|emphysema
366794|NCT01572792|Airflow Obstruction, Chronic|airflow obstruction, chronic
366795|NCT01572792|Chronic Airflow Obstruction|chronic airflow obstruction
366796|NCT01572792|Chronic Obstructive Airway Disease|chronic obstructive airway disease
366797|NCT01572792|Chronic Obstructive Lung Disease|chronic obstructive lung disease
366798|NCT01572779|dorsavi|dorsavi
366799|NCT01572779|vimove|vimove
366800|NCT01572779|biofeedback|biofeedback
366801|NCT01572779|objective movement data|objective movement data
366802|NCT01572779|back pain|back pain
366803|NCT01572766|Osteoporosis|osteoporosis
366804|NCT01572766|Pharmacist|pharmacist
366805|NCT01572766|Behavior Change|behavior change
366806|NCT01572766|FRAX|frax
366807|NCT01572766|Osteopenia|osteopenia
366808|NCT01572727|BKM120|bkm120
366809|NCT01572727|paclitaxel|paclitaxel
366810|NCT01572727|breast cancer|breast cancer
366811|NCT01572727|metastatic|metastatic
366812|NCT01572727|locally advanced|locally advanced
366813|NCT01572727|PI3K|pi3k
366814|NCT01572727|PIK3CA|pik3ca
366815|NCT01572727|PTEN|pten
366816|NCT01572714|Exercise|exercise
366817|NCT01572714|Self Care|self care
366818|NCT01572714|Fatigue|fatigue
366819|NCT01572675|Pharmacoepidemiological|pharmacoepidemiological
366820|NCT01572675|Longitudinal|longitudinal
366821|NCT01572675|Observational|observational
366822|NCT01572662|Leukemia|leukemia
366823|NCT01572662|Acute myeloid leukemia|acute myeloid leukemia
366824|NCT01572662|Acute lymphocytic leukemia|acute lymphocytic leukemia
366825|NCT01572662|Chronic myeloid leukemia|chronic myeloid leukemia
366826|NCT01572662|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
366827|NCT01572662|Myeloproliferative Diseases|myeloproliferative diseases
366828|NCT01572662|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
366829|NCT01572662|Hodgkins lymphoma|hodgkins lymphoma
366830|NCT01572662|Multiple myeloma|multiple myeloma
366831|NCT01572662|Myelodysplastic syndrome|myelodysplastic syndrome
366832|NCT01572662|MDS|mds
366833|NCT01572662|Fludarabine monophosphate|fludarabine monophosphate
366834|NCT01572662|Fludarabine phosphate|fludarabine phosphate
366835|NCT01572662|Fludara|fludara
366836|NCT01572662|Busulfan|busulfan
366837|NCT01572662|Busulfex|busulfex
366838|NCT01572662|Myleran|myleran
366839|NCT01572662|Tacrolimus|tacrolimus
366840|NCT01572662|Prograf|prograf
366841|NCT01572662|Methotrexate|methotrexate
366842|NCT01572662|G-CSF|g-csf
366843|NCT01572662|Filgrastim|filgrastim
366844|NCT01572662|Neupogen|neupogen
366845|NCT01572662|Stem cell transplant|stem cell transplant
366846|NCT01572662|Allogeneic Transplantation|allogeneic transplantation
366847|NCT01572636|Hurler Syndrome|hurler syndrome
366848|NCT01572623|Therapeutic strategies for carotid artery stenting|therapeutic strategies for carotid artery stenting
366849|NCT01572610|CKD patients with type 2 diabetes|ckd patients with type 2 diabetes
366850|NCT01572597|Helicobacter pylori|helicobacter pylori
366851|NCT01572597|antibiotic resistance|antibiotic resistance
366852|NCT01572597|N-acetylcystein|n-acetylcystein
366853|NCT01572597|biofilm|biofilm
366854|NCT01572597|second-line eradication treatment|second-line eradication treatment
366855|NCT01572584|Pneumothorax|pneumothorax
366856|NCT01572584|Lung ultrasound|lung ultrasound
366857|NCT01572584|Chest sonography|chest sonography
366858|NCT01572571|Emergency ultrasound|emergency ultrasound
366859|NCT01572571|Focused ultrasound|focused ultrasound
366860|NCT01572571|Point-of-care ultrasound|point-of-care ultrasound
366861|NCT01572571|Undifferentiated hypotension|undifferentiated hypotension
366862|NCT01572558|Appendectomy|appendectomy
366863|NCT01572558|Nonsurgical treatment with antibiotics|nonsurgical treatment with antibiotics
366864|NCT01572545|bone turnover|bone turnover
366865|NCT01572545|denosumab|denosumab
366866|NCT01572545|postmenopausal osteoporosis|postmenopausal osteoporosis
366867|NCT01572545|sclerostin|sclerostin
366868|NCT01572545|zolendronic acid|zolendronic acid
366869|NCT01572532|Adverse Perinatal Outcomes|adverse perinatal outcomes
366870|NCT01572532|Treatment of abnormal vaginal flora|treatment of abnormal vaginal flora
366871|NCT01572519|Relapsed Hodgkin lymphoma|relapsed hodgkin lymphoma
366872|NCT01572519|Refractory Hodgkin lymphoma|refractory hodgkin lymphoma
366873|NCT01572519|JNJ-40346527|jnj-40346527
366874|NCT01572519|Dose-escalation|dose-escalation
366875|NCT01572519|Pharmacokinetics|pharmacokinetics
366876|NCT01572506|Anemia|anemia
366877|NCT01572506|Elderly|elderly
366878|NCT01572506|Mechanisms|mechanisms
366879|NCT01572506|Red Cell Survival|red cell survival
367006|NCT01571973|depression|depression
366880|NCT01572493|Pharmacokinetics of lL-15|pharmacokinetics of ll-15
366881|NCT01572493|Cytokine Therapy|cytokine therapy
366882|NCT01572493|Effects of rhlL-15 on T-cells and NK cells|effects of rhll-15 on t-cells and nk cells
366883|NCT01572493|Immunotherapy|immunotherapy
366884|NCT01572480|Proteasome Inhibitor|proteasome inhibitor
366885|NCT01572480|Immunomodulatory Agents|immunomodulatory agents
366886|NCT01572480|Combination Therapy|combination therapy
366887|NCT01572480|Anti-Myeloma Activity|anti-myeloma activity
366888|NCT01572480|Smoldering Multiple Myeloma|smoldering multiple myeloma
366889|NCT01572480|SMM|smm
366890|NCT01572467|Leydig cell tumor|leydig cell tumor
366891|NCT01572467|ovarian stromal cancer|ovarian stromal cancer
366892|NCT01572467|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
366893|NCT01572467|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
366894|NCT01572454|coronary artery bypass graft|coronary artery bypass graft
366895|NCT01572454|hypokalemia|hypokalemia
366896|NCT01572454|cardiac arrhythmia|cardiac arrhythmia
366897|NCT01572454|dexmedetomidine|dexmedetomidine
366898|NCT01572454|remifentanil|remifentanil
366899|NCT01572428|Proximal Colon Cancer|proximal colon cancer
366900|NCT01572428|Serrated Colon Lesions|serrated colon lesions
366901|NCT01572428|Narrow Band Imaging|narrow band imaging
366902|NCT01572415|Screening for Type 2 diabetes|screening for type 2 diabetes
366903|NCT01572402|Diet|diet
366904|NCT01572402|Gastrointestinal peptides|gastrointestinal peptides
366905|NCT01572402|Insulin secretion|insulin secretion
366906|NCT01572402|Oxidative stress|oxidative stress
366907|NCT01572402|Plasma lipids|plasma lipids
366908|NCT01572402|Postprandial|postprandial
366909|NCT01572402|Type 2 diabetes|type 2 diabetes
366910|NCT01572389|Diabetes Mellitus|diabetes mellitus
366911|NCT01572389|Depression|depression
366912|NCT01572389|Affective Symptoms|affective symptoms
366913|NCT01572389|Self Care|self care
366914|NCT01572389|Telemedicine|telemedicine
366915|NCT01572389|Psychotherapy|psychotherapy
366916|NCT01572376|Pressure ulcers|pressure ulcers
366917|NCT01572376|Chronic wounds|chronic wounds
366918|NCT01572376|Spinal cord injury patients|spinal cord injury patients
366919|NCT01572376|Bone marrow|bone marrow
366920|NCT01572376|Mononuclear|mononuclear
366921|NCT01572376|Debridement|debridement
366922|NCT01572363|Fontan|fontan
366923|NCT01572363|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
366924|NCT01572363|Sildenafil|sildenafil
366925|NCT01572337|NIV|niv
366926|NCT01572337|acute respiratory failure|acute respiratory failure
366927|NCT01572337|hypoxia|hypoxia
366928|NCT01572337|hypercapnia|hypercapnia
366929|NCT01572337|non-invasive ventilation|non-invasive ventilation
366930|NCT01572337|hospital ward|hospital ward
366931|NCT01572324|Cholangiocarcinoma|cholangiocarcinoma
366932|NCT01572324|gallbladder cancer|gallbladder cancer
366933|NCT01572324|Infusions|infusions
366934|NCT01572324|Intra-Arterial|intra-arterial
366935|NCT01572311|Aerobic exercise|aerobic exercise
366936|NCT01572311|Cognition|cognition
366937|NCT01572311|Dual Task|dual task
366938|NCT01572311|Gait Training|gait training
366939|NCT01572311|Group-based exercise|group-based exercise
366940|NCT01572311|Older adults|older adults
366941|NCT01572285|Hemiplegic|hemiplegic
366942|NCT01572285|Shoulder Pain|shoulder pain
366943|NCT01572285|Transforaminal|transforaminal
366944|NCT01572285|Treatment|treatment
366945|NCT01572285|Interventional|interventional
366946|NCT01572272|Distal Capnography|distal capnography
366947|NCT01572272|CO2|co2
366948|NCT01572272|neonates|neonates
366949|NCT01572272|conventional ventilation|conventional ventilation
366950|NCT01572246|electrosurgery|electrosurgery
366951|NCT01572246|Cardiac surgical procedures|cardiac surgical procedures
366952|NCT01572246|Surgical procedures, operative|surgical procedures, operative
366953|NCT01572246|Defibrillators|defibrillators
366954|NCT01572233|Fatigue,Physical Activity,Hepatitis C Virus Infection|fatigue,physical activity,hepatitis c virus infection
366955|NCT01572220|Hospitalized patients|hospitalized patients
366956|NCT01572207|Multiple Sclerosis|multiple sclerosis
366957|NCT01572207|Exercise|exercise
366958|NCT01572207|Physical activity|physical activity
366959|NCT01572207|Quality of life|quality of life
366960|NCT01572194|CF|cf
366961|NCT01572168|Fatigue|fatigue
366962|NCT01572142|Parkinson disease|parkinson disease
366963|NCT01572142|smell|smell
366964|NCT01572142|cognitive|cognitive
366965|NCT01572116|sufentanil|sufentanil
366966|NCT01572116|irreversible pulpitis|irreversible pulpitis
366967|NCT01572116|intra ligament injection|intra ligament injection
366968|NCT01572090|Body mass index|body mass index
366969|NCT01572090|Body fat|body fat
366970|NCT01572090|Obesity|obesity
366971|NCT01572090|Bariatric surgery|bariatric surgery
366972|NCT01572090|Conventional dietary treatment|conventional dietary treatment
366973|NCT01572090|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
366974|NCT01572090|Cardiometabolic risk factors|cardiometabolic risk factors
366975|NCT01572090|Inflammation|inflammation
366976|NCT01572090|Adipokines|adipokines
366977|NCT01572090|Gastrointestinal hormones|gastrointestinal hormones
366978|NCT01572090|Comorbidity improvement|comorbidity improvement
366979|NCT01572090|Energy intake|energy intake
366980|NCT01572090|Energy expenditure|energy expenditure
366981|NCT01572090|Physical activity|physical activity
366982|NCT01572064|MRI|mri
366983|NCT01572064|liver biopsy|liver biopsy
366984|NCT01572064|serological markers|serological markers
366985|NCT01572051|osteoarthritis|osteoarthritis
366986|NCT01572051|knee osteoarthritis|knee osteoarthritis
366987|NCT01572051|education|education
366988|NCT01572012|Pharmacokinetics|pharmacokinetics
366989|NCT01572012|Safety|safety
366990|NCT01572012|Healthy Volunteers|healthy volunteers
366991|NCT01572012|tolerability|tolerability
366992|NCT01571999|pharmacokinetics|pharmacokinetics
366993|NCT01571999|GW642444|gw642444
366994|NCT01571999|GSK573719|gsk573719
366995|NCT01571999|vilanterol|vilanterol
366996|NCT01571999|renal impairment|renal impairment
366997|NCT01571999|safety|safety
366998|NCT01571999|COPD|copd
366999|NCT01571986|NIV|niv
367000|NCT01571986|acute respiratory failure|acute respiratory failure
367001|NCT01571986|hypoxia|hypoxia
367002|NCT01571986|hypercapnia|hypercapnia
367003|NCT01571986|non-invasive ventilation|non-invasive ventilation
367004|NCT01571986|hospital ward|hospital ward
367005|NCT01571973|pharmaceutical care|pharmaceutical care
367007|NCT01571973|compliance|compliance
367008|NCT01571973|pharmacist's intervention|pharmacist's intervention
367009|NCT01571973|Dáder|dáder
367010|NCT01571947|Insulinaemia|insulinaemia
367011|NCT01571947|inflammatory markers|inflammatory markers
367012|NCT01571947|gastrointestinal peptides|gastrointestinal peptides
367013|NCT01571947|SFA|sfa
367014|NCT01571947|dietary fats|dietary fats
367015|NCT01571947|carbohydrate|carbohydrate
367016|NCT01571947|insulin sensitivity|insulin sensitivity
367017|NCT01571934|Hemophilia A|hemophilia a
367018|NCT01571908|rocuronium|rocuronium
367019|NCT01571908|succinylcholine|succinylcholine
367020|NCT01571908|magnesiumsulphate|magnesiumsulphate
367021|NCT01571908|intubation conditions|intubation conditions
367022|NCT01571895|Autoimmune inflammatory blistering disorder|autoimmune inflammatory blistering disorder
367023|NCT01571882|Plant sterol - Policosanols - Hypercholesterolemia - Dairy|plant sterol - policosanols - hypercholesterolemia - dairy
367024|NCT01571869|Plant sterol - hypercholesterolemia - dairy - meal|plant sterol - hypercholesterolemia - dairy - meal
367025|NCT01571856|Acute Diarrhea|acute diarrhea
367026|NCT01571856|Zinc|zinc
367027|NCT01571856|Children|children
367028|NCT01571843|Hyperparathyroidism, Primary|hyperparathyroidism, primary
367029|NCT01571843|Bone Diseases, Metabolic|bone diseases, metabolic
367030|NCT01571843|Osteoporosis, Postmenopausal|osteoporosis, postmenopausal
367031|NCT01571843|Bone Loss, Postmenopausal|bone loss, postmenopausal
367032|NCT01571830|food allergy|food allergy
367033|NCT01571830|nutrient intake|nutrient intake
367034|NCT01571830|growth|growth
367035|NCT01571817|Insulin Dependent|insulin dependent
367036|NCT01571804|Anesthesia|anesthesia
367037|NCT01571804|pregabalin|pregabalin
367038|NCT01571804|sevoflurane|sevoflurane
367039|NCT01571804|laparoscopic cholecystectomy|laparoscopic cholecystectomy
367040|NCT01571791|Ketorolac|ketorolac
367041|NCT01571791|lidocaine|lidocaine
367042|NCT01571791|valvular hear diseases|valvular hear diseases
367043|NCT01571791|cesarean section|cesarean section
367044|NCT01571778|Hand Hygiene|hand hygiene
367045|NCT01571778|Non-sterile Glove Use|non-sterile glove use
367046|NCT01571765|maternal|maternal
367047|NCT01571765|newborn|newborn
367048|NCT01571765|child|child
367049|NCT01571752|Drug Abuse/Dependence|drug abuse/dependence
367050|NCT01571752|Drug Abuse|drug abuse
367051|NCT01571752|Drug Dependence|drug dependence
367052|NCT01571739|Biomarker|biomarker
367053|NCT01571739|Latent Tuberculosis|latent tuberculosis
367054|NCT01571739|IGRA|igra
367055|NCT01571739|Isoniazid|isoniazid
367056|NCT01571739|TB Lymphadenopathy|tb lymphadenopathy
367057|NCT01571739|Tuberculosis|tuberculosis
367058|NCT01571739|TB|tb
367059|NCT01571726|(18)-Fluciclatide PET/CT|(18)-fluciclatide pet/ct
367060|NCT01571726|Serum M-Protein|serum m-protein
367061|NCT01571726|Percentage of Plasma Cells in the Bone Marrow|percentage of plasma cells in the bone marrow
367062|NCT01571726|Ratio of Normal/Abnormal Percentage of Plasma Cells in the Bone Marrow|ratio of normal/abnormal percentage of plasma cells in the bone marrow
367063|NCT01571726|Multiple Myeloma|multiple myeloma
367064|NCT01571700|Mechanical Dysynchrony|mechanical dysynchrony
367065|NCT01571700|Electrical Dysynchrony|electrical dysynchrony
367066|NCT01571687|expedition|expedition
367067|NCT01571687|hypoxia|hypoxia
367068|NCT01571687|blood coagulation disorders|blood coagulation disorders
367069|NCT01571687|cell-derived microparticles|cell-derived microparticles
367070|NCT01571687|oxidative stress|oxidative stress
367071|NCT01571687|N-Acetylcystein|n-acetylcystein
367072|NCT01571687|vitamins|vitamins
367073|NCT01571674|Cervical|cervical
367074|NCT01571674|Clinical Prediction Rule|clinical prediction rule
367075|NCT01571674|Exercise|exercise
367076|NCT01571674|Manipulation|manipulation
367077|NCT01571674|Manual therapy|manual therapy
367078|NCT01571674|Mobilization|mobilization
367079|NCT01571674|Physical Therapy|physical therapy
367080|NCT01571674|Prognosis|prognosis
367081|NCT01571674|Shoulder pain|shoulder pain
367082|NCT01571674|Thoracic|thoracic
367083|NCT01571661|KGT-1142|kgt-1142
367084|NCT01571661|safety|safety
367085|NCT01571661|pharmacokinetics|pharmacokinetics
367086|NCT01571661|single-dose escalation|single-dose escalation
367087|NCT01571661|tolerability|tolerability
367088|NCT01571635|Beta-Thalassaemia|beta-thalassaemia
367089|NCT01571622|Whey protein|whey protein
367090|NCT01571622|type 2 diabetes|type 2 diabetes
367091|NCT01571596|XLH|xlh
367092|NCT01571583|Chronic HCV infection|chronic hcv infection
367093|NCT01571583|Genotype 1 chronic HCV|genotype 1 chronic hcv
367094|NCT01571583|Liver transplantation|liver transplantation
367095|NCT01571583|Hepatitis C|hepatitis c
367096|NCT01571583|Hep C|hep c
367097|NCT01571583|HCV|hcv
367098|NCT01571583|Telaprevir|telaprevir
367099|NCT01571583|Pegylated-Interferon-alfa-2a|pegylated-interferon-alfa-2a
367100|NCT01571583|Ribavirin|ribavirin
367101|NCT01571570|Healthy volunteers|healthy volunteers
367102|NCT01571570|Food effect|food effect
367103|NCT01571570|Capsule|capsule
367104|NCT01571570|Formulations|formulations
367105|NCT01571570|Liquid formulation|liquid formulation
367106|NCT01571570|Concept K|concept k
367107|NCT01571570|Concept L|concept l
367108|NCT01571570|Oral suspension|oral suspension
367109|NCT01571570|Oral solution|oral solution
367110|NCT01571570|TMC435HPC1002|tmc435hpc1002
367111|NCT01571570|TMC435|tmc435
367112|NCT01571570|HPC|hpc
367113|NCT01571518|G-CSF|g-csf
367114|NCT01571518|neutropenia|neutropenia
367115|NCT01571518|TAC|tac
367116|NCT01571505|Oral vaccines|oral vaccines
367117|NCT01571505|Vaccine Responsiveness|vaccine responsiveness
367118|NCT01571505|Tropical Enteropathy|tropical enteropathy
367119|NCT01571492|Postoperative Pain|postoperative pain
367120|NCT01571492|Nerve block|nerve block
367121|NCT01571492|Total Hip Arthroplasty|total hip arthroplasty
367122|NCT01571492|Postoperative analgesia|postoperative analgesia
367123|NCT01571492|Lumbar Plexus Catheters|lumbar plexus catheters
367124|NCT01571492|L2 Paravertebral Catheters|l2 paravertebral catheters
367125|NCT01571479|laparoscopic cholecystectomy|laparoscopic cholecystectomy
367126|NCT01571479|mini-instrument|mini-instrument
367127|NCT01571466|HIV Seronegativity|hiv seronegativity
367128|NCT01571466|HIV Preventive Vaccine|hiv preventive vaccine
367129|NCT01571453|MDD|mdd
367130|NCT01571440|Bone|bone
367131|NCT01571440|adolescents|adolescents
367132|NCT01571440|fiber|fiber
367133|NCT01571440|healthy|healthy
367134|NCT01571440|boys|boys
367135|NCT01571440|girls|girls
367136|NCT01571440|camp|camp
367137|NCT01571440|calcium|calcium
367138|NCT01571427|Behavioral intervention|behavioral intervention
367139|NCT01571427|Social engagement|social engagement
367140|NCT01571427|Conversational engagement|conversational engagement
367141|NCT01571427|Social network|social network
367142|NCT01571427|Cognitive Reserve|cognitive reserve
367143|NCT01571427|Alzheimer's disease|alzheimer's disease
367144|NCT01571401|Kidney cancer survivors|kidney cancer survivors
367145|NCT01571401|Randomized Controlled Trial|randomized controlled trial
367146|NCT01571401|Physical Activity|physical activity
367147|NCT01571401|Theory of Planned Behaviour|theory of planned behaviour
367148|NCT01571401|Quality of life|quality of life
367149|NCT01571388|dacomitinib|dacomitinib
367150|NCT01571388|PF-00299804|pf-00299804
367151|NCT01571388|hepatic impairment|hepatic impairment
367152|NCT01571388|pharmacokinetics|pharmacokinetics
367153|NCT01571375|Traumatic Brain Injury|traumatic brain injury
367154|NCT01571375|HEMS|hems
367155|NCT01571375|Out-of-hospital|out-of-hospital
367156|NCT01571375|Finland|finland
367157|NCT01571362|oxycodone|oxycodone
367158|NCT01571362|naltrexone|naltrexone
367159|NCT01571362|chronic pain|chronic pain
367160|NCT01571362|low back pain|low back pain
367161|NCT01571349|rebalanced hemostasis|rebalanced hemostasis
367162|NCT01571349|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
367163|NCT01571349|coagulation status|coagulation status
367164|NCT01571323|post partum haemorrhage at cesarean section|post partum haemorrhage at cesarean section
367165|NCT01571297|Diabetes Mellitus|diabetes mellitus
367166|NCT01571297|Delayed Gastric Emptying|delayed gastric emptying
367167|NCT01571297|Gastroparesis|gastroparesis
367168|NCT01571297|Gastrointestinal Motility Disorder|gastrointestinal motility disorder
367169|NCT01571271|biliary|biliary
367170|NCT01571271|lithotripsy|lithotripsy
367171|NCT01571271|gall stones|gall stones
367172|NCT01571271|bile duct|bile duct
367173|NCT01571271|Biliary stones|biliary stones
367174|NCT01571258|SMS|sms
367175|NCT01571258|Obesity|obesity
367176|NCT01571258|Text Messaging|text messaging
367177|NCT01571258|Intervention|intervention
367178|NCT01571258|Mobile Phone|mobile phone
367179|NCT01571245|Heart rate variability|heart rate variability
367180|NCT01571245|Attentional Bias|attentional bias
367181|NCT01571232|Macular Edema|macular edema
367182|NCT01571232|DME|dme
367183|NCT01571232|PDR|pdr
367184|NCT01571232|NPDR|npdr
367185|NCT01571232|Ozurdex|ozurdex
367186|NCT01571232|Dexamethasone|dexamethasone
367187|NCT01571232|Avastin|avastin
367188|NCT01571232|Bevacizumab|bevacizumab
367189|NCT01571219|RA|ra
367190|NCT01571219|Biosimilar|biosimilar
367191|NCT01571206|AS|as
367192|NCT01571206|Biosimilar|biosimilar
367193|NCT01571180|Obesity|obesity
367194|NCT01571180|Gastric bypass|gastric bypass
367195|NCT01571180|Medication|medication
367196|NCT01571180|Medication counseling|medication counseling
367197|NCT01571180|Dietary pattern|dietary pattern
367198|NCT01571180|Follow-up of patients|follow-up of patients
367199|NCT01571167|Methamphetamine|methamphetamine
367200|NCT01571167|Chantix|chantix
367201|NCT01571167|Varenicline|varenicline
367202|NCT01571141|HPV|hpv
367203|NCT01571141|polyhexamethylene biguanide|polyhexamethylene biguanide
367204|NCT01571141|intraepithelial lesions|intraepithelial lesions
367205|NCT01571141|regression rate|regression rate
367206|NCT01571128|HIV|hiv
367207|NCT01571128|Prevention & Control|prevention & control
367208|NCT01571128|Intervention Studies|intervention studies
367209|NCT01571128|Adolescent|adolescent
367210|NCT01571128|Gender|gender
367211|NCT01571128|Combination prevention|combination prevention
367212|NCT01571128|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
367213|NCT01571128|Cash Transfer|cash transfer
367214|NCT01571128|Medical Male Circumcision|medical male circumcision
367215|NCT01571128|HIV Testing|hiv testing
367216|NCT01571128|Mobile Health|mobile health
367217|NCT01571115|insomnia|insomnia
367218|NCT01571115|resistance physical exercise|resistance physical exercise
367219|NCT01571115|stretching|stretching
367220|NCT01571089|Dialectical behavior therapy|dialectical behavior therapy
367221|NCT01571089|cognitive behavioral therapy|cognitive behavioral therapy
368299|NCT01566448|Mucositis|mucositis
367222|NCT01571089|emotion regulation|emotion regulation
367223|NCT01571089|emotion dysregulation|emotion dysregulation
367224|NCT01571089|anxiety disorders|anxiety disorders
367225|NCT01571089|skills training|skills training
367226|NCT01571076|PGS|pgs
367227|NCT01571076|CGH|cgh
367228|NCT01571076|Aneuploidy|aneuploidy
367229|NCT01571076|Advanced maternal age|advanced maternal age
367230|NCT01571076|Male factor|male factor
367231|NCT01571050|toothpastes|toothpastes
367232|NCT01571050|dental fluorosis|dental fluorosis
367233|NCT01571050|fluoride|fluoride
367234|NCT01571050|bioavailability|bioavailability
367235|NCT01571037|mechanical circulatory assist device|mechanical circulatory assist device
367236|NCT01571024|FOLFOX6|folfox6
367237|NCT01571024|BKM120|bkm120
367238|NCT01571024|Advanced Solid Tumors|advanced solid tumors
367239|NCT01571024|Metastatic|metastatic
367240|NCT01571024|Colorectal Cancer|colorectal cancer
367241|NCT01571024|Pancreatic Cancer|pancreatic cancer
367242|NCT01571011|Adolescent|adolescent
367243|NCT01571011|Randomized Trial|randomized trial
367244|NCT01571011|Internet|internet
367245|NCT01571011|Depressive Disorder|depressive disorder
367246|NCT01571011|Primary Care|primary care
367247|NCT01571011|Prevention|prevention
367248|NCT01570985|shoulder capsulitis|shoulder capsulitis
367249|NCT01570985|frozen shoulder|frozen shoulder
367250|NCT01570985|adhesive capsulitis|adhesive capsulitis
367251|NCT01570985|distension|distension
367252|NCT01570985|corticosteroid injection|corticosteroid injection
367253|NCT01570985|intraarticular injection|intraarticular injection
367254|NCT01570972|schizophrenia|schizophrenia
367255|NCT01570972|schizoaffective disorder|schizoaffective disorder
367256|NCT01570972|bipolar disorder with psychotic features|bipolar disorder with psychotic features
367257|NCT01570972|major depression with psychotic features|major depression with psychotic features
367258|NCT01570972|recent-onset psychosis|recent-onset psychosis
367259|NCT01570972|first-episode psychosis|first-episode psychosis
367260|NCT01570972|cognitive behavioral therapy|cognitive behavioral therapy
367261|NCT01570972|multifamily group psychoeducation|multifamily group psychoeducation
367262|NCT01570946|Lifestyle changes to prevent type 2 diabetes|lifestyle changes to prevent type 2 diabetes
367263|NCT01570933|cardio-pulmonary bypass|cardio-pulmonary bypass
367264|NCT01570920|Activity limitations|activity limitations
367265|NCT01570920|restriction of participation|restriction of participation
367266|NCT01570920|chronic stroke survival|chronic stroke survival
367267|NCT01570920|physical activity|physical activity
367268|NCT01570920|walking|walking
367269|NCT01570881|postoperative delirium|postoperative delirium
367270|NCT01570881|melatonin|melatonin
367271|NCT01570881|sevoflurane|sevoflurane
367272|NCT01570868|Leukemia|leukemia
367273|NCT01570868|Chronic Myeloid Leukemia|chronic myeloid leukemia
367274|NCT01570868|CML|cml
367275|NCT01570868|Chronic Phase|chronic phase
367276|NCT01570868|Cytogenetic response|cytogenetic response
367277|NCT01570868|CCyR|ccyr
367278|NCT01570868|Major molecular response|major molecular response
367279|NCT01570868|MMR|mmr
367280|NCT01570868|Complete molecular response|complete molecular response
367281|NCT01570868|CMR|cmr
367282|NCT01570868|Ponatinib|ponatinib
367283|NCT01570868|AP24534|ap24534
367284|NCT01570855|Lung cancer|lung cancer
367285|NCT01570855|chemosensitivity|chemosensitivity
367286|NCT01570842|Gastroesophageal reflux disease|gastroesophageal reflux disease
367287|NCT01570842|GERD|gerd
367288|NCT01570842|Barrett's esophagus|barrett's esophagus
367289|NCT01570816|stroke|stroke
367290|NCT01570816|partial paralysis|partial paralysis
367291|NCT01570816|gait correction|gait correction
367292|NCT01570816|functional electrical stimulation|functional electrical stimulation
367293|NCT01570816|paraplegia|paraplegia
367294|NCT01570816|tetraplegia|tetraplegia
367295|NCT01570816|spinal cord injury|spinal cord injury
367296|NCT01570803|peripheral arterial disease,|peripheral arterial disease,
367297|NCT01570803|atherosclerosis,|atherosclerosis,
367298|NCT01570803|nitinol,|nitinol,
367299|NCT01570803|stents|stents
367300|NCT01570777|Resistant hypertension|resistant hypertension
367301|NCT01570777|Renal denervation|renal denervation
367302|NCT01570777|Standardized medication regimen|standardized medication regimen
367303|NCT01570777|Endovascular|endovascular
367304|NCT01570777|Primary hypertension|primary hypertension
367305|NCT01570777|Cardiovascular diseases|cardiovascular diseases
367306|NCT01570777|Vascular diseases|vascular diseases
367307|NCT01570764|Systemic sclerosis|systemic sclerosis
367308|NCT01570764|Interstitial lung disease|interstitial lung disease
367309|NCT01570764|Worsening|worsening
367310|NCT01570764|Cyclophosphamide|cyclophosphamide
367311|NCT01570764|Intravenous|intravenous
367312|NCT01570738|sleep disorders|sleep disorders
367313|NCT01570738|sleep apnea|sleep apnea
367314|NCT01570738|ambulatory device|ambulatory device
367315|NCT01570738|polysomnography|polysomnography
367316|NCT01570738|WatchPAT|watchpat
367317|NCT01570725|Immersive virtual reality|immersive virtual reality
367318|NCT01570725|e-health|e-health
367319|NCT01570725|surgery|surgery
367320|NCT01570725|anxiety|anxiety
367321|NCT01570725|relaxation|relaxation
367322|NCT01570725|Patients who undergo ambulatory surgical operations|patients who undergo ambulatory surgical operations
367323|NCT01570699|Cross-sectional observational study|cross-sectional observational study
367324|NCT01570699|COMT polymorphism|comt polymorphism
367325|NCT01570699|Opiate-users|opiate-users
367326|NCT01570699|Opiate dependence|opiate dependence
367327|NCT01570686|Food effect, hypertension, aliskiren|food effect, hypertension, aliskiren
367328|NCT01570673|quality of life|quality of life
367329|NCT01570673|urinary bladder|urinary bladder
367330|NCT01570673|symptoms|symptoms
367331|NCT01570673|children|children
367332|NCT01570634|Clostridium difficile|clostridium difficile
367333|NCT01570634|infection|infection
367334|NCT01570634|diarrhea|diarrhea
367335|NCT01570634|cramping|cramping
367336|NCT01570621|achalasia|achalasia
367337|NCT01570621|peroral endoscopic myotomy|peroral endoscopic myotomy
367338|NCT01570621|LES pressure|les pressure
367339|NCT01570621|postoperative complication|postoperative complication
367340|NCT01570621|symptom relief|symptom relief
367341|NCT01570621|esophageal barium|esophageal barium
367342|NCT01570608|Ranibizumab|ranibizumab
367343|NCT01570608|Bevacizumab|bevacizumab
367344|NCT01570608|Verteporfin|verteporfin
367345|NCT01570608|age-related macular degeneration|age-related macular degeneration
367346|NCT01570595|Tobacco Use Cessation|tobacco use cessation
367347|NCT01570595|Tobacco Cessation|tobacco cessation
367348|NCT01570595|Tobacco Use Disorder|tobacco use disorder
367349|NCT01570595|Tobacco Dependence|tobacco dependence
367350|NCT01570595|Tobacco-Use Disorder|tobacco-use disorder
367351|NCT01570595|Virus, Human Immunodeficiency|virus, human immunodeficiency
367352|NCT01570582|recurrent ovarian|recurrent ovarian
367353|NCT01570582|ECG|ecg
367354|NCT01570582|GOG performance|gog performance
367355|NCT01570582|Hematologic g|hematologic g
367356|NCT01570582|Blood chemistry and urinalysis h|blood chemistry and urinalysis h
367357|NCT01570569|Volunteers|volunteers
367358|NCT01570556|Hemodialysis|hemodialysis
367359|NCT01570556|Inflammation|inflammation
367360|NCT01570556|Bacteriuria|bacteriuria
367361|NCT01570556|Interleukin 6|interleukin 6
367362|NCT01570556|C reactive protein|c reactive protein
367363|NCT01570543|implants|implants
367364|NCT01570543|knee implants|knee implants
367365|NCT01570543|hip implants|hip implants
367366|NCT01570543|metallic implants|metallic implants
367367|NCT01570504|Strongyloidiasis|strongyloidiasis
367368|NCT01570504|Strongyloides stercoralis|strongyloides stercoralis
367369|NCT01570504|Ivermectin|ivermectin
367370|NCT01570465|AML|aml
367371|NCT01570465|adult|adult
367372|NCT01570465|AML1310 GIMEMA study|aml1310 gimema study
367373|NCT01570452|matrilysin|matrilysin
367374|NCT01570452|MMP-7|mmp-7
367375|NCT01570452|colorectal cancer|colorectal cancer
367376|NCT01570452|adenoma|adenoma
367377|NCT01570452|lymph nodes|lymph nodes
367378|NCT01570426|Bipolar disorder|bipolar disorder
367379|NCT01570426|Mood disorders|mood disorders
367380|NCT01570426|ADHD|adhd
367381|NCT01570426|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
367382|NCT01570426|Attention Deficit Disorder without Hyperactivity|attention deficit disorder without hyperactivity
367383|NCT01570426|Anxiety disorders|anxiety disorders
367384|NCT01570426|Generalized anxiety disorder|generalized anxiety disorder
367385|NCT01570426|Magnetic resonance imaging|magnetic resonance imaging
367386|NCT01570426|Mental disorders|mental disorders
367387|NCT01570426|Mental disorders diagnosed in childhood|mental disorders diagnosed in childhood
367388|NCT01570426|affective neuroscience|affective neuroscience
367389|NCT01570426|emotion|emotion
367390|NCT01570426|MRI|mri
367391|NCT01570426|fMRI|fmri
367392|NCT01570426|neurocognitive tasks|neurocognitive tasks
367393|NCT01570426|imaging|imaging
367394|NCT01570426|Healthy controls|healthy controls
367395|NCT01570426|typical development|typical development
367396|NCT01570400|social phobia|social phobia
367397|NCT01570400|social anxiety|social anxiety
367398|NCT01570400|cognitive bias modification|cognitive bias modification
367399|NCT01570374|Cognitive behavioral therapy|cognitive behavioral therapy
367400|NCT01570374|Internet|internet
367401|NCT01570374|Anxiety|anxiety
367402|NCT01570374|Generalized anxiety disorder|generalized anxiety disorder
367403|NCT01570361|Atrial Fibrillation|atrial fibrillation
367404|NCT01570361|Arrhythmias, Cardiac|arrhythmias, cardiac
367405|NCT01570361|Heart Diseases|heart diseases
367406|NCT01570361|Cardiovascular Diseases|cardiovascular diseases
367407|NCT01570361|Pathologic Processes|pathologic processes
367408|NCT01570348|Crohn's Disease|crohn's disease
367409|NCT01570348|Allogeneic bone marrow transplantation|allogeneic bone marrow transplantation
367410|NCT01570348|Hematopoietic cell transplantation|hematopoietic cell transplantation
367411|NCT01570335|SBAR,|sbar,
367412|NCT01570335|SAQ,|saq,
367413|NCT01570335|Team Resource Management|team resource management
367414|NCT01570322|Dementia - Alzheimer - Quality of life|dementia - alzheimer - quality of life
367415|NCT01570309|vitamin D,|vitamin d,
367416|NCT01570309|vitamin D deficiency|vitamin d deficiency
367417|NCT01570309|coronary artery disease|coronary artery disease
367418|NCT01570309|ergocalciferol|ergocalciferol
367419|NCT01570309|endothelial function|endothelial function
367420|NCT01570309|adhesion molecules|adhesion molecules
367421|NCT01570309|inflammation|inflammation
367422|NCT01570309|IL-12|il-12
367423|NCT01570309|interferon-gamma|interferon-gamma
367424|NCT01570309|CXCL-10|cxcl-10
367425|NCT01570309|reactive hyperemia peripheral arterial tonometry|reactive hyperemia peripheral arterial tonometry
367426|NCT01570309|endothelial dysfunction|endothelial dysfunction
367427|NCT01570309|cytokines|cytokines
367428|NCT01570309|chemokines|chemokines
367429|NCT01570296|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
367430|NCT01570296|tumors harbor molecular|tumors harbor molecular
367431|NCT01570296|alterations of PI3K pathway|alterations of pi3k pathway
367432|NCT01570296|known to overexpress EGFR|known to overexpress egfr
367433|NCT01570283|post allogeneic hematopoietic stem cell transplant|post allogeneic hematopoietic stem cell transplant
367434|NCT01570283|cytotoxic T lymphocytes|cytotoxic t lymphocytes
367435|NCT01570283|Cytomegalovirus|cytomegalovirus
367436|NCT01570283|CMV|cmv
367437|NCT01570283|adenovirus|adenovirus
367438|NCT01570283|Epstein-Barr virus|epstein-barr virus
367439|NCT01570283|EBV|ebv
367440|NCT01570283|Human polyomavirus type I|human polyomavirus type i
367441|NCT01570283|BK virus|bk virus
367442|NCT01570283|Human herpesvirus 6|human herpesvirus 6
367443|NCT01570283|HHV6|hhv6
367444|NCT01570270|Hypercholesterolemia|hypercholesterolemia
367445|NCT01570270|Endocannabinoids|endocannabinoids
367446|NCT01570257|normal pressure hydrocephalus|normal pressure hydrocephalus
367447|NCT01570257|ventriculoperitoneal shunt|ventriculoperitoneal shunt
367448|NCT01570257|overdrainage|overdrainage
367449|NCT01570257|subdural effusion|subdural effusion
367450|NCT01570231|remote ischemic preconditioning|remote ischemic preconditioning
367451|NCT01570231|octogenarian|octogenarian
367452|NCT01570231|intracranial arterial stenosis|intracranial arterial stenosis
367453|NCT01570231|stroke recurrence|stroke recurrence
367454|NCT01570218|breast cancer|breast cancer
367455|NCT01570218|gynecological cancer|gynecological cancer
367456|NCT01570218|radiotherapy|radiotherapy
367457|NCT01570218|fatigue|fatigue
367458|NCT01570218|musicotherapy|musicotherapy
367459|NCT01570192|gram negative pathogens|gram negative pathogens
367460|NCT01570192|Pseudomonas aeruginosa|pseudomonas aeruginosa
367461|NCT01570192|Acinetobacter|acinetobacter
367462|NCT01570192|HCAP|hcap
367463|NCT01570192|VABP|vabp
367464|NCT01570192|HABP|habp
367465|NCT01570179|bariatric surgery|bariatric surgery
367466|NCT01570179|residual paralysis|residual paralysis
367467|NCT01570179|surgical conditions|surgical conditions
367468|NCT01570166|Hepatocellular Carcinoma|hepatocellular carcinoma
367469|NCT01570166|RFA|rfa
367470|NCT01570166|HR|hr
367471|NCT01570127|Individualized Acupuncture|individualized acupuncture
367472|NCT01570127|Standardized Acupuncture|standardized acupuncture
367473|NCT01570127|Low Back Pain|low back pain
367474|NCT01570127|Randomized Controlled Trial|randomized controlled trial
367475|NCT01570114|Covered metallic stent|covered metallic stent
367476|NCT01570114|colon|colon
367477|NCT01570114|benign stricture|benign stricture
367478|NCT01570075|Hepatocellular Carcinoma|hepatocellular carcinoma
367479|NCT01570075|RFA|rfa
367480|NCT01570075|HR|hr
367481|NCT01570062|Inflammation|inflammation
367482|NCT01570062|Pathologic Processes|pathologic processes
367483|NCT01570049|Single arm|single arm
367484|NCT01570049|Open label|open label
367485|NCT01570049|Bendamustine HCl|bendamustine hcl
367486|NCT01570049|Non-hodgkin's lymphoma|non-hodgkin's lymphoma
367487|NCT01570036|stage I breast cancer|stage i breast cancer
367488|NCT01570036|stage II breast cancer|stage ii breast cancer
367489|NCT01570036|stage IIIA breast cancer|stage iiia breast cancer
367490|NCT01570036|stage IIIB breast cancer|stage iiib breast cancer
367491|NCT01570036|stage IIIC breast cancer|stage iiic breast cancer
367492|NCT01570036|male breast cancer|male breast cancer
367493|NCT01570023|Deglutition|deglutition
367494|NCT01570023|Exercise|exercise
367495|NCT01569997|Dementia|dementia
367496|NCT01569997|emergency hospitalization|emergency hospitalization
367497|NCT01569997|nursing home|nursing home
367498|NCT01569997|multidisciplinary meeting|multidisciplinary meeting
367499|NCT01569997|cognitive decline|cognitive decline
367500|NCT01569997|disability|disability
367501|NCT01569997|residents|residents
367502|NCT01569997|facilities|facilities
367503|NCT01569997|long term care unit|long term care unit
367504|NCT01569997|health policy|health policy
367505|NCT01569997|general practitioner|general practitioner
367506|NCT01569997|prevention|prevention
367507|NCT01569984|Colorectal|colorectal
367508|NCT01569971|Transition Program|transition program
367509|NCT01569971|Perspectives|perspectives
367759|NCT01568840|Posture|posture
367510|NCT01569932|chemobrain, chemotherapy, cognitive impairments, fcMRI, neurocognitive Assessments|chemobrain, chemotherapy, cognitive impairments, fcmri, neurocognitive assessments
367511|NCT01569919|Phase II|phase ii
367512|NCT01569919|Single arm|single arm
367513|NCT01569919|Vaccine|vaccine
367514|NCT01569906|Atopic Dermatitis|atopic dermatitis
367515|NCT01569893|Telemonitoring|telemonitoring
367516|NCT01569893|Telemedicine|telemedicine
367517|NCT01569893|Diabetes mellitus|diabetes mellitus
367518|NCT01569880|Blood gas response|blood gas response
367519|NCT01569880|Exercise|exercise
367520|NCT01569880|Gas exchange|gas exchange
367521|NCT01569880|Hypoxia altitude simulation test|hypoxia altitude simulation test
367522|NCT01569880|Pulmonary function|pulmonary function
367523|NCT01569828|LCZ696|lcz696
367524|NCT01569828|pharmacokinetics|pharmacokinetics
367525|NCT01569815|Renal Impairment,|renal impairment,
367526|NCT01569815|LCZ696|lcz696
367527|NCT01569802|breast cancer screening|breast cancer screening
367528|NCT01569802|tomosynthesis|tomosynthesis
367529|NCT01569802|FFDM|ffdm
367530|NCT01569789|cytokines|cytokines
367531|NCT01569789|inflammation|inflammation
367532|NCT01569789|vagus nerve|vagus nerve
367533|NCT01569789|TNF|tnf
367534|NCT01569776|Cow milk allergy|cow milk allergy
367535|NCT01569776|CMA|cma
367536|NCT01569763|endometrial ablation|endometrial ablation
367537|NCT01569750|CD20-positive B-cell non-Hodgkin lymphoma|cd20-positive b-cell non-hodgkin lymphoma
367538|NCT01569750|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
367539|NCT01569750|Mantle cell lymphoma|mantle cell lymphoma
367540|NCT01569750|Follicular lymphoma|follicular lymphoma
367541|NCT01569750|Ibrutinib|ibrutinib
367542|NCT01569750|R-CHOP|r-chop
367543|NCT01569750|Rituximab|rituximab
367544|NCT01569750|Cyclophosphamide|cyclophosphamide
367545|NCT01569750|Doxorubicin|doxorubicin
367546|NCT01569750|Vincristine|vincristine
367547|NCT01569750|Prednisone|prednisone
367548|NCT01569737|ella|ella
367549|NCT01569737|ulipristal acetate|ulipristal acetate
367550|NCT01569737|pregnancy|pregnancy
367551|NCT01569737|emergency contraception|emergency contraception
367552|NCT01569724|hypertriglyceridemia|hypertriglyceridemia
367553|NCT01569724|bexarotene|bexarotene
367554|NCT01569711|chronic and resistant major depressive disorder|chronic and resistant major depressive disorder
367555|NCT01569711|deep brain stimulation|deep brain stimulation
367556|NCT01569698|pediatric|pediatric
367557|NCT01569698|acute renal failure|acute renal failure
367558|NCT01569698|acute extra renal replacement therapy|acute extra renal replacement therapy
367559|NCT01569698|Intermittent Hemodialysis|intermittent hemodialysis
367560|NCT01569698|Continuous Renal Replacement Therapies|continuous renal replacement therapies
367561|NCT01569698|Peritoneal Dialysis|peritoneal dialysis
367562|NCT01569685|PTSD|ptsd
367563|NCT01569685|Traumatic Stress|traumatic stress
367564|NCT01569685|Depressions|depressions
367565|NCT01569685|Refugees|refugees
367566|NCT01569672|Navigator|navigator
367567|NCT01569659|Schizophrenia|schizophrenia
367568|NCT01569659|Refractory|refractory
367569|NCT01569659|Treatment resistant|treatment resistant
367570|NCT01569659|Lurasidone|lurasidone
367571|NCT01569646|monocytes|monocytes
367572|NCT01569646|culprit vessels|culprit vessels
367573|NCT01569620|Colorectal Cancer Screening|colorectal cancer screening
367574|NCT01569620|CRC|crc
367575|NCT01569620|Screening Colonoscopy|screening colonoscopy
367576|NCT01569620|Hispanics|hispanics
367577|NCT01569620|Latinos|latinos
367578|NCT01569607|Neurophysiology|neurophysiology
367579|NCT01569607|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
367580|NCT01569607|Neurology|neurology
367581|NCT01569607|Stroke|stroke
367582|NCT01569607|Physical Medicine and Rehabilitation|physical medicine and rehabilitation
367583|NCT01569581|Human Enterovirus 71 (EV71)|human enterovirus 71 (ev71)
367584|NCT01569581|Hand, Foot and Mouth Disease (HFMD)|hand, foot and mouth disease (hfmd)
367585|NCT01569581|Inactivated Vaccine|inactivated vaccine
367586|NCT01569581|Human Diploid cell (KMB17)|human diploid cell (kmb17)
367587|NCT01569581|Adverse reactions associated with vaccine|adverse reactions associated with vaccine
367588|NCT01569581|Efficacy|efficacy
367589|NCT01569568|Neuroimaging|neuroimaging
367590|NCT01569568|MRI|mri
367591|NCT01569568|Urea cycle|urea cycle
367592|NCT01569568|hyperammonemia|hyperammonemia
367593|NCT01569568|cognitive function|cognitive function
367594|NCT01569568|ornithine transcarbamylase deficiency|ornithine transcarbamylase deficiency
367595|NCT01569516|Alzheimer's Disease|alzheimer's disease
367596|NCT01569516|Octohydroaminoacridine Succinate|octohydroaminoacridine succinate
367597|NCT01569503|Crohn's Disease|crohn's disease
367598|NCT01569503|VNS|vns
367599|NCT01569503|vagus nerve stimulation|vagus nerve stimulation
367600|NCT01569503|inflammation|inflammation
367601|NCT01569503|Inflammatory bowel diseases|inflammatory bowel diseases
367602|NCT01569503|TNF|tnf
367603|NCT01569464|Rotigotine|rotigotine
367604|NCT01569464|Restless Legs Syndrome|restless legs syndrome
367605|NCT01569464|Neupro®|neupro®
367606|NCT01569451|Multiple Sclerosis|multiple sclerosis
367607|NCT01569451|Glatiramer Acetate|glatiramer acetate
367608|NCT01569451|Rituximab|rituximab
367609|NCT01569451|Relapsing forms of Multiple Sclerosis|relapsing forms of multiple sclerosis
367610|NCT01569451|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
367611|NCT01569425|PCOS|pcos
367612|NCT01569399|Alcohol dependance|alcohol dependance
367613|NCT01569399|rTMS|rtms
367614|NCT01569399|craving|craving
367615|NCT01569399|alcohol consumption|alcohol consumption
367616|NCT01569386|pulse wave velocity|pulse wave velocity
367617|NCT01569386|low intensity physical activity|low intensity physical activity
367618|NCT01569386|hemiplegia|hemiplegia
367619|NCT01569373|Allogeneic stem cell transplant|allogeneic stem cell transplant
367620|NCT01569373|Graft versus Host Disease|graft versus host disease
367621|NCT01569373|GVHD|gvhd
367622|NCT01569360|Spinal cord injury|spinal cord injury
367623|NCT01569360|Tetraplegia|tetraplegia
367624|NCT01569360|Paraplegia|paraplegia
367625|NCT01569360|Respiratory function|respiratory function
367626|NCT01569360|Corset|corset
367627|NCT01569347|Cocaine|cocaine
367628|NCT01569347|Cocaine-induced psychosis|cocaine-induced psychosis
367629|NCT01569347|Genetic|genetic
367630|NCT01569347|Clinical|clinical
367631|NCT01569347|Biological|biological
367760|NCT01568840|Muscle Stretching Exercises|muscle stretching exercises
367761|NCT01568840|Dyskinesias|dyskinesias
367762|NCT01568840|Neck pain|neck pain
367632|NCT01569334|identify early non invasive markers that index the endothelial lesion/ regeneration potential in association with CAV in heart transplanted recipients (HTR)|identify early non invasive markers that index the endothelial lesion/ regeneration potential in association with cav in heart transplanted recipients (htr)
367633|NCT01569308|Cardiac output|cardiac output
367634|NCT01569308|Pulse pressure variation|pulse pressure variation
367635|NCT01569308|Fluid responsiveness|fluid responsiveness
367636|NCT01569308|Low tidal volume|low tidal volume
367637|NCT01569295|Zydelig|zydelig
367638|NCT01569295|CLL|cll
367639|NCT01569295|CAL 101|cal 101
367640|NCT01569295|CAL-101|cal-101
367641|NCT01569295|GS 1101|gs 1101
367642|NCT01569295|GS-1101|gs-1101
367643|NCT01569295|PI3K|pi3k
367644|NCT01569295|Rituxan|rituxan
367645|NCT01569295|Rituximab|rituximab
367646|NCT01569295|Bendamustine|bendamustine
367647|NCT01569295|Leukemia|leukemia
367648|NCT01569295|idelalisib|idelalisib
367649|NCT01569282|Surgical bypass|surgical bypass
367650|NCT01569282|Hepaticojejunostomy|hepaticojejunostomy
367651|NCT01569282|Gastrojejunostomy|gastrojejunostomy
367652|NCT01569282|Biliary stent|biliary stent
367653|NCT01569282|Enteral stent|enteral stent
367654|NCT01569269|chemotherapy induced peripheral neuropathy|chemotherapy induced peripheral neuropathy
367655|NCT01569269|cancer|cancer
367656|NCT01569269|psychological distress|psychological distress
367657|NCT01569269|mindfulness|mindfulness
367658|NCT01569269|complementary and alternative|complementary and alternative
367659|NCT01569243|Diabetes mellitus|diabetes mellitus
367660|NCT01569243|Text messaging|text messaging
367661|NCT01569243|Physical activity|physical activity
367662|NCT01569230|Knee osteoarthritis|knee osteoarthritis
367663|NCT01569230|acupuncture|acupuncture
367664|NCT01569230|sham acupuncture|sham acupuncture
367665|NCT01569217|Diaphragm|diaphragm
367666|NCT01569217|Abdomen|abdomen
367667|NCT01569217|Breathing pattern|breathing pattern
367668|NCT01569217|dyspnea|dyspnea
367669|NCT01569191|Ocular allergy|ocular allergy
367670|NCT01569191|Tear supplement|tear supplement
367671|NCT01569191|Cold compress|cold compress
367672|NCT01569178|stem cells|stem cells
367673|NCT01569178|acute myocardial infarction|acute myocardial infarction
367674|NCT01569178|heart failure|heart failure
367675|NCT01569178|heart attack|heart attack
367676|NCT01569178|bone marrow|bone marrow
367677|NCT01569178|intracoronary reinfusion|intracoronary reinfusion
367678|NCT01569178|bone marrow derived mononuclear cells|bone marrow derived mononuclear cells
367679|NCT01569178|Left ventricular function improvement|left ventricular function improvement
367680|NCT01569178|mortality|mortality
367681|NCT01569165|Acidogenicity|acidogenicity
367682|NCT01569165|Acidulated phosphate fluoride|acidulated phosphate fluoride
367683|NCT01569165|dental plaque|dental plaque
367684|NCT01569165|water rinsing|water rinsing
367685|NCT01569139|Validation|validation
367686|NCT01569139|Concordance|concordance
367687|NCT01569139|Myocardial infarction|myocardial infarction
367688|NCT01569139|Myocardial Ischaemia National Audit Project|myocardial ischaemia national audit project
367689|NCT01569139|General Practice Research Database|general practice research database
367690|NCT01569139|Hospital Episode Statistics|hospital episode statistics
367691|NCT01569139|ONS mortality|ons mortality
367692|NCT01569113|ella|ella
367693|NCT01569113|ellaOne|ellaone
367694|NCT01569113|quickstart|quickstart
367695|NCT01569113|contraception|contraception
367696|NCT01569113|combined oral pill|combined oral pill
367697|NCT01569113|microgynon|microgynon
367698|NCT01569087|empegfilgrastim|empegfilgrastim
367699|NCT01569087|pegylated filgrastim|pegylated filgrastim
367700|NCT01569087|neutropenia|neutropenia
367701|NCT01569087|febrile neutropenia|febrile neutropenia
367702|NCT01569087|chemotherapy-associated neutropenia|chemotherapy-associated neutropenia
367703|NCT01569087|breast cancer|breast cancer
367704|NCT01569087|docetaxel|docetaxel
367705|NCT01569087|doxorubicin|doxorubicin
367706|NCT01569074|Rheumatoid Arthritis|rheumatoid arthritis
367707|NCT01569061|overactive bladder|overactive bladder
367708|NCT01569061|laser therapy|laser therapy
367709|NCT01569061|urinary incontinence|urinary incontinence
367710|NCT01569061|urinary urgency|urinary urgency
367711|NCT01569035|oligohudramnios|oligohudramnios
367712|NCT01569035|oral anti coagulant|oral anti coagulant
367713|NCT01569035|Dopplar ultrasound|dopplar ultrasound
367714|NCT01569022|post traumatic stress disorder|post traumatic stress disorder
367715|NCT01569022|continuous positive airway pressure|continuous positive airway pressure
367716|NCT01569022|oral appliance|oral appliance
367717|NCT01569009|Bronchiectasis|bronchiectasis
367718|NCT01569009|Physical activity|physical activity
367719|NCT01569009|Activity monitor|activity monitor
367720|NCT01569009|Pedometer|pedometer
367721|NCT01568996|atypical nevi|atypical nevi
367722|NCT01568996|melanoma|melanoma
367723|NCT01568996|sulforaphane|sulforaphane
367724|NCT01568996|broccoli|broccoli
367725|NCT01568996|lesions|lesions
367726|NCT01568996|STAT1|stat1
367727|NCT01568996|STAT3|stat3
367728|NCT01568970|rehabilitation|rehabilitation
367729|NCT01568970|return to work|return to work
367730|NCT01568970|sick leave|sick leave
367731|NCT01568957|Gait|gait
367732|NCT01568957|Dual-task|dual-task
367733|NCT01568957|Obstacle avoidance|obstacle avoidance
367734|NCT01568957|Attention allocation|attention allocation
367735|NCT01568944|periodontal|periodontal
367736|NCT01568944|disease|disease
367737|NCT01568944|dendritic|dendritic
367738|NCT01568944|cells|cells
367739|NCT01568944|antibiotics|antibiotics
367740|NCT01568931|thrombectomy|thrombectomy
367741|NCT01568905|smoker|smoker
367742|NCT01568905|smoking|smoking
367743|NCT01568905|nicotine levels|nicotine levels
367744|NCT01568905|tobacco|tobacco
367745|NCT01568905|nicotine|nicotine
367746|NCT01568892|ART-experienced|art-experienced
367747|NCT01568892|GSK1349572|gsk1349572
367748|NCT01568892|Integrase inhibitor resistance|integrase inhibitor resistance
367749|NCT01568892|Dolutegravir|dolutegravir
367750|NCT01568879|Recurrent gout|recurrent gout
367751|NCT01568879|Tophaceous gout|tophaceous gout
367752|NCT01568879|Gout flares|gout flares
367753|NCT01568879|Arthritis|arthritis
367754|NCT01568879|Joint Diseases|joint diseases
367755|NCT01568879|Rheumatic Diseases|rheumatic diseases
367756|NCT01568866|multiple myeloma|multiple myeloma
367757|NCT01568866|relapsed multiple myeloma|relapsed multiple myeloma
367758|NCT01568840|Physical Therapy Modalities|physical therapy modalities
367763|NCT01568814|colonoscopy|colonoscopy
367764|NCT01568814|bowel preparation|bowel preparation
367765|NCT01568814|polyethylene glycol|polyethylene glycol
367766|NCT01568814|low residue meal|low residue meal
367767|NCT01568801|Integrated Services|integrated services
367768|NCT01568801|Health Services for the Elderly|health services for the elderly
367769|NCT01568801|Community Services|community services
367770|NCT01568788|Respiratory Tract Infections; Orthomyxoviridae Infections|respiratory tract infections; orthomyxoviridae infections
367771|NCT01568775|End Stage Renal Disease|end stage renal disease
367772|NCT01568775|Dialysis|dialysis
367773|NCT01568775|aliskiren|aliskiren
367774|NCT01568775|SPP100A|spp100a
367775|NCT01568762|Asthma|asthma
367776|NCT01568762|VAK694|vak694
367777|NCT01568762|QAX576|qax576
367778|NCT01568762|QBX258|qbx258
367779|NCT01568762|pharmacokinetics|pharmacokinetics
367780|NCT01568749|otc|otc
367781|NCT01568749|Analgesia|analgesia
367782|NCT01568749|Paracetamol|paracetamol
367783|NCT01568736|Hyper IgD Syndrome (HIDS)|hyper igd syndrome (hids)
367784|NCT01568736|Mevalonate Kinase Deficiency (MKD)|mevalonate kinase deficiency (mkd)
367785|NCT01568723|Barrett's esophagus|barrett's esophagus
367786|NCT01568723|high grade dysplasia|high grade dysplasia
367787|NCT01568723|ablation|ablation
367788|NCT01568723|radiofrequency ablation|radiofrequency ablation
367789|NCT01568723|esophageal cancer|esophageal cancer
367790|NCT01568710|Blood Flow|blood flow
367791|NCT01568710|Endothelium|endothelium
367792|NCT01568710|Nitric Oxide|nitric oxide
367793|NCT01568710|Oximetry|oximetry
367794|NCT01568710|Laser Doppler|laser doppler
367795|NCT01568710|Sickle Cell Disease|sickle cell disease
367796|NCT01568697|Oral Microbiome|oral microbiome
367797|NCT01568697|Periodontitis|periodontitis
367798|NCT01568697|Oral Mucosal Immunity|oral mucosal immunity
367799|NCT01568697|Oral Infection|oral infection
367800|NCT01568697|Immune Disorder|immune disorder
367801|NCT01568697|Periodontal Disease|periodontal disease
367802|NCT01568697|Gum Disease|gum disease
367803|NCT01568697|Healthy Volunteer|healthy volunteer
367804|NCT01568697|HV|hv
367805|NCT01568684|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
367806|NCT01568684|Depression|depression
367807|NCT01568684|Depression Treatment|depression treatment
367808|NCT01568684|Major Depression|major depression
367809|NCT01568684|Unipolar Depression|unipolar depression
367810|NCT01568671|Adult|adult
367811|NCT01568671|Body Fat Distribution|body fat distribution
367812|NCT01568671|Healthy|healthy
367813|NCT01568671|Metabolic Rate|metabolic rate
367814|NCT01568671|Thermophysiology|thermophysiology
367815|NCT01568671|Brown Fat|brown fat
367816|NCT01568671|Healthy Volunteer|healthy volunteer
367817|NCT01568671|HV|hv
367818|NCT01568658|Hereditary Myopathies|hereditary myopathies
367819|NCT01568658|Neuropathology|neuropathology
367820|NCT01568658|Muscular Dystrophy|muscular dystrophy
367821|NCT01568658|Inherited Neuromuscular Condition|inherited neuromuscular condition
367822|NCT01568658|Inherited Neuropathy|inherited neuropathy
367823|NCT01568658|Inherited Myopathy|inherited myopathy
367824|NCT01568658|Hereditary Spastic Paraplegia|hereditary spastic paraplegia
367825|NCT01568658|Healthy Volunteer|healthy volunteer
367826|NCT01568658|HV|hv
367827|NCT01568645|Sickle Cell Anemia|sickle cell anemia
367828|NCT01568645|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
367829|NCT01568645|Platelet Derived Growth Factor|platelet derived growth factor
367830|NCT01568645|Beta Adrenergic Receptor Blocker|beta adrenergic receptor blocker
367831|NCT01568645|Pulmonary Vascular Disease|pulmonary vascular disease
367832|NCT01568645|Sickle Cell Disease|sickle cell disease
367833|NCT01568645|Pulmonary Hypertension|pulmonary hypertension
367834|NCT01568632|Dose Limiting Toxicity|dose limiting toxicity
367835|NCT01568632|Maximum Tolerated Dose|maximum tolerated dose
367836|NCT01568632|Telomerase Inhibitor|telomerase inhibitor
367837|NCT01568632|Safety|safety
367838|NCT01568632|Solid Tumor|solid tumor
367839|NCT01568632|Lymphoma|lymphoma
367840|NCT01568619|cardiopulmonary exercise test|cardiopulmonary exercise test
367841|NCT01568619|cardiac output|cardiac output
367842|NCT01568606|Heart Failure|heart failure
367843|NCT01568606|Obesity|obesity
367844|NCT01568606|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
367845|NCT01568580|Hemophilia A|hemophilia a
367846|NCT01568580|Factor VIII|factor viii
367847|NCT01568580|Recombinant|recombinant
367848|NCT01568567|safety|safety
367849|NCT01568567|tolerance|tolerance
367850|NCT01568567|lactobacillus Reuteri|lactobacillus reuteri
367851|NCT01568541|children|children
367852|NCT01568541|dentifrice|dentifrice
367853|NCT01568541|fluoride|fluoride
367854|NCT01568541|dental fluorosis|dental fluorosis
367855|NCT01568515|HPV vaccine|hpv vaccine
367856|NCT01568515|Vaccine adherence|vaccine adherence
367857|NCT01568515|Vaccine utilization|vaccine utilization
367858|NCT01568515|Electronic Messaging|electronic messaging
367859|NCT01568502|dobutamine stress|dobutamine stress
367860|NCT01568502|inducible ischemia|inducible ischemia
367861|NCT01568502|CAD|cad
367862|NCT01568476|Regional anesthesia|regional anesthesia
367863|NCT01568476|Sciatic nerve block|sciatic nerve block
367864|NCT01568476|foot surgery|foot surgery
367865|NCT01568476|ankle surgery|ankle surgery
367866|NCT01568476|Interneural local anesthetic|interneural local anesthetic
367867|NCT01568463|Inter-scalene Block|inter-scalene block
367868|NCT01568463|Regional Anesthesia|regional anesthesia
367869|NCT01568463|shoulder surgeries|shoulder surgeries
367870|NCT01568450|Oxycodone, controlled release formulation|oxycodone, controlled release formulation
367871|NCT01568437|Laparoscopic gastric-bypass surgery|laparoscopic gastric-bypass surgery
367872|NCT01568437|TAP block|tap block
367873|NCT01568424|Heart Failure|heart failure
367874|NCT01568424|Right Ventricular Failure|right ventricular failure
367875|NCT01568424|Levitronix|levitronix
367876|NCT01568424|Thoratec Corporation|thoratec corporation
367877|NCT01568411|None - normal volunteers|none - normal volunteers
367878|NCT01568398|Gastric or duodenal ulcer|gastric or duodenal ulcer
367879|NCT01568385|Gastric or duodenal ulcer|gastric or duodenal ulcer
367880|NCT01568372|pediatric|pediatric
367881|NCT01568372|tonsillectomy|tonsillectomy
367882|NCT01568372|pain management|pain management
367883|NCT01568372|nurse follow-up|nurse follow-up
367884|NCT01568346|Newly diagnosed|newly diagnosed
367885|NCT01568346|Early stage|early stage
367886|NCT01568333|Decitabine|decitabine
367887|NCT01568333|Immune thrombocytopenia|immune thrombocytopenia
367888|NCT01568320|Aorta|aorta
367889|NCT01568320|Thoracic|thoracic
367890|NCT01568320|Aortic dissection|aortic dissection
367891|NCT01568320|Rupture|rupture
367892|NCT01568320|Type B|type b
367893|NCT01568320|DeBakey type III|debakey type iii
367894|NCT01568320|Endovascular|endovascular
367895|NCT01568307|Major depressive disorder|major depressive disorder
367896|NCT01568307|Serotonin transporter|serotonin transporter
367897|NCT01568307|Sympathetic nervous system activation|sympathetic nervous system activation
367898|NCT01568307|Cardiovascular risk factors|cardiovascular risk factors
367899|NCT01568307|Serotonin re-uptake inhibitor|serotonin re-uptake inhibitor
367900|NCT01568281|Bioequivalence|bioequivalence
367901|NCT01568281|pharmacokinetics|pharmacokinetics
367902|NCT01568281|safety|safety
367903|NCT01568281|anastrozole|anastrozole
367904|NCT01568281|Arimidex|arimidex
367905|NCT01568281|Japanese|japanese
367906|NCT01568281|healthy subject|healthy subject
367907|NCT01568268|palonosetron|palonosetron
367908|NCT01568268|postoperative nausea and vomiting|postoperative nausea and vomiting
367909|NCT01568255|myopathic symptoms|myopathic symptoms
367910|NCT01568242|Cataract|cataract
367911|NCT01568242|Phacoemulsification|phacoemulsification
367912|NCT01568242|Temperature|temperature
367913|NCT01568242|Vitreous|vitreous
367914|NCT01568229|schizophrenia negative symptoms|schizophrenia negative symptoms
367915|NCT01568216|schizophrenia negative symptoms|schizophrenia negative symptoms
367916|NCT01568203|single dose, safety, healthy subjects, schizoaffective disorder, AMG 579|single dose, safety, healthy subjects, schizoaffective disorder, amg 579
367917|NCT01568190|House dust mites sensitisation|house dust mites sensitisation
367918|NCT01568177|MCD|mcd
367919|NCT01568164|Epicardial Catheter-based Restoration|epicardial catheter-based restoration
367920|NCT01568164|Surgical/Left Ventricular Reconstruction|surgical/left ventricular reconstruction
367921|NCT01568164|Ventricular Remodeling|ventricular remodeling
367922|NCT01568164|Dor|dor
367923|NCT01568151|Colorectal Cancer|colorectal cancer
367924|NCT01568151|Screening|screening
367925|NCT01568151|Education|education
367926|NCT01568151|Testing|testing
367927|NCT01568138|Ventricular Remodeling|ventricular remodeling
367928|NCT01568112|BG00012|bg00012
367929|NCT01568112|gastrointestinal events|gastrointestinal events
367930|NCT01568112|flushing events|flushing events
367931|NCT01568112|dose titration|dose titration
367932|NCT01568112|pre-medication|pre-medication
367933|NCT01568112|aspirin|aspirin
367934|NCT01568073|Parkinson|parkinson
367935|NCT01568073|PD|pd
367936|NCT01568073|Wearing-off|wearing-off
367937|NCT01568073|Levodopa/DDCI|levodopa/ddci
367938|NCT01568060|Safety|safety
367939|NCT01568060|Infanrix-IPV|infanrix-ipv
367940|NCT01568060|Post-marketing surveillance|post-marketing surveillance
367941|NCT01568060|Diphtheria, tetanus, pertussis and poliomyelitis|diphtheria, tetanus, pertussis and poliomyelitis
367942|NCT01568047|Parkinson Disease|parkinson disease
367943|NCT01568047|BIA 9-1067|bia 9-1067
367944|NCT01568034|Parkinson's Disease|parkinson's disease
367945|NCT01568034|BIA 9-1067|bia 9-1067
367946|NCT01567995|eczematous|eczematous
367947|NCT01567995|dermatitis|dermatitis
367948|NCT01567982|tDCS|tdcs
367949|NCT01567982|brain stimulation|brain stimulation
367950|NCT01567982|addiction|addiction
367951|NCT01567982|substance dependence|substance dependence
367952|NCT01567982|craving|craving
367953|NCT01567982|cognition|cognition
367954|NCT01567969|mental health services|mental health services
367955|NCT01567969|child behavior disorders|child behavior disorders
367956|NCT01567969|child psychiatry|child psychiatry
367957|NCT01567956|Ulcerative colitis|ulcerative colitis
367958|NCT01567943|alcohol abuse|alcohol abuse
367959|NCT01567943|drug abuse|drug abuse
367960|NCT01567943|schizophrenia|schizophrenia
367961|NCT01567943|bipolar disorder|bipolar disorder
367962|NCT01567943|major depressive disorder|major depressive disorder
367963|NCT01567943|contingency management|contingency management
367964|NCT01567943|psychosocial treatment|psychosocial treatment
367965|NCT01567930|Temsirolimus|temsirolimus
367966|NCT01567930|HCC|hcc
367967|NCT01567930|Advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
367968|NCT01567917|Venous thromboembolism|venous thromboembolism
367969|NCT01567917|Colorectal cancer|colorectal cancer
367970|NCT01567917|Postoperative period|postoperative period
367971|NCT01567917|detected on 5th~14th days after surgery (by doppler US) or the follow-up period of postoperative 1 month|detected on 5th~14th days after surgery (by doppler us) or the follow-up period of postoperative 1 month
367972|NCT01567904|thrombosis|thrombosis
367973|NCT01567904|Central Venous Line|central venous line
367974|NCT01567904|CVL|cvl
367975|NCT01567891|Ovarian Cancer|ovarian cancer
367976|NCT01567891|Cell Therapy|cell therapy
367977|NCT01567891|T Cell Therapy|t cell therapy
367978|NCT01567891|NY-ESO-1|ny-eso-1
367979|NCT01567891|Immuno-oncology|immuno-oncology
367980|NCT01567891|Metastatic|metastatic
367981|NCT01567891|Previously treated|previously treated
367982|NCT01567891|T Cell Receptor|t cell receptor
367983|NCT01567878|ultrasound|ultrasound
367984|NCT01567878|MASEI index|masei index
367985|NCT01567878|clinical and ultrasound correlation|clinical and ultrasound correlation
367986|NCT01567878|enthesis ultrasound|enthesis ultrasound
367987|NCT01567878|articular ultrasound|articular ultrasound
367988|NCT01567878|ankylosing spondylitis ultrasound|ankylosing spondylitis ultrasound
367989|NCT01567878|radiographic and ultrasound correlation|radiographic and ultrasound correlation
367990|NCT01567852|orientation|orientation
367991|NCT01567852|post-anesthesia recovery|post-anesthesia recovery
367992|NCT01567852|electroconvulsive therapy|electroconvulsive therapy
367993|NCT01567839|degree of pulpal anesthesia obtained|degree of pulpal anesthesia obtained
367994|NCT01567839|primary infiltration in the lower first molar|primary infiltration in the lower first molar
367995|NCT01567826|YELLO|yello
367996|NCT01567826|Atorvastatin|atorvastatin
367997|NCT01567826|Simvastatin|simvastatin
367998|NCT01567826|Rosuvastatin|rosuvastatin
367999|NCT01567826|lipid therapy|lipid therapy
368000|NCT01567826|Statin therapy|statin therapy
368001|NCT01567826|Coronary artery disease|coronary artery disease
368002|NCT01567826|CHD|chd
368003|NCT01567813|Warts|warts
368004|NCT01567813|Papillomavirus infections|papillomavirus infections
368005|NCT01567813|DNA virus infections|dna virus infections
368006|NCT01567813|Virus diseases|virus diseases
368007|NCT01567813|Skin diseases, viral|skin diseases, viral
368008|NCT01567813|Tumor virus infections|tumor virus infections
368009|NCT01567813|Skin diseases, infectious|skin diseases, infectious
368010|NCT01567813|Skin diseases|skin diseases
368011|NCT01567800|Procedure/Surgery: 18F-Fluoroazomycin Arabinoside (18F-FAZA)|procedure/surgery: 18f-fluoroazomycin arabinoside (18f-faza)
368012|NCT01567787|Proton Radiation Therapy|proton radiation therapy
368013|NCT01567787|Spinal tumors|spinal tumors
368014|NCT01567787|Neurofibroma(NF1)|neurofibroma(nf1)
368015|NCT01567787|Malignant peripheral nerve sheath tumor(MPNST)|malignant peripheral nerve sheath tumor(mpnst)
368016|NCT01567774|Coronary artery disease|coronary artery disease
368017|NCT01567774|dual antiplatelet therapy|dual antiplatelet therapy
368018|NCT01567774|atorvastatin|atorvastatin
368019|NCT01567774|rosuvastatin|rosuvastatin
368020|NCT01567761|IOP|iop
368021|NCT01567748|CABG|cabg
368022|NCT01567748|Coronary Artery Bypass|coronary artery bypass
368023|NCT01567748|Central Aortic Pressure|central aortic pressure
368024|NCT01567748|Peripheral Arterial Waveform|peripheral arterial waveform
368025|NCT01567735|Hepatitis C|hepatitis c
368026|NCT01567735|TMC435HPC3011|tmc435hpc3011
368027|NCT01567735|TMC435|tmc435
368028|NCT01567722|HIV infection|hiv infection
368029|NCT01567722|adult diffuse large cell lymphoma|adult diffuse large cell lymphoma
368030|NCT01567722|anal cancer|anal cancer
368031|NCT01567722|cervical cancer|cervical cancer
368032|NCT01567722|non-small cell lung cancer|non-small cell lung cancer
368033|NCT01567722|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
368034|NCT01567696|Revision,|revision,
368035|NCT01567683|Safety and Tolerability of Limtop and vehicle|safety and tolerability of limtop and vehicle
368036|NCT01567683|of Limtop and vehicle|of limtop and vehicle
368037|NCT01567657|Sedation in TEE|sedation in tee
368038|NCT01567657|Blood pressure drop during TEE|blood pressure drop during tee
368039|NCT01567657|Safety of sedation in TEE|safety of sedation in tee
368040|NCT01567644|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
368041|NCT01567644|Myocardial Ischemia|myocardial ischemia
368042|NCT01567644|Refractory Angina|refractory angina
368043|NCT01567631|Classical Procedure|classical procedure
368044|NCT01567631|Intrahepatic Glisson's Approach|intrahepatic glisson's approach
368045|NCT01567631|laparoscopic hepatectomy|laparoscopic hepatectomy
368046|NCT01567631|Minimal invasive surgery|minimal invasive surgery
368047|NCT01567631|Endoscopic stapling devices|endoscopic stapling devices
368048|NCT01567618|Docetaxel|docetaxel
368049|NCT01567618|Fluorouracil|fluorouracil
368050|NCT01567618|First line therapy|first line therapy
368051|NCT01567618|Gastric cancer|gastric cancer
368052|NCT01567605|spinal cord injury|spinal cord injury
368053|NCT01567605|autonomic dysreflexia|autonomic dysreflexia
368054|NCT01567605|blood pressure|blood pressure
368055|NCT01567605|bowel care management|bowel care management
368056|NCT01567605|defecation|defecation
368057|NCT01567592|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
368058|NCT01567592|Myocardial Ischemia|myocardial ischemia
368059|NCT01567592|Refractory Angina|refractory angina
368060|NCT01567579|congenital heart defects|congenital heart defects
368061|NCT01567566|home based daily exercise program|home based daily exercise program
368062|NCT01567566|local lumbopelvic stabilizer muscles|local lumbopelvic stabilizer muscles
368063|NCT01567566|hip stabilizer muscles|hip stabilizer muscles
368064|NCT01567566|real time ultrasound imaging|real time ultrasound imaging
368065|NCT01567553|inflammatory disease of the central nervous system|inflammatory disease of the central nervous system
368066|NCT01567553|early clinical deficit|early clinical deficit
368067|NCT01567553|multiple sclerosis (MS)|multiple sclerosis (ms)
368068|NCT01567540|Chronic Hepatitis C|chronic hepatitis c
368069|NCT01567540|Interferon protein 10|interferon protein 10
368070|NCT01567540|Chemokine gradients|chemokine gradients
368071|NCT01567540|Sitagliptin|sitagliptin
368072|NCT01567527|Aripiprazole|aripiprazole
368073|NCT01567527|Intramuscular (IM) Depot|intramuscular (im) depot
368074|NCT01567527|Bipolar|bipolar
368075|NCT01567514|Deep occlusal caries restored with resin composite|deep occlusal caries restored with resin composite
368076|NCT01567514|on Pit and Fissure Surface Penetrating Into Dentin|on pit and fissure surface penetrating into dentin
368077|NCT01567488|Advanced|advanced
368078|NCT01567488|Non functioning|non functioning
368079|NCT01567488|Well differentiated|well differentiated
368080|NCT01567462|bladder cancer|bladder cancer
368081|NCT01567462|transurethral resection of bladder tumors|transurethral resection of bladder tumors
368082|NCT01567423|Malaria|malaria
368083|NCT01567423|Plasmodium falciparum|plasmodium falciparum
368084|NCT01567423|Children|children
368085|NCT01567423|Efficacy|efficacy
368086|NCT01567423|Uncomplicated malaria|uncomplicated malaria
368087|NCT01567410|e-learning|e-learning
368088|NCT01567410|education|education
368089|NCT01567384|cancer|cancer
368090|NCT01567384|neoplasms|neoplasms
368091|NCT01567384|tumors|tumors
368092|NCT01567345|Pain|pain
368093|NCT01567345|cancer|cancer
368094|NCT01567345|Intrathecal|intrathecal
368095|NCT01567345|analgesia|analgesia
368096|NCT01567345|Morphine|morphine
368097|NCT01567345|Implantable pump|implantable pump
368098|NCT01567319|Sensitization|sensitization
368099|NCT01567319|Skin Prick Test|skin prick test
368100|NCT01567319|Standardization|standardization
368101|NCT01567319|sources of: D. glomerata, L. perenne, S. cereale and O. europaea|sources of: d. glomerata, l. perenne, s. cereale and o. europaea
368102|NCT01567306|Allergy|allergy
368103|NCT01567306|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
368104|NCT01567306|Subcutaneous Immunotherapy|subcutaneous immunotherapy
368105|NCT01567306|Phleum pratense pollen extract|phleum pratense pollen extract
368106|NCT01567267|Evidence-based Medicine|evidence-based medicine
368107|NCT01567267|Good Scientific Practice|good scientific practice
368108|NCT01567267|Problem-based Learning|problem-based learning
368109|NCT01567267|Critical health literacy|critical health literacy
368110|NCT01567267|Educational intervention|educational intervention
368111|NCT01567254|guided imaginary|guided imaginary
368112|NCT01567241|clinical hypnosis|clinical hypnosis
368113|NCT01567241|relaxation music|relaxation music
368114|NCT01567241|reproduction techniques|reproduction techniques
368115|NCT01567241|insemination|insemination
368116|NCT01567241|embryo transfer|embryo transfer
368117|NCT01567241|pregnancy rate|pregnancy rate
368118|NCT01567228|obesity|obesity
368119|NCT01567228|overweight|overweight
368120|NCT01567228|dental caries|dental caries
368121|NCT01567228|school problems|school problems
368122|NCT01567228|school failure|school failure
368123|NCT01567228|child BMI > 85th percentile|child bmi > 85th percentile
368124|NCT01567228|Needing dental preventive services|needing dental preventive services
368125|NCT01567228|Needing academic support for school problems|needing academic support for school problems
368126|NCT01567215|granuloma umbilical|granuloma umbilical
368127|NCT01567202|Brain tumor|brain tumor
368128|NCT01567202|Glioma|glioma
368129|NCT01567202|Glioblastoma|glioblastoma
368130|NCT01567202|Tumor stem cells|tumor stem cells
368131|NCT01567202|Immunotherapy|immunotherapy
368133|NCT01567189|Exercise therapy|exercise therapy
368134|NCT01567189|cost effectiveness|cost effectiveness
368135|NCT01567189|cardiac rehabilitation|cardiac rehabilitation
368136|NCT01567189|home-based exercise|home-based exercise
368137|NCT01567176|Sirtuins|sirtuins
368138|NCT01567176|Aging|aging
368139|NCT01567176|Metabolic disease|metabolic disease
368140|NCT01567163|Advanced Malignant Solid Tumors|advanced malignant solid tumors
368141|NCT01567124|Schizophrenia|schizophrenia
368142|NCT01567124|Moxonidine|moxonidine
368143|NCT01567124|Sympathetic nervous system activation|sympathetic nervous system activation
368144|NCT01567124|Cardiometabolic side effects of antipsychotics|cardiometabolic side effects of antipsychotics
368145|NCT01567111|Primary aldosteronism|primary aldosteronism
368146|NCT01567111|Aldosterone producing adenoma|aldosterone producing adenoma
368147|NCT01567111|Bilateral adrenal hyperplasia|bilateral adrenal hyperplasia
368148|NCT01567111|Metomidate-Positron emission tomography|metomidate-positron emission tomography
368149|NCT01567072|NSAID|nsaid
368150|NCT01567072|bone fracture|bone fracture
368151|NCT01567072|heal|heal
368152|NCT01567033|Diabetes|diabetes
368153|NCT01567033|Obesity|obesity
368154|NCT01567033|Home visiting|home visiting
368155|NCT01567020|Central Auditory Processing|central auditory processing
368156|NCT01567020|Traumatic Brain Injury|traumatic brain injury
368157|NCT01567020|Hearing Loss|hearing loss
368158|NCT01567007|pedometer|pedometer
368159|NCT01567007|physical activity|physical activity
368160|NCT01567007|workplace|workplace
368161|NCT01566994|smoking cessation|smoking cessation
368162|NCT01566981|Diabetes mellitus tip II|diabetes mellitus tip ii
368163|NCT01566981|eHealth solution|ehealth solution
368164|NCT01566981|Health Information Technology|health information technology
368165|NCT01566981|quality of life|quality of life
368166|NCT01566981|family medicine|family medicine
368167|NCT01566981|satisfaction with e-health care|satisfaction with e-health care
368168|NCT01566981|primary care|primary care
368169|NCT01566968|COPD|copd
368170|NCT01566968|Asthma|asthma
368171|NCT01566968|Healthy volunteers|healthy volunteers
368172|NCT01566968|Chronic cough|chronic cough
368173|NCT01566968|Smokers|smokers
368174|NCT01566968|Cough challenge|cough challenge
368175|NCT01566968|Cough challenge testing.|cough challenge testing.
368176|NCT01566955|transgastric|transgastric
368177|NCT01566955|NOTES|notes
368178|NCT01566955|Gastrotomy|gastrotomy
368179|NCT01566955|BRCA 1/2|brca 1/2
368180|NCT01566942|FOLFIRI|folfiri
368181|NCT01566942|FOLFOX|folfox
368182|NCT01566942|adjuvant chemotherapy|adjuvant chemotherapy
368183|NCT01566942|advanced colorectal cancer|advanced colorectal cancer
368184|NCT01566929|Obesity|obesity
368185|NCT01566929|In vitro fertilization|in vitro fertilization
368186|NCT01566929|Low calorie diet (LCD)|low calorie diet (lcd)
368187|NCT01566929|Obstetric outcome|obstetric outcome
368188|NCT01566929|Weight reduction|weight reduction
368189|NCT01566903|arterial stenosis|arterial stenosis
368190|NCT01566903|arteriovenous malformations|arteriovenous malformations
368191|NCT01566903|Post-treatment follow-up|post-treatment follow-up
368192|NCT01566890|sickle cell|sickle cell
368193|NCT01566890|sickle cell crisis|sickle cell crisis
368194|NCT01566890|sickle cell pain crisis|sickle cell pain crisis
368195|NCT01566890|vaso-occlusive crisis|vaso-occlusive crisis
368196|NCT01566890|vaso-occlusion|vaso-occlusion
368197|NCT01566890|sickle cell anemia|sickle cell anemia
368198|NCT01566890|sickle cell disease|sickle cell disease
368199|NCT01566890|genetic diseases|genetic diseases
368200|NCT01566890|adenosine 2A Receptor Agonists|adenosine 2a receptor agonists
368201|NCT01566890|Lexiscan|lexiscan
368202|NCT01566890|Regadenoson|regadenoson
368203|NCT01566890|contrast-enhanced ultrasound|contrast-enhanced ultrasound
368204|NCT01566890|Hydroxyurea|hydroxyurea
368205|NCT01566877|Multiple Ascending Dose (MAD)|multiple ascending dose (mad)
368206|NCT01566877|Marburg Virus|marburg virus
368207|NCT01566877|Post Exposure Prophylaxis|post exposure prophylaxis
368208|NCT01566864|hypertension|hypertension
368209|NCT01566864|disparities|disparities
368210|NCT01566864|care management|care management
368211|NCT01566864|provider education|provider education
368212|NCT01566864|audit and feedback|audit and feedback
368213|NCT01566864|Omron|omron
368214|NCT01566864|African Americans|african americans
368215|NCT01566864|organizational change|organizational change
368216|NCT01566864|implementation research|implementation research
368217|NCT01566838|Visual analog pain score|visual analog pain score
368218|NCT01566838|Length of stay|length of stay
368219|NCT01566838|Hospital Cost|hospital cost
368220|NCT01566838|Subpleural pain catheter|subpleural pain catheter
368221|NCT01566838|Bupivacaine|bupivacaine
368222|NCT01566825|amitriptyline|amitriptyline
368223|NCT01566825|sleep dependent memory consolidation|sleep dependent memory consolidation
368224|NCT01566812|Breast Feeding|breast feeding
368225|NCT01566812|Cardiovascular Risk|cardiovascular risk
368226|NCT01566799|Locally advanced breast cancer|locally advanced breast cancer
368227|NCT01566799|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
368228|NCT01566799|Metformin|metformin
368229|NCT01566799|Pathologic Complete Response|pathologic complete response
368230|NCT01566773|COPD|copd
368231|NCT01566760|food effect|food effect
368232|NCT01566760|bioavailability|bioavailability
368233|NCT01566760|pharmacokinetics|pharmacokinetics
368234|NCT01566760|fesoterodine|fesoterodine
368235|NCT01566760|5-hydroxymethyl tolterodine|5-hydroxymethyl tolterodine
368236|NCT01566760|treatment of overactive bladder|treatment of overactive bladder
368237|NCT01566734|Surgical Wound Infection|surgical wound infection
368238|NCT01566734|cefazolin|cefazolin
368239|NCT01566734|Cesarean Section|cesarean section
368240|NCT01566708|Acute Tinnitus|acute tinnitus
368241|NCT01566708|Recent Onset Tinnitus|recent onset tinnitus
368242|NCT01566708|Music Therapy|music therapy
368243|NCT01566708|fMRI|fmri
368244|NCT01566708|Therapy Evaluation|therapy evaluation
368245|NCT01566682|Lung Lesion|lung lesion
368246|NCT01566682|Lung Mass|lung mass
368247|NCT01566682|Lung Nodule|lung nodule
368248|NCT01566682|Lung Cancer|lung cancer
368249|NCT01566682|Low-Dose CT|low-dose ct
368250|NCT01566682|CT|ct
368251|NCT01566682|Diagnostic|diagnostic
368252|NCT01566682|Evaluation|evaluation
368253|NCT01566682|Bioconductance|bioconductance
368254|NCT01566682|ProLung|prolung
368255|NCT01566669|Cyclooxygenase inhibitors|cyclooxygenase inhibitors
368256|NCT01566669|Morphine|morphine
368257|NCT01566669|Analgesia|analgesia
368258|NCT01566669|patient-controlled|patient-controlled
368259|NCT01566669|Gynecologic surgical procedures|gynecologic surgical procedures
368260|NCT01566656|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
368261|NCT01566656|Non-myeloablative preparative regimen|non-myeloablative preparative regimen
368262|NCT01566656|Total lymphoid irradiation|total lymphoid irradiation
368263|NCT01566656|Anti-thymocyte globulin|anti-thymocyte globulin
368264|NCT01566656|Lymphoid malignancies|lymphoid malignancies
368265|NCT01566643|Helicobacter pylori|helicobacter pylori
368266|NCT01566643|antibiotic resistance|antibiotic resistance
368267|NCT01566643|sequential-concomitant hybrid therapy|sequential-concomitant hybrid therapy
368268|NCT01566630|human recombinant RLX030|human recombinant rlx030
368269|NCT01566630|Pre-eclampsia|pre-eclampsia
368270|NCT01566630|hemodynamics|hemodynamics
368271|NCT01566630|Pharmacokinetics|pharmacokinetics
368272|NCT01566604|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
368273|NCT01566604|NVA237|nva237
368274|NCT01566591|Bipolar Depression|bipolar depression
368275|NCT01566552|AMBISOME|ambisome
368276|NCT01566552|VISCERAL LEISHMANIASIS|visceral leishmaniasis
368277|NCT01566552|SINGLE DOSE|single dose
368278|NCT01566539|Social cooperation|social cooperation
368279|NCT01566539|Oxytocin|oxytocin
368280|NCT01566539|Vasopressin|vasopressin
368281|NCT01566539|Prisoner's Dilemma game|prisoner's dilemma game
368282|NCT01566539|Empathy|empathy
368283|NCT01566539|fMRI|fmri
368284|NCT01566513|Peer Support|peer support
368285|NCT01566513|Cost Effectiveness|cost effectiveness
368286|NCT01566513|Reducing Hospital use|reducing hospital use
368287|NCT01566513|Serious Mental Illness|serious mental illness
368288|NCT01566500|Epilepsy|epilepsy
368289|NCT01566500|Medication Adherence|medication adherence
368290|NCT01566487|Bioequivalence|bioequivalence
368291|NCT01566487|Quetiapine fumarate|quetiapine fumarate
368292|NCT01566487|crossover|crossover
368293|NCT01566461|Drug-Coated Angioplasty Balloon|drug-coated angioplasty balloon
368294|NCT01566461|Drug Coated Angioplasty Balloon|drug coated angioplasty balloon
368295|NCT01566461|Peripheral Artery Disease|peripheral artery disease
368296|NCT01566461|Experimental|experimental
368297|NCT01566461|Percutaneous Transluminal Angioplasty (PTA)|percutaneous transluminal angioplasty (pta)
368298|NCT01566448|Ketamine|ketamine
368300|NCT01566448|Oral ketamine rinse|oral ketamine rinse
368301|NCT01566409|Constipation|constipation
368302|NCT01566409|Maintenance treatment|maintenance treatment
368303|NCT01566409|Ultrasound of rectum|ultrasound of rectum
368304|NCT01566396|Fractional,|fractional,
368305|NCT01566396|RF,|rf,
368306|NCT01566396|Wrinkles|wrinkles
368307|NCT01566396|Safety|safety
368308|NCT01566396|Efficacy|efficacy
368309|NCT01566396|treatment|treatment
368310|NCT01566370|alcoholism|alcoholism
368311|NCT01566370|alcohol use disorder|alcohol use disorder
368312|NCT01566370|alcohol dependence|alcohol dependence
368313|NCT01566370|alcohol abuse|alcohol abuse
368314|NCT01566370|bipolar|bipolar
368315|NCT01566370|anticonvulsant|anticonvulsant
368316|NCT01566370|zonisamide|zonisamide
368317|NCT01566357|dental erosion|dental erosion
368318|NCT01566357|enamel|enamel
368319|NCT01566357|dentin|dentin
368320|NCT01566344|Premature Ventricular Complex|premature ventricular complex
368321|NCT01566344|Cardiomyopathy|cardiomyopathy
368322|NCT01566344|Left ventricular dysfunction|left ventricular dysfunction
368323|NCT01566344|Catheter Ablation|catheter ablation
368324|NCT01566344|Anti-Arrhythmic Agents|anti-arrhythmic agents
368325|NCT01566344|Randomized Clinical Trial|randomized clinical trial
368326|NCT01566331|Safe Delivery|safe delivery
368327|NCT01566331|reduction of pain|reduction of pain
368328|NCT01566331|reduction stage of labor|reduction stage of labor
368329|NCT01566318|Depression|depression
368330|NCT01566318|Anxiety|anxiety
368331|NCT01566318|Geriatric mental health|geriatric mental health
368332|NCT01566279|solid tumors|solid tumors
368333|NCT01566279|all comers|all comers
368334|NCT01566279|everolimus|everolimus
368335|NCT01566279|biomarker|biomarker
368336|NCT01566279|next generation sequencing|next generation sequencing
368337|NCT01566266|gut flora|gut flora
368338|NCT01566266|antibiotics|antibiotics
368339|NCT01566266|lipid metabolism|lipid metabolism
368340|NCT01566266|LDL cholesterol|ldl cholesterol
368341|NCT01566253|planned caesarian section, analgesic, PCOA|planned caesarian section, analgesic, pcoa
368342|NCT01566240|cervical cancer|cervical cancer
368343|NCT01566240|Chemotherapy|chemotherapy
368344|NCT01566240|Paclitaxel|paclitaxel
368345|NCT01566240|Carboplatin|carboplatin
368346|NCT01566240|Cisplatin|cisplatin
368347|NCT01566240|Radiotherapy|radiotherapy
368348|NCT01566240|Chemoradiation|chemoradiation
368349|NCT01566240|Brachytherapy|brachytherapy
368350|NCT01566240|Stage IB2 Cervical Cancer|stage ib2 cervical cancer
368351|NCT01566240|Stage IIA Cervical Cancer|stage iia cervical cancer
368352|NCT01566240|Stage IIB Cervical Cancer|stage iib cervical cancer
368353|NCT01566240|Stage IIIB Cervical Cancer|stage iiib cervical cancer
368354|NCT01566240|Stage IVA Cervical Cancer|stage iva cervical cancer
368355|NCT01566227|overdenture|overdenture
368356|NCT01566227|implant|implant
368357|NCT01566227|edentulism|edentulism
368358|NCT01566214|coronary heart disease (CHD)|coronary heart disease (chd)
368359|NCT01566214|myocardial infarction (MI)|myocardial infarction (mi)
368360|NCT01566214|acute coronary syndromes (ACS)|acute coronary syndromes (acs)
368361|NCT01566201|Arterial stiffness|arterial stiffness
368362|NCT01566201|Endothelial function|endothelial function
368363|NCT01566201|Left ventricular function|left ventricular function
368364|NCT01566201|Apoptosis|apoptosis
368365|NCT01566201|Nitrooxidative stress|nitrooxidative stress
368366|NCT01566175|Neovasc Reducer|neovasc reducer
368367|NCT01566175|Coronary Sinus|coronary sinus
368368|NCT01566175|Refractory Angina Pectoris|refractory angina pectoris
368369|NCT01566175|angina class 3-4|angina class 3-4
368370|NCT01566162|Lurasidone|lurasidone
368371|NCT01566162|Latuda|latuda
368372|NCT01566162|Schizophrenia|schizophrenia
368373|NCT01566136|hip fracture patients|hip fracture patients
368374|NCT01566136|cognitive impairment|cognitive impairment
368375|NCT01566136|rehabilitation model of care|rehabilitation model of care
368376|NCT01566123|retroperitoneal soft tissue sarcoma|retroperitoneal soft tissue sarcoma
368377|NCT01566123|IMRT|imrt
368378|NCT01566123|IORT|iort
368379|NCT01566110|pediatric|pediatric
368380|NCT01566110|dietary treatment|dietary treatment
368381|NCT01566110|celiac disease|celiac disease
368382|NCT01566110|T1D|t1d
368383|NCT01566097|Cluster randomized trial|cluster randomized trial
368384|NCT01566097|Decision aids|decision aids
368385|NCT01566097|Culturally-appropriate decision aids|culturally-appropriate decision aids
368386|NCT01566058|Post partum|post partum
368387|NCT01566058|mother-child relationships|mother-child relationships
368388|NCT01566045|Prostate Cancer|prostate cancer
368389|NCT01566045|Biopsy|biopsy
368390|NCT01566032|pulmonary air leak|pulmonary air leak
368391|NCT01566032|Thopaz|thopaz
368392|NCT01566032|analog|analog
368393|NCT01566032|digital|digital
368394|NCT01566006|Mycophenolate mofetil (MMF)|mycophenolate mofetil (mmf)
368395|NCT01566006|Diabetic Nephropathy|diabetic nephropathy
368396|NCT01566006|proteinuria|proteinuria
368397|NCT01566006|Diabetic Nephropathy in Chronic Kidney Disease patients stages 2-4|diabetic nephropathy in chronic kidney disease patients stages 2-4
368398|NCT01565980|Lung cancer|lung cancer
368399|NCT01565980|mindfulness therapy|mindfulness therapy
368400|NCT01565980|active treatment (radiation and/or chemotherapy)|active treatment (radiation and/or chemotherapy)
368401|NCT01565967|AutoLog|autolog
368402|NCT01565967|Post market release|post market release
368403|NCT01565967|Non-interventional|non-interventional
368404|NCT01565954|Sickle Cell Disease|sickle cell disease
368405|NCT01565954|Respiration Disorders|respiration disorders
368406|NCT01565954|Polysomnography|polysomnography
368407|NCT01565941|Cardiovascular|cardiovascular
368408|NCT01565941|Respiratory|respiratory
368409|NCT01565941|Failure|failure
368410|NCT01565941|Heart|heart
368411|NCT01565941|Lung|lung
368412|NCT01565941|Continuous glucose monitoring|continuous glucose monitoring
368413|NCT01565941|Tight glycemic control|tight glycemic control
368414|NCT01565941|Subcutaneous|subcutaneous
368415|NCT01565941|Insulin|insulin
368416|NCT01565941|Algorithm|algorithm
368417|NCT01565928|Prostate cancer|prostate cancer
368418|NCT01565928|docetaxel|docetaxel
368419|NCT01565928|MDV3100|mdv3100
368420|NCT01565928|enzalutamide|enzalutamide
368421|NCT01565928|Xtandi|xtandi
368422|NCT01565902|BAF312|baf312
368423|NCT01565902|Pharmacokinetics|pharmacokinetics
368424|NCT01565902|Hepatic impairment|hepatic impairment
368425|NCT01565876|weight bearing|weight bearing
368426|NCT01565876|physiological load|physiological load
368427|NCT01565863|Perceived Disability|perceived disability
368428|NCT01565863|Mental Wellness|mental wellness
368429|NCT01565863|Employment|employment
368430|NCT01565863|Social Integration and Engagement|social integration and engagement
368431|NCT01565863|Goal Achievement|goal achievement
368432|NCT01565850|HIV-1|hiv-1
368433|NCT01565850|HIV|hiv
368434|NCT01565850|Treatment-Naive|treatment-naive
368435|NCT01565837|Melanoma|melanoma
368436|NCT01565837|Malignant Melanoma|malignant melanoma
368437|NCT01565837|Metastatic|metastatic
368438|NCT01565837|Oligometastatic|oligometastatic
368439|NCT01565837|Radiosurgery|radiosurgery
368440|NCT01565837|Radiosurgery, Stereotactic|radiosurgery, stereotactic
368441|NCT01565837|Stereotactic Radiosurgery|stereotactic radiosurgery
368442|NCT01565837|Ipilimumab|ipilimumab
368443|NCT01565837|Yervoy|yervoy
368444|NCT01565837|MDX-010|mdx-010
368445|NCT01565837|Circulating Tumor Cells|circulating tumor cells
368446|NCT01565811|colon neoplasm, rectal neoplasm, liver metastasis|colon neoplasm, rectal neoplasm, liver metastasis
368447|NCT01565798|healthcare-acquired infections|healthcare-acquired infections
368448|NCT01565798|colonization|colonization
368449|NCT01565798|copper-alloy surfaces|copper-alloy surfaces
368450|NCT01565785|Child parent home self-management|child parent home self-management
368451|NCT01565772|Lung cancer|lung cancer
368452|NCT01565772|Stage III|stage iii
368453|NCT01565759|Gene expression|gene expression
368454|NCT01565759|Lithium|lithium
368455|NCT01565759|Healthy volunteers|healthy volunteers
368456|NCT01565759|Lymphoblastoid cell lines|lymphoblastoid cell lines
368457|NCT01565746|BAY88-8223|bay88-8223
368458|NCT01565746|radium-223 dichloride|radium-223 dichloride
368459|NCT01565746|prostate cancer|prostate cancer
368460|NCT01565720|Isavuconazole|isavuconazole
368461|NCT01565720|Healthy Volunteers|healthy volunteers
368462|NCT01565720|BAL8557|bal8557
368463|NCT01565707|Pediatric|pediatric
368464|NCT01565707|Solifenacin succinate suspension|solifenacin succinate suspension
368465|NCT01565707|Phase 3|phase 3
368466|NCT01565707|Pharmacokinetics|pharmacokinetics
368467|NCT01565707|Overactive bladder (OAB)|overactive bladder (oab)
368468|NCT01565694|Cognitive Function|cognitive function
368469|NCT01565694|Phase 3|phase 3
368470|NCT01565694|Neurogenic Detrusor Overactivity|neurogenic detrusor overactivity
368471|NCT01565694|Pharmacokinetics|pharmacokinetics
368472|NCT01565694|Ocular Accommodation|ocular accommodation
368473|NCT01565694|Urodynamics|urodynamics
368474|NCT01565681|Healthy Volunteers|healthy volunteers
368475|NCT01565681|B cell CD40 receptor occupancy|b cell cd40 receptor occupancy
368476|NCT01565681|anti-CD40 monoclonal antibody|anti-cd40 monoclonal antibody
368477|NCT01565668|FLT3-ITD positive Acute Myeloid Leukemia (AML)|flt3-itd positive acute myeloid leukemia (aml)
368478|NCT01565668|AC220|ac220
368479|NCT01565668|Relapse|relapse
368480|NCT01565668|Refractory|refractory
368481|NCT01565655|Rheumatoid Arthritis|rheumatoid arthritis
368482|NCT01565655|ASP015K|asp015k
368483|NCT01565642|Dementia, decision making|dementia, decision making
368484|NCT01565629|Autism|autism
368485|NCT01565629|Asperger's Syndrome|asperger's syndrome
368486|NCT01565629|Treatment|treatment
368487|NCT01565629|Cognitive-behavioral therapy|cognitive-behavioral therapy
368488|NCT01565629|Anxiety|anxiety
368489|NCT01565629|Children|children
368490|NCT01565629|Therapy|therapy
368491|NCT01565616|Severe Sickle Cell Disease|severe sickle cell disease
368492|NCT01565616|Hematopoietic cell transplantation (HCT)|hematopoietic cell transplantation (hct)
368493|NCT01565616|Hematopoietic Stem Cell Therapy|hematopoietic stem cell therapy
368494|NCT01565616|Bone Marrow Transplant|bone marrow transplant
368495|NCT01565616|Hematologic Diseases|hematologic diseases
368496|NCT01565616|Genetic Diseases|genetic diseases
368497|NCT01565616|Anemia|anemia
368498|NCT01565616|Hemolytic|hemolytic
368499|NCT01565616|Congenital|congenital
368500|NCT01565616|Human Leukocyte Antigen|human leukocyte antigen
368501|NCT01565616|HLA|hla
368502|NCT01565603|Hypoxia|hypoxia
368503|NCT01565603|Exercise|exercise
368504|NCT01565603|Sleep|sleep
368505|NCT01565603|Brain|brain
368506|NCT01565603|Neuromuscular function|neuromuscular function
368507|NCT01565603|Heart|heart
368508|NCT01565590|aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
368509|NCT01565590|dexmedetomidine|dexmedetomidine
368510|NCT01565590|cytokines|cytokines
368511|NCT01565577|Neisseria meningitidis B:14, P1-7, 16|neisseria meningitidis b:14, p1-7, 16
368512|NCT01565577|Serum bactericidal activity|serum bactericidal activity
368513|NCT01565577|Menbvac|menbvac
368514|NCT01565564|Gestational diabetes mellitus|gestational diabetes mellitus
368515|NCT01565564|intervention|intervention
368516|NCT01565564|shared care|shared care
368517|NCT01565564|pregnancy outcome|pregnancy outcome
368518|NCT01565564|macrosomia|macrosomia
368519|NCT01565564|pregnancy-induced hypertension|pregnancy-induced hypertension
368520|NCT01565551|Traumatic Brain Injury|traumatic brain injury
368521|NCT01565551|Common Data Elements|common data elements
368522|NCT01565551|Prognostic Models|prognostic models
368523|NCT01565551|Neuroimaging|neuroimaging
368524|NCT01565551|Biomarkers|biomarkers
368525|NCT01565551|Genetic Variants|genetic variants
368526|NCT01565551|Concussion|concussion
368527|NCT01565551|Psychological Health|psychological health
368528|NCT01565538|Cancer|cancer
368529|NCT01565538|Non-small-cell lung cancer|non-small-cell lung cancer
368530|NCT01565538|Adenocarcinoma|adenocarcinoma
368531|NCT01565538|EGFR gene mutation|egfr gene mutation
368532|NCT01565538|Chemotherapy|chemotherapy
368533|NCT01565538|Pemetrexed|pemetrexed
368534|NCT01565538|Erlotinib|erlotinib
368535|NCT01565525|well child visit|well child visit
368536|NCT01565525|anticipatory guidance|anticipatory guidance
368537|NCT01565525|obesity prevention|obesity prevention
368538|NCT01565525|infant feeding|infant feeding
368539|NCT01565512|randomized trial|randomized trial
368540|NCT01565512|robotic prostatectomy|robotic prostatectomy
368541|NCT01565512|prostate cancer|prostate cancer
368542|NCT01565512|foley catheter discomfort|foley catheter discomfort
368543|NCT01565499|Neoadjuvant nab-paclitaxel luminal breast cancer|neoadjuvant nab-paclitaxel luminal breast cancer
368544|NCT01565486|operation time|operation time
368545|NCT01565486|complication rate|complication rate
368546|NCT01565486|costs|costs
368547|NCT01565486|admission time|admission time
368548|NCT01565486|RFS|rfs
368549|NCT01565486|OS|os
368550|NCT01565473|non-motor symptoms|non-motor symptoms
368551|NCT01565460|pancreas|pancreas
368552|NCT01565460|biliary|biliary
368553|NCT01565460|stricture|stricture
368554|NCT01565421|Cancer|cancer
368555|NCT01565421|Neoplasms|neoplasms
368556|NCT01565421|Solid Tumor|solid tumor
368557|NCT01565421|Ovarian Cancer|ovarian cancer
368558|NCT01565421|Solid Malignancies|solid malignancies
368559|NCT01565395|ALS|als
368560|NCT01565395|PD|pd
368561|NCT01565382|Amyloid imaging|amyloid imaging
368562|NCT01565382|Positron Emission Tomography|positron emission tomography
368563|NCT01565382|18F-AV-45|18f-av-45
368564|NCT01565382|florbetapir F 18|florbetapir f 18
368565|NCT01565382|Diagnostic imaging|diagnostic imaging
368566|NCT01565369|Amyloid imaging|amyloid imaging
368567|NCT01565369|Positron Emission Tomography|positron emission tomography
368568|NCT01565369|18F-AV-45|18f-av-45
368569|NCT01565369|florbetapir F 18|florbetapir f 18
368570|NCT01565369|Diagnostic imaging|diagnostic imaging
368571|NCT01565356|Amyloid imaging|amyloid imaging
368572|NCT01565356|Positron Emission Tomography|positron emission tomography
368573|NCT01565356|18F-AV-45|18f-av-45
368574|NCT01565356|florbetapir F 18|florbetapir f 18
368575|NCT01565356|Diagnostic imaging|diagnostic imaging
368576|NCT01565343|Amyloid imaging|amyloid imaging
368577|NCT01565343|Positron Emission Tomography|positron emission tomography
368578|NCT01565343|18F-AV-45|18f-av-45
368579|NCT01565343|florbetapir F 18|florbetapir f 18
368580|NCT01565343|Diagnostic imaging|diagnostic imaging
368581|NCT01565330|Amyloid imaging|amyloid imaging
368582|NCT01565330|Positron Emission Tomography|positron emission tomography
368583|NCT01565330|18F-AV-45|18f-av-45
368584|NCT01565330|florbetapir F 18|florbetapir f 18
368585|NCT01565330|Diagnostic imaging|diagnostic imaging
368586|NCT01565304|Teen pregnancy|teen pregnancy
368587|NCT01565304|Sexually transmitted infections|sexually transmitted infections
368588|NCT01565304|Sexual risk behaviors|sexual risk behaviors
368589|NCT01565291|Amyloid imaging|amyloid imaging
368590|NCT01565291|Positron Emission Tomography|positron emission tomography
368591|NCT01565291|18F-AV-45|18f-av-45
368592|NCT01565291|florbetapir F 18|florbetapir f 18
368593|NCT01565291|Diagnostic imaging|diagnostic imaging
368594|NCT01565278|Parenteral nutrition|parenteral nutrition
368595|NCT01565278|fish oil|fish oil
368596|NCT01565278|liver disease|liver disease
368597|NCT01565278|Omegaven|omegaven
368598|NCT01565278|hepatic|hepatic
368599|NCT01565278|liver biopsy|liver biopsy
368600|NCT01565278|bilirubin|bilirubin
368601|NCT01565265|ovarian hyperstimulation|ovarian hyperstimulation
368602|NCT01565265|GnRH antagonist|gnrh antagonist
368603|NCT01565265|GnRH agonist|gnrh agonist
368604|NCT01565265|assisted reproduction|assisted reproduction
368605|NCT01565265|FSH|fsh
368606|NCT01565265|LH|lh
368607|NCT01565252|Egg,Omega 3, Omega 6|egg,omega 3, omega 6
368608|NCT01565239|Warfarin|warfarin
368609|NCT01565239|Monitoring|monitoring
368610|NCT01565239|prothrombin time|prothrombin time
368611|NCT01565239|Fiix prothrombin time|fiix prothrombin time
368612|NCT01565239|international normalized ratio (INR)|international normalized ratio (inr)
368613|NCT01565239|new test|new test
368614|NCT01565226|Capnography|capnography
368615|NCT01565226|CO2|co2
368616|NCT01565226|neonates|neonates
368617|NCT01565226|High Frequency ventilation (HFV)|high frequency ventilation (hfv)
368618|NCT01565213|primary health care,common mental disorders,|primary health care,common mental disorders,
368619|NCT01565213|group therapy|group therapy
368620|NCT01565200|HER2|her2
368621|NCT01565200|Metastatic Breast Cancer|metastatic breast cancer
368622|NCT01565187|Hand Transplantation|hand transplantation
368623|NCT01565174|cannabis|cannabis
368624|NCT01565174|THC|thc
368625|NCT01565174|COMT|comt
368626|NCT01565174|psychosis|psychosis
368627|NCT01565174|D2|d2
368628|NCT01565161|Obesity|obesity
368629|NCT01565161|Overweight|overweight
368630|NCT01565148|Diabetic Macular Edema (DME)|diabetic macular edema (dme)
368631|NCT01565109|NESC|nesc
368632|NCT01565109|NEOADJUVANT|neoadjuvant
368633|NCT01565109|GASTRIC|gastric
368634|NCT01565070|Osteoarthritis|osteoarthritis
368635|NCT01565070|Pain|pain
368636|NCT01565070|Quality of life|quality of life
368637|NCT01565057|emulsion|emulsion
368638|NCT01565057|emptying|emptying
368639|NCT01565057|protein|protein
368640|NCT01565057|layering|layering
368641|NCT01565044|Stroke|stroke
368642|NCT01565044|hemiplegia|hemiplegia
368643|NCT01565044|automatic pilot|automatic pilot
368644|NCT01565044|upper-limb rehabilitation|upper-limb rehabilitation
368645|NCT01565031|Asthma|asthma
368646|NCT01565018|Rotigotine|rotigotine
368647|NCT01565018|Neupro®|neupro®
368648|NCT01565018|Transdermal Patch|transdermal patch
368649|NCT01565018|Bioequivalence|bioequivalence
368650|NCT01565005|MCPH|mcph
368651|NCT01565005|FANCONI ANEMIA|fanconi anemia
368652|NCT01564992|Parkinson's disease|parkinson's disease
368653|NCT01564992|Pharmacogenetics|pharmacogenetics
368654|NCT01564992|Genetics|genetics
368655|NCT01564979|botulinum toxin|botulinum toxin
368656|NCT01564979|facial nerve|facial nerve
368657|NCT01564979|hemifacial spasm|hemifacial spasm
368658|NCT01564979|tears|tears
368659|NCT01564966|transplantation|transplantation
368660|NCT01564966|inflammation|inflammation
368661|NCT01564966|endothelial dysfunction|endothelial dysfunction
368662|NCT01564953|vitamin D|vitamin d
368663|NCT01564953|calcium|calcium
368664|NCT01564953|magnesium|magnesium
368665|NCT01564953|COPD|copd
368666|NCT01564953|QoL|qol
368667|NCT01564940|Cervical cap insemination|cervical cap insemination
368668|NCT01564940|Usability Study|usability study
368669|NCT01564927|deqi electroacupuncture|deqi electroacupuncture
368670|NCT01564927|BP HR HRV|bp hr hrv
368671|NCT01564875|Simvast CR|simvast cr
368672|NCT01564875|Zocor|zocor
368673|NCT01564862|Drug Therapy|drug therapy
368674|NCT01564849|Pomegranate fruit extract|pomegranate fruit extract
368675|NCT01564849|Sinusitis|sinusitis
368676|NCT01564849|rhinitis|rhinitis
368677|NCT01564849|nasal polyps|nasal polyps
368678|NCT01564823|Crohn´s disease|crohn´s disease
368679|NCT01564823|Metronidazole|metronidazole
368680|NCT01564823|Azathioprine|azathioprine
368681|NCT01564823|Adalimumab|adalimumab
368682|NCT01564823|post-chirurgic recurrence|post-chirurgic recurrence
368683|NCT01564810|liver metastasis|liver metastasis
368684|NCT01564810|colorectal cancer|colorectal cancer
368685|NCT01564810|cetuximab|cetuximab
368686|NCT01564810|chemotherapy|chemotherapy
368687|NCT01564797|Diabetes|diabetes
368688|NCT01564797|haemoglobin A1C|haemoglobin a1c
368689|NCT01564797|Hispanic|hispanic
368690|NCT01564797|Behavioural Intervention|behavioural intervention
368691|NCT01564771|Pneumococcal serotypes|pneumococcal serotypes
368692|NCT01564771|Community Acquired Pneumonia (CAP)|community acquired pneumonia (cap)
368693|NCT01564758|non-interventional|non-interventional
368694|NCT01564758|non-comparative|non-comparative
368695|NCT01564758|open-label study|open-label study
368696|NCT01564758|safety|safety
368697|NCT01564758|Linezolid|linezolid
368698|NCT01564758|gram positive infections|gram positive infections
368699|NCT01564758|Filipino|filipino
368700|NCT01564732|morbid obesity|morbid obesity
368701|NCT01564732|gastric band|gastric band
368702|NCT01564719|clergy|clergy
368703|NCT01564719|weight loss|weight loss
368704|NCT01564719|holistic|holistic
368705|NCT01564719|stress|stress
368706|NCT01564719|spiritual|spiritual
368707|NCT01564706|Amyloid imaging|amyloid imaging
368708|NCT01564706|Positron Emission Tomography|positron emission tomography
368709|NCT01564706|18F-AV-45|18f-av-45
368710|NCT01564706|florbetapir F 18|florbetapir f 18
368711|NCT01564706|Diagnostic imaging|diagnostic imaging
368712|NCT01564693|anorexia|anorexia
368713|NCT01564693|cancer|cancer
368714|NCT01564693|hypothalamus|hypothalamus
368715|NCT01564693|inflammation|inflammation
368716|NCT01564680|Lower abdominal surgery|lower abdominal surgery
368717|NCT01564680|Paracetamol|paracetamol
368718|NCT01564680|Lornoxicam|lornoxicam
368719|NCT01564680|Morphine|morphine
368720|NCT01564667|PTSD|ptsd
368721|NCT01564667|Posttraumatic Stress|posttraumatic stress
368722|NCT01564667|Post Traumatic Stress|post traumatic stress
368723|NCT01564667|Attention Bias|attention bias
368724|NCT01564667|Threat Bias|threat bias
368725|NCT01564667|Combat|combat
368726|NCT01564667|Warzone|warzone
368727|NCT01564641|knee|knee
368728|NCT01564641|osteoarthritis|osteoarthritis
368729|NCT01564641|bicompartmental|bicompartmental
368730|NCT01564641|arthroplasty|arthroplasty
368731|NCT01564641|joint diseases|joint diseases
368732|NCT01564628|CAD|cad
368733|NCT01564615|Catheter related bloodstream infection|catheter related bloodstream infection
368734|NCT01564615|Umbilical venous catheter|umbilical venous catheter
368735|NCT01564615|Silver|silver
368736|NCT01564615|Preterm infants|preterm infants
368737|NCT01564602|2-channel single port laparoscopy|2-channel single port laparoscopy
368738|NCT01564602|multiple-channel port laparoscopy|multiple-channel port laparoscopy
368739|NCT01564576|Laparoscopic surgery|laparoscopic surgery
368740|NCT01564576|Anesthesiology|anesthesiology
368741|NCT01564576|Neuromuscular blockade|neuromuscular blockade
368742|NCT01564550|Type 2 diabetes|type 2 diabetes
368743|NCT01564550|Very-low-density-lipoprotein(VLDL)|very-low-density-lipoprotein(vldl)
368744|NCT01564550|VLDL1|vldl1
368745|NCT01564550|VLDL2|vldl2
368746|NCT01564550|hyperinsulinemia|hyperinsulinemia
368747|NCT01564550|diet|diet
368748|NCT01564537|Drug therapy|drug therapy
368749|NCT01564524|Craniomaxillofacial (CMF) Battle-injured (BI)|craniomaxillofacial (cmf) battle-injured (bi)
368750|NCT01564524|Facial Trauma|facial trauma
368751|NCT01564524|Fat Grafts|fat grafts
368752|NCT01564524|Autogenous Fat Transfers (AFT)|autogenous fat transfers (aft)
368753|NCT01564524|Wounded warriors|wounded warriors
368754|NCT01564511|Multiple Sclerosis|multiple sclerosis
368755|NCT01564511|Robotic Rahabilitation|robotic rahabilitation
368756|NCT01564511|Fatigue|fatigue
368757|NCT01564511|Gait disorder|gait disorder
368758|NCT01564498|anthocyanins|anthocyanins
368759|NCT01564498|antioxidant|antioxidant
368760|NCT01564498|polyphenols|polyphenols
368761|NCT01564498|bioavailability|bioavailability
368762|NCT01564498|cholesterol|cholesterol
368763|NCT01564498|insulin sensitivity|insulin sensitivity
368764|NCT01564498|glucose tolerance|glucose tolerance
368765|NCT01564498|atherosclerosis|atherosclerosis
368766|NCT01564498|metabolic syndrome|metabolic syndrome
368767|NCT01564446|medication|medication
368768|NCT01564446|discharge|discharge
368769|NCT01564446|adherence|adherence
368770|NCT01564446|compliance|compliance
368771|NCT01564446|secure message|secure message
368772|NCT01564433|robotics|robotics
368773|NCT01564433|rehabilitation|rehabilitation
368774|NCT01564433|gait|gait
368775|NCT01564433|cerebral palsy|cerebral palsy
368776|NCT01564420|pharmacokinetic/pharmacodynamic modeling|pharmacokinetic/pharmacodynamic modeling
368777|NCT01564420|intrathecal morphine|intrathecal morphine
368778|NCT01564420|postoperative analgesia|postoperative analgesia
368779|NCT01564420|patient-controlled analgesia device|patient-controlled analgesia device
368780|NCT01564407|ICX‐RHY‐013|icx‐rhy‐013
368781|NCT01564407|Restrictive scar contracture|restrictive scar contracture
368782|NCT01564407|Restrictive hypertrophic scar|restrictive hypertrophic scar
368783|NCT01564407|Burn Scar|burn scar
368784|NCT01564407|Burn Scar contractures|burn scar contractures
368785|NCT01564407|Scar|scar
368786|NCT01564394|qigong|qigong
368787|NCT01564394|mindfulness meditation|mindfulness meditation
368788|NCT01564394|fatigue|fatigue
368789|NCT01564394|prostate cancer|prostate cancer
368790|NCT01564381|Cardiovascular disease|cardiovascular disease
368791|NCT01564368|stage II breast cancer|stage ii breast cancer
368792|NCT01564368|stage IIIA breast cancer|stage iiia breast cancer
368793|NCT01564368|stage IIIB breast cancer|stage iiib breast cancer
368794|NCT01564368|stage IIIC breast cancer|stage iiic breast cancer
368795|NCT01564368|stage IV breast cancer|stage iv breast cancer
368796|NCT01564368|HER2-negative breast cancer|her2-negative breast cancer
368797|NCT01564368|HER2-positive breast cancer|her2-positive breast cancer
368798|NCT01564342|wound irrigation|wound irrigation
368799|NCT01564342|tap water irrigation|tap water irrigation
368800|NCT01564342|wound infection|wound infection
368801|NCT01564342|wound irrigation solution|wound irrigation solution
368802|NCT01564329|endostar|endostar
368803|NCT01564329|CT Perfusion|ct perfusion
368804|NCT01564329|Advanced Primary Lung Adenocarcinoma|advanced primary lung adenocarcinoma
368805|NCT01564303|Carnitine|carnitine
368806|NCT01564303|Phosphodiesterase type 5 (PDE5) inhibitor|phosphodiesterase type 5 (pde5) inhibitor
368807|NCT01564303|Contrast Media-induced Nephropathy (CMN)|contrast media-induced nephropathy (cmn)
368808|NCT01564290|acute diarrhea|acute diarrhea
368809|NCT01564290|probiotics|probiotics
368810|NCT01564290|children|children
368811|NCT01564264|Uterine Neoplasms|uterine neoplasms
368812|NCT01564264|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
368813|NCT01564238|calcium retention|calcium retention
368814|NCT01564238|sodium retention|sodium retention
368815|NCT01564225|XLHED|xlhed
368816|NCT01564212|heat loss|heat loss
368817|NCT01564212|laminar airflow|laminar airflow
368818|NCT01564212|operating rooms|operating rooms
368819|NCT01564160|Fish Oil|fish oil
368820|NCT01564160|EPA|epa
368821|NCT01564160|DHA|dha
368822|NCT01564160|Omega-Score|omega-score
368823|NCT01564160|Omega-3 Fatty Acids|omega-3 fatty acids
368824|NCT01564160|Green-Lipped Mussel|green-lipped mussel
368825|NCT01564160|Omega-score < 5.2%|omega-score < 5.2%
368826|NCT01564147|Therapeutic Education, Rheumatoid Arthritis|therapeutic education, rheumatoid arthritis
368827|NCT01564134|response vaccination|response vaccination
368828|NCT01564108|Intravitreal Ranibizumab|intravitreal ranibizumab
368829|NCT01564108|Non-infectious uveitis|non-infectious uveitis
368830|NCT01564108|Refractory Cystoid Macular Oedema|refractory cystoid macular oedema
368831|NCT01564108|Lucentis|lucentis
368832|NCT01564108|LIMO|limo
368833|NCT01564095|Liver transplantation|liver transplantation
368834|NCT01564095|EDC|edc
368835|NCT01564095|IRI|iri
368836|NCT01564095|graft survival|graft survival
368837|NCT01564095|graft function|graft function
368838|NCT01564095|graft preconditioning|graft preconditioning
368839|NCT01564095|Tacrolimus rinse|tacrolimus rinse
368840|NCT01564095|randomised multicenter trial|randomised multicenter trial
368841|NCT01564082|endotracheal intubation|endotracheal intubation
368842|NCT01564082|GlideScope|glidescope
368843|NCT01564069|Chronic pain|chronic pain
368844|NCT01564069|Intrathecal pain management|intrathecal pain management
368845|NCT01564056|Adjuvant systemic treatment|adjuvant systemic treatment
368846|NCT01564056|Breast cancer|breast cancer
368847|NCT01564056|Elderly patients|elderly patients
368848|NCT01564030|Pregnancy|pregnancy
368849|NCT01564030|Respiratory aspiration|respiratory aspiration
368850|NCT01564030|Gastric contents|gastric contents
368851|NCT01564030|Ultrasound|ultrasound
368852|NCT01564017|Allergy|allergy
368853|NCT01564017|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
368854|NCT01564017|Immunotherapy|immunotherapy
368855|NCT01564017|D. pteronyssinus|d. pteronyssinus
368856|NCT01564017|house dust allergy|house dust allergy
368857|NCT01564004|breech presentation at term|breech presentation at term
368858|NCT01564004|pregnancy|pregnancy
368859|NCT01564004|external cephalic version (ECV)|external cephalic version (ecv)
368860|NCT01564004|clinical hypnosis|clinical hypnosis
368861|NCT01564004|neuro-linguistic programming (NLP)|neuro-linguistic programming (nlp)
368862|NCT01563991|surgery|surgery
368863|NCT01563991|fluid|fluid
368864|NCT01563991|morbidity|morbidity
368865|NCT01563978|Rheumatoid Arthritis|rheumatoid arthritis
368866|NCT01563965|Preoperative fasting|preoperative fasting
368867|NCT01563965|Acute phase proteins|acute phase proteins
368868|NCT01563965|Carbohydrates|carbohydrates
368869|NCT01563965|Protein hydrolizate|protein hydrolizate
368870|NCT01563965|Inflammatory response|inflammatory response
368871|NCT01563965|Surgery|surgery
368872|NCT01563939|Labour analgesia|labour analgesia
368873|NCT01563939|Pregnancy|pregnancy
368874|NCT01563939|IVPCA|ivpca
368875|NCT01563913|Parkinsons disease|parkinsons disease
368876|NCT01563913|supplement|supplement
368877|NCT01563913|DHA|dha
368878|NCT01563913|dyskinesia|dyskinesia
368879|NCT01563913|abnormal movements|abnormal movements
368880|NCT01563900|fatigue|fatigue
368881|NCT01563900|multiple sclerosis|multiple sclerosis
368882|NCT01563900|sleep apnea|sleep apnea
368883|NCT01563900|CPAP|cpap
368884|NCT01563887|Type 1 Diabetes|type 1 diabetes
368885|NCT01563887|Hypoglycemia|hypoglycemia
368886|NCT01563887|Driving|driving
368887|NCT01563887|Driving safety|driving safety
368888|NCT01563887|Internet|internet
368889|NCT01563887|Web|web
368890|NCT01563887|Treatment|treatment
368891|NCT01563887|Intervention|intervention
368892|NCT01563874|Antibodies|antibodies
368893|NCT01563874|Reverse Phase Microarrays|reverse phase microarrays
368894|NCT01563874|Epigenetics|epigenetics
368895|NCT01563874|Acetylation|acetylation
368896|NCT01563874|Methylation|methylation
368897|NCT01563874|Lymphoma|lymphoma
368898|NCT01563861|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
368899|NCT01563861|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
368900|NCT01563861|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
368901|NCT01563861|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
368902|NCT01563835|Termination of pregnancy|termination of pregnancy
368903|NCT01563835|Epidural|epidural
368904|NCT01563835|IV PCA|iv pca
368905|NCT01563822|Follicular Fluid|follicular fluid
368906|NCT01563822|uterine cavity|uterine cavity
368907|NCT01563822|Implantation rates|implantation rates
368908|NCT01563822|ICSI|icsi
368909|NCT01563796|bladder cancer|bladder cancer
368910|NCT01563796|TCC|tcc
368911|NCT01563796|urine|urine
368912|NCT01563796|protein ELISA|protein elisa
368913|NCT01563783|Fibroids|fibroids
368914|NCT01563783|Myomas|myomas
368915|NCT01563783|leiomyomata|leiomyomata
368916|NCT01563783|menorrhagia|menorrhagia
368917|NCT01563783|Acessa Procedure|acessa procedure
368918|NCT01563783|Radiofrequency Ablation|radiofrequency ablation
368919|NCT01563783|RFA|rfa
368920|NCT01563770|Hyperlipidemia|hyperlipidemia
368921|NCT01563770|Hypertension|hypertension
368922|NCT01563770|Vasodilation|vasodilation
368923|NCT01563770|Oxidative stress|oxidative stress
368924|NCT01563770|Inflammation|inflammation
368925|NCT01563770|Hemostasis|hemostasis
368926|NCT01563770|Hemorheology|hemorheology
368927|NCT01563770|Cardiovascular diseases|cardiovascular diseases
368928|NCT01563770|Cardiovascular agents|cardiovascular agents
368929|NCT01563770|Salvia miltiorrhiza|salvia miltiorrhiza
368930|NCT01563770|Danshen|danshen
368931|NCT01563770|Danshen root extract|danshen root extract
368932|NCT01563770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
368933|NCT01563770|Therapeutic Uses|therapeutic uses
368934|NCT01563744|colonoscopy|colonoscopy
368935|NCT01563744|bowel preparation|bowel preparation
368936|NCT01563744|tolerability|tolerability
368937|NCT01563744|EGD-assisted|egd-assisted
368938|NCT01563731|Blood pressure medicines|blood pressure medicines
368939|NCT01563731|Lipid lowering medicines|lipid lowering medicines
368940|NCT01563731|Hypertension|hypertension
368941|NCT01563731|Stroke|stroke
368942|NCT01563731|Dementia|dementia
368943|NCT01563731|Heart attack|heart attack
368944|NCT01563731|Heart failure|heart failure
368945|NCT01563705|Neuromuscular Disorders|neuromuscular disorders
368946|NCT01563705|GSD III|gsd iii
368947|NCT01563705|glycogen storage disease|glycogen storage disease
368948|NCT01563692|RSV|rsv
368949|NCT01563692|Immune response|immune response
368950|NCT01563679|cancer|cancer
368951|NCT01563679|locoregional therapies|locoregional therapies
368952|NCT01563679|RFA|rfa
368953|NCT01563679|Cryoablation|cryoablation
368954|NCT01563679|Microwave ablation|microwave ablation
368955|NCT01563679|chemical ablation|chemical ablation
368956|NCT01563679|Irreversible electroporation|irreversible electroporation
368957|NCT01563653|predicting surgical success|predicting surgical success
368958|NCT01563653|simple diagnostic test device|simple diagnostic test device
368959|NCT01563640|dengue|dengue
368960|NCT01563588|breast cancer|breast cancer
368961|NCT01563588|chemotherapy|chemotherapy
368962|NCT01563588|first line treatment|first line treatment
368963|NCT01563588|treatments include a chemotherapy|treatments include a chemotherapy
368964|NCT01563588|last treatment not performed more than 9 months earlier|last treatment not performed more than 9 months earlier
368965|NCT01563575|Recognition Process|recognition process
368966|NCT01563575|Health Promotion|health promotion
368967|NCT01563575|HPH|hph
368968|NCT01563575|WHO|who
368969|NCT01563575|Hospitals|hospitals
368970|NCT01563575|Health Services|health services
368971|NCT01563575|Health Gain|health gain
368972|NCT01563575|Service Delivery|service delivery
368973|NCT01563575|Quality Management|quality management
368974|NCT01563536|Hepatitis C,Genotype 1|hepatitis c,genotype 1
368975|NCT01563510|Hepatolithiasis|hepatolithiasis
368976|NCT01563510|Minimal invasive surgery|minimal invasive surgery
368977|NCT01563510|Laparoscopic hepatectomy|laparoscopic hepatectomy
368978|NCT01563510|Choledochoscope|choledochoscope
368979|NCT01563484|Primary Hepatocellular Carcinoma(HCC)|primary hepatocellular carcinoma(hcc)
368980|NCT01563484|Transarterial chemoembolization (TACE)|transarterial chemoembolization (tace)
368981|NCT01563484|Liver function|liver function
368982|NCT01563484|Renal function|renal function
368983|NCT01563432|crossover|crossover
368984|NCT01563432|pharmacokinetic|pharmacokinetic
368985|NCT01563432|hyperuricemia|hyperuricemia
368986|NCT01563432|gout|gout
368987|NCT01563419|Insulin|insulin
368988|NCT01563419|Diabetes|diabetes
368989|NCT01563419|Low vision|low vision
368990|NCT01563406|Needleless connectors|needleless connectors
368991|NCT01563406|catheter hubs|catheter hubs
368992|NCT01563393|tool for nutritional evaluation|tool for nutritional evaluation
368993|NCT01563393|children|children
368994|NCT01563393|malnutrition|malnutrition
368995|NCT01563380|total knee arthroplasty|total knee arthroplasty
368996|NCT01563380|osteoarthritis|osteoarthritis
368997|NCT01563380|autologous Platelet rich plasma|autologous platelet rich plasma
368998|NCT01563380|complications|complications
368999|NCT01563380|blood loss|blood loss
369000|NCT01563380|Pain|pain
369001|NCT01563380|functional outcome|functional outcome
369002|NCT01563367|Anaemia|anaemia
369003|NCT01563367|Cardiac surgery|cardiac surgery
369004|NCT01563354|neuroendocrine carcinoma; lung; thymus; pasireotide LAR; everolimus|neuroendocrine carcinoma; lung; thymus; pasireotide lar; everolimus
369005|NCT01563328|Dolutegravir, GSK1349572, DTG, BCV, TVR, drug interaction|dolutegravir, gsk1349572, dtg, bcv, tvr, drug interaction
369006|NCT01563315|Community-Acquired Infections|community-acquired infections
369007|NCT01563315|Pneumonia/microbiology|pneumonia/microbiology
369008|NCT01563315|Pneumonia/diagnosis|pneumonia/diagnosis
369009|NCT01563315|Prognosis|prognosis
369010|NCT01563315|Prospective Studies|prospective studies
369011|NCT01563302|Advanced Cancers|advanced cancers
369012|NCT01563302|DLBCL|dlbcl
369013|NCT01563302|Advanced Lymphoma|advanced lymphoma
369014|NCT01563276|Progressive Supranuclear Palsy|progressive supranuclear palsy
369015|NCT01563276|PSP|psp
369016|NCT01563276|Falls|falls
369017|NCT01563276|Gait|gait
369018|NCT01563276|Balance|balance
369019|NCT01563276|Parkinson's Disease|parkinson's disease
369020|NCT01563276|PD|pd
369021|NCT01563263|IC43|ic43
369022|NCT01563263|Pseudomonas Aeruginosa|pseudomonas aeruginosa
369023|NCT01563263|mechanically ventilated ICU patients|mechanically ventilated icu patients
369024|NCT01563263|ICU patients|icu patients
369025|NCT01563250|Acute Coronary Syndrome|acute coronary syndrome
369026|NCT01563250|Cardiac Biomarkers|cardiac biomarkers
369027|NCT01563250|point of care testing|point of care testing
369028|NCT01563224|GABA-B|gaba-b
369029|NCT01563211|breast cancer therapy|breast cancer therapy
369030|NCT01563211|toxicity|toxicity
369031|NCT01563211|side effect profile|side effect profile
369032|NCT01563198|MRI departments and facilities|mri departments and facilities
369033|NCT01563198|Noncompletion of MRI|noncompletion of mri
369034|NCT01563185|JIA|jia
369035|NCT01563185|ibuprofen|ibuprofen
369036|NCT01563185|famotidine|famotidine
369037|NCT01563185|pediatrics|pediatrics
369038|NCT01563185|for > 1 month|for > 1 month
369039|NCT01563159|Belgium|belgium
369040|NCT01563159|hospitals|hospitals
369041|NCT01563159|Rotavirus|rotavirus
369042|NCT01563146|Rotavirus|rotavirus
369043|NCT01563146|hospitals|hospitals
369044|NCT01563146|Belgium|belgium
369045|NCT01563133|endomicroscopy|endomicroscopy
369046|NCT01563133|needle-based|needle-based
369047|NCT01563133|pancreatic|pancreatic
369048|NCT01563133|cyst|cyst
369049|NCT01563133|mass|mass
369050|NCT01563133|EUSFNA|eusfna
369051|NCT01563107|Orthostatic Intolerance|orthostatic intolerance
369052|NCT01563107|Tachycardia|tachycardia
369053|NCT01563107|Orthostatic Hypotension|orthostatic hypotension
369054|NCT01563107|Sodium|sodium
369055|NCT01563094|Bone Density|bone density
369056|NCT01563094|Lactation|lactation
369057|NCT01563094|Bone Turnover Markers|bone turnover markers
369058|NCT01563081|Allergic rhinitis|allergic rhinitis
369059|NCT01563081|Pediatric|pediatric
369060|NCT01563081|Pruritus|pruritus
369061|NCT01563081|Levocetirizine|levocetirizine
369062|NCT01563068|plaque psoriasis|plaque psoriasis
369063|NCT01563068|pediatric|pediatric
369064|NCT01563068|adolescent|adolescent
369065|NCT01563042|immunogenicity|immunogenicity
369066|NCT01563042|GSK2434735|gsk2434735
369067|NCT01563042|pharmacokinetics (PK)|pharmacokinetics (pk)
369068|NCT01563042|PK|pk
369069|NCT01563042|biospecific antibody|biospecific antibody
369070|NCT01563016|schizophrenia|schizophrenia
369071|NCT01563016|Psychotic Disorders|psychotic disorders
369072|NCT01563016|Psychoses|psychoses
369073|NCT01563003|Autism|autism
369074|NCT01563003|Asperger's Syndrome|asperger's syndrome
369075|NCT01563003|Pervasive Developmental Disorder Not Otherwise Specified|pervasive developmental disorder not otherwise specified
369076|NCT01563003|Treatment|treatment
369077|NCT01563003|Cognitive-behavioral therapy|cognitive-behavioral therapy
369078|NCT01563003|Anxiety|anxiety
369079|NCT01563003|Children|children
369080|NCT01563003|Therapy|therapy
369081|NCT01562951|Crohn's disease|crohn's disease
369082|NCT01562951|mucosal inflammation|mucosal inflammation
369083|NCT01562951|lesions|lesions
369084|NCT01562938|Respiratory Syncytial Virus|respiratory syncytial virus
369085|NCT01562912|radiofrequency|radiofrequency
369086|NCT01562912|ablation|ablation
369087|NCT01562912|atrial fibrillation|atrial fibrillation
369088|NCT01562912|PVAC|pvac
369089|NCT01562899|MEK162|mek162
369090|NCT01562899|AMG 479|amg 479
369091|NCT01562899|Ganitumab|ganitumab
369092|NCT01562899|colorectal adenocarcinoma|colorectal adenocarcinoma
369093|NCT01562899|pancreatic adenocarcinoma|pancreatic adenocarcinoma
369094|NCT01562899|melanoma|melanoma
369095|NCT01562899|KRAS|kras
369096|NCT01562899|BRAF|braf
369097|NCT01562886|Rilpivirine CSF pharmacokinetics|rilpivirine csf pharmacokinetics
369098|NCT01562873|pSTAT3+|pstat3+
369099|NCT01562860|median nerve|median nerve
369100|NCT01562860|carpal tunnel syndrome|carpal tunnel syndrome
369101|NCT01562860|Pronator Teres Release|pronator teres release
369102|NCT01562782|Elevated triglycerides|elevated triglycerides
369103|NCT01562782|Diabetes Mellitus|diabetes mellitus
369104|NCT01562782|Dyslipidemia|dyslipidemia
369105|NCT01562782|Lipid Metabolic Disorders|lipid metabolic disorders
369106|NCT01562782|Body Weight|body weight
369107|NCT01562730|Coronary Artery Disease|coronary artery disease
369108|NCT01562730|Myocardial Ischemia|myocardial ischemia
369109|NCT01562730|Coronary Disease|coronary disease
369110|NCT01562730|Heart Diseases|heart diseases
369111|NCT01562730|Cardiovascular Diseases|cardiovascular diseases
369112|NCT01562730|Arteriosclerosis|arteriosclerosis
369209|NCT01562275|MEK|mek
369113|NCT01562730|Arterial Occlusive Diseases|arterial occlusive diseases
369114|NCT01562730|Vascular Diseases|vascular diseases
369115|NCT01562730|iECG|iecg
369116|NCT01562730|12 leads ECG|12 leads ecg
369117|NCT01562704|mechanism of action of paracetamol in the brain structures|mechanism of action of paracetamol in the brain structures
369118|NCT01562691|nasal packing|nasal packing
369119|NCT01562691|nasal airway|nasal airway
369120|NCT01562691|septoplasty|septoplasty
369121|NCT01562691|oxygen saturation|oxygen saturation
369122|NCT01562691|postoperative pain|postoperative pain
369123|NCT01562678|fMRI|fmri
369124|NCT01562678|Liraglutide|liraglutide
369125|NCT01562678|diabetes|diabetes
369126|NCT01562678|GLP-1|glp-1
369127|NCT01562665|All patients with NSCLC attending participating hospitals|all patients with nsclc attending participating hospitals
369128|NCT01562639|maintenance therapy,|maintenance therapy,
369129|NCT01562639|repeatedly recurring,|repeatedly recurring,
369130|NCT01562639|relapsing reflux oesophagitis,|relapsing reflux oesophagitis,
369131|NCT01562639|Nexium|nexium
369132|NCT01562613|Stroke|stroke
369133|NCT01562613|Hypertension|hypertension
369134|NCT01562600|NSAIDs|nsaids
369135|NCT01562600|Gastric ulcer or duodenal ulcer|gastric ulcer or duodenal ulcer
369136|NCT01562600|Nexium|nexium
369137|NCT01562548|upper back/neck/shoulder muscle spasm|upper back/neck/shoulder muscle spasm
369138|NCT01562535|pulled elbow|pulled elbow
369139|NCT01562535|nursemaid elbow|nursemaid elbow
369140|NCT01562509|Non-Hodgkin lymphoma (NHL)|non-hodgkin lymphoma (nhl)
369141|NCT01562509|Quality of health care|quality of health care
369142|NCT01562509|Oncology Service Hospital|oncology service hospital
369143|NCT01562509|Patient-centredness|patient-centredness
369144|NCT01562509|PROMs|proms
369145|NCT01562496|Parkinson's disease|parkinson's disease
369146|NCT01562496|Neuroprotective|neuroprotective
369147|NCT01562496|Intensive exercise|intensive exercise
369148|NCT01562483|postsurgical pain|postsurgical pain
369149|NCT01562483|abdominal pain|abdominal pain
369150|NCT01562483|visceral pain|visceral pain
369151|NCT01562483|chronic pain|chronic pain
369152|NCT01562470|cellulite|cellulite
369153|NCT01562470|reduction|reduction
369154|NCT01562470|cream|cream
369155|NCT01562470|thighs|thighs
369156|NCT01562470|women|women
369157|NCT01562444|Long term immunogenicity study|long term immunogenicity study
369158|NCT01562418|Ergonomics|ergonomics
369159|NCT01562418|musculoskeletal symptoms|musculoskeletal symptoms
369160|NCT01562418|kinematics|kinematics
369161|NCT01562405|Relapsed|relapsed
369162|NCT01562405|Refractory|refractory
369163|NCT01562392|dietary prevention|dietary prevention
369164|NCT01562392|cognitive performance|cognitive performance
369165|NCT01562392|metabolic syndrome|metabolic syndrome
369166|NCT01562392|colonic fermentation|colonic fermentation
369167|NCT01562392|sub clinical inflammation|sub clinical inflammation
369168|NCT01562392|cognition and metabolism|cognition and metabolism
369169|NCT01562379|complementary food supplements|complementary food supplements
369170|NCT01562379|stunting|stunting
369171|NCT01562379|wasting|wasting
369172|NCT01562379|growth|growth
369173|NCT01562379|Bangladesh|bangladesh
369174|NCT01562379|infant feeding|infant feeding
369175|NCT01562366|Iliotibial Band Release|iliotibial band release
369176|NCT01562366|Trochanteric Bursectomy|trochanteric bursectomy
369177|NCT01562366|Micro debridement|micro debridement
369178|NCT01562353|Opioid Dependence|opioid dependence
369179|NCT01562353|Opioids for the treatment of pain|opioids for the treatment of pain
369180|NCT01562340|Hemodialysis|hemodialysis
369181|NCT01562340|End stage renal disease|end stage renal disease
369182|NCT01562340|Oxidative stress|oxidative stress
369183|NCT01562340|Inflammation|inflammation
369184|NCT01562340|Endothelial dysfunction|endothelial dysfunction
369185|NCT01562340|Cardiovascular disease|cardiovascular disease
369186|NCT01562340|Antioxidants|antioxidants
369187|NCT01562340|Flavonoids|flavonoids
369188|NCT01562314|Mild to Moderate Ulcerative Colitis|mild to moderate ulcerative colitis
369189|NCT01562301|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
369190|NCT01562301|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
369191|NCT01562301|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
369192|NCT01562301|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
369193|NCT01562301|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
369194|NCT01562301|carboplatin|carboplatin
369195|NCT01562301|Paraplatin|paraplatin
369196|NCT01562301|docetaxel|docetaxel
369197|NCT01562301|Taxotere|taxotere
369198|NCT01562301|Anvirzel|anvirzel
369199|NCT01562301|nerium oleander|nerium oleander
369200|NCT01562301|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
369201|NCT01562301|NSCLC|nsclc
369202|NCT01562288|HER2-positive breast cancer|her2-positive breast cancer
369203|NCT01562288|HER2-negative breast cancer|her2-negative breast cancer
369204|NCT01562288|stage IA breast cancer|stage ia breast cancer
369205|NCT01562288|stage IB breast cancer|stage ib breast cancer
369206|NCT01562288|stage II breast cancer|stage ii breast cancer
369207|NCT01562288|stage IIIA breast cancer|stage iiia breast cancer
369208|NCT01562275|GDC0973|gdc0973
369210|NCT01562275|MEK inhibitor|mek inhibitor
369211|NCT01562275|GDC0068|gdc0068
369212|NCT01562275|Akt|akt
369213|NCT01562275|Akt inhibitor|akt inhibitor
369214|NCT01562262|Apnea|apnea
369215|NCT01562262|PVT|pvt
369216|NCT01562262|Reaction Time|reaction time
369217|NCT01562249|clinical evaluation|clinical evaluation
369218|NCT01562249|controlled clinical trial|controlled clinical trial
369219|NCT01562249|electromyography|electromyography
369220|NCT01562249|exercise program|exercise program
369221|NCT01562249|motor control|motor control
369222|NCT01562223|stage IIA prostate cancer|stage iia prostate cancer
369223|NCT01562223|stage IIB prostate cancer|stage iib prostate cancer
369224|NCT01562223|stage III prostate cancer|stage iii prostate cancer
369225|NCT01562223|stage IV prostate cancer|stage iv prostate cancer
369226|NCT01562223|adenocarcinoma of the prostate|adenocarcinoma of the prostate
369227|NCT01562210|NSCLC|nsclc
369228|NCT01562210|Olaparib|olaparib
369229|NCT01562210|CCRT|ccrt
369230|NCT01562197|axitinib|axitinib
369231|NCT01562197|glioblastoma|glioblastoma
369232|NCT01562197|recurrent|recurrent
369233|NCT01562171|Overweight|overweight
369234|NCT01562171|Obese|obese
369235|NCT01562171|Obesity|obesity
369236|NCT01562171|Cholesterol|cholesterol
369237|NCT01562171|Hypercholesterolemia|hypercholesterolemia
369238|NCT01562171|LDL-Cholesterol|ldl-cholesterol
369239|NCT01562145|Rotator cuff tear, matrix metalloproteinase, tissue inhibitor of matrix metalloproteinase, partial-thickness tear, full-thickness tear, plasma.|rotator cuff tear, matrix metalloproteinase, tissue inhibitor of matrix metalloproteinase, partial-thickness tear, full-thickness tear, plasma.
369240|NCT01562132|cryptococcus|cryptococcus
369241|NCT01562132|HIV|hiv
369242|NCT01562119|Burns|burns
369243|NCT01562119|Wound repair|wound repair
369244|NCT01562119|Skin substitutes|skin substitutes
369245|NCT01562106|Cancer of Endometrium|cancer of endometrium
369246|NCT01562106|Cancer of the Endometrium|cancer of the endometrium
369247|NCT01562106|Carcinoma of Endometrium|carcinoma of endometrium
369248|NCT01562106|Endometrial Carcinoma|endometrial carcinoma
369249|NCT01562106|Endometrium Cancer|endometrium cancer
369250|NCT01562106|Neoplasms, Endometrial|neoplasms, endometrial
369251|NCT01562093|Adrenal Cortex Hormones|adrenal cortex hormones
369252|NCT01562093|Spirometry|spirometry
369253|NCT01562093|Administration, Intranasal|administration, intranasal
369254|NCT01562093|Nasal blockage|nasal blockage
369255|NCT01562093|Nasal sprays|nasal sprays
369256|NCT01562080|hyperlipidemia|hyperlipidemia
369257|NCT01562080|metabolic syndrome|metabolic syndrome
369258|NCT01562080|yeast red|yeast red
369259|NCT01562080|berberine|berberine
369260|NCT01562080|policosanol|policosanol
369261|NCT01562080|astaxanthin|astaxanthin
369262|NCT01562067|Cervical tumors,vascular changes,Sonographic characteristics|cervical tumors,vascular changes,sonographic characteristics
369263|NCT01562041|Cardiovascular disease|cardiovascular disease
369264|NCT01562041|Exercise Treadmill Test|exercise treadmill test
369265|NCT01562041|Ranolazine|ranolazine
369266|NCT01562041|Angina|angina
369267|NCT01562041|Myocardial ischemia|myocardial ischemia
369268|NCT01562028|non small cell lung cancer|non small cell lung cancer
369269|NCT01562028|advanced|advanced
369270|NCT01562028|non-squamous|non-squamous
369271|NCT01562028|EGFR|egfr
369272|NCT01562028|mutations|mutations
369273|NCT01562002|limbus|limbus
369274|NCT01562002|cornea|cornea
369275|NCT01562002|insufficiency syndrome|insufficiency syndrome
369276|NCT01562002|stem cell transplant|stem cell transplant
369277|NCT01561963|Apremilast|apremilast
369278|NCT01561963|drug interaction|drug interaction
369279|NCT01561963|pharmacokinetics|pharmacokinetics
369280|NCT01561911|Clinical Trial|clinical trial
369281|NCT01561911|Phase I|phase i
369282|NCT01561911|Antibodies|antibodies
369283|NCT01561911|Monoclonal|monoclonal
369284|NCT01561898|Schizophrenia|schizophrenia
369285|NCT01561898|JNS007ER|jns007er
369286|NCT01561898|Paliperidone extended-release|paliperidone extended-release
369287|NCT01561885|Clinical Pathways|clinical pathways
369288|NCT01561885|Length of Stay|length of stay
369289|NCT01561885|Patient-Centered Care|patient-centered care
369290|NCT01561885|Pragmatic Randomized Controlled Trial|pragmatic randomized controlled trial
369291|NCT01561859|Early Course Schizophrenia|early course schizophrenia
369292|NCT01561859|Cognitive Enhancement Therapy|cognitive enhancement therapy
369293|NCT01561859|Enriched Supportive Therapy|enriched supportive therapy
369294|NCT01561846|Conjugated Linoleic Acid|conjugated linoleic acid
369295|NCT01561846|LDL-cholesterol|ldl-cholesterol
369296|NCT01561846|Endocannabinoids|endocannabinoids
369297|NCT01561833|relapsed or refractory T cell lymphoma|relapsed or refractory t cell lymphoma
369298|NCT01561820|mild cognitive impairment|mild cognitive impairment
369299|NCT01561820|cognitive disorders|cognitive disorders
369300|NCT01561820|exercise|exercise
369301|NCT01561794|Ciprofloxacin|ciprofloxacin
369302|NCT01561794|Bacterial pneumonia|bacterial pneumonia
369303|NCT01561794|Community Acquired Pneumonia (CAP)|community acquired pneumonia (cap)
369304|NCT01561794|Hospital Acquired Pneumonia (HAP)|hospital acquired pneumonia (hap)
369305|NCT01561794|Secondary infection of chronic respiratory disease|secondary infection of chronic respiratory disease
369306|NCT01561794|400 mg BID/TID|400 mg bid/tid
369307|NCT01561781|Phase 1|phase 1
369308|NCT01561781|healthy volunteers|healthy volunteers
369309|NCT01561781|pharmacokinetics|pharmacokinetics
369310|NCT01561781|vandetanib|vandetanib
369311|NCT01561781|digoxin|digoxin
369312|NCT01561755|HIV associated myelopathy|hiv associated myelopathy
369313|NCT01561742|minocycline, augmentation, schizophrenia|minocycline, augmentation, schizophrenia
369314|NCT01561729|nasogastric tube|nasogastric tube
369315|NCT01561729|orogastric tube|orogastric tube
369316|NCT01561729|RightSpot pH Indicator|rightspot ph indicator
369317|NCT01561729|suction tube|suction tube
369318|NCT01561729|RightBio Metrics|rightbio metrics
369319|NCT01561729|RightLevel|rightlevel
369320|NCT01561729|RightSpot Infant|rightspot infant
369321|NCT01561729|NG Tube|ng tube
369322|NCT01561729|pH|ph
369323|NCT01561729|Gastric Acidity|gastric acidity
369324|NCT01561716|video games|video games
369325|NCT01561716|energy expenditure|energy expenditure
369326|NCT01561716|physical activity|physical activity
369327|NCT01561716|exercise physiology|exercise physiology
369328|NCT01561703|Healthcare utilization|healthcare utilization
369329|NCT01561703|Tonsillectomy|tonsillectomy
369330|NCT01561703|Adenoidectomy/Tonsillectomy|adenoidectomy/tonsillectomy
369331|NCT01561703|Antibiotics|antibiotics
369332|NCT01561677|obstructive sleep apnea|obstructive sleep apnea
369333|NCT01561677|syndrome survival|syndrome survival
369334|NCT01561677|ischemic stroke|ischemic stroke
369335|NCT01561677|continuous positive airway pressure|continuous positive airway pressure
369336|NCT01561677|handicap|handicap
369337|NCT01561664|obesity|obesity
369338|NCT01561664|insulin resistance|insulin resistance
369339|NCT01561651|cardiac surgery|cardiac surgery
369340|NCT01561651|left atrial appendage|left atrial appendage
369341|NCT01561651|atrial fibrillation|atrial fibrillation
369342|NCT01561651|stroke|stroke
369343|NCT01561651|non-CNS systemic embolism|non-cns systemic embolism
369344|NCT01561638|Pulsed|pulsed
369345|NCT01561638|radiofrequency|radiofrequency
369346|NCT01561638|single-dose|single-dose
369347|NCT01561638|shoulder pain|shoulder pain
369348|NCT01561638|Pain lasts more than one month|pain lasts more than one month
369349|NCT01561638|patients referred to the pain clinic from the shoulder clinic|patients referred to the pain clinic from the shoulder clinic
369350|NCT01561638|Failed all conservative therapies available|failed all conservative therapies available
369351|NCT01561625|COPD|copd
369352|NCT01561625|exercise training|exercise training
369353|NCT01561612|Breastfeeding|breastfeeding
369354|NCT01561612|Child Health|child health
369355|NCT01561612|Obesity|obesity
369356|NCT01561612|Blood Pressure|blood pressure
369357|NCT01561612|Asthma|asthma
369358|NCT01561612|Cognitive Development|cognitive development
369359|NCT01561612|Behavior|behavior
369360|NCT01561612|Eczema|eczema
369361|NCT01561612|Lung Function|lung function
369362|NCT01561612|Spirometry|spirometry
369363|NCT01561599|hepatocyte growth factor mimetic|hepatocyte growth factor mimetic
369364|NCT01561599|hepatocyte growth factor(HGF)|hepatocyte growth factor(hgf)
369365|NCT01561599|Delayed Graft Function (DGF)|delayed graft function (dgf)
369366|NCT01561599|Kidney transplantation|kidney transplantation
369367|NCT01561586|Cervical cancer|cervical cancer
369368|NCT01561586|Concurrent chemoradiation|concurrent chemoradiation
369369|NCT01561586|Cisplatin|cisplatin
369370|NCT01561573|Point of Care Ultrasound|point of care ultrasound
369371|NCT01561573|Emergency Ultrasound|emergency ultrasound
369372|NCT01561573|Colles Fracture|colles fracture
369373|NCT01561573|Fracture Reduction|fracture reduction
369374|NCT01561573|Bedside Ultrasound|bedside ultrasound
369375|NCT01561560|DAILIES TOTAL1|dailies total1
369376|NCT01561560|contact lenses|contact lenses
369377|NCT01561560|myopia|myopia
369378|NCT01561547|pain|pain
369379|NCT01561547|preterm neonate|preterm neonate
369380|NCT01561547|sucrose|sucrose
369381|NCT01561547|kangaroo mother care|kangaroo mother care
369382|NCT01561534|fibula flap|fibula flap
369383|NCT01561534|oral implants|oral implants
369384|NCT01561534|computer-guided|computer-guided
369385|NCT01561508|diabetes mellitus|diabetes mellitus
369386|NCT01561508|children|children
369387|NCT01561495|scheduled to receive RT either pre- or postoperatively|scheduled to receive rt either pre- or postoperatively
369388|NCT01561482|Prostate carcinoma|prostate carcinoma
369389|NCT01561482|Prostate cancer|prostate cancer
369390|NCT01561482|Prostate Specific Antigen|prostate specific antigen
369392|NCT01561482|Metformin|metformin
369393|NCT01561482|Simvastatin|simvastatin
369394|NCT01561482|Radiation therapy|radiation therapy
369395|NCT01561482|Prostatectomy|prostatectomy
369396|NCT01561469|Linezolid|linezolid
369397|NCT01561469|Vancomycin|vancomycin
369398|NCT01561469|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
369399|NCT01561469|Respiratory Tract Infections|respiratory tract infections
369400|NCT01561456|non-small-cell lung cancer|non-small-cell lung cancer
369401|NCT01561456|squamous cell carcinoma|squamous cell carcinoma
369402|NCT01561456|adenocarcinoma of the lung|adenocarcinoma of the lung
369403|NCT01561456|IGF-1 inhibitor|igf-1 inhibitor
369404|NCT01561456|docetaxel|docetaxel
369405|NCT01561456|AXL1717|axl1717
369406|NCT01561456|NSCLC|nsclc
369407|NCT01561456|SCC|scc
369408|NCT01561456|AC|ac
369409|NCT01561443|Breast cancer,|breast cancer,
369410|NCT01561443|hormone positive,|hormone positive,
369411|NCT01561430|beta-secretase inhibitor|beta-secretase inhibitor
369412|NCT01561326|cervical cancer|cervical cancer
369413|NCT01561326|follow-up|follow-up
369414|NCT01561326|Pap test|pap test
369415|NCT01561326|Medical management|medical management
369416|NCT01561326|Colposcopy|colposcopy
369417|NCT01561313|On label Humira users|on label humira users
369418|NCT01561313|Pain|pain
369419|NCT01561313|Rheumatoid Arthritis,|rheumatoid arthritis,
369420|NCT01561300|Black tea|black tea
369421|NCT01561300|Flow Mediated Dilation|flow mediated dilation
369422|NCT01561300|Vascular function|vascular function
369423|NCT01561300|India|india
369424|NCT01561261|fasciotomy|fasciotomy
369425|NCT01561261|ACS|acs
369426|NCT01561248|EHEC|ehec
369427|NCT01561248|O104:H4|o104:h4
369428|NCT01561248|German|german
369429|NCT01561248|outbreak|outbreak
369430|NCT01561248|polyethylene glycol|polyethylene glycol
369431|NCT01561248|Bowel lavage|bowel lavage
369432|NCT01561235|Protein|protein
369433|NCT01561235|Appetite|appetite
369434|NCT01561235|Satiety|satiety
369435|NCT01561235|Energi intake|energi intake
369436|NCT01561235|Appetite regulating hormones|appetite regulating hormones
369437|NCT01561235|Dose-response|dose-response
369438|NCT01561222|calcitrol|calcitrol
369439|NCT01561222|Bone mineral density|bone mineral density
369440|NCT01561222|Osteoprotegin|osteoprotegin
369441|NCT01561222|Vascular calcification|vascular calcification
369442|NCT01561209|amitryptiline|amitryptiline
369443|NCT01561209|Chronic pain|chronic pain
369444|NCT01561209|Neck pain|neck pain
369445|NCT01561196|arteria cannulation|arteria cannulation
369446|NCT01561196|Ultrasound|ultrasound
369447|NCT01561196|pain|pain
369448|NCT01561196|complications|complications
369449|NCT01561183|Vital pulp therapy|vital pulp therapy
369450|NCT01561183|Pulp cap|pulp cap
369451|NCT01561183|pulpotomy|pulpotomy
369452|NCT01561183|calcium enriched mixture|calcium enriched mixture
369453|NCT01561183|CEM cement|cem cement
369454|NCT01561183|Endodontic|endodontic
369455|NCT01561170|Electromagnetic|electromagnetic
369456|NCT01561170|Field therapy|field therapy
369457|NCT01561170|Chronically venous ulcer|chronically venous ulcer
369458|NCT01561170|Venous insufficiens|venous insufficiens
369459|NCT01561157|porphyria|porphyria
369460|NCT01561157|acute intermittent|acute intermittent
369461|NCT01561157|coproporphyria|coproporphyria
369462|NCT01561157|variegate|variegate
369463|NCT01561157|erythropoietic|erythropoietic
369464|NCT01561157|protoporphyria|protoporphyria
369465|NCT01561157|hepatoerythropoietic|hepatoerythropoietic
369466|NCT01561157|cutanea tarda|cutanea tarda
369467|NCT01561157|AIP|aip
369468|NCT01561157|HCP|hcp
369469|NCT01561157|VP|vp
369470|NCT01561157|ADP|adp
369471|NCT01561157|ALAD|alad
369472|NCT01561157|PCT|pct
369473|NCT01561157|HEP|hep
369474|NCT01561157|CEP|cep
369475|NCT01561157|EPP|epp
369476|NCT01561157|XLP|xlp
369477|NCT01561144|Defibrillators, Implantable|defibrillators, implantable
369478|NCT01561144|Cardiac arrhythmias|cardiac arrhythmias
369479|NCT01561144|Heart Disease|heart disease
369480|NCT01561131|Obesity|obesity
369481|NCT01561131|Protein intake|protein intake
369482|NCT01561131|Calcium intake|calcium intake
369483|NCT01561131|Weight loss|weight loss
369484|NCT01561131|Weight maintenance|weight maintenance
369485|NCT01561131|Blood lipid profile|blood lipid profile
369486|NCT01561131|Diet induced thermogenesis|diet induced thermogenesis
369487|NCT01561118|hemodialysis|hemodialysis
369488|NCT01561118|dialysis efficacy|dialysis efficacy
369489|NCT01561118|cardiorespiratory capacity|cardiorespiratory capacity
369490|NCT01561118|exercise capacity|exercise capacity
369491|NCT01561118|children and adolescents|children and adolescents
369492|NCT01561092|Stroke|stroke
369493|NCT01561092|RCT|rct
369494|NCT01561092|SSRI|ssri
369495|NCT01561092|Outcome|outcome
369496|NCT01561079|Buprenorphine|buprenorphine
369497|NCT01561079|Methadone|methadone
369498|NCT01561079|Fetal neurobehavior|fetal neurobehavior
369499|NCT01561079|Infant neurobehavior|infant neurobehavior
369500|NCT01561066|Fibrin glue|fibrin glue
369501|NCT01561066|Platelet|platelet
369502|NCT01561066|Autologous derivation|autologous derivation
369503|NCT01561066|Prospective randomized trial|prospective randomized trial
369504|NCT01561066|Fistulas|fistulas
369505|NCT01561053|Alzheimer's disease|alzheimer's disease
369506|NCT01561053|AB peptide|ab peptide
369507|NCT01561053|Albumin|albumin
369508|NCT01561053|Intravenous immune globulin|intravenous immune globulin
369509|NCT01561053|IGIV|igiv
369510|NCT01561040|Dry Eye syndrome|dry eye syndrome
369511|NCT01561040|tear film deficiency|tear film deficiency
369512|NCT01561040|Essential Fatty Acid nutritional supplements|essential fatty acid nutritional supplements
369513|NCT01561040|Omega three supplements|omega three supplements
369514|NCT01560988|Asthma|asthma
369515|NCT01560988|Borage|borage
369516|NCT01560988|Echium|echium
369517|NCT01560988|Botanical|botanical
369518|NCT01560949|Pancreatic Cancer|pancreatic cancer
369519|NCT01560949|Adenocarcinoma of the Pancreas|adenocarcinoma of the pancreas
369520|NCT01560949|High Risk Resectable|high risk resectable
369521|NCT01560949|Borderline Resectable|borderline resectable
369522|NCT01560949|Chemotherapy|chemotherapy
369523|NCT01560949|Chemoradiation therapy|chemoradiation therapy
369524|NCT01560949|Oxaliplatin|oxaliplatin
369525|NCT01560949|Eloxatin|eloxatin
369526|NCT01560949|Irinotecan|irinotecan
369527|NCT01560949|CPT-11|cpt-11
369528|NCT01560949|Camptosar|camptosar
369529|NCT01560949|5-FU|5-fu
369530|NCT01560949|5-Fluorouracil|5-fluorouracil
369531|NCT01560949|Adrucil|adrucil
369532|NCT01560949|Efudex|efudex
369533|NCT01560949|Gemcitabine|gemcitabine
369534|NCT01560949|Gemcitabine Hydrochloride|gemcitabine hydrochloride
369535|NCT01560949|Gemzar|gemzar
369536|NCT01560949|Radiation Therapy|radiation therapy
369537|NCT01560949|XRT|xrt
369538|NCT01560949|RT|rt
369539|NCT01560949|External Beam Radiation Therapy|external beam radiation therapy
369540|NCT01560936|bacterial contamination|bacterial contamination
369541|NCT01560923|hormone refractory prostate cancer|hormone refractory prostate cancer
369542|NCT01560910|with or without GERD symptoms|with or without gerd symptoms
369543|NCT01560910|presenting to gastrointestinal clinic of Maharaj Nakorn Chiangmai Hospital|presenting to gastrointestinal clinic of maharaj nakorn chiangmai hospital
369544|NCT01560910|November 2009 to November 2010|november 2009 to november 2010
369545|NCT01560910|GERD|gerd
369546|NCT01560910|NERD|nerd
369547|NCT01560871|Heart failure|heart failure
369548|NCT01560871|inspiratory muscle training|inspiratory muscle training
369549|NCT01560871|physical activity|physical activity
369550|NCT01560845|autologous bone marrow stem cells|autologous bone marrow stem cells
369551|NCT01560845|portal hypertension|portal hypertension
369552|NCT01560845|surgery|surgery
369553|NCT01560845|liver cirrhosis|liver cirrhosis
369554|NCT01560819|ulcerative colitis, gut microbial transplantation|ulcerative colitis, gut microbial transplantation
369555|NCT01560806|hypertension|hypertension
369556|NCT01560806|cardiovascular risk factor|cardiovascular risk factor
369557|NCT01560806|lifestyle|lifestyle
369558|NCT01560793|Influenza|influenza
369559|NCT01560793|Vaccines|vaccines
369560|NCT01560793|H5N1|h5n1
369561|NCT01560780|Coronary Artery Bypass|coronary artery bypass
369562|NCT01560780|thrombosis|thrombosis
369563|NCT01560780|prasugrel|prasugrel
369564|NCT01560767|Pain relief|pain relief
369565|NCT01560767|Arthroplasty|arthroplasty
369566|NCT01560767|periarticular knee infiltration|periarticular knee infiltration
369567|NCT01560754|Randomized|randomized
369568|NCT01560754|Placebo-controlled|placebo-controlled
369569|NCT01560754|Double-blind|double-blind
369570|NCT01560754|Multi-center|multi-center
369571|NCT01560754|Disease-modifying potential|disease-modifying potential
369572|NCT01560754|transdermal nicotine|transdermal nicotine
369573|NCT01560741|Chronic respiratory failure|chronic respiratory failure
369574|NCT01560741|Noninvasive Mechanical Ventilation|noninvasive mechanical ventilation
369575|NCT01560741|Home-care|home-care
369576|NCT01560741|Telemedicine|telemedicine
369577|NCT01560741|COPD|copd
369578|NCT01560728|Post Traumatic Stress Disorder|post traumatic stress disorder
369579|NCT01560728|Major Depressive Disorder|major depressive disorder
369580|NCT01560728|Dysthymia|dysthymia
369581|NCT01560728|Generalized Anxiety Disorder|generalized anxiety disorder
369582|NCT01560728|Social Phobia|social phobia
369583|NCT01560728|Panic Disorder|panic disorder
369584|NCT01560715|Retinitis pigmentosa|retinitis pigmentosa
369585|NCT01560715|stem cell|stem cell
369586|NCT01560715|bone marrow|bone marrow
369587|NCT01560715|retinal dysprophy|retinal dysprophy
369588|NCT01560702|autologous blood|autologous blood
369589|NCT01560702|epinephrine|epinephrine
369590|NCT01560702|endoscopy|endoscopy
369591|NCT01560702|ulcer|ulcer
369592|NCT01560702|hemostasis|hemostasis
369593|NCT01560689|bone marrow transplantation|bone marrow transplantation
369594|NCT01560689|obstructive lung disease|obstructive lung disease
369595|NCT01560689|bronchodilators|bronchodilators
369596|NCT01560689|inhaled steroids|inhaled steroids
369597|NCT01560689|late-onset pulmonary complication|late-onset pulmonary complication
369598|NCT01560676|Internet|internet
369599|NCT01560676|School based|school based
369600|NCT01560676|Obesity Prevention Program|obesity prevention program
369601|NCT01560676|Adolescents|adolescents
369602|NCT01560663|Breast Cancer|breast cancer
369603|NCT01560663|Neoadjuvant therapy|neoadjuvant therapy
369604|NCT01560663|Triple negative|triple negative
369605|NCT01560663|predictor of response|predictor of response
369606|NCT01560663|predictor of resistance|predictor of resistance
369607|NCT01560663|Continuous Renal Replacement Therapy|continuous renal replacement therapy
369608|NCT01560650|CRRT|crrt
369609|NCT01560650|cardiac surgery associated acute kidney injury|cardiac surgery associated acute kidney injury
369610|NCT01560650|Intensity|intensity
369611|NCT01560637|PAH|pah
369612|NCT01560637|PH|ph
369613|NCT01560637|FREEDOM|freedom
369614|NCT01560637|6 minute walk test|6 minute walk test
369615|NCT01560637|treprostinil|treprostinil
369616|NCT01560637|open label|open label
369617|NCT01560624|PAH|pah
369618|NCT01560624|PH|ph
369619|NCT01560624|Clinical Worsening|clinical worsening
369620|NCT01560624|Freedom|freedom
369621|NCT01560624|Freedom-Ev|freedom-ev
369622|NCT01560624|Treprostinil|treprostinil
369623|NCT01560624|UT-15C|ut-15c
369624|NCT01560624|6 Minute walk test|6 minute walk test
369625|NCT01560598|GERD|gerd
369626|NCT01560598|reflux esophagitis|reflux esophagitis
369627|NCT01560598|adipokine|adipokine
369628|NCT01560598|especially|especially
369629|NCT01560598|endoscopically proven|endoscopically proven
369630|NCT01560585|Isotretinoin|isotretinoin
369631|NCT01560585|Alzheimer's disease|alzheimer's disease
369632|NCT01560585|Dementia|dementia
369633|NCT01560585|Retinoid|retinoid
369634|NCT01560572|kidney transplantation|kidney transplantation
369635|NCT01560572|immunosuppression|immunosuppression
369636|NCT01560572|steroids|steroids
369637|NCT01560572|tacrolimus OD|tacrolimus od
369638|NCT01560559|Primary esophageal achalasia|primary esophageal achalasia
369639|NCT01560559|endoscopic myotomy|endoscopic myotomy
369640|NCT01560559|high resolution manometry|high resolution manometry
369641|NCT01560520|acute ischemic stroke|acute ischemic stroke
369642|NCT01560520|accelerometer|accelerometer
369643|NCT01560481|metformin glycinate|metformin glycinate
369644|NCT01560481|pharmacokinetics|pharmacokinetics
369645|NCT01560481|pharmacodynamics|pharmacodynamics
369646|NCT01560468|Hepatitis C Virus Infection|hepatitis c virus infection
369647|NCT01560468|Liver Transplantation|liver transplantation
369648|NCT01560455|stent|stent
369649|NCT01560455|bifurcation|bifurcation
369650|NCT01560455|coronary|coronary
369651|NCT01560442|Analgesics, opioids|analgesics, opioids
369652|NCT01560442|Opiate substitution treatment|opiate substitution treatment
369653|NCT01560442|Methadone|methadone
369654|NCT01560442|Buprenorphine|buprenorphine
369655|NCT01560442|Hyperalgesia|hyperalgesia
369656|NCT01560442|Pupil|pupil
369657|NCT01560442|Pain|pain
369658|NCT01560442|Psychophysics|psychophysics
369659|NCT01560442|previous illicit drug intake, under a substitution program|previous illicit drug intake, under a substitution program
369660|NCT01560429|anesthesia and analgesia|anesthesia and analgesia
369661|NCT01560429|Epidural Anesthesia|epidural anesthesia
369662|NCT01560429|administration schedules, drug|administration schedules, drug
369663|NCT01560416|Metastatic|metastatic
369664|NCT01560416|HR positive|hr positive
369665|NCT01560416|ER positive|er positive
369666|NCT01560403|Short bowel syndrome|short bowel syndrome
369667|NCT01560403|Parenteral nutrition|parenteral nutrition
369668|NCT01560403|PN|pn
369669|NCT01560403|HPN|hpn
369670|NCT01560403|TPN|tpn
369671|NCT01560403|SBS|sbs
369672|NCT01560390|Sedation|sedation
369673|NCT01560390|ICU|icu
369674|NCT01560390|Ketamine|ketamine
369675|NCT01560390|Confusion|confusion
369676|NCT01560390|Hyperalgesia|hyperalgesia
369677|NCT01560377|Laparoscopic low anterior colon resection|laparoscopic low anterior colon resection
369678|NCT01560377|Laparoscopic left colectomy|laparoscopic left colectomy
369679|NCT01560377|Colectomy|colectomy
369680|NCT01560377|Rectal cancer|rectal cancer
369681|NCT01560377|Colon cancer|colon cancer
369682|NCT01560377|Crohn's Disease|crohn's disease
369683|NCT01560377|Polyp|polyp
369684|NCT01560377|Procidentia|procidentia
369685|NCT01560377|Diverticulitis|diverticulitis
369686|NCT01560364|Renal replacement therapy|renal replacement therapy
369687|NCT01560364|Hemofilter clotting|hemofilter clotting
369688|NCT01560364|Clotting risk factor|clotting risk factor
369689|NCT01560364|Hemofilter clotting prevention|hemofilter clotting prevention
369690|NCT01560351|Pathological gambling|pathological gambling
369691|NCT01560351|craving|craving
369692|NCT01560351|repeated Transcranial Magnetic Stimulation|repeated transcranial magnetic stimulation
369693|NCT01560351|craving cues|craving cues
369694|NCT01560338|Pharmacokinetics|pharmacokinetics
369695|NCT01560338|Midazolam|midazolam
369696|NCT01560338|Morphine|morphine
369697|NCT01560338|Cardiac Arrest|cardiac arrest
369698|NCT01560338|Hypothermia|hypothermia
369699|NCT01560325|Solid Tumor, Tubulin inhibitor|solid tumor, tubulin inhibitor
369700|NCT01560312|Renal denervation|renal denervation
369701|NCT01560312|Resistant hypertension|resistant hypertension
369702|NCT01560312|Spironolactone|spironolactone
369703|NCT01560312|Long-term Outcome|long-term outcome
369704|NCT01560299|hyperthyroidism|hyperthyroidism
369705|NCT01560299|radio-iodine|radio-iodine
369706|NCT01560299|I-131|i-131
369707|NCT01560299|methimazole|methimazole
369708|NCT01560299|graves disease|graves disease
369709|NCT01560286|PKU|pku
369710|NCT01560286|Injections|injections
369711|NCT01560286|PEG-PAL|peg-pal
369712|NCT01560286|PAL|pal
369713|NCT01560247|Stroke|stroke
369714|NCT01560247|Ischemic Stroke|ischemic stroke
369715|NCT01560247|Revascularization|revascularization
369716|NCT01560247|Mechanical thrombectomy|mechanical thrombectomy
369717|NCT01560247|Neurothrombectomy|neurothrombectomy
369718|NCT01560234|Safety|safety
369719|NCT01560234|tolerability|tolerability
369720|NCT01560234|healthy|healthy
369721|NCT01560234|pharmacokinetic|pharmacokinetic
369722|NCT01560234|pharmacodynamic|pharmacodynamic
369723|NCT01560234|inhaled|inhaled
369724|NCT01560208|infectious keratitis|infectious keratitis
369725|NCT01560208|infective keratitis|infective keratitis
369726|NCT01560208|prospective multicentre study|prospective multicentre study
369727|NCT01560208|Asia|asia
369728|NCT01560195|neutropenia|neutropenia
369729|NCT01560195|febrile neutropenia|febrile neutropenia
369730|NCT01560195|chemotherapy|chemotherapy
369731|NCT01560182|Lentiviral vector|lentiviral vector
369732|NCT01560182|Metachromatic Leukodystrophy|metachromatic leukodystrophy
369733|NCT01560182|Gene Therapy|gene therapy
369734|NCT01560169|Celiac Disease|celiac disease
369735|NCT01560169|Coeliac Disease|coeliac disease
369736|NCT01560169|Celiac Sprue|celiac sprue
369737|NCT01560169|Keilakia Disease|keilakia disease
369738|NCT01560117|AGMT|agmt
369739|NCT01560117|NHL|nhl
369740|NCT01560104|Randomized|randomized
369741|NCT01560104|metastatic|metastatic
369742|NCT01560104|ABT-888|abt-888
369743|NCT01560104|paclitaxel|paclitaxel
369744|NCT01560104|non-small cell lung cancer|non-small cell lung cancer
369745|NCT01560104|PARP|parp
369746|NCT01560104|veliparib|veliparib
369747|NCT01560104|progression free survival|progression free survival
369748|NCT01560104|carboplatin|carboplatin
369749|NCT01560091|clearance rate|clearance rate
369750|NCT01560078|Tuberculosis|tuberculosis
369751|NCT01560078|Pleural effusion|pleural effusion
369752|NCT01560078|Category 3|category 3
369753|NCT01560052|end stage kidney disease|end stage kidney disease
369754|NCT01560052|IgA nephropathy|iga nephropathy
369755|NCT01560039|Neuropathic pain|neuropathic pain
369756|NCT01560039|neurostimulation|neurostimulation
369757|NCT01560026|ovarian preservation|ovarian preservation
369758|NCT01560013|Alcohol|alcohol
369759|NCT01560013|naltrexone|naltrexone
369760|NCT01560013|cue reactivity|cue reactivity
369761|NCT01560013|PET|pet
369762|NCT01560000|The focus of this study is to determine satiety|the focus of this study is to determine satiety
369763|NCT01559987|plaque removal methods|plaque removal methods
369764|NCT01559987|oral hygiene devices|oral hygiene devices
369765|NCT01559974|Peripheral arterial disease|peripheral arterial disease
369766|NCT01559974|PAOD|paod
369767|NCT01559974|Vitamin D|vitamin d
369768|NCT01559974|Walking impairment|walking impairment
369769|NCT01559961|bladder|bladder
369770|NCT01559961|cystitis|cystitis
369771|NCT01559961|frequency|frequency
369772|NCT01559961|nocturia|nocturia
369773|NCT01559961|pain|pain
369774|NCT01559961|urgency|urgency
369775|NCT01559948|Low back pain|low back pain
369776|NCT01559948|Sacroiliac joint pain|sacroiliac joint pain
369777|NCT01559948|Lumbopelvic stabilization program|lumbopelvic stabilization program
369778|NCT01559948|Pelvic compression belt|pelvic compression belt
369779|NCT01559948|Deep abdominal muscles|deep abdominal muscles
369780|NCT01559935|Multiple Myeloma|multiple myeloma
369781|NCT01559922|Acne|acne
369782|NCT01559909|Lower limb loss|lower limb loss
369783|NCT01559909|Leg amputation|leg amputation
369784|NCT01559909|walking study|walking study
369785|NCT01559909|socket technology|socket technology
369786|NCT01559896|egg protein hydrolysate|egg protein hydrolysate
369787|NCT01559883|cancer|cancer
369788|NCT01559883|thrombosis|thrombosis
369789|NCT01559883|pulmonary embolism|pulmonary embolism
369790|NCT01559883|anticoagulation|anticoagulation
369791|NCT01559883|low molecular weight heparin|low molecular weight heparin
369792|NCT01559870|cardiac surgery|cardiac surgery
369793|NCT01559870|cytokine|cytokine
369794|NCT01559870|clinical scoring system|clinical scoring system
369795|NCT01559870|risk factor|risk factor
369796|NCT01559857|Depression|depression
369797|NCT01559857|Insulin resistance|insulin resistance
369798|NCT01559857|Mood disorder|mood disorder
369799|NCT01559844|Hepatitis|hepatitis
369800|NCT01559844|Chronic|chronic
369801|NCT01559844|hepatocellular carcinoma|hepatocellular carcinoma
369802|NCT01559844|HCC|hcc
369803|NCT01559844|transplant|transplant
369804|NCT01559831|Japanese Encephalitis|japanese encephalitis
369805|NCT01559831|IXIARO|ixiaro
369806|NCT01559831|Japanese Encephalitis Vaccine|japanese encephalitis vaccine
369807|NCT01559805|HIV|hiv
369808|NCT01559805|Viral Load|viral load
369809|NCT01559805|Risk|risk
369810|NCT01559805|Patient Compliance|patient compliance
369811|NCT01559805|Homosexuality, Male|homosexuality, male
369812|NCT01559805|Anti-Retroviral Agents|anti-retroviral agents
369813|NCT01559779|Obesity|obesity
369814|NCT01559779|Roux-en-Y gastric bypass|roux-en-y gastric bypass
369815|NCT01559779|Incretin hormones|incretin hormones
369816|NCT01559779|Beta cell function|beta cell function
369817|NCT01559766|Vitamin A|vitamin a
369818|NCT01559766|Dietary requirement|dietary requirement
369819|NCT01559766|Dietary records|dietary records
369820|NCT01559766|Deuterated retinol dilution technique|deuterated retinol dilution technique
369821|NCT01559766|Chinese children|chinese children
369822|NCT01559766|Dietary intake of vitamin A|dietary intake of vitamin a
369823|NCT01559766|Vitamin A liver reserves|vitamin a liver reserves
369824|NCT01559753|Antibiotic|antibiotic
369825|NCT01559753|treatment|treatment
369826|NCT01559753|ventilator associated pneumonia|ventilator associated pneumonia
369827|NCT01559753|duration|duration
369828|NCT01559740|regional anesthesia|regional anesthesia
369829|NCT01559740|children|children
369830|NCT01559740|postoperative pain relief|postoperative pain relief
369831|NCT01559727|heart failure|heart failure
369832|NCT01559727|diuresis|diuresis
369833|NCT01559727|prednisone|prednisone
369834|NCT01559714|Troponin|troponin
369835|NCT01559714|Exercise|exercise
369836|NCT01559714|MRI|mri
369837|NCT01559701|Safety|safety
369838|NCT01559701|PF-00345439|pf-00345439
369839|NCT01559701|Remoxy|remoxy
369840|NCT01559701|PTI-821|pti-821
369841|NCT01559675|Corticosteroids|corticosteroids
369842|NCT01559675|perioperative|perioperative
369843|NCT01559675|colorectal surgery|colorectal surgery
369844|NCT01559662|chewing gum|chewing gum
369845|NCT01559662|ileus|ileus
369846|NCT01559662|gastrointestinal function|gastrointestinal function
369847|NCT01559662|colorectal surgery|colorectal surgery
369848|NCT01559662|abdominal surgery|abdominal surgery
369849|NCT01559649|Stroke|stroke
369850|NCT01559649|Deglutition|deglutition
369851|NCT01559649|Deglutition Disorders|deglutition disorders
369852|NCT01559649|Nurse Screening|nurse screening
369853|NCT01559636|seroconversion|seroconversion
369854|NCT01559636|oral polio vaccine|oral polio vaccine
369855|NCT01559636|OPV|opv
369856|NCT01559636|poliomyelitis|poliomyelitis
369857|NCT01559636|diarrhea|diarrhea
369858|NCT01559636|seroimmunity|seroimmunity
369859|NCT01559610|cardiac surgery|cardiac surgery
369860|NCT01559610|orientation|orientation
369861|NCT01559610|nursing|nursing
369862|NCT01559597|controlled temperature chain|controlled temperature chain
369863|NCT01559597|outside the cold chain|outside the cold chain
369864|NCT01559597|vaccination|vaccination
369865|NCT01559597|prevention of mother to child transmission|prevention of mother to child transmission
369866|NCT01559584|Alopecia|alopecia
369867|NCT01559584|Areata|areata
369868|NCT01559584|Phototherapy|phototherapy
369869|NCT01559584|Phototoxic|phototoxic
369870|NCT01559584|Ultraviolet A|ultraviolet a
369871|NCT01559584|Randomized controlled trial|randomized controlled trial
369872|NCT01559584|Interferon gamma|interferon gamma
369873|NCT01559584|Transforming growth factor beta-1|transforming growth factor beta-1
369874|NCT01559584|Insulin like growth factor-1|insulin like growth factor-1
369875|NCT01559571|Retinopathy of Prematurity|retinopathy of prematurity
369876|NCT01559545|Clostridium difficile associated diarrhea|clostridium difficile associated diarrhea
369877|NCT01559545|Metronidazole|metronidazole
369878|NCT01559545|CDAD|cdad
369879|NCT01559532|Deep vein thrombosis|deep vein thrombosis
369880|NCT01559532|Thromboembolism|thromboembolism
369881|NCT01559532|Tourniquet|tourniquet
369882|NCT01559532|Knee prosthesis.|knee prosthesis.
369883|NCT01559519|TIPS|tips
369884|NCT01559519|albumin|albumin
369885|NCT01559519|hepatic encephalopathy|hepatic encephalopathy
369886|NCT01559519|hyponatremia|hyponatremia
369887|NCT01559519|hypovolemia|hypovolemia
369888|NCT01559519|cirrhosis|cirrhosis
369889|NCT01559506|CFU|cfu
369890|NCT01559506|surgery site|surgery site
369891|NCT01559493|atherosclerotic lesion assessment|atherosclerotic lesion assessment
369892|NCT01559480|Endometriosis|endometriosis
369893|NCT01559480|Desogestrel|desogestrel
369894|NCT01559480|Placebo|placebo
369895|NCT01559467|Myocardial infarction|myocardial infarction
369896|NCT01559467|Randomized Controlled Trial|randomized controlled trial
369897|NCT01559467|Magnetic Resonance Imaging|magnetic resonance imaging
369898|NCT01559467|Coronary Angiography|coronary angiography
369899|NCT01559467|Tomography, X-Ray Computed|tomography, x-ray computed
369900|NCT01559467|Mortality|mortality
369901|NCT01559467|Complications|complications
369902|NCT01559467|Quality of Life|quality of life
369903|NCT01559467|Cost-Benefit Analysis|cost-benefit analysis
369904|NCT01559454|chronic pain|chronic pain
369905|NCT01559454|opioid dependence|opioid dependence
369906|NCT01559454|methadone|methadone
369907|NCT01559454|buprenorphine|buprenorphine
369908|NCT01559454|substance use disorder|substance use disorder
369909|NCT01559441|beetroot juice|beetroot juice
369910|NCT01559441|nitrate|nitrate
369911|NCT01559441|vascular activity|vascular activity
369912|NCT01559441|postprandial state|postprandial state
369913|NCT01559428|Plant sterols|plant sterols
369914|NCT01559428|Plant stanols|plant stanols
369915|NCT01559428|Oxyphytosterols|oxyphytosterols
369916|NCT01559428|Cardiovascular Disease|cardiovascular disease
369917|NCT01559415|Adipocytes|adipocytes
369918|NCT01559389|Urge Urinary Incontinence|urge urinary incontinence
369919|NCT01559389|Vesicare|vesicare
369920|NCT01559389|Urinary Incontinence|urinary incontinence
369921|NCT01559389|Sexual function|sexual function
369922|NCT01559350|OPCAB|opcab
369923|NCT01559337|defect|defect
369924|NCT01559337|dorsal branch of the proper digital nerve|dorsal branch of the proper digital nerve
369925|NCT01559337|proper digital nerve|proper digital nerve
369926|NCT01559337|nerve transfer|nerve transfer
369927|NCT01559337|finger sensory reconstruction|finger sensory reconstruction
369928|NCT01559311|Bradycardia|bradycardia
369929|NCT01559298|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
369930|NCT01559298|Antithrombotic treatment|antithrombotic treatment
369931|NCT01559298|Clopidogrel|clopidogrel
369932|NCT01559298|Aspirin|aspirin
369933|NCT01559298|Myocardial Infarction|myocardial infarction
369934|NCT01559298|Ischemic stroke|ischemic stroke
369935|NCT01559298|Major bleeding|major bleeding
369936|NCT01559285|epidural, local, ropivacaine|epidural, local, ropivacaine
369937|NCT01559285|epidural administration|epidural administration
369938|NCT01559285|stroke volume variability|stroke volume variability
369939|NCT01559272|Schizophrenia|schizophrenia
369940|NCT01559272|Paliperidone palmitate|paliperidone palmitate
369941|NCT01559272|R092670|r092670
369942|NCT01559272|Paliperidone|paliperidone
369943|NCT01559272|3-month formulation|3-month formulation
369944|NCT01559272|Pharmacokinetics|pharmacokinetics
369945|NCT01559259|ibuprofen|ibuprofen
369946|NCT01559259|acetaminophen|acetaminophen
369947|NCT01559259|pain|pain
369948|NCT01559259|molar extraction|molar extraction
369949|NCT01559246|Cardiac Arrhythmia Monitoring|cardiac arrhythmia monitoring
369950|NCT01559246|Holter Monitoring|holter monitoring
369951|NCT01559246|Continuous ECG monitoring|continuous ecg monitoring
369952|NCT01559246|Event monitoring|event monitoring
369953|NCT01559246|Observational|observational
369954|NCT01559207|nucleosome|nucleosome
369955|NCT01559207|plasma nucleosome concentrations|plasma nucleosome concentrations
369956|NCT01559207|free DNA|free dna
369957|NCT01559207|plasma free DNA concentrations|plasma free dna concentrations
369958|NCT01559181|Offspring of mothers with type 1 diabetes|offspring of mothers with type 1 diabetes
369959|NCT01559181|Pregnancy and programing|pregnancy and programing
369960|NCT01559181|Intrauterine hyperglycaemia|intrauterine hyperglycaemia
369961|NCT01559181|Study focuses on offspring of mothers with type 1 diabetes|study focuses on offspring of mothers with type 1 diabetes
369962|NCT01559155|proteasomes|proteasomes
369963|NCT01559155|proteasome concentration|proteasome concentration
369964|NCT01559155|disease activity|disease activity
369965|NCT01559155|proteolytic activity|proteolytic activity
369966|NCT01559155|autoantibodies|autoantibodies
369967|NCT01559155|proteasome autoantibody|proteasome autoantibody
369968|NCT01559142|Crohn Disease|crohn disease
369969|NCT01559142|infliximab|infliximab
369970|NCT01559142|azathioprine|azathioprine
369971|NCT01559103|Rheumatoid Arthritis|rheumatoid arthritis
369972|NCT01559103|Phase I|phase i
369973|NCT01559103|Biologic|biologic
369974|NCT01559090|Japan|japan
369975|NCT01559090|Phase2|phase2
369976|NCT01559090|Safety|safety
369977|NCT01559090|Tolerability|tolerability
369978|NCT01559090|Systemic Lupus Erythematosus|systemic lupus erythematosus
369979|NCT01559090|SLE, MEDI-546|sle, medi-546
369980|NCT01559077|ATTR|attr
369981|NCT01559051|COPD|copd
369982|NCT01559051|Pulmonary|pulmonary
369983|NCT01559051|Lungs|lungs
369984|NCT01559038|Assessing Effectiveness in Psoriatic Arthritis|assessing effectiveness in psoriatic arthritis
369985|NCT01559025|Type 1 diabetes|type 1 diabetes
369986|NCT01559025|Vildagliptin|vildagliptin
369987|NCT01559025|Galvus|galvus
369988|NCT01559012|Hyperemesis Gravidarum|hyperemesis gravidarum
369989|NCT01559012|treatment|treatment
369990|NCT01559012|transdermal clonidine|transdermal clonidine
369991|NCT01558986|Antibiotic prophylaxis|antibiotic prophylaxis
369992|NCT01558986|surgical site infection|surgical site infection
369993|NCT01558986|modified radical mastectomy|modified radical mastectomy
369994|NCT01558986|Prevention of surgical site infection (SSI) in patients undergoing MRM for breast cancer|prevention of surgical site infection (ssi) in patients undergoing mrm for breast cancer
369995|NCT01558960|Retinoblastoma|retinoblastoma
369996|NCT01558947|gastric cancer|gastric cancer
369997|NCT01558947|Peri-operative chemotherapy|peri-operative chemotherapy
369998|NCT01558934|lofexidine|lofexidine
369999|NCT01558934|methadone|methadone
370000|NCT01558934|interaction|interaction
370001|NCT01558934|pharmacodynamic|pharmacodynamic
370002|NCT01558934|ECG|ecg
370003|NCT01558934|QTc|qtc
370004|NCT01558921|rectal cancer|rectal cancer
370005|NCT01558921|radiotherapy|radiotherapy
370006|NCT01558921|chemotherapy|chemotherapy
370007|NCT01558921|5x5|5x5
370008|NCT01558921|capecitbine|capecitbine
370009|NCT01558921|oxaliplatin|oxaliplatin
370010|NCT01558921|CAPOX|capox
370011|NCT01558921|FOLFOX|folfox
370012|NCT01558921|folinic acid|folinic acid
370013|NCT01558921|fluorouracil|fluorouracil
370014|NCT01558908|critical limb ischemia|critical limb ischemia
370015|NCT01558895|Infrared ray heat treatment|infrared ray heat treatment
370016|NCT01558895|liver cirrhosis|liver cirrhosis
370017|NCT01558895|refractory ascites|refractory ascites
370018|NCT01558882|Essure|essure
370019|NCT01558882|Change in uterine cytokines|change in uterine cytokines
370020|NCT01558882|Change in uterine natural killer cells|change in uterine natural killer cells
370021|NCT01558882|cytokine|cytokine
370318|NCT01557686|Hematologic|hematologic
370022|NCT01558882|natural killer cell|natural killer cell
370023|NCT01558856|refractory overactive bladder|refractory overactive bladder
370024|NCT01558856|neuromodulation|neuromodulation
370025|NCT01558856|sacral nerves|sacral nerves
370026|NCT01558843|Sodium Management|sodium management
370027|NCT01558843|Neurointensive Care|neurointensive care
370028|NCT01558843|Hyponatremia|hyponatremia
370029|NCT01558830|amiodarone|amiodarone
370030|NCT01558830|ranolazine|ranolazine
370031|NCT01558830|safety|safety
370032|NCT01558830|arrhythmia|arrhythmia
370033|NCT01558817|CPR|cpr
370034|NCT01558817|Palliative|palliative
370035|NCT01558817|Outcome|outcome
370036|NCT01558804|Streptococcus pyogenes|streptococcus pyogenes
370037|NCT01558804|Streptococcus|streptococcus
370038|NCT01558791|PTSD|ptsd
370039|NCT01558791|patient education handout|patient education handout
370040|NCT01558765|Rehabilitation|rehabilitation
370041|NCT01558765|Integrated rehabilitation programme|integrated rehabilitation programme
370042|NCT01558765|Exercise training|exercise training
370043|NCT01558765|Psycho-educational care|psycho-educational care
370044|NCT01558752|Total hip replacement|total hip replacement
370045|NCT01558752|Bone mineral density (BMD)|bone mineral density (bmd)
370046|NCT01558739|Ruxolitinib|ruxolitinib
370047|NCT01558739|INC424|inc424
370048|NCT01558739|myelofibrosis|myelofibrosis
370049|NCT01558739|PMF|pmf
370050|NCT01558739|post polycythemia myelofibrosis|post polycythemia myelofibrosis
370051|NCT01558739|PPV MF|ppv mf
370052|NCT01558739|post-essential thrombocythemia myelofibrosis|post-essential thrombocythemia myelofibrosis
370053|NCT01558739|PET-MF|pet-mf
370054|NCT01558739|Primary Myelofibrosis|primary myelofibrosis
370055|NCT01558739|Polycythemia|polycythemia
370056|NCT01558739|Thrombocythemia|thrombocythemia
370057|NCT01558739|Essential Thrombocytosis|essential thrombocytosis
370058|NCT01558739|myeloproliferative Disorders|myeloproliferative disorders
370059|NCT01558739|Bone Marrow Diseases|bone marrow diseases
370060|NCT01558739|Haematologic Diseases|haematologic diseases
370061|NCT01558739|Blood Coagulation Disorders|blood coagulation disorders
370062|NCT01558739|Blood Platelet Disorders|blood platelet disorders
370063|NCT01558739|Haemorrhagic Disorders|haemorrhagic disorders
370064|NCT01558726|Case Management|case management
370065|NCT01558726|Crack abuse/dependents|crack abuse/dependents
370066|NCT01558726|Evaluation|evaluation
370067|NCT01558726|Inpatient|inpatient
370068|NCT01558726|ASI|asi
370069|NCT01558726|Treatment retention|treatment retention
370070|NCT01558726|Abstinence|abstinence
370071|NCT01558713|parturient|parturient
370072|NCT01558700|osteoarthritis|osteoarthritis
370073|NCT01558700|pain|pain
370074|NCT01558700|brain|brain
370075|NCT01558700|gray matter|gray matter
370076|NCT01558687|Oncology|oncology
370077|NCT01558687|newly diagnosed inoperable glioblastoma|newly diagnosed inoperable glioblastoma
370078|NCT01558687|temolozomide|temolozomide
370079|NCT01558687|radiotherapy|radiotherapy
370080|NCT01558687|dynamic MRI|dynamic mri
370081|NCT01558687|Positron emission tomography|positron emission tomography
370082|NCT01558687|[18]FET tracer|[18]fet tracer
370083|NCT01558687|cilengitide|cilengitide
370084|NCT01558687|World Health Organization [WHO] Grade IV|world health organization [who] grade iv
370085|NCT01558661|axitinib (AG-013736)|axitinib (ag-013736)
370086|NCT01558661|recurrent|recurrent
370087|NCT01558661|metastatic|metastatic
370088|NCT01558661|12-004|12-004
370089|NCT01558648|Minimally Invasive Esophagectomy|minimally invasive esophagectomy
370090|NCT01558648|Open Esophagectomy|open esophagectomy
370091|NCT01558648|Quality of Life|quality of life
370092|NCT01558648|12-003|12-003
370093|NCT01558635|Atrial Fibrillation|atrial fibrillation
370094|NCT01558635|Surgical ablation|surgical ablation
370095|NCT01558635|Maze procedure|maze procedure
370096|NCT01558635|AF|af
370097|NCT01558622|postoperative analgesia|postoperative analgesia
370098|NCT01558622|dexketoprofen trometamol|dexketoprofen trometamol
370099|NCT01558622|tramadol hydrochloride|tramadol hydrochloride
370100|NCT01558622|pethidine|pethidine
370101|NCT01558622|laparoscopic Nissen fundoplication|laparoscopic nissen fundoplication
370102|NCT01558583|Colon|colon
370103|NCT01558583|Prostate|prostate
370104|NCT01558583|Cancer|cancer
370105|NCT01558544|Ovarian tissue cryopreservation|ovarian tissue cryopreservation
370106|NCT01558544|Ovarian tissue transplantation|ovarian tissue transplantation
370107|NCT01558544|Fertility preservation|fertility preservation
370108|NCT01558544|Risk of premature ovarian failure|risk of premature ovarian failure
370109|NCT01558531|peripheral arterial disease|peripheral arterial disease
370110|NCT01558531|drug-eluting balloon|drug-eluting balloon
370111|NCT01558531|restenosis|restenosis
370112|NCT01558518|Handheld echocardiography|handheld echocardiography
370113|NCT01558518|V-scan|v-scan
370114|NCT01558518|Handheld ultrasound|handheld ultrasound
370115|NCT01558518|Portable ultrasound|portable ultrasound
370116|NCT01558505|critical limb ischemia|critical limb ischemia
370117|NCT01558505|drug-eluting balloon|drug-eluting balloon
370118|NCT01558505|restenosis|restenosis
370119|NCT01558492|Metastatic Castrate Resistant Prostate Cancer|metastatic castrate resistant prostate cancer
370120|NCT01558492|CRPC|crpc
370121|NCT01558479|Parkinson's Disease|parkinson's disease
370122|NCT01558479|Genetics|genetics
370123|NCT01558479|Family Research|family research
370124|NCT01558479|Hereditary Neurodegenerative Diseases|hereditary neurodegenerative diseases
370125|NCT01558466|newborn|newborn
370126|NCT01558466|INO|ino
370127|NCT01558466|Sildenafil|sildenafil
370128|NCT01558466|PPHN|pphn
370129|NCT01558440|Nutrition rehabilitation|nutrition rehabilitation
370130|NCT01558440|severe malnutrition|severe malnutrition
370131|NCT01558440|infant formula|infant formula
370132|NCT01558440|F-100|f-100
370133|NCT01558414|Cholecystectomy|cholecystectomy
370134|NCT01558414|Minimally invasive surgery|minimally invasive surgery
370135|NCT01558414|Laparoscopic surgery|laparoscopic surgery
370136|NCT01558414|Single incision surgery|single incision surgery
370137|NCT01558401|physical activity|physical activity
370138|NCT01558401|elderly|elderly
370139|NCT01558401|women|women
370140|NCT01558401|efficiency|efficiency
370141|NCT01558362|myocardial perfusion imaging|myocardial perfusion imaging
370142|NCT01558362|single photon emission tomography|single photon emission tomography
370143|NCT01558362|Coronary artery disease|coronary artery disease
370144|NCT01558362|gamma camera imaging|gamma camera imaging
370145|NCT01558362|Phase 1 clinical trial|phase 1 clinical trial
370146|NCT01558362|cyclotron|cyclotron
370147|NCT01558349|Epispot|epispot
370148|NCT01558349|CellSearch|cellsearch
370149|NCT01558349|Circulating melanoma cells|circulating melanoma cells
370150|NCT01558349|circulating cells|circulating cells
370151|NCT01558336|Schistosoma haematobium|schistosoma haematobium
370152|NCT01558336|schoolchildren|schoolchildren
370153|NCT01558336|Central Sudan|central sudan
370154|NCT01558336|Praziquantel|praziquantel
370155|NCT01558323|LCQ908, Renal Impairment, Pharmacokinetics|lcq908, renal impairment, pharmacokinetics
370156|NCT01558284|Irritable bowel syndrome|irritable bowel syndrome
370157|NCT01558284|Neu-P11|neu-p11
370158|NCT01558284|Melatonin|melatonin
370159|NCT01558284|D-IBS|d-ibs
370160|NCT01558271|GLP-1|glp-1
370161|NCT01558245|ischemic stroke; in-stent restenosis; tissue kallikrein;|ischemic stroke; in-stent restenosis; tissue kallikrein;
370162|NCT01558245|the middle cerebral artery; atherosclerotic stenosis|the middle cerebral artery; atherosclerotic stenosis
370163|NCT01558232|Stroke|stroke
370164|NCT01558232|Tibion|tibion
370165|NCT01558232|Bionics|bionics
370166|NCT01558232|Rehab|rehab
370167|NCT01558232|Therapy|therapy
370168|NCT01558232|Robotics|robotics
370169|NCT01558232|Intention|intention
370170|NCT01558219|Metastatic prostate cancer|metastatic prostate cancer
370171|NCT01558206|PTE|pte
370172|NCT01558206|Emergency bedside ultrasonography|emergency bedside ultrasonography
370173|NCT01558206|pulmonary CT Angiography|pulmonary ct angiography
370174|NCT01558206|Pulmonary Wedge infarction|pulmonary wedge infarction
370175|NCT01558206|Pulmonary Thromboembolism|pulmonary thromboembolism
370176|NCT01558193|Aggression DHA|aggression dha
370177|NCT01558193|Docosahexaenoic acid|docosahexaenoic acid
370178|NCT01558193|Impulsivity|impulsivity
370179|NCT01558193|Minerals|minerals
370180|NCT01558193|Vitamins|vitamins
370181|NCT01558167|Dose limiting toxicity of Lenalidomide|dose limiting toxicity of lenalidomide
370182|NCT01558167|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
370183|NCT01558154|depression|depression
370184|NCT01558154|Chinese herb|chinese herb
370185|NCT01558154|acupuncture|acupuncture
370186|NCT01558154|Psychotherapy|psychotherapy
370187|NCT01558154|Transcranial magnetic stimulation|transcranial magnetic stimulation
370188|NCT01558141|IVF stimulation.|ivf stimulation.
370189|NCT01558141|Poor responders.|poor responders.
370190|NCT01558141|IVF patients with poor response to stimulation|ivf patients with poor response to stimulation
370191|NCT01558115|Columbia University|columbia university
370192|NCT01558115|Primary hyperparathyroidism|primary hyperparathyroidism
370193|NCT01558115|Low bone density|low bone density
370194|NCT01558115|Denosumab|denosumab
370195|NCT01558115|Prolia|prolia
370196|NCT01558102|brain aneurysm PED Pipeline|brain aneurysm ped pipeline
370197|NCT01558076|Sickle cell anemia|sickle cell anemia
370198|NCT01558076|exercise testing|exercise testing
370199|NCT01558076|cardiopulmonary disease|cardiopulmonary disease
370200|NCT01558063|Ketamine|ketamine
370201|NCT01558063|Major Depressive Disorder|major depressive disorder
370202|NCT01558063|Treatment|treatment
370203|NCT01558063|Depression|depression
370204|NCT01558037|transplant|transplant
370205|NCT01558037|solid organ transplant|solid organ transplant
370206|NCT01558037|kidney transplant|kidney transplant
370207|NCT01558037|liver transplant|liver transplant
370208|NCT01558037|pancreas transplant|pancreas transplant
370209|NCT01558037|heart transplant|heart transplant
370210|NCT01558037|CMV|cmv
370211|NCT01558037|Cytomegalovirus|cytomegalovirus
370212|NCT01558024|compression stockings|compression stockings
370213|NCT01558024|physiopathology|physiopathology
370214|NCT01558011|gastric adenocarcinoma|gastric adenocarcinoma
370215|NCT01558011|Capecitabine and oxaliplatin (XELOX)|capecitabine and oxaliplatin (xelox)
370216|NCT01558011|Docetaxel and capecitabine (TX)|docetaxel and capecitabine (tx)
370217|NCT01558011|Using genetic polymorphisms|using genetic polymorphisms
370218|NCT01558011|drug metabolism and immunohistochemical stain|drug metabolism and immunohistochemical stain
370219|NCT01558011|predict the efficacy|predict the efficacy
370220|NCT01557998|Test and linkage to care|test and linkage to care
370221|NCT01557998|Injecting drug user (IDU)|injecting drug user (idu)
370222|NCT01557998|Prevention with positives|prevention with positives
370223|NCT01557998|ART adherence|art adherence
370224|NCT01557998|point of care CD4 counts|point of care cd4 counts
370225|NCT01557998|Peer case management|peer case management
370226|NCT01557998|Conditional cash transfer|conditional cash transfer
370227|NCT01557985|children|children
370228|NCT01557985|regional anesthesia|regional anesthesia
370229|NCT01557985|postoperative pain management|postoperative pain management
370230|NCT01557985|local anesthetic solution|local anesthetic solution
370231|NCT01557985|toxicity|toxicity
370232|NCT01557933|ECT|ect
370233|NCT01557933|Bipolar Disorder|bipolar disorder
370234|NCT01557920|apnea|apnea
370235|NCT01557920|airway collapsibility|airway collapsibility
370236|NCT01557920|healthy|healthy
370237|NCT01557920|hypercapnia|hypercapnia
370238|NCT01557920|general anesthesia|general anesthesia
370239|NCT01557920|breathing-swallow coordination|breathing-swallow coordination
370240|NCT01557920|aspiration|aspiration
370241|NCT01557907|Diabetes|diabetes
370242|NCT01557907|Diabetes Mellitus|diabetes mellitus
370243|NCT01557907|Type 1 diabetes|type 1 diabetes
370244|NCT01557907|Insulin Pump users|insulin pump users
370245|NCT01557907|Intradermal insulin|intradermal insulin
370246|NCT01557894|Social anxiety disorders|social anxiety disorders
370247|NCT01557894|Social phobia|social phobia
370248|NCT01557894|Anxiety sensitivity|anxiety sensitivity
370249|NCT01557894|Irrational thinking|irrational thinking
370250|NCT01557894|Guided self-help|guided self-help
370251|NCT01557894|Internet-delivered treatment|internet-delivered treatment
370252|NCT01557855|Corus CAD|corus cad
370253|NCT01557855|ASGES|asges
370254|NCT01557855|Age/Sex/Gene Expression Score|age/sex/gene expression score
370255|NCT01557855|Gene Expression|gene expression
370256|NCT01557855|GES|ges
370257|NCT01557855|CAD|cad
370258|NCT01557855|CVD|cvd
370259|NCT01557855|CHD|chd
370260|NCT01557855|Precision Medicine|precision medicine
370261|NCT01557855|Clinical Utility|clinical utility
370262|NCT01557855|Registry|registry
370263|NCT01557855|Coronary Artery Disease|coronary artery disease
370264|NCT01557855|Coronary Heart Disease|coronary heart disease
370265|NCT01557855|Cardiovascular Disease|cardiovascular disease
370266|NCT01557855|Angina Pectoris|angina pectoris
370267|NCT01557855|Chest Pain|chest pain
370268|NCT01557855|Registry I|registry i
370269|NCT01557855|Registry-I|registry-i
370270|NCT01557842|Ischemic|ischemic
370271|NCT01557842|Ventricular Tachycardia|ventricular tachycardia
370272|NCT01557842|Implantable Cardioverter Defibrillators|implantable cardioverter defibrillators
370273|NCT01557842|Antiarrhythmic Drug Therapy|antiarrhythmic drug therapy
370274|NCT01557842|Ablation|ablation
370275|NCT01557842|Electrophysiology|electrophysiology
370276|NCT01557829|spondylolisthesis|spondylolisthesis
370277|NCT01557829|disc degeneration|disc degeneration
370278|NCT01557829|lumbar interbody fusion|lumbar interbody fusion
370279|NCT01557829|randomized controlled trial|randomized controlled trial
370280|NCT01557829|ceramic interbody spacer|ceramic interbody spacer
370281|NCT01557816|osteoarthritis|osteoarthritis
370282|NCT01557816|knee|knee
370283|NCT01557816|Naproxen|naproxen
370284|NCT01557803|Immune reconstitution inflammatory syndrome|immune reconstitution inflammatory syndrome
370285|NCT01557803|Biomarkers|biomarkers
370286|NCT01557803|HIV|hiv
370287|NCT01557803|ART|art
370288|NCT01557803|predictive factors|predictive factors
370289|NCT01557803|epidemiological pattern|epidemiological pattern
370290|NCT01557803|Gabon|gabon
370291|NCT01557790|Adult male|adult male
370292|NCT01557790|18 years or older|18 years or older
370293|NCT01557790|clinical diagnosis|clinical diagnosis
370294|NCT01557751|Total knee arthroplasty|total knee arthroplasty
370295|NCT01557751|Total knee replacement|total knee replacement
370296|NCT01557751|Genetics of pain|genetics of pain
370297|NCT01557738|Exercise|exercise
370298|NCT01557738|Blood Flow|blood flow
370299|NCT01557738|Nitric Oxide|nitric oxide
370300|NCT01557738|Aging|aging
370301|NCT01557738|Antioxidant|antioxidant
370302|NCT01557738|Flavanol|flavanol
370303|NCT01557738|Young (18-30 yrs)|young (18-30 yrs)
370304|NCT01557738|Aging (60 - 80 yrs)|aging (60 - 80 yrs)
370305|NCT01557725|Knee Replacement, Total|knee replacement, total
370306|NCT01557725|Hip Replacement, Total|hip replacement, total
370307|NCT01557725|Thromboembolism, Venous|thromboembolism, venous
370308|NCT01557725|prophylaxis|prophylaxis
370309|NCT01557725|Enhanced recovery|enhanced recovery
370310|NCT01557686|Cancer Related fatigue|cancer related fatigue
370311|NCT01557686|Quality of Life|quality of life
370312|NCT01557686|Psychosocial Intervention|psychosocial intervention
370313|NCT01557686|Rehabilitation|rehabilitation
370314|NCT01557686|Physical Fitness|physical fitness
370315|NCT01557686|Physical Activity|physical activity
370316|NCT01557686|Exercise Therapy|exercise therapy
370317|NCT01557686|Exercise|exercise
370319|NCT01557686|Hematological|hematological
370320|NCT01557686|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
370321|NCT01557686|Acute Myeloid Leukemia|acute myeloid leukemia
370322|NCT01557686|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
370323|NCT01557686|Acute Leukemia|acute leukemia
370324|NCT01557673|Nasogastric|nasogastric
370325|NCT01557673|Small bowel water|small bowel water
370326|NCT01557673|Diarrhoea|diarrhoea
370327|NCT01557673|Mesenteric blood flow|mesenteric blood flow
370328|NCT01557673|Enteral feeding|enteral feeding
370329|NCT01557621|Immunization reminder/recall|immunization reminder/recall
370330|NCT01557621|Reminder/Recall systems|reminder/recall systems
370331|NCT01557621|Population based Recall|population based recall
370332|NCT01557621|Practice based Recall|practice based recall
370333|NCT01557608|cancer|cancer
370334|NCT01557608|chemotherapy|chemotherapy
370335|NCT01557608|photon stimulation|photon stimulation
370336|NCT01557608|neuropathy|neuropathy
370337|NCT01557608|pain|pain
370338|NCT01557582|IPAH|ipah
370339|NCT01557582|HPAH|hpah
370340|NCT01557582|APAH CTD|apah ctd
370341|NCT01557582|APAH HIV|apah hiv
370342|NCT01557582|APAH PoPH|apah poph
370343|NCT01557582|APAH Drugs/Toxins|apah drugs/toxins
370344|NCT01557582|APAH CHD repaired|apah chd repaired
370345|NCT01557582|APAH CHD unrepaired|apah chd unrepaired
370346|NCT01557569|methamphetamine|methamphetamine
370347|NCT01557569|addiction|addiction
370348|NCT01557569|relapse|relapse
370349|NCT01557569|atomoxetine|atomoxetine
370350|NCT01557556|CRH Antagonist|crh antagonist
370351|NCT01557556|Nicotine|nicotine
370352|NCT01557556|Nicotine Dependence|nicotine dependence
370353|NCT01557556|Smoking|smoking
370354|NCT01557556|Stress|stress
370355|NCT01557543|Coronary Artery Bypass Grafting|coronary artery bypass grafting
370356|NCT01557543|Coronary Artery Disease|coronary artery disease
370357|NCT01557543|Transmyocardial Revascularization|transmyocardial revascularization
370358|NCT01557543|Bone Marrow Stromal Cells|bone marrow stromal cells
370359|NCT01557517|cGVHD|cgvhd
370360|NCT01557517|Oral cGVHD|oral cgvhd
370361|NCT01557517|Topical|topical
370362|NCT01557517|Oral Rinse|oral rinse
370363|NCT01557517|Clobetasol|clobetasol
370364|NCT01557517|Oral Graft-Versus-Host Disease|oral graft-versus-host disease
370365|NCT01557517|GVHD|gvhd
370366|NCT01557491|Alopecia|alopecia
370367|NCT01557491|Coronal Incision|coronal incision
370368|NCT01557491|Scar Quality|scar quality
370369|NCT01557478|breast cancer|breast cancer
370370|NCT01557478|melatonin|melatonin
370371|NCT01557478|adjuvant therapy|adjuvant therapy
370372|NCT01557478|quality of life|quality of life
370373|NCT01557478|pain|pain
370374|NCT01557478|sleep|sleep
370375|NCT01557478|survival|survival
370376|NCT01557478|adverse events|adverse events
370377|NCT01557452|JIA|jia
370378|NCT01557426|skin|skin
370379|NCT01557426|soft tissue|soft tissue
370380|NCT01557426|infection|infection
370381|NCT01557426|cellulitis|cellulitis
370382|NCT01557426|abscess|abscess
370383|NCT01557413|Humerus|humerus
370384|NCT01557413|fracture|fracture
370385|NCT01557413|nail|nail
370386|NCT01557413|plate|plate
370387|NCT01557413|tuberosity|tuberosity
370388|NCT01557400|Duchenne muscular dystrophy|duchenne muscular dystrophy
370389|NCT01557400|Becker muscular dystrophy|becker muscular dystrophy
370390|NCT01557400|Nonsense mutation|nonsense mutation
370391|NCT01557400|Premature stop codon|premature stop codon
370392|NCT01557400|DMD|dmd
370393|NCT01557400|BMD|bmd
370394|NCT01557400|nmDBMD|nmdbmd
370395|NCT01557400|DBMD|dbmd
370396|NCT01557400|Ataluren|ataluren
370397|NCT01557400|PTC124|ptc124
370398|NCT01557387|Pseudopolyp|pseudopolyp
370399|NCT01557387|Inflammatory bowel disease|inflammatory bowel disease
370400|NCT01557374|Rheumatoid arthritis|rheumatoid arthritis
370401|NCT01557374|Disease activity|disease activity
370402|NCT01557374|Remission|remission
370403|NCT01557374|Lowest Effective DOse|lowest effective dose
370404|NCT01557374|Abatacept Tocilizumab|abatacept tocilizumab
370405|NCT01557374|ACR-EULAR 2010|acr-eular 2010
370406|NCT01557361|renal replacement therapy|renal replacement therapy
370407|NCT01557361|dialysis|dialysis
370408|NCT01557361|acute kidney injury|acute kidney injury
370409|NCT01557361|hemodialysis|hemodialysis
370410|NCT01557361|critical illness|critical illness
370411|NCT01557335|To evaluate adenosine diphosphate (ADP)-induced platelet aggregation|to evaluate adenosine diphosphate (adp)-induced platelet aggregation
370412|NCT01557309|traumatic rotator cuff tear|traumatic rotator cuff tear
370413|NCT01557309|arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
370414|NCT01557309|age|age
370415|NCT01557309|early rotator cuff repair|early rotator cuff repair
370416|NCT01557296|Diet|diet
370417|NCT01557296|Dietary treatment|dietary treatment
370418|NCT01557296|Particle size|particle size
370419|NCT01557296|Gastroparesis|gastroparesis
370420|NCT01557296|Diabetes Mellitus|diabetes mellitus
370421|NCT01557257|single- and multiple-dose pharmacokinetics|single- and multiple-dose pharmacokinetics
370422|NCT01557257|ALO-02|alo-02
370423|NCT01557257|OxyContin|oxycontin
370424|NCT01557244|neurogenic detrusor overactivity|neurogenic detrusor overactivity
370425|NCT01557244|neurogenic bladder|neurogenic bladder
370426|NCT01557244|neuropathic bladder|neuropathic bladder
370427|NCT01557244|neurologic disease|neurologic disease
370428|NCT01557244|fesoterodine|fesoterodine
370429|NCT01557231|OA|oa
370430|NCT01557231|osteoarthritis|osteoarthritis
370431|NCT01557231|pain|pain
370432|NCT01557231|variability|variability
370433|NCT01557231|activity|activity
370434|NCT01557231|treatment|treatment
370435|NCT01557218|Dietary variety|dietary variety
370436|NCT01557218|Vegetable intake|vegetable intake
370437|NCT01557218|Fruit intake|fruit intake
370438|NCT01557205|optical coherence tomography|optical coherence tomography
370439|NCT01557205|cell imaging|cell imaging
370440|NCT01557192|Depression|depression
370441|NCT01557192|Bipolar Depression|bipolar depression
370442|NCT01557192|LFMS|lfms
370443|NCT01557192|Electromagnetic Stimulation|electromagnetic stimulation
370444|NCT01557166|OSA|osa
370445|NCT01557153|Late-life Unremitted Depression|late-life unremitted depression
370446|NCT01557140|Chagas cardiomyopathy,|chagas cardiomyopathy,
370447|NCT01557140|Renin-angiotensin system,|renin-angiotensin system,
370448|NCT01557140|Beta-blockers,|beta-blockers,
370449|NCT01557140|Enalapril,|enalapril,
370450|NCT01557140|Carvedilol,|carvedilol,
370451|NCT01557140|Renin-angiotensin system inhibitors,|renin-angiotensin system inhibitors,
370452|NCT01557140|Brain natriuretic peptide level,|brain natriuretic peptide level,
370453|NCT01557140|Left ventricular ejection fraction,|left ventricular ejection fraction,
370454|NCT01557140|Chemokines|chemokines
370455|NCT01557127|Renal cell carcinoma,|renal cell carcinoma,
370456|NCT01557127|Sorafenib|sorafenib
370457|NCT01557127|Dosing|dosing
370458|NCT01557114|unresectable Stage III or stage IV advanced malignant melanoma|unresectable stage iii or stage iv advanced malignant melanoma
370459|NCT01557088|coronary artery disease|coronary artery disease
370460|NCT01557088|coronary artery spasm|coronary artery spasm
370461|NCT01557088|small vessel coronary artery disease|small vessel coronary artery disease
370462|NCT01557075|High dose statin|high dose statin
370463|NCT01557062|Fibromyalgia|fibromyalgia
370464|NCT01557062|Hydrotherapy|hydrotherapy
370465|NCT01557062|Sleep|sleep
370466|NCT01557062|Pain|pain
370467|NCT01557062|Body Temperature|body temperature
370468|NCT01557049|chronic low back pain|chronic low back pain
370469|NCT01557049|Postural global reeducation|postural global reeducation
370470|NCT01557049|randomized|randomized
370471|NCT01557049|physical rehabilitation|physical rehabilitation
370472|NCT01557036|Brain Aneurysm|brain aneurysm
370473|NCT01556997|Hypertension|hypertension
370474|NCT01556997|Essential Hypertension|essential hypertension
370475|NCT01556984|diabetic foot|diabetic foot
370476|NCT01556984|digital subtraction angiography|digital subtraction angiography
370477|NCT01556984|endothelial function|endothelial function
370478|NCT01556984|Patients with diabetes|patients with diabetes
370479|NCT01556984|Age 40 to 70 years old|age 40 to 70 years old
370480|NCT01556984|Endothelial function are determined|endothelial function are determined
370481|NCT01556945|P. falciparum|p. falciparum
370482|NCT01556945|vaccine|vaccine
370483|NCT01556945|healthy volunteers|healthy volunteers
370484|NCT01556919|GERD|gerd
370485|NCT01556919|Esophagitis|esophagitis
370486|NCT01556893|Flap Creation|flap creation
370487|NCT01556893|Femtosecond Laser|femtosecond laser
370488|NCT01556893|corneal flap prior to LASIK procedure|corneal flap prior to lasik procedure
370489|NCT01556880|Drivers|drivers
370490|NCT01556880|Chinese|chinese
370491|NCT01556880|Short Message Service|short message service
370492|NCT01556880|Cellular Phone|cellular phone
370493|NCT01556867|Umbilical cord care|umbilical cord care
370494|NCT01556867|dry cord care|dry cord care
370495|NCT01556867|antiseptic|antiseptic
370496|NCT01556867|Omphalitis|omphalitis
370497|NCT01556867|umbilical cord drop|umbilical cord drop
370498|NCT01556867|hospitalized in maternity hospital|hospitalized in maternity hospital
370499|NCT01556854|ginkgo leaves|ginkgo leaves
370500|NCT01556854|butylphthalide|butylphthalide
370501|NCT01556854|edaravone|edaravone
370502|NCT01556854|citicoline|citicoline
370503|NCT01556854|cerebrolysin|cerebrolysin
370504|NCT01556854|piracetam|piracetam
370505|NCT01556854|Neuroprotectants|neuroprotectants
370506|NCT01556841|Randomised|randomised
370507|NCT01556841|Controlled|controlled
370508|NCT01556841|Trovax|trovax
370509|NCT01556841|MVA-5T4|mva-5t4
370510|NCT01556841|5T4|5t4
370511|NCT01556841|Immunotherapy|immunotherapy
370512|NCT01556841|Relapsed|relapsed
370513|NCT01556841|Asymptomatic|asymptomatic
370514|NCT01556841|Epithelial|epithelial
370515|NCT01556841|Ovarian|ovarian
370516|NCT01556841|Fallopian|fallopian
370517|NCT01556841|Peritoneal|peritoneal
370518|NCT01556815|Hepatocellular Carcinoma|hepatocellular carcinoma
370519|NCT01556815|Sorafenib|sorafenib
370520|NCT01556815|Transarterial Chemoembolization|transarterial chemoembolization
370521|NCT01556815|HBV|hbv
370522|NCT01556802|stroke|stroke
370523|NCT01556802|sequelaes|sequelaes
370524|NCT01556802|minocicline|minocicline
370525|NCT01556789|ONT-10|ont-10
370526|NCT01556789|MUC1|muc1
370527|NCT01556789|Vaccine|vaccine
370528|NCT01556789|Phase 1|phase 1
370529|NCT01556789|Solid Tumors|solid tumors
370530|NCT01556789|Dose escalation|dose escalation
370531|NCT01556776|CLL|cll
370532|NCT01556776|High Risk|high risk
370533|NCT01556776|Maintenance|maintenance
370534|NCT01556763|Schizophrenia|schizophrenia
370535|NCT01556763|Schizoaffective|schizoaffective
370536|NCT01556763|CNS|cns
370537|NCT01556737|isoflavone|isoflavone
370538|NCT01556737|supplement|supplement
370539|NCT01556737|daidzein|daidzein
370540|NCT01556737|genistein|genistein
370541|NCT01556737|gene expression|gene expression
370542|NCT01556724|Peripheral nerve blocks|peripheral nerve blocks
370543|NCT01556724|Ropivacaine concentrations in lumbar plexus catheters|ropivacaine concentrations in lumbar plexus catheters
370544|NCT01556724|Postoperative pain|postoperative pain
370545|NCT01556724|Total hip replacement|total hip replacement
370546|NCT01556711|Head Injury|head injury
370547|NCT01556711|Head Trauma|head trauma
370548|NCT01556711|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
370549|NCT01556711|Emergency Department|emergency department
370550|NCT01556698|Acne Vulgaris|acne vulgaris
370551|NCT01556698|Acne|acne
370552|NCT01556672|small bowel lesions|small bowel lesions
370553|NCT01556672|Crohn's Disease|crohn's disease
370554|NCT01556672|Plaque psoriasis|plaque psoriasis
370555|NCT01556672|adalimumab|adalimumab
370556|NCT01556672|capsule endoscopy|capsule endoscopy
370557|NCT01556659|Left ventricular thrombus|left ventricular thrombus
370558|NCT01556659|Acute myocardial infarction|acute myocardial infarction
370559|NCT01556659|Anticoagulation|anticoagulation
370560|NCT01556646|Cirrhosis|cirrhosis
370561|NCT01556646|Hepatic Encephalopathy|hepatic encephalopathy
370562|NCT01556646|Hyponatremia|hyponatremia
370563|NCT01556646|Brain MRI|brain mri
370564|NCT01556646|Health-related quality of life|health-related quality of life
370565|NCT01556646|cognitive function|cognitive function
370566|NCT01556620|PtiO2|ptio2
370567|NCT01556620|NIRS|nirs
370568|NCT01556607|Respiratory Syncytial Virus Infection|respiratory syncytial virus infection
370569|NCT01556607|RSV|rsv
370570|NCT01556594|Hypoglycemia|hypoglycemia
370571|NCT01556594|Diabetes mellitus|diabetes mellitus
370572|NCT01556581|back pain|back pain
370573|NCT01556581|primary care|primary care
370574|NCT01556581|physical therapy|physical therapy
370575|NCT01556568|Noonan Syndrome, hypertrophic cardiomyopathy.|noonan syndrome, hypertrophic cardiomyopathy.
370576|NCT01556555|Sclerosing cholangitis|sclerosing cholangitis
370577|NCT01556555|Spyglass|spyglass
370578|NCT01556555|Endoscopic retrograde cholangiopancreaticography|endoscopic retrograde cholangiopancreaticography
370579|NCT01556542|peripheral arterial disease|peripheral arterial disease
370580|NCT01556542|drug-eluting balloon|drug-eluting balloon
370581|NCT01556542|restenosis|restenosis
370582|NCT01556477|MDS|mds
370583|NCT01556477|AML|aml
370584|NCT01556477|Azacitidine|azacitidine
370585|NCT01556477|Lenalidomide|lenalidomide
370586|NCT01556477|del5q|del5q
370587|NCT01556464|Obstructive sleep apnea|obstructive sleep apnea
370588|NCT01556464|CPAP|cpap
370589|NCT01556425|opioid use disorder|opioid use disorder
370590|NCT01556425|treatment|treatment
370591|NCT01556425|heroin|heroin
370592|NCT01556425|extended-release naltrexone|extended-release naltrexone
370593|NCT01556425|incentives|incentives
370594|NCT01556425|cotningency management|cotningency management
370595|NCT01556425|employment-based reinforcement|employment-based reinforcement
370596|NCT01556425|therapeutic workplace|therapeutic workplace
370597|NCT01556412|endoscopic ultrasound|endoscopic ultrasound
370598|NCT01556412|primary sclerosing cholangitis|primary sclerosing cholangitis
370599|NCT01556412|EUS|eus
370600|NCT01556412|cholestatic hepatopathy|cholestatic hepatopathy
370601|NCT01556399|Duodenal adenoma|duodenal adenoma
370602|NCT01556399|Ampullary adenoma|ampullary adenoma
370603|NCT01556386|acute lymphoblastic leukemia|acute lymphoblastic leukemia
370604|NCT01556386|single nucleotide polymorphism|single nucleotide polymorphism
370605|NCT01556373|acute systemic inflammation|acute systemic inflammation
370606|NCT01556373|arterial stiffness|arterial stiffness
370607|NCT01556373|Carotid-femoral pulse wave velocity|carotid-femoral pulse wave velocity
370608|NCT01556360|genetic hemochromatosis|genetic hemochromatosis
370609|NCT01556360|Iron overload|iron overload
370610|NCT01556360|C282 homozygosity|c282 homozygosity
370611|NCT01556347|alloantibody|alloantibody
370612|NCT01556347|immunologic|immunologic
370613|NCT01556347|memory|memory
370614|NCT01556347|heart|heart
370615|NCT01556347|transplant|transplant
370616|NCT01556347|desensitization|desensitization
370617|NCT01556334|premature ruptured membranes|premature ruptured membranes
370618|NCT01556334|azithromycin|azithromycin
370619|NCT01556334|erythromycin|erythromycin
370620|NCT01556334|latency|latency
370621|NCT01556334|antibiotics|antibiotics
370622|NCT01556321|Obesity|obesity
370623|NCT01556321|Body weight|body weight
370624|NCT01556321|Gut flora|gut flora
370625|NCT01556321|Fat absorption|fat absorption
370626|NCT01556308|Dowling Meara|dowling meara
370627|NCT01556308|Epidermolysis bullosa|epidermolysis bullosa
370628|NCT01556308|inflammation|inflammation
370629|NCT01556295|Nurses|nurses
370630|NCT01556295|Low back pain|low back pain
370631|NCT01556295|Gesture behavior|gesture behavior
370632|NCT01556295|Knowlegde|knowlegde
370633|NCT01556282|Hepatocellular Carcinoma|hepatocellular carcinoma
370634|NCT01556282|portal vein thrombosis|portal vein thrombosis
370635|NCT01556282|HCC|hcc
370636|NCT01556243|stage IA breast cancer|stage ia breast cancer
370637|NCT01556243|stage IB breast cancer|stage ib breast cancer
370638|NCT01556243|stage II breast cancer|stage ii breast cancer
370639|NCT01556243|ductal breast carcinoma in situ|ductal breast carcinoma in situ
370640|NCT01556243|lobular breast carcinoma in situ|lobular breast carcinoma in situ
370641|NCT01556230|pituitary gland|pituitary gland
370642|NCT01556230|pituitary adenoma|pituitary adenoma
370643|NCT01556230|pituitary tumor|pituitary tumor
370644|NCT01556230|hypophysis|hypophysis
370645|NCT01556230|endocrine|endocrine
370646|NCT01556230|neuroendocrine|neuroendocrine
370647|NCT01556230|hormone|hormone
370648|NCT01556217|Healthy volunteers|healthy volunteers
370649|NCT01556217|JNJ-39393406-aaa|jnj-39393406-aaa
370650|NCT01556217|Pharmacokinetics|pharmacokinetics
370651|NCT01556217|Central brain penetrance|central brain penetrance
370652|NCT01556217|Cerebral spinal fluid|cerebral spinal fluid
370653|NCT01556204|Endometriosis|endometriosis
370654|NCT01556191|lung cancer|lung cancer
370655|NCT01556191|women|women
370656|NCT01556178|Hydrocephalus|hydrocephalus
370657|NCT01556178|Survivin|survivin
370658|NCT01556178|miRNA|mirna
370659|NCT01556165|Rasagiline|rasagiline
370660|NCT01556165|Azilect|azilect
370661|NCT01556165|Parkinson´s Disease|parkinson´s disease
370662|NCT01556165|Motor fluctuations|motor fluctuations
370663|NCT01556139|Endurance|endurance
370664|NCT01556139|exercise training|exercise training
370665|NCT01556139|6-min walking test|6-min walking test
370666|NCT01556126|Coronary artery disease|coronary artery disease
370667|NCT01556126|Drug Eluting Stent|drug eluting stent
370668|NCT01556126|All comers patients|all comers patients
370669|NCT01556113|fatty liver|fatty liver
370670|NCT01556113|hypertriglyceridemia|hypertriglyceridemia
370671|NCT01556113|elevated liver enzymes|elevated liver enzymes
370672|NCT01556100|18F-DTBZ AV-133 imaging|18f-dtbz av-133 imaging
370673|NCT01556087|opioids|opioids
370674|NCT01556087|distress tolerance|distress tolerance
370675|NCT01556087|buprenorphine|buprenorphine
370676|NCT01556074|Post traumatic stress disorder|post traumatic stress disorder
370677|NCT01556074|PTSD|ptsd
370678|NCT01556074|Insomnia|insomnia
370679|NCT01556074|Sleep|sleep
370680|NCT01556074|Yoga|yoga
370681|NCT01556074|Meditation|meditation
370682|NCT01556074|Mental Health|mental health
370683|NCT01556074|Sleep Quality|sleep quality
370684|NCT01556074|Actigraphy|actigraphy
370685|NCT01556074|Sleep Diaries|sleep diaries
370686|NCT01556074|Autonomic|autonomic
370687|NCT01556074|Social Health|social health
370688|NCT01556074|Interoception|interoception
370689|NCT01556074|Attention Regulation|attention regulation
370690|NCT01556074|Emotion Regulation|emotion regulation
370691|NCT01556061|Laryngoscopy|laryngoscopy
370692|NCT01556061|Airway Management|airway management
370693|NCT01556061|Intubation|intubation
370694|NCT01556048|Behavior therapy|behavior therapy
370695|NCT01556048|Bereavement|bereavement
370696|NCT01556048|Complicated grief|complicated grief
370697|NCT01556048|Depression|depression
370698|NCT01556048|Posttraumatic Stress Disorder|posttraumatic stress disorder
370699|NCT01556035|oncodermatology|oncodermatology
370700|NCT01556035|hematology|hematology
370701|NCT01556035|cutaneous B cell lymphoma|cutaneous b cell lymphoma
370702|NCT01556035|lenalidomide|lenalidomide
370703|NCT01556022|Ischemic heart disease|ischemic heart disease
370704|NCT01556022|Coronary artery disease|coronary artery disease
370705|NCT01556022|Chronic heart failure|chronic heart failure
370706|NCT01556022|Cardiovascular disease|cardiovascular disease
370707|NCT01556022|Adult stem cells|adult stem cells
370708|NCT01556022|Adipose derived regenerative cells|adipose derived regenerative cells
370709|NCT01556009|Basal Cell Carcinoma|basal cell carcinoma
370710|NCT01556009|Photodynamic Therapy|photodynamic therapy
370711|NCT01555996|older|older
370712|NCT01555996|delirium|delirium
370713|NCT01555996|cognitive status|cognitive status
370714|NCT01555996|occupational therapy|occupational therapy
370715|NCT01555996|critically ill patients|critically ill patients
370716|NCT01555983|cannabis|cannabis
370717|NCT01555983|central neuropathic pain|central neuropathic pain
370718|NCT01555983|analgesia|analgesia
370719|NCT01555970|Obsessive-compulsive disorder|obsessive-compulsive disorder
370720|NCT01555970|Treatment|treatment
370721|NCT01555970|Glutamate|glutamate
370722|NCT01555970|N-Acetylcysteine|n-acetylcysteine
370723|NCT01555918|Pharmacokinetics|pharmacokinetics
370724|NCT01555918|Healthy volunteers|healthy volunteers
370725|NCT01555918|Isavuconazole|isavuconazole
370726|NCT01555918|BAL4815|bal4815
370727|NCT01555918|BAL8728|bal8728
370728|NCT01555918|BAL8557|bal8557
370729|NCT01555905|Respiratory Muscle Strength|respiratory muscle strength
370730|NCT01555892|EBV|ebv
370731|NCT01555892|Hodgkin's Lymphoma|hodgkin's lymphoma
370732|NCT01555892|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
370733|NCT01555892|Lymphoma Relapse|lymphoma relapse
370734|NCT01555892|Autologous or Syngeneic Stem Cell Transplant|autologous or syngeneic stem cell transplant
370735|NCT01555892|T/NK-lymphoproliferative disease|t/nk-lymphoproliferative disease
370736|NCT01555892|LMP|lmp
370737|NCT01555892|BARF1|barf1
370738|NCT01555892|EBNA1|ebna1
370739|NCT01555879|Retrospective|retrospective
370740|NCT01555879|Database|database
370741|NCT01555879|Data warehouse|data warehouse
370742|NCT01555879|Data mining|data mining
370743|NCT01555879|Collaborative effectiveness|collaborative effectiveness
370744|NCT01555879|Comparative effectiveness|comparative effectiveness
370745|NCT01555879|Outcome based medicine|outcome based medicine
370746|NCT01555879|Evidence based medicine|evidence based medicine
370747|NCT01555866|isavuconazole|isavuconazole
370748|NCT01555866|BAL4815|bal4815
370749|NCT01555866|BAL8557|bal8557
370750|NCT01555866|BAL8728|bal8728
370751|NCT01555840|Magnetically guided capsule endoscopy (MGCE)|magnetically guided capsule endoscopy (mgce)
370752|NCT01555840|Gastroscopy|gastroscopy
370753|NCT01555827|Retina|retina
370754|NCT01555827|ALzheimer's disease|alzheimer's disease
370755|NCT01555827|neurodegenerative signs|neurodegenerative signs
370756|NCT01555814|dopamine|dopamine
370757|NCT01555814|first episode|first episode
370758|NCT01555814|reward|reward
370759|NCT01555814|cognition|cognition
370760|NCT01555814|MRI|mri
370761|NCT01555814|fMRI|fmri
370762|NCT01555814|PPI|ppi
370763|NCT01555814|P300|p300
370764|NCT01555814|P50 gating|p50 gating
370765|NCT01555814|endophenotypes|endophenotypes
370766|NCT01555801|esophageal cancer|esophageal cancer
370767|NCT01555801|early cancer|early cancer
370768|NCT01555801|ultrasonography (EUS)|ultrasonography (eus)
370769|NCT01555801|stage|stage
370770|NCT01555788|type 1 diabetes,|type 1 diabetes,
370771|NCT01555788|diaport,|diaport,
370772|NCT01555788|artificial pancreas,|artificial pancreas,
370773|NCT01555788|zone mpc algorithm,|zone mpc algorithm,
370774|NCT01555788|ap system,|ap system,
370775|NCT01555788|intraperitoneal insulin|intraperitoneal insulin
370776|NCT01555775|exercise-induced muscle damage|exercise-induced muscle damage
370777|NCT01555775|nutritional recovery|nutritional recovery
370778|NCT01555775|nutritional supplement|nutritional supplement
370779|NCT01555775|natural food|natural food
370780|NCT01555736|allergic rhinitis|allergic rhinitis
370781|NCT01555736|perennial immunotherapy|perennial immunotherapy
370782|NCT01555736|preseasonal immunotherapy|preseasonal immunotherapy
370783|NCT01555697|Schizophrenia|schizophrenia
370784|NCT01555697|prepulse inhibition|prepulse inhibition
370785|NCT01555697|neurocognition|neurocognition
370786|NCT01555697|working memory|working memory
370787|NCT01555697|memantine|memantine
370913|NCT01555255|pregnancy|pregnancy
370788|NCT01555697|MATRICS Consensus Cognitive Battery|matrics consensus cognitive battery
370789|NCT01555684|MS|ms
370790|NCT01555684|CCSVI|ccsvi
370791|NCT01555671|labor,|labor,
370792|NCT01555671|meperidine,|meperidine,
370793|NCT01555671|active phase,|active phase,
370794|NCT01555671|duration of labor|duration of labor
370795|NCT01555658|Long Lesions|long lesions
370796|NCT01555658|Stent Implantation|stent implantation
370797|NCT01555645|Breast cancer|breast cancer
370798|NCT01555645|Stress management|stress management
370799|NCT01555645|Stepped care|stepped care
370800|NCT01555645|Randomized|randomized
370801|NCT01555619|Left heart pacing lead|left heart pacing lead
370802|NCT01555619|Cardiac resynchronization therapy (CRT)|cardiac resynchronization therapy (crt)
370803|NCT01555619|Heart Failure|heart failure
370804|NCT01555619|Quadripolar pacing|quadripolar pacing
370805|NCT01555606|Psoriasis|psoriasis
370806|NCT01555606|Patient-reported outcome|patient-reported outcome
370807|NCT01555606|Quality of Life|quality of life
370808|NCT01555593|COPD|copd
370809|NCT01555593|FeNO|feno
370810|NCT01555593|Bronchial inflammation|bronchial inflammation
370811|NCT01555593|Small airways|small airways
370812|NCT01555593|Decubitus|decubitus
370813|NCT01555580|myasthenia gravis|myasthenia gravis
370814|NCT01555580|autoimmune|autoimmune
370815|NCT01555580|GM-CSF|gm-csf
370816|NCT01555567|ACL|acl
370817|NCT01555567|muscle|muscle
370818|NCT01555567|quadriceps|quadriceps
370819|NCT01555567|strength|strength
370820|NCT01555554|Post-traumatic stress disorder|post-traumatic stress disorder
370821|NCT01555554|Propranolol|propranolol
370822|NCT01555554|surgery|surgery
370823|NCT01555554|anesthesia|anesthesia
370824|NCT01555541|relapsed|relapsed
370825|NCT01555541|refractory|refractory
370826|NCT01555541|DLBCL|dlbcl
370827|NCT01555541|lymphoma|lymphoma
370828|NCT01555541|B-cell|b-cell
370829|NCT01555541|diffuse|diffuse
370830|NCT01555528|Growth disorders|growth disorders
370831|NCT01555528|Saizen|saizen
370832|NCT01555528|Easypod|easypod
370833|NCT01555528|Growth hormone|growth hormone
370834|NCT01555528|Pediatric subject|pediatric subject
370835|NCT01555489|Pancreatic Neoplasms|pancreatic neoplasms
370836|NCT01555489|Pancreatic Cancer cells|pancreatic cancer cells
370837|NCT01555489|Digestive System Neoplasms|digestive system neoplasms
370838|NCT01555489|Neoplasms by Site|neoplasms by site
370839|NCT01555489|Neoplasms|neoplasms
370840|NCT01555489|Endocrine Gland Neoplasms|endocrine gland neoplasms
370841|NCT01555489|Digestive System Diseases|digestive system diseases
370842|NCT01555489|Pancreatic Diseases|pancreatic diseases
370843|NCT01555489|Endocrine System Diseases|endocrine system diseases
370844|NCT01555489|Ascorbic Acid|ascorbic acid
370845|NCT01555489|Gemcitabine Vitamins|gemcitabine vitamins
370846|NCT01555489|Vitamin C|vitamin c
370847|NCT01555489|Antioxidants|antioxidants
370848|NCT01555489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
370849|NCT01555489|Pharmacologic Actions|pharmacologic actions
370850|NCT01555489|Protective Agents|protective agents
370851|NCT01555489|Physiological Effects of Drugs|physiological effects of drugs
370852|NCT01555489|Micronutrients|micronutrients
370853|NCT01555489|Growth Substances|growth substances
370854|NCT01555489|Erlotinib|erlotinib
370855|NCT01555489|Integrative Medicine|integrative medicine
370856|NCT01555489|Alternative Medicine|alternative medicine
370857|NCT01555489|Complementary Medicine|complementary medicine
370858|NCT01555476|Pharmacokinetics|pharmacokinetics
370859|NCT01555463|Rosacea|rosacea
370860|NCT01555450|Colorectal cancer screening|colorectal cancer screening
370861|NCT01555450|Social inequalities|social inequalities
370862|NCT01555450|Patient Navigator|patient navigator
370863|NCT01555437|capsule endoscopy scoring index|capsule endoscopy scoring index
370864|NCT01555437|Harvey-Bradshaw index|harvey-bradshaw index
370865|NCT01555437|C-reactive protein|c-reactive protein
370866|NCT01555437|serum albumin|serum albumin
370867|NCT01555437|hemoglobin|hemoglobin
370868|NCT01555424|25-hydroxyvitamin D|25-hydroxyvitamin d
370869|NCT01555424|Institutionalized seniors|institutionalized seniors
370870|NCT01555424|SF-36 survey|sf-36 survey
370871|NCT01555424|Winter|winter
370872|NCT01555411|Cardiovascular epidemiology|cardiovascular epidemiology
370873|NCT01555411|Prospective, observational cohort study|prospective, observational cohort study
370874|NCT01555411|Biomarkers|biomarkers
370875|NCT01555411|Cardio- and cerebrovascular imaging|cardio- and cerebrovascular imaging
370876|NCT01555398|Fenofibric acid|fenofibric acid
370877|NCT01555398|HIP0901|hip0901
370878|NCT01555398|food effect|food effect
370879|NCT01555385|Mental workload|mental workload
370880|NCT01555385|Multitasking|multitasking
370881|NCT01555385|Protein|protein
370882|NCT01555385|Tryptophan|tryptophan
370883|NCT01555372|unstable distal clavicular fractures (Neer 2b)|unstable distal clavicular fractures (neer 2b)
370884|NCT01555372|Study Protocol|study protocol
370885|NCT01555372|Fracture Fixation|fracture fixation
370886|NCT01555346|Down syndrome|down syndrome
370887|NCT01555346|fetal aneuploidy|fetal aneuploidy
370888|NCT01555346|trisomy|trisomy
370889|NCT01555346|noninvasive prenatal test|noninvasive prenatal test
370890|NCT01555307|total hip arthroplasty|total hip arthroplasty
370891|NCT01555307|total knee arthroplasty|total knee arthroplasty
370892|NCT01555307|balance exercises|balance exercises
370893|NCT01555307|force plate|force plate
370894|NCT01555307|berg balance scale|berg balance scale
370895|NCT01555307|timed up and go test|timed up and go test
370896|NCT01555294|(subclinical)atherosclerosis|(subclinical)atherosclerosis
370897|NCT01555294|non-invasive measurements|non-invasive measurements
370898|NCT01555294|intima-media thickness|intima-media thickness
370899|NCT01555294|flow-mediated dilation|flow-mediated dilation
370900|NCT01555294|pulse wave velocity and analysis|pulse wave velocity and analysis
370901|NCT01555294|fatal and non-fatal cardiovascular events|fatal and non-fatal cardiovascular events
370902|NCT01555294|ankle-brachial index (at rest and after exercise)|ankle-brachial index (at rest and after exercise)
370903|NCT01555294|general population|general population
370904|NCT01555294|Familial Combined Hyperlipidemia|familial combined hyperlipidemia
370905|NCT01555281|Multiple Myeloma|multiple myeloma
370906|NCT01555281|Kahler Disease|kahler disease
370907|NCT01555281|Lenalidomide|lenalidomide
370908|NCT01555281|Revlimid|revlimid
370909|NCT01555281|Nelfinavir|nelfinavir
370910|NCT01555281|Viracept|viracept
370911|NCT01555281|Dexamethasone|dexamethasone
370912|NCT01555255|malaria|malaria
370914|NCT01555255|placental malaria|placental malaria
370915|NCT01555255|malaria in pregnancy|malaria in pregnancy
370916|NCT01555255|birth weight|birth weight
370917|NCT01555255|anemia|anemia
370918|NCT01555242|Advanced Cancer|advanced cancer
370919|NCT01555242|Lymphoma|lymphoma
370920|NCT01555242|Refractory|refractory
370921|NCT01555229|Secretion drainage|secretion drainage
370922|NCT01555229|Ventilator-associated pneumonia|ventilator-associated pneumonia
370923|NCT01555229|Tracheal fibroscopy|tracheal fibroscopy
370924|NCT01555216|Forefoot surgery|forefoot surgery
370925|NCT01555190|myo-inositol|myo-inositol
370926|NCT01555190|folic acid|folic acid
370927|NCT01555177|Peri-operative myocardial infarction|peri-operative myocardial infarction
370928|NCT01555177|Non-ST elevation myocardial infarction|non-st elevation myocardial infarction
370929|NCT01555177|Optical coherence tomography|optical coherence tomography
370930|NCT01555151|Asthma|asthma
370931|NCT01555138|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
370932|NCT01555138|Indacaterol|indacaterol
370933|NCT01555138|Salmeterol/fluticasone propionate|salmeterol/fluticasone propionate
370934|NCT01555125|Psoriasis|psoriasis
370935|NCT01555099|COPD, FEV1, AZD5423|copd, fev1, azd5423
370936|NCT01555086|Lymphadenectomy|lymphadenectomy
370937|NCT01555086|Prostate cancer|prostate cancer
370938|NCT01555060|hemoglobin recovery|hemoglobin recovery
370939|NCT01555060|iron recovery|iron recovery
370940|NCT01555060|iron supplements|iron supplements
370941|NCT01555034|obesity|obesity
370942|NCT01555034|movement therapy|movement therapy
370943|NCT01555034|exercise|exercise
370944|NCT01555034|behaviour|behaviour
370945|NCT01554995|LCB01-0371|lcb01-0371
370946|NCT01554982|Participation Limited|participation limited
370947|NCT01554982|Long Term|long term
370948|NCT01554982|Safety Extension|safety extension
370949|NCT01554956|Plasminogen Deficiency|plasminogen deficiency
370950|NCT01554956|Ligneous Conjunctivitis|ligneous conjunctivitis
370951|NCT01554956|Plasminogen|plasminogen
370952|NCT01554956|Ligneous Conjunctivitis in Plasminogen Deficient Patients|ligneous conjunctivitis in plasminogen deficient patients
370953|NCT01554943|CMF|cmf
370954|NCT01554943|HEC|hec
370955|NCT01554943|EC|ec
370956|NCT01554943|node positive|node positive
370957|NCT01554943|breast cancer|breast cancer
370958|NCT01554930|HFMD|hfmd
370959|NCT01554930|Traditional Chinese Medicine|traditional chinese medicine
370960|NCT01554930|Xiyanping|xiyanping
370961|NCT01554917|Rheumatoid Arthritis|rheumatoid arthritis
370962|NCT01554917|Iguratimod|iguratimod
370963|NCT01554904|Sleep Study|sleep study
370964|NCT01554904|Snoring|snoring
370965|NCT01554904|Sleep Apnea|sleep apnea
370966|NCT01554904|Muscle Laxity|muscle laxity
370967|NCT01554904|Oral Appliance|oral appliance
370968|NCT01554904|Facial Muscles|facial muscles
370969|NCT01554904|Neck Muscles|neck muscles
370970|NCT01554904|Upper Airway|upper airway
370971|NCT01554904|Muscle Strength|muscle strength
370972|NCT01554904|Dynamic Resistance|dynamic resistance
370973|NCT01554904|Oral Exercise|oral exercise
370974|NCT01554904|Facial Toning|facial toning
370975|NCT01554904|Facial Muscle Strength|facial muscle strength
370976|NCT01554904|Strap Muscles of the Neck|strap muscles of the neck
370977|NCT01554904|Apnea-Hypopnea|apnea-hypopnea
370978|NCT01554891|brain injuries, traumatic|brain injuries, traumatic
370979|NCT01554891|military personnel|military personnel
370980|NCT01554891|classification|classification
370981|NCT01554891|diagnosis|diagnosis
370982|NCT01554891|instrumentation|instrumentation
370983|NCT01554878|osteochondral defect of the knee|osteochondral defect of the knee
370984|NCT01554865|obesity|obesity
370985|NCT01554865|men|men
370986|NCT01554865|sexual function|sexual function
370987|NCT01554865|urinary tract symptoms|urinary tract symptoms
370988|NCT01554865|endothelial function|endothelial function
370989|NCT01554865|inflammation|inflammation
370990|NCT01554865|quality of life|quality of life
370991|NCT01554852|myeloma|myeloma
370992|NCT01554852|lenalidomide|lenalidomide
370993|NCT01554852|Revlimid|revlimid
370994|NCT01554852|cyclophosphamide|cyclophosphamide
370995|NCT01554852|dexamethasone|dexamethasone
370996|NCT01554852|bortezomib|bortezomib
370997|NCT01554852|Velcade|velcade
370998|NCT01554852|vorinostat|vorinostat
370999|NCT01554852|Zolinza|zolinza
371000|NCT01554852|stem cell|stem cell
371001|NCT01554852|carfilzomib|carfilzomib
371002|NCT01554852|Kyprolis|kyprolis
371003|NCT01554826|Pediatric influenza vaccine|pediatric influenza vaccine
371004|NCT01554813|Influenza Vaccine, Vaccination,|influenza vaccine, vaccination,
371005|NCT01554800|Lecithin Cholesterol Acyl Transferase|lecithin cholesterol acyl transferase
371006|NCT01554800|LCAT|lcat
371007|NCT01554800|rhLCAT|rhlcat
371008|NCT01554800|Enzyme replacement therapy|enzyme replacement therapy
371009|NCT01554800|High-Density Lipoprotein (HDL)|high-density lipoprotein (hdl)
371010|NCT01554800|Cholesterol|cholesterol
371011|NCT01554800|Cholesterol ester|cholesterol ester
371012|NCT01554800|LCAT Deficiency|lcat deficiency
371013|NCT01554787|After stroke with fatigue|after stroke with fatigue
371014|NCT01554774|COPD|copd
371015|NCT01554774|PVR|pvr
371016|NCT01554761|astigmatism|astigmatism
371017|NCT01554761|pseudophakia|pseudophakia
371018|NCT01554748|total joint arthroplasty|total joint arthroplasty
371019|NCT01554748|thumb|thumb
371020|NCT01554748|trapeziometacarpal joint|trapeziometacarpal joint
371021|NCT01554748|osteoarthritis|osteoarthritis
371022|NCT01554735|obesity|obesity
371023|NCT01554735|men|men
371024|NCT01554735|sexual function|sexual function
371025|NCT01554735|urinary tract symptoms|urinary tract symptoms
371026|NCT01554735|endothelial function|endothelial function
371027|NCT01554735|inflammation|inflammation
371028|NCT01554735|quality of life|quality of life
371029|NCT01554722|Ultrasound guidance|ultrasound guidance
371030|NCT01554722|Femoral nerve block|femoral nerve block
371031|NCT01554722|Needle placement|needle placement
371032|NCT01554722|Intraneural needle insertion|intraneural needle insertion
371033|NCT01554709|bypass|bypass
371034|NCT01554709|cannula|cannula
371035|NCT01554696|Rheumatoid Arthritis|rheumatoid arthritis
371036|NCT01554696|ASP015K|asp015k
371037|NCT01554683|Alzheimer's Disease|alzheimer's disease
371038|NCT01554683|Seizures|seizures
371039|NCT01554683|Memory|memory
371040|NCT01554683|Executive|executive
371041|NCT01554670|Arthroscopic subacromial decompression|arthroscopic subacromial decompression
371042|NCT01554670|Bipolar radiofrequency|bipolar radiofrequency
371043|NCT01554670|Tendon debridement|tendon debridement
371044|NCT01554670|Shoulder surgery|shoulder surgery
371045|NCT01554657|Pneumonia, Bacterial|pneumonia, bacterial
371046|NCT01554644|Cleansing|cleansing
371047|NCT01554644|Chronic Leg Ulcers|chronic leg ulcers
371048|NCT01554644|Diabetic Patients|diabetic patients
371049|NCT01554631|Bioequivalence|bioequivalence
371050|NCT01554631|Acarbose|acarbose
371051|NCT01554631|ODT|odt
371052|NCT01554618|exenatide|exenatide
371053|NCT01554618|type 2 diabetes|type 2 diabetes
371054|NCT01554618|GLP-1 receptor agonist|glp-1 receptor agonist
371055|NCT01554592|Heart Failure|heart failure
371056|NCT01554592|Statin withdrawal|statin withdrawal
371057|NCT01554566|honey|honey
371058|NCT01554566|diabetes|diabetes
371059|NCT01554566|lipids|lipids
371060|NCT01554566|c-peptide|c-peptide
371061|NCT01554553|Sleeve gastrectomy|sleeve gastrectomy
371062|NCT01554553|Posterior crural repair|posterior crural repair
371063|NCT01554540|Treprostinil|treprostinil
371064|NCT01554540|Scleroderma|scleroderma
371065|NCT01554540|Iontophoresis|iontophoresis
371066|NCT01554527|polysomnography|polysomnography
371067|NCT01554527|child|child
371068|NCT01554527|continuous positive airway pressure|continuous positive airway pressure
371069|NCT01554527|tonsillectomy|tonsillectomy
371070|NCT01554527|neuropsychological tests|neuropsychological tests
371071|NCT01554527|cognition|cognition
371072|NCT01554527|sleepiness|sleepiness
371073|NCT01554527|behavior|behavior
371074|NCT01554514|ADAMTS13|adamts13
371075|NCT01554514|Rituximab|rituximab
371076|NCT01554514|Thrombotic thrombocytopenic purpura|thrombotic thrombocytopenic purpura
371077|NCT01554514|TTP|ttp
371078|NCT01554514|Plasma exchange|plasma exchange
371079|NCT01554501|stress|stress
371080|NCT01554501|self-control|self-control
371081|NCT01554501|emotion regulation|emotion regulation
371082|NCT01554501|health|health
371083|NCT01554488|asthma|asthma
371084|NCT01554488|COPD|copd
371085|NCT01554488|sleep apnea, obstructive|sleep apnea, obstructive
371086|NCT01554475|herbal drugs|herbal drugs
371087|NCT01554475|dietary supplements|dietary supplements
371088|NCT01554475|drug interactions|drug interactions
371089|NCT01554462|Attention|attention
371090|NCT01554462|Cognitive control|cognitive control
371091|NCT01554462|ADHD|adhd
371092|NCT01554462|Healthy|healthy
371093|NCT01554462|EPA|epa
371094|NCT01554462|Eicosapentaenoic acid|eicosapentaenoic acid
371095|NCT01554462|DHA|dha
371096|NCT01554462|Docosahexaenoic acid|docosahexaenoic acid
371097|NCT01554462|PUFA|pufa
371098|NCT01554462|Omega-3|omega-3
371099|NCT01554449|Stroke|stroke
371100|NCT01554449|Upper arm|upper arm
371101|NCT01554449|Rehabilitation|rehabilitation
371102|NCT01554449|Motor function|motor function
371103|NCT01554449|Video games|video games
371104|NCT01554449|Virtual reality|virtual reality
371105|NCT01554449|Occupational Therapy|occupational therapy
371106|NCT01554449|Functional MRI|functional mri
371107|NCT01554436|Smoking|smoking
371108|NCT01554436|Neuropsychology|neuropsychology
371109|NCT01554436|Abstinence|abstinence
371110|NCT01554436|Prognosis|prognosis
371111|NCT01554436|Nicotine Dependence, Cigarettes, with Other Nicotine-induced Disorders|nicotine dependence, cigarettes, with other nicotine-induced disorders
371112|NCT01554423|HIV Prevention Intervention|hiv prevention intervention
371113|NCT01554410|Cervical|cervical
371114|NCT01554410|Carcinoma|carcinoma
371115|NCT01554410|Gemcitabine|gemcitabine
371116|NCT01554410|Gemzar|gemzar
371117|NCT01554410|Cisplatin|cisplatin
371118|NCT01554410|IMRT|imrt
371119|NCT01554410|Radiation|radiation
371120|NCT01554410|External Beam|external beam
371121|NCT01554410|Brachytherapy|brachytherapy
371122|NCT01554397|Cervical|cervical
371123|NCT01554397|Carcinoma|carcinoma
371124|NCT01554397|Cisplatin|cisplatin
371125|NCT01554397|IMRT|imrt
371126|NCT01554397|Radiation|radiation
371127|NCT01554397|INTERTECC|intertecc
371128|NCT01554397|International|international
371129|NCT01554397|External Beam|external beam
371130|NCT01554397|Brachytherapy|brachytherapy
371131|NCT01554397|LDR|ldr
371132|NCT01554397|HDR|hdr
371133|NCT01554397|IGRT|igrt
371134|NCT01554397|CBCT|cbct
371135|NCT01554384|Tuberculosis|tuberculosis
371136|NCT01554384|diagnosis|diagnosis
371137|NCT01554384|Xpert MTB/RIF|xpert mtb/rif
371138|NCT01554384|point-of-treatment|point-of-treatment
371139|NCT01554384|randomized controlled trial|randomized controlled trial
371140|NCT01554371|Solid tumor|solid tumor
371141|NCT01554371|Metastatic breast cancer|metastatic breast cancer
371142|NCT01554371|Unresectable or metastatic carcinoma|unresectable or metastatic carcinoma
371143|NCT01554371|Neuropathy|neuropathy
371144|NCT01554371|Eribulin|eribulin
371145|NCT01554371|Cyclophosphamide|cyclophosphamide
371146|NCT01554358|Gestational diabetes mellitus|gestational diabetes mellitus
371147|NCT01554358|Lifestyle intervention|lifestyle intervention
371148|NCT01554332|Motor Cortex Stimulation|motor cortex stimulation
371149|NCT01554332|Neuropathic pain|neuropathic pain
371150|NCT01554319|Antisense oligonucleotide|antisense oligonucleotide
371151|NCT01554319|Asthma|asthma
371152|NCT01554319|Healthy subjects|healthy subjects
371153|NCT01554319|Phase 1|phase 1
371154|NCT01554319|Transcription factor GATA-3|transcription factor gata-3
371155|NCT01554319|Oral inhalation|oral inhalation
371156|NCT01554280|Stricture|stricture
371157|NCT01554280|Dysphagia|dysphagia
371158|NCT01554267|Mastectomy skin flap necrosis|mastectomy skin flap necrosis
371159|NCT01554267|Breast reconstruction|breast reconstruction
371160|NCT01554267|Indocyanine Green Dye|indocyanine green dye
371161|NCT01554254|Cord blood transplant|cord blood transplant
371162|NCT01554254|hematological malignancy|hematological malignancy
371163|NCT01554254|inherited metabolic disease|inherited metabolic disease
371164|NCT01554254|Mucositis|mucositis
371165|NCT01554254|Neutrophil engraftment|neutrophil engraftment
371166|NCT01554254|Platelet recovery|platelet recovery
371167|NCT01554254|Immune reconstitution|immune reconstitution
371168|NCT01554241|vitamin D3|vitamin d3
371169|NCT01554241|D3|d3
371170|NCT01554241|cholecalciferol|cholecalciferol
371171|NCT01554241|25-OH vitamin D|25-oh vitamin d
371172|NCT01554241|elderly|elderly
371173|NCT01554241|nursing home resident|nursing home resident
371174|NCT01554215|parenting|parenting
371175|NCT01554215|child behavior|child behavior
371176|NCT01554215|attachment|attachment
371177|NCT01554202|Alzheimer's disease|alzheimer's disease
371178|NCT01554202|MCI|mci
371179|NCT01554202|genetic|genetic
371180|NCT01554202|AV45-PET|av45-pet
371181|NCT01554176|Current depressive episode|current depressive episode
371182|NCT01554176|moderate to severe|moderate to severe
371183|NCT01554163|Osteoarthritis|osteoarthritis
371184|NCT01554163|Celecoxib|celecoxib
371185|NCT01554163|Etoricoxib|etoricoxib
371186|NCT01554150|Primary Health Care|primary health care
371187|NCT01554150|Mental Health|mental health
371188|NCT01554150|Cognitive Therapy|cognitive therapy
371189|NCT01554124|Meningitis|meningitis
371190|NCT01554124|Neonates|neonates
371191|NCT01554124|Meropenem|meropenem
371192|NCT01554111|Bowel Evacuants|bowel evacuants
371193|NCT01554111|Purgatives|purgatives
371194|NCT01554098|Polyp detection|polyp detection
371195|NCT01554098|Supine|supine
371196|NCT01554098|Colonoscope withdrawal|colonoscope withdrawal
371197|NCT01554098|Patient position|patient position
371198|NCT01554098|Dynamic position change|dynamic position change
371199|NCT01554072|home-based|home-based
371200|NCT01554072|pulmonary rehabilitation|pulmonary rehabilitation
371201|NCT01554072|COPD|copd
371202|NCT01554059|Rectal cancer|rectal cancer
371203|NCT01554059|Adenocarcinoma|adenocarcinoma
371204|NCT01554059|Bevacizumab|bevacizumab
371205|NCT01554059|Chemoradiation|chemoradiation
371206|NCT01554046|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
371207|NCT01554046|Methylphenidate- RITALIN IR (Immediate Release)|methylphenidate- ritalin ir (immediate release)
371208|NCT01554033|European Huntington's Disease Network|european huntington's disease network
371209|NCT01554033|Huntington patients in KOREA|huntington patients in korea
371210|NCT01554020|Blood glucose|blood glucose
371211|NCT01554020|Insulin sensitivity|insulin sensitivity
371212|NCT01554020|Oral glucose tolerance|oral glucose tolerance
371213|NCT01554007|Crohn's disease|crohn's disease
371214|NCT01553981|Interstitial lung disease|interstitial lung disease
371215|NCT01553981|Scleroderma|scleroderma
371216|NCT01553955|PRP,|prp,
371217|NCT01553955|Platelet|platelet
371218|NCT01553955|Manual|manual
371219|NCT01553942|NSCLC|nsclc
371220|NCT01553929|MCI|mci
371221|NCT01553903|Hormonal therapy|hormonal therapy
371222|NCT01553903|Breast Cancer|breast cancer
371223|NCT01553903|AEBS|aebs
371224|NCT01553903|Oxysterols|oxysterols
371225|NCT01553890|SSc= scleroderma|ssc= scleroderma
371226|NCT01553890|ICF+ informed consent form|icf+ informed consent form
371227|NCT01553890|age 18 to 85|age 18 to 85
371228|NCT01553890|healthy|healthy
371229|NCT01553838|prostate biopsy|prostate biopsy
371230|NCT01553838|MRI guided biopsy|mri guided biopsy
371231|NCT01553838|TRUS guided biopsy|trus guided biopsy
371232|NCT01553812|forced oscillation technique|forced oscillation technique
371233|NCT01553812|COPD|copd
371234|NCT01553812|elderly|elderly
371235|NCT01553812|airway resistance|airway resistance
371236|NCT01553812|airtrapping|airtrapping
371237|NCT01553786|T-cell lymphoma|t-cell lymphoma
371238|NCT01553786|CHOp|chop
371239|NCT01553786|lenalidomide|lenalidomide
371240|NCT01553773|Hyaluroic acid|hyaluroic acid
371241|NCT01553773|Estradiol|estradiol
371242|NCT01553773|Isoflavone|isoflavone
371243|NCT01553773|Skin|skin
371244|NCT01553773|Postmenopause|postmenopause
371245|NCT01553760|Cataract|cataract
371246|NCT01553760|TRI-MICS|tri-mics
371247|NCT01553760|ACM|acm
371248|NCT01553760|MICS|mics
371249|NCT01553760|phacoemulsification|phacoemulsification
371250|NCT01553747|Irritable bowel syndrome with diarrhea|irritable bowel syndrome with diarrhea
371251|NCT01553747|Irritable bowel syndrome|irritable bowel syndrome
371252|NCT01553747|Diarrhea predominant irritable bowel syndrome|diarrhea predominant irritable bowel syndrome
371253|NCT01553747|Colonic diseases|colonic diseases
371254|NCT01553747|Colonic diseases, functional|colonic diseases, functional
371255|NCT01553747|Digestive system disease|digestive system disease
371256|NCT01553747|Gastrointestinal disease|gastrointestinal disease
371257|NCT01553747|Intestinal disease|intestinal disease
371258|NCT01553747|Colonic pseudo-obstruction|colonic pseudo-obstruction
371259|NCT01553747|Diarrhea|diarrhea
371260|NCT01553747|Signs and symptoms, Digestive|signs and symptoms, digestive
371261|NCT01553734|QT prolongation|qt prolongation
371262|NCT01553734|Azithromycin|azithromycin
371263|NCT01553734|macrolide|macrolide
371264|NCT01553734|pneumonia|pneumonia
371265|NCT01553734|ECG changes|ecg changes
371266|NCT01553708|Wound healing|wound healing
371267|NCT01553708|Epithelialization|epithelialization
371268|NCT01553708|Safety|safety
371269|NCT01553695|Touble|touble
371270|NCT01553695|deficit|deficit
371271|NCT01553695|attention|attention
371272|NCT01553695|hyperactivity|hyperactivity
371273|NCT01553695|Touble deficit attention with hyperactivity|touble deficit attention with hyperactivity
371274|NCT01553682|HIV|hiv
371275|NCT01553682|STDs|stds
371276|NCT01553682|African American Females|african american females
371277|NCT01553682|Alcohol|alcohol
371278|NCT01553656|Advanced cancer|advanced cancer
371279|NCT01553656|Metastatic|metastatic
371280|NCT01553656|NSCLC|nsclc
371281|NCT01553643|Huang-Chi-Wu-Wu-Tang|huang-chi-wu-wu-tang
371282|NCT01553643|Intracranial arterial prominent stenosis|intracranial arterial prominent stenosis
371283|NCT01553630|Fractures|fractures
371284|NCT01553630|distal femur fractures|distal femur fractures
371285|NCT01553630|distal tibial fracures|distal tibial fracures
371286|NCT01553604|breast prosthesis implantation|breast prosthesis implantation
371287|NCT01553604|bandages|bandages
371288|NCT01553604|skin colonization|skin colonization
371289|NCT01553604|surgical site infection|surgical site infection
371290|NCT01553604|augmentation mammaplasty|augmentation mammaplasty
371291|NCT01553604|dressing wear time|dressing wear time
371292|NCT01553591|Irritable bowel syndrome with diarrhea|irritable bowel syndrome with diarrhea
371293|NCT01553591|Irritable bowel syndrome|irritable bowel syndrome
371294|NCT01553591|Diarrhea Predominant Irritable Bowel Syndrome|diarrhea predominant irritable bowel syndrome
371295|NCT01553591|Colonic diseases|colonic diseases
371296|NCT01553591|Colonic diseases, functional|colonic diseases, functional
371297|NCT01553591|Digestive system disease|digestive system disease
371298|NCT01553591|Gastrointestinal disease|gastrointestinal disease
371299|NCT01553591|Intestinal disease|intestinal disease
371300|NCT01553591|Colonic pseudo-obstruction|colonic pseudo-obstruction
371301|NCT01553591|Diarrhea|diarrhea
371302|NCT01553591|Signs and symptoms, Digestive|signs and symptoms, digestive
371303|NCT01553565|10 mm in diameter|10 mm in diameter
371304|NCT01553565|antithrombotic agents|antithrombotic agents
371305|NCT01553552|Schistosoma haematobium|schistosoma haematobium
371306|NCT01553552|schistosoma mansoni|schistosoma mansoni
371307|NCT01553552|Anemia|anemia
371308|NCT01553552|Underweight|underweight
371309|NCT01553552|stunting|stunting
371310|NCT01553552|Blastocystis|blastocystis
371311|NCT01553526|International|international
371312|NCT01553526|Multicenter|multicenter
371313|NCT01553526|Observational registry|observational registry
371314|NCT01553526|All-comers open label registry|all-comers open label registry
371315|NCT01553526|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
371316|NCT01553526|Stenting|stenting
371317|NCT01553526|Treatment of Coronary Artery Disease|treatment of coronary artery disease
371318|NCT01553526|Coronary revascularization|coronary revascularization
371319|NCT01553526|Percutaneous Coronary Intervention|percutaneous coronary intervention
371320|NCT01553526|STEMI|stemi
371321|NCT01553526|NSTEMI|nstemi
371322|NCT01553526|Ischemia|ischemia
371323|NCT01553526|Angina|angina
371324|NCT01553526|Subgroups|subgroups
371325|NCT01553526|Acute Myocardial Infarction|acute myocardial infarction
371326|NCT01553526|Diabetes|diabetes
371327|NCT01553526|Small Vessels|small vessels
371328|NCT01553526|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
371329|NCT01553513|PET|pet
371330|NCT01553513|Coronary Artery Disease|coronary artery disease
371331|NCT01553513|Inflammation|inflammation
371332|NCT01553513|Plaque|plaque
371333|NCT01553513|Atherosclerosis|atherosclerosis
371334|NCT01553500|NAFLD|nafld
371335|NCT01553500|insulin resistance|insulin resistance
371336|NCT01553500|children|children
371337|NCT01553487|vibration|vibration
371338|NCT01553487|muscle strength|muscle strength
371339|NCT01553487|bone loss|bone loss
371340|NCT01553487|immobilization|immobilization
371341|NCT01553487|fracture|fracture
371342|NCT01553474|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
371343|NCT01553474|Eye Diseases|eye diseases
371344|NCT01553461|Transplant|transplant
371345|NCT01553461|Umbilical Cord Blood|umbilical cord blood
371346|NCT01553461|Graft Rejection|graft rejection
371347|NCT01553461|Graft Versus Host Disease|graft versus host disease
371348|NCT01553448|disseminated neuroblastoma|disseminated neuroblastoma
371349|NCT01553448|hereditary neuroblastoma|hereditary neuroblastoma
371350|NCT01553448|localized resectable neuroblastoma|localized resectable neuroblastoma
371351|NCT01553448|localized unresectable neuroblastoma|localized unresectable neuroblastoma
371352|NCT01553448|stage 4S neuroblastoma|stage 4s neuroblastoma
371353|NCT01553435|Dextromethorphan|dextromethorphan
371354|NCT01553435|Morphine|morphine
371355|NCT01553435|Fentanyl|fentanyl
371356|NCT01553435|Opioid|opioid
371357|NCT01553435|analgesia|analgesia
371358|NCT01553435|Efficacy|efficacy
371359|NCT01553422|Intrabdominal Pressure|intrabdominal pressure
371360|NCT01553422|Emergency Bedside Ultrasonography|emergency bedside ultrasonography
371361|NCT01553422|Abdominal Compartment Syndrome|abdominal compartment syndrome
371362|NCT01553409|Hypertension|hypertension
371363|NCT01553409|Ferritin|ferritin
371364|NCT01553409|Phlebotomy|phlebotomy
371365|NCT01553409|Blood donation|blood donation
371366|NCT01553383|OSA|osa
371367|NCT01553357|Plasma cell leukemia|plasma cell leukemia
371368|NCT01553357|Lenalidomide|lenalidomide
371369|NCT01553357|Dexamethasone|dexamethasone
371370|NCT01553357|Multiple myeloma|multiple myeloma
371371|NCT01553357|Bortezomib|bortezomib
371372|NCT01553357|Stem cell transplantation|stem cell transplantation
371373|NCT01553344|sclerostin|sclerostin
371374|NCT01553344|osteomalacia|osteomalacia
371375|NCT01553344|vitamin D deficiency|vitamin d deficiency
371376|NCT01553331|laparoscopic cholecystectomy|laparoscopic cholecystectomy
371377|NCT01553318|Fibromyalgia|fibromyalgia
371378|NCT01553318|FMS|fms
371379|NCT01553305|exercise programme|exercise programme
371380|NCT01553292|Respiratory distress syndrome|respiratory distress syndrome
371381|NCT01553292|Preterm infants|preterm infants
371382|NCT01553292|Vascular catheter|vascular catheter
371383|NCT01553292|Surfactant|surfactant
371384|NCT01553292|CPAP|cpap
371385|NCT01553292|ECALMIST|ecalmist
371386|NCT01553266|Diabetes Mellitus|diabetes mellitus
371387|NCT01553266|diabetes care|diabetes care
371388|NCT01553266|diabetes self-management education|diabetes self-management education
371389|NCT01553266|primary care physicians|primary care physicians
371390|NCT01553266|interprofessional collaboration|interprofessional collaboration
371391|NCT01553266|diabetes education programs|diabetes education programs
371392|NCT01553266|qualitative|qualitative
371393|NCT01553266|quantitative|quantitative
371394|NCT01553266|implementation|implementation
371395|NCT01553266|evaluation|evaluation
371396|NCT01553266|health services|health services
371397|NCT01553266|coordinated care|coordinated care
371398|NCT01553266|integrated care|integrated care
371399|NCT01553266|patient care processes|patient care processes
371400|NCT01553253|Postcholecystectomy Pain|postcholecystectomy pain
371401|NCT01553253|Chronic Postoperative Pain|chronic postoperative pain
371402|NCT01553253|Visceral Pain|visceral pain
371403|NCT01553253|Referred pain|referred pain
371404|NCT01553253|Somatic pain|somatic pain
371405|NCT01553253|Quantitative Sensory Testing|quantitative sensory testing
371406|NCT01553240|TMS|tms
371407|NCT01553240|functional MRI|functional mri
371408|NCT01553240|Supplementary motor cortex|supplementary motor cortex
371409|NCT01553240|Right Temporoparietal junction( RTPJ)|right temporoparietal junction( rtpj)
371410|NCT01553227|OSAHS: Obstructive Sleep Apnea hypopnea Syndrome|osahs: obstructive sleep apnea hypopnea syndrome
371411|NCT01553227|OHS: Obesity Hypoventilation Syndrome|ohs: obesity hypoventilation syndrome
371412|NCT01553227|Auto-trilevel ventilation|auto-trilevel ventilation
371413|NCT01553227|BiPAP ventilation|bipap ventilation
371414|NCT01553214|Healthy Volunteers|healthy volunteers
371415|NCT01553214|Granulocyte Transfusion|granulocyte transfusion
371416|NCT01553214|Granulocytapheresis|granulocytapheresis
371417|NCT01553214|Leukapheresis|leukapheresis
371418|NCT01553214|Cytokine Stimulation|cytokine stimulation
371419|NCT01553214|Healthy Volunteer|healthy volunteer
371420|NCT01553214|HV|hv
371421|NCT01553201|Quality of Life|quality of life
371422|NCT01553201|Endometriosis|endometriosis
371423|NCT01553201|Botulinum Toxin A|botulinum toxin a
371424|NCT01553201|Pelvic Pain Spasm|pelvic pain spasm
371425|NCT01553201|Chronic Pelvic Pain|chronic pelvic pain
371426|NCT01553188|Anti-Angiogenesis|anti-angiogenesis
371427|NCT01553188|Ang 1|ang 1
371428|NCT01553188|Ang 2|ang 2
371429|NCT01553188|Peptide-Fc fusion protein|peptide-fc fusion protein
371430|NCT01553188|Small Molecule|small molecule
371431|NCT01553175|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
371432|NCT01553175|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
371433|NCT01553162|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
371534|NCT01552655|Bone scintigraphy|bone scintigraphy
371434|NCT01553162|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
371435|NCT01553136|alcohol-related disorders|alcohol-related disorders
371436|NCT01553136|Cholinergic Drugs|cholinergic drugs
371437|NCT01553136|varenicline|varenicline
371438|NCT01553136|Chantix|chantix
371439|NCT01553123|Leiomyomas|leiomyomas
371440|NCT01553110|Cold|cold
371441|NCT01553110|Acute Rhinosinusitis|acute rhinosinusitis
371442|NCT01553110|Allergic Rhinitis|allergic rhinitis
371443|NCT01553097|Breast Cancer|breast cancer
371444|NCT01553097|Neurocognitive Impairment|neurocognitive impairment
371445|NCT01553097|Quality of Life|quality of life
371446|NCT01553097|Cytokines|cytokines
371447|NCT01553084|Smoking Cessation|smoking cessation
371448|NCT01553084|Smoking|smoking
371449|NCT01553084|Nicotine|nicotine
371450|NCT01553071|Malignancy, Relapsed|malignancy, relapsed
371451|NCT01553071|Chemotherapy, Intravenous|chemotherapy, intravenous
371452|NCT01553058|Psoriasis|psoriasis
371453|NCT01553058|Cardiovascular Disease|cardiovascular disease
371454|NCT01553058|FDG/PET-CT|fdg/pet-ct
371455|NCT01553058|NB-UVB Phototherapy|nb-uvb phototherapy
371456|NCT01553058|Vascular Inflammation|vascular inflammation
371457|NCT01553058|Lipid Biomarkers|lipid biomarkers
371458|NCT01553045|symptom burden|symptom burden
371459|NCT01553045|atrial fibrillation|atrial fibrillation
371460|NCT01553045|biomarkers|biomarkers
371461|NCT01553045|intracardiac pressures|intracardiac pressures
371462|NCT01553032|Immuno-(Chemo-)and Radiotherapy|immuno-(chemo-)and radiotherapy
371463|NCT01553032|Erbitux®|erbitux®
371464|NCT01553032|Skin changes in Head and neck cancer|skin changes in head and neck cancer
371465|NCT01553019|Proton radiation|proton radiation
371466|NCT01553019|Chemotherapy|chemotherapy
371467|NCT01553019|Pancreatic cancer|pancreatic cancer
371468|NCT01553019|Postoperative|postoperative
371469|NCT01553006|rhinosinusitis|rhinosinusitis
371470|NCT01553006|cefditoren pivoxil|cefditoren pivoxil
371471|NCT01552993|prematurity|prematurity
371472|NCT01552993|retinopathy|retinopathy
371473|NCT01552993|pain|pain
371474|NCT01552993|acetaminophen|acetaminophen
371475|NCT01552980|Gastric cancer|gastric cancer
371476|NCT01552980|Adenocarcinoma|adenocarcinoma
371477|NCT01552980|SOX|sox
371478|NCT01552967|Colorectal cancer|colorectal cancer
371479|NCT01552967|Adenocarcinoma|adenocarcinoma
371480|NCT01552967|XELOX|xelox
371481|NCT01552954|hypertension|hypertension
371482|NCT01552954|Chronic kidney disease|chronic kidney disease
371483|NCT01552954|albuminuria|albuminuria
371484|NCT01552954|low salt diet|low salt diet
371485|NCT01552954|Angiotensin II receptor blocker|angiotensin ii receptor blocker
371486|NCT01552941|Vagus Nerve|vagus nerve
371487|NCT01552941|Vagal Nerve Stimulation|vagal nerve stimulation
371488|NCT01552941|Rheumatoid Arthritis|rheumatoid arthritis
371489|NCT01552941|Implantable Medical Device|implantable medical device
371490|NCT01552915|ADHD|adhd
371491|NCT01552902|ADHD|adhd
371492|NCT01552863|pharmacokinetics|pharmacokinetics
371493|NCT01552863|bioavailability|bioavailability
371494|NCT01552863|oxycodone.|oxycodone.
371495|NCT01552850|pharmacokinetics|pharmacokinetics
371496|NCT01552850|relative bioavailability|relative bioavailability
371497|NCT01552850|oxycodone|oxycodone
371498|NCT01552837|Diffusion Tensor Imaging,|diffusion tensor imaging,
371499|NCT01552837|quetiapine|quetiapine
371500|NCT01552837|Bipolar Disorder|bipolar disorder
371501|NCT01552837|hippocampus|hippocampus
371502|NCT01552837|Volume Brain Morphometry|volume brain morphometry
371503|NCT01552837|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
371504|NCT01552837|effect of quetiapine on hippocampal neurogenesis|effect of quetiapine on hippocampal neurogenesis
371505|NCT01552824|LUTO|luto
371506|NCT01552824|posterior urethral valves|posterior urethral valves
371507|NCT01552824|urethral atresia|urethral atresia
371508|NCT01552772|Safety|safety
371509|NCT01552772|Tolerability|tolerability
371510|NCT01552772|Schizophrenia|schizophrenia
371511|NCT01552772|Aripiprazole|aripiprazole
371512|NCT01552759|Appetite Hormones|appetite hormones
371513|NCT01552759|Binge Eating Disorder|binge eating disorder
371514|NCT01552759|Obesity|obesity
371515|NCT01552759|Cortisol|cortisol
371516|NCT01552759|Stress|stress
371517|NCT01552746|Postoperative shoulder pain|postoperative shoulder pain
371518|NCT01552746|Persisting postoperative pain|persisting postoperative pain
371519|NCT01552720|aorta|aorta
371520|NCT01552720|dissection|dissection
371521|NCT01552720|feature|feature
371522|NCT01552707|Spondylolisthesis|spondylolisthesis
371523|NCT01552707|Degenerative discopathy|degenerative discopathy
371524|NCT01552707|Mesenchymal Stem Cells|mesenchymal stem cells
371525|NCT01552707|Bone marrow|bone marrow
371526|NCT01552707|Tissue engineering|tissue engineering
371527|NCT01552707|Spinal fusion|spinal fusion
371528|NCT01552694|cardiometabolic complications|cardiometabolic complications
371529|NCT01552681|baminercept treatment|baminercept treatment
371530|NCT01552668|Clostridium difficile infection|clostridium difficile infection
371531|NCT01552668|fidaxomicin|fidaxomicin
371532|NCT01552655|Dual-time PET/CT|dual-time pet/ct
371533|NCT01552655|Breast cancer recurrence|breast cancer recurrence
371535|NCT01552655|CT thorax upper abdomen|ct thorax upper abdomen
371536|NCT01552642|Comprehensive Health Enhancement Support System (CHESS)|comprehensive health enhancement support system (chess)
371537|NCT01552629|Atopic dermatitis|atopic dermatitis
371538|NCT01552629|Atopic eczema|atopic eczema
371539|NCT01552629|Skin Diseases|skin diseases
371540|NCT01552629|QGE031|qge031
371541|NCT01552603|glucose sensors|glucose sensors
371542|NCT01552603|artificial pancreas|artificial pancreas
371543|NCT01552603|Diabetes Mellitus|diabetes mellitus
371544|NCT01552577|Post-Concussion Syndrome|post-concussion syndrome
371545|NCT01552577|Concussion|concussion
371546|NCT01552577|Brain Injury|brain injury
371547|NCT01552577|TBI|tbi
371548|NCT01552577|Military Personnel|military personnel
371549|NCT01552577|Eye-tracking|eye-tracking
371550|NCT01552577|Neurocognitive Function|neurocognitive function
371551|NCT01552577|Assessment|assessment
371552|NCT01552551|Falls|falls
371553|NCT01552551|exercise|exercise
371554|NCT01552551|safety|safety
371555|NCT01552551|injury|injury
371556|NCT01552551|Older adults|older adults
371557|NCT01552538|Rheumatoid Arthritis|rheumatoid arthritis
371558|NCT01552538|Vagus Nerve|vagus nerve
371559|NCT01552538|Vagal Nerve Stimulation|vagal nerve stimulation
371560|NCT01552525|acute kidney injury|acute kidney injury
371561|NCT01552525|asymmetric dimethylarginine|asymmetric dimethylarginine
371562|NCT01552525|symmetric dimethylarginine|symmetric dimethylarginine
371563|NCT01552525|l-arginine|l-arginine
371564|NCT01552525|arterial stiffness|arterial stiffness
371565|NCT01552525|augmentation index|augmentation index
371566|NCT01552525|pulse wave velocity|pulse wave velocity
371567|NCT01552512|Stunting|stunting
371568|NCT01552512|Hidden Hunger|hidden hunger
371569|NCT01552512|Diarrhea|diarrhea
371570|NCT01552512|Vitamin A Deficiency|vitamin a deficiency
371571|NCT01552486|chiropractic|chiropractic
371572|NCT01552486|manipulation|manipulation
371573|NCT01552486|radiculopathy|radiculopathy
371574|NCT01552486|sciatica|sciatica
371575|NCT01552486|lumbar|lumbar
371576|NCT01552486|disc|disc
371577|NCT01552486|herniation|herniation
371578|NCT01552486|protrusion|protrusion
371579|NCT01552473|TBI|tbi
371580|NCT01552473|Traumatic Brain Injury|traumatic brain injury
371581|NCT01552473|combat related injury|combat related injury
371582|NCT01552473|blast injury|blast injury
371583|NCT01552473|concussion|concussion
371584|NCT01552473|sleep problems|sleep problems
371585|NCT01552473|attention problems|attention problems
371586|NCT01552473|memory problems|memory problems
371587|NCT01552473|headaches|headaches
371588|NCT01552473|dizziness|dizziness
371589|NCT01552473|OEF|oef
371590|NCT01552473|OIF|oif
371591|NCT01552473|Veterans|veterans
371592|NCT01552473|Civilian|civilian
371593|NCT01552460|Autism Spectrum Disorders|autism spectrum disorders
371594|NCT01552460|Brain Imaging|brain imaging
371595|NCT01552460|Genetics|genetics
371596|NCT01552434|Advanced Cancers|advanced cancers
371597|NCT01552434|Advanced Malignancy|advanced malignancy
371598|NCT01552434|Metastatic cancer|metastatic cancer
371599|NCT01552434|Temsirolimus|temsirolimus
371600|NCT01552434|CCI-779|cci-779
371601|NCT01552434|Torisel|torisel
371602|NCT01552434|Bevacizumab|bevacizumab
371603|NCT01552434|Avastin|avastin
371604|NCT01552434|rhuMAb-VEGF|rhumab-vegf
371605|NCT01552434|Anti-VEGF Monoclonal Antibody|anti-vegf monoclonal antibody
371606|NCT01552434|Cetuximab|cetuximab
371607|NCT01552434|C225|c225
371608|NCT01552434|Erbitux|erbitux
371609|NCT01552434|IMC-C225|imc-c225
371610|NCT01552434|Valproic Acid|valproic acid
371611|NCT01552434|Depakene|depakene
371612|NCT01552421|Cholecystectomy|cholecystectomy
371613|NCT01552421|Natural Orifice Transluminal Endoscopic Surgery|natural orifice transluminal endoscopic surgery
371614|NCT01552421|Transvaginal cholecystectomy|transvaginal cholecystectomy
371615|NCT01552421|Postoperative outcome|postoperative outcome
371616|NCT01552408|Non Proliferative Diabetic Retinopathy|non proliferative diabetic retinopathy
371617|NCT01552408|Diabetic Retinopathy|diabetic retinopathy
371618|NCT01552408|Macular Edema|macular edema
371619|NCT01552408|Background Diabetic Retinopathy|background diabetic retinopathy
371620|NCT01552408|Pre Proliferative Diabetic Retinopathy|pre proliferative diabetic retinopathy
371621|NCT01552382|vitamin D|vitamin d
371622|NCT01552382|25-hydroxyvitamin D|25-hydroxyvitamin d
371623|NCT01552382|MACCE|macce
371624|NCT01552382|mortality|mortality
371625|NCT01552382|cardiac|cardiac
371626|NCT01552382|cerebrovascular|cerebrovascular
371627|NCT01552369|CMV|cmv
371628|NCT01552369|cytomegalovirus infections|cytomegalovirus infections
371629|NCT01552369|ganciclovir|ganciclovir
371630|NCT01552369|liver transplant|liver transplant
371631|NCT01552369|preemptive therapy|preemptive therapy
371632|NCT01552369|prophylaxis|prophylaxis
371633|NCT01552369|valganciclovir|valganciclovir
371634|NCT01552330|Primaquine|primaquine
371635|NCT01552330|Pyronaridine-artesunate|pyronaridine-artesunate
371636|NCT01552317|chronic kidney disease|chronic kidney disease
371637|NCT01552304|Obstructive sleep apnea|obstructive sleep apnea
371638|NCT01552304|Oxygen therapy|oxygen therapy
371639|NCT01552304|Surgery|surgery
371640|NCT01552304|Anesthesia|anesthesia
371641|NCT01552291|Malnourishment|malnourishment
371642|NCT01552291|Gastrointestinal tumors|gastrointestinal tumors
371643|NCT01552291|Immunocompetence|immunocompetence
371644|NCT01552265|Mild Cognitive Impairment|mild cognitive impairment
371645|NCT01552265|Alzheimer's Disease|alzheimer's disease
371646|NCT01552252|POs-Ca|pos-ca
371647|NCT01552252|calcium additives|calcium additives
371648|NCT01552252|drink|drink
371649|NCT01552239|Soft tissue sarcoma|soft tissue sarcoma
371650|NCT01552239|Intensity-Modulated Radiation Therapy (IMRT)|intensity-modulated radiation therapy (imrt)
371651|NCT01552239|Tomotherapy|tomotherapy
371652|NCT01552239|Safety Margins|safety margins
371653|NCT01552239|Image-guided Radiation Therapy|image-guided radiation therapy
371654|NCT01552239|Brachytherapy|brachytherapy
371655|NCT01552239|interstitial|interstitial
371656|NCT01552200|Colorectal Cancer|colorectal cancer
371657|NCT01552200|Polyp|polyp
371658|NCT01552200|Adenoma|adenoma
371659|NCT01552200|Detection Rate|detection rate
371660|NCT01552200|Colonoscopy|colonoscopy
371661|NCT01552200|NaviAid™ G-Eye procedure|naviaid™ g-eye procedure
371662|NCT01552200|NaviAid™ G-Eye system|naviaid™ g-eye system
371663|NCT01552200|G-Eye procedure|g-eye procedure
371664|NCT01552200|G-Eye system|g-eye system
371665|NCT01552187|cardiac surgery|cardiac surgery
371666|NCT01552187|post-pericardiotomy syndrome|post-pericardiotomy syndrome
371667|NCT01552187|atrial fibrillation|atrial fibrillation
371668|NCT01552187|pericardial effusion|pericardial effusion
371669|NCT01552187|pleural effusion|pleural effusion
371670|NCT01552187|prevention|prevention
371671|NCT01552187|colchicine|colchicine
371672|NCT01552174|MGD|mgd
371673|NCT01552174|ocular surface pathologies|ocular surface pathologies
371674|NCT01552161|Angiography|angiography
371675|NCT01552161|Atherosclerosis|atherosclerosis
371676|NCT01552161|Asthma|asthma
371677|NCT01552161|Tryptase|tryptase
371678|NCT01552161|Eosinophil cationic protein|eosinophil cationic protein
371679|NCT01552135|titanium dioxide|titanium dioxide
371680|NCT01552135|nanoparticles|nanoparticles
371681|NCT01552135|skin|skin
371682|NCT01552135|penetrate|penetrate
371683|NCT01552109|symptomatic stable angina|symptomatic stable angina
371684|NCT01552109|subjects with symptomatic stable angina visiting non-interventional consulting physicians for treatment and meets the inclusion/exclusion criteria|subjects with symptomatic stable angina visiting non-interventional consulting physicians for treatment and meets the inclusion/exclusion criteria
371685|NCT01552096|Anaesthesia|anaesthesia
371686|NCT01552096|tonsillectomy|tonsillectomy
371687|NCT01552096|inflammatory response|inflammatory response
371688|NCT01552096|stress response|stress response
371689|NCT01552096|tramadol|tramadol
371690|NCT01552096|lidocaine|lidocaine
371691|NCT01552083|sleep apnea|sleep apnea
371692|NCT01552083|screening|screening
371693|NCT01552083|community pharmacy|community pharmacy
371694|NCT01552044|retina|retina
371695|NCT01552031|COPD exacerbations|copd exacerbations
371696|NCT01552031|FOT variability|fot variability
371697|NCT01551992|Sutures|sutures
371698|NCT01551992|Pelvic Organ Prolapse|pelvic organ prolapse
371699|NCT01551992|Sacrocolpopexy|sacrocolpopexy
371700|NCT01551992|Laparoscopy|laparoscopy
371701|NCT01551979|Schizophrenia|schizophrenia
371702|NCT01551979|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
371703|NCT01551966|Esophageal varices|esophageal varices
371704|NCT01551966|Portal hypertension in children|portal hypertension in children
371705|NCT01551966|Wireless capsule endoscopy|wireless capsule endoscopy
371706|NCT01551953|chronic bronchitis|chronic bronchitis
371707|NCT01551953|emphysema|emphysema
371708|NCT01551953|pulmonary|pulmonary
371709|NCT01551953|COPD|copd
371710|NCT01551940|Sialorrhea|sialorrhea
371711|NCT01551940|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
371712|NCT01551940|Botulinum toxin|botulinum toxin
371713|NCT01551927|expectations|expectations
371714|NCT01551914|Ultrasonic scissors|ultrasonic scissors
371715|NCT01551914|thyroidectomy|thyroidectomy
371716|NCT01551901|Back pain|back pain
371717|NCT01551901|Spinal fusion|spinal fusion
371718|NCT01551901|Degenerative disc disease (DDD)|degenerative disc disease (ddd)
371719|NCT01551901|Lower back pain|lower back pain
371720|NCT01551901|Fusion|fusion
371721|NCT01551888|COPD|copd
371722|NCT01551888|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
371723|NCT01551888|Chronic Bronchitis|chronic bronchitis
371724|NCT01551888|Emphysema|emphysema
371725|NCT01551888|Airflow Obstruction, Chronic|airflow obstruction, chronic
371726|NCT01551888|Chronic Airflow Obstruction|chronic airflow obstruction
371727|NCT01551888|Chronic Obstructive Airway Disease|chronic obstructive airway disease
371728|NCT01551888|Chronic Obstructive Lung Disease|chronic obstructive lung disease
371729|NCT01551875|CIMT|cimt
371730|NCT01551875|cardiovascular disease|cardiovascular disease
371731|NCT01551875|correlation with cardiovascular Risk factors|correlation with cardiovascular risk factors
371732|NCT01551862|lower body lift|lower body lift
371733|NCT01551862|body contouring surgery|body contouring surgery
371734|NCT01551862|massive weight loss|massive weight loss
371838|NCT01551368|letrozole|letrozole
371735|NCT01551836|pharmacokinetics|pharmacokinetics
371736|NCT01551836|paracetamol|paracetamol
371737|NCT01551823|Influenza Virus Vaccine (Split Virion, Inactivated)|influenza virus vaccine (split virion, inactivated)
371738|NCT01551823|Influenza|influenza
371739|NCT01551810|Influenza Virus Vaccine (Split Virion, Inactivated)|influenza virus vaccine (split virion, inactivated)
371740|NCT01551810|Influenza|influenza
371741|NCT01551784|Statin treatment|statin treatment
371742|NCT01551784|Cardiovascular disease|cardiovascular disease
371743|NCT01551784|Statin treatment induced HDL changes and the effect on cardiovascular disease|statin treatment induced hdl changes and the effect on cardiovascular disease
371744|NCT01551771|CCR3 antagonist|ccr3 antagonist
371745|NCT01551758|Exacerbation|exacerbation
371746|NCT01551758|Adult|adult
371747|NCT01551758|COPD|copd
371748|NCT01551758|Respiratory|respiratory
371749|NCT01551745|Papillary Serous Ovarian Cancer|papillary serous ovarian cancer
371750|NCT01551745|Endometrioid Ovarian Cancer|endometrioid ovarian cancer
371751|NCT01551745|Epithelial Ovarian Cancer|epithelial ovarian cancer
371752|NCT01551732|Anger|anger
371753|NCT01551732|Aggression|aggression
371754|NCT01551732|Biofeedback|biofeedback
371755|NCT01551732|Videogame|videogame
371756|NCT01551719|Bacterial infection of skin or soft tissues|bacterial infection of skin or soft tissues
371757|NCT01551706|Total antioxidant capacity|total antioxidant capacity
371759|NCT01551706|8-OHdG|8-ohdg
371760|NCT01551706|8-isoprostane|8-isoprostane
371761|NCT01551706|oxLDL|oxldl
371762|NCT01551693|Stage III|stage iii
371763|NCT01551693|Stage IV|stage iv
371764|NCT01551693|Unresectable|unresectable
371765|NCT01551693|Metastatic|metastatic
371766|NCT01551667|S. aureus|s. aureus
371767|NCT01551654|Pain|pain
371768|NCT01551654|Colonoscopy|colonoscopy
371769|NCT01551654|TENS|tens
371770|NCT01551654|Acupuncture|acupuncture
371771|NCT01551641|Esophageal Cancer|esophageal cancer
371772|NCT01551641|Chemoradiotherapy|chemoradiotherapy
371773|NCT01551641|VEGF|vegf
371774|NCT01551641|Thalidomide|thalidomide
371775|NCT01551615|Phase 1|phase 1
371776|NCT01551615|healthy volunteers|healthy volunteers
371777|NCT01551615|pharmacokinetics|pharmacokinetics
371778|NCT01551615|vandetanib|vandetanib
371779|NCT01551615|metformin|metformin
371780|NCT01551615|AUC(0-t)|auc(0-t)
371781|NCT01551615|t1/2|t1/2
371782|NCT01551615|tmax|tmax
371783|NCT01551615|CL/F|cl/f
371784|NCT01551615|Vz/F|vz/f
371785|NCT01551615|Cmax|cmax
371786|NCT01551602|AK159|ak159
371787|NCT01551602|teriparatide acetate|teriparatide acetate
371788|NCT01551589|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
371789|NCT01551589|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
371790|NCT01551589|Clinical target volume|clinical target volume
371791|NCT01551589|Safety|safety
371792|NCT01551589|Prognosis|prognosis
371793|NCT01551550|Glaucoma Drainage Device, Tube Exposure, Amniotic Membrane|glaucoma drainage device, tube exposure, amniotic membrane
371794|NCT01551537|Healthy females|healthy females
371795|NCT01551537|Post-marketing surveillance (PMS)|post-marketing surveillance (pms)
371796|NCT01551537|Human papillomavirus vaccine|human papillomavirus vaccine
371797|NCT01551537|Sri Lanka|sri lanka
371798|NCT01551537|Cervarix|cervarix
371799|NCT01551524|Leukemia|leukemia
371800|NCT01551524|Lymphoma|lymphoma
371801|NCT01551524|C240588.448|c240588.448
371802|NCT01551524|C115.378.400|c115.378.400
371803|NCT01551511|chronic pancreatitis|chronic pancreatitis
371804|NCT01551511|abdominal pain|abdominal pain
371805|NCT01551511|visceral pain|visceral pain
371806|NCT01551511|chronic pain|chronic pain
371807|NCT01551498|Hashimoto Disease|hashimoto disease
371808|NCT01551498|Thyroiditis|thyroiditis
371809|NCT01551459|Uveal|uveal
371810|NCT01551459|Melanoma|melanoma
371811|NCT01551459|Metastatic|metastatic
371812|NCT01551459|Sunitinib|sunitinib
371813|NCT01551433|esophagectomy|esophagectomy
371814|NCT01551433|ESOPHAGUS|esophagus
371815|NCT01551433|Wipox instrument|wipox instrument
371816|NCT01551433|Tissue Oxygenation|tissue oxygenation
371817|NCT01551433|Anastomotic Leak|anastomotic leak
371818|NCT01551433|11-192|11-192
371819|NCT01551420|Amputation|amputation
371820|NCT01551420|Prosthetic Design|prosthetic design
371821|NCT01551420|Upper Extremity|upper extremity
371822|NCT01551407|Hexvix|hexvix
371823|NCT01551407|bladder cancer|bladder cancer
371824|NCT01551407|cystoscopy|cystoscopy
371825|NCT01551407|Patients with known or suspicion of bladder cancer|patients with known or suspicion of bladder cancer
371826|NCT01551394|sepsis|sepsis
371827|NCT01551394|neonates|neonates
371828|NCT01551394|meropenem|meropenem
371829|NCT01551381|Safety|safety
371830|NCT01551381|Tolerability|tolerability
371831|NCT01551381|Pharmacokinetics|pharmacokinetics
371832|NCT01551381|Pharmacodynamics|pharmacodynamics
371833|NCT01551368|male factor|male factor
371834|NCT01551368|intrauterine insemination|intrauterine insemination
371835|NCT01551368|LH surge|lh surge
371836|NCT01551368|controlled ovarian stimulation|controlled ovarian stimulation
371837|NCT01551368|clomiphene citrate|clomiphene citrate
371839|NCT01551368|human menopausal gonadotropins|human menopausal gonadotropins
371840|NCT01551355|behavioral modification|behavioral modification
371841|NCT01551355|health communication|health communication
371842|NCT01551355|prevention|prevention
371843|NCT01551342|bladder cancer|bladder cancer
371844|NCT01551342|Transitional cell carcinoma (TCC)|transitional cell carcinoma (tcc)
371845|NCT01551329|depression|depression
371846|NCT01551329|alcohol|alcohol
371847|NCT01551329|comorbidity|comorbidity
371848|NCT01551329|ketamine|ketamine
371849|NCT01551329|glutamate|glutamate
371850|NCT01551329|NMDA|nmda
371851|NCT01551316|safety|safety
371852|NCT01551316|pharmacokinetics|pharmacokinetics
371853|NCT01551316|spirometry|spirometry
371854|NCT01551290|Ulcerative colitis|ulcerative colitis
371855|NCT01551290|UC|uc
371856|NCT01551290|Remicade|remicade
371857|NCT01551290|Infliximab|infliximab
371858|NCT01551290|Chinese patients|chinese patients
371859|NCT01551290|Mayo score|mayo score
371860|NCT01551290|Mucosal healing|mucosal healing
371861|NCT01551290|Rectal bleeding|rectal bleeding
371862|NCT01551290|Inflammatory bowel disease|inflammatory bowel disease
371863|NCT01551290|IBD|ibd
371864|NCT01551238|Energy expenditure|energy expenditure
371865|NCT01551238|Sleep|sleep
371866|NCT01551238|Protein|protein
371867|NCT01551238|Carbohydrate|carbohydrate
371868|NCT01551225|Randomized controlled trial|randomized controlled trial
371869|NCT01551225|Escitalopram|escitalopram
371870|NCT01551225|Irritable bowel syndrome|irritable bowel syndrome
371871|NCT01551225|Panic disorder|panic disorder
371872|NCT01551212|Liver transplantation|liver transplantation
371873|NCT01551212|everolimus|everolimus
371874|NCT01551212|kidney function|kidney function
371875|NCT01551186|Probiotics|probiotics
371876|NCT01551173|Dyslipidemias|dyslipidemias
371877|NCT01551173|Fluvastatin sodium|fluvastatin sodium
371878|NCT01551173|Chinese|chinese
371879|NCT01551160|Non-technical skills|non-technical skills
371880|NCT01551160|Crisis resource management|crisis resource management
371881|NCT01551160|Medical Emergency Team|medical emergency team
371882|NCT01551160|Rapid Response Team|rapid response team
371883|NCT01551147|asthma|asthma
371884|NCT01551147|ONO-6950|ono-6950
371885|NCT01551147|asthma in adult patients|asthma in adult patients
371886|NCT01551134|Gastroesophageal Reflux|gastroesophageal reflux
371887|NCT01551134|Fundoplication|fundoplication
371888|NCT01551134|Randomized Controlled Trial|randomized controlled trial
371889|NCT01551134|General Surgery|general surgery
371890|NCT01551134|Child|child
371891|NCT01551134|Laparoscopy|laparoscopy
371892|NCT01551108|Children|children
371893|NCT01551108|physical activity|physical activity
371894|NCT01551095|PEGJ|pegj
371895|NCT01551095|PEG-J|peg-j
371896|NCT01551095|percutaneous endoscopic gastrostomy|percutaneous endoscopic gastrostomy
371897|NCT01551095|feeding tube|feeding tube
371898|NCT01551095|gastroparesis|gastroparesis
371899|NCT01551095|acute pancreatitis|acute pancreatitis
371900|NCT01551095|stroke|stroke
371901|NCT01551095|respiratory failure|respiratory failure
371902|NCT01551095|GERD|gerd
371903|NCT01551095|balloon|balloon
371904|NCT01551095|self-propelled|self-propelled
371905|NCT01551043|adult patients|adult patients
371906|NCT01551043|aged 18|aged 18
371907|NCT01551043|CD19+ ALL relapsed|cd19+ all relapsed
371908|NCT01551043|after allogeneic SCT|after allogeneic sct
371909|NCT01551030|KIDNEY|kidney
371910|NCT01551030|URETER|ureter
371911|NCT01551030|URINARY BLADDER|urinary bladder
371912|NCT01551030|Buparlisib|buparlisib
371913|NCT01551030|11-060|11-060
371914|NCT01551017|total knee endoprostheses|total knee endoprostheses
371915|NCT01551017|swelling|swelling
371916|NCT01551017|mobilisation|mobilisation
371917|NCT01551004|C. diff|c. diff
371918|NCT01551004|C. difficile|c. difficile
371919|NCT01551004|Clostridium difficile|clostridium difficile
371920|NCT01551004|CRS3123|crs3123
371921|NCT01550965|Quality of Life|quality of life
371922|NCT01550965|Costs of Ulcerative Colitis|costs of ulcerative colitis
371923|NCT01550965|Health Care Utilization|health care utilization
371924|NCT01550939|Biometry of the Eye|biometry of the eye
371925|NCT01550939|Intraocular Lens Implantation|intraocular lens implantation
371926|NCT01550939|IOL|iol
371927|NCT01550926|orlistat|orlistat
371928|NCT01550926|overweight|overweight
371929|NCT01550926|bioequivalence|bioequivalence
371930|NCT01550913|Substance use|substance use
371931|NCT01550913|perinatal depression|perinatal depression
371932|NCT01550913|pregnant|pregnant
371933|NCT01550900|Colorectum|colorectum
371934|NCT01550900|Metachronous ctalColonic Neoplastic Polyps|metachronous ctalcolonic neoplastic polyps
371935|NCT01550900|Chemoprevention|chemoprevention
371936|NCT01550900|Colonic adenoma(s)|colonic adenoma(s)
371937|NCT01550900|Pre-cancerous tumor(s) on the colon|pre-cancerous tumor(s) on the colon
371938|NCT01550900|Metformin ER|metformin er
371939|NCT01550900|Extended Release|extended release
371940|NCT01550900|Placebo|placebo
371941|NCT01550900|Sugar pill|sugar pill
371942|NCT01550874|Physical Activity|physical activity
371943|NCT01550874|Epilepsy|epilepsy
371944|NCT01550874|Children|children
371945|NCT01550874|Motivation|motivation
371946|NCT01550861|infertility|infertility
371947|NCT01550861|in vitro maturation (IVM)|in vitro maturation (ivm)
371948|NCT01550861|in vitro fertilization (IVF)|in vitro fertilization (ivf)
371949|NCT01550861|natural cycle|natural cycle
371950|NCT01550835|Symptomatic carotid artery stenosis|symptomatic carotid artery stenosis
371951|NCT01550822|stroke, lifestyle habits|stroke, lifestyle habits
371952|NCT01550809|T1DM|t1dm
371953|NCT01550809|CSII|csii
371955|NCT01550809|postprandial control|postprandial control
371956|NCT01550809|glycemic variability|glycemic variability
371957|NCT01550809|Prandial insulin dosing in Type 1 diabetes treated with continuous subcutaneous insulin infusion|prandial insulin dosing in type 1 diabetes treated with continuous subcutaneous insulin infusion
371958|NCT01550796|Tinnitus|tinnitus
371959|NCT01550796|Brain Fitness Program|brain fitness program
371960|NCT01550796|Posit Science|posit science
371961|NCT01550796|D-cycloserine|d-cycloserine
371962|NCT01550796|Cognitive Training|cognitive training
371963|NCT01550783|Cervical cancer|cervical cancer
371964|NCT01550783|Atypical squamous cells of undetermined significance|atypical squamous cells of undetermined significance
371965|NCT01550783|Stage 0 cervical cancer|stage 0 cervical cancer
371966|NCT01550783|Cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
371967|NCT01550783|Cervical|cervical
371968|NCT01550783|intraepithelial neoplasia grade 2|intraepithelial neoplasia grade 2
371969|NCT01550783|Cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
371970|NCT01550783|Human papillomavirus|human papillomavirus
371971|NCT01550783|HPV|hpv
371972|NCT01550744|Psoriasis|psoriasis
371973|NCT01550744|Ustekinumab|ustekinumab
371974|NCT01550744|STELARA|stelara
371975|NCT01550744|Skin disease|skin disease
371976|NCT01550744|Monoclonal|monoclonal
371977|NCT01550731|advance care planning|advance care planning
371978|NCT01550731|health communication|health communication
371979|NCT01550731|aging|aging
371980|NCT01550718|Aerobic Exercise|aerobic exercise
371981|NCT01550718|Alzheimer's Disease|alzheimer's disease
371982|NCT01550718|Burden and Stress|burden and stress
371983|NCT01550718|Caregiving Issues|caregiving issues
371984|NCT01550718|Quality of Life|quality of life
371985|NCT01550718|Early Stage Memory Loss|early stage memory loss
371986|NCT01550705|Protoporphyria|protoporphyria
371987|NCT01550705|Porphyria|porphyria
371988|NCT01550705|Porphyrins|porphyrins
371989|NCT01550666|negative symptoms|negative symptoms
371990|NCT01550653|Memory|memory
371991|NCT01550653|GLP-1|glp-1
371992|NCT01550653|Liraglutide|liraglutide
371993|NCT01550653|energy output|energy output
371994|NCT01550653|Memory facilitation|memory facilitation
371995|NCT01550653|GLP-1 analogue|glp-1 analogue
371996|NCT01550640|remifentanil|remifentanil
371997|NCT01550640|Caesarean operation|caesarean operation
371998|NCT01550640|general anaesthesia|general anaesthesia
371999|NCT01550640|hypertension|hypertension
372000|NCT01550640|newborn's adaptation|newborn's adaptation
372001|NCT01550640|pharmacogenetics|pharmacogenetics
372002|NCT01550627|preterm infants < 32 weeks of gestation|preterm infants < 32 weeks of gestation
372003|NCT01550614|Angina Pectoris|angina pectoris
372004|NCT01550614|Myocardial Ischemia|myocardial ischemia
372005|NCT01550614|Chest Pain|chest pain
372006|NCT01550614|Coronary Artery Disease|coronary artery disease
372007|NCT01550614|Heart Diseases|heart diseases
372008|NCT01550614|Cardiovascular Diseases|cardiovascular diseases
372009|NCT01550614|Myocardial Perfusion|myocardial perfusion
372010|NCT01550614|Reversible Perfusion Defect Size|reversible perfusion defect size
372011|NCT01550614|SPECT-MIBI|spect-mibi
372012|NCT01550614|Anti-Anginal Medication|anti-anginal medication
372013|NCT01550614|Quality of Life|quality of life
372014|NCT01550601|morbid obesity|morbid obesity
372015|NCT01550601|gastrectomy|gastrectomy
372016|NCT01550601|gastrinaemia|gastrinaemia
372017|NCT01550601|comorbidity|comorbidity
372018|NCT01550601|gastric antrum|gastric antrum
372019|NCT01550588|PFO|pfo
372020|NCT01550588|Stroke|stroke
372021|NCT01550549|Amyloid imaging|amyloid imaging
372022|NCT01550549|Positron Emission Tomography|positron emission tomography
372023|NCT01550549|18F-AV-45|18f-av-45
372024|NCT01550549|florbetapir F 18|florbetapir f 18
372025|NCT01550549|Diagnostic imaging|diagnostic imaging
372026|NCT01550536|basal metabolic rate|basal metabolic rate
372027|NCT01550536|resting energy expenditure|resting energy expenditure
372028|NCT01550536|menopause|menopause
372029|NCT01550536|physical activity|physical activity
372030|NCT01550536|metabolic syndrome|metabolic syndrome
372031|NCT01550523|Brain Tumor|brain tumor
372032|NCT01550510|Stage IV Colorectal cancer|stage iv colorectal cancer
372033|NCT01550510|Colorectal Neoplasms|colorectal neoplasms
372034|NCT01550510|Intestinal Neoplasms|intestinal neoplasms
372035|NCT01550510|Gastrointestinal Neoplasms|gastrointestinal neoplasms
372036|NCT01550510|Digestive System Neoplasms|digestive system neoplasms
372037|NCT01550510|Neoplasms by Site|neoplasms by site
372038|NCT01550510|Neoplasms|neoplasms
372039|NCT01550510|Digestive System Diseases|digestive system diseases
372040|NCT01550510|Gastrointestinal Diseases|gastrointestinal diseases
372041|NCT01550510|Colonic Diseases|colonic diseases
372042|NCT01550510|Intestinal Diseases|intestinal diseases
372043|NCT01550510|Rectal Diseases|rectal diseases
372044|NCT01550510|Ascorbic Acid|ascorbic acid
372045|NCT01550510|Vitamins|vitamins
372046|NCT01550510|Irinotecan|irinotecan
372047|NCT01550510|Integrative Medicine|integrative medicine
372048|NCT01550510|Complementary Medicine|complementary medicine
372049|NCT01550510|Alternative Medicine Antioxidants|alternative medicine antioxidants
372050|NCT01550510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
372051|NCT01550510|Pharmacologic Actions|pharmacologic actions
372052|NCT01550510|Protective Agents|protective agents
372053|NCT01550510|Physiological Effects of Drugs|physiological effects of drugs
372054|NCT01550510|Micronutrients|micronutrients
372055|NCT01550510|Growth Substances|growth substances
372056|NCT01550510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic
372057|NCT01550510|Antineoplastic Agents|antineoplastic agents
372058|NCT01550510|Therapeutic Uses|therapeutic uses
372059|NCT01550510|Radiation-Sensitizing Agents|radiation-sensitizing agents
372060|NCT01550510|Topoisomerase I Inhibitors|topoisomerase i inhibitors
372061|NCT01550510|Topoisomerase Inhibitors|topoisomerase inhibitors
372062|NCT01550510|Enzyme Inhibitors|enzyme inhibitors
372063|NCT01550497|back pain|back pain
372064|NCT01550497|scoliosis|scoliosis
372065|NCT01550497|home exercise program|home exercise program
372066|NCT01550471|Mild asthma and allergic rhinitis|mild asthma and allergic rhinitis
372067|NCT01550458|Clinical Trial, Phase I|clinical trial, phase i
372068|NCT01550458|Human Volunteers|human volunteers
372069|NCT01550458|Healthy Volunteers|healthy volunteers
372070|NCT01550458|mibefradil|mibefradil
372071|NCT01550458|Posicor®|posicor®
372072|NCT01550445|Steroid withdrawal, Kidney transplantation|steroid withdrawal, kidney transplantation
372073|NCT01550419|Ventilator-associated pneumonia|ventilator-associated pneumonia
372074|NCT01550419|Ischemic stroke|ischemic stroke
372075|NCT01550419|Atorvastatin|atorvastatin
372076|NCT01550419|Morbidity|morbidity
372077|NCT01550419|Mortality|mortality
372078|NCT01550406|Pancreatic fistula|pancreatic fistula
372079|NCT01550406|distal Pancreatectomy|distal pancreatectomy
372080|NCT01550393|stage II Wilms tumor|stage ii wilms tumor
372081|NCT01550393|stage III Wilms tumor|stage iii wilms tumor
372082|NCT01550393|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
372083|NCT01550380|Endometrial cancer|endometrial cancer
372084|NCT01550341|HIV|hiv
372085|NCT01550341|AIDS|aids
372086|NCT01550341|Opiate Addiction|opiate addiction
372087|NCT01550341|Drug Dependence|drug dependence
372088|NCT01550341|Buprenorphine|buprenorphine
372089|NCT01550328|Screening for Type 2 diabetes|screening for type 2 diabetes
372090|NCT01550315|POTS|pots
372091|NCT01550315|endothelial function|endothelial function
372092|NCT01550315|high salt vs low salt diet|high salt vs low salt diet
372093|NCT01550315|PAT protocol|pat protocol
372094|NCT01550315|Calf blood flow|calf blood flow
372095|NCT01550315|forearm mediated dilation|forearm mediated dilation
372096|NCT01550302|Superficial Cervical Plexus Block|superficial cervical plexus block
372097|NCT01550302|Thoracic Surgery|thoracic surgery
372098|NCT01550302|Thoracotomy|thoracotomy
372099|NCT01550302|Video-Assisted Thoracoscopic Surgery|video-assisted thoracoscopic surgery
372100|NCT01550289|Dengue Fever|dengue fever
372101|NCT01550289|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
372102|NCT01550289|CYD Dengue Vaccine|cyd dengue vaccine
372103|NCT01550289|Dengue Virus|dengue virus
372104|NCT01550289|Flavivirus|flavivirus
372105|NCT01550276|Effectiveness|effectiveness
372106|NCT01550276|Tension-type headache|tension-type headache
372107|NCT01550276|Manual therapy|manual therapy
372108|NCT01550263|Hip Preservation|hip preservation
372109|NCT01550263|Hip Arthroscopy|hip arthroscopy
372110|NCT01550263|Hip Pain|hip pain
372111|NCT01550263|Psychological distress|psychological distress
372112|NCT01550250|Breast cancer|breast cancer
372113|NCT01550250|Arm lymphedema|arm lymphedema
372114|NCT01550250|Compression therapy|compression therapy
372115|NCT01550237|radiotherapy, image-guided|radiotherapy, image-guided
372116|NCT01550237|adverse effects|adverse effects
372117|NCT01550237|position verification|position verification
372118|NCT01550237|safety margins|safety margins
372119|NCT01550198|newborn|newborn
372120|NCT01550198|shock|shock
372121|NCT01550198|hemodynamics|hemodynamics
372122|NCT01550198|cardiac output|cardiac output
372123|NCT01550198|blood pressure|blood pressure
372124|NCT01550172|dementia caregivers|dementia caregivers
372125|NCT01550172|caregivers|caregivers
372126|NCT01550172|Alzheimer's caregivers|alzheimer's caregivers
372127|NCT01550172|caregiver sleep|caregiver sleep
372128|NCT01550172|heart disease risk|heart disease risk
372129|NCT01550172|dementia|dementia
372130|NCT01550172|Alzheimer's Disease|alzheimer's disease
372131|NCT01550159|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
372132|NCT01550159|Cardiac Surgery|cardiac surgery
372133|NCT01550159|General Anesthesia|general anesthesia
372134|NCT01550159|Neuropsychological Tests|neuropsychological tests
372135|NCT01550146|Fractured neck of femur|fractured neck of femur
372136|NCT01550146|Dexamethasone|dexamethasone
372137|NCT01550133|Peptides|peptides
372138|NCT01550133|Hormones|hormones
372139|NCT01550133|Appetite|appetite
372140|NCT01550133|Humans|humans
372141|NCT01550133|Obese|obese
372142|NCT01550133|Beverage|beverage
372143|NCT01550133|Solid food|solid food
372144|NCT01550133|cephalic phase|cephalic phase
372145|NCT01550120|taste|taste
372146|NCT01550120|fat|fat
372147|NCT01550120|threshold|threshold
372148|NCT01550120|sensitivity|sensitivity
372149|NCT01550120|human|human
372150|NCT01550107|Sarcopenia|sarcopenia
372151|NCT01550107|Allopurinol|allopurinol
372152|NCT01550107|Xanthine Oxidase|xanthine oxidase
372153|NCT01550107|MR Spectroscopy|mr spectroscopy
372154|NCT01550094|obese|obese
372155|NCT01550094|regional anesthesia|regional anesthesia
372156|NCT01550094|anesthesia|anesthesia
372157|NCT01550094|anesthesiology|anesthesiology
372158|NCT01550094|surgery|surgery
372159|NCT01550094|foot|foot
372160|NCT01550094|foot surgery|foot surgery
372161|NCT01550094|ankle|ankle
372162|NCT01550094|ankle surgery|ankle surgery
372163|NCT01550094|orthopedics|orthopedics
372164|NCT01550094|orthopedic surgery|orthopedic surgery
372165|NCT01550094|sports medicine|sports medicine
372166|NCT01550094|sports medicine surgery|sports medicine surgery
372167|NCT01550094|Ochsner Hospital|ochsner hospital
372168|NCT01550094|Ochsner Clinic|ochsner clinic
372169|NCT01550094|New Orleans|new orleans
372170|NCT01550094|Louisiana|louisiana
372171|NCT01550094|Jefferson|jefferson
372172|NCT01550094|Soberon|soberon
372173|NCT01550081|exercise intensity|exercise intensity
372174|NCT01550081|aerobic interval training|aerobic interval training
372175|NCT01550081|cardiac rehabilitation|cardiac rehabilitation
372176|NCT01550081|group exercise|group exercise
372177|NCT01550068|Rheumatic Heart Disease|rheumatic heart disease
372178|NCT01550055|KRAS wild-type|kras wild-type
372179|NCT01550055|Metastatic Colorectal Cancer|metastatic colorectal cancer
372180|NCT01550055|CMAB009 Plus Irinotecan|cmab009 plus irinotecan
372181|NCT01550055|Phase II/III|phase ii/iii
372182|NCT01550029|Smoking|smoking
372183|NCT01550029|Tobacco|tobacco
372184|NCT01550029|Nicotine|nicotine
372185|NCT01550029|Bipolar|bipolar
372186|NCT01550016|dengue warning signs|dengue warning signs
372187|NCT01550016|latin america|latin america
372188|NCT01550016|south east asia|south east asia
372189|NCT01550016|other febrile illnesses|other febrile illnesses
372190|NCT01550016|dengue classification|dengue classification
372191|NCT01550003|Cimzia|cimzia
372192|NCT01550003|JIA|jia
372193|NCT01550003|Polyarticular|polyarticular
372194|NCT01550003|Oligoarticular|oligoarticular
372195|NCT01550003|Enthesitis-related-Arthritis|enthesitis-related-arthritis
372196|NCT01550003|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
372197|NCT01550003|Juvenile Psoriatic Arthritis|juvenile psoriatic arthritis
372198|NCT01550003|Certolizumab Pegol|certolizumab pegol
372199|NCT01550003|PASCAL|pascal
372200|NCT01550003|CDP870|cdp870
372201|NCT01549977|Drug Therapy|drug therapy
372202|NCT01549964|Drug Therapy|drug therapy
372203|NCT01549951|Metastatic castrate resistant prostate cancer, mCRPC, orteronel, TAK-700, Phase 2, QT, QTc|metastatic castrate resistant prostate cancer, mcrpc, orteronel, tak-700, phase 2, qt, qtc
372204|NCT01549938|Vitamin D|vitamin d
372205|NCT01549938|Cholecalciferol|cholecalciferol
372206|NCT01549938|Respiratory tract infection|respiratory tract infection
372207|NCT01549912|Rotator Cuff Tears|rotator cuff tears
372208|NCT01549912|Dislocation|dislocation
372209|NCT01549912|Shoulder Dislocation|shoulder dislocation
372210|NCT01549899|Insomnia|insomnia
372211|NCT01549899|Cognitive|cognitive
372212|NCT01549899|Behavioral|behavioral
372213|NCT01549899|Therapy|therapy
372214|NCT01549899|Internet|internet
372215|NCT01549899|Depression|depression
372216|NCT01549899|Substance Use|substance use
372217|NCT01549899|Post-Tramatic Stress Disorder|post-tramatic stress disorder
372218|NCT01549886|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
372219|NCT01549886|Zevalin|zevalin
372220|NCT01549886|Motexafin Gadolinium|motexafin gadolinium
372221|NCT01549860|Venous Insufficiency|venous insufficiency
372222|NCT01549860|Reflux|reflux
372223|NCT01549860|Lower Extremity Ulcer|lower extremity ulcer
372224|NCT01549847|Postpoliomyelitis Syndrome|postpoliomyelitis syndrome
372225|NCT01549847|Piracetam|piracetam
372226|NCT01549847|L-Carnitine|l-carnitine
372227|NCT01549808|ADL|adl
372228|NCT01549808|activities of daily living|activities of daily living
372229|NCT01549808|level of function|level of function
372230|NCT01549795|Liver transplantation|liver transplantation
372231|NCT01549795|Neoadjuvant radio- chemo-therapy|neoadjuvant radio- chemo-therapy
372232|NCT01549782|Prebiotics|prebiotics
372233|NCT01549782|Microbiota|microbiota
372234|NCT01549782|Radiotherapy|radiotherapy
372235|NCT01549782|Gynaecological Cancer|gynaecological cancer
372236|NCT01549756|stage 4 stomach cancer|stage 4 stomach cancer
372237|NCT01549756|stage 4 gastric cancer|stage 4 gastric cancer
372238|NCT01549717|Early warning score|early warning score
372239|NCT01549717|Physiological score|physiological score
372240|NCT01549717|Track and trigger score|track and trigger score
372241|NCT01549717|Scoring system|scoring system
372242|NCT01549717|Physiological model|physiological model
372243|NCT01549717|Monitoring|monitoring
372244|NCT01549717|Patient monitoring|patient monitoring
372245|NCT01549717|Wireless monitoring|wireless monitoring
372246|NCT01549717|Wearable monitor|wearable monitor
372247|NCT01549704|Total knee arthroplasty|total knee arthroplasty
372248|NCT01549704|Adductor canal blockade (ACB)|adductor canal blockade (acb)
372249|NCT01549704|High pain responders|high pain responders
372250|NCT01549704|US-guided nerve block|us-guided nerve block
372251|NCT01549691|Premedication|premedication
372252|NCT01549691|Benzodiazepine|benzodiazepine
372253|NCT01549691|Anti-anxiety agents|anti-anxiety agents
372254|NCT01549691|Anxiety|anxiety
372255|NCT01549691|Surgery|surgery
372256|NCT01549691|Adult|adult
372257|NCT01549691|Human|human
372258|NCT01549678|Plantar fasciitis|plantar fasciitis
372259|NCT01549678|foot pain|foot pain
372260|NCT01549678|insoles|insoles
372261|NCT01549678|foot function|foot function
372262|NCT01549678|electronic baropodometer|electronic baropodometer
372263|NCT01549678|plantar pressure|plantar pressure
372264|NCT01549678|gait analysis|gait analysis
372265|NCT01549665|Graft-Versus-Host Disease|graft-versus-host disease
372266|NCT01549665|GVHD|gvhd
372267|NCT01549665|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
372268|NCT01549665|Stem Cell Transplantation|stem cell transplantation
372269|NCT01549665|Allogeneic hematopoietic transplant|allogeneic hematopoietic transplant
372270|NCT01549665|Mesenchymal Stem Cells|mesenchymal stem cells
372271|NCT01549665|Unrelated Donors|unrelated donors
372272|NCT01549665|Cord Blood Stem Cell Transplantation|cord blood stem cell transplantation
372273|NCT01549639|Propofol|propofol
372274|NCT01549639|Target controlled infusion|target controlled infusion
372275|NCT01549639|General anaesthesia|general anaesthesia
372276|NCT01549626|Flaxseed|flaxseed
372277|NCT01549626|Women|women
372278|NCT01549626|Obesity|obesity
372279|NCT01549626|No smokers|no smokers
372280|NCT01549574|crizotinib|crizotinib
372281|NCT01549574|pharmacokinetics|pharmacokinetics
372282|NCT01549574|esomeprazole|esomeprazole
372283|NCT01549574|proton pump inhibitor|proton pump inhibitor
372284|NCT01549574|drug drug interaction|drug drug interaction
372285|NCT01549574|healthy volunteers|healthy volunteers
372286|NCT01549561|behavior problems|behavior problems
372287|NCT01549561|foster care|foster care
372288|NCT01549561|parent training|parent training
372289|NCT01549561|youth skills training|youth skills training
372290|NCT01549548|CML|cml
372291|NCT01549522|patients or caregivers|patients or caregivers
372292|NCT01549522|for caregivers, loved one must still be living|for caregivers, loved one must still be living
372293|NCT01549496|HCV|hcv
372294|NCT01549496|pharmacokinetics|pharmacokinetics
372295|NCT01549496|boceprevir|boceprevir
372296|NCT01549496|hypertension|hypertension
372297|NCT01549496|amlodipine|amlodipine
372298|NCT01549496|diltiazem|diltiazem
372299|NCT01549483|asthma|asthma
372300|NCT01549483|airway hyperresponsiveness|airway hyperresponsiveness
372301|NCT01549483|asymptomatic airway hyperresponsiveness|asymptomatic airway hyperresponsiveness
372302|NCT01549483|small airways|small airways
372303|NCT01549457|latent tuberculosis|latent tuberculosis
372304|NCT01549457|text message interventions|text message interventions
372305|NCT01549457|medication adherence|medication adherence
372307|NCT01549444|aldosterone|aldosterone
372308|NCT01549444|neonate|neonate
372309|NCT01549431|Multiple Myeloma|multiple myeloma
372310|NCT01549418|Gastrointestinal bleeding|gastrointestinal bleeding
372311|NCT01549418|Lower gastrointestinal bleeding (LGIB)|lower gastrointestinal bleeding (lgib)
372312|NCT01549418|Polypectomy|polypectomy
372313|NCT01549418|Large colorectal polyps|large colorectal polyps
372314|NCT01549418|ASA|asa
372315|NCT01549418|Aspirin|aspirin
372316|NCT01549418|Acetylsalicylic acid|acetylsalicylic acid
372317|NCT01549418|Colorectal Neoplasms|colorectal neoplasms
372318|NCT01549418|Intestinal Neoplasms|intestinal neoplasms
372319|NCT01549418|Gastrointestinal Neoplasms|gastrointestinal neoplasms
372320|NCT01549418|Digestive System Neoplasms|digestive system neoplasms
372321|NCT01549418|Neoplasms by Site|neoplasms by site
372322|NCT01549418|Neoplasms|neoplasms
372323|NCT01549418|Digestive System Diseases|digestive system diseases
372324|NCT01549418|Gastrointestinal Diseases|gastrointestinal diseases
372325|NCT01549418|Colonic Diseases|colonic diseases
372326|NCT01549418|Intestinal Diseases|intestinal diseases
372327|NCT01549418|Rectal Diseases|rectal diseases
372328|NCT01549405|percutanous nephrolitotomy,intercostal nerve block, Ultrasound|percutanous nephrolitotomy,intercostal nerve block, ultrasound
372329|NCT01549392|dynamic enhanced ct scan|dynamic enhanced ct scan
372330|NCT01549392|mri spectroscopy|mri spectroscopy
372331|NCT01549392|recurrent gliomas|recurrent gliomas
372332|NCT01549379|Head and neck cancer|head and neck cancer
372333|NCT01549379|Radiation|radiation
372334|NCT01549379|Chemotherapy|chemotherapy
372335|NCT01549379|Surgery|surgery
372336|NCT01549379|Dynamic contrast enhanced computed tomography|dynamic contrast enhanced computed tomography
372337|NCT01549340|Rhinitis|rhinitis
372338|NCT01549340|Allergen immunotherapy|allergen immunotherapy
372339|NCT01549327|Virtual Patient Navigation|virtual patient navigation
372340|NCT01549327|Randomized Clinical Trial|randomized clinical trial
372341|NCT01549327|Empowerment|empowerment
372342|NCT01549327|Cost-Effectiveness|cost-effectiveness
372343|NCT01549327|Cancer Information Preferences|cancer information preferences
372344|NCT01549314|Cystic fibrosis related bone disease|cystic fibrosis related bone disease
372345|NCT01549314|Cystic fibrosis|cystic fibrosis
372346|NCT01549314|Ivacaftor|ivacaftor
372347|NCT01549249|cone outer segment tips line|cone outer segment tips line
372348|NCT01549249|inner segment/outer segment junction line|inner segment/outer segment junction line
372349|NCT01549249|optical coherence tomography|optical coherence tomography
372350|NCT01549249|epiretinal membrane|epiretinal membrane
372351|NCT01549236|Chagas Disease|chagas disease
372352|NCT01549236|Trypanosoma Cruzi|trypanosoma cruzi
372353|NCT01549236|T.Cruzi|t.cruzi
372354|NCT01549223|Uterine Atony|uterine atony
372355|NCT01549223|Hypotension|hypotension
372356|NCT01549223|Cesarean Delivery|cesarean delivery
372357|NCT01549223|Hemorrhage|hemorrhage
372358|NCT01549223|Phenylephrine|phenylephrine
372359|NCT01549223|Ephedrine|ephedrine
372360|NCT01549210|gout|gout
372361|NCT01549210|gouty arthritis|gouty arthritis
372362|NCT01549197|PTSD|ptsd
372363|NCT01549184|secondary ITP|secondary itp
372364|NCT01549184|hydroxychloroquine|hydroxychloroquine
372365|NCT01549184|Systemic Lupus Erythematosus|systemic lupus erythematosus
372366|NCT01549171|Human ART|human art
372367|NCT01549171|Prostacyclin|prostacyclin
372368|NCT01549171|Iloprost|iloprost
372369|NCT01549171|Pregnancy|pregnancy
372370|NCT01549158|loop diuretics|loop diuretics
372371|NCT01549158|torasemide prolonged release|torasemide prolonged release
372372|NCT01549158|torasemide immediate release|torasemide immediate release
372373|NCT01549158|Sutril Neo|sutril neo
372374|NCT01549158|pharmacodynamic profile of Torasemide-PR|pharmacodynamic profile of torasemide-pr
372375|NCT01549145|Severe|severe
372376|NCT01549145|Ongoing|ongoing
372377|NCT01549145|Unilateral|unilateral
372378|NCT01549145|present for more than 6 months|present for more than 6 months
372379|NCT01549132|Clinically significant macular oedema|clinically significant macular oedema
372380|NCT01549132|Retinal Oximetry|retinal oximetry
372381|NCT01549132|Spectral imaging|spectral imaging
372382|NCT01549132|Retinal Laser therapy|retinal laser therapy
372383|NCT01549132|Intravitreal Anti-VEGF Injection therapy|intravitreal anti-vegf injection therapy
372384|NCT01549119|HIV-1|hiv-1
372385|NCT01549119|HIV|hiv
372386|NCT01549119|immunotherapy|immunotherapy
372387|NCT01549119|active immunotherapy|active immunotherapy
372388|NCT01549119|vaccine|vaccine
372389|NCT01549119|virulence|virulence
372390|NCT01549119|innate immunity|innate immunity
372391|NCT01549119|NK cells|nk cells
372392|NCT01549093|Non-small cell lung cancer|non-small cell lung cancer
372393|NCT01549093|Endostar|endostar
372394|NCT01549093|Continued Pumping into|continued pumping into
372395|NCT01549093|Gemcitabine|gemcitabine
372396|NCT01549093|Carboplatin|carboplatin
372397|NCT01549080|traditional chinese medicine and thalassemia|traditional chinese medicine and thalassemia
372398|NCT01549067|Advanced|advanced
372399|NCT01549067|Colorectal Cancer|colorectal cancer
372400|NCT01549067|Targeted chemotherapy|targeted chemotherapy
372401|NCT01549067|Surgery|surgery
372402|NCT01549067|Radiotherapy|radiotherapy
372403|NCT01549041|schizophrenia|schizophrenia
372404|NCT01549041|asenapine|asenapine
372405|NCT01549041|Once daily|once daily
372406|NCT01549041|twice daily|twice daily
372407|NCT01549015|Urea Cycle Defects|urea cycle defects
372408|NCT01549015|CPSD|cpsd
372409|NCT01549015|OTCD|otcd
372410|NCT01549015|ASSD|assd
372411|NCT01549015|ASLD|asld
372412|NCT01549002|Abscess|abscess
372413|NCT01549002|Pain|pain
372414|NCT01549002|Administration intranasal|administration intranasal
372415|NCT01549002|Infusions intravenous|infusions intravenous
372416|NCT01548989|linguistic validation of a new questionnaire|linguistic validation of a new questionnaire
372417|NCT01548976|linguistic validation of the PISQ-R questionnaire|linguistic validation of the pisq-r questionnaire
372418|NCT01548963|Tight glycemia control|tight glycemia control
372419|NCT01548963|Model Predictive Control algorithm|model predictive control algorithm
372420|NCT01548963|Cardiac surgery patients|cardiac surgery patients
372421|NCT01548950|Congenital heart disease|congenital heart disease
372422|NCT01548950|Pulmonary arterial hypertension|pulmonary arterial hypertension
372423|NCT01548950|Sildenafil|sildenafil
372424|NCT01548950|Bosentan|bosentan
372425|NCT01548950|Pediatric cardiac surgery|pediatric cardiac surgery
372426|NCT01548937|I-123 ADAM Serotonin transporter imaging|i-123 adam serotonin transporter imaging
372427|NCT01548924|Patients with malignant solid tumors of any histologically confirmed, not susceptible of cure, which have received the standard treatment available|patients with malignant solid tumors of any histologically confirmed, not susceptible of cure, which have received the standard treatment available
372428|NCT01548872|HTk solution|htk solution
372429|NCT01548872|Cardioplegia|cardioplegia
372430|NCT01548872|myocardial protection|myocardial protection
372431|NCT01548872|pediatric cardiac surgery|pediatric cardiac surgery
372432|NCT01548859|Myocardial protection|myocardial protection
372433|NCT01548859|Myocardial injury|myocardial injury
372434|NCT01548859|Anaesthetic preconditioning|anaesthetic preconditioning
372435|NCT01548859|Pediatric cardiac surgery|pediatric cardiac surgery
372436|NCT01548859|Troponin I|troponin i
372437|NCT01548859|Sevoflurane|sevoflurane
372438|NCT01548859|Midazolam|midazolam
372439|NCT01548846|tomotherapy|tomotherapy
372440|NCT01548846|xerostomy|xerostomy
372441|NCT01548846|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
372442|NCT01548833|Myopia|myopia
372443|NCT01548833|Contact Lenses|contact lenses
372444|NCT01548820|Hepatitis B virus|hepatitis b virus
372445|NCT01548820|Lamivudine|lamivudine
372446|NCT01548820|Resistance to treatment|resistance to treatment
372447|NCT01548794|spinal anesthesia|spinal anesthesia
372448|NCT01548794|bupivacaine|bupivacaine
372449|NCT01548794|lidocaine|lidocaine
372450|NCT01548794|local infiltration anesthesia|local infiltration anesthesia
372451|NCT01548794|recovery|recovery
372452|NCT01548794|duration of anesthesia|duration of anesthesia
372453|NCT01548794|outpatient herniorrhaphy|outpatient herniorrhaphy
372454|NCT01548781|arm|arm
372455|NCT01548781|strength|strength
372456|NCT01548781|coordination|coordination
372457|NCT01548781|physical therapy|physical therapy
372458|NCT01548781|robotics|robotics
372459|NCT01548781|stroke|stroke
372460|NCT01548781|synergy|synergy
372461|NCT01548768|Rheumatoid Arthritis|rheumatoid arthritis
372462|NCT01548768|Cardiovascular disease|cardiovascular disease
372463|NCT01548768|Myocardium|myocardium
372464|NCT01548768|TNF-alpha inhibitors|tnf-alpha inhibitors
372465|NCT01548768|ESCAPE|escape
372466|NCT01548768|Co-morbidities|co-morbidities
372467|NCT01548768|RHYTHM|rhythm
372468|NCT01548755|Home monitoring|home monitoring
372469|NCT01548755|cardiomessenger|cardiomessenger
372470|NCT01548755|ICD|icd
372471|NCT01548742|Meditation|meditation
372472|NCT01548729|Cystic Fibrosis|cystic fibrosis
372473|NCT01548729|Diabetes Related Cystic Fibrosis|diabetes related cystic fibrosis
372474|NCT01548729|Lung transplantation|lung transplantation
372475|NCT01548729|Pancreatic islets|pancreatic islets
372476|NCT01548716|Pruritis in hemodialysis patients|pruritis in hemodialysis patients
372477|NCT01548716|25-Vitamin D in chronic kidney disease|25-vitamin d in chronic kidney disease
372478|NCT01548703|metabotropic glutamate receptors 2 and 3|metabotropic glutamate receptors 2 and 3
372479|NCT01548703|antagonist|antagonist
372480|NCT01548703|mGluR|mglur
372481|NCT01548703|ketamine|ketamine
372482|NCT01548703|BDNF|bdnf
372483|NCT01548703|Depression|depression
372484|NCT01548703|Major Depressive Disorder|major depressive disorder
372485|NCT01548703|Treatment Resistant Depression|treatment resistant depression
372486|NCT01548703|Mood Disorder|mood disorder
372487|NCT01548703|Phase 1 safety, tolerability and pharmacokinetics study|phase 1 safety, tolerability and pharmacokinetics study
372488|NCT01548690|ornithine|ornithine
372489|NCT01548690|phenylacetate|phenylacetate
372490|NCT01548690|acetaminophen toxicity|acetaminophen toxicity
372491|NCT01548690|acute liver failure|acute liver failure
372492|NCT01548690|hepatitis B|hepatitis b
372493|NCT01548690|autoimmune hepatitis|autoimmune hepatitis
372494|NCT01548690|drug-induced liver injury|drug-induced liver injury
372495|NCT01548677|Circulating Tumour Cells|circulating tumour cells
372496|NCT01548677|HER2 negative primary breast cancer|her2 negative primary breast cancer
372497|NCT01548677|HER2 positive CTC|her2 positive ctc
372498|NCT01548677|Trastuzumab|trastuzumab
372499|NCT01548664|Total knee replacement|total knee replacement
372500|NCT01548664|Outpatient|outpatient
372501|NCT01548664|Randomized controlled trial|randomized controlled trial
372502|NCT01548664|Video games|video games
372503|NCT01548638|Tobacco|tobacco
372504|NCT01548638|Smoking|smoking
372505|NCT01548638|Galantamine|galantamine
372506|NCT01548625|risk of cardiovascular events|risk of cardiovascular events
372507|NCT01548612|Schizophrenia|schizophrenia
372508|NCT01548612|Nitric oxide|nitric oxide
372509|NCT01548612|Sodium nitroprusside|sodium nitroprusside
372510|NCT01548599|HIV|hiv
372511|NCT01548599|Malnutrition|malnutrition
372512|NCT01548599|Food Security|food security
372513|NCT01548599|Kenya|kenya
372514|NCT01548586|tDCS|tdcs
372515|NCT01548586|Diaphragm|diaphragm
372516|NCT01548586|Cortical Excitability|cortical excitability
372517|NCT01548586|MEPs|meps
372518|NCT01548586|TMS|tms
372519|NCT01548573|multiple myeloma|multiple myeloma
372520|NCT01548573|POEMS (Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes)|poems (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes)
372521|NCT01548573|amyloidosis|amyloidosis
372522|NCT01548573|bone marrow transplant|bone marrow transplant
372523|NCT01548573|autologous|autologous
372524|NCT01548560|HIV Infections|hiv infections
372525|NCT01548560|Anti-HIV agents|anti-hiv agents
372526|NCT01548560|HIV-1|hiv-1
372527|NCT01548547|intravenous line|intravenous line
372528|NCT01548547|simulation education|simulation education
372529|NCT01548534|Metastatic Breast Cancer|metastatic breast cancer
372530|NCT01548534|First-Line chemotherapy|first-line chemotherapy
372531|NCT01548534|Taxane or Anthracycline|taxane or anthracycline
372532|NCT01548534|DHA|dha
372533|NCT01548534|PUFA|pufa
372534|NCT01548534|Dietary supplementation|dietary supplementation
372535|NCT01548534|First-Line Taxane or Anthracycline based chemotherapy|first-line taxane or anthracycline based chemotherapy
372536|NCT01548521|Prader-Willi, neonates, poor suckling|prader-willi, neonates, poor suckling
372537|NCT01548508|Advanced Chronic Heart Failure, physical therapy, Exercise|advanced chronic heart failure, physical therapy, exercise
372538|NCT01548495|MDS|mds
372539|NCT01548495|Autoantibodies|autoantibodies
372540|NCT01548495|Erythropoietin|erythropoietin
372541|NCT01548495|Autoantibodies in MDS patients treated with EPO|autoantibodies in mds patients treated with epo
372542|NCT01548469|Mild periodontitis|mild periodontitis
372543|NCT01548469|Bio Mineral toothpaste|bio mineral toothpaste
372544|NCT01548469|Geumjin Thermal Water|geumjin thermal water
372545|NCT01548456|femur fracture|femur fracture
372546|NCT01548456|internal fixation|internal fixation
372547|NCT01548456|intramedullary nailing|intramedullary nailing
372548|NCT01548443|Wound Healing|wound healing
372549|NCT01548443|hydrocolloid|hydrocolloid
372550|NCT01548443|Wound Dressing|wound dressing
372551|NCT01548443|Medifoam H|medifoam h
372552|NCT01548443|Duoderm THIN|duoderm thin
372553|NCT01548443|Mild Acute Trauma|mild acute trauma
372554|NCT01548417|Alcohol|alcohol
372555|NCT01548417|Relapse|relapse
372556|NCT01548378|HGF|hgf
372557|NCT01548378|Gene|gene
372558|NCT01548378|Critical Limb Ischemia|critical limb ischemia
372559|NCT01548365|Nursing Services|nursing services
372560|NCT01548365|Catheterization, Central Venous|catheterization, central venous
372561|NCT01548365|Catheters Indwelling|catheters indwelling
372562|NCT01548365|Catheterization, Peripheral|catheterization, peripheral
372563|NCT01548352|Syncope|syncope
372564|NCT01548352|Unconsciousness|unconsciousness
372565|NCT01548352|Syncope, vasovagal, neurally-mediated|syncope, vasovagal, neurally-mediated
372566|NCT01548352|Syncope, cardiogenic|syncope, cardiogenic
372567|NCT01548352|Cardiac arrhythmia|cardiac arrhythmia
372568|NCT01548352|Sudden cardiac death|sudden cardiac death
372569|NCT01548352|Syncopal episode|syncopal episode
372570|NCT01548326|Vaccination Failure|vaccination failure
372571|NCT01548326|Nonresponder|nonresponder
372572|NCT01548326|Hepatitis B virus|hepatitis b virus
372573|NCT01548326|Atorvastatin|atorvastatin
372574|NCT01548326|Immunization against viral Hepatitis|immunization against viral hepatitis
372575|NCT01548313|human milk|human milk
372576|NCT01548313|nutrition|nutrition
372577|NCT01548313|breastfed child|breastfed child
372578|NCT01548313|microbiota|microbiota
372579|NCT01548313|fatty acids|fatty acids
372580|NCT01548313|intestinal microbiota|intestinal microbiota
372581|NCT01548313|probiotics|probiotics
372582|NCT01548300|cardiometabolic disease|cardiometabolic disease
372583|NCT01548287|Mild Cognitive Impairment|mild cognitive impairment
372584|NCT01548287|Mild Alzheimer's disease|mild alzheimer's disease
372585|NCT01548287|Safety|safety
372586|NCT01548287|Tolerability|tolerability
372587|NCT01548274|endothelial progenitor cells|endothelial progenitor cells
372588|NCT01548261|obtain the oral mucosal tissue from healthy donors|obtain the oral mucosal tissue from healthy donors
372589|NCT01548222|type 2 diabetes|type 2 diabetes
372590|NCT01548222|continuous glucose|continuous glucose
372591|NCT01548222|basal insulin|basal insulin
372592|NCT01548196|nephrolithotomy|nephrolithotomy
372593|NCT01548170|Pharmacokinetic|pharmacokinetic
372594|NCT01548170|Sunitinib|sunitinib
372595|NCT01548170|Ketoconazol|ketoconazol
372596|NCT01548170|interaction, Phase I|interaction, phase i
372597|NCT01548157|HCP1007|hcp1007
372598|NCT01548157|Rosuvastatin|rosuvastatin
372599|NCT01548157|Omega-3|omega-3
372600|NCT01548144|Advanced Cancers|advanced cancers
372601|NCT01548144|Advanced Malignancies|advanced malignancies
372602|NCT01548144|Crizotinib|crizotinib
372603|NCT01548144|PF-02341066|pf-02341066
372604|NCT01548144|Pazopanib|pazopanib
372605|NCT01548144|Gw786034|gw786034
372606|NCT01548144|Pemetrexed|pemetrexed
372607|NCT01548144|LY231514|ly231514
372608|NCT01548144|Alimta|alimta
372609|NCT01548144|MTA|mta
372610|NCT01548144|Multitargeted Antifolate|multitargeted antifolate
372611|NCT01548144|NSC-698037|nsc-698037
372612|NCT01548131|fear of childbirth|fear of childbirth
372613|NCT01548131|delivery mode|delivery mode
372614|NCT01548131|delivery satisfaction|delivery satisfaction
372615|NCT01548118|Human papillomavirus|human papillomavirus
372616|NCT01548118|vaccine|vaccine
372617|NCT01548118|cervical infection|cervical infection
372618|NCT01548118|cervical cancer|cervical cancer
372619|NCT01548105|Pelvic organ prolapse|pelvic organ prolapse
372620|NCT01548105|smoking and collagen metabolism|smoking and collagen metabolism
372621|NCT01548092|Recto-vaginal fistula|recto-vaginal fistula
372622|NCT01548092|Adipose Derived Stem Cells|adipose derived stem cells
372623|NCT01548079|ursodeoxycholic acid|ursodeoxycholic acid
372624|NCT01548079|fatty liver disease|fatty liver disease
372625|NCT01548079|morbid obesity|morbid obesity
372626|NCT01548079|bariatric surgery|bariatric surgery
372627|NCT01548079|NAFLD|nafld
372628|NCT01548053|Primary care|primary care
372629|NCT01548053|Dementia|dementia
372630|NCT01548053|Knowledge translation|knowledge translation
372631|NCT01548053|Quality of care|quality of care
372632|NCT01548053|Qualitative methods|qualitative methods
372633|NCT01548053|Alzheimer's disease|alzheimer's disease
372634|NCT01548040|NMES|nmes
372635|NCT01548040|Muscle|muscle
372636|NCT01548040|strength|strength
372637|NCT01548040|TKA|tka
372638|NCT01548040|Focus to show shorter muscle recovery after Knee operation|focus to show shorter muscle recovery after knee operation
372639|NCT01548027|TAP block|tap block
372640|NCT01548027|postoperative analgesia|postoperative analgesia
372641|NCT01548014|Crohn's disease|crohn's disease
372642|NCT01548014|VSL #3|vsl #3
372643|NCT01548014|infliximab|infliximab
372644|NCT01548001|Rheumatoid Arthritis|rheumatoid arthritis
372645|NCT01548001|Iguratimod|iguratimod
372646|NCT01548001|Methotrexate|methotrexate
372647|NCT01547988|Aging|aging
372648|NCT01547988|Falls|falls
372649|NCT01547988|Balance Control|balance control
372650|NCT01547988|Voluntary Step Execution Test|voluntary step execution test
372651|NCT01547988|Dual-Task|dual-task
372652|NCT01547988|Self-reported function|self-reported function
372653|NCT01547975|surgical outcomes after corneal transplantation|surgical outcomes after corneal transplantation
372654|NCT01547975|Retrospective analysis|retrospective analysis
372655|NCT01547975|corneal transplantation|corneal transplantation
372656|NCT01547949|pain|pain
372657|NCT01547949|inflammation|inflammation
372658|NCT01547949|muscle damage|muscle damage
372659|NCT01547923|Colorectal Cancer|colorectal cancer
372660|NCT01547923|DihydroPyrimidine Dehydrogenase|dihydropyrimidine dehydrogenase
372661|NCT01547923|Lethal toxicity|lethal toxicity
372662|NCT01547923|Fluoropyrimidine|fluoropyrimidine
372663|NCT01547910|fatty liver|fatty liver
372664|NCT01547910|hepatitis|hepatitis
372665|NCT01547910|insulin resistance|insulin resistance
372666|NCT01547910|unsaturated fatty acids|unsaturated fatty acids
372667|NCT01547910|NAFLD, children|nafld, children
372668|NCT01547884|Immune Responses|immune responses
372669|NCT01547884|Mycobacterial Antigens|mycobacterial antigens
372670|NCT01547884|Tissue-invasive Helminth Parasites|tissue-invasive helminth parasites
372671|NCT01547871|Natural History Study|natural history study
372800|NCT01547468|Ochsner Clinic|ochsner clinic
372672|NCT01547871|Spinal Muscular Atrophy (SMA)|spinal muscular atrophy (sma)
372673|NCT01547871|Natural History|natural history
372674|NCT01547858|Hematotoxicity|hematotoxicity
372675|NCT01547858|Formaldehyde|formaldehyde
372676|NCT01547858|Cross-Sectional Study|cross-sectional study
372677|NCT01547858|Occupational Exposure|occupational exposure
372678|NCT01547845|Disparities|disparities
372679|NCT01547845|Patient Reported Outcomes|patient reported outcomes
372680|NCT01547845|Symptoms|symptoms
372681|NCT01547845|Symptom Surveillance|symptom surveillance
372682|NCT01547832|Cholesterol|cholesterol
372683|NCT01547832|Early Onset Parkinson's Disease|early onset parkinson's disease
372684|NCT01547832|Fat Metabolism|fat metabolism
372685|NCT01547832|Insulin Resistance|insulin resistance
372686|NCT01547832|PARK2 Mutations|park2 mutations
372687|NCT01547819|TBI|tbi
372688|NCT01547819|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
372689|NCT01547819|PTSD|ptsd
372690|NCT01547819|PET Imaging|pet imaging
372691|NCT01547819|11C-Flumazenil|11c-flumazenil
372692|NCT01547806|Autologous Hematopoietic Cell Transplantation|autologous hematopoietic cell transplantation
372693|NCT01547806|Plasma Cell Myeloma|plasma cell myeloma
372694|NCT01547806|Mobilization|mobilization
372695|NCT01547806|Apheresis|apheresis
372696|NCT01547806|Plerixafor|plerixafor
372697|NCT01547793|Hemolytic Severity|hemolytic severity
372698|NCT01547793|Erythrocyte|erythrocyte
372699|NCT01547793|Sickle Cell Disease|sickle cell disease
372700|NCT01547793|SD|sd
372701|NCT01547780|MRI|mri
372702|NCT01547780|Positron Emission Tomograhy (PET)|positron emission tomograhy (pet)
372703|NCT01547780|Inflammation|inflammation
372704|NCT01547780|Microglial Activation|microglial activation
372705|NCT01547780|Traumatic Brain Injury|traumatic brain injury
372706|NCT01547780|TBI|tbi
372707|NCT01547767|Metabolism|metabolism
372708|NCT01547767|Muscle|muscle
372709|NCT01547767|Mutation|mutation
372710|NCT01547767|ISCU Myopathy|iscu myopathy
372711|NCT01547767|Myopathy|myopathy
372712|NCT01547754|Neuroinflammation|neuroinflammation
372713|NCT01547754|HIV|hiv
372714|NCT01547754|Positron Emission Tomograhy (PET)|positron emission tomograhy (pet)
372715|NCT01547754|Mild Neurocognitive Disorder|mild neurocognitive disorder
372716|NCT01547754|P-Glycoprotein|p-glycoprotein
372717|NCT01547754|Mild Cognitive Disorder|mild cognitive disorder
372718|NCT01547754|Healthy Volunteer|healthy volunteer
372719|NCT01547754|HV|hv
372720|NCT01547741|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
372721|NCT01547741|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
372722|NCT01547741|HER2-negative breast cancer|her2-negative breast cancer
372723|NCT01547741|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
372724|NCT01547741|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
372725|NCT01547741|stage IA breast cancer|stage ia breast cancer
372726|NCT01547741|stage IB breast cancer|stage ib breast cancer
372727|NCT01547741|stage II breast cancer|stage ii breast cancer
372728|NCT01547741|stage IIIA breast cancer|stage iiia breast cancer
372729|NCT01547741|stage IIIC breast cancer|stage iiic breast cancer
372730|NCT01547728|antithrombin|antithrombin
372731|NCT01547728|Heparin Resistant|heparin resistant
372732|NCT01547728|Cardiac Surgery|cardiac surgery
372733|NCT01547715|Meningococcal,|meningococcal,
372734|NCT01547715|ACWY,|acwy,
372735|NCT01547715|bacterial meningitis,|bacterial meningitis,
372736|NCT01547715|conjugate vaccine,|conjugate vaccine,
372737|NCT01547715|healthy, children,|healthy, children,
372738|NCT01547715|adolescents,|adolescents,
372739|NCT01547715|adults,|adults,
372740|NCT01547715|India|india
372741|NCT01547702|ADHD|adhd
372742|NCT01547702|attention|attention
372743|NCT01547702|inattention|inattention
372744|NCT01547702|hyperactivity|hyperactivity
372745|NCT01547702|classroom intervention|classroom intervention
372746|NCT01547702|teacher education|teacher education
372747|NCT01547702|web-based intervention|web-based intervention
372748|NCT01547663|pain scale|pain scale
372749|NCT01547663|craniotomy|craniotomy
372750|NCT01547637|Obturator nerve block|obturator nerve block
372751|NCT01547637|Regional anesthesia|regional anesthesia
372752|NCT01547637|TURBT|turbt
372753|NCT01547624|Neck|neck
372754|NCT01547624|Spine|spine
372755|NCT01547624|Muscles|muscles
372756|NCT01547624|Activity|activity
372757|NCT01547624|Coordination|coordination
372758|NCT01547611|Rehabilitation|rehabilitation
372759|NCT01547611|Cervical Spine|cervical spine
372760|NCT01547611|Radiculopathy|radiculopathy
372761|NCT01547611|Disc|disc
372762|NCT01547611|Surgery|surgery
372763|NCT01547585|Cholesterol|cholesterol
372764|NCT01547585|Cardiovascular disease|cardiovascular disease
372765|NCT01547585|Soy|soy
372766|NCT01547585|Dose-response|dose-response
372767|NCT01547572|Video education|video education
372768|NCT01547572|Enhanced recovery|enhanced recovery
372769|NCT01547572|Reducing hospital stay|reducing hospital stay
372770|NCT01547572|Improving patient satisfaction|improving patient satisfaction
372771|NCT01547533|Chagas disease|chagas disease
372772|NCT01547533|lactation|lactation
372773|NCT01547533|breastmilk|breastmilk
372774|NCT01547533|postpartum period|postpartum period
372775|NCT01547533|infants|infants
372776|NCT01547533|pediatric clinical pharmacology|pediatric clinical pharmacology
372777|NCT01547533|developmental clinical pharmacology|developmental clinical pharmacology
372778|NCT01547533|parasitology|parasitology
372779|NCT01547533|trypanosoma cruzi|trypanosoma cruzi
372780|NCT01547520|meperidine|meperidine
372781|NCT01547520|esophagogastroduodenoscopy|esophagogastroduodenoscopy
372782|NCT01547520|unsedated|unsedated
372783|NCT01547520|minimal sedation|minimal sedation
372784|NCT01547507|hemodynamics|hemodynamics
372785|NCT01547507|respiratory|respiratory
372786|NCT01547494|Migraines|migraines
372787|NCT01547494|Diet, Vegetarian|diet, vegetarian
372788|NCT01547494|Diet, Fat-Restricted|diet, fat-restricted
372789|NCT01547494|Pain|pain
372790|NCT01547468|hip fracture|hip fracture
372791|NCT01547468|elderly|elderly
372792|NCT01547468|delirium|delirium
372793|NCT01547468|broken hip|broken hip
372794|NCT01547468|hip|hip
372795|NCT01547468|surgery|surgery
372796|NCT01547468|orthopedic|orthopedic
372797|NCT01547468|orthopedic surgery|orthopedic surgery
372798|NCT01547468|pain|pain
372799|NCT01547468|anesthesia|anesthesia
372801|NCT01547468|Ochsner Hospital|ochsner hospital
372802|NCT01547468|Leslie Thomas MD|leslie thomas md
372803|NCT01547468|New Orleans|new orleans
372804|NCT01547468|Louisiana|louisiana
372805|NCT01547455|Statin|statin
372806|NCT01547455|kidney function|kidney function
372807|NCT01547455|antiinflammatory effect|antiinflammatory effect
372808|NCT01547442|aphakia|aphakia
372809|NCT01547442|secondary intraocular lens|secondary intraocular lens
372810|NCT01547442|congenital cataract|congenital cataract
372811|NCT01547442|marfan syndrome|marfan syndrome
372812|NCT01547442|pediatric cataract|pediatric cataract
372813|NCT01547442|ectopia lentis|ectopia lentis
372814|NCT01547442|subluxated lens|subluxated lens
372815|NCT01547429|aphakia|aphakia
372816|NCT01547429|secondary intraocular lens|secondary intraocular lens
372817|NCT01547416|Diaphragmatic dysfunction|diaphragmatic dysfunction
372818|NCT01547416|General anesthesia|general anesthesia
372819|NCT01547416|Epidural Anesthesia|epidural anesthesia
372820|NCT01547403|Screening for Type 2 Diabetes|screening for type 2 diabetes
372821|NCT01547390|preeclampsia|preeclampsia
372822|NCT01547390|Aspirin|aspirin
372823|NCT01547377|atherosclerosis|atherosclerosis
372824|NCT01547377|zinc and selenium status|zinc and selenium status
372825|NCT01547377|rosuvastatin|rosuvastatin
372826|NCT01547377|oxidative stress biomarkers|oxidative stress biomarkers
372827|NCT01547377|inflammation biomarkers|inflammation biomarkers
372828|NCT01547364|Caudal|caudal
372829|NCT01547364|Epidural|epidural
372830|NCT01547364|Dextrose|dextrose
372831|NCT01547364|Analgesia|analgesia
372832|NCT01547364|TRVP1|trvp1
372833|NCT01547351|Relapse in multiple sclerosis|relapse in multiple sclerosis
372834|NCT01547351|Psychometric properties of the patient self-report questionnaire|psychometric properties of the patient self-report questionnaire
372835|NCT01547351|Evaluation of ARMS questionnaire|evaluation of arms questionnaire
372836|NCT01547338|Breast|breast
372837|NCT01547338|Reconstruction|reconstruction
372838|NCT01547299|prostate cancer|prostate cancer
372839|NCT01547299|prostatectomy|prostatectomy
372840|NCT01547299|neoadjuvant|neoadjuvant
372841|NCT01547286|Asthma|asthma
372842|NCT01547286|Allergen Challenge|allergen challenge
372843|NCT01547286|Cat allergen|cat allergen
372844|NCT01547286|Dust mite allergen|dust mite allergen
372845|NCT01547286|Airway Hyper-responsiveness|airway hyper-responsiveness
372846|NCT01547286|Positron Emission Tomography - Computed Tomography|positron emission tomography - computed tomography
372847|NCT01547286|Nitrogen isotopes|nitrogen isotopes
372848|NCT01547286|Blood flow|blood flow
372849|NCT01547247|colonoscopy|colonoscopy
372850|NCT01547247|cap-assisted colonoscopy|cap-assisted colonoscopy
372851|NCT01547247|water immersion colonoscopy|water immersion colonoscopy
372852|NCT01547234|Multiple Sclerosis|multiple sclerosis
372853|NCT01547234|ambulation|ambulation
372854|NCT01547234|manual function|manual function
372855|NCT01547234|Fampridine|fampridine
372856|NCT01547221|otomycosis|otomycosis
372857|NCT01547221|3% boric acid|3% boric acid
372858|NCT01547221|1% clotrimazole ear drop|1% clotrimazole ear drop
372859|NCT01547208|ICD shocks|icd shocks
372860|NCT01547208|Ventricular tachycardias ablation|ventricular tachycardias ablation
372861|NCT01547208|Timing of ablation|timing of ablation
372862|NCT01547208|Electrical storm|electrical storm
372863|NCT01547208|Arrhythmic storm|arrhythmic storm
372864|NCT01547195|fibromyalgia|fibromyalgia
372865|NCT01547195|swimming|swimming
372866|NCT01547169|memory|memory
372867|NCT01547169|intranasal insulin|intranasal insulin
372868|NCT01547169|Alzheimer's disease|alzheimer's disease
372869|NCT01547156|patient decision support|patient decision support
372870|NCT01547156|telemonitoring|telemonitoring
372871|NCT01547156|self-management|self-management
372872|NCT01547156|remote patient monitoring|remote patient monitoring
372873|NCT01547156|active assistance technology|active assistance technology
372874|NCT01547156|selfcare|selfcare
372875|NCT01547143|Secondary hemophagocytic lymphohistiocytosis of adults|secondary hemophagocytic lymphohistiocytosis of adults
372876|NCT01547130|Colonoscopy|colonoscopy
372877|NCT01547130|Yoga|yoga
372878|NCT01547130|Complementary and alternative medicine|complementary and alternative medicine
372879|NCT01547130|Bowel cleansing|bowel cleansing
372880|NCT01547130|Large bowel preparation|large bowel preparation
372881|NCT01547130|Cancer screening|cancer screening
372882|NCT01547130|Colorectal cancer|colorectal cancer
372883|NCT01547117|POTS|pots
372884|NCT01547117|Orthostatic Intolerance|orthostatic intolerance
372885|NCT01547117|Orthostatic Tachycardia|orthostatic tachycardia
372886|NCT01547091|Mesenchymal Stem Cells|mesenchymal stem cells
372887|NCT01547091|Rheumatoid Arthritis|rheumatoid arthritis
372888|NCT01547065|TEE and renal resistive index|tee and renal resistive index
372889|NCT01547052|DBT, child, emotion regulation, behavior problems, residential care|dbt, child, emotion regulation, behavior problems, residential care
372890|NCT01547039|Carotid endarterectomy|carotid endarterectomy
372891|NCT01547039|Transcranial doppler|transcranial doppler
372892|NCT01547039|Micro embolic signals|micro embolic signals
372893|NCT01547039|Platelets|platelets
372894|NCT01547039|Aspirin|aspirin
372895|NCT01547026|schizophrenia|schizophrenia
372896|NCT01547026|exercise|exercise
372897|NCT01547026|sport|sport
372898|NCT01547026|weight control|weight control
372899|NCT01547026|fitness|fitness
372900|NCT01547000|Tourette Syndrome|tourette syndrome
372901|NCT01547000|Tourette Disorder|tourette disorder
372902|NCT01547000|Tics|tics
372903|NCT01547000|Motor tics|motor tics
372904|NCT01547000|Vocal tics|vocal tics
372905|NCT01547000|Intuniv|intuniv
372906|NCT01547000|Guanfacine|guanfacine
372907|NCT01547000|Medication|medication
372908|NCT01547000|Drug|drug
372909|NCT01547000|Placebo|placebo
372910|NCT01547000|Child|child
372911|NCT01547000|Children|children
372912|NCT01547000|Adolescent|adolescent
372913|NCT01546987|adenocarcinoma of the prostate|adenocarcinoma of the prostate
372914|NCT01546987|stage I prostate cancer|stage i prostate cancer
372915|NCT01546987|stage IIA prostate cancer|stage iia prostate cancer
372916|NCT01546987|stage IIB prostate cancer|stage iib prostate cancer
372917|NCT01546987|stage III prostate cancer|stage iii prostate cancer
372918|NCT01546987|stage IV prostate cancer|stage iv prostate cancer
372919|NCT01546974|Mechanical Ventilation|mechanical ventilation
372920|NCT01546974|Humidification system|humidification system
372921|NCT01546974|Patients submitted to mechanical ventilation for at least 48 hours|patients submitted to mechanical ventilation for at least 48 hours
372922|NCT01546961|Chloroquine|chloroquine
372923|NCT01546961|Uncomplicated vivax malaria|uncomplicated vivax malaria
372924|NCT01546948|Methadone|methadone
372925|NCT01546948|Hydromorphone|hydromorphone
373121|NCT01545947|Neoplasms|neoplasms
372926|NCT01546948|Hepatobiliary surgery|hepatobiliary surgery
372927|NCT01546948|Postoperative pain|postoperative pain
372928|NCT01546935|Influenza|influenza
372929|NCT01546935|Oseltamivir|oseltamivir
372930|NCT01546935|Lower tract respiratory infection|lower tract respiratory infection
372931|NCT01546922|Hydrocortisone|hydrocortisone
372932|NCT01546922|Cognition|cognition
372933|NCT01546922|Adrenal insufficiency|adrenal insufficiency
372934|NCT01546922|Quality of Life|quality of life
372935|NCT01546922|Common Somatic Complaints|common somatic complaints
372936|NCT01546922|Cardiovascular/Metabolic Profile|cardiovascular/metabolic profile
372937|NCT01546922|Somatosensation|somatosensation
372938|NCT01546883|Atrial fibrillation|atrial fibrillation
372939|NCT01546883|MRI|mri
372940|NCT01546857|orthopedic pain|orthopedic pain
372941|NCT01546844|SMS|sms
372942|NCT01546844|text|text
372943|NCT01546844|text messages|text messages
372944|NCT01546844|text messaging|text messaging
372945|NCT01546844|diabetes|diabetes
372946|NCT01546844|diabetes mellitus|diabetes mellitus
372947|NCT01546844|type II diabetes|type ii diabetes
372948|NCT01546844|type II diabetes mellitus|type ii diabetes mellitus
372949|NCT01546844|type 2 diabetes|type 2 diabetes
372950|NCT01546844|type 2 diabetes mellitus|type 2 diabetes mellitus
372951|NCT01546844|Beacon|beacon
372952|NCT01546818|HIV|hiv
372953|NCT01546818|Vaccine|vaccine
372954|NCT01546818|HIV-1 infections|hiv-1 infections
372955|NCT01546805|Blepharospasm|blepharospasm
372956|NCT01546805|Hemifacial spasm|hemifacial spasm
372957|NCT01546805|Botox|botox
372958|NCT01546805|Zinc|zinc
372959|NCT01546792|exercise|exercise
372960|NCT01546792|diet|diet
372961|NCT01546792|lifestyle|lifestyle
372962|NCT01546792|sleep apnoea|sleep apnoea
372963|NCT01546792|obesity|obesity
372964|NCT01546766|Diabetes|diabetes
372965|NCT01546766|Pupillary response|pupillary response
372966|NCT01546766|Retinal disorders|retinal disorders
372967|NCT01546766|Midperipheral ischemia|midperipheral ischemia
372968|NCT01546766|Fundus photography|fundus photography
372969|NCT01546766|Optical coherence tomography|optical coherence tomography
372970|NCT01546753|Walnut hypersensitivity|walnut hypersensitivity
372971|NCT01546753|Tree nut hypersensitivity|tree nut hypersensitivity
372972|NCT01546753|Oral immunotherapy|oral immunotherapy
372973|NCT01546753|Food allergy|food allergy
372974|NCT01546753|Walnut allergy|walnut allergy
372975|NCT01546753|tree nut allergy|tree nut allergy
372976|NCT01546740|Glaucoma, Compliance, Prevalence|glaucoma, compliance, prevalence
372977|NCT01546727|Preschoolers|preschoolers
372978|NCT01546727|Obesity|obesity
372979|NCT01546727|Behavioral Treatment|behavioral treatment
372980|NCT01546675|Amputation|amputation
372981|NCT01546675|Prosthesis Design|prosthesis design
372982|NCT01546675|Biomechanics|biomechanics
372983|NCT01546662|Rhinitis|rhinitis
372984|NCT01546636|Cerebral desaturation events|cerebral desaturation events
372985|NCT01546636|Cerebral oximetry|cerebral oximetry
372986|NCT01546636|Beach chair position|beach chair position
372987|NCT01546610|Rheumatoid foot|rheumatoid foot
372988|NCT01546610|foot pain|foot pain
372989|NCT01546610|insoles|insoles
372990|NCT01546610|foot function|foot function
372991|NCT01546610|electronic baropodometer|electronic baropodometer
372992|NCT01546610|plantar pressure|plantar pressure
372993|NCT01546610|gait analysis|gait analysis
372994|NCT01546597|Metformin|metformin
372995|NCT01546597|Ranolazine|ranolazine
372996|NCT01546597|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
372997|NCT01546558|Metformin|metformin
372998|NCT01546558|Ranolazine|ranolazine
372999|NCT01546558|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
373000|NCT01546532|Heart failure|heart failure
373001|NCT01546532|RLX030|rlx030
373002|NCT01546532|hemodynamics|hemodynamics
373003|NCT01546532|cardiovascular diseases|cardiovascular diseases
373004|NCT01546480|Chronic postoperative pain|chronic postoperative pain
373005|NCT01546480|Postcholecystectomy pain|postcholecystectomy pain
373006|NCT01546480|Inflammation|inflammation
373007|NCT01546480|Interleukines|interleukines
373008|NCT01546467|Schizophrenia|schizophrenia
373009|NCT01546467|Schizoaffective disorder|schizoaffective disorder
373010|NCT01546467|Psychosis|psychosis
373011|NCT01546467|Early phase|early phase
373012|NCT01546467|Cognitive remediation|cognitive remediation
373013|NCT01546467|Functional outcome|functional outcome
373014|NCT01546454|Premenopausal women|premenopausal women
373015|NCT01546454|coronary heart disease|coronary heart disease
373016|NCT01546454|menstrual cycle|menstrual cycle
373017|NCT01546454|lipids|lipids
373018|NCT01546441|primary care|primary care
373019|NCT01546441|aging|aging
373020|NCT01546441|interprofessional care|interprofessional care
373021|NCT01546441|multimorbidity|multimorbidity
373022|NCT01546428|c-MET|c-met
373023|NCT01546428|Advanced solid tumor|advanced solid tumor
373024|NCT01546415|Phase 4|phase 4
373025|NCT01546415|Desferasirox|desferasirox
373026|NCT01546415|Iron Overload|iron overload
373027|NCT01546415|Aplastic Anemia|aplastic anemia
373120|NCT01545986|Power training|power training
373028|NCT01546389|Malaria, vaccine, PfSPZ, challenge|malaria, vaccine, pfspz, challenge
373029|NCT01546350|infertility, recurrent pregnancy loss, miscarriage|infertility, recurrent pregnancy loss, miscarriage
373030|NCT01546337|anemia|anemia
373031|NCT01546337|non-myeloid haemopathy|non-myeloid haemopathy
373032|NCT01546337|myelodysplastic syndrome|myelodysplastic syndrome
373033|NCT01546337|Erythropoiesis stimulating agents|erythropoiesis stimulating agents
373034|NCT01546337|predictive markers|predictive markers
373035|NCT01546324|Maternal Blood|maternal blood
373036|NCT01546324|PGD|pgd
373037|NCT01546324|PGS|pgs
373038|NCT01546324|Natera|natera
373039|NCT01546324|Gene Security Network|gene security network
373040|NCT01546324|Non-invasive prenatal diagnosis|non-invasive prenatal diagnosis
373041|NCT01546311|prosthetic socket|prosthetic socket
373042|NCT01546311|residual limb volume fluctuation|residual limb volume fluctuation
373043|NCT01546311|instantaneous bladder|instantaneous bladder
373044|NCT01546298|Contact Dermatitis|contact dermatitis
373045|NCT01546285|The focus of this study is to demonstrate that DINAMAP® SuperSTATTM NIBP algorithm has been implemented correctly without performance losses to the B40 monitor|the focus of this study is to demonstrate that dinamap® superstattm nibp algorithm has been implemented correctly without performance losses to the b40 monitor
373046|NCT01546272|Subcutaneous resorbable sutures|subcutaneous resorbable sutures
373047|NCT01546272|Tolerance / effectiveness of subcutaneous suture|tolerance / effectiveness of subcutaneous suture
373048|NCT01546272|Reduced operative time and anesthesia time|reduced operative time and anesthesia time
373049|NCT01546272|Medico-economic evaluation|medico-economic evaluation
373050|NCT01546272|Accidental exposure to blood|accidental exposure to blood
373051|NCT01546259|colonoscopy|colonoscopy
373052|NCT01546259|water|water
373053|NCT01546259|female|female
373054|NCT01546259|BMI|bmi
373055|NCT01546259|unsedated|unsedated
373056|NCT01546259|low BMI female patients|low bmi female patients
373057|NCT01546259|Intubation|intubation
373058|NCT01546246|colonoscopy|colonoscopy
373059|NCT01546246|water|water
373060|NCT01546246|incomplete|incomplete
373061|NCT01546246|failed|failed
373062|NCT01546246|unsedated|unsedated
373063|NCT01546233|Lung cancer|lung cancer
373064|NCT01546233|Chemotherapy|chemotherapy
373065|NCT01546233|Multidisciplinary self care programme|multidisciplinary self care programme
373066|NCT01546233|Fatigue|fatigue
373067|NCT01546220|colonoscopy|colonoscopy
373068|NCT01546220|elder patient|elder patient
373069|NCT01546220|water|water
373070|NCT01546220|unsedated|unsedated
373071|NCT01546207|ventricular tachycardia|ventricular tachycardia
373072|NCT01546207|catheter ablation|catheter ablation
373073|NCT01546207|VT|vt
373074|NCT01546194|Informed consent|informed consent
373075|NCT01546194|Perioperative period|perioperative period
373076|NCT01546194|Morning of surgery|morning of surgery
373077|NCT01546194|Anesthesiology|anesthesiology
373078|NCT01546181|photoreceptors|photoreceptors
373079|NCT01546181|retinal pigment epithelium|retinal pigment epithelium
373080|NCT01546181|adaptive optics|adaptive optics
373081|NCT01546168|Atrial Fibrillation ablation|atrial fibrillation ablation
373082|NCT01546168|Esophageal Deviation|esophageal deviation
373083|NCT01546168|AF|af
373084|NCT01546116|adefovir|adefovir
373085|NCT01546116|lamivudine|lamivudine
373086|NCT01546116|entecavir resistance|entecavir resistance
373087|NCT01546103|Vitamin D deficiency|vitamin d deficiency
373088|NCT01546090|Alprazolam|alprazolam
373089|NCT01546090|benzodiazepines|benzodiazepines
373090|NCT01546090|Inferior alveolar nerve block|inferior alveolar nerve block
373091|NCT01546090|irreversible pulpitis|irreversible pulpitis
373092|NCT01546090|local anesthesia|local anesthesia
373093|NCT01546064|Bile duct anastomosis|bile duct anastomosis
373094|NCT01546064|Biliary complications|biliary complications
373095|NCT01546051|metabotropic glutamate receptors 2 and 3|metabotropic glutamate receptors 2 and 3
373096|NCT01546051|antagonist|antagonist
373097|NCT01546051|mGluR|mglur
373098|NCT01546051|ketamine|ketamine
373099|NCT01546051|BDNF|bdnf
373100|NCT01546051|Depression|depression
373101|NCT01546051|Major Depressive Disorder|major depressive disorder
373102|NCT01546051|Mood Disorder|mood disorder
373103|NCT01546051|Treatment Resistant Depression|treatment resistant depression
373104|NCT01546051|Phase 1 safety, tolerability and pharmacokinetics study|phase 1 safety, tolerability and pharmacokinetics study
373105|NCT01546038|Hedgehog Inhibitor|hedgehog inhibitor
373106|NCT01546038|Acute Myeloid Leukemia|acute myeloid leukemia
373107|NCT01546038|Myelodysplastic syndrome|myelodysplastic syndrome
373108|NCT01546038|Intensive chemotherapy|intensive chemotherapy
373109|NCT01546038|LDAC|ldac
373110|NCT01546038|glasdegib|glasdegib
373111|NCT01545999|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
373112|NCT01545999|Dorsolateral Prefrontal Cortex (DLPFC)|dorsolateral prefrontal cortex (dlpfc)
373113|NCT01545999|Schizophrenia|schizophrenia
373114|NCT01545999|Working Memory|working memory
373115|NCT01545999|Paired Associative Stimulation (PAS)|paired associative stimulation (pas)
373116|NCT01545999|Electroencephalography (EEG)|electroencephalography (eeg)
373117|NCT01545999|Cognition|cognition
373118|NCT01545986|Joint Replacement|joint replacement
373119|NCT01545986|Exercise|exercise
373122|NCT01545947|Pulmonary|pulmonary
373123|NCT01545947|Lung Cancer|lung cancer
373124|NCT01545947|Cancer of the Lung|cancer of the lung
373125|NCT01545947|Stage IIIB Non-Small Cell Lung Cancer|stage iiib non-small cell lung cancer
373126|NCT01545947|IV Non-Small Cell Lung Cancer|iv non-small cell lung cancer
373127|NCT01545947|Non-Small Cell Lung Cancer|non-small cell lung cancer
373128|NCT01545934|Overweight|overweight
373129|NCT01545934|Obese|obese
373130|NCT01545934|Pregnancy|pregnancy
373131|NCT01545934|Weight Gain|weight gain
373132|NCT01545921|Quality Of Life|quality of life
373133|NCT01545921|Cancer|cancer
373134|NCT01545921|End of life|end of life
373135|NCT01545921|palliative setting|palliative setting
373136|NCT01545908|Fecal transplant|fecal transplant
373137|NCT01545908|induction of remission|induction of remission
373138|NCT01545908|active ulcerative colitis|active ulcerative colitis
373139|NCT01545882|prostate|prostate
373140|NCT01545882|hormone-resistant|hormone-resistant
373141|NCT01545882|degarelix|degarelix
373142|NCT01545882|firmagon|firmagon
373143|NCT01545882|anti-androgens|anti-androgens
373144|NCT01545882|total androgen blockade|total androgen blockade
373145|NCT01545882|injection|injection
373146|NCT01545869|carbon dioxide laser|carbon dioxide laser
373147|NCT01545869|fractional resurfacing|fractional resurfacing
373148|NCT01545869|freckles|freckles
373149|NCT01545869|melanosis|melanosis
373150|NCT01545856|Parkinson's Disease|parkinson's disease
373151|NCT01545856|cardiovascular events|cardiovascular events
373152|NCT01545856|Levodopa|levodopa
373153|NCT01545843|depression|depression
373154|NCT01545843|sleep|sleep
373155|NCT01545843|treatment|treatment
373156|NCT01545830|Metabolic syndrome|metabolic syndrome
373157|NCT01545830|Insulin resistance|insulin resistance
373158|NCT01545830|Vitamin D deficiency|vitamin d deficiency
373159|NCT01545817|Renal cell carcinoma|renal cell carcinoma
373160|NCT01545817|GW786034|gw786034
373161|NCT01545817|Everolimus|everolimus
373162|NCT01545817|Pazopanib|pazopanib
373163|NCT01545804|Hepatocellular carcinoma|hepatocellular carcinoma
373164|NCT01545778|Substance abuse detection|substance abuse detection
373165|NCT01545778|Opioids abuse|opioids abuse
373166|NCT01545778|Tapentadol immediate-release (IR)|tapentadol immediate-release (ir)
373167|NCT01545778|Oxycodone immediate-release (IR)|oxycodone immediate-release (ir)
373168|NCT01545765|Healthy volunteers|healthy volunteers
373169|NCT01545752|elearning|elearning
373170|NCT01545752|CD-based education|cd-based education
373171|NCT01545739|Pacemaker therapy|pacemaker therapy
373276|NCT01545531|cystatin C.|cystatin c.
373172|NCT01545739|Cardiac resynchronisation therapy (CRT)|cardiac resynchronisation therapy (crt)
373173|NCT01545726|Asthma|asthma
373174|NCT01545726|Sputum eosinophilia|sputum eosinophilia
373175|NCT01545726|CRTH2 receptor|crth2 receptor
373176|NCT01545726|PGD2 antagonist|pgd2 antagonist
373177|NCT01545713|renal|renal
373178|NCT01545713|kidney|kidney
373179|NCT01545713|transplant|transplant
373180|NCT01545713|living donor|living donor
373181|NCT01545700|dexamethasone|dexamethasone
373182|NCT01545700|hyperglycemia|hyperglycemia
373183|NCT01545700|gynecologic surgery|gynecologic surgery
373184|NCT01545687|pain|pain
373185|NCT01545687|oral complications of radiation therapy|oral complications of radiation therapy
373186|NCT01545687|weight changes|weight changes
373187|NCT01545687|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
373188|NCT01545687|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
373189|NCT01545687|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
373190|NCT01545687|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
373191|NCT01545687|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
373192|NCT01545687|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
373193|NCT01545687|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
373194|NCT01545687|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
373195|NCT01545687|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
373196|NCT01545687|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
373197|NCT01545687|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
373198|NCT01545687|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
373199|NCT01545687|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
373200|NCT01545687|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
373201|NCT01545687|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
373202|NCT01545687|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
373203|NCT01545687|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
373204|NCT01545687|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
373205|NCT01545687|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
373288|NCT01545492|pressure|pressure
373206|NCT01545687|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
373207|NCT01545687|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
373208|NCT01545687|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
373209|NCT01545687|stage IVA squamous cell carcinoma of the larynx|stage iva squamous cell carcinoma of the larynx
373210|NCT01545687|stage IVA squamous cell carcinoma of the oropharynx|stage iva squamous cell carcinoma of the oropharynx
373211|NCT01545687|stage IVA verrucous carcinoma of the larynx|stage iva verrucous carcinoma of the larynx
373212|NCT01545687|stage IVB squamous cell carcinoma of the larynx|stage ivb squamous cell carcinoma of the larynx
373213|NCT01545687|stage IVB squamous cell carcinoma of the oropharynx|stage ivb squamous cell carcinoma of the oropharynx
373214|NCT01545687|stage IVB verrucous carcinoma of the larynx|stage ivb verrucous carcinoma of the larynx
373215|NCT01545687|stage IVC squamous cell carcinoma of the larynx|stage ivc squamous cell carcinoma of the larynx
373216|NCT01545687|stage IVC squamous cell carcinoma of the oropharynx|stage ivc squamous cell carcinoma of the oropharynx
373217|NCT01545687|stage IVC verrucous carcinoma of the larynx|stage ivc verrucous carcinoma of the larynx
373218|NCT01545687|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
373219|NCT01545687|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
373220|NCT01545687|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
373221|NCT01545687|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
373222|NCT01545687|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
373223|NCT01545687|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
373224|NCT01545687|stage IVA squamous cell carcinoma of the lip and oral cavity|stage iva squamous cell carcinoma of the lip and oral cavity
373225|NCT01545687|stage IVA verrucous carcinoma of the oral cavity|stage iva verrucous carcinoma of the oral cavity
373226|NCT01545687|stage IVB squamous cell carcinoma of the lip and oral cavity|stage ivb squamous cell carcinoma of the lip and oral cavity
373227|NCT01545687|stage IVB verrucous carcinoma of the oral cavity|stage ivb verrucous carcinoma of the oral cavity
373228|NCT01545687|stage IVC squamous cell carcinoma of the lip and oral cavity|stage ivc squamous cell carcinoma of the lip and oral cavity
373229|NCT01545687|stage IVC verrucous carcinoma of the oral cavity|stage ivc verrucous carcinoma of the oral cavity
373230|NCT01545687|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
373231|NCT01545687|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
373232|NCT01545674|Aneuploidy|aneuploidy
373233|NCT01545674|Non-invasive Prenatal Diagnosis|non-invasive prenatal diagnosis
373234|NCT01545674|Prenatal Blood Test|prenatal blood test
373235|NCT01545674|Prenatal Aneuploidy Screening|prenatal aneuploidy screening
373236|NCT01545674|Trisomy 13|trisomy 13
373237|NCT01545674|Trisomy 18|trisomy 18
373238|NCT01545674|Trisomy 21|trisomy 21
373239|NCT01545674|Trisomy|trisomy
373240|NCT01545674|Down Syndrome|down syndrome
373241|NCT01545674|Turner Syndrome|turner syndrome
373242|NCT01545674|Edwards Syndrome|edwards syndrome
373243|NCT01545661|Tuberculosis|tuberculosis
373244|NCT01545661|diagnosis|diagnosis
373245|NCT01545661|sputum induction|sputum induction
373246|NCT01545661|primary care|primary care
373247|NCT01545648|breast|breast
373248|NCT01545648|cancer|cancer
373249|NCT01545648|early|early
373251|NCT01545648|disseminated|disseminated
373252|NCT01545648|tumor|tumor
373253|NCT01545648|cells|cells
373254|NCT01545635|Major trauma|major trauma
373255|NCT01545635|Injury Severity Score|injury severity score
373256|NCT01545635|ISS > 15|iss > 15
373257|NCT01545635|clinical signs|clinical signs
373258|NCT01545635|risk of blood loss|risk of blood loss
373259|NCT01545635|coagulopathy|coagulopathy
373260|NCT01545635|rotational thrombelastometry|rotational thrombelastometry
373261|NCT01545635|ROTEM|rotem
373262|NCT01545609|Text messaging|text messaging
373263|NCT01545609|birth control|birth control
373264|NCT01545609|adolescents|adolescents
373265|NCT01545596|Intraoperative Monitoring|intraoperative monitoring
373266|NCT01545596|Decision Support Systems|decision support systems
373267|NCT01545596|anesthesia outcomes|anesthesia outcomes
373268|NCT01545557|Volume loss|volume loss
373269|NCT01545544|B-Cell Non Hodgkin Lymphomas|b-cell non hodgkin lymphomas
373270|NCT01545544|Hepatitis C|hepatitis c
373271|NCT01545531|glomerular filtration rate|glomerular filtration rate
373272|NCT01545531|iohexol|iohexol
373273|NCT01545531|hematopoietic cell transplant|hematopoietic cell transplant
373274|NCT01545531|kidney function|kidney function
373275|NCT01545531|gold standard measure|gold standard measure
373277|NCT01545518|Refractory epilepsy|refractory epilepsy
373278|NCT01545518|Cryptogenic epilepsy|cryptogenic epilepsy
373279|NCT01545518|Autoimmune disorders|autoimmune disorders
373280|NCT01545518|IVIG|ivig
373281|NCT01545518|Immunomodulatory therapy|immunomodulatory therapy
373282|NCT01545518|Autoantibodies|autoantibodies
373283|NCT01545492|CHIPS|chips
373284|NCT01545492|famine|famine
373285|NCT01545492|reprogramming|reprogramming
373286|NCT01545492|developmental|developmental
373287|NCT01545492|blood|blood
373289|NCT01545492|randomised|randomised
373290|NCT01545492|randomized|randomized
373291|NCT01545492|hypertension|hypertension
373292|NCT01545492|anthropometry|anthropometry
373293|NCT01545492|measurement|measurement
373294|NCT01545492|genetics|genetics
373295|NCT01545492|epigenetics|epigenetics
373296|NCT01545492|methylation|methylation
373297|NCT01545492|cortisol|cortisol
373298|NCT01545492|stress|stress
373299|NCT01545492|DNA|dna
373300|NCT01545492|growth|growth
373301|NCT01545492|weight|weight
373302|NCT01545492|length|length
373303|NCT01545492|height|height
373304|NCT01545479|ECA|eca
373305|NCT01545479|BOLD-MRI|bold-mri
373306|NCT01545479|kidney|kidney
373307|NCT01545466|Migraines|migraines
373308|NCT01545466|Behavioral|behavioral
373309|NCT01545466|Complementary and Alternative Medicine|complementary and alternative medicine
373310|NCT01545466|Mindfulness Meditation|mindfulness meditation
373311|NCT01545466|Mindfulness Based Stress Reduction|mindfulness based stress reduction
373312|NCT01545427|Scleroderma|scleroderma
373313|NCT01545427|Randomized controled trial|randomized controled trial
373314|NCT01545427|Pilot study|pilot study
373315|NCT01545427|Gleevec (imatinib)|gleevec (imatinib)
373316|NCT01545427|Biomarkers|biomarkers
373317|NCT01545414|Self-help treatment|self-help treatment
373318|NCT01545414|Internet treatment|internet treatment
373319|NCT01545414|Cognitive Behavioral Therapy|cognitive behavioral therapy
373320|NCT01545414|Internet-based Cognitive Behavioral Therapy|internet-based cognitive behavioral therapy
373321|NCT01545401|chronic disease management|chronic disease management
373322|NCT01545401|Chronic Care Model|chronic care model
373323|NCT01545401|multifaceted intervention|multifaceted intervention
373324|NCT01545401|primary care|primary care
373325|NCT01545401|type 2 diabetes mellitus|type 2 diabetes mellitus
373326|NCT01545401|hypertension|hypertension
373327|NCT01545375|nasopharyngeal carriage|nasopharyngeal carriage
373328|NCT01545375|safety|safety
373329|NCT01545375|immunogenicity|immunogenicity
373330|NCT01545375|US|us
373331|NCT01545375|Pneumococcal vaccine|pneumococcal vaccine
373332|NCT01545375|efficacy|efficacy
373333|NCT01545375|Streptococcus pneumoniae|streptococcus pneumoniae
373334|NCT01545375|infants|infants
373335|NCT01545349|LGG|lgg
373336|NCT01545349|Immune response|immune response
373337|NCT01545349|Influenza vaccine|influenza vaccine
373338|NCT01545349|Elderly|elderly
373339|NCT01545349|Healthy|healthy
373340|NCT01545349|Microbiome|microbiome
373341|NCT01545323|Netherton syndrome|netherton syndrome
373342|NCT01545323|Gene therapy|gene therapy
373343|NCT01545323|SPINK5|spink5
373344|NCT01545297|dexmedetomidine|dexmedetomidine
373345|NCT01545297|conscious sedation|conscious sedation
373346|NCT01545297|awake craniotomy|awake craniotomy
373347|NCT01545297|brain mapping|brain mapping
373348|NCT01545284|chronic hand dermatitis|chronic hand dermatitis
373349|NCT01545284|acitretin|acitretin
373350|NCT01545284|PGA|pga
373351|NCT01545271|Xenon|xenon
373352|NCT01545271|Hypothermia|hypothermia
373353|NCT01545271|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
373354|NCT01545271|Newborn|newborn
373355|NCT01545271|Term|term
373356|NCT01545271|Neuroprotection|neuroprotection
373357|NCT01545271|Cooling|cooling
373358|NCT01545271|HIE|hie
373359|NCT01545245|atopic asthma|atopic asthma
373360|NCT01545245|recurrent wheezing|recurrent wheezing
373361|NCT01545245|preterm infants|preterm infants
373362|NCT01545245|palivizumab|palivizumab
373363|NCT01545245|respiratory syncytial virus|respiratory syncytial virus
373364|NCT01545245|RSV|rsv
373365|NCT01545232|Massive Transfusion|massive transfusion
373366|NCT01545232|Trauma|trauma
373367|NCT01545232|Coagulopathy|coagulopathy
373368|NCT01545232|Trauma Induced Coagulopathy|trauma induced coagulopathy
373369|NCT01545232|Plasma|plasma
373370|NCT01545232|Platelets|platelets
373371|NCT01545232|Red Blood Cells|red blood cells
373372|NCT01545232|Mortality|mortality
373373|NCT01545232|Wounds and Injuries|wounds and injuries
373374|NCT01545232|Shock, Hemorrhagic|shock, hemorrhagic
373375|NCT01545232|Shock|shock
373376|NCT01545232|Pathologic Processes|pathologic processes
373377|NCT01545232|Hemorrhage|hemorrhage
373378|NCT01545232|Hemostatics|hemostatics
373379|NCT01545232|Coagulation|coagulation
373380|NCT01545232|Transfusion-related acute lung injury (TRALI)|transfusion-related acute lung injury (trali)
373381|NCT01545232|Inflammation|inflammation
373382|NCT01545193|Elderly|elderly
373383|NCT01545193|Residual neuromuscular blockade|residual neuromuscular blockade
373384|NCT01545180|Observatory|observatory
373385|NCT01545180|Heart failure|heart failure
373386|NCT01545180|Post-capillary pulmonary hypertension|post-capillary pulmonary hypertension
373387|NCT01545180|HTPcap|htpcap
373388|NCT01545167|African Americans|african americans
373389|NCT01545167|pancreatitis|pancreatitis
373390|NCT01545167|controls|controls
373391|NCT01545141|metastatic|metastatic
373392|NCT01545141|recurrent|recurrent
373393|NCT01545141|peritoneal metastasis|peritoneal metastasis
373394|NCT01545141|cytoreductive surgery|cytoreductive surgery
373496|NCT01544712|bone marrow|bone marrow
373395|NCT01545141|hyperthermic intraperitoneal chemoperfusion|hyperthermic intraperitoneal chemoperfusion
373396|NCT01545141|HIPEC|hipec
373397|NCT01545141|hepatic metastasis|hepatic metastasis
373398|NCT01545141|extrahepatic metastasis|extrahepatic metastasis
373399|NCT01545141|vaccine|vaccine
373400|NCT01545128|COPD|copd
373401|NCT01545128|Pulmonary rehabilitation|pulmonary rehabilitation
373402|NCT01545115|Children|children
373403|NCT01545115|Immunity|immunity
373404|NCT01545115|Sub-Saharan|sub-saharan
373405|NCT01545115|Pertussis|pertussis
373406|NCT01545115|Malaria|malaria
373407|NCT01545115|Nutrition|nutrition
373408|NCT01545115|antibodies|antibodies
373409|NCT01545011|Inspiratory muscle training|inspiratory muscle training
373410|NCT01545011|COPD|copd
373411|NCT01545011|Conventional respiratory rehabilitation|conventional respiratory rehabilitation
373412|NCT01545011|Dyspnea scale|dyspnea scale
373413|NCT01544985|pediatrics|pediatrics
373414|NCT01544985|emergency medicine|emergency medicine
373415|NCT01544985|pain|pain
373416|NCT01544985|bladder catheterization|bladder catheterization
373417|NCT01544972|Patent Ductus Arteriosus|patent ductus arteriosus
373418|NCT01544972|Paracetamol|paracetamol
373419|NCT01544972|Ibuprofen|ibuprofen
373420|NCT01544972|Serum levels|serum levels
373421|NCT01544972|Preterm infant|preterm infant
373422|NCT01544959|Narcotic|narcotic
373423|NCT01544959|Opioid|opioid
373424|NCT01544959|betablocking drug|betablocking drug
373425|NCT01544959|postoperative pain|postoperative pain
373426|NCT01544959|postoperative nausea and vomiting|postoperative nausea and vomiting
373427|NCT01544959|breast cancer|breast cancer
373428|NCT01544959|hyperalgesia|hyperalgesia
373429|NCT01544959|cancer recurrence|cancer recurrence
373430|NCT01544959|anesthesia|anesthesia
373431|NCT01544959|mastectomy|mastectomy
373432|NCT01544959|chronic postsurgical pain syndrome|chronic postsurgical pain syndrome
373433|NCT01544959|acute postoperative pain|acute postoperative pain
373434|NCT01544959|postmastectomy pain syndrome|postmastectomy pain syndrome
373435|NCT01544959|pain|pain
373436|NCT01544959|ambulatory surgery|ambulatory surgery
373437|NCT01544946|pediatrics|pediatrics
373438|NCT01544946|emergency medicine|emergency medicine
373439|NCT01544946|pain|pain
373440|NCT01544946|nasopharyngeal aspiration|nasopharyngeal aspiration
373441|NCT01544933|spinal fractures|spinal fractures
373442|NCT01544933|Thoracic vertebrae|thoracic vertebrae
373443|NCT01544933|spinal canal|spinal canal
373444|NCT01544933|kyphosis|kyphosis
373445|NCT01544907|Drug Eluting Balloon|drug eluting balloon
373446|NCT01544907|Arteriovenous fistula or graft stenosis|arteriovenous fistula or graft stenosis
373447|NCT01544894|Postmenopausal osteoporosis|postmenopausal osteoporosis
373448|NCT01544894|Compliance|compliance
373449|NCT01544894|Bone mineral density|bone mineral density
373450|NCT01544894|Bonemarkers|bonemarkers
373451|NCT01544881|Pharmacokinetics|pharmacokinetics
373452|NCT01544881|Pharmacodynamics|pharmacodynamics
373453|NCT01544881|Hyperglycemia|hyperglycemia
373454|NCT01544881|Insulin|insulin
373455|NCT01544868|Total Energy Expenditure|total energy expenditure
373456|NCT01544868|Protein Balance|protein balance
373457|NCT01544868|Burns|burns
373458|NCT01544855|Health young participants|health young participants
373459|NCT01544842|Oral lichen planus|oral lichen planus
373460|NCT01544842|Tacrolimus ointment|tacrolimus ointment
373461|NCT01544842|Triamcinolone paste|triamcinolone paste
373462|NCT01544829|theobromine|theobromine
373463|NCT01544829|heart rate|heart rate
373464|NCT01544829|blood lipids|blood lipids
373465|NCT01544803|Randomized Controlled Trial|randomized controlled trial
373466|NCT01544803|Alcohol|alcohol
373467|NCT01544803|Internet|internet
373468|NCT01544803|Screening|screening
373469|NCT01544803|Brief intervention|brief intervention
373470|NCT01544803|Personalized feedback|personalized feedback
373471|NCT01544790|Esophageal carcinoma|esophageal carcinoma
373472|NCT01544790|Esophageal cancer|esophageal cancer
373473|NCT01544790|Robotic surgery|robotic surgery
373474|NCT01544790|Esophagectomy|esophagectomy
373475|NCT01544790|Minimally invasive|minimally invasive
373476|NCT01544777|Aphakia|aphakia
373477|NCT01544777|Cataract|cataract
373478|NCT01544764|Diphtheria-Tetanus-Pertussis Vaccine|diphtheria-tetanus-pertussis vaccine
373479|NCT01544764|Measles-Mumps-Rubella Vaccine|measles-mumps-rubella vaccine
373480|NCT01544764|Meningococcal Vaccines|meningococcal vaccines
373481|NCT01544764|Hepatitis B Vaccines|hepatitis b vaccines
373482|NCT01544764|Chickenpox Vaccine|chickenpox vaccine
373483|NCT01544764|Papillomavirus Vaccines|papillomavirus vaccines
373484|NCT01544751|NAFLD|nafld
373485|NCT01544751|metformin|metformin
373486|NCT01544751|atorvastatin|atorvastatin
373487|NCT01544751|metabolic syndrome|metabolic syndrome
373488|NCT01544738|Parkinson Disease|parkinson disease
373489|NCT01544738|sensory stimulation|sensory stimulation
373490|NCT01544738|Bradykinesia|bradykinesia
373491|NCT01544725|Procedural sedation|procedural sedation
373492|NCT01544725|Ketamine-propofol|ketamine-propofol
373493|NCT01544725|Ketamine|ketamine
373494|NCT01544712|osteonecrosis|osteonecrosis
373495|NCT01544712|cell-based therapy|cell-based therapy
373497|NCT01544712|mesenchymal stem cell|mesenchymal stem cell
373499|NCT01544712|core decompression|core decompression
373500|NCT01544699|stroke|stroke
373501|NCT01544686|neutropenia|neutropenia
373502|NCT01544686|cancer|cancer
373503|NCT01544686|fever|fever
373504|NCT01544686|central venous catheter|central venous catheter
373505|NCT01544686|infection|infection
373506|NCT01544660|spine and hip scan|spine and hip scan
373507|NCT01544660|BMD|bmd
373508|NCT01544647|Knee osteoarthritis|knee osteoarthritis
373509|NCT01544647|spa therapy|spa therapy
373510|NCT01544647|spa modalities|spa modalities
373511|NCT01544634|Asthma|asthma
373512|NCT01544634|Propranolol|propranolol
373513|NCT01544634|Inhaled corticosteroids|inhaled corticosteroids
373514|NCT01544634|Steroid sparing agent|steroid sparing agent
373515|NCT01544634|Airway hyper-responsiveness|airway hyper-responsiveness
373516|NCT01544621|Real life smoking cessation. NON-drug NON-intervention study|real life smoking cessation. non-drug non-intervention study
373517|NCT01544608|Acute psychotic episode of Schizophrenia|acute psychotic episode of schizophrenia
373518|NCT01544595|Psoriasis, inflammatory skin disease|psoriasis, inflammatory skin disease
373519|NCT01544595|scaly patches|scaly patches
373520|NCT01544595|secukinumab (AIN457)|secukinumab (ain457)
373521|NCT01544595|Psoriasis Area and Severity Index (PASI)|psoriasis area and severity index (pasi)
373522|NCT01544595|Investigator Global Assessment (IGA) mod 2011|investigator global assessment (iga) mod 2011
373523|NCT01544582|Pegylated Interferon|pegylated interferon
373524|NCT01544582|boceprevir|boceprevir
373525|NCT01544582|telaprevir|telaprevir
373526|NCT01544569|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
373527|NCT01544556|abdominoplasty|abdominoplasty
373528|NCT01544543|COPD|copd
373529|NCT01544530|Brain-death|brain-death
373530|NCT01544530|organ donation|organ donation
373531|NCT01544517|Helicobacter pylori|helicobacter pylori
373532|NCT01544517|Concomitant therapy|concomitant therapy
373533|NCT01544517|Sequential therapy|sequential therapy
373534|NCT01544517|levofloxacin|levofloxacin
373535|NCT01544504|Radiodermatitis|radiodermatitis
373536|NCT01544504|Prevention|prevention
373537|NCT01544504|Radiotherapy|radiotherapy
373538|NCT01544504|Breast|breast
373539|NCT01544504|Radiation Dermatitis|radiation dermatitis
373540|NCT01544491|Paediatric kidney transplantation|paediatric kidney transplantation
373541|NCT01544491|Early MMF to everolimus conversion|early mmf to everolimus conversion
373542|NCT01544491|Composite efficacy (biopsy-proven acute rejection, graft loss or death)|composite efficacy (biopsy-proven acute rejection, graft loss or death)
373543|NCT01544491|Renal function|renal function
373544|NCT01544465|Parkinson's disease|parkinson's disease
373545|NCT01544465|Sleep Quality|sleep quality
373546|NCT01544465|Daytime sleepiness|daytime sleepiness
373547|NCT01544465|physical therapy|physical therapy
373548|NCT01544465|exercise|exercise
373549|NCT01544452|MR|mr
373550|NCT01544452|CT|ct
373551|NCT01544452|ultrasonography|ultrasonography
373552|NCT01544452|MR colonography|mr colonography
373553|NCT01544452|MR rectum|mr rectum
373554|NCT01544452|MR liver|mr liver
373555|NCT01544439|Temporomandibular joint disorders|temporomandibular joint disorders
373556|NCT01544439|Stress psychological|stress psychological
373557|NCT01544439|Depression|depression
373558|NCT01544439|Quality of Life|quality of life
373559|NCT01544426|Office hysteroscopy,|office hysteroscopy,
373560|NCT01544426|intrauterine insemination|intrauterine insemination
373561|NCT01544426|endometrial scrap|endometrial scrap
373562|NCT01544413|laparoscopic sentinel lymph node biopsy|laparoscopic sentinel lymph node biopsy
373563|NCT01544413|quality control study|quality control study
373564|NCT01544413|early gastric cancer|early gastric cancer
373565|NCT01544400|reverse anorexia,|reverse anorexia,
373566|NCT01544400|anorexia athletics|anorexia athletics
373567|NCT01544387|Preterm Premature Rupture Of Membranes|preterm premature rupture of membranes
373568|NCT01544387|PPROM|pprom
373569|NCT01544387|Pregnancy|pregnancy
373570|NCT01544387|Bed rest.|bed rest.
373571|NCT01544374|Breast Cancer|breast cancer
373572|NCT01544374|Treatment Disparities|treatment disparities
373573|NCT01544374|Tracking and Feedback|tracking and feedback
373574|NCT01544374|Registry|registry
373575|NCT01544374|Cancer Therapy Disparities|cancer therapy disparities
373576|NCT01544374|Adjuvant Treatment|adjuvant treatment
373577|NCT01544374|Racial Disparities|racial disparities
373578|NCT01544374|Underuse of Adjuvant Treatment|underuse of adjuvant treatment
373579|NCT01544361|Healthy subjects|healthy subjects
373580|NCT01544361|MEDI7814|medi7814
373581|NCT01544361|FTiH|ftih
373582|NCT01544348|Allergic|allergic
373583|NCT01544348|Atopic Dermatitis|atopic dermatitis
373584|NCT01544348|MEDI4212|medi4212
373585|NCT01544322|solid tumors|solid tumors
373586|NCT01544322|recurrent|recurrent
373587|NCT01544322|advanced|advanced
373588|NCT01544322|metastatic|metastatic
373589|NCT01544322|refractory|refractory
373590|NCT01544283|Shoulder Pain|shoulder pain
373591|NCT01544283|Shoulder Impingement Syndrome|shoulder impingement syndrome
373592|NCT01544270|milk protein|milk protein
373593|NCT01544270|probiotics|probiotics
373594|NCT01544270|stress|stress
373595|NCT01544270|cortisol|cortisol
373596|NCT01544270|heart beat|heart beat
373597|NCT01544257|Osteopathic manipulative treatment|osteopathic manipulative treatment
373598|NCT01544257|alternative medicine|alternative medicine
373599|NCT01544257|complementary medicine|complementary medicine
373600|NCT01544257|neonatology|neonatology
373601|NCT01544257|neonatal care|neonatal care
373602|NCT01544257|prematurity|prematurity
373603|NCT01544257|allied health care|allied health care
373604|NCT01544244|comparison of physical therapy strategies|comparison of physical therapy strategies
373605|NCT01544231|Neutrophil Gelatinase Associated Lipocalin|neutrophil gelatinase associated lipocalin
373606|NCT01544231|predicting acute kidney failure|predicting acute kidney failure
373607|NCT01544231|emergency room|emergency room
373608|NCT01544218|Alcohol related disorders|alcohol related disorders
373609|NCT01544192|Antioxidant|antioxidant
373610|NCT01544192|α−tocopherol|α−tocopherol
373611|NCT01544192|Vitamin E|vitamin e
373612|NCT01544192|Gingko Biloba|gingko biloba
373613|NCT01544192|Glaucoma|glaucoma
373614|NCT01544192|Neuroprotection|neuroprotection
373615|NCT01544192|Retina|retina
373616|NCT01544179|Non Small Cell Lung Cancer|non small cell lung cancer
373617|NCT01544179|Gefitinib|gefitinib
373618|NCT01544179|Pemetrexed|pemetrexed
373619|NCT01544179|Treatment Beyond Progression|treatment beyond progression
373620|NCT01544166|Gadolinium, Pediatrics, MRI, contrast|gadolinium, pediatrics, mri, contrast
373621|NCT01544153|Web based behavioral intervention|web based behavioral intervention
373622|NCT01544153|Adherence|adherence
373623|NCT01544153|Smoking cessation|smoking cessation
373624|NCT01544153|Social network|social network
373625|NCT01544153|Nicotine replacement therapy|nicotine replacement therapy
373626|NCT01544153|Social support|social support
373627|NCT01544140|Phase 1|phase 1
373628|NCT01544140|healthy volunteers|healthy volunteers
373629|NCT01544140|pharmacokinetics|pharmacokinetics
373630|NCT01544140|vandetanib|vandetanib
373631|NCT01544140|midazolam|midazolam
373632|NCT01544127|Veterans|veterans
373633|NCT01544127|Motivational Interviewing|motivational interviewing
373634|NCT01544127|Inpatients|inpatients
373635|NCT01544127|Suicide, Attempted|suicide, attempted
373636|NCT01544101|Rheumatoid Arthritis|rheumatoid arthritis
373637|NCT01544101|Diet, Vegetarian|diet, vegetarian
373638|NCT01544101|Diet, Fat-Restricted|diet, fat-restricted
373639|NCT01544101|Pain|pain
373640|NCT01544088|randomized controlled trial|randomized controlled trial
373641|NCT01544088|PTSD|ptsd
373642|NCT01544088|cognitive behavioral treatment|cognitive behavioral treatment
373643|NCT01544088|group treatment|group treatment
373644|NCT01544062|Cardiac surgery|cardiac surgery
373645|NCT01544062|Acute Pain|acute pain
373646|NCT01544062|Wound Hyperalgesia|wound hyperalgesia
373647|NCT01544062|Intravenous Acetaminophen|intravenous acetaminophen
373648|NCT01544062|Patient Satisfaction|patient satisfaction
373649|NCT01544049|fallopian tube removal|fallopian tube removal
373650|NCT01544049|salpingectomy|salpingectomy
373651|NCT01544049|ovarian cancer prevention|ovarian cancer prevention
373652|NCT01544036|AKI|aki
373653|NCT01544036|contrast nephropathy|contrast nephropathy
373654|NCT01544036|renal blood flow|renal blood flow
373655|NCT01544023|breast reconstruction|breast reconstruction
373656|NCT01544023|mesh|mesh
373657|NCT01544023|implant reconstruction|implant reconstruction
373658|NCT01544023|acellular dermal matrix|acellular dermal matrix
373659|NCT01544023|titanized polypropylene mesh|titanized polypropylene mesh
373660|NCT01544023|TiLOOP Bra|tiloop bra
373661|NCT01544023|TiLOOP|tiloop
373662|NCT01544023|implant based breast reconstruction|implant based breast reconstruction
373663|NCT01544010|Transtheoretical Model|transtheoretical model
373664|NCT01544010|Tailored Print Intervention|tailored print intervention
373665|NCT01544010|Population-based|population-based
373666|NCT01544010|Behavioral Intervention|behavioral intervention
373667|NCT01543984|health care workers|health care workers
373668|NCT01543984|tailored physical activity|tailored physical activity
373669|NCT01543984|prevention|prevention
373670|NCT01543984|spine|spine
373671|NCT01543984|upper body|upper body
373672|NCT01543984|pain related to Spine or Upper body|pain related to spine or upper body
373673|NCT01543971|Peripheral blood stem cell mobilization|peripheral blood stem cell mobilization
373674|NCT01543971|CD34+ count|cd34+ count
373675|NCT01543945|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
373676|NCT01543945|Ambulatory|ambulatory
373677|NCT01543945|Gynecologic laparoscopy|gynecologic laparoscopy
373678|NCT01543945|Incidence of postoperative nausea and vomiting.|incidence of postoperative nausea and vomiting.
373679|NCT01543932|antiplatelet effect|antiplatelet effect
373680|NCT01543932|prasugrel|prasugrel
373681|NCT01543932|clopidogrel|clopidogrel
373682|NCT01543932|stable angina|stable angina
373683|NCT01543893|neck pain|neck pain
373684|NCT01543893|shoulder pain|shoulder pain
373685|NCT01543893|resistance training|resistance training
373686|NCT01543854|Heart failure|heart failure
373687|NCT01543854|RLX030|rlx030
373688|NCT01543854|Hemodynamics|hemodynamics
373689|NCT01543854|Cardiovascular Diseases|cardiovascular diseases
373690|NCT01543841|advanced cancer|advanced cancer
373691|NCT01543841|healthy|healthy
373692|NCT01543841|blood sample|blood sample
373693|NCT01543841|TEM|tem
373694|NCT01543841|TIE-2 expressing monocytes|tie-2 expressing monocytes
373695|NCT01543841|ANG1|ang1
373696|NCT01543841|ANG2|ang2
373697|NCT01543828|COPD|copd
373698|NCT01543828|Indacatarol|indacatarol
373699|NCT01543828|placebo|placebo
373700|NCT01543828|crossover|crossover
373701|NCT01543828|patient perception|patient perception
373702|NCT01543815|Psychological Distress|psychological distress
373703|NCT01543815|Depression|depression
373704|NCT01543815|Anxiety|anxiety
373705|NCT01543815|Well-Being Therapy|well-being therapy
373706|NCT01543815|Heart Failure|heart failure
373707|NCT01543815|Quality of Life|quality of life
373708|NCT01543815|Adherence|adherence
373709|NCT01543802|soft-tissue sarcoma|soft-tissue sarcoma
373710|NCT01543802|pazopanib|pazopanib
373711|NCT01543802|antiangiogenetic treatment|antiangiogenetic treatment
373712|NCT01543802|endothelial progenitor cells|endothelial progenitor cells
373713|NCT01543802|preoperative therapy|preoperative therapy
373714|NCT01543789|Umbilical Hernia|umbilical hernia
373715|NCT01543763|metastatic|metastatic
373716|NCT01543763|solid|solid
373717|NCT01543763|sarcoma|sarcoma
373718|NCT01543763|progression|progression
373719|NCT01543750|episodic ataxia|episodic ataxia
373720|NCT01543750|CACNA1A mutations|cacna1a mutations
373721|NCT01543724|Lithium|lithium
373722|NCT01543724|Bipolar disorder|bipolar disorder
373723|NCT01543724|Multimodal Brain Imaging|multimodal brain imaging
373724|NCT01543711|Breast cancer|breast cancer
373725|NCT01543711|persistent pain|persistent pain
373726|NCT01543711|neuropathic pain|neuropathic pain
373727|NCT01543711|lymphedema|lymphedema
373728|NCT01543698|Advanced solid tumor,|advanced solid tumor,
373729|NCT01543698|BRAF V600 mutation|braf v600 mutation
373730|NCT01543672|lung|lung
373731|NCT01543672|SBRT|sbrt
373732|NCT01543672|MLD|mld
373733|NCT01543672|toxicity|toxicity
373734|NCT01543659|89Zr-DFO-huJ591|89zr-dfo-huj591
373735|NCT01543659|prostate|prostate
373736|NCT01543659|Pet scan|pet scan
373737|NCT01543659|11-126|11-126
373738|NCT01543646|Hepatology|hepatology
373739|NCT01543646|Liver Cirrhosis|liver cirrhosis
373740|NCT01543646|Fatty Liver|fatty liver
373741|NCT01543620|kidney safety|kidney safety
373742|NCT01543620|biomarkers|biomarkers
373743|NCT01543620|serum creatinine|serum creatinine
373744|NCT01543620|BUN|bun
373745|NCT01543620|cystic fibrosis|cystic fibrosis
373746|NCT01543620|head and neck cancer|head and neck cancer
373747|NCT01543620|renal injury|renal injury
373748|NCT01543620|drug induced acute kidney injury|drug induced acute kidney injury
373749|NCT01543620|aminoglycoside|aminoglycoside
373750|NCT01543620|cisplatin|cisplatin
373751|NCT01543620|nephrotoxicity|nephrotoxicity
373752|NCT01543620|biomarker qualification|biomarker qualification
373753|NCT01543607|Bile duct|bile duct
373754|NCT01543607|Cholangiocarcinoma|cholangiocarcinoma
373755|NCT01543607|Bile duct stenosis|bile duct stenosis
373756|NCT01543607|Malignant bile duct obstruction|malignant bile duct obstruction
373757|NCT01543607|Malignant bile duct stricture|malignant bile duct stricture
373758|NCT01543607|Radiofrequency ablation|radiofrequency ablation
373759|NCT01543607|RFA|rfa
373760|NCT01543607|Endoscopic RFA catheter|endoscopic rfa catheter
373761|NCT01543607|EndoHPB|endohpb
373762|NCT01543594|Rheumatoid arthritis|rheumatoid arthritis
373763|NCT01543594|Seronegative polyarthritis|seronegative polyarthritis
373764|NCT01543594|Biologic drugs|biologic drugs
373765|NCT01543594|Safety efficacy biologics polyarthritis|safety efficacy biologics polyarthritis
373766|NCT01543581|Basal Cell Carcinoma|basal cell carcinoma
373767|NCT01543581|Treatment of Skin Cancer|treatment of skin cancer
373768|NCT01543568|Age related Macular Degeneration|age related macular degeneration
373769|NCT01543568|Recalcitrant Age Related Macular Degeneration|recalcitrant age related macular degeneration
373770|NCT01543555|myocardial infarction|myocardial infarction
373771|NCT01543555|statin|statin
373772|NCT01543555|perioperative care|perioperative care
373773|NCT01543555|peripheral vascular diseases|peripheral vascular diseases
373774|NCT01543555|anesthesiology|anesthesiology
373775|NCT01543542|1-3 brain metastases from any primary cancer|1-3 brain metastases from any primary cancer
373776|NCT01543516|Asthma|asthma
373777|NCT01543516|Sputum|sputum
373778|NCT01543516|Blood|blood
373779|NCT01543516|Inflammation|inflammation
373780|NCT01543516|adaptive immune system|adaptive immune system
373781|NCT01543516|innate immune system|innate immune system
373782|NCT01543464|Indeolamine 2,3 dioxygenase|indeolamine 2,3 dioxygenase
373783|NCT01543464|Survivin|survivin
373784|NCT01543464|Montanide|montanide
373785|NCT01543464|Imiquimod|imiquimod
373786|NCT01543464|GMCSF|gmcsf
373787|NCT01543438|ED utilization|ed utilization
373788|NCT01543438|video education|video education
373789|NCT01543438|mobile health|mobile health
373790|NCT01543438|streaming media|streaming media
373791|NCT01543438|underserved populations|underserved populations
373792|NCT01543425|Neuropathic Pain|neuropathic pain
373793|NCT01543425|Adenocorticotrophic axis|adenocorticotrophic axis
374092|NCT01542203|BMI|bmi
373794|NCT01543425|Psychological state|psychological state
373795|NCT01543412|FOLFIRI|folfiri
373796|NCT01543412|Metastases|metastases
373797|NCT01543412|pancreatic adenocarcinoma|pancreatic adenocarcinoma
373798|NCT01543412|locally advanced or metastatic pancreatic adenocarcinoma|locally advanced or metastatic pancreatic adenocarcinoma
373799|NCT01543399|Tibolone|tibolone
373800|NCT01543399|climacteric|climacteric
373801|NCT01543399|Doppler|doppler
373802|NCT01543399|hormone replacement therapy|hormone replacement therapy
373803|NCT01543386|Polyphenol|polyphenol
373804|NCT01543386|Curcumin|curcumin
373805|NCT01543386|Endothelium, vascular|endothelium, vascular
373806|NCT01543386|Endothelium-dependant relaxing factor|endothelium-dependant relaxing factor
373807|NCT01543386|Smoking|smoking
373808|NCT01543386|Transcriptome|transcriptome
373809|NCT01543373|Coronary artery disease|coronary artery disease
373810|NCT01543373|Optical Coherence Tomography|optical coherence tomography
373811|NCT01543373|Tissue coverage|tissue coverage
373812|NCT01543373|DES|des
373813|NCT01543360|axillary vein|axillary vein
373814|NCT01543360|sub clavian vein|sub clavian vein
373815|NCT01543360|comparison of strategies|comparison of strategies
373816|NCT01543347|UTI|uti
373817|NCT01543347|ESBL|esbl
373818|NCT01543347|AmpC Enterobacteriaceae|ampc enterobacteriaceae
373819|NCT01543334|intensive care|intensive care
373820|NCT01543334|antibiotic levels in blood samples|antibiotic levels in blood samples
373821|NCT01543321|tetrabenazine|tetrabenazine
373822|NCT01543321|movement disorders|movement disorders
373823|NCT01543321|tardive disorders|tardive disorders
373824|NCT01543295|Non-Treponemal|non-treponemal
373825|NCT01543295|Treponemal|treponemal
373826|NCT01543282|endoscopic ultrasonography|endoscopic ultrasonography
373827|NCT01543282|fine needle aspiration cytology|fine needle aspiration cytology
373828|NCT01543282|22 gauge|22 gauge
373829|NCT01543282|25 gauge|25 gauge
373830|NCT01543269|Obesity|obesity
373831|NCT01543269|Lipid disorders|lipid disorders
373832|NCT01543256|benign biliary strictures secondary to chronic pancreatitis|benign biliary strictures secondary to chronic pancreatitis
373833|NCT01543243|postural balance|postural balance
373834|NCT01543243|strength|strength
373835|NCT01543230|Non-Inflammatory Degenerative Joint Disease|non-inflammatory degenerative joint disease
373836|NCT01543217|COPD|copd
373837|NCT01543204|plaque psoriasis|plaque psoriasis
373838|NCT01543204|etanercept|etanercept
373839|NCT01543204|adalimumab|adalimumab
373840|NCT01543191|Lung Diseases|lung diseases
373841|NCT01543191|Respiratory Tract Diseases|respiratory tract diseases
373842|NCT01543191|Fibrosis|fibrosis
373843|NCT01543178|IBS|ibs
373844|NCT01543178|IBS-D|ibs-d
373845|NCT01543178|IBS with diarrhea|ibs with diarrhea
373846|NCT01543178|Diarrhea|diarrhea
373847|NCT01543178|Irritable bowel syndrome with diarrhea|irritable bowel syndrome with diarrhea
373848|NCT01543165|Renal colic|renal colic
373849|NCT01543165|Analgesia|analgesia
373850|NCT01543165|Nefopam|nefopam
373851|NCT01543165|Ketorolac|ketorolac
373852|NCT01543152|HIV|hiv
373853|NCT01543152|autologous cell therapy|autologous cell therapy
373854|NCT01543152|cyclophosphamide|cyclophosphamide
373855|NCT01543139|Bipolar Depression|bipolar depression
373856|NCT01543139|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
373857|NCT01543139|Cytidine-|cytidine-
373858|NCT01543139|Creatine-|creatine-
373859|NCT01543113|melanoma|melanoma
373860|NCT01543113|white-caucasian population|white-caucasian population
373861|NCT01543100|MGUS|mgus
373862|NCT01543074|HDAC|hdac
373863|NCT01543074|histone acetylation|histone acetylation
373864|NCT01543074|broccoli sprout extract|broccoli sprout extract
373865|NCT01543074|garlic oil|garlic oil
373866|NCT01543074|PBMCs|pbmcs
373867|NCT01543048|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
373868|NCT01543048|Virological tests|virological tests
373869|NCT01543048|CIN3|cin3
373870|NCT01543048|Cervical cancer|cervical cancer
373871|NCT01543048|Conization|conization
373872|NCT01543048|within women treated by conization for a CIN3|within women treated by conization for a cin3
373873|NCT01543035|HIV infection|hiv infection
373874|NCT01543035|lipid lowering drugs|lipid lowering drugs
373875|NCT01543035|etravirine|etravirine
373876|NCT01543035|patient|patient
373877|NCT01543035|statin treatment|statin treatment
373878|NCT01543035|EFV or boosted PI antiretroviral treatment|efv or boosted pi antiretroviral treatment
373879|NCT01543009|child|child
373880|NCT01543009|venipuncture|venipuncture
373881|NCT01543009|pain|pain
373882|NCT01542983|breast cancer|breast cancer
373883|NCT01542983|bright light|bright light
373884|NCT01542983|insomnia|insomnia
373885|NCT01542983|fatigue|fatigue
373886|NCT01542970|intervention|intervention
373887|NCT01542970|lactobacillus reuteri|lactobacillus reuteri
373888|NCT01542970|omega-3 fatty acids|omega-3 fatty acids
373889|NCT01542970|pregnancy|pregnancy
373890|NCT01542970|lactation|lactation
373891|NCT01542970|allergic symptoms|allergic symptoms
373892|NCT01542970|IgE associated disease|ige associated disease
373893|NCT01542970|gastrointestinal function|gastrointestinal function
373894|NCT01542957|Major Depressive Disorder|major depressive disorder
373895|NCT01542957|Dysthymic Disorder|dysthymic disorder
373896|NCT01542957|Depression|depression
373897|NCT01542957|Cognitive Behavior Therapy|cognitive behavior therapy
373898|NCT01542957|Personal Construct Theory|personal construct theory
373899|NCT01542957|Repertory Grid Technique|repertory grid technique
373900|NCT01542957|Cognitive Conflicts|cognitive conflicts
373901|NCT01542957|Personal dilemmas|personal dilemmas
373902|NCT01542944|Acute myeloid leukemia|acute myeloid leukemia
373903|NCT01542944|Myelodysplastic syndrome|myelodysplastic syndrome
373904|NCT01542944|Stem Cell Mobilization|stem cell mobilization
373905|NCT01542944|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
373906|NCT01542931|Oral squamous cell carcinoma|oral squamous cell carcinoma
373907|NCT01542931|Induction chemotherapy|induction chemotherapy
373908|NCT01542931|Surgery|surgery
373909|NCT01542931|Radiotherapy|radiotherapy
373910|NCT01542918|Recurrent|recurrent
373911|NCT01542918|Refractory|refractory
373912|NCT01542918|CNS|cns
373913|NCT01542918|Intraocular|intraocular
373914|NCT01542918|Lymphoma|lymphoma
373915|NCT01542892|Sarcopenia|sarcopenia
373916|NCT01542892|Nutrition|nutrition
373917|NCT01542892|Vitamin D|vitamin d
373918|NCT01542892|Exercise|exercise
373919|NCT01542866|ranibizumab|ranibizumab
373920|NCT01542866|Age related Macular Degeneration|age related macular degeneration
373921|NCT01542866|AMD|amd
373922|NCT01542866|Health Management Tool|health management tool
373923|NCT01542866|HMT|hmt
373924|NCT01542866|Best Corrected Visual Acuity|best corrected visual acuity
373925|NCT01542866|Investigator's Clinical Judgement of Change|investigator's clinical judgement of change
373926|NCT01542866|Choroidal Neovascularization|choroidal neovascularization
373927|NCT01542866|Central Retinal Subfield Thickness|central retinal subfield thickness
373928|NCT01542866|visual function self test|visual function self test
373929|NCT01542840|surgery|surgery
373930|NCT01542840|orthopedic surgery|orthopedic surgery
373931|NCT01542840|foot surgery|foot surgery
373932|NCT01542840|leg surgery|leg surgery
373933|NCT01542840|ankle surgery|ankle surgery
373934|NCT01542840|leg|leg
373935|NCT01542840|foot|foot
373936|NCT01542840|ankle|ankle
373937|NCT01542840|anesthesia|anesthesia
373938|NCT01542840|local anesthesia|local anesthesia
373939|NCT01542840|regional anesthesia|regional anesthesia
373940|NCT01542840|Ochsner Clinic|ochsner clinic
373941|NCT01542840|Ochsner Hospital|ochsner hospital
373942|NCT01542840|New Orleans|new orleans
373943|NCT01542840|Louisiana|louisiana
373944|NCT01542840|Kristie Osteen, MD|kristie osteen, md
373945|NCT01542827|neck pain|neck pain
373946|NCT01542827|menthol|menthol
373947|NCT01542814|Screening Mammogram|screening mammogram
373948|NCT01542814|Diagnostic Mammogram|diagnostic mammogram
373949|NCT01542814|Benign|benign
373950|NCT01542814|Malignant|malignant
373951|NCT01542814|BI-RADS Categories|bi-rads categories
373952|NCT01542801|Effect of Preventive Antibiotics|effect of preventive antibiotics
373953|NCT01542788|HCV genotype 2 (GT-2)|hcv genotype 2 (gt-2)
373954|NCT01542788|HCV genotype 3 (GT-3)|hcv genotype 3 (gt-3)
373955|NCT01542788|HCV|hcv
373956|NCT01542788|Sustained Virologic Response|sustained virologic response
373957|NCT01542788|Direct Acting Antiviral|direct acting antiviral
373958|NCT01542788|Combination Therapy|combination therapy
373959|NCT01542788|Interferon intolerant|interferon intolerant
373960|NCT01542788|Interferon ineligible|interferon ineligible
373961|NCT01542788|GS-7977|gs-7977
373962|NCT01542788|Ribavirin|ribavirin
373963|NCT01542762|Deep venous thrombosis|deep venous thrombosis
373964|NCT01542762|Pulmonary Embolism|pulmonary embolism
373965|NCT01542762|Lower leg Cast immobilization|lower leg cast immobilization
373966|NCT01542749|BVA-100 Blood volume analyzer|bva-100 blood volume analyzer
373967|NCT01542749|Human serum albumin labeled with Iodine 131|human serum albumin labeled with iodine 131
373968|NCT01542723|Deep venous thrombosis|deep venous thrombosis
373969|NCT01542723|Pulmonary Embolism|pulmonary embolism
373970|NCT01542723|Arthroscopy of the knee|arthroscopy of the knee
373971|NCT01542697|magnesium sulpahate|magnesium sulpahate
373972|NCT01542697|postoperative analgesia|postoperative analgesia
373973|NCT01542684|Leukemia|leukemia
373974|NCT01542684|Myelodysplastic Syndrome|myelodysplastic syndrome
373975|NCT01542684|MDS|mds
373976|NCT01542684|Azacytidine|azacytidine
373977|NCT01542684|5-Azacytidine|5-azacytidine
373978|NCT01542684|5-AZA|5-aza
373979|NCT01542684|Vidaza|vidaza
373980|NCT01542684|5-AZC|5-azc
373981|NCT01542684|Aza-CR|aza-cr
373982|NCT01542684|Ladakamycin|ladakamycin
373983|NCT01542684|NSC-102816|nsc-102816
373984|NCT01542684|GM-CSF|gm-csf
373985|NCT01542684|Sargramostim|sargramostim
373986|NCT01542684|Leukine|leukine
373987|NCT01542671|lifestyle change|lifestyle change
373988|NCT01542671|obesity treatment|obesity treatment
373989|NCT01542671|physical activity|physical activity
373990|NCT01542671|primary care|primary care
373991|NCT01542671|quality of life|quality of life
373992|NCT01542645|Fentanyl|fentanyl
373993|NCT01542645|Methadone|methadone
373994|NCT01542645|Thoracic Surgery|thoracic surgery
374091|NCT01542203|Breast Cancer|breast cancer
373995|NCT01542632|safety and immunogenicity of dengue vaccine|safety and immunogenicity of dengue vaccine
373996|NCT01542606|PH|ph
373997|NCT01542606|SCREENING|screening
373998|NCT01542606|EARLY WARNING|early warning
373999|NCT01542606|VAGINAL HEALTH|vaginal health
374000|NCT01542606|VAGINAL SECRETION|vaginal secretion
374001|NCT01542606|VAGINAL PH|vaginal ph
374002|NCT01542580|Revision surgery|revision surgery
374003|NCT01542567|Diclofenac|diclofenac
374004|NCT01542567|BCG|bcg
374005|NCT01542567|BLADDER IRRIGATIONS|bladder irrigations
374006|NCT01542554|Diabetes mellitus|diabetes mellitus
374007|NCT01542554|Chinese|chinese
374008|NCT01542554|Glycaemic index|glycaemic index
374009|NCT01542528|ADHD|adhd
374010|NCT01542528|Executive function|executive function
374011|NCT01542528|Inhibitory control|inhibitory control
374012|NCT01542528|Computer games|computer games
374013|NCT01542528|Sports activities|sports activities
374014|NCT01542528|Good Behavior Game|good behavior game
374015|NCT01542515|Allograft|allograft
374016|NCT01542515|Arthroplasty|arthroplasty
374017|NCT01542515|Basal Joint|basal joint
374018|NCT01542515|carpometacarpal joint|carpometacarpal joint
374019|NCT01542515|Thumb|thumb
374020|NCT01542515|meniscus|meniscus
374021|NCT01542515|osteoarthritis|osteoarthritis
374022|NCT01542515|Patients with Stages I - III arthritis of the the thumb carpometacarpal joint|patients with stages i - iii arthritis of the the thumb carpometacarpal joint
374023|NCT01542502|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
374024|NCT01542502|Diastolic heart failure|diastolic heart failure
374025|NCT01542502|Aerobic exercise performance|aerobic exercise performance
374026|NCT01542437|Non-Small Cell Lung Cancer|non-small cell lung cancer
374027|NCT01542398|community-based|community-based
374028|NCT01542398|war-affected|war-affected
374029|NCT01542398|psychosocial support|psychosocial support
374030|NCT01542398|family-focused|family-focused
374031|NCT01542398|psychological distress|psychological distress
374032|NCT01542398|adolescents|adolescents
374033|NCT01542398|Democratic Republic of Congo|democratic republic of congo
374034|NCT01542398|family functioning|family functioning
374035|NCT01542398|community functioning|community functioning
374036|NCT01542398|daily functioning|daily functioning
374037|NCT01542385|Delayed stenting|delayed stenting
374038|NCT01542385|Deferred stenting|deferred stenting
374039|NCT01542385|Late stenting|late stenting
374040|NCT01542385|postponed stenting|postponed stenting
374041|NCT01542385|Thrombectomy|thrombectomy
374042|NCT01542385|Percutaneous coronary intervention|percutaneous coronary intervention
374043|NCT01542385|PCI|pci
374044|NCT01542385|Angioplasty|angioplasty
374045|NCT01542385|STEMI|stemi
374046|NCT01542385|acute myocardial infarction|acute myocardial infarction
374047|NCT01542372|PTSD|ptsd
374048|NCT01542372|Cognitive behavioral therapy (CBT)|cognitive behavioral therapy (cbt)
374049|NCT01542372|Medication augmentation|medication augmentation
374050|NCT01542372|Treatment-resistant PTSD|treatment-resistant ptsd
374051|NCT01542372|Cambodian refugees|cambodian refugees
374052|NCT01542372|Culturally sensitive treatment|culturally sensitive treatment
374053|NCT01542359|Yoga, Hypertension|yoga, hypertension
374054|NCT01542359|Blood Pressure|blood pressure
374055|NCT01542359|Autonomic Nervous system|autonomic nervous system
374056|NCT01542346|Wound closure|wound closure
374057|NCT01542346|cosmetic outcome|cosmetic outcome
374058|NCT01542333|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
374059|NCT01542333|stage I Wilms tumor|stage i wilms tumor
374060|NCT01542333|stage II Wilms tumor|stage ii wilms tumor
374061|NCT01542333|stage III Wilms tumor|stage iii wilms tumor
374062|NCT01542333|stage IV Wilms tumor|stage iv wilms tumor
374063|NCT01542333|stage V Wilms tumor|stage v wilms tumor
374064|NCT01542320|probiotic|probiotic
374065|NCT01542320|Lactobacillus reuteri DSM 17938|lactobacillus reuteri dsm 17938
374066|NCT01542320|healthy infants|healthy infants
374067|NCT01542307|migraine|migraine
374068|NCT01542307|oxygen therapy|oxygen therapy
374069|NCT01542294|gastric cancer|gastric cancer
374070|NCT01542294|S-1|s-1
374071|NCT01542294|oxaliplatin|oxaliplatin
374072|NCT01542294|adjuvant chemotherapy|adjuvant chemotherapy
374073|NCT01542281|liver resection|liver resection
374074|NCT01542281|hepatectomy|hepatectomy
374075|NCT01542281|pre-habilitation|pre-habilitation
374076|NCT01542268|pentoxifylline|pentoxifylline
374077|NCT01542268|tight junction signalling|tight junction signalling
374078|NCT01542268|intestinal epithelial barrier|intestinal epithelial barrier
374079|NCT01542268|irritable bowel syndrome|irritable bowel syndrome
374080|NCT01542255|Metronomic Therapy|metronomic therapy
374081|NCT01542255|Metastatic Melanoma|metastatic melanoma
374082|NCT01542255|Vinblastine|vinblastine
374083|NCT01542255|Cyclophosphamide|cyclophosphamide
374084|NCT01542255|Dacarbazine|dacarbazine
374085|NCT01542242|Diabetes Mellitus Type 2|diabetes mellitus type 2
374086|NCT01542242|Prader Willi Syndrome|prader willi syndrome
374087|NCT01542229|Post Traumatic Stress Disorder|post traumatic stress disorder
374088|NCT01542229|Severe Mental Illness|severe mental illness
374089|NCT01542203|doxorubicin|doxorubicin
374090|NCT01542203|cyclophosphamide|cyclophosphamide
374093|NCT01542190|cataract surgery|cataract surgery
374094|NCT01542190|cystoid macular edema|cystoid macular edema
374095|NCT01542190|angiography|angiography
374096|NCT01542177|hypoxia|hypoxia
374097|NCT01542177|pancreas|pancreas
374098|NCT01542177|cancer|cancer
374099|NCT01542177|pancreatic cancer|pancreatic cancer
374100|NCT01542177|18F-FAZA|18f-faza
374101|NCT01542177|18F-Fluoroazomycin Arabinoside|18f-fluoroazomycin arabinoside
374102|NCT01542177|Positron Emission Tomography|positron emission tomography
374103|NCT01542177|PET|pet
374104|NCT01542164|Calcium intake|calcium intake
374105|NCT01542164|Fat excretion|fat excretion
374106|NCT01542164|Energy excretion|energy excretion
374107|NCT01542164|Gut micro flora|gut micro flora
374108|NCT01542151|Labor, induced|labor, induced
374109|NCT01542151|Sleep|sleep
374110|NCT01542151|Fatigue|fatigue
374111|NCT01542151|Patient satisfaction|patient satisfaction
374112|NCT01542151|Circadian rhythm|circadian rhythm
374113|NCT01542138|Inflammatory hyperpigmentation, axillar pigmentation|inflammatory hyperpigmentation, axillar pigmentation
374114|NCT01542125|Patients aged 3 to 16 years presenting for|patients aged 3 to 16 years presenting for
374115|NCT01542125|removal of smooth percutaneous interosseus pins|removal of smooth percutaneous interosseus pins
374116|NCT01542125|after orthopeadic surgery|after orthopeadic surgery
374117|NCT01542112|Patient-Centered Care|patient-centered care
374118|NCT01542112|Patient Satisfaction|patient satisfaction
374119|NCT01542112|Interventional study|interventional study
374120|NCT01542112|Patient Expectations|patient expectations
374121|NCT01542112|Hospitalization|hospitalization
374122|NCT01542086|intermediate pre-test|intermediate pre-test
374123|NCT01542086|probability of significant coronary heart disease|probability of significant coronary heart disease
374124|NCT01542073|myocardial infarction|myocardial infarction
374125|NCT01542073|angiogenesis|angiogenesis
374126|NCT01542073|integrin receptor imaging|integrin receptor imaging
374127|NCT01542073|68Ga-BNOTA-PRGD2|68ga-bnota-prgd2
374128|NCT01542047|Metastatic|metastatic
374129|NCT01542047|Solid tumors|solid tumors
374130|NCT01542047|carboplatin|carboplatin
374131|NCT01542047|Paraplatin|paraplatin
374132|NCT01542047|Pazopanib|pazopanib
374133|NCT01542047|Votrient|votrient
374134|NCT01542047|Alkylating agent|alkylating agent
374135|NCT01542047|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
374136|NCT01542047|Metastatic disease|metastatic disease
374137|NCT01542021|prostate|prostate
374138|NCT01542021|Degarelix|degarelix
374139|NCT01542021|injections|injections
374140|NCT01542021|radical prostatectomy|radical prostatectomy
374141|NCT01542021|11-182|11-182
374142|NCT01541995|contrast medium enhanced post mortem CT|contrast medium enhanced post mortem ct
374143|NCT01541995|virtual autopsy|virtual autopsy
374144|NCT01541995|To evaluate the value of contrast medium enhanced post-mortem CT in virtual autopsy focussing on thromboembolic and vascular conditions|to evaluate the value of contrast medium enhanced post-mortem ct in virtual autopsy focussing on thromboembolic and vascular conditions
374145|NCT01541969|Ear|ear
374146|NCT01541969|Hearing|hearing
374147|NCT01541956|type 2 diabetes;|type 2 diabetes;
374148|NCT01541956|vildagliptin;|vildagliptin;
374149|NCT01541956|metformin;|metformin;
374150|NCT01541943|Atorvastatin|atorvastatin
374151|NCT01541943|Losartan|losartan
374152|NCT01541943|Essential Hypertension|essential hypertension
374153|NCT01541943|Hyperlipidemia|hyperlipidemia
374154|NCT01541904|Ocular Allergy.|ocular allergy.
374155|NCT01541904|Seasonal Allergic Conjunctivitis|seasonal allergic conjunctivitis
374156|NCT01541904|Perennial Allergic Conjunctivitis|perennial allergic conjunctivitis
374157|NCT01541904|Conjunctivitis, Allergic|conjunctivitis, allergic
374158|NCT01541904|Ocular Antihistamines.|ocular antihistamines.
374159|NCT01541891|PRO-148|pro-148
374160|NCT01541891|Dry eye syndrome|dry eye syndrome
374161|NCT01541865|hypertension, renal denervation, uncontrolled hypertension, medication resistant hypertension|hypertension, renal denervation, uncontrolled hypertension, medication resistant hypertension
374162|NCT01541852|Vascular Inflammation|vascular inflammation
374163|NCT01541852|FDG PET-CT|fdg pet-ct
374164|NCT01541852|COPD|copd
374165|NCT01541852|Atherosclerosis|atherosclerosis
374166|NCT01541852|p38 MAP kinase inhibitor|p38 map kinase inhibitor
374167|NCT01541839|Nasal septum|nasal septum
374168|NCT01541839|Nasal surgical procedures|nasal surgical procedures
374169|NCT01541826|aronia|aronia
374170|NCT01541826|LDL cholesterol|ldl cholesterol
374171|NCT01541826|polyphenols|polyphenols
374172|NCT01541826|bioavailability|bioavailability
374173|NCT01541826|oxidative stress|oxidative stress
374174|NCT01541813|Rare iron overload|rare iron overload
374175|NCT01541813|hepcidin|hepcidin
374176|NCT01541774|Atherectomy|atherectomy
374177|NCT01541774|Atherosclerosis|atherosclerosis
374178|NCT01541774|Peripheral artery disease|peripheral artery disease
374179|NCT01541761|Obesity|obesity
374180|NCT01541761|Child|child
374181|NCT01541761|Hispanic|hispanic
374182|NCT01541761|Prevention|prevention
374183|NCT01541761|Nutrition|nutrition
374184|NCT01541761|Parenting|parenting
374185|NCT01541735|Diabetes|diabetes
374186|NCT01541735|Insulin|insulin
374187|NCT01541735|Pantoprazole|pantoprazole
374188|NCT01541722|Urea cycle disorders|urea cycle disorders
374189|NCT01541709|This is a single-center|this is a single-center
374190|NCT01541709|prospective|prospective
374191|NCT01541709|single-arm|single-arm
374192|NCT01541709|open-label phase II study|open-label phase ii study
374193|NCT01541696|zinc|zinc
374194|NCT01541696|zn|zn
374195|NCT01541696|EZP (exchangeable zinc pools)multivitamin MN|ezp (exchangeable zinc pools)multivitamin mn
374196|NCT01541683|PEG-electrolyte solution|peg-electrolyte solution
374197|NCT01541683|bowel cleansing|bowel cleansing
374198|NCT01541683|Mentholyptus drops|mentholyptus drops
374199|NCT01541683|Palatability|palatability
374200|NCT01541657|Ankle Instability|ankle instability
374201|NCT01541657|Sensorimotor Control|sensorimotor control
374202|NCT01541657|Sensory|sensory
374203|NCT01541657|Postural Control|postural control
374204|NCT01541657|Balance|balance
374205|NCT01541657|Gait|gait
374206|NCT01541644|Acupuncture Therapy|acupuncture therapy
374207|NCT01541644|bortezomib-induced peripheral neuropathy|bortezomib-induced peripheral neuropathy
374208|NCT01541631|Human Immunodeficiency Virus-1|human immunodeficiency virus-1
374209|NCT01541631|Schistosoma mansoni|schistosoma mansoni
374210|NCT01541631|Anemia|anemia
374211|NCT01541631|Immune response|immune response
374212|NCT01541631|Opportunistic infections|opportunistic infections
374213|NCT01541631|Tanzania|tanzania
374214|NCT01541618|MS|ms
374215|NCT01541618|RRMS|rrms
374216|NCT01541618|RR Multiple Sclerosis|rr multiple sclerosis
374217|NCT01541592|Insulin resistance|insulin resistance
374218|NCT01541592|Endothelial dysfunction|endothelial dysfunction
374219|NCT01541592|saturated fat|saturated fat
374220|NCT01541592|monounsaturated fat|monounsaturated fat
374221|NCT01541592|polyunsaturated fat|polyunsaturated fat
374222|NCT01541579|Perianal fistulising Crohn's disease.|perianal fistulising crohn's disease.
374223|NCT01541566|arterial hypertension|arterial hypertension
374224|NCT01541566|metabolic syndrome|metabolic syndrome
374225|NCT01541566|home blood pressure|home blood pressure
374226|NCT01541566|ambulatory blood pressure|ambulatory blood pressure
374227|NCT01541566|office blood pressure|office blood pressure
374228|NCT01541566|telemedicine|telemedicine
374229|NCT01541527|non neutralizing antibody|non neutralizing antibody
374230|NCT01541527|Epitopic profile|epitopic profile
374231|NCT01541527|Clinical relevance|clinical relevance
374232|NCT01541501|Central Corneal Thickness|central corneal thickness
374233|NCT01541501|Pachymetry|pachymetry
374234|NCT01541462|mechanical ventilation|mechanical ventilation
374235|NCT01541462|weaning|weaning
374236|NCT01541462|pressure support|pressure support
374237|NCT01541462|spontaneous breathing|spontaneous breathing
374238|NCT01541462|Long-term acute care facility|long-term acute care facility
374239|NCT01541462|mortality|mortality
374240|NCT01541449|AMD|amd
374241|NCT01541449|PLAQUENIL|plaquenil
374242|NCT01541449|CNV|cnv
374243|NCT01541436|Remote Ischemic Preconditioning|remote ischemic preconditioning
374244|NCT01541436|Nociception|nociception
374245|NCT01541436|Central Sensitization|central sensitization
374246|NCT01541436|Peripheral Sensitization|peripheral sensitization
374247|NCT01541397|Hyperphenylalaninemia|hyperphenylalaninemia
374248|NCT01541397|Phenylketonuria|phenylketonuria
374249|NCT01541397|Adults|adults
374250|NCT01541397|Bone Mineral Density|bone mineral density
374251|NCT01541384|Kidney transplant|kidney transplant
374252|NCT01541384|Adherence|adherence
374253|NCT01541384|Electronic pill bottles|electronic pill bottles
374254|NCT01541371|Schizophrenia|schizophrenia
374255|NCT01541371|Paliperidone extended-release tablets|paliperidone extended-release tablets
374256|NCT01541332|relapsed refractory|relapsed refractory
374257|NCT01541332|multiple myeloma|multiple myeloma
374258|NCT01541332|pomalidomide|pomalidomide
374259|NCT01541332|Doxil|doxil
374260|NCT01541332|dexamethasone|dexamethasone
374261|NCT01541332|Oncotherapeutics|oncotherapeutics
374262|NCT01541319|Cardiac Surgery|cardiac surgery
374263|NCT01541319|Erythrocyte Transfusion|erythrocyte transfusion
374264|NCT01541306|C-type natriuretic peptide|c-type natriuretic peptide
374265|NCT01541306|dwarfism|dwarfism
374266|NCT01541306|growth|growth
374267|NCT01541306|achondroplasia|achondroplasia
374268|NCT01541306|hypochondroplasia|hypochondroplasia
374269|NCT01541306|biomarker|biomarker
374270|NCT01541293|Abortion, Induced|abortion, induced
374271|NCT01541293|Laminaria|laminaria
374272|NCT01541293|Pain management|pain management
374273|NCT01541293|Cervical preparation|cervical preparation
374274|NCT01541293|Dilation and Evacuation|dilation and evacuation
374275|NCT01541280|Allogreffe, LAM , MDS|allogreffe, lam , mds
374276|NCT01541280|Azacitidine (VidazaÒ)|azacitidine (vidazaò)
374277|NCT01541280|Injection de lymphocytes de donneur (DLI)|injection de lymphocytes de donneur (dli)
374278|NCT01541267|aliskiren|aliskiren
374279|NCT01541267|eplerenon|eplerenon
374280|NCT01541267|telmisartan|telmisartan
374281|NCT01541267|direct renin inhibitor|direct renin inhibitor
374282|NCT01541267|ACE inhibitor|ace inhibitor
374283|NCT01541267|mineralocorticoid inhibitor|mineralocorticoid inhibitor
374284|NCT01541267|proteinuria|proteinuria
374285|NCT01541267|chronic kidney diseases|chronic kidney diseases
374286|NCT01541267|renin-angiotensin-aldosterone system|renin-angiotensin-aldosterone system
374287|NCT01541254|intracranial aneurysm|intracranial aneurysm
374288|NCT01541254|wide-neck|wide-neck
374289|NCT01541254|saccular|saccular
374290|NCT01541254|endovascular treatment|endovascular treatment
374291|NCT01541254|coil embolization|coil embolization
374292|NCT01541254|stent|stent
374293|NCT01541254|bare platinum|bare platinum
374294|NCT01541241|Intrauterine contraceptive device (IUD) is one of the most frequently used methods of birth control around the world|intrauterine contraceptive device (iud) is one of the most frequently used methods of birth control around the world
374295|NCT01541241|Uterine Hemodynamic changes|uterine hemodynamic changes
374296|NCT01541228|actinic keratosis|actinic keratosis
374297|NCT01541228|photodynamic therapy|photodynamic therapy
374298|NCT01541228|5-aminolevulinic acid|5-aminolevulinic acid
374299|NCT01541202|chronic heart failure|chronic heart failure
374300|NCT01541202|neuregulin|neuregulin
374301|NCT01541202|mortality|mortality
374302|NCT01541189|hypertension|hypertension
374303|NCT01541189|valsartan|valsartan
374304|NCT01541176|Corticotherapy|corticotherapy
374305|NCT01541176|Fibrosis|fibrosis
374306|NCT01541176|Numerical reading|numerical reading
374307|NCT01541176|18-70 years|18-70 years
374308|NCT01541176|first renal transplant was lost due to rejection|first renal transplant was lost due to rejection
374309|NCT01541176|first or second renal transplant|first or second renal transplant
374310|NCT01541163|Ischemia|ischemia
374311|NCT01541163|Brain Infarction|brain infarction
374312|NCT01541163|Acute Stroke|acute stroke
374313|NCT01541163|Heart Diseases|heart diseases
374314|NCT01541163|Myocardial Infarction|myocardial infarction
374315|NCT01541150|Pedophilia|pedophilia
374316|NCT01541150|Impaired Decision making|impaired decision making
374317|NCT01541150|Insight|insight
374318|NCT01541150|Cognitive Distorsions|cognitive distorsions
374319|NCT01541150|Impulsiveness|impulsiveness
374320|NCT01541137|thoracotomy|thoracotomy
374321|NCT01541137|pain|pain
374322|NCT01541137|NSAID|nsaid
374323|NCT01541137|PCA|pca
374324|NCT01541137|TEA|tea
374325|NCT01541137|chronic|chronic
374326|NCT01541124|cancer pain|cancer pain
374327|NCT01541124|analgesia|analgesia
374328|NCT01541124|morphine|morphine
374329|NCT01541111|Cancer pain|cancer pain
374330|NCT01541111|Magnesiun|magnesiun
374331|NCT01541085|Human Immunodeficiency Virus; HIV; Highly Active Antiretroviral Therapy; HAART; Darunavir; Ritonavir; Efavirenz; Kinetics; Immunological Recovery|human immunodeficiency virus; hiv; highly active antiretroviral therapy; haart; darunavir; ritonavir; efavirenz; kinetics; immunological recovery
374332|NCT01541072|Lymphoma, B-cell|lymphoma, b-cell
374333|NCT01541072|Lymphocyte reconstitution|lymphocyte reconstitution
374334|NCT01541072|Lymphocyte subsets|lymphocyte subsets
374335|NCT01541072|Peripheral stem cell transplantation|peripheral stem cell transplantation
374336|NCT01541072|Induction chemotherapy|induction chemotherapy
374337|NCT01541072|growth factor|growth factor
374338|NCT01541072|Granulocyte Colony-stimulating factor|granulocyte colony-stimulating factor
374339|NCT01541072|Pegfilgrastim|pegfilgrastim
374340|NCT01541072|Filgrastim|filgrastim
374341|NCT01541059|Third molar extraction|third molar extraction
374342|NCT01541059|local anesthesia|local anesthesia
374343|NCT01541059|ropivacaine|ropivacaine
374344|NCT01541046|pediatric|pediatric
374345|NCT01541046|infantile colic|infantile colic
374346|NCT01541046|probiotic treatment|probiotic treatment
374347|NCT01541033|autism|autism
374348|NCT01541033|children|children
374349|NCT01541007|Prostate Cancer|prostate cancer
374350|NCT01541007|Metastatic|metastatic
374351|NCT01541007|Castration Resistant|castration resistant
374352|NCT01540994|Neoplasms|neoplasms
374353|NCT01540994|Urogenital neoplasm|urogenital neoplasm
374354|NCT01540994|Genital neoplasms, male|genital neoplasms, male
374355|NCT01540955|Reduce Cognitive Complaints|reduce cognitive complaints
374356|NCT01540955|improve cognitive function|improve cognitive function
374357|NCT01540955|post-treatment breast cancer patients|post-treatment breast cancer patients
374358|NCT01540942|Crohn's disease|crohn's disease
374359|NCT01540942|Nutrition|nutrition
374360|NCT01540942|Bowel resection|bowel resection
374361|NCT01540942|Postoperative recurrence|postoperative recurrence
374362|NCT01540942|complication|complication
374363|NCT01540942|Active disease|active disease
374364|NCT01540929|Smallpox|smallpox
374365|NCT01540929|ACAM2000®|acam2000®
374366|NCT01540929|Smallpox vaccine|smallpox vaccine
374367|NCT01540916|acid-base equilibrium|acid-base equilibrium
374368|NCT01540916|renal system|renal system
374369|NCT01540916|urinary electrolytes|urinary electrolytes
374370|NCT01540903|Malaria Challenge|malaria challenge
374371|NCT01540903|Plasmodium falciparum|plasmodium falciparum
374372|NCT01540903|PfSPZ Challenge|pfspz challenge
374373|NCT01540903|Controlled|controlled
374374|NCT01540903|human|human
374375|NCT01540903|malaria infection|malaria infection
374376|NCT01540864|Obesity|obesity
374377|NCT01540864|Overweight|overweight
374378|NCT01540864|Body Mass Index|body mass index
374379|NCT01540851|Osteoarthritis|osteoarthritis
374380|NCT01540851|Total Knee Replacement|total knee replacement
374667|NCT01539343|Infection|infection
374381|NCT01540851|total Knee Arthroplasty|total knee arthroplasty
374382|NCT01540851|Post operative recovery, TKA|post operative recovery, tka
374383|NCT01540851|Post-operative recovery TKR|post-operative recovery tkr
374384|NCT01540851|Care Navigator|care navigator
374385|NCT01540838|Bacterial meningitis|bacterial meningitis
374386|NCT01540838|infusion|infusion
374387|NCT01540838|bolus|bolus
374388|NCT01540838|paracetamol|paracetamol
374389|NCT01540812|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
374390|NCT01540799|Migraine|migraine
374391|NCT01540799|High disability migraine|high disability migraine
374392|NCT01540799|Sphenopalatine ganglion|sphenopalatine ganglion
374393|NCT01540799|Neuromodulation|neuromodulation
374394|NCT01540799|Neurostimulation|neurostimulation
374395|NCT01540799|Autonomic nervous system|autonomic nervous system
374396|NCT01540786|OAB|oab
374397|NCT01540786|High Resolution Urodynamics|high resolution urodynamics
374398|NCT01540773|growth hormone|growth hormone
374399|NCT01540747|intrafollicular melatonin|intrafollicular melatonin
374400|NCT01540747|PCOS|pcos
374401|NCT01540747|embryos quality|embryos quality
374402|NCT01540747|oocytes quality|oocytes quality
374403|NCT01540734|paracetamol|paracetamol
374404|NCT01540734|pharmacokinetic|pharmacokinetic
374405|NCT01540721|paracetamol|paracetamol
374406|NCT01540721|pharmacokinetics|pharmacokinetics
374407|NCT01540708|Asthma|asthma
374408|NCT01540708|Respiratory|respiratory
374409|NCT01540708|COPD|copd
374410|NCT01540695|Any patient with a routine basal cell or squamous cell carcinoma|any patient with a routine basal cell or squamous cell carcinoma
374411|NCT01540695|of the skin diagnosed on frozen histology during a Mohs procedure|of the skin diagnosed on frozen histology during a mohs procedure
374412|NCT01540682|Male and female patients with HNSCC of the oral cavity, oropharynx, hypopharynx, larynx,|male and female patients with hnscc of the oral cavity, oropharynx, hypopharynx, larynx,
374413|NCT01540682|nasopharynx or paranasal sinuses that is considered appropriate|nasopharynx or paranasal sinuses that is considered appropriate
374414|NCT01540682|for definitive cetuximab-based radiation therapy.|for definitive cetuximab-based radiation therapy.
374415|NCT01540669|constipation|constipation
374416|NCT01540669|functional constipation|functional constipation
374417|NCT01540669|polydextrose|polydextrose
374418|NCT01540669|whole gut transit time|whole gut transit time
374419|NCT01540656|Stress incontinence|stress incontinence
374420|NCT01540656|Incontinence|incontinence
374421|NCT01540656|prostate cancer|prostate cancer
374422|NCT01540656|Radical Prostatectomy vibration|radical prostatectomy vibration
374423|NCT01540656|nerve stimulation|nerve stimulation
374424|NCT01540643|abdominal aortic aneurysm|abdominal aortic aneurysm
374425|NCT01540643|iliac leg graft|iliac leg graft
374426|NCT01540617|Low back pain|low back pain
374427|NCT01540617|Proprioception|proprioception
374428|NCT01540617|Postural control|postural control
374429|NCT01540617|Spine|spine
374430|NCT01540617|Variability|variability
374431|NCT01540617|MRI|mri
374432|NCT01540617|Vibration|vibration
374433|NCT01540617|Brain|brain
374434|NCT01540604|DMD|dmd
374435|NCT01540604|BMD|bmd
374436|NCT01540604|symptomatic carriers|symptomatic carriers
374437|NCT01540591|repeated implantation failure|repeated implantation failure
374438|NCT01540591|intralipid|intralipid
374439|NCT01540552|lung cancer|lung cancer
374440|NCT01540552|precancerous condition|precancerous condition
374441|NCT01540552|lung nodules|lung nodules
374442|NCT01540552|CT Scan|ct scan
374443|NCT01540500|Pharmacokinetics|pharmacokinetics
374444|NCT01540500|Drug Interaction|drug interaction
374445|NCT01540474|Interference of malaria infection|interference of malaria infection
374446|NCT01540461|HCC|hcc
374447|NCT01540435|Colorectal cancer|colorectal cancer
374448|NCT01540435|Liver metastases|liver metastases
374449|NCT01540435|Perioperative treatment|perioperative treatment
374450|NCT01540435|Liver resection|liver resection
374451|NCT01540422|vein grafts|vein grafts
374452|NCT01540422|coronary bypass|coronary bypass
374453|NCT01540422|endoscopic harvest|endoscopic harvest
374454|NCT01540422|endoscopic vein harvest|endoscopic vein harvest
374455|NCT01540409|DMD, Duchenne, Eteplirsen, dystrophy, dystrophin, exon 51|dmd, duchenne, eteplirsen, dystrophy, dystrophin, exon 51
374456|NCT01540396|Gestational Diabetes|gestational diabetes
374457|NCT01540383|Communication|communication
374458|NCT01540383|Language|language
374459|NCT01540383|Treatment|treatment
374460|NCT01540383|Intervention|intervention
374461|NCT01540383|Therapy|therapy
374462|NCT01540383|Efficacy|efficacy
374463|NCT01540383|Maintenance|maintenance
374464|NCT01540383|Recovery|recovery
374465|NCT01540383|Outcome|outcome
374466|NCT01540383|Rehabilitation|rehabilitation
374467|NCT01540383|Treatment Intensity|treatment intensity
374468|NCT01540383|Language Impairment|language impairment
374469|NCT01540383|Intensive Language Therapy|intensive language therapy
374470|NCT01540383|Functional Communication|functional communication
374471|NCT01540383|Functional Improvement|functional improvement
374472|NCT01540383|Evidence-Based Intervention|evidence-based intervention
374473|NCT01540383|High-Frequency|high-frequency
374474|NCT01540357|mindfulness-based therapy|mindfulness-based therapy
374475|NCT01540357|chronic tinnitus;|chronic tinnitus;
374476|NCT01540344|peritoneal carcinomatosis|peritoneal carcinomatosis
374477|NCT01540344|cytoreductive surgery|cytoreductive surgery
374478|NCT01540344|HIPEC|hipec
374479|NCT01540344|colorectal cancer|colorectal cancer
374480|NCT01540318|ultrasonography|ultrasonography
374481|NCT01540318|Abdominal Injuries|abdominal injuries
374482|NCT01540318|Trauma|trauma
374483|NCT01540305|Obsessive Compulsive Disorder|obsessive compulsive disorder
374484|NCT01540305|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
374485|NCT01540305|Treatment|treatment
374486|NCT01540292|Crohn's disease|crohn's disease
374487|NCT01540292|Mesenchymal Stem Cell|mesenchymal stem cell
374488|NCT01540292|Cell therapy|cell therapy
374489|NCT01540292|Allogeneic|allogeneic
374490|NCT01540292|Inflammatory disorders|inflammatory disorders
374491|NCT01540292|Autoimmune disorders|autoimmune disorders
374492|NCT01540266|physician-patient communication|physician-patient communication
374493|NCT01540266|information structuring|information structuring
374494|NCT01540266|emergency department|emergency department
374495|NCT01540240|HIV treatment|hiv treatment
374496|NCT01540240|zidovudine|zidovudine
374497|NCT01540240|dose reduction|dose reduction
374498|NCT01540240|anaemia|anaemia
374499|NCT01540240|safety and efficacy comparison|safety and efficacy comparison
374500|NCT01540227|Syphilis|syphilis
374501|NCT01540227|Penicillin|penicillin
374502|NCT01540214|Urinary Bladder, Overactive|urinary bladder, overactive
374503|NCT01540214|Pelvic Organ Prolapse|pelvic organ prolapse
374504|NCT01540214|Gynecologic Surgical Procedures|gynecologic surgical procedures
374505|NCT01540214|Urodynamics|urodynamics
374506|NCT01540201|one lung ventilation|one lung ventilation
374507|NCT01540201|gas exchange|gas exchange
374508|NCT01540201|inverse-ratio ventilation|inverse-ratio ventilation
374509|NCT01540188|Drug user|drug user
374510|NCT01540188|Family member|family member
374511|NCT01540188|Intervention|intervention
374512|NCT01540188|Community|community
374513|NCT01540188|Support|support
374514|NCT01540175|Autologous stem cell transplant|autologous stem cell transplant
374515|NCT01540175|Immune reconstitution|immune reconstitution
374516|NCT01540162|preterm newborn|preterm newborn
374517|NCT01540162|neonatology|neonatology
374518|NCT01540162|EcN|ecn
374519|NCT01540162|Nissle|nissle
374520|NCT01540162|Mutaflor|mutaflor
374521|NCT01540162|prophylaxis|prophylaxis
374522|NCT01540162|infection|infection
374523|NCT01540110|Locally Advanced or Node Positive Primary Breast Cancer|locally advanced or node positive primary breast cancer
374524|NCT01540084|Cocktail sedation|cocktail sedation
374525|NCT01540084|ERCP|ercp
374776|NCT01539083|Consolidation therapy|consolidation therapy
374526|NCT01540071|Hormone refractory prostate cancer|hormone refractory prostate cancer
374527|NCT01540071|HRPC|hrpc
374528|NCT01540071|Androgen independent prostate cancer|androgen independent prostate cancer
374529|NCT01540071|CRPC|crpc
374530|NCT01540071|Castration and Taxane Resistant Prostate Cancer|castration and taxane resistant prostate cancer
374531|NCT01540045|Non-Small Cell Lung Cancer|non-small cell lung cancer
374532|NCT01540045|Dysgeusia|dysgeusia
374533|NCT01540045|Antineoplastic Combined Chemotherapy Protocols|antineoplastic combined chemotherapy protocols
374534|NCT01540045|Paclitaxel|paclitaxel
374535|NCT01540045|Cisplatin|cisplatin
374536|NCT01540019|anorexia|anorexia
374537|NCT01540019|Paullinia cupana|paullinia cupana
374538|NCT01540019|loss of weight|loss of weight
374539|NCT01539993|Hepatocellular carcinoma|hepatocellular carcinoma
374540|NCT01539993|Liver metastases|liver metastases
374541|NCT01539993|Cholangiocarcinoma|cholangiocarcinoma
374542|NCT01539993|Percutaneous treatments|percutaneous treatments
374543|NCT01539993|RFA|rfa
374544|NCT01539993|TACE|tace
374545|NCT01539993|DEB|deb
374546|NCT01539980|Sericin scaffold|sericin scaffold
374547|NCT01539980|Wound healing|wound healing
374548|NCT01539980|Skin graft donor|skin graft donor
374549|NCT01539967|Laparoscopic Sleeve Gastrectomy|laparoscopic sleeve gastrectomy
374550|NCT01539967|Obesity follow-up|obesity follow-up
374551|NCT01539954|Alcohol related disorders|alcohol related disorders
374552|NCT01539941|Co-occurring adolescent substance use and ADHD|co-occurring adolescent substance use and adhd
374553|NCT01539928|Dual time PET/CT|dual time pet/ct
374554|NCT01539928|glucose-6-phosphatase|glucose-6-phosphatase
374555|NCT01539915|Psoriasis|psoriasis
374556|NCT01539915|Stable plaque psoriasis|stable plaque psoriasis
374557|NCT01539915|lesions|lesions
374558|NCT01539915|TNF-alpha|tnf-alpha
374559|NCT01539915|BCT194|bct194
374560|NCT01539902|MSC for the treatment of Lupus Nephritis|msc for the treatment of lupus nephritis
374561|NCT01539876|locally advanced breast cancer patients|locally advanced breast cancer patients
374562|NCT01539850|obesity|obesity
374563|NCT01539850|gastric stimulation|gastric stimulation
374564|NCT01539850|morbid obesity|morbid obesity
374565|NCT01539837|Parkinson's disease|parkinson's disease
374566|NCT01539837|Brain Iron|brain iron
374567|NCT01539837|Iron chelation|iron chelation
374568|NCT01539837|Oxidative stress|oxidative stress
374569|NCT01539811|Foot Infections|foot infections
374570|NCT01539811|Diabetes|diabetes
374571|NCT01539811|Antibiotic|antibiotic
374572|NCT01539798|Saline solution|saline solution
374573|NCT01539798|Sodium Chloride|sodium chloride
374574|NCT01539798|Hypoalbuminemia|hypoalbuminemia
374575|NCT01539798|Weight Gain|weight gain
374576|NCT01539785|HIPEC|hipec
374577|NCT01539785|Hyperthermic|hyperthermic
374578|NCT01539785|ovarian cancer|ovarian cancer
374579|NCT01539785|recurrence|recurrence
374580|NCT01539759|Postpartum Contraception|postpartum contraception
374581|NCT01539759|Intrauterine Devices|intrauterine devices
374582|NCT01539746|Aortic stenosis|aortic stenosis
374583|NCT01539746|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
374584|NCT01539746|TAVI|tavi
374585|NCT01539746|Predilation|predilation
374586|NCT01539746|Balloon valvuloplasty|balloon valvuloplasty
374587|NCT01539746|BAV|bav
374588|NCT01539746|CoreValve|corevalve
374589|NCT01539720|emergency contraception|emergency contraception
374590|NCT01539720|Ella|ella
374591|NCT01539720|Mirena IUD|mirena iud
374592|NCT01539720|post-coital contraception|post-coital contraception
374593|NCT01539720|Liletta IUD|liletta iud
374594|NCT01539707|Neurogenic Detrusor Overactivity|neurogenic detrusor overactivity
374595|NCT01539707|Solifenacin succinate suspension|solifenacin succinate suspension
374596|NCT01539707|Pharmacokinetics|pharmacokinetics
374597|NCT01539707|Phase 1|phase 1
374598|NCT01539681|Hepatocellular Carcinoma|hepatocellular carcinoma
374599|NCT01539681|Cancer, Liver|cancer, liver
374600|NCT01539681|Sorafenib|sorafenib
374601|NCT01539681|Nexavar|nexavar
374602|NCT01539668|Cervical Cancer|cervical cancer
374603|NCT01539668|HPV|hpv
374604|NCT01539668|Secondary prevention|secondary prevention
374605|NCT01539655|Phase 1|phase 1
374606|NCT01539655|healthy volunteers|healthy volunteers
374607|NCT01539655|pharmacokinetics|pharmacokinetics
374608|NCT01539655|vandetanib|vandetanib
374609|NCT01539655|omeprazole|omeprazole
374610|NCT01539655|ranitidine|ranitidine
374611|NCT01539642|In patient, post operative pain|in patient, post operative pain
374612|NCT01539642|Adult post-operative inpatients who are expected to require parenteral opioid analgesia for at least 48 hours after open abdominal surgery|adult post-operative inpatients who are expected to require parenteral opioid analgesia for at least 48 hours after open abdominal surgery
374613|NCT01539629|Heart failure|heart failure
374614|NCT01539629|Autothreshold|autothreshold
374615|NCT01539629|Pacing|pacing
374616|NCT01539629|CRT-D recipients|crt-d recipients
374617|NCT01539629|Left Ventricular evoked response signals|left ventricular evoked response signals
374618|NCT01539616|Hypertriglyceridemia|hypertriglyceridemia
374619|NCT01539616|Dyslipidemia|dyslipidemia
374620|NCT01539603|drug eluting balloon|drug eluting balloon
374621|NCT01539603|bare metal stent|bare metal stent
374622|NCT01539603|drug eluting stent|drug eluting stent
374623|NCT01539603|coronary artery disease|coronary artery disease
374624|NCT01539590|hepatocyte growth factor mimetic|hepatocyte growth factor mimetic
374625|NCT01539590|hepatocyte growth factor(HGF)|hepatocyte growth factor(hgf)
374626|NCT01539590|Myocardial Infarction|myocardial infarction
374627|NCT01539590|Acute ST Segment Elevation Myocardial Infarction (STEMI)|acute st segment elevation myocardial infarction (stemi)
374628|NCT01539590|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
374629|NCT01539538|Adult post-operative inpatients who|adult post-operative inpatients who
374630|NCT01539538|are expected to require parenteral|are expected to require parenteral
374631|NCT01539538|opioid analgesia for at least 48|opioid analgesia for at least 48
374632|NCT01539538|hours after open abdominal surgery|hours after open abdominal surgery
374633|NCT01539538|or hip/knee replacement surgery|or hip/knee replacement surgery
374634|NCT01539512|CLL|cll
374635|NCT01539512|CAL-101|cal-101
374636|NCT01539512|GS 1101|gs 1101
374637|NCT01539512|PI3K|pi3k
374638|NCT01539512|GS-US-312-0117|gs-us-312-0117
374639|NCT01539512|idelalisib|idelalisib
374640|NCT01539460|Axillary osmidrosis|axillary osmidrosis
374641|NCT01539460|liposuction|liposuction
374642|NCT01539460|minimally invasive surgery|minimally invasive surgery
374643|NCT01539447|Hip arthroscopy|hip arthroscopy
374644|NCT01539447|Femoroacetabular impingement|femoroacetabular impingement
374645|NCT01539447|Heterotopic ossification|heterotopic ossification
374777|NCT01539083|Subcutaneous|subcutaneous
374646|NCT01539447|Heterotopic bone formation|heterotopic bone formation
374647|NCT01539434|COPD|copd
374648|NCT01539434|Behavioral intervention|behavioral intervention
374649|NCT01539434|Physical capacity|physical capacity
374650|NCT01539434|Physical activity|physical activity
374651|NCT01539421|COPD|copd
374652|NCT01539421|exercise endurance|exercise endurance
374653|NCT01539395|Relapsing Remitting|relapsing remitting
374654|NCT01539395|MS|ms
374655|NCT01539382|cardiac surgery|cardiac surgery
374656|NCT01539382|neurocognitive assessment|neurocognitive assessment
374657|NCT01539382|neurocognitive function|neurocognitive function
374658|NCT01539369|dietary intervention|dietary intervention
374659|NCT01539369|dietary fibre|dietary fibre
374660|NCT01539369|weight loss|weight loss
374661|NCT01539369|weight maintenance|weight maintenance
374662|NCT01539356|Hepcidin|hepcidin
374663|NCT01539356|Preterm Infants|preterm infants
374664|NCT01539356|Anemia|anemia
374665|NCT01539356|Sepsis|sepsis
374666|NCT01539356|Ferritin|ferritin
374668|NCT01539343|Catheter-related bloodstream infection|catheter-related bloodstream infection
374669|NCT01539343|CRBSI|crbsi
374670|NCT01539343|Antimicrobial Lock Therapy|antimicrobial lock therapy
374671|NCT01539343|ALT|alt
374672|NCT01539343|Central Line Associated Bloodstream Infection|central line associated bloodstream infection
374673|NCT01539343|CLABSI|clabsi
374674|NCT01539343|Central Venous Catheter|central venous catheter
374675|NCT01539343|CVC|cvc
374676|NCT01539343|Quantitative blood cultures|quantitative blood cultures
374677|NCT01539343|QBC|qbc
374678|NCT01539330|voriconazole|voriconazole
374679|NCT01539330|microdialysis|microdialysis
374680|NCT01539330|sequence therapy|sequence therapy
374681|NCT01539330|pharmacokinetics|pharmacokinetics
374682|NCT01539330|Target Site Pharmacokinetics|target site pharmacokinetics
374683|NCT01539317|Vulvodynia|vulvodynia
374684|NCT01539317|Dyspareunia|dyspareunia
374685|NCT01539317|Breast Cancer|breast cancer
374686|NCT01539317|Menopause|menopause
374687|NCT01539317|Vaginal dryness|vaginal dryness
374688|NCT01539317|Painful intercourse|painful intercourse
374689|NCT01539291|CLL|cll
374690|NCT01539291|CAL-101|cal-101
374691|NCT01539291|CAL 101|cal 101
374692|NCT01539291|GS-1101|gs-1101
374693|NCT01539291|GS 1101|gs 1101
374694|NCT01539291|PI3K|pi3k
374695|NCT01539291|Leukemia|leukemia
374696|NCT01539291|GS-US-312-0116|gs-us-312-0116
374697|NCT01539291|idelalisib|idelalisib
374698|NCT01539278|Sleep Apnea, Obstructive|sleep apnea, obstructive
374699|NCT01539278|Child|child
374700|NCT01539278|Tonsillectomy|tonsillectomy
374701|NCT01539278|Adenoidectomy|adenoidectomy
374702|NCT01539265|urinary calculus|urinary calculus
374703|NCT01539265|ureteral stones|ureteral stones
374704|NCT01539265|medical expulsive therapy|medical expulsive therapy
374705|NCT01539252|hemodialysis|hemodialysis
374706|NCT01539252|adequacy|adequacy
374707|NCT01539252|phosphate clearance|phosphate clearance
374708|NCT01539252|double dialyzer|double dialyzer
374709|NCT01539252|two dialyzers in parallel|two dialyzers in parallel
374710|NCT01539239|Glaucoma|glaucoma
374711|NCT01539239|POAG|poag
374712|NCT01539239|Cataract|cataract
374713|NCT01539226|HIV Infections|hiv infections
374714|NCT01539226|Anti-HIV agents|anti-hiv agents
374715|NCT01539226|HIV-1|hiv-1
374716|NCT01539213|Psoriasis|psoriasis
374717|NCT01539213|interstitial fluid|interstitial fluid
374718|NCT01539213|open flow microperfusion|open flow microperfusion
374719|NCT01539213|IL-17|il-17
374720|NCT01539213|inflammatory skin disease|inflammatory skin disease
374721|NCT01539213|scaly patches|scaly patches
374722|NCT01539213|Healthy volunteers and psoriasis patients|healthy volunteers and psoriasis patients
374723|NCT01539187|uterine fibroid RF ablation|uterine fibroid rf ablation
374724|NCT01539187|intrauterine ultrasound|intrauterine ultrasound
374725|NCT01539187|VizAblate|vizablate
374726|NCT01539161|Chagas Disease|chagas disease
374727|NCT01539161|Chagasic|chagasic
374728|NCT01539161|Reveal XT|reveal xt
374729|NCT01539161|Implantable Cardiac Monitor|implantable cardiac monitor
374730|NCT01539161|ICM|icm
374731|NCT01539148|Quality of Life|quality of life
374732|NCT01539148|Qol|qol
374733|NCT01539148|Questionnaire|questionnaire
374734|NCT01539148|Survey|survey
374735|NCT01539148|Insulin Potentiation Targeted Low Dose Chemotherapy|insulin potentiation targeted low dose chemotherapy
374736|NCT01539148|IPTLD|iptld
374737|NCT01539148|Nutritional Therapy|nutritional therapy
374738|NCT01539148|Chemotherapy|chemotherapy
374739|NCT01539148|Cancer Treatment|cancer treatment
374740|NCT01539148|Kotsanis Institute|kotsanis institute
374741|NCT01539148|The Best Answer for Cancer Foundation|the best answer for cancer foundation
374742|NCT01539148|Liberty IRB|liberty irb
374743|NCT01539148|Texas|texas
374744|NCT01539135|Aspiration, Respiratory|aspiration, respiratory
374745|NCT01539122|osteoarthritis|osteoarthritis
374746|NCT01539122|shoulder replacement|shoulder replacement
374747|NCT01539109|Incomplete Spinal Cord Injury|incomplete spinal cord injury
374748|NCT01539109|Quadriplegia|quadriplegia
374749|NCT01539109|Tetraplegia|tetraplegia
374750|NCT01539109|SCI|sci
374751|NCT01539109|Spinal Cord Disease|spinal cord disease
374752|NCT01539109|Spinal Cord Injury|spinal cord injury
374753|NCT01539109|iSCI|isci
374754|NCT01539109|Transcranial Direct Current Stimulation|transcranial direct current stimulation
374755|NCT01539109|tDCS|tdcs
374756|NCT01539109|SCI recovery|sci recovery
374757|NCT01539109|brain stimulation|brain stimulation
374758|NCT01539109|rehabilitation|rehabilitation
374759|NCT01539096|Stroke|stroke
374760|NCT01539096|Rehabilitation|rehabilitation
374761|NCT01539096|Paresis|paresis
374762|NCT01539096|Paralysis|paralysis
374763|NCT01539096|Recovery|recovery
374764|NCT01539096|tDCS|tdcs
374765|NCT01539096|Transcranial Direct Current Stimulation|transcranial direct current stimulation
374766|NCT01539096|CIMT|cimt
374767|NCT01539096|Constraint Induced Movement Therapy|constraint induced movement therapy
374768|NCT01539096|Stroke therapy|stroke therapy
374769|NCT01539096|MRI|mri
374770|NCT01539096|Hand|hand
374771|NCT01539096|CVA|cva
374977|NCT01538420|Safety|safety
374772|NCT01539096|Cerebrovascular accident|cerebrovascular accident
374773|NCT01539083|Multiple Myeloma|multiple myeloma
374774|NCT01539083|Bortezomib|bortezomib
374775|NCT01539083|VELCADE|velcade
374778|NCT01539083|Thalidomide|thalidomide
374779|NCT01539083|Prednisolone|prednisolone
374780|NCT01539083|Autologous stem cell transplant (ASCT)|autologous stem cell transplant (asct)
374781|NCT01539083|VELCADE, cyclophosphamide, dexamethasone (VCD) induction therapy|velcade, cyclophosphamide, dexamethasone (vcd) induction therapy
374782|NCT01539070|Nutritional intervention|nutritional intervention
374783|NCT01539070|Childhood obesity|childhood obesity
374784|NCT01539070|Physical activity|physical activity
374785|NCT01539070|Feeding practices|feeding practices
374786|NCT01539057|Liver|liver
374787|NCT01539057|Surgery|surgery
374788|NCT01539057|hemostasis|hemostasis
374789|NCT01539057|coagulation|coagulation
374790|NCT01539057|Fibrinogen|fibrinogen
374791|NCT01539044|reversal|reversal
374792|NCT01539044|muscle relaxant|muscle relaxant
374793|NCT01539044|sugammadex|sugammadex
374794|NCT01539031|Alzheimer Disease|alzheimer disease
374795|NCT01539031|Dementia|dementia
374796|NCT01539031|Delirium|delirium
374797|NCT01539031|Amnestic|amnestic
374798|NCT01539031|Cognitive Disorders|cognitive disorders
374799|NCT01539031|Donepezil|donepezil
374800|NCT01539031|Brain Diseases|brain diseases
374801|NCT01539031|Central Nervous System Diseases|central nervous system diseases
374802|NCT01539031|Nervous System Diseases|nervous system diseases
374803|NCT01539031|Tauopathies|tauopathies
374804|NCT01539031|Neurodegenerative Diseases|neurodegenerative diseases
374805|NCT01539031|Mental Disorders|mental disorders
374806|NCT01539031|Cholinesterase Inhibitors|cholinesterase inhibitors
374807|NCT01539031|Enzy|enzy
374808|NCT01539005|Recurrence|recurrence
374809|NCT01539005|Tuberculosis|tuberculosis
374810|NCT01538992|renal denervation|renal denervation
374811|NCT01538992|heart failure|heart failure
374812|NCT01538979|Grass pollen allergy|grass pollen allergy
374813|NCT01538979|Immunotherapy|immunotherapy
374814|NCT01538979|Recombinant vaccine|recombinant vaccine
374815|NCT01538979|Rhinitis, allergic, seasonal|rhinitis, allergic, seasonal
374816|NCT01538966|acromegaly|acromegaly
374817|NCT01538966|pituitary|pituitary
374818|NCT01538966|pegvisomant|pegvisomant
374819|NCT01538966|somavert|somavert
374820|NCT01538966|lanreotide|lanreotide
374821|NCT01538966|octreotide|octreotide
374822|NCT01538953|diarrhea|diarrhea
374823|NCT01538953|handwashing|handwashing
374824|NCT01538953|point-of-use water treatment|point-of-use water treatment
374825|NCT01538953|diarrhea longitudinal prevalence|diarrhea longitudinal prevalence
374826|NCT01538940|Influenza|influenza
374827|NCT01538940|Vaccine|vaccine
374828|NCT01538940|Thailand|thailand
374829|NCT01538927|fibrin sealant|fibrin sealant
374830|NCT01538927|tissue adhesive|tissue adhesive
374831|NCT01538927|wound healing|wound healing
374832|NCT01538927|interleukin 1 beta|interleukin 1 beta
374833|NCT01538927|interleukin 8|interleukin 8
374834|NCT01538901|actinic keratoses|actinic keratoses
374835|NCT01538901|organ transplant recipients|organ transplant recipients
374836|NCT01538901|photodynamic therapy|photodynamic therapy
374837|NCT01538901|imiquimod|imiquimod
374838|NCT01538888|WHOLE BODY VIBRATION|whole body vibration
374839|NCT01538888|AGED|aged
374840|NCT01538888|VO2|vo2
374841|NCT01538888|muscle strength|muscle strength
374842|NCT01538875|Hypertension, pregnancy induced|hypertension, pregnancy induced
374843|NCT01538875|Hydralazine|hydralazine
374844|NCT01538875|Labetalol|labetalol
374845|NCT01538823|Surgery, Renal Cell Cancer|surgery, renal cell cancer
374846|NCT01538810|CT imaging|ct imaging
374847|NCT01538797|YF476|yf476
374848|NCT01538797|gastrin receptor antagonist|gastrin receptor antagonist
374849|NCT01538797|gastric pH|gastric ph
374850|NCT01538797|healthy subjects|healthy subjects
374851|NCT01538797|ranitidine|ranitidine
374852|NCT01538784|YF476|yf476
374853|NCT01538784|gastrin receptor antagonist|gastrin receptor antagonist
374854|NCT01538784|gastric pH|gastric ph
374855|NCT01538784|healthy subjects|healthy subjects
374856|NCT01538771|Myocardial infarction|myocardial infarction
374857|NCT01538771|Erythropoietin|erythropoietin
374858|NCT01538771|Myocardial reperfusion injury|myocardial reperfusion injury
374859|NCT01538758|calcifying tendinitis|calcifying tendinitis
374860|NCT01538758|rotator cuff|rotator cuff
374861|NCT01538745|Pain|pain
374862|NCT01538745|Emergency Department|emergency department
374863|NCT01538745|Morphine|morphine
374864|NCT01538745|Ketamine|ketamine
374865|NCT01538706|Hospital-based home care|hospital-based home care
374866|NCT01538706|Pediatric oncology|pediatric oncology
374867|NCT01538693|BDNF|bdnf
374868|NCT01538693|serotonin|serotonin
374869|NCT01538693|high-intensity|high-intensity
374870|NCT01538693|exercise|exercise
374871|NCT01538667|Lung|lung
374872|NCT01538667|Scintigraphy|scintigraphy
374873|NCT01538667|Pharmacokinetics|pharmacokinetics
374874|NCT01538667|Inhalation|inhalation
374875|NCT01538667|Ciprofloxacin|ciprofloxacin
374876|NCT01538654|obesity|obesity
374877|NCT01538654|PSMF ( protein sparing modified fast)|psmf ( protein sparing modified fast)
374878|NCT01538654|Enteral nutrition|enteral nutrition
374879|NCT01538654|Tube feeding|tube feeding
374880|NCT01538654|VLCD ( very low calorie diet)|vlcd ( very low calorie diet)
374881|NCT01538654|Pulmonary function tests|pulmonary function tests
374882|NCT01538654|body composition|body composition
374883|NCT01538654|FFM ( fat free mass)|ffm ( fat free mass)
374884|NCT01538654|Body fat|body fat
374885|NCT01538654|Handgripstregth|handgripstregth
374886|NCT01538628|Prostate cancer|prostate cancer
374887|NCT01538628|Spacer|spacer
374888|NCT01538615|Family meals|family meals
374889|NCT01538615|Home food environment|home food environment
374890|NCT01538615|Electronic media|electronic media
374891|NCT01538602|PCOS|pcos
374892|NCT01538602|cardiovascular disorders|cardiovascular disorders
374893|NCT01538563|ON 01910.Na|on 01910.na
374894|NCT01538563|rigosertib sodium|rigosertib sodium
374895|NCT01538563|rogosertib|rogosertib
374896|NCT01538550|cancer|cancer
374897|NCT01538550|colon|colon
374898|NCT01538550|rectum|rectum
374899|NCT01538550|adenoma|adenoma
374900|NCT01538550|screening|screening
374901|NCT01538550|iFOBT|ifobt
374902|NCT01538550|flexible sigmoidoscopy|flexible sigmoidoscopy
374903|NCT01538550|randomized trial|randomized trial
374904|NCT01538537|ON 01910.Na|on 01910.na
374905|NCT01538537|rigosertib Sodium|rigosertib sodium
374906|NCT01538537|rigosertib|rigosertib
374907|NCT01538498|PCI|pci
374908|NCT01538498|Ovarian cancer|ovarian cancer
374909|NCT01538485|Vitamin D|vitamin d
374910|NCT01538485|regulatory T cells|regulatory t cells
374911|NCT01538485|GUT|gut
374912|NCT01538472|Lymphoma|lymphoma
374913|NCT01538472|Relapse B-cell CD20+ non-Hodgkin's lymphoma|relapse b-cell cd20+ non-hodgkin's lymphoma
374914|NCT01538472|High-dose BEAM chemotherapy|high-dose beam chemotherapy
374915|NCT01538472|Y Zevalin|y zevalin
374916|NCT01538472|In Zevalin|in zevalin
374917|NCT01538472|Rituxan|rituxan
374918|NCT01538472|Rituximab|rituximab
374919|NCT01538472|BCNU|bcnu
374920|NCT01538472|1,3-bis(2-chloroethyl)-1-nitrosourea bis-chloronitrosourea|1,3-bis(2-chloroethyl)-1-nitrosourea bis-chloronitrosourea
374921|NCT01538472|Carmustine|carmustine
374922|NCT01538472|BiCNU|bicnu
374923|NCT01538472|VP-16|vp-16
374924|NCT01538472|Ara-C|ara-c
374925|NCT01538472|Cytarabine|cytarabine
374926|NCT01538472|Cytosar|cytosar
374927|NCT01538472|DepoCyt|depocyt
374928|NCT01538472|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
374929|NCT01538472|Melphalan|melphalan
374930|NCT01538472|Alkeran|alkeran
374931|NCT01538472|G-CSF|g-csf
374932|NCT01538472|Filgrastim|filgrastim
374933|NCT01538472|Neupogen|neupogen
374934|NCT01538472|Stem cell infusion|stem cell infusion
374935|NCT01538472|Autologous stem cell transplantation|autologous stem cell transplantation
374936|NCT01538459|Blood Glucose|blood glucose
374937|NCT01538459|Bupivacaine|bupivacaine
374938|NCT01538459|Interscalene Nerve Block|interscalene nerve block
374939|NCT01538459|Regional Anesthesia|regional anesthesia
374940|NCT01538459|Pain Blockade|pain blockade
374941|NCT01538459|Arthroscopic Surgery|arthroscopic surgery
374942|NCT01538459|Arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
374943|NCT01538459|Dexamethasone|dexamethasone
374944|NCT01538459|Anti-Inflammatory Agents|anti-inflammatory agents
374945|NCT01538459|Therapeutic Uses|therapeutic uses
374946|NCT01538459|Physiological Effects of Drugs|physiological effects of drugs
374947|NCT01538459|Glucocorticoids|glucocorticoids
374948|NCT01538459|Anesthetics, Local|anesthetics, local
374949|NCT01538459|Anesthetics|anesthetics
374950|NCT01538459|Sensory System Agents|sensory system agents
374951|NCT01538459|Adjuvants, Anesthesia|adjuvants, anesthesia
374952|NCT01538459|Anesthesiology|anesthesiology
374953|NCT01538459|Injections|injections
374954|NCT01538459|Adult|adult
374955|NCT01538459|Analgesia/methods|analgesia/methods
374956|NCT01538459|Brachial Plexus/drug effects|brachial plexus/drug effects
374957|NCT01538459|Brachial Plexus/surgery|brachial plexus/surgery
374958|NCT01538459|Brachial Plexus/ultrasonography|brachial plexus/ultrasonography
374959|NCT01538459|Bupivacaine/administration & dosage|bupivacaine/administration & dosage
374960|NCT01538459|Dexamethasone/administration & dosage|dexamethasone/administration & dosage
374961|NCT01538459|Drug Therapy, Combination|drug therapy, combination
374962|NCT01538459|Female|female
374963|NCT01538459|Humans|humans
374964|NCT01538459|Male|male
374965|NCT01538459|Nerve Block/methods|nerve block/methods
374966|NCT01538459|Pain, Postoperative/etiology|pain, postoperative/etiology
374967|NCT01538459|Pain, Postoperative/prevention & control|pain, postoperative/prevention & control
374968|NCT01538459|Prospective Studies|prospective studies
374969|NCT01538459|Time Factors|time factors
374970|NCT01538446|Elderly|elderly
374971|NCT01538446|Acute coronary syndrome|acute coronary syndrome
374972|NCT01538446|Percutaneous coronary intervention|percutaneous coronary intervention
374973|NCT01538446|Prasugrel|prasugrel
374974|NCT01538446|Platelet function test|platelet function test
374975|NCT01538433|diagnosis|diagnosis
374976|NCT01538433|IgA nephropathy|iga nephropathy
374978|NCT01538420|Tolerability|tolerability
374979|NCT01538420|Pharmacokinetics|pharmacokinetics
374980|NCT01538420|Pharmacodynamics|pharmacodynamics
374981|NCT01538407|Strength training|strength training
374982|NCT01538407|Biomechanics|biomechanics
374983|NCT01538407|Quadriceps|quadriceps
374984|NCT01538407|Gait|gait
374985|NCT01538394|smoking cessation|smoking cessation
374986|NCT01538394|abstinence|abstinence
374987|NCT01538394|clinical trial|clinical trial
374988|NCT01538394|varenicline|varenicline
374989|NCT01538394|nicotine|nicotine
374990|NCT01538381|Neoadjuvant targeted therapy|neoadjuvant targeted therapy
374991|NCT01538381|Preoperative targeted therapy|preoperative targeted therapy
374992|NCT01538381|Afatinib|afatinib
374993|NCT01538368|MRCP|mrcp
374994|NCT01538368|ERCP|ercp
374995|NCT01538368|EUS|eus
374996|NCT01538368|Image interpretation|image interpretation
374997|NCT01538368|MRCP findings|mrcp findings
374998|NCT01538368|endoscopic intervention(s)|endoscopic intervention(s)
374999|NCT01538355|multiple sclerosis|multiple sclerosis
375000|NCT01538355|diet|diet
375001|NCT01538355|prolonged fasting|prolonged fasting
375002|NCT01538355|caloric restriction|caloric restriction
375003|NCT01538355|ketogenic low glycemic load treatment|ketogenic low glycemic load treatment
375004|NCT01538355|health related quality of life|health related quality of life
375005|NCT01538355|ketogenic diet|ketogenic diet
375006|NCT01538355|neurodegeneration|neurodegeneration
375007|NCT01538355|neuroinflammation|neuroinflammation
375008|NCT01538329|Dyskinesia|dyskinesia
375009|NCT01538329|L-DOPA|l-dopa
375010|NCT01538329|Early introduced treatment|early introduced treatment
375011|NCT01538329|Amantadine|amantadine
375012|NCT01538316|Prostate cancer|prostate cancer
375013|NCT01538316|dietary supplements|dietary supplements
375014|NCT01538316|quercetin|quercetin
375015|NCT01538316|genistein|genistein
375016|NCT01538316|prostate-specific antigen|prostate-specific antigen
375017|NCT01538316|oxidative Status|oxidative status
375018|NCT01538303|STEMI|stemi
375019|NCT01538303|absolute flow|absolute flow
375020|NCT01538303|microvascular resistance|microvascular resistance
375021|NCT01538290|Calibration|calibration
375022|NCT01538290|Validation|validation
375023|NCT01538290|Transfer function|transfer function
375024|NCT01538290|SphygmoCor|sphygmocor
375025|NCT01538290|Arteriograph|arteriograph
375026|NCT01538277|contact force catheter|contact force catheter
375027|NCT01538277|loop recorder|loop recorder
375028|NCT01538251|ulcerative colitis|ulcerative colitis
375029|NCT01538251|propionyl-l-carnitine|propionyl-l-carnitine
375030|NCT01538225|Spasticity|spasticity
375031|NCT01538212|Alzheimer's disease|alzheimer's disease
375032|NCT01538212|retrospective|retrospective
375033|NCT01538212|Axona|axona
375034|NCT01538199|Device study|device study
375035|NCT01538199|Depression|depression
375036|NCT01538199|Major Depression|major depression
375037|NCT01538199|Major Depressive Disorder|major depressive disorder
375038|NCT01538199|MDD|mdd
375039|NCT01538199|Device for depression|device for depression
375040|NCT01538199|Alternatives to medication for depression|alternatives to medication for depression
375041|NCT01538199|Massachusetts General Hospital|massachusetts general hospital
375042|NCT01538199|Boston|boston
375043|NCT01538186|Coronary intervention|coronary intervention
375044|NCT01538186|PCI of the side branch|pci of the side branch
375045|NCT01538173|surgical side infection|surgical side infection
375046|NCT01538173|breast reduction|breast reduction
375047|NCT01538173|reduction mammaplasty|reduction mammaplasty
375048|NCT01538173|prospective trial|prospective trial
375049|NCT01538173|microcirculation|microcirculation
375050|NCT01538173|breast surgery|breast surgery
375051|NCT01538160|recombinant factor VIIa|recombinant factor viia
375052|NCT01538160|factor XI deficiency|factor xi deficiency
375053|NCT01538147|Restless Leg Syndrome|restless leg syndrome
375054|NCT01538147|Severe Preeclampsia|severe preeclampsia
375055|NCT01538134|Antibodies, anticardiolipin|antibodies, anticardiolipin
375056|NCT01538134|Antibodies, B2 Glycoprotein I|antibodies, b2 glycoprotein i
375057|NCT01538134|Lupus Anticoagulant|lupus anticoagulant
375058|NCT01538134|Fetal Growth Restriction|fetal growth restriction
375059|NCT01538121|Antibodies, anticardiolipin|antibodies, anticardiolipin
375060|NCT01538121|Antibodies, B2 Glycoprotein I|antibodies, b2 glycoprotein i
375061|NCT01538121|Lupus Anticoagulant|lupus anticoagulant
375062|NCT01538121|Severe Preeclampsia|severe preeclampsia
375063|NCT01538082|Anxiety disorders|anxiety disorders
375064|NCT01538082|Depressive disorders|depressive disorders
375065|NCT01538082|Metabolic syndrome|metabolic syndrome
375066|NCT01538082|Stress disorders|stress disorders
375067|NCT01538082|Primary care|primary care
375068|NCT01538069|Heart failure|heart failure
375069|NCT01538069|Sleep apnea syndromes|sleep apnea syndromes
375070|NCT01538069|Exercise|exercise
375071|NCT01538069|Continuous Positive Airway Pressure|continuous positive airway pressure
375072|NCT01538056|AAA|aaa
375073|NCT01538043|Cost-effectiveness analysis|cost-effectiveness analysis
375074|NCT01538043|Cost-utility analysis|cost-utility analysis
375075|NCT01538043|Osteoarthritis|osteoarthritis
375076|NCT01538043|Spa therapy|spa therapy
375077|NCT01538043|Randomized clinical trial|randomized clinical trial
375078|NCT01538043|Mechanisms of action|mechanisms of action
375079|NCT01538030|Fetal membranes, premature rupture|fetal membranes, premature rupture
375080|NCT01538030|Cesarean section|cesarean section
375081|NCT01538030|Perinatal mortality|perinatal mortality
375082|NCT01538030|Neonatal sepsis|neonatal sepsis
375083|NCT01538030|Amniotic Fluid Volume|amniotic fluid volume
375084|NCT01538004|Blood pressure determination|blood pressure determination
375085|NCT01538004|Primary health care|primary health care
375086|NCT01538004|Office visits|office visits
375087|NCT01538004|Reproducibility of results|reproducibility of results
375088|NCT01537991|radiotherapy|radiotherapy
375089|NCT01537991|non small cell lung cancer|non small cell lung cancer
375090|NCT01537991|isotoxic|isotoxic
375091|NCT01537978|spinal cord injury, video gaming, functional improvement|spinal cord injury, video gaming, functional improvement
375092|NCT01537965|hepatitis|hepatitis
375093|NCT01537965|fibrosis|fibrosis
375094|NCT01537965|elastography|elastography
375095|NCT01537952|facial paralysis, facial nerve, borreliosis, Bell's palsy|facial paralysis, facial nerve, borreliosis, bell's palsy
375096|NCT01537939|Physical Activity|physical activity
375097|NCT01537939|Walking|walking
375098|NCT01537939|Pedometer|pedometer
375099|NCT01537939|Body Composition|body composition
375100|NCT01537939|Aerobic Fitness|aerobic fitness
375101|NCT01537926|HALT|halt
375102|NCT01537926|HCM|hcm
375103|NCT01537874|Secondhand smoke|secondhand smoke
375104|NCT01537874|Pediatric disease|pediatric disease
375105|NCT01537848|EUS|eus
375106|NCT01537848|Endoscopic ultrasound|endoscopic ultrasound
375107|NCT01537848|abdominal collection|abdominal collection
375108|NCT01537848|post-operative|post-operative
375109|NCT01537848|post-surgical|post-surgical
375110|NCT01537835|healthcare|healthcare
375111|NCT01537835|worker|worker
375112|NCT01537835|uniforms|uniforms
375113|NCT01537835|bacterial|bacterial
375114|NCT01537835|contamination|contamination
375115|NCT01537822|intrauterine polyps|intrauterine polyps
375116|NCT01537822|myomas|myomas
375117|NCT01537822|residual placental tissue|residual placental tissue
375118|NCT01537809|Vitamin D|vitamin d
375119|NCT01537809|Vitamin D Deficiency|vitamin d deficiency
375120|NCT01537809|Avitaminosis|avitaminosis
375121|NCT01537809|Deficiency Diseases|deficiency diseases
375122|NCT01537809|Blood lipids|blood lipids
375123|NCT01537796|Obesity|obesity
375124|NCT01537796|Exercise|exercise
375125|NCT01537783|abscess|abscess
375126|NCT01537770|Vertebroplasty|vertebroplasty
375127|NCT01537770|Low energy osteoporotic vertebral fractures|low energy osteoporotic vertebral fractures
375128|NCT01537770|of the thoracic and/or lumbar spine|of the thoracic and/or lumbar spine
375129|NCT01537744|expansion cohort|expansion cohort
375130|NCT01537705|Medical food|medical food
375131|NCT01537705|Neuropathy|neuropathy
375132|NCT01537705|Diabetes|diabetes
375133|NCT01537705|Neuropathic Pain|neuropathic pain
375134|NCT01537679|Caregiver|caregiver
375135|NCT01537679|meditation|meditation
375136|NCT01537679|relaxation|relaxation
375137|NCT01537679|stress|stress
375138|NCT01537627|Motor activity|motor activity
375139|NCT01537627|Exercise|exercise
375140|NCT01537627|Rehabilitation|rehabilitation
375141|NCT01537601|Posterior urethral valves|posterior urethral valves
375142|NCT01537601|Febrile urinary tract infection|febrile urinary tract infection
375143|NCT01537601|Circumcision|circumcision
375144|NCT01537601|Antibioprophylaxis|antibioprophylaxis
375145|NCT01537601|Impact on family|impact on family
375146|NCT01537588|anterior cruciate ligament|anterior cruciate ligament
375147|NCT01537588|hamstring|hamstring
375148|NCT01537588|semitendinosus|semitendinosus
375149|NCT01537588|gracilis|gracilis
375150|NCT01537588|graft|graft
375151|NCT01537562|Copper IUD|copper iud
375152|NCT01537562|LNG-IUS|lng-ius
375153|NCT01537562|intrauterine contraception|intrauterine contraception
375154|NCT01537562|medical abortion|medical abortion
375155|NCT01537562|postabortion contraception|postabortion contraception
375156|NCT01537549|Progressive supranuclear palsy|progressive supranuclear palsy
375157|NCT01537549|alpha-lipoic acid|alpha-lipoic acid
375158|NCT01537549|L-acetyl carnitine|l-acetyl carnitine
375159|NCT01537549|antioxidant|antioxidant
375160|NCT01537549|magnetic resonance spectroscopy|magnetic resonance spectroscopy
375161|NCT01537549|neurodegeneration|neurodegeneration
375162|NCT01537549|glutathione|glutathione
375163|NCT01537536|Breast cancer|breast cancer
375164|NCT01537536|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
375165|NCT01537536|EndoTAG-1|endotag-1
375166|NCT01537523|physical|physical
375167|NCT01537523|psychological|psychological
375168|NCT01537523|fracture hip|fracture hip
375169|NCT01537497|Phase 1|phase 1
375170|NCT01537497|Single Doses|single doses
375171|NCT01537497|Pharmacodynamics|pharmacodynamics
375172|NCT01537497|Healthy Volunteers|healthy volunteers
375173|NCT01537484|massage|massage
375174|NCT01537484|osteoarthritis|osteoarthritis
375175|NCT01537484|light touch|light touch
375176|NCT01537484|Swedish|swedish
375178|NCT01537471|Meclizine|meclizine
375179|NCT01537471|Startle|startle
375180|NCT01537471|Sensory processing|sensory processing
375181|NCT01537471|antihistamines|antihistamines
375182|NCT01537445|Diabetes Mellitus|diabetes mellitus
375183|NCT01537445|Pancreas|pancreas
375184|NCT01537445|Renal failure|renal failure
375185|NCT01537445|Transplantation|transplantation
375186|NCT01537432|Psoriasis, Plaque-type psoriasis|psoriasis, plaque-type psoriasis
375187|NCT01537432|Plaque|plaque
375188|NCT01537432|Secukinumab|secukinumab
375189|NCT01537432|AIN457A|ain457a
375190|NCT01537432|PASI|pasi
375191|NCT01537432|DLQI|dlqi
375192|NCT01537432|IGA|iga
375193|NCT01537419|Suicide|suicide
375194|NCT01537419|Depression|depression
375195|NCT01537419|Family Relationships|family relationships
375196|NCT01537406|BREAST IRRADIATION USING INTENSITY MODULATED RADIATION THERAPY|breast irradiation using intensity modulated radiation therapy
375197|NCT01537393|cornea|cornea
375198|NCT01537393|transplant|transplant
375199|NCT01537393|preservation|preservation
375200|NCT01537393|endothelial keratoplasty|endothelial keratoplasty
375201|NCT01537367|Human immunodeficiency virus|human immunodeficiency virus
375202|NCT01537367|HIV primary care|hiv primary care
375203|NCT01537328|Total knee arthroplasty|total knee arthroplasty
375204|NCT01537328|quadriceps|quadriceps
375205|NCT01537328|muscle|muscle
375206|NCT01537328|arthroplasty|arthroplasty
375207|NCT01537328|joint diseases|joint diseases
375208|NCT01537328|musculoskeletal diseases|musculoskeletal diseases
375209|NCT01537315|Kidney Failure, Chronic|kidney failure, chronic
375210|NCT01537315|Cardiovascular Disease|cardiovascular disease
375211|NCT01537315|Arteriosclerosis|arteriosclerosis
375212|NCT01537302|Chronic Total Occlusion|chronic total occlusion
375213|NCT01537302|Optimal Coherence Tomography|optimal coherence tomography
375214|NCT01537302|Lumivascular|lumivascular
375215|NCT01537289|Trauma|trauma
375216|NCT01537289|Pneumothorax|pneumothorax
375217|NCT01537276|hysterosalpingography|hysterosalpingography
375218|NCT01537276|Fluoroscopy|fluoroscopy
375219|NCT01537276|diagnostic accuracy|diagnostic accuracy
375220|NCT01537263|Aneurysmal Subarachnoid Hemorrhage|aneurysmal subarachnoid hemorrhage
375221|NCT01537263|SAB|sab
375222|NCT01537263|SAH|sah
375223|NCT01537263|Ultrasound|ultrasound
375224|NCT01537263|Perfusion imaging|perfusion imaging
375225|NCT01537250|CAP|cap
375226|NCT01537237|Atrial Fibrillation|atrial fibrillation
375227|NCT01537237|Catheter-based ablation|catheter-based ablation
375228|NCT01537237|Pulmonary vein isolation|pulmonary vein isolation
375229|NCT01537237|Electro-anatomical mapping|electro-anatomical mapping
375230|NCT01537237|Rotational angiography|rotational angiography
375231|NCT01537224|Electrophysiology|electrophysiology
375232|NCT01537224|Subthalamic nucleus|subthalamic nucleus
375233|NCT01537224|Parkinson|parkinson
375234|NCT01537211|Dysvascular|dysvascular
375235|NCT01537211|amputation|amputation
375236|NCT01537211|above knee|above knee
375237|NCT01537211|ambulation|ambulation
375238|NCT01537198|Postmarketing Drug Surveillance|postmarketing drug surveillance
375239|NCT01537172|ONO-4053 healthy subjects|ono-4053 healthy subjects
375240|NCT01537172|3 part adaptive design|3 part adaptive design
375241|NCT01537159|AML|aml
375242|NCT01537146|unicompartmental|unicompartmental
375243|NCT01537146|osteoarthritis|osteoarthritis
375244|NCT01537146|varus|varus
375245|NCT01537146|malalignment|malalignment
375246|NCT01537146|opening wedge|opening wedge
375247|NCT01537146|HTO|hto
375248|NCT01537146|high|high
375249|NCT01537146|tibia|tibia
375250|NCT01537146|osteotomy|osteotomy
375251|NCT01537094|low vitamin c|low vitamin c
375252|NCT01537094|reduced growth hormone secretion|reduced growth hormone secretion
375253|NCT01537068|Dysthymic disorder|dysthymic disorder
375254|NCT01537068|Dysthymia|dysthymia
375255|NCT01537068|Chronic non-major depression|chronic non-major depression
375256|NCT01537068|Non-major chronic depression|non-major chronic depression
375257|NCT01537068|Chronic depressive disorder|chronic depressive disorder
375258|NCT01537068|Antidepressant treatment|antidepressant treatment
375259|NCT01537055|H pylori eradication|h pylori eradication
375260|NCT01537042|Rotigotine|rotigotine
375261|NCT01537042|Neupro|neupro
375262|NCT01537042|Restless Legs Syndrome|restless legs syndrome
375263|NCT01537042|RLS|rls
375264|NCT01537042|End-Stage Renal Disease|end-stage renal disease
375265|NCT01537029|Breast cancer|breast cancer
375266|NCT01537029|Pharmacokinetics|pharmacokinetics
375267|NCT01537029|Obesity|obesity
375268|NCT01537029|Doxorubicin|doxorubicin
375269|NCT01537029|Cyclophosphamide|cyclophosphamide
375270|NCT01537029|Weight|weight
375271|NCT01536977|quality of life|quality of life
375272|NCT01536925|Behavioral Economics|behavioral economics
375273|NCT01536925|Drug self administration|drug self administration
375274|NCT01536925|Opioid|opioid
375275|NCT01536912|HIV positive|hiv positive
375276|NCT01536899|HIV positive|hiv positive
375277|NCT01536899|Medical Marijuana|medical marijuana
375278|NCT01536873|treatment experienced patients|treatment experienced patients
375279|NCT01536873|Integrase resistance|integrase resistance
375280|NCT01536834|Verruca|verruca
375281|NCT01536834|Plantar Wart|plantar wart
375282|NCT01536834|Medical Device|medical device
375283|NCT01536834|Podiatry|podiatry
375284|NCT01536834|Footcare|footcare
375285|NCT01536821|Parkinson disease|parkinson disease
375286|NCT01536821|Parkinson's Disease|parkinson's disease
375287|NCT01536821|PD|pd
375288|NCT01536821|LRRK2|lrrk2
375289|NCT01536821|genetics|genetics
375290|NCT01536821|genes|genes
375291|NCT01536808|Diabetes mellitus|diabetes mellitus
375292|NCT01536808|accelerated aging|accelerated aging
375293|NCT01536808|cellular senescence|cellular senescence
375294|NCT01536808|diabetic cardiomyopathy|diabetic cardiomyopathy
375295|NCT01536808|strain imaging|strain imaging
375296|NCT01536808|strain rate imaging,|strain rate imaging,
375297|NCT01536808|echocardiography|echocardiography
375298|NCT01536795|Ointment to treat leishmania skin lesions|ointment to treat leishmania skin lesions
375299|NCT01536782|head and neck cancer|head and neck cancer
375300|NCT01536782|chemoradiation therapy|chemoradiation therapy
375301|NCT01536782|bolus feeding|bolus feeding
375302|NCT01536782|gravity feeding|gravity feeding
375303|NCT01536782|pump feeding|pump feeding
375304|NCT01536782|optimal enteral feeding method|optimal enteral feeding method
375305|NCT01536782|To determine the optimal tube feeding method by analyzing percent weigtht loss.|to determine the optimal tube feeding method by analyzing percent weigtht loss.
375306|NCT01536782|To determine the optimal tube feeding method by analyzing tolerance of enteral feeds.|to determine the optimal tube feeding method by analyzing tolerance of enteral feeds.
375307|NCT01536782|To determine the optimal tube feeding method by analyzing percent met of estimated calories and protein.|to determine the optimal tube feeding method by analyzing percent met of estimated calories and protein.
375308|NCT01536769|Metagenomic analysis|metagenomic analysis
375309|NCT01536769|Microbiota|microbiota
375310|NCT01536756|Depressive disorder|depressive disorder
375311|NCT01536756|exercise|exercise
375312|NCT01536756|pain|pain
375313|NCT01536756|physical|physical
375314|NCT01536756|psychological|psychological
375315|NCT01536756|Chinese|chinese
375316|NCT01536756|mild to severe depressive disorders|mild to severe depressive disorders
375317|NCT01536717|atrial septal defect|atrial septal defect
375318|NCT01536717|mitral valve annuloplasty|mitral valve annuloplasty
375319|NCT01536717|aortic valve annuloplasty|aortic valve annuloplasty
375320|NCT01536717|open heart surgery|open heart surgery
375321|NCT01536717|oxycodone consumption|oxycodone consumption
375322|NCT01536717|articain|articain
375323|NCT01536717|bupivacaine|bupivacaine
375324|NCT01536717|pain after sternotomy|pain after sternotomy
375325|NCT01536717|postoperative pain|postoperative pain
375326|NCT01536717|wound infusion|wound infusion
375327|NCT01536704|nicotine lozenge|nicotine lozenge
375328|NCT01536704|nicotine|nicotine
375329|NCT01536704|nicotine replacement therapy|nicotine replacement therapy
375330|NCT01536691|ramosetron|ramosetron
375331|NCT01536691|ondansetron|ondansetron
375332|NCT01536691|aprepitant|aprepitant
375333|NCT01536691|chemotherapy induced nausea & vomiting|chemotherapy induced nausea & vomiting
375334|NCT01536587|influence of bronchodilatation with salmeterol on the autonomic nervous systems in COPD patients will be measured using MSNA.|influence of bronchodilatation with salmeterol on the autonomic nervous systems in copd patients will be measured using msna.
375335|NCT01536587|Relation of COPD and sympathetic nerve activity is to be evaluated,|relation of copd and sympathetic nerve activity is to be evaluated,
375336|NCT01536561|Tositumomab and/or Iodine I 131 Tositumomab|tositumomab and/or iodine i 131 tositumomab
375337|NCT01536561|B-cell non-Hodgkin's lymphoma|b-cell non-hodgkin's lymphoma
375338|NCT01536561|Dose-limiting toxicity|dose-limiting toxicity
375339|NCT01536561|Bexxar|bexxar
375340|NCT01536548|hemodialysis|hemodialysis
375341|NCT01536548|cannulation|cannulation
375342|NCT01536548|AV-fistula|av-fistula
375343|NCT01536548|buttonhole technique|buttonhole technique
375344|NCT01536535|Ulcerative Colitis|ulcerative colitis
375345|NCT01536535|mesalamine|mesalamine
375346|NCT01536535|corticosteroids|corticosteroids
375347|NCT01536535|PROTECT|protect
375348|NCT01536522|Asthma|asthma
375349|NCT01536522|Allergic Asthma|allergic asthma
375350|NCT01536522|Non-allergic Asthma|non-allergic asthma
375351|NCT01536496|trauma|trauma
375352|NCT01536496|hemorrhagic shock|hemorrhagic shock
375353|NCT01536496|thrombelastography|thrombelastography
375354|NCT01536496|coagulopathy|coagulopathy
375355|NCT01536496|transfusion|transfusion
375356|NCT01536496|resuscitation|resuscitation
375357|NCT01536483|Butyrate|butyrate
375358|NCT01536483|Preterms|preterms
375359|NCT01536483|Very Low Birth Weight (<1250g)|very low birth weight (<1250g)
375360|NCT01536483|Rectocolonic enemas|rectocolonic enemas
375361|NCT01536483|Digestive maturation|digestive maturation
375362|NCT01536483|Parenteral nutrition weaning|parenteral nutrition weaning
375363|NCT01536483|ECUN|ecun
375364|NCT01536483|Whole gut transit time|whole gut transit time
375365|NCT01536470|Intraoperative hemodynamic|intraoperative hemodynamic
375366|NCT01536470|Arterial pressure|arterial pressure
375367|NCT01536470|Postoperative complications|postoperative complications
375368|NCT01536470|Intraoperative fluids|intraoperative fluids
375369|NCT01536470|Noradrenaline|noradrenaline
375370|NCT01536457|asthma|asthma
375371|NCT01536457|children|children
375372|NCT01536457|gastroesophageal reflux|gastroesophageal reflux
375373|NCT01536457|retrospective|retrospective
375374|NCT01536457|data analysis|data analysis
375375|NCT01536444|Mohs surgery|mohs surgery
375376|NCT01536444|Excisional skin surgery|excisional skin surgery
375377|NCT01536444|Micrografting|micrografting
375378|NCT01536431|Diabetes|diabetes
375379|NCT01536418|Crohn's disease, chemokine receptor 9 antagonist, Crohn's Disease Activity Index|crohn's disease, chemokine receptor 9 antagonist, crohn's disease activity index
375380|NCT01536418|active treatment|active treatment
375381|NCT01536392|Cancer of the Cervix|cancer of the cervix
375382|NCT01536392|Anti-emetic therapy|anti-emetic therapy
375383|NCT01536392|Granisetron|granisetron
375384|NCT01536392|Transdermal patch|transdermal patch
375385|NCT01536392|Ondansetron|ondansetron
375386|NCT01536392|Zofran|zofran
375387|NCT01536392|Questionnaires|questionnaires
375388|NCT01536392|Surveys|surveys
375389|NCT01536392|Study Drug Diary|study drug diary
375390|NCT01536379|Infection|infection
375391|NCT01536379|Quality of Life|quality of life
375392|NCT01536366|Parkinson Disease|parkinson disease
375393|NCT01536366|BIA 9-1067|bia 9-1067
375394|NCT01536340|post discharge adverse events|post discharge adverse events
375395|NCT01536340|discontinuities in care|discontinuities in care
375396|NCT01536340|medical injury|medical injury
375397|NCT01536327|Metachromatic Leukodystrophy|metachromatic leukodystrophy
375398|NCT01536327|Demyelinating Diseases|demyelinating diseases
375399|NCT01536314|Pre-emptive administration|pre-emptive administration
375400|NCT01536314|Post-operative administration|post-operative administration
375401|NCT01536314|Prophylaxis|prophylaxis
375402|NCT01536314|Memantine|memantine
375403|NCT01536314|Post-mastectomy/tumorectomy|post-mastectomy/tumorectomy
375404|NCT01536314|Neuropathic pain|neuropathic pain
375405|NCT01536301|oxycodone|oxycodone
375406|NCT01536301|morphine|morphine
375407|NCT01536301|hip replacement|hip replacement
375408|NCT01536301|analgesia|analgesia
375409|NCT01536301|post operative analgesia|post operative analgesia
375410|NCT01536288|acute mountain sickness|acute mountain sickness
375411|NCT01536288|AMS|ams
375412|NCT01536288|Rhodiola Crenulata|rhodiola crenulata
375413|NCT01536288|mountaineering|mountaineering
375414|NCT01536288|pulse oximetry|pulse oximetry
375415|NCT01536288|oxygen saturation|oxygen saturation
375416|NCT01536275|critical illness|critical illness
375417|NCT01536275|children|children
375418|NCT01536275|nutrition|nutrition
375419|NCT01536275|metabolism|metabolism
375420|NCT01536236|Diabetes|diabetes
375421|NCT01536236|Polyneuropathy|polyneuropathy
375422|NCT01536236|Spinal cord stimulation|spinal cord stimulation
375423|NCT01536223|Nasopharyngeal Carcinoma (NPC)|nasopharyngeal carcinoma (npc)
375424|NCT01536223|cisplatin and 5-fluorouracil (PF)|cisplatin and 5-fluorouracil (pf)
375425|NCT01536223|docetaxel,cisplatin and 5-fluorouracil(TPF)|docetaxel,cisplatin and 5-fluorouracil(tpf)
375426|NCT01536223|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
375427|NCT01536223|intensity modulated radiotherapy(IMRT)|intensity modulated radiotherapy(imrt)
375428|NCT01536210|ADHD(attention Deficit Hyperactivity Disorder)|adhd(attention deficit hyperactivity disorder)
375429|NCT01536197|obesity|obesity
375430|NCT01536197|gastric bypass|gastric bypass
375431|NCT01536197|gastric banding|gastric banding
375432|NCT01536197|sleeve gastrectomy|sleeve gastrectomy
375433|NCT01536197|weight loss|weight loss
375434|NCT01536197|taste perception|taste perception
375435|NCT01536184|Fetal Alcohol Spectrum Disorder|fetal alcohol spectrum disorder
375436|NCT01536184|FASD|fasd
375437|NCT01536171|runners|runners
375438|NCT01536171|mid-foot strike|mid-foot strike
375439|NCT01536171|fore foot strike|fore foot strike
375440|NCT01536171|metabolic costs|metabolic costs
375441|NCT01536171|trained runners (men,women) with a FM strike|trained runners (men,women) with a fm strike
375442|NCT01536171|shod running|shod running
375443|NCT01536171|barefoot running|barefoot running
375444|NCT01536158|Patent Ductus Arteriosus|patent ductus arteriosus
375445|NCT01536158|Paracetamol|paracetamol
375446|NCT01536158|Ibuprofen|ibuprofen
375447|NCT01536158|Preterm infant|preterm infant
375448|NCT01536145|IGF-1R inhibitor|igf-1r inhibitor
375449|NCT01536145|CP-751871|cp-751871
375450|NCT01536145|multiple myeloma|multiple myeloma
375451|NCT01536132|Levosimendan|levosimendan
375452|NCT01536132|chronic heart failure|chronic heart failure
375453|NCT01536132|inotropic drug|inotropic drug
375454|NCT01536119|Breastfeeding|breastfeeding
375455|NCT01536119|Coparenting|coparenting
375456|NCT01536119|Infant feeding|infant feeding
375457|NCT01536119|Fathers' support|fathers' support
375458|NCT01536119|Breastfeeding support|breastfeeding support
375459|NCT01536119|Breastfeeding support intervention|breastfeeding support intervention
375460|NCT01536119|clinical trial|clinical trial
375461|NCT01536106|Cell therapy, Bone marrow stem cells, cardiac cell therapy|cell therapy, bone marrow stem cells, cardiac cell therapy
375462|NCT01536041|asthma|asthma
375463|NCT01536041|Adult|adult
375464|NCT01536015|Rotigotine|rotigotine
375465|NCT01536015|Neupro®|neupro®
375466|NCT01536015|Levodopa|levodopa
375563|NCT01535625|CAD|cad
375467|NCT01536015|Gastrointestinal Dysfunction|gastrointestinal dysfunction
375468|NCT01536002|Bariatric surgery|bariatric surgery
375469|NCT01536002|Anesthetics, intravenous|anesthetics, intravenous
375470|NCT01536002|Propofol|propofol
375471|NCT01536002|Pharmacokinetics|pharmacokinetics
375472|NCT01535989|B-cell Non Hodgkin's Lymphomas|b-cell non hodgkin's lymphomas
375473|NCT01535989|CD22 positive|cd22 positive
375474|NCT01535950|Age-related macular degeneration|age-related macular degeneration
375475|NCT01535950|intravitreal, neovascular|intravitreal, neovascular
375476|NCT01535950|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
375477|NCT01535950|wet AMD|wet amd
375478|NCT01535950|Age-related|age-related
375479|NCT01535950|Macular degeneration|macular degeneration
375480|NCT01535950|Intravitreal|intravitreal
375481|NCT01535950|Neovascular|neovascular
375482|NCT01535924|Hodgkin's Lymphoma|hodgkin's lymphoma
375483|NCT01535924|relapsed|relapsed
375484|NCT01535924|refractory|refractory
375485|NCT01535911|ketogenic diet|ketogenic diet
375486|NCT01535911|brain tumors|brain tumors
375487|NCT01535898|MRI|mri
375488|NCT01535898|MR imaging Pulse Sequence|mr imaging pulse sequence
375489|NCT01535898|High Resolution Diffusion-weighted|high resolution diffusion-weighted
375490|NCT01535898|Questionnaire|questionnaire
375491|NCT01535898|12-033|12-033
375492|NCT01535885|Cytoxic T Lymphocytes(CTL)|cytoxic t lymphocytes(ctl)
375493|NCT01535885|T-cell Depleted|t-cell depleted
375494|NCT01535885|Allogeneic Transplant|allogeneic transplant
375495|NCT01535885|Epstein Barr Virus|epstein barr virus
375496|NCT01535885|Adenovirus|adenovirus
375497|NCT01535885|Cytomegalovirus|cytomegalovirus
375498|NCT01535885|Hematopoietic progenitor cell transplantation|hematopoietic progenitor cell transplantation
375499|NCT01535846|taste|taste
375500|NCT01535846|mindful eating|mindful eating
375501|NCT01535846|intuitive eating|intuitive eating
375502|NCT01535846|attitude|attitude
375503|NCT01535846|behavior|behavior
375504|NCT01535833|robotic sacral colpopexy|robotic sacral colpopexy
375505|NCT01535833|Learning curve|learning curve
375506|NCT01535833|Pelvic Organ Prolapse|pelvic organ prolapse
375507|NCT01535833|Robotic Surgery|robotic surgery
375508|NCT01535820|Healthy volunteers|healthy volunteers
375509|NCT01535820|ORTHO EVRA|ortho evra
375510|NCT01535820|Contraceptive hormones|contraceptive hormones
375511|NCT01535820|Transdermal patch|transdermal patch
375512|NCT01535820|Progestin norelgestromin (NGMN)|progestin norelgestromin (ngmn)
375513|NCT01535820|Estrogen ethinyl estradiol (EE)|estrogen ethinyl estradiol (ee)
375514|NCT01535820|JNJ-93964|jnj-93964
375515|NCT01535820|JNJ-622206|jnj-622206
375516|NCT01535807|Atrial Fibrillation|atrial fibrillation
375517|NCT01535807|Cardiac surgery|cardiac surgery
375518|NCT01535807|Coronary Artery Bypass Graft|coronary artery bypass graft
375519|NCT01535807|CorMatrix extra cellular matrix|cormatrix extra cellular matrix
375520|NCT01535807|Heart surgery|heart surgery
375521|NCT01535807|Inflammatory Biomarkers|inflammatory biomarkers
375522|NCT01535807|Myocardial Infarction|myocardial infarction
375523|NCT01535807|identify proteomic inflammatory biomarkers|identify proteomic inflammatory biomarkers
375524|NCT01535794|HPV vaccine|hpv vaccine
375525|NCT01535794|acceptability|acceptability
375526|NCT01535794|males|males
375527|NCT01535794|men who have sex with men|men who have sex with men
375528|NCT01535781|pertrochanteric fracture|pertrochanteric fracture
375529|NCT01535781|tranexamic acid|tranexamic acid
375530|NCT01535781|postoperative blood loss|postoperative blood loss
375531|NCT01535781|blood loss|blood loss
375532|NCT01535781|hidden blood loss|hidden blood loss
375533|NCT01535781|blood transfusions|blood transfusions
375534|NCT01535755|noninvasive mechanical ventilation|noninvasive mechanical ventilation
375535|NCT01535755|ventilator weaning|ventilator weaning
375536|NCT01535742|laryngeal mask airway|laryngeal mask airway
375537|NCT01535742|children|children
375538|NCT01535742|tracheal intubation|tracheal intubation
375539|NCT01535742|fiberoptic bronchoscopy|fiberoptic bronchoscopy
375540|NCT01535690|Laser|laser
375541|NCT01535690|Clinical trial|clinical trial
375542|NCT01535690|Non-surgical periodontal therapy|non-surgical periodontal therapy
375543|NCT01535690|Periodontitis|periodontitis
375544|NCT01535690|bleeding on probing and radiographic bone loss|bleeding on probing and radiographic bone loss
375545|NCT01535690|minimum of 2 teeth with probing depth (PD) ≥ 7 mm and|minimum of 2 teeth with probing depth (pd) ≥ 7 mm and
375546|NCT01535690|2 other teeth with PD ≥ 5 mm|2 other teeth with pd ≥ 5 mm
375547|NCT01535690|mininum 16 teeth in both jaws|mininum 16 teeth in both jaws
375548|NCT01535677|Phase 1|phase 1
375549|NCT01535677|healthy volunteers|healthy volunteers
375550|NCT01535677|cross-over study|cross-over study
375551|NCT01535677|Bioavailability|bioavailability
375552|NCT01535677|Bioequivalence|bioequivalence
375553|NCT01535677|Cmax|cmax
375554|NCT01535677|tmax|tmax
375555|NCT01535677|AUC|auc
375556|NCT01535677|AUC(0-t)|auc(0-t)
375557|NCT01535677|λz|λz
375558|NCT01535677|tlast|tlast
375559|NCT01535664|Multiple Sclerosis|multiple sclerosis
375560|NCT01535664|MS|ms
375561|NCT01535625|Coronary artery disease|coronary artery disease
375562|NCT01535625|Atherosclerosis|atherosclerosis
375564|NCT01535599|Acute Otitis Externa|acute otitis externa
375565|NCT01535586|CPAP|cpap
375566|NCT01535586|MAD|mad
375567|NCT01535586|sleep apnea|sleep apnea
375568|NCT01535586|PTSD|ptsd
375569|NCT01535573|Cocaine|cocaine
375570|NCT01535573|citalopram|citalopram
375571|NCT01535573|treatment|treatment
375572|NCT01535573|serotonin|serotonin
375573|NCT01535560|Acute otitis externa|acute otitis externa
375574|NCT01535547|isavuconazole|isavuconazole
375575|NCT01535547|tacrolimus|tacrolimus
375576|NCT01535547|Healthy Volunteers|healthy volunteers
375577|NCT01535547|BAL8557|bal8557
375578|NCT01535534|sepsis|sepsis
375579|NCT01535534|inflammation|inflammation
375580|NCT01535534|diagnosis|diagnosis
375581|NCT01535534|prognosis|prognosis
375582|NCT01535534|survival|survival
375583|NCT01535534|mortality|mortality
375584|NCT01535495|beta-antagonist|beta-antagonist
375585|NCT01535495|propranolol|propranolol
375586|NCT01535495|diabetic retinopathy|diabetic retinopathy
375587|NCT01535495|diabetes|diabetes
375588|NCT01535495|angiogenesis|angiogenesis
375589|NCT01535495|neovascularization|neovascularization
375590|NCT01535482|Cognitive therapy|cognitive therapy
375591|NCT01535482|Suicide|suicide
375592|NCT01535482|Older men|older men
375593|NCT01535482|suicide ideation|suicide ideation
375594|NCT01535469|cryptococcal meningitis|cryptococcal meningitis
375595|NCT01535469|hiv|hiv
375596|NCT01535469|aids|aids
375597|NCT01535469|implementation science|implementation science
375598|NCT01535469|stepped wedge design|stepped wedge design
375599|NCT01535469|retention-in-care|retention-in-care
375600|NCT01535456|MDS|mds
375601|NCT01535456|AML|aml
375602|NCT01535456|5 azacitidine|5 azacitidine
375603|NCT01535456|FLT PET|flt pet
375604|NCT01535443|PRO-155|pro-155
375605|NCT01535443|Ocular NSAIDs|ocular nsaids
375606|NCT01535443|Safety and tolerability|safety and tolerability
375607|NCT01535443|Ocular Inflammation|ocular inflammation
375608|NCT01535443|Ocular Paint|ocular paint
375609|NCT01535430|brain mapping|brain mapping
375610|NCT01535430|brain tumor|brain tumor
375611|NCT01535417|Osteoarthritis|osteoarthritis
375612|NCT01535391|Chronic Myeloid Leukemia,|chronic myeloid leukemia,
375613|NCT01535391|Nilotinib,|nilotinib,
375614|NCT01535391|Philadelphia positive,|philadelphia positive,
375615|NCT01535391|BCR-ABL+|bcr-abl+
375616|NCT01535391|Early chronic phase|early chronic phase
375617|NCT01535365|muscular sprain|muscular sprain
375618|NCT01535365|acute back pain|acute back pain
375619|NCT01535365|acute neck pain|acute neck pain
375620|NCT01535365|heat treatment|heat treatment
375621|NCT01535365|cold treatment|cold treatment
375622|NCT01535339|mild Traumatic Brain Injury|mild traumatic brain injury
375623|NCT01535339|mTBI|mtbi
375624|NCT01535339|Concussion|concussion
375625|NCT01535326|colonoscopy|colonoscopy
375626|NCT01535300|Ultrasound|ultrasound
375627|NCT01535300|Minimal transverse tracheal diameter|minimal transverse tracheal diameter
375628|NCT01535300|Endotracheal tube size|endotracheal tube size
375629|NCT01535300|Paediatric age-based formulas|paediatric age-based formulas
375630|NCT01535300|Sonographic measurement of the trachea|sonographic measurement of the trachea
375631|NCT01535287|Dexmedetomidine|dexmedetomidine
375632|NCT01535287|Emergence Agitation|emergence agitation
375633|NCT01535287|Myringotomy|myringotomy
375634|NCT01535287|Children|children
375635|NCT01535287|General Anesthesia|general anesthesia
375636|NCT01535274|Cerebral oxygenation|cerebral oxygenation
375637|NCT01535274|Beach chair position|beach chair position
375638|NCT01535274|General anesthetic technique|general anesthetic technique
375639|NCT01535274|Inspired oxygen fraction|inspired oxygen fraction
375640|NCT01535274|End tidal carbon dioxide|end tidal carbon dioxide
375641|NCT01535261|Ophthalmology|ophthalmology
375642|NCT01535261|Ranibizumab|ranibizumab
375643|NCT01535261|Central Retinal Vein Occlusion|central retinal vein occlusion
375644|NCT01535248|ERCP|ercp
375645|NCT01535248|Transthoracic Echocardiography|transthoracic echocardiography
375646|NCT01535248|Air Embolus|air embolus
375647|NCT01535248|ERCP associated air embolus|ercp associated air embolus
375648|NCT01535235|HIV|hiv
375649|NCT01535235|Lymphoid fibrosis|lymphoid fibrosis
375650|NCT01535222|cardiac surgery|cardiac surgery
375651|NCT01535222|coronary artery bypass graft|coronary artery bypass graft
375652|NCT01535222|cardiopulmonary bypass|cardiopulmonary bypass
375653|NCT01535222|haemostasis modulator|haemostasis modulator
375654|NCT01535222|blood loss|blood loss
375655|NCT01535222|direct inhibitor of plasmin and plasma kallikrein|direct inhibitor of plasmin and plasma kallikrein
375656|NCT01535222|CABG|cabg
375657|NCT01535222|CPB|cpb
375658|NCT01535209|Stereotactic radiotherapy|stereotactic radiotherapy
375659|NCT01535209|Whole-brain radiotherapy|whole-brain radiotherapy
375660|NCT01535209|Resection cavity|resection cavity
375661|NCT01535196|vitamin D|vitamin d
375662|NCT01535196|heart failure|heart failure
375663|NCT01535183|irinotecan|irinotecan
375664|NCT01535183|brain tumor|brain tumor
375665|NCT01535183|pediatrics|pediatrics
375666|NCT01535183|salvage therapy|salvage therapy
375667|NCT01535183|chemotherapy|chemotherapy
375668|NCT01535170|lactoferrin|lactoferrin
375669|NCT01535170|selective decontamination of digestive tract|selective decontamination of digestive tract
375670|NCT01535170|antimicrobial activity|antimicrobial activity
375671|NCT01535170|prolonged mechanical ventilation|prolonged mechanical ventilation
375672|NCT01535170|respiratory care center|respiratory care center
375673|NCT01535157|Chemotherapy|chemotherapy
375674|NCT01535131|otitis media|otitis media
375675|NCT01535131|cleft palate|cleft palate
375676|NCT01535118|Allergies|allergies
375677|NCT01535118|Immunotherapy|immunotherapy
375678|NCT01535092|HCV recurrence|hcv recurrence
375679|NCT01535092|HCV reinfection|hcv reinfection
375680|NCT01535092|Liver transplantation|liver transplantation
375681|NCT01535092|Legalon SIL|legalon sil
375682|NCT01535092|silibinin|silibinin
375683|NCT01535092|viral load|viral load
375684|NCT01535079|sore throat pain|sore throat pain
375685|NCT01535079|tonsillopharyngitis|tonsillopharyngitis
375686|NCT01535079|upper respiratory tract infection|upper respiratory tract infection
375687|NCT01535066|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
375688|NCT01535066|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
375689|NCT01535066|stage IA breast cancer|stage ia breast cancer
375690|NCT01535066|stage IB breast cancer|stage ib breast cancer
375691|NCT01535066|stage II breast cancer|stage ii breast cancer
375692|NCT01535066|stage IIIA breast cancer|stage iiia breast cancer
375693|NCT01535066|stage IIIB breast cancer|stage iiib breast cancer
375694|NCT01535066|stage IIIC breast cancer|stage iiic breast cancer
375695|NCT01535066|pain|pain
375696|NCT01535040|cancer survivor|cancer survivor
375697|NCT01535040|stage I non-small cell lung cancer|stage i non-small cell lung cancer
375698|NCT01535040|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
375699|NCT01535040|tobacco use disorder|tobacco use disorder
375700|NCT01535040|stage IA breast cancer|stage ia breast cancer
375701|NCT01535040|stage IB breast cancer|stage ib breast cancer
375702|NCT01535040|stage II breast cancer|stage ii breast cancer
375703|NCT01535040|stage IIIA breast cancer|stage iiia breast cancer
375704|NCT01535040|stage IIIB breast cancer|stage iiib breast cancer
375705|NCT01535040|stage IIIC breast cancer|stage iiic breast cancer
375706|NCT01535040|stage I prostate cancer|stage i prostate cancer
375707|NCT01535040|stage IIA prostate cancer|stage iia prostate cancer
375708|NCT01535040|stage IIB prostate cancer|stage iib prostate cancer
375709|NCT01535040|stage III prostate cancer|stage iii prostate cancer
375710|NCT01535040|stage I colon cancer|stage i colon cancer
375711|NCT01535040|stage IIA colon cancer|stage iia colon cancer
375712|NCT01535040|stage IIB colon cancer|stage iib colon cancer
375713|NCT01535040|stage IIC colon cancer|stage iic colon cancer
375714|NCT01535040|stage IIIA colon cancer|stage iiia colon cancer
375715|NCT01535040|stage IIIB colon cancer|stage iiib colon cancer
375716|NCT01535040|stage IIIC colon cancer|stage iiic colon cancer
375717|NCT01535040|stage I rectal cancer|stage i rectal cancer
375718|NCT01535040|stage IIA rectal cancer|stage iia rectal cancer
375719|NCT01535040|stage IIB rectal cancer|stage iib rectal cancer
375720|NCT01535040|stage IIC rectal cancer|stage iic rectal cancer
375721|NCT01535040|stage IIIA rectal cancer|stage iiia rectal cancer
375722|NCT01535040|stage IIIB rectal cancer|stage iiib rectal cancer
375723|NCT01535040|stage IIIC rectal cancer|stage iiic rectal cancer
375724|NCT01535027|teriparatide|teriparatide
375725|NCT01535027|alendronate|alendronate
375726|NCT01535027|raloxifene|raloxifene
375727|NCT01535027|bone mineral density|bone mineral density
375728|NCT01535001|Osteoarthritis, Knee|osteoarthritis, knee
375729|NCT01535001|Treatment Outcome|treatment outcome
375730|NCT01535001|Time Factors|time factors
375731|NCT01535001|Rehabilitation|rehabilitation
375732|NCT01535001|Combined Modality Therapy|combined modality therapy
375733|NCT01535001|Middle Aged|middle aged
375734|NCT01535001|Aged|aged
375735|NCT01535001|Aged, 80 and over|aged, 80 and over
375736|NCT01535001|Male|male
375737|NCT01535001|Female|female
375738|NCT01535001|Humans|humans
375739|NCT01535001|Analysis of Variance|analysis of variance
375740|NCT01534975|cardiac CT|cardiac ct
375741|NCT01534975|enhancement|enhancement
375742|NCT01534975|contrast|contrast
375743|NCT01534975|safety|safety
375744|NCT01534975|image quality|image quality
375745|NCT01534962|Atrial Fibrillation|atrial fibrillation
375746|NCT01534962|Ranolazine|ranolazine
375747|NCT01534962|Arrhythmias, Cardiac|arrhythmias, cardiac
375748|NCT01534962|Antiarrhythmic Agents|antiarrhythmic agents
375749|NCT01534962|Cardiac Electroversion|cardiac electroversion
375750|NCT01534962|Ranexa|ranexa
375751|NCT01534949|DLBCL, Biosimilar|dlbcl, biosimilar
375752|NCT01534936|schizophrenia|schizophrenia
375753|NCT01534936|atypical antipsychotics|atypical antipsychotics
375754|NCT01534936|depressive symptoms|depressive symptoms
375755|NCT01534923|Doctor-Patient Communication|doctor-patient communication
375756|NCT01534923|questionnaire|questionnaire
375757|NCT01534923|survey|survey
375758|NCT01534923|12-017|12-017
375759|NCT01534910|garlic|garlic
375760|NCT01534910|ct angiography|ct angiography
375761|NCT01534910|atherosclerosis|atherosclerosis
375762|NCT01534910|carotid IMT|carotid imt
375763|NCT01534897|thyroid cancer|thyroid cancer
375764|NCT01534897|Tall cell PTC|tall cell ptc
375765|NCT01534897|Poorly differentiated thyroid carcinoma|poorly differentiated thyroid carcinoma
375766|NCT01534897|metastatic|metastatic
375767|NCT01534884|RA, Biosimilar|ra, biosimilar
375768|NCT01534871|Cardiac rehabilitation|cardiac rehabilitation
375769|NCT01534871|Exercise|exercise
375770|NCT01534871|Systemic inflammation|systemic inflammation
375771|NCT01534871|Cardiovascular disease risk|cardiovascular disease risk
375772|NCT01534858|polyhexanide, polihexanide, PHMB, Prontosan, burns, wounds|polyhexanide, polihexanide, phmb, prontosan, burns, wounds
375773|NCT01534832|surgical smoke|surgical smoke
375774|NCT01534832|laparoscopic surgery|laparoscopic surgery
375775|NCT01534832|impaired vision|impaired vision
375776|NCT01534819|Abdominal aortic aneurysm|abdominal aortic aneurysm
375778|NCT01534819|Endograft|endograft
375779|NCT01534819|interventional treatment of AAA|interventional treatment of aaa
375780|NCT01534806|Migraine|migraine
375781|NCT01534793|Quality assessment|quality assessment
375782|NCT01534793|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
375783|NCT01534793|Enucleation of the prostate|enucleation of the prostate
375784|NCT01534793|LUMENIS|lumenis
375785|NCT01534793|Laser|laser
375786|NCT01534793|Learning Curve|learning curve
375787|NCT01534728|Hepatitis C|hepatitis c
375788|NCT01534728|CD8 epitopes|cd8 epitopes
375789|NCT01534702|Acute Myeloid Leukemia|acute myeloid leukemia
375790|NCT01534702|chemotherapy|chemotherapy
375791|NCT01534702|clofarabine|clofarabine
375792|NCT01534676|iron|iron
375793|NCT01534676|transfusion|transfusion
375794|NCT01534676|red blood cells|red blood cells
375795|NCT01534676|sickle cell disease|sickle cell disease
375796|NCT01534676|thalassemia|thalassemia
375797|NCT01534676|blood donors|blood donors
375798|NCT01534663|Heart Failure|heart failure
375799|NCT01534663|Skeletal Muscle Function|skeletal muscle function
375800|NCT01534663|Metabolism|metabolism
375801|NCT01534663|Inflammation|inflammation
375802|NCT01534663|Glutamine|glutamine
375803|NCT01534663|Fish oil|fish oil
375804|NCT01534663|Muscle Function|muscle function
375805|NCT01534650|motion sensors|motion sensors
375806|NCT01534650|tremor|tremor
375807|NCT01534650|bradykinesia|bradykinesia
375808|NCT01534650|gait|gait
375809|NCT01534650|balance|balance
375810|NCT01534650|dyskinesia|dyskinesia
375811|NCT01534624|Induced Pluripotent Stem Cell (iPS) Cell Lines|induced pluripotent stem cell (ips) cell lines
375812|NCT01534624|Addiction|addiction
375813|NCT01534624|Addiction-Associated Human Gene Variants|addiction-associated human gene variants
375814|NCT01534624|Dopamine Transporter|dopamine transporter
375815|NCT01534598|DNA Methylation|dna methylation
375816|NCT01534598|Advanced Cancer|advanced cancer
375817|NCT01534598|Methyltransferase Inhibitor|methyltransferase inhibitor
375818|NCT01534598|Epigenetics|epigenetics
375819|NCT01534598|Gene Re-Expression|gene re-expression
375820|NCT01534598|Cancer|cancer
375821|NCT01534598|Solid Tumor|solid tumor
375822|NCT01534585|nasopharyngeal carcinoma(NPC)|nasopharyngeal carcinoma(npc)
375823|NCT01534585|Icotinib|icotinib
375824|NCT01534585|Intensity Modulation Radiation Therapy(IMRT)|intensity modulation radiation therapy(imrt)
375825|NCT01534546|neoadjuvant chemotherapy|neoadjuvant chemotherapy
375826|NCT01534546|adjuvant chemotherapy|adjuvant chemotherapy
375827|NCT01534546|DFS|dfs
375828|NCT01534546|OS|os
375829|NCT01534546|safety|safety
375830|NCT01534546|resectable locally advanced gastric carcinoma|resectable locally advanced gastric carcinoma
375831|NCT01534546|potentially resectable locally advanced gastric carcinoma|potentially resectable locally advanced gastric carcinoma
375832|NCT01534533|early atherosclerosis|early atherosclerosis
375833|NCT01534533|serum lutein|serum lutein
375834|NCT01534533|serum lycopene|serum lycopene
375835|NCT01534533|intima-media thickness|intima-media thickness
375836|NCT01534533|arterial stiffness|arterial stiffness
375837|NCT01534533|combined effect|combined effect
375838|NCT01534520|Intrauterine Device|intrauterine device
375839|NCT01534520|Pain|pain
375840|NCT01534520|Lidocaine|lidocaine
375841|NCT01534494|alcohol dependence|alcohol dependence
375842|NCT01534494|psilocybin|psilocybin
375843|NCT01534494|clinical trial|clinical trial
375844|NCT01534494|motivational enhancement therapy|motivational enhancement therapy
375845|NCT01534481|NICHD Neonatal Research Network|nichd neonatal research network
375846|NCT01534481|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
375847|NCT01534481|Prematurity|prematurity
375848|NCT01534481|Neurodevelopmental Impairment|neurodevelopmental impairment
375849|NCT01534481|Donor Breast Milk|donor breast milk
375850|NCT01534481|Preterm Formula|preterm formula
375851|NCT01534455|German Breast Group|german breast group
375852|NCT01534455|GBG Forschungs GmbH|gbg forschungs gmbh
375853|NCT01534455|GBG|gbg
375854|NCT01534455|GBG 64|gbg 64
375855|NCT01534455|E-VITA|e-vita
375856|NCT01534455|Breast Cancer|breast cancer
375857|NCT01534455|Metastatic Breast Cancer|metastatic breast cancer
375858|NCT01534455|Eribulin|eribulin
375859|NCT01534455|Lapatinib|lapatinib
375860|NCT01534455|Halaven|halaven
375861|NCT01534455|Tyverb|tyverb
375862|NCT01534429|pain|pain
375863|NCT01534416|Paracervical Block|paracervical block
375864|NCT01534416|Laparoscopic Surgery|laparoscopic surgery
375865|NCT01534416|Postoperative Pain|postoperative pain
375866|NCT01534416|Bupivacaine|bupivacaine
375867|NCT01534416|Hysterectomy|hysterectomy
375868|NCT01534416|Myomectomy|myomectomy
375869|NCT01534416|Randomized Trial|randomized trial
375870|NCT01534403|Lupus|lupus
375871|NCT01534403|Monoclonal antibody|monoclonal antibody
375872|NCT01534403|B-cell immunotherapy|b-cell immunotherapy
375873|NCT01534403|Epratuzumab|epratuzumab
375874|NCT01534390|microparticles|microparticles
375875|NCT01534390|in-line microfilters|in-line microfilters
375876|NCT01534390|systemic inflammation|systemic inflammation
375877|NCT01534390|organ failure|organ failure
375878|NCT01534390|critical illness|critical illness
375879|NCT01534390|adult|adult
375880|NCT01534377|Depression|depression
375881|NCT01534377|Adolescents|adolescents
375882|NCT01534364|acute renal failure|acute renal failure
375883|NCT01534364|acute kidney injury|acute kidney injury
375884|NCT01534364|diet|diet
375885|NCT01534364|caloric restriction|caloric restriction
375886|NCT01534364|cardiac surgery|cardiac surgery
375887|NCT01534364|cardiothoracic surgery|cardiothoracic surgery
375888|NCT01534338|Sleep|sleep
375889|NCT01534338|inflammation|inflammation
375890|NCT01534338|mindfulness|mindfulness
375891|NCT01534338|meditation|meditation
375892|NCT01534338|randomized controlled trial|randomized controlled trial
375893|NCT01534312|Glycopeptides|glycopeptides
375894|NCT01534312|Dietary proteins|dietary proteins
375895|NCT01534286|Prescription Medical Food|prescription medical food
375896|NCT01534286|Theramine|theramine
375897|NCT01534286|Knee surgery|knee surgery
375898|NCT01534273|Mild Cognitive Impairment|mild cognitive impairment
375899|NCT01534247|Phase I|phase i
375900|NCT01534247|drug to drug|drug to drug
375901|NCT01534247|CAZ-AVI|caz-avi
375902|NCT01534247|Healthy volunteer|healthy volunteer
375903|NCT01534247|pharmacokinetics|pharmacokinetics
375904|NCT01534247|open label|open label
375905|NCT01534247|metronidazole|metronidazole
375906|NCT01534247|safety|safety
375907|NCT01534234|CRT-D device|crt-d device
375908|NCT01534234|Severe HF (NYHA Class III or ambulatory IV)|severe hf (nyha class iii or ambulatory iv)
375909|NCT01534234|stable, optimal drug regimen|stable, optimal drug regimen
375910|NCT01534234|sinus rhythm|sinus rhythm
375911|NCT01534221|Ischemic Heart Disease|ischemic heart disease
375912|NCT01534182|Relapsing Remitting Multiple Sclerosis (RRMS)|relapsing remitting multiple sclerosis (rrms)
375913|NCT01534182|Fingolimod|fingolimod
375914|NCT01534182|Disease Modifying Therapy (DMT)|disease modifying therapy (dmt)
375915|NCT01534182|TSQM-9|tsqm-9
375916|NCT01534169|Graves' disease|graves' disease
375917|NCT01534169|Dexamethasone|dexamethasone
375918|NCT01534169|Function of regulatory T cells|function of regulatory t cells
375919|NCT01534169|The proportion of Th1 and Th2 cells|the proportion of th1 and th2 cells
375920|NCT01534130|Chronic Fatigue Syndrome|chronic fatigue syndrome
375921|NCT01534130|Sleep Disorder, Adjustment|sleep disorder, adjustment
375922|NCT01534130|Acupuncture|acupuncture
375923|NCT01534104|fMRI|fmri
375924|NCT01534104|DTI|dti
375925|NCT01534104|DSI|dsi
375926|NCT01534104|tractography|tractography
375927|NCT01534104|neurological/physical testing|neurological/physical testing
375928|NCT01534104|Motor and Language Pathways|motor and language pathways
375929|NCT01534104|resting state fMRI|resting state fmri
375930|NCT01534104|12-008|12-008
375931|NCT01534091|overweight|overweight
375932|NCT01534091|obese|obese
375933|NCT01534091|children|children
375934|NCT01534091|exercise|exercise
375935|NCT01534091|physical activity|physical activity
375936|NCT01534091|pedometer|pedometer
375937|NCT01534078|non-bulky|non-bulky
375938|NCT01534078|limited stage|limited stage
375939|NCT01534065|Hernia|hernia
375940|NCT01534065|Intervertebral Disk Displacement|intervertebral disk displacement
375941|NCT01534065|Pathological Conditions, Anatomical|pathological conditions, anatomical
375942|NCT01534065|Spinal Diseases|spinal diseases
375943|NCT01534065|Bone Diseases|bone diseases
375944|NCT01534065|Musculoskeletal Diseases|musculoskeletal diseases
375945|NCT01534052|Prostate Cancer|prostate cancer
375946|NCT01534052|Castration-Resistant Prostate Cancer (CRPC)|castration-resistant prostate cancer (crpc)
375947|NCT01534052|MDV3100|mdv3100
375948|NCT01534052|Androgen receptor signaling inhibitor|androgen receptor signaling inhibitor
375949|NCT01534013|Closed loop insulin delivery|closed loop insulin delivery
375950|NCT01534000|Cardiac CT|cardiac ct
375951|NCT01534000|Ischemic heat disease|ischemic heat disease
375952|NCT01534000|Stress test|stress test
375953|NCT01533987|Male|male
375954|NCT01533987|Overweight|overweight
375955|NCT01533987|Juice Plus|juice plus
375956|NCT01533961|neglected disease|neglected disease
375957|NCT01533961|africa|africa
375958|NCT01533961|new drug|new drug
375959|NCT01533961|oral drug|oral drug
375960|NCT01533961|parasite|parasite
375961|NCT01533896|Obesity prevention|obesity prevention
375962|NCT01533896|Primary care|primary care
375963|NCT01533896|Education|education
375964|NCT01533883|Mitral|mitral
375965|NCT01533883|Valve|valve
375966|NCT01533883|Annuloplasty|annuloplasty
375967|NCT01533883|Transatrial|transatrial
375968|NCT01533883|Transapical|transapical
375969|NCT01533883|Transfemoral|transfemoral
375970|NCT01533883|Mitral valve insufficiency|mitral valve insufficiency
375971|NCT01533870|Phase 1|phase 1
375972|NCT01533870|Healthy male and female volunteers|healthy male and female volunteers
375973|NCT01533870|Drug-drug interaction|drug-drug interaction
375974|NCT01533870|Pharmacokinetics|pharmacokinetics
375975|NCT01533870|NKTR-118|nktr-118
375976|NCT01533870|Bioavailability|bioavailability
375977|NCT01533870|Plasma AUC and Cmax|plasma auc and cmax
375978|NCT01533870|Plasma AUC0-t and t1/2λz and tmax|plasma auc0-t and t1/2λz and tmax
375979|NCT01533857|Black tea|black tea
375980|NCT01533857|phenolic acids|phenolic acids
375981|NCT01533844|CDAD|cdad
375982|NCT01533844|Neonates|neonates
375983|NCT01533844|Clostridium difficile|clostridium difficile
375984|NCT01533818|Fast breathing|fast breathing
375985|NCT01533818|Young infants|young infants
375986|NCT01533818|Management|management
375987|NCT01533818|Amoxicillin|amoxicillin
375988|NCT01533818|Placebo|placebo
375989|NCT01533805|Lumbago|lumbago
375990|NCT01533805|Exercise therapy|exercise therapy
375991|NCT01533805|Spine|spine
375992|NCT01533792|Treatment|treatment
375993|NCT01533792|pregnant women|pregnant women
375994|NCT01533792|periodontitis|periodontitis
375995|NCT01533792|dental scaling|dental scaling
375996|NCT01533792|dental plaque|dental plaque
375997|NCT01533779|children|children
375998|NCT01533779|malignancy|malignancy
375999|NCT01533779|neutrophil|neutrophil
376000|NCT01533779|neutrophil extracellular traps|neutrophil extracellular traps
376001|NCT01533779|superoxide production|superoxide production
376002|NCT01533779|hydrogen peroxide production|hydrogen peroxide production
376003|NCT01533779|chemotaxis|chemotaxis
376004|NCT01533779|myeloperoxidase|myeloperoxidase
376005|NCT01533779|immunosurveillance|immunosurveillance
376006|NCT01533779|cancer cell lines|cancer cell lines
376007|NCT01533753|hot flashes|hot flashes
376008|NCT01533753|prostate cancer|prostate cancer
376009|NCT01533727|Cytokine-Induced Killer Cell|cytokine-induced killer cell
376010|NCT01533727|NSCLC|nsclc
376011|NCT01533727|adjuvant therapy|adjuvant therapy
376012|NCT01533714|Rheumatoid Arthritis|rheumatoid arthritis
376013|NCT01533714|Monoclonal antibody|monoclonal antibody
376014|NCT01533714|Interleukin-6|interleukin-6
376015|NCT01533714|Olokizumab|olokizumab
376016|NCT01533714|CDP6038|cdp6038
376017|NCT01533701|Hypoxia|hypoxia
376018|NCT01533701|Fetal blood sampling|fetal blood sampling
376019|NCT01533701|Lactate|lactate
376020|NCT01533701|pH|ph
376021|NCT01533701|base deficit|base deficit
376022|NCT01533701|angiogenic factors|angiogenic factors
376023|NCT01533701|suspected fetal hypoxia|suspected fetal hypoxia
376024|NCT01533675|suture, tensile strength, wound care, saline, hydrogen peroxide, skin closure, wounds, wound healing, wound cleansing, antiseptics|suture, tensile strength, wound care, saline, hydrogen peroxide, skin closure, wounds, wound healing, wound cleansing, antiseptics
376025|NCT01533662|phenylephrine|phenylephrine
376026|NCT01533662|hypotension|hypotension
376027|NCT01533662|spinal anesthesia|spinal anesthesia
376028|NCT01533662|lower limb orthopedic surgery|lower limb orthopedic surgery
376029|NCT01533649|Behavioral intervention|behavioral intervention
376030|NCT01533649|Seizure self-efficacy|seizure self-efficacy
376031|NCT01533649|Psychosocial outcomes|psychosocial outcomes
376032|NCT01533649|Quality of Life in Epilepsy|quality of life in epilepsy
376033|NCT01533636|Cystic Fibrosis, Healthy|cystic fibrosis, healthy
376034|NCT01533610|Post-Traumatic Stress disorder|post-traumatic stress disorder
376035|NCT01533610|Stellate ganglion|stellate ganglion
376036|NCT01533610|cervical plexus|cervical plexus
376037|NCT01533610|local anesthesia|local anesthesia
376038|NCT01533610|anxiety|anxiety
376039|NCT01533597|Overactive bladder|overactive bladder
376040|NCT01533597|Solifenacin succinate|solifenacin succinate
376041|NCT01533597|Tamsulosin|tamsulosin
376042|NCT01533571|Guided Bone Regeneration|guided bone regeneration
376043|NCT01533571|Dental Implant|dental implant
376044|NCT01533571|Alveolar Ridge Augmentation|alveolar ridge augmentation
376045|NCT01533571|Socket graft|socket graft
376046|NCT01533558|caspofungin|caspofungin
376047|NCT01533558|pharmacokinetics|pharmacokinetics
376048|NCT01533558|invasive fungal infection|invasive fungal infection
376049|NCT01533558|candidiasis|candidiasis
376050|NCT01533558|aspergillosis|aspergillosis
376051|NCT01533558|intensive care|intensive care
376052|NCT01533545|Mepivacaine|mepivacaine
376053|NCT01533545|Epinephrine|epinephrine
376054|NCT01533545|Brachial plexus block|brachial plexus block
376055|NCT01533545|Renal insufficiency|renal insufficiency
376056|NCT01533532|Gonadotropin-Releasing Hormone (GnRH) antagonist|gonadotropin-releasing hormone (gnrh) antagonist
376057|NCT01533519|Neuropeptide Y|neuropeptide y
376058|NCT01533519|Intranasal Administration|intranasal administration
376059|NCT01533519|PTSD|ptsd
376060|NCT01533519|Trauma|trauma
376061|NCT01533506|treatment with stiripentol|treatment with stiripentol
376062|NCT01533493|ADHD|adhd
376063|NCT01533493|Executive Function|executive function
376064|NCT01533493|Namenda|namenda
376065|NCT01533493|Concerta|concerta
376066|NCT01533480|Adenovirus|adenovirus
376067|NCT01533480|Conjunctivitis|conjunctivitis
376068|NCT01533480|keratoconjunctivitis|keratoconjunctivitis
376069|NCT01533480|viral shedding|viral shedding
376070|NCT01533480|subepithelial infiltrate|subepithelial infiltrate
376071|NCT01533480|bulbar injection|bulbar injection
376072|NCT01533467|Delivery rupture|delivery rupture
376073|NCT01533467|perineal protection device|perineal protection device
376074|NCT01533467|reduce perineal tears|reduce perineal tears
376075|NCT01533454|Obesity|obesity
376076|NCT01533454|Weight loss|weight loss
376077|NCT01533454|Incentives|incentives
376078|NCT01533454|Motivation|motivation
376079|NCT01533441|anticoagulant therapy|anticoagulant therapy
376080|NCT01533441|INR|inr
376081|NCT01533441|vitamin K2|vitamin k2
376082|NCT01533441|vitamin K antagonist|vitamin k antagonist
376083|NCT01533428|Painful Diabetic Peripheral Neuropathy,|painful diabetic peripheral neuropathy,
376084|NCT01533428|Capsaicin 8% transdermal delivery system|capsaicin 8% transdermal delivery system
376085|NCT01533415|Anxiety|anxiety
376086|NCT01533415|Anxiety Disorders|anxiety disorders
376087|NCT01533402|Cognitive behavior therapy|cognitive behavior therapy
376088|NCT01533402|Internet|internet
376089|NCT01533402|Anxiety disorders|anxiety disorders
376090|NCT01533402|Children|children
376091|NCT01533376|Sturge Weber|sturge weber
376092|NCT01533376|SWS|sws
376093|NCT01533376|Timolol|timolol
376094|NCT01533376|Port wine mark|port wine mark
376095|NCT01533363|Hemorrhoids|hemorrhoids
376096|NCT01533363|Surgery|surgery
376097|NCT01533363|Hemorrhoidopexy|hemorrhoidopexy
376098|NCT01533363|Milligan Morgan|milligan morgan
376099|NCT01533350|Ultrasonography|ultrasonography
376100|NCT01533350|late follicle phase|late follicle phase
376101|NCT01533350|homogeneous endometrium|homogeneous endometrium
376102|NCT01533350|receptivity|receptivity
376103|NCT01533350|biochemical factor|biochemical factor
376104|NCT01533350|ultrastructure|ultrastructure
376105|NCT01533350|endometrial echo pattern|endometrial echo pattern
376106|NCT01533337|dorsal digital free flap|dorsal digital free flap
376107|NCT01533337|dorsal branch of proper digital nerve|dorsal branch of proper digital nerve
376108|NCT01533337|dorsal branch of proper digital artery|dorsal branch of proper digital artery
376109|NCT01533337|proper digital artery|proper digital artery
376110|NCT01533324|hepatocellular carcinoma|hepatocellular carcinoma
376111|NCT01533324|S-1|s-1
376112|NCT01533324|Leucovorin|leucovorin
376113|NCT01533324|fluorouracil|fluorouracil
376114|NCT01533311|nonpolypoid colorectal neoplasms(NP-CRN)|nonpolypoid colorectal neoplasms(np-crn)
376115|NCT01533311|prevalence|prevalence
376116|NCT01533311|histology|histology
376117|NCT01533285|Major depressive disorder|major depressive disorder
376118|NCT01533285|MDD|mdd
376119|NCT01533285|Psychiatry disorders|psychiatry disorders
376120|NCT01533285|Psychosocial stressor|psychosocial stressor
376121|NCT01533285|Psychosocial stress|psychosocial stress
376122|NCT01533285|Typhoid vaccination|typhoid vaccination
376123|NCT01533285|Typhoid vaccine|typhoid vaccine
376124|NCT01533272|HIV infection|hiv infection
376125|NCT01533272|Postexposure prophylaxis|postexposure prophylaxis
376126|NCT01533259|HIV-1|hiv-1
376127|NCT01533259|HIV|hiv
376128|NCT01533259|Treatment Experienced|treatment experienced
376129|NCT01533233|thoracoscopy|thoracoscopy
376130|NCT01533233|lung cancer|lung cancer
376131|NCT01533233|lobectomy|lobectomy
376132|NCT01533233|epidural anesthesia|epidural anesthesia
376133|NCT01533220|nasal and nasopharyngeal congestion|nasal and nasopharyngeal congestion
376134|NCT01533168|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
376135|NCT01533168|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
376136|NCT01533168|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
376137|NCT01533155|Phase 1|phase 1
376138|NCT01533155|Healthy male and female volunteers|healthy male and female volunteers
376139|NCT01533155|Drug-drug interaction|drug-drug interaction
376140|NCT01533155|Pharmacokinetics|pharmacokinetics
376141|NCT01533155|NKTR-118|nktr-118
376142|NCT01533142|lipids|lipids
376143|NCT01533129|Hypogonadism|hypogonadism
376144|NCT01533129|Endothelial dysfunction|endothelial dysfunction
376145|NCT01533129|Inflammation|inflammation
376146|NCT01533129|Insulin resistance|insulin resistance
376147|NCT01533129|Testosterone replacement therapy|testosterone replacement therapy
376148|NCT01533116|Parkinson Disease|parkinson disease
376149|NCT01533116|BIA 9-1067|bia 9-1067
376150|NCT01533077|Parkinson Disease|parkinson disease
376151|NCT01533077|BIA 9-1067|bia 9-1067
376152|NCT01533051|Chronic hepatitis B|chronic hepatitis b
376153|NCT01533051|Nucleos(t)ide analogue|nucleos(t)ide analogue
376154|NCT01533051|Antiviral treatment|antiviral treatment
376155|NCT01533051|Korea|korea
376156|NCT01533025|anterior cruciate ligament|anterior cruciate ligament
376157|NCT01533025|Achilles|achilles
376158|NCT01533025|free tendon|free tendon
376159|NCT01533025|bone-tendon|bone-tendon
376160|NCT01533025|free tendon Achilles allograft|free tendon achilles allograft
376469|NCT01531634|Hope Scale|hope scale
376161|NCT01533025|Achilles allograft with calcaneal bone block on its end|achilles allograft with calcaneal bone block on its end
376162|NCT01532999|Posttraumatic Stress Disorder|posttraumatic stress disorder
376163|NCT01532999|Meditation|meditation
376164|NCT01532999|Present Centered Group Therapy|present centered group therapy
376165|NCT01532999|mindfulness|mindfulness
376166|NCT01532999|MBSR|mbsr
376167|NCT01532999|complementary alternative medicine|complementary alternative medicine
376168|NCT01532986|Quality of Health Care|quality of health care
376169|NCT01532986|Nursing Care Management|nursing care management
376170|NCT01532986|Care Coordination|care coordination
376171|NCT01532986|Randomized Trials|randomized trials
376172|NCT01532960|breast cancer|breast cancer
376173|NCT01532960|peptide vaccine|peptide vaccine
376174|NCT01532960|immunotherapy|immunotherapy
376175|NCT01532934|substance use|substance use
376176|NCT01532934|psychopathy|psychopathy
376177|NCT01532934|motivational enhancement|motivational enhancement
376178|NCT01532934|criminal recidivism|criminal recidivism
376179|NCT01532908|Liver Transplantation|liver transplantation
376180|NCT01532895|Pain|pain
376181|NCT01532895|Cancer pain|cancer pain
376182|NCT01532895|Hydromorphone|hydromorphone
376183|NCT01532895|Hydromorphone OROS|hydromorphone oros
376184|NCT01532895|Narcotic analgesics|narcotic analgesics
376185|NCT01532895|Opioid-naive|opioid-naive
376186|NCT01532856|multiple myeloma|multiple myeloma
376187|NCT01532856|thalidomide|thalidomide
376188|NCT01532856|comparative|comparative
376189|NCT01532856|elderly|elderly
376190|NCT01532843|Hepatitis B|hepatitis b
376191|NCT01532843|sustained response|sustained response
376192|NCT01532843|peginterferon|peginterferon
376193|NCT01532843|nucleos(t)ide analogues|nucleos(t)ide analogues
376194|NCT01532830|vagus nerve stimulation|vagus nerve stimulation
376195|NCT01532830|vagal nerve stimulation|vagal nerve stimulation
376196|NCT01532830|nVNS|nvns
376197|NCT01532830|VNS|vns
376198|NCT01532830|migraine|migraine
376199|NCT01532830|non invasive|non invasive
376200|NCT01532830|gammacore|gammacore
376201|NCT01532804|Unresectable metastases|unresectable metastases
376202|NCT01532791|MELAS|melas
376203|NCT01532791|mitochondrial DNA mutation|mitochondrial dna mutation
376204|NCT01532791|mtDNA mutation|mtdna mutation
376205|NCT01532791|mitochondrial DNA|mitochondrial dna
376206|NCT01532791|mitochondria|mitochondria
376207|NCT01532791|m.3243A>G mutation|m.3243a>g mutation
376208|NCT01532765|Internal limiting membrane|internal limiting membrane
376209|NCT01532765|Indocyanine green dye|indocyanine green dye
376210|NCT01532739|Mild Cognitive Impairment|mild cognitive impairment
376211|NCT01532739|Aging|aging
376212|NCT01532739|Memory|memory
376213|NCT01532739|Executive Function|executive function
376214|NCT01532739|Cognitive Intervention|cognitive intervention
376215|NCT01532739|Memory Training|memory training
376216|NCT01532739|Mental Health|mental health
376217|NCT01532726|Partial-Onset Seizures|partial-onset seizures
376218|NCT01532726|Eslicarbazepine Acetate|eslicarbazepine acetate
376219|NCT01532726|ESL|esl
376220|NCT01532726|BIA 2-093|bia 2-093
376221|NCT01532726|BIAL|bial
376222|NCT01532661|TRAUMA|trauma
376223|NCT01532661|HAEMORRHAGIC|haemorrhagic
376224|NCT01532661|rVIIa|rviia
376225|NCT01532661|Complication of Trauma hemorrhage|complication of trauma hemorrhage
376226|NCT01532661|bleeding|bleeding
376227|NCT01532661|rFVIIa administration for hemorrhage after trauma|rfviia administration for hemorrhage after trauma
376228|NCT01532648|Ulcerative Colitis|ulcerative colitis
376229|NCT01532635|hematologic malignancy|hematologic malignancy
376230|NCT01532635|leukemia|leukemia
376231|NCT01532635|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
376232|NCT01532635|ALL|all
376233|NCT01532635|Acute myelogenous leukemia|acute myelogenous leukemia
376234|NCT01532635|AML|aml
376235|NCT01532635|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
376236|NCT01532635|CLL|cll
376237|NCT01532635|lymphoma|lymphoma
376238|NCT01532635|hodgkin's lymphoma|hodgkin's lymphoma
376239|NCT01532635|non-hodgkin's lymphoma|non-hodgkin's lymphoma
376240|NCT01532635|myeloma|myeloma
376241|NCT01532635|allogeneic stem cell transplant|allogeneic stem cell transplant
376242|NCT01532635|TJU 2-step|tju 2-step
376243|NCT01532635|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
376244|NCT01532635|HSCT|hsct
376245|NCT01532635|bone marrow transplant|bone marrow transplant
376246|NCT01532635|Cyclophosphamide|cyclophosphamide
376247|NCT01532635|MMF|mmf
376248|NCT01532635|Mycophenolate Mofetil|mycophenolate mofetil
376249|NCT01532622|Blueberry|blueberry
376250|NCT01532609|Methadone maintenance therapy|methadone maintenance therapy
376251|NCT01532609|Behavioral intervention|behavioral intervention
376252|NCT01532609|Service provider|service provider
376253|NCT01532609|Drug use|drug use
376254|NCT01532570|Behcet's disease|behcet's disease
376255|NCT01532570|intestinal Behcet's disease|intestinal behcet's disease
376256|NCT01532570|neuro-Behcet's disease|neuro-behcet's disease
376257|NCT01532570|vascular Behcet's disease|vascular behcet's disease
376258|NCT01532544|Severe pneumonia|severe pneumonia
376259|NCT01532531|Collateral Meridian Therapy|collateral meridian therapy
376260|NCT01532531|Knee Osteoarthritis|knee osteoarthritis
376261|NCT01532518|Feeding intolerance|feeding intolerance
376262|NCT01532518|Infant|infant
376263|NCT01532518|tachykinin antagonist|tachykinin antagonist
376264|NCT01532518|Infant colic|infant colic
376265|NCT01532518|Nepadutant|nepadutant
376266|NCT01532505|cardiopulmonary bypass|cardiopulmonary bypass
376267|NCT01532505|Postcardiotomy vasodilatory shock|postcardiotomy vasodilatory shock
376268|NCT01532505|Microcirculation|microcirculation
376269|NCT01532505|Catecholamines|catecholamines
376270|NCT01532505|Vasopressin|vasopressin
376271|NCT01532492|Questionnaire|questionnaire
376272|NCT01532492|WORC|worc
376273|NCT01532492|Rotator cuff|rotator cuff
376274|NCT01532492|Reliability|reliability
376275|NCT01532492|Validity|validity
376276|NCT01532492|Responsiveness|responsiveness
376277|NCT01532479|Osteoradionecrosis|osteoradionecrosis
376278|NCT01532479|Xerostomia|xerostomia
376279|NCT01532466|fentanyl-induced coughing, rocuronium|fentanyl-induced coughing, rocuronium
376280|NCT01532401|Blood pressure|blood pressure
376281|NCT01532388|Randomized Controlled Trial|randomized controlled trial
376283|NCT01532388|Drugs|drugs
376284|NCT01532388|Internet|internet
376285|NCT01532388|Screening|screening
376286|NCT01532388|Brief intervention|brief intervention
376287|NCT01532375|Kochujang,|kochujang,
376288|NCT01532375|visceral fat|visceral fat
376289|NCT01532375|population|population
376290|NCT01532349|chronic kidney disease|chronic kidney disease
376291|NCT01532349|anemia|anemia
376292|NCT01532336|adenovirus|adenovirus
376293|NCT01532336|conjunctivitis|conjunctivitis
376294|NCT01532336|pinkeye|pinkeye
376295|NCT01532323|Oral disorders|oral disorders
376296|NCT01532310|systemic lupus erythematosus|systemic lupus erythematosus
376297|NCT01532310|belimumab|belimumab
376298|NCT01532310|pregnancy|pregnancy
376299|NCT01532297|citrate dialysate|citrate dialysate
376300|NCT01532297|dialysis|dialysis
376301|NCT01532297|calcium|calcium
376302|NCT01532284|aneuploid oocytes|aneuploid oocytes
376303|NCT01532284|ICSI|icsi
376304|NCT01532284|IVF|ivf
376305|NCT01532284|Polar Body Biopsy|polar body biopsy
376306|NCT01532271|mild Traumatic Brain Injury|mild traumatic brain injury
376307|NCT01532271|mTBI|mtbi
376308|NCT01532271|Concussion|concussion
376309|NCT01532258|BMI|bmi
376310|NCT01532258|Weight loss|weight loss
376311|NCT01532258|Nutrition|nutrition
376312|NCT01532258|Diet|diet
376313|NCT01532258|Mediterranean diet|mediterranean diet
376314|NCT01532258|Online program|online program
376315|NCT01532258|web-based program|web-based program
376316|NCT01532258|Oxidative stress|oxidative stress
376317|NCT01532258|F2 isoprostanes|f2 isoprostanes
376318|NCT01532232|PLACEBO|placebo
376319|NCT01532232|VARENICLINE (CHANTIX)|varenicline (chantix)
376320|NCT01532232|Self-reported cigarettes smokers|self-reported cigarettes smokers
376321|NCT01532232|Smoking Cessation|smoking cessation
376322|NCT01532232|11-136|11-136
376323|NCT01532206|Remote ischemic preconditioning|remote ischemic preconditioning
376324|NCT01532206|inflammation|inflammation
376325|NCT01532180|Obstructive sleep apnea, neurostimulation, hypoglossal nerve|obstructive sleep apnea, neurostimulation, hypoglossal nerve
376326|NCT01532141|Parkinson Disease|parkinson disease
376327|NCT01532141|BIA 9-1067|bia 9-1067
376328|NCT01532128|Parkinson Disease|parkinson disease
376329|NCT01532128|BIA 9-1067|bia 9-1067
376330|NCT01532115|Parkinson Disease|parkinson disease
376331|NCT01532115|BIA 9-1067|bia 9-1067
376332|NCT01532102|Genital warts|genital warts
376333|NCT01532102|Anogenital warts|anogenital warts
376334|NCT01532102|HPV|hpv
376335|NCT01532102|Human papillomavirus|human papillomavirus
376336|NCT01532102|Antiviral|antiviral
376337|NCT01532076|osteoporosis|osteoporosis
376338|NCT01532076|prox. humeral fracture|prox. humeral fracture
376339|NCT01532076|geriatric trauma|geriatric trauma
376340|NCT01532076|mesenchymal stem cells|mesenchymal stem cells
376341|NCT01532063|Difficult intubation|difficult intubation
376342|NCT01532063|Intensive care units|intensive care units
376343|NCT01532063|Risk factors|risk factors
376344|NCT01532063|Incidence|incidence
376345|NCT01532063|Complications|complications
376346|NCT01532063|Intubation in Intensive Care Unit|intubation in intensive care unit
376347|NCT01532063|More than 2 attempts of intubation|more than 2 attempts of intubation
376348|NCT01532063|Intubation attempts lasting more than 10 minutes|intubation attempts lasting more than 10 minutes
376349|NCT01532050|OSAS|osas
376350|NCT01532050|American Academy of Sleep Medicine Task Force|american academy of sleep medicine task force
376351|NCT01532037|Randomised controlled trial|randomised controlled trial
376352|NCT01532037|Multiple Sclerosis|multiple sclerosis
376353|NCT01532037|Fatigue|fatigue
376354|NCT01532037|Cognitive Behavioural Therapy|cognitive behavioural therapy
376355|NCT01532037|Self Help|self help
376356|NCT01532024|Optical Imaging|optical imaging
376357|NCT01532024|Neutrophil|neutrophil
376358|NCT01532024|Elastase|elastase
376359|NCT01532024|Molecular Imaging|molecular imaging
376360|NCT01532024|Acute Lung Injury|acute lung injury
376361|NCT01532024|ARDS|ards
376573|NCT01531231|emotions|emotions
376362|NCT01532011|Advanced Cancers|advanced cancers
376363|NCT01532011|Solid Tumors|solid tumors
376364|NCT01532011|Erlotinib|erlotinib
376365|NCT01532011|Erlotinib Hydrochloride|erlotinib hydrochloride
376366|NCT01532011|OSI-774|osi-774
376367|NCT01532011|Tarceva|tarceva
376368|NCT01532011|Pralatrexate|pralatrexate
376369|NCT01532011|Folotyn|folotyn
376370|NCT01532011|PDX-010|pdx-010
376371|NCT01531998|Myeloma|myeloma
376372|NCT01531998|Multiple Myeloma|multiple myeloma
376373|NCT01531998|MM|mm
376374|NCT01531998|Newly diagnosed|newly diagnosed
376375|NCT01531998|Lenalidomide|lenalidomide
376376|NCT01531998|CC-5013|cc-5013
376377|NCT01531998|Revlimid|revlimid
376378|NCT01531998|Bortezomib|bortezomib
376379|NCT01531998|Velcade|velcade
376380|NCT01531998|LDP-341|ldp-341
376381|NCT01531998|MLN341|mln341
376382|NCT01531998|PS-341|ps-341
376383|NCT01531998|Siltuximab|siltuximab
376384|NCT01531998|CNTO 328|cnto 328
376385|NCT01531998|Anti-IL-6 Antibody|anti-il-6 antibody
376386|NCT01531998|Dexamethasone|dexamethasone
376387|NCT01531998|Decadron|decadron
376388|NCT01531998|M. D. Anderson Symptom Inventory Module|m. d. anderson symptom inventory module
376389|NCT01531998|MDASI-MM|mdasi-mm
376390|NCT01531998|Questionnaires|questionnaires
376391|NCT01531998|Surveys|surveys
376392|NCT01531985|Congenital Heart Disease|congenital heart disease
376393|NCT01531985|Acute Kidney Injury|acute kidney injury
376394|NCT01531985|Cardiopulmonary Bypass|cardiopulmonary bypass
376395|NCT01531985|Biomarkers|biomarkers
376396|NCT01531972|Single-photon Emission Computed Tomography|single-photon emission computed tomography
376397|NCT01531972|Healthy Volunteers|healthy volunteers
376398|NCT01531972|Tomography|tomography
376399|NCT01531959|Midodrine|midodrine
376400|NCT01531959|Hypotension|hypotension
376401|NCT01531959|Intensive care unit|intensive care unit
376402|NCT01531959|IV vasopressors|iv vasopressors
376403|NCT01531959|ICU discharge|icu discharge
376404|NCT01531946|Diffusion Tensor Imaging|diffusion tensor imaging
376405|NCT01531933|Prediabetic|prediabetic
376406|NCT01531933|Primary prevention|primary prevention
376407|NCT01531933|Type 2 diabetes mellitus|type 2 diabetes mellitus
376408|NCT01531907|GLP2|glp2
376409|NCT01531907|Obesity|obesity
376410|NCT01531907|Premenopausal|premenopausal
376411|NCT01531907|Bone|bone
376412|NCT01531907|Formation|formation
376413|NCT01531907|Resorption|resorption
376414|NCT01531894|solid tumor|solid tumor
376415|NCT01531894|GSK2110183|gsk2110183
376416|NCT01531894|hematologic malignancy|hematologic malignancy
376417|NCT01531894|AKT inhibitor|akt inhibitor
376418|NCT01531894|cancer|cancer
376419|NCT01531894|safety|safety
376420|NCT01531868|Decision making|decision making
376421|NCT01531868|Carotid stenosis|carotid stenosis
376422|NCT01531855|T1DM, Exercise|t1dm, exercise
376423|NCT01531842|Conjunctival bacterial flora|conjunctival bacterial flora
376424|NCT01531842|prophylactic topical antibiotic|prophylactic topical antibiotic
376425|NCT01531842|injection|injection
376426|NCT01531842|intravitreal injection|intravitreal injection
376427|NCT01531842|bacterial resistance|bacterial resistance
376428|NCT01531842|serial injection|serial injection
376429|NCT01531842|serial intravitreal injections|serial intravitreal injections
376431|NCT01531842|CRVO|crvo
376432|NCT01531842|AMD|amd
376433|NCT01531842|BRVO|brvo
376434|NCT01531829|pulmonary embolism|pulmonary embolism
376435|NCT01531829|right ventricular dysfunction|right ventricular dysfunction
376436|NCT01531829|Thrombolysis|thrombolysis
376437|NCT01531829|Heparin|heparin
376438|NCT01531816|Pediatrics,|pediatrics,
376439|NCT01531816|Critically ill Children|critically ill children
376440|NCT01531816|immobility|immobility
376441|NCT01531790|Endostar|endostar
376442|NCT01531790|Carboplatin|carboplatin
376443|NCT01531790|Pemetrexed|pemetrexed
376444|NCT01531790|NSCLC|nsclc
376445|NCT01531790|Phase I|phase i
376446|NCT01531777|Advanced Colorectal Cancer|advanced colorectal cancer
376447|NCT01531764|Metastatic breast cancer|metastatic breast cancer
376448|NCT01531764|intermediate HER2 expression|intermediate her2 expression
376449|NCT01531764|Afatinib|afatinib
376450|NCT01531751|HCO-HD|hco-hd
376451|NCT01531751|survival|survival
376452|NCT01531751|cardiac biomarkers|cardiac biomarkers
376453|NCT01531751|AL amyloidosis|al amyloidosis
376454|NCT01531751|Light Chain Amyloidosis|light chain amyloidosis
376455|NCT01531738|Taste|taste
376456|NCT01531738|bariatric surgery|bariatric surgery
376457|NCT01531738|food preferences|food preferences
376458|NCT01531738|reward|reward
376459|NCT01531738|progressive ratio task|progressive ratio task
376460|NCT01531725|Stents|stents
376461|NCT01531712|neoadjuvant treatment|neoadjuvant treatment
376462|NCT01531712|borderline resectability|borderline resectability
376463|NCT01531686|intraosseous vascular access|intraosseous vascular access
376464|NCT01531686|CT examination|ct examination
376465|NCT01531634|Borderline Personality Disorder|borderline personality disorder
376466|NCT01531634|Women|women
376467|NCT01531634|Dynamic Cognitive Intervention|dynamic cognitive intervention
376468|NCT01531634|Recovery|recovery
376470|NCT01531621|metastatic colorectal cancer|metastatic colorectal cancer
376471|NCT01531608|melanoma|melanoma
376472|NCT01531608|imaging|imaging
376473|NCT01531608|sentinel node|sentinel node
376474|NCT01531608|biopsy|biopsy
376475|NCT01531595|metastatic colorectal cancer|metastatic colorectal cancer
376476|NCT01531582|Angelman|angelman
376477|NCT01531582|Minocycline|minocycline
376478|NCT01531582|cognitive|cognitive
376479|NCT01531582|children|children
376480|NCT01531582|tetracycline|tetracycline
376481|NCT01531569|Flaxseed|flaxseed
376482|NCT01531569|Lignans|lignans
376483|NCT01531569|Pharmacokinetics|pharmacokinetics
376484|NCT01531543|Vacuum Assisted Closure (VAC)|vacuum assisted closure (vac)
376485|NCT01531543|Laparostomy|laparostomy
376486|NCT01531543|Severe peritonitis|severe peritonitis
376487|NCT01531530|Shigella|shigella
376488|NCT01531530|Vaccine|vaccine
376489|NCT01531530|Mucosal immunity|mucosal immunity
376490|NCT01531517|Pedyphar|pedyphar
376491|NCT01531517|Ointment|ointment
376492|NCT01531517|Healing|healing
376493|NCT01531517|Diabetic|diabetic
376494|NCT01531517|Foot Ulcer|foot ulcer
376495|NCT01531504|hysterectomies|hysterectomies
376496|NCT01531504|uterine manipulator|uterine manipulator
376497|NCT01531491|Emergence|emergence
376498|NCT01531491|Hypercapnia|hypercapnia
376499|NCT01531491|Hypocapnia|hypocapnia
376500|NCT01531491|Propofol|propofol
376501|NCT01531478|Childhood cancer|childhood cancer
376502|NCT01531478|Cancer|cancer
376503|NCT01531478|Sequels|sequels
376504|NCT01531478|Complications|complications
376505|NCT01531478|Chemotherapy|chemotherapy
376506|NCT01531478|Radiotherapy|radiotherapy
376507|NCT01531478|Surgery|surgery
376508|NCT01531465|Respiratory insufficiency|respiratory insufficiency
376509|NCT01531465|Infants|infants
376510|NCT01531465|High Flow Nasal Cannula (HFNC)|high flow nasal cannula (hfnc)
376511|NCT01531465|Nasal Continuous Positive Airway Pressure (NCPAP)|nasal continuous positive airway pressure (ncpap)
376512|NCT01531452|Stomach Neoplasms|stomach neoplasms
376513|NCT01531452|drug therapy|drug therapy
376514|NCT01531452|oxaliplatin|oxaliplatin
376515|NCT01531452|s1|s1
376516|NCT01531439|Narcotic Antagonists|narcotic antagonists
376517|NCT01531439|Naloxone infusion|naloxone infusion
376518|NCT01531439|Postoperative pruritis|postoperative pruritis
376519|NCT01531439|Patient controlled analgesia|patient controlled analgesia
376520|NCT01531439|Pediatric|pediatric
376521|NCT01531439|Children|children
376522|NCT01531426|resuscitation|resuscitation
376523|NCT01531426|hypothermia|hypothermia
376524|NCT01531426|outcome|outcome
376525|NCT01531387|Phase III|phase iii
376526|NCT01531387|Sickle cell anemia|sickle cell anemia
376527|NCT01531387|Conditional transcranial doppler velocities|conditional transcranial doppler velocities
376528|NCT01531387|Reduce risk of conversion to abnormally high transcranial doppler velocities|reduce risk of conversion to abnormally high transcranial doppler velocities
376529|NCT01531387|Pediatric patients|pediatric patients
376530|NCT01531374|Valvular Heart Disease|valvular heart disease
376531|NCT01531374|Critical Aortic Stenosis|critical aortic stenosis
376532|NCT01531374|Severe Aortic Stenosis|severe aortic stenosis
376533|NCT01531374|Extreme Risk|extreme risk
376534|NCT01531374|High Risk|high risk
376535|NCT01531374|Aortic Valve Replacement|aortic valve replacement
376536|NCT01531361|Advanced Cancers|advanced cancers
376537|NCT01531361|Advanced Malignancies|advanced malignancies
376538|NCT01531361|Metastatic cancers|metastatic cancers
376539|NCT01531361|Vemurafenib|vemurafenib
376540|NCT01531361|PLX4032|plx4032
376541|NCT01531361|R05185426|r05185426
376542|NCT01531361|Sorafenib|sorafenib
376543|NCT01531361|Nexavar|nexavar
376544|NCT01531361|Bay 43-9006|bay 43-9006
376545|NCT01531361|Crizotinib|crizotinib
376546|NCT01531361|PF-02341066|pf-02341066
376547|NCT01531361|Xalkori|xalkori
376548|NCT01531361|Maximum tolerated dose|maximum tolerated dose
376549|NCT01531361|MTD|mtd
376550|NCT01531361|Dose limiting toxicity|dose limiting toxicity
376551|NCT01531361|DLT|dlt
376552|NCT01531348|Retinitis pigmentosa|retinitis pigmentosa
376553|NCT01531348|Bone marrow-derived mesenchymal stem cells|bone marrow-derived mesenchymal stem cells
376554|NCT01531348|Intravitreal injection|intravitreal injection
376555|NCT01531335|adults|adults
376556|NCT01531322|13vPnC|13vpnc
376557|NCT01531322|Healthy subjects|healthy subjects
376558|NCT01531322|China|china
376559|NCT01531309|Liver impairment|liver impairment
376560|NCT01531309|Major Depression Disorder|major depression disorder
376561|NCT01531309|Sublingual tablet|sublingual tablet
376562|NCT01531296|MRI|mri
376563|NCT01531296|Lower Extremity Rotational|lower extremity rotational
376564|NCT01531296|Femoral Version|femoral version
376565|NCT01531296|Tibial Torsion|tibial torsion
376566|NCT01531283|unacylated ghrelin|unacylated ghrelin
376567|NCT01531283|beta cell function|beta cell function
376568|NCT01531231|heart disease|heart disease
376569|NCT01531231|unstable angina|unstable angina
376570|NCT01531231|myocardial infarction|myocardial infarction
376571|NCT01531231|behavioral|behavioral
376572|NCT01531231|cardiovascular|cardiovascular
376574|NCT01531218|Campylobacter|campylobacter
376575|NCT01531218|concisus|concisus
376576|NCT01531218|diarrhea|diarrhea
376577|NCT01531218|fever|fever
376578|NCT01531218|abdominal pain|abdominal pain
376579|NCT01531218|vomiting|vomiting
376580|NCT01531205|recurrent|recurrent
376581|NCT01531205|high risk|high risk
376582|NCT01531192|Lactobacillus reuteri|lactobacillus reuteri
376583|NCT01531192|Nystatin|nystatin
376584|NCT01531192|Very Low Birth Weight Infants|very low birth weight infants
376585|NCT01531192|Candida Colonization|candida colonization
376586|NCT01531166|Chronic hepatitis B|chronic hepatitis b
376587|NCT01531166|pegylated Interferon-alpha 2a|pegylated interferon-alpha 2a
376588|NCT01531166|Korean|korean
376589|NCT01531153|Cocaine use decreases, increases or stays the same|cocaine use decreases, increases or stays the same
376590|NCT01531140|colonoscopy cleansing|colonoscopy cleansing
376591|NCT01531140|PEG|peg
376592|NCT01531140|sennosides|sennosides
376593|NCT01531140|children|children
376594|NCT01531114|Diabetes mellitus|diabetes mellitus
376595|NCT01531114|antiplatelet effect|antiplatelet effect
376596|NCT01531114|prasugrel|prasugrel
376597|NCT01531114|ticagrelor|ticagrelor
376598|NCT01531114|STEMI|stemi
376599|NCT01531114|Insulin|insulin
376600|NCT01531101|Transference work|transference work
376601|NCT01531101|Psychodynamic|psychodynamic
376602|NCT01531101|Depression|depression
376603|NCT01531101|Treatment|treatment
376604|NCT01531101|Adolescent|adolescent
376605|NCT01531088|Nursing Home|nursing home
376606|NCT01531075|HBV, Inflammatory bowel disease, immunosuppressor|hbv, inflammatory bowel disease, immunosuppressor
376607|NCT01531062|nigella sativa|nigella sativa
376608|NCT01531062|dyslipidemia|dyslipidemia
376609|NCT01531062|elderly|elderly
376610|NCT01531049|smoking cessation|smoking cessation
376611|NCT01531049|young adults|young adults
376612|NCT01531049|motivational counselling|motivational counselling
376613|NCT01531049|smoking|smoking
376614|NCT01531049|nicotine replacement therapy|nicotine replacement therapy
376615|NCT01531049|therapy|therapy
376616|NCT01531023|Extended-Spectrum Beta-lactamase Producing Bacteria|extended-spectrum beta-lactamase producing bacteria
376617|NCT01531010|Neonate|neonate
376618|NCT01531010|Premature|premature
376619|NCT01531010|Pressure limited ventilation|pressure limited ventilation
376620|NCT01531010|Volume ventilation|volume ventilation
376621|NCT01530997|Human Papilloma Virus|human papilloma virus
376622|NCT01530997|Oropharynx|oropharynx
376623|NCT01530997|Oropharyngeal Squamous Cell Carcinoma|oropharyngeal squamous cell carcinoma
376624|NCT01530997|Squamous Cell Carcinoma|squamous cell carcinoma
376625|NCT01530997|Radiation Therapy|radiation therapy
376626|NCT01530997|Chemotherapy|chemotherapy
376627|NCT01530997|p16|p16
376628|NCT01530984|prostate cancer|prostate cancer
376629|NCT01530984|metastatic castrate resistant prostate cancer|metastatic castrate resistant prostate cancer
376630|NCT01530984|Chemotherapy-naïve patients|chemotherapy-naïve patients
376631|NCT01530984|Anti-CTLA4 blockade|anti-ctla4 blockade
376632|NCT01530984|systemic GM-CSF|systemic gm-csf
376633|NCT01530984|Ipilimumab|ipilimumab
376634|NCT01530971|oxygen|oxygen
376635|NCT01530971|pregnancy|pregnancy
376636|NCT01530971|caesarean section|caesarean section
376637|NCT01530971|anesthetic techniques|anesthetic techniques
376638|NCT01530958|CKD|ckd
376639|NCT01530958|Automated Telephone Self Management|automated telephone self management
376640|NCT01530958|Registry|registry
376641|NCT01530958|CKD awareness|ckd awareness
376642|NCT01530958|Self efficacy|self efficacy
376643|NCT01530932|sepsis|sepsis
376644|NCT01530932|tissue oxygenation|tissue oxygenation
376645|NCT01530932|tissue perfusion|tissue perfusion
376646|NCT01530932|immune reaction|immune reaction
376647|NCT01530906|Eating disorders|eating disorders
376648|NCT01530906|Bulimia|bulimia
376649|NCT01530906|rTMS|rtms
376650|NCT01530906|Treatment|treatment
376651|NCT01530893|flavonoids|flavonoids
376652|NCT01530893|vascular function|vascular function
376653|NCT01530893|randomised controlled trial|randomised controlled trial
376654|NCT01530893|placebo controlled|placebo controlled
376655|NCT01530880|Fever reduction|fever reduction
376656|NCT01530880|Fever burden|fever burden
376657|NCT01530880|intravenous ibuprofen|intravenous ibuprofen
376658|NCT01530867|Dietary Supplements|dietary supplements
376659|NCT01530867|Physician-patient communication|physician-patient communication
376660|NCT01530867|Qualitative study|qualitative study
376661|NCT01530867|Audio recorded office visits|audio recorded office visits
376662|NCT01530854|sepsis|sepsis
376663|NCT01530854|free fatty acids|free fatty acids
376664|NCT01530854|emergency department|emergency department
376665|NCT01530841|Myotonic dystrophy type 1|myotonic dystrophy type 1
376666|NCT01530841|Home ventilation|home ventilation
376667|NCT01530841|Respiratory insufficiency|respiratory insufficiency
376668|NCT01530841|Neuromuscular|neuromuscular
376669|NCT01530828|Immunoreactive Trypsinogen|immunoreactive trypsinogen
376670|NCT01530828|Nectrotizing Enterocolitis|nectrotizing enterocolitis
376671|NCT01530828|Premature Infants|premature infants
376672|NCT01530828|Serial IRT|serial irt
376876|NCT01529905|outcome|outcome
376673|NCT01530802|laparoscopic myomectomy, leiomyoma, blood loss, uterine artery|laparoscopic myomectomy, leiomyoma, blood loss, uterine artery
376674|NCT01530789|Telemedecine|telemedecine
376675|NCT01530789|Telemedecine nurse|telemedecine nurse
376676|NCT01530789|Delegation of tasks|delegation of tasks
376677|NCT01530789|Type 1 diabetes|type 1 diabetes
376678|NCT01530776|Pregnancy|pregnancy
376679|NCT01530776|Postpartum|postpartum
376680|NCT01530776|Weight Retention|weight retention
376681|NCT01530776|Behavioral|behavioral
376682|NCT01530776|Electronically-mediated|electronically-mediated
376683|NCT01530763|Infections|infections
376684|NCT01530763|Pediatrics|pediatrics
376685|NCT01530763|Teflaro|teflaro
376686|NCT01530763|cephalosporin|cephalosporin
376687|NCT01530750|postoperative atrial fibrillation|postoperative atrial fibrillation
376688|NCT01530750|internal loop recorder|internal loop recorder
376689|NCT01530750|risk factors|risk factors
376690|NCT01530750|coronary artery bypass surgery|coronary artery bypass surgery
376691|NCT01530737|pediatric|pediatric
376692|NCT01530737|Antithrombin|antithrombin
376693|NCT01530737|anticoagulation efficiency|anticoagulation efficiency
376694|NCT01530737|cardiac surgery|cardiac surgery
376695|NCT01530724|abdominal obesity|abdominal obesity
376696|NCT01530698|dendritic cell vaccination|dendritic cell vaccination
376697|NCT01530698|melanoma|melanoma
376698|NCT01530698|toll like receptor ligands|toll like receptor ligands
376699|NCT01530698|mRNA electroporation|mrna electroporation
376700|NCT01530698|vaccines|vaccines
376701|NCT01530685|cinnamon|cinnamon
376702|NCT01530685|chromium|chromium
376703|NCT01530685|prediabete|prediabete
376704|NCT01530685|overweight|overweight
376705|NCT01530672|HIV|hiv
376706|NCT01530672|Syphilis|syphilis
376707|NCT01530672|Combination|combination
376708|NCT01530672|POC|poc
376709|NCT01530672|point-of-care|point-of-care
376710|NCT01530672|MBIO|mbio
376711|NCT01530659|Retinitis pigmentosa|retinitis pigmentosa
376712|NCT01530659|Usher syndrome type 2|usher syndrome type 2
376713|NCT01530659|Usher syndrome type 3|usher syndrome type 3
376714|NCT01530659|Cone photoreceptor|cone photoreceptor
376715|NCT01530659|Vision|vision
376716|NCT01530659|Blind|blind
376717|NCT01530646|obesity|obesity
376718|NCT01530646|overweight|overweight
376719|NCT01530646|muscle|muscle
376720|NCT01530646|protein|protein
376721|NCT01530646|muscle protein synthesis|muscle protein synthesis
376722|NCT01530646|muscle protein breakdown|muscle protein breakdown
376723|NCT01530646|whey|whey
376724|NCT01530646|soy|soy
376725|NCT01530646|caloric restriction|caloric restriction
376726|NCT01530620|Antimuscarinics|antimuscarinics
376727|NCT01530620|Neurogenic bladder|neurogenic bladder
376728|NCT01530620|Propiverine|propiverine
376729|NCT01530620|Urodynamics|urodynamics
376730|NCT01530607|Early Stage Breast Cancer|early stage breast cancer
376731|NCT01530607|Reduce Ovarian Failure Following Chemotherapy|reduce ovarian failure following chemotherapy
376732|NCT01530594|Untreated|untreated
376733|NCT01530594|Without intent for immediate autologous stem cell transplant|without intent for immediate autologous stem cell transplant
376734|NCT01530568|Intensive care, TB, tracheal aspirates, Gene Xpert|intensive care, tb, tracheal aspirates, gene xpert
376735|NCT01530542|bioavailability|bioavailability
376736|NCT01530542|food effect|food effect
376737|NCT01530542|oxycodone|oxycodone
376738|NCT01530542|management of acute and chronic moderate to severe pain|management of acute and chronic moderate to severe pain
376739|NCT01530529|PF-05180999|pf-05180999
376740|NCT01530529|safety|safety
376741|NCT01530529|pharmacokinetics|pharmacokinetics
376742|NCT01530529|relative bioavailability|relative bioavailability
376743|NCT01530529|Mental Disorders|mental disorders
376744|NCT01530529|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
376745|NCT01530529|Schizophrenia|schizophrenia
376746|NCT01530516|Malocclusion, Angle Class II|malocclusion, angle class ii
376747|NCT01530503|biliary tract cancer|biliary tract cancer
376748|NCT01530503|advanced disease|advanced disease
376749|NCT01530503|chemotherapy|chemotherapy
376750|NCT01530490|IVF|ivf
376751|NCT01530490|ovarian hyperstimulation syndrome|ovarian hyperstimulation syndrome
376752|NCT01530490|cabergoline|cabergoline
376753|NCT01530490|hydroxyethyl starch|hydroxyethyl starch
376754|NCT01530490|prevention|prevention
376755|NCT01530477|Bone mineral density|bone mineral density
376756|NCT01530477|weight|weight
376757|NCT01530477|body composition|body composition
376758|NCT01530477|DEXA|dexa
376759|NCT01530477|DXA|dxa
376760|NCT01530464|High altitude induced fatigue|high altitude induced fatigue
376761|NCT01530464|High altitude induced pulmonary Hypertension|high altitude induced pulmonary hypertension
376762|NCT01530451|Nocturia|nocturia
376763|NCT01530451|Obstructive sleep Apnoea|obstructive sleep apnoea
376764|NCT01530451|Desmopressin|desmopressin
376765|NCT01530438|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
376766|NCT01530425|pediatric wheelchairs|pediatric wheelchairs
376767|NCT01530425|low-income|low-income
376768|NCT01530425|comparisons|comparisons
376769|NCT01530412|Quality of Life|quality of life
376770|NCT01530412|Free-living activity|free-living activity
376771|NCT01530412|Exacerbation|exacerbation
376772|NCT01530412|Rehabilitation|rehabilitation
376773|NCT01530386|Lacosamide|lacosamide
376774|NCT01530386|Vimpat|vimpat
376775|NCT01530373|hot flashes|hot flashes
376776|NCT01530373|breast cancer|breast cancer
376777|NCT01530373|aromatase inhibitors|aromatase inhibitors
376778|NCT01530373|solifenacin|solifenacin
376779|NCT01530373|clonidine|clonidine
376780|NCT01530373|quality of life|quality of life
376781|NCT01530347|Glucose monitoring|glucose monitoring
376782|NCT01530347|non-invasive glucometer|non-invasive glucometer
376783|NCT01530347|Self glucose monitoring|self glucose monitoring
376784|NCT01530321|cervicogenic headache|cervicogenic headache
376785|NCT01530321|spinal manipulation|spinal manipulation
376786|NCT01530321|chiropractic|chiropractic
376787|NCT01530321|randomized controlled trial|randomized controlled trial
376788|NCT01530321|dose-response|dose-response
376789|NCT01530321|efficacy|efficacy
376790|NCT01530308|Delirium|delirium
376791|NCT01530282|Respiratory Insufficiency [C08.618.846]|respiratory insufficiency [c08.618.846]
376792|NCT01530269|intermediate|intermediate
376793|NCT01530269|high|high
376794|NCT01530269|risk|risk
376795|NCT01530269|radiation|radiation
376796|NCT01530269|therapy|therapy
376797|NCT01530269|planning|planning
376798|NCT01530269|surgical|surgical
376799|NCT01530269|immunotherapy|immunotherapy
376800|NCT01530269|chemotherapy|chemotherapy
376801|NCT01530269|hormone|hormone
376802|NCT01530256|allograph|allograph
376803|NCT01530256|steroid refractory|steroid refractory
376804|NCT01530230|cesarean section|cesarean section
376805|NCT01530230|electrocardiography|electrocardiography
376806|NCT01530230|heart|heart
376807|NCT01530230|hypotension|hypotension
376808|NCT01530230|ischemia|ischemia
376809|NCT01530230|oxytocin|oxytocin
376810|NCT01530230|preeclampsia|preeclampsia
376811|NCT01530230|regional anesthesia|regional anesthesia
376812|NCT01530230|ECG changes suggestive of myocardial ischemia|ecg changes suggestive of myocardial ischemia
376813|NCT01530217|Analgesics|analgesics
376814|NCT01530217|Ibuprofen|ibuprofen
376815|NCT01530217|Inflammation|inflammation
376816|NCT01530217|Tooth Bleaching|tooth bleaching
376817|NCT01530204|knee arthritis|knee arthritis
376818|NCT01530204|knee osteoarthritis|knee osteoarthritis
376819|NCT01530204|knee pain|knee pain
376820|NCT01530204|cognitive behavioral therapy|cognitive behavioral therapy
376821|NCT01530204|physical therapy|physical therapy
376822|NCT01530204|depression prevention|depression prevention
376823|NCT01530191|depression|depression
376824|NCT01530191|anxiety|anxiety
376825|NCT01530191|pelvic organ prolapse|pelvic organ prolapse
376826|NCT01530191|POP|pop
376827|NCT01530178|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
376828|NCT01530165|IFG|ifg
376829|NCT01530165|IGTT|igtt
376830|NCT01530152|Truwiev PCD laryngoscope|truwiev pcd laryngoscope
376831|NCT01530152|Macintosh laryngoscope|macintosh laryngoscope
376832|NCT01530126|periodontitis|periodontitis
376833|NCT01530113|Childhood sexual abuse|childhood sexual abuse
376834|NCT01530113|Vaginismus|vaginismus
376835|NCT01530113|Partial vaginismus|partial vaginismus
376836|NCT01530113|Labor dystocia|labor dystocia
376837|NCT01530113|Depression|depression
376838|NCT01530100|Edema|edema
376839|NCT01530100|Pain|pain
376840|NCT01530100|Lower laser therapy|lower laser therapy
376841|NCT01530100|orthognathics surgery|orthognathics surgery
376842|NCT01530087|colostomy|colostomy
376843|NCT01530087|ileostomy|ileostomy
376844|NCT01530087|irritant dermatitis|irritant dermatitis
376845|NCT01530087|two piece barrier|two piece barrier
376846|NCT01530074|Mandibular nerve|mandibular nerve
376847|NCT01530074|Mental nerve|mental nerve
376848|NCT01530074|Mandibular incisive nerve|mandibular incisive nerve
376849|NCT01530074|Local anesthesia|local anesthesia
376850|NCT01530074|None, only healthy subjects will be enrolled in this study|none, only healthy subjects will be enrolled in this study
376851|NCT01530035|cardiac|cardiac
376852|NCT01530035|vascular|vascular
376853|NCT01530035|muscular|muscular
376854|NCT01530035|adaptations|adaptations
376855|NCT01530035|soccer training|soccer training
376856|NCT01530035|strength training|strength training
376857|NCT01530022|Lacosamide|lacosamide
376858|NCT01530022|Vimpat|vimpat
376859|NCT01530022|Cognition|cognition
376860|NCT01530022|Mental Processes|mental processes
376861|NCT01530022|Adverse Effects|adverse effects
376862|NCT01530009|Antroduodenal manometry|antroduodenal manometry
376863|NCT01530009|Child|child
376864|NCT01530009|Adolescent|adolescent
376865|NCT01530009|Amoxicillin|amoxicillin
376866|NCT01530009|Gastrointestinal Motility|gastrointestinal motility
376867|NCT01529957|Volunteers|volunteers
376868|NCT01529918|Diabetes|diabetes
376869|NCT01529918|Self-screening|self-screening
376870|NCT01529918|Web-based technology|web-based technology
376871|NCT01529918|follow-up clinical care|follow-up clinical care
376872|NCT01529918|randomized control trial|randomized control trial
376873|NCT01529905|depression|depression
376874|NCT01529905|mania|mania
376875|NCT01529905|bipolar|bipolar
376877|NCT01529905|cognitive|cognitive
376878|NCT01529879|edentulism|edentulism
376879|NCT01529879|dental implants|dental implants
376880|NCT01529879|clinical study|clinical study
376881|NCT01529879|Nanotite Certain Tapered implant|nanotite certain tapered implant
376882|NCT01529879|randomized|randomized
376883|NCT01529879|crestal bone level|crestal bone level
376884|NCT01529866|clinical study|clinical study
376885|NCT01529866|edentulism|edentulism
376886|NCT01529866|dental implants|dental implants
376887|NCT01529866|Nanotite Certain Tapered implant|nanotite certain tapered implant
376888|NCT01529866|randomized|randomized
376889|NCT01529866|crestal bone level|crestal bone level
376890|NCT01529866|immediate loading|immediate loading
376891|NCT01529814|edentulism|edentulism
376892|NCT01529814|dental implants|dental implants
376893|NCT01529814|clinical study|clinical study
376894|NCT01529814|Nanotite Certain Tapered implant|nanotite certain tapered implant
376895|NCT01529814|randomized|randomized
376896|NCT01529814|crestal bone level|crestal bone level
376897|NCT01529814|early loading|early loading
376898|NCT01529801|edentulism|edentulism
376899|NCT01529801|dental implants|dental implants
376900|NCT01529801|clinical study|clinical study
376901|NCT01529801|randomized|randomized
376902|NCT01529801|Osseotite Certain Tapered|osseotite certain tapered
376903|NCT01529801|Crestal bone level|crestal bone level
376904|NCT01529788|abobotulinum toxin lateral orbital lines|abobotulinum toxin lateral orbital lines
376905|NCT01529788|BotoxCosmetic|botoxcosmetic
376906|NCT01529788|Dysport|dysport
376907|NCT01529788|onabotulinum toxin|onabotulinum toxin
376908|NCT01529788|wrinkles|wrinkles
376909|NCT01529788|lateral orbital lines|lateral orbital lines
376910|NCT01529775|partial edentulism|partial edentulism
376911|NCT01529775|dental implants|dental implants
376912|NCT01529775|Osseotite Certain Prevail Tapered|osseotite certain prevail tapered
376913|NCT01529775|Osseotite Certain Tapered|osseotite certain tapered
376914|NCT01529775|Crestal bone level|crestal bone level
376915|NCT01529775|randomized|randomized
376916|NCT01529775|clinical study|clinical study
376917|NCT01529762|edentulism|edentulism
376918|NCT01529762|dental implants|dental implants
376919|NCT01529762|Osseotite Certain Tapered|osseotite certain tapered
376920|NCT01529762|randomized|randomized
376921|NCT01529762|clinical study|clinical study
376922|NCT01529762|partial edentulism|partial edentulism
376923|NCT01529762|immediate loading|immediate loading
376924|NCT01529762|crestal bone level|crestal bone level
376925|NCT01529736|edentulism|edentulism
376926|NCT01529736|dental implants|dental implants
376927|NCT01529736|early loading|early loading
376928|NCT01529736|crestal bone level|crestal bone level
376929|NCT01529736|high torque insertion|high torque insertion
376930|NCT01529736|low torque insertion|low torque insertion
376931|NCT01529736|randomized|randomized
376932|NCT01529736|Osseotite|osseotite
376933|NCT01529736|clinical study|clinical study
376934|NCT01529723|Stroke|stroke
376935|NCT01529723|Dysphagia screening|dysphagia screening
376936|NCT01529710|Schistosomiasis hematobium|schistosomiasis hematobium
376937|NCT01529710|Schistosomiasis mansoni|schistosomiasis mansoni
376938|NCT01529697|Asthma|asthma
376939|NCT01529697|Inhaler use|inhaler use
376940|NCT01529684|Cancer, solid tumors|cancer, solid tumors
376941|NCT01529684|oncology patients|oncology patients
376942|NCT01529684|OSI-906|osi-906
376943|NCT01529684|mass balance|mass balance
376944|NCT01529684|Absorption, Metabolism, and Excretion of OSI-906|absorption, metabolism, and excretion of osi-906
376945|NCT01529684|Metabolic profile of 906|metabolic profile of 906
376946|NCT01529684|Pharmacokinetics of 14C-OSI-906|pharmacokinetics of 14c-osi-906
376947|NCT01529658|Renal function|renal function
376948|NCT01529658|Renal hypothermia|renal hypothermia
376949|NCT01529658|Nephrology|nephrology
376950|NCT01529658|Nephrectomy|nephrectomy
376951|NCT01529658|Renal tumor|renal tumor
376952|NCT01529658|Urology|urology
376953|NCT01529658|Kidney|kidney
376954|NCT01529645|pertussis|pertussis
376955|NCT01529645|booster vaccine|booster vaccine
376956|NCT01529645|tetanus|tetanus
376957|NCT01529645|diphtheria in adults|diphtheria in adults
376958|NCT01529632|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
376959|NCT01529632|COPD|copd
376960|NCT01529632|QVA149|qva149
376961|NCT01529632|QAB149|qab149
376962|NCT01529632|NVA237|nva237
376963|NCT01529632|indacaterol|indacaterol
376964|NCT01529632|glycopyrronium bromide|glycopyrronium bromide
376965|NCT01529619|Rivastigmine|rivastigmine
376966|NCT01529619|Alzheimer's disease|alzheimer's disease
376967|NCT01529619|Transdermal patch|transdermal patch
376968|NCT01529606|dental restoration|dental restoration
376969|NCT01529606|dental caries|dental caries
376970|NCT01529606|tooth cavity|tooth cavity
376971|NCT01529593|Advanced Cancers|advanced cancers
376972|NCT01529593|Metastatic cancer|metastatic cancer
376973|NCT01529593|Tumor response|tumor response
376974|NCT01529593|Dose limiting toxicity|dose limiting toxicity
376975|NCT01529593|DLT|dlt
376976|NCT01529593|Maximum tolerated dose|maximum tolerated dose
376977|NCT01529593|MTD|mtd
376978|NCT01529593|Temsirolimus|temsirolimus
376979|NCT01529593|CCI-779|cci-779
376980|NCT01529593|Torisel|torisel
376981|NCT01529593|Metformin|metformin
376982|NCT01529580|Autism Spectrum Disorder|autism spectrum disorder
376983|NCT01529580|language|language
376984|NCT01529580|intervention|intervention
376985|NCT01529580|school-age|school-age
376986|NCT01529554|Acute Coronary Syndromes|acute coronary syndromes
376987|NCT01529554|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
376988|NCT01529554|Infarct size|infarct size
376989|NCT01529554|inflammation|inflammation
376990|NCT01529554|everolimus|everolimus
376991|NCT01529541|CWP-0403|cwp-0403
376992|NCT01529541|Sitagliptin|sitagliptin
376993|NCT01529541|Metformin|metformin
376994|NCT01529541|type 2 DM|type 2 dm
376995|NCT01529528|CWP-0403|cwp-0403
376996|NCT01529528|type 2 DM|type 2 dm
376997|NCT01529528|Efficacy|efficacy
376998|NCT01529528|Safety|safety
376999|NCT01529528|Phase 3|phase 3
377000|NCT01529515|Schizophrenia|schizophrenia
377001|NCT01529515|R092670|r092670
377002|NCT01529515|Paliperidone Palmitate|paliperidone palmitate
377003|NCT01529515|Paliperidone palmitate 3 month formulation (PP3M)|paliperidone palmitate 3 month formulation (pp3m)
377004|NCT01529502|Blood Transfusion, Autologous|blood transfusion, autologous
377005|NCT01529502|Blood Preservation/adverse effects|blood preservation/adverse effects
377006|NCT01529502|Blood Transfusion/adverse effects|blood transfusion/adverse effects
377007|NCT01529502|Endothelium, Vascular/physiopathology|endothelium, vascular/physiopathology
377008|NCT01529502|Hemoglobins|hemoglobins
377009|NCT01529502|Nitric Oxide|nitric oxide
377010|NCT01529502|Pulmonary Hypertension|pulmonary hypertension
377011|NCT01529489|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
377012|NCT01529489|Physical training|physical training
377013|NCT01529489|Oxygen uptake kinetic|oxygen uptake kinetic
377014|NCT01529489|Heart rate kinetic|heart rate kinetic
377015|NCT01529476|Ofloxacin|ofloxacin
377016|NCT01529476|Levofloxacin|levofloxacin
377017|NCT01529476|Ofloxacin hydrochloride|ofloxacin hydrochloride
377018|NCT01529463|Congestive Heart Failure|congestive heart failure
377019|NCT01529450|basal cell carcinoma, sonidegib, smoothened inhibitor, hedgehog|basal cell carcinoma, sonidegib, smoothened inhibitor, hedgehog
377020|NCT01529437|allergy|allergy
377021|NCT01529437|immunology|immunology
377022|NCT01529437|immune tolerance|immune tolerance
377023|NCT01529437|immunotherapy|immunotherapy
377024|NCT01529424|Hypertriglyceridemia|hypertriglyceridemia
377025|NCT01529411|urothelium|urothelium
377026|NCT01529411|transitional|transitional
377027|NCT01529411|carcinoma|carcinoma
377028|NCT01529411|cancer|cancer
377029|NCT01529411|metastatic|metastatic
377030|NCT01529411|tract|tract
377031|NCT01529398|knee osteoarthritis|knee osteoarthritis
377032|NCT01529398|exercise therapy|exercise therapy
377033|NCT01529398|resistance training|resistance training
377034|NCT01529398|proprioception|proprioception
377035|NCT01529385|swollen leg|swollen leg
377036|NCT01529385|diabetes|diabetes
377037|NCT01529385|compression stockings|compression stockings
377038|NCT01529385|edema|edema
377039|NCT01529372|Hypertension|hypertension
377040|NCT01529372|Blood pressure|blood pressure
377041|NCT01529372|Renal denervation|renal denervation
377042|NCT01529359|Irritable Bowel Syndrome|irritable bowel syndrome
377043|NCT01529359|Probiotics|probiotics
377044|NCT01529346|Postoperative dental pain|postoperative dental pain
377045|NCT01529307|Biologic,|biologic,
377046|NCT01529307|solid tumors,|solid tumors,
377047|NCT01529307|Death Receptor 5 agonist,|death receptor 5 agonist,
377048|NCT01529307|caspase-8|caspase-8
377049|NCT01529294|Hepatic impairment|hepatic impairment
377050|NCT01529294|Iloperidone|iloperidone
377051|NCT01529294|ILO522D|ilo522d
377052|NCT01529294|Pharmacokinetics|pharmacokinetics
377053|NCT01529268|Nonalcoholic Fatty Liver Disease (NAFLD)|nonalcoholic fatty liver disease (nafld)
377054|NCT01529268|Cysteamine bitartrate delayed release|cysteamine bitartrate delayed release
377055|NCT01529268|Children|children
377056|NCT01529255|Chronic Hepatitis B|chronic hepatitis b
377057|NCT01529255|Compensated Chronic hepatitis B|compensated chronic hepatitis b
377058|NCT01529216|DIAMOND System|diamond system
377059|NCT01529216|T2DM|t2dm
377060|NCT01529216|Randomized study|randomized study
377061|NCT01529216|Electrical stimulation|electrical stimulation
377062|NCT01529216|Fundus|fundus
377063|NCT01529190|pregabalin|pregabalin
377064|NCT01529190|postoperative pain control|postoperative pain control
377065|NCT01529190|interleukin-6|interleukin-6
377066|NCT01529190|acute pain|acute pain
377067|NCT01529177|Metformin|metformin
377068|NCT01529177|Insulin resistance|insulin resistance
377069|NCT01529177|male infertility|male infertility
377070|NCT01529177|unexplained Oligozspermia|unexplained oligozspermia
377071|NCT01529177|Clomiphene citrate|clomiphene citrate
377072|NCT01529177|Unexplained azoospermia|unexplained azoospermia
377073|NCT01529164|endostatin|endostatin
377074|NCT01529164|chemotherapy|chemotherapy
377075|NCT01529164|antiangiogenesis agent|antiangiogenesis agent
377076|NCT01529164|colorectal cancer|colorectal cancer
377077|NCT01529151|Dizziness|dizziness
377078|NCT01529151|Vertigo|vertigo
377079|NCT01529151|Benign Paroxysmal Positional Vertigo|benign paroxysmal positional vertigo
377080|NCT01529151|Labyrinthitis|labyrinthitis
377081|NCT01529151|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
377082|NCT01529151|Vestibular Rehabilitation Therapy|vestibular rehabilitation therapy
377083|NCT01529138|Cancer|cancer
377084|NCT01529112|Locally Advanced|locally advanced
377085|NCT01529112|Metastatic Non-Squamous Non-Small Cell Lung Cancer|metastatic non-squamous non-small cell lung cancer
377086|NCT01529099|Osteoarthritis|osteoarthritis
377087|NCT01529099|Knee|knee
377088|NCT01529099|Knee replacement|knee replacement
377089|NCT01529099|Knee implant|knee implant
377090|NCT01529099|Knee arthroplasty|knee arthroplasty
377091|NCT01529099|Unicompartmental|unicompartmental
377092|NCT01529099|Primary|primary
377093|NCT01529099|Partial|partial
377094|NCT01529099|Patellofemoral|patellofemoral
377095|NCT01529099|Medial|medial
377096|NCT01529099|Lateral|lateral
377097|NCT01529099|Bicompartmental|bicompartmental
377098|NCT01529099|Cemented|cemented
377099|NCT01529099|Post-traumatic arthritis of the tibio-femoral and/or patellofemoral articular surfaces|post-traumatic arthritis of the tibio-femoral and/or patellofemoral articular surfaces
377100|NCT01529099|History of Gout or pseudo-gout.|history of gout or pseudo-gout.
377101|NCT01529086|prostate cancer|prostate cancer
377102|NCT01529086|dutasteride|dutasteride
377103|NCT01529086|for cause prostate biopsy|for cause prostate biopsy
377104|NCT01529073|HIV|hiv
377105|NCT01529073|genotype 4 HCV|genotype 4 hcv
377106|NCT01529073|pegylated interferon|pegylated interferon
377107|NCT01529073|ribavirin|ribavirin
377108|NCT01529073|nitazoxanide|nitazoxanide
377109|NCT01529060|phenylbutyrate|phenylbutyrate
377110|NCT01529060|MSUD|msud
377111|NCT01529060|Buphenyl-TM|buphenyl-tm
377112|NCT01529034|Epilepsy|epilepsy
377113|NCT01529034|seizure clusters|seizure clusters
377114|NCT01529034|acute repetitive seizures|acute repetitive seizures
377115|NCT01529034|rescue treatment|rescue treatment
377116|NCT01529021|Pain management|pain management
377117|NCT01529021|vaccination|vaccination
377118|NCT01529021|immunization|immunization
377119|NCT01529021|pediatric|pediatric
377120|NCT01529021|robotics|robotics
377121|NCT01529021|human-robot interaction|human-robot interaction
377122|NCT01529008|Osteonecrosis|osteonecrosis
377123|NCT01529008|Femoral Head|femoral head
377124|NCT01529008|Hip|hip
377125|NCT01529008|Orthopedics|orthopedics
377126|NCT01529008|Bone|bone
377127|NCT01529008|Musculoskeletal Disorders|musculoskeletal disorders
377128|NCT01528995|fecal incontinence|fecal incontinence
377129|NCT01528995|anal incontinence|anal incontinence
377130|NCT01528995|obstetric sphincter injuries|obstetric sphincter injuries
377131|NCT01528995|OASIS|oasis
377132|NCT01528995|double incontinence|double incontinence
377133|NCT01528995|urinary incontinence|urinary incontinence
377134|NCT01528995|sexual function|sexual function
377135|NCT01528995|sacral nerve modulation|sacral nerve modulation
377136|NCT01528995|sacral nerve stimulation|sacral nerve stimulation
377137|NCT01528995|Interstim|interstim
377138|NCT01528995|anal bulking injections|anal bulking injections
377139|NCT01528995|Permacol|permacol
377140|NCT01528969|oral microbiota|oral microbiota
377141|NCT01528969|mutans streptococci|mutans streptococci
377142|NCT01528969|xylitol|xylitol
377143|NCT01528956|adrenocortical carcinoma|adrenocortical carcinoma
377144|NCT01528943|To evaluate the effect of prostacycline on endothelial integrity during major abdominal surgery|to evaluate the effect of prostacycline on endothelial integrity during major abdominal surgery
377145|NCT01528930|Lung Diseases|lung diseases
377146|NCT01528930|Anti-Infective Agents|anti-infective agents
377147|NCT01528930|Therapeutic Uses|therapeutic uses
377148|NCT01528930|Amikacin|amikacin
377149|NCT01528917|Lysosomal Storage Disease|lysosomal storage disease
377150|NCT01528917|Late Onset Lysosomal Acid Lipase (LAL) Deficiency|late onset lysosomal acid lipase (lal) deficiency
377151|NCT01528917|Acid cholesteryl ester hydrolase deficiency, type 2|acid cholesteryl ester hydrolase deficiency, type 2
377152|NCT01528917|Acid lipase disease|acid lipase disease
377153|NCT01528917|Cholesterol ester hydrolase deficiency|cholesterol ester hydrolase deficiency
377154|NCT01528917|LAL Deficiency|lal deficiency
377155|NCT01528917|LIPA Deficiency|lipa deficiency
377156|NCT01528917|Wolman disease|wolman disease
377157|NCT01528904|pregnancy|pregnancy
377158|NCT01528904|autoimmune thyroid disease|autoimmune thyroid disease
377159|NCT01528904|fetal thyroid hormones|fetal thyroid hormones
377160|NCT01528904|antithyroid antibodies|antithyroid antibodies
377161|NCT01528904|ultrasound parameters|ultrasound parameters
377162|NCT01528891|tonsillectomy|tonsillectomy
377163|NCT01528891|emergence agitation|emergence agitation
377164|NCT01528878|Liver Cancer|liver cancer
377165|NCT01528878|Hepatocellular Carcinoma|hepatocellular carcinoma
377166|NCT01528878|HCC|hcc
377167|NCT01528878|Metastatic Cancer to Liver|metastatic cancer to liver
377168|NCT01528878|Metastatic Colon Cancer|metastatic colon cancer
377169|NCT01528878|Metastatic Colo-rectal Cancer|metastatic colo-rectal cancer
377170|NCT01528878|mCRC|mcrc
377171|NCT01528878|Liver Function|liver function
377172|NCT01528878|Child-Pugh|child-pugh
377173|NCT01528865|virus|virus
377174|NCT01528865|K(HML2)[HERV-K(HML2)]|k(hml2)[herv-k(hml2)]
377175|NCT01528865|Lymphoma|lymphoma
377176|NCT01528865|Human endogenous retrovirus-K(HLM2)[HERV-K(HML2)]|human endogenous retrovirus-k(hlm2)[herv-k(hml2)]
377177|NCT01528852|neonatal Mortality|neonatal mortality
377178|NCT01528852|chlorhexidine cord care|chlorhexidine cord care
377179|NCT01528852|cord infections|cord infections
377180|NCT01528852|african settings|african settings
377181|NCT01528852|clinical trials|clinical trials
377182|NCT01528839|Bipolar disorder|bipolar disorder
377183|NCT01528839|Bipolar depression|bipolar depression
377184|NCT01528839|Thyroid abnormality|thyroid abnormality
377185|NCT01528839|mood stabilizer|mood stabilizer
377186|NCT01528839|antidepressants|antidepressants
377187|NCT01528839|currently depressed|currently depressed
377188|NCT01528826|metastatic triple-negative breast cancer|metastatic triple-negative breast cancer
377189|NCT01528826|vinorebine|vinorebine
377190|NCT01528826|oxaliplatin|oxaliplatin
377191|NCT01528813|Erbium-doped yttrium aluminium garnet laser|erbium-doped yttrium aluminium garnet laser
377192|NCT01528813|Er:YAG|er:yag
377193|NCT01528813|Amorolfine lacquer|amorolfine lacquer
377194|NCT01528813|Dermatophytes|dermatophytes
377195|NCT01528813|Subungual distal lateral onychomycosis|subungual distal lateral onychomycosis
377196|NCT01528813|Drug delivery|drug delivery
377197|NCT01528800|Vitamin K|vitamin k
377198|NCT01528800|Chronic kidney disease|chronic kidney disease
377199|NCT01528800|vascular calcification|vascular calcification
377200|NCT01528800|hemodialysis|hemodialysis
377201|NCT01528800|coronary artery calcification|coronary artery calcification
377202|NCT01528787|Intraocular pressure|intraocular pressure
377203|NCT01528787|visual field|visual field
377204|NCT01528787|Ocular hypertension or open angle glaucoma|ocular hypertension or open angle glaucoma
377205|NCT01528774|Melanoma|melanoma
377206|NCT01528774|Circulating Tumor Cells|circulating tumor cells
377207|NCT01528774|Prostate cancer|prostate cancer
377208|NCT01528774|Sarcoma|sarcoma
377209|NCT01528774|Renal Cancer|renal cancer
377210|NCT01528774|Pancreatic neuroendocrine cancer|pancreatic neuroendocrine cancer
377211|NCT01528774|Other solid tumor|other solid tumor
377212|NCT01528761|physical activity|physical activity
377213|NCT01528761|older adults|older adults
377214|NCT01528761|physical function|physical function
377215|NCT01528761|health-related quality of life|health-related quality of life
377216|NCT01528761|prosocial behavior|prosocial behavior
377217|NCT01528761|social cognitive theory|social cognitive theory
377218|NCT01528722|Emergency laparoscopic cholecystectomy|emergency laparoscopic cholecystectomy
377219|NCT01528722|Pain scores|pain scores
377220|NCT01528722|Intraperitoneal local anaesthesia|intraperitoneal local anaesthesia
377221|NCT01528722|Cholecystitis|cholecystitis
377222|NCT01528709|Statin,|statin,
377223|NCT01528709|CABG,|cabg,
377224|NCT01528709|saphenous vein graft,|saphenous vein graft,
377225|NCT01528709|graft occlusion,|graft occlusion,
377226|NCT01528709|lipids|lipids
377227|NCT01528696|Obesity|obesity
377228|NCT01528696|Cesarean Section|cesarean section
377229|NCT01528696|Wound care|wound care
377230|NCT01528657|Sick Sinus Syndrome|sick sinus syndrome
377231|NCT01528657|Ventricular pacing|ventricular pacing
377232|NCT01528657|Minimal ventricular pacing|minimal ventricular pacing
377233|NCT01528657|Ventricular pacing suppression|ventricular pacing suppression
377234|NCT01528657|Intrinsic rhythm support|intrinsic rhythm support
377235|NCT01528657|Long term AV|long term av
377236|NCT01528644|iron|iron
377237|NCT01528644|fortification|fortification
377238|NCT01528644|alginate|alginate
377239|NCT01528644|iron deficiency|iron deficiency
377240|NCT01528618|Advanced Nasopharyngeal Carcinoma|advanced nasopharyngeal carcinoma
377241|NCT01528618|treatment|treatment
377242|NCT01528605|lutein|lutein
377243|NCT01528605|zeaxanthin|zeaxanthin
377244|NCT01528605|age-related macular degeneration|age-related macular degeneration
377245|NCT01528605|supplementation|supplementation
377246|NCT01528605|macular pigment optical density|macular pigment optical density
377247|NCT01528605|visual function|visual function
377248|NCT01528605|serum concentration|serum concentration
377249|NCT01528579|Whiplash|whiplash
377250|NCT01528579|Rehabilitation|rehabilitation
377251|NCT01528579|Physiotherapy|physiotherapy
377252|NCT01528579|Exercises|exercises
377253|NCT01528566|osteoarthritis, knee|osteoarthritis, knee
377254|NCT01528566|Cognitive impairment|cognitive impairment
377255|NCT01528566|Tai Chi|tai chi
377256|NCT01528553|genu valgus|genu valgus
377257|NCT01528553|lower limb|lower limb
377258|NCT01528553|paediatric|paediatric
377259|NCT01528553|epiphysiodesis|epiphysiodesis
377260|NCT01528540|chronic pancreatitis|chronic pancreatitis
377261|NCT01528540|pregabalin|pregabalin
377262|NCT01528540|antioxidant|antioxidant
377263|NCT01528514|Myocardial infarction|myocardial infarction
377264|NCT01528514|Coronary artery bypass grafting|coronary artery bypass grafting
377265|NCT01528514|Anti-oxidant|anti-oxidant
377266|NCT01528514|Curcuminoids|curcuminoids
377267|NCT01528475|Therapeutic Hypothermia|therapeutic hypothermia
377268|NCT01528475|Cardiac arrest|cardiac arrest
377269|NCT01528462|Stroke|stroke
377270|NCT01528462|Ischemic Attack, Transient|ischemic attack, transient
377271|NCT01528462|Sleep Disorders|sleep disorders
377272|NCT01528462|Sleep Apnea Syndromes|sleep apnea syndromes
377273|NCT01528462|Restless Legs Syndrome|restless legs syndrome
377274|NCT01528462|Chronobiology Disorders|chronobiology disorders
377275|NCT01528449|babesia|babesia
377276|NCT01528449|blood donation|blood donation
377277|NCT01528449|transfusion transmitted babesiosis|transfusion transmitted babesiosis
377278|NCT01528436|Cerebral Palsy|cerebral palsy
377279|NCT01528436|Umbilical Cord Blood|umbilical cord blood
377280|NCT01528436|Rehabilitation|rehabilitation
377281|NCT01528423|XtremeCT|xtremect
377282|NCT01528423|Density|density
377283|NCT01528423|pQCT|pqct
377284|NCT01528423|Turnover|turnover
377285|NCT01528423|Bone|bone
377286|NCT01528423|short-term reproducibility|short-term reproducibility
377287|NCT01528397|defect|defect
377288|NCT01528397|dorsal branch of the proper digital nerve|dorsal branch of the proper digital nerve
377289|NCT01528397|proper digital nerve|proper digital nerve
377290|NCT01528397|second dorsal metacarpal artery|second dorsal metacarpal artery
377291|NCT01528397|pedicled nerve graft.|pedicled nerve graft.
377292|NCT01528384|Arginine|arginine
377293|NCT01528384|Arginine deiminase|arginine deiminase
377294|NCT01528384|Argininosuccinate synthetase|argininosuccinate synthetase
377295|NCT01528384|Phase 1|phase 1
377296|NCT01528384|Pediatric|pediatric
377297|NCT01528384|Failed other treatments|failed other treatments
377298|NCT01528384|Pediatric patients|pediatric patients
377299|NCT01528371|Intravenous sedation|intravenous sedation
377300|NCT01528371|Midazolam|midazolam
377301|NCT01528371|Dental treatment|dental treatment
377302|NCT01528371|White-coat hypertension|white-coat hypertension
377303|NCT01528371|STAI|stai
377304|NCT01528371|Dental patients|dental patients
377305|NCT01528371|Transient hypertension|transient hypertension
377306|NCT01528358|sepsis|sepsis
377307|NCT01528358|tissue oximetry|tissue oximetry
377308|NCT01528358|NIRS|nirs
377310|NCT01528345|Breast Cancer|breast cancer
377311|NCT01528345|HER2-, HR+|her2-, hr+
377312|NCT01528345|post-menopausal|post-menopausal
377313|NCT01528345|Locally advanced or metastatic Breast Cancer (HER2-, HR+)|locally advanced or metastatic breast cancer (her2-, hr+)
377314|NCT01528332|Musculoskeletal pain|musculoskeletal pain
377315|NCT01528332|Back pain|back pain
377316|NCT01528332|Chronic pain|chronic pain
377317|NCT01528319|Arthroscopic Bankart repair|arthroscopic bankart repair
377318|NCT01528319|Suture anchor|suture anchor
377319|NCT01528319|Shoulder dislocation|shoulder dislocation
377320|NCT01528306|HP802-247|hp802-247
377321|NCT01528306|EB (epidermolysis bullosa)|eb (epidermolysis bullosa)
377322|NCT01528280|Shift work|shift work
377323|NCT01528280|Hepatitis A vaccination|hepatitis a vaccination
377324|NCT01528280|humoral response|humoral response
377325|NCT01528280|cellular response|cellular response
377326|NCT01528267|Emphysema, lung volume reduction, autologous blood|emphysema, lung volume reduction, autologous blood
377327|NCT01528254|Type 2 Diabetes Mellitus,|type 2 diabetes mellitus,
377328|NCT01528254|Vildagliptin,|vildagliptin,
377329|NCT01528254|Elderly Patients|elderly patients
377330|NCT01528241|ABP688|abp688
377331|NCT01528241|Tracer|tracer
377332|NCT01528241|Depression|depression
377333|NCT01528202|Sleep, circadian cycle, melatonin|sleep, circadian cycle, melatonin
377334|NCT01528189|Insulin, surgery, infection|insulin, surgery, infection
377335|NCT01528176|FGF-23, CKD, Cyp24, 24,25(OH)2D, vitamin D metabolism|fgf-23, ckd, cyp24, 24,25(oh)2d, vitamin d metabolism
377336|NCT01528163|Head and neck|head and neck
377337|NCT01528163|Squamous cell carcinoma|squamous cell carcinoma
377338|NCT01528163|Randomized|randomized
377339|NCT01528163|palliative treatment|palliative treatment
377340|NCT01528098|polyethylene glycol|polyethylene glycol
377341|NCT01528098|bisacodyl|bisacodyl
377342|NCT01528085|Philadelphia chromsome|philadelphia chromsome
377343|NCT01528085|BCR-ABL|bcr-abl
377344|NCT01528085|ALL|all
377345|NCT01528085|acute lymphoblastic leukemia|acute lymphoblastic leukemia
377346|NCT01528085|Nilotinib|nilotinib
377347|NCT01528085|Tasigna|tasigna
377348|NCT01528072|Dynesys Dynamic Stabilization System|dynesys dynamic stabilization system
377349|NCT01528072|Spondylolithesis|spondylolithesis
377350|NCT01528072|pseudoarthrosis|pseudoarthrosis
377351|NCT01528072|neurologic impairment|neurologic impairment
377352|NCT01528072|failed fusion|failed fusion
377353|NCT01528059|Diabetes|diabetes
377354|NCT01528059|Gastric cancer|gastric cancer
377355|NCT01528059|Gastric bypass|gastric bypass
377356|NCT01528046|central nervous system (CNS)|central nervous system (cns)
377357|NCT01528046|malignancy|malignancy
377358|NCT01528046|relapsed|relapsed
377359|NCT01528046|refractory|refractory
377360|NCT01528046|pediatric|pediatric
377361|NCT01528046|recurrent|recurrent
377362|NCT01528033|surgical wound|surgical wound
377363|NCT01528033|wound healing disorder|wound healing disorder
377364|NCT01528033|Wound healing impairment|wound healing impairment
377365|NCT01528033|post surgical wound healing disorder|post surgical wound healing disorder
377366|NCT01528033|abdominal wound healing impairment|abdominal wound healing impairment
377367|NCT01528033|Vacuum Assisted Closure|vacuum assisted closure
377474|NCT01527448|bipolar|bipolar
377368|NCT01528033|negative pressure wound therapy|negative pressure wound therapy
377369|NCT01528007|Pathological gambling|pathological gambling
377370|NCT01528007|Treatment intervention|treatment intervention
377371|NCT01527994|Aprepitant|aprepitant
377372|NCT01527994|Intravenous heroin dependence|intravenous heroin dependence
377373|NCT01527981|Depression|depression
377374|NCT01527981|Diabetes|diabetes
377375|NCT01527981|Adherence|adherence
377376|NCT01527981|Medication|medication
377377|NCT01527981|Glucose|glucose
377378|NCT01527981|Insulin|insulin
377379|NCT01527955|Kelee|kelee
377380|NCT01527955|Meditation|meditation
377381|NCT01527955|Stress|stress
377382|NCT01527955|Anxiety|anxiety
377383|NCT01527955|Depression|depression
377384|NCT01527955|Brain|brain
377385|NCT01527955|Mind|mind
377386|NCT01527942|Pain Management|pain management
377387|NCT01527903|propofol|propofol
377388|NCT01527903|midazolam|midazolam
377389|NCT01527903|sedation|sedation
377390|NCT01527903|ICU|icu
377391|NCT01527890|intravenous patient-controlled analgesia|intravenous patient-controlled analgesia
377392|NCT01527890|IV PCA|iv pca
377393|NCT01527877|BKM120|bkm120
377394|NCT01527877|head and neck cancer|head and neck cancer
377395|NCT01527877|squamous cell carcinoma|squamous cell carcinoma
377396|NCT01527864|NSCLC|nsclc
377397|NCT01527851|Post-bariatric surgery|post-bariatric surgery
377398|NCT01527851|Excess skin|excess skin
377399|NCT01527851|Physical fitness|physical fitness
377400|NCT01527851|Physical activity|physical activity
377401|NCT01527851|Barriers to physical activity|barriers to physical activity
377402|NCT01527851|Plastic surgery|plastic surgery
377403|NCT01527851|Quality of life|quality of life
377404|NCT01527851|Self-esteem|self-esteem
377405|NCT01527838|Hematologic malignancies|hematologic malignancies
377406|NCT01527799|Sickle cell anemia|sickle cell anemia
377407|NCT01527799|Exercise testing|exercise testing
377408|NCT01527799|Cardiopulmonary disease|cardiopulmonary disease
377409|NCT01527786|Major Depressive Disorder, Postpartum Onset|major depressive disorder, postpartum onset
377410|NCT01527773|COPD|copd
377411|NCT01527773|Cardiovascular disease|cardiovascular disease
377412|NCT01527773|Phenotypes|phenotypes
377413|NCT01527760|Essential Hypertension|essential hypertension
377414|NCT01527760|Viscum album mother tincture|viscum album mother tincture
377415|NCT01527760|one group pretest post-test study|one group pretest post-test study
377416|NCT01527747|Type 2 Diabetes|type 2 diabetes
377417|NCT01527747|Hypertriglyceridemia|hypertriglyceridemia
377418|NCT01527747|dipeptidyl peptidase-4 (DPP-4)|dipeptidyl peptidase-4 (dpp-4)
377419|NCT01527747|glucagon-like peptide-1 (glp-1)|glucagon-like peptide-1 (glp-1)
377420|NCT01527734|Comparison study|comparison study
377421|NCT01527721|keratoconus|keratoconus
377422|NCT01527721|CxL|cxl
377423|NCT01527721|CxL combined with t-PRK|cxl combined with t-prk
377424|NCT01527695|Phase IIa|phase iia
377425|NCT01527695|AZD3241|azd3241
377426|NCT01527695|microglia activation|microglia activation
377427|NCT01527695|safety|safety
377428|NCT01527695|Pharmacodynamics and pharmacokinetics analyses|pharmacodynamics and pharmacokinetics analyses
377429|NCT01527695|Parkinson patients|parkinson patients
377430|NCT01527682|Intraocular pressure|intraocular pressure
377431|NCT01527682|Latanoprost|latanoprost
377432|NCT01527682|Dorzolamide|dorzolamide
377433|NCT01527669|Red yeast rice|red yeast rice
377434|NCT01527669|lovastatin|lovastatin
377435|NCT01527669|Pharmacokinetics|pharmacokinetics
377436|NCT01527578|Healthy children|healthy children
377437|NCT01527578|Healthy adults|healthy adults
377438|NCT01527578|individuals ages 7-60|individuals ages 7-60
377439|NCT01527526|DMPA|dmpa
377440|NCT01527526|insulin resistance|insulin resistance
377441|NCT01527526|cardiovascular disease|cardiovascular disease
377442|NCT01527526|BMI|bmi
377443|NCT01527526|weight gain|weight gain
377444|NCT01527526|thrombosis|thrombosis
377445|NCT01527513|Partial Epilepsy|partial epilepsy
377446|NCT01527513|eslicarbazepine acetate|eslicarbazepine acetate
377447|NCT01527513|Children|children
377448|NCT01527500|AMD|amd
377449|NCT01527500|Age-related Macular Degeneration|age-related macular degeneration
377450|NCT01527500|geographic atrophy|geographic atrophy
377451|NCT01527500|GA|ga
377452|NCT01527500|Dry AMD|dry amd
377453|NCT01527500|Blindness|blindness
377454|NCT01527500|Drusen|drusen
377455|NCT01527500|GA lesion|ga lesion
377456|NCT01527487|breast cancer|breast cancer
377457|NCT01527487|eribulin|eribulin
377458|NCT01527487|Halaven|halaven
377459|NCT01527487|taxotere|taxotere
377460|NCT01527474|postpartum|postpartum
377461|NCT01527474|postpartum depression|postpartum depression
377462|NCT01527474|PPD|ppd
377463|NCT01527474|escitalopram|escitalopram
377464|NCT01527461|lung neoplasms|lung neoplasms
377465|NCT01527461|dogs|dogs
377466|NCT01527461|sweat|sweat
377467|NCT01527461|smell|smell
377468|NCT01527448|postpartum|postpartum
377469|NCT01527448|postpartum depression|postpartum depression
377470|NCT01527448|PPD|ppd
377471|NCT01527448|quetiapine XR|quetiapine xr
377472|NCT01527448|quetiapine|quetiapine
377473|NCT01527448|seroquel|seroquel
377475|NCT01527448|bipolar disorder|bipolar disorder
377476|NCT01527448|bipolar disorder, type II|bipolar disorder, type ii
377477|NCT01527435|Best corrected visual acuity|best corrected visual acuity
377478|NCT01527435|Slit lamp examination|slit lamp examination
377479|NCT01527435|Ophthalmoscopy with contact lens/indirect ophthalmoscope|ophthalmoscopy with contact lens/indirect ophthalmoscope
377480|NCT01527435|OCT assessment|oct assessment
377481|NCT01527435|Fundus photos, fluorescein angiogram, ICG angiogram|fundus photos, fluorescein angiogram, icg angiogram
377482|NCT01527422|Aggressive Non-Hodgkin's Lymphoma|aggressive non-hodgkin's lymphoma
377483|NCT01527409|Exercise|exercise
377484|NCT01527409|Diet|diet
377485|NCT01527409|Posttraumatic growth|posttraumatic growth
377486|NCT01527396|endometrial cancer|endometrial cancer
377487|NCT01527396|lymph node metastasis|lymph node metastasis
377488|NCT01527396|lymphadenectomy|lymphadenectomy
377489|NCT01527396|risk criteria|risk criteria
377490|NCT01527383|Shingles|shingles
377491|NCT01527357|fibrin sealant|fibrin sealant
377492|NCT01527357|thrombin|thrombin
377493|NCT01527357|fibrinogen|fibrinogen
377494|NCT01527357|hemostasis|hemostasis
377495|NCT01527344|OCT|oct
377496|NCT01527344|IVUS|ivus
377497|NCT01527344|CAV|cav
377498|NCT01527318|NLSDM|nlsdm
377499|NCT01527318|Lipid accumulation|lipid accumulation
377500|NCT01527305|Schizophrenia|schizophrenia
377501|NCT01527305|Antipsychotics|antipsychotics
377502|NCT01527305|Paliperidone Palmitate|paliperidone palmitate
377503|NCT01527305|Paliperidone|paliperidone
377504|NCT01527305|Invega|invega
377505|NCT01527305|Sustenna|sustenna
377506|NCT01527305|Psychotic disorder|psychotic disorder
377507|NCT01527305|Psychosis|psychosis
377508|NCT01527292|Vertebral Metastasis|vertebral metastasis
377509|NCT01527292|pain control|pain control
377510|NCT01527292|VAP|vap
377511|NCT01527292|SRT+VAP|srt+vap
377512|NCT01527279|atrial fibrillation|atrial fibrillation
377513|NCT01527279|paroxysmal|paroxysmal
377514|NCT01527279|cardioversion|cardioversion
377515|NCT01527279|antazoline|antazoline
377516|NCT01527266|carbohydrate|carbohydrate
377517|NCT01527266|performance|performance
377518|NCT01527266|cycling|cycling
377519|NCT01527253|Cardiometabolic risk|cardiometabolic risk
377520|NCT01527253|Metabolic syndrome|metabolic syndrome
377521|NCT01527253|Prebiotics|prebiotics
377522|NCT01527253|Legumes|legumes
377523|NCT01527253|Wholegrain cereal|wholegrain cereal
377524|NCT01527253|Functional diet|functional diet
377525|NCT01527253|Low glycemic index diet|low glycemic index diet
377526|NCT01527240|Volume of cerebral infarction|volume of cerebral infarction
377527|NCT01527240|Stroke|stroke
377528|NCT01527240|CsA|csa
377529|NCT01527240|NIHSS|nihss
377530|NCT01527227|Children of mentally ill|children of mentally ill
377531|NCT01527214|Lung cancer|lung cancer
377532|NCT01527214|early detection|early detection
377533|NCT01527214|CT scan|ct scan
377534|NCT01527214|General Practice|general practice
377535|NCT01527214|Effect of Computed Tomography scans|effect of computed tomography scans
377536|NCT01527214|Clinical medical education|clinical medical education
377537|NCT01527201|Arthroscopy|arthroscopy
377538|NCT01527201|Debridement|debridement
377539|NCT01527188|HDM|hdm
377540|NCT01527188|allergic rhinitis|allergic rhinitis
377541|NCT01527162|Cerebral palsy|cerebral palsy
377542|NCT01527162|orthotics|orthotics
377543|NCT01527162|solid ankle foot orthoses|solid ankle foot orthoses
377544|NCT01527123|GSK2585823, benzoic acid, hippuric acid, acne vulgaris, pharmacokinetics|gsk2585823, benzoic acid, hippuric acid, acne vulgaris, pharmacokinetics
377545|NCT01527110|zanamivir|zanamivir
377546|NCT01527110|Seasonal Influenza|seasonal influenza
377547|NCT01527110|H1N1|h1n1
377548|NCT01527110|intravenous|intravenous
377549|NCT01527110|neuraminidase inhibitor|neuraminidase inhibitor
377550|NCT01527110|Pandemic|pandemic
377551|NCT01527110|Relenza|relenza
377552|NCT01527110|Influenza B virus|influenza b virus
377553|NCT01527110|Influenza A virus|influenza a virus
377554|NCT01527097|Cardiovascular Diseases|cardiovascular diseases
377555|NCT01527097|Pharmacologic Actions|pharmacologic actions
377556|NCT01527097|Endothelial Function|endothelial function
377557|NCT01527097|Dermatology|dermatology
377558|NCT01527097|Inflammatory Disease|inflammatory disease
377559|NCT01527097|Skin Disease|skin disease
377560|NCT01527058|lung cancer|lung cancer
377561|NCT01527058|integrin receptor|integrin receptor
377562|NCT01527058|68Ga-BNOTA-PRGD2|68ga-bnota-prgd2
377563|NCT01527058|PET/CT|pet/ct
377564|NCT01527058|efficacy and safety|efficacy and safety
377565|NCT01527032|amyloidosis|amyloidosis
377566|NCT01527032|stem cell transplant|stem cell transplant
377567|NCT01527019|Acute Cystitis|acute cystitis
377568|NCT01526967|ostomy|ostomy
377569|NCT01526967|peristomal skin breakdown|peristomal skin breakdown
377570|NCT01526967|ConvaTec Moldable Skin Barriers|convatec moldable skin barriers
377571|NCT01526928|cancer|cancer
377572|NCT01526928|metastatic|metastatic
377573|NCT01526928|locally advanced|locally advanced
377574|NCT01526928|lung|lung
377575|NCT01526928|non-small cell lung cancer|non-small cell lung cancer
377576|NCT01526928|NSCLC|nsclc
377577|NCT01526928|epidermal growth factor receptor|epidermal growth factor receptor
377578|NCT01526928|EGFR|egfr
377579|NCT01526928|T790M|t790m
377580|NCT01526928|CO-1686|co-1686
377581|NCT01526928|unresectable|unresectable
377582|NCT01526928|recurrent|recurrent
377583|NCT01526928|EGFR-directed therapy|egfr-directed therapy
377584|NCT01526928|irreversible EGFR inhibitor|irreversible egfr inhibitor
377585|NCT01526928|TIGER|tiger
377586|NCT01526928|Rociletinib|rociletinib
377587|NCT01526915|PRF|prf
377588|NCT01526915|PLATELET RICH FIBRIN|platelet rich fibrin
377589|NCT01526915|BISPHOSPHONATES|bisphosphonates
377590|NCT01526902|contact lenses|contact lenses
377591|NCT01526889|Non-infectious uveitis|non-infectious uveitis
377592|NCT01526889|Panuveitis|panuveitis
377593|NCT01526889|Vitreous haze|vitreous haze
377594|NCT01526889|Visual acuity|visual acuity
377595|NCT01526876|Intracranial Pressure|intracranial pressure
377596|NCT01526876|Cerebral Perfusion Pressure|cerebral perfusion pressure
377597|NCT01526876|Clevidipine Butyrate|clevidipine butyrate
377598|NCT01526863|Allergy|allergy
377599|NCT01526863|Egg|egg
377600|NCT01526850|cGVHD|cgvhd
377601|NCT01526837|Brain tumor|brain tumor
377602|NCT01526837|GBM|gbm
377603|NCT01526837|Brain cancer|brain cancer
377604|NCT01526811|Endurant|endurant
377605|NCT01526811|Stent Graft|stent graft
377606|NCT01526811|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
377607|NCT01526798|End-Stage Renal Disease (ESRD)|end-stage renal disease (esrd)
377608|NCT01526798|chronic Inflammation|chronic inflammation
377609|NCT01526798|EPO Resistance|epo resistance
377610|NCT01526798|ESA Resistance|esa resistance
377611|NCT01526798|high cut-off dialysis|high cut-off dialysis
377612|NCT01526798|hemodialysis|hemodialysis
377613|NCT01526772|Transnasal|transnasal
377614|NCT01526772|Transoral|transoral
377615|NCT01526772|Roux en Y gastric bypass|roux en y gastric bypass
377616|NCT01526772|Upper Endoscopy|upper endoscopy
377617|NCT01526772|Obesity|obesity
377618|NCT01526759|dietary fiber|dietary fiber
377619|NCT01526759|energy intake|energy intake
377620|NCT01526759|satiety|satiety
377621|NCT01526759|physicochemical properties|physicochemical properties
377622|NCT01526759|men and women|men and women
377623|NCT01526759|Healthy adults|healthy adults
377624|NCT01526746|End stage renal disease|end stage renal disease
377625|NCT01526746|ESRD|esrd
377626|NCT01526746|kidney disease|kidney disease
377627|NCT01526746|renal impairment|renal impairment
377628|NCT01526746|renal|renal
377629|NCT01526733|Type 1 Diabetes|type 1 diabetes
377630|NCT01526733|Continuous Subcutaneous Insulin Infusion (CSII)|continuous subcutaneous insulin infusion (csii)
377631|NCT01526720|Type 2 diabetes mellitus|type 2 diabetes mellitus
377632|NCT01526720|Beta cell function|beta cell function
377633|NCT01526720|Insulin sensitivity|insulin sensitivity
377634|NCT01526720|Genetics of diabetes|genetics of diabetes
377635|NCT01526707|To identify changes in FKBP51 expression with inhaled steroid treatment in asthma|to identify changes in fkbp51 expression with inhaled steroid treatment in asthma
377636|NCT01526694|relapsed or refractory multiple myeloma|relapsed or refractory multiple myeloma
377637|NCT01526681|Sensory Nerve|sensory nerve
377638|NCT01526681|Mixed Nerve|mixed nerve
377639|NCT01526681|Motor Nerve|motor nerve
377640|NCT01526668|Benign gynecological disease|benign gynecological disease
377641|NCT01526668|Surgery|surgery
377642|NCT01526668|Postoperative follow-up strategy|postoperative follow-up strategy
377643|NCT01526668|Pain threshold|pain threshold
377644|NCT01526668|Chronic pelvic pain|chronic pelvic pain
377645|NCT01526668|[E04.950.300.399]|[e04.950.300.399]
377646|NCT01526668|[C13.351.500]|[c13.351.500]
377647|NCT01526668|[F02.463.593.710.560]|[f02.463.593.710.560]
377648|NCT01526668|[N02.421.585.722.700]|[n02.421.585.722.700]
377649|NCT01526668|Postoperative Care|postoperative care
377650|NCT01526655|Endometrial cancer|endometrial cancer
377651|NCT01526655|Robot assisted laparoscopy|robot assisted laparoscopy
377652|NCT01526655|Abdominal hysterectomy|abdominal hysterectomy
377653|NCT01526655|Fast track program|fast track program
377654|NCT01526629|ICD|icd
377655|NCT01526629|Remote follow-up|remote follow-up
377656|NCT01526616|PCOS|pcos
377657|NCT01526616|metformin|metformin
377658|NCT01526616|spironolactone|spironolactone
377659|NCT01526616|metabolic syndrome|metabolic syndrome
377660|NCT01526616|hyperandrogenism|hyperandrogenism
377661|NCT01526603|peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
377662|NCT01526603|autologous stem cell transplant|autologous stem cell transplant
377663|NCT01526577|phase1|phase1
377664|NCT01526577|healthy subjects|healthy subjects
377665|NCT01526577|antiplatelet agent|antiplatelet agent
377666|NCT01526564|Chemotherapy-induced peripheral neuropathy (CIPN)|chemotherapy-induced peripheral neuropathy (cipn)
377667|NCT01526551|Human Papillomavirus|human papillomavirus
377668|NCT01526525|tramadol|tramadol
377669|NCT01526525|ketamine|ketamine
377670|NCT01526525|parecoxib|parecoxib
377671|NCT01526525|paracetamol|paracetamol
377672|NCT01526525|numerical rating scale (NRS)|numerical rating scale (nrs)
377673|NCT01526525|McGill (SF-MPQ)|mcgill (sf-mpq)
377674|NCT01526525|electronic pressure algometer|electronic pressure algometer
377675|NCT01526525|Spielberger State Trait Anxiety Inventory STAI Y-6 item|spielberger state trait anxiety inventory stai y-6 item
377676|NCT01526512|Metronomic cyclophosphamide|metronomic cyclophosphamide
377677|NCT01526512|Metronomic capecitabine|metronomic capecitabine
377678|NCT01526512|HER2-negative breast cancer|her2-negative breast cancer
377679|NCT01526499|Metronomic cyclophosphamide|metronomic cyclophosphamide
377680|NCT01526499|metastatic breast cancer|metastatic breast cancer
377681|NCT01526499|first line|first line
377682|NCT01526499|docetaxel|docetaxel
377683|NCT01526486|melanoma|melanoma
377685|NCT01526486|inguinal|inguinal
377686|NCT01526486|lymph nodes|lymph nodes
377687|NCT01526486|groin|groin
377688|NCT01526486|lymphadenectomy|lymphadenectomy
377689|NCT01526486|groin dissection|groin dissection
377690|NCT01526486|skin cancer|skin cancer
377691|NCT01526486|penile cancer|penile cancer
377692|NCT01526486|urethral cancer|urethral cancer
377693|NCT01526486|scrotal cancer|scrotal cancer
377694|NCT01526486|Paget's disease|paget's disease
377695|NCT01526473|Alphavirus|alphavirus
377696|NCT01526473|Vaccine|vaccine
377697|NCT01526473|Immunotherapy|immunotherapy
377698|NCT01526473|HER2|her2
377699|NCT01526460|Platelet|platelet
377700|NCT01526460|Atorvastatin|atorvastatin
377701|NCT01526460|Rosuvastatin|rosuvastatin
377702|NCT01526460|Multiplate|multiplate
377703|NCT01526460|reactivity|reactivity
377704|NCT01526447|Neck Pain|neck pain
377705|NCT01526447|Craniosacral Manipulation|craniosacral manipulation
377706|NCT01526447|Complementary Therapies|complementary therapies
377707|NCT01526447|Randomized Controlled Trial|randomized controlled trial
377708|NCT01526447|Sensory Thresholds|sensory thresholds
377709|NCT01526447|Quality of Life|quality of life
377710|NCT01526434|Cimzia|cimzia
377711|NCT01526434|Non-interventional|non-interventional
377712|NCT01526434|Multicenter|multicenter
377713|NCT01526434|Postmarketing|postmarketing
377714|NCT01526434|Local|local
377715|NCT01526421|HIV|hiv
377716|NCT01526421|Antiretroviral therapy, highly active|antiretroviral therapy, highly active
377717|NCT01526408|Meniere's Disease|meniere's disease
377718|NCT01526408|Vertigo|vertigo
377719|NCT01526408|Hearing loss|hearing loss
377720|NCT01526408|Tinnitus|tinnitus
377721|NCT01526408|Anti-viral|anti-viral
377722|NCT01526408|Famciclovir|famciclovir
377723|NCT01526395|electroconvulsive therapy|electroconvulsive therapy
377724|NCT01526395|ECT|ect
377725|NCT01526395|unmodified|unmodified
377726|NCT01526395|anesthesia|anesthesia
377727|NCT01526395|propofol|propofol
377728|NCT01526382|septic shock|septic shock
377729|NCT01526382|acute respiratory distress syndrome|acute respiratory distress syndrome
377730|NCT01526382|transpulmonary thermodilution technique|transpulmonary thermodilution technique
377731|NCT01526382|mortality|mortality
377732|NCT01526369|HER2-positive metastatic breast cancer.|her2-positive metastatic breast cancer.
377733|NCT01526356|Angiofibroma|angiofibroma
377734|NCT01526356|Tuberous Sclerosis|tuberous sclerosis
377735|NCT01526356|Rapamycin|rapamycin
377736|NCT01526356|Sirolimus|sirolimus
377737|NCT01526356|mTOR|mtor
377738|NCT01526343|Patients|patients
377739|NCT01526330|Degenerative disc disease|degenerative disc disease
377740|NCT01526330|YH14618|yh14618
377741|NCT01526330|Penial 2000|penial 2000
377742|NCT01526330|Penial 2K|penial 2k
377743|NCT01526317|Drug interaction|drug interaction
377744|NCT01526317|Rosuvastatin|rosuvastatin
377745|NCT01526317|Metformin SR|metformin sr
377746|NCT01526317|Pharmacokinetic|pharmacokinetic
377747|NCT01526291|Myopia|myopia
377748|NCT01526291|Hyperopia|hyperopia
377749|NCT01526291|Astigmatism|astigmatism
377750|NCT01526291|Patient-reported outcomes|patient-reported outcomes
377751|NCT01526291|Patient satisfaction|patient satisfaction
377752|NCT01526291|Refractive Error|refractive error
377753|NCT01526291|Emmetropia|emmetropia
377754|NCT01526291|Dry eyes|dry eyes
377755|NCT01526291|glare|glare
377756|NCT01526291|halos|halos
377757|NCT01526291|patient expectations|patient expectations
377758|NCT01526278|alendronate|alendronate
377759|NCT01526278|Maxmarvil®|maxmarvil®
377760|NCT01526265|Smoking Cessation|smoking cessation
377761|NCT01526265|Work-site|work-site
377762|NCT01526265|Incentives|incentives
377763|NCT01526265|Health Behavior|health behavior
377764|NCT01526265|Smoking|smoking
377765|NCT01526252|speckle tracking echocardiography|speckle tracking echocardiography
377766|NCT01526252|database|database
377767|NCT01526239|Colorectal cancer screening|colorectal cancer screening
377768|NCT01526239|colon cancer screening|colon cancer screening
377769|NCT01526239|colonoscopy|colonoscopy
377770|NCT01526226|High flow nasal cannula|high flow nasal cannula
377771|NCT01526226|Discomfort|discomfort
377772|NCT01526200|CLM|clm
377773|NCT01526187|Public Health and Epidemiology|public health and epidemiology
377774|NCT01526187|Bacteriology|bacteriology
377775|NCT01526187|Infectious and Tropical|infectious and tropical
377776|NCT01526174|autoimmune|autoimmune
377777|NCT01526174|hearing loss|hearing loss
377778|NCT01526174|bilateral hearing loss|bilateral hearing loss
377779|NCT01526174|steroid-dependent|steroid-dependent
377780|NCT01526161|Asthma|asthma
377781|NCT01526161|Children|children
377782|NCT01526161|Therapy|therapy
377783|NCT01526161|Fluticasone|fluticasone
377784|NCT01526161|Salmeterol|salmeterol
377785|NCT01526161|Montelukast|montelukast
377786|NCT01526135|National multicentric phase III superiority trial|national multicentric phase iii superiority trial
377787|NCT01526122|Clopidogrel|clopidogrel
377788|NCT01526122|Aspirin|aspirin
377789|NCT01526122|coadministration|coadministration
377790|NCT01526109|elderly|elderly
377791|NCT01526109|quality of life|quality of life
377792|NCT01526109|functional capacity|functional capacity
377793|NCT01526109|cognitive function|cognitive function
377794|NCT01526109|physical exercise|physical exercise
377795|NCT01526083|Male Healthy Volunteers|male healthy volunteers
377796|NCT01526057|rheumatoid arthritis|rheumatoid arthritis
377797|NCT01526057|rituximab|rituximab
377798|NCT01526057|methotrexate|methotrexate
377799|NCT01526057|anti-TNF|anti-tnf
377800|NCT01526044|hyperglycemia|hyperglycemia
377801|NCT01526044|hypoglycemia|hypoglycemia
377802|NCT01526044|insulin|insulin
377803|NCT01526044|critical illness|critical illness
377804|NCT01526044|intensive insulin therapy|intensive insulin therapy
377805|NCT01526044|continuous glucose monitoring|continuous glucose monitoring
377806|NCT01526044|CGM|cgm
377807|NCT01526044|interstitial fluid glucose|interstitial fluid glucose
377808|NCT01526044|intensive care unit|intensive care unit
377809|NCT01526044|Blood glucose|blood glucose
377810|NCT01526031|frozen shoulder|frozen shoulder
377811|NCT01526031|bee venom acupuncture|bee venom acupuncture
377812|NCT01526018|Intake|intake
377813|NCT01526018|Formula feeding|formula feeding
377814|NCT01525992|Community Pharmacy Services|community pharmacy services
377815|NCT01525992|Pharmacists|pharmacists
377816|NCT01525992|Diabetes Mellitus|diabetes mellitus
377817|NCT01525992|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
377818|NCT01525992|Self Care|self care
377819|NCT01525992|Randomized Controlled Trial|randomized controlled trial
377820|NCT01525979|Stroke rehabilitation|stroke rehabilitation
377821|NCT01525979|Unilateral arm training|unilateral arm training
377822|NCT01525979|Bilateral arm training|bilateral arm training
377823|NCT01525979|Robot-assisted arm training|robot-assisted arm training
377824|NCT01525979|Kinematic analysis|kinematic analysis
377825|NCT01525979|Functional magnetic resonance image|functional magnetic resonance image
377826|NCT01525979|Motor recovery|motor recovery
377827|NCT01525979|Quality of life|quality of life
377828|NCT01525953|esophageal cancer|esophageal cancer
377829|NCT01525953|radiochemotherapy|radiochemotherapy
377830|NCT01525953|prognosis|prognosis
377831|NCT01525940|colon capsule endoscopy|colon capsule endoscopy
377832|NCT01525940|CT-colonography|ct-colonography
377833|NCT01525940|Patients|patients
377834|NCT01525940|incomplete colonoscopy|incomplete colonoscopy
377835|NCT01525927|Oropharyngeal Neoplasms|oropharyngeal neoplasms
377836|NCT01525927|Neoplasms, Oropharyngeal|neoplasms, oropharyngeal
377837|NCT01525927|Oropharynx Neoplasms|oropharynx neoplasms
377838|NCT01525914|prostate cancer|prostate cancer
377839|NCT01525914|PSA kinetics|psa kinetics
377840|NCT01525914|PSA doubling time|psa doubling time
377841|NCT01525914|active surveillance|active surveillance
377842|NCT01525901|SHANK3|shank3
377843|NCT01525901|IGF-1|igf-1
377844|NCT01525901|Autism|autism
377845|NCT01525888|Contrast induced nephropathy|contrast induced nephropathy
377846|NCT01525875|pseudoxanthoma elasticum|pseudoxanthoma elasticum
377847|NCT01525875|calcification|calcification
377848|NCT01525836|Purpura|purpura
377849|NCT01525836|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
377850|NCT01525797|Liver Transplant|liver transplant
377851|NCT01525784|rtCGMS|rtcgms
377852|NCT01525784|glycemic control|glycemic control
377853|NCT01525784|type 1 diabetes mellitus|type 1 diabetes mellitus
377854|NCT01525784|youth|youth
377855|NCT01525771|Advanced Gastric cancer|advanced gastric cancer
377856|NCT01525771|Xeloda (Capecitabine)|xeloda (capecitabine)
377857|NCT01525771|Cisplatin|cisplatin
377858|NCT01525771|Taxotere (Docetaxel)|taxotere (docetaxel)
377859|NCT01525732|Achalasia, Hypertensive LES|achalasia, hypertensive les
377860|NCT01525719|cholangiocarcinoma|cholangiocarcinoma
377861|NCT01525719|RAD001|rad001
377862|NCT01525719|everolimus|everolimus
377863|NCT01525706|Endoscopic Ultrasound|endoscopic ultrasound
377864|NCT01525706|Pancreatic Mucinous Cystic Neoplasm|pancreatic mucinous cystic neoplasm
377865|NCT01525706|Fine Needle Injection|fine needle injection
377866|NCT01525706|Ethanol Ablation|ethanol ablation
377867|NCT01525706|Paclitaxel Ablation|paclitaxel ablation
377868|NCT01525693|diabetes|diabetes
377869|NCT01525693|diabetics|diabetics
377870|NCT01525693|high glucose|high glucose
377871|NCT01525693|Chinese patients|chinese patients
377872|NCT01525680|PTSD|ptsd
377873|NCT01525667|THA|tha
377874|NCT01525667|Muscle injury|muscle injury
377875|NCT01525654|Rheumatoid Arthritis|rheumatoid arthritis
377876|NCT01525654|peer support|peer support
377877|NCT01525654|self-efficacy|self-efficacy
377878|NCT01525654|medication adherence|medication adherence
377879|NCT01525602|advanced, incurable solid tumors|advanced, incurable solid tumors
377880|NCT01525589|Breast cancer|breast cancer
377881|NCT01525589|PM01183|pm01183
377882|NCT01525589|lurbinectedin|lurbinectedin
377883|NCT01525589|Pharma Mar|pharma mar
377884|NCT01525576|booster program|booster program
377885|NCT01525576|internet|internet
377886|NCT01525576|cbt|cbt
377887|NCT01525576|Study the specific effects of adding a booster program|study the specific effects of adding a booster program
377888|NCT01525563|Duphaston Study|duphaston study
377889|NCT01525550|neuroendocrine tumors|neuroendocrine tumors
377890|NCT01525550|adenoma islet cells|adenoma islet cells
377891|NCT01525550|carcinoma islet cells|carcinoma islet cells
377892|NCT01525550|pancreatic neoplasms|pancreatic neoplasms
377893|NCT01525550|angiogenesis inhibitors|angiogenesis inhibitors
377894|NCT01525550|sunitinib|sunitinib
377895|NCT01525550|neoplasms|neoplasms
377896|NCT01525550|carcinoma|carcinoma
377897|NCT01525550|adenoma|adenoma
377898|NCT01525537|Anesthesia General|anesthesia general
377899|NCT01525537|Anesthetics Inhalation|anesthetics inhalation
377900|NCT01525537|Diagnostic techniques and procedures|diagnostic techniques and procedures
377901|NCT01525524|tDCS|tdcs
377902|NCT01525524|Major Depression|major depression
377903|NCT01525524|Stroke|stroke
377904|NCT01525498|Pelvic Organ Prolapse|pelvic organ prolapse
377905|NCT01525498|Catheterization|catheterization
377906|NCT01525498|Urinary tract infection|urinary tract infection
377907|NCT01525498|Urinary retention|urinary retention
377908|NCT01525472|obesity|obesity
377909|NCT01525472|adipose tissue|adipose tissue
377910|NCT01525472|angiogenesis|angiogenesis
377911|NCT01525472|senecence|senecence
377912|NCT01525459|Glioma|glioma
377913|NCT01525459|PBMC subpopulations|pbmc subpopulations
377914|NCT01525459|Gene expression|gene expression
377915|NCT01525459|Metabolomics|metabolomics
377916|NCT01525459|Immunological status|immunological status
377917|NCT01525459|miRNA|mirna
377918|NCT01525459|Proteomics|proteomics
377919|NCT01525446|NSCLC|nsclc
377920|NCT01525446|Lung Cancer|lung cancer
377921|NCT01525394|lymphomas|lymphomas
377922|NCT01525394|Refractory solid tumors|refractory solid tumors
377923|NCT01525368|mild cognitive impairment|mild cognitive impairment
377924|NCT01525368|Alzheimer's disease|alzheimer's disease
377925|NCT01525368|cognitive intervention|cognitive intervention
377926|NCT01525368|cognitive reserve|cognitive reserve
377927|NCT01525355|EUS|eus
377928|NCT01525355|ERCP|ercp
377929|NCT01525355|Intraoperative cholangiogram|intraoperative cholangiogram
377930|NCT01525355|Cholecystectomy|cholecystectomy
377931|NCT01525355|Common Bile Duct Stones|common bile duct stones
377932|NCT01525355|Strictures|strictures
377933|NCT01525355|Stenosis|stenosis
377934|NCT01525355|Duodenum|duodenum
377935|NCT01525355|Dilated Bile duct|dilated bile duct
377936|NCT01525355|Non-filling of the duodenum by contrast|non-filling of the duodenum by contrast
377937|NCT01525329|Actinic Keratosis|actinic keratosis
377938|NCT01525329|Photodynamic Therapy|photodynamic therapy
377939|NCT01525316|Late Onset Neonatal Sepsis|late onset neonatal sepsis
377940|NCT01525316|Neonates|neonates
377941|NCT01525316|Lactoferrin|lactoferrin
377942|NCT01525316|Infections|infections
377943|NCT01525316|Prevention|prevention
377944|NCT01525316|Neurodevelopment|neurodevelopment
377945|NCT01525303|headaches|headaches
377946|NCT01525303|behavioral treatment|behavioral treatment
377947|NCT01525303|physical activity|physical activity
377948|NCT01525290|wake-up stroke|wake-up stroke
377949|NCT01525290|thrombolysis|thrombolysis
377950|NCT01525290|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
377951|NCT01525290|diffusion weighted imaging (DWI)|diffusion weighted imaging (dwi)
377952|NCT01525290|fluid attenuated inversion recovery (FLAIR)|fluid attenuated inversion recovery (flair)
377953|NCT01525264|Mammography|mammography
377954|NCT01525251|primary caregiver|primary caregiver
377955|NCT01525251|neuroblastoma|neuroblastoma
377956|NCT01525251|support group|support group
377957|NCT01525251|posttraumatic stress|posttraumatic stress
377958|NCT01525251|uncertainty|uncertainty
377959|NCT01525199|Non-Small Cell Lung Cancer,|non-small cell lung cancer,
377960|NCT01525199|Epidermal Growth Factor Receptor mutation,|epidermal growth factor receptor mutation,
377961|NCT01525199|Lung cancer,|lung cancer,
377962|NCT01525199|Lung adenocarcinoma|lung adenocarcinoma
377963|NCT01525186|Weight|weight
377964|NCT01525186|Food intakes|food intakes
377965|NCT01525186|Feeding|feeding
377966|NCT01525160|Clot structure|clot structure
377967|NCT01525160|Haemostasis|haemostasis
377968|NCT01525160|Gel point|gel point
377969|NCT01525160|Fractal dimension|fractal dimension
377970|NCT01525160|serum amyloid A|serum amyloid a
377971|NCT01525160|C-reactive protein|c-reactive protein
377972|NCT01525160|vascular cell adhesion molecule-1|vascular cell adhesion molecule-1
377973|NCT01525160|intercellular adhesion molecule-1|intercellular adhesion molecule-1
377974|NCT01525134|Tests, Diagnostic|tests, diagnostic
377975|NCT01525134|Mycobacterium tuberculosis|mycobacterium tuberculosis
377976|NCT01525134|Mycobacterium tuberculosis antigens|mycobacterium tuberculosis antigens
377977|NCT01525134|TB|tb
377978|NCT01525134|Tuberculosis|tuberculosis
377979|NCT01525134|Tuberculosis, Pulmonary|tuberculosis, pulmonary
377980|NCT01525134|Tuberculosis, Miliary|tuberculosis, miliary
377981|NCT01525134|Lipoarabinomannan|lipoarabinomannan
377982|NCT01525121|mechanical ventilation|mechanical ventilation
377983|NCT01525121|chest physiotherapy|chest physiotherapy
377984|NCT01525121|critical care|critical care
377985|NCT01525121|pneumonia|pneumonia
377986|NCT01525121|Mechanically ventilated patients with pulmonary infection.|mechanically ventilated patients with pulmonary infection.
377987|NCT01525108|Medication adherence|medication adherence
377988|NCT01525108|Blood pressure|blood pressure
377989|NCT01525108|Home-based blood pressure measurement|home-based blood pressure measurement
377990|NCT01525108|Blood Pressure Determination|blood pressure determination
377991|NCT01525108|Blood Pressure Monitors|blood pressure monitors
377992|NCT01525108|Blood Pressure Monitoring, Ambulatory|blood pressure monitoring, ambulatory
377993|NCT01525095|Candida|candida
377994|NCT01525095|Diagnostic Assay|diagnostic assay
377995|NCT01525095|Blood culture|blood culture
377996|NCT01525095|Sepsis|sepsis
377997|NCT01525095|T2 Magnetic Relaxation|t2 magnetic relaxation
377998|NCT01525056|rectal cancer|rectal cancer
377999|NCT01525056|imaging|imaging
378000|NCT01525056|PET|pet
378001|NCT01525056|MRI|mri
378002|NCT01525043|Epicondylitis|epicondylitis
378003|NCT01525004|Solid organ transplant|solid organ transplant
378004|NCT01525004|Flu vaccine|flu vaccine
378005|NCT01524965|Locking Plate|locking plate
378006|NCT01524965|Physiotherapy|physiotherapy
378007|NCT01524926|Phase 2|phase 2
378008|NCT01524926|Crizotinib|crizotinib
378009|NCT01524926|Anaplastic large cell lymphoma|anaplastic large cell lymphoma
378010|NCT01524926|Inflammatory myofibroblastic tumor|inflammatory myofibroblastic tumor
378011|NCT01524926|Papillary renal cell carcinoma type 1|papillary renal cell carcinoma type 1
378012|NCT01524926|Alveolar soft part sarcoma|alveolar soft part sarcoma
378013|NCT01524926|Clear cell sarcoma|clear cell sarcoma
378014|NCT01524926|Alveolar rhabdomyosarcoma|alveolar rhabdomyosarcoma
378015|NCT01524874|vitamin d|vitamin d
378016|NCT01524874|cholecalciferol|cholecalciferol
378017|NCT01524874|nutritional supplements|nutritional supplements
378018|NCT01524874|hypovitaminosis d|hypovitaminosis d
378019|NCT01524874|klotho|klotho
378020|NCT01524874|toll like receptor 4|toll like receptor 4
378021|NCT01524861|Tako-Tsubo|tako-tsubo
378022|NCT01524861|Sympathetic heart innervation|sympathetic heart innervation
378023|NCT01524861|MIBG|mibg
378024|NCT01524861|Alpha-lipoic acid|alpha-lipoic acid
378025|NCT01524861|L-acetyl carnitine|l-acetyl carnitine
378026|NCT01524848|Clinical trial|clinical trial
378027|NCT01524848|Investigational drugs|investigational drugs
378028|NCT01524848|Gastrointestinal stromal tumors|gastrointestinal stromal tumors
378029|NCT01524848|Pazopanib|pazopanib
378030|NCT01524835|Tissue Donors|tissue donors
378031|NCT01524835|Lung|lung
378032|NCT01524835|Transplants|transplants
378033|NCT01524835|Transplantation|transplantation
378034|NCT01524822|Military|military
378035|NCT01524822|Traumatic Brain Injury|traumatic brain injury
378036|NCT01524822|Cognitive Testing|cognitive testing
378037|NCT01524822|Neuroimaging|neuroimaging
378038|NCT01524822|Brain Function|brain function
378039|NCT01524796|Real-life|real-life
378040|NCT01524796|non-interventional|non-interventional
378041|NCT01524796|observational|observational
378042|NCT01524796|peripheral neuropathic pain|peripheral neuropathic pain
378043|NCT01524796|Lyrica|lyrica
378044|NCT01524796|pregabalin|pregabalin
378045|NCT01524783|Neuroendocrine tumor|neuroendocrine tumor
378046|NCT01524783|NET|net
378047|NCT01524783|progressive|progressive
378048|NCT01524783|advanced|advanced
378049|NCT01524783|gastrointestinal|gastrointestinal
378050|NCT01524783|GI or lung origin|gi or lung origin
378051|NCT01524783|nonfunctional|nonfunctional
378052|NCT01524783|everolimus|everolimus
378053|NCT01524783|Advanced NET of GI origin|advanced net of gi origin
378054|NCT01524783|Advanced NET of lung origin|advanced net of lung origin
378055|NCT01524744|oral lichen planus treatment pimecrolimus|oral lichen planus treatment pimecrolimus
378056|NCT01524718|radiation|radiation
378057|NCT01524718|time surgery|time surgery
378058|NCT01524705|Pilot Study|pilot study
378059|NCT01524705|Prospective Randomized Trial|prospective randomized trial
378060|NCT01524705|Comparative Effectiveness|comparative effectiveness
378061|NCT01524705|Glycemic Variability|glycemic variability
378062|NCT01524705|insulin glargine|insulin glargine
378063|NCT01524705|exenatide|exenatide
378064|NCT01524705|basal insulin|basal insulin
378065|NCT01524705|bolus insulin|bolus insulin
378066|NCT01524679|chronic hepatitis B|chronic hepatitis b
378067|NCT01524653|VTE|vte
378068|NCT01524653|DVT|dvt
378069|NCT01524653|Chemo|chemo
378070|NCT01524653|Metastatic|metastatic
378071|NCT01524653|Advanced|advanced
378072|NCT01524653|Systemic therapy|systemic therapy
378073|NCT01524653|statin|statin
378074|NCT01524653|biomarkers|biomarkers
378075|NCT01524640|oral cholera vaccine|oral cholera vaccine
378076|NCT01524640|safety and immunogenicity|safety and immunogenicity
378077|NCT01524640|bridging study|bridging study
378078|NCT01524640|ethiopia|ethiopia
378079|NCT01524627|Smokers|smokers
378080|NCT01524627|fMRI|fmri
378081|NCT01524627|varenicline|varenicline
378082|NCT01524614|continuous positive airway pressure|continuous positive airway pressure
378083|NCT01524614|nasal mask|nasal mask
378084|NCT01524614|upper airway obstruction|upper airway obstruction
378085|NCT01524601|Immunosuppression|immunosuppression
378086|NCT01524601|Everolimus|everolimus
378087|NCT01524601|rosuvastatin|rosuvastatin
378088|NCT01524601|fluvastatin|fluvastatin
378089|NCT01524601|Lipid lowering|lipid lowering
378090|NCT01524588|Genotype|genotype
378091|NCT01524588|Phenotype|phenotype
378092|NCT01524588|Genotypic Variation Between Patients|genotypic variation between patients
378093|NCT01524588|Genotypic Phenotypic Relationships|genotypic phenotypic relationships
378094|NCT01524575|pancreatic cancer|pancreatic cancer
378095|NCT01524575|ERCC1|ercc1
378096|NCT01524575|oxaliplatin|oxaliplatin
378097|NCT01524575|gemcitabine|gemcitabine
378098|NCT01524562|Fibrosis|fibrosis
378099|NCT01524562|Cirrhosis|cirrhosis
378100|NCT01524562|Africa|africa
378101|NCT01524562|Schistosomiasis|schistosomiasis
378102|NCT01524562|Aflatoxin|aflatoxin
378103|NCT01524562|Liver Disease|liver disease
378104|NCT01524549|Cardiovascular|cardiovascular
378105|NCT01524549|P450s|p450s
378106|NCT01524549|Flow-Mediated Dilatation|flow-mediated dilatation
378107|NCT01524549|Brachial Artery Ultrasound|brachial artery ultrasound
378108|NCT01524549|Endothelial Cell Function|endothelial cell function
378109|NCT01524549|Healthy Volunteer|healthy volunteer
378110|NCT01524549|HV|hv
378111|NCT01524536|Hypereosinophilia|hypereosinophilia
378112|NCT01524536|Hypereosinophilic Syndrome|hypereosinophilic syndrome
378113|NCT01524536|Corticosteroids|corticosteroids
378114|NCT01524536|Therapy|therapy
378115|NCT01524536|HES|hes
378116|NCT01524523|Gene Expression|gene expression
378117|NCT01524523|Acute Pain|acute pain
378118|NCT01524523|Nitric Oxide|nitric oxide
378119|NCT01524523|Pain|pain
378120|NCT01524523|Bone Marrow|bone marrow
378121|NCT01524510|OSAS|osas
378122|NCT01524510|AHI|ahi
378123|NCT01524510|MRA|mra
378124|NCT01524510|CFD|cfd
378125|NCT01524497|losing interest and feelings of guilt|losing interest and feelings of guilt
378126|NCT01524497|poor concentration|poor concentration
378127|NCT01524497|loss of appetite|loss of appetite
378128|NCT01524497|suicide|suicide
378129|NCT01524484|Data quality|data quality
378130|NCT01524484|Anesthesia|anesthesia
378131|NCT01524484|Quality assurance|quality assurance
378132|NCT01524471|Hypertensive LES|hypertensive les
378133|NCT01524445|Bortezomib|bortezomib
378134|NCT01524445|Velcade|velcade
378135|NCT01524445|multiple myeloma|multiple myeloma
378136|NCT01524445|retrospective study, response rate, medical resource utilization|retrospective study, response rate, medical resource utilization
378137|NCT01524432|Clotrimazole|clotrimazole
378138|NCT01524432|Microcapsules|microcapsules
378139|NCT01524419|spontaneous labor|spontaneous labor
378140|NCT01524419|term|term
378141|NCT01524419|surgical|surgical
378142|NCT01524419|mechanical|mechanical
378143|NCT01524419|fetal or maternal complications|fetal or maternal complications
378144|NCT01524406|Muscle Atrophy|muscle atrophy
378145|NCT01524393|Assisted Reproductive Techniques|assisted reproductive techniques
378146|NCT01524393|Pregnancy|pregnancy
378147|NCT01524393|Pulmonary Embolism|pulmonary embolism
378148|NCT01524393|Venous Thromboembolism|venous thromboembolism
378149|NCT01524380|Schizophrenia|schizophrenia
378150|NCT01524380|clinical trial|clinical trial
378151|NCT01524380|risperidone|risperidone
378152|NCT01524380|ginkgo biloba extract|ginkgo biloba extract
378153|NCT01524380|antioxidant|antioxidant
378154|NCT01524354|depth of anesthesia|depth of anesthesia
378155|NCT01524354|valve surgery|valve surgery
378156|NCT01524341|Acute malaria|acute malaria
378157|NCT01524341|KAE609|kae609
378158|NCT01524328|Complementary and alternative medicine|complementary and alternative medicine
378159|NCT01524328|HRQoL, Inflammatory bowel disease|hrqol, inflammatory bowel disease
378160|NCT01524315|Thiamine|thiamine
378161|NCT01524315|Vitamin B1|vitamin b1
378162|NCT01524315|Thiamine Deficiency|thiamine deficiency
378163|NCT01524315|Thiamine supplementation|thiamine supplementation
378164|NCT01524315|Cardiac surgery|cardiac surgery
378165|NCT01524315|Lactic Acid|lactic acid
378166|NCT01524302|pneumonia|pneumonia
378167|NCT01524302|ceftaroline|ceftaroline
378168|NCT01524302|community-aquired|community-aquired
378169|NCT01524250|Multiple Sclerosis|multiple sclerosis
378170|NCT01524250|relapse|relapse
378171|NCT01524250|demyelination|demyelination
378172|NCT01524250|treatment|treatment
378173|NCT01524250|corticosteroids|corticosteroids
378174|NCT01524224|Metastases|metastases
378175|NCT01524224|Neoplasm|neoplasm
378176|NCT01524224|Advanced Cancer|advanced cancer
378177|NCT01524224|Metastatic Cancer|metastatic cancer
378178|NCT01524211|Aortic Aneurysms|aortic aneurysms
378179|NCT01524185|childhood trauma|childhood trauma
378180|NCT01524185|intergenerational trauma|intergenerational trauma
378181|NCT01524185|child neglect|child neglect
378182|NCT01524185|child maltreatment|child maltreatment
378183|NCT01524185|mental health|mental health
378184|NCT01524172|child trauma exposure|child trauma exposure
378185|NCT01524172|mental health|mental health
378186|NCT01524172|yoga|yoga
378187|NCT01524172|mood regulation|mood regulation
378188|NCT01524172|child maltreatment|child maltreatment
378189|NCT01524159|cardiovascular disease|cardiovascular disease
378190|NCT01524146|Unresectable Cholangiocarcinoma|unresectable cholangiocarcinoma
378191|NCT01524146|Biliary obstruction|biliary obstruction
378192|NCT01524146|Stent obstruction|stent obstruction
378193|NCT01524146|Biliary stricture|biliary stricture
378194|NCT01524146|Photodynamic therapy|photodynamic therapy
378195|NCT01524146|PDT|pdt
378196|NCT01524146|Ablation|ablation
378197|NCT01524133|combat-related PTSD|combat-related ptsd
378198|NCT01524133|Posttraumatic stress disorder|posttraumatic stress disorder
378199|NCT01524133|prolonged exposure therapy|prolonged exposure therapy
378200|NCT01524133|sertraline|sertraline
378201|NCT01524133|military|military
378202|NCT01524133|veterans|veterans
378203|NCT01524133|VA hospital|va hospital
378204|NCT01524133|mental illness|mental illness
378205|NCT01524120|Mucosal healing|mucosal healing
378206|NCT01524107|Prophylaxis Antibiotics|prophylaxis antibiotics
378207|NCT01524107|Maternal Complications|maternal complications
378208|NCT01524107|Neonatal Complications|neonatal complications
378209|NCT01524107|Cord Prolapse|cord prolapse
378210|NCT01524107|Elective Caesarian Section|elective caesarian section
378211|NCT01524107|Maternal Morbidity|maternal morbidity
378212|NCT01524107|Neonatal Morbidity|neonatal morbidity
378213|NCT01524094|colorectal cancer|colorectal cancer
378214|NCT01524094|cytoreductive surgery|cytoreductive surgery
378215|NCT01524094|intraperitoneal chemotherapy|intraperitoneal chemotherapy
378216|NCT01524094|systemic chemotherapy|systemic chemotherapy
378217|NCT01524094|Peritoneal Metastatic Disease From the Colon or Rectum|peritoneal metastatic disease from the colon or rectum
378218|NCT01524081|antibiotic prophylaxis|antibiotic prophylaxis
378219|NCT01524081|emergent surgery|emergent surgery
378220|NCT01524081|surgical site infection|surgical site infection
378221|NCT01524068|Acute Idiopathic Pulmonary Fibrosis Exacerbations|acute idiopathic pulmonary fibrosis exacerbations
378222|NCT01524068|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
378223|NCT01524068|IPF|ipf
378224|NCT01524042|Satisfaction|satisfaction
378225|NCT01524042|colonoscopy|colonoscopy
378226|NCT01524042|double pants|double pants
378227|NCT01524042|single pants|single pants
378228|NCT01524029|Digital Breast Tomosynthesis|digital breast tomosynthesis
378229|NCT01524029|Digital Mammography|digital mammography
378230|NCT01524029|Breast cancer detection|breast cancer detection
378231|NCT01524016|Oncogenic osteomalacia|oncogenic osteomalacia
378232|NCT01524016|mesenchymal tumor|mesenchymal tumor
378233|NCT01524016|Somatostatin receptor|somatostatin receptor
378234|NCT01524016|68Ga-DOTATATE|68ga-dotatate
378235|NCT01524016|PET/CT|pet/ct
378236|NCT01524003|community based participatory research|community based participatory research
378237|NCT01523977|ALL|all
378238|NCT01523977|pediatric|pediatric
378239|NCT01523977|relapse|relapse
378240|NCT01523964|DMD|dmd
378241|NCT01523964|EIM|eim
378242|NCT01523964|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
378243|NCT01523964|electrical impedance myography|electrical impedance myography
378244|NCT01523951|topical local anaesthesia|topical local anaesthesia
378245|NCT01523951|cooling|cooling
378246|NCT01523951|capsaicin 8%|capsaicin 8%
378247|NCT01523951|epidermal nerve fiber density|epidermal nerve fiber density
378248|NCT01523951|treatment pain|treatment pain
378249|NCT01523925|Functional electrical therapy|functional electrical therapy
378250|NCT01523925|Bilateral arm training|bilateral arm training
378251|NCT01523925|Constraint induced therapy|constraint induced therapy
378252|NCT01523925|Stroke rehabilitation|stroke rehabilitation
378253|NCT01523925|Clinical evaluation|clinical evaluation
378254|NCT01523925|Kinematic analysis|kinematic analysis
378255|NCT01523912|radiofrequency ablation|radiofrequency ablation
378256|NCT01523912|gastric dysplasia|gastric dysplasia
378257|NCT01523912|gastric neoplasia|gastric neoplasia
378258|NCT01523899|SSTI|ssti
378259|NCT01523899|cutaneous abscess|cutaneous abscess
378260|NCT01523899|boil|boil
378261|NCT01523847|Hodgkin Lymphoma|hodgkin lymphoma
378262|NCT01523847|Cardiopathic|cardiopathic
378263|NCT01523847|elderly|elderly
378264|NCT01523847|Myocet|myocet
378265|NCT01523834|Diffuse Large B-cell Lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
378266|NCT01523834|Panobinostat|panobinostat
378267|NCT01523834|Patients with relapsed/refractory DLBCL.|patients with relapsed/refractory dlbcl.
378268|NCT01523808|pancreatic cancer|pancreatic cancer
378269|NCT01523808|asparaginase|asparaginase
378270|NCT01523795|Energy intake|energy intake
378271|NCT01523795|Video games|video games
378272|NCT01523795|Television|television
378273|NCT01523795|Physical activity|physical activity
378274|NCT01523795|Obesity|obesity
378275|NCT01523782|Acute Lymphoblastic leukemia|acute lymphoblastic leukemia
378276|NCT01523782|Elderly patient|elderly patient
378277|NCT01523782|Asparaginase|asparaginase
378278|NCT01523769|prematurity|prematurity
378279|NCT01523769|umbilical cord milking|umbilical cord milking
378384|NCT01523431|Neutropenia|neutropenia
378280|NCT01523769|delayed cord clamping|delayed cord clamping
378281|NCT01523769|neonatal transfusion|neonatal transfusion
378282|NCT01523730|Schizophrenia|schizophrenia
378283|NCT01523730|Nicotine|nicotine
378284|NCT01523730|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
378285|NCT01523730|Cognition|cognition
378286|NCT01523730|EEG|eeg
378287|NCT01523717|procalcitonin|procalcitonin
378288|NCT01523717|decrease over 72 hours|decrease over 72 hours
378289|NCT01523717|severe sepsis|severe sepsis
378290|NCT01523717|septic shock|septic shock
378291|NCT01523691|Healthy individuals|healthy individuals
378292|NCT01523678|Ovarian Cancer|ovarian cancer
378293|NCT01523678|Endometrial Cancer|endometrial cancer
378294|NCT01523678|Endometrial Carcinoma|endometrial carcinoma
378295|NCT01523678|Uterine Cervical Cancer|uterine cervical cancer
378296|NCT01523678|Paclitaxel|paclitaxel
378297|NCT01523678|Carboplatin|carboplatin
378298|NCT01523678|Neupogen|neupogen
378299|NCT01523678|Filgrastim|filgrastim
378300|NCT01523678|Ovarian Diseases|ovarian diseases
378301|NCT01523678|Peritoneal Diseases|peritoneal diseases
378302|NCT01523678|Fallopian Tube Diseases|fallopian tube diseases
378303|NCT01523678|Endocrine System Diseases|endocrine system diseases
378304|NCT01523678|Endometrial Diseases|endometrial diseases
378305|NCT01523678|Uterine Cervical Diseases|uterine cervical diseases
378306|NCT01523678|Neoplasms|neoplasms
378307|NCT01523678|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
378308|NCT01523678|Ovarian Neoplasms|ovarian neoplasms
378309|NCT01523678|Peritoneal Neoplasms|peritoneal neoplasms
378310|NCT01523678|Fallopian Tube Neoplasms|fallopian tube neoplasms
378311|NCT01523678|Neoplasms, Endometrial|neoplasms, endometrial
378312|NCT01523678|Cervical Neoplasms|cervical neoplasms
378313|NCT01523678|Genital Neoplasms, Female|genital neoplasms, female
378314|NCT01523678|Urogenital Neoplasms|urogenital neoplasms
378315|NCT01523678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic
378316|NCT01523678|Genital Diseases, Female|genital diseases, female
378317|NCT01523639|liver injury|liver injury
378318|NCT01523639|steatosis|steatosis
378319|NCT01523639|KRAS-Wild-Type|kras-wild-type
378320|NCT01523639|metastatic colorectal cancer|metastatic colorectal cancer
378321|NCT01523639|metformin|metformin
378322|NCT01523639|placebo|placebo
378323|NCT01523639|chemotherapy|chemotherapy
378324|NCT01523626|Trauma|trauma
378325|NCT01523626|Injur*|injur*
378326|NCT01523626|Emergen*|emergen*
378327|NCT01523626|Computed Tomography|computed tomography
378328|NCT01523626|Total body|total body
378329|NCT01523626|TBCT|tbct
378330|NCT01523626|Whole body|whole body
378331|NCT01523626|WBCT|wbct
378332|NCT01523626|Full body|full body
378333|NCT01523626|Pan CT|pan ct
378334|NCT01523613|Dental caries|dental caries
378335|NCT01523613|Proximal surfaces|proximal surfaces
378336|NCT01523613|Posterior teeth|posterior teeth
378337|NCT01523613|Carious lesions|carious lesions
378338|NCT01523613|Tooth diseases|tooth diseases
378339|NCT01523613|Dental restorations|dental restorations
378340|NCT01523613|Glass-ionomer|glass-ionomer
378341|NCT01523600|whole body vibration|whole body vibration
378342|NCT01523600|physical functioning|physical functioning
378343|NCT01523600|falls|falls
378344|NCT01523600|older people|older people
378345|NCT01523600|prevention|prevention
378346|NCT01523574|oxaliplatin|oxaliplatin
378347|NCT01523574|vitamin e|vitamin e
378348|NCT01523574|neuropathy|neuropathy
378349|NCT01523574|peripheral|peripheral
378350|NCT01523574|prophylaxis|prophylaxis
378351|NCT01523561|dance|dance
378352|NCT01523561|intervention|intervention
378353|NCT01523561|adolescent|adolescent
378354|NCT01523561|girls|girls
378355|NCT01523548|Carbon Monoxide|carbon monoxide
378356|NCT01523548|Hypertension, Pulmonary|hypertension, pulmonary
378357|NCT01523522|Fecal incontinence|fecal incontinence
378358|NCT01523522|Myoblast|myoblast
378359|NCT01523522|Surgery|surgery
378360|NCT01523509|Dental Caries|dental caries
378361|NCT01523509|Radiography, Dental|radiography, dental
378362|NCT01523509|Contrast media|contrast media
378363|NCT01523509|Tooth|tooth
378365|NCT01523496|Vitamin D Deficiency|vitamin d deficiency
378366|NCT01523483|preterm birth|preterm birth
378367|NCT01523483|preterm labor|preterm labor
378368|NCT01523483|progesterone|progesterone
378369|NCT01523483|uterine electromyography|uterine electromyography
378370|NCT01523483|cervical length|cervical length
378371|NCT01523470|non-invasive ventilator|non-invasive ventilator
378372|NCT01523457|metastatic pancreatic cancer|metastatic pancreatic cancer
378373|NCT01523457|locally advanced pancreatic cancer|locally advanced pancreatic cancer
378374|NCT01523457|FOLFIRINOX|folfirinox
378375|NCT01523457|phase II|phase ii
378376|NCT01523457|progression free survival|progression free survival
378377|NCT01523444|Adolescents|adolescents
378378|NCT01523444|Screening|screening
378379|NCT01523444|Advice|advice
378380|NCT01523444|Referral|referral
378381|NCT01523431|Colorectal cancer|colorectal cancer
378382|NCT01523431|Irinotecan|irinotecan
378383|NCT01523431|UGT1A1 genotype|ugt1a1 genotype
378385|NCT01523431|diarrhea|diarrhea
378386|NCT01523431|response|response
378387|NCT01523431|pharmacokinetic|pharmacokinetic
378388|NCT01523418|Xarelto|xarelto
378389|NCT01523418|Thromboembolism, Venous|thromboembolism, venous
378390|NCT01523418|Orthopedic surgery|orthopedic surgery
378391|NCT01523418|Factor Xa inhibitor|factor xa inhibitor
378392|NCT01523418|Observational study|observational study
378393|NCT01523405|Non Interventional Study, Type II Diabetes Mellitus, Quality of Life|non interventional study, type ii diabetes mellitus, quality of life
378394|NCT01523392|Stable Coronary Artery Disease, CAD|stable coronary artery disease, cad
378395|NCT01523379|Causalgia|causalgia
378396|NCT01523379|CRPS|crps
378397|NCT01523379|complex regional pain syndrome|complex regional pain syndrome
378398|NCT01523379|Dynastat|dynastat
378399|NCT01523379|Parecoxib|parecoxib
378400|NCT01523366|Stable Coronary Artery Disease, CAD|stable coronary artery disease, cad
378401|NCT01523353|Prehabilitation|prehabilitation
378402|NCT01523353|Exercise|exercise
378403|NCT01523353|Colorectal Cancer|colorectal cancer
378404|NCT01523353|Surgery|surgery
378405|NCT01523327|Uric acid|uric acid
378406|NCT01523314|diabetic macular edema|diabetic macular edema
378407|NCT01523314|intravitreal injection|intravitreal injection
378408|NCT01523314|dexamethasone|dexamethasone
378409|NCT01523314|Cyclodextrin|cyclodextrin
378410|NCT01523314|eye drops|eye drops
378411|NCT01523314|bevacizumab|bevacizumab
378412|NCT01523314|macular laser|macular laser
378413|NCT01523301|Rotigotine|rotigotine
378414|NCT01523301|Neupro|neupro
378415|NCT01523301|Depressive Symptom|depressive symptom
378416|NCT01523301|Idiopathic Parkinson's disease|idiopathic parkinson's disease
378417|NCT01523275|mitomycin-C|mitomycin-c
378418|NCT01523275|laryngotracheal stenosis|laryngotracheal stenosis
378419|NCT01523275|subglottic stenosis|subglottic stenosis
378420|NCT01523275|tracheal stenosis|tracheal stenosis
378421|NCT01523275|endoscopic airway surgery|endoscopic airway surgery
378422|NCT01523262|preconditioning|preconditioning
378423|NCT01523262|aortic aneurysm|aortic aneurysm
378424|NCT01523249|3D ultrasonography|3d ultrasonography
378425|NCT01523249|epidural|epidural
378426|NCT01523249|neuraxial anesthesia|neuraxial anesthesia
378427|NCT01523249|neuraxial analgesia|neuraxial analgesia
378428|NCT01523249|pregnant woman|pregnant woman
378429|NCT01523249|parturients|parturients
378430|NCT01523236|Allergic Rhinitis|allergic rhinitis
378431|NCT01523236|Bioequivalence|bioequivalence
378432|NCT01523210|spasticity|spasticity
378433|NCT01523210|Diffusor tensor imaging|diffusor tensor imaging
378434|NCT01523210|distribution|distribution
378435|NCT01523210|botulinum toxin|botulinum toxin
378436|NCT01523210|physiotherapy|physiotherapy
378437|NCT01523197|Obstructive Sleep Apnea hypopnea Syndrome|obstructive sleep apnea hypopnea syndrome
378438|NCT01523197|COPD|copd
378439|NCT01523197|overlap syndrome|overlap syndrome
378440|NCT01523197|Auto-trilevel ventilation|auto-trilevel ventilation
378441|NCT01523197|BiPAP ventilation|bipap ventilation
378442|NCT01523184|Chronic constipation (CC)|chronic constipation (cc)
378443|NCT01523184|Functional Constipation (FC)|functional constipation (fc)
378444|NCT01523184|Gastric Emptying|gastric emptying
378445|NCT01523184|Colon Transit|colon transit
378446|NCT01523184|multiple doses of YKP10811|multiple doses of ykp10811
378447|NCT01523184|gastrointestinal transit|gastrointestinal transit
378448|NCT01523184|colonic transit|colonic transit
378449|NCT01523158|Allergic Rhinitis|allergic rhinitis
378450|NCT01523158|Immunotherapy|immunotherapy
378451|NCT01523145|Atrial fibrillation|atrial fibrillation
378452|NCT01523145|Radio Frequency Ablation|radio frequency ablation
378453|NCT01523145|Rehabilitation|rehabilitation
378454|NCT01523145|Physical capacity|physical capacity
378455|NCT01523145|Quality of life|quality of life
378456|NCT01523145|Integrated rehabilitation|integrated rehabilitation
378457|NCT01523106|Crohn's disease|crohn's disease
378458|NCT01523106|carnitine|carnitine
378459|NCT01523067|Vasomera|vasomera
378460|NCT01523067|PB1046|pb1046
378461|NCT01523067|Hypertension|hypertension
378462|NCT01523054|metoprolol, acute myocardial infarction, pharmacokinetics, pharmacodynamics|metoprolol, acute myocardial infarction, pharmacokinetics, pharmacodynamics
378463|NCT01523015|Adenocarcinoma|adenocarcinoma
378464|NCT01523015|esophago-gastric cancer|esophago-gastric cancer
378465|NCT01523015|chemotherapy|chemotherapy
378466|NCT01523015|chemoradiotherapy|chemoradiotherapy
378467|NCT01523015|surgery|surgery
378468|NCT01522989|Cancer|cancer
378469|NCT01522989|Advanced|advanced
378470|NCT01522989|Refractory|refractory
378471|NCT01522950|hypertension|hypertension
378472|NCT01522950|prevention|prevention
378473|NCT01522950|endothelial function|endothelial function
378474|NCT01522924|tobacco cessation treatment|tobacco cessation treatment
378475|NCT01522924|standardized patients|standardized patients
378476|NCT01522924|dental students|dental students
378477|NCT01522924|tobacco cessation treatment education|tobacco cessation treatment education
378478|NCT01522898|Heart Failure|heart failure
378479|NCT01522898|Atrial Fibrillation|atrial fibrillation
378480|NCT01522885|Chest tube|chest tube
378481|NCT01522885|placement|placement
378482|NCT01522885|mal positioning|mal positioning
378483|NCT01522872|TH-302|th-302
378484|NCT01522872|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
378485|NCT01522872|Bortezomib|bortezomib
378486|NCT01522872|Phase 1/2|phase 1/2
378487|NCT01522872|Hypoxia|hypoxia
378488|NCT01522872|Myeloma|myeloma
378489|NCT01522872|Evofosfamide|evofosfamide
378490|NCT01522872|Pomalidomide|pomalidomide
378491|NCT01522872|Pimonidazole|pimonidazole
378492|NCT01522859|COPD|copd
378493|NCT01522859|Telehealth|telehealth
378494|NCT01522859|health related quality of life|health related quality of life
378495|NCT01522833|NSLCL|nslcl
378496|NCT01522833|Erlotinib|erlotinib
378497|NCT01522833|Tarceva|tarceva
378498|NCT01522807|Phase 1|phase 1
378499|NCT01522807|Single Doses|single doses
378500|NCT01522807|Biocomparison|biocomparison
378501|NCT01522807|Pharmacokinetics|pharmacokinetics
378502|NCT01522807|Healthy Volunteers|healthy volunteers
378503|NCT01522768|ESOPHAGUS|esophagus
378504|NCT01522768|STOMACH|stomach
378505|NCT01522768|Afatinib|afatinib
378506|NCT01522768|paclitaxel|paclitaxel
378507|NCT01522768|trastuzumab|trastuzumab
378508|NCT01522768|11-166|11-166
378509|NCT01522755|Pacing lead|pacing lead
378510|NCT01522755|implant|implant
378511|NCT01522755|pacemaker|pacemaker
378512|NCT01522742|psoriasis|psoriasis
378513|NCT01522742|cardiovascular disease risk|cardiovascular disease risk
378514|NCT01522742|atherosclerosis|atherosclerosis
378515|NCT01522742|etanercept (enbrel)|etanercept (enbrel)
378516|NCT01522729|Chronic pulmonary obstructive disease|chronic pulmonary obstructive disease
378517|NCT01522729|Muscle dysfunction|muscle dysfunction
378518|NCT01522729|Exercise intolerance|exercise intolerance
378519|NCT01522729|Muscle afferents|muscle afferents
378520|NCT01522729|Ventilation|ventilation
378521|NCT01522703|asthma|asthma
378522|NCT01522703|allergic rhinitis|allergic rhinitis
378523|NCT01522703|dietary interventions|dietary interventions
378524|NCT01522703|mouse allergy|mouse allergy
378525|NCT01522690|Accelerometer|accelerometer
378526|NCT01522690|gait analysis|gait analysis
378527|NCT01522690|Healthy subjects|healthy subjects
378528|NCT01522677|tumor immunology|tumor immunology
378529|NCT01522677|neoadjuvant|neoadjuvant
378530|NCT01522677|colonoscopy|colonoscopy
378531|NCT01522677|photosensitization|photosensitization
378532|NCT01522651|Atrial Fibrillation|atrial fibrillation
378533|NCT01522651|Ranolazine|ranolazine
378534|NCT01522651|Dronedarone|dronedarone
378535|NCT01522651|Dual Chamber Pacemakers|dual chamber pacemakers
378536|NCT01522625|chronic hepatitis B|chronic hepatitis b
378537|NCT01522625|hepatitis B viral DNA|hepatitis b viral dna
378538|NCT01522625|antiviral therapy|antiviral therapy
378539|NCT01522625|Tenofovir|tenofovir
378540|NCT01522612|KRAS Wild Type|kras wild type
378541|NCT01522612|Frail Elderly|frail elderly
378542|NCT01522612|QLQ-C30|qlq-c30
378543|NCT01522612|QLQ-ELD14|qlq-eld14
378544|NCT01522612|CGA|cga
378545|NCT01522612|EGFR|egfr
378546|NCT01522612|Cetuximab|cetuximab
378547|NCT01522612|5-FU|5-fu
378548|NCT01522599|ARDS: Acute Respiratory Distress Syndrome|ards: acute respiratory distress syndrome
378549|NCT01522599|LOW FLOW ECCO2-R: EXTRA-CORPOREAL CO2 REMOVAL|low flow ecco2-r: extra-corporeal co2 removal
378550|NCT01522599|VILI: Ventilator Induced Lung Injury|vili: ventilator induced lung injury
378551|NCT01522573|Cholangiocarcinoma|cholangiocarcinoma
378552|NCT01522573|Pancreatic Cancer|pancreatic cancer
378553|NCT01522573|Bile Duct Cancer|bile duct cancer
378554|NCT01522573|Biliary Stricture|biliary stricture
378555|NCT01522573|Biliary obstruction|biliary obstruction
378556|NCT01522573|Stent obstruction|stent obstruction
378557|NCT01522573|Proximal duct stricture|proximal duct stricture
378558|NCT01522573|Distal duct stricture|distal duct stricture
378559|NCT01522573|Ampullary Cancer|ampullary cancer
378560|NCT01522573|Biliary sphincter stenosis|biliary sphincter stenosis
378561|NCT01522573|Impacted stones|impacted stones
378562|NCT01522573|Chronic pancreatitis|chronic pancreatitis
378563|NCT01522573|Peri-ampullary diverticula|peri-ampullary diverticula
378564|NCT01522573|Altered anatomy|altered anatomy
378565|NCT01522573|Endoscopic ultrasound|endoscopic ultrasound
378566|NCT01522573|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
378567|NCT01522573|Multicenter|multicenter
378568|NCT01522560|CA2 and CA3 residents|ca2 and ca3 residents
378569|NCT01522560|Pediatric Anesthesia|pediatric anesthesia
378570|NCT01522547|Pomalidomide|pomalidomide
378571|NCT01522547|Sickle Cell Disease|sickle cell disease
378572|NCT01522547|Fetal Hemoglobin|fetal hemoglobin
378573|NCT01522534|injuries|injuries
378574|NCT01522534|pain|pain
378575|NCT01522534|Block, Nerve|block, nerve
378576|NCT01522534|morphine|morphine
378577|NCT01522534|Prehospital Emergency Care|prehospital emergency care
378578|NCT01522521|AK156|ak156
378579|NCT01522508|Analgesia|analgesia
378580|NCT01522508|Anesthetics|anesthetics
378581|NCT01522508|Diagnostic Techniques and Procedures|diagnostic techniques and procedures
378582|NCT01522482|fatty acids|fatty acids
378583|NCT01522482|cardiovascular disease|cardiovascular disease
378584|NCT01522482|genotype|genotype
378585|NCT01522482|apoE|apoe
378586|NCT01522469|FLT3|flt3
378587|NCT01522469|Crenolanib|crenolanib
378588|NCT01522469|Acute|acute
378589|NCT01522469|myeloid|myeloid
378590|NCT01522469|leukemia|leukemia
378591|NCT01522469|relapsed|relapsed
378592|NCT01522469|refractory|refractory
378593|NCT01522443|prostate cancer|prostate cancer
378594|NCT01522443|castration resistant prostate cancer|castration resistant prostate cancer
378595|NCT01522443|bone pain|bone pain
378596|NCT01522443|CRPC|crpc
378597|NCT01522430|Resistant hypertension|resistant hypertension
378598|NCT01522430|Renal denervation|renal denervation
378599|NCT01522430|Ambulatory blood pressure|ambulatory blood pressure
378600|NCT01522430|Renal function|renal function
378601|NCT01522430|Simplicity catheter|simplicity catheter
378602|NCT01522430|Sham procedure|sham procedure
378603|NCT01522404|Mild Cognitive Impairment|mild cognitive impairment
378604|NCT01522404|Memory Loss|memory loss
378605|NCT01522404|Alzheimer's Disease|alzheimer's disease
378606|NCT01522378|cardiac resynchronization therapy|cardiac resynchronization therapy
378607|NCT01522365|Dental implants|dental implants
378608|NCT01522365|XiVE CAD/CAM bridge|xive cad/cam bridge
378609|NCT01522352|Bioprosthesis,|bioprosthesis,
378610|NCT01522352|aortic valve replacement|aortic valve replacement
378611|NCT01522352|Magna Ease|magna ease
378612|NCT01522352|Mitroflow|mitroflow
378613|NCT01522352|Trifecta|trifecta
378614|NCT01522339|NICU|nicu
378615|NCT01522339|MRI|mri
378616|NCT01522339|Neonatal|neonatal
378617|NCT01522339|Safety|safety
378618|NCT01522339|Efficacy|efficacy
378619|NCT01522339|Cincinnati|cincinnati
378620|NCT01522326|Acute Mountain Sickness|acute mountain sickness
378621|NCT01522326|High Altitude Headache|high altitude headache
378622|NCT01522326|Lake Louise AMS Score|lake louise ams score
378623|NCT01522326|Visual Analog Scale|visual analog scale
378624|NCT01522326|Ibuprofen|ibuprofen
378625|NCT01522326|Metoclopramide|metoclopramide
378626|NCT01522326|Nepal|nepal
378627|NCT01522300|Tomosynthesis|tomosynthesis
378628|NCT01522300|breast cancer|breast cancer
378629|NCT01522300|specificity|specificity
378630|NCT01522300|sensitivity|sensitivity
378631|NCT01522300|To assess efficacy of Tomosynthesis by evaluating its sensitivity and specificity in detecting the multicentricity of mammary tumor|to assess efficacy of tomosynthesis by evaluating its sensitivity and specificity in detecting the multicentricity of mammary tumor
378632|NCT01522287|Obsessive Compulsive Disorder|obsessive compulsive disorder
378633|NCT01522287|Computer Assisted Therapy|computer assisted therapy
378634|NCT01522287|Cognitive Behavior Therapy|cognitive behavior therapy
378635|NCT01522287|Cognitive Therapy|cognitive therapy
378636|NCT01522261|Mechanical Bowel Prep|mechanical bowel prep
378637|NCT01522248|influenza vaccine|influenza vaccine
378638|NCT01522248|cytokines|cytokines
378639|NCT01522248|chemokines|chemokines
378640|NCT01522248|symptoms|symptoms
378641|NCT01522235|Autoimmune autonomic neuropathy|autoimmune autonomic neuropathy
378642|NCT01522235|Orthostatic hypotension|orthostatic hypotension
378643|NCT01522235|Dysautonomia|dysautonomia
378644|NCT01522235|Autonomic failure|autonomic failure
378645|NCT01522235|Peripheral autonomic neuropathy|peripheral autonomic neuropathy
378646|NCT01522222|cardiopulmonary bypass surgery|cardiopulmonary bypass surgery
378647|NCT01522222|CABG|cabg
378648|NCT01522222|PEEP|peep
378649|NCT01522209|CRLM|crlm
378650|NCT01522209|Primovist MRI|primovist mri
378651|NCT01522209|CEIOUS|ceious
378652|NCT01522196|SCD|scd
378653|NCT01522183|Atypical Hemolytic-Uremic Syndrome|atypical hemolytic-uremic syndrome
378654|NCT01522183|aHUS|ahus
378655|NCT01522183|Thrombotic Microangiopathy|thrombotic microangiopathy
378656|NCT01522183|TMA|tma
378657|NCT01522170|Atypical Hemolytic Uremic Syndrome|atypical hemolytic uremic syndrome
378658|NCT01522170|aHUS|ahus
378659|NCT01522170|Eculizumab|eculizumab
378660|NCT01522157|Diet|diet
378661|NCT01522157|Low-carbohydrate|low-carbohydrate
378662|NCT01522157|Postprandial|postprandial
378663|NCT01522157|Type 2 diabetes mellitus|type 2 diabetes mellitus
378664|NCT01522131|bioresorbable membrane|bioresorbable membrane
378665|NCT01522118|Prostate Cancer|prostate cancer
378666|NCT01522118|High Intensity Focused Ultrasound|high intensity focused ultrasound
378667|NCT01522118|Magnetic Resonance guided Focused Ultrasound|magnetic resonance guided focused ultrasound
378668|NCT01522118|Non-invasive therapy|non-invasive therapy
378669|NCT01522118|Focal Disease|focal disease
378670|NCT01522105|Meningitis|meningitis
378671|NCT01522105|Central Nervous System Infections|central nervous system infections
378672|NCT01522105|Pediatrics|pediatrics
378673|NCT01522105|Daptomycin|daptomycin
378674|NCT01522105|Anti-Bacterial Agents|anti-bacterial agents
378675|NCT01522105|Therapeutic Use|therapeutic use
378676|NCT01522105|Pharmacologic Actions|pharmacologic actions
378677|NCT01522092|Exacerbations|exacerbations
378678|NCT01522079|spinal muscular atrophy|spinal muscular atrophy
378679|NCT01522079|heart rate variability|heart rate variability
378680|NCT01522079|posture|posture
378681|NCT01522079|air stacking|air stacking
378682|NCT01522040|Asthma|asthma
378683|NCT01522040|Magnesium|magnesium
378684|NCT01522040|Adrenergic Receptor|adrenergic receptor
378685|NCT01522014|Joint Replacement|joint replacement
378686|NCT01522014|Health Related Quality of Life|health related quality of life
378687|NCT01522014|Functional Outcomes|functional outcomes
378688|NCT01522014|Revision Rate|revision rate
378689|NCT01522001|Acute Coronary Syndrome|acute coronary syndrome
378690|NCT01522001|Myocardial Ischemia|myocardial ischemia
378691|NCT01522001|Shared Care|shared care
378692|NCT01522001|Rehabilitation|rehabilitation
378693|NCT01522001|Community|community
378694|NCT01522001|Cardiac Rehabilitation|cardiac rehabilitation
378695|NCT01522001|Hospital|hospital
378696|NCT01521988|Atrial flutter|atrial flutter
378697|NCT01521988|Atrial fibrillation|atrial fibrillation
378698|NCT01521988|Catheter ablation|catheter ablation
378699|NCT01521975|HBV DNA|hbv dna
378700|NCT01521975|LdT|ldt
378701|NCT01521975|ADV|adv
378702|NCT01521975|HBeAg negative hepatitis|hbeag negative hepatitis
378703|NCT01521975|CHB|chb
378704|NCT01521949|Prostate Cancer|prostate cancer
378705|NCT01521949|Nutraceutical|nutraceutical
378706|NCT01521949|Acai Juice|acai juice
378707|NCT01521923|Certolizumab Pegol - Cimzia|certolizumab pegol - cimzia
378708|NCT01521923|Rheumatoid Arthritis|rheumatoid arthritis
378709|NCT01521910|survival|survival
378710|NCT01521910|protein restriction|protein restriction
378711|NCT01521910|diabetic nephropathy|diabetic nephropathy
378712|NCT01521910|type 1 diabetes|type 1 diabetes
378713|NCT01521910|GFR|gfr
378714|NCT01521910|ESRD|esrd
378715|NCT01521910|progressive renal disease|progressive renal disease
378716|NCT01521897|Pneumococcal Vaccine|pneumococcal vaccine
378717|NCT01521897|Prevenar|prevenar
378718|NCT01521897|7-valent|7-valent
378719|NCT01521897|Special Use-result surveillance|special use-result surveillance
378720|NCT01521871|Tissue glue|tissue glue
378721|NCT01521871|Cyanoacrylate|cyanoacrylate
378722|NCT01521871|Wound closure|wound closure
378723|NCT01521871|Living donor nephrectomy|living donor nephrectomy
378724|NCT01521871|Surgical wound closure|surgical wound closure
378725|NCT01521845|elective percutaneous coronary intervention|elective percutaneous coronary intervention
378726|NCT01521845|hs-CRP|hs-crp
378727|NCT01521845|CKMB and troponin I|ckmb and troponin i
378728|NCT01521819|AMD|amd
378729|NCT01521819|V-Ped|v-ped
378730|NCT01521819|Vascularized Pigment Epithelial Detachment|vascularized pigment epithelial detachment
378731|NCT01521819|Iray|iray
378732|NCT01521819|radiation|radiation
378733|NCT01521819|retina|retina
378734|NCT01521819|macula|macula
378735|NCT01521819|radiotherapy|radiotherapy
378736|NCT01521806|insulin sensitivity|insulin sensitivity
378737|NCT01521806|resistant starch|resistant starch
378738|NCT01521780|hepatocellular carcinoma|hepatocellular carcinoma
378739|NCT01521780|MRI|mri
378740|NCT01521780|pharmacogenomics|pharmacogenomics
378741|NCT01521780|beta-catenin|beta-catenin
378742|NCT01521767|pharmacokinetics|pharmacokinetics
378743|NCT01521767|relative bioavailability|relative bioavailability
378744|NCT01521767|tolterodine microspheres in powder blend|tolterodine microspheres in powder blend
378745|NCT01521767|Overactive Urinary Bladder|overactive urinary bladder
378746|NCT01521741|Breast Cancer|breast cancer
378747|NCT01521741|Lymphedema|lymphedema
378748|NCT01521741|symptoms|symptoms
378749|NCT01521728|ALS|als
378750|NCT01521728|Exercise|exercise
378751|NCT01521728|Resistance|resistance
378752|NCT01521728|Endurance|endurance
378753|NCT01521702|adenocarcinoma|adenocarcinoma
378754|NCT01521702|pancreatic head|pancreatic head
378755|NCT01521689|MRD negative CR|mrd negative cr
378756|NCT01521676|breast cancer|breast cancer
378757|NCT01521663|Moderate to severe idiopathic RLS|moderate to severe idiopathic rls
378758|NCT01521650|Probiotics|probiotics
378759|NCT01521650|Anaesthesia|anaesthesia
378760|NCT01521650|Intubation|intubation
378761|NCT01521650|Pathogenic bacteria|pathogenic bacteria
378762|NCT01521611|Radioimmunotherapy|radioimmunotherapy
378763|NCT01521611|Transplant|transplant
378764|NCT01521611|BMT|bmt
378765|NCT01521611|yttrium|yttrium
378766|NCT01521611|indium|indium
378767|NCT01521598|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
378768|NCT01521572|chronic obstructive pulmonary disease,|chronic obstructive pulmonary disease,
378769|NCT01521572|bronchial reversibility,|bronchial reversibility,
378770|NCT01521572|bronchodilator,|bronchodilator,
378771|NCT01521572|respiratory impedance,|respiratory impedance,
378772|NCT01521572|forced oscillation technique,|forced oscillation technique,
378773|NCT01521572|plethysmography,|plethysmography,
378774|NCT01521572|spirometry|spirometry
378775|NCT01521572|Diagnostic Techniques, Respiratory System|diagnostic techniques, respiratory system
378776|NCT01521546|Duchenne muscular dystrophy|duchenne muscular dystrophy
378777|NCT01521546|cardiomyopathy|cardiomyopathy
378778|NCT01521546|aldosterone antagonist|aldosterone antagonist
378779|NCT01521533|Relapsed Multiple Myeloma|relapsed multiple myeloma
378780|NCT01521533|NOX-A12|nox-a12
378781|NCT01521533|Velcade|velcade
378782|NCT01521533|Dexamethasone|dexamethasone
378783|NCT01521533|Spiegelmer|spiegelmer
378784|NCT01521533|Chemosensitization|chemosensitization
378885|NCT01521117|balance|balance
378785|NCT01521533|Stromal cell-derived factor-1 (SDF-1)|stromal cell-derived factor-1 (sdf-1)
378786|NCT01521533|CXCL12|cxcl12
378787|NCT01521520|type 1 diabetes|type 1 diabetes
378788|NCT01521520|magnetic resonance imaging|magnetic resonance imaging
378789|NCT01521520|insulitis|insulitis
378790|NCT01521520|ferumoxytol|ferumoxytol
378791|NCT01521494|Hemodialysis|hemodialysis
378792|NCT01521494|Hyperphosphatemia|hyperphosphatemia
378793|NCT01521468|Coronary artery disease|coronary artery disease
378794|NCT01521468|Diagnostic accuracy|diagnostic accuracy
378795|NCT01521468|CT coronary angiography|ct coronary angiography
378796|NCT01521468|Positron emission tomography|positron emission tomography
378797|NCT01521468|Single photon emission tomography|single photon emission tomography
378798|NCT01521468|Noninvasive techniques|noninvasive techniques
378799|NCT01521468|Cardiac catheterization|cardiac catheterization
378800|NCT01521468|Fractional flow reserve|fractional flow reserve
378801|NCT01521442|PTSD|ptsd
378802|NCT01521442|Yoga|yoga
378803|NCT01521442|Complementary and Alternative Medicine (CAM)|complementary and alternative medicine (cam)
378804|NCT01521416|Illness|illness
378805|NCT01521416|Influenza|influenza
378806|NCT01521416|Cost|cost
378807|NCT01521416|UK|uk
378808|NCT01521403|Blastocystis hominis|blastocystis hominis
378809|NCT01521403|Metronidazole|metronidazole
378810|NCT01521377|LAMA|lama
378811|NCT01521377|Respiratory|respiratory
378812|NCT01521377|COPD|copd
378813|NCT01521377|Tolerability|tolerability
378814|NCT01521377|Beta-2 Agonist|beta-2 agonist
378815|NCT01521377|Safety|safety
378816|NCT01521377|Pharmacokinetics|pharmacokinetics
378817|NCT01521377|Pharmacodynamics|pharmacodynamics
378818|NCT01521377|LABA|laba
378819|NCT01521377|Muscarinic Receptor Agonist|muscarinic receptor agonist
378820|NCT01521377|Healthy subjects|healthy subjects
378821|NCT01521377|Moxifloxacin|moxifloxacin
378822|NCT01521377|Anticholinergic|anticholinergic
378823|NCT01521377|GW642444|gw642444
378824|NCT01521377|GSK573719|gsk573719
378825|NCT01521377|QTc|qtc
378826|NCT01521364|pharmacokinetic|pharmacokinetic
378827|NCT01521364|drug-interaction|drug-interaction
378828|NCT01521364|linezolid|linezolid
378829|NCT01521364|clarithromycin|clarithromycin
378830|NCT01521364|Mycobacterium tuberculosis|mycobacterium tuberculosis
378831|NCT01521351|microwave radiometry|microwave radiometry
378832|NCT01521351|cardiovascular events|cardiovascular events
378833|NCT01521351|carotid artery disease|carotid artery disease
378834|NCT01521351|stroke|stroke
378835|NCT01521351|myocardial infarction|myocardial infarction
378836|NCT01521338|Cystic Fibrosis|cystic fibrosis
378837|NCT01521338|G551D|g551d
378838|NCT01521338|G551D Mutation|g551d mutation
378839|NCT01521312|Impaired glucose tolerance|impaired glucose tolerance
378840|NCT01521312|Saxagliptin|saxagliptin
378841|NCT01521312|Cardiovascular risk integrators|cardiovascular risk integrators
378842|NCT01521312|Vago-sympathetic activity|vago-sympathetic activity
378843|NCT01521312|Arterial stiffness|arterial stiffness
378844|NCT01521312|Endothelial function|endothelial function
378845|NCT01521299|hydroxyurea|hydroxyurea
378846|NCT01521299|S phase|s phase
378847|NCT01521299|G2 phase|g2 phase
378848|NCT01521299|pharmacokinetics|pharmacokinetics
378849|NCT01521286|Spain|spain
378850|NCT01521286|cost|cost
378851|NCT01521286|complications|complications
378852|NCT01521286|incidence|incidence
378853|NCT01521286|adults|adults
378854|NCT01521286|quality of life|quality of life
378855|NCT01521286|Herpes Zoster|herpes zoster
378856|NCT01521286|Surveillance|surveillance
378857|NCT01521273|beans|beans
378858|NCT01521273|biofortification|biofortification
378859|NCT01521273|phytic acid|phytic acid
378860|NCT01521273|iron|iron
378861|NCT01521273|iron isotopes|iron isotopes
378862|NCT01521273|different phytic acid concentrations|different phytic acid concentrations
378863|NCT01521260|dental implants|dental implants
378864|NCT01521260|microbiology|microbiology
378865|NCT01521260|chlorhexidine|chlorhexidine
378866|NCT01521247|Asthma|asthma
378867|NCT01521247|Transition program|transition program
378868|NCT01521247|Pediatric|pediatric
378869|NCT01521247|Adult|adult
378870|NCT01521208|Out-of-Hospital cardiac arrest (OHCA)|out-of-hospital cardiac arrest (ohca)
378871|NCT01521208|Chest compressions|chest compressions
378872|NCT01521208|LUCAS device|lucas device
378873|NCT01521195|pediatric|pediatric
378874|NCT01521195|ECMO|ecmo
378875|NCT01521195|extracorporeal blood flow|extracorporeal blood flow
378876|NCT01521195|VO2|vo2
378877|NCT01521182|Probiotic - dairy product - influenza vaccination - healthy elderly|probiotic - dairy product - influenza vaccination - healthy elderly
378878|NCT01521169|Plant sterol - Hypercholesterolemia - Diet - Dairy|plant sterol - hypercholesterolemia - diet - dairy
378879|NCT01521156|Plant sterols - Hypercholesterolemia - Diet - Dairy|plant sterols - hypercholesterolemia - diet - dairy
378880|NCT01521143|EOC|eoc
378881|NCT01521130|Benign Childhood Epilepsy With Centrotemporal Spikes|benign childhood epilepsy with centrotemporal spikes
378882|NCT01521130|Benign Rolandic Epilepsy|benign rolandic epilepsy
378883|NCT01521117|donepezil|donepezil
378884|NCT01521117|parkinson's disease|parkinson's disease
378886|NCT01521117|cholinesterase inhibitor|cholinesterase inhibitor
378887|NCT01521104|narrow band imaging（NBI）|narrow band imaging（nbi）
378888|NCT01521104|colorectal lesions|colorectal lesions
378889|NCT01521104|predicting histology|predicting histology
378890|NCT01521091|narrow band imaging（NBI）|narrow band imaging（nbi）
378891|NCT01521091|indigo carmine|indigo carmine
378892|NCT01521091|acetic acid|acetic acid
378893|NCT01521091|colorectal lesions|colorectal lesions
378894|NCT01521091|predicting histology|predicting histology
378895|NCT01521065|AMD|amd
378896|NCT01521065|Wet AMD|wet amd
378897|NCT01521039|aGVHD|agvhd
378898|NCT01521039|Acute Graft-versus-Host Disease|acute graft-versus-host disease
378899|NCT01521039|allogeneic stem cell transplantation|allogeneic stem cell transplantation
378900|NCT01521039|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
378901|NCT01521039|MicroRNA Expression|microrna expression
378902|NCT01521000|Breast Cancer|breast cancer
378903|NCT01521000|Lymphedema|lymphedema
378904|NCT01521000|Sentinel Node Biopsy|sentinel node biopsy
378905|NCT01521000|Axillary Dissection|axillary dissection
378906|NCT01520987|Parkinson Disease|parkinson disease
378907|NCT01520987|BIA 9-1067|bia 9-1067
378908|NCT01520961|Partial Hip Arthroplasty|partial hip arthroplasty
378909|NCT01520948|Parkinson disease|parkinson disease
378910|NCT01520948|Incontinence|incontinence
378911|NCT01520935|Office of National Statistics|office of national statistics
378912|NCT01520935|Burden of Disease|burden of disease
378913|NCT01520935|Influenza|influenza
378914|NCT01520935|Hospital Episode Statistics|hospital episode statistics
378915|NCT01520935|General Practitioners Research Database|general practitioners research database
378916|NCT01520922|Relapsed or Refractory Chronic Lymphocytic Leukemia|relapsed or refractory chronic lymphocytic leukemia
378917|NCT01520922|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
378918|NCT01520922|CLL|cll
378919|NCT01520922|Cancer|cancer
378920|NCT01520922|Lymphoid leukemia|lymphoid leukemia
378921|NCT01520922|Lymphoblastic leukemia|lymphoblastic leukemia
378922|NCT01520909|immune thrombocytopenic purpura|immune thrombocytopenic purpura
378923|NCT01520909|pediatrics|pediatrics
378924|NCT01520909|chronic ITP|chronic itp
378925|NCT01520909|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
378926|NCT01520909|eltrombopag|eltrombopag
378927|NCT01520909|Chronic Immune Thrombocytopenia|chronic immune thrombocytopenia
378928|NCT01520909|platelet disorder|platelet disorder
378929|NCT01520909|thrombocytopenia|thrombocytopenia
378930|NCT01520896|Phase 1|phase 1
378931|NCT01520896|Healthy male and female volunteers|healthy male and female volunteers
378932|NCT01520896|Drug-drug interaction|drug-drug interaction
378933|NCT01520896|Pharmacokinetics|pharmacokinetics
378934|NCT01520896|NKTR-118|nktr-118
378935|NCT01520870|Dacomitinib|dacomitinib
378936|NCT01520870|PF-299804|pf-299804
378937|NCT01520870|Glioblastoma, Recurrent|glioblastoma, recurrent
378938|NCT01520870|EGFR|egfr
378939|NCT01520857|Laparoscopic inguinal hernia repair|laparoscopic inguinal hernia repair
378940|NCT01520857|TAPP|tapp
378941|NCT01520857|Spinal Anesthesia|spinal anesthesia
378942|NCT01520857|General Anesthesia|general anesthesia
378943|NCT01520805|acute myeloid leukemia|acute myeloid leukemia
378944|NCT01520805|myelodysplastic syndrome|myelodysplastic syndrome
378945|NCT01520805|refractory|refractory
378946|NCT01520805|relapsed|relapsed
378947|NCT01520805|hypomethylating agents|hypomethylating agents
378948|NCT01520792|pharmacogenetic of paracetamol|pharmacogenetic of paracetamol
378949|NCT01520792|Pain threshold|pain threshold
378950|NCT01520779|Hepatocellular cacinoma|hepatocellular cacinoma
378951|NCT01520779|Radiofrequancy ablation|radiofrequancy ablation
378952|NCT01520779|Intrahepatic recurrence|intrahepatic recurrence
378953|NCT01520766|glass fiber posts|glass fiber posts
378954|NCT01520766|titanium posts|titanium posts
378955|NCT01520766|postendodontic restoration|postendodontic restoration
378956|NCT01520766|self-adhesive resin cement|self-adhesive resin cement
378957|NCT01520740|Gold Stage III|gold stage iii
378958|NCT01520740|Gold Stage IV|gold stage iv
378959|NCT01520740|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
378960|NCT01520740|COPD|copd
378961|NCT01520740|Lung Volume Reduction Surgery|lung volume reduction surgery
378962|NCT01520740|LVRS|lvrs
378963|NCT01520740|Bronchoscopic Lung Volume Reduction|bronchoscopic lung volume reduction
378964|NCT01520740|BLVR|blvr
378965|NCT01520740|Upper Lobe Predominant|upper lobe predominant
378966|NCT01520740|ULP|ulp
378967|NCT01520740|Heterogeneous|heterogeneous
378968|NCT01520740|Homogeneous|homogeneous
378969|NCT01520727|BIA 9-1067|bia 9-1067
378970|NCT01520714|Congestive Heart Failure (CHF)|congestive heart failure (chf)
378971|NCT01520714|Cardiac Resynchronization Therapy (CRT)|cardiac resynchronization therapy (crt)
378972|NCT01520714|BiVentricular Implantable Cardioverter Defibrillator (BiVICD)|biventricular implantable cardioverter defibrillator (bivicd)
378973|NCT01520714|Fraction|fraction
378974|NCT01520701|head and neck cancer|head and neck cancer
378975|NCT01520701|Hydrotac®|hydrotac®
378976|NCT01520701|radiodermatitis|radiodermatitis
378977|NCT01520701|algia|algia
378978|NCT01520701|radiotherapy|radiotherapy
379073|NCT01520311|Myocardial Ischemia|myocardial ischemia
378979|NCT01520688|Mild persistent or mild intermittent asthma|mild persistent or mild intermittent asthma
378980|NCT01520675|chronic pancreatitis|chronic pancreatitis
378981|NCT01520675|randomized controlled trial|randomized controlled trial
378982|NCT01520675|endoscopic therapy|endoscopic therapy
378983|NCT01520675|surgery|surgery
378984|NCT01520675|ESWL|eswl
378985|NCT01520662|patient-centered care|patient-centered care
378986|NCT01520662|wellness|wellness
378987|NCT01520662|preventive services|preventive services
378988|NCT01520662|primary care|primary care
378989|NCT01520662|To accomplish Aim 2, we will conduct a nine-month pre-post|to accomplish aim 2, we will conduct a nine-month pre-post
378990|NCT01520662|randomized controlled trial (RCT) in four primary care|randomized controlled trial (rct) in four primary care
378991|NCT01520662|practices. The study will focus on the impact of a patient|practices. the study will focus on the impact of a patient
378992|NCT01520662|Wellness Portal on the quantity and quality of preventive|wellness portal on the quantity and quality of preventive
378993|NCT01520662|care patients receive in primary care practices.|care patients receive in primary care practices.
378994|NCT01520649|Neurogenesis|neurogenesis
378995|NCT01520649|hippocampal stem cells|hippocampal stem cells
378996|NCT01520649|depression|depression
378997|NCT01520649|stroke|stroke
378998|NCT01520636|stroke|stroke
378999|NCT01520636|early rehabilitation|early rehabilitation
379000|NCT01520636|motor recovery|motor recovery
379001|NCT01520636|functional recovery|functional recovery
379002|NCT01520623|Allogeneic haematopoietic stem cell transplantation (HSCT)|allogeneic haematopoietic stem cell transplantation (hsct)
379003|NCT01520623|Myeloablative conditioning for an haematological malignancy|myeloablative conditioning for an haematological malignancy
379004|NCT01520623|Graft-versus-host disease (GvHD)|graft-versus-host disease (gvhd)
379005|NCT01520623|Activation of complement system|activation of complement system
379006|NCT01520623|Gut GVHD|gut gvhd
379007|NCT01520610|Tako-TSUBO Cardiomyopathy|tako-tsubo cardiomyopathy
379008|NCT01520610|Stress Cardiomyopathy|stress cardiomyopathy
379009|NCT01520610|Myocardiopathies|myocardiopathies
379010|NCT01520610|Acute Coronary Syndrome|acute coronary syndrome
379011|NCT01520610|Gene|gene
379012|NCT01520597|Multicentric|multicentric
379013|NCT01520597|National|national
379014|NCT01520597|Prospective on|prospective on
379015|NCT01520597|Listeriosis|listeriosis
379016|NCT01520597|Listeria|listeria
379017|NCT01520571|Computer Assistance|computer assistance
379018|NCT01520571|Total Knee Arthroplasty|total knee arthroplasty
379019|NCT01520571|conventional|conventional
379020|NCT01520558|Acute Myeloid Leukemia|acute myeloid leukemia
379021|NCT01520558|High Risk Relapse|high risk relapse
379022|NCT01520558|Complete Remission|complete remission
379023|NCT01520558|Allogeneic Natural Killer Cells|allogeneic natural killer cells
379024|NCT01520545|Gablofen|gablofen
379025|NCT01520545|baclofen injection|baclofen injection
379026|NCT01520519|Leukemia|leukemia
379027|NCT01520519|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
379028|NCT01520519|CLL|cll
379029|NCT01520519|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
379030|NCT01520519|SLL|sll
379031|NCT01520519|Rituximab|rituximab
379032|NCT01520519|Rituxan|rituxan
379033|NCT01520519|PCI-32765|pci-32765
379034|NCT01520506|Hypertension|hypertension
379035|NCT01520506|Kidney Diseases|kidney diseases
379036|NCT01520506|Kidney Failure, Chronic|kidney failure, chronic
379037|NCT01520506|Vascular Diseases|vascular diseases
379038|NCT01520506|Cardiovascular Diseases|cardiovascular diseases
379039|NCT01520506|Urologic Diseases|urologic diseases
379040|NCT01520506|Renal Insufficiency, Chronic|renal insufficiency, chronic
379041|NCT01520506|Renal Insufficiency|renal insufficiency
379042|NCT01520493|pulmonary arterial hypertension|pulmonary arterial hypertension
379043|NCT01520493|skeletal muscle microcirculation|skeletal muscle microcirculation
379044|NCT01520493|exercise induced blood flow|exercise induced blood flow
379045|NCT01520480|survival after surgery|survival after surgery
379046|NCT01520480|Pathological Subtrochanteric Fractures|pathological subtrochanteric fractures
379047|NCT01520467|SRS|srs
379048|NCT01520467|PWS|pws
379049|NCT01520467|pathological adrenarche|pathological adrenarche
379050|NCT01520467|aromatase inhibitor|aromatase inhibitor
379051|NCT01520467|Children|children
379052|NCT01520454|Leptin resistance|leptin resistance
379053|NCT01520454|Free fatty acids|free fatty acids
379054|NCT01520454|Lipotoxicity|lipotoxicity
379055|NCT01520441|Botulinum Toxin|botulinum toxin
379056|NCT01520441|Prostate Cancer|prostate cancer
379057|NCT01520441|BPH|bph
379058|NCT01520441|LUTS|luts
379059|NCT01520402|Genetic Determinants of Warfarin Dose Variability|genetic determinants of warfarin dose variability
379060|NCT01520389|cancer|cancer
379061|NCT01520389|solid tumors|solid tumors
379062|NCT01520389|oncology|oncology
379063|NCT01520389|Phase I|phase i
379064|NCT01520389|EGFR|egfr
379065|NCT01520389|EGF receptor (ErbB1)|egf receptor (erbb1)
379066|NCT01520389|irinotecan|irinotecan
379067|NCT01520363|Rett syndrome|rett syndrome
379068|NCT01520363|RTT|rtt
379069|NCT01520363|MECP2|mecp2
379070|NCT01520363|dextromethorphan|dextromethorphan
379071|NCT01520363|DM|dm
379072|NCT01520311|Coronary Artery Disease|coronary artery disease
379074|NCT01520311|Coronary Disease|coronary disease
379075|NCT01520311|Heart Diseases|heart diseases
379076|NCT01520311|Cardiovascular Diseases|cardiovascular diseases
379077|NCT01520311|Arteriosclerosis|arteriosclerosis
379078|NCT01520311|Arterial Occlusive Diseases|arterial occlusive diseases
379079|NCT01520311|Vascular Diseases|vascular diseases
379080|NCT01520311|CABG|cabg
379081|NCT01520311|SVG|svg
379082|NCT01520311|eSVS Mesh|esvs mesh
379083|NCT01520311|Bypass Grafting|bypass grafting
379084|NCT01520285|hypertension|hypertension
379085|NCT01520285|Blood pressure decrease|blood pressure decrease
379086|NCT01520285|efficacy|efficacy
379087|NCT01520272|HPV18 Immunogenicity|hpv18 immunogenicity
379088|NCT01520272|HPV16 Immunogenicity|hpv16 immunogenicity
379089|NCT01520272|Bivalent HPV16/18 Vaccine|bivalent hpv16/18 vaccine
379090|NCT01520272|Less than 3 Dosed of the Bivalent HPV Vaccine|less than 3 dosed of the bivalent hpv vaccine
379091|NCT01520272|HP Vaccine|hp vaccine
379092|NCT01520259|Gallbaldder|gallbaldder
379093|NCT01520259|Gallstones|gallstones
379094|NCT01520259|Inflammation|inflammation
379095|NCT01520259|Cholecystectomy|cholecystectomy
379096|NCT01520259|Cancer|cancer
379097|NCT01520259|Gallbaldder Cancer|gallbaldder cancer
379098|NCT01520246|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
379099|NCT01520246|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
379100|NCT01520246|adult T-cell leukemia/lymphoma|adult t-cell leukemia/lymphoma
379101|NCT01520233|disseminated neuroblastoma|disseminated neuroblastoma
379102|NCT01520233|localized unresectable neuroblastoma|localized unresectable neuroblastoma
379103|NCT01520233|recurrent neuroblastoma|recurrent neuroblastoma
379104|NCT01520233|regional neuroblastoma|regional neuroblastoma
379105|NCT01520233|stage 4S neuroblastoma|stage 4s neuroblastoma
379106|NCT01520194|genital warts|genital warts
379107|NCT01520194|HPV|hpv
379108|NCT01520194|psychosocial burden|psychosocial burden
379109|NCT01520194|economic burden|economic burden
379110|NCT01520194|female genital warts|female genital warts
379111|NCT01520168|Incisional hernia|incisional hernia
379112|NCT01520168|Mesh|mesh
379113|NCT01520168|Surgery|surgery
379114|NCT01520168|Composix Kugel|composix kugel
379115|NCT01520168|IPOM technique|ipom technique
379116|NCT01520155|lupus erythematosus|lupus erythematosus
379117|NCT01520155|cardiovascular risk|cardiovascular risk
379118|NCT01520142|Healthy participants|healthy participants
379119|NCT01520142|Pharmacodynamic|pharmacodynamic
379120|NCT01520142|Pharmacokinetics|pharmacokinetics
379121|NCT01520142|Intravenous Endotoxin-Induced Model|intravenous endotoxin-induced model
379122|NCT01520142|Acute Inflammation|acute inflammation
379123|NCT01520142|JNJ-26528398|jnj-26528398
379124|NCT01520142|Anti-inflammatory|anti-inflammatory
379125|NCT01520129|Bipolar Disorder|bipolar disorder
379126|NCT01520129|Bipolar NOS|bipolar nos
379127|NCT01520129|Bipolar Depression|bipolar depression
379128|NCT01520103|Metastatic breast cancer|metastatic breast cancer
379129|NCT01520103|locally advanced breast cancer|locally advanced breast cancer
379130|NCT01520103|Her2/new negative|her2/new negative
379131|NCT01520103|HER2 negative|her2 negative
379132|NCT01520090|contraception|contraception
379133|NCT01520090|family planning|family planning
379134|NCT01520090|egyptian|egyptian
379135|NCT01520090|knowledge|knowledge
379136|NCT01520077|alopecia areata|alopecia areata
379137|NCT01520077|vytorin|vytorin
379138|NCT01520077|statin|statin
379139|NCT01520077|hair growth|hair growth
379140|NCT01520064|Emphysema|emphysema
379141|NCT01520064|GOLD Stage III|gold stage iii
379142|NCT01520064|GOLD Stage IV|gold stage iv
379143|NCT01520064|AeriSeal System|aeriseal system
379144|NCT01520064|Homogeneous|homogeneous
379145|NCT01520064|Heterogeneous|heterogeneous
379146|NCT01520064|Upper Lobe Predominant|upper lobe predominant
379147|NCT01520064|ULP|ulp
379148|NCT01520064|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
379149|NCT01520064|COPD|copd
379150|NCT01520064|Lung Volume Reduction Surgery|lung volume reduction surgery
379151|NCT01520064|LVRS|lvrs
379152|NCT01520064|Bronchoscopic Lung Volume Reduction|bronchoscopic lung volume reduction
379153|NCT01520064|BLVR|blvr
379154|NCT01520051|Asthma|asthma
379155|NCT01520051|Viral|viral
379156|NCT01520051|Infection|infection
379157|NCT01520051|Inflammation|inflammation
379158|NCT01520051|Mepolizumab|mepolizumab
379159|NCT01520051|Eosinophilia|eosinophilia
379160|NCT01520025|Radiopharmaceutical|radiopharmaceutical
379161|NCT01520025|18FDG PET|18fdg pet
379162|NCT01520025|CTA|cta
379163|NCT01520025|Multi-modality imaging|multi-modality imaging
379164|NCT01520025|Metabolic Imaging of Ischemia|metabolic imaging of ischemia
379165|NCT01520025|Myocardial blood flow|myocardial blood flow
379166|NCT01520025|Myocardial blood flow reserve|myocardial blood flow reserve
379167|NCT01519999|Shared decision making|shared decision making
379168|NCT01519999|Ambulatory Care|ambulatory care
379169|NCT01519999|Patient-Centered Care|patient-centered care
379170|NCT01519999|Community-wide intervention|community-wide intervention
379171|NCT01519999|Intervention Study|intervention study
379172|NCT01519999|Longitudinal Studies|longitudinal studies
379173|NCT01519986|Vitamin D|vitamin d
379174|NCT01519986|Cholecalciferol|cholecalciferol
379175|NCT01519986|Supplementation|supplementation
379176|NCT01519986|Dietary Supplements|dietary supplements
379177|NCT01519986|Dietary Fats|dietary fats
379178|NCT01519986|25-hydroxyvitamin D|25-hydroxyvitamin d
379179|NCT01519973|Diagnostic imaging|diagnostic imaging
379180|NCT01519973|Single Photon Emission Computed Tomography|single photon emission computed tomography
379181|NCT01519973|Positron emission tomography|positron emission tomography
379182|NCT01519973|Computed tomography|computed tomography
379183|NCT01519973|Attenuation|attenuation
379184|NCT01519973|Resolution|resolution
379185|NCT01519973|Scatter|scatter
379186|NCT01519973|Radiopharmaceutical|radiopharmaceutical
379187|NCT01519934|Ulthera® System|ulthera® system
379188|NCT01519934|Ultherapy™ Treatment|ultherapy™ treatment
379189|NCT01519934|Ulthera, Inc.|ulthera, inc.
379190|NCT01519934|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
379191|NCT01519908|cardiac resynchronization therapy|cardiac resynchronization therapy
379192|NCT01519908|biomarkers|biomarkers
379193|NCT01519908|response|response
379194|NCT01519895|quality of life|quality of life
379195|NCT01519895|anxiety|anxiety
379196|NCT01519895|stress|stress
379197|NCT01519895|carers|carers
379198|NCT01519895|colorectal or colon cancer|colorectal or colon cancer
379199|NCT01519882|Rotigotine|rotigotine
379200|NCT01519882|Neupro|neupro
379201|NCT01519882|Polysomnography|polysomnography
379202|NCT01519882|Sleep efficiency|sleep efficiency
379203|NCT01519882|Advanced Idiopathic Parkinson's Disease|advanced idiopathic parkinson's disease
379204|NCT01519882|Sleep Disorder|sleep disorder
379205|NCT01519869|peritoneal|peritoneal
379206|NCT01519869|carcinoma|carcinoma
379207|NCT01519869|ovarian|ovarian
379208|NCT01519869|fallopian tube|fallopian tube
379209|NCT01519869|neoadjuvant chemotherapy|neoadjuvant chemotherapy
379210|NCT01519869|surgical debulking|surgical debulking
379211|NCT01519856|open|open
379212|NCT01519856|non-intervention|non-intervention
379213|NCT01519856|observational|observational
379214|NCT01519843|stroke|stroke
379215|NCT01519830|Anemia, Iron-Deficiency|anemia, iron-deficiency
379216|NCT01519830|Blood Donors|blood donors
379217|NCT01519817|Vaccine Therapy|vaccine therapy
379218|NCT01519817|Dose-Limiting Toxicity|dose-limiting toxicity
379219|NCT01519817|Maximum Tolerated Dose|maximum tolerated dose
379220|NCT01519817|Clinical Response|clinical response
379221|NCT01519817|Immune Response|immune response
379222|NCT01519817|Cancer|cancer
379223|NCT01519817|Solid Tumor|solid tumor
379224|NCT01519791|Certolizumab Pegol - Cimzia|certolizumab pegol - cimzia
379225|NCT01519791|Methotrexate|methotrexate
379226|NCT01519791|Rheumatoid Arthritis|rheumatoid arthritis
379227|NCT01519752|Tinea Pedis|tinea pedis
379228|NCT01519713|Meningitis|meningitis
379229|NCT01519713|Meningococcal Meningitis|meningococcal meningitis
379230|NCT01519713|Meningococcal Infections|meningococcal infections
379231|NCT01519713|Meningococcal conjugate Vaccine|meningococcal conjugate vaccine
379232|NCT01519713|Menactra®|menactra®
379233|NCT01519700|Filgrastim|filgrastim
379234|NCT01519700|G-CSF, neutropenia|g-csf, neutropenia
379235|NCT01519700|supportive care|supportive care
379236|NCT01519700|breast cancer|breast cancer
379237|NCT01519687|hyperuricemia|hyperuricemia
379238|NCT01519687|gout|gout
379239|NCT01519687|levotofisopam|levotofisopam
379240|NCT01519661|Tobramycin Inhalation powder|tobramycin inhalation powder
379241|NCT01519661|Cystic fibrosis|cystic fibrosis
379242|NCT01519661|Lung disease|lung disease
379243|NCT01519661|Anti-bacterial agents|anti-bacterial agents
379244|NCT01519648|Invasive fungal infection|invasive fungal infection
379245|NCT01519648|Acute leukemia (AL)|acute leukemia (al)
379246|NCT01519648|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
379247|NCT01519648|Antifungal stewardship|antifungal stewardship
379248|NCT01519648|Neutropenia|neutropenia
379249|NCT01519648|Hematological malignancies|hematological malignancies
379250|NCT01519635|Kidney oxygenation|kidney oxygenation
379251|NCT01519635|Stage 1 or 2 hypertension|stage 1 or 2 hypertension
379252|NCT01519635|BOLD-IRM|bold-irm
379253|NCT01519622|End of life decisions|end of life decisions
379254|NCT01519622|Perception of illness|perception of illness
379255|NCT01519609|Bowel prep|bowel prep
379256|NCT01519609|Safety|safety
379257|NCT01519609|Efficacy|efficacy
379258|NCT01519583|walking|walking
379259|NCT01519583|physical activity|physical activity
379260|NCT01519583|sedentary behavior|sedentary behavior
379261|NCT01519570|Herpes Zoster vaccine|herpes zoster vaccine
379262|NCT01519570|Electronic patient portal|electronic patient portal
379263|NCT01519570|Electronic medical record|electronic medical record
379264|NCT01519570|Primary care|primary care
379265|NCT01519570|Immunizations|immunizations
379266|NCT01519544|Sleep|sleep
379267|NCT01519544|High Altitude|high altitude
379268|NCT01519544|High-altitude Sleep Disturbance|high-altitude sleep disturbance
379269|NCT01519544|Acute Mountain Sickness|acute mountain sickness
379270|NCT01519544|Difficulty Sleeping at High Altitude|difficulty sleeping at high altitude
379271|NCT01519544|Periodic Breathing|periodic breathing
379272|NCT01519544|Actigraphy|actigraphy
379273|NCT01519544|Acetazolamide|acetazolamide
379274|NCT01519544|Temazepam|temazepam
379275|NCT01519544|Groningen Sleep Quality Questionnaire survey|groningen sleep quality questionnaire survey
379276|NCT01519544|Stanford Sleepiness Scale|stanford sleepiness scale
379277|NCT01519544|Lake Louise Acute Mountain Sickness Score|lake louise acute mountain sickness score
379278|NCT01519518|ST elevation myocardial infarction|st elevation myocardial infarction
379279|NCT01519518|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
379280|NCT01519518|Unfractionated heparin|unfractionated heparin
379281|NCT01519518|Bivalirudin|bivalirudin
379282|NCT01519518|primary angioplasty|primary angioplasty
379283|NCT01519505|Prevention|prevention
379284|NCT01519505|Diabetes mellitus|diabetes mellitus
379285|NCT01519505|Lifestyle changes|lifestyle changes
379286|NCT01519505|Cardiovascular risk|cardiovascular risk
379287|NCT01519505|Cost-effectiveness|cost-effectiveness
379288|NCT01519492|Skin and Subcutaneous Tissue Bacterial Infections|skin and subcutaneous tissue bacterial infections
379289|NCT01519479|Congestive Heart Failure|congestive heart failure
379290|NCT01519479|Heart Failure|heart failure
379291|NCT01519479|Palliative Care|palliative care
379292|NCT01519479|Palliative Medicine|palliative medicine
379293|NCT01519466|Diabetes|diabetes
379294|NCT01519466|SMBG|smbg
379295|NCT01519466|Insulin calculator|insulin calculator
379296|NCT01519453|Asthma|asthma
379297|NCT01519453|Preschool|preschool
379298|NCT01519453|Health Disparities|health disparities
379299|NCT01519453|Implementation|implementation
379300|NCT01519440|unintended extension|unintended extension
379301|NCT01519440|blunt|blunt
379302|NCT01519440|sharp|sharp
379303|NCT01519440|maternal blood loss|maternal blood loss
379304|NCT01519401|PCOS|pcos
379305|NCT01519401|drospirenone ethinylestradiol|drospirenone ethinylestradiol
379306|NCT01519401|androgens|androgens
379307|NCT01519401|metabolism|metabolism
379308|NCT01519388|Neuromuscular disorder|neuromuscular disorder
379309|NCT01519388|Respiratory failure|respiratory failure
379310|NCT01519388|Swallowing|swallowing
379311|NCT01519388|Mechanical ventilation|mechanical ventilation
379312|NCT01519375|Osteoarthritis|osteoarthritis
379313|NCT01519375|Rheumatoid Arthritis|rheumatoid arthritis
379314|NCT01519375|Ankylosing Spondylitis|ankylosing spondylitis
379315|NCT01519362|Polyacrylamide hydrogel|polyacrylamide hydrogel
379316|NCT01519362|leukocytopenia|leukocytopenia
379317|NCT01519362|migration|migration
379318|NCT01519362|complication|complication
379319|NCT01519362|epicranial aponeurosis|epicranial aponeurosis
379320|NCT01519362|PAAG injection|paag injection
379321|NCT01519349|Becker muscular dystrophy|becker muscular dystrophy
379322|NCT01519349|BMD|bmd
379323|NCT01519349|muscular dystrophy|muscular dystrophy
379324|NCT01519349|inclusion body myositis|inclusion body myositis
379325|NCT01519349|IBM|ibm
379326|NCT01519349|Follistatin|follistatin
379327|NCT01519310|choline metabolism|choline metabolism
379328|NCT01519310|gut flora|gut flora
379329|NCT01519310|phosphatidylcholine|phosphatidylcholine
379330|NCT01519310|lecithin|lecithin
379331|NCT01519297|Preeclampsia|preeclampsia
379332|NCT01519297|Pregnancy Induced Hypertension|pregnancy induced hypertension
379333|NCT01519284|Parkinson Disease|parkinson disease
379334|NCT01519284|BIA 9-1067|bia 9-1067
379335|NCT01519271|Parkinson's Disease|parkinson's disease
379336|NCT01519271|Mild Cognitive Impairment|mild cognitive impairment
379337|NCT01519271|Cognition|cognition
379338|NCT01519271|Memory|memory
379339|NCT01519271|Attention|attention
379340|NCT01519271|Exelon|exelon
379341|NCT01519271|Rivastigmine|rivastigmine
379342|NCT01519258|ARDS|ards
379343|NCT01519245|coronary artery bypass grafting|coronary artery bypass grafting
379344|NCT01519245|tranexamic acid|tranexamic acid
379345|NCT01519245|antifibrinolytic|antifibrinolytic
379346|NCT01519245|administration, topical|administration, topical
379347|NCT01519245|operative blood salvage|operative blood salvage
379348|NCT01519232|hepatocellular carcinoma|hepatocellular carcinoma
379349|NCT01519219|hepatic irradiation|hepatic irradiation
379350|NCT01519219|IC-GREEN|ic-green
379351|NCT01519206|Ulthera® System|ulthera® system
379352|NCT01519206|Ultherapy™ Treatment|ultherapy™ treatment
379353|NCT01519206|Ulthera, Inc.|ulthera, inc.
379354|NCT01519193|Aggressive Behavior|aggressive behavior
379355|NCT01519193|Appetitive Aggression|appetitive aggression
379356|NCT01519193|Post-Traumatic Stress Disorder|post-traumatic stress disorder
379357|NCT01519180|gastroparesis|gastroparesis
379358|NCT01519180|gastric emptying|gastric emptying
379359|NCT01519180|antro-duodenal manometry|antro-duodenal manometry
379360|NCT01519154|deep sedation|deep sedation
379361|NCT01519154|propofol|propofol
379362|NCT01519154|ketamine|ketamine
379363|NCT01519154|child|child
379364|NCT01519154|preschool child|preschool child
379365|NCT01519154|infant|infant
379366|NCT01519154|recovery and quality of sedation|recovery and quality of sedation
379367|NCT01519141|Human Immunodeficiency Virus|human immunodeficiency virus
379368|NCT01519141|Atherosclerosis|atherosclerosis
379369|NCT01519141|Inflammation|inflammation
380064|NCT01516463|Santyl|santyl
379370|NCT01519141|Endothelial Function|endothelial function
379371|NCT01519141|Thrombosis|thrombosis
379372|NCT01519128|Healthy|healthy
379373|NCT01519128|TMC278|tmc278
379374|NCT01519128|TMC278IFD1001|tmc278ifd1001
379375|NCT01519128|Human immunodeficiency virus - type 1|human immunodeficiency virus - type 1
379376|NCT01519128|Pharmacokinetics|pharmacokinetics
379377|NCT01519128|Digoxin|digoxin
379378|NCT01519115|deep cervical flexors|deep cervical flexors
379379|NCT01519115|spine stabilization|spine stabilization
379380|NCT01519115|posture|posture
379381|NCT01519115|function|function
379382|NCT01519115|neck pain|neck pain
379383|NCT01519089|chronic|chronic
379384|NCT01519089|severe|severe
379385|NCT01519089|moderate|moderate
379386|NCT01519089|treatment|treatment
379387|NCT01519089|safety|safety
379388|NCT01519089|efficacy|efficacy
379389|NCT01519089|CP-690|cp-690
379390|NCT01519089|550|550
379391|NCT01519089|Plaque psoriasis|plaque psoriasis
379392|NCT01519089|Psoriasis Vulgaris|psoriasis vulgaris
379393|NCT01519089|Psoriatic Arthritis|psoriatic arthritis
379394|NCT01519089|tofacitinib|tofacitinib
379395|NCT01519089|Xeljanz|xeljanz
379396|NCT01519076|stroke|stroke
379397|NCT01519063|Alcohol|alcohol
379398|NCT01519063|Drinking|drinking
379399|NCT01519063|Drinkers|drinkers
379400|NCT01519063|Alcohol Drinking|alcohol drinking
379401|NCT01519063|Memantine|memantine
379402|NCT01519063|Naltrexone|naltrexone
379403|NCT01519063|Alcohol Dependence|alcohol dependence
379404|NCT01519063|Alcohol Abuse|alcohol abuse
379405|NCT01519063|Alcohol-Related Disorders|alcohol-related disorders
379406|NCT01519063|Ethanol|ethanol
379407|NCT01519063|Alcoholism|alcoholism
379408|NCT01519037|calcimimetic agent|calcimimetic agent
379409|NCT01519037|RAAS|raas
379410|NCT01519037|renin|renin
379411|NCT01519037|aldosterone|aldosterone
379412|NCT01519024|hypertrophy|hypertrophy
379413|NCT01519024|breast|breast
379414|NCT01519024|postural balance|postural balance
379415|NCT01519011|Myelodysplastic Syndromes|myelodysplastic syndromes
379416|NCT01519011|MDS|mds
379417|NCT01519011|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
379418|NCT01519011|CMML|cmml
379419|NCT01519011|Acute Myeloid Leukemia|acute myeloid leukemia
379420|NCT01519011|AML|aml
379421|NCT01519011|Vidaza|vidaza
379422|NCT01519011|oral azacitidine|oral azacitidine
379423|NCT01519011|aza|aza
379424|NCT01519011|oral aza|oral aza
379425|NCT01519011|pharmacokinetics|pharmacokinetics
379426|NCT01519011|hematology|hematology
379427|NCT01519011|myeloid disease|myeloid disease
379429|NCT01518998|Fimasartan|fimasartan
379430|NCT01518998|Amlodipine|amlodipine
379431|NCT01518998|antihypertension|antihypertension
379432|NCT01518972|Alcohol|alcohol
379433|NCT01518972|Abuse|abuse
379434|NCT01518972|Use|use
379435|NCT01518972|Disorder|disorder
379436|NCT01518972|Dependence|dependence
379437|NCT01518972|Symptoms|symptoms
379438|NCT01518972|Alcoholic|alcoholic
379439|NCT01518972|Alcoholism|alcoholism
379440|NCT01518972|Prazosin|prazosin
379441|NCT01518972|Drug|drug
379442|NCT01518972|Medicine|medicine
379443|NCT01518972|Medication|medication
379444|NCT01518972|Treatment|treatment
379445|NCT01518972|Study|study
379446|NCT01518972|Placebo|placebo
379447|NCT01518972|Medical|medical
379448|NCT01518972|Management|management
379449|NCT01518972|Craving|craving
379450|NCT01518972|Consumption|consumption
379451|NCT01518972|Binge|binge
379452|NCT01518972|Drinking|drinking
379453|NCT01518972|Drink|drink
379454|NCT01518972|Heavy|heavy
379455|NCT01518972|PTSD|ptsd
379456|NCT01518972|Trauma|trauma
379457|NCT01518972|Post|post
379458|NCT01518972|Posttraumatic|posttraumatic
379459|NCT01518946|Symptomatic Orthostatic Hypotension|symptomatic orthostatic hypotension
379460|NCT01518933|HCV recurrence|hcv recurrence
379461|NCT01518933|stable liver transplanted patients|stable liver transplanted patients
379462|NCT01518920|Age related sensorineural hearing loss|age related sensorineural hearing loss
379463|NCT01518920|PF-04958242|pf-04958242
379464|NCT01518907|cellulite|cellulite
379465|NCT01518907|Xiaflex|xiaflex
379466|NCT01518894|PF-04958242|pf-04958242
379467|NCT01518894|multiple dose|multiple dose
379468|NCT01518894|Safety|safety
379469|NCT01518894|schizophrenia|schizophrenia
379470|NCT01518842|ischemic retinopathy, stem cell,bone marrow|ischemic retinopathy, stem cell,bone marrow
379471|NCT01518829|hepatocellular carcinom|hepatocellular carcinom
379472|NCT01518829|postablation syndrom|postablation syndrom
379473|NCT01518829|procalcitonin|procalcitonin
379474|NCT01518816|antioxidant preterm labor|antioxidant preterm labor
379475|NCT01518803|Obesity|obesity
379476|NCT01518803|Adolescence|adolescence
379477|NCT01518803|Lipid metabolism|lipid metabolism
379478|NCT01518803|Mediterranean diet|mediterranean diet
379479|NCT01518803|Chylomicron|chylomicron
379480|NCT01518803|Macrophages|macrophages
379481|NCT01518790|PEG 3350|peg 3350
379482|NCT01518790|boston bowel preparation scale|boston bowel preparation scale
379483|NCT01518790|colonoscopy cleanout|colonoscopy cleanout
379484|NCT01518790|bowel preparation|bowel preparation
379485|NCT01518790|miralax|miralax
379486|NCT01518790|gatorade|gatorade
379487|NCT01518790|cleanout efficacy|cleanout efficacy
379488|NCT01518790|Focus of study is efficacy of PEG 3350 cleanout for improving diagnostic yield of colonoscopy.|focus of study is efficacy of peg 3350 cleanout for improving diagnostic yield of colonoscopy.
379489|NCT01518777|Coronary Artery Disease|coronary artery disease
379490|NCT01518725|Muscle Power|muscle power
379491|NCT01518725|Vitamin D|vitamin d
379492|NCT01518725|Vitamins|vitamins
379493|NCT01518725|Cholecalciferol|cholecalciferol
379494|NCT01518712|Healthy Volunteers|healthy volunteers
379495|NCT01518712|Bioequivalence|bioequivalence
379496|NCT01518712|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
379497|NCT01518712|Metformin IR|metformin ir
379498|NCT01518686|Norm values|norm values
379499|NCT01518686|semi-automated kinetic perimetry|semi-automated kinetic perimetry
379500|NCT01518686|isopters|isopters
379501|NCT01518686|mathematical model|mathematical model
379502|NCT01518686|luminance|luminance
379503|NCT01518686|test-retest reliability|test-retest reliability
379504|NCT01518686|deviation|deviation
379505|NCT01518686|age dependance|age dependance
379506|NCT01518686|different age groups|different age groups
379507|NCT01518686|Healthy subjects|healthy subjects
379508|NCT01518660|Resistance Training|resistance training
379509|NCT01518660|Strength Training|strength training
379510|NCT01518647|Bodily Distress Syndrome|bodily distress syndrome
379511|NCT01518647|Medically unexplained symptoms|medically unexplained symptoms
379512|NCT01518647|Functional somatic symptoms|functional somatic symptoms
379513|NCT01518647|Functional somatic syndromes|functional somatic syndromes
379514|NCT01518647|Treatment|treatment
379515|NCT01518647|Acceptance and Commitment Therapy|acceptance and commitment therapy
379516|NCT01518634|Bodily Distress Syndrome|bodily distress syndrome
379517|NCT01518634|Medically unexplained symptoms|medically unexplained symptoms
379518|NCT01518634|Functional somatic symptoms|functional somatic symptoms
379519|NCT01518634|Functional somatic syndromes|functional somatic syndromes
379520|NCT01518634|Treatment|treatment
379521|NCT01518634|Imipramine|imipramine
379522|NCT01518634|Tricyclic antidepressant|tricyclic antidepressant
379523|NCT01518608|Alfentanil|alfentanil
379524|NCT01518608|Tracheal intubation|tracheal intubation
379525|NCT01518608|Rapid sequence induction|rapid sequence induction
379526|NCT01518595|patients|patients
379527|NCT01518582|Cervicobrachial|cervicobrachial
379528|NCT01518582|neuralgia|neuralgia
379529|NCT01518582|symptomatic cervical discopathy|symptomatic cervical discopathy
379530|NCT01518569|ulinastatin|ulinastatin
379531|NCT01518569|systemic inflammation|systemic inflammation
379532|NCT01518569|cardiac surgery|cardiac surgery
379533|NCT01518569|cardiopulmonary bypass|cardiopulmonary bypass
379534|NCT01518556|Idarubicin|idarubicin
379535|NCT01518556|Remission Induction|remission induction
379536|NCT01518556|Maximum Tolerated Dose|maximum tolerated dose
379537|NCT01518556|Survival|survival
379538|NCT01518543|arthrodesis|arthrodesis
379539|NCT01518543|arthrodesis in the following joints:Ankle, 1st MTP, Metatarso - Cuneiform (1st), Navicular - Cuneiform, Talo-Navicular, Calcaneum - Cuboid;|arthrodesis in the following joints:ankle, 1st mtp, metatarso - cuneiform (1st), navicular - cuneiform, talo-navicular, calcaneum - cuboid;
379540|NCT01518530|Chronic Neck Pain, Occiflex, Computerized Mobilization|chronic neck pain, occiflex, computerized mobilization
379541|NCT01518517|acute lymphoblastic leukemia|acute lymphoblastic leukemia
379542|NCT01518517|relapse|relapse
379543|NCT01518517|asparaginase|asparaginase
379544|NCT01518504|Thoracic|thoracic
379545|NCT01518504|Manipulation|manipulation
379546|NCT01518504|Manual Therapy|manual therapy
379547|NCT01518504|Mobilization|mobilization
379548|NCT01518504|Shoulder|shoulder
379549|NCT01518504|Range of Motion|range of motion
379550|NCT01518452|working memory training, computerized|working memory training, computerized
379551|NCT01518452|clinical assessment|clinical assessment
379552|NCT01518452|quantitative EEG|quantitative eeg
379553|NCT01518452|child, preschool|child, preschool
379554|NCT01518439|neuromuscular|neuromuscular
379555|NCT01518439|cough|cough
379556|NCT01518439|restrictive|restrictive
379557|NCT01518426|Brain computer interface|brain computer interface
379558|NCT01518426|EEG recording|eeg recording
379559|NCT01518426|Electrodes|electrodes
379560|NCT01518413|Sora./Irino. combination therapy|sora./irino. combination therapy
379561|NCT01518400|Pediatric Cancer|pediatric cancer
379562|NCT01518400|Cancer Late Effects|cancer late effects
379563|NCT01518400|Cancer Survivor|cancer survivor
379564|NCT01518400|Cancer Survivorship|cancer survivorship
379565|NCT01518387|Hyperphosphatemia in ESRD (End Stage Renal Disease) patients on dialysis|hyperphosphatemia in esrd (end stage renal disease) patients on dialysis
379566|NCT01518374|Male or female subjects at least 18 years of age|male or female subjects at least 18 years of age
379567|NCT01518374|AD|ad
379568|NCT01518374|MCI|mci
379569|NCT01518348|Patch Test|patch test
379570|NCT01518348|Contact Dermatitis|contact dermatitis
379571|NCT01518348|Allergy|allergy
379572|NCT01518348|Children|children
379573|NCT01518348|PREA|prea
380065|NCT01516463|Bacitracin|bacitracin
379574|NCT01518335|platelet rich plasma|platelet rich plasma
379575|NCT01518335|ankle|ankle
379576|NCT01518335|sprain|sprain
379577|NCT01518335|injection|injection
379578|NCT01518335|Platelet Rich Plasma therapy|platelet rich plasma therapy
379579|NCT01518335|focal, invasive therapy for sprains|focal, invasive therapy for sprains
379580|NCT01518322|Asthma|asthma
379581|NCT01518322|Fractional Exhaled Nitric Oxide|fractional exhaled nitric oxide
379582|NCT01518322|Respiratory Symptoms|respiratory symptoms
379583|NCT01518322|NIOX MINO|niox mino
379584|NCT01518322|Inhaled corticosteroids|inhaled corticosteroids
379585|NCT01518322|Nitric Oxide|nitric oxide
379586|NCT01518296|Pelvic Organ Prolapse Quantification (POPQ)|pelvic organ prolapse quantification (popq)
379587|NCT01518296|POPQ|popq
379588|NCT01518296|Urodynamic test|urodynamic test
379589|NCT01518283|Weekly cabazitaxel.|weekly cabazitaxel.
379590|NCT01518283|Advanced Hormone-refractory prostate Cancer.|advanced hormone-refractory prostate cancer.
379591|NCT01518283|Unfit patients.|unfit patients.
379592|NCT01518244|Primary open angle-glaucoma|primary open angle-glaucoma
379593|NCT01518244|Ocular hypertension|ocular hypertension
379594|NCT01518244|Pigment dispersion glaucoma|pigment dispersion glaucoma
379595|NCT01518231|stroke|stroke
379596|NCT01518231|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
379597|NCT01518218|Sickle cell disease|sickle cell disease
379598|NCT01518218|laying-on-of-hands|laying-on-of-hands
379599|NCT01518218|morbidity|morbidity
379600|NCT01518218|mortality|mortality
379601|NCT01518205|diabetic foot ulcers,|diabetic foot ulcers,
379602|NCT01518205|peripheral arterial disease,|peripheral arterial disease,
379603|NCT01518205|heparin-induced extracorporal lipid apheresis.|heparin-induced extracorporal lipid apheresis.
379604|NCT01518205|inflammatory markers|inflammatory markers
379605|NCT01518205|type 2 diabetes|type 2 diabetes
379606|NCT01518205|LDL-cholesterol|ldl-cholesterol
379607|NCT01518192|erythema migrans|erythema migrans
379608|NCT01518192|doxycycline|doxycycline
379609|NCT01518192|cefuroxime axetil|cefuroxime axetil
379610|NCT01518192|post-Lyme disease symptoms|post-lyme disease symptoms
379611|NCT01518192|background symptoms in general population|background symptoms in general population
379612|NCT01518179|Colles' Fracture|colles' fracture
379613|NCT01518179|Compression Bandages|compression bandages
379614|NCT01518179|Occupational therapy|occupational therapy
379615|NCT01518179|Rehabilitation|rehabilitation
379616|NCT01518179|Smith's fracture|smith's fracture
379617|NCT01518153|Blood and Marrow Transplantation|blood and marrow transplantation
379618|NCT01518153|Lymphoma|lymphoma
379619|NCT01518153|Myeloma|myeloma
379620|NCT01518153|Myeloproliferative Diseases|myeloproliferative diseases
379621|NCT01518153|Leukemia|leukemia
379622|NCT01518153|Myelodysplastic syndrome|myelodysplastic syndrome
379623|NCT01518153|MDS|mds
379624|NCT01518153|Hodgkin disease|hodgkin disease
379625|NCT01518153|Multiple myeloma|multiple myeloma
379626|NCT01518153|Fludarabine|fludarabine
379627|NCT01518153|Fludarabine Phosphate|fludarabine phosphate
379628|NCT01518153|Fludara|fludara
379629|NCT01518153|Melphalan|melphalan
379630|NCT01518153|Alkeran|alkeran
379631|NCT01518153|Tacrolimus|tacrolimus
379632|NCT01518153|Prograf|prograf
379633|NCT01518153|Methotrexate|methotrexate
379634|NCT01518153|G-CSF|g-csf
379635|NCT01518153|Filgrastim|filgrastim
379636|NCT01518153|NeupogenTM|neupogentm
379637|NCT01518153|Donor Lymphocyte Infusion|donor lymphocyte infusion
379638|NCT01518153|DLI|dli
379639|NCT01518153|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
379640|NCT01518153|Graft-vs-host disease|graft-vs-host disease
379641|NCT01518153|GvHD|gvhd
379642|NCT01518153|T-lymphocytes|t-lymphocytes
379643|NCT01518153|T-cells|t-cells
379644|NCT01518153|Alemtuzumab|alemtuzumab
379645|NCT01518153|CAMPATH-1H|campath-1h
379646|NCT01518153|Campath|campath
379647|NCT01518140|Advanced Cancers|advanced cancers
379648|NCT01518140|Locally advanced|locally advanced
379649|NCT01518140|Recurrent|recurrent
379650|NCT01518140|Metastatic disease|metastatic disease
379651|NCT01518140|Oxygen Delivery Modalities|oxygen delivery modalities
379652|NCT01518140|Shortness of breath|shortness of breath
379653|NCT01518140|Dyspnea|dyspnea
379654|NCT01518140|VapoTherm|vapotherm
379655|NCT01518140|Bilevel positive airway pressure|bilevel positive airway pressure
379656|NCT01518140|BiPAP|bipap
379657|NCT01518140|Non-rebreather mask|non-rebreather mask
379658|NCT01518127|Macular Degeneration|macular degeneration
379659|NCT01518114|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
379660|NCT01518114|Exercise Training|exercise training
379661|NCT01518114|Cardiac Rehabilitation|cardiac rehabilitation
379662|NCT01518114|Heart Failure|heart failure
379663|NCT01518101|patient preference|patient preference
379664|NCT01518101|vildagliptin|vildagliptin
379665|NCT01518101|liraglutide|liraglutide
379666|NCT01518075|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
379667|NCT01518075|Non invasive mechanical ventilation|non invasive mechanical ventilation
379668|NCT01518075|Breathing-swallowing interaction|breathing-swallowing interaction
379669|NCT01518075|Intensive Care Unit|intensive care unit
379670|NCT01518049|Affective Disorders, Psychotic|affective disorders, psychotic
379671|NCT01518049|Psychometrics|psychometrics
379672|NCT01518049|Biological Markers|biological markers
379673|NCT01518023|diabetes mellitus|diabetes mellitus
379674|NCT01518023|prediabetes|prediabetes
379675|NCT01518023|fasting blood glucose|fasting blood glucose
379676|NCT01518023|HbA1c|hba1c
379677|NCT01518023|Roux en Y gastric bypass|roux en y gastric bypass
379678|NCT01518023|Cancer gastrectomy|cancer gastrectomy
379679|NCT01518023|Cancer colorectal surgery|cancer colorectal surgery
379680|NCT01518010|Brain injury|brain injury
379681|NCT01518010|Cognitive rehabilitation|cognitive rehabilitation
379682|NCT01518010|Video game|video game
379683|NCT01517997|Drug coated balloons|drug coated balloons
379684|NCT01517997|Drug eluting stents|drug eluting stents
379685|NCT01517984|recipients of living-donor kidney allografts|recipients of living-donor kidney allografts
379686|NCT01517984|antithymocyte globulin (ATG) induction|antithymocyte globulin (atg) induction
379687|NCT01517984|calcineurin inhibitors (CNIs)|calcineurin inhibitors (cnis)
379688|NCT01517984|CNI withdrawal|cni withdrawal
379689|NCT01517971|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
379690|NCT01517971|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
379691|NCT01517971|adenocarcinoma of the lung|adenocarcinoma of the lung
379692|NCT01517971|squamous cell lung cancer|squamous cell lung cancer
379693|NCT01517958|Transient tachypnea of the newborn|transient tachypnea of the newborn
379694|NCT01517958|Respiratory Distress Syndrome|respiratory distress syndrome
379695|NCT01517958|Lung Ultrasound|lung ultrasound
379696|NCT01517958|Neonates|neonates
379697|NCT01517945|Survivors|survivors
379698|NCT01517945|Quality of Life|quality of life
379699|NCT01517945|Questionnaire|questionnaire
379700|NCT01517945|11-204|11-204
379701|NCT01517919|peer support|peer support
379702|NCT01517919|peer leader|peer leader
379703|NCT01517919|community health worker|community health worker
379704|NCT01517919|empowerment|empowerment
379705|NCT01517919|self-management|self-management
379706|NCT01517906|eating disorder behaviors|eating disorder behaviors
379707|NCT01517906|well being|well being
379708|NCT01517906|functional health|functional health
379709|NCT01517893|vitiligo|vitiligo
379710|NCT01517893|simvastatin|simvastatin
379711|NCT01517880|Hereditary Inclusion Body Myopathy (HIBM)|hereditary inclusion body myopathy (hibm)
379712|NCT01517880|GNE myopathies|gne myopathies
379713|NCT01517880|distal myopathy with rimmed vacuoles [DMRV]|distal myopathy with rimmed vacuoles [dmrv]
379714|NCT01517880|Nonaka disease|nonaka disease
379715|NCT01517867|preschool children behavior problems|preschool children behavior problems
379716|NCT01517867|child between 2 and 5 years old|child between 2 and 5 years old
379717|NCT01517841|peritoneal dialysis|peritoneal dialysis
379718|NCT01517841|modality choice|modality choice
379719|NCT01517841|kidney disease|kidney disease
379720|NCT01517828|Intubation|intubation
379721|NCT01517828|Delivery room|delivery room
379722|NCT01517828|Sedation|sedation
379723|NCT01517828|Analgesia|analgesia
379724|NCT01517815|Septic shock|septic shock
379725|NCT01517815|overweight|overweight
379726|NCT01517815|critically ill|critically ill
379727|NCT01517815|pharmacokinetic|pharmacokinetic
379728|NCT01517815|doripenem|doripenem
379729|NCT01517815|piperacillin-tazobactam|piperacillin-tazobactam
379730|NCT01517802|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
379731|NCT01517802|Metastatic breast cancer|metastatic breast cancer
379732|NCT01517802|Abiraterone acetate|abiraterone acetate
379733|NCT01517802|Low-dose corticosteroid treatment|low-dose corticosteroid treatment
379734|NCT01517802|Long-term access|long-term access
379735|NCT01517789|Surgery|surgery
379736|NCT01517789|Optic Nerve and Pathway Injury|optic nerve and pathway injury
379737|NCT01517789|visual event-related potential|visual event-related potential
379738|NCT01517776|High grade glioma|high grade glioma
379739|NCT01517776|Glioblastoma multiforme|glioblastoma multiforme
379740|NCT01517776|Anaplastic astrocytoma|anaplastic astrocytoma
379741|NCT01517776|Diffuse intrinsic pontine glioma|diffuse intrinsic pontine glioma
379742|NCT01517776|Relapse|relapse
379743|NCT01517776|refractory tumour disease|refractory tumour disease
379744|NCT01517776|Relapsed or refractory high grade gliomas and diffuse intrinsic pontine gliomas|relapsed or refractory high grade gliomas and diffuse intrinsic pontine gliomas
379745|NCT01517763|Obstructive Sleep Apnea|obstructive sleep apnea
379746|NCT01517763|Humidification|humidification
379747|NCT01517763|Continuous Positive Airway Pressure|continuous positive airway pressure
379748|NCT01517763|ICON|icon
379749|NCT01517763|ThermoSmart|thermosmart
379750|NCT01517763|SensAwake|sensawake
379751|NCT01517750|Obstructive Sleep Apnea|obstructive sleep apnea
379752|NCT01517750|Humidification|humidification
379753|NCT01517750|Continuous Positive Airway Pressure|continuous positive airway pressure
379754|NCT01517750|ICON|icon
379755|NCT01517750|ThermoSmart|thermosmart
379756|NCT01517724|MM|mm
379757|NCT01517724|HDT|hdt
379758|NCT01517724|ASCT|asct
379759|NCT01517724|consolidation|consolidation
379760|NCT01517724|bortezomib|bortezomib
379761|NCT01517711|pharmacotherapy|pharmacotherapy
379762|NCT01517711|combat disorders|combat disorders
379763|NCT01517685|Eicosapentaenoic acid|eicosapentaenoic acid
379764|NCT01517685|EPA|epa
379765|NCT01517685|Docosahexaenoic acid|docosahexaenoic acid
379766|NCT01517685|DHA|dha
379767|NCT01517685|Omega 3 fat|omega 3 fat
379768|NCT01517685|alpha-linoleic acid|alpha-linoleic acid
379769|NCT01517685|ALA|ala
379770|NCT01517685|fish oil|fish oil
379771|NCT01517685|flax seed oil|flax seed oil
379772|NCT01517672|PTSD|ptsd
379773|NCT01517672|domestic violence|domestic violence
379774|NCT01517672|intimate partner violence|intimate partner violence
379775|NCT01517672|functional MRI|functional mri
379776|NCT01517672|neuroimaging|neuroimaging
379777|NCT01517659|Lipolysis|lipolysis
379778|NCT01517659|Cryolipolysis|cryolipolysis
379779|NCT01517659|Fat Reduction|fat reduction
379780|NCT01517646|Lipolysis|lipolysis
379781|NCT01517646|Cryolipolysis|cryolipolysis
379782|NCT01517646|Fat Reduction|fat reduction
379783|NCT01517633|Amniotic fluid leakage|amniotic fluid leakage
379784|NCT01517633|Urinary incontinence|urinary incontinence
379785|NCT01517581|Brown adipose tissue|brown adipose tissue
379786|NCT01517542|diet|diet
379787|NCT01517542|DASH|dash
379788|NCT01517542|Stroke|stroke
379789|NCT01517542|Nutritional counseling|nutritional counseling
379790|NCT01517529|Hepatitis C|hepatitis c
379791|NCT01517529|HCV|hcv
379792|NCT01517516|fMRI|fmri
379793|NCT01517516|resting state|resting state
379794|NCT01517516|structural MRI|structural mri
379795|NCT01517516|functional MRI|functional mri
379796|NCT01517477|Open angle|open angle
379797|NCT01517477|Glaucoma|glaucoma
379798|NCT01517477|surgery|surgery
379799|NCT01517477|Glaucoma, Open-Angle|glaucoma, open-angle
379800|NCT01517477|Ocular Hypertension|ocular hypertension
379801|NCT01517477|Eye Diseases|eye diseases
379802|NCT01517464|neoplasm|neoplasm
379803|NCT01517464|bladder cancer|bladder cancer
379804|NCT01517464|advances solid tumors|advances solid tumors
379805|NCT01517438|agitation, desflurane, children|agitation, desflurane, children
379806|NCT01517399|Oncology|oncology
379807|NCT01517399|pharmacokinetics|pharmacokinetics
379808|NCT01517399|PK interaction in advanced solid tumors with our drug and other drugs|pk interaction in advanced solid tumors with our drug and other drugs
379809|NCT01517386|paravertebral space|paravertebral space
379810|NCT01517386|needle placement|needle placement
379811|NCT01517386|tissue identification|tissue identification
379812|NCT01517386|regional|regional
379813|NCT01517373|T2DM|t2dm
379814|NCT01517373|PF-04937319|pf-04937319
379815|NCT01517373|Phase 2|phase 2
379816|NCT01517360|Schizophrenia|schizophrenia
379817|NCT01517360|Social Cognition|social cognition
379818|NCT01517360|Oxytocin|oxytocin
379819|NCT01517347|IL2|il2
379820|NCT01517347|relapse|relapse
379821|NCT01517347|GVHD|gvhd
379822|NCT01517347|survival|survival
379823|NCT01517347|allogeneic stem cell transplantation|allogeneic stem cell transplantation
379824|NCT01517347|MRD|mrd
379825|NCT01517347|CR|cr
379826|NCT01517308|HCV|hcv
379827|NCT01517308|Hepatitis|hepatitis
379828|NCT01517308|Genotype 2 or 3|genotype 2 or 3
379829|NCT01517308|Pegylated Interferon|pegylated interferon
379830|NCT01517308|Duration|duration
379831|NCT01517295|Pharmacokinetics|pharmacokinetics
379832|NCT01517295|Hydromorphone|hydromorphone
379833|NCT01517295|Hydrocodone|hydrocodone
379834|NCT01517295|APAP|apap
379835|NCT01517269|Parent education|parent education
379836|NCT01517256|Chronic pain|chronic pain
379837|NCT01517256|Primary care|primary care
379838|NCT01517256|Multidisciplinary group therapy|multidisciplinary group therapy
379839|NCT01517256|Embedded mixed-methods study|embedded mixed-methods study
379840|NCT01517243|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
379841|NCT01517243|sunitinib|sunitinib
379842|NCT01517243|alternating|alternating
379843|NCT01517243|temsirolimus|temsirolimus
379844|NCT01517230|Cluster-randomised trial|cluster-randomised trial
379845|NCT01517230|Comprehensive mass media campaign|comprehensive mass media campaign
379846|NCT01517230|Rural community radio|rural community radio
379847|NCT01517230|Under-five child mortality|under-five child mortality
379848|NCT01517230|Preventive and curative behaviours|preventive and curative behaviours
379849|NCT01517230|Burkina Faso|burkina faso
379850|NCT01517230|Health care seeking behavior|health care seeking behavior
379851|NCT01517230|Childbirth|childbirth
379852|NCT01517217|girdle|girdle
379853|NCT01517217|laparotomy|laparotomy
379854|NCT01517217|pulmonary function|pulmonary function
379855|NCT01517217|postoperative pain|postoperative pain
379856|NCT01517217|mobilisation|mobilisation
379857|NCT01517204|Trachway(R) intubating stylet|trachway(r) intubating stylet
379858|NCT01517204|Left sided double lumen endobronchial tube|left sided double lumen endobronchial tube
379859|NCT01517204|Efficacy|efficacy
379860|NCT01517204|Intubation complication|intubation complication
379861|NCT01517191|Influenza|influenza
379862|NCT01517191|Respiratory Infection|respiratory infection
379863|NCT01517165|Opioid Dependence|opioid dependence
379864|NCT01517165|Pioglitazone|pioglitazone
379865|NCT01517165|Buprenorphine|buprenorphine
379866|NCT01517152|Symptoms|symptoms
379867|NCT01517152|Patient-Reported Outcomes|patient-reported outcomes
379868|NCT01517152|Linguistic Validation|linguistic validation
379869|NCT01517152|Toxicity|toxicity
379870|NCT01517152|PRO-CTCAE|pro-ctcae
379871|NCT01517152|Adverse Events|adverse events
379872|NCT01517152|Translation|translation
379873|NCT01517152|Questionnaire|questionnaire
379874|NCT01517139|Diet and Nutrition|diet and nutrition
379875|NCT01517139|Pregnancy Folic Acid|pregnancy folic acid
379876|NCT01517139|In Utero Exposure|in utero exposure
379877|NCT01517139|DNA Methylation|dna methylation
379878|NCT01517139|Physical Activity|physical activity
379879|NCT01517126|Youth Suicide|youth suicide
379880|NCT01517126|Suicide Screening|suicide screening
379881|NCT01517126|Developmental Delay|developmental delay
379882|NCT01517126|Intellectual Disability|intellectual disability
379883|NCT01517126|Assessment Instrument|assessment instrument
379884|NCT01517126|Mental Retardation|mental retardation
379885|NCT01517126|Suicidal Thoughts|suicidal thoughts
379886|NCT01517126|Suicidal Behavior|suicidal behavior
379887|NCT01517113|Endothelial Dysfunction|endothelial dysfunction
379888|NCT01517113|Hepatic|hepatic
379889|NCT01517113|Adiposity|adiposity
379890|NCT01517113|Cytokines|cytokines
379891|NCT01517113|Muscle Mass|muscle mass
379892|NCT01517113|Coronary Artery Disease|coronary artery disease
379893|NCT01517113|Aging|aging
379894|NCT01517113|Inflammation|inflammation
379895|NCT01517100|Glucose|glucose
379896|NCT01517100|Insulin Secretion|insulin secretion
379897|NCT01517100|Insulin Action|insulin action
379898|NCT01517100|Endocannabinoids|endocannabinoids
379899|NCT01517100|Insulin|insulin
379900|NCT01517100|Metabolism|metabolism
379901|NCT01517087|Motor Function|motor function
379902|NCT01517087|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
379903|NCT01517087|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
379904|NCT01517087|Diffusion Tensor Imaging|diffusion tensor imaging
379905|NCT01517087|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
379906|NCT01517087|Healthy Volunteer|healthy volunteer
379907|NCT01517087|HV|hv
379908|NCT01517074|Sirolimus|sirolimus
379909|NCT01517074|Scleritis|scleritis
379910|NCT01517074|Autoimmune Scleritis|autoimmune scleritis
379911|NCT01517061|Phantom Limb Pain|phantom limb pain
379912|NCT01517061|Genetic Polymorphisms|genetic polymorphisms
379913|NCT01517061|Genetic Susceptibility|genetic susceptibility
379914|NCT01517061|Amputation|amputation
379915|NCT01517048|Body Composition|body composition
379916|NCT01517048|Obesity|obesity
379917|NCT01517048|Overweight|overweight
379918|NCT01517048|Energy Homeostasis|energy homeostasis
379919|NCT01517048|Nociception|nociception
379920|NCT01517048|Prader-Willi Syndrome|prader-willi syndrome
379921|NCT01517048|Genetic Disorder|genetic disorder
379922|NCT01517048|Healthy Volunteer|healthy volunteer
379923|NCT01517048|HV|hv
379924|NCT01517035|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
379925|NCT01517035|Stem Cell Transplant|stem cell transplant
379926|NCT01517035|Transplant|transplant
379927|NCT01517035|Myelodyplastic Syndrome|myelodyplastic syndrome
379928|NCT01517035|MDS|mds
379929|NCT01517035|Leukemia|leukemia
379930|NCT01517022|smoking cessation|smoking cessation
379931|NCT01517022|early sputum smear conversion|early sputum smear conversion
379932|NCT01517009|Neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
379933|NCT01517009|D1extra-resection|d1extra-resection
379934|NCT01516996|Neoadjuvant|neoadjuvant
379935|NCT01516996|Concurrent Chemoradiotherapy,CCRT|concurrent chemoradiotherapy,ccrt
379936|NCT01516996|Nimotuzumab|nimotuzumab
379937|NCT01516996|Locoregionally Advanced Oropharynx|locoregionally advanced oropharynx
379938|NCT01516996|Hypopharynx cancer|hypopharynx cancer
379939|NCT01516996|Randomized|randomized
379940|NCT01516996|Multicenter|multicenter
379941|NCT01516983|Safety|safety
379942|NCT01516983|EGFR-TKI|egfr-tki
379943|NCT01516983|NSCLC|nsclc
379944|NCT01516983|Icotinib|icotinib
379945|NCT01516983|WBRT|wbrt
379946|NCT01516970|Human Immunodeficiency Virus (HIV) Post exposure prophylaxis|human immunodeficiency virus (hiv) post exposure prophylaxis
379947|NCT01516970|DRV/r|drv/r
379948|NCT01516970|Occupational injury|occupational injury
379949|NCT01516970|Non-occupational exposure|non-occupational exposure
379950|NCT01516970|Prezista|prezista
379951|NCT01516970|Darunavir/r|darunavir/r
379952|NCT01516957|Psoriatic Arthritis|psoriatic arthritis
379953|NCT01516957|IL-17|il-17
379954|NCT01516957|AMG 827|amg 827
379955|NCT01516957|AMG827|amg827
379956|NCT01516957|Musculoskeletal Disease|musculoskeletal disease
379957|NCT01516957|Spondylarthropathy|spondylarthropathy
379958|NCT01516944|Tegafur，Gimeracil and Oteracil Potassium Capsules|tegafur，gimeracil and oteracil potassium capsules
379959|NCT01516944|Capecitabine|capecitabine
379960|NCT01516944|Oxaliplatin|oxaliplatin
379961|NCT01516944|perioperative Chemotherapy|perioperative chemotherapy
379962|NCT01516944|Gastric Cancer|gastric cancer
379963|NCT01516931|repetitive Transcranial Magnetic Stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
379964|NCT01516931|Depression|depression
379965|NCT01516931|Venlafaxine|venlafaxine
379966|NCT01516931|Relapse|relapse
379967|NCT01516879|Cholesterol|cholesterol
379968|NCT01516879|High Cholesterol|high cholesterol
379969|NCT01516879|Elevated Cholesterol|elevated cholesterol
379970|NCT01516879|Raised Cholesterol|raised cholesterol
379971|NCT01516866|Androgen receptor-directed therapy|androgen receptor-directed therapy
379972|NCT01516866|NaF PET/CT|naf pet/ct
379973|NCT01516866|antimicrotubule directed chemotherapy|antimicrotubule directed chemotherapy
379974|NCT01516840|acute symptomatic deep vein thrombosis|acute symptomatic deep vein thrombosis
379975|NCT01516827|PTSD|ptsd
379976|NCT01516827|Children and Adolescents|children and adolescents
379977|NCT01516827|Post-Traumatic Stress Disorder in Children and Adolescents|post-traumatic stress disorder in children and adolescents
379978|NCT01516814|acute symptomatic pulmonary embolism|acute symptomatic pulmonary embolism
379979|NCT01516801|Prostate Cancer Screening|prostate cancer screening
379980|NCT01516801|Pragmatic Trial|pragmatic trial
379981|NCT01516801|Health Literacy|health literacy
379982|NCT01516775|preoperative care|preoperative care
379983|NCT01516775|preoperative period|preoperative period
379984|NCT01516775|fasting|fasting
379985|NCT01516762|Radium 223|radium 223
379986|NCT01516762|Alpharadin|alpharadin
379987|NCT01516762|Prostate Cancer|prostate cancer
379988|NCT01516762|Bone metastases|bone metastases
379989|NCT01516762|Castrate resistant prostate cancer|castrate resistant prostate cancer
379990|NCT01516762|Hormone refractory prostate cancer|hormone refractory prostate cancer
379991|NCT01516749|hidradenitis suppurativa|hidradenitis suppurativa
379992|NCT01516749|anakinra|anakinra
379993|NCT01516736|Pegfilgrastim|pegfilgrastim
379994|NCT01516736|G-CSF|g-csf
379995|NCT01516736|neutropenia|neutropenia
379996|NCT01516736|breast cancer|breast cancer
379997|NCT01516736|myelosuppressive chemotherapy|myelosuppressive chemotherapy
379998|NCT01516723|drug-eluting stent|drug-eluting stent
379999|NCT01516723|chronic total occlusion|chronic total occlusion
380000|NCT01516723|hybrid sirolimus-eluting stent|hybrid sirolimus-eluting stent
380001|NCT01516723|everolimus-eluting stent|everolimus-eluting stent
380002|NCT01516710|Open liver resection|open liver resection
380003|NCT01516710|Laparoscopic liver resection|laparoscopic liver resection
380004|NCT01516710|Colorectal cancer liver metastases|colorectal cancer liver metastases
380005|NCT01516697|thoracic electric bioimpedance|thoracic electric bioimpedance
380006|NCT01516697|cardiac output monitoring|cardiac output monitoring
380007|NCT01516697|cesarean section|cesarean section
380008|NCT01516697|spinal anesthesia|spinal anesthesia
380009|NCT01516671|Subarachnoid hemorrhage|subarachnoid hemorrhage
380010|NCT01516671|Cerebral vasospasm|cerebral vasospasm
380011|NCT01516671|Neuroinflammation|neuroinflammation
380012|NCT01516671|Bilateral Bispectral Index|bilateral bispectral index
380013|NCT01516658|intracranial aneurysm|intracranial aneurysm
380014|NCT01516658|endovascular therapy|endovascular therapy
380015|NCT01516658|detachable coil|detachable coil
380016|NCT01516658|recanalization|recanalization
380017|NCT01516645|Squamous cell type tumor|squamous cell type tumor
380018|NCT01516632|Cellular Phone|cellular phone
380019|NCT01516632|Mobile Phone|mobile phone
380020|NCT01516632|Cognitive Behavior Therapy|cognitive behavior therapy
380021|NCT01516632|Technology|technology
380022|NCT01516632|Smoking cessation|smoking cessation
380023|NCT01516632|young adults|young adults
380024|NCT01516619|NHL|nhl
380025|NCT01516619|chemotherapy-induced grade-4 thrombocytopenia|chemotherapy-induced grade-4 thrombocytopenia
380026|NCT01516606|MALT|malt
380027|NCT01516606|refractory|refractory
380028|NCT01516606|relapsed|relapsed
380029|NCT01516606|extranodal|extranodal
380030|NCT01516606|relapsed or refractory extranodal marginal zone lymphoma|relapsed or refractory extranodal marginal zone lymphoma
380031|NCT01516593|HIV|hiv
380032|NCT01516593|Burkitt's lymphoma|burkitt's lymphoma
380033|NCT01516593|intensive|intensive
380034|NCT01516593|short term|short term
380035|NCT01516593|immuno-chemotherapy|immuno-chemotherapy
380036|NCT01516593|HIV-positive patients with Burkitt's lymphoma|hiv-positive patients with burkitt's lymphoma
380037|NCT01516554|Multiple Sclerosis|multiple sclerosis
380038|NCT01516554|Fatigue|fatigue
380039|NCT01516528|COPD|copd
380040|NCT01516528|exacerbation|exacerbation
380041|NCT01516528|comorbidities|comorbidities
380042|NCT01516528|lung function|lung function
380043|NCT01516528|burden|burden
380044|NCT01516528|chronic bronchitis|chronic bronchitis
380045|NCT01516528|emphysema|emphysema
380046|NCT01516528|prevalence|prevalence
380047|NCT01516528|cardiovascular disease|cardiovascular disease
380048|NCT01516515|Actinic Keratosis|actinic keratosis
380049|NCT01516515|AK|ak
380050|NCT01516502|laser therapy|laser therapy
380051|NCT01516502|myofascial pain syndrome|myofascial pain syndrome
380052|NCT01516502|acupoint|acupoint
380053|NCT01516502|trigger point|trigger point
380054|NCT01516502|range of motion|range of motion
380055|NCT01516489|screening|screening
380056|NCT01516489|colon cancer|colon cancer
380057|NCT01516489|incentives|incentives
380058|NCT01516489|behavioral economics|behavioral economics
380059|NCT01516463|burn|burn
380060|NCT01516463|partial thickness burn|partial thickness burn
380061|NCT01516463|second degree burn|second degree burn
380062|NCT01516463|minor burn|minor burn
380063|NCT01516463|scar|scar
380066|NCT01516463|outpatient burn center|outpatient burn center
380067|NCT01516463|scar appearance|scar appearance
380068|NCT01516463|Kansas City|kansas city
380069|NCT01516463|University of Kansas Medical Center|university of kansas medical center
380070|NCT01516463|KUMC|kumc
380071|NCT01516450|GSK1550188, belimumab, SLE, healthy, Japanese, pharmacokinetics, safety|gsk1550188, belimumab, sle, healthy, japanese, pharmacokinetics, safety
380072|NCT01516437|Chronic Obstructive Pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
380073|NCT01516424|Blonanserin|blonanserin
380074|NCT01516411|Health Promotion|health promotion
380075|NCT01516411|Physical Activity|physical activity
380076|NCT01516411|Sedentary Time|sedentary time
380077|NCT01516411|Smartphones|smartphones
380078|NCT01516385|spinal cord injury|spinal cord injury
380079|NCT01516385|biomarkers|biomarkers
380080|NCT01516385|rehabilitation|rehabilitation
380081|NCT01516385|functional independence|functional independence
380082|NCT01516385|prognosis|prognosis
380083|NCT01516372|GEn, moxifloxacin, cardiac repolarisation, QT/QTc|gen, moxifloxacin, cardiac repolarisation, qt/qtc
380084|NCT01516346|Heart Failure|heart failure
380085|NCT01516346|Heart failure with preserved ejection fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
380086|NCT01516346|Vasodilators|vasodilators
380087|NCT01516346|Isosorbide dinitrate|isosorbide dinitrate
380088|NCT01516346|Hydralazine|hydralazine
380089|NCT01516346|wave reflections|wave reflections
380090|NCT01516346|arterial stiffness|arterial stiffness
380091|NCT01516346|hemodynamics|hemodynamics
380092|NCT01516333|glycemic Index|glycemic index
380093|NCT01516320|Type 2 Diabetes|type 2 diabetes
380094|NCT01516320|Gastric Bypass|gastric bypass
380095|NCT01516320|Laparoscopic Banding|laparoscopic banding
380096|NCT01516320|Vertical Sleeve Gastrectomy|vertical sleeve gastrectomy
380097|NCT01516294|AMD|amd
380098|NCT01516294|PCV|pcv
380099|NCT01516294|Iray|iray
380100|NCT01516294|radiation|radiation
380101|NCT01516294|retina|retina
380102|NCT01516294|macula|macula
380103|NCT01516294|radiotherapy|radiotherapy
380104|NCT01516281|TBI|tbi
380105|NCT01516281|PD|pd
380106|NCT01516268|Cesarean Delivery|cesarean delivery
380107|NCT01516268|TAP block|tap block
380108|NCT01516268|sufentanyl|sufentanyl
380109|NCT01516268|Narcotic dosages|narcotic dosages
380110|NCT01516216|previously untreated|previously untreated
380111|NCT01516203|AZD5847,dose-ranging,Mycobacterium tuberculosis,Rifafour,tuberculosis|azd5847,dose-ranging,mycobacterium tuberculosis,rifafour,tuberculosis
380112|NCT01516190|stage I-III breast cancer|stage i-iii breast cancer
380113|NCT01516177|Kidney Transplantation|kidney transplantation
380114|NCT01516177|kidney transplant|kidney transplant
380115|NCT01516177|renal transplant|renal transplant
380116|NCT01516177|immunosuppression|immunosuppression
380117|NCT01516164|Laryngoscopy|laryngoscopy
380118|NCT01516164|Videolaryngoscopy|videolaryngoscopy
380119|NCT01516164|Ease of Intubation|ease of intubation
380120|NCT01516151|Hypertriglyceridemia|hypertriglyceridemia
380121|NCT01516138|Glucose-insulin-potassium|glucose-insulin-potassium
380122|NCT01516138|Cardiac surgery|cardiac surgery
380123|NCT01516125|healthy adult|healthy adult
380124|NCT01516125|genetic variation|genetic variation
380125|NCT01516125|botanical oils|botanical oils
380126|NCT01516125|polyunsaturated fatty acid|polyunsaturated fatty acid
380127|NCT01516125|fish oil|fish oil
380128|NCT01516125|fat metabolism|fat metabolism
380129|NCT01516125|Genetic variation of fat metabolism in healthy adults|genetic variation of fat metabolism in healthy adults
380130|NCT01516112|ICD, home monitoring, cardiomessenger, implant|icd, home monitoring, cardiomessenger, implant
380131|NCT01516099|Physical activity counselor|physical activity counselor
380132|NCT01516099|Active and healthy lifestyle|active and healthy lifestyle
380133|NCT01516099|General Practitioner|general practitioner
380134|NCT01516099|Social-cultural Organization|social-cultural organization
380135|NCT01516086|Controlled|controlled
380136|NCT01516086|uncontrolled|uncontrolled
380137|NCT01516073|partially controlled|partially controlled
380138|NCT01516073|uncontrolled|uncontrolled
380139|NCT01516047|Hepatic impairment|hepatic impairment
380140|NCT01516047|Pharmacology|pharmacology
380141|NCT01516047|Pharmacokinetics|pharmacokinetics
380142|NCT01516047|Pharmacodynamics|pharmacodynamics
380143|NCT01516047|Abiraterone acetate suspension|abiraterone acetate suspension
380144|NCT01516047|JNJ-212082|jnj-212082
380145|NCT01516034|Tattoo removal|tattoo removal
380146|NCT01516034|ultrasound|ultrasound
380147|NCT01516021|Fat ingestion|fat ingestion
380148|NCT01516021|hypothalamus|hypothalamus
380149|NCT01516021|insula|insula
380150|NCT01516021|fMRI|fmri
380151|NCT01516021|CBF|cbf
380152|NCT01516008|Hallux Valgus|hallux valgus
380153|NCT01516008|Bunionectomy|bunionectomy
380154|NCT01516008|Bunion|bunion
380155|NCT01516008|Acute pain|acute pain
380156|NCT01516008|Tapentadol|tapentadol
380157|NCT01516008|Tapentadol IR|tapentadol ir
380158|NCT01515995|Magnesium sulfate|magnesium sulfate
380159|NCT01515995|Childhood asthma|childhood asthma
380160|NCT01515995|Emergency department|emergency department
380161|NCT01515982|Alzheimer's disease|alzheimer's disease
380261|NCT01515540|placebo|placebo
380162|NCT01515982|Aerobic exercise|aerobic exercise
380163|NCT01515982|Physical training|physical training
380164|NCT01515982|Cognitive function|cognitive function
380165|NCT01515982|Functional capacity.|functional capacity.
380166|NCT01515956|Mucopolysaccharidosis IVA type A|mucopolysaccharidosis iva type a
380167|NCT01515956|MPS IVA Type A|mps iva type a
380168|NCT01515956|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
380169|NCT01515956|MPS IVA|mps iva
380170|NCT01515956|Morquio A Syndrome|morquio a syndrome
380171|NCT01515956|Lysosomal Storage Disorder|lysosomal storage disorder
380172|NCT01515956|LSD|lsd
380173|NCT01515956|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
380174|NCT01515956|N-acetylgalactosamine-6-sulfate|n-acetylgalactosamine-6-sulfate
380175|NCT01515956|sulfatase|sulfatase
380176|NCT01515956|galactose-6-sulfatase|galactose-6-sulfatase
380177|NCT01515956|GALNS|galns
380178|NCT01515956|enzyme replacement therapy|enzyme replacement therapy
380179|NCT01515956|ERT|ert
380180|NCT01515943|Convergence insufficiency|convergence insufficiency
380181|NCT01515930|Parenting|parenting
380182|NCT01515930|Parental Monitoring|parental monitoring
380183|NCT01515930|Diabetes|diabetes
380184|NCT01515930|Care|care
380185|NCT01515917|Veterans|veterans
380186|NCT01515917|Traumatic Brain Injury|traumatic brain injury
380187|NCT01515917|TBI|tbi
380188|NCT01515917|Substance Abuse|substance abuse
380189|NCT01515917|Substance Dependence|substance dependence
380190|NCT01515917|Veterans with traumatic brain injury (TBI)|veterans with traumatic brain injury (tbi)
380191|NCT01515917|Veterans with substance abuse or dependence|veterans with substance abuse or dependence
380192|NCT01515904|obesity management|obesity management
380193|NCT01515904|adolescents|adolescents
380194|NCT01515904|body mass index|body mass index
380195|NCT01515904|treatment outcomes|treatment outcomes
380196|NCT01515904|program evaluation|program evaluation
380197|NCT01515891|Parkinson Disease|parkinson disease
380198|NCT01515891|BIA 9-1067|bia 9-1067
380199|NCT01515852|stress level|stress level
380200|NCT01515852|stereotactic biopsy|stereotactic biopsy
380201|NCT01515852|brain lesion|brain lesion
380202|NCT01515852|general anesthesia|general anesthesia
380203|NCT01515852|local anesthesia|local anesthesia
380204|NCT01515839|SPECT|spect
380205|NCT01515839|Imaging|imaging
380206|NCT01515839|Football|football
380207|NCT01515839|Traumatic brain injury|traumatic brain injury
380208|NCT01515839|Regional cerebral blood flow|regional cerebral blood flow
380209|NCT01515826|Cataract surgery|cataract surgery
380210|NCT01515826|Topical therapy|topical therapy
380211|NCT01515826|Prevention of inflammation|prevention of inflammation
380212|NCT01515826|Inflammation of infection|inflammation of infection
380213|NCT01515800|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
380214|NCT01515800|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
380215|NCT01515800|stage IA breast cancer|stage ia breast cancer
380216|NCT01515800|stage IB breast cancer|stage ib breast cancer
380217|NCT01515800|stage II breast cancer|stage ii breast cancer
380218|NCT01515800|stage IIIA breast cancer|stage iiia breast cancer
380219|NCT01515787|stage IIA rectal cancer|stage iia rectal cancer
380220|NCT01515787|stage IIIA rectal cancer|stage iiia rectal cancer
380221|NCT01515787|stage IIIB rectal cancer|stage iiib rectal cancer
380222|NCT01515774|Parkinson's disease|parkinson's disease
380223|NCT01515774|Pramipexole|pramipexole
380224|NCT01515722|Medication Persistence|medication persistence
380225|NCT01515722|Compliance|compliance
380226|NCT01515722|Health Education Intervention (HEI)|health education intervention (hei)
380227|NCT01515709|Cohort Studies|cohort studies
380228|NCT01515709|Longitudinal Studies|longitudinal studies
380229|NCT01515696|VLBW infant|vlbw infant
380230|NCT01515696|Meconium|meconium
380231|NCT01515696|Enteral nutrition|enteral nutrition
380232|NCT01515696|Meconium passage|meconium passage
380233|NCT01515683|Nervousness before anesthesia|nervousness before anesthesia
380234|NCT01515670|THA|tha
380235|NCT01515670|TKA|tka
380236|NCT01515670|Fast-track|fast-track
380237|NCT01515670|Enhanced recovery|enhanced recovery
380238|NCT01515670|preoperative co-morbidity|preoperative co-morbidity
380239|NCT01515670|postoperative morbidity|postoperative morbidity
380240|NCT01515670|Arthroplasty|arthroplasty
380241|NCT01515670|Replacement|replacement
380242|NCT01515670|Hip|hip
380243|NCT01515670|Knee|knee
380244|NCT01515670|Morbidity|morbidity
380245|NCT01515644|Healthy infants|healthy infants
380246|NCT01515644|Infant formula|infant formula
380247|NCT01515644|Prebiotics|prebiotics
380248|NCT01515566|Advanced Cancer|advanced cancer
380249|NCT01515566|Dyspnea|dyspnea
380250|NCT01515566|Exercise-induced breakthrough dyspnea|exercise-induced breakthrough dyspnea
380251|NCT01515566|Shortness of breath|shortness of breath
380252|NCT01515566|Fentanyl|fentanyl
380253|NCT01515566|Sublimaze|sublimaze
380254|NCT01515566|Placebo|placebo
380255|NCT01515566|Normal saline|normal saline
380256|NCT01515566|NS|ns
380257|NCT01515566|Questionnaires|questionnaires
380258|NCT01515566|Surveys|surveys
380259|NCT01515566|Walk test|walk test
380260|NCT01515540|chronic back pain|chronic back pain
380262|NCT01515540|fmri|fmri
380263|NCT01515540|brain imaging|brain imaging
380264|NCT01515527|Leukemia|leukemia
380265|NCT01515527|Acute myeloid leukemia|acute myeloid leukemia
380266|NCT01515527|AML|aml
380267|NCT01515527|myelodysplastic syndrome|myelodysplastic syndrome
380268|NCT01515527|MDS|mds
380269|NCT01515527|Cytarabine|cytarabine
380270|NCT01515527|Ara-C|ara-c
380271|NCT01515527|Cytosar|cytosar
380272|NCT01515527|DepoCyt|depocyt
380273|NCT01515527|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
380274|NCT01515527|Decitabine|decitabine
380275|NCT01515527|Dacogen|dacogen
380276|NCT01515527|Cladribine|cladribine
380277|NCT01515527|Leustatin|leustatin
380278|NCT01515527|2-CdA|2-cda
380279|NCT01515514|polyps|polyps
380280|NCT01515514|inflammatory bowel disease|inflammatory bowel disease
380281|NCT01515514|associated neoplasia|associated neoplasia
380282|NCT01515501|Constipation|constipation
380283|NCT01515501|Hirschsprung Disease|hirschsprung disease
380284|NCT01515488|Triage|triage
380285|NCT01515488|Automated|automated
380286|NCT01515488|Admitting|admitting
380287|NCT01515488|Pediatric ED|pediatric ed
380288|NCT01515475|Hyperopia|hyperopia
380289|NCT01515475|Glasses|glasses
380290|NCT01515462|Lentiviral vector|lentiviral vector
380291|NCT01515462|Gene therapy|gene therapy
380292|NCT01515462|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
380293|NCT01515436|Rolandic Epilepsy|rolandic epilepsy
380294|NCT01515436|Benign Childhood Epilepsy with Centrotemporal Spikes (BCECTS)|benign childhood epilepsy with centrotemporal spikes (bcects)
380295|NCT01515436|Epilepsy|epilepsy
380296|NCT01515436|Seizures|seizures
380297|NCT01515436|Music|music
380298|NCT01515436|Mozart|mozart
380299|NCT01515436|Beethoven|beethoven
380300|NCT01515423|Schizophrenia|schizophrenia
380301|NCT01515423|R092670|r092670
380302|NCT01515423|Paliperidone Palmitate|paliperidone palmitate
380303|NCT01515423|Paliperidone palmitate 1 month formulation (PP1M)|paliperidone palmitate 1 month formulation (pp1m)
380304|NCT01515423|Paliperidone palmitate 3 month formulation (PP3M)|paliperidone palmitate 3 month formulation (pp3m)
380305|NCT01515410|Parkinson's disease|parkinson's disease
380306|NCT01515410|PD|pd
380307|NCT01515410|stage2/3Parkinson's|stage2/3parkinson's
380308|NCT01515410|Advanced Parkinson's Disease with Motor Fluctuations|advanced parkinson's disease with motor fluctuations
380309|NCT01515345|clopidogrel-nonresponder|clopidogrel-nonresponder
380310|NCT01515345|stent thrombosis|stent thrombosis
380311|NCT01515319|Obesity|obesity
380312|NCT01515319|Peptide YY|peptide yy
380313|NCT01515319|Food intake|food intake
380314|NCT01515319|Safety|safety
380315|NCT01515319|Pharmacokinetics|pharmacokinetics
380316|NCT01515306|Advanced Malignant Solid Tumors|advanced malignant solid tumors
380317|NCT01515280|chronic cough|chronic cough
380318|NCT01515267|EF|ef
380319|NCT01515267|EDV|edv
380320|NCT01515267|ESV|esv
380321|NCT01515267|Biplane|biplane
380322|NCT01515267|Echocardiography|echocardiography
380323|NCT01515254|Children|children
380324|NCT01515254|Obesity Prevention|obesity prevention
380325|NCT01515254|Child Overweight|child overweight
380326|NCT01515254|Eating Behavior|eating behavior
380327|NCT01515254|Energy Compensation|energy compensation
380328|NCT01515254|Food Intake|food intake
380329|NCT01515254|Parenting Behavior|parenting behavior
380330|NCT01515241|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
380331|NCT01515241|Familial Hypercholesterolemia|familial hypercholesterolemia
380332|NCT01515241|HDL mimetic|hdl mimetic
380333|NCT01515241|ApoA-1|apoa-1
380334|NCT01515228|requiring drug eluting stents|requiring drug eluting stents
380335|NCT01515215|Major Depression Disorder|major depression disorder
380336|NCT01515215|Treatment Resistance|treatment resistance
380337|NCT01515215|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
380338|NCT01515150|diverticulitis|diverticulitis
380339|NCT01515150|Out-patient management|out-patient management
380340|NCT01515150|Antibiotics|antibiotics
380341|NCT01515137|Head and Neck|head and neck
380342|NCT01515137|Locally Advanced Head and Neck Squamous Cell Carcinoma|locally advanced head and neck squamous cell carcinoma
380343|NCT01515124|Lymphedema|lymphedema
380344|NCT01515124|Strength training intervention|strength training intervention
380345|NCT01515124|Weight loss intervention|weight loss intervention
380346|NCT01515124|Breast cancer recurrence|breast cancer recurrence
380347|NCT01515124|Cost Effectiveness|cost effectiveness
380348|NCT01515111|Non-communicable diseases|non-communicable diseases
380349|NCT01515111|Preventive services|preventive services
380350|NCT01515111|Medical education|medical education
380351|NCT01515111|Guatemala|guatemala
380352|NCT01515072|Remote Ischemic Preconditioning|remote ischemic preconditioning
380353|NCT01515072|Brain death organ donors|brain death organ donors
380354|NCT01515072|Delayed graft function|delayed graft function
380355|NCT01515072|Donor management|donor management
380356|NCT01515072|Pulsatile perfusion|pulsatile perfusion
380357|NCT01515059|obesity|obesity
380358|NCT01515059|diabetes|diabetes
380359|NCT01515059|bariatric surgery|bariatric surgery
380360|NCT01515059|gastric bypass|gastric bypass
380361|NCT01515059|insulin|insulin
380362|NCT01515059|glucose|glucose
380363|NCT01515059|incretins|incretins
380364|NCT01515059|leptin|leptin
380365|NCT01515059|ghrelin|ghrelin
380366|NCT01515046|Vitamins|vitamins
380367|NCT01515046|Complementary medicine|complementary medicine
380368|NCT01515046|Pancreatic cancer|pancreatic cancer
380369|NCT01515046|Ascorbate|ascorbate
380370|NCT01515046|Ascorbic Acid|ascorbic acid
380371|NCT01515046|Antioxidants|antioxidants
380372|NCT01515046|Gemcitabine|gemcitabine
380373|NCT01515046|Pharmacologic actions|pharmacologic actions
380374|NCT01515033|Coronary artery disease|coronary artery disease
380375|NCT01515033|Exercise|exercise
380376|NCT01515033|Ventilatory efficiency|ventilatory efficiency
380377|NCT01515020|bacteremia|bacteremia
380378|NCT01515020|meticillin-resistant Staphylococcus aureus|meticillin-resistant staphylococcus aureus
380379|NCT01515020|nosocomial infection|nosocomial infection
380380|NCT01515020|healthcare-associated infection|healthcare-associated infection
380381|NCT01515020|rapid molecular diagnostic test|rapid molecular diagnostic test
380382|NCT01515007|Bronchiectasis, non-CF, Ciprofloxacin, Liposome|bronchiectasis, non-cf, ciprofloxacin, liposome
380383|NCT01514981|Asthma|asthma
380384|NCT01514942|PCOS|pcos
380385|NCT01514942|Insulin resistance|insulin resistance
380386|NCT01514942|Myo-inositol|myo-inositol
380387|NCT01514942|D-chiro-inositol|d-chiro-inositol
380388|NCT01514929|Thorough QT|thorough qt
380389|NCT01514903|anti erectile dysfunction agent|anti erectile dysfunction agent
380390|NCT01514877|tumors metastatic to brain|tumors metastatic to brain
380391|NCT01514877|non-small cell lung cancer|non-small cell lung cancer
380392|NCT01514877|Icotinib|icotinib
380393|NCT01514851|Hyperphosphatemia in ESRD (End Stage Renal Disease) patients on dialysis|hyperphosphatemia in esrd (end stage renal disease) patients on dialysis
380394|NCT01514838|ASP1941|asp1941
380395|NCT01514838|ipragliflozin|ipragliflozin
380396|NCT01514838|plasma glucose|plasma glucose
380397|NCT01514838|urine glucose|urine glucose
380398|NCT01514825|YM150|ym150
380399|NCT01514825|Plasma concentration|plasma concentration
380400|NCT01514825|darexaban|darexaban
380401|NCT01514825|Healthy elderly subject|healthy elderly subject
380402|NCT01514825|Pharmacokinetics of YM150|pharmacokinetics of ym150
380403|NCT01514812|YM150|ym150
380404|NCT01514812|digoxin|digoxin
380405|NCT01514812|drug-drug interaction|drug-drug interaction
380406|NCT01514812|Plasma concentration|plasma concentration
380407|NCT01514812|darexaban|darexaban
380408|NCT01514812|Pharmacokinetics of digoxin|pharmacokinetics of digoxin
380409|NCT01514799|gastric bypass|gastric bypass
380410|NCT01514799|morbid obesity|morbid obesity
380411|NCT01514799|gut function|gut function
380412|NCT01514799|weight loss|weight loss
380413|NCT01514786|Colorectal Cancer|colorectal cancer
380414|NCT01514786|Screening|screening
380415|NCT01514786|Prevention|prevention
380416|NCT01514773|left ventricular systolic dysfunction|left ventricular systolic dysfunction
380417|NCT01514773|implantable cardioverter defibrillator|implantable cardioverter defibrillator
380418|NCT01514773|systolic heart failure|systolic heart failure
380419|NCT01514773|congestive heart failure|congestive heart failure
380420|NCT01514773|Ischemic cardiomyopathy|ischemic cardiomyopathy
380421|NCT01514773|Nonischemic cardiomyopathy|nonischemic cardiomyopathy
380422|NCT01514773|ICD|icd
380423|NCT01514773|ICD utilization|icd utilization
380424|NCT01514773|ICD implantation|icd implantation
380425|NCT01514773|defibrillator|defibrillator
380426|NCT01514773|defibrillator therapy|defibrillator therapy
380427|NCT01514773|sudden cardiac death|sudden cardiac death
380428|NCT01514760|Adolescents|adolescents
380429|NCT01514760|Mobile based applications|mobile based applications
380430|NCT01514760|Asthma action plan|asthma action plan
380431|NCT01514760|Self Efficacy|self efficacy
380432|NCT01514734|Primary open-angle glaucoma|primary open-angle glaucoma
380433|NCT01514734|Ocular hypertension|ocular hypertension
380434|NCT01514734|Pigment dispersion glaucoma|pigment dispersion glaucoma
380435|NCT01514721|Open-angle glaucoma|open-angle glaucoma
380436|NCT01514721|Ocular hypertension|ocular hypertension
380437|NCT01514721|Pigment dispersion glaucoma|pigment dispersion glaucoma
380438|NCT01514708|Influenza|influenza
380439|NCT01514708|Vaccination|vaccination
380440|NCT01514708|Vaccine|vaccine
380441|NCT01514708|Pregnancy|pregnancy
380442|NCT01514695|endoscopy|endoscopy
380443|NCT01514695|sedation|sedation
380444|NCT01514695|opioid|opioid
380445|NCT01514695|narcotic|narcotic
380446|NCT01514682|schizophrenia|schizophrenia
380447|NCT01514682|anti-inflammatory|anti-inflammatory
380448|NCT01514682|salsalate|salsalate
380449|NCT01514682|statins|statins
380450|NCT01514682|omega-3-fatty acids|omega-3-fatty acids
380451|NCT01514643|tibial plateau fracture|tibial plateau fracture
380452|NCT01514643|tibial plafond fracture|tibial plafond fracture
380453|NCT01514643|inflammatory cytokine profile|inflammatory cytokine profile
380454|NCT01514643|synovial fluid|synovial fluid
380455|NCT01514643|blood serum|blood serum
380456|NCT01514643|Post-traumatic osteoarthritis (PTOA)|post-traumatic osteoarthritis (ptoa)
380457|NCT01514617|Leiomyoma|leiomyoma
380458|NCT01514617|Diffusion weighted MRI|diffusion weighted mri
380459|NCT01514617|Perfusion MRI|perfusion mri
380460|NCT01514617|Uterine artery embolization|uterine artery embolization
380461|NCT01514617|Volumetric Response|volumetric response
380462|NCT01514617|Women with symptomatic leiomyomas|women with symptomatic leiomyomas
380463|NCT01514604|Anesthesia and analgesia|anesthesia and analgesia
380464|NCT01514604|ultrasonography|ultrasonography
380465|NCT01514604|education|education
380466|NCT01514578|safety|safety
380467|NCT01514578|tolerability|tolerability
380468|NCT01514578|TRV130A|trv130a
380469|NCT01514565|Triple negative Breast Cancer|triple negative breast cancer
380470|NCT01514565|RB|rb
380471|NCT01514565|PTEN|pten
380472|NCT01514565|Chemotherapy|chemotherapy
380473|NCT01514565|Neoadjuvant|neoadjuvant
380474|NCT01514552|Functional food|functional food
380475|NCT01514552|Strawberries|strawberries
380476|NCT01514552|Gummies|gummies
380477|NCT01514552|Smoker|smoker
380478|NCT01514552|Nonsmoker|nonsmoker
380479|NCT01514539|Human milk, Ghrelin,PYY and maternal obesity.|human milk, ghrelin,pyy and maternal obesity.
380480|NCT01514526|Adrenocortical carcinoma|adrenocortical carcinoma
380481|NCT01514461|Hyperlipoproteinemia (HLP Type I)|hyperlipoproteinemia (hlp type i)
380482|NCT01514461|Fasting Triglycerides|fasting triglycerides
380483|NCT01514448|Kidney cancer|kidney cancer
380484|NCT01514448|mRCC|mrcc
380485|NCT01514448|metastic renal cell carcinoma|metastic renal cell carcinoma
380486|NCT01514448|everolimus|everolimus
380487|NCT01514448|sunitinib|sunitinib
380488|NCT01514448|pazopanib|pazopanib
380489|NCT01514435|depression|depression
380490|NCT01514435|FDG-PET|fdg-pet
380491|NCT01514435|Electroconvulsive therapy|electroconvulsive therapy
380492|NCT01514435|glucose metabolism|glucose metabolism
380493|NCT01514422|Bipolar disorder|bipolar disorder
380494|NCT01514422|depression|depression
380495|NCT01514422|minocycline|minocycline
380496|NCT01514422|mood disorders|mood disorders
380497|NCT01514422|bipolar depression|bipolar depression
380498|NCT01514409|5-hydroxytryptophan|5-hydroxytryptophan
380499|NCT01514409|Mood|mood
380500|NCT01514409|Emotional Processing|emotional processing
380501|NCT01514409|Emotional Cognition|emotional cognition
380502|NCT01514409|Nutritional Supplement|nutritional supplement
380503|NCT01514409|Low mood|low mood
380504|NCT01514396|Pediatric|pediatric
380505|NCT01514396|Wounds|wounds
380506|NCT01514383|wounds|wounds
380507|NCT01514370|Multiple Sclerosis|multiple sclerosis
380508|NCT01514370|Relapsing|relapsing
380509|NCT01514370|Interferon beta 1a|interferon beta 1a
380510|NCT01514370|Curcumin|curcumin
380511|NCT01514344|OAL|oal
380512|NCT01514344|MALT|malt
380513|NCT01514344|conjunctiva|conjunctiva
380514|NCT01514344|indolent|indolent
380515|NCT01514344|CD20+|cd20+
380516|NCT01514331|Ventilator Induced Lung Injury|ventilator induced lung injury
380517|NCT01514331|Neonatal respiratory distress|neonatal respiratory distress
380518|NCT01514331|Mechanical ventilation|mechanical ventilation
380519|NCT01514279|Overweight|overweight
380520|NCT01514279|Obese|obese
380521|NCT01514279|Over Nutrition|over nutrition
380522|NCT01514279|Nutrition Disorders|nutrition disorders
380523|NCT01514279|Body weight|body weight
380524|NCT01514279|Signs and Symptoms|signs and symptoms
380525|NCT01514266|proven diagnosis|proven diagnosis
380526|NCT01514266|COPD|copd
380527|NCT01514266|sputum|sputum
380528|NCT01514253|glucose|glucose
380529|NCT01514253|analgesic|analgesic
380530|NCT01514253|newborns|newborns
380531|NCT01514240|mild to moderate active Crohn's disease|mild to moderate active crohn's disease
380532|NCT01514240|affecting ileum|affecting ileum
380533|NCT01514240|ileocecal region|ileocecal region
380534|NCT01514240|ascending colon|ascending colon
380535|NCT01514240|score of 180-400 on the CDAI|score of 180-400 on the cdai
380536|NCT01514214|ERCP|ercp
380537|NCT01514214|biliary stricture|biliary stricture
380538|NCT01514214|viaduct|viaduct
380539|NCT01514214|cancer|cancer
380540|NCT01514188|sarcoma|sarcoma
380541|NCT01514188|soft-tissue sarcoma|soft-tissue sarcoma
380542|NCT01514188|Metastatic,locally advanced, or unresectable soft tissue sarcoma|metastatic,locally advanced, or unresectable soft tissue sarcoma
380543|NCT01514175|Ketorolac|ketorolac
380544|NCT01514175|Caldolor|caldolor
380545|NCT01514175|Chronic Pelvic Pain|chronic pelvic pain
380546|NCT01514162|Trifecta Valve|trifecta valve
380547|NCT01514149|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
380548|NCT01514149|T2DM|t2dm
380549|NCT01514149|diabetes|diabetes
380550|NCT01514149|ConjuChem|conjuchem
380551|NCT01514149|GLP-1|glp-1
380552|NCT01514149|Glucagon-like peptide-1|glucagon-like peptide-1
380553|NCT01514149|exendin-4|exendin-4
380554|NCT01514149|modified exendin-4|modified exendin-4
380555|NCT01514123|VGX-100|vgx-100
380556|NCT01514123|Bevacizumab|bevacizumab
380557|NCT01514123|VEGF-C|vegf-c
380558|NCT01514123|First-In-Human|first-in-human
380559|NCT01514123|Dose Escalation|dose escalation
380560|NCT01514123|Advanced Solid Tumors|advanced solid tumors
380561|NCT01514123|Angiogenesis Inhibitors|angiogenesis inhibitors
380562|NCT01514123|Angiogenesis Modulating Agents|angiogenesis modulating agents
380563|NCT01514123|Pharmacologic Actions|pharmacologic actions
380564|NCT01514123|Antibodies, Monoclonal|antibodies, monoclonal
380565|NCT01514123|Phase 1|phase 1
380566|NCT01514123|Oncology|oncology
380567|NCT01514123|Advanced malignancy|advanced malignancy
380568|NCT01514097|emergency|emergency
380569|NCT01514097|pediatric|pediatric
380570|NCT01514097|fracture|fracture
380571|NCT01514097|pain|pain
380572|NCT01514084|laceration|laceration
380573|NCT01514084|emergency|emergency
380574|NCT01514084|cosmetic outcomes|cosmetic outcomes
380575|NCT01514084|patient satisfaction|patient satisfaction
380576|NCT01514084|suture|suture
380577|NCT01514071|head injury|head injury
380578|NCT01514071|CT|ct
380579|NCT01514071|emergency|emergency
380580|NCT01514071|radiation|radiation
380581|NCT01514045|Quality of Life|quality of life
380582|NCT01514019|SLCO2B1 genotype|slco2b1 genotype
380583|NCT01514019|effect of apple juice|effect of apple juice
380584|NCT01514006|Primary hip arthroplasty|primary hip arthroplasty
380585|NCT01514006|postoperative anemia|postoperative anemia
380586|NCT01514006|functional outcomes|functional outcomes
380587|NCT01513993|CHF|chf
380588|NCT01513993|Telemonitoring|telemonitoring
380589|NCT01513980|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
380590|NCT01513980|Telemonitoring|telemonitoring
380591|NCT01513967|Alzheimer,|alzheimer,
380592|NCT01513967|dementia|dementia
380593|NCT01513954|Infertility|infertility
380594|NCT01513941|Chronic hepatitis C|chronic hepatitis c
380595|NCT01513941|Genotype 1 chronic hepatitis C|genotype 1 chronic hepatitis c
380596|NCT01513941|Treatment experienced with HCV-1/HIV-1 coinfection|treatment experienced with hcv-1/hiv-1 coinfection
380597|NCT01513941|Telaprevir|telaprevir
380598|NCT01513941|Pegylated-Interferon-alfa-2a|pegylated-interferon-alfa-2a
380599|NCT01513941|Ribavirin|ribavirin
380600|NCT01513941|HCV-1/HIV-1 coinfection|hcv-1/hiv-1 coinfection
380601|NCT01513941|Hepatitis C|hepatitis c
380602|NCT01513928|pharmacokinetics|pharmacokinetics
380603|NCT01513928|relative bioavailability|relative bioavailability
380604|NCT01513928|formulation comparison|formulation comparison
380605|NCT01513915|parents|parents
380606|NCT01513915|group cognitive behavioral intervention|group cognitive behavioral intervention
380607|NCT01513915|anxiety disorder|anxiety disorder
380608|NCT01513915|children|children
380609|NCT01513915|FRIENDS program|friends program
380610|NCT01513902|Arthritis|arthritis
380611|NCT01513902|Pediatric|pediatric
380612|NCT01513902|Tofacitinib|tofacitinib
380613|NCT01513902|JIA|jia
380614|NCT01513850|Liver Transplantation|liver transplantation
380615|NCT01513850|HBV|hbv
380616|NCT01513850|HBV Recurrence|hbv recurrence
380617|NCT01513850|HBsAg Positive|hbsag positive
380618|NCT01513824|stress|stress
380619|NCT01513824|biofeed back guided treatment|biofeed back guided treatment
380620|NCT01513824|acupressure|acupressure
380621|NCT01513824|ischemic heart disease|ischemic heart disease
380622|NCT01513811|bowel preparation|bowel preparation
380623|NCT01513811|constipation|constipation
380624|NCT01513811|polyethylene glycol|polyethylene glycol
380625|NCT01513811|itopride|itopride
380626|NCT01513798|Diet Therapy|diet therapy
380627|NCT01513798|Exercise Therapy|exercise therapy
380628|NCT01513798|Insulin Resistance|insulin resistance
380629|NCT01513785|H. pylori|h. pylori
380630|NCT01513785|Dual therapy|dual therapy
380631|NCT01513785|Amoxicillin|amoxicillin
380632|NCT01513785|Rabeprazole|rabeprazole
380633|NCT01513759|Fibrinolysis|fibrinolysis
380634|NCT01513759|catheter directed fibrinolysis|catheter directed fibrinolysis
380635|NCT01513759|ultrasound accelerated fibrinolysis|ultrasound accelerated fibrinolysis
380636|NCT01513759|recombinant t-PA|recombinant t-pa
380637|NCT01513759|Activase|activase
380638|NCT01513746|Type 1 Diabetes|type 1 diabetes
380639|NCT01513746|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
380640|NCT01513746|Eating Disorders|eating disorders
380641|NCT01513746|Insulin Omission|insulin omission
380642|NCT01513720|Bioequivalence|bioequivalence
380643|NCT01513720|Lamotrigine|lamotrigine
380644|NCT01513720|crossover|crossover
380645|NCT01513707|kidney transplantation|kidney transplantation
380646|NCT01513707|hemodialysis|hemodialysis
380647|NCT01513707|peritoneal dialysis|peritoneal dialysis
380648|NCT01513694|Mesenchymal Stem Cells|mesenchymal stem cells
380649|NCT01513694|Stem Cells|stem cells
380650|NCT01513694|Intervertebral disc disease|intervertebral disc disease
380651|NCT01513681|Bioequivalence|bioequivalence
380652|NCT01513681|Lamotrigine|lamotrigine
380653|NCT01513681|crossover|crossover
380654|NCT01513655|COPD|copd
380655|NCT01513655|Home NIV|home niv
380656|NCT01513655|NIV|niv
380657|NCT01513642|physiotherapy|physiotherapy
380658|NCT01513642|cardiac surgery|cardiac surgery
380659|NCT01513642|breath Stacking|breath stacking
380660|NCT01513629|Autism spectrum disorders|autism spectrum disorders
380661|NCT01513629|structural connectivity|structural connectivity
380662|NCT01513629|diffusion spectrum imaging|diffusion spectrum imaging
380663|NCT01513629|sibling|sibling
380664|NCT01513629|endophenotype|endophenotype
380665|NCT01513616|COPD|copd
380666|NCT01513616|dyspnea|dyspnea
380667|NCT01513616|exercise|exercise
380668|NCT01513616|measurement|measurement
380669|NCT01513616|respiratory physiology|respiratory physiology
380670|NCT01513577|Lumbar fusion|lumbar fusion
380671|NCT01513577|Pedicular screws|pedicular screws
380672|NCT01513577|Minimal invasive technique|minimal invasive technique
380673|NCT01513577|Randomized controlled trial|randomized controlled trial
380674|NCT01513564|Disc disease|disc disease
380675|NCT01513564|Spondylolisthesis|spondylolisthesis
380676|NCT01513538|Pacemaker programming|pacemaker programming
380677|NCT01513538|Bradyarrhythmia|bradyarrhythmia
380678|NCT01513499|Eating behavior|eating behavior
380679|NCT01513499|Appetite|appetite
380680|NCT01513499|Oxytocin|oxytocin
380681|NCT01513499|Neuropeptide|neuropeptide
380682|NCT01513460|Chronic Obstructive Pulmonary Disease,|chronic obstructive pulmonary disease,
380683|NCT01513460|NVA 237,|nva 237,
380684|NCT01513460|glycopyrronium,|glycopyrronium,
380685|NCT01513460|COPD|copd
380686|NCT01513447|sterile water injections|sterile water injections
380687|NCT01513447|back labor|back labor
380688|NCT01513421|Infected|infected
380689|NCT01513421|Intra-abdominal|intra-abdominal
380690|NCT01513421|Collection|collection
380691|NCT01513421|Drainage|drainage
380692|NCT01513421|Percutaneous|percutaneous
380693|NCT01513408|breast cancer|breast cancer
380694|NCT01513408|CD8+|cd8+
380695|NCT01513408|Foxp3|foxp3
380696|NCT01513408|neoadjuvant chemotherapy|neoadjuvant chemotherapy
380697|NCT01513395|Cervical assessment|cervical assessment
380698|NCT01513395|Focal myometrial contractions|focal myometrial contractions
380699|NCT01513382|Pilonidal sinus|pilonidal sinus
380700|NCT01513382|Methylene blue|methylene blue
380701|NCT01513382|Histopathology|histopathology
380702|NCT01513382|Surgery|surgery
380703|NCT01513369|Diabetes|diabetes
380704|NCT01513369|iron deficiency|iron deficiency
380705|NCT01513356|breast|breast
380706|NCT01513356|cancer|cancer
380707|NCT01513356|BKM120|bkm120
380708|NCT01513317|Myelodysplastic Syndrome|myelodysplastic syndrome
380709|NCT01513317|MDS|mds
380710|NCT01513317|Blood and lymphatic diseases|blood and lymphatic diseases
380711|NCT01513317|Siltuximab|siltuximab
380712|NCT01513317|Anemic|anemic
380713|NCT01513265|reduction polypharmacy|reduction polypharmacy
380714|NCT01513265|clinical outcomes|clinical outcomes
380715|NCT01513265|pharmaceutical care|pharmaceutical care
380716|NCT01513265|clinical pharmacy|clinical pharmacy
380717|NCT01513265|geriatrics|geriatrics
380718|NCT01513265|medication review|medication review
380719|NCT01513265|potentially inappropriate drugs|potentially inappropriate drugs
380720|NCT01513252|Cognitive decline|cognitive decline
380721|NCT01513252|prevention|prevention
380722|NCT01513252|omega-3 fatty acids|omega-3 fatty acids
380723|NCT01513252|nutrition exercise|nutrition exercise
380724|NCT01513252|cognitive training|cognitive training
380725|NCT01513252|social activities|social activities
380726|NCT01513252|frailty|frailty
380727|NCT01513239|Clostridium difficile|clostridium difficile
380728|NCT01513239|Clostridium difficile infection (CDI)|clostridium difficile infection (cdi)
380729|NCT01513239|recurrent Clostridium difficile|recurrent clostridium difficile
380730|NCT01513239|vancomycin|vancomycin
380731|NCT01513239|metronidazole|metronidazole
380732|NCT01513239|monoclonal antibody|monoclonal antibody
380733|NCT01513226|cycled light|cycled light
380734|NCT01513226|dim light|dim light
380735|NCT01513226|circadian rhythm|circadian rhythm
380736|NCT01513226|actigraphy, sleep|actigraphy, sleep
380737|NCT01513226|premature infant|premature infant
380738|NCT01513213|Arterial cannulation|arterial cannulation
380739|NCT01513213|Blood gas|blood gas
380740|NCT01513213|Carbon dioxide|carbon dioxide
380741|NCT01513213|Arterial blood|arterial blood
380742|NCT01513213|Oxygen|oxygen
380743|NCT01513213|Oxygen fractions|oxygen fractions
380744|NCT01513187|Advanced renal cell carcinoma|advanced renal cell carcinoma
380745|NCT01513187|SOGUG|sogug
380746|NCT01513187|Pazopanib|pazopanib
380747|NCT01513187|Pazopanib in combination with interferon alpha 2A|pazopanib in combination with interferon alpha 2a
380748|NCT01513174|GOAL|goal
380749|NCT01513174|Lung|lung
380750|NCT01513174|Non small cell lung cancer|non small cell lung cancer
380751|NCT01513174|EGFR mutations|egfr mutations
380752|NCT01513161|pruritus|pruritus
380753|NCT01513135|HIV,|hiv,
380754|NCT01513135|HAART-treated|haart-treated
380755|NCT01513135|participants|participants
380756|NCT01513135|Tat protein,|tat protein,
380757|NCT01513135|Therapeutic immunization|therapeutic immunization
380758|NCT01513109|WT1 positive Acute Myeloid Leukemia|wt1 positive acute myeloid leukemia
380759|NCT01513109|Antigen specific cancer immunotherapeutic|antigen specific cancer immunotherapeutic
380760|NCT01513109|Ex vivo regulatory T cell depletion|ex vivo regulatory t cell depletion
380761|NCT01513109|In vivo regulatory T cell depletion|in vivo regulatory t cell depletion
380762|NCT01513096|colonoscopy|colonoscopy
380763|NCT01513096|bowel preparation|bowel preparation
380764|NCT01513096|PEG|peg
380765|NCT01513096|Prokinetics|prokinetics
380766|NCT01513070|Quick-Acting Heart Reliever|quick-acting heart reliever
380767|NCT01513070|Coronary Artery Stenosis|coronary artery stenosis
380768|NCT01513070|Coronary Heart Disease|coronary heart disease
380769|NCT01513070|Suxiao Jiuxin Pill|suxiao jiuxin pill
380770|NCT01513070|Chinese Herbal Drugs|chinese herbal drugs
380771|NCT01513070|Traditional Chinese Medicine|traditional chinese medicine
380772|NCT01513070|Chinese Medicine|chinese medicine
380773|NCT01513070|Angina Pectoris|angina pectoris
380774|NCT01513070|Isosorbide Dinitrate|isosorbide dinitrate
380775|NCT01513070|Myocardial Perfusion Imaging|myocardial perfusion imaging
380776|NCT01513070|Clinical Trial|clinical trial
380777|NCT01513057|bioequivalence|bioequivalence
380778|NCT01513057|Mycophenolate Mofetil|mycophenolate mofetil
380779|NCT01513057|crossover|crossover
380780|NCT01513044|bioequivalence|bioequivalence
380781|NCT01513044|Mycophenolate Mofetil|mycophenolate mofetil
380782|NCT01513044|crossover|crossover
380783|NCT01513031|Atrial fibrillation|atrial fibrillation
380784|NCT01513031|Anti-arrhythmic medication|anti-arrhythmic medication
380785|NCT01513031|Medication adherence|medication adherence
380786|NCT01513018|OLV|olv
380787|NCT01513018|one lung ventilation|one lung ventilation
380788|NCT01513005|Laparoscopic Sleeve Gastrectomy|laparoscopic sleeve gastrectomy
380789|NCT01513005|obesity management|obesity management
380790|NCT01512966|Diabetic Macular Edema|diabetic macular edema
380791|NCT01512966|DME|dme
380792|NCT01512966|VEGF Trap-Eye|vegf trap-eye
380793|NCT01512966|best-corrected visual acuity (BCVA)|best-corrected visual acuity (bcva)
380794|NCT01512953|PPI|ppi
380795|NCT01512953|clopidogrel|clopidogrel
380796|NCT01512953|2C19|2c19
380797|NCT01512953|Lansoprazole|lansoprazole
380798|NCT01512940|obesity|obesity
380799|NCT01512940|Laparoscopic Greater Curvature Plication|laparoscopic greater curvature plication
380925|NCT01512485|crossover|crossover
380800|NCT01512940|Percent Excess weight Loss|percent excess weight loss
380801|NCT01512940|comorbidities|comorbidities
380802|NCT01512940|BMI|bmi
380803|NCT01512940|Bariatric Surgery|bariatric surgery
380804|NCT01512927|electronic stethoscope|electronic stethoscope
380805|NCT01512927|arteriovenous fistula|arteriovenous fistula
380806|NCT01512927|hemodialysis,|hemodialysis,
380807|NCT01512914|Gynecologic laparoscopic surgery|gynecologic laparoscopic surgery
380808|NCT01512914|Postoperative pain|postoperative pain
380809|NCT01512914|Nebulization|nebulization
380810|NCT01512914|Ropivacaine|ropivacaine
380811|NCT01512888|SCID|scid
380812|NCT01512888|SCID-X1|scid-x1
380813|NCT01512888|X-linked SCID|x-linked scid
380814|NCT01512888|immunodeficiency|immunodeficiency
380815|NCT01512888|gene therapy|gene therapy
380816|NCT01512875|Helicobacter pylori|helicobacter pylori
380817|NCT01512875|water contamination|water contamination
380818|NCT01512875|Lima, Peru|lima, peru
380819|NCT01512862|Calcitriol|calcitriol
380820|NCT01512862|Off-label|off-label
380821|NCT01512849|TA-7284|ta-7284
380822|NCT01512849|JNJ-28431754|jnj-28431754
380823|NCT01512849|Canagliflozin|canagliflozin
380824|NCT01512849|Renal Impairment|renal impairment
380825|NCT01512849|Sodium Glucose Co-transporter2 (SGLT2) inhibitor|sodium glucose co-transporter2 (sglt2) inhibitor
380826|NCT01512836|COPD|copd
380827|NCT01512836|Case management|case management
380828|NCT01512836|CEA|cea
380829|NCT01512836|Health economy|health economy
380830|NCT01512836|Quality of Life|quality of life
380831|NCT01512823|randomised controlled trial|randomised controlled trial
380832|NCT01512823|educational intervention|educational intervention
380833|NCT01512823|occupational therapy|occupational therapy
380834|NCT01512810|Endometrial|endometrial
380835|NCT01512810|Cancer|cancer
380836|NCT01512810|Intraoperative Consultation|intraoperative consultation
380837|NCT01512797|Januvia|januvia
380838|NCT01512797|Sitagliptin|sitagliptin
380839|NCT01512797|Diabetes|diabetes
380840|NCT01512797|Gastric-Bypass|gastric-bypass
380841|NCT01512784|Quadrivalent Human Papillomavirus Vaccine (HPV) Gardasil|quadrivalent human papillomavirus vaccine (hpv) gardasil
380842|NCT01512784|HIV infection|hiv infection
380843|NCT01512784|Evaluation of quadrivalent HPV vaccine in adolescents and young adults.|evaluation of quadrivalent hpv vaccine in adolescents and young adults.
380844|NCT01512758|East Asian Patients|east asian patients
380845|NCT01512758|Advanced solid tumors|advanced solid tumors
380846|NCT01512758|Lymphomas|lymphomas
380847|NCT01512758|MLN8237|mln8237
380848|NCT01512758|Alisertib|alisertib
380849|NCT01512758|Aurora A Kinase Inhibitor|aurora a kinase inhibitor
380850|NCT01512706|Human Enterovirus 71 (EV71)|human enterovirus 71 (ev71)
380851|NCT01512706|Hand, Foot and Mouth Disease|hand, foot and mouth disease
380852|NCT01512706|Inactivated Vaccine|inactivated vaccine
380853|NCT01512706|Human Diploid cell|human diploid cell
380854|NCT01512706|Safety|safety
380855|NCT01512706|Immunogenicity|immunogenicity
380856|NCT01512706|Adverse reactions associated with vaccine|adverse reactions associated with vaccine
380857|NCT01512680|Functional Insulin Thearpy|functional insulin thearpy
380858|NCT01512680|Carbs counting|carbs counting
380859|NCT01512680|Type 1 diabetes mellitus|type 1 diabetes mellitus
380860|NCT01512680|Insulin pump|insulin pump
380861|NCT01512680|Treatment by external insulin pump|treatment by external insulin pump
380862|NCT01512654|diabetes|diabetes
380863|NCT01512654|diadvisor|diadvisor
380864|NCT01512654|type 1 diabetes|type 1 diabetes
380865|NCT01512654|type 2 diabetes|type 2 diabetes
380866|NCT01512654|glucose prediction|glucose prediction
380867|NCT01512654|cgm prediction|cgm prediction
380868|NCT01512654|algorithm|algorithm
380869|NCT01512654|therapy advices|therapy advices
380870|NCT01512641|children dissociative disorders schizophrenia|children dissociative disorders schizophrenia
380871|NCT01512615|Rehabilitation|rehabilitation
380872|NCT01512615|Exercise training|exercise training
380873|NCT01512615|Psycho-educational care|psycho-educational care
380874|NCT01512602|Borderline Personality Disorder traits|borderline personality disorder traits
380875|NCT01512602|Suicide prevention|suicide prevention
380876|NCT01512602|Self-harm|self-harm
380877|NCT01512602|Dialectical Behavior Therapy|dialectical behavior therapy
380878|NCT01512602|DBT|dbt
380879|NCT01512602|Collaborative Assessment and Management of Suicidology|collaborative assessment and management of suicidology
380880|NCT01512602|CAMS|cams
380881|NCT01512589|Proton Beam Therapy|proton beam therapy
380882|NCT01512589|PBT|pbt
380883|NCT01512589|Intensity-Modulated Radiation Therapy|intensity-modulated radiation therapy
380884|NCT01512589|IMRT|imrt
380885|NCT01512589|Esophageal cancer|esophageal cancer
380886|NCT01512589|Adenocarcinoma|adenocarcinoma
380887|NCT01512589|Squamous cell carcinoma|squamous cell carcinoma
380888|NCT01512589|Cervical esophagus|cervical esophagus
380889|NCT01512589|Thoracic esophagus|thoracic esophagus
380890|NCT01512589|Gastroesophageal junction|gastroesophageal junction
380891|NCT01512589|Cardia of stomach|cardia of stomach
380892|NCT01512589|Questionnaires|questionnaires
380893|NCT01512589|Surveys|surveys
380894|NCT01512589|Symptom scores|symptom scores
380895|NCT01512589|Quality of life|quality of life
380896|NCT01512589|QOL|qol
380897|NCT01512576|whiplash|whiplash
380898|NCT01512576|chronic pain|chronic pain
380899|NCT01512576|sensitization|sensitization
380900|NCT01512576|treatment|treatment
380901|NCT01512576|acupuncture|acupuncture
380902|NCT01512576|relaxation|relaxation
380903|NCT01512563|paclitaxel|paclitaxel
380904|NCT01512563|drug eluting stent|drug eluting stent
380905|NCT01512550|Radiostereometric Analysis (RSA)|radiostereometric analysis (rsa)
380906|NCT01512550|Total hip arthroplasty (THA)|total hip arthroplasty (tha)
380907|NCT01512550|Hip anatomy|hip anatomy
380908|NCT01512550|Hip biomechanics|hip biomechanics
380909|NCT01512537|Vitamin D|vitamin d
380910|NCT01512537|UVB|uvb
380911|NCT01512537|Vitamin D supplementation|vitamin d supplementation
380912|NCT01512524|Traumatic Brain Injury|traumatic brain injury
380913|NCT01512524|Quality of Life (QoL)|quality of life (qol)
380914|NCT01512524|hypopituitarism,GH|hypopituitarism,gh
380915|NCT01512511|laparoscopic cholecystectomy|laparoscopic cholecystectomy
380916|NCT01512511|pneumoperitoneum|pneumoperitoneum
380917|NCT01512511|nitrous oxide|nitrous oxide
380918|NCT01512511|carbon dioxide|carbon dioxide
380919|NCT01512498|VV GVHD|vv gvhd
380920|NCT01512498|girls|girls
380921|NCT01512498|adolescents|adolescents
380922|NCT01512498|HSCT|hsct
380923|NCT01512485|Bioequivalence|bioequivalence
380924|NCT01512485|Clopidogrel|clopidogrel
380926|NCT01512472|localized prostate cancer|localized prostate cancer
380927|NCT01512472|degarelix|degarelix
380928|NCT01512472|intermittent androgen deprivation therapy|intermittent androgen deprivation therapy
380929|NCT01512459|Bioavailability|bioavailability
380930|NCT01512459|Venlafaxine|venlafaxine
380931|NCT01512459|two way crossover|two way crossover
380932|NCT01512446|Osteoporosis|osteoporosis
380933|NCT01512446|Osteoporotic fractures|osteoporotic fractures
380934|NCT01512446|Bisphosphonate|bisphosphonate
380935|NCT01512446|Pretreatment with bisphosphonates|pretreatment with bisphosphonates
380936|NCT01512433|acupuncture|acupuncture
380937|NCT01512433|methadone|methadone
380938|NCT01512407|Hepatocellular Carcinoma|hepatocellular carcinoma
380939|NCT01512407|Randomised controlled trial|randomised controlled trial
380940|NCT01512407|Transarterial chemoembolisation|transarterial chemoembolisation
380941|NCT01512394|bowel preparation|bowel preparation
380942|NCT01512381|heart failure|heart failure
380943|NCT01512381|CRT|crt
380944|NCT01512381|atrial fibrillation|atrial fibrillation
380945|NCT01512381|AV junction ablation|av junction ablation
380946|NCT01512368|Fibroblast growth factor 21 (FGF21)|fibroblast growth factor 21 (fgf21)
380947|NCT01512368|Exercise|exercise
380948|NCT01512368|Metabolic equivalents (METs)|metabolic equivalents (mets)
380949|NCT01512368|Lipolysis|lipolysis
380950|NCT01512368|Glucose|glucose
380951|NCT01512368|Free fatty acids (FFAs)|free fatty acids (ffas)
380952|NCT01512368|Epinephrine|epinephrine
380953|NCT01512342|pacing|pacing
380954|NCT01512342|activity management|activity management
380955|NCT01512342|relaxation|relaxation
380956|NCT01512342|physiotherapy|physiotherapy
380957|NCT01512342|occupational therapy|occupational therapy
380958|NCT01512342|autonomic nervous system|autonomic nervous system
380959|NCT01512329|neurology|neurology
380960|NCT01512329|physiotherapy|physiotherapy
380961|NCT01512329|physical therapy|physical therapy
380962|NCT01512329|occupational therapy|occupational therapy
380963|NCT01512329|stress management|stress management
380964|NCT01512329|activity management|activity management
380965|NCT01512329|treatment|treatment
380966|NCT01512316|Fear|fear
380967|NCT01512316|Cycloserine|cycloserine
380968|NCT01512316|Conditioning|conditioning
380969|NCT01512316|Functional neuroimaging|functional neuroimaging
380970|NCT01512316|Anxiety disorders|anxiety disorders
380971|NCT01512303|PTSD|ptsd
380972|NCT01512303|Veterans' Health|veterans' health
380973|NCT01512303|Meditation|meditation
380974|NCT01512303|MRI, Functional|mri, functional
380975|NCT01512290|Auditory verbal hallucinations|auditory verbal hallucinations
380976|NCT01512290|Transcranial Magnetic stimulation|transcranial magnetic stimulation
380977|NCT01512290|Theta Burst frequency|theta burst frequency
380978|NCT01512277|vaccines|vaccines
380979|NCT01512277|safety|safety
380980|NCT01512277|drug tolerance|drug tolerance
380981|NCT01512277|immunogenic protein|immunogenic protein
380982|NCT01512277|antibody response|antibody response
380983|NCT01512277|cytokine|cytokine
380984|NCT01512264|Aphasia|aphasia
380985|NCT01512264|Stroke|stroke
380986|NCT01512264|functional Magnetic resonance imaging|functional magnetic resonance imaging
380987|NCT01512264|fMRI|fmri
380988|NCT01512264|Language recovery after stroke|language recovery after stroke
380989|NCT01512264|constraint induced aphasia therapy|constraint induced aphasia therapy
380990|NCT01512264|CIAT|ciat
380991|NCT01512264|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
380992|NCT01512264|rTMS|rtms
380993|NCT01512251|BKM120|bkm120
380994|NCT01512251|BRAF|braf
380995|NCT01512251|Melanoma|melanoma
380996|NCT01512251|PI3K|pi3k
380997|NCT01512238|Medicine adherence|medicine adherence
380998|NCT01512238|Drug substitution|drug substitution
380999|NCT01512238|Herb-drug interaction|herb-drug interaction
381000|NCT01512238|Herbal medicine|herbal medicine
381001|NCT01512238|Dietary supplements|dietary supplements
381002|NCT01512238|Over-the-counter products|over-the-counter products
381003|NCT01512238|On-line prescription records|on-line prescription records
381004|NCT01512238|Personal electronic medicine profile|personal electronic medicine profile
381005|NCT01512238|Intentional non-adherence|intentional non-adherence
381006|NCT01512238|Unintentional non-adherence|unintentional non-adherence
381007|NCT01512225|breastmilk|breastmilk
381008|NCT01512225|domperidone|domperidone
381009|NCT01512225|preterm|preterm
381010|NCT01512212|thyroid|thyroid
381011|NCT01512212|fine|fine
381012|NCT01512212|needle|needle
381013|NCT01512212|aspiration|aspiration
381014|NCT01512212|biopsy|biopsy
381015|NCT01512212|new|new
381016|NCT01512212|technique|technique
381017|NCT01512199|U3-1287|u3-1287
381018|NCT01512199|Trastuzumab|trastuzumab
381019|NCT01512199|Paclitaxel|paclitaxel
381020|NCT01512199|newly diagnosed HER-2 positive|newly diagnosed her-2 positive
381021|NCT01512199|breast cancer|breast cancer
381022|NCT01512199|metastatic|metastatic
381023|NCT01512186|Clear cell renal cancer|clear cell renal cancer
381024|NCT01512173|Propranolol gel|propranolol gel
381025|NCT01512173|Hemangioma|hemangioma
381026|NCT01512173|capillary neoplasm|capillary neoplasm
381027|NCT01512173|vascular tissue|vascular tissue
381028|NCT01512173|neoplasm by histologic type|neoplasm by histologic type
381029|NCT01512173|neoplasm|neoplasm
381030|NCT01512173|therapeutic uses|therapeutic uses
381031|NCT01512173|pharmacologic actions|pharmacologic actions
381032|NCT01512173|adrenergic beta-antagonists|adrenergic beta-antagonists
381033|NCT01512173|adrenergic antagonist|adrenergic antagonist
381034|NCT01512173|adrenergics agent|adrenergics agent
381035|NCT01512173|neurotransmitter agent|neurotransmitter agent
381036|NCT01512173|molecular mechanism of pharmacological action|molecular mechanism of pharmacological action
381037|NCT01512173|physiological effects of drugs|physiological effects of drugs
381038|NCT01512160|Post-surgical dental pain|post-surgical dental pain
381039|NCT01512147|SSEP measurements|ssep measurements
381040|NCT01512147|MEP measurements|mep measurements
381041|NCT01512147|Pediatric Patients|pediatric patients
381042|NCT01512147|Neurosurgery|neurosurgery
381043|NCT01512147|General Anesthesia|general anesthesia
381044|NCT01512134|Obesity|obesity
381045|NCT01512134|DBS|dbs
381046|NCT01512082|Pain|pain
381047|NCT01512082|Delayed onset muscle soreness|delayed onset muscle soreness
381048|NCT01512082|Pulsed electromagnetic field|pulsed electromagnetic field
381049|NCT01512082|Marathon|marathon
381050|NCT01512069|randomized controlled trial|randomized controlled trial
381051|NCT01512069|internet|internet
381052|NCT01512069|diet|diet
381053|NCT01512069|exercise|exercise
381054|NCT01512069|health planning|health planning
381055|NCT01512069|the TTM|the ttm
381056|NCT01512056|Influenza vaccine|influenza vaccine
381057|NCT01512056|dialysis|dialysis
381058|NCT01512056|vaccine|vaccine
381059|NCT01512056|Seroprotection|seroprotection
381060|NCT01512056|Seroresponse|seroresponse
381061|NCT01512056|Seroconversion|seroconversion
381062|NCT01512056|Safety of the vaccine|safety of the vaccine
381063|NCT01512043|Breathlessness|breathlessness
381064|NCT01512043|Symptoms|symptoms
381065|NCT01512043|Quality of life|quality of life
381066|NCT01512017|skin lesions or defects|skin lesions or defects
381067|NCT01512004|Overactive Bladder|overactive bladder
381068|NCT01512004|urgent micturition|urgent micturition
381069|NCT01512004|frequent micturition|frequent micturition
381070|NCT01512004|urge urinary incontinence|urge urinary incontinence
381071|NCT01511991|cardiac surgery|cardiac surgery
381072|NCT01511991|sevoflurane|sevoflurane
381073|NCT01511991|tissue Doppler|tissue doppler
381074|NCT01511978|Lambert-Eaton|lambert-eaton
381075|NCT01511978|Eaton-Lambert|eaton-lambert
381076|NCT01511978|myasthenia|myasthenia
381077|NCT01511978|myasthenic|myasthenic
381078|NCT01511978|LEMS|lems
381079|NCT01511978|LES|les
381080|NCT01511978|DAP|dap
381081|NCT01511978|diaminopyridine|diaminopyridine
381082|NCT01511978|3,4-diaminopyridine|3,4-diaminopyridine
381083|NCT01511978|3,4-DAP|3,4-dap
381084|NCT01511952|music therapy|music therapy
381085|NCT01511952|entrainment|entrainment
381086|NCT01511952|premature infants|premature infants
381087|NCT01511952|live music intervention|live music intervention
381088|NCT01511952|parent preferred lullabies|parent preferred lullabies
381089|NCT01511939|Knee pain|knee pain
381090|NCT01511939|Anticoagulant|anticoagulant
381091|NCT01511939|Warfarin|warfarin
381092|NCT01511939|Dabigatran|dabigatran
381093|NCT01511939|Clopidogrel|clopidogrel
381094|NCT01511939|Aspirin|aspirin
381095|NCT01511939|Topical NSAID|topical nsaid
381096|NCT01511939|Osteoarthritis|osteoarthritis
381097|NCT01511926|Vimovo™ treated patients and prescribing patterns|vimovo™ treated patients and prescribing patterns
381098|NCT01511926|Risk of gastrointestinal side effects|risk of gastrointestinal side effects
381099|NCT01511913|Unresectable or metastatic cutaneous melanoma|unresectable or metastatic cutaneous melanoma
381100|NCT01511887|Patent Ductus Arteriosus|patent ductus arteriosus
381101|NCT01511887|PDA|pda
381102|NCT01511887|Term newborns|term newborns
381103|NCT01511887|Ibuprofen|ibuprofen
381104|NCT01511874|ELIGARD|eligard
381105|NCT01511874|Prostate cancer|prostate cancer
381106|NCT01511848|Iron chelation|iron chelation
381107|NCT01511848|Iron balance|iron balance
381108|NCT01511848|Secondary iron overload|secondary iron overload
381109|NCT01511848|deferoxamine|deferoxamine
381110|NCT01511848|deferasirox|deferasirox
381111|NCT01511848|Deferiprone|deferiprone
381112|NCT01511848|1- Beta-thalassemia major patients;|1- beta-thalassemia major patients;
381113|NCT01511848|Patients with high iron stores|patients with high iron stores
381114|NCT01511848|Serum ferritin consistently > 2500 mcg/l and or increasing trend over previous 12 months|serum ferritin consistently > 2500 mcg/l and or increasing trend over previous 12 months
381115|NCT01511848|Liver iron >14 mg/g dry weight- by R2 MRI|liver iron >14 mg/g dry weight- by r2 mri
381116|NCT01511848|2- Sickle cell disease|2- sickle cell disease
381117|NCT01511848|3- Other causes of transfusional iron hemosiderosis|3- other causes of transfusional iron hemosiderosis
381118|NCT01511835|diabetes|diabetes
381119|NCT01511835|pregnancy|pregnancy
381120|NCT01511835|myo-inositol|myo-inositol
381121|NCT01511822|PCOS|pcos
381122|NCT01511822|Insulin resistance|insulin resistance
381123|NCT01511822|Hyperandrogenism|hyperandrogenism
381124|NCT01511822|Myo-inositol|myo-inositol
381125|NCT01511809|HIV-1|hiv-1
381126|NCT01511796|stroke|stroke
381127|NCT01511796|upper limb rehabilitation function|upper limb rehabilitation function
381128|NCT01511770|Bioequivalence|bioequivalence
381129|NCT01511770|Fluconazole|fluconazole
381130|NCT01511770|Crossover|crossover
381131|NCT01511757|Bioequivalence|bioequivalence
381132|NCT01511757|Fluconazole|fluconazole
381133|NCT01511757|Crossover|crossover
381134|NCT01511744|Respiratory Tract Infections; Orthomyxoviridae Infections|respiratory tract infections; orthomyxoviridae infections
381135|NCT01511731|Bioequivalence|bioequivalence
381136|NCT01511731|famotidine|famotidine
381137|NCT01511731|Crossover|crossover
381138|NCT01511718|Bioequivalence|bioequivalence
381139|NCT01511718|Ondansetron|ondansetron
381140|NCT01511718|crossover|crossover
381141|NCT01511705|Bioequivalence|bioequivalence
381142|NCT01511705|Ondansetron|ondansetron
381143|NCT01511705|crossover|crossover
381144|NCT01511679|Alcohol abuse|alcohol abuse
381145|NCT01511666|cardiac arrest|cardiac arrest
381146|NCT01511666|mechanical chest compressions|mechanical chest compressions
381147|NCT01511666|intraarrest cooling|intraarrest cooling
381148|NCT01511666|ECLS|ecls
381149|NCT01511653|screening colonoscopy|screening colonoscopy
381150|NCT01511653|colon cancer early detection|colon cancer early detection
381151|NCT01511653|rectal cancer early detection|rectal cancer early detection
381152|NCT01511653|colorectal cancer prevention|colorectal cancer prevention
381153|NCT01511653|biomarker validation|biomarker validation
381154|NCT01511640|marijuana|marijuana
381155|NCT01511640|addiction|addiction
381156|NCT01511640|treatment|treatment
381157|NCT01511640|pharmacotherapy|pharmacotherapy
381158|NCT01511640|cannabinoid|cannabinoid
381159|NCT01511614|fMRI|fmri
381160|NCT01511614|Nicotine Withdrawal|nicotine withdrawal
381161|NCT01511601|Apheresis|apheresis
381162|NCT01511601|Leukocytes|leukocytes
381163|NCT01511601|Plasma|plasma
381356|NCT01510873|pITO|pito
381164|NCT01511601|Plamodium Falciparum Malaria|plamodium falciparum malaria
381165|NCT01511601|Immunology|immunology
381166|NCT01511588|Kallmann Syndrome|kallmann syndrome
381167|NCT01511588|Delayed Puberty|delayed puberty
381168|NCT01511588|GnRH Deficiency|gnrh deficiency
381169|NCT01511588|Infertility|infertility
381170|NCT01511588|Hypogonadotropic Hypogonadism|hypogonadotropic hypogonadism
381171|NCT01511588|Amenorrhea|amenorrhea
381172|NCT01511588|Hypogonadism|hypogonadism
381173|NCT01511575|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
381174|NCT01511575|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
381175|NCT01511575|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
381176|NCT01511562|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
381177|NCT01511562|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
381178|NCT01511562|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
381179|NCT01511562|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
381180|NCT01511562|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
381181|NCT01511562|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
381182|NCT01511523|Liver|liver
381183|NCT01511523|Fatty|fatty
381184|NCT01511523|Non Alcoholic|non alcoholic
381185|NCT01511523|Vitamin E|vitamin e
381186|NCT01511523|Silymarin|silymarin
381187|NCT01511523|Carnitine|carnitine
381188|NCT01511523|Supplement|supplement
381189|NCT01511523|NAFLD|nafld
381190|NCT01511510|PF-04958242|pf-04958242
381191|NCT01511510|multiple dose|multiple dose
381192|NCT01511510|safety|safety
381193|NCT01511510|schizophrenia|schizophrenia
381194|NCT01511497|Phase 1|phase 1
381195|NCT01511497|PF-04427429|pf-04427429
381196|NCT01511484|fruit|fruit
381197|NCT01511484|vegetables|vegetables
381198|NCT01511484|appearance|appearance
381199|NCT01511484|skin color|skin color
381200|NCT01511484|carotenoids|carotenoids
381201|NCT01511484|diet|diet
381202|NCT01511471|Ticagrelor|ticagrelor
381203|NCT01511471|platelet reactivity|platelet reactivity
381204|NCT01511471|clopidogrel|clopidogrel
381205|NCT01511471|haemodialysis|haemodialysis
381206|NCT01511458|Pregnancy|pregnancy
381207|NCT01511458|Fetal aneuploidy|fetal aneuploidy
381208|NCT01511458|Trisomy 21|trisomy 21
381209|NCT01511458|Down Syndrome|down syndrome
381210|NCT01511458|Prenatal screening|prenatal screening
381211|NCT01511458|Non-invasive prenatal testing|non-invasive prenatal testing
381212|NCT01511458|First trimester|first trimester
381213|NCT01511458|Combined screening|combined screening
381214|NCT01511458|Nuchal translucency|nuchal translucency
381215|NCT01511458|PAPP-A|papp-a
381216|NCT01511458|hCG|hcg
381217|NCT01511458|cell free DNA|cell free dna
381218|NCT01511458|cf DNA|cf dna
381219|NCT01511458|DNA|dna
381220|NCT01511458|Performance characteristics of non-invasive first trimester screening|performance characteristics of non-invasive first trimester screening
381221|NCT01511458|Harmony Prenatal Test|harmony prenatal test
381222|NCT01511445|Cervicobrachial pain|cervicobrachial pain
381223|NCT01511445|radicular pain|radicular pain
381224|NCT01511445|arm pain|arm pain
381225|NCT01511445|myelopathy|myelopathy
381226|NCT01511445|radiculitis|radiculitis
381227|NCT01511445|Radiating pain with or without signs of myelopathy.|radiating pain with or without signs of myelopathy.
381228|NCT01511432|Relative bioavailability|relative bioavailability
381229|NCT01511432|telaprevir formulations|telaprevir formulations
381230|NCT01511419|Influenza|influenza
381231|NCT01511419|Vaccine|vaccine
381232|NCT01511419|Pandemic|pandemic
381233|NCT01511419|H7N3|h7n3
381234|NCT01511406|Psychosis|psychosis
381235|NCT01511406|Schizophrenia|schizophrenia
381236|NCT01511406|Cognitive behavioral therapy|cognitive behavioral therapy
381237|NCT01511406|Self esteem|self esteem
381238|NCT01511406|Depression|depression
381239|NCT01511393|GLP1|glp1
381240|NCT01511393|Glucagon like peptide|glucagon like peptide
381241|NCT01511393|liraglutide|liraglutide
381242|NCT01511393|exenatide extended release|exenatide extended release
381243|NCT01511393|albiglutide|albiglutide
381244|NCT01511393|dulaglutide|dulaglutide
381245|NCT01511380|juvenile|juvenile
381246|NCT01511380|randomized trial|randomized trial
381247|NCT01511380|substance abuse|substance abuse
381248|NCT01511380|sexual risk|sexual risk
381249|NCT01511380|contingency management|contingency management
381250|NCT01511367|moderate to severe persistent reversible asthma|moderate to severe persistent reversible asthma
381251|NCT01511354|critically ill children|critically ill children
381252|NCT01511354|ICU|icu
381253|NCT01511354|24hr protein balance|24hr protein balance
381254|NCT01511354|stable isotopes|stable isotopes
381255|NCT01511354|fed state|fed state
381256|NCT01511341|Telenursing|telenursing
381257|NCT01511341|Children|children
381258|NCT01511341|Chronic Illness|chronic illness
381259|NCT01511341|Nursing|nursing
381260|NCT01511328|HPV testing|hpv testing
381261|NCT01511328|Primary screening|primary screening
381262|NCT01511328|Cervical Cancer|cervical cancer
381263|NCT01511315|Moderate to severe psoriasis|moderate to severe psoriasis
381264|NCT01511289|Radotinib|radotinib
381265|NCT01511289|CML-CP|cml-cp
381266|NCT01511289|Chronic Myeloid Leukemia, chronic phase|chronic myeloid leukemia, chronic phase
381267|NCT01511276|Breast cancer|breast cancer
381268|NCT01511276|Sex hormones|sex hormones
381269|NCT01511276|Physical activity|physical activity
381270|NCT01511263|Epigallocatechin gallate|epigallocatechin gallate
381271|NCT01511263|AL amyloidosis|al amyloidosis
381272|NCT01511250|Normal healthy adults and children|normal healthy adults and children
381273|NCT01511250|Safety and tolerability|safety and tolerability
381274|NCT01511250|Active vaccine|active vaccine
381275|NCT01511250|Placebo|placebo
381276|NCT01511250|Dengue virus vaccine|dengue virus vaccine
381277|NCT01511250|Immune response|immune response
381278|NCT01511237|HIV-1 infection|hiv-1 infection
381279|NCT01511237|Prophylaxis|prophylaxis
381280|NCT01511237|Mother-to-child transmission HIV-1|mother-to-child transmission hiv-1
381281|NCT01511237|Thailand|thailand
381282|NCT01511237|Developing Countries|developing countries
381283|NCT01511224|Bloodstream infections|bloodstream infections
381284|NCT01511224|Acinetobacter|acinetobacter
381285|NCT01511224|Drug resistant Acinetobacter baumannii bacteremia|drug resistant acinetobacter baumannii bacteremia
381286|NCT01511211|Dexamethasone|dexamethasone
381287|NCT01511211|lower limb block|lower limb block
381288|NCT01511211|ultrasound guided femoral nerve block|ultrasound guided femoral nerve block
381289|NCT01511211|ultrasound guided obturator nerve block|ultrasound guided obturator nerve block
381290|NCT01511211|ultrasound guided sciatic nerve block|ultrasound guided sciatic nerve block
381291|NCT01511211|ropivacaine|ropivacaine
381292|NCT01511211|total knee arthroplasty|total knee arthroplasty
381293|NCT01511211|Post surgical pain after total knee arthroplasty|post surgical pain after total knee arthroplasty
381294|NCT01511146|oxaliplatin|oxaliplatin
381295|NCT01511146|mitomycin|mitomycin
381296|NCT01511146|gemcitabine|gemcitabine
381297|NCT01511146|intrahepatic|intrahepatic
381298|NCT01511146|liver metastasis|liver metastasis
381299|NCT01511146|response in liver metastasis|response in liver metastasis
381300|NCT01511146|downsized to operation|downsized to operation
381301|NCT01511133|Laboratory evaluations|laboratory evaluations
381302|NCT01511133|infants|infants
381303|NCT01511133|Porcine circovirus type 1 (PCV-1)|porcine circovirus type 1 (pcv-1)
381304|NCT01511133|serologic response|serologic response
381305|NCT01511133|human rotavirus (HRV) vaccine|human rotavirus (hrv) vaccine
381306|NCT01511107|acute otitis media|acute otitis media
381307|NCT01511107|ear infection|ear infection
381308|NCT01511107|antimicrobial therapy|antimicrobial therapy
381309|NCT01511107|antimicrobial resistance|antimicrobial resistance
381310|NCT01511094|ab-interno trabeculectomy,|ab-interno trabeculectomy,
381311|NCT01511094|intraocular pressure,|intraocular pressure,
381312|NCT01511094|open angle glaucoma|open angle glaucoma
381313|NCT01511094|trabeculectomy|trabeculectomy
381314|NCT01511094|Goniocurettage|goniocurettage
381315|NCT01511094|Non-Filtering Surgery|non-filtering surgery
381316|NCT01511081|Non-small-cell lung cancer|non-small-cell lung cancer
381317|NCT01511081|NSCLC|nsclc
381318|NCT01511081|Centrally-located|centrally-located
381319|NCT01511081|Recurrent|recurrent
381320|NCT01511081|Squamous cell carcinoma|squamous cell carcinoma
381321|NCT01511081|Adenocarcinoma|adenocarcinoma
381322|NCT01511081|Large cell carcinoma|large cell carcinoma
381323|NCT01511081|Bronchioloalveolar cell carcinoma|bronchioloalveolar cell carcinoma
381324|NCT01511081|Non-small cell carcinoma not otherwise specified|non-small cell carcinoma not otherwise specified
381325|NCT01511081|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
381326|NCT01511081|SBRT|sbrt
381327|NCT01511081|Stereotactic Body Proton Therapy|stereotactic body proton therapy
381328|NCT01511081|SBPT|sbpt
381329|NCT01511068|PAP|pap
381330|NCT01511055|Ovarian Cancer|ovarian cancer
381331|NCT01511016|lipid kinetics|lipid kinetics
381332|NCT01511016|fat oxidation|fat oxidation
381333|NCT01511003|calcineurin inhibitor|calcineurin inhibitor
381334|NCT01511003|Prograf|prograf
381335|NCT01511003|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
381336|NCT01511003|Tacrolimus|tacrolimus
381337|NCT01510990|Non-small cell lung cancer|non-small cell lung cancer
381338|NCT01510990|Gefitinib|gefitinib
381339|NCT01510990|FDG-PET|fdg-pet
381340|NCT01510977|colonoscopy|colonoscopy
381341|NCT01510977|bowel preparation|bowel preparation
381342|NCT01510964|Breast cancer|breast cancer
381343|NCT01510964|Patient involvement|patient involvement
381344|NCT01510964|Question prompt-sheet|question prompt-sheet
381345|NCT01510964|Doctor-patient communication|doctor-patient communication
381346|NCT01510964|RCT|rct
381347|NCT01510951|AMGEN|amgen
381348|NCT01510951|PSORIASIS|psoriasis
381349|NCT01510951|SAFETY|safety
381350|NCT01510938|Children|children
381351|NCT01510938|Respiratory Tract Infections|respiratory tract infections
381352|NCT01510938|Prevention|prevention
381353|NCT01510886|MDD, management, Andalusia, Database, PismaEP|mdd, management, andalusia, database, pismaep
381354|NCT01510873|Health-related quality of life|health-related quality of life
381355|NCT01510873|Fatigue|fatigue
381357|NCT01510873|Primary Immune Thrombocytopenic Purpura|primary immune thrombocytopenic purpura
381358|NCT01510834|Computerized Tailored Intervention|computerized tailored intervention
381359|NCT01510834|CTI|cti
381360|NCT01510834|Post Traumatic Stress Disorder|post traumatic stress disorder
381361|NCT01510834|PTSD|ptsd
381362|NCT01510834|Smoking|smoking
381363|NCT01510834|Anxiety|anxiety
381364|NCT01510834|Depression|depression
381365|NCT01510821|endoscopic vein harvest|endoscopic vein harvest
381366|NCT01510821|saphenous vein graft|saphenous vein graft
381367|NCT01510821|endothelial function|endothelial function
381368|NCT01510808|aggressive periodontitis orthodontic stability|aggressive periodontitis orthodontic stability
381369|NCT01510795|Kidney transplantation|kidney transplantation
381370|NCT01510795|Mineralocorticoid receptors|mineralocorticoid receptors
381371|NCT01510795|Spironolactone|spironolactone
381372|NCT01510743|open heart surgery|open heart surgery
381373|NCT01510743|lung surgery|lung surgery
381374|NCT01510743|spine surgery|spine surgery
381375|NCT01510743|hepatobiliary surgery|hepatobiliary surgery
381376|NCT01510730|gastric tumor|gastric tumor
381377|NCT01510730|Helicobacter pylori|helicobacter pylori
381378|NCT01510730|endoscopic resection|endoscopic resection
381379|NCT01510730|metachronous neoplasms|metachronous neoplasms
381380|NCT01510717|Intraocular Lens|intraocular lens
381381|NCT01510717|Monofocal|monofocal
381382|NCT01510717|Multifocal|multifocal
381383|NCT01510691|Oxygenation of the retinal vessels|oxygenation of the retinal vessels
381384|NCT01510691|vitroretinal surgery|vitroretinal surgery
381385|NCT01510678|Diet Quality|diet quality
381386|NCT01510665|Weight gain in pregnancy|weight gain in pregnancy
381387|NCT01510665|Metabolic and Inflammatory markers|metabolic and inflammatory markers
381388|NCT01510652|Cardiac Resynchronization therapy,|cardiac resynchronization therapy,
381389|NCT01510652|Heart Failure,|heart failure,
381390|NCT01510652|Left Ventricular Lead,|left ventricular lead,
381391|NCT01510652|Quadripolar Left ventricular Lead,|quadripolar left ventricular lead,
381392|NCT01510652|Phrenic Nerve Stimulation,|phrenic nerve stimulation,
381393|NCT01510652|Intra and post operative related complications|intra and post operative related complications
381394|NCT01510626|Multiple food allergies|multiple food allergies
381395|NCT01510613|Pomalidomide|pomalidomide
381396|NCT01510613|Dexamethasone|dexamethasone
381397|NCT01510613|treatment|treatment
381398|NCT01510613|AL amyloidosis|al amyloidosis
381399|NCT01510600|stage 4S neuroblastoma|stage 4s neuroblastoma
381400|NCT01510600|localized resectable neuroblastoma|localized resectable neuroblastoma
381401|NCT01510600|localized unresectable neuroblastoma|localized unresectable neuroblastoma
381402|NCT01510600|recurrent neuroblastoma|recurrent neuroblastoma
381403|NCT01510600|regional neuroblastoma|regional neuroblastoma
381404|NCT01510587|obesity|obesity
381405|NCT01510587|prevention|prevention
381406|NCT01510587|preteen|preteen
381407|NCT01510587|nutrition|nutrition
381408|NCT01510587|physical activity|physical activity
381409|NCT01510587|body image|body image
381410|NCT01510587|family dynamics|family dynamics
381411|NCT01510574|postpartum hemorrhage, PPH, misoprostol|postpartum hemorrhage, pph, misoprostol
381412|NCT01510561|metastatic pancreatic adenocarcinoma|metastatic pancreatic adenocarcinoma
381413|NCT01510561|pancreatic cancer|pancreatic cancer
381414|NCT01510561|metastatic pancreatic cancer|metastatic pancreatic cancer
381415|NCT01510548|Disc prolapse|disc prolapse
381416|NCT01510548|Pain|pain
381417|NCT01510548|Disability|disability
381418|NCT01510535|Osteoartritis|osteoartritis
381419|NCT01510535|Knee|knee
381420|NCT01510535|LBSA0103|lbsa0103
381421|NCT01510535|Hyruan Plus Inj.|hyruan plus inj.
381422|NCT01510522|Diabetes|diabetes
381423|NCT01510522|Glucophage|glucophage
381424|NCT01510522|Metformin|metformin
381425|NCT01510522|sachets|sachets
381426|NCT01510522|tablets|tablets
381427|NCT01510509|Drug Eluting Stent|drug eluting stent
381428|NCT01510509|Bioactive Bare Metal Stent|bioactive bare metal stent
381429|NCT01510496|Chronic pain|chronic pain
381430|NCT01510496|genetic polymorphisms|genetic polymorphisms
381431|NCT01510496|postoperative pain|postoperative pain
381432|NCT01510483|obesity prevention|obesity prevention
381433|NCT01510483|tobacco prevention|tobacco prevention
381434|NCT01510483|nutrition|nutrition
381435|NCT01510483|physical activity|physical activity
381436|NCT01510483|sedentary activity|sedentary activity
381437|NCT01510483|tobacco use|tobacco use
381438|NCT01510483|tobacco exposure|tobacco exposure
381439|NCT01510483|prevention|prevention
381440|NCT01510483|clinician intervention|clinician intervention
381441|NCT01510483|preteen|preteen
381442|NCT01510483|adolescents|adolescents
381443|NCT01510470|AstraTech Osseospeed Profile Implant|astratech osseospeed profile implant
381444|NCT01510470|Marginal bone level|marginal bone level
381445|NCT01510470|soft tissue|soft tissue
381446|NCT01510470|soft tissue responds|soft tissue responds
381447|NCT01510457|Knee Osteoarthritis|knee osteoarthritis
381448|NCT01510457|Degenerative Joint Disease|degenerative joint disease
381449|NCT01510457|Chronic Pain|chronic pain
381450|NCT01510457|Knee Pain|knee pain
381451|NCT01510418|Hemophilia|hemophilia
381452|NCT01510418|Spouse|spouse
381453|NCT01510418|Significant Other|significant other
381454|NCT01510418|Quality of Life|quality of life
381455|NCT01510405|Subjects undergoing or who have undergone thoracic surgery for presumed lung cancer.|subjects undergoing or who have undergone thoracic surgery for presumed lung cancer.
381456|NCT01510405|The following procedures are allowed: Wedge resection, lobectomy, bilobectomy, segmentectomy and pneumonectomy thoracic surgical operations are permitted.|the following procedures are allowed: wedge resection, lobectomy, bilobectomy, segmentectomy and pneumonectomy thoracic surgical operations are permitted.
381457|NCT01510392|Optical coherence tomography|optical coherence tomography
381458|NCT01510392|Glaucoma|glaucoma
381459|NCT01510392|Macula|macula
381460|NCT01510392|Keratoconus|keratoconus
381461|NCT01510392|Screening|screening
381462|NCT01510379|nausea|nausea
381463|NCT01510379|vomiting|vomiting
381464|NCT01510379|post-operative|post-operative
381465|NCT01510379|foregut surgery|foregut surgery
381466|NCT01510366|Inactivated Poliomyelitis Vaccine|inactivated poliomyelitis vaccine
381467|NCT01510366|Sabin Strains|sabin strains
381468|NCT01510366|poliomyelitis|poliomyelitis
381469|NCT01510340|adherence|adherence
381470|NCT01510340|HIV|hiv
381471|NCT01510340|antiretroviral therapy|antiretroviral therapy
381472|NCT01510340|tailored web intervention|tailored web intervention
381473|NCT01510327|drug-eluting stents|drug-eluting stents
381474|NCT01510327|DES|des
381475|NCT01510327|atherosclerotic|atherosclerotic
381476|NCT01510301|Self-report|self-report
381477|NCT01510301|Self-management|self-management
381478|NCT01510301|Hypertension|hypertension
381479|NCT01510301|Adherence|adherence
381480|NCT01510301|Cell phone|cell phone
381481|NCT01510301|Drug treatment|drug treatment
381482|NCT01510301|Medical Adherence|medical adherence
381483|NCT01510288|GVAX|gvax
381484|NCT01510288|Ipilimumab|ipilimumab
381485|NCT01510288|prostate cancer|prostate cancer
381486|NCT01510275|cardio-thoracic surgery|cardio-thoracic surgery
381487|NCT01510275|patients|patients
381488|NCT01510275|pulmonary volume|pulmonary volume
381489|NCT01510275|respiratory muscle performance|respiratory muscle performance
381490|NCT01510262|Repeat STI patients|repeat sti patients
381491|NCT01510262|HIV|hiv
381492|NCT01510262|Cost effectiveness|cost effectiveness
381493|NCT01510262|Resource scarce|resource scarce
381494|NCT01510262|Urban clinics|urban clinics
381495|NCT01510249|calcaneal spur|calcaneal spur
381496|NCT01510249|shock wave therapy|shock wave therapy
381497|NCT01510249|ultrasound therapy|ultrasound therapy
381498|NCT01510236|Adolescence|adolescence
381499|NCT01510236|Cancer|cancer
381500|NCT01510236|Depression|depression
381501|NCT01510236|Anxiety|anxiety
381502|NCT01510236|Self-help via internet|self-help via internet
381503|NCT01510223|Fats|fats
381504|NCT01510223|Macronutrients|macronutrients
381505|NCT01510223|appetite|appetite
381506|NCT01510223|gastric emptying|gastric emptying
381507|NCT01510223|Gastrointestinal transit|gastrointestinal transit
381508|NCT01510210|Atrial Fibrillation|atrial fibrillation
381509|NCT01510210|Arrhythmia|arrhythmia
381510|NCT01510210|Rhythm control|rhythm control
381511|NCT01510197|Atrial Fibrillation|atrial fibrillation
381512|NCT01510197|Arrhythmia|arrhythmia
381513|NCT01510197|Rhythm control|rhythm control
381514|NCT01510171|platelet inhibitor|platelet inhibitor
381515|NCT01510171|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
381516|NCT01510171|stent|stent
381517|NCT01510171|prasugrel|prasugrel
381518|NCT01510171|ticagrelor|ticagrelor
381519|NCT01510145|Glaucoma|glaucoma
381520|NCT01510145|Open-angle glaucoma|open-angle glaucoma
381521|NCT01510145|Ocular hypertension|ocular hypertension
381522|NCT01510145|Hypertension|hypertension
381523|NCT01510145|Eye Diseases|eye diseases
381524|NCT01510145|Vascular Diseases|vascular diseases
381525|NCT01510145|Cardiovascular Diseases|cardiovascular diseases
381526|NCT01510145|Travoprost|travoprost
381527|NCT01510145|Antihypertensive Agents|antihypertensive agents
381528|NCT01510145|Cardiovascular Agents|cardiovascular agents
381529|NCT01510145|Therapeutic Uses|therapeutic uses
381530|NCT01510145|Pharmacologic Actions|pharmacologic actions
381531|NCT01510132|OAG|oag
381532|NCT01510132|OHT|oht
381533|NCT01510093|type 2 diabetes mellitus, endogenous insulin|type 2 diabetes mellitus, endogenous insulin
381534|NCT01510080|Computer-assisted live supervision|computer-assisted live supervision
381535|NCT01510080|"Bug-in-the-eye supervision"|"bug-in-the-eye supervision"
381536|NCT01510080|Delayed video-based supervision|delayed video-based supervision
381537|NCT01510080|Cognitive behavioral therapy supervision|cognitive behavioral therapy supervision
381538|NCT01510067|CLE|cle
381539|NCT01510067|Lupus|lupus
381540|NCT01510067|Lupus Erythematosus|lupus erythematosus
381541|NCT01510054|miRNA in endometrium|mirna in endometrium
381542|NCT01510041|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
381543|NCT01510041|Physical therapy|physical therapy
381544|NCT01510041|Dyspnea|dyspnea
381545|NCT01510041|Inspiratory muscle training|inspiratory muscle training
381546|NCT01510041|Activities of daily living|activities of daily living
381547|NCT01510028|Intrathecal Drug Delivery Device (IDDD)|intrathecal drug delivery device (iddd)
381647|NCT01509573|prevention therapy|prevention therapy
381548|NCT01510028|Recombinant human arylsulfatase A (rhASA)|recombinant human arylsulfatase a (rhasa)
381549|NCT01510028|Metachromatic Leukodystrophy (MLD)|metachromatic leukodystrophy (mld)
381550|NCT01510015|cannabis|cannabis
381551|NCT01510015|psychostimulants|psychostimulants
381552|NCT01510015|psychosis|psychosis
381553|NCT01510002|papillary thyroid cancer|papillary thyroid cancer
381554|NCT01510002|central neck dissection|central neck dissection
381555|NCT01510002|survival|survival
381556|NCT01510002|locoregional control|locoregional control
381557|NCT01510002|morbidity|morbidity
381558|NCT01509989|Adherence|adherence
381559|NCT01509989|Compliance|compliance
381560|NCT01509989|Systemic Lupus Erythematosus|systemic lupus erythematosus
381561|NCT01509989|Hydroxychloroquine|hydroxychloroquine
381562|NCT01509989|Blood monitoring|blood monitoring
381563|NCT01509989|Flares|flares
381564|NCT01509976|Triclosan|triclosan
381565|NCT01509976|Triclocarban|triclocarban
381566|NCT01509976|Microbial flora|microbial flora
381567|NCT01509976|Obesity|obesity
381568|NCT01509963|MSKCC nomogram|mskcc nomogram
381569|NCT01509963|Tenon score|tenon score
381570|NCT01509963|metastatic SN|metastatic sn
381571|NCT01509963|low risk of metastatic non-SN|low risk of metastatic non-sn
381572|NCT01509963|additional ALND|additional alnd
381573|NCT01509937|end stage renal disease|end stage renal disease
381574|NCT01509937|maintenance hemodialysis|maintenance hemodialysis
381575|NCT01509937|dry weight|dry weight
381576|NCT01509937|bioimpedance spectroscopy analysis|bioimpedance spectroscopy analysis
381577|NCT01509937|body composition monitor|body composition monitor
381578|NCT01509937|Fresenius BCM|fresenius bcm
381579|NCT01509937|Ultrafiltration|ultrafiltration
381580|NCT01509924|Walking capacity|walking capacity
381581|NCT01509924|Mental Fatigue|mental fatigue
381582|NCT01509924|Quality of Life|quality of life
381583|NCT01509924|Cognition|cognition
381584|NCT01509924|Motor activity|motor activity
381585|NCT01509924|Exercise|exercise
381586|NCT01509872|Trauma-Focused Cognitive Behavior Therapy|trauma-focused cognitive behavior therapy
381587|NCT01509872|War-affected Children|war-affected children
381588|NCT01509872|Post-traumatic Stress Symptoms|post-traumatic stress symptoms
381589|NCT01509872|Psychosocial Distress|psychosocial distress
381590|NCT01509859|proximal femur nail|proximal femur nail
381591|NCT01509859|pfna|pfna
381592|NCT01509859|intertan|intertan
381593|NCT01509859|weight bearing|weight bearing
381594|NCT01509859|pertrochanteric fracture|pertrochanteric fracture
381595|NCT01509859|femur neck fracture|femur neck fracture
381596|NCT01509846|Shigella|shigella
381597|NCT01509846|vaccine|vaccine
381598|NCT01509846|shigellosis|shigellosis
381599|NCT01509846|dysentery|dysentery
381600|NCT01509846|whole cell|whole cell
381601|NCT01509833|ICSI Ovarian stimulation|icsi ovarian stimulation
381602|NCT01509833|hCG low dose|hcg low dose
381603|NCT01509833|Oocyte maturity|oocyte maturity
381604|NCT01509833|poor respond|poor respond
381605|NCT01509807|Ileostomy reversal|ileostomy reversal
381606|NCT01509794|CME|cme
381607|NCT01509794|Simulation|simulation
381608|NCT01509794|Affective engagement|affective engagement
381609|NCT01509794|Cognitive performance|cognitive performance
381610|NCT01509781|simple mastectomy|simple mastectomy
381611|NCT01509781|modified radical mastectomy|modified radical mastectomy
381612|NCT01509781|wound care|wound care
381613|NCT01509781|suction drain|suction drain
381614|NCT01509781|adaptive suture|adaptive suture
381615|NCT01509768|MPS IIIB|mps iiib
381616|NCT01509729|Knee|knee
381617|NCT01509729|Arthroscopy|arthroscopy
381618|NCT01509729|Lidocaine patch|lidocaine patch
381619|NCT01509729|Pain management after knee arthroscopy|pain management after knee arthroscopy
381620|NCT01509716|Predialysis|predialysis
381621|NCT01509703|COPD|copd
381622|NCT01509703|Nasal High Flow Therapy|nasal high flow therapy
381623|NCT01509703|tracheotomy stent|tracheotomy stent
381624|NCT01509703|tracheotomy|tracheotomy
381625|NCT01509690|Incident|incident
381626|NCT01509690|Hemodialysis|hemodialysis
381627|NCT01509677|Roflumilast|roflumilast
381628|NCT01509677|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
381629|NCT01509677|COPD|copd
381630|NCT01509651|antagonists neuromuscular block|antagonists neuromuscular block
381631|NCT01509651|neuromuscular block, monitoring|neuromuscular block, monitoring
381632|NCT01509651|neuromuscular function|neuromuscular function
381633|NCT01509638|Ileostomy reversal|ileostomy reversal
381634|NCT01509625|Fulvestrant|fulvestrant
381635|NCT01509625|Faslodex|faslodex
381636|NCT01509612|cancer|cancer
381637|NCT01509612|additive homeopathy|additive homeopathy
381638|NCT01509612|patients with advanced malignant tumors|patients with advanced malignant tumors
381639|NCT01509599|Venous disease|venous disease
381640|NCT01509599|Venous disorders|venous disorders
381641|NCT01509599|Venous insufficiency|venous insufficiency
381642|NCT01509599|Venous ulcers|venous ulcers
381643|NCT01509599|Cryotherapy|cryotherapy
381644|NCT01509586|smoking|smoking
381645|NCT01509586|smoking cessation|smoking cessation
381646|NCT01509586|Potentially Reduced Exposure Products (PREPs)|potentially reduced exposure products (preps)
381648|NCT01509573|depressive symptoms|depressive symptoms
381649|NCT01509573|anxiety|anxiety
381650|NCT01509573|parenting|parenting
381651|NCT01509573|family functioning|family functioning
381652|NCT01509573|resilience, psychological|resilience, psychological
381653|NCT01509573|Developing countries|developing countries
381654|NCT01509573|Rwanda|rwanda
381655|NCT01509573|HIV/AIDS|hiv/aids
381656|NCT01509534|pacemaker|pacemaker
381657|NCT01509534|implantable loop recorder|implantable loop recorder
381658|NCT01509534|syncope|syncope
381659|NCT01509521|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
381660|NCT01509521|Fetal heartrate|fetal heartrate
381661|NCT01509521|Ephedrine|ephedrine
381662|NCT01509521|Phenylephrine|phenylephrine
381663|NCT01509508|HIV|hiv
381664|NCT01509508|Prevention|prevention
381665|NCT01509508|Treatment|treatment
381666|NCT01509508|South Africa|south africa
381667|NCT01509495|Heart Failure|heart failure
381668|NCT01509495|HF|hf
381669|NCT01509482|insulin resistance|insulin resistance
381670|NCT01509482|unexplained azoospermia|unexplained azoospermia
381671|NCT01509482|unexplained oligospermia|unexplained oligospermia
381672|NCT01509469|Ileal brake|ileal brake
381673|NCT01509469|Casein|casein
381674|NCT01509469|Sucrose|sucrose
381675|NCT01509469|Ileal infusion|ileal infusion
381676|NCT01509456|bone metabolism|bone metabolism
381677|NCT01509456|potassium bicarbonate|potassium bicarbonate
381678|NCT01509456|alkaline salt|alkaline salt
381679|NCT01509456|acid base balance|acid base balance
381680|NCT01509456|bed rest|bed rest
381681|NCT01509443|Asthma|asthma
381682|NCT01509443|Obesity|obesity
381683|NCT01509443|Breathing exercise|breathing exercise
381684|NCT01509417|pyloric stenosis|pyloric stenosis
381685|NCT01509404|CMV|cmv
381686|NCT01509404|cytomegalovirus|cytomegalovirus
381687|NCT01509404|transplant|transplant
381688|NCT01509378|ICD|icd
381689|NCT01509378|ATP therapy|atp therapy
381690|NCT01509378|Rescue Shock therapy|rescue shock therapy
381691|NCT01509365|cardiovascular disease|cardiovascular disease
381692|NCT01509365|maintenance dose|maintenance dose
381693|NCT01509365|clopidogrel|clopidogrel
381694|NCT01509365|overweight|overweight
381695|NCT01509365|antiplatelet agents|antiplatelet agents
381696|NCT01509352|fundoplication|fundoplication
381697|NCT01509352|gastric reflux|gastric reflux
381698|NCT01509339|Vancomycin|vancomycin
381699|NCT01509339|Inhalation|inhalation
381700|NCT01509339|Nebulization|nebulization
381701|NCT01509339|Pharmacokinetics|pharmacokinetics
381702|NCT01509326|headache|headache
381703|NCT01509326|chiropractic|chiropractic
381704|NCT01509326|manipulation|manipulation
381705|NCT01509326|acupressure|acupressure
381706|NCT01509326|self-care|self-care
381707|NCT01509313|endometrial polyps|endometrial polyps
381708|NCT01509313|uterine polyps|uterine polyps
381709|NCT01509313|morcellator|morcellator
381710|NCT01509313|hysteroscopy|hysteroscopy
381711|NCT01509300|TBI|tbi
381712|NCT01509300|Fludarabine|fludarabine
381713|NCT01509300|CD3 depletion|cd3 depletion
381714|NCT01509300|Children and adolescents|children and adolescents
381715|NCT01509300|Haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
381716|NCT01509287|Donnai-Barrow Syndrome (DBS)|donnai-barrow syndrome (dbs)
381717|NCT01509287|metabolic testing|metabolic testing
381718|NCT01509287|genes|genes
381719|NCT01509287|genetic|genetic
381720|NCT01509274|Plantar fasciitis|plantar fasciitis
381721|NCT01509274|Plasma|plasma
381722|NCT01509274|PRP|prp
381723|NCT01509274|Heel pain|heel pain
381724|NCT01509261|Erosive Esophagitis|erosive esophagitis
381725|NCT01509261|Ilaprazole|ilaprazole
381726|NCT01509261|GERD|gerd
381727|NCT01509248|Theophylline|theophylline
381728|NCT01509235|cystic fibrosis|cystic fibrosis
381729|NCT01509235|Lung function|lung function
381730|NCT01509235|physical exercise|physical exercise
381731|NCT01509222|Health promotion|health promotion
381732|NCT01509222|Dietary Counseling|dietary counseling
381733|NCT01509209|vasomotor|vasomotor
381734|NCT01509209|pseudoephedrine|pseudoephedrine
381735|NCT01509209|levocetirizine|levocetirizine
381736|NCT01509196|Fenofibric acid|fenofibric acid
381737|NCT01509196|HIP0901|hip0901
381738|NCT01509196|Lipidilsupra|lipidilsupra
381739|NCT01509183|asthma|asthma
381740|NCT01509183|healthcare utilization costs|healthcare utilization costs
381741|NCT01509157|Type 1 diabetes|type 1 diabetes
381742|NCT01509157|Continuous Glucose Monitoring|continuous glucose monitoring
381743|NCT01509157|Nocturnal Hypoglycemia|nocturnal hypoglycemia
381744|NCT01509144|Safety of this HIV vaccine|safety of this hiv vaccine
381745|NCT01509092|traumatic macular hole|traumatic macular hole
381746|NCT01509092|vitrectomy|vitrectomy
381747|NCT01509092|observation|observation
381748|NCT01509066|vegetarian|vegetarian
381749|NCT01509066|vegan|vegan
381750|NCT01509066|low calorie|low calorie
381751|NCT01509066|infertility|infertility
381752|NCT01509066|PCOS|pcos
381753|NCT01509053|Schizophrenia|schizophrenia
381754|NCT01509040|Resuscitated from Out-of-Hospital Cardiac Arrest|resuscitated from out-of-hospital cardiac arrest
381755|NCT01509027|hemodialysis|hemodialysis
381756|NCT01509027|hyperphoshatemia|hyperphoshatemia
381757|NCT01509027|compliance|compliance
381758|NCT01509014|Statins|statins
381759|NCT01509014|Adherence|adherence
381760|NCT01509014|Pharmacists|pharmacists
381761|NCT01509001|type 2 diabetes|type 2 diabetes
381762|NCT01509001|metformin|metformin
381763|NCT01509001|glimepiride|glimepiride
381764|NCT01509001|glucose control|glucose control
381765|NCT01509001|vascular reactivity|vascular reactivity
381766|NCT01509001|Adverse Reaction to Other Drugs and Medicines|adverse reaction to other drugs and medicines
381767|NCT01508988|ONO-9054|ono-9054
381768|NCT01508988|adult healthy volunteers|adult healthy volunteers
381769|NCT01508988|single dose|single dose
381770|NCT01508988|phase 1|phase 1
381771|NCT01508975|satiety|satiety
381772|NCT01508975|obesity|obesity
381773|NCT01508975|food intake|food intake
381774|NCT01508962|Disease onset|disease onset
381775|NCT01508962|Disease progression|disease progression
381776|NCT01508884|intradermal|intradermal
381777|NCT01508884|influenza|influenza
381778|NCT01508884|vaccination|vaccination
381779|NCT01508845|vitamin D|vitamin d
381780|NCT01508845|vitamin D absorption|vitamin d absorption
381781|NCT01508845|vitamin D deficiency|vitamin d deficiency
381782|NCT01508819|Patients over 75|patients over 75
381783|NCT01508819|acute pathology|acute pathology
381784|NCT01508819|ICU admission|icu admission
381785|NCT01508793|Sleep|sleep
381786|NCT01508793|Obesity|obesity
381787|NCT01508793|Children|children
381788|NCT01508793|Eating behaviors|eating behaviors
381789|NCT01508793|Activity|activity
381790|NCT01508754|Continuous positive airway pressure|continuous positive airway pressure
381791|NCT01508754|Ambulatory blood pressures|ambulatory blood pressures
381792|NCT01508741|Insomnia|insomnia
381793|NCT01508741|Frequent Nocturnal Awakening|frequent nocturnal awakening
381794|NCT01508741|Irritability|irritability
381795|NCT01508741|Moody|moody
381796|NCT01508741|Moodiness|moodiness
381797|NCT01508741|Coping Ability|coping ability
381798|NCT01508741|Coping Behavior|coping behavior
381799|NCT01508741|Stress|stress
381800|NCT01508741|Feeling Overwhelmed|feeling overwhelmed
381801|NCT01508728|unoperated severe sprain of the knee with partial or total rupture of the anterior|unoperated severe sprain of the knee with partial or total rupture of the anterior
381802|NCT01508728|cruciate ligament and medial or lateral collateral ligament|cruciate ligament and medial or lateral collateral ligament
381803|NCT01508715|subacromial|subacromial
381804|NCT01508715|rotator cuff|rotator cuff
381805|NCT01508715|impingement|impingement
381806|NCT01508715|physical therapy|physical therapy
381807|NCT01508715|eccentric exercise|eccentric exercise
381808|NCT01508715|concentric exercise|concentric exercise
381809|NCT01508702|Gout|gout
381810|NCT01508689|Cereal bar|cereal bar
381811|NCT01508689|Calcium-fortified|calcium-fortified
381812|NCT01508689|Calcium intake|calcium intake
381813|NCT01508676|neuropathic pain|neuropathic pain
381814|NCT01508676|postherpetic neuralgia|postherpetic neuralgia
381815|NCT01508676|complex regional pain syndrome|complex regional pain syndrome
381816|NCT01508676|reflex sympathetic dystrophy|reflex sympathetic dystrophy
381817|NCT01508663|Coronary artery disease 75years of age or older|coronary artery disease 75years of age or older
381818|NCT01508650|heart failure|heart failure
381819|NCT01508637|air pollution|air pollution
381820|NCT01508637|vasoconstriction|vasoconstriction
381821|NCT01508637|blood pressure|blood pressure
381822|NCT01508637|diesel exhaust|diesel exhaust
381823|NCT01508624|Randomised controlled trial|randomised controlled trial
381824|NCT01508624|Pain|pain
381825|NCT01508624|Recovery|recovery
381826|NCT01508624|Office based surgery|office based surgery
381827|NCT01508611|dental caries|dental caries
381828|NCT01508611|permanent teeth|permanent teeth
381829|NCT01508611|silver diamine fluoride|silver diamine fluoride
381830|NCT01508611|tooth eruption|tooth eruption
381831|NCT01508598|Pediatric|pediatric
381832|NCT01508598|Obesity|obesity
381833|NCT01508598|Bariatric surgery|bariatric surgery
381834|NCT01508598|Cardiovascular disease|cardiovascular disease
381835|NCT01508585|Bariatric surgery|bariatric surgery
381836|NCT01508585|Cognitive Behavioral Therapy|cognitive behavioral therapy
381837|NCT01508585|Telephone based CBT|telephone based cbt
381838|NCT01508585|Obesity|obesity
381839|NCT01508572|breast cancer|breast cancer
381840|NCT01508572|VEGF|vegf
381841|NCT01508572|optical imaging|optical imaging
381842|NCT01508559|HIV|hiv
381843|NCT01508559|Neurocognitive|neurocognitive
381844|NCT01508546|breast cancer|breast cancer
381845|NCT01508546|axillary dissection|axillary dissection
381846|NCT01508533|Disease burden|disease burden
381847|NCT01508533|Rotavirus gastroenteritis|rotavirus gastroenteritis
381848|NCT01508520|early gastric cancer|early gastric cancer
381849|NCT01508520|stomach neoplasms|stomach neoplasms
381850|NCT01508520|magnifying endoscopy|magnifying endoscopy
381851|NCT01508520|narrow band imaging|narrow band imaging
381852|NCT01508507|Oral|oral
381853|NCT01508507|Cholera|cholera
381854|NCT01508507|Vaccine|vaccine
381855|NCT01508507|Herd|herd
381856|NCT01508507|Risk|risk
381857|NCT01508507|population|population
381858|NCT01508507|Matched|matched
381859|NCT01508507|Control|control
381860|NCT01508507|Case|case
381861|NCT01508507|Bias|bias
381862|NCT01508494|modification of fMRI maps after galantamine/placebo|modification of fmri maps after galantamine/placebo
381863|NCT01508481|Vitamin D|vitamin d
381864|NCT01508481|Diabetes|diabetes
381865|NCT01508481|pancreas beta cell function|pancreas beta cell function
381866|NCT01508481|insulin resistance|insulin resistance
381867|NCT01508481|Deficiency of Vitamin D3|deficiency of vitamin d3
381868|NCT01508468|Rituximab|rituximab
381869|NCT01508468|membranous nephropathy|membranous nephropathy
381870|NCT01508468|anti-PLA2R antibody|anti-pla2r antibody
381871|NCT01508429|Postpartum hemorrhage|postpartum hemorrhage
381872|NCT01508429|PPH|pph
381873|NCT01508429|misoprostol|misoprostol
381874|NCT01508429|home deliveries|home deliveries
381875|NCT01508416|Multiple Myeloma|multiple myeloma
381876|NCT01508416|Newly diagnosed|newly diagnosed
381877|NCT01508416|Thrombin generation|thrombin generation
381878|NCT01508416|TFPI|tfpi
381879|NCT01508416|Tissue Factor pathway inhibitor|tissue factor pathway inhibitor
381880|NCT01508416|Protein S|protein s
381881|NCT01508416|Thrombosis|thrombosis
381882|NCT01508416|Chemotherapy|chemotherapy
381883|NCT01508390|prostate|prostate
381884|NCT01508377|posttraumatic stress disorder|posttraumatic stress disorder
381885|NCT01508377|internet-based psychotherapy|internet-based psychotherapy
381886|NCT01508377|cognitive restructuring|cognitive restructuring
381887|NCT01508377|exposure|exposure
381888|NCT01508364|renal cell carcinoma, first targeted therapy, observational study|renal cell carcinoma, first targeted therapy, observational study
381889|NCT01508351|Propofol|propofol
381890|NCT01508351|Induction|induction
381891|NCT01508351|Hypotension|hypotension
381892|NCT01508351|General population|general population
381893|NCT01508338|HMB beta-hydroxy-beta-methylbutyrate|hmb beta-hydroxy-beta-methylbutyrate
381894|NCT01508338|ATP (adenosine-triphosphate)|atp (adenosine-triphosphate)
381895|NCT01508338|trained athletes|trained athletes
381896|NCT01508325|Bisoprolol|bisoprolol
381897|NCT01508325|Hypertension|hypertension
381898|NCT01508325|Blood pressure|blood pressure
381899|NCT01508325|Heart rate|heart rate
381900|NCT01508312|CARBOPLATIN|carboplatin
381901|NCT01508312|ETOPOSIDE (VP-16)|etoposide (vp-16)
381902|NCT01508312|IFOSFAMIDE|ifosfamide
381903|NCT01508312|SGN-35 (BRENTUXIMAB VEDOTIN)|sgn-35 (brentuximab vedotin)
381904|NCT01508312|11-142|11-142
381905|NCT01508299|skin test|skin test
381906|NCT01508299|raw food|raw food
381907|NCT01508299|commercial extract|commercial extract
381908|NCT01508286|telaprevir|telaprevir
381909|NCT01508286|hepatitis C|hepatitis c
381910|NCT01508286|early access program|early access program
381911|NCT01508273|Breast Cancer|breast cancer
381912|NCT01508273|Breast Cancer Survivors|breast cancer survivors
381913|NCT01508273|High risk cancer survivors|high risk cancer survivors
381914|NCT01508273|Stage II to IIIC breast cancer|stage ii to iiic breast cancer
381915|NCT01508273|African American|african american
381916|NCT01508273|AA|aa
381917|NCT01508273|Hispanic|hispanic
381918|NCT01508273|Non-Hispanic White|non-hispanic white
381919|NCT01508273|Operable invasive breast carcinoma|operable invasive breast carcinoma
381920|NCT01508273|Aerobic and resistance training|aerobic and resistance training
381921|NCT01508273|Pedometer|pedometer
381922|NCT01508273|Telephone Counseling Calls|telephone counseling calls
381923|NCT01508273|Physical activity report|physical activity report
381924|NCT01508273|PAR|par
381925|NCT01508273|Functional Assessment of Cancer Therapy-Breast|functional assessment of cancer therapy-breast
381926|NCT01508273|FACT-B|fact-b
381927|NCT01508273|Health related quality of life|health related quality of life
381929|NCT01508260|Leukemia|leukemia
381930|NCT01508260|Aquapheresis|aquapheresis
381931|NCT01508260|Ultrafiltration|ultrafiltration
381932|NCT01508260|Aquadex pump|aquadex pump
381933|NCT01508260|Severe Fluid Overload|severe fluid overload
381934|NCT01508260|Diuretic therapy|diuretic therapy
381935|NCT01508260|Dyspnea|dyspnea
381936|NCT01508260|Orthopnea|orthopnea
381937|NCT01508260|Paroxysmal nocturnal dyspnea|paroxysmal nocturnal dyspnea
381938|NCT01508260|PND|pnd
381939|NCT01508260|Peripheral edema|peripheral edema
381940|NCT01508260|Rales|rales
381941|NCT01508260|Jugular venous distension|jugular venous distension
381942|NCT01508260|JVD|jvd
381943|NCT01508260|Hypoxia|hypoxia
381944|NCT01508260|Pulmonary edema by chest X-ray|pulmonary edema by chest x-ray
381945|NCT01508260|Furosemide|furosemide
381946|NCT01508260|Lasix|lasix
381947|NCT01508247|efficacy|efficacy
381948|NCT01508247|safety|safety
381949|NCT01508247|inactivated vaccine (Vero Cell) against EV71|inactivated vaccine (vero cell) against ev71
381950|NCT01508247|EV71-associated diseases|ev71-associated diseases
381951|NCT01508221|brain metastasis|brain metastasis
381952|NCT01508208|Hypertension|hypertension
381953|NCT01508208|24 hour urine protein|24 hour urine protein
381954|NCT01508208|Protein/creatinine ratio|protein/creatinine ratio
381955|NCT01508195|Healthy Volunteers|healthy volunteers
381956|NCT01508195|Bioequivalence|bioequivalence
381957|NCT01508195|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
381958|NCT01508195|Metformin IR|metformin ir
381959|NCT01508182|Healthy Volunteers|healthy volunteers
381960|NCT01508182|Bioequivalence|bioequivalence
381961|NCT01508182|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
381962|NCT01508182|Metformin IR|metformin ir
381963|NCT01508169|elderly|elderly
381964|NCT01508169|balance|balance
381965|NCT01508169|insole|insole
381966|NCT01508169|foot orthosis|foot orthosis
381967|NCT01508169|orthotics|orthotics
381968|NCT01508156|Hepatitis C|hepatitis c
381969|NCT01508156|HCV|hcv
381970|NCT01508156|treatment-naive|treatment-naive
381971|NCT01508143|Abortion|abortion
381972|NCT01508143|Pregnancy|pregnancy
381973|NCT01508143|Termination|termination
381974|NCT01508143|Misoprostol|misoprostol
381975|NCT01508117|GBM|gbm
381976|NCT01508117|brain tumor|brain tumor
381977|NCT01508104|solid tumor|solid tumor
381978|NCT01508104|glioblastoma multiforme|glioblastoma multiforme
381979|NCT01508104|GBM|gbm
381980|NCT01508104|brain tumor|brain tumor
381981|NCT01508104|neuroendocrine tumor|neuroendocrine tumor
381982|NCT01508091|Obesity|obesity
381983|NCT01508091|ageing|ageing
381984|NCT01508052|core temperature|core temperature
381985|NCT01508052|sequential compression device|sequential compression device
381986|NCT01508052|total intravenous anesthesia|total intravenous anesthesia
381987|NCT01508039|Intranasal|intranasal
381988|NCT01508039|Chitin Micro-particles|chitin micro-particles
381989|NCT01508039|Immunological Effects|immunological effects
381990|NCT01508039|Nasal mucosa|nasal mucosa
381991|NCT01508039|Cytokines|cytokines
381992|NCT01508039|Immunological Effects from Intranasal Chitin Micro-Particles|immunological effects from intranasal chitin micro-particles
381993|NCT01508026|Stage 1|stage 1
381994|NCT01508026|Stage 2|stage 2
381995|NCT01508026|Hypertension|hypertension
381996|NCT01508013|Melanoma|melanoma
381997|NCT01508013|Basal Cell Carcinoma|basal cell carcinoma
381998|NCT01508013|Squamous Cell Carcinoma|squamous cell carcinoma
381999|NCT01508000|Liver metastases|liver metastases
382000|NCT01508000|Colorectal Cancer|colorectal cancer
382001|NCT01508000|KRAS wild type|kras wild type
382002|NCT01508000|FOLFOX|folfox
382003|NCT01508000|Bevacizumab|bevacizumab
382004|NCT01508000|Panitumumab|panitumumab
382005|NCT01508000|Randomized|randomized
382006|NCT01508000|Phase II|phase ii
382007|NCT01508000|Perioperative treatment|perioperative treatment
382008|NCT01508000|Adjuvant|adjuvant
382009|NCT01508000|Neo-adjuvant|neo-adjuvant
382010|NCT01508000|Surgery|surgery
382011|NCT01508000|Progression Free Survival|progression free survival
382012|NCT01507987|Externalized Conductors, visual lead an|externalized conductors, visual lead an
382013|NCT01507974|preventive|preventive
382014|NCT01507974|antibiotic treatment|antibiotic treatment
382015|NCT01507974|urinary tract infection|urinary tract infection
382016|NCT01507974|pregnancy|pregnancy
382017|NCT01507974|puerperium|puerperium
382018|NCT01507948|Posttraumatic Stress Disorder (PTSD)|posttraumatic stress disorder (ptsd)
382019|NCT01507948|Psychotherapy|psychotherapy
382020|NCT01507948|non-medication treatment|non-medication treatment
382021|NCT01507948|Prolonged Exposure|prolonged exposure
382022|NCT01507948|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
382023|NCT01507948|Anxiety Disorders|anxiety disorders
382024|NCT01507948|emotion|emotion
382025|NCT01507948|emotion regulation|emotion regulation
382026|NCT01507948|functional MRI|functional mri
382027|NCT01507948|Affective Symptoms|affective symptoms
382028|NCT01507935|Healthy infants|healthy infants
382029|NCT01507935|Infant formula|infant formula
382030|NCT01507935|Prebiotics oligosaccharides|prebiotics oligosaccharides
382031|NCT01507935|Colonisation Resistance|colonisation resistance
382032|NCT01507935|Gut Microbiota|gut microbiota
382033|NCT01507922|Fenoverine|fenoverine
382034|NCT01507922|Irritable Bowel Syndrome|irritable bowel syndrome
382035|NCT01507922|Abdominal pain|abdominal pain
382036|NCT01507922|BSS|bss
382037|NCT01507909|EEG|eeg
382038|NCT01507909|related visual|related visual
382039|NCT01507909|and verbal cues|and verbal cues
382040|NCT01507883|Supervision|supervision
382041|NCT01507883|embryos|embryos
382042|NCT01507883|Resulting|resulting
382043|NCT01507870|body mass index|body mass index
382044|NCT01507857|EV71 vaccine|ev71 vaccine
382045|NCT01507857|HFMD|hfmd
382046|NCT01507857|efficacy|efficacy
382047|NCT01507857|EV71 associated disease|ev71 associated disease
382048|NCT01507844|COPD|copd
382049|NCT01507844|CPAP|cpap
382050|NCT01507844|Sham|sham
382051|NCT01507844|FEV1|fev1
382052|NCT01507844|IC|ic
382053|NCT01507844|RV/TLC|rv/tlc
382054|NCT01507818|Arthroscopic Rotator Cuff Repair|arthroscopic rotator cuff repair
382055|NCT01507818|Electromagnetic field treatment|electromagnetic field treatment
382056|NCT01507818|Pulsed Radio Frequency treatment|pulsed radio frequency treatment
382057|NCT01507818|Non-invasive|non-invasive
382058|NCT01507818|Non-thermal|non-thermal
382059|NCT01507805|Electroacupuncture|electroacupuncture
382060|NCT01507805|preconditioning|preconditioning
382061|NCT01507805|Non-cardiac surgery|non-cardiac surgery
382062|NCT01507805|Coronary heart disease|coronary heart disease
382063|NCT01507792|Cough|cough
382064|NCT01507792|Laryngismus|laryngismus
382065|NCT01507792|Bronchial spasm|bronchial spasm
382066|NCT01507792|Deficiency diseases|deficiency diseases
382067|NCT01507766|severe acute pancreatitis|severe acute pancreatitis
382068|NCT01507766|intra-abdominal pressure|intra-abdominal pressure
382069|NCT01507766|enteral nutrition|enteral nutrition
382070|NCT01507753|childhood bipolar disorder|childhood bipolar disorder
382071|NCT01507727|hyponatremia|hyponatremia
382072|NCT01507727|Non-hypovolemic and Non-acute hyponatremia|non-hypovolemic and non-acute hyponatremia
382073|NCT01507727|Tolvaptan|tolvaptan
382074|NCT01507714|Preventive|preventive
382075|NCT01507714|tvt-o|tvt-o
382076|NCT01507714|stress incontinence|stress incontinence
382077|NCT01507701|adolescents|adolescents
382078|NCT01507688|Stroke|stroke
382079|NCT01507675|suicide|suicide
382080|NCT01507675|psychometric properties|psychometric properties
382081|NCT01507675|military|military
382082|NCT01507675|veterans|veterans
382083|NCT01507675|Interpersonal needs questionnaire|interpersonal needs questionnaire
382084|NCT01507675|Acquired capability for suicide|acquired capability for suicide
382085|NCT01507675|mental health|mental health
382086|NCT01507675|Survey of Life Principles|survey of life principles
382087|NCT01507675|Risk assessment|risk assessment
382088|NCT01507662|Bone Density|bone density
382089|NCT01507662|Absorptiometry, Photon|absorptiometry, photon
382090|NCT01507662|Osteoporosis|osteoporosis
382091|NCT01507662|Bone, Diseases, Metabolic|bone, diseases, metabolic
382092|NCT01507662|Patient Education as Topic|patient education as topic
382093|NCT01507662|Fractures, Bone/Prevention and Control|fractures, bone/prevention and control
382094|NCT01507649|postnatal depression|postnatal depression
382095|NCT01507649|quality of life|quality of life
382096|NCT01507636|apraxia|apraxia
382097|NCT01507636|occupational therapy|occupational therapy
382098|NCT01507636|multiple sclerosis|multiple sclerosis
382099|NCT01507636|manual dexterity|manual dexterity
382100|NCT01507623|NAPS|naps
382101|NCT01507623|Hypoxia|hypoxia
382102|NCT01507623|Propofol|propofol
382103|NCT01507623|capnography|capnography
382104|NCT01507623|endoscopy|endoscopy
382105|NCT01507623|Sedation|sedation
382106|NCT01507610|sumatriptan|sumatriptan
382107|NCT01507610|bioavailability|bioavailability
382108|NCT01507597|Glucagon-like peptide-1|glucagon-like peptide-1
382109|NCT01507597|Glucagon|glucagon
382110|NCT01507597|Normal physiology|normal physiology
382111|NCT01507597|T2DM|t2dm
382112|NCT01507597|T1DM|t1dm
382113|NCT01507571|Incurable cancer|incurable cancer
382114|NCT01507571|Palliative care|palliative care
382115|NCT01507571|Dignity Therapy|dignity therapy
382116|NCT01507571|Loss of dignity|loss of dignity
382117|NCT01507571|Patient Dignity Intventory|patient dignity intventory
382118|NCT01507571|Eortc QLQ-C15-PAL|eortc qlq-c15-pal
382119|NCT01507571|Structured Interview for Symptoms and Concerns|structured interview for symptoms and concerns
382120|NCT01507571|Hospital Anxiety and Depression Scale|hospital anxiety and depression scale
382121|NCT01507558|Peripheral Arterial Disease|peripheral arterial disease
382122|NCT01507558|Femoral popliteal lesions|femoral popliteal lesions
382123|NCT01507545|mCRC|mcrc
382124|NCT01507545|chemorefractory metastatic colorectal cancer|chemorefractory metastatic colorectal cancer
382125|NCT01507506|Glioblastoma|glioblastoma
382126|NCT01507506|Radiotherapy|radiotherapy
382127|NCT01507506|Intensity modulated radiation therapy (IMRT)|intensity modulated radiation therapy (imrt)
382128|NCT01507506|Magnetic resonance spectroscopic imaging (MRSI)|magnetic resonance spectroscopic imaging (mrsi)
382129|NCT01507493|gene polymorphism|gene polymorphism
382130|NCT01507493|SCN9A|scn9a
382131|NCT01507493|pain perception|pain perception
382132|NCT01507493|postoperative pain|postoperative pain
382133|NCT01507480|Hemorrhagic Hereditary Telangiectasia (HHT)|hemorrhagic hereditary telangiectasia (hht)
382134|NCT01507480|Antiangiogenic therapies|antiangiogenic therapies
382135|NCT01507480|Bevacizumab|bevacizumab
382136|NCT01507467|Head and neck carcinoma|head and neck carcinoma
382137|NCT01507467|Accelerated radiotherapy|accelerated radiotherapy
382138|NCT01507467|Hypoxic modification with Nimorazole|hypoxic modification with nimorazole
382139|NCT01507441|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
382140|NCT01507441|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
382141|NCT01507441|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
382142|NCT01507415|Cohort Studies|cohort studies
382143|NCT01507415|Longitudinal Studies|longitudinal studies
382144|NCT01507415|Patient Readmission|patient readmission
382145|NCT01507415|Hospitalization|hospitalization
382146|NCT01507415|Disability Evaluation|disability evaluation
382147|NCT01507376|Ovulation induction|ovulation induction
382148|NCT01507376|urinary|urinary
382149|NCT01507376|hCG|hcg
382150|NCT01507376|recombinant hCG|recombinant hcg
382151|NCT01507350|obesity related glmerulopathy|obesity related glmerulopathy
382152|NCT01507350|51 Cr-EDTA clearance|51 cr-edta clearance
382153|NCT01507350|impaired renal function|impaired renal function
382259|NCT01506856|Paclitaxel|paclitaxel
382154|NCT01507350|gastric band|gastric band
382155|NCT01507350|GFR measurement|gfr measurement
382156|NCT01507350|gastric bypass|gastric bypass
382157|NCT01507350|sleeve gastrectomy|sleeve gastrectomy
382158|NCT01507298|Physical activity|physical activity
382159|NCT01507298|Accelerometry|accelerometry
382160|NCT01507298|Oesophageal pH|oesophageal ph
382161|NCT01507298|Capsule endoscopy|capsule endoscopy
382162|NCT01507259|Determine effect on cerebral vasculature|determine effect on cerebral vasculature
382163|NCT01507246|open colectomy|open colectomy
382164|NCT01507233|open colectomy|open colectomy
382165|NCT01507233|colectomy|colectomy
382166|NCT01507220|open colectomy|open colectomy
382167|NCT01507207|Dysphagia|dysphagia
382168|NCT01507207|aspiration|aspiration
382169|NCT01507207|pediatric|pediatric
382170|NCT01507207|injection laryngoplasty|injection laryngoplasty
382171|NCT01507181|suicidal ideation|suicidal ideation
382172|NCT01507181|major depression|major depression
382173|NCT01507181|treatment resistant|treatment resistant
382174|NCT01507181|ketamine|ketamine
382175|NCT01507181|glutamate|glutamate
382176|NCT01507155|Major|major
382177|NCT01507155|Depressive|depressive
382178|NCT01507155|Disorder|disorder
382179|NCT01507155|Depression|depression
382180|NCT01507155|MDD|mdd
382181|NCT01507155|Treatment Resistant|treatment resistant
382182|NCT01507155|Anxiety|anxiety
382183|NCT01507155|GAD|gad
382184|NCT01507142|saliva|saliva
382185|NCT01507142|diagnostics|diagnostics
382186|NCT01507142|HIV|hiv
382187|NCT01507142|AIDS|aids
382188|NCT01507129|dehydration|dehydration
382189|NCT01507129|plasma|plasma
382190|NCT01507129|osmolality|osmolality
382191|NCT01507129|saliva|saliva
382192|NCT01507129|urine|urine
382193|NCT01507129|biomarkers|biomarkers
382194|NCT01507129|hypertonic|hypertonic
382195|NCT01507129|isotonic|isotonic
382196|NCT01507129|hydration|hydration
382197|NCT01507103|Tecemotide (L-BLP25)|tecemotide (l-blp25)
382198|NCT01507103|Cyclophosphamide (CPA)|cyclophosphamide (cpa)
382199|NCT01507103|Mode of action|mode of action
382200|NCT01507103|Neoplasms|neoplasms
382201|NCT01507103|Neoplasms by Site|neoplasms by site
382202|NCT01507103|Carcinomas|carcinomas
382203|NCT01507103|Antineoplastic Agents|antineoplastic agents
382204|NCT01507103|Neoadjuvant|neoadjuvant
382205|NCT01507103|Radiotherapy Pharmacologic Actions|radiotherapy pharmacologic actions
382206|NCT01507103|Immunosuppressive Agents|immunosuppressive agents
382207|NCT01507103|Immunologic Function|immunologic function
382208|NCT01507103|Therapeutic Uses|therapeutic uses
382209|NCT01507103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
382210|NCT01507090|children for whom there is no scale to determine weight|children for whom there is no scale to determine weight
382211|NCT01507077|Obese|obese
382212|NCT01507077|Obesity|obesity
382213|NCT01507077|Overweight|overweight
382214|NCT01507064|hepatocellular carcinoma|hepatocellular carcinoma
382215|NCT01507064|sorafenib|sorafenib
382216|NCT01507064|laser ablation|laser ablation
382217|NCT01507051|Rivaroxaban|rivaroxaban
382218|NCT01507051|Xa-Factors|xa-factors
382219|NCT01507051|Warfarin|warfarin
382220|NCT01507051|Thrombosis|thrombosis
382221|NCT01507051|Embolism|embolism
382222|NCT01507038|Diabetes Mellitus|diabetes mellitus
382223|NCT01507038|YH14617|yh14617
382224|NCT01507038|Exenatide|exenatide
382225|NCT01507038|Yuhan|yuhan
382226|NCT01507025|hinge position|hinge position
382227|NCT01507025|dry eye|dry eye
382228|NCT01507012|Berry phenolics|berry phenolics
382229|NCT01507012|mood|mood
382230|NCT01507012|cognition|cognition
382231|NCT01507012|adults|adults
382232|NCT01506999|Angina Pectoris|angina pectoris
382233|NCT01506999|SNPs|snps
382234|NCT01506999|Genetic|genetic
382235|NCT01506999|Myocardial Infarction|myocardial infarction
382236|NCT01506999|Cardiovascular Risk Factors|cardiovascular risk factors
382237|NCT01506986|Ulcer bleeding|ulcer bleeding
382238|NCT01506986|Aspirin|aspirin
382239|NCT01506986|Helicobacter pylori|helicobacter pylori
382240|NCT01506986|H. pylori|h. pylori
382241|NCT01506986|Hospitalisation for ulcer bleeding|hospitalisation for ulcer bleeding
382242|NCT01506973|histologically or cytologically documented|histologically or cytologically documented
382243|NCT01506947|Hemodialysis|hemodialysis
382244|NCT01506947|Chronic kidney disease|chronic kidney disease
382245|NCT01506947|Secondary hyperparathyroidism,|secondary hyperparathyroidism,
382246|NCT01506921|racemic ketamine|racemic ketamine
382247|NCT01506921|S-ketamine|s-ketamine
382248|NCT01506921|Cerebral blood flow|cerebral blood flow
382249|NCT01506921|Magnetic resonance imaging|magnetic resonance imaging
382250|NCT01506921|arterial spin labeling|arterial spin labeling
382251|NCT01506921|healthy volunteers|healthy volunteers
382252|NCT01506908|craving|craving
382253|NCT01506895|Diabetic Macular Edema|diabetic macular edema
382254|NCT01506856|Epithelial ovarian cancer|epithelial ovarian cancer
382255|NCT01506856|Fallopian tube cancer|fallopian tube cancer
382256|NCT01506856|peritoneal cancer|peritoneal cancer
382257|NCT01506856|intraperitoneal therapy|intraperitoneal therapy
382258|NCT01506856|Carboplatin|carboplatin
382260|NCT01506843|IgA antibody|iga antibody
382261|NCT01506843|IgE antibody|ige antibody
382262|NCT01506843|IgG1/IgG4 subclasses|igg1/igg4 subclasses
382263|NCT01506843|Mite allergy|mite allergy
382264|NCT01506843|Sublingual immunotherapy|sublingual immunotherapy
382265|NCT01506843|Saliva|saliva
382266|NCT01506830|Adhesives.|adhesives.
382267|NCT01506830|Composites.|composites.
382268|NCT01506830|Noncarious cervical lesions.|noncarious cervical lesions.
382269|NCT01506830|Clinical performance.|clinical performance.
382270|NCT01506830|Treatment|treatment
382271|NCT01506817|fibromyalgia|fibromyalgia
382272|NCT01506817|DCE-MRI|dce-mri
382273|NCT01506817|neurogenic inflammation|neurogenic inflammation
382274|NCT01506817|contrast-enhancement patterns|contrast-enhancement patterns
382275|NCT01506804|Shoulder|shoulder
382276|NCT01506804|Impingement|impingement
382277|NCT01506804|Ultrasound|ultrasound
382278|NCT01506804|injection of glucocorticosteroid|injection of glucocorticosteroid
382279|NCT01506804|exercise|exercise
382280|NCT01506791|Bioequivalence|bioequivalence
382281|NCT01506791|Desloratadine and pseudoephedrine|desloratadine and pseudoephedrine
382282|NCT01506791|crossover|crossover
382283|NCT01506778|Endometrial Sampling Procedure|endometrial sampling procedure
382284|NCT01506778|Likert Scala|likert scala
382285|NCT01506778|Pipelle|pipelle
382286|NCT01506778|Tenaculum|tenaculum
382287|NCT01506778|Visual Analog Pain Scala|visual analog pain scala
382288|NCT01506765|Schizophrenia|schizophrenia
382289|NCT01506765|glutathione|glutathione
382290|NCT01506765|NAC|nac
382291|NCT01506765|Neurological scales|neurological scales
382292|NCT01506765|Magnetic Resonance Spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
382293|NCT01506765|EEG/evoked potentials|eeg/evoked potentials
382294|NCT01506765|fibroblasts|fibroblasts
382295|NCT01506765|patients who receive NAC|patients who receive nac
382296|NCT01506765|patients who receive placebo|patients who receive placebo
382297|NCT01506752|Bioequivalence|bioequivalence
382298|NCT01506752|Healthy Subjects|healthy subjects
382299|NCT01506752|Donepezil|donepezil
382300|NCT01506739|Bioequivalence|bioequivalence
382301|NCT01506739|Healthy Subjects|healthy subjects
382302|NCT01506739|Donepezil|donepezil
382303|NCT01506726|anemia|anemia
382304|NCT01506726|unexplained anemia|unexplained anemia
382305|NCT01506726|elderly|elderly
382306|NCT01506726|geriatric|geriatric
382307|NCT01506726|older adults|older adults
382308|NCT01506726|UAE|uae
382309|NCT01506726|over 65|over 65
382310|NCT01506726|salsalate|salsalate
382311|NCT01506726|PACTTE|pactte
382312|NCT01506726|pactee|pactee
382313|NCT01506726|aging|aging
382314|NCT01506726|aged|aged
382315|NCT01506726|old|old
382316|NCT01506726|older|older
382317|NCT01506687|Colorectal cancer screening|colorectal cancer screening
382318|NCT01506687|50 years or older|50 years or older
382319|NCT01506661|Rheumatoid arthritis|rheumatoid arthritis
382320|NCT01506661|vaccination|vaccination
382321|NCT01506661|immune response|immune response
382322|NCT01506661|varicella zoster|varicella zoster
382323|NCT01506609|PARP|parp
382324|NCT01506609|TMZ|tmz
382325|NCT01506609|Temodal|temodal
382326|NCT01506609|Carboplatin|carboplatin
382327|NCT01506609|veliparib|veliparib
382328|NCT01506609|BRCA2 mutation carrier|brca2 mutation carrier
382329|NCT01506609|Breast cancer|breast cancer
382330|NCT01506609|Metastatic breast cancer|metastatic breast cancer
382331|NCT01506609|temozolomide|temozolomide
382332|NCT01506609|BRCA1 mutation carrier|brca1 mutation carrier
382333|NCT01506609|ABT-888|abt-888
382334|NCT01506609|Paclitaxel|paclitaxel
382335|NCT01506609|Recurrent breast cancer|recurrent breast cancer
382336|NCT01506609|Temodar|temodar
382337|NCT01506609|Locally recurrent|locally recurrent
382338|NCT01506596|Liposarcoma|liposarcoma
382339|NCT01506583|cough|cough
382340|NCT01506583|myalgia|myalgia
382341|NCT01506583|nasal obstruction|nasal obstruction
382342|NCT01506583|sore throat|sore throat
382343|NCT01506583|headache|headache
382344|NCT01506583|fatigue|fatigue
382345|NCT01506583|feverishness|feverishness
382346|NCT01506583|Patients who exhibit flu-like symptoms during a flu season, including cough, myalgia, nasal obstruction, sore throat, headache, fatigue, and/or feverishness.|patients who exhibit flu-like symptoms during a flu season, including cough, myalgia, nasal obstruction, sore throat, headache, fatigue, and/or feverishness.
382347|NCT01506557|vitamin D|vitamin d
382348|NCT01506557|vitamin D deficiency|vitamin d deficiency
382349|NCT01506557|breastfeeding|breastfeeding
382350|NCT01506557|body composition|body composition
382351|NCT01506557|bone mineral content|bone mineral content
382352|NCT01506544|HU|hu
382353|NCT01506544|Hydroxyurea|hydroxyurea
382354|NCT01506544|Sickle cell|sickle cell
382355|NCT01506544|Pediatric|pediatric
382356|NCT01506531|gastroschisis|gastroschisis
382357|NCT01506531|silo|silo
382358|NCT01506531|primary closure|primary closure
382359|NCT01506518|Muscular Dystrophy, Duchenne|muscular dystrophy, duchenne
382360|NCT01506518|Ultrasound|ultrasound
382361|NCT01506518|Imaging|imaging
382362|NCT01506518|Acoustic Radiation Force|acoustic radiation force
382363|NCT01506518|Double Push|double push
382364|NCT01506505|Cardiovascular prevention|cardiovascular prevention
382365|NCT01506505|Polypill|polypill
382366|NCT01506505|Combination therapy|combination therapy
382367|NCT01506492|Randomized controlled trial|randomized controlled trial
382368|NCT01506492|Depression|depression
382369|NCT01506492|Cancer|cancer
382370|NCT01506492|Psychotherapy|psychotherapy
382371|NCT01506492|Quality of life|quality of life
382372|NCT01506479|Parkinson Disease|parkinson disease
382373|NCT01506479|Basal Ganglia Disease|basal ganglia disease
382374|NCT01506479|Central Nervous System Diseases|central nervous system diseases
382375|NCT01506479|Nervous System Diseases|nervous system diseases
382376|NCT01506479|Movement Disorders|movement disorders
382377|NCT01506479|Neurodegenerative Diseases|neurodegenerative diseases
382378|NCT01506479|Brain Diseases|brain diseases
382379|NCT01506466|chemotherapy|chemotherapy
382380|NCT01506466|metabolism|metabolism
382381|NCT01506466|weight|weight
382382|NCT01506466|body composition|body composition
382383|NCT01506453|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
382384|NCT01506453|Neuropathy|neuropathy
382385|NCT01506453|Neuropathic Pain|neuropathic pain
382386|NCT01506453|Vincristine|vincristine
382387|NCT01506453|TOTAL XVI Protocol|total xvi protocol
382388|NCT01506427|Newly Diagnosed|newly diagnosed
382389|NCT01506427|Head and Neck Cancer|head and neck cancer
382390|NCT01506427|PET Imaging|pet imaging
382391|NCT01506414|Purpura|purpura
382392|NCT01506414|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
382393|NCT01506401|ARDS|ards
382394|NCT01506401|ventilator-induced lung injury|ventilator-induced lung injury
382395|NCT01506401|lung protective ventilation|lung protective ventilation
382396|NCT01506401|high frequency oscillation|high frequency oscillation
382397|NCT01506388|labour induction|labour induction
382398|NCT01506388|Foley catheter|foley catheter
382399|NCT01506388|misoprostol|misoprostol
382400|NCT01506388|isosorbide mononitrate|isosorbide mononitrate
382401|NCT01506375|seasonal allergic rhinoconjunctivitis|seasonal allergic rhinoconjunctivitis
382402|NCT01506375|grass pollen|grass pollen
382403|NCT01506375|allergen specific immunotherapy|allergen specific immunotherapy
382404|NCT01506362|Ulcerative Colitis|ulcerative colitis
382405|NCT01506362|IBD|ibd
382406|NCT01506349|celiac disease|celiac disease
382407|NCT01506349|gluten|gluten
382408|NCT01506349|fog|fog
382409|NCT01506349|attention|attention
382410|NCT01506336|GIST|gist
382411|NCT01506336|resistant|resistant
382412|NCT01506336|imatinib|imatinib
382413|NCT01506336|gastro intestinal stromal tumor resistant to imatinib|gastro intestinal stromal tumor resistant to imatinib
382414|NCT01506323|Complementary Therapy|complementary therapy
382415|NCT01506323|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
382416|NCT01506323|Veterans Health|veterans health
382417|NCT01506323|Clinical Trials, Randomized|clinical trials, randomized
382418|NCT01506323|Mindfulness|mindfulness
382419|NCT01506323|Spirituality|spirituality
382420|NCT01506323|Meditation|meditation
382421|NCT01506323|Mind-body therapy|mind-body therapy
382422|NCT01506310|gestational diabetes mellitus|gestational diabetes mellitus
382423|NCT01506310|fasting glucose|fasting glucose
382424|NCT01506310|insulin resistance|insulin resistance
382425|NCT01506310|birth-weight|birth-weight
382426|NCT01506310|Glucose values|glucose values
382427|NCT01506310|Insulin concentrations|insulin concentrations
382428|NCT01506310|Cesarean sections|cesarean sections
382429|NCT01506297|obesity|obesity
382430|NCT01506297|satiety|satiety
382431|NCT01506297|body weight management|body weight management
382432|NCT01506284|Forced oscillatory technique|forced oscillatory technique
382433|NCT01506284|Laser interferometry|laser interferometry
382434|NCT01506284|Intravenous anesthesia|intravenous anesthesia
382435|NCT01506284|Mechanical ventilation|mechanical ventilation
382436|NCT01506284|Pressure controlled ventilation|pressure controlled ventilation
382437|NCT01506284|Airways mechanical properties|airways mechanical properties
382438|NCT01506284|Respiratory system reactance|respiratory system reactance
382439|NCT01506284|Oscillatory mechanics|oscillatory mechanics
382440|NCT01506284|Atelectasis|atelectasis
382441|NCT01506271|Complicated Intra-abdominal Infections|complicated intra-abdominal infections
382442|NCT01506258|CD34+|cd34+
382443|NCT01506258|perinatal hypoxia|perinatal hypoxia
382444|NCT01506258|autologous hematopoietic stem cells|autologous hematopoietic stem cells
382445|NCT01506258|cord and placental blood|cord and placental blood
382446|NCT01506258|cerebral palsy|cerebral palsy
382447|NCT01506245|Obesity|obesity
382448|NCT01506245|Children|children
382449|NCT01506245|Behavior|behavior
382450|NCT01506245|Family|family
382451|NCT01506245|Exercise|exercise
382452|NCT01506232|ADHD|adhd
382453|NCT01506232|Pediatric Bipolar Disorder|pediatric bipolar disorder
382454|NCT01506232|Autism|autism
382455|NCT01506232|Autism Spectrum Disorders|autism spectrum disorders
382456|NCT01506232|EEG|eeg
382457|NCT01506232|Brain Flow Analyses|brain flow analyses
382458|NCT01506219|Randomized controlled trial|randomized controlled trial
382459|NCT01506219|Comprehensive geriatric care|comprehensive geriatric care
382562|NCT01505907|Safety|safety
382460|NCT01506219|Activity of daily living|activity of daily living
382461|NCT01506219|Quality of life|quality of life
382462|NCT01506219|Healthcare utilization|healthcare utilization
382463|NCT01506219|Community rehabilitation unit|community rehabilitation unit
382464|NCT01506219|Medication adjustment|medication adjustment
382465|NCT01506206|Deep Brain Stimulation|deep brain stimulation
382466|NCT01506206|Impulsivity|impulsivity
382467|NCT01506193|safety|safety
382468|NCT01506193|healthy|healthy
382469|NCT01506193|conjugated|conjugated
382470|NCT01506193|immunogenicity|immunogenicity
382471|NCT01506193|children|children
382472|NCT01506193|MenC vaccine|menc vaccine
382473|NCT01506193|MMRV vaccine|mmrv vaccine
382474|NCT01506180|acute medical care|acute medical care
382475|NCT01506180|comprehensive geriatric assessment|comprehensive geriatric assessment
382476|NCT01506180|Health Services for the Aged|health services for the aged
382477|NCT01506180|Geriatric Assessment|geriatric assessment
382478|NCT01506180|Geriatrics|geriatrics
382479|NCT01506180|Aged|aged
382480|NCT01506154|bursitis/tendonitis and/or subdeltoid bursitis|bursitis/tendonitis and/or subdeltoid bursitis
382481|NCT01506141|MPS II|mps ii
382482|NCT01506141|MPS 2|mps 2
382483|NCT01506141|lysosomal storage disorder|lysosomal storage disorder
382484|NCT01506141|mps symptoms|mps symptoms
382485|NCT01506141|enlarged adenoids|enlarged adenoids
382486|NCT01506141|elaprase|elaprase
382487|NCT01506141|hunter's syndrome|hunter's syndrome
382488|NCT01506141|MPS2|mps2
382489|NCT01506141|hunters disease|hunters disease
382490|NCT01506141|hunter's disease treatment|hunter's disease treatment
382491|NCT01506141|hunter syndrome therapy|hunter syndrome therapy
382492|NCT01506141|iduronate sulfatase|iduronate sulfatase
382493|NCT01506141|mps society|mps society
382494|NCT01506141|MPSII|mpsii
382495|NCT01506141|hunter syndrome treatment|hunter syndrome treatment
382496|NCT01506141|hunter's disease|hunter's disease
382497|NCT01506141|iduronate 2 sulfatase|iduronate 2 sulfatase
382498|NCT01506141|mucopolysaccharides|mucopolysaccharides
382499|NCT01506141|mps diagnosis|mps diagnosis
382500|NCT01506141|chronic ear infection|chronic ear infection
382501|NCT01506141|hunters syndrome|hunters syndrome
382502|NCT01506141|ert treatment|ert treatment
382503|NCT01506141|lysosomal storage disease|lysosomal storage disease
382504|NCT01506141|hunter disease|hunter disease
382505|NCT01506141|enzyme replacement therapy|enzyme replacement therapy
382506|NCT01506141|idursulfase|idursulfase
382507|NCT01506141|hunter's syndrome treatment|hunter's syndrome treatment
382508|NCT01506128|HPV|hpv
382509|NCT01506128|Menstrual blood|menstrual blood
382510|NCT01506128|HPV detection using menstrual blood|hpv detection using menstrual blood
382511|NCT01506115|Hepatocellular carcinoma|hepatocellular carcinoma
382512|NCT01506115|Obstructive jaundice|obstructive jaundice
382513|NCT01506115|Photodynamic therapy|photodynamic therapy
382514|NCT01506089|IVF|ivf
382515|NCT01506089|infertility|infertility
382516|NCT01506089|PGD|pgd
382517|NCT01506089|embryo|embryo
382518|NCT01506089|temperature|temperature
382519|NCT01506089|incubator|incubator
382520|NCT01506089|CCS|ccs
382521|NCT01506089|culture|culture
382522|NCT01506089|incubator-36 degrees Celsius|incubator-36 degrees celsius
382523|NCT01506089|incubator-37 degrees Celsius|incubator-37 degrees celsius
382524|NCT01506063|Bioequivalence|bioequivalence
382525|NCT01506063|Levocetirizine|levocetirizine
382526|NCT01506063|Crossover|crossover
382527|NCT01506050|Bioequivalence|bioequivalence
382528|NCT01506050|Desloratadine|desloratadine
382529|NCT01506050|crossover|crossover
382530|NCT01506037|Bioequivalence|bioequivalence
382531|NCT01506037|Desloratadine|desloratadine
382532|NCT01506037|crossover|crossover
382533|NCT01506024|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
382534|NCT01506024|Surgical Procedures, Operative|surgical procedures, operative
382535|NCT01506024|Surgical Procedures, Minimally Invasive|surgical procedures, minimally invasive
382536|NCT01505985|Hip fracture|hip fracture
382537|NCT01505985|SPPB|sppb
382538|NCT01505985|Functional recovery|functional recovery
382539|NCT01505972|screening colonoscopy|screening colonoscopy
382540|NCT01505972|attendance|attendance
382541|NCT01505972|response|response
382542|NCT01505972|colorectal cancer|colorectal cancer
382543|NCT01505959|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
382544|NCT01505959|Apnea|apnea
382545|NCT01505959|Sleep Apnea|sleep apnea
382546|NCT01505959|Telemedicine|telemedicine
382547|NCT01505959|CPAP compliance|cpap compliance
382548|NCT01505946|Thrombin|thrombin
382549|NCT01505946|Hemophilia|hemophilia
382550|NCT01505946|Inhibitors|inhibitors
382551|NCT01505946|Immunotolerance|immunotolerance
382552|NCT01505946|Haemostatic|haemostatic
382553|NCT01505946|FVIII|fviii
382554|NCT01505946|Epitopes|epitopes
382555|NCT01505946|Moderately severe Hemophilia A with inhibitor|moderately severe hemophilia a with inhibitor
382556|NCT01505933|upper|upper
382557|NCT01505933|airway|airway
382558|NCT01505933|dimensions|dimensions
382559|NCT01505933|propofol|propofol
382560|NCT01505933|dexmedetomidine|dexmedetomidine
382561|NCT01505907|Pharmacokinetics|pharmacokinetics
382563|NCT01505907|Healthy Males|healthy males
382564|NCT01505868|Prostate Cancer|prostate cancer
382565|NCT01505868|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
382566|NCT01505868|mCRPC|mcrpc
382567|NCT01505868|Prior treatment with docetaxel|prior treatment with docetaxel
382568|NCT01505868|Cabazitaxel|cabazitaxel
382569|NCT01505868|Jevtana|jevtana
382570|NCT01505868|Carboplatin|carboplatin
382571|NCT01505868|Paraplatin|paraplatin
382572|NCT01505868|Prednisone|prednisone
382573|NCT01505855|Crohn's disease|crohn's disease
382574|NCT01505855|Pneumococcal vaccination|pneumococcal vaccination
382575|NCT01505842|Ulcerative colitis|ulcerative colitis
382576|NCT01505842|Crohn's disease|crohn's disease
382577|NCT01505842|Chromoendoscopy|chromoendoscopy
382578|NCT01505842|Dysplasia|dysplasia
382579|NCT01505842|Neoplasia|neoplasia
382580|NCT01505842|Inflammatory Bowel Disease|inflammatory bowel disease
382581|NCT01505816|Cataract|cataract
382582|NCT01505816|Vision|vision
382583|NCT01505816|Intraocular lens|intraocular lens
382584|NCT01505816|Multifocal|multifocal
382585|NCT01505816|Toric|toric
382586|NCT01505803|Type 2 diabetes mellitus|type 2 diabetes mellitus
382587|NCT01505803|Dietary supplements|dietary supplements
382588|NCT01505803|Hyperglycemia|hyperglycemia
382589|NCT01505803|Insulin resistance|insulin resistance
382590|NCT01505803|Dyslipidemia|dyslipidemia
382591|NCT01505803|Inflammation|inflammation
382592|NCT01505803|Oxidative stress|oxidative stress
382593|NCT01505803|Zinc|zinc
382594|NCT01505803|Omega 3|omega 3
382595|NCT01505777|irritable bowel syndrome without predominant diarrhea|irritable bowel syndrome without predominant diarrhea
382596|NCT01505777|Probiotics(Medirac) 10/mosapride 10mg|probiotics(medirac) 10/mosapride 10mg
382597|NCT01505777|Probiotics(Medirac) 15/mosapride 10mg|probiotics(medirac) 15/mosapride 10mg
382598|NCT01505777|Probiotics(Medirac) 15/mosapride 15mg|probiotics(medirac) 15/mosapride 15mg
382599|NCT01505777|Probiotics(Medirac) 30/mosapride 15mg|probiotics(medirac) 30/mosapride 15mg
382600|NCT01505777|Probiotics(Medirac) placebo/mosapride placebo|probiotics(medirac) placebo/mosapride placebo
382601|NCT01505764|Cachexia|cachexia
382602|NCT01505751|Outcome of cervical cancer|outcome of cervical cancer
382603|NCT01505725|Nicotine Reinforcement|nicotine reinforcement
382604|NCT01505725|Tobacco Craving|tobacco craving
382605|NCT01505725|Behavior Genetics|behavior genetics
382606|NCT01505725|Smoking|smoking
382607|NCT01505712|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
382608|NCT01505712|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
382609|NCT01505712|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
382610|NCT01505712|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
382611|NCT01505699|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
382612|NCT01505699|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
382613|NCT01505673|Insulin|insulin
382614|NCT01505673|Glucagon-like peptide|glucagon-like peptide
382615|NCT01505673|Liraglutide|liraglutide
382616|NCT01505673|Beta-Cell|beta-cell
382617|NCT01505673|pancreatic steatosis|pancreatic steatosis
382618|NCT01505673|hepatic steatosis|hepatic steatosis
382619|NCT01505660|Adherence|adherence
382620|NCT01505660|Depression|depression
382621|NCT01505660|Care management|care management
382622|NCT01505660|Stepped care|stepped care
382623|NCT01505660|HIV|hiv
382624|NCT01505660|Patient reported outcomes|patient reported outcomes
382625|NCT01505660|Antiretroviral medication adherence|antiretroviral medication adherence
382626|NCT01505621|Aging|aging
382627|NCT01505621|Protein accumulation|protein accumulation
382628|NCT01505621|Protein damage|protein damage
382629|NCT01505569|autologous transplantation|autologous transplantation
382630|NCT01505569|high risk solid tumor|high risk solid tumor
382631|NCT01505569|relapsed solid tumor|relapsed solid tumor
382632|NCT01505478|Sepsis|sepsis
382633|NCT01505478|Clinical Prediction Rule|clinical prediction rule
382634|NCT01505478|Clinical Informatics|clinical informatics
382635|NCT01505478|Machine Learning|machine learning
382636|NCT01505465|Total Knee Replacement|total knee replacement
382637|NCT01505465|Pain|pain
382638|NCT01505465|Confusion|confusion
382639|NCT01505465|Sleep|sleep
382640|NCT01505439|solifenacin|solifenacin
382641|NCT01505439|bladder symptom|bladder symptom
382642|NCT01505426|ASP1941|asp1941
382643|NCT01505426|ipragliflozin|ipragliflozin
382644|NCT01505426|metformin|metformin
382645|NCT01505426|plasma glucose|plasma glucose
382646|NCT01505426|urine glucose|urine glucose
382647|NCT01505413|advanced unresectable or metastatic Pancreatic Cancer|advanced unresectable or metastatic pancreatic cancer
382648|NCT01505400|Molecular profiling|molecular profiling
382649|NCT01505400|Advanced cancer|advanced cancer
382650|NCT01505400|Breast cancer|breast cancer
382651|NCT01505400|Non-small cell lung cancer|non-small cell lung cancer
382652|NCT01505400|Colorectal cancer|colorectal cancer
382653|NCT01505400|Genitourinary cancer|genitourinary cancer
382654|NCT01505400|Pancreatobiliary gastrointestinal cancer|pancreatobiliary gastrointestinal cancer
382655|NCT01505400|Upper aerodigestive tract cancer|upper aerodigestive tract cancer
382656|NCT01505400|Gynecological cancers|gynecological cancers
382657|NCT01505400|Phase I|phase i
382658|NCT01505400|Phase I Clinical Trial Candidates|phase i clinical trial candidates
382659|NCT01505400|melanoma cancer|melanoma cancer
382660|NCT01505400|rare cancer|rare cancer
382661|NCT01505400|unknown primary cancer|unknown primary cancer
382662|NCT01505387|Weight maintenance|weight maintenance
382663|NCT01505387|Overweight|overweight
382664|NCT01505387|Obese|obese
382665|NCT01505387|Weight management|weight management
382666|NCT01505374|Bilateral total knee replacement|bilateral total knee replacement
382667|NCT01505374|Femoral Nerve Block|femoral nerve block
382668|NCT01505374|Saphenous Nerve Block|saphenous nerve block
382669|NCT01505361|probiotic|probiotic
382670|NCT01505361|Lactobacillus salivarius|lactobacillus salivarius
382671|NCT01505361|mastitis|mastitis
382672|NCT01505361|prevention|prevention
382673|NCT01505361|group B streptococci|group b streptococci
382674|NCT01505361|intrapartum prophylaxis|intrapartum prophylaxis
382675|NCT01505348|feeding patterns|feeding patterns
382676|NCT01505348|aerobic exercise|aerobic exercise
382677|NCT01505348|osteoclasts|osteoclasts
382678|NCT01505335|alveolar nerve, inferior|alveolar nerve, inferior
382679|NCT01505335|ultrasound|ultrasound
382680|NCT01505335|digital radiography, dental|digital radiography, dental
382681|NCT01505335|nerve injury|nerve injury
382682|NCT01505322|daily activities|daily activities
382683|NCT01505309|Aortic Diseases|aortic diseases
382684|NCT01505309|Vascular Diseases|vascular diseases
382685|NCT01505309|Cardiovascular Diseases|cardiovascular diseases
382686|NCT01505309|Treatment Outcome|treatment outcome
382687|NCT01505309|Aorta Dissection|aorta dissection
382688|NCT01505309|Aorta Aneurysm|aorta aneurysm
382689|NCT01505309|Aorta pseudoaneurysm|aorta pseudoaneurysm
382690|NCT01505309|Endovascular aortic repair|endovascular aortic repair
382691|NCT01505296|Catheter ablation|catheter ablation
382692|NCT01505257|Delirium|delirium
382693|NCT01505257|Dementia|dementia
382694|NCT01505257|Confusion Assessment Method|confusion assessment method
382695|NCT01505231|Shock|shock
382696|NCT01505231|norepinephrine|norepinephrine
382697|NCT01505231|vasopressin|vasopressin
382698|NCT01505231|cardiac surgery|cardiac surgery
382699|NCT01505218|Sedation|sedation
382700|NCT01505218|propofol|propofol
382701|NCT01505218|patient-controlled|patient-controlled
382702|NCT01505218|safety|safety
382703|NCT01505205|Gist,c-KIT,PDGFRA,DOG1,mutation|gist,c-kit,pdgfra,dog1,mutation
382704|NCT01505192|Those in Labor, Delivery and the Puerperium|those in labor, delivery and the puerperium
382705|NCT01505179|HFPEF|hfpef
382706|NCT01505179|Heart Failure|heart failure
382707|NCT01505179|HF w/ preserved EF|hf w/ preserved ef
382708|NCT01505179|Preserved EF|preserved ef
382709|NCT01505179|Preserved Ejection Fraction|preserved ejection fraction
382710|NCT01505179|Diastolic Dysfunction|diastolic dysfunction
382711|NCT01505166|colorectal carcinoma|colorectal carcinoma
382712|NCT01505166|colon cancer|colon cancer
382713|NCT01505166|liver metastases|liver metastases
382714|NCT01505153|Advanced cancer|advanced cancer
382715|NCT01505153|Metastatic cancer|metastatic cancer
382716|NCT01505153|solid tumors|solid tumors
382717|NCT01505153|Melanoma|melanoma
382718|NCT01505140|Andrology|andrology
382719|NCT01505140|Fertility|fertility
382720|NCT01505140|Reproduction|reproduction
382721|NCT01505140|Diet|diet
382722|NCT01505140|Nutritional Sciences|nutritional sciences
382723|NCT01505140|Fatty Acids|fatty acids
382724|NCT01505140|Antioxidants|antioxidants
382725|NCT01505140|Body weight changes|body weight changes
382726|NCT01505127|Drug Therapy|drug therapy
382727|NCT01505114|HIV Prevention|hiv prevention
382728|NCT01505114|PrEP|prep
382729|NCT01505114|Maraviroc|maraviroc
382730|NCT01505088|Iontophoresis|iontophoresis
382731|NCT01505088|Non-Infectious Anterior Segment Uveitis|non-infectious anterior segment uveitis
382732|NCT01505088|Ophthalmology|ophthalmology
382733|NCT01505075|prostatic neoplasms|prostatic neoplasms
382734|NCT01505075|radiotherapy|radiotherapy
382735|NCT01505075|hypofractionated|hypofractionated
382736|NCT01505075|high risk prostate cancer|high risk prostate cancer
382737|NCT01505062|Usher Syndrome Retinitis Pigmentosa|usher syndrome retinitis pigmentosa
382738|NCT01505062|Usher Syndrome associated Retinitis Pigmentosa|usher syndrome associated retinitis pigmentosa
382739|NCT01505049|immunology|immunology
382740|NCT01505049|vaccination|vaccination
382741|NCT01505049|human papillomavirus|human papillomavirus
382742|NCT01505036|Diabetes Mellitus|diabetes mellitus
382743|NCT01505036|smart-care|smart-care
382744|NCT01505036|U-health care|u-health care
382745|NCT01505010|Treatment-resistant hypertension|treatment-resistant hypertension
382746|NCT01505010|Renal denervation|renal denervation
382747|NCT01505010|Sympathetic nervous system|sympathetic nervous system
382748|NCT01504997|DaVinci|davinci
382749|NCT01504997|Robot assisted surgery|robot assisted surgery
382750|NCT01504997|Gastrectomy|gastrectomy
382751|NCT01504997|Safety|safety
382752|NCT01504997|Gastric Cancer|gastric cancer
382753|NCT01504984|Evaluation of the pharmacokinetics equivalence|evaluation of the pharmacokinetics equivalence
382754|NCT01504984|Healthy volunteers|healthy volunteers
383131|NCT01503606|duration|duration
382755|NCT01504984|Single dose over the period I and II(crossover)|single dose over the period i and ii(crossover)
382756|NCT01504984|Healthy male volunteers|healthy male volunteers
382757|NCT01504971|Gastroesophageal Reflux;|gastroesophageal reflux;
382758|NCT01504971|Endoscopy;|endoscopy;
382759|NCT01504971|Esophageal pH monitoring;|esophageal ph monitoring;
382760|NCT01504971|Narrow band imaging;|narrow band imaging;
382761|NCT01504971|Autofluorescence imaging;|autofluorescence imaging;
382762|NCT01504971|White light imaging;|white light imaging;
382763|NCT01504958|Alzheimer's disease|alzheimer's disease
382764|NCT01504958|Cognitive Training|cognitive training
382765|NCT01504958|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
382766|NCT01504945|chronic coronary artery disease|chronic coronary artery disease
382767|NCT01504932|black raspberry lozenges|black raspberry lozenges
382768|NCT01504932|Appalachian|appalachian
382769|NCT01504932|Oral Cancer|oral cancer
382770|NCT01504919|Psychosocial|psychosocial
382771|NCT01504919|Behavioral intervention|behavioral intervention
382772|NCT01504919|Nicotine patch|nicotine patch
382773|NCT01504919|Latinos|latinos
382774|NCT01504919|Mexican American|mexican american
382775|NCT01504919|Motivation and Problem Solving|motivation and problem solving
382776|NCT01504919|MAPS|maps
382777|NCT01504919|Cancer risk reduction|cancer risk reduction
382778|NCT01504919|Smoking cessation|smoking cessation
382779|NCT01504919|Overweight/obese smokers|overweight/obese smokers
382780|NCT01504919|BMI greater than or equal to 25|bmi greater than or equal to 25
382781|NCT01504919|Wellness program|wellness program
382782|NCT01504919|Questionnaires|questionnaires
382783|NCT01504919|Surveys|surveys
382784|NCT01504919|Self-help materials|self-help materials
382785|NCT01504919|Pamphlets|pamphlets
382786|NCT01504906|Phase 1|phase 1
382787|NCT01504906|Healthy male volunteers|healthy male volunteers
382788|NCT01504906|pharmacokinetics|pharmacokinetics
382789|NCT01504906|cyclosporine|cyclosporine
382790|NCT01504906|ticagrelor|ticagrelor
382791|NCT01504906|Bioavailability (plasma AUC, Cmax, plasma AUC0-t, t1/2λz, tmax)|bioavailability (plasma auc, cmax, plasma auc0-t, t1/2λz, tmax)
382792|NCT01504893|ventilation|ventilation
382793|NCT01504893|PEEP|peep
382794|NCT01504893|Acute Lung Injury|acute lung injury
382795|NCT01504893|pneumonectomy|pneumonectomy
382796|NCT01504893|ARDS|ards
382797|NCT01504880|Mitral Regurgitation|mitral regurgitation
382798|NCT01504880|Tricuspid Regurgitation|tricuspid regurgitation
382799|NCT01504880|Vena Contracta|vena contracta
382800|NCT01504867|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
382801|NCT01504867|Acute Lung Injury|acute lung injury
382802|NCT01504867|ARDS|ards
382803|NCT01504867|ALI|ali
382804|NCT01504867|aspirin|aspirin
382805|NCT01504867|prevention|prevention
382806|NCT01504854|Alzheimer's disease|alzheimer's disease
382807|NCT01504854|Dementia|dementia
382808|NCT01504854|Brain diseases|brain diseases
382809|NCT01504854|Resveratrol|resveratrol
382810|NCT01504854|Memory problems|memory problems
382811|NCT01504854|Mental disorders|mental disorders
382812|NCT01504854|Cognitive disorders|cognitive disorders
382813|NCT01504828|Energy Metabolism|energy metabolism
382814|NCT01504828|Ageing|ageing
382815|NCT01504828|left ventricle|left ventricle
382816|NCT01504828|energetics|energetics
382817|NCT01504828|function|function
382818|NCT01504815|advanced head and neck cancer|advanced head and neck cancer
382819|NCT01504815|adaptive radiotherapy|adaptive radiotherapy
382820|NCT01504815|cisplatinum|cisplatinum
382821|NCT01504802|Growth hormone|growth hormone
382822|NCT01504802|C-type natriuretic peptide|c-type natriuretic peptide
382823|NCT01504802|amino-terminal propeptide of C-type natriuretic peptide|amino-terminal propeptide of c-type natriuretic peptide
382824|NCT01504802|insulin-like growth factor-I|insulin-like growth factor-i
382825|NCT01504802|bone specific alkaline phosphatase|bone specific alkaline phosphatase
382826|NCT01504802|leptin|leptin
382827|NCT01504802|deoxypyridinoline|deoxypyridinoline
382828|NCT01504802|growth velocity|growth velocity
382829|NCT01504802|pharmacodynamic|pharmacodynamic
382830|NCT01504802|biomarker|biomarker
382831|NCT01504789|Breast Cancer|breast cancer
382832|NCT01504789|Breast Cancer Survivors|breast cancer survivors
382833|NCT01504789|Exercise|exercise
382834|NCT01504789|Hispanic|hispanic
382835|NCT01504789|Mexican-American|mexican-american
382836|NCT01504789|Puerto Rican|puerto rican
382837|NCT01504789|Culturally tailored exercise|culturally tailored exercise
382838|NCT01504789|Fitness tests|fitness tests
382839|NCT01504789|Questionnaires|questionnaires
382840|NCT01504789|Surveys|surveys
382841|NCT01504789|Culturally tailored written material|culturally tailored written material
382842|NCT01504776|MCL|mcl
382843|NCT01504776|Lymphoma|lymphoma
382844|NCT01504776|Panobinostat|panobinostat
382845|NCT01504763|Massage|massage
382846|NCT01504763|Chair massage|chair massage
382847|NCT01504763|Relaxation|relaxation
382848|NCT01504763|Nurses|nurses
382849|NCT01504750|Length of Stay [E02.760.400.480]|length of stay [e02.760.400.480]
382850|NCT01504750|Activities of Daily Living [I03.050]|activities of daily living [i03.050]
382851|NCT01504737|Exercise|exercise
383132|NCT01503606|cefazolin|cefazolin
382852|NCT01504737|Physical Activity|physical activity
382853|NCT01504737|Physiotherapy|physiotherapy
382854|NCT01504737|Exercise test|exercise test
382855|NCT01504737|Quality of Life|quality of life
382856|NCT01504737|Aortic Valve Replacement|aortic valve replacement
382857|NCT01504724|central macular thickness|central macular thickness
382858|NCT01504698|Manipulative treatment|manipulative treatment
382859|NCT01504698|Children|children
382860|NCT01504698|Neck pain|neck pain
382861|NCT01504698|Back pain|back pain
382862|NCT01504698|Effect|effect
382863|NCT01504698|Adolescence|adolescence
382864|NCT01504698|Advise|advise
382865|NCT01504698|Exercise|exercise
382866|NCT01504685|Morbid obesity|morbid obesity
382867|NCT01504685|Obesity surgery|obesity surgery
382868|NCT01504685|Gastric bypass|gastric bypass
382869|NCT01504685|Banded gastric bypass|banded gastric bypass
382870|NCT01504672|Drug related problems|drug related problems
382871|NCT01504659|bipolar disorder|bipolar disorder
382872|NCT01504659|treatment resistance|treatment resistance
382873|NCT01504659|depression|depression
382874|NCT01504659|ketamine|ketamine
382875|NCT01504659|intranasal|intranasal
382876|NCT01504659|child|child
382877|NCT01504646|Asthma|asthma
382878|NCT01504646|Exercise-Induced Bronchoconstriction|exercise-induced bronchoconstriction
382879|NCT01504646|lipids|lipids
382880|NCT01504646|n-3 PUFA|n-3 pufa
382881|NCT01504646|airway inflammation|airway inflammation
382882|NCT01504646|Bronchoconstriction|bronchoconstriction
382883|NCT01504633|cognitive function|cognitive function
382884|NCT01504633|omega-3 PUFA (DHA)|omega-3 pufa (dha)
382885|NCT01504633|iron|iron
382886|NCT01504633|nutrigenomics|nutrigenomics
382887|NCT01504633|under-two year old children|under-two year old children
382888|NCT01504633|Indonesia|indonesia
382889|NCT01504620|diabetes mellitus|diabetes mellitus
382890|NCT01504620|blood glucose self-assessment|blood glucose self-assessment
382891|NCT01504620|Accuracy|accuracy
382892|NCT01504620|Intra-Assay precision|intra-assay precision
382893|NCT01504620|Hematocrit interference|hematocrit interference
382894|NCT01504607|corneal endothelium|corneal endothelium
382895|NCT01504607|congenital cataract surgery|congenital cataract surgery
382896|NCT01504607|IOL implantation|iol implantation
382897|NCT01504594|Dilated cardiomyopathy|dilated cardiomyopathy
382898|NCT01504594|Idiopathic|idiopathic
382899|NCT01504594|Bone Marrow|bone marrow
382900|NCT01504594|Stem Cells|stem cells
382901|NCT01504594|CD34 +|cd34 +
382902|NCT01504594|Autologous|autologous
382903|NCT01504555|hypercortisolism, dexamethasone, alcoholism,obesity.|hypercortisolism, dexamethasone, alcoholism,obesity.
382904|NCT01504542|Immunotherapy|immunotherapy
382905|NCT01504529|Rotigotine (Neupro)|rotigotine (neupro)
382906|NCT01504529|Non-Motor Symptoms|non-motor symptoms
382907|NCT01504529|Advanced Parkinson's Disease|advanced parkinson's disease
382908|NCT01504529|Local study|local study
382909|NCT01504529|Spain|spain
382910|NCT01504529|Observational study|observational study
382911|NCT01504529|Non-interventional study|non-interventional study
382912|NCT01504529|Retrospective study|retrospective study
382913|NCT01504529|Post-marketing study|post-marketing study
382914|NCT01504529|Multicenter study|multicenter study
382915|NCT01504516|Bioequivalence|bioequivalence
382916|NCT01504516|Donepezil|donepezil
382917|NCT01504516|crossover|crossover
382918|NCT01504503|Bioequivalence|bioequivalence
382919|NCT01504503|Donepezil|donepezil
382920|NCT01504503|crossover|crossover
382921|NCT01504490|Advanced cancer|advanced cancer
382922|NCT01504477|colorectal cancer|colorectal cancer
382923|NCT01504477|relapsed|relapsed
382924|NCT01504477|refractory|refractory
382925|NCT01504477|Kras wild type|kras wild type
382926|NCT01504464|knee joint osteoarthritis mesenchymal stem cell|knee joint osteoarthritis mesenchymal stem cell
382927|NCT01504451|Atrial fibrillation|atrial fibrillation
382928|NCT01504451|Ablation|ablation
382929|NCT01504451|Implantable loop recorder|implantable loop recorder
382930|NCT01504412|Pain|pain
382931|NCT01504412|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
382932|NCT01504399|Pituitary surgery|pituitary surgery
382933|NCT01504399|Transsphenoidal surgery|transsphenoidal surgery
382934|NCT01504399|Anterior skull base surgery|anterior skull base surgery
382935|NCT01504399|Endoscopic surgery|endoscopic surgery
382936|NCT01504399|Patient survey|patient survey
382937|NCT01504399|Nasal complications|nasal complications
382938|NCT01504373|NAVA|nava
382939|NCT01504373|neurally adjusted ventilatory support|neurally adjusted ventilatory support
382940|NCT01504373|lung injury|lung injury
382941|NCT01504373|ventilation|ventilation
382942|NCT01504373|lung volume distribution|lung volume distribution
382943|NCT01504373|oxygen cost of breathing|oxygen cost of breathing
382944|NCT01504360|sarcoma|sarcoma
382945|NCT01504360|radiation therapy|radiation therapy
382946|NCT01504360|predictive essay|predictive essay
382947|NCT01504321|Polycystic Ovary syndrome|polycystic ovary syndrome
382948|NCT01504321|PCOS|pcos
382949|NCT01504321|sympathetic nervous system|sympathetic nervous system
382950|NCT01504321|moxonidine|moxonidine
382951|NCT01504308|uterine fibroids|uterine fibroids
382952|NCT01504308|uterine leiomyomas|uterine leiomyomas
382953|NCT01504308|magnetic resonance imaging|magnetic resonance imaging
382954|NCT01504308|focused ultrasound|focused ultrasound
382955|NCT01504256|Adenocarcinoma|adenocarcinoma
382956|NCT01504256|Esophagogastric Junction|esophagogastric junction
382957|NCT01504256|Peritoneal Carcinomatosis|peritoneal carcinomatosis
382958|NCT01504256|Catumaxomab|catumaxomab
382959|NCT01504256|AIO-STO-0110|aio-sto-0110
382960|NCT01504243|CD163;|cd163;
382961|NCT01504243|SNPs;|snps;
382962|NCT01504243|prognosis;|prognosis;
382963|NCT01504243|control（normal person）|control（normal person）
382964|NCT01504230|To ascertain the mechanisms for effectively controlling balance in seniors with osteoporosis and to provide a basis for developing fall prevention programs.|to ascertain the mechanisms for effectively controlling balance in seniors with osteoporosis and to provide a basis for developing fall prevention programs.
382965|NCT01504230|To develop biomechanical models that control the entire body's center of mass (CoM) during upright quiet stance in seniors with osteoporosis.|to develop biomechanical models that control the entire body's center of mass (com) during upright quiet stance in seniors with osteoporosis.
382966|NCT01504230|To identify the mechanism to control the entire body's CoM after receiving a balance perturbation in seniors with osteoporosis.|to identify the mechanism to control the entire body's com after receiving a balance perturbation in seniors with osteoporosis.
382967|NCT01504217|Healthy older people over 65 years old|healthy older people over 65 years old
382968|NCT01504204|adherence|adherence
382969|NCT01504204|adapalene|adapalene
382970|NCT01504204|benzoyl peroxide|benzoyl peroxide
382971|NCT01504204|sample|sample
382972|NCT01504204|topical treatment|topical treatment
382973|NCT01504191|myocardial infarction|myocardial infarction
382974|NCT01504191|depression|depression
382975|NCT01504191|anxiety|anxiety
382976|NCT01504191|Internet‐based CBT|internet‐based cbt
382977|NCT01504191|genetic disposition|genetic disposition
382978|NCT01504178|Noradrenergic system and pain in Parkinson's disease|noradrenergic system and pain in parkinson's disease
382979|NCT01504165|Renal impairment|renal impairment
382980|NCT01504165|Pharmacokinetic|pharmacokinetic
382981|NCT01504165|cilengitide|cilengitide
382982|NCT01504165|subjects with mild|subjects with mild
382983|NCT01504165|moderate or severe renal impairment compared to subjects with normal renal function|moderate or severe renal impairment compared to subjects with normal renal function
382984|NCT01504152|International travel|international travel
382985|NCT01504152|cancer patients|cancer patients
382986|NCT01504152|HSCT|hsct
382987|NCT01504152|Quality of Life|quality of life
382988|NCT01504152|questionnaire|questionnaire
382989|NCT01504152|11-176|11-176
382990|NCT01504126|Ovarian Cancer|ovarian cancer
382991|NCT01504126|Primary peritoneal carcinoma|primary peritoneal carcinoma
382992|NCT01504126|Fallopian tube cancer|fallopian tube cancer
382993|NCT01504126|Invasive epithelial ovarian cancer|invasive epithelial ovarian cancer
382994|NCT01504126|Serous adenocarcinoma|serous adenocarcinoma
382995|NCT01504126|Endometrioid adenocarcinoma|endometrioid adenocarcinoma
382996|NCT01504126|Mucinous adenocarcinoma|mucinous adenocarcinoma
382997|NCT01504126|Undifferentiated carcinoma|undifferentiated carcinoma
382998|NCT01504126|Clear cell carcinoma|clear cell carcinoma
382999|NCT01504126|Mixed epithelial carcinoma|mixed epithelial carcinoma
383000|NCT01504126|Adenocarcinoma not otherwise specified|adenocarcinoma not otherwise specified
383001|NCT01504126|Primary Müllerian epithelial adenocarcinoma|primary müllerian epithelial adenocarcinoma
383002|NCT01504126|Propranolol|propranolol
383003|NCT01504126|Beta-blocker|beta-blocker
383004|NCT01504113|Target therapy|target therapy
383005|NCT01504113|Biologics|biologics
383006|NCT01504113|Psoriasis|psoriasis
383007|NCT01504113|Latent virus|latent virus
383008|NCT01504113|Human papillomaviruses|human papillomaviruses
383009|NCT01504113|Cytomegalovirus|cytomegalovirus
383010|NCT01504113|Epstein-Barr virus|epstein-barr virus
383011|NCT01504113|Tumor necrosis factor|tumor necrosis factor
383012|NCT01504087|patient in critical care|patient in critical care
383013|NCT01504074|Irvine Gass syndrome|irvine gass syndrome
383014|NCT01504074|multimodal imaging|multimodal imaging
383015|NCT01504074|SD-OCT|sd-oct
383016|NCT01504074|CME secondary to cataract surgery|cme secondary to cataract surgery
383017|NCT01504074|in vivo correlation of morphology and function|in vivo correlation of morphology and function
383018|NCT01504061|surgical|surgical
383019|NCT01504061|scars|scars
383020|NCT01504061|Mederma|mederma
383021|NCT01504048|Microscopic colitis|microscopic colitis
383022|NCT01504048|Intestinal Diseases|intestinal diseases
383023|NCT01504048|Inflammatory Bowel Diseases|inflammatory bowel diseases
383024|NCT01504035|Donor site pain|donor site pain
383025|NCT01504035|Iliac crest|iliac crest
383026|NCT01504035|Bone graft|bone graft
383027|NCT01504035|Hemostatic putty|hemostatic putty
383028|NCT01504035|lidocaine|lidocaine
383029|NCT01504035|Donor site pain following harvest of iliac crest bone grafts|donor site pain following harvest of iliac crest bone grafts
383030|NCT01504022|Hypertension|hypertension
383031|NCT01504022|self-monitoring|self-monitoring
383032|NCT01504022|internet|internet
383033|NCT01504022|lifestyle modification|lifestyle modification
383034|NCT01504009|Nervous System Disease|nervous system disease
383035|NCT01504009|Neurodegenerative Disease|neurodegenerative disease
383321|NCT01502748|stroke|stroke
383036|NCT01504009|Motor Neuron Disease|motor neuron disease
383037|NCT01504009|ALS|als
383038|NCT01504009|Muscle training|muscle training
383039|NCT01504009|Muscle atrophy|muscle atrophy
383040|NCT01503996|dehydration|dehydration
383041|NCT01503996|risk factor|risk factor
383042|NCT01503996|glaucoma|glaucoma
383043|NCT01503996|Controls|controls
383044|NCT01503983|Gastric Cancer with Metastasis|gastric cancer with metastasis
383045|NCT01503983|HER2-positive|her2-positive
383046|NCT01503970|chondral lesions|chondral lesions
383047|NCT01503970|knee|knee
383048|NCT01503957|Allergic rhinitis|allergic rhinitis
383049|NCT01503957|Allergen|allergen
383050|NCT01503957|Allergy|allergy
383051|NCT01503957|Dustmite|dustmite
383052|NCT01503931|alcohol dependence, functional magnetic resonance imaging, genetics, endophenotypes, dopamine,|alcohol dependence, functional magnetic resonance imaging, genetics, endophenotypes, dopamine,
383053|NCT01503931|glutamate|glutamate
383054|NCT01503918|Critical Illness|critical illness
383055|NCT01503918|Critical Care|critical care
383056|NCT01503918|Valganciclovir|valganciclovir
383057|NCT01503918|Ganciclovir|ganciclovir
383058|NCT01503918|Aciclovir|aciclovir
383059|NCT01503918|Valaciclovir|valaciclovir
383060|NCT01503918|Cytomegalovirus|cytomegalovirus
383061|NCT01503905|breast cancer|breast cancer
383062|NCT01503905|neoadjuvant chemotherapy|neoadjuvant chemotherapy
383063|NCT01503905|amenorrhea|amenorrhea
383064|NCT01503892|Small Fiber Neuropathy|small fiber neuropathy
383065|NCT01503892|Metanx Effect on Small Fiber Neuropathy|metanx effect on small fiber neuropathy
383066|NCT01503892|Metanx Effect on Diabetic Peripheral Neuropathy|metanx effect on diabetic peripheral neuropathy
383067|NCT01503879|general anaesthesia|general anaesthesia
383068|NCT01503879|invasive mechanical ventilation|invasive mechanical ventilation
383069|NCT01503879|DLCO|dlco
383071|NCT01503853|Medical Costs|medical costs
383072|NCT01503853|Health Care|health care
383073|NCT01503853|Focus Groups|focus groups
383074|NCT01503827|Whole Brain Radiotherapy|whole brain radiotherapy
383075|NCT01503827|Brain metastases|brain metastases
383076|NCT01503827|Melanoma|melanoma
383077|NCT01503827|Stage IV Metastatic Melanoma|stage iv metastatic melanoma
383078|NCT01503827|Neurocognitive function|neurocognitive function
383079|NCT01503827|Quality of life|quality of life
383080|NCT01503814|hypertension|hypertension
383081|NCT01503814|primary care|primary care
383082|NCT01503814|cardiovascular disease prevention|cardiovascular disease prevention
383083|NCT01503814|high cardiovascular risk|high cardiovascular risk
383084|NCT01503814|diuretics|diuretics
383085|NCT01503814|aspirin|aspirin
383086|NCT01503814|smoking cessation|smoking cessation
383087|NCT01503814|salt reduction|salt reduction
383088|NCT01503814|Tibet|tibet
383089|NCT01503801|Preterm neonates|preterm neonates
383090|NCT01503801|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
383091|NCT01503801|Chronic lung disease|chronic lung disease
383092|NCT01503801|Inhaled nitric oxide|inhaled nitric oxide
383093|NCT01503801|Respiratory therapy|respiratory therapy
383094|NCT01503775|intracranial|intracranial
383095|NCT01503775|ruptured|ruptured
383096|NCT01503775|non-ruptured|non-ruptured
383097|NCT01503775|aneurysms|aneurysms
383098|NCT01503775|Intracranial ruptured or non-ruptured aneurysms|intracranial ruptured or non-ruptured aneurysms
383099|NCT01503762|Hand Flexor tendon Injuries|hand flexor tendon injuries
383100|NCT01503762|hand Extensor Tendon Injuries|hand extensor tendon injuries
383101|NCT01503762|Hand Joint Dislocations and subluxation|hand joint dislocations and subluxation
383102|NCT01503736|Kidney Diseases|kidney diseases
383103|NCT01503736|Kidney Failure, Chronic|kidney failure, chronic
383104|NCT01503736|Hyperphosphatemia|hyperphosphatemia
383105|NCT01503736|Urologic Diseases|urologic diseases
383106|NCT01503736|Renal Insufficiency, Chronic|renal insufficiency, chronic
383107|NCT01503736|Renal Insufficiency|renal insufficiency
383108|NCT01503736|Phosphorus Metabolism Disorders|phosphorus metabolism disorders
383109|NCT01503710|Proteinuria predict outcome|proteinuria predict outcome
383110|NCT01503710|BNP and NGAL predict outcome|bnp and ngal predict outcome
383111|NCT01503710|Pre-operative GFR and proteinuria|pre-operative gfr and proteinuria
383112|NCT01503697|Breast Cancer|breast cancer
383113|NCT01503697|High Risk|high risk
383114|NCT01503697|Imaging|imaging
383115|NCT01503697|Angiogenesis|angiogenesis
383116|NCT01503684|sepsis|sepsis
383117|NCT01503671|left ventricular diastolic function|left ventricular diastolic function
383118|NCT01503671|inflammation|inflammation
383119|NCT01503671|peritoneal dialysis|peritoneal dialysis
383120|NCT01503671|LV diastolic function changes after statin intervention|lv diastolic function changes after statin intervention
383121|NCT01503658|Clopidogrel,|clopidogrel,
383122|NCT01503658|Aspirin,|aspirin,
383123|NCT01503658|Pharmacogenomics|pharmacogenomics
383124|NCT01503645|kidney diseases|kidney diseases
383125|NCT01503645|drugs, Chinese herbal|drugs, chinese herbal
383126|NCT01503645|aristolochic acid|aristolochic acid
383127|NCT01503645|polymorphism, genetic|polymorphism, genetic
383128|NCT01503619|small cell lung cancer|small cell lung cancer
383129|NCT01503606|preterm premature rupture of membrane|preterm premature rupture of membrane
383130|NCT01503606|antibiotics|antibiotics
383133|NCT01503606|clarithromycin|clarithromycin
383134|NCT01503541|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
383135|NCT01503541|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
383136|NCT01503541|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
383137|NCT01503541|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
383138|NCT01503541|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
383139|NCT01503541|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
383140|NCT01503541|adult acute myeloid leukemia|adult acute myeloid leukemia
383141|NCT01503528|arthroplasty|arthroplasty
383142|NCT01503528|wound|wound
383143|NCT01503528|catheter|catheter
383144|NCT01503528|local|local
383145|NCT01503528|anesthesia|anesthesia
383146|NCT01503528|infiltration|infiltration
383147|NCT01503528|Total Knee Arthroplasty|total knee arthroplasty
383148|NCT01503502|Myelogenous Leukemia|myelogenous leukemia
383149|NCT01503502|chronce|chronce
383150|NCT01503502|Philadelphia Chromosome Positive|philadelphia chromosome positive
383151|NCT01503502|Flumatinib|flumatinib
383152|NCT01503489|Switch.|switch.
383153|NCT01503476|gastro esophageal reflux disease|gastro esophageal reflux disease
383154|NCT01503463|Congestive Heart Failure|congestive heart failure
383155|NCT01503463|Telemedicine|telemedicine
383156|NCT01503385|Celecoxib|celecoxib
383157|NCT01503385|phase II|phase ii
383158|NCT01503359|glutamic acid|glutamic acid
383159|NCT01503359|sarcosine|sarcosine
383160|NCT01503359|NMDA|nmda
383161|NCT01503359|schizophrenia|schizophrenia
383162|NCT01503346|Appetite Loss|appetite loss
383163|NCT01503333|exercise|exercise
383164|NCT01503333|adolescent|adolescent
383165|NCT01503333|intervention|intervention
383166|NCT01503333|female|female
383167|NCT01503333|counseling|counseling
383168|NCT01503320|To evaluate|to evaluate
383169|NCT01503320|efficacy|efficacy
383170|NCT01503320|enteral glutamine|enteral glutamine
383171|NCT01503307|prenatal chd diagnosis|prenatal chd diagnosis
383172|NCT01503307|postpartum chd diagnosis|postpartum chd diagnosis
383173|NCT01503307|parenting|parenting
383174|NCT01503307|internal working models|internal working models
383175|NCT01503294|Temporal artery thermometer|temporal artery thermometer
383176|NCT01503294|Pulmonary artery thermistor|pulmonary artery thermistor
383177|NCT01503281|Children|children
383178|NCT01503281|Physical activity|physical activity
383179|NCT01503281|Home-based treatment|home-based treatment
383180|NCT01503281|Body mass index (z-BMI)|body mass index (z-bmi)
383181|NCT01503281|Percentage body fat|percentage body fat
383182|NCT01503281|Waist circumference|waist circumference
383183|NCT01503268|Atrial fibrillation|atrial fibrillation
383184|NCT01503268|Ablation|ablation
383185|NCT01503268|Percutaneous ablation|percutaneous ablation
383186|NCT01503268|Minimally-invasive thoracoscopic ablation|minimally-invasive thoracoscopic ablation
383187|NCT01503268|Implantable loop recorder|implantable loop recorder
383188|NCT01503255|CBT|cbt
383189|NCT01503255|alcohol|alcohol
383190|NCT01503255|HIV|hiv
383191|NCT01503255|Kenya|kenya
383192|NCT01503255|paraprofessional|paraprofessional
383193|NCT01503216|randomized controlled trial|randomized controlled trial
383194|NCT01503216|vitamin D|vitamin d
383195|NCT01503216|bioavailability|bioavailability
383196|NCT01503203|Older|older
383197|NCT01503203|virtual systems|virtual systems
383198|NCT01503203|low back pain|low back pain
383199|NCT01503203|postural balance|postural balance
383200|NCT01503190|Breast Cancer|breast cancer
383201|NCT01503190|Young Women|young women
383202|NCT01503190|Pregnancy Associated Breast Cancer|pregnancy associated breast cancer
383203|NCT01503190|Pregnancy|pregnancy
383204|NCT01503190|Premenopausal Breast Cancer|premenopausal breast cancer
383205|NCT01503164|Obstructive sleep apnea|obstructive sleep apnea
383206|NCT01503164|Sleep Apnea|sleep apnea
383207|NCT01503164|Sleep-disordered breathing|sleep-disordered breathing
383208|NCT01503164|Insulin sensitivity|insulin sensitivity
383209|NCT01503164|Glucose tolerance|glucose tolerance
383210|NCT01503164|Type 2 diabetes|type 2 diabetes
383211|NCT01503151|attention bias modification treatment|attention bias modification treatment
383212|NCT01503151|interpretive bias modification|interpretive bias modification
383213|NCT01503151|cognitive bias modification|cognitive bias modification
383214|NCT01503151|attention training|attention training
383215|NCT01503151|social anxiety|social anxiety
383216|NCT01503138|Intimate Partner Violence|intimate partner violence
383217|NCT01503138|Depressive Symptoms|depressive symptoms
383218|NCT01503138|Intervention|intervention
383219|NCT01503138|Randomized Controlled Trial|randomized controlled trial
383220|NCT01503138|Mainland Chinese|mainland chinese
383221|NCT01503138|Immigrants|immigrants
383222|NCT01503138|Women|women
383223|NCT01503125|GAN|gan
383224|NCT01503125|Giant Axonal Neuropathy|giant axonal neuropathy
383225|NCT01503125|Neuromuscular Disease|neuromuscular disease
383226|NCT01503125|Natural History Study|natural history study
383227|NCT01503125|Observational Study|observational study
383322|NCT01502748|Magnesium|magnesium
383228|NCT01503112|Glucagon-Like Peptide 1, DPP4 protein, Therapeutics, Hypoglycemic Agents, C-Peptide, Type 2 Diabetes Mellitus,|glucagon-like peptide 1, dpp4 protein, therapeutics, hypoglycemic agents, c-peptide, type 2 diabetes mellitus,
383229|NCT01503099|ITB|itb
383230|NCT01503099|PTB|ptb
383231|NCT01503099|CD|cd
383232|NCT01503073|stroke|stroke
383233|NCT01503060|pediatrics|pediatrics
383234|NCT01503060|Pain|pain
383235|NCT01503060|Immunization|immunization
383236|NCT01503034|Pregnant women|pregnant women
383237|NCT01503021|Soluble ferric pyrophosphate|soluble ferric pyrophosphate
383238|NCT01503021|Chronic kidney disease|chronic kidney disease
383239|NCT01503021|Chronic hemodialysis|chronic hemodialysis
383240|NCT01503021|Ferric pyrophosphate citrate|ferric pyrophosphate citrate
383241|NCT01502995|Assistive devices|assistive devices
383242|NCT01502995|Freezing of gait|freezing of gait
383243|NCT01502995|Gait disorders|gait disorders
383244|NCT01502995|Gait hesitation|gait hesitation
383245|NCT01502995|Gait ignition failure|gait ignition failure
383246|NCT01502995|Laser light|laser light
383247|NCT01502995|Parkinson's disease|parkinson's disease
383248|NCT01502995|Rolling walker|rolling walker
383249|NCT01502995|Visual Cue|visual cue
383250|NCT01502995|Walker|walker
383251|NCT01502982|DLBCL|dlbcl
383252|NCT01502982|high risk|high risk
383253|NCT01502982|young|young
383254|NCT01502969|diarrhea|diarrhea
383255|NCT01502969|fever|fever
383256|NCT01502969|nausea|nausea
383257|NCT01502969|vomit|vomit
383258|NCT01502969|irritability|irritability
383259|NCT01502956|Refractory Urinary Urge Incontinence|refractory urinary urge incontinence
383260|NCT01502956|Botox A®|botox a®
383261|NCT01502956|Interstim® Device|interstim® device
383262|NCT01502943|Complementary Therapies|complementary therapies
383263|NCT01502943|Traditional Chinese Medicine|traditional chinese medicine
383264|NCT01502943|Quality of life|quality of life
383265|NCT01502943|Seattle angina questionnaire (SAQ)|seattle angina questionnaire (saq)
383266|NCT01502943|SF-12|sf-12
383267|NCT01502943|Measure Your Medical Outcome Profile (MYMOP)|measure your medical outcome profile (mymop)
383268|NCT01502943|Phlegm and blood stasis Syndrome|phlegm and blood stasis syndrome
383269|NCT01502943|Qi deficiency and blood stasis Syndrome|qi deficiency and blood stasis syndrome
383270|NCT01502943|Invigorating Spleen to Remove Phlegm or replenish Qi|invigorating spleen to remove phlegm or replenish qi
383271|NCT01502943|Activating blood and dissolving stasis|activating blood and dissolving stasis
383272|NCT01502943|Traditional Chinese medicine SYndrome Scale (TCMsys)|traditional chinese medicine syndrome scale (tcmsys)
383273|NCT01502943|Patients Report Outcomes(PRO)|patients report outcomes(pro)
383274|NCT01502943|clinical efficacy|clinical efficacy
383275|NCT01502943|evaluative index|evaluative index
383276|NCT01502917|Brain stem glioma|brain stem glioma
383277|NCT01502917|CNS|cns
383278|NCT01502917|MAB 124I-8H9|mab 124i-8h9
383279|NCT01502917|infusion cannula|infusion cannula
383280|NCT01502917|DIPG|dipg
383281|NCT01502917|Diffuse Intrinsic Pontine Glioma|diffuse intrinsic pontine glioma
383282|NCT01502917|11-011|11-011
383283|NCT01502904|SES vs BES|ses vs bes
383284|NCT01502891|Comparative Effectiveness Research|comparative effectiveness research
383285|NCT01502891|Decision Support Techniques|decision support techniques
383286|NCT01502891|Decision Making|decision making
383287|NCT01502878|Nut allergy|nut allergy
383414|NCT01502306|Self-help|self-help
383288|NCT01502878|Double-blind placebo-controlled (DBPC) oral nut challenge|double-blind placebo-controlled (dbpc) oral nut challenge
383289|NCT01502878|Nut oral immunotherapy (OIT)|nut oral immunotherapy (oit)
383290|NCT01502878|Nut oral desensitization|nut oral desensitization
383291|NCT01502852|OEF/OIF Veterans|oef/oif veterans
383292|NCT01502852|Traumatic Brain Injury|traumatic brain injury
383293|NCT01502852|Community Mental Health|community mental health
383294|NCT01502826|Childhood obesity|childhood obesity
383295|NCT01502826|Endothelial dysfunction|endothelial dysfunction
383296|NCT01502826|Inflammation|inflammation
383297|NCT01502826|Insulin resistance|insulin resistance
383298|NCT01502813|Neuropsychological testing|neuropsychological testing
383299|NCT01502813|Dietary supplements|dietary supplements
383300|NCT01502800|Metastatic|metastatic
383301|NCT01502800|Unresectable|unresectable
383302|NCT01502800|Recurrent advanced|recurrent advanced
383303|NCT01502787|hypertension|hypertension
383304|NCT01502787|blood pressure|blood pressure
383305|NCT01502787|blood pressure medications|blood pressure medications
383306|NCT01502787|metoprolol|metoprolol
383307|NCT01502787|nebivolol|nebivolol
383308|NCT01502787|handgrip exercise|handgrip exercise
383309|NCT01502787|lower body negative pressure|lower body negative pressure
383310|NCT01502787|angiotensin II|angiotensin ii
383311|NCT01502787|sympathetic nerve activity|sympathetic nerve activity
383312|NCT01502787|flow mediated dilation|flow mediated dilation
383313|NCT01502787|nitric oxide|nitric oxide
383314|NCT01502787|microneurography|microneurography
383315|NCT01502774|STEMI|stemi
383316|NCT01502774|cyclosporine|cyclosporine
383317|NCT01502774|reperfusion injury|reperfusion injury
383318|NCT01502761|stroke|stroke
383319|NCT01502761|Magnesium|magnesium
383320|NCT01502761|endovascular|endovascular
383323|NCT01502748|Endovascular|endovascular
383324|NCT01502735|dengue|dengue
383325|NCT01502735|dengue fever|dengue fever
383326|NCT01502735|monovalent dengue vaccine|monovalent dengue vaccine
383327|NCT01502709|Single blind|single blind
383328|NCT01502709|Randomized|randomized
383329|NCT01502709|Controlled clinical trial|controlled clinical trial
383330|NCT01502696|ulcerated primary cutaneous melanoma|ulcerated primary cutaneous melanoma
383331|NCT01502696|Stage II|stage ii
383332|NCT01502696|PEG IFN alfa-2b|peg ifn alfa-2b
383333|NCT01502696|T(2-4)bN0M0|t(2-4)bn0m0
383334|NCT01502683|Stroke|stroke
383335|NCT01502683|neurocognitive dysfunction|neurocognitive dysfunction
383336|NCT01502683|cerebral embolic events|cerebral embolic events
383337|NCT01502670|Pulmonary nodules|pulmonary nodules
383338|NCT01502657|percutaneous tracheostomy|percutaneous tracheostomy
383339|NCT01502657|ultrasonography|ultrasonography
383340|NCT01502657|echography|echography
383341|NCT01502657|critical care|critical care
383342|NCT01502644|low back pain|low back pain
383343|NCT01502644|opioids|opioids
383344|NCT01502644|mood symptoms|mood symptoms
383345|NCT01502618|Adolescent Medicine Trials Network for HIV/AIDS Interventions|adolescent medicine trials network for hiv/aids interventions
383346|NCT01502618|Human Immunodeficiency Virus|human immunodeficiency virus
383347|NCT01502605|5-ALA|5-ala
383348|NCT01502605|Aminolevulinic Acid|aminolevulinic acid
383349|NCT01502605|Craniotomy|craniotomy
383350|NCT01502605|Brain Tumor|brain tumor
383351|NCT01502605|Surgical Resection|surgical resection
383352|NCT01502605|Neurosurgery|neurosurgery
383353|NCT01502592|MDX-010 (Ipilimumab)|mdx-010 (ipilimumab)
383354|NCT01502592|Cryoablation|cryoablation
383355|NCT01502592|Total mastectomy planned|total mastectomy planned
383356|NCT01502592|11-202|11-202
383357|NCT01502579|IgA nephropathy|iga nephropathy
383358|NCT01502566|educational intervention|educational intervention
383359|NCT01502566|dentals caries|dentals caries
383360|NCT01502566|population|population
383361|NCT01502566|new populational caries prevention strategies.|new populational caries prevention strategies.
383362|NCT01502553|blood pressure|blood pressure
383363|NCT01502553|heart rate|heart rate
383364|NCT01502540|pain|pain
383365|NCT01502540|craniotomy|craniotomy
383366|NCT01502527|Vulvo vaginal atrophy|vulvo vaginal atrophy
383367|NCT01502527|Femarelle|femarelle
383368|NCT01502514|CHF|chf
383369|NCT01502514|ischemia|ischemia
383370|NCT01502514|Heart Failure|heart failure
383371|NCT01502501|CHF|chf
383372|NCT01502501|Heart Failure|heart failure
383373|NCT01502501|Non-Ischemic|non-ischemic
383374|NCT01502501|nonischemic|nonischemic
383375|NCT01502501|nonischemia|nonischemia
383376|NCT01502488|Autistic|autistic
383377|NCT01502488|ASC therapy|asc therapy
383378|NCT01502488|ADSC|adsc
383379|NCT01502475|Complementary Alternative Medicine|complementary alternative medicine
383380|NCT01502475|Veteran|veteran
383381|NCT01502475|Attitudes|attitudes
383382|NCT01502475|Beliefs|beliefs
383383|NCT01502462|Clinical course and prognostic factors in patients with severe isolated TR|clinical course and prognostic factors in patients with severe isolated tr
383384|NCT01502449|telemedicine, telephonic, PTSD|telemedicine, telephonic, ptsd
383385|NCT01502436|posttraumatic stress disorder|posttraumatic stress disorder
383386|NCT01502436|traumatic brain injury|traumatic brain injury
383387|NCT01502436|Suicide Attempt|suicide attempt
383388|NCT01502436|Veterans|veterans
383389|NCT01502423|On label Humira users|on label humira users
383390|NCT01502423|Rheumatoid Arthritis|rheumatoid arthritis
383391|NCT01502423|Pain|pain
383392|NCT01502397|hepatitis B|hepatitis b
383393|NCT01502397|anti-HBc|anti-hbc
383394|NCT01502397|HBsAg|hbsag
383395|NCT01502397|rituximab|rituximab
383396|NCT01502397|occult HBV|occult hbv
383397|NCT01502384|healthy 1st degree relatives of pd patients|healthy 1st degree relatives of pd patients
383398|NCT01502371|Asthma|asthma
383399|NCT01502371|Children|children
383400|NCT01502371|Persistent|persistent
383401|NCT01502358|dengue|dengue
383402|NCT01502358|dengue fever|dengue fever
383403|NCT01502358|dengue disease|dengue disease
383404|NCT01502358|tetravalent dengue vaccine|tetravalent dengue vaccine
383405|NCT01502358|Vaxfectin®|vaxfectin®
383406|NCT01502345|HFRS|hfrs
383407|NCT01502332|Mechanical ventilation|mechanical ventilation
383408|NCT01502332|Open lung approach|open lung approach
383409|NCT01502332|Blood gases|blood gases
383410|NCT01502332|Cardiac surgery|cardiac surgery
383411|NCT01502332|Pulmonary complications|pulmonary complications
383412|NCT01502306|Smoking cessation|smoking cessation
383413|NCT01502306|Telephone|telephone
383415|NCT01502306|Smoking abstinence|smoking abstinence
383416|NCT01502306|Incentives|incentives
383417|NCT01502306|Nicotine-replacement therapy|nicotine-replacement therapy
383418|NCT01502306|Medi-Cal|medi-cal
383419|NCT01502306|Medicaid|medicaid
383420|NCT01502280|extent of resection|extent of resection
383421|NCT01502280|Glioma|glioma
383422|NCT01502280|5-ALA|5-ala
383423|NCT01502280|tumor fluorescence|tumor fluorescence
383424|NCT01502280|confocal microscopy|confocal microscopy
383425|NCT01502267|Waiting list|waiting list
383426|NCT01502267|Deceased donor kidney transplantation|deceased donor kidney transplantation
383427|NCT01502267|Desensitization|desensitization
383428|NCT01502267|anti HLA antibody|anti hla antibody
383429|NCT01502254|Informed consent|informed consent
383430|NCT01502254|Cancer clinical trials|cancer clinical trials
383431|NCT01502254|Patient information|patient information
383432|NCT01502254|Knowledge|knowledge
383433|NCT01502254|Questionnaire|questionnaire
383434|NCT01502254|Patient Eligible for a Phase II or III Cancer Clinical Trial|patient eligible for a phase ii or iii cancer clinical trial
383435|NCT01502254|Scheduled Clinical Visit for Information About a Trial|scheduled clinical visit for information about a trial
383436|NCT01502241|elderly|elderly
383437|NCT01502241|brain tumors|brain tumors
383438|NCT01502241|MGMT|mgmt
383439|NCT01502241|chemotherapy|chemotherapy
383440|NCT01502241|Newly diagnosed|newly diagnosed
383441|NCT01502241|patients > 65 years|patients > 65 years
383442|NCT01502202|lung adenocarcinoma|lung adenocarcinoma
383443|NCT01502202|never smoker|never smoker
383444|NCT01502202|1st line treatment|1st line treatment
383445|NCT01502202|Intercalation administration|intercalation administration
383446|NCT01502202|Gefitinib|gefitinib
383447|NCT01502202|never smokers|never smokers
383448|NCT01502189|patient education as topic|patient education as topic
383449|NCT01502189|representational approach|representational approach
383450|NCT01502189|parents|parents
383451|NCT01502189|childhood cancer|childhood cancer
383452|NCT01502189|paediatric oncology|paediatric oncology
383453|NCT01502189|nursing|nursing
383454|NCT01502189|parents of children with cancer|parents of children with cancer
383455|NCT01502189|Stress|stress
383456|NCT01502189|Health Knowledge|health knowledge
383457|NCT01502189|Attitudes|attitudes
383458|NCT01502189|Practice|practice
383459|NCT01502176|atrial fibrillation|atrial fibrillation
383460|NCT01502176|registry|registry
383461|NCT01502163|perioperative hypothermia|perioperative hypothermia
383462|NCT01502163|prewarming|prewarming
383463|NCT01502163|forced air warming|forced air warming
383464|NCT01502163|insulation|insulation
383465|NCT01502150|Pediatric Cancer|pediatric cancer
383466|NCT01502150|Proton Radiation Therapy|proton radiation therapy
383467|NCT01502150|Proton beam radiotherapy|proton beam radiotherapy
383468|NCT01502150|PBT|pbt
383469|NCT01502150|Data Collection|data collection
383470|NCT01502150|Database|database
383471|NCT01502150|Acute and late normal tissue toxicities|acute and late normal tissue toxicities
383472|NCT01502150|Dosimetric data|dosimetric data
383473|NCT01502150|Toxicity data|toxicity data
383474|NCT01502111|decreased level of consciousness|decreased level of consciousness
383475|NCT01502111|hypoxemia|hypoxemia
383476|NCT01502111|ineffective ventilation|ineffective ventilation
383477|NCT01502111|airway obstruction|airway obstruction
383478|NCT01502111|combative or unresponsive|combative or unresponsive
383479|NCT01502111|relief of pain or distress|relief of pain or distress
383480|NCT01502111|cardiopulmonary arrest|cardiopulmonary arrest
383481|NCT01502085|multiple myeloma lenalidomide|multiple myeloma lenalidomide
383482|NCT01502072|Ribavirin|ribavirin
383483|NCT01502072|Ribavirin Aerosol|ribavirin aerosol
383484|NCT01502072|Respiratory Syncytial Virus|respiratory syncytial virus
383485|NCT01502072|RSV|rsv
383486|NCT01502072|upper respiratory tract infection|upper respiratory tract infection
383487|NCT01502072|URI|uri
383488|NCT01502072|Lower respiratory tract Infection|lower respiratory tract infection
383489|NCT01502072|LRI|lri
383490|NCT01502072|pneumonia|pneumonia
383491|NCT01502072|aerosolized ribavirin|aerosolized ribavirin
383492|NCT01502072|HSCT|hsct
383493|NCT01502072|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
383494|NCT01502072|oral ribavirin therapy|oral ribavirin therapy
383495|NCT01502059|Pilates|pilates
383496|NCT01502059|Exercise|exercise
383497|NCT01502059|Treatment|treatment
383498|NCT01502059|Low back pain|low back pain
383499|NCT01502059|Pain|pain
383500|NCT01502059|Function|function
383501|NCT01502046|Huntington's disease, cannabinoids|huntington's disease, cannabinoids
383502|NCT01502033|Adolescent Depression|adolescent depression
383503|NCT01502033|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
383504|NCT01502020|actinic keratoses|actinic keratoses
383505|NCT01502020|actinic keratosis|actinic keratosis
383506|NCT01502020|imiquimod, 3.75%|imiquimod, 3.75%
383507|NCT01502020|imiquimod|imiquimod
383508|NCT01502020|Zyclara|zyclara
383509|NCT01502020|Actinic keratoses of the face or balding scalp|actinic keratoses of the face or balding scalp
383510|NCT01502007|Activity Level|activity level
383511|NCT01502007|Overweight|overweight
383512|NCT01502007|Obesity|obesity
383513|NCT01501994|Activity level|activity level
383514|NCT01501994|Weight|weight
383515|NCT01501994|Body Fat|body fat
383516|NCT01501994|Well Being|well being
383517|NCT01501981|heart failure|heart failure
383518|NCT01501981|MR-proANP|mr-proanp
383519|NCT01501981|MR-proADM|mr-proadm
383520|NCT01501981|decompensation|decompensation
383521|NCT01501981|Copeptin|copeptin
383522|NCT01501981|CT-proET1|ct-proet1
383523|NCT01501981|NT-proBNP|nt-probnp
383524|NCT01501968|Colistin|colistin
383525|NCT01501968|ascorbic acid|ascorbic acid
383526|NCT01501968|renal toxicity|renal toxicity
383527|NCT01501955|Osteoarthritis|osteoarthritis
383528|NCT01501942|Asthma|asthma
383529|NCT01501942|Allergen induced asthma|allergen induced asthma
383530|NCT01501942|ATS Criteria (1)|ats criteria (1)
383531|NCT01501929|hypertension|hypertension
383532|NCT01501929|blood pressure|blood pressure
383533|NCT01501929|blood pressure medications|blood pressure medications
383534|NCT01501929|metoprolol|metoprolol
383535|NCT01501929|nebivolol|nebivolol
383536|NCT01501929|vascular oxidative stress|vascular oxidative stress
383537|NCT01501929|nitric oxide|nitric oxide
383538|NCT01501929|nitric oxide synthase (eNOS)|nitric oxide synthase (enos)
383539|NCT01501929|endothelium|endothelium
383540|NCT01501929|endothelial dysfunction|endothelial dysfunction
383541|NCT01501929|endothelial cell protein expression|endothelial cell protein expression
383542|NCT01501929|microvascular blood flow|microvascular blood flow
383543|NCT01501929|flow mediated dilation|flow mediated dilation
383544|NCT01501929|handgrip exercise|handgrip exercise
383545|NCT01501929|endothelial cell collection|endothelial cell collection
383546|NCT01501929|microbubbles|microbubbles
383547|NCT01501929|Definity|definity
383548|NCT01501890|Threatened Abortion|threatened abortion
383549|NCT01501890|Progesterone|progesterone
383550|NCT01501890|Subchorionic Hematoma|subchorionic hematoma
383551|NCT01501890|Pre-Eclampsia|pre-eclampsia
383552|NCT01501890|Abruptio Placentae|abruptio placentae
383553|NCT01501890|Fetal Growth Retardation|fetal growth retardation
383554|NCT01501890|Premature Birth|premature birth
383555|NCT01501877|Smoking|smoking
383556|NCT01501877|Type 2 Diabetes|type 2 diabetes
383557|NCT01501877|Smoking cessation|smoking cessation
383558|NCT01501864|HIV prevention|hiv prevention
383559|NCT01501864|HSV-2|hsv-2
383560|NCT01501864|Schooling|schooling
383561|NCT01501864|Kenya|kenya
383562|NCT01501864|Orphans|orphans
383563|NCT01501864|School support|school support
383564|NCT01501799|acne|acne
383565|NCT01501799|adapalene/benzoyl peroxide|adapalene/benzoyl peroxide
383566|NCT01501799|Epiduo|epiduo
383567|NCT01501799|Mild to severe acne vulgaris|mild to severe acne vulgaris
383568|NCT01501786|children|children
383569|NCT01501786|sedation|sedation
383570|NCT01501786|propofol|propofol
383571|NCT01501786|ketamine|ketamine
383572|NCT01501773|Acute ischemic stroke|acute ischemic stroke
383573|NCT01501747|Placebo effect|placebo effect
383574|NCT01501747|drug half life|drug half life
383575|NCT01501747|pharmacokinetics|pharmacokinetics
383576|NCT01501734|CHF|chf
383577|NCT01501734|watch-pat|watch-pat
383578|NCT01501734|embletta x|embletta x
383579|NCT01501734|endothelial function|endothelial function
383580|NCT01501721|prevention|prevention
383581|NCT01501721|workers|workers
383582|NCT01501721|clinical trials|clinical trials
383583|NCT01501721|obesity|obesity
383584|NCT01501708|caspofungin|caspofungin
383585|NCT01501708|IFI|ifi
383586|NCT01501708|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
383587|NCT01501695|tic disorder|tic disorder
383588|NCT01501695|pediatric|pediatric
383589|NCT01501682|ventralex|ventralex
383590|NCT01501682|ventral hernia|ventral hernia
383591|NCT01501669|irinotecan|irinotecan
383592|NCT01501669|capecitabine|capecitabine
383593|NCT01501669|metastatic breast cancer|metastatic breast cancer
383594|NCT01501643|Non invasive positive pressure ventilation|non invasive positive pressure ventilation
383595|NCT01501643|Spirometry|spirometry
383596|NCT01501643|Acute chest syndrome|acute chest syndrome
383597|NCT01501643|Sickle cell disease|sickle cell disease
383598|NCT01501643|Vaso-occlusive crisis|vaso-occlusive crisis
383599|NCT01501630|Comparison of imaging modalities|comparison of imaging modalities
383600|NCT01501630|Impact on patient management|impact on patient management
383601|NCT01501630|Optimisation of cost of the diagnostic strategy|optimisation of cost of the diagnostic strategy
383602|NCT01501617|Hair Loss|hair loss
383603|NCT01501617|Androgenetic Alopecia|androgenetic alopecia
383604|NCT01501617|Baldness|baldness
383605|NCT01501617|Male pattern baldness|male pattern baldness
383606|NCT01501617|Male pattern hair loss|male pattern hair loss
383607|NCT01501617|Hair Regrowth|hair regrowth
383608|NCT01501617|Alopecia|alopecia
383609|NCT01501617|Hair growth|hair growth
383610|NCT01501617|Regrow Hair|regrow hair
383611|NCT01501604|PIK3CA mutation|pik3ca mutation
383612|NCT01501604|Advanced solid tumors|advanced solid tumors
383613|NCT01501591|Placebo effect|placebo effect
383614|NCT01501591|placebo drug interaction|placebo drug interaction
383615|NCT01501591|placebo -controlled clinical trials|placebo -controlled clinical trials
383616|NCT01501578|Pulmonary fibrosis|pulmonary fibrosis
383617|NCT01501578|Telomerase mutation|telomerase mutation
383618|NCT01501565|Postoperative pain|postoperative pain
383619|NCT01501565|Transverse abdominal blockade|transverse abdominal blockade
383620|NCT01501565|Efficacy|efficacy
383621|NCT01501565|Safety|safety
383622|NCT01501565|Urology|urology
383623|NCT01501552|Primary health care|primary health care
383719|NCT01501136|NK/T cell lymphoma|nk/t cell lymphoma
383624|NCT01501552|Identification and Brief Intervention Programmes|identification and brief intervention programmes
383625|NCT01501552|Hazardous and harmful alcohol consumption|hazardous and harmful alcohol consumption
383626|NCT01501539|Hypergranulation tissue|hypergranulation tissue
383627|NCT01501539|Gastrostomy tube|gastrostomy tube
383628|NCT01501539|Hydrocolloid dressing|hydrocolloid dressing
383629|NCT01501539|Silver hydrocolloid dressing|silver hydrocolloid dressing
383630|NCT01501539|Gastrostomy tube dislodgement|gastrostomy tube dislodgement
383631|NCT01501539|Wound infection|wound infection
383632|NCT01501539|Peristomal skin breakdown|peristomal skin breakdown
383633|NCT01501526|herpes esophagitis|herpes esophagitis
383634|NCT01501526|dysphagia|dysphagia
383635|NCT01501526|vocal fold palsy|vocal fold palsy
383636|NCT01501526|immunocompetent|immunocompetent
383637|NCT01501526|husky voice|husky voice
383638|NCT01501513|colonoscopy|colonoscopy
383639|NCT01501513|bowel preparation|bowel preparation
383640|NCT01501513|endoscopy|endoscopy
383641|NCT01501500|botulinum toxin type A|botulinum toxin type a
383642|NCT01501500|hallux valgus angle|hallux valgus angle
383643|NCT01501500|foot function index|foot function index
383644|NCT01501500|VAS pain scale|vas pain scale
383645|NCT01501487|breast cancer|breast cancer
383646|NCT01501487|neo adjuvant therapy|neo adjuvant therapy
383647|NCT01501474|Confocal|confocal
383648|NCT01501474|malignant biliary stricture|malignant biliary stricture
383649|NCT01501474|Sensitivity, specificity and accuracy of CholangioFlex in malignant biliary stricture diagnosis|sensitivity, specificity and accuracy of cholangioflex in malignant biliary stricture diagnosis
383650|NCT01501474|sensitivity, specificity and accuracy of Fluorescent in situ Hybridization(FISH) in malignant biliary stricture diagnosis|sensitivity, specificity and accuracy of fluorescent in situ hybridization(fish) in malignant biliary stricture diagnosis
383651|NCT01501435|Safety|safety
383652|NCT01501435|Pharmacokinetics|pharmacokinetics
383653|NCT01501422|postmenopause|postmenopause
383654|NCT01501422|sleep quality|sleep quality
383655|NCT01501422|estrogen|estrogen
383656|NCT01501422|objective sleep quality|objective sleep quality
383657|NCT01501422|actigraph|actigraph
383658|NCT01501409|Sodium lauryl sulfate (SLS)|sodium lauryl sulfate (sls)
383659|NCT01501409|recurrent aphthous stomatitis (RAS)|recurrent aphthous stomatitis (ras)
383660|NCT01501409|dentifrice|dentifrice
383661|NCT01501409|pain|pain
383662|NCT01501370|Myeloma|myeloma
383663|NCT01501370|Biochemical relapse|biochemical relapse
383664|NCT01501357|caries|caries
383665|NCT01501357|primary molars|primary molars
383666|NCT01501357|plaque|plaque
383667|NCT01501357|toothbrushing|toothbrushing
383668|NCT01501344|osteoporosis|osteoporosis
383669|NCT01501344|postmenopausal women|postmenopausal women
383670|NCT01501344|bone remodelling|bone remodelling
383671|NCT01501344|bone turnover markers|bone turnover markers
383672|NCT01501331|Congestive Heart Failure|congestive heart failure
383673|NCT01501331|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
383674|NCT01501331|Internal Cardioverter Defibrillators|internal cardioverter defibrillators
383675|NCT01501318|SBIRT|sbirt
383676|NCT01501318|brief intervention|brief intervention
383677|NCT01501318|alcohol|alcohol
383678|NCT01501318|drug abuse|drug abuse
383679|NCT01501305|influence|influence
383680|NCT01501305|carob powder|carob powder
383681|NCT01501305|probiotics|probiotics
383682|NCT01501305|duration|duration
383683|NCT01501279|pudendal nerve block|pudendal nerve block
383684|NCT01501279|postoperative pain|postoperative pain
383685|NCT01501279|bladder spasm|bladder spasm
383686|NCT01501266|postmenopausal breast cancer|postmenopausal breast cancer
383687|NCT01501266|Faslodex|faslodex
383688|NCT01501266|cohort|cohort
383689|NCT01501253|CKD-828|ckd-828
383690|NCT01501253|Hypertension|hypertension
383691|NCT01501253|Primary Hypertension|primary hypertension
383692|NCT01501253|S-Amlodipine|s-amlodipine
383693|NCT01501253|Telmisartan|telmisartan
383694|NCT01501253|Non-Responder|non-responder
383695|NCT01501240|Magnetic resonance image|magnetic resonance image
383696|NCT01501240|gadoxetic acid|gadoxetic acid
383697|NCT01501240|hepatocellular carcinoma|hepatocellular carcinoma
383698|NCT01501240|liver cirrhosis|liver cirrhosis
383699|NCT01501227|ventilator associated pneumonia|ventilator associated pneumonia
383700|NCT01501214|atosiban|atosiban
383701|NCT01501214|in vitro fertilization|in vitro fertilization
383702|NCT01501214|subfertility|subfertility
383703|NCT01501201|Obesity|obesity
383704|NCT01501201|Diabetes|diabetes
383705|NCT01501201|Bariatric Surgery|bariatric surgery
383706|NCT01501188|Chronic Venous Insufficiency|chronic venous insufficiency
383707|NCT01501188|Kinesio Taping|kinesio taping
383708|NCT01501188|Electromyography|electromyography
383709|NCT01501188|Range of ankle motion|range of ankle motion
383710|NCT01501175|superficial vein thrombosis|superficial vein thrombosis
383711|NCT01501175|Saint Etienne region|saint etienne region
383712|NCT01501162|hepatitis, alcohol|hepatitis, alcohol
383713|NCT01501149|NK/T cell lymphoma|nk/t cell lymphoma
383714|NCT01501149|chemotherapy|chemotherapy
383715|NCT01501149|clinical trial|clinical trial
383716|NCT01501149|RR|rr
383717|NCT01501149|PFS|pfs
383718|NCT01501149|OS|os
383720|NCT01501136|chemotherapy|chemotherapy
383721|NCT01501136|clinical trial|clinical trial
383722|NCT01501136|RR|rr
383723|NCT01501136|PFS|pfs
383724|NCT01501136|OS|os
383725|NCT01501123|Time to sedation of agitated patients|time to sedation of agitated patients
383726|NCT01501110|Euthyroid Sick Syndrome|euthyroid sick syndrome
383727|NCT01501110|low T3 syndrome|low t3 syndrome
383728|NCT01501110|deiodases|deiodases
383729|NCT01501110|oxidative stress|oxidative stress
383730|NCT01501110|ischemic heart disease|ischemic heart disease
383731|NCT01501084|functional MRI|functional mri
383732|NCT01501084|Structural MRI|structural mri
383733|NCT01501084|obesity|obesity
383734|NCT01501084|resting state networks|resting state networks
383735|NCT01501071|Laparoscopic Nissen fundoplication|laparoscopic nissen fundoplication
383736|NCT01501071|Esophageal calibration|esophageal calibration
383737|NCT01501071|Postoperative dysphagia|postoperative dysphagia
383738|NCT01501045|TMS|tms
383739|NCT01501045|CPM|cpm
383740|NCT01501045|headache|headache
383741|NCT01501045|migraine|migraine
383742|NCT01501045|EEG|eeg
383743|NCT01501045|psychophysics|psychophysics
383744|NCT01501032|Diabetes Type 1|diabetes type 1
383745|NCT01501032|Artificial Pancreas|artificial pancreas
383746|NCT01501006|Physicians|physicians
383747|NCT01500993|Rectal cancer|rectal cancer
383748|NCT01500993|Chemoradiotherapy|chemoradiotherapy
383749|NCT01500993|Capecitabine|capecitabine
383750|NCT01500993|phase-III trial|phase-iii trial
383751|NCT01500980|malaria|malaria
383752|NCT01500980|challenge|challenge
383753|NCT01500980|P. falciparum|p. falciparum
383754|NCT01500980|prevention|prevention
383755|NCT01500928|Insulin Pump|insulin pump
383756|NCT01500928|Glycemic Control|glycemic control
383757|NCT01500928|Type 1 Diabetes|type 1 diabetes
383758|NCT01500915|AMD|amd
383759|NCT01500915|ranibizumab|ranibizumab
383760|NCT01500915|antiVEGF|antivegf
383761|NCT01500915|regimen of injections|regimen of injections
383762|NCT01500915|anti VEGF regimen|anti vegf regimen
383763|NCT01500915|PRN|prn
383764|NCT01500915|treat and extend|treat and extend
383765|NCT01500902|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
383766|NCT01500902|Percutaneous Intervention (PCI)|percutaneous intervention (pci)
383767|NCT01500902|Coronary Stent (CStent)|coronary stent (cstent)
383768|NCT01500902|Percutaneous Transluminal Coronary Angioplasty (PTCA)|percutaneous transluminal coronary angioplasty (ptca)
383769|NCT01500902|stent placement|stent placement
383770|NCT01500902|balloon angioplasty|balloon angioplasty
383771|NCT01500889|Anal fissure|anal fissure
383772|NCT01500889|Advancement flap|advancement flap
383773|NCT01500889|Internal sphincterotomy|internal sphincterotomy
383774|NCT01500876|lung cancer|lung cancer
383775|NCT01500863|endometrial receptivity|endometrial receptivity
383776|NCT01500863|gene arrays|gene arrays
383777|NCT01500863|agonist triggering|agonist triggering
383778|NCT01500863|Endometrial gene expression|endometrial gene expression
383779|NCT01500863|OHSS|ohss
383780|NCT01500850|Type 2 Diabetes mellitus|type 2 diabetes mellitus
383781|NCT01500850|NPH insulin|nph insulin
383782|NCT01500850|Insulin Glargine|insulin glargine
383783|NCT01500850|cardiovascular biomarkers|cardiovascular biomarkers
383784|NCT01500850|hsCRP, adiponectin|hscrp, adiponectin
383785|NCT01500850|intact proinsulin|intact proinsulin
383786|NCT01500850|cardiovascular risk|cardiovascular risk
383787|NCT01500837|Staphylococcus aureus|staphylococcus aureus
383788|NCT01500837|osteoarticular infection|osteoarticular infection
383789|NCT01500837|clindamycin|clindamycin
383790|NCT01500837|serum concentration|serum concentration
383791|NCT01500837|orthopedic surgery|orthopedic surgery
383792|NCT01500824|Crizotinib|crizotinib
383793|NCT01500824|ALK|alk
383794|NCT01500824|NSCLC|nsclc
383795|NCT01500824|Non-Small Cell Lung Cancer|non-small cell lung cancer
383796|NCT01500824|Asian|asian
383797|NCT01500811|chondrocyte hip osteoarthritis intra articular injection|chondrocyte hip osteoarthritis intra articular injection
383798|NCT01500772|Hepatitis C|hepatitis c
383799|NCT01500772|PI treatment failure|pi treatment failure
383800|NCT01500759|chronic heart failure|chronic heart failure
383801|NCT01500759|heart failure|heart failure
383802|NCT01500759|hf|hf
383803|NCT01500759|sleep-disordered breathing|sleep-disordered breathing
383804|NCT01500759|sdb|sdb
383805|NCT01500759|nyha|nyha
383806|NCT01500759|lvef|lvef
383807|NCT01500759|cheyne stokes|cheyne stokes
383808|NCT01500759|central sleep apnoea|central sleep apnoea
383809|NCT01500759|sleep apnoea|sleep apnoea
383810|NCT01500746|chronic wound treatment|chronic wound treatment
383811|NCT01500746|pulse lavage|pulse lavage
383812|NCT01500746|serial pulse lavage|serial pulse lavage
383813|NCT01500746|wounds|wounds
383814|NCT01500746|bacterial colonization of wounds|bacterial colonization of wounds
383815|NCT01500733|Treatment|treatment
383816|NCT01500733|CLL (Chronic Lymphocytic Leukemia)|cll (chronic lymphocytic leukemia)
383817|NCT01500733|SLL (Small Lymphocytic Lymphoma)|sll (small lymphocytic lymphoma)
383818|NCT01500733|Leukemia|leukemia
383819|NCT01500733|Lymphocytic Leukemia|lymphocytic leukemia
383820|NCT01500733|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
383821|NCT01500733|CLL|cll
383822|NCT01500733|Small Lymphocytic Leukemia|small lymphocytic leukemia
383823|NCT01500733|SLL|sll
383824|NCT01500668|Botox|botox
383825|NCT01500668|catocholamine|catocholamine
383826|NCT01500668|shock|shock
383827|NCT01500668|vasomotor|vasomotor
383828|NCT01500668|Vasopressin|vasopressin
383829|NCT01500668|botulinum toxin|botulinum toxin
383830|NCT01500655|burn|burn
383831|NCT01500655|skin graft donor site|skin graft donor site
383832|NCT01500655|analgesia for donor site|analgesia for donor site
383833|NCT01500629|Allergic Rhinitis|allergic rhinitis
383834|NCT01500629|Hayfever|hayfever
383835|NCT01500629|Pollen Allergy|pollen allergy
383836|NCT01500616|Chronic Hepatitis C Infection|chronic hepatitis c infection
383837|NCT01500616|Chronic Hepatitis C Co-Infected Patients|chronic hepatitis c co-infected patients
383838|NCT01500616|Hepatitis C|hepatitis c
383839|NCT01500616|Severe Fibrosis|severe fibrosis
383840|NCT01500616|Compensated Cirrhosis|compensated cirrhosis
383841|NCT01500616|VX-950HPC3005|vx-950hpc3005
383842|NCT01500603|post-radical prostatectomy|post-radical prostatectomy
383843|NCT01500603|stress urinary incontinence|stress urinary incontinence
383844|NCT01500603|periurethral Pro-ACT balloons|periurethral pro-act balloons
383845|NCT01500603|AdvanceXP retrourethral male sling|advancexp retrourethral male sling
383846|NCT01500590|Diabetes|diabetes
383847|NCT01500590|hypertensive|hypertensive
383848|NCT01500590|without albuminuria|without albuminuria
383849|NCT01500577|Prevention|prevention
383850|NCT01500577|Breast Cancer|breast cancer
383851|NCT01500577|Proliferation|proliferation
383852|NCT01500577|Breast Cancer Prevention|breast cancer prevention
383853|NCT01500564|Stroke|stroke
383854|NCT01500564|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
383855|NCT01500564|motor function|motor function
383856|NCT01500551|Arthritis|arthritis
383857|NCT01500551|Pediatric|pediatric
383858|NCT01500551|Tofacitinib|tofacitinib
383859|NCT01500551|Long-term|long-term
383860|NCT01500551|JIA|jia
383861|NCT01500551|CP-690,550|cp-690,550
383862|NCT01500551|Xeljanz|xeljanz
383863|NCT01500538|Follicular lymphoma|follicular lymphoma
383864|NCT01500538|Marginal zone lymphoma|marginal zone lymphoma
383865|NCT01500538|Mantle cell lymphoma|mantle cell lymphoma
383866|NCT01500538|thrombocytopenia|thrombocytopenia
383867|NCT01500538|eltrombopag|eltrombopag
383868|NCT01500538|vorinostat|vorinostat
383869|NCT01500538|lymphoma|lymphoma
383870|NCT01500525|asthma|asthma
383871|NCT01500525|children|children
383872|NCT01500525|accuracy of bronchodilator response|accuracy of bronchodilator response
383873|NCT01500499|adult acute myeloid leukemia|adult acute myeloid leukemia
383874|NCT01500499|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
383875|NCT01500447|Hypogonadotropic Hypogonadism|hypogonadotropic hypogonadism
383876|NCT01500447|Kallmann Syndrome|kallmann syndrome
383877|NCT01500447|Delayed Puberty|delayed puberty
383878|NCT01500447|Infertility|infertility
383879|NCT01500447|Hypothalamic Amenorrhea|hypothalamic amenorrhea
383880|NCT01500447|Early Puberty|early puberty
383881|NCT01500447|Late Puberty|late puberty
383882|NCT01500447|Hypogonadism|hypogonadism
383883|NCT01500447|Amenorrhea|amenorrhea
383884|NCT01500447|Endocrine Diseases|endocrine diseases
383885|NCT01500434|drug-eluting stents|drug-eluting stents
383886|NCT01500434|DES|des
383887|NCT01500434|atherosclerotic|atherosclerotic
383888|NCT01500421|Hypothermia, Induced|hypothermia, induced
383889|NCT01500395|Aortic Diseases|aortic diseases
383890|NCT01500395|Vascular Diseases|vascular diseases
383891|NCT01500395|Cardiovascular Diseases|cardiovascular diseases
383892|NCT01500395|Treatment Outcome|treatment outcome
383893|NCT01500395|Aorta Dissection|aorta dissection
383894|NCT01500395|Aorta Aneurysm|aorta aneurysm
383895|NCT01500395|Aorta pseudoaneurysm|aorta pseudoaneurysm
383896|NCT01500395|Endovascular aortic repair|endovascular aortic repair
383897|NCT01500395|Hybrid operation|hybrid operation
383898|NCT01500395|Debranching|debranching
383899|NCT01500369|atrial fibrillation|atrial fibrillation
383900|NCT01500369|remote ischemic conditioning|remote ischemic conditioning
383901|NCT01500356|cardiovascular disease|cardiovascular disease
383902|NCT01500356|obesity|obesity
383903|NCT01500356|exercise|exercise
383904|NCT01500343|heart failure|heart failure
383905|NCT01500343|probiotics|probiotics
383906|NCT01500343|Saccharomyces boulardii|saccharomyces boulardii
383907|NCT01500343|cardio-intestinal syndrome|cardio-intestinal syndrome
383908|NCT01500343|gut|gut
383909|NCT01500343|inflammation|inflammation
383910|NCT01500317|tapentadol|tapentadol
383911|NCT01500317|oxycodone|oxycodone
383912|NCT01500317|mu-opiate|mu-opiate
383913|NCT01500317|stomach|stomach
383914|NCT01500317|small intestine|small intestine
383915|NCT01500317|colon|colon
383916|NCT01500317|motility|motility
383917|NCT01500317|nausea|nausea
383918|NCT01500317|constipation|constipation
383919|NCT01500304|Melanoma|melanoma
383920|NCT01500304|Lymph Nodes|lymph nodes
383921|NCT01500304|Lymph Node Dissection|lymph node dissection
383922|NCT01500304|Minimally invasive|minimally invasive
383923|NCT01500291|anesthesia stress|anesthesia stress
383924|NCT01500278|Certolizumab Pegol|certolizumab pegol
383925|NCT01500278|Cimzia|cimzia
383926|NCT01500278|Adalimumab|adalimumab
383927|NCT01500278|Humira|humira
383928|NCT01500278|Rheumatoid Arthritis|rheumatoid arthritis
383929|NCT01500265|hepatitis B virus|hepatitis b virus
383930|NCT01500265|early screening tools|early screening tools
383931|NCT01500265|renal proximal tubular tolerance|renal proximal tubular tolerance
383932|NCT01500252|Total Knee Replacement|total knee replacement
383933|NCT01500252|Patellar Resurfacing|patellar resurfacing
383934|NCT01500252|Health Related Quality of Life|health related quality of life
383935|NCT01500226|Rolapitant|rolapitant
383936|NCT01500226|Nausea|nausea
383937|NCT01500226|Vomiting|vomiting
383938|NCT01500226|CINV|cinv
383939|NCT01500226|Chemotherapy|chemotherapy
383940|NCT01500213|Rolapitant|rolapitant
383941|NCT01500213|Nausea|nausea
383942|NCT01500213|Vomiting|vomiting
383943|NCT01500213|CINV|cinv
383944|NCT01500213|Chemotherapy|chemotherapy
383945|NCT01500187|white spot lesions|white spot lesions
383946|NCT01500187|fixed orthodontic brackets|fixed orthodontic brackets
383947|NCT01500187|fluoride varnish|fluoride varnish
383948|NCT01500187|fluoride gel|fluoride gel
383949|NCT01500174|skin|skin
383950|NCT01500174|decubitus|decubitus
383951|NCT01500174|pressure|pressure
383952|NCT01500174|sore|sore
383953|NCT01500174|spinal cord injury|spinal cord injury
383954|NCT01500161|Leukemia|leukemia
383955|NCT01500161|Lymphoma|lymphoma
383956|NCT01500161|Myeloma|myeloma
383957|NCT01500161|Aplastic Anemia|aplastic anemia
383958|NCT01500161|Myelodysplasia|myelodysplasia
383960|NCT01500161|ALL|all
383961|NCT01500161|CLL|cll
383962|NCT01500161|CML|cml
383963|NCT01500148|Mitral Valve Prolapse|mitral valve prolapse
383964|NCT01500148|Mitral Valve Disease|mitral valve disease
383965|NCT01500148|Mitral Valve Regurgitation|mitral valve regurgitation
383966|NCT01500148|Mitral Valve Insufficiency|mitral valve insufficiency
383967|NCT01500148|Mitral Valve Incompetence|mitral valve incompetence
383968|NCT01500148|Percutaneous Mitral Valve Repair|percutaneous mitral valve repair
383969|NCT01500148|Posterior leaflet prolapse|posterior leaflet prolapse
383970|NCT01500148|Mitral valve degeneration|mitral valve degeneration
383971|NCT01500135|Vascular Surgery|vascular surgery
383972|NCT01500135|Secondary treatment of needle hole bleeding|secondary treatment of needle hole bleeding
383973|NCT01500135|Subjects undergoing vascular surgery and who need supportive treatment in order to control bleeding|subjects undergoing vascular surgery and who need supportive treatment in order to control bleeding
383974|NCT01500109|cleft palate surgery|cleft palate surgery
383975|NCT01500109|post-operative pain management|post-operative pain management
383976|NCT01500109|Acetaminophen|acetaminophen
383977|NCT01500096|Fatigue|fatigue
383978|NCT01500096|HIV/AIDS|hiv/aids
383979|NCT01500096|American ginseng|american ginseng
383980|NCT01500096|Panax quinquefolius|panax quinquefolius
383981|NCT01500096|Fatigue Severity Scale|fatigue severity scale
383982|NCT01500096|CD4 count|cd4 count
383983|NCT01500096|plasma HIV RNA|plasma hiv rna
383984|NCT01500096|cytokines|cytokines
383985|NCT01500096|IL-6|il-6
383986|NCT01500096|sTNFR1|stnfr1
383987|NCT01500096|sTNFR2|stnfr2
383988|NCT01500083|iNHL|inhl
383989|NCT01500083|CLL|cll
383990|NCT01500070|Peripheral Arterial Disease|peripheral arterial disease
383991|NCT01500070|Claudication|claudication
383992|NCT01500070|Drug-Eluting Stent|drug-eluting stent
383993|NCT01500070|BTK|btk
383994|NCT01500070|Everolimus|everolimus
383995|NCT01500070|CLI|cli
383996|NCT01500057|enlarged prostate|enlarged prostate
383997|NCT01500044|Radiculopathy|radiculopathy
383998|NCT01500044|Rehabilitation|rehabilitation
383999|NCT01500044|Mobilization|mobilization
384000|NCT01500044|Exercise|exercise
384001|NCT01500044|Physical Therapy|physical therapy
384002|NCT01500018|Phase I|phase i
384003|NCT01500018|healthy recreational polydrug users|healthy recreational polydrug users
384004|NCT01500018|abuse liability|abuse liability
384005|NCT01500018|TC-5214|tc-5214
384006|NCT01500018|Single dose crossover study to evaluate the abuse potential of TC-5214|single dose crossover study to evaluate the abuse potential of tc-5214
384007|NCT01499992|Shoulder rehabilitation|shoulder rehabilitation
384008|NCT01499992|Rotator cuff tear|rotator cuff tear
384009|NCT01499992|Physiotherapy|physiotherapy
384010|NCT01499992|aqua therapy|aqua therapy
384011|NCT01499992|Therapy dosage|therapy dosage
384012|NCT01499992|adjunctive aquatic physical therapy|adjunctive aquatic physical therapy
384013|NCT01499979|Ischemia-reperfusion injury|ischemia-reperfusion injury
384014|NCT01499979|In situ hypothermic perfusion|in situ hypothermic perfusion
384015|NCT01499979|In situ hypothermic preservation|in situ hypothermic preservation
384016|NCT01499966|Lateral Ankle Sprain|lateral ankle sprain
384017|NCT01499966|Plaster of Paris|plaster of paris
384018|NCT01499966|Tubigrip|tubigrip
384019|NCT01499953|superficial vein thrombosis|superficial vein thrombosis
384020|NCT01499953|thrombosis|thrombosis
384021|NCT01499953|SVT|svt
384022|NCT01499940|peripheral neuropathy|peripheral neuropathy
384023|NCT01499940|vitamin D status|vitamin d status
384024|NCT01499940|oxaliplatin|oxaliplatin
384025|NCT01499927|Early reassessment of intravenous antiinfective therapy|early reassessment of intravenous antiinfective therapy
384026|NCT01499914|vaccination H1N1|vaccination h1n1
384027|NCT01499914|cystic fibrosis|cystic fibrosis
384028|NCT01499901|deafness|deafness
384029|NCT01499901|unilateral implantation|unilateral implantation
384030|NCT01499901|bilateral|bilateral
384031|NCT01499901|auditory perception|auditory perception
384032|NCT01499888|Sickle Cell Disease|sickle cell disease
384033|NCT01499888|Subtype Hgb SS|subtype hgb ss
384034|NCT01499888|Subtype Hgb SC|subtype hgb sc
384035|NCT01499888|Subtype Hgb SB|subtype hgb sb
384036|NCT01499888|Chronic Transfusion Therapy|chronic transfusion therapy
384037|NCT01499888|Prior Stroke|prior stroke
384038|NCT01499888|Allogeneic|allogeneic
384039|NCT01499888|Stem Cell Transplantation|stem cell transplantation
384040|NCT01499888|Alemtuzumab|alemtuzumab
384041|NCT01499888|Sirolimus|sirolimus
384042|NCT01499888|Total Body Irradiation|total body irradiation
384043|NCT01499888|Hydroxyurea Intolerant|hydroxyurea intolerant
384044|NCT01499875|Pharmacokinetic|pharmacokinetic
384045|NCT01499875|Pharmacodynamic|pharmacodynamic
384046|NCT01499875|Phenoxymethylpenicillin|phenoxymethylpenicillin
384047|NCT01499875|Children|children
384048|NCT01499862|Stroke|stroke
384049|NCT01499862|Tibion|tibion
384050|NCT01499862|Bionics|bionics
384051|NCT01499862|Rehab|rehab
384052|NCT01499862|Therapy|therapy
384053|NCT01499862|Robotics|robotics
384054|NCT01499862|Intention|intention
384055|NCT01499849|Rolapitant|rolapitant
384056|NCT01499849|Nausea|nausea
384057|NCT01499849|Vomiting|vomiting
384058|NCT01499849|CINV|cinv
384059|NCT01499849|Chemotherapy|chemotherapy
384060|NCT01499823|Permeability Map|permeability map
384061|NCT01499823|High-Grade Glioma|high-grade glioma
384062|NCT01499810|Hypertension|hypertension
384063|NCT01499810|Radiofrequency Catheter Ablation|radiofrequency catheter ablation
384064|NCT01499810|Renal Artery|renal artery
384065|NCT01499810|Sympathetic Nerve Block|sympathetic nerve block
384066|NCT01499797|frailty|frailty
384067|NCT01499797|frail elders|frail elders
384068|NCT01499797|multicomponent intervention|multicomponent intervention
384069|NCT01499797|overall functioning|overall functioning
384070|NCT01499797|cost-effectiveness|cost-effectiveness
384071|NCT01499797|integrated care|integrated care
384072|NCT01499797|primary care|primary care
384073|NCT01499797|community dwelling|community dwelling
384074|NCT01499745|Idiopathic pulmonary fibrosis (IPF) patients|idiopathic pulmonary fibrosis (ipf) patients
384075|NCT01499732|Premature endothelial dysfunction|premature endothelial dysfunction
384076|NCT01499732|Early Rheumatoid Arthritis|early rheumatoid arthritis
384077|NCT01499732|established rheumatoid arthritis|established rheumatoid arthritis
384078|NCT01499732|Premature endothelial dysfunction in early rheumatoid arthritis|premature endothelial dysfunction in early rheumatoid arthritis
384079|NCT01499732|Premature endothelial dysfunction in established rheumatoid arthritis|premature endothelial dysfunction in established rheumatoid arthritis
384080|NCT01499732|Endothelial function in healthy subjects|endothelial function in healthy subjects
384081|NCT01499719|Sinusitis|sinusitis
384082|NCT01499719|Disease|disease
384083|NCT01499719|Chronic|chronic
384084|NCT01499719|Sinonasal|sinonasal
384085|NCT01499706|Motivational Interviewing|motivational interviewing
384086|NCT01499706|Telephone|telephone
384087|NCT01499706|HIV|hiv
384088|NCT01499706|AIDS|aids
384089|NCT01499706|Older Adults|older adults
384090|NCT01499693|Proton Pump Inhibitors|proton pump inhibitors
384091|NCT01499693|gastric pH|gastric ph
384092|NCT01499680|Degenerative Lumbar Conditions|degenerative lumbar conditions
384093|NCT01499667|Relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
384094|NCT01499667|multiple sclerosis (MS)|multiple sclerosis (ms)
384095|NCT01499667|safety|safety
384096|NCT01499667|tolerability|tolerability
384097|NCT01499667|health outcomes|health outcomes
384098|NCT01499667|fingolimod|fingolimod
384099|NCT01499667|disease control|disease control
384100|NCT01499667|MRI|mri
384101|NCT01499654|SPECT MPI|spect mpi
384102|NCT01499654|Tomography, Emission-Computed, Single-Photon|tomography, emission-computed, single-photon
384103|NCT01499654|Wide Beam Reconstruction|wide beam reconstruction
384104|NCT01499641|discectomy|discectomy
384105|NCT01499641|methylprednisolone|methylprednisolone
384106|NCT01499641|randomized control trial|randomized control trial
384107|NCT01499615|adverse events|adverse events
384108|NCT01499615|adverse cardiovascular events|adverse cardiovascular events
384109|NCT01499615|early warning|early warning
384110|NCT01499602|Endometrial hyperplasia,|endometrial hyperplasia,
384111|NCT01499602|LNG-IUS,|lng-ius,
384112|NCT01499602|Progestin|progestin
384113|NCT01499589|anesthesia-controlled time|anesthesia-controlled time
384114|NCT01499589|turnover time|turnover time
384115|NCT01499576|Mass Screening|mass screening
384116|NCT01499576|Endoscopy, Gastrointestinal|endoscopy, gastrointestinal
384117|NCT01499576|Stomach Neoplasms|stomach neoplasms
384118|NCT01499576|Metaplasia|metaplasia
384119|NCT01499576|Diagnosis|diagnosis
384120|NCT01499576|Acetic acid|acetic acid
384121|NCT01499576|Chromoendoscopy|chromoendoscopy
384122|NCT01499550|transnasal high flow therapy|transnasal high flow therapy
384123|NCT01499550|COPD|copd
384124|NCT01499537|Stenosis of biliary ways|stenosis of biliary ways
384125|NCT01499524|ICP, GDM|icp, gdm
384126|NCT01499511|Hypertension|hypertension
384127|NCT01499511|Mortality|mortality
384128|NCT01499511|Morbidity|morbidity
384129|NCT01499511|Coronary Heart Disease|coronary heart disease
384130|NCT01499511|Stroke|stroke
384131|NCT01499511|Diabetes|diabetes
384132|NCT01499498|Healthy volunteers|healthy volunteers
384133|NCT01499485|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
384134|NCT01499485|Obesity Hypoventilation Syndrome|obesity hypoventilation syndrome
384135|NCT01499485|Alkalosis|alkalosis
384136|NCT01499485|Respiration, Artificial|respiration, artificial
384137|NCT01499485|Acetazolamide|acetazolamide
384138|NCT01499485|Intensive care|intensive care
384139|NCT01499485|Adult|adult
384140|NCT01499459|liver cirrhosis|liver cirrhosis
384141|NCT01499459|autologous mesenchymal stem cell transplantation|autologous mesenchymal stem cell transplantation
384142|NCT01499342|Stent|stent
384143|NCT01499342|Atherosclerotic occlusive disease|atherosclerotic occlusive disease
384144|NCT01499342|Peripheral arterial disease|peripheral arterial disease
384145|NCT01499342|Superficial femoral artery|superficial femoral artery
384146|NCT01499342|SFA|sfa
384147|NCT01499329|Stent therapy|stent therapy
384148|NCT01499316|Coronary artery disease|coronary artery disease
384149|NCT01499316|Fractional flow reserve|fractional flow reserve
384150|NCT01499303|lymphoma|lymphoma
384151|NCT01499303|DLBCL|dlbcl
384152|NCT01499303|fostamatinib|fostamatinib
384153|NCT01499303|Diffuse Large B-Cell Lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
384154|NCT01499290|Ceftazidime|ceftazidime
384155|NCT01499290|Meropenem|meropenem
384156|NCT01499290|Metronidazole|metronidazole
384157|NCT01499290|Anti-Bacterial Agents|anti-bacterial agents
384158|NCT01499290|Anti-Infective Agents|anti-infective agents
384159|NCT01499290|Antiprotozoal Agents|antiprotozoal agents
384160|NCT01499290|Antiparasitic Agents|antiparasitic agents
384161|NCT01499290|cIAI, Complicated Intra-Abdominal Infection|ciai, complicated intra-abdominal infection
384162|NCT01499277|complicated skin and soft tissue infections (cSSTI)|complicated skin and soft tissue infections (cssti)
384163|NCT01499277|skin infection|skin infection
384164|NCT01499277|ceftaroline|ceftaroline
384165|NCT01499277|wound infection|wound infection
384166|NCT01499277|cellulitis|cellulitis
384167|NCT01499277|burn infection|burn infection
384168|NCT01499277|bacterial infection|bacterial infection
384169|NCT01499277|vancomycin|vancomycin
384170|NCT01499264|MySkin patch|myskin patch
384171|NCT01499251|glioblastoma|glioblastoma
384172|NCT01499238|Efficacy|efficacy
384173|NCT01499238|safety|safety
384174|NCT01499238|nasal SIMV|nasal simv
384175|NCT01499238|nasal CPAP|nasal cpap
384176|NCT01499238|infants who are >35 gestational week with wet lung|infants who are >35 gestational week with wet lung
384177|NCT01499199|cerebrospinal fluid (CSF)|cerebrospinal fluid (csf)
384178|NCT01499199|ART-naive|art-naive
384179|NCT01499199|integrase inhibitor|integrase inhibitor
384180|NCT01499199|dolutegravir|dolutegravir
384181|NCT01499199|antiretroviral therapy naive|antiretroviral therapy naive
384182|NCT01499186|Local vibration, elderly, bone, muscle, functionality|local vibration, elderly, bone, muscle, functionality
384183|NCT01499160|endocrine resistant|endocrine resistant
384184|NCT01499160|everolimus|everolimus
384185|NCT01499160|lapatinib|lapatinib
384186|NCT01499160|letrozole|letrozole
384187|NCT01499147|Acute myeloid leukemia|acute myeloid leukemia
384188|NCT01499147|First remission|first remission
384189|NCT01499147|Acute lymphocytic leukemia|acute lymphocytic leukemia
384190|NCT01499147|Acute leukemia|acute leukemia
384191|NCT01499147|Second remission|second remission
384192|NCT01499147|Early relapse|early relapse
384193|NCT01499147|Partial remission|partial remission
384194|NCT01499147|Accelerated phase|accelerated phase
384195|NCT01499147|Blast-crisis|blast-crisis
384196|NCT01499147|Chronic myelogenous leukemia|chronic myelogenous leukemia
384197|NCT01499147|Chronic phase|chronic phase
384198|NCT01499147|Recurrent malignant lymphoma|recurrent malignant lymphoma
384199|NCT01499147|Refractory malignant lymphoma|refractory malignant lymphoma
384200|NCT01499147|Hodgkin's disease|hodgkin's disease
384201|NCT01499147|Multiple myeloma.|multiple myeloma.
384202|NCT01499147|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
384203|NCT01499147|Myeloproliferative disorder|myeloproliferative disorder
384204|NCT01499147|Polycythemia vera|polycythemia vera
384205|NCT01499147|Myelofibrosis|myelofibrosis
384206|NCT01499147|Severe aplastic anemia|severe aplastic anemia
384207|NCT01499108|type 2 diabetes|type 2 diabetes
384208|NCT01499108|hypertension|hypertension
384209|NCT01499108|liraglutide|liraglutide
384210|NCT01499108|kidney function|kidney function
384211|NCT01499056|osteoarthritis|osteoarthritis
384212|NCT01499056|hip joint|hip joint
384213|NCT01499056|mesenchymal stem cell|mesenchymal stem cell
384214|NCT01499043|CRPC|crpc
384215|NCT01499043|Prostate Cancer|prostate cancer
384216|NCT01499043|Bone metastasis|bone metastasis
384217|NCT01499043|Advanced Castration-Resistant Prostate Cancer (CRPC)|advanced castration-resistant prostate cancer (crpc)
384218|NCT01499017|Single Ascending Dose Study in healthy subjects|single ascending dose study in healthy subjects
384219|NCT01499004|tofacitinib|tofacitinib
384220|NCT01499004|CP-690|cp-690
384221|NCT01499004|550|550
384222|NCT01499004|relative bioavailability|relative bioavailability
384223|NCT01499004|modified release|modified release
384224|NCT01499004|Phase 1|phase 1
384225|NCT01498991|Incomplete Spinal Cord Injury|incomplete spinal cord injury
384226|NCT01498991|Rehabilitation|rehabilitation
384227|NCT01498991|AMES device|ames device
384228|NCT01498991|Lower Extremity|lower extremity
384229|NCT01498991|Gait|gait
384230|NCT01498991|Paraplegia|paraplegia
384231|NCT01498965|food allergy|food allergy
384232|NCT01498965|eczema|eczema
384233|NCT01498965|Vitamin D status|vitamin d status
384234|NCT01498965|body composition|body composition
384235|NCT01498965|obesity|obesity
384236|NCT01498965|neurodevelopmental and behavioural outcome|neurodevelopmental and behavioural outcome
384237|NCT01498952|HCC, liver cancer, hepatocellular carcinoma, MEDI-573, anti-IGF|hcc, liver cancer, hepatocellular carcinoma, medi-573, anti-igf
384238|NCT01498887|Multiple Sclerosis|multiple sclerosis
384239|NCT01498887|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
384240|NCT01498887|Fingolimod|fingolimod
384241|NCT01498887|Early multiple sclerosis|early multiple sclerosis
384242|NCT01498887|Naive patients|naive patients
384243|NCT01498874|Acne|acne
384244|NCT01498874|Acne Vulgaris|acne vulgaris
384245|NCT01498835|Soft tissue sarcoma|soft tissue sarcoma
384246|NCT01498835|Radiation therapy|radiation therapy
384247|NCT01498835|Sunitinib|sunitinib
384248|NCT01498822|Levetiracetam|levetiracetam
384249|NCT01498822|Oxcarbazepine|oxcarbazepine
384250|NCT01498822|treatment failure|treatment failure
384251|NCT01498822|partial epilepsy|partial epilepsy
384252|NCT01498809|Orthostatic intolerance in people with spinal cord injury|orthostatic intolerance in people with spinal cord injury
384253|NCT01498744|Skin and Soft Tissue Abscess|skin and soft tissue abscess
384254|NCT01498744|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
384255|NCT01498744|Incision and Drainage|incision and drainage
384256|NCT01498744|Clindamycin|clindamycin
384257|NCT01498744|Trimethoprim-sulfamethoxazole|trimethoprim-sulfamethoxazole
384258|NCT01498744|Skin Infection|skin infection
384259|NCT01498731|Copeptin|copeptin
384260|NCT01498731|Troponin|troponin
384261|NCT01498731|Acute Coronary Syndrome|acute coronary syndrome
384262|NCT01498731|Rule-out of acute myocardial infarction|rule-out of acute myocardial infarction
384263|NCT01498731|Emergency Medicine|emergency medicine
384264|NCT01498718|Influenza A (H1N1)|influenza a (h1n1)
384265|NCT01498718|Influenza A (H3N2)|influenza a (h3n2)
384266|NCT01498718|Influenza B|influenza b
384267|NCT01498718|Trivalent Inactivated Vaccine (TIV)|trivalent inactivated vaccine (tiv)
384268|NCT01498718|Healthy Adults|healthy adults
384269|NCT01498705|Intraventricular Hemorrhage|intraventricular hemorrhage
384270|NCT01498705|Intracerebral Hemorrhage|intracerebral hemorrhage
384271|NCT01498705|Cerebrovascular Disorders|cerebrovascular disorders
384272|NCT01498705|Brain Diseases|brain diseases
384273|NCT01498705|Central Nervous System Diseases|central nervous system diseases
384274|NCT01498705|Nervous System Diseases|nervous system diseases
384275|NCT01498705|Vascular Diseases|vascular diseases
384276|NCT01498705|Procalcitonin Level|procalcitonin level
384277|NCT01498692|drug-eluting stents|drug-eluting stents
384278|NCT01498692|DES|des
384279|NCT01498692|atherosclerotic|atherosclerotic
384280|NCT01498640|XIAFLEX|xiaflex
384281|NCT01498640|XIAPEX|xiapex
384282|NCT01498640|Dupuytren's disease|dupuytren's disease
384283|NCT01498640|contracture|contracture
384284|NCT01498627|Autoimmune diseases (AIDs)|autoimmune diseases (aids)
384285|NCT01498627|Cervarix|cervarix
384286|NCT01498627|PGRx information system|pgrx information system
384287|NCT01498614|Diabetes mellitus|diabetes mellitus
384288|NCT01498614|depression|depression
384289|NCT01498614|anxiety|anxiety
384290|NCT01498614|negative self image|negative self image
384291|NCT01498614|alexithymia|alexithymia
384292|NCT01498614|metabolic control|metabolic control
384293|NCT01498614|diabetes complications|diabetes complications
384294|NCT01498601|oral hygiene|oral hygiene
384295|NCT01498601|tracheostomy|tracheostomy
384296|NCT01498601|deglutition disorders|deglutition disorders
384297|NCT01498601|enteral nutrition|enteral nutrition
384298|NCT01498601|brain injury|brain injury
384299|NCT01498601|coma|coma
384300|NCT01498588|Breast Neoplasms|breast neoplasms
384301|NCT01498588|Breast Cancer|breast cancer
384302|NCT01498588|Breast Tumors|breast tumors
384303|NCT01498588|Cancer of the Breast|cancer of the breast
384304|NCT01498588|Neoplasms, Breast|neoplasms, breast
384305|NCT01498588|Tumors, Breast|tumors, breast
384306|NCT01498575|Teen driving|teen driving
384307|NCT01498575|Behind the wheel practice driving|behind the wheel practice driving
384308|NCT01498575|Parent supervision|parent supervision
384309|NCT01498549|Abstinent cocaine users|abstinent cocaine users
384310|NCT01498549|cognitive testing|cognitive testing
384311|NCT01498523|Camel milk|camel milk
384312|NCT01498523|Postprandial glycaemic response|postprandial glycaemic response
384313|NCT01498523|postprandial insulinaemic response|postprandial insulinaemic response
384314|NCT01498523|Glycaemic index|glycaemic index
384315|NCT01498510|chronic pain|chronic pain
384316|NCT01498510|cognitive behavior therapy|cognitive behavior therapy
384317|NCT01498510|web-based intervention|web-based intervention
384318|NCT01498484|EBV-specific T-cell lines|ebv-specific t-cell lines
384319|NCT01498484|11-130|11-130
384320|NCT01498458|German Breast Group|german breast group
384321|NCT01498458|GBG Forschungs GmbH|gbg forschungs gmbh
384323|NCT01498458|GBG 62|gbg 62
384324|NCT01498458|PazoX|pazox
384325|NCT01498458|Breast Cancer|breast cancer
384326|NCT01498458|Metastatic Breast Cancer|metastatic breast cancer
384327|NCT01498458|Pazopanib|pazopanib
384328|NCT01498458|Abraxane|abraxane
384329|NCT01498458|Capecitabine|capecitabine
384330|NCT01498458|Xeloda|xeloda
384331|NCT01498445|Leukemia|leukemia
384332|NCT01498445|Chronic myelogenous leukemia|chronic myelogenous leukemia
384333|NCT01498445|Chronic myeloid leukemia|chronic myeloid leukemia
384334|NCT01498445|CML|cml
384335|NCT01498445|Accelerated phase|accelerated phase
384336|NCT01498445|Blastic phase|blastic phase
384337|NCT01498445|Dasatinib|dasatinib
384338|NCT01498445|BMS-354825|bms-354825
384339|NCT01498445|Sprycel|sprycel
384340|NCT01498445|Decitabine|decitabine
384341|NCT01498445|Dacogen|dacogen
384342|NCT01498419|Tuberculosis|tuberculosis
384343|NCT01498419|Serial Sputum Colony Counts|serial sputum colony counts
384344|NCT01498419|Colony Forming Units|colony forming units
384345|NCT01498419|Time to Sputum Culture Positivity|time to sputum culture positivity
384346|NCT01498419|PA824|pa824
384347|NCT01498419|pretomanid|pretomanid
384348|NCT01498406|cutaneous lupus erythematosus|cutaneous lupus erythematosus
384349|NCT01498406|vitamin D|vitamin d
384350|NCT01498406|quality of life|quality of life
384351|NCT01498393|fungal nail|fungal nail
384352|NCT01498380|Dexmedetomidine|dexmedetomidine
384353|NCT01498380|Precedex|precedex
384354|NCT01498380|TIVA|tiva
384355|NCT01498380|Rapid bolus|rapid bolus
384356|NCT01498367|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
384357|NCT01498367|Telemedicine|telemedicine
384358|NCT01498354|Transanal endoscopic microsurgery|transanal endoscopic microsurgery
384359|NCT01498354|Transanal endoscopic operations|transanal endoscopic operations
384360|NCT01498354|Rectal adenomas|rectal adenomas
384361|NCT01498354|Transanal endoscopic surgery|transanal endoscopic surgery
384362|NCT01498354|"Rectal adenocarcinomas in situ"|"rectal adenocarcinomas in situ"
384363|NCT01498341|Hypoparathyroidism|hypoparathyroidism
384364|NCT01498341|Epidemiology|epidemiology
384365|NCT01498341|Prognosis|prognosis
384366|NCT01498341|Symptoms|symptoms
384367|NCT01498328|EGFRvIII|egfrviii
384368|NCT01498328|Glioblastoma|glioblastoma
384369|NCT01498328|Rindopepimut|rindopepimut
384370|NCT01498328|CDX-110|cdx-110
384371|NCT01498328|Small cell|small cell
384372|NCT01498328|Giant cell|giant cell
384373|NCT01498328|Brain Cancer|brain cancer
384374|NCT01498328|Brain Tumor|brain tumor
384375|NCT01498328|Gliosarcoma|gliosarcoma
384376|NCT01498328|oligodendroglial|oligodendroglial
384377|NCT01498328|radiotherapy|radiotherapy
384378|NCT01498328|chemoradiation|chemoradiation
384379|NCT01498328|Tumor|tumor
384380|NCT01498328|Bevacizumab|bevacizumab
384381|NCT01498328|Relapsed|relapsed
384382|NCT01498328|Returned|returned
384383|NCT01498328|Recurrent|recurrent
384384|NCT01498328|EGFR variant III|egfr variant iii
384385|NCT01498302|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
384386|NCT01498289|recurrent esophageal cancer|recurrent esophageal cancer
384387|NCT01498289|stage IV esophageal cancer|stage iv esophageal cancer
384388|NCT01498289|recurrent gastric cancer|recurrent gastric cancer
384389|NCT01498289|stage IV gastric cancer|stage iv gastric cancer
384390|NCT01498289|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
384391|NCT01498289|stage IIIB gastric cancer|stage iiib gastric cancer
384392|NCT01498289|stage IIIC gastric cancer|stage iiic gastric cancer
384393|NCT01498289|stage IIIB esophageal cancer|stage iiib esophageal cancer
384394|NCT01498289|stage IIIC esophageal cancer|stage iiic esophageal cancer
384395|NCT01498289|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
384396|NCT01498289|adenocarcinoma of the stomach|adenocarcinoma of the stomach
384397|NCT01498276|Family History|family history
384398|NCT01498276|Family Health History|family health history
384399|NCT01498276|Disease Risk Assessment|disease risk assessment
384400|NCT01498263|Family Systems|family systems
384401|NCT01498263|Caregiving|caregiving
384402|NCT01498263|Alzheimer Disease|alzheimer disease
384403|NCT01498263|Family History|family history
384404|NCT01498263|Alzheimer's Disease|alzheimer's disease
384405|NCT01498263|AD|ad
384406|NCT01498237|Photoacoustic endoscopy|photoacoustic endoscopy
384407|NCT01498224|Cataract surgery|cataract surgery
384408|NCT01498211|volunteer|volunteer
384409|NCT01498198|Rotator Cuff|rotator cuff
384410|NCT01498198|WCB|wcb
384617|NCT01497288|Population PK|population pk
384411|NCT01498172|Non muscle invasive bladder cancer|non muscle invasive bladder cancer
384412|NCT01498159|Diabetes Mellitus|diabetes mellitus
384413|NCT01498159|Pharmacists|pharmacists
384414|NCT01498159|Community Health Aides|community health aides
384415|NCT01498146|cryptogenic stroke|cryptogenic stroke
384416|NCT01498146|atrial fibrillation|atrial fibrillation
384417|NCT01498146|longterm monitoring|longterm monitoring
384418|NCT01498146|loop recorder|loop recorder
384419|NCT01498133|Skin-to-skin contact|skin-to-skin contact
384420|NCT01498133|Decolonization|decolonization
384421|NCT01498133|MRSA|mrsa
384422|NCT01498120|Rotigotine|rotigotine
384423|NCT01498120|Restless Legs Syndrome|restless legs syndrome
384424|NCT01498120|RLS|rls
384425|NCT01498120|Long-term|long-term
384426|NCT01498120|Adolescents|adolescents
384427|NCT01498107|online intervention|online intervention
384428|NCT01498107|computerized CBT|computerized cbt
384429|NCT01498107|e-health|e-health
384430|NCT01498094|Bronchiolitis|bronchiolitis
384431|NCT01498094|High|high
384432|NCT01498094|Flow|flow
384433|NCT01498094|Oxygen|oxygen
384434|NCT01498094|Therapy|therapy
384435|NCT01498094|Nasal|nasal
384436|NCT01498094|Cannulae|cannulae
384437|NCT01498094|Prongs|prongs
384438|NCT01498081|COPD, pulmonary disease|copd, pulmonary disease
384439|NCT01498068|Genotype 1 chronic Hepatitis C|genotype 1 chronic hepatitis c
384440|NCT01498068|VX-950HPC3007|vx-950hpc3007
384441|NCT01498068|VX-950|vx-950
384442|NCT01498068|Hepatitis C|hepatitis c
384443|NCT01498068|Telaprevir|telaprevir
384444|NCT01498068|HCV|hcv
384445|NCT01498055|lung cancer|lung cancer
384446|NCT01498055|CIK cells|cik cells
384447|NCT01498055|therapy|therapy
384448|NCT01498029|Cartilage, Articular|cartilage, articular
384449|NCT01498016|acute leukemia|acute leukemia
384450|NCT01498016|allogeneic stem cell transplantation|allogeneic stem cell transplantation
384451|NCT01498016|busulfan|busulfan
384452|NCT01498003|coronary disease|coronary disease
384453|NCT01498003|stents|stents
384454|NCT01498003|thrombosis|thrombosis
384455|NCT01498003|myocardial infarction|myocardial infarction
384456|NCT01498003|prognosis|prognosis
384457|NCT01497990|Burns|burns
384458|NCT01497990|Ertapenem|ertapenem
384459|NCT01497990|Pharmacokinetics|pharmacokinetics
384460|NCT01497977|phytoestrogens|phytoestrogens
384461|NCT01497977|postmenopause|postmenopause
384462|NCT01497977|serum lipids|serum lipids
384463|NCT01497925|Arginine deiminase|arginine deiminase
384464|NCT01497925|Arginine|arginine
384465|NCT01497925|Solid tumors|solid tumors
384466|NCT01497925|Prostate cancer|prostate cancer
384467|NCT01497925|Phase 1 study|phase 1 study
384468|NCT01497899|HIV-1|hiv-1
384469|NCT01497899|HIV|hiv
384470|NCT01497899|Treatment-Naive|treatment-naive
384471|NCT01497886|Stroke|stroke
384472|NCT01497886|Children|children
384473|NCT01497886|Hip Hop Stroke|hip hop stroke
384474|NCT01497886|New York City|new york city
384475|NCT01497873|Small Cell Lung Cancer|small cell lung cancer
384476|NCT01497873|Belotecan|belotecan
384477|NCT01497873|Topotecan|topotecan
384478|NCT01497860|pediatric|pediatric
384479|NCT01497860|children|children
384480|NCT01497860|glioma|glioma
384481|NCT01497860|low-grade|low-grade
384482|NCT01497860|vinorelbine|vinorelbine
384483|NCT01497860|recurrent|recurrent
384484|NCT01497860|progressive|progressive
384485|NCT01497847|Post-Infectious Irritable Bowel Syndrome|post-infectious irritable bowel syndrome
384486|NCT01497847|PI-IBS|pi-ibs
384487|NCT01497834|Hepatitis C Virus Infection|hepatitis c virus infection
384488|NCT01497821|Amgen|amgen
384489|NCT01497821|Phase 1|phase 1
384490|NCT01497821|First in Human|first in human
384491|NCT01497821|Relapsed / Refractory Renal Cell Carcinoma (RCC)|relapsed / refractory renal cell carcinoma (rcc)
384492|NCT01497821|Kidney Cancer|kidney cancer
384493|NCT01497821|Clinical Trial|clinical trial
384494|NCT01497821|Antibody drug conjugate (ADC)|antibody drug conjugate (adc)
384495|NCT01497821|Open-label|open-label
384496|NCT01497821|Oncology|oncology
384497|NCT01497808|previously untreated|previously untreated
384498|NCT01497808|previously treated|previously treated
384499|NCT01497808|bone, lung, liver or subcutaneous involvement|bone, lung, liver or subcutaneous involvement
384500|NCT01497808|nodal involvement|nodal involvement
384501|NCT01497808|without evidence of brain involvement|without evidence of brain involvement
384502|NCT01497782|virtual reality, simulator, feedback, laparoscopy, training|virtual reality, simulator, feedback, laparoscopy, training
384503|NCT01497769|vaccine|vaccine
384504|NCT01497769|immunogenicity|immunogenicity
384505|NCT01497743|Scleroderma|scleroderma
384506|NCT01497743|gastrointestinal|gastrointestinal
384507|NCT01497743|bloating|bloating
384508|NCT01497743|reflux|reflux
384509|NCT01497730|Arthroplasty, Replacement, Knee,|arthroplasty, replacement, knee,
384510|NCT01497704|Cancer|cancer
384511|NCT01497704|Tumor|tumor
384512|NCT01497704|Oncology|oncology
384513|NCT01497704|Antiangiogenesis|antiangiogenesis
384514|NCT01497691|Asthma|asthma
384515|NCT01497691|Pediatrics|pediatrics
384516|NCT01497691|BiPAP|bipap
384517|NCT01497691|Noninvasive Positive Pressure Ventilation|noninvasive positive pressure ventilation
384518|NCT01497678|MTURR|mturr
384519|NCT01497678|ECM|ecm
384520|NCT01497678|Muscle Loss|muscle loss
384521|NCT01497678|Tendon|tendon
384522|NCT01497678|Tendon Repair|tendon repair
384523|NCT01497678|Muscle Repair|muscle repair
384524|NCT01497678|Soft Tissue Repair|soft tissue repair
384525|NCT01497678|Scaffold|scaffold
384526|NCT01497678|Extracellular Matrix|extracellular matrix
384527|NCT01497665|GRN1005|grn1005
384528|NCT01497665|ANG1005|ang1005
384529|NCT01497665|LRP-1|lrp-1
384530|NCT01497665|Targeted Therapy|targeted therapy
384531|NCT01497665|Brain Tumor|brain tumor
384532|NCT01497665|Blood Brain Barrier|blood brain barrier
384533|NCT01497665|Peptide-Drug Conjugate (PDC)|peptide-drug conjugate (pdc)
384534|NCT01497665|Brain Metastases|brain metastases
384535|NCT01497665|Paclitaxel|paclitaxel
384536|NCT01497665|Taxol|taxol
384537|NCT01497665|NSCLC|nsclc
384538|NCT01497665|Non-Small Cell Lung Cancer|non-small cell lung cancer
384539|NCT01497652|Parkinson's Disease|parkinson's disease
384540|NCT01497652|Cognition|cognition
384541|NCT01497652|Rasagiline|rasagiline
384542|NCT01497652|MoCA|moca
384543|NCT01497652|Mild Cognitive Impairment in Parkinson's Disease|mild cognitive impairment in parkinson's disease
384544|NCT01497639|dystonia|dystonia
384545|NCT01497639|pallidal stimulation|pallidal stimulation
384546|NCT01497639|deep brain stimulation|deep brain stimulation
384547|NCT01497639|deep brain stimulation of GPi|deep brain stimulation of gpi
384548|NCT01497639|GPi|gpi
384549|NCT01497639|interleaving stimulation|interleaving stimulation
384550|NCT01497626|Advanced cancer|advanced cancer
384551|NCT01497626|Solid tumor|solid tumor
384552|NCT01497613|Socialization|socialization
384553|NCT01497613|Well-being|well-being
384554|NCT01497613|Quality of Life|quality of life
384555|NCT01497613|Connectivity|connectivity
384556|NCT01497548|Depression|depression
384557|NCT01497548|cancer|cancer
384558|NCT01497548|methylphenidate|methylphenidate
384559|NCT01497548|pharmacotherapy|pharmacotherapy
384560|NCT01497522|Vildagliptin|vildagliptin
384561|NCT01497522|Type 2 diabetes|type 2 diabetes
384562|NCT01497522|HbA1c|hba1c
384563|NCT01497522|Fasting plasma glucose|fasting plasma glucose
384564|NCT01497496|leukemia|leukemia
384565|NCT01497496|lymphoma|lymphoma
384566|NCT01497496|consolidative therapy|consolidative therapy
384567|NCT01497496|combination regimen|combination regimen
384568|NCT01497496|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
384569|NCT01497496|Small Lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
384570|NCT01497470|paclitaxel|paclitaxel
384571|NCT01497470|carboplatin|carboplatin
384572|NCT01497470|custirsen|custirsen
384573|NCT01497470|drug-drug interaction|drug-drug interaction
384574|NCT01497470|pharmacokinetics|pharmacokinetics
384575|NCT01497470|cancer|cancer
384576|NCT01497444|recurrent adult primary liver cancer|recurrent adult primary liver cancer
384577|NCT01497444|recurrent renal cell cancer|recurrent renal cell cancer
384578|NCT01497444|advanced adult primary liver cancer|advanced adult primary liver cancer
384579|NCT01497444|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
384580|NCT01497444|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
384581|NCT01497405|Gender-based Violence|gender-based violence
384582|NCT01497405|HIV|hiv
384583|NCT01497405|Randomized Controlled Trial|randomized controlled trial
384584|NCT01497405|Sexually Transmitted Diseases|sexually transmitted diseases
384585|NCT01497405|Substance Abuse Detection|substance abuse detection
384586|NCT01497405|Test, Treat and Retain|test, treat and retain
384587|NCT01497379|Hereditary retinal|hereditary retinal
384588|NCT01497379|degeneration outer|degeneration outer
384589|NCT01497379|retinal layers|retinal layers
384590|NCT01497379|photoreceptor rods cones|photoreceptor rods cones
384591|NCT01497379|Retinitis pigmentosa|retinitis pigmentosa
384592|NCT01497379|blindness|blindness
384593|NCT01497379|reading ability|reading ability
384594|NCT01497379|retina implant|retina implant
384595|NCT01497379|subretinal|subretinal
384596|NCT01497366|HCV genotype 2 (GT-2)|hcv genotype 2 (gt-2)
384597|NCT01497366|HCV genotype 3 (GT-3)|hcv genotype 3 (gt-3)
384598|NCT01497353|Cord clamping|cord clamping
384599|NCT01497353|newborn|newborn
384600|NCT01497353|Skin contact|skin contact
384601|NCT01497353|Placental transfusion|placental transfusion
384602|NCT01497353|Delivery room|delivery room
384603|NCT01497340|Cord clamping|cord clamping
384604|NCT01497340|newborn|newborn
384605|NCT01497340|Placental trasfusion|placental trasfusion
384606|NCT01497340|Delivery room|delivery room
384607|NCT01497327|HEPATITIS C, CHRONIC|hepatitis c, chronic
384608|NCT01497327|HCV|hcv
384609|NCT01497327|hepatic impairment|hepatic impairment
384610|NCT01497314|healthy term infants|healthy term infants
384611|NCT01497314|growth|growth
384612|NCT01497314|infant formula|infant formula
384613|NCT01497301|Diabetes|diabetes
384614|NCT01497301|Group Visit|group visit
384615|NCT01497301|Shared Medical Appointment|shared medical appointment
384616|NCT01497288|Intranasal fentanyl spray|intranasal fentanyl spray
384618|NCT01497262|Multiple Sclerosis|multiple sclerosis
384619|NCT01497262|Relapsing-Remitting|relapsing-remitting
384620|NCT01497249|Dietary Fiber|dietary fiber
384621|NCT01497249|Blood glucose control|blood glucose control
384622|NCT01497249|Fermentability|fermentability
384623|NCT01497249|Tolerability|tolerability
384624|NCT01497223|Phase II|phase ii
384625|NCT01497223|Double-Blind|double-blind
384626|NCT01497223|Placebo-Controlled|placebo-controlled
384627|NCT01497223|Vulvovaginal Candidiasis|vulvovaginal candidiasis
384628|NCT01497223|Moderate to Severe|moderate to severe
384629|NCT01497223|Acute|acute
384630|NCT01497223|Treatment of Moderate to Severe Vulvovaginal Candidiasis|treatment of moderate to severe vulvovaginal candidiasis
384631|NCT01497197|Reproduction Techniques|reproduction techniques
384632|NCT01497197|Reproductive Medicine|reproductive medicine
384633|NCT01497197|Assisted Reproductive Technics|assisted reproductive technics
384634|NCT01497197|Pregnancy Rate|pregnancy rate
384635|NCT01497197|Ovulation Induction|ovulation induction
384636|NCT01497197|Ovarian Stimulation|ovarian stimulation
384637|NCT01497197|Oocytes|oocytes
384638|NCT01497197|Implantation|implantation
384639|NCT01497184|Leukemia|leukemia
384640|NCT01497184|Lymphoma|lymphoma
384641|NCT01497184|Allogeneic donor lymphocyte infusion|allogeneic donor lymphocyte infusion
384642|NCT01497184|DLI|dli
384643|NCT01497184|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
384644|NCT01497184|HSCT|hsct
384645|NCT01497184|Bone marrow transplant|bone marrow transplant
384646|NCT01497184|CD19-specific T cells|cd19-specific t cells
384647|NCT01497184|T cell infusion|t cell infusion
384648|NCT01497184|B-Lineage lymphoid malignancies|b-lineage lymphoid malignancies
384649|NCT01497184|CD19+ lymphoid malignancies|cd19+ lymphoid malignancies
384650|NCT01497184|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
384651|NCT01497184|ALL|all
384652|NCT01497184|Biphenotypic leukemia CD19+ in advanced remission|biphenotypic leukemia cd19+ in advanced remission
384653|NCT01497184|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
384654|NCT01497184|NHL|nhl
384655|NCT01497184|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
384656|NCT01497184|Small lymphocytic lymphoma|small lymphocytic lymphoma
384657|NCT01497184|Follicular lymphoma|follicular lymphoma
384658|NCT01497184|Mantle cell lymphoma with active disease at time of transplant|mantle cell lymphoma with active disease at time of transplant
384659|NCT01497171|Cystocele|cystocele
384660|NCT01497171|Bladder prolapse|bladder prolapse
384661|NCT01497171|Anterior prolapse|anterior prolapse
384662|NCT01497171|Vaginal prolapse|vaginal prolapse
384663|NCT01497171|Uterine prolapse|uterine prolapse
384664|NCT01497171|Urinary incontinence|urinary incontinence
384665|NCT01497158|tobacco cessation|tobacco cessation
384666|NCT01497119|Moderate atopic dermatitis|moderate atopic dermatitis
384667|NCT01497119|JNJ-39758979|jnj-39758979
384668|NCT01497119|Japanese patients|japanese patients
384669|NCT01497106|Insulin resistance|insulin resistance
384670|NCT01497106|Abdominal obesity|abdominal obesity
384671|NCT01497106|Calorie restriction|calorie restriction
384672|NCT01497093|Myeloma|myeloma
384673|NCT01497093|Multiple Myeloma|multiple myeloma
384674|NCT01497093|Relapsed Multiple Myeloma|relapsed multiple myeloma
384675|NCT01497093|Relapsed and Refractory Multiple Myeloma|relapsed and refractory multiple myeloma
384676|NCT01497093|Refractory Myeloma|refractory myeloma
384677|NCT01497093|Resistant Multiple Myeloma|resistant multiple myeloma
384678|NCT01497093|Treatment-resistant Multiple Myeloma|treatment-resistant multiple myeloma
384679|NCT01497093|Pomalidomide|pomalidomide
384680|NCT01497093|Lenalidomide-resistant|lenalidomide-resistant
384681|NCT01497080|distal radius fracture|distal radius fracture
384682|NCT01497080|Condition|condition
384683|NCT01497080|risk factors|risk factors
384684|NCT01497080|adverse activity transitions following DRF|adverse activity transitions following drf
384685|NCT01497080|optimal assessment approach|optimal assessment approach
384686|NCT01497054|B type natriuretic peptide|b type natriuretic peptide
384687|NCT01497054|Patent Ductus Arteriosus|patent ductus arteriosus
384688|NCT01497054|Preterm infant|preterm infant
384689|NCT01497028|Co-morbid disease resolution|co-morbid disease resolution
384690|NCT01497002|AML|aml
384691|NCT01496989|HIV|hiv
384692|NCT01496989|AIDS|aids
384693|NCT01496989|HIV vaccine|hiv vaccine
384694|NCT01496989|HIV prevention|hiv prevention
384695|NCT01496976|leukemia|leukemia
384696|NCT01496976|lymphoma|lymphoma
384697|NCT01496976|consolidative therapy|consolidative therapy
384698|NCT01496976|combination regimen|combination regimen
384699|NCT01496976|CLL|cll
384700|NCT01496976|SLL|sll
384701|NCT01496963|Thalassemia|thalassemia
384702|NCT01496963|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
384703|NCT01496950|migraine|migraine
384704|NCT01496924|Dysphagia|dysphagia
384705|NCT01496924|Intensive care units|intensive care units
384706|NCT01496924|Deglutition disorders|deglutition disorders
384707|NCT01496924|Rehabilitation|rehabilitation
384708|NCT01496911|Diving|diving
384709|NCT01496911|Drugs|drugs
384710|NCT01496911|Antihistamines|antihistamines
384711|NCT01496911|Performance|performance
384712|NCT01496898|Microflora|microflora
384713|NCT01496898|Vaginal|vaginal
384714|NCT01496898|Cervical|cervical
384715|NCT01496898|Uterine|uterine
384716|NCT01496898|Inflammation|inflammation
384717|NCT01496898|Cytokine|cytokine
384718|NCT01496898|Intrauterine Device|intrauterine device
384719|NCT01496898|Levonorgestrel|levonorgestrel
384720|NCT01496885|stroke|stroke
384721|NCT01496872|Newborn cranial somatic dysfunction|newborn cranial somatic dysfunction
384722|NCT01496872|Newborn observational study|newborn observational study
384723|NCT01496872|Somatic dysfunction|somatic dysfunction
384724|NCT01496872|Cranial strain pattern|cranial strain pattern
384725|NCT01496872|Osteopathy|osteopathy
384726|NCT01496859|Baska mask|baska mask
384727|NCT01496859|supraglottic airway|supraglottic airway
384728|NCT01496859|airway management|airway management
384729|NCT01496846|Articaine|articaine
384730|NCT01496846|Lidocaine|lidocaine
384731|NCT01496846|Anesthesia, Local|anesthesia, local
384732|NCT01496846|Endodontics|endodontics
384733|NCT01496846|Molar|molar
384734|NCT01496846|Dental Pulp Diseases|dental pulp diseases
384735|NCT01496833|Aortic Diseases|aortic diseases
384736|NCT01496833|Vascular Diseases|vascular diseases
384737|NCT01496833|Cardiovascular Diseases|cardiovascular diseases
384738|NCT01496833|Treatment Outcome|treatment outcome
384739|NCT01496833|Aorta Dissection|aorta dissection
384740|NCT01496833|Aorta Aneurysm|aorta aneurysm
384741|NCT01496833|Aorta pseudoaneurysm|aorta pseudoaneurysm
384742|NCT01496833|Endovascular aortic repair|endovascular aortic repair
384743|NCT01496807|unresectable|unresectable
384744|NCT01496807|stage 3|stage 3
384745|NCT01496807|stage 4|stage 4
384746|NCT01496807|autoimmune|autoimmune
384747|NCT01496807|antibodies|antibodies
384748|NCT01496781|Endoscopic Hemostasis|endoscopic hemostasis
384749|NCT01496781|metallic hemoclip|metallic hemoclip
384750|NCT01496781|EndoClot Absorbable Polysaccharide Hemostat|endoclot absorbable polysaccharide hemostat
384751|NCT01496781|Colonic Polyps|colonic polyps
384752|NCT01496729|Kidney transplantation|kidney transplantation
384753|NCT01496729|Transversus abdominis plane (TAP) block|transversus abdominis plane (tap) block
384754|NCT01496716|Osteoarthritis|osteoarthritis
384755|NCT01496716|obesity|obesity
384756|NCT01496716|quality of life|quality of life
384757|NCT01496703|reasons for MMF dose reduction|reasons for mmf dose reduction
384758|NCT01496690|Anxiety-comorbidity to schizophrenia|anxiety-comorbidity to schizophrenia
384759|NCT01496690|Double-blinded randomized placebo controlled trial|double-blinded randomized placebo controlled trial
384760|NCT01496690|Pregabalin|pregabalin
384761|NCT01496677|volunteer|volunteer
384762|NCT01496651|Percutaneous coronary intervention|percutaneous coronary intervention
384763|NCT01496651|Coronary artery bypass graft operation|coronary artery bypass graft operation
384764|NCT01496651|Left Main|left main
384765|NCT01496638|PCI|pci
384766|NCT01496638|Bifurcation lesion|bifurcation lesion
384767|NCT01496625|Biological Specimens|biological specimens
384768|NCT01496625|Retinal Disease|retinal disease
384769|NCT01496625|Phenotype|phenotype
384770|NCT01496625|Phenotype-Genotype correlation|phenotype-genotype correlation
384771|NCT01496625|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
384772|NCT01496625|AMD|amd
384773|NCT01496625|Diabetic Retinopathy|diabetic retinopathy
384774|NCT01496625|Healthy Volunteer|healthy volunteer
384775|NCT01496625|HV|hv
384776|NCT01496612|Epilepsy|epilepsy
384777|NCT01496612|Temporal Lobe Epilepsy|temporal lobe epilepsy
384778|NCT01496612|Serotonin 1A Receptor|serotonin 1a receptor
384779|NCT01496612|Seizures|seizures
384780|NCT01496599|Brain Imaging|brain imaging
384781|NCT01496599|Parkinson's Disease|parkinson's disease
384782|NCT01496599|Parkinsonism|parkinsonism
384783|NCT01496599|Parkinson Disease|parkinson disease
384784|NCT01496599|PD|pd
384785|NCT01496599|Healthy Volunteer|healthy volunteer
384786|NCT01496599|HV|hv
384787|NCT01496586|Fatigue|fatigue
384788|NCT01496586|Traumatic Brain Injury|traumatic brain injury
384789|NCT01496586|Motivational Incentive|motivational incentive
384790|NCT01496586|TBI|tbi
384791|NCT01496560|colonoscopy|colonoscopy
384792|NCT01496560|pain|pain
384793|NCT01496560|rectal balloon|rectal balloon
384794|NCT01496547|feasibility, effective and safety|feasibility, effective and safety
384795|NCT01496547|intensive chemotherapy|intensive chemotherapy
384796|NCT01496547|RIC regimen|ric regimen
384797|NCT01496547|refractory or relapse leukemia|refractory or relapse leukemia
384798|NCT01496547|allogeneic stem cell transplantation|allogeneic stem cell transplantation
384799|NCT01496534|advanced solid tumors|advanced solid tumors
384800|NCT01496534|bladder cancer|bladder cancer
384801|NCT01496534|gemcitabine|gemcitabine
384802|NCT01496534|cisplatin|cisplatin
384803|NCT01496534|carboplatin|carboplatin
384804|NCT01496534|solid tumors|solid tumors
384805|NCT01496521|Aspirin|aspirin
384806|NCT01496521|polyphenols|polyphenols
384807|NCT01496521|Chemoprevention|chemoprevention
384808|NCT01496508|high-frequency oscillatory ventilation|high-frequency oscillatory ventilation
384809|NCT01496508|respiratory distress syndrome|respiratory distress syndrome
384810|NCT01496508|preterm infants|preterm infants
384811|NCT01496508|neurodevelopment|neurodevelopment
384908|NCT01495988|Stage IV melanoma|stage iv melanoma
384812|NCT01496508|preterm infants with severe respiratory distress syndrome|preterm infants with severe respiratory distress syndrome
384813|NCT01496482|Dry eye Syndromes|dry eye syndromes
384814|NCT01496469|Drug Therapy|drug therapy
384815|NCT01496456|Dental caries|dental caries
384816|NCT01496456|Proximal surfaces|proximal surfaces
384817|NCT01496456|Posterior teeth|posterior teeth
384818|NCT01496456|Carious lesions|carious lesions
384819|NCT01496456|Tooth diseases|tooth diseases
384820|NCT01496456|Preventive therapy|preventive therapy
384821|NCT01496443|Drug Therapy|drug therapy
384822|NCT01496430|Drug Therapy|drug therapy
384823|NCT01496430|Hypertension and Diabetes|hypertension and diabetes
384824|NCT01496417|Kidney Transplantation|kidney transplantation
384825|NCT01496417|Biopsy|biopsy
384826|NCT01496417|Belatacept|belatacept
384827|NCT01496404|Electrocautery|electrocautery
384828|NCT01496391|imaging|imaging
384829|NCT01496391|renal function|renal function
384830|NCT01496391|I-123 OIH|i-123 oih
384831|NCT01496391|Tc-99m MAG 3|tc-99m mag 3
384832|NCT01496378|Chronic Pain|chronic pain
384833|NCT01496378|Abdominal Pain|abdominal pain
384834|NCT01496378|Headache|headache
384835|NCT01496378|Adolescents|adolescents
384836|NCT01496378|Children|children
384837|NCT01496378|Parents|parents
384838|NCT01496378|Problem-Solving Skills Training|problem-solving skills training
384839|NCT01496365|Keywords: pain, diabetes, neuropathy|keywords: pain, diabetes, neuropathy
384840|NCT01496352|Surgical site infection|surgical site infection
384841|NCT01496352|Colorectal surgery|colorectal surgery
384842|NCT01496326|Osteoarthritis|osteoarthritis
384843|NCT01496326|knee pain|knee pain
384844|NCT01496313|medullary thyroid cancer|medullary thyroid cancer
384845|NCT01496313|metastatic|metastatic
384846|NCT01496313|thyroid cancer|thyroid cancer
384847|NCT01496313|carcinoma of the thyroid|carcinoma of the thyroid
384848|NCT01496313|receptor tyrosine kinase inhibitor|receptor tyrosine kinase inhibitor
384849|NCT01496313|VEGFR|vegfr
384850|NCT01496313|Unresectable locally advanced thyroid cancer|unresectable locally advanced thyroid cancer
384851|NCT01496300|Navigation OrthoPilot Hip TEP THA|navigation orthopilot hip tep tha
384852|NCT01496261|Clopidogrel|clopidogrel
384853|NCT01496261|Aspirin|aspirin
384854|NCT01496261|Combination|combination
384855|NCT01496261|Pharmacokinetics|pharmacokinetics
384856|NCT01496261|Phase 1|phase 1
384857|NCT01496248|Major depressive disorder|major depressive disorder
384858|NCT01496248|Residual symptoms|residual symptoms
384859|NCT01496248|Korean red ginseng|korean red ginseng
384860|NCT01496222|mild cognitive impairment|mild cognitive impairment
384861|NCT01496222|Montreal Cognitive Assessment test|montreal cognitive assessment test
384862|NCT01496209|Infarction|infarction
384863|NCT01496209|Myocardial Infarction|myocardial infarction
384864|NCT01496209|Ventricular Dysfunction, Left|ventricular dysfunction, left
384865|NCT01496209|Heart Disease|heart disease
384866|NCT01496209|Cardiovascular Disease|cardiovascular disease
384867|NCT01496209|Chronic Ischemia|chronic ischemia
384868|NCT01496196|hemoptisis|hemoptisis
384869|NCT01496196|bleeding|bleeding
384870|NCT01496196|tranexamic acid|tranexamic acid
384871|NCT01496157|Primary Prostate Cancer|primary prostate cancer
384872|NCT01496144|Chronic non specific low back pain|chronic non specific low back pain
384873|NCT01496144|Manual therapy|manual therapy
384874|NCT01496144|Active exercises|active exercises
384875|NCT01496144|Pain|pain
384876|NCT01496144|Disability|disability
384877|NCT01496131|Tecemotide|tecemotide
384878|NCT01496131|Prostate Cancer|prostate cancer
384879|NCT01496131|Goserelin|goserelin
384880|NCT01496131|Cyclophosphamide|cyclophosphamide
384881|NCT01496131|Radiotherapy|radiotherapy
384882|NCT01496118|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
384883|NCT01496118|carfilzomib|carfilzomib
384884|NCT01496118|panobinostat|panobinostat
384885|NCT01496092|Keto Acid|keto acid
384886|NCT01496092|Peritoneal dialysis|peritoneal dialysis
384887|NCT01496092|Insulin resistance|insulin resistance
384888|NCT01496079|Maternal immunization|maternal immunization
384889|NCT01496079|Infant immunization|infant immunization
384890|NCT01496079|Influenza vaccine|influenza vaccine
384891|NCT01496079|Passive transfer of immunity|passive transfer of immunity
384892|NCT01496053|Cytokine levels in blood|cytokine levels in blood
384893|NCT01496053|Calprotectin in feces|calprotectin in feces
384894|NCT01496053|Clinical symptom score.|clinical symptom score.
384895|NCT01496027|cerebral oxygenation|cerebral oxygenation
384896|NCT01496027|NIRS|nirs
384897|NCT01496027|tissue oximeters|tissue oximeters
384898|NCT01496027|near infrared spectroscopy|near infrared spectroscopy
384899|NCT01496027|newborn|newborn
384900|NCT01496014|open fracture wounds|open fracture wounds
384901|NCT01496014|infections|infections
384902|NCT01496014|tibia fractures|tibia fractures
384903|NCT01496014|antibiotic therapies in severe fractures|antibiotic therapies in severe fractures
384904|NCT01496014|All severe open fracture of the tibia bone|all severe open fracture of the tibia bone
384905|NCT01496001|Early unilateral breast cancer|early unilateral breast cancer
384906|NCT01495988|Metastatic melanoma|metastatic melanoma
384907|NCT01495988|BRAF-mutant|braf-mutant
384909|NCT01495988|Vemurafenib|vemurafenib
384910|NCT01495988|Bevacizumab|bevacizumab
384911|NCT01495988|Cobimetinib|cobimetinib
384912|NCT01495975|Diabetes Mellitus|diabetes mellitus
384913|NCT01495975|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
384914|NCT01495975|Hospitalization|hospitalization
384915|NCT01495975|Patient Discharge|patient discharge
384916|NCT01495962|Damage Control Laparotomy|damage control laparotomy
384917|NCT01495962|Open Abdomen|open abdomen
384918|NCT01495962|Botulinum Toxin A|botulinum toxin a
384919|NCT01495962|Primary Fascial Closure|primary fascial closure
384920|NCT01495949|etomidate|etomidate
384921|NCT01495949|cortisol level|cortisol level
384922|NCT01495949|inotrope|inotrope
384923|NCT01495949|cardiac patients|cardiac patients
384924|NCT01495936|One Lung Ventilation (OLV)|one lung ventilation (olv)
384925|NCT01495936|Continuous Positive Airway Pressure (CPAP)|continuous positive airway pressure (cpap)
384926|NCT01495936|Positive End Expiratory Pressure (PEEP)|positive end expiratory pressure (peep)
384927|NCT01495936|Lung recruitment maneuver|lung recruitment maneuver
384928|NCT01495936|Hypoxia|hypoxia
384929|NCT01495923|low back pain|low back pain
384930|NCT01495923|radiculopathy|radiculopathy
384931|NCT01495923|injection|injection
384932|NCT01495910|21-hydroxylase deficiency|21-hydroxylase deficiency
384933|NCT01495910|Androstenedione|androstenedione
384934|NCT01495910|Abiraterone acetate|abiraterone acetate
384935|NCT01495910|Pharmacokinetics|pharmacokinetics
384936|NCT01495910|Pharmacodynamics|pharmacodynamics
384937|NCT01495910|Dose-finding|dose-finding
384938|NCT01495897|Dystonia|dystonia
384939|NCT01495897|Cerebellar|cerebellar
384940|NCT01495897|ocular movements|ocular movements
384941|NCT01495897|DYT 11|dyt 11
384942|NCT01495897|sensorimotor integration|sensorimotor integration
384943|NCT01495858|Naproxen sodium|naproxen sodium
384944|NCT01495858|Diphenhydramine|diphenhydramine
384945|NCT01495845|pharmacogenomics|pharmacogenomics
384946|NCT01495845|feasibility|feasibility
384947|NCT01495845|community pharmacy|community pharmacy
384948|NCT01495845|personalized medicine|personalized medicine
384949|NCT01495845|clopidogrel|clopidogrel
384950|NCT01495845|Plavix|plavix
384951|NCT01495832|Adult Obesity|adult obesity
384952|NCT01495832|Cardiometabolic health|cardiometabolic health
384953|NCT01495832|Pulse Foods|pulse foods
384954|NCT01495832|Beans, Peas, Lentils|beans, peas, lentils
384955|NCT01495832|Cognitive Function|cognitive function
384956|NCT01495819|Nicotine|nicotine
384957|NCT01495819|smokers|smokers
384958|NCT01495819|vitals associated with smoking|vitals associated with smoking
384959|NCT01495806|functional dyspepsia|functional dyspepsia
384960|NCT01495806|irritable bowel syndrome|irritable bowel syndrome
384961|NCT01495806|functional abdominal pain|functional abdominal pain
384962|NCT01495793|Rotigotine|rotigotine
384963|NCT01495793|Restless Legs Syndrome|restless legs syndrome
384964|NCT01495793|RLS|rls
384965|NCT01495793|Children|children
384966|NCT01495793|Adolescents|adolescents
384967|NCT01495780|Behavioral|behavioral
384968|NCT01495780|Remote monitoring|remote monitoring
384969|NCT01495767|childhood uveitis|childhood uveitis
384970|NCT01495767|health-related quality of life|health-related quality of life
384971|NCT01495767|gender|gender
384972|NCT01495754|coffee|coffee
384973|NCT01495754|overweight/obese|overweight/obese
384974|NCT01495754|appetite|appetite
384975|NCT01495754|energy intake|energy intake
384976|NCT01495754|inflammation|inflammation
384977|NCT01495754|glucose metabolism|glucose metabolism
384978|NCT01495754|randomized controlled trial|randomized controlled trial
384979|NCT01495741|Mania|mania
384980|NCT01495741|Manic|manic
384981|NCT01495741|Depressive|depressive
384982|NCT01495741|Manic Depressive|manic depressive
384983|NCT01495728|Cervical Radiculopathy|cervical radiculopathy
384984|NCT01495728|Neck Pain|neck pain
384985|NCT01495728|Manipulation|manipulation
384986|NCT01495702|HIV-1|hiv-1
384987|NCT01495702|HIV|hiv
384988|NCT01495702|Treatment Experienced|treatment experienced
384989|NCT01495689|Smoking Cessation|smoking cessation
384990|NCT01495689|respirology Out-patient setting|respirology out-patient setting
384991|NCT01495689|SmartCard|smartcard
384992|NCT01495676|Bladder cancer|bladder cancer
384993|NCT01495676|Organ-conserving strategy|organ-conserving strategy
384994|NCT01495676|Radiochemotherapy|radiochemotherapy
384995|NCT01495676|non metastatic|non metastatic
384996|NCT01495663|refractory|refractory
384997|NCT01495663|relapsed|relapsed
384998|NCT01495663|non-small cell lung cancer|non-small cell lung cancer
384999|NCT01495663|triple-negative breast cancer|triple-negative breast cancer
385000|NCT01495663|soft tissue sarcoma|soft tissue sarcoma
385001|NCT01495663|colorectal cancer|colorectal cancer
385002|NCT01495663|esophageal cancer|esophageal cancer
385003|NCT01495663|prostate cancer|prostate cancer
385004|NCT01495663|ovarian cancer|ovarian cancer
385005|NCT01495650|Comprehensive Adjuvant Care|comprehensive adjuvant care
385006|NCT01495650|Cancer-related fatigue|cancer-related fatigue
385007|NCT01495650|Therapeutic patient education|therapeutic patient education
385008|NCT01495650|Physical Activity|physical activity
385009|NCT01495650|Nutritional counselling|nutritional counselling
385010|NCT01495650|Rehabilitation|rehabilitation
385011|NCT01495637|pediatric|pediatric
385012|NCT01495637|trauma|trauma
385013|NCT01495637|critical|critical
385014|NCT01495637|GM-CSF|gm-csf
385015|NCT01495637|immune|immune
385016|NCT01495624|rotator cuff repair|rotator cuff repair
385017|NCT01495624|capsular shift|capsular shift
385018|NCT01495624|shoulder arthroplasty|shoulder arthroplasty
385019|NCT01495624|subacromial decompression|subacromial decompression
385020|NCT01495624|18 and 75 years|18 and 75 years
385021|NCT01495611|postoperative,|postoperative,
385022|NCT01495611|pediatric|pediatric
385023|NCT01495611|pharmacogenetic|pharmacogenetic
385024|NCT01495611|opioid|opioid
385025|NCT01495611|morphine|morphine
385026|NCT01495611|perioperative|perioperative
385027|NCT01495611|respiratory depression|respiratory depression
385028|NCT01495598|Human Herpesvirus-8/HHV8|human herpesvirus-8/hhv8
385029|NCT01495598|Immune Modulation|immune modulation
385030|NCT01495598|CC-4047|cc-4047
385031|NCT01495598|IMiD|imid
385032|NCT01495598|Kaposi Sarcoma|kaposi sarcoma
385033|NCT01495585|Hepatitis|hepatitis
385034|NCT01495585|Delta|delta
385035|NCT01495585|Treatment|treatment
385036|NCT01495585|Lonafarnib|lonafarnib
385037|NCT01495585|Hepatitis D|hepatitis d
385038|NCT01495572|Malignant Melanoma|malignant melanoma
385039|NCT01495572|Immunotherapy|immunotherapy
385040|NCT01495572|Cell Therapy|cell therapy
385041|NCT01495572|HLA-A2 Positive|hla-a2 positive
385042|NCT01495572|Skin Cancer|skin cancer
385043|NCT01495546|total hip arthroplasty|total hip arthroplasty
385044|NCT01495546|THA|tha
385045|NCT01495546|prosthesis type Lepine|prosthesis type lepine
385046|NCT01495520|Arrhythmias|arrhythmias
385047|NCT01495520|palpitations|palpitations
385048|NCT01495494|Nasal Strip|nasal strip
385049|NCT01495481|Supraventricular Tachycardia|supraventricular tachycardia
385050|NCT01495481|SVT|svt
385051|NCT01495481|Reentrant Tachycardia|reentrant tachycardia
385052|NCT01495481|Dexmedetomidine|dexmedetomidine
385053|NCT01495481|Adenosine|adenosine
385054|NCT01495468|pegylated somatropin|pegylated somatropin
385055|NCT01495468|PEG-rhGH|peg-rhgh
385056|NCT01495468|growth hormone|growth hormone
385057|NCT01495468|Growth Hormone Deficiency|growth hormone deficiency
385058|NCT01495468|phase III study|phase iii study
385059|NCT01495429|catheter related large vein thrombosis|catheter related large vein thrombosis
385060|NCT01495429|upper extremity deep venous thrombosis|upper extremity deep venous thrombosis
385061|NCT01495429|central venous catheters|central venous catheters
385062|NCT01495429|upper extremity catheter related large vein thrombosis|upper extremity catheter related large vein thrombosis
385063|NCT01495403|liver cirrhosis|liver cirrhosis
385064|NCT01495403|muscle cramps|muscle cramps
385065|NCT01495390|Biomarkers|biomarkers
385066|NCT01495390|Biological Markers|biological markers
385067|NCT01495390|Surrogate Markers|surrogate markers
385068|NCT01495390|Clinical Markers|clinical markers
385069|NCT01495390|Plasma|plasma
385070|NCT01495390|Cerebrospinal Fluid|cerebrospinal fluid
385071|NCT01495390|DNA|dna
385072|NCT01495390|Serum|serum
385073|NCT01495390|RNA|rna
385074|NCT01495377|swallowing difficulties|swallowing difficulties
385075|NCT01495377|remifentanil|remifentanil
385076|NCT01495377|pulmonary aspiration|pulmonary aspiration
385077|NCT01495377|scintigraphy|scintigraphy
385078|NCT01495364|STEMI|stemi
385079|NCT01495325|Firefighter|firefighter
385080|NCT01495325|Woodsmoke|woodsmoke
385081|NCT01495325|Vascular function|vascular function
385082|NCT01495325|Air Pollution|air pollution
385083|NCT01495325|Endothelial function|endothelial function
385084|NCT01495325|Thrombosis|thrombosis
385085|NCT01495312|IOP fluctuations|iop fluctuations
385086|NCT01495312|during two 24-hour periods|during two 24-hour periods
385087|NCT01495299|relationship|relationship
385088|NCT01495299|IOP fluctuations|iop fluctuations
385089|NCT01495299|glaucoma|glaucoma
385090|NCT01495299|cataract surgery|cataract surgery
385091|NCT01495299|SENSIMED Triggerfish|sensimed triggerfish
385092|NCT01495286|newborn infant|newborn infant
385093|NCT01495286|acupuncture|acupuncture
385094|NCT01495286|safety|safety
385095|NCT01495286|pain|pain
385096|NCT01495260|XALD|xald
385097|NCT01495260|AMN|amn
385098|NCT01495247|Locally advanced|locally advanced
385099|NCT01495247|metastatic|metastatic
385100|NCT01495247|breast cancer|breast cancer
385101|NCT01495247|HER2 negative|her2 negative
385102|NCT01495247|PI3K pathway|pi3k pathway
385103|NCT01495247|paclitaxel|paclitaxel
385104|NCT01495247|mTOR inhibitor|mtor inhibitor
385105|NCT01495234|Spinal degeneration|spinal degeneration
385106|NCT01495195|Acetylcholine|acetylcholine
385107|NCT01495195|Cholinesterases|cholinesterases
385108|NCT01495195|Cocaine|cocaine
385109|NCT01495195|Self-Administration|self-administration
385110|NCT01495182|Dietary fiber|dietary fiber
385111|NCT01495182|Gastrointestinal toleration|gastrointestinal toleration
385112|NCT01495182|Fecal weight|fecal weight
385113|NCT01495169|Antipsychotic|antipsychotic
385114|NCT01495169|Schizophrenia|schizophrenia
385115|NCT01495169|Bipolar disorder|bipolar disorder
385116|NCT01495169|Iloperidone|iloperidone
385117|NCT01495143|Glucose|glucose
385118|NCT01495143|Lactate pyruvate ratio|lactate pyruvate ratio
385119|NCT01495143|Glycerol|glycerol
385120|NCT01495143|Paraspinal muscle|paraspinal muscle
385121|NCT01495143|Microdialysis|microdialysis
385122|NCT01495117|surgical site infection|surgical site infection
385123|NCT01495117|chlorhexidine gluconate|chlorhexidine gluconate
385124|NCT01495117|povidone iodine|povidone iodine
385125|NCT01495091|coronary artery disease|coronary artery disease
385126|NCT01495091|cardiovascular disease|cardiovascular disease
385127|NCT01495091|exercise stress testing|exercise stress testing
385128|NCT01495091|biomarkers|biomarkers
385129|NCT01495091|NT-pro-BNP|nt-pro-bnp
385130|NCT01495078|telemonitoring|telemonitoring
385131|NCT01495078|heart failure|heart failure
385132|NCT01495065|GSK2251052, healthy volunteer, safety, tolerability, pharmacokinetics, single|gsk2251052, healthy volunteer, safety, tolerability, pharmacokinetics, single
385133|NCT01495052|naked oat (Avena nuda L.)|naked oat (avena nuda l.)
385134|NCT01495052|diabetes mellitus|diabetes mellitus
385135|NCT01495052|RCT|rct
385136|NCT01495026|Healthy male subjects|healthy male subjects
385137|NCT01495026|North-East Asian ancestry|north-east asian ancestry
385138|NCT01495026|Bioequivalence|bioequivalence
385139|NCT01495026|Food effect|food effect
385140|NCT01495026|Tamsulosin hydrochloride|tamsulosin hydrochloride
385141|NCT01495026|Cross-over design|cross-over design
385142|NCT01495026|Pilot bioequivalence|pilot bioequivalence
385143|NCT01495026|Dutasteride (GI198745)|dutasteride (gi198745)
385144|NCT01495013|non-inferiority|non-inferiority
385145|NCT01495013|glimepiride|glimepiride
385146|NCT01495013|LDL cholesterol|ldl cholesterol
385147|NCT01495013|fixed dose combination|fixed dose combination
385148|NCT01495013|atorvastatin|atorvastatin
385149|NCT01495013|Diabetes Mellitus|diabetes mellitus
385150|NCT01495000|India|india
385151|NCT01495000|dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
385152|NCT01495000|bone mineral density|bone mineral density
385153|NCT01495000|denosumab|denosumab
385154|NCT01494987|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
385155|NCT01494974|Glaucoma|glaucoma
385156|NCT01494974|Pediatric|pediatric
385157|NCT01494974|Ahmed|ahmed
385158|NCT01494974|Congenital|congenital
385159|NCT01494974|FP7|fp7
385160|NCT01494974|FP8|fp8
385161|NCT01494961|Partner HIV testing|partner hiv testing
385162|NCT01494961|Couple HIV counseling|couple hiv counseling
385163|NCT01494961|Couple communication on sexual and reproductive health|couple communication on sexual and reproductive health
385164|NCT01494961|HIV incidence|hiv incidence
385165|NCT01494961|Incidence of pregnancies|incidence of pregnancies
385166|NCT01494961|Disclosure|disclosure
385167|NCT01494961|Condom use|condom use
385168|NCT01494922|Skin scarring|skin scarring
385169|NCT01494922|cicatrix|cicatrix
385170|NCT01494922|hypertrophic scar|hypertrophic scar
385171|NCT01494922|hypertrophic scar prevention|hypertrophic scar prevention
385172|NCT01494909|protein digestion|protein digestion
385173|NCT01494909|fat absorption|fat absorption
385174|NCT01494909|gut function|gut function
385175|NCT01494909|glucose absorption|glucose absorption
385176|NCT01494909|CF|cf
385177|NCT01494909|pancreatic intake|pancreatic intake
385178|NCT01494909|feeding|feeding
385179|NCT01494896|Pulmonary Hypertension|pulmonary hypertension
385180|NCT01494896|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
385181|NCT01494896|COPD|copd
385182|NCT01494896|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
385183|NCT01494896|Tyvaso|tyvaso
385184|NCT01494896|Inhaled Treprostinil Sodium|inhaled treprostinil sodium
385185|NCT01494896|Ventilation Perfusion Matching|ventilation perfusion matching
385186|NCT01494896|HO Group 1 Pulmonary Arterial Hypertension|ho group 1 pulmonary arterial hypertension
385187|NCT01494896|Concomitant Chronic Obstructive Pulmonary Disease|concomitant chronic obstructive pulmonary disease
385188|NCT01494883|Mindfulness Based Stress Reduction|mindfulness based stress reduction
385189|NCT01494883|lung cancer|lung cancer
385190|NCT01494883|psychological distress|psychological distress
385191|NCT01494883|caretakers|caretakers
385192|NCT01494870|acute coronary syndrome|acute coronary syndrome
385193|NCT01494870|percutaneous coronary intervention|percutaneous coronary intervention
385194|NCT01494870|left bundle branch block|left bundle branch block
385195|NCT01494857|Ulcerative colitis|ulcerative colitis
385196|NCT01494857|biological treatment|biological treatment
385197|NCT01494857|anti-TNF|anti-tnf
385198|NCT01494844|Patient Monitoring|patient monitoring
385199|NCT01494844|Capnography|capnography
385200|NCT01494844|Human Engineering|human engineering
385201|NCT01494818|Contact lenses|contact lenses
385202|NCT01494818|Contact lens solutions|contact lens solutions
385203|NCT01494805|Age-related Macular Degeneration|age-related macular degeneration
385204|NCT01494805|AAV|aav
385205|NCT01494805|AMD|amd
385206|NCT01494805|Wet AMD|wet amd
385207|NCT01494805|Neovascular AMD|neovascular amd
385208|NCT01494805|Gene Therapy|gene therapy
385209|NCT01494805|Ocular|ocular
385210|NCT01494805|Ocular Gene Therapy|ocular gene therapy
385211|NCT01494805|Eye diseases|eye diseases
385212|NCT01494805|Macular Degeneration|macular degeneration
385213|NCT01494805|Retinal Degeneration|retinal degeneration
385214|NCT01494805|Retinal Neovascularization|retinal neovascularization
385215|NCT01494805|Wet Macular Degeneration|wet macular degeneration
385216|NCT01494805|Retinal Diseases|retinal diseases
385217|NCT01494779|children|children
385218|NCT01494766|RLS|rls
385219|NCT01494740|H1N1|h1n1
385220|NCT01494740|Vaccine|vaccine
385221|NCT01494740|Immunogenicity|immunogenicity
385222|NCT01494740|Safety|safety
385223|NCT01494740|infants|infants
385224|NCT01494727|Safety|safety
385225|NCT01494727|Pharmacokinetics|pharmacokinetics
385226|NCT01494714|Healthy volunteers|healthy volunteers
385227|NCT01494714|JNJ 10229570-AAA|jnj 10229570-aaa
385228|NCT01494714|Skin irritation|skin irritation
385229|NCT01494714|Skin photo irritation|skin photo irritation
385230|NCT01494701|Spinal Muscular Atrophy|spinal muscular atrophy
385231|NCT01494701|SMA|sma
385232|NCT01494701|SMN|smn
385233|NCT01494701|SMNRx|smnrx
385234|NCT01494701|ISIS-SMNRx|isis-smnrx
385235|NCT01494701|ISIS-SMN Rx|isis-smn rx
385236|NCT01494701|ISIS 396443|isis 396443
385237|NCT01494701|IONIS-SMNRx|ionis-smnrx
385238|NCT01494701|IONIS-SMN Rx|ionis-smn rx
385239|NCT01494701|Spinraza|spinraza
385240|NCT01494675|procalcitonin|procalcitonin
385241|NCT01494675|duration of the antibiotic therapy|duration of the antibiotic therapy
385242|NCT01494675|sepsis|sepsis
385243|NCT01494662|HER2 Positive|her2 positive
385244|NCT01494662|BrCa|brca
385245|NCT01494649|dentinal|dentinal
385246|NCT01494649|hypersensitivity|hypersensitivity
385247|NCT01494636|Capsaicin Challenge|capsaicin challenge
385248|NCT01494636|Pharmacodynamics|pharmacodynamics
385249|NCT01494636|Safety|safety
385250|NCT01494636|Pharmacokinetics|pharmacokinetics
385251|NCT01494636|Oral GSK2339345|oral gsk2339345
385252|NCT01494636|Tolerability|tolerability
385253|NCT01494636|FTIH|ftih
385254|NCT01494636|Chronic Cough|chronic cough
385255|NCT01494623|working memory|working memory
385256|NCT01494623|schizophrenia|schizophrenia
385257|NCT01494623|cognition|cognition
385258|NCT01494623|rTMS|rtms
385259|NCT01494610|safety|safety
385260|NCT01494610|replicated cross-over design|replicated cross-over design
385261|NCT01494610|pharmacodynamics|pharmacodynamics
385262|NCT01494610|Fluticasone propionate/Salmeterol|fluticasone propionate/salmeterol
385263|NCT01494610|capsule-based inhaler|capsule-based inhaler
385264|NCT01494610|COPD|copd
385265|NCT01494610|asthma|asthma
385266|NCT01494610|multi dose dry powder inhaler|multi dose dry powder inhaler
385267|NCT01494610|bioavailability|bioavailability
385268|NCT01494610|pharmacokinetics|pharmacokinetics
385269|NCT01494597|Isavuconazole|isavuconazole
385270|NCT01494597|Cyclosporine|cyclosporine
385271|NCT01494597|Healthy Volunteers|healthy volunteers
385272|NCT01494597|BAL8557|bal8557
385273|NCT01494597|Pharmacokinetics of isavuconazole|pharmacokinetics of isavuconazole
385274|NCT01494597|Pharmacokinetics of cyclosporine|pharmacokinetics of cyclosporine
385275|NCT01494558|Overall survival|overall survival
385276|NCT01494545|DAILIES TOTAL1|dailies total1
385277|NCT01494545|Alcon|alcon
385278|NCT01494545|contact lens|contact lens
385279|NCT01494519|External ring fixation|external ring fixation
385280|NCT01494519|internal fixation|internal fixation
385281|NCT01494519|traumatic tibia fracture|traumatic tibia fracture
385282|NCT01494506|Pancreatic cancer|pancreatic cancer
385283|NCT01494506|MM-398|mm-398
385284|NCT01494506|PEP02|pep02
385285|NCT01494506|Metastatic pancreatic cancer|metastatic pancreatic cancer
385286|NCT01494506|Gemcitabine refractory pancreatic cancer|gemcitabine refractory pancreatic cancer
385287|NCT01494506|Second line pancreatic cancer treatment|second line pancreatic cancer treatment
385288|NCT01494506|Pancreatic cancer post gemcitabine therapy|pancreatic cancer post gemcitabine therapy
385289|NCT01494493|symptomatic degenerative disc disease|symptomatic degenerative disc disease
385290|NCT01494480|ALS|als
385291|NCT01494480|stem cell|stem cell
385292|NCT01494467|PPR|ppr
385293|NCT01494454|Lumbar degenerative disc disease|lumbar degenerative disc disease
385294|NCT01494441|lumbar degenerative disc disease|lumbar degenerative disc disease
385295|NCT01494428|symptomatic degenerative disc disease|symptomatic degenerative disc disease
385296|NCT01494415|Squamous Cell Lung Cancer|squamous cell lung cancer
385297|NCT01494415|radiation therapy|radiation therapy
385298|NCT01494415|chemotherapy|chemotherapy
385299|NCT01494402|Healthy volunteer, Japanese males, homo-EM|healthy volunteer, japanese males, homo-em
385300|NCT01494389|CD4+T lymphocyte subsets|cd4+t lymphocyte subsets
385301|NCT01494389|sepsis|sepsis
385302|NCT01494389|immunoparalysis|immunoparalysis
385303|NCT01494350|cutaneous leishmaniasis|cutaneous leishmaniasis
385304|NCT01494350|topical treatment|topical treatment
385305|NCT01494350|Tunisia|tunisia
385306|NCT01494337|LASER|laser
385307|NCT01494337|BPH|bph
385308|NCT01494337|Prostate surgery|prostate surgery
385309|NCT01494337|HOLEP|holep
385310|NCT01494337|Green light PVP|green light pvp
385311|NCT01494324|Liver|liver
385312|NCT01494324|Thermal Ablation|thermal ablation
385313|NCT01494324|Dynamic CT|dynamic ct
385314|NCT01494324|09-122|09-122
385315|NCT01494311|Arterial catheter|arterial catheter
385316|NCT01494311|arterial cannula|arterial cannula
385317|NCT01494311|Rapydan|rapydan
385318|NCT01494311|lidocaine/tetracaine patch|lidocaine/tetracaine patch
385319|NCT01494311|topical anaesthesia|topical anaesthesia
385320|NCT01494298|Type 2 diabetes|type 2 diabetes
385321|NCT01494298|African American|african american
385322|NCT01494298|cholesterol|cholesterol
385323|NCT01494298|lipoprotein|lipoprotein
385324|NCT01494298|apolipoprotein|apolipoprotein
385325|NCT01494285|Acne Vulgaris|acne vulgaris
385326|NCT01494285|Topical|topical
385327|NCT01494285|Foam|foam
385328|NCT01494272|caudal epidural analgesia|caudal epidural analgesia
385329|NCT01494272|elective circumcision|elective circumcision
385330|NCT01494272|elective inguinal herniorrhaphy|elective inguinal herniorrhaphy
385331|NCT01494259|immediate breast reconstruction|immediate breast reconstruction
385332|NCT01494259|pain control|pain control
385333|NCT01494259|post mastectomy pain control|post mastectomy pain control
385334|NCT01494246|Adult|adult
385335|NCT01494246|computer-assisted instruction|computer-assisted instruction
385336|NCT01494246|electronic mail|electronic mail
385337|NCT01494246|program evaluation|program evaluation
385338|NCT01494246|smoking cessation/methods|smoking cessation/methods
385339|NCT01494246|continued abstinence|continued abstinence
385340|NCT01494220|Bispectral index; anesthesia|bispectral index; anesthesia
385341|NCT01494220|liver transplantation|liver transplantation
385342|NCT01494220|independent factors|independent factors
385343|NCT01494220|outcome|outcome
385344|NCT01494220|Living donor liver transplantation|living donor liver transplantation
385345|NCT01494207|worksite|worksite
385346|NCT01494207|interventions|interventions
385347|NCT01494207|motivational interviewing|motivational interviewing
385348|NCT01494207|physical activity|physical activity
385349|NCT01494194|Mold sensitized|mold sensitized
385350|NCT01494181|obstructive sleep apnea|obstructive sleep apnea
385351|NCT01494181|vascular events|vascular events
385352|NCT01494168|Hypertension|hypertension
385353|NCT01494168|Arterial stiffness|arterial stiffness
385354|NCT01494168|Obesity|obesity
385355|NCT01494168|Bariatric surgery|bariatric surgery
385356|NCT01494155|resectable pancreatic cancer|resectable pancreatic cancer
385357|NCT01494155|pancreaticoduodenectomy|pancreaticoduodenectomy
385358|NCT01494142|Registry|registry
385359|NCT01494142|Atopic Dermatitis|atopic dermatitis
385360|NCT01494142|Eczema Herpeticum|eczema herpeticum
385361|NCT01494142|GWAS|gwas
385362|NCT01494142|Staphylococcus aureus|staphylococcus aureus
385363|NCT01494116|Pediatrics|pediatrics
385364|NCT01494116|Fluid|fluid
385365|NCT01494116|Bolus|bolus
385366|NCT01494116|Resuscitation|resuscitation
385367|NCT01494116|Shock|shock
385368|NCT01494103|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
385369|NCT01494103|Myelodysplastic syndrome|myelodysplastic syndrome
385370|NCT01494103|Acute myeloid leukemia|acute myeloid leukemia
385371|NCT01494103|Chronic myelogenous leukemia|chronic myelogenous leukemia
385372|NCT01494103|Non Hodgkin lymphoma|non hodgkin lymphoma
385373|NCT01494103|Hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
385374|NCT01494103|Familial hemophagocytic lymphohistiocytosis|familial hemophagocytic lymphohistiocytosis
385375|NCT01494103|Hemophagocytic syndrome|hemophagocytic syndrome
385376|NCT01494103|Epstein Barr virus infection|epstein barr virus infection
385377|NCT01494103|X-linked lymphoproliferative disease|x-linked lymphoproliferative disease
385378|NCT01494090|Venous thromboembolism|venous thromboembolism
385379|NCT01494090|Hip fracture|hip fracture
385380|NCT01494090|Cardiovascular events|cardiovascular events
385381|NCT01494090|Statin|statin
385382|NCT01494077|Pancreatic Cyst Fluid|pancreatic cyst fluid
385383|NCT01494077|Dilution|dilution
385384|NCT01494077|Carcinoembryonic Antigen (CEA)|carcinoembryonic antigen (cea)
385385|NCT01494051|fatty acid oxidation disorders|fatty acid oxidation disorders
385386|NCT01494025|Diabetes|diabetes
385387|NCT01494025|Pre-diabetes|pre-diabetes
385388|NCT01494025|Obese|obese
385389|NCT01493999|Clopidogrel|clopidogrel
385390|NCT01493999|prasugrel|prasugrel
385391|NCT01493999|HPR|hpr
385392|NCT01493999|loading dose|loading dose
385393|NCT01493999|maintenance dose|maintenance dose
385394|NCT01493999|stent thrombosis|stent thrombosis
385395|NCT01493999|platelet reactivity|platelet reactivity
385396|NCT01493999|Coronary intervention|coronary intervention
385397|NCT01493999|stent implantation|stent implantation
385398|NCT01493986|Ropivacaine|ropivacaine
385399|NCT01493986|Brachial plexus|brachial plexus
385400|NCT01493973|Erythropoietin|erythropoietin
385401|NCT01493973|EPO|epo
385402|NCT01493973|Friedreich|friedreich
385403|NCT01493973|Ataxia|ataxia
385404|NCT01493973|Epoetin alfa|epoetin alfa
385405|NCT01493973|VO2 max|vo2 max
385406|NCT01493973|SARA|sara
385407|NCT01493973|EQ-5D|eq-5d
385408|NCT01493973|frataxin|frataxin
385409|NCT01493960|Colitis, Ulcerative|colitis, ulcerative
385410|NCT01493960|Gastrointestinal Diseases|gastrointestinal diseases
385411|NCT01493960|Inflammatory Bowel Diseases|inflammatory bowel diseases
385412|NCT01493960|Immunomodulatory Therapy|immunomodulatory therapy
385413|NCT01493960|Glucocorticoids|glucocorticoids
385414|NCT01493960|Anti-Inflammatory Agents|anti-inflammatory agents
385415|NCT01493960|Therapeutic uses|therapeutic uses
385416|NCT01493934|metabolic syndrome|metabolic syndrome
385417|NCT01493934|type 2 diabetes mellitus|type 2 diabetes mellitus
385418|NCT01493934|insulin resistance|insulin resistance
385419|NCT01493934|Scintigraphy|scintigraphy
385420|NCT01493921|SR-T100 Clinical treatment against Actinic Keratosis|sr-t100 clinical treatment against actinic keratosis
385421|NCT01493921|Actinic keratosis skin lesion treatment with SR-T100 gel|actinic keratosis skin lesion treatment with sr-t100 gel
385422|NCT01493921|Skin lesion treatment with SR-T100 gel|skin lesion treatment with sr-t100 gel
385423|NCT01493921|SR-T100 gel treatment against skin lesion|sr-t100 gel treatment against skin lesion
385424|NCT01493921|Clinical efficacy study of SR-T100 gel|clinical efficacy study of sr-t100 gel
385425|NCT01493908|Placebo effect;|placebo effect;
385426|NCT01493908|Pain; Analgesic;|pain; analgesic;
385427|NCT01493908|Electrical shock|electrical shock
385428|NCT01493908|control in healthy volunteers|control in healthy volunteers
385429|NCT01493882|Uncontrolled Persistent Asthma, Dyspnea, Wheezing|uncontrolled persistent asthma, dyspnea, wheezing
385430|NCT01493869|Normal healthy adult subjects|normal healthy adult subjects
385431|NCT01493869|Adult subjects with hepatic impairment|adult subjects with hepatic impairment
385432|NCT01493830|neuroblastoma|neuroblastoma
385433|NCT01493804|Near Infrared Spectroscopy|near infrared spectroscopy
385434|NCT01493804|EEG|eeg
385435|NCT01493804|Brain Connectivity|brain connectivity
385436|NCT01493804|Healthy Volunteer|healthy volunteer
385437|NCT01493804|HV|hv
385438|NCT01493791|CDB-2914|cdb-2914
385439|NCT01493791|Abnormal Urine Bleeding|abnormal urine bleeding
385440|NCT01493791|Abnormal Uterine Bleeding|abnormal uterine bleeding
385441|NCT01493700|heated circuit|heated circuit
385442|NCT01493700|body temperature|body temperature
385443|NCT01493674|folate|folate
385444|NCT01493674|homocysteine|homocysteine
385445|NCT01493674|cognitive function|cognitive function
385446|NCT01493674|eating disorders|eating disorders
385447|NCT01493674|depression.|depression.
385448|NCT01493661|Sleep|sleep
385449|NCT01493661|Polysomnography|polysomnography
385450|NCT01493661|Reaction Time|reaction time
385451|NCT01493661|Sleep Deprivation|sleep deprivation
385452|NCT01493661|Psychophysiology|psychophysiology
385453|NCT01493661|Chronic sleep restriction|chronic sleep restriction
385454|NCT01493661|healthy|healthy
385455|NCT01493661|without sleep complaints|without sleep complaints
385456|NCT01493648|statins|statins
385457|NCT01493648|side effects|side effects
385458|NCT01493648|muscle|muscle
385459|NCT01493648|vitamin D|vitamin d
385460|NCT01493648|biopsy|biopsy
385461|NCT01493648|strength|strength
385462|NCT01493648|fatigue|fatigue
385463|NCT01493622|Schizophrenia minocycline cognition|schizophrenia minocycline cognition
385464|NCT01493596|Safety|safety
385465|NCT01493596|Tolerability|tolerability
385466|NCT01493583|severely obese|severely obese
385467|NCT01493583|Roux-en Y gastric bypass surgery (RYGB)|roux-en y gastric bypass surgery (rygb)
385468|NCT01493583|brain activity by fMRI|brain activity by fmri
385469|NCT01493583|visual presentation of food and non-food-related pictures|visual presentation of food and non-food-related pictures
385470|NCT01493544|COPD|copd
385471|NCT01493544|smokers|smokers
385472|NCT01493544|primary care|primary care
385473|NCT01493531|Gout|gout
385474|NCT01493518|SAFETY|safety
385475|NCT01493518|ADULT|adult
385476|NCT01493518|PSORIASIS|psoriasis
385477|NCT01493518|INFLAMMATION|inflammation
385478|NCT01493505|Primary Peritoneal Cancer|primary peritoneal cancer
385479|NCT01493492|proteomics,urinary,sepsis,prognosis|proteomics,urinary,sepsis,prognosis
385480|NCT01493466|proteomics,|proteomics,
385481|NCT01493466|serum,|serum,
385482|NCT01493466|sepsis,|sepsis,
385483|NCT01493466|potential biomarkers,|potential biomarkers,
385484|NCT01493466|dynamic changes|dynamic changes
385485|NCT01493466|normal|normal
385486|NCT01493440|atosiban|atosiban
385487|NCT01493440|clinical pregnancy|clinical pregnancy
385488|NCT01493440|implantation rate|implantation rate
385489|NCT01493440|uterine contractility|uterine contractility
385490|NCT01493440|IVF-ET|ivf-et
385491|NCT01493427|Glaucoma|glaucoma
385492|NCT01493427|OAG|oag
385493|NCT01493427|OHT|oht
385494|NCT01493414|Myelofibrosis|myelofibrosis
385495|NCT01493414|Primary myelofibrosis|primary myelofibrosis
385496|NCT01493414|PMF|pmf
385497|NCT01493414|Post polycythemia myelofibrosis|post polycythemia myelofibrosis
385498|NCT01493414|PPV MF|ppv mf
385499|NCT01493414|Post-essential thrombocythemia myelofibrosis|post-essential thrombocythemia myelofibrosis
385500|NCT01493414|PET-MF|pet-mf
385501|NCT01493414|INC424|inc424
385502|NCT01493414|Ruxolitinib|ruxolitinib
385503|NCT01493375|Contamination, hip operation, knee operation|contamination, hip operation, knee operation
385504|NCT01493362|Bulimia Nervosa|bulimia nervosa
385505|NCT01493362|PET Imaging|pet imaging
385506|NCT01493362|Dopamine|dopamine
385507|NCT01493349|Colonic diverticula|colonic diverticula
385508|NCT01493349|Diverticulitis|diverticulitis
385509|NCT01493323|Psychic pain|psychic pain
385510|NCT01493323|Social exclusion|social exclusion
385511|NCT01493323|Mood disorders|mood disorders
385512|NCT01493323|Suicide, attempted|suicide, attempted
385513|NCT01493323|Magnetic Resonance Imaging, Functional|magnetic resonance imaging, functional
385514|NCT01493323|Genetic|genetic
385515|NCT01493323|Physic pain|physic pain
385516|NCT01493297|Retinyl palmitate, beta-carotene, stable isotopes, radio isotopes|retinyl palmitate, beta-carotene, stable isotopes, radio isotopes
385517|NCT01493284|aortic stenosis|aortic stenosis
385518|NCT01493284|aortic valve stenosis|aortic valve stenosis
385519|NCT01493284|valvular heart disease|valvular heart disease
385520|NCT01493284|aortic valve replacement|aortic valve replacement
385521|NCT01493284|transcatheter aortic valve implantation|transcatheter aortic valve implantation
385522|NCT01493284|TAVI|tavi
385523|NCT01493258|Diabetes|diabetes
385524|NCT01493258|Comparative Effectiveness Research|comparative effectiveness research
385525|NCT01493258|Interactive computer-assisted education|interactive computer-assisted education
385526|NCT01493258|Informatics|informatics
385527|NCT01493245|Chronic Pain|chronic pain
385528|NCT01493245|JNS020QD|jns020qd
385529|NCT01493245|Fentanyl|fentanyl
385530|NCT01493245|Opioid analgesics|opioid analgesics
385531|NCT01493232|Lingualized occlusion|lingualized occlusion
385532|NCT01493232|Complete denture occlusion|complete denture occlusion
385533|NCT01493232|Fully bilateral balanced occlusion|fully bilateral balanced occlusion
385534|NCT01493232|Patient satisfaction of complete denture|patient satisfaction of complete denture
385535|NCT01493219|Glioblastoma|glioblastoma
385536|NCT01493219|Glioblastoma Multiforme|glioblastoma multiforme
385537|NCT01493219|Astrocytoma|astrocytoma
385538|NCT01493219|Gliosarcoma|gliosarcoma
385539|NCT01493219|Glioma WHO grade IV|glioma who grade iv
385668|NCT01492608|preterm birth|preterm birth
385540|NCT01493206|intraoperative radiotherapy|intraoperative radiotherapy
385541|NCT01493167|cast|cast
385542|NCT01493167|splint|splint
385543|NCT01493167|circumferential casting|circumferential casting
385544|NCT01493167|casting techniques|casting techniques
385545|NCT01493167|fracture in extremity|fracture in extremity
385546|NCT01493154|HPV|hpv
385547|NCT01493154|Head and Neck Cancer|head and neck cancer
385548|NCT01493154|Vaccine|vaccine
385549|NCT01493154|Immunotherapy|immunotherapy
385550|NCT01493154|Cyclophosphamide|cyclophosphamide
385551|NCT01493154|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
385552|NCT01493141|MOMHR|momhr
385553|NCT01493141|THA|tha
385554|NCT01493141|Osteoarthritis|osteoarthritis
385555|NCT01493128|atrial fibrillation|atrial fibrillation
385556|NCT01493128|atrial cells|atrial cells
385557|NCT01493128|myocardial tissue|myocardial tissue
385558|NCT01493128|t-tubules|t-tubules
385559|NCT01493128|immunofluorescence|immunofluorescence
385560|NCT01493102|septic shock|septic shock
385561|NCT01493102|norepinephrine|norepinephrine
385562|NCT01493102|vasopressin|vasopressin
385563|NCT01493102|hypotension|hypotension
385564|NCT01493076|ERCP|ercp
385565|NCT01493076|Cannulation|cannulation
385566|NCT01493076|Precut|precut
385567|NCT01493076|Mini-spincterotome|mini-spincterotome
385568|NCT01493063|preterm infant|preterm infant
385569|NCT01493050|Diabetic Nephropathy|diabetic nephropathy
385570|NCT01493050|Sevelamer Carbonate|sevelamer carbonate
385571|NCT01493037|STEMI|stemi
385572|NCT01493037|PICSO|picso
385573|NCT01493037|Coronary Sinus|coronary sinus
385574|NCT01493037|Involving Left Anterior Descending Coronary Artery|involving left anterior descending coronary artery
385575|NCT01492998|Hepatitis C virus|hepatitis c virus
385576|NCT01492998|Biliary salts|biliary salts
385577|NCT01492998|Farnesoid X receptor|farnesoid x receptor
385578|NCT01492998|Guggulsterone|guggulsterone
385579|NCT01492972|Prostate|prostate
385580|NCT01492972|proton|proton
385581|NCT01492972|radiation|radiation
385582|NCT01492972|intermediate risk|intermediate risk
385583|NCT01492946|Malnutrition|malnutrition
385584|NCT01492946|Post-operative outcome|post-operative outcome
385585|NCT01492946|Phase angle|phase angle
385586|NCT01492946|MUST|must
385587|NCT01492946|Clavien Dindo classification|clavien dindo classification
385588|NCT01492946|Bioelectrical impedance analysis|bioelectrical impedance analysis
385589|NCT01492933|Ethanol|ethanol
385590|NCT01492933|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
385591|NCT01492933|Spectroscopy|spectroscopy
385592|NCT01492933|Alcohol Use|alcohol use
385593|NCT01492907|Heterocyclic amine carcinogens|heterocyclic amine carcinogens
385594|NCT01492907|meat-borne carcinogens|meat-borne carcinogens
385595|NCT01492881|relapsed multiple myeloma|relapsed multiple myeloma
385596|NCT01492881|refractory multiple myeloma|refractory multiple myeloma
385597|NCT01492881|vorinostat|vorinostat
385598|NCT01492881|bortezomib|bortezomib
385599|NCT01492881|doxil|doxil
385600|NCT01492868|sinusitis|sinusitis
385601|NCT01492868|upper respiratory infection|upper respiratory infection
385602|NCT01492855|Meniscal lesions|meniscal lesions
385603|NCT01492855|MRI|mri
385604|NCT01492855|arthroscopic treatment|arthroscopic treatment
385813|NCT01492127|proteasome|proteasome
385605|NCT01492829|HIV prevention|hiv prevention
385606|NCT01492829|sexually transmitted infection prevention|sexually transmitted infection prevention
385607|NCT01492829|HIV knowledge|hiv knowledge
385608|NCT01492829|relationship power|relationship power
385609|NCT01492829|depression|depression
385610|NCT01492829|coping|coping
385611|NCT01492829|social support|social support
385612|NCT01492829|internally displaced persons|internally displaced persons
385613|NCT01492829|community health worker|community health worker
385614|NCT01492829|HIV/STI educational video|hiv/sti educational video
385615|NCT01492829|substance use|substance use
385616|NCT01492829|women's health|women's health
385617|NCT01492816|HIV prevention|hiv prevention
385618|NCT01492816|HIV positive communities|hiv positive communities
385619|NCT01492803|HIV infection|hiv infection
385620|NCT01492803|Probiotics|probiotics
385621|NCT01492764|Ventricular Tachyarrhythmia|ventricular tachyarrhythmia
385622|NCT01492764|Ablation|ablation
385623|NCT01492764|Electrophysiology|electrophysiology
385624|NCT01492764|Human|human
385625|NCT01492764|Mapping|mapping
385626|NCT01492751|Prostatic Neoplasms|prostatic neoplasms
385627|NCT01492751|Radiotherapy conformal|radiotherapy conformal
385628|NCT01492751|brachytherapy|brachytherapy
385629|NCT01492751|radical prostatectomy|radical prostatectomy
385630|NCT01492751|Quality of life|quality of life
385631|NCT01492751|biochemical relapse|biochemical relapse
385632|NCT01492751|biochemical failure|biochemical failure
385633|NCT01492751|survival|survival
385634|NCT01492751|Clinically localized prostate cancer|clinically localized prostate cancer
385635|NCT01492738|Acupuncture|acupuncture
385636|NCT01492738|anxiety|anxiety
385637|NCT01492738|memory|memory
385638|NCT01492712|Propofol|propofol
385639|NCT01492712|Pharmacokinetics|pharmacokinetics
385640|NCT01492712|Pharmacodynamics|pharmacodynamics
385641|NCT01492712|Infusion Pumps|infusion pumps
385642|NCT01492699|PTSD|ptsd
385643|NCT01492699|Post Traumatic Stress Disorder|post traumatic stress disorder
385644|NCT01492686|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
385645|NCT01492673|Ewing's sarcoma|ewing's sarcoma
385646|NCT01492673|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
385647|NCT01492673|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
385648|NCT01492673|TOPOTECAN|topotecan
385649|NCT01492673|11-183|11-183
385650|NCT01492673|POETIC|poetic
385651|NCT01492660|Ultrasonography|ultrasonography
385652|NCT01492660|nerve block|nerve block
385653|NCT01492660|catheters|catheters
385654|NCT01492660|needle|needle
385655|NCT01492660|anesthesia|anesthesia
385656|NCT01492647|Acne vulgaris|acne vulgaris
385657|NCT01492647|JNJ 10229570-AAA|jnj 10229570-aaa
385658|NCT01492647|Japanese patients|japanese patients
385659|NCT01492647|Topical treatment|topical treatment
385660|NCT01492634|bioimpedance|bioimpedance
385661|NCT01492634|overhydration|overhydration
385662|NCT01492634|dry weight|dry weight
385663|NCT01492621|major depression|major depression
385664|NCT01492621|DTI|dti
385665|NCT01492621|inflammatory markers|inflammatory markers
385666|NCT01492621|cognition|cognition
385667|NCT01492608|magnesium sulphate|magnesium sulphate
385669|NCT01492608|cerebral palsy|cerebral palsy
385670|NCT01492595|contact|contact
385671|NCT01492556|Recurrent|recurrent
385672|NCT01492556|Metastatic|metastatic
385673|NCT01492556|Breast cancer|breast cancer
385674|NCT01492543|Advanced|advanced
385675|NCT01492543|Metastatic|metastatic
385676|NCT01492543|Breast cancer|breast cancer
385677|NCT01492530|Men who have sex with Men and Women|men who have sex with men and women
385678|NCT01492530|HIV Prevention|hiv prevention
385679|NCT01492530|Behavioral Intervention|behavioral intervention
385680|NCT01492530|Condom use|condom use
385681|NCT01492530|African American MSMW|african american msmw
385682|NCT01492517|Controlled Human exposure study|controlled human exposure study
385683|NCT01492517|Air Pollution|air pollution
385684|NCT01492517|Gene expression|gene expression
385685|NCT01492517|Epigenetic|epigenetic
385686|NCT01492517|Cardiovascular|cardiovascular
385687|NCT01492491|SUPRA-HFR|supra-hfr
385688|NCT01492491|adsorpition|adsorpition
385689|NCT01492491|vitamins|vitamins
385690|NCT01492491|large toxins|large toxins
385691|NCT01492465|Type 2 diabetes|type 2 diabetes
385692|NCT01492452|guidelines for nursing|guidelines for nursing
385693|NCT01492452|anxiety|anxiety
385694|NCT01492452|cardiac surgery|cardiac surgery
385695|NCT01492452|pediatrics|pediatrics
385696|NCT01492439|Psychosis|psychosis
385697|NCT01492439|Psychosis NOS|psychosis nos
385698|NCT01492439|Schizophrenia|schizophrenia
385699|NCT01492439|Schizoaffective Disorder|schizoaffective disorder
385700|NCT01492439|Bipolar Disorder|bipolar disorder
385701|NCT01492426|Hepatitis C Virus|hepatitis c virus
385702|NCT01492413|Overweight|overweight
385703|NCT01492413|Obesity|obesity
385704|NCT01492387|community-acquired pneumonia|community-acquired pneumonia
385705|NCT01492387|healthcare-associated pneumonia|healthcare-associated pneumonia
385706|NCT01492387|antibiotic therapy|antibiotic therapy
385707|NCT01492387|Duration of therapy|duration of therapy
385708|NCT01492361|Coronary Artery Disease|coronary artery disease
385709|NCT01492361|Myocardial Ischemia|myocardial ischemia
385710|NCT01492361|Coronary Disease|coronary disease
385711|NCT01492361|Heart Diseases|heart diseases
385712|NCT01492361|Acute Coronary Syndrome|acute coronary syndrome
385713|NCT01492361|Cardiovascular Diseases|cardiovascular diseases
385714|NCT01492361|Arteriosclerosis|arteriosclerosis
385715|NCT01492361|Arterial Occlusive Diseases|arterial occlusive diseases
385716|NCT01492361|Vascular Diseases|vascular diseases
385717|NCT01492361|Angina Pectoris|angina pectoris
385718|NCT01492361|Chest Pain|chest pain
385719|NCT01492361|Anticholesteremic Agents|anticholesteremic agents
385720|NCT01492361|Hypolipidemic Agents|hypolipidemic agents
385721|NCT01492361|Lipid Regulating Agents|lipid regulating agents
385722|NCT01492361|hypertriglyceridemia|hypertriglyceridemia
385723|NCT01492361|omega-3 fatty acids|omega-3 fatty acids
385724|NCT01492361|statin|statin
385725|NCT01492361|triglycerides|triglycerides
385726|NCT01492361|EPA|epa
385727|NCT01492361|docosahexaenoic acid|docosahexaenoic acid
385728|NCT01492361|fish|fish
385729|NCT01492361|fatty acids|fatty acids
385730|NCT01492361|fibrates|fibrates
385731|NCT01492361|niacin|niacin
385732|NCT01492361|lipids|lipids
385733|NCT01492361|lipoprotein|lipoprotein
385734|NCT01492361|atorvastatin|atorvastatin
385735|NCT01492361|Lovaza|lovaza
385736|NCT01492361|simvastatin|simvastatin
385737|NCT01492361|lovastatin|lovastatin
385738|NCT01492361|pravastatin|pravastatin
385739|NCT01492361|fluvastatin|fluvastatin
385740|NCT01492361|rosuvastatin|rosuvastatin
385741|NCT01492361|Trilipix|trilipix
385742|NCT01492361|Vytorin|vytorin
385743|NCT01492361|Simcor|simcor
385744|NCT01492361|ezetimibe|ezetimibe
385745|NCT01492361|Zetia|zetia
385746|NCT01492361|ethyl-EPA|ethyl-epa
385747|NCT01492361|ethyl icosapentate|ethyl icosapentate
385748|NCT01492361|Crestor|crestor
385749|NCT01492361|Zocor|zocor
385750|NCT01492361|Lipitor|lipitor
385751|NCT01492361|LDL|ldl
385752|NCT01492361|HDL|hdl
385753|NCT01492361|cholesterol|cholesterol
385754|NCT01492361|dyslipidemia|dyslipidemia
385755|NCT01492361|AMR101|amr101
385756|NCT01492361|Cardiovascular Disease, Unspecified|cardiovascular disease, unspecified
385757|NCT01492361|VASCEPA|vascepa
385758|NCT01492361|icosapent ethyl|icosapent ethyl
385759|NCT01492348|collaborative care|collaborative care
385760|NCT01492348|PTSD|ptsd
385761|NCT01492348|military|military
385762|NCT01492348|Depression|depression
385763|NCT01492348|primary care|primary care
385764|NCT01492348|care management|care management
385765|NCT01492348|stepped care|stepped care
385766|NCT01492348|telehealth|telehealth
385767|NCT01492348|OIF|oif
385768|NCT01492348|OEF|oef
385769|NCT01492348|preference-based treatment|preference-based treatment
385770|NCT01492348|cost effectiveness|cost effectiveness
385771|NCT01492348|web-based treatment|web-based treatment
385772|NCT01492348|telephonic CBT|telephonic cbt
385773|NCT01492348|evidence-based treatment|evidence-based treatment
385774|NCT01492335|Cognitive decline|cognitive decline
385775|NCT01492335|Cognitive impairment|cognitive impairment
385776|NCT01492322|Smoker|smoker
385777|NCT01492322|SPECT|spect
385778|NCT01492322|Dopamine|dopamine
385779|NCT01492322|Nicotine Sated condition|nicotine sated condition
385780|NCT01492322|Nicotine withdrawal condition|nicotine withdrawal condition
385781|NCT01492309|Major Depressive Disorder|major depressive disorder
385782|NCT01492309|Pregnancy|pregnancy
385783|NCT01492309|Brain Derived Neurotrophic Factor|brain derived neurotrophic factor
385784|NCT01492309|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
385785|NCT01492283|NAFLD|nafld
385786|NCT01492283|Incretin hormones|incretin hormones
385787|NCT01492270|Prostate Cancer|prostate cancer
385788|NCT01492270|Multi parametric MRI|multi parametric mri
385789|NCT01492270|Prostate HistoScanning|prostate histoscanning
385790|NCT01492270|Transperineal prostate mapping biopsy|transperineal prostate mapping biopsy
385791|NCT01492257|shared decision making|shared decision making
385792|NCT01492257|decision aids|decision aids
385793|NCT01492257|total joint arthroplasty|total joint arthroplasty
385794|NCT01492257|osteoarthritis|osteoarthritis
385795|NCT01492244|Knee pain|knee pain
385796|NCT01492244|map|map
385797|NCT01492244|questionnaire|questionnaire
385798|NCT01492244|survey|survey
385799|NCT01492231|gastroenterology|gastroenterology
385800|NCT01492231|Endoscopy, Digestive System|endoscopy, digestive system
385801|NCT01492231|Endosonography|endosonography
385802|NCT01492231|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
385803|NCT01492231|gastrointestinal endoscopy|gastrointestinal endoscopy
385804|NCT01492192|Angiogenesis|angiogenesis
385805|NCT01492192|PET-CT|pet-ct
385806|NCT01492192|Perfusion-CT|perfusion-ct
385807|NCT01492179|Surgery: Abdominal hysterectomy|surgery: abdominal hysterectomy
385808|NCT01492179|Anesthetics: Local|anesthetics: local
385809|NCT01492179|Postoperative: Pain|postoperative: pain
385810|NCT01492179|Drugs: Morphine|drugs: morphine
385811|NCT01492127|Hepatocellular carcinoma|hepatocellular carcinoma
385812|NCT01492127|cirrhosis|cirrhosis
385814|NCT01492127|alpha-fetoprotein|alpha-fetoprotein
385815|NCT01492114|C-reactive protein|c-reactive protein
385816|NCT01492114|Resveratrol|resveratrol
385817|NCT01492114|Redox index|redox index
385818|NCT01492088|Pediatric|pediatric
385819|NCT01492088|Lymphoma|lymphoma
385820|NCT01492088|Hodgkin|hodgkin
385821|NCT01492088|Anaplastic Large-cell|anaplastic large-cell
385822|NCT01492088|Relapsed|relapsed
385823|NCT01492088|Refractory|refractory
385824|NCT01492088|Drug therapy|drug therapy
385825|NCT01492075|Postoperative pain|postoperative pain
385826|NCT01492075|Anesthetics: Local anesthetics|anesthetics: local anesthetics
385827|NCT01492075|Surgery: Hysterectomy|surgery: hysterectomy
385828|NCT01492062|Type 1 diabetes mellitus|type 1 diabetes mellitus
385829|NCT01492062|artificial pancreas|artificial pancreas
385830|NCT01492062|closed-loop|closed-loop
385831|NCT01492049|Colorectal Neoplasms|colorectal neoplasms
385832|NCT01492049|Promoting Health Literacy|promoting health literacy
385833|NCT01492049|Patient education program|patient education program
385834|NCT01492049|Colorectal Cancer Screening|colorectal cancer screening
385835|NCT01492049|CRCS|crcs
385836|NCT01492049|Patient decision aid|patient decision aid
385837|NCT01492049|PtDA|ptda
385838|NCT01492049|Video|video
385839|NCT01492049|Questionnaires|questionnaires
385840|NCT01492049|Surveys|surveys
385841|NCT01492036|Replication-Competent Retrovirus|replication-competent retrovirus
385842|NCT01492036|RCR|rcr
385843|NCT01492036|Gene transfer therapy|gene transfer therapy
385844|NCT01492036|Registry|registry
385845|NCT01492036|Medical information database|medical information database
385846|NCT01492036|Vector or vector-treated cells|vector or vector-treated cells
385847|NCT01492036|Blood draw|blood draw
385848|NCT01492036|Computed tomography|computed tomography
385849|NCT01492036|CT|ct
385850|NCT01492036|Questionnaires|questionnaires
385851|NCT01492036|Surveys|surveys
385852|NCT01492036|Gene Transfer Research|gene transfer research
385853|NCT01492036|National Gene Vector Biorepository and Coordinating Center|national gene vector biorepository and coordinating center
385854|NCT01492036|NGVB|ngvb
385855|NCT01492023|neuropsychological|neuropsychological
385856|NCT01492023|rehabilitation|rehabilitation
385857|NCT01492023|multiple sclerosis|multiple sclerosis
385858|NCT01492023|RCT study|rct study
385859|NCT01492010|skeletal muscle|skeletal muscle
385860|NCT01492010|FSR|fsr
385861|NCT01492010|resistance exercise|resistance exercise
385862|NCT01492010|leucine|leucine
385863|NCT01492010|protein|protein
385864|NCT01491958|Leukemia|leukemia
385865|NCT01491958|AML|aml
385866|NCT01491958|ALL|all
385867|NCT01491958|MDS|mds
385868|NCT01491945|Abdominal aortic aneurysm|abdominal aortic aneurysm
385869|NCT01491945|Renal stent|renal stent
385870|NCT01491945|Juxtarenal|juxtarenal
385871|NCT01491945|Pararenal|pararenal
385872|NCT01491945|Endovascular|endovascular
385873|NCT01491932|Parkinson Disease|parkinson disease
385874|NCT01491932|L-dopa|l-dopa
385875|NCT01491932|Levodopa|levodopa
385876|NCT01491932|Dyskinesia|dyskinesia
385877|NCT01491919|High Blood Pressure|high blood pressure
385878|NCT01491919|Hypertension|hypertension
385879|NCT01491919|Renal Transplantation|renal transplantation
385880|NCT01491919|Kidney Transplantation|kidney transplantation
385881|NCT01491893|GBM|gbm
385882|NCT01491893|Brain Tumor|brain tumor
385883|NCT01491893|Poliovirus Vaccine|poliovirus vaccine
385884|NCT01491893|WHO Grade IV Malignant Glioma|who grade iv malignant glioma
385885|NCT01491880|cognitive behavior therapy|cognitive behavior therapy
385886|NCT01491880|telemedicine|telemedicine
385887|NCT01491880|rural|rural
385888|NCT01491880|Latinos|latinos
385889|NCT01491880|children|children
385890|NCT01491867|intraocular pressure|intraocular pressure
385891|NCT01491854|Long-term|long-term
385892|NCT01491854|safety|safety
385893|NCT01491854|follow-up|follow-up
385894|NCT01491854|growth hormone treatment|growth hormone treatment
385895|NCT01491854|short children|short children
385896|NCT01491854|Small for Gestational Age|small for gestational age
385897|NCT01491854|Somatropin|somatropin
385898|NCT01491828|Apnea|apnea
385899|NCT01491828|Sleep apnea|sleep apnea
385900|NCT01491828|Snoring|snoring
385901|NCT01491828|Hypoglossal nerve stimulation|hypoglossal nerve stimulation
385902|NCT01491828|Laynx stimulation|laynx stimulation
385903|NCT01491802|COPD|copd
385904|NCT01491802|Combination therapy|combination therapy
385905|NCT01491802|Anticholinergic|anticholinergic
385906|NCT01491802|Beta2-agonist|beta2-agonist
385907|NCT01491802|Exercise|exercise
385908|NCT01491802|Dyspnea|dyspnea
385909|NCT01491802|Respiratory mechanics|respiratory mechanics
385910|NCT01491789|spinal cord injury|spinal cord injury
385911|NCT01491789|Virtual sailing|virtual sailing
385912|NCT01491789|Vsail|vsail
385913|NCT01491776|Group A Streptococcus|group a streptococcus
385914|NCT01491776|Strep A|strep a
385915|NCT01491776|Rapid Test|rapid test
385916|NCT01491776|Pharyngitis|pharyngitis
385917|NCT01491750|SURGERY|surgery
385918|NCT01491750|TOTAL JOINT REPLACEMENT|total joint replacement
385919|NCT01491750|TOTAL KNEE REPLACEMENT|total knee replacement
385920|NCT01491750|GUIDED IMAGERY|guided imagery
385921|NCT01491750|COMPLEMENTARY AND ALTERNATIVE THERAPY|complementary and alternative therapy
385922|NCT01491711|Superficial basal cell carcinoma|superficial basal cell carcinoma
385923|NCT01491711|Carcinoma, Basal Cell|carcinoma, basal cell
385924|NCT01491711|Skin diseases|skin diseases
385925|NCT01491711|Connective tissue diseases|connective tissue diseases
385926|NCT01491711|Treatment|treatment
385927|NCT01491711|Drug therapy|drug therapy
385928|NCT01491711|Efficacy|efficacy
385929|NCT01491711|Photodynamic therapy|photodynamic therapy
385930|NCT01491711|Photosensitizing Agents/therapeutic use|photosensitizing agents/therapeutic use
385931|NCT01491711|Aminolevulinic acid|aminolevulinic acid
385932|NCT01491711|Methylaminolevulinate|methylaminolevulinate
385933|NCT01491711|Pain measurement|pain measurement
385934|NCT01491711|Health Care Economics and Organizations|health care economics and organizations
385935|NCT01491698|stomach|stomach
385936|NCT01491698|surgery|surgery
385937|NCT01491698|Total Gastrectomy|total gastrectomy
385938|NCT01491698|Roux-En-Y Pouch Reconstruction|roux-en-y pouch reconstruction
385939|NCT01491698|Conventional Roux-En-Y Reconstruction|conventional roux-en-y reconstruction
385940|NCT01491698|Quality of Life|quality of life
385941|NCT01491698|11-170|11-170
385942|NCT01491672|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
385943|NCT01491672|Second Line|second line
385944|NCT01491672|Everolimus|everolimus
385945|NCT01491672|RAD001|rad001
385946|NCT01491646|pulmonary hypertension|pulmonary hypertension
385947|NCT01491646|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
385948|NCT01491646|Characterize and quantify RV vortex flow|characterize and quantify rv vortex flow
385949|NCT01491646|Assess feasibility of cardiac MR for RVDD diagnosis|assess feasibility of cardiac mr for rvdd diagnosis
385950|NCT01491646|Biomarker information to help diagnose|biomarker information to help diagnose
385951|NCT01491633|Lung cancer|lung cancer
385952|NCT01491633|NSCLC|nsclc
385953|NCT01491633|Stage IIIB|stage iiib
385954|NCT01491633|Stage IV|stage iv
385955|NCT01491620|poikiloderma of Civatte|poikiloderma of civatte
385956|NCT01491620|red dyschromia|red dyschromia
385957|NCT01491620|brown dyschromia|brown dyschromia
385958|NCT01491620|sun damage|sun damage
385959|NCT01491620|neck|neck
385960|NCT01491620|chest|chest
385961|NCT01491620|dyschromia|dyschromia
385962|NCT01491620|pigmentation disorders|pigmentation disorders
385963|NCT01491620|erythema|erythema
385964|NCT01491620|photosensitivity disorders|photosensitivity disorders
385965|NCT01491620|sun exposure|sun exposure
385966|NCT01491620|telangiectasia|telangiectasia
385967|NCT01491620|hyperpigmentation|hyperpigmentation
385968|NCT01491620|hypopigmentation|hypopigmentation
385969|NCT01491607|post-exposure prophylaxis|post-exposure prophylaxis
385970|NCT01491607|toxin neutralization assay|toxin neutralization assay
385971|NCT01491594|Metastatic sarcoma|metastatic sarcoma
385972|NCT01491594|Bone sarcoma|bone sarcoma
385973|NCT01491581|anthropometry|anthropometry
385974|NCT01491581|zinc|zinc
385975|NCT01491581|iodine|iodine
385976|NCT01491581|vitamin D|vitamin d
385977|NCT01491581|calcium|calcium
385978|NCT01491581|school children|school children
385979|NCT01491581|food supplement|food supplement
385980|NCT01491568|symptomatic degenerative disc disease at two levels|symptomatic degenerative disc disease at two levels
385981|NCT01491555|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
385982|NCT01491555|DMD|dmd
385983|NCT01491555|controls|controls
385984|NCT01491555|EIM|eim
385985|NCT01491555|QUS|qus
385986|NCT01491542|Symptomatic Degenerative Disc Disease|symptomatic degenerative disc disease
385987|NCT01491529|Parkinson Disease|parkinson disease
385988|NCT01491529|L-dopa|l-dopa
385989|NCT01491529|Levodopa|levodopa
385990|NCT01491529|Dyskinesia|dyskinesia
385991|NCT01491529|Amantadine|amantadine
385992|NCT01491516|Lumbar degenerative disc disease|lumbar degenerative disc disease
385993|NCT01491503|montelukast|montelukast
385994|NCT01491503|levocetirizine|levocetirizine
385995|NCT01491503|interaction|interaction
385996|NCT01491490|Schizophrenia|schizophrenia
385997|NCT01491490|Functional psychosis|functional psychosis
385998|NCT01491490|Schizophreniform|schizophreniform
385999|NCT01491490|Acute psychosis|acute psychosis
386000|NCT01491464|symptomatic degenerative disc disease|symptomatic degenerative disc disease
386001|NCT01491451|Degenerative lumbar disc disease|degenerative lumbar disc disease
386002|NCT01491425|symptomatic degenerative disc disease|symptomatic degenerative disc disease
386003|NCT01491412|Schizophrenia|schizophrenia
386004|NCT01491412|antipsychotics|antipsychotics
386005|NCT01491412|real life treatment|real life treatment
386006|NCT01491412|non-interventional|non-interventional
386007|NCT01491386|symptomatic degenerative disc disease|symptomatic degenerative disc disease
386008|NCT01491373|Degenerative Disc Disease|degenerative disc disease
386009|NCT01491373|Symptomatic Degenerative Disc Disease|symptomatic degenerative disc disease
386010|NCT01491360|Presbyopia|presbyopia
386011|NCT01491360|sclera|sclera
386012|NCT01491360|LaserACE|laserace
386013|NCT01491347|BDNF|bdnf
386014|NCT01491347|withdrawal|withdrawal
386015|NCT01491347|alcohol|alcohol
386016|NCT01491347|psychiatry|psychiatry
386017|NCT01491334|POP|pop
386018|NCT01491334|Pelvic Floor|pelvic floor
386019|NCT01491334|Pelvic Organ Prolapse|pelvic organ prolapse
386020|NCT01491321|chronic low back pain|chronic low back pain
386021|NCT01491321|bee venom acupuncture|bee venom acupuncture
386022|NCT01491295|Lamivudine|lamivudine
386023|NCT01491295|adefovir add on treatment|adefovir add on treatment
386024|NCT01491295|tenofovir|tenofovir
386025|NCT01491295|chronic hepatitis B|chronic hepatitis b
386026|NCT01491282|human brown adipose tissue activity|human brown adipose tissue activity
386027|NCT01491282|obesity|obesity
386028|NCT01491282|energy metabolism|energy metabolism
386029|NCT01491282|adaptive thermogenesis|adaptive thermogenesis
386030|NCT01491269|chronic pain|chronic pain
386031|NCT01491269|internet delivered CBT|internet delivered cbt
386032|NCT01491269|tertiary intervention|tertiary intervention
386033|NCT01491269|mindfulness|mindfulness
386034|NCT01491269|applied relaxation|applied relaxation
386035|NCT01491269|guided self help|guided self help
386036|NCT01491256|Index of microcirculatory resistance|index of microcirculatory resistance
386037|NCT01491256|atorvastatin|atorvastatin
386038|NCT01491256|drug-eluting stent|drug-eluting stent
386039|NCT01491256|acute coronary syndrome|acute coronary syndrome
386040|NCT01491243|contrast-induced nephropathy|contrast-induced nephropathy
386041|NCT01491230|cancer|cancer
386042|NCT01491230|neutrophil extracellular traps|neutrophil extracellular traps
386043|NCT01491230|autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
386044|NCT01491230|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
386045|NCT01491230|chemotaxis|chemotaxis
386046|NCT01491230|superoxide production|superoxide production
386047|NCT01491230|hydrogen peroxide production|hydrogen peroxide production
386048|NCT01491230|myeloperoxidase|myeloperoxidase
386049|NCT01491217|Oraxol®|oraxol®
386050|NCT01491217|oral paclitaxel|oral paclitaxel
386051|NCT01491217|paclitaxel|paclitaxel
386052|NCT01491217|HM30181A|hm30181a
386054|NCT01491217|DLT|dlt
386055|NCT01491217|RD|rd
386056|NCT01491191|surgical pain|surgical pain
386057|NCT01491191|chronic pain|chronic pain
386058|NCT01491191|prevention|prevention
386059|NCT01491191|palmitoylethanolamide|palmitoylethanolamide
386060|NCT01491165|umbilical cord mesenchyma stem cell|umbilical cord mesenchyma stem cell
386061|NCT01491152|Cerebral Palsy|cerebral palsy
386062|NCT01491152|Whole Body Vibration|whole body vibration
386063|NCT01491152|Infant|infant
386064|NCT01491152|Motor development|motor development
386065|NCT01491152|Physiotherapy|physiotherapy
386066|NCT01491139|Radiotherapy|radiotherapy
386067|NCT01491139|Biomarkers, pharmacological|biomarkers, pharmacological
386068|NCT01491139|Pharmacokinetics|pharmacokinetics
386069|NCT01491139|Genetic Markers|genetic markers
386070|NCT01491139|Cisplatin|cisplatin
386071|NCT01491139|Poly(ADP-ribose) Polymerases|poly(adp-ribose) polymerases
386072|NCT01491139|AZD 2281|azd 2281
386073|NCT01491139|Radiotherapy, Intensity-Modulated|radiotherapy, intensity-modulated
386074|NCT01491139|Head and Neck|head and neck
386075|NCT01491139|Chemoradiotherapy|chemoradiotherapy
386076|NCT01491139|SCC|scc
386077|NCT01491126|Gastroscopy|gastroscopy
386078|NCT01491126|Colonoscopy|colonoscopy
386079|NCT01491126|Anesthesia|anesthesia
386080|NCT01491126|Recovery|recovery
386081|NCT01491113|Levetiracetam|levetiracetam
386082|NCT01491113|Oral administration|oral administration
386083|NCT01491113|Japanese|japanese
386084|NCT01491113|Non-epileptic|non-epileptic
386085|NCT01491113|Healthy|healthy
386086|NCT01491113|Renal impaired subjects|renal impaired subjects
386087|NCT01491100|Cognition|cognition
386088|NCT01491100|Physical Activity|physical activity
386089|NCT01491100|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
386090|NCT01491087|Pentaxim®|pentaxim®
386091|NCT01491087|Whole-cell Pertussis vaccine|whole-cell pertussis vaccine
386092|NCT01491087|Acellular Pertussis vaccine|acellular pertussis vaccine
386093|NCT01491087|Haemophilus influenzae type b polysaccharide|haemophilus influenzae type b polysaccharide
386094|NCT01491087|Inactivated Polio vaccine|inactivated polio vaccine
386095|NCT01491087|Pentavac®|pentavac®
386096|NCT01491061|periprocedural myocardial infarction|periprocedural myocardial infarction
386097|NCT01491061|ranolazine|ranolazine
386098|NCT01491048|Hip osteoarthritis|hip osteoarthritis
386099|NCT01491048|Physiotherapy|physiotherapy
386100|NCT01491048|THA|tha
386101|NCT01491035|Children|children
386102|NCT01491035|Adolescents|adolescents
386103|NCT01491035|Pharmacokinetic|pharmacokinetic
386104|NCT01491035|Pharmacodynamic|pharmacodynamic
386105|NCT01491022|parkinson's|parkinson's
386106|NCT01491022|gait dysfunction|gait dysfunction
386107|NCT01491022|ampyra|ampyra
386108|NCT01491022|4-aminopyridine|4-aminopyridine
386109|NCT01491009|Dexmedetomidine|dexmedetomidine
386110|NCT01491009|midazolam|midazolam
386111|NCT01491009|remifentanil|remifentanil
386112|NCT01491009|mini-mental state examination|mini-mental state examination
386113|NCT01491009|monitored anaesthesia care|monitored anaesthesia care
386114|NCT01491009|cystoscopy|cystoscopy
386115|NCT01491009|sedation|sedation
386116|NCT01490996|Curcumin|curcumin
386117|NCT01490996|Colorectal cancer|colorectal cancer
386118|NCT01490996|metastases|metastases
386119|NCT01490996|FOLFOX|folfox
386120|NCT01490983|Chronic Myeloid Leukemia|chronic myeloid leukemia
386121|NCT01490983|Chronic Phase CML|chronic phase cml
386122|NCT01490970|Sarcoma Database|sarcoma database
386123|NCT01490957|HD|hd
386124|NCT01490957|NHL|nhl
386125|NCT01490931|acute pain|acute pain
386126|NCT01490931|dental pain|dental pain
386127|NCT01490931|intranasal ketorolac|intranasal ketorolac
386128|NCT01490931|dental implant surgery|dental implant surgery
386129|NCT01490918|Type-II diabetes mellitus|type-ii diabetes mellitus
386130|NCT01490918|Acarbose|acarbose
386131|NCT01490918|ACADEMIC|academic
386132|NCT01490905|Medical food|medical food
386133|NCT01490905|Theramine|theramine
386134|NCT01490905|Ibuprofen|ibuprofen
386135|NCT01490905|Amino acids|amino acids
386136|NCT01490905|Convenience Pack Kit|convenience pack kit
386137|NCT01490892|breast abnormality|breast abnormality
386138|NCT01490892|ultrasound imaging|ultrasound imaging
386139|NCT01490892|ultrasound contrast agent|ultrasound contrast agent
386140|NCT01490892|subharmonic imaging|subharmonic imaging
386141|NCT01490879|DFU|dfu
386142|NCT01490879|Diabetic Foot Ulcer|diabetic foot ulcer
386143|NCT01490879|Ulcers|ulcers
386144|NCT01490879|Foot Ulcers|foot ulcers
386145|NCT01490879|chronic wound|chronic wound
386146|NCT01490879|wounds|wounds
386147|NCT01490879|Nexagon|nexagon
386148|NCT01490879|CoDa|coda
386149|NCT01490866|Colorectal Cancer|colorectal cancer
386150|NCT01490866|Axitinib|axitinib
386151|NCT01490866|FOLFOX/Bevacizumab|folfox/bevacizumab
386152|NCT01490853|Ph pos CML|ph pos cml
386153|NCT01490853|Philadelphia positive Chronic Myeloid Leukemia|philadelphia positive chronic myeloid leukemia
386154|NCT01490840|Fatigue|fatigue
386155|NCT01490840|MS|ms
386156|NCT01490840|Multiple Sclerosis|multiple sclerosis
386157|NCT01490840|Exercise|exercise
386158|NCT01490840|Physical activity|physical activity
386159|NCT01490840|Physical training|physical training
386160|NCT01490840|Fingolimod|fingolimod
386161|NCT01490814|PAF|paf
386162|NCT01490814|two episodes within the last twelve months one episode documented|two episodes within the last twelve months one episode documented
386163|NCT01490814|Documented treatment failure of at least one antiarrhythmic|documented treatment failure of at least one antiarrhythmic
386164|NCT01490814|drug AAD Type I or III including β-blocker and AAD intolerance|drug aad type i or iii including β-blocker and aad intolerance
386165|NCT01490801|childhood Hodgkin lymphoma|childhood hodgkin lymphoma
386166|NCT01490801|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
386167|NCT01490801|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
386168|NCT01490801|Epstein-Barr virus infection|epstein-barr virus infection
386169|NCT01490775|Chronic Myeloid Leukemia|chronic myeloid leukemia
386170|NCT01490762|PK|pk
386171|NCT01490762|PD|pd
386172|NCT01490749|Esophageal Cancer|esophageal cancer
386173|NCT01490749|Neoplasms, Esophageal|neoplasms, esophageal
386174|NCT01490736|Acne|acne
386175|NCT01490736|Sebum gland disease|sebum gland disease
386176|NCT01490723|Leukemia|leukemia
386177|NCT01490723|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
386178|NCT01490723|Lymphoma|lymphoma
386179|NCT01490723|CD20+ lymphoid malignancies|cd20+ lymphoid malignancies
386180|NCT01490723|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
386181|NCT01490723|Allogeneic transplantation|allogeneic transplantation
386182|NCT01490723|Rituximab|rituximab
386183|NCT01490723|Rituxan|rituxan
386184|NCT01490723|In ibritumomab|in ibritumomab
386185|NCT01490723|Y ibritumomab|y ibritumomab
386186|NCT01490723|Zevalin|zevalin
386187|NCT01490723|Fludarabine Phosphate|fludarabine phosphate
386188|NCT01490723|Fludara|fludara
386189|NCT01490723|Bendamustine Hydrochloride|bendamustine hydrochloride
386190|NCT01490723|Bendamustine HCL|bendamustine hcl
386191|NCT01490723|CEP-18083|cep-18083
386192|NCT01490723|SDX-105|sdx-105
386193|NCT01490723|Treanda|treanda
386194|NCT01490723|Stem Cell Transplantation|stem cell transplantation
386195|NCT01490723|Planar Scintigraphy|planar scintigraphy
386196|NCT01490723|Spect Scan|spect scan
386197|NCT01490723|Single Photon Emission-Computed Tomography|single photon emission-computed tomography
386198|NCT01490723|CT Scan|ct scan
386199|NCT01490723|Computed Tomography|computed tomography
386200|NCT01490723|G-CSF|g-csf
386201|NCT01490723|Filgrastim|filgrastim
386202|NCT01490723|Neupogen|neupogen
386203|NCT01490723|Thymoglobulin|thymoglobulin
386204|NCT01490723|ATG|atg
386205|NCT01490723|Antithymocyte Globulin|antithymocyte globulin
386206|NCT01490723|Methotrexate|methotrexate
386207|NCT01490723|Mycophenolate|mycophenolate
386208|NCT01490723|MMF|mmf
386209|NCT01490723|Mycophenolate Mofetil|mycophenolate mofetil
386210|NCT01490723|CellCept|cellcept
386211|NCT01490723|Tacrolimus|tacrolimus
386212|NCT01490723|Prograf|prograf
386213|NCT01490710|NAVA|nava
386214|NCT01490710|Hemodynamic|hemodynamic
386215|NCT01490710|Cardiac Index|cardiac index
386216|NCT01490710|Children with admission weight > 5kg|children with admission weight > 5kg
386217|NCT01490697|stress disorders|stress disorders
386218|NCT01490697|posttraumatic|posttraumatic
386219|NCT01490697|memory|memory
386220|NCT01490697|mifepristone|mifepristone
386221|NCT01490697|d-cycloserine|d-cycloserine
386222|NCT01490697|psychophysiology|psychophysiology
386223|NCT01490684|candidiasis|candidiasis
386224|NCT01490684|critically ill|critically ill
386225|NCT01490684|outcomes|outcomes
386226|NCT01490645|ACS patients participating in a SCP|acs patients participating in a scp
386227|NCT01490645|QoL after ACS|qol after acs
386228|NCT01490645|ASC Patients's needs|asc patients's needs
386229|NCT01490632|Moderate|moderate
386230|NCT01490632|Severe|severe
386231|NCT01490632|Plaque|plaque
386232|NCT01490632|Chronic|chronic
386233|NCT01490619|Type 1 diabetes|type 1 diabetes
386234|NCT01490619|Adolescent|adolescent
386235|NCT01490619|Resilience|resilience
386236|NCT01490619|Prevention|prevention
386237|NCT01490619|Depression|depression
386238|NCT01490593|Canadian|canadian
386239|NCT01490593|Eye|eye
386240|NCT01490593|Injury|injury
386241|NCT01490593|Registry|registry
386242|NCT01490580|Pain|pain
386243|NCT01490580|Newborn|newborn
386244|NCT01490580|Anaesthesia|anaesthesia
386245|NCT01490580|opioids|opioids
386246|NCT01490580|propofol|propofol
386247|NCT01490580|neuromuscular blocker|neuromuscular blocker
386248|NCT01490580|atropine|atropine
386249|NCT01490567|Impaired Cognition Schizophrenia|impaired cognition schizophrenia
386250|NCT01490554|Skin aging|skin aging
386251|NCT01490554|fibroblasts|fibroblasts
386252|NCT01490554|transplantation|transplantation
386253|NCT01490554|autologous|autologous
386254|NCT01490541|Gastric intestinal metaplasia|gastric intestinal metaplasia
386255|NCT01490528|Pediatric IBD|pediatric ibd
386256|NCT01490515|non-invasive,|non-invasive,
386257|NCT01490515|metabolomics,|metabolomics,
386258|NCT01490515|morphology,|morphology,
386259|NCT01490515|embryo selection,|embryo selection,
386260|NCT01490515|implantation rates|implantation rates
386261|NCT01490489|EG-VEGF|eg-vegf
386262|NCT01490489|Endocrine Gland-derived Vascular Endothelial Growth Factor|endocrine gland-derived vascular endothelial growth factor
386263|NCT01490489|Pre-eclampsia|pre-eclampsia
386264|NCT01490489|intra-uterine growth retardation|intra-uterine growth retardation
386265|NCT01490489|prognosis|prognosis
386266|NCT01490476|Neurofibromatosis Type 2 with Vestibular Schwannoma|neurofibromatosis type 2 with vestibular schwannoma
386267|NCT01490476|Vestibular Schwannoma|vestibular schwannoma
386268|NCT01490476|Peripheral Nervous System Diseases|peripheral nervous system diseases
386269|NCT01490476|Otorhinolaryngologic Diseases|otorhinolaryngologic diseases
386270|NCT01490476|Vestibulocochlear Nerve Diseases|vestibulocochlear nerve diseases
386271|NCT01490463|Treatment of|treatment of
386272|NCT01490437|Advanced urothelial carcinoma|advanced urothelial carcinoma
386273|NCT01490424|TREM-1;|trem-1;
386274|NCT01490424|SNPs;|snps;
386275|NCT01490424|prognosis|prognosis
386276|NCT01490424|control（normal person）|control（normal person）
386277|NCT01490411|Specific immunotherapy|specific immunotherapy
386278|NCT01490411|SIT|sit
386279|NCT01490411|SCIT|scit
386280|NCT01490411|recombinant|recombinant
386281|NCT01490398|Hypertension|hypertension
386282|NCT01490398|Rosuvastatin|rosuvastatin
386283|NCT01490398|Coronary flow reserve|coronary flow reserve
386284|NCT01490359|human immunodeficiency virus|human immunodeficiency virus
386285|NCT01490359|randomized controlled trial|randomized controlled trial
386286|NCT01490359|intervention studies|intervention studies
386287|NCT01490359|South Africa|south africa
386288|NCT01490359|men|men
386289|NCT01490359|sexually behavior|sexually behavior
386290|NCT01490359|social cognitive theory|social cognitive theory
386291|NCT01490346|HIV 1|hiv 1
386292|NCT01490346|Pharmacokinetics|pharmacokinetics
386293|NCT01490346|Drug levels|drug levels
386294|NCT01490346|Treatment naive|treatment naive
386295|NCT01490320|Violence prevention|violence prevention
386296|NCT01490320|Media|media
386297|NCT01490320|Primary care|primary care
386298|NCT01490320|Parenting|parenting
386299|NCT01490307|parenting intervention|parenting intervention
386300|NCT01490307|Family Check-Up|family check-up
386301|NCT01490307|Anxiety Disorders|anxiety disorders
386302|NCT01490307|Depression|depression
386303|NCT01490307|Depressive Disorder|depressive disorder
386304|NCT01490307|Conduct Disorder|conduct disorder
386305|NCT01490307|Mental Disorders|mental disorders
386306|NCT01490307|Behavioral Symptoms|behavioral symptoms
386307|NCT01490307|Mood Disorders|mood disorders
386308|NCT01490307|Mental Disorders Diagnosed in Childhood|mental disorders diagnosed in childhood
386309|NCT01490307|Substance-Related Disorders|substance-related disorders
386310|NCT01490294|Cardiac MRI|cardiac mri
386311|NCT01490294|gadobutrol|gadobutrol
386312|NCT01490281|Fibromyalgia|fibromyalgia
386313|NCT01490281|exercise|exercise
386314|NCT01490281|physical activity|physical activity
386315|NCT01490281|pain|pain
386316|NCT01490268|Pharmacokinetic-pharmacodynamic modeling|pharmacokinetic-pharmacodynamic modeling
386317|NCT01490268|Patient-controlled analgesia|patient-controlled analgesia
386621|NCT01488903|obesity|obesity
386318|NCT01490268|Target-controlled infusion|target-controlled infusion
386319|NCT01490268|Hydromorphone|hydromorphone
386320|NCT01490268|Sufentanil|sufentanil
386321|NCT01490268|after thoracotomy|after thoracotomy
386322|NCT01490268|cardiac surgery|cardiac surgery
386323|NCT01490255|platelet reactivity|platelet reactivity
386324|NCT01490255|aspirin|aspirin
386325|NCT01490255|clopidogrel|clopidogrel
386326|NCT01490229|nutraceuticals|nutraceuticals
386327|NCT01490229|statin|statin
386328|NCT01490216|cocaine|cocaine
386329|NCT01490216|lisdexamfetamine|lisdexamfetamine
386330|NCT01490216|vyvanse|vyvanse
386331|NCT01490203|Gd-EOB-DTPA|gd-eob-dtpa
386332|NCT01490203|MRI|mri
386333|NCT01490203|Hepatectomy|hepatectomy
386334|NCT01490203|Hepatocellular Carcinoma|hepatocellular carcinoma
386335|NCT01490203|Liver Function Tests|liver function tests
386336|NCT01490177|Multiple food allergies|multiple food allergies
386337|NCT01490151|Hormone|hormone
386338|NCT01490151|Diabetes|diabetes
386339|NCT01490151|Mellitus|mellitus
386340|NCT01490151|Type 1|type 1
386341|NCT01490151|Immune|immune
386342|NCT01490151|Metabolic disorder|metabolic disorder
386343|NCT01490138|β-D-Glucan test|β-d-glucan test
386344|NCT01490138|IFI|ifi
386345|NCT01490125|COPD|copd
386346|NCT01490125|Dyspnea|dyspnea
386347|NCT01490125|QVA149|qva149
386348|NCT01490125|tiotropium|tiotropium
386349|NCT01490073|Intrauterine device|intrauterine device
386350|NCT01490073|Pain|pain
386351|NCT01490073|Contraception|contraception
386352|NCT01490073|Nitroglycerin|nitroglycerin
386353|NCT01490073|Nitric oxide donor|nitric oxide donor
386354|NCT01490073|Intrauterine device insertion|intrauterine device insertion
386355|NCT01490060|cancer|cancer
386356|NCT01490060|fosaprepitant|fosaprepitant
386357|NCT01490060|Ifosfamide-based Multi-day Chemotherapy|ifosfamide-based multi-day chemotherapy
386358|NCT01490060|Chemotherapy-induced nausea and vomiting|chemotherapy-induced nausea and vomiting
386359|NCT01490060|CINV|cinv
386360|NCT01490060|multi-day chemotherapy regimens|multi-day chemotherapy regimens
386361|NCT01490060|antiemetics|antiemetics
386362|NCT01490060|adverse effect|adverse effect
386363|NCT01490060|doxorubicin plus ifosfamide|doxorubicin plus ifosfamide
386364|NCT01490060|AI|ai
386365|NCT01490060|AI and vincristine|ai and vincristine
386366|NCT01490060|VAI|vai
386367|NCT01490060|aprepitant|aprepitant
386368|NCT01490060|prevention|prevention
386369|NCT01490060|nausea|nausea
386370|NCT01490060|vomiting|vomiting
386371|NCT01490060|emetogenic chemotherapy|emetogenic chemotherapy
386372|NCT01490034|obesity|obesity
386373|NCT01490034|energy intake|energy intake
386374|NCT01490034|appetite|appetite
386375|NCT01490034|food form|food form
386376|NCT01490034|beverage|beverage
386377|NCT01490034|learning|learning
386378|NCT01490034|dietary compensation|dietary compensation
386379|NCT01490021|Healthy young men|healthy young men
386380|NCT01489995|Food effect|food effect
386381|NCT01489995|GR181413A|gr181413a
386382|NCT01489995|AT1001|at1001
386383|NCT01489995|migalastat hydrochloride|migalastat hydrochloride
386384|NCT01489995|Lysosomal storage disorders|lysosomal storage disorders
386385|NCT01489995|Pharmacokinetics|pharmacokinetics
386386|NCT01489982|Parkinson's disease|parkinson's disease
386387|NCT01489982|insomnia|insomnia
386388|NCT01489969|sleep latency|sleep latency
386389|NCT01489969|Sleep maintenance|sleep maintenance
386390|NCT01489969|Sleep fragmentation|sleep fragmentation
386391|NCT01489969|Polysomnography|polysomnography
386392|NCT01489956|Keyhole Limpet Hemocyanin (KLH)|keyhole limpet hemocyanin (klh)
386393|NCT01489956|Immucothel|immucothel
386394|NCT01489956|Native KLH|native klh
386395|NCT01489956|Healthy volunteers|healthy volunteers
386396|NCT01489956|Oral tolerance|oral tolerance
386397|NCT01489956|Immunogenicity|immunogenicity
386398|NCT01489956|Autoimmune diseases|autoimmune diseases
386399|NCT01489930|Exercise|exercise
386400|NCT01489930|Aging|aging
386401|NCT01489930|Sarcopenia|sarcopenia
386402|NCT01489930|Mitochondria|mitochondria
386403|NCT01489917|radial artery occlusion|radial artery occlusion
386404|NCT01489917|hemostasis|hemostasis
386405|NCT01489917|coronary intervention|coronary intervention
386406|NCT01489917|radial approach|radial approach
386407|NCT01489904|drooling|drooling
386408|NCT01489904|cerebral palsy|cerebral palsy
386409|NCT01489891|Esophagogastroduodenoscopy|esophagogastroduodenoscopy
386410|NCT01489891|Lidocaine|lidocaine
386411|NCT01489891|Propofol|propofol
386412|NCT01489878|Coagulase-negative staphylococci|coagulase-negative staphylococci
386413|NCT01489878|Staphylococcus epidermidis|staphylococcus epidermidis
386414|NCT01489878|Staphylococcus aureus|staphylococcus aureus
386415|NCT01489878|Anti-bacterial agents|anti-bacterial agents
386416|NCT01489878|Drug resistance, Microbial|drug resistance, microbial
386417|NCT01489878|Methicillin resistance|methicillin resistance
386418|NCT01489878|Β-lactams|β-lactams
386419|NCT01489878|Fluoroquinolones|fluoroquinolones
386420|NCT01489878|Macrolides|macrolides
386421|NCT01489878|Synergistin|synergistin
386422|NCT01489878|General practitioners|general practitioners
386916|NCT01487785|gemcitabine|gemcitabine
386423|NCT01489878|Antibiotic selection pressure|antibiotic selection pressure
386424|NCT01489878|Ambulatory antibiotherapy|ambulatory antibiotherapy
386425|NCT01489878|Community patients|community patients
386426|NCT01489865|Pancreas cancer|pancreas cancer
386427|NCT01489865|Veliparib|veliparib
386428|NCT01489865|oxaliplatin|oxaliplatin
386429|NCT01489852|Assisted reproductive treatment|assisted reproductive treatment
386430|NCT01489852|GnRH antagonist|gnrh antagonist
386431|NCT01489852|Estrogen pre-treatment|estrogen pre-treatment
386432|NCT01489852|Ovarian stimulation|ovarian stimulation
386433|NCT01489839|periodontal disease|periodontal disease
386434|NCT01489839|biomarkers|biomarkers
386435|NCT01489839|periodontal treatment|periodontal treatment
386436|NCT01489839|clinical attachment level|clinical attachment level
386437|NCT01489826|Cancer|cancer
386438|NCT01489800|feeding|feeding
386439|NCT01489800|complications|complications
386440|NCT01489800|radical cystectomy|radical cystectomy
386441|NCT01489787|Surgery|surgery
386442|NCT01489787|Ultrasonic therapy|ultrasonic therapy
386443|NCT01489787|Liver|liver
386444|NCT01489761|long lesions|long lesions
386445|NCT01489761|drug eluting stents|drug eluting stents
386446|NCT01489735|GERD|gerd
386447|NCT01489735|GERD Q QUESTIONNAIRE|gerd q questionnaire
386448|NCT01489722|Leukemia|leukemia
386449|NCT01489722|AML|aml
386450|NCT01489722|AZD1208|azd1208
386451|NCT01489709|overactive bladder|overactive bladder
386452|NCT01489709|solifenacin|solifenacin
386453|NCT01489709|Overactive bladder questionnaire|overactive bladder questionnaire
386454|NCT01489709|Overactive Bladder Symptom Score|overactive bladder symptom score
386455|NCT01489709|satisfaction score|satisfaction score
386456|NCT01489696|Pharmacokinetics|pharmacokinetics
386457|NCT01489696|Mirabegron|mirabegron
386458|NCT01489696|Tamsulosin|tamsulosin
386459|NCT01489696|Phase 1|phase 1
386460|NCT01489683|intubating conditions|intubating conditions
386461|NCT01489683|propofol|propofol
386462|NCT01489683|remifentanil|remifentanil
386463|NCT01489683|topical lidocaine|topical lidocaine
386464|NCT01489657|Obesity|obesity
386465|NCT01489657|Bariatric Surgery|bariatric surgery
386466|NCT01489657|Sleeve Gastrectomy|sleeve gastrectomy
386467|NCT01489657|Metabolite Profiling|metabolite profiling
386468|NCT01489631|Epidural|epidural
386469|NCT01489631|Local infiltration|local infiltration
386470|NCT01489631|Knee|knee
386471|NCT01489631|Arthroplasty|arthroplasty
386472|NCT01489618|Common variable immunodeficiency|common variable immunodeficiency
386473|NCT01489618|pneumococcal vaccine|pneumococcal vaccine
386474|NCT01489618|prime boost|prime boost
386475|NCT01489605|Orotracheal intubation, videolaryngoscopy|orotracheal intubation, videolaryngoscopy
386476|NCT01489566|Hepatocellular,Carcinoma,recurrence|hepatocellular,carcinoma,recurrence
386477|NCT01489553|Egg hypersensitivity|egg hypersensitivity
386478|NCT01489553|egg allergy|egg allergy
386479|NCT01489553|egg protein allergy|egg protein allergy
386480|NCT01489540|Burn|burn
386481|NCT01489540|Depth|depth
386482|NCT01489540|Diagnosis|diagnosis
386483|NCT01489540|Laser Doppler Imaging|laser doppler imaging
386484|NCT01489527|Vaccine|vaccine
386485|NCT01489527|Placebo|placebo
386486|NCT01489527|sexually transmitted infection (STI)|sexually transmitted infection (sti)
386487|NCT01489527|HIV|hiv
386488|NCT01489527|Human Immunodeficiency|human immunodeficiency
386489|NCT01489527|Gardasil|gardasil
386490|NCT01489527|HPV|hpv
386491|NCT01489527|human papillomavirus|human papillomavirus
386492|NCT01489514|peanut allergy|peanut allergy
386493|NCT01489514|hypoallergenic peanut extracts|hypoallergenic peanut extracts
386494|NCT01489514|epicutaneous skin prick testing|epicutaneous skin prick testing
386495|NCT01489501|Caomecs, Transplantation, Limbal stem cell deficiency,|caomecs, transplantation, limbal stem cell deficiency,
386496|NCT01489488|Relative bioavailability study|relative bioavailability study
386497|NCT01489475|children|children
386498|NCT01489475|congenital heart defects|congenital heart defects
386499|NCT01489475|cardiopulmonary bypass|cardiopulmonary bypass
386500|NCT01489475|modified ultrafiltration|modified ultrafiltration
386501|NCT01489475|angiopoietins|angiopoietins
386502|NCT01489475|cytokines|cytokines
386503|NCT01489462|Arthritis|arthritis
386504|NCT01489462|Osteoarthritis|osteoarthritis
386505|NCT01489462|Strength Training|strength training
386506|NCT01489449|drug coated balloon|drug coated balloon
386507|NCT01489449|NSTEMI|nstemi
386508|NCT01489436|gallstone disease|gallstone disease
386509|NCT01489436|cholecystectomy|cholecystectomy
386510|NCT01489436|minimally invasive|minimally invasive
386511|NCT01489436|surgical|surgical
386512|NCT01489436|laparoscopic|laparoscopic
386513|NCT01489436|single port|single port
386514|NCT01489436|cytokine|cytokine
386515|NCT01489423|stage IIIC melanoma|stage iiic melanoma
386516|NCT01489423|stage IV melanoma|stage iv melanoma
386517|NCT01489423|recurrent melanoma|recurrent melanoma
386518|NCT01489397|Confocol laser endomicroscopy|confocol laser endomicroscopy
386519|NCT01489397|Feasibility of Confocol laser endomicroscopy|feasibility of confocol laser endomicroscopy
386520|NCT01489384|Rheumatoid arthritis|rheumatoid arthritis
386521|NCT01489384|DAS28|das28
386522|NCT01489358|Vaccine-Mediated Protection|vaccine-mediated protection
386523|NCT01489358|Antibody Response|antibody response
386524|NCT01489358|Chikungunya Virus|chikungunya virus
386525|NCT01489358|Immune Response|immune response
386526|NCT01489358|Healthy Volunteer|healthy volunteer
386527|NCT01489358|Humoral Inmunity|humoral inmunity
386528|NCT01489358|Virus-like Particles|virus-like particles
386529|NCT01489345|ONO-2952|ono-2952
386530|NCT01489345|Healthy adult subjects|healthy adult subjects
386531|NCT01489345|Multiple dose|multiple dose
386532|NCT01489345|Safety|safety
386533|NCT01489345|Tolerability|tolerability
386534|NCT01489345|Pharmacokinetics|pharmacokinetics
386535|NCT01489332|rectal cancer|rectal cancer
386536|NCT01489332|capecitabine|capecitabine
386537|NCT01489332|radiotherapy|radiotherapy
386538|NCT01489332|locally advanced rectal cancer|locally advanced rectal cancer
386539|NCT01489319|inflammation|inflammation
386540|NCT01489319|body composition|body composition
386541|NCT01489319|hyperandrogenism|hyperandrogenism
386542|NCT01489319|insulin resistance|insulin resistance
386543|NCT01489306|Respiratory Syncytial Virus Infection|respiratory syncytial virus infection
386544|NCT01489306|RSV|rsv
386545|NCT01489280|Temple Touch Pro|temple touch pro
386546|NCT01489280|Medisim|medisim
386547|NCT01489280|temperature|temperature
386548|NCT01489280|surgery|surgery
386549|NCT01489267|cerebellar ataxia|cerebellar ataxia
386550|NCT01489267|hereditary disease|hereditary disease
386551|NCT01489267|stem cell|stem cell
386552|NCT01489254|Multiple Sclerosis,|multiple sclerosis,
386553|NCT01489254|Relapsing-Remitting Multiple Sclerosis,|relapsing-remitting multiple sclerosis,
386554|NCT01489254|glatiramer acetate,|glatiramer acetate,
386555|NCT01489254|MRI,|mri,
386556|NCT01489254|lesions,|lesions,
386557|NCT01489254|MS relapse rate,|ms relapse rate,
386558|NCT01489254|Copaxone|copaxone
386559|NCT01489241|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
386560|NCT01489241|Telemedicine|telemedicine
386561|NCT01489228|Chagas Disease|chagas disease
386562|NCT01489202|drug-eluting stent|drug-eluting stent
386563|NCT01489202|percutaneous coronary intervention|percutaneous coronary intervention
386564|NCT01489176|Stress Echocardiography|stress echocardiography
386565|NCT01489176|Real-Time Perfusion Imaging|real-time perfusion imaging
386566|NCT01489176|Regadenoson|regadenoson
386567|NCT01489176|Optison|optison
386568|NCT01489163|Gestational Diabetes|gestational diabetes
386569|NCT01489163|Weight Loss|weight loss
386570|NCT01489163|Physical Activity|physical activity
386571|NCT01489163|Pregnancy|pregnancy
386572|NCT01489163|Postpartum|postpartum
386573|NCT01489163|Intervention|intervention
386574|NCT01489150|Acute respiratory failure|acute respiratory failure
386575|NCT01489150|Hypercapnia|hypercapnia
386576|NCT01489150|Non invasive ventilation|non invasive ventilation
386577|NCT01489150|End-tidal CO2|end-tidal co2
386578|NCT01489124|Infection|infection
386579|NCT01489124|Imipenem|imipenem
386580|NCT01489124|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
386581|NCT01489124|pharmacokinetic|pharmacokinetic
386582|NCT01489124|pharmacodynamic|pharmacodynamic
386583|NCT01489098|Body composition|body composition
386584|NCT01489098|Protein Metabolism|protein metabolism
386585|NCT01489085|ventilation|ventilation
386586|NCT01489085|automated|automated
386587|NCT01489033|Allergic rhinitis|allergic rhinitis
386588|NCT01489033|Phleum pratense|phleum pratense
386589|NCT01489033|Timothy grass pollen allergy|timothy grass pollen allergy
386590|NCT01489033|subcutaneous immunotherapy|subcutaneous immunotherapy
386591|NCT01489020|Allergy|allergy
386592|NCT01489020|Immunotherapy|immunotherapy
386593|NCT01489020|Allergic Rhinoconjunctivitis|allergic rhinoconjunctivitis
386594|NCT01489020|D. pteronyssinus|d. pteronyssinus
386595|NCT01489020|house dust allergy|house dust allergy
386596|NCT01489007|vegetarian|vegetarian
386597|NCT01489007|children|children
386598|NCT01489007|iron|iron
386599|NCT01489007|iron absorption|iron absorption
386600|NCT01488981|Radio Frequency Microstimulator|radio frequency microstimulator
386601|NCT01488981|Traumatic Brain Injury|traumatic brain injury
386602|NCT01488981|TBI|tbi
386603|NCT01488981|Arm Rehabilitation|arm rehabilitation
386604|NCT01488981|electrical stimulation|electrical stimulation
386605|NCT01488981|FES|fes
386606|NCT01488968|high risk prostate cancer|high risk prostate cancer
386607|NCT01488968|hypofractionated radiation treatment|hypofractionated radiation treatment
386608|NCT01488968|higher biological doses|higher biological doses
386609|NCT01488968|acceptable rectal toxicity|acceptable rectal toxicity
386610|NCT01488968|Radiation Treatment|radiation treatment
386611|NCT01488955|bacterial infection|bacterial infection
386612|NCT01488942|HIV|hiv
386613|NCT01488942|reinforcement|reinforcement
386614|NCT01488942|medication adherence|medication adherence
386615|NCT01488942|patient compliance|patient compliance
386616|NCT01488942|antiretroviral therapy, highly active|antiretroviral therapy, highly active
386617|NCT01488916|Vitamin D|vitamin d
386618|NCT01488916|Postprandial Glucose|postprandial glucose
386619|NCT01488916|Type 2 Diabetes|type 2 diabetes
386620|NCT01488903|genetic susceptibility|genetic susceptibility
386622|NCT01488903|body composition|body composition
386623|NCT01488903|the metabolic syndrome|the metabolic syndrome
386624|NCT01488903|women|women
386625|NCT01488890|Dengue fever|dengue fever
386626|NCT01488890|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
386627|NCT01488890|CYD dengue vaccine|cyd dengue vaccine
386628|NCT01488890|Yellow Fever|yellow fever
386629|NCT01488890|Flavivirus|flavivirus
386630|NCT01488877|Type 2 diabetes mellitus. albuminuria.|type 2 diabetes mellitus. albuminuria.
386631|NCT01488864|Hot flashes|hot flashes
386632|NCT01488864|Vasomotor symptoms|vasomotor symptoms
386633|NCT01488864|Menopause|menopause
386634|NCT01488864|Applied Relaxation|applied relaxation
386635|NCT01488864|Health Related Quality of Life|health related quality of life
386636|NCT01488864|Salivary cortisol|salivary cortisol
386637|NCT01488851|Osteo necrosis of the Jaw|osteo necrosis of the jaw
386638|NCT01488812|Hip-fracture|hip-fracture
386639|NCT01488799|Anxiety|anxiety
386640|NCT01488799|Generalized Anxiety Disorder|generalized anxiety disorder
386641|NCT01488799|Motivational Interviewing|motivational interviewing
386642|NCT01488799|Cognitive Behavioural Therapy|cognitive behavioural therapy
386643|NCT01488799|Psychotherapy|psychotherapy
386644|NCT01488786|Assistive Technology|assistive technology
386645|NCT01488786|Non-Surgical Visual Prosthetic|non-surgical visual prosthetic
386646|NCT01488786|Sensory Substitution|sensory substitution
386647|NCT01488773|asthma|asthma
386648|NCT01488773|asthma control|asthma control
386649|NCT01488773|inhaled glucocorticosteroid|inhaled glucocorticosteroid
386650|NCT01488773|ICS|ics
386651|NCT01488773|leukotriene antagonist|leukotriene antagonist
386652|NCT01488773|LTRA|ltra
386653|NCT01488773|montelukast|montelukast
386654|NCT01488773|fluticasone|fluticasone
386655|NCT01488773|salmeterol|salmeterol
386656|NCT01488773|observational study|observational study
386657|NCT01488773|repeated measures|repeated measures
386658|NCT01488773|retrospective|retrospective
386659|NCT01488747|Omega-3 fatty acids|omega-3 fatty acids
386660|NCT01488747|Phospholipid fatty acids|phospholipid fatty acids
386661|NCT01488747|chymlomicron fatty acids|chymlomicron fatty acids
386662|NCT01488747|Bioavailability fo fish oil supplements in healthy adults|bioavailability fo fish oil supplements in healthy adults
386663|NCT01488734|Vitamin D|vitamin d
386664|NCT01488734|Mushroom|mushroom
386665|NCT01488734|Cholecalciferol|cholecalciferol
386666|NCT01488734|Prediabetes|prediabetes
386667|NCT01488734|Metabolic Syndrome|metabolic syndrome
386668|NCT01488708|Lupus|lupus
386669|NCT01488708|SLE|sle
386670|NCT01488708|Systemic Lupus Erythematosus|systemic lupus erythematosus
386671|NCT01488708|Immune System Disease|immune system disease
386672|NCT01488695|intubation|intubation
386673|NCT01488695|double lumen tube|double lumen tube
386674|NCT01488682|Head and neck cancer|head and neck cancer
386675|NCT01488682|Neck dissection|neck dissection
386676|NCT01488682|Harmonic scalpel|harmonic scalpel
386677|NCT01488669|head and neck neoplasms|head and neck neoplasms
386678|NCT01488669|neck dissection|neck dissection
386679|NCT01488669|robotics|robotics
386680|NCT01488656|Antioxidants|antioxidants
386681|NCT01488656|Dietary supplements|dietary supplements
386682|NCT01488656|Forced vital lung capacity|forced vital lung capacity
386683|NCT01488656|Exhaled nitric oxide|exhaled nitric oxide
386684|NCT01488656|Air pollution|air pollution
386685|NCT01488643|Bronchospasm|bronchospasm
386686|NCT01488643|Laparoscopic Gastrectomy|laparoscopic gastrectomy
386687|NCT01488643|Obesity|obesity
386688|NCT01488630|substance abuse|substance abuse
386689|NCT01488630|alcohol|alcohol
386690|NCT01488630|drug|drug
386691|NCT01488630|smoking|smoking
386692|NCT01488630|HIV screening|hiv screening
386693|NCT01488617|Surgery|surgery
386694|NCT01488617|Psychosocial Factors|psychosocial factors
386695|NCT01488617|Psychological Distress|psychological distress
386696|NCT01488617|Outcome Assessment (Health Care)|outcome assessment (health care)
386697|NCT01488578|Overactive Bladder|overactive bladder
386698|NCT01488578|Japanese|japanese
386699|NCT01488578|Tolterodine|tolterodine
386700|NCT01488578|Detrusitol|detrusitol
386701|NCT01488578|Detrol|detrol
386702|NCT01488578|Postmarketing commitment plan.|postmarketing commitment plan.
386703|NCT01488552|pancreatic cancer|pancreatic cancer
386704|NCT01488552|pancreatic adenocarcinoma|pancreatic adenocarcinoma
386705|NCT01488552|Stage IV pancreatic cancer|stage iv pancreatic cancer
386706|NCT01488552|pancreas|pancreas
386707|NCT01488552|pancreatic|pancreatic
386708|NCT01488539|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
386709|NCT01488539|PTSD|ptsd
386710|NCT01488539|Adult Survivors of Child Abuse|adult survivors of child abuse
386711|NCT01488539|Women|women
386712|NCT01488539|Interpersonal violence|interpersonal violence
386713|NCT01488539|psychological trauma|psychological trauma
386714|NCT01488526|Hepatitis B|hepatitis b
386715|NCT01488526|Vertical transmission|vertical transmission
386716|NCT01488526|Pregnancy|pregnancy
386717|NCT01488526|Antiviral treatment|antiviral treatment
386718|NCT01488513|ABC294640|abc294640
386719|NCT01488513|RedHill Biopharma, Ltd.|redhill biopharma, ltd.
386720|NCT01488513|ABC-101|abc-101
386721|NCT01488513|Medical University of South Carolina|medical university of south carolina
386722|NCT01488513|Apogee Biotechnology Corporation|apogee biotechnology corporation
386723|NCT01488500|Wood smoke|wood smoke
386724|NCT01488500|inflammation|inflammation
386725|NCT01488500|lung function|lung function
386726|NCT01488500|arterial stiffness|arterial stiffness
386727|NCT01488500|heart rate variability|heart rate variability
386728|NCT01488500|Respiratory and systemic inflammation following exposure to woodsmoke in healthy volunteers|respiratory and systemic inflammation following exposure to woodsmoke in healthy volunteers
386729|NCT01488487|HCC|hcc
386730|NCT01488487|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
386731|NCT01488487|Metastatic Hepatocellular Carcinoma|metastatic hepatocellular carcinoma
386732|NCT01488487|Liver Cancer|liver cancer
386733|NCT01488474|regional anesthesia|regional anesthesia
386734|NCT01488474|peripheral nerve stimulation|peripheral nerve stimulation
386735|NCT01488474|diabetes|diabetes
386736|NCT01488474|diabetic neuropathy|diabetic neuropathy
386737|NCT01488461|Congenital cerebellar ataxias|congenital cerebellar ataxias
386738|NCT01488461|Genetics|genetics
386739|NCT01488461|Gene ATCAY|gene atcay
386740|NCT01488461|Gene ABC7|gene abc7
386741|NCT01488461|Cerebellar atrophy|cerebellar atrophy
386742|NCT01488448|Hypertonic saline|hypertonic saline
386743|NCT01488448|Bronchiolitis|bronchiolitis
386744|NCT01488448|Infants|infants
386745|NCT01488448|Wheezing|wheezing
386746|NCT01488448|Nebulized|nebulized
386747|NCT01488448|Bronchodilator|bronchodilator
386748|NCT01488396|Cyclosporin|cyclosporin
386749|NCT01488396|Stevens-Johnson syndrome|stevens-johnson syndrome
386750|NCT01488396|Dry eye|dry eye
386751|NCT01488383|Hyperglycemia|hyperglycemia
386752|NCT01488383|Diabetes|diabetes
386753|NCT01488383|Blood glucose|blood glucose
386754|NCT01488383|Hypertension|hypertension
386755|NCT01488383|Anti hypertensive agents|anti hypertensive agents
386756|NCT01488383|Anti hypertensive drugs|anti hypertensive drugs
386757|NCT01488383|Anti hypertensive|anti hypertensive
386758|NCT01488370|breathing tube placement|breathing tube placement
386759|NCT01488357|Breast cancer|breast cancer
386760|NCT01488357|UNC|unc
386761|NCT01488357|Lineberger|lineberger
386762|NCT01488357|Breast Reconstruction|breast reconstruction
386763|NCT01488357|Mastectomy|mastectomy
386764|NCT01488318|Cetuximab|cetuximab
386765|NCT01488318|Dasatinib|dasatinib
386766|NCT01488318|Squamous Cell|squamous cell
386767|NCT01488318|Head and Neck|head and neck
386768|NCT01488318|After Cetuximab Containing Chemoradiotherapy|after cetuximab containing chemoradiotherapy
386769|NCT01488318|Recurrent|recurrent
386770|NCT01488318|Metastatic|metastatic
386771|NCT01488305|MNP|mnp
386772|NCT01488305|AAMA program|aama program
386773|NCT01488305|Nepal|nepal
386774|NCT01488305|HFP|hfp
386775|NCT01488305|IYCF|iycf
386776|NCT01488305|BCC|bcc
386777|NCT01488292|mental health|mental health
386778|NCT01488292|social skills|social skills
386779|NCT01488279|Pre-diabetes|pre-diabetes
386780|NCT01488279|Impaired fasting glucose|impaired fasting glucose
386781|NCT01488279|Impaired glucose tolerance|impaired glucose tolerance
386782|NCT01488279|Steroid-induced hyperglycemia|steroid-induced hyperglycemia
386783|NCT01488266|depression|depression
386784|NCT01488266|depressive|depressive
386785|NCT01488266|major|major
386786|NCT01488266|aripiprazole|aripiprazole
386787|NCT01488266|switching|switching
386788|NCT01488266|augmentation|augmentation
386789|NCT01488266|antidepressant|antidepressant
386790|NCT01488253|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
386791|NCT01488253|Graft vs Host disease|graft vs host disease
386792|NCT01488253|Prevention|prevention
386793|NCT01488253|Sirolimus|sirolimus
386794|NCT01488253|Tacrolimus|tacrolimus
386795|NCT01488240|burn|burn
386796|NCT01488240|scar|scar
386797|NCT01488240|laser|laser
386798|NCT01488227|Vitamin D status in athletes|vitamin d status in athletes
386799|NCT01488227|Vitamin D|vitamin d
386800|NCT01488227|25(OH)D|25(oh)d
386801|NCT01488227|athletes|athletes
386802|NCT01488227|body composition|body composition
386803|NCT01488227|inflammatory markers|inflammatory markers
386804|NCT01488227|illness|illness
386805|NCT01488227|injury|injury
386806|NCT01488214|Systemic Sclerosis|systemic sclerosis
386807|NCT01488214|neuropsychiatric manifestations|neuropsychiatric manifestations
386808|NCT01488214|magnetic resonance imaging|magnetic resonance imaging
386809|NCT01488201|Psoriasis|psoriasis
386810|NCT01488188|Influenza vaccine|influenza vaccine
386811|NCT01488188|nasal route|nasal route
386812|NCT01488188|sublingual route|sublingual route
386813|NCT01488188|immunogenicity|immunogenicity
386814|NCT01488188|safety|safety
386815|NCT01488175|TKA|tka
386816|NCT01488175|RSA|rsa
386817|NCT01488175|Tourniquet|tourniquet
386818|NCT01488175|Arthroplasty|arthroplasty
386819|NCT01488175|Knee|knee
386820|NCT01488149|Fentanyl|fentanyl
386821|NCT01488149|Bupivacaine|bupivacaine
386822|NCT01488149|Nalbuphine|nalbuphine
386823|NCT01488136|Type 1 diabetes|type 1 diabetes
386824|NCT01488136|Hypoglycaemia|hypoglycaemia
386825|NCT01488136|Diazoxide|diazoxide
386826|NCT01488123|Breast, Cancer, Survivorship, Integrative, Complementary|breast, cancer, survivorship, integrative, complementary
386827|NCT01488097|Enzyme Replacement Therapy (ERT)|enzyme replacement therapy (ert)
386828|NCT01488097|Lysosomal Storage Disease|lysosomal storage disease
386829|NCT01488097|Late Onset Lysosomal Acid Lipase (LAL) Deficiency|late onset lysosomal acid lipase (lal) deficiency
386830|NCT01488097|Acid cholesteryl ester hydrolase deficiency, type 2|acid cholesteryl ester hydrolase deficiency, type 2
386831|NCT01488097|Acid lipase disease|acid lipase disease
386832|NCT01488097|Cholesterol ester hydrolase deficiency|cholesterol ester hydrolase deficiency
386833|NCT01488097|LAL Deficiency|lal deficiency
386834|NCT01488097|LIPA Deficiency|lipa deficiency
386835|NCT01488097|Wolman disease|wolman disease
386836|NCT01488084|Saphenous vein graft patency|saphenous vein graft patency
386837|NCT01488084|Coronary artery bypass surgery|coronary artery bypass surgery
386838|NCT01488084|Coronary artery disease|coronary artery disease
386839|NCT01488071|Depression|depression
386840|NCT01488071|Multimodal antidepressant|multimodal antidepressant
386841|NCT01488045|Colonoscopy|colonoscopy
386842|NCT01488045|Propofol|propofol
386843|NCT01488045|Cancer Screening|cancer screening
386844|NCT01488006|Primary Glenohumeral Osteoarthritis|primary glenohumeral osteoarthritis
386845|NCT01488006|Total shoulder arthroplasty|total shoulder arthroplasty
386846|NCT01488006|Total shoulder replacement|total shoulder replacement
386847|NCT01488006|Osteoarthritis|osteoarthritis
386848|NCT01488006|Multicenter study|multicenter study
386849|NCT01487993|Obesity|obesity
386850|NCT01487993|Children|children
386851|NCT01487993|Adolescents|adolescents
386852|NCT01487993|Metformin|metformin
386853|NCT01487993|Insulin resistance|insulin resistance
386854|NCT01487967|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
386855|NCT01487967|ADHD|adhd
386856|NCT01487967|Preferences|preferences
386857|NCT01487967|Goals|goals
386858|NCT01487967|Decision Making|decision making
386859|NCT01487954|skin reactions secondary to radiation therapy|skin reactions secondary to radiation therapy
386860|NCT01487928|breastfed|breastfed
386861|NCT01487928|human milk cream|human milk cream
386862|NCT01487928|human milk fat|human milk fat
386863|NCT01487928|caloric supplement|caloric supplement
386864|NCT01487915|Cisplatin-unfit condition|cisplatin-unfit condition
386865|NCT01487902|Chemotherapy-naive|chemotherapy-naive
386866|NCT01487876|DNA vaccine|dna vaccine
386867|NCT01487876|HBV|hbv
386868|NCT01487876|Chronic hepatitis B (CHB)|chronic hepatitis b (chb)
386869|NCT01487876|T-cell|t-cell
386870|NCT01487863|prostate cancer|prostate cancer
386871|NCT01487863|prostate|prostate
386872|NCT01487863|androgen independent prostate cancer (AIPC)|androgen independent prostate cancer (aipc)
386873|NCT01487863|androgen-independent|androgen-independent
386874|NCT01487863|androgen independent|androgen independent
386875|NCT01487863|hormone insensitive|hormone insensitive
386876|NCT01487863|hormone-insensitive|hormone-insensitive
386877|NCT01487863|prostate specific antigen (PSA)|prostate specific antigen (psa)
386878|NCT01487863|prostatic adenocarcinoma|prostatic adenocarcinoma
386879|NCT01487863|hormone-refractory|hormone-refractory
386880|NCT01487863|hormone refractory|hormone refractory
386881|NCT01487863|hormone refractory prostate cancer (HRPC)|hormone refractory prostate cancer (hrpc)
386882|NCT01487863|immune therapy|immune therapy
386883|NCT01487863|immunotherapy|immunotherapy
386884|NCT01487863|vaccine|vaccine
386885|NCT01487863|dendritic cells|dendritic cells
386886|NCT01487863|antigen-presenting cells|antigen-presenting cells
386887|NCT01487863|antigen presenting cells|antigen presenting cells
386888|NCT01487863|cancer vaccine|cancer vaccine
386889|NCT01487863|therapeutic vaccine|therapeutic vaccine
386890|NCT01487863|therapeutic cancer vaccine|therapeutic cancer vaccine
386891|NCT01487863|recombinant|recombinant
386892|NCT01487863|biological|biological
386893|NCT01487863|biopharmaceutical|biopharmaceutical
386894|NCT01487863|biotechnology|biotechnology
386895|NCT01487863|biotech|biotech
386896|NCT01487863|castration resistant prostate cancer (CRPC)|castration resistant prostate cancer (crpc)
386897|NCT01487863|castration-resistant prostate cancer (CRPC)|castration-resistant prostate cancer (crpc)
386898|NCT01487863|castration-resistance|castration-resistance
386899|NCT01487863|sipuleucel-T|sipuleucel-t
386900|NCT01487863|abiraterone|abiraterone
386901|NCT01487863|prednisone|prednisone
386902|NCT01487863|sequence|sequence
386903|NCT01487863|sequencing|sequencing
386904|NCT01487850|wind instruments|wind instruments
386905|NCT01487850|molds|molds
386906|NCT01487850|hypersensitivity pneumonitis|hypersensitivity pneumonitis
386907|NCT01487850|fungal contamination of wind instruments|fungal contamination of wind instruments
386908|NCT01487850|specific antibodies against molds in musicians' sera|specific antibodies against molds in musicians' sera
386909|NCT01487850|musicians|musicians
386910|NCT01487837|Fibrinogen|fibrinogen
386911|NCT01487837|Blood coagulation disorders|blood coagulation disorders
386912|NCT01487837|Postoperative bleeding|postoperative bleeding
386913|NCT01487837|Transfusions|transfusions
386914|NCT01487785|metastatic pancreatic cancer|metastatic pancreatic cancer
386915|NCT01487785|LDE225|lde225
386917|NCT01487785|locally advanced|locally advanced
386918|NCT01487785|adenocarcinoma|adenocarcinoma
386919|NCT01487746|APLA|apla
386920|NCT01487746|APS|aps
386921|NCT01487746|Stroke|stroke
386922|NCT01487746|minor anti body|minor anti body
386923|NCT01487746|major anti body|major anti body
386924|NCT01487746|APLA antibodies in Serum|apla antibodies in serum
386925|NCT01487733|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
386926|NCT01487733|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
386927|NCT01487733|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
387038|NCT01487460|Hyperlipidemia|hyperlipidemia
386928|NCT01487733|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
386929|NCT01487733|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
386930|NCT01487733|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
386931|NCT01487733|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
386932|NCT01487733|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
386933|NCT01487733|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
386934|NCT01487733|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
386935|NCT01487733|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
386936|NCT01487733|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
386937|NCT01487733|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
386938|NCT01487733|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
386939|NCT01487733|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
386940|NCT01487733|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
386941|NCT01487733|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
386942|NCT01487733|stage IVA squamous cell carcinoma of the larynx|stage iva squamous cell carcinoma of the larynx
386943|NCT01487733|stage IVA squamous cell carcinoma of the lip and oral cavity|stage iva squamous cell carcinoma of the lip and oral cavity
386944|NCT01487733|stage IVA squamous cell carcinoma of the oropharynx|stage iva squamous cell carcinoma of the oropharynx
386945|NCT01487733|stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iva squamous cell carcinoma of the paranasal sinus and nasal cavity
386946|NCT01487733|stage IVB squamous cell carcinoma of the larynx|stage ivb squamous cell carcinoma of the larynx
386947|NCT01487733|stage IVB squamous cell carcinoma of the lip and oral cavity|stage ivb squamous cell carcinoma of the lip and oral cavity
386948|NCT01487733|stage IVB squamous cell carcinoma of the oropharynx|stage ivb squamous cell carcinoma of the oropharynx
386949|NCT01487733|stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivb squamous cell carcinoma of the paranasal sinus and nasal cavity
386950|NCT01487733|stage IVC squamous cell carcinoma of the larynx|stage ivc squamous cell carcinoma of the larynx
386951|NCT01487733|stage IVC squamous cell carcinoma of the lip and oral cavity|stage ivc squamous cell carcinoma of the lip and oral cavity
386952|NCT01487733|stage IVC squamous cell carcinoma of the oropharynx|stage ivc squamous cell carcinoma of the oropharynx
386953|NCT01487733|stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivc squamous cell carcinoma of the paranasal sinus and nasal cavity
386954|NCT01487733|recurrent salivary gland cancer|recurrent salivary gland cancer
386955|NCT01487733|stage III salivary gland cancer|stage iii salivary gland cancer
386956|NCT01487733|stage IVA salivary gland cancer|stage iva salivary gland cancer
386957|NCT01487733|stage IVB salivary gland cancer|stage ivb salivary gland cancer
386958|NCT01487733|stage IVC salivary gland cancer|stage ivc salivary gland cancer
386959|NCT01487720|Castration-resistant prostate cancer|castration-resistant prostate cancer
386960|NCT01487720|Docetaxel-refractory status|docetaxel-refractory status
386961|NCT01487707|pregnancy|pregnancy
386962|NCT01487707|maternal mortality|maternal mortality
386963|NCT01487707|neonatal mortality|neonatal mortality
386964|NCT01487707|community intervention|community intervention
386965|NCT01487707|voluntary health worker|voluntary health worker
386966|NCT01487707|safe birth kit|safe birth kit
386967|NCT01487707|maternal child health|maternal child health
386968|NCT01487694|back cohosh|back cohosh
386969|NCT01487694|cimicifuga racemosa|cimicifuga racemosa
386970|NCT01487694|menopausal symptoms|menopausal symptoms
386971|NCT01487694|hot flashes|hot flashes
386972|NCT01487694|Kupperman index|kupperman index
386973|NCT01487694|MENQOL|menqol
386974|NCT01487668|chronic mental disorders|chronic mental disorders
386975|NCT01487668|cardiovascular disease|cardiovascular disease
386976|NCT01487668|behavior change|behavior change
386977|NCT01487655|Open-angle glaucoma|open-angle glaucoma
386978|NCT01487655|Low tension glaucoma|low tension glaucoma
386979|NCT01487655|Color Doppler Imaging|color doppler imaging
386980|NCT01487629|Diabetic Retinopathy|diabetic retinopathy
386981|NCT01487629|Macular Edema|macular edema
386982|NCT01487629|Bevacizumab|bevacizumab
386983|NCT01487629|Ranibizumab|ranibizumab
386984|NCT01487616|Mullerian anomalies|mullerian anomalies
387092|NCT01487213|Urine hCG|urine hcg
386985|NCT01487616|Congenital uterine malformations or anomalies|congenital uterine malformations or anomalies
386986|NCT01487616|Arcuate|arcuate
386987|NCT01487616|Septate|septate
386988|NCT01487616|Subseptate|subseptate
386989|NCT01487616|Bicornuate|bicornuate
386990|NCT01487616|Unicornuate|unicornuate
386991|NCT01487616|Didelphys|didelphys
386992|NCT01487616|T-shaped|t-shaped
386993|NCT01487603|Patients|patients
386994|NCT01487603|undiagnosed enlarged|undiagnosed enlarged
386995|NCT01487603|lymph nodes|lymph nodes
386996|NCT01487590|pregnancy|pregnancy
386997|NCT01487590|breech|breech
386998|NCT01487590|acupuncture|acupuncture
386999|NCT01487590|moxibustion|moxibustion
387000|NCT01487590|version|version
387001|NCT01487577|Allogeneic blood and marrow transplantation (BMT)|allogeneic blood and marrow transplantation (bmt)
387002|NCT01487577|Graft versus host disease|graft versus host disease
387003|NCT01487577|Mycophenolate mofetil|mycophenolate mofetil
387004|NCT01487577|Pharmacokinetics|pharmacokinetics
387005|NCT01487564|Healthy volunteers|healthy volunteers
387006|NCT01487564|Pharmacokinetics|pharmacokinetics
387007|NCT01487564|OROS Hydromorphone|oros hydromorphone
387008|NCT01487564|Hydromorphone|hydromorphone
387009|NCT01487564|Taiwan|taiwan
387010|NCT01487564|UGT2B7 Gene|ugt2b7 gene
387011|NCT01487551|Systemic sclerosis|systemic sclerosis
387012|NCT01487551|Biomarkers|biomarkers
387013|NCT01487525|symptomatic knee osteoarthritis|symptomatic knee osteoarthritis
387014|NCT01487525|partial blood flow restriction|partial blood flow restriction
387015|NCT01487525|knee extensor strength|knee extensor strength
387016|NCT01487512|Healthy Volunteers|healthy volunteers
387017|NCT01487512|Dose Proportionality|dose proportionality
387018|NCT01487512|Pharmacokinetics|pharmacokinetics
387019|NCT01487512|OROS Hydromorphone|oros hydromorphone
387020|NCT01487512|Hydromorphone|hydromorphone
387021|NCT01487512|Taiwan|taiwan
387022|NCT01487486|Polycystic Ovary Syndrome|polycystic ovary syndrome
387023|NCT01487486|PCOS|pcos
387024|NCT01487486|Follicular Fluid|follicular fluid
387025|NCT01487486|Proteomics|proteomics
387026|NCT01487486|Glyco-proteomics|glyco-proteomics
387027|NCT01487473|Meditation|meditation
387028|NCT01487473|Mindfulness|mindfulness
387029|NCT01487473|Attention|attention
387030|NCT01487473|Chronic Pain|chronic pain
387031|NCT01487473|Depression|depression
387032|NCT01487473|Anxiety|anxiety
387033|NCT01487473|Stress|stress
387034|NCT01487473|Acceptance|acceptance
387035|NCT01487473|Pain intensity|pain intensity
387036|NCT01487473|Pain disability|pain disability
387037|NCT01487460|High cholesterol levels|high cholesterol levels
387039|NCT01487460|High-density Lipoprotein|high-density lipoprotein
387040|NCT01487460|Low-density Lipoprotein|low-density lipoprotein
387041|NCT01487460|Simvastatin|simvastatin
387042|NCT01487434|Attendance|attendance
387043|NCT01487434|Truancy|truancy
387044|NCT01487434|Student engagement|student engagement
387045|NCT01487434|Mentoring|mentoring
387046|NCT01487434|Monitoring|monitoring
387047|NCT01487434|Case management|case management
387048|NCT01487395|Alzheimer|alzheimer
387049|NCT01487395|Donepezil|donepezil
387050|NCT01487395|biomarkers|biomarkers
387051|NCT01487395|battery|battery
387052|NCT01487395|cognition|cognition
387053|NCT01487395|imaging|imaging
387054|NCT01487395|neurophysiological|neurophysiological
387055|NCT01487356|Colonoscopy|colonoscopy
387056|NCT01487356|quality assurance|quality assurance
387057|NCT01487356|withdrawal time|withdrawal time
387058|NCT01487356|polyp detection rate|polyp detection rate
387059|NCT01487343|Oral Chemotherapy|oral chemotherapy
387060|NCT01487343|capecitabine|capecitabine
387061|NCT01487343|questionnaire|questionnaire
387062|NCT01487343|breast|breast
387063|NCT01487343|gastric|gastric
387064|NCT01487343|11-194|11-194
387065|NCT01487330|aortic stenosis|aortic stenosis
387066|NCT01487330|aortic valve stenosis|aortic valve stenosis
387067|NCT01487330|valvular heart disease|valvular heart disease
387068|NCT01487330|aortic valve replacement|aortic valve replacement
387069|NCT01487330|transcatheter aortic valve implantation|transcatheter aortic valve implantation
387070|NCT01487330|TAVI|tavi
387071|NCT01487330|TAVR|tavr
387072|NCT01487317|Delirium|delirium
387073|NCT01487317|acetylcholinesterase inhibitor|acetylcholinesterase inhibitor
387074|NCT01487317|Elderly|elderly
387075|NCT01487317|Emergency department|emergency department
387076|NCT01487291|Thrombophilia tests|thrombophilia tests
387077|NCT01487291|Hypofibrinolysis|hypofibrinolysis
387078|NCT01487291|Fibrinolysis|fibrinolysis
387079|NCT01487278|postpartum hemorrhage|postpartum hemorrhage
387080|NCT01487278|prevention|prevention
387081|NCT01487278|misoprostol|misoprostol
387082|NCT01487278|Uniject|uniject
387083|NCT01487278|oxytocin|oxytocin
387084|NCT01487265|Erlotinib|erlotinib
387085|NCT01487265|BKM120|bkm120
387086|NCT01487265|NSCLC|nsclc
387087|NCT01487226|Cervical cancer|cervical cancer
387088|NCT01487213|Medical abortion|medical abortion
387089|NCT01487213|Termination of pregnancy|termination of pregnancy
387090|NCT01487213|Mifepristone|mifepristone
387091|NCT01487213|Misoprostol|misoprostol
387093|NCT01487213|Follow Up|follow up
387094|NCT01487213|Termination of unwanted pregnancy. Self assessment (follow up) after medical abortion|termination of unwanted pregnancy. self assessment (follow up) after medical abortion
387095|NCT01487200|Osteoarthritis|osteoarthritis
387096|NCT01487200|Knee|knee
387097|NCT01487200|Steroid|steroid
387098|NCT01487200|intra-articular|intra-articular
387099|NCT01487200|injection|injection
387100|NCT01487187|Cord-milking|cord-milking
387101|NCT01487187|hemodynamic|hemodynamic
387102|NCT01487187|preterm infants|preterm infants
387103|NCT01487161|osteoarthritis|osteoarthritis
387104|NCT01487161|knee|knee
387105|NCT01487161|pain|pain
387106|NCT01487161|corticosteroid|corticosteroid
387107|NCT01487161|intra-articular|intra-articular
387108|NCT01487161|injection|injection
387109|NCT01487135|Thorough QT (TQT)|thorough qt (tqt)
387110|NCT01487135|EVP-6124|evp-6124
387111|NCT01487122|Diathermy|diathermy
387112|NCT01487122|Neck Pain|neck pain
387113|NCT01487109|Type 2 diabetes|type 2 diabetes
387114|NCT01487109|chronic kidney disease|chronic kidney disease
387115|NCT01487083|schizophrenia|schizophrenia
387116|NCT01487083|LY2140023|ly2140023
387117|NCT01487083|pomaglumetad methionil|pomaglumetad methionil
387118|NCT01487057|thyroid cancer|thyroid cancer
387119|NCT01487057|dislipidemia|dislipidemia
387120|NCT01487057|cardiovascular risk|cardiovascular risk
387121|NCT01487044|DME|dme
387122|NCT01487031|Autologous Stem Cell Transplantation|autologous stem cell transplantation
387123|NCT01487031|multiple myeloma|multiple myeloma
387124|NCT01487031|non-Hodgkin|non-hodgkin
387125|NCT01487031|Hodgkin lymphoma|hodgkin lymphoma
387126|NCT01487031|Music Therapy|music therapy
387127|NCT01487031|Nausea|nausea
387128|NCT01487031|Pain|pain
387129|NCT01487018|Zygomatic Fractures|zygomatic fractures
387130|NCT01487018|Surgery, Computer-Assisted|surgery, computer-assisted
387131|NCT01487018|Facial Asymmetry|facial asymmetry
387132|NCT01487005|ozone|ozone
387133|NCT01487005|air pollution|air pollution
387134|NCT01487005|vascular function|vascular function
387135|NCT01487005|cardiac function|cardiac function
387136|NCT01487005|inflammation|inflammation
387137|NCT01486953|respiratory resistance|respiratory resistance
387138|NCT01486953|lung compliance|lung compliance
387139|NCT01486953|desflurane|desflurane
387140|NCT01486953|sevoflurane|sevoflurane
387141|NCT01486836|Cardiac disease (ICD indication)|cardiac disease (icd indication)
387142|NCT01486810|cocaine|cocaine
387143|NCT01486810|lisdexamfetamine|lisdexamfetamine
387144|NCT01486797|Relapsed Chronic Lymphocytic Leukemia (CLL)|relapsed chronic lymphocytic leukemia (cll)
387145|NCT01486797|NOX-A12|nox-a12
387146|NCT01486797|Bendamustine|bendamustine
387147|NCT01486797|Rituximab|rituximab
387148|NCT01486797|Spiegelmer|spiegelmer
387149|NCT01486797|Chemosensitization|chemosensitization
387150|NCT01486797|Stromal cell-derived factor-1 (SDF-1)|stromal cell-derived factor-1 (sdf-1)
387151|NCT01486797|CXCL12|cxcl12
387152|NCT01486784|equal to or greater than age 60 years|equal to or greater than age 60 years
387153|NCT01486784|non-M3 AML|non-m3 aml
387154|NCT01486784|relapsed disease|relapsed disease
387155|NCT01486784|primary refractory disease|primary refractory disease
387156|NCT01486784|not appropriate or willing candidates for aggressive therapy|not appropriate or willing candidates for aggressive therapy
387157|NCT01486784|AML|aml
387158|NCT01486771|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
387159|NCT01486732|Cerebral Palsy|cerebral palsy
387160|NCT01486732|Umbilical Cord Blood|umbilical cord blood
387161|NCT01486732|FLT-PET|flt-pet
387162|NCT01486719|Finger pulp reconstruction|finger pulp reconstruction
387163|NCT01486719|dorsal branch|dorsal branch
387164|NCT01486719|proper digital nerve|proper digital nerve
387165|NCT01486719|palmar arterial arch|palmar arterial arch
387166|NCT01486719|dorsal digital island flap|dorsal digital island flap
387167|NCT01486706|Overactive Bladder|overactive bladder
387168|NCT01486706|Gabapentin|gabapentin
387169|NCT01486706|Quality of Life|quality of life
387170|NCT01486706|Urodynamic|urodynamic
387171|NCT01486706|safety|safety
387172|NCT01486706|Efficacy|efficacy
387173|NCT01486693|cytomegalovirus|cytomegalovirus
387174|NCT01486693|uveitis|uveitis
387175|NCT01486680|Gastric bypass|gastric bypass
387176|NCT01486680|Silastic ring gastric bypass|silastic ring gastric bypass
387177|NCT01486680|Roux-en-Y gastric bypass|roux-en-y gastric bypass
387178|NCT01486680|Sleeve gastrectomy|sleeve gastrectomy
387179|NCT01486680|Body composition analysis|body composition analysis
387180|NCT01486667|focus of study instead|focus of study instead
387181|NCT01486654|Cortical stimulation|cortical stimulation
387182|NCT01486654|Ischemic Stroke|ischemic stroke
387183|NCT01486654|Aphasia|aphasia
387184|NCT01486654|Speech and Language Rehabilitation|speech and language rehabilitation
387185|NCT01486641|femoral neck fracture|femoral neck fracture
387186|NCT01486641|arthroplasty|arthroplasty
387187|NCT01486641|surgical approach|surgical approach
387188|NCT01486641|anterolateral|anterolateral
387189|NCT01486641|posterolateral|posterolateral
387190|NCT01486615|premedication|premedication
387191|NCT01486615|premedicants|premedicants
387192|NCT01486615|preoperative anxiety|preoperative anxiety
387193|NCT01486615|melatonin|melatonin
387194|NCT01486615|alprazolam|alprazolam
387195|NCT01486602|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
387196|NCT01486602|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
387197|NCT01486589|emergency care|emergency care
387198|NCT01486589|cardiac autonomic function|cardiac autonomic function
387199|NCT01486589|deceleration capacity|deceleration capacity
387200|NCT01486537|samples|samples
387201|NCT01486537|children|children
387202|NCT01486537|the age group 3-13 years|the age group 3-13 years
387203|NCT01486524|pharmacogenomic biomarker|pharmacogenomic biomarker
387204|NCT01486524|predictive marker|predictive marker
387205|NCT01486524|prospective-retrospective|prospective-retrospective
387206|NCT01486524|propensity score|propensity score
387207|NCT01486524|matched-patients trial|matched-patients trial
387208|NCT01486511|Liver disease|liver disease
387209|NCT01486511|Pulmonary embolism|pulmonary embolism
387210|NCT01486511|Thrombophilia|thrombophilia
387211|NCT01486511|Death|death
387212|NCT01486485|renal replacement therapy|renal replacement therapy
387213|NCT01486472|Adjuvant chemotherapy|adjuvant chemotherapy
387214|NCT01486446|IEM|iem
387215|NCT01486446|EM|em
387216|NCT01486446|Erythromelalgia|erythromelalgia
387217|NCT01486446|Erythermalgia|erythermalgia
387218|NCT01486446|Red neuralgia|red neuralgia
387219|NCT01486446|Peripheral Vascular Disease|peripheral vascular disease
387220|NCT01486446|Vascular Disease|vascular disease
387221|NCT01486446|Cardiovascular Disease|cardiovascular disease
387222|NCT01486433|eicosapentaenoic acid|eicosapentaenoic acid
387223|NCT01486433|docosapentaenoic acid|docosapentaenoic acid
387224|NCT01486433|arachidonic acid|arachidonic acid
387225|NCT01486433|hypertriglyceridemia|hypertriglyceridemia
387226|NCT01486433|simvastatin|simvastatin
387227|NCT01486420|Quinell grade|quinell grade
387228|NCT01486420|Open surgery|open surgery
387229|NCT01486420|corticosteroid injections|corticosteroid injections
387230|NCT01486420|randomized controlled trial|randomized controlled trial
387231|NCT01486420|Trigger finger|trigger finger
387232|NCT01486407|Airway management|airway management
387233|NCT01486355|Mortality|mortality
387234|NCT01486355|Morbidity|morbidity
387235|NCT01486355|Hospitalisations/consultations|hospitalisations/consultations
387236|NCT01486355|Growth|growth
387237|NCT01486355|Measles infection|measles infection
387238|NCT01486329|Pancreatic cancer|pancreatic cancer
387239|NCT01486329|Cancer vaccine|cancer vaccine
387240|NCT01486329|Gemcitabine|gemcitabine
387241|NCT01486329|Inoperable|inoperable
387242|NCT01486329|Gemcitabine chemotherapy|gemcitabine chemotherapy
387243|NCT01486329|Locally advanced|locally advanced
387244|NCT01486303|Facial Cosmetic acupuncture|facial cosmetic acupuncture
387245|NCT01486303|Skin Rejuvenation|skin rejuvenation
387246|NCT01486303|Skin Aging|skin aging
387247|NCT01486290|Intervention|intervention
387248|NCT01486290|Cost Effective|cost effective
387249|NCT01486290|Elderly|elderly
387250|NCT01486290|Glycemic Control|glycemic control
387251|NCT01486277|Lymphoma, T-Cell, Cutaneous|lymphoma, t-cell, cutaneous
387252|NCT01486277|T-cell lymphoma|t-cell lymphoma
387253|NCT01486277|Lymphoma|lymphoma
387254|NCT01486277|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
387255|NCT01486277|JNJ-26481585|jnj-26481585
387256|NCT01486238|Diabetic Macular Edema|diabetic macular edema
387257|NCT01486212|Ischemia-reperfusion injury|ischemia-reperfusion injury
387258|NCT01486212|Oxidative markers|oxidative markers
387259|NCT01486212|Inflammatory markers|inflammatory markers
387260|NCT01486199|cystic fibrosis|cystic fibrosis
387261|NCT01486199|mucociliary clearance|mucociliary clearance
387262|NCT01486199|airway surface liquid|airway surface liquid
387263|NCT01486199|nuclear medicine|nuclear medicine
387264|NCT01486186|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
387265|NCT01486186|Double-Blind Method|double-blind method
387266|NCT01486186|Medicine, Chinese Traditional|medicine, chinese traditional
387267|NCT01486186|Humans|humans
387268|NCT01486186|Treatment Outcome|treatment outcome
387269|NCT01486173|PUFA|pufa
387270|NCT01486173|Iron|iron
387271|NCT01486173|Neurological development|neurological development
387272|NCT01486173|Premature infant|premature infant
387273|NCT01486147|Food labeling|food labeling
387274|NCT01486147|Nutrition|nutrition
387275|NCT01486147|Memory|memory
387276|NCT01486147|Diet|diet
387277|NCT01486134|Hepatocellular carcinoma|hepatocellular carcinoma
387278|NCT01486134|Radiofrequency ablation|radiofrequency ablation
387279|NCT01486134|Multipolar mode|multipolar mode
387280|NCT01486134|Recurrence|recurrence
387281|NCT01486134|Cirrhosis|cirrhosis
387282|NCT01486134|MR temperature monitoring|mr temperature monitoring
387283|NCT01486134|large tumor|large tumor
387284|NCT01486121|Surgery|surgery
387285|NCT01486121|Critical illness|critical illness
387286|NCT01486121|Mechanical ventilation|mechanical ventilation
387287|NCT01486121|Organ dysfunction syndrome|organ dysfunction syndrome
387288|NCT01486121|Intensive Care Units Sedation|intensive care units sedation
387289|NCT01486121|Analgesia|analgesia
387290|NCT01486121|Treatment protocol|treatment protocol
387291|NCT01486121|Nursing protocol|nursing protocol
387292|NCT01486121|Outcome|outcome
387293|NCT01486121|Pain|pain
387294|NCT01486121|Neurological disorders|neurological disorders
387295|NCT01486121|Delirium|delirium
387296|NCT01486121|Muscular weakness|muscular weakness
387297|NCT01486121|Psychological disorders|psychological disorders
387298|NCT01486121|Anxiety|anxiety
387299|NCT01486121|Depression|depression
387300|NCT01486121|Stress disorders|stress disorders
387301|NCT01486121|Post-Traumatic|post-traumatic
387302|NCT01486108|tonic, burst and placebo stimulation|tonic, burst and placebo stimulation
387303|NCT01486082|OCA 10|oca 10
387304|NCT01486082|Antibiogram|antibiogram
387305|NCT01486082|Eradication|eradication
387306|NCT01486069|Dentofacial Deformity|dentofacial deformity
387307|NCT01486069|Orthognathic Surgery|orthognathic surgery
387308|NCT01486069|Mandible|mandible
387309|NCT01486069|Orthognathic Surgical Procedures|orthognathic surgical procedures
387310|NCT01486056|epilepsy|epilepsy
387311|NCT01486056|ECG|ecg
387312|NCT01486056|device placement|device placement
387313|NCT01486043|Induction chemotherapy|induction chemotherapy
387314|NCT01486043|Transient hyperglycemia|transient hyperglycemia
387315|NCT01486043|Metformin|metformin
387316|NCT01486043|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
387317|NCT01486043|Insulin resistance|insulin resistance
387318|NCT01486043|Hyperglycemia|hyperglycemia
387319|NCT01486043|Insulin|insulin
387320|NCT01486030|Atherosclerosis|atherosclerosis
387321|NCT01486030|Corus CAD|corus cad
387322|NCT01486030|Age/Sex/Gene Expression Score|age/sex/gene expression score
387323|NCT01486030|ASGES|asges
387324|NCT01486030|Gene Expression|gene expression
387325|NCT01486030|GES|ges
387326|NCT01486030|CAD|cad
387327|NCT01486030|CVD|cvd
387328|NCT01486030|CHD|chd
387329|NCT01486030|Precision Medicine|precision medicine
387330|NCT01486030|Exercise Stress Test|exercise stress test
387331|NCT01486030|Coronary Artery Disease|coronary artery disease
387332|NCT01486030|Angina Pectoris|angina pectoris
387333|NCT01486030|Chest Pain|chest pain
387334|NCT01486030|Cardiovascular Disease|cardiovascular disease
387335|NCT01486030|Coronary Heart Disease|coronary heart disease
387336|NCT01486030|EXERCISE|exercise
387337|NCT01486017|ASP015K|asp015k
387338|NCT01486017|healthy subjects|healthy subjects
387339|NCT01486017|bioavailability|bioavailability
387340|NCT01486017|rheumatoid arthritis|rheumatoid arthritis
387341|NCT01486017|psoriasis|psoriasis
387342|NCT01486017|transplantation|transplantation
387343|NCT01486004|Hepatitis C Virus|hepatitis c virus
387344|NCT01486004|TMC435|tmc435
387345|NCT01486004|TMC435-TiDP16-C124|tmc435-tidp16-c124
387346|NCT01486004|TMC435-C124|tmc435-c124
387347|NCT01486004|HCV|hcv
387348|NCT01486004|Hepatitis C|hepatitis c
387349|NCT01486004|Hep C|hep c
387350|NCT01486004|Healthy participants|healthy participants
387351|NCT01485991|Hepatitis C|hepatitis c
387352|NCT01485991|TMC435HPC3001|tmc435hpc3001
387353|NCT01485991|TMC435|tmc435
387354|NCT01485991|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
387355|NCT01485991|HEP C|hep c
387356|NCT01485991|Genotype 1|genotype 1
387357|NCT01485991|Treatment experienced|treatment experienced
387358|NCT01485991|Null responders|null responders
387359|NCT01485991|Partial responders|partial responders
387360|NCT01485978|Alport Syndrome|alport syndrome
387361|NCT01485978|chronic kidney disease|chronic kidney disease
387362|NCT01485978|renal fibrosis|renal fibrosis
387363|NCT01485978|nephroprotection|nephroprotection
387364|NCT01485978|pediatric study|pediatric study
387365|NCT01485965|Huntington Disease|huntington disease
387366|NCT01485965|Basal Ganglia Diseases|basal ganglia diseases
387367|NCT01485965|Brain Diseases|brain diseases
387368|NCT01485965|Central Nervous System Diseases|central nervous system diseases
387369|NCT01485965|Nervous System Diseases|nervous system diseases
387370|NCT01485965|Dementia|dementia
387371|NCT01485965|Chorea|chorea
387372|NCT01485965|Dyskinesias|dyskinesias
387373|NCT01485965|Movement Disorders|movement disorders
387374|NCT01485965|Heredodegenerative Disorders, Nervous System|heredodegenerative disorders, nervous system
387375|NCT01485965|Neurodegenerative Diseases|neurodegenerative diseases
387376|NCT01485965|Genetic Diseases, Inborn|genetic diseases, inborn
387377|NCT01485965|Cognition Disorders|cognition disorders
387378|NCT01485965|Mental Disorders|mental disorders
387379|NCT01485952|Huntington Disease|huntington disease
387380|NCT01485952|Basal Ganglia Diseases|basal ganglia diseases
387381|NCT01485952|Brain Diseases|brain diseases
387382|NCT01485952|Central Nervous System Diseases|central nervous system diseases
387383|NCT01485952|Nervous System Diseases|nervous system diseases
387384|NCT01485952|Dementia|dementia
387385|NCT01485952|Chorea|chorea
387386|NCT01485952|Dyskinesias|dyskinesias
387387|NCT01485952|Movement Disorders|movement disorders
387388|NCT01485952|Heredodegenerative Disorders, Nervous System|heredodegenerative disorders, nervous system
387389|NCT01485952|Neurodegenerative Diseases|neurodegenerative diseases
387390|NCT01485952|Genetic Diseases, Inborn|genetic diseases, inborn
387391|NCT01485952|Cognition Disorders|cognition disorders
387392|NCT01485952|Mental Disorders|mental disorders
387393|NCT01485939|lidocaine patch|lidocaine patch
387394|NCT01485939|laparoscopic cholecystectomy|laparoscopic cholecystectomy
387395|NCT01485913|Education|education
387396|NCT01485913|Diabetes|diabetes
387397|NCT01485913|Prevention complications|prevention complications
387398|NCT01485913|Prevention of complications of diabetes|prevention of complications of diabetes
387399|NCT01485887|Venlafaxine ER|venlafaxine er
387400|NCT01485887|long-term extension|long-term extension
387401|NCT01485887|Japan|japan
387402|NCT01485874|BIBF 1120|bibf 1120
387403|NCT01485835|Multiple Myeloma|multiple myeloma
387404|NCT01485835|Bortezomib|bortezomib
387405|NCT01485835|Velcade|velcade
387406|NCT01485835|Ganetespib|ganetespib
387407|NCT01485822|Glaucoma|glaucoma
387408|NCT01485822|Travatan|travatan
387409|NCT01485822|Trabeculectomy|trabeculectomy
387410|NCT01485796|PIDD|pidd
387411|NCT01485783|Hypertension|hypertension
387412|NCT01485757|patients|patients
387413|NCT01485744|metastatic|metastatic
387414|NCT01485744|untreated|untreated
387415|NCT01485744|advanced|advanced
387416|NCT01485731|Cervical|cervical
387417|NCT01485731|Cancer|cancer
387418|NCT01485731|Uterine Cervix|uterine cervix
387419|NCT01485731|Squamous Cell|squamous cell
387420|NCT01485731|Adenocarcinoma|adenocarcinoma
387421|NCT01485718|Obesity|obesity
387422|NCT01485718|Overweight|overweight
387423|NCT01485718|Weight loss|weight loss
387424|NCT01485705|severe bacterial infection|severe bacterial infection
387425|NCT01485692|Violence|violence
387426|NCT01485692|Aggression|aggression
387427|NCT01485692|Psychiatric emergencies|psychiatric emergencies
387428|NCT01485692|Psychomotor agitation|psychomotor agitation
387429|NCT01485692|Violent patient|violent patient
387430|NCT01485679|18 fluoro deoxy glucose positrons emission tomography combined with computed tomography,|18 fluoro deoxy glucose positrons emission tomography combined with computed tomography,
387431|NCT01485679|Patients with intraductal papillary mucinous tumor of the pancreas|patients with intraductal papillary mucinous tumor of the pancreas
387432|NCT01485679|intraductal papillary mucinous|intraductal papillary mucinous
387433|NCT01485679|pancreas|pancreas
387434|NCT01485666|Thoratec|thoratec
387435|NCT01485666|HeartMate II|heartmate ii
387436|NCT01485666|heart-assist devices|heart-assist devices
387437|NCT01485666|driveline or percutaneous lead management|driveline or percutaneous lead management
387438|NCT01485666|HeartMate II Percutaneous Lead Management|heartmate ii percutaneous lead management
387439|NCT01485653|Brachial Plexus|brachial plexus
387440|NCT01485653|Mepivacaine|mepivacaine
387441|NCT01485653|Ultrasound|ultrasound
387442|NCT01485653|Axillary|axillary
387443|NCT01485653|Block|block
387444|NCT01485640|Schizophrenia|schizophrenia
387445|NCT01485640|bipolar disorder|bipolar disorder
387446|NCT01485640|Lurasidone|lurasidone
387447|NCT01485640|Latuda|latuda
387448|NCT01485627|Cancer|cancer
387449|NCT01485627|Communication|communication
387450|NCT01485627|prognosis|prognosis
387451|NCT01485575|Chromovitrectomy|chromovitrectomy
387452|NCT01485575|Indocyanine green|indocyanine green
387453|NCT01485575|ICG|icg
387454|NCT01485575|Brilliant Blue G|brilliant blue g
387455|NCT01485575|BBG|bbg
387456|NCT01485575|Trypan blue|trypan blue
387457|NCT01485575|TB|tb
387458|NCT01485575|Internal limiting membrane|internal limiting membrane
387459|NCT01485575|ILM|ilm
387460|NCT01485562|postpartum haemorrhage|postpartum haemorrhage
387461|NCT01485562|misoprostol|misoprostol
387462|NCT01485562|treatment|treatment
387463|NCT01485562|prophylaxis|prophylaxis
387464|NCT01485562|home births|home births
387465|NCT01485549|Multiple system atrophy (MSA)|multiple system atrophy (msa)
387466|NCT01485549|alpha-synucleinopathies|alpha-synucleinopathies
387467|NCT01485549|biological markers|biological markers
387468|NCT01485549|cerebrospinal fluid|cerebrospinal fluid
387469|NCT01485549|plasma|plasma
387470|NCT01485536|Lymphoma|lymphoma
387471|NCT01485536|Relapsed/refractory lymphoma|relapsed/refractory lymphoma
387472|NCT01485536|AUY922|auy922
387473|NCT01485523|Allergic rhinitis|allergic rhinitis
387474|NCT01485523|Nasal provocation test|nasal provocation test
387475|NCT01485510|Maltreatment|maltreatment
387476|NCT01485510|Infant Mental Health|infant mental health
387477|NCT01485510|Infant mental health in maltreated children|infant mental health in maltreated children
387478|NCT01485497|APNEA|apnea
387479|NCT01485471|Middle Ear Infection|middle ear infection
387480|NCT01485458|Incomplete spinal cord injury|incomplete spinal cord injury
387481|NCT01485458|Cervical canal stenosis|cervical canal stenosis
387482|NCT01485458|Ossification of the posterior longitudinal ligament|ossification of the posterior longitudinal ligament
387483|NCT01485458|Surgery|surgery
387484|NCT01485458|Decompression|decompression
387485|NCT01485445|bioequivalence|bioequivalence
387486|NCT01485445|pharmacokinetics|pharmacokinetics
387487|NCT01485445|Fluticasone Furoate|fluticasone furoate
387488|NCT01485445|Vilanterol|vilanterol
387489|NCT01485432|Renal transplant surgery|renal transplant surgery
387490|NCT01485432|hemodynamic management|hemodynamic management
387491|NCT01485432|PiCCO|picco
387492|NCT01485432|delayed graft function|delayed graft function
387493|NCT01485419|Sex hormones|sex hormones
387494|NCT01485419|Testosterone|testosterone
387495|NCT01485419|Estradiol|estradiol
387496|NCT01485406|Haemophilus influenzae|haemophilus influenzae
387497|NCT01485406|Safety|safety
387498|NCT01485406|Pneumococcal vaccine|pneumococcal vaccine
387499|NCT01485406|Streptococcus pneumoniae|streptococcus pneumoniae
387500|NCT01485406|Immunogenicity|immunogenicity
387501|NCT01485406|Toddlers|toddlers
387502|NCT01485380|Dexmedetomidine|dexmedetomidine
387503|NCT01485380|Sleep|sleep
387504|NCT01485380|MRI-PET|mri-pet
387505|NCT01485380|EEG|eeg
387506|NCT01485367|Senile Purpura|senile purpura
387507|NCT01485367|Adapalene 0.3%|adapalene 0.3%
387508|NCT01485354|Stroke|stroke
387509|NCT01485354|Rehabilitation|rehabilitation
387510|NCT01485341|gluten sensitivity|gluten sensitivity
387511|NCT01485328|Dyspepsia|dyspepsia
387512|NCT01485328|Flatulence|flatulence
387513|NCT01485328|Aerophagia|aerophagia
387514|NCT01485328|Constipation|constipation
387515|NCT01485302|mild to moderate Alzheimer's Disease|mild to moderate alzheimer's disease
387516|NCT01485276|Parkinson's Disease|parkinson's disease
387517|NCT01485276|Deep Brain Stimulation|deep brain stimulation
387518|NCT01485276|Gait|gait
387519|NCT01485276|Electrophysiology|electrophysiology
387520|NCT01485276|Parkinson Disease|parkinson disease
387521|NCT01485276|PD|pd
387522|NCT01485263|Deep Brain Stimulation|deep brain stimulation
387523|NCT01485263|OCD|ocd
387524|NCT01485250|Healthy Volunteers|healthy volunteers
387525|NCT01485250|Motivations|motivations
387526|NCT01485250|Decision Making|decision making
387527|NCT01485250|Motivation|motivation
387528|NCT01485224|Hereditary hemorrhagic telangiectasia|hereditary hemorrhagic telangiectasia
387529|NCT01485224|Epistaxis|epistaxis
387530|NCT01485224|Thalidomide|thalidomide
387531|NCT01485211|progressive keratoconus|progressive keratoconus
387532|NCT01485211|thin corneas|thin corneas
387533|NCT01485211|cross-linking|cross-linking
387534|NCT01485211|hypo-osmolar riboflavin|hypo-osmolar riboflavin
387535|NCT01485198|osteoarthritis|osteoarthritis
387536|NCT01485198|knee|knee
387537|NCT01485198|stem cell therapy|stem cell therapy
387538|NCT01485198|bone marrow|bone marrow
387539|NCT01485198|G-CSF|g-csf
387540|NCT01485185|Donepezil|donepezil
387541|NCT01485185|allodynia|allodynia
387542|NCT01485185|Gabapentin|gabapentin
387543|NCT01485185|Sural nerve stimulation|sural nerve stimulation
387544|NCT01485185|Electrical hyperalgesia|electrical hyperalgesia
387545|NCT01485159|prevalence|prevalence
387546|NCT01485159|COPD|copd
387547|NCT01485159|emphysema|emphysema
387548|NCT01485159|co-morbidities|co-morbidities
387549|NCT01485159|ischemic heart disease|ischemic heart disease
387550|NCT01485159|chronic bronchitis|chronic bronchitis
387551|NCT01485159|spirometry|spirometry
387552|NCT01485159|burden|burden
387553|NCT01485133|colonoscopy|colonoscopy
387554|NCT01485133|water|water
387555|NCT01485133|surgery|surgery
387556|NCT01485133|unsedated|unsedated
387557|NCT01485120|Blood pressure (low, normal, high)|blood pressure (low, normal, high)
387558|NCT01485107|Ulthera® System|ulthera® system
387559|NCT01485107|Ultherapy™ treatment|ultherapy™ treatment
387560|NCT01485107|Ulthera, Inc.|ulthera, inc.
387561|NCT01485107|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
387562|NCT01485094|neuralgia|neuralgia
387563|NCT01485094|postherpetic|postherpetic
387564|NCT01485081|Bifurcation|bifurcation
387565|NCT01485081|Drug-eluting balloon|drug-eluting balloon
387566|NCT01485081|Paclitaxel-eluting balloon|paclitaxel-eluting balloon
387567|NCT01485081|Angioplasty|angioplasty
387568|NCT01485081|Coronary artery disease|coronary artery disease
387569|NCT01485081|Coronary artery stenosis|coronary artery stenosis
387570|NCT01485068|Restenosis|restenosis
387571|NCT01485068|Paclitaxel-eluting balloon|paclitaxel-eluting balloon
387572|NCT01485068|Angioplasty|angioplasty
387573|NCT01485068|Coronary artery disease|coronary artery disease
387574|NCT01485068|Coronary artery stenosis|coronary artery stenosis
387575|NCT01485055|aGVHD|agvhd
387576|NCT01485055|GVHD|gvhd
387577|NCT01485055|Graft versus host disease|graft versus host disease
387578|NCT01485055|Acute graft versus host disease|acute graft versus host disease
387579|NCT01485055|Steroid refractory graft versus host disease|steroid refractory graft versus host disease
387580|NCT01485055|Bone marrow transplant|bone marrow transplant
387581|NCT01485055|BMT|bmt
387582|NCT01485055|HSCT|hsct
387583|NCT01485055|infliximab|infliximab
387584|NCT01485055|basiliximab|basiliximab
387585|NCT01485055|Monoclonal antibody treatment|monoclonal antibody treatment
387586|NCT01485042|Phase 1|phase 1
387587|NCT01485042|pazopanib|pazopanib
387588|NCT01485042|TH-302|th-302
387589|NCT01485042|advanced solid tumors|advanced solid tumors
387590|NCT01485016|epilepsy|epilepsy
387591|NCT01485016|ECG|ecg
387592|NCT01485016|accelerometer|accelerometer
387593|NCT01484990|Parkinson's Disease|parkinson's disease
387594|NCT01484990|levodopa|levodopa
387595|NCT01484990|carbidopa|carbidopa
387596|NCT01484990|Duodopa|duodopa
387597|NCT01484990|intestinal gel|intestinal gel
387598|NCT01484977|Lacosamide|lacosamide
387599|NCT01484977|Epilepsy|epilepsy
387600|NCT01484977|Levetiracetam|levetiracetam
387601|NCT01484977|Sodium Channel Blockers|sodium channel blockers
387602|NCT01484964|ASP015K|asp015k
387603|NCT01484964|healthy subjects|healthy subjects
387604|NCT01484964|bioavailability|bioavailability
387605|NCT01484964|food effect|food effect
387606|NCT01484964|rheumatoid arthritis|rheumatoid arthritis
387607|NCT01484964|psoriasis|psoriasis
387608|NCT01484964|transplantation|transplantation
387609|NCT01484951|Open-angle glaucoma|open-angle glaucoma
387610|NCT01484951|Ocular hypertension|ocular hypertension
387611|NCT01484951|Pigment dispersion glaucoma|pigment dispersion glaucoma
387612|NCT01484938|Soft contact lenses|soft contact lenses
387613|NCT01484938|Multi-purpose solution|multi-purpose solution
387614|NCT01484938|Corneal staining|corneal staining
387615|NCT01484925|Barrett's esophagus|barrett's esophagus
387616|NCT01484912|Green tea polyphenols|green tea polyphenols
387617|NCT01484912|Chronic Stable Angina|chronic stable angina
387618|NCT01484899|Pulmonary arterial Hypertension|pulmonary arterial hypertension
387619|NCT01484899|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
387620|NCT01484899|smoking|smoking
387621|NCT01484886|Hemoglobin|hemoglobin
387622|NCT01484886|Congenital heart disease|congenital heart disease
387623|NCT01484886|Cardiac surgery|cardiac surgery
387624|NCT01484886|Red blood cell transfusion|red blood cell transfusion
387625|NCT01484886|Number of red blood cell transfusions|number of red blood cell transfusions
387626|NCT01484873|Exenatide|exenatide
387627|NCT01484873|Byetta|byetta
387628|NCT01484873|Hypothalamic Obesity|hypothalamic obesity
387629|NCT01484873|Obesity|obesity
387630|NCT01484873|Craniopharyngioma|craniopharyngioma
387631|NCT01484860|AUY922|auy922
387632|NCT01484860|Pancreas|pancreas
387633|NCT01484860|Pancreatic cancer|pancreatic cancer
387634|NCT01484860|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
387635|NCT01484860|Cancer of the pancreas|cancer of the pancreas
387636|NCT01484860|Metastatic|metastatic
387637|NCT01484860|Advanced|advanced
387638|NCT01484860|Advanced disease|advanced disease
387639|NCT01484860|Prior systemic anticancer therapy|prior systemic anticancer therapy
387640|NCT01484847|advanced|advanced
387641|NCT01484847|PF-00299804|pf-00299804
387642|NCT01484847|head and neck|head and neck
387643|NCT01484847|pharmacokinetic|pharmacokinetic
387644|NCT01484847|squamous cell carcinoma|squamous cell carcinoma
387645|NCT01484847|gastrojejunostomy|gastrojejunostomy
387646|NCT01484847|feeding tube|feeding tube
387647|NCT01484834|Physical Activity|physical activity
387648|NCT01484834|Occupational Health|occupational health
387649|NCT01484834|Quality of Life|quality of life
387650|NCT01484834|Health Promotion|health promotion
387651|NCT01484821|Sarcopenia|sarcopenia
387652|NCT01484821|ARFI|arfi
387653|NCT01484821|DEXA|dexa
387654|NCT01484821|Cancer|cancer
387655|NCT01484808|PSA Density|psa density
387656|NCT01484808|Prostate Cancer|prostate cancer
387657|NCT01484808|Prostate Biopsy|prostate biopsy
387658|NCT01484808|PSA|psa
387659|NCT01484795|noninvasive ventilation|noninvasive ventilation
387660|NCT01484795|autonomic nervous system|autonomic nervous system
387661|NCT01484782|Hypertension|hypertension
387662|NCT01484782|Telephone Care Management|telephone care management
387663|NCT01484782|Blood pressure|blood pressure
387664|NCT01484782|Medication adherence|medication adherence
387665|NCT01484782|Interactive Voice Response (IVR)|interactive voice response (ivr)
387666|NCT01484782|Cloud computing|cloud computing
387667|NCT01484756|respiratory infection|respiratory infection
387668|NCT01484756|independent elderly|independent elderly
387669|NCT01484756|zinc|zinc
387670|NCT01484756|vitamins|vitamins
387671|NCT01484743|recurrence|recurrence
387672|NCT01484743|readmission|readmission
387673|NCT01484743|reoperation|reoperation
387674|NCT01484743|mortality|mortality
387675|NCT01484743|morbidity|morbidity
387676|NCT01484704|Carcinoma ductale mammae|carcinoma ductale mammae
387677|NCT01484678|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
387678|NCT01484678|Magnetic Resonance Imaging|magnetic resonance imaging
387679|NCT01484678|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
387681|NCT01484665|PSA screening|psa screening
387682|NCT01484665|Decision aids|decision aids
387683|NCT01484652|Moderate Post-Operative Pain|moderate post-operative pain
387684|NCT01484652|Severe Post-Operative Pain|severe post-operative pain
387685|NCT01484652|Bunionectomy|bunionectomy
387686|NCT01484639|transfusion|transfusion
387687|NCT01484639|cardiac surgery|cardiac surgery
387688|NCT01484626|Relapsed Multiple Myeloma|relapsed multiple myeloma
387689|NCT01484626|Refractory Multiple Myeloma|refractory multiple myeloma
387690|NCT01484626|Bendamustine|bendamustine
387691|NCT01484626|Bortezomib|bortezomib
387692|NCT01484626|Lenalidomide|lenalidomide
387693|NCT01484626|Dexamethasone|dexamethasone
387694|NCT01484626|Treanda|treanda
387695|NCT01484626|Velcade|velcade
387696|NCT01484626|Revlimid|revlimid
387697|NCT01484613|Hear Failure|hear failure
387798|NCT01484132|Bisphenol-A|bisphenol-a
387698|NCT01484613|Cardiac resynchronization|cardiac resynchronization
387699|NCT01484613|CRT-D|crt-d
387700|NCT01484613|quadripolar|quadripolar
387701|NCT01484600|Volunteers|volunteers
387702|NCT01484587|Moderate to Severe Plaque-Type Psoriasis|moderate to severe plaque-type psoriasis
387703|NCT01484587|Psoriasis|psoriasis
387704|NCT01484587|Plaque-type psoriasis|plaque-type psoriasis
387705|NCT01484587|CNTO 1959|cnto 1959
387706|NCT01484587|Japanese participants|japanese participants
387707|NCT01484574|Critical limb ischemia|critical limb ischemia
387708|NCT01484574|Buerger's disease|buerger's disease
387709|NCT01484574|Critical limb ischemia due to Buerger's disease|critical limb ischemia due to buerger's disease
387710|NCT01484561|Phase 1|phase 1
387711|NCT01484522|Influenza|influenza
387712|NCT01484522|Perinatal|perinatal
387713|NCT01484522|immunogenicity|immunogenicity
387714|NCT01484522|Monovalent vaccine|monovalent vaccine
387715|NCT01484522|Children|children
387716|NCT01484522|Youth|youth
387717|NCT01484522|H1N1|h1n1
387718|NCT01484522|Adolescent|adolescent
387719|NCT01484522|Flu|flu
387720|NCT01484509|walking impairment|walking impairment
387721|NCT01484509|claudication|claudication
387722|NCT01484509|treadmill|treadmill
387723|NCT01484509|questionnaire|questionnaire
387724|NCT01484496|Subcutaneous|subcutaneous
387725|NCT01484496|Lupus|lupus
387726|NCT01484496|Systemic Lupus Erythematosus|systemic lupus erythematosus
387727|NCT01484496|SLE|sle
387728|NCT01484496|Belimumab|belimumab
387729|NCT01484496|Autoimmune Disease|autoimmune disease
387730|NCT01484496|Antibodies|antibodies
387731|NCT01484470|Stem cell transplantation|stem cell transplantation
387732|NCT01484470|Stem Cell expansion|stem cell expansion
387733|NCT01484470|Elderly|elderly
387734|NCT01484457|Diabetes Mellitus|diabetes mellitus
387735|NCT01484457|Closed Loop|closed loop
387736|NCT01484457|Artificial Pancreas|artificial pancreas
387737|NCT01484418|Chronic Low Back Pain|chronic low back pain
387738|NCT01484418|Cognitive Behavioural Therapy|cognitive behavioural therapy
387739|NCT01484418|Exposure|exposure
387740|NCT01484418|Fear avoidance|fear avoidance
387741|NCT01484418|Cognitive Behavioural Therapy in chronic low back pain|cognitive behavioural therapy in chronic low back pain
387742|NCT01484418|Exposure in vivo in chronic low back pain|exposure in vivo in chronic low back pain
387743|NCT01484405|surgical approach for total hip arthroplasty|surgical approach for total hip arthroplasty
387744|NCT01484392|open angle glaucoma|open angle glaucoma
387745|NCT01484392|compliance|compliance
387746|NCT01484392|adherence|adherence
387747|NCT01484379|Primary Hyperparathyroidism|primary hyperparathyroidism
387748|NCT01484379|multigland disease|multigland disease
387749|NCT01484379|neck exploration|neck exploration
387750|NCT01484379|elderly|elderly
387751|NCT01484366|fractures of both radius and ulna|fractures of both radius and ulna
387752|NCT01484353|Diabetes|diabetes
387753|NCT01484340|smoking|smoking
387754|NCT01484340|administration, cutaneous|administration, cutaneous
387755|NCT01484327|Heart Failure|heart failure
387756|NCT01484327|Acute Myocardial Infarction|acute myocardial infarction
387757|NCT01484327|LVEF|lvef
387758|NCT01484314|Relapsed|relapsed
387759|NCT01484301|Chronic pain|chronic pain
387760|NCT01484301|Opioids|opioids
387761|NCT01484301|Tolerability|tolerability
387762|NCT01484275|High-risk smoldering multiple myeloma|high-risk smoldering multiple myeloma
387763|NCT01484275|Multiple myeloma|multiple myeloma
387764|NCT01484275|Siltuximab|siltuximab
387765|NCT01484249|embolic|embolic
387766|NCT01484249|filters|filters
387767|NCT01484249|brachiocephalic|brachiocephalic
387768|NCT01484249|neurovasculature|neurovasculature
387769|NCT01484249|debris|debris
387770|NCT01484236|Lymphangioleiomyomatosis|lymphangioleiomyomatosis
387771|NCT01484223|Primary Health Care|primary health care
387772|NCT01484223|Somatization symptoms|somatization symptoms
387773|NCT01484223|Cognitive Behavioral Therapy|cognitive behavioral therapy
387774|NCT01484223|Nursing intervention|nursing intervention
387775|NCT01484197|Asthma|asthma
387776|NCT01484197|Indacaterol|indacaterol
387777|NCT01484197|QAB149|qab149
387778|NCT01484184|Completely paralyzed|completely paralyzed
387779|NCT01484184|Chronically injured|chronically injured
387780|NCT01484184|Central Pattern Generator|central pattern generator
387781|NCT01484184|Locomotion|locomotion
387782|NCT01484184|Secondary complications|secondary complications
387783|NCT01484184|Activity-based training|activity-based training
387784|NCT01484184|Treadmill training|treadmill training
387785|NCT01484184|Spinal cord injury|spinal cord injury
387786|NCT01484184|Paraplegia|paraplegia
387787|NCT01484184|Tetraplegia|tetraplegia
387788|NCT01484171|Acute Myeloid Leukemia|acute myeloid leukemia
387789|NCT01484171|idarubicin|idarubicin
387790|NCT01484171|Microtransplantation|microtransplantation
387791|NCT01484158|Myocardial Infarction|myocardial infarction
387792|NCT01484145|Onychomycosis|onychomycosis
387793|NCT01484145|Nail fungus|nail fungus
387794|NCT01484145|Tinea Unguium|tinea unguium
387795|NCT01484132|Dental Caries|dental caries
387796|NCT01484132|Dental Restorative Materials|dental restorative materials
387797|NCT01484132|Dental Composite|dental composite
387799|NCT01484119|seasonal allergic rhinitis|seasonal allergic rhinitis
387800|NCT01484093|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
387801|NCT01484093|CYTARABINE (ARA-C)|cytarabine (ara-c)
387802|NCT01484093|DOXORUBICIN/ADRIAMYCIN|doxorubicin/adriamycin
387803|NCT01484093|PREDNISONE|prednisone
387804|NCT01484093|RITUXIMAB|rituximab
387805|NCT01484093|TOSITUMOMAB (BEXXAR)|tositumomab (bexxar)
387806|NCT01484093|Iodine|iodine
387807|NCT01484093|VINCRISTIN|vincristin
387808|NCT01484093|Lymphoma|lymphoma
387809|NCT01484093|Chemo-Radioimmunotherapy|chemo-radioimmunotherapy
387810|NCT01484093|Autologous Transplantation|autologous transplantation
387811|NCT01484093|Untreated|untreated
387812|NCT01484093|11-095|11-095
387813|NCT01484067|Herpes Simplex Virus|herpes simplex virus
387814|NCT01484041|Breast cancer|breast cancer
387815|NCT01484041|postmenopausal|postmenopausal
387816|NCT01484002|Hip replacement|hip replacement
387817|NCT01484002|Crosslinked and conventional polyethylene|crosslinked and conventional polyethylene
387818|NCT01484002|Oxidation|oxidation
387819|NCT01484002|Crosslink density|crosslink density
387820|NCT01484002|Outcome|outcome
387821|NCT01483989|Dry Eye|dry eye
387822|NCT01483989|Epithelial changes|epithelial changes
387823|NCT01483950|Dyslipidemia|dyslipidemia
387824|NCT01483950|Statins|statins
387825|NCT01483950|Total Cholesterol|total cholesterol
387826|NCT01483950|Low density lipoprotein (LDL) cholesterol|low density lipoprotein (ldl) cholesterol
387827|NCT01483950|High density lipoprotein (HDL) cholesterol|high density lipoprotein (hdl) cholesterol
387828|NCT01483937|Keywords provided by BalanceSense, LLC:|keywords provided by balancesense, llc:
387829|NCT01483937|Physical Therapy|physical therapy
387830|NCT01483937|Rehabilitation|rehabilitation
387831|NCT01483937|Disequilibrium|disequilibrium
387832|NCT01483937|Balance dysfunction or disorder|balance dysfunction or disorder
387833|NCT01483937|Vestibular|vestibular
387834|NCT01483937|Mild Traumatic Brain Injury (mTBI)|mild traumatic brain injury (mtbi)
387835|NCT01483937|Vibrotactile|vibrotactile
387836|NCT01483924|Mild to Moderate Chronic Plaque Psoriasis|mild to moderate chronic plaque psoriasis
387837|NCT01483898|critical limb ischemia|critical limb ischemia
387838|NCT01483898|REVIVE|revive
387839|NCT01483898|peripheral vascular disease|peripheral vascular disease
387840|NCT01483898|CLI|cli
387841|NCT01483898|PAD|pad
387842|NCT01483898|MSC|msc
387843|NCT01483898|stem cells|stem cells
387844|NCT01483898|cell therapy|cell therapy
387845|NCT01483872|salvage infected hemodialysis catheters|salvage infected hemodialysis catheters
387846|NCT01483872|novel catheter lock solution|novel catheter lock solution
387847|NCT01483846|Neuropathic Pain|neuropathic pain
387848|NCT01483846|Capsaicin Induced Pain|capsaicin induced pain
387849|NCT01483807|speech|speech
387850|NCT01483807|speech therapy|speech therapy
387851|NCT01483807|apraxia of speech|apraxia of speech
387852|NCT01483794|genital warts|genital warts
387853|NCT01483781|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
387854|NCT01483781|Plasma Volume|plasma volume
387855|NCT01483781|Canagliflozin|canagliflozin
387856|NCT01483781|Metformin|metformin
387857|NCT01483781|Hemoglobin A1c|hemoglobin a1c
387858|NCT01483781|Hypertension|hypertension
387859|NCT01483781|Angiotensin-Converting Enzyme Inhibitors (ACEIs)|angiotensin-converting enzyme inhibitors (aceis)
387860|NCT01483781|Angiotensin Receptor Blockers (ARBs)|angiotensin receptor blockers (arbs)
387861|NCT01483781|Pharmacodynamics|pharmacodynamics
387862|NCT01483781|Pharmacokinetics|pharmacokinetics
387863|NCT01483768|Sleeve gastrectomy|sleeve gastrectomy
387864|NCT01483768|Obesity surgery|obesity surgery
387865|NCT01483768|Iron deficiency|iron deficiency
387866|NCT01483768|HEPCIDINE|hepcidine
387867|NCT01483755|Myocardial infarction|myocardial infarction
387868|NCT01483755|Postconditioning|postconditioning
387869|NCT01483690|Relapse|relapse
387870|NCT01483690|Lymphoblastic|lymphoblastic
387871|NCT01483690|Leukemia|leukemia
387872|NCT01483690|Decitabine|decitabine
387873|NCT01483690|Vorinostat|vorinostat
387874|NCT01483690|Refractory|refractory
387875|NCT01483690|Acute|acute
387876|NCT01483690|Childhood|childhood
387877|NCT01483690|Pediatric|pediatric
387878|NCT01483690|ALL|all
387879|NCT01483677|Laparoscopy|laparoscopy
387880|NCT01483677|video games|video games
387881|NCT01483677|Nintendo Wii|nintendo wii
387882|NCT01483677|Playstation|playstation
387883|NCT01483664|patient outcomes|patient outcomes
387884|NCT01483664|Survivorship|survivorship
387885|NCT01483664|Communication Skills|communication skills
387886|NCT01483664|Communication strategies|communication strategies
387887|NCT01483664|Physicians communication|physicians communication
387888|NCT01483664|11-180|11-180
387889|NCT01483651|diabetes|diabetes
387890|NCT01483651|glucagon|glucagon
387891|NCT01483651|insulin|insulin
387892|NCT01483651|dideuterated glucose|dideuterated glucose
387893|NCT01483638|duration of disease response|duration of disease response
387894|NCT01483638|axitinib|axitinib
387895|NCT01483612|Body Weight|body weight
387896|NCT01483612|Female|female
387897|NCT01483612|Infertility, Female/therapy|infertility, female/therapy
387997|NCT01483183|A-fib|a-fib
387898|NCT01483612|Infertility, Female/physiopathology|infertility, female/physiopathology
387899|NCT01483612|Obesity/physiopathology|obesity/physiopathology
387900|NCT01483612|Polycystic ovary syndrome|polycystic ovary syndrome
387901|NCT01483612|Pregnancy|pregnancy
387902|NCT01483612|Pregnancy Outcome|pregnancy outcome
387903|NCT01483612|Weight Loss|weight loss
387904|NCT01483599|Moderate to Severe Plaque-Type Psoriasis|moderate to severe plaque-type psoriasis
387905|NCT01483599|Psoriasis|psoriasis
387906|NCT01483599|Plaque-type psoriasis|plaque-type psoriasis
387907|NCT01483599|CNTO 1959|cnto 1959
387908|NCT01483599|adalimumab|adalimumab
387909|NCT01483573|low back pain|low back pain
387910|NCT01483573|straight leg raise|straight leg raise
387911|NCT01483560|REMOVAL|removal
387912|NCT01483560|metformin|metformin
387913|NCT01483560|carotid IMT|carotid imt
387914|NCT01483560|LDL Cholesterol|ldl cholesterol
387915|NCT01483560|endothelial function|endothelial function
387916|NCT01483560|retinopathy|retinopathy
387917|NCT01483560|HbA1c|hba1c
387918|NCT01483534|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
387919|NCT01483534|Pulmonary|pulmonary
387920|NCT01483534|Intervention|intervention
387921|NCT01483534|Device|device
387922|NCT01483534|Denervation|denervation
387923|NCT01483534|Lung|lung
387924|NCT01483534|Holaira, Inc.|holaira, inc.
387925|NCT01483534|Innovative Pulmonary Solutions, Inc.|innovative pulmonary solutions, inc.
387926|NCT01483521|Randomized|randomized
387927|NCT01483521|Home visitation|home visitation
387928|NCT01483521|Externalizing disorder|externalizing disorder
387929|NCT01483521|Parenting stress|parenting stress
387930|NCT01483521|Childhood externalizing disorders|childhood externalizing disorders
387931|NCT01483521|Positional defiant|positional defiant
387932|NCT01483508|flavanols|flavanols
387933|NCT01483508|procyanidins|procyanidins
387934|NCT01483508|absorption|absorption
387935|NCT01483508|cocoa polyphenols|cocoa polyphenols
387936|NCT01483508|Flavanol and procyanidin absorption in healthy volunteers|flavanol and procyanidin absorption in healthy volunteers
387937|NCT01483482|clavicle fractures|clavicle fractures
387938|NCT01483482|midshaft clavicle fractures|midshaft clavicle fractures
387939|NCT01483482|conservative treatment|conservative treatment
387940|NCT01483482|surgical treatment|surgical treatment
387941|NCT01483482|functional outcome|functional outcome
387942|NCT01483482|clinical assessment|clinical assessment
387943|NCT01483482|adults|adults
387944|NCT01483456|Accidental falls|accidental falls
387945|NCT01483456|safety management|safety management
387946|NCT01483456|aged|aged
387947|NCT01483456|inpatient|inpatient
387948|NCT01483456|stepped wedge design|stepped wedge design
387949|NCT01483443|oophrectomy|oophrectomy
387950|NCT01483443|survival|survival
387951|NCT01483430|Blood pressure|blood pressure
387952|NCT01483430|Korea red ginseng|korea red ginseng
387953|NCT01483430|Ambulatory blood pressure|ambulatory blood pressure
387954|NCT01483430|Pulse wave velocity|pulse wave velocity
387955|NCT01483417|SILS|sils
387956|NCT01483417|Laparoscopic hysterectomy|laparoscopic hysterectomy
387957|NCT01483417|Cosmetic outcome|cosmetic outcome
387958|NCT01483417|Pain|pain
387959|NCT01483404|microcirculation|microcirculation
387960|NCT01483404|caput femoris|caput femoris
387961|NCT01483391|Bipolar disorder|bipolar disorder
387962|NCT01483391|Major depressive disorder|major depressive disorder
387963|NCT01483391|Mania|mania
387964|NCT01483391|Depression|depression
387965|NCT01483391|Cyclothymic Disorder|cyclothymic disorder
387966|NCT01483313|Anesthestics|anesthestics
387967|NCT01483313|Minor surgery|minor surgery
387968|NCT01483313|Wechsler Intelligence Scale for Children|wechsler intelligence scale for children
387969|NCT01483313|Cognitiion|cognitiion
387970|NCT01483300|breast cancer|breast cancer
387971|NCT01483300|gemcitabine|gemcitabine
387972|NCT01483300|lobaplatin|lobaplatin
387973|NCT01483300|cisplatin|cisplatin
387974|NCT01483287|Gastrointestinal Symptoms|gastrointestinal symptoms
387975|NCT01483287|Bloating|bloating
387976|NCT01483287|Distention|distention
387977|NCT01483274|AML|aml
387978|NCT01483274|vaccine|vaccine
387979|NCT01483261|Trauma-Focused Cognitive Behavior Therapy|trauma-focused cognitive behavior therapy
387980|NCT01483261|Sexually Exploited Girls|sexually exploited girls
387981|NCT01483261|Post-traumatic Stress Symptoms|post-traumatic stress symptoms
387982|NCT01483261|Psychosocial Distress|psychosocial distress
387983|NCT01483248|Menstrual blood|menstrual blood
387984|NCT01483248|Mesenchymal stem cell|mesenchymal stem cell
387985|NCT01483248|Liver cirrhosis|liver cirrhosis
387986|NCT01483235|cardiac rehabilitation|cardiac rehabilitation
387987|NCT01483235|prevention|prevention
387988|NCT01483235|exercise capacity|exercise capacity
387989|NCT01483222|Low Back Pain|low back pain
387990|NCT01483222|Braces|braces
387991|NCT01483222|Prevention|prevention
387992|NCT01483209|Digital ischemia|digital ischemia
387993|NCT01483209|Vasopressor|vasopressor
387994|NCT01483183|Atrial fibrillation|atrial fibrillation
387995|NCT01483183|Paroxysmal Atrial fibrillation|paroxysmal atrial fibrillation
387996|NCT01483183|Persistent Atrial fibrillation|persistent atrial fibrillation
387998|NCT01483144|Familial Adenomatous Polyposis|familial adenomatous polyposis
387999|NCT01483144|Eflornithine|eflornithine
388000|NCT01483144|Sulindac|sulindac
388001|NCT01483118|PCOS|pcos
388002|NCT01483118|Insulin resistance|insulin resistance
388003|NCT01483118|Cinnamon extract|cinnamon extract
388004|NCT01483118|Irregular menstrual cycles|irregular menstrual cycles
388005|NCT01483118|Ovarian cysts|ovarian cysts
388006|NCT01483105|VCUG|vcug
388007|NCT01483105|Child|child
388008|NCT01483105|Hypnosis|hypnosis
388009|NCT01483105|Relaxation|relaxation
388010|NCT01483105|Voiding cystourethrography|voiding cystourethrography
388011|NCT01483079|donor human milk products|donor human milk products
388012|NCT01483079|post-discharge|post-discharge
388013|NCT01483079|growth|growth
388014|NCT01483079|development|development
388015|NCT01483053|Major depressive disorder|major depressive disorder
388016|NCT01483053|Sympathetic nervous system activation|sympathetic nervous system activation
388017|NCT01483053|Cardiovascular risk factors|cardiovascular risk factors
388018|NCT01483053|Agomelatine|agomelatine
388019|NCT01483053|Escitalopram|escitalopram
388020|NCT01483040|wide angle view colonoscopy|wide angle view colonoscopy
388021|NCT01483040|PeerScope B System™|peerscope b system™
388022|NCT01483014|Gastrointestinal,|gastrointestinal,
388023|NCT01483014|stromal,|stromal,
388024|NCT01483014|neoadjuvant,|neoadjuvant,
388025|NCT01483014|imatinib,|imatinib,
388026|NCT01483014|mesylate,|mesylate,
388027|NCT01483014|pre-operatory|pre-operatory
388028|NCT01483001|Cancer Stem Cells|cancer stem cells
388029|NCT01483001|Chemo-Sensitivity Assay|chemo-sensitivity assay
388030|NCT01483001|Cancer Treatment|cancer treatment
388031|NCT01482988|prevalence of the Dectin-1 polymorphism (Tyr238X)|prevalence of the dectin-1 polymorphism (tyr238x)
388032|NCT01482975|tobacco|tobacco
388033|NCT01482975|alcohol|alcohol
388034|NCT01482975|diet|diet
388035|NCT01482975|exercise|exercise
388036|NCT01482962|Drug Therapy|drug therapy
388037|NCT01482949|RCC|rcc
388038|NCT01482949|Kidney Cancer|kidney cancer
388039|NCT01482949|Renal Cancer|renal cancer
388040|NCT01482949|Arcelis|arcelis
388041|NCT01482923|Tobacco Use Assessment|tobacco use assessment
388042|NCT01482923|smoke tobacco|smoke tobacco
388043|NCT01482923|quit smoking|quit smoking
388044|NCT01482923|tobacco cessation|tobacco cessation
388045|NCT01482923|HIV/AIDS|hiv/aids
388046|NCT01482923|Community-Based Service Organizations|community-based service organizations
388047|NCT01482923|11-173|11-173
388048|NCT01482923|Low-Income Persons Living with HIV/AIDS|low-income persons living with hiv/aids
388049|NCT01482897|Discal sciatica, infiltrations|discal sciatica, infiltrations
388050|NCT01482897|Subjects|subjects
388051|NCT01482897|evolving|evolving
388052|NCT01482884|tralokinumab|tralokinumab
388053|NCT01482884|inflammatory bowel disease|inflammatory bowel disease
388054|NCT01482884|moderate to severe ulcerative colitis|moderate to severe ulcerative colitis
388055|NCT01482871|Diabetic Macular Edema|diabetic macular edema
388056|NCT01482832|Randomized trial|randomized trial
388057|NCT01482832|Postpartum depression|postpartum depression
388058|NCT01482832|Adolescent pregnancy|adolescent pregnancy
388059|NCT01482832|Interpersonal psychotherapy|interpersonal psychotherapy
388060|NCT01482806|Depression|depression
388061|NCT01482806|Anxiety|anxiety
388062|NCT01482806|Primary care|primary care
388063|NCT01482806|Cognitive Behavioral Therapy|cognitive behavioral therapy
388064|NCT01482806|Internet|internet
388065|NCT01482806|Support groups|support groups
388066|NCT01482806|Technology assisted|technology assisted
388067|NCT01482741|Quality of Life|quality of life
388068|NCT01482741|Focus groups|focus groups
388069|NCT01482741|Risks of Ionizing Radiation|risks of ionizing radiation
388070|NCT01482741|Risk of medical imaging|risk of medical imaging
388071|NCT01482741|11-185|11-185
388072|NCT01482715|gBRCA ovarian cancer|gbrca ovarian cancer
388073|NCT01482715|platinum sensitive|platinum sensitive
388074|NCT01482715|PARP Inhibitor|parp inhibitor
388075|NCT01482715|Rucaparib|rucaparib
388076|NCT01482715|CO-338|co-338
388077|NCT01482715|PF 01367338|pf 01367338
388078|NCT01482715|AG 14699|ag 14699
388079|NCT01482715|BRCA1|brca1
388080|NCT01482715|BRCA2|brca2
388081|NCT01482715|platinum sensitive ovarian cancer|platinum sensitive ovarian cancer
388082|NCT01482715|platinum sensitive gBRCA ovarian cancer|platinum sensitive gbrca ovarian cancer
388083|NCT01482715|gynecological cancer|gynecological cancer
388084|NCT01482715|relapsed disease|relapsed disease
388085|NCT01482715|homologous recombination deficiency|homologous recombination deficiency
388086|NCT01482715|HRD|hrd
388087|NCT01482702|breast cancer survivor|breast cancer survivor
388088|NCT01482702|weight loss|weight loss
388089|NCT01482702|postmenopausal|postmenopausal
388090|NCT01482702|Weight loss for overweight postmenopausal breast cancer survivors|weight loss for overweight postmenopausal breast cancer survivors
388091|NCT01482689|Bioavailability|bioavailability
388092|NCT01482689|Vitamin D metabolism|vitamin d metabolism
388093|NCT01482689|Bone turnover|bone turnover
388094|NCT01482663|Hand eczema|hand eczema
388095|NCT01482663|Hand dermatitis|hand dermatitis
388197|NCT01482234|prompts|prompts
388096|NCT01482663|Chronic hand eczema|chronic hand eczema
388097|NCT01482663|Chronic hand dermatitis|chronic hand dermatitis
388098|NCT01482663|Contact dermatitis|contact dermatitis
388099|NCT01482663|Skin disease|skin disease
388100|NCT01482663|Self-management|self-management
388101|NCT01482650|Baska mask|baska mask
388102|NCT01482650|LMA|lma
388103|NCT01482650|laryngeal mask airway|laryngeal mask airway
388104|NCT01482650|supraglottic airway device|supraglottic airway device
388105|NCT01482624|hyaluronan|hyaluronan
388106|NCT01482624|hyaluronic acid|hyaluronic acid
388107|NCT01482611|Hepatitis C Virus|hepatitis c virus
388108|NCT01482611|JNJ-47910382|jnj-47910382
388109|NCT01482611|47910382HPC1001|47910382hpc1001
388110|NCT01482611|HCV|hcv
388111|NCT01482611|Hepatitis C|hepatitis c
388112|NCT01482611|Hep C|hep c
388113|NCT01482611|Healthy participants|healthy participants
388114|NCT01482611|Japanese|japanese
388115|NCT01482611|Caucasians|caucasians
388116|NCT01482598|Heart Failure|heart failure
388117|NCT01482598|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
388118|NCT01482598|Remote Care|remote care
388119|NCT01482598|Disease Management|disease management
388120|NCT01482585|lung adenocarcinoma|lung adenocarcinoma
388121|NCT01482585|prognosis|prognosis
388122|NCT01482585|tumor aggressiveness|tumor aggressiveness
388123|NCT01482585|imaging biomarker|imaging biomarker
388124|NCT01482585|genetic biomarker|genetic biomarker
388125|NCT01482572|biopsy|biopsy
388126|NCT01482572|needle aspiration|needle aspiration
388127|NCT01482572|mutational analysis|mutational analysis
388128|NCT01482559|Dopamine|dopamine
388129|NCT01482559|Intraventricular haemorrhage|intraventricular haemorrhage
388130|NCT01482559|Periventricular Leukomalacia|periventricular leukomalacia
388131|NCT01482559|Neurodisability|neurodisability
388132|NCT01482559|Infant|infant
388133|NCT01482546|colonoscopy|colonoscopy
388134|NCT01482546|trainees|trainees
388135|NCT01482546|water|water
388136|NCT01482546|adenoma detection rate|adenoma detection rate
388137|NCT01482546|cecal intubation rate|cecal intubation rate
388138|NCT01482494|Myopathies|myopathies
388139|NCT01482494|Pompe disease|pompe disease
388140|NCT01482494|Polymyositis|polymyositis
388141|NCT01482494|Respiratory Insufficiency|respiratory insufficiency
388142|NCT01482481|Patient Care Planning|patient care planning
388143|NCT01482481|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
388144|NCT01482481|Cardiovascular Risk Factors|cardiovascular risk factors
388145|NCT01482481|Primary Health Care|primary health care
388146|NCT01482481|Spain|spain
388147|NCT01482455|Insulin resistance|insulin resistance
388148|NCT01482455|vascular impairment|vascular impairment
388149|NCT01482455|diabetes|diabetes
388150|NCT01482442|Liver, HCC|liver, hcc
388151|NCT01482442|Liver, interventional procedures|liver, interventional procedures
388152|NCT01482442|Liver, randomized studies|liver, randomized studies
388153|NCT01482442|Liver, targeted therapy|liver, targeted therapy
388154|NCT01482442|Liver, RADIOEMBOLIZATION|liver, radioembolization
388155|NCT01482429|ventilator weaning|ventilator weaning
388156|NCT01482429|protocol|protocol
388157|NCT01482416|hormone replacement therapy|hormone replacement therapy
388158|NCT01482416|Doppler velocimetry|doppler velocimetry
388159|NCT01482416|Flow-mediated dilation|flow-mediated dilation
388160|NCT01482416|menopause|menopause
388161|NCT01482364|HOTMAN System|hotman system
388162|NCT01482364|Hemodynamic integrated management|hemodynamic integrated management
388163|NCT01482351|apnea|apnea
388164|NCT01482351|cognition|cognition
388165|NCT01482351|memory|memory
388166|NCT01482351|function|function
388167|NCT01482351|amnestic mild cognitive impairment|amnestic mild cognitive impairment
388168|NCT01482351|older adults|older adults
388169|NCT01482351|Alzheimer's Disease|alzheimer's disease
388170|NCT01482338|PMS|pms
388171|NCT01482338|Low-dose combine contraceptives pills|low-dose combine contraceptives pills
388172|NCT01482338|COC|coc
388173|NCT01482299|pS6 Ser 240/4|ps6 ser 240/4
388174|NCT01482299|RAD001 (everolimus)|rad001 (everolimus)
388175|NCT01482299|second-line treatment|second-line treatment
388176|NCT01482299|advanced gastric cancer|advanced gastric cancer
388177|NCT01482286|Exercise|exercise
388178|NCT01482286|Diet|diet
388179|NCT01482286|Insulin resistance|insulin resistance
388180|NCT01482286|Weight|weight
388181|NCT01482273|catheter-directed thrombolysis|catheter-directed thrombolysis
388182|NCT01482273|ilio-femoral deep vein thrombosis|ilio-femoral deep vein thrombosis
388183|NCT01482273|Postthrombotic syndrome|postthrombotic syndrome
388184|NCT01482273|Phlebographic scores|phlebographic scores
388185|NCT01482273|Phlebography|phlebography
388186|NCT01482273|Catheters|catheters
388187|NCT01482234|physical activity|physical activity
388188|NCT01482234|exercise|exercise
388189|NCT01482234|walking|walking
388190|NCT01482234|pedometers|pedometers
388191|NCT01482234|goal setting|goal setting
388192|NCT01482234|text messages|text messages
388193|NCT01482234|motivation|motivation
388194|NCT01482234|intrinsic motivation|intrinsic motivation
388195|NCT01482234|extrinsic motivation|extrinsic motivation
388196|NCT01482234|self determination theory|self determination theory
388198|NCT01482221|Major Depressive Disorder|major depressive disorder
388199|NCT01482221|MDD|mdd
388200|NCT01482221|Inadequate Response to Antidepressant Therapy|inadequate response to antidepressant therapy
388201|NCT01482221|Channel blocker of the NMDA class of glutamate receptors|channel blocker of the nmda class of glutamate receptors
388202|NCT01482208|Dehydration|dehydration
388203|NCT01482208|Hydration|hydration
388204|NCT01482208|Muscle composition|muscle composition
388205|NCT01482208|Diarrhea|diarrhea
388206|NCT01482208|Pediatrics|pediatrics
388207|NCT01482208|Neonatology|neonatology
388208|NCT01482208|Ultrasound|ultrasound
388209|NCT01482195|Retinal Disease|retinal disease
388210|NCT01482182|Non-small cell lung cancer|non-small cell lung cancer
388211|NCT01482182|Diffusion-weighted MRI|diffusion-weighted mri
388212|NCT01482182|18F-FDG PET|18f-fdg pet
388213|NCT01482182|Treatment response|treatment response
388214|NCT01482182|Prognosis|prognosis
388215|NCT01482169|Left heart catheterization|left heart catheterization
388216|NCT01482169|Fractional flow reserve|fractional flow reserve
388217|NCT01482169|Adenoscan®|adenoscan®
388218|NCT01482169|Regadenoson|regadenoson
388219|NCT01482156|Advanced solid tumors|advanced solid tumors
388220|NCT01482156|Metastatic renal cell carcinoma (mRCC)|metastatic renal cell carcinoma (mrcc)
388221|NCT01482156|ER+/HER2-Metastatic breast cancer (MBC)|er+/her2-metastatic breast cancer (mbc)
388222|NCT01482156|Dose finding study|dose finding study
388223|NCT01482156|mTOR|mtor
388224|NCT01482156|Pl3K|pl3k
388225|NCT01482156|BEZ235|bez235
388226|NCT01482156|RAD001|rad001
388227|NCT01482156|Everolimus|everolimus
388228|NCT01482156|Afinitor®|afinitor®
388229|NCT01482156|ER+/HER2- metastatic breast cancer|er+/her2- metastatic breast cancer
388230|NCT01482143|Fragile X Syndrome|fragile x syndrome
388231|NCT01482143|pharmacokinetics|pharmacokinetics
388232|NCT01482143|safety and tolerability|safety and tolerability
388233|NCT01482130|Exercise|exercise
388234|NCT01482130|osteoporosis|osteoporosis
388235|NCT01482130|prevention|prevention
388236|NCT01482117|CYP2C19|cyp2c19
388237|NCT01482117|CYP3A5|cyp3a5
388238|NCT01482117|Clopidogrel|clopidogrel
388239|NCT01482117|Cilostazol|cilostazol
388240|NCT01482117|Healthy|healthy
388241|NCT01482104|Photochemotherapy|photochemotherapy
388242|NCT01482104|methyl 5-aminolevulinate|methyl 5-aminolevulinate
388243|NCT01482091|fentanyl|fentanyl
388244|NCT01482091|intranasal|intranasal
388245|NCT01482091|sickle cell|sickle cell
388246|NCT01482091|vasoocclusive crisis|vasoocclusive crisis
388247|NCT01482091|pain crisis|pain crisis
388248|NCT01482091|pediatrics|pediatrics
388249|NCT01482078|Magnesium Sulphate|magnesium sulphate
388250|NCT01482078|Neuroprotection|neuroprotection
388251|NCT01482078|Neuraxial Anesthesia|neuraxial anesthesia
388252|NCT01482078|Sedation|sedation
388253|NCT01482078|Respiratory function|respiratory function
388254|NCT01482078|Cesarean Section|cesarean section
388255|NCT01482078|Obstetrical Anesthesia|obstetrical anesthesia
388256|NCT01482065|Non Alcoholic Fatty Liver Disease|non alcoholic fatty liver disease
388257|NCT01482065|NAFLD|nafld
388258|NCT01482065|Continuous Positive Airway Pressure|continuous positive airway pressure
388259|NCT01482065|CPAP|cpap
388260|NCT01482065|CPAP Therapy|cpap therapy
388261|NCT01482065|Apnea Hypopnea Index|apnea hypopnea index
388262|NCT01482065|Non alcoholic steatohepatitis|non alcoholic steatohepatitis
388263|NCT01482065|NASH|nash
388264|NCT01482065|OSA|osa
388265|NCT01482065|Obstructive Sleep Apnea|obstructive sleep apnea
388266|NCT01482065|AHI|ahi
388267|NCT01482052|Central Nervous System Infections|central nervous system infections
388268|NCT01482052|Meningitis|meningitis
388269|NCT01482052|toxoid|toxoid
388270|NCT01482052|Meningococcal vaccine|meningococcal vaccine
388271|NCT01482052|conjugate vaccines|conjugate vaccines
388272|NCT01482039|short cervix|short cervix
388273|NCT01482039|cervical shortening|cervical shortening
388274|NCT01482039|preterm birth|preterm birth
388275|NCT01482026|Epilepsy|epilepsy
388276|NCT01482026|Attention deficit|attention deficit
388277|NCT01482026|ADHD rating scale IV|adhd rating scale iv
388278|NCT01482000|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
388279|NCT01482000|Adult|adult
388280|NCT01482000|therapeutic use|therapeutic use
388281|NCT01482000|Humans|humans
388282|NCT01482000|Treatment Outcome|treatment outcome
388283|NCT01482000|daoyin therapy|daoyin therapy
388284|NCT01481987|Microperimetry|microperimetry
388285|NCT01481987|OCT|oct
388286|NCT01481987|idiopathic epiretinal membrane|idiopathic epiretinal membrane
388287|NCT01481974|liver transplantation|liver transplantation
388288|NCT01481974|treprostinil|treprostinil
388289|NCT01481961|Alzheimer's disease|alzheimer's disease
388290|NCT01481961|rTMS|rtms
388291|NCT01481961|cognition|cognition
388292|NCT01481948|physical activity|physical activity
388293|NCT01481948|fruit and vegetable|fruit and vegetable
388294|NCT01481948|water|water
388295|NCT01481948|girls|girls
388296|NCT01481948|African American|african american
388297|NCT01481948|online|online
388298|NCT01481935|Antibiotic resistant bacteria|antibiotic resistant bacteria
388299|NCT01481935|Colonization|colonization
388300|NCT01481935|Hospital cleaning|hospital cleaning
388301|NCT01481935|Environmental cleaning|environmental cleaning
388302|NCT01481935|Infection Control|infection control
388303|NCT01481922|Lumbar puncture|lumbar puncture
388304|NCT01481922|Flow rate|flow rate
388305|NCT01481922|Backache|backache
388306|NCT01481922|Pain|pain
388307|NCT01481922|Undifferentiated headache|undifferentiated headache
388308|NCT01481922|Post-lumbar puncture headache|post-lumbar puncture headache
388309|NCT01481909|Assessment of wheal and flare development|assessment of wheal and flare development
388310|NCT01481909|Assessment of life quality|assessment of life quality
388311|NCT01481896|Hip replacement|hip replacement
388312|NCT01481896|Metal-on-metal bearings|metal-on-metal bearings
388313|NCT01481896|Osteolysis|osteolysis
388314|NCT01481896|Metal ion levels|metal ion levels
388315|NCT01481896|Outcome|outcome
388316|NCT01481883|Schizophrenia|schizophrenia
388317|NCT01481883|Mental Illness|mental illness
388318|NCT01481883|SERM|serm
388319|NCT01481883|Raloxifene|raloxifene
388320|NCT01481870|renal cell carcinoma|renal cell carcinoma
388321|NCT01481870|sorafenib|sorafenib
388322|NCT01481870|sunitinib|sunitinib
388323|NCT01481870|crossover|crossover
388324|NCT01481844|sequential therapy|sequential therapy
388325|NCT01481844|second line treatment|second line treatment
388326|NCT01481844|H pylori|h pylori
388327|NCT01481792|Keratorefractive Surgical Procedures|keratorefractive surgical procedures
388328|NCT01481766|child development|child development
388329|NCT01481766|screening|screening
388330|NCT01481766|Non-anemic iron deficiency|non-anemic iron deficiency
388331|NCT01481766|primary care pediatrics|primary care pediatrics
388332|NCT01481766|prevention and health promotion|prevention and health promotion
388333|NCT01481740|spinal induced hypotension|spinal induced hypotension
388334|NCT01481740|nausea and vomiting|nausea and vomiting
388335|NCT01481740|cesarean delivery|cesarean delivery
388336|NCT01481727|acute exacerbation of COPD number|acute exacerbation of copd number
388337|NCT01481727|acute exacerbation of COPD severity|acute exacerbation of copd severity
388338|NCT01481714|Sodium picosulphate|sodium picosulphate
388339|NCT01481714|Split-dose|split-dose
388340|NCT01481714|Bowel cleansing|bowel cleansing
388341|NCT01481714|colonoscopy|colonoscopy
388342|NCT01481714|Degree of bowel cleansing during colonoscopy|degree of bowel cleansing during colonoscopy
388343|NCT01481701|ovarian carcinoma|ovarian carcinoma
388344|NCT01481701|Bordet|bordet
388345|NCT01481701|relapse|relapse
388346|NCT01481688|Dialysis adequacy|dialysis adequacy
388347|NCT01481688|Urea clearance|urea clearance
388348|NCT01481688|Phosphate clearance|phosphate clearance
388349|NCT01481688|Beta 2 microglobulin clearance|beta 2 microglobulin clearance
388350|NCT01481688|Intradialytic exercise|intradialytic exercise
388351|NCT01481688|Haemodialysis patients|haemodialysis patients
388352|NCT01481675|biliopancreatic diversion|biliopancreatic diversion
388353|NCT01481675|sleeve gastrectomy|sleeve gastrectomy
388354|NCT01481675|diabetes mellitus|diabetes mellitus
388355|NCT01481675|weight loss|weight loss
388356|NCT01481675|ghrelin|ghrelin
388358|NCT01481675|GLP-1|glp-1
388359|NCT01481662|SUSAC's Syndrome|susac's syndrome
388360|NCT01481662|encephalopathy|encephalopathy
388361|NCT01481662|hearing loss|hearing loss
388362|NCT01481662|retinal artery branch occlusions|retinal artery branch occlusions
388363|NCT01481662|Diffusion tensor MRI|diffusion tensor mri
388364|NCT01481649|hepatitis B|hepatitis b
388365|NCT01481649|anti-HBc|anti-hbc
388366|NCT01481649|HBsAg|hbsag
388367|NCT01481649|HSCT|hsct
388368|NCT01481649|recipients|recipients
388369|NCT01481636|Obstructive sleep apnea|obstructive sleep apnea
388370|NCT01481636|correlation|correlation
388371|NCT01481636|AHI|ahi
388372|NCT01481636|symptoms|symptoms
388373|NCT01481636|mechanisms|mechanisms
388374|NCT01481623|Diabetes|diabetes
388375|NCT01481623|neonatal|neonatal
388376|NCT01481623|consanguinity|consanguinity
388377|NCT01481623|monogenic|monogenic
388378|NCT01481623|metabolism|metabolism
388379|NCT01481610|Kidney Failure, Chronic|kidney failure, chronic
388380|NCT01481610|Arthralgia|arthralgia
388381|NCT01481610|NSAID|nsaid
388382|NCT01481610|Diclofenac|diclofenac
388383|NCT01481610|Lumiracoxib|lumiracoxib
388384|NCT01481610|Safety|safety
388385|NCT01481597|deuteporfin|deuteporfin
388386|NCT01481597|safety|safety
388387|NCT01481597|tolerability|tolerability
388388|NCT01481597|pharmacokinetics|pharmacokinetics
388389|NCT01481597|healthy volunteers|healthy volunteers
388390|NCT01481584|Dietary protein|dietary protein
388391|NCT01481584|Canola protein|canola protein
388392|NCT01481584|Protein metabolism|protein metabolism
388393|NCT01481584|Protein-enriched drinks|protein-enriched drinks
388394|NCT01481584|Nitrogen balance|nitrogen balance
388395|NCT01481571|Media for vitrification/warming of human oocytes|media for vitrification/warming of human oocytes
388396|NCT01481558|Apathy|apathy
388397|NCT01481558|Alzheimer's Disease|alzheimer's disease
388398|NCT01481558|Dementia|dementia
388399|NCT01481545|locally advanced|locally advanced
388400|NCT01481545|high risk|high risk
388401|NCT01481545|preoperative therapy|preoperative therapy
388402|NCT01481532|Antineoplastic agent|antineoplastic agent
388403|NCT01481519|Conjunctivitis|conjunctivitis
388404|NCT01481519|Ocular diseases|ocular diseases
388405|NCT01481519|Artificial tears|artificial tears
388406|NCT01481493|rheumatoid arthritis|rheumatoid arthritis
388407|NCT01481480|shoulder|shoulder
388408|NCT01481480|rotator cuff|rotator cuff
388409|NCT01481480|tendon transfer|tendon transfer
388410|NCT01481480|arthroscopic repair|arthroscopic repair
388411|NCT01481467|influenza vaccination|influenza vaccination
388412|NCT01481467|intervention mapping|intervention mapping
388413|NCT01481467|hospital care|hospital care
388414|NCT01481467|respiratory infections|respiratory infections
388415|NCT01481467|vaccination|vaccination
388416|NCT01481454|Influenza|influenza
388417|NCT01481454|Quadrivalent Inactivated Influenza Vaccine|quadrivalent inactivated influenza vaccine
388418|NCT01481454|Trivalent Inactivated Influenza Vaccine|trivalent inactivated influenza vaccine
388419|NCT01481441|Contrast Enhanced Ultrasound (CEUS)|contrast enhanced ultrasound (ceus)
388420|NCT01481441|Prostate cancer|prostate cancer
388421|NCT01481441|Quantification|quantification
388422|NCT01481441|Prostate biopsies|prostate biopsies
388423|NCT01481441|Transrectal ultrasound (TRUS)|transrectal ultrasound (trus)
388424|NCT01481441|Microbubbles|microbubbles
388425|NCT01481428|High risk behavior|high risk behavior
388426|NCT01481428|Drug court clients|drug court clients
388427|NCT01481428|Substance abuse|substance abuse
388428|NCT01481428|HIV intervention|hiv intervention
388429|NCT01481428|Treatment Court Clients|treatment court clients
388430|NCT01481415|left atrial|left atrial
388431|NCT01481415|three-dimensional echocardioraphy|three-dimensional echocardioraphy
388432|NCT01481415|left atrial function|left atrial function
388433|NCT01481402|Heart failure|heart failure
388434|NCT01481402|Liothyronine|liothyronine
388435|NCT01481402|Low T3 syndrome|low t3 syndrome
388436|NCT01481389|Blood lipids|blood lipids
388437|NCT01481389|risk factor for cardiovascular diseases|risk factor for cardiovascular diseases
388438|NCT01481376|Parietex™ ProGrip™|parietex™ progrip™
388439|NCT01481376|Laparoscopic Transabdominal preperitoneal|laparoscopic transabdominal preperitoneal
388440|NCT01481376|TAPP|tapp
388441|NCT01481376|Inguinal hernia repair|inguinal hernia repair
388442|NCT01481363|dementia|dementia
388443|NCT01481363|communication|communication
388444|NCT01481363|carers|carers
388445|NCT01481363|caregivers|caregivers
388446|NCT01481363|psychosocial support systems|psychosocial support systems
388447|NCT01481363|education|education
388448|NCT01481337|colon|colon
388449|NCT01481337|endoscopy|endoscopy
388450|NCT01481337|resection|resection
388451|NCT01481324|Clubfoot|clubfoot
388452|NCT01481324|Compliance|compliance
388453|NCT01481324|Brace wear|brace wear
388454|NCT01481285|Bioelectrical Impedance Measurement|bioelectrical impedance measurement
388455|NCT01481285|Adults|adults
388456|NCT01481272|Salvage therapy in DLBCL|salvage therapy in dlbcl
388457|NCT01481259|Nonsquamous non-small cell lung cancer|nonsquamous non-small cell lung cancer
388458|NCT01481259|Maintenance therapy|maintenance therapy
388459|NCT01481259|Immunotherapy|immunotherapy
388460|NCT01481259|Autologous cytokine-induced killer cell|autologous cytokine-induced killer cell
388461|NCT01481259|Pemetrexed|pemetrexed
388462|NCT01481246|neurorehabilitation|neurorehabilitation
388463|NCT01481246|cognition|cognition
388464|NCT01481246|aging|aging
388465|NCT01481246|MCI|mci
388466|NCT01481246|cognitive decline|cognitive decline
388467|NCT01481233|oral colchicine|oral colchicine
388468|NCT01481233|castrate-resistant prostate cancer|castrate-resistant prostate cancer
388469|NCT01481233|failed taxotere based chemotherapy|failed taxotere based chemotherapy
388470|NCT01481220|Myelodysplastic syndrome|myelodysplastic syndrome
388471|NCT01481220|azacitidine|azacitidine
388472|NCT01481220|Eltrombopag|eltrombopag
388473|NCT01481220|Thrombopoietin-receptor agonist|thrombopoietin-receptor agonist
388474|NCT01481220|Thrombocytopenia|thrombocytopenia
388475|NCT01481220|Transfusion dependency|transfusion dependency
388476|NCT01481220|Safety study|safety study
388477|NCT01481207|magnetic resonance spectroscopy|magnetic resonance spectroscopy
388478|NCT01481207|magnetic resonance imaging|magnetic resonance imaging
388479|NCT01481194|Multiple Myeloma|multiple myeloma
388480|NCT01481181|zinc water diarrhoea growth preschool children|zinc water diarrhoea growth preschool children
388481|NCT01481155|actinic keratosis|actinic keratosis
388482|NCT01481155|field cancerisation|field cancerisation
388483|NCT01481116|Drug Therapy|drug therapy
388484|NCT01481103|Over the counter medication|over the counter medication
388485|NCT01481103|Acupuncture|acupuncture
388486|NCT01481090|Infertility|infertility
388487|NCT01481090|acupuncture|acupuncture
388488|NCT01481090|frozen embryos|frozen embryos
388489|NCT01481090|endometrium|endometrium
388490|NCT01481090|TCM|tcm
388491|NCT01481064|Patient centredness|patient centredness
388492|NCT01481064|Quality of life|quality of life
388493|NCT01481064|Multifaceted approach|multifaceted approach
388494|NCT01481064|Fertility care|fertility care
388495|NCT01481038|early detection|early detection
388496|NCT01481038|CRBSI|crbsi
388497|NCT01481025|Climacteric|climacteric
388498|NCT01481025|Depression|depression
388499|NCT01481025|Herbal treatment|herbal treatment
388500|NCT01481012|Heart transplantation|heart transplantation
388501|NCT01481012|Coronary artery bypass graft (CABG) surgery|coronary artery bypass graft (cabg) surgery
388502|NCT01481012|Left ventricular assist device implantation surgeries|left ventricular assist device implantation surgeries
388503|NCT01480999|Laparotomy|laparotomy
388504|NCT01480999|Open Surgery|open surgery
388505|NCT01480999|Laparoscopy|laparoscopy
388506|NCT01480999|Robotic surgery|robotic surgery
388507|NCT01480960|lung transplantation|lung transplantation
388508|NCT01480960|whole body vibration|whole body vibration
388509|NCT01480960|exercise training|exercise training
388510|NCT01480960|pulmonary rehabilitation|pulmonary rehabilitation
388511|NCT01480947|probiotics|probiotics
388512|NCT01480947|pediatric|pediatric
388513|NCT01480947|salmonella|salmonella
388514|NCT01480947|rotavirus|rotavirus
388515|NCT01480947|gastroenteritis|gastroenteritis
388516|NCT01480934|Diabetes,posterior capsule opacification,case control study|diabetes,posterior capsule opacification,case control study
388517|NCT01480921|heart failure|heart failure
388518|NCT01480921|health related quality of life|health related quality of life
388519|NCT01480921|exercise capacity|exercise capacity
388520|NCT01480921|home based exercise training|home based exercise training
388521|NCT01480921|supervised exercise training|supervised exercise training
388522|NCT01480908|Right bundle branch block|right bundle branch block
388523|NCT01480908|Ventricular septal defect|ventricular septal defect
388524|NCT01480908|Echocardiography|echocardiography
388525|NCT01480908|MRI|mri
388526|NCT01480908|Exercise testing|exercise testing
388527|NCT01480895|Diabetes Mellitus Type 2|diabetes mellitus type 2
388528|NCT01480895|Gestational Diabetes Mellitus|gestational diabetes mellitus
388529|NCT01480895|Glucose Intolerance|glucose intolerance
388530|NCT01480895|Physical exercise|physical exercise
388531|NCT01480895|Nutritional Habits|nutritional habits
388532|NCT01480895|Dyslipidemia|dyslipidemia
388533|NCT01480882|Manual percussion|manual percussion
388534|NCT01480882|Mechanical percussion|mechanical percussion
388535|NCT01480882|Chronic bronchiectasis|chronic bronchiectasis
388536|NCT01480882|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
388537|NCT01480882|Wet sputum weight|wet sputum weight
388538|NCT01480882|Dry sputum weight|dry sputum weight
388539|NCT01480869|Breast cancer|breast cancer
388540|NCT01480869|Vitamin D supplementation|vitamin d supplementation
388541|NCT01480869|in neoadjuvant|in neoadjuvant
388542|NCT01480869|adjuvant setting|adjuvant setting
388543|NCT01480843|simplification|simplification
388544|NCT01480843|glargine|glargine
388545|NCT01480843|elderly|elderly
388546|NCT01480830|Quality|quality
388547|NCT01480830|indicators|indicators
388548|NCT01480804|Barriers|barriers
388549|NCT01480804|Intervention|intervention
388550|NCT01480804|Elderly|elderly
388551|NCT01480804|glycemic control|glycemic control
388552|NCT01480791|resistance arteries|resistance arteries
388553|NCT01480791|endothelial dysfunction|endothelial dysfunction
388554|NCT01480791|aortic stiffness|aortic stiffness
388555|NCT01480778|hormonal response, levonorgestrel, ethinyl estradiol|hormonal response, levonorgestrel, ethinyl estradiol
388556|NCT01480752|In the patients with symptomatic Irreversible Pulpitis|in the patients with symptomatic irreversible pulpitis
388557|NCT01480739|Phase 1, AZD5069, safety and tolerability, healthy volunteer,|phase 1, azd5069, safety and tolerability, healthy volunteer,
388558|NCT01480713|HIV-1|hiv-1
388559|NCT01480713|protease inhibitors|protease inhibitors
388560|NCT01480713|integrase inhibitors|integrase inhibitors
388561|NCT01480713|raltegravir|raltegravir
388562|NCT01480713|viral replication|viral replication
388563|NCT01480713|treatment intensification|treatment intensification
388564|NCT01480713|viral pathogenesis|viral pathogenesis
388565|NCT01480713|immune activation|immune activation
388566|NCT01480700|eggs|eggs
388567|NCT01480700|Optical Macular Pigment|optical macular pigment
388568|NCT01480700|Age Macular Degeneration|age macular degeneration
388569|NCT01480700|study for the Age Macular Degeneration prevention|study for the age macular degeneration prevention
388570|NCT01480687|Hypertension|hypertension
388571|NCT01480687|Endothelial dysfunction|endothelial dysfunction
388572|NCT01480687|Vascular stiffness|vascular stiffness
388573|NCT01480661|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
388574|NCT01480661|Computed Tomography scan|computed tomography scan
388575|NCT01480661|Functional Respiratory Imaging|functional respiratory imaging
388576|NCT01480661|Roflumilast|roflumilast
388577|NCT01480661|Health Related Quality of Life|health related quality of life
388578|NCT01480635|Incomplete Colonoscopy|incomplete colonoscopy
388579|NCT01480635|Efficacy of PillCam Colon2|efficacy of pillcam colon2
388580|NCT01480622|healthy subjects|healthy subjects
388581|NCT01480622|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
388582|NCT01480622|hepatitis|hepatitis
388583|NCT01480622|pharmacokinetics|pharmacokinetics
388584|NCT01480583|GRN1005|grn1005
388585|NCT01480583|ANG1005|ang1005
388586|NCT01480583|Peptide-Drug Conjugate (PDC)|peptide-drug conjugate (pdc)
388587|NCT01480583|LRP-1|lrp-1
388588|NCT01480583|Targeted Therapy|targeted therapy
388589|NCT01480583|Breast Cancer|breast cancer
388590|NCT01480583|Brain Metastases|brain metastases
388591|NCT01480583|Brain Tumor|brain tumor
388592|NCT01480583|Blood Brain Barrier|blood brain barrier
388593|NCT01480583|Trastuzumab|trastuzumab
388594|NCT01480583|Herceptin|herceptin
388595|NCT01480583|Paclitaxel|paclitaxel
388596|NCT01480583|Taxol|taxol
388597|NCT01480583|Breast cancer with brain metastases|breast cancer with brain metastases
388598|NCT01480557|cataract|cataract
388599|NCT01480557|phacoemulsification|phacoemulsification
388600|NCT01480557|liquefaction|liquefaction
388601|NCT01480557|torsional ip|torsional ip
388602|NCT01480557|endothelial cell count|endothelial cell count
388603|NCT01480557|central corneal edema|central corneal edema
388604|NCT01480557|central corneal sensitivity|central corneal sensitivity
388605|NCT01480544|Institutional Deliveries|institutional deliveries
388606|NCT01480544|Maternal Health|maternal health
388607|NCT01480544|Infant Health|infant health
388608|NCT01480544|Private Medical Providers|private medical providers
388609|NCT01480544|Provider Incentives|provider incentives
388610|NCT01480544|Randomized Control Trial|randomized control trial
388611|NCT01480531|aorta|aorta
388612|NCT01480531|aneurysm|aneurysm
388613|NCT01480531|dissection|dissection
388614|NCT01480518|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
388615|NCT01480505|Retinal detachment|retinal detachment
388616|NCT01480505|high myopia|high myopia
388617|NCT01480505|macular hole|macular hole
388618|NCT01480505|axial length|axial length
388619|NCT01480505|Scleral buckling|scleral buckling
388620|NCT01480505|Vitrectomy|vitrectomy
388621|NCT01480505|Visual acuity|visual acuity
388622|NCT01480505|fundus examination results|fundus examination results
388623|NCT01480492|HBV|hbv
388624|NCT01480492|Immune|immune
388625|NCT01480492|antiviral therapy|antiviral therapy
388626|NCT01480479|EGFRvIII|egfrviii
388627|NCT01480479|Glioblastoma|glioblastoma
388628|NCT01480479|Small cell|small cell
388629|NCT01480479|Giant cell|giant cell
388630|NCT01480479|Gliosarcoma|gliosarcoma
388631|NCT01480479|oligodendroglial|oligodendroglial
388632|NCT01480479|Brain Cancer|brain cancer
388633|NCT01480479|Brain Tumor|brain tumor
388634|NCT01480479|radiotherapy|radiotherapy
388635|NCT01480479|chemoradiation|chemoradiation
388636|NCT01480479|Tumor|tumor
388637|NCT01480479|temozolomide|temozolomide
388638|NCT01480479|EGFR variant III|egfr variant iii
388639|NCT01480466|Overweight|overweight
388640|NCT01480466|Obesity|obesity
388641|NCT01480466|Body mass index|body mass index
388642|NCT01480466|Weight|weight
388643|NCT01480466|Primary care|primary care
388644|NCT01480453|Osteoarthritis|osteoarthritis
388645|NCT01480453|Rheumatoid arthritis|rheumatoid arthritis
388646|NCT01480453|Post-traumatic arthritis|post-traumatic arthritis
388647|NCT01480453|Ununited humeral head fracture|ununited humeral head fracture
388648|NCT01480453|Irreducible 3- and 4-part proximal humeral fractures|irreducible 3- and 4-part proximal humeral fractures
388649|NCT01480453|Avascular necrosis|avascular necrosis
388650|NCT01480440|Reverse Total Shoulder Arthroplasty|reverse total shoulder arthroplasty
388651|NCT01480440|Reverse TSA|reverse tsa
388652|NCT01480440|Osteoarthritis|osteoarthritis
388653|NCT01480440|Rheumatoid Arthritis|rheumatoid arthritis
388654|NCT01480440|Post-traumatic arthritis|post-traumatic arthritis
388655|NCT01480440|Ununited humeral head fracture|ununited humeral head fracture
388656|NCT01480440|Irreducible 3-and 4-part proximal humeral fractures|irreducible 3-and 4-part proximal humeral fractures
388657|NCT01480440|Avascular necrosis|avascular necrosis
388658|NCT01480440|Gross rotator cuff deficiency|gross rotator cuff deficiency
388659|NCT01480440|Failed total shoulder arthroplasty (both glenoid and humeral components require revision|failed total shoulder arthroplasty (both glenoid and humeral components require revision
388660|NCT01480427|Children aged 0-12 years|children aged 0-12 years
388661|NCT01480427|IgE mediated food allergy|ige mediated food allergy
388662|NCT01480414|bone marrow mono nuclear stem cell ischemic ulcer|bone marrow mono nuclear stem cell ischemic ulcer
388663|NCT01480401|Patients with stable heart failure|patients with stable heart failure
388664|NCT01480388|Rheumatoid arthritis|rheumatoid arthritis
388665|NCT01480388|Swollen and tender joints|swollen and tender joints
388666|NCT01480388|Dose range finding study|dose range finding study
388667|NCT01480388|Concurrent treatment with methotrexate|concurrent treatment with methotrexate
388668|NCT01480375|prostate cancer detection|prostate cancer detection
388669|NCT01480375|prostate biopsy|prostate biopsy
388670|NCT01480375|3d navigation|3d navigation
388671|NCT01480375|trans rectal ultrasound|trans rectal ultrasound
388672|NCT01480362|Diabetic foot wound|diabetic foot wound
388673|NCT01480362|Amputation wound|amputation wound
388674|NCT01480362|Chronic wound|chronic wound
388675|NCT01480349|Post-Hemorrhagic Hydrocephalus|post-hemorrhagic hydrocephalus
388676|NCT01480349|Intraventricular Hemorrhage|intraventricular hemorrhage
388677|NCT01480349|Low Birth Weight Premature Infants|low birth weight premature infants
388678|NCT01480336|Arrhythmia|arrhythmia
388679|NCT01480323|Malignant melanoma|malignant melanoma
388680|NCT01480297|Pain|pain
388681|NCT01480297|Neuropathy|neuropathy
388682|NCT01480297|Diabetes type 1|diabetes type 1
388683|NCT01480284|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
388684|NCT01480284|Chronic Hepatitis B|chronic hepatitis b
388685|NCT01480271|Allergic Rhinitis|allergic rhinitis
388686|NCT01480271|Healthy Volunteers|healthy volunteers
388687|NCT01480271|Single Dose Escalation|single dose escalation
388688|NCT01480271|TLR7 agonist|tlr7 agonist
388689|NCT01480271|First Time in Human Study|first time in human study
388690|NCT01480258|combination vaccine|combination vaccine
388691|NCT01480258|diphtheria|diphtheria
388692|NCT01480258|pertussis|pertussis
388693|NCT01480258|tetanus|tetanus
388694|NCT01480258|hepatitis B|hepatitis b
388695|NCT01480258|Hep B|hep b
388696|NCT01480258|Haemophilus influenzae b|haemophilus influenzae b
388697|NCT01480258|Hib|hib
388698|NCT01480258|polio|polio
388699|NCT01480258|poliovirus|poliovirus
388700|NCT01480245|968|968
388701|NCT01480245|Duchenne|duchenne
388702|NCT01480245|DMD|dmd
388703|NCT01480245|drisapersen|drisapersen
388704|NCT01480219|voriconazole|voriconazole
388705|NCT01480219|non-melanoma skin cancer|non-melanoma skin cancer
388706|NCT01480219|confounding|confounding
388707|NCT01480219|statistical adjustment|statistical adjustment
388708|NCT01480219|risk adjustment|risk adjustment
388709|NCT01480219|lung transplant|lung transplant
388710|NCT01480219|heart/lung transplant|heart/lung transplant
388711|NCT01480219|immunosuppression|immunosuppression
388712|NCT01480193|Tinnitus|tinnitus
388713|NCT01480167|VCF|vcf
388714|NCT01480167|Osteoporosis|osteoporosis
388715|NCT01480167|Minimally Invasive|minimally invasive
388716|NCT01480167|Non-operative management|non-operative management
388717|NCT01480167|Medical Management|medical management
388718|NCT01480128|Single-port|single-port
388719|NCT01480128|Laparoscopy|laparoscopy
388720|NCT01480128|colectomy|colectomy
388721|NCT01480128|Single port|single port
388722|NCT01480128|colon cancer|colon cancer
388723|NCT01480128|minimally invasive surgery|minimally invasive surgery
388724|NCT01480115|antral follicle count|antral follicle count
388725|NCT01480115|automated antral follicle count|automated antral follicle count
388726|NCT01480115|ovarian reserve|ovarian reserve
388727|NCT01480102|Percutaneous nephrolithotomy|percutaneous nephrolithotomy
388728|NCT01480102|Paravertebral block|paravertebral block
388729|NCT01480102|bupivacaine|bupivacaine
388730|NCT01480089|Surgical Pain Management|surgical pain management
388731|NCT01480089|Robotic surgery|robotic surgery
388732|NCT01480089|Ropivacaine|ropivacaine
388733|NCT01480076|Quality of Life|quality of life
388734|NCT01480076|Multiple Sclerosis|multiple sclerosis
388735|NCT01480050|adult giant cell glioblastoma|adult giant cell glioblastoma
388736|NCT01480050|adult glioblastoma|adult glioblastoma
388737|NCT01480050|adult anaplastic astrocytoma|adult anaplastic astrocytoma
388738|NCT01480050|adult anaplastic ependymoma|adult anaplastic ependymoma
388739|NCT01480050|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
388740|NCT01480050|adult mixed glioma|adult mixed glioma
388741|NCT01480050|recurrent adult brain tumor|recurrent adult brain tumor
388742|NCT01480024|healthy women|healthy women
388743|NCT01480024|oocytes|oocytes
388744|NCT01480024|in vitro fertilization|in vitro fertilization
388745|NCT01480024|pregnancy|pregnancy
388746|NCT01480024|childbearing-age|childbearing-age
388747|NCT01480011|Lactobacillus CD2 lozenges|lactobacillus cd2 lozenges
388748|NCT01480011|high-dose chemotherapy induced|high-dose chemotherapy induced
388749|NCT01480011|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
388750|NCT01479998|smoking cessation|smoking cessation
388751|NCT01479998|NRT nicotine replacement therapy|nrt nicotine replacement therapy
388752|NCT01479998|CBT cognitive behavioral therapy|cbt cognitive behavioral therapy
388753|NCT01479998|contingency management|contingency management
388754|NCT01479972|Tuberculosis|tuberculosis
388755|NCT01479972|Vaccine|vaccine
388756|NCT01479972|Live vaccine|live vaccine
388757|NCT01479972|rBCG|rbcg
388758|NCT01479959|Tracheostomy|tracheostomy
388759|NCT01479959|positive end expiratory pressure|positive end expiratory pressure
388760|NCT01479959|speech|speech
388761|NCT01479959|respiratory failure|respiratory failure
388762|NCT01479959|ventilation|ventilation
388763|NCT01479959|neuromuscular disorders|neuromuscular disorders
388764|NCT01479933|vitamin D|vitamin d
388765|NCT01479933|cholecalciferol|cholecalciferol
388766|NCT01479933|supplementation|supplementation
388767|NCT01479933|prediabetic state|prediabetic state
388768|NCT01479933|obesity|obesity
388769|NCT01479933|glucose metabolism|glucose metabolism
388770|NCT01479933|gene expression|gene expression
388771|NCT01479933|transcriptomics|transcriptomics
388772|NCT01479933|epigenomics|epigenomics
388773|NCT01479933|immunological function|immunological function
388774|NCT01479933|insulin sensitivity|insulin sensitivity
388775|NCT01479933|peripheral mononuclear cells|peripheral mononuclear cells
388776|NCT01479920|Depressive Disorder|depressive disorder
388777|NCT01479920|Depressive Symptoms|depressive symptoms
388778|NCT01479920|Depressive Syndrome|depressive syndrome
388779|NCT01479920|Emotional Depression|emotional depression
388780|NCT01479881|Hepatitis C Virus|hepatitis c virus
388781|NCT01479881|TMC435|tmc435
389205|NCT01478360|Respiratory|respiratory
388782|NCT01479881|TMC435-TiDP16-C120|tmc435-tidp16-c120
388783|NCT01479881|TMC435-C120|tmc435-c120
388784|NCT01479881|HCV|hcv
388785|NCT01479881|Hepatitis C|hepatitis c
388786|NCT01479881|Hep C|hep c
388787|NCT01479881|Healthy participants|healthy participants
388788|NCT01479868|Hepatitis C virus genotype-1|hepatitis c virus genotype-1
388789|NCT01479868|Human immunodeficiency virus-type 1|human immunodeficiency virus-type 1
388790|NCT01479868|HCV-1|hcv-1
388791|NCT01479868|HIV-1|hiv-1
388792|NCT01479868|TMC435|tmc435
388793|NCT01479868|Pegylated interferon alpha-2a|pegylated interferon alpha-2a
388794|NCT01479868|PegIFNα-2a|pegifnα-2a
388795|NCT01479868|Pegasys|pegasys
388796|NCT01479868|Ribavirin|ribavirin
388797|NCT01479868|RBV|rbv
388798|NCT01479868|Copegus|copegus
388799|NCT01479855|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
388800|NCT01479855|Alzheimers disease|alzheimers disease
388801|NCT01479855|Vitamines|vitamines
388802|NCT01479855|Nutrients|nutrients
388803|NCT01479829|Bipolar depression|bipolar depression
388804|NCT01479829|Celecoxib|celecoxib
388805|NCT01479829|Escitalopram|escitalopram
388806|NCT01479829|Inflammation|inflammation
388807|NCT01479816|continence|continence
388808|NCT01479816|index|index
388809|NCT01479790|Visante AS-OCT|visante as-oct
388810|NCT01479790|Cirrus AS-OCT|cirrus as-oct
388811|NCT01479790|Thermography|thermography
388812|NCT01479790|Tear evaporation|tear evaporation
388813|NCT01479790|Tear evaporimetry|tear evaporimetry
388814|NCT01479777|Spinal Cord Injury|spinal cord injury
388815|NCT01479777|Functional electrical stimulation|functional electrical stimulation
388816|NCT01479777|Rehabilitation|rehabilitation
388817|NCT01479751|Rocuronium|rocuronium
388818|NCT01479751|magnesium|magnesium
388819|NCT01479751|priming|priming
388820|NCT01479751|ketamine|ketamine
388821|NCT01479751|intubation|intubation
388822|NCT01479738|arthroplasty|arthroplasty
388823|NCT01479738|graft|graft
388824|NCT01479738|capitate|capitate
388825|NCT01479738|artery|artery
388826|NCT01479725|interstitial cystitis|interstitial cystitis
388827|NCT01479712|Irrigation|irrigation
388828|NCT01479712|Cesarean Section|cesarean section
388829|NCT01479712|Nausea|nausea
388830|NCT01479712|Infection|infection
388831|NCT01479699|Olive leaf extract|olive leaf extract
388832|NCT01479699|Polyphenols|polyphenols
388833|NCT01479699|Vascular function|vascular function
388834|NCT01479699|Bioavailability|bioavailability
388835|NCT01479699|Cytokines|cytokines
388836|NCT01479686|GLIOMA|glioma
388837|NCT01479686|NEURONAVIGATION|neuronavigation
388838|NCT01479686|INTERVENTIONAL MRI|interventional mri
388839|NCT01479673|Enteral Nutrition|enteral nutrition
388840|NCT01479673|Parenteral Nutrition|parenteral nutrition
388841|NCT01479673|Indirect Calorimetry|indirect calorimetry
388842|NCT01479673|Intravenous Feeding|intravenous feeding
388843|NCT01479660|Probiotics|probiotics
388844|NCT01479660|ulcerative colitis|ulcerative colitis
388845|NCT01479660|inflammatory bowel disease|inflammatory bowel disease
388846|NCT01479634|HIV|hiv
388847|NCT01479634|ART|art
388848|NCT01479621|Dose Ranging|dose ranging
388849|NCT01479621|Fluticasone Propionate|fluticasone propionate
388850|NCT01479621|Dry Powder Inhaler (DPI)|dry powder inhaler (dpi)
388851|NCT01479621|Non-steroidal|non-steroidal
388852|NCT01479621|Asthma|asthma
388853|NCT01479595|Asthma|asthma
388854|NCT01479595|Interleukin|interleukin
388855|NCT01479595|QBX258|qbx258
388856|NCT01479595|QAX576|qax576
388857|NCT01479595|VAK694|vak694
388858|NCT01479582|Adult and Pediatric|adult and pediatric
388859|NCT01479582|Unlicensed Cord Blood Unit IND|unlicensed cord blood unit ind
388860|NCT01479582|NMDP|nmdp
388861|NCT01479582|Transplant|transplant
388862|NCT01479582|Hematologic Malignancies|hematologic malignancies
388863|NCT01479582|Leukemia|leukemia
388864|NCT01479582|Multiple Myeloma|multiple myeloma
388865|NCT01479582|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
388866|NCT01479582|CML|cml
388867|NCT01479582|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
388868|NCT01479582|Myelodyplastic Syndrome|myelodyplastic syndrome
388869|NCT01479582|MDS|mds
388870|NCT01479582|Thalassemia|thalassemia
388871|NCT01479582|Lysosomal Storage Diseases|lysosomal storage diseases
388872|NCT01479569|MRI Catheterization|mri catheterization
388873|NCT01479569|Pericardiocentesis|pericardiocentesis
388874|NCT01479569|MRI Safety|mri safety
388875|NCT01479569|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
388876|NCT01479556|Pregabalin|pregabalin
388877|NCT01479556|Neuropathic pain|neuropathic pain
388878|NCT01479556|At-level neuropathic pain|at-level neuropathic pain
388879|NCT01479556|Non-evoked neuropathic pain|non-evoked neuropathic pain
388880|NCT01479556|Evoked neuropathic pain|evoked neuropathic pain
388881|NCT01479556|Sub-acute spinal cord injury|sub-acute spinal cord injury
388882|NCT01479543|Probiotic|probiotic
388883|NCT01479543|Immunity|immunity
388884|NCT01479543|Gastrointestinal symptoms|gastrointestinal symptoms
388885|NCT01479530|Rasagiline|rasagiline
388886|NCT01479530|Azilect|azilect
388887|NCT01479530|Parkinson´s Disease|parkinson´s disease
388888|NCT01479530|Motor fluctuations|motor fluctuations
388889|NCT01479517|operative|operative
388890|NCT01479517|dental procedure|dental procedure
388891|NCT01479504|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
388892|NCT01479504|neoadjuvant chemotherapy|neoadjuvant chemotherapy
388893|NCT01479504|concurrent chemoradiotherapy|concurrent chemoradiotherapy
388894|NCT01479504|Nedaplatin|nedaplatin
388895|NCT01479491|Japan|japan
388896|NCT01479491|Retrospective|retrospective
388897|NCT01479491|Observational|observational
388898|NCT01479491|Epidemiological study|epidemiological study
388899|NCT01479491|Children aged < 12 months|children aged < 12 months
388900|NCT01479491|Intussusception|intussusception
388901|NCT01479465|GSI|gsi
388902|NCT01479465|Gilead|gilead
388903|NCT01479465|Gilead Sciences|gilead sciences
388904|NCT01479465|GS-6624|gs-6624
388905|NCT01479465|Colorectal Cancer|colorectal cancer
388906|NCT01479465|KRAS|kras
388907|NCT01479465|Oncology|oncology
388908|NCT01479465|monoclonal antibody|monoclonal antibody
388909|NCT01479452|obesity|obesity
388910|NCT01479452|bariatric surgery|bariatric surgery
388911|NCT01479452|weight loss|weight loss
388912|NCT01479426|Erectile dysfunction|erectile dysfunction
388913|NCT01479426|Korean Red Ginseng|korean red ginseng
388914|NCT01479426|IIEF|iief
388915|NCT01479426|MSHQ|mshq
388916|NCT01479413|Schizophrenia|schizophrenia
388917|NCT01479413|Oxidative stress|oxidative stress
388918|NCT01479413|Mitochondria|mitochondria
388919|NCT01479400|antipsychotic|antipsychotic
388920|NCT01479400|schizophrenia|schizophrenia
388921|NCT01479400|infant development|infant development
388922|NCT01479387|Zevalin|zevalin
388923|NCT01479387|CD20+|cd20+
388924|NCT01479387|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
388925|NCT01479387|Mantle cell lymphoma|mantle cell lymphoma
388926|NCT01479374|Allergic Conjunctivitis|allergic conjunctivitis
388927|NCT01479374|Ocular Allergy|ocular allergy
388928|NCT01479361|Atovaquone|atovaquone
388929|NCT01479361|Drug Interaction|drug interaction
388930|NCT01479361|Pharmacokinetics|pharmacokinetics
388931|NCT01479361|Efavirenz|efavirenz
388932|NCT01479361|Atazanavir-Ritonavir|atazanavir-ritonavir
388933|NCT01479361|HIV|hiv
388934|NCT01479348|Imaging|imaging
388935|NCT01479348|Radiopharmaceutical|radiopharmaceutical
388936|NCT01479348|Safety|safety
388937|NCT01479348|Dosimetry|dosimetry
388938|NCT01479348|Drug Distribution|drug distribution
388939|NCT01479348|Cancer|cancer
388940|NCT01479322|Intima-media thickness|intima-media thickness
388941|NCT01479322|Ghrelin|ghrelin
388942|NCT01479322|Prader-Willi syndrome|prader-willi syndrome
388943|NCT01479309|Advanced Malignancies|advanced malignancies
388944|NCT01479309|Solid Tumors|solid tumors
388945|NCT01479309|Melanoma|melanoma
388946|NCT01479309|Renal Cell Carcinoma|renal cell carcinoma
388947|NCT01479309|Phase I Studies|phase i studies
388948|NCT01479309|Sodium Stibogluconate|sodium stibogluconate
388949|NCT01479309|Interferon Alpha-2b|interferon alpha-2b
388950|NCT01479309|Intron A|intron a
388951|NCT01479309|SSG|ssg
388952|NCT01479283|Infection|infection
388953|NCT01479283|Bone Neoplasms|bone neoplasms
388954|NCT01479283|Prosthesis|prosthesis
388955|NCT01479283|Anti-Bacterial Agents|anti-bacterial agents
388956|NCT01479283|Randomized|randomized
388957|NCT01479270|recovery|recovery
388958|NCT01479270|postoperative|postoperative
388959|NCT01479270|pain|pain
388960|NCT01479270|laparoscopy|laparoscopy
388961|NCT01479270|hysterectomy|hysterectomy
388962|NCT01479270|ropivacaine|ropivacaine
388963|NCT01479270|TAP block|tap block
388964|NCT01479270|local anesthesia|local anesthesia
388965|NCT01479257|Cancer|cancer
388966|NCT01479257|Risk factors|risk factors
388967|NCT01479257|Latinos|latinos
388968|NCT01479257|Hispanic Americans|hispanic americans
388969|NCT01479257|Hispanics|hispanics
388970|NCT01479257|Latino resident|latino resident
388971|NCT01479257|Houston metropolitan area|houston metropolitan area
388972|NCT01479257|Spanish speaking|spanish speaking
388973|NCT01479257|Cancer risk behaviors|cancer risk behaviors
388974|NCT01479257|Questionnaires|questionnaires
388975|NCT01479257|Surveys|surveys
388976|NCT01479257|Accelerometer|accelerometer
388977|NCT01479244|HER2|her2
388978|NCT01479244|low or intermediate|low or intermediate
388979|NCT01479244|breast cancer|breast cancer
388980|NCT01479244|node-positive tumors|node-positive tumors
388981|NCT01479231|GERD|gerd
388982|NCT01479231|Eosinophilic esophagitis|eosinophilic esophagitis
388983|NCT01479231|Proton pump inhibitor|proton pump inhibitor
388984|NCT01479231|dysphagia|dysphagia
388985|NCT01479205|specific immunotherapy|specific immunotherapy
388986|NCT01479205|bronchial allergen provocation|bronchial allergen provocation
388987|NCT01479205|specific IgE|specific ige
388988|NCT01479205|specific IgG|specific igg
388989|NCT01479205|specific IgG4|specific igg4
388990|NCT01479205|SIT|sit
388991|NCT01479192|breast|breast
388992|NCT01479192|cancer|cancer
388993|NCT01479192|prevention|prevention
388994|NCT01479192|fenretinide|fenretinide
388995|NCT01479179|Breast Cancer|breast cancer
388996|NCT01479179|Metastatic Breast Cancer|metastatic breast cancer
388997|NCT01479179|HER-2-overexpressing breast cancer|her-2-overexpressing breast cancer
388998|NCT01479179|Human epidermal growth factor receptor|human epidermal growth factor receptor
388999|NCT01479179|AMG 479|amg 479
389000|NCT01479179|Trastuzumab|trastuzumab
389001|NCT01479179|Herceptin|herceptin
389002|NCT01479166|cystic fibrosis|cystic fibrosis
389003|NCT01479166|HRCT|hrct
389004|NCT01479166|Sputum|sputum
389005|NCT01479166|Blood|blood
389006|NCT01479166|Inflammation|inflammation
389007|NCT01479166|adaptive immune system|adaptive immune system
389008|NCT01479166|innate immune system|innate immune system
389009|NCT01479153|Central venous catheterization|central venous catheterization
389010|NCT01479153|Major complications|major complications
389011|NCT01479153|Internal Jugular|internal jugular
389012|NCT01479153|Femoral|femoral
389013|NCT01479153|Subclavian|subclavian
389014|NCT01479140|myocardial infarction|myocardial infarction
389015|NCT01479140|dissection|dissection
389016|NCT01479140|coronary Fibromuscular Dysplasia|coronary fibromuscular dysplasia
389017|NCT01479140|coronary ectasia|coronary ectasia
389018|NCT01479140|atherosclerotic Coronary Artery Disease|atherosclerotic coronary artery disease
389019|NCT01479140|coronary vasculitis|coronary vasculitis
389020|NCT01479140|coronary embolism|coronary embolism
389021|NCT01479140|congenital coronary anomaly|congenital coronary anomaly
389022|NCT01479127|Levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
389023|NCT01479127|Advanced Parkinson's disease|advanced parkinson's disease
389024|NCT01479127|Severe motor fluctuations|severe motor fluctuations
389025|NCT01479127|Dyskinesia|dyskinesia
389026|NCT01479101|neo adjuvant, breast cancer|neo adjuvant, breast cancer
389027|NCT01479088|Cinacalcet|cinacalcet
389028|NCT01479088|PK|pk
389029|NCT01479088|Secondary Hyperparathyroidism|secondary hyperparathyroidism
389030|NCT01479088|Paediatric|paediatric
389031|NCT01479088|Chronic Kidney Disease|chronic kidney disease
389032|NCT01479088|Dialysis|dialysis
389033|NCT01479075|central insulin|central insulin
389034|NCT01479075|insulin resistance|insulin resistance
389035|NCT01479075|energy metabolism|energy metabolism
389036|NCT01479062|behavior change|behavior change
389037|NCT01479062|pre-diabetes|pre-diabetes
389038|NCT01479062|prevention|prevention
389039|NCT01479062|diabetes prevention|diabetes prevention
389040|NCT01479062|Hemoglobin A1c|hemoglobin a1c
389041|NCT01479062|glucose|glucose
389042|NCT01479062|physical activity|physical activity
389043|NCT01479062|nutrition|nutrition
389044|NCT01479062|email|email
389045|NCT01479062|web|web
389046|NCT01479062|obesity|obesity
389047|NCT01479049|congenital heart disease|congenital heart disease
389048|NCT01479049|cardiac surgery|cardiac surgery
389049|NCT01479049|cardiopulmonary bypass|cardiopulmonary bypass
389050|NCT01479049|cardioplegia|cardioplegia
389051|NCT01479036|breast cancer|breast cancer
389052|NCT01479036|neoadjuvant chemotherapy|neoadjuvant chemotherapy
389053|NCT01479036|recombinant human endostatin (endostar)|recombinant human endostatin (endostar)
389054|NCT01479036|docetaxel|docetaxel
389055|NCT01479036|epirubicin|epirubicin
389056|NCT01478984|NSTEMI|nstemi
389057|NCT01478984|PCI|pci
389058|NCT01478984|onestage|onestage
389059|NCT01478984|multistaged|multistaged
389060|NCT01478971|Anemia|anemia
389061|NCT01478971|Chronic Renal Failure|chronic renal failure
389062|NCT01478971|CRF|crf
389063|NCT01478971|Chronic Kidney Disease|chronic kidney disease
389064|NCT01478971|CKD|ckd
389065|NCT01478971|Erythropoietin|erythropoietin
389066|NCT01478971|Hematide|hematide
389067|NCT01478971|Peginesatide|peginesatide
389068|NCT01478971|Hemoglobin|hemoglobin
389069|NCT01478971|Hgb|hgb
389070|NCT01478971|Red Blood Cell|red blood cell
389071|NCT01478971|Red Blood Cell Production|red blood cell production
389072|NCT01478971|Dialysis|dialysis
389073|NCT01478958|fatty acids|fatty acids
389074|NCT01478958|cardiovascular disease|cardiovascular disease
389075|NCT01478958|vascular function|vascular function
389076|NCT01478958|microparticles|microparticles
389077|NCT01478945|vitiligo|vitiligo
389078|NCT01478945|early vitiligo|early vitiligo
389079|NCT01478945|focal vitiligo|focal vitiligo
389080|NCT01478932|dyspnea|dyspnea
389081|NCT01478932|diaphragmatic breathing|diaphragmatic breathing
389082|NCT01478932|Heart failure|heart failure
389083|NCT01478919|Endoscopic Mucosal Resection|endoscopic mucosal resection
389084|NCT01478919|Laterally Spreading Tumor|laterally spreading tumor
389085|NCT01478919|Local Residual Neoplasia|local residual neoplasia
389086|NCT01478919|Colonoscopy|colonoscopy
389087|NCT01478919|Therapy|therapy
389088|NCT01478893|nicotine vaccine|nicotine vaccine
389089|NCT01478893|smoking vaccine|smoking vaccine
389090|NCT01478893|smoking cessation|smoking cessation
389091|NCT01478893|SEL-068|sel-068
389092|NCT01478867|celiac disease|celiac disease
389093|NCT01478867|gluten-free diet|gluten-free diet
389094|NCT01478867|gluten peptides|gluten peptides
389095|NCT01478867|feces|feces
389096|NCT01478841|insulin resistance|insulin resistance
389206|NCT01478360|Lung|lung
389097|NCT01478841|type 2 diabetes (T2D)|type 2 diabetes (t2d)
389098|NCT01478841|cardiovascular complications|cardiovascular complications
389099|NCT01478841|polyphenolic compounds derived from red grape marc extracts|polyphenolic compounds derived from red grape marc extracts
389100|NCT01478841|oxidative stress|oxidative stress
389101|NCT01478802|Mechanical Ventilation|mechanical ventilation
389102|NCT01478802|High frequency oscillation|high frequency oscillation
389103|NCT01478802|Acute Respiratory Distress syndrome|acute respiratory distress syndrome
389104|NCT01478776|ASP|asp
389105|NCT01478776|LCN2|lcn2
389106|NCT01478776|RBP4|rbp4
389107|NCT01478776|C5L2|c5l2
389108|NCT01478763|PDRP|pdrp
389109|NCT01478763|vitreous|vitreous
389110|NCT01478763|protein|protein
389111|NCT01478763|vitrectomy|vitrectomy
389112|NCT01478750|obesity|obesity
389113|NCT01478750|fat|fat
389114|NCT01478750|appetite|appetite
389115|NCT01478750|digestion|digestion
389116|NCT01478737|PDRP|pdrp
389117|NCT01478737|vitreous hemorrhage|vitreous hemorrhage
389118|NCT01478737|vitrectomy|vitrectomy
389119|NCT01478698|peritoneal dialysis|peritoneal dialysis
389120|NCT01478698|peritoneal dialysis, continuous ambulatory|peritoneal dialysis, continuous ambulatory
389121|NCT01478698|peritonitis|peritonitis
389122|NCT01478685|Relapsed or Refractory Solid Tumors|relapsed or refractory solid tumors
389123|NCT01478672|Promotion health|promotion health
389124|NCT01478659|Diet|diet
389125|NCT01478659|Fiber|fiber
389126|NCT01478659|Adult|adult
389127|NCT01478659|Fructooligosaccharide|fructooligosaccharide
389128|NCT01478646|breathing therapy|breathing therapy
389129|NCT01478646|reflective breathing therapy|reflective breathing therapy
389130|NCT01478646|COPD|copd
389131|NCT01478646|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
389132|NCT01478633|Alzheimer's disease|alzheimer's disease
389133|NCT01478633|Dementia|dementia
389134|NCT01478633|Galantamine|galantamine
389135|NCT01478633|Donepezil|donepezil
389136|NCT01478607|Painful Diabetic Peripheral Neuropathy|painful diabetic peripheral neuropathy
389137|NCT01478607|Qutenza|qutenza
389138|NCT01478594|metastatic colorectal cancer|metastatic colorectal cancer
389139|NCT01478594|Avastin|avastin
389140|NCT01478594|bevacizumab|bevacizumab
389141|NCT01478594|tivozanib|tivozanib
389142|NCT01478594|mFOLFOX6|mfolfox6
389143|NCT01478594|BATON-CRC|baton-crc
389144|NCT01478594|AV951|av951
389145|NCT01478594|ASP4130|asp4130
389146|NCT01478581|PCI-32765|pci-32765
389147|NCT01478581|Multiple Myeloma|multiple myeloma
389148|NCT01478581|Relapsed Refractory Multiple Myeloma|relapsed refractory multiple myeloma
389149|NCT01478581|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
389150|NCT01478568|Pharmacokinetics|pharmacokinetics
389151|NCT01478568|Mirabegron|mirabegron
389152|NCT01478568|Phase 1|phase 1
389153|NCT01478555|Dry Eye|dry eye
389154|NCT01478542|DLBCL|dlbcl
389155|NCT01478542|Liposomal Vincristine (Marqibo)|liposomal vincristine (marqibo)
389156|NCT01478542|Optimised Rituximab|optimised rituximab
389157|NCT01478542|Toxicity|toxicity
389158|NCT01478542|Elderly Patients|elderly patients
389159|NCT01478542|FDG-PET|fdg-pet
389160|NCT01478542|Bulky Disease|bulky disease
389161|NCT01478542|Radiation|radiation
389162|NCT01478542|age >60 years|age >60 years
389163|NCT01478542|First line Therapy|first line therapy
389164|NCT01478542|Vitamin D|vitamin d
389165|NCT01478529|Pharmacokinetics|pharmacokinetics
389166|NCT01478529|Mirabegron|mirabegron
389167|NCT01478529|Phase 1|phase 1
389168|NCT01478516|autologous plasmin|autologous plasmin
389169|NCT01478516|macular edema|macular edema
389170|NCT01478516|vitreous|vitreous
389171|NCT01478503|Pharmacokinetics|pharmacokinetics
389172|NCT01478503|Mirabegron|mirabegron
389173|NCT01478503|Phase 1|phase 1
389174|NCT01478503|Dose-Escalation|dose-escalation
389175|NCT01478490|Pharmacokinetics,|pharmacokinetics,
389176|NCT01478490|Mirabegron|mirabegron
389177|NCT01478490|Metoprolol|metoprolol
389178|NCT01478490|CYP2D6|cyp2d6
389179|NCT01478490|Phase 1|phase 1
389180|NCT01478477|Breast Cancer|breast cancer
389181|NCT01478451|DOMS|doms
389182|NCT01478438|Unifocal|unifocal
389183|NCT01478438|20mm in diameter|20mm in diameter
389184|NCT01478438|measures|measures
389185|NCT01478438|5mm away from the skin and chest|5mm away from the skin and chest
389186|NCT01478425|Prevention|prevention
389187|NCT01478425|Pollen|pollen
389188|NCT01478425|Allergy|allergy
389189|NCT01478425|Rhinitis|rhinitis
389190|NCT01478412|Prostate cancer|prostate cancer
389191|NCT01478412|Low risk|low risk
389192|NCT01478412|Intermediate risk|intermediate risk
389193|NCT01478412|T1|t1
389194|NCT01478412|T2a|t2a
389195|NCT01478412|T2b|t2b
389196|NCT01478412|Gleason 6|gleason 6
389197|NCT01478412|Gleason 7|gleason 7
389198|NCT01478412|PSA 10|psa 10
389199|NCT01478412|PSA 20|psa 20
389200|NCT01478373|GIST|gist
389201|NCT01478373|Dovitinib|dovitinib
389202|NCT01478360|Asthma|asthma
389203|NCT01478360|Secukinumab|secukinumab
389204|NCT01478360|Therapeutic Uses|therapeutic uses
389207|NCT01478360|Pulmonary|pulmonary
389208|NCT01478360|inhaled|inhaled
389209|NCT01478360|corticosteroids|corticosteroids
389210|NCT01478347|Neisseria, Meningitis, Group B, Vaccine, At-risk, Adults|neisseria, meningitis, group b, vaccine, at-risk, adults
389211|NCT01478334|High intensity exercise|high intensity exercise
389212|NCT01478334|cardiovascular risk factors|cardiovascular risk factors
389213|NCT01478321|Information Not Provided|information not provided
389214|NCT01478308|prostate|prostate
389215|NCT01478308|castration resistant|castration resistant
389216|NCT01478308|hormone resistant|hormone resistant
389217|NCT01478308|CRPC|crpc
389218|NCT01478295|Nursing intervention|nursing intervention
389219|NCT01478295|Primary Health care|primary health care
389220|NCT01478295|caregiver|caregiver
389221|NCT01478295|strain|strain
389222|NCT01478282|dabigatran|dabigatran
389223|NCT01478282|rivaroxaban|rivaroxaban
389224|NCT01478282|oral anticoagulants|oral anticoagulants
389225|NCT01478282|coagulation|coagulation
389226|NCT01478282|bleeding|bleeding
389227|NCT01478282|plasma concentrates|plasma concentrates
389228|NCT01478269|Aggressive B-cell lymphoma|aggressive b-cell lymphoma
389229|NCT01478269|R-CHOP|r-chop
389230|NCT01478256|blepharitis|blepharitis
389231|NCT01478256|topical erythromycin|topical erythromycin
389232|NCT01478256|topical besifloxocin|topical besifloxocin
389233|NCT01478243|Keloid|keloid
389234|NCT01478230|Pharmacokinetics|pharmacokinetics
389235|NCT01478217|lung ultrasonography|lung ultrasonography
389236|NCT01478217|pressure-volume loops|pressure-volume loops
389237|NCT01478217|ARDS|ards
389238|NCT01478204|Alzheimer's disease|alzheimer's disease
389239|NCT01478204|Sleep quality|sleep quality
389240|NCT01478204|Anticholinesterase drugs|anticholinesterase drugs
389241|NCT01478191|Hodgkin's Lymphoma|hodgkin's lymphoma
389242|NCT01478191|Ifosfamide, Gemcitabine and Vinorelbine (IGEV)|ifosfamide, gemcitabine and vinorelbine (igev)
389243|NCT01478191|High Dose Chemotherapy (HDCT)|high dose chemotherapy (hdct)
389244|NCT01478191|Autologous Hematopoietic Stem Cells Transplantation (AHSCT)|autologous hematopoietic stem cells transplantation (ahsct)
389245|NCT01478178|Glioma|glioma
389246|NCT01478178|Glioblastoma|glioblastoma
389247|NCT01478178|Glioblastoma multiforme|glioblastoma multiforme
389248|NCT01478178|GBM|gbm
389249|NCT01478178|brain tumor|brain tumor
389250|NCT01478178|brain cancer|brain cancer
389251|NCT01478178|recurrent brain tumor|recurrent brain tumor
389252|NCT01478178|recurrent brain cancer|recurrent brain cancer
389253|NCT01478178|refractory brain tumor|refractory brain tumor
389254|NCT01478178|refractory brain cancer|refractory brain cancer
389255|NCT01478178|recurrent GBM|recurrent gbm
389256|NCT01478178|refractory GBM|refractory gbm
389257|NCT01478178|recurrent glioma|recurrent glioma
389258|NCT01478178|refractory glioma|refractory glioma
389259|NCT01478178|recurrent glioblastoma|recurrent glioblastoma
389260|NCT01478178|refractory glioblastoma|refractory glioblastoma
389261|NCT01478178|recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
389262|NCT01478178|refractory glioblastoma multiforme|refractory glioblastoma multiforme
389263|NCT01478178|failed temodar|failed temodar
389264|NCT01478178|failed temozolomide|failed temozolomide
389265|NCT01478178|temodar refractory|temodar refractory
389266|NCT01478178|temozolomide refractory|temozolomide refractory
389267|NCT01478178|failed avastin|failed avastin
389268|NCT01478178|avastin refractory|avastin refractory
389269|NCT01478178|failed bevacizumab|failed bevacizumab
389270|NCT01478178|bevacizumab refractory|bevacizumab refractory
389271|NCT01478178|avastin failure|avastin failure
389272|NCT01478178|bevacizumab failure|bevacizumab failure
389273|NCT01478178|temodar failure|temodar failure
389274|NCT01478178|temozolomide failure|temozolomide failure
389275|NCT01478165|Palonosetron|palonosetron
389276|NCT01478165|PONV(postoperative nausea and vomiting)|ponv(postoperative nausea and vomiting)
389277|NCT01478165|TIVA(Total intravenous anesthesia)|tiva(total intravenous anesthesia)
389278|NCT01478152|Asthma|asthma
389279|NCT01478152|Ectoin|ectoin
389280|NCT01478152|Ectoine|ectoine
389281|NCT01478152|FeNO|feno
389282|NCT01478152|Metacholin|metacholin
389283|NCT01478152|sRaw|sraw
389284|NCT01478139|anorectal fistula|anorectal fistula
389285|NCT01478139|acellular dermal matrix|acellular dermal matrix
389286|NCT01478139|ligation of intersphincteric fistula tract|ligation of intersphincteric fistula tract
389287|NCT01478139|ligation of intersphincteric fistula tract and plug|ligation of intersphincteric fistula tract and plug
389288|NCT01478139|complications of treatment|complications of treatment
389289|NCT01478139|recurrence|recurrence
389290|NCT01478113|Major Depressive Disorder|major depressive disorder
389291|NCT01478113|Therapy|therapy
389292|NCT01478113|Medication study|medication study
389293|NCT01478113|Depression|depression
389294|NCT01478113|Therapy study|therapy study
389295|NCT01478100|Coronary artery disease|coronary artery disease
389296|NCT01478100|CT|ct
389297|NCT01478100|Computational flow dynamics|computational flow dynamics
389298|NCT01478074|Acute Myeloid Leukemia|acute myeloid leukemia
389299|NCT01478074|Relapsed leukemia|relapsed leukemia
389300|NCT01478074|Refractory leukemia|refractory leukemia
389301|NCT01478074|Natural Killer Cells|natural killer cells
389809|NCT01475708|Outcome|outcome
389302|NCT01478074|Adoptive immunotherapy|adoptive immunotherapy
389303|NCT01478074|NK cell infusion|nk cell infusion
389304|NCT01478074|Haploidentical|haploidentical
389305|NCT01478074|KIR mismatch|kir mismatch
389306|NCT01478074|Fludarabine|fludarabine
389307|NCT01478074|Cytarabine|cytarabine
389308|NCT01478074|Ara-C|ara-c
389309|NCT01478074|ALT-801|alt-801
389310|NCT01478048|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
389311|NCT01478035|Phenytoin prophylaxis|phenytoin prophylaxis
389312|NCT01478035|Pneumococcal meningitis|pneumococcal meningitis
389313|NCT01478035|Randomized|randomized
389314|NCT01478035|Placebo-controlled|placebo-controlled
389315|NCT01478035|Double blind|double blind
389316|NCT01478035|Patient 50 years or older|patient 50 years or older
389317|NCT01478022|DMD|dmd
389318|NCT01478022|Duchenne|duchenne
389319|NCT01478022|Muscular Dystrophy|muscular dystrophy
389320|NCT01477996|intravitreal therapy|intravitreal therapy
389321|NCT01477996|pain scales|pain scales
389322|NCT01477996|gauge|gauge
389323|NCT01477996|Pain Scores|pain scores
389324|NCT01477996|Visual Analog Scale|visual analog scale
389325|NCT01477983|atrial fibrillation|atrial fibrillation
389326|NCT01477983|catheter ablation|catheter ablation
389327|NCT01477983|adenosine triphosphate|adenosine triphosphate
389328|NCT01477983|antiarrhythmic drugs|antiarrhythmic drugs
389329|NCT01477970|GnRH antagonists|gnrh antagonists
389330|NCT01477970|OHSS|ohss
389331|NCT01477970|ovarian stimulation|ovarian stimulation
389332|NCT01477957|weight loss after bariatric surgery|weight loss after bariatric surgery
389333|NCT01477957|Insulin sensitivity|insulin sensitivity
389334|NCT01477957|insulin resistance|insulin resistance
389335|NCT01477944|Statins pattern of use|statins pattern of use
389336|NCT01477944|Hypercholesterolemic patients|hypercholesterolemic patients
389337|NCT01477944|Statins|statins
389338|NCT01477931|Bupropion hydrochloride extended release|bupropion hydrochloride extended release
389339|NCT01477931|Wellbutrin XL|wellbutrin xl
389340|NCT01477931|Major Depressive Disorder with Atypical Features|major depressive disorder with atypical features
389341|NCT01477918|prevalence|prevalence
389342|NCT01477918|Korea|korea
389343|NCT01477905|priming|priming
389344|NCT01477905|remifentanil|remifentanil
389345|NCT01477905|target-controlled infusion|target-controlled infusion
389346|NCT01477840|Misoprostol|misoprostol
389347|NCT01477840|Oxytocin|oxytocin
389348|NCT01477840|Cesarean Delivery|cesarean delivery
389349|NCT01477840|Blood Loss|blood loss
389350|NCT01477814|colorectal cancer|colorectal cancer
389351|NCT01477814|screening|screening
389352|NCT01477814|colonoscopy|colonoscopy
389353|NCT01477814|fecal immunochemical test|fecal immunochemical test
389354|NCT01477814|clinical guidelines|clinical guidelines
389355|NCT01477788|pelvic mass|pelvic mass
389356|NCT01477788|ovarian mass|ovarian mass
389357|NCT01477788|ultrasound|ultrasound
389358|NCT01477788|serum markers|serum markers
389359|NCT01477788|ovarian malignancy|ovarian malignancy
389360|NCT01477775|myocardial infarction|myocardial infarction
389361|NCT01477775|coronary stent|coronary stent
389362|NCT01477775|Oral P2Y12 receptor blocker|oral p2y12 receptor blocker
389363|NCT01477775|Platelet reactivity units (PRU)|platelet reactivity units (pru)
389364|NCT01477762|startle response|startle response
389365|NCT01477762|fear conditioning|fear conditioning
389366|NCT01477762|PTSD|ptsd
389367|NCT01477749|prostate cancer|prostate cancer
389368|NCT01477749|prostate|prostate
389369|NCT01477749|immune therapy|immune therapy
389370|NCT01477749|immunotherapy|immunotherapy
389371|NCT01477749|vaccine|vaccine
389372|NCT01477749|dendritic cells|dendritic cells
389373|NCT01477749|antigen-presenting cells|antigen-presenting cells
389374|NCT01477749|antigen presenting cells|antigen presenting cells
389375|NCT01477749|cancer vaccine|cancer vaccine
389376|NCT01477749|PSA|psa
389377|NCT01477749|prostatic adenocarcinoma|prostatic adenocarcinoma
389378|NCT01477736|Neurogenic bladder|neurogenic bladder
389379|NCT01477736|Urodynamic|urodynamic
389380|NCT01477736|Quality of life|quality of life
389381|NCT01477710|Mechanical ventilation|mechanical ventilation
389382|NCT01477710|Tidal volume|tidal volume
389383|NCT01477710|Respiratory rate|respiratory rate
389384|NCT01477697|Trauma|trauma
389385|NCT01477671|Dengue|dengue
389386|NCT01477671|Dengue Fever|dengue fever
389387|NCT01477671|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
389388|NCT01477658|Congenital Complete Atrioventricular Heart Block|congenital complete atrioventricular heart block
389389|NCT01477658|Pacemaker|pacemaker
389390|NCT01477658|Cardiac pacing|cardiac pacing
389391|NCT01477658|Children|children
389392|NCT01477658|Heart failure|heart failure
389393|NCT01477658|Ventricular dyssynchrony|ventricular dyssynchrony
389394|NCT01477658|Echocardiography|echocardiography
389395|NCT01477658|Quality of life|quality of life
389396|NCT01477658|Six-minute walk test|six-minute walk test
389397|NCT01477658|Young adults|young adults
389398|NCT01477619|Pharmacokinetics|pharmacokinetics
389399|NCT01477606|Acute myeloid leukemia|acute myeloid leukemia
389400|NCT01477606|FLT3-ITD|flt3-itd
389401|NCT01477606|midostaurin (PKC412)|midostaurin (pkc412)
389402|NCT01477593|circumcision, chinese children, pain|circumcision, chinese children, pain
389403|NCT01477554|Women|women
389404|NCT01477554|Maternal morbidity|maternal morbidity
389405|NCT01477554|Maternal mortality|maternal mortality
389406|NCT01477554|Perinatal mortality|perinatal mortality
389407|NCT01477554|Perinatal morbidity|perinatal morbidity
389408|NCT01477554|Training|training
389409|NCT01477554|Obstetric Emergency|obstetric emergency
389410|NCT01477554|Medical team|medical team
389411|NCT01477554|Simulation|simulation
389412|NCT01477541|Prenatal care|prenatal care
389413|NCT01477541|Maternal mortality|maternal mortality
389414|NCT01477541|Perinatal mortality|perinatal mortality
389415|NCT01477541|Perinatal|perinatal
389416|NCT01477541|Puerperium|puerperium
389417|NCT01477541|Puerperium care|puerperium care
389418|NCT01477541|Midwives|midwives
389419|NCT01477541|Midwife|midwife
389420|NCT01477541|Obstetric|obstetric
389421|NCT01477541|Nurse|nurse
389422|NCT01477541|Integration|integration
389423|NCT01477541|Alternative personnel|alternative personnel
389424|NCT01477541|Skilled attendant|skilled attendant
389425|NCT01477541|Birth attendant|birth attendant
389426|NCT01477541|Delivery|delivery
389427|NCT01477541|Delivery services|delivery services
389428|NCT01477541|Best practices|best practices
389429|NCT01477541|Rural|rural
389430|NCT01477528|HeartMate II|heartmate ii
389431|NCT01477528|Anticoagulation|anticoagulation
389432|NCT01477528|Thoratec Corporation|thoratec corporation
389433|NCT01477502|urinary tract infection|urinary tract infection
389434|NCT01477502|spinal cord injury|spinal cord injury
389435|NCT01477502|homeopathy|homeopathy
389436|NCT01477502|prevention|prevention
389438|NCT01477476|Diabetes|diabetes
389439|NCT01477476|Type I Diabetes|type i diabetes
389440|NCT01477463|quality of life|quality of life
389441|NCT01477450|Hypobaric hypoxemia|hypobaric hypoxemia
389442|NCT01477450|Altitude|altitude
389443|NCT01477450|Oxygen|oxygen
389444|NCT01477450|oxygen concentrator|oxygen concentrator
389445|NCT01477437|teens|teens
389446|NCT01477437|adolescents|adolescents
389447|NCT01477437|Internet intervention|internet intervention
389448|NCT01477437|Hemophilia|hemophilia
389449|NCT01477424|Drug-drug interaction|drug-drug interaction
389450|NCT01477424|Pharmacokinetics|pharmacokinetics
389451|NCT01477424|PA21|pa21
389452|NCT01477411|Drug-drug interaction|drug-drug interaction
389453|NCT01477411|Pharmacokinetics|pharmacokinetics
389454|NCT01477411|PA21|pa21
389455|NCT01477385|dental caries|dental caries
389456|NCT01477385|primary teeth|primary teeth
389457|NCT01477385|permanent teeth|permanent teeth
389458|NCT01477385|silver diamine fluoride|silver diamine fluoride
389459|NCT01477372|Pregnancy|pregnancy
389460|NCT01477372|Exercise|exercise
389461|NCT01477372|Excessive weight gain|excessive weight gain
389462|NCT01477372|Outcomes|outcomes
389463|NCT01477372|Urinary incontinence|urinary incontinence
389464|NCT01477359|Sarcoidosis|sarcoidosis
389465|NCT01477333|Tyvaso|tyvaso
389466|NCT01477333|UT-15C SR|ut-15c sr
389467|NCT01477333|PAH|pah
389468|NCT01477320|Enteral Nutrition|enteral nutrition
389469|NCT01477320|Stress Ulcer Prophylaxis|stress ulcer prophylaxis
389470|NCT01477320|Critically Ill Patients|critically ill patients
389471|NCT01477320|Overt and significant GI bleeding|overt and significant gi bleeding
389472|NCT01477320|Stress gastropathy|stress gastropathy
389473|NCT01477320|Clostridium Difficile pseudomembranous colitis|clostridium difficile pseudomembranous colitis
389474|NCT01477320|Vital AF|vital af
389475|NCT01477320|Small peptide fish oil structured lipids|small peptide fish oil structured lipids
389476|NCT01477320|Fructose oligosaccharide|fructose oligosaccharide
389477|NCT01477307|obesity|obesity
389478|NCT01477307|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
389479|NCT01477294|Total|total
389480|NCT01477294|Intra and Extracellular Water|intra and extracellular water
389481|NCT01477294|Energy Expenditure, Physical Activity|energy expenditure, physical activity
389482|NCT01477294|Body Composition|body composition
389483|NCT01477294|Dilution Techniques|dilution techniques
389484|NCT01477281|chronic venous insufficiency|chronic venous insufficiency
389485|NCT01477281|Daflon|daflon
389486|NCT01477281|Venaflon|venaflon
389487|NCT01477268|antidepressants|antidepressants
389488|NCT01477268|depression|depression
389489|NCT01477268|zoloft|zoloft
389490|NCT01477268|psychiatry|psychiatry
389491|NCT01477268|psychology|psychology
389492|NCT01477255|daily assessment|daily assessment
389493|NCT01477255|electronic diary|electronic diary
389494|NCT01477255|coping strategies|coping strategies
389495|NCT01477255|resiliency of cancer patients|resiliency of cancer patients
389496|NCT01477255|psychology|psychology
389497|NCT01477242|vomiting|vomiting
389498|NCT01477242|anti-emetics|anti-emetics
389499|NCT01477242|ketamine|ketamine
389500|NCT01477242|sedation|sedation
389501|NCT01477229|Rectal cancer|rectal cancer
389502|NCT01477229|Quality of Life|quality of life
389503|NCT01477229|Abdominoperineal Resection|abdominoperineal resection
389504|NCT01477229|Anterior Resection|anterior resection
390013|NCT01475006|brain tumor|brain tumor
389505|NCT01477229|Palliative cancer treatment|palliative cancer treatment
389506|NCT01477229|Radio chemotherapy|radio chemotherapy
389507|NCT01477216|Glycemic index|glycemic index
389508|NCT01477216|Glycemic responses|glycemic responses
389509|NCT01477216|Insulin responses|insulin responses
389510|NCT01477216|Insulinemic index|insulinemic index
389511|NCT01477216|Carbohydrates|carbohydrates
389512|NCT01477216|Methodology|methodology
389513|NCT01477216|Glucose metabolism|glucose metabolism
389514|NCT01477177|Barrett's esophagus dysplasia|barrett's esophagus dysplasia
389515|NCT01477164|Exercise|exercise
389516|NCT01477164|Aging|aging
389517|NCT01477164|Sarcopenia|sarcopenia
389518|NCT01477164|Muscle function|muscle function
389519|NCT01477151|isoflurane|isoflurane
389520|NCT01477151|sevoflurane|sevoflurane
389521|NCT01477151|troponin|troponin
389522|NCT01477151|anesthesia|anesthesia
389523|NCT01477151|cardioprotection|cardioprotection
389524|NCT01477151|preconditioning|preconditioning
389525|NCT01477151|cardiac surgery|cardiac surgery
389526|NCT01477151|cardiac anesthesia|cardiac anesthesia
389527|NCT01477138|Sick Sinus Syndrome|sick sinus syndrome
389528|NCT01477138|Cardiac Pacing, Artificial|cardiac pacing, artificial
389529|NCT01477138|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
389530|NCT01477138|Pacemaker, Artificial|pacemaker, artificial
389531|NCT01477138|SSS|sss
389532|NCT01477125|adhd|adhd
389533|NCT01477125|adults|adults
389534|NCT01477125|working memory|working memory
389535|NCT01477125|training|training
389536|NCT01477125|RCT|rct
389537|NCT01477112|Type 2 diabetes|type 2 diabetes
389538|NCT01477112|β-carotene|β-carotene
389539|NCT01477112|Oxidative balance|oxidative balance
389540|NCT01477112|Oxidants|oxidants
389541|NCT01477112|Antioxidants|antioxidants
389542|NCT01477086|Sarcopenia|sarcopenia
389543|NCT01477086|Hip fracture|hip fracture
389544|NCT01477086|Frailty|frailty
389545|NCT01477073|in-vitro fertilization|in-vitro fertilization
389546|NCT01477073|reproductive disorder|reproductive disorder
389547|NCT01477034|Vitamin D deficiency|vitamin d deficiency
389548|NCT01477034|Obesity|obesity
389549|NCT01477034|Inflammation|inflammation
389550|NCT01477034|Low-grade, chronic inflammation|low-grade, chronic inflammation
389551|NCT01477034|Adipose tissue inflammation|adipose tissue inflammation
389552|NCT01477034|Diabetes|diabetes
389553|NCT01477034|Type 2 diabetes mellitus|type 2 diabetes mellitus
389554|NCT01477034|Insulin resistance|insulin resistance
389555|NCT01477034|Intestinal permeability|intestinal permeability
389556|NCT01477008|Knee|knee
389557|NCT01477008|Cartilage repair|cartilage repair
389558|NCT01477008|Cartilage regeneration|cartilage regeneration
389559|NCT01477008|Chondral|chondral
389560|NCT01477008|Osteochondral|osteochondral
389561|NCT01477008|Biphasic scaffold|biphasic scaffold
389562|NCT01477008|Medical device|medical device
389563|NCT01477008|Autologous|autologous
389564|NCT01477008|Synthetic|synthetic
389565|NCT01477008|Medial condyle|medial condyle
389566|NCT01477008|Lateral condyle|lateral condyle
389567|NCT01477008|Trochlea|trochlea
389568|NCT01476995|Cardiovascular system|cardiovascular system
389569|NCT01476995|gastrointestinal system|gastrointestinal system
389570|NCT01476995|kidneys|kidneys
389571|NCT01476995|liver|liver
389572|NCT01476995|lungs|lungs
389573|NCT01476969|Ischemia reperfusion injury|ischemia reperfusion injury
389574|NCT01476969|Cardiopulmonary bypass|cardiopulmonary bypass
389575|NCT01476969|Remote Ischemic Postconditioning|remote ischemic postconditioning
389576|NCT01476969|Other Functional Disturbances Following Cardiac Surgery|other functional disturbances following cardiac surgery
389577|NCT01476930|migraine|migraine
389578|NCT01476930|prophylactic treatment|prophylactic treatment
389579|NCT01476930|cupping|cupping
389580|NCT01476930|serkangabin|serkangabin
389581|NCT01476904|Asthma|asthma
389582|NCT01476904|Bronchial Asthma|bronchial asthma
389583|NCT01476904|Shortness of breath|shortness of breath
389584|NCT01476891|MBSR|mbsr
389585|NCT01476891|Cancer|cancer
389586|NCT01476891|Online|online
389587|NCT01476891|Mindfulness Meditation|mindfulness meditation
389588|NCT01476891|Randomized Waitlist Controlled Trial|randomized waitlist controlled trial
389589|NCT01476878|Radiosurgery|radiosurgery
389590|NCT01476878|Frameless radiosurgery|frameless radiosurgery
389591|NCT01476878|Accuracy|accuracy
389592|NCT01476800|Drugs, Investigational|drugs, investigational
389593|NCT01476800|pharmacokinetics|pharmacokinetics
389594|NCT01476800|Urinary Bladder, Overactive|urinary bladder, overactive
389595|NCT01476800|YM178|ym178
389596|NCT01476800|Mirabegron|mirabegron
389597|NCT01476787|Follicular lymphoma|follicular lymphoma
389598|NCT01476787|Non-Hodgkins Follicular Lymphoma|non-hodgkins follicular lymphoma
389599|NCT01476787|treatment for Follicular Lymphoma|treatment for follicular lymphoma
389600|NCT01476787|rituximab treatment|rituximab treatment
389601|NCT01476787|rituximab and lenalidomide treatment|rituximab and lenalidomide treatment
389602|NCT01476761|Surgical tissue resection|surgical tissue resection
389603|NCT01476761|Tissue dissection|tissue dissection
389604|NCT01476761|Tissue transection|tissue transection
390108|NCT01474616|Mobility|mobility
389605|NCT01476761|Anastomosis of gastrointestina tissue|anastomosis of gastrointestina tissue
389606|NCT01476722|Silicone Hydrogel|silicone hydrogel
389607|NCT01476722|Soft Contact Lenses|soft contact lenses
389608|NCT01476722|Multi-Purpose Solution|multi-purpose solution
389609|NCT01476709|Puncture; Instrument|puncture; instrument
389610|NCT01476709|Optics and Photonics|optics and photonics
389611|NCT01476709|Pain|pain
389612|NCT01476696|Sickle cell disease|sickle cell disease
389613|NCT01476696|pediatrics|pediatrics
389614|NCT01476696|SCD|scd
389615|NCT01476696|children|children
389616|NCT01476696|child|child
389617|NCT01476696|kids|kids
389618|NCT01476696|pain crisis|pain crisis
389619|NCT01476696|sickle cell anemia|sickle cell anemia
389620|NCT01476696|sickle cell pain|sickle cell pain
389621|NCT01476683|Antidiarrheals|antidiarrheals
389622|NCT01476670|Posterior fossa brain tumor|posterior fossa brain tumor
389623|NCT01476670|Cerebral blood flow|cerebral blood flow
389624|NCT01476670|Cerebral autoregulation|cerebral autoregulation
389625|NCT01476670|Carbon dioxide reactivity|carbon dioxide reactivity
389626|NCT01476670|Transcranial Doppler|transcranial doppler
389627|NCT01476657|Phase 1|phase 1
389628|NCT01476644|Health related quality of life|health related quality of life
389629|NCT01476644|Clinical measures of vision|clinical measures of vision
389630|NCT01476618|Provider Perspectives|provider perspectives
389631|NCT01476618|Barriers|barriers
389632|NCT01476618|OIF/OEF Veterans|oif/oef veterans
389633|NCT01476605|prolotherapy|prolotherapy
389634|NCT01476605|Platelet rich plasma|platelet rich plasma
389635|NCT01476605|tennis elbow|tennis elbow
389636|NCT01476605|lateral epicondylosis|lateral epicondylosis
389637|NCT01476592|gastrointestinal neuroendocrine tumor|gastrointestinal neuroendocrine tumor
389638|NCT01476579|Coronary CT|coronary ct
389639|NCT01476579|Sensitivity|sensitivity
389640|NCT01476579|Specificity|specificity
389641|NCT01476579|Radiation|radiation
389642|NCT01476579|Tomography, X-Ray Computed|tomography, x-ray computed
389643|NCT01476579|Coronary angiography|coronary angiography
389644|NCT01476566|aged|aged
389645|NCT01476566|family practice|family practice
389646|NCT01476553|gastric cancer|gastric cancer
389647|NCT01476553|extensive intraperitoneal lavage|extensive intraperitoneal lavage
389648|NCT01476553|EIPL|eipl
389649|NCT01476553|intraperitoneal tumor cells|intraperitoneal tumor cells
389650|NCT01476553|peritoneal carcinomatosis|peritoneal carcinomatosis
389651|NCT01476514|Hyperekplexia|hyperekplexia
389652|NCT01476514|Pain modulation|pain modulation
389653|NCT01476514|Glycine receptors|glycine receptors
389654|NCT01476514|Hyperalgesia|hyperalgesia
389655|NCT01476514|Spinal inhibitory interneurons|spinal inhibitory interneurons
389656|NCT01476501|vitamin D|vitamin d
389657|NCT01476501|bone health|bone health
389658|NCT01476501|diabetes|diabetes
389659|NCT01476501|nephropathy|nephropathy
389660|NCT01476462|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
389661|NCT01476462|Ponte-di-Legno consortium|ponte-di-legno consortium
389662|NCT01476462|Second cancer|second cancer
389663|NCT01476462|Survival|survival
389664|NCT01476449|Diabetic Macular Edema|diabetic macular edema
389665|NCT01476449|Diabetic Retinal Swelling|diabetic retinal swelling
389666|NCT01476449|DIabetic Eye Disease|diabetic eye disease
389667|NCT01476436|Cardio vascular risk factors|cardio vascular risk factors
389668|NCT01476423|Glanzmann's Thrombasthenia|glanzmann's thrombasthenia
389669|NCT01476397|full-term|full-term
389670|NCT01476397|formula-fed infants|formula-fed infants
389671|NCT01476384|Glucose|glucose
389672|NCT01476384|insulin|insulin
389673|NCT01476384|Glycocalyx|glycocalyx
389674|NCT01476384|Muscle|muscle
389675|NCT01476384|Vascularisation|vascularisation
389676|NCT01476384|young|young
389677|NCT01476384|elderly|elderly
389678|NCT01476371|Group treatment|group treatment
389679|NCT01476371|Mindfulness|mindfulness
389680|NCT01476371|Minor mental disorders|minor mental disorders
389681|NCT01476371|Inflammation|inflammation
389682|NCT01476332|eyes|eyes
389683|NCT01476332|cis-urocanic acid|cis-urocanic acid
389684|NCT01476332|safety|safety
389685|NCT01476332|tolerability|tolerability
389686|NCT01476332|pharmacokinetics|pharmacokinetics
389687|NCT01476306|feasibility|feasibility
389688|NCT01476306|effectiveness|effectiveness
389689|NCT01476306|Parkinson disease care|parkinson disease care
389690|NCT01476306|care via telemedicine|care via telemedicine
389691|NCT01476293|Infiltration|infiltration
389692|NCT01476293|Extravasation|extravasation
389693|NCT01476293|Leaking|leaking
389694|NCT01476293|PIV Infiltration|piv infiltration
389695|NCT01476293|IV Infiltration|iv infiltration
389696|NCT01476293|Optical Detection of Infiltration|optical detection of infiltration
389697|NCT01476293|Optical Monitoring|optical monitoring
389698|NCT01476280|antiemetics|antiemetics
389699|NCT01476280|ramosetron|ramosetron
389700|NCT01476280|palonosetron|palonosetron
389701|NCT01476280|PONV(postoperative nausea and vomiting)|ponv(postoperative nausea and vomiting)
389702|NCT01476254|Postoperative pulmonary complications|postoperative pulmonary complications
389703|NCT01476254|Laparoscopic surgery|laparoscopic surgery
389704|NCT01476215|paracetamol|paracetamol
389705|NCT01476202|craving, provoked craving, smoking cessation, nicotine replacement therapy, NRT|craving, provoked craving, smoking cessation, nicotine replacement therapy, nrt
389706|NCT01476189|pharmacokinetic|pharmacokinetic
389707|NCT01476189|paracetamol|paracetamol
389708|NCT01476189|Healthy volunteer|healthy volunteer
389709|NCT01476189|steady state|steady state
389710|NCT01476176|Bioequivalence|bioequivalence
389711|NCT01476176|Pharmacokinetics|pharmacokinetics
389712|NCT01476176|Healthy volunteers|healthy volunteers
389713|NCT01476176|paracetamol|paracetamol
389714|NCT01476176|caffeine|caffeine
389715|NCT01476163|AT1001|at1001
389716|NCT01476163|Lysosomal storage disease|lysosomal storage disease
389717|NCT01476163|Lysosomal Storage Disorder|lysosomal storage disorder
389718|NCT01476163|migalastat|migalastat
389719|NCT01476163|Fabry disease|fabry disease
389720|NCT01476163|Fabry|fabry
389721|NCT01476163|Amicus|amicus
389722|NCT01476137|oncology|oncology
389723|NCT01476137|solid tumors|solid tumors
389724|NCT01476137|multiple myeloma|multiple myeloma
389725|NCT01476137|AKT inhibitor|akt inhibitor
389726|NCT01476137|MEK inhibitor|mek inhibitor
389727|NCT01476111|tumor antigens|tumor antigens
389728|NCT01476111|observational|observational
389729|NCT01476111|breast cancer|breast cancer
389730|NCT01476111|biomarkers|biomarkers
389731|NCT01476111|Neoadjuvant|neoadjuvant
389732|NCT01476059|Treatment compliance|treatment compliance
389733|NCT01476059|Pediatric|pediatric
389734|NCT01476059|Asthma|asthma
389735|NCT01476046|Acute Lung Injury (ALI)|acute lung injury (ali)
389736|NCT01476046|Acute Respiratory Distress Syndrome (ARDS)|acute respiratory distress syndrome (ards)
389737|NCT01476033|Oxidative stress|oxidative stress
389738|NCT01476033|inflammation|inflammation
389739|NCT01476033|blood flow|blood flow
389740|NCT01476020|Drug eluting stent|drug eluting stent
389741|NCT01476020|Dual antiplatelet therapy|dual antiplatelet therapy
389742|NCT01476020|bleeding|bleeding
389743|NCT01476020|stent thrombosis|stent thrombosis
389744|NCT01476020|follow-up of the drug eluting stent|follow-up of the drug eluting stent
389745|NCT01476007|primary health care|primary health care
389746|NCT01476007|Vitamin B 12 Deficiency|vitamin b 12 deficiency
389747|NCT01475981|JTK-853|jtk-853
389748|NCT01475981|single dose|single dose
389749|NCT01475942|elderly|elderly
389750|NCT01475942|probiotic|probiotic
389751|NCT01475942|bowel function|bowel function
389752|NCT01475942|pathogen|pathogen
389753|NCT01475942|constipation|constipation
389754|NCT01475942|diarrhoea|diarrhoea
389755|NCT01475942|Subclinical levels|subclinical levels
389756|NCT01475929|irritable bowel syndrome|irritable bowel syndrome
389757|NCT01475929|probiotic|probiotic
389758|NCT01475916|Asthma|asthma
389759|NCT01475916|Educational program|educational program
389760|NCT01475916|Quality of life|quality of life
389761|NCT01475916|School-aged children|school-aged children
389762|NCT01475903|Obesity|obesity
389763|NCT01475903|Sleeve gastrectomy|sleeve gastrectomy
389764|NCT01475903|Nutritional impact|nutritional impact
389765|NCT01475903|Vitamin deficiency|vitamin deficiency
389766|NCT01475890|HIV/AIDS|hiv/aids
389767|NCT01475890|Nutrition|nutrition
389768|NCT01475877|bromfenac|bromfenac
389769|NCT01475877|nepafenac|nepafenac
389770|NCT01475877|PRK|prk
389771|NCT01475877|epithelial healing,|epithelial healing,
389772|NCT01475864|Choledocholithiasis|choledocholithiasis
389773|NCT01475864|metal stents|metal stents
389774|NCT01475864|biliary duct stent|biliary duct stent
389775|NCT01475851|Tenofovir disoproxil fumarate, compensated chronic hepatitis B|tenofovir disoproxil fumarate, compensated chronic hepatitis b
389776|NCT01475838|HIV-1|hiv-1
389777|NCT01475838|HIV|hiv
389778|NCT01475838|Treatment Experienced|treatment experienced
389779|NCT01475812|COPD|copd
389780|NCT01475812|activities of daily living|activities of daily living
389781|NCT01475812|pulmonary hyperinflation|pulmonary hyperinflation
389782|NCT01475812|exercise|exercise
389783|NCT01475786|nerve pain|nerve pain
389784|NCT01475786|diabetic nerve pain|diabetic nerve pain
389785|NCT01475786|throbbing|throbbing
389786|NCT01475786|burning|burning
389787|NCT01475786|painful feet|painful feet
389788|NCT01475786|tingling|tingling
389789|NCT01475786|numbness|numbness
389790|NCT01475773|self-esteem|self-esteem
389791|NCT01475773|personality|personality
389792|NCT01475773|quality of life|quality of life
389793|NCT01475773|malocclusion|malocclusion
389794|NCT01475773|orthodontics|orthodontics
389795|NCT01475760|chronic kidney disease|chronic kidney disease
389796|NCT01475760|serum phosphorus|serum phosphorus
389797|NCT01475760|salivary phosphorus|salivary phosphorus
389798|NCT01475760|FGF23|fgf23
389799|NCT01475734|glucose clamp|glucose clamp
389800|NCT01475734|hypoglycemia|hypoglycemia
389801|NCT01475721|ADVAIR|advair
389802|NCT01475721|Asthma|asthma
389803|NCT01475721|safety|safety
389804|NCT01475721|FLOVENT|flovent
389805|NCT01475708|Lyme borreliosis|lyme borreliosis
389806|NCT01475708|Erythema migrans|erythema migrans
389807|NCT01475708|Doxycycline|doxycycline
389808|NCT01475708|Subjective symptoms|subjective symptoms
389810|NCT01475695|Mass balance|mass balance
389811|NCT01475695|intravenous|intravenous
389812|NCT01475695|GSK2251052|gsk2251052
389813|NCT01475695|Healthy volunteer|healthy volunteer
389814|NCT01475695|Antimicrobial|antimicrobial
389815|NCT01475695|Radiolabel|radiolabel
389816|NCT01475682|Obstructive sleep apnea|obstructive sleep apnea
389817|NCT01475682|cardiometabolic complications|cardiometabolic complications
389818|NCT01475682|Effects of CPAP treatment|effects of cpap treatment
389819|NCT01475643|Pediatric cataract|pediatric cataract
389820|NCT01475630|temporomandibular joint|temporomandibular joint
389821|NCT01475630|rehabilitation medicine|rehabilitation medicine
389822|NCT01475630|joint diseases|joint diseases
389823|NCT01475630|physical therapy|physical therapy
389824|NCT01475604|Pulsed Radio Frequency, Electromagnetic Field therapy|pulsed radio frequency, electromagnetic field therapy
389825|NCT01475591|persistent neuromusculoskeletal pain|persistent neuromusculoskeletal pain
389827|NCT01475591|shoulder|shoulder
389828|NCT01475591|back-area|back-area
389829|NCT01475591|risk|risk
389830|NCT01475591|longlasting|longlasting
389831|NCT01475591|pain syndrome|pain syndrome
389832|NCT01475578|Vascular Dementia|vascular dementia
389833|NCT01475565|polycystic ovary syndrome (PCOS)|polycystic ovary syndrome (pcos)
389834|NCT01475565|insulin sensitivity|insulin sensitivity
389835|NCT01475565|insulin resistance|insulin resistance
389836|NCT01475565|gestational diabetes|gestational diabetes
389837|NCT01475565|pregnancy|pregnancy
389838|NCT01475565|estrogen|estrogen
389839|NCT01475565|glucose intolerance|glucose intolerance
389840|NCT01475565|obesity|obesity
389841|NCT01475565|ovulatory disorder|ovulatory disorder
389842|NCT01475565|racial differences|racial differences
389843|NCT01475565|hyperandrogenism|hyperandrogenism
389844|NCT01475552|platelet reactivity|platelet reactivity
389845|NCT01475552|platelet function assay|platelet function assay
389846|NCT01475552|abciximab|abciximab
389847|NCT01475552|tailored therapy|tailored therapy
389848|NCT01475539|Polio|polio
389849|NCT01475539|Poliovirus|poliovirus
389850|NCT01475539|Oral poliovirus vaccine|oral poliovirus vaccine
389851|NCT01475539|IMOVAX Polio®|imovax polio®
389852|NCT01475526|grocery store|grocery store
389853|NCT01475526|nutrition|nutrition
389854|NCT01475526|Latino|latino
389855|NCT01475526|Hispanic|hispanic
389856|NCT01475513|oral contraceptive|oral contraceptive
389857|NCT01475513|birth control pill|birth control pill
389858|NCT01475513|women|women
389859|NCT01475513|healthy volunteer|healthy volunteer
389860|NCT01475513|insulin sensitivity|insulin sensitivity
389861|NCT01475513|insulin resistance|insulin resistance
389862|NCT01475513|cardiovascular risk factors|cardiovascular risk factors
389863|NCT01475513|endothelial function|endothelial function
389864|NCT01475513|estrogen metabolism|estrogen metabolism
389865|NCT01475513|racial difference|racial difference
389866|NCT01475513|glucose intolerance|glucose intolerance
389867|NCT01475474|incontinence|incontinence
389868|NCT01475474|bowel|bowel
389869|NCT01475474|movement|movement
389870|NCT01475474|fecal|fecal
389871|NCT01475474|anal|anal
389872|NCT01475474|diarrhea|diarrhea
389873|NCT01475474|stool|stool
389874|NCT01475474|rectal|rectal
389875|NCT01475474|feces|feces
389876|NCT01475474|uncontrolled|uncontrolled
389877|NCT01475474|loose|loose
389878|NCT01475474|leakage|leakage
389879|NCT01475474|rectum|rectum
389880|NCT01475474|BM|bm
389881|NCT01475474|watery|watery
389882|NCT01475474|urgent|urgent
389883|NCT01475474|flatulence|flatulence
389884|NCT01475474|gas|gas
389885|NCT01475461|Phase 2|phase 2
389886|NCT01475461|type 2 diabetes mellitus|type 2 diabetes mellitus
389887|NCT01475461|PF-04937319|pf-04937319
389888|NCT01475448|biomechanics|biomechanics
389889|NCT01475448|motor control|motor control
389890|NCT01475448|movement|movement
389891|NCT01475448|walking|walking
389892|NCT01475448|running|running
389893|NCT01475448|sedentarism|sedentarism
389894|NCT01475448|joint moment|joint moment
389895|NCT01475409|anti-TNF|anti-tnf
389896|NCT01475409|tuberculosis|tuberculosis
389897|NCT01475409|QuantiFERON-TB Gold In-Tube|quantiferon-tb gold in-tube
389898|NCT01475409|tuberculin skin test|tuberculin skin test
389899|NCT01475409|rheumatoid arthritis|rheumatoid arthritis
389900|NCT01475409|spondyloarthritis|spondyloarthritis
389901|NCT01475396|exercise|exercise
389902|NCT01475396|physical activity|physical activity
389903|NCT01475396|cognition|cognition
389904|NCT01475396|brain|brain
389905|NCT01475396|aging|aging
389906|NCT01475396|BDNF|bdnf
389907|NCT01475383|Tourette's Syndrome in adults|tourette's syndrome in adults
389908|NCT01475383|Safety and Efficacy|safety and efficacy
389909|NCT01475383|Randomized|randomized
389910|NCT01475383|Placebo Control|placebo control
389911|NCT01475383|Cross-over|cross-over
389912|NCT01475370|Acute myeloid leukemia|acute myeloid leukemia
389913|NCT01475370|WT1|wt1
389914|NCT01475357|congenital heart defects|congenital heart defects
389915|NCT01475357|growth failure|growth failure
390012|NCT01475006|Antibody drug conjugate|antibody drug conjugate
389916|NCT01475344|Trauma patient with major bleeding|trauma patient with major bleeding
389917|NCT01475331|pancreatic cyst|pancreatic cyst
389918|NCT01475331|chemotherapy|chemotherapy
389919|NCT01475331|ethanol|ethanol
389920|NCT01475331|ablation|ablation
389921|NCT01475318|complete abortion rate|complete abortion rate
389922|NCT01475318|side effects|side effects
389923|NCT01475318|induction-to-abortion interval|induction-to-abortion interval
389924|NCT01475305|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
389925|NCT01475305|Healthy adults|healthy adults
389926|NCT01475305|MEDI-557|medi-557
389927|NCT01475305|Intranasal challenge|intranasal challenge
389928|NCT01475305|Human model|human model
389929|NCT01475292|COPD|copd
389930|NCT01475279|Warfarin|warfarin
389931|NCT01475279|Dantonic|dantonic
389932|NCT01475279|Pharmacodynamics|pharmacodynamics
389933|NCT01475279|Pharmacokinetics|pharmacokinetics
389934|NCT01475279|Interaction|interaction
389935|NCT01475266|Bladder Cancer|bladder cancer
389936|NCT01475266|NMIBC|nmibc
389937|NCT01475266|TURBT|turbt
389938|NCT01475266|Apaziquone|apaziquone
389939|NCT01475266|EOquin|eoquin
389940|NCT01475266|Immediate instillation|immediate instillation
389941|NCT01475240|HIV|hiv
389942|NCT01475227|HIV|hiv
389943|NCT01475227|Bilirubin|bilirubin
389944|NCT01475214|potassium bicarbonate|potassium bicarbonate
389945|NCT01475214|urinary N-telopeptide|urinary n-telopeptide
389946|NCT01475214|urinary nitrogen|urinary nitrogen
389947|NCT01475214|net acid excretion|net acid excretion
389948|NCT01475201|Type 2 diabetes|type 2 diabetes
389949|NCT01475201|Hypertension|hypertension
389950|NCT01475201|Primary Care|primary care
389951|NCT01475201|Physical Activity|physical activity
389952|NCT01475201|Behavioural Intervention|behavioural intervention
389953|NCT01475201|Pedometer|pedometer
389954|NCT01475201|Accelerometer|accelerometer
389955|NCT01475201|Arterial Stiffness|arterial stiffness
389956|NCT01475201|Carotid femoral pulse wave velocity|carotid femoral pulse wave velocity
389957|NCT01475201|Vascular disease risk|vascular disease risk
389958|NCT01475201|Vascular disease prevention|vascular disease prevention
389959|NCT01475201|Intervention|intervention
389960|NCT01475188|specific subcutaneous immunotherapy|specific subcutaneous immunotherapy
389961|NCT01475188|seasonal allergic rhinitis|seasonal allergic rhinitis
389962|NCT01475188|regulatory lymphocytes|regulatory lymphocytes
389963|NCT01475188|signal transduction|signal transduction
389964|NCT01475188|histamine receptor|histamine receptor
389965|NCT01475162|acute Graft versus Host Disease (aGVHD)|acute graft versus host disease (agvhd)
389966|NCT01475162|steroid refractory acute Graft versus Host Disease (aGVHD)|steroid refractory acute graft versus host disease (agvhd)
389967|NCT01475162|chronic Graft versus Host Disease (cGVHD)|chronic graft versus host disease (cgvhd)
389968|NCT01475162|corticosteroids|corticosteroids
389969|NCT01475162|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
389970|NCT01475149|Antiphospholipid syndrome|antiphospholipid syndrome
389971|NCT01475149|Antiphospholipid antibodies|antiphospholipid antibodies
389972|NCT01475149|Systemic lupus erythematosus|systemic lupus erythematosus
389973|NCT01475149|Annexin A5 and Annexin A5 resistance assay|annexin a5 and annexin a5 resistance assay
389974|NCT01475123|Nicorandil|nicorandil
389975|NCT01475123|Randomized control study|randomized control study
389976|NCT01475123|Hemodialysis|hemodialysis
389977|NCT01475123|Coronary Artery Disease|coronary artery disease
389978|NCT01475110|Imatinib|imatinib
389979|NCT01475110|Chronic Myeloid Leukaemia|chronic myeloid leukaemia
389980|NCT01475110|Nilotinib|nilotinib
389981|NCT01475110|Adult patients|adult patients
389982|NCT01475110|Imatinib resistant|imatinib resistant
389983|NCT01475097|AE - Adverse event|ae - adverse event
389984|NCT01475097|Arteriography|arteriography
389985|NCT01475097|IA - Intra-arterial|ia - intra-arterial
389986|NCT01475097|IOCM - Iso-Osmolar Contrast Medium|iocm - iso-osmolar contrast medium
389987|NCT01475097|LOCM - Low-Osmolar Contrast Medium|locm - low-osmolar contrast medium
389988|NCT01475097|Patient Comfort|patient comfort
389989|NCT01475097|Body Image Disturbance|body image disturbance
389990|NCT01475097|Patient|patient
389991|NCT01475084|Flex-rigid pleuroscopy|flex-rigid pleuroscopy
389992|NCT01475084|cryobiopsy|cryobiopsy
389993|NCT01475084|pleural biopsy|pleural biopsy
389994|NCT01475084|pleural effusion|pleural effusion
389995|NCT01475084|safety|safety
389996|NCT01475084|thoracoscopy|thoracoscopy
389997|NCT01475045|COPD|copd
389998|NCT01475032|Asthma|asthma
389999|NCT01475032|children|children
390000|NCT01475032|chronic treatment|chronic treatment
390001|NCT01475019|Obesity|obesity
390002|NCT01475019|Polycystic Ovaries Syndrome|polycystic ovaries syndrome
390003|NCT01475019|Orlistat|orlistat
390004|NCT01475019|Sibutramine|sibutramine
390005|NCT01475019|Androgen levels|androgen levels
390006|NCT01475019|Insulin resistance|insulin resistance
390007|NCT01475006|Epidermal Growth Factor Receptor Variant III|epidermal growth factor receptor variant iii
390008|NCT01475006|EGFRvIII|egfrviii
390009|NCT01475006|Glioma|glioma
390010|NCT01475006|Anaplastic Astrocytomas|anaplastic astrocytomas
390011|NCT01475006|Glioblastoma Multiforme|glioblastoma multiforme
390014|NCT01474980|Congenital Myasthenic Syndrome|congenital myasthenic syndrome
390015|NCT01474980|Pregnancy|pregnancy
390016|NCT01474980|Outcome|outcome
390017|NCT01474967|polycystic ovary syndrome|polycystic ovary syndrome
390018|NCT01474967|lipid profile|lipid profile
390019|NCT01474967|metformin|metformin
390020|NCT01474954|HIV|hiv
390021|NCT01474954|Antiretroviral Medication|antiretroviral medication
390022|NCT01474954|Cardiovascular Disease Risk|cardiovascular disease risk
390023|NCT01474941|Multiple Dose Study Overweight Healthy Subjects Body Weight Modified-Release Formulation|multiple dose study overweight healthy subjects body weight modified-release formulation
390024|NCT01474928|Asthma|asthma
390025|NCT01474928|Community-based participatory research|community-based participatory research
390026|NCT01474928|Educational intervention|educational intervention
390027|NCT01474928|Ethno-cultural community|ethno-cultural community
390028|NCT01474928|Video recording|video recording
390029|NCT01474928|Patient education handout|patient education handout
390030|NCT01474915|Neurosurgery|neurosurgery
390031|NCT01474902|pediatric|pediatric
390032|NCT01474902|asymptotic venous thrombosis|asymptotic venous thrombosis
390033|NCT01474902|Enoxaparin|enoxaparin
390034|NCT01474902|pediatric cardiac surgery|pediatric cardiac surgery
390035|NCT01474889|Hypoglycemia, Unawareness, RT-CGM, Type 1 Diabetes|hypoglycemia, unawareness, rt-cgm, type 1 diabetes
390036|NCT01474876|Post-marketing observational study (PMOS) Protocol|post-marketing observational study (pmos) protocol
390037|NCT01474876|Effectiveness of Adalimumab (HUMIRA®)|effectiveness of adalimumab (humira®)
390038|NCT01474876|Psoriatic Arthritis|psoriatic arthritis
390039|NCT01474876|Ankylosing Spondylitis|ankylosing spondylitis
390040|NCT01474850|mechanical ventilation|mechanical ventilation
390041|NCT01474850|pressure control ventilation|pressure control ventilation
390042|NCT01474850|lung recruitment|lung recruitment
390043|NCT01474850|positive end expiratory pressure|positive end expiratory pressure
390044|NCT01474850|opto-electronic plethysmography|opto-electronic plethysmography
390045|NCT01474850|chest wall volume variation|chest wall volume variation
390046|NCT01474850|intravenous anesthesia|intravenous anesthesia
390047|NCT01474837|depressive disorders|depressive disorders
390048|NCT01474837|exercise therapy|exercise therapy
390049|NCT01474824|Cardiac output|cardiac output
390050|NCT01474824|Stroke volume|stroke volume
390051|NCT01474811|Hepatitis|hepatitis
390052|NCT01474811|Hepatitis C|hepatitis c
390053|NCT01474811|HCV-TARGET|hcv-target
390054|NCT01474811|HCV|hcv
390055|NCT01474811|Observational Study|observational study
390056|NCT01474798|Acne Vulgaris|acne vulgaris
390057|NCT01474785|Obesity|obesity
390058|NCT01474785|Bariatric surgery|bariatric surgery
390059|NCT01474785|Nashville, Tennessee|nashville, tennessee
390060|NCT01474772|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
390061|NCT01474772|Pain on Walking|pain on walking
390062|NCT01474772|Pregabalin|pregabalin
390063|NCT01474746|Fragile X Syndrome|fragile x syndrome
390064|NCT01474746|Pediatrics|pediatrics
390065|NCT01474746|sertraline|sertraline
390066|NCT01474746|autism|autism
390067|NCT01474733|resident education|resident education
390068|NCT01474733|health literacy|health literacy
390069|NCT01474733|curriculum|curriculum
390070|NCT01474720|Systemic Lupus Erythematosus|systemic lupus erythematosus
390071|NCT01474720|Lupus|lupus
390072|NCT01474720|SLE|sle
390073|NCT01474720|Zostavax|zostavax
390074|NCT01474720|shingles|shingles
390075|NCT01474707|COPD|copd
390076|NCT01474707|Educational materials|educational materials
390077|NCT01474707|Cultural background|cultural background
390078|NCT01474707|Instructional videos|instructional videos
390079|NCT01474707|Patient education handouts|patient education handouts
390080|NCT01474707|Lung age|lung age
390081|NCT01474694|prospective study|prospective study
390082|NCT01474694|multicenter trial|multicenter trial
390083|NCT01474694|analysis, computer assisted image|analysis, computer assisted image
390084|NCT01474694|CE marked|ce marked
390085|NCT01474694|medical devices|medical devices
390086|NCT01474694|catheter ablation|catheter ablation
390087|NCT01474681|hematologic malignancies|hematologic malignancies
390088|NCT01474681|leukemia|leukemia
390089|NCT01474681|lymphoma|lymphoma
390090|NCT01474655|epiretinal membrane|epiretinal membrane
390091|NCT01474655|visual acuity|visual acuity
390092|NCT01474655|metamorphopsia|metamorphopsia
390093|NCT01474655|thickness of retinal layers|thickness of retinal layers
390094|NCT01474655|spectral domain optical coherence tomography|spectral domain optical coherence tomography
390095|NCT01474642|Advanced or recurrent esophageal squamous cell carcinoma|advanced or recurrent esophageal squamous cell carcinoma
390096|NCT01474642|Randomizes phase II trial|randomizes phase ii trial
390097|NCT01474642|Capecitabine|capecitabine
390098|NCT01474642|Cisplatin|cisplatin
390099|NCT01474642|Genexol|genexol
390100|NCT01474629|oxidative stress|oxidative stress
390101|NCT01474629|inflammation|inflammation
390102|NCT01474629|endotoxemia|endotoxemia
390103|NCT01474629|strenuous exercise|strenuous exercise
390104|NCT01474616|Aging|aging
390105|NCT01474616|Health Services|health services
390106|NCT01474616|Knowledge Translation|knowledge translation
390107|NCT01474616|Long-Term Care Facilities|long-term care facilities
390109|NCT01474616|Psychosocial And Health Behaviours|psychosocial and health behaviours
390110|NCT01474603|observational study|observational study
390111|NCT01474577|stress test|stress test
390112|NCT01474577|cardiac issues|cardiac issues
390113|NCT01474577|Rb-82 PET Myocardial Perfusion Imaging|rb-82 pet myocardial perfusion imaging
390114|NCT01474577|11-150|11-150
390115|NCT01474577|one or more 82Rb myocardial perfusion stress tests|one or more 82rb myocardial perfusion stress tests
390116|NCT01474564|Blood draw|blood draw
390117|NCT01474564|pancreas|pancreas
390118|NCT01474564|Tumorigenic Cells|tumorigenic cells
390119|NCT01474564|11-141|11-141
390120|NCT01474551|Vemurafenib|vemurafenib
390121|NCT01474551|skin cancer|skin cancer
390122|NCT01474551|Stage IV|stage iv
390123|NCT01474551|advanced stage III|advanced stage iii
390124|NCT01474551|11-091|11-091
390125|NCT01474538|diabetes|diabetes
390126|NCT01474538|type 2 diabetes|type 2 diabetes
390127|NCT01474538|insulin pump|insulin pump
390128|NCT01474538|continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
390129|NCT01474538|CSII|csii
390130|NCT01474538|A1C|a1c
390131|NCT01474486|thiamin|thiamin
390132|NCT01474486|pyridoxine|pyridoxine
390133|NCT01474486|vitamin D|vitamin d
390134|NCT01474486|zinc|zinc
390135|NCT01474486|congestive heart failure (CHF)|congestive heart failure (chf)
390136|NCT01474486|ischemic cardiomyopathy|ischemic cardiomyopathy
390137|NCT01474486|nutritional injury|nutritional injury
390138|NCT01474486|quality of life|quality of life
390139|NCT01474473|CACIPLIQ20|cacipliq20
390140|NCT01474473|Matrix Therapy|matrix therapy
390141|NCT01474473|Diabetic foot|diabetic foot
390142|NCT01474460|warfarin|warfarin
390143|NCT01474460|phytonadione|phytonadione
390144|NCT01474460|INR|inr
390145|NCT01474447|low back pain|low back pain
390146|NCT01474434|coronary artery disease,|coronary artery disease,
390147|NCT01474434|LCQ908,|lcq908,
390148|NCT01474434|hyperlipidemia,|hyperlipidemia,
390149|NCT01474434|hypertriglyceridemia,|hypertriglyceridemia,
390150|NCT01474434|pradigastat|pradigastat
390151|NCT01474421|Parkinson's disease|parkinson's disease
390152|NCT01474421|Dyskinesia|dyskinesia
390153|NCT01474421|Movement disorders|movement disorders
390154|NCT01474421|L-dopa|l-dopa
390155|NCT01474408|Coronary artery bypass|coronary artery bypass
390156|NCT01474408|Exercise therapy|exercise therapy
390157|NCT01474408|Revascularization (PCI)|revascularization (pci)
390158|NCT01474395|schizophrenia|schizophrenia
390159|NCT01474395|cognitive remediation|cognitive remediation
390160|NCT01474395|NMDA|nmda
390161|NCT01474382|OraVerse|oraverse
390162|NCT01474382|Safety|safety
390163|NCT01474382|Efficacy|efficacy
390164|NCT01474382|Pediatric|pediatric
390165|NCT01474382|Reversal of dental anesthesia|reversal of dental anesthesia
390166|NCT01474369|Drug Therapy|drug therapy
390167|NCT01474356|brachytherapy|brachytherapy
390168|NCT01474356|interstitial hyperthermia|interstitial hyperthermia
390169|NCT01474356|cervical cancer|cervical cancer
390170|NCT01474356|side effects|side effects
390171|NCT01474356|Locally advanced cervical cancer patients|locally advanced cervical cancer patients
390172|NCT01474343|Neurodegenerative Diseases|neurodegenerative diseases
390173|NCT01474343|Nervous System Diseases|nervous system diseases
390174|NCT01474343|Genetic Diseases, Inborn|genetic diseases, inborn
390175|NCT01474343|Metabolic Diseases|metabolic diseases
390176|NCT01474343|Gene Therapy|gene therapy
390177|NCT01474343|Adenovirus Associated Vector|adenovirus associated vector
390178|NCT01474330|Pomalidomide|pomalidomide
390179|NCT01474330|safety|safety
390180|NCT01474330|tolerability|tolerability
390181|NCT01474330|pharmacokinetics|pharmacokinetics
390182|NCT01474304|craniotomy|craniotomy
390183|NCT01474304|tumor resection|tumor resection
390184|NCT01474304|aneurysm|aneurysm
390185|NCT01474304|revascularization|revascularization
390186|NCT01474304|opioid|opioid
390187|NCT01474304|nausea|nausea
390188|NCT01474304|vomiting|vomiting
390189|NCT01474304|acetaminophen|acetaminophen
390190|NCT01474265|smoking cessation|smoking cessation
390191|NCT01474265|varenicline|varenicline
390192|NCT01474265|sympathovagal balance|sympathovagal balance
390193|NCT01474265|quit attempts|quit attempts
390194|NCT01474265|MSNA|msna
390195|NCT01474226|lysine|lysine
390196|NCT01474226|rice|rice
390197|NCT01474226|bioavailability|bioavailability
390198|NCT01474213|dexmedetomidine|dexmedetomidine
390199|NCT01474213|remifentanil|remifentanil
390200|NCT01474213|awake nasotracheal fibreoptic intubation|awake nasotracheal fibreoptic intubation
390201|NCT01474213|oral maxillofacial surgery|oral maxillofacial surgery
390202|NCT01474213|difficult airway|difficult airway
390203|NCT01474213|adult|adult
390204|NCT01474200|Ultrafiltration|ultrafiltration
390205|NCT01474200|Aquapheresis|aquapheresis
390206|NCT01474200|Diuretics|diuretics
390207|NCT01474200|Loop Diuretics|loop diuretics
390208|NCT01474200|Aquadex Flexflow System|aquadex flexflow system
390209|NCT01474200|Gambro UF Solutions|gambro uf solutions
390210|NCT01474187|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
390211|NCT01474187|rectal cancer|rectal cancer
390212|NCT01474187|phase I study|phase i study
390213|NCT01474187|irinotecan|irinotecan
390214|NCT01474148|paraplegia|paraplegia
390215|NCT01474148|tetraplegia|tetraplegia
390216|NCT01474148|Spinal cord injured|spinal cord injured
390217|NCT01474148|FES|fes
390218|NCT01474135|Glaucoma|glaucoma
390219|NCT01474135|Ocular Hypertension|ocular hypertension
390220|NCT01474122|digital ulcers|digital ulcers
390221|NCT01474122|systemic sclerosis|systemic sclerosis
390222|NCT01474109|systemic sclerosis|systemic sclerosis
390223|NCT01474109|digital ulcers|digital ulcers
390224|NCT01474096|clinical practice guideline-primary health care|clinical practice guideline-primary health care
390225|NCT01474083|Type 2 diabetes mellitus|type 2 diabetes mellitus
390226|NCT01474083|pharmacokinetics|pharmacokinetics
390227|NCT01474083|pharmacodynamics|pharmacodynamics
390228|NCT01474070|Glaucoma|glaucoma
390229|NCT01474070|Goldmann Tonometry|goldmann tonometry
390230|NCT01474070|Dynamic Contour Tonometry|dynamic contour tonometry
390231|NCT01474057|PTSD|ptsd
390232|NCT01474057|combat trauma|combat trauma
390233|NCT01474057|telemedicine|telemedicine
390234|NCT01474057|primary care interventions|primary care interventions
390235|NCT01474057|CBT|cbt
390236|NCT01474057|self-managed treatment|self-managed treatment
390237|NCT01474057|web-based intervention|web-based intervention
390238|NCT01474057|internet treatment|internet treatment
390239|NCT01474031|total hip arthroplasty|total hip arthroplasty
390240|NCT01474031|biomechanics|biomechanics
390241|NCT01474031|direct anterior approach|direct anterior approach
390242|NCT01474005|laryngectomy|laryngectomy
390243|NCT01474005|artificial larynx|artificial larynx
390244|NCT01474005|breathing|breathing
390245|NCT01474005|swallowing|swallowing
390246|NCT01474005|upper airway|upper airway
390247|NCT01473979|cardiac surgery|cardiac surgery
390248|NCT01473979|poststernotomy wound infections|poststernotomy wound infections
390249|NCT01473979|delayed secondary closure of sternum|delayed secondary closure of sternum
390250|NCT01473927|Inflammatory bowel diseases|inflammatory bowel diseases
390251|NCT01473927|Crohn disease|crohn disease
390252|NCT01473927|Ficolin-2|ficolin-2
390253|NCT01473927|C-Reactive Protein|c-reactive protein
390254|NCT01473927|Calprotectin|calprotectin
390255|NCT01473927|Inflammatory markers|inflammatory markers
390256|NCT01473927|SES-CD|ses-cd
390257|NCT01473901|BKM120|bkm120
390258|NCT01473901|temozolomide|temozolomide
390259|NCT01473901|glioblastoma multiforme|glioblastoma multiforme
390260|NCT01473901|GBM|gbm
390261|NCT01473901|Newly diagnosed|newly diagnosed
390262|NCT01473888|T89(Dantonic®)|t89(dantonic®)
390263|NCT01473888|Cooperstown 5+1 cocktail probes|cooperstown 5+1 cocktail probes
390264|NCT01473888|CYP450|cyp450
390265|NCT01473875|LIPA|lipa
390266|NCT01473875|Wolman Disease|wolman disease
390267|NCT01473875|Wolman Phenotype|wolman phenotype
390268|NCT01473875|Acid Lipase Deficiency|acid lipase deficiency
390269|NCT01473875|Acid Cholesteryl Hydrolase|acid cholesteryl hydrolase
390270|NCT01473875|Acid Lipase Disease Deficiency, type 2|acid lipase disease deficiency, type 2
390271|NCT01473875|Cholesteryl Ester Storage Disease (CESD)|cholesteryl ester storage disease (cesd)
390272|NCT01473875|Cholesteryl Ester Hydrolase Deficiency|cholesteryl ester hydrolase deficiency
390273|NCT01473875|Early Onset LAL-Deficiency (Wolman Disease)|early onset lal-deficiency (wolman disease)
390274|NCT01473875|LAL Deficiency|lal deficiency
390275|NCT01473875|Late Onset Lysosomal Acid Lipase Deficiency (CESD)|late onset lysosomal acid lipase deficiency (cesd)
390276|NCT01473875|Wolman Disease (early onset LAL Deficiency)|wolman disease (early onset lal deficiency)
390277|NCT01473875|Related Disorders:|related disorders:
390278|NCT01473875|Non-alcoholic Fatty Liver Disease (NAFLD)|non-alcoholic fatty liver disease (nafld)
390279|NCT01473875|Non-alcoholic Steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
390280|NCT01473875|Alcoholic Liver Disease|alcoholic liver disease
390281|NCT01473875|Cryptogenic Cirrhosis|cryptogenic cirrhosis
390282|NCT01473875|Niemann-Pick Disease (NPD) Type C|niemann-pick disease (npd) type c
390283|NCT01473875|Chanarin Dorfman Syndrome|chanarin dorfman syndrome
390284|NCT01473862|adolescent|adolescent
390285|NCT01473862|bereavement|bereavement
390286|NCT01473862|cancer|cancer
390287|NCT01473862|coping skills|coping skills
390288|NCT01473849|Cytomegalovirus|cytomegalovirus
390289|NCT01473849|Liver transplantation|liver transplantation
390290|NCT01473849|Hepatitis C virus|hepatitis c virus
390291|NCT01473849|Patients who underwent first liver transplantation due to hepatopathy caused by HCV,confirmed by detection of HCV RNA previously to transplantation|patients who underwent first liver transplantation due to hepatopathy caused by hcv,confirmed by detection of hcv rna previously to transplantation
390292|NCT01473836|Metronidazole|metronidazole
390293|NCT01473836|intra-abdominal infection|intra-abdominal infection
390294|NCT01473836|pelvic inflammatory disease|pelvic inflammatory disease
390295|NCT01473836|anaerobe|anaerobe
390296|NCT01473823|food allergy|food allergy
390297|NCT01473823|eczema|eczema
390298|NCT01473823|sensitisation|sensitisation
390299|NCT01473823|omega-3 long chain polyunsaturated fatty acids|omega-3 long chain polyunsaturated fatty acids
390300|NCT01473823|prevention|prevention
390301|NCT01473823|asthma|asthma
390302|NCT01473810|HIV|hiv
390303|NCT01473810|vaccination|vaccination
390304|NCT01473810|T cells|t cells
390305|NCT01473810|mucosal immunity|mucosal immunity
390306|NCT01473810|safety|safety
390307|NCT01473810|nasal administration|nasal administration
390308|NCT01473810|DTH skin test|dth skin test
390309|NCT01473771|Suicide|suicide
390310|NCT01473771|Suicide, Attempted|suicide, attempted
390311|NCT01473758|COPD|copd
390312|NCT01473758|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
390313|NCT01473758|Roflumilast|roflumilast
390314|NCT01473745|Alar Base Suture; Nasolabial Change; 3D stereogrammetry|alar base suture; nasolabial change; 3d stereogrammetry
390315|NCT01473732|CNI toxicity|cni toxicity
390316|NCT01473732|CAI|cai
390317|NCT01473719|alcohol use|alcohol use
390318|NCT01473719|marijuana use|marijuana use
390319|NCT01473719|STI|sti
390320|NCT01473706|Malnutrition|malnutrition
390321|NCT01473706|Nutrition status|nutrition status
390322|NCT01473706|Elderly|elderly
390323|NCT01473706|Nutrition screening|nutrition screening
390324|NCT01473693|Quality of Life|quality of life
390325|NCT01473693|Lung cancer|lung cancer
390326|NCT01473693|MRI|mri
390327|NCT01473693|Surgery|surgery
390328|NCT01473693|induction chemotherapy|induction chemotherapy
390329|NCT01473693|11-145|11-145
390330|NCT01473680|minority breast cancer patients|minority breast cancer patients
390331|NCT01473680|EEG|eeg
390332|NCT01473680|Evaluation|evaluation
390333|NCT01473680|Questionnaires|questionnaires
390334|NCT01473680|11-139|11-139
390335|NCT01473641|Etonogestrel|etonogestrel
390336|NCT01473641|Contraceptive implant|contraceptive implant
390337|NCT01473641|Safety|safety
390338|NCT01473628|early stage follicular lymphoma|early stage follicular lymphoma
390339|NCT01473628|indolent non-Hodgkin's lymphomas|indolent non-hodgkin's lymphomas
390340|NCT01473628|Lymphoma|lymphoma
390341|NCT01473628|Follicular Lymphoma|follicular lymphoma
390342|NCT01473628|FL|fl
390343|NCT01473628|Rituximab|rituximab
390344|NCT01473628|Rituxan|rituxan
390345|NCT01473628|Radiation|radiation
390346|NCT01473628|Radiation Therapy|radiation therapy
390347|NCT01473628|XRT|xrt
390348|NCT01473576|type II diabetes|type ii diabetes
390349|NCT01473576|protein synthesis|protein synthesis
390350|NCT01473576|nitrate|nitrate
390351|NCT01473576|elderly|elderly
390352|NCT01473550|Mental Health|mental health
390353|NCT01473550|Smart Technology|smart technology
390354|NCT01473550|Mood disorder|mood disorder
390355|NCT01473550|Psychotic disorder|psychotic disorder
390356|NCT01473537|dental caries/prevention and control|dental caries/prevention and control
390357|NCT01473537|oral health|oral health
390358|NCT01473537|cariostatic agents|cariostatic agents
390359|NCT01473524|Primary Biliary Cholangitis|primary biliary cholangitis
390360|NCT01473524|Primary Biliary Cirrhosis|primary biliary cirrhosis
390361|NCT01473524|PBC|pbc
390362|NCT01473524|Cirrhosis|cirrhosis
390363|NCT01473524|Liver|liver
390364|NCT01473511|Behavioural intervention|behavioural intervention
390365|NCT01473511|Distance intervention|distance intervention
390366|NCT01473511|Parenting intervention|parenting intervention
390367|NCT01473498|Sepsis|sepsis
390368|NCT01473498|Acute kidney injury|acute kidney injury
390369|NCT01473498|Mean arterial pressure|mean arterial pressure
390370|NCT01473498|Catecholamines|catecholamines
390371|NCT01473498|Renal doppler|renal doppler
390372|NCT01473485|Brain Tumor|brain tumor
390373|NCT01473485|Glioma|glioma
390374|NCT01473485|Brain Cancer|brain cancer
390375|NCT01473485|Metastatic Brain Cancer|metastatic brain cancer
390376|NCT01473472|Prophylaxis|prophylaxis
390377|NCT01473472|HIV infection|hiv infection
390378|NCT01473472|tenofovir|tenofovir
390379|NCT01473472|emtricitabine|emtricitabine
390380|NCT01473472|men who have sex with men|men who have sex with men
390381|NCT01473459|best fertility protocol|best fertility protocol
390382|NCT01473459|(BMI > 30)|(bmi > 30)
390383|NCT01473459|women|women
390384|NCT01473459|PCOS|pcos
390385|NCT01473446|Goal directed fluid therapy|goal directed fluid therapy
390386|NCT01473446|perioperative fluid therapy|perioperative fluid therapy
390387|NCT01473446|LiDCOrapid|lidcorapid
390388|NCT01473446|Postoperative outcome|postoperative outcome
390389|NCT01473446|Open abdominal surgery|open abdominal surgery
390390|NCT01473433|Regenerative medicine|regenerative medicine
390391|NCT01473433|Myocardial infarction|myocardial infarction
390392|NCT01473394|Major depressive disorder|major depressive disorder
390393|NCT01473394|Depression|depression
390394|NCT01473381|Major Depressive Disorder|major depressive disorder
390395|NCT01473381|Depression|depression
390396|NCT01473368|human Gut Microbiota|human gut microbiota
390397|NCT01473368|gut microbiota|gut microbiota
390398|NCT01473368|gut microbiome|gut microbiome
390399|NCT01473368|probiotic|probiotic
390400|NCT01473368|antibiotic|antibiotic
390401|NCT01473368|antibiotic-associated diarrhea|antibiotic-associated diarrhea
390402|NCT01473368|intestinal bacterial overgrowth|intestinal bacterial overgrowth
390403|NCT01473342|Healthy survivorship|healthy survivorship
390404|NCT01473342|Smartphones|smartphones
390405|NCT01473342|Treatment|treatment
390406|NCT01473329|diabetes care|diabetes care
390407|NCT01473329|diabetes education|diabetes education
390408|NCT01473329|diabetes control|diabetes control
390409|NCT01473303|stage IV pancreatic cancer|stage iv pancreatic cancer
390410|NCT01473303|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
390411|NCT01473290|diarrhea|diarrhea
390412|NCT01473290|constipation, impaction, and bowel obstruction|constipation, impaction, and bowel obstruction
390413|NCT01473290|gastrointestinal complications|gastrointestinal complications
390414|NCT01473290|fatigue|fatigue
390415|NCT01473290|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
390416|NCT01473290|cognitive/functional effects|cognitive/functional effects
390417|NCT01473290|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
390418|NCT01473277|Hemiplegic shoulder pain|hemiplegic shoulder pain
390419|NCT01473277|Botulinum toxin type A (BT-A)|botulinum toxin type a (bt-a)
390420|NCT01473277|Steroid|steroid
390421|NCT01473277|Intra-articular injection|intra-articular injection
390422|NCT01473277|Pain score of 45 or greater on a 0-100 mm VAS|pain score of 45 or greater on a 0-100 mm vas
390423|NCT01473277|Duration of HSP for at least one month|duration of hsp for at least one month
390424|NCT01473277|Pain refractoriness to conventional treatment|pain refractoriness to conventional treatment
390425|NCT01473264|CC10|cc10
390426|NCT01473264|BPD|bpd
390427|NCT01473264|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
390428|NCT01473264|premature infants|premature infants
390429|NCT01473264|neonates|neonates
390430|NCT01473264|pulmonary inflammation|pulmonary inflammation
390431|NCT01473264|lung function|lung function
390432|NCT01473264|RDS|rds
390433|NCT01473238|Desktop computer|desktop computer
390434|NCT01473238|Mobile|mobile
390435|NCT01473238|iPad|ipad
390436|NCT01473238|Evaluation|evaluation
390437|NCT01473238|User experience|user experience
390438|NCT01473238|Benefits|benefits
390439|NCT01473238|Cost analysis|cost analysis
390440|NCT01473199|focal defect|focal defect
390441|NCT01473199|focal lesion|focal lesion
390442|NCT01473199|chondral lesion|chondral lesion
390443|NCT01473199|osteochondral lesion|osteochondral lesion
390444|NCT01473186|morbid obesity|morbid obesity
390445|NCT01473186|endometrial pathology|endometrial pathology
390446|NCT01473186|menstrual irregularities|menstrual irregularities
390448|NCT01473173|Tolerability|tolerability
390449|NCT01473173|Pharmacokinetics|pharmacokinetics
390450|NCT01473173|Pharmacodynamics|pharmacodynamics
390451|NCT01473147|GLP-1 analogue|glp-1 analogue
390452|NCT01473147|CSII|csii
390453|NCT01473147|insulin|insulin
390454|NCT01473147|type 2 diabetes mellitus|type 2 diabetes mellitus
390455|NCT01473121|Hepatocellular carcinoma|hepatocellular carcinoma
390456|NCT01473121|Registry|registry
390457|NCT01473121|Turkey|turkey
390458|NCT01473108|Healthy volunteers, proof-of-concept trial, PK and PD|healthy volunteers, proof-of-concept trial, pk and pd
390459|NCT01473095|AKT|akt
390460|NCT01473095|ARQ 092|arq 092
390461|NCT01473095|Targeted therapy|targeted therapy
390462|NCT01473095|Molecular therapy|molecular therapy
390463|NCT01473095|Biomarker|biomarker
390464|NCT01473095|Phase 1|phase 1
390465|NCT01473095|Phase I|phase i
390466|NCT01473095|Endometrial cancer|endometrial cancer
390467|NCT01473095|Lymphoma|lymphoma
390468|NCT01473095|AKT pathway|akt pathway
390469|NCT01473095|AKT signaling|akt signaling
390470|NCT01473095|AKT inhibitor|akt inhibitor
390471|NCT01473095|AKT pan inhibitor|akt pan inhibitor
390472|NCT01473095|AKT1|akt1
390473|NCT01473095|AKT2|akt2
390474|NCT01473095|AKT3|akt3
390475|NCT01473095|AKT1 mutation|akt1 mutation
390476|NCT01473095|AKT1-E17K|akt1-e17k
390477|NCT01473095|AKT1-E17K mutation|akt1-e17k mutation
390478|NCT01473095|AKT 2 inhibitor|akt 2 inhibitor
390479|NCT01473095|AKT 3 inhibitor|akt 3 inhibitor
390480|NCT01473095|AKT 3 amplification|akt 3 amplification
390481|NCT01473095|PI3K AKT mTOR signalling pathway|pi3k akt mtor signalling pathway
390482|NCT01473095|mTOR inhibitor|mtor inhibitor
390483|NCT01473095|PI3K inhibitor|pi3k inhibitor
390484|NCT01473095|Clinical oncology|clinical oncology
390485|NCT01473095|Tumor|tumor
390486|NCT01473095|Tumour|tumour
390487|NCT01473095|PIK3CA H1047R mutation|pik3ca h1047r mutation
390488|NCT01473069|JTK-853|jtk-853
390489|NCT01473069|Healthy subjects|healthy subjects
390490|NCT01473056|Hepatitis C|hepatitis c
390491|NCT01473056|JTK-853|jtk-853
390492|NCT01473043|Axitinib|axitinib
390493|NCT01473043|metastatic renal cell carcinoma|metastatic renal cell carcinoma
390494|NCT01473030|Benign prostate|benign prostate
390495|NCT01473030|serum DHT|serum dht
390496|NCT01473030|Dutasteride|dutasteride
390497|NCT01473030|PSA|psa
390498|NCT01473030|Avodart|avodart
390499|NCT01473004|Sir-spheres|sir-spheres
390500|NCT01473004|Liver Metastases|liver metastases
390501|NCT01473004|Selective internal radiation|selective internal radiation
390502|NCT01473004|Yttrium-90|yttrium-90
390503|NCT01473004|Uveal|uveal
390504|NCT01473004|Melanoma|melanoma
390505|NCT01473004|Ocular melanoma|ocular melanoma
390506|NCT01472991|ADHD|adhd
390507|NCT01472978|C. difficile|c. difficile
390508|NCT01472965|central line|central line
390509|NCT01472965|adolescents|adolescents
390510|NCT01472965|children|children
390511|NCT01472965|bloodstream infection|bloodstream infection
390512|NCT01472965|antibiotic lock therapy|antibiotic lock therapy
390513|NCT01472965|catheter lock therapy|catheter lock therapy
390514|NCT01472965|ethanol lock therapy|ethanol lock therapy
390515|NCT01472952|sepsis|sepsis
390516|NCT01472952|immune cells|immune cells
390517|NCT01472952|immune reaction|immune reaction
390518|NCT01472952|trauma|trauma
390519|NCT01472952|Immune activation|immune activation
390520|NCT01472926|acute ischaemic stroke|acute ischaemic stroke
390521|NCT01472926|stroke|stroke
390522|NCT01472926|thrombolysis|thrombolysis
390523|NCT01472926|thrombolytic drug therapy|thrombolytic drug therapy
390524|NCT01472926|CT perfusion|ct perfusion
390525|NCT01472926|CT angiography|ct angiography
390526|NCT01472926|brain imaging|brain imaging
390527|NCT01472913|Prospective randomised double-blind study|prospective randomised double-blind study
390528|NCT01472913|Fibrin sealant|fibrin sealant
390529|NCT01472913|Bilateral simultaneous total knee arthroplasty|bilateral simultaneous total knee arthroplasty
390530|NCT01472913|Blood loss|blood loss
390531|NCT01472913|Postoperative pain|postoperative pain
390532|NCT01472913|Complications|complications
390533|NCT01472900|acne vulgaris|acne vulgaris
390534|NCT01472874|Wilson Disease|wilson disease
390535|NCT01472874|Trientine|trientine
390536|NCT01472874|One Daily Dosage|one daily dosage
390537|NCT01472861|coculture|coculture
390538|NCT01472861|endometrial biopsy|endometrial biopsy
390539|NCT01472861|IVF poor responders|ivf poor responders
390540|NCT01472835|sedation|sedation
390541|NCT01472835|sensitivity|sensitivity
390542|NCT01472835|specificity|specificity
390543|NCT01472835|validity|validity
390544|NCT01472835|diagnostic injection|diagnostic injection
390545|NCT01472822|Omija|omija
390546|NCT01472822|knee osteoarthritis|knee osteoarthritis
390547|NCT01472809|ZYGK1|zygk1
390548|NCT01472809|Cadila|cadila
390549|NCT01472809|Zydus|zydus
390550|NCT01472809|ZRC|zrc
390551|NCT01472809|Zydus Research Center|zydus research center
390552|NCT01472809|Phase 1|phase 1
390553|NCT01472809|Diabetes|diabetes
390554|NCT01472796|African American|african american
390555|NCT01472796|Vitamin D deficient|vitamin d deficient
390556|NCT01472783|BRCA1 mutation|brca1 mutation
390557|NCT01472783|BRCA2 mutation|brca2 mutation
390558|NCT01472783|Ovarian cancer|ovarian cancer
390559|NCT01472783|PARP inhibitor|parp inhibitor
390560|NCT01472770|Colorectal cancer|colorectal cancer
390561|NCT01472770|Metastatic|metastatic
390562|NCT01472770|Treatment resistant|treatment resistant
390563|NCT01472744|Executive function|executive function
390564|NCT01472744|Aging|aging
390565|NCT01472744|Physical activity|physical activity
390566|NCT01472731|GC1008|gc1008
390567|NCT01472731|PET imaging|pet imaging
390568|NCT01472731|primary brain tumors|primary brain tumors
390569|NCT01472731|recurrent high grade glioma's|recurrent high grade glioma's
390570|NCT01472705|drug-eluting coronary stent|drug-eluting coronary stent
390571|NCT01472705|percutaneous coronary intervention|percutaneous coronary intervention
390572|NCT01472692|Prehypertension|prehypertension
390573|NCT01472692|Gout|gout
390574|NCT01472692|Puls Wave Velocity|puls wave velocity
390575|NCT01472692|Hypertension|hypertension
390576|NCT01472692|24 hour blood pressure|24 hour blood pressure
390577|NCT01472679|fat mass|fat mass
390578|NCT01472679|fat free mass|fat free mass
390579|NCT01472679|body mass index|body mass index
390580|NCT01472666|Medium chain fatty acids|medium chain fatty acids
390581|NCT01472666|Saturated fatty acids|saturated fatty acids
390582|NCT01472666|Whey protein|whey protein
390583|NCT01472666|Casein protein|casein protein
390584|NCT01472666|Metabolic syndrome|metabolic syndrome
390585|NCT01472666|Type 2 diabetes|type 2 diabetes
390586|NCT01472666|Cardiovascular disease|cardiovascular disease
390587|NCT01472666|Dairy products|dairy products
390588|NCT01472666|Dietary intervention|dietary intervention
390589|NCT01472653|Head and neck Cancer|head and neck cancer
390590|NCT01472653|Radiochemotherapy|radiochemotherapy
390591|NCT01472653|Radioimmunotherapy|radioimmunotherapy
390592|NCT01472653|Skin rush|skin rush
390593|NCT01472653|locoregional control|locoregional control
390594|NCT01472653|Survival|survival
390595|NCT01472653|Toxicity|toxicity
390596|NCT01472640|CHF, Diabetes; Liraglutid, Ecco|chf, diabetes; liraglutid, ecco
390598|NCT01472627|Bortezomib|bortezomib
390599|NCT01472627|Velcade|velcade
390600|NCT01472614|Type-2 diabetes mellitus|type-2 diabetes mellitus
390601|NCT01472614|Add-on therapy|add-on therapy
390602|NCT01472575|rotavirus|rotavirus
390603|NCT01472575|gastroenteritis|gastroenteritis
390604|NCT01472575|vaccination|vaccination
390605|NCT01472575|hospitalisation|hospitalisation
390606|NCT01472562|mantle cell lymphoma|mantle cell lymphoma
390607|NCT01472549|Preoperative|preoperative
390608|NCT01472549|Antiseptics|antiseptics
390609|NCT01472549|Comparative|comparative
390610|NCT01472549|Cost|cost
390611|NCT01472549|Effectiveness|effectiveness
390612|NCT01472536|Influenza|influenza
390613|NCT01472536|Non pharmaceutical intervention|non pharmaceutical intervention
390614|NCT01472536|Sequestration|sequestration
390615|NCT01472536|Social network|social network
390616|NCT01472510|Diabetic|diabetic
390617|NCT01472510|Macular|macular
390618|NCT01472510|Edema|edema
390619|NCT01472510|Ranibizumab|ranibizumab
390620|NCT01472510|anti-VEGF|anti-vegf
390621|NCT01472497|hypertension|hypertension
390622|NCT01472497|insulin resistance|insulin resistance
390623|NCT01472497|oral glucose tolerance test|oral glucose tolerance test
390624|NCT01472497|AGE|age
390625|NCT01472497|inflammatory cytokine|inflammatory cytokine
390626|NCT01472484|beans|beans
390627|NCT01472484|lpa mutant|lpa mutant
390628|NCT01472484|polyphenols|polyphenols
390629|NCT01472484|phytic acid|phytic acid
390630|NCT01472484|stable iron isotopes|stable iron isotopes
390631|NCT01472471|Childhood Asthma|childhood asthma
390632|NCT01472471|Oxidative stress|oxidative stress
390633|NCT01472471|Urinary 8-isoprostane|urinary 8-isoprostane
390634|NCT01472458|Cardiac arrest|cardiac arrest
390635|NCT01472458|Hypothermia|hypothermia
390636|NCT01472458|Post Cardiac Arrest Care|post cardiac arrest care
390637|NCT01472458|Survivors of cardiac arrest|survivors of cardiac arrest
390638|NCT01472445|Vitamin D|vitamin d
390639|NCT01472445|Obesity|obesity
390640|NCT01472432|type 2 diabetes|type 2 diabetes
390641|NCT01472432|healing|healing
390642|NCT01472432|foot ulcers|foot ulcers
390643|NCT01472432|vildagliptin|vildagliptin
390644|NCT01472419|metastatic esophageal squamous cell carcinoma|metastatic esophageal squamous cell carcinoma
390645|NCT01472419|Fluoropyrimidine/platinum-based first-line chemotherapy|fluoropyrimidine/platinum-based first-line chemotherapy
390646|NCT01472419|prognosis|prognosis
390647|NCT01472406|type 1 diabetes mellitus|type 1 diabetes mellitus
390648|NCT01472406|closed-loop artificial pancreas|closed-loop artificial pancreas
390649|NCT01472393|creatine supplementation|creatine supplementation
390650|NCT01472393|bone mass|bone mass
390651|NCT01472393|postmenopausal women|postmenopausal women
390652|NCT01472393|muscle function|muscle function
390653|NCT01472393|bone markers|bone markers
390654|NCT01472354|HIV|hiv
390655|NCT01472354|Hepatitis C|hepatitis c
390656|NCT01472354|Decision-Making|decision-making
390657|NCT01472354|chronic|chronic
390658|NCT01472328|Oxidative stress|oxidative stress
390659|NCT01472328|Insulin resistance|insulin resistance
390660|NCT01472315|sleep apnea|sleep apnea
390661|NCT01472315|women|women
390662|NCT01472315|postmenopause|postmenopause
390663|NCT01472315|hormone treatment|hormone treatment
390664|NCT01472289|CLI|cli
390665|NCT01472289|Peripheral arterial disease|peripheral arterial disease
390666|NCT01472276|Behaviour change|behaviour change
390667|NCT01472276|Weight loss|weight loss
390668|NCT01472276|Cardiovascular risk|cardiovascular risk
390669|NCT01472276|Diet|diet
390670|NCT01472276|Physical activity|physical activity
390671|NCT01472276|Overweight|overweight
390672|NCT01472276|Obesity|obesity
390673|NCT01472276|Internet|internet
390674|NCT01472263|HTLV-1|htlv-1
390675|NCT01472263|tropical spastic paraparesis|tropical spastic paraparesis
390676|NCT01472263|Immune System Diseases|immune system diseases
390677|NCT01472263|Physical disability|physical disability
390678|NCT01472263|pentoxifylline|pentoxifylline
390679|NCT01472250|Advanced Gastric Cancer|advanced gastric cancer
390680|NCT01472250|chemotherapy|chemotherapy
390681|NCT01472250|quality of life|quality of life
390682|NCT01472250|treatment expense|treatment expense
390683|NCT01472250|patients accepted first-line chemotherapy|patients accepted first-line chemotherapy
390684|NCT01472224|Transcranial ultrasound|transcranial ultrasound
390685|NCT01472224|Haematoma expansion|haematoma expansion
390686|NCT01472198|GSI|gsi
390687|NCT01472198|Gilead|gilead
390688|NCT01472198|Gilead Sciences|gilead sciences
390689|NCT01472198|Pancreatic Cancer|pancreatic cancer
390690|NCT01472198|PC|pc
390691|NCT01472198|Gemcitabine|gemcitabine
390692|NCT01472198|Phase 2|phase 2
390693|NCT01472198|Phase II|phase ii
390694|NCT01472198|GS-6624|gs-6624
390695|NCT01472198|Oncology|oncology
390696|NCT01472198|Monoclonal Antibody|monoclonal antibody
390697|NCT01472185|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
390698|NCT01472172|Flex-rigid pleuroscopy|flex-rigid pleuroscopy
390699|NCT01472172|cryobiopsy|cryobiopsy
390700|NCT01472172|pleural biopsy|pleural biopsy
390701|NCT01472172|pleural effusion|pleural effusion
390702|NCT01472172|safety|safety
390703|NCT01472172|thoracoscopy|thoracoscopy
390704|NCT01472146|Neoadjuvant therapy|neoadjuvant therapy
390705|NCT01472146|Breast cancer HER2 positive|breast cancer her2 positive
390706|NCT01472146|zolendronic acid|zolendronic acid
390707|NCT01472133|Respiration Rate|respiration rate
390708|NCT01472133|ECG|ecg
390709|NCT01472133|Pulse oximetry|pulse oximetry
390710|NCT01472133|Photoplethysmograph|photoplethysmograph
390711|NCT01472133|PPG|ppg
390712|NCT01472133|Physiology|physiology
390713|NCT01472107|Pregnancy|pregnancy
390714|NCT01472107|APL female patients|apl female patients
390715|NCT01472068|Incontinence|incontinence
390716|NCT01472068|NMES|nmes
390822|NCT01471652|fatigue|fatigue
390717|NCT01472055|Hematopoietic stem cell transplantation with fludarabine based conditioning|hematopoietic stem cell transplantation with fludarabine based conditioning
390718|NCT01472042|Traumatic Brain Injury|traumatic brain injury
390719|NCT01472042|Sport Concussion|sport concussion
390720|NCT01472042|Head Injury|head injury
390721|NCT01472042|Sports Injury|sports injury
390722|NCT01472029|Adenocarcinoma|adenocarcinoma
390723|NCT01472029|Gastroesophageal junction|gastroesophageal junction
390724|NCT01472029|Stomach|stomach
390725|NCT01472029|HER2|her2
390726|NCT01472016|c-Met overexpression|c-met overexpression
390727|NCT01472016|MET amplification|met amplification
390728|NCT01472016|Neoplasms|neoplasms
390729|NCT01472016|h224G11|h224g11
390730|NCT01471990|PACAP38|pacap38
390731|NCT01471990|MMA|mma
390732|NCT01471990|migraine|migraine
390733|NCT01471990|angiography|angiography
390734|NCT01471990|VIP|vip
390735|NCT01471990|vasodilatation|vasodilatation
390736|NCT01471912|Macular Holes|macular holes
390737|NCT01471912|spectral domain optical coherence tomography|spectral domain optical coherence tomography
390738|NCT01471912|elongation of foveal tissue|elongation of foveal tissue
390739|NCT01471912|M-score|m-score
390740|NCT01471873|Posterior corneal surface elevation|posterior corneal surface elevation
390741|NCT01471873|Pentacam-Scheimpflung imaging|pentacam-scheimpflung imaging
390742|NCT01471873|variability|variability
390743|NCT01471873|progressive keratoconus|progressive keratoconus
390744|NCT01471873|corneal cross-linking|corneal cross-linking
390745|NCT01471847|Locally advanced|locally advanced
390746|NCT01471847|metastatic|metastatic
390747|NCT01471847|breast cancer|breast cancer
390748|NCT01471847|HER2 positive|her2 positive
390749|NCT01471847|PI3K|pi3k
390750|NCT01471847|mTOR|mtor
390751|NCT01471847|trastuzumab|trastuzumab
390752|NCT01471847|targeted therapy|targeted therapy
390753|NCT01471847|LABC|labc
390754|NCT01471847|MBC|mbc
390755|NCT01471782|ALL|all
390756|NCT01471782|relapsed, refractory B-precursor ALL|relapsed, refractory b-precursor all
390757|NCT01471782|Leukemia|leukemia
390758|NCT01471782|Leukemia, Lymphoid|leukemia, lymphoid
390759|NCT01471782|Precursor Cell Lymphoblastic Leukemia|precursor cell lymphoblastic leukemia
390760|NCT01471782|Neoplasms by Histologic Type|neoplasms by histologic type
390761|NCT01471782|Neoplasms|neoplasms
390762|NCT01471782|Lymphoproliferative Disorders|lymphoproliferative disorders
390763|NCT01471782|Lymphatic Diseases|lymphatic diseases
390764|NCT01471782|Immunoproliferative Disorders|immunoproliferative disorders
390765|NCT01471782|Antibodies, Bispecific|antibodies, bispecific
390766|NCT01471769|pediatric|pediatric
390767|NCT01471769|pain|pain
390768|NCT01471756|sessile neoplasms|sessile neoplasms
390769|NCT01471756|flat neoplasms|flat neoplasms
390770|NCT01471756|gastric cancer|gastric cancer
390771|NCT01471743|nutrition|nutrition
390772|NCT01471743|surgery|surgery
390773|NCT01471743|immune|immune
390774|NCT01471730|Transfusions|transfusions
390775|NCT01471730|Fresh Frozen Plasma|fresh frozen plasma
390776|NCT01471730|Fibrinogen|fibrinogen
390777|NCT01471730|Prothrombin complex|prothrombin complex
390778|NCT01471717|PK|pk
390779|NCT01471717|pharmacokinetics|pharmacokinetics
390780|NCT01471717|INX08189|inx08189
390781|NCT01471717|Victrelis|victrelis
390782|NCT01471717|Inhibitex|inhibitex
390783|NCT01471704|Pharmacokinetics|pharmacokinetics
390784|NCT01471704|PK|pk
390785|NCT01471704|INX08189|inx08189
390786|NCT01471704|Verapamil|verapamil
390787|NCT01471704|Inhibitex|inhibitex
390788|NCT01471678|Cross-over design|cross-over design
390789|NCT01471678|Pilot bioequivalence|pilot bioequivalence
390790|NCT01471678|North east Asian ancestry|north east asian ancestry
390791|NCT01471678|GI198745|gi198745
390792|NCT01471678|Tamsulosin hydrochloride|tamsulosin hydrochloride
390793|NCT01471678|healthy male subjects|healthy male subjects
390794|NCT01471678|Bioequivalence|bioequivalence
390795|NCT01471678|Dutasteride|dutasteride
390796|NCT01471561|Osmolarity|osmolarity
390797|NCT01471561|Cataract|cataract
390798|NCT01471561|Dry Eye|dry eye
390799|NCT01471548|tumor|tumor
390800|NCT01471548|cancer|cancer
390801|NCT01471548|phase1|phase1
390802|NCT01471548|TKI258|tki258
390803|NCT01471418|TMJ|tmj
390804|NCT01471418|orofacial pain|orofacial pain
390805|NCT01471418|synovitis|synovitis
390806|NCT01471418|arthroscopy|arthroscopy
390807|NCT01471379|Irritable Bowel Syndrome|irritable bowel syndrome
390808|NCT01471379|IBS|ibs
390809|NCT01471379|Savella|savella
390810|NCT01471379|Milnacipran|milnacipran
390811|NCT01471379|Abdominal Pain|abdominal pain
390812|NCT01471366|Hyperlipidemias|hyperlipidemias
390813|NCT01471366|Dyslipidemias|dyslipidemias
390814|NCT01471366|Fatty Acids, Omega-3|fatty acids, omega-3
390815|NCT01471366|Fish Oils|fish oils
390816|NCT01471353|Metastatic|metastatic
390817|NCT01471353|Colon Cancer|colon cancer
390818|NCT01471353|Rectal Cancer|rectal cancer
390819|NCT01471652|myalgic encephalopathy|myalgic encephalopathy
390820|NCT01471652|chronic fatigue syndrome|chronic fatigue syndrome
390821|NCT01471652|post viral infection|post viral infection
390823|NCT01471652|muscle pain|muscle pain
390824|NCT01471652|unrefreshing sleep|unrefreshing sleep
390825|NCT01471652|fuzzy thought|fuzzy thought
390826|NCT01471652|poor memory|poor memory
390827|NCT01471652|forgetfulness|forgetfulness
390828|NCT01471639|18 years and older,|18 years and older,
390829|NCT01471639|previously healthy|previously healthy
390830|NCT01471639|men and nonpregnant women|men and nonpregnant women
390831|NCT01471639|emergency department|emergency department
390832|NCT01471626|sleep apnea|sleep apnea
390833|NCT01471626|polysomnography|polysomnography
390834|NCT01471626|telemedicine|telemedicine
390835|NCT01471613|spinal cord injury|spinal cord injury
390836|NCT01471613|umbilical cord blood cell|umbilical cord blood cell
390837|NCT01471613|cell transplant|cell transplant
390838|NCT01471613|lithium carbonate|lithium carbonate
390839|NCT01471600|upper gastrointestinal endoscopy|upper gastrointestinal endoscopy
390840|NCT01471600|general anesthesia|general anesthesia
390841|NCT01471535|chronic hepatitis B|chronic hepatitis b
390842|NCT01471509|Glycemic Index|glycemic index
390843|NCT01471509|LoBAG Diet|lobag diet
390844|NCT01471509|Insulin|insulin
390845|NCT01471509|Glucagon|glucagon
390846|NCT01471496|duodenal ulcer|duodenal ulcer
390847|NCT01471496|upper gastrointestinal system bleeding|upper gastrointestinal system bleeding
390848|NCT01471496|injection therapy|injection therapy
390849|NCT01471483|Geriatric Assessment|geriatric assessment
390850|NCT01471483|Quality of Life|quality of life
390851|NCT01471483|11-164|11-164
390852|NCT01471483|Fallopian Tubes|fallopian tubes
390853|NCT01471470|Advanced gastric cancer|advanced gastric cancer
390854|NCT01471470|Neoadjuvant|neoadjuvant
390855|NCT01471470|Bevacizumab|bevacizumab
390856|NCT01471457|bacterial|bacterial
390857|NCT01471457|vaginosis|vaginosis
390858|NCT01471457|pessary|pessary
390859|NCT01471457|discharge|discharge
390860|NCT01471444|Blood And Marrow Transplantation|blood and marrow transplantation
390861|NCT01471444|Leukemia|leukemia
390862|NCT01471444|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
390863|NCT01471444|Acute myeloid leukemia|acute myeloid leukemia
390864|NCT01471444|AML|aml
390865|NCT01471444|Myelodysplastic syndrome|myelodysplastic syndrome
390866|NCT01471444|MDS|mds
390867|NCT01471444|Progression free survival|progression free survival
390868|NCT01471444|Rate of engraftment|rate of engraftment
390869|NCT01471444|Toxicity|toxicity
390870|NCT01471444|Relapse rate|relapse rate
390871|NCT01471444|Graft-vs-host disease|graft-vs-host disease
390872|NCT01471444|GvHD|gvhd
390873|NCT01471444|Progression-free survival|progression-free survival
390874|NCT01471444|PFS|pfs
390875|NCT01471444|Overall survival|overall survival
390876|NCT01471444|OS|os
390877|NCT01471444|Fludarabine|fludarabine
390878|NCT01471444|Fludarabine Phosphate|fludarabine phosphate
390879|NCT01471444|Fludara|fludara
390880|NCT01471444|Clofarabine|clofarabine
390881|NCT01471444|Clofarex|clofarex
390882|NCT01471444|Clolar|clolar
390883|NCT01471444|Busulfan|busulfan
390884|NCT01471444|Busulfex|busulfex
390885|NCT01471444|Myleran|myleran
390886|NCT01471444|Thymoglobulin|thymoglobulin
390887|NCT01471444|ATG|atg
390888|NCT01471444|Antithymocyte Globulin|antithymocyte globulin
390889|NCT01471444|Methotrexate|methotrexate
390890|NCT01471444|Tacrolimus|tacrolimus
390891|NCT01471444|Prograf|prograf
390892|NCT01471392|Identigene|identigene
390893|NCT01471392|STD Test|std test
390894|NCT01471392|Chlamydia|chlamydia
390895|NCT01471392|Gonorrhoeae|gonorrhoeae
390896|NCT01471392|APTIMA|aptima
390897|NCT01471392|Sexually Transmitted Disease|sexually transmitted disease
390898|NCT01471301|systemic lupus erythematosus|systemic lupus erythematosus
390899|NCT01471301|rheumatoid arthritis|rheumatoid arthritis
390900|NCT01471288|well differentiated thyroid cancer|well differentiated thyroid cancer
390901|NCT01471288|Carum Carvi|carum carvi
390902|NCT01471288|Normal controls|normal controls
390903|NCT01471275|type 2 diabetes|type 2 diabetes
390904|NCT01471275|obesity|obesity
390905|NCT01471275|hypertriglyceridemia|hypertriglyceridemia
390906|NCT01471262|Complications|complications
390907|NCT01471262|Mortality|mortality
390908|NCT01471262|Liver|liver
390909|NCT01471262|Failure|failure
390910|NCT01471249|esophageal stenting|esophageal stenting
390911|NCT01471249|palliative|palliative
390912|NCT01471249|dysphagia|dysphagia
390913|NCT01471236|cartilage|cartilage
390914|NCT01471236|bone|bone
390915|NCT01471184|Allergic Rhinitis|allergic rhinitis
390916|NCT01471184|Conjunctivitis|conjunctivitis
390917|NCT01471184|Bitop|bitop
390918|NCT01471184|Eye|eye
390919|NCT01471184|Eye Drops|eye drops
390920|NCT01471184|Nasal Spray|nasal spray
390921|NCT01471184|Total Nasal Symptom Score|total nasal symptom score
390922|NCT01471184|Total Ocular Symptom Score|total ocular symptom score
390923|NCT01471184|AUC|auc
390924|NCT01471171|COPD|copd
390925|NCT01471171|Antimuscarinic|antimuscarinic
390926|NCT01471158|Primary open-angle glaucoma|primary open-angle glaucoma
390927|NCT01471158|ocular hypertension|ocular hypertension
391230|NCT01470027|glutathione|glutathione
390928|NCT01471158|pigment dispersion glaucoma|pigment dispersion glaucoma
390929|NCT01471145|opioid dependence|opioid dependence
390930|NCT01471145|heroin dependence|heroin dependence
390931|NCT01471145|extended release depot naltrexone|extended release depot naltrexone
390932|NCT01471145|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
390933|NCT01471145|dopamine transporter|dopamine transporter
390934|NCT01471145|Single Photon Emission Computed Tomography|single photon emission computed tomography
390935|NCT01471119|sublingual immunotherapy|sublingual immunotherapy
390936|NCT01471119|atopic dermatitis|atopic dermatitis
390937|NCT01471119|Dermatophagoides Farinae Drops|dermatophagoides farinae drops
390938|NCT01471106|Breast Cancer|breast cancer
390939|NCT01471106|Estrogen Receptor Negative Breast Cancer|estrogen receptor negative breast cancer
390940|NCT01471106|Biomarker studies|biomarker studies
390941|NCT01471106|Ki-67|ki-67
390942|NCT01471106|Dasatinib|dasatinib
390943|NCT01471106|BMS-354825|bms-354825
390944|NCT01471106|Sprycel|sprycel
390945|NCT01471080|laparoscopic hepatectomy|laparoscopic hepatectomy
390946|NCT01471080|radio-frequency ablation|radio-frequency ablation
390947|NCT01471080|giant cavernous hemangiomas|giant cavernous hemangiomas
390948|NCT01471080|liver|liver
390949|NCT01471067|Blood And Marrow Transplantation|blood and marrow transplantation
390950|NCT01471067|Leukemia|leukemia
390951|NCT01471067|Lymphoma|lymphoma
390952|NCT01471067|Pediatrics|pediatrics
390953|NCT01471067|Cord blood transplant|cord blood transplant
390954|NCT01471067|Cord Blood Fucosylation|cord blood fucosylation
390955|NCT01471067|Hematologic Malignancies|hematologic malignancies
390956|NCT01471067|Acute Myelogenous Leukemia|acute myelogenous leukemia
390957|NCT01471067|AML|aml
390958|NCT01471067|Myelodysplastic Syndrome|myelodysplastic syndrome
390959|NCT01471067|MDS|mds
390960|NCT01471067|High-risk cytogenetics|high-risk cytogenetics
390961|NCT01471067|Secondary leukemia from prior chemotherapy|secondary leukemia from prior chemotherapy
390962|NCT01471067|Langerhan's cell histiocytosis|langerhan's cell histiocytosis
390963|NCT01471067|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
390964|NCT01471067|ALL|all
390965|NCT01471067|complete remission|complete remission
390966|NCT01471067|Philadelphia chromosome|philadelphia chromosome
390967|NCT01471067|translocation 4;11|translocation 4;11
390968|NCT01471067|Hypodiploidy|hypodiploidy
390969|NCT01471067|Chronic Myeloid Leukemia|chronic myeloid leukemia
390970|NCT01471067|CML|cml
390971|NCT01471067|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
390972|NCT01471067|NHL|nhl
390973|NCT01471067|Hodgkin's Disease|hodgkin's disease
390974|NCT01471067|HD|hd
390975|NCT01471067|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
390976|NCT01471067|CLL|cll
390977|NCT01471067|Melphalan|melphalan
390978|NCT01471067|Alkeran|alkeran
390979|NCT01471067|Thiotepa|thiotepa
390980|NCT01471067|Fludarabine|fludarabine
390981|NCT01471067|Fludarabine Phosphate|fludarabine phosphate
390982|NCT01471067|Fludara|fludara
390983|NCT01471067|Mycophenolate Mofetil|mycophenolate mofetil
390984|NCT01471067|MMF|mmf
390985|NCT01471067|CellCept|cellcept
390986|NCT01471067|Tacrolimus|tacrolimus
390987|NCT01471067|Prograf|prograf
390988|NCT01471067|Rituximab|rituximab
390989|NCT01471067|Rituxan|rituxan
390990|NCT01471067|ATG|atg
390991|NCT01471067|Antithymocyte Globulin|antithymocyte globulin
390992|NCT01471067|Thymoglobulin|thymoglobulin
390993|NCT01471054|Plaque radiotherapy|plaque radiotherapy
390994|NCT01471054|Brachytherapy|brachytherapy
390995|NCT01471054|Macular edema|macular edema
390996|NCT01471054|Cystoid macular edema|cystoid macular edema
390997|NCT01471054|Uveal melanoma|uveal melanoma
390998|NCT01471054|Radiation maculopathy|radiation maculopathy
390999|NCT01471054|Radiation retinopathy|radiation retinopathy
391000|NCT01471054|Ozurdex|ozurdex
391001|NCT01471054|Dexamethasone intravitreal implant|dexamethasone intravitreal implant
391002|NCT01471041|End Stage Renal Disease|end stage renal disease
391003|NCT01471041|Hemodialysis|hemodialysis
391004|NCT01471041|AV fistula|av fistula
391005|NCT01471041|Kidney failure|kidney failure
391006|NCT01471028|Acute alcoholic hepatitis|acute alcoholic hepatitis
391007|NCT01471028|alcoholic|alcoholic
391008|NCT01471028|hepatitis|hepatitis
391009|NCT01471028|liver|liver
391010|NCT01471015|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
391011|NCT01471015|Cooling Therapy|cooling therapy
391012|NCT01471015|HIE|hie
391013|NCT01470989|gouty arthritis|gouty arthritis
391014|NCT01470976|Goal-directed therapy|goal-directed therapy
391015|NCT01470976|Hemodynamic optimization|hemodynamic optimization
391016|NCT01470976|Cardiac surgery|cardiac surgery
391017|NCT01470963|Referral|referral
391018|NCT01470963|Quality of Health Care|quality of health care
391019|NCT01470950|Functional Electrical Stimulation|functional electrical stimulation
391020|NCT01470950|Signalling Pathways|signalling pathways
391021|NCT01470937|diabetes acarbose alphaglucosidase prevention|diabetes acarbose alphaglucosidase prevention
391022|NCT01470924|acute lymphoblastic leukemia|acute lymphoblastic leukemia
391023|NCT01470924|relapse|relapse
391024|NCT01470924|salvage|salvage
391025|NCT01470924|prognostic|prognostic
391026|NCT01470911|Antisense oligonucleotide|antisense oligonucleotide
391027|NCT01470911|Asthma|asthma
391028|NCT01470911|Healthy subjects|healthy subjects
391029|NCT01470911|Phase 1|phase 1
391030|NCT01470911|Transcription factor GATA-3|transcription factor gata-3
391031|NCT01470911|Oral inhalation|oral inhalation
391032|NCT01470898|bispectral index monitoring|bispectral index monitoring
391033|NCT01470898|extubation|extubation
391034|NCT01470898|analgesia|analgesia
391035|NCT01470898|abdominal surgery|abdominal surgery
391036|NCT01470885|glucose|glucose
391037|NCT01470885|prognosis|prognosis
391038|NCT01470885|glycated hemoglobin|glycated hemoglobin
391039|NCT01470859|De Novo parkinson's disease|de novo parkinson's disease
391040|NCT01470859|initial treatment|initial treatment
391041|NCT01470859|pramipexole|pramipexole
391042|NCT01470859|Levodopa|levodopa
391043|NCT01470859|Parkinson's disease-related spatial covariance pattern|parkinson's disease-related spatial covariance pattern
391044|NCT01470846|epidural analgesia|epidural analgesia
391045|NCT01470846|morphin analgesia|morphin analgesia
391046|NCT01470846|laparotomy|laparotomy
391047|NCT01470833|Achilles tendon|achilles tendon
391048|NCT01470833|rupture|rupture
391049|NCT01470833|non-operative|non-operative
391050|NCT01470833|treatment|treatment
391051|NCT01470820|Neonates|neonates
391052|NCT01470820|Hyperbilirubinemia|hyperbilirubinemia
391053|NCT01470820|Phototherapy|phototherapy
391054|NCT01470820|Light irradiance|light irradiance
391055|NCT01470820|Saturation point|saturation point
391056|NCT01470807|Artificial Pancreas|artificial pancreas
391057|NCT01470807|Insulin Pump|insulin pump
391058|NCT01470807|Continuous Glucose Monitor|continuous glucose monitor
391059|NCT01470807|Closed Loop|closed loop
391060|NCT01470794|GBM|gbm
391061|NCT01470794|HGG|hgg
391062|NCT01470794|High grade glioma|high grade glioma
391063|NCT01470794|Malignant glioma|malignant glioma
391064|NCT01470794|Grade III glioma|grade iii glioma
391065|NCT01470794|Grad IV glioma|grad iv glioma
391066|NCT01470794|glioma|glioma
391067|NCT01470794|glioblastoma|glioblastoma
391068|NCT01470794|Grade IV astrocytoma|grade iv astrocytoma
391069|NCT01470794|brain cancer|brain cancer
391070|NCT01470794|recurrent glioblastoma|recurrent glioblastoma
391071|NCT01470794|AA|aa
391072|NCT01470794|AOD|aod
391073|NCT01470794|anaplastic astrocytoma|anaplastic astrocytoma
391074|NCT01470794|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
391075|NCT01470794|Anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
391076|NCT01470781|Bipolar Disorder|bipolar disorder
391077|NCT01470781|Psychosis|psychosis
391078|NCT01470781|Cognition|cognition
391079|NCT01470781|Cognitive Remediation|cognitive remediation
391080|NCT01470755|Pediatrics|pediatrics
391081|NCT01470755|Bronchial wheeze|bronchial wheeze
391082|NCT01470755|bronchodilator|bronchodilator
391083|NCT01470755|lung function|lung function
391084|NCT01470755|airway resistance|airway resistance
391085|NCT01470729|Spinocerebellar ataxia, energy metabolism, NMR spectroscopy|spinocerebellar ataxia, energy metabolism, nmr spectroscopy
391086|NCT01470716|EGFR mutation|egfr mutation
391087|NCT01470716|NSCLC|nsclc
391088|NCT01470703|Acute Respiratory Distress Syndrome,|acute respiratory distress syndrome,
391089|NCT01470703|ECMO, Extracorporeal Membrane Oxygenation|ecmo, extracorporeal membrane oxygenation
391090|NCT01470703|Randomized controlled trial|randomized controlled trial
391091|NCT01470703|Positive-Pressure ventilation|positive-pressure ventilation
391092|NCT01470703|Survival Rate|survival rate
391093|NCT01470690|HVC infection|hvc infection
391094|NCT01470690|gastric acid-related disorders|gastric acid-related disorders
391095|NCT01470690|proton pump inhibitor|proton pump inhibitor
391096|NCT01470690|interaction|interaction
391097|NCT01470690|pharmacokinetics|pharmacokinetics
391098|NCT01470690|boceprevir|boceprevir
391099|NCT01470690|omeprazole|omeprazole
391100|NCT01470677|lymph cyst|lymph cyst
391101|NCT01470677|lymphocele|lymphocele
391102|NCT01470677|fibrin|fibrin
391103|NCT01470677|collagen|collagen
391104|NCT01470677|prevention|prevention
391105|NCT01470677|cancer|cancer
391106|NCT01470651|HCV+|hcv+
391107|NCT01470651|HCV treatment|hcv treatment
391108|NCT01470651|Fatigue|fatigue
391109|NCT01470651|patients starting alpha interferon/ribavirin treatment|patients starting alpha interferon/ribavirin treatment
391110|NCT01470638|Flt3-L|flt3-l
391111|NCT01470638|CSF|csf
391112|NCT01470625|Dying|dying
391113|NCT01470625|Patients|patients
391114|NCT01470625|Hospice|hospice
391115|NCT01470625|Liverpool Care Pathways|liverpool care pathways
391116|NCT01470612|Ulcerative colitis|ulcerative colitis
391117|NCT01470612|open-label|open-label
391118|NCT01470612|long term treatment|long term treatment
391119|NCT01470586|Colorectal cancer|colorectal cancer
391120|NCT01470586|Surgical resection|surgical resection
391121|NCT01470586|Oxidative Stress Markers|oxidative stress markers
391122|NCT01470586|Controls|controls
391123|NCT01470560|Mindfulness|mindfulness
391124|NCT01470560|Mindfulness-Based Stress Reduction|mindfulness-based stress reduction
391125|NCT01470560|Meditation|meditation
391126|NCT01470560|Yoga|yoga
391127|NCT01470547|Liver Cirrhosis|liver cirrhosis
391128|NCT01470547|Portal Vein Thrombosis|portal vein thrombosis
391129|NCT01470547|Cirrhosis Complications|cirrhosis complications
391130|NCT01470547|Registry|registry
391131|NCT01470547|Italian|italian
391132|NCT01470534|Dietary supplement|dietary supplement
391133|NCT01470534|Carbohydrate loading|carbohydrate loading
391134|NCT01470534|Insulin resistance|insulin resistance
391135|NCT01470534|Surgery|surgery
391136|NCT01470521|Multiple sclerosis|multiple sclerosis
391137|NCT01470521|Hookworm larvae|hookworm larvae
391138|NCT01470521|Necator americanus|necator americanus
391139|NCT01470521|Treg cells|treg cells
391140|NCT01470508|Bulimia|bulimia
391141|NCT01470508|Binge-Eating Disorder|binge-eating disorder
391142|NCT01470508|Eating Disorders|eating disorders
391143|NCT01470482|Total knee|total knee
391144|NCT01470482|Tourniquet|tourniquet
391145|NCT01470482|Blood loss|blood loss
391146|NCT01470482|pain|pain
391147|NCT01470482|range of motion|range of motion
391148|NCT01470391|Adductor-Canal-Blockade|adductor-canal-blockade
391149|NCT01470391|Femoral Nerve Block|femoral nerve block
391150|NCT01470391|Postoperative Pain|postoperative pain
391151|NCT01470391|Total Knee Arthroplasty|total knee arthroplasty
391152|NCT01470378|Lymphedema|lymphedema
391153|NCT01470378|Magnetic Resonance Imaging|magnetic resonance imaging
391154|NCT01470378|Plastic Surgery|plastic surgery
391155|NCT01470352|migraine|migraine
391156|NCT01470352|pain|pain
391157|NCT01470352|CPM|cpm
391158|NCT01470352|offset analgesia|offset analgesia
391159|NCT01470352|fMRI|fmri
391160|NCT01470339|endogenous pain modulation|endogenous pain modulation
391161|NCT01470339|migraine|migraine
391162|NCT01470339|fMRI|fmri
391163|NCT01470339|duloxetine|duloxetine
391164|NCT01470339|preventive migraine treatment|preventive migraine treatment
391165|NCT01470326|Osteoporosis|osteoporosis
391166|NCT01470326|Post menopausal women|post menopausal women
391167|NCT01470326|SERM|serm
391168|NCT01470326|Japanese|japanese
391169|NCT01470326|Viviant|viviant
391170|NCT01470326|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
391171|NCT01470326|Long term treatment|long term treatment
391172|NCT01470313|Safety and tolerability|safety and tolerability
391173|NCT01470313|cutaneous lupus erythematosus|cutaneous lupus erythematosus
391174|NCT01470313|efficacy|efficacy
391175|NCT01470287|Infants,|infants,
391176|NCT01470287|Immunogenicity,|immunogenicity,
391177|NCT01470287|Safety|safety
391178|NCT01470274|Blood volume|blood volume
391179|NCT01470274|CO-rebreathing|co-rebreathing
391180|NCT01470274|COPD|copd
391181|NCT01470274|CVD|cvd
391182|NCT01470261|methylphenidate|methylphenidate
391183|NCT01470261|ritalin|ritalin
391184|NCT01470261|Attention Deficit Disorder|attention deficit disorder
391185|NCT01470248|Lung Cancer|lung cancer
391186|NCT01470248|Carcinoma, small cell|carcinoma, small cell
391187|NCT01470248|Trisenox|trisenox
391188|NCT01470248|Arsenic trioxide|arsenic trioxide
391189|NCT01470248|phase II trial|phase ii trial
391190|NCT01470235|screening|screening
391191|NCT01470235|genetic|genetic
391192|NCT01470235|cancer|cancer
391193|NCT01470222|Worksite|worksite
391194|NCT01470222|group weight loss|group weight loss
391195|NCT01470222|behavioral components|behavioral components
391196|NCT01470209|lung cancer with activated mTOR/PI3K pathway|lung cancer with activated mtor/pi3k pathway
391197|NCT01470209|alterations in PIK3CA, NF1, TSC1/TSC2, mTOR, KRAS, LKB1, PTEN|alterations in pik3ca, nf1, tsc1/tsc2, mtor, kras, lkb1, pten
391198|NCT01470196|WM|wm
391199|NCT01470196|untreated|untreated
391200|NCT01470196|symptomatic|symptomatic
391201|NCT01470183|Lupus Nephritis|lupus nephritis
391202|NCT01470170|Sedative bronchoscope|sedative bronchoscope
391203|NCT01470170|Alfentanil doses|alfentanil doses
391204|NCT01470170|Propofol|propofol
391205|NCT01470170|Targeted controlled infusion|targeted controlled infusion
391206|NCT01470170|Hypoxemia|hypoxemia
391207|NCT01470131|multiple myeloma|multiple myeloma
391208|NCT01470131|relapse|relapse
391209|NCT01470131|second line therapy|second line therapy
391210|NCT01470131|bortezomib|bortezomib
391211|NCT01470131|dexamethasone|dexamethasone
391212|NCT01470105|questionnaire|questionnaire
391213|NCT01470105|11-121|11-121
391214|NCT01470092|Menopause|menopause
391215|NCT01470092|Depression|depression
391216|NCT01470066|peripheral T cell lymphomas|peripheral t cell lymphomas
391217|NCT01470066|interim PET/CT|interim pet/ct
391218|NCT01470066|prognosis|prognosis
391219|NCT01470066|Positron-emission tomography/Computerized tomography|positron-emission tomography/computerized tomography
391220|NCT01470053|mometasone furoate|mometasone furoate
391221|NCT01470053|azelastine HCl|azelastine hcl
391222|NCT01470053|perennial allergic rhinitis|perennial allergic rhinitis
391223|NCT01470040|traumatic brain injury|traumatic brain injury
391224|NCT01470040|chronic subdural hematoma|chronic subdural hematoma
391225|NCT01470040|aspirin|aspirin
391226|NCT01470040|antiplatelet therapy|antiplatelet therapy
391227|NCT01470027|magnetic resonance spectroscopy|magnetic resonance spectroscopy
391228|NCT01470027|N-acetylcysteine|n-acetylcysteine
391229|NCT01470027|antioxidant|antioxidant
391231|NCT01470014|isolated left ventricular non-compaction|isolated left ventricular non-compaction
391232|NCT01470014|cardiac computed tomography|cardiac computed tomography
391233|NCT01470014|cardiac magnet resonance imaging|cardiac magnet resonance imaging
391234|NCT01470014|echocardiography|echocardiography
391235|NCT01469975|cancer|cancer
391236|NCT01469975|relapse or refractory|relapse or refractory
391237|NCT01469962|morbid obesity|morbid obesity
391238|NCT01469962|bariatric surgery|bariatric surgery
391239|NCT01469962|NASH|nash
391240|NCT01469962|Liver fibrosis|liver fibrosis
391241|NCT01469962|Fibrotest|fibrotest
391242|NCT01469949|Improvement of the accuracy of Lumbar repositioning|improvement of the accuracy of lumbar repositioning
391243|NCT01469936|Fibromyalgia|fibromyalgia
391244|NCT01469936|Irritable Bowel Syndrome|irritable bowel syndrome
391245|NCT01469923|Phase 1|phase 1
391246|NCT01469923|obese|obese
391247|NCT01469923|healthy male volunteers|healthy male volunteers
391248|NCT01469923|multiple doses|multiple doses
391249|NCT01469923|dose escalation|dose escalation
391250|NCT01469923|pharmacokinetics|pharmacokinetics
391251|NCT01469923|pharmakodynamics|pharmakodynamics
391252|NCT01469897|JIA|jia
391253|NCT01469897|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
391254|NCT01469897|Cost of Care|cost of care
391255|NCT01469897|Quality of Life|quality of life
391256|NCT01469897|QOL|qol
391257|NCT01469884|Renal allograft recipients|renal allograft recipients
391258|NCT01469884|Hepatitis C virus (HCV)|hepatitis c virus (hcv)
391259|NCT01469884|Certican|certican
391260|NCT01469884|Calcineurin inhibitor(tacrolimus or cyclosporin)|calcineurin inhibitor(tacrolimus or cyclosporin)
391261|NCT01469871|Dressing|dressing
391262|NCT01469871|Blisters|blisters
391263|NCT01469871|Silicone|silicone
391264|NCT01469845|hospital admissions|hospital admissions
391265|NCT01469845|acute bronchiolitis|acute bronchiolitis
391266|NCT01469845|under one year old|under one year old
391267|NCT01469845|requiring oxygen therapy|requiring oxygen therapy
391268|NCT01469832|fundus flavimaculatus|fundus flavimaculatus
391269|NCT01469832|Retinal Diseases|retinal diseases
391270|NCT01469832|Macular Degeneration|macular degeneration
391271|NCT01469832|SMD|smd
391272|NCT01469832|juvenile macular dystrophy|juvenile macular dystrophy
391273|NCT01469819|chronic constipation|chronic constipation
391274|NCT01469819|constipation|constipation
391275|NCT01469819|idiopathic constipation|idiopathic constipation
391276|NCT01469819|SmartPill|smartpill
391277|NCT01469819|Wireless Motility Capsule|wireless motility capsule
391278|NCT01469819|lubiprostone (Amitiza)|lubiprostone (amitiza)
391279|NCT01469819|small intestinal bacterial overgrowth|small intestinal bacterial overgrowth
391280|NCT01469780|Pain|pain
391281|NCT01469780|Health behavior change|health behavior change
391282|NCT01469780|Coronary angioplasty|coronary angioplasty
391283|NCT01469780|Cardiovascular disease|cardiovascular disease
391284|NCT01469780|Outcomes|outcomes
391285|NCT01469780|Morbidity|morbidity
391286|NCT01469780|Mortality|mortality
391287|NCT01469767|eczema|eczema
391288|NCT01469767|itch|itch
391289|NCT01469767|scratching|scratching
391290|NCT01469767|actigraphy|actigraphy
391291|NCT01469767|adherence|adherence
391292|NCT01469754|lymphoma|lymphoma
391293|NCT01469754|survivors|survivors
391294|NCT01469754|posttraumatic growth|posttraumatic growth
391295|NCT01469754|posttraumatic stress|posttraumatic stress
391296|NCT01469754|longitudinal|longitudinal
391297|NCT01469728|VATS|vats
391298|NCT01469728|awake thoracic surgery|awake thoracic surgery
391299|NCT01469728|pleurodesis|pleurodesis
391300|NCT01469728|talc|talc
391301|NCT01469728|TEA|tea
391302|NCT01469728|epidural anesthesia|epidural anesthesia
391303|NCT01469728|Video-Assisted|video-assisted
391304|NCT01469728|Anesthesia Epidural|anesthesia epidural
391305|NCT01469715|Continuous Glucose Monitor|continuous glucose monitor
391306|NCT01469702|cat-scratch disease|cat-scratch disease
391307|NCT01469702|Bartonella henselae|bartonella henselae
391308|NCT01469702|corticosteroids|corticosteroids
391309|NCT01469702|treatment|treatment
391310|NCT01469689|People|people
391311|NCT01469689|living|living
391312|NCT01469689|community|community
391313|NCT01469676|Coronary Artery Bypass Surgery|coronary artery bypass surgery
391314|NCT01469676|Cardiopulmonary Bypass|cardiopulmonary bypass
391315|NCT01469676|Leukocyte Reduction Filtrations|leukocyte reduction filtrations
391316|NCT01469676|Pulmonary Function|pulmonary function
391317|NCT01469676|Systemic Inflammatory Response|systemic inflammatory response
391318|NCT01469663|Borderline Personality Disorder|borderline personality disorder
391319|NCT01469663|Major Depression|major depression
391320|NCT01469663|Electroencephalogram|electroencephalogram
391321|NCT01469663|N2|n2
391322|NCT01469663|Error Related Negativity|error related negativity
391323|NCT01469663|Emotional Processing|emotional processing
391324|NCT01469663|Levels of Emotional Awareness|levels of emotional awareness
391325|NCT01469650|vitamin D3|vitamin d3
391326|NCT01469650|prematurity|prematurity
391327|NCT01469650|parathyroid hormone|parathyroid hormone
391328|NCT01469650|25(OH)D|25(oh)d
391329|NCT01469650|NICU hospitalization|nicu hospitalization
391330|NCT01469624|Contrast Induced Nephropathy|contrast induced nephropathy
391331|NCT01469624|Pentoxifylline|pentoxifylline
391332|NCT01469624|PCI|pci
391333|NCT01469611|advanced/metastatic colorectal carcinoma|advanced/metastatic colorectal carcinoma
391334|NCT01469585|continuous oral contraceptives|continuous oral contraceptives
391335|NCT01469585|MMP expression|mmp expression
391336|NCT01469572|Neuroendocrine hepatic tumors|neuroendocrine hepatic tumors
391337|NCT01469572|Liver cancer|liver cancer
391338|NCT01469572|Metastatic liver cancer|metastatic liver cancer
391339|NCT01469559|Insulin|insulin
391340|NCT01469559|Diabetic neuropathy|diabetic neuropathy
391341|NCT01469559|Intranasal administration|intranasal administration
391342|NCT01469559|Pilot project|pilot project
391343|NCT01469546|Squamous Cell Carcinoma of the Head and Neck|squamous cell carcinoma of the head and neck
391344|NCT01469533|Spine|spine
391345|NCT01469533|Manipulation|manipulation
391346|NCT01469533|Pain Threshold|pain threshold
391347|NCT01469533|Electromyography.|electromyography.
391348|NCT01469520|HIV|hiv
391349|NCT01469520|AIDS|aids
391350|NCT01469520|Treatment|treatment
391351|NCT01469494|DIEP flap|diep flap
391352|NCT01469494|SIEA flap|siea flap
391353|NCT01469494|breast reconstruction|breast reconstruction
391354|NCT01469494|objective isokinetic abdominal strength testing|objective isokinetic abdominal strength testing
391355|NCT01469494|fat necrosis|fat necrosis
391356|NCT01469494|flap loss|flap loss
391357|NCT01469494|seroma rate|seroma rate
391358|NCT01469494|abdominal wound breakdown|abdominal wound breakdown
391359|NCT01469494|Breast-Q|breast-q
391360|NCT01469494|abdominal wall outcome questionnaire|abdominal wall outcome questionnaire
391361|NCT01469481|diabetes mellitus|diabetes mellitus
391362|NCT01469481|ADME|adme
391363|NCT01469455|Local metastatic melanoma|local metastatic melanoma
391364|NCT01469455|relapsed cutaneous/subcutaneous tumors|relapsed cutaneous/subcutaneous tumors
391365|NCT01469455|melanoma-in-transit|melanoma-in-transit
391366|NCT01469442|Biliary fistula|biliary fistula
391367|NCT01469442|prevention|prevention
391368|NCT01469442|hepatectomy|hepatectomy
391369|NCT01469442|external stent|external stent
391370|NCT01469442|Hepatectomy of more 2 segments|hepatectomy of more 2 segments
391371|NCT01469442|Not emergency or laparoscopy surgery|not emergency or laparoscopy surgery
391372|NCT01469429|oral cancer|oral cancer
391373|NCT01469416|rosuvastatin|rosuvastatin
391374|NCT01469416|clopidogrel|clopidogrel
391375|NCT01469416|pharmacokinetics|pharmacokinetics
391376|NCT01469416|drug interaction|drug interaction
391377|NCT01469416|healthy volunteer|healthy volunteer
391378|NCT01469416|drug transporter|drug transporter
391379|NCT01469403|Osteoarthritis, knee|osteoarthritis, knee
391380|NCT01469403|Obesity|obesity
391381|NCT01469403|Weight Loss|weight loss
391382|NCT01469403|Arthroplasty|arthroplasty
391383|NCT01469377|Major depressive disorder|major depressive disorder
391384|NCT01469377|Depression|depression
391385|NCT01469364|Lung Transplant|lung transplant
391386|NCT01469364|Lung Transplant Recipient|lung transplant recipient
391387|NCT01469351|Alzheimers disease|alzheimers disease
391388|NCT01469325|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
391389|NCT01469325|Depression|depression
391390|NCT01469325|left prefrontal|left prefrontal
391391|NCT01469312|Low Biologically Available Glucose Diet (LoBAG diet)|low biologically available glucose diet (lobag diet)
391392|NCT01469312|Diabetes|diabetes
391393|NCT01469312|Glycemic Index|glycemic index
391394|NCT01469299|Ligament Balance, Total Knee Arthroplasty, Intra-operative Sensors|ligament balance, total knee arthroplasty, intra-operative sensors
391395|NCT01469286|delayed gastric emptying|delayed gastric emptying
391396|NCT01469286|nausea|nausea
391397|NCT01469286|vomiting|vomiting
391398|NCT01469286|abdominal discomfort|abdominal discomfort
391399|NCT01469273|Diarrhea|diarrhea
391400|NCT01469273|EcN|ecn
391401|NCT01469273|E. coli strain Nissle 1917|e. coli strain nissle 1917
391402|NCT01469273|Gastrointestinal infection|gastrointestinal infection
391403|NCT01469273|Infant|infant
391404|NCT01469273|Newborn|newborn
391405|NCT01469273|Probiotic drug|probiotic drug
391406|NCT01469273|Prevention|prevention
391407|NCT01469273|Prophylaxis|prophylaxis
391408|NCT01469260|Overweight|overweight
391409|NCT01469260|Obesity|obesity
391410|NCT01469260|Pregnancy|pregnancy
391411|NCT01469260|Weight gain|weight gain
391412|NCT01469260|Pedometer|pedometer
391413|NCT01469260|Exercise|exercise
391414|NCT01469247|Brain cancer|brain cancer
391415|NCT01469247|Recurrent or progressive brainstem glioma|recurrent or progressive brainstem glioma
391416|NCT01469247|Diffuse Intrinsic Pontine Glioma|diffuse intrinsic pontine glioma
391417|NCT01469247|DIPG|dipg
391418|NCT01469247|Reirradiation|reirradiation
391419|NCT01469247|ReRT|rert
391420|NCT01469247|Photon radiation therapy|photon radiation therapy
391421|NCT01469247|XRT|xrt
391422|NCT01469221|Bladder Cancer|bladder cancer
391423|NCT01469221|Non-Muscle Invasive Bladder Cancer|non-muscle invasive bladder cancer
391424|NCT01469221|NMIBC|nmibc
391425|NCT01469221|Apaziquone|apaziquone
391426|NCT01469221|EOquin|eoquin
391427|NCT01469221|GU Cancer|gu cancer
391428|NCT01469221|TURBT|turbt
391429|NCT01469208|Gastroschisis|gastroschisis
391430|NCT01469208|NICU inpatients|nicu inpatients
391431|NCT01469208|Post surgical repair|post surgical repair
391432|NCT01469208|Music Therapy|music therapy
391433|NCT01469195|lead rectangle|lead rectangle
391434|NCT01469195|radiation exposure|radiation exposure
391435|NCT01469195|operators|operators
391436|NCT01469195|radial approach|radial approach
391437|NCT01469195|coronary procedures|coronary procedures
391438|NCT01469195|percutaneous coronary intervention|percutaneous coronary intervention
391439|NCT01469182|Immunology|immunology
391440|NCT01469169|Iloprost|iloprost
391441|NCT01469169|Inhalation|inhalation
391442|NCT01469169|Pulmonary Hypertension|pulmonary hypertension
391443|NCT01469169|Pulmonary Artery Hypertension|pulmonary artery hypertension
391444|NCT01469169|Japanese Patients|japanese patients
391445|NCT01469156|polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
391446|NCT01469156|choroidal neovascularization|choroidal neovascularization
391447|NCT01469156|ranibizumab|ranibizumab
391448|NCT01469156|Lucentis|lucentis
391449|NCT01469130|MEK, Advanced solid tumor|mek, advanced solid tumor
391450|NCT01469117|Developmental disabilities|developmental disabilities
391451|NCT01469117|Enteral Nutrition|enteral nutrition
391452|NCT01469117|Tube feeding|tube feeding
391453|NCT01469117|Nutrition support|nutrition support
391454|NCT01469104|Diabetes|diabetes
391455|NCT01469091|Acute admittance|acute admittance
391456|NCT01469091|Current smoker|current smoker
391457|NCT01469078|Chronic Kidney Disease|chronic kidney disease
391458|NCT01469078|CKD stage 5|ckd stage 5
391459|NCT01469078|Iron deficiency|iron deficiency
391460|NCT01469065|inpatient|inpatient
391461|NCT01469065|diabetes|diabetes
391462|NCT01469065|phase 1|phase 1
391463|NCT01469039|Alkermes|alkermes
391464|NCT01469039|schizophrenia|schizophrenia
391465|NCT01469039|ALKS 9072|alks 9072
391466|NCT01469039|ALKS 9070|alks 9070
391467|NCT01469039|aripiprazole lauroxil|aripiprazole lauroxil
391468|NCT01468948|Essential Tremor|essential tremor
391469|NCT01468948|Tremor|tremor
391470|NCT01468948|Octanol|octanol
391471|NCT01468948|Octanoic Acid|octanoic acid
391472|NCT01468935|Uterus|uterus
391473|NCT01468935|Endometrium|endometrium
391474|NCT01468935|Bone Marrow Transplant|bone marrow transplant
391475|NCT01468935|Gynecology|gynecology
391476|NCT01468935|Healthy Volunteer|healthy volunteer
391477|NCT01468935|HV|hv
391478|NCT01468935|Stem Cell Transplant|stem cell transplant
391479|NCT01468935|Endometriosis|endometriosis
391480|NCT01468922|Pazopanib|pazopanib
391481|NCT01468922|Tivantinib|tivantinib
391482|NCT01468922|MET Inhibitor|met inhibitor
391483|NCT01468922|Advanced Cancer|advanced cancer
391484|NCT01468922|Anti-Angiogenesis|anti-angiogenesis
391485|NCT01468922|Cancer|cancer
391486|NCT01468922|Solid Tumor|solid tumor
391487|NCT01468922|Sarcoma|sarcoma
391488|NCT01468883|Breast Cancer|breast cancer
391489|NCT01468883|Surgery|surgery
391490|NCT01468883|Radiation|radiation
391491|NCT01468857|Clinical Stress Markers|clinical stress markers
391492|NCT01468857|Chronic Stress|chronic stress
391493|NCT01468857|Allogeneic Hematopoietic Stem Cell Transplant|allogeneic hematopoietic stem cell transplant
391494|NCT01468857|HSCT Caregivers|hsct caregivers
391495|NCT01468857|Cancer Caregivers|cancer caregivers
391496|NCT01468857|Stress|stress
391497|NCT01468857|Family Caregivers|family caregivers
391498|NCT01468844|Central Retinal Vein Occlusion|central retinal vein occlusion
391499|NCT01468844|Minocycline|minocycline
391500|NCT01468844|Retinal Vein Occlusion|retinal vein occlusion
391501|NCT01468844|CRVO|crvo
391502|NCT01468831|Branch Retinal Vein Occlusion|branch retinal vein occlusion
391503|NCT01468831|Minocycline|minocycline
391504|NCT01468831|Macular Edema|macular edema
391505|NCT01468831|Retinal Vein Occlusion|retinal vein occlusion
391506|NCT01468831|BRVO|brvo
391507|NCT01468818|Metastatic Melanoma|metastatic melanoma
391508|NCT01468818|Adoptive Cell Therapy|adoptive cell therapy
391509|NCT01468818|Skin Cancer|skin cancer
391510|NCT01468805|Environmental Intervention|environmental intervention
391511|NCT01468805|Indoor Allergens|indoor allergens
391512|NCT01468805|Cockroach|cockroach
391513|NCT01468805|Health Disparities|health disparities
391514|NCT01468805|Multi-Center|multi-center
391515|NCT01468805|Asthma|asthma
391516|NCT01468805|Environment|environment
391517|NCT01468792|systemic sclerosis|systemic sclerosis
391518|NCT01468792|pulmonary arterial hypertension|pulmonary arterial hypertension
391519|NCT01468779|Periampullary cancer|periampullary cancer
391520|NCT01468779|Surgery|surgery
391521|NCT01468779|Dietary supplementation|dietary supplementation
391522|NCT01468779|Nutritional assessment|nutritional assessment
391523|NCT01468753|Conception in HIV Discordant Couples|conception in hiv discordant couples
391524|NCT01468753|Reproduction in HIV Discordant Couples|reproduction in hiv discordant couples
391525|NCT01468753|Vaginal Insemination|vaginal insemination
391526|NCT01468727|dental caries|dental caries
391527|NCT01468727|mutans streptococci|mutans streptococci
391528|NCT01468727|lactobacilli|lactobacilli
391529|NCT01468727|bacterial transmission|bacterial transmission
391530|NCT01468727|bacterial colonization|bacterial colonization
391531|NCT01468714|Drug Interaction|drug interaction
391532|NCT01468714|pharmacokinetics|pharmacokinetics
391533|NCT01468714|ketoconazole|ketoconazole
391534|NCT01468714|CYP3A|cyp3a
391535|NCT01468688|Imatinib mesylate|imatinib mesylate
391536|NCT01468688|BKM120|bkm120
391537|NCT01468688|GIST|gist
391538|NCT01468649|Breast Cancer|breast cancer
391539|NCT01468649|Sentinel Lymph Node Mapping|sentinel lymph node mapping
391540|NCT01468649|Intraoperative Imaging|intraoperative imaging
391541|NCT01468636|Warts|warts
391542|NCT01468636|HPV|hpv
391543|NCT01468636|Zinc|zinc
391544|NCT01468623|Colorectal cancer, metastatic|colorectal cancer, metastatic
391545|NCT01468623|FOLFOX6|folfox6
391546|NCT01468623|5-FU|5-fu
391547|NCT01468623|First line|first line
391548|NCT01468623|bevacizumab|bevacizumab
391549|NCT01468610|depression|depression
391550|NCT01468610|cognition|cognition
391551|NCT01468610|occupational functioning|occupational functioning
391552|NCT01468610|productivity|productivity
391553|NCT01468610|neuropsychology|neuropsychology
391554|NCT01468610|desvenlafaxine|desvenlafaxine
391555|NCT01468610|antidepressants|antidepressants
391556|NCT01468597|Emergent|emergent
391557|NCT01468597|Cardiac surgery|cardiac surgery
391558|NCT01468597|On-pump|on-pump
391559|NCT01468597|Platelet function|platelet function
391560|NCT01468584|Genotype 2|genotype 2
391561|NCT01468571|Potassium Sparing Diuretics|potassium sparing diuretics
391562|NCT01468571|Right-sided heart failure|right-sided heart failure
391563|NCT01468571|Edema|edema
391564|NCT01468558|Drug Drug Interaction Study in Normal Healthy Volunteers|drug drug interaction study in normal healthy volunteers
391565|NCT01468545|Education|education
391566|NCT01468545|Ventavis|ventavis
391567|NCT01468545|Adherence|adherence
391568|NCT01468545|PAH|pah
391569|NCT01468545|Pulmonary artery hypertension|pulmonary artery hypertension
391570|NCT01468519|Diabetes mellitus, type 2|diabetes mellitus, type 2
391571|NCT01468519|Erectile dysfunction|erectile dysfunction
391572|NCT01468519|continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
391573|NCT01468519|CSII|csii
391574|NCT01468519|insulin|insulin
391575|NCT01468506|Chronic Kidney Disease|chronic kidney disease
391576|NCT01468506|arteriovenous fistula|arteriovenous fistula
391577|NCT01468493|FSGS|fsgs
391578|NCT01468493|suPAR|supar
391579|NCT01468480|direct pulp capping|direct pulp capping
391580|NCT01468480|MTA|mta
391581|NCT01468480|Single visit pulp cap|single visit pulp cap
391582|NCT01468480|Multical|multical
391583|NCT01468467|AC220|ac220
391584|NCT01468467|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
391585|NCT01468467|Transplantation|transplantation
391586|NCT01468467|Stem Cell Transplantation|stem cell transplantation
391587|NCT01468467|Allogeneic Transplantation|allogeneic transplantation
391588|NCT01468467|FMS-like tyrosine kinase (FLT3)|fms-like tyrosine kinase (flt3)
391589|NCT01468467|FMS-like tyrosine kinase (FLT3) Inhibitor|fms-like tyrosine kinase (flt3) inhibitor
391590|NCT01468467|Kinase|kinase
391591|NCT01468467|Kinase Inhibitor|kinase inhibitor
391592|NCT01468467|Pharmacokinetics|pharmacokinetics
391593|NCT01468467|ASP2689|asp2689
391594|NCT01468467|quizartinib|quizartinib
391595|NCT01468454|Congenital Hyperinsulinism (CHI)|congenital hyperinsulinism (chi)
391596|NCT01468454|hyperinsulinism|hyperinsulinism
391597|NCT01468454|Persistent Hyperinsulinemic Hypoglycemia of Infancy (PHHI)|persistent hyperinsulinemic hypoglycemia of infancy (phhi)
391598|NCT01468454|CHI|chi
391599|NCT01468454|PHHI|phhi
391600|NCT01468454|Pancreatectomy|pancreatectomy
391601|NCT01468454|18F-DOPA|18f-dopa
391602|NCT01468454|PET/CT scan|pet/ct scan
391603|NCT01468441|ovarian stimulation|ovarian stimulation
391604|NCT01468441|GnRH agonist|gnrh agonist
391605|NCT01468441|GnRH antagonist|gnrh antagonist
391606|NCT01468441|hCG microdose|hcg microdose
391607|NCT01468441|ICSI|icsi
391608|NCT01468415|Methylprednisolone|methylprednisolone
391609|NCT01468415|trans sacral block|trans sacral block
391610|NCT01468415|phenol|phenol
391611|NCT01468402|Leiomyoma|leiomyoma
391612|NCT01468402|uterine artery embolization|uterine artery embolization
391613|NCT01468402|magnetic resonance imaging|magnetic resonance imaging
391614|NCT01468389|Gastric Cancer|gastric cancer
391615|NCT01468389|capecitabine|capecitabine
391616|NCT01468389|maintenance treatment|maintenance treatment
391617|NCT01468376|impaired glucose tolerance|impaired glucose tolerance
391618|NCT01468376|pre-diabetes|pre-diabetes
391619|NCT01468363|Dry weight|dry weight
391620|NCT01468363|Body composition monitor|body composition monitor
391621|NCT01468363|Hemodialysis|hemodialysis
391622|NCT01468363|Zonguldak|zonguldak
391623|NCT01468337|Central Serous Chorioretinopathy|central serous chorioretinopathy
391624|NCT01468337|Interferon-Gamma (IFN-Gamma)|interferon-gamma (ifn-gamma)
391625|NCT01468337|Jakstat|jakstat
391626|NCT01468337|Retinal Eye Disease|retinal eye disease
391627|NCT01468337|Macular Eye Disease|macular eye disease
391628|NCT01468337|CSC|csc
391629|NCT01468324|Brain|brain
391630|NCT01468324|Angiogenesis|angiogenesis
391631|NCT01468324|Radiotherapy|radiotherapy
391632|NCT01468324|Malignant|malignant
391633|NCT01468324|Tumor|tumor
391634|NCT01468324|Glioma|glioma
391635|NCT01468324|Glioblastoma Multiforme|glioblastoma multiforme
391636|NCT01468324|Brain Tumor|brain tumor
391637|NCT01468311|Immunotherapy|immunotherapy
391638|NCT01468311|Resistant Hodgkins Lymphoma|resistant hodgkins lymphoma
391639|NCT01468311|Auto Stem Cell Transplant|auto stem cell transplant
391640|NCT01468311|Combination Chemo and Radiolabeled Monoclonal Antibody|combination chemo and radiolabeled monoclonal antibody
391641|NCT01468311|Hodgkin Lymphoma|hodgkin lymphoma
391642|NCT01468298|back pain|back pain
391643|NCT01468298|physical therapy|physical therapy
391644|NCT01468298|spine|spine
391645|NCT01468298|rehabilitation|rehabilitation
391646|NCT01468298|exercise|exercise
391647|NCT01468285|interventional,placebo controlled|interventional,placebo controlled
391648|NCT01468272|asthma children NEXT DPI LABA ICS inhalation|asthma children next dpi laba ics inhalation
391649|NCT01468246|Breast Cancer|breast cancer
391650|NCT01468246|Cohort|cohort
391651|NCT01468246|Young Women|young women
391652|NCT01468246|Survivorship|survivorship
391653|NCT01468246|Fertility|fertility
391654|NCT01468233|placebo controlled|placebo controlled
391655|NCT01468233|double blind|double blind
391656|NCT01468233|adalimumab|adalimumab
391657|NCT01468233|TNF|tnf
391658|NCT01468233|psoriasis|psoriasis
391659|NCT01468233|HS|hs
391660|NCT01468233|PIONEER II|pioneer ii
391661|NCT01468233|hidradenitis suppurativa|hidradenitis suppurativa
391662|NCT01468233|acne inversa|acne inversa
391663|NCT01468233|boil|boil
391664|NCT01468233|acne|acne
391665|NCT01468220|tissue metabolism|tissue metabolism
391666|NCT01468220|skeletal muscle|skeletal muscle
391667|NCT01468220|adipose tissue|adipose tissue
391668|NCT01468220|HIF|hif
391669|NCT01468207|acne|acne
391670|NCT01468207|psoriasis|psoriasis
391671|NCT01468207|hidradenitis suppurativa|hidradenitis suppurativa
391672|NCT01468207|TNF|tnf
391673|NCT01468207|HS|hs
391674|NCT01468207|PIONEER I|pioneer i
391675|NCT01468207|acne inversa|acne inversa
391676|NCT01468207|boil|boil
391677|NCT01468207|placebo controlled|placebo controlled
391678|NCT01468207|Double blind|double blind
391679|NCT01468207|adalimumab|adalimumab
391680|NCT01468194|AMS|ams
391681|NCT01468194|HAPE|hape
391682|NCT01468194|high altitude|high altitude
391683|NCT01468194|oxygen|oxygen
391684|NCT01468194|saturation|saturation
391685|NCT01468194|mountain|mountain
391686|NCT01468194|climbing|climbing
391687|NCT01468194|breathing|breathing
391688|NCT01468181|Type 2 diabetes mellitus|type 2 diabetes mellitus
391689|NCT01468181|Oral antihyperglycemic medications|oral antihyperglycemic medications
391690|NCT01468181|Long-Term Safety|long-term safety
391691|NCT01468181|GLP 1|glp 1
391692|NCT01468181|Glucagon like peptide 1|glucagon like peptide 1
391693|NCT01468155|PVA|pva
391694|NCT01468155|peri procedural bleeding complications|peri procedural bleeding complications
391695|NCT01468116|Type 2 diabetes|type 2 diabetes
391696|NCT01468116|Gastric bypass surgery|gastric bypass surgery
391697|NCT01468116|Obesity|obesity
391698|NCT01468116|Mitochondrial function|mitochondrial function
391699|NCT01468103|intraocular pressure|intraocular pressure
391700|NCT01468103|Peripheral anterior synechiae|peripheral anterior synechiae
391701|NCT01468090|Inflammatory bowel disease|inflammatory bowel disease
391702|NCT01468090|Crohn's disease|crohn's disease
391703|NCT01468090|Ulcerative colitis|ulcerative colitis
391704|NCT01468090|Disease course|disease course
391705|NCT01468090|Phenotype|phenotype
391706|NCT01468090|Biological treatment|biological treatment
391707|NCT01468064|Central Nervous System Diseases|central nervous system diseases
391708|NCT01468064|Stroke|stroke
391709|NCT01468064|Infarction, Middle Cerebral Artery|infarction, middle cerebral artery
391710|NCT01468064|Cerebral Infarction|cerebral infarction
391711|NCT01468064|Cerebrovascular Accident|cerebrovascular accident
391712|NCT01468064|Stem Cell Transplantation|stem cell transplantation
391713|NCT01468064|Mesenchymal Stem Cell Transplantation|mesenchymal stem cell transplantation
391714|NCT01468064|Bone marrow stromal cells|bone marrow stromal cells
391715|NCT01468064|Mesenchymal Stem Cells|mesenchymal stem cells
391716|NCT01468064|Endothelial progenitor cells|endothelial progenitor cells
391717|NCT01468064|Adult Stem Cells|adult stem cells
391718|NCT01468064|Cell Therapy|cell therapy
391719|NCT01468051|predialysed|predialysed
391720|NCT01468051|chronic|chronic
391721|NCT01468051|renal failure patients|renal failure patients
391722|NCT01468025|NSAIDs|nsaids
391723|NCT01468025|Theramine|theramine
391724|NCT01468025|naproxen|naproxen
391725|NCT01468025|Low back pain|low back pain
391726|NCT01468025|amino acids|amino acids
391727|NCT01468025|CRP|crp
391728|NCT01468025|Medical Food|medical food
391729|NCT01468012|cocaine dependence|cocaine dependence
391730|NCT01468012|levodopa|levodopa
391731|NCT01468012|carbidopa|carbidopa
391732|NCT01468012|entacapone|entacapone
391733|NCT01467999|cannabis dependence|cannabis dependence
391734|NCT01467999|marijuana dependence|marijuana dependence
391735|NCT01467999|guanfacine|guanfacine
391736|NCT01467986|neuroblastoma|neuroblastoma
391737|NCT01467986|molecular targeted therapy|molecular targeted therapy
391738|NCT01467986|protein kinase inhibitor|protein kinase inhibitor
391739|NCT01467986|mTOR Inhibitor|mtor inhibitor
391740|NCT01467986|cytostatic topoisomerase-I-inhibitor|cytostatic topoisomerase-i-inhibitor
391741|NCT01467986|temozolomide|temozolomide
391742|NCT01467986|irinotecan|irinotecan
391743|NCT01467986|dasatinib|dasatinib
391744|NCT01467986|rapamycin|rapamycin
391745|NCT01467973|Heart Failure|heart failure
391746|NCT01467973|Heart Failure, Diastolic|heart failure, diastolic
391747|NCT01467973|Heart Failure, Systolic|heart failure, systolic
391748|NCT01467973|Middle-East|middle-east
391749|NCT01467908|Diagnosed vegetative state after stroke or traumatic brain injury|diagnosed vegetative state after stroke or traumatic brain injury
391750|NCT01467869|abnormal semen|abnormal semen
391751|NCT01467869|assisted conception|assisted conception
391752|NCT01467856|Tetraplegia|tetraplegia
391753|NCT01467843|Cognitive Behavioral Therapy|cognitive behavioral therapy
391754|NCT01467843|Mindfulness Based Stress Reduction|mindfulness based stress reduction
391755|NCT01467830|absorbable sutures efficacy|absorbable sutures efficacy
391756|NCT01467830|reducing Adverse effect to be caused from surgery|reducing adverse effect to be caused from surgery
391757|NCT01467830|Inguinal Hernia repair with mesh|inguinal hernia repair with mesh
391758|NCT01467817|body mass|body mass
391759|NCT01467817|abdominal fat|abdominal fat
391760|NCT01467817|whole body lean mass|whole body lean mass
391761|NCT01467817|insulin resistance|insulin resistance
391762|NCT01467817|caloric intake|caloric intake
391763|NCT01467817|expenditure|expenditure
391764|NCT01467817|endurance|endurance
391765|NCT01467817|Strength|strength
391766|NCT01467817|TC:HDL ratio|tc:hdl ratio
391767|NCT01467817|LDL:HDL ratio|ldl:hdl ratio
391768|NCT01467817|area under the TG response curve|area under the tg response curve
391769|NCT01467817|feeding challenge|feeding challenge
391770|NCT01467817|fasting and post-prandial whole body fat oxidation|fasting and post-prandial whole body fat oxidation
391771|NCT01467817|HRQoL|hrqol
391772|NCT01467804|efficacy,|efficacy,
391773|NCT01467804|safety,|safety,
391774|NCT01467804|JWXYJN|jwxyjn
391775|NCT01467791|ambrisentan|ambrisentan
391776|NCT01467791|Bosentan|bosentan
391777|NCT01467791|Iloprost|iloprost
391778|NCT01467778|skin|skin
391779|NCT01467752|reconstruction|reconstruction
391780|NCT01467752|metacarpophalangeal joint|metacarpophalangeal joint
391781|NCT01467752|bone graft|bone graft
391782|NCT01467752|MCP joint|mcp joint
391783|NCT01467726|Alzheimer's disease|alzheimer's disease
391784|NCT01467726|Elderly|elderly
391785|NCT01467713|Drug Therapy|drug therapy
391786|NCT01467700|Drug Therapy|drug therapy
391787|NCT01467674|Diabetes mellitus|diabetes mellitus
391788|NCT01467674|Chronic periodontitis|chronic periodontitis
391789|NCT01467674|Malondialdehyde|malondialdehyde
391790|NCT01467674|Glutathione peroxidase|glutathione peroxidase
391791|NCT01467674|Paraoxonase|paraoxonase
391792|NCT01467648|Infection|infection
391793|NCT01467648|Doripenem|doripenem
391794|NCT01467648|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
391795|NCT01467648|pharmacokinetic|pharmacokinetic
391796|NCT01467648|pharmacodynamic|pharmacodynamic
391797|NCT01467635|Endobronchial ultrasound|endobronchial ultrasound
391798|NCT01467635|Transbronchial needle aspiration|transbronchial needle aspiration
391799|NCT01467635|Transbronchial biopsy forceps|transbronchial biopsy forceps
391800|NCT01467635|Mediastinal lymphadenopathy|mediastinal lymphadenopathy
391801|NCT01467635|Hilar lymphadenopathy|hilar lymphadenopathy
391802|NCT01467622|chest tube drainage|chest tube drainage
391803|NCT01467622|pulmonary air leak|pulmonary air leak
391804|NCT01467622|lung resection|lung resection
391805|NCT01467609|Pillcam colon capsule endoscopy|pillcam colon capsule endoscopy
391806|NCT01467609|conventional colonoscopy|conventional colonoscopy
391807|NCT01467609|ulcerative colitis|ulcerative colitis
391808|NCT01467609|endoscopic manifestation|endoscopic manifestation
391809|NCT01467609|colonoscopy|colonoscopy
391810|NCT01467596|Ultrasound|ultrasound
391811|NCT01467596|Brachial block|brachial block
391812|NCT01467596|Levobupivacaine|levobupivacaine
391813|NCT01467596|Minimum|minimum
391814|NCT01467596|Volume|volume
391815|NCT01467596|Minimum volume of Levobupivacaine 0,5%|minimum volume of levobupivacaine 0,5%
391816|NCT01467583|Fondaparinux|fondaparinux
391817|NCT01467583|Renal Failure|renal failure
391818|NCT01467583|Critically Ill|critically ill
391819|NCT01467570|diarrhea|diarrhea
391820|NCT01467557|adverse events|adverse events
391821|NCT01467544|Tai Chi|tai chi
391822|NCT01467531|HIV, GSK1265744, GSK1349572, dolutegravir, rilpivirine, drug interaction, pharmacokinetics|hiv, gsk1265744, gsk1349572, dolutegravir, rilpivirine, drug interaction, pharmacokinetics
391823|NCT01467518|methadone|methadone
391824|NCT01467518|Opiate-dependent|opiate-dependent
391825|NCT01467492|VX-950, Incivek|vx-950, incivek
391826|NCT01467466|renal|renal
391827|NCT01467466|cardiovascular|cardiovascular
391828|NCT01467466|kidney|kidney
391829|NCT01467466|heart|heart
391830|NCT01467466|clinical trial|clinical trial
391831|NCT01467466|double-blind|double-blind
391832|NCT01467466|multi-site trial|multi-site trial
391833|NCT01467466|randomized|randomized
391834|NCT01467466|drug treatment|drug treatment
391835|NCT01467466|IV solutions|iv solutions
391836|NCT01467466|antioxidant|antioxidant
391837|NCT01467440|Glaucoma and Ocular Hypertension|glaucoma and ocular hypertension
391838|NCT01467388|patients with glaucoma or ocular hypertension|patients with glaucoma or ocular hypertension
391839|NCT01467362|xerosis|xerosis
391840|NCT01467362|dry skin|dry skin
391841|NCT01467362|dermatitis|dermatitis
391842|NCT01467362|pruritus|pruritus
391843|NCT01467362|eczema|eczema
391844|NCT01467362|emollient|emollient
391845|NCT01467362|corticosteroid|corticosteroid
391846|NCT01467349|Raltegravir|raltegravir
391847|NCT01467349|efficacy|efficacy
391848|NCT01467349|safety|safety
391849|NCT01467349|raltegravir-containing regimens|raltegravir-containing regimens
391850|NCT01467349|HIV urban clinic setting|hiv urban clinic setting
391851|NCT01467310|GSK1120212|gsk1120212
391852|NCT01467310|TNBC|tnbc
391853|NCT01467310|Triple Negative Breast Cancer|triple negative breast cancer
391854|NCT01467310|Surgical Resection|surgical resection
391855|NCT01467297|Chronic bronchitis|chronic bronchitis
391856|NCT01467297|exacerbations|exacerbations
391857|NCT01467297|treatment|treatment
391858|NCT01467297|ceftidoren|ceftidoren
391859|NCT01467297|levofloxacin|levofloxacin
391860|NCT01467297|inflammation|inflammation
391861|NCT01467284|Obesity|obesity
391862|NCT01467284|Workplace|workplace
391863|NCT01467284|Intervention|intervention
391864|NCT01467284|Diet|diet
391865|NCT01467284|Exercise|exercise
391866|NCT01467245|Thoracoscopy|thoracoscopy
391867|NCT01467245|congenital diaphragmatic hernia|congenital diaphragmatic hernia
391868|NCT01467245|oesophageal atresia|oesophageal atresia
391869|NCT01467245|hypercapnia|hypercapnia
391870|NCT01467245|acidosis|acidosis
391871|NCT01467245|cerebral oxygenation|cerebral oxygenation
391872|NCT01467245|neonates|neonates
391873|NCT01467219|early|early
391874|NCT01467219|high risk|high risk
391875|NCT01467206|Stroke|stroke
391876|NCT01467206|Physiotherapy|physiotherapy
391877|NCT01467206|Motor training|motor training
391878|NCT01467206|Rehabilitation|rehabilitation
391879|NCT01467180|septeX|septex
391880|NCT01467180|CVVH|cvvh
391881|NCT01467180|CVHD|cvhd
391882|NCT01467180|myoglobin|myoglobin
391883|NCT01467167|Anesthesia|anesthesia
391884|NCT01467167|Smart Pilot View|smart pilot view
391885|NCT01467167|Pain control|pain control
391886|NCT01467167|Recovery|recovery
391887|NCT01467128|Elderly|elderly
391888|NCT01467128|Hospital|hospital
391889|NCT01467128|Adverse Drug|adverse drug
391890|NCT01467128|Pharmacist|pharmacist
391891|NCT01467128|Prevention|prevention
391892|NCT01467115|loco regionally advanced|loco regionally advanced
391893|NCT01467115|head and neck cancer|head and neck cancer
391894|NCT01467115|chemotherapy|chemotherapy
391895|NCT01467115|radiation|radiation
391896|NCT01467102|chronic post surgical pain|chronic post surgical pain
391897|NCT01467102|Pain|pain
391898|NCT01467102|Risk factors of chronic post surgical pain|risk factors of chronic post surgical pain
391899|NCT01467102|predictive risk factors|predictive risk factors
391900|NCT01467102|chronic post-surgical pain (CPSP)|chronic post-surgical pain (cpsp)
391901|NCT01467102|international level|international level
391902|NCT01467102|epidemiology of CPSP|epidemiology of cpsp
391903|NCT01467102|Europe|europe
391904|NCT01467102|observational|observational
391905|NCT01467102|prospective|prospective
391906|NCT01467089|Schizophrenia|schizophrenia
391907|NCT01467089|Extrapyramidal symptoms|extrapyramidal symptoms
391908|NCT01467089|Tardive dyskinesia|tardive dyskinesia
391909|NCT01467089|Two Way Video Assessment|two way video assessment
391910|NCT01467063|Type I Diabetes|type i diabetes
391911|NCT01467063|Insulin Resistance|insulin resistance
391912|NCT01467063|Glutamine|glutamine
391913|NCT01467063|Amino Acids|amino acids
391914|NCT01467063|Glucagon like peptide 1|glucagon like peptide 1
391915|NCT01467063|Glutathione|glutathione
391916|NCT01467063|Citrulline|citrulline
391917|NCT01467063|Arginine|arginine
391918|NCT01467063|Nitric Oxide|nitric oxide
391919|NCT01467050|Adverse drug event|adverse drug event
391920|NCT01467050|Adverse drug reaction|adverse drug reaction
391921|NCT01467050|Inappropriate prescribing|inappropriate prescribing
391922|NCT01467050|Elderly|elderly
391923|NCT01467050|Hospital-acquired|hospital-acquired
391924|NCT01467037|Rotavirus|rotavirus
391925|NCT01467037|Gastroenteritis|gastroenteritis
391926|NCT01467037|Vaccination|vaccination
391927|NCT01467037|Pediatrics|pediatrics
391928|NCT01467024|HTLV|htlv
391929|NCT01467024|Confirmatory|confirmatory
391930|NCT01467024|Supplemental|supplemental
391931|NCT01467024|Blot|blot
391932|NCT01467024|HTLV-I|htlv-i
391933|NCT01467024|HTLV-II|htlv-ii
391934|NCT01467011|Myfortic|myfortic
391935|NCT01467011|Mycophenolic acid|mycophenolic acid
391936|NCT01467011|Prograf|prograf
391937|NCT01467011|Tacrolimus|tacrolimus
391938|NCT01467011|Liver transplantation|liver transplantation
391939|NCT01466972|Advanced|advanced
391940|NCT01466972|Breast|breast
391941|NCT01466972|Cancer|cancer
391942|NCT01466972|Hormone Resistance|hormone resistance
391943|NCT01466972|Pazopanib|pazopanib
391944|NCT01466972|anastrozole|anastrozole
391945|NCT01466972|arimidex|arimidex
391946|NCT01466972|letrozole|letrozole
391947|NCT01466972|femara|femara
391948|NCT01466959|hemodialysis|hemodialysis
391949|NCT01466959|dialysate|dialysate
391950|NCT01466959|acetate based dialysate|acetate based dialysate
391951|NCT01466959|citrasate dialysate|citrasate dialysate
391952|NCT01466959|heparin anticoagulation|heparin anticoagulation
391953|NCT01466959|hemodynamic stability|hemodynamic stability
391954|NCT01466946|lung cancer|lung cancer
391955|NCT01466946|Hispanic/Latino patients|hispanic/latino patients
391956|NCT01466946|interviews|interviews
391957|NCT01466946|11-109|11-109
391958|NCT01466933|parenting intervention|parenting intervention
391959|NCT01466933|child development|child development
391960|NCT01466933|low and middle income countries|low and middle income countries
391961|NCT01466920|Total knee arthroplasty|total knee arthroplasty
391962|NCT01466907|complication|complication
391963|NCT01466907|depression|depression
391964|NCT01466907|follow-up|follow-up
391965|NCT01466907|intervention|intervention
391966|NCT01466907|nurse-led|nurse-led
391967|NCT01466907|outcome|outcome
391968|NCT01466907|secondary prevention|secondary prevention
391969|NCT01466907|stroke|stroke
391970|NCT01466894|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
391971|NCT01466894|NAFLD|nafld
391972|NCT01466894|Fatty liver|fatty liver
391973|NCT01466894|NASH|nash
391974|NCT01466868|Diffuse Large B cell Lymphoma|diffuse large b cell lymphoma
391975|NCT01466868|AKT|akt
391976|NCT01466868|MK 2206|mk 2206
391977|NCT01466868|objective response rate|objective response rate
391978|NCT01466868|progression free survival|progression free survival
391979|NCT01466868|overall survival|overall survival
391980|NCT01466868|safety|safety
391981|NCT01466855|Retinoblastoma|retinoblastoma
391982|NCT01466829|sternotomy|sternotomy
391983|NCT01466829|parathyroid hormone|parathyroid hormone
391984|NCT01466829|bone healing|bone healing
391985|NCT01466816|Lipid metabolism|lipid metabolism
391986|NCT01466803|Buprenorphine|buprenorphine
391987|NCT01466803|Vorikonazole|vorikonazole
391988|NCT01466803|Interactions|interactions
391989|NCT01466803|Pharmacokinetics|pharmacokinetics
391990|NCT01466803|Pharmacodynamics|pharmacodynamics
391991|NCT01466803|Voriconazole|voriconazole
391992|NCT01466790|Hepatitis C|hepatitis c
391993|NCT01466790|TMC435|tmc435
391994|NCT01466790|PSI-7977|psi-7977
391995|NCT01466790|GS7977|gs7977
391996|NCT01466790|Ribavirin|ribavirin
391997|NCT01466790|HCV|hcv
391998|NCT01466790|Hep C|hep c
391999|NCT01466790|Genotype 1|genotype 1
392000|NCT01466777|Endometrium cancer|endometrium cancer
392001|NCT01466777|Robotic-assisted laparoscopy|robotic-assisted laparoscopy
392002|NCT01466777|Traditional laparoscopy|traditional laparoscopy
392003|NCT01466777|Laparoscopic surgery|laparoscopic surgery
392004|NCT01466777|Treatment|treatment
392005|NCT01466777|Operation time|operation time
392006|NCT01466777|Bleeding|bleeding
392007|NCT01466777|Complications|complications
392008|NCT01466777|Conversions|conversions
392009|NCT01466777|Pelvic lymph node|pelvic lymph node
392010|NCT01466764|biomarkers|biomarkers
392011|NCT01466751|Computerized neurobehavioral intervention|computerized neurobehavioral intervention
392012|NCT01466738|Healthy volunteer|healthy volunteer
392013|NCT01466738|Rhinovirus|rhinovirus
392014|NCT01466738|Cold virus|cold virus
392015|NCT01466738|HRV-16|hrv-16
392016|NCT01466725|Lupus|lupus
392017|NCT01466725|Discoid Lupus|discoid lupus
392018|NCT01466725|DLE|dle
392019|NCT01466725|Cutaneous Lupus|cutaneous lupus
392020|NCT01466686|Recurrent Glioblastoma Multiforme|recurrent glioblastoma multiforme
392021|NCT01466686|Recurrent Anaplastic Astrocytoma|recurrent anaplastic astrocytoma
392022|NCT01466686|Surgery|surgery
392023|NCT01466686|Adjuvant Radiation|adjuvant radiation
392024|NCT01466686|Adjuvant Temozolomide|adjuvant temozolomide
392025|NCT01466673|Acne Vulgaris|acne vulgaris
392026|NCT01466673|Ethinyl estradiol|ethinyl estradiol
392027|NCT01466673|Norgestimate|norgestimate
392028|NCT01466673|Desogestrel|desogestrel
392029|NCT01466673|Tricilest|tricilest
392030|NCT01466673|Oilezz|oilezz
392031|NCT01466647|NSCLC|nsclc
392032|NCT01466621|cardiac resynchronization therapy|cardiac resynchronization therapy
392033|NCT01466621|heart failure|heart failure
392034|NCT01466621|mortality|mortality
392035|NCT01466608|OATP1B1|oatp1b1
392036|NCT01466608|Rosuvastatin|rosuvastatin
392037|NCT01466608|lipidomics|lipidomics
392038|NCT01466608|pharmacodynamics|pharmacodynamics
392039|NCT01466582|HIV-1-infection|hiv-1-infection
392040|NCT01466582|comorbidity|comorbidity
392041|NCT01466582|ageing|ageing
392042|NCT01466569|Advanced Solid Tumor|advanced solid tumor
392043|NCT01466569|Gastric Cancer|gastric cancer
392044|NCT01466569|Oncology|oncology
392045|NCT01466569|monoclonal Antibody|monoclonal antibody
392046|NCT01466543|Vascular dementia|vascular dementia
392047|NCT01466543|Subcortical vascular dementia|subcortical vascular dementia
392048|NCT01466543|Phosphodiesterase 5|phosphodiesterase 5
392049|NCT01466543|Udenafil|udenafil
392050|NCT01466530|Full term pregnancy > 36 weeks|full term pregnancy > 36 weeks
392051|NCT01466530|Cesarean delivery|cesarean delivery
392052|NCT01466530|General anesthesia|general anesthesia
392053|NCT01466517|Relative Bioavailability Study|relative bioavailability study
392054|NCT01466517|Ibuprofen|ibuprofen
392055|NCT01466517|Alivium|alivium
392056|NCT01466504|P63|p63
392057|NCT01466504|Sorafenib|sorafenib
392058|NCT01466504|Regorafenib|regorafenib
392059|NCT01466504|rash|rash
392060|NCT01466504|skin toxicity|skin toxicity
392061|NCT01466504|RCC|rcc
392062|NCT01466504|HCC|hcc
392063|NCT01466504|colorectal carcinoma|colorectal carcinoma
392064|NCT01466491|Pain during first-trimester surgical abortion|pain during first-trimester surgical abortion
392065|NCT01466465|Vitamin D|vitamin d
392066|NCT01466465|SIT|sit
392067|NCT01466465|Grass pollen|grass pollen
392068|NCT01466465|allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
392069|NCT01466439|rTMS|rtms
392070|NCT01466439|P50|p50
392071|NCT01466439|inhibitory|inhibitory
392072|NCT01466439|facilitatory|facilitatory
392073|NCT01466439|physiological process|physiological process
392074|NCT01466439|brain changes|brain changes
392075|NCT01466426|Venous thromboembolic disease|venous thromboembolic disease
392076|NCT01466426|Deep veinous thrombosis|deep veinous thrombosis
392077|NCT01466426|Pulmonary embolism|pulmonary embolism
392078|NCT01466413|Intrinsic Aging of Skin|intrinsic aging of skin
392079|NCT01466400|health benefits of infant formula|health benefits of infant formula
392080|NCT01466387|Adults|adults
392081|NCT01466387|international travel vaccination|international travel vaccination
392082|NCT01466387|Meningococcal disease|meningococcal disease
392083|NCT01466387|meningococcal meningitis|meningococcal meningitis
392084|NCT01466387|typhoid|typhoid
392085|NCT01466387|yellow fever|yellow fever
392086|NCT01466387|rabies|rabies
392087|NCT01466387|Japanese encephalitis|japanese encephalitis
392088|NCT01466361|Nicotine|nicotine
392089|NCT01466361|Nicotine craving|nicotine craving
392090|NCT01466348|Paracetomol|paracetomol
392091|NCT01466348|Caffeine|caffeine
392092|NCT01466348|Common cold|common cold
392093|NCT01466322|Healthy volunteers|healthy volunteers
392094|NCT01466322|GSK2018682|gsk2018682
392095|NCT01466322|Pharmacokinetics|pharmacokinetics
392096|NCT01466322|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
392097|NCT01466322|Pharmacodynamics|pharmacodynamics
392098|NCT01466309|AHI|ahi
392099|NCT01466309|ESS|ess
392100|NCT01466309|VAS|vas
392101|NCT01466309|FOSQ|fosq
392102|NCT01466309|SF-36|sf-36
392103|NCT01466296|CERBRAL PALSY|cerbral palsy
392104|NCT01466296|Poststroke/CVA Paresis|poststroke/cva paresis
392105|NCT01466296|REHABILITATION|rehabilitation
392106|NCT01466296|WALKING|walking
392107|NCT01466296|PERUTURBATION|peruturbation
392108|NCT01466283|childhood rhabdomyosarcoma|childhood rhabdomyosarcoma
392109|NCT01466270|fatigue|fatigue
392110|NCT01466270|sleep disorders|sleep disorders
392111|NCT01466270|depression|depression
392112|NCT01466270|anxiety disorder|anxiety disorder
392113|NCT01466270|cognitive/functional effects|cognitive/functional effects
392114|NCT01466270|breast cancer|breast cancer
392115|NCT01466270|cancer survivor|cancer survivor
392116|NCT01466257|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
392117|NCT01466257|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
392118|NCT01466257|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
392119|NCT01466257|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
392120|NCT01466257|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
392121|NCT01466257|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
392122|NCT01466257|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
392123|NCT01466257|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
392124|NCT01466257|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
392125|NCT01466257|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
392126|NCT01466257|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
392127|NCT01466257|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
392128|NCT01466257|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
392129|NCT01466257|stage IVA squamous cell carcinoma of the larynx|stage iva squamous cell carcinoma of the larynx
392130|NCT01466257|stage IVA squamous cell carcinoma of the lip and oral cavity|stage iva squamous cell carcinoma of the lip and oral cavity
392131|NCT01466257|stage IVA squamous cell carcinoma of the oropharynx|stage iva squamous cell carcinoma of the oropharynx
392392|NCT01465347|GBM|gbm
392132|NCT01466257|stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iva squamous cell carcinoma of the paranasal sinus and nasal cavity
392133|NCT01466257|stage IVB squamous cell carcinoma of the larynx|stage ivb squamous cell carcinoma of the larynx
392134|NCT01466257|stage IVB squamous cell carcinoma of the lip and oral cavity|stage ivb squamous cell carcinoma of the lip and oral cavity
392135|NCT01466257|stage IVB squamous cell carcinoma of the oropharynx|stage ivb squamous cell carcinoma of the oropharynx
392136|NCT01466257|stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivb squamous cell carcinoma of the paranasal sinus and nasal cavity
392137|NCT01466257|stage IVC squamous cell carcinoma of the larynx|stage ivc squamous cell carcinoma of the larynx
392138|NCT01466257|stage IVC squamous cell carcinoma of the lip and oral cavity|stage ivc squamous cell carcinoma of the lip and oral cavity
392139|NCT01466257|stage IVC squamous cell carcinoma of the oropharynx|stage ivc squamous cell carcinoma of the oropharynx
392140|NCT01466257|stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivc squamous cell carcinoma of the paranasal sinus and nasal cavity
392141|NCT01466257|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
392142|NCT01466244|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
392143|NCT01466244|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
392144|NCT01466244|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
392145|NCT01466244|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
392146|NCT01466244|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
392147|NCT01466244|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
392148|NCT01466244|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
392149|NCT01466244|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
392150|NCT01466244|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
392151|NCT01466244|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
392152|NCT01466244|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
392153|NCT01466244|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
392154|NCT01466244|stage IVA squamous cell carcinoma of the larynx|stage iva squamous cell carcinoma of the larynx
392155|NCT01466244|stage IVA squamous cell carcinoma of the lip and oral cavity|stage iva squamous cell carcinoma of the lip and oral cavity
392156|NCT01466244|stage IVA squamous cell carcinoma of the oropharynx|stage iva squamous cell carcinoma of the oropharynx
392157|NCT01466244|stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iva squamous cell carcinoma of the paranasal sinus and nasal cavity
392158|NCT01466244|stage IVB squamous cell carcinoma of the larynx|stage ivb squamous cell carcinoma of the larynx
392159|NCT01466244|stage IVB squamous cell carcinoma of the lip and oral cavity|stage ivb squamous cell carcinoma of the lip and oral cavity
392160|NCT01466244|stage IVB squamous cell carcinoma of the oropharynx|stage ivb squamous cell carcinoma of the oropharynx
392161|NCT01466244|stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivb squamous cell carcinoma of the paranasal sinus and nasal cavity
392162|NCT01466244|stage IVC squamous cell carcinoma of the larynx|stage ivc squamous cell carcinoma of the larynx
392163|NCT01466244|stage IVC squamous cell carcinoma of the lip and oral cavity|stage ivc squamous cell carcinoma of the lip and oral cavity
392164|NCT01466244|stage IVC squamous cell carcinoma of the oropharynx|stage ivc squamous cell carcinoma of the oropharynx
392165|NCT01466244|stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivc squamous cell carcinoma of the paranasal sinus and nasal cavity
392166|NCT01466244|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
392167|NCT01466231|refractory germ cell cancer|refractory germ cell cancer
392168|NCT01466231|everolimus|everolimus
392169|NCT01466218|pulmonary function abnormalities|pulmonary function abnormalities
392170|NCT01466218|pulmonary disease|pulmonary disease
392171|NCT01466218|cardiac disease|cardiac disease
392172|NCT01466218|cardiopulmonary disease|cardiopulmonary disease
392173|NCT01466218|obstructive sleep apnea|obstructive sleep apnea
392174|NCT01466218|OSA|osa
392175|NCT01466218|cardiovascular disease|cardiovascular disease
392176|NCT01466218|CVD|cvd
392177|NCT01466218|particulate matter|particulate matter
392178|NCT01466205|schizotypal personality disorder|schizotypal personality disorder
392179|NCT01466205|cognitive impairment|cognitive impairment
392180|NCT01466205|working memory|working memory
392181|NCT01466192|Genotype 2|genotype 2
392182|NCT01466179|B-ALL|b-all
392183|NCT01466179|relapsed ALL|relapsed all
392184|NCT01466179|refractory ALL|refractory all
392185|NCT01466179|adult ALL|adult all
392186|NCT01466179|Leukemia|leukemia
392187|NCT01466179|Leukemia, Lymphoid|leukemia, lymphoid
392188|NCT01466179|precursor cell lymphoblastic leukemia-lymphoma|precursor cell lymphoblastic leukemia-lymphoma
392189|NCT01466179|Lymphatic diseases|lymphatic diseases
392190|NCT01466179|Lymphoproliferative disorders|lymphoproliferative disorders
392191|NCT01466179|bispecific antibody|bispecific antibody
392192|NCT01466179|anti-CD19|anti-cd19
392193|NCT01466179|Immunotherapeutic treatment|immunotherapeutic treatment
392491|NCT01464957|pediatric|pediatric
392194|NCT01466179|immunoproliferative disorders|immunoproliferative disorders
392195|NCT01466153|Chronic lymphocytic leukemia; leukemia; B-Cell malignancy; anti-CD19; monoclonal antibody; CLL; Refractory; Relapse; Non-Hodgkin's Lymphoma|chronic lymphocytic leukemia; leukemia; b-cell malignancy; anti-cd19; monoclonal antibody; cll; refractory; relapse; non-hodgkin's lymphoma
392196|NCT01466140|Patient Satisfaction|patient satisfaction
392197|NCT01466140|Request for help|request for help
392198|NCT01466140|General practice|general practice
392199|NCT01466127|Effect of oxytocin on learning|effect of oxytocin on learning
392200|NCT01466114|multiple sclerosis|multiple sclerosis
392201|NCT01466114|MS|ms
392202|NCT01466114|relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
392203|NCT01466114|RRMS|rrms
392204|NCT01466114|secondary progressive multiple sclerosis|secondary progressive multiple sclerosis
392205|NCT01466114|SPMS|spms
392206|NCT01466114|primary progressive multiple sclerosis|primary progressive multiple sclerosis
392207|NCT01466114|estrogen|estrogen
392208|NCT01466114|estriol|estriol
392209|NCT01466101|Hysterectomy|hysterectomy
392210|NCT01466101|Pain|pain
392211|NCT01466101|Pregabalin|pregabalin
392212|NCT01466088|Alzheimer's Disease|alzheimer's disease
392213|NCT01466088|AD|ad
392214|NCT01466088|Dementia|dementia
392215|NCT01466062|Immunocompromised medical conditions|immunocompromised medical conditions
392216|NCT01466062|Respiratory Syncytial Virus Infection|respiratory syncytial virus infection
392217|NCT01466062|Infant|infant
392218|NCT01466062|Newborn|newborn
392219|NCT01466062|Young children|young children
392220|NCT01466049|Ovarian Cancer|ovarian cancer
392221|NCT01466049|Adnexal Mass|adnexal mass
392222|NCT01466049|Pelvic Mass|pelvic mass
392223|NCT01466036|metastatic|metastatic
392224|NCT01466023|thyroid metabolism during pregnancy|thyroid metabolism during pregnancy
392225|NCT01466023|impact on neonate|impact on neonate
392226|NCT01466010|osteoma, osteoid|osteoma, osteoid
392227|NCT01466010|surgical procedures, operative|surgical procedures, operative
392228|NCT01466010|bone neoplasms|bone neoplasms
392229|NCT01465997|Lacosamide|lacosamide
392230|NCT01465984|Paracetamol|paracetamol
392231|NCT01465984|Morphine sulfates|morphine sulfates
392232|NCT01465984|Acute pain|acute pain
392233|NCT01465971|high|high
392234|NCT01465971|altitude|altitude
392235|NCT01465971|acute|acute
392236|NCT01465971|mountain|mountain
392237|NCT01465971|sickness|sickness
392238|NCT01465971|sleep|sleep
392239|NCT01465971|disorder|disorder
392240|NCT01465971|periodic|periodic
392241|NCT01465971|breathing|breathing
392242|NCT01465971|hyperventilation|hyperventilation
392243|NCT01465971|apnea|apnea
392244|NCT01465945|TEM for rectal lesions|tem for rectal lesions
392245|NCT01465945|Sutured defect|sutured defect
392246|NCT01465945|Unsutured defect|unsutured defect
392247|NCT01465932|Nursing staff|nursing staff
392248|NCT01465932|Physical Therapy (Specialty)|physical therapy (specialty)
392249|NCT01465919|depression|depression
392250|NCT01465919|interferon|interferon
392251|NCT01465919|chronic hepatitis C|chronic hepatitis c
392252|NCT01465919|mirtazapine|mirtazapine
392253|NCT01465906|COPD|copd
392254|NCT01465893|vitamin d|vitamin d
392255|NCT01465880|Smoking research study|smoking research study
392256|NCT01465867|Selenium|selenium
392257|NCT01465867|Pregnancy|pregnancy
392258|NCT01465867|Auto-immune thyroiditis|auto-immune thyroiditis
392259|NCT01465867|Post-partum thyroiditis|post-partum thyroiditis
392260|NCT01465867|Miscarriage|miscarriage
392261|NCT01465867|Pre-eclampsia|pre-eclampsia
392262|NCT01465867|Implantation and Pregnancy rate|implantation and pregnancy rate
392263|NCT01465867|Infertility|infertility
392264|NCT01465854|lung cancer|lung cancer
392265|NCT01465854|smoking|smoking
392266|NCT01465854|molecular epidemiology|molecular epidemiology
392267|NCT01465854|genetic polymorphism|genetic polymorphism
392268|NCT01465854|risk factors|risk factors
392269|NCT01465854|never smokers|never smokers
392270|NCT01465854|histologically/cytologically confirmed|histologically/cytologically confirmed
392271|NCT01465841|intracranial aneurysms|intracranial aneurysms
392272|NCT01465841|Peripheral aneurysms|peripheral aneurysms
392273|NCT01465841|acute treatment|acute treatment
392274|NCT01465841|PC 400 System|pc 400 system
392275|NCT01465841|packing density|packing density
392276|NCT01465828|antiplatelet effect|antiplatelet effect
392277|NCT01465828|prasugrel|prasugrel
392278|NCT01465828|clopidogrel|clopidogrel
392279|NCT01465828|ACS|acs
392280|NCT01465802|non-small cell lung cancer|non-small cell lung cancer
392281|NCT01465802|advanced|advanced
392282|NCT01465802|previously treated|previously treated
392283|NCT01465776|SCC of the oral cavity|scc of the oral cavity
392284|NCT01465776|black raspberries|black raspberries
392285|NCT01465763|tofacitinib|tofacitinib
392286|NCT01465763|CP-690|cp-690
392287|NCT01465763|550|550
392288|NCT01465763|Moderate to severe ulcerative colitis|moderate to severe ulcerative colitis
392289|NCT01465763|phase 3 clinical trial|phase 3 clinical trial
392290|NCT01465763|Mayo score|mayo score
392291|NCT01465737|epidemiology|epidemiology
392292|NCT01465737|uterine cancer|uterine cancer
392293|NCT01465737|Taiwan|taiwan
392294|NCT01465724|Insulin resistance|insulin resistance
392295|NCT01465724|Insulin sensitivity|insulin sensitivity
392296|NCT01465724|HOMA-IR|homa-ir
392297|NCT01465724|blood pressure|blood pressure
392298|NCT01465724|Renal denervation|renal denervation
392299|NCT01465724|renal sympathetic denervation|renal sympathetic denervation
392300|NCT01465724|renal ablation|renal ablation
392301|NCT01465711|Peritonitis|peritonitis
392302|NCT01465711|Sepsis|sepsis
392303|NCT01465711|General Surgery|general surgery
392304|NCT01465711|Intensive Care Units|intensive care units
392305|NCT01465711|Sensitivity and Specificity|sensitivity and specificity
392306|NCT01465698|exercise|exercise
392307|NCT01465698|counseling|counseling
392308|NCT01465698|movement control|movement control
392309|NCT01465698|fear avoidance|fear avoidance
392310|NCT01465685|MDMA|mdma
392311|NCT01465685|pharmacokinetics|pharmacokinetics
392312|NCT01465685|pharmacodynamics|pharmacodynamics
392313|NCT01465685|emotions|emotions
392314|NCT01465685|Mechanism of action of MDMA|mechanism of action of mdma
392315|NCT01465685|Interaction study|interaction study
392439|NCT01465191|genetics|genetics
392316|NCT01465685|Effect of MDMA and methylphenidate on emotions|effect of mdma and methylphenidate on emotions
392317|NCT01465672|copeptin|copeptin
392318|NCT01465672|SIADH|siadh
392319|NCT01465672|Diabetes insipidus|diabetes insipidus
392320|NCT01465672|transphenoidal pituitary adenoma resection|transphenoidal pituitary adenoma resection
392321|NCT01465672|pituitary adenoma|pituitary adenoma
392322|NCT01465672|tumors close to pituitary gland|tumors close to pituitary gland
392323|NCT01465672|tumors close to hypothalamus|tumors close to hypothalamus
392324|NCT01465646|levothyroxine|levothyroxine
392325|NCT01465646|bioavailability|bioavailability
392326|NCT01465633|bioavailability|bioavailability
392327|NCT01465633|levothyroxine|levothyroxine
392328|NCT01465620|Peripheral Nervous System Diseases|peripheral nervous system diseases
392329|NCT01465620|Diabetic Polyneuropathy|diabetic polyneuropathy
392330|NCT01465620|Metabolic Syndrome X|metabolic syndrome x
392331|NCT01465607|Condom use|condom use
392332|NCT01465594|Pain Measurement|pain measurement
392333|NCT01465581|incontinence|incontinence
392334|NCT01465581|dysfunctional voiding|dysfunctional voiding
392335|NCT01465581|neurogenic bladder disturbance|neurogenic bladder disturbance
392336|NCT01465581|filum terminale|filum terminale
392337|NCT01465581|spinal cord tethering|spinal cord tethering
392338|NCT01465581|conus|conus
392339|NCT01465568|osteoporosis|osteoporosis
392340|NCT01465568|denosumab|denosumab
392341|NCT01465568|RANKL|rankl
392342|NCT01465568|glucocorticoids|glucocorticoids
392343|NCT01465555|Clinical Alert|clinical alert
392344|NCT01465555|Cognitive Behavioral Intervention|cognitive behavioral intervention
392345|NCT01465555|Web-based|web-based
392346|NCT01465555|Substance Abuse Treatment|substance abuse treatment
392347|NCT01465542|Acetaminophen Toxicity|acetaminophen toxicity
392348|NCT01465542|Acetaminophen Overdose|acetaminophen overdose
392349|NCT01465542|N-acetylcysteine|n-acetylcysteine
392350|NCT01465542|Liver Toxicity|liver toxicity
392351|NCT01465503|bleeding|bleeding
392352|NCT01465503|percutaneous coronary intervention|percutaneous coronary intervention
392353|NCT01465503|heparin|heparin
392354|NCT01465503|bivalirudin|bivalirudin
392355|NCT01465490|Monitoring|monitoring
392356|NCT01465490|Feedback|feedback
392357|NCT01465490|Substance Abuse Treatment|substance abuse treatment
392358|NCT01465477|Fibromyalgia|fibromyalgia
392359|NCT01465477|Influenza vaccination|influenza vaccination
392360|NCT01465451|colorectal cancer|colorectal cancer
392361|NCT01465451|curative resection|curative resection
392362|NCT01465451|intra-operative chemotherapy|intra-operative chemotherapy
392363|NCT01465451|5-fluorouracil|5-fluorouracil
392364|NCT01465451|chemotherapy|chemotherapy
392365|NCT01465425|extracolonic findings|extracolonic findings
392366|NCT01465425|ECFs|ecfs
392367|NCT01465425|CT colonography|ct colonography
392368|NCT01465425|computed tomography colonography|computed tomography colonography
392369|NCT01465425|National CT Colonography Trial|national ct colonography trial
392370|NCT01465425|ACRIN 6664|acrin 6664
392371|NCT01465412|Parkinson disease|parkinson disease
392372|NCT01465373|In-Vitro Fertilization|in-vitro fertilization
392373|NCT01465373|Donor Egg IVF|donor egg ivf
392374|NCT01465360|Alzheimer's disease|alzheimer's disease
392376|NCT01465360|Non AD dementia|non ad dementia
392377|NCT01465360|Mild Cognitive Impairment|mild cognitive impairment
392378|NCT01465360|MCI|mci
392379|NCT01465360|Vascular dementia|vascular dementia
392380|NCT01465360|Fronto-temporal dementia|fronto-temporal dementia
392381|NCT01465360|Primary progressive aphasia|primary progressive aphasia
392382|NCT01465360|Parkinson's Disease dementia|parkinson's disease dementia
392383|NCT01465360|Mixed dementia|mixed dementia
392384|NCT01465360|Blood signature|blood signature
392385|NCT01465360|Diagnosis|diagnosis
392386|NCT01465360|AclarusDx|aclarusdx
392387|NCT01465360|Alzheimer's Disease and other non-AD dementia|alzheimer's disease and other non-ad dementia
392388|NCT01465360|Exonhit|exonhit
392389|NCT01465347|Primary brain tumor|primary brain tumor
392390|NCT01465347|Glioblastoma|glioblastoma
392391|NCT01465347|Glioma|glioma
392393|NCT01465347|Radiation therapy|radiation therapy
392394|NCT01465334|17p Deletion CLL|17p deletion cll
392395|NCT01465308|head and neck cancer|head and neck cancer
392396|NCT01465308|radiotherapy induced xerostomia|radiotherapy induced xerostomia
392397|NCT01465308|radiotherapy induced oral mucositis|radiotherapy induced oral mucositis
392398|NCT01465308|RCT|rct
392399|NCT01465308|symptom management|symptom management
392400|NCT01465295|Scoliosis|scoliosis
392401|NCT01465295|Adolescent Idiopathic Scoliosis (AIS)|adolescent idiopathic scoliosis (ais)
392402|NCT01465295|Scoliosis treatment|scoliosis treatment
392403|NCT01465295|Fusionless spinal surgery|fusionless spinal surgery
392404|NCT01465295|Vertebral stapling|vertebral stapling
392405|NCT01465295|Spinal stapling|spinal stapling
392406|NCT01465295|Non-fusion|non-fusion
392407|NCT01465295|Spinal curvature|spinal curvature
392408|NCT01465295|Curvature of the spine|curvature of the spine
392409|NCT01465295|Spinal bracing alternative|spinal bracing alternative
392410|NCT01465295|HemiBridge|hemibridge
392411|NCT01465295|SpineForm|spineform
392412|NCT01465295|Dr. Eric Wall|dr. eric wall
392413|NCT01465295|Dr. George Thompson|dr. george thompson
392414|NCT01465295|Spinal clip|spinal clip
392415|NCT01465295|Cincinnati Children's Hospital Medical Center|cincinnati children's hospital medical center
392416|NCT01465295|University Hospitals Case Medical Center, Rainbow Babies|university hospitals case medical center, rainbow babies
392417|NCT01465282|psoriasis vulgaris|psoriasis vulgaris
392418|NCT01465282|topical ointment|topical ointment
392419|NCT01465269|TBI|tbi
392420|NCT01465269|Social Competence|social competence
392421|NCT01465256|Aspirin|aspirin
392422|NCT01465256|Colon polypectomy|colon polypectomy
392423|NCT01465256|Bleeding|bleeding
392424|NCT01465243|Efficacy|efficacy
392425|NCT01465243|Safety|safety
392426|NCT01465243|EGFR-TKI|egfr-tki
392427|NCT01465243|phase IV|phase iv
392428|NCT01465243|NSCLC|nsclc
392429|NCT01465243|Dose escalation|dose escalation
392430|NCT01465230|chronic lymphocytic leukemia|chronic lymphocytic leukemia
392431|NCT01465230|maintenance therapy|maintenance therapy
392432|NCT01465217|medication adherence|medication adherence
392433|NCT01465217|African Americans|african americans
392434|NCT01465204|Behavior Change|behavior change
392435|NCT01465204|Hygiene & Sanitation Marketing|hygiene & sanitation marketing
392436|NCT01465191|cesarean|cesarean
392437|NCT01465191|postoperative|postoperative
392438|NCT01465191|morphine|morphine
392440|NCT01465191|opioid|opioid
392441|NCT01465178|hypovitaminosis D|hypovitaminosis d
392442|NCT01465178|vitamin D insufficiency|vitamin d insufficiency
392443|NCT01465178|low vitamin D|low vitamin d
392444|NCT01465165|Depression|depression
392445|NCT01465165|Positron emission tomography|positron emission tomography
392446|NCT01465165|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
392447|NCT01465165|glucose metabolism|glucose metabolism
392448|NCT01465165|ATP|atp
392449|NCT01465165|phosphocreatine|phosphocreatine
392450|NCT01465113|Barrett's Esophagus|barrett's esophagus
392451|NCT01465113|Vitamin D3|vitamin d3
392452|NCT01465113|cholecalciferol|cholecalciferol
392453|NCT01465113|15-Prostaglandin Dehydrogenase Expression|15-prostaglandin dehydrogenase expression
392454|NCT01465113|metformin|metformin
392455|NCT01465100|phenylketonuria|phenylketonuria
392456|NCT01465100|hepatocyte|hepatocyte
392457|NCT01465087|Multiple Sclerosis|multiple sclerosis
392458|NCT01465087|Breath|breath
392459|NCT01465087|Diagnosis|diagnosis
392460|NCT01465087|Discrimination MS/healthy subj. via exhaled breath samples|discrimination ms/healthy subj. via exhaled breath samples
392461|NCT01465087|Discrimination MS/other neurological and autoimmune diseases|discrimination ms/other neurological and autoimmune diseases
392462|NCT01465074|nicotine|nicotine
392463|NCT01465074|memory|memory
392464|NCT01465074|plasticity|plasticity
392465|NCT01465074|TMS|tms
392466|NCT01465074|Paired Associative Stimulation|paired associative stimulation
392467|NCT01465061|Online social network|online social network
392468|NCT01465061|Psoriasis|psoriasis
392469|NCT01465061|Filipino|filipino
392470|NCT01465048|Malaria|malaria
392471|NCT01465048|Protozoan Infections|protozoan infections
392472|NCT01465048|Parasitic Diseases|parasitic diseases
392473|NCT01465048|Malaria Challenge|malaria challenge
392474|NCT01465022|Breastfeeding rates|breastfeeding rates
392475|NCT01465022|Contraceptive continuation|contraceptive continuation
392476|NCT01465022|Birth control pills|birth control pills
392477|NCT01465022|Lactation|lactation
392478|NCT01465009|Sore Throat|sore throat
392479|NCT01464996|non-carious cervical lesions|non-carious cervical lesions
392480|NCT01464996|bonded restorations|bonded restorations
392481|NCT01464996|composites|composites
392482|NCT01464996|adhesives|adhesives
392483|NCT01464970|DIEP perfusion|diep perfusion
392484|NCT01464970|Zone IV|zone iv
392485|NCT01464970|Free Flap|free flap
392486|NCT01464970|Breast Cancer Reconstruction|breast cancer reconstruction
392487|NCT01464970|Perfusion of Zone IV of DIEP flaps|perfusion of zone iv of diep flaps
392488|NCT01464957|skin cancer prevention|skin cancer prevention
392489|NCT01464957|precaution adoption process model|precaution adoption process model
392490|NCT01464957|semi-tailored newsletter|semi-tailored newsletter
392492|NCT01464957|behavioral intervention|behavioral intervention
392493|NCT01464944|Upper Respiratory Tract Infections|upper respiratory tract infections
392494|NCT01464918|gastric cancer|gastric cancer
392495|NCT01464918|colon cancer|colon cancer
392496|NCT01464918|endoscopic submucosal dissection|endoscopic submucosal dissection
392497|NCT01464905|RRMS|rrms
392498|NCT01464892|Imagery rescripting|imagery rescripting
392499|NCT01464892|Imagery rescripting and reprocessing therapy|imagery rescripting and reprocessing therapy
392500|NCT01464892|Skills Training in affective and interpersonal regulation|skills training in affective and interpersonal regulation
392501|NCT01464892|Post-traumatic Stress Disorder|post-traumatic stress disorder
392502|NCT01464892|Childhood abuse|childhood abuse
392503|NCT01464892|Childhood sexual abuse|childhood sexual abuse
392504|NCT01464840|Pregnancy|pregnancy
392505|NCT01464840|Cesarean section|cesarean section
392506|NCT01464840|Antibiotic|antibiotic
392507|NCT01464827|Hepatitis C Genotype 1|hepatitis c genotype 1
392508|NCT01464827|Hepatitis C|hepatitis c
392509|NCT01464827|Interferon-Free|interferon-free
392510|NCT01464827|HCV|hcv
392511|NCT01464827|Chronic Hepatitis C|chronic hepatitis c
392512|NCT01464814|probiotic|probiotic
392513|NCT01464814|fish oil|fish oil
392514|NCT01464814|digestion|digestion
392515|NCT01464814|viability|viability
392516|NCT01464801|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
392517|NCT01464801|Non-alcoholic Steatohepatitis|non-alcoholic steatohepatitis
392518|NCT01464801|Resveratrol|resveratrol
392519|NCT01464801|Human study|human study
392520|NCT01464788|stroke|stroke
392521|NCT01464788|Argatroban|argatroban
392522|NCT01464788|thrombin-inhibition|thrombin-inhibition
392523|NCT01464788|thrombolysis|thrombolysis
392524|NCT01464788|anticoagulation|anticoagulation
392525|NCT01464775|Endometriosis|endometriosis
392526|NCT01464775|Laparoscopy|laparoscopy
392527|NCT01464775|Narrow Band Imaging|narrow band imaging
392528|NCT01464762|Tuberculosis|tuberculosis
392529|NCT01464762|TMC207TBC3001|tmc207tbc3001
392530|NCT01464762|TMC207|tmc207
392531|NCT01464762|Early access|early access
392532|NCT01464762|TB|tb
392533|NCT01464762|Drug resistant|drug resistant
392534|NCT01464762|Multi drug-resistant|multi drug-resistant
392535|NCT01464762|Extensively drug-resistant|extensively drug-resistant
392536|NCT01464749|multiple sclerosis|multiple sclerosis
392537|NCT01464749|gait rehabilitation|gait rehabilitation
392538|NCT01464736|aerobic exercise|aerobic exercise
392539|NCT01464736|noninvasive ventilation|noninvasive ventilation
392540|NCT01464736|functionality|functionality
392541|NCT01464697|hot flushes/hot flashes|hot flushes/hot flashes
392542|NCT01464697|night sweats|night sweats
392543|NCT01464697|sleep problems|sleep problems
392544|NCT01464697|negative mood|negative mood
392545|NCT01464697|anxiety|anxiety
392546|NCT01464697|perimenopause|perimenopause
392547|NCT01464697|progesterone|progesterone
392548|NCT01464697|vasomotor symptoms|vasomotor symptoms
392549|NCT01464697|premenopause|premenopause
392550|NCT01464671|Coronary Artery Disease|coronary artery disease
392551|NCT01464671|Stable Angina|stable angina
392552|NCT01464671|Percutaneous Coronary Intervention|percutaneous coronary intervention
392553|NCT01464658|panniculitis|panniculitis
392554|NCT01464658|panniculectomy|panniculectomy
392555|NCT01464632|medial knee replacement|medial knee replacement
392556|NCT01464619|Parenting|parenting
392557|NCT01464619|Early Child Development|early child development
392558|NCT01464606|pleuropulmonary blastoma|pleuropulmonary blastoma
392559|NCT01464606|pediatric|pediatric
392560|NCT01464606|lung cysts|lung cysts
392561|NCT01464593|Colorectal Liver Metastasis|colorectal liver metastasis
392562|NCT01464593|Colon Cancer|colon cancer
392563|NCT01464593|Liver Cancer|liver cancer
392564|NCT01464593|Liver Metastasis|liver metastasis
392565|NCT01464593|Liver metastases|liver metastases
392566|NCT01464567|Weaning|weaning
392567|NCT01464567|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
392568|NCT01464567|Spontaneous Breathing Trial|spontaneous breathing trial
392569|NCT01464554|adolescents|adolescents
392570|NCT01464554|alcohol|alcohol
392571|NCT01464554|drugs|drugs
392572|NCT01464554|delinquency|delinquency
392573|NCT01464554|intervention|intervention
392574|NCT01464541|Orbit|orbit
392575|NCT01464541|Fracture|fracture
392576|NCT01464541|measurement|measurement
392577|NCT01464541|CT|ct
392578|NCT01464541|intraoperative|intraoperative
392579|NCT01464528|hysteroscopy|hysteroscopy
392580|NCT01464528|postoperative complications|postoperative complications
392581|NCT01464528|adhesions|adhesions
392582|NCT01464528|hyaluronic gel|hyaluronic gel
392583|NCT01464528|prevention|prevention
392584|NCT01464515|Mild Cognitive Impairment, So Stated|mild cognitive impairment, so stated
392585|NCT01464515|Deep Transcranial Magnetic Stimulation|deep transcranial magnetic stimulation
392586|NCT01464502|Heart failure|heart failure
392587|NCT01464502|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
392588|NCT01464502|Acute haemodynamic response|acute haemodynamic response
392589|NCT01464502|Responder|responder
392590|NCT01464489|Intubation time|intubation time
392591|NCT01464489|Atropine|atropine
392592|NCT01464489|Propofol anesthesia|propofol anesthesia
392593|NCT01464463|Depression|depression
392594|NCT01464463|Exercise|exercise
392595|NCT01464463|Psychoneuroimmunology|psychoneuroimmunology
392596|NCT01464463|Cognitive Behavioral Therapy|cognitive behavioral therapy
392597|NCT01464463|CBASP|cbasp
392598|NCT01464450|Pharmacokinetics|pharmacokinetics
392599|NCT01464450|Bioavailability|bioavailability
392600|NCT01464450|Healthy Participants|healthy participants
392601|NCT01464437|diabetes|diabetes
392602|NCT01464437|mellitus|mellitus
392603|NCT01464437|metformin|metformin
392604|NCT01464424|Glaucoma|glaucoma
392605|NCT01464424|Ocular Hypertension|ocular hypertension
392606|NCT01464424|Open-Angle Glaucoma|open-angle glaucoma
392607|NCT01464424|Intraocular Pressure|intraocular pressure
392608|NCT01464411|chronic myelogenous leukemia|chronic myelogenous leukemia
392609|NCT01464411|chronic phase|chronic phase
392610|NCT01464411|Phase II|phase ii
392611|NCT01464411|dasatinib|dasatinib
392612|NCT01464398|Polycystic Ovary Syndrome|polycystic ovary syndrome
392613|NCT01464398|stress|stress
392614|NCT01464398|mindfulness|mindfulness
392615|NCT01464398|meditation|meditation
392616|NCT01464398|health education|health education
392617|NCT01464398|women|women
392618|NCT01464398|overweight|overweight
392619|NCT01464398|obesity|obesity
392620|NCT01464372|Urinary Incontinence, Urge|urinary incontinence, urge
392621|NCT01464372|Peripheral Nerve Stimulation|peripheral nerve stimulation
392622|NCT01464359|umbilical cord blood transplant|umbilical cord blood transplant
392623|NCT01464346|diabetes|diabetes
392624|NCT01464346|glucose sensor|glucose sensor
392625|NCT01464346|CGM|cgm
392626|NCT01464333|Crohn's Disease|crohn's disease
392627|NCT01464320|Safety|safety
392628|NCT01464320|Type 2 diabetes|type 2 diabetes
392629|NCT01464320|Kidney disease|kidney disease
392630|NCT01464294|CAD/CAM|cad/cam
392631|NCT01464294|crowns|crowns
392632|NCT01464294|onlays|onlays
392633|NCT01464294|composite block|composite block
392634|NCT01464294|milled restorations|milled restorations
392635|NCT01464281|nucleoside|nucleoside
392636|NCT01464281|peginterferon alfa-2a|peginterferon alfa-2a
392637|NCT01464268|Keratoconus|keratoconus
392638|NCT01464268|Corneal Ectasia|corneal ectasia
392639|NCT01464268|Collagen Crosslinking|collagen crosslinking
392640|NCT01464268|Riboflavin|riboflavin
392641|NCT01464255|contact lenses|contact lenses
392642|NCT01464242|Cutaneous Leishmaniasis|cutaneous leishmaniasis
392643|NCT01464242|pentoxifylline|pentoxifylline
392644|NCT01464242|immunomodulation|immunomodulation
392645|NCT01464216|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
392646|NCT01464216|Prostate cancer|prostate cancer
392647|NCT01464216|FACBC PET|facbc pet
392648|NCT01464216|Hypoxia imaging|hypoxia imaging
392649|NCT01464203|Computed tomographic coronary angiography|computed tomographic coronary angiography
392650|NCT01464203|multi-slice CT|multi-slice ct
392651|NCT01464203|angina|angina
392652|NCT01464203|cost-effectiveness|cost-effectiveness
392653|NCT01464190|PA21|pa21
392654|NCT01464190|Phosphate Binder|phosphate binder
392655|NCT01464177|malignant glioma|malignant glioma
392656|NCT01464177|glioblastoma|glioblastoma
392657|NCT01464177|radiotherapy|radiotherapy
392658|NCT01464177|randomized|randomized
392659|NCT01464164|Diamond Blackfan anemia|diamond blackfan anemia
392660|NCT01464164|DBA|dba
392661|NCT01464164|Blackfan Diamond anemia|blackfan diamond anemia
392662|NCT01464164|Congenital pure red cell aplasia|congenital pure red cell aplasia
392663|NCT01464164|Aase-Smith II Syndrome|aase-smith ii syndrome
392664|NCT01464164|Aase Syndrome|aase syndrome
392665|NCT01464164|Anemia, Congenital Pure Red Cell|anemia, congenital pure red cell
392666|NCT01464164|Aplasia, Congenital Pure Red Cell|aplasia, congenital pure red cell
392667|NCT01464164|BDA|bda
392668|NCT01464164|Congenital Hypoplastic Anemia|congenital hypoplastic anemia
392669|NCT01464164|Erythrogenesis Imperfecta|erythrogenesis imperfecta
392670|NCT01464164|Hypoplastic Congenital Anemia|hypoplastic congenital anemia
392671|NCT01464164|Inherited Erythroblastopenia|inherited erythroblastopenia
392672|NCT01464164|pure red cell aplasia|pure red cell aplasia
392673|NCT01464164|bone marrow failure syndrome|bone marrow failure syndrome
392674|NCT01464151|IBD|ibd
392675|NCT01464151|colitis|colitis
392676|NCT01464151|dysplasia|dysplasia
392677|NCT01464151|colorectal cancer|colorectal cancer
392678|NCT01464138|Malaria|malaria
392679|NCT01464125|Malaria|malaria
392680|NCT01464125|Plasmodium falciparum|plasmodium falciparum
392681|NCT01464125|acute uncomplicated|acute uncomplicated
392682|NCT01464112|Multiple myeloma that has relapsed or is progressive following prior therapy|multiple myeloma that has relapsed or is progressive following prior therapy
392683|NCT01464112|Relapsed Multiple Myeloma|relapsed multiple myeloma
392684|NCT01464112|JNJ 26481585|jnj 26481585
392685|NCT01464112|VELCADE|velcade
392686|NCT01464112|Bortezomib|bortezomib
392687|NCT01464112|Dexamethasone|dexamethasone
392688|NCT01464086|patients with Li Fraumeni syndrome|patients with li fraumeni syndrome
392689|NCT01464073|NIDDM|niddm
392690|NCT01464073|obesity|obesity
392691|NCT01464073|lifestyle intervention|lifestyle intervention
392692|NCT01464073|physical exercise|physical exercise
392693|NCT01464073|diet|diet
392694|NCT01464073|LIPOXmax|lipoxmax
392695|NCT01464073|FATmax|fatmax
392696|NCT01464073|fat oxydation rate|fat oxydation rate
392697|NCT01464060|Helicobacter pylori|helicobacter pylori
392698|NCT01464060|Quadruple therapy|quadruple therapy
392699|NCT01464060|Clarithromycin resistance|clarithromycin resistance
392700|NCT01464021|Study|study
392701|NCT01464021|prospective|prospective
392702|NCT01464021|Rheumatoid|rheumatoid
392703|NCT01464021|Observational study|observational study
392704|NCT01464021|Arthritis|arthritis
392705|NCT01464021|Adalimumab|adalimumab
392706|NCT01463995|severe neurological diseases|severe neurological diseases
392707|NCT01463995|neurological intensive care unit|neurological intensive care unit
392708|NCT01463995|prediction|prediction
392709|NCT01463995|long-term outcome|long-term outcome
392710|NCT01463995|biomarkers|biomarkers
392711|NCT01463995|prediction of long-term outcome|prediction of long-term outcome
392712|NCT01463982|Advanced solid cancer|advanced solid cancer
392713|NCT01463969|PCOS and PTX3 levels|pcos and ptx3 levels
392714|NCT01463956|Boceprevir|boceprevir
392715|NCT01463956|HCV infection|hcv infection
392716|NCT01463956|Antiviral therapy|antiviral therapy
392717|NCT01463956|Liver transplantation|liver transplantation
392718|NCT01463930|Total Knee Replacement|total knee replacement
392719|NCT01463930|Expectations|expectations
392720|NCT01463930|Audiovisual videodisc|audiovisual videodisc
392721|NCT01463917|Coronary Artery Bypass|coronary artery bypass
392722|NCT01463917|Off-Pump|off-pump
392723|NCT01463917|Saline Solution|saline solution
392724|NCT01463917|Hypertonic|hypertonic
392725|NCT01463904|Morbid obesity|morbid obesity
392726|NCT01463904|duodenal switch|duodenal switch
392727|NCT01463904|diabetes|diabetes
392728|NCT01463904|decrease in cardiac risk|decrease in cardiac risk
392729|NCT01463904|remission of T2DM|remission of t2dm
392730|NCT01463891|Eribulin Mesylate|eribulin mesylate
392731|NCT01463891|inoperable or recurrent breast cancer|inoperable or recurrent breast cancer
392732|NCT01463878|glycemic control|glycemic control
392733|NCT01463878|glycemic variability|glycemic variability
392734|NCT01463878|mean blood glucose level|mean blood glucose level
392735|NCT01463852|vincristine|vincristine
392736|NCT01463852|JNK|jnk
392737|NCT01463852|phosphorylation|phosphorylation
392738|NCT01463852|cll|cll
392739|NCT01463852|vinca alkaloid|vinca alkaloid
392740|NCT01463852|apoptosis|apoptosis
392741|NCT01463839|sleep disorder|sleep disorder
392742|NCT01463839|malocclusion|malocclusion
392743|NCT01463839|children|children
392744|NCT01463826|bruxism|bruxism
392745|NCT01463826|children|children
392746|NCT01463826|oral breathing|oral breathing
392747|NCT01463826|dental caries|dental caries
392748|NCT01463813|bone density conservation agents|bone density conservation agents
392749|NCT01463813|cancer|cancer
392750|NCT01463813|cardiovascular disease|cardiovascular disease
392751|NCT01463813|cholecalciferol|cholecalciferol
392752|NCT01463813|diabetes mellitus, type 2|diabetes mellitus, type 2
392753|NCT01463813|dietary supplements|dietary supplements
392754|NCT01463813|primary prevention|primary prevention
392755|NCT01463813|vitamin D|vitamin d
392756|NCT01463800|Heart Defects, congenital|heart defects, congenital
392757|NCT01463787|Infertility|infertility
392758|NCT01463787|varicocelectomy|varicocelectomy
392759|NCT01463787|microsurgery|microsurgery
392760|NCT01463787|Chinese men|chinese men
392761|NCT01463787|pregnancy rate|pregnancy rate
392762|NCT01463774|Healthy Volunteers|healthy volunteers
392763|NCT01463774|Bioequivalence|bioequivalence
392764|NCT01463774|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
392765|NCT01463774|Metformin|metformin
392766|NCT01463761|High-level athlete|high-level athlete
392767|NCT01463761|ANS activity|ans activity
392768|NCT01463761|Overtraining|overtraining
392769|NCT01463735|Cirrhotic patients|cirrhotic patients
392770|NCT01463722|Respiratory distress syndrome|respiratory distress syndrome
392771|NCT01463722|Lung maturity|lung maturity
392772|NCT01463722|lamellar body|lamellar body
392773|NCT01463709|basal cell carcinoma|basal cell carcinoma
392774|NCT01463709|Basal Cell Nevus Syndrome|basal cell nevus syndrome
392775|NCT01463709|Electric Field|electric field
392776|NCT01463709|Nanosecond pulse|nanosecond pulse
392777|NCT01463670|LENALIDOMIDE (CC-5013)|lenalidomide (cc-5013)
392778|NCT01463670|BONE MARROW|bone marrow
392779|NCT01463670|11-107|11-107
392780|NCT01463657|Aging|aging
392781|NCT01463644|Mepolizumab|mepolizumab
392782|NCT01463644|COPD|copd
392783|NCT01463644|eosinophilic bronchitis|eosinophilic bronchitis
392784|NCT01463644|exacerbation|exacerbation
392785|NCT01463644|anti-interleukin 5 (IL5)|anti-interleukin 5 (il5)
392786|NCT01463605|radiotherapy|radiotherapy
392787|NCT01463605|targeted therapy|targeted therapy
392788|NCT01463605|esophageal cancer|esophageal cancer
392789|NCT01463605|older|older
392790|NCT01463592|Renessans|renessans
392791|NCT01463592|HCV|hcv
392792|NCT01463579|Intensive Care Unit|intensive care unit
392793|NCT01463579|Critical Illness|critical illness
392794|NCT01463579|Rehabilitation|rehabilitation
392795|NCT01463579|Exercise Programme|exercise programme
392796|NCT01463566|arthritis|arthritis
392797|NCT01463553|primary spontaneous pneumothorax|primary spontaneous pneumothorax
392798|NCT01463553|VATS|vats
392799|NCT01463553|pleurodesis|pleurodesis
392800|NCT01463553|recurrence rate|recurrence rate
392801|NCT01463540|Enteral nutrition|enteral nutrition
392802|NCT01463540|Gastrostomy, adverse effects|gastrostomy, adverse effects
392803|NCT01463540|Gastrostomy, nursing|gastrostomy, nursing
392804|NCT01463540|Endoscopy,gastrointestinal|endoscopy,gastrointestinal
392805|NCT01463540|Surgical wound infection|surgical wound infection
392806|NCT01463527|Hypoventilation during sedation|hypoventilation during sedation
392807|NCT01463527|Hypoxia associated with hypoventilation|hypoxia associated with hypoventilation
392808|NCT01463514|Pulmonary Hypertension,|pulmonary hypertension,
392809|NCT01463514|NIRS,|nirs,
392810|NCT01463514|Near-infrared spectroscopy,|near-infrared spectroscopy,
392811|NCT01463514|cerebral tissue oxygenation,|cerebral tissue oxygenation,
392812|NCT01463514|cerebral blood flow|cerebral blood flow
392813|NCT01463501|Esophageal cancer|esophageal cancer
392814|NCT01463501|Resectable|resectable
392815|NCT01463501|Neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
392816|NCT01463501|Adjuvant chemoradiotherapy|adjuvant chemoradiotherapy
392817|NCT01463475|MSC|msc
392818|NCT01463475|Allogeneic|allogeneic
392819|NCT01463475|Bone marrow cells|bone marrow cells
392820|NCT01463475|Healthy subject donors|healthy subject donors
392821|NCT01463475|Collection of MSC from bone marrow aspirate|collection of msc from bone marrow aspirate
392822|NCT01463475|Bronchiolitis obliterans syndrome (BOS)|bronchiolitis obliterans syndrome (bos)
392823|NCT01463449|Obesity|obesity
392824|NCT01463449|Soluble-CD163|soluble-cd163
392825|NCT01463449|Macrophage|macrophage
392826|NCT01463449|Inflammation|inflammation
392827|NCT01463436|endothelial function|endothelial function
392828|NCT01463436|postmenopausal|postmenopausal
392829|NCT01463436|soy isoflavone supplementation|soy isoflavone supplementation
392830|NCT01463436|osteoporosis|osteoporosis
392831|NCT01463384|Magnetic Resonance Imaging|magnetic resonance imaging
392832|NCT01463384|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
392833|NCT01463384|Neuroinflammation|neuroinflammation
392834|NCT01463384|Mild Cognitive Impairment|mild cognitive impairment
392835|NCT01463384|Alzheimer's Disease|alzheimer's disease
392836|NCT01463384|Minocycline|minocycline
392837|NCT01463371|Bronchiectasis|bronchiectasis
392838|NCT01463371|Oxidative stress markers|oxidative stress markers
392839|NCT01463371|Airway inflammation|airway inflammation
392840|NCT01463358|Syncope|syncope
392841|NCT01463358|Bifascicular block|bifascicular block
392842|NCT01463358|Bradycardia pacing|bradycardia pacing
392843|NCT01463345|Blood conservation|blood conservation
392844|NCT01463345|Transfusion|transfusion
392845|NCT01463345|Hemoglobin trigger|hemoglobin trigger
392846|NCT01463345|Transfusion trigger|transfusion trigger
392847|NCT01463345|Cardiac surgery|cardiac surgery
392848|NCT01463345|Transfusion triggers post cardiac surgery|transfusion triggers post cardiac surgery
392849|NCT01463332|Propofol|propofol
392850|NCT01463332|Pain|pain
392851|NCT01463332|Dexmedetomidine|dexmedetomidine
392852|NCT01463319|colonoscopy|colonoscopy
392853|NCT01463319|warm water method|warm water method
392854|NCT01463319|hydrocolonoscopy|hydrocolonoscopy
392855|NCT01463319|unsedated colonoscopy|unsedated colonoscopy
392856|NCT01463306|safety|safety
392857|NCT01463306|partial onset seizures|partial onset seizures
392858|NCT01463306|primary generalized tonic-clonic seizures|primary generalized tonic-clonic seizures
392859|NCT01463306|pregabalin|pregabalin
392860|NCT01463306|pediatric|pediatric
392861|NCT01463306|adult|adult
392862|NCT01463306|open-label|open-label
392863|NCT01463306|long term|long term
392864|NCT01463293|constipation|constipation
392865|NCT01463293|probiotic|probiotic
392866|NCT01463293|functional constipation|functional constipation
392867|NCT01463293|IBS-C|ibs-c
392868|NCT01463280|Platelets|platelets
392869|NCT01463280|Inhibition|inhibition
392870|NCT01463280|Lidocaine|lidocaine
392871|NCT01463280|Thromboembolism|thromboembolism
392872|NCT01463280|Prevention|prevention
392873|NCT01463280|Lidocaine effects on platelets|lidocaine effects on platelets
392874|NCT01463267|Heart Failure|heart failure
392875|NCT01463254|Femplant|femplant
392876|NCT01463254|AE adverse event|ae adverse event
392877|NCT01463254|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
392878|NCT01463254|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
392879|NCT01463254|ART antiretroviral therapy|art antiretroviral therapy
392880|NCT01463254|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
392881|NCT01463254|DCF data collection forms|dcf data collection forms
392882|NCT01463254|DMC Data Monitoring Committee|dmc data monitoring committee
392883|NCT01463254|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
392884|NCT01463254|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
392885|NCT01463254|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
392886|NCT01463254|ICH International Conference of Harmonisation|ich international conference of harmonisation
392887|NCT01463254|IND Investigational New Drug Application|ind investigational new drug application
392888|NCT01463254|IRB Institutional Review Board|irb institutional review board
392889|NCT01463254|IU international units|iu international units
392890|NCT01463254|mg milligram(s)|mg milligram(s)
392891|NCT01463254|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
392892|NCT01463254|PCR polymerase chain reaction|pcr polymerase chain reaction
392893|NCT01463254|SAE serious adverse event|sae serious adverse event
392894|NCT01463254|µg microgram|µg microgram
392895|NCT01463254|ULN upper limit of the normal range|uln upper limit of the normal range
392896|NCT01463254|WB Western Blot|wb western blot
392897|NCT01463228|Healthy Volunteers|healthy volunteers
392898|NCT01463228|Bioequivalence|bioequivalence
392899|NCT01463228|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
392900|NCT01463228|Metformin IR|metformin ir
392901|NCT01463215|Ambroxol|ambroxol
392902|NCT01463215|Type I Gaucher Disease|type i gaucher disease
392903|NCT01463202|Postpartum contraception|postpartum contraception
392904|NCT01463202|Contraceptive continuation|contraceptive continuation
392905|NCT01463202|Breastfeeding|breastfeeding
392906|NCT01463202|Postpartum depression|postpartum depression
392907|NCT01463202|Progestins|progestins
392908|NCT01463189|arthritis|arthritis
392909|NCT01463189|self management|self management
392910|NCT01463176|Music Therapy|music therapy
392911|NCT01463176|Child Psychology|child psychology
392912|NCT01463176|Vaccination|vaccination
392913|NCT01463163|Platelet reactivity|platelet reactivity
392914|NCT01463163|Ticagrelor|ticagrelor
392915|NCT01463163|Prasugrel|prasugrel
392916|NCT01463150|Platelet reactivity|platelet reactivity
392917|NCT01463150|Clopidogrel|clopidogrel
392918|NCT01463150|Prasugrel|prasugrel
392919|NCT01463137|social phobia|social phobia
392920|NCT01463137|anxiety|anxiety
392921|NCT01463124|School Nurse|school nurse
392922|NCT01463124|Overweight|overweight
392923|NCT01463124|Obesity|obesity
392924|NCT01463124|Counseling|counseling
392925|NCT01463124|Intervention|intervention
392926|NCT01463124|Exercise|exercise
392927|NCT01463111|Bipolar|bipolar
392928|NCT01463111|Manic depression|manic depression
392929|NCT01463111|Mood stabilizer|mood stabilizer
392930|NCT01463111|Decision|decision
392931|NCT01463111|Neuroeconomics|neuroeconomics
392932|NCT01463059|Rheumatoid Arthritis|rheumatoid arthritis
392933|NCT01463059|Monoclonal Antibody|monoclonal antibody
392934|NCT01463059|Interleukin-6|interleukin-6
392935|NCT01463059|Olokizumab|olokizumab
392936|NCT01463059|CDP6038|cdp6038
392937|NCT01463046|leukemia|leukemia
392938|NCT01463046|AML|aml
392939|NCT01463046|AMS|ams
392940|NCT01463046|panobinostat|panobinostat
392941|NCT01463046|cytarabine|cytarabine
392942|NCT01463046|daunorubicin|daunorubicin
392943|NCT01463046|HDAC|hdac
392944|NCT01463033|Post-Traumatic epilepsy|post-traumatic epilepsy
392945|NCT01463033|Traumatic brain injury|traumatic brain injury
392946|NCT01463033|Epilepsy prevention|epilepsy prevention
392947|NCT01463033|Levetiracetam|levetiracetam
392948|NCT01463020|Depression|depression
392949|NCT01463020|Smartphone|smartphone
392950|NCT01463020|Behavioural activation|behavioural activation
392951|NCT01463020|Mindfulness|mindfulness
392952|NCT01463007|invasive ductal cancer|invasive ductal cancer
392953|NCT01463007|tubular breast cancer|tubular breast cancer
392954|NCT01463007|breast cancer|breast cancer
392955|NCT01463007|colloid|colloid
392956|NCT01463007|ER positive|er positive
392957|NCT01463007|radiation|radiation
392958|NCT01462994|Patients with GIST treated with standard therapy harboring activating mutations of CKIT and PDGFRA|patients with gist treated with standard therapy harboring activating mutations of ckit and pdgfra
392959|NCT01462968|Heparin treatment during cardiac surgery|heparin treatment during cardiac surgery
392960|NCT01462968|Heparin reversal after cardiac surgery|heparin reversal after cardiac surgery
392961|NCT01462968|Thrombin generation|thrombin generation
392962|NCT01462968|Endogenous Thrombin potential|endogenous thrombin potential
392963|NCT01462942|COPD|copd
392964|NCT01462942|Bronchitis|bronchitis
392965|NCT01462942|Chronic|chronic
392966|NCT01462942|Emphysema|emphysema
392967|NCT01462929|COPD|copd
392968|NCT01462929|antimuscarinic|antimuscarinic
392969|NCT01462916|honey|honey
392970|NCT01462916|mucositis|mucositis
392971|NCT01462916|bee products|bee products
392972|NCT01462903|TIL|til
392973|NCT01462903|NPC|npc
392974|NCT01462903|hepatocellular carcinoma|hepatocellular carcinoma
392975|NCT01462903|immunotherapy|immunotherapy
392976|NCT01462890|Ovarian Carcinoma|ovarian carcinoma
392977|NCT01462890|Bevacizumab|bevacizumab
392978|NCT01462890|Paclitaxel|paclitaxel
392979|NCT01462890|Carboplatin|carboplatin
392980|NCT01462877|Lipid Regulating Agents|lipid regulating agents
392981|NCT01462877|Drug Therapy|drug therapy
392982|NCT01462877|cardiovascular diseases|cardiovascular diseases
392983|NCT01462877|hypertriglyceridemia|hypertriglyceridemia
392984|NCT01462877|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
392985|NCT01462877|fenofibrate|fenofibrate
392986|NCT01462877|Dyslipidemias|dyslipidemias
392987|NCT01462877|Combination|combination
392988|NCT01462864|Polycystic Ovary Syndrome|polycystic ovary syndrome
392989|NCT01462864|Lifestyle|lifestyle
392990|NCT01462864|Structured Education|structured education
392991|NCT01462864|Walking Activity|walking activity
392992|NCT01462864|Exercise|exercise
392993|NCT01462864|Overweight|overweight
392994|NCT01462864|Impaired Glucose Regulation|impaired glucose regulation
392995|NCT01462864|Diabetes Prevention|diabetes prevention
392996|NCT01462851|healthy volunteer|healthy volunteer
392997|NCT01462851|safety|safety
392998|NCT01462851|pharmacokinetic|pharmacokinetic
392999|NCT01462851|pharmacodynamic|pharmacodynamic
393000|NCT01462838|advanced HPV-|advanced hpv-
393001|NCT01462838|p16INK4a-positive|p16ink4a-positive
393002|NCT01462838|cervical|cervical
393003|NCT01462838|vulvar,|vulvar,
393004|NCT01462838|vaginal|vaginal
393005|NCT01462838|penile|penile
393006|NCT01462838|anal|anal
393007|NCT01462838|head|head
393008|NCT01462838|neck|neck
393009|NCT01462825|Inflammation|inflammation
393010|NCT01462825|cytokines|cytokines
393011|NCT01462825|chemotaxis|chemotaxis
393012|NCT01462825|tomatoes|tomatoes
393013|NCT01462825|cardiovascular disease|cardiovascular disease
393014|NCT01462812|Migraine|migraine
393015|NCT01462812|Headache|headache
393016|NCT01462812|Sumatriptan|sumatriptan
393017|NCT01462799|PBL|pbl
393018|NCT01462799|patient education|patient education
393019|NCT01462799|coronary heart disease|coronary heart disease
393020|NCT01462799|empowerment|empowerment
393021|NCT01462799|self-efficacy|self-efficacy
393022|NCT01462799|self-care|self-care
393023|NCT01462799|Focus on to determine the long term effectiveness of PBL in patient education by comparison of standardized homesent information in patients with CHD.|focus on to determine the long term effectiveness of pbl in patient education by comparison of standardized homesent information in patients with chd.
393024|NCT01462799|Further focus is on patients' self-care goals, beliefs, self-efficacy and empowerment to make lifestyle changes.|further focus is on patients' self-care goals, beliefs, self-efficacy and empowerment to make lifestyle changes.
393025|NCT01462773|malignant|malignant
393026|NCT01462773|melanoma|melanoma
393027|NCT01462708|Parkinson Disease|parkinson disease
393028|NCT01462708|Molecular NeuroImaging|molecular neuroimaging
393029|NCT01462682|focus group study|focus group study
393030|NCT01462682|sleep deprivation|sleep deprivation
393031|NCT01462682|surgery|surgery
393032|NCT01462669|Ezogabine|ezogabine
393033|NCT01462669|Pharmacokinetics|pharmacokinetics
393034|NCT01462669|Retigabine|retigabine
393035|NCT01462656|anti-epileptic drug|anti-epileptic drug
393036|NCT01462656|ezogabine|ezogabine
393037|NCT01462656|AED polytherapy|aed polytherapy
393038|NCT01462656|epilepsy|epilepsy
393039|NCT01462656|AED monotherapy|aed monotherapy
393040|NCT01462656|retigabine|retigabine
393041|NCT01462656|urinary retention|urinary retention
393042|NCT01462643|Psoriasis Plaque Test|psoriasis plaque test
393043|NCT01462643|topical|topical
393044|NCT01462643|ointment|ointment
393045|NCT01462591|wave reflection|wave reflection
393046|NCT01462591|augmentation Index|augmentation index
393047|NCT01462591|heart rate variability|heart rate variability
393048|NCT01462591|wasted left ventricular energy|wasted left ventricular energy
393049|NCT01462578|Neoplasms benign, malignant and unspecified|neoplasms benign, malignant and unspecified
393050|NCT01462578|Acute myeloid leukemia|acute myeloid leukemia
393051|NCT01462578|AML|aml
393052|NCT01462578|Myelodysplastic syndrome|myelodysplastic syndrome
393053|NCT01462578|MDS|mds
393054|NCT01462565|flolan|flolan
393055|NCT01462565|pulmonary arterial hypertension|pulmonary arterial hypertension
393056|NCT01462565|thermo stable formulation|thermo stable formulation
393057|NCT01462565|epoprostenol sodium|epoprostenol sodium
393058|NCT01462565|modified sterile diluent|modified sterile diluent
393059|NCT01462552|liver function testing|liver function testing
393060|NCT01462552|Breast cancer|breast cancer
393061|NCT01462552|lapatanib|lapatanib
393062|NCT01462513|Colon carcinoma|colon carcinoma
393063|NCT01462513|Rectum carcinoma|rectum carcinoma
393064|NCT01462513|Liver metastases|liver metastases
393065|NCT01462500|Miltefosine|miltefosine
393066|NCT01462500|pharmacokinetics|pharmacokinetics
393067|NCT01462500|cutaneous leishmaniasis|cutaneous leishmaniasis
393068|NCT01462487|Pregnancy safety|pregnancy safety
393069|NCT01462487|zanamivir|zanamivir
393070|NCT01462487|influenza|influenza
393071|NCT01462474|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
393072|NCT01462461|Phantom Limb|phantom limb
393073|NCT01462461|Amputation, Traumatic|amputation, traumatic
393074|NCT01462461|Electromyography|electromyography
393075|NCT01462461|Visual Analog Pain Scale|visual analog pain scale
393076|NCT01462448|Phantom Limb|phantom limb
393077|NCT01462448|Genetic Variation|genetic variation
393078|NCT01462448|DNA Sequence Analysis|dna sequence analysis
393079|NCT01462448|Amputation, Traumatic|amputation, traumatic
393080|NCT01462448|Single Nucleotide Polymorphism|single nucleotide polymorphism
393081|NCT01462448|Visual Analog Pain Scale|visual analog pain scale
393082|NCT01462448|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
393083|NCT01462448|Inflammatory Antibody|inflammatory antibody
393084|NCT01462448|Peripheral Nerve Damage|peripheral nerve damage
393085|NCT01462422|Postpartum hemorrhage|postpartum hemorrhage
393086|NCT01462422|Prevention|prevention
393087|NCT01462422|Misoprostol|misoprostol
393088|NCT01462422|Developing countries|developing countries
393089|NCT01462422|Nurse midwife|nurse midwife
393090|NCT01462409|obstructive sleep apnea|obstructive sleep apnea
393091|NCT01462409|humidification|humidification
393092|NCT01462409|mask|mask
393093|NCT01462409|heated tubing|heated tubing
393094|NCT01462396|Neuroblastoma|neuroblastoma
393095|NCT01462396|Relapsed|relapsed
393096|NCT01462396|Refractory|refractory
393097|NCT01462383|Advanced Cancer|advanced cancer
393098|NCT01462383|Malignancy|malignancy
393099|NCT01462383|Cardiac complications|cardiac complications
393100|NCT01462383|Electrocardiograms|electrocardiograms
393101|NCT01462383|ECG|ecg
393102|NCT01462383|Chart Review|chart review
393103|NCT01462383|Data Review|data review
393104|NCT01462383|Data Analysis|data analysis
393105|NCT01462383|Phase I|phase i
393106|NCT01462383|Clinical Research Study|clinical research study
393107|NCT01462357|Human papillomavirus|human papillomavirus
393108|NCT01462357|Safety|safety
393109|NCT01462357|HPV vaccine|hpv vaccine
393110|NCT01462357|Immune response|immune response
393111|NCT01462344|pediatric|pediatric
393112|NCT01462344|ADVAIR|advair
393113|NCT01462344|FLOVENT|flovent
393114|NCT01462344|asthma|asthma
393115|NCT01462331|Isomaltooligosaccharide|isomaltooligosaccharide
393116|NCT01462331|Human Consumption|human consumption
393117|NCT01462331|Dose tolerance|dose tolerance
393118|NCT01462331|Prebiotic|prebiotic
393119|NCT01462331|Short chain fatty acids|short chain fatty acids
393120|NCT01462331|Blood glucose|blood glucose
393121|NCT01462331|Dose tolerance and prebiotic effect|dose tolerance and prebiotic effect
393122|NCT01462318|Pre-filled syringe|pre-filled syringe
393123|NCT01462318|Pharmacokinetic|pharmacokinetic
393124|NCT01462318|Daclizumab High Yield Process|daclizumab high yield process
393125|NCT01462318|immunogenicity|immunogenicity
393126|NCT01462305|SAD|sad
393127|NCT01462305|Seasonal Affective Disorder|seasonal affective disorder
393128|NCT01462305|Winter Blues|winter blues
393129|NCT01462305|Seasonal Depression|seasonal depression
393130|NCT01462292|968|968
393131|NCT01462292|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
393132|NCT01462292|GSK2402968|gsk2402968
393133|NCT01462292|DMD|dmd
393134|NCT01462292|Duchenne|duchenne
393135|NCT01462292|GSK|gsk
393136|NCT01462279|acute respiratory failure|acute respiratory failure
393137|NCT01462279|thiamine|thiamine
393138|NCT01462279|oxygen consumption|oxygen consumption
393139|NCT01462279|VO2|vo2
393140|NCT01462253|Adult patients|adult patients
393141|NCT01462253|Refractory|refractory
393142|NCT01462253|Relapsed|relapsed
393143|NCT01462253|clofarabine|clofarabine
393144|NCT01462253|cyclophosphamide|cyclophosphamide
393145|NCT01462253|refractory and relapsed acute lymphoblastic leukemia|refractory and relapsed acute lymphoblastic leukemia
393146|NCT01462253|ALL|all
393147|NCT01462240|arthritis|arthritis
393148|NCT01462227|Hypoglycemia|hypoglycemia
393149|NCT01462227|Type 1 diabetes|type 1 diabetes
393150|NCT01462201|focused ultrasound|focused ultrasound
393151|NCT01462201|mechanical fat destruction|mechanical fat destruction
393152|NCT01462201|Body Sculpting|body sculpting
393153|NCT01462188|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
393154|NCT01462188|Primary angioplasty|primary angioplasty
393155|NCT01462188|stent|stent
393156|NCT01462136|PK study|pk study
393157|NCT01462097|Chronic kidney disease|chronic kidney disease
393158|NCT01462097|Exercise|exercise
393159|NCT01462097|Aerobic capacity|aerobic capacity
393160|NCT01462097|Learning and memory|learning and memory
393161|NCT01462097|Executive function|executive function
393162|NCT01462097|Endothelial function|endothelial function
393163|NCT01462084|sleeping|sleeping
393164|NCT01462084|opioid medications|opioid medications
393165|NCT01462084|positive airway pressure|positive airway pressure
393166|NCT01462058|SPAQ|spaq
393167|NCT01462058|Sigh-SAD|sigh-sad
393168|NCT01462058|Hamilton 29|hamilton 29
393169|NCT01462058|Vitamin D3|vitamin d3
393170|NCT01462058|p25(OH)D|p25(oh)d
393171|NCT01462045|Exercise|exercise
393172|NCT01462045|Stress|stress
393173|NCT01462045|PTSD|ptsd
393174|NCT01462045|Mindfulness|mindfulness
393175|NCT01462045|Breathing|breathing
393176|NCT01462045|Cortisol|cortisol
393177|NCT01462032|Preschool Children|preschool children
393178|NCT01462032|ADHD|adhd
393179|NCT01462032|Treatment|treatment
393180|NCT01462032|Non-pharmacological|non-pharmacological
393181|NCT01462019|nipple trauma|nipple trauma
393182|NCT01462019|breast feeding|breast feeding
393183|NCT01462019|phototherapy|phototherapy
393184|NCT01462019|wound healing|wound healing
393185|NCT01461993|vaccine|vaccine
393186|NCT01461993|rLP2086|rlp2086
393187|NCT01461993|Gardasil|gardasil
393188|NCT01461993|HPV|hpv
393189|NCT01461993|meningitis B|meningitis b
393190|NCT01461993|N. meningitidis serogroup B|n. meningitidis serogroup b
393191|NCT01461993|adolescents|adolescents
393192|NCT01461993|single-blind|single-blind
393193|NCT01461993|Meningococcal Vaccines|meningococcal vaccines
393194|NCT01461980|vaccine|vaccine
393195|NCT01461980|rLP2086|rlp2086
393196|NCT01461980|MCV4|mcv4
393197|NCT01461980|Tdap|tdap
393198|NCT01461980|meningitis B|meningitis b
393199|NCT01461980|N. meningitidis serogroup B|n. meningitidis serogroup b
393200|NCT01461980|adolescents|adolescents
393201|NCT01461980|observer-blind|observer-blind
393202|NCT01461941|Dermatitis|dermatitis
393203|NCT01461941|Atopic|atopic
393204|NCT01461915|Pancreatic Cancer|pancreatic cancer
393205|NCT01461902|traumatic brain injury|traumatic brain injury
393206|NCT01461902|brain injury|brain injury
393207|NCT01461902|head injury|head injury
393208|NCT01461902|vasospasm|vasospasm
393209|NCT01461889|transfusion-related acute lung injury|transfusion-related acute lung injury
393210|NCT01461889|Blood Component Transfusion|blood component transfusion
393211|NCT01461889|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
393212|NCT01461889|Cirrhosis|cirrhosis
393213|NCT01461889|Fresh frozen plasma|fresh frozen plasma
393214|NCT01461837|sickle cell disease|sickle cell disease
393215|NCT01461837|stem cell transplantation|stem cell transplantation
393216|NCT01461837|haploidentical|haploidentical
393217|NCT01461824|Birth Control|birth control
393218|NCT01461824|Contraceptive Methods|contraceptive methods
393219|NCT01461824|Female Contraception|female contraception
393220|NCT01461824|Weight Gain|weight gain
393221|NCT01461824|Bone Density|bone density
393222|NCT01461811|toric|toric
393223|NCT01461811|contact lenses|contact lenses
393224|NCT01461811|daily disposable contact lenses|daily disposable contact lenses
393225|NCT01461811|astigmatism|astigmatism
393226|NCT01461811|soft contact lenses|soft contact lenses
393227|NCT01461811|contact lens comfort|contact lens comfort
393228|NCT01461798|plant stanols|plant stanols
393229|NCT01461798|lipids|lipids
393230|NCT01461798|cardiovascular disease|cardiovascular disease
393231|NCT01461785|Platelet rich plasma|platelet rich plasma
393232|NCT01461785|Dermal improvement|dermal improvement
393233|NCT01461785|Graft survival|graft survival
393234|NCT01461733|atrial fibrillation|atrial fibrillation
393235|NCT01461733|amiodarone|amiodarone
393236|NCT01461720|Bone marrow|bone marrow
393237|NCT01461720|Autologous|autologous
393238|NCT01461720|Mesenchymal stem cells|mesenchymal stem cells
393239|NCT01461720|Unilateral middle cerebral artery infarct|unilateral middle cerebral artery infarct
393240|NCT01461707|Cellular phone|cellular phone
393241|NCT01461707|exercise|exercise
393242|NCT01461707|pregnant women|pregnant women
393243|NCT01461707|obesity|obesity
393244|NCT01461707|overweight|overweight
393245|NCT01461707|physical activity|physical activity
393246|NCT01461694|Hirsutism|hirsutism
393247|NCT01461694|Laser|laser
393248|NCT01461694|Hair Reduction|hair reduction
393249|NCT01461694|IPL|ipl
393250|NCT01461694|Intense Pulsed Light|intense pulsed light
393251|NCT01461681|Palliative care|palliative care
393252|NCT01461681|Symptom management|symptom management
393253|NCT01461681|Heart failure|heart failure
393254|NCT01461668|MRSA|mrsa
393255|NCT01461668|MRSA resistant to mupirocin|mrsa resistant to mupirocin
393256|NCT01461642|Asthma|asthma
393257|NCT01461642|ICT Support|ict support
393258|NCT01461642|ACT|act
393259|NCT01461642|PEF|pef
393260|NCT01461629|cognitive impairment|cognitive impairment
393261|NCT01461629|cognitive function|cognitive function
393262|NCT01461629|hospitalization|hospitalization
393263|NCT01461629|self-management|self-management
393264|NCT01461629|cardiac disease|cardiac disease
393265|NCT01461629|heart failure|heart failure
393266|NCT01461616|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
393267|NCT01461603|critical illness|critical illness
393268|NCT01461603|protein metabolism|protein metabolism
393269|NCT01461603|pharmaconutrients|pharmaconutrients
393270|NCT01461564|screening|screening
393271|NCT01461564|colonoscopy|colonoscopy
393272|NCT01461564|carbon dioxide|carbon dioxide
393273|NCT01461564|air|air
393274|NCT01461564|pain score|pain score
393275|NCT01461564|complications|complications
393276|NCT01461551|troponin I|troponin i
393277|NCT01461551|creatine kinase mb|creatine kinase mb
393278|NCT01461551|hospital days|hospital days
393279|NCT01461551|lymphocyte apoptosis|lymphocyte apoptosis
393280|NCT01461551|intensive care unit days|intensive care unit days
393281|NCT01461538|Acute Lymphoid Leukemia|acute lymphoid leukemia
393282|NCT01461538|Myelodysplastic Syndrome|myelodysplastic syndrome
393283|NCT01461538|Acute Myeloid Leukemia|acute myeloid leukemia
393284|NCT01461538|Solid Tumors|solid tumors
393285|NCT01461538|Anemia, Refractory, with Excess of Blasts|anemia, refractory, with excess of blasts
393286|NCT01461538|Antibodies, Monoclonal|antibodies, monoclonal
393287|NCT01461538|Antibody-Drug Conjugate|antibody-drug conjugate
393288|NCT01461538|Antigens, CD30|antigens, cd30
393289|NCT01461538|Drug Therapy|drug therapy
393290|NCT01461538|Hematologic Diseases|hematologic diseases
393291|NCT01461538|Immunotherapy|immunotherapy
393292|NCT01461538|Monomethyl Auristatin E|monomethyl auristatin e
393994|NCT01458717|recurrence|recurrence
393293|NCT01461525|Low Rectal Cancer|low rectal cancer
393294|NCT01461525|Sphincter preservation|sphincter preservation
393295|NCT01461525|Abdominoperineal resection|abdominoperineal resection
393296|NCT01461525|Quality of life|quality of life
393297|NCT01461525|Sexual function|sexual function
393298|NCT01461525|Urinary function|urinary function
393299|NCT01461525|Oncologic outcome|oncologic outcome
393300|NCT01461499|Hypertension|hypertension
393301|NCT01461499|Albuminuria|albuminuria
393302|NCT01461499|Direct renin inhibitor|direct renin inhibitor
393303|NCT01461499|Angiotensin receptor blocker|angiotensin receptor blocker
393304|NCT01461499|Type 2 diabetes|type 2 diabetes
393305|NCT01461486|Continuous positive airway pressure|continuous positive airway pressure
393306|NCT01461486|Oral appliance|oral appliance
393307|NCT01461486|mild Obstructive Sleep Apnea Syndrome|mild obstructive sleep apnea syndrome
393308|NCT01461473|Obstructive Sleep Apnea|obstructive sleep apnea
393309|NCT01461473|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
393310|NCT01461473|Sleep Apnea Syndrome, Obstructive|sleep apnea syndrome, obstructive
393311|NCT01461473|Syndrome, Obstructive Sleep Apnea|syndrome, obstructive sleep apnea
393312|NCT01461473|Syndrome, Sleep Apnea, Obstructive|syndrome, sleep apnea, obstructive
393313|NCT01461473|Syndrome, Upper Airway Resistance, Sleep Apnea|syndrome, upper airway resistance, sleep apnea
393314|NCT01461473|Upper Airway Resistance Sleep Apnea Syndrome|upper airway resistance sleep apnea syndrome
393315|NCT01461460|volunteer|volunteer
393316|NCT01461434|atrial fibrillation|atrial fibrillation
393317|NCT01461434|biomarkers|biomarkers
393318|NCT01461434|stroke prevention|stroke prevention
393319|NCT01461434|implantable loop recorder|implantable loop recorder
393320|NCT01461421|Obesity|obesity
393321|NCT01461421|Primary Care|primary care
393322|NCT01461421|Behavior Modification|behavior modification
393323|NCT01461408|HPV Vaccination|hpv vaccination
393324|NCT01461408|Beauty Salons|beauty salons
393325|NCT01461408|Health Education|health education
393326|NCT01461408|Sexual Health|sexual health
393327|NCT01461395|IVF|ivf
393328|NCT01461343|pulmonary hypertension, PET imaging, CT/PET|pulmonary hypertension, pet imaging, ct/pet
393329|NCT01461330|diabetes|diabetes
393330|NCT01461330|exercise|exercise
393331|NCT01461330|DASH diet|dash diet
393332|NCT01461330|ABPM|abpm
393333|NCT01461304|fatty acid oxidation|fatty acid oxidation
393334|NCT01461304|triheptanoin|triheptanoin
393335|NCT01461304|long-chain fatty acid oxidation disorders|long-chain fatty acid oxidation disorders
393336|NCT01461304|LCHADD|lchadd
393337|NCT01461304|VLCADD|vlcadd
393338|NCT01461304|CPT1|cpt1
393339|NCT01461304|CPT2|cpt2
393340|NCT01461304|TFP|tfp
393341|NCT01461304|Glycogen Storage Disorders|glycogen storage disorders
393342|NCT01461304|GSD|gsd
393343|NCT01461304|Pyruvate Carboxylase|pyruvate carboxylase
393344|NCT01461304|PC|pc
393345|NCT01461304|ACAD9|acad9
393346|NCT01461304|Barth|barth
393347|NCT01461291|Primary open-angle glaucoma|primary open-angle glaucoma
393348|NCT01461291|POAG|poag
393349|NCT01461291|Trabecular meshwork|trabecular meshwork
393350|NCT01461291|iStent inject|istent inject
393351|NCT01461278|Primary open-angle glaucoma|primary open-angle glaucoma
393352|NCT01461278|POAG|poag
393353|NCT01461278|Cataract surgery|cataract surgery
393354|NCT01461278|Suprachoroidal space|suprachoroidal space
393355|NCT01461278|Suprachoroidal stent|suprachoroidal stent
393356|NCT01461278|iStent supra|istent supra
393357|NCT01461265|Painful bone metastases|painful bone metastases
393358|NCT01461265|Bone metastases|bone metastases
393359|NCT01461265|Metastatic bone tumors|metastatic bone tumors
393360|NCT01461265|Metastatic bone pain|metastatic bone pain
393361|NCT01461265|Cryoablation|cryoablation
393362|NCT01461265|Cryotherapy|cryotherapy
393363|NCT01461265|Cryosurgery|cryosurgery
393364|NCT01461252|Painful bone metastases|painful bone metastases
393365|NCT01461252|Bone metastases|bone metastases
393366|NCT01461252|Metastatic bone tumors|metastatic bone tumors
393367|NCT01461252|Metastatic bone pain|metastatic bone pain
393368|NCT01461252|Cryoablation|cryoablation
393369|NCT01461252|Cryotherapy|cryotherapy
393370|NCT01461252|Cryosurgery|cryosurgery
393371|NCT01461252|Radiation therapy|radiation therapy
393372|NCT01461252|Radiotherapy|radiotherapy
393373|NCT01461239|survival|survival
393374|NCT01461239|debonding|debonding
393375|NCT01461239|endodontic treated teeth|endodontic treated teeth
393376|NCT01461226|overweight|overweight
393377|NCT01461226|cardiovascular risk factors|cardiovascular risk factors
393378|NCT01461226|exercise training|exercise training
393379|NCT01461226|endothelial function|endothelial function
393380|NCT01461226|endothelium|endothelium
393381|NCT01461226|endothelial progenitor cells|endothelial progenitor cells
393382|NCT01461213|Tapetoretinal degeneration, choroideraemia, X-linked|tapetoretinal degeneration, choroideraemia, x-linked
393383|NCT01461213|retinitis pigmentosa|retinitis pigmentosa
393384|NCT01461187|Exercise|exercise
393385|NCT01461187|Pregnancy|pregnancy
393386|NCT01461187|Childbirth|childbirth
393387|NCT01461187|Vaginal|vaginal
393388|NCT01461187|Cesarean section|cesarean section
393389|NCT01461174|Sleep deprivation|sleep deprivation
393390|NCT01461174|Cognitive Functions|cognitive functions
393391|NCT01461174|young male|young male
393392|NCT01461148|UICC stage III/IV MSI-H colorectal cancer|uicc stage iii/iv msi-h colorectal cancer
393393|NCT01461109|Parkinson Disease|parkinson disease
393394|NCT01461109|Alzheimer Disease|alzheimer disease
393395|NCT01461109|[18F] CFPyPB|[18f] cfpypb
393396|NCT01461109|GlyT1|glyt1
393397|NCT01461083|Parkinson Disease|parkinson disease
393398|NCT01461083|[18F]MPPF|[18f]mppf
393399|NCT01461070|Breast Cancer|breast cancer
393400|NCT01461070|Post Menopausal Estrogens|post menopausal estrogens
393401|NCT01461070|Fecal Microbes|fecal microbes
393402|NCT01461031|pain|pain
393403|NCT01461031|orthognathic|orthognathic
393404|NCT01461018|Immune globulin subcutaneous|immune globulin subcutaneous
393405|NCT01461018|SCIG|scig
393406|NCT01461018|Primary immunodeficiency|primary immunodeficiency
393407|NCT01461018|PID|pid
393408|NCT01461005|Spondylolisthesis|spondylolisthesis
393409|NCT01461005|Neurologic impairment|neurologic impairment
393410|NCT01461005|Kyphosis|kyphosis
393411|NCT01461005|Pseudarthrosis|pseudarthrosis
393412|NCT01460992|Pacemaker therapy|pacemaker therapy
393413|NCT01460992|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
393414|NCT01460992|EVIA/ENTOVIS|evia/entovis
393415|NCT01460979|Ovarian Cancer|ovarian cancer
393416|NCT01460979|Endometrial Carcinoma|endometrial carcinoma
393417|NCT01460979|Temsirolimus|temsirolimus
393418|NCT01460966|Distal protection device|distal protection device
393419|NCT01460966|Thrombus aspiration|thrombus aspiration
393420|NCT01460966|Coronary Artery Disease|coronary artery disease
393421|NCT01460966|Coronary Disease|coronary disease
393422|NCT01460966|Acute Coronary Syndrome|acute coronary syndrome
393423|NCT01460953|curriculum|curriculum
393424|NCT01460953|training|training
393425|NCT01460953|Medical student Knowledge|medical student knowledge
393426|NCT01460940|refractory Hodgkin's lymphoma|refractory hodgkin's lymphoma
393427|NCT01460940|panobinostat|panobinostat
393428|NCT01460940|lenalidomide|lenalidomide
393429|NCT01460914|ECP|ecp
393430|NCT01460914|CTCL|ctcl
393431|NCT01460914|Extracorporeal photopheresis|extracorporeal photopheresis
393432|NCT01460914|Cutaneous T Cell Lymphoma|cutaneous t cell lymphoma
393433|NCT01460914|GVHD|gvhd
393434|NCT01460914|Graft versus host disease|graft versus host disease
393435|NCT01460901|Neuroblastoma|neuroblastoma
393436|NCT01460901|Relapsed|relapsed
393437|NCT01460901|Refractory|refractory
393438|NCT01460875|high risk melanoma|high risk melanoma
393439|NCT01460875|lymph node disease|lymph node disease
393440|NCT01460862|Asthma|asthma
393441|NCT01460862|Omalizumab|omalizumab
393442|NCT01460849|Cystic fibrosis|cystic fibrosis
393443|NCT01460836|Cystic fibrosis|cystic fibrosis
393444|NCT01460823|Hearing loss|hearing loss
393445|NCT01460823|Cochlear Implantation|cochlear implantation
393446|NCT01460823|Image guided surgery|image guided surgery
393447|NCT01460797|Glycemic index|glycemic index
393448|NCT01460797|Caloric restriction|caloric restriction
393449|NCT01460797|Energy intake|energy intake
393450|NCT01460797|Glucose|glucose
393451|NCT01460797|Lipid Metabolism|lipid metabolism
393452|NCT01460797|Cholesterol|cholesterol
393453|NCT01460797|HDL Cholesterol|hdl cholesterol
393454|NCT01460797|LDL Cholesterol|ldl cholesterol
393455|NCT01460797|Obesity|obesity
393456|NCT01460797|Metformin|metformin
393457|NCT01460784|Metabolic dysfunction|metabolic dysfunction
393458|NCT01460784|Insulin resistance|insulin resistance
393459|NCT01460784|Brown adipose tissue|brown adipose tissue
393460|NCT01460784|Dyslipidemia|dyslipidemia
393461|NCT01460771|childhood dystonia|childhood dystonia
393462|NCT01460758|Depression|depression
393463|NCT01460758|Transcranial magnetic stimulation|transcranial magnetic stimulation
393464|NCT01460758|rTMS|rtms
393465|NCT01460758|DLPFC|dlpfc
393466|NCT01460758|medial frontal cortex|medial frontal cortex
393467|NCT01460758|anterior cingulate complex|anterior cingulate complex
393468|NCT01460745|Erbitux|erbitux
393469|NCT01460745|CRC|crc
393470|NCT01460745|mCRC|mcrc
393471|NCT01460745|Liver|liver
393472|NCT01460745|Metastases|metastases
393473|NCT01460732|Hypertension|hypertension
393474|NCT01460732|Nocturnal BP dipping|nocturnal bp dipping
393475|NCT01460732|Home Blood pressure Monitoring|home blood pressure monitoring
393476|NCT01460732|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
393477|NCT01460706|Glioma|glioma
393478|NCT01460706|68Ga-DOTATOC|68ga-dotatoc
393479|NCT01460706|PET/CT|pet/ct
393480|NCT01460706|Somatostatin receptor|somatostatin receptor
393481|NCT01460693|Leukemia|leukemia
393482|NCT01460693|Myeloid|myeloid
393483|NCT01460693|Chronic|chronic
393484|NCT01460693|Chronic-Phase|chronic-phase
393485|NCT01460693|CML|cml
393486|NCT01460680|Fibromyalgia|fibromyalgia
393487|NCT01460680|Systemic Lupus Erythematosus|systemic lupus erythematosus
393488|NCT01460680|Omega-3 Fatty acids|omega-3 fatty acids
393489|NCT01460680|Magnesium|magnesium
393490|NCT01460667|Laparoscopic Roux-en-Y Gastric Bypass|laparoscopic roux-en-y gastric bypass
393491|NCT01460667|Post-Operative Pain|post-operative pain
393492|NCT01460667|IV Acetaminophen|iv acetaminophen
393493|NCT01460667|Post-Operative Nausea and Vomiting|post-operative nausea and vomiting
393494|NCT01460628|fatigue|fatigue
393495|NCT01460628|menopausal symptoms|menopausal symptoms
393496|NCT01460628|hot flashes|hot flashes
393497|NCT01460628|Vasomotor symptoms|vasomotor symptoms
393498|NCT01460628|perimenopause|perimenopause
393499|NCT01460628|related Quality of life|related quality of life
393500|NCT01460615|Postoperative pancreatitis|postoperative pancreatitis
393501|NCT01460615|Postoperative complications|postoperative complications
393502|NCT01460615|Delayed gastric emptying|delayed gastric emptying
393503|NCT01460615|Leakage|leakage
393504|NCT01460615|Fistula|fistula
393505|NCT01460615|Acinar cell|acinar cell
393506|NCT01460615|Risk patient|risk patient
393507|NCT01460615|Pancreaticoduodenectomy|pancreaticoduodenectomy
393508|NCT01460615|Whipple|whipple
393509|NCT01460615|Cortisone|cortisone
393510|NCT01460602|Lymphoma|lymphoma
393511|NCT01460602|Follicular|follicular
393512|NCT01460602|Marginal Zone|marginal zone
393513|NCT01460602|Mantle Cell|mantle cell
393514|NCT01460602|Velcade|velcade
393515|NCT01460602|bortezomib|bortezomib
393516|NCT01460602|Nipent|nipent
393517|NCT01460602|pentastatin|pentastatin
393518|NCT01460602|Rituxan|rituxan
393519|NCT01460602|rituximab|rituximab
393520|NCT01460602|Turturro|turturro
393521|NCT01460602|Shreveport|shreveport
393522|NCT01460589|colon cancer|colon cancer
393523|NCT01460589|Chemotherapy|chemotherapy
393524|NCT01460589|adjuvant|adjuvant
393525|NCT01460576|prematurity|prematurity
393526|NCT01460576|respiratory disease|respiratory disease
393527|NCT01460576|bronchopulmonary dysplasia|bronchopulmonary dysplasia
393528|NCT01460563|craniotomy|craniotomy
393529|NCT01460563|sodium valproate|sodium valproate
393530|NCT01460563|rocuronium|rocuronium
393531|NCT01460550|delayed gastric emptying(DGE)|delayed gastric emptying(dge)
393532|NCT01460550|pancreaticoduodenectomy(PD)|pancreaticoduodenectomy(pd)
393533|NCT01460550|randomized controlled trial(RCT)|randomized controlled trial(rct)
393534|NCT01460550|gastro- or duodeno- jejunostomy reconstruction|gastro- or duodeno- jejunostomy reconstruction
393535|NCT01460550|morbidity|morbidity
393536|NCT01460537|phase I|phase i
393537|NCT01460537|phosphatidylinositol-3 kinase inhibitor|phosphatidylinositol-3 kinase inhibitor
393538|NCT01460537|gemcitabine|gemcitabine
393539|NCT01460537|cisplatin|cisplatin
393540|NCT01460537|maximum tolerated dose|maximum tolerated dose
393541|NCT01460524|bronchiolitis|bronchiolitis
393542|NCT01460524|saline|saline
393543|NCT01460524|nebulization|nebulization
393544|NCT01460524|hypertonic|hypertonic
393545|NCT01460511|Mild bronchial asthma|mild bronchial asthma
393546|NCT01460498|Leukemia|leukemia
393547|NCT01460498|Chronic Myeloid Leukemia|chronic myeloid leukemia
393548|NCT01460498|CML|cml
393549|NCT01460498|Complete cytogenetic remission|complete cytogenetic remission
393550|NCT01460498|CCyR|ccyr
393551|NCT01460498|Minimal residual disease|minimal residual disease
393552|NCT01460498|Philadelphia chromosome (Ph)-|philadelphia chromosome (ph)-
393553|NCT01460498|BCR/ABL-positive|bcr/abl-positive
393554|NCT01460498|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
393555|NCT01460498|TKI|tki
393556|NCT01460498|Azacitidine|azacitidine
393557|NCT01460498|5-Azacytidine|5-azacytidine
393558|NCT01460498|5-AZA|5-aza
393559|NCT01460498|Vidaza|vidaza
393560|NCT01460498|5-AZC|5-azc
393561|NCT01460498|AZA-CR|aza-cr
393562|NCT01460498|Ladakamycin|ladakamycin
393563|NCT01460498|NSC-102816|nsc-102816
393564|NCT01460472|NSCLC|nsclc
393565|NCT01460472|Lung cancer, small-cell|lung cancer, small-cell
393566|NCT01460472|advanced lung cancer|advanced lung cancer
393567|NCT01460472|therapeutic vaccine|therapeutic vaccine
393568|NCT01460472|anti-idiotypic vaccine|anti-idiotypic vaccine
393569|NCT01460472|1E10|1e10
393570|NCT01460459|diabetes|diabetes
393571|NCT01460459|self-monitoring of blood glucose|self-monitoring of blood glucose
393572|NCT01460459|frequency|frequency
393573|NCT01460433|HIV 1|hiv 1
393574|NCT01460433|Herpes Simplex Type 2|herpes simplex type 2
393575|NCT01460433|Treatment experienced|treatment experienced
393576|NCT01460420|Allogeneic transplantation|allogeneic transplantation
393577|NCT01460420|Hematologic malignancies|hematologic malignancies
393578|NCT01460420|Multiple myeloma|multiple myeloma
393579|NCT01460420|RIC (Reduced Intensity Conditioning)|ric (reduced intensity conditioning)
393580|NCT01460394|Healthy|healthy
393581|NCT01460394|Control|control
393582|NCT01460355|strabismus surgery|strabismus surgery
393583|NCT01460355|botulinum toxin|botulinum toxin
393584|NCT01460355|esotropia|esotropia
393585|NCT01460355|exotropia|exotropia
393586|NCT01460355|blepharoptosis|blepharoptosis
393587|NCT01460342|Prostatic hyperplasia|prostatic hyperplasia
393588|NCT01460342|Benign prostatic hyperplasia|benign prostatic hyperplasia
393589|NCT01460342|Lower urinary tract|lower urinary tract
393590|NCT01460329|intensive care units|intensive care units
393591|NCT01460329|pediatric|pediatric
393592|NCT01460329|cardiac index|cardiac index
393593|NCT01460329|Doppler Ultrasonography|doppler ultrasonography
394201|NCT01457768|Registry|registry
393594|NCT01460316|Conotruncal cardiac defects|conotruncal cardiac defects
393595|NCT01460316|methylation|methylation
393596|NCT01460316|genotype|genotype
393597|NCT01460316|cobalamin|cobalamin
393598|NCT01460316|folates|folates
393599|NCT01460316|nutrition|nutrition
393600|NCT01460303|Transurethral catheterization|transurethral catheterization
393601|NCT01460303|Urinary retention|urinary retention
393602|NCT01460303|Bladder dysfunction|bladder dysfunction
393603|NCT01460303|Patient comfort|patient comfort
393604|NCT01460303|Pelvic Reconstructive Surgery|pelvic reconstructive surgery
393605|NCT01460303|Postoperative bladder dysfunction|postoperative bladder dysfunction
393606|NCT01460303|Postoperative urinary retention|postoperative urinary retention
393607|NCT01460277|hemiplegic|hemiplegic
393608|NCT01460277|balance|balance
393609|NCT01460277|hydrotherapy|hydrotherapy
393610|NCT01460264|Prospective Cohort Study|prospective cohort study
393611|NCT01460264|Respiratory Function Tests|respiratory function tests
393612|NCT01460264|Computed Tomography|computed tomography
393613|NCT01460264|Electrocardiography|electrocardiography
393614|NCT01460264|Peripheral Arterial Disease|peripheral arterial disease
393615|NCT01460251|type 1 diabetes|type 1 diabetes
393616|NCT01460251|beta cell|beta cell
393617|NCT01460251|immunomodulation|immunomodulation
393618|NCT01460251|immunointervention|immunointervention
393619|NCT01460238|Lipoprotein Lipase|lipoprotein lipase
393620|NCT01460238|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
393621|NCT01460238|CLL|cll
393622|NCT01460225|constipation|constipation
393623|NCT01460225|chronic idiopathic constipation|chronic idiopathic constipation
393624|NCT01460225|no prior history of surgery to the colon|no prior history of surgery to the colon
393625|NCT01460225|not on any type of medication that could alter gastrointestinal motility or transit|not on any type of medication that could alter gastrointestinal motility or transit
393626|NCT01460212|Cognitive-Behavior Therapy|cognitive-behavior therapy
393627|NCT01460212|Magnetic Resonance Imaging|magnetic resonance imaging
393628|NCT01460212|major depressive disorder|major depressive disorder
393629|NCT01460186|Germ line polymorphisms|germ line polymorphisms
393630|NCT01460173|alertness test|alertness test
393631|NCT01460173|sleepiness|sleepiness
393632|NCT01460173|vigilance|vigilance
393633|NCT01460173|Sleep Apnea, Obstructive|sleep apnea, obstructive
393634|NCT01460147|Hemophilia|hemophilia
393635|NCT01460134|CD27 expressing Hematologic Malignancies|cd27 expressing hematologic malignancies
393636|NCT01460134|CD27 expressing Solid Tumors|cd27 expressing solid tumors
393637|NCT01460134|chronic lymphocytic leukemia|chronic lymphocytic leukemia
393638|NCT01460134|Burkett's lymphoma|burkett's lymphoma
393639|NCT01460134|mantle cell lymphoma|mantle cell lymphoma
393640|NCT01460134|primary lymphoma of the central nervous system|primary lymphoma of the central nervous system
393641|NCT01460134|marginal zone B cell lymphoma|marginal zone b cell lymphoma
393642|NCT01460134|solid tumor|solid tumor
393643|NCT01460134|metastatic melanoma|metastatic melanoma
393644|NCT01460134|renal (clear) cell carcinoma|renal (clear) cell carcinoma
393645|NCT01460134|hormone-refractory prostate adenocarcinoma|hormone-refractory prostate adenocarcinoma
393646|NCT01460134|ovarian cancer|ovarian cancer
393647|NCT01460134|colorectal adenocarcinoma|colorectal adenocarcinoma
393648|NCT01460134|non-small cell lung cancer|non-small cell lung cancer
393649|NCT01460121|Phobic Postural Vertigo|phobic postural vertigo
393650|NCT01460121|Visual Vertigo|visual vertigo
393651|NCT01460121|Chronic Subjective Dizziness|chronic subjective dizziness
393652|NCT01460121|Motion and Space Discomfort|motion and space discomfort
393653|NCT01460121|SpotOn|spoton
393654|NCT01460108|PLVR|plvr
393655|NCT01460108|AeriSeal|aeriseal
393656|NCT01460108|Treatment|treatment
393657|NCT01460108|Device|device
393658|NCT01460108|Breathing|breathing
393659|NCT01460108|COPD|copd
393660|NCT01460108|emphysema|emphysema
393661|NCT01460108|polymeric lung volume reduction|polymeric lung volume reduction
393662|NCT01460108|heterogeneous|heterogeneous
393663|NCT01460108|homogeneous|homogeneous
393664|NCT01460108|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
393665|NCT01460095|diabetes|diabetes
393666|NCT01460095|translational research|translational research
393667|NCT01460095|HbA1c|hba1c
393668|NCT01460095|education|education
393669|NCT01460082|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
393670|NCT01460082|acute exacerbation|acute exacerbation
393671|NCT01460082|endothelial dysfunction|endothelial dysfunction
393672|NCT01460082|flow mediated dilation|flow mediated dilation
393673|NCT01460082|systemic inflammation|systemic inflammation
393674|NCT01460069|psoriasis|psoriasis
393675|NCT01460069|liraglutide|liraglutide
393676|NCT01460069|morbidity|morbidity
393677|NCT01460069|PASI|pasi
393678|NCT01460069|DLQI|dlqi
393679|NCT01460056|peritoneal dialysis|peritoneal dialysis
393680|NCT01460056|endotoxin-associated sterile peritonitis|endotoxin-associated sterile peritonitis
393681|NCT01460030|Hypercalcemia in patients with parathyroid carcinoma or intractable PHPT|hypercalcemia in patients with parathyroid carcinoma or intractable phpt
393682|NCT01460004|patellar tendinopathy|patellar tendinopathy
393683|NCT01460004|jumper's knee|jumper's knee
393684|NCT01459991|walnut|walnut
393685|NCT01459991|mediterranean|mediterranean
393686|NCT01459978|CUmulative SUM (CUSUM)|cumulative sum (cusum)
393687|NCT01459978|quality indicators|quality indicators
393688|NCT01459978|obstetrics|obstetrics
393689|NCT01459965|Jaundice|jaundice
393690|NCT01459965|Biliary stents|biliary stents
393691|NCT01459965|Palliation|palliation
393692|NCT01459965|Quality of Life|quality of life
393693|NCT01459965|Endoscopic Retrograde Cholangiography|endoscopic retrograde cholangiography
393694|NCT01459952|occurences of flu|occurences of flu
393695|NCT01459952|occurences of common cold|occurences of common cold
393696|NCT01459939|Osteoarthritis|osteoarthritis
393697|NCT01459926|Opioid induced constipation|opioid induced constipation
393698|NCT01459926|OIC|oic
393699|NCT01459926|Constipation|constipation
393700|NCT01459926|Opioid side effects|opioid side effects
393701|NCT01459926|Morphine induced constipation|morphine induced constipation
393702|NCT01459926|Opioid therapy|opioid therapy
393703|NCT01459913|VX-950|vx-950
393704|NCT01459913|INCIVEK|incivek
393705|NCT01459913|INCIVO|incivo
393706|NCT01459900|Treatment Resistant Hypertension|treatment resistant hypertension
393707|NCT01459887|untreated, CD20-positive|untreated, cd20-positive
393708|NCT01459874|Home Monitoring|home monitoring
393709|NCT01459874|Remote monitoring|remote monitoring
393710|NCT01459874|Telecardiology|telecardiology
393711|NCT01459874|Organizational model|organizational model
393712|NCT01459874|Patient indicated for pacemaker, ICD, CRT-P, or CRT-D|patient indicated for pacemaker, icd, crt-p, or crt-d
393713|NCT01459861|early ambulation|early ambulation
393714|NCT01459861|knee arthroplasty|knee arthroplasty
393715|NCT01459848|Salivary cortisol measured after DVD watching or block play|salivary cortisol measured after dvd watching or block play
393716|NCT01459835|TV|tv
393717|NCT01459835|Violence|violence
393718|NCT01459835|DVDs|dvds
393719|NCT01459835|Behavior|behavior
393720|NCT01459835|Preschool children|preschool children
393721|NCT01459822|sepsis|sepsis
393722|NCT01459822|miRNA|mirna
393723|NCT01459783|Caregivers|caregivers
393724|NCT01459783|Comparative Effectiveness Research|comparative effectiveness research
393725|NCT01459783|Cost Effectiveness|cost effectiveness
393726|NCT01459783|Patient Care Management|patient care management
393727|NCT01459783|Social Work|social work
393728|NCT01459770|glomerular filtration rate|glomerular filtration rate
393729|NCT01459770|albuminuria|albuminuria
393730|NCT01459770|medical therapy|medical therapy
393731|NCT01459770|hospital discharge|hospital discharge
393732|NCT01459770|hospital readmission|hospital readmission
393733|NCT01459770|CKD complications|ckd complications
393734|NCT01459770|CKD risk factors|ckd risk factors
393735|NCT01459757|Retrospective|retrospective
393736|NCT01459757|GIST|gist
393737|NCT01459757|sunitinib|sunitinib
393738|NCT01459757|mutational|mutational
393739|NCT01459744|Heart failure|heart failure
393740|NCT01459744|Palliative care|palliative care
393741|NCT01459744|Communication|communication
393742|NCT01459718|Severe cardiac iron overload|severe cardiac iron overload
393743|NCT01459718|deferasirox|deferasirox
393744|NCT01459718|β-thalassaemia|β-thalassaemia
393745|NCT01459718|cardiac dysfunction|cardiac dysfunction
393746|NCT01459705|Combat Disorders|combat disorders
393747|NCT01459705|Exposure Therapy|exposure therapy
393748|NCT01459705|Army Personnel|army personnel
393749|NCT01459692|Seizures|seizures
393750|NCT01459692|Epilepsy|epilepsy
393751|NCT01459692|Auditory Stimulation|auditory stimulation
393752|NCT01459692|Music|music
393753|NCT01459666|Scar|scar
393754|NCT01459666|Forehead|forehead
393755|NCT01459666|Skin Cancer|skin cancer
393756|NCT01459666|MOHS Surgery|mohs surgery
393757|NCT01459666|Dermatology|dermatology
393758|NCT01459653|Febrile neutropenia|febrile neutropenia
393759|NCT01459653|cancer|cancer
393760|NCT01459653|chemotherapy,|chemotherapy,
393761|NCT01459653|primary prophylaxis|primary prophylaxis
393762|NCT01459653|secondary prophylaxis|secondary prophylaxis
393763|NCT01459653|filgrastim|filgrastim
393764|NCT01459653|granulocyte colony stimulating factor|granulocyte colony stimulating factor
393765|NCT01459653|observational study|observational study
393766|NCT01459653|noninterventional study|noninterventional study
393767|NCT01459640|Osteoarthritis|osteoarthritis
393768|NCT01459640|Bone marrow|bone marrow
393769|NCT01459640|Mesenchymal stem cells|mesenchymal stem cells
393770|NCT01459640|Autologous|autologous
393771|NCT01459640|Mild osteoarthritis|mild osteoarthritis
393772|NCT01459640|Moderate osteoarthritis|moderate osteoarthritis
393773|NCT01459627|DAPT- Dual Antiplatelet Therapy|dapt- dual antiplatelet therapy
393774|NCT01459627|STEMI|stemi
393775|NCT01459601|diabetes mellitus|diabetes mellitus
393776|NCT01459601|FBS|fbs
393777|NCT01459601|HbA1C|hba1c
393778|NCT01459601|Cabergoline|cabergoline
393779|NCT01459575|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
393780|NCT01459575|antiretroviral therapy|antiretroviral therapy
393781|NCT01459575|China|china
393782|NCT01459549|hepatolithiasis|hepatolithiasis
393783|NCT01459549|sphincter of oddi laxity|sphincter of oddi laxity
393784|NCT01459549|choledochojejunostomy|choledochojejunostomy
393785|NCT01459536|Aging|aging
393786|NCT01459523|Peripheral Nerve Block|peripheral nerve block
393787|NCT01459523|Perineural Catheter|perineural catheter
393788|NCT01459523|Orthopedic Surgery|orthopedic surgery
393789|NCT01459523|Ultrasound|ultrasound
393790|NCT01459510|Violence prevention|violence prevention
393791|NCT01459510|Parenting|parenting
393792|NCT01459510|Discipline|discipline
393793|NCT01459497|non-small cell lung cancer|non-small cell lung cancer
393794|NCT01459497|Stages II or III non-small cell lung cancer|stages ii or iii non-small cell lung cancer
393795|NCT01459484|Non metastatic extremities high grade osteosarcoma|non metastatic extremities high grade osteosarcoma
393796|NCT01459458|intimate partner violence|intimate partner violence
393797|NCT01459458|gender-based violence|gender-based violence
393798|NCT01459458|domestic violence|domestic violence
393799|NCT01459458|unintended pregnancy|unintended pregnancy
393800|NCT01459445|ethinylestradiol 30µg-drospirenone|ethinylestradiol 30µg-drospirenone
393801|NCT01459445|flow-mediated dilatation|flow-mediated dilatation
393802|NCT01459445|endothelial dysfunction|endothelial dysfunction
393803|NCT01459445|hsCRP|hscrp
393804|NCT01459445|metformin|metformin
393805|NCT01459445|polycystic ovary syndrome|polycystic ovary syndrome
393806|NCT01459406|Gastrointestinal physiology|gastrointestinal physiology
393807|NCT01459406|Gastrointestinal response to sugars|gastrointestinal response to sugars
393808|NCT01459406|MRI|mri
393809|NCT01459406|gastrointestinal|gastrointestinal
393810|NCT01459406|stomach|stomach
393811|NCT01459406|small bowel|small bowel
393812|NCT01459406|colon|colon
393813|NCT01459406|glucose|glucose
393814|NCT01459406|fructose|fructose
393815|NCT01459406|fructan|fructan
393816|NCT01459406|FODMAP|fodmap
393817|NCT01459393|Actinic keratosis|actinic keratosis
393818|NCT01459393|Photodynamic therapy|photodynamic therapy
393819|NCT01459393|5-aminolevulinic acid|5-aminolevulinic acid
393820|NCT01459393|Cryotherapy|cryotherapy
393821|NCT01459367|Drug Therapy|drug therapy
393822|NCT01459341|CLI Critical limb ischemia|cli critical limb ischemia
393823|NCT01459341|PVD peripheral vascular disease|pvd peripheral vascular disease
393824|NCT01459341|NIRS near infrared spectroscopy|nirs near infrared spectroscopy
393825|NCT01459341|TCPO2 - transcutaneous oxygen pressure|tcpo2 - transcutaneous oxygen pressure
393826|NCT01459328|rectal carcinoma|rectal carcinoma
393827|NCT01459328|long course chemo-radiation|long course chemo-radiation
393828|NCT01459328|short course chemo-rdiation|short course chemo-rdiation
393829|NCT01459328|Locally Advanced Rectal Carcinoma|locally advanced rectal carcinoma
393830|NCT01459315|Healthy|healthy
393831|NCT01459315|Male|male
393832|NCT01459315|GSK1349572|gsk1349572
393833|NCT01459315|Dolutegravir|dolutegravir
393834|NCT01459315|DTG|dtg
393835|NCT01459315|Integrase|integrase
393836|NCT01459315|HIV|hiv
393837|NCT01459302|FALS|fals
393838|NCT01459302|ALS|als
393839|NCT01459302|SALS|sals
393840|NCT01459302|MND|mnd
393841|NCT01459302|SOD1|sod1
393842|NCT01459302|ALS GENES|als genes
393843|NCT01459302|PLS|pls
393844|NCT01459302|PMA|pma
393845|NCT01459302|ALS/FTD|als/ftd
393846|NCT01459302|FAMILIAL ALS|familial als
393847|NCT01459302|SPORADIC ALS|sporadic als
393848|NCT01459302|GENETICS|genetics
393849|NCT01459302|FTD|ftd
393850|NCT01459302|Miyoshi myopathy|miyoshi myopathy
393851|NCT01459276|seasonal|seasonal
393852|NCT01459276|prevention|prevention
393853|NCT01459276|influenza|influenza
393854|NCT01459276|infection|infection
393855|NCT01459276|influenza vaccine|influenza vaccine
393856|NCT01459276|vaccine|vaccine
393857|NCT01459276|influenza in humans|influenza in humans
393858|NCT01459263|GSV|gsv
393859|NCT01459263|insufficiency|insufficiency
393860|NCT01459263|ClariVein device|clarivein device
393861|NCT01459263|safety|safety
393862|NCT01459263|efficacy|efficacy
393863|NCT01459263|QOL|qol
393864|NCT01459250|AGO178C,|ago178c,
393865|NCT01459250|renal impairment,|renal impairment,
393866|NCT01459250|ESRD,|esrd,
393867|NCT01459250|pharmacokinetics|pharmacokinetics
393868|NCT01459237|Cushing's Disease|cushing's disease
393869|NCT01459237|Microadenoma|microadenoma
393870|NCT01459237|PET Imaging|pet imaging
393871|NCT01459237|Cushing Disease Tumor|cushing disease tumor
393872|NCT01459237|Pituitary Tumors|pituitary tumors
393873|NCT01459211|CLL|cll
393874|NCT01459185|Non-small cell lung cancer|non-small cell lung cancer
393875|NCT01459185|Adjuvant chemotherapy|adjuvant chemotherapy
393876|NCT01459185|oral fluoropyrimidine|oral fluoropyrimidine
393877|NCT01459185|S-1|s-1
393878|NCT01459185|Feasibility study|feasibility study
393879|NCT01459185|Surgery|surgery
393880|NCT01459172|breast cancer prevention|breast cancer prevention
393881|NCT01459159|Hematology|hematology
393882|NCT01459159|MDS|mds
393883|NCT01459159|Myelodysplastic Syndrome|myelodysplastic syndrome
393884|NCT01459159|Low risk MDS|low risk mds
393885|NCT01459159|Int-1 risk MDS|int-1 risk mds
393886|NCT01459159|Transfusion dependence|transfusion dependence
393887|NCT01459159|Telintra|telintra
393888|NCT01459159|ezatiostat|ezatiostat
393889|NCT01459159|ezatiostat hydrochloride|ezatiostat hydrochloride
393890|NCT01459159|TLK199|tlk199
393891|NCT01459159|Glutathione|glutathione
393892|NCT01459159|Glutathione analog|glutathione analog
393893|NCT01459159|Glutathione Transferase|glutathione transferase
393894|NCT01459159|Glutathione Transferase P1-1 inhibitor|glutathione transferase p1-1 inhibitor
393895|NCT01459159|GST P1-1 inhibitor|gst p1-1 inhibitor
393896|NCT01459159|Apoptosis|apoptosis
393897|NCT01459159|Differentiation|differentiation
393898|NCT01459159|Enzyme inhibitor|enzyme inhibitor
393899|NCT01459159|non-del (5q)|non-del (5q)
393900|NCT01459159|non-deletion 5q|non-deletion 5q
393901|NCT01459146|IPT|ipt
393902|NCT01459146|malaria|malaria
393903|NCT01459146|ACT|act
393904|NCT01459146|schistosomiasis|schistosomiasis
393905|NCT01459146|Hemoglobin|hemoglobin
393906|NCT01459146|Anemia|anemia
393907|NCT01459146|Sustained attention|sustained attention
393908|NCT01459146|Recall|recall
393909|NCT01459146|Schoolchildren|schoolchildren
393910|NCT01459146|Kassena-Nankana|kassena-nankana
393911|NCT01459133|investigational|investigational
393912|NCT01459133|inhaled insulin product|inhaled insulin product
393913|NCT01459120|Home-based HIV-testing|home-based hiv-testing
393914|NCT01459120|Voluntary Counseling and Testing|voluntary counseling and testing
393915|NCT01459120|Community based testing|community based testing
393916|NCT01459120|HIV/AIDS|hiv/aids
393917|NCT01459120|Lesotho|lesotho
393918|NCT01459107|Hand Transplant|hand transplant
393919|NCT01459107|Composite Tissue Allotransplantation (CTA)|composite tissue allotransplantation (cta)
393920|NCT01459107|Vascularized Composite Allotransplantation (VCA)|vascularized composite allotransplantation (vca)
393921|NCT01459107|Composite Tissue|composite tissue
393922|NCT01459107|Amputation|amputation
393923|NCT01459107|Upper limb|upper limb
393924|NCT01459107|Immunosuppression|immunosuppression
393925|NCT01459094|Healthy Volunteers|healthy volunteers
393926|NCT01459094|Oral bioavailability|oral bioavailability
393927|NCT01459094|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
393928|NCT01459094|Metformin IR|metformin ir
393929|NCT01459029|Schizophrenia|schizophrenia
393930|NCT01459029|NMDA receptor|nmda receptor
393931|NCT01459029|D-serine|d-serine
393932|NCT01459029|Recent onset|recent onset
393933|NCT01459029|Negative symptoms|negative symptoms
393934|NCT01459029|Cognition|cognition
393935|NCT01459016|Mild Cognitive Impairment|mild cognitive impairment
393936|NCT01459016|Brain Imaging Biomarkers|brain imaging biomarkers
393937|NCT01459016|Magnetic resonance imaging biomarker|magnetic resonance imaging biomarker
393938|NCT01459016|Positron Emission Tomography|positron emission tomography
393939|NCT01458977|Lípid-lowering effect|lípid-lowering effect
393940|NCT01458977|Tenofovir|tenofovir
393941|NCT01458977|Dyslipidemia|dyslipidemia
393942|NCT01458964|Fibromyalgia|fibromyalgia
393943|NCT01458951|Tofacitinib|tofacitinib
393944|NCT01458951|CP-690|cp-690
393945|NCT01458951|550|550
393946|NCT01458951|Moderate to severe ulcerative colitis|moderate to severe ulcerative colitis
393947|NCT01458951|phase 3 clinical trial|phase 3 clinical trial
393948|NCT01458951|Mayo score|mayo score
393949|NCT01458925|Colorectal cancer|colorectal cancer
393950|NCT01458925|Colonic polyps|colonic polyps
393951|NCT01458899|Phase 1|phase 1
393952|NCT01458899|healthy male|healthy male
393953|NCT01458899|nonpregnant female|nonpregnant female
393954|NCT01458899|volunteers|volunteers
393955|NCT01458899|pharmacokinetics|pharmacokinetics
393956|NCT01458899|TC 5214|tc 5214
393957|NCT01458899|The effect of food on the pharmacokinetics of TC-5214|the effect of food on the pharmacokinetics of tc-5214
393958|NCT01458873|infiltration|infiltration
393959|NCT01458873|extravasation|extravasation
393960|NCT01458847|bladder cancer|bladder cancer
393961|NCT01458847|cis-urocanic acid|cis-urocanic acid
393962|NCT01458847|primary|primary
393963|NCT01458847|recurrent|recurrent
393964|NCT01458847|non-muscle|non-muscle
393965|NCT01458834|Smoking|smoking
393966|NCT01458834|Attentional bias|attentional bias
393967|NCT01458834|Craving|craving
393968|NCT01458821|Tinnitus|tinnitus
393969|NCT01458808|salt|salt
393970|NCT01458808|inflammation|inflammation
393971|NCT01458808|hypervolemia|hypervolemia
393972|NCT01458808|diet|diet
393973|NCT01458782|Cartilage repair|cartilage repair
393974|NCT01458782|Chondrocytes|chondrocytes
393975|NCT01458782|Stemcells|stemcells
393976|NCT01458756|liver transplant patients|liver transplant patients
393977|NCT01458756|hepatic transplantation|hepatic transplantation
393978|NCT01458743|pharmacokinetics|pharmacokinetics
393979|NCT01458730|PCNSL|pcnsl
393980|NCT01458730|Immunochemotherapy|immunochemotherapy
393981|NCT01458730|Intraspinal Depocyt|intraspinal depocyt
393982|NCT01458730|Maintenance temozolomide|maintenance temozolomide
393983|NCT01458717|pancreas|pancreas
393984|NCT01458717|cancer|cancer
393985|NCT01458717|borderline resectable|borderline resectable
393986|NCT01458717|locally advanced|locally advanced
393987|NCT01458717|resectability|resectability
393988|NCT01458717|chemotherapy|chemotherapy
393989|NCT01458717|radiation|radiation
393990|NCT01458717|chemoradiation|chemoradiation
393991|NCT01458717|neoadjuvant|neoadjuvant
393992|NCT01458717|survival|survival
393993|NCT01458717|prognosis|prognosis
393995|NCT01458717|response rate|response rate
393996|NCT01458652|AST-120|ast-120
393997|NCT01458652|HDF|hdf
393998|NCT01458652|Replacement Volume described above|replacement volume described above
393999|NCT01458639|Pulmonary embolism|pulmonary embolism
394000|NCT01458639|PE|pe
394001|NCT01458626|mirtazapine|mirtazapine
394002|NCT01458626|paroxetine|paroxetine
394003|NCT01458626|major depression|major depression
394004|NCT01458626|early improvement|early improvement
394005|NCT01458613|Mucopolysaccharidoses|mucopolysaccharidoses
394006|NCT01458613|Mucopolysaccharidosis VI|mucopolysaccharidosis vi
394007|NCT01458613|Metabolism, Inborn Errors|metabolism, inborn errors
394008|NCT01458613|Genetic Diseases, Inborn|genetic diseases, inborn
394009|NCT01458613|Mucinoses|mucinoses
394010|NCT01458613|Connective Tissue Diseases|connective tissue diseases
394011|NCT01458613|Metabolic Diseases|metabolic diseases
394012|NCT01458600|ophthalmopathy|ophthalmopathy
394013|NCT01458600|prevention|prevention
394014|NCT01458600|diclofenac|diclofenac
394015|NCT01458587|Actinic keratosis|actinic keratosis
394016|NCT01458574|Janus kinase inhibitor|janus kinase inhibitor
394017|NCT01458574|JAK 3 inhibitor|jak 3 inhibitor
394018|NCT01458574|inflammatory bowel disease|inflammatory bowel disease
394019|NCT01458574|ulcerative colitis|ulcerative colitis
394020|NCT01458574|OCTAVE|octave
394021|NCT01458574|CP-690|cp-690
394022|NCT01458574|550|550
394023|NCT01458574|tofacitinib|tofacitinib
394024|NCT01458574|Xeljanz|xeljanz
394025|NCT01458561|Hemostatic agent|hemostatic agent
394026|NCT01458561|Liver surgery|liver surgery
394027|NCT01458561|Hemostasis|hemostasis
394028|NCT01458548|1st-line therapy|1st-line therapy
394029|NCT01458548|single agent rituximab|single agent rituximab
394030|NCT01458548|CHOP|chop
394031|NCT01458548|PTLD|ptld
394032|NCT01458535|Genotype 1|genotype 1
394033|NCT01458535|Genotype 2|genotype 2
394034|NCT01458535|Genotype 3|genotype 3
394035|NCT01458535|Hepatitis C Virus|hepatitis c virus
394036|NCT01458535|ABT-450/r|abt-450/r
394037|NCT01458535|Ribavirin|ribavirin
394038|NCT01458535|ABT-267|abt-267
394039|NCT01458535|Ombitasvir|ombitasvir
394040|NCT01458535|Paritaprevir|paritaprevir
394041|NCT01458522|Nonconvulsive Seizures|nonconvulsive seizures
394042|NCT01458509|Quality of Life|quality of life
394043|NCT01458509|patient outcomes|patient outcomes
394044|NCT01458509|questionaires|questionaires
394045|NCT01458509|11-101|11-101
394046|NCT01458470|huntington|huntington
394047|NCT01458470|huntingtin|huntingtin
394048|NCT01458470|memantine|memantine
394049|NCT01458470|ebixa|ebixa
394050|NCT01458470|namenda|namenda
394051|NCT01458444|Respiratory Insufficiency|respiratory insufficiency
394052|NCT01458444|Cardiothoracic Surgery|cardiothoracic surgery
394053|NCT01458444|Ventilation system|ventilation system
394054|NCT01458431|cesarean section|cesarean section
394055|NCT01458431|wound infusion|wound infusion
394056|NCT01458431|Local anesthetic levobupivacaine|local anesthetic levobupivacaine
394057|NCT01458431|Pain management|pain management
394058|NCT01458418|Eosinophil|eosinophil
394059|NCT01458418|Esophagitis|esophagitis
394060|NCT01458405|Myocardial Infarction|myocardial infarction
394061|NCT01458405|Heart Attack|heart attack
394062|NCT01458405|Stem cell|stem cell
394063|NCT01458405|Left ventricular dysfunction|left ventricular dysfunction
394064|NCT01458405|Congestive heart failure|congestive heart failure
394065|NCT01458366|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
394066|NCT01458366|Lymphoma|lymphoma
394067|NCT01458366|B-Cell Lymphoma|b-cell lymphoma
394068|NCT01458353|Right-sided colon cancer|right-sided colon cancer
394069|NCT01458353|Ileocolonic anastomosis|ileocolonic anastomosis
394070|NCT01458353|stapled anastomosis|stapled anastomosis
394071|NCT01458353|handsewn anastomosis|handsewn anastomosis
394072|NCT01458353|peritoneal contamination|peritoneal contamination
394073|NCT01458353|microbiological spectrum|microbiological spectrum
394074|NCT01458340|Adult ADHD|adult adhd
394075|NCT01458340|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
394076|NCT01458327|MDMA|mdma
394077|NCT01458327|PTSD|ptsd
394078|NCT01458327|psychotherapy|psychotherapy
394079|NCT01458314|Physical exercise|physical exercise
394080|NCT01458314|Rehabilitation|rehabilitation
394081|NCT01458314|NIV|niv
394082|NCT01458301|Drug Therapy|drug therapy
394083|NCT01458275|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
394084|NCT01458275|Ciclesonide|ciclesonide
394085|NCT01458275|Ciclesonide Nasal Aerosol|ciclesonide nasal aerosol
394086|NCT01458262|cerebral oxymetry|cerebral oxymetry
394087|NCT01458262|systemic oxymetry|systemic oxymetry
394088|NCT01458262|hepatic surgery|hepatic surgery
394089|NCT01458262|liver transplantation|liver transplantation
394090|NCT01458249|Soft Tissue Sarcoma|soft tissue sarcoma
394091|NCT01458223|spine surgery|spine surgery
394092|NCT01458223|postoperative infection|postoperative infection
394093|NCT01458223|postoperative antibiotics|postoperative antibiotics
394094|NCT01458197|Overactive Bladder|overactive bladder
394095|NCT01458197|Tarafenacin|tarafenacin
394096|NCT01458184|risk factors for complications|risk factors for complications
394097|NCT01458184|precarious medical situations|precarious medical situations
394098|NCT01458171|Immune globulin subcutaneous|immune globulin subcutaneous
394099|NCT01458171|SCIG|scig
394100|NCT01458171|Primary immunodeficiency|primary immunodeficiency
394101|NCT01458171|PID|pid
394102|NCT01458158|Gelatinases|gelatinases
394103|NCT01458158|kidney disease|kidney disease
394104|NCT01458158|diabetes mellitus type 2|diabetes mellitus type 2
394105|NCT01458132|subject follow-up|subject follow-up
394106|NCT01458132|HIV infection|hiv infection
394107|NCT01458132|registry|registry
394108|NCT01458132|seizures|seizures
394109|NCT01458132|GSK2248761|gsk2248761
394110|NCT01458119|Fabry disease|fabry disease
394111|NCT01458119|Lysosomal storage disease|lysosomal storage disease
394112|NCT01458119|migalastat HCl|migalastat hcl
394113|NCT01458119|AT1001|at1001
394114|NCT01458080|ENABLE|enable
394115|NCT01458080|invasive procedures|invasive procedures
394116|NCT01458080|Thrombocytopenia|thrombocytopenia
394117|NCT01458080|Thromboembolic events|thromboembolic events
394118|NCT01458080|Eltrombopag|eltrombopag
394119|NCT01458080|Hepatitis C|hepatitis c
394120|NCT01458080|HCV|hcv
394121|NCT01458054|pharmacokinetics|pharmacokinetics
394122|NCT01458054|omeprazole|omeprazole
394123|NCT01458054|ritonavir|ritonavir
394124|NCT01458054|healthy subjects|healthy subjects
394125|NCT01458054|drug interaction|drug interaction
394126|NCT01458041|Critical limb ischaemia|critical limb ischaemia
394127|NCT01458041|Iloprost|iloprost
394128|NCT01458041|Quality of life|quality of life
394129|NCT01458041|Visual analogue scale|visual analogue scale
394130|NCT01458028|BAY85-3934|bay85-3934
394131|NCT01458028|pharmacokinetics|pharmacokinetics
394132|NCT01458028|age|age
394133|NCT01458028|gender|gender
394134|NCT01458015|QST|qst
394135|NCT01458015|neuropathic pain|neuropathic pain
394136|NCT01458015|tapentadol pr|tapentadol pr
394137|NCT01458015|oxycodone|oxycodone
394138|NCT01457989|retention rate|retention rate
394139|NCT01457989|epilepsy|epilepsy
394140|NCT01457989|responder rate|responder rate
394141|NCT01457989|seizure freedom|seizure freedom
394142|NCT01457989|discontinuation rate|discontinuation rate
394143|NCT01457989|safety assessment|safety assessment
394144|NCT01457989|reduction in seizure frequency|reduction in seizure frequency
394145|NCT01457989|open-label|open-label
394146|NCT01457976|cancer|cancer
394147|NCT01457976|obesity|obesity
394148|NCT01457976|personal responsibility|personal responsibility
394149|NCT01457950|denosumab|denosumab
394150|NCT01457950|Republic of Korea|republic of korea
394151|NCT01457950|dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
394152|NCT01457937|HCV|hcv
394153|NCT01457937|Menopause|menopause
394154|NCT01457937|Peg IFN|peg ifn
394155|NCT01457937|Ribavirin|ribavirin
394156|NCT01457937|Boceprevir|boceprevir
394157|NCT01457924|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
394158|NCT01457924|Ofatumumab|ofatumumab
394159|NCT01457898|Cardiac surgery|cardiac surgery
394160|NCT01457898|Non-invasive ventilation|non-invasive ventilation
394161|NCT01457885|AML|aml
394162|NCT01457872|Heroin addiction|heroin addiction
394163|NCT01457872|Substance use disorders|substance use disorders
394164|NCT01457872|Substitution treatment|substitution treatment
394165|NCT01457872|Syringe exchange|syringe exchange
394166|NCT01457846|gastro-oesophageal junction cancer|gastro-oesophageal junction cancer
394167|NCT01457846|gastric cancer|gastric cancer
394168|NCT01457846|lower third oesophageal cancer|lower third oesophageal cancer
394169|NCT01457846|polysomy|polysomy
394170|NCT01457846|amplification|amplification
394171|NCT01457846|FGFR|fgfr
394172|NCT01457820|Allopurinol|allopurinol
394173|NCT01457820|Angina|angina
394174|NCT01457820|Acute coronary syndrome|acute coronary syndrome
394175|NCT01457807|Phase 1|phase 1
394176|NCT01457807|Parkinson's disease|parkinson's disease
394177|NCT01457807|pharmacodynamic|pharmacodynamic
394178|NCT01457807|biomarkers|biomarkers
394179|NCT01457807|pharmacokinetics|pharmacokinetics
394180|NCT01457807|extended release formulation|extended release formulation
394181|NCT01457794|Metabolic Syndrome X|metabolic syndrome x
394182|NCT01457794|Fatty Acids, Omega-3|fatty acids, omega-3
394183|NCT01457794|Learning|learning
394184|NCT01457794|Attention|attention
394185|NCT01457794|Nutritional Status|nutritional status
394186|NCT01457794|Nutrition Assessments|nutrition assessments
394187|NCT01457794|Body Weight|body weight
394188|NCT01457794|Physical Activity|physical activity
394189|NCT01457794|Sleep|sleep
394190|NCT01457794|Child Nutrition Sciences|child nutrition sciences
394191|NCT01457781|Inhaled nitric oxide|inhaled nitric oxide
394192|NCT01457781|pulmonary arterial hypertension|pulmonary arterial hypertension
394193|NCT01457781|pulmonary hypertension|pulmonary hypertension
394194|NCT01457781|PAH|pah
394195|NCT01457768|Hepatitis C|hepatitis c
394196|NCT01457768|HCV|hcv
394197|NCT01457768|Sustained Virologic Response|sustained virologic response
394198|NCT01457768|Direct Acting Antiviral|direct acting antiviral
394199|NCT01457768|Combination Therapy|combination therapy
394200|NCT01457768|Tegobuvir|tegobuvir
394202|NCT01457768|HCV RNA|hcv rna
394203|NCT01457768|Treatment experienced|treatment experienced
394204|NCT01457768|Treatment naive|treatment naive
394205|NCT01457768|GS 9451|gs 9451
394206|NCT01457768|GS 5885|gs 5885
394207|NCT01457768|Sequence|sequence
394208|NCT01457768|GS 5816|gs 5816
394209|NCT01457768|GS 7977|gs 7977
394210|NCT01457768|Sofosbuvir|sofosbuvir
394211|NCT01457768|Sovaldi™|sovaldi™
394213|NCT01457768|Ledipasvir|ledipasvir
394214|NCT01457768|LDV|ldv
394215|NCT01457755|Hepatitis C|hepatitis c
394216|NCT01457755|HCV|hcv
394217|NCT01457755|Sustained Virologic Response|sustained virologic response
394218|NCT01457755|Direct Acting Antiviral|direct acting antiviral
394219|NCT01457755|Combination Therapy|combination therapy
394220|NCT01457755|Tegobuvir|tegobuvir
394221|NCT01457755|Registry|registry
394222|NCT01457755|HCV RNA|hcv rna
394223|NCT01457755|Treatment experienced|treatment experienced
394224|NCT01457755|Treatment naive|treatment naive
394225|NCT01457755|GS 9451|gs 9451
394226|NCT01457755|GS 5885|gs 5885
394227|NCT01457755|GS 7977|gs 7977
394228|NCT01457755|GS 5816|gs 5816
394229|NCT01457755|Sofosbuvir|sofosbuvir
394230|NCT01457755|Sovaldi™|sovaldi™
394231|NCT01457755|SOF|sof
394232|NCT01457755|Ledipasvir|ledipasvir
394233|NCT01457755|LDV|ldv
394234|NCT01457742|Osteoarthritis|osteoarthritis
394235|NCT01457729|ergometer|ergometer
394236|NCT01457729|training|training
394237|NCT01457729|motivation|motivation
394238|NCT01457729|telemonitoring|telemonitoring
394239|NCT01457729|sleep apnea|sleep apnea
394240|NCT01457716|Healthy volunteer study|healthy volunteer study
394241|NCT01457703|LH pulsatility|lh pulsatility
394242|NCT01457703|Obesity|obesity
394243|NCT01457703|Reproduction|reproduction
394244|NCT01457690|Vitamin E pegylated|vitamin e pegylated
394245|NCT01457690|chylomicron retention|chylomicron retention
394246|NCT01457690|Familial Hypocholesterolemia|familial hypocholesterolemia
394247|NCT01457690|Hypobetalipoproteinemias|hypobetalipoproteinemias
394248|NCT01457651|Recruitment|recruitment
394249|NCT01457651|Coronary artery bypass grafting|coronary artery bypass grafting
394250|NCT01457651|Postoperative period|postoperative period
394251|NCT01457638|nasal obstruction|nasal obstruction
394252|NCT01457638|rhinoplasty|rhinoplasty
394253|NCT01457638|turbinate surgery|turbinate surgery
394254|NCT01457638|quality of life|quality of life
394255|NCT01457638|acoustic rhinometry|acoustic rhinometry
394256|NCT01457625|fetuin A liver fat content visceral obesity mortality|fetuin a liver fat content visceral obesity mortality
394257|NCT01457612|Insulin Resistant|insulin resistant
394258|NCT01457612|Dietary Supplements|dietary supplements
394259|NCT01457612|Nutrition|nutrition
394260|NCT01457612|Antioxidant|antioxidant
394261|NCT01457612|Inflammation|inflammation
394262|NCT01457599|liver-colorectal metastases-computertomography-guided-wire-chemotherapy-complete response|liver-colorectal metastases-computertomography-guided-wire-chemotherapy-complete response
394263|NCT01457599|Feasibility, safety|feasibility, safety
394264|NCT01457586|Heart Surgery|heart surgery
394265|NCT01457586|Blood Transfusion|blood transfusion
394266|NCT01457586|Postoperative Complications|postoperative complications
394267|NCT01457560|Oral polio vaccine (OPV)|oral polio vaccine (opv)
394268|NCT01457560|DTPa-HBV-IPV/Hib vaccine|dtpa-hbv-ipv/hib vaccine
394269|NCT01457547|HEXAVACTM|hexavactm
394270|NCT01457547|InfanrixTM HEXA|infanrixtm hexa
394271|NCT01457547|DTPa-HBV-IPV-Hib|dtpa-hbv-ipv-hib
394272|NCT01457547|DTPa-HBV-IPV/Hib|dtpa-hbv-ipv/hib
394273|NCT01457521|pain|pain
394274|NCT01457521|medical abortion|medical abortion
394275|NCT01457508|combination vaccine|combination vaccine
394276|NCT01457508|DTPa-HBV-IPV|dtpa-hbv-ipv
394277|NCT01457508|Hib|hib
394278|NCT01457495|Infants|infants
394279|NCT01457495|combined vaccine|combined vaccine
394280|NCT01457495|DTPa-HBV-IPV/Hib|dtpa-hbv-ipv/hib
394281|NCT01457495|DTPa-IPV/Hib|dtpa-ipv/hib
394282|NCT01457495|safety|safety
394283|NCT01457495|Immunogenicity|immunogenicity
394284|NCT01457495|HBV|hbv
394285|NCT01457482|Fear|fear
394286|NCT01457482|Childbirth|childbirth
394287|NCT01457482|Art therapy|art therapy
394288|NCT01457482|Therapeutic conversations|therapeutic conversations
394289|NCT01457482|W-DEQ|w-deq
394290|NCT01457456|Mucopolysaccharidoses|mucopolysaccharidoses
394291|NCT01457456|Mucopolysaccharidosis IV|mucopolysaccharidosis iv
394292|NCT01457456|Carbohydrate Metabolism, Inborn Errors|carbohydrate metabolism, inborn errors
394293|NCT01457456|Metabolism, Inborn Errors|metabolism, inborn errors
394294|NCT01457456|Genetic Diseases, Inborn|genetic diseases, inborn
394295|NCT01457456|Lysosomal Storage Diseases|lysosomal storage diseases
394296|NCT01457456|Connective Tissue Diseases|connective tissue diseases
394297|NCT01457456|Metabolic Diseases|metabolic diseases
394298|NCT01457456|Musculoskeletal Diseases|musculoskeletal diseases
394299|NCT01457443|Glycogen Storage Disease|glycogen storage disease
394300|NCT01457443|Glycogen Storage Disease Type II|glycogen storage disease type ii
394301|NCT01457443|Metabolic Diseases|metabolic diseases
394302|NCT01457443|Carbohydrate Metabolism, Inborn Errors|carbohydrate metabolism, inborn errors
394303|NCT01457443|Metabolism, Inborn Errors|metabolism, inborn errors
394304|NCT01457443|Genetic Diseases, Inborn|genetic diseases, inborn
394305|NCT01457443|Lysosomal Storage Diseases, Nervous System|lysosomal storage diseases, nervous system
394306|NCT01457417|Cancer|cancer
394307|NCT01457417|Oncology|oncology
394308|NCT01457404|integrated cognitive behavioral therapy|integrated cognitive behavioral therapy
394309|NCT01457404|cognitive behavioral therapy|cognitive behavioral therapy
394310|NCT01457404|addiction|addiction
394311|NCT01457404|posttraumatic stress disorder (PTSD)|posttraumatic stress disorder (ptsd)
394312|NCT01457391|cognitive behavioral therapy|cognitive behavioral therapy
394313|NCT01457391|addiction|addiction
394314|NCT01457391|posttraumatic stress disorder (PTSD)|posttraumatic stress disorder (ptsd)
394315|NCT01457378|Gastrointestinal symptoms|gastrointestinal symptoms
394316|NCT01457378|healthy subjects|healthy subjects
394317|NCT01457378|IBS|ibs
394318|NCT01457378|HRQoL|hrqol
394319|NCT01457378|questionnaires|questionnaires
394320|NCT01457352|Baclofen, spasticity|baclofen, spasticity
394321|NCT01457339|Schizophrenia|schizophrenia
394322|NCT01457326|Immersion therapy|immersion therapy
394323|NCT01457326|early weight bearing physical therapy|early weight bearing physical therapy
394324|NCT01457300|Rehabilitation outcome|rehabilitation outcome
394325|NCT01457300|Aged|aged
394326|NCT01457300|Aged, 80 and over|aged, 80 and over
394327|NCT01457300|Activities of daily living|activities of daily living
394328|NCT01457274|AMBULATORY CARE|ambulatory care
394329|NCT01457274|AWARENESS AND RECALL|awareness and recall
394330|NCT01457274|Propofol|propofol
394331|NCT01457274|Patient Safety and Satisfaction|patient safety and satisfaction
394332|NCT01457274|Colonoscopy|colonoscopy
394333|NCT01457274|Elective outpatient colonoscopy|elective outpatient colonoscopy
394334|NCT01457274|Procedural sedation|procedural sedation
394335|NCT01457261|interstitial lung disease|interstitial lung disease
394336|NCT01457261|drug deposition|drug deposition
394337|NCT01457261|lung imaging|lung imaging
394338|NCT01457261|respiratory|respiratory
394339|NCT01457248|after aortic surgery|after aortic surgery
394340|NCT01457235|Bipolar disorder|bipolar disorder
394341|NCT01457235|Cognitive Remediation|cognitive remediation
394342|NCT01457235|Cognition|cognition
394343|NCT01457235|Cognitive function|cognitive function
394344|NCT01457235|Mood disorders|mood disorders
394345|NCT01457235|Affective disorders|affective disorders
394346|NCT01457222|Mindfulness|mindfulness
394347|NCT01457222|Stress|stress
394348|NCT01457222|Cognition|cognition
394349|NCT01457222|Psychological health|psychological health
394350|NCT01457222|Primary prevention|primary prevention
394351|NCT01457209|PCOS|pcos
394352|NCT01457209|Insulin resistance|insulin resistance
394353|NCT01457209|Acupuncture|acupuncture
394354|NCT01457196|Cancer Genetics|cancer genetics
394355|NCT01457183|pulsed lavage|pulsed lavage
394356|NCT01457183|evaluate containment|evaluate containment
394357|NCT01457183|evaluate tolerability|evaluate tolerability
394358|NCT01457170|Pulmonary Hypertension|pulmonary hypertension
394359|NCT01457170|Heart Failure|heart failure
394360|NCT01457170|Apelin|apelin
394361|NCT01457170|Haemodynamics|haemodynamics
394362|NCT01457170|pulmonary vascular resistance|pulmonary vascular resistance
394363|NCT01457170|cardiac output|cardiac output
394364|NCT01457144|Mantle cell lymphoma|mantle cell lymphoma
394365|NCT01457144|Rituximab|rituximab
394366|NCT01457144|bendamustine|bendamustine
394367|NCT01457144|Velcade|velcade
394368|NCT01457144|Dexamethasone|dexamethasone
394369|NCT01457131|Metastatic Cancer|metastatic cancer
394370|NCT01457131|Immunotherapy|immunotherapy
394371|NCT01457131|Gene Therapy|gene therapy
394372|NCT01457131|Metastatic Melanoma|metastatic melanoma
394373|NCT01457131|Metastatic Kidney Cancer|metastatic kidney cancer
394374|NCT01457118|Open Label multicenter extension study advanced solid tumors|open label multicenter extension study advanced solid tumors
394375|NCT01457105|Malignant strictures of the main biliary duct|malignant strictures of the main biliary duct
394376|NCT01457092|benign biliary strictures|benign biliary strictures
394377|NCT01457092|chronic pancreatitis|chronic pancreatitis
394378|NCT01457079|Keloid|keloid
394379|NCT01457079|Radiation Therapy|radiation therapy
394380|NCT01457079|Hypertrophic Scar|hypertrophic scar
394381|NCT01457053|Acute decompensated heart failure|acute decompensated heart failure
394382|NCT01457053|Myocardial blood flow|myocardial blood flow
394383|NCT01457053|Coronary flow reserve|coronary flow reserve
394384|NCT01457053|Ultrafiltration|ultrafiltration
394385|NCT01457053|Diuretics|diuretics
394386|NCT01457040|Acute Lymphoblastic leukemia|acute lymphoblastic leukemia
394387|NCT01457040|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
394388|NCT01457027|Influenza|influenza
394389|NCT01457027|Virus|virus
394390|NCT01457027|Vaccination|vaccination
394391|NCT01457027|Immunisation|immunisation
394392|NCT01457014|chronic pain|chronic pain
394393|NCT01457014|sleep disordered breathing|sleep disordered breathing
394394|NCT01457014|Opioids|opioids
394395|NCT01457001|chronic haemodialysis|chronic haemodialysis
394396|NCT01457001|25-OH-D vitamin|25-oh-d vitamin
394397|NCT01456975|Ascending aorta aneurism|ascending aorta aneurism
394398|NCT01456975|Aortic insufficiency|aortic insufficiency
394399|NCT01456962|Immune reconstitution|immune reconstitution
394400|NCT01456962|CD4+ T cells|cd4+ t cells
394401|NCT01456949|Atrial fibrillation (AF)|atrial fibrillation (af)
394402|NCT01456949|Paroxysmal atrial fibrillation (PAF)|paroxysmal atrial fibrillation (paf)
394403|NCT01456949|Arrythmias|arrythmias
394404|NCT01456949|Cardiac Arrythmias|cardiac arrythmias
394405|NCT01456949|Cardiac ablation|cardiac ablation
394406|NCT01456949|Cryoablation|cryoablation
394407|NCT01456936|smoking cessation|smoking cessation
394408|NCT01456936|psychiatric disease|psychiatric disease
394409|NCT01456923|DNA damaging agents|dna damaging agents
394410|NCT01456910|Physical education|physical education
394411|NCT01456910|People with mental disabilities|people with mental disabilities
394412|NCT01456910|muscular strength dynamometer|muscular strength dynamometer
394413|NCT01456910|Performance Evaluation|performance evaluation
394414|NCT01456910|Occupational health|occupational health
394415|NCT01456884|Music therapy|music therapy
394416|NCT01456884|Infants|infants
394417|NCT01456884|Children|children
394418|NCT01456884|Adolescents|adolescents
394419|NCT01456884|pediatric|pediatric
394420|NCT01456884|palliative care|palliative care
394421|NCT01456884|neurological impairment|neurological impairment
394422|NCT01456884|metabolic condition|metabolic condition
394423|NCT01456884|pain management|pain management
394424|NCT01456871|Mechanoreceptors|mechanoreceptors
394425|NCT01456871|PIP joint|pip joint
394426|NCT01456871|Ligamento-muscular reflexes|ligamento-muscular reflexes
394427|NCT01456858|Malaria Prevention Refugee Emergency|malaria prevention refugee emergency
394428|NCT01456858|Malaria, Falciparum C03.752.530.650|malaria, falciparum c03.752.530.650
394429|NCT01456845|Plasma levels|plasma levels
394430|NCT01456845|isoniazid|isoniazid
394431|NCT01456845|rifampicin|rifampicin
394432|NCT01456845|pyrazinamide|pyrazinamide
394433|NCT01456845|hepatoxicity|hepatoxicity
394434|NCT01456832|hyponatremia|hyponatremia
394435|NCT01456832|renal transplant|renal transplant
394436|NCT01456819|autologous|autologous
394437|NCT01456819|bone marrow|bone marrow
394438|NCT01456819|critical limb ischemia|critical limb ischemia
394439|NCT01456819|efficacy|efficacy
394440|NCT01456819|mesenchymal stem cells|mesenchymal stem cells
394441|NCT01456819|mononuclear cells|mononuclear cells
394442|NCT01456806|T2DM|t2dm
394443|NCT01456806|Cardiovascular risk factors|cardiovascular risk factors
394444|NCT01456806|Metabolic control|metabolic control
394445|NCT01456806|Well-being|well-being
394446|NCT01456806|Cost|cost
394447|NCT01456806|Cost-consequence|cost-consequence
394448|NCT01456793|Pregnancy prevention|pregnancy prevention
394449|NCT01456793|Pregnancy|pregnancy
394450|NCT01456793|Birth|birth
394451|NCT01456793|Contraceptive use|contraceptive use
394452|NCT01456793|Adolescents|adolescents
394453|NCT01456780|Meibomian gland dysfunction|meibomian gland dysfunction
394454|NCT01456780|Blepharitis|blepharitis
394455|NCT01456780|Dry Eye|dry eye
394456|NCT01456780|Ocular Inflammation|ocular inflammation
394457|NCT01456780|MGD|mgd
394458|NCT01456780|Zylet|zylet
394459|NCT01456780|Lotemax|lotemax
394460|NCT01456780|Artificial Tear|artificial tear
394461|NCT01456754|Insulin Metabolism|insulin metabolism
394462|NCT01456754|Glucose Metabolism|glucose metabolism
394463|NCT01456754|Substrate Partitioning|substrate partitioning
394464|NCT01456754|Muscle Biopsies|muscle biopsies
394465|NCT01456754|Feeding Frequency|feeding frequency
394466|NCT01456754|Insulin|insulin
394467|NCT01456741|endobronchial needle aspiration (EBNA)|endobronchial needle aspiration (ebna)
394468|NCT01456741|transbronchial needle aspiration (TBNA)|transbronchial needle aspiration (tbna)
394469|NCT01456741|rapid on-site evaluation (ROSE)|rapid on-site evaluation (rose)
394470|NCT01456741|lung cancer|lung cancer
394471|NCT01456728|Helicobacter pylori|helicobacter pylori
394472|NCT01456728|Progastria|progastria
394473|NCT01456728|Lactobacillus reuteri|lactobacillus reuteri
394474|NCT01456728|omeprazole|omeprazole
394475|NCT01456728|triple therapy|triple therapy
394476|NCT01456728|probiotic|probiotic
394477|NCT01456715|Human Papillomavirus Vaccines|human papillomavirus vaccines
394478|NCT01456715|Immunogenicity Gardasil Cervarix|immunogenicity gardasil cervarix
394479|NCT01456715|Booster dose|booster dose
394480|NCT01456702|SVV|svv
394481|NCT01456702|hemodynamic monitoring|hemodynamic monitoring
394482|NCT01456702|goal-directed volume therapie|goal-directed volume therapie
394483|NCT01456689|Myeloma|myeloma
394484|NCT01456689|Multiple Myeloma|multiple myeloma
394485|NCT01456689|MM|mm
394486|NCT01456676|LDE225|lde225
394487|NCT01456676|nilotinib|nilotinib
394488|NCT01456676|Chronic myeloid leukemia|chronic myeloid leukemia
394489|NCT01456676|CML|cml
394490|NCT01456676|Philadelphia positive|philadelphia positive
394491|NCT01456676|Ph+|ph+
394492|NCT01456676|resistant|resistant
394493|NCT01456676|Resistant Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP)|resistant philadelphia chromosome positive chronic myeloid leukemia (ph+ cml) in chronic phase (cp)
394494|NCT01456663|AFQ056|afq056
394495|NCT01456663|Hepatic impairment|hepatic impairment
394496|NCT01456663|Hepatic impaired|hepatic impaired
394497|NCT01456650|Type 2 diabetes|type 2 diabetes
394498|NCT01456650|ABCA1 alleles|abca1 alleles
394499|NCT01456650|Glyburide|glyburide
394500|NCT01456637|Insomnia|insomnia
394501|NCT01456637|Intervention|intervention
394502|NCT01456637|Self-help|self-help
394503|NCT01456637|Internet|internet
394504|NCT01456598|Stomach neoplasm|stomach neoplasm
394505|NCT01456598|Laparoscopy|laparoscopy
394506|NCT01456585|Histological documentation|histological documentation
394507|NCT01456585|primary adenocarcinoma of the pancreas|primary adenocarcinoma of the pancreas
394508|NCT01456585|surgically eligible|surgically eligible
394509|NCT01456585|tumor resection|tumor resection
394510|NCT01456585|curative intent|curative intent
394511|NCT01456572|glucagon-like peptide-1|glucagon-like peptide-1
394512|NCT01456572|peptide tyrosine tyrosine|peptide tyrosine tyrosine
394513|NCT01456572|ghrelin|ghrelin
394514|NCT01456572|stomach|stomach
394515|NCT01456572|small intestine|small intestine
394516|NCT01456572|gastric emptying|gastric emptying
394517|NCT01456559|Hypovolemia|hypovolemia
394518|NCT01456559|Lower body negative pressure|lower body negative pressure
394519|NCT01456559|Photoplethysmography|photoplethysmography
394520|NCT01456546|CYP2C19*17|cyp2c19*17
394521|NCT01456546|Pharmacokinetics|pharmacokinetics
394522|NCT01456546|Pharmacodynamics|pharmacodynamics
394523|NCT01456533|hyponatremia|hyponatremia
394524|NCT01456533|hypernatremia|hypernatremia
394525|NCT01456520|pharmacokinetics|pharmacokinetics
394526|NCT01456520|bioequivalence|bioequivalence
394527|NCT01456520|hydrocodone|hydrocodone
394528|NCT01456520|acetaminophen|acetaminophen
394529|NCT01456520|moderate to moderately severe pain|moderate to moderately severe pain
394530|NCT01456507|Food effect|food effect
394531|NCT01456507|bioavailability|bioavailability
394532|NCT01456507|oxycodone|oxycodone
394533|NCT01456507|sequestered Naltrexone|sequestered naltrexone
394534|NCT01456507|management of moderate to severe pain|management of moderate to severe pain
394535|NCT01456494|Obstructive Lung Disease|obstructive lung disease
394536|NCT01456494|COPD|copd
394537|NCT01456494|Asthma|asthma
394538|NCT01456494|Inhaler|inhaler
394539|NCT01456494|Metered-Dose Inhaler|metered-dose inhaler
394540|NCT01456494|Education|education
394541|NCT01456494|Hospital-based education|hospital-based education
394542|NCT01456481|reflex fainting|reflex fainting
394543|NCT01456481|vasovagal syncope|vasovagal syncope
394544|NCT01456481|midodrine|midodrine
394545|NCT01456468|Cholangitis, Sclerosing|cholangitis, sclerosing
394546|NCT01456468|Tretinoin|tretinoin
394547|NCT01456468|Ursodeoxycholic Acid|ursodeoxycholic acid
394548|NCT01456455|Central nervous system|central nervous system
394549|NCT01456455|pathological markers|pathological markers
394550|NCT01456429|invasive staging|invasive staging
394551|NCT01456429|mediastinal lymph nodes|mediastinal lymph nodes
394552|NCT01456429|endosonography|endosonography
394553|NCT01456429|surgical staging|surgical staging
394554|NCT01456429|lung cancer|lung cancer
394555|NCT01456416|RRMS|rrms
394556|NCT01456416|Multiple Sclerosis|multiple sclerosis
394557|NCT01456416|Glatiramer Acetate|glatiramer acetate
394558|NCT01456416|Autoimmune Comorbidities|autoimmune comorbidities
394559|NCT01456416|Psoriasis|psoriasis
394560|NCT01456416|Autoimmune Thyroiditis|autoimmune thyroiditis
394561|NCT01456416|Vasculitis|vasculitis
394562|NCT01456416|Rheumatoid Arthritis|rheumatoid arthritis
394563|NCT01456403|Carotid|carotid
394564|NCT01456403|endarterectomy|endarterectomy
394565|NCT01456403|vulnerable plaque|vulnerable plaque
394566|NCT01456403|Ultrasound|ultrasound
394567|NCT01456403|MRI|mri
394568|NCT01456403|PET/CT|pet/ct
394569|NCT01456390|Open angle glaucoma|open angle glaucoma
394570|NCT01456390|Prior trabeculectomy|prior trabeculectomy
394571|NCT01456377|lumbar stenosis|lumbar stenosis
394572|NCT01456377|systemic corticosteroids|systemic corticosteroids
394573|NCT01456377|outcome|outcome
394574|NCT01456377|security|security
394575|NCT01456364|clopidogrel low response|clopidogrel low response
394576|NCT01456364|ticagrelor|ticagrelor
394577|NCT01456364|prasugrel|prasugrel
394578|NCT01456364|platelet aggregation|platelet aggregation
394579|NCT01456351|Event free survival|event free survival
394580|NCT01456351|Remission rates|remission rates
394581|NCT01456351|Toxicity|toxicity
394582|NCT01456351|Overall survival|overall survival
394583|NCT01456351|Efficiency costs|efficiency costs
394584|NCT01456351|Recurrent low grade|recurrent low grade
394585|NCT01456338|cognitive behavior therapy|cognitive behavior therapy
394586|NCT01456338|addiction|addiction
394587|NCT01456338|posttraumatic stress disorder (PTSD)|posttraumatic stress disorder (ptsd)
394588|NCT01456312|Peginterferon alfa 2a|peginterferon alfa 2a
394589|NCT01456312|Entecavir|entecavir
394590|NCT01456312|Response Guided Therapy|response guided therapy
394591|NCT01456312|Chronic Hepatitis B|chronic hepatitis b
394592|NCT01456299|laryngeal mask airway|laryngeal mask airway
394593|NCT01456299|insertion|insertion
394594|NCT01456299|sevoflurane|sevoflurane
394595|NCT01456299|remifentanil|remifentanil
394596|NCT01456273|biopsychosocial model|biopsychosocial model
394597|NCT01456273|biomedical model|biomedical model
394598|NCT01456273|functional dyspepsia|functional dyspepsia
394599|NCT01456260|Drug Therapy|drug therapy
394600|NCT01456247|Drug Therapy|drug therapy
394601|NCT01456221|Obesity|obesity
394602|NCT01456221|Insulin resistance|insulin resistance
394603|NCT01456221|Omega3 long chain polyunsaturated fatty acids|omega3 long chain polyunsaturated fatty acids
394604|NCT01456195|Drug Therapy|drug therapy
394605|NCT01456169|High Blood Pressure|high blood pressure
394606|NCT01456169|Drug Therapy|drug therapy
394607|NCT01456156|hepatocellular carcinoma|hepatocellular carcinoma
394608|NCT01456156|postoperative radiotherapy|postoperative radiotherapy
394609|NCT01456143|Squamous Cell Carcinoma|squamous cell carcinoma
394610|NCT01456143|Neoplasia|neoplasia
394611|NCT01456143|Optical imaging|optical imaging
394612|NCT01456143|Head and Neck Cancer|head and neck cancer
394613|NCT01456143|Oropharynx|oropharynx
394614|NCT01456143|Larynx|larynx
394615|NCT01456143|Oral Cavity|oral cavity
394616|NCT01456117|Drug Therapy|drug therapy
394617|NCT01456117|pharmacodynamics|pharmacodynamics
394618|NCT01456117|pharmacokinetics|pharmacokinetics
394619|NCT01456104|vaccine|vaccine
394620|NCT01456104|stage IIB|stage iib
394621|NCT01456104|stage IIC|stage iic
394622|NCT01456104|stage III|stage iii
394623|NCT01456104|stage IV (MIa)|stage iv (mia)
394624|NCT01456104|Langerhans-type dendritic cells|langerhans-type dendritic cells
394625|NCT01456104|Immune Responses|immune responses
394626|NCT01456104|10-229|10-229
394627|NCT01456091|adolescent pregnancy|adolescent pregnancy
394628|NCT01456091|adolescent birth|adolescent birth
394629|NCT01456091|rapid repeat pregnancy|rapid repeat pregnancy
394630|NCT01456091|rapid repeat birth|rapid repeat birth
394631|NCT01456091|youth development|youth development
394632|NCT01456091|Pregnancy in Adolescence|pregnancy in adolescence
394633|NCT01456078|Neuroendocrine tumor|neuroendocrine tumor
394634|NCT01456078|Liver metastases|liver metastases
394635|NCT01456078|177Lu-DOTA-TATE|177lu-dota-tate
394636|NCT01456078|Safety|safety
394637|NCT01456078|Kidney dosimetry|kidney dosimetry
394638|NCT01456078|Dose escalation|dose escalation
394639|NCT01456078|Neuroendocrine tumors, with liver metastases.|neuroendocrine tumors, with liver metastases.
394640|NCT01456026|Diabetes|diabetes
394641|NCT01456026|Advanced glycation endproducts|advanced glycation endproducts
394642|NCT01456026|Endothelium|endothelium
394643|NCT01456000|atrial fibrillation|atrial fibrillation
394644|NCT01456000|AF|af
394645|NCT01456000|PAF|paf
394646|NCT01456000|PVI|pvi
394647|NCT01456000|ablation|ablation
394648|NCT01456000|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
394649|NCT01456000|pulmonary vein isolation|pulmonary vein isolation
394650|NCT01455987|Osteochondritis dissecans|osteochondritis dissecans
394651|NCT01455987|Juvenile osteochondritis dissecans|juvenile osteochondritis dissecans
394652|NCT01455987|Knee|knee
394653|NCT01455987|Osteochondral|osteochondral
394654|NCT01455987|Outcome|outcome
394655|NCT01455974|hypertension|hypertension
394656|NCT01455974|arterial stiffness|arterial stiffness
394657|NCT01455974|left ventricular hypertrophy|left ventricular hypertrophy
394658|NCT01455961|Real life setting|real life setting
394659|NCT01455961|Bipolar Disorder|bipolar disorder
394660|NCT01455961|Registry based Data Base Audit|registry based data base audit
394661|NCT01455948|sinusitis|sinusitis
394662|NCT01455948|chronic|chronic
394663|NCT01455948|Functional endoscopic sinus surgery|functional endoscopic sinus surgery
394664|NCT01455948|balloon sinuplasty|balloon sinuplasty
394665|NCT01455844|Hypertriglyceridemia|hypertriglyceridemia
394666|NCT01455792|Biopsy|biopsy
394667|NCT01455792|MRI and ultrasound soft image fusion|mri and ultrasound soft image fusion
394668|NCT01455792|Gold standard TRUS biopsy|gold standard trus biopsy
394669|NCT01455779|Stress Urinary Incontinence|stress urinary incontinence
394670|NCT01455779|Incontinence|incontinence
394671|NCT01455779|SUI|sui
394672|NCT01455779|Renessa|renessa
394673|NCT01455766|postpneumonectomy pulmonary edema|postpneumonectomy pulmonary edema
394674|NCT01455766|extravascular lung water|extravascular lung water
394675|NCT01455753|Influenza|influenza
394676|NCT01455753|Proximity|proximity
394677|NCT01455740|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
394678|NCT01455740|HIV|hiv
394679|NCT01455740|Commitment|commitment
394680|NCT01455740|Financial Incentives|financial incentives
394681|NCT01455727|Pharmaceutical care|pharmaceutical care
394682|NCT01455727|Diabetes Mellitus|diabetes mellitus
394683|NCT01455714|hypertenion|hypertenion
394684|NCT01455714|exertional dyspnoea|exertional dyspnoea
394685|NCT01455714|heart failure|heart failure
394686|NCT01455714|biomarkers|biomarkers
394687|NCT01455688|critically ill patients|critically ill patients
394688|NCT01455688|HIV infection|hiv infection
394689|NCT01455688|HAART|haart
394690|NCT01455688|mortality|mortality
394691|NCT01455675|cystic fibrosis|cystic fibrosis
394692|NCT01455662|cardiac arrest|cardiac arrest
394693|NCT01455649|Kidney|kidney
394694|NCT01455649|Transplant|transplant
394695|NCT01455649|Immunosuppression|immunosuppression
394696|NCT01455649|Everolimus|everolimus
394697|NCT01455649|Graft function|graft function
394698|NCT01455636|pediatric|pediatric
394699|NCT01455636|micronutrient powder|micronutrient powder
394700|NCT01455636|hand hygiene|hand hygiene
394701|NCT01455636|low birth weight|low birth weight
394702|NCT01455636|infant feeding|infant feeding
394703|NCT01455636|hand sanitizers|hand sanitizers
394704|NCT01455623|CMT|cmt
394705|NCT01455610|Computed tomography|computed tomography
394706|NCT01455610|Contrast enhancement|contrast enhancement
394707|NCT01455610|Pancreas|pancreas
394708|NCT01455610|Cancer|cancer
394709|NCT01455610|Resectability|resectability
394710|NCT01455597|Postmenopausal Women|postmenopausal women
394711|NCT01455597|Vaginal Dryness|vaginal dryness
394712|NCT01455597|Postmenopausal Vulvovaginal Atrophy|postmenopausal vulvovaginal atrophy
394713|NCT01455584|HM781-36B|hm781-36b
394714|NCT01455558|Pharmacokinetics|pharmacokinetics
394715|NCT01455545|Asthma|asthma
394716|NCT01455545|Degree of Control|degree of control
394717|NCT01455545|Exhaled Nitric Oxide|exhaled nitric oxide
394718|NCT01455545|Asthma Control Test|asthma control test
394719|NCT01455519|Low Back Pain|low back pain
394720|NCT01455519|Back Pain|back pain
394721|NCT01455519|Chronic back pain|chronic back pain
394722|NCT01455506|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
394723|NCT01455506|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
394724|NCT01455506|Bone Marrow Transplant|bone marrow transplant
394725|NCT01455506|Stem Cell Transplant|stem cell transplant
394726|NCT01455480|Second Degree Burn|second degree burn
394727|NCT01455480|partial thickness burns|partial thickness burns
394728|NCT01455467|Open angle glaucoma|open angle glaucoma
394729|NCT01455467|Pigmentary glaucoma|pigmentary glaucoma
394730|NCT01455467|Pseudoexfoliative glaucoma|pseudoexfoliative glaucoma
394731|NCT01455441|GLP-1|glp-1
394732|NCT01455441|Training|training
394733|NCT01455441|Exercise|exercise
394734|NCT01455441|Type 2 Diabetes|type 2 diabetes
394735|NCT01455428|Pregabalin|pregabalin
394736|NCT01455428|Postherpetic Neuralgia ( PHN )|postherpetic neuralgia ( phn )
394737|NCT01455402|Respiratory Syncytial Virus, Chronic Obstructive Pulmonary Disease, Congestive Heart Failure, Observational|respiratory syncytial virus, chronic obstructive pulmonary disease, congestive heart failure, observational
394738|NCT01455389|Lung Cancer|lung cancer
394739|NCT01455389|Non-small cell lung cancer|non-small cell lung cancer
394740|NCT01455389|NSCLC|nsclc
394741|NCT01455389|FUS1-nanoparticles|fus1-nanoparticles
394742|NCT01455389|DOTAP:Chol-fus1|dotap:chol-fus1
394743|NCT01455389|DOTAP:Cholesterol-Fus1 Liposome Complex|dotap:cholesterol-fus1 liposome complex
394744|NCT01455389|Erlotinib|erlotinib
394745|NCT01455389|Erlotinib Hydrochloride|erlotinib hydrochloride
394746|NCT01455389|OSI-774|osi-774
394747|NCT01455389|Tarceva|tarceva
394748|NCT01455389|Dexamethasone|dexamethasone
394749|NCT01455389|Decadron|decadron
394750|NCT01455389|Diphenhydramine|diphenhydramine
394751|NCT01455389|Benadryl|benadryl
394752|NCT01455389|Benylin Cough SyrupPharmacokinetic|benylin cough syruppharmacokinetic
394753|NCT01455389|PK|pk
394754|NCT01455376|brain injury|brain injury
394755|NCT01455376|cognitive function|cognitive function
394756|NCT01455376|sodium lactate|sodium lactate
394757|NCT01455376|MMSE score|mmse score
394758|NCT01455350|provoked vestibulodynia|provoked vestibulodynia
394759|NCT01455350|multimodal physiotherapy|multimodal physiotherapy
394760|NCT01455350|lidocaine|lidocaine
394761|NCT01455337|severe alcoholic hepatitis|severe alcoholic hepatitis
394762|NCT01455324|prosthetic socket|prosthetic socket
394763|NCT01455324|residual limb volume fluctuation|residual limb volume fluctuation
394764|NCT01455324|conformable socket liner|conformable socket liner
394765|NCT01455311|cystic pancreatic tumors|cystic pancreatic tumors
394766|NCT01455311|cystic pancreatic lesions|cystic pancreatic lesions
394767|NCT01455311|gastrointestinal|gastrointestinal
394768|NCT01455311|GI|gi
394769|NCT01455311|EUS-FNA|eus-fna
394770|NCT01455311|EchoBrush®|echobrush®
394771|NCT01455311|cytology brush|cytology brush
394772|NCT01455311|endoscopic|endoscopic
394773|NCT01455298|Alpha-1 AT deficiency|alpha-1 at deficiency
394774|NCT01455298|liver injury|liver injury
394775|NCT01455298|Transient Elastography|transient elastography
394776|NCT01455298|FibroTest|fibrotest
394777|NCT01455285|dysmenorrhea|dysmenorrhea
394778|NCT01455285|transcutaneous electrical nerve stimulation (TENS|transcutaneous electrical nerve stimulation (tens
394779|NCT01455285|analgesia|analgesia
394780|NCT01455285|pain visual analog scale|pain visual analog scale
394781|NCT01455285|McGill pain questionnaire|mcgill pain questionnaire
394782|NCT01455259|AdCD40L|adcd40l
394783|NCT01455259|Adenoviral vector|adenoviral vector
394784|NCT01455259|CD40L|cd40l
394785|NCT01455259|CD154|cd154
394786|NCT01455259|malignant melanoma|malignant melanoma
394787|NCT01455246|Cirrhosis|cirrhosis
394788|NCT01455246|Nosocomial Spontaneous Bacterial Peritonitis|nosocomial spontaneous bacterial peritonitis
394789|NCT01455246|Ascites|ascites
394790|NCT01455246|Daptomycin|daptomycin
394791|NCT01455246|Meropenem|meropenem
394792|NCT01455246|Ceftazidime|ceftazidime
394793|NCT01455246|Nosocomial infection|nosocomial infection
394794|NCT01455246|Multi drug resistant bacteria|multi drug resistant bacteria
394795|NCT01455246|Sepsis|sepsis
394796|NCT01455246|Albumin|albumin
394797|NCT01455233|cornea|cornea
394798|NCT01455233|ocular antibiotic|ocular antibiotic
394799|NCT01455233|cataract surgery|cataract surgery
394800|NCT01455220|Multiple Sclerosis|multiple sclerosis
394801|NCT01455220|Sexual Dysfunction|sexual dysfunction
394802|NCT01455220|Quality of Life|quality of life
394803|NCT01455207|Magnetic Resonance Imaging|magnetic resonance imaging
394804|NCT01455207|Positon Emission Tomography|positon emission tomography
394805|NCT01455207|Behavior|behavior
394806|NCT01455194|ciclesonide|ciclesonide
394807|NCT01455194|asthma|asthma
394808|NCT01455181|Hypoparathyroidism|hypoparathyroidism
394809|NCT01455181|NPSP558|npsp558
394810|NCT01455181|Parathyroid Hormone 1-84|parathyroid hormone 1-84
394811|NCT01455181|PTH 1-84|pth 1-84
394812|NCT01455168|anterior capsule shrinkage|anterior capsule shrinkage
394813|NCT01455168|capsular tension ring|capsular tension ring
394814|NCT01455168|exfoliation syndrome|exfoliation syndrome
394815|NCT01455168|phacoemulsification and aspiration|phacoemulsification and aspiration
394816|NCT01455155|stroke|stroke
394817|NCT01455155|Art therapy|art therapy
394818|NCT01455155|Music therapy|music therapy
394819|NCT01455155|Creative therapy|creative therapy
394820|NCT01455155|Efficacy|efficacy
394821|NCT01455129|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
394822|NCT01455129|COPD|copd
394823|NCT01455129|COPD exacerbation|copd exacerbation
394824|NCT01455129|treatment|treatment
394825|NCT01455129|tiotropium|tiotropium
394826|NCT01455129|anticholinergic|anticholinergic
394827|NCT01455129|acute exacerbation of COPD (AECOPD)|acute exacerbation of copd (aecopd)
394828|NCT01455116|Sepsis|sepsis
394829|NCT01455116|Multi organ dysfunction syndrome|multi organ dysfunction syndrome
394830|NCT01455116|Mild Induced Hypothermia|mild induced hypothermia
394831|NCT01455077|obesity|obesity
394832|NCT01455077|sleep apnea|sleep apnea
394833|NCT01455077|portable monitoring|portable monitoring
394834|NCT01455025|Plerixafor granulocyte-colony stimulating factor|plerixafor granulocyte-colony stimulating factor
394835|NCT01455025|Chemotherapy in relapse|chemotherapy in relapse
394836|NCT01455025|Acute Myeloid Leukemia|acute myeloid leukemia
394837|NCT01455012|Rotigotine|rotigotine
394838|NCT01455012|Neupro|neupro
394839|NCT01455012|RLS|rls
394840|NCT01455012|Cardiovascular Risk|cardiovascular risk
394841|NCT01455012|Nocturnal Blood Pressure|nocturnal blood pressure
394842|NCT01454999|veteran|veteran
394843|NCT01454999|smoking|smoking
394844|NCT01454999|stage of change|stage of change
394845|NCT01454999|cell phone|cell phone
394846|NCT01454999|computerized tailored intervention|computerized tailored intervention
394847|NCT01454986|Healthy subjects|healthy subjects
394848|NCT01454973|type 2 diabetes|type 2 diabetes
394849|NCT01454973|beta cell function|beta cell function
394850|NCT01454973|meal tolerance test|meal tolerance test
394851|NCT01454973|maximum stimulation test|maximum stimulation test
394852|NCT01454973|method standardization|method standardization
394853|NCT01454973|insulin secretion|insulin secretion
394854|NCT01454960|Antibiotics|antibiotics
394855|NCT01454960|Inappropriate Prescribing|inappropriate prescribing
394856|NCT01454960|Respiratory Tract Infections|respiratory tract infections
394857|NCT01454960|Behavioral Research|behavioral research
394858|NCT01454947|Antibiotics|antibiotics
394859|NCT01454947|Inappropriate Prescribing|inappropriate prescribing
394860|NCT01454947|Respiratory Tract Infections|respiratory tract infections
394861|NCT01454947|Behavioral Research|behavioral research
394862|NCT01454921|HIV|hiv
394863|NCT01454921|Adolescent Trials Network|adolescent trials network
394864|NCT01454908|partial knee arthroplasty|partial knee arthroplasty
394865|NCT01454895|noise-induced hearing loss|noise-induced hearing loss
394866|NCT01454895|prevention|prevention
394867|NCT01454895|farmers|farmers
394868|NCT01454882|Direct calorimetry|direct calorimetry
394869|NCT01454882|Indirect calorimetry|indirect calorimetry
394870|NCT01454882|Energy Expenditure|energy expenditure
394871|NCT01454869|heparin|heparin
394872|NCT01454843|Myopia|myopia
394873|NCT01454843|Astigmatism|astigmatism
394874|NCT01454843|Aberrations|aberrations
394875|NCT01454843|Wavefront|wavefront
394876|NCT01454843|LASIK|lasik
394877|NCT01454843|Wavefront LASIK|wavefront lasik
394878|NCT01454830|Social support|social support
394879|NCT01454830|Cognition|cognition
394880|NCT01454830|Adaptation, psychological|adaptation, psychological
394881|NCT01454830|Health behavior|health behavior
394882|NCT01454830|Patient education|patient education
394883|NCT01454817|Quality of Life|quality of life
394884|NCT01454817|Implantable Cardiac Defibrillators|implantable cardiac defibrillators
394885|NCT01454817|ICDs|icds
394886|NCT01454804|Advanced Cancers|advanced cancers
394887|NCT01454804|Solid Tumors|solid tumors
394888|NCT01454804|Pazopanib|pazopanib
394889|NCT01454804|GW786034|gw786034
394890|NCT01454804|Lapatinib|lapatinib
394891|NCT01454804|Tykerb|tykerb
394892|NCT01454804|GW572016|gw572016
394893|NCT01454804|Trastuzumab|trastuzumab
394894|NCT01454804|Herceptin|herceptin
394895|NCT01454791|multiple sclerosis|multiple sclerosis
394896|NCT01454791|diclofenac|diclofenac
394897|NCT01454791|subcutaneous injection|subcutaneous injection
394898|NCT01454791|glatiramer acetate|glatiramer acetate
394899|NCT01454791|Copaxone|copaxone
394900|NCT01454778|restenosis|restenosis
394901|NCT01454778|peripheral vascular disease|peripheral vascular disease
394902|NCT01454778|lower extremity ischemia|lower extremity ischemia
394903|NCT01454778|claudication|claudication
394904|NCT01454752|malaria|malaria
394905|NCT01454752|anaemia|anaemia
394906|NCT01454752|cognition|cognition
394907|NCT01454752|intermittent preventive treatment|intermittent preventive treatment
394908|NCT01454752|children|children
394909|NCT01454752|schools|schools
394910|NCT01454752|insecticide-treated nets|insecticide-treated nets
394911|NCT01454739|rFVIIIFc|rfviiifc
394912|NCT01454739|A-LONG Extension|a-long extension
394913|NCT01454726|Dizziness|dizziness
394914|NCT01454726|Meniere's disease|meniere's disease
394915|NCT01454726|Diaoshi Jifa therapy|diaoshi jifa therapy
394916|NCT01454700|Type 1 diabetes mellitus|type 1 diabetes mellitus
394917|NCT01454700|Albuminuria|albuminuria
394918|NCT01454700|Late diabetes complications|late diabetes complications
394919|NCT01454700|CSII|csii
394920|NCT01454700|CGM|cgm
394921|NCT01454700|Glycaemic control|glycaemic control
394922|NCT01454661|Probiotics|probiotics
394923|NCT01454661|Premature infant|premature infant
394924|NCT01454661|Intestinal microbiota|intestinal microbiota
394925|NCT01454661|Intestinal immunity|intestinal immunity
394926|NCT01454661|Breastfeeding|breastfeeding
394927|NCT01454648|Traumatic Brain Injury|traumatic brain injury
394928|NCT01454648|EMS|ems
394929|NCT01454648|Out-of-Hospital|out-of-hospital
394930|NCT01454635|depression|depression
394931|NCT01454635|treatment response|treatment response
394932|NCT01454635|selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
394933|NCT01454622|Healthy Volunteers|healthy volunteers
394934|NCT01454622|Bioequivalence|bioequivalence
394935|NCT01454622|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
394936|NCT01454622|Metformin IR|metformin ir
394937|NCT01454609|cervical plexus block|cervical plexus block
394938|NCT01454609|thyroidectomy|thyroidectomy
394939|NCT01454609|postoperative analgesia|postoperative analgesia
394940|NCT01454596|Cell Therapy|cell therapy
394941|NCT01454596|Gene Therapy|gene therapy
394942|NCT01454596|Immunotherapy|immunotherapy
394943|NCT01454596|Brain Cancer|brain cancer
394944|NCT01454596|Glioma|glioma
394945|NCT01454596|Glioblastoma|glioblastoma
394946|NCT01454583|renin inhibitor|renin inhibitor
394947|NCT01454583|ACE inhibitor|ace inhibitor
394948|NCT01454583|ARB (AT1 receptor blockers)|arb (at1 receptor blockers)
394949|NCT01454583|RAS blockade|ras blockade
394950|NCT01454570|exoskeleton walking system|exoskeleton walking system
394951|NCT01454570|paraplegia|paraplegia
394952|NCT01454570|paralysis|paralysis
394953|NCT01454557|Acquired Brain Injury|acquired brain injury
394954|NCT01454557|Heart Rate Variability (HRV)|heart rate variability (hrv)
394955|NCT01454557|Auditory Stimuli|auditory stimuli
394956|NCT01454557|Physical Activity|physical activity
394957|NCT01454518|hip arthroscopy|hip arthroscopy
394958|NCT01454518|post operative analgesia|post operative analgesia
394959|NCT01454505|Healthy subjects|healthy subjects
394960|NCT01454505|Nasal allergies|nasal allergies
394961|NCT01454505|Allergies|allergies
394962|NCT01454505|Environmental Exposure Chamber|environmental exposure chamber
394963|NCT01454505|EEC|eec
394964|NCT01454505|Ragweed|ragweed
394965|NCT01454492|Allergy rhinitis|allergy rhinitis
394966|NCT01454492|Geographic tongue|geographic tongue
394967|NCT01454479|Lapatinib|lapatinib
394968|NCT01454479|Ixabepilone|ixabepilone
394969|NCT01454479|HER-2|her-2
394970|NCT01454479|Endometrial Carcinoma|endometrial carcinoma
394971|NCT01454466|prevention|prevention
394972|NCT01454466|retinal break|retinal break
394973|NCT01454466|vitrectomy|vitrectomy
394974|NCT01454466|partial posterior hyaloidectomy|partial posterior hyaloidectomy
394975|NCT01454453|amisulpride|amisulpride
394976|NCT01454453|receptor occupancy|receptor occupancy
394977|NCT01454453|antipsychotic sensitivity|antipsychotic sensitivity
394978|NCT01454440|Coronary artery disease|coronary artery disease
394979|NCT01454440|Eptifibatide|eptifibatide
394980|NCT01454440|Percutaneous coronary intervention|percutaneous coronary intervention
394981|NCT01454440|stable coronary artery disease|stable coronary artery disease
394982|NCT01454440|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
394983|NCT01454440|DES|des
394984|NCT01454375|Smoking|smoking
394985|NCT01454362|nicotine|nicotine
394986|NCT01454362|inhalator|inhalator
394987|NCT01454362|electronic cigarette|electronic cigarette
394988|NCT01454362|tobacco|tobacco
394989|NCT01454349|Benign prostatic hyperplasia|benign prostatic hyperplasia
394990|NCT01454349|BPH|bph
394991|NCT01454349|Enlarged prostate|enlarged prostate
394992|NCT01454349|Lower urinary tract symptoms (LUTS)|lower urinary tract symptoms (luts)
394993|NCT01454336|MSCs|mscs
394994|NCT01454336|Pioglitazon|pioglitazon
394995|NCT01454336|fibrosis|fibrosis
394996|NCT01454336|liver|liver
394997|NCT01454323|Chronic Myocardial Ischemia|chronic myocardial ischemia
394998|NCT01454323|Cell therapy|cell therapy
394999|NCT01454323|Bone marrow mononuclear cells|bone marrow mononuclear cells
395000|NCT01454310|Skin substitutes|skin substitutes
395001|NCT01454310|Split-thickness skin graft|split-thickness skin graft
395002|NCT01454310|Burn wound|burn wound
395003|NCT01454310|Scar formation|scar formation
395004|NCT01454310|Skin quality|skin quality
395005|NCT01454297|Myeloma|myeloma
395006|NCT01454297|Multiple Myeloma|multiple myeloma
395007|NCT01454297|Observational|observational
395008|NCT01454297|Longitudinal|longitudinal
395009|NCT01454271|Total Hip arthroplasty|total hip arthroplasty
395010|NCT01454271|Hip Osteoarthritis|hip osteoarthritis
395011|NCT01454271|Infection after Total Hip Arthroplasty|infection after total hip arthroplasty
395012|NCT01454245|39439335EDI1013|39439335edi1013
395013|NCT01454245|Bioavailability|bioavailability
395014|NCT01454245|Pharmacokinetics|pharmacokinetics
395015|NCT01454232|Obesity|obesity
395016|NCT01454232|adipose tissue inflammation|adipose tissue inflammation
395017|NCT01454232|Low grade systemic inflammation|low grade systemic inflammation
395018|NCT01454232|gut microbiota|gut microbiota
395019|NCT01454232|Bariatric surgery|bariatric surgery
395020|NCT01454206|cannabis abuse|cannabis abuse
395021|NCT01454206|alcohol abuse|alcohol abuse
395022|NCT01454206|substance abuse|substance abuse
395023|NCT01454180|Therapeutic targets in Pancreas|therapeutic targets in pancreas
395024|NCT01454167|vacum drains|vacum drains
395025|NCT01454167|operational wounds|operational wounds
395026|NCT01454167|infections|infections
395027|NCT01454167|seroma|seroma
395028|NCT01454167|acid base|acid base
395029|NCT01454167|glucose|glucose
395030|NCT01454167|lactate|lactate
395031|NCT01454154|TBI|tbi
395032|NCT01454154|Traumatic Brain Injury|traumatic brain injury
395033|NCT01454141|Depressed mood|depressed mood
395034|NCT01454128|exercise base rehabilitation|exercise base rehabilitation
395035|NCT01454128|heart failure|heart failure
395036|NCT01454128|periodic breathing|periodic breathing
395037|NCT01454128|aerobic fitness|aerobic fitness
395038|NCT01454089|bladder|bladder
395039|NCT01454089|urinary tract|urinary tract
395040|NCT01454089|transitional cell carcinoma|transitional cell carcinoma
395041|NCT01454089|metastatic bladder cancer|metastatic bladder cancer
395042|NCT01454089|chemotherapy|chemotherapy
395043|NCT01454076|Cmax: maximum plasma concentration|cmax: maximum plasma concentration
395044|NCT01454076|AUC0-tlast: area under the plasma concentration-time curve from time zero to the time of the last quantifiable concentration|auc0-tlast: area under the plasma concentration-time curve from time zero to the time of the last quantifiable concentration
395045|NCT01454063|cataract|cataract
395046|NCT01454063|lens replacement|lens replacement
395047|NCT01454050|ICD therapy|icd therapy
395048|NCT01454050|RV/LV Capture Control|rv/lv capture control
395049|NCT01454050|Safety and Efficacy|safety and efficacy
395050|NCT01454011|hypogonadism|hypogonadism
395051|NCT01454011|testosterone|testosterone
395052|NCT01454011|HDL cholesterol subgroups|hdl cholesterol subgroups
395053|NCT01454011|hsCRP|hscrp
395054|NCT01454011|HOMA-IR|homa-ir
395055|NCT01453972|Exercise|exercise
395056|NCT01453972|High-intensity|high-intensity
395057|NCT01453972|Interval training|interval training
395058|NCT01453959|hypertension|hypertension
395059|NCT01453959|salt sensitivity|salt sensitivity
395060|NCT01453959|fludrocortisone|fludrocortisone
395061|NCT01453946|Crohn's Disease|crohn's disease
395062|NCT01453933|Anti-HIV Agents|anti-hiv agents
395063|NCT01453933|Anti-Retroviral Agents|anti-retroviral agents
395064|NCT01453933|Antiviral Agents|antiviral agents
395065|NCT01453933|Anti-Infective Agents|anti-infective agents
395066|NCT01453933|Lopinavir/ritonavir|lopinavir/ritonavir
395067|NCT01453920|Age Related Macular Degeneration|age related macular degeneration
395068|NCT01453920|Choroidal Neovascular Membrane|choroidal neovascular membrane
395069|NCT01453894|Colorectal Cancer Screening|colorectal cancer screening
395070|NCT01453894|Fecal Occult Blood Testing|fecal occult blood testing
395071|NCT01453881|Asthma|asthma
395072|NCT01453881|pMDI|pmdi
395073|NCT01453881|Beclomethasone|beclomethasone
395074|NCT01453881|Formoterol|formoterol
395075|NCT01453881|Efficacy|efficacy
395076|NCT01453868|Multiple Sclerosis|multiple sclerosis
395077|NCT01453868|non impact aerobics|non impact aerobics
395078|NCT01453855|Open-Angle Glaucoma|open-angle glaucoma
395079|NCT01453855|Ocular Hypertension|ocular hypertension
395080|NCT01453842|Glucagon-like peptide-1|glucagon-like peptide-1
395081|NCT01453842|Glucose-dependant insulinotropic polypeptide|glucose-dependant insulinotropic polypeptide
395082|NCT01453842|Glucagon|glucagon
395083|NCT01453842|Peptide PYY|peptide pyy
395084|NCT01453842|2-oleyl glycerol|2-oleyl glycerol
395085|NCT01453816|Renal insufficiency|renal insufficiency
395086|NCT01453816|kidney failure|kidney failure
395087|NCT01453803|Liposuction|liposuction
395088|NCT01453803|ADSC|adsc
395089|NCT01453803|ASC|asc
395090|NCT01453803|stem cell|stem cell
395091|NCT01453803|Parkinson's Disease|parkinson's disease
395092|NCT01453803|Parkinson's|parkinson's
395093|NCT01453803|therapy|therapy
395094|NCT01453790|depression|depression
395095|NCT01453790|treatment|treatment
395096|NCT01453790|motivation to seek follow up|motivation to seek follow up
395097|NCT01453777|diffuse brain lesion|diffuse brain lesion
395098|NCT01453751|Diabetes|diabetes
395099|NCT01453751|Type 2 Diabetes|type 2 diabetes
395100|NCT01453738|Osteoarthritis|osteoarthritis
395101|NCT01453738|Knee|knee
395102|NCT01453738|Stem cells|stem cells
395103|NCT01453738|Mesenchymal Stem Cells|mesenchymal stem cells
395104|NCT01453712|coronary artery disease|coronary artery disease
395105|NCT01453712|coronary CT angiography|coronary ct angiography
395106|NCT01453712|radiation dose|radiation dose
395107|NCT01453712|iterative image reconstruction|iterative image reconstruction
395108|NCT01453712|detection|detection
395109|NCT01453699|Bereavement|bereavement
395110|NCT01453699|early parental death|early parental death
395111|NCT01453699|grief|grief
395112|NCT01453699|affective disorders|affective disorders
395113|NCT01453699|depression, depressive symptoms|depression, depressive symptoms
395114|NCT01453699|socioeconomic factors|socioeconomic factors
395115|NCT01453699|suicide|suicide
395116|NCT01453699|attempted suicide|attempted suicide
395117|NCT01453699|antidepressive agents|antidepressive agents
395118|NCT01453699|cardiovascular diseases|cardiovascular diseases
395119|NCT01453699|quality of life|quality of life
395120|NCT01453699|Long-term health effects|long-term health effects
395121|NCT01453699|Socioeconomic outcomes|socioeconomic outcomes
395122|NCT01453699|Psychosocial well-being|psychosocial well-being
395123|NCT01453686|Alopecia Areata|alopecia areata
395124|NCT01453686|Hydrocortisone|hydrocortisone
395125|NCT01453686|Clobetasol Propionate|clobetasol propionate
395126|NCT01453686|Randomized Controlled Trial|randomized controlled trial
395127|NCT01453673|knee|knee
395128|NCT01453673|Cruciate Ligament|cruciate ligament
395129|NCT01453673|Meniscus|meniscus
395130|NCT01453660|Endothelial Function|endothelial function
395131|NCT01453660|Endo-PAT2000 system|endo-pat2000 system
395132|NCT01453660|11-140|11-140
395133|NCT01453647|Fibromyalgia|fibromyalgia
395134|NCT01453647|self-efficacy|self-efficacy
395135|NCT01453647|fatigue|fatigue
395136|NCT01453647|stress|stress
395137|NCT01453647|cytokine|cytokine
395138|NCT01453634|chronic kidney disease (CKD)|chronic kidney disease (ckd)
395139|NCT01453634|secondary hyperparathyroidism (SHPT)|secondary hyperparathyroidism (shpt)
395140|NCT01453634|hemodialysis (HD)|hemodialysis (hd)
395141|NCT01453621|prediction rules|prediction rules
395142|NCT01453621|computerized clinical decision support|computerized clinical decision support
395143|NCT01453621|traumatic brain injury|traumatic brain injury
395144|NCT01453621|blunt head trauma|blunt head trauma
395145|NCT01453595|Kidney|kidney
395146|NCT01453595|renal cell carcinoma|renal cell carcinoma
395147|NCT01453595|BEZ235|bez235
395148|NCT01453595|11-080|11-080
395149|NCT01453582|Chest stuffiness of TCM|chest stuffiness of tcm
395150|NCT01453582|Qi deficiency and blood stasis of TCM|qi deficiency and blood stasis of tcm
395151|NCT01453556|Laparoscopic surgery|laparoscopic surgery
395152|NCT01453556|Right colectomy|right colectomy
395153|NCT01453556|Mechanical anastomosis|mechanical anastomosis
395154|NCT01453556|Post-operative ileum|post-operative ileum
395155|NCT01453530|Recovery|recovery
395156|NCT01453530|Street fitness|street fitness
395157|NCT01453530|Sugammadex|sugammadex
395158|NCT01453530|Alertness|alertness
395159|NCT01453530|Ambulatory surgery|ambulatory surgery
395160|NCT01453517|bariatric|bariatric
395161|NCT01453517|obesity|obesity
395162|NCT01453517|post-surgery|post-surgery
395163|NCT01453517|intervention|intervention
395164|NCT01453465|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
395165|NCT01453465|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
395166|NCT01453452|weight changes|weight changes
395167|NCT01453452|fatigue|fatigue
395168|NCT01453452|depression|depression
395169|NCT01453452|anxiety disorder|anxiety disorder
395170|NCT01453452|pain|pain
395171|NCT01453452|cognitive/functional effects|cognitive/functional effects
395172|NCT01453452|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
395173|NCT01453452|cancer survivor|cancer survivor
395174|NCT01453452|stage IA breast cancer|stage ia breast cancer
395175|NCT01453452|stage IB breast cancer|stage ib breast cancer
395176|NCT01453452|stage II breast cancer|stage ii breast cancer
395177|NCT01453452|stage IIIA breast cancer|stage iiia breast cancer
395178|NCT01453452|stage IIIB breast cancer|stage iiib breast cancer
395179|NCT01453452|stage IIIC breast cancer|stage iiic breast cancer
395180|NCT01453452|stage I colon cancer|stage i colon cancer
395181|NCT01453452|stage IIA colon cancer|stage iia colon cancer
395182|NCT01453452|stage IIB colon cancer|stage iib colon cancer
395183|NCT01453452|stage IIC colon cancer|stage iic colon cancer
395184|NCT01453452|stage IIIA colon cancer|stage iiia colon cancer
395185|NCT01453452|stage IIIB colon cancer|stage iiib colon cancer
395186|NCT01453452|stage IIIC colon cancer|stage iiic colon cancer
395187|NCT01453452|stage I rectal cancer|stage i rectal cancer
395188|NCT01453452|stage IIA rectal cancer|stage iia rectal cancer
395189|NCT01453452|stage IIB rectal cancer|stage iib rectal cancer
395190|NCT01453452|stage IIC rectal cancer|stage iic rectal cancer
395191|NCT01453452|stage IIIA rectal cancer|stage iiia rectal cancer
395690|NCT01451593|Phenytoin|phenytoin
395192|NCT01453452|stage IIIB rectal cancer|stage iiib rectal cancer
395193|NCT01453452|stage IIIC rectal cancer|stage iiic rectal cancer
395194|NCT01453439|Body dysmorphic disorder|body dysmorphic disorder
395195|NCT01453439|Obsessive compulsive spectrum disorder|obsessive compulsive spectrum disorder
395196|NCT01453439|Body image|body image
395197|NCT01453439|Appearance concerns|appearance concerns
395198|NCT01453400|aspirin|aspirin
395199|NCT01453400|acetylsalicylic acid|acetylsalicylic acid
395200|NCT01453400|pharyngitis|pharyngitis
395201|NCT01453400|sore throat|sore throat
395202|NCT01453387|MEK inhibitor|mek inhibitor
395203|NCT01453387|Solid Tumor|solid tumor
395204|NCT01453387|Phase I|phase i
395205|NCT01453374|opioid dependence|opioid dependence
395206|NCT01453374|VIVITROL|vivitrol
395207|NCT01453374|criminal justice|criminal justice
395208|NCT01453361|FANG|fang
395209|NCT01453361|Melanoma|melanoma
395210|NCT01453361|Vigil|vigil
395211|NCT01453348|meningococcal|meningococcal
395212|NCT01453348|conjugate|conjugate
395213|NCT01453348|vaccine|vaccine
395214|NCT01453348|adults|adults
395215|NCT01453335|Veins|veins
395216|NCT01453335|Catheter Segments|catheter segments
395217|NCT01453335|Vascular Access|vascular access
395218|NCT01453335|VeinViewer Vision|veinviewer vision
395219|NCT01453322|Veins|veins
395220|NCT01453322|Vascular Access|vascular access
395221|NCT01453322|IV complications|iv complications
395222|NCT01453322|VeinViewer Vision|veinviewer vision
395223|NCT01453309|lumbar fusion|lumbar fusion
395224|NCT01453309|transfusion|transfusion
395225|NCT01453309|cell-saver|cell-saver
395226|NCT01453309|cost-effectiveness|cost-effectiveness
395227|NCT01453296|Asthma|asthma
395228|NCT01453296|Tolerability|tolerability
395229|NCT01453296|Safety|safety
395230|NCT01453296|Pharmacokinetics|pharmacokinetics
395231|NCT01453296|GW642444|gw642444
395232|NCT01453283|DNA Repair|dna repair
395233|NCT01453283|Nucleotide Excision Repair|nucleotide excision repair
395234|NCT01453283|Trabectedine|trabectedine
395235|NCT01453283|Phase I|phase i
395236|NCT01453283|Sarcoma|sarcoma
395237|NCT01453283|Cytotoxic|cytotoxic
395238|NCT01453283|Chemotherapy|chemotherapy
395239|NCT01453283|Solid Tumor|solid tumor
395240|NCT01453283|Malignant Tumor|malignant tumor
395241|NCT01453283|Rhabdomyosarcoma|rhabdomyosarcoma
395242|NCT01453283|Ewing Sarcoma|ewing sarcoma
395243|NCT01453283|Neuroblastoma|neuroblastoma
395244|NCT01453283|Wilm's Tumor|wilm's tumor
395245|NCT01453283|Hepatic Tumor|hepatic tumor
395246|NCT01453283|Brain Tumor|brain tumor
395247|NCT01453270|Sepsis|sepsis
395248|NCT01453270|Emergency medicine|emergency medicine
395249|NCT01453270|Cardiac output|cardiac output
395250|NCT01453270|Stroke volume|stroke volume
395251|NCT01453270|Lactate|lactate
395252|NCT01453257|Molecular Targets|molecular targets
395253|NCT01453257|Personalize Treatment|personalize treatment
395254|NCT01453257|Colon Cancer|colon cancer
395255|NCT01453257|Complete Response Rate|complete response rate
395256|NCT01453244|Chronic hepatitis C|chronic hepatitis c
395257|NCT01453244|Pharmacogenomics|pharmacogenomics
395258|NCT01453244|IL28B|il28b
395259|NCT01453244|ITPA|itpa
395260|NCT01453231|bariatric surgery|bariatric surgery
395261|NCT01453231|plastic surgery|plastic surgery
395262|NCT01453231|thigh|thigh
395263|NCT01453231|obesity|obesity
395264|NCT01453231|body image|body image
395265|NCT01453231|quality of life|quality of life
395266|NCT01453218|Renal insufficiency|renal insufficiency
395267|NCT01453218|Liver transplant|liver transplant
395268|NCT01453218|Acute rejection|acute rejection
395269|NCT01453218|Infections|infections
395270|NCT01453218|Hepatitis C recurrence|hepatitis c recurrence
395271|NCT01453205|Lymphoma, Non-Hodgkin's Lymphoma, Diffuse Large B-Cell Lymphoma, DLBCL, B-Cell Malignancy, anti-CD19, monoclonal antibody, second line, ASCT, Refractory|lymphoma, non-hodgkin's lymphoma, diffuse large b-cell lymphoma, dlbcl, b-cell malignancy, anti-cd19, monoclonal antibody, second line, asct, refractory
395272|NCT01453192|Raltegravir|raltegravir
395273|NCT01453192|Renal transplantation|renal transplantation
395274|NCT01453192|HIV-1|hiv-1
395275|NCT01453192|Acute renal graft rejection|acute renal graft rejection
395276|NCT01453179|actinic keratosis|actinic keratosis
395277|NCT01453179|invasive SCC|invasive scc
395278|NCT01453179|in situ SCC|in situ scc
395279|NCT01453179|histological classification|histological classification
395280|NCT01453179|histological progression|histological progression
395281|NCT01453179|clinical clearance|clinical clearance
395282|NCT01453179|cryotherapy|cryotherapy
395283|NCT01453153|pancreatic|pancreatic
395284|NCT01453153|Cancer|cancer
395285|NCT01453153|Stage IV|stage iv
395286|NCT01453153|untreated|untreated
395287|NCT01453127|dementia|dementia
395288|NCT01453127|parkinsonism|parkinsonism
395289|NCT01453127|mild cognitive impairment|mild cognitive impairment
395290|NCT01453127|REM sleep behavior disorder|rem sleep behavior disorder
395291|NCT01453114|Cognitive Behavioral Therapy|cognitive behavioral therapy
395293|NCT01453114|relapse|relapse
395294|NCT01453114|postpartum depression|postpartum depression
395295|NCT01453114|depression recurrence|depression recurrence
395296|NCT01453114|depression relapse|depression relapse
395297|NCT01453101|Multiple Myeloma|multiple myeloma
395298|NCT01453101|Transplant|transplant
395299|NCT01453088|multiple myeloma|multiple myeloma
395300|NCT01453088|transplant|transplant
395301|NCT01453075|hepatitis C|hepatitis c
395302|NCT01453075|herpes simplex type 2|herpes simplex type 2
395303|NCT01453075|veterans|veterans
395304|NCT01453062|Ofatumumab|ofatumumab
395305|NCT01453062|Chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
395306|NCT01453062|Arzerra|arzerra
395307|NCT01453049|rosiglitazone/glimepiride, fix dose, type 2 diabetes|rosiglitazone/glimepiride, fix dose, type 2 diabetes
395308|NCT01453036|Peptic ulcer|peptic ulcer
395309|NCT01453036|Helicobacter pylori|helicobacter pylori
395310|NCT01453036|Clarithromycin|clarithromycin
395311|NCT01453036|23S rRNA|23s rrna
395312|NCT01453036|Resistance|resistance
395313|NCT01453023|pediatric ages 5 to 11 years|pediatric ages 5 to 11 years
395314|NCT01453010|SaeboFlex|saeboflex
395315|NCT01453010|Stroke rehabilitation|stroke rehabilitation
395316|NCT01453010|Upper Limb Rehabilitation|upper limb rehabilitation
395317|NCT01453010|Acute Stroke|acute stroke
395318|NCT01452997|mosquito|mosquito
395319|NCT01452997|allergy|allergy
395320|NCT01452997|bite|bite
395321|NCT01452997|ant-inflammatory|ant-inflammatory
395322|NCT01452997|Aedes aegypti mosquito bite|aedes aegypti mosquito bite
395323|NCT01452984|Non-Melanoma skin cancer patients who have undergone or about to undergo Mohs surgery|non-melanoma skin cancer patients who have undergone or about to undergo mohs surgery
395324|NCT01452984|who are treated within the University of Pennsylvania Health System|who are treated within the university of pennsylvania health system
395325|NCT01452971|tumor susceptibility gene|tumor susceptibility gene
395326|NCT01452971|glycine N-methyltransferase (GNMT)|glycine n-methyltransferase (gnmt)
395327|NCT01452971|polycyclic aromatic hydrocarbons (PAHs)|polycyclic aromatic hydrocarbons (pahs)
395328|NCT01452971|lung cancer|lung cancer
395329|NCT01452958|Endotoxin|endotoxin
395330|NCT01452958|LPS|lps
395331|NCT01452958|TNF-α|tnf-α
395332|NCT01452958|insulin resistance|insulin resistance
395333|NCT01452958|metabolism|metabolism
395334|NCT01452932|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
395335|NCT01452932|Dyspnea|dyspnea
395336|NCT01452932|Exercise test|exercise test
395337|NCT01452932|Endurance training|endurance training
395338|NCT01452919|schizophrenia, LY2140023, pomaglumetad methionil|schizophrenia, ly2140023, pomaglumetad methionil
395339|NCT01452906|Drug-drug interaction|drug-drug interaction
395340|NCT01452906|Pharmacokinetics|pharmacokinetics
395341|NCT01452906|PA21|pa21
395342|NCT01452906|Drug Interaction Potentiation|drug interaction potentiation
395343|NCT01452880|Remifentanil|remifentanil
395344|NCT01452880|Lithotripsy|lithotripsy
395345|NCT01452880|Conscious Sedation|conscious sedation
395346|NCT01452867|Airway|airway
395347|NCT01452867|Bag-Valve -Mask- Ventilation|bag-valve -mask- ventilation
395348|NCT01452867|Laryngeal Mask - Ventilation|laryngeal mask - ventilation
395349|NCT01452867|Laryngeal Tube - Ventilation|laryngeal tube - ventilation
395350|NCT01452854|LGG|lgg
395351|NCT01452854|Temozolomide|temozolomide
395352|NCT01452854|Temodar|temodar
395353|NCT01452854|Ovarian Aging|ovarian aging
395354|NCT01452854|Infertility|infertility
395355|NCT01452854|Chemotherapy|chemotherapy
395356|NCT01452841|grapefruit|grapefruit
395357|NCT01452841|weight loss|weight loss
395358|NCT01452841|blood pressure|blood pressure
395359|NCT01452841|lipids|lipids
395360|NCT01452841|inflammation|inflammation
395361|NCT01452828|Renal Impairment|renal impairment
395362|NCT01452815|diabetic gastroparesis|diabetic gastroparesis
395363|NCT01452815|delayed gastric emptying|delayed gastric emptying
395364|NCT01452815|gastroparesis|gastroparesis
395365|NCT01452815|diabetes mellitus, Type 1|diabetes mellitus, type 1
395366|NCT01452815|diabetes mellitus, Type 2|diabetes mellitus, type 2
395367|NCT01452802|HeartMate II|heartmate ii
395368|NCT01452802|heart-assist device|heart-assist device
395369|NCT01452802|medical management|medical management
395370|NCT01452802|optimal medical management|optimal medical management
395371|NCT01452802|Heart Failure NYHA Class IIIB/IV|heart failure nyha class iiib/iv
395372|NCT01452802|Thoratec Corporation|thoratec corporation
395373|NCT01452789|neonatal abstinence syndrome|neonatal abstinence syndrome
395374|NCT01452789|buprenorphine|buprenorphine
395375|NCT01452789|morphine|morphine
395376|NCT01452789|pharmacokinetics|pharmacokinetics
395377|NCT01452776|Drug Therapy|drug therapy
395378|NCT01452763|Drug Therapy|drug therapy
395379|NCT01452750|Drug Therapy|drug therapy
395380|NCT01452737|colonoscopy|colonoscopy
395381|NCT01452737|bowel preparation|bowel preparation
395382|NCT01452737|Golytely|golytely
395383|NCT01452724|Drug Therapy|drug therapy
395384|NCT01452711|Drug Therapy|drug therapy
395385|NCT01452698|Drug Therapy|drug therapy
395386|NCT01452685|Drug Therapy|drug therapy
395387|NCT01452672|Breast cancer|breast cancer
395388|NCT01452672|Radiotherapy|radiotherapy
395389|NCT01452672|Post-mastectomy|post-mastectomy
395390|NCT01452672|Molecular characterization|molecular characterization
395391|NCT01452659|Drug Therapy|drug therapy
395392|NCT01452646|acute myeloid leukemia|acute myeloid leukemia
395393|NCT01452646|risk-adapted therapy|risk-adapted therapy
395394|NCT01452646|MRD-directed therapy|mrd-directed therapy
395395|NCT01452646|young adults|young adults
395396|NCT01452633|pain|pain
395397|NCT01452633|laparoscopy|laparoscopy
395398|NCT01452633|reduction|reduction
395399|NCT01452620|Endovascular Abdominal Aortic Aneurysm Repair (EVAR)|endovascular abdominal aortic aneurysm repair (evar)
395400|NCT01452620|Abdominal Aortic aneurysm (AAA)|abdominal aortic aneurysm (aaa)
395401|NCT01452607|Ebselen|ebselen
395402|NCT01452581|Transfusion|transfusion
395403|NCT01452581|Red blood cells|red blood cells
395404|NCT01452581|Postoperative|postoperative
395405|NCT01452581|Dizziness|dizziness
395406|NCT01452581|Hip Arthroplasty|hip arthroplasty
395407|NCT01452568|Thromboembolic complications|thromboembolic complications
395408|NCT01452568|Bleeding complications|bleeding complications
395409|NCT01452568|Haemorrhagic complications|haemorrhagic complications
395410|NCT01452568|Anticoagulant therapy|anticoagulant therapy
395411|NCT01452568|Aspirin|aspirin
395412|NCT01452568|biological Aorta Valve|biological aorta valve
395413|NCT01452555|HIV|hiv
395414|NCT01452555|HIV Prevention|hiv prevention
395415|NCT01452555|HIV testing|hiv testing
395416|NCT01452555|HIV Rapid Test|hiv rapid test
395417|NCT01452542|Genz-112638|genz-112638
395418|NCT01452529|Pain|pain
395419|NCT01452529|Opioid|opioid
395420|NCT01452516|PLF|plf
395421|NCT01452516|lumbar fusion|lumbar fusion
395422|NCT01452516|bone graft|bone graft
395423|NCT01452516|biologics|biologics
395424|NCT01452503|AE adverse event|ae adverse event
395425|NCT01452503|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
395426|NCT01452503|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
395427|NCT01452503|ART antiretroviral therapy|art antiretroviral therapy
395428|NCT01452503|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
395429|NCT01452503|DCF data collection forms|dcf data collection forms
395430|NCT01452503|DMC Data Monitoring Committee|dmc data monitoring committee
395431|NCT01452503|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
395432|NCT01452503|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
395433|NCT01452503|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
395434|NCT01452503|ICH International Conference of Harmonization|ich international conference of harmonization
395435|NCT01452503|IND Investigational New Drug Application|ind investigational new drug application
395436|NCT01452503|IRB Institutional Review Board|irb institutional review board
395437|NCT01452503|IU International units|iu international units
395438|NCT01452503|mg milligram(s)|mg milligram(s)
395439|NCT01452503|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
395440|NCT01452503|PCR polymerase chain reaction|pcr polymerase chain reaction
395441|NCT01452503|SAE serious adverse event|sae serious adverse event
395442|NCT01452503|µg microgram|µg microgram
395443|NCT01452503|ULN upper limit of the normal range|uln upper limit of the normal range
395444|NCT01452503|WB Western Blot|wb western blot
395445|NCT01452490|Onychomycosis|onychomycosis
395446|NCT01452490|Toenail Fungus|toenail fungus
395447|NCT01452477|Polycystic Ovary Syndrome|polycystic ovary syndrome
395448|NCT01452477|Cryptotanshinone|cryptotanshinone
395449|NCT01452464|observational|observational
395450|NCT01452464|serogroup A, B, Y, W|serogroup a, b, y, w
395451|NCT01452464|meningococcal meningitis|meningococcal meningitis
395452|NCT01452464|meningococcal vaccines|meningococcal vaccines
395453|NCT01452464|safety|safety
395454|NCT01452464|MenACYW-CRM|menacyw-crm
395455|NCT01452464|post-marketing|post-marketing
395456|NCT01452464|adolescents|adolescents
395457|NCT01452438|observational|observational
395458|NCT01452438|serogroup A, B, Y, W|serogroup a, b, y, w
395459|NCT01452438|meningococcal meningitis|meningococcal meningitis
395460|NCT01452438|meningococcal vaccines|meningococcal vaccines
395461|NCT01452438|safety|safety
395462|NCT01452438|MenACYW-CRM|menacyw-crm
395463|NCT01452438|post-marketing|post-marketing
395464|NCT01452438|children|children
395465|NCT01452425|Human volunteers|human volunteers
395466|NCT01452412|Alkali|alkali
395467|NCT01452412|Sodium bicarbonate|sodium bicarbonate
395468|NCT01452412|Kidney disease|kidney disease
395469|NCT01452412|Acidosis|acidosis
395470|NCT01452386|Constipation|constipation
395471|NCT01452386|Stimulation Treatment|stimulation treatment
395472|NCT01452373|Hot flush(es)|hot flush(es)
395473|NCT01452373|Hot flash(es)|hot flash(es)
395474|NCT01452373|Vasomotor symptoms|vasomotor symptoms
395475|NCT01452373|Dehydroepiandrosterone (DHEA)|dehydroepiandrosterone (dhea)
395476|NCT01452373|Prasterone|prasterone
395477|NCT01452373|Acolbifene|acolbifene
395478|NCT01452373|Selective estrogen receptor modulator (SERM)|selective estrogen receptor modulator (serm)
395479|NCT01452373|Antiestrogen|antiestrogen
395480|NCT01452373|Menopause|menopause
395481|NCT01452373|Postmenopausal women|postmenopausal women
395482|NCT01452360|chronic kidney disease|chronic kidney disease
395483|NCT01452321|Transcranial Magnetic Stimulation;|transcranial magnetic stimulation;
395484|NCT01452321|Postpartum Depression;|postpartum depression;
395485|NCT01452321|Clinical Performance;|clinical performance;
395486|NCT01452321|Cognitive Performance;|cognitive performance;
395487|NCT01452321|Social Performance|social performance
395488|NCT01452308|Gilead|gilead
395489|NCT01452308|Gilead Sciences|gilead sciences
395490|NCT01452308|GSI|gsi
395491|NCT01452308|Liver Fibrosis|liver fibrosis
395492|NCT01452308|Liver|liver
395493|NCT01452308|Fibrosis|fibrosis
395494|NCT01452295|liver|liver
395495|NCT01452295|liver failure|liver failure
395496|NCT01452295|acute liver failure|acute liver failure
395497|NCT01452295|ELAD|elad
395498|NCT01452295|alcoholic hepatitis|alcoholic hepatitis
395499|NCT01452295|acute on chronic hepatitis|acute on chronic hepatitis
395500|NCT01452282|Ankle Brachial Index|ankle brachial index
395501|NCT01452282|Perioperative care|perioperative care
395502|NCT01452282|General Surgery|general surgery
395503|NCT01452282|Acute Coronary Syndromes|acute coronary syndromes
395504|NCT01452282|Cardiovascular Complications|cardiovascular complications
395505|NCT01452243|Vitamin D|vitamin d
395506|NCT01452243|Calcium|calcium
395507|NCT01452243|Elderly|elderly
395508|NCT01452230|Bariatric Surgery Candidate|bariatric surgery candidate
395509|NCT01452230|Severely obese|severely obese
395510|NCT01452230|Bariatric surgery|bariatric surgery
395511|NCT01452230|Physical activity|physical activity
395512|NCT01452230|Physical fitness|physical fitness
395513|NCT01452230|Comorbidities|comorbidities
395514|NCT01452230|Quality of life|quality of life
395515|NCT01452230|Surgical complications|surgical complications
395516|NCT01452217|Pancreas|pancreas
395517|NCT01452217|Chronic pancreatitis|chronic pancreatitis
395518|NCT01452217|Perfusion|perfusion
395519|NCT01452217|Blood flow|blood flow
395520|NCT01452217|Magnetic resonance imaging|magnetic resonance imaging
395521|NCT01452204|PEMF|pemf
395522|NCT01452204|magneto|magneto
395523|NCT01452204|shoulder|shoulder
395524|NCT01452204|impingement|impingement
395525|NCT01452191|Cluster Randomised Controlled Trial|cluster randomised controlled trial
395526|NCT01452191|Community Health Services|community health services
395527|NCT01452191|prevention & control|prevention & control
395528|NCT01452191|Accidents, Home|accidents, home
395529|NCT01452191|Child Health Services|child health services
395530|NCT01452178|Cardiovascular diseases|cardiovascular diseases
395531|NCT01452178|Glucometabolic disorders|glucometabolic disorders
395532|NCT01452178|Type-D personality|type-d personality
395533|NCT01452165|Cardiovascular diseases|cardiovascular diseases
395534|NCT01452165|Hypertrophy, Left ventricle|hypertrophy, left ventricle
395535|NCT01452165|Echocardiography|echocardiography
395536|NCT01452165|Prognosis|prognosis
395537|NCT01452152|Pharmacogenomics|pharmacogenomics
395538|NCT01452152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
395539|NCT01452139|STEMI|stemi
395540|NCT01452139|Pharmacogenetics|pharmacogenetics
395541|NCT01452139|Prasugrel|prasugrel
395542|NCT01452139|Clopidogrel|clopidogrel
395543|NCT01452139|Percutaneous Coronary Intervention|percutaneous coronary intervention
395544|NCT01452113|Diabetes Mellitus|diabetes mellitus
395545|NCT01452113|DPP-IV protein|dpp-iv protein
395546|NCT01452113|Glucagon-Like Peptide 1|glucagon-like peptide 1
395547|NCT01452113|autonomic neuropathy|autonomic neuropathy
395548|NCT01452100|embolism|embolism
395549|NCT01452100|cholesterol cristal|cholesterol cristal
395550|NCT01452100|creatinine|creatinine
395551|NCT01452100|renal insufficiency|renal insufficiency
395552|NCT01452100|prednisone|prednisone
395553|NCT01452100|systemic atheroembolism|systemic atheroembolism
395554|NCT01452087|insulin sensitivity|insulin sensitivity
395555|NCT01452087|exercise|exercise
395556|NCT01452074|Insulin Sensitivity|insulin sensitivity
395557|NCT01452074|Exercise Training|exercise training
395558|NCT01452074|Weight Loss|weight loss
395559|NCT01452074|Fat Metabolism|fat metabolism
395560|NCT01452061|Autism Spectrum Disorder|autism spectrum disorder
395561|NCT01452061|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
395562|NCT01452061|Developmental Delay|developmental delay
395563|NCT01452048|insulin sensitivity|insulin sensitivity
395564|NCT01452048|fatty acid metabolism|fatty acid metabolism
395565|NCT01452035|insulin sensitivity|insulin sensitivity
395566|NCT01452035|fatty acid metabolism|fatty acid metabolism
395567|NCT01452035|exercise|exercise
395568|NCT01452022|inductigraft|inductigraft
395569|NCT01452022|osteoinductive|osteoinductive
395570|NCT01452022|synthetic bone graft|synthetic bone graft
395571|NCT01452022|posterolateral lumbar fusion|posterolateral lumbar fusion
395572|NCT01452022|post market|post market
395573|NCT01452022|lumbar spinal stenosis|lumbar spinal stenosis
395574|NCT01452009|open angle glaucoma|open angle glaucoma
395575|NCT01452009|ocular hypertension|ocular hypertension
395576|NCT01451996|direct-to-consumer advertising|direct-to-consumer advertising
395577|NCT01451983|Autism|autism
395578|NCT01451983|PTEN|pten
395579|NCT01451983|macrocephaly|macrocephaly
395580|NCT01451970|high fat diet treatment|high fat diet treatment
395581|NCT01451970|insulin sensitivity|insulin sensitivity
395582|NCT01451957|exercise|exercise
395583|NCT01451957|fatty acid metabolism|fatty acid metabolism
395584|NCT01451957|insulin sensitivity|insulin sensitivity
395585|NCT01451944|Asthma|asthma
395586|NCT01451944|Home Health Nursing|home health nursing
395587|NCT01451944|Patient education|patient education
395588|NCT01451931|kidney stone|kidney stone
395589|NCT01451931|urolithiasis|urolithiasis
395590|NCT01451931|urinary tract infection|urinary tract infection
395591|NCT01451931|ultrasound|ultrasound
395592|NCT01451931|computed tomography|computed tomography
395593|NCT01451931|safety|safety
395594|NCT01451931|cost|cost
395595|NCT01451931|accuracy|accuracy
395596|NCT01451918|Dyslipidaemia|dyslipidaemia
395597|NCT01451918|Insulin resistance|insulin resistance
395598|NCT01451918|Type 2 Diabetes|type 2 diabetes
395599|NCT01451892|Obesity|obesity
395600|NCT01451892|dance|dance
395601|NCT01451892|gait|gait
395602|NCT01451892|balance|balance
395603|NCT01451892|posture|posture
395604|NCT01451892|dance therapy|dance therapy
395605|NCT01451879|Pompe Disease|pompe disease
395606|NCT01451879|Infusion Associated Reaction|infusion associated reaction
395607|NCT01451879|Immune-modulation regimen|immune-modulation regimen
395608|NCT01451866|resistance training|resistance training
395609|NCT01451866|Healthy People Programs|healthy people programs
395610|NCT01451853|Lung Cancer|lung cancer
395611|NCT01451853|Head and Neck Cancer|head and neck cancer
395612|NCT01451853|Hearing Loss|hearing loss
395613|NCT01451853|Ototoxicity|ototoxicity
395614|NCT01451853|Tinnitus|tinnitus
395615|NCT01451853|Deafness|deafness
395616|NCT01451853|SPI-1005|spi-1005
395617|NCT01451853|Cisplatin|cisplatin
395618|NCT01451853|Carboplatin|carboplatin
395619|NCT01451853|Ebselen|ebselen
395620|NCT01451827|Kidney Disease|kidney disease
395621|NCT01451827|Polycystic Kidney Disease|polycystic kidney disease
395622|NCT01451827|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
395623|NCT01451827|PKD|pkd
395624|NCT01451827|ADPKD|adpkd
395625|NCT01451814|smoking cessation|smoking cessation
395626|NCT01451801|Hepatitis B|hepatitis b
395627|NCT01451801|non responders|non responders
395628|NCT01451801|cellular immune response|cellular immune response
395629|NCT01451801|cytokines|cytokines
395630|NCT01451801|predictors|predictors
395631|NCT01451801|HBsAg|hbsag
395632|NCT01451788|RCT|rct
395633|NCT01451788|Gelatin matrix|gelatin matrix
395634|NCT01451788|thrombin|thrombin
395635|NCT01451788|idiopathic scoliosis|idiopathic scoliosis
395636|NCT01451788|Surgery|surgery
395637|NCT01451762|pain|pain
395638|NCT01451762|anesthesia|anesthesia
395639|NCT01451762|surgery|surgery
395640|NCT01451762|postoperative|postoperative
395641|NCT01451749|Mild cognitive impairment|mild cognitive impairment
395642|NCT01451736|First-episode Schizophrenia|first-episode schizophrenia
395643|NCT01451736|Schizoaffective Disorder, Depressed Type (recent-onset)|schizoaffective disorder, depressed type (recent-onset)
395644|NCT01451736|Schizophreniform Disorder|schizophreniform disorder
395645|NCT01451736|oral risperidone|oral risperidone
395646|NCT01451736|long-acting injectable paliperidone palmitate|long-acting injectable paliperidone palmitate
395647|NCT01451736|functional outcome|functional outcome
395648|NCT01451723|Multiple Sclerosis|multiple sclerosis
395649|NCT01451723|Polyphenon E|polyphenon e
395650|NCT01451723|Green tea|green tea
395651|NCT01451723|EGCG|egcg
395652|NCT01451723|Epigallocatechin-galleate|epigallocatechin-galleate
395653|NCT01451723|Placebo|placebo
395654|NCT01451723|Randomized controlled trial|randomized controlled trial
395655|NCT01451710|enough steroids|enough steroids
395656|NCT01451710|MCD|mcd
395657|NCT01451710|efficacy|efficacy
395658|NCT01451684|pregnancy|pregnancy
395659|NCT01451684|fetus|fetus
395660|NCT01451684|euploid|euploid
395661|NCT01451671|fetal|fetal
395662|NCT01451671|aneuploidy|aneuploidy
395663|NCT01451671|non-invasive|non-invasive
395664|NCT01451671|prenatal|prenatal
395665|NCT01451671|cell free DNA|cell free dna
395666|NCT01451658|Variceal bleeding|variceal bleeding
395667|NCT01451658|portal hypertension|portal hypertension
395668|NCT01451658|hepatocellular carcinoma|hepatocellular carcinoma
395669|NCT01451658|endoscopic variceal ligation|endoscopic variceal ligation
395670|NCT01451658|non-selective beta-blocker|non-selective beta-blocker
395671|NCT01451658|rebleeding|rebleeding
395672|NCT01451645|Gout|gout
395673|NCT01451632|Metastatic Colorectal cancer|metastatic colorectal cancer
395674|NCT01451632|Kras wild-type|kras wild-type
395675|NCT01451632|Squamous cell head and neck cancer|squamous cell head and neck cancer
395676|NCT01451632|Non-small cell lung cancer|non-small cell lung cancer
395677|NCT01451632|Triple negative breast cancer|triple negative breast cancer
395678|NCT01451632|EGFR|egfr
395679|NCT01451632|ErbB3|erbb3
395680|NCT01451632|MM-121|mm-121
395681|NCT01451632|Cetuximab|cetuximab
395682|NCT01451632|Irinotecan|irinotecan
395683|NCT01451606|Chronic Pelvic Pain (CPP)|chronic pelvic pain (cpp)
395684|NCT01451606|Pelvic Pain|pelvic pain
395685|NCT01451593|Optic neuritis|optic neuritis
395686|NCT01451593|Multiple sclerosis|multiple sclerosis
395687|NCT01451593|Retinal nerve fibre layer|retinal nerve fibre layer
395688|NCT01451593|Axonal loss|axonal loss
395689|NCT01451593|Neuroprotection|neuroprotection
395691|NCT01451593|MRI|mri
395692|NCT01451593|Optical coherence tomography|optical coherence tomography
395693|NCT01451593|Sodium Channel Blockers|sodium channel blockers
395694|NCT01451580|Phase II|phase ii
395695|NCT01451580|Metastatic Breast Cancer|metastatic breast cancer
395696|NCT01451567|Nurses, Workload, Musculoskeletal System, Intervention|nurses, workload, musculoskeletal system, intervention
395697|NCT01451554|weight|weight
395698|NCT01451554|body mass index|body mass index
395699|NCT01451554|obesity|obesity
395700|NCT01451554|portion control plate|portion control plate
395701|NCT01451554|diet|diet
395702|NCT01451554|exercise|exercise
395703|NCT01451528|Umbilical Cord Blood|umbilical cord blood
395704|NCT01451528|Allogeneic|allogeneic
395705|NCT01451528|Traumatic Brain Injury|traumatic brain injury
395706|NCT01451515|Lymphoblastic lymphoma|lymphoblastic lymphoma
395707|NCT01451502|umbilical cord blood|umbilical cord blood
395708|NCT01451489|FSGS|fsgs
395709|NCT01451489|FK506|fk506
395711|NCT01451476|Ageing|ageing
395712|NCT01451463|Huntington's Disease|huntington's disease
395713|NCT01451463|Chorea|chorea
395714|NCT01451463|Gait|gait
395715|NCT01451463|Balance|balance
395716|NCT01451450|Peanut Allergy|peanut allergy
395717|NCT01451411|Serum Sodium|serum sodium
395718|NCT01451411|Euvolemia|euvolemia
395719|NCT01451411|Hypervolemia|hypervolemia
395720|NCT01451411|Vaprisol®|vaprisol®
395721|NCT01451411|Conivaptan|conivaptan
395722|NCT01451411|YM087|ym087
395723|NCT01451372|Diabetes|diabetes
395724|NCT01451372|CGM|cgm
395725|NCT01451372|CSII|csii
395726|NCT01451346|Pilot study|pilot study
395727|NCT01451333|HIV|hiv
395728|NCT01451333|Efavirenz|efavirenz
395729|NCT01451333|Central Nervous System (CNS)|central nervous system (cns)
395730|NCT01451333|Lumbar puncture|lumbar puncture
395731|NCT01451333|Dose reduction|dose reduction
395732|NCT01451320|Prosthetic valve|prosthetic valve
395733|NCT01451320|thrombosis|thrombosis
395734|NCT01451320|TROIA|troia
395735|NCT01451320|tPA|tpa
395736|NCT01451320|TEE|tee
395737|NCT01451307|Congenital abnormalities|congenital abnormalities
395738|NCT01451307|Digestive system abnormalities|digestive system abnormalities
395739|NCT01451307|Neonatal surgery|neonatal surgery
395740|NCT01451307|Neonatal anesthesia|neonatal anesthesia
395741|NCT01451307|Bayley Scales of Infant Development II|bayley scales of infant development ii
395742|NCT01451294|Cerebral autoregulation|cerebral autoregulation
395743|NCT01451281|Ultrasonography|ultrasonography
395744|NCT01451281|Muscular Dystrophy|muscular dystrophy
395745|NCT01451281|Neuromuscular Disease|neuromuscular disease
395746|NCT01451281|Oligonucleotide|oligonucleotide
395747|NCT01451281|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
395748|NCT01451281|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
395749|NCT01451281|DND|dnd
395750|NCT01451268|60 to 150 Days After Allogeneic Stem Cell Transplantation|60 to 150 days after allogeneic stem cell transplantation
395751|NCT01451268|High Risk MDS|high risk mds
395752|NCT01451268|MDS|mds
395753|NCT01451268|AML|aml
395754|NCT01451255|pulsatility|pulsatility
395755|NCT01451255|normal subjects|normal subjects
395756|NCT01451255|mild pulmonary hypertension|mild pulmonary hypertension
395757|NCT01451255|exercise-associated pulmonary hypertension|exercise-associated pulmonary hypertension
395758|NCT01451242|Heart Rate Variability|heart rate variability
395759|NCT01451242|Acquired Brain Injury|acquired brain injury
395760|NCT01451242|Physical Activity|physical activity
395761|NCT01451229|pharmacokinetics|pharmacokinetics
395762|NCT01451229|pharmacodynamics|pharmacodynamics
395763|NCT01451216|Acquired brain injury|acquired brain injury
395764|NCT01451216|Balance control|balance control
395765|NCT01451216|Functional reach|functional reach
395766|NCT01451203|Cimzia|cimzia
395767|NCT01451203|Early RA|early ra
395768|NCT01451203|Certolizumab Pegol|certolizumab pegol
395769|NCT01451190|Androgenetic Alopecia|androgenetic alopecia
395770|NCT01451190|Male Pattern Baldness|male pattern baldness
395771|NCT01451190|Female Pattern Baldness|female pattern baldness
395772|NCT01451190|Hair Loss|hair loss
395773|NCT01451190|Baldness|baldness
395774|NCT01451177|Androgenetic Alopecia|androgenetic alopecia
395775|NCT01451177|Male Pattern Baldness|male pattern baldness
395776|NCT01451177|Female Pattern Baldness|female pattern baldness
395777|NCT01451177|Hair Loss|hair loss
395778|NCT01451177|Baldness|baldness
395779|NCT01451151|Androgenetic Alopecia|androgenetic alopecia
395780|NCT01451151|Male Pattern Baldness|male pattern baldness
395781|NCT01451151|Female Pattern Baldness|female pattern baldness
395782|NCT01451151|Hair Loss|hair loss
395783|NCT01451151|Baldness|baldness
395784|NCT01451138|Androgenetic Alopecia|androgenetic alopecia
395785|NCT01451138|Male Pattern Baldness|male pattern baldness
395786|NCT01451138|Female Pattern Baldness|female pattern baldness
395787|NCT01451138|Hair Loss|hair loss
395788|NCT01451138|Baldness|baldness
395789|NCT01451125|Androgenetic Alopecia|androgenetic alopecia
395790|NCT01451125|Male Pattern Baldness|male pattern baldness
395791|NCT01451125|Female Pattern Baldness|female pattern baldness
395792|NCT01451125|Hair Loss Baldness|hair loss baldness
395793|NCT01451112|Androgenetic Alopecia|androgenetic alopecia
395794|NCT01451112|Male Pattern Baldness|male pattern baldness
395795|NCT01451112|Female Pattern Baldness|female pattern baldness
395796|NCT01451112|Hair Loss|hair loss
395797|NCT01451112|Baldness|baldness
395798|NCT01451099|Androgenetic Alopecia|androgenetic alopecia
395799|NCT01451099|Male Pattern Baldness|male pattern baldness
395800|NCT01451099|Female Pattern Baldness|female pattern baldness
395801|NCT01451099|Hair Loss|hair loss
395802|NCT01451099|Baldness|baldness
395803|NCT01451086|Safety|safety
395804|NCT01451086|Immunogenicity|immunogenicity
395805|NCT01451086|Pneumococcal vaccine|pneumococcal vaccine
395806|NCT01451073|Androgenetic Alopecia|androgenetic alopecia
395807|NCT01451073|Male Pattern Baldness|male pattern baldness
395808|NCT01451073|Female Pattern Baldness|female pattern baldness
395809|NCT01451073|Hair Loss|hair loss
395810|NCT01451073|Baldness|baldness
395811|NCT01451060|vasopressors|vasopressors
395812|NCT01451060|cesarean anesthesia|cesarean anesthesia
395813|NCT01451060|hypotension|hypotension
395814|NCT01451047|Androgenetic Alopecia|androgenetic alopecia
395815|NCT01451047|Male Pattern Baldness|male pattern baldness
395816|NCT01451047|Female Pattern Baldness|female pattern baldness
395817|NCT01451047|Hair Loss|hair loss
395818|NCT01451047|Baldness|baldness
395819|NCT01451034|WHYX lesion|whyx lesion
395820|NCT01451034|endoscopic resection|endoscopic resection
395821|NCT01451034|complete resection|complete resection
395822|NCT01451034|complete resection rate|complete resection rate
395823|NCT01451034|endoscopic feature|endoscopic feature
395824|NCT01451034|Average size discrepancy|average size discrepancy
395825|NCT01451021|Androgenetic Alopecia|androgenetic alopecia
395826|NCT01451021|Male Pattern Baldness|male pattern baldness
395827|NCT01451021|Female Pattern Baldness|female pattern baldness
395828|NCT01451021|Hair Loss|hair loss
395829|NCT01451021|Baldness|baldness
395830|NCT01451008|Anastomosis|anastomosis
395831|NCT01451008|Compression|compression
395832|NCT01451008|Colon|colon
395833|NCT01450995|Migraine|migraine
395834|NCT01450995|Headache, Migraine|headache, migraine
395835|NCT01450982|Rheumatoid Arthritis|rheumatoid arthritis
395836|NCT01450982|JNJ-38518168|jnj-38518168
395837|NCT01450982|Methotrexate|methotrexate
395838|NCT01450969|Operator Comfort Assessment|operator comfort assessment
395839|NCT01450969|Radiation protection|radiation protection
395840|NCT01450969|Measurement of Radiation Exposure|measurement of radiation exposure
395841|NCT01450969|Endovascular Interventional Radiology|endovascular interventional radiology
395842|NCT01450956|congenital heart diseases|congenital heart diseases
395843|NCT01450956|cardiopulmonary bypass|cardiopulmonary bypass
395844|NCT01450956|Pediatric|pediatric
395845|NCT01450956|sevoflurane|sevoflurane
395846|NCT01450943|Diabetic Foot Ulcer|diabetic foot ulcer
395847|NCT01450943|Chronic wounds|chronic wounds
395848|NCT01450943|Chronic ulcers|chronic ulcers
395849|NCT01450943|Oasis|oasis
395850|NCT01450943|Dermagraft|dermagraft
395851|NCT01450943|Adaptic|adaptic
395852|NCT01450930|Adrenal insufficiency|adrenal insufficiency
395853|NCT01450930|Addison's disease|addison's disease
395854|NCT01450891|Alzheimer's disease|alzheimer's disease
395855|NCT01450891|Diagnosis|diagnosis
395856|NCT01450891|Costs|costs
395857|NCT01450891|Benefits|benefits
395858|NCT01450891|subjective and/or objective memory complaints|subjective and/or objective memory complaints
395859|NCT01450878|high dose of EPO|high dose of epo
395860|NCT01450878|transplant kidney|transplant kidney
395861|NCT01450878|cadaveric organ donor|cadaveric organ donor
395862|NCT01450878|mono-organ (kidney) retrieval|mono-organ (kidney) retrieval
395863|NCT01450878|patient|patient
395864|NCT01450878|kidney graft|kidney graft
395865|NCT01450865|neuropathy|neuropathy
395866|NCT01450865|axonal excitability|axonal excitability
395867|NCT01450865|myelinated nerve|myelinated nerve
395868|NCT01450865|human|human
395869|NCT01450865|ectopic discharge|ectopic discharge
395870|NCT01450865|flupirtine|flupirtine
395871|NCT01450852|Melanocortin Receptor|melanocortin receptor
395872|NCT01450852|Monocyte|monocyte
395873|NCT01450852|Resistance Training|resistance training
395874|NCT01450852|Inflammation|inflammation
395875|NCT01450852|Markers of Inflammation|markers of inflammation
395876|NCT01450839|Transdermal Administration|transdermal administration
395877|NCT01450839|Japanese|japanese
395878|NCT01450839|elderly|elderly
395879|NCT01450839|male|male
395880|NCT01450839|volunteers|volunteers
395881|NCT01450826|Chemotherapy induced nausea and vomiting|chemotherapy induced nausea and vomiting
395882|NCT01450826|CINV|cinv
395883|NCT01450826|Glioma|glioma
395884|NCT01450826|Temozolomide|temozolomide
395885|NCT01450826|Temodar|temodar
395886|NCT01450826|Aprepitant|aprepitant
395887|NCT01450826|Emend|emend
395888|NCT01450826|Ondansetron|ondansetron
395889|NCT01450826|Zofran|zofran
395890|NCT01450826|Pro00031206|pro00031206
395891|NCT01450826|Affronti|affronti
395892|NCT01450826|Peters|peters
395893|NCT01450826|Duke|duke
395894|NCT01450826|Preston Robert Tisch Brain Tumor Center|preston robert tisch brain tumor center
395895|NCT01450800|urinary tract infection|urinary tract infection
395896|NCT01450800|gynecologic surgery|gynecologic surgery
395897|NCT01450800|post-operative complications|post-operative complications
395898|NCT01450800|nitrofurantoin|nitrofurantoin
395899|NCT01450787|dry eyes|dry eyes
395900|NCT01450787|diabetes|diabetes
395901|NCT01450748|sodium alginate|sodium alginate
395902|NCT01450748|laryngopharyngeal reflux|laryngopharyngeal reflux
395903|NCT01450748|combined impedance-pH monitoring|combined impedance-ph monitoring
395904|NCT01450722|Chronic lower limb ischemia|chronic lower limb ischemia
395905|NCT01450722|claudication|claudication
395906|NCT01450722|chronic critical ischemia|chronic critical ischemia
395907|NCT01450709|Probiotics|probiotics
395908|NCT01450709|Kibow Biotics|kibow biotics
395909|NCT01450709|Dialysis|dialysis
395910|NCT01450709|Gut based uremic toxin removal|gut based uremic toxin removal
395911|NCT01450670|Probiotics|probiotics
395912|NCT01450670|Kibow Biotics|kibow biotics
395913|NCT01450670|Dialysis|dialysis
395914|NCT01450670|Gut based uremic toxin removal|gut based uremic toxin removal
395915|NCT01450657|Chronic Kidney failure stage three and four|chronic kidney failure stage three and four
395916|NCT01450657|Probiotics|probiotics
395917|NCT01450657|Kibow Biotics|kibow biotics
395918|NCT01450657|Dialysis|dialysis
395919|NCT01450657|Gut based uremic toxin removal|gut based uremic toxin removal
395920|NCT01450644|Advanced|advanced
395921|NCT01450644|Progressive|progressive
395922|NCT01450644|Idiopathic Fibrotic Interstitial Lung Disease|idiopathic fibrotic interstitial lung disease
395923|NCT01450644|Palliative Care|palliative care
395924|NCT01450644|Randomised|randomised
395925|NCT01450644|Controlled|controlled
395926|NCT01450631|surgical site infection|surgical site infection
395927|NCT01450631|nosocomial infection|nosocomial infection
395928|NCT01450631|post-operative complication|post-operative complication
395929|NCT01450631|surgical incision risk|surgical incision risk
395930|NCT01450631|surgical incision infection|surgical incision infection
395931|NCT01450631|negative pressure wound therapy|negative pressure wound therapy
395932|NCT01450631|wound management|wound management
395933|NCT01450631|cesarean section surgery|cesarean section surgery
395934|NCT01450631|wound dehiscence|wound dehiscence
395935|NCT01450631|wound infection|wound infection
395936|NCT01450631|surgical closure|surgical closure
395937|NCT01450631|wound disruption|wound disruption
395938|NCT01450631|subcutaneous approximation|subcutaneous approximation
395939|NCT01450631|wound separation|wound separation
395940|NCT01450631|seroma|seroma
395941|NCT01450631|hematoma|hematoma
395942|NCT01450631|subcutaneous closure|subcutaneous closure
395943|NCT01450631|obesity|obesity
395944|NCT01450631|cesarean|cesarean
395945|NCT01450631|incision|incision
395946|NCT01450631|massive obesity|massive obesity
395947|NCT01450631|obese|obese
395948|NCT01450631|pregnancy|pregnancy
395949|NCT01450631|cesarean delivery|cesarean delivery
395950|NCT01450631|superobesity|superobesity
395951|NCT01450631|wound complication|wound complication
395952|NCT01450592|Carbohydrate, Dietary|carbohydrate, dietary
395953|NCT01450579|Recombinant Influenza HA vaccine|recombinant influenza ha vaccine
395954|NCT01450579|Immunogenicity of ASP7373|immunogenicity of asp7373
395955|NCT01450566|ureteroscopy (URS)|ureteroscopy (urs)
395956|NCT01450566|ureteral stent placement|ureteral stent placement
395957|NCT01450566|Ureteral Calculi|ureteral calculi
395958|NCT01450566|Renal Calculi|renal calculi
395959|NCT01450553|Tissue Collection|tissue collection
395960|NCT01450553|Lung Cancer|lung cancer
395961|NCT01450553|Non-Small Cell Lung Cancer|non-small cell lung cancer
395962|NCT01450553|Early Stage Lung Cancer|early stage lung cancer
395963|NCT01450527|Etiology and outcomes of ARDS|etiology and outcomes of ards
395964|NCT01450488|primary progressive multiple sclerosis|primary progressive multiple sclerosis
395965|NCT01450488|relapse-free secondary progressive multiple sclerosis|relapse-free secondary progressive multiple sclerosis
395966|NCT01450449|GBM, fractionation, short course, standard course|gbm, fractionation, short course, standard course
395967|NCT01450423|Epilepsy|epilepsy
395968|NCT01450423|Physical activity|physical activity
395969|NCT01450423|Cardio exercise|cardio exercise
395970|NCT01450423|Physical fitness|physical fitness
395971|NCT01450423|Cognitive function|cognitive function
395972|NCT01450410|Dyslipemia, HDL composition|dyslipemia, hdl composition
395973|NCT01450397|Dupuytren's Contracture|dupuytren's contracture
395974|NCT01450384|protocol specific|protocol specific
395975|NCT01450371|Autonomic Nervous System|autonomic nervous system
395976|NCT01450371|Neuromodulation|neuromodulation
395977|NCT01450371|Blood flow control|blood flow control
395978|NCT01450371|Exercise|exercise
395979|NCT01450358|Sepsis|sepsis
395980|NCT01450358|Real time PCR|real time pcr
395981|NCT01450358|Blood culture|blood culture
395982|NCT01450358|Bacteremia diagnosis|bacteremia diagnosis
395983|NCT01450358|Fungemia diagnosis|fungemia diagnosis
395984|NCT01450345|Clinical diagnosis of inguinal hernia|clinical diagnosis of inguinal hernia
395985|NCT01450345|Patient undergo operation under daycare basis|patient undergo operation under daycare basis
395986|NCT01450345|ASA I-II|asa i-ii
395987|NCT01450345|Written consent|written consent
395988|NCT01450332|ACL|acl
395989|NCT01450332|arthroscopy|arthroscopy
395990|NCT01450332|ligament|ligament
395991|NCT01450332|rupture|rupture
395992|NCT01450332|reconstruction|reconstruction
395993|NCT01450332|ACLR|aclr
395994|NCT01450332|accelerated rehabilitation program|accelerated rehabilitation program
395995|NCT01450319|K-RAS|k-ras
395996|NCT01450319|FcγRII/IIIa genotypes|fcγrii/iiia genotypes
395997|NCT01450319|CRC|crc
395998|NCT01450319|Colorectal cancer|colorectal cancer
395999|NCT01450293|Immune response|immune response
396000|NCT01450267|Cystic Fibrosis|cystic fibrosis
396001|NCT01450267|Glutathione|glutathione
396002|NCT01450254|Hip Osteoarthritis|hip osteoarthritis
396003|NCT01450254|Gait Patterns|gait patterns
396004|NCT01450254|Neuromuscular retraining|neuromuscular retraining
396005|NCT01450241|Febrile neutropenia|febrile neutropenia
396006|NCT01450241|Unexplained fever|unexplained fever
396007|NCT01450241|Duration|duration
396008|NCT01450241|Short-term antibiotic treatment|short-term antibiotic treatment
396009|NCT01450228|primary insomnia|primary insomnia
396010|NCT01450215|Relapsed and refractory Multiple Myeloma|relapsed and refractory multiple myeloma
396011|NCT01450202|Carbon dioxide insufflation|carbon dioxide insufflation
396012|NCT01450202|Colonoscopy|colonoscopy
396013|NCT01450202|Esophagogastroduodenoscopy|esophagogastroduodenoscopy
396014|NCT01450202|Bowel insufflation|bowel insufflation
396015|NCT01450202|Postprocedure pain|postprocedure pain
396016|NCT01450202|Pain Due to Certain Specified Procedures|pain due to certain specified procedures
396017|NCT01450189|Acute HIV|acute hiv
396018|NCT01450189|Transmission Prevention|transmission prevention
396019|NCT01450189|Randomized Pilot study|randomized pilot study
396020|NCT01450176|eye|eye
396021|NCT01450176|itching|itching
396022|NCT01450176|allergies|allergies
396023|NCT01450163|Neuropathic pain|neuropathic pain
396024|NCT01450163|prevention|prevention
396025|NCT01450163|prophylaxis|prophylaxis
396026|NCT01450163|chemotherapy|chemotherapy
396027|NCT01450163|neuropathy|neuropathy
396028|NCT01450163|Oxaliplatin|oxaliplatin
396029|NCT01450163|pregabalin|pregabalin
396030|NCT01450150|Major Depression|major depression
396031|NCT01450150|Transcranial Direct Current Stimulation|transcranial direct current stimulation
396032|NCT01450150|Randomized, Sham-Controlled Trial|randomized, sham-controlled trial
396033|NCT01450150|tDCS|tdcs
396034|NCT01450137|Giant Cell Arteritis|giant cell arteritis
396035|NCT01450137|Tocilizumab|tocilizumab
396036|NCT01450137|Antibodies, Monoclonal|antibodies, monoclonal
396037|NCT01450137|Glucocorticoids|glucocorticoids
396038|NCT01450111|Lacosamide|lacosamide
396039|NCT01450059|Human Immunodeficiency Virus|human immunodeficiency virus
396040|NCT01450059|Microchimerism|microchimerism
396041|NCT01450059|Maternal-Fetal Exchange|maternal-fetal exchange
396042|NCT01450059|Gestation|gestation
396043|NCT01450059|HiV-vertical transmission|hiv-vertical transmission
396044|NCT01450046|pancreas|pancreas
396045|NCT01450046|gastrointestinal|gastrointestinal
396046|NCT01450046|GI|gi
396047|NCT01450046|prevention|prevention
396048|NCT01450046|vitamin E|vitamin e
396049|NCT01450033|kidney|kidney
396050|NCT01450033|renal|renal
396051|NCT01450033|transplant|transplant
396052|NCT01450033|transplantation|transplantation
396053|NCT01450033|adolescent|adolescent
396054|NCT01450033|pediatric|pediatric
396055|NCT01450033|mentor|mentor
396056|NCT01450033|mentoring|mentoring
396057|NCT01450033|medication|medication
396058|NCT01450033|adherence|adherence
396059|NCT01450033|immunosuppressant|immunosuppressant
396060|NCT01450033|heart|heart
396061|NCT01450033|liver|liver
396062|NCT01450020|cancer survivor|cancer survivor
396063|NCT01450007|Pain blockade|pain blockade
396064|NCT01450007|Ropivacaine|ropivacaine
396065|NCT01450007|Dexamethasone|dexamethasone
396066|NCT01449994|knee|knee
396067|NCT01449994|hip|hip
396068|NCT01449994|ankle|ankle
396069|NCT01449994|foot|foot
396070|NCT01449994|pain|pain
396071|NCT01449994|lower limb|lower limb
396072|NCT01449994|activator|activator
396073|NCT01449994|instrumental|instrumental
396074|NCT01449994|chiropractic|chiropractic
396075|NCT01449994|Painful functional conditions of the lower extremity|painful functional conditions of the lower extremity
396076|NCT01449981|Adolescents|adolescents
396077|NCT01449981|Alcohol Abuse|alcohol abuse
396078|NCT01449981|Alcohol Dependence|alcohol dependence
396079|NCT01449981|Drug Abuse|drug abuse
396080|NCT01449981|Drug Dependence|drug dependence
396081|NCT01449981|Substance Use Disorder|substance use disorder
396082|NCT01449981|Alcoholics Anonymous|alcoholics anonymous
396083|NCT01449981|Motivational Enhancement Therapy|motivational enhancement therapy
396084|NCT01449981|Cognitive Behavioral Therapy|cognitive behavioral therapy
396085|NCT01449955|PTSD|ptsd
396086|NCT01449942|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
396088|NCT01449942|LMP1|lmp1
396089|NCT01449929|ritonavir|ritonavir
396090|NCT01449929|HIV|hiv
396091|NCT01449929|HAART|haart
396092|NCT01449929|darunavir|darunavir
396093|NCT01449929|antiretroviral|antiretroviral
396094|NCT01449929|dolutegravir|dolutegravir
396095|NCT01449929|GSK1349572|gsk1349572
396096|NCT01449916|Sepsis|sepsis
396097|NCT01449916|Severe Sepsis|severe sepsis
396098|NCT01449916|Protocol|protocol
396099|NCT01449916|Zambia|zambia
396100|NCT01449890|follow up care|follow up care
396101|NCT01449890|e-mail|e-mail
396102|NCT01449890|effectiveness|effectiveness
396103|NCT01449890|depressive disorders|depressive disorders
396104|NCT01449877|Ocular Toxoplasmosis|ocular toxoplasmosis
396105|NCT01449877|Retinochoroiditis|retinochoroiditis
396106|NCT01449877|Prophylaxis|prophylaxis
396107|NCT01449864|upper GI malignancies|upper gi malignancies
396108|NCT01449864|concurrent chemoradiation with continuous infusion 5-Fluorouracil chemotherapy|concurrent chemoradiation with continuous infusion 5-fluorouracil chemotherapy
396109|NCT01449825|hepatic safety|hepatic safety
396110|NCT01449825|prescriber compliance|prescriber compliance
396111|NCT01449825|pazopanib|pazopanib
396112|NCT01449825|epidemiology|epidemiology
396113|NCT01449812|combination vaccine|combination vaccine
396114|NCT01449812|booster vaccination|booster vaccination
396115|NCT01449786|Mal d 1, Bet v 1, sublingual immunotherapy,|mal d 1, bet v 1, sublingual immunotherapy,
396116|NCT01449760|Ankle sprain|ankle sprain
396117|NCT01449760|Balance|balance
396118|NCT01449760|Gait|gait
396119|NCT01449747|Type 2 diabetes mellitus|type 2 diabetes mellitus
396120|NCT01449747|Dipeptidyl peptidase IV inhibitors|dipeptidyl peptidase iv inhibitors
396121|NCT01449747|Glucagon-like peptide 1|glucagon-like peptide 1
396122|NCT01449721|Sepsis|sepsis
396123|NCT01449721|Multiple organ failure|multiple organ failure
396124|NCT01449721|Resuscitation|resuscitation
396125|NCT01449708|Bariatric Surgery|bariatric surgery
396126|NCT01449708|TIVA|tiva
396127|NCT01449708|PONV|ponv
396128|NCT01449708|non-opioid|non-opioid
396129|NCT01449708|OSA|osa
396130|NCT01449695|PAD|pad
396131|NCT01449695|CVA|cva
396132|NCT01449695|ACS|acs
396133|NCT01449682|BRVO|brvo
396134|NCT01449682|CRVO|crvo
396135|NCT01449682|Macular Edema|macular edema
396136|NCT01449682|Anti-VEGF|anti-vegf
396137|NCT01449682|Ozurdex|ozurdex
396138|NCT01449669|pharmacokinetics|pharmacokinetics
396139|NCT01449669|cefazolin|cefazolin
396140|NCT01449669|microdialysis sampling|microdialysis sampling
396141|NCT01449669|interstitial fluid|interstitial fluid
396142|NCT01449669|skeletal muscle|skeletal muscle
396143|NCT01449669|plasma|plasma
396144|NCT01449669|children|children
396145|NCT01449643|Obesity|obesity
396146|NCT01449643|Diaphragm|diaphragm
396147|NCT01449643|Inspiratory muscular training|inspiratory muscular training
396148|NCT01449617|Carotid stenosis|carotid stenosis
396149|NCT01449617|Aspirin plus Clopidogrel|aspirin plus clopidogrel
396150|NCT01449617|Residual platelet reactivity|residual platelet reactivity
396151|NCT01449604|Stereotactic radiotherapy|stereotactic radiotherapy
396152|NCT01449604|SRS|srs
396153|NCT01449604|SRT|srt
396154|NCT01449604|vestibular schwannoma|vestibular schwannoma
396155|NCT01449591|BFH772|bfh772
396156|NCT01449591|rosacea|rosacea
396157|NCT01449591|erythemato-telangiectatic rosacea|erythemato-telangiectatic rosacea
396158|NCT01449565|methamphetamine|methamphetamine
396159|NCT01449565|high-risk sexual behavior|high-risk sexual behavior
396160|NCT01449565|HIV prevention|hiv prevention
396161|NCT01449539|Hyperbaric oxygen|hyperbaric oxygen
396162|NCT01449539|mobilize|mobilize
396163|NCT01449539|stem cells|stem cells
396164|NCT01449539|growth factor|growth factor
396165|NCT01449526|contact lens|contact lens
396166|NCT01449500|Dyspeptic H.pylori-infection|dyspeptic h.pylori-infection
396167|NCT01449487|Experimental pain|experimental pain
396168|NCT01449487|IBS|ibs
396169|NCT01449487|Rectum|rectum
396170|NCT01449448|pain relief|pain relief
396171|NCT01449448|Hypermobility, Joint|hypermobility, joint
396172|NCT01449448|increased strength|increased strength
396173|NCT01449448|increased patient satisfaction|increased patient satisfaction
396174|NCT01449435|Asthma|asthma
396175|NCT01449435|children|children
396176|NCT01449435|predictors of exacerbation|predictors of exacerbation
396177|NCT01449435|Methacholine challenge|methacholine challenge
396178|NCT01449435|Pulmonary function testing|pulmonary function testing
396179|NCT01449409|Uncontrolled asthma|uncontrolled asthma
396180|NCT01449409|Asthma risk|asthma risk
396181|NCT01449409|Asthma impairment|asthma impairment
396182|NCT01449409|Real time asthma outreach program|real time asthma outreach program
396183|NCT01449396|acupuncture|acupuncture
396184|NCT01449396|in vitro fertilization|in vitro fertilization
396185|NCT01449396|embryo transfer|embryo transfer
396186|NCT01449383|cross over|cross over
396187|NCT01449383|dietary intervention|dietary intervention
396188|NCT01449383|fibre|fibre
396189|NCT01449383|red meat|red meat
396190|NCT01449383|microbiota|microbiota
396191|NCT01449370|INK1117|ink1117
396192|NCT01449370|PIK3CA|pik3ca
396193|NCT01449370|KINASE|kinase
396194|NCT01449370|TUMOR|tumor
396195|NCT01449370|CANCER|cancer
396196|NCT01449370|Locally advanced or metastatic solid tumors|locally advanced or metastatic solid tumors
396197|NCT01449370|not eligible for standard of care therapy|not eligible for standard of care therapy
396198|NCT01449357|NSCLC|nsclc
396199|NCT01449357|Zalutumumab|zalutumumab
396200|NCT01449357|Efficacy|efficacy
396201|NCT01449357|Safety|safety
396202|NCT01449344|relapsed|relapsed
396203|NCT01449344|refractory|refractory
396204|NCT01449318|Pain|pain
396205|NCT01449318|quantitative sensory testing|quantitative sensory testing
396206|NCT01449292|PLVR|plvr
396207|NCT01449292|ELVR|elvr
396208|NCT01449292|AeriSeal System|aeriseal system
396209|NCT01449292|foam sealant|foam sealant
396210|NCT01449292|emphysematous lung sealant|emphysematous lung sealant
396211|NCT01449292|ELS|els
396212|NCT01449292|COPD|copd
396213|NCT01449292|emphysema|emphysema
396214|NCT01449292|polymeric lung volume reduction|polymeric lung volume reduction
396215|NCT01449292|heterogeneous|heterogeneous
396216|NCT01449292|Respiratory Tract Diseases|respiratory tract diseases
396217|NCT01449292|Lung Diseases|lung diseases
396218|NCT01449292|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
396219|NCT01449266|Dotarem|dotarem
396220|NCT01449266|Dialyses|dialyses
396221|NCT01449266|Dialysed|dialysed
396222|NCT01449266|Safety|safety
396223|NCT01449266|Safety and dialysability of Dotarem in dialysed patients|safety and dialysability of dotarem in dialysed patients
396224|NCT01449240|Hunter syndrome|hunter syndrome
396225|NCT01449240|Mucopolysaccharidosis II|mucopolysaccharidosis ii
396226|NCT01449240|Iduronate 2-Sulfatase Deficiency|iduronate 2-sulfatase deficiency
396227|NCT01449240|Lumbar puncture|lumbar puncture
396228|NCT01449240|Cerebrospinal fluid (CSF)|cerebrospinal fluid (csf)
396229|NCT01449240|Pediatric|pediatric
396230|NCT01449240|Adult|adult
396231|NCT01449240|Biomarkers|biomarkers
396232|NCT01449227|adhesive capsulitis|adhesive capsulitis
396233|NCT01449227|hip|hip
396234|NCT01449214|Thoracic epidural|thoracic epidural
396235|NCT01449214|Epidural anesthesia|epidural anesthesia
396236|NCT01449214|Ultrasound|ultrasound
396237|NCT01449214|Palpation|palpation
396238|NCT01449214|Thoracic spine|thoracic spine
396239|NCT01449201|PF-00299804, head and neck cancer, squamous cell carcinoma|pf-00299804, head and neck cancer, squamous cell carcinoma
396240|NCT01449188|ondansetron|ondansetron
396241|NCT01449188|moxifloxacin|moxifloxacin
396242|NCT01449188|Zofran|zofran
396243|NCT01449188|thorough QT study|thorough qt study
396244|NCT01449188|IV|iv
396245|NCT01449175|AeriSeal|aeriseal
396246|NCT01449175|treatment|treatment
396247|NCT01449175|device|device
396248|NCT01449175|breathing|breathing
396249|NCT01449175|COPD|copd
396250|NCT01449175|emphysema|emphysema
396251|NCT01449175|polymeric lung volume reduction (PLVR)|polymeric lung volume reduction (plvr)
396252|NCT01449175|biologic lung volume reduction (BLVR)|biologic lung volume reduction (blvr)
396253|NCT01449175|heterogeneous|heterogeneous
396254|NCT01449175|homogeneous|homogeneous
396255|NCT01449175|Respiratory Tract Diseases|respiratory tract diseases
396256|NCT01449175|Lung Diseases|lung diseases
396257|NCT01449175|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
396258|NCT01449162|severe persistent asthma|severe persistent asthma
396259|NCT01449162|patients treated with oral corticosteroids|patients treated with oral corticosteroids
396260|NCT01449149|Age 18 or greater|age 18 or greater
396261|NCT01449149|No prior radiation|no prior radiation
396262|NCT01449136|Antibacterial agents|antibacterial agents
396263|NCT01449136|Deciduous Teeth|deciduous teeth
396264|NCT01449136|Clinical Trial|clinical trial
396265|NCT01449123|Asthma|asthma
396266|NCT01449123|mannitol challenge test|mannitol challenge test
396267|NCT01449123|Sweden|sweden
396268|NCT01449123|primary care|primary care
396269|NCT01449110|Primary prevention|primary prevention
396270|NCT01449110|Secondary prevention|secondary prevention
396271|NCT01449110|Resveratrol|resveratrol
396272|NCT01449110|Grape|grape
396273|NCT01449110|Cardiovascular|cardiovascular
396274|NCT01449110|Nutraceutical|nutraceutical
396275|NCT01449110|Food complement|food complement
396276|NCT01449097|Adductor-Canal-blockade,|adductor-canal-blockade,
396277|NCT01449097|human volunteers,|human volunteers,
396278|NCT01449097|US-guided nerve block|us-guided nerve block
396279|NCT01449097|femoral nerve block|femoral nerve block
396280|NCT01449084|Pancreatic duct stenting|pancreatic duct stenting
396281|NCT01449084|Post-endoscopic pancreatitis|post-endoscopic pancreatitis
396282|NCT01449071|Lupus|lupus
396283|NCT01449071|Monoclonal antibody|monoclonal antibody
396284|NCT01449071|B-cell immunotherapy|b-cell immunotherapy
396285|NCT01449071|Epratuzumab|epratuzumab
396286|NCT01449058|Advanced solid tumor,|advanced solid tumor,
396287|NCT01449058|AML|aml
396288|NCT01449058|high risk and very high risk MDS|high risk and very high risk mds
396289|NCT01449058|dose escalation,|dose escalation,
396290|NCT01449058|RAS/BRAF mutation,|ras/braf mutation,
396291|NCT01449058|PI3K inhibitor,|pi3k inhibitor,
396292|NCT01449058|MEK inhibitor,|mek inhibitor,
396293|NCT01449058|BYL719,|byl719,
396294|NCT01449058|MEK162|mek162
396295|NCT01449045|IPTc|iptc
396296|NCT01449045|Community Case Management|community case management
396297|NCT01449045|Home Management for malaria|home management for malaria
396298|NCT01449032|Patients|patients
396299|NCT01449019|GLP-1|glp-1
396300|NCT01449019|Exendin(9-39)|exendin(9-39)
396301|NCT01449019|Insulin|insulin
396302|NCT01449019|Glucagon|glucagon
396303|NCT01449019|T2DM|t2dm
396304|NCT01449019|incretin effect|incretin effect
396305|NCT01449019|human physiology|human physiology
396306|NCT01449006|HIV|hiv
396307|NCT01449006|HAND|hand
396308|NCT01449006|Maraviroc|maraviroc
396309|NCT01449006|Neurocognitive|neurocognitive
396310|NCT01449006|Neurology|neurology
396311|NCT01449006|Human Immunodeficiency Virus|human immunodeficiency virus
396312|NCT01449006|HIV Associated Neurocognitive Disorders|hiv associated neurocognitive disorders
396313|NCT01448980|massage|massage
396314|NCT01448980|stroke spasticity|stroke spasticity
396315|NCT01448928|Zevalin|zevalin
396316|NCT01448928|CD20+|cd20+
396317|NCT01448928|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
396318|NCT01448928|Mantle Cell Lymphoma|mantle cell lymphoma
396319|NCT01448915|HIV|hiv
396320|NCT01448915|Human immunodeficiency virus|human immunodeficiency virus
396321|NCT01448915|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
396322|NCT01448915|AIDS virus|aids virus
396323|NCT01448915|Immunodeficiency Virus, Human|immunodeficiency virus, human
396324|NCT01448915|Virus, Human Immunodeficiency|virus, human immunodeficiency
396325|NCT01448915|Hepatitis C|hepatitis c
396326|NCT01448915|Hepatitis C, chronic|hepatitis c, chronic
396327|NCT01448915|Hepatitis C virus|hepatitis c virus
396328|NCT01448915|Hepatitis C antibodies|hepatitis c antibodies
396329|NCT01448915|Hepatitis C antigens|hepatitis c antigens
396330|NCT01448902|Allergic rhinitis|allergic rhinitis
396331|NCT01448902|CRTH2|crth2
396332|NCT01448889|contrast induced nephropathy|contrast induced nephropathy
396333|NCT01448889|oxigen|oxigen
396334|NCT01448889|coronary angiography|coronary angiography
396335|NCT01448876|Chlamydia trachomatis|chlamydia trachomatis
396336|NCT01448876|anorectal|anorectal
396337|NCT01448876|cervicovaginal|cervicovaginal
396338|NCT01448876|MSM|msm
396339|NCT01448876|women|women
396340|NCT01448876|treatment|treatment
396341|NCT01448876|RNA|rna
396342|NCT01448876|bacterial load|bacterial load
396343|NCT01448876|sexual behaviour|sexual behaviour
396344|NCT01448876|Azythromycin treated|azythromycin treated
396345|NCT01448850|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
396346|NCT01448850|MEDI8968|medi8968
396347|NCT01448824|Low High-density Lipoprotein (HDL)|low high-density lipoprotein (hdl)
396348|NCT01448824|Cholesterol (HDL-C)|cholesterol (hdl-c)
396349|NCT01448798|radical prostatectomy|radical prostatectomy
396350|NCT01448798|robotic surgery|robotic surgery
396351|NCT01448798|erectile dysfunction|erectile dysfunction
396352|NCT01448798|continence|continence
396353|NCT01448785|obesity|obesity
396354|NCT01448785|gastric stimulation|gastric stimulation
396355|NCT01448785|morbid obesity|morbid obesity
396356|NCT01448772|Dronabinol|dronabinol
396357|NCT01448772|fasting|fasting
396358|NCT01448759|Patients receiving docetaxel or paclitaxel. All tumors.|patients receiving docetaxel or paclitaxel. all tumors.
396359|NCT01448746|gastric cancer|gastric cancer
396360|NCT01448746|VTE|vte
396361|NCT01448746|incidence|incidence
396362|NCT01448733|acne vulgaris|acne vulgaris
396363|NCT01448720|Schizophrenia|schizophrenia
396364|NCT01448720|Paliperidone palmitate|paliperidone palmitate
396365|NCT01448720|Long-acting injectable antipsychotic medication|long-acting injectable antipsychotic medication
396366|NCT01448707|Darunavir (DRV)|darunavir (drv)
396367|NCT01448707|TMC114|tmc114
396368|NCT01448707|Prezista|prezista
396369|NCT01448707|HIV|hiv
396370|NCT01448707|virologic response|virologic response
396371|NCT01448707|neurocognitive function|neurocognitive function
396372|NCT01448694|Hemorrhage|hemorrhage
396373|NCT01448681|Intracranial Hypertension|intracranial hypertension
396374|NCT01448681|Elevated ICP (Intracranial Pressure)|elevated icp (intracranial pressure)
396375|NCT01448668|pancreatic cancer|pancreatic cancer
396376|NCT01448668|mistletoe|mistletoe
396377|NCT01448668|supportive treatment|supportive treatment
396378|NCT01448668|long-term study|long-term study
396379|NCT01448668|non-interventional cohort study|non-interventional cohort study
396380|NCT01448668|controlled study with parallel groups|controlled study with parallel groups
396381|NCT01448655|colorectal cancer|colorectal cancer
396382|NCT01448655|mistletoe|mistletoe
396383|NCT01448655|supportive treatment|supportive treatment
396384|NCT01448655|long-term study|long-term study
396385|NCT01448655|non-interventional cohort study|non-interventional cohort study
396386|NCT01448655|controlled study with parallel groups|controlled study with parallel groups
396387|NCT01448603|Ragweed allergy|ragweed allergy
396388|NCT01448603|ToleroMune ragweed|toleromune ragweed
396389|NCT01448603|immunotherapy|immunotherapy
396390|NCT01448590|post dural puncture headache|post dural puncture headache
396391|NCT01448590|accidental dural puncture|accidental dural puncture
396392|NCT01448590|PDPH|pdph
396393|NCT01448590|ADP|adp
396394|NCT01448590|spinal catheter|spinal catheter
396395|NCT01448590|epidural catheter|epidural catheter
396396|NCT01448590|intrathecal catheter|intrathecal catheter
396397|NCT01448590|dural puncture|dural puncture
396398|NCT01448590|systemic review|systemic review
396399|NCT01448564|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
396400|NCT01448564|Fatigue|fatigue
396401|NCT01448564|laser therapy|laser therapy
396402|NCT01448551|Obesity|obesity
396403|NCT01448551|Treatment|treatment
396404|NCT01448551|Adolescents|adolescents
396405|NCT01448551|Text Messages|text messages
396406|NCT01448551|Mobile phones|mobile phones
396407|NCT01448551|Multidisciplinary|multidisciplinary
396408|NCT01448538|Medication Non-Adherence|medication non-adherence
396409|NCT01448538|Medication Persistence|medication persistence
396410|NCT01448538|wet macular degeneration|wet macular degeneration
396411|NCT01448512|HIV|hiv
396412|NCT01448512|Pregnancy|pregnancy
396413|NCT01448512|Prevention|prevention
396414|NCT01448512|Couples|couples
396415|NCT01448499|schizophrenia|schizophrenia
396416|NCT01448499|clozapine|clozapine
396417|NCT01448499|amisulpride|amisulpride
396418|NCT01448499|combination|combination
396419|NCT01448499|treatment resistant|treatment resistant
396420|NCT01448486|HIV|hiv
396421|NCT01448486|HAND|hand
396422|NCT01448486|Human Immunodeficiency Virus|human immunodeficiency virus
396423|NCT01448486|Raltegravir|raltegravir
396424|NCT01448486|HIV Associated Neurocognitive Disorders|hiv associated neurocognitive disorders
396425|NCT01448486|Neuro-HAART|neuro-haart
396426|NCT01448486|Neurocognitive|neurocognitive
396427|NCT01448486|Neurology|neurology
396428|NCT01448473|Head trauma|head trauma
396429|NCT01448473|Children|children
396430|NCT01448473|Radiography|radiography
396431|NCT01448434|Osteoarthritis|osteoarthritis
396432|NCT01448434|Knee|knee
396433|NCT01448434|Stem cell|stem cell
396434|NCT01448434|MSC|msc
396435|NCT01448421|TAVR|tavr
396436|NCT01448408|Forme Fruste Keratoconus|forme fruste keratoconus
396437|NCT01448408|Corneal Biomechanical properties|corneal biomechanical properties
396438|NCT01448408|Anterior Segment Parameters|anterior segment parameters
396439|NCT01448408|Diagnostic Capacity|diagnostic capacity
396440|NCT01448395|Mass Balance|mass balance
396441|NCT01448395|Metabolite Identification and Profiling|metabolite identification and profiling
396442|NCT01448395|Metabolite profile and Identification of [14C]NXL104|metabolite profile and identification of [14c]nxl104
396443|NCT01448395|Mass Balance Recovery|mass balance recovery
396444|NCT01448369|meibomian gland dysfunction|meibomian gland dysfunction
396445|NCT01448369|hot compress|hot compress
396446|NCT01448369|eyelid warming|eyelid warming
396447|NCT01448369|meibum|meibum
396448|NCT01448356|Controlled adverse chamber|controlled adverse chamber
396449|NCT01448356|tear film stability|tear film stability
396450|NCT01448356|tear film evaporation|tear film evaporation
396451|NCT01448356|tear film break up time|tear film break up time
396452|NCT01448356|humidity|humidity
396453|NCT01448356|temperature|temperature
396454|NCT01448343|transfusion|transfusion
396455|NCT01448343|potassium|potassium
396456|NCT01448330|clopidogrel|clopidogrel
396457|NCT01448330|aspinin|aspinin
396458|NCT01448330|combination|combination
396459|NCT01448291|Contraception|contraception
396460|NCT01448291|Nuvaring|nuvaring
396461|NCT01448291|Vaginal inflammation|vaginal inflammation
396462|NCT01448291|Bacterial vaginosis|bacterial vaginosis
396463|NCT01448291|Nugent score|nugent score
396464|NCT01448278|Anterior cruciate ligament|anterior cruciate ligament
396465|NCT01448278|Arthroscopy|arthroscopy
396466|NCT01448278|Incomplete bone tunnels|incomplete bone tunnels
396467|NCT01448278|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
396468|NCT01448265|atrial fibrillation|atrial fibrillation
396469|NCT01448265|catheter ablation|catheter ablation
396470|NCT01448265|circular mapping catheter|circular mapping catheter
396471|NCT01448265|cryoballoon|cryoballoon
396472|NCT01448252|T cell vaccination|t cell vaccination
396473|NCT01448252|Immunotherapy|immunotherapy
396474|NCT01448252|Tolerance|tolerance
396476|NCT01448252|clinical efficacy|clinical efficacy
396477|NCT01448213|DMEK|dmek
396478|NCT01448213|Rejection|rejection
396479|NCT01448213|Corticosteroid|corticosteroid
396480|NCT01448200|hepatitis C|hepatitis c
396481|NCT01448200|NS5A inhibitor|ns5a inhibitor
396482|NCT01448200|Phase 1|phase 1
396483|NCT01448200|genotype-1|genotype-1
396484|NCT01448200|genotype-2|genotype-2
396485|NCT01448200|genotype-3|genotype-3
396486|NCT01448187|Lung cancer, France|lung cancer, france
396487|NCT01448174|salusin-alpha|salusin-alpha
396488|NCT01448174|atorvastatin|atorvastatin
396489|NCT01448174|CD36|cd36
396490|NCT01448174|Hemodialysis|hemodialysis
396491|NCT01448161|Pediatric|pediatric
396492|NCT01448161|Adult|adult
396493|NCT01448161|ICU|icu
396494|NCT01448148|Mild cognitive impairment|mild cognitive impairment
396495|NCT01448122|Prevention of pigmentation|prevention of pigmentation
396496|NCT01448109|Sepsis|sepsis
396497|NCT01448109|Corticosteroid|corticosteroid
396498|NCT01448096|primary breast diffuse large B cell lymphoma|primary breast diffuse large b cell lymphoma
396499|NCT01448096|rituximab|rituximab
396500|NCT01448096|prophylactic intrathecal chemotherapy|prophylactic intrathecal chemotherapy
396501|NCT01448096|CNS recurrence|cns recurrence
396502|NCT01448083|I-131 MIBG therapy|i-131 mibg therapy
396503|NCT01448083|whole body I-123 MIBG scintigraphy|whole body i-123 mibg scintigraphy
396504|NCT01448057|Paracetamol|paracetamol
396505|NCT01448057|dimethindene maleate|dimethindene maleate
396506|NCT01448057|phenylephrine hydrochloride|phenylephrine hydrochloride
396507|NCT01448057|cold and flu symptoms|cold and flu symptoms
396508|NCT01448044|hepatitis C virus|hepatitis c virus
396509|NCT01448031|Acetyl Salicylic Acid|acetyl salicylic acid
396510|NCT01448031|Bioavailability|bioavailability
396511|NCT01448031|Healthy Volunteers|healthy volunteers
396512|NCT01448005|Coronary Artery Bypass Grafting|coronary artery bypass grafting
396513|NCT01448005|Resuscitation|resuscitation
396514|NCT01448005|Sudden Cardiac Death|sudden cardiac death
396515|NCT01448005|Ventricular Dysfunction|ventricular dysfunction
396516|NCT01447992|Artificial Pancreas|artificial pancreas
396517|NCT01447992|Insulin Pump|insulin pump
396518|NCT01447992|Continuous Glucose Monitor|continuous glucose monitor
396519|NCT01447992|Closed Loop|closed loop
396520|NCT01447979|Artificial Pancreas|artificial pancreas
396521|NCT01447979|Insulin Pump|insulin pump
396522|NCT01447979|Continuous Glucose Monitor|continuous glucose monitor
396523|NCT01447979|Closed Loop|closed loop
396524|NCT01447966|OCD|ocd
396525|NCT01447966|Obsessive Compulsive Disorder|obsessive compulsive disorder
396526|NCT01447966|Child|child
396527|NCT01447966|Pediatric|pediatric
396528|NCT01447966|CBT|cbt
396529|NCT01447966|Therapy|therapy
396530|NCT01447966|ERP|erp
396531|NCT01447966|Exposure Response Prevention|exposure response prevention
396532|NCT01447966|Preschool|preschool
396533|NCT01447966|Cognitive Behavioral|cognitive behavioral
396534|NCT01447953|Activity|activity
396535|NCT01447953|disability|disability
396536|NCT01447953|life-role|life-role
396537|NCT01447953|multimodal rehabilitation|multimodal rehabilitation
396538|NCT01447953|primary health care|primary health care
396539|NCT01447953|persistent pain|persistent pain
396540|NCT01447953|randomized controlled trial|randomized controlled trial
396541|NCT01447953|Musculoskeletal back pain|musculoskeletal back pain
396542|NCT01447940|Telemedicine|telemedicine
396543|NCT01447940|Type 1 diabetes|type 1 diabetes
396544|NCT01447940|economic cost of Type 1 diabetes|economic cost of type 1 diabetes
396545|NCT01447940|ePortal Meos|eportal meos
396546|NCT01447914|c-Met Inhibitor ARQ-197|c-met inhibitor arq-197
396547|NCT01447914|tivantinib|tivantinib
396548|NCT01447914|multiple myeloma|multiple myeloma
396549|NCT01447914|plasma cell proliferative disorder|plasma cell proliferative disorder
396550|NCT01447914|Hypercalcemia|hypercalcemia
396551|NCT01447914|hematologic malignancy|hematologic malignancy
396552|NCT01447914|plasma cell dyscrasia|plasma cell dyscrasia
396553|NCT01447914|cast nephropathy|cast nephropathy
396554|NCT01447914|amyloidosis|amyloidosis
396555|NCT01447914|osteolysis|osteolysis
396556|NCT01447914|Renal insufficiency|renal insufficiency
396557|NCT01447914|Anemia|anemia
396558|NCT01447914|Bone lytic lesions|bone lytic lesions
396559|NCT01447914|severe osteopenia|severe osteopenia
396560|NCT01447914|pathologic fractures|pathologic fractures
396561|NCT01447914|biopsy-proven plasmacytoma|biopsy-proven plasmacytoma
396562|NCT01447901|Hyperlipoproteinemia Type I|hyperlipoproteinemia type i
396563|NCT01447888|Spine surgery|spine surgery
396564|NCT01447888|Chronic pain|chronic pain
396565|NCT01447888|Opioid tolerant|opioid tolerant
396566|NCT01447888|Pain management in spine surgery patients|pain management in spine surgery patients
396567|NCT01447862|recent-onset|recent-onset
396568|NCT01447849|Chronic Constipation|chronic constipation
396569|NCT01447836|indocyanine green|indocyanine green
396570|NCT01447836|sepsis|sepsis
396571|NCT01447836|liver injury|liver injury
396572|NCT01447836|abdominal perfusion pressure|abdominal perfusion pressure
396573|NCT01447823|Oesophageal bolus obstruction|oesophageal bolus obstruction
396574|NCT01447823|Gastroscopy|gastroscopy
396575|NCT01447823|phmetry|phmetry
396576|NCT01447810|Constraint-Induced Movement therapy|constraint-induced movement therapy
396577|NCT01447810|Pediatric|pediatric
396578|NCT01447810|Hemiplegia|hemiplegia
396579|NCT01447810|Brain Tumor|brain tumor
396580|NCT01447810|Rehabilitation|rehabilitation
396581|NCT01447797|Irbesartan|irbesartan
396582|NCT01447797|Atorvastatin|atorvastatin
396583|NCT01447797|combination|combination
396584|NCT01447784|HDM allergy|hdm allergy
396585|NCT01447784|Rhinoconunctivitis|rhinoconunctivitis
396586|NCT01447784|Environmental Exposure Chamber|environmental exposure chamber
396587|NCT01447784|Immunotherapy|immunotherapy
396588|NCT01447784|ToleroMune HDM|toleromune hdm
396589|NCT01447771|Decision making|decision making
396590|NCT01447771|Decisional aide|decisional aide
396591|NCT01447745|Visceral obesity|visceral obesity
396592|NCT01447745|Cardiometabolic risk|cardiometabolic risk
396593|NCT01447745|Atherosclerosis|atherosclerosis
396594|NCT01447745|Ectopic fat|ectopic fat
396595|NCT01447745|Carotid plaque|carotid plaque
396596|NCT01447745|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
396597|NCT01447745|Computed tomography (CT)|computed tomography (ct)
396598|NCT01447732|Monoclonal antibody (Mab)|monoclonal antibody (mab)
396697|NCT01447316|bariatric surgery.|bariatric surgery.
396599|NCT01447732|Antibody dependent cellular cytotoxicity (ADCC)|antibody dependent cellular cytotoxicity (adcc)
396600|NCT01447732|Complement-dependent toxicity (CDC)|complement-dependent toxicity (cdc)
396601|NCT01447732|Non-fucosylated immunoglobulin G|non-fucosylated immunoglobulin g
396602|NCT01447706|Ovarian Cancer|ovarian cancer
396603|NCT01447706|Platinum-resistant|platinum-resistant
396604|NCT01447706|Platinum-refractory|platinum-refractory
396605|NCT01447706|Fallopian tube cancer|fallopian tube cancer
396606|NCT01447706|Peritoneal Cancer|peritoneal cancer
396607|NCT01447706|Paclitaxel|paclitaxel
396608|NCT01447706|ErbB3|erbb3
396609|NCT01447706|Phase II|phase ii
396610|NCT01447706|locally advanced/metastatic or recurrent|locally advanced/metastatic or recurrent
396611|NCT01447693|uremia|uremia
396612|NCT01447693|pruritus|pruritus
396613|NCT01447693|oliva-omega 3|oliva-omega 3
396614|NCT01447680|HIV infection|hiv infection
396615|NCT01447680|HCV infection|hcv infection
396616|NCT01447680|SMARTube|smartube
396617|NCT01447680|SMARTplasma|smartplasma
396618|NCT01447667|Hepatic fibrosis|hepatic fibrosis
396619|NCT01447667|Magnetic resonance elastography|magnetic resonance elastography
396620|NCT01447667|Hepatocellular carcinoma|hepatocellular carcinoma
396621|NCT01447667|Recurrence|recurrence
396622|NCT01447654|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
396623|NCT01447654|Hypertrophic obstructive cardiomyopathy|hypertrophic obstructive cardiomyopathy
396624|NCT01447654|Hypertrophy|hypertrophy
396625|NCT01447654|Losartan|losartan
396626|NCT01447654|Angiotensin II receptor antagonist|angiotensin ii receptor antagonist
396627|NCT01447641|Cluster Headache|cluster headache
396628|NCT01447641|Trigeminal Autonomic Cephalalgias|trigeminal autonomic cephalalgias
396629|NCT01447641|Sleep|sleep
396630|NCT01447641|Circadian Rhythms|circadian rhythms
396631|NCT01447628|Idiopathic pulmonary arterial hypertension (IPAH)|idiopathic pulmonary arterial hypertension (ipah)
396632|NCT01447628|Iron deficiency|iron deficiency
396633|NCT01447615|Orphaned children and youth|orphaned children and youth
396634|NCT01447615|Economic empowerment|economic empowerment
396635|NCT01447615|Uganda|uganda
396636|NCT01447615|HIV/AIDS|hiv/aids
396637|NCT01447615|Sub-Saharan Africa|sub-saharan africa
396638|NCT01447602|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
396639|NCT01447602|Dysthymia|dysthymia
396640|NCT01447602|Depressive Disorder Not Otherwise Specified (DDNOS)|depressive disorder not otherwise specified (ddnos)
396641|NCT01447589|Radiosensitiser|radiosensitiser
396642|NCT01447563|Bioequivalence|bioequivalence
396643|NCT01447563|Bioavailability|bioavailability
396644|NCT01447550|Bosentan|bosentan
396645|NCT01447550|Buerguer disease|buerguer disease
396646|NCT01447537|Cirrhosis|cirrhosis
396647|NCT01447537|Exercise|exercise
396648|NCT01447537|Relaxation|relaxation
396649|NCT01447537|Muscle mass|muscle mass
396650|NCT01447537|Effort tolerance|effort tolerance
396651|NCT01447511|Drug Interactions|drug interactions
396652|NCT01447511|Warfarin|warfarin
396653|NCT01447511|Genetics|genetics
396654|NCT01447511|CYP2C9|cyp2c9
396655|NCT01447511|Healthy Volunteers|healthy volunteers
396656|NCT01447485|Hypertension, chronic kidney disease|hypertension, chronic kidney disease
396657|NCT01447485|nephrotic syndrome|nephrotic syndrome
396658|NCT01447485|pharmacokinetics|pharmacokinetics
396659|NCT01447472|MDMA,|mdma,
396660|NCT01447472|pharmacokinetics,|pharmacokinetics,
396661|NCT01447472|pharmacodynamics,|pharmacodynamics,
396662|NCT01447472|CYP2D6, COMT,|cyp2d6, comt,
396663|NCT01447472|SERT, 5-HTTLPR, gender,|sert, 5-httlpr, gender,
396664|NCT01447472|dextromethorphan,|dextromethorphan,
396665|NCT01447472|caffeine.|caffeine.
396666|NCT01447459|Asthma|asthma
396667|NCT01447459|Asthma Education|asthma education
396668|NCT01447433|Calcium Carbonate|calcium carbonate
396669|NCT01447433|Vitamin D|vitamin d
396670|NCT01447433|Body weight|body weight
396671|NCT01447433|Body fat|body fat
396672|NCT01447433|Metabolic parameters|metabolic parameters
396673|NCT01447433|Energy restriction|energy restriction
396674|NCT01447433|Very-low calcium consumers|very-low calcium consumers
396675|NCT01447433|Obesity|obesity
396676|NCT01447433|Overweight|overweight
396677|NCT01447407|Staphylococcal infections|staphylococcal infections
396678|NCT01447407|Yeast infections|yeast infections
396679|NCT01447407|Candidiasis|candidiasis
396680|NCT01447368|chronic kidney disease|chronic kidney disease
396681|NCT01447368|peritoneal dialysis|peritoneal dialysis
396682|NCT01447368|secondary hyperparathyroidism|secondary hyperparathyroidism
396683|NCT01447368|parathyroidectomy|parathyroidectomy
396684|NCT01447368|vascular calcification|vascular calcification
396685|NCT01447368|cinacalcet|cinacalcet
396686|NCT01447329|pain|pain
396687|NCT01447329|acupuncture|acupuncture
396688|NCT01447329|knee|knee
396689|NCT01447329|debridement|debridement
396690|NCT01447329|surgery|surgery
396691|NCT01447329|arthroscopic knee surgery debridement|arthroscopic knee surgery debridement
396692|NCT01447316|body composition|body composition
396693|NCT01447316|gait|gait
396694|NCT01447316|quality of life|quality of life
396695|NCT01447316|Patients|patients
396696|NCT01447316|undergoing|undergoing
396698|NCT01447303|knee|knee
396699|NCT01447303|osteoarthritis|osteoarthritis
396700|NCT01447303|hyaluronic acid|hyaluronic acid
396701|NCT01447303|viscosupplementation|viscosupplementation
396702|NCT01447290|preeclampsia|preeclampsia
396703|NCT01447290|protein|protein
396704|NCT01447290|creatinine|creatinine
396705|NCT01447290|protein:creatinine ratio|protein:creatinine ratio
396706|NCT01447277|ACL reconstruction|acl reconstruction
396707|NCT01447277|Femoral Block|femoral block
396708|NCT01447277|Sciatic Block|sciatic block
396709|NCT01447264|Rheumatoid arthritis|rheumatoid arthritis
396710|NCT01447264|Muscle strength|muscle strength
396711|NCT01447264|Body composition|body composition
396712|NCT01447264|Physical activity|physical activity
396713|NCT01447264|Water exercises|water exercises
396714|NCT01447264|Hydrotherapy|hydrotherapy
396715|NCT01447264|Randomized controlled clinical trial|randomized controlled clinical trial
396716|NCT01447251|Obstructive Sleep Apnea|obstructive sleep apnea
396717|NCT01447251|Diabetes Mellitus type 2|diabetes mellitus type 2
396718|NCT01447251|DM2|dm2
396719|NCT01447251|OSA|osa
396720|NCT01447251|CPAP|cpap
396721|NCT01447251|continuous positive airway pressure|continuous positive airway pressure
396722|NCT01447238|pancreatic cysts|pancreatic cysts
396723|NCT01447238|EUS/FNA|eus/fna
396724|NCT01447238|Needle-based Confocal Laser Endomicroscopy (nCLE)|needle-based confocal laser endomicroscopy (ncle)
396725|NCT01447238|fiber optic imaging|fiber optic imaging
396726|NCT01447238|EUS/FNA of pancreatic cysts|eus/fna of pancreatic cysts
396727|NCT01447225|Advanced-stage|advanced-stage
396728|NCT01447225|Solid Tumors|solid tumors
396729|NCT01447225|MM-121|mm-121
396730|NCT01447225|Carboplatin|carboplatin
396731|NCT01447225|Pemetrexed|pemetrexed
396732|NCT01447225|Gemcitabine|gemcitabine
396733|NCT01447225|Cabazitaxel|cabazitaxel
396734|NCT01447225|ErbB3|erbb3
396735|NCT01447225|Phase I|phase i
396736|NCT01447225|Cancer|cancer
396737|NCT01447212|Opioid Dependence|opioid dependence
396738|NCT01447212|Long-term Opioid Injectors|long-term opioid injectors
396739|NCT01447212|Opioid Substitution Treatment|opioid substitution treatment
396740|NCT01447212|Hydromorphone|hydromorphone
396741|NCT01447212|Diamorphine|diamorphine
396742|NCT01447212|Diacetylmorphine|diacetylmorphine
396743|NCT01447199|Bladder cancer|bladder cancer
396744|NCT01447199|Colorectal cancer|colorectal cancer
396745|NCT01447199|Endometrial cancer|endometrial cancer
396746|NCT01447199|Kidney cancer|kidney cancer
396747|NCT01447199|Skin cancer|skin cancer
396748|NCT01447199|Uterus cancer|uterus cancer
396749|NCT01447199|Molecular Predisposition|molecular predisposition
396750|NCT01447199|Hereditary Nonpolyposis Colon Cancer|hereditary nonpolyposis colon cancer
396751|NCT01447199|HNPCC|hnpcc
396752|NCT01447199|Molecular genetic testing|molecular genetic testing
396753|NCT01447199|Gene mutations|gene mutations
396754|NCT01447199|Mutation analyses|mutation analyses
396755|NCT01447199|Genetic polymorphisms|genetic polymorphisms
396756|NCT01447199|Family history of cancer|family history of cancer
396757|NCT01447199|Early age of cancer onset|early age of cancer onset
396758|NCT01447199|Little/no personal or family history of cancer|little/no personal or family history of cancer
396759|NCT01447199|Spouses|spouses
396760|NCT01447199|Questionnaires|questionnaires
396761|NCT01447199|Blood sample|blood sample
396762|NCT01447199|Saliva Sample|saliva sample
396763|NCT01447186|Prostate cancer screening|prostate cancer screening
396764|NCT01447186|Prostate Cancer|prostate cancer
396765|NCT01447186|Patient Decision Aid|patient decision aid
396766|NCT01447186|Spanish Speaking Men|spanish speaking men
396767|NCT01447186|Spanish-language slide set|spanish-language slide set
396768|NCT01447186|Focus group|focus group
396769|NCT01447186|Interview|interview
396770|NCT01447186|Survey|survey
396771|NCT01447173|Asthma|asthma
396772|NCT01447173|Pulmonary Function Test|pulmonary function test
396773|NCT01447173|Vitamin D|vitamin d
396774|NCT01447160|facet joint|facet joint
396775|NCT01447160|back pain|back pain
396776|NCT01447160|osteoarthritis|osteoarthritis
396777|NCT01447160|infiltration|infiltration
396778|NCT01447108|Trigeminal Neuralgia|trigeminal neuralgia
396779|NCT01447108|Tic Douloureux|tic douloureux
396780|NCT01447108|Low Intensity Low Frequency Surface Acoustic Wave Ultrasound|low intensity low frequency surface acoustic wave ultrasound
396781|NCT01447095|Subarachnoid hemorrhage|subarachnoid hemorrhage
396782|NCT01447095|vasospasm|vasospasm
396783|NCT01447095|prostacyclin|prostacyclin
396784|NCT01447082|atypical|atypical
396785|NCT01447082|antipsychotics|antipsychotics
396786|NCT01447082|quetiapine|quetiapine
396787|NCT01447069|heart failure stage 3|heart failure stage 3
396788|NCT01447069|beta 2 agonist|beta 2 agonist
396789|NCT01447069|N-terminal pro-brain natriuretic peptide|n-terminal pro-brain natriuretic peptide
396790|NCT01447069|ejection fraction <35%|ejection fraction <35%
396791|NCT01447056|Hodgkin lymphoma|hodgkin lymphoma
396792|NCT01447056|Non-Hodgkin lymphoma|non-hodgkin lymphoma
396793|NCT01447056|Lymphoproliferative disorder|lymphoproliferative disorder
396794|NCT01447056|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
396795|NCT01447056|Leiomyosarcoma|leiomyosarcoma
396796|NCT01447056|EBV Cytotoxic T Lymphocytes|ebv cytotoxic t lymphocytes
396797|NCT01447043|retrospective studies|retrospective studies
396798|NCT01447030|Biliary strictur|biliary strictur
396799|NCT01447030|Hepatojejunostomy|hepatojejunostomy
396800|NCT01447030|Iatrogenic major bile duct injury|iatrogenic major bile duct injury
396801|NCT01446991|prostate neoplasm|prostate neoplasm
396802|NCT01446991|brachytherapy|brachytherapy
396803|NCT01446991|androgen ablation|androgen ablation
396804|NCT01446991|benign prostatic hypertrophy|benign prostatic hypertrophy
396805|NCT01446991|prostate size reduction|prostate size reduction
396806|NCT01446991|localized prostate cancer with prostate volume > 40 cc|localized prostate cancer with prostate volume > 40 cc
396807|NCT01446978|hepatitis A vaccine|hepatitis a vaccine
396808|NCT01446978|TNF-alfa inhibitory drugs|tnf-alfa inhibitory drugs
396809|NCT01446978|Rheumatoid arthritis|rheumatoid arthritis
396810|NCT01446978|methotrexate|methotrexate
396811|NCT01446965|myocardial infarction, acute|myocardial infarction, acute
396812|NCT01446965|myocardial infarction|myocardial infarction
396813|NCT01446965|ventricular dysfunction|ventricular dysfunction
396814|NCT01446965|death, sudden, cardiac|death, sudden, cardiac
396815|NCT01446965|death, sudden|death, sudden
396816|NCT01446965|death|death
396817|NCT01446965|ventricular tachycardia|ventricular tachycardia
396818|NCT01446965|ventricular fibrillation|ventricular fibrillation
396819|NCT01446965|defibrillation, electric|defibrillation, electric
396820|NCT01446965|cardioversion, electric|cardioversion, electric
396821|NCT01446965|electric countershock|electric countershock
396822|NCT01446965|defibrillators, external|defibrillators, external
396823|NCT01446952|prevention|prevention
396824|NCT01446952|pancreas|pancreas
396825|NCT01446939|MRI|mri
396826|NCT01446939|Parkinson's disease|parkinson's disease
396827|NCT01446939|Essential tremor|essential tremor
396828|NCT01446939|Ultrasonography|ultrasonography
396829|NCT01446939|Diagnosis|diagnosis
396830|NCT01446926|Pneumonia|pneumonia
396831|NCT01446926|Pneumococcal Infections|pneumococcal infections
396832|NCT01446926|Streptococcus pneumoniae Infections|streptococcus pneumoniae infections
396833|NCT01446926|Pneumococcal vaccines|pneumococcal vaccines
396834|NCT01446913|Sleep Apnea|sleep apnea
396835|NCT01446913|CPAP adherence|cpap adherence
396836|NCT01446913|behavioral adherence|behavioral adherence
396837|NCT01446913|stroke|stroke
396838|NCT01446900|Rituximab|rituximab
396839|NCT01446900|Cladribine|cladribine
396840|NCT01446900|Chronic Lymphocytic Leukaemia|chronic lymphocytic leukaemia
396841|NCT01446900|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
396842|NCT01446887|Deep Vein Thrombosis|deep vein thrombosis
396843|NCT01446887|total hip arthroplasty|total hip arthroplasty
396844|NCT01446887|prophylactic anticoagulation|prophylactic anticoagulation
396845|NCT01446887|randomized study|randomized study
396846|NCT01446874|Incidence of post-operative pneumonia in patients undergoing surgery for primary lung cancer or primary esophageal cancer|incidence of post-operative pneumonia in patients undergoing surgery for primary lung cancer or primary esophageal cancer
396847|NCT01446861|Cystic fibrosis|cystic fibrosis
396848|NCT01446861|Pancreas|pancreas
396849|NCT01446861|Exocrine function|exocrine function
396850|NCT01446861|Ultrasound|ultrasound
396851|NCT01446861|Contrast ultrasound|contrast ultrasound
396852|NCT01446848|iron deficiency|iron deficiency
396853|NCT01446848|pulmonary hypertension|pulmonary hypertension
396854|NCT01446848|iron supplements|iron supplements
396855|NCT01446848|ferrous sulfate|ferrous sulfate
396856|NCT01446822|urinary bladder neoplasm|urinary bladder neoplasm
396857|NCT01446822|bipolar transurethral resection|bipolar transurethral resection
396858|NCT01446822|monopolar transurethral resection|monopolar transurethral resection
396859|NCT01446822|obturator nerve|obturator nerve
396860|NCT01446796|Ventricular assist device|ventricular assist device
396861|NCT01446783|COL5A1|col5a1
396862|NCT01446783|Collagen disorders|collagen disorders
396863|NCT01446783|IGF-I|igf-i
396864|NCT01446783|Collagen synthesis|collagen synthesis
396865|NCT01446757|quality of life|quality of life
396866|NCT01446757|feeling of security|feeling of security
396867|NCT01446757|costs|costs
396868|NCT01446757|multiprofessional team|multiprofessional team
396869|NCT01446757|geriatric competence|geriatric competence
396870|NCT01446731|Prostate cancer|prostate cancer
396871|NCT01446718|quadrivalent vaccine|quadrivalent vaccine
396872|NCT01446718|Human Papillomavirus|human papillomavirus
396873|NCT01446692|Major depressive disorder|major depressive disorder
396874|NCT01446692|primary care|primary care
396875|NCT01446692|real-world evidence|real-world evidence
396876|NCT01446692|database|database
396877|NCT01446679|Lipitor|lipitor
396878|NCT01446679|HMG-CoA reductase inhibitor|hmg-coa reductase inhibitor
396879|NCT01446666|hepatocellular carcinoma|hepatocellular carcinoma
396880|NCT01446666|surveillance|surveillance
396881|NCT01446666|gadoxetic acid|gadoxetic acid
396882|NCT01446666|MRI|mri
396883|NCT01446653|Fetal Alcohol Spectrum Disorders|fetal alcohol spectrum disorders
396884|NCT01446653|FASDs|fasds
396885|NCT01446653|AEP risk|aep risk
396886|NCT01446653|binge drinking|binge drinking
396887|NCT01446653|ineffective contraception|ineffective contraception
396888|NCT01446627|Absorbable vicryl subcuticular staples|absorbable vicryl subcuticular staples
397289|NCT01445132|BCL|bcl
396889|NCT01446627|metal staples|metal staples
396890|NCT01446627|wound healing|wound healing
396891|NCT01446627|cesarean section|cesarean section
396892|NCT01446601|Apnea|apnea
396893|NCT01446601|OSA|osa
396894|NCT01446601|Sleep Apnea Syndromes|sleep apnea syndromes
396895|NCT01446601|Sleep Apnea, Obstructive|sleep apnea, obstructive
396896|NCT01446601|Hypoglossal Nerve Stimulation|hypoglossal nerve stimulation
396897|NCT01446601|Sleep Disorders|sleep disorders
396898|NCT01446601|Tongue|tongue
396899|NCT01446536|Quality|quality
396900|NCT01446536|Improvement|improvement
396901|NCT01446523|endotoxins HE|endotoxins he
396902|NCT01446510|VTE|vte
396903|NCT01446510|DVT|dvt
396904|NCT01446510|PE|pe
396905|NCT01446510|Risk assessment|risk assessment
396906|NCT01446510|risk score|risk score
396907|NCT01446510|risk analysis|risk analysis
396908|NCT01446510|Venous thromboembolism risk|venous thromboembolism risk
396909|NCT01446497|Normal tension glaucoma|normal tension glaucoma
396910|NCT01446497|Antiglaucoma ophthalmic solution|antiglaucoma ophthalmic solution
396911|NCT01446497|Brimonidine|brimonidine
396912|NCT01446497|Timolol|timolol
396913|NCT01446497|Combination drugs|combination drugs
396914|NCT01446484|Renal transplantation|renal transplantation
396915|NCT01446484|Kidney transplantation|kidney transplantation
396916|NCT01446484|CD4+CD25+CD127lowFoxP3+ T Regulatory Cells|cd4+cd25+cd127lowfoxp3+ t regulatory cells
396917|NCT01446484|T reg|t reg
396918|NCT01446484|Campath|campath
396919|NCT01446471|Bedside Ultrasound|bedside ultrasound
396920|NCT01446471|Point of care ultrasound|point of care ultrasound
396921|NCT01446471|cardiac arrest|cardiac arrest
396922|NCT01446458|Cancer of Pancreas|cancer of pancreas
396923|NCT01446458|Cancer of the Pancreas|cancer of the pancreas
396924|NCT01446458|Neoplasms, Pancreatic|neoplasms, pancreatic
396925|NCT01446458|Pancreas Cancer|pancreas cancer
396926|NCT01446458|Pancreas Neoplasms|pancreas neoplasms
396927|NCT01446458|Entry Term Pancreatic Cancer|entry term pancreatic cancer
396928|NCT01446445|Cytomegalovirus|cytomegalovirus
396929|NCT01446445|renal transplant|renal transplant
396930|NCT01446432|Dupuytren's Contracture|dupuytren's contracture
396931|NCT01446419|chronic axial low back pain|chronic axial low back pain
396932|NCT01446419|vertebrogenic pain|vertebrogenic pain
396933|NCT01446419|Radio frequency ablation|radio frequency ablation
396934|NCT01446406|Bipolar disorder|bipolar disorder
396935|NCT01446406|Electronic daily monitoring|electronic daily monitoring
396936|NCT01446406|Affective episodes|affective episodes
396937|NCT01446354|Blood component transfusion|blood component transfusion
396938|NCT01446354|Hypothermic|hypothermic
396939|NCT01446341|Ankle sprain|ankle sprain
396940|NCT01446341|Functional rehabilitation|functional rehabilitation
396941|NCT01446341|Immobilization|immobilization
396942|NCT01446328|Antipsychotic Drugs|antipsychotic drugs
396943|NCT01446328|Randomized Controlled Trial|randomized controlled trial
396944|NCT01446328|Treatment Effectiveness|treatment effectiveness
396945|NCT01446328|Translational Research|translational research
396946|NCT01446315|asthma|asthma
396947|NCT01446315|asthma care system|asthma care system
396948|NCT01446315|effectiveness|effectiveness
396949|NCT01446315|primary care|primary care
396950|NCT01446315|practice based research network|practice based research network
396951|NCT01446302|Dialysis|dialysis
396952|NCT01446302|Protein-energy wasting|protein-energy wasting
396953|NCT01446302|Insulin-Like Growth Factor I|insulin-like growth factor i
396954|NCT01446302|Insulin-Like Growth Factor Binding Protein 1|insulin-like growth factor binding protein 1
396955|NCT01446302|Inflammation|inflammation
396956|NCT01446289|Group B streptococcus|group b streptococcus
396957|NCT01446289|GBS|gbs
396958|NCT01446289|Vaccine|vaccine
397081|NCT01445795|Inhibitex|inhibitex
396959|NCT01446289|Prevention of group B streptococcus infection|prevention of group b streptococcus infection
396960|NCT01446276|Obesity|obesity
396961|NCT01446276|Resveratrol|resveratrol
396962|NCT01446276|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
396963|NCT01446276|Insulin sensitivity|insulin sensitivity
396964|NCT01446276|Lipid turnover|lipid turnover
396965|NCT01446276|Liver fat content|liver fat content
396966|NCT01446263|Radial access|radial access
396967|NCT01446263|Femoral access|femoral access
396968|NCT01446263|Coronary angiography|coronary angiography
396969|NCT01446263|Coronary artery bypass graft|coronary artery bypass graft
396970|NCT01446250|Chronic hepatitis C|chronic hepatitis c
396971|NCT01446250|Cyclophilin inhibitor|cyclophilin inhibitor
396972|NCT01446224|adverse events|adverse events
396973|NCT01446224|pazopanib|pazopanib
396974|NCT01446224|Torsades des Pointes|torsades des pointes
396975|NCT01446224|renal cell carcinoma|renal cell carcinoma
396976|NCT01446224|anti-VEGF agents|anti-vegf agents
396977|NCT01446224|observational data|observational data
396978|NCT01446224|cardiac ischemia|cardiac ischemia
396979|NCT01446211|gusperimus|gusperimus
396980|NCT01446211|Wegeners granulomatosis|wegeners granulomatosis
396981|NCT01446211|relapse|relapse
396983|NCT01446185|HR+, N- or pN1(mi), Her2- breast cancer adjuvant population|hr+, n- or pn1(mi), her2- breast cancer adjuvant population
396984|NCT01446185|Early Breast cancer|early breast cancer
396985|NCT01446185|Gene Expression|gene expression
396986|NCT01446185|Node-Negative|node-negative
396987|NCT01446185|treatment options|treatment options
396988|NCT01446185|Hormone receptor positive|hormone receptor positive
396989|NCT01446172|Long term outcome|long term outcome
396990|NCT01446159|MEDI-573, breast cancer, metastatic, aromatase inhibitor, anti-IGF|medi-573, breast cancer, metastatic, aromatase inhibitor, anti-igf
396991|NCT01446146|Posttraumatic Stress Disorder|posttraumatic stress disorder
396992|NCT01446146|PTSD Treatment|ptsd treatment
396993|NCT01446146|Decision making|decision making
396994|NCT01446146|Veterans|veterans
396995|NCT01446133|Leukemia|leukemia
396996|NCT01446133|Lymphoma|lymphoma
396997|NCT01446133|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
396998|NCT01446133|CLL|cll
396999|NCT01446133|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
397000|NCT01446133|SLL|sll
397001|NCT01446133|Initial Treatment|initial treatment
397002|NCT01446133|Subsequent Therapy|subsequent therapy
397003|NCT01446133|Rituximab|rituximab
397004|NCT01446133|Rituxan|rituxan
397005|NCT01446133|Lenalidomide|lenalidomide
397006|NCT01446133|CC-5013|cc-5013
397007|NCT01446133|Revlimid|revlimid
397008|NCT01446120|this is phase one study. The study population are healthy volunteers.|this is phase one study. the study population are healthy volunteers.
397009|NCT01446107|tooth decay|tooth decay
397010|NCT01446107|fluoride|fluoride
397011|NCT01446107|sealant|sealant
397012|NCT01446107|prevention|prevention
397013|NCT01446094|Coronary artery disease|coronary artery disease
397014|NCT01446081|chemotherapy|chemotherapy
397015|NCT01446081|exercise|exercise
397016|NCT01446081|quality of life|quality of life
397017|NCT01446081|cancer-related fatigue|cancer-related fatigue
397018|NCT01446081|elderly|elderly
397019|NCT01446081|physical fitness|physical fitness
397020|NCT01446055|Peripheral arterial disease|peripheral arterial disease
397021|NCT01446055|Buerger's disease|buerger's disease
397022|NCT01446055|atherosclerotic arterial occlusion|atherosclerotic arterial occlusion
397023|NCT01446055|bone marrow mononuclear cell|bone marrow mononuclear cell
397024|NCT01446055|chronic limb ischemia|chronic limb ischemia
397025|NCT01446029|Telemonitoring|telemonitoring
397026|NCT01446029|Chronic Kidney Disease|chronic kidney disease
397027|NCT01446016|Breast Cancer|breast cancer
397028|NCT01446016|Breast Tumors|breast tumors
397029|NCT01446016|Cancer of Breast|cancer of breast
397030|NCT01446016|Cancer of the Breast|cancer of the breast
397031|NCT01446016|Human Mammary Carcinoma|human mammary carcinoma
397032|NCT01446016|Mammary Carcinoma, Human|mammary carcinoma, human
397033|NCT01446016|Mammary Neoplasm, Human|mammary neoplasm, human
397034|NCT01446016|Mammary Neoplasms, Human|mammary neoplasms, human
397035|NCT01446016|Neoplasms, Breast|neoplasms, breast
397036|NCT01446016|Tumors, Breast|tumors, breast
397037|NCT01446016|Taxotere|taxotere
397038|NCT01446016|Chloroquine|chloroquine
397039|NCT01446016|Paclitaxel|paclitaxel
397040|NCT01446016|Taxol|taxol
397041|NCT01446016|Ixabepilone|ixabepilone
397042|NCT01446016|Abraxane|abraxane
397043|NCT01446016|Metastatic Breast Cancer|metastatic breast cancer
397044|NCT01446016|Advanced Breast Cancer|advanced breast cancer
397045|NCT01446016|Anthracycline|anthracycline
397046|NCT01445990|free tissue flaps|free tissue flaps
397047|NCT01445990|lactic acid|lactic acid
397048|NCT01445990|glucose|glucose
397049|NCT01445990|thrombosis|thrombosis
397050|NCT01445990|diagnostic test|diagnostic test
397051|NCT01445990|Pedicle postoperative complications diagnosis|pedicle postoperative complications diagnosis
397052|NCT01445977|Sonitus Medical|sonitus medical
397053|NCT01445977|SoundBite|soundbite
397054|NCT01445977|Single Sided Deafness|single sided deafness
397055|NCT01445977|Conductive Hearing Loss|conductive hearing loss
397056|NCT01445977|Unilateral Hearing Loss|unilateral hearing loss
397057|NCT01445964|SLCO2B1 genotype|slco2b1 genotype
397058|NCT01445964|effect of apple juice|effect of apple juice
397059|NCT01445886|Nail Psoriasis|nail psoriasis
397060|NCT01445886|Indigo Naturalis|indigo naturalis
397061|NCT01445886|Indirubin|indirubin
397062|NCT01445886|Calcipotriol|calcipotriol
397063|NCT01445886|Nail Psoriasis Severity Index|nail psoriasis severity index
397064|NCT01445873|Pulmonary arterial hypertension|pulmonary arterial hypertension
397065|NCT01445873|sitaxentan sodium|sitaxentan sodium
397066|NCT01445873|Thelin|thelin
397067|NCT01445860|DDI|ddi
397068|NCT01445860|pharmacokinetics|pharmacokinetics
397069|NCT01445847|Laryngospasm|laryngospasm
397070|NCT01445847|Lidocaine|lidocaine
397071|NCT01445834|outcome of pelvic floor muscle physiotherapy|outcome of pelvic floor muscle physiotherapy
397072|NCT01445834|female|female
397073|NCT01445834|stress urinary incontinence|stress urinary incontinence
397074|NCT01445834|urgency urinary incontinence|urgency urinary incontinence
397075|NCT01445834|mixed urinary incontinence|mixed urinary incontinence
397076|NCT01445821|Autologous Stem Cell Transplantation|autologous stem cell transplantation
397077|NCT01445808|psychodynamic psychotherapy|psychodynamic psychotherapy
397078|NCT01445808|coronary heart disease|coronary heart disease
397079|NCT01445808|physical activity|physical activity
397080|NCT01445808|secondary prevention|secondary prevention
397082|NCT01445795|Chronic Hepatitis|chronic hepatitis
397083|NCT01445795|Hepatitis C Virus|hepatitis c virus
397084|NCT01445782|Safety|safety
397085|NCT01445782|tolerability|tolerability
397086|NCT01445782|healthy|healthy
397087|NCT01445782|inhaled|inhaled
397088|NCT01445769|Myelofibrosis|myelofibrosis
397089|NCT01445769|Primary Myelofibrosis|primary myelofibrosis
397090|NCT01445769|PMF|pmf
397091|NCT01445769|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
397092|NCT01445769|PPV-MF|ppv-mf
397093|NCT01445769|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
397094|NCT01445769|PET-MF|pet-mf
397095|NCT01445769|Open label|open label
397096|NCT01445769|Ruxolitinib|ruxolitinib
397097|NCT01445769|18424|18424
397098|NCT01445769|Jak inhibitor|jak inhibitor
397099|NCT01445756|Intrauterine Device|intrauterine device
397100|NCT01445743|Tdap Vaccine|tdap vaccine
397101|NCT01445743|Pregnant woman|pregnant woman
397102|NCT01445743|Pertussis|pertussis
397103|NCT01445730|fructose|fructose
397104|NCT01445730|hypertriglyceridemia|hypertriglyceridemia
397105|NCT01445730|postprandial lipids|postprandial lipids
397106|NCT01445730|de novo lipogenesis|de novo lipogenesis
397107|NCT01445730|stable isotopes|stable isotopes
397108|NCT01445717|GBS, Streptococcus, .|gbs, streptococcus, .
397109|NCT01445717|Group B|group b
397110|NCT01445704|Weight loss|weight loss
397111|NCT01445704|Probiotics|probiotics
397112|NCT01445704|Gastric Bypass|gastric bypass
397113|NCT01445691|Benign Neoplasms, Brain|benign neoplasms, brain
397114|NCT01445691|Brain Cancer|brain cancer
397115|NCT01445691|Brain Neoplasms, Benign|brain neoplasms, benign
397116|NCT01445691|Brain Neoplasms, Malignant|brain neoplasms, malignant
397117|NCT01445691|Brain Tumor, Primary|brain tumor, primary
397118|NCT01445691|Brain Tumor, Recurrent|brain tumor, recurrent
397119|NCT01445691|Brain Tumors|brain tumors
397120|NCT01445691|Intracranial Neoplasms|intracranial neoplasms
397121|NCT01445691|Neoplasms, Brain|neoplasms, brain
397122|NCT01445691|Neoplasms, Intracranial|neoplasms, intracranial
397123|NCT01445691|Primary Brain Neoplasms|primary brain neoplasms
397124|NCT01445691|Primary Malignant Brain Neoplasms|primary malignant brain neoplasms
397125|NCT01445691|Primary Malignant Brain Tumors|primary malignant brain tumors
397126|NCT01445691|Gliomas|gliomas
397127|NCT01445691|Glioblastoma|glioblastoma
397128|NCT01445691|Surgery|surgery
397129|NCT01445691|5-ALA|5-ala
397130|NCT01445691|Aminolevulinic acid|aminolevulinic acid
397131|NCT01445691|Fluorescence|fluorescence
397132|NCT01445678|cIAI|ciai
397133|NCT01445639|dexmedetomidine|dexmedetomidine
397134|NCT01445639|sedation|sedation
397135|NCT01445639|neurosurgery|neurosurgery
397136|NCT01445639|postoperative care|postoperative care
397137|NCT01445613|Carotid|carotid
397138|NCT01445613|Stent|stent
397139|NCT01445613|Carotid Endarterectomy|carotid endarterectomy
397140|NCT01445600|Impetigo|impetigo
397141|NCT01445600|secondarily-infected traumatic lesions|secondarily-infected traumatic lesions
397142|NCT01445600|retapamulin|retapamulin
397143|NCT01445587|bortezomib|bortezomib
397144|NCT01445587|AKT inhibitor|akt inhibitor
397145|NCT01445587|multiple myeloma|multiple myeloma
397146|NCT01445587|GSK2110183|gsk2110183
397147|NCT01445587|hematologic malignancies|hematologic malignancies
397148|NCT01445561|Interleukin-2|interleukin-2
397149|NCT01445561|IL-2|il-2
397150|NCT01445561|Stem Cells|stem cells
397151|NCT01445561|Regulatory T Cells (T regs)|regulatory t cells (t regs)
397152|NCT01445561|Natural Killer Cells (NK cells)|natural killer cells (nk cells)
397153|NCT01445561|Healthy Volunteer|healthy volunteer
397154|NCT01445561|HV|hv
397155|NCT01445548|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
397156|NCT01445548|Geographic Atrophy|geographic atrophy
397157|NCT01445548|Bilateral Geographic Atrophy|bilateral geographic atrophy
397158|NCT01445548|Sirolimus|sirolimus
397159|NCT01445548|Age Related Macular Degeneration|age related macular degeneration
397160|NCT01445548|AMD|amd
397161|NCT01445535|CD2 Positive|cd2 positive
397162|NCT01445535|Toxicity|toxicity
397163|NCT01445535|EBV Lymphoma|ebv lymphoma
397164|NCT01445535|Chemotherapy Naive|chemotherapy naive
397165|NCT01445535|Maximum Tolerated Dose|maximum tolerated dose
397166|NCT01445535|Lymphoma|lymphoma
397167|NCT01445535|T-Cell Lymphoma|t-cell lymphoma
397168|NCT01445535|NK T-Cell Lymphoma|nk t-cell lymphoma
397169|NCT01445522|PARP Inhibitor|parp inhibitor
397170|NCT01445522|DNA Damage|dna damage
397171|NCT01445522|Chemotherapy|chemotherapy
397172|NCT01445522|Advanced Cancer|advanced cancer
397173|NCT01445522|DNA Repair|dna repair
397174|NCT01445509|Angiogenesis|angiogenesis
397175|NCT01445509|VEGF|vegf
397176|NCT01445509|SRC|src
397177|NCT01445509|Targeted Therapy|targeted therapy
397178|NCT01445509|Cancer|cancer
397179|NCT01445509|Solid Tumor|solid tumor
397180|NCT01445483|Cancer|cancer
397181|NCT01445483|Radiation|radiation
397182|NCT01445483|Brain|brain
397183|NCT01445483|Neuropsychological Outcome|neuropsychological outcome
397184|NCT01445483|Metastasis|metastasis
397185|NCT01445483|Brain Metastasis|brain metastasis
397186|NCT01445444|Habit Reversal Training|habit reversal training
397187|NCT01445444|Hair Pulling|hair pulling
397188|NCT01445444|Children|children
397189|NCT01445444|Trich|trich
397190|NCT01445444|cognitive behavioral therapy|cognitive behavioral therapy
397191|NCT01445444|TTM|ttm
397192|NCT01445444|psychotherapy|psychotherapy
397193|NCT01445418|Genetic|genetic
397194|NCT01445418|BRCA|brca
397195|NCT01445418|Ovarian Cancer, sporadic epithelial ovarian cancer|ovarian cancer, sporadic epithelial ovarian cancer
397196|NCT01445418|Breast Cancer, triple negative breast cancer|breast cancer, triple negative breast cancer
397197|NCT01445418|Metastatic|metastatic
397198|NCT01445418|Breast Cancer|breast cancer
397199|NCT01445418|Ovarian Cancer|ovarian cancer
397200|NCT01445405|Proteasome|proteasome
397201|NCT01445405|Bortezomib|bortezomib
397202|NCT01445405|NF-kappaB|nf-kappab
397203|NCT01445405|Cetuximab|cetuximab
397204|NCT01445405|Epidermal Growth Factor|epidermal growth factor
397205|NCT01445405|Head and Neck Cancer|head and neck cancer
397206|NCT01445405|Squamous Cell Carcinoma|squamous cell carcinoma
397207|NCT01445405|Oral Cancer|oral cancer
397208|NCT01445392|Recombinant Immunotoxin|recombinant immunotoxin
397209|NCT01445392|Monoclonal Antibody|monoclonal antibody
397210|NCT01445392|Pseudomonas Exotoxin|pseudomonas exotoxin
397211|NCT01445392|Targeted Therapy|targeted therapy
397212|NCT01445392|Pleural Mesothelioma|pleural mesothelioma
397213|NCT01445392|Mesothelioma|mesothelioma
397214|NCT01445392|Epithelial Pleural Mesothelioma|epithelial pleural mesothelioma
397215|NCT01445379|Solid Tumor|solid tumor
397216|NCT01445379|Monoclonal Antibody|monoclonal antibody
397217|NCT01445379|Pediatrics|pediatrics
397218|NCT01445379|Pharmacokinetics|pharmacokinetics
397219|NCT01445379|Immunotherapy|immunotherapy
397220|NCT01445379|Sarcoma|sarcoma
397221|NCT01445379|Lymphoma|lymphoma
397222|NCT01445379|Neuroblastoma|neuroblastoma
397223|NCT01445340|Topical Depsi|topical depsi
397224|NCT01445340|Cutaneous T Cell Lymphoma|cutaneous t cell lymphoma
397225|NCT01445340|CTCL|ctcl
397226|NCT01445340|Mycosis Fungoides|mycosis fungoides
397227|NCT01445327|Blood|blood
397228|NCT01445327|Urine|urine
397229|NCT01445327|Stool|stool
397230|NCT01445327|Tumor Marker|tumor marker
397231|NCT01445327|Radiation Therapy|radiation therapy
397232|NCT01445327|Gastrointestinal Cancer|gastrointestinal cancer
397233|NCT01445327|Esophageal Cancer|esophageal cancer
397234|NCT01445327|Stomach|stomach
397235|NCT01445327|Pancreatic Cancer|pancreatic cancer
397236|NCT01445314|Stored Data|stored data
397237|NCT01445314|Neurobehavioral|neurobehavioral
397238|NCT01445314|Behavior|behavior
397239|NCT01445314|Quality of Life|quality of life
397240|NCT01445301|twice daily|twice daily
397241|NCT01445301|once daily|once daily
397242|NCT01445301|CLDM 1%-BPO 3% gel|cldm 1%-bpo 3% gel
397243|NCT01445301|Clindamycin (CLDM)|clindamycin (cldm)
397244|NCT01445301|benzoyl peroxide (BPO)|benzoyl peroxide (bpo)
397245|NCT01445301|inflammatory lesion|inflammatory lesion
397246|NCT01445301|non-inflammatory lesion|non-inflammatory lesion
397247|NCT01445301|acne vulgaris|acne vulgaris
397248|NCT01445288|Neurotoxicity|neurotoxicity
397249|NCT01445288|Brain Tumor|brain tumor
397250|NCT01445288|Children|children
397251|NCT01445288|Angiogenesis|angiogenesis
397252|NCT01445288|Imaging|imaging
397253|NCT01445288|Central Nervous System Tumor|central nervous system tumor
397254|NCT01445288|CNS Tumor|cns tumor
397255|NCT01445249|regional anaesthetic techniques|regional anaesthetic techniques
397256|NCT01445249|surgery orthopaedic|surgery orthopaedic
397257|NCT01445236|Operational tolerance|operational tolerance
397258|NCT01445236|Biomarkers|biomarkers
397259|NCT01445236|Liver Transplantation|liver transplantation
397260|NCT01445223|HIV|hiv
397261|NCT01445223|Antiretroviral therapy|antiretroviral therapy
397262|NCT01445223|efavirenz|efavirenz
397263|NCT01445223|lopinavir|lopinavir
397264|NCT01445223|atazanavir|atazanavir
397265|NCT01445223|randomised controlled clinical trial|randomised controlled clinical trial
397266|NCT01445210|Postoperative pain|postoperative pain
397267|NCT01445210|Major ankle surgery|major ankle surgery
397268|NCT01445210|Continuous nerve block|continuous nerve block
397269|NCT01445210|Saphenous nerve|saphenous nerve
397270|NCT01445210|Ropivacaine|ropivacaine
397271|NCT01445171|Aortic Valve Replacement|aortic valve replacement
397272|NCT01445158|ShopTalk|shoptalk
397273|NCT01445158|Comprehension|comprehension
397274|NCT01445158|Donors|donors
397275|NCT01445158|Education|education
397276|NCT01445158|Stem Cell Transplant|stem cell transplant
397277|NCT01445158|Sibling Donor|sibling donor
397278|NCT01445145|End-of-Life|end-of-life
397279|NCT01445145|Advance Directive|advance directive
397280|NCT01445145|Pediatric Cancer|pediatric cancer
397281|NCT01445145|Adolescents|adolescents
397282|NCT01445145|Young Adults|young adults
397283|NCT01445132|Adoptive Immunotherapy|adoptive immunotherapy
397284|NCT01445132|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
397285|NCT01445132|Refractory Tumor|refractory tumor
397286|NCT01445132|Resection|resection
397287|NCT01445132|B-Cell Malignancies|b-cell malignancies
397288|NCT01445132|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
397290|NCT01445132|B-Cell Lymphoid Malignancy|b-cell lymphoid malignancy
397291|NCT01445119|Brain|brain
397292|NCT01445119|Tumor|tumor
397293|NCT01445119|Radiation|radiation
397294|NCT01445119|Antiangiogenesis|antiangiogenesis
397295|NCT01445119|Chemotherapy|chemotherapy
397296|NCT01445119|Brain Tumor|brain tumor
397297|NCT01445119|Glioma|glioma
397298|NCT01445106|HIV Protease Inhibitor|hiv protease inhibitor
397299|NCT01445106|Drug Repositioning|drug repositioning
397300|NCT01445106|Akt/Mtor Inhibitor|akt/mtor inhibitor
397301|NCT01445106|Targeted Therapy|targeted therapy
397302|NCT01445106|Off - Label Drugs|off - label drugs
397303|NCT01445106|Nelfinavir|nelfinavir
397304|NCT01445106|Protease Inhibitor|protease inhibitor
397305|NCT01445106|Solid Tumor|solid tumor
397306|NCT01445106|Phase I|phase i
397307|NCT01445106|Malignant Tumor|malignant tumor
397308|NCT01445080|MTD|mtd
397309|NCT01445080|Phase I/II|phase i/ii
397310|NCT01445080|Pediatric|pediatric
397311|NCT01445080|Solid Tumor|solid tumor
397312|NCT01445080|Leukemia|leukemia
397313|NCT01445080|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
397314|NCT01445080|CML|cml
397315|NCT01445080|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
397316|NCT01445080|ALL|all
397317|NCT01445080|Acute Myeloid Leukemia|acute myeloid leukemia
397318|NCT01445080|AML|aml
397319|NCT01445080|Juevenile Myelomoncytic Leukemia|juevenile myelomoncytic leukemia
397320|NCT01445080|JMML|jmml
397321|NCT01445054|111 Indium Trastuzumab Imaging|111 indium trastuzumab imaging
397322|NCT01445054|PET|pet
397323|NCT01445054|Optimal Scanning Strategy|optimal scanning strategy
397324|NCT01445054|Breast Cancer|breast cancer
397325|NCT01445041|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
397326|NCT01445041|Autologous Umbilical Cord Blood|autologous umbilical cord blood
397327|NCT01445041|Newborn Infants|newborn infants
397328|NCT01445015|adolescents|adolescents
397329|NCT01445002|grass pollen allergy|grass pollen allergy
397330|NCT01445002|immunotherapy|immunotherapy
397331|NCT01445002|recombinant vaccine|recombinant vaccine
397332|NCT01444989|"Sun spots"|"sun spots"
397333|NCT01444989|"Pre-cancerous skin lesion"|"pre-cancerous skin lesion"
397334|NCT01444976|age range of 18-83|age range of 18-83
397335|NCT01444924|Pain control|pain control
397336|NCT01444924|Gynecologic Oncology|gynecologic oncology
397337|NCT01444924|Surgery|surgery
397338|NCT01444911|Sexual Dysfunction|sexual dysfunction
397339|NCT01444911|Gynecologic cancer|gynecologic cancer
397340|NCT01444911|Cancer survivor|cancer survivor
397341|NCT01444911|Vaginal dilator|vaginal dilator
397342|NCT01444898|Prader-Willi Syndrome|prader-willi syndrome
397343|NCT01444898|Obesity|obesity
397344|NCT01444898|Weight|weight
397345|NCT01444898|Exenatide|exenatide
397346|NCT01444898|Byetta|byetta
397347|NCT01444898|Pediatrics|pediatrics
397348|NCT01444898|Adolescents|adolescents
397349|NCT01444885|Variant angina|variant angina
397350|NCT01444885|Cilostazol|cilostazol
397351|NCT01444846|Temporary Auditory Threshold Shift|temporary auditory threshold shift
397352|NCT01444846|Hearing Loss|hearing loss
397353|NCT01444846|Deafness|deafness
397354|NCT01444846|SPI-1005|spi-1005
397355|NCT01444846|Ebselen|ebselen
397356|NCT01444833|hypertension|hypertension
397357|NCT01444833|obesity|obesity
397358|NCT01444833|metabolism|metabolism
397359|NCT01444833|angiotensin|angiotensin
397360|NCT01444820|radiation therapy|radiation therapy
397361|NCT01444820|hypofractionation|hypofractionation
397362|NCT01444820|hormonal therapy|hormonal therapy
397363|NCT01444820|high risk adenocarcinoma of the prostate|high risk adenocarcinoma of the prostate
397364|NCT01444807|sorafenib|sorafenib
397365|NCT01444807|metastatic renal cell carcinoma|metastatic renal cell carcinoma
397366|NCT01444807|metastasectomy|metastasectomy
397367|NCT01444794|Lower limb spasticity|lower limb spasticity
397368|NCT01444781|Diphtheria|diphtheria
397369|NCT01444781|Tetanus|tetanus
397370|NCT01444781|Whooping Cough|whooping cough
397371|NCT01444781|Hepatitis B|hepatitis b
397372|NCT01444781|Poliomyelitis|poliomyelitis
397373|NCT01444781|Pediatric combined vaccine|pediatric combined vaccine
397374|NCT01444781|Invasive Hib infections|invasive hib infections
397375|NCT01444768|Alert Systems, Medication|alert systems, medication
397376|NCT01444768|Computerized Physician Order Entry System|computerized physician order entry system
397377|NCT01444768|CPOE|cpoe
397378|NCT01444768|Medication Alert Systems|medication alert systems
397379|NCT01444768|Medical Order Entry Systems|medical order entry systems
397380|NCT01444755|Locally advanced gastric cancer|locally advanced gastric cancer
397381|NCT01444755|neoadjuvant chemotherapy|neoadjuvant chemotherapy
397382|NCT01444742|Leukemia|leukemia
397383|NCT01444742|Myeloproliferative Diseases|myeloproliferative diseases
397384|NCT01444742|Myelodysplastic Syndrome|myelodysplastic syndrome
397385|NCT01444742|(MDS)|(mds)
397386|NCT01444742|Relapsing|relapsing
397387|NCT01444742|Refractory|refractory
397388|NCT01444742|Clofarabine|clofarabine
397389|NCT01444742|Clofarex|clofarex
397390|NCT01444742|Clolar|clolar
397391|NCT01444742|Cytarabine|cytarabine
397392|NCT01444742|Ara-C|ara-c
397393|NCT01444742|Cytosar|cytosar
397394|NCT01444742|DepoCyt|depocyt
397395|NCT01444742|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
397396|NCT01444729|'Dupuytren's contracture'|'dupuytren's contracture'
397397|NCT01444729|'xiapex'|'xiapex'
397398|NCT01444729|'surgery'|'surgery'
397399|NCT01444716|Advanced Cancers|advanced cancers
397400|NCT01444716|Leukemia|leukemia
397401|NCT01444716|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
397402|NCT01444716|CLL|cll
397403|NCT01444716|Elderly|elderly
397404|NCT01444716|Ofatumumab|ofatumumab
397405|NCT01444716|Arzerra|arzerra
397406|NCT01444703|Thoracic surgery|thoracic surgery
397407|NCT01444703|double-lumen endotracheal tube|double-lumen endotracheal tube
397408|NCT01444703|intubation|intubation
397409|NCT01444703|extubation|extubation
397410|NCT01444703|sore throat|sore throat
397411|NCT01444703|prevention of post-extubation sore throat|prevention of post-extubation sore throat
397412|NCT01444690|Antiretroviral therapy|antiretroviral therapy
397413|NCT01444690|Acquired Immunodeficiency Syndrome/complications*|acquired immunodeficiency syndrome/complications*
397414|NCT01444690|Anti-HIV Agents/adverse effects|anti-hiv agents/adverse effects
397415|NCT01444677|Safety|safety
397416|NCT01444677|Tolerability|tolerability
397417|NCT01444677|Pharmacokinetic|pharmacokinetic
397418|NCT01444651|Tadalafil|tadalafil
397419|NCT01444651|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors
397420|NCT01444651|Cyclic Guanylyl Monophosphate Pathway|cyclic guanylyl monophosphate pathway
397421|NCT01444651|Pharmacologic Actions|pharmacologic actions
397422|NCT01444651|Vasodilator Agents|vasodilator agents
397423|NCT01444651|Cardiovascular Agents|cardiovascular agents
397424|NCT01444651|Obesity|obesity
397425|NCT01444651|Glycemic Traits|glycemic traits
397426|NCT01444651|Insulin Resistance|insulin resistance
397427|NCT01444651|Glucose Metabolism|glucose metabolism
397428|NCT01444638|pregnancy|pregnancy
397429|NCT01444638|Caesarian|caesarian
397430|NCT01444638|section|section
397431|NCT01444638|spinal|spinal
397432|NCT01444625|UV radiation|uv radiation
397433|NCT01444625|photoprotection|photoprotection
397434|NCT01444625|flavanols rich chocolate|flavanols rich chocolate
397435|NCT01444612|cancer surgery|cancer surgery
397436|NCT01444612|venous thromboembolism|venous thromboembolism
397437|NCT01444612|hospitalization|hospitalization
397438|NCT01444612|anticoagulants|anticoagulants
397439|NCT01444612|costs and cost analysis|costs and cost analysis
397440|NCT01444612|thromboprophylaxis|thromboprophylaxis
397441|NCT01444599|coronary atherosclerosis|coronary atherosclerosis
397442|NCT01444599|virtual histology intravascular ultrasound|virtual histology intravascular ultrasound
397443|NCT01444599|fractional flow reserve|fractional flow reserve
397444|NCT01444586|non-interventional|non-interventional
397445|NCT01444586|Xarelto|xarelto
397446|NCT01444586|knee replacement|knee replacement
397447|NCT01444586|hip replecement|hip replecement
397448|NCT01444586|Russia|russia
397449|NCT01444573|Rate control|rate control
397450|NCT01444573|ILR|ilr
397451|NCT01444547|esophageal cancer|esophageal cancer
397452|NCT01444547|paclitaxel|paclitaxel
397453|NCT01444547|cisplatin|cisplatin
397454|NCT01444534|mobile phone application|mobile phone application
397455|NCT01444534|diabetes type 1|diabetes type 1
397456|NCT01444534|self-management|self-management
397457|NCT01444534|telemedicin|telemedicin
397458|NCT01444521|advanced gastric cancer|advanced gastric cancer
397459|NCT01444521|irinotecan|irinotecan
397460|NCT01444521|cisplatin|cisplatin
397461|NCT01444495|rectal cancer|rectal cancer
397462|NCT01444495|radiotherapy|radiotherapy
397463|NCT01444495|overall survival|overall survival
397464|NCT01444495|recurrence rate|recurrence rate
397465|NCT01444495|downstaging|downstaging
397466|NCT01444469|Asthma exacerbations|asthma exacerbations
397467|NCT01444469|Respiratory disease|respiratory disease
397468|NCT01444469|Viral infection|viral infection
397469|NCT01444469|Macrolide/ketolide antibiotics|macrolide/ketolide antibiotics
397470|NCT01444469|Mycoplasma pneumoniae (M. pneumoniae)|mycoplasma pneumoniae (m. pneumoniae)
397471|NCT01444469|Chlamydophila pneumoniae (C. pneumoniae)|chlamydophila pneumoniae (c. pneumoniae)
397472|NCT01444456|Breast Cancer|breast cancer
397473|NCT01444456|Lung Cancer|lung cancer
397474|NCT01444456|Ovarian Cancer|ovarian cancer
397475|NCT01444456|Prostate Cancer|prostate cancer
397476|NCT01444456|Colorectal Cancer|colorectal cancer
397477|NCT01444456|Aranesp|aranesp
397478|NCT01444456|Chemotherapy induced anaemia|chemotherapy induced anaemia
397479|NCT01444456|Chemotherapy|chemotherapy
397480|NCT01444456|Bladder Cancer|bladder cancer
397481|NCT01444456|Endometrial Cancer|endometrial cancer
397482|NCT01444456|Renal Cancer|renal cancer
397483|NCT01444456|Pancreatic Cancer|pancreatic cancer
397484|NCT01444456|Esophageal Cancer|esophageal cancer
397485|NCT01444456|Gastric Cancer|gastric cancer
397486|NCT01444443|Type 1 diabetes|type 1 diabetes
397487|NCT01444443|Glucose control|glucose control
397488|NCT01444443|Closed-loop|closed-loop
397489|NCT01444443|Insulin pump|insulin pump
397490|NCT01444443|Glucose sensor|glucose sensor
397491|NCT01444430|Symbicort pMDI|symbicort pmdi
397492|NCT01444430|Asthma|asthma
397493|NCT01444430|safety|safety
397494|NCT01444430|budesonide|budesonide
397495|NCT01444417|Immune (Idiopathic) Thrombocytopenic Purpura|immune (idiopathic) thrombocytopenic purpura
397496|NCT01444417|Pediatric Immune (Idiopathic) Thrombocytopenic Purpura|pediatric immune (idiopathic) thrombocytopenic purpura
397497|NCT01444417|Immune Thrombocytopenia|immune thrombocytopenia
397498|NCT01444404|Solid Tumors|solid tumors
397499|NCT01444404|Phase 1|phase 1
397500|NCT01444404|Clinical Trial|clinical trial
397501|NCT01444391|Tympanostomy tube placement|tympanostomy tube placement
397502|NCT01444391|iontophoresis|iontophoresis
397503|NCT01444378|Atherosclerosis|atherosclerosis
397504|NCT01444378|Claudication|claudication
397505|NCT01444378|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
397506|NCT01444378|Stent|stent
397507|NCT01444365|Osteoarthritis of the knee|osteoarthritis of the knee
397508|NCT01444352|Pneumococcal infections|pneumococcal infections
397509|NCT01444352|Streptococcus pneumoniae Infections|streptococcus pneumoniae infections
397510|NCT01444352|Pneumococcal Vaccines|pneumococcal vaccines
397511|NCT01444339|Pneumococcal Infections|pneumococcal infections
397512|NCT01444339|Streptococcus Pneumoniae Infections|streptococcus pneumoniae infections
397513|NCT01444339|Pneumococcal Vaccine|pneumococcal vaccine
397514|NCT01444326|Keywords;|keywords;
397515|NCT01444326|Cardiovascular disease|cardiovascular disease
397516|NCT01444326|Dairy|dairy
397517|NCT01444326|Inflammation|inflammation
397518|NCT01444326|Blood lipids|blood lipids
397519|NCT01444300|multiple sclerosis|multiple sclerosis
397520|NCT01444300|postural balance|postural balance
397521|NCT01444300|gait|gait
397522|NCT01444300|fatigue|fatigue
397523|NCT01444261|iron deficiency|iron deficiency
397524|NCT01444261|anemia|anemia
397525|NCT01444248|Amaryl MEX|amaryl mex
397526|NCT01444235|CAD, ACVB|cad, acvb
397527|NCT01444222|Myocardial contractility|myocardial contractility
397528|NCT01444222|Quantification of regurgitant flow|quantification of regurgitant flow
397529|NCT01444222|exercise capacity|exercise capacity
397530|NCT01444209|pituitary gland|pituitary gland
397531|NCT01444196|ACU|acu
397532|NCT01444196|acquired cold urticaria|acquired cold urticaria
397533|NCT01444183|Epilepsy|epilepsy
397534|NCT01444183|seizures|seizures
397535|NCT01444183|stress reduction|stress reduction
397536|NCT01444170|eccentric exercise|eccentric exercise
397537|NCT01444170|exercise induce muscle damage|exercise induce muscle damage
397538|NCT01444170|isometric strength|isometric strength
397539|NCT01444170|range of motion|range of motion
397540|NCT01444170|self report symptoms|self report symptoms
397541|NCT01444170|mechanical pain threshold|mechanical pain threshold
397542|NCT01444144|Ankle|ankle
397543|NCT01444144|Fracture|fracture
397544|NCT01444144|Elderly|elderly
397545|NCT01444144|At-risk Population|at-risk population
397546|NCT01444144|Ankle Fracture in at-risk elderly population|ankle fracture in at-risk elderly population
397547|NCT01444131|Smoking|smoking
397548|NCT01444131|Smoking cessation|smoking cessation
397549|NCT01444131|Pharmaceutical aids|pharmaceutical aids
397550|NCT01444105|Open angle glaucoma|open angle glaucoma
397551|NCT01444105|Pseudoexfoliative glaucoma|pseudoexfoliative glaucoma
397552|NCT01444079|Liver transplantation|liver transplantation
397553|NCT01444079|Rejection|rejection
397554|NCT01444079|Tolerance|tolerance
397555|NCT01444040|Open angle glaucoma|open angle glaucoma
397556|NCT01444040|POAG|poag
397557|NCT01444040|Ocular hypertension|ocular hypertension
397558|NCT01444040|Pseudoexfoliative glaucoma|pseudoexfoliative glaucoma
397559|NCT01444040|Naïve to treatment|naïve to treatment
397560|NCT01444014|YF476|yf476
397561|NCT01444014|netazepide|netazepide
397562|NCT01444014|hypergastrinaemia|hypergastrinaemia
397563|NCT01444014|gastric carcinoids|gastric carcinoids
397564|NCT01444001|Pneumococcal Infections|pneumococcal infections
397565|NCT01444001|Pneumococcal Vaccines|pneumococcal vaccines
397566|NCT01444001|pneumococcal protein|pneumococcal protein
397567|NCT01443988|Open angle glaucoma|open angle glaucoma
397568|NCT01443988|POAG|poag
397569|NCT01443988|Ocular hypertension|ocular hypertension
397570|NCT01443988|Pseudoexfoliative glaucoma|pseudoexfoliative glaucoma
397571|NCT01443988|Naïve to treatment|naïve to treatment
397572|NCT01443975|Total Hip Arthroplasty|total hip arthroplasty
397573|NCT01443975|Osteoarthritis|osteoarthritis
397574|NCT01443962|laparoscopic cholecystectomy|laparoscopic cholecystectomy
397575|NCT01443962|PEEP|peep
397576|NCT01443962|rSO2|rso2
397577|NCT01443949|fMRI|fmri
397578|NCT01443949|Reward|reward
397579|NCT01443949|Adolescents|adolescents
397580|NCT01443949|Impulse Control|impulse control
397581|NCT01443949|Cabergoline|cabergoline
397582|NCT01443936|Influenza Vaccine|influenza vaccine
397583|NCT01443936|H5N1 Influenza|h5n1 influenza
397584|NCT01443936|Normal Volunteer|normal volunteer
397585|NCT01443936|Adenovirus|adenovirus
397586|NCT01443936|Live Virus Vaccine|live virus vaccine
397587|NCT01443936|Healthy Volunteer|healthy volunteer
397588|NCT01443936|HV|hv
397589|NCT01443923|Hepatitis|hepatitis
397590|NCT01443923|Immunological Response|immunological response
397591|NCT01443923|Virological Response|virological response
397592|NCT01443923|Resistance Mutations|resistance mutations
397593|NCT01443923|Viral Kinetics|viral kinetics
397594|NCT01443923|Hepatitis C|hepatitis c
397595|NCT01443923|HCV|hcv
397596|NCT01443910|Body Weight|body weight
397597|NCT01443910|Immersive Virtual Enviroment Technology|immersive virtual enviroment technology
397598|NCT01443897|Vitamin D|vitamin d
397599|NCT01443871|Volunteer|volunteer
397600|NCT01443858|Smoking Cessation|smoking cessation
397601|NCT01443858|Cigarette Smoking|cigarette smoking
397602|NCT01443858|Meclizine|meclizine
397603|NCT01443858|Nicotine Patch|nicotine patch
397604|NCT01443845|COPD|copd
397605|NCT01443845|Exacerbations|exacerbations
397606|NCT01443845|Roflumilast|roflumilast
397607|NCT01443845|Daliresp|daliresp
397608|NCT01443832|ferrous sulfate|ferrous sulfate
397609|NCT01443832|iron absorption|iron absorption
397610|NCT01443832|Beninese women|beninese women
397611|NCT01443832|fonio|fonio
397612|NCT01443819|Radiculopathy|radiculopathy
397613|NCT01443819|Transforaminal|transforaminal
397614|NCT01443819|Disc Protrusion|disc protrusion
397615|NCT01443806|oseltamivir metabolism|oseltamivir metabolism
397616|NCT01443806|Carboxylesterase 1|carboxylesterase 1
397617|NCT01443780|Selenium|selenium
397618|NCT01443780|Q10|q10
397619|NCT01443780|dietary supplement|dietary supplement
397620|NCT01443780|elderly population|elderly population
397621|NCT01443780|intervention|intervention
397622|NCT01443780|All-cause mortality|all-cause mortality
397623|NCT01443780|cardiac function|cardiac function
397624|NCT01443767|Cardiac Output|cardiac output
397625|NCT01443767|esCCO|escco
397626|NCT01443767|Pulse Wave Transit Time|pulse wave transit time
397627|NCT01443767|PiCCO|picco
397628|NCT01443767|Pulse Contour Analysis|pulse contour analysis
397629|NCT01443767|Non-invasive Monitoring|non-invasive monitoring
397630|NCT01443767|Partial Liver Resection|partial liver resection
397631|NCT01443741|FIT Therapy|fit therapy
397632|NCT01443741|Diabetes mellitus|diabetes mellitus
397633|NCT01443741|Insulin pump|insulin pump
397634|NCT01443741|Pediatric|pediatric
397635|NCT01443728|sickle cell disease|sickle cell disease
397636|NCT01443728|acute chest syndrome|acute chest syndrome
397637|NCT01443728|respiratory complications|respiratory complications
397638|NCT01443728|vitamin D|vitamin d
397639|NCT01443715|MDD|mdd
397640|NCT01443715|Dysthymia|dysthymia
397641|NCT01443715|Depressive Disorder Not Otherwise Specified (DDNOS)|depressive disorder not otherwise specified (ddnos)
397642|NCT01443702|Kidney Calculi|kidney calculi
397643|NCT01443702|Iranian traditional medicine|iranian traditional medicine
397644|NCT01443702|Lapis judaicus|lapis judaicus
397645|NCT01443689|Extensive Burn|extensive burn
397646|NCT01443689|Human Cord Blood Mononuclear Cells|human cord blood mononuclear cells
397647|NCT01443689|Human Umbilical Cord Mesenchymal Stem Cells|human umbilical cord mesenchymal stem cells
397648|NCT01443637|Coronary Artery Disease|coronary artery disease
397649|NCT01443637|CAD|cad
397650|NCT01443637|Atherosclerosis|atherosclerosis
397651|NCT01443637|Myocardial Infarction|myocardial infarction
397652|NCT01443637|MI|mi
397653|NCT01443637|CONFIRM|confirm
397654|NCT01443637|Coronary Computed Tomographic Angiography|coronary computed tomographic angiography
397655|NCT01443637|CCTA|ccta
397656|NCT01443624|iron|iron
397657|NCT01443624|critical illness|critical illness
397658|NCT01443624|oxidative stress|oxidative stress
397659|NCT01443611|Infants|infants
397660|NCT01443598|Pulmonary arterial hypertension,|pulmonary arterial hypertension,
397661|NCT01443598|Interstitial lung disease at HRCT|interstitial lung disease at hrct
397662|NCT01443585|Progressive Addition Lens|progressive addition lens
397663|NCT01443585|Multifocal|multifocal
397664|NCT01443585|Presbyopia|presbyopia
397665|NCT01443572|Kasai operation under general anesthesia|kasai operation under general anesthesia
397666|NCT01443559|Xenogenic|xenogenic
397667|NCT01443546|oocyte donor|oocyte donor
397668|NCT01443546|oocyte recipient|oocyte recipient
397669|NCT01443546|ovulation trigger|ovulation trigger
397670|NCT01443533|Contraception|contraception
397671|NCT01443533|Contraception behavior|contraception behavior
397672|NCT01443533|Postnatal care|postnatal care
397673|NCT01443533|Health education|health education
397674|NCT01443533|Randomized controlled trial|randomized controlled trial
397675|NCT01443520|Pharmacokinetics|pharmacokinetics
397676|NCT01443520|Pharmacodynamics|pharmacodynamics
397677|NCT01443507|aerobic capacity|aerobic capacity
397678|NCT01443507|maximal oxygen uptake|maximal oxygen uptake
397679|NCT01443507|aerobic endurance|aerobic endurance
397680|NCT01443507|work economy|work economy
397681|NCT01443507|lactate threshold|lactate threshold
397682|NCT01443507|endurance training|endurance training
397683|NCT01443507|exercise intensity|exercise intensity
397684|NCT01443494|septic shock|septic shock
397685|NCT01443494|microcirculation|microcirculation
397686|NCT01443494|norepinephrine|norepinephrine
397687|NCT01443494|fluid|fluid
397688|NCT01443481|solid tumors|solid tumors
397689|NCT01443481|hepatic impairment|hepatic impairment
397690|NCT01443481|Child-Pugh classification|child-pugh classification
397691|NCT01443481|pharmacokinetics|pharmacokinetics
397692|NCT01443481|PK|pk
397693|NCT01443481|RECIST 1.1|recist 1.1
397694|NCT01443468|Tp53|tp53
397695|NCT01443468|Cancer|cancer
397696|NCT01443468|Hereditary|hereditary
397697|NCT01443468|Genetic Testing|genetic testing
397698|NCT01443468|Screening|screening
397699|NCT01443468|Li-Fraumeni Syndrome|li-fraumeni syndrome
397700|NCT01443468|LFS|lfs
397701|NCT01443455|menopause|menopause
397702|NCT01443455|sedentary|sedentary
397703|NCT01443455|overweight|overweight
397704|NCT01443442|Conjunctivitis|conjunctivitis
397705|NCT01443442|Allergic|allergic
397706|NCT01443442|Bepotastine besilate|bepotastine besilate
397707|NCT01443442|Loteprednol etabonate|loteprednol etabonate
397708|NCT01443429|TRK-100STP|trk-100stp
397709|NCT01443429|PK|pk
397710|NCT01443429|beraprost sodium|beraprost sodium
397711|NCT01443429|Japanese males and females|japanese males and females
397712|NCT01443429|Subjects with mild/moderate/severe patients|subjects with mild/moderate/severe patients
397713|NCT01443429|renal impairment|renal impairment
397714|NCT01443416|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
397715|NCT01443416|invasive pneumococcal disease|invasive pneumococcal disease
397716|NCT01443416|vaccination|vaccination
397717|NCT01443416|children|children
397718|NCT01443403|Opioid Therapy|opioid therapy
397719|NCT01443403|Non-Malignant Chronic Pain|non-malignant chronic pain
397720|NCT01443403|Opioid-Induced Constipation|opioid-induced constipation
397721|NCT01443390|Whole genome sequencing|whole genome sequencing
397722|NCT01443390|Advanced Refractory Cancer|advanced refractory cancer
397724|NCT01443377|rectal cancer|rectal cancer
397725|NCT01443377|KRAS|kras
397726|NCT01443377|Panitumumab|panitumumab
397727|NCT01443377|neoadjuvant|neoadjuvant
397728|NCT01443377|Radiochemotherapy|radiochemotherapy
397729|NCT01443377|antibody|antibody
397730|NCT01443377|locally advanced KRAS wild type rectal cancer|locally advanced kras wild type rectal cancer
397731|NCT01443364|Certolizumab pegol - Cimzia|certolizumab pegol - cimzia
397732|NCT01443364|Rheumatoid Arthritis|rheumatoid arthritis
397733|NCT01443364|Power Doppler Ultrasonography|power doppler ultrasonography
397734|NCT01443364|Italy|italy
397735|NCT01443364|Moderate-severe Rheumatoid Arthritis|moderate-severe rheumatoid arthritis
397736|NCT01443351|ITP|itp
397737|NCT01443351|romiplostim|romiplostim
397738|NCT01443351|eltrombopag|eltrombopag
397739|NCT01443351|bone marrow fibrosis|bone marrow fibrosis
397740|NCT01443351|long-term safety|long-term safety
397741|NCT01443338|Triptergium wilfordii|triptergium wilfordii
397742|NCT01443338|Acitretin|acitretin
397743|NCT01443338|psoriasis vulgaris|psoriasis vulgaris
397744|NCT01443325|Persistent Postherniorrhaphy inguinal Pain|persistent postherniorrhaphy inguinal pain
397745|NCT01443312|Beta globin gene|beta globin gene
397746|NCT01443312|Alfa globin gene|alfa globin gene
397747|NCT01443312|xmn1 polymorphism|xmn1 polymorphism
397748|NCT01443273|Newborns|newborns
397749|NCT01443260|oncolytic virus|oncolytic virus
397750|NCT01443260|oncolytic|oncolytic
397751|NCT01443260|GL-ONC1|gl-onc1
397752|NCT01443260|Vaccinia|vaccinia
397753|NCT01443260|Vaccinia virus|vaccinia virus
397754|NCT01443260|Genelux|genelux
397755|NCT01443260|Genelux GmbH|genelux gmbh
397756|NCT01443260|peritoneal|peritoneal
397757|NCT01443260|peritoneal carcinomatosis|peritoneal carcinomatosis
397758|NCT01443260|cancer|cancer
397759|NCT01443260|abdominal cancer|abdominal cancer
397760|NCT01443260|imaging|imaging
397761|NCT01443234|Depression|depression
397762|NCT01443234|Cognitive Bias|cognitive bias
397763|NCT01443234|Internet|internet
397764|NCT01443221|mitiglinide|mitiglinide
397765|NCT01443221|metformin|metformin
397766|NCT01443221|Pharmacokinetics|pharmacokinetics
397767|NCT01443221|Safety|safety
397768|NCT01443208|pharmacokinetics|pharmacokinetics
397769|NCT01443208|safety|safety
397770|NCT01443208|desvenlafaxine|desvenlafaxine
397771|NCT01443208|Korean healthy subjects|korean healthy subjects
397772|NCT01443169|Pharmacokinetic|pharmacokinetic
397773|NCT01443169|relative oral bioavailability|relative oral bioavailability
397774|NCT01443169|pregabalin|pregabalin
397775|NCT01443156|Diet|diet
397776|NCT01443156|Sleep deficiency|sleep deficiency
397777|NCT01443156|Cancer|cancer
397778|NCT01443156|Obesity|obesity
397779|NCT01443156|Diabetes|diabetes
397780|NCT01443156|Shift work|shift work
397781|NCT01443156|Work schedule|work schedule
397782|NCT01443156|Cardiovascular disease|cardiovascular disease
397783|NCT01443156|Body composition|body composition
397784|NCT01443156|Body mass index|body mass index
397785|NCT01443156|Body fat percentage|body fat percentage
397786|NCT01443143|Diabetes|diabetes
397787|NCT01443143|Obesity|obesity
397788|NCT01443143|Glycemic|glycemic
397789|NCT01443143|Portion-control|portion-control
397790|NCT01443143|Commercial diet|commercial diet
397791|NCT01443130|malaria,Malawi,pregnancy|malaria,malawi,pregnancy
397792|NCT01443104|coronary artery disease|coronary artery disease
397793|NCT01443104|drug-eluting stents|drug-eluting stents
397794|NCT01443104|polymers|polymers
397795|NCT01443091|very low birth weight infants|very low birth weight infants
397796|NCT01443091|VLBW infants|vlbw infants
397797|NCT01443091|colostrum|colostrum
397798|NCT01443078|Carboplatin|carboplatin
397799|NCT01443078|Cisplatin|cisplatin
397800|NCT01443078|Pemetrexed (Altima)|pemetrexed (altima)
397801|NCT01443078|Taxotere (Docetaxel)|taxotere (docetaxel)
397802|NCT01443078|Vinorelbine Tartrate (Navelbine)|vinorelbine tartrate (navelbine)
397803|NCT01443078|Stage IB-III|stage ib-iii
397804|NCT01443078|non squamous|non squamous
397805|NCT01443078|non-small cell lung cancer|non-small cell lung cancer
397806|NCT01443078|11-106|11-106
397807|NCT01443065|Adenocarcinoma|adenocarcinoma
397808|NCT01443065|Locally advanced (non operable) or metastatic|locally advanced (non operable) or metastatic
397809|NCT01443065|First line treatment|first line treatment
397810|NCT01443052|Gait stability|gait stability
397811|NCT01443052|Spatiotemporal parameters|spatiotemporal parameters
397812|NCT01443052|Walking|walking
397813|NCT01443052|Elderly people|elderly people
397814|NCT01443052|Stroke|stroke
397815|NCT01443052|Fallers|fallers
397816|NCT01443039|drug metabolizing enzymes and drug transporter|drug metabolizing enzymes and drug transporter
397817|NCT01443039|Roux-en Y-Gastric Bypass|roux-en y-gastric bypass
397818|NCT01443039|Obesity|obesity
397819|NCT01443039|Drug Availability|drug availability
397820|NCT01443039|BMI over 35kg/m² and comorbidities or >40kg/m²|bmi over 35kg/m² and comorbidities or >40kg/m²
397821|NCT01443026|Intraepithelial Prostatic Neoplasia|intraepithelial prostatic neoplasia
397822|NCT01443026|Prostatic neoplasms|prostatic neoplasms
397823|NCT01443026|Male urogenital disease|male urogenital disease
397824|NCT01443026|Prostate|prostate
397825|NCT01443013|Tolerance|tolerance
397826|NCT01443013|Renal Transplantation|renal transplantation
397827|NCT01443013|Chronic allograft nephropathy|chronic allograft nephropathy
397828|NCT01443000|Observational study|observational study
397829|NCT01443000|IOIS|iois
397830|NCT01443000|Orbital Pseudotumor|orbital pseudotumor
397831|NCT01443000|Outcome|outcome
397832|NCT01443000|Treatment|treatment
397833|NCT01442987|Irbesartan|irbesartan
397834|NCT01442987|Atorvastatin|atorvastatin
397835|NCT01442987|Hypertension|hypertension
397836|NCT01442987|Hyperlipidemia|hyperlipidemia
397837|NCT01442974|nab-paclitaxel|nab-paclitaxel
397838|NCT01442974|neoadjuvant treatment|neoadjuvant treatment
397839|NCT01442974|SPARC|sparc
397840|NCT01442974|Pancreatic Cancer|pancreatic cancer
397841|NCT01442961|pain, postoperative|pain, postoperative
397842|NCT01442961|hysterectomy, vaginal|hysterectomy, vaginal
397843|NCT01442961|surgery, gynecological|surgery, gynecological
397844|NCT01442948|-CD16+ monocytes|-cd16+ monocytes
397845|NCT01442935|Adenocarcinoma|adenocarcinoma
397846|NCT01442935|Non-resectable hepatic metastases|non-resectable hepatic metastases
397847|NCT01442935|First-line treatment|first-line treatment
397848|NCT01442922|L3-L4|l3-l4
397849|NCT01442922|L4-L5|l4-l5
397850|NCT01442922|L5-S1|l5-s1
397851|NCT01442922|Human Meniscus Allograft|human meniscus allograft
397852|NCT01442922|Nucleus pulposus|nucleus pulposus
397853|NCT01442922|Minimally invasive surgery|minimally invasive surgery
397854|NCT01442922|Degeneration of L3-L4 Intervertebral Disc|degeneration of l3-l4 intervertebral disc
397855|NCT01442922|Degeneration of L4-L5 Intervertebral Disc|degeneration of l4-l5 intervertebral disc
397856|NCT01442922|Degeneration of L5-S1 Intervertebral Disc|degeneration of l5-s1 intervertebral disc
397857|NCT01442909|lung cancer|lung cancer
397858|NCT01442909|docetaxel|docetaxel
397859|NCT01442909|pemetrexed|pemetrexed
397860|NCT01442883|Treatment Resistant|treatment resistant
397861|NCT01442857|Magnetic Resonance Imaging|magnetic resonance imaging
397862|NCT01442857|Nerve Net|nerve net
397863|NCT01442857|Brachial Plexus|brachial plexus
397864|NCT01442857|Nerve block|nerve block
397865|NCT01442844|Mohs|mohs
397866|NCT01442844|Scalp|scalp
397867|NCT01442831|metabolic profile of TR-700 in plasma urine|metabolic profile of tr-700 in plasma urine
397868|NCT01442818|vaginal reconstructive surgery|vaginal reconstructive surgery
397869|NCT01442805|Cognitive Behavior Therapy|cognitive behavior therapy
397870|NCT01442805|Virtual Reality Exposure Therapy|virtual reality exposure therapy
397871|NCT01442805|Psychophysiological Measures|psychophysiological measures
397872|NCT01442805|Driving Phobia|driving phobia
397873|NCT01442805|Flying Phobia|flying phobia
397874|NCT01442792|Angioplasty, Balloon, Coronary|angioplasty, balloon, coronary
397875|NCT01442779|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
397876|NCT01442779|Interferon alpha|interferon alpha
397877|NCT01442766|cholinesterase inhibitor|cholinesterase inhibitor
397878|NCT01442766|donepezil|donepezil
397879|NCT01442766|motor|motor
397880|NCT01442766|stroke|stroke
397881|NCT01442753|Spanish speaking|spanish speaking
397882|NCT01442740|Functional Endoscopic Sinus Surgery|functional endoscopic sinus surgery
397883|NCT01442740|Reverse Trendelenburg Position|reverse trendelenburg position
397884|NCT01442727|arsenical melanosis|arsenical melanosis
397885|NCT01442727|arsenical melanoses|arsenical melanoses
397886|NCT01442727|arsenical keratosis|arsenical keratosis
397887|NCT01442727|arsenical keratoses|arsenical keratoses
397888|NCT01442727|arsenical cancer|arsenical cancer
397889|NCT01442727|arsenic cancers|arsenic cancers
397890|NCT01442727|arsenic|arsenic
397891|NCT01442727|arsenicosis|arsenicosis
397892|NCT01442727|arsenic exposure|arsenic exposure
397893|NCT01442727|arsenic toxicity|arsenic toxicity
397894|NCT01442727|arsenic poisoning|arsenic poisoning
397895|NCT01442727|drinking water|drinking water
397896|NCT01442727|selenium|selenium
397897|NCT01442727|selenite|selenite
397898|NCT01442727|sodium selenite|sodium selenite
397899|NCT01442675|Meningitis|meningitis
397900|NCT01442675|Meningococcal Infection|meningococcal infection
397901|NCT01442675|Menactra®|menactra®
397902|NCT01442662|Metastatic or relapsed uterine or soft tissue leiomyosarcoma|metastatic or relapsed uterine or soft tissue leiomyosarcoma
397903|NCT01442649|Adenocarcinoma|adenocarcinoma
397904|NCT01442649|Metastatic|metastatic
397905|NCT01442649|Second-line treatment|second-line treatment
397906|NCT01442649|Progressive disease after first-line treatment with bevacizumab|progressive disease after first-line treatment with bevacizumab
397907|NCT01442649|Non-mutated (wild-type) KRAS.|non-mutated (wild-type) kras.
397908|NCT01442623|Vestibular Rehabilitation|vestibular rehabilitation
397909|NCT01442623|Balance|balance
397910|NCT01442623|Virtual Reality|virtual reality
397911|NCT01442623|Gait|gait
397912|NCT01442623|Dizziness|dizziness
397913|NCT01442610|Rasagiline|rasagiline
397914|NCT01442610|Sleep disorder|sleep disorder
397915|NCT01442610|Parkinson's disease|parkinson's disease
397916|NCT01442610|Sleep Disturbances in patients with parkinsons's disease|sleep disturbances in patients with parkinsons's disease
397917|NCT01442597|cognitive behavior therapy|cognitive behavior therapy
397918|NCT01442597|computer assisted instruction|computer assisted instruction
397919|NCT01442597|drug abuse therapy|drug abuse therapy
397920|NCT01442597|educational resource design and development|educational resource design and development
397921|NCT01442584|ovary|ovary
397922|NCT01442584|cortex|cortex
397923|NCT01442584|transplantation|transplantation
397924|NCT01442571|Adult Men and Women, who underwent arthroscopy of the knee with cartilage injury of ICRS grade 2 or higher|adult men and women, who underwent arthroscopy of the knee with cartilage injury of icrs grade 2 or higher
397925|NCT01442558|relief|relief
397926|NCT01442558|Intra-operative|intra-operative
397927|NCT01442545|Rheumatoid Arthritis|rheumatoid arthritis
397928|NCT01442545|JNJ-39758979|jnj-39758979
397929|NCT01442545|Methotrexate|methotrexate
397930|NCT01442532|Healthy male volunteer|healthy male volunteer
397931|NCT01442532|JNJ-38518168|jnj-38518168
397932|NCT01442532|Midazolam|midazolam
397933|NCT01442519|non-muscle invasive urothelial bladder cancer|non-muscle invasive urothelial bladder cancer
397934|NCT01442519|intravesical therapy|intravesical therapy
397936|NCT01442519|mitomycin|mitomycin
397937|NCT01442519|electromotive drug administration|electromotive drug administration
397938|NCT01442519|Bladder Cancer Stage 0, Without Cancer in Situ|bladder cancer stage 0, without cancer in situ
397939|NCT01442506|acetic acid|acetic acid
397940|NCT01442506|virtual chromoendosopy|virtual chromoendosopy
397941|NCT01442493|Methadone Treatment|methadone treatment
397942|NCT01442493|Opiate dependence|opiate dependence
397943|NCT01442493|Services research|services research
397944|NCT01442480|air pollution|air pollution
397945|NCT01442480|fatty acid supplementation|fatty acid supplementation
397946|NCT01442467|mitral annular calcification|mitral annular calcification
397947|NCT01442467|MAC|mac
397948|NCT01442467|left atrial pressure|left atrial pressure
397949|NCT01442467|LAP|lap
397950|NCT01442467|left ventricular end diastolic pressure|left ventricular end diastolic pressure
397951|NCT01442467|LVEDP|lvedp
397952|NCT01442467|Echocardiogram|echocardiogram
397953|NCT01442454|chronic pancreatitis|chronic pancreatitis
397954|NCT01442441|chronic pancreatitis|chronic pancreatitis
397955|NCT01442428|TB|tb
397956|NCT01442428|AIDS|aids
397957|NCT01442428|HIV|hiv
397958|NCT01442428|IRIS|iris
397959|NCT01442428|immune reconstitution inflammatory syndrome|immune reconstitution inflammatory syndrome
397960|NCT01442428|anti-inflammatory|anti-inflammatory
397961|NCT01442428|treatment|treatment
397962|NCT01442376|Prevention of Chemotherapy-Induced Nausea and Vomiting|prevention of chemotherapy-induced nausea and vomiting
397963|NCT01442376|Palonosetron|palonosetron
397964|NCT01442376|Ondansetron|ondansetron
397965|NCT01442376|Pediatric|pediatric
397966|NCT01442363|Crohn's disease|crohn's disease
397967|NCT01442363|perianal|perianal
397968|NCT01442363|inflammatory bowel disease|inflammatory bowel disease
397970|NCT01442350|Fabry disease|fabry disease
397971|NCT01442350|annexin 5|annexin 5
397972|NCT01442350|miosin|miosin
397973|NCT01442350|sarcoma|sarcoma
397974|NCT01442350|alfa-galactosidase|alfa-galactosidase
397975|NCT01442350|fibrosis|fibrosis
397976|NCT01442350|apoptosis|apoptosis
397977|NCT01442350|biomarkers|biomarkers
397978|NCT01442350|NT-proBNP|nt-probnp
397979|NCT01442337|de novo kidney transplant|de novo kidney transplant
397980|NCT01442337|kidney transplant|kidney transplant
397981|NCT01442337|ASP8597|asp8597
397982|NCT01442337|diannexin|diannexin
397983|NCT01442337|ischemia-reperfusion injury|ischemia-reperfusion injury
397984|NCT01442324|Laparotomic surgery|laparotomic surgery
397985|NCT01442324|Laparoscopic surgery|laparoscopic surgery
397986|NCT01442324|Percutaneos tumour ablation|percutaneos tumour ablation
397987|NCT01442324|Irreversible electroporation (IRE)|irreversible electroporation (ire)
397988|NCT01442311|Hepatitis C Virus|hepatitis c virus
397989|NCT01442311|Chronic Hepatitis C|chronic hepatitis c
397990|NCT01442311|Methadone|methadone
397991|NCT01442311|Injection Drug User|injection drug user
397992|NCT01442311|Adherence|adherence
397993|NCT01442311|Directly Observed Treatment|directly observed treatment
397994|NCT01442298|bloodless field|bloodless field
397995|NCT01442298|cuff pressure|cuff pressure
397996|NCT01442298|limb occlusion pressure|limb occlusion pressure
397997|NCT01442259|Renal impairment,|renal impairment,
397998|NCT01442259|pharmacokinetics,|pharmacokinetics,
397999|NCT01442259|safety|safety
398000|NCT01442246|Benefit of|benefit of
398001|NCT01442246|adjuvant|adjuvant
398002|NCT01442246|treatment|treatment
398003|NCT01442246|prostatectomy|prostatectomy
398004|NCT01442233|multiple sclerosis|multiple sclerosis
398005|NCT01442233|plasma exchange|plasma exchange
398006|NCT01442207|Premature Birth|premature birth
398007|NCT01442207|Placenta Previa|placenta previa
398008|NCT01442194|Multiple sclerosis|multiple sclerosis
398009|NCT01442194|fingolimod|fingolimod
398010|NCT01442194|observational study|observational study
398011|NCT01442168|Uncomplicated Falciparum Malaria|uncomplicated falciparum malaria
398012|NCT01442168|Plasmodium falciparum|plasmodium falciparum
398013|NCT01442168|Antimalarial treatment|antimalarial treatment
398014|NCT01442168|Sevuparin/DF02|sevuparin/df02
398015|NCT01442168|Adjuvant therapy|adjuvant therapy
398016|NCT01442168|Malanil|malanil
398017|NCT01442168|Peripheral blood parasitemia|peripheral blood parasitemia
398018|NCT01442168|Rosette formation|rosette formation
398019|NCT01442168|Maximum tolerated dose|maximum tolerated dose
398020|NCT01442155|Colorectal cancer|colorectal cancer
398021|NCT01442155|Adjuvant setting|adjuvant setting
398022|NCT01442155|Capecitabine|capecitabine
398023|NCT01442155|Oxaliplatin|oxaliplatin
398024|NCT01442142|obesity|obesity
398025|NCT01442142|pediatric|pediatric
398026|NCT01442142|childhood|childhood
398027|NCT01442142|overweight|overweight
398028|NCT01442129|Heart Failure|heart failure
398029|NCT01442129|Left Ventricular Assist Device|left ventricular assist device
398030|NCT01442129|Heart Transplantation|heart transplantation
398031|NCT01442129|Cardiomyopathy|cardiomyopathy
398032|NCT01442129|Destination Therapy|destination therapy
398033|NCT01442129|Cell Therapy|cell therapy
398034|NCT01442064|CNV|cnv
398035|NCT01442064|Lucentis|lucentis
398036|NCT01442064|AMD|amd
398037|NCT01442064|Age-related macular degeneration|age-related macular degeneration
398038|NCT01442064|RVO|rvo
398039|NCT01442064|Macular edema secondary to retinal vein occlusion|macular edema secondary to retinal vein occlusion
398040|NCT01442051|Acute Normovolemic Hemodilution|acute normovolemic hemodilution
398041|NCT01442051|Cytoreductive Surgery|cytoreductive surgery
398042|NCT01442051|laparotomy|laparotomy
398043|NCT01442051|11-149|11-149
398044|NCT01442051|advanced primary epithelial ovarian cancer|advanced primary epithelial ovarian cancer
398045|NCT01442025|Crohn's Disease|crohn's disease
398046|NCT01442025|IFX trough level|ifx trough level
398047|NCT01442012|PONV|ponv
398048|NCT01442012|ACUPUNCTURE|acupuncture
398049|NCT01441999|Rigid rods|rigid rods
398050|NCT01441999|less rigid rods|less rigid rods
398051|NCT01441999|prevent kyphosis|prevent kyphosis
398052|NCT01441999|long constructs|long constructs
398053|NCT01441986|dextromethorphan|dextromethorphan
398054|NCT01441986|amantadine|amantadine
398055|NCT01441986|blood glucose lowering effect|blood glucose lowering effect
398056|NCT01441986|oral glucose tolerance test|oral glucose tolerance test
398057|NCT01441960|Succinylcholine|succinylcholine
398058|NCT01441960|Rocuronium|rocuronium
398059|NCT01441960|ECT|ect
398060|NCT01441947|ER+|er+
398061|NCT01441947|PR+|pr+
398062|NCT01441947|Human Epidermal Growth Factor Receptor (HER) 2 negative|human epidermal growth factor receptor (her) 2 negative
398063|NCT01441947|metastatic|metastatic
398064|NCT01441921|pistachio intake|pistachio intake
398065|NCT01441921|insulin resistance|insulin resistance
398066|NCT01441921|type 2 diabetes mellitus|type 2 diabetes mellitus
398067|NCT01441908|Cardiovascular|cardiovascular
398068|NCT01441908|Multi-analyte|multi-analyte
398069|NCT01441908|Statin|statin
398070|NCT01441908|Dyslipidemia|dyslipidemia
398071|NCT01441895|Refractive Cataract Extraction|refractive cataract extraction
398072|NCT01441895|Femtosecond laser|femtosecond laser
398073|NCT01441895|arcuate relaxing incisions|arcuate relaxing incisions
398074|NCT01441895|Dry Eye post cataract refraction|dry eye post cataract refraction
398075|NCT01441869|Phase 1, Healthy male volunteers, pharmacokinetics, saxagliptin/ metformin , Diabex|phase 1, healthy male volunteers, pharmacokinetics, saxagliptin/ metformin , diabex
398076|NCT01441856|Open|open
398077|NCT01441856|Laparoscopic|laparoscopic
398078|NCT01441856|Hemihepatectomy|hemihepatectomy
398079|NCT01441856|Enhanced Recovery After Surgery|enhanced recovery after surgery
398080|NCT01441856|Functional recovery|functional recovery
398081|NCT01441843|quality of life|quality of life
398082|NCT01441843|lorazepam|lorazepam
398083|NCT01441843|anxiety|anxiety
398084|NCT01441843|premedication|premedication
398085|NCT01441843|surgery|surgery
398086|NCT01441843|Adult patients|adult patients
398087|NCT01441843|Ambulatory Surgical Procedures|ambulatory surgical procedures
398088|NCT01441843|Postoperative Period|postoperative period
398089|NCT01441830|shoulder|shoulder
398090|NCT01441830|subacromial|subacromial
398091|NCT01441830|impingement|impingement
398092|NCT01441830|tendinopathy|tendinopathy
398093|NCT01441830|rESWT|reswt
398094|NCT01441830|shock wave|shock wave
398095|NCT01441830|ESWT|eswt
398096|NCT01441830|RSWT|rswt
398097|NCT01441791|PEEP|peep
398098|NCT01441791|Positive end-expiratory pressure|positive end-expiratory pressure
398099|NCT01441791|Recruitment maneuver|recruitment maneuver
398100|NCT01441791|Open lung approach|open lung approach
398101|NCT01441791|Post-operative complications|post-operative complications
398102|NCT01441791|Open abdominal surgery|open abdominal surgery
398103|NCT01441778|nasal irrigation|nasal irrigation
398104|NCT01441778|allergic rhinitis|allergic rhinitis
398105|NCT01441778|children|children
398106|NCT01441765|Kidney|kidney
398107|NCT01441765|Metastatic|metastatic
398108|NCT01441765|Stage IV|stage iv
398109|NCT01441726|Advanced dementia|advanced dementia
398110|NCT01441726|Quality|quality
398111|NCT01441726|Terminal care|terminal care
398112|NCT01441713|Hormone treatment|hormone treatment
398113|NCT01441713|castration|castration
398114|NCT01441713|Orchiectomy|orchiectomy
398115|NCT01441713|treatment frequency|treatment frequency
398116|NCT01441713|treatment satisfaction|treatment satisfaction
398117|NCT01441713|side effects|side effects
398118|NCT01441700|Prone emergence|prone emergence
398119|NCT01441700|supine emergence|supine emergence
398120|NCT01441700|coughing|coughing
398121|NCT01441700|haemodynamic stimulation|haemodynamic stimulation
398122|NCT01441700|lumbar surgery|lumbar surgery
398123|NCT01441687|Health status unknown|health status unknown
398124|NCT01441687|healthy,no evidence of disease|healthy,no evidence of disease
398125|NCT01441674|Occupational Therapy|occupational therapy
398126|NCT01441661|Sunitinib|sunitinib
398127|NCT01441661|kidney diseases|kidney diseases
398128|NCT01441661|urogenital neoplasms|urogenital neoplasms
398129|NCT01441661|kidney cancer|kidney cancer
398130|NCT01441648|conjunctival injection|conjunctival injection
398131|NCT01441648|conjunctival papillary hypertrophy|conjunctival papillary hypertrophy
398132|NCT01441648|pannus formation|pannus formation
398133|NCT01441648|corneal epitheliopathy|corneal epitheliopathy
398134|NCT01441648|Schirmer test|schirmer test
398135|NCT01441648|Impression cytology|impression cytology
398136|NCT01441648|confocal microscopy|confocal microscopy
398137|NCT01441648|Scanning electronmicroscopy (SEM)|scanning electronmicroscopy (sem)
398138|NCT01441648|bacterial adhesion determination|bacterial adhesion determination
398139|NCT01441635|Elagolix|elagolix
398140|NCT01441635|Uterine Fibroids|uterine fibroids
398141|NCT01441635|Elagolix sodium|elagolix sodium
398142|NCT01441635|Leiomyomata|leiomyomata
398143|NCT01441635|Heavy Uterine Bleeding|heavy uterine bleeding
398144|NCT01441635|Menorrhagia|menorrhagia
398145|NCT01441635|ABT-620|abt-620
398146|NCT01441622|Continuous Positive Airway Pressure (CPAP)|continuous positive airway pressure (cpap)
398147|NCT01441622|AL539|al539
398148|NCT01441622|Home-monitoring|home-monitoring
398149|NCT01441609|Th9 cells|th9 cells
398151|NCT01441609|non/poor responsiveness to hepatitis B|non/poor responsiveness to hepatitis b
398152|NCT01441609|collect blood samples after vaccination|collect blood samples after vaccination
398153|NCT01441583|pacemaker, CRT-P, auto threshold|pacemaker, crt-p, auto threshold
398154|NCT01441570|kidney|kidney
398155|NCT01441570|transplant|transplant
398156|NCT01441570|hypertension|hypertension
398157|NCT01441570|nebivolol|nebivolol
398158|NCT01441570|metoprolol|metoprolol
398159|NCT01441570|bystolic|bystolic
398160|NCT01441570|toprol|toprol
398161|NCT01441557|mechanical ventilation|mechanical ventilation
398162|NCT01441544|active video games|active video games
398163|NCT01441544|Energy expenditure|energy expenditure
398164|NCT01441531|narcotic use|narcotic use
398165|NCT01441531|Other Acute Pain|other acute pain
398166|NCT01441492|Distal pancreatectomy|distal pancreatectomy
398167|NCT01441492|Pancreas resection|pancreas resection
398168|NCT01441466|bronchiolitis|bronchiolitis
398169|NCT01441466|RSV|rsv
398170|NCT01441453|Hepatocellular carcinoma|hepatocellular carcinoma
398171|NCT01441453|Cirrhosis|cirrhosis
398172|NCT01441453|Liver resection|liver resection
398173|NCT01441453|FibroScan|fibroscan
398174|NCT01441440|venlafaxine ER|venlafaxine er
398175|NCT01441440|Major depressive disorder|major depressive disorder
398176|NCT01441440|Japan|japan
398177|NCT01441440|placebo-controlled|placebo-controlled
398178|NCT01441427|feeding intolerance|feeding intolerance
398179|NCT01441427|recombinant growth factors|recombinant growth factors
398180|NCT01441427|G-CSF|g-csf
398181|NCT01441427|EPO|epo
398182|NCT01441427|necrotizing enterocolitis|necrotizing enterocolitis
398183|NCT01441414|CVX-060|cvx-060
398184|NCT01441414|PF-04856884|pf-04856884
398185|NCT01441414|AG-013736|ag-013736
398186|NCT01441414|axitinib|axitinib
398187|NCT01441414|mRCC|mrcc
398188|NCT01441414|metastatic renal cell cancer|metastatic renal cell cancer
398189|NCT01441414|second line|second line
398294|NCT01441037|Androgen|androgen
398190|NCT01441414|anti-angiogenic|anti-angiogenic
398191|NCT01441414|Ang-2|ang-2
398192|NCT01441401|Gabapentin|gabapentin
398193|NCT01441401|Epilepsies|epilepsies
398194|NCT01441401|safety|safety
398195|NCT01441388|Phase 1b|phase 1b
398196|NCT01441388|crizotinib|crizotinib
398197|NCT01441388|sunitinib|sunitinib
398198|NCT01441388|axitinib|axitinib
398199|NCT01441388|sorafenib|sorafenib
398200|NCT01441388|bevacizumab|bevacizumab
398201|NCT01441388|cMET inhibitor|cmet inhibitor
398202|NCT01441388|VEGF inhibitor|vegf inhibitor
398203|NCT01441388|crizotinib combination|crizotinib combination
398204|NCT01441375|Sickle cell anemia|sickle cell anemia
398205|NCT01441362|during double-lumen|during double-lumen
398206|NCT01441362|tube intubation|tube intubation
398207|NCT01441349|Simvastatin|simvastatin
398208|NCT01441349|SCLC|sclc
398209|NCT01441349|Extensive Disease|extensive disease
398210|NCT01441323|Obesity|obesity
398211|NCT01441323|Type 2 Diabetes|type 2 diabetes
398212|NCT01441323|Cardiovascular Risk|cardiovascular risk
398213|NCT01441323|Cancer|cancer
398214|NCT01441323|African American|african american
398215|NCT01441323|Adolescents|adolescents
398216|NCT01441323|Strength Training|strength training
398217|NCT01441323|Nutrition|nutrition
398218|NCT01441310|Gastric cancer|gastric cancer
398219|NCT01441310|Sentinel node navigation surgery|sentinel node navigation surgery
398220|NCT01441310|Dual method|dual method
398221|NCT01441310|Recurrence|recurrence
398222|NCT01441297|recurrent small cell lung cancer|recurrent small cell lung cancer
398223|NCT01441284|pramipexole|pramipexole
398224|NCT01441284|essential tremor|essential tremor
398225|NCT01441284|cross-over|cross-over
398226|NCT01441245|acute heart failure|acute heart failure
398227|NCT01441245|diuretics|diuretics
398228|NCT01441245|BNP|bnp
398229|NCT01441245|Renal function|renal function
398230|NCT01441245|acute decompensated Heart Failure,|acute decompensated heart failure,
398231|NCT01441245|volume overload|volume overload
398232|NCT01441206|rifampin|rifampin
398233|NCT01441206|infants|infants
398234|NCT01441193|HIV|hiv
398235|NCT01441193|preventive vaccine|preventive vaccine
398236|NCT01441193|Tat|tat
398237|NCT01441193|Env|env
398238|NCT01441180|Direct Acting Antiviral|direct acting antiviral
398239|NCT01441180|Liver|liver
398240|NCT01441180|Hepatitis C|hepatitis c
398241|NCT01441180|HCV|hcv
398242|NCT01441167|Healthy Subjects|healthy subjects
398243|NCT01441167|Immunogenicity|immunogenicity
398244|NCT01441167|Vaccine-Mediated Protection|vaccine-mediated protection
398245|NCT01441167|Sporozoites|sporozoites
398246|NCT01441167|Parasitemia|parasitemia
398247|NCT01441167|Healthy Volunteer|healthy volunteer
398248|NCT01441167|HV|hv
398249|NCT01441154|Hypothyroidism|hypothyroidism
398250|NCT01441154|Thyroid Cancer|thyroid cancer
398251|NCT01441154|Triiodothyronine (T3)|triiodothyronine (t3)
398252|NCT01441154|Energy Expenditure|energy expenditure
398253|NCT01441154|Thyroid Hormone|thyroid hormone
398254|NCT01441141|GCH1|gch1
398255|NCT01441141|Pain Sensitivity|pain sensitivity
398256|NCT01441141|Quantitative Sensory Testing (QST)|quantitative sensory testing (qst)
398257|NCT01441141|Genetic Variation|genetic variation
398258|NCT01441141|Sickle Cell Anemia|sickle cell anemia
398259|NCT01441128|Lung Neoplasms|lung neoplasms
398260|NCT01441128|Epithelial-Mesenchymal Transition Factor (c-Met)|epithelial-mesenchymal transition factor (c-met)
398261|NCT01441128|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
398262|NCT01441128|Hepatocyte Growth Factor Receptor|hepatocyte growth factor receptor
398263|NCT01441128|Epidermal Growth Factor Receptor|epidermal growth factor receptor
398264|NCT01441128|Non Small Cell Lung Cancer|non small cell lung cancer
398265|NCT01441128|NSCLC|nsclc
398266|NCT01441115|Metastasis|metastasis
398267|NCT01441115|Cancer|cancer
398268|NCT01441115|Radiation Therapy|radiation therapy
398269|NCT01441115|Locally Advanced|locally advanced
398270|NCT01441115|Palliation|palliation
398271|NCT01441115|Metastatic Cancer|metastatic cancer
398272|NCT01441102|Diabetic Macular Edema|diabetic macular edema
398273|NCT01441102|Microglia|microglia
398274|NCT01441102|Dextromethorphan|dextromethorphan
398275|NCT01441089|Pharmacogenetics|pharmacogenetics
398276|NCT01441089|Pharmacokinetics|pharmacokinetics
398277|NCT01441089|Pharmacodynamics|pharmacodynamics
398278|NCT01441089|Clinical Outcome|clinical outcome
398279|NCT01441089|Drug Metabolism and Transport|drug metabolism and transport
398280|NCT01441089|Cancer|cancer
398281|NCT01441076|Behcet's Disease|behcet's disease
398282|NCT01441076|Aphthous Ulcer|aphthous ulcer
398283|NCT01441076|Uveitis|uveitis
398284|NCT01441076|IL-1|il-1
398285|NCT01441076|Autoinflammation|autoinflammation
398286|NCT01441076|BD|bd
398287|NCT01441063|Kaposi Sarcoma Herpesvirus|kaposi sarcoma herpesvirus
398288|NCT01441063|Human Immunodeficiency Virus|human immunodeficiency virus
398289|NCT01441063|Tocilizumab|tocilizumab
398290|NCT01441063|Multicentric Castleman Disease|multicentric castleman disease
398291|NCT01441063|Interleukin-6|interleukin-6
398292|NCT01441063|Castleman Disease|castleman disease
398293|NCT01441037|Aplastic Anemia|aplastic anemia
398295|NCT01441037|Telomeres|telomeres
398296|NCT01441024|Immunocompromised|immunocompromised
398297|NCT01441024|Respiratory Tract Disease|respiratory tract disease
398298|NCT01441024|Viral Shedding|viral shedding
398299|NCT01441024|Fever|fever
398300|NCT01441024|Pharmacokinetics|pharmacokinetics
398301|NCT01441024|Parainfluenza Infection|parainfluenza infection
398302|NCT01441024|Flu|flu
398303|NCT01441011|weight loss|weight loss
398304|NCT01441011|breast cancer|breast cancer
398305|NCT01441011|obesity|obesity
398306|NCT01441011|overweight|overweight
398307|NCT01441011|rural women|rural women
398308|NCT01441011|community based|community based
398309|NCT01441011|Secondary Prevention|secondary prevention
398310|NCT01440985|Tooth Staining|tooth staining
398311|NCT01440972|knee osteoarthritis|knee osteoarthritis
398312|NCT01440972|symptomatic knee osteoarthritis|symptomatic knee osteoarthritis
398313|NCT01440972|isotonic leg-press strength|isotonic leg-press strength
398314|NCT01440972|isokinetic knee extensor strength|isokinetic knee extensor strength
398315|NCT01440972|quadriceps volume|quadriceps volume
398316|NCT01440959|This is a single-center|this is a single-center
398317|NCT01440959|prospective|prospective
398318|NCT01440959|single-arm|single-arm
398319|NCT01440959|open-label phase II study|open-label phase ii study
398320|NCT01440933|sugammadex|sugammadex
398321|NCT01440933|rocuronium|rocuronium
398322|NCT01440933|magnesiumsulphate|magnesiumsulphate
398323|NCT01440933|neuromuscular monitoring|neuromuscular monitoring
398324|NCT01440920|Acute myeloid leukemia|acute myeloid leukemia
398325|NCT01440920|WT1|wt1
398326|NCT01440907|Health Information Technology|health information technology
398327|NCT01440907|Health Records, Personal|health records, personal
398328|NCT01440907|Hospital Information Systems|hospital information systems
398329|NCT01440907|Patient Access to Records|patient access to records
398330|NCT01440907|Medical Records|medical records
398331|NCT01440907|Medical Record Systems, Computerized|medical record systems, computerized
398332|NCT01440894|weight|weight
398333|NCT01440894|body fat|body fat
398334|NCT01440894|total body water|total body water
398335|NCT01440894|bone mass|bone mass
398336|NCT01440894|muscle mass|muscle mass
398337|NCT01440881|renal failure|renal failure
398338|NCT01440881|cardiopulmonary bypass|cardiopulmonary bypass
398339|NCT01440868|Respiratory Distress Syndrome, Newborn|respiratory distress syndrome, newborn
398340|NCT01440868|Delivery Rooms|delivery rooms
398341|NCT01440868|Resuscitation|resuscitation
398342|NCT01440868|Premature Birth|premature birth
398343|NCT01440868|Infant, Newborn|infant, newborn
398344|NCT01440868|Respiration, Artificial|respiration, artificial
398345|NCT01440855|Survivorship|survivorship
398346|NCT01440855|cancer control|cancer control
398347|NCT01440855|psychosocial interventions|psychosocial interventions
398348|NCT01440855|Facing Forward|facing forward
398349|NCT01440842|Stress hyperglycaemia|stress hyperglycaemia
398350|NCT01440829|Transjugular Intrahepatic Portosystemic Shunt|transjugular intrahepatic portosystemic shunt
398351|NCT01440829|TIPS|tips
398352|NCT01440829|Liver Cirrhosis|liver cirrhosis
398353|NCT01440829|LOLA|lola
398354|NCT01440829|L-ornithine-L-aspartate|l-ornithine-l-aspartate
398355|NCT01440829|Refractory Ascites|refractory ascites
398356|NCT01440803|osteoporosis|osteoporosis
398357|NCT01440803|premenopausal|premenopausal
398358|NCT01440803|forteo|forteo
398359|NCT01440803|idiopathic|idiopathic
398360|NCT01440803|Idiopathic Osteoporosis in Premenopausal Women|idiopathic osteoporosis in premenopausal women
398361|NCT01440777|Insomnia|insomnia
398362|NCT01440777|Sleep|sleep
398363|NCT01440777|Stress|stress
398364|NCT01440777|Online program|online program
398365|NCT01440777|Web-based program|web-based program
398366|NCT01440777|Cognitive Behavioral Therapy for Insomnia (CBT-i)|cognitive behavioral therapy for insomnia (cbt-i)
398367|NCT01440764|dyspnea|dyspnea
398368|NCT01440764|Laboratory model of dyspnea in healthy subjects|laboratory model of dyspnea in healthy subjects
398369|NCT01440751|ologen collagen matrix|ologen collagen matrix
398370|NCT01440751|mitomycin-C|mitomycin-c
398371|NCT01440751|trabeculectomy|trabeculectomy
398372|NCT01440751|glaucoma|glaucoma
398373|NCT01440751|filtering surgery|filtering surgery
398374|NCT01440738|general population|general population
398375|NCT01440725|muscle|muscle
398376|NCT01440725|injuries|injuries
398377|NCT01440725|platelet-rich plasma|platelet-rich plasma
398378|NCT01440725|autologous|autologous
398379|NCT01440725|haematoma|haematoma
398380|NCT01440712|Gastrografin|gastrografin
398381|NCT01440712|Postoperative ileus|postoperative ileus
398382|NCT01440712|Colo-rectal surgery|colo-rectal surgery
398383|NCT01440712|Effects on morbidity and mortality of postoperative ileus|effects on morbidity and mortality of postoperative ileus
398384|NCT01440699|Crohn's fistula|crohn's fistula
398385|NCT01440686|Pharmacokinetics|pharmacokinetics
398386|NCT01440686|Pharmacodynamics|pharmacodynamics
398387|NCT01440686|Safety|safety
398388|NCT01440686|Male|male
398389|NCT01440673|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
398390|NCT01440647|Respiration, Artificial|respiration, artificial
398391|NCT01440647|Infant, Premature|infant, premature
398490|NCT01440387|Influenza|influenza
398392|NCT01440647|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
398393|NCT01440647|Continuous Positive Airway Pressure|continuous positive airway pressure
398394|NCT01440647|Non-Invasive Positive-Pressure Ventilation|non-invasive positive-pressure ventilation
398395|NCT01440647|Intermittent Positive-Pressure Ventilation|intermittent positive-pressure ventilation
398396|NCT01440647|High-Frequency Ventilation|high-frequency ventilation
398397|NCT01440634|Peripheral arterial disease|peripheral arterial disease
398398|NCT01440634|Community Medicine|community medicine
398399|NCT01440634|Exercise Test|exercise test
398400|NCT01440634|Exercise Therapy|exercise therapy
398401|NCT01440621|Cancer related fatigue|cancer related fatigue
398402|NCT01440621|Quality of life|quality of life
398403|NCT01440621|Modafinil|modafinil
398404|NCT01440621|Radiation therapy|radiation therapy
398405|NCT01440621|Radiotherapy|radiotherapy
398406|NCT01440582|Myeloma|myeloma
398407|NCT01440582|Multiple Myeloma|multiple myeloma
398408|NCT01440582|MM|mm
398409|NCT01440582|Newly diagnosed|newly diagnosed
398410|NCT01440582|Transplant eligible|transplant eligible
398411|NCT01440582|Panobinostat|panobinostat
398412|NCT01440582|LBH589B|lbh589b
398413|NCT01440582|Bortezomib|bortezomib
398414|NCT01440582|Velcade|velcade
398415|NCT01440582|LDP-341|ldp-341
398416|NCT01440582|MLN341|mln341
398417|NCT01440582|PS-341|ps-341
398418|NCT01440582|Lenalidomide|lenalidomide
398419|NCT01440582|CC-5013|cc-5013
398420|NCT01440582|Revlimid|revlimid
398421|NCT01440582|Dexamethasone|dexamethasone
398422|NCT01440582|Decadron|decadron
398423|NCT01440582|Symptom questionnaire|symptom questionnaire
398424|NCT01440582|Survey|survey
398425|NCT01440569|HIV-1|hiv-1
398426|NCT01440569|HIV|hiv
398427|NCT01440569|Treatment Naïve|treatment naïve
398428|NCT01440569|Treatment Experienced|treatment experienced
398429|NCT01440556|Allogeneic bone marrow transplantation|allogeneic bone marrow transplantation
398430|NCT01440556|Multiple myeloma|multiple myeloma
398431|NCT01440543|colonoscopy|colonoscopy
398432|NCT01440543|water immersion|water immersion
398433|NCT01440543|CO2 insufflation|co2 insufflation
398434|NCT01440543|patients referred for diagnostic outpatient colonoscopy|patients referred for diagnostic outpatient colonoscopy
398435|NCT01440543|(screening, surveillance, symptoms)|(screening, surveillance, symptoms)
398436|NCT01440543|patient discomfort associated with diagnostic colonoscopy|patient discomfort associated with diagnostic colonoscopy
398437|NCT01440530|Diabetes Internet Education|diabetes internet education
398438|NCT01440530|Diabetes Education|diabetes education
398439|NCT01440530|Diabetes Self-Care|diabetes self-care
398440|NCT01440530|Diabetes Self-Management|diabetes self-management
398441|NCT01440530|Diabetes Behavior Intervention|diabetes behavior intervention
398442|NCT01440517|CE-MRI - Contrast-enhanced magnetic resonance imaging|ce-mri - contrast-enhanced magnetic resonance imaging
398443|NCT01440517|DM - Diabetes mellitus|dm - diabetes mellitus
398444|NCT01440517|EKG - Echocardiography|ekg - echocardiography
398445|NCT01440517|HFPEF - Heart failure preserved left ventricular ejection fraction|hfpef - heart failure preserved left ventricular ejection fraction
398446|NCT01440517|LVEF - Left Ventricular Ejection Fraction|lvef - left ventricular ejection fraction
398447|NCT01440504|Cancer|cancer
398448|NCT01440504|Ovarian|ovarian
398449|NCT01440504|chemotherapy|chemotherapy
398450|NCT01440504|BH3-mimetic|bh3-mimetic
398451|NCT01440504|platin|platin
398452|NCT01440504|ex-vivo|ex-vivo
398453|NCT01440491|low back pain|low back pain
398454|NCT01440491|exercise|exercise
398455|NCT01440491|booklet|booklet
398456|NCT01440465|chemotherapy|chemotherapy
398457|NCT01440465|cancer|cancer
398458|NCT01440465|nausea|nausea
398459|NCT01440465|vomiting|vomiting
398460|NCT01440452|TM|tm
398461|NCT01440452|MS|ms
398462|NCT01440452|Spinal Cord Injury|spinal cord injury
398463|NCT01440452|Functional electrical stimulation|functional electrical stimulation
398464|NCT01440452|Rehabilitation|rehabilitation
398465|NCT01440452|Growth factors|growth factors
398466|NCT01440452|Cytokines|cytokines
398467|NCT01440439|insulin glargine|insulin glargine
398468|NCT01440439|insulin detemir|insulin detemir
398469|NCT01440439|hypoglycaemia|hypoglycaemia
398470|NCT01440439|metabolism|metabolism
398471|NCT01440439|Exercise|exercise
398472|NCT01440426|gingival recession|gingival recession
398473|NCT01440426|root coverage|root coverage
398474|NCT01440426|periodontal surgery|periodontal surgery
398475|NCT01440426|collagen matrix|collagen matrix
398476|NCT01440426|mucograft|mucograft
398477|NCT01440426|multiple exposed teeth|multiple exposed teeth
398478|NCT01440413|anti-tumor immune response|anti-tumor immune response
398479|NCT01440413|neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
398480|NCT01440413|relapse|relapse
398481|NCT01440413|long term survival|long term survival
398482|NCT01440413|histo-pathological response|histo-pathological response
398483|NCT01440413|tumor cell death|tumor cell death
398484|NCT01440413|tumor associated antigens|tumor associated antigens
398485|NCT01440413|Calreticulin|calreticulin
398486|NCT01440413|Localized breast cancer|localized breast cancer
398487|NCT01440400|Ultrasound|ultrasound
398488|NCT01440400|Spinal anesthesia|spinal anesthesia
398489|NCT01440400|Cesarean section|cesarean section
398491|NCT01440387|Phase III|phase iii
398492|NCT01440387|Seasonal influenza|seasonal influenza
398493|NCT01440374|acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
398494|NCT01440374|acute myelogenous leukemia (AML)|acute myelogenous leukemia (aml)
398495|NCT01440374|acute non lymphocytic leukemia (ANLL)|acute non lymphocytic leukemia (anll)
398496|NCT01440374|myeloproliferative disease (MDS)|myeloproliferative disease (mds)
398497|NCT01440374|myelodysplastic syndrome ( secondary acute myeloid leukemia)|myelodysplastic syndrome ( secondary acute myeloid leukemia)
398498|NCT01440374|refractory acute myeloid leukemia|refractory acute myeloid leukemia
398499|NCT01440348|Achilles allograft|achilles allograft
398500|NCT01440348|cruciate ligament|cruciate ligament
398501|NCT01440348|reconstruction|reconstruction
398502|NCT01440335|Fenoterol|fenoterol
398503|NCT01440335|Pharmacodynamics|pharmacodynamics
398504|NCT01440335|Pharmacokinetics|pharmacokinetics
398505|NCT01440335|Safety|safety
398506|NCT01440335|Beta Adrenergic Agonist|beta adrenergic agonist
398507|NCT01440322|Myopia|myopia
398508|NCT01440322|Contact lenses|contact lenses
398509|NCT01440309|biliary cirrhosis|biliary cirrhosis
398510|NCT01440283|Neuroblastoma|neuroblastoma
398511|NCT01440283|Radiation Therapy|radiation therapy
398512|NCT01440270|Oral cancer|oral cancer
398513|NCT01440270|Oropharyngeal cancer|oropharyngeal cancer
398514|NCT01440270|Induction chemotherapy|induction chemotherapy
398515|NCT01440270|Targeted chemotherapy|targeted chemotherapy
398516|NCT01440270|Surgery|surgery
398517|NCT01440270|Radiotherapy|radiotherapy
398518|NCT01440270|Effects of Chemotherapy|effects of chemotherapy
398519|NCT01440244|mediastinoscopy|mediastinoscopy
398520|NCT01440244|pleural evaluation|pleural evaluation
398521|NCT01440244|pleural biopsy|pleural biopsy
398522|NCT01440244|pleurodesis|pleurodesis
398523|NCT01440231|Rheumatology|rheumatology
398524|NCT01440231|Double-Blind|double-blind
398525|NCT01440231|Placebo-Controlled|placebo-controlled
398526|NCT01440231|Multidose|multidose
398527|NCT01440231|Dose-Response|dose-response
398528|NCT01440231|Phase II|phase ii
398529|NCT01440231|Systemic Lupus Erythematosus|systemic lupus erythematosus
398530|NCT01440231|SLE|sle
398531|NCT01440231|Atacicept|atacicept
398532|NCT01440218|Idiopathic diseases|idiopathic diseases
398533|NCT01440218|family member of the affected individual|family member of the affected individual
398534|NCT01440218|unknown etiology|unknown etiology
398535|NCT01440205|Flu Shot|flu shot
398536|NCT01440192|Sarcoidosis|sarcoidosis
398537|NCT01440192|Stem cells|stem cells
398538|NCT01440192|PDA001|pda001
398539|NCT01440192|Celgene|celgene
398540|NCT01440192|Human Placenta-Derived cells|human placenta-derived cells
398541|NCT01440192|Cenplacel-L|cenplacel-l
398542|NCT01440166|Human healthy volunteers|human healthy volunteers
398543|NCT01440153|Dance|dance
398544|NCT01440153|Injury|injury
398545|NCT01440153|Physical condition|physical condition
398546|NCT01440153|Exercise|exercise
398547|NCT01440114|emergence agitation|emergence agitation
398548|NCT01440114|pediatric patient|pediatric patient
398549|NCT01440114|fentanyl|fentanyl
398550|NCT01440114|incidence of emergence agitation|incidence of emergence agitation
398551|NCT01440114|severity of emergence agitation|severity of emergence agitation
398552|NCT01440114|adverse outcome from intervention|adverse outcome from intervention
398553|NCT01440088|TH-302|th-302
398554|NCT01440088|TH-CR-406|th-cr-406
398555|NCT01440088|SARC021|sarc021
398556|NCT01440088|Locally Advanced Soft Tissue Sarcoma|locally advanced soft tissue sarcoma
398557|NCT01440088|Metastatic Soft Tissue Sarcoma|metastatic soft tissue sarcoma
398558|NCT01440088|Sarcoma|sarcoma
398559|NCT01440088|Doxorubicin|doxorubicin
398560|NCT01440088|Evofosfamide|evofosfamide
398561|NCT01440075|Kawasaki disease|kawasaki disease
398562|NCT01440049|patients with MI- on top of treatment add Eplerenone - assess LVEF and BP|patients with mi- on top of treatment add eplerenone - assess lvef and bp
398563|NCT01440036|carotid artery|carotid artery
398564|NCT01440036|Atherosclerotic plaque|atherosclerotic plaque
398565|NCT01440036|paraoxygenase 1 PON1|paraoxygenase 1 pon1
398566|NCT01440036|Patients undergoing carotid artery endarterectomy CEA for carotid artery stenosis|patients undergoing carotid artery endarterectomy cea for carotid artery stenosis
398567|NCT01440023|tic disorder|tic disorder
398568|NCT01440023|tourette syndrome|tourette syndrome
398569|NCT01440023|habit reversal|habit reversal
398570|NCT01440023|response inhibition|response inhibition
398571|NCT01440023|cognitive retraining|cognitive retraining
398572|NCT01440010|IORT|iort
398573|NCT01440010|Boost|boost
398574|NCT01440010|Breast cancer|breast cancer
398575|NCT01440010|Local recurrence|local recurrence
398576|NCT01440010|Toxicity|toxicity
398577|NCT01440010|LENT SOMA|lent soma
398578|NCT01440010|TARGIT|targit
398579|NCT01440010|Quality Control Registry|quality control registry
398580|NCT01439997|Nocturnal polyuria|nocturnal polyuria
398581|NCT01439984|PE|pe
398582|NCT01439984|IELT|ielt
398583|NCT01439984|DCIT|dcit
398584|NCT01439971|Phase 1|phase 1
398585|NCT01439971|Safety|safety
398586|NCT01439971|Pharmacokinetic|pharmacokinetic
398587|NCT01439971|Pharmacodynamic|pharmacodynamic
398588|NCT01439958|Inhalation|inhalation
398589|NCT01439958|Lung Transplantation|lung transplantation
398590|NCT01439958|Cyclosporine|cyclosporine
398591|NCT01439945|hot flashes|hot flashes
398592|NCT01439945|cancer survivor|cancer survivor
398593|NCT01439945|breast cancer|breast cancer
398594|NCT01439932|plantar fasciitis|plantar fasciitis
398595|NCT01439932|heel pain|heel pain
398596|NCT01439932|manual treatment|manual treatment
398597|NCT01439932|dorsi flexion|dorsi flexion
398598|NCT01439906|Degenerative scoliosis|degenerative scoliosis
398599|NCT01439906|Pain|pain
398600|NCT01439906|Deformity correction|deformity correction
398601|NCT01439906|Instrumented arthrodesis|instrumented arthrodesis
398602|NCT01439893|Chronic heart failure|chronic heart failure
398603|NCT01439893|rhNRG-1|rhnrg-1
398604|NCT01439893|Cardiac remodeling|cardiac remodeling
398605|NCT01439880|High cholesterol|high cholesterol
398606|NCT01439880|Raised cholesterol|raised cholesterol
398607|NCT01439880|Cholesterol|cholesterol
398608|NCT01439880|Elevated Cholesterol|elevated cholesterol
398609|NCT01439867|Dialysis|dialysis
398610|NCT01439867|Sensipar|sensipar
398611|NCT01439867|Mimpara|mimpara
398612|NCT01439867|Hemodialysis|hemodialysis
398613|NCT01439867|Peritoneal Dialysis|peritoneal dialysis
398614|NCT01439867|Renal|renal
398615|NCT01439867|Parathyroid hormone|parathyroid hormone
398616|NCT01439867|Pediatric|pediatric
398617|NCT01439854|Insulin sensitivity|insulin sensitivity
398618|NCT01439854|Mitochondrial function|mitochondrial function
398619|NCT01439854|Glucose toxicity|glucose toxicity
398620|NCT01439854|Glucosuria|glucosuria
398621|NCT01439841|HIV|hiv
398622|NCT01439841|microbial translocation|microbial translocation
398623|NCT01439841|immune activation|immune activation
398624|NCT01439841|probiotics|probiotics
398625|NCT01439828|Cannabis|cannabis
398626|NCT01439828|N-Acetylcystein|n-acetylcystein
398627|NCT01439828|Dependence|dependence
398628|NCT01439828|Abuse|abuse
398629|NCT01439828|Craving|craving
398630|NCT01439828|Genetic|genetic
398631|NCT01439802|Postpartum IUD|postpartum iud
398632|NCT01439802|Cesarean Delivery|cesarean delivery
398633|NCT01439802|6 months postpartum|6 months postpartum
398634|NCT01439802|satisfaction|satisfaction
398635|NCT01439789|Chronic Heart Failure|chronic heart failure
398636|NCT01439789|rhNRG-1|rhnrg-1
398637|NCT01439789|NT-proBNP|nt-probnp
398638|NCT01439776|chronic hepatitis C|chronic hepatitis c
398639|NCT01439776|SVR|svr
398640|NCT01439776|Vit D|vit d
398641|NCT01439776|Peginterferon alfa 2a|peginterferon alfa 2a
398642|NCT01439776|Ribavirin|ribavirin
398643|NCT01439763|Bullies|bullies
398644|NCT01439763|Bully victims|bully victims
398645|NCT01439763|Psychiatric symptoms|psychiatric symptoms
398646|NCT01439750|mantle cell lymphoma|mantle cell lymphoma
398647|NCT01439750|lymphoma|lymphoma
398648|NCT01439737|Asthma|asthma
398649|NCT01439737|metabolomics|metabolomics
398650|NCT01439737|exhaled breath condensate|exhaled breath condensate
398651|NCT01439724|Oral mucositis|oral mucositis
398652|NCT01439724|Low Level Laser Therapy|low level laser therapy
398653|NCT01439724|Head and neck cancer|head and neck cancer
398654|NCT01439711|ductal breast carcinoma in situ|ductal breast carcinoma in situ
398655|NCT01439711|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
398656|NCT01439698|Cholangiocarcinoma|cholangiocarcinoma
398657|NCT01439698|Pancreatic Cancer|pancreatic cancer
398658|NCT01439698|Bile Duct Cancer|bile duct cancer
398659|NCT01439698|Biliary Stricture|biliary stricture
398660|NCT01439698|Bile duct obstruction|bile duct obstruction
398661|NCT01439698|ENDOHPB|endohpb
398662|NCT01439698|Radio Frequency Ablation|radio frequency ablation
398663|NCT01439698|RFA|rfa
398664|NCT01439698|ERCP|ercp
398665|NCT01439698|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
398666|NCT01439698|Registry|registry
398667|NCT01439698|Multicenter|multicenter
398668|NCT01439685|Cholangiocarcinoma|cholangiocarcinoma
398669|NCT01439685|PDT|pdt
398670|NCT01439685|Photodynamic Therapy|photodynamic therapy
398671|NCT01439685|Bile Duct|bile duct
398672|NCT01439685|Bile Duct Obstruction|bile duct obstruction
398673|NCT01439685|Jaundice|jaundice
398674|NCT01439685|Biliary Stent|biliary stent
398675|NCT01439685|ERCP|ercp
398676|NCT01439685|Obstructive Jaundice|obstructive jaundice
398677|NCT01439672|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
398678|NCT01439659|Ovarian Cancer|ovarian cancer
398679|NCT01439659|Epithelial ovarian cancer|epithelial ovarian cancer
398680|NCT01439659|First clinical remission|first clinical remission
398681|NCT01439659|Nutritional Supplements|nutritional supplements
398682|NCT01439659|Juice Plus +|juice plus +
398683|NCT01439659|Juice Plus + Complete|juice plus + complete
398684|NCT01439659|Dietary counseling|dietary counseling
398685|NCT01439646|empirical|empirical
398686|NCT01439646|ICU|icu
398687|NCT01439646|high risk patient|high risk patient
398688|NCT01439633|Barrett's Esophagus|barrett's esophagus
398689|NCT01439633|Esophagus|esophagus
398690|NCT01439633|OCT|oct
398691|NCT01439633|Imaging|imaging
398692|NCT01439620|Biliary Stricture|biliary stricture
398693|NCT01439620|OCT|oct
398694|NCT01439620|Imaging|imaging
398695|NCT01439607|Gaucher disease|gaucher disease
398696|NCT01439594|Barrett's Esophagus|barrett's esophagus
398697|NCT01439594|Esophagus|esophagus
398698|NCT01439594|OCT|oct
398699|NCT01439594|Imaging|imaging
398700|NCT01439594|Radiofrequency Ablation|radiofrequency ablation
398701|NCT01439594|BARRX|barrx
398702|NCT01439581|patients|patients
398703|NCT01439581|susceptible to|susceptible to
398704|NCT01439581|hospital|hospital
398705|NCT01439581|acquired pressure|acquired pressure
398706|NCT01439568|Cancer|cancer
398707|NCT01439568|Lung|lung
398708|NCT01439568|Metastasis|metastasis
398709|NCT01439555|Early Alzheimer|early alzheimer
398710|NCT01439555|Mild Cognitive Impairment|mild cognitive impairment
398711|NCT01439555|Drug treatment|drug treatment
398712|NCT01439555|Cerebral blood flow|cerebral blood flow
398713|NCT01439555|Endothelial facilitation|endothelial facilitation
398714|NCT01439555|Cognitive improvement|cognitive improvement
398715|NCT01439542|High risk prostate cancer|high risk prostate cancer
398716|NCT01439529|Cardiac|cardiac
398717|NCT01439529|Resynchronization|resynchronization
398718|NCT01439529|Therapy|therapy
398719|NCT01439477|exercise|exercise
398720|NCT01439477|healthy eating|healthy eating
398721|NCT01439477|heart disease|heart disease
398722|NCT01439477|prevention & control|prevention & control
398723|NCT01439477|Middle aged|middle aged
398724|NCT01439477|Women|women
398725|NCT01439477|Health promotion|health promotion
398726|NCT01439451|Balance control|balance control
398727|NCT01439451|Aging|aging
398728|NCT01439451|Balance reactions|balance reactions
398729|NCT01439451|Perturbation|perturbation
398730|NCT01439451|above seventy years old|above seventy years old
398731|NCT01439425|psoriasis|psoriasis
398732|NCT01439425|obesity|obesity
398733|NCT01439425|body mass index|body mass index
398734|NCT01439425|disease remission|disease remission
398735|NCT01439425|diet|diet
398736|NCT01439412|Low back pain|low back pain
398737|NCT01439412|Acupuncture|acupuncture
398738|NCT01439412|General practice|general practice
398739|NCT01439399|postoperative pain|postoperative pain
398740|NCT01439399|postoperative care|postoperative care
398741|NCT01439399|intravenous lidocaine|intravenous lidocaine
398742|NCT01439399|intravenous ketamine|intravenous ketamine
398743|NCT01439399|morphine consumption|morphine consumption
398744|NCT01439373|chronic hepatitis C|chronic hepatitis c
398745|NCT01439373|NS5A inhibitor|ns5a inhibitor
398746|NCT01439373|ribavirin|ribavirin
398747|NCT01439373|pegylated interferon|pegylated interferon
398748|NCT01439373|GSK2336805|gsk2336805
398749|NCT01439360|Vaccine|vaccine
398750|NCT01439360|Seasonal Flu|seasonal flu
398751|NCT01439360|Efficacy|efficacy
398752|NCT01439360|Children|children
398753|NCT01439347|Marqibo|marqibo
398754|NCT01439347|HALLMARQ|hallmarq
398755|NCT01439347|leukemia|leukemia
398756|NCT01439347|front-line|front-line
398757|NCT01439347|ALL|all
398758|NCT01439347|acute lymphoblastic leukemia|acute lymphoblastic leukemia
398759|NCT01439334|Brief|brief
398760|NCT01439334|Online|online
398761|NCT01439334|Image|image
398762|NCT01439334|Interactive|interactive
398763|NCT01439334|Young Adult|young adult
398764|NCT01439334|Primary Care|primary care
398765|NCT01439321|treatment satisfaction|treatment satisfaction
398766|NCT01439321|romiplostim|romiplostim
398767|NCT01439321|eltrombopag|eltrombopag
398768|NCT01439321|chronic immune thrombocytopenic pupura|chronic immune thrombocytopenic pupura
398769|NCT01439308|NAR|nar
398770|NCT01439308|Capsaicin challenge|capsaicin challenge
398771|NCT01439295|Ascorbyl peroxide|ascorbyl peroxide
398772|NCT01439295|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
398773|NCT01439295|Redox status|redox status
398774|NCT01439295|Necrotising entercolitis|necrotising entercolitis
398775|NCT01439295|Retinopathy of prematurity|retinopathy of prematurity
398776|NCT01439295|Patent ductus arteriosus|patent ductus arteriosus
398777|NCT01439295|Intraventricular hemorrhage|intraventricular hemorrhage
398778|NCT01439295|Periventricular leucomalacia|periventricular leucomalacia
398779|NCT01439282|Estrogen Receptor-Positive Early Stage Breast Cancer|estrogen receptor-positive early stage breast cancer
398780|NCT01439269|Separation stress|separation stress
398781|NCT01439269|Family Nurture|family nurture
398782|NCT01439269|Maternal Confidence|maternal confidence
398783|NCT01439269|Maternal Competence|maternal competence
398784|NCT01439269|Calming Cycle|calming cycle
398785|NCT01439269|Kangaroo Care|kangaroo care
398786|NCT01439269|Infant Neurodevelopment|infant neurodevelopment
398787|NCT01439269|Infant Psychological Development|infant psychological development
398788|NCT01439269|Post-partum depression|post-partum depression
398789|NCT01439269|Mother-infant Co-regulation|mother-infant co-regulation
398790|NCT01439243|Bioequivalence|bioequivalence
398791|NCT01439243|Healthy Subjects|healthy subjects
398792|NCT01439243|Donepezil|donepezil
398793|NCT01439230|Bioequivalence|bioequivalence
398794|NCT01439230|Healthy Subjects|healthy subjects
398795|NCT01439230|Donepezil|donepezil
398796|NCT01439217|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
398797|NCT01439217|Survivor|survivor
398798|NCT01439217|Sibling control|sibling control
398799|NCT01439191|HER2-Overexpressed|her2-overexpressed
398800|NCT01439165|Adacel vaccine|adacel vaccine
398801|NCT01439165|Tetanus|tetanus
398802|NCT01439165|Diphtheria|diphtheria
398803|NCT01439165|whooping cough|whooping cough
398804|NCT01439152|Oncology|oncology
398805|NCT01439152|Solid tumors|solid tumors
398806|NCT01439152|Antibody drug conjugate (ADC)|antibody drug conjugate (adc)
398807|NCT01439152|Treatment Emergent Adverse Events|treatment emergent adverse events
398808|NCT01439152|Mesothelin|mesothelin
398809|NCT01439139|Osteoporosis|osteoporosis
398810|NCT01439139|ultrasound|ultrasound
398811|NCT01439139|sonometer|sonometer
398812|NCT01439139|DXA|dxa
398813|NCT01439126|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
398814|NCT01439113|Ultrasound, Difficult access|ultrasound, difficult access
398815|NCT01439100|Parkinson's disease|parkinson's disease
398816|NCT01439100|severe pain|severe pain
398817|NCT01439100|OXN PR|oxn pr
398818|NCT01439100|randomised|randomised
398819|NCT01439087|Colonic Polyps|colonic polyps
398820|NCT01439087|OCT|oct
398821|NCT01439087|Imaging|imaging
398822|NCT01439087|Colon|colon
398823|NCT01439087|Polyp|polyp
398824|NCT01439074|Burn injuries|burn injuries
398825|NCT01439074|Mepilex Ag|mepilex ag
398826|NCT01439074|SSD Ag|ssd ag
398827|NCT01439074|Partial thickness|partial thickness
398828|NCT01439061|Growth disorders|growth disorders
398829|NCT01439061|Saizen|saizen
398830|NCT01439061|Easypod|easypod
398831|NCT01439061|Growth hormone|growth hormone
398832|NCT01439061|Pediatric subject|pediatric subject
398833|NCT01439048|Placenta|placenta
398834|NCT01439048|Cord Blood|cord blood
398835|NCT01439048|PAH|pah
398836|NCT01439048|Environmental Markers|environmental markers
398837|NCT01439048|Toll-Like Receptors|toll-like receptors
398838|NCT01439035|Celiac Disease|celiac disease
398839|NCT01439035|Duodenal|duodenal
398840|NCT01439035|OCT|oct
398841|NCT01439035|Imaging|imaging
398842|NCT01439022|Parkinson's Disease|parkinson's disease
398843|NCT01439022|Exercise|exercise
398844|NCT01439022|Treatment Outcome|treatment outcome
398845|NCT01439022|Patient Adherence|patient adherence
398846|NCT01439009|Heart failure|heart failure
398847|NCT01439009|Volume overload|volume overload
398848|NCT01439009|Tolvaptan|tolvaptan
398849|NCT01439009|loop diuretics|loop diuretics
398850|NCT01438996|Typhoid fever|typhoid fever
398851|NCT01438996|Glycoconjugate vaccine|glycoconjugate vaccine
398852|NCT01438996|Vi polysaccharide|vi polysaccharide
398853|NCT01438996|Immunogenicity|immunogenicity
398854|NCT01438957|Dexmedetomidine|dexmedetomidine
398855|NCT01438957|Sedation|sedation
398856|NCT01438957|Non-intubation|non-intubation
398857|NCT01438957|epidural anesthesia|epidural anesthesia
398858|NCT01438957|spinal anesthesia|spinal anesthesia
398860|NCT01438944|Patch|patch
398861|NCT01438944|smoking|smoking
398862|NCT01438944|addiction|addiction
398863|NCT01438931|Dexmedetomidine|dexmedetomidine
398864|NCT01438931|Sedation|sedation
398865|NCT01438931|Non-intubation|non-intubation
398866|NCT01438931|local anesthesia|local anesthesia
398867|NCT01438918|Knee|knee
398868|NCT01438918|Osteoarthritis|osteoarthritis
398869|NCT01438918|X-ray|x-ray
398870|NCT01438918|Joint Space Narrowing|joint space narrowing
398871|NCT01438905|Ankle Sprain|ankle sprain
398872|NCT01438905|Chronic Ankle Instability|chronic ankle instability
398873|NCT01438905|Ankle Mobilization|ankle mobilization
398874|NCT01438905|Talocrural Joint Mobilization|talocrural joint mobilization
398875|NCT01438905|Cortical Muscle Activation|cortical muscle activation
398876|NCT01438905|Spinal Muscle Activation|spinal muscle activation
398877|NCT01438892|rheumatoid arthritis|rheumatoid arthritis
398878|NCT01438892|therapy compliance|therapy compliance
398879|NCT01438879|CSF|csf
398880|NCT01438879|PCR|pcr
398881|NCT01438879|lymphocytic herpesvirus|lymphocytic herpesvirus
398882|NCT01438879|CNS|cns
398883|NCT01438866|Dental caries|dental caries
398884|NCT01438866|Fissure sealant|fissure sealant
398885|NCT01438866|Fluoride varnish|fluoride varnish
398886|NCT01438866|Primary molar|primary molar
398887|NCT01438853|Sepsis|sepsis
398888|NCT01438853|Acute Lung Injury|acute lung injury
398889|NCT01438853|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
398890|NCT01438853|ALI/ARDS|ali/ards
398891|NCT01438853|Lung Disease|lung disease
398892|NCT01438840|Chronic Immune Thrombocytopenia|chronic immune thrombocytopenia
398893|NCT01438788|Bethlem myopathy|bethlem myopathy
398894|NCT01438788|Ullrich congenital muscular dystrophy|ullrich congenital muscular dystrophy
398895|NCT01438788|Low protein diet|low protein diet
398896|NCT01438788|Autophagy|autophagy
398897|NCT01438788|Pilot clinical trial|pilot clinical trial
398898|NCT01438775|Benign prostatic hyperplasia|benign prostatic hyperplasia
398899|NCT01438775|BPH|bph
398900|NCT01438775|Enlarged prostate|enlarged prostate
398901|NCT01438775|Lower urinary tract symptoms|lower urinary tract symptoms
398902|NCT01438775|LUTS|luts
398903|NCT01438775|LUTS secondary to BPH|luts secondary to bph
398904|NCT01438775|LUTS/BPH|luts/bph
398905|NCT01438775|Benign prostatic obstruction|benign prostatic obstruction
398906|NCT01438775|BPO|bpo
398907|NCT01438775|Bladder outlet obstruction|bladder outlet obstruction
398908|NCT01438775|BOO|boo
398909|NCT01438762|Anterior Knee Pain|anterior knee pain
398910|NCT01438736|Focus:|focus:
398911|NCT01438736|preceding|preceding
398912|NCT01438736|desogestrel predicts|desogestrel predicts
398913|NCT01438736|pattern of following|pattern of following
398914|NCT01438736|etonogestrel implant|etonogestrel implant
398915|NCT01438723|ischemia reperfusion injury|ischemia reperfusion injury
398916|NCT01438723|CABG|cabg
398917|NCT01438723|metformin|metformin
398918|NCT01438723|Hs-troponin-I|hs-troponin-i
398919|NCT01438697|sleep|sleep
398920|NCT01438697|insomnia|insomnia
398921|NCT01438697|internet|internet
398922|NCT01438697|CBT|cbt
398923|NCT01438684|chronic vegetative state|chronic vegetative state
398924|NCT01438684|functional MRI|functional mri
398925|NCT01438671|WiiFit|wiifit
398926|NCT01438671|Standing Balance|standing balance
398927|NCT01438671|Neurological Population|neurological population
398928|NCT01438658|uveal melanoma|uveal melanoma
398929|NCT01438658|metastatic uveal melanoma|metastatic uveal melanoma
398930|NCT01438645|Colonoscopy|colonoscopy
398931|NCT01438645|Colon cancer screening|colon cancer screening
398932|NCT01438632|Insulin action|insulin action
398933|NCT01438632|Jet injector|jet injector
398934|NCT01438632|Diabetes Mellitus|diabetes mellitus
398935|NCT01438632|Pharmacodynamics|pharmacodynamics
398936|NCT01438632|Pharmacokinetics|pharmacokinetics
398937|NCT01438632|Insulin analogs|insulin analogs
398938|NCT01438632|Insulin aspart|insulin aspart
398939|NCT01438619|sodium|sodium
398940|NCT01438619|blood pressure|blood pressure
398941|NCT01438619|pulse wave velocity|pulse wave velocity
398942|NCT01438619|random digit dialling|random digit dialling
398943|NCT01438593|Stroke|stroke
398944|NCT01438593|Brain disease|brain disease
398945|NCT01438593|Ischemia|ischemia
398946|NCT01438593|Cerebral infraction|cerebral infraction
398947|NCT01438593|Cord Blood|cord blood
398948|NCT01438580|atrial ﬁbrillation|atrial ﬁbrillation
398949|NCT01438580|stroke|stroke
398950|NCT01438580|warfarin|warfarin
398951|NCT01438580|aspirin|aspirin
398952|NCT01438567|oxycodone naloxone combination|oxycodone naloxone combination
398953|NCT01438567|severe chronic and non-malignant pain|severe chronic and non-malignant pain
398954|NCT01438567|Malignant and non-malignant pain that requires around-the clock opioid therapy|malignant and non-malignant pain that requires around-the clock opioid therapy
398955|NCT01438567|Opioid related constipation|opioid related constipation
398956|NCT01438541|No skin breakdown|no skin breakdown
398957|NCT01438541|Prevention|prevention
398958|NCT01438541|protection of the skin|protection of the skin
398959|NCT01438528|Growth disorders|growth disorders
398960|NCT01438528|Saizen|saizen
398961|NCT01438528|Easypod|easypod
398962|NCT01438528|Growth hormone|growth hormone
398963|NCT01438528|Pediatric subject|pediatric subject
398964|NCT01438515|MRSA|mrsa
398965|NCT01438515|doxycycline|doxycycline
398966|NCT01438515|rifampin|rifampin
398967|NCT01438515|mupirocin|mupirocin
398968|NCT01438515|chlorhexidine gluconate|chlorhexidine gluconate
398969|NCT01438515|decolonization|decolonization
398970|NCT01438515|methicillin-resistant staphylococcus aureus|methicillin-resistant staphylococcus aureus
398971|NCT01438502|cardiac surgery|cardiac surgery
398972|NCT01438502|cardio-pulmonary-bypass|cardio-pulmonary-bypass
398973|NCT01438489|MEDI-546|medi-546
398974|NCT01438489|Anifrolumab|anifrolumab
398975|NCT01438489|Systemic Lupus Erythematosus|systemic lupus erythematosus
398976|NCT01438476|Liver Cancer|liver cancer
398977|NCT01438476|Pancreatic Cancer|pancreatic cancer
398978|NCT01438476|Thoracic epidural analgesia|thoracic epidural analgesia
398979|NCT01438476|TEA|tea
398980|NCT01438476|Intravenous patient-controlled analgesia|intravenous patient-controlled analgesia
398981|NCT01438476|IVPCA|ivpca
398982|NCT01438476|Pain control|pain control
398983|NCT01438476|Quality of life|quality of life
398984|NCT01438476|QOL|qol
398985|NCT01438476|Surgical resection|surgical resection
398986|NCT01438463|non-seasonal allergy|non-seasonal allergy
398987|NCT01438463|house dust mite|house dust mite
398988|NCT01438463|immunotherapy|immunotherapy
398989|NCT01438463|dose response|dose response
398990|NCT01438450|Thalidomide|thalidomide
398991|NCT01438450|Capecitabine|capecitabine
398992|NCT01438450|Advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
398993|NCT01438450|Therapy|therapy
398994|NCT01438450|Supportive care|supportive care
398995|NCT01438437|Hepatocellular carcinoma|hepatocellular carcinoma
398996|NCT01438437|Radiofrequency ablation|radiofrequency ablation
398997|NCT01438437|Percutaneous acetic acid ablation|percutaneous acetic acid ablation
398998|NCT01438437|Tumour response|tumour response
398999|NCT01438411|Cholic Acid|cholic acid
399000|NCT01438411|Inborn Error|inborn error
399001|NCT01438411|Bile Acid Metabolism|bile acid metabolism
399195|NCT01437631|colon polyp|colon polyp
399002|NCT01438411|Inborn Error of Bile Acid Synthesis|inborn error of bile acid synthesis
399003|NCT01438398|Submucosal endoscopic myotomy|submucosal endoscopic myotomy
399004|NCT01438398|Per Oral Endoscopic Myotomy|per oral endoscopic myotomy
399005|NCT01438398|Natural Orifice Transluminal Endoscopic Surgery|natural orifice transluminal endoscopic surgery
399006|NCT01438385|Pancreatico-biliary|pancreatico-biliary
399007|NCT01438385|Biliary|biliary
399008|NCT01438385|Bile Duct|bile duct
399009|NCT01438385|Gastrointestinal disorder|gastrointestinal disorder
399010|NCT01438385|Esophageal disorder|esophageal disorder
399011|NCT01438372|Iron Deficiency Anemia|iron deficiency anemia
399012|NCT01438372|Inflammatory Bowel Disease|inflammatory bowel disease
399013|NCT01438372|Children|children
399014|NCT01438359|Drug-drug interaction|drug-drug interaction
399015|NCT01438359|Pharmacokinetics|pharmacokinetics
399016|NCT01438359|PA21|pa21
399017|NCT01438359|Drug Interaction Potentiation|drug interaction potentiation
399018|NCT01438346|Substance Abuse|substance abuse
399019|NCT01438346|Substance Addiction|substance addiction
399020|NCT01438346|Substance Dependence|substance dependence
399021|NCT01438346|Treatment program|treatment program
399022|NCT01438333|Chronic Peridodontitis|chronic peridodontitis
399023|NCT01438333|probiotics|probiotics
399024|NCT01438333|lactobacillus brevis|lactobacillus brevis
399025|NCT01438333|full mouth disinfection|full mouth disinfection
399026|NCT01438320|Treatment naive|treatment naive
399027|NCT01438320|Contraindications to standard therapies|contraindications to standard therapies
399028|NCT01438320|Alternative hepatitis C therapy|alternative hepatitis c therapy
399029|NCT01438307|Non-small cell lung cancer|non-small cell lung cancer
399030|NCT01438307|Cabazitaxel-XRP6258|cabazitaxel-xrp6258
399031|NCT01438307|P-glycoprotein|p-glycoprotein
399032|NCT01438307|taxane|taxane
399033|NCT01438307|Advanced NSCLC|advanced nsclc
399034|NCT01438294|Asthma|asthma
399035|NCT01438294|childhood|childhood
399036|NCT01438294|exercise|exercise
399037|NCT01438281|ocular pain|ocular pain
399038|NCT01438281|dry eye|dry eye
399039|NCT01438281|siRNA|sirna
399040|NCT01438242|Major|major
399041|NCT01438242|Depressive|depressive
399042|NCT01438242|Disorder|disorder
399043|NCT01438242|Depression|depression
399044|NCT01438242|Treatment Resistant|treatment resistant
399045|NCT01438229|Catheter-based renal artery ablation|catheter-based renal artery ablation
399046|NCT01438229|Hypertension|hypertension
399047|NCT01438229|Resistant to Conventional Therapy|resistant to conventional therapy
399048|NCT01438216|Pharmacokinetics|pharmacokinetics
399049|NCT01438216|Intensive Care|intensive care
399050|NCT01438216|Candidemia|candidemia
399051|NCT01438216|Invasive candidiasis|invasive candidiasis
399052|NCT01438216|Anidulafungin|anidulafungin
399053|NCT01438203|manipulation|manipulation
399054|NCT01438203|mobilization|mobilization
399055|NCT01438203|low back pain|low back pain
399056|NCT01438203|treatment|treatment
399057|NCT01438177|myeloma|myeloma
399058|NCT01438177|multiple myeloma|multiple myeloma
399059|NCT01438177|relapsed myeloma|relapsed myeloma
399060|NCT01438177|refractory myeloma|refractory myeloma
399061|NCT01438164|FDG-PET|fdg-pet
399062|NCT01438164|cancer|cancer
399063|NCT01438164|staging|staging
399064|NCT01438164|Evaluate the cost impact in the evaluation of oncologic patients.|evaluate the cost impact in the evaluation of oncologic patients.
399065|NCT01438151|Crohn's disease|crohn's disease
399066|NCT01438151|Remicade|remicade
399067|NCT01438151|infliximab|infliximab
399068|NCT01438138|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
399069|NCT01438138|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
399070|NCT01438138|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
399071|NCT01438138|childhood acute basophilic leukemia|childhood acute basophilic leukemia
399072|NCT01438138|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
399073|NCT01438138|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
399074|NCT01438138|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
399075|NCT01438138|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
399076|NCT01438138|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
399077|NCT01438138|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
399078|NCT01438138|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
399079|NCT01438138|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
399080|NCT01438138|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
399081|NCT01438112|cancer|cancer
399082|NCT01438112|bladder cancer|bladder cancer
399083|NCT01438112|transitional cell|transitional cell
399084|NCT01438112|virus|virus
399085|NCT01438112|oncolytic|oncolytic
399086|NCT01438112|GM-CSF|gm-csf
399087|NCT01438112|adenovirus|adenovirus
399088|NCT01438112|intravesical|intravesical
399089|NCT01438112|neoadjuvant|neoadjuvant
399090|NCT01438112|cystectomy|cystectomy
399091|NCT01438112|gene therapy|gene therapy
399092|NCT01438112|oncolytic virus|oncolytic virus
399093|NCT01438112|carcinoma in situ|carcinoma in situ
399221|NCT01437514|rectal cancer|rectal cancer
399094|NCT01438112|carcinoma in situ concurrent with papillary tumors|carcinoma in situ concurrent with papillary tumors
399095|NCT01438099|epidural analgesia|epidural analgesia
399096|NCT01438099|ultrasound|ultrasound
399097|NCT01438099|labor analgesia|labor analgesia
399098|NCT01438099|labor|labor
399099|NCT01438086|Heart Failure|heart failure
399100|NCT01438086|Myocardial Infarction|myocardial infarction
399101|NCT01438047|Port Wine Stain|port wine stain
399102|NCT01438021|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
399103|NCT01438008|Sucrose|sucrose
399104|NCT01438008|Pain|pain
399105|NCT01437995|Asthma|asthma
399106|NCT01437995|Step down therapy|step down therapy
399107|NCT01437995|Inhaled corticosteroids|inhaled corticosteroids
399108|NCT01437995|Long-acting beta agonists|long-acting beta agonists
399109|NCT01437995|Fluticasone Salmeterol|fluticasone salmeterol
399110|NCT01437982|post-operative inflammation|post-operative inflammation
399111|NCT01437982|conjunctivitis|conjunctivitis
399112|NCT01437982|safety|safety
399113|NCT01437982|Seasonal allergic conjunctivitis|seasonal allergic conjunctivitis
399114|NCT01437982|Giant papillary conjunctivitis|giant papillary conjunctivitis
399115|NCT01437969|Possible association|possible association
399116|NCT01437969|between severity|between severity
399117|NCT01437969|IL28B genetic variants|il28b genetic variants
399118|NCT01437969|patients|patients
399119|NCT01437969|different HCV genotypes|different hcv genotypes
399120|NCT01437956|Calcineurin|calcineurin
399121|NCT01437956|Bronchiolitis|bronchiolitis
399122|NCT01437956|Epithelial lung injury|epithelial lung injury
399123|NCT01437956|Rhinovirus|rhinovirus
399124|NCT01437956|Respiratory Syncytial Virus|respiratory syncytial virus
399125|NCT01437956|Asthma|asthma
399126|NCT01437943|Transplant|transplant
399127|NCT01437943|Failure|failure
399128|NCT01437943|Kidney|kidney
399129|NCT01437930|n-3 LC-PUFA|n-3 lc-pufa
399130|NCT01437930|hypertriglyceridemic|hypertriglyceridemic
399131|NCT01437930|human|human
399132|NCT01437930|TAG|tag
399133|NCT01437917|glycemic index|glycemic index
399134|NCT01437904|Renal Calculi|renal calculi
399135|NCT01437904|Percutaneous nephrolithotomy (PCNL)|percutaneous nephrolithotomy (pcnl)
399136|NCT01437891|PTSD|ptsd
399137|NCT01437891|Military veteran|military veteran
399138|NCT01437891|Gulf War|gulf war
399139|NCT01437891|Fibromyalgia|fibromyalgia
399140|NCT01437891|Gulf War Syndrome|gulf war syndrome
399141|NCT01437878|PH|ph
399142|NCT01437878|COPD|copd
399143|NCT01437865|MRI|mri
399144|NCT01437865|lymph node metastases|lymph node metastases
399145|NCT01437865|breast cancer|breast cancer
399146|NCT01437865|gadofosveset|gadofosveset
399147|NCT01437839|Food effect study|food effect study
399148|NCT01437839|Pharmacokinetics|pharmacokinetics
399149|NCT01437839|Apixaban|apixaban
399150|NCT01437826|chemoprevention|chemoprevention
399151|NCT01437826|colorectal cancer|colorectal cancer
399152|NCT01437826|metachronous adenoma|metachronous adenoma
399153|NCT01437826|randomized trial|randomized trial
399154|NCT01437813|DM2|dm2
399155|NCT01437813|glimepiride|glimepiride
399156|NCT01437813|metformin extended release|metformin extended release
399157|NCT01437800|DM2|dm2
399158|NCT01437800|glimepiride|glimepiride
399159|NCT01437800|metformin extended release|metformin extended release
399160|NCT01437774|Acute ischemic stroke|acute ischemic stroke
399161|NCT01437748|Small Airways|small airways
399162|NCT01437748|Closing volume|closing volume
399163|NCT01437748|Closing Capacity|closing capacity
399164|NCT01437748|Tiotropium|tiotropium
399165|NCT01437748|Indacaterol|indacaterol
399166|NCT01437748|COPD|copd
399167|NCT01437735|Asthma|asthma
399168|NCT01437735|QAW039|qaw039
399169|NCT01437722|BV|bv
399170|NCT01437722|Bacterial vaginosis|bacterial vaginosis
399171|NCT01437722|recurrent|recurrent
399172|NCT01437722|SPL7013 Gel|spl7013 gel
399173|NCT01437722|VivaGel|vivagel
399174|NCT01437709|Bendamustine HCL|bendamustine hcl
399175|NCT01437709|Ofatumumab (GSK 1841157)|ofatumumab (gsk 1841157)
399176|NCT01437709|Immunotherapy|immunotherapy
399177|NCT01437709|Chemoimmunotherapy|chemoimmunotherapy
399178|NCT01437709|11-050|11-050
399179|NCT01437696|Aging|aging
399180|NCT01437696|Vitamin D|vitamin d
399181|NCT01437696|Bone health|bone health
399182|NCT01437696|Inflammation|inflammation
399183|NCT01437696|Men|men
399184|NCT01437683|Craniocerebral Trauma|craniocerebral trauma
399185|NCT01437683|Quality of life|quality of life
399186|NCT01437683|Long term outcome|long term outcome
399187|NCT01437683|Activities of Daily Living|activities of daily living
399188|NCT01437683|Cognitive Deficiency|cognitive deficiency
399189|NCT01437683|Health Care Quality, Access, and Evaluation|health care quality, access, and evaluation
399190|NCT01437644|Cerebral Palsy|cerebral palsy
399191|NCT01437644|Hip displacement|hip displacement
399192|NCT01437644|Hip surgery|hip surgery
399193|NCT01437644|Post-operative pain|post-operative pain
399194|NCT01437644|Botulinum Toxin|botulinum toxin
399196|NCT01437631|endoscopic polypectomy|endoscopic polypectomy
399197|NCT01437631|postpolypectomy bleeding|postpolypectomy bleeding
399198|NCT01437631|prophylactic clip application|prophylactic clip application
399199|NCT01437605|Resected|resected
399200|NCT01437605|Skin|skin
399201|NCT01437605|Stage IV|stage iv
399202|NCT01437579|interstitial cystitis|interstitial cystitis
399203|NCT01437579|bladder pain syndrome|bladder pain syndrome
399204|NCT01437579|intratrigonal injection|intratrigonal injection
399205|NCT01437579|botulinum toxin|botulinum toxin
399206|NCT01437553|IVUS|ivus
399207|NCT01437553|iMAP|imap
399208|NCT01437553|Catheterization|catheterization
399209|NCT01437553|Acute Coronary Syndrome|acute coronary syndrome
399210|NCT01437540|COPD|copd
399211|NCT01437540|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
399212|NCT01437540|Chronic Bronchitis|chronic bronchitis
399213|NCT01437540|Emphysema|emphysema
399214|NCT01437540|Airflow Obstruction, Chronic|airflow obstruction, chronic
399215|NCT01437540|Chronic Airflow Obstruction|chronic airflow obstruction
399216|NCT01437540|Chronic Obstructive Airway Disease|chronic obstructive airway disease
399217|NCT01437540|Chronic Obstructive Lung Disease|chronic obstructive lung disease
399218|NCT01437527|anorexia nervosa|anorexia nervosa
399219|NCT01437527|CMME-TCA Unit|cmme-tca unit
399220|NCT01437527|Centre Hospitalier Sainte Anne|centre hospitalier sainte anne
399222|NCT01437514|Endosonography|endosonography
399223|NCT01437514|preoperative short-course radiotherapy|preoperative short-course radiotherapy
399224|NCT01437514|preoperative adjuvant therapy|preoperative adjuvant therapy
399225|NCT01437514|neoadjuvant therapy|neoadjuvant therapy
399226|NCT01437514|short-term high-dose preoperative radiotherapy|short-term high-dose preoperative radiotherapy
399227|NCT01437514|total mesorectal excision|total mesorectal excision
399228|NCT01437514|circumferential resection margin|circumferential resection margin
399229|NCT01437514|local recurrence|local recurrence
399230|NCT01437514|overall survival|overall survival
399231|NCT01437514|metastasis|metastasis
399232|NCT01437514|complication|complication
399233|NCT01437501|glucoraphanin|glucoraphanin
399234|NCT01437501|sulforaphane|sulforaphane
399235|NCT01437501|pharmacokinetics|pharmacokinetics
399236|NCT01437501|pharmacodynamics|pharmacodynamics
399237|NCT01437501|broccoli sprout|broccoli sprout
399238|NCT01437501|carcinogens, environment|carcinogens, environment
399239|NCT01437488|Urothelial carcinoma|urothelial carcinoma
399240|NCT01437488|Urothelial cancer|urothelial cancer
399242|NCT01437475|HIV|hiv
399243|NCT01437475|Immunization|immunization
399244|NCT01437475|HBV Immunization rate among HIV positive individuals|hbv immunization rate among hiv positive individuals
399245|NCT01437462|Pain, Postoperative|pain, postoperative
399246|NCT01437462|Anesthetics, intravenous|anesthetics, intravenous
399247|NCT01437462|Anesthetics, inhalation|anesthetics, inhalation
399248|NCT01437462|Otherwise healthy adults undergoing general anesthesia for gynecological disease.|otherwise healthy adults undergoing general anesthesia for gynecological disease.
399249|NCT01437449|Quality of Life|quality of life
399250|NCT01437436|otitis media|otitis media
399251|NCT01437436|obesity|obesity
399252|NCT01437436|ventilation tube|ventilation tube
399253|NCT01437423|Diphtheria|diphtheria
399254|NCT01437423|Tetanus|tetanus
399255|NCT01437423|Pertussis|pertussis
399256|NCT01437423|Poliomyelitis|poliomyelitis
399257|NCT01437423|TETRAXIM™|tetraxim™
399258|NCT01437397|COPD|copd
399259|NCT01437397|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
399260|NCT01437397|Chronic Bronchitis|chronic bronchitis
399261|NCT01437397|Emphysema|emphysema
399262|NCT01437397|Airflow Obstruction, Chronic|airflow obstruction, chronic
399263|NCT01437397|Chronic Airflow Obstruction|chronic airflow obstruction
399264|NCT01437397|Chronic Obstructive Airway Disease|chronic obstructive airway disease
399265|NCT01437397|Chronic Obstructive Lung Disease|chronic obstructive lung disease
399266|NCT01437371|Heart failure|heart failure
399267|NCT01437371|Aged and over 80|aged and over 80
399268|NCT01437371|clinical trial|clinical trial
399269|NCT01437371|quality of life|quality of life
399270|NCT01437358|Epidural catheter|epidural catheter
399271|NCT01437358|Epidural analgesia|epidural analgesia
399272|NCT01437358|Intensive care unit|intensive care unit
399273|NCT01437358|Safety|safety
399274|NCT01437306|lofexidine|lofexidine
399275|NCT01437306|food effect|food effect
399276|NCT01437306|pharmacokinetics|pharmacokinetics
399277|NCT01437306|healthy volunteer|healthy volunteer
399278|NCT01437293|cocaine|cocaine
399279|NCT01437280|Tumors|tumors
399280|NCT01437280|Solid Tumors|solid tumors
399281|NCT01437254|99mTc Pertechnetate|99mtc pertechnetate
399282|NCT01437254|thyroidectomy|thyroidectomy
399283|NCT01437241|HIV-infection|hiv-infection
399284|NCT01437241|Etravirine|etravirine
399285|NCT01437241|Treatment|treatment
399286|NCT01437241|Non-nucleoside reverse-transcriptase inhibitor|non-nucleoside reverse-transcriptase inhibitor
399287|NCT01437215|aneurysm|aneurysm
399288|NCT01437215|renal stent|renal stent
399289|NCT01437215|juxtarenal|juxtarenal
399290|NCT01437215|pararenal|pararenal
399291|NCT01437202|imatinib|imatinib
399292|NCT01437202|drug resistance|drug resistance
399293|NCT01437202|pharmacogenetics|pharmacogenetics
399294|NCT01437189|Parkinson's disease|parkinson's disease
399295|NCT01437189|depression|depression
399296|NCT01437189|sertraline|sertraline
399297|NCT01437189|intervention|intervention
399298|NCT01437176|surgery|surgery
399299|NCT01437176|fixation|fixation
399300|NCT01437176|intramedullary nail|intramedullary nail
399301|NCT01437150|surgery|surgery
399302|NCT01437150|fixation|fixation
399303|NCT01437150|bone plate|bone plate
399304|NCT01437137|elective surgery of short duration (less than 2 hr) undergoing general anesthesia using supraglottic airway|elective surgery of short duration (less than 2 hr) undergoing general anesthesia using supraglottic airway
399305|NCT01437111|Osteoporosis|osteoporosis
399306|NCT01437111|Postmenopausal|postmenopausal
399307|NCT01437098|Valvular Heart Disease|valvular heart disease
399308|NCT01437098|Severe Aortic Stenosis|severe aortic stenosis
399309|NCT01437098|Aortic Valve Replacement|aortic valve replacement
399310|NCT01437085|Needle deflection|needle deflection
399311|NCT01437085|Prostate Deformation|prostate deformation
399312|NCT01437085|Prostate Brachytherapy|prostate brachytherapy
399313|NCT01437085|Needles|needles
399314|NCT01437046|Alcohol drinking|alcohol drinking
399315|NCT01437046|Alcohol craving|alcohol craving
399316|NCT01437033|Breath Tests|breath tests
399317|NCT01437033|Human Volunteers|human volunteers
399318|NCT01437033|Pilot Study|pilot study
399319|NCT01437033|Breath Test|breath test
399320|NCT01437020|IL-10|il-10
399321|NCT01437020|Leishmaniasis|leishmaniasis
399322|NCT01437020|Immunotherapy|immunotherapy
399323|NCT01437007|SNALP|snalp
399324|NCT01437007|Regional Therapy|regional therapy
399325|NCT01437007|Stage IV Disease|stage iv disease
399326|NCT01437007|Adenocarcinoma|adenocarcinoma
399327|NCT01437007|Unresectable|unresectable
399328|NCT01437007|Liver Metastases|liver metastases
399329|NCT01437007|Colorectal Cancer|colorectal cancer
399330|NCT01437007|Stomach Cancer|stomach cancer
399331|NCT01437007|Gastric Cancer|gastric cancer
399332|NCT01437007|Breast Cancer|breast cancer
399333|NCT01437007|Ovarian Cancer|ovarian cancer
399334|NCT01437007|Pancreatic Cancer|pancreatic cancer
399335|NCT01437007|Liver Cancer|liver cancer
399336|NCT01436994|thyrotoxic|thyrotoxic
399337|NCT01436994|thyrotoxicosis|thyrotoxicosis
399338|NCT01436994|paediatric|paediatric
399339|NCT01436994|endocrinology|endocrinology
399340|NCT01436994|block and replace|block and replace
399341|NCT01436994|dose titration|dose titration
399342|NCT01436994|carbimazole|carbimazole
399343|NCT01436981|papaverine|papaverine
399344|NCT01436981|pharmacokinetic|pharmacokinetic
399345|NCT01436981|CABG|cabg
399346|NCT01436981|Injury of Internal Mammary Artery|injury of internal mammary artery
399347|NCT01436981|Complications Due to Coronary Artery Bypass Graft|complications due to coronary artery bypass graft
399348|NCT01436968|immunotherapy, cytotoxicity, tumor vaccine, prostate cancer, radiotherapy|immunotherapy, cytotoxicity, tumor vaccine, prostate cancer, radiotherapy
399349|NCT01436929|silymarin|silymarin
399350|NCT01436929|hepatotoxicity|hepatotoxicity
399351|NCT01436929|tuberculosis|tuberculosis
399352|NCT01436929|HREZ|hrez
399353|NCT01436916|prediabetes|prediabetes
399354|NCT01436916|oral cholecalciferol|oral cholecalciferol
399355|NCT01436903|menorrhagia|menorrhagia
399356|NCT01436903|dysfunctional uterine bleeding|dysfunctional uterine bleeding
399357|NCT01436903|endometrial ablation|endometrial ablation
399358|NCT01436903|cavatermTM|cavatermtm
399359|NCT01436903|probe|probe
399360|NCT01436890|Chronic Persistent Asthma|chronic persistent asthma
399362|NCT01436877|bladder neck obstruction|bladder neck obstruction
399363|NCT01436877|Bladder neck obstruction secondary to BPH|bladder neck obstruction secondary to bph
399364|NCT01436864|Recombinant Human VEGF Receptor-Fc Fusion Protein (KH902|recombinant human vegf receptor-fc fusion protein (kh902
399365|NCT01436864|)|)
399366|NCT01436864|age-related macular degeneration (AMD)|age-related macular degeneration (amd)
399367|NCT01436864|choroidal neovascularization (CNV)|choroidal neovascularization (cnv)
399368|NCT01436864|intravitreal injection|intravitreal injection
399369|NCT01436864|best corrected visual acuity (BCVA)|best corrected visual acuity (bcva)
399370|NCT01436864|central retinal thickness|central retinal thickness
399371|NCT01436851|rhinitis|rhinitis
399372|NCT01436851|allergy|allergy
399373|NCT01436851|occupational|occupational
399374|NCT01436851|storage mites|storage mites
399375|NCT01436851|nasal lavage|nasal lavage
399376|NCT01436851|challenge test|challenge test
399377|NCT01436851|ECP|ecp
399378|NCT01436851|alfa2Macroglobuline|alfa2macroglobuline
399379|NCT01436838|Relapsing-Remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
399380|NCT01436838|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
399381|NCT01436825|Haemophilia A|haemophilia a
399382|NCT01436825|Factor VIII|factor viii
399383|NCT01436825|Pharmacokinetic|pharmacokinetic
399384|NCT01436825|Computer Tool validation|computer tool validation
399385|NCT01436812|cerebral oxymetry|cerebral oxymetry
399386|NCT01436812|laparoscopy|laparoscopy
399387|NCT01436812|PEEP|peep
399388|NCT01436799|propofol|propofol
399389|NCT01436799|desflurane|desflurane
399690|NCT01435525|Nexium|nexium
399390|NCT01436799|cerebrovascular circulation|cerebrovascular circulation
399391|NCT01436799|sitting|sitting
399392|NCT01436786|cytokines|cytokines
399393|NCT01436786|Guided imagery|guided imagery
399394|NCT01436760|IBS|ibs
399395|NCT01436747|Kidney transplantation|kidney transplantation
399396|NCT01436747|Proteinuria|proteinuria
399397|NCT01436747|Albuminuria|albuminuria
399398|NCT01436747|Vitamin D|vitamin d
399399|NCT01436747|Paricalcitol|paricalcitol
399400|NCT01436721|Effectiveness|effectiveness
399401|NCT01436721|Device success|device success
399402|NCT01436721|Hepatectomy|hepatectomy
399403|NCT01436708|pelvic organ prolapse|pelvic organ prolapse
399404|NCT01436708|urinary symptoms|urinary symptoms
399405|NCT01436708|sexual function|sexual function
399406|NCT01436695|seizure early detection|seizure early detection
399407|NCT01436682|Nerve Blocks|nerve blocks
399408|NCT01436656|BRAF mutant,|braf mutant,
399409|NCT01436656|BRAF mutated,|braf mutated,
399410|NCT01436656|melanoma,|melanoma,
399411|NCT01436656|metastatic,|metastatic,
399412|NCT01436656|advanced,|advanced,
399413|NCT01436656|RAF kinase inhibitor|raf kinase inhibitor
399414|NCT01436656|BRAF V600 mutation|braf v600 mutation
399415|NCT01436643|Depression|depression
399416|NCT01436643|Multiple Sclerosis|multiple sclerosis
399417|NCT01436643|Fingolimod|fingolimod
399418|NCT01436643|Venlafaxine|venlafaxine
399419|NCT01436643|Fluoxetine|fluoxetine
399420|NCT01436630|Exercise Tolerance|exercise tolerance
399421|NCT01436630|Step Test|step test
399422|NCT01436630|Stroke|stroke
399423|NCT01436630|Walking|walking
399424|NCT01436617|cancer|cancer
399425|NCT01436617|colon|colon
399426|NCT01436617|Head and neck|head and neck
399427|NCT01436617|cetuximab|cetuximab
399428|NCT01436617|anti-cetuximab dosage|anti-cetuximab dosage
399429|NCT01436604|cardiac MRI|cardiac mri
399430|NCT01436604|Cancer|cancer
399431|NCT01436604|Breast|breast
399432|NCT01436604|Herceptin|herceptin
399433|NCT01436604|LV dysfunction|lv dysfunction
399434|NCT01436591|Cancer|cancer
399435|NCT01436591|Breast|breast
399436|NCT01436591|18FDG|18fdg
399437|NCT01436591|Axillary|axillary
399438|NCT01436591|Positron Emission Tomography|positron emission tomography
399439|NCT01436552|MCI|mci
399440|NCT01436552|Depression|depression
399441|NCT01436552|Alzheimer|alzheimer
399442|NCT01436552|Life events|life events
399443|NCT01436526|Bioequivalence|bioequivalence
399444|NCT01436513|bioequivalence|bioequivalence
399445|NCT01436513|menometrorrhagia|menometrorrhagia
399446|NCT01436513|climacteric disturbance|climacteric disturbance
399447|NCT01436513|Estrogen Replacement Therapy|estrogen replacement therapy
399448|NCT01436513|Estrogens Conjugated|estrogens conjugated
399449|NCT01436500|Hepatorenal Syndrome|hepatorenal syndrome
399450|NCT01436500|HRS|hrs
399451|NCT01436500|ifetroban|ifetroban
399452|NCT01436487|ischemic stroke|ischemic stroke
399453|NCT01436487|adult stem cells|adult stem cells
399454|NCT01436474|Varenicline|varenicline
399455|NCT01436474|Chantix|chantix
399456|NCT01436474|Chronic Pain|chronic pain
399457|NCT01436474|Opioid dependence|opioid dependence
399458|NCT01436448|efficacy|efficacy
399459|NCT01436448|Lactobacillus Rhamnosus|lactobacillus rhamnosus
399460|NCT01436448|glucose intolerance|glucose intolerance
399461|NCT01436448|feasibility|feasibility
399462|NCT01436448|compliance and safety|compliance and safety
399463|NCT01436448|reducing glucose intolerance during and after pregnancy|reducing glucose intolerance during and after pregnancy
399464|NCT01436435|PAD|pad
399465|NCT01436435|peripheral artery disease|peripheral artery disease
399466|NCT01436435|atherectomy|atherectomy
399467|NCT01436422|Dengue Virus|dengue virus
399468|NCT01436422|Dengue Fever|dengue fever
399469|NCT01436422|Dengue Vaccine|dengue vaccine
399470|NCT01436422|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
399471|NCT01436422|Dengue Shock Syndrome|dengue shock syndrome
399472|NCT01436409|vaginal touch|vaginal touch
399473|NCT01436409|deliveries assisted|deliveries assisted
399474|NCT01436409|echography|echography
399475|NCT01436409|assisted delivery|assisted delivery
399476|NCT01436396|Dengue|dengue
399477|NCT01436396|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
399478|NCT01436396|CYD Dengue Vaccines|cyd dengue vaccines
399479|NCT01436396|Yellow Fever|yellow fever
399480|NCT01436396|Stamaril®|stamaril®
399481|NCT01436396|Flavivirus Infections|flavivirus infections
399482|NCT01436383|high altitude|high altitude
399483|NCT01436383|hypobaric hypoxia|hypobaric hypoxia
399484|NCT01436383|metabolomics|metabolomics
399485|NCT01436383|oxidative stress|oxidative stress
399486|NCT01436383|acute mountain sickness|acute mountain sickness
399487|NCT01436370|influenza, rheumatoid arthritis, TNF-alpha-inhibitor, Fluzone®, Fluzone® High Dose|influenza, rheumatoid arthritis, tnf-alpha-inhibitor, fluzone®, fluzone® high dose
399488|NCT01436357|AdCh3NSmut1|adch3nsmut1
399489|NCT01436357|Hepatitis C|hepatitis c
399490|NCT01436357|MVA-NSmut|mva-nsmut
399491|NCT01436357|vaccine|vaccine
399492|NCT01436344|esophageal electrocardiography|esophageal electrocardiography
399493|NCT01436344|electrocardiography|electrocardiography
399691|NCT01435512|PTSD|ptsd
399494|NCT01436344|atrial electrogram|atrial electrogram
399495|NCT01436344|atrial function, left|atrial function, left
399496|NCT01436331|First episode psychosis|first episode psychosis
399497|NCT01436331|Early Psychosis|early psychosis
399498|NCT01436331|Cognitive Behavioural therapy|cognitive behavioural therapy
399499|NCT01436331|Psychosocial Intervention|psychosocial intervention
399500|NCT01436331|Assertive Community treatment|assertive community treatment
399501|NCT01436331|Family Intervention|family intervention
399502|NCT01436331|Mental Disorders|mental disorders
399503|NCT01436331|Psychotic Disorders|psychotic disorders
399504|NCT01436331|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
399505|NCT01436331|Affective Disorders, Psychotic|affective disorders, psychotic
399506|NCT01436318|Healthy Kids|healthy kids
399507|NCT01436318|Respiratory|respiratory
399508|NCT01436318|Volunteers|volunteers
399509|NCT01436305|immunosuppressive (IS) regimens|immunosuppressive (is) regimens
399510|NCT01436305|long-term graft function|long-term graft function
399511|NCT01436305|CNI (calcineurin Inhibitor )-free IS regimen|cni (calcineurin inhibitor )-free is regimen
399512|NCT01436305|CNI (calcineurin Inhibitor ) IS regimen|cni (calcineurin inhibitor ) is regimen
399513|NCT01436305|corticosteroids|corticosteroids
399514|NCT01436292|Hypoalbuminemia|hypoalbuminemia
399515|NCT01436292|Burns|burns
399516|NCT01436292|Albumin|albumin
399517|NCT01436292|Organ dysfunction|organ dysfunction
399518|NCT01436292|Outcome|outcome
399519|NCT01436240|Patient-Reported Outcomes|patient-reported outcomes
399520|NCT01436240|Common Terminology Criteria for Adverse Events|common terminology criteria for adverse events
399521|NCT01436240|PRO-CTCAE|pro-ctcae
399522|NCT01436240|Native Spanish Speaking|native spanish speaking
399523|NCT01436240|Spanish Translation|spanish translation
399524|NCT01436240|Cognitive Interview|cognitive interview
399525|NCT01436240|Questionnaire|questionnaire
399526|NCT01436240|11-133|11-133
399527|NCT01436240|Adverse Events|adverse events
399528|NCT01436240|chemotherapy|chemotherapy
399529|NCT01436240|radiation therapy|radiation therapy
399530|NCT01436240|treatment in previous 6 months|treatment in previous 6 months
399531|NCT01436227|Von Hippel-Lindau Syndrome|von hippel-lindau syndrome
399532|NCT01436227|VHL|vhl
399533|NCT01436227|Von Hippel-Lindau related lesion|von hippel-lindau related lesion
399534|NCT01436227|Pazopanib|pazopanib
399535|NCT01436227|GW786034|gw786034
399536|NCT01436188|Biological Markers|biological markers
399537|NCT01436188|Healthy Volunteer|healthy volunteer
399538|NCT01436188|Alzheimer's Disease (AD)|alzheimer's disease (ad)
399539|NCT01436188|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
399540|NCT01436188|Cerebrospinal fluid (CSF)|cerebrospinal fluid (csf)
399541|NCT01436188|CSF proteins|csf proteins
399542|NCT01436136|Cardiovascular disease|cardiovascular disease
399543|NCT01436136|HIV|hiv
399544|NCT01436136|Antiretroviral treatment|antiretroviral treatment
399545|NCT01436136|team interventions|team interventions
399546|NCT01436136|Framingham risk score|framingham risk score
399547|NCT01436123|Plasmonic Photothermal Therapy|plasmonic photothermal therapy
399548|NCT01436123|Nanoparticles|nanoparticles
399549|NCT01436123|Stem cells|stem cells
399550|NCT01436123|Atherosclerosis|atherosclerosis
399551|NCT01436123|Bioengineering|bioengineering
399552|NCT01436123|Biodegradable stenting|biodegradable stenting
399553|NCT01436123|Repair disease|repair disease
399554|NCT01436097|Healthy Eating|healthy eating
399555|NCT01436097|Health Behavior|health behavior
399556|NCT01436097|Incentive|incentive
399557|NCT01436097|Work-site|work-site
399558|NCT01436084|Leukemia|leukemia
399559|NCT01436084|Myelodysplastic syndrome|myelodysplastic syndrome
399560|NCT01436084|MDS|mds
399561|NCT01436084|SB1518|sb1518
399562|NCT01436058|side effect|side effect
399563|NCT01436058|mesenchymal stem cell|mesenchymal stem cell
399564|NCT01436058|ankle|ankle
399565|NCT01436058|osteoarthritis|osteoarthritis
399566|NCT01436045|Memory|memory
399567|NCT01436045|Insulin glulisine|insulin glulisine
399568|NCT01436045|Alzheimer's Disease|alzheimer's disease
399569|NCT01436019|Juvenile idiopathic arthritis|juvenile idiopathic arthritis
399570|NCT01436019|Rheumatic diseases|rheumatic diseases
399571|NCT01436019|Antibodies|antibodies
399572|NCT01436019|Biological therapy|biological therapy
399573|NCT01436006|MDCT|mdct
399574|NCT01436006|radiation|radiation
399575|NCT01436006|dose|dose
399576|NCT01435993|Multiple Sclerosis, Secondary-Progressive with relapses|multiple sclerosis, secondary-progressive with relapses
399577|NCT01435980|type 2 diabetes|type 2 diabetes
399578|NCT01435980|Gastric Bypass|gastric bypass
399579|NCT01435980|GLP-1|glp-1
399580|NCT01435980|adiponectin|adiponectin
399581|NCT01435967|Rotarix™|rotarix™
399582|NCT01435967|Observational|observational
399583|NCT01435967|ecological|ecological
399584|NCT01435954|benign prostatic hyperplasia|benign prostatic hyperplasia
399585|NCT01435954|surgery|surgery
399586|NCT01435954|5-alpha-reductase inhibitor|5-alpha-reductase inhibitor
399587|NCT01435954|enlarged prostate|enlarged prostate
399588|NCT01435954|acute urinary retention|acute urinary retention
399589|NCT01435941|mailed survey|mailed survey
399692|NCT01435512|CBT|cbt
399590|NCT01435941|non-steroidal anti-inflammatory drug|non-steroidal anti-inflammatory drug
399591|NCT01435941|migraine disorders|migraine disorders
399592|NCT01435941|headache|headache
399593|NCT01435928|Schizophrenia|schizophrenia
399594|NCT01435928|Lurasidone|lurasidone
399595|NCT01435928|Latuda|latuda
399596|NCT01435902|exercise-induced bronchospasm|exercise-induced bronchospasm
399597|NCT01435902|Activity/Exercise induced bronchospasm|activity/exercise induced bronchospasm
399598|NCT01435902|asthma|asthma
399599|NCT01435889|Acute respiratory distress syndrome|acute respiratory distress syndrome
399600|NCT01435889|Children|children
399601|NCT01435889|Long term respiratory sequelae|long term respiratory sequelae
399602|NCT01435889|Pulmonary function tests|pulmonary function tests
399603|NCT01435889|Computed tomography, lung|computed tomography, lung
399604|NCT01435850|hip arthroplasty|hip arthroplasty
399605|NCT01435850|primary stability|primary stability
399606|NCT01435850|secondary stability|secondary stability
399607|NCT01435850|EBRA|ebra
399608|NCT01435837|Voice|voice
399609|NCT01435837|aerodynamics|aerodynamics
399610|NCT01435837|acoustics|acoustics
399611|NCT01435824|healthy adult volunteers|healthy adult volunteers
399612|NCT01435824|comparative bioavailability|comparative bioavailability
399613|NCT01435824|amoxicillin|amoxicillin
399614|NCT01435824|breast milk|breast milk
399615|NCT01435824|Amoxicillin Bioavailability in breast milk|amoxicillin bioavailability in breast milk
399616|NCT01435811|Norovirus|norovirus
399617|NCT01435798|chronic pain|chronic pain
399618|NCT01435798|central neuropathic pain|central neuropathic pain
399619|NCT01435798|spinal cord injury|spinal cord injury
399620|NCT01435798|dextromethorphan|dextromethorphan
399621|NCT01435798|lidocaine|lidocaine
399622|NCT01435798|combination therapy|combination therapy
399623|NCT01435798|analgesia|analgesia
399624|NCT01435785|PKPD|pkpd
399625|NCT01435785|Propofol|propofol
399627|NCT01435785|Elderly patients|elderly patients
399628|NCT01435746|liver transplantation|liver transplantation
399629|NCT01435746|intensive care|intensive care
399630|NCT01435746|red blood cell transfusion|red blood cell transfusion
399631|NCT01435733|ASD|asd
399632|NCT01435733|Divorce|divorce
399633|NCT01435720|Multiple myeloma|multiple myeloma
399634|NCT01435720|B cell lymphoma|b cell lymphoma
399635|NCT01435720|Hematologic disease|hematologic disease
399636|NCT01435720|Blood protein disorder|blood protein disorder
399637|NCT01435720|Neoplasm, plasma cell|neoplasm, plasma cell
399638|NCT01435720|Mantle Cell Lymphoma|mantle cell lymphoma
399639|NCT01435720|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
399640|NCT01435720|Plasma Cell Leukemia|plasma cell leukemia
399641|NCT01435720|B cell malignancy|b cell malignancy
399642|NCT01435707|epidural steroid injection|epidural steroid injection
399643|NCT01435707|triamcinolone|triamcinolone
399644|NCT01435707|fasting blood glucose|fasting blood glucose
399645|NCT01435707|diabetes mellitus|diabetes mellitus
399646|NCT01435694|multiple sclerosis|multiple sclerosis
399647|NCT01435694|gait rehabilitation|gait rehabilitation
399648|NCT01435681|DYT-1|dyt-1
399649|NCT01435681|DYT1|dyt1
399650|NCT01435681|DYT 1|dyt 1
399651|NCT01435681|dystonia|dystonia
399652|NCT01435681|DBS|dbs
399653|NCT01435681|deep brain stimulation|deep brain stimulation
399654|NCT01435681|TMS|tms
399655|NCT01435681|transcranial magnetic stimulation|transcranial magnetic stimulation
399656|NCT01435668|alcohol|alcohol
399657|NCT01435668|hazardous or harmful drinking|hazardous or harmful drinking
399658|NCT01435668|emergency department (ED)|emergency department (ed)
399659|NCT01435616|diabetes mellitus|diabetes mellitus
399660|NCT01435616|type 2 diabetes mellitus|type 2 diabetes mellitus
399661|NCT01435616|insulin naive|insulin naive
399662|NCT01435616|insulin treatment|insulin treatment
399663|NCT01435603|Prevention & Control|prevention & control
399664|NCT01435603|Hyperglycemia|hyperglycemia
399665|NCT01435603|Obesity|obesity
399666|NCT01435603|Diabetes Mellitus|diabetes mellitus
399667|NCT01435603|Cost Benefit Analysis|cost benefit analysis
399668|NCT01435577|Bunionectomy|bunionectomy
399669|NCT01435577|Postsurgical Pain|postsurgical pain
399670|NCT01435577|Acute Pain|acute pain
399671|NCT01435564|Mobile phone|mobile phone
399672|NCT01435564|Sedentary lifestyle|sedentary lifestyle
399673|NCT01435564|Physical activity|physical activity
399674|NCT01435564|Prevention|prevention
399675|NCT01435564|Health Promotion|health promotion
399676|NCT01435564|Exercise|exercise
399677|NCT01435564|eHealth|ehealth
399678|NCT01435564|Electronic diary|electronic diary
399679|NCT01435551|Alzheimer|alzheimer
399680|NCT01435551|Dementia|dementia
399681|NCT01435538|interprofessional teamwork|interprofessional teamwork
399682|NCT01435538|care pathways|care pathways
399683|NCT01435538|team communication|team communication
399684|NCT01435538|team coordination|team coordination
399685|NCT01435538|Chronic Obstructive Pulmonary Disease Teams|chronic obstructive pulmonary disease teams
399686|NCT01435538|Proximal Femur Fracture Teams|proximal femur fracture teams
399687|NCT01435525|triple therapy|triple therapy
399688|NCT01435525|Helicobacter pylori|helicobacter pylori
399689|NCT01435525|eradication|eradication
399693|NCT01435512|Intimate Partner Violence|intimate partner violence
399694|NCT01435512|Treatment|treatment
399695|NCT01435499|immunotherapy|immunotherapy
399696|NCT01435499|vaccine|vaccine
399697|NCT01435499|GVAX|gvax
399698|NCT01435499|GM-CSF|gm-csf
399699|NCT01435486|caffeine|caffeine
399700|NCT01435486|apnea|apnea
399701|NCT01435486|bronchiolitis|bronchiolitis
399702|NCT01435473|pediatrics|pediatrics
399703|NCT01435473|thrombosis|thrombosis
399704|NCT01435473|thromboembolic complications|thromboembolic complications
399705|NCT01435473|pediatric cardiac surgery|pediatric cardiac surgery
399706|NCT01435460|ocular allergy|ocular allergy
399707|NCT01435447|efficacy|efficacy
399708|NCT01435447|safety|safety
399709|NCT01435447|conditioning|conditioning
399710|NCT01435447|fludarabine|fludarabine
399711|NCT01435447|busulfan|busulfan
399712|NCT01435447|cyclophosphamide|cyclophosphamide
399713|NCT01435447|adult|adult
399714|NCT01435434|subjects sustaining Non union/delayed fractures and requiring surgical intervention for treatment|subjects sustaining non union/delayed fractures and requiring surgical intervention for treatment
399715|NCT01435408|STEMI|stemi
399716|NCT01435408|Ischemic postconditioning|ischemic postconditioning
399717|NCT01435408|Deferred stenting|deferred stenting
399718|NCT01435408|Primary PCI|primary pci
399719|NCT01435356|Urinary Bladder neoplasms|urinary bladder neoplasms
399720|NCT01435356|Lymphoproliferative Disorders|lymphoproliferative disorders
399721|NCT01435356|Immune System Diseases|immune system diseases
399722|NCT01435356|Cystectomy|cystectomy
399723|NCT01435356|Adjuvants, Immunologic|adjuvants, immunologic
399724|NCT01435356|Immunologic Factors|immunologic factors
399725|NCT01435330|Safety|safety
399726|NCT01435330|BVS857|bvs857
399727|NCT01435330|insulin resistance|insulin resistance
399728|NCT01435317|Acoustic CR®-neuromodulation|acoustic cr®-neuromodulation
399729|NCT01435317|ANM T30 CR®-System|anm t30 cr®-system
399730|NCT01435278|Weight maintenance|weight maintenance
399731|NCT01435278|BMI|bmi
399732|NCT01435278|Body weight|body weight
399733|NCT01435278|Overweight|overweight
399734|NCT01435278|Obesity|obesity
399735|NCT01435278|Satiety|satiety
399736|NCT01435265|Psoriasis|psoriasis
399737|NCT01435265|Dermatology|dermatology
399738|NCT01435265|Phase IV|phase iv
399739|NCT01435265|Nurse Education|nurse education
399740|NCT01435265|Adalimumab|adalimumab
399741|NCT01435265|Humira|humira
399742|NCT01435226|Hepatitis C|hepatitis c
399743|NCT01435226|HCV|hcv
399744|NCT01435226|Rapid Virologic Response|rapid virologic response
399745|NCT01435226|Sustained Virologic Response|sustained virologic response
399746|NCT01435226|Direct Acting Antiviral|direct acting antiviral
399747|NCT01435226|Combination Therapy|combination therapy
399748|NCT01435226|Tegobuvir|tegobuvir
399749|NCT01435226|Treatment Experienced|treatment experienced
399750|NCT01435226|HCV RNA|hcv rna
399751|NCT01435226|Polymerase inhibitor|polymerase inhibitor
399752|NCT01435226|Protease inhibitor|protease inhibitor
399753|NCT01435226|Interferon intolerant|interferon intolerant
399754|NCT01435226|Interferon ineligible|interferon ineligible
399755|NCT01435226|GS-9190|gs-9190
399756|NCT01435226|GS-9451|gs-9451
399757|NCT01435226|GS-5885|gs-5885
399758|NCT01435226|Chronic Genotype 1a or 1b|chronic genotype 1a or 1b
399759|NCT01435213|alpha2-adrenoceptor|alpha2-adrenoceptor
399760|NCT01435213|receptor occupancy|receptor occupancy
399761|NCT01435213|positron emission tomography|positron emission tomography
399762|NCT01435213|[11C]ORM-13070|[11c]orm-13070
399763|NCT01435213|striatum|striatum
399764|NCT01435213|brain|brain
399765|NCT01435213|noradrenaline|noradrenaline
399766|NCT01435213|norepinephrine|norepinephrine
399767|NCT01435213|endogenous|endogenous
399768|NCT01435213|binding|binding
399769|NCT01435213|Validation studies|validation studies
399770|NCT01435200|Intravenous iron|intravenous iron
399771|NCT01435200|gynecologic cancer blood transfusion|gynecologic cancer blood transfusion
399772|NCT01435174|ranolazine|ranolazine
399773|NCT01435174|end-stage renal disease|end-stage renal disease
399774|NCT01435174|pharmacokinetics|pharmacokinetics
399775|NCT01435174|cardiovascular disease|cardiovascular disease
399776|NCT01435161|paroxysmal atrial fibrillation, hypertension|paroxysmal atrial fibrillation, hypertension
399777|NCT01435148|Deep Brain Stimulation|deep brain stimulation
399778|NCT01435148|Treatment Resistant Depression|treatment resistant depression
399779|NCT01435122|progressive advanced carcinoid tumors|progressive advanced carcinoid tumors
399780|NCT01435122|advanced|advanced
399781|NCT01435122|unresectable|unresectable
399782|NCT01435122|metastatic|metastatic
399783|NCT01435122|cancerous tumors|cancerous tumors
399784|NCT01435122|neuroendocrine|neuroendocrine
399785|NCT01435122|digestive tract|digestive tract
399786|NCT01435122|lungs|lungs
399787|NCT01435122|renal|renal
399788|NCT01435122|ovarian|ovarian
399789|NCT01435122|thymic|thymic
399790|NCT01435122|hepatic|hepatic
399791|NCT01435109|Osteoarthritis|osteoarthritis
399792|NCT01435109|Exercise|exercise
399793|NCT01435109|Diet|diet
399794|NCT01435109|Coping Skills|coping skills
399795|NCT01435109|Education, Medical|education, medical
399796|NCT01435083|Nocturia|nocturia
399797|NCT01435070|Colles' fracture|colles' fracture
399798|NCT01435070|Radius fracture|radius fracture
399799|NCT01435070|grip strength|grip strength
399800|NCT01435070|pinch strength|pinch strength
399801|NCT01435070|range of movement|range of movement
399802|NCT01435070|PRWE|prwe
399803|NCT01435070|DASH|dash
399804|NCT01435070|EQ-5D|eq-5d
399805|NCT01435070|Kirschner wire|kirschner wire
399806|NCT01435070|Volar locking plate|volar locking plate
399807|NCT01435057|Abdominal Obesity|abdominal obesity
399808|NCT01435057|training|training
399809|NCT01435057|fat|fat
399810|NCT01435057|insulin|insulin
399811|NCT01435057|glucose|glucose
399812|NCT01435057|diet|diet
399813|NCT01435044|Hepatitis C|hepatitis c
399814|NCT01435044|Chronic|chronic
399815|NCT01435044|HCV|hcv
399816|NCT01435031|Angioplasty|angioplasty
399817|NCT01435031|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
399818|NCT01435031|Chronic total coronary occlusions|chronic total coronary occlusions
399819|NCT01435031|Coronary Artery Disease (CAD)|coronary artery disease (cad)
399820|NCT01435031|Coronary artery stenosis|coronary artery stenosis
399821|NCT01435031|Total coronary occlusion|total coronary occlusion
399822|NCT01435005|Prevention and control|prevention and control
399823|NCT01435005|Exercise|exercise
399824|NCT01435005|Sedentary lifestyle|sedentary lifestyle
399825|NCT01435005|Biological markers|biological markers
399826|NCT01434966|Lumbopelvic Manipulation|lumbopelvic manipulation
399827|NCT01434966|Lumbosacral Manipulation|lumbosacral manipulation
399828|NCT01434966|Sacroiliac Manipulation|sacroiliac manipulation
399829|NCT01434966|TENS Spine|tens spine
399830|NCT01434966|TENS Knee|tens knee
399831|NCT01434966|Knee Pain|knee pain
399832|NCT01434966|Chronic Knee Pain|chronic knee pain
399833|NCT01434953|Prehypertension|prehypertension
399834|NCT01434953|Blood pressure screening|blood pressure screening
399835|NCT01434953|White coat effect|white coat effect
399836|NCT01434940|Alzheimer disease|alzheimer disease
399837|NCT01434940|Depression|depression
399838|NCT01434940|Differential diagnosis|differential diagnosis
399839|NCT01434940|Eye movement|eye movement
399840|NCT01434914|Ulcus cruris|ulcus cruris
399841|NCT01434914|chronic wounds|chronic wounds
399842|NCT01434914|octenisept®|octenisept®
399843|NCT01434901|Diabetes|diabetes
399844|NCT01434901|Blood Sugar|blood sugar
399845|NCT01434901|Xenin-25|xenin-25
399846|NCT01434901|GIP|gip
399847|NCT01434901|Muscarinic|muscarinic
399848|NCT01434888|pharmacokinetics|pharmacokinetics
399849|NCT01434862|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
399850|NCT01434849|infantile hemangioma|infantile hemangioma
399851|NCT01434849|very low birth weight infants|very low birth weight infants
399852|NCT01434849|premature infants|premature infants
399853|NCT01434836|Anti-depressant effects|anti-depressant effects
399854|NCT01434823|nocturnal staffing|nocturnal staffing
399855|NCT01434823|intensivist staffing|intensivist staffing
399856|NCT01434823|intensivist coverage|intensivist coverage
399857|NCT01434823|ICU patient-centered outcomes|icu patient-centered outcomes
399858|NCT01434823|ICU resource utilization|icu resource utilization
399859|NCT01434823|patients admitted to the medical intensive care unit|patients admitted to the medical intensive care unit
399860|NCT01434823|Sleep Deprivation|sleep deprivation
399861|NCT01434823|Inattention|inattention
399862|NCT01434823|Work Hours|work hours
399863|NCT01434810|Hyperbilirubinemia, Neonatal|hyperbilirubinemia, neonatal
399864|NCT01434797|Infection|infection
399865|NCT01434797|Permanent central venous catheter|permanent central venous catheter
399866|NCT01434797|Device Related|device related
399867|NCT01434784|lung cancer|lung cancer
399868|NCT01434784|quality of life|quality of life
399869|NCT01434758|Mycobacterium tuberculosis|mycobacterium tuberculosis
399870|NCT01434758|Culture yield|culture yield
399871|NCT01434745|SLOS|slos
399872|NCT01434745|Cholesterol Supplementation|cholesterol supplementation
399873|NCT01434745|Simvastatin|simvastatin
399874|NCT01434732|Superior vena cava flow|superior vena cava flow
399875|NCT01434732|umbilical cord milking|umbilical cord milking
399876|NCT01434732|hemodynamics|hemodynamics
399877|NCT01434732|systemic blood flow|systemic blood flow
399878|NCT01434719|Streptococcus suis|streptococcus suis
399879|NCT01434719|Sepsis|sepsis
399880|NCT01434719|Porcine Respiratory and Reproductive System virus|porcine respiratory and reproductive system virus
399881|NCT01434719|Pig disease|pig disease
399882|NCT01434719|Epidemiology|epidemiology
399884|NCT01434706|acute infection|acute infection
399885|NCT01434706|primary infection|primary infection
399886|NCT01434706|seroconverters|seroconverters
399887|NCT01434693|T. suis ova|t. suis ova
399888|NCT01434693|Crohn's disease|crohn's disease
399889|NCT01434680|Meningococcal disease|meningococcal disease
399890|NCT01434680|vaccines|vaccines
399891|NCT01434680|toddlers|toddlers
399892|NCT01434680|prevention|prevention
399893|NCT01434680|Meningitis|meningitis
399894|NCT01434667|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
399895|NCT01434667|Alzheimer's disease (AD)|alzheimer's disease (ad)
399896|NCT01434667|APOE|apoe
399897|NCT01434667|genetics|genetics
399898|NCT01434667|risk assessment|risk assessment
399899|NCT01434667|education|education
399900|NCT01434667|genetic counseling|genetic counseling
399901|NCT01434667|Mild Cognitive Impairment, So Stated|mild cognitive impairment, so stated
399902|NCT01434654|HAND|hand
399903|NCT01434654|HIV|hiv
399904|NCT01434654|Neurology|neurology
399905|NCT01434654|Neurocognitive|neurocognitive
399906|NCT01434654|Neuro-HAART|neuro-haart
399907|NCT01434654|HIV Associated Neurocognitive Disorders (HAND)|hiv associated neurocognitive disorders (hand)
399908|NCT01434641|myocardial perfusion SPECT|myocardial perfusion spect
399909|NCT01434641|wide beam reconstruction|wide beam reconstruction
399910|NCT01434641|Tc-99m sestamibi|tc-99m sestamibi
399911|NCT01434628|Male Circumcision|male circumcision
399912|NCT01434628|HIV Prevention|hiv prevention
399913|NCT01434628|HIV Infections|hiv infections
399914|NCT01434615|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
399915|NCT01434615|Moderate to advanced|moderate to advanced
399916|NCT01434615|patients|patients
399917|NCT01434615|current consensus guidelines|current consensus guidelines
399918|NCT01434602|Chemotherapy|chemotherapy
399919|NCT01434602|Brain Tumor|brain tumor
399920|NCT01434602|Glioblastoma|glioblastoma
399921|NCT01434602|Anaplastic Glioma|anaplastic glioma
399922|NCT01434589|internet addiction|internet addiction
399923|NCT01434589|computer game addiction|computer game addiction
399924|NCT01434589|STICA|stica
399925|NCT01434589|short-term treatment|short-term treatment
399926|NCT01434589|psychotherapy|psychotherapy
399927|NCT01434589|internet and computer game addiction|internet and computer game addiction
399928|NCT01434563|HIV|hiv
399929|NCT01434563|neurocognitive disorder|neurocognitive disorder
399930|NCT01434563|primary care|primary care
399931|NCT01434563|HIV negative|hiv negative
399932|NCT01434563|HAND|hand
399933|NCT01434563|CNS|cns
399934|NCT01434550|pancreas|pancreas
399935|NCT01434550|pancreatic cancer|pancreatic cancer
399936|NCT01434550|SBRT|sbrt
399937|NCT01434550|stereotactic body radiation|stereotactic body radiation
399938|NCT01434550|radiation therapy|radiation therapy
399939|NCT01434550|unresectable|unresectable
399940|NCT01434550|non-metastatic|non-metastatic
399941|NCT01434550|tissue, blood, research imaging|tissue, blood, research imaging
399942|NCT01434550|TBRI|tbri
399943|NCT01434537|pediatric anesthesia|pediatric anesthesia
399944|NCT01434537|venepuncture|venepuncture
399945|NCT01434537|peripheral venous access|peripheral venous access
399946|NCT01434511|hemophilia A|hemophilia a
399947|NCT01434511|haemophilia A|haemophilia a
399948|NCT01434511|blood coagulation disorders|blood coagulation disorders
399949|NCT01434511|hemorrhagic disorders|hemorrhagic disorders
399950|NCT01434511|coagulation protein disorder|coagulation protein disorder
399951|NCT01434511|hematologic diseases|hematologic diseases
399952|NCT01434511|congenital hemophilia A|congenital hemophilia a
399953|NCT01434498|Hepatitis C|hepatitis c
399954|NCT01434498|HCV|hcv
399955|NCT01434498|Rapid Virologic Response|rapid virologic response
399956|NCT01434498|Sustained Virologic Response|sustained virologic response
399957|NCT01434498|Direct Acting Antiviral|direct acting antiviral
399958|NCT01434498|Combination Therapy|combination therapy
399959|NCT01434498|Tegobuvir|tegobuvir
399960|NCT01434498|Treatment naïve|treatment naïve
399961|NCT01434498|HCV RNA|hcv rna
399962|NCT01434498|Polymerase inhibitor|polymerase inhibitor
399963|NCT01434498|Protease inhibitor|protease inhibitor
399964|NCT01434498|Interferon intolerant|interferon intolerant
399965|NCT01434498|Interferon ineligible|interferon ineligible
399966|NCT01434498|GS-9190|gs-9190
399967|NCT01434498|GS-9451|gs-9451
399968|NCT01434498|GS-5885|gs-5885
399969|NCT01434485|gastric ulcer, duodenal ulcer, anastomotic ulcer, reflux oesophagitis, non-erosive reflux disease, Zollinger-Ellison syndrome, Nexium|gastric ulcer, duodenal ulcer, anastomotic ulcer, reflux oesophagitis, non-erosive reflux disease, zollinger-ellison syndrome, nexium
399970|NCT01434459|Pancreatic neoplasms|pancreatic neoplasms
399971|NCT01434459|Cholangiocarcinoma|cholangiocarcinoma
399972|NCT01434420|triple negative breast cancer|triple negative breast cancer
399973|NCT01434407|Advanced glycation endproducts|advanced glycation endproducts
399974|NCT01434407|Satiety|satiety
399975|NCT01434407|Obesity|obesity
399976|NCT01434407|Inflammation|inflammation
399977|NCT01434407|Insulin resistance|insulin resistance
399978|NCT01434394|Oral cancer|oral cancer
399979|NCT01434394|Oropharyngeal cancer|oropharyngeal cancer
399980|NCT01434394|Induction chemotherapy|induction chemotherapy
399981|NCT01434394|Targeted chemotherapy|targeted chemotherapy
399982|NCT01434394|Surgery|surgery
399983|NCT01434394|Radiotherapy|radiotherapy
399984|NCT01434381|Recombinant|recombinant
399985|NCT01434381|Proteins|proteins
399986|NCT01434381|Antigen|antigen
399987|NCT01434381|Membrane|membrane
399988|NCT01434381|Assay|assay
399989|NCT01434381|Malaria|malaria
399990|NCT01434368|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
399991|NCT01434368|Normal Development|normal development
399992|NCT01434368|Puberty|puberty
399993|NCT01434368|Brain Function|brain function
399994|NCT01434368|Gonadal Steroids|gonadal steroids
399995|NCT01434368|Brain Structure|brain structure
399996|NCT01434368|Healthy Volunteer|healthy volunteer
399997|NCT01434368|HV|hv
399998|NCT01434342|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
399999|NCT01434342|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
400000|NCT01434342|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
400001|NCT01434342|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
400002|NCT01434342|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
400003|NCT01434342|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
400004|NCT01434342|limited stage small cell lung cancer|limited stage small cell lung cancer
400005|NCT01434342|tobacco use disorder|tobacco use disorder
400006|NCT01434342|Breast Cancer|breast cancer
400007|NCT01434342|Cervical Cancer|cervical cancer
400008|NCT01434342|head & neck cancer|head & neck cancer
400009|NCT01434342|Prostate Cancer|prostate cancer
400010|NCT01434342|All histologies|all histologies
400011|NCT01434329|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
400012|NCT01434290|radiation toxicity|radiation toxicity
400013|NCT01434290|sexual dysfunction|sexual dysfunction
400014|NCT01434290|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
400015|NCT01434290|adenocarcinoma of the prostate|adenocarcinoma of the prostate
400016|NCT01434290|stage I prostate cancer|stage i prostate cancer
400017|NCT01434290|stage IIA prostate cancer|stage iia prostate cancer
400018|NCT01434277|Preservative|preservative
400019|NCT01434277|Eye Drops|eye drops
400020|NCT01434264|rehabilitation|rehabilitation
400021|NCT01434251|Hypotension|hypotension
400022|NCT01434251|premature infants|premature infants
400023|NCT01434251|near infrared spectroscopy|near infrared spectroscopy
400024|NCT01434238|infant feeding|infant feeding
400025|NCT01434238|HIV|hiv
400026|NCT01434238|growth|growth
400027|NCT01434238|anemia|anemia
400028|NCT01434225|Neonatal seizures|neonatal seizures
400029|NCT01434225|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
400030|NCT01434225|Electroencephalography|electroencephalography
400031|NCT01434225|Bumetanide|bumetanide
400032|NCT01434212|HCV dynamics|hcv dynamics
400033|NCT01434212|Mathematical model|mathematical model
400034|NCT01434212|Interferon|interferon
400035|NCT01434212|Predict|predict
400036|NCT01434212|Hepatitis C Virus|hepatitis c virus
400037|NCT01434199|magnetic endoscope imaging|magnetic endoscope imaging
400038|NCT01434199|colonoscopy|colonoscopy
400039|NCT01434199|caecal intubation|caecal intubation
400040|NCT01434173|Liver Diseases|liver diseases
400041|NCT01434173|Anti-Bacterial Agents|anti-bacterial agents
400042|NCT01434173|Fluoroquinolones|fluoroquinolones
400043|NCT01434173|Amoxicillin|amoxicillin
400044|NCT01434173|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination
400045|NCT01434173|Clarithromycin|clarithromycin
400046|NCT01434173|Doxycycline|doxycycline
400047|NCT01434173|Cefuroxime|cefuroxime
400048|NCT01434173|Case-Control Studies|case-control studies
400049|NCT01434173|Retrospective Studies|retrospective studies
400050|NCT01434173|Cohort Studies|cohort studies
400051|NCT01434173|Epidemiologic Research Design|epidemiologic research design
400052|NCT01434173|Epidemiologic Studies|epidemiologic studies
400053|NCT01434173|HealthCore Integrated Research Database (non-MESH)|healthcore integrated research database (non-mesh)
400054|NCT01434173|United States|united states
400055|NCT01434173|Human|human
400056|NCT01434173|Insurance Claim Review|insurance claim review
400057|NCT01434160|Intrauterine|intrauterine
400058|NCT01434160|contraception|contraception
400059|NCT01434160|adolescent|adolescent
400060|NCT01434147|locally advanced rectal cancer|locally advanced rectal cancer
400061|NCT01434147|preoperative induction chemotherapy chemoradiotherapy|preoperative induction chemotherapy chemoradiotherapy
400062|NCT01434134|Anthracyclines|anthracyclines
400063|NCT01434134|Trastuzumab|trastuzumab
400064|NCT01434108|cirrhosis, gastrointestinal bleeding|cirrhosis, gastrointestinal bleeding
400065|NCT01434095|microperimetry|microperimetry
400066|NCT01434095|fixation point|fixation point
400067|NCT01434095|retinal sensitivity|retinal sensitivity
400068|NCT01434095|photodynamic therapy|photodynamic therapy
400069|NCT01434095|chronic central serous chorioretinopathy|chronic central serous chorioretinopathy
400070|NCT01434082|sleep|sleep
400071|NCT01434082|school-age children|school-age children
400072|NCT01434082|Children with and without arthritis|children with and without arthritis
400073|NCT01434069|colon|colon
400074|NCT01434069|rectum|rectum
400075|NCT01434069|small bowel|small bowel
400076|NCT01434069|pancreas|pancreas
400077|NCT01434069|gastric|gastric
400078|NCT01434069|esophageal|esophageal
400079|NCT01434069|metastatic|metastatic
400080|NCT01434069|unresectable|unresectable
400081|NCT01434069|GI|gi
400082|NCT01434069|combination therapy|combination therapy
400083|NCT01434069|dose escalation|dose escalation
400084|NCT01434069|solid tumor|solid tumor
400085|NCT01434056|Liver disease|liver disease
400086|NCT01434056|Hepatic encephalopathy|hepatic encephalopathy
400087|NCT01434056|MELD|meld
400187|NCT01433510|Allergic|allergic
400088|NCT01434056|Liver transplantation|liver transplantation
400089|NCT01434043|Cardiac CT perfusion|cardiac ct perfusion
400090|NCT01434043|Positron emission tomography perfusion|positron emission tomography perfusion
400091|NCT01434043|Quantitative perfusion|quantitative perfusion
400092|NCT01434017|PONV|ponv
400093|NCT01434017|Dexamethasone|dexamethasone
400094|NCT01434017|Droperidol|droperidol
400095|NCT01434017|Ondansetron|ondansetron
400096|NCT01434017|Tonsillectomy|tonsillectomy
400097|NCT01434004|prostate cancer|prostate cancer
400098|NCT01433965|Bone marrow transplantation|bone marrow transplantation
400099|NCT01433965|Maintenance lenalidomide|maintenance lenalidomide
400100|NCT01433939|colonoscopy|colonoscopy
400101|NCT01433939|position changes|position changes
400102|NCT01433939|patient comfort|patient comfort
400103|NCT01433926|Breast cancer.|breast cancer.
400104|NCT01433926|Trastuzumab.|trastuzumab.
400105|NCT01433926|Complete remission.|complete remission.
400106|NCT01433900|glaucoma|glaucoma
400107|NCT01433900|intraocular pressure|intraocular pressure
400108|NCT01433900|ocular surface|ocular surface
400109|NCT01433900|benzalkonium chloride|benzalkonium chloride
400110|NCT01433887|Peginterferon alfa-2a|peginterferon alfa-2a
400111|NCT01433887|ribavirin|ribavirin
400112|NCT01433874|Shoulder pain|shoulder pain
400113|NCT01433874|Upper abdominal pain|upper abdominal pain
400114|NCT01433874|Laparoscopic surgery|laparoscopic surgery
400115|NCT01433874|Abdominal fullness|abdominal fullness
400116|NCT01433861|gastric cancer|gastric cancer
400117|NCT01433861|proximal gastrectomy|proximal gastrectomy
400118|NCT01433861|total gastrectomy|total gastrectomy
400119|NCT01433861|laparoscopy|laparoscopy
400120|NCT01433861|reflux esophagitis|reflux esophagitis
400121|NCT01433861|double tract reconstruction|double tract reconstruction
400122|NCT01433835|Cytomegalovirus|cytomegalovirus
400123|NCT01433835|Antiviral|antiviral
400124|NCT01433835|Safety|safety
400125|NCT01433835|Healthy|healthy
400126|NCT01433809|thyroid cancer|thyroid cancer
400127|NCT01433809|thyroid neoplasm|thyroid neoplasm
400128|NCT01433809|thyroid adenoma|thyroid adenoma
400129|NCT01433796|antiretroviral therapy|antiretroviral therapy
400130|NCT01433796|tuberculosis|tuberculosis
400131|NCT01433796|health centres|health centres
400132|NCT01433796|Ethiopia|ethiopia
400133|NCT01433757|dystonia|dystonia
400134|NCT01433757|DYT-1|dyt-1
400135|NCT01433757|AMPICILLIN|ampicillin
400136|NCT01433744|C-Reactive protein|c-reactive protein
400137|NCT01433744|risk|risk
400138|NCT01433731|CTCL|ctcl
400139|NCT01433731|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
400140|NCT01433718|Effectivness|effectivness
400141|NCT01433718|Neuromuscular Training|neuromuscular training
400142|NCT01433718|Resistance Training|resistance training
400143|NCT01433718|Modification|modification
400144|NCT01433718|Anterior Cruciate Ligament Risk Factors|anterior cruciate ligament risk factors
400145|NCT01433718|Drop-Jump|drop-jump
400146|NCT01433718|Knee Separation|knee separation
400147|NCT01433718|Resistance training program|resistance training program
400148|NCT01433705|heart|heart
400149|NCT01433705|perfusion|perfusion
400150|NCT01433705|glucose|glucose
400151|NCT01433692|Addictions|addictions
400152|NCT01433692|Adolescents|adolescents
400153|NCT01433692|Primary Health Care|primary health care
400154|NCT01433692|Brief Intervention|brief intervention
400155|NCT01433679|Health Behavior|health behavior
400156|NCT01433679|Exercise|exercise
400157|NCT01433679|Adolescent Behavior|adolescent behavior
400158|NCT01433679|Motivation|motivation
400159|NCT01433679|Biological Markers|biological markers
400160|NCT01433653|Comorbid|comorbid
400161|NCT01433653|Complicated|complicated
400162|NCT01433640|image on multi-modalities|image on multi-modalities
400163|NCT01433640|visualize cancer lesions|visualize cancer lesions
400164|NCT01433640|highly suspicious lesions|highly suspicious lesions
400165|NCT01433627|acute coronary syndromes|acute coronary syndromes
400166|NCT01433627|myocardial infarction|myocardial infarction
400167|NCT01433627|access site|access site
400168|NCT01433627|bivalirudin|bivalirudin
400169|NCT01433627|bleedings|bleedings
400170|NCT01433601|Adherence|adherence
400171|NCT01433601|Peer support|peer support
400172|NCT01433601|Treatment failure|treatment failure
400173|NCT01433588|Managing infant pain|managing infant pain
400174|NCT01433588|27 - 36+6 weeks gestation|27 - 36+6 weeks gestation
400175|NCT01433588|Preterm infants|preterm infants
400176|NCT01433562|breast cancer|breast cancer
400177|NCT01433562|neoadjuvant therapy|neoadjuvant therapy
400178|NCT01433562|Stage II/III|stage ii/iii
400179|NCT01433536|cranial trauma with or without high velocity fracture to inferior limb|cranial trauma with or without high velocity fracture to inferior limb
400180|NCT01433536|spinal trauma with or without high velocity fracture to inferior limb|spinal trauma with or without high velocity fracture to inferior limb
400181|NCT01433536|high velocity fracture to inferior limb|high velocity fracture to inferior limb
400182|NCT01433523|HDM|hdm
400183|NCT01433523|AIT|ait
400184|NCT01433523|asthma|asthma
400185|NCT01433523|asthma exacerbation|asthma exacerbation
400186|NCT01433523|House dust mite induced asthma|house dust mite induced asthma
400188|NCT01433510|Rhinoconjunctivitis|rhinoconjunctivitis
400189|NCT01433510|Immunotherapy|immunotherapy
400190|NCT01433497|multiple sclerosis|multiple sclerosis
400191|NCT01433497|primary progressive|primary progressive
400192|NCT01433497|relapse-free|relapse-free
400193|NCT01433497|secondary progressive|secondary progressive
400194|NCT01433484|cardiovascular disease|cardiovascular disease
400195|NCT01433484|coronary heart disease|coronary heart disease
400196|NCT01433484|obesity|obesity
400197|NCT01433484|weight loss|weight loss
400198|NCT01433484|genomics|genomics
400199|NCT01433471|Ulcerative Colitis|ulcerative colitis
400200|NCT01433471|Trichuris Suis Ova|trichuris suis ova
400201|NCT01433471|Inflammatory Bowel Disease|inflammatory bowel disease
400202|NCT01433471|Mucus|mucus
400203|NCT01433458|Hepatic impairment|hepatic impairment
400204|NCT01433458|healthy volunteers|healthy volunteers
400205|NCT01433458|RLX030|rlx030
400206|NCT01433458|pharmacokinetics|pharmacokinetics
400207|NCT01433445|Myelofibrosis|myelofibrosis
400208|NCT01433445|Panobinostat|panobinostat
400209|NCT01433445|Ruxolitinib|ruxolitinib
400210|NCT01433445|MF|mf
400211|NCT01433445|PMF|pmf
400212|NCT01433445|PPV|ppv
400213|NCT01433445|PPV-MF|ppv-mf
400214|NCT01433445|PET|pet
400215|NCT01433445|PET-MF|pet-mf
400216|NCT01433445|JAK2|jak2
400217|NCT01433445|DACi|daci
400218|NCT01433432|Crohn's Disease|crohn's disease
400219|NCT01433419|Drug Therapy|drug therapy
400220|NCT01433406|Drug Therapy|drug therapy
400221|NCT01433393|Drug Therapy|drug therapy
400222|NCT01433380|Phase 1|phase 1
400223|NCT01433380|Single Doses|single doses
400224|NCT01433380|Pharmacodynamics|pharmacodynamics
400225|NCT01433380|Healthy Volunteers|healthy volunteers
400226|NCT01433367|total disc replacement|total disc replacement
400227|NCT01433367|cervical disc disease|cervical disc disease
400228|NCT01433354|Fragile X Syndrome|fragile x syndrome
400229|NCT01433354|Martin-Bell Syndrome|martin-bell syndrome
400230|NCT01433354|Genetic Diseases|genetic diseases
400231|NCT01433354|X-Linked|x-linked
400232|NCT01433354|Escalante's syndrome|escalante's syndrome
400233|NCT01433341|Normal young athletes|normal young athletes
400234|NCT01433328|Remodulin|remodulin
400235|NCT01433328|Treprostinil|treprostinil
400236|NCT01433315|sleep deprivation|sleep deprivation
400237|NCT01433315|sleep restriction|sleep restriction
400238|NCT01433302|Breast cancer|breast cancer
400239|NCT01433302|Genitourinary cancer|genitourinary cancer
400240|NCT01433302|Gynecological cancer|gynecological cancer
400241|NCT01433302|Malignant Female Reproductive System Neoplasm|malignant female reproductive system neoplasm
400242|NCT01433302|Melanoma|melanoma
400243|NCT01433302|Sarcoma|sarcoma
400244|NCT01433302|Inflammatory Response|inflammatory response
400245|NCT01433302|Inflammatory proteins|inflammatory proteins
400246|NCT01433302|Tissue Fibrosis|tissue fibrosis
400247|NCT01433302|Lymphatico-venous Bypass Surgery|lymphatico-venous bypass surgery
400248|NCT01433302|Punch biopsy|punch biopsy
400249|NCT01433302|Lab collections|lab collections
400250|NCT01433302|Th2 immune phenotype|th2 immune phenotype
400251|NCT01433302|Lymphedema|lymphedema
400252|NCT01433289|HIV|hiv
400253|NCT01433289|safety|safety
400254|NCT01433289|toxicity|toxicity
400255|NCT01433289|pharmacokinetics|pharmacokinetics
400256|NCT01433289|Polyphenon E|polyphenon e
400257|NCT01433289|EGCG|egcg
400258|NCT01433289|green tea|green tea
400259|NCT01433289|CD4|cd4
400260|NCT01433289|viral load|viral load
400261|NCT01433276|Fluid resuscitation|fluid resuscitation
400262|NCT01433276|hemorrhagic shock|hemorrhagic shock
400263|NCT01433276|Totilac|totilac
400264|NCT01433276|Ringer's|ringer's
400265|NCT01433276|trauma|trauma
400266|NCT01433263|Wasting syndrome|wasting syndrome
400267|NCT01433263|emaciation|emaciation
400268|NCT01433263|lung cancer|lung cancer
400269|NCT01433263|adenocarcinoma|adenocarcinoma
400270|NCT01433263|pancreatic cancer|pancreatic cancer
400271|NCT01433250|Multiple Sclerosis,|multiple sclerosis,
400272|NCT01433250|demyelinating autoimmune diseases,|demyelinating autoimmune diseases,
400273|NCT01433250|interleukin-17,|interleukin-17,
400274|NCT01433250|monoclonal human antibody|monoclonal human antibody
400275|NCT01433237|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
400276|NCT01433237|adult rhabdomyosarcoma|adult rhabdomyosarcoma
400277|NCT01433237|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
400278|NCT01433237|adult soft tissue sarcoma|adult soft tissue sarcoma
400279|NCT01433237|childhood rhabdomyosarcoma|childhood rhabdomyosarcoma
400280|NCT01433224|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
400281|NCT01433224|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
400282|NCT01433224|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
400283|NCT01433224|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
400284|NCT01433185|PMTCT|pmtct
400285|NCT01433185|SMS|sms
400286|NCT01433185|HIV Infections|hiv infections
400287|NCT01433185|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
400288|NCT01433185|Prevention & Control|prevention & control
400289|NCT01433185|Patient Compliance|patient compliance
400290|NCT01433185|Cellular Phone|cellular phone
400291|NCT01433185|Randomized Controlled Trial|randomized controlled trial
400292|NCT01433172|stage IV|stage iv
400293|NCT01433172|adenocarcinoma|adenocarcinoma
400294|NCT01433172|vaccine therapy|vaccine therapy
400295|NCT01433172|immunology|immunology
400296|NCT01433172|tumor vaccine|tumor vaccine
400297|NCT01433172|colony stimulating factor(CSF)|colony stimulating factor(csf)
400298|NCT01433172|granulocyte-macrophage colony-stimulating factor (GM-CSF)|granulocyte-macrophage colony-stimulating factor (gm-csf)
400299|NCT01433172|CC chemokine ligand 21 (CCL21)|cc chemokine ligand 21 (ccl21)
400300|NCT01433172|Chemokine [C-C motif] ligand 21 (CCL21)|chemokine [c-c motif] ligand 21 (ccl21)
400301|NCT01433172|human leukocyte antigen serotype (HLA)|human leukocyte antigen serotype (hla)
400302|NCT01433159|Pressure Ulcers|pressure ulcers
400303|NCT01433159|Spinal Cord Injury|spinal cord injury
400304|NCT01433159|Healthpoint|healthpoint
400305|NCT01433159|Xenaderm|xenaderm
400306|NCT01433159|011-101|011-101
400307|NCT01433146|Temperament|temperament
400308|NCT01433146|Anxiety|anxiety
400309|NCT01433146|Depression|depression
400310|NCT01433146|Colorectal Cancer|colorectal cancer
400311|NCT01433120|Obesity|obesity
400312|NCT01433120|Insulin resistance|insulin resistance
400313|NCT01433120|Microbiota|microbiota
400314|NCT01433120|Probiotic|probiotic
400315|NCT01433120|Prebiotic|prebiotic
400316|NCT01433107|Tinea pedis|tinea pedis
400317|NCT01433107|Terbinafine film forming solution|terbinafine film forming solution
400318|NCT01433094|Adherence|adherence
400319|NCT01433094|Psychoeducation|psychoeducation
400320|NCT01433094|Pharmacotherapy|pharmacotherapy
400321|NCT01433094|Schizophrenia|schizophrenia
400322|NCT01433094|Family support|family support
400323|NCT01433068|Adult Soft Tissue Sarcoma of the extremities and Trunk wall|adult soft tissue sarcoma of the extremities and trunk wall
400324|NCT01433055|Schizophrenia|schizophrenia
400325|NCT01433055|Cognitive Symptoms|cognitive symptoms
400326|NCT01433055|Clozapine|clozapine
400327|NCT01433042|small bowel disease|small bowel disease
400328|NCT01433029|Surgical Procedure|surgical procedure
400329|NCT01433029|Assessment|assessment
400330|NCT01433029|Cardiothoracic Surgery|cardiothoracic surgery
400331|NCT01433029|Coronary artery bypass|coronary artery bypass
400332|NCT01433029|CAB|cab
400333|NCT01433029|Video recordings|video recordings
400334|NCT01433029|Global rating scale|global rating scale
400335|NCT01433029|GRS|grs
400336|NCT01433029|Cardiothoracic surgeon|cardiothoracic surgeon
400337|NCT01433029|Surgical trainees|surgical trainees
400338|NCT01433016|HCC Hepatocellular carcinoma|hcc hepatocellular carcinoma
400339|NCT01433016|OBT Octanoate Breath Test|obt octanoate breath test
400340|NCT01433003|Thrombotic thrombocytopenia purpura|thrombotic thrombocytopenia purpura
400341|NCT01433003|hemolytic uremic syndrome|hemolytic uremic syndrome
400342|NCT01433003|plasma exchange|plasma exchange
400343|NCT01433003|Improve treatment response|improve treatment response
400344|NCT01433003|TTP/HUS|ttp/hus
400345|NCT01432990|SCI|sci
400346|NCT01432990|gait|gait
400347|NCT01432990|rehabilitation|rehabilitation
400348|NCT01432990|robotic|robotic
400349|NCT01432964|Orbital Fractures|orbital fractures
400350|NCT01432964|Fracture Fixation|fracture fixation
400351|NCT01432964|Blow-out Fractures|blow-out fractures
400352|NCT01432964|Surgical Mesh|surgical mesh
400353|NCT01432964|Titanium|titanium
400354|NCT01432964|Computer-assisted Image Processing|computer-assisted image processing
400355|NCT01432925|Buruli ulcer|buruli ulcer
400356|NCT01432925|Mycobacterium ulcerans|mycobacterium ulcerans
400357|NCT01432925|Streptomycin|streptomycin
400358|NCT01432925|Rifampicin|rifampicin
400359|NCT01432925|Functional limitations|functional limitations
400360|NCT01432925|surgery|surgery
400361|NCT01432925|Bénin|bénin
400362|NCT01432899|Neurophysiology|neurophysiology
400363|NCT01432899|Hemidystonia|hemidystonia
400364|NCT01432899|Childhood-onset|childhood-onset
400365|NCT01432899|Motion Analysis|motion analysis
400366|NCT01432899|Neuroimaging|neuroimaging
400367|NCT01432899|Childhood Onset Hemidystonia|childhood onset hemidystonia
400368|NCT01432899|Healthy Volunteer|healthy volunteer
400369|NCT01432899|HV|hv
400370|NCT01432886|Breast Cancer|breast cancer
400371|NCT01432873|BMT|bmt
400372|NCT01432873|HSCT|hsct
400373|NCT01432860|Skin Self Examination|skin self examination
400374|NCT01432847|Best Disease|best disease
400375|NCT01432847|Late-Onset Retinal Degeneration (L-ORD)|late-onset retinal degeneration (l-ord)
400376|NCT01432847|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
400377|NCT01432847|Induced Pluripotent Stem Cell (iPS) Cell Lines|induced pluripotent stem cell (ips) cell lines
400378|NCT01432847|Retinal Degeneration|retinal degeneration
400379|NCT01432847|Age-Related Macular Degeneration|age-related macular degeneration
400380|NCT01432847|AMD|amd
400381|NCT01432834|non-anterior astigmatism correction|non-anterior astigmatism correction
400382|NCT01432834|Allegretto Wave excimer laser|allegretto wave excimer laser
400383|NCT01432834|wavefront optimized ablation profile (WFO)|wavefront optimized ablation profile (wfo)
400384|NCT01432834|LASIK|lasik
400385|NCT01432834|PRK|prk
400386|NCT01432821|Epilepsy,|epilepsy,
400387|NCT01432821|dopamine|dopamine
400388|NCT01432821|yawning,|yawning,
400389|NCT01432821|blinking eyelids,|blinking eyelids,
400390|NCT01432821|electroencephalography|electroencephalography
400391|NCT01432795|chronic venous insufficiency|chronic venous insufficiency
400392|NCT01432795|post-thrombotic syndrome|post-thrombotic syndrome
400393|NCT01432795|medical compression therapy|medical compression therapy
400394|NCT01432795|compression stocking|compression stocking
400395|NCT01432795|gliding aid|gliding aid
400396|NCT01432795|stocking butler|stocking butler
400397|NCT01432795|adherence to treatment|adherence to treatment
400398|NCT01432782|Weight loss|weight loss
400399|NCT01432782|Dysphagia|dysphagia
400400|NCT01432782|Esophageal hypermotility|esophageal hypermotility
400401|NCT01432782|Chest Pain|chest pain
400402|NCT01432769|enteral nutrition|enteral nutrition
400403|NCT01432769|malnutrition|malnutrition
400404|NCT01432769|cardiac surgery|cardiac surgery
400405|NCT01432756|HIV|hiv
400406|NCT01432743|3D mapping|3d mapping
400407|NCT01432743|Image integration|image integration
400408|NCT01432743|Atrial fibrillation|atrial fibrillation
400409|NCT01432743|Catheter Ablation|catheter ablation
400410|NCT01432704|MS|ms
400411|NCT01432704|vitamin D|vitamin d
400412|NCT01432704|environment|environment
400413|NCT01432691|Hip-fracture|hip-fracture
400414|NCT01432691|RSA|rsa
400415|NCT01432678|vitamin D|vitamin d
400416|NCT01432678|asthma|asthma
400417|NCT01432665|HSDD|hsdd
400418|NCT01432639|Myocardial infarction|myocardial infarction
400419|NCT01432639|Autonomic function|autonomic function
400420|NCT01432639|Arterial Stiffness|arterial stiffness
400421|NCT01432639|Endothelial function|endothelial function
400422|NCT01432639|Inflammation|inflammation
400423|NCT01432639|Rehabilitation program|rehabilitation program
400424|NCT01432639|Exercise|exercise
400425|NCT01432626|stress induced cardiomyopathy|stress induced cardiomyopathy
400426|NCT01432626|broken heart syndrome|broken heart syndrome
400427|NCT01432626|Takotsubo cardiomyopathy|takotsubo cardiomyopathy
400428|NCT01432626|transient apical ballooning syndrome|transient apical ballooning syndrome
400429|NCT01432626|apical ballooning cardiomyopathy|apical ballooning cardiomyopathy
400430|NCT01432626|stress cardiomyopathy|stress cardiomyopathy
400431|NCT01432626|non-ischemic cardiomyopathy|non-ischemic cardiomyopathy
400432|NCT01432613|Myositis|myositis
400433|NCT01432613|Magnetic Resonance Imaging|magnetic resonance imaging
400434|NCT01432613|Muscle biopsy|muscle biopsy
400435|NCT01432613|Sensitivity and Specificity|sensitivity and specificity
400436|NCT01432600|Multiple Myeloma|multiple myeloma
400437|NCT01432600|Relapsed|relapsed
400438|NCT01432600|Refractory|refractory
400439|NCT01432600|Corticosteroids|corticosteroids
400440|NCT01432587|Amyloidosis|amyloidosis
400441|NCT01432587|Transthyretin|transthyretin
400442|NCT01432587|Neuropathies|neuropathies
400443|NCT01432587|Diflunisal|diflunisal
400444|NCT01432587|Familial|familial
400445|NCT01432574|HPV|hpv
400446|NCT01432561|Lysosomal Storage Diseases|lysosomal storage diseases
400447|NCT01432561|Metabolic Diseases|metabolic diseases
400448|NCT01432561|Metabolism, Inborn Errors|metabolism, inborn errors
400449|NCT01432548|Ischemic|ischemic
400450|NCT01432548|preconditioning|preconditioning
400451|NCT01432548|liver|liver
400452|NCT01432548|resection|resection
400453|NCT01432522|Intranasal epinephrine|intranasal epinephrine
400454|NCT01432522|Plasma epinephrine level|plasma epinephrine level
400455|NCT01432509|Pre-diabetes|pre-diabetes
400456|NCT01432509|Type 2 diabetes|type 2 diabetes
400457|NCT01432509|Biomarkers|biomarkers
400458|NCT01432509|Cohort|cohort
400459|NCT01432509|Diabetes Risk Score|diabetes risk score
400460|NCT01432509|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
400461|NCT01432509|Glucose Intolerance|glucose intolerance
400462|NCT01432509|Prediabetic State|prediabetic state
400463|NCT01432509|Glucose Metabolism Disorders|glucose metabolism disorders
400464|NCT01432509|Metabolic Diseases|metabolic diseases
400465|NCT01432509|Endocrine System Diseases|endocrine system diseases
400466|NCT01432509|Hyperglycemia|hyperglycemia
400467|NCT01432496|Laparoscopic|laparoscopic
400468|NCT01432496|Colectomy|colectomy
400469|NCT01432496|Nebulization|nebulization
400470|NCT01432496|Ropivacaine|ropivacaine
400471|NCT01432483|Cancer|cancer
400472|NCT01432483|ONTAK|ontak
400473|NCT01432483|Denileukin diftitox|denileukin diftitox
400474|NCT01432483|persistent or recurrent disease|persistent or recurrent disease
400475|NCT01432483|requiring continued delivery of essential cancer therapy|requiring continued delivery of essential cancer therapy
400476|NCT01432470|vaginal atrophy|vaginal atrophy
400477|NCT01432444|Schizophrenia|schizophrenia
400478|NCT01432418|rehabilitation|rehabilitation
400479|NCT01432418|wheelchairs|wheelchairs
400480|NCT01432418|safety|safety
400481|NCT01432418|disability evaluation|disability evaluation
400482|NCT01432418|motor skills|motor skills
400483|NCT01432405|Diabetes|diabetes
400484|NCT01432392|gastroesophageal reflux disease|gastroesophageal reflux disease
400485|NCT01432392|GERD questionnaire|gerd questionnaire
400486|NCT01432392|primary care setting|primary care setting
400487|NCT01432340|Influenza|influenza
400488|NCT01432340|Influenza vaccine|influenza vaccine
400489|NCT01432340|Influenza vaccine effectiveness study|influenza vaccine effectiveness study
400490|NCT01432327|motor activity|motor activity
400491|NCT01432327|randomized controlled trial|randomized controlled trial
400492|NCT01432327|feedback|feedback
400493|NCT01432314|patient's survival|patient's survival
400494|NCT01432314|tumor response|tumor response
400495|NCT01432314|safety|safety
400496|NCT01432301|fluorouracil overdose|fluorouracil overdose
400497|NCT01432301|fluorouracil toxicity|fluorouracil toxicity
400498|NCT01432301|capecitabine overdose|capecitabine overdose
400499|NCT01432301|capecitabine toxicity|capecitabine toxicity
400500|NCT01432275|Diabetes|diabetes
400501|NCT01432275|SMBG|smbg
400502|NCT01432275|Insulin calculator|insulin calculator
400503|NCT01432262|prevention of pneumococcal diseases|prevention of pneumococcal diseases
400504|NCT01432249|pediatric psoriasis|pediatric psoriasis
400505|NCT01432249|enbrel|enbrel
400506|NCT01432249|safety|safety
400507|NCT01432249|efficacy|efficacy
400508|NCT01432236|Pregabalin|pregabalin
400509|NCT01432236|Lyrica|lyrica
400510|NCT01432236|depression|depression
400511|NCT01432223|Trastuzumab|trastuzumab
400512|NCT01432223|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
400513|NCT01432223|Primary chemotherapy|primary chemotherapy
400514|NCT01432210|post-prandial absorption|post-prandial absorption
400515|NCT01432210|provitamin A carotenoids|provitamin a carotenoids
400516|NCT01432210|vitamin A|vitamin a
400517|NCT01432210|avocado|avocado
400518|NCT01432210|tomato|tomato
400519|NCT01432210|carrot|carrot
400520|NCT01432197|HRQOL|hrqol
400521|NCT01432197|Occupational therapy|occupational therapy
400522|NCT01432197|ADL intervention|adl intervention
400523|NCT01432197|Cancer patients|cancer patients
400524|NCT01432184|cerebral|cerebral
400525|NCT01432184|hypoxia|hypoxia
400526|NCT01432171|Brain cancer|brain cancer
400527|NCT01432171|Central nervous system|central nervous system
400528|NCT01432171|Seizure prophylaxis|seizure prophylaxis
400529|NCT01432171|High-Grade Gliomas|high-grade gliomas
400530|NCT01432171|HGG|hgg
400531|NCT01432171|Supratentorial high-grade glioma|supratentorial high-grade glioma
400532|NCT01432171|Malignant glioma|malignant glioma
400533|NCT01432171|Lacosamide|lacosamide
400534|NCT01432171|Vimpat|vimpat
400535|NCT01432171|Placebo|placebo
400536|NCT01432171|Sugar pill|sugar pill
400537|NCT01432158|Invasive pneumococcal disease|invasive pneumococcal disease
400538|NCT01432145|BRCA defective|brca defective
400539|NCT01432132|Head and Neck Cancer|head and neck cancer
400540|NCT01432132|Body Image Adaptation|body image adaptation
400541|NCT01432132|Post surgical body image|post surgical body image
400542|NCT01432132|Audio-recorded interview|audio-recorded interview
400543|NCT01432132|Questionnaire|questionnaire
400544|NCT01432132|Survey|survey
400545|NCT01432119|Advanced Cancers|advanced cancers
400546|NCT01432119|Advanced Malignancies|advanced malignancies
400547|NCT01432119|Liver Metastases|liver metastases
400548|NCT01432119|SIR-Spheres|sir-spheres
400549|NCT01432119|Selective internal radiation|selective internal radiation
400550|NCT01432119|Yttrium-90|yttrium-90
400551|NCT01432119|Cetuximab|cetuximab
400552|NCT01432119|C225|c225
400553|NCT01432119|Erbitux|erbitux
400554|NCT01432119|Erlotinib|erlotinib
400555|NCT01432119|Erlotinib Hydrochloride|erlotinib hydrochloride
400556|NCT01432119|Tarceva|tarceva
400557|NCT01432119|OSI-774|osi-774
400558|NCT01432106|Hypertension|hypertension
400559|NCT01432106|Metabolic Syndrome|metabolic syndrome
400560|NCT01432106|African American|african american
400561|NCT01432093|liver transplant|liver transplant
400562|NCT01432093|high blood sugars|high blood sugars
400563|NCT01432093|hospital hyperglycemia|hospital hyperglycemia
400564|NCT01432093|post-transplant hyperglycemia|post-transplant hyperglycemia
400565|NCT01432093|post liver transplant|post liver transplant
400566|NCT01432093|post liver-kidney transplant|post liver-kidney transplant
400567|NCT01432080|Pulmonary disease, chronic obstructive|pulmonary disease, chronic obstructive
400568|NCT01432080|Viral respiratory tract infections|viral respiratory tract infections
400569|NCT01432080|Respiratory syncytial viruses|respiratory syncytial viruses
400570|NCT01432080|Influenza virus A|influenza virus a
400571|NCT01432080|Influenza virus B|influenza virus b
400572|NCT01432080|Transplantation, Allogeneic|transplantation, allogeneic
400573|NCT01432067|cancer|cancer
400574|NCT01432067|geriatry|geriatry
400575|NCT01432067|curative care|curative care
400576|NCT01432067|physical activity|physical activity
400577|NCT01432054|Human Tissue Repository|human tissue repository
400578|NCT01432041|Injury prevention|injury prevention
400579|NCT01432041|smoke alarms|smoke alarms
400580|NCT01432041|car seats|car seats
400581|NCT01432015|aprepitant|aprepitant
400582|NCT01432015|fosaprepitant|fosaprepitant
400583|NCT01432015|gynecologic cancer|gynecologic cancer
400584|NCT01432015|emesis|emesis
400585|NCT01432002|breast carcinoma|breast carcinoma
400586|NCT01432002|FDG|fdg
400587|NCT01432002|PET/CT|pet/ct
400588|NCT01432002|PET/IRM|pet/irm
400589|NCT01431950|fluticasone furoate|fluticasone furoate
400590|NCT01431937|Pharmacodynamics|pharmacodynamics
400591|NCT01431937|Pharmacokinetics|pharmacokinetics
400592|NCT01431924|outcomes|outcomes
400593|NCT01431924|observational|observational
400594|NCT01431924|retrospective|retrospective
400595|NCT01431924|database|database
400596|NCT01431924|asthma|asthma
400597|NCT01431898|HCV RNA|hcv rna
400598|NCT01431898|Polymerase inhibitor|polymerase inhibitor
400599|NCT01431898|Treatment naïve and Treatment experienced|treatment naïve and treatment experienced
400600|NCT01431898|GS-9669|gs-9669
400601|NCT01431898|Hepatitis C|hepatitis c
400602|NCT01431898|HCV|hcv
400603|NCT01431885|fibronectin|fibronectin
400604|NCT01431885|cervical length|cervical length
400605|NCT01431872|Aromatase Inhibitors|aromatase inhibitors
400606|NCT01431859|pollen|pollen
400607|NCT01431859|allergy|allergy
400608|NCT01431859|food|food
400609|NCT01431859|immunotherapy|immunotherapy
400610|NCT01431833|Hepatic Impairment|hepatic impairment
400611|NCT01431833|Matched control subjects|matched control subjects
400612|NCT01431820|Onychomycosis|onychomycosis
400613|NCT01431820|Toenail Fungus|toenail fungus
400614|NCT01431820|luliconazole|luliconazole
400615|NCT01431820|Antifungal|antifungal
400616|NCT01431820|Topical|topical
400617|NCT01431794|Pancreatic ductal adenocarcinoma (PDA)Neoplasms|pancreatic ductal adenocarcinoma (pda)neoplasms
400618|NCT01431794|LDE225|lde225
400619|NCT01431794|nab-paclitaxel|nab-paclitaxel
400620|NCT01431794|abraxane|abraxane
400621|NCT01431794|gemcitabine|gemcitabine
400622|NCT01431794|neoadjuvant|neoadjuvant
400623|NCT01431794|cytotoxic|cytotoxic
400624|NCT01431794|hedgehog (Hh) inhibitors|hedgehog (hh) inhibitors
400625|NCT01431794|stromal cells|stromal cells
400626|NCT01431794|resectable PDA|resectable pda
400627|NCT01431794|Pancreatic Diseases|pancreatic diseases
400628|NCT01431794|Carcinoma|carcinoma
400629|NCT01431768|Influenza|influenza
400630|NCT01431768|Human|human
400631|NCT01431768|Orthomyxoviridae infections|orthomyxoviridae infections
400632|NCT01431768|RNA Virus Infections|rna virus infections
400633|NCT01431768|Virus Diseases|virus diseases
400634|NCT01431768|Respiratory Tract infections|respiratory tract infections
400635|NCT01431768|Respiratory Tract Diseases|respiratory tract diseases
400636|NCT01431742|buccal soluble film|buccal soluble film
400637|NCT01431742|Pain|pain
400638|NCT01431742|Back Pain|back pain
400639|NCT01431742|Low Back Pain|low back pain
400640|NCT01431742|Buprenorphine|buprenorphine
400641|NCT01431742|Analgesics, Opioid|analgesics, opioid
400642|NCT01431742|Analgesics|analgesics
400643|NCT01431703|narrow band imaging|narrow band imaging
400644|NCT01431703|learning curve|learning curve
400645|NCT01431703|colorectal|colorectal
400646|NCT01431703|differential diagnosis|differential diagnosis
400647|NCT01431703|with colorectal lesion|with colorectal lesion
400648|NCT01431703|NBI with magnification|nbi with magnification
400649|NCT01431690|Eicosapentaenoic Acid|eicosapentaenoic acid
400650|NCT01431690|Docosahexaenoic Acid|docosahexaenoic acid
400651|NCT01431690|Warfarin|warfarin
400652|NCT01431690|Hypertriglyceridemia|hypertriglyceridemia
400653|NCT01431690|Omega-3 free fatty acids|omega-3 free fatty acids
400654|NCT01431690|Omega-3 ethyl ester acids|omega-3 ethyl ester acids
400655|NCT01431690|Epanova|epanova
400656|NCT01431690|Lovaza|lovaza
400657|NCT01431690|pharmacokinetics|pharmacokinetics
400658|NCT01431690|low-fat meal|low-fat meal
400659|NCT01431677|Muscle|muscle
400660|NCT01431677|Biopsy|biopsy
400661|NCT01431677|Energetics|energetics
400662|NCT01431677|Sarcopenia|sarcopenia
400663|NCT01431677|Frailty|frailty
400664|NCT01431664|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
400665|NCT01431664|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
400666|NCT01431664|acute leukemias of ambiguous lineage|acute leukemias of ambiguous lineage
400667|NCT01431664|acute undifferentiated leukemia|acute undifferentiated leukemia
400668|NCT01431664|secondary acute myeloid leukemia|secondary acute myeloid leukemia
400669|NCT01431651|Food and beverages|food and beverages
400670|NCT01431651|Food|food
400671|NCT01431651|Dietary supplements|dietary supplements
400672|NCT01431638|Gout|gout
400673|NCT01431638|arthritis|arthritis
400674|NCT01431638|gout flare|gout flare
400675|NCT01431638|acute gout|acute gout
400676|NCT01431638|gouty|gouty
400677|NCT01431638|rheumatic disease|rheumatic disease
400678|NCT01431638|uric acid|uric acid
400679|NCT01431638|podagra|podagra
400680|NCT01431625|COPD|copd
400681|NCT01431625|Exercise Training|exercise training
400682|NCT01431612|Pharmacokinetics, kidney;|pharmacokinetics, kidney;
400683|NCT01431612|Receptors, adrenergic;|receptors, adrenergic;
400684|NCT01431612|Fluids, i.v.;|fluids, i.v.;
400685|NCT01431612|Sympathetic nervous system, esmolol;|sympathetic nervous system, esmolol;
400686|NCT01431612|Sympathetic nervous system, phenylephrine|sympathetic nervous system, phenylephrine
400687|NCT01431599|Locally advanced rectal cancer|locally advanced rectal cancer
400688|NCT01431586|JDTic|jdtic
400689|NCT01431586|cocaine dependence|cocaine dependence
400690|NCT01431586|kappa-opioid antagonist|kappa-opioid antagonist
400691|NCT01431573|Depression|depression
400692|NCT01431560|ankle|ankle
400693|NCT01431560|metallic|metallic
400694|NCT01431560|biodegradable|biodegradable
400695|NCT01431560|Freedom|freedom
400696|NCT01431508|Hypertension|hypertension
400697|NCT01431495|platelet agregation|platelet agregation
400698|NCT01431495|clopidogrel|clopidogrel
400699|NCT01431495|major adverse cardiac events (MACE)|major adverse cardiac events (mace)
400700|NCT01431482|skin symptoms|skin symptoms
400701|NCT01431456|Prevention|prevention
400702|NCT01431456|venous thromboembolism after knee arthroplasty|venous thromboembolism after knee arthroplasty
400703|NCT01431443|Randomized double blind trial|randomized double blind trial
400704|NCT01431443|Cocoa flavonoids|cocoa flavonoids
400705|NCT01431443|Endothelial function|endothelial function
400706|NCT01431443|Blood pressure|blood pressure
400707|NCT01431443|Pregnant women|pregnant women
400708|NCT01431443|Preeclampsia|preeclampsia
400709|NCT01431443|Uterine artery flow|uterine artery flow
400710|NCT01431443|Pulsatility index|pulsatility index
400711|NCT01431430|Vitamine D|vitamine d
400712|NCT01431430|renal transplantation|renal transplantation
400713|NCT01431430|diabetes mellitus|diabetes mellitus
400714|NCT01431430|cancer|cancer
400715|NCT01431430|cardiovascular complications|cardiovascular complications
400716|NCT01431417|Shoulder|shoulder
400717|NCT01431417|Outcome treatment|outcome treatment
400718|NCT01431417|Validation Studies as topic|validation studies as topic
400719|NCT01431417|Biomechanics|biomechanics
400720|NCT01431417|Shoulder, Joint Instability|shoulder, joint instability
400721|NCT01431391|Immune therapy|immune therapy
400722|NCT01431391|Cancer vaccine|cancer vaccine
400723|NCT01431391|Therapeutic vaccine|therapeutic vaccine
400724|NCT01431391|Therapeutic cancer vaccine|therapeutic cancer vaccine
400725|NCT01431391|Vaccine|vaccine
400726|NCT01431391|Dendritic cells|dendritic cells
400728|NCT01431391|Androgen deprivation therapy|androgen deprivation therapy
400729|NCT01431391|Prostatic Neoplasms|prostatic neoplasms
400730|NCT01431391|Genital Neoplasms, Male|genital neoplasms, male
400731|NCT01431391|Urogenital Neoplasms|urogenital neoplasms
400732|NCT01431391|Neoplasms|neoplasms
400733|NCT01431391|Prostatic Diseases|prostatic diseases
400734|NCT01431391|Androgens|androgens
400735|NCT01431391|Hormones|hormones
400736|NCT01431391|Adenocarcinoma|adenocarcinoma
400737|NCT01431391|Carcinoma|carcinoma
400738|NCT01431391|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
400739|NCT01431391|Immunology|immunology
400740|NCT01431391|Hormone therapy|hormone therapy
400741|NCT01431391|Immunotherapy|immunotherapy
400742|NCT01431391|Luteinizing hormone-releasing hormone (LHRH)|luteinizing hormone-releasing hormone (lhrh)
400743|NCT01431378|CT scan|ct scan
400744|NCT01431378|CNS|cns
400745|NCT01431378|Thorax|thorax
400746|NCT01431378|Abdomen|abdomen
400747|NCT01431378|staging of a known or suspected lung cancer|staging of a known or suspected lung cancer
400748|NCT01431378|suspected urolithiasis|suspected urolithiasis
400749|NCT01431378|known or suspected focal liver lesion|known or suspected focal liver lesion
400750|NCT01431365|exercise|exercise
400751|NCT01431365|topography|topography
400752|NCT01431365|cravings|cravings
400753|NCT01431365|smoking behaviour|smoking behaviour
400754|NCT01431352|Polycystic ovary syndrome|polycystic ovary syndrome
400755|NCT01431352|Randomized controlled trial|randomized controlled trial
400756|NCT01431352|Chinese herbal medicine|chinese herbal medicine
400757|NCT01431352|Chinese herbal medicine granules|chinese herbal medicine granules
400758|NCT01431352|Letrozole|letrozole
400759|NCT01431352|Live birth|live birth
400760|NCT01431326|adenovirus|adenovirus
400761|NCT01431326|anaesthetic|anaesthetic
400762|NCT01431326|anesthesia|anesthesia
400763|NCT01431326|anticoagulant|anticoagulant
400764|NCT01431326|anti-epileptic|anti-epileptic
400765|NCT01431326|anti-inflammatory|anti-inflammatory
400766|NCT01431326|antimicrobial|antimicrobial
400767|NCT01431326|anti-psychotic|anti-psychotic
400768|NCT01431326|antiviral|antiviral
400769|NCT01431326|anxiety|anxiety
400770|NCT01431326|anxiolysis|anxiolysis
400771|NCT01431326|anxiolytic|anxiolytic
400772|NCT01431326|autism|autism
400773|NCT01431326|autistic disorder|autistic disorder
400774|NCT01431326|benzodiazepine|benzodiazepine
400775|NCT01431326|bipolar disorder|bipolar disorder
400776|NCT01431326|convulsions|convulsions
400777|NCT01431326|epilepsy|epilepsy
400778|NCT01431326|headaches|headaches
400779|NCT01431326|herpes simplex virus|herpes simplex virus
400780|NCT01431326|herpes simplex virus (HSV)|herpes simplex virus (hsv)
400781|NCT01431326|hypertension|hypertension
400782|NCT01431326|infantile hemangioma|infantile hemangioma
400783|NCT01431326|infection|infection
400784|NCT01431326|inflammation|inflammation
400785|NCT01431326|influenza|influenza
400786|NCT01431326|lower respiratory tract infection (LRTI)|lower respiratory tract infection (lrti)
400787|NCT01431326|meningitis|meningitis
400788|NCT01431326|migraines|migraines
400789|NCT01431326|muscle spasms|muscle spasms
400790|NCT01431326|pain|pain
400791|NCT01431326|pneumonia|pneumonia
400792|NCT01431326|prophylaxis|prophylaxis
400793|NCT01431326|retinitis|retinitis
400794|NCT01431326|schizophrenia|schizophrenia
400795|NCT01431326|sedation|sedation
400796|NCT01431326|sedative|sedative
400797|NCT01431326|seizures|seizures
400798|NCT01431326|septicemia|septicemia
400799|NCT01431326|swelling|swelling
400800|NCT01431326|thromboprophylaxis|thromboprophylaxis
400801|NCT01431326|thrombosis|thrombosis
400802|NCT01431326|urinary tract infection|urinary tract infection
400803|NCT01431326|urinary tract infection (UTI)|urinary tract infection (uti)
400804|NCT01431326|withdrawal|withdrawal
400805|NCT01431326|empiric therapy|empiric therapy
400806|NCT01431326|staphylococci|staphylococci
400807|NCT01431313|pulmonary hypertension|pulmonary hypertension
400808|NCT01431300|central veins|central veins
400809|NCT01431300|thorax|thorax
400810|NCT01431300|superior vena cava|superior vena cava
400811|NCT01431300|Central vein imaging|central vein imaging
400812|NCT01431261|Chronic neck pain|chronic neck pain
400813|NCT01431261|Whiplash|whiplash
400814|NCT01431261|Whiplash Associated Disorders|whiplash associated disorders
400815|NCT01431261|Chronic Pain|chronic pain
400816|NCT01431261|Neck exercises|neck exercises
400817|NCT01431261|Training|training
400818|NCT01431261|Pacing|pacing
400819|NCT01431261|Patient Education|patient education
400820|NCT01431261|Pain Management|pain management
400821|NCT01431261|Whiplash Injuries|whiplash injuries
400822|NCT01431261|Musculoskeletal|musculoskeletal
400823|NCT01431248|Preterm Premature Rupture of Membranes|preterm premature rupture of membranes
400824|NCT01431248|Erythromycin|erythromycin
400825|NCT01431248|Azithromycin|azithromycin
400826|NCT01431235|ADHD|adhd
400827|NCT01431235|SUD|sud
400828|NCT01431235|cognitive behavioral therapy|cognitive behavioral therapy
400829|NCT01431222|severe mitral regurgitation|severe mitral regurgitation
400830|NCT01431222|interventional mitral valve reconstruction|interventional mitral valve reconstruction
400831|NCT01431222|inoperable|inoperable
400832|NCT01431222|EuroSCORE|euroscore
400833|NCT01431222|STS Risk Score|sts risk score
400834|NCT01431222|MitraClip|mitraclip
400835|NCT01431222|fluoroscopy|fluoroscopy
400836|NCT01431222|echocardiography|echocardiography
400837|NCT01431222|percutaneous treatment of mitral regurgitation|percutaneous treatment of mitral regurgitation
400838|NCT01431196|breast cancer|breast cancer
400839|NCT01431196|neoadjuvant chemotherapy|neoadjuvant chemotherapy
400840|NCT01431196|autologous dendritic cell vaccination|autologous dendritic cell vaccination
400841|NCT01431183|influenza|influenza
400842|NCT01431183|vaccine|vaccine
400843|NCT01431183|reminder / recall|reminder / recall
400844|NCT01431183|immunization registry|immunization registry
400845|NCT01431183|immunization information systems|immunization information systems
400846|NCT01431157|Sleep Apnea Syndrome|sleep apnea syndrome
400847|NCT01431157|Heart Failure|heart failure
400848|NCT01431157|Oxygen Inhalation Therapy|oxygen inhalation therapy
400849|NCT01431144|soft tissue thickness|soft tissue thickness
400850|NCT01431144|dental implant|dental implant
400851|NCT01431144|soft tissue recession|soft tissue recession
400852|NCT01431144|implant exposure|implant exposure
400853|NCT01431131|graft placement|graft placement
400854|NCT01431131|bone resorption|bone resorption
400855|NCT01431118|iron metabolism|iron metabolism
400856|NCT01431118|hepcidin|hepcidin
400857|NCT01431118|dragon boating|dragon boating
400858|NCT01431118|sport-specific stress|sport-specific stress
400859|NCT01431118|iron|iron
400860|NCT01431118|anaemia|anaemia
400861|NCT01431118|sport|sport
400862|NCT01431105|Kawasaki disease|kawasaki disease
400863|NCT01431079|HPV|hpv
400864|NCT01431079|College men|college men
400865|NCT01431079|HPV vaccine|hpv vaccine
400866|NCT01431079|Health belief model|health belief model
400867|NCT01431079|HPV vaccine acceptance|hpv vaccine acceptance
400868|NCT01431053|exemestane|exemestane
400869|NCT01431053|aspirin|aspirin
400870|NCT01431053|quality of life|quality of life
400871|NCT01431040|Bowel Prep|bowel prep
400872|NCT01431040|No bowel prep|no bowel prep
400873|NCT01431040|Vaginal reconstructive or obliterative surgery|vaginal reconstructive or obliterative surgery
400874|NCT01431027|Heart Failure|heart failure
400875|NCT01431027|Diastolic Heart Failure|diastolic heart failure
400876|NCT01431027|Heart Failure with Normal Ejection Fraction|heart failure with normal ejection fraction
400877|NCT01431014|orthognathic surgery|orthognathic surgery
400878|NCT01431014|steroid|steroid
400879|NCT01431014|swelling|swelling
400880|NCT01431014|3-dimensional photogrammetry|3-dimensional photogrammetry
400881|NCT01431001|Depression|depression
400882|NCT01431001|MDD|mdd
400883|NCT01431001|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
400884|NCT01431001|Depressive Disorder|depressive disorder
400885|NCT01431001|TMS|tms
400886|NCT01430988|Head Injuries|head injuries
400887|NCT01430988|Head Trauma|head trauma
400888|NCT01430988|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
400889|NCT01430988|Emergency Department|emergency department
400890|NCT01430988|Accident & Emergency|accident & emergency
400891|NCT01430975|Radiation Exposure|radiation exposure
400892|NCT01430975|Rubidium 82|rubidium 82
400893|NCT01430975|Strontium 82|strontium 82
400894|NCT01430975|Strontium 85|strontium 85
400895|NCT01430962|EBUS|ebus
400896|NCT01430962|mediastinal lymph nodes|mediastinal lymph nodes
400897|NCT01430962|mediastinal masses|mediastinal masses
400898|NCT01430962|anesthesia|anesthesia
400899|NCT01430962|moderate sedation|moderate sedation
400900|NCT01430949|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
400901|NCT01430949|Catheter Ablation|catheter ablation
400902|NCT01430949|Pulmonary Vein Isolation|pulmonary vein isolation
400903|NCT01430949|Radio Frequency Ablation|radio frequency ablation
400904|NCT01430936|Vascular Diseases|vascular diseases
400905|NCT01430936|Hypertension|hypertension
400906|NCT01430936|Chronic Kidney Disease|chronic kidney disease
400907|NCT01430936|COPD|copd
400908|NCT01430923|Refrigeration free latanoprost|refrigeration free latanoprost
400909|NCT01430910|Phase 1|phase 1
400910|NCT01430910|open label|open label
400911|NCT01430910|ceftazidime|ceftazidime
400912|NCT01430910|pharmacokinetics|pharmacokinetics
400913|NCT01430910|urinary tract infection|urinary tract infection
400914|NCT01430910|intra-abdominal infection|intra-abdominal infection
400915|NCT01430897|d-TGA|d-tga
400916|NCT01430897|dextro Transposition of the great arteries|dextro transposition of the great arteries
400917|NCT01430897|systemic right ventricle|systemic right ventricle
400918|NCT01430897|right ventricular failure|right ventricular failure
400919|NCT01430897|Atrial switch procedure|atrial switch procedure
400920|NCT01430884|coronary aspirate blood|coronary aspirate blood
400921|NCT01430884|particular debris / microemboli|particular debris / microemboli
400922|NCT01430884|distal occlusion device|distal occlusion device
400923|NCT01430858|Fracture|fracture
400924|NCT01430858|Anabolic|anabolic
400925|NCT01430858|Vibration|vibration
400926|NCT01430858|Strain Gauge|strain gauge
400927|NCT01430858|Focus - Osteoporosis|focus - osteoporosis
400928|NCT01430845|GDD|gdd
400929|NCT01430845|CP|cp
400930|NCT01430845|MR|mr
400931|NCT01430845|PDD|pdd
400932|NCT01430845|ASD|asd
400933|NCT01430845|BSID|bsid
400934|NCT01430832|PTSD|ptsd
400935|NCT01430832|Preterm|preterm
400936|NCT01430832|Premature|premature
400937|NCT01430832|VLBW|vlbw
400938|NCT01430819|Influenza|influenza
400939|NCT01430819|Influenza Virus Vaccine|influenza virus vaccine
400940|NCT01430819|Fluzone® 2011-2012 Formulation|fluzone® 2011-2012 formulation
400941|NCT01430819|Fluzone® High-Dose 2011-2012 Formulation|fluzone® high-dose 2011-2012 formulation
400942|NCT01430819|Trivalent Inactivated Influenza Vaccine|trivalent inactivated influenza vaccine
400943|NCT01430780|Coronary artery disease|coronary artery disease
400944|NCT01430780|nitrate|nitrate
400945|NCT01430780|endothelium|endothelium
400946|NCT01430767|adherence|adherence
400947|NCT01430754|Blindness|blindness
400948|NCT01430754|Eye Diseases|eye diseases
400949|NCT01430754|Nap Disorders|nap disorders
400950|NCT01430754|Circadian Rhythm Disorders|circadian rhythm disorders
400951|NCT01430754|Sleep Disorders|sleep disorders
400952|NCT01430754|Circadian Rhythm Sleep Disorders|circadian rhythm sleep disorders
400953|NCT01430754|Dyssomnias|dyssomnias
400954|NCT01430754|Nervous System Diseases|nervous system diseases
400955|NCT01430741|Implementation Science|implementation science
400956|NCT01430741|Supportive Housing|supportive housing
400957|NCT01430741|Co-occurring disorders|co-occurring disorders
400958|NCT01430741|Cluster randomized controlled trial|cluster randomized controlled trial
400959|NCT01430741|Hybrid implementation-effectiveness trial|hybrid implementation-effectiveness trial
400960|NCT01430715|active video game|active video game
400961|NCT01430715|video gaming|video gaming
400962|NCT01430715|accelerometery|accelerometery
400963|NCT01430715|MVPA|mvpa
400964|NCT01430715|outdoor play|outdoor play
400965|NCT01430715|children|children
400966|NCT01430715|unstructured|unstructured
400967|NCT01430715|energy expenditure|energy expenditure
400968|NCT01430689|Influenza|influenza
400969|NCT01430689|Pregnancy|pregnancy
400970|NCT01430689|Neonates|neonates
400971|NCT01430676|Incisional hernia|incisional hernia
400972|NCT01430676|recurrence|recurrence
400973|NCT01430676|longterm|longterm
400974|NCT01430663|aspergillosis|aspergillosis
400975|NCT01430663|bronchoalveolar lavage|bronchoalveolar lavage
400976|NCT01430663|galactomannan|galactomannan
400977|NCT01430663|pcr|pcr
400978|NCT01430663|hematological patients|hematological patients
400979|NCT01430650|Oral estrogens|oral estrogens
400980|NCT01430650|transdermal estrogens|transdermal estrogens
400981|NCT01430650|endometrial priming|endometrial priming
400982|NCT01430637|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
400983|NCT01430637|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
400984|NCT01430637|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
400985|NCT01430637|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
400986|NCT01430637|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
400987|NCT01430637|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
400988|NCT01430637|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
400989|NCT01430637|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
400990|NCT01430637|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
400991|NCT01430637|adult desmoplastic small round cell tumor|adult desmoplastic small round cell tumor
400992|NCT01430624|Rape|rape
400993|NCT01430624|Secondary prevention|secondary prevention
400994|NCT01430624|Intervention|intervention
400995|NCT01430611|Meningitis|meningitis
400996|NCT01430611|Neisseria meningitidis|neisseria meningitidis
400997|NCT01430611|Meningo A+C®|meningo a+c®
400998|NCT01430611|Meng Ling Kang®|meng ling kang®
400999|NCT01430598|Full Thickness Rotator Cuff Tear and Acromial Spur|full thickness rotator cuff tear and acromial spur
401000|NCT01430585|Ki-67|ki-67
401001|NCT01430585|postmenopausal early breast cancer|postmenopausal early breast cancer
401002|NCT01430585|ER positive/HER2 negative early breast cancer|er positive/her2 negative early breast cancer
401003|NCT01430572|Advanced Cancers|advanced cancers
401004|NCT01430572|Solid Tumors|solid tumors
401005|NCT01430572|PI3KCA Mutation Positive/PTEN|pi3kca mutation positive/pten
401006|NCT01430572|Refractory to standard therapy|refractory to standard therapy
401007|NCT01430572|Relapsed after standard therapy|relapsed after standard therapy
401008|NCT01430572|Pazopanib|pazopanib
401009|NCT01430572|GW786034|gw786034
401010|NCT01430572|Everolimus|everolimus
401011|NCT01430572|Afinitor|afinitor
401012|NCT01430572|RAD001|rad001
401013|NCT01430559|Validation of the WOMAC in Chinese subjects with osteoarthritis of the knee|validation of the womac in chinese subjects with osteoarthritis of the knee
401014|NCT01430546|Relapsed and Refractory Multiple Myeloma|relapsed and refractory multiple myeloma
401015|NCT01430533|dermal sensitization potential|dermal sensitization potential
401016|NCT01430507|Anti-inflammatory drugs, DMARD|anti-inflammatory drugs, dmard
401017|NCT01430481|rosehip|rosehip
401018|NCT01430481|osteoarthritis|osteoarthritis
401019|NCT01430481|pain|pain
401020|NCT01430481|knee|knee
401021|NCT01430481|RCT|rct
401022|NCT01430468|Glenoid component position|glenoid component position
401023|NCT01430468|patient specific instruments|patient specific instruments
401024|NCT01430455|Major Depressive Episode|major depressive episode
401025|NCT01430455|Depression NOS|depression nos
401026|NCT01430455|Bipolar Disorder|bipolar disorder
401027|NCT01430455|Bipolar Disorder I|bipolar disorder i
401028|NCT01430455|Bipolar Disorder II|bipolar disorder ii
401029|NCT01430455|Bipolar Depression|bipolar depression
401030|NCT01430455|Major Depression|major depression
401031|NCT01430416|Uveal melanoma|uveal melanoma
401032|NCT01430416|phase 1|phase 1
401033|NCT01430416|AEB071|aeb071
401034|NCT01430416|Metastatic|metastatic
401035|NCT01430403|persistent allergic asthma|persistent allergic asthma
401036|NCT01430403|asthma exacerbations reduction|asthma exacerbations reduction
401037|NCT01430403|Xolair® (omalizumab)|xolair® (omalizumab)
401038|NCT01430403|Flovent® Diskus® (fluticasone)|flovent® diskus® (fluticasone)
401039|NCT01430403|placebo|placebo
401040|NCT01430403|inhaled corticosteroid therapy|inhaled corticosteroid therapy
401041|NCT01430403|anti-immunoglobulin E therapy|anti-immunoglobulin e therapy
401042|NCT01430403|anti-IgE therapy|anti-ige therapy
401043|NCT01430390|In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic|in vitro expanded allogeneic epstein-barr virus specific cytotoxic
401044|NCT01430390|T-Lymphocytes (EBV-CTLs)|t-lymphocytes (ebv-ctls)
401045|NCT01430390|CD19 specific T-cells|cd19 specific t-cells
401046|NCT01430390|11-038|11-038
401047|NCT01430377|periprocedural myonecrosis|periprocedural myonecrosis
401048|NCT01430377|procedure time|procedure time
401049|NCT01430377|fluoroscopy time|fluoroscopy time
401050|NCT01430364|coronary bifurcation stenosis|coronary bifurcation stenosis
401051|NCT01430364|dedicated bifurcation stent|dedicated bifurcation stent
401052|NCT01430364|sirolymus|sirolymus
401053|NCT01430364|PTS|pts
401054|NCT01430364|BiOSS Lym|bioss lym
401055|NCT01430351|Brain cancer|brain cancer
401056|NCT01430351|Central nervous system|central nervous system
401057|NCT01430351|Glioblastoma Multiforme|glioblastoma multiforme
401058|NCT01430351|GBM|gbm
401059|NCT01430351|Post Radiation Therapy|post radiation therapy
401060|NCT01430351|Post-RT|post-rt
401061|NCT01430351|External beam radiotherapy|external beam radiotherapy
401062|NCT01430351|XRT|xrt
401063|NCT01430351|Supratentorial glioblastoma|supratentorial glioblastoma
401064|NCT01430351|Gliosarcoma|gliosarcoma
401065|NCT01430351|Grade IV astrocytoma|grade iv astrocytoma
401066|NCT01430351|Temozolomide|temozolomide
401067|NCT01430351|Temodar|temodar
401068|NCT01430351|Memantine|memantine
401069|NCT01430351|Namenda|namenda
401070|NCT01430351|Mefloquine|mefloquine
401071|NCT01430351|Apo-Mefloquine|apo-mefloquine
401072|NCT01430351|Lariam|lariam
401073|NCT01430351|Metformin|metformin
401074|NCT01430325|Hyperbaric oxygen|hyperbaric oxygen
401075|NCT01430312|dermal irritative potential|dermal irritative potential
401076|NCT01430286|Caregivers|caregivers
401077|NCT01430286|Alzheimer Disease|alzheimer disease
401078|NCT01430286|Psychological stress|psychological stress
401079|NCT01430286|Psychological adaptation|psychological adaptation
401080|NCT01430286|Self-efficacy|self-efficacy
401081|NCT01430286|Randomized controlled trial|randomized controlled trial
401275|NCT01429454|Psychosis|psychosis
401082|NCT01430273|Antiplatelet therapy|antiplatelet therapy
401083|NCT01430273|Surgery|surgery
401084|NCT01430273|Bleeding|bleeding
401085|NCT01430273|Platelet aggregation|platelet aggregation
401086|NCT01430260|efficacy|efficacy
401087|NCT01430260|ciclesonide|ciclesonide
401088|NCT01430260|levocetirizine|levocetirizine
401089|NCT01430260|allergic rhinitis|allergic rhinitis
401090|NCT01430247|amblyopia|amblyopia
401091|NCT01430247|amblyogenic factors|amblyogenic factors
401092|NCT01430247|screening|screening
401093|NCT01430247|preschool children|preschool children
401094|NCT01430247|visual acuity|visual acuity
401095|NCT01430247|prevalence|prevalence
401096|NCT01430234|Chronic pancreatitis|chronic pancreatitis
401097|NCT01430234|Exocrine insufficiency|exocrine insufficiency
401098|NCT01430234|Pancreatic enzyme replacement therapy|pancreatic enzyme replacement therapy
401099|NCT01430234|Self-administration|self-administration
401100|NCT01430221|prediabetes|prediabetes
401101|NCT01430221|severity of depressive symptoms|severity of depressive symptoms
401102|NCT01430221|mindfulness|mindfulness
401103|NCT01430221|personalized health planning|personalized health planning
401104|NCT01430221|cardiometabolic diseases prevention|cardiometabolic diseases prevention
401105|NCT01430208|endometrial pathology|endometrial pathology
401106|NCT01430195|vitiligo|vitiligo
401107|NCT01430195|depigmentation|depigmentation
401108|NCT01430195|phototherapy|phototherapy
401109|NCT01430195|non-segmental vitiligo|non-segmental vitiligo
401110|NCT01430182|Adult|adult
401111|NCT01430182|Female|female
401112|NCT01430182|Humans|humans
401113|NCT01430182|Intraoperative Care/methods|intraoperative care/methods
401114|NCT01430182|Male|male
401115|NCT01430182|Methadone/administration & dosage|methadone/administration & dosage
401116|NCT01430182|Analgesics/therapeutic use|analgesics/therapeutic use
401117|NCT01430182|Methadone/therapeutic use|methadone/therapeutic use
401118|NCT01430182|Morphine/therapeutic use|morphine/therapeutic use
401119|NCT01430182|Middle Aged|middle aged
401120|NCT01430182|Pain Measurement/drug effects|pain measurement/drug effects
401121|NCT01430182|Pain Measurement/methods|pain measurement/methods
401122|NCT01430182|Pain, Postoperative/prevention & control|pain, postoperative/prevention & control
401123|NCT01430182|Prospective Studies|prospective studies
401124|NCT01430182|Double-Blind Method|double-blind method
401125|NCT01430182|Tibial Fractures/surgery|tibial fractures/surgery
401126|NCT01430182|Young Adult|young adult
401127|NCT01430182|Orthopedics|orthopedics
401128|NCT01430169|Xiaflex|xiaflex
401129|NCT01430169|Xiapex|xiapex
401130|NCT01430169|Collagenase clostridium histolyticum|collagenase clostridium histolyticum
401131|NCT01430156|Renal Transplantation|renal transplantation
401132|NCT01430156|Ischemia-reperfusion injury|ischemia-reperfusion injury
401133|NCT01430156|Heme-oxygenase 1|heme-oxygenase 1
401134|NCT01430156|Heme arginate|heme arginate
401135|NCT01430143|Exercise|exercise
401136|NCT01430130|scar|scar
401137|NCT01430130|incision|incision
401138|NCT01430130|wound healing|wound healing
401139|NCT01430130|scarring|scarring
401140|NCT01430130|scar revision|scar revision
401141|NCT01430117|Immunotherapy|immunotherapy
401142|NCT01430117|Skin prick test|skin prick test
401143|NCT01430117|Standardization|standardization
401144|NCT01430117|Poa pratensis|poa pratensis
401145|NCT01430078|ASP015K|asp015k
401146|NCT01430078|Healthy subjects|healthy subjects
401147|NCT01430078|Pharmacokinetics of ASP015K|pharmacokinetics of asp015k
401148|NCT01430065|transplant|transplant
401149|NCT01430065|ASP015K|asp015k
401150|NCT01430065|tacrolimus|tacrolimus
401151|NCT01430065|Prograf|prograf
401152|NCT01430065|healthy volunteers|healthy volunteers
401153|NCT01430039|Crohn's disease|crohn's disease
401154|NCT01430039|ulcerative colitis|ulcerative colitis
401155|NCT01430039|Syndecan-1|syndecan-1
401156|NCT01430026|chronic sinusitis|chronic sinusitis
401157|NCT01430026|gentamicin nasal irrigation|gentamicin nasal irrigation
401158|NCT01429987|Chronic Idiopathic Constipation|chronic idiopathic constipation
401159|NCT01429987|Constipation|constipation
401160|NCT01429987|Sign and Symptoms: Digestive|sign and symptoms: digestive
401161|NCT01429974|amniotic fluid|amniotic fluid
401162|NCT01429974|post term pregnancies|post term pregnancies
401163|NCT01429948|Stroke, Ischemic|stroke, ischemic
401164|NCT01429948|Patent foramen ovale|patent foramen ovale
401165|NCT01429948|Magnetic resonance imaging|magnetic resonance imaging
401166|NCT01429948|Paradoxical embolism|paradoxical embolism
401167|NCT01429948|Transcranial Doppler|transcranial doppler
401168|NCT01429948|Silent cerebral infarct|silent cerebral infarct
401169|NCT01429935|dental pain model|dental pain model
401170|NCT01429935|Ginger powder|ginger powder
401171|NCT01429935|CRP|crp
401172|NCT01429909|Functional magnetic resonance imaging|functional magnetic resonance imaging
401173|NCT01429909|T2*|t2*
401174|NCT01429909|cortex and basal ganglia|cortex and basal ganglia
401175|NCT01429909|Parkinson's disease|parkinson's disease
401176|NCT01429896|peanut allergy|peanut allergy
401177|NCT01429896|food allergy|food allergy
401178|NCT01429896|thresholds|thresholds
401179|NCT01429896|anaphylaxis|anaphylaxis
401180|NCT01429896|food labelling|food labelling
401181|NCT01429896|food challenges|food challenges
401182|NCT01429896|peanut challenges|peanut challenges
401183|NCT01429857|Troponin concentration in heart failure|troponin concentration in heart failure
401184|NCT01429844|Calcineurin inhibitors|calcineurin inhibitors
401185|NCT01429844|Bronchiolitis obliterans|bronchiolitis obliterans
401186|NCT01429844|Lung transplantation|lung transplantation
401187|NCT01429844|Cyclosporine|cyclosporine
401188|NCT01429844|Tacrolimus|tacrolimus
401189|NCT01429844|Mycophenolate|mycophenolate
401190|NCT01429844|Steroids|steroids
401191|NCT01429844|Chronic rejection|chronic rejection
401192|NCT01429844|Acute rejection|acute rejection
401193|NCT01429844|Obliterative bronchiolitis|obliterative bronchiolitis
401194|NCT01429818|Endothelial dysfunction|endothelial dysfunction
401195|NCT01429818|Diabetes mellitus|diabetes mellitus
401196|NCT01429818|glimepiride|glimepiride
401197|NCT01429818|metformin|metformin
401198|NCT01429805|Hip arthroscopy|hip arthroscopy
401199|NCT01429779|General surgery|general surgery
401200|NCT01429766|Breath holding times|breath holding times
401201|NCT01429766|Phases of respiration|phases of respiration
401202|NCT01429766|Radiotherapy|radiotherapy
401203|NCT01429753|Cardiac resychronisation therapy|cardiac resychronisation therapy
401204|NCT01429753|Heart failure|heart failure
401205|NCT01429753|Imaging guided LV lead placement|imaging guided lv lead placement
401206|NCT01429740|PF 05180999|pf 05180999
401207|NCT01429740|safety|safety
401208|NCT01429740|pharmacokinetics|pharmacokinetics
401209|NCT01429727|Spontaneous coronary artery dissection|spontaneous coronary artery dissection
401210|NCT01429727|SCAD|scad
401211|NCT01429727|coronary artery disease|coronary artery disease
401212|NCT01429727|myocardial infarction|myocardial infarction
401213|NCT01429727|coronary dissection|coronary dissection
401214|NCT01429714|Elastic Compression Stockings|elastic compression stockings
401215|NCT01429714|Deep Venous Thrombosis|deep venous thrombosis
401216|NCT01429714|Post Thrombotic Syndrome|post thrombotic syndrome
401217|NCT01429701|Dermatitis|dermatitis
401218|NCT01429701|Dermatitis, Atopic|dermatitis, atopic
401219|NCT01429662|postmenopause|postmenopause
401220|NCT01429662|hypertension|hypertension
401221|NCT01429662|relaxation|relaxation
401222|NCT01429662|SBP 140-159 mmHg|sbp 140-159 mmhg
401223|NCT01429662|DBP 90-99 mmHg|dbp 90-99 mmhg
401224|NCT01429662|stage 1 or mild hypertension|stage 1 or mild hypertension
401225|NCT01429649|pure pulmonary ground glass opacity|pure pulmonary ground glass opacity
401226|NCT01429636|perimenopause|perimenopause
401227|NCT01429636|postmenopause|postmenopause
401228|NCT01429636|vasomotor symptoms|vasomotor symptoms
401229|NCT01429636|relaxation|relaxation
401230|NCT01429623|Mild Cognitive Impairment|mild cognitive impairment
401231|NCT01429623|Early Stage Dementia|early stage dementia
401232|NCT01429623|Conversion to Alzheimer's disease|conversion to alzheimer's disease
401233|NCT01429623|Memory Impairment|memory impairment
401234|NCT01429610|acute lymphoblastic leukemia|acute lymphoblastic leukemia
401235|NCT01429610|rituximab|rituximab
401236|NCT01429610|VPDL|vpdl
401237|NCT01429610|CD20|cd20
401238|NCT01429597|Cerebrovascular Accident|cerebrovascular accident
401239|NCT01429597|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
401240|NCT01429597|Fabry Disease|fabry disease
401241|NCT01429597|Fabry´s Disease|fabry´s disease
401242|NCT01429597|Anderson-Fabry Disease|anderson-fabry disease
401243|NCT01429597|CVA (Cerebrovascular Accident)|cva (cerebrovascular accident)
401244|NCT01429597|Stroke, Acute|stroke, acute
401245|NCT01429597|Cerebral Stroke|cerebral stroke
401246|NCT01429584|bupivacaine concentration|bupivacaine concentration
401247|NCT01429584|interscalene nerve block|interscalene nerve block
401248|NCT01429584|diaphragm function|diaphragm function
401249|NCT01429584|diaphragm weakness|diaphragm weakness
401250|NCT01429558|treatment resistant obsessive-compulsive disorder|treatment resistant obsessive-compulsive disorder
401251|NCT01429545|Tocolysis|tocolysis
401252|NCT01429545|atosiban|atosiban
401253|NCT01429545|nifedipine|nifedipine
401254|NCT01429545|combination|combination
401255|NCT01429532|Cataract|cataract
401256|NCT01429519|chronic wound|chronic wound
401257|NCT01429519|ulcerated wound|ulcerated wound
401258|NCT01429519|venous insufficiency|venous insufficiency
401259|NCT01429519|lymphatic insufficiency|lymphatic insufficiency
401260|NCT01429519|neuropathic wound|neuropathic wound
401261|NCT01429519|diabetic ulcer|diabetic ulcer
401262|NCT01429519|post- operative|post- operative
401263|NCT01429519|post-traumatic chronic wound|post-traumatic chronic wound
401264|NCT01429506|Sleeve gastrectomy|sleeve gastrectomy
401265|NCT01429506|Intensive medical management|intensive medical management
401266|NCT01429480|Analgesia, postoperative|analgesia, postoperative
401267|NCT01429467|Glucose Variability|glucose variability
401268|NCT01429467|Continuous Glucose Monitoring|continuous glucose monitoring
401269|NCT01429467|Hypoxia-inducible Factor (HIF)|hypoxia-inducible factor (hif)
401270|NCT01429467|Vascular Endothelial Growth Factor (VEGF)|vascular endothelial growth factor (vegf)
401271|NCT01429467|Erythropoietin|erythropoietin
401272|NCT01429467|Cortisol|cortisol
401273|NCT01429454|Prodromal|prodromal
401274|NCT01429454|Schizophrenia|schizophrenia
401276|NCT01429454|Omega|omega
401277|NCT01429428|Cellulitis|cellulitis
401278|NCT01429428|Skin ultra-sound images|skin ultra-sound images
401279|NCT01429428|Treatment|treatment
401280|NCT01429428|Infra-red light|infra-red light
401281|NCT01429415|pediatric|pediatric
401282|NCT01429415|Acute Asthma|acute asthma
401283|NCT01429415|Inhaled Magnesium|inhaled magnesium
401284|NCT01429402|Botulinum toxin A.|botulinum toxin a.
401285|NCT01429402|Cleft lip scar|cleft lip scar
401286|NCT01429389|Down syndrome|down syndrome
401287|NCT01429389|fetal aneuploidy|fetal aneuploidy
401288|NCT01429389|trisomy|trisomy
401289|NCT01429389|noninvasive screening test|noninvasive screening test
401290|NCT01429376|Chronic heart failure|chronic heart failure
401291|NCT01429376|Pulmonary function abnormalities/impairment|pulmonary function abnormalities/impairment
401292|NCT01429376|Restriction|restriction
401293|NCT01429376|Airway obstruction|airway obstruction
401294|NCT01429376|Diffusion impairment|diffusion impairment
401295|NCT01429376|Pulmonary function tests|pulmonary function tests
401296|NCT01429376|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
401297|NCT01429376|Prevalence|prevalence
401298|NCT01429376|Overdiagnosis|overdiagnosis
401299|NCT01429376|Underdiagnosis|underdiagnosis
401300|NCT01429376|Systemic inflammation|systemic inflammation
401301|NCT01429376|Diagnostic Errors|diagnostic errors
401302|NCT01429363|contained herniated lumbar discs|contained herniated lumbar discs
401303|NCT01429363|TDD|tdd
401304|NCT01429363|Case series|case series
401305|NCT01429363|RCT|rct
401306|NCT01429350|ischemic stroke|ischemic stroke
401307|NCT01429350|acute intervention|acute intervention
401308|NCT01429350|thrombolysis|thrombolysis
401309|NCT01429350|rtPA|rtpa
401310|NCT01429350|internal carotid artery|internal carotid artery
401311|NCT01429350|middle cerebral artery|middle cerebral artery
401312|NCT01429350|mechanical thrombectomy|mechanical thrombectomy
401313|NCT01429350|Penumbra System|penumbra system
401314|NCT01429350|clot length|clot length
401315|NCT01429350|mRS|mrs
401316|NCT01429350|NIHSS|nihss
401317|NCT01429337|Pharmacokinetics|pharmacokinetics
401318|NCT01429337|Hepatic impaired patients|hepatic impaired patients
401319|NCT01429337|Healthy volunteers|healthy volunteers
401320|NCT01429337|Varying degrees of hepatic impairment|varying degrees of hepatic impairment
401321|NCT01429324|Near infrared spectroscopy|near infrared spectroscopy
401322|NCT01429324|neuromonitoring|neuromonitoring
401323|NCT01429324|aortic arch surgery|aortic arch surgery
401324|NCT01429311|Atopic Dermatitis|atopic dermatitis
401325|NCT01429311|Eczema herpeticum|eczema herpeticum
401326|NCT01429311|Interferon gamma|interferon gamma
401327|NCT01429311|IFNγ|ifnγ
401328|NCT01429298|Acute|acute
401329|NCT01429298|Pain|pain
401330|NCT01429298|Emergency Department|emergency department
401331|NCT01429298|Hydromorphone|hydromorphone
401332|NCT01429298|Protocol|protocol
401333|NCT01429285|Pain|pain
401334|NCT01429285|Hydromorphone|hydromorphone
401335|NCT01429285|Acute|acute
401336|NCT01429285|Emergency Department|emergency department
401337|NCT01429272|Bipolar Disorder|bipolar disorder
401338|NCT01429272|Minocycline|minocycline
401339|NCT01429259|Cystic Fibrosis|cystic fibrosis
401340|NCT01429259|Acute Pulmonary Exacerbations|acute pulmonary exacerbations
401341|NCT01429259|Pseudomonas aeruginosa|pseudomonas aeruginosa
401342|NCT01429246|Hypertension|hypertension
401343|NCT01429246|Diet Therapy|diet therapy
401344|NCT01429246|Sodium Chloride, Dietary|sodium chloride, dietary
401345|NCT01429246|Tibet|tibet
401346|NCT01429246|Aged|aged
401347|NCT01429233|Observational|observational
401348|NCT01429233|Colombia|colombia
401349|NCT01429220|deep brain stimulation|deep brain stimulation
401350|NCT01429220|monopolar review|monopolar review
401351|NCT01429220|motion sensors|motion sensors
401352|NCT01429220|tremor|tremor
401353|NCT01429220|bradykinesia|bradykinesia
401354|NCT01429207|levodopa|levodopa
401355|NCT01429207|tremor|tremor
401356|NCT01429207|bradykinesia|bradykinesia
401357|NCT01429207|motion sensors|motion sensors
401358|NCT01429194|Weight Loss|weight loss
401359|NCT01429194|Trans-oral Endoscopic Procedure|trans-oral endoscopic procedure
401360|NCT01429194|Gastric Plication|gastric plication
401361|NCT01429181|Peripheral Neuropathic Pain|peripheral neuropathic pain
401362|NCT01429155|End stage liver disease|end stage liver disease
401363|NCT01429155|Living donor liver transplantation|living donor liver transplantation
401364|NCT01429155|Hepatitis C|hepatitis c
401365|NCT01429155|Interleukin 28B|interleukin 28b
401366|NCT01429129|Smoking|smoking
401367|NCT01429129|Nicotine|nicotine
401368|NCT01429129|Nicotine Replacement Therapy|nicotine replacement therapy
401369|NCT01429129|Nicotine Patch|nicotine patch
401370|NCT01429129|Nicoderm|nicoderm
401371|NCT01429129|Mass Distribution|mass distribution
401372|NCT01429129|Tobacco Control|tobacco control
401373|NCT01429129|Randomized Controlled Trial|randomized controlled trial
401374|NCT01429116|Blindness|blindness
401375|NCT01429116|Eye Diseases|eye diseases
401376|NCT01429116|Nap Disorders|nap disorders
401474|NCT01428830|catheter|catheter
401377|NCT01429116|Circadian Rhythm Disorders|circadian rhythm disorders
401378|NCT01429116|Sleep Disorders|sleep disorders
401379|NCT01429116|Circadian Rhythm Sleep Disorders|circadian rhythm sleep disorders
401380|NCT01429116|Dyssomnias|dyssomnias
401381|NCT01429116|Nervous System Diseases|nervous system diseases
401382|NCT01429090|Pharmacokinetics|pharmacokinetics
401383|NCT01429090|Accommodation, Ocular|accommodation, ocular
401384|NCT01429090|Reflex, Pupillary|reflex, pupillary
401385|NCT01429090|Salivation|salivation
401386|NCT01429077|Levodopa|levodopa
401387|NCT01429077|Ischemic Stroke|ischemic stroke
401388|NCT01429077|Aphasia|aphasia
401389|NCT01429077|Speech Rehabilitation|speech rehabilitation
401390|NCT01429051|Break through pain|break through pain
401391|NCT01429051|BTP|btp
401392|NCT01429051|Cancer|cancer
401393|NCT01429051|Intranasal Fentanyl Spray|intranasal fentanyl spray
401394|NCT01429051|INFS|infs
401395|NCT01429051|cancer patients|cancer patients
401396|NCT01429038|end-stage|end-stage
401397|NCT01429038|liver diseases|liver diseases
401398|NCT01429038|cirrhosis|cirrhosis
401399|NCT01429038|cancer|cancer
401400|NCT01429038|fulminant hepatic failure|fulminant hepatic failure
401401|NCT01429038|metabolic hepatic diseases|metabolic hepatic diseases
401402|NCT01429038|congenital hepatic diseases|congenital hepatic diseases
401403|NCT01429038|renal diseases|renal diseases
401404|NCT01429025|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
401405|NCT01429025|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
401406|NCT01429025|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
401407|NCT01429025|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
401408|NCT01429025|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
401409|NCT01429025|Waldenström macroglobulinemia|waldenström macroglobulinemia
401410|NCT01429025|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
401411|NCT01429025|splenic marginal zone lymphoma|splenic marginal zone lymphoma
401412|NCT01429012|bone|bone
401413|NCT01429012|nonunion fracture|nonunion fracture
401414|NCT01429012|atrophic nonunion fracture|atrophic nonunion fracture
401415|NCT01429012|callus|callus
401416|NCT01429012|mesenchymal stem cells|mesenchymal stem cells
401417|NCT01429012|cell therapy|cell therapy
401418|NCT01429012|autologous|autologous
401419|NCT01429012|indium|indium
401420|NCT01429012|Pet-scan|pet-scan
401421|NCT01428999|probiotics|probiotics
401422|NCT01428999|gastrointestinal function|gastrointestinal function
401423|NCT01428999|intestinal bacteria flora|intestinal bacteria flora
401424|NCT01428986|maraviroc|maraviroc
401425|NCT01428986|osteoclasts|osteoclasts
401426|NCT01428986|Receptors, CCR5|receptors, ccr5
401427|NCT01428986|Chemokine CCL5|chemokine ccl5
401428|NCT01428973|Allogeneic hematopoeitic cell transplantation|allogeneic hematopoeitic cell transplantation
401429|NCT01428973|Graft-Versus-Host Disease|graft-versus-host disease
401430|NCT01428973|Prophylaxis|prophylaxis
401431|NCT01428973|Reduced-intensity conditioning|reduced-intensity conditioning
401432|NCT01428973|Immunosuppressive regimen|immunosuppressive regimen
401433|NCT01428973|HLA-matched donor|hla-matched donor
401434|NCT01428973|Progression free survival|progression free survival
401435|NCT01428973|Overall survival|overall survival
401436|NCT01428960|Palm mid fraction|palm mid fraction
401437|NCT01428960|Shea butter|shea butter
401438|NCT01428960|sn-1, sn-3 fatty acids|sn-1, sn-3 fatty acids
401439|NCT01428960|Cholesterol|cholesterol
401440|NCT01428960|Postprandial lipemia,|postprandial lipemia,
401441|NCT01428960|Inflammatory markers|inflammatory markers
401442|NCT01428960|Satiety|satiety
401443|NCT01428960|Gut hormone|gut hormone
401444|NCT01428960|Insulin|insulin
401445|NCT01428921|Long-term efficacy|long-term efficacy
401446|NCT01428921|Education programme|education programme
401447|NCT01428921|Adherence|adherence
401448|NCT01428921|OSA|osa
401449|NCT01428921|CPAP|cpap
401450|NCT01428908|immunogenicity|immunogenicity
401451|NCT01428908|safety|safety
401452|NCT01428908|group A, C polysaccharide meningitis|group a, c polysaccharide meningitis
401453|NCT01428908|type b haemophilus Influenza|type b haemophilus influenza
401454|NCT01428908|conjugate vaccine|conjugate vaccine
401455|NCT01428895|Bone Metastases|bone metastases
401456|NCT01428895|Femoral Metastases|femoral metastases
401457|NCT01428882|Propofol|propofol
401458|NCT01428882|Midazolam|midazolam
401459|NCT01428882|Moderate sedation|moderate sedation
401460|NCT01428882|Deep sedation|deep sedation
401461|NCT01428882|Colonoscopy|colonoscopy
401462|NCT01428869|Statins|statins
401463|NCT01428869|acetylsalicylic acid|acetylsalicylic acid
401464|NCT01428869|dutasteride|dutasteride
401465|NCT01428869|Prostate Cancer|prostate cancer
401466|NCT01428869|Lower urinary tract symptoms|lower urinary tract symptoms
401467|NCT01428869|prevention|prevention
401468|NCT01428869|drug interactions|drug interactions
401469|NCT01428843|Inflammatory Bowel Disease|inflammatory bowel disease
401470|NCT01428843|Anemia|anemia
401471|NCT01428843|Anti-TNF alpha theray|anti-tnf alpha theray
401472|NCT01428843|Ferrisat perfusion|ferrisat perfusion
401473|NCT01428830|fistula|fistula
401475|NCT01428830|surgery|surgery
401476|NCT01428830|obstetrics|obstetrics
401477|NCT01428830|gynecology|gynecology
401478|NCT01428830|urology|urology
401479|NCT01428817|pregnancy|pregnancy
401480|NCT01428817|postpartum hemorrhage|postpartum hemorrhage
401481|NCT01428817|Cesarean delivery|cesarean delivery
401482|NCT01428817|carbetocin|carbetocin
401483|NCT01428804|Resistant Major Depression|resistant major depression
401484|NCT01428804|Mood disorders|mood disorders
401485|NCT01428804|tDCS|tdcs
401486|NCT01428791|Geriatrics|geriatrics
401487|NCT01428791|Older adults|older adults
401488|NCT01428791|Health Disparities|health disparities
401489|NCT01428791|Health Services for the Aged|health services for the aged
401490|NCT01428791|Interdisciplinary Health Team|interdisciplinary health team
401491|NCT01428791|Depressive symptoms|depressive symptoms
401492|NCT01428791|Metabolic Syndrome X|metabolic syndrome x
401493|NCT01428791|Overweight|overweight
401494|NCT01428791|Obesity|obesity
401495|NCT01428791|Hypertension|hypertension
401496|NCT01428791|Hyperglycemia|hyperglycemia
401497|NCT01428791|Dyslipidemias|dyslipidemias
401498|NCT01428778|Marathon running|marathon running
401499|NCT01428778|Brain MRI|brain mri
401500|NCT01428778|ECG recording|ecg recording
401501|NCT01428778|Blood tests|blood tests
401502|NCT01428752|colonoscopy|colonoscopy
401503|NCT01428752|colorectal neoplasms|colorectal neoplasms
401504|NCT01428752|screening|screening
401505|NCT01428752|family history|family history
401506|NCT01428739|cancer|cancer
401507|NCT01428739|MRS|mrs
401508|NCT01428739|Treatment response|treatment response
401509|NCT01428726|NT-KO-003|nt-ko-003
401510|NCT01428726|RRMS|rrms
401511|NCT01428726|efficacy|efficacy
401512|NCT01428726|safety|safety
401513|NCT01428726|Phase IIa|phase iia
401514|NCT01428713|menorrhagia|menorrhagia
401515|NCT01428713|oral contraceptives|oral contraceptives
401516|NCT01428713|oral tranexamic acid|oral tranexamic acid
401517|NCT01428687|Weight loss|weight loss
401518|NCT01428687|Sleep duration|sleep duration
401519|NCT01428674|Interpersonal mindful compassion|interpersonal mindful compassion
401520|NCT01428674|Loving kindness meditation|loving kindness meditation
401521|NCT01428674|Autonomic Nervous System|autonomic nervous system
401522|NCT01428674|Heart rate variability|heart rate variability
401523|NCT01428674|Respiratory rate|respiratory rate
401524|NCT01428674|Relaxation|relaxation
401525|NCT01428661|tasimelteon|tasimelteon
401526|NCT01428661|Major Depressive Disorder|major depressive disorder
401527|NCT01428661|MDD|mdd
401528|NCT01428661|depression|depression
401529|NCT01428648|Parkinson|parkinson
401530|NCT01428648|ballroom dancing|ballroom dancing
401531|NCT01428635|Leukemia|leukemia
401532|NCT01428635|Thrombocytopenia|thrombocytopenia
401533|NCT01428635|Tyrosine kinase therapy|tyrosine kinase therapy
401534|NCT01428635|TKI|tki
401535|NCT01428635|Chronic myeloid leukemia|chronic myeloid leukemia
401536|NCT01428635|CML|cml
401537|NCT01428635|Platelet count|platelet count
401538|NCT01428635|Clonal evolution|clonal evolution
401539|NCT01428635|Eltrombopag|eltrombopag
401540|NCT01428635|Promacta|promacta
401541|NCT01428635|Myelofibrosis|myelofibrosis
401542|NCT01428635|MF|mf
401543|NCT01428609|Amalgam|amalgam
401544|NCT01428609|Mercury|mercury
401545|NCT01428609|Endodontics|endodontics
401546|NCT01428609|Apicoectomy|apicoectomy
401547|NCT01428596|HIV-1|hiv-1
401548|NCT01428596|therapeutic vaccine|therapeutic vaccine
401549|NCT01428596|immunotherapy|immunotherapy
401550|NCT01428596|AIDS|aids
401551|NCT01428583|Chronic noncancer pain|chronic noncancer pain
401552|NCT01428583|oxycodone|oxycodone
401553|NCT01428583|naltrexone|naltrexone
401554|NCT01428570|sleep apnea, obstructive|sleep apnea, obstructive
401555|NCT01428570|intubation|intubation
401556|NCT01428557|Heart Failure|heart failure
401557|NCT01428557|Epidemiology|epidemiology
401558|NCT01428557|Evidence-Based Practice|evidence-based practice
401559|NCT01428492|AKT Inhibitor|akt inhibitor
401560|NCT01428492|hematologic malignancies|hematologic malignancies
401561|NCT01428492|GSK2110183|gsk2110183
401562|NCT01428492|bortezomib|bortezomib
401563|NCT01428492|multiple myeloma|multiple myeloma
401564|NCT01428492|dexamethasone|dexamethasone
401565|NCT01428453|Alzheimer's disease|alzheimer's disease
401566|NCT01428427|Gemcitabine|gemcitabine
401567|NCT01428427|MEK inhibitor|mek inhibitor
401568|NCT01428427|GSK1120212|gsk1120212
401569|NCT01428414|HER2|her2
401570|NCT01428414|Breast cancer|breast cancer
401571|NCT01428414|neoadjuvant chemotherapy|neoadjuvant chemotherapy
401572|NCT01428414|efficacy|efficacy
401573|NCT01428414|safety|safety
401574|NCT01428401|Complementary therapies|complementary therapies
401575|NCT01428401|Acute hemorrhagic stroke|acute hemorrhagic stroke
401576|NCT01428388|macular edema|macular edema
401577|NCT01428388|vein occlusion|vein occlusion
401578|NCT01428388|bevacizumab|bevacizumab
401579|NCT01428388|ranibizumab|ranibizumab
401580|NCT01428388|vascular endothelial growth factor|vascular endothelial growth factor
401581|NCT01428375|intravenous paracetamol|intravenous paracetamol
401582|NCT01428375|intrapartum analgesia|intrapartum analgesia
401583|NCT01428375|labor pain|labor pain
401584|NCT01428375|intrapartum pains|intrapartum pains
401585|NCT01428362|donepezil|donepezil
401586|NCT01428362|VI-1121|vi-1121
401587|NCT01428349|Incarcerated offenders|incarcerated offenders
401588|NCT01428349|emotionally reactive|emotionally reactive
401589|NCT01428349|emotionally stable|emotionally stable
401590|NCT01428349|psychopathy|psychopathy
401591|NCT01428310|dietary supplement|dietary supplement
401592|NCT01428310|nutraceutical|nutraceutical
401593|NCT01428297|Atopic dermatitis|atopic dermatitis
401594|NCT01428297|Eczema|eczema
401595|NCT01428297|Skin Diseases, Eczematous|skin diseases, eczematous
401596|NCT01428297|Netherton syndrome|netherton syndrome
401597|NCT01428297|Skin Diseases, Genetic|skin diseases, genetic
401598|NCT01428297|BPR277|bpr277
401599|NCT01428284|Healthy Volunteers|healthy volunteers
401600|NCT01428284|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
401601|NCT01428284|Pharmacokinetic|pharmacokinetic
401602|NCT01428284|Probenecid|probenecid
401603|NCT01428258|Diet therapy|diet therapy
401604|NCT01428258|Low phenylalanine diet|low phenylalanine diet
401605|NCT01428258|Attention|attention
401606|NCT01428258|Executive function|executive function
401607|NCT01428232|Breastfeeding|breastfeeding
401608|NCT01428232|Baby Friendly Hospital Initiative|baby friendly hospital initiative
401609|NCT01428232|Well-child clinics|well-child clinics
401610|NCT01428219|Prostate|prostate
401611|NCT01428219|Cancer|cancer
401612|NCT01428219|Metastatic|metastatic
401613|NCT01428206|palliative care|palliative care
401614|NCT01428206|nursing homes|nursing homes
401615|NCT01428206|Liverpool care pathway|liverpool care pathway
401616|NCT01428193|PCOS|pcos
401617|NCT01428193|hyperandrogenemia|hyperandrogenemia
401618|NCT01428180|preterm neonates|preterm neonates
401619|NCT01428180|hemodynamically relevant patent ductus arteriosus|hemodynamically relevant patent ductus arteriosus
401620|NCT01428167|Thyroid cancer|thyroid cancer
401621|NCT01428167|Hashimotos thyroiditis|hashimotos thyroiditis
401622|NCT01428167|Thyroidectomy|thyroidectomy
401623|NCT01428167|Anti-inflammatory factors|anti-inflammatory factors
401624|NCT01428154|paediatric|paediatric
401625|NCT01428154|dialysis|dialysis
401626|NCT01428154|CKD|ckd
401627|NCT01428154|pediatric|pediatric
401628|NCT01428141|Cancer|cancer
401629|NCT01428141|Gastrointestinal Cancer|gastrointestinal cancer
401630|NCT01428115|monoclonal|monoclonal
401631|NCT01428115|anxiety|anxiety
401632|NCT01428115|antibodies|antibodies
401633|NCT01428115|adalimumab|adalimumab
401634|NCT01428115|severe crohn's disease|severe crohn's disease
401635|NCT01428115|quality of life|quality of life
401636|NCT01428115|biological products|biological products
401637|NCT01428102|Thromboelastography|thromboelastography
401638|NCT01428102|TEG|teg
401639|NCT01428102|Coagulation|coagulation
401640|NCT01428102|RapidTEG|rapidteg
401641|NCT01428102|Kaolin|kaolin
401642|NCT01428089|hyperandrogenemia|hyperandrogenemia
401643|NCT01428076|Varicose Veins|varicose veins
401644|NCT01428076|SFJ Reflux|sfj reflux
401645|NCT01428050|whipple|whipple
401646|NCT01428050|hypertonic saline|hypertonic saline
401647|NCT01428050|pancreaticoduodenectomy|pancreaticoduodenectomy
401648|NCT01428050|fluid restriction|fluid restriction
401649|NCT01428050|resuscitation strategy|resuscitation strategy
401650|NCT01428037|Vaginal Misoprostol|vaginal misoprostol
401651|NCT01428037|Cervical Ripening|cervical ripening
401652|NCT01428037|Labor Induced|labor induced
401653|NCT01428024|efficacy|efficacy
401654|NCT01428024|safety|safety
401655|NCT01428024|Restylane|restylane
401656|NCT01428024|Lip products|lip products
401657|NCT01428024|injection techniques|injection techniques
401658|NCT01428011|Hypertension|hypertension
401659|NCT01428011|Patient-Provider Communication|patient-provider communication
401660|NCT01428011|Medication Adherence|medication adherence
401661|NCT01428011|Race Concordance|race concordance
401662|NCT01427998|diabetes|diabetes
401663|NCT01427998|blood glucose|blood glucose
401664|NCT01427998|olive leaf extract|olive leaf extract
401665|NCT01427946|KRAS mutant|kras mutant
401666|NCT01427946|Non-Small Cell Lung Cancer|non-small cell lung cancer
401667|NCT01427946|NSCLC|nsclc
401668|NCT01427933|Breast Cancer|breast cancer
401669|NCT01427907|Serum phosphorus levels|serum phosphorus levels
401670|NCT01427894|Prematurity|prematurity
401671|NCT01427894|Music|music
401672|NCT01427894|Kangaroo Care|kangaroo care
401673|NCT01427894|Bonding Mother infant|bonding mother infant
401674|NCT01427868|LB80380|lb80380
401675|NCT01427868|bioequivalence|bioequivalence
401676|NCT01427855|Dietary Protein|dietary protein
401677|NCT01427855|Red Meat|red meat
401678|NCT01427855|White Meat|white meat
401679|NCT01427855|Vegetable Protein|vegetable protein
401680|NCT01427855|Saturated Fat|saturated fat
401681|NCT01427855|LDL Subclasses|ldl subclasses
401682|NCT01427855|Cholesterol|cholesterol
401683|NCT01427855|Atherogenic Dyslipidemia|atherogenic dyslipidemia
401684|NCT01427842|Trough concentration|trough concentration
401685|NCT01427842|Vancomycin|vancomycin
401686|NCT01427842|Pharmacokinetics|pharmacokinetics
401687|NCT01427829|pilot|pilot
401688|NCT01427829|randomized controlled trial|randomized controlled trial
401689|NCT01427829|RCT|rct
401690|NCT01427829|computer|computer
401691|NCT01427829|screening|screening
401692|NCT01427829|community heath center|community heath center
401693|NCT01427829|psychosocial|psychosocial
401694|NCT01427829|immigrant|immigrant
401695|NCT01427816|Dry eye syndromes|dry eye syndromes
401696|NCT01427816|Corneal diseases|corneal diseases
401697|NCT01427816|Conjunctival diseases|conjunctival diseases
401698|NCT01427803|Actual Use Trial|actual use trial
401699|NCT01427764|Dentin sensitivity|dentin sensitivity
401700|NCT01427764|Dental scaling|dental scaling
401701|NCT01427764|Ultrasonic|ultrasonic
401702|NCT01427764|manual and ultrasonic instrumentation|manual and ultrasonic instrumentation
401703|NCT01427725|Digestive System Diseases|digestive system diseases
401704|NCT01427725|Therapeutic Uses|therapeutic uses
401705|NCT01427725|Pancreatectomy|pancreatectomy
401706|NCT01427725|Gastrointestinal Agents|gastrointestinal agents
401707|NCT01427725|Pancreatic Diseases|pancreatic diseases
401708|NCT01427725|Pancrelipase|pancrelipase
401709|NCT01427725|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
401710|NCT01427712|Digestive System Diseases|digestive system diseases
401711|NCT01427712|Cystic Fibrosis|cystic fibrosis
401712|NCT01427712|Therapeutic Uses|therapeutic uses
401713|NCT01427712|Gastrointestinal Agents|gastrointestinal agents
401714|NCT01427712|Pancreatic Diseases|pancreatic diseases
401715|NCT01427712|Pancrelipase|pancrelipase
401716|NCT01427712|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
401717|NCT01427673|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
401718|NCT01427673|Obstructive Sleep Apnea|obstructive sleep apnea
401719|NCT01427673|Overlap Syndrome|overlap syndrome
401720|NCT01427673|COPD|copd
401721|NCT01427673|OSA|osa
401722|NCT01427660|Diabetes|diabetes
401723|NCT01427660|Decision Aid|decision aid
401724|NCT01427660|AntiHyperglycemic Medication|antihyperglycemic medication
401725|NCT01427660|Tailored health information|tailored health information
401726|NCT01427660|Medication information|medication information
401727|NCT01427647|Laparoscopy|laparoscopy
401728|NCT01427647|Anesthesia, Epidural|anesthesia, epidural
401729|NCT01427634|Heart Failure|heart failure
401730|NCT01427634|Ventricular Assist Device|ventricular assist device
401731|NCT01427634|Palliative Care|palliative care
401732|NCT01427595|hyperandrogenemia|hyperandrogenemia
401733|NCT01427569|Diabetes|diabetes
401734|NCT01427569|Chronic wound|chronic wound
401735|NCT01427556|Food intake|food intake
401736|NCT01427556|Breakfast eating|breakfast eating
401737|NCT01427543|behavioral intervention|behavioral intervention
401738|NCT01427543|HIV risk reduction|hiv risk reduction
401739|NCT01427543|African Americans|african americans
401740|NCT01427543|incarceration|incarceration
401741|NCT01427543|bisexual|bisexual
401742|NCT01427543|reduce risk behaviors|reduce risk behaviors
401743|NCT01427530|brain activity|brain activity
401744|NCT01427530|implanted with DBS electrodes|implanted with dbs electrodes
401745|NCT01427517|Parkinson's disease|parkinson's disease
401746|NCT01427517|Gaucher's disease|gaucher's disease
401747|NCT01427517|Control|control
401748|NCT01427504|HCV|hcv
401749|NCT01427504|HIV|hiv
401750|NCT01427478|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
401751|NCT01427478|Post operative radio-chemotherapy|post operative radio-chemotherapy
401752|NCT01427478|Randomisation|randomisation
401753|NCT01427478|Maintenance treatment|maintenance treatment
401754|NCT01427478|Afatinib|afatinib
401755|NCT01427465|Brief|brief
401756|NCT01427465|Image|image
401757|NCT01427465|Intervention|intervention
401758|NCT01427465|Adolescents|adolescents
401759|NCT01427465|School|school
401760|NCT01427452|Live Donor|live donor
401761|NCT01427452|Kidney Donation|kidney donation
401762|NCT01427452|Living Donation|living donation
401763|NCT01427452|Live Donor Kidney Transplantation|live donor kidney transplantation
401764|NCT01427452|Donor Nephrectomy|donor nephrectomy
401765|NCT01427439|MDD|mdd
401766|NCT01427439|Non-interventional study|non-interventional study
401767|NCT01427439|Observational study|observational study
401768|NCT01427426|Health|health
401769|NCT01427426|Vitality|vitality
401770|NCT01427426|Well-being|well-being
401771|NCT01427426|Nutritional Supplement|nutritional supplement
401772|NCT01427426|Phytonutrient|phytonutrient
401773|NCT01427426|Greens|greens
401774|NCT01427413|blastocoele fluid|blastocoele fluid
401775|NCT01427413|mass spectrometry|mass spectrometry
401776|NCT01427413|metabolomics|metabolomics
401777|NCT01427400|Breast expander|breast expander
401778|NCT01427400|Breast reconstruction|breast reconstruction
401779|NCT01427400|Implants|implants
401780|NCT01427400|Botox|botox
401781|NCT01427387|ASP0456|asp0456
401782|NCT01427387|Pharmacokinetics|pharmacokinetics
401783|NCT01427387|safety|safety
401784|NCT01427387|tolerability|tolerability
401785|NCT01427387|food effect|food effect
401786|NCT01427374|hemodialysis|hemodialysis
401787|NCT01427374|peritoneal dialysis|peritoneal dialysis
401788|NCT01427374|chronic kidney disease|chronic kidney disease
401789|NCT01427374|cardiovascular risk factors|cardiovascular risk factors
401790|NCT01427374|cardiac imaging|cardiac imaging
401791|NCT01427374|dialysis|dialysis
401792|NCT01427374|parathyroid hormone|parathyroid hormone
401793|NCT01427374|vitamin D|vitamin d
401794|NCT01427374|coronary artery calcification|coronary artery calcification
401795|NCT01427374|left ventricular hypertrophy|left ventricular hypertrophy
401796|NCT01427374|genetic predisposition|genetic predisposition
401797|NCT01427374|biochemical markers|biochemical markers
401798|NCT01427374|infection|infection
401799|NCT01427374|pharmacogenomics|pharmacogenomics
401800|NCT01427335|OHSS|ohss
401801|NCT01427335|ICSI|icsi
401802|NCT01427335|calcium injection|calcium injection
401803|NCT01427322|lapatinib|lapatinib
401804|NCT01427322|radiation therapy|radiation therapy
401805|NCT01427322|metastases|metastases
401806|NCT01427309|Influenza|influenza
401807|NCT01427309|Trivalent Inactivated Influenza Vaccine|trivalent inactivated influenza vaccine
401808|NCT01427309|High-Dose Trivalent Inactivated Influenza Vaccine|high-dose trivalent inactivated influenza vaccine
401809|NCT01427309|Fluzone® High-Dose|fluzone® high-dose
401810|NCT01427309|Influenza vaccines|influenza vaccines
401811|NCT01427296|Colon Cleansing|colon cleansing
401812|NCT01427296|Bowel Prep|bowel prep
401813|NCT01427296|Colonoscopy|colonoscopy
401814|NCT01427283|Low back pain|low back pain
401815|NCT01427283|Chronic pain|chronic pain
401816|NCT01427283|Opioid|opioid
401817|NCT01427283|Constipation|constipation
401818|NCT01427283|Moderate to severe|moderate to severe
401819|NCT01427270|Low back pain|low back pain
401820|NCT01427270|Chronic pain|chronic pain
401821|NCT01427270|Opioid|opioid
401822|NCT01427270|Constipation|constipation
401823|NCT01427270|Moderate to severe chronic low back pain|moderate to severe chronic low back pain
401824|NCT01427244|HER2+|her2+
401825|NCT01427244|Histologic confirmation|histologic confirmation
401826|NCT01427244|measurable disease|measurable disease
401827|NCT01427244|HER2 positive|her2 positive
401828|NCT01427244|HER2 overexpression|her2 overexpression
401829|NCT01427244|persistent vulvar Paget's disease|persistent vulvar paget's disease
401830|NCT01427244|recurrent vulvar Paget's disease|recurrent vulvar paget's disease
401831|NCT01427231|Cognitive performance|cognitive performance
401832|NCT01427231|Attention|attention
401833|NCT01427231|Memory|memory
401834|NCT01427231|Glucose|glucose
401835|NCT01427231|Sacharose|sacharose
401836|NCT01427231|Elderly|elderly
401837|NCT01427231|Memory complaints|memory complaints
401838|NCT01427218|pharmacist|pharmacist
401839|NCT01427218|medication therapy management|medication therapy management
401840|NCT01427218|evidence based medicine|evidence based medicine
401841|NCT01427205|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
401842|NCT01427205|HNSCC|hnscc
401843|NCT01427205|recurrent|recurrent
401844|NCT01427205|metastatic|metastatic
401845|NCT01427205|oral cavity|oral cavity
401846|NCT01427205|Cetuximab|cetuximab
401847|NCT01427205|C225|c225
401848|NCT01427205|Erbitux|erbitux
401849|NCT01427205|IMC-C225|imc-c225
401850|NCT01427205|OSI-906|osi-906
401851|NCT01427205|Placebo|placebo
401852|NCT01427205|sugar pill|sugar pill
401853|NCT01427205|oropharynx|oropharynx
401854|NCT01427205|larynx|larynx
401855|NCT01427205|hypopharynx|hypopharynx
401856|NCT01427192|Breathing-Related Sleep Disorder|breathing-related sleep disorder
401857|NCT01427192|Pulmonary Hypertension|pulmonary hypertension
401858|NCT01427179|Spontaneous coronary artery dissection|spontaneous coronary artery dissection
401859|NCT01427179|SCAD|scad
401860|NCT01427166|Breast Cancer|breast cancer
401861|NCT01427166|Cording|cording
401862|NCT01427166|Lymphedema|lymphedema
401863|NCT01427166|upper extremity cording|upper extremity cording
401864|NCT01427166|following treatment|following treatment
401865|NCT01427153|knee osteoarthritis|knee osteoarthritis
401866|NCT01427153|physical therapy|physical therapy
401867|NCT01427153|corticosteroid|corticosteroid
401868|NCT01427153|treatment|treatment
401869|NCT01427140|Liver fat|liver fat
401870|NCT01427140|Polyunsaturated fatty acids (PUFA)|polyunsaturated fatty acids (pufa)
401871|NCT01427140|Saturated fatty acids (SFA)|saturated fatty acids (sfa)
401872|NCT01427140|Weight gain|weight gain
401873|NCT01427140|Overfeed|overfeed
401874|NCT01427140|Dietary fatty acids|dietary fatty acids
401875|NCT01427140|Palm oil|palm oil
401876|NCT01427140|Sunflower oil|sunflower oil
401877|NCT01427114|extranodal marginal zone lymphoma|extranodal marginal zone lymphoma
401878|NCT01427114|ocular adnexal lymphoma|ocular adnexal lymphoma
401879|NCT01427114|mucosa associated lymphoid tissue|mucosa associated lymphoid tissue
401880|NCT01427114|cyclophosphamide|cyclophosphamide
401881|NCT01427114|vincristine|vincristine
401882|NCT01427114|prednisolone|prednisolone
401883|NCT01427101|Pseudomyxoma Peritonei|pseudomyxoma peritonei
401884|NCT01427101|Cytoreductive surgery|cytoreductive surgery
401885|NCT01427101|Debulking surgery|debulking surgery
401886|NCT01427101|Intraperitoneal chemotherapy|intraperitoneal chemotherapy
401887|NCT01427088|rTMS-induced cumulative pattern of sBDNF|rtms-induced cumulative pattern of sbdnf
401888|NCT01427075|Magnetic Resonance Imaging|magnetic resonance imaging
401889|NCT01427075|Sleep Apnea, Obstructive|sleep apnea, obstructive
401890|NCT01427075|Pharyngeal Muscles|pharyngeal muscles
401891|NCT01427062|parkinson's disease|parkinson's disease
401892|NCT01427062|balance|balance
401893|NCT01427062|anticipatory postural adjustment|anticipatory postural adjustment
401894|NCT01427062|componsatory postural adjustment|componsatory postural adjustment
401895|NCT01427062|falls|falls
401896|NCT01427049|renal denervation|renal denervation
401897|NCT01427049|renal sympathetic denervation|renal sympathetic denervation
401898|NCT01427049|renal ablation|renal ablation
401899|NCT01427049|resistant hypertension|resistant hypertension
401900|NCT01427049|hypertension|hypertension
401901|NCT01427049|renal oxygenation|renal oxygenation
401902|NCT01427049|renal perfusion|renal perfusion
401903|NCT01427023|APTIMA Trichomonas vaginalis Assay|aptima trichomonas vaginalis assay
401904|NCT01427023|APTIMA|aptima
401905|NCT01427023|trichomonas|trichomonas
401906|NCT01427023|trichomonas vaginalis|trichomonas vaginalis
401907|NCT01426997|Major Depressive Disorder|major depressive disorder
401908|NCT01426997|Depression|depression
401909|NCT01426971|Migraine|migraine
401910|NCT01426945|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
401911|NCT01426945|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
401912|NCT01426945|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
401913|NCT01426945|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
401914|NCT01426945|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
401915|NCT01426932|Vestibular Function Tests|vestibular function tests
401916|NCT01426932|Caloric Test|caloric test
401917|NCT01426932|Electronystagmography|electronystagmography
401918|NCT01426932|Prediction|prediction
401919|NCT01426919|Traumatic Brain Injury|traumatic brain injury
401920|NCT01426919|Head Injury|head injury
401921|NCT01426893|Respiratory disease|respiratory disease
401922|NCT01426893|COPD|copd
401923|NCT01426880|GBG|gbg
401924|NCT01426880|German Breast Group|german breast group
401925|NCT01426880|neo-adjuvant|neo-adjuvant
401926|NCT01426880|GBG Forschungs GmbH|gbg forschungs gmbh
401927|NCT01426880|Tubular breast cancer stage II|tubular breast cancer stage ii
401928|NCT01426880|Mucinous breast cancer stage II|mucinous breast cancer stage ii
401929|NCT01426880|Invasive ductal breast cancer|invasive ductal breast cancer
401930|NCT01426880|Tubular breast cancer stage III|tubular breast cancer stage iii
401931|NCT01426880|HER-2 positive breast cancer|her-2 positive breast cancer
401932|NCT01426880|Inflammatory breast cancer stage IV|inflammatory breast cancer stage iv
401933|NCT01426880|Inflammatory breast cancer|inflammatory breast cancer
401934|NCT01426867|Open-Angle Glaucoma|open-angle glaucoma
401935|NCT01426867|Ocular Hypertension|ocular hypertension
401936|NCT01426867|Intraocular Pressure|intraocular pressure
401937|NCT01426867|Brinzolamide|brinzolamide
401938|NCT01426867|Brimonidine|brimonidine
401939|NCT01426854|Cataract Surgery|cataract surgery
401940|NCT01426854|Anti-ocular Inflammation|anti-ocular inflammation
401941|NCT01426854|Anti-ocular Pain|anti-ocular pain
401942|NCT01426841|Small cell lung cancer|small cell lung cancer
401943|NCT01426841|Adaptive radiotherapy|adaptive radiotherapy
401944|NCT01426841|Thoracic radiotherapy|thoracic radiotherapy
401945|NCT01426828|adult|adult
401946|NCT01426828|symptomatic multiple myeloma|symptomatic multiple myeloma
401947|NCT01426828|myeloma|myeloma
401948|NCT01426828|diagnosis within 12 months of initiation of systemic therapy|diagnosis within 12 months of initiation of systemic therapy
401949|NCT01426815|Peripheral spondylarthritis according to ASAS- criteria|peripheral spondylarthritis according to asas- criteria
401950|NCT01426802|metformin|metformin
401951|NCT01426802|vildagliptin|vildagliptin
401952|NCT01426802|T2DM|t2dm
401953|NCT01426789|Rheumatoid Arthritis|rheumatoid arthritis
401954|NCT01426789|IgG1K monoclonal antibody|igg1k monoclonal antibody
401955|NCT01426789|Interleukin-17A neutralizing|interleukin-17a neutralizing
401956|NCT01426776|Cheyne-Stokes respiration|cheyne-stokes respiration
401957|NCT01426776|Heart valve disease|heart valve disease
401958|NCT01426776|Central Sleep Apnea|central sleep apnea
401959|NCT01426763|HAE|hae
401960|NCT01426763|C1 esterase inhibitor|c1 esterase inhibitor
401961|NCT01426763|C1 INH|c1 inh
401962|NCT01426763|Subcutaneous|subcutaneous
401963|NCT01426763|hyaluronidase|hyaluronidase
401964|NCT01426763|rHuPH20|rhuph20
401965|NCT01426750|Nutritional support.|nutritional support.
401966|NCT01426750|Cancer.|cancer.
401967|NCT01426750|Malnutrition.|malnutrition.
401968|NCT01426750|Child.|child.
401969|NCT01426750|Adolescent|adolescent
401970|NCT01426724|Vitamin D|vitamin d
401971|NCT01426724|Chronic Kidney Disease|chronic kidney disease
401972|NCT01426724|Hyperparathyroidism|hyperparathyroidism
401973|NCT01426724|Renal Blood Flow|renal blood flow
401974|NCT01426724|Proteinuria|proteinuria
401975|NCT01426724|Inflammation|inflammation
401976|NCT01426724|Renin Angiotensin System|renin angiotensin system
401977|NCT01426698|delayed cord clamping|delayed cord clamping
401978|NCT01426698|developmental delay|developmental delay
401979|NCT01426685|sudden death|sudden death
401980|NCT01426685|coronary artery disease|coronary artery disease
401981|NCT01426685|diabetes|diabetes
401982|NCT01426672|Strabismic deviation less than 12 prism diopeters|strabismic deviation less than 12 prism diopeters
401983|NCT01426659|language|language
401984|NCT01426659|constraints|constraints
401985|NCT01426659|premature|premature
401986|NCT01426659|phonology|phonology
401987|NCT01426659|implied|implied
401988|NCT01426659|early development (< 5 years)|early development (< 5 years)
401989|NCT01426646|gastric cancer|gastric cancer
401990|NCT01426646|S-1|s-1
401991|NCT01426646|cisplatin|cisplatin
401992|NCT01426646|adjuvant chemotherapy|adjuvant chemotherapy
401993|NCT01426633|L-sarcomas|l-sarcomas
401994|NCT01426620|NSCLC|nsclc
401995|NCT01426620|blueberry|blueberry
401996|NCT01426620|salvage therapy|salvage therapy
401997|NCT01426620|docetaxel|docetaxel
401998|NCT01426620|non-small cell lung cancer|non-small cell lung cancer
401999|NCT01426620|second-line|second-line
402000|NCT01426620|polyphenol|polyphenol
402001|NCT01426594|Observational|observational
402002|NCT01426594|Colombia|colombia
402003|NCT01426594|Metpure XL|metpure xl
402004|NCT01426581|Asthma|asthma
402005|NCT01426581|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
402006|NCT01426581|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
402007|NCT01426581|Lung Disease, Obstructive|lung disease, obstructive
402008|NCT01426581|Self-management|self-management
402009|NCT01426581|Health Literacy|health literacy
402010|NCT01426568|Multi-Convergent Therapy|multi-convergent therapy
402011|NCT01426568|Mindfulness Meditation|mindfulness meditation
402012|NCT01426568|Functional Abdominal Symptoms|functional abdominal symptoms
402013|NCT01426568|Irritable Bowel Syndrome|irritable bowel syndrome
402014|NCT01426568|Inflammatory Bowel Disease|inflammatory bowel disease
402015|NCT01426568|Psychological Stress|psychological stress
402016|NCT01426555|Disorder of Bone Density and Structure, Unspecified|disorder of bone density and structure, unspecified
402017|NCT01426555|Weakening of the bone structure|weakening of the bone structure
402018|NCT01426542|brain injury|brain injury
402019|NCT01426542|stroke|stroke
402020|NCT01426542|cerebral palsy|cerebral palsy
402021|NCT01426542|seizures|seizures
402022|NCT01426516|Treatment Resistant|treatment resistant
402023|NCT01426516|Depression|depression
402024|NCT01426477|Ventral hernia|ventral hernia
402025|NCT01426477|Abdominal wall hernia|abdominal wall hernia
402026|NCT01426477|Incisional hernia|incisional hernia
402027|NCT01426477|Biologic mesh|biologic mesh
402028|NCT01426477|Veritas Collagen Matrix|veritas collagen matrix
402029|NCT01426477|Veritas|veritas
402030|NCT01426464|Glaucoma|glaucoma
402031|NCT01426464|Xalatan|xalatan
402032|NCT01426464|Transdermal|transdermal
402033|NCT01426451|Dramatherapy|dramatherapy
402034|NCT01426451|Group tutoring activities|group tutoring activities
402035|NCT01426451|Impairment|impairment
402036|NCT01426451|Emotional and behavioural problems|emotional and behavioural problems
402037|NCT01426451|Learning difficulties|learning difficulties
402038|NCT01426425|Cardiac cryoablation|cardiac cryoablation
402039|NCT01426425|AVNRT|avnrt
402040|NCT01426425|heart disease|heart disease
402041|NCT01426425|tachycardia|tachycardia
402042|NCT01426425|AtrioVentricular Nodal Reentrant Tachycardia|atrioventricular nodal reentrant tachycardia
402043|NCT01426425|Supraventricular tachycardia|supraventricular tachycardia
402044|NCT01426425|SVT|svt
402045|NCT01426360|dentifrice|dentifrice
402046|NCT01426360|potassium nitrate|potassium nitrate
402047|NCT01426360|strontium chloride|strontium chloride
402048|NCT01426347|Rheumatoid Arthritis|rheumatoid arthritis
402049|NCT01426347|Vitamin D deficiency|vitamin d deficiency
402050|NCT01426347|Disability|disability
402051|NCT01426321|Cardiac resynchronization therapy|cardiac resynchronization therapy
402052|NCT01426321|Echocardiography|echocardiography
402053|NCT01426321|Cardiac computed tomography|cardiac computed tomography
402054|NCT01426295|hematologic disease candidates for autologous or allogeneic bone marrow|hematologic disease candidates for autologous or allogeneic bone marrow
402055|NCT01426282|Out-patient Compliance|out-patient compliance
402056|NCT01426282|Nurse, Heath Education|nurse, heath education
402057|NCT01426282|Cardiovascular Diseases|cardiovascular diseases
402058|NCT01426282|Treatment and Prevention|treatment and prevention
402059|NCT01426256|vitamin D|vitamin d
402060|NCT01426256|cholecalciferol|cholecalciferol
402061|NCT01426256|cystic fibrosis|cystic fibrosis
402062|NCT01426256|respiratory tract infection|respiratory tract infection
402063|NCT01426256|immunity|immunity
402064|NCT01426256|intervention studies|intervention studies
402065|NCT01426256|inflammation|inflammation
402066|NCT01426256|dietary supplements|dietary supplements
402067|NCT01426256|alpha-Defensins|alpha-defensins
402068|NCT01426256|Cytokines|cytokines
402069|NCT01426256|mortality|mortality
402070|NCT01426256|biological markers|biological markers
402071|NCT01426256|Biomedical Research|biomedical research
402072|NCT01426230|PHN|phn
402073|NCT01426230|Post Herpetic Neuralgia|post herpetic neuralgia
402074|NCT01426230|Shingles|shingles
402075|NCT01426230|HZ roster|hz roster
402076|NCT01426204|Hepatitis C|hepatitis c
402077|NCT01426204|Retreatment|retreatment
402078|NCT01426204|Failures|failures
402079|NCT01426204|Infergen|infergen
402080|NCT01426204|Interferon Alfacon-1|interferon alfacon-1
402081|NCT01426191|Cefotaxime sulbactam sodium|cefotaxime sulbactam sodium
402082|NCT01426191|Phase IV clinical studies|phase iv clinical studies
402083|NCT01426191|Respiratory and urinary tract infections|respiratory and urinary tract infections
402084|NCT01426178|Respiratory Insufficiency|respiratory insufficiency
402085|NCT01426178|Respiration, Artificial|respiration, artificial
402086|NCT01426178|Intermittent Positive-Pressure Ventilation|intermittent positive-pressure ventilation
402087|NCT01426178|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
402088|NCT01426178|Non Invasive Ventilation|non invasive ventilation
402089|NCT01426165|hypomagnesemia|hypomagnesemia
402090|NCT01426165|magnesium|magnesium
402091|NCT01426165|magnesium sulfate|magnesium sulfate
402092|NCT01426152|IVF|ivf
402093|NCT01426152|progesterone|progesterone
402094|NCT01426152|ovulation induction|ovulation induction
402095|NCT01426152|pregnancy rates|pregnancy rates
402096|NCT01426152|Female Infertility Due to Nonimplantation|female infertility due to nonimplantation
402097|NCT01426126|urothelial carcinoma|urothelial carcinoma
402098|NCT01426126|gemcitabine|gemcitabine
402099|NCT01426126|platinum|platinum
402100|NCT01426126|refractory|refractory
402101|NCT01426126|salvage chemotherapy|salvage chemotherapy
402102|NCT01426100|CKD-828|ckd-828
402103|NCT01426100|Hypertension|hypertension
402104|NCT01426100|Primary Hypertension|primary hypertension
402105|NCT01426100|S-Amlodipine|s-amlodipine
402106|NCT01426100|Telmisartan|telmisartan
402107|NCT01426100|Amlodipine|amlodipine
402108|NCT01426100|Non-Responder|non-responder
402109|NCT01426061|Complementary and alternative medicine|complementary and alternative medicine
402110|NCT01426061|Reflexology|reflexology
402111|NCT01426061|Homeopathy|homeopathy
402112|NCT01426061|Asthma|asthma
402113|NCT01426061|Randomized controlled trial|randomized controlled trial
402114|NCT01426035|SUPERFICIAL VARICOSE VEINS|superficial varicose veins
402115|NCT01426022|alcohol|alcohol
402116|NCT01426022|mood|mood
402117|NCT01426022|postprandial|postprandial
402118|NCT01426009|COPD|copd
402120|NCT01425996|PVTT|pvtt
402121|NCT01425983|stress|stress
402122|NCT01425983|lability and irritative disturbances|lability and irritative disturbances
402123|NCT01425983|dietary supplement|dietary supplement
402124|NCT01425983|amino acid composition|amino acid composition
402125|NCT01425983|psychological neurological questionnaire (PNF)|psychological neurological questionnaire (pnf)
402126|NCT01425970|Inhibitex|inhibitex
402127|NCT01425970|Chronic Hepatitis|chronic hepatitis
402128|NCT01425970|Hepatitis C Virus|hepatitis c virus
402129|NCT01425957|MEMORY and COGNITIVE IMPAIRMENT|memory and cognitive impairment
402130|NCT01425957|ALZHEIMER DISEASE CONVERSION|alzheimer disease conversion
402131|NCT01425957|Amyloid beta-Peptides|amyloid beta-peptides
402132|NCT01425944|Sturge Weber Syndrome|sturge weber syndrome
402133|NCT01425944|Biomarkers|biomarkers
402134|NCT01425944|DNA arrays|dna arrays
402135|NCT01425944|brain vessel malformations|brain vessel malformations
402136|NCT01425918|Autism Spectrum Disorder|autism spectrum disorder
402137|NCT01425918|language|language
402138|NCT01425918|social|social
402139|NCT01425918|toddlers|toddlers
402140|NCT01425905|Female|female
402141|NCT01425905|Depression|depression
402142|NCT01425905|Obesity|obesity
402143|NCT01425905|Insulin Resistance|insulin resistance
402144|NCT01425905|Adolescents|adolescents
402145|NCT01425905|Overweight|overweight
402146|NCT01425905|Type 2 Diabetes Risk|type 2 diabetes risk
402147|NCT01425905|Mood|mood
402148|NCT01425892|Salivary Gland|salivary gland
402149|NCT01425892|Pathogenesis|pathogenesis
402150|NCT01425892|Sj(SqrRoot)(Delta)gren s Syndrome|sj(sqrroot)(delta)gren s syndrome
402151|NCT01425892|Sjogren Syndrome|sjogren syndrome
402152|NCT01425866|Diabetes Mellitus|diabetes mellitus
402153|NCT01425866|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
402154|NCT01425866|Structured self-management education|structured self-management education
402155|NCT01425866|Therapeutic patient education|therapeutic patient education
402156|NCT01425866|Lifestyle changes|lifestyle changes
402157|NCT01425866|Self-management Blood glucose|self-management blood glucose
402158|NCT01425866|Empowerment|empowerment
402159|NCT01425866|Adult learning|adult learning
402160|NCT01425866|Socio-constructivism|socio-constructivism
402161|NCT01425866|Health management network|health management network
402162|NCT01425866|Reunion island|reunion island
402163|NCT01425840|Lidocaine,|lidocaine,
402164|NCT01425840|liposome encapsulation,|liposome encapsulation,
402165|NCT01425840|topical anesthesia,|topical anesthesia,
402166|NCT01425840|palatal mucosa|palatal mucosa
402167|NCT01425827|duloxetine|duloxetine
402168|NCT01425827|osteoarthritis|osteoarthritis
402169|NCT01425827|pain|pain
402170|NCT01425827|function|function
402171|NCT01425814|COPD|copd
402172|NCT01425801|COPD|copd
402173|NCT01425788|Grass pollen induced allergic rhinoconjunctivitis|grass pollen induced allergic rhinoconjunctivitis
402174|NCT01425775|SLE|sle
402175|NCT01425775|disease activity markers|disease activity markers
402176|NCT01425775|vitamin D|vitamin d
402177|NCT01425749|melanoma|melanoma
402178|NCT01425749|MAGE-A3|mage-a3
402179|NCT01425749|immunotherapy|immunotherapy
402180|NCT01425749|adjuvant|adjuvant
402181|NCT01425749|skin cancer|skin cancer
402182|NCT01425749|skin diseases|skin diseases
402183|NCT01425749|immunology|immunology
402184|NCT01425736|Nimotuzumab|nimotuzumab
402185|NCT01425736|Chemotherapy|chemotherapy
402186|NCT01425736|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
402187|NCT01425723|B-LONG|b-long
402188|NCT01425723|B-YOND|b-yond
402189|NCT01425723|B-LONG Extension|b-long extension
402190|NCT01425723|rFIXFc|rfixfc
402191|NCT01425723|Severe Hemophilia B|severe hemophilia b
402192|NCT01425710|Pheochromocytoma|pheochromocytoma
402193|NCT01425710|Adrenalectomy|adrenalectomy
402194|NCT01425710|Cardiac output|cardiac output
402195|NCT01425710|Fluid managment|fluid managment
402196|NCT01425710|Esopagheal doppler sonography|esopagheal doppler sonography
402197|NCT01425697|Adult Cardiac surgery|adult cardiac surgery
402198|NCT01425697|Surgery site infections|surgery site infections
402199|NCT01425684|MRI|mri
402200|NCT01425684|Smoking|smoking
402201|NCT01425684|Schizophrenia|schizophrenia
402202|NCT01425671|Schizophrenia|schizophrenia
402203|NCT01425671|Family|family
402204|NCT01425671|Psychosis|psychosis
402205|NCT01425658|Fentanyl|fentanyl
402206|NCT01425658|clonidine|clonidine
402207|NCT01425658|intrathcal|intrathcal
402208|NCT01425658|bupivacaine|bupivacaine
402209|NCT01425645|gestational diabetes|gestational diabetes
402210|NCT01425645|GDM|gdm
402211|NCT01425645|prevention|prevention
402212|NCT01425632|TAU-284|tau-284
402213|NCT01425632|Bepotastine besilate|bepotastine besilate
402214|NCT01425632|Histamine H1 receptor antagonists|histamine h1 receptor antagonists
402215|NCT01425619|Anxiety Disorder due to Allergy Skin Testing|anxiety disorder due to allergy skin testing
402216|NCT01425580|Congestive Heart Failure|congestive heart failure
402217|NCT01425580|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
402218|NCT01425580|GLP-1|glp-1
402219|NCT01425580|Liraglutide|liraglutide
402220|NCT01425567|cholestasis|cholestasis
402221|NCT01425567|parenteral nutrition|parenteral nutrition
402222|NCT01425554|Vascular malformations in the internal jugular veins|vascular malformations in the internal jugular veins
402223|NCT01425515|hypertension|hypertension
402224|NCT01425515|genomics|genomics
402225|NCT01425502|High risk prescribing|high risk prescribing
402226|NCT01425502|Primary care|primary care
402227|NCT01425502|Non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
402228|NCT01425502|Anti-platelet agents|anti-platelet agents
402229|NCT01425502|Stepped wedge design|stepped wedge design
402230|NCT01425502|Cluster randomised controlled trial|cluster randomised controlled trial
402231|NCT01425502|United Kingdom|united kingdom
402232|NCT01425489|Leukodystrophy, Globoid Cell|leukodystrophy, globoid cell
402233|NCT01425489|Hereditary Central Nervous System Demyelinating Diseases|hereditary central nervous system demyelinating diseases
402234|NCT01425489|Brain Diseases, Metabolic, Inborn|brain diseases, metabolic, inborn
402235|NCT01425489|Central Nervous System Diseases|central nervous system diseases
402236|NCT01425489|Nervous System Diseases|nervous system diseases
402237|NCT01425489|Sphingolipidoses|sphingolipidoses
402238|NCT01425489|Leukoencephalopathies|leukoencephalopathies
402239|NCT01425489|Demyelinating Diseases|demyelinating diseases
402240|NCT01425489|Metabolism, Inborn Errors|metabolism, inborn errors
402241|NCT01425489|Genetic Diseases, Inborn|genetic diseases, inborn
402242|NCT01425489|Lipidoses|lipidoses
402243|NCT01425489|Lipid Metabolism, Inborn Errors|lipid metabolism, inborn errors
402244|NCT01425489|Lysosomal Storage Diseases|lysosomal storage diseases
402245|NCT01425489|Metabolic Diseases|metabolic diseases
402246|NCT01425489|Lipid Metabolism DisordersLeukodystrophy, Globoid Cell|lipid metabolism disordersleukodystrophy, globoid cell
402247|NCT01425476|breast|breast
402248|NCT01425476|high risk women|high risk women
402249|NCT01425476|biomarkers|biomarkers
402250|NCT01425476|vitamin D|vitamin d
402251|NCT01425463|Ferrous (II) Glycine Sulphate Complex|ferrous (ii) glycine sulphate complex
402252|NCT01425463|Polyferose|polyferose
402253|NCT01425463|Ferro Sanol duodenal|ferro sanol duodenal
402254|NCT01425463|Niferex|niferex
402255|NCT01425463|Iron Deficiency Anemia|iron deficiency anemia
402256|NCT01425437|Keloid|keloid
402257|NCT01425424|Vitamin D|vitamin d
402258|NCT01425424|Prediabetes|prediabetes
402259|NCT01425424|Prehypertension|prehypertension
402260|NCT01425411|hypertension|hypertension
402261|NCT01425411|left ventricular hypertrophy|left ventricular hypertrophy
402262|NCT01425411|angiotensin receptor blocker|angiotensin receptor blocker
402263|NCT01425411|midwall mechanics|midwall mechanics
402264|NCT01425411|tissue Doppler imaging|tissue doppler imaging
402265|NCT01425411|Hypertension with left ventricular hypertrophy|hypertension with left ventricular hypertrophy
402266|NCT01425385|liver failure|liver failure
402267|NCT01425385|liver transplantation|liver transplantation
402268|NCT01425372|vaccine|vaccine
402269|NCT01425372|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
402270|NCT01425372|immune responses|immune responses
402271|NCT01425372|primary immunisation|primary immunisation
402272|NCT01425372|Vaccine responses to primary immunisation in the UK|vaccine responses to primary immunisation in the uk
402273|NCT01425359|Chronic angina|chronic angina
402274|NCT01425359|Angina pectoris|angina pectoris
402275|NCT01425359|Coronary artery disease|coronary artery disease
402276|NCT01425359|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
402277|NCT01425346|Ophthalmic, healthy eye, fluorescence, lens|ophthalmic, healthy eye, fluorescence, lens
402278|NCT01425333|Ovarian endometriomas|ovarian endometriomas
402279|NCT01425333|Laparoscopy|laparoscopy
402280|NCT01425333|Cystectomy|cystectomy
402281|NCT01425333|Ablation|ablation
402282|NCT01425307|Phase III|phase iii
402283|NCT01425307|Sickle cell anemia|sickle cell anemia
402284|NCT01425307|Abnormally high Transcranial Doppler velocities.|abnormally high transcranial doppler velocities.
402285|NCT01425307|Reduce risk of primary stroke|reduce risk of primary stroke
402286|NCT01425307|Pediatric patients|pediatric patients
402287|NCT01425307|Chelation therapy|chelation therapy
402288|NCT01425294|Chinese post-menopausal women|chinese post-menopausal women
402289|NCT01425294|oestrogen receptor-positive locally advanced|oestrogen receptor-positive locally advanced
402290|NCT01425294|metastatic breast cancer|metastatic breast cancer
402291|NCT01425294|fulvestrant 250 mg|fulvestrant 250 mg
402292|NCT01425294|failure to adjuvant anti-oestrogen therapy|failure to adjuvant anti-oestrogen therapy
402293|NCT01425281|Bioabsorbable|bioabsorbable
402294|NCT01425281|Coronary scaffold|coronary scaffold
402295|NCT01425281|Coronary Stent|coronary stent
402296|NCT01425281|Everolimus|everolimus
402297|NCT01425281|Drug eluting stents|drug eluting stents
402298|NCT01425281|Angioplasty|angioplasty
402299|NCT01425281|Coronary artery disease|coronary artery disease
402300|NCT01425281|Total coronary occlusion|total coronary occlusion
402301|NCT01425281|Coronary artery restenosis|coronary artery restenosis
402302|NCT01425281|Stent thrombosis|stent thrombosis
402303|NCT01425281|Myocardial ischemia|myocardial ischemia
402304|NCT01425281|Coronary artery stenosis|coronary artery stenosis
402305|NCT01425268|Tissue Expansion|tissue expansion
402306|NCT01425268|Tissue Expander|tissue expander
402307|NCT01425268|Breast Tissue Expansion|breast tissue expansion
402308|NCT01425268|Breast Tissue Expander|breast tissue expander
402309|NCT01425268|Breast Reconstruction|breast reconstruction
402310|NCT01425268|Two Stage Breast Reconstruction|two stage breast reconstruction
402311|NCT01425268|2 Stage Breast Reconstruction|2 stage breast reconstruction
402312|NCT01425255|Type 1 diabetes|type 1 diabetes
402313|NCT01425255|Sleep quality|sleep quality
402314|NCT01425255|Parents|parents
402315|NCT01425242|inflammation|inflammation
402316|NCT01425242|aneurysm|aneurysm
402317|NCT01425242|hypertension|hypertension
402318|NCT01425242|aliskiren|aliskiren
402319|NCT01425229|steady state|steady state
402320|NCT01425229|bosentan|bosentan
402321|NCT01425229|clarithromycin|clarithromycin
402322|NCT01425216|Keloid|keloid
402323|NCT01425216|Patient who have extensive or massive keloids|patient who have extensive or massive keloids
402324|NCT01425177|Retained CBD Stones|retained cbd stones
402325|NCT01425177|Recurrent CBD Stones|recurrent cbd stones
402326|NCT01425164|hemodialysis|hemodialysis
402327|NCT01425164|coronary heart disease|coronary heart disease
402328|NCT01425164|angina|angina
402329|NCT01425164|betablocker|betablocker
402330|NCT01425164|carvedilol|carvedilol
402331|NCT01425164|ivabradine|ivabradine
402332|NCT01425138|psoriasis|psoriasis
402333|NCT01425138|systematic review|systematic review
402334|NCT01425138|meta-analyses|meta-analyses
402335|NCT01425125|nonedematous hyponatremia|nonedematous hyponatremia
402336|NCT01425125|fractional urate excretion|fractional urate excretion
402337|NCT01425112|trabeculectomy|trabeculectomy
402338|NCT01425112|bevacizumab|bevacizumab
402339|NCT01425112|anti-VEGF|anti-vegf
402340|NCT01425112|Efficacy|efficacy
402341|NCT01425086|Incubator,|incubator,
402342|NCT01425086|hypothermia,|hypothermia,
402343|NCT01425086|preterm,|preterm,
402471|NCT01424813|dry powder inhaler|dry powder inhaler
402344|NCT01425086|low-birthweight infants,|low-birthweight infants,
402345|NCT01425086|embrace device,|embrace device,
402346|NCT01425086|phase change materials|phase change materials
402348|NCT01425073|HIV|hiv
402349|NCT01425073|Co-Infections|co-infections
402350|NCT01425073|Malaria|malaria
402351|NCT01425073|Pneumonia|pneumonia
402352|NCT01425073|Diarrhea|diarrhea
402353|NCT01425060|Contraception|contraception
402354|NCT01425060|Unintended pregnancy|unintended pregnancy
402355|NCT01425060|HIV|hiv
402356|NCT01425060|HIV Risk|hiv risk
402357|NCT01425060|Sexually Transmitted Infections|sexually transmitted infections
402358|NCT01425060|Women|women
402359|NCT01425060|Pregnancy|pregnancy
402360|NCT01425060|Neonatal Health|neonatal health
402361|NCT01425060|Drug Use|drug use
402362|NCT01425060|Drug Treatment|drug treatment
402363|NCT01425060|Opioids|opioids
402364|NCT01425047|mangosteen|mangosteen
402365|NCT01425047|xanthones|xanthones
402366|NCT01425047|dietary supplement|dietary supplement
402367|NCT01425047|botanical supplement|botanical supplement
402368|NCT01425047|bioavailability|bioavailability
402369|NCT01425047|Determine bioavailability of mangosteen xanthones in adults|determine bioavailability of mangosteen xanthones in adults
402370|NCT01425034|Cast|cast
402371|NCT01425034|motion|motion
402372|NCT01425034|thumb CMC arthritis|thumb cmc arthritis
402373|NCT01425034|Collateral Ligament of Metacarpophalangeal Joint|collateral ligament of metacarpophalangeal joint
402374|NCT01424995|trigger thumb|trigger thumb
402375|NCT01424995|flexor pollicis longus tendon of the thumb|flexor pollicis longus tendon of the thumb
402376|NCT01424995|stenosis tenosynovitis|stenosis tenosynovitis
402377|NCT01424982|Leukemia|leukemia
402378|NCT01424982|Ph-positive acute lymphoblastic leukemia|ph-positive acute lymphoblastic leukemia
402379|NCT01424982|ALL|all
402380|NCT01424982|Philadelphia (Ph) chromosome|philadelphia (ph) chromosome
402381|NCT01424982|BCR-ABL|bcr-abl
402382|NCT01424982|Depo-Medrol|depo-medrol
402383|NCT01424982|Medrol|medrol
402384|NCT01424982|Solu-Medrol|solu-medrol
402385|NCT01424982|Methylprednisolone|methylprednisolone
402386|NCT01424982|Vincristine|vincristine
402387|NCT01424982|Dexamethasone|dexamethasone
402388|NCT01424982|Decadron|decadron
402389|NCT01424982|Ponatinib|ponatinib
402390|NCT01424982|G-CSF|g-csf
402391|NCT01424982|Filgrastim|filgrastim
402392|NCT01424982|NeupogenTM|neupogentm
402393|NCT01424982|Cyclophosphamide|cyclophosphamide
402394|NCT01424982|Cytoxan|cytoxan
402395|NCT01424982|Neosar|neosar
402396|NCT01424982|Doxorubicin|doxorubicin
402397|NCT01424982|Doxorubicin Hydrochloride|doxorubicin hydrochloride
402398|NCT01424982|Adriamycin PFS|adriamycin pfs
402399|NCT01424982|Adriamycin RDF|adriamycin rdf
402400|NCT01424982|Adriamycin|adriamycin
402401|NCT01424982|Rubex|rubex
402402|NCT01424982|Rituximab|rituximab
402403|NCT01424982|Rituxan|rituxan
402404|NCT01424982|Mesna|mesna
402405|NCT01424982|Mesnex|mesnex
402406|NCT01424982|Cytarabine|cytarabine
402407|NCT01424982|Ara-C|ara-c
402408|NCT01424982|Cytosar|cytosar
402409|NCT01424982|DepoCyt|depocyt
402410|NCT01424982|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
402411|NCT01424982|Methotrexate|methotrexate
402412|NCT01424982|Leucovorin|leucovorin
402413|NCT01424982|Wellcovorin|wellcovorin
402414|NCT01424982|Citrovorum|citrovorum
402415|NCT01424982|Prednisone|prednisone
402416|NCT01424982|NeulastaTM|neulastatm
402417|NCT01424982|PEG-G-CSF|peg-g-csf
402418|NCT01424969|rotator cuff repair|rotator cuff repair
402419|NCT01424969|arthroscopic|arthroscopic
402420|NCT01424969|platelet-rich plasma|platelet-rich plasma
402421|NCT01424969|platelet-rich fibrin matrix|platelet-rich fibrin matrix
402422|NCT01424969|outcomes|outcomes
402423|NCT01424969|tendon healing|tendon healing
402424|NCT01424969|magnetic resonance imaging|magnetic resonance imaging
402425|NCT01424956|breast|breast
402426|NCT01424956|breast cancer|breast cancer
402427|NCT01424956|breast screening|breast screening
402428|NCT01424956|breast cancer screening|breast cancer screening
402429|NCT01424956|ultrasound|ultrasound
402430|NCT01424956|ultrasonography|ultrasonography
402431|NCT01424956|mammogram|mammogram
402432|NCT01424956|mammography|mammography
402433|NCT01424956|breast density|breast density
402434|NCT01424956|dense breasts|dense breasts
402435|NCT01424956|early detection|early detection
402436|NCT01424956|somo v|somo v
402437|NCT01424956|somo•v|somo•v
402438|NCT01424956|U-Systems|u-systems
402439|NCT01424956|Automated Breast Ultrasound|automated breast ultrasound
402440|NCT01424956|Ultrasonography, Mammary|ultrasonography, mammary
402441|NCT01424956|Breast Neoplasms|breast neoplasms
402442|NCT01424956|Breast Density > 50% (BI-RADS III & IV)|breast density > 50% (bi-rads iii & iv)
402443|NCT01424943|prevention|prevention
402444|NCT01424943|evidence-based parenting intervention|evidence-based parenting intervention
402445|NCT01424943|children|children
402446|NCT01424943|disabilities|disabilities
402447|NCT01424943|IDEA Part C|idea part c
402448|NCT01424943|Stepping Stones Triple P|stepping stones triple p
402449|NCT01424930|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
402450|NCT01424930|CRPC|crpc
402451|NCT01424930|Abiraterone Acetate|abiraterone acetate
402452|NCT01424930|Prednisone|prednisone
402453|NCT01424930|Food Safety|food safety
402454|NCT01424917|Cardiac Allograft Vasculopathy|cardiac allograft vasculopathy
402455|NCT01424904|Ergogenic aid|ergogenic aid
402456|NCT01424904|Exercise endurance|exercise endurance
402457|NCT01424904|High performance|high performance
402458|NCT01424904|Time trial performance|time trial performance
402459|NCT01424904|Glutathione|glutathione
402460|NCT01424878|Molecular Analysis of Medullary Thyroid Carcinoma Tissues|molecular analysis of medullary thyroid carcinoma tissues
402461|NCT01424865|HER2-positive breast cancer|her2-positive breast cancer
402462|NCT01424865|stage II breast cancer|stage ii breast cancer
402463|NCT01424865|stage IIIA breast cancer|stage iiia breast cancer
402464|NCT01424852|Probiotics|probiotics
402465|NCT01424852|Caries|caries
402466|NCT01424852|Oral flora|oral flora
402467|NCT01424839|SIOP CNS GCT II|siop cns gct ii
402566|NCT01424332|Pharmacodynamics|pharmacodynamics
402567|NCT01424332|pharmacokinetics|pharmacokinetics
402468|NCT01424839|Patients with the primary disease of an Intracranial Germ Cell Tumors|patients with the primary disease of an intracranial germ cell tumors
402469|NCT01424826|Healthy volunteers|healthy volunteers
402470|NCT01424813|Asthma|asthma
402472|NCT01424813|short-acting beta2-agonist|short-acting beta2-agonist
402473|NCT01424813|SABA|saba
402474|NCT01424813|bronchoconstriction|bronchoconstriction
402475|NCT01424813|bronchodilation|bronchodilation
402476|NCT01424813|bronchodilator|bronchodilator
402477|NCT01424813|metered dose inhaler|metered dose inhaler
402478|NCT01424774|Radiation Exposure|radiation exposure
402479|NCT01424774|Rubidium 82|rubidium 82
402480|NCT01424774|Strontium 82|strontium 82
402481|NCT01424774|Strontium 85|strontium 85
402482|NCT01424748|Noni juice|noni juice
402483|NCT01424748|Safety|safety
402484|NCT01424735|Best corrected Visual Acuity|best corrected visual acuity
402485|NCT01424735|Pupillary Reaction|pupillary reaction
402486|NCT01424735|Colour vision|colour vision
402487|NCT01424735|Disc edema|disc edema
402488|NCT01424722|ICD Indicated patients|icd indicated patients
402489|NCT01424722|documented CAD|documented cad
402490|NCT01424709|Chemotherapy|chemotherapy
402491|NCT01424709|Individual therapy|individual therapy
402492|NCT01424709|RRM1|rrm1
402493|NCT01424709|BRCA1|brca1
402494|NCT01424696|growth measures|growth measures
402495|NCT01424696|nutritional status|nutritional status
402496|NCT01424696|pulmonary infection|pulmonary infection
402497|NCT01424696|inflammatory markers|inflammatory markers
402498|NCT01424696|pancreatic enzyme replacement therapy|pancreatic enzyme replacement therapy
402499|NCT01424683|Qol|qol
402500|NCT01424683|Quality of life|quality of life
402501|NCT01424683|VAS|vas
402502|NCT01424683|Visual Analogue Scale|visual analogue scale
402503|NCT01424683|CABG|cabg
402504|NCT01424683|Coronary Artery Bypass Graft|coronary artery bypass graft
402505|NCT01424683|Qol conversion|qol conversion
402506|NCT01424683|post hoc HTA|post hoc hta
402507|NCT01424670|Multidrug resistant tuberculosis|multidrug resistant tuberculosis
402508|NCT01424657|MRCP|mrcp
402509|NCT01424657|ERCP|ercp
402510|NCT01424657|BILIARY OBSTRUCTION|biliary obstruction
402511|NCT01424657|EFFECTIVENESS|effectiveness
402512|NCT01424644|meningitis|meningitis
402513|NCT01424644|human papillomavirus|human papillomavirus
402514|NCT01424644|tetanus|tetanus
402515|NCT01424644|diptheria|diptheria
402516|NCT01424644|pertussis|pertussis
402517|NCT01424618|Donor eggs|donor eggs
402518|NCT01424618|Donor oocytes|donor oocytes
402519|NCT01424618|Pregnancy|pregnancy
402520|NCT01424618|Embryo Implantation|embryo implantation
402521|NCT01424618|Infertility|infertility
402522|NCT01424618|IVF|ivf
402523|NCT01424605|left-sided double lumen bronchial tube|left-sided double lumen bronchial tube
402524|NCT01424605|GlideScope videolaryngoscope|glidescope videolaryngoscope
402525|NCT01424605|direct laryngoscope|direct laryngoscope
402526|NCT01424592|Portable sleep apnea testing|portable sleep apnea testing
402527|NCT01424592|Positive airway pressure therapy|positive airway pressure therapy
402528|NCT01424592|Polysomnography|polysomnography
402529|NCT01424566|Cancer pain|cancer pain
402530|NCT01424566|Opioid therapy|opioid therapy
402531|NCT01424566|Inadequate analgesia|inadequate analgesia
402532|NCT01424566|Optimized chronic opioid therapy|optimized chronic opioid therapy
402533|NCT01424553|Low birthweight|low birthweight
402534|NCT01424553|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
402535|NCT01424553|Lung development|lung development
402536|NCT01424553|Airway obstruction|airway obstruction
402537|NCT01424553|Asthma|asthma
402538|NCT01424527|Chronic Obstructive Pulmonary Disease(COPD)|chronic obstructive pulmonary disease(copd)
402539|NCT01424527|COPD Assessment Test(CAT)|copd assessment test(cat)
402540|NCT01424501|Tuberculosis vaccine|tuberculosis vaccine
402541|NCT01424501|HIV-negative|hiv-negative
402542|NCT01424501|tuberculosis treatment|tuberculosis treatment
402543|NCT01424488|sugammadex|sugammadex
402544|NCT01424488|reversal|reversal
402545|NCT01424488|pipecuronium-induced neuromuscular blockade|pipecuronium-induced neuromuscular blockade
402546|NCT01424462|healthy volunteers|healthy volunteers
402547|NCT01424462|firategrast|firategrast
402548|NCT01424462|Pharmacokinetics|pharmacokinetics
402549|NCT01424462|modified release|modified release
402550|NCT01424436|CSF sampling|csf sampling
402551|NCT01424436|Alzheimer's disease|alzheimer's disease
402552|NCT01424436|Amyloid beta levels|amyloid beta levels
402553|NCT01424423|Safety|safety
402554|NCT01424423|GSK1223249|gsk1223249
402555|NCT01424423|Pharmacokinetics|pharmacokinetics
402556|NCT01424423|Single dose escalation|single dose escalation
402557|NCT01424423|anti-GSK1223249 antibodies|anti-gsk1223249 antibodies
402558|NCT01424423|Multiple Sclerosis|multiple sclerosis
402559|NCT01424410|paediatric schistosomiasis morbidity immunology|paediatric schistosomiasis morbidity immunology
402560|NCT01424384|healthy volunteers|healthy volunteers
402561|NCT01424384|Anxiety Disorder|anxiety disorder
402562|NCT01424384|neuropsychological tests|neuropsychological tests
402563|NCT01424345|Kidney Transplantation|kidney transplantation
402564|NCT01424345|Immunosuppression|immunosuppression
402565|NCT01424345|Immune monitoring|immune monitoring
402568|NCT01424332|darexaban|darexaban
402569|NCT01424332|Acetyl Salicylic Acid|acetyl salicylic acid
402570|NCT01424332|darexaban glucuronide|darexaban glucuronide
402571|NCT01424332|YM150|ym150
402572|NCT01424332|YM-222714|ym-222714
402573|NCT01424332|Phase 1|phase 1
402574|NCT01424319|Endothelin Receptor Antagonists|endothelin receptor antagonists
402575|NCT01424319|Proteinuria|proteinuria
402576|NCT01424306|Inflammation|inflammation
402577|NCT01424306|Intestinal permeability|intestinal permeability
402578|NCT01424306|Type 2 diabetes mellitus|type 2 diabetes mellitus
402579|NCT01424306|Cardiovascular disease|cardiovascular disease
402580|NCT01424306|Obesity|obesity
402581|NCT01424306|Sweetened beverages|sweetened beverages
402582|NCT01424306|Sugar|sugar
402583|NCT01424306|Fructose|fructose
402584|NCT01424306|Glucose|glucose
402585|NCT01424306|High-fructose corn syrup|high-fructose corn syrup
402586|NCT01424293|Rectal Cancer|rectal cancer
402587|NCT01424293|Colon Cancer|colon cancer
402588|NCT01424293|Diverticulitis|diverticulitis
402589|NCT01424293|Anastamosis|anastamosis
402590|NCT01424293|colectomy|colectomy
402591|NCT01424293|low anterior resection|low anterior resection
402592|NCT01424267|low profile|low profile
402593|NCT01424267|endovascular graft|endovascular graft
402594|NCT01424267|endovascular procedure|endovascular procedure
402595|NCT01424267|aortic aneurysm, abdominal aortic aneurysm|aortic aneurysm, abdominal aortic aneurysm
402596|NCT01424254|Gastrointestinal Bleeding of Obscure Origin|gastrointestinal bleeding of obscure origin
402597|NCT01424241|Sandostatin LAR|sandostatin lar
402598|NCT01424228|Long term|long term
402599|NCT01424228|Constipation|constipation
402600|NCT01424228|Digestive signs and symptoms|digestive signs and symptoms
402601|NCT01424202|Post extubation failure|post extubation failure
402602|NCT01424202|Mechanical Insufflation-Exsufflation|mechanical insufflation-exsufflation
402603|NCT01424202|Noninvasive Ventilation|noninvasive ventilation
402604|NCT01424202|Weaning|weaning
402605|NCT01424189|Cataract surgery|cataract surgery
402606|NCT01424189|Intraocular lens|intraocular lens
402607|NCT01424150|Postoperative fluid|postoperative fluid
402608|NCT01424150|surgery|surgery
402609|NCT01424150|anaesthesia|anaesthesia
402610|NCT01424150|fluid|fluid
402611|NCT01424150|mortality|mortality
402612|NCT01424150|morbidity|morbidity
402613|NCT01424111|Biomarkers|biomarkers
402614|NCT01424111|Depression|depression
402615|NCT01424111|Major Depressive Disorder|major depressive disorder
402616|NCT01424111|Escitalopram|escitalopram
402617|NCT01424072|stress psychological|stress psychological
402618|NCT01424072|coping behavior|coping behavior
402619|NCT01424059|fear|fear
402620|NCT01424059|labor|labor
402621|NCT01424059|induction|induction
402622|NCT01424059|amniotomy|amniotomy
402623|NCT01424059|WEDQ-B|wedq-b
402624|NCT01424059|parous|parous
402625|NCT01424059|cesarean section|cesarean section
402626|NCT01424046|type 1 diabetes|type 1 diabetes
402627|NCT01424046|basal insulin|basal insulin
402628|NCT01424046|developing world|developing world
402629|NCT01424046|comparative effectiveness|comparative effectiveness
402630|NCT01424033|Interstitial lung disease|interstitial lung disease
402631|NCT01424033|Connective tissue disease|connective tissue disease
402632|NCT01424033|Scleroderma|scleroderma
402633|NCT01424033|Rheumatoid arthritis|rheumatoid arthritis
402634|NCT01424033|Sjogren's syndrome|sjogren's syndrome
402635|NCT01424033|Mixed connective tissue disease|mixed connective tissue disease
402636|NCT01424033|Dermatomyositis|dermatomyositis
402637|NCT01424033|Polymyositis|polymyositis
402638|NCT01424033|Systemic lupus erythematosis|systemic lupus erythematosis
402639|NCT01424020|Questionnaire|questionnaire
402640|NCT01424020|peripheral artery disease|peripheral artery disease
402641|NCT01424020|execise|execise
402642|NCT01424007|Obese|obese
402643|NCT01424007|Women|women
402644|NCT01424007|Weight loss|weight loss
402645|NCT01424007|Exercise|exercise
402646|NCT01424007|Physical activity|physical activity
402647|NCT01424007|Diet|diet
402648|NCT01424007|Female|female
402649|NCT01423994|syncope|syncope
402650|NCT01423994|fainting|fainting
402651|NCT01423994|implantable loop recorder|implantable loop recorder
402652|NCT01423994|pacemaker|pacemaker
402653|NCT01423994|heart block|heart block
402654|NCT01423994|bifascicular heart block|bifascicular heart block
402655|NCT01423981|Keloid|keloid
402656|NCT01423981|Scar|scar
402657|NCT01423981|hypertrophic scar|hypertrophic scar
402658|NCT01423981|familial keloid|familial keloid
402659|NCT01423968|Sepsis|sepsis
402660|NCT01423968|Inflammation|inflammation
402661|NCT01423968|Lipopolysaccharide|lipopolysaccharide
402662|NCT01423968|Muscle protein turnover|muscle protein turnover
402663|NCT01423968|Insulin resistance|insulin resistance
402664|NCT01423955|Erythropoietin|erythropoietin
402665|NCT01423955|Erythropoetin|erythropoetin
402666|NCT01423955|Cardiac surgery|cardiac surgery
402667|NCT01423955|Ischemia|ischemia
402668|NCT01423955|Reperfusion|reperfusion
402669|NCT01423955|Renal function|renal function
402670|NCT01423955|Cystatin C|cystatin c
402671|NCT01423955|Creatinine|creatinine
402672|NCT01423955|Safety|safety
402673|NCT01423929|Oxygen|oxygen
402674|NCT01423929|Myocardial infarction|myocardial infarction
402675|NCT01423929|Ambulance|ambulance
402676|NCT01423929|Percutaneous coronary intervention|percutaneous coronary intervention
402677|NCT01423929|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
402678|NCT01423916|Schizophrenia|schizophrenia
402679|NCT01423916|QTc Interval|qtc interval
402680|NCT01423903|Phase I|phase i
402681|NCT01423903|STAT-3 inhibitor|stat-3 inhibitor
402682|NCT01423903|solid tumors|solid tumors
402683|NCT01423890|Breast Cancer|breast cancer
402684|NCT01423890|Oncotype DX|oncotype dx
402685|NCT01423890|Adjuvant! Online|adjuvant! online
402686|NCT01423890|Decisional Conflict Scale|decisional conflict scale
402687|NCT01423877|bariatric surgery|bariatric surgery
402688|NCT01423877|diabetes|diabetes
402689|NCT01423877|sleeve gastrectomy|sleeve gastrectomy
402690|NCT01423877|gastric bypass|gastric bypass
402691|NCT01423877|gastric banding|gastric banding
402692|NCT01423864|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
402693|NCT01423864|Multi-organ Dysfunction Syndrome|multi-organ dysfunction syndrome
402694|NCT01423864|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
402695|NCT01423851|Keywords provided by NS Pharma, Inc.:|keywords provided by ns pharma, inc.:
402696|NCT01423851|JAK2 kinase inhibitor|jak2 kinase inhibitor
402697|NCT01423851|NS-018|ns-018
402698|NCT01423851|Myeloproliferative Neoplasms|myeloproliferative neoplasms
402699|NCT01423851|Primary Myelofibrosis|primary myelofibrosis
402700|NCT01423851|post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
402701|NCT01423851|post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
402702|NCT01423851|Additional relevant MeSH terms:|additional relevant mesh terms:
402703|NCT01423851|Bone Marrow Diseases|bone marrow diseases
402704|NCT01423851|Hematologic Diseases|hematologic diseases
402705|NCT01423851|Polycythemia Vera|polycythemia vera
402706|NCT01423851|Thrombocythemia, Essential|thrombocythemia, essential
402707|NCT01423851|PMF|pmf
402708|NCT01423851|post-PV MF|post-pv mf
402709|NCT01423851|post-ET MF|post-et mf
402710|NCT01423838|Overactive bladder|overactive bladder
402711|NCT01423838|Solifenacin|solifenacin
402712|NCT01423838|Oxybutynin|oxybutynin
402713|NCT01423812|HIV|hiv
402714|NCT01423812|treatment-experienced|treatment-experienced
402715|NCT01423812|protease inhibitor|protease inhibitor
402716|NCT01423812|adherence|adherence
402717|NCT01423812|lipids|lipids
402718|NCT01423799|Quality of life|quality of life
402719|NCT01423799|Cancer|cancer
402720|NCT01423799|Immunonutrition|immunonutrition
402721|NCT01423760|Vaccine|vaccine
402722|NCT01423760|Stimuvax|stimuvax
402723|NCT01423760|Tecemotide|tecemotide
402724|NCT01423760|L-BLP25|l-blp25
402725|NCT01423760|Non-Small Cell Lung Carcinoma|non-small cell lung carcinoma
402726|NCT01423760|Multiple Myeloma|multiple myeloma
402727|NCT01423747|ALL|all
402728|NCT01423747|HSCT|hsct
402729|NCT01423747|children|children
402730|NCT01423747|adolescents|adolescents
402731|NCT01423734|ADRENAL GLAND|adrenal gland
402732|NCT01423734|MRI|mri
402733|NCT01423734|11-122|11-122
402734|NCT01423708|Liver Transplantation|liver transplantation
402735|NCT01423708|Graft Rejection|graft rejection
402736|NCT01423708|Graft Survival|graft survival
402737|NCT01423708|Transplantation Immunology|transplantation immunology
402738|NCT01423708|Anti-Rejection Therapy|anti-rejection therapy
402739|NCT01423708|Immunosuppression|immunosuppression
402740|NCT01423708|Organ Transplantation|organ transplantation
402741|NCT01423708|Host vs Graft Reaction|host vs graft reaction
402742|NCT01423708|Gastroenterology|gastroenterology
402743|NCT01423708|Hepatology|hepatology
402744|NCT01423669|Psychotic Disorders|psychotic disorders
402745|NCT01423643|HIV|hiv
402746|NCT01423643|Human immunodeficiency virus|human immunodeficiency virus
402747|NCT01423643|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
402748|NCT01423643|AIDS Virus|aids virus
402749|NCT01423643|Immunodeficiency Virus, Human|immunodeficiency virus, human
402750|NCT01423643|Virus, Human Immunodeficiency|virus, human immunodeficiency
402751|NCT01423643|Hepatitis C|hepatitis c
402752|NCT01423643|Hepatitis C, chronic|hepatitis c, chronic
402753|NCT01423643|Hepatitis C virus|hepatitis c virus
402754|NCT01423643|Hepatitis C antibodies|hepatitis c antibodies
402755|NCT01423643|Hepatitis C antigens|hepatitis c antigens
402756|NCT01423630|fatty liver|fatty liver
402757|NCT01423630|probiotics|probiotics
402758|NCT01423630|Lactobacillus|lactobacillus
402759|NCT01423630|fruit|fruit
402760|NCT01423630|fibre|fibre
402761|NCT01423630|dietary intervention|dietary intervention
402762|NCT01423630|obesity|obesity
402763|NCT01423617|overweight|overweight
402764|NCT01423617|weight loss|weight loss
402765|NCT01423617|body fat|body fat
402766|NCT01423617|waist circumference|waist circumference
402767|NCT01423617|satiety|satiety
402768|NCT01423617|appetite|appetite
402769|NCT01423604|Metastatic pancreatic cancer|metastatic pancreatic cancer
402770|NCT01423591|Infliximab|infliximab
402771|NCT01423591|polymyalgia rheumatica|polymyalgia rheumatica
402772|NCT01423591|refractory|refractory
402773|NCT01423591|double blind|double blind
402774|NCT01423591|placebo controlled|placebo controlled
402775|NCT01423591|trial|trial
402776|NCT01423578|craving|craving
402777|NCT01423578|mood|mood
402778|NCT01423578|cue reactivity|cue reactivity
402779|NCT01423578|smoking behavior|smoking behavior
402780|NCT01423578|quit smoking|quit smoking
402781|NCT01423578|prevention|prevention
402782|NCT01423578|Hatha yoga|hatha yoga
402783|NCT01423578|cardiovascular exercise|cardiovascular exercise
402784|NCT01423565|Deep Brain Stimulation|deep brain stimulation
402785|NCT01423565|Parkinson's Disease|parkinson's disease
402786|NCT01423565|Subthalamic Nucleus|subthalamic nucleus
402787|NCT01423565|Constant Current|constant current
402788|NCT01423552|Heart transplantation|heart transplantation
402789|NCT01423552|Immunosuppression|immunosuppression
402790|NCT01423552|Pharmacokinetics|pharmacokinetics
402791|NCT01423552|Pharmacogenetics|pharmacogenetics
402792|NCT01423513|ankle tape|ankle tape
402793|NCT01423513|Hoffmann reflex|hoffmann reflex
402794|NCT01423513|Balance|balance
402795|NCT01423500|ALL|all
402796|NCT01423500|HSCT|hsct
402797|NCT01423500|children|children
402798|NCT01423500|adolescents|adolescents
402799|NCT01423487|Metformin|metformin
402800|NCT01423487|Risperidone|risperidone
402801|NCT01423487|Prevention|prevention
402802|NCT01423487|weight gain|weight gain
402803|NCT01423487|Amenorrhea|amenorrhea
402804|NCT01423474|Radiotherapy|radiotherapy
402805|NCT01423474|Hypofractionation|hypofractionation
402806|NCT01423448|Depression|depression
402807|NCT01423448|mental health|mental health
402808|NCT01423448|wellbeing|wellbeing
402809|NCT01423448|online bulletin board|online bulletin board
402810|NCT01423448|online support group|online support group
402811|NCT01423435|TRK-100STP|trk-100stp
402812|NCT01423435|PK|pk
402813|NCT01423435|beraprost sodium|beraprost sodium
402814|NCT01423422|Exercise stress test|exercise stress test
402815|NCT01423422|Effort Angina|effort angina
402816|NCT01423422|Exercise induced angina|exercise induced angina
402817|NCT01423409|visual analog pain scale|visual analog pain scale
402818|NCT01423409|Deaf persons|deaf persons
402819|NCT01423409|clinical trial|clinical trial
402820|NCT01423409|multicentric|multicentric
402821|NCT01423396|Alzheimer's disease|alzheimer's disease
402822|NCT01423396|cardiovascular risk factors|cardiovascular risk factors
402823|NCT01423383|Keloid|keloid
402824|NCT01423370|Erectile Dysfunction|erectile dysfunction
402825|NCT01423370|YHD1023|yhd1023
402826|NCT01423370|YCD190|ycd190
402827|NCT01423370|Cialis|cialis
402828|NCT01423370|Yuhan|yuhan
402829|NCT01423357|HIV prevention|hiv prevention
402830|NCT01423357|condom distribution|condom distribution
402831|NCT01423357|youth peer education|youth peer education
402832|NCT01423357|high risk places|high risk places
402833|NCT01423357|condom use|condom use
402834|NCT01423357|prevention through increased condom use|prevention through increased condom use
402835|NCT01423344|multiple myeloma|multiple myeloma
402836|NCT01423344|Free light chains|free light chains
402837|NCT01423331|Postpartum depression|postpartum depression
402838|NCT01423331|maternal mental health|maternal mental health
402839|NCT01423305|Asthma|asthma
402840|NCT01423266|High Protein Diet in heart failure|high protein diet in heart failure
402841|NCT01423266|obesity and heart failure|obesity and heart failure
402842|NCT01423266|Weight management in Heart failure|weight management in heart failure
402843|NCT01423266|heart failure, diabetes and obesity|heart failure, diabetes and obesity
402844|NCT01423253|Depression|depression
402845|NCT01423253|Lurasidone|lurasidone
402846|NCT01423253|Latuda|latuda
402847|NCT01423240|Depression|depression
402848|NCT01423240|Lurasidone|lurasidone
402849|NCT01423240|Latuda|latuda
402850|NCT01423227|COPD|copd
402851|NCT01423227|exercise|exercise
402852|NCT01423227|rehabilitation|rehabilitation
402853|NCT01423227|dyspnea|dyspnea
402854|NCT01423227|quality of life|quality of life
402855|NCT01423227|economic evaluation|economic evaluation
402856|NCT01423214|rectal cancer|rectal cancer
402857|NCT01423214|robot|robot
402858|NCT01423214|laparoscopy|laparoscopy
402859|NCT01423214|total mesorectal excision|total mesorectal excision
402860|NCT01423214|robotic surgery|robotic surgery
402861|NCT01423201|TIA|tia
402862|NCT01423201|triage|triage
402863|NCT01423201|Lp-PLA2|lp-pla2
402864|NCT01423201|Proteomic|proteomic
402865|NCT01423201|Genomic|genomic
402866|NCT01423188|ApolipoproteinA1|apolipoproteina1
402867|NCT01423188|HDL-C|hdl-c
402868|NCT01423188|Atherosclerosis|atherosclerosis
402869|NCT01423175|high risk acute myeloid leukemia|high risk acute myeloid leukemia
402870|NCT01423175|advanced myelodysplastic syndrome|advanced myelodysplastic syndrome
402871|NCT01423175|allogenic stem cell transplantation|allogenic stem cell transplantation
402872|NCT01423175|clofarabine|clofarabine
402873|NCT01423162|Iron absorption|iron absorption
402874|NCT01423162|Oats|oats
402875|NCT01423162|fortified oat beverages|fortified oat beverages
402876|NCT01423149|subfoveal choroidal neovascularization|subfoveal choroidal neovascularization
402877|NCT01423149|pathologic myopia|pathologic myopia
402878|NCT01423136|Patients undergoing non-cardiac Surgery|patients undergoing non-cardiac surgery
402879|NCT01423123|Paclitaxel|paclitaxel
402880|NCT01423123|Trastuzumab|trastuzumab
402881|NCT01423123|Neratinib|neratinib
402882|NCT01423123|Breast Cancer|breast cancer
402883|NCT01423123|HER2-positive|her2-positive
402884|NCT01423110|sporadic Inclusion Body Myositis|sporadic inclusion body myositis
402885|NCT01423097|osteoarthritis symptoms|osteoarthritis symptoms
402886|NCT01423084|Meningococcal Meningitis|meningococcal meningitis
402887|NCT01423084|prevention, vaccination|prevention, vaccination
402888|NCT01423084|adolescents|adolescents
402889|NCT01423071|Pulmonary Hypertension|pulmonary hypertension
402890|NCT01423071|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
402891|NCT01423071|Prevalence|prevalence
402892|NCT01423071|Quality of life|quality of life
402893|NCT01423045|Chronic kidney disease|chronic kidney disease
402894|NCT01423045|Urine osmolarity|urine osmolarity
402895|NCT01423045|Glomerular filtration rate|glomerular filtration rate
402896|NCT01423032|relapsed|relapsed
402897|NCT01423019|Weight Loss|weight loss
402898|NCT01423019|Body Composition|body composition
402899|NCT01423019|Fat Free Mass|fat free mass
402900|NCT01423019|Bone Mineral Density|bone mineral density
402901|NCT01423019|Adipose Tissue|adipose tissue
402902|NCT01423019|Dual-Energy X-Ray Absorptiometry|dual-energy x-ray absorptiometry
402903|NCT01423019|Body Fat|body fat
402904|NCT01423019|Eating and appetite control|eating and appetite control
402905|NCT01423019|Basal Metabolic Rate|basal metabolic rate
402906|NCT01423006|Pilot|pilot
402907|NCT01423006|Ablation|ablation
402908|NCT01423006|Low Risk|low risk
402909|NCT01423006|Radio Frequency|radio frequency
402910|NCT01423006|RFA|rfa
402911|NCT01423006|minimally invasive|minimally invasive
402912|NCT01423006|prostate gland|prostate gland
402913|NCT01422993|Oxaliplatin Induced|oxaliplatin induced
402914|NCT01422993|Peripheral Neuropathy|peripheral neuropathy
402915|NCT01422993|Strength|strength
402916|NCT01422993|Balance|balance
402917|NCT01422993|Training Program|training program
402918|NCT01422993|Colon|colon
402919|NCT01422993|Rectal|rectal
402920|NCT01422980|dairy product|dairy product
402921|NCT01422980|upper gastric discomfort|upper gastric discomfort
402922|NCT01422980|adult|adult
402923|NCT01422967|Osteoarthritis|osteoarthritis
402924|NCT01422967|Sleep|sleep
402925|NCT01422967|muscle strength|muscle strength
402926|NCT01422967|balance|balance
402927|NCT01422928|Radiotherapy|radiotherapy
402928|NCT01422928|Acupuncture|acupuncture
402929|NCT01422928|Immune System|immune system
402930|NCT01422915|Sorbent|sorbent
402931|NCT01422915|Resin|resin
402932|NCT01422915|EPP|epp
402933|NCT01422915|Cutaneous porphyria|cutaneous porphyria
402934|NCT01422915|Adult|adult
402935|NCT01422915|over age 21|over age 21
402936|NCT01422915|without intercurrent illness|without intercurrent illness
402937|NCT01422915|not pregnant|not pregnant
402938|NCT01422915|willing to participate|willing to participate
402939|NCT01422902|Schizophrenia|schizophrenia
402940|NCT01422902|Cognitive deficits|cognitive deficits
402941|NCT01422902|Cognitive remediation|cognitive remediation
402942|NCT01422902|Software|software
402943|NCT01422902|Brain Plasticity|brain plasticity
402944|NCT01422889|Atherosclerosis|atherosclerosis
402945|NCT01422889|Coronary Artery Disease|coronary artery disease
402946|NCT01422863|weight loss|weight loss
402947|NCT01422863|exercise|exercise
402948|NCT01422863|diet|diet
402949|NCT01422863|sleep apnea|sleep apnea
402950|NCT01422863|aging|aging
402951|NCT01422850|hormone-refractory prostate cancer|hormone-refractory prostate cancer
402952|NCT01422850|Immunotherapy|immunotherapy
402953|NCT01422837|opioid|opioid
402954|NCT01422837|dependence|dependence
402955|NCT01422837|VIVITROL|vivitrol
402956|NCT01422811|Public health|public health
402957|NCT01422811|Policy|policy
402958|NCT01422811|Training|training
402959|NCT01422785|Acne Vulgaris|acne vulgaris
402960|NCT01422720|Epilepsy|epilepsy
402961|NCT01422720|ESL|esl
402962|NCT01422720|Eslicarbazepine Acetate|eslicarbazepine acetate
402963|NCT01422720|BIAL|bial
402964|NCT01422720|BIA|bia
402965|NCT01422720|Partial-onset Seizures|partial-onset seizures
402966|NCT01422694|Sacroiliitis|sacroiliitis
402967|NCT01422694|Ankylosing Spondylitis|ankylosing spondylitis
402968|NCT01422694|Spondyloarthritis|spondyloarthritis
402969|NCT01422694|HLA-B27|hla-b27
402970|NCT01422694|Enthesitis-Related Arthritis|enthesitis-related arthritis
402971|NCT01422681|COPD|copd
402972|NCT01422668|Glycemic index|glycemic index
402973|NCT01422668|Dates|dates
402974|NCT01422668|Diabetes|diabetes
402975|NCT01422668|Coffee|coffee
402976|NCT01422629|Breast Fibroadenoma|breast fibroadenoma
402977|NCT01422629|High Intensity Focused Ultrasound|high intensity focused ultrasound
402978|NCT01422616|Ischemic stroke|ischemic stroke
402979|NCT01422616|High blood pressure|high blood pressure
402980|NCT01422616|Thrombolysis|thrombolysis
402981|NCT01422616|Antihypertensive drugs|antihypertensive drugs
402982|NCT01422616|Disability|disability
402983|NCT01422616|Clinical trial|clinical trial
402984|NCT01422603|High risk|high risk
402985|NCT01422603|AML|aml
402986|NCT01422603|MDS|mds
402987|NCT01422590|sitagliptin|sitagliptin
402988|NCT01422590|mitiglinide|mitiglinide
402989|NCT01422590|type 2 diabetes mellitus|type 2 diabetes mellitus
402990|NCT01422590|Pharmacodynamics|pharmacodynamics
402991|NCT01422590|Safety|safety
402992|NCT01422551|stress management intervention|stress management intervention
402993|NCT01422551|breast cancer|breast cancer
402994|NCT01422551|quality of life|quality of life
402995|NCT01422551|psychosocial adaptation|psychosocial adaptation
402996|NCT01422538|Ulthera® System|ulthera® system
402997|NCT01422538|Ultherapy™ treatment|ultherapy™ treatment
402998|NCT01422538|Ulthera, Inc.|ulthera, inc.
402999|NCT01422538|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
403000|NCT01422538|Skin laxity on the face and neck.|skin laxity on the face and neck.
403001|NCT01422512|seasonal influenza|seasonal influenza
403002|NCT01422512|vaccine|vaccine
403003|NCT01422499|pediatric oncology|pediatric oncology
403004|NCT01422499|relapsed solid tumor|relapsed solid tumor
403005|NCT01422499|lymphoma|lymphoma
403006|NCT01422499|leukemia|leukemia
403007|NCT01422499|vorinostat|vorinostat
403008|NCT01422486|Hematology|hematology
403009|NCT01422486|MDS|mds
403010|NCT01422486|Myelodysplastic Syndrome|myelodysplastic syndrome
403011|NCT01422486|Low risk MDS|low risk mds
403012|NCT01422486|Intermediate-1 risk MDS|intermediate-1 risk mds
403013|NCT01422486|Int-1 risk MDS|int-1 risk mds
403014|NCT01422486|Transfusion dependence|transfusion dependence
403015|NCT01422486|Lenalidomide refractory|lenalidomide refractory
403016|NCT01422486|Revlimid refractory|revlimid refractory
403017|NCT01422486|Lenalidomide resistant|lenalidomide resistant
403018|NCT01422486|Revlimid resistant|revlimid resistant
403019|NCT01422486|Telintra|telintra
403020|NCT01422486|ezatiostat|ezatiostat
403021|NCT01422486|ezatiostat hydrochloride|ezatiostat hydrochloride
403022|NCT01422486|TLK199|tlk199
403023|NCT01422486|Glutathione|glutathione
403024|NCT01422486|Glutathione analog|glutathione analog
403025|NCT01422486|Glutathione Transferase|glutathione transferase
403026|NCT01422486|Glutathione Transferase P1-1 inhibitor|glutathione transferase p1-1 inhibitor
403027|NCT01422486|GST P1-1 inhibitor|gst p1-1 inhibitor
403028|NCT01422486|Apoptosis|apoptosis
403029|NCT01422486|Differentiation|differentiation
403030|NCT01422486|Enzyme inhibitor|enzyme inhibitor
403031|NCT01422473|Hemorrhoids|hemorrhoids
403032|NCT01422473|Rectal Diseases|rectal diseases
403033|NCT01422473|Intestinal Diseases|intestinal diseases
403034|NCT01422473|Gastrointestinal Diseases|gastrointestinal diseases
403035|NCT01422473|Digestive System Diseases|digestive system diseases
403036|NCT01422460|Osteoarthritis|osteoarthritis
403037|NCT01422460|PRP|prp
403038|NCT01422460|PRGF|prgf
403039|NCT01422447|mental health education|mental health education
403040|NCT01422447|community-based|community-based
403041|NCT01422434|A national|a national
403042|NCT01422434|multi-centre|multi-centre
403043|NCT01422434|prospective|prospective
403044|NCT01422434|randomised|randomised
403045|NCT01422434|double-blind|double-blind
403046|NCT01422434|active-controlled|active-controlled
403047|NCT01422434|3-arm|3-arm
403048|NCT01422434|parallel group|parallel group
403049|NCT01422434|4 week study|4 week study
403050|NCT01422421|type 2 diabetes|type 2 diabetes
403051|NCT01422421|coronary artery disease|coronary artery disease
403052|NCT01422421|hypertension|hypertension
403053|NCT01422421|dyslipidemia|dyslipidemia
403054|NCT01422395|Vitrification|vitrification
403055|NCT01422395|Egg Freezing|egg freezing
403056|NCT01422395|Oocyte Cryopreservation|oocyte cryopreservation
403057|NCT01422382|Healthy Volunteers|healthy volunteers
403058|NCT01422369|Healthy Volunteers|healthy volunteers
403059|NCT01422356|cohort study|cohort study
403060|NCT01422356|men who have sex with men|men who have sex with men
403061|NCT01422343|peripheral arterial disease|peripheral arterial disease
403062|NCT01422343|cell-derived microparticles|cell-derived microparticles
403063|NCT01422343|immunity, innate|immunity, innate
403064|NCT01422343|blood coagulation|blood coagulation
403065|NCT01422330|Human Immunodeficiency Virus (HIV) infection|human immunodeficiency virus (hiv) infection
403066|NCT01422330|TMC125IFD3002|tmc125ifd3002
403067|NCT01422330|TMC125|tmc125
403068|NCT01422330|Intelence|intelence
403069|NCT01422330|HIV|hiv
403070|NCT01422317|n-3 fatty acids|n-3 fatty acids
403071|NCT01422317|randomized double-blind study|randomized double-blind study
403072|NCT01422317|coronary events|coronary events
403073|NCT01422317|serum lipids|serum lipids
403074|NCT01422317|antithrombotic effects of omega-3 fatty acids|antithrombotic effects of omega-3 fatty acids
403075|NCT01422317|anti-inflammatory effects of omega-3 fatty acids|anti-inflammatory effects of omega-3 fatty acids
403076|NCT01422317|prognostic biomarkers in myocardial infarction (MI)-patients|prognostic biomarkers in myocardial infarction (mi)-patients
403077|NCT01422291|Low back pain|low back pain
403078|NCT01422291|paracetamol|paracetamol
403079|NCT01422291|dexketoprofen|dexketoprofen
403080|NCT01422291|morphine|morphine
403081|NCT01422252|Falls Elderly persons|falls elderly persons
403082|NCT01422252|Isolated At risk for falls|isolated at risk for falls
403083|NCT01422252|Fall detection device|fall detection device
403084|NCT01422252|Precocious detection Vigi'Fall®|precocious detection vigi'fall®
403085|NCT01422239|smoking|smoking
403086|NCT01422239|treatment|treatment
403087|NCT01422239|perceived risks|perceived risks
403088|NCT01422226|IUD|iud
403089|NCT01422226|contraception|contraception
403090|NCT01422226|nulliparous|nulliparous
403091|NCT01422226|women|women
403092|NCT01422213|MDD|mdd
403093|NCT01422213|Cognitive dysfunction|cognitive dysfunction
403094|NCT01422200|DMD|dmd
403095|NCT01422200|SMA|sma
403096|NCT01422200|CMD|cmd
403097|NCT01422200|flu vaccine|flu vaccine
403098|NCT01422187|enzyme replacement therapy|enzyme replacement therapy
403099|NCT01422174|Primary prevention|primary prevention
403100|NCT01422174|Latin America|latin america
403101|NCT01422174|Sudden death|sudden death
403102|NCT01422174|Myocardial infarction|myocardial infarction
403103|NCT01422174|Ejection Fraction|ejection fraction
403104|NCT01422174|ICD|icd
403105|NCT01422161|Rehabilitation|rehabilitation
403106|NCT01422161|Fingers|fingers
403107|NCT01422161|Grasp|grasp
403108|NCT01422161|Hand|hand
403109|NCT01422161|Strength|strength
403110|NCT01422161|Brain Infraction|brain infraction
403111|NCT01422161|Pathology|pathology
403112|NCT01422161|Physiopathology|physiopathology
403113|NCT01422161|Functional Laterality|functional laterality
403114|NCT01422161|Neuronal Plasticity|neuronal plasticity
403115|NCT01422161|Psychomotor Performance|psychomotor performance
403116|NCT01422161|Biomechanics|biomechanics
403117|NCT01422161|Touch|touch
403118|NCT01422161|Weight-Bearing|weight-bearing
403119|NCT01422148|cardiac surgery|cardiac surgery
403120|NCT01422148|atrial fibrillation|atrial fibrillation
403121|NCT01422148|minocycline|minocycline
403122|NCT01422148|amiodarone|amiodarone
403123|NCT01422135|PK and safety|pk and safety
403124|NCT01422135|Pharmacokinetic profile (PK) and safety|pharmacokinetic profile (pk) and safety
403125|NCT01422122|vitamin D|vitamin d
403126|NCT01422122|pregnancy|pregnancy
403127|NCT01422122|periodontal health|periodontal health
403128|NCT01422122|biomarkers|biomarkers
403129|NCT01422109|YH14659|yh14659
403130|NCT01422109|Aspirin|aspirin
403131|NCT01422109|Clopidogrel|clopidogrel
403132|NCT01422109|Yuhan|yuhan
403133|NCT01422070|mortality|mortality
403134|NCT01422070|intensive care|intensive care
403135|NCT01422070|critical care|critical care
403136|NCT01422070|intermediate care|intermediate care
403137|NCT01422057|diabetes|diabetes
403138|NCT01422057|coronary artery disease|coronary artery disease
403139|NCT01422057|ischemic heart disease|ischemic heart disease
403140|NCT01422057|autonomic function|autonomic function
403141|NCT01422057|heart rate turbulence|heart rate turbulence
403142|NCT01422057|deceleration capacity|deceleration capacity
403143|NCT01422057|severe autonomic failure|severe autonomic failure
403144|NCT01422044|aortic stenosis|aortic stenosis
403145|NCT01422044|autonomic function|autonomic function
403146|NCT01422031|Primary care|primary care
403147|NCT01422031|Family doctor|family doctor
403148|NCT01422031|Consultation|consultation
403149|NCT01422031|utilization|utilization
403150|NCT01422031|Non-drug managements|non-drug managements
403151|NCT01422031|Patient enablement index|patient enablement index
403152|NCT01422018|clinically significant macular edema|clinically significant macular edema
403153|NCT01422018|diabetic macular edema|diabetic macular edema
403154|NCT01422018|focal edema|focal edema
403155|NCT01422018|focal laser photocoagulation|focal laser photocoagulation
403156|NCT01422018|hard exudates|hard exudates
403157|NCT01422018|intravitreal bevacizumab|intravitreal bevacizumab
403158|NCT01422005|Rehabilitation|rehabilitation
403159|NCT01422005|Fingers|fingers
403160|NCT01422005|Grasp|grasp
403161|NCT01422005|Hand|hand
403162|NCT01422005|Strength|strength
403163|NCT01422005|Brain Infraction|brain infraction
403164|NCT01422005|Hand Function|hand function
403165|NCT01422005|Post Stroke|post stroke
403166|NCT01422005|Neural mechanisms|neural mechanisms
403167|NCT01422005|Motor Control|motor control
403168|NCT01422005|Motor Function|motor function
403169|NCT01421992|randomized|randomized
403170|NCT01421992|double-blind|double-blind
403171|NCT01421992|crossover|crossover
403172|NCT01421992|methylphenidate|methylphenidate
403173|NCT01421992|excessive daytime sleepiness|excessive daytime sleepiness
403174|NCT01421966|chronic ulcers|chronic ulcers
403175|NCT01421966|diabetic foot ulcers|diabetic foot ulcers
403176|NCT01421953|Positron Emission Tomography|positron emission tomography
403177|NCT01421953|Computed Tomography|computed tomography
403178|NCT01421953|Lung cancer|lung cancer
403179|NCT01421940|Udenafil|udenafil
403180|NCT01421940|rectal cancer|rectal cancer
403181|NCT01421940|penile rehabilitation|penile rehabilitation
403182|NCT01421940|total mesorectal excision|total mesorectal excision
403183|NCT01421927|lenalidomide|lenalidomide
403184|NCT01421914|Ultrasound|ultrasound
403185|NCT01421914|Axillary block|axillary block
403186|NCT01421914|Bupivacaine|bupivacaine
403187|NCT01421914|Minimum|minimum
403188|NCT01421914|Volume|volume
403189|NCT01421914|Minimum volume of bupivacaine 0,5%|minimum volume of bupivacaine 0,5%
403190|NCT01421901|Acute appendicitis|acute appendicitis
403191|NCT01421901|Surgery|surgery
403192|NCT01421901|Antibiotics|antibiotics
403193|NCT01421901|comparison surgery and antibiotics|comparison surgery and antibiotics
403194|NCT01421901|resolutions of symptoms|resolutions of symptoms
403195|NCT01421888|Immunity|immunity
403196|NCT01421888|Urea Cycle Disorder|urea cycle disorder
403197|NCT01421888|Nutrition|nutrition
403198|NCT01421888|Vaccination|vaccination
403199|NCT01421888|Influenza|influenza
403200|NCT01421875|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
403201|NCT01421875|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
403202|NCT01421875|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
403203|NCT01421875|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
403204|NCT01421875|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
403205|NCT01421875|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
403206|NCT01421875|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
403207|NCT01421875|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
403208|NCT01421875|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
403209|NCT01421875|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
403210|NCT01421875|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
403211|NCT01421875|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
403212|NCT01421875|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
403213|NCT01421875|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
403214|NCT01421875|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
403215|NCT01421862|adult acute basophilic leukemia|adult acute basophilic leukemia
403216|NCT01421862|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
403217|NCT01421862|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
403218|NCT01421862|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
403219|NCT01421862|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
403220|NCT01421862|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
403221|NCT01421862|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
403222|NCT01421862|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
403223|NCT01421862|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
403224|NCT01421862|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
403225|NCT01421862|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
403226|NCT01421862|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
403227|NCT01421862|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
403228|NCT01421862|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
403229|NCT01421862|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
403230|NCT01421862|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
403231|NCT01421862|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
403232|NCT01421849|single implant denture|single implant denture
403233|NCT01421849|Elderly with an unstable mandibular denture|elderly with an unstable mandibular denture
403234|NCT01421836|stent patency|stent patency
403235|NCT01421836|EUS guided insertion|eus guided insertion
403236|NCT01421836|ERCP guided insertion|ercp guided insertion
403237|NCT01421823|Fecal Incontinence|fecal incontinence
403238|NCT01421823|Alpha agonist|alpha agonist
403239|NCT01421732|Dengue fever|dengue fever
403240|NCT01421732|severe dengue fever|severe dengue fever
403241|NCT01421732|NS1 detection assay|ns1 detection assay
403242|NCT01421732|Prognosis|prognosis
403243|NCT01421732|Diagnosis|diagnosis
403244|NCT01421719|Parkinson's Disease|parkinson's disease
403245|NCT01421719|Neurogenic Bladder|neurogenic bladder
403246|NCT01421719|Urinary Incontinence|urinary incontinence
403247|NCT01421719|botulinum toxin|botulinum toxin
403248|NCT01421719|cystoscopy|cystoscopy
403249|NCT01421719|Effect of Other Parasympatholytics [Anticholinergics and Antimuscarinics] and Spasmolytics|effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics
403250|NCT01421706|clarithromycin|clarithromycin
403251|NCT01421706|sibutramine|sibutramine
403252|NCT01421706|clopidogrel|clopidogrel
403253|NCT01421693|Gatifloxacin|gatifloxacin
403254|NCT01421693|Ceftriaxone|ceftriaxone
403255|NCT01421693|Enteric fever|enteric fever
403256|NCT01421693|Typhoid fever|typhoid fever
403257|NCT01421667|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
403258|NCT01421667|Antigens, CD30|antigens, cd30
403259|NCT01421667|Antibody-Drug Conjugate|antibody-drug conjugate
403260|NCT01421667|Antibodies, Monoclonal|antibodies, monoclonal
403261|NCT01421667|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
403964|NCT01419106|Hypotension|hypotension
403262|NCT01421667|Monomethyl auristatin E|monomethyl auristatin e
403263|NCT01421667|Drug Therapy|drug therapy
403264|NCT01421667|Immunotherapy|immunotherapy
403265|NCT01421667|Hematologic Diseases|hematologic diseases
403266|NCT01421667|Lymphoma|lymphoma
403267|NCT01421667|Lymphoma, B-Cell|lymphoma, b-cell
403268|NCT01421667|Lymphoma, T-Cell|lymphoma, t-cell
403269|NCT01421654|OSA|osa
403270|NCT01421654|Sleep Apnea|sleep apnea
403271|NCT01421654|PAP|pap
403272|NCT01421654|positive airway pressure|positive airway pressure
403273|NCT01421641|Tenaculum|tenaculum
403274|NCT01421641|Pain|pain
403275|NCT01421641|Lidocaine|lidocaine
403276|NCT01421628|older adults|older adults
403277|NCT01421628|exercise|exercise
403278|NCT01421628|stretching|stretching
403279|NCT01421628|mobility|mobility
403280|NCT01421615|Bacterial vaginosis|bacterial vaginosis
403281|NCT01421615|Probiotics|probiotics
403282|NCT01421615|Lactobacilli|lactobacilli
403283|NCT01421615|Pregnancy outcome|pregnancy outcome
403284|NCT01421615|Randomized controlled trial|randomized controlled trial
403285|NCT01421602|Inguinal Hernia|inguinal hernia
403286|NCT01421602|Self-fixating mesh|self-fixating mesh
403287|NCT01421602|Progrip|progrip
403288|NCT01421602|Hernia Recurrence|hernia recurrence
403289|NCT01421602|Mesh, Surgical|mesh, surgical
403290|NCT01421602|Recurrence|recurrence
403291|NCT01421589|Growth hormone|growth hormone
403292|NCT01421589|GH|gh
403293|NCT01421589|Obesity|obesity
403294|NCT01421589|Mitochondrial function|mitochondrial function
403295|NCT01421589|reduced growth hormone secretion|reduced growth hormone secretion
403296|NCT01421550|umbilical|umbilical
403297|NCT01421550|hernia|hernia
403298|NCT01421550|cirrhosis|cirrhosis
403299|NCT01421550|ascites|ascites
403300|NCT01421550|conservative|conservative
403301|NCT01421550|surgery|surgery
403302|NCT01421550|optimal management|optimal management
403303|NCT01421537|Thromboprophylaxis|thromboprophylaxis
403304|NCT01421537|enoxaparin|enoxaparin
403305|NCT01421524|Neoplasm|neoplasm
403306|NCT01421524|Malignancy|malignancy
403307|NCT01421524|Carcinoma|carcinoma
403308|NCT01421524|Lymphoma|lymphoma
403309|NCT01421524|Multiple Myeloma|multiple myeloma
403310|NCT01421524|DNA-PK inhibitor|dna-pk inhibitor
403311|NCT01421524|Advanced Solid Tumors|advanced solid tumors
403312|NCT01421524|Glioblastoma multiforme|glioblastoma multiforme
403313|NCT01421524|Hepatocellular Carcinoma|hepatocellular carcinoma
403314|NCT01421524|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
403315|NCT01421524|Mantel Cell Lymphoma|mantel cell lymphoma
403316|NCT01421524|Advanced unresectable Solid Tumors|advanced unresectable solid tumors
403317|NCT01421524|Primary CNS Lymphoma|primary cns lymphoma
403318|NCT01421511|ABSSSI|absssi
403319|NCT01421511|Tedizolid Phosphate|tedizolid phosphate
403320|NCT01421511|TR-701|tr-701
403321|NCT01421511|Acute Bacterial Skin and Skin Structure Infections|acute bacterial skin and skin structure infections
403322|NCT01421498|Dry Eye|dry eye
403323|NCT01421498|ophthalmic delivery|ophthalmic delivery
403324|NCT01421472|Breast Cancer|breast cancer
403325|NCT01421472|Neoadjuvant|neoadjuvant
403326|NCT01421472|Her2 negative|her2 negative
403327|NCT01421472|Her2 non-overexpressing|her2 non-overexpressing
403328|NCT01421472|Estrogen Receptor Positive|estrogen receptor positive
403329|NCT01421472|Triple Negative|triple negative
403330|NCT01421472|MM-121|mm-121
403331|NCT01421472|Paclitaxel|paclitaxel
403332|NCT01421459|Diabetes|diabetes
403333|NCT01421459|Type 2 Diabetes|type 2 diabetes
403334|NCT01421446|Neuropsychology|neuropsychology
403335|NCT01421433|Clonixin|clonixin
403336|NCT01421433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
403337|NCT01421433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors
403338|NCT01421433|Lysine|lysine
403339|NCT01421433|L-Lysine|l-lysine
403340|NCT01421433|Lysine Acetate|lysine acetate
403341|NCT01421433|Lysine Hydrochloride|lysine hydrochloride
403342|NCT01421433|Amitriptyline|amitriptyline
403343|NCT01421420|Alzheimer's|alzheimer's
403344|NCT01421420|Dementia|dementia
403345|NCT01421420|Mild Cognitive Impairment|mild cognitive impairment
403346|NCT01421407|Secondary hyperparathyroidism|secondary hyperparathyroidism
403347|NCT01421407|End stage renal disease|end stage renal disease
403348|NCT01421407|Parathyroid hyperplasia|parathyroid hyperplasia
403349|NCT01421407|High Intensity Focused Ultrasound|high intensity focused ultrasound
403350|NCT01421394|spinal cord injury(SCI)|spinal cord injury(sci)
403351|NCT01421394|diffusion tensor imaging(DTI)|diffusion tensor imaging(dti)
403352|NCT01421394|tractography|tractography
403353|NCT01421381|leber's hereditary optic neuropathy|leber's hereditary optic neuropathy
403354|NCT01421381|idebenone|idebenone
403355|NCT01421342|Mood Disorder|mood disorder
403356|NCT01421342|Depression|depression
403357|NCT01421342|Depressive Disorder|depressive disorder
403358|NCT01421342|Depressive Disorder, Major|depressive disorder, major
403359|NCT01421342|Bupropion|bupropion
403360|NCT01421342|Aripiprazole|aripiprazole
403361|NCT01421342|Remission|remission
403362|NCT01421342|Relapse|relapse
403363|NCT01421342|Cost-Effectiveness|cost-effectiveness
403364|NCT01421342|Atypical Antipsychotic|atypical antipsychotic
403365|NCT01421342|Antidepressant|antidepressant
403366|NCT01421342|Augmentation|augmentation
403367|NCT01421342|Veterans|veterans
403368|NCT01421342|Mental Health|mental health
403369|NCT01421316|Patients treated with whole brain radiotherapy in the setting of brain metastases|patients treated with whole brain radiotherapy in the setting of brain metastases
403370|NCT01421316|Patients treated with whole brain radiotherapy in the prophylactic treatment for small cell lung cancer (extended disease).|patients treated with whole brain radiotherapy in the prophylactic treatment for small cell lung cancer (extended disease).
403371|NCT01421290|Cartilage lesions in the knee joint|cartilage lesions in the knee joint
403372|NCT01421264|concussion|concussion
403373|NCT01421264|gabapentin|gabapentin
403374|NCT01421264|neurontin|neurontin
403375|NCT01421264|insomnia|insomnia
403376|NCT01421251|H1N1|h1n1
403377|NCT01421251|Flu|flu
403378|NCT01421251|Influenza|influenza
403379|NCT01421251|Vaccine|vaccine
403380|NCT01421251|Manitoba|manitoba
403381|NCT01421251|Canada|canada
403382|NCT01421251|Safety|safety
403383|NCT01421238|Decision Making|decision making
403384|NCT01421238|Premature infant|premature infant
403385|NCT01421238|Informed consent|informed consent
403386|NCT01421238|Prematurity|prematurity
403387|NCT01421238|Framing|framing
403388|NCT01421238|Negotiation Model|negotiation model
403389|NCT01421225|Closed Loop Insulin Delivery|closed loop insulin delivery
403390|NCT01421225|Diabetes|diabetes
403391|NCT01421225|Type 1 Diabetes|type 1 diabetes
403392|NCT01421225|Artificial pancreas|artificial pancreas
403393|NCT01421212|Liver Transplantation|liver transplantation
403394|NCT01421212|Liver Disease|liver disease
403395|NCT01421212|Hepatitis B|hepatitis b
403396|NCT01421212|Hepatitis B Infection|hepatitis b infection
403397|NCT01421212|Hepatitis B Associated Liver Disease|hepatitis b associated liver disease
403398|NCT01421212|HBV|hbv
403399|NCT01421199|Otitis Media with Effusion|otitis media with effusion
403400|NCT01421199|Middle Ear Effusion|middle ear effusion
403401|NCT01421186|Multiple Myeloma|multiple myeloma
403402|NCT01421186|MOR03087 (MOR202)|mor03087 (mor202)
403403|NCT01421186|Lenalidomide|lenalidomide
403404|NCT01421186|Pomalidomide|pomalidomide
403405|NCT01421186|CD38|cd38
403406|NCT01421173|Lymphoma|lymphoma
403407|NCT01421173|Lymphoid malignancies|lymphoid malignancies
403408|NCT01421173|Relapsed|relapsed
403409|NCT01421173|Refractory|refractory
403410|NCT01421173|Autologous hematopoietic cell support|autologous hematopoietic cell support
403411|NCT01421173|Stem cell infusion|stem cell infusion
403412|NCT01421173|Hodgkin's lymphoma|hodgkin's lymphoma
403413|NCT01421173|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
403414|NCT01421173|Vorinostat|vorinostat
403415|NCT01421173|SAHA|saha
403416|NCT01421173|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
403417|NCT01421173|MSK-390|msk-390
403418|NCT01421173|Zolinza|zolinza
403419|NCT01421173|Busulfan|busulfan
403420|NCT01421173|Busulfex|busulfex
403421|NCT01421173|Myleran|myleran
403422|NCT01421173|Gemcitabine|gemcitabine
403423|NCT01421173|Gemcitabine Hydrochloride|gemcitabine hydrochloride
403424|NCT01421173|Gemzar|gemzar
403425|NCT01421173|Melphalan|melphalan
403426|NCT01421173|Alkeran|alkeran
403427|NCT01421173|Rituximab|rituximab
403428|NCT01421173|Rituxan|rituxan
403429|NCT01421173|Dexamethasone|dexamethasone
403430|NCT01421173|Decadron|decadron
403431|NCT01421173|G-CSF|g-csf
403432|NCT01421173|Filgrastim|filgrastim
403433|NCT01421173|NeupogenTM|neupogentm
403434|NCT01421173|Palifermin|palifermin
403435|NCT01421173|Kepivance|kepivance
403436|NCT01421160|Chronic|chronic
403437|NCT01421160|Inflammatory|inflammatory
403438|NCT01421160|Joint|joint
403439|NCT01421160|Pain|pain
403440|NCT01421147|Diabetes|diabetes
403441|NCT01421147|Type 1 Diabetes|type 1 diabetes
403442|NCT01421147|Diabetes Mellitus|diabetes mellitus
403443|NCT01421134|depression|depression
403444|NCT01421134|Lurasidone|lurasidone
403445|NCT01421134|Latuda|latuda
403446|NCT01421108|oral health|oral health
403447|NCT01421108|dental brushing|dental brushing
403448|NCT01421108|dental flossing|dental flossing
403449|NCT01421095|Fertility|fertility
403450|NCT01421095|adolescent|adolescent
403451|NCT01421095|young adult|young adult
403452|NCT01421095|cancer survivors|cancer survivors
403453|NCT01421082|LVRS (Lung Volume Reduction Surgery)|lvrs (lung volume reduction surgery)
403454|NCT01421082|LVRC (Lung Volume Reduction Coil)|lvrc (lung volume reduction coil)
403455|NCT01421082|Emphysema|emphysema
403456|NCT01421082|coil|coil
403457|NCT01421082|RePneu|repneu
403458|NCT01421069|Use of etanercept to treat pediatric subjects with extended oligoarticular JIA|use of etanercept to treat pediatric subjects with extended oligoarticular jia
403459|NCT01421069|enthestitis related arthritis (ERA)|enthestitis related arthritis (era)
403460|NCT01421069|or psoriatic arthritis (PsA).|or psoriatic arthritis (psa).
403461|NCT01421043|bioequivalence study|bioequivalence study
403462|NCT01421043|triazolam|triazolam
403463|NCT01421043|liquid oral drops|liquid oral drops
403464|NCT01421043|tablet|tablet
403465|NCT01421030|quality of life|quality of life
403466|NCT01421030|congenital heart disease|congenital heart disease
403467|NCT01421030|open heart surgery|open heart surgery
403468|NCT01421030|percutaneous pulmonary valve implantation|percutaneous pulmonary valve implantation
403469|NCT01421030|costs|costs
403470|NCT01421017|radiation therapy|radiation therapy
403471|NCT01421017|combination therapy|combination therapy
403472|NCT01421017|immunotherapy|immunotherapy
403473|NCT01421017|immune response modifier|immune response modifier
403474|NCT01421017|immunostimulatory|immunostimulatory
403475|NCT01421017|immunomodulator|immunomodulator
403477|NCT01421004|tumors|tumors
403478|NCT01421004|phase I|phase i
403479|NCT01421004|crossover|crossover
403480|NCT01421004|bioequivalence|bioequivalence
403481|NCT01420965|Anti PD-1 Monoclonal Antibody|anti pd-1 monoclonal antibody
403482|NCT01420965|Vaccine|vaccine
403483|NCT01420965|Autologous Cellular Immunotherapy|autologous cellular immunotherapy
403484|NCT01420965|Prostate Cancer|prostate cancer
403485|NCT01420952|Positron Emission Tomograhy (PET)|positron emission tomograhy (pet)
403486|NCT01420952|Metabolic Glutamate Receptors|metabolic glutamate receptors
403487|NCT01420952|Brain|brain
403488|NCT01420939|TBI|tbi
403489|NCT01420939|Brain|brain
403490|NCT01420939|Traumatic Brain Injury|traumatic brain injury
403491|NCT01420939|Biomarkers|biomarkers
403492|NCT01420939|Healthy Volunteer|healthy volunteer
403493|NCT01420939|HV|hv
403494|NCT01420913|To evaluate the pharmacokinetic characteristics of Lyrica, YHD1119 A,B,C|to evaluate the pharmacokinetic characteristics of lyrica, yhd1119 a,b,c
403495|NCT01420887|CPM|cpm
403496|NCT01420887|elbow joint surgery|elbow joint surgery
403497|NCT01420887|continuous passive motion|continuous passive motion
403498|NCT01420887|Recovery after surgery to restore elbow motion|recovery after surgery to restore elbow motion
403499|NCT01420861|castrate resistant|castrate resistant
403500|NCT01420848|stress disorders|stress disorders
403501|NCT01420848|anxiety disorders|anxiety disorders
403502|NCT01420835|Stress|stress
403503|NCT01420835|Quality of life|quality of life
403504|NCT01420796|Parkinson's disease|parkinson's disease
403505|NCT01420796|dysphagia|dysphagia
403506|NCT01420796|swallowing treatment|swallowing treatment
403507|NCT01420757|operation time|operation time
403508|NCT01420757|length of hospital stay|length of hospital stay
403509|NCT01420744|Endotracheal ventilation|endotracheal ventilation
403510|NCT01420744|Bacterial pneumonia|bacterial pneumonia
403511|NCT01420731|sexual life, back pain|sexual life, back pain
403512|NCT01420718|partial pulpotomy|partial pulpotomy
403513|NCT01420718|Cvek pulpotomy|cvek pulpotomy
403514|NCT01420718|MTA|mta
403515|NCT01420718|iRootBP|irootbp
403516|NCT01420718|dentin bridge|dentin bridge
403517|NCT01420705|Bacille Calmette-Guérin|bacille calmette-guérin
403518|NCT01420705|DTP|dtp
403519|NCT01420705|Vaccination|vaccination
403520|NCT01420705|Allergy|allergy
403521|NCT01420705|Atopy|atopy
403522|NCT01420705|Guinea-Bissau|guinea-bissau
403523|NCT01420692|Tip 2 DM|tip 2 dm
403524|NCT01420692|Endothelium|endothelium
403525|NCT01420692|Gliclazide|gliclazide
403526|NCT01420692|Insulin detemir|insulin detemir
403527|NCT01420679|Lymphoproliferative Disorders|lymphoproliferative disorders
403528|NCT01420679|Lymphoma|lymphoma
403529|NCT01420679|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
403530|NCT01420679|T-cell Lymphoma|t-cell lymphoma
403531|NCT01420640|Fibromyalgia|fibromyalgia
403532|NCT01420640|Tai Chi|tai chi
403533|NCT01420640|mind-body exercise|mind-body exercise
403534|NCT01420640|aerobic exercise|aerobic exercise
403535|NCT01420640|exercise|exercise
403536|NCT01420640|pain|pain
403537|NCT01420614|radial access|radial access
403538|NCT01420614|primary angioplasty|primary angioplasty
403539|NCT01420614|trial|trial
403540|NCT01420614|randomization|randomization
403541|NCT01420614|outcome|outcome
403542|NCT01420601|Torisel|torisel
403543|NCT01420601|Long-term use|long-term use
403544|NCT01420601|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
403545|NCT01420588|Oncologic Investigations|oncologic investigations
403546|NCT01420588|Gastric Diseases|gastric diseases
403547|NCT01420588|Gastric Cancer|gastric cancer
403548|NCT01420588|Gastric Ulcer|gastric ulcer
403549|NCT01420588|Breath Analysis|breath analysis
403550|NCT01420588|Volatile Biomarkers|volatile biomarkers
403551|NCT01420588|Nanosensors Array|nanosensors array
403552|NCT01420588|Discriminant Factor Analysis|discriminant factor analysis
403553|NCT01420588|GC-MS|gc-ms
403554|NCT01420588|Breath Tests|breath tests
403555|NCT01420575|Schizophrenia|schizophrenia
403556|NCT01420575|Schizoaffective Disorder|schizoaffective disorder
403557|NCT01420575|Shared Decision|shared decision
403558|NCT01420575|Decision Aid|decision aid
403559|NCT01420575|Antipsychotic|antipsychotic
403560|NCT01420575|Weight Gain|weight gain
403561|NCT01420575|Olanzapine|olanzapine
403562|NCT01420575|Lexapro|lexapro
403563|NCT01420575|Perphenazine|perphenazine
403564|NCT01420562|allogeneic HSCT|allogeneic hsct
403565|NCT01420562|posaconazole|posaconazole
403566|NCT01420562|prophylaxis|prophylaxis
403567|NCT01420562|mucositis|mucositis
403568|NCT01420562|pharmacokinetics|pharmacokinetics
403569|NCT01420549|Hypercholesterolemia|hypercholesterolemia
403570|NCT01420549|Dyslipidemia|dyslipidemia
403571|NCT01420536|Bilateral Balanced Occlusion|bilateral balanced occlusion
403572|NCT01420536|Canine Guidance|canine guidance
403573|NCT01420536|Complete Denture|complete denture
403574|NCT01420536|Denture Retention|denture retention
403575|NCT01420536|Dental Occlusion|dental occlusion
403576|NCT01420536|Edentulous|edentulous
403577|NCT01420536|Edentulism|edentulism
403578|NCT01420536|Mandibular movement|mandibular movement
403579|NCT01420536|Mastication|mastication
403580|NCT01420536|Patient Acceptance of Health Care|patient acceptance of health care
403581|NCT01420536|Patient Satisfaction|patient satisfaction
403582|NCT01420523|HIV|hiv
403583|NCT01420523|Lipohypertrophy|lipohypertrophy
403584|NCT01420510|Patients satisfaction|patients satisfaction
403585|NCT01420510|Side effects|side effects
403586|NCT01420497|methylprednisolone|methylprednisolone
403587|NCT01420497|intra articular infiltration|intra articular infiltration
403588|NCT01420497|glycemia|glycemia
403589|NCT01420497|epidural infiltration|epidural infiltration
403590|NCT01420497|diabetes|diabetes
403591|NCT01420484|CNAP|cnap
403592|NCT01420484|continuous non-invasive arterial pressure|continuous non-invasive arterial pressure
403593|NCT01420484|IAP|iap
403594|NCT01420484|blood pressure|blood pressure
403595|NCT01420484|analgosedation|analgosedation
403596|NCT01420484|high-risk patients|high-risk patients
403597|NCT01420484|rapid-pacing|rapid-pacing
403598|NCT01420471|Endoscopic Sinus Surgery|endoscopic sinus surgery
403599|NCT01420471|Triamcinolone|triamcinolone
403600|NCT01420471|Merocel Middle Meatus Spacers|merocel middle meatus spacers
403601|NCT01420458|bioequivalence|bioequivalence
403602|NCT01420432|Ankylosing Spondylitis|ankylosing spondylitis
403603|NCT01420432|Umbilical Cord/placenta-Derived MSC|umbilical cord/placenta-derived msc
403604|NCT01420432|Transplantation|transplantation
403605|NCT01420419|nipple pain|nipple pain
403606|NCT01420419|breastfeeding|breastfeeding
403607|NCT01420419|nipple damage|nipple damage
403608|NCT01420419|lanolin|lanolin
403609|NCT01420419|clinical trial|clinical trial
403610|NCT01420406|lactation|lactation
403611|NCT01420406|cryptoxanthin|cryptoxanthin
403612|NCT01420406|beta-carotene|beta-carotene
403613|NCT01420406|vitamin A|vitamin a
403614|NCT01420393|Heart Failure|heart failure
403615|NCT01420393|Atrial Fibrillation|atrial fibrillation
403616|NCT01420393|Catheter Ablation|catheter ablation
403617|NCT01420393|Anti-arrhythmic Medications|anti-arrhythmic medications
403618|NCT01420393|Cardiovascular Mortality|cardiovascular mortality
403619|NCT01420367|Paediatric|paediatric
403620|NCT01420367|Simple|simple
403621|NCT01420367|Non-perforated|non-perforated
403622|NCT01420354|Metabolic stones|metabolic stones
403623|NCT01420354|kidney stones|kidney stones
403624|NCT01420354|renal calculi|renal calculi
403625|NCT01420354|metabolic evaluation|metabolic evaluation
403626|NCT01420341|Meliodosis|meliodosis
403627|NCT01420341|Co-trimoxazole|co-trimoxazole
403628|NCT01420341|Relapse|relapse
403629|NCT01420315|vitamin D|vitamin d
403630|NCT01420315|deficiency|deficiency
403631|NCT01420315|alzheimer's disease|alzheimer's disease
403632|NCT01420302|critical illness|critical illness
403633|NCT01420302|intensive care|intensive care
403634|NCT01420302|insulin|insulin
403635|NCT01420302|glucose|glucose
403636|NCT01420302|algorithm|algorithm
403637|NCT01420302|blood glucose control|blood glucose control
403638|NCT01420289|Ischemic ulcers|ischemic ulcers
403639|NCT01420289|PAD|pad
403640|NCT01420289|Intermittent Claudication Pain|intermittent claudication pain
403641|NCT01420276|Female sexual function|female sexual function
403642|NCT01420263|premature infant|premature infant
403643|NCT01420263|feeding|feeding
403644|NCT01420263|residuals|residuals
403645|NCT01420263|fresh feeds|fresh feeds
403646|NCT01420263|full feeds|full feeds
403647|NCT01420263|digestive system|digestive system
403648|NCT01420250|Prostate cancer|prostate cancer
403649|NCT01420250|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
403650|NCT01420237|Noninflammatory joint disease of the hip.|noninflammatory joint disease of the hip.
403651|NCT01420224|Air travel|air travel
403652|NCT01420224|Aircraft cabin hypoxia|aircraft cabin hypoxia
403653|NCT01420224|Pulmonary artery pressure|pulmonary artery pressure
403654|NCT01420224|Hypoxic pulmonary vasoconstriction|hypoxic pulmonary vasoconstriction
403655|NCT01420224|Pulmonary hypertension|pulmonary hypertension
403656|NCT01420211|pharmacokinetics|pharmacokinetics
403657|NCT01420211|MRI|mri
403658|NCT01420211|liver|liver
403659|NCT01420211|drug transporter|drug transporter
403660|NCT01420211|Gd-EOB-DTPA|gd-eob-dtpa
403661|NCT01420198|Diabetes type 2|diabetes type 2
403662|NCT01420198|Lifestyle intervention|lifestyle intervention
403663|NCT01420198|QALY|qaly
403664|NCT01420198|Ethnic group|ethnic group
403665|NCT01420198|Impaired glucose tolerance|impaired glucose tolerance
403666|NCT01420198|Impaired fasting glucose|impaired fasting glucose
403667|NCT01420185|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
403668|NCT01420185|stage II breast cancer|stage ii breast cancer
403669|NCT01420185|stage IIIA breast cancer|stage iiia breast cancer
403670|NCT01420159|Pain|pain
403671|NCT01420159|Trauma|trauma
403672|NCT01420159|Analgesia|analgesia
403673|NCT01420133|Corticosteroids|corticosteroids
403674|NCT01420133|Diet low in sugar and salt|diet low in sugar and salt
403675|NCT01420133|Dermatological disease|dermatological disease
403676|NCT01420133|Corticosteroids Allergy|corticosteroids allergy
403677|NCT01420133|3 Months|3 months
403678|NCT01420120|Biodegradable stent, PAD|biodegradable stent, pad
403679|NCT01420107|Infant, Premature|infant, premature
403680|NCT01420107|Delivery Rooms|delivery rooms
403681|NCT01420107|Video Recording|video recording
403682|NCT01420107|Outcome Assessment (Health Care)|outcome assessment (health care)
403683|NCT01420094|Drugs, Investigational|drugs, investigational
403684|NCT01420094|Acetylsalicylic Acid|acetylsalicylic acid
403685|NCT01420094|Aspirin|aspirin
403686|NCT01420094|dental pain|dental pain
403687|NCT01420081|uterine neoplasms|uterine neoplasms
403688|NCT01420081|endometrial|endometrial
403689|NCT01420081|uterine|uterine
403690|NCT01420081|cancer|cancer
403691|NCT01420081|PI3K|pi3k
403692|NCT01420081|mTOR|mtor
403693|NCT01420081|PI3K/mTOR|pi3k/mtor
403694|NCT01420081|recurrent|recurrent
403695|NCT01420081|metastatic|metastatic
403696|NCT01420068|Pediatric|pediatric
403697|NCT01420068|hypertension|hypertension
403698|NCT01420068|aliskiren|aliskiren
403699|NCT01420055|Multiple sclerosis|multiple sclerosis
403700|NCT01420055|Fingolimod|fingolimod
403701|NCT01420055|Coping|coping
403702|NCT01420055|Anxiety|anxiety
403703|NCT01420055|France|france
403704|NCT01420055|Treatment Satisfaction Questionnaire for Medication-9 items (TSQM 9)|treatment satisfaction questionnaire for medication-9 items (tsqm 9)
403705|NCT01420055|Active|active
403706|NCT01420029|Low birth weight neonates|low birth weight neonates
403707|NCT01420029|Neurodevelopmental outcome|neurodevelopmental outcome
403708|NCT01420029|Thyroid dysfunction|thyroid dysfunction
403709|NCT01420029|Extrauterine growth|extrauterine growth
403710|NCT01420029|Plasticizers|plasticizers
403711|NCT01420016|Cardiovascular risk|cardiovascular risk
403712|NCT01420003|Allergen Challenge|allergen challenge
403713|NCT01420003|B cell activation|b cell activation
403714|NCT01420003|M1 prime related biomarkers|m1 prime related biomarkers
403715|NCT01419977|sickle cell disease|sickle cell disease
403716|NCT01419977|vaso-occlusive crisis|vaso-occlusive crisis
403717|NCT01419977|anticoagulation|anticoagulation
403718|NCT01419964|Vitiligo|vitiligo
403719|NCT01419964|Macular depigmentation|macular depigmentation
403720|NCT01419964|Stachytarpheta cayensensis|stachytarpheta cayensensis
403721|NCT01419951|Behavioral treatment|behavioral treatment
403722|NCT01419951|Preschool aged children|preschool aged children
403723|NCT01419951|Obesity|obesity
403724|NCT01419938|Light therapy|light therapy
403725|NCT01419938|circadian rhythm|circadian rhythm
403726|NCT01419938|CBT|cbt
403727|NCT01419925|influenza vaccine|influenza vaccine
403728|NCT01419925|peptide|peptide
403729|NCT01419925|universal|universal
403730|NCT01419925|prime|prime
403731|NCT01419925|boost|boost
403732|NCT01419925|TIV|tiv
403733|NCT01419925|HAI|hai
403734|NCT01419925|Hemagglutination Inhibition|hemagglutination inhibition
403735|NCT01419925|elderly|elderly
403736|NCT01419899|Brief intervention|brief intervention
403737|NCT01419899|Rapid testing|rapid testing
403738|NCT01419873|Hyperglycaemia|hyperglycaemia
403739|NCT01419873|Very low birthweight infants|very low birthweight infants
403740|NCT01419873|Insulin|insulin
403741|NCT01419860|Microcirculation|microcirculation
403742|NCT01419860|Colon|colon
403743|NCT01419860|Anastomosis|anastomosis
403744|NCT01419860|ICG|icg
403745|NCT01419860|Gastro surgery|gastro surgery
403746|NCT01419860|benign colon diseases requiring resection|benign colon diseases requiring resection
403747|NCT01419834|CNS|cns
403748|NCT01419834|Brain|brain
403749|NCT01419834|MAB 3F8|mab 3f8
403750|NCT01419834|Hu3F8|hu3f8
403751|NCT01419834|11-009|11-009
403752|NCT01419821|Vitamin D|vitamin d
403753|NCT01419821|Bone densitometry|bone densitometry
403754|NCT01419821|Vitamin D supplementation|vitamin d supplementation
403755|NCT01419821|Growth|growth
403756|NCT01419808|Scaphoid|scaphoid
403757|NCT01419808|Non-Union|non-union
403758|NCT01419808|Proximal pole|proximal pole
403759|NCT01419808|Bone Graft|bone graft
403760|NCT01419808|Vascularized|vascularized
403761|NCT01419808|Non-Vascularized|non-vascularized
403762|NCT01419808|PREE|pree
403763|NCT01419782|bone|bone
403764|NCT01419782|osteocyte|osteocyte
403765|NCT01419782|rest muscle electrical activity|rest muscle electrical activity
403766|NCT01419782|whole-body vibration|whole-body vibration
403767|NCT01419782|sclerostin|sclerostin
403768|NCT01419769|symptomatic pancreatic pseudocyst|symptomatic pancreatic pseudocyst
403769|NCT01419769|pancreatic pseudocyst|pancreatic pseudocyst
403770|NCT01419769|transluminal drainage|transluminal drainage
403771|NCT01419769|minimally invasive|minimally invasive
403772|NCT01419769|Nitinol stent|nitinol stent
403773|NCT01419769|transmural endoscopic drainage|transmural endoscopic drainage
403774|NCT01419769|catheter based|catheter based
403775|NCT01419743|Vitamin D deficiency|vitamin d deficiency
403776|NCT01419743|Supplementation|supplementation
403777|NCT01419743|Infertility|infertility
403778|NCT01419743|Clinical pregnancy rates|clinical pregnancy rates
403779|NCT01419717|cancer|cancer
403780|NCT01419717|bone metastases|bone metastases
403781|NCT01419717|breast cancer|breast cancer
403782|NCT01419717|prostate cancer|prostate cancer
403783|NCT01419704|other hemoglobinopathies|other hemoglobinopathies
403784|NCT01419704|chimerism|chimerism
403785|NCT01419704|sickle cell|sickle cell
403786|NCT01419704|thalassemia|thalassemia
403787|NCT01419704|Marrow/Enriched Hematopoetic Stem Cell Transplant|marrow/enriched hematopoetic stem cell transplant
403788|NCT01419691|auranofin|auranofin
403789|NCT01419691|chronic lymphocytic leukemia|chronic lymphocytic leukemia
403790|NCT01419691|relapsed|relapsed
403791|NCT01419691|refractory|refractory
403792|NCT01419691|CLL|cll
403793|NCT01419691|SLL|sll
403794|NCT01419691|PLL|pll
403795|NCT01419678|posaconazole|posaconazole
403796|NCT01419678|PK blood sampling|pk blood sampling
403797|NCT01419665|Follicular Lymphoma|follicular lymphoma
403798|NCT01419665|Biosimilar|biosimilar
403799|NCT01419665|GP13-301|gp13-301
403800|NCT01419665|rituximab|rituximab
403801|NCT01419665|Antibodies|antibodies
403802|NCT01419665|CD20|cd20
403803|NCT01419652|percutaneous coronary intervention|percutaneous coronary intervention
403804|NCT01419639|Neurofibromatosis Type II|neurofibromatosis type ii
403805|NCT01419639|cranial nerve schwannomas|cranial nerve schwannomas
403806|NCT01419639|meningiomas|meningiomas
403807|NCT01419639|ependymomas|ependymomas
403808|NCT01419613|healthy lifestyle|healthy lifestyle
403809|NCT01419613|physical activity|physical activity
403810|NCT01419613|behavior|behavior
403811|NCT01419613|motivational|motivational
403812|NCT01419613|interview|interview
403813|NCT01419613|breast cancer survivor|breast cancer survivor
403814|NCT01419600|Phase 1|phase 1
403815|NCT01419600|healthy volunteers|healthy volunteers
403816|NCT01419600|safety|safety
403817|NCT01419600|tolerability|tolerability
403818|NCT01419600|pharmacokinetics|pharmacokinetics
403819|NCT01419600|single ascending dose study|single ascending dose study
403820|NCT01419587|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
403821|NCT01419587|Non small cell lung cancer|non small cell lung cancer
403822|NCT01419587|NSCLC|nsclc
403823|NCT01419587|Ketogenic Diet|ketogenic diet
403824|NCT01419587|radiotherapy|radiotherapy
403825|NCT01419587|paclitaxel|paclitaxel
403826|NCT01419587|carboplatin|carboplatin
403827|NCT01419574|Carotid Artery Plaque|carotid artery plaque
403828|NCT01419574|Contrast Agents|contrast agents
403829|NCT01419574|Vasa Vasorum|vasa vasorum
403830|NCT01419574|MRI|mri
403831|NCT01419574|Intraplaque Hemorrhage|intraplaque hemorrhage
403832|NCT01419574|Solid Tumor|solid tumor
403833|NCT01419574|Metastatic Solid Tumor|metastatic solid tumor
403834|NCT01419561|KSHV|kshv
403835|NCT01419561|KICS|kics
403836|NCT01419561|HIV|hiv
403837|NCT01419561|Cytokines|cytokines
403838|NCT01419561|HHV-8|hhv-8
403839|NCT01419561|KSHV Inflammatory Cytokine Syndrome|kshv inflammatory cytokine syndrome
403840|NCT01419561|Kaposi Sarcoma Heres Virus|kaposi sarcoma heres virus
403841|NCT01419548|ABT-888|abt-888
403842|NCT01419548|Liver Dysfunction|liver dysfunction
403843|NCT01419548|Kidney Dysfunction|kidney dysfunction
403844|NCT01419548|PARP Inhibitor|parp inhibitor
403845|NCT01419548|Pharmacokinetics|pharmacokinetics
403846|NCT01419548|Cancer|cancer
403847|NCT01419535|Metabolism|metabolism
403848|NCT01419535|Cortisol|cortisol
403849|NCT01419535|Hypercortisolism|hypercortisolism
403850|NCT01419535|Glucose Intolerance|glucose intolerance
403851|NCT01419522|Traumatic Brain Injury|traumatic brain injury
403852|NCT01419522|Walking Impairment|walking impairment
403853|NCT01419522|Gait Training|gait training
403854|NCT01419522|TBI|tbi
403855|NCT01419509|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
403856|NCT01419509|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
403857|NCT01419509|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
403858|NCT01419509|mixed childhood rhabdomyosarcoma|mixed childhood rhabdomyosarcoma
403859|NCT01419509|pleomorphic childhood rhabdomyosarcoma|pleomorphic childhood rhabdomyosarcoma
403860|NCT01419509|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
403861|NCT01419509|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
403862|NCT01419496|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
403863|NCT01419496|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
403864|NCT01419496|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
403865|NCT01419496|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
403866|NCT01419496|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
403867|NCT01419496|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
403868|NCT01419496|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
403869|NCT01419496|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
403870|NCT01419483|Pancreatic neoplasms|pancreatic neoplasms
403871|NCT01419483|Pancreatic cancer|pancreatic cancer
403872|NCT01419483|Ketogenic Diet|ketogenic diet
403873|NCT01419483|radiotherapy|radiotherapy
403874|NCT01419483|gemcitabine|gemcitabine
403875|NCT01419457|Healthy|healthy
403876|NCT01419457|hepatic impairment|hepatic impairment
403877|NCT01419457|T-705a|t-705a
403878|NCT01419457|Favipiravir|favipiravir
403879|NCT01419444|Voice|voice
403880|NCT01419444|Muscle Tension Dysphonia|muscle tension dysphonia
403881|NCT01419444|Hyperfunction|hyperfunction
403882|NCT01419444|Treatment|treatment
403883|NCT01419431|Colon cancer|colon cancer
403884|NCT01419418|Peripheral Arterial Disease (PAD)|peripheral arterial disease (pad)
403885|NCT01419418|Qualitative analysis|qualitative analysis
403886|NCT01419418|Patients' perspective|patients' perspective
403887|NCT01419405|analgesia|analgesia
403888|NCT01419405|acute experimental pain|acute experimental pain
403889|NCT01419405|cold pressor test|cold pressor test
403890|NCT01419405|pregabalin|pregabalin
403891|NCT01419405|remifentanil|remifentanil
403892|NCT01419392|sildenafil citrate|sildenafil citrate
403893|NCT01419392|Doppler Ultrasonography|doppler ultrasonography
403894|NCT01419392|nitric oxide|nitric oxide
403895|NCT01419392|total antioxidant capacity|total antioxidant capacity
403896|NCT01419379|COPD exacerbation rate|copd exacerbation rate
403897|NCT01419353|Infertility, IVF, Estrogen|infertility, ivf, estrogen
403898|NCT01419327|Fosrenol|fosrenol
403899|NCT01419327|Hyperphosphatemia|hyperphosphatemia
403900|NCT01419327|Hemodialysis|hemodialysis
403901|NCT01419314|Physical Therapy|physical therapy
403902|NCT01419314|Splint|splint
403903|NCT01419314|Sleep|sleep
403904|NCT01419314|Pain|pain
403905|NCT01419314|6 min walk|6 min walk
403906|NCT01419314|forward reach|forward reach
403907|NCT01419314|Function|function
403908|NCT01419301|multiple sclerosis|multiple sclerosis
403909|NCT01419301|glatiramer acetate|glatiramer acetate
403910|NCT01419301|stress reduction|stress reduction
403911|NCT01419301|medication adherence|medication adherence
403912|NCT01419288|Amputees|amputees
403913|NCT01419262|Vitamin D|vitamin d
403914|NCT01419262|Randomized Controlled Trial|randomized controlled trial
403915|NCT01419262|Child, Preschool|child, preschool
403916|NCT01419262|Dietary Supplements|dietary supplements
403917|NCT01419262|Respiratory Tract Infections|respiratory tract infections
403918|NCT01419262|Asthma|asthma
403919|NCT01419249|Growth Hormone Deficiency|growth hormone deficiency
403920|NCT01419249|Turner syndrome|turner syndrome
403921|NCT01419249|Pharmacogenetics|pharmacogenetics
403922|NCT01419249|Recombinant Human Growth Hormone therapy|recombinant human growth hormone therapy
403923|NCT01419236|Ejaculatory Dysfunction|ejaculatory dysfunction
403924|NCT01419236|Orgasmic Dysfunction|orgasmic dysfunction
403925|NCT01419236|Sexual Dysfunction|sexual dysfunction
403926|NCT01419236|Climax Dysfunction|climax dysfunction
403927|NCT01419236|Erectile Dysfunction|erectile dysfunction
403928|NCT01419236|Impotence|impotence
403929|NCT01419236|Hypogonadism|hypogonadism
403930|NCT01419236|Low testosterone|low testosterone
403931|NCT01419236|Low t|low t
403932|NCT01419223|Qualitative research|qualitative research
403933|NCT01419223|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
403934|NCT01419223|Refusal to Participate|refusal to participate
403935|NCT01419210|Complementary Medicine|complementary medicine
403936|NCT01419210|Traditional Medicine|traditional medicine
403937|NCT01419184|Complicated Skin and Skin Structure Infections (cSSSI)|complicated skin and skin structure infections (csssi)
403938|NCT01419184|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
403939|NCT01419184|Daptomycin|daptomycin
403940|NCT01419184|Vancomycin|vancomycin
403941|NCT01419184|Antibiotics|antibiotics
403942|NCT01419158|Alpha-1 antitrypsin|alpha-1 antitrypsin
403943|NCT01419158|Alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
403944|NCT01419158|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
403945|NCT01419145|cachexia|cachexia
403946|NCT01419145|neoplasms|neoplasms
403947|NCT01419145|complications|complications
403948|NCT01419145|combined modality therapy|combined modality therapy
403949|NCT01419145|exercise therapy|exercise therapy
403950|NCT01419145|diet therapy|diet therapy
403951|NCT01419145|anti-inflammatory agents|anti-inflammatory agents
403952|NCT01419132|furosemide|furosemide
403953|NCT01419132|hypertonic saline solution|hypertonic saline solution
403954|NCT01419132|troponin I|troponin i
403955|NCT01419119|vitamin D insufficiency|vitamin d insufficiency
403956|NCT01419119|Cholecalciferol|cholecalciferol
403958|NCT01419119|Parathyroid Hormone|parathyroid hormone
403959|NCT01419119|25-hydroxyvitamin D3|25-hydroxyvitamin d3
403960|NCT01419119|RDA, recommended daily intake (nutrition policy)|rda, recommended daily intake (nutrition policy)
403961|NCT01419119|Vitamin D|vitamin d
403962|NCT01419119|Hypovitaminosis-D|hypovitaminosis-d
403963|NCT01419119|Pharmacologic treatment|pharmacologic treatment
403965|NCT01419106|Emergency care|emergency care
403966|NCT01419106|Point of care Ultrasound|point of care ultrasound
403967|NCT01419106|Shock|shock
403968|NCT01419093|Physical Activity|physical activity
403969|NCT01419093|Exercise|exercise
403970|NCT01419080|Peripheral Arterial Disease|peripheral arterial disease
403971|NCT01419080|Quality of Life|quality of life
403972|NCT01419080|Quality of Care|quality of care
403973|NCT01419067|Proton Therapy|proton therapy
403974|NCT01419067|Radical resection|radical resection
403975|NCT01419041|renal impairment|renal impairment
403976|NCT01419041|crizotinib|crizotinib
403977|NCT01419041|pharmacokinetics|pharmacokinetics
403978|NCT01419028|Hypophosphatasia|hypophosphatasia
403980|NCT01419028|Bone disease|bone disease
403981|NCT01419028|Soft bones|soft bones
403982|NCT01419028|Low alkaline phosphatase|low alkaline phosphatase
403983|NCT01419028|Genetic metabolic disorder|genetic metabolic disorder
403984|NCT01419028|Alkaline phosphatase|alkaline phosphatase
403985|NCT01419028|Tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
403986|NCT01419028|Rickets|rickets
403987|NCT01419028|Osteomalacia|osteomalacia
403988|NCT01419015|SAPIEN XT Valve (20mm)|sapien xt valve (20mm)
403989|NCT01419015|Cardiovascular Disease|cardiovascular disease
403990|NCT01419015|Valvular Heart Disease|valvular heart disease
403991|NCT01419015|Aortic Stenosis|aortic stenosis
403992|NCT01419015|Heart Valve Therapy|heart valve therapy
403993|NCT01419015|Transcatheter|transcatheter
403994|NCT01419015|Transfemoral|transfemoral
403995|NCT01419015|Efficacy endpoints|efficacy endpoints
403996|NCT01419015|Indexed Aortic Valve Area|indexed aortic valve area
403997|NCT01419015|NYHA|nyha
403998|NCT01419002|Pancreatic Cancer|pancreatic cancer
403999|NCT01419002|Adenocarcinoma|adenocarcinoma
404000|NCT01419002|Neoadjuvant Radiotherapy|neoadjuvant radiotherapy
404001|NCT01418976|physical therapy techniques|physical therapy techniques
404002|NCT01418976|brain injuries, traumatic|brain injuries, traumatic
404003|NCT01418976|walking|walking
404004|NCT01418976|gait|gait
404005|NCT01418976|postural balance|postural balance
404006|NCT01418950|Prematurity Counseling for pregnant women and their family|prematurity counseling for pregnant women and their family
404007|NCT01418937|HPV vaccine|hpv vaccine
404008|NCT01418937|serious adverse events (SAEs)|serious adverse events (saes)
404009|NCT01418937|medically significant conditions|medically significant conditions
404010|NCT01418937|cervical neoplasia|cervical neoplasia
404011|NCT01418924|sclerostin|sclerostin
404012|NCT01418924|estradiol|estradiol
404013|NCT01418924|progesterone|progesterone
404014|NCT01418924|testosteron|testosteron
404015|NCT01418924|sex hormones|sex hormones
404016|NCT01418898|Iron deficiency anemia|iron deficiency anemia
404017|NCT01418898|iron|iron
404018|NCT01418898|zinc|zinc
404019|NCT01418898|vitamin A|vitamin a
404020|NCT01418898|vitamin C|vitamin c
404021|NCT01418898|oats|oats
404022|NCT01418885|subcortical ischemic vascular disease|subcortical ischemic vascular disease
404023|NCT01418872|Obesity|obesity
404024|NCT01418872|Cardiovascular Diseases Prevention|cardiovascular diseases prevention
404025|NCT01418872|Paediatrics|paediatrics
404026|NCT01418859|cervical cancer|cervical cancer
404027|NCT01418859|postoperation|postoperation
404028|NCT01418859|chemotherapy|chemotherapy
404029|NCT01418859|radiotherapy|radiotherapy
404030|NCT01418846|voriconazole|voriconazole
404031|NCT01418846|saliva|saliva
404032|NCT01418846|pharmacokinetics|pharmacokinetics
404033|NCT01418833|voriconazole|voriconazole
404034|NCT01418833|therapeutic drug monitoring|therapeutic drug monitoring
404035|NCT01418833|plasma levels|plasma levels
404036|NCT01418833|dose adjustment|dose adjustment
404037|NCT01418820|hemianopia|hemianopia
404038|NCT01418820|visual field defect|visual field defect
404039|NCT01418820|stroke|stroke
404040|NCT01418820|non-invasive brain stimulation|non-invasive brain stimulation
404041|NCT01418820|alternating current stimulation|alternating current stimulation
404042|NCT01418794|Acute Coronary Syndromes|acute coronary syndromes
404043|NCT01418794|Drug eluting stent|drug eluting stent
404044|NCT01418794|Diffused lesion|diffused lesion
404045|NCT01418781|gout|gout
404046|NCT01418781|cost|cost
404047|NCT01418781|utilization|utilization
404048|NCT01418768|COPD|copd
404049|NCT01418768|CAT|cat
404050|NCT01418768|Rehabilitation|rehabilitation
404051|NCT01418768|chronic obstructive pulmonary disease GOLD III/IV|chronic obstructive pulmonary disease gold iii/iv
404052|NCT01418755|Platelet-Rich Plasma|platelet-rich plasma
404053|NCT01418755|Knee|knee
404054|NCT01418755|Tibiofemoral Chondromalacia|tibiofemoral chondromalacia
404055|NCT01418755|Injection|injection
404056|NCT01418742|skin toxicity|skin toxicity
404057|NCT01418716|Disease Management|disease management
404058|NCT01418716|Quality Improvement|quality improvement
404059|NCT01418716|Cooperative Behavior (collaboration)|cooperative behavior (collaboration)
404060|NCT01418677|Unspecified Advance Solid Tumor, Protocol Specific|unspecified advance solid tumor, protocol specific
404061|NCT01418664|vitamin D|vitamin d
404062|NCT01418664|adverse pregnancy outcome|adverse pregnancy outcome
404063|NCT01418664|Pakistan|pakistan
404064|NCT01418638|Major Depressive Disorder|major depressive disorder
404065|NCT01418638|Antidepressants|antidepressants
404066|NCT01418573|glucose, insulin, post prandial|glucose, insulin, post prandial
404067|NCT01418560|renal artery|renal artery
404068|NCT01418560|sympathetic nerves|sympathetic nerves
404069|NCT01418560|modification|modification
404070|NCT01418560|chronic renal failure|chronic renal failure
404071|NCT01418521|Cardiac surgery|cardiac surgery
404072|NCT01418521|Balanced 3rd generation Hydroxyethyl starch|balanced 3rd generation hydroxyethyl starch
404073|NCT01418521|Tetraspan|tetraspan
404074|NCT01418521|Ringer-albumin|ringer-albumin
404075|NCT01418469|COPD|copd
404076|NCT01418469|protein metabolism|protein metabolism
404077|NCT01418469|branched-chain amino acid metabolism|branched-chain amino acid metabolism
404078|NCT01418469|exercise|exercise
404079|NCT01418469|protein feeding|protein feeding
404080|NCT01418456|diabetes|diabetes
404081|NCT01418456|antibiotics|antibiotics
404082|NCT01418456|clean foot ulcers|clean foot ulcers
404083|NCT01418404|Stroke|stroke
404084|NCT01418404|Effects of TS in U/E motor recovery|effects of ts in u/e motor recovery
404085|NCT01418404|Brain mapping|brain mapping
404086|NCT01418404|Kinematics analysis|kinematics analysis
404087|NCT01418391|minimal laparotomy|minimal laparotomy
404088|NCT01418391|TAP block|tap block
404089|NCT01418391|morphine consumption|morphine consumption
404090|NCT01418391|post-operative analgesia|post-operative analgesia
404091|NCT01418378|Sigma|sigma
404092|NCT01418378|cruciate|cruciate
404093|NCT01418378|retaining|retaining
404094|NCT01418378|fixed|fixed
404095|NCT01418378|primary|primary
404096|NCT01418378|total|total
404097|NCT01418378|knee|knee
404098|NCT01418378|arthroplasty|arthroplasty
404099|NCT01418378|cemented|cemented
404100|NCT01418378|osteoarthritis|osteoarthritis
404101|NCT01418352|Tourette's Disorder|tourette's disorder
404102|NCT01418352|tic disorders|tic disorders
404103|NCT01418339|Tourette's Disorder|tourette's disorder
404104|NCT01418339|tic disorders|tic disorders
404105|NCT01418326|Cancer - breast|cancer - breast
404106|NCT01418326|colo-rectal|colo-rectal
404107|NCT01418326|skin|skin
404108|NCT01418313|Atherosclerosis|atherosclerosis
404109|NCT01418313|Non-invasive imaging|non-invasive imaging
404110|NCT01418313|Magnetic Resonance Imaging|magnetic resonance imaging
404112|NCT01418313|Positron Emission Tomography|positron emission tomography
404113|NCT01418313|PET/CT|pet/ct
404114|NCT01418313|PET/MRI|pet/mri
404115|NCT01418313|Inflammation|inflammation
404116|NCT01418313|Neovascularization|neovascularization
404117|NCT01418261|uncontrolled hypertension|uncontrolled hypertension
404118|NCT01418261|renal denervation|renal denervation
404119|NCT01418248|cardiac catheterization|cardiac catheterization
404120|NCT01418248|echocardiography|echocardiography
404121|NCT01418235|HIV Infections|hiv infections
404122|NCT01418235|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
404123|NCT01418235|Lentivirus Infections|lentivirus infections
404124|NCT01418235|Retroviridae Infections|retroviridae infections
404125|NCT01418235|RNA Virus Infections|rna virus infections
404126|NCT01418235|Virus Diseases|virus diseases
404127|NCT01418235|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
404128|NCT01418235|Sexually Transmitted Diseases|sexually transmitted diseases
404129|NCT01418235|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
404130|NCT01418235|Immune System Diseases|immune system diseases
404131|NCT01418235|Slow Virus Diseases|slow virus diseases
404132|NCT01418209|Menopause|menopause
404133|NCT01418209|Vasomotor|vasomotor
404134|NCT01418209|Symptoms|symptoms
404135|NCT01418209|Estradiol|estradiol
404136|NCT01418209|Venlafaxine|venlafaxine
404137|NCT01418196|TMAO|tmao
404138|NCT01418196|Children|children
404139|NCT01418196|Dietary choline|dietary choline
404140|NCT01418196|Cardiovascular disease risk|cardiovascular disease risk
404141|NCT01418196|Atherogenic dyslipidemia|atherogenic dyslipidemia
404142|NCT01418183|Orthognathic surgery|orthognathic surgery
404143|NCT01418183|Pain control|pain control
404144|NCT01418183|Trigeminal nerve|trigeminal nerve
404145|NCT01418183|Levobupivacaine|levobupivacaine
404146|NCT01418170|myofascial pain syndrome|myofascial pain syndrome
404147|NCT01418170|myofascial trigger points|myofascial trigger points
404148|NCT01418170|spinal manipulative therapy|spinal manipulative therapy
404149|NCT01418170|algometer|algometer
404150|NCT01418170|pressure pain thresholds|pressure pain thresholds
404151|NCT01418157|Acute mountain sickness|acute mountain sickness
404152|NCT01418157|Rapid ascent|rapid ascent
404153|NCT01418157|High altitude headache|high altitude headache
404154|NCT01418157|Mountain Medicine Society Nepal|mountain medicine society nepal
404155|NCT01418131|Proctitis|proctitis
404156|NCT01418131|resistant|resistant
404157|NCT01418131|ulcerative colitis|ulcerative colitis
404158|NCT01418131|inflammatory bowel disease|inflammatory bowel disease
404159|NCT01418118|noradrenaline|noradrenaline
404160|NCT01418118|norepinephrine|norepinephrine
404161|NCT01418118|epinephrine|epinephrine
404162|NCT01418118|adrenaline|adrenaline
404163|NCT01418118|dobutamine|dobutamine
404164|NCT01418118|dopexamine|dopexamine
404165|NCT01418118|inotrope|inotrope
404166|NCT01418118|pressor|pressor
404167|NCT01418118|sympathomimetic|sympathomimetic
404168|NCT01418118|free flap|free flap
404169|NCT01418118|transplantation|transplantation
404170|NCT01418118|free tissue transfer|free tissue transfer
404171|NCT01418118|microsurgery|microsurgery
404172|NCT01418118|survival|survival
404173|NCT01418105|spine injuries|spine injuries
404174|NCT01418105|brain lesions|brain lesions
404175|NCT01418105|dysphagia|dysphagia
404176|NCT01418079|Spectroscopy, near infrared|spectroscopy, near infrared
404177|NCT01418079|cerebral oxygenation|cerebral oxygenation
404178|NCT01418027|NAFLD|nafld
404179|NCT01418027|exercise|exercise
404180|NCT01418027|hepatic triglycerides|hepatic triglycerides
404181|NCT01418001|GEMCITABINE|gemcitabine
404182|NCT01418001|GW786034 (PAZOPANIB)|gw786034 (pazopanib)
404183|NCT01418001|TAXOTERE (DOCETAXEL)|taxotere (docetaxel)
404184|NCT01418001|11-104|11-104
404185|NCT01417988|TB|tb
404186|NCT01417975|exercise|exercise
404187|NCT01417975|smoking satisfaction|smoking satisfaction
404188|NCT01417975|topography|topography
404189|NCT01417975|cravings|cravings
404190|NCT01417962|Autopsy|autopsy
404191|NCT01417962|MRI|mri
404192|NCT01417962|Stillbirths|stillbirths
404193|NCT01417962|Neonatal death|neonatal death
404194|NCT01417962|Sudden Infant death|sudden infant death
404195|NCT01417923|chronic musculo-skeletal pain|chronic musculo-skeletal pain
404196|NCT01417923|therapeutic&serology effects of vitamin D|therapeutic&serology effects of vitamin d
404197|NCT01417923|CRP, IL-6, IL-8, TNF and prostaglandin E2|crp, il-6, il-8, tnf and prostaglandin e2
404198|NCT01417923|patients suffering from chronic musculo-skeletal pain|patients suffering from chronic musculo-skeletal pain
404199|NCT01417884|molecular cardiology|molecular cardiology
404200|NCT01417884|molecular epidemiology|molecular epidemiology
404201|NCT01417884|platelets|platelets
404202|NCT01417884|cardiovascular disease|cardiovascular disease
404203|NCT01417858|intra-ocular pressure|intra-ocular pressure
404204|NCT01417858|iridectomy|iridectomy
404205|NCT01417858|gonioscopy|gonioscopy
404206|NCT01417858|ocular tonometry|ocular tonometry
404207|NCT01417832|Dental caries|dental caries
404208|NCT01417832|Proximal surfaces|proximal surfaces
404209|NCT01417832|Preventive therapy|preventive therapy
404210|NCT01417832|Dental radiography|dental radiography
404211|NCT01417832|Treatment efficacy|treatment efficacy
404212|NCT01417832|Young adults|young adults
404213|NCT01417806|small cell lung cancer|small cell lung cancer
404214|NCT01417806|somatostatin|somatostatin
404215|NCT01417806|topotecan|topotecan
404216|NCT01417793|Smoking cessation rate|smoking cessation rate
404217|NCT01417767|myelodysplastic syndromes|myelodysplastic syndromes
404218|NCT01417767|Decitabine|decitabine
404219|NCT01417767|homoharringtonine|homoharringtonine
404220|NCT01417767|cytarabine|cytarabine
404221|NCT01417767|G-CSF|g-csf
404222|NCT01417754|toremifene|toremifene
404223|NCT01417728|endomicroscopy|endomicroscopy
404224|NCT01417728|inflammatory bowel disease|inflammatory bowel disease
404225|NCT01417728|mucosal healing|mucosal healing
404226|NCT01417728|infliximab|infliximab
404227|NCT01417689|glaucoma|glaucoma
404228|NCT01417689|randomized controlled trial|randomized controlled trial
404229|NCT01417689|eye drops|eye drops
404230|NCT01417689|instillation|instillation
404231|NCT01417689|compliance|compliance
404232|NCT01417676|prostate cancer|prostate cancer
404233|NCT01417676|locally advanced|locally advanced
404234|NCT01417676|lymph node positive|lymph node positive
404235|NCT01417676|radiation therapy|radiation therapy
404236|NCT01417676|morbidity|morbidity
404237|NCT01417676|early morbidity|early morbidity
404238|NCT01417676|late morbidity|late morbidity
404239|NCT01417663|Aging|aging
404240|NCT01417663|Cardiovascular disease|cardiovascular disease
404241|NCT01417663|Endothelial function|endothelial function
404242|NCT01417663|Physical activity|physical activity
404243|NCT01417663|Advanced Glycation Endproducts|advanced glycation endproducts
404244|NCT01417663|AGE crosslink breakers|age crosslink breakers
404245|NCT01417650|temporomandibular disorder|temporomandibular disorder
404246|NCT01417650|laser therapy|laser therapy
404247|NCT01417650|osteoarthritis|osteoarthritis
404249|NCT01417637|myofacial pain syndrome|myofacial pain syndrome
404250|NCT01417637|low level laser therapy|low level laser therapy
404251|NCT01417637|LLLT|lllt
404252|NCT01417624|Heart Failure|heart failure
404253|NCT01417624|Cardiac Resynchronisation Therapy|cardiac resynchronisation therapy
404254|NCT01417611|screening colonoscopy|screening colonoscopy
404255|NCT01417598|Balance|balance
404256|NCT01417598|Gait|gait
404257|NCT01417598|Physical activity|physical activity
404258|NCT01417585|Activities of daily living|activities of daily living
404259|NCT01417585|Caregiver burden|caregiver burden
404260|NCT01417585|Client centered|client centered
404261|NCT01417585|Life satisfaction|life satisfaction
404262|NCT01417585|Participation|participation
404263|NCT01417585|Patient satisfaction|patient satisfaction
404264|NCT01417585|Rehabilitation|rehabilitation
404361|NCT01417104|CVA|cva
404265|NCT01417585|Self rated impact of stroke|self rated impact of stroke
404266|NCT01417585|Stroke|stroke
404267|NCT01417546|Dose-Limiting Toxicity|dose-limiting toxicity
404268|NCT01417546|Maximum Tolerated Dose|maximum tolerated dose
404269|NCT01417546|Immune Response|immune response
404270|NCT01417546|Pharmacokinetics|pharmacokinetics
404271|NCT01417546|Dose Escalation|dose escalation
404272|NCT01417546|Cancer|cancer
404273|NCT01417546|Metastatic Solid Tumor|metastatic solid tumor
404274|NCT01417546|Solid Tumor|solid tumor
404275|NCT01417533|Hereditary Inclusion Body Myopathy|hereditary inclusion body myopathy
404276|NCT01417533|N-Acetyl-D-mannosamine (ManNAc)|n-acetyl-d-mannosamine (mannac)
404277|NCT01417533|UDP-N-acetyglucosamine 2-epimerase (GNE)|udp-n-acetyglucosamine 2-epimerase (gne)
404278|NCT01417533|Sialic Acid|sialic acid
404279|NCT01417533|Muscular Dystrophy|muscular dystrophy
404280|NCT01417533|HIBM|hibm
404281|NCT01417520|Histiocytosis|histiocytosis
404282|NCT01417520|Xanthomatosis|xanthomatosis
404283|NCT01417520|Fibrosis|fibrosis
404284|NCT01417520|Osteosclerosis|osteosclerosis
404285|NCT01417520|Erdheim-Chester Disease|erdheim-chester disease
404286|NCT01417520|ECD|ecd
404287|NCT01417494|adenocarcinoma of the colon|adenocarcinoma of the colon
404288|NCT01417494|stage IVA colon cancer|stage iva colon cancer
404289|NCT01417494|stage IVB colon cancer|stage ivb colon cancer
404290|NCT01417494|adenocarcinoma of the rectum|adenocarcinoma of the rectum
404291|NCT01417494|stage IVA rectal cancer|stage iva rectal cancer
404292|NCT01417494|stage IVB rectal cancer|stage ivb rectal cancer
404293|NCT01417481|cystic fibrosis|cystic fibrosis
404294|NCT01417481|glycine|glycine
404295|NCT01417481|airway inflammation|airway inflammation
404296|NCT01417468|Cognitive Rehabilitation|cognitive rehabilitation
404297|NCT01417468|Learning Styles|learning styles
404298|NCT01417468|Learning Modes|learning modes
404299|NCT01417468|Learning Modalities|learning modalities
404300|NCT01417468|Multiple Intelligences|multiple intelligences
404301|NCT01417468|Educational Intervention|educational intervention
404302|NCT01417468|Instructional Design|instructional design
404303|NCT01417455|Rheumatoid arthritis|rheumatoid arthritis
404304|NCT01417455|Ankylosing spondylitis|ankylosing spondylitis
404305|NCT01417455|Osteoclasts|osteoclasts
404306|NCT01417455|TNF antagonists|tnf antagonists
404307|NCT01417442|papillary thyroid carcinoma|papillary thyroid carcinoma
404308|NCT01417442|BRAF V600E|braf v600e
404309|NCT01417442|poor prognosis|poor prognosis
404310|NCT01417442|aggressive|aggressive
404311|NCT01417429|galantamine|galantamine
404312|NCT01417429|subjective nicotine|subjective nicotine
404313|NCT01417429|tobacco withdrawal symptoms|tobacco withdrawal symptoms
404314|NCT01417429|nicotine|nicotine
404315|NCT01417390|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
404316|NCT01417364|Sarcopenia|sarcopenia
404317|NCT01417364|Aging muscle|aging muscle
404318|NCT01417364|Testosterone administration|testosterone administration
404319|NCT01417364|Bone metabolism|bone metabolism
404320|NCT01417351|pregnancy|pregnancy
404321|NCT01417351|immune function|immune function
404322|NCT01417338|Hypertension,pulmonary|hypertension,pulmonary
404323|NCT01417338|Mortality|mortality
404324|NCT01417338|Risk factors|risk factors
404325|NCT01417312|Multiple sclerosis|multiple sclerosis
404326|NCT01417312|Green tea extract|green tea extract
404327|NCT01417312|Metabolism|metabolism
404328|NCT01417299|chronic vegetative state|chronic vegetative state
404329|NCT01417299|RPh201|rph201
404330|NCT01417299|functional MRI|functional mri
404331|NCT01417273|Multiple sclerosis|multiple sclerosis
404332|NCT01417273|immune system|immune system
404333|NCT01417273|vitamin A|vitamin a
404334|NCT01417273|(MSFC)Multiple Sclerosis Functional Composite|(msfc)multiple sclerosis functional composite
404335|NCT01417273|(EDSS)Expanded Disability Status Scale|(edss)expanded disability status scale
404336|NCT01417273|(MRI)Magnetic resonance imaging|(mri)magnetic resonance imaging
404337|NCT01417247|renal artery|renal artery
404338|NCT01417247|sympathetic nerves|sympathetic nerves
404339|NCT01417247|modification|modification
404340|NCT01417247|metabolic syndrome|metabolic syndrome
404341|NCT01417221|renal artery|renal artery
404342|NCT01417221|sympathetic nerves|sympathetic nerves
404343|NCT01417221|modification|modification
404344|NCT01417221|essential hypertension|essential hypertension
404345|NCT01417221|primary hypertension|primary hypertension
404346|NCT01417195|Assisted Reproductive Technology|assisted reproductive technology
404347|NCT01417182|Patients with Advanced Prostate Cancer|patients with advanced prostate cancer
404348|NCT01417143|dovitinib|dovitinib
404349|NCT01417130|Naproxen|naproxen
404350|NCT01417130|Celecoxib|celecoxib
404351|NCT01417130|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
404352|NCT01417117|Intracerebral Hemorrhage|intracerebral hemorrhage
404353|NCT01417117|Ischemic Stroke|ischemic stroke
404354|NCT01417117|Diffusion Weight Imaging Abnormalities|diffusion weight imaging abnormalities
404355|NCT01417117|Neurologic Outcome|neurologic outcome
404356|NCT01417104|plaque|plaque
404357|NCT01417104|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
404358|NCT01417104|high blood pressure|high blood pressure
404359|NCT01417104|MI|mi
404360|NCT01417104|heart attack|heart attack
404362|NCT01417104|stroke|stroke
404363|NCT01417104|PAD|pad
404364|NCT01417091|Brittle bone disease|brittle bone disease
404365|NCT01417091|inherited|inherited
404366|NCT01417091|connective tissue disorder|connective tissue disorder
404367|NCT01417091|fracture|fracture
404368|NCT01417065|Cancer|cancer
404369|NCT01417065|mTOR inhibitor Temsirolimus|mtor inhibitor temsirolimus
404370|NCT01417065|Torisel|torisel
404371|NCT01417065|CCI-779|cci-779
404372|NCT01417065|pharmacodynamic targets|pharmacodynamic targets
404373|NCT01417026|Autism Spectrum Disorders|autism spectrum disorders
404374|NCT01417026|Oxytocin|oxytocin
404375|NCT01417026|Clinical Trial|clinical trial
404376|NCT01417026|Computer-based Intervention|computer-based intervention
404377|NCT01417026|Social Perception|social perception
404378|NCT01417026|Social Motivation|social motivation
404379|NCT01417026|Social Cognition|social cognition
404380|NCT01417013|Dry eye or lubricant eye drops|dry eye or lubricant eye drops
404381|NCT01417000|Cancer|cancer
404382|NCT01417000|Cancer vaccine|cancer vaccine
404383|NCT01417000|Listeria monocytogenes|listeria monocytogenes
404384|NCT01417000|Listeria-based vaccines|listeria-based vaccines
404385|NCT01417000|GVAX|gvax
404386|NCT01417000|Cyclophosphamide|cyclophosphamide
404387|NCT01417000|Cytoxan|cytoxan
404388|NCT01417000|T regulatory cells|t regulatory cells
404389|NCT01417000|Heterologous Prime-Boost|heterologous prime-boost
404390|NCT01417000|Immunotherapy|immunotherapy
404391|NCT01417000|Mesothelin|mesothelin
404392|NCT01417000|Pancreatic cancer|pancreatic cancer
404393|NCT01416974|19-28Z RETROVIRUS|19-28z retrovirus
404394|NCT01416974|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
404395|NCT01416974|autologous T cells|autologous t cells
404396|NCT01416974|Leukapheresis|leukapheresis
404397|NCT01416974|11-048|11-048
404398|NCT01416961|Squamous Cell|squamous cell
404399|NCT01416961|Non-squamous cell|non-squamous cell
404400|NCT01416948|Cognitive Complaints, TBI, PTSD|cognitive complaints, tbi, ptsd
404401|NCT01416935|Atrial Fibrillation|atrial fibrillation
404402|NCT01416935|Anti-Arrhythmic Medication|anti-arrhythmic medication
404403|NCT01416909|Medication-induced|medication-induced
404404|NCT01416909|Constipation in Cancer|constipation in cancer
404405|NCT01416896|End stage Renal Disease|end stage renal disease
404406|NCT01416896|Hemodialysis|hemodialysis
404407|NCT01416896|Oxidative Stress|oxidative stress
404408|NCT01416896|Inflammation|inflammation
404409|NCT01416883|oral mucosal absorption|oral mucosal absorption
404410|NCT01416883|pharmacokinetics|pharmacokinetics
404411|NCT01416883|safety|safety
404412|NCT01416883|bicalutamide|bicalutamide
404413|NCT01416883|Japanese|japanese
404414|NCT01416883|healthy subject|healthy subject
404415|NCT01416870|Bioequivalence|bioequivalence
404416|NCT01416870|pharmacokinetics|pharmacokinetics
404417|NCT01416870|safety|safety
404418|NCT01416870|bicalutamide|bicalutamide
404419|NCT01416870|Casodex|casodex
404420|NCT01416870|Japanese|japanese
404421|NCT01416870|healthy subject|healthy subject
404422|NCT01416857|Medicare|medicare
404423|NCT01416844|Metastatic melanoma|metastatic melanoma
404424|NCT01416844|anti-OX40|anti-ox40
404425|NCT01416844|Immunostimulatory|immunostimulatory
404426|NCT01416831|metastatic melanoma|metastatic melanoma
404427|NCT01416831|IL-2|il-2
404428|NCT01416831|Interleukin 2|interleukin 2
404429|NCT01416831|Radiation|radiation
404430|NCT01416831|Stereotactic Body Radiation Treatment|stereotactic body radiation treatment
404431|NCT01416831|SBRT|sbrt
404432|NCT01416831|Immunotherapy|immunotherapy
404433|NCT01416818|Depression;|depression;
404434|NCT01416818|Parkinson's disease;|parkinson's disease;
404435|NCT01416818|antidepressant|antidepressant
404436|NCT01416805|childhood anxiety disorders|childhood anxiety disorders
404437|NCT01416805|cognitive behavioral therapy|cognitive behavioral therapy
404438|NCT01416805|CBT|cbt
404439|NCT01416805|Generalized Anxiety Disorder|generalized anxiety disorder
404440|NCT01416805|Social Phobia|social phobia
404441|NCT01416805|Separation Anxiety Disorder|separation anxiety disorder
404442|NCT01416805|Psychotherapy|psychotherapy
404443|NCT01416805|Counseling|counseling
404444|NCT01416805|Social Anxiety Disorder|social anxiety disorder
404445|NCT01416779|Writing Intervention|writing intervention
404446|NCT01416779|Bereaved Caregivers|bereaved caregivers
404447|NCT01416779|Older Adults|older adults
404448|NCT01416779|hope|hope
404449|NCT01416779|inventory of daily widowed life|inventory of daily widowed life
404450|NCT01416766|Blood Pressure Monitors|blood pressure monitors
404451|NCT01416766|Medical Informatics|medical informatics
404452|NCT01416766|Disease Management|disease management
404453|NCT01416766|Comparative Effectiveness Research|comparative effectiveness research
404454|NCT01416753|hemodialysis|hemodialysis
404455|NCT01416753|blood volume monitoring|blood volume monitoring
404456|NCT01416740|Indirect magnetic resonance arthrogram|indirect magnetic resonance arthrogram
404457|NCT01416740|Direct magnetic resonance arthrogram|direct magnetic resonance arthrogram
404458|NCT01416740|Diagnostic tests for shoulder pain|diagnostic tests for shoulder pain
404459|NCT01416727|Patient Simulation|patient simulation
404460|NCT01416727|Education, Medical, Graduate|education, medical, graduate
404461|NCT01416727|Internship and Residency|internship and residency
404462|NCT01416727|Psychiatry|psychiatry
404463|NCT01416701|COPD|copd
404464|NCT01416701|Vitamin D|vitamin d
404465|NCT01416701|Pulmonary rehabilitation|pulmonary rehabilitation
404466|NCT01416688|therapy-related toxicity|therapy-related toxicity
404467|NCT01416688|dermatologic complications|dermatologic complications
404468|NCT01416688|stage I colon cancer|stage i colon cancer
404469|NCT01416688|stage IIA colon cancer|stage iia colon cancer
404470|NCT01416688|stage IIB colon cancer|stage iib colon cancer
404471|NCT01416688|stage IIC colon cancer|stage iic colon cancer
404472|NCT01416688|stage IIIA colon cancer|stage iiia colon cancer
404473|NCT01416688|stage IIIB colon cancer|stage iiib colon cancer
404474|NCT01416688|stage IIIC colon cancer|stage iiic colon cancer
404475|NCT01416688|stage IVA colon cancer|stage iva colon cancer
404476|NCT01416688|stage IVB colon cancer|stage ivb colon cancer
404477|NCT01416688|stage I rectal cancer|stage i rectal cancer
404478|NCT01416688|stage IIA rectal cancer|stage iia rectal cancer
404479|NCT01416688|stage IIB rectal cancer|stage iib rectal cancer
404480|NCT01416688|stage IIC rectal cancer|stage iic rectal cancer
404481|NCT01416688|stage IIIA rectal cancer|stage iiia rectal cancer
404482|NCT01416688|stage IIIB rectal cancer|stage iiib rectal cancer
404483|NCT01416688|stage IIIC rectal cancer|stage iiic rectal cancer
404484|NCT01416688|stage IVA rectal cancer|stage iva rectal cancer
404485|NCT01416688|stage IVB rectal cancer|stage ivb rectal cancer
404486|NCT01416688|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
404487|NCT01416688|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
404488|NCT01416688|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
404489|NCT01416688|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
404490|NCT01416688|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
404491|NCT01416688|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
404492|NCT01416688|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
404493|NCT01416688|extensive stage small cell lung cancer|extensive stage small cell lung cancer
404494|NCT01416688|limited stage small cell lung cancer|limited stage small cell lung cancer
404495|NCT01416688|recurrent small cell lung cancer|recurrent small cell lung cancer
404496|NCT01416688|recurrent colon cancer|recurrent colon cancer
404497|NCT01416688|recurrent rectal cancer|recurrent rectal cancer
404498|NCT01416688|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
404499|NCT01416662|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
404500|NCT01416662|stage IA pancreatic cancer|stage ia pancreatic cancer
404501|NCT01416662|stage IB pancreatic cancer|stage ib pancreatic cancer
404502|NCT01416662|stage IIA pancreatic cancer|stage iia pancreatic cancer
404503|NCT01416623|Advanced solid cancer|advanced solid cancer
404504|NCT01416623|Henatinib|henatinib
404505|NCT01416623|phase I|phase i
404506|NCT01416597|Influenza|influenza
404507|NCT01416597|Systematic review|systematic review
404508|NCT01416597|Meta-analysis|meta-analysis
404509|NCT01416597|Mismatched strains|mismatched strains
404510|NCT01416597|Cross-protection|cross-protection
404511|NCT01416571|H5N1|h5n1
404512|NCT01416571|Influenza vaccine|influenza vaccine
404513|NCT01416571|influenza infection|influenza infection
404514|NCT01416571|GSK1557484A|gsk1557484a
404515|NCT01416558|German Breast Group|german breast group
404516|NCT01416558|GBG Forschungs GmbH|gbg forschungs gmbh
404517|NCT01416558|GBG|gbg
404518|NCT01416558|GBG 65|gbg 65
404519|NCT01416558|Tiffany|tiffany
404520|NCT01416558|Breast Cancer|breast cancer
404521|NCT01416558|Metastatic Breast Cancer|metastatic breast cancer
404522|NCT01416558|Nab-Paclitaxel|nab-paclitaxel
404523|NCT01416558|Abraxane|abraxane
404524|NCT01416558|Taxane Failure|taxane failure
404525|NCT01416545|Primary Prevention|primary prevention
404526|NCT01416545|Cardiovascular disease|cardiovascular disease
404527|NCT01416545|Child|child
404528|NCT01416545|Behavior modification|behavior modification
404529|NCT01416545|Activities, Educational|activities, educational
404530|NCT01416532|coronary Atheroslcerosis|coronary atheroslcerosis
404531|NCT01416532|Computed Tomography|computed tomography
404532|NCT01416519|Continuous Positive Airway Pressure|continuous positive airway pressure
404533|NCT01416519|Cough|cough
404534|NCT01416519|Oxygen Inhalation Therapy|oxygen inhalation therapy
404535|NCT01416506|Pneumonia, surveillance|pneumonia, surveillance
404536|NCT01416493|acute rheumatoid arthritis|acute rheumatoid arthritis
404537|NCT01416480|Theobromine|theobromine
404538|NCT01416480|cough|cough
404539|NCT01416480|acute bronchitis|acute bronchitis
404540|NCT01416467|lysosomal storage disease|lysosomal storage disease
404541|NCT01416467|AAV vector|aav vector
404542|NCT01416467|gene transfer|gene transfer
404543|NCT01416467|disease characterization|disease characterization
404544|NCT01416441|Tourette's Disorder|tourette's disorder
404545|NCT01416441|tic disorders|tic disorders
404546|NCT01416428|multiple myeloma|multiple myeloma
404547|NCT01416428|waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
404548|NCT01416415|Glaucoma, Open-Angle|glaucoma, open-angle
404549|NCT01416415|Ophthalmic Solutions, Eye drops|ophthalmic solutions, eye drops
404550|NCT01416415|Instructional Films and Videos|instructional films and videos
404551|NCT01416402|Hyperuricemia|hyperuricemia
404552|NCT01416402|gout|gout
404553|NCT01416402|serum uric acid|serum uric acid
404554|NCT01416389|Locally|locally
404555|NCT01416389|Recurrent|recurrent
404556|NCT01416389|Breast|breast
404557|NCT01416389|Cancer|cancer
404558|NCT01416363|firategrast|firategrast
404559|NCT01416363|pharmacokinetics, modified release, firategrast,|pharmacokinetics, modified release, firategrast,
404560|NCT01416363|simulated gastro-retentive|simulated gastro-retentive
404561|NCT01416363|pharmacokinetics|pharmacokinetics
404562|NCT01416363|healthy volunteers, simulated gastro-retentive|healthy volunteers, simulated gastro-retentive
404563|NCT01416363|healthy volunteers|healthy volunteers
404564|NCT01416363|modified release|modified release
404565|NCT01416324|pharmacodynamics|pharmacodynamics
404566|NCT01416324|first time in human|first time in human
404567|NCT01416324|pharmacokinetics|pharmacokinetics
404568|NCT01416298|Acute Kidney Injury|acute kidney injury
404569|NCT01416298|Critically ill children|critically ill children
404570|NCT01416298|Biomarkers|biomarkers
404571|NCT01416298|NGAL|ngal
404572|NCT01416298|Fluid Overload|fluid overload
404573|NCT01416298|Continuous Renal Replacement Therapy (CRRT)|continuous renal replacement therapy (crrt)
404574|NCT01416285|Congestive heart failure (CHF)|congestive heart failure (chf)
404575|NCT01416285|CHF education|chf education
404576|NCT01416285|self-care training|self-care training
404577|NCT01416285|CHF center|chf center
404578|NCT01416259|QTc Prolongation|qtc prolongation
404579|NCT01416246|Stem cell Infusions|stem cell infusions
404580|NCT01416246|Autologous Stem Cell Transplant|autologous stem cell transplant
404581|NCT01416246|11-105|11-105
404582|NCT01416233|autologous|autologous
404583|NCT01416233|fat|fat
404584|NCT01416233|orbit|orbit
404585|NCT01416233|atrophy|atrophy
404586|NCT01416233|cannula|cannula
404587|NCT01416220|depression|depression
404588|NCT01416220|bipolar disorder|bipolar disorder
404589|NCT01416220|manic depressive illness|manic depressive illness
404590|NCT01416194|Osteoporosis|osteoporosis
404591|NCT01416181|Natalizumab|natalizumab
404592|NCT01416181|secondary|secondary
404593|NCT01416181|multiple sclerosis|multiple sclerosis
404594|NCT01416181|MS|ms
404595|NCT01416181|SPMS|spms
404596|NCT01416181|Tysabri|tysabri
404597|NCT01416168|Colon|colon
404598|NCT01416168|Geriatric|geriatric
404599|NCT01416168|McCorkle Model|mccorkle model
404600|NCT01416168|Questionnaire|questionnaire
404601|NCT01416116|Tramadol|tramadol
404602|NCT01416116|QUTENZA|qutenza
404603|NCT01416116|Pre-treatment|pre-treatment
404604|NCT01416116|Tolerability|tolerability
404605|NCT01416090|syndactyly|syndactyly
404606|NCT01416077|fluid|fluid
404607|NCT01416077|goal-directed|goal-directed
404608|NCT01416077|FloTrac|flotrac
404609|NCT01416077|pulse contour analysis|pulse contour analysis
404610|NCT01416077|postoperative complications|postoperative complications
404611|NCT01416077|anesthesia|anesthesia
404612|NCT01416077|esophagus|esophagus
404613|NCT01416038|vaccine|vaccine
404614|NCT01416038|immunotherapy|immunotherapy
404615|NCT01416038|ovarian|ovarian
404616|NCT01416038|fallopian tube|fallopian tube
404617|NCT01416038|peritoneal|peritoneal
404618|NCT01416038|cancer|cancer
404619|NCT01416038|tumor|tumor
404620|NCT01416038|Phase 1|phase 1
404621|NCT01416038|Phase I|phase i
404622|NCT01416038|combination therapy|combination therapy
404623|NCT01416025|Voriconazole|voriconazole
404624|NCT01416025|Therapeutic drug monitoring|therapeutic drug monitoring
404625|NCT01416025|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
404626|NCT01416025|Hematologic malignancy|hematologic malignancy
404627|NCT01416025|Invasive mould infection|invasive mould infection
404628|NCT01415999|anthracycline|anthracycline
404629|NCT01415999|cardiac function|cardiac function
404630|NCT01415999|echocardiography|echocardiography
404631|NCT01415999|biomarkers|biomarkers
404632|NCT01415986|Advanced head and neck cancer|advanced head and neck cancer
404633|NCT01415986|Squamous cell carcinoma|squamous cell carcinoma
404634|NCT01415986|SCC|scc
404635|NCT01415986|HNSCC|hnscc
404636|NCT01415973|beef|beef
404637|NCT01415973|protein|protein
404638|NCT01415973|synergy|synergy
404639|NCT01415973|intact beef constituents|intact beef constituents
404640|NCT01415973|protein constituent|protein constituent
404641|NCT01415973|Nutrient Synergy|nutrient synergy
404642|NCT01415960|Prostate Cancer|prostate cancer
404643|NCT01415960|androgen deprivation therapy.|androgen deprivation therapy.
404644|NCT01415960|Leuprolide Acetate Depot Formulation|leuprolide acetate depot formulation
404645|NCT01415960|Pharmacokinetics|pharmacokinetics
404646|NCT01415960|testosterone|testosterone
404647|NCT01415960|serum luteinizing hormone|serum luteinizing hormone
404648|NCT01415960|follicle-stimulating hormone|follicle-stimulating hormone
404649|NCT01415960|prostate-specific antigen|prostate-specific antigen
404650|NCT01415947|Heart disease|heart disease
404651|NCT01415947|Device|device
404652|NCT01415947|Mitral valve|mitral valve
404653|NCT01415947|leaflet prolapse|leaflet prolapse
404654|NCT01415947|Heart valve disease|heart valve disease
404655|NCT01415947|Cardiovascular disease|cardiovascular disease
404656|NCT01415947|Neochordae|neochordae
404657|NCT01415921|heart failure|heart failure
404658|NCT01415921|autonomic function|autonomic function
404659|NCT01415921|sympathovagal balance|sympathovagal balance
404660|NCT01415921|cholinesterase inhibitors|cholinesterase inhibitors
404661|NCT01415921|pharmacology|pharmacology
404662|NCT01415908|advanced degenerative disease of the lumbosacral spine|advanced degenerative disease of the lumbosacral spine
404663|NCT01415908|lumbosacral spine|lumbosacral spine
404664|NCT01415908|radiculopathy|radiculopathy
404665|NCT01415908|degenerative instability|degenerative instability
404666|NCT01415908|spondylolisthesis|spondylolisthesis
404667|NCT01415908|retrolisthesis|retrolisthesis
404668|NCT01415908|lateral listhesis|lateral listhesis
404669|NCT01415908|spinal stenosis|spinal stenosis
404670|NCT01415908|disc herniation|disc herniation
404671|NCT01415908|INFUSE Bone Graft|infuse bone graft
404672|NCT01415908|CD HORIZON Spinal System|cd horizon spinal system
404673|NCT01415908|CAPSTONE Spinal System|capstone spinal system
404674|NCT01415895|back pain|back pain
404675|NCT01415895|cervical pain|cervical pain
404676|NCT01415895|neuropathic pain|neuropathic pain
404677|NCT01415895|radicular pain|radicular pain
404678|NCT01415869|Ventricular Assist Device|ventricular assist device
404679|NCT01415869|Gastrointestinal Bleeding|gastrointestinal bleeding
404680|NCT01415869|VAD|vad
404681|NCT01415856|pulsed electromagnetic fields device|pulsed electromagnetic fields device
404682|NCT01415856|Torino II|torino ii
404683|NCT01415856|postoperative knee pain|postoperative knee pain
404684|NCT01415856|knee replacement|knee replacement
404685|NCT01415830|Anti-Scorpion venom serum|anti-scorpion venom serum
404686|NCT01415830|venom|venom
404687|NCT01415830|efficacy|efficacy
404688|NCT01415830|safety|safety
404689|NCT01415830|children|children
404690|NCT01415817|Quality Improvement|quality improvement
404691|NCT01415817|Adenoma Detection Rate|adenoma detection rate
404692|NCT01415817|Polyp detection rate|polyp detection rate
404693|NCT01415817|Colonoscopy|colonoscopy
404694|NCT01415817|Training|training
404695|NCT01415817|Colorectal cancer screening|colorectal cancer screening
404696|NCT01415804|Dissection|dissection
404697|NCT01415804|Aorta|aorta
404698|NCT01415804|Surgery|surgery
404699|NCT01415791|oral mucosal absorption|oral mucosal absorption
404700|NCT01415791|pharmacokinetics|pharmacokinetics
404701|NCT01415791|safety|safety
404702|NCT01415791|bicalutamide|bicalutamide
404703|NCT01415791|Japanese|japanese
404704|NCT01415791|healthy subject|healthy subject
404705|NCT01415778|Bioequivalence|bioequivalence
404706|NCT01415778|pharmacokinetics|pharmacokinetics
404707|NCT01415778|safety|safety
404708|NCT01415778|bicalutamide|bicalutamide
404709|NCT01415778|Casodex|casodex
404710|NCT01415778|Japanese|japanese
404711|NCT01415778|healthy subject|healthy subject
404712|NCT01415765|Germinal Center Like B-Cell (GCB) DLBCL|germinal center like b-cell (gcb) dlbcl
404713|NCT01415765|Activated B-Cell Like (ABC) DLBCL|activated b-cell like (abc) dlbcl
404714|NCT01415765|NF-KappaB Pathway|nf-kappab pathway
404715|NCT01415765|Drug Resistance|drug resistance
404716|NCT01415765|Nedd-8 Activating Enzyme Inhibitor|nedd-8 activating enzyme inhibitor
404717|NCT01415765|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
404718|NCT01415765|Lymphoma|lymphoma
404719|NCT01415752|neurotoxicity|neurotoxicity
404720|NCT01415752|therapy-related toxicity|therapy-related toxicity
404721|NCT01415752|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
404843|NCT01415310|Quality improvement|quality improvement
404722|NCT01415752|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
404723|NCT01415752|stage I mantle cell lymphoma|stage i mantle cell lymphoma
404724|NCT01415752|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
404725|NCT01415752|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
404726|NCT01415739|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
404727|NCT01415739|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
404728|NCT01415739|adenocarcinoma of the lung|adenocarcinoma of the lung
404729|NCT01415739|squamous cell lung cancer|squamous cell lung cancer
404730|NCT01415726|Cord blood stem cells|cord blood stem cells
404731|NCT01415726|inflammation|inflammation
404732|NCT01415726|type 2 diabetes|type 2 diabetes
404733|NCT01415726|stem cell educator|stem cell educator
404734|NCT01415726|autoimmunity|autoimmunity
404735|NCT01415726|immune modulation|immune modulation
404736|NCT01415713|enroll the 80 patients in this trial|enroll the 80 patients in this trial
404737|NCT01415700|feet STEPPAGE of central neurological origin|feet steppage of central neurological origin
404738|NCT01415700|implanted functional electrical stimulation|implanted functional electrical stimulation
404739|NCT01415700|feet orthosis|feet orthosis
404740|NCT01415687|preoperative care|preoperative care
404741|NCT01415687|colonoscopy|colonoscopy
404742|NCT01415687|cathartics|cathartics
404743|NCT01415674|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
404744|NCT01415674|pre operative treatment|pre operative treatment
404745|NCT01415674|Afatinib|afatinib
404746|NCT01415674|BIBW2992|bibw2992
404747|NCT01415674|Biological markers|biological markers
404748|NCT01415648|with surgical indication|with surgical indication
404749|NCT01415648|Cerebral oximetry|cerebral oximetry
404750|NCT01415648|carotid endarterectomy|carotid endarterectomy
404751|NCT01415648|MRI|mri
404752|NCT01415648|ischemic lesion|ischemic lesion
404753|NCT01415648|cost/effectiveness analysis|cost/effectiveness analysis
404754|NCT01415648|Neurocognitive Outcome|neurocognitive outcome
404755|NCT01415648|protein S-100B|protein s-100b
404756|NCT01415635|Nutritional risk, Hospital food, Nutritional Intervention|nutritional risk, hospital food, nutritional intervention
404757|NCT01415622|plasma therapy|plasma therapy
404758|NCT01415622|ulcus cruris|ulcus cruris
404759|NCT01415609|Gastrointestinal neoplasia|gastrointestinal neoplasia
404760|NCT01415609|Submucosal resection|submucosal resection
404761|NCT01415570|Protein-energy wasting (PEW)|protein-energy wasting (pew)
404762|NCT01415570|racial disparities|racial disparities
404763|NCT01415570|hemodialysis|hemodialysis
404764|NCT01415570|survival paradoxes|survival paradoxes
404765|NCT01415570|Stage 5|stage 5
404766|NCT01415557|micronutrient|micronutrient
404767|NCT01415557|healthy children|healthy children
404768|NCT01415557|vitamins|vitamins
404769|NCT01415557|minerals|minerals
404770|NCT01415557|cognition|cognition
404771|NCT01415557|physical performance|physical performance
404772|NCT01415557|iron|iron
404773|NCT01415557|Micronutrient status|micronutrient status
404774|NCT01415557|Cognitive Performance|cognitive performance
404775|NCT01415544|Diabetes|diabetes
404776|NCT01415531|Stage 1|stage 1
404777|NCT01415531|Stage 2|stage 2
404778|NCT01415531|Hypertension|hypertension
404779|NCT01415518|Severe chronic obstructive pulmonary disease (COPD) patients|severe chronic obstructive pulmonary disease (copd) patients
404780|NCT01415505|Stage 1|stage 1
404781|NCT01415505|Stage 2|stage 2
404782|NCT01415505|Hypertension|hypertension
404783|NCT01415505|1 year open label safety study|1 year open label safety study
404784|NCT01415492|Exercise|exercise
404785|NCT01415492|Physical activity|physical activity
404786|NCT01415492|Cigarette Smoking|cigarette smoking
404787|NCT01415492|Smoking cessation|smoking cessation
404788|NCT01415492|Multi Vitamin intake|multi vitamin intake
404789|NCT01415492|Vegetable consumption|vegetable consumption
404790|NCT01415492|Fruit consumption|fruit consumption
404791|NCT01415492|Meat consumption|meat consumption
404792|NCT01415479|Colon cancer|colon cancer
404793|NCT01415479|Screening|screening
404794|NCT01415479|Decision-making|decision-making
404795|NCT01415453|retinitis pigmentosa|retinitis pigmentosa
404796|NCT01415453|acoustic radiation force ultrasound|acoustic radiation force ultrasound
404797|NCT01415453|RP|rp
404798|NCT01415453|visual field loss|visual field loss
404799|NCT01415453|Photoreceptor|photoreceptor
404800|NCT01415453|Vision loss|vision loss
404801|NCT01415453|retina|retina
404802|NCT01415453|progressive vision loss|progressive vision loss
404803|NCT01415453|ultrasound|ultrasound
404804|NCT01415440|ADHD|adhd
404805|NCT01415440|Vyvanse|vyvanse
404806|NCT01415440|stimulant medication|stimulant medication
404807|NCT01415440|ADD|add
404808|NCT01415427|Mucopolysaccharidosis IV type A|mucopolysaccharidosis iv type a
404809|NCT01415427|MPS IV Type A|mps iv type a
404810|NCT01415427|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
404811|NCT01415427|MPS IVA|mps iva
404812|NCT01415427|Morquio A Syndrome|morquio a syndrome
404813|NCT01415427|Lysosomal Storage Disorder|lysosomal storage disorder
404814|NCT01415427|LSD|lsd
404815|NCT01415427|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
404816|NCT01415427|N-acetylgalactosamine-6-sulfate sulfatase|n-acetylgalactosamine-6-sulfate sulfatase
404817|NCT01415427|galactose-6-sulfatase|galactose-6-sulfatase
404818|NCT01415427|GALNS|galns
404819|NCT01415427|enzyme replacement therapy|enzyme replacement therapy
404820|NCT01415427|ERT|ert
404821|NCT01415414|Image quality|image quality
404822|NCT01415414|CNR|cnr
404823|NCT01415414|SNR|snr
404824|NCT01415414|Abdominal|abdominal
404825|NCT01415414|Pelvic|pelvic
404826|NCT01415401|Glaucoma|glaucoma
404827|NCT01415401|Ocular hypertension|ocular hypertension
404828|NCT01415401|Intraocular pressure (IOP)|intraocular pressure (iop)
404829|NCT01415401|Open angle glaucoma|open angle glaucoma
404830|NCT01415401|Pigment dispersion glaucoma|pigment dispersion glaucoma
404831|NCT01415401|Pigmentary|pigmentary
404832|NCT01415388|Maintenance of normal blood triglyceride levels|maintenance of normal blood triglyceride levels
404833|NCT01415375|prostate-specific antigen (146-154)|prostate-specific antigen (146-154)
404834|NCT01415375|prostate-specific antigen (154-163)|prostate-specific antigen (154-163)
404835|NCT01415362|transcranial direct current stimulation|transcranial direct current stimulation
404836|NCT01415362|electroencephalography|electroencephalography
404837|NCT01415323|Emergency services, psychiatric|emergency services, psychiatric
404838|NCT01415323|Psychomotor agitation|psychomotor agitation
404839|NCT01415323|Suicide|suicide
404840|NCT01415323|Violence|violence
404841|NCT01415310|Geriatric Psychiatry|geriatric psychiatry
404842|NCT01415310|Quality register|quality register
404844|NCT01415310|Quality control|quality control
405045|NCT01414335|vitamins|vitamins
404845|NCT01415310|Research elderly patients with psychiatric disorders|research elderly patients with psychiatric disorders
404846|NCT01415297|Phase 1|phase 1
404847|NCT01415297|advanced solid tumors|advanced solid tumors
404848|NCT01415284|Obstetric anesthesia|obstetric anesthesia
404849|NCT01415284|Spinal anesthesia|spinal anesthesia
404850|NCT01415284|Hypotension|hypotension
404851|NCT01415284|Fluid therapy|fluid therapy
404852|NCT01415284|Cesarean section|cesarean section
404853|NCT01415284|phenylephrine|phenylephrine
404854|NCT01415284|cardiac output|cardiac output
404855|NCT01415271|diabetes|diabetes
404856|NCT01415271|A1c|a1c
404857|NCT01415271|internet|internet
404858|NCT01415271|long term care|long term care
404859|NCT01415258|cancer|cancer
404860|NCT01415258|vulnerability|vulnerability
404861|NCT01415258|frail|frail
404862|NCT01415232|Obesity|obesity
404863|NCT01415232|Ultrasound|ultrasound
404864|NCT01415219|rehabilitation|rehabilitation
404865|NCT01415219|exercise|exercise
404866|NCT01415219|efficacy|efficacy
404867|NCT01415219|functional status|functional status
404868|NCT01415206|Behavioral changes|behavioral changes
404869|NCT01415206|Multiple risks|multiple risks
404870|NCT01415180|sepsis|sepsis
404871|NCT01415180|health related quality of life|health related quality of life
404872|NCT01415180|functional status|functional status
404873|NCT01415180|chronic comorbid conditions|chronic comorbid conditions
404874|NCT01415180|organ dysfunction|organ dysfunction
404875|NCT01415154|TMS|tms
404876|NCT01415154|Major Depressive Disorder|major depressive disorder
404877|NCT01415154|NeuroStar TMS|neurostar tms
404878|NCT01415141|genotype 1|genotype 1
404879|NCT01415141|IL28B CC polymorphism|il28b cc polymorphism
404880|NCT01415141|telaprevir|telaprevir
404881|NCT01415141|peginterferon|peginterferon
404882|NCT01415141|ribavirin|ribavirin
404883|NCT01415115|diabetes|diabetes
404884|NCT01415115|hypertension|hypertension
404885|NCT01415089|Cancer|cancer
404886|NCT01415089|Quality of life|quality of life
404887|NCT01415089|Family caregiver|family caregiver
404888|NCT01415089|Stress and coping|stress and coping
404889|NCT01415089|Web-based intervention|web-based intervention
404890|NCT01415089|Communication|communication
404891|NCT01415063|Hepatocellular Carcinoma|hepatocellular carcinoma
404892|NCT01415063|RFA|rfa
404893|NCT01415063|TACE|tace
404894|NCT01415050|Osteoporosis|osteoporosis
404895|NCT01415050|Menopause|menopause
404896|NCT01415050|Raloxifane|raloxifane
404897|NCT01415050|Alendronate|alendronate
404898|NCT01415037|Annular Array Ultrasound|annular array ultrasound
404899|NCT01415037|Ultrasound Exam|ultrasound exam
404900|NCT01415037|Posterior Vitreous Detachment|posterior vitreous detachment
404901|NCT01415037|PVD|pvd
404902|NCT01415037|Diabetic Retinopathy|diabetic retinopathy
404903|NCT01415024|CRT|crt
404904|NCT01415024|Dual LV|dual lv
404905|NCT01415024|Triple Ventricle stimulation|triple ventricle stimulation
404906|NCT01415024|two leftventricular leads|two leftventricular leads
404907|NCT01415024|Av VV optimization|av vv optimization
404908|NCT01415024|Lv dp/dt measurement|lv dp/dt measurement
404909|NCT01415011|Afatinib (BIBW2992)|afatinib (bibw2992)
404910|NCT01415011|EGFR Mutation|egfr mutation
404911|NCT01415011|Non Small Cell Lung Cancer|non small cell lung cancer
404912|NCT01415011|Poor performance status|poor performance status
404913|NCT01415011|Elderly|elderly
404914|NCT01414985|Batten Disease|batten disease
404915|NCT01414972|Atherosclerosis|atherosclerosis
404916|NCT01414972|Coronary Artery Disease|coronary artery disease
404917|NCT01414972|Vitamin A|vitamin a
404918|NCT01414972|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
404919|NCT01414972|gene expression|gene expression
404920|NCT01414959|intensive care patient|intensive care patient
404921|NCT01414959|intubation|intubation
404922|NCT01414959|(please change wording as you like!)|(please change wording as you like!)
404923|NCT01414920|Drug Therapy|drug therapy
404924|NCT01414907|Drinking Behavior|drinking behavior
404925|NCT01414907|Harm Reduction|harm reduction
404926|NCT01414907|Tobacco Use Cessation|tobacco use cessation
404927|NCT01414907|Smoking Cessation|smoking cessation
404928|NCT01414907|Rehabilitation|rehabilitation
404929|NCT01414907|Health Promotion|health promotion
404930|NCT01414907|Nutrition Therapy|nutrition therapy
404931|NCT01414907|Feeding Behavior|feeding behavior
404932|NCT01414907|Exercise|exercise
404933|NCT01414881|ApoB (Apolipoprotein B)|apob (apolipoprotein b)
404934|NCT01414881|LDL (low density lipoprotein)|ldl (low density lipoprotein)
404935|NCT01414881|mipomersen|mipomersen
404936|NCT01414868|Leukotriene|leukotriene
404937|NCT01414868|leukotriene receptor antagonist|leukotriene receptor antagonist
404938|NCT01414868|bronchial provocation test|bronchial provocation test
404939|NCT01414868|therapeutic outcome|therapeutic outcome
404940|NCT01414829|Peptic disease|peptic disease
404941|NCT01414829|Helicobacter pylori|helicobacter pylori
404942|NCT01414829|Different methods|different methods
404943|NCT01414816|Multiple Sclerosis|multiple sclerosis
404944|NCT01414816|Clinical Isolated Syndrome (CIS)|clinical isolated syndrome (cis)
405046|NCT01414335|chronic infection|chronic infection
404945|NCT01414803|rosuvastatin, fenofibrate, creatine kinase, alanine aminotransferase|rosuvastatin, fenofibrate, creatine kinase, alanine aminotransferase
404946|NCT01414790|human acellular dermal matrix|human acellular dermal matrix
404947|NCT01414790|parotid tumor|parotid tumor
404948|NCT01414790|total parotidectomy|total parotidectomy
404949|NCT01414777|c-section|c-section
404950|NCT01414777|Hypotension after spinal anesthesia for C-section|hypotension after spinal anesthesia for c-section
404951|NCT01414764|rotator cuff tendon repair surgery|rotator cuff tendon repair surgery
404952|NCT01414764|supraspinatus tendon repair|supraspinatus tendon repair
404953|NCT01414751|Risk communication|risk communication
404954|NCT01414751|Shared decision making|shared decision making
404955|NCT01414751|Cardiovascular diseases|cardiovascular diseases
404956|NCT01414751|Hypercholesterolemia|hypercholesterolemia
404957|NCT01414751|Prevention|prevention
404958|NCT01414725|Multiple Sclerosis|multiple sclerosis
404959|NCT01414725|Mobility|mobility
404960|NCT01414725|Balance|balance
404961|NCT01414725|Core Stability|core stability
404962|NCT01414725|Physiotherapy|physiotherapy
404963|NCT01414712|Low- and Intermediate-Risk Prostate Cancer|low- and intermediate-risk prostate cancer
404964|NCT01414699|dietary variety|dietary variety
404965|NCT01414699|course sequence|course sequence
404966|NCT01414699|preschool|preschool
404967|NCT01414699|child feeding|child feeding
404968|NCT01414673|IUI|iui
404969|NCT01414673|HCG|hcg
404970|NCT01414673|Spontaneous LH|spontaneous lh
404971|NCT01414673|pregnancy|pregnancy
404972|NCT01414660|interleukin 7|interleukin 7
404973|NCT01414660|transplantation|transplantation
404974|NCT01414660|liver|liver
404975|NCT01414660|kidney|kidney
404976|NCT01414660|islet|islet
404977|NCT01414660|diabetes|diabetes
404978|NCT01414647|Bilberry|bilberry
404979|NCT01414647|Vaccinium myrtillus|vaccinium myrtillus
404980|NCT01414647|Metabolic syndrome|metabolic syndrome
404981|NCT01414647|Glucose metabolism|glucose metabolism
404982|NCT01414647|Lipid metabolism|lipid metabolism
404983|NCT01414647|Inflammation|inflammation
404984|NCT01414647|Gene expression|gene expression
404985|NCT01414621|CABG|cabg
404986|NCT01414595|adenocarcinoma of the lung|adenocarcinoma of the lung
404987|NCT01414595|adenosquamous cell lung cancer|adenosquamous cell lung cancer
404988|NCT01414595|non-small cell lung cancer|non-small cell lung cancer
404989|NCT01414595|squamous cell lung cancer|squamous cell lung cancer
404990|NCT01414582|tDCS|tdcs
404991|NCT01414582|Stroke|stroke
404992|NCT01414582|Functional MRI|functional mri
404993|NCT01414582|Motor Learning|motor learning
404994|NCT01414543|violence|violence
404995|NCT01414517|Prebiotics|prebiotics
404996|NCT01414517|Acute Intestinal Injury|acute intestinal injury
404997|NCT01414517|Chronic radiation enteritis|chronic radiation enteritis
404998|NCT01414504|pneumococcal,|pneumococcal,
404999|NCT01414504|pneumococcal polysaccharide vaccine,|pneumococcal polysaccharide vaccine,
405000|NCT01414504|challenge dose,|challenge dose,
405001|NCT01414504|hyporesponsiveness,|hyporesponsiveness,
405002|NCT01414504|Papua New Guinea|papua new guinea
405003|NCT01414478|emesis|emesis
405004|NCT01414478|nausea|nausea
405005|NCT01414465|Fatty acids|fatty acids
405006|NCT01414465|orlistat|orlistat
405007|NCT01414465|lipase|lipase
405008|NCT01414465|BMC (Body Mass Index) between 30 to 40 kg/m2|bmc (body mass index) between 30 to 40 kg/m2
405009|NCT01414465|Women|women
405010|NCT01414465|18 to 45 years|18 to 45 years
405011|NCT01414465|Premenopausal stage|premenopausal stage
405012|NCT01414452|Myocardial Infarction|myocardial infarction
405013|NCT01414452|Reperfusion injury|reperfusion injury
405014|NCT01414452|Adiponectin|adiponectin
405015|NCT01414452|endothelial progenitor cells|endothelial progenitor cells
405016|NCT01414413|HIV|hiv
405017|NCT01414413|AIDS|aids
405018|NCT01414413|Antiretroviral therapy|antiretroviral therapy
405019|NCT01414413|Community-based study|community-based study
405020|NCT01414413|Cluster-randomised trial|cluster-randomised trial
405021|NCT01414413|HIV testing|hiv testing
405022|NCT01414413|Africa|africa
405023|NCT01414400|Bacteremia|bacteremia
405024|NCT01414400|Spyglass|spyglass
405025|NCT01414400|Cholangioscopy|cholangioscopy
405026|NCT01414387|carotid stenosis|carotid stenosis
405027|NCT01414387|cerebral embolization|cerebral embolization
405028|NCT01414387|stents|stents
405029|NCT01414387|stroke|stroke
405030|NCT01414374|iron|iron
405031|NCT01414374|anemia|anemia
405032|NCT01414374|herbal medicine|herbal medicine
405033|NCT01414374|phytotherapy|phytotherapy
405034|NCT01414374|Centella asiatica|centella asiatica
405035|NCT01414374|Hibiscus sabdariffa|hibiscus sabdariffa
405036|NCT01414361|Coronary artery stenosis|coronary artery stenosis
405037|NCT01414361|Fractional flow reserve|fractional flow reserve
405038|NCT01414361|Intravascular ultrasonography|intravascular ultrasonography
405039|NCT01414348|participation|participation
405040|NCT01414348|activities of daily living|activities of daily living
405041|NCT01414348|brain injuries|brain injuries
405042|NCT01414348|executive function|executive function
405043|NCT01414335|amino acids|amino acids
405044|NCT01414335|immune system|immune system
405047|NCT01414335|common cold|common cold
405048|NCT01414335|ear|ear
405049|NCT01414335|nose|nose
405050|NCT01414335|throat|throat
405051|NCT01414309|Heart Failure|heart failure
405052|NCT01414309|Central Sleep Apnea|central sleep apnea
405053|NCT01414309|Sleep Disordered Breathing|sleep disordered breathing
405054|NCT01414309|Cardiac Dysfunction|cardiac dysfunction
405055|NCT01414257|Rheumatrex|rheumatrex
405056|NCT01414257|High Dose|high dose
405057|NCT01414244|Irritable Bowel Syndrome|irritable bowel syndrome
405058|NCT01414244|Glutamine|glutamine
405059|NCT01414244|Intestinal Permeability|intestinal permeability
405060|NCT01414231|AML|aml
405061|NCT01414231|acute myeloid leukaemia|acute myeloid leukaemia
405062|NCT01414231|low vs intermediate dose AraC|low vs intermediate dose arac
405063|NCT01414231|CR rate|cr rate
405064|NCT01414231|patients <60 years|patients <60 years
405065|NCT01414218|elderly|elderly
405066|NCT01414218|humor|humor
405067|NCT01414218|general well being|general well being
405068|NCT01414218|psychological distress|psychological distress
405069|NCT01414218|health quality of life|health quality of life
405070|NCT01414179|nutrition|nutrition
405071|NCT01414179|environnement|environnement
405072|NCT01414179|cardiovascular pathology|cardiovascular pathology
405073|NCT01414153|choroidal neovascularization|choroidal neovascularization
405074|NCT01414153|age-related macular degeneration|age-related macular degeneration
405075|NCT01414153|iSONEP|isonep
405076|NCT01414153|sonepcizumab|sonepcizumab
405077|NCT01414153|Lucentis|lucentis
405078|NCT01414153|ranibizumab|ranibizumab
405079|NCT01414153|Avastin|avastin
405080|NCT01414153|bevacizumab|bevacizumab
405081|NCT01414153|Eylea|eylea
405082|NCT01414153|aflibercept|aflibercept
405083|NCT01414140|Mirena, contraception|mirena, contraception
405084|NCT01414114|Clinical Trial, Phase 2|clinical trial, phase 2
405085|NCT01414114|Renal Dialysis|renal dialysis
405086|NCT01414114|Secondary Hyperparathyroidism|secondary hyperparathyroidism
405087|NCT01414114|Chronic kidney disease-mineral and bone disorder|chronic kidney disease-mineral and bone disorder
405088|NCT01414114|Parathyroid hormone|parathyroid hormone
405089|NCT01414101|Rheumatoid Arthritis|rheumatoid arthritis
405090|NCT01414088|Nephrology|nephrology
405091|NCT01414088|ENaC|enac
405092|NCT01414088|NCC|ncc
405093|NCT01414088|NKCC|nkcc
405094|NCT01414088|Sodium channels|sodium channels
405095|NCT01414088|renal biomarkers|renal biomarkers
405096|NCT01414075|Kidney|kidney
405097|NCT01414075|ESRD|esrd
405098|NCT01414075|Renal|renal
405099|NCT01414075|End-Stage Renal Disease|end-stage renal disease
405100|NCT01414075|Anemia|anemia
405101|NCT01414075|Oral anemia treatment|oral anemia treatment
405102|NCT01414075|Hemoglobin levels|hemoglobin levels
405103|NCT01414075|Hemodialysis|hemodialysis
405104|NCT01414075|Peritoneal|peritoneal
405105|NCT01414075|HD|hd
405106|NCT01414075|PD|pd
405107|NCT01414075|Hb|hb
405108|NCT01414075|Erythropoietin|erythropoietin
405109|NCT01414075|Blood count|blood count
405110|NCT01414062|Breast Cancer|breast cancer
405111|NCT01414062|Healthy meals|healthy meals
405112|NCT01414062|Cocinar|cocinar
405113|NCT01414062|Dietary|dietary
405114|NCT01414062|Dietary Intervention|dietary intervention
405115|NCT01414062|fruits and vegetables|fruits and vegetables
405116|NCT01414062|Cancer survivor|cancer survivor
405117|NCT01414062|Nutrition|nutrition
405118|NCT01414049|CABG|cabg
405119|NCT01414049|Off-pump CABG|off-pump cabg
405120|NCT01414049|Beating heart|beating heart
405121|NCT01414049|Graft patency|graft patency
405122|NCT01414049|Computed tomography angiography|computed tomography angiography
405123|NCT01414049|Angiographic evaluation of coronary graft patency|angiographic evaluation of coronary graft patency
405124|NCT01414036|cigarette smoking|cigarette smoking
405125|NCT01414036|patient navigation|patient navigation
405126|NCT01414036|primary care|primary care
405127|NCT01414023|High OCI-R scores|high oci-r scores
405128|NCT01414010|healthy volunteers|healthy volunteers
405129|NCT01414010|gut microbiota|gut microbiota
405130|NCT01414010|gut microbiome|gut microbiome
405131|NCT01414010|prebiotic|prebiotic
405132|NCT01414010|probiotic|probiotic
405133|NCT01414010|antibiotic|antibiotic
405134|NCT01414010|antibiotic-associated diarrhea|antibiotic-associated diarrhea
405135|NCT01414010|intestinal bacterial overgrowth|intestinal bacterial overgrowth
405136|NCT01413984|Trauma|trauma
405137|NCT01413984|incarceration|incarceration
405138|NCT01413984|treatment|treatment
405139|NCT01413984|substance abuse|substance abuse
405140|NCT01413958|Nasal Decongestants|nasal decongestants
405141|NCT01413958|Rhinitis, Allergic, Seasonal|rhinitis, allergic, seasonal
405142|NCT01413958|Rhinitis|rhinitis
405143|NCT01413958|Nose Conditions|nose conditions
405144|NCT01413958|Respiratory Tract Diseases|respiratory tract diseases
405145|NCT01413958|Phenylephrine|phenylephrine
405146|NCT01413945|Ileocecal valve|ileocecal valve
405147|NCT01413945|Irritable bowel syndrome|irritable bowel syndrome
405148|NCT01413945|small bowel bacteria|small bowel bacteria
405149|NCT01413867|hemorrhoids|hemorrhoids
405150|NCT01413867|circular staplers|circular staplers
405151|NCT01413867|mucosal resection|mucosal resection
405152|NCT01413867|hemostatic suture|hemostatic suture
405153|NCT01413841|PCI|pci
405154|NCT01413841|oxygen|oxygen
405155|NCT01413828|breast cancer|breast cancer
405156|NCT01413828|adjuvant chemotherapy|adjuvant chemotherapy
405157|NCT01413828|trastuzumab|trastuzumab
405158|NCT01413828|anthracycline|anthracycline
405159|NCT01413815|peri-operative|peri-operative
405160|NCT01413815|cardiovascular risk|cardiovascular risk
405161|NCT01413815|oral supplementation|oral supplementation
405162|NCT01413815|amino acid L-arginine|amino acid l-arginine
405163|NCT01413802|Thyroid surgery|thyroid surgery
405164|NCT01413763|Actinic keratosis|actinic keratosis
405165|NCT01413763|Atrial ectopy|atrial ectopy
405166|NCT01413724|Administered analgesic therapy|administered analgesic therapy
405167|NCT01413711|IS|is
405168|NCT01413711|Pharmacokinetics|pharmacokinetics
405169|NCT01413711|Area under the curve|area under the curve
405170|NCT01413711|Maximum plasma concentration|maximum plasma concentration
405171|NCT01413711|Time to maximum concentration|time to maximum concentration
405172|NCT01413685|tacrolimus|tacrolimus
405173|NCT01413685|calcineurin|calcineurin
405174|NCT01413685|pharmacodynamic|pharmacodynamic
405175|NCT01413685|TDM|tdm
405176|NCT01413685|pharmacokinetics|pharmacokinetics
405177|NCT01413672|ostomy|ostomy
405178|NCT01413672|colostomy|colostomy
405179|NCT01413672|ileostomy|ileostomy
405180|NCT01413672|barrier|barrier
405181|NCT01413672|irritation|irritation
405182|NCT01413659|Colorectal surgery|colorectal surgery
405183|NCT01413659|Surgical site infection|surgical site infection
405184|NCT01413659|Symbiotic|symbiotic
405185|NCT01413646|obesity|obesity
405186|NCT01413646|walnuts|walnuts
405187|NCT01413646|endothelial function|endothelial function
405188|NCT01413620|Vitamin E|vitamin e
405189|NCT01413620|Burn|burn
405190|NCT01413620|Oxidation|oxidation
405191|NCT01413620|Lung Dysfunction|lung dysfunction
405192|NCT01413620|Fatty Liver|fatty liver
405193|NCT01413620|Lipid Peroxidation|lipid peroxidation
405194|NCT01413607|nephrectomy|nephrectomy
405195|NCT01413607|self retaining sutures|self retaining sutures
405196|NCT01413607|laparoscopy|laparoscopy
405197|NCT01413594|cerebral palsy|cerebral palsy
405198|NCT01413594|constraint-induced therapy|constraint-induced therapy
405199|NCT01413594|constraint-induced movement therapy|constraint-induced movement therapy
405200|NCT01413594|CP|cp
405201|NCT01413594|hemiplegia|hemiplegia
405202|NCT01413594|hand|hand
405203|NCT01413594|forced use|forced use
405204|NCT01413594|motor control|motor control
405205|NCT01413594|children|children
405206|NCT01413594|HABIT|habit
405207|NCT01413594|Hand-arm bimanual intensive therapy|hand-arm bimanual intensive therapy
405208|NCT01413594|bilateral training|bilateral training
405209|NCT01413594|bimanual training|bimanual training
405210|NCT01413594|functional therapy|functional therapy
405211|NCT01413594|physical therapy|physical therapy
405212|NCT01413594|occupational therapy|occupational therapy
405213|NCT01413594|intensive|intensive
405214|NCT01413594|pediatric|pediatric
405215|NCT01413594|development|development
405216|NCT01413594|upper extremity|upper extremity
405217|NCT01413594|hemiplegic|hemiplegic
405218|NCT01413594|childhood stroke|childhood stroke
405219|NCT01413581|rhBSSL|rhbssl
405220|NCT01413581|preterm infants|preterm infants
405221|NCT01413581|Swedish Orphan Biovitrum|swedish orphan biovitrum
405222|NCT01413581|growth velocity|growth velocity
405223|NCT01413581|Prevention of growth restriction|prevention of growth restriction
405224|NCT01413555|blood culture|blood culture
405225|NCT01413555|emergency department|emergency department
405226|NCT01413555|quality improvement|quality improvement
405227|NCT01413542|DPPIV inhibitors|dppiv inhibitors
405228|NCT01413542|ACE inhibitors|ace inhibitors
405229|NCT01413542|Bradykinin|bradykinin
405230|NCT01413542|glucagon-like peptide (GLP-1)|glucagon-like peptide (glp-1)
405231|NCT01413542|BNP|bnp
405232|NCT01413542|diabetes|diabetes
405233|NCT01413542|hypertension|hypertension
405234|NCT01413529|HIV infected persons with co-occurring drug use|hiv infected persons with co-occurring drug use
405235|NCT01413516|Varenicline|varenicline
405236|NCT01413516|Placebo|placebo
405237|NCT01413516|Inpatient|inpatient
405238|NCT01413503|Pheochromocytoma|pheochromocytoma
405239|NCT01413503|Paraganglioma|paraganglioma
405240|NCT01413503|MIBG|mibg
405241|NCT01413503|131I-MIBG|131i-mibg
405242|NCT01413503|Resistant|resistant
405243|NCT01413503|Relapsed|relapsed
405244|NCT01413503|Treatment|treatment
405245|NCT01413503|UCSF|ucsf
405246|NCT01413503|Pediatric|pediatric
405247|NCT01413503|Adult|adult
405248|NCT01413503|Oncology|oncology
405249|NCT01413490|hepatitis C virus|hepatitis c virus
405250|NCT01413490|Interferon|interferon
405251|NCT01413490|rimantadine|rimantadine
405252|NCT01413490|liver|liver
405253|NCT01413477|Allergic contact dermatitis|allergic contact dermatitis
405254|NCT01413477|Nickel allergy|nickel allergy
405255|NCT01413477|Desensitization therapy|desensitization therapy
405256|NCT01413464|Renal Transplant|renal transplant
405257|NCT01413464|Venous Thrombosis|venous thrombosis
405258|NCT01413464|Deep Vein Thrombosis|deep vein thrombosis
405259|NCT01413464|Prophylaxis|prophylaxis
405260|NCT01413464|Bleeding|bleeding
405261|NCT01413451|Monoclonal IgG Antibody|monoclonal igg antibody
405262|NCT01413451|Biodistribution|biodistribution
405263|NCT01413451|Pharmacokinetics|pharmacokinetics
405264|NCT01413451|HACA|haca
405265|NCT01413451|Safety|safety
405266|NCT01413451|Mesothelioma|mesothelioma
405267|NCT01413451|Ovarian Cancer|ovarian cancer
405268|NCT01413451|Pancreatic Duct Cancer|pancreatic duct cancer
405269|NCT01413451|Non-Small Cell Lung Cancer|non-small cell lung cancer
405270|NCT01413438|Bevacizumab|bevacizumab
405271|NCT01413438|Quality of Life|quality of life
405272|NCT01413438|Glioblastoma Multiforme|glioblastoma multiforme
405273|NCT01413438|Neurosurgery|neurosurgery
405274|NCT01413438|Glioblastoma|glioblastoma
405275|NCT01413438|GBM|gbm
405276|NCT01413438|Brain Tumor|brain tumor
405277|NCT01413425|Smith-Lemli-Opitz Syndrome|smith-lemli-opitz syndrome
405278|NCT01413425|Cholesterol|cholesterol
405279|NCT01413425|SLOS|slos
405280|NCT01413412|Ventral Hernia|ventral hernia
405281|NCT01413412|Postoperative Pain|postoperative pain
405282|NCT01413412|Ventral Hernia Pain Questionnaire|ventral hernia pain questionnaire
405283|NCT01413412|Postoperative Abdominal wall and muscle function|postoperative abdominal wall and muscle function
405284|NCT01413412|Biodex|biodex
405285|NCT01413386|paclitaxel|paclitaxel
405286|NCT01413386|drug eluting stent|drug eluting stent
405287|NCT01413373|cephalometry|cephalometry
405288|NCT01413373|three-dimensional|three-dimensional
405289|NCT01413373|CT scan|ct scan
405290|NCT01413373|lateral radiography|lateral radiography
405291|NCT01413373|facial symmetry|facial symmetry
405292|NCT01413373|maxillomandibular dysmorphoses|maxillomandibular dysmorphoses
405293|NCT01413334|Coronary artery disease|coronary artery disease
405294|NCT01413334|CT|ct
405295|NCT01413321|Brain Injuries|brain injuries
405296|NCT01413321|Post Traumatic Encephalopathy|post traumatic encephalopathy
405297|NCT01413321|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
405298|NCT01413321|Cerebral Stroke|cerebral stroke
405299|NCT01413321|Vascular Accidents, Brain|vascular accidents, brain
405300|NCT01413321|Cerebrovascular Apoplexy|cerebrovascular apoplexy
405301|NCT01413321|Cerebrovascular Accident|cerebrovascular accident
405302|NCT01413321|hemiparesis|hemiparesis
405303|NCT01413308|Fontan|fontan
405304|NCT01413308|lung function test|lung function test
405305|NCT01413308|nitric oxide production|nitric oxide production
405306|NCT01413308|NYHA class 1-2 without acute or chronic specified lung disease|nyha class 1-2 without acute or chronic specified lung disease
405307|NCT01413295|Colorectal Neoplasms|colorectal neoplasms
405308|NCT01413295|Dendritic Cells|dendritic cells
405309|NCT01413282|Acute coronary syndrome|acute coronary syndrome
405310|NCT01413269|breast cancer patients|breast cancer patients
405311|NCT01413269|breast conservation surgery|breast conservation surgery
405312|NCT01413269|hypofractionated radiotherapy|hypofractionated radiotherapy
405313|NCT01413243|Multipe sclerosis, Trichuris suis ova|multipe sclerosis, trichuris suis ova
405314|NCT01413230|Systemic lupus erythematosus|systemic lupus erythematosus
405315|NCT01413230|vitamin D supplementation|vitamin d supplementation
405316|NCT01413230|regulatory T cells|regulatory t cells
405317|NCT01413230|Th17 cells|th17 cells
405318|NCT01413204|TA-7284|ta-7284
405319|NCT01413204|JNJ-28431754|jnj-28431754
405320|NCT01413204|Canagliflozin|canagliflozin
405321|NCT01413204|Sodium Glucose Co-transporter (SGLT2 inhibitor)|sodium glucose co-transporter (sglt2 inhibitor)
405322|NCT01413178|Myeloma|myeloma
405323|NCT01413178|Multiple Myeloma|multiple myeloma
405324|NCT01413178|Light chain Multiple Myeloma|light chain multiple myeloma
405325|NCT01413178|MM|mm
405326|NCT01413178|Autologous Hematopoietic Stem Cell Transplantation|autologous hematopoietic stem cell transplantation
405327|NCT01413178|Busulfan|busulfan
405328|NCT01413178|Busulfex|busulfex
405329|NCT01413178|Myleran|myleran
405330|NCT01413178|Melphalan|melphalan
405331|NCT01413178|Alkeran|alkeran
405332|NCT01413178|G-CSF|g-csf
405333|NCT01413178|Filgrastim|filgrastim
405334|NCT01413178|NeupogenTM|neupogentm
405335|NCT01413178|Questionnaire|questionnaire
405336|NCT01413178|Survey|survey
405337|NCT01413178|Quality of Life|quality of life
405338|NCT01413178|QOL|qol
405339|NCT01413152|men having sex with men|men having sex with men
405340|NCT01413139|peripheral Vascular Disease|peripheral vascular disease
405341|NCT01413139|claudication|claudication
405342|NCT01413139|rest pain|rest pain
405343|NCT01413126|Peanut|peanut
405344|NCT01413126|Blood glucose|blood glucose
405345|NCT01413126|Insulin|insulin
405346|NCT01413126|Non-esterified free fatty acids|non-esterified free fatty acids
405347|NCT01413126|Glucagon-like peptide-1|glucagon-like peptide-1
405348|NCT01413126|Peptide YY|peptide yy
405349|NCT01413126|Cholecystokinin|cholecystokinin
405350|NCT01413126|Appetitive|appetitive
405351|NCT01413126|Food intake|food intake
405352|NCT01413087|Pancreatic cancer|pancreatic cancer
405353|NCT01413087|Gemcitabine|gemcitabine
405354|NCT01413087|BC-819|bc-819
405355|NCT01413087|Adenocarcinoma|adenocarcinoma
405356|NCT01413087|Resectable|resectable
405357|NCT01413087|H19 gene|h19 gene
405358|NCT01413087|DTA-H19|dta-h19
405359|NCT01413087|BioCancell|biocancell
405360|NCT01413074|End Stage Renal Disease|end stage renal disease
405361|NCT01413074|ESRD|esrd
405362|NCT01413074|Peritoneal Dialysis|peritoneal dialysis
405363|NCT01413074|PD|pd
405364|NCT01413074|Hemodialysis|hemodialysis
405365|NCT01413074|HD|hd
405366|NCT01413061|Other Hindfoot Conditions requiring Subtalar Arthrodesis|other hindfoot conditions requiring subtalar arthrodesis
405367|NCT01413061|Post-traumatic Arthritis|post-traumatic arthritis
405368|NCT01413048|Essential Hypertension|essential hypertension
405369|NCT01413048|Hypertension|hypertension
405370|NCT01413035|Diabetes|diabetes
405371|NCT01413035|Diabetes Medicines: Oral Hypoglycemic Drugs and Insulins.|diabetes medicines: oral hypoglycemic drugs and insulins.
405372|NCT01413035|Umbilical Cord/placenta-Derived MSC|umbilical cord/placenta-derived msc
405373|NCT01413035|Transplantation|transplantation
405374|NCT01413009|delirium|delirium
405375|NCT01413009|ICU|icu
405376|NCT01413009|spontaneous awakening trials|spontaneous awakening trials
405377|NCT01413009|spontaneous breathing trials|spontaneous breathing trials
405378|NCT01413009|early mobility|early mobility
405379|NCT01412970|hemodynamic monitoring|hemodynamic monitoring
405380|NCT01412970|volume responsiveness|volume responsiveness
405381|NCT01412970|electrical impedance tomography|electrical impedance tomography
405382|NCT01412957|Best Supportive Care|best supportive care
405383|NCT01412957|Panitumumab|panitumumab
405384|NCT01412957|Chemorefractory|chemorefractory
405385|NCT01412957|Wild-type KRAS|wild-type kras
405386|NCT01412957|Overall Survival|overall survival
405387|NCT01412957|Phase 3|phase 3
405388|NCT01412944|Psoriasis|psoriasis
405389|NCT01412944|plaque|plaque
405390|NCT01412944|inflammatory skin disease|inflammatory skin disease
405391|NCT01412944|scaly patches|scaly patches
405392|NCT01412944|AIN457|ain457
405393|NCT01412944|secukinumab|secukinumab
405394|NCT01412944|Moderate to severe|moderate to severe
405395|NCT01412918|Tinnitus|tinnitus
405396|NCT01412918|Inhibitor Device|inhibitor device
405397|NCT01412918|SCN9 gene|scn9 gene
405398|NCT01412918|Ringing in the ears|ringing in the ears
405399|NCT01412918|Milwaukee|milwaukee
405400|NCT01412918|Medical College of Wisconsin|medical college of wisconsin
405401|NCT01412905|screening|screening
405402|NCT01412905|diabetic retinopathy|diabetic retinopathy
405403|NCT01412892|Neurofibromatosis type 1|neurofibromatosis type 1
405404|NCT01412892|Everolimus|everolimus
405405|NCT01412892|Plexiform neurofibromas|plexiform neurofibromas
405406|NCT01412892|Rapamycin|rapamycin
405407|NCT01412879|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
405408|NCT01412879|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
405409|NCT01412879|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
405410|NCT01412879|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
405411|NCT01412866|schizophrenia|schizophrenia
405412|NCT01412866|severe mental illness|severe mental illness
405413|NCT01412866|nicotine|nicotine
405414|NCT01412866|smoking|smoking
405415|NCT01412866|motivation|motivation
405416|NCT01412866|electronic decision support system|electronic decision support system
405417|NCT01412866|motivational interviewing|motivational interviewing
405418|NCT01412853|localized|localized
405419|NCT01412840|Ureterolithiasis|ureterolithiasis
405420|NCT01412840|Pain|pain
405421|NCT01412840|Complementary|complementary
405422|NCT01412840|RCT|rct
405423|NCT01412827|Single-photon emission computed tomography|single-photon emission computed tomography
405424|NCT01412827|myocardial perfusion imaging|myocardial perfusion imaging
405425|NCT01412827|rest/stress|rest/stress
405426|NCT01412827|treadmill|treadmill
405427|NCT01412827|persantine|persantine
405428|NCT01412827|half-dose|half-dose
405429|NCT01412827|radiotracer|radiotracer
405430|NCT01412827|tetrofosmin|tetrofosmin
405431|NCT01412827|Thallium|thallium
405432|NCT01412827|cadmium zinc telluride|cadmium zinc telluride
405433|NCT01412827|diagnostic|diagnostic
405434|NCT01412827|prognostic|prognostic
405435|NCT01412814|Total knee arthroplasty|total knee arthroplasty
405436|NCT01412814|Total knee replacement|total knee replacement
405437|NCT01412814|End-stage knee osteoarthritis|end-stage knee osteoarthritis
405438|NCT01412814|Gait patterns|gait patterns
405439|NCT01412814|Neuromuscular education|neuromuscular education
405440|NCT01412801|Group B streptococcus|group b streptococcus
405441|NCT01412801|GBS|gbs
405442|NCT01412801|Vaccine|vaccine
405443|NCT01412801|Prevention of group B streptococcus infection|prevention of group b streptococcus infection
405444|NCT01412788|breast cancer|breast cancer
405445|NCT01412788|Breast Conserving Surgery|breast conserving surgery
405446|NCT01412788|Peri-areolar Incision|peri-areolar incision
405447|NCT01412775|stress|stress
405448|NCT01412775|burnout|burnout
405449|NCT01412775|exhaustion|exhaustion
405450|NCT01412762|Surgery|surgery
405451|NCT01412762|interview|interview
405452|NCT01412762|11-087|11-087
405453|NCT01412749|registry|registry
405454|NCT01412749|database|database
405455|NCT01412749|eHNS|ehns
405456|NCT01412749|Endoscopic Head and Neck Surgery|endoscopic head and neck surgery
405457|NCT01412749|Transoral Endoscopic Surgery Trial|transoral endoscopic surgery trial
405458|NCT01412749|TEST|test
405459|NCT01412749|melanoma|melanoma
405460|NCT01412749|head and neck surgery|head and neck surgery
405461|NCT01412723|Iron Deficiency|iron deficiency
405462|NCT01412723|Child, Preschool|child, preschool
405463|NCT01412723|Dietary Iron|dietary iron
405464|NCT01412723|Ferrous sulfate|ferrous sulfate
405465|NCT01412723|Bis-glycino iron II|bis-glycino iron ii
405466|NCT01412710|Type 2 Diabetes|type 2 diabetes
405467|NCT01412710|Cholecalciferol|cholecalciferol
405468|NCT01412710|Vitamin D|vitamin d
405469|NCT01412710|Insulin resistance|insulin resistance
405470|NCT01412710|Cardiovascular disease risk|cardiovascular disease risk
405471|NCT01412710|Minorities|minorities
405472|NCT01412697|Rural youth|rural youth
405473|NCT01412697|Theory-based intervention|theory-based intervention
405474|NCT01412697|Randomized by schools|randomized by schools
405475|NCT01412697|Fruit and vegetable intake|fruit and vegetable intake
405476|NCT01412697|Health classes|health classes
405477|NCT01412671|Nexavar|nexavar
405478|NCT01412671|unresectable or advanced renal cell carcinoma|unresectable or advanced renal cell carcinoma
405479|NCT01412645|Obesity|obesity
405480|NCT01412645|Inflammation|inflammation
405481|NCT01412645|Metabolic Syndrome|metabolic syndrome
405482|NCT01412645|Insulin sensitivity|insulin sensitivity
405483|NCT01412645|Osteoporosis|osteoporosis
405484|NCT01412645|Bone turnover|bone turnover
405485|NCT01412645|Ectopic fat accumulation|ectopic fat accumulation
405486|NCT01412645|Resveratrol|resveratrol
405487|NCT01412619|Neurological Outcome|neurological outcome
405488|NCT01412619|Intraoperative intracerebral Oxygen level|intraoperative intracerebral oxygen level
405489|NCT01412619|Mean arterial blood pressure|mean arterial blood pressure
405490|NCT01412619|Central venous blood pressure|central venous blood pressure
405491|NCT01412619|Cardiac output|cardiac output
405492|NCT01412619|Serum Lactate|serum lactate
405493|NCT01412619|Venous oxygen saturation|venous oxygen saturation
405494|NCT01412619|Fluid balance|fluid balance
405495|NCT01412606|Unexplained infertility-endometrial scratching|unexplained infertility-endometrial scratching
405496|NCT01412606|effect of endometrial biopsy (scratching) on clinical pregnancy rates in women with unexplained infertility|effect of endometrial biopsy (scratching) on clinical pregnancy rates in women with unexplained infertility
405497|NCT01412567|Hepatitis B|hepatitis b
405498|NCT01412567|HBsAg|hbsag
405499|NCT01412567|Antenatal|antenatal
405500|NCT01412567|Pregnancy|pregnancy
405501|NCT01412567|Vertical transmission|vertical transmission
405502|NCT01412567|Placenta|placenta
405503|NCT01412567|HBV DNA|hbv dna
405504|NCT01412554|Insulin resistance|insulin resistance
405505|NCT01412554|Diabetes mellitus|diabetes mellitus
405506|NCT01412554|Adipositas|adipositas
405507|NCT01412541|Arms|arms
405508|NCT01412541|Experimental|experimental
405509|NCT01412541|Drug Coated Angioplasty Balloon|drug coated angioplasty balloon
405510|NCT01412541|Active Comparator|active comparator
405511|NCT01412541|Standard Angioplasty Balloon|standard angioplasty balloon
405512|NCT01412515|mTOR inhibitors|mtor inhibitors
405513|NCT01412502|Tissue Donors|tissue donors
405514|NCT01412502|Tissue and Organ Procurement|tissue and organ procurement
405515|NCT01412502|Brain death|brain death
405516|NCT01412502|Withdrawal of life support|withdrawal of life support
405517|NCT01412489|Uterine synechiae|uterine synechiae
405518|NCT01412489|HyalobarrierR Gel Endo|hyalobarrierr gel endo
405519|NCT01412489|Operative hysteroscopy|operative hysteroscopy
405520|NCT01412489|submucous myoma|submucous myoma
405521|NCT01412450|symptomatic popliteal artery stenosis or occlusion|symptomatic popliteal artery stenosis or occlusion
405523|NCT01412437|MRI|mri
405524|NCT01412437|neurocognition|neurocognition
405525|NCT01412437|sapropterin dihydrochloride|sapropterin dihydrochloride
405526|NCT01412424|acromegaly|acromegaly
405527|NCT01412424|IGF-1|igf-1
405528|NCT01412424|growth hormone|growth hormone
405529|NCT01412424|Octreolin|octreolin
405530|NCT01412424|octreotide|octreotide
405531|NCT01412424|somatostatin analog|somatostatin analog
405532|NCT01412411|Anemia|anemia
405533|NCT01412411|Growth|growth
405534|NCT01412411|Infants|infants
405535|NCT01412411|Focus of the study is to assess the level of anemia and growth indicators among the infants|focus of the study is to assess the level of anemia and growth indicators among the infants
405536|NCT01412398|Fosrenol|fosrenol
405537|NCT01412398|Hyperphosphatemia|hyperphosphatemia
405538|NCT01412398|Continuous Cyclic Peritoneal Dialysis|continuous cyclic peritoneal dialysis
405539|NCT01412372|Irritable Bowel Syndrome|irritable bowel syndrome
405540|NCT01412372|Diarrhea|diarrhea
405541|NCT01412372|Mesalamine|mesalamine
405542|NCT01412372|Gastroenteritis|gastroenteritis
405543|NCT01412372|abdominal pain|abdominal pain
405544|NCT01412372|hypersensitivity|hypersensitivity
405545|NCT01412359|TPN Cholestasis|tpn cholestasis
405546|NCT01412346|human|human
405547|NCT01412346|clinical trial|clinical trial
405548|NCT01412346|dietary intervention study|dietary intervention study
405549|NCT01412346|blood pressure|blood pressure
405550|NCT01412346|cardiovascular biomarkers|cardiovascular biomarkers
405551|NCT01412346|nutritional biomarkers|nutritional biomarkers
405552|NCT01412346|gene expression|gene expression
405553|NCT01412307|Hodgkin Lymphoma|hodgkin lymphoma
405554|NCT01412307|Lenalidomide|lenalidomide
405555|NCT01412307|Bendamustine|bendamustine
405556|NCT01412307|Salvage therapy|salvage therapy
405557|NCT01412307|Palliation|palliation
405558|NCT01412294|gastric cancer|gastric cancer
405559|NCT01412294|recurrent gastric cancer|recurrent gastric cancer
405560|NCT01412294|adenocarcinoma of the stomach|adenocarcinoma of the stomach
405561|NCT01412294|capecitabine|capecitabine
405562|NCT01412294|xp|xp
405563|NCT01412281|Influenza|influenza
405564|NCT01412281|Virus|virus
405565|NCT01412281|Vaccination|vaccination
405566|NCT01412281|Immunisation|immunisation
405567|NCT01412268|Obesity|obesity
405568|NCT01412268|Bariatric surgery|bariatric surgery
405569|NCT01412268|Behavioral changes|behavioral changes
405570|NCT01412268|Eating habits|eating habits
405571|NCT01412268|Eating addiction|eating addiction
405572|NCT01412242|Deep vein thrombosis|deep vein thrombosis
405573|NCT01412242|Ultrasonography|ultrasonography
405574|NCT01412242|Pulmonary embolism|pulmonary embolism
405575|NCT01412242|D-dimer|d-dimer
405576|NCT01412242|Pre-test probability|pre-test probability
405577|NCT01412229|Head and neck cancer|head and neck cancer
405578|NCT01412229|Phase II|phase ii
405579|NCT01412229|Locally advanced|locally advanced
405580|NCT01412229|Squamous Cell|squamous cell
405581|NCT01412229|Carboplatin|carboplatin
405582|NCT01412229|Nab-paclitaxel|nab-paclitaxel
405583|NCT01412229|Abraxane|abraxane
405584|NCT01412229|Cetuximab|cetuximab
405585|NCT01412229|Induction|induction
405586|NCT01412229|Chemotherapy|chemotherapy
405587|NCT01412216|Sedentarism|sedentarism
405588|NCT01412216|Physical inactivity|physical inactivity
405589|NCT01412216|Fish oil|fish oil
405590|NCT01412216|Omega-3 fatty acids|omega-3 fatty acids
405591|NCT01412216|Endothelial dysfunction|endothelial dysfunction
405592|NCT01412216|Insulin resistance|insulin resistance
405593|NCT01412216|Metabolic syndrome|metabolic syndrome
405594|NCT01412216|peripheral arterial disease|peripheral arterial disease
405595|NCT01412203|Physical activity|physical activity
405596|NCT01412203|Healthy weight|healthy weight
405597|NCT01412203|Healthy eating|healthy eating
405598|NCT01412203|Physical fitness|physical fitness
405599|NCT01412203|Children|children
405600|NCT01412203|School based|school based
405601|NCT01412203|Community based|community based
405602|NCT01412203|Obesity|obesity
405603|NCT01412203|Health promotion|health promotion
405604|NCT01412203|Socio-ecological|socio-ecological
405605|NCT01412203|Environment based|environment based
405606|NCT01412190|Skin rejuvenation|skin rejuvenation
405607|NCT01412177|Meniere's Disease|meniere's disease
405608|NCT01412177|Vertigo|vertigo
405609|NCT01412177|Definitive vertigo|definitive vertigo
405610|NCT01412177|Vertigo episodes|vertigo episodes
405611|NCT01412177|Vertigo frequency|vertigo frequency
405612|NCT01412177|Tinnitus|tinnitus
405613|NCT01412177|Hearing loss|hearing loss
405614|NCT01412177|Aural fullness|aural fullness
405615|NCT01412164|DES|des
405616|NCT01412164|CAD|cad
405617|NCT01412164|FIREHAWK|firehawk
405618|NCT01412164|MicroPort|microport
405619|NCT01412164|PCI|pci
405620|NCT01412151|Symptomatic|symptomatic
405621|NCT01412151|Huntington's Disease|huntington's disease
405622|NCT01412151|HD|hd
405623|NCT01412125|Biomarkers|biomarkers
405624|NCT01412125|Genetic polymorphism|genetic polymorphism
405625|NCT01412125|Neuroimaging markers|neuroimaging markers
405626|NCT01412125|Neuropsychology|neuropsychology
405627|NCT01412099|Exercise|exercise
405628|NCT01412099|Fast Foods|fast foods
405629|NCT01412099|Fruits|fruits
405630|NCT01412099|Vegetables|vegetables
405631|NCT01412099|Beverages|beverages
405632|NCT01412099|Non-traditional college students|non-traditional college students
405633|NCT01412099|Motivational Interviewing|motivational interviewing
405634|NCT01412099|Peer Counselors|peer counselors
405635|NCT01412099|Cancer Prevention|cancer prevention
405636|NCT01412073|caesarean section, intrapartum haemorrhage|caesarean section, intrapartum haemorrhage
405637|NCT01412060|Schizophrenia|schizophrenia
405638|NCT01412060|Schizophrenic Disorder|schizophrenic disorder
405639|NCT01412047|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
405640|NCT01412047|PNH|pnh
405641|NCT01412047|Human Anti-Human Antibody|human anti-human antibody
405642|NCT01412047|HAHA|haha
405643|NCT01412047|Soliris|soliris
405644|NCT01412047|eculizumab|eculizumab
405645|NCT01412034|Homozygous Familial Hypercholesterolemia|homozygous familial hypercholesterolemia
405646|NCT01412034|Familial Hypercholesterolemia|familial hypercholesterolemia
405647|NCT01412034|HDL mimetic|hdl mimetic
405648|NCT01412034|ApoA-1|apoa-1
405649|NCT01412021|Arthritis, Juvenile Rheumatoid|arthritis, juvenile rheumatoid
405650|NCT01412008|MRI|mri
405651|NCT01412008|Magnetic Resonance Imaging|magnetic resonance imaging
405652|NCT01412008|Botox|botox
405653|NCT01412008|botulinum toxin|botulinum toxin
405654|NCT01412008|neurological|neurological
405655|NCT01412008|stroke|stroke
405656|NCT01412008|spasticity|spasticity
405657|NCT01412008|muscle stiffness|muscle stiffness
405658|NCT01412008|diffusion|diffusion
405659|NCT01412008|Weill Cornell|weill cornell
405660|NCT01412008|New York Presbyterian Hospital|new york presbyterian hospital
405661|NCT01412008|O'Dell|o'dell
405662|NCT01411995|intrauterine device|intrauterine device
405663|NCT01411995|pain|pain
405664|NCT01411995|lidocaine gel|lidocaine gel
405665|NCT01411982|PACAP (pituitary adenylate cyclase-activating polypeptide)|pacap (pituitary adenylate cyclase-activating polypeptide)
405666|NCT01411982|Nephrotic syndrome|nephrotic syndrome
405667|NCT01411982|Thrombosis|thrombosis
405668|NCT01411982|Platelets|platelets
405669|NCT01411969|external nasal dilator strip|external nasal dilator strip
405670|NCT01411969|nasal valve|nasal valve
405671|NCT01411969|acoustic rhinometry|acoustic rhinometry
405672|NCT01411956|Health Behavior Theory|health behavior theory
405673|NCT01411956|Patient Education|patient education
405674|NCT01411956|Hypertension|hypertension
405675|NCT01411956|Health beliefs related to hypertension and hypertension treatment|health beliefs related to hypertension and hypertension treatment
405676|NCT01411943|Epigenetics|epigenetics
405677|NCT01411943|Inflammatory|inflammatory
405678|NCT01411943|Psychoneurologic Symptoms|psychoneurologic symptoms
405679|NCT01411943|Cognitive Dysfunction|cognitive dysfunction
405680|NCT01411943|Pain|pain
405681|NCT01411943|Fatigue|fatigue
405682|NCT01411943|Sleep Disturbance|sleep disturbance
405683|NCT01411943|Depression|depression
405684|NCT01411943|Depressive Symptoms|depressive symptoms
405685|NCT01411943|Anxiety|anxiety
405686|NCT01411943|Breast Cancer|breast cancer
405687|NCT01411930|Insulin resistance|insulin resistance
405688|NCT01411930|Antipsychotics|antipsychotics
405689|NCT01411930|Olanzapine|olanzapine
405690|NCT01411930|Aripiprazole|aripiprazole
405691|NCT01411917|surgical stomas|surgical stomas
405692|NCT01411917|Nerve block|nerve block
405693|NCT01411904|Leukemia|leukemia
405694|NCT01411904|magnetic needle|magnetic needle
405695|NCT01411904|magnetic nanoparticles|magnetic nanoparticles
405696|NCT01411904|CD34|cd34
405697|NCT01411891|Arthroplasty|arthroplasty
405698|NCT01411891|Infection Control|infection control
405699|NCT01411878|Teen Pregnancy Prevention|teen pregnancy prevention
405700|NCT01411865|Pragmatic randomized controlled trial|pragmatic randomized controlled trial
405701|NCT01411865|Cardiovascular risk reduction|cardiovascular risk reduction
405702|NCT01411865|Knowledge translation|knowledge translation
405703|NCT01411865|Clinical practice guidelines|clinical practice guidelines
405704|NCT01411865|Administrative databases|administrative databases
405705|NCT01411852|fluid volume resuscitation|fluid volume resuscitation
405706|NCT01411852|trauma|trauma
405707|NCT01411852|hemorrhagic shock|hemorrhagic shock
405708|NCT01411839|Depression|depression
405709|NCT01411839|Latinos|latinos
405710|NCT01411839|Adherence|adherence
405711|NCT01411839|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
405712|NCT01411839|HIV/AIDS|hiv/aids
405713|NCT01411826|Colon cancer screening|colon cancer screening
405714|NCT01411787|Breast cancer|breast cancer
405715|NCT01411787|neoadjuvant chemotherapy|neoadjuvant chemotherapy
405716|NCT01411787|exercise|exercise
405717|NCT01411787|Ki-67|ki-67
405718|NCT01411774|Obsessive-compulsive disorder|obsessive-compulsive disorder
405719|NCT01411774|OCD|ocd
405720|NCT01411761|indirect hyperbilirubinemia|indirect hyperbilirubinemia
405721|NCT01411761|very low birth weight infants|very low birth weight infants
405722|NCT01411722|Electrical Activity of Diaphragm|electrical activity of diaphragm
405723|NCT01411722|Weaning outcome|weaning outcome
405724|NCT01411722|NAVA|nava
405725|NCT01411683|Cost estimates|cost estimates
405726|NCT01411683|Complete Denture|complete denture
405727|NCT01411683|Dental Economics|dental economics
405728|NCT01411683|Dental Implants|dental implants
405857|NCT01411202|Pleurx catheter|pleurx catheter
405729|NCT01411683|Dental Prosthesis, Implant-Supported|dental prosthesis, implant-supported
405730|NCT01411683|Denture Retention|denture retention
405731|NCT01411683|Edentulous|edentulous
405732|NCT01411683|Edentulism|edentulism
405733|NCT01411683|Mini dental implant|mini dental implant
405734|NCT01411683|Oral Health-Related Quality of Life|oral health-related quality of life
405735|NCT01411683|Overdenture|overdenture
405736|NCT01411683|Patient Acceptance of Health Care|patient acceptance of health care
405737|NCT01411683|Quality of Health Care|quality of health care
405738|NCT01411683|Quality of Life|quality of life
405739|NCT01411683|Patient Satisfaction|patient satisfaction
405740|NCT01411670|Human Protein C|human protein c
405741|NCT01411670|Activated protein C|activated protein c
405742|NCT01411670|Microcirculation|microcirculation
405743|NCT01411670|Septic Shock|septic shock
405744|NCT01411670|Sepsis|sepsis
405745|NCT01411644|POF|pof
405746|NCT01411644|IOF|iof
405747|NCT01411644|Poor response|poor response
405748|NCT01411644|early menopause|early menopause
405749|NCT01411644|Primary amenorrhea|primary amenorrhea
405750|NCT01411631|Polyphenols|polyphenols
405751|NCT01411631|Cognition|cognition
405752|NCT01411631|Cognitive function|cognitive function
405753|NCT01411631|Driving performance|driving performance
405754|NCT01411631|Stress|stress
405755|NCT01411618|Antiplaque agents|antiplaque agents
405756|NCT01411618|chemical plaque control|chemical plaque control
405757|NCT01411618|oral hygiene|oral hygiene
405758|NCT01411618|essential oils|essential oils
405759|NCT01411618|alcohol|alcohol
405760|NCT01411618|mouthwash|mouthwash
405761|NCT01411605|Obesity|obesity
405762|NCT01411605|Adolescent|adolescent
405763|NCT01411605|Exercise training|exercise training
405764|NCT01411605|Exercise tolerance|exercise tolerance
405765|NCT01411592|All-Ceramic|all-ceramic
405766|NCT01411592|Resin-bonded Fixed Dental Protheses|resin-bonded fixed dental protheses
405767|NCT01411592|Single Retainer|single retainer
405768|NCT01411592|Randomized Clinical Trial|randomized clinical trial
405769|NCT01411592|Resin Bond|resin bond
405770|NCT01411592|Bonding System|bonding system
405771|NCT01411579|liver|liver
405772|NCT01411579|metastases|metastases
405773|NCT01411579|hepatocarcinoma|hepatocarcinoma
405774|NCT01411579|MR|mr
405775|NCT01411579|DWI|dwi
405776|NCT01411579|chemotherapy|chemotherapy
405777|NCT01411566|KLIPS|klips
405778|NCT01411553|ICU|icu
405779|NCT01411553|Telemetry|telemetry
405780|NCT01411553|ECG lead wire monitoring|ecg lead wire monitoring
405781|NCT01411553|Infection|infection
405782|NCT01411553|Nuisance alarms|nuisance alarms
405783|NCT01411540|Body composition|body composition
405784|NCT01411540|Health markers|health markers
405785|NCT01411540|Diet|diet
405786|NCT01411527|Hormones|hormones
405787|NCT01411527|Endocrine Disrupters|endocrine disrupters
405788|NCT01411527|Polymorphism, Genetic|polymorphism, genetic
405789|NCT01411514|Relapsing remittent multipse sclerosis|relapsing remittent multipse sclerosis
405790|NCT01411514|Secondary progressive multiple sclerosis|secondary progressive multiple sclerosis
405791|NCT01411514|Clinically isolated syndrome|clinically isolated syndrome
405792|NCT01411514|Primary progressive multiple sclerosis|primary progressive multiple sclerosis
405793|NCT01411501|Acupuncture|acupuncture
405794|NCT01411501|Functional constipation|functional constipation
405795|NCT01411488|Focus: anal erosion|focus: anal erosion
405796|NCT01411449|Primovist|primovist
405797|NCT01411449|MRI agent|mri agent
405798|NCT01411436|Nexavar|nexavar
405799|NCT01411436|unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
405800|NCT01411423|Nexavar|nexavar
405801|NCT01411423|Unresectable or advanced renal cell carcinoma|unresectable or advanced renal cell carcinoma
405802|NCT01411410|phase I|phase i
405803|NCT01411410|phosphatidylinositol 3΄-kinase (PI3K)|phosphatidylinositol 3΄-kinase (pi3k)
405804|NCT01411410|paclitaxel|paclitaxel
405805|NCT01411410|Maximum tolerated Dose|maximum tolerated dose
405806|NCT01411397|Infection|infection
405807|NCT01411397|Prosthesis|prosthesis
405808|NCT01411397|Recurrence|recurrence
405809|NCT01411397|Strangulation|strangulation
405810|NCT01411384|Keratoconus (KC)|keratoconus (kc)
405811|NCT01411384|Corneal collagen cross-linking (CXL)|corneal collagen cross-linking (cxl)
405812|NCT01411384|Corneal hysteresis (CH)|corneal hysteresis (ch)
405813|NCT01411384|Corneal resistance factor (CRF)|corneal resistance factor (crf)
405814|NCT01411384|Ocular Response Analyzer (ORA)|ocular response analyzer (ora)
405815|NCT01411371|Atrial fibrillation|atrial fibrillation
405816|NCT01411371|Heart failure|heart failure
405817|NCT01411371|Catheter ablation|catheter ablation
405818|NCT01411358|influenza|influenza
405819|NCT01411358|vaccine|vaccine
405820|NCT01411358|immunogenicity|immunogenicity
405821|NCT01411345|Prostate Cancer|prostate cancer
405822|NCT01411345|Prostate Adenocarcinoma|prostate adenocarcinoma
405823|NCT01411332|Prostate Cancer|prostate cancer
405824|NCT01411332|Prostate Adenocarcinoma|prostate adenocarcinoma
405825|NCT01411319|Prostate Cancer|prostate cancer
405826|NCT01411319|Prostate Adenocarcinoma|prostate adenocarcinoma
405827|NCT01411293|cardiovascular disease|cardiovascular disease
405828|NCT01411293|oxidative stress|oxidative stress
405829|NCT01411293|dairy consumption|dairy consumption
405830|NCT01411293|metabolic syndrome|metabolic syndrome
405831|NCT01411293|obesity|obesity
405832|NCT01411293|endothelial function|endothelial function
405833|NCT01411267|Relapse|relapse
405834|NCT01411267|Lymphoblastic|lymphoblastic
405835|NCT01411267|Leukemia|leukemia
405836|NCT01411267|AC220|ac220
405837|NCT01411267|Refractory|refractory
405838|NCT01411267|Myelogenous|myelogenous
405839|NCT01411267|Acute|acute
405840|NCT01411267|Childhood|childhood
405841|NCT01411267|Pediatric|pediatric
405842|NCT01411267|ALL|all
405843|NCT01411267|AML|aml
405844|NCT01411254|DME|dme
405845|NCT01411241|Dengue|dengue
405846|NCT01411241|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
405847|NCT01411241|CYD Dengue Vaccines|cyd dengue vaccines
405848|NCT01411241|Pentaxim™|pentaxim™
405849|NCT01411228|Gaucher disease|gaucher disease
405850|NCT01411228|pediatrics|pediatrics
405851|NCT01411215|Rheumatoid arthritis|rheumatoid arthritis
405852|NCT01411215|ankylosing spondylitis|ankylosing spondylitis
405853|NCT01411215|observational study|observational study
405854|NCT01411202|Malignant Pleural Effusion|malignant pleural effusion
405855|NCT01411202|Doxycycline|doxycycline
405856|NCT01411202|Pleurodesis|pleurodesis
405858|NCT01411189|therapeutic upper gastrointestinal endoscopy|therapeutic upper gastrointestinal endoscopy
405859|NCT01411189|percutaneous endoscopic gastrostomy|percutaneous endoscopic gastrostomy
405860|NCT01411189|endoscopic mucosal resection|endoscopic mucosal resection
405861|NCT01411189|endoscopic submucosal dissection|endoscopic submucosal dissection
405862|NCT01411189|PEG|peg
405863|NCT01411189|EMR|emr
405864|NCT01411189|ESD|esd
405865|NCT01411189|endoscopic hemostasis|endoscopic hemostasis
405866|NCT01411176|upper gastrointestinal endoscopy|upper gastrointestinal endoscopy
405867|NCT01411176|suspected gastric cancer|suspected gastric cancer
405868|NCT01411163|Premanifest|premanifest
405869|NCT01411163|At-Risk|at-risk
405870|NCT01411163|Huntington's Disease|huntington's disease
405871|NCT01411163|HD|hd
405872|NCT01411150|Premanifest|premanifest
405873|NCT01411150|At-Risk|at-risk
405874|NCT01411150|Huntington's Disease|huntington's disease
405875|NCT01411150|HD|hd
405876|NCT01411124|gabapentin|gabapentin
405877|NCT01411124|restless leg syndrome|restless leg syndrome
405878|NCT01411111|Drug-drug interaction|drug-drug interaction
405879|NCT01411111|rosuvastatin|rosuvastatin
405880|NCT01411111|asthma|asthma
405881|NCT01411111|FLAP inhibitor|flap inhibitor
405882|NCT01411085|Schizophrenia|schizophrenia
405883|NCT01411085|Alcoholism|alcoholism
405884|NCT01411085|Dual Diagnosis|dual diagnosis
405885|NCT01411085|Desipramine|desipramine
405886|NCT01411085|Risperidone|risperidone
405887|NCT01411072|Biomarker directed adjuvant chemotherapy|biomarker directed adjuvant chemotherapy
405888|NCT01411072|resected pancreas cancer|resected pancreas cancer
405889|NCT01411059|yoga biomechanics seniors|yoga biomechanics seniors
405890|NCT01411046|Glucocorticoid|glucocorticoid
405891|NCT01411046|polymorphism|polymorphism
405892|NCT01411046|Glucocorticoid receptor gene|glucocorticoid receptor gene
405893|NCT01411046|rheumatoid arthritis|rheumatoid arthritis
405894|NCT01411046|adrenal insufficiency|adrenal insufficiency
405895|NCT01411046|prednisolone treatment|prednisolone treatment
405896|NCT01411007|Nicotine|nicotine
405897|NCT01411007|Cigarettes|cigarettes
405898|NCT01411007|Smoker|smoker
405899|NCT01411007|realtime fMRI|realtime fmri
405900|NCT01411007|brain imaging|brain imaging
405901|NCT01411007|imaging|imaging
405902|NCT01410994|glomerular filtration rate|glomerular filtration rate
405903|NCT01410955|probiotics|probiotics
405904|NCT01410955|diarrhoea|diarrhoea
405905|NCT01410955|prevention|prevention
405906|NCT01410955|colon cancer|colon cancer
405907|NCT01410955|irinotecan|irinotecan
405908|NCT01410942|Prostate Cancer|prostate cancer
405909|NCT01410942|Multimodal Therapy|multimodal therapy
405910|NCT01410942|MMT|mmt
405911|NCT01410942|Fatigue|fatigue
405912|NCT01410942|Cognitive Behavioral Therapy|cognitive behavioral therapy
405913|NCT01410942|CBT|cbt
405914|NCT01410942|Radiation therapy|radiation therapy
405915|NCT01410942|Radiotherapy|radiotherapy
405916|NCT01410942|RT|rt
405917|NCT01410942|Functional Assessment of Chronic Illness Therapy - Fatigue|functional assessment of chronic illness therapy - fatigue
405918|NCT01410942|FACIT-F|facit-f
405919|NCT01410942|Androgen deprivation therapy|androgen deprivation therapy
405920|NCT01410942|Methylphenidate|methylphenidate
405921|NCT01410942|Methylphenidate Hydrochloride|methylphenidate hydrochloride
405922|NCT01410942|Ritalin|ritalin
405923|NCT01410942|Concerta|concerta
405924|NCT01410942|Placebo|placebo
405925|NCT01410942|Sugar Pill|sugar pill
405926|NCT01410929|multiple myeloma|multiple myeloma
405927|NCT01410929|VCF|vcf
405928|NCT01410929|Vertebral Compression Fracture|vertebral compression fracture
405929|NCT01410929|Spine|spine
405930|NCT01410929|Kyphoplasty|kyphoplasty
405931|NCT01410929|Back pain|back pain
405932|NCT01410929|Cancer|cancer
405933|NCT01410916|STEC-HUS|stec-hus
405934|NCT01410916|Shiga-like toxin-producing Escherichia Coli Hemolytic-Uremic Syndrome|shiga-like toxin-producing escherichia coli hemolytic-uremic syndrome
405935|NCT01410916|uncontrolled complement activation|uncontrolled complement activation
405936|NCT01410864|cerebrospinal fluid leaks|cerebrospinal fluid leaks
405937|NCT01410864|dural opening|dural opening
405938|NCT01410864|dural sealing|dural sealing
405939|NCT01410838|Obesity|obesity
405940|NCT01410838|Food preferences|food preferences
405941|NCT01410838|Eating Behavior|eating behavior
405942|NCT01410825|WAS|was
405943|NCT01410825|Wiskott|wiskott
405944|NCT01410825|Gene Transfer|gene transfer
405945|NCT01410825|Gene Therapy|gene therapy
405946|NCT01410812|Interest in exercising more|interest in exercising more
405947|NCT01410799|Growth Hormone Releasing Hormone|growth hormone releasing hormone
405948|NCT01410799|Growth Hormone Insufficiency|growth hormone insufficiency
405949|NCT01410799|Aging|aging
405950|NCT01410799|Growth Hormone|growth hormone
405951|NCT01410799|Physiologic Effects of Drugs|physiologic effects of drugs
405952|NCT01410799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
405953|NCT01410799|Hormones|hormones
405954|NCT01410760|Imaging study|imaging study
405955|NCT01410760|Perfusion Computerised Tomography|perfusion computerised tomography
405956|NCT01410747|long-term treatment|long-term treatment
405957|NCT01410747|tacrolimus|tacrolimus
405958|NCT01410747|renal failure|renal failure
405959|NCT01410734|cholecystectomy|cholecystectomy
405960|NCT01410734|chronic right upper quadrant pain|chronic right upper quadrant pain
405961|NCT01410721|TBI|tbi
405962|NCT01410721|PTSD|ptsd
405963|NCT01410721|Veterans|veterans
405964|NCT01410708|Human Breast Cancer Tissue|human breast cancer tissue
405965|NCT01410708|Dasatinin|dasatinin
405966|NCT01410695|Rheumatoid Arthritis|rheumatoid arthritis
405967|NCT01410695|RA|ra
405968|NCT01410695|masitinib|masitinib
405969|NCT01410695|DMARD|dmard
405970|NCT01410695|methotrexate|methotrexate
405971|NCT01410682|oral hygiene|oral hygiene
405972|NCT01410682|ventilator-associated pneumonia|ventilator-associated pneumonia
405973|NCT01410682|infection control|infection control
405974|NCT01410682|intensive care|intensive care
405975|NCT01410682|pediatric nursing|pediatric nursing
405976|NCT01410682|pediatrics|pediatrics
405977|NCT01410669|Self-efficacy|self-efficacy
405978|NCT01410669|Intimate partner violence|intimate partner violence
405979|NCT01410669|Randomized clinical trial|randomized clinical trial
405980|NCT01410669|Depression|depression
405981|NCT01410656|Survivors|survivors
405982|NCT01410643|puberty|puberty
405983|NCT01410643|body composition|body composition
405984|NCT01410643|metabolism|metabolism
405985|NCT01410643|obesity|obesity
405986|NCT01410643|optimization of body composition|optimization of body composition
405987|NCT01410643|pubertal transition|pubertal transition
405988|NCT01410604|Metformin|metformin
405989|NCT01410604|Obesity|obesity
405990|NCT01410604|Insulin resistance|insulin resistance
405991|NCT01410604|Interleukin six|interleukin six
405992|NCT01410604|Adiponectin|adiponectin
405993|NCT01410604|High sensitivity C reactive protein.|high sensitivity c reactive protein.
405994|NCT01410604|Tumour Necrosis Factor alpha|tumour necrosis factor alpha
405995|NCT01410591|transjugular intrahepatic portosystemic shunt|transjugular intrahepatic portosystemic shunt
405996|NCT01410591|TIPS|tips
405997|NCT01410591|liver cirrhosis|liver cirrhosis
405998|NCT01410591|variceal bleeding|variceal bleeding
405999|NCT01410591|8- or 10-mm covered stent|8- or 10-mm covered stent
406000|NCT01410578|sTRE-1|stre-1
406001|NCT01410578|PCT|pct
406002|NCT01410578|CRP|crp
406003|NCT01410578|sepsis|sepsis
406004|NCT01410578|bacteremia|bacteremia
406005|NCT01410578|FUO|fuo
406006|NCT01410578|diagnosis|diagnosis
406007|NCT01410578|prognosis|prognosis
406008|NCT01410565|Bladder Cancer|bladder cancer
406009|NCT01410565|Non-Muscle Invasive Bladder Cancer|non-muscle invasive bladder cancer
406010|NCT01410565|NMIBC|nmibc
406011|NCT01410565|Apaziquone|apaziquone
406012|NCT01410565|EOquin|eoquin
406013|NCT01410565|GU Cancer|gu cancer
406014|NCT01410565|TURBT|turbt
406015|NCT01410552|Primary prevention|primary prevention
406016|NCT01410552|Secondary prevention|secondary prevention
406017|NCT01410539|Stent Thrombosis|stent thrombosis
406018|NCT01410539|Percutaneous Coronary Intervention|percutaneous coronary intervention
406019|NCT01410539|Bare Metal Stent|bare metal stent
406020|NCT01410539|Drug Eluting Stent|drug eluting stent
406021|NCT01410539|Residual Platelet Reactivity|residual platelet reactivity
406022|NCT01410539|Optical Coherence Tomography|optical coherence tomography
406023|NCT01410539|OCT|oct
406024|NCT01410526|VAC|vac
406025|NCT01410526|Severe abdominal sepsis|severe abdominal sepsis
406026|NCT01410526|Peritoneal immune reaction|peritoneal immune reaction
406027|NCT01410526|Peritonitis|peritonitis
406028|NCT01410526|Immune peritoneal reaction when abdominal sepsis is treated with VAC|immune peritoneal reaction when abdominal sepsis is treated with vac
406029|NCT01410500|multiple myeloma|multiple myeloma
406030|NCT01410487|pulmonary circulation|pulmonary circulation
406031|NCT01410474|Meningococcal|meningococcal
406032|NCT01410474|ACWY|acwy
406033|NCT01410474|bacterial meningitis|bacterial meningitis
406034|NCT01410474|conjugate vaccine|conjugate vaccine
406035|NCT01410474|healthy|healthy
406036|NCT01410474|children|children
406037|NCT01410474|adolescents|adolescents
406038|NCT01410474|Taiwan|taiwan
406039|NCT01410461|painful bladder|painful bladder
406040|NCT01410461|physical therapy|physical therapy
406041|NCT01410461|levator ani|levator ani
406042|NCT01410448|Immunosuppression|immunosuppression
406043|NCT01410448|Kidney transplantation|kidney transplantation
406044|NCT01410448|everolimus|everolimus
406045|NCT01410448|safety|safety
406046|NCT01410422|COPD|copd
406047|NCT01410422|Bronchiectasis|bronchiectasis
406048|NCT01410422|Metabolomics|metabolomics
406049|NCT01410409|Osteoarthritis, Knee|osteoarthritis, knee
406050|NCT01410409|Treatment Outcome|treatment outcome
406051|NCT01410409|Time Factors|time factors
406052|NCT01410409|Arthroplasty, Replacement|arthroplasty, replacement
406053|NCT01410409|Rehabilitation|rehabilitation
406054|NCT01410409|Combined Modality Therapy|combined modality therapy
406055|NCT01410409|Middle Aged|middle aged
406056|NCT01410409|Aged|aged
406057|NCT01410409|Aged, 80 and over|aged, 80 and over
406058|NCT01410409|Male|male
406059|NCT01410409|Female|female
406060|NCT01410409|Humans|humans
406061|NCT01410409|Analysis of Variance|analysis of variance
406062|NCT01410396|Atrial Fibrillation|atrial fibrillation
406063|NCT01410396|Stroke|stroke
406064|NCT01410383|hypercholesterolemia,|hypercholesterolemia,
406065|NCT01410383|dyslipidemia,|dyslipidemia,
406066|NCT01410383|thyroid,|thyroid,
406067|NCT01410383|safety,|safety,
406068|NCT01410383|Heterozygous Familial Hypercholesterolaemia|heterozygous familial hypercholesterolaemia
406069|NCT01410383|coronary artery disease|coronary artery disease
406070|NCT01410370|Endostar|endostar
406071|NCT01410370|Radiotherapy|radiotherapy
406072|NCT01410370|Brain Metastases|brain metastases
406073|NCT01410357|serious mental illness|serious mental illness
406074|NCT01410357|diabetes|diabetes
406075|NCT01410344|HIV|hiv
406076|NCT01410344|ALL|all
406077|NCT01410344|AML|aml
406078|NCT01410344|MDS|mds
406079|NCT01410344|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
406080|NCT01410331|CLI|cli
406081|NCT01410331|peripheral vascular disease|peripheral vascular disease
406082|NCT01410331|PVD|pvd
406083|NCT01410331|PAD|pad
406084|NCT01410331|SDF-1|sdf-1
406085|NCT01410318|Atherosclerosis|atherosclerosis
406086|NCT01410318|PESA|pesa
406087|NCT01410318|Subclinical|subclinical
406088|NCT01410318|Cardiovascular diseases|cardiovascular diseases
406089|NCT01410318|Coronary disease|coronary disease
406090|NCT01410318|Heart diseases|heart diseases
406091|NCT01410318|Heart Failure|heart failure
406092|NCT01410318|Myocardial Infarction|myocardial infarction
406093|NCT01410318|Stroke|stroke
406094|NCT01410318|Arteriosclerosis|arteriosclerosis
406095|NCT01410305|Vitamin D Deficiency|vitamin d deficiency
406096|NCT01410305|HIV+ Children|hiv+ children
406097|NCT01410305|HIV+ Young Adults|hiv+ young adults
406098|NCT01410292|fiber|fiber
406099|NCT01410292|glycemic index|glycemic index
406100|NCT01410292|glycemic response|glycemic response
406101|NCT01410292|diabetes|diabetes
406102|NCT01410292|ghrelin|ghrelin
406103|NCT01410279|pulmonary hypertension|pulmonary hypertension
406104|NCT01410279|inspiratory muscle training|inspiratory muscle training
406105|NCT01410279|inspiratory muscle weakness|inspiratory muscle weakness
406106|NCT01410279|pulmonary functional|pulmonary functional
406107|NCT01410279|functional capacity|functional capacity
406108|NCT01410279|quality of life|quality of life
406109|NCT01410266|medical abortion|medical abortion
406110|NCT01410266|first trimester|first trimester
406111|NCT01410266|follow-up|follow-up
406112|NCT01410266|pregnancy test|pregnancy test
406113|NCT01410214|NSCLC|nsclc
406114|NCT01410214|EGFR Mutation Positive|egfr mutation positive
406115|NCT01410214|complete resection|complete resection
406116|NCT01410214|Erlotinib Versus NVB/Cisplatin as Adjuvant treatment|erlotinib versus nvb/cisplatin as adjuvant treatment
406117|NCT01410201|Epiretinal Membrane|epiretinal membrane
406118|NCT01410201|Macular Edema|macular edema
406119|NCT01410201|Dexamethasone Intravitreal Implant (Ozurdex)|dexamethasone intravitreal implant (ozurdex)
406120|NCT01410201|Pars Plana Vitrectomy|pars plana vitrectomy
406121|NCT01410188|open-angle glaucoma|open-angle glaucoma
406122|NCT01410188|glaucoma|glaucoma
406123|NCT01410188|ocular hypertension|ocular hypertension
406124|NCT01410188|intraocular pressure|intraocular pressure
406125|NCT01410162|Renal|renal
406126|NCT01410162|Kidney/Pancreas|kidney/pancreas
406127|NCT01410162|Transplant|transplant
406128|NCT01410162|conversion|conversion
406129|NCT01410162|bioequivalence|bioequivalence
406130|NCT01410162|Mycophenolate Acid|mycophenolate acid
406131|NCT01410149|PAV (proportional assist ventilation); sleep; polysomnography; mechanical ventilation|pav (proportional assist ventilation); sleep; polysomnography; mechanical ventilation
406132|NCT01410136|Knee|knee
406133|NCT01410136|Femur|femur
406134|NCT01410136|Articular cartilage|articular cartilage
406135|NCT01410136|Lesions|lesions
406136|NCT01410136|Defects|defects
406137|NCT01410136|Osteochondral graft|osteochondral graft
406138|NCT01410136|Cartilage treatments|cartilage treatments
406139|NCT01410136|Osteochondritis Dissecans|osteochondritis dissecans
406140|NCT01410136|OCD|ocd
406141|NCT01410110|Substance Abuse|substance abuse
406142|NCT01410110|Substance Dependence|substance dependence
406143|NCT01410110|Cognitive Impairment|cognitive impairment
406144|NCT01410084|vitamin D|vitamin d
406145|NCT01410084|falls|falls
406146|NCT01410084|deficiency|deficiency
406147|NCT01410084|insufficiency|insufficiency
406148|NCT01410071|Sphincter of Oddi Dysfunction|sphincter of oddi dysfunction
406149|NCT01410058|HIV|hiv
406150|NCT01410058|antiretroviral drug interaction|antiretroviral drug interaction
406151|NCT01410058|herbal medicine|herbal medicine
406152|NCT01410058|pharmacokinetics|pharmacokinetics
406153|NCT01410058|herbal pharmacology|herbal pharmacology
406154|NCT01410045|Turner syndrome|turner syndrome
406155|NCT01410045|infertility|infertility
406156|NCT01410045|ovarian insufficiency|ovarian insufficiency
406157|NCT01410045|ovarian cryopreservation|ovarian cryopreservation
406158|NCT01410032|clavicle|clavicle
406159|NCT01410032|clavicular|clavicular
406160|NCT01410032|fracture|fracture
406161|NCT01410032|midshaft|midshaft
406162|NCT01410032|plate|plate
406163|NCT01410032|ESIN|esin
406164|NCT01410032|intramedullary|intramedullary
406165|NCT01410032|flexible|flexible
406166|NCT01410032|nailing|nailing
406167|NCT01410019|X-linked Severe Combined Immunodeficiency (SCID-X1)|x-linked severe combined immunodeficiency (scid-x1)
406168|NCT01410019|severe infection|severe infection
406169|NCT01410019|gene therapy|gene therapy
406170|NCT01410019|HLA identical family donor|hla identical family donor
406171|NCT01410019|without HLA identical unrelated donor|without hla identical unrelated donor
406172|NCT01410006|NF1|nf1
406173|NCT01410006|neurofibromatosis|neurofibromatosis
406174|NCT01410006|NF|nf
406175|NCT01409993|BMI greater than 25|bmi greater than 25
406176|NCT01409993|Elevated fasting blood sugar (100-125mg/dL)|elevated fasting blood sugar (100-125mg/dl)
406177|NCT01409980|delta phalanx|delta phalanx
406178|NCT01409980|thumb reconstructed|thumb reconstructed
406179|NCT01409980|triphalangeal thumbs|triphalangeal thumbs
406180|NCT01409967|Anemia|anemia
406181|NCT01409967|Transfusion|transfusion
406182|NCT01409967|Biological markers|biological markers
406183|NCT01409954|Fusion|fusion
406184|NCT01409954|Spine|spine
406185|NCT01409954|Decompression|decompression
406186|NCT01409954|Pseudarthrosis|pseudarthrosis
406187|NCT01409954|bone harvest|bone harvest
406188|NCT01409954|Instrumented posterolateral fusion|instrumented posterolateral fusion
406189|NCT01409941|cerebral oxygen saturation,|cerebral oxygen saturation,
406190|NCT01409941|NTproBNP|ntprobnp
406191|NCT01409941|hsTNT|hstnt
406192|NCT01409941|GDF-15|gdf-15
406193|NCT01409928|obesity|obesity
406194|NCT01409928|adolescent|adolescent
406195|NCT01409928|pediatric|pediatric
406196|NCT01409928|weight loss|weight loss
406197|NCT01409928|bariatric surgery|bariatric surgery
406198|NCT01409928|gastric banding|gastric banding
406199|NCT01409915|Alzheimer's disease|alzheimer's disease
406200|NCT01409915|neuropsychological assessment|neuropsychological assessment
406201|NCT01409915|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
406202|NCT01409915|Leukine|leukine
406203|NCT01409876|histoscanning|histoscanning
406204|NCT01409876|brachytherapy|brachytherapy
406205|NCT01409863|post surgical or post traumatic scar on face or scalp|post surgical or post traumatic scar on face or scalp
406206|NCT01409837|Oligospermia|oligospermia
406207|NCT01409837|Male infertility|male infertility
406208|NCT01409837|Lisinopril|lisinopril
406209|NCT01409824|clinical decision support system|clinical decision support system
406210|NCT01409824|performance based incentives|performance based incentives
406211|NCT01409824|quality of maternal health care services|quality of maternal health care services
406212|NCT01409798|Hyperparathyroidism|hyperparathyroidism
406213|NCT01409798|Hypercalcemia|hypercalcemia
406214|NCT01409785|supraglottic airway devices in children|supraglottic airway devices in children
406215|NCT01409759|Perforators|perforators
406216|NCT01409759|Interposition plasty|interposition plasty
406217|NCT01409759|Contracture release|contracture release
406218|NCT01409746|twin|twin
406219|NCT01409746|brain development|brain development
406220|NCT01409746|MRI|mri
406221|NCT01409720|bony metastases|bony metastases
406222|NCT01409720|physical exercise|physical exercise
406223|NCT01409694|Alzheimer Disease|alzheimer disease
406224|NCT01409694|Vitamin D|vitamin d
406225|NCT01409694|Cholecalciferol|cholecalciferol
406226|NCT01409694|Memantine|memantine
406227|NCT01409694|Cognition Disorders|cognition disorders
406228|NCT01409655|AIDS, HIV, Adherence, Compliance, Contingency management|aids, hiv, adherence, compliance, contingency management
406229|NCT01409616|Pharmacodynamics|pharmacodynamics
406230|NCT01409616|darexaban|darexaban
406231|NCT01409616|Acetyl Salicylic Acid|acetyl salicylic acid
406232|NCT01409616|clopidogrel|clopidogrel
406233|NCT01409616|YM150|ym150
406234|NCT01409616|Phase 1|phase 1
406235|NCT01409603|Pharmacodynamics|pharmacodynamics
406236|NCT01409603|darexaban|darexaban
406237|NCT01409603|naproxen|naproxen
406238|NCT01409603|YM150|ym150
406239|NCT01409603|Phase 1|phase 1
406240|NCT01409590|Schizophrenia|schizophrenia
406241|NCT01409590|weight gain|weight gain
406242|NCT01409590|atypical neuroleptics|atypical neuroleptics
406243|NCT01409577|Coronary stenosis|coronary stenosis
406244|NCT01409577|stent|stent
406245|NCT01409577|fractional flow reserve|fractional flow reserve
406246|NCT01409564|Alzheimer's dementia|alzheimer's dementia
406247|NCT01409564|Cilostazol|cilostazol
406248|NCT01409551|Pleural effusion|pleural effusion
406249|NCT01409551|VATS|vats
406250|NCT01409551|hyperthermia|hyperthermia
406251|NCT01409551|thoracostomy|thoracostomy
406252|NCT01409551|pleurodesis|pleurodesis
406253|NCT01409512|Heart rate variability, anti cholinergic medication|heart rate variability, anti cholinergic medication
406254|NCT01409499|hepatocellular carcinoma, treatments, survival|hepatocellular carcinoma, treatments, survival
406255|NCT01409486|Pompe disease|pompe disease
406256|NCT01409486|Alpha glucosidase|alpha glucosidase
406257|NCT01409486|Newborn screening|newborn screening
406258|NCT01409486|Tandem Mass Spectrometry (LC-MS-MS)|tandem mass spectrometry (lc-ms-ms)
406259|NCT01409486|The study aims:|the study aims:
406260|NCT01409486|To establish the control mean values of alpha glucosidase activity in Dry blood spots of Newborn babies from Israel.|to establish the control mean values of alpha glucosidase activity in dry blood spots of newborn babies from israel.
406261|NCT01409486|To include the alpha glucosidase assay in the newborn screening program in Israel|to include the alpha glucosidase assay in the newborn screening program in israel
406262|NCT01409473|Prostate cancer|prostate cancer
406263|NCT01409473|Stereotactic body radiotherapy|stereotactic body radiotherapy
406264|NCT01409473|Radiosurgery|radiosurgery
406265|NCT01409473|Intensity-modulated radiotherapy|intensity-modulated radiotherapy
406266|NCT01409473|SBRT|sbrt
406267|NCT01409473|IMRT|imrt
406268|NCT01409473|Early-stage prostate cancer|early-stage prostate cancer
406269|NCT01409473|Low-risk prostate cancer|low-risk prostate cancer
406270|NCT01409473|Intermediate-risk prostate cancer|intermediate-risk prostate cancer
406271|NCT01409473|Intraprostatic lesions|intraprostatic lesions
406273|NCT01409421|adherence|adherence
406274|NCT01409421|glaucoma|glaucoma
406275|NCT01409421|motivational interviewing|motivational interviewing
406276|NCT01409408|Hypertension|hypertension
406277|NCT01409408|Diabetes Mellitus|diabetes mellitus
406278|NCT01409408|Vascular stiffness|vascular stiffness
406279|NCT01409408|Endothelial function|endothelial function
406280|NCT01409395|Drug drug interaction|drug drug interaction
406281|NCT01409382|neonatal hypoglycemia|neonatal hypoglycemia
406282|NCT01409382|pregnancy|pregnancy
406283|NCT01409382|physical activity|physical activity
406284|NCT01409382|sedentary lifestyle|sedentary lifestyle
406285|NCT01409382|high-glycemic index diet|high-glycemic index diet
406286|NCT01409382|take-home baby|take-home baby
406287|NCT01409382|recurrent miscarriages|recurrent miscarriages
406288|NCT01409382|preterm delivery|preterm delivery
406289|NCT01409356|Obesity|obesity
406290|NCT01409356|Portal hypertension|portal hypertension
406291|NCT01409356|Cirrhosis|cirrhosis
406292|NCT01409356|Diet|diet
406293|NCT01409356|Exercise|exercise
406294|NCT01409343|advanced solid cancers|advanced solid cancers
406295|NCT01409343|metastatic solid cancers|metastatic solid cancers
406296|NCT01409330|insulin sensitivity|insulin sensitivity
406297|NCT01409330|type 2 diabetes|type 2 diabetes
406298|NCT01409330|diet intervention|diet intervention
406299|NCT01409317|Major Depression|major depression
406300|NCT01409317|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
406301|NCT01409317|Deep Transcranial Magnetic Stimulation|deep transcranial magnetic stimulation
406302|NCT01409317|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
406303|NCT01409317|rTMS|rtms
406304|NCT01409317|DTMS|dtms
406305|NCT01409317|fMRI|fmri
406306|NCT01409317|Randomized, Sham-Controlled Trial|randomized, sham-controlled trial
406307|NCT01409304|Major depression|major depression
406308|NCT01409304|Deep Transcranial Magnetic Stimulation|deep transcranial magnetic stimulation
406309|NCT01409304|Naturalistic Trial|naturalistic trial
406310|NCT01409304|DTMS|dtms
406311|NCT01409291|low socioeconomic status|low socioeconomic status
406312|NCT01409291|stress|stress
406313|NCT01409291|women|women
406314|NCT01409291|children|children
406315|NCT01409291|cortisol|cortisol
406316|NCT01409265|stroke rehabilitation|stroke rehabilitation
406317|NCT01409265|perceptual deficits|perceptual deficits
406318|NCT01409252|Stroke|stroke
406319|NCT01409252|intracerebral hemorrhage|intracerebral hemorrhage
406320|NCT01409252|surgery|surgery
406321|NCT01409239|hospital|hospital
406322|NCT01409239|diabetes|diabetes
406323|NCT01409239|glycemic variability|glycemic variability
406324|NCT01409239|autonomic tone|autonomic tone
406325|NCT01409226|high-risk of breast cancer|high-risk of breast cancer
406326|NCT01409226|BRCA1 mutation carrier|brca1 mutation carrier
406327|NCT01409226|BRCA2 mutation carrier|brca2 mutation carrier
406328|NCT01409226|diagnostic|diagnostic
406329|NCT01409226|MRI|mri
406330|NCT01409226|BI-RADS 4|bi-rads 4
406331|NCT01409226|mammographically occult|mammographically occult
406332|NCT01409200|Prostate cancer|prostate cancer
406333|NCT01409200|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
406334|NCT01409200|Ductal adenocarcinoma|ductal adenocarcinoma
406335|NCT01409200|Androgen deprivation therapy|androgen deprivation therapy
406336|NCT01409200|ADT|adt
406337|NCT01409200|Hormonal therapy|hormonal therapy
406338|NCT01409200|Suspected lymph node metastasis|suspected lymph node metastasis
406339|NCT01409200|TxN1M0 or TxNxM1a|txn1m0 or txnxm1a
406340|NCT01409200|Progression-free|progression-free
406341|NCT01409200|Pathologic complete response|pathologic complete response
406342|NCT01409200|pCR|pcr
406343|NCT01409200|Systemic therapy|systemic therapy
406344|NCT01409200|Radical prostatectomy|radical prostatectomy
406345|NCT01409200|Pelvic lymph node dissection|pelvic lymph node dissection
406346|NCT01409200|Axitinib|axitinib
406347|NCT01409200|AG-013736|ag-013736
406348|NCT01409187|Melanoma|melanoma
406349|NCT01409187|Metastatic Melanoma|metastatic melanoma
406350|NCT01409187|Cytotoxic Drugs|cytotoxic drugs
406351|NCT01409187|IPI-Biotherapy|ipi-biotherapy
406352|NCT01409187|Ipilimumab|ipilimumab
406353|NCT01409187|Yervoy|yervoy
406354|NCT01409187|BMS-734016|bms-734016
406355|NCT01409187|MDX010|mdx010
406356|NCT01409187|Interferon|interferon
406357|NCT01409187|IFN Alpha-2b|ifn alpha-2b
406358|NCT01409187|Intron A|intron a
406359|NCT01409187|Interferon Apha-2b|interferon apha-2b
406360|NCT01409187|Interleukin-2|interleukin-2
406361|NCT01409187|IL-2|il-2
406362|NCT01409187|Aldesleukin|aldesleukin
406363|NCT01409187|Proleukin|proleukin
406364|NCT01409174|Melanoma|melanoma
406365|NCT01409174|Metastatic|metastatic
406366|NCT01409174|IPI-Biochemotherapy|ipi-biochemotherapy
406367|NCT01409174|Chemonaive|chemonaive
406368|NCT01409174|Advanced stage IV|advanced stage iv
406369|NCT01409174|Unresectable stage III melanoma|unresectable stage iii melanoma
406370|NCT01409174|1.0 cm or larger|1.0 cm or larger
406371|NCT01409174|Ipilimumab|ipilimumab
406372|NCT01409174|Yervoy|yervoy
406373|NCT01409174|BMS-734016|bms-734016
406374|NCT01409174|MDX010|mdx010
406375|NCT01409174|Interferon Alpha-2b|interferon alpha-2b
406376|NCT01409174|Intron A|intron a
406377|NCT01409174|Temozolomide|temozolomide
406378|NCT01409174|Temodar|temodar
406379|NCT01409174|Cisplatin|cisplatin
406380|NCT01409174|Platinol-AQ|platinol-aq
406381|NCT01409174|Platinol|platinol
406382|NCT01409174|CDDP|cddp
406383|NCT01409174|Interleukin-2|interleukin-2
406384|NCT01409174|IL-2|il-2
406385|NCT01409174|Aldesleukin|aldesleukin
406386|NCT01409174|Proleukin|proleukin
406387|NCT01409161|Leukemia|leukemia
406388|NCT01409161|Acute Promyelocytic Leukemia|acute promyelocytic leukemia
406389|NCT01409161|APL|apl
406390|NCT01409161|ATRA|atra
406391|NCT01409161|Tretinoin|tretinoin
406392|NCT01409161|All-trans retinoic acid|all-trans retinoic acid
406393|NCT01409161|Vesanoid|vesanoid
406394|NCT01409161|ATO|ato
406395|NCT01409161|Arsenic trioxide|arsenic trioxide
406396|NCT01409161|Trisenox|trisenox
406397|NCT01409161|GO|go
406398|NCT01409161|Gemtuzumab|gemtuzumab
406399|NCT01409161|Mylotarg|mylotarg
406400|NCT01409161|Gemtuzumab ozogamicin|gemtuzumab ozogamicin
406401|NCT01409161|Methylprednisolone|methylprednisolone
406402|NCT01409161|Depo-Medrol|depo-medrol
406403|NCT01409161|Medrol|medrol
406404|NCT01409161|Solu-Medrol|solu-medrol
406405|NCT01409148|Radioimmunoimaging|radioimmunoimaging
406406|NCT01409148|AL Amyloidosis|al amyloidosis
406407|NCT01409148|PET/CT|pet/ct
406408|NCT01409135|Nectin 4 protein, humans|nectin 4 protein, humans
406409|NCT01409135|Cancer|cancer
406410|NCT01409135|Pharmacokinetics of AGS-22M6E|pharmacokinetics of ags-22m6e
406411|NCT01409135|Pharmacokinetics of ASG-22CE|pharmacokinetics of asg-22ce
406412|NCT01409135|Safety|safety
406413|NCT01409135|Clinical Trial, Phase 1|clinical trial, phase 1
406414|NCT01409135|ASG-22ME|asg-22me
406415|NCT01409135|AGS-22M6E|ags-22m6e
406416|NCT01409135|ASG-22CE|asg-22ce
406417|NCT01409135|ASG-22C3|asg-22c3
406418|NCT01409122|vasodilator|vasodilator
406419|NCT01409122|nitric oxide|nitric oxide
406420|NCT01409122|sodium nitrite|sodium nitrite
406421|NCT01409122|sildenafil|sildenafil
406422|NCT01409122|PDE-5|pde-5
406423|NCT01409122|pulmonary hypertension|pulmonary hypertension
406424|NCT01409122|pulmonary arterial hypertension|pulmonary arterial hypertension
406425|NCT01409109|Schizophrenia|schizophrenia
406426|NCT01409109|Schizoaffective|schizoaffective
406427|NCT01409109|Neuroimaging|neuroimaging
406428|NCT01409109|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
406429|NCT01409109|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
406430|NCT01409109|Spectroscopy|spectroscopy
406431|NCT01409083|infiltration|infiltration
406432|NCT01409083|extravasation|extravasation
406433|NCT01409083|end-tidal carbon dioxide|end-tidal carbon dioxide
406434|NCT01409083|sodium bicarbonate|sodium bicarbonate
406435|NCT01409070|MDS|mds
406436|NCT01409057|Inflammation parameters|inflammation parameters
406437|NCT01409057|Various blood values|various blood values
406438|NCT01409057|Clinical Outcome|clinical outcome
406439|NCT01409057|Residence in ICU/ Hospital|residence in icu/ hospital
406440|NCT01409057|SAPS-Score|saps-score
406441|NCT01409057|SOFA-Score|sofa-score
406442|NCT01409057|Duration of artificial respiration|duration of artificial respiration
406443|NCT01409044|Patient-Controlled Analgesia (PCA)|patient-controlled analgesia (pca)
406444|NCT01409044|Music Listening|music listening
406445|NCT01409044|Opioids|opioids
406446|NCT01409044|Post Surgical Intensive Care Patient|post surgical intensive care patient
406447|NCT01409044|Patient-Controlled Analgesia|patient-controlled analgesia
406448|NCT01409031|newborns|newborns
406449|NCT01409031|respiratory failure|respiratory failure
406450|NCT01409031|pulmonary hypertension|pulmonary hypertension
406451|NCT01409031|treatment|treatment
406452|NCT01409018|pediatric|pediatric
406453|NCT01409018|cancer|cancer
406454|NCT01409018|invasive fungal disease|invasive fungal disease
406455|NCT01409018|antifungal agent|antifungal agent
406456|NCT01408992|Hearing screening|hearing screening
406457|NCT01408992|Questionnaire|questionnaire
406458|NCT01408992|Hearing disability|hearing disability
406459|NCT01408979|Severe preeclampsia|severe preeclampsia
406460|NCT01408979|magnesium sulfate|magnesium sulfate
406461|NCT01408979|anticonvulsivant|anticonvulsivant
406462|NCT01408966|Dark chocolate|dark chocolate
406463|NCT01408966|Catechins|catechins
406464|NCT01408966|Intrahepatic endothelial dysfunction|intrahepatic endothelial dysfunction
406465|NCT01408966|Cirrhosis|cirrhosis
406466|NCT01408966|Portal Hypertension|portal hypertension
406467|NCT01408953|Keloid|keloid
406468|NCT01408927|Thienopyridine resistance|thienopyridine resistance
406469|NCT01408927|Aspirin resistance|aspirin resistance
406470|NCT01408927|Platelet reactivity|platelet reactivity
406471|NCT01408901|peripheral arterial disease|peripheral arterial disease
406472|NCT01408901|granulocyte macrophage colony stimulating factor|granulocyte macrophage colony stimulating factor
406473|NCT01408901|PAD|pad
406474|NCT01408901|GM-CSF|gm-csf
406475|NCT01408901|sargramostim|sargramostim
406476|NCT01408901|leukine|leukine
406477|NCT01408901|treadmill exercise|treadmill exercise
406478|NCT01408875|Chronic Heart Failure|chronic heart failure
406479|NCT01408875|Cardiac rehabilitation|cardiac rehabilitation
406480|NCT01408875|Exercise training|exercise training
406481|NCT01408875|Peak VO2|peak vo2
406482|NCT01408875|Electrical myostimulation|electrical myostimulation
406483|NCT01408862|GLP1|glp1
406484|NCT01408862|GIP|gip
406485|NCT01408862|platelets|platelets
406486|NCT01408862|human|human
406487|NCT01408862|aggregation|aggregation
406488|NCT01408849|Endoscopy|endoscopy
406489|NCT01408849|Herbal medicine|herbal medicine
406490|NCT01408849|Phytotherapy|phytotherapy
406491|NCT01408836|Vasculitis|vasculitis
406492|NCT01408836|ANCA|anca
406493|NCT01408836|Therapy|therapy
406494|NCT01408836|Plasma exchange|plasma exchange
406495|NCT01408836|Immunosuppression|immunosuppression
406496|NCT01408823|Pediatrics|pediatrics
406497|NCT01408823|Scoliosis|scoliosis
406498|NCT01408823|Pharmacokinetics|pharmacokinetics
406499|NCT01408823|Hemorrhage|hemorrhage
406500|NCT01408823|Orthopedic Surgery|orthopedic surgery
406501|NCT01408810|infliximab|infliximab
406502|NCT01408810|ulcerative colitis|ulcerative colitis
406503|NCT01408810|histologic remission|histologic remission
406504|NCT01408797|clonal deletion|clonal deletion
406505|NCT01408797|kidney transplantation|kidney transplantation
406506|NCT01408784|calories|calories
406507|NCT01408784|counting|counting
406508|NCT01408784|obesity|obesity
406509|NCT01408784|overweight|overweight
406510|NCT01408784|categories|categories
406511|NCT01408784|calorie|calorie
406512|NCT01408784|method|method
406513|NCT01408784|counting calories|counting calories
406514|NCT01408784|lose weight|lose weight
406515|NCT01408784|diet|diet
406516|NCT01408784|energy balance|energy balance
406517|NCT01408784|energy intake|energy intake
406518|NCT01408784|24 hours recall|24 hours recall
406519|NCT01408784|food intake|food intake
406520|NCT01408771|Urodynamics|urodynamics
406521|NCT01408771|Overactive Bladder|overactive bladder
406522|NCT01408745|medical device|medical device
406523|NCT01408745|sternal closure|sternal closure
406524|NCT01408745|sternotomy|sternotomy
406525|NCT01408745|dehiscence|dehiscence
406526|NCT01408745|sternal wound healing|sternal wound healing
406527|NCT01408745|randomized trial|randomized trial
406528|NCT01408745|steel wire|steel wire
406529|NCT01408732|Epistaxis|epistaxis
406530|NCT01408732|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
406531|NCT01408732|HHT|hht
406532|NCT01408732|Sclerotherapy|sclerotherapy
406533|NCT01408732|Epistaxis (nosebleeds) due to Hereditary Hemorrhagic Telangiectasia|epistaxis (nosebleeds) due to hereditary hemorrhagic telangiectasia
406534|NCT01408719|Beta-Glucan|beta-glucan
406535|NCT01408719|Barley|barley
406536|NCT01408719|Molecular Weight|molecular weight
406537|NCT01408719|Viscosity|viscosity
406538|NCT01408719|Cholesterol|cholesterol
406539|NCT01408719|Stable isotope|stable isotope
406540|NCT01408719|Gene-nutrient interaction|gene-nutrient interaction
406541|NCT01408719|Gut microbiota|gut microbiota
406542|NCT01408693|hip fracture|hip fracture
406543|NCT01408693|hemiarthroplasty|hemiarthroplasty
406544|NCT01408693|endoprosthesis|endoprosthesis
406545|NCT01408693|elderly|elderly
406546|NCT01408693|minimally invasive surgery|minimally invasive surgery
406547|NCT01408693|anterior approach|anterior approach
406548|NCT01408693|geriatric patients|geriatric patients
406549|NCT01408680|End-stage Renal Disease|end-stage renal disease
406550|NCT01408680|Hemodialysis|hemodialysis
406551|NCT01408680|Cardiovascular Disease|cardiovascular disease
406552|NCT01408680|Antioxidants|antioxidants
406553|NCT01408680|Atherosclerosis|atherosclerosis
406554|NCT01408680|Coenzyme Q10|coenzyme q10
406555|NCT01408667|insulin sensitivity|insulin sensitivity
406556|NCT01408667|cardiometabolic risk|cardiometabolic risk
406557|NCT01408667|hyperinsulinemic euglycemic clamp|hyperinsulinemic euglycemic clamp
406558|NCT01408654|Suicidal Ideation|suicidal ideation
406559|NCT01408654|Loneliness|loneliness
406560|NCT01408654|Social Support|social support
406561|NCT01408654|Voluntary Workers|voluntary workers
406562|NCT01408654|Friends/Companions|friends/companions
406563|NCT01408654|Prevention|prevention
406564|NCT01408654|Aged|aged
406565|NCT01408641|topiramate|topiramate
406566|NCT01408641|PTSD|ptsd
406567|NCT01408641|drinking|drinking
406568|NCT01408641|alcohol|alcohol
406569|NCT01408602|Rheumatoid Arthritis|rheumatoid arthritis
406570|NCT01408589|alcohol|alcohol
406571|NCT01408589|craving|craving
406572|NCT01408589|mood|mood
406573|NCT01408589|optimum dose of atomoxetine|optimum dose of atomoxetine
406574|NCT01408576|Lupus|lupus
406575|NCT01408576|Monoclonal antibody|monoclonal antibody
406576|NCT01408576|B-Cell immunotherapy|b-cell immunotherapy
406577|NCT01408576|Epratuzumab|epratuzumab
406578|NCT01408563|NHL|nhl
406579|NCT01408563|lymphoma|lymphoma
406580|NCT01408563|leukemia|leukemia
406581|NCT01408563|myelodysplastic disorder|myelodysplastic disorder
406582|NCT01408563|aplastic anemia|aplastic anemia
406583|NCT01408550|IVIG in pemphigoid|ivig in pemphigoid
406584|NCT01408550|Patients with bullous pemphigoid unresponsive to corticosteroids|patients with bullous pemphigoid unresponsive to corticosteroids
406585|NCT01408537|inactivated Japanese encephalitis vaccine|inactivated japanese encephalitis vaccine
406586|NCT01408537|vero cell|vero cell
406587|NCT01408537|children|children
406588|NCT01408537|immunogenicity|immunogenicity
406589|NCT01408537|safety|safety
406590|NCT01408524|Hypertension|hypertension
406591|NCT01408524|emergence|emergence
406592|NCT01408524|craniotomy|craniotomy
406593|NCT01408524|Hypertension during the emergence after craniotomy|hypertension during the emergence after craniotomy
406594|NCT01408498|Testosterone|testosterone
406595|NCT01408498|Social psychology|social psychology
406596|NCT01408498|Human behavior|human behavior
406597|NCT01408459|Prostate cancer prevention|prostate cancer prevention
406598|NCT01408446|Hypertension|hypertension
406599|NCT01408446|Menthol|menthol
406600|NCT01408446|Metabolism|metabolism
406601|NCT01408433|embryo transfer|embryo transfer
406602|NCT01408433|in-vitro fertilization (IVF)|in-vitro fertilization (ivf)
406603|NCT01408433|pre-implantation diagnosis (PGD)|pre-implantation diagnosis (pgd)
406604|NCT01408433|infertility|infertility
406605|NCT01408433|single embryo transfer|single embryo transfer
406606|NCT01408433|two embryo transfer|two embryo transfer
406607|NCT01408433|double embryo transfer|double embryo transfer
406608|NCT01408420|Renal insufficiency|renal insufficiency
406609|NCT01408420|Acute Kidney Injury|acute kidney injury
406610|NCT01408420|Postoperative|postoperative
406611|NCT01408420|Extracorporeal Circulation|extracorporeal circulation
406612|NCT01408420|Heart surgery|heart surgery
406613|NCT01408407|Patients with anal canal, low rectal or gynecological cancer|patients with anal canal, low rectal or gynecological cancer
406614|NCT01408394|safety|safety
406615|NCT01408394|pharmacokinetics|pharmacokinetics
406616|NCT01408394|controlled release|controlled release
406617|NCT01408394|formulation|formulation
406618|NCT01408381|Critical Limb Ischemia (CLI)|critical limb ischemia (cli)
406619|NCT01408381|Cell Therapy|cell therapy
406620|NCT01408381|Bone marrow mononuclear cells|bone marrow mononuclear cells
406621|NCT01408368|Graves' disease|graves' disease
406622|NCT01408368|total thyroidectomy|total thyroidectomy
406623|NCT01408368|bilateral subtotal thyroidectomy|bilateral subtotal thyroidectomy
406624|NCT01408368|Graves' ophthalmopathy|graves' ophthalmopathy
406625|NCT01408368|morbidity rate|morbidity rate
406626|NCT01408342|Alemtuzumab|alemtuzumab
406627|NCT01408342|Rituximab|rituximab
406628|NCT01408342|Aplastic anemia|aplastic anemia
406629|NCT01408342|cyclosporine|cyclosporine
406630|NCT01408316|Healthy Volunteer|healthy volunteer
406631|NCT01408316|PX-866|px-866
406632|NCT01408316|PI3K Inhibitor|pi3k inhibitor
406633|NCT01408303|dyslipidemia|dyslipidemia
406634|NCT01408303|hyperlipidemia|hyperlipidemia
406635|NCT01408303|cardiovascular risk|cardiovascular risk
406636|NCT01408290|seasonal|seasonal
406637|NCT01408290|prevention|prevention
406638|NCT01408290|influenza|influenza
406639|NCT01408290|infection|infection
406640|NCT01408290|influenza vaccine|influenza vaccine
406641|NCT01408290|vaccine|vaccine
406642|NCT01408290|influenza in humans|influenza in humans
406643|NCT01408277|Diabetic Foot Ulcers|diabetic foot ulcers
406644|NCT01408277|Diabetic Foot Wounds|diabetic foot wounds
406645|NCT01408238|Immunotherapy|immunotherapy
406646|NCT01408238|Skin prick test|skin prick test
406647|NCT01408238|Standardization|standardization
406648|NCT01408238|Secale cereale|secale cereale
406649|NCT01408225|MGUS|mgus
406650|NCT01408225|Multiple Myeloma|multiple myeloma
406651|NCT01408225|Tissue Bank|tissue bank
406652|NCT01408199|Lenalidomide|lenalidomide
406653|NCT01408199|Refractory Cutaneous Lupus|refractory cutaneous lupus
406654|NCT01408186|aspirin|aspirin
406655|NCT01408186|PPI|ppi
406656|NCT01408186|H2RA|h2ra
406657|NCT01408173|caffeine|caffeine
406658|NCT01408173|apnea|apnea
406659|NCT01408173|prematurity|prematurity
406660|NCT01408147|Postpartum weight retention|postpartum weight retention
406661|NCT01408147|Low income women|low income women
406662|NCT01408147|WIC|wic
406663|NCT01408147|Online|online
406664|NCT01408134|Inter-reader variability of myocardial viability imaging|inter-reader variability of myocardial viability imaging
406665|NCT01408121|Platelet reactivity|platelet reactivity
406666|NCT01408121|Genotyping|genotyping
406667|NCT01408108|Hiatal hernia|hiatal hernia
406668|NCT01408108|Gastro-oesophageal reflux disease|gastro-oesophageal reflux disease
406669|NCT01408108|Laparoscopic hiatal repair|laparoscopic hiatal repair
406670|NCT01408108|Laparoscopic anti-reflux surgery|laparoscopic anti-reflux surgery
406671|NCT01408108|Partially absorbable lightweight mesh|partially absorbable lightweight mesh
406672|NCT01408095|diabetes|diabetes
406673|NCT01408095|glimepiride|glimepiride
406674|NCT01408095|diabetes type II|diabetes type ii
406675|NCT01408095|diabetes type 2|diabetes type 2
406676|NCT01408095|Type 2 diabetes|type 2 diabetes
406677|NCT01408095|diabetes mellitus|diabetes mellitus
406678|NCT01408069|headache|headache
406679|NCT01408069|migraine|migraine
406680|NCT01408056|Hemangioma|hemangioma
406681|NCT01408056|Infantile Hemangioma|infantile hemangioma
406682|NCT01408056|Ulcerated Hemangioma|ulcerated hemangioma
406683|NCT01408056|Timolol|timolol
406684|NCT01408056|Beta blocker|beta blocker
406685|NCT01408056|Vascular anomaly|vascular anomaly
406686|NCT01408030|epistaxis|epistaxis
406687|NCT01408030|HHT|hht
406688|NCT01408030|bevacizumab|bevacizumab
406689|NCT01408030|tranexamic acid|tranexamic acid
406690|NCT01408030|nosebleed|nosebleed
406691|NCT01408030|estrogen|estrogen
406692|NCT01408004|Renal carcinoma|renal carcinoma
406693|NCT01408004|Resistance|resistance
406694|NCT01408004|Reversible|reversible
406695|NCT01408004|Translational|translational
406696|NCT01407991|Enteral tube placement|enteral tube placement
406697|NCT01407978|Influenza|influenza
406698|NCT01407978|Pandemic vaccine|pandemic vaccine
406699|NCT01407978|Seasonal vaccine|seasonal vaccine
406700|NCT01407978|Prevention|prevention
406701|NCT01407978|Influenza vaccine|influenza vaccine
406702|NCT01407978|Influenza in humans|influenza in humans
406703|NCT01407978|Pandemic influenza in humans|pandemic influenza in humans
406704|NCT01407978|Influenza vaccine for children|influenza vaccine for children
406705|NCT01407978|Influenza vaccine for adolescents|influenza vaccine for adolescents
406706|NCT01407978|Seasonal vaccine for children|seasonal vaccine for children
406707|NCT01407978|Seasonal vaccine for adolescents|seasonal vaccine for adolescents
406708|NCT01407965|obesity|obesity
406709|NCT01407965|pharmacokinetic|pharmacokinetic
406710|NCT01407965|ertapenem|ertapenem
406711|NCT01407965|meropenem|meropenem
406712|NCT01407952|treatment trial|treatment trial
406713|NCT01407952|cerebral aneurysm|cerebral aneurysm
406714|NCT01407952|randomized|randomized
406715|NCT01407952|coils|coils
406716|NCT01407952|endovascular|endovascular
406717|NCT01407952|HEAT|heat
406718|NCT01407952|bare platinum|bare platinum
406719|NCT01407952|Hydrogel|hydrogel
406720|NCT01407952|Hydrocoil|hydrocoil
406721|NCT01407939|Bitter Taste|bitter taste
406722|NCT01407939|Bitter Blockers|bitter blockers
406723|NCT01407939|Pediatric Medications|pediatric medications
406724|NCT01407939|Sensory methodology|sensory methodology
406725|NCT01407939|Children|children
406726|NCT01407926|Depression|depression
406727|NCT01407926|Aging|aging
406728|NCT01407926|Clinical Effectiveness|clinical effectiveness
406729|NCT01407926|Home Care|home care
406730|NCT01407926|Nurse-Led|nurse-led
406731|NCT01407900|CD NP|cd np
406732|NCT01407900|dual receptor|dual receptor
406733|NCT01407900|NPR A|npr a
406734|NCT01407900|NPR B|npr b
406735|NCT01407900|Adult, aged over 45|adult, aged over 45
406736|NCT01407887|children|children
406737|NCT01407874|Gout|gout
406738|NCT01407874|Hyperuricemia|hyperuricemia
406739|NCT01407874|Arthritis|arthritis
406740|NCT01407874|Joint Disease|joint disease
406741|NCT01407874|Allopurinol|allopurinol
406742|NCT01407874|Renal Insufficiency|renal insufficiency
406743|NCT01407835|Immunotherapy|immunotherapy
406744|NCT01407835|Skin prick test|skin prick test
406745|NCT01407835|Standardization|standardization
406746|NCT01407835|Dactylis glomerata|dactylis glomerata
406747|NCT01407822|Lung cancer|lung cancer
406748|NCT01407822|IIIA-N2|iiia-n2
406749|NCT01407822|Neo-adjuvant treatment|neo-adjuvant treatment
406750|NCT01407822|EGFR mutations|egfr mutations
406751|NCT01407822|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
406752|NCT01407796|lung inflammation|lung inflammation
406753|NCT01407796|positron emission tomography (PET)|positron emission tomography (pet)
406754|NCT01407796|fluorodeoxyglucose (FDG)|fluorodeoxyglucose (fdg)
406755|NCT01407796|inducible nitric oxide synthase (iNOS)|inducible nitric oxide synthase (inos)
406756|NCT01407796|lung anti-inflammatory therapy|lung anti-inflammatory therapy
406757|NCT01407783|Post-partum depression|post-partum depression
406758|NCT01407783|Low-income mothers|low-income mothers
406759|NCT01407783|home nurse visitation|home nurse visitation
406760|NCT01407770|radiation toxicity|radiation toxicity
406761|NCT01407770|skin reactions secondary to radiation therapy|skin reactions secondary to radiation therapy
406762|NCT01407770|pain|pain
406763|NCT01407770|fatigue|fatigue
406764|NCT01407770|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
406765|NCT01407770|depression|depression
406766|NCT01407770|cognitive/functional effects|cognitive/functional effects
406767|NCT01407770|stage IA breast cancer|stage ia breast cancer
406768|NCT01407770|stage IB breast cancer|stage ib breast cancer
406769|NCT01407770|stage II breast cancer|stage ii breast cancer
406770|NCT01407770|stage IIIA breast cancer|stage iiia breast cancer
406771|NCT01407770|ductal breast carcinoma in situ|ductal breast carcinoma in situ
406772|NCT01407757|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
406773|NCT01407757|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
406774|NCT01407757|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
406775|NCT01407757|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
406776|NCT01407757|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
406777|NCT01407757|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
406778|NCT01407757|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
406779|NCT01407757|adult acute basophilic leukemia|adult acute basophilic leukemia
406780|NCT01407757|childhood acute basophilic leukemia|childhood acute basophilic leukemia
406781|NCT01407757|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
406782|NCT01407757|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
406783|NCT01407757|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
406784|NCT01407757|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
406785|NCT01407757|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
406786|NCT01407757|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
406787|NCT01407757|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
406788|NCT01407757|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
406789|NCT01407757|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
406790|NCT01407757|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
406791|NCT01407757|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
406792|NCT01407757|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
406793|NCT01407757|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
406794|NCT01407757|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
406795|NCT01407757|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
406796|NCT01407757|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
406797|NCT01407757|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
406798|NCT01407757|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
406799|NCT01407757|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
406800|NCT01407757|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
406801|NCT01407757|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
406802|NCT01407731|disseminated neuroblastoma|disseminated neuroblastoma
406803|NCT01407731|localized resectable neuroblastoma|localized resectable neuroblastoma
406804|NCT01407731|localized unresectable neuroblastoma|localized unresectable neuroblastoma
406805|NCT01407731|stage 4S neuroblastoma|stage 4s neuroblastoma
406806|NCT01407718|Knee pain|knee pain
406807|NCT01407718|tibial nailing|tibial nailing
406808|NCT01407705|spinal cord injury with traumatic event|spinal cord injury with traumatic event
406809|NCT01407692|menstrual cycle|menstrual cycle
406810|NCT01407692|estrogen|estrogen
406811|NCT01407679|cutaneous lupus erythematosus|cutaneous lupus erythematosus
406812|NCT01407679|discoid lupus erythematosus|discoid lupus erythematosus
406813|NCT01407679|subacute cutaneous lupus erythematosus|subacute cutaneous lupus erythematosus
406814|NCT01407679|lupus erythematosus tumidus|lupus erythematosus tumidus
406815|NCT01407666|paravertebral block|paravertebral block
406816|NCT01407666|epidural block|epidural block
406817|NCT01407666|pain management|pain management
406818|NCT01407666|liver resection|liver resection
406819|NCT01407666|comparison|comparison
406820|NCT01407653|Low back pain|low back pain
406821|NCT01407653|virtual reality|virtual reality
406822|NCT01407640|Insulin allergy|insulin allergy
406823|NCT01407640|adverse drug reaction|adverse drug reaction
406824|NCT01407640|diabetes|diabetes
406825|NCT01407640|type 1 hypersensitivity|type 1 hypersensitivity
406826|NCT01407640|immediate hypersensitivity|immediate hypersensitivity
406827|NCT01407640|type 4 hypersensitivity|type 4 hypersensitivity
406828|NCT01407640|insulin analogs|insulin analogs
406829|NCT01407640|intradermal testing|intradermal testing
406830|NCT01407640|insulin antibody|insulin antibody
406831|NCT01407640|mast cell|mast cell
406832|NCT01407640|CD+ TCELL|cd+ tcell
406833|NCT01407627|human|human
406834|NCT01407627|fructose|fructose
406835|NCT01407627|dextrose|dextrose
406836|NCT01407627|renin angiotensin system|renin angiotensin system
406837|NCT01407627|kidney|kidney
406838|NCT01407627|renal hemodynamics|renal hemodynamics
406839|NCT01407614|Subarachnoid hemorrhage|subarachnoid hemorrhage
406840|NCT01407614|delayed cerebral ischemia|delayed cerebral ischemia
406942|NCT01407172|PAD|pad
406841|NCT01407614|external lumbar drainage|external lumbar drainage
406842|NCT01407614|vasospasm|vasospasm
406843|NCT01407601|vitamin K|vitamin k
406844|NCT01407601|MK-7|mk-7
406845|NCT01407601|Hemodialysis|hemodialysis
406846|NCT01407601|vascular calcification|vascular calcification
406847|NCT01407601|Matrix Gla protein|matrix gla protein
406848|NCT01407601|Osteocalcin|osteocalcin
406849|NCT01407588|Atrial fibrillation|atrial fibrillation
406850|NCT01407588|Ablation|ablation
406851|NCT01407575|Buprenorphine|buprenorphine
406852|NCT01407575|Receptors, opioid|receptors, opioid
406853|NCT01407575|Receptors, opioid, kappa|receptors, opioid, kappa
406854|NCT01407536|Stroke|stroke
406855|NCT01407536|Thermal Stimulation|thermal stimulation
406856|NCT01407536|Upper Extremity|upper extremity
406857|NCT01407536|Motor Recovery|motor recovery
406858|NCT01407536|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
406859|NCT01407523|Levetiracetam|levetiracetam
406860|NCT01407523|Infusion|infusion
406861|NCT01407523|Epilepsy|epilepsy
406862|NCT01407523|Partial Onset Seizures|partial onset seizures
406863|NCT01407497|HIV|hiv
406864|NCT01407497|Vaccine|vaccine
406865|NCT01407497|DNA|dna
406866|NCT01407497|Prevention|prevention
406867|NCT01407484|Infertility|infertility
406868|NCT01407484|Assisted reproductive technology|assisted reproductive technology
406869|NCT01407484|Double blind therapeutical trial|double blind therapeutical trial
406870|NCT01407484|Multicentric study|multicentric study
406871|NCT01407484|Prospective randomized study|prospective randomized study
406872|NCT01407471|aldosterone|aldosterone
406873|NCT01407471|clobetasol|clobetasol
406874|NCT01407471|atrophy|atrophy
406875|NCT01407471|skin|skin
406876|NCT01407471|epidermis|epidermis
406877|NCT01407471|wound healing|wound healing
406878|NCT01407471|mineral corticoid receptor|mineral corticoid receptor
406879|NCT01407471|spironolactone|spironolactone
406880|NCT01407445|Menopause|menopause
406881|NCT01407445|Sexual dysfunction|sexual dysfunction
406882|NCT01407445|Tribulus|tribulus
406883|NCT01407445|Sexuality|sexuality
406884|NCT01407445|Phytotherapeutic Drugs|phytotherapeutic drugs
406885|NCT01407432|Male infertility|male infertility
406886|NCT01407432|folic acid|folic acid
406887|NCT01407432|in VITRO fertilization|in vitro fertilization
406888|NCT01407432|sperm parameters|sperm parameters
406889|NCT01407432|MTHFR genotype|mthfr genotype
406890|NCT01407419|Rheumatoid Arthritis|rheumatoid arthritis
406891|NCT01407393|overweight|overweight
406892|NCT01407393|obesity|obesity
406893|NCT01407393|weight loss|weight loss
406894|NCT01407393|body fat|body fat
406895|NCT01407393|waste cirumference|waste cirumference
406896|NCT01407393|satiety|satiety
406897|NCT01407393|appetite|appetite
406898|NCT01407380|Advanced malignancies|advanced malignancies
406899|NCT01407380|solid tumors|solid tumors
406900|NCT01407380|cancer|cancer
406901|NCT01407367|patient safety|patient safety
406902|NCT01407367|chronic kidney disease|chronic kidney disease
406903|NCT01407367|medical errors|medical errors
406904|NCT01407354|robotic weight support|robotic weight support
406905|NCT01407354|aquatic exercise|aquatic exercise
406906|NCT01407354|incomplete motor spinal cord injury|incomplete motor spinal cord injury
406907|NCT01407354|ASIA C and D|asia c and d
406908|NCT01407328|shoulder arthroscopic surgery|shoulder arthroscopic surgery
406909|NCT01407328|respiratory discomfort|respiratory discomfort
406910|NCT01407328|airway obstruction|airway obstruction
406911|NCT01407328|restrictive pathology|restrictive pathology
406912|NCT01407328|diaphragm palsy|diaphragm palsy
406913|NCT01407315|Continuous subcutaneous glucose monitoring|continuous subcutaneous glucose monitoring
406914|NCT01407315|Type 1 Diabetes|type 1 diabetes
406915|NCT01407302|Laryngeal mask airway|laryngeal mask airway
406916|NCT01407302|internal jugular vein cannulation|internal jugular vein cannulation
406917|NCT01407263|radical prostatectomy|radical prostatectomy
406918|NCT01407263|anastomotic suturing|anastomotic suturing
406919|NCT01407263|lymph node dissection|lymph node dissection
406920|NCT01407263|11-096|11-096
406921|NCT01407237|HIV-infection|hiv-infection
406922|NCT01407237|renin|renin
406923|NCT01407237|aldosterone|aldosterone
406924|NCT01407237|visceral fat|visceral fat
406925|NCT01407224|Exclusive Breastfeeding|exclusive breastfeeding
406926|NCT01407224|Skin to skin contact|skin to skin contact
406927|NCT01407224|Cord Clumping|cord clumping
406928|NCT01407224|Prelactial feeding|prelactial feeding
406929|NCT01407211|multiple sclerosis|multiple sclerosis
406930|NCT01407211|Myelin Oligodendrocyte Glycoprotein(MOG)|myelin oligodendrocyte glycoprotein(mog)
406931|NCT01407211|Vitamin A|vitamin a
406932|NCT01407211|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
406933|NCT01407211|gene expression|gene expression
406934|NCT01407211|Th1 Cells|th1 cells
406935|NCT01407211|Th2 Cells|th2 cells
406936|NCT01407198|High Risk Chordoma|high risk chordoma
406937|NCT01407185|heart failure|heart failure
406938|NCT01407185|quality of life|quality of life
406939|NCT01407185|fall prevention|fall prevention
406940|NCT01407185|endurance|endurance
406941|NCT01407185|resistive training|resistive training
406943|NCT01407172|Peripheral arterial disease|peripheral arterial disease
406944|NCT01407172|Hydrogen Sulfide|hydrogen sulfide
406945|NCT01407172|Gasotransmitter|gasotransmitter
406946|NCT01407159|type b dissection|type b dissection
406947|NCT01407159|thoracic stentgraft|thoracic stentgraft
406948|NCT01407159|aortic stent|aortic stent
406949|NCT01407159|clinical and technical success|clinical and technical success
406950|NCT01407159|safety and feasibility of E-XL aortic stent|safety and feasibility of e-xl aortic stent
406951|NCT01407146|acute myocardial infarction|acute myocardial infarction
406952|NCT01407146|care-seeking behavior|care-seeking behavior
406953|NCT01407146|acute coronary syndrome|acute coronary syndrome
406954|NCT01407146|care-seeking delay|care-seeking delay
406955|NCT01407146|cardiac delay|cardiac delay
406956|NCT01407146|prehospital delay|prehospital delay
406957|NCT01407146|acute myocardial infarction & PTSD|acute myocardial infarction & ptsd
406958|NCT01407146|help seeking behaviors|help seeking behaviors
406959|NCT01407146|seeking treatment|seeking treatment
406960|NCT01407146|cardiac patients|cardiac patients
406961|NCT01407146|decision time|decision time
406962|NCT01407133|Neuro-otology|neuro-otology
406963|NCT01407133|Chronic tinnitus|chronic tinnitus
406964|NCT01407133|Sensory disability|sensory disability
406965|NCT01407133|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
406966|NCT01407133|Dose escalation|dose escalation
406967|NCT01407120|Prevention|prevention
406968|NCT01407120|Divorce|divorce
406969|NCT01407107|nitroglycerin|nitroglycerin
406970|NCT01407107|5-flourouracil|5-flourouracil
406971|NCT01407107|radiation therapy|radiation therapy
406972|NCT01407107|neo-adjuvant treatment|neo-adjuvant treatment
406973|NCT01407094|Depression, Major Depressive Disorder, Mood Disorder|depression, major depressive disorder, mood disorder
406974|NCT01407081|cognitive rehabilitation|cognitive rehabilitation
406975|NCT01407081|SMART goals|smart goals
406976|NCT01407081|telehealth|telehealth
406977|NCT01407055|Coronary Artery Bypass Graft Surgery (CABG)|coronary artery bypass graft surgery (cabg)
406978|NCT01407055|Patients' Expectations|patients' expectations
406979|NCT01407055|Coronary Heart Disease|coronary heart disease
406980|NCT01407055|Illness Perception Intervention|illness perception intervention
406981|NCT01407055|Randomized Controlled Trial|randomized controlled trial
406982|NCT01407042|unicondylar knee arthroplasty|unicondylar knee arthroplasty
406983|NCT01407042|mobile-bearing|mobile-bearing
406984|NCT01407042|patellofemoral pain|patellofemoral pain
406985|NCT01407016|metronidazole infusion|metronidazole infusion
406986|NCT01407003|T2DM, blood glucose, OGTT, LIK066|t2dm, blood glucose, ogtt, lik066
406987|NCT01406990|aspirin resistance|aspirin resistance
406988|NCT01406990|hyporesponsive|hyporesponsive
406989|NCT01406990|CAD|cad
406990|NCT01406990|women|women
406991|NCT01406977|Hypophosphatasia|hypophosphatasia
406992|NCT01406977|HPP|hpp
406993|NCT01406977|Rathbun's disease|rathbun's disease
406994|NCT01406964|Chlamidia Antibody test, Hysterosalpyngography, Tubal disease|chlamidia antibody test, hysterosalpyngography, tubal disease
406995|NCT01406951|sTREM-1|strem-1
406996|NCT01406951|PCT|pct
406997|NCT01406951|CPIS|cpis
406998|NCT01406951|VAP|vap
406999|NCT01406951|EVC|evc
407000|NCT01406951|diagnosis|diagnosis
407001|NCT01406951|prognosis|prognosis
407002|NCT01406938|Psoriasis|psoriasis
407003|NCT01406938|plaque|plaque
407004|NCT01406938|inflammatory skin disease|inflammatory skin disease
407005|NCT01406938|scaly patches|scaly patches
407006|NCT01406938|AIN457|ain457
407007|NCT01406938|secukinumab|secukinumab
407008|NCT01406938|Moderate to Severe Plaque-type Psoriasis|moderate to severe plaque-type psoriasis
407009|NCT01406912|Stroke Rehabilitation|stroke rehabilitation
407010|NCT01406912|Ischemic Stroke|ischemic stroke
407011|NCT01406912|Virtual Reality|virtual reality
407012|NCT01406912|Nintendo Wii|nintendo wii
407013|NCT01406912|Recreational Activity|recreational activity
407014|NCT01406912|Motor Function|motor function
407015|NCT01406886|Modifiable environmental|modifiable environmental
407016|NCT01406886|behavioral factors|behavioral factors
407017|NCT01406873|Myotonic Dystrophy|myotonic dystrophy
407018|NCT01406873|Myotonic Dystrophy Type 1 (DM1)|myotonic dystrophy type 1 (dm1)
407019|NCT01406873|Muscular Dystrophy|muscular dystrophy
407020|NCT01406873|Mexiletine|mexiletine
407021|NCT01406860|Headaches|headaches
407022|NCT01406860|Migraines|migraines
407023|NCT01406860|Tension headaches|tension headaches
407024|NCT01406860|Cluster headaches|cluster headaches
407025|NCT01406847|Spinal Manipulation|spinal manipulation
407026|NCT01406847|Body-based intervention|body-based intervention
407027|NCT01406847|Experimental pain|experimental pain
407028|NCT01406834|PTSD|ptsd
407029|NCT01406834|Veterans|veterans
407030|NCT01406834|Killing|killing
407031|NCT01406834|Military|military
407032|NCT01406821|PRP|prp
407033|NCT01406821|platelet-rich-plasma|platelet-rich-plasma
407034|NCT01406821|platelet|platelet
407035|NCT01406821|tendinosis|tendinosis
407036|NCT01406821|tendinitis|tendinitis
407037|NCT01406821|tendonitis|tendonitis
407038|NCT01406821|tendinopathy|tendinopathy
407039|NCT01406821|enthesopathy|enthesopathy
407040|NCT01406821|muscle|muscle
407041|NCT01406821|sport|sport
407042|NCT01406821|tendon|tendon
407043|NCT01406821|patella|patella
407044|NCT01406821|patellar tendon|patellar tendon
407045|NCT01406808|genetic|genetic
407046|NCT01406808|atherosclerosis|atherosclerosis
407047|NCT01406808|myocardial infarction|myocardial infarction
407048|NCT01406808|risk|risk
407049|NCT01406808|preventive cardiology|preventive cardiology
407050|NCT01406795|Post Thrombotic Syndrome|post thrombotic syndrome
407051|NCT01406795|Venous Stasis|venous stasis
407052|NCT01406795|Venous Occlusions|venous occlusions
407053|NCT01406795|Venous Stenosis|venous stenosis
407054|NCT01406782|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
407055|NCT01406782|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
407056|NCT01406782|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
407057|NCT01406782|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
407058|NCT01406743|Spine and pelvis parameters|spine and pelvis parameters
407059|NCT01406743|Sagittal balance|sagittal balance
407060|NCT01406743|Database|database
407061|NCT01406730|running exercise|running exercise
407062|NCT01406730|cardiac hypertrophy|cardiac hypertrophy
407063|NCT01406730|blood|blood
407064|NCT01406730|maximum oxygen uptake|maximum oxygen uptake
407065|NCT01406730|intervention|intervention
407066|NCT01406730|untrained|untrained
407067|NCT01406730|males|males
407068|NCT01406717|SPIL1033|spil1033
407069|NCT01406717|type 2 diabetes mellitus|type 2 diabetes mellitus
407070|NCT01406691|sleep|sleep
407071|NCT01406691|delayed sleep phase disorder|delayed sleep phase disorder
407072|NCT01406691|circadian|circadian
407073|NCT01406691|teen|teen
407074|NCT01406691|adolescent|adolescent
407075|NCT01406678|remote ischemic preconditioning|remote ischemic preconditioning
407076|NCT01406678|coronary artery bypass grafting|coronary artery bypass grafting
407077|NCT01406678|myocardial injury|myocardial injury
407078|NCT01406665|diabetes|diabetes
407079|NCT01406665|impaired glucose tolerance|impaired glucose tolerance
407080|NCT01406652|septic bursitis|septic bursitis
407081|NCT01406652|bursectomy|bursectomy
407082|NCT01406652|primary closure|primary closure
407083|NCT01406639|Hereditary Hemorrhagic Telangiectasia (HHT)|hereditary hemorrhagic telangiectasia (hht)
407084|NCT01406639|Nosebleeds|nosebleeds
407085|NCT01406639|Ranibizumab|ranibizumab
407086|NCT01406639|Lucentis|lucentis
407087|NCT01406626|HIV|hiv
407088|NCT01406626|AIDS|aids
407089|NCT01406626|Health navigation|health navigation
407090|NCT01406626|Viral load|viral load
407091|NCT01406626|Corrections|corrections
407092|NCT01406613|Observational|observational
407093|NCT01406613|Bone Density|bone density
407094|NCT01406613|alendronate|alendronate
407095|NCT01406613|ibandronate|ibandronate
407096|NCT01406613|risedronate|risedronate
407097|NCT01406613|postmenopausal|postmenopausal
407098|NCT01406613|osteoporosis|osteoporosis
407099|NCT01406600|recombinant hCG|recombinant hcg
407100|NCT01406600|poor responder|poor responder
407101|NCT01406600|oocyte maturity|oocyte maturity
407102|NCT01406587|Burning|burning
407103|NCT01406587|Dysuria|dysuria
407104|NCT01406587|Frequency|frequency
407105|NCT01406587|Pain|pain
407106|NCT01406587|Uncomplicated Urinary Tract Infection|uncomplicated urinary tract infection
407107|NCT01406587|Uncomplicated UTI|uncomplicated uti
407108|NCT01406587|Urinary Tract Infection|urinary tract infection
407109|NCT01406587|UTI|uti
407110|NCT01406587|Burning during urination associated with uncomplicated urinary tract infection|burning during urination associated with uncomplicated urinary tract infection
407111|NCT01406587|Urination frequency associated with uncomplicated urinary tract infection|urination frequency associated with uncomplicated urinary tract infection
407112|NCT01406587|Pain associated with uncomplicated urinary tract infection|pain associated with uncomplicated urinary tract infection
407113|NCT01406574|Hepatocellular carcinoma|hepatocellular carcinoma
407114|NCT01406561|Meniscectomy|meniscectomy
407115|NCT01406561|Knee Pain|knee pain
407116|NCT01406561|Postoperative Pain|postoperative pain
407117|NCT01406548|Osteopenia|osteopenia
407118|NCT01406548|osteoporosis|osteoporosis
407119|NCT01406548|low bone mineral density|low bone mineral density
407120|NCT01406535|Phosphodiesterase 5 inhibition|phosphodiesterase 5 inhibition
407121|NCT01406535|myocardial perfusion|myocardial perfusion
407122|NCT01406535|angiogenesis|angiogenesis
407123|NCT01406535|coronary artery disease|coronary artery disease
407124|NCT01406535|therapy refractory|therapy refractory
407125|NCT01406522|Acetylcholine|acetylcholine
407126|NCT01406522|Cholinesterases|cholinesterases
407127|NCT01406522|Cocaine|cocaine
407128|NCT01406522|Self-Administration|self-administration
407129|NCT01406509|Safety|safety
407130|NCT01406509|Conjugate vaccine|conjugate vaccine
407131|NCT01406496|Insulin bolus|insulin bolus
407132|NCT01406496|glucose excursions|glucose excursions
407133|NCT01406496|post-prandial|post-prandial
407134|NCT01406496|timing|timing
407135|NCT01406496|meal content|meal content
407136|NCT01406483|Platelet reactivity|platelet reactivity
407137|NCT01406483|CABG|cabg
407138|NCT01406483|Perioperative and in hospital bleeding|perioperative and in hospital bleeding
407139|NCT01406470|IGIV|igiv
407140|NCT01406470|Primary Immune Deficiency|primary immune deficiency
407141|NCT01406470|Immunoglobulin G|immunoglobulin g
407142|NCT01406457|Subarachnoid Hemorrhage|subarachnoid hemorrhage
407143|NCT01406444|Anorexia Nervosa|anorexia nervosa
407144|NCT01406444|Osteopenia|osteopenia
407145|NCT01406444|Osteoporosis|osteoporosis
407146|NCT01406444|Bone density|bone density
407147|NCT01406431|pitavastatin|pitavastatin
407148|NCT01406431|Livalo|livalo
407149|NCT01406418|Influenza|influenza
407150|NCT01406418|Virus|virus
407151|NCT01406418|Monoclonal|monoclonal
407152|NCT01406418|Antibody|antibody
407153|NCT01406418|Immunization|immunization
407154|NCT01406418|Treatment|treatment
407155|NCT01406405|Degenerative disc disease|degenerative disc disease
407156|NCT01406405|spinal stenosis|spinal stenosis
407157|NCT01406405|herniated disc|herniated disc
407158|NCT01406392|Misoprostol|misoprostol
407159|NCT01406392|Sublingual|sublingual
407160|NCT01406392|Induced|induced
407161|NCT01406392|Labor|labor
407162|NCT01406366|Pediatric oral health|pediatric oral health
407163|NCT01406366|Bright Futures|bright futures
407164|NCT01406366|Health promotion|health promotion
407165|NCT01406353|Mitral Stenosis|mitral stenosis
407166|NCT01406353|Mitral Valvuloplasty|mitral valvuloplasty
407167|NCT01406314|Phase 1|phase 1
407168|NCT01406314|Patient|patient
407169|NCT01406314|Systemic Amyloidosis|systemic amyloidosis
407170|NCT01406314|Amyloidosis|amyloidosis
407171|NCT01406301|prescribing information|prescribing information
407172|NCT01406288|hemolytic-uremic syndrome|hemolytic-uremic syndrome
407173|NCT01406288|shiga-toxin-producing E. Coli|shiga-toxin-producing e. coli
407174|NCT01406262|albiglutide|albiglutide
407175|NCT01406262|QT interval|qt interval
407176|NCT01406262|cardiac repolarization|cardiac repolarization
407177|NCT01406262|ECG study|ecg study
407178|NCT01406249|unresectable gastric cancer|unresectable gastric cancer
407179|NCT01406249|recurrent gastric cancer|recurrent gastric cancer
407180|NCT01406249|StageIV gastric cancer|stageiv gastric cancer
407181|NCT01406249|adenocarcinoma of the stomach|adenocarcinoma of the stomach
407182|NCT01406249|XP|xp
407183|NCT01406249|SP|sp
407184|NCT01406236|Female|female
407185|NCT01406236|urgent or elective percutaneous coronary intervention|urgent or elective percutaneous coronary intervention
407186|NCT01406236|PCI|pci
407187|NCT01406236|diagnostic angiography|diagnostic angiography
407188|NCT01406223|Nicotine addiction|nicotine addiction
407189|NCT01406223|Cigarette smoking|cigarette smoking
407190|NCT01406223|Smoking cessation|smoking cessation
407191|NCT01406223|Zyban|zyban
407192|NCT01406223|Chantix|chantix
407193|NCT01406223|Nicotine patches|nicotine patches
407194|NCT01406223|varenicline|varenicline
407195|NCT01406223|bupropion|bupropion
407196|NCT01406223|fMRI|fmri
407197|NCT01406210|Lung Transplant|lung transplant
407198|NCT01406210|REflux Surgery|reflux surgery
407199|NCT01406210|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
407200|NCT01406210|Fundoplication|fundoplication
407201|NCT01406197|Progesterone|progesterone
407202|NCT01406197|Progestins|progestins
407203|NCT01406197|Preterm labor|preterm labor
407204|NCT01406197|Premature birth|premature birth
407205|NCT01406197|Uterine electromyography|uterine electromyography
407206|NCT01406197|Uterine contractility|uterine contractility
407207|NCT01406184|Child Abuse|child abuse
407208|NCT01406184|Child Neglect|child neglect
407209|NCT01406184|Child Hospital Emergency Room Presentations|child hospital emergency room presentations
407210|NCT01406184|Child Well-Care Compliance|child well-care compliance
407211|NCT01406184|Child Immunization Compliance|child immunization compliance
407212|NCT01406171|Isavuconazole|isavuconazole
407213|NCT01406171|ASP9766|asp9766
407214|NCT01406171|BAL8557|bal8557
407215|NCT01406171|Midazolam|midazolam
407216|NCT01406171|Healthy volunteers|healthy volunteers
407217|NCT01406158|Solifenacin succinate|solifenacin succinate
407218|NCT01406158|VESIcare|vesicare
407219|NCT01406158|Healthy Volunteers|healthy volunteers
407220|NCT01406158|YM905|ym905
407221|NCT01406145|Alzheimer's Disease|alzheimer's disease
407222|NCT01406145|ASP0777|asp0777
407223|NCT01406132|ASP015K|asp015k
407224|NCT01406132|Healthy volunteers|healthy volunteers
407225|NCT01406106|Hypercholesterolemia|hypercholesterolemia
407226|NCT01406106|Lipids|lipids
407227|NCT01406106|Cardiovascular disease|cardiovascular disease
407228|NCT01406106|Risks factors|risks factors
407229|NCT01406106|Primary Care|primary care
407230|NCT01406093|Candidemia|candidemia
407231|NCT01406093|Early-onset|early-onset
407232|NCT01406093|Late-onset|late-onset
407233|NCT01406093|Health-care associated|health-care associated
407234|NCT01406093|Nosocomial|nosocomial
407235|NCT01406080|Photoaging|photoaging
407236|NCT01406080|Photodamage|photodamage
407237|NCT01406080|Adapalene|adapalene
407238|NCT01406080|Differin|differin
407239|NCT01406067|social skills training,|social skills training,
407240|NCT01406067|social competence training,|social competence training,
407241|NCT01406067|Oppositional Defiant Disorder|oppositional defiant disorder
407763|NCT01403766|iohexol|iohexol
407242|NCT01406067|peer related aggressive behavior|peer related aggressive behavior
407243|NCT01406067|randomized controlled trial|randomized controlled trial
407244|NCT01406054|athletes|athletes
407245|NCT01406054|injury prevention|injury prevention
407246|NCT01406054|neuromuscular training|neuromuscular training
407247|NCT01406054|public school|public school
407248|NCT01406054|physical education|physical education
407249|NCT01406054|knee|knee
407250|NCT01406054|sports|sports
407252|NCT01406054|KIPP|kipp
407253|NCT01406041|Fluid and electrolyte imbalance|fluid and electrolyte imbalance
407254|NCT01406041|Hyponatremia|hyponatremia
407255|NCT01406041|Hypernatremia|hypernatremia
407256|NCT01406041|Electrolytes disorder|electrolytes disorder
407257|NCT01406028|IVF|ivf
407258|NCT01406028|Stress|stress
407259|NCT01406028|Infertility|infertility
407260|NCT01406015|Obesity|obesity
407261|NCT01406015|Insulin resistance|insulin resistance
407262|NCT01406015|Mineralocorticoid receptor|mineralocorticoid receptor
407263|NCT01406002|Pharmacokinetics|pharmacokinetics
407264|NCT01406002|darexaban|darexaban
407265|NCT01406002|YM150|ym150
407266|NCT01406002|rifampicin|rifampicin
407267|NCT01406002|Phase 1|phase 1
407268|NCT01405989|Pharmacokinetics|pharmacokinetics
407269|NCT01405989|darexaban|darexaban
407270|NCT01405989|ketoconazole|ketoconazole
407271|NCT01405989|Phase 1|phase 1
407272|NCT01405976|sleep apneas|sleep apneas
407273|NCT01405976|noninvasive ventilation|noninvasive ventilation
407274|NCT01405976|CPAP|cpap
407275|NCT01405963|Amgen|amgen
407276|NCT01405963|AMG 157|amg 157
407277|NCT01405963|Asthma|asthma
407278|NCT01405898|hypertension|hypertension
407279|NCT01405898|nitrite|nitrite
407280|NCT01405898|blood pressure|blood pressure
407281|NCT01405898|endothelial function|endothelial function
407282|NCT01405885|Universal Influenza|universal influenza
407283|NCT01405885|Intradermal DNA vaccine|intradermal dna vaccine
407284|NCT01405885|Electroporation|electroporation
407285|NCT01405885|H1 and H5|h1 and h5
407286|NCT01405885|DNA Vaccination|dna vaccination
407287|NCT01405885|Influenza|influenza
407288|NCT01405885|INO-3510|ino-3510
407289|NCT01405859|Tourette|tourette
407290|NCT01405859|tic|tic
407291|NCT01405859|Tourette's|tourette's
407292|NCT01405859|Tourette syndrome|tourette syndrome
407293|NCT01405859|Tourette's syndrome|tourette's syndrome
407294|NCT01405807|Vasculitis|vasculitis
407295|NCT01405807|ANCA|anca
407296|NCT01405807|Refractory|refractory
407297|NCT01405742|Hemophilia|hemophilia
407298|NCT01405742|Prophylaxis|prophylaxis
407299|NCT01405742|Recombinant factor VIII|recombinant factor viii
407300|NCT01405716|Mindfulness|mindfulness
407301|NCT01405716|Back Pain|back pain
407302|NCT01405716|Older adults|older adults
407303|NCT01405703|Clavicle Fractures|clavicle fractures
407304|NCT01405703|Numbness|numbness
407305|NCT01405703|Percutaneous plate fixation|percutaneous plate fixation
407306|NCT01405703|open plate fixation|open plate fixation
407307|NCT01405703|incision related numbness|incision related numbness
407308|NCT01405703|union rates|union rates
407309|NCT01405703|subjective|subjective
407310|NCT01405703|questionnaire based outcomes|questionnaire based outcomes
407311|NCT01405703|Diaphyseal|diaphyseal
407312|NCT01405690|CAD|cad
407313|NCT01405690|CTCA|ctca
407314|NCT01405690|multidetector computer tomography (MDCT)|multidetector computer tomography (mdct)
407315|NCT01405677|Hepatitis A|hepatitis a
407316|NCT01405677|Vaccination|vaccination
407317|NCT01405677|Immunisation|immunisation
407318|NCT01405651|ONO-6950|ono-6950
407319|NCT01405651|Healthy adult subjects|healthy adult subjects
407320|NCT01405625|Asthma|asthma
407321|NCT01405625|Health literacy|health literacy
407322|NCT01405625|Parent knowledge of appropriate action plan steps|parent knowledge of appropriate action plan steps
407323|NCT01405599|Ulimorelin|ulimorelin
407324|NCT01405599|Hepatic Impairment|hepatic impairment
407325|NCT01405586|elderly|elderly
407326|NCT01405586|chemotherapy|chemotherapy
407327|NCT01405573|Child Pugh B|child pugh b
407328|NCT01405573|first line|first line
407329|NCT01405547|Gestational Diabetes|gestational diabetes
407330|NCT01405547|Gestational Hyperglycemia|gestational hyperglycemia
407331|NCT01405547|Gestational Insulinemia|gestational insulinemia
407332|NCT01405547|Maternal Obesity|maternal obesity
407333|NCT01405547|Human Milk|human milk
407334|NCT01405547|Lactogenesis|lactogenesis
407335|NCT01405547|Obstetrics|obstetrics
407336|NCT01405547|Nutrition|nutrition
407337|NCT01405547|Infant Growth|infant growth
407338|NCT01405534|Catheterization, Central Venous|catheterization, central venous
407339|NCT01405521|typhoid vaccine M01ZH09|typhoid vaccine m01zh09
407340|NCT01405521|Ty21a typhoid vaccine|ty21a typhoid vaccine
407341|NCT01405508|N01258|n01258
407342|NCT01405508|Brivaracetam|brivaracetam
407343|NCT01405508|Epilepsy|epilepsy
407344|NCT01405508|IV|iv
407345|NCT01405508|intravenous|intravenous
407346|NCT01405495|Posttraumatic Stress Disorder|posttraumatic stress disorder
407347|NCT01405495|Working Memory|working memory
407348|NCT01405495|Attentional Bias|attentional bias
407349|NCT01405495|Connectivity|connectivity
407350|NCT01405495|Structural Neuroimaging|structural neuroimaging
407351|NCT01405495|Functional Neuroimaging|functional neuroimaging
407352|NCT01405495|Diffusion Tensor Imaging|diffusion tensor imaging
407353|NCT01405495|Arterial Spin Labelling|arterial spin labelling
407354|NCT01405495|Cortisol|cortisol
407355|NCT01405495|Psychophysiology|psychophysiology
407356|NCT01405495|Early development of|early development of
407357|NCT01405482|Botulinum Toxin Type A|botulinum toxin type a
407358|NCT01405482|Thoracic Outlet Syndrome|thoracic outlet syndrome
407359|NCT01405469|Achalasia|achalasia
407360|NCT01405469|Heller myotomy|heller myotomy
407361|NCT01405469|Dysphagia|dysphagia
407362|NCT01405469|Peroral Endoscopic Myotomy|peroral endoscopic myotomy
407363|NCT01405456|HIV-infection|hiv-infection
407364|NCT01405456|eplerenone|eplerenone
407365|NCT01405456|aldosterone|aldosterone
407366|NCT01405456|visceral fat|visceral fat
407367|NCT01405456|lipodystrophy|lipodystrophy
407368|NCT01405443|Simulator training|simulator training
407369|NCT01405443|Flexible endoscopy|flexible endoscopy
407370|NCT01405443|Gastrointestinal endoscopy|gastrointestinal endoscopy
407371|NCT01405443|Colonoscopy|colonoscopy
407372|NCT01405443|Training|training
407373|NCT01405443|Performance|performance
407374|NCT01405417|Achalasia|achalasia
407375|NCT01405417|Heller myotomy|heller myotomy
407376|NCT01405417|Dysphagia|dysphagia
407377|NCT01405417|Peroral Endoscopic Myotomy|peroral endoscopic myotomy
407378|NCT01405404|parenting childcare discounts child behavior|parenting childcare discounts child behavior
407379|NCT01405404|No Intervention Control|no intervention control
407380|NCT01405404|Intervention no childcare discount|intervention no childcare discount
407381|NCT01405404|Intervention with childcare discount|intervention with childcare discount
407382|NCT01405391|Pharma Mar|pharma mar
407383|NCT01405391|PM01183|pm01183
407384|NCT01405391|Non-Colorectal Cancer (non-CRC)|non-colorectal cancer (non-crc)
407385|NCT01405391|Dose finding phase I|dose finding phase i
407386|NCT01405365|Periodontitis|periodontitis
407387|NCT01405365|Periodontal diseases|periodontal diseases
407388|NCT01405365|Obesity|obesity
407389|NCT01405365|Metronidazole|metronidazole
407390|NCT01405365|Prognosis|prognosis
407391|NCT01405365|Probing depth|probing depth
407392|NCT01405365|Periodontal attachment loss|periodontal attachment loss
407393|NCT01405352|obesity|obesity
407394|NCT01405352|vitamin A|vitamin a
407395|NCT01405352|immune system|immune system
407396|NCT01405326|rheumatoid arthritis|rheumatoid arthritis
407397|NCT01405326|biological therapy|biological therapy
407398|NCT01405326|adalimumab|adalimumab
407399|NCT01405326|ability to work|ability to work
407400|NCT01405326|sick leaves|sick leaves
407401|NCT01405287|stent|stent
407402|NCT01405287|drug eluting stent|drug eluting stent
407403|NCT01405287|healing|healing
407404|NCT01405287|endothelium|endothelium
407405|NCT01405287|DES|des
407406|NCT01405287|OCT|oct
407407|NCT01405287|MI|mi
407408|NCT01405287|ACS|acs
407409|NCT01405248|Butylphthalide|butylphthalide
407410|NCT01405235|Paclitaxel/Topotecan|paclitaxel/topotecan
407411|NCT01405235|Cisplatin/Topotecan|cisplatin/topotecan
407412|NCT01405222|exacerbation|exacerbation
407413|NCT01405222|COPD|copd
407414|NCT01405222|Cough|cough
407415|NCT01405209|EKG|ekg
407416|NCT01405209|AF|af
407417|NCT01405209|biosignals|biosignals
407418|NCT01405196|double-blind|double-blind
407419|NCT01405196|placebo-controlled|placebo-controlled
407420|NCT01405196|multicenter|multicenter
407421|NCT01405196|dose-ranging|dose-ranging
407422|NCT01405196|efficacy|efficacy
407423|NCT01405196|safety|safety
407424|NCT01405196|lupus.|lupus.
407425|NCT01405183|Hepatitis C|hepatitis c
407426|NCT01405183|Renal Cell Carcinoma|renal cell carcinoma
407427|NCT01405183|Colorectal Cancer|colorectal cancer
407428|NCT01405170|bioequivalence study|bioequivalence study
407429|NCT01405170|methylprednisolone|methylprednisolone
407430|NCT01405170|suspension|suspension
407431|NCT01405170|tablets|tablets
407432|NCT01405170|fed|fed
407433|NCT01405157|bioequivalence study|bioequivalence study
407434|NCT01405157|methylprednisolone|methylprednisolone
407435|NCT01405157|suspension|suspension
407436|NCT01405157|tablets|tablets
407437|NCT01405157|fasting|fasting
407438|NCT01405144|Photoaging|photoaging
407439|NCT01405144|Actinic keratosis|actinic keratosis
407440|NCT01405144|5-fluoruracil|5-fluoruracil
407441|NCT01405144|Carcinogenesis|carcinogenesis
407442|NCT01405131|bioequivalence study|bioequivalence study
407443|NCT01405131|methylprednisolone|methylprednisolone
407444|NCT01405131|suspension|suspension
407445|NCT01405131|tablets|tablets
407446|NCT01405118|Drug-Drug Interaction Healthy Volunteers CP-690|drug-drug interaction healthy volunteers cp-690
407447|NCT01405118|550 Metformin|550 metformin
407448|NCT01405092|volume|volume
407449|NCT01405092|acute kidney injury|acute kidney injury
407450|NCT01405092|continuous renal replacement|continuous renal replacement
407451|NCT01405079|Lung cancer|lung cancer
407452|NCT01405079|II-IIIA(N1-N2)|ii-iiia(n1-n2)
407453|NCT01405079|Adjuvant treatment|adjuvant treatment
407454|NCT01405079|EGFR mutations|egfr mutations
407455|NCT01405079|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
407456|NCT01405066|Computed Tomography (CT)|computed tomography (ct)
407457|NCT01405066|Ionizing radiation|ionizing radiation
407458|NCT01405066|Advanced medical imaging|advanced medical imaging
407459|NCT01405066|Radiation Dose Audit Reports|radiation dose audit reports
407460|NCT01405053|Central Nervous System|central nervous system
407461|NCT01405040|Cardiac|cardiac
407462|NCT01405040|Output|output
407463|NCT01405040|Preload|preload
407464|NCT01405040|Lung|lung
407465|NCT01405040|Water|water
407466|NCT01405027|HCV|hcv
407467|NCT01405027|Genotype1|genotype1
407468|NCT01405027|Naive|naive
407469|NCT01405027|Partial responder|partial responder
407470|NCT01405027|Relapser|relapser
407471|NCT01405014|Hold Me Tight|hold me tight
407472|NCT01405014|Emotionally Focused Therapy|emotionally focused therapy
407473|NCT01405014|Relationship enhancement|relationship enhancement
407474|NCT01405014|Couples counseling|couples counseling
407475|NCT01405014|Marital therapy|marital therapy
407476|NCT01405014|Acquired brain injury|acquired brain injury
407477|NCT01405014|Traumatic brain injury|traumatic brain injury
407478|NCT01405014|Stroke|stroke
407479|NCT01405001|Emergencies|emergencies
407480|NCT01405001|War|war
407481|NCT01405001|Intubation, Intratracheal|intubation, intratracheal
407482|NCT01404988|Heart Failure|heart failure
407483|NCT01404988|Telemedicine|telemedicine
407484|NCT01404988|Medication Adherence|medication adherence
407485|NCT01404975|Delirium|delirium
407486|NCT01404975|PVB|pvb
407487|NCT01404975|PCA|pca
407488|NCT01404975|Opioid|opioid
407489|NCT01404975|Aortic Valve replacement|aortic valve replacement
407490|NCT01404962|Haemophilus influenza type b|haemophilus influenza type b
407491|NCT01404962|children|children
407492|NCT01404962|Korea|korea
407493|NCT01404962|vaccine|vaccine
407494|NCT01404962|Prevention of haemophilus influenza type b|prevention of haemophilus influenza type b
407495|NCT01404949|Tretinoin|tretinoin
407496|NCT01404949|all-trans retinoic acid|all-trans retinoic acid
407497|NCT01404949|ATRA|atra
407498|NCT01404949|Vesanoid|vesanoid
407499|NCT01404949|Arsenic Trioxide|arsenic trioxide
407500|NCT01404949|ATO|ato
407501|NCT01404949|Trisenox|trisenox
407502|NCT01404949|11-040|11-040
407503|NCT01404936|Lymphoma|lymphoma
407504|NCT01404936|Hodgkin's Disease|hodgkin's disease
407505|NCT01404936|Stage III and IV|stage iii and iv
407506|NCT01404936|Adriamycin|adriamycin
407507|NCT01404936|Doxorubicin|doxorubicin
407508|NCT01404936|Rubex|rubex
407509|NCT01404936|Bleomycin|bleomycin
407510|NCT01404936|Bleomycin Sulfate|bleomycin sulfate
407511|NCT01404936|BLM|blm
407512|NCT01404936|Dacarbazine|dacarbazine
407513|NCT01404936|DTIC-DOME|dtic-dome
407514|NCT01404936|Interferon-2A|interferon-2a
407515|NCT01404936|Interferon-Alfa-2a|interferon-alfa-2a
407516|NCT01404936|Roferon-A|roferon-a
407517|NCT01404936|Velban|velban
407518|NCT01404936|Vinblastine|vinblastine
407519|NCT01404910|Pregnancy|pregnancy
407520|NCT01404910|Preeclampsia|preeclampsia
407521|NCT01404910|Pre-term|pre-term
407522|NCT01404910|sFlt-1|sflt-1
407523|NCT01404910|Apheresis|apheresis
407524|NCT01404910|Hypertension|hypertension
407525|NCT01404910|Proteinuria|proteinuria
407526|NCT01404910|VEGF|vegf
407527|NCT01404897|carbohydrate|carbohydrate
407528|NCT01404897|DASH diet|dash diet
407529|NCT01404897|blood pressure|blood pressure
407530|NCT01404897|cholesterol|cholesterol
407531|NCT01404884|myopia|myopia
407532|NCT01404884|astigmatism|astigmatism
407533|NCT01404884|presbyopia|presbyopia
407534|NCT01404884|SUPRACOR|supracor
407535|NCT01404884|multifocal|multifocal
407536|NCT01404871|OCD|ocd
407537|NCT01404871|pharmacogenetics|pharmacogenetics
407538|NCT01404871|cortical inhibition|cortical inhibition
407539|NCT01404871|genetics|genetics
407540|NCT01404858|IVF|ivf
407541|NCT01404858|Lifestyle habits|lifestyle habits
407542|NCT01404845|exudative AMD|exudative amd
407543|NCT01404845|dietary supplements|dietary supplements
407544|NCT01404845|macular pigment|macular pigment
407545|NCT01404845|lutein|lutein
407546|NCT01404845|zeaxanthin|zeaxanthin
407547|NCT01404845|Nutrof total|nutrof total
407548|NCT01404845|in one eye|in one eye
407549|NCT01404832|Gastroesophageal reflux|gastroesophageal reflux
407550|NCT01404832|Proton pump inhibitor|proton pump inhibitor
407551|NCT01404832|Eosinophilic esophagitis|eosinophilic esophagitis
407552|NCT01404793|Liver Transplantation|liver transplantation
407553|NCT01404793|Solid Phase Micro Extraction|solid phase micro extraction
407554|NCT01404793|Rocuronium|rocuronium
407555|NCT01404793|Metabolomics|metabolomics
407556|NCT01404793|Pharmacokinetics|pharmacokinetics
407557|NCT01404793|Clinical Marker|clinical marker
407558|NCT01404780|Double lumen ET intubation|double lumen et intubation
407559|NCT01404780|Laryngoscope|laryngoscope
407560|NCT01404780|Lung Surgery|lung surgery
407561|NCT01404767|Vascular surgery|vascular surgery
407562|NCT01404767|esmolol|esmolol
407563|NCT01404767|hemodynamic control|hemodynamic control
407564|NCT01404754|MDMA|mdma
407565|NCT01404754|mood|mood
407566|NCT01404754|subjective effects|subjective effects
407567|NCT01404754|interpersonal closeness|interpersonal closeness
407568|NCT01404741|MDS|mds
407569|NCT01404741|CMML|cmml
407570|NCT01404741|allogeneic stem cell transplantation|allogeneic stem cell transplantation
407571|NCT01404741|5-azacytidine|5-azacytidine
407572|NCT01404728|Vaginal length|vaginal length
407573|NCT01404728|Sexual dysfunction|sexual dysfunction
407574|NCT01404715|Drug drug interaction|drug drug interaction
407575|NCT01404702|Neuroblastoma|neuroblastoma
407576|NCT01404702|Pediatrics|pediatrics
407577|NCT01404702|Refractory|refractory
407578|NCT01404702|Immunotherapy|immunotherapy
407579|NCT01404702|Biological therapy|biological therapy
407580|NCT01404702|Lymphocytes|lymphocytes
407581|NCT01404702|Cancer|cancer
407582|NCT01404702|Bisphosphonate|bisphosphonate
407583|NCT01404689|dexmedetomidine|dexmedetomidine
407584|NCT01404689|midazolam|midazolam
407585|NCT01404689|ERCP|ercp
407586|NCT01404689|cholangiopancreatography|cholangiopancreatography
407587|NCT01404689|sedation|sedation
407588|NCT01404689|propofol|propofol
407589|NCT01404676|Glucose variability|glucose variability
407590|NCT01404676|Oxidative stress|oxidative stress
407591|NCT01404676|Endothelial cell function|endothelial cell function
407592|NCT01404663|bone marrow CD133 transplantation side effects|bone marrow cd133 transplantation side effects
407593|NCT01404663|side effects|side effects
407594|NCT01404650|GIST|gist
407595|NCT01404650|Refractory|refractory
407596|NCT01404650|Gastrointestinal|gastrointestinal
407597|NCT01404650|Stromal|stromal
407598|NCT01404650|Tumor|tumor
407599|NCT01404611|with tubes|with tubes
407600|NCT01404559|Amputee|amputee
407601|NCT01404559|Transtibial|transtibial
407602|NCT01404559|Military|military
407603|NCT01404559|Gait|gait
407604|NCT01404559|Rehabilitation|rehabilitation
407605|NCT01404546|stroke smoking cessation cost-free pharmacotherapy|stroke smoking cessation cost-free pharmacotherapy
407606|NCT01404533|NTBI|ntbi
407607|NCT01404533|Iron|iron
407608|NCT01404533|Absorption|absorption
407609|NCT01404520|#14 Cancer Related fatigue|#14 cancer related fatigue
407610|NCT01404520|#13 Quality of Life|#13 quality of life
407611|NCT01404520|"#12 Psychosocial Intervention[ti/ab]"|"#12 psychosocial intervention[ti/ab]"
407612|NCT01404520|#11 Rehabilitation[tw]|#11 rehabilitation[tw]
407613|NCT01404520|"#10 Physical Fitness[tw]"|"#10 physical fitness[tw]"
407614|NCT01404520|"#9 Physical Activity[tw]"|"#9 physical activity[tw]"
407615|NCT01404520|"#8 Exercise Therapy[tw]"|"#8 exercise therapy[tw]"
407616|NCT01404520|#7 Exercise[tw]|#7 exercise[tw]
407617|NCT01404520|#6 Hematologic[tw]|#6 hematologic[tw]
407618|NCT01404520|#5 Hematological[tw]|#5 hematological[tw]
407619|NCT01404520|#4 Leukemia, Myeloid, Acute[mh]|#4 leukemia, myeloid, acute[mh]
407620|NCT01404520|"#3 Acute Myeloid Leukemia[tw]"|"#3 acute myeloid leukemia[tw]"
407621|NCT01404520|"#2 Acute Lymphoblastic Leukemia[tw]"|"#2 acute lymphoblastic leukemia[tw]"
407622|NCT01404520|"#1 Acute Leukemia[tw]"|"#1 acute leukemia[tw]"
407623|NCT01404507|Acute Myocardial Infarction|acute myocardial infarction
407624|NCT01404494|Haptic Skills|haptic skills
407625|NCT01404494|Computer Assisted Interface|computer assisted interface
407626|NCT01404494|TBI|tbi
407627|NCT01404494|Traumatic Brain Injury|traumatic brain injury
407628|NCT01404481|Urinary retention|urinary retention
407629|NCT01404481|CISC|cisc
407630|NCT01404481|Single use|single use
407631|NCT01404481|Re use|re use
407632|NCT01404442|midazolam|midazolam
407633|NCT01404442|ketamine|ketamine
407634|NCT01404442|intrathecal|intrathecal
407635|NCT01404442|pain|pain
407636|NCT01404429|Rheumatoid arthritis|rheumatoid arthritis
407637|NCT01404429|Active|active
407638|NCT01404390|Phase I|phase i
407639|NCT01404390|Japanese|japanese
407640|NCT01404377|breast surgery : postoperative pain; ropivacaine|breast surgery : postoperative pain; ropivacaine
407641|NCT01404364|Triamcinolone|triamcinolone
407642|NCT01404364|Chlorpromazine|chlorpromazine
407643|NCT01404364|Refractory glaucoma|refractory glaucoma
407644|NCT01404364|Blind painful eye|blind painful eye
407645|NCT01404351|Reduction mammaplasty|reduction mammaplasty
407646|NCT01404351|Breast reduction|breast reduction
407647|NCT01404351|PlasmaBlade|plasmablade
407648|NCT01404351|PEAK|peak
407649|NCT01404325|Lung transplantation|lung transplantation
407650|NCT01404325|everolimus|everolimus
407651|NCT01404325|kidney function|kidney function
407652|NCT01404299|Frailty,|frailty,
407653|NCT01404299|nutritional supplementation,|nutritional supplementation,
407654|NCT01404299|functional status|functional status
407655|NCT01404260|chemotherapy|chemotherapy
407656|NCT01404260|maintenance therapy|maintenance therapy
407657|NCT01404260|gefitinib|gefitinib
407658|NCT01404247|retina|retina
407659|NCT01404247|optic nerve|optic nerve
407660|NCT01404247|fovea|fovea
407661|NCT01404247|Eyes|eyes
407662|NCT01404247|Neonates|neonates
407663|NCT01404234|Cystic fibrosis|cystic fibrosis
407664|NCT01404234|CF|cf
407665|NCT01404234|PA|pa
407666|NCT01404234|Pseudomonas aeruginosa|pseudomonas aeruginosa
407667|NCT01404234|AZLI|azli
407668|NCT01404234|aztreonam|aztreonam
407669|NCT01404234|Chronic Pseudomonas aeruginosa|chronic pseudomonas aeruginosa
407670|NCT01404195|Nutritional supplement|nutritional supplement
407671|NCT01404195|CaHMB|cahmb
407672|NCT01404195|Barthel index|barthel index
407673|NCT01404195|Frailty|frailty
407674|NCT01404182|seasonal|seasonal
407675|NCT01404182|prevention|prevention
407676|NCT01404182|influenza|influenza
407677|NCT01404182|infection|infection
407678|NCT01404182|influenza vaccine|influenza vaccine
407679|NCT01404182|vaccine|vaccine
407680|NCT01404182|influenza in humans|influenza in humans
407681|NCT01404169|Alzheimer Disease|alzheimer disease
407682|NCT01404169|Dementia|dementia
407683|NCT01404169|Delirium|delirium
407684|NCT01404169|Amnestic|amnestic
407685|NCT01404169|Cognitive Disorders|cognitive disorders
407686|NCT01404169|Donepezil|donepezil
407687|NCT01404169|Brain Diseases|brain diseases
407688|NCT01404169|Central Nervous System Diseases|central nervous system diseases
407689|NCT01404169|Nervous System Diseases|nervous system diseases
407690|NCT01404169|Tauopathies|tauopathies
407691|NCT01404169|Neurodegenerative Diseases|neurodegenerative diseases
407692|NCT01404169|Mental Disorders|mental disorders
407693|NCT01404169|Cholinesterase Inhibitors|cholinesterase inhibitors
407694|NCT01404169|Enzy|enzy
407695|NCT01404156|Esophageal cancer|esophageal cancer
407696|NCT01404156|Neoadjuvant|neoadjuvant
407697|NCT01404156|Chemotherapy|chemotherapy
407698|NCT01404156|Chemoradiation|chemoradiation
407699|NCT01404156|Surgery|surgery
407700|NCT01404156|Esophagectomy|esophagectomy
407701|NCT01404156|Adenocarcinoma|adenocarcinoma
407702|NCT01404156|Gastroesophageal|gastroesophageal
407703|NCT01404130|isotretinoin|isotretinoin
407704|NCT01404130|hippocampus|hippocampus
407705|NCT01404130|memory|memory
407706|NCT01404130|learning|learning
407707|NCT01404130|CANTAB|cantab
407708|NCT01404065|transcranial direct current stimulation|transcranial direct current stimulation
407709|NCT01404052|transcranial direct current stimulation|transcranial direct current stimulation
407710|NCT01404052|transcranial ultrasound|transcranial ultrasound
407711|NCT01404039|learning|learning
407712|NCT01404039|pain perception|pain perception
407713|NCT01404026|Transcranial Direct Current Stimulation|transcranial direct current stimulation
407714|NCT01404013|Montelukast|montelukast
407715|NCT01404013|Cough variant asthma|cough variant asthma
407716|NCT01404013|Inhaled Corticosteroid|inhaled corticosteroid
407717|NCT01403987|Education|education
407718|NCT01403987|Ascites|ascites
407719|NCT01403987|Liver|liver
407720|NCT01403987|Guidelines|guidelines
407721|NCT01403922|Phase I, Randomised, Placebo-Controlled, Double-Blind,Hypertensive Patients, Blood Pressure, Calcium Channel Blockers, Beta Blockers, ACE Inhibitors|phase i, randomised, placebo-controlled, double-blind,hypertensive patients, blood pressure, calcium channel blockers, beta blockers, ace inhibitors
407722|NCT01403922|Scientific terminology: To determine if treatment with TC5214 alone or in combination with Anti-Hypertensive Medications has an effect on sitting blood pressure|scientific terminology: to determine if treatment with tc5214 alone or in combination with anti-hypertensive medications has an effect on sitting blood pressure
407723|NCT01403922|Laymen terminology: Hypertension|laymen terminology: hypertension
407724|NCT01403896|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
407725|NCT01403896|Plerixafor|plerixafor
407726|NCT01403896|Healthy Donors|healthy donors
407727|NCT01403896|Stem Cell Graft|stem cell graft
407728|NCT01403883|Rectal cancer|rectal cancer
407729|NCT01403883|Temporary stoma|temporary stoma
407730|NCT01403883|Psychological disorders|psychological disorders
407731|NCT01403870|Low Back Pain|low back pain
407732|NCT01403857|Acceptability|acceptability
407733|NCT01403857|liking|liking
407734|NCT01403844|resonance Raman spectroscopy|resonance raman spectroscopy
407735|NCT01403844|Dietary Guidelines|dietary guidelines
407736|NCT01403844|fruits|fruits
407737|NCT01403844|biomarkers|biomarkers
407738|NCT01403844|carotenoids|carotenoids
407739|NCT01403844|MyPlate|myplate
407740|NCT01403844|vegetables|vegetables
407741|NCT01403818|ASP1941|asp1941
407742|NCT01403818|ipragliflozin|ipragliflozin
407743|NCT01403818|Mitiglinide calcium hydrate|mitiglinide calcium hydrate
407744|NCT01403818|Drug-Drug interaction|drug-drug interaction
407745|NCT01403818|Pharmacokinetics|pharmacokinetics
407746|NCT01403805|Oral care|oral care
407747|NCT01403805|Vaccine|vaccine
407748|NCT01403805|Pneumonia|pneumonia
407749|NCT01403805|Elderly|elderly
407750|NCT01403805|Prevention|prevention
407751|NCT01403805|Primary care|primary care
407752|NCT01403792|Human Immunodeficiency Virus|human immunodeficiency virus
407753|NCT01403792|Neutralising monoclonal antibody|neutralising monoclonal antibody
407754|NCT01403779|Intensity-Modulated Radiation Therapy (IMRT)|intensity-modulated radiation therapy (imrt)
407755|NCT01403779|Breast cancer|breast cancer
407756|NCT01403779|Hypofractionation|hypofractionation
407757|NCT01403766|pediatric|pediatric
407758|NCT01403766|kidney|kidney
407759|NCT01403766|transplant|transplant
407760|NCT01403766|GFR|gfr
407761|NCT01403766|creatinine|creatinine
407762|NCT01403766|cystatin C|cystatin c
407764|NCT01403753|Obesity|obesity
407765|NCT01403753|Child|child
407766|NCT01403753|Dietary Habits|dietary habits
407767|NCT01403740|acquired haemophilia|acquired haemophilia
407768|NCT01403740|factor VIII|factor viii
407769|NCT01403727|Biopsy of liver tumors|biopsy of liver tumors
407770|NCT01403714|acute heart failure|acute heart failure
407771|NCT01403701|physical therapy|physical therapy
407772|NCT01403701|pelvic prolapse|pelvic prolapse
407773|NCT01403701|incontinence|incontinence
407774|NCT01403701|quality of life|quality of life
407775|NCT01403688|fertility high risk, controlled ovarian stimulation, breast cancer|fertility high risk, controlled ovarian stimulation, breast cancer
407776|NCT01403675|women with cancer whose ovarian tissue has been collected and stored in liquid nitrogen before cancer therapy (surgery, chemotherapy, radiotherapy),|women with cancer whose ovarian tissue has been collected and stored in liquid nitrogen before cancer therapy (surgery, chemotherapy, radiotherapy),
407777|NCT01403675|who are in remission (no recurrence of disease for 5 years),|who are in remission (no recurrence of disease for 5 years),
407778|NCT01403675|who are in normal organ function and have no contraindication for surgery or pregnancy, and|who are in normal organ function and have no contraindication for surgery or pregnancy, and
407779|NCT01403675|who wish to restore ovarian function using stored ovarian tissue.|who wish to restore ovarian function using stored ovarian tissue.
407780|NCT01403662|bipolar disorder|bipolar disorder
407781|NCT01403662|depression|depression
407782|NCT01403662|major depression|major depression
407783|NCT01403662|bipolar I depression|bipolar i depression
407784|NCT01403662|bipolar II depression|bipolar ii depression
407785|NCT01403662|bipolar I disorder|bipolar i disorder
407786|NCT01403662|bipolar II disorder|bipolar ii disorder
407787|NCT01403662|minocycline|minocycline
407788|NCT01403662|minocin|minocin
407789|NCT01403623|Hypothermia|hypothermia
407790|NCT01403623|Newborn|newborn
407791|NCT01403623|Resuscitation|resuscitation
407792|NCT01403623|Plastic bag|plastic bag
407793|NCT01403610|TH-302|th-302
407794|NCT01403610|Bevacizumab|bevacizumab
407795|NCT01403610|Phase 2|phase 2
407796|NCT01403610|Glioma|glioma
407797|NCT01403610|High Grade Glioma|high grade glioma
407798|NCT01403610|CNS|cns
407799|NCT01403597|Skin wrinkling|skin wrinkling
407800|NCT01403597|Skin aging|skin aging
407801|NCT01403597|Skin pigmentation|skin pigmentation
407802|NCT01403545|Safety|safety
407803|NCT01403545|Tolerability|tolerability
407804|NCT01403545|Pharmacokinetics|pharmacokinetics
407805|NCT01403545|Liposomal Curcumin|liposomal curcumin
407806|NCT01403532|Hypogonadotropic Hypogonadism|hypogonadotropic hypogonadism
407807|NCT01403532|Kallmann Syndrome|kallmann syndrome
407808|NCT01403532|LH|lh
407809|NCT01403532|FSH|fsh
407810|NCT01403506|kidney transplantation|kidney transplantation
407811|NCT01403506|N-Acetyl Cysteine|n-acetyl cysteine
407812|NCT01403506|living donor|living donor
407813|NCT01403506|delayed graft function|delayed graft function
407814|NCT01403493|Irritable bowel syndrome|irritable bowel syndrome
407815|NCT01403493|Patient education|patient education
407816|NCT01403480|Basal Cell Carcinoma|basal cell carcinoma
407817|NCT01403467|Bronchial disease|bronchial disease
407818|NCT01403467|asthma|asthma
407819|NCT01403467|continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
407820|NCT01403467|Bronchoconstriction|bronchoconstriction
407821|NCT01403454|chronic kidney disease|chronic kidney disease
407822|NCT01403454|web-based application|web-based application
407823|NCT01403454|dialysis education|dialysis education
407824|NCT01403441|Refractory Bipolar Depression|refractory bipolar depression
407825|NCT01403428|Asthma|asthma
407826|NCT01403428|non invasive ventilation|non invasive ventilation
407827|NCT01403428|pediatrics|pediatrics
407828|NCT01403428|noninvasive positive pressure ventilation (NPPV)|noninvasive positive pressure ventilation (nppv)
407829|NCT01403402|Congenital Muscular Dystrophy|congenital muscular dystrophy
407830|NCT01403402|Congenital Myopathy|congenital myopathy
407831|NCT01403402|Neuromuscular Diseases|neuromuscular diseases
407832|NCT01403402|Musculoskeletal Diseases|musculoskeletal diseases
407833|NCT01403389|Kidney Transplant|kidney transplant
407834|NCT01403389|Delayed Graft Function|delayed graft function
407835|NCT01403350|Malaria|malaria
407836|NCT01403350|Fever|fever
407837|NCT01403350|Acute febrile illness|acute febrile illness
407838|NCT01403350|Pneumonia|pneumonia
407839|NCT01403350|Community health worker|community health worker
407840|NCT01403350|Rapid diagnostic test|rapid diagnostic test
407841|NCT01403337|peripheral arterial disease|peripheral arterial disease
407842|NCT01403337|myocardial infarction|myocardial infarction
407843|NCT01403324|metastatic or locally advanced differentiated thyroid cancer|metastatic or locally advanced differentiated thyroid cancer
407844|NCT01403324|planned for a therapeutic activity of 131I after thyroid hormone withdrawal|planned for a therapeutic activity of 131i after thyroid hormone withdrawal
407845|NCT01403311|Anaplastic astrocytoma|anaplastic astrocytoma
407846|NCT01403311|Astrocytoma|astrocytoma
407847|NCT01403311|Brain stem glioma|brain stem glioma
407848|NCT01403311|Ependymoma|ependymoma
407849|NCT01403311|Glioblastoma|glioblastoma
407850|NCT01403311|Glioblastoma multiforme|glioblastoma multiforme
407851|NCT01403311|Gliosarcoma|gliosarcoma
407852|NCT01403311|oligodendroglioma|oligodendroglioma
408055|NCT01402531|Bevacizumab|bevacizumab
407853|NCT01403311|Medulloblastoma|medulloblastoma
407854|NCT01403311|Mixed astrocytoma-ependymoma|mixed astrocytoma-ependymoma
407855|NCT01403311|ALA|ala
407856|NCT01403298|Adolescent|adolescent
407857|NCT01403298|HIV|hiv
407858|NCT01403298|AIDS|aids
407859|NCT01403298|Sexual risk|sexual risk
407860|NCT01403298|Family|family
407861|NCT01403298|Prevention|prevention
407862|NCT01403298|Juvenile Drug Court|juvenile drug court
407863|NCT01403298|Juvenile Justice|juvenile justice
407864|NCT01403298|Drug Use|drug use
407865|NCT01403298|Marijuana|marijuana
407866|NCT01403285|Glioblastoma|glioblastoma
407867|NCT01403285|stable disease|stable disease
407868|NCT01403272|pressure ulcers|pressure ulcers
407869|NCT01403272|stage 1|stage 1
407870|NCT01403272|stage 2|stage 2
407871|NCT01403272|stage 3|stage 3
407872|NCT01403272|stage 4|stage 4
407873|NCT01403272|wounds|wounds
407874|NCT01403272|sores|sores
407875|NCT01403272|infection|infection
407876|NCT01403272|bioburden|bioburden
407877|NCT01403272|bacterial contamination|bacterial contamination
407878|NCT01403272|bed linen|bed linen
407879|NCT01403272|sheets|sheets
407880|NCT01403272|underpad|underpad
407881|NCT01403272|skin assessment|skin assessment
407882|NCT01403272|microclimate|microclimate
407883|NCT01403272|shear|shear
407884|NCT01403272|friction|friction
407885|NCT01403272|moisture|moisture
407886|NCT01403272|fabrics|fabrics
407887|NCT01403272|long term care|long term care
407888|NCT01403272|nursing home|nursing home
407889|NCT01403272|decubitus ulcer|decubitus ulcer
407890|NCT01403272|bed ridden|bed ridden
407891|NCT01403272|anti-microbial|anti-microbial
407892|NCT01403259|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
407893|NCT01403259|S-1|s-1
407894|NCT01403259|Oxaliplatin|oxaliplatin
407895|NCT01403246|CLL|cll
407896|NCT01403246|Lenalidomide|lenalidomide
407897|NCT01403246|Chlorambucil|chlorambucil
407898|NCT01403246|No previous treatment|no previous treatment
407899|NCT01403233|Pharmacokinetics|pharmacokinetics
407900|NCT01403233|Safety|safety
407901|NCT01403207|Sex differences|sex differences
407902|NCT01403207|knee joint|knee joint
407903|NCT01403207|inflammatory mediators|inflammatory mediators
407904|NCT01403207|Vitamin D|vitamin d
407905|NCT01403207|osteoarthritis|osteoarthritis
407906|NCT01403194|Sleep Disordered Breathing|sleep disordered breathing
407907|NCT01403194|CPAP|cpap
407908|NCT01403194|BiPAP|bipap
407909|NCT01403194|Cardiovascular risk markers|cardiovascular risk markers
407910|NCT01403181|HCV|hcv
407911|NCT01403181|T cells|t cells
407912|NCT01403181|cytokines|cytokines
407913|NCT01403181|cytotoxicity|cytotoxicity
407914|NCT01403181|proliferation|proliferation
407915|NCT01403168|Osteopathy|osteopathy
407916|NCT01403168|Breast cancer|breast cancer
407917|NCT01403168|Pain|pain
407918|NCT01403155|H5N1|h5n1
407919|NCT01403155|Avian Influenza|avian influenza
407920|NCT01403155|DNA Vaccine|dna vaccine
407921|NCT01403155|Intradermal (ID) Injection|intradermal (id) injection
407922|NCT01403155|Electroporation|electroporation
407923|NCT01403155|Healthy Adults|healthy adults
407924|NCT01403142|heart transplant|heart transplant
407925|NCT01403142|vasculopathy|vasculopathy
407926|NCT01403129|keratoconus|keratoconus
407927|NCT01403129|keratoconus-suspect|keratoconus-suspect
407928|NCT01403129|ultrasound exam|ultrasound exam
407929|NCT01403129|acoustic radiation force ultrasound exam|acoustic radiation force ultrasound exam
407930|NCT01403116|testosterone|testosterone
407931|NCT01403116|male hypogonadism|male hypogonadism
407932|NCT01403116|low testosterone|low testosterone
407933|NCT01403090|Pulmonary Embolism|pulmonary embolism
407934|NCT01403090|Deep Vein Thrombosis|deep vein thrombosis
407935|NCT01403090|Venous Thromboembolism|venous thromboembolism
407936|NCT01403090|Central Line Catheter|central line catheter
407937|NCT01403090|Vena Cava Filters|vena cava filters
407938|NCT01403077|Superficial femoral artery|superficial femoral artery
407939|NCT01403077|Peripheral arterial disease|peripheral arterial disease
407940|NCT01403077|Atherosclerosis|atherosclerosis
407941|NCT01403077|Intermittent Claudication|intermittent claudication
407942|NCT01403077|Vascular Diseases|vascular diseases
407943|NCT01403077|Cardiovascular Diseases|cardiovascular diseases
407944|NCT01403064|Oral mucositis; head and neck cancer; chemotherapy; radiotherapy|oral mucositis; head and neck cancer; chemotherapy; radiotherapy
407945|NCT01403038|healthy volunteers|healthy volunteers
407946|NCT01403038|elagolix|elagolix
407947|NCT01403038|endometriosis|endometriosis
407948|NCT01403038|ovarian reserve|ovarian reserve
407949|NCT01403038|gonadotropin-releasing hormone antagonist|gonadotropin-releasing hormone antagonist
407950|NCT01403038|ovulation|ovulation
407951|NCT01403038|ovarian activity|ovarian activity
407952|NCT01403012|To identify clinical and metabolomic markers that underlie variability in response to systemic therapy in psoriasis|to identify clinical and metabolomic markers that underlie variability in response to systemic therapy in psoriasis
407953|NCT01403012|To identify metabolomic signatures associated with psoriasis|to identify metabolomic signatures associated with psoriasis
408056|NCT01402531|Avastin|avastin
408057|NCT01402518|achalasia|achalasia
407954|NCT01403012|To identify possible treatment-specific metabolomic signatures|to identify possible treatment-specific metabolomic signatures
407955|NCT01402999|Growth disorders|growth disorders
407956|NCT01402999|Saizen|saizen
407957|NCT01402999|Easypod|easypod
407958|NCT01402999|Growth hormone|growth hormone
407959|NCT01402999|Pediatric subject|pediatric subject
407960|NCT01402986|Asthma|asthma
407961|NCT01402986|Tralokinumab|tralokinumab
407962|NCT01402986|CAT-354|cat-354
407963|NCT01402960|High-Definition Transcranial Direct Current Stimulation|high-definition transcranial direct current stimulation
407964|NCT01402908|Hepatocellular Carcinoma|hepatocellular carcinoma
407965|NCT01402908|PI-88|pi-88
407966|NCT01402908|Phase III|phase iii
407967|NCT01402908|Adjuvant Therapy|adjuvant therapy
407968|NCT01402908|Hepatoma|hepatoma
407969|NCT01402908|Liver Cancer|liver cancer
407970|NCT01402895|Nerve conduction|nerve conduction
407971|NCT01402895|H-reflex, mobilizations|h-reflex, mobilizations
407972|NCT01402895|with neurodynamic component|with neurodynamic component
407973|NCT01402882|traumatic brain injury|traumatic brain injury
407974|NCT01402882|tranexamic acid|tranexamic acid
407975|NCT01402882|antifibrinolytic|antifibrinolytic
407976|NCT01402882|randomised|randomised
407977|NCT01402882|clinical trial|clinical trial
407978|NCT01402869|Methemoglobin|methemoglobin
407979|NCT01402869|Methemoglobinemia|methemoglobinemia
407980|NCT01402869|Prilocaine|prilocaine
407981|NCT01402869|Lidocaine|lidocaine
407982|NCT01402856|Prevention|prevention
407983|NCT01402856|Adolescent|adolescent
407984|NCT01402856|Trauma|trauma
407985|NCT01402856|Driving|driving
407986|NCT01402843|phase III combination study|phase iii combination study
407987|NCT01402830|cancer|cancer
407988|NCT01402830|depression|depression
407989|NCT01402830|pain|pain
407990|NCT01402817|NF1|nf1
407991|NCT01402817|plexiform neurofibromas|plexiform neurofibromas
407992|NCT01402817|Sunitinib|sunitinib
407993|NCT01402817|Sutent®|sutent®
407994|NCT01402739|PoC|poc
407995|NCT01402739|ROTEM|rotem
407996|NCT01402739|Multiplate|multiplate
407997|NCT01402739|transfusion|transfusion
407998|NCT01402739|cardiac surgery|cardiac surgery
407999|NCT01402739|drainage blood loss|drainage blood loss
408000|NCT01402739|chest tube output|chest tube output
408001|NCT01402726|renal artery|renal artery
408002|NCT01402726|sympathetic nerves|sympathetic nerves
408003|NCT01402726|modification|modification
408004|NCT01402726|heart failure|heart failure
408005|NCT01402700|Peripheral arterial disease|peripheral arterial disease
408006|NCT01402700|claudication|claudication
408007|NCT01402700|stent|stent
408008|NCT01402700|VISI-Pro|visi-pro
408009|NCT01402700|Iliac artery|iliac artery
408010|NCT01402687|Stem Cell Transplant|stem cell transplant
408011|NCT01402687|Mucositis|mucositis
408012|NCT01402674|Obesity treatment|obesity treatment
408013|NCT01402674|Phentermine|phentermine
408014|NCT01402674|Withholding treatment|withholding treatment
408015|NCT01402674|Phentermine dependence|phentermine dependence
408016|NCT01402661|rheumatoid arthritis|rheumatoid arthritis
408017|NCT01402661|psoriatic arthritis|psoriatic arthritis
408018|NCT01402661|disease registry|disease registry
408019|NCT01402648|Non adenomatous mucosa|non adenomatous mucosa
408020|NCT01402648|Estrogen Receptor beta and apoptosis|estrogen receptor beta and apoptosis
408021|NCT01402648|Adenoma recurrence|adenoma recurrence
408022|NCT01402648|Screening colonoscopy every 3-5 years|screening colonoscopy every 3-5 years
408023|NCT01402648|patients at intermediate risk for CRC|patients at intermediate risk for crc
408024|NCT01402635|crowding|crowding
408025|NCT01402635|Point-of-Care Systems|point-of-care systems
408026|NCT01402635|emergency medicine|emergency medicine
408027|NCT01402609|Continuity of care|continuity of care
408028|NCT01402609|Patient safety|patient safety
408029|NCT01402609|Communication between acute and community care providers|communication between acute and community care providers
408030|NCT01402596|Deep Sedation|deep sedation
408031|NCT01402596|Pediatrics|pediatrics
408032|NCT01402596|Emergency Hospital Services|emergency hospital services
408033|NCT01402596|Midazolam|midazolam
408034|NCT01402596|Chloral hydrate|chloral hydrate
408035|NCT01402596|Randomized controlled trial|randomized controlled trial
408036|NCT01402583|Hepatitis C|hepatitis c
408037|NCT01402583|Gender|gender
408038|NCT01402583|Menopause|menopause
408039|NCT01402583|Sustained viral response|sustained viral response
408040|NCT01402583|Cytokines|cytokines
408041|NCT01402570|disability|disability
408042|NCT01402570|polio|polio
408043|NCT01402570|rehabilitation|rehabilitation
408044|NCT01402570|wellness|wellness
408045|NCT01402557|Obesity|obesity
408046|NCT01402557|Body Weight Changes|body weight changes
408047|NCT01402557|Internet|internet
408048|NCT01402544|AMD|amd
408049|NCT01402544|Choroidal neovascularization|choroidal neovascularization
408050|NCT01402544|Ranibizumab|ranibizumab
408051|NCT01402544|Age-related Macular Degeneration|age-related macular degeneration
408052|NCT01402544|Genome|genome
408053|NCT01402531|Hereditary hemorrhagic telangiectasia (HHT)|hereditary hemorrhagic telangiectasia (hht)
408054|NCT01402531|nosebleed|nosebleed
408058|NCT01402518|myotomy|myotomy
408059|NCT01402518|endoscopic myotomy|endoscopic myotomy
408060|NCT01402518|difficulty swallowing|difficulty swallowing
408061|NCT01402505|obesity|obesity
408062|NCT01402505|sleeve gastrectomy|sleeve gastrectomy
408063|NCT01402505|transvaginal NOTES|transvaginal notes
408064|NCT01402492|Cocaine-Related disorders|cocaine-related disorders
408065|NCT01402492|Cocaine|cocaine
408066|NCT01402492|Substance-Related disorders|substance-related disorders
408067|NCT01402492|Opioid abuse|opioid abuse
408068|NCT01402492|Opioid dependence|opioid dependence
408069|NCT01402492|abuse|abuse
408070|NCT01402492|addiction|addiction
408071|NCT01402492|treatment|treatment
408072|NCT01402492|buprenorphine|buprenorphine
408073|NCT01402492|naltrexone|naltrexone
408074|NCT01402492|Suboxone|suboxone
408075|NCT01402492|Vivitrol|vivitrol
408076|NCT01402479|migraine,|migraine,
408077|NCT01402479|ramipril,|ramipril,
408078|NCT01402479|hypertension|hypertension
408079|NCT01402466|Drug users|drug users
408080|NCT01402466|criminal justice|criminal justice
408081|NCT01402466|HIV care|hiv care
408082|NCT01402466|HAART|haart
408083|NCT01402466|incarceration|incarceration
408084|NCT01402453|Incentives|incentives
408085|NCT01402453|Social psychology|social psychology
408086|NCT01402453|Randomized trial|randomized trial
408087|NCT01402453|Hypertension|hypertension
408088|NCT01402453|Intervention|intervention
408089|NCT01402453|Pilot Study|pilot study
408090|NCT01402440|Diffuse Large B-Cell Lymphoma,|diffuse large b-cell lymphoma,
408091|NCT01402440|Phase 1,|phase 1,
408092|NCT01402440|CD79 Mutation|cd79 mutation
408093|NCT01402427|Coronary Artery Disease|coronary artery disease
408094|NCT01402427|Coronary Angiography|coronary angiography
408095|NCT01402427|Percutaneous Coronary Intervention|percutaneous coronary intervention
408096|NCT01402427|Transradial|transradial
408097|NCT01402427|Radial Artery Spasm|radial artery spasm
408098|NCT01402427|Verapamil|verapamil
408099|NCT01402427|Adverse Effects|adverse effects
408100|NCT01402414|atopic dermatitis|atopic dermatitis
408101|NCT01402414|NB-UVB|nb-uvb
408102|NCT01402414|phototherapy|phototherapy
408103|NCT01402414|balneophototherapy|balneophototherapy
408104|NCT01402414|Bath-PUVA|bath-puva
408105|NCT01402414|SCORAD index|scorad index
408106|NCT01402401|HER2+,|her2+,
408107|NCT01402401|Gastric Cancer,|gastric cancer,
408108|NCT01402401|HSP90,|hsp90,
408109|NCT01402401|2nd-line,|2nd-line,
408110|NCT01402401|Trastuzumab|trastuzumab
408111|NCT01402375|Pain Management|pain management
408112|NCT01402375|Emergency Medicine|emergency medicine
408113|NCT01402375|Extremity Injuries|extremity injuries
408114|NCT01402362|Ethiopians|ethiopians
408115|NCT01402362|Diabetes Mellitus|diabetes mellitus
408116|NCT01402362|Glucose tolerance|glucose tolerance
408117|NCT01402362|Israel|israel
408118|NCT01402362|Included in the year 2000 study|included in the year 2000 study
408119|NCT01402349|Chronic rhinosinusitis, SNOT 22, Quality of life|chronic rhinosinusitis, snot 22, quality of life
408120|NCT01402336|Polycystic ovary syndrome|polycystic ovary syndrome
408121|NCT01402336|ovulation induction|ovulation induction
408122|NCT01402336|In vitro fertilization-embryo transfer|in vitro fertilization-embryo transfer
408123|NCT01402310|Onset of labor|onset of labor
408124|NCT01402310|Bishop score|bishop score
408125|NCT01402310|Cervical length|cervical length
408126|NCT01402310|Multiple proteins|multiple proteins
408127|NCT01402310|Cervicovaginal fluid|cervicovaginal fluid
408128|NCT01402297|apocynin|apocynin
408129|NCT01402297|COPD|copd
408130|NCT01402284|Novel Drug Combinations|novel drug combinations
408131|NCT01402284|Protease Inhibitors|protease inhibitors
408132|NCT01402284|Decreased Peripheral Neuropathy|decreased peripheral neuropathy
408133|NCT01402284|Auto Stem Cell Transplant|auto stem cell transplant
408134|NCT01402284|Multiple Myeloma|multiple myeloma
408135|NCT01402271|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
408136|NCT01402271|recurrent fallopian tube cancer|recurrent fallopian tube cancer
408137|NCT01402271|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
408138|NCT01402245|pneumonia|pneumonia
408139|NCT01402245|pneumococcal polysaccharide vaccine|pneumococcal polysaccharide vaccine
408140|NCT01402245|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
408141|NCT01402232|contrast-induced nephropathy|contrast-induced nephropathy
408142|NCT01402232|contrast medium|contrast medium
408143|NCT01402232|creatinine clearance|creatinine clearance
408144|NCT01402232|coronary angiography|coronary angiography
408145|NCT01402232|diabetes|diabetes
408146|NCT01402232|chronic kidney disease|chronic kidney disease
408147|NCT01402232|predictive model|predictive model
408148|NCT01402219|contrast-induced nephropathy|contrast-induced nephropathy
408149|NCT01402219|contrast medium|contrast medium
408150|NCT01402219|creatinine clearance|creatinine clearance
408151|NCT01402219|coronary angiography|coronary angiography
408152|NCT01402219|chronic kidney disease|chronic kidney disease
408153|NCT01402206|Depression|depression
408154|NCT01402206|Intervention|intervention
408155|NCT01402206|Primary health care|primary health care
408156|NCT01402193|Breast Cancer|breast cancer
408157|NCT01402193|Timing of Radiotherapy|timing of radiotherapy
408158|NCT01402193|TGF-beta1|tgf-beta1
408159|NCT01402180|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
408160|NCT01402180|lymph nodes recurrence|lymph nodes recurrence
408161|NCT01402180|chemoradiation|chemoradiation
408162|NCT01402180|Nimotuzumab|nimotuzumab
408163|NCT01402141|Chungkookjang|chungkookjang
408164|NCT01402141|histamine|histamine
408165|NCT01402141|skin reaction|skin reaction
408166|NCT01402141|wheal|wheal
408167|NCT01402128|Soluble fiber|soluble fiber
408168|NCT01402128|Polycan|polycan
408169|NCT01402128|Overweight|overweight
408170|NCT01402128|LDL-C(Low Density Lipoprotein-cholesterol)|ldl-c(low density lipoprotein-cholesterol)
408171|NCT01402115|Polycan|polycan
408172|NCT01402115|Bone metabolism|bone metabolism
408173|NCT01402115|Osteocalcin|osteocalcin
408174|NCT01402115|Deoxypyridinoline|deoxypyridinoline
408175|NCT01402102|Aged garlic|aged garlic
408176|NCT01402102|Hyperlipidemic|hyperlipidemic
408177|NCT01402102|LDL|ldl
408178|NCT01402102|HDL|hdl
408179|NCT01402102|Triglyceride|triglyceride
408180|NCT01402089|phenotyping|phenotyping
408181|NCT01402089|cytochrome p450|cytochrome p450
408182|NCT01402089|erlotinib|erlotinib
408183|NCT01402089|sunitinib|sunitinib
408184|NCT01402089|lung cancer|lung cancer
408185|NCT01402089|renal-cell cancer|renal-cell cancer
408186|NCT01402089|gastrointestinal stromal tumor|gastrointestinal stromal tumor
408187|NCT01402076|Pharmacokinetics|pharmacokinetics
408188|NCT01402076|Drug Interaction|drug interaction
408189|NCT01402063|Brain Tumors|brain tumors
408190|NCT01402063|Glioblastoma Multiforme|glioblastoma multiforme
408191|NCT01402063|GBM|gbm
408192|NCT01402050|Time from the start of the induction to delivery|time from the start of the induction to delivery
408193|NCT01402037|type 1 diabetes|type 1 diabetes
408194|NCT01402037|Prevention|prevention
408195|NCT01402037|First degree relatives|first degree relatives
408196|NCT01402037|High risk for type 1 diabetes|high risk for type 1 diabetes
408197|NCT01402011|Prolotherapy|prolotherapy
408198|NCT01402011|regenerative injection therapy|regenerative injection therapy
408199|NCT01402011|dextrose injections|dextrose injections
408200|NCT01401998|cystic kidney disease|cystic kidney disease
408201|NCT01401998|polycystic kidney disease|polycystic kidney disease
408202|NCT01401998|congenital hepatic fibrosis|congenital hepatic fibrosis
408203|NCT01401998|genetic disease|genetic disease
408204|NCT01401985|Opioid induced constipation|opioid induced constipation
408205|NCT01401985|OIC|oic
408206|NCT01401985|Constipation|constipation
408207|NCT01401985|Opioid side effects|opioid side effects
408208|NCT01401985|morphine induced constipation|morphine induced constipation
408209|NCT01401972|prostate|prostate
408210|NCT01401972|cancer|cancer
408211|NCT01401972|ultrasound|ultrasound
408212|NCT01401972|spectroscopy|spectroscopy
408213|NCT01401959|Metastatic Breast Cancer|metastatic breast cancer
408214|NCT01401959|Adjuvant|adjuvant
408215|NCT01401959|Residual Disease|residual disease
408216|NCT01401959|eribulin|eribulin
408217|NCT01401959|Trastuzumab|trastuzumab
408218|NCT01401920|internal jugular vein cannulation|internal jugular vein cannulation
408219|NCT01401920|cross-sectional area|cross-sectional area
408220|NCT01401920|passive leg elevation|passive leg elevation
408221|NCT01401920|trendelenburg position|trendelenburg position
408222|NCT01401920|open heart surgery|open heart surgery
408223|NCT01401907|Palliative care|palliative care
408224|NCT01401907|Lung|lung
408225|NCT01401907|Gastric|gastric
408226|NCT01401907|Liver|liver
408227|NCT01401907|Pancreatic|pancreatic
408228|NCT01401907|Esophageal|esophageal
408229|NCT01401907|Caregiver|caregiver
408230|NCT01401894|advanced cancer|advanced cancer
408231|NCT01401868|solid tumor|solid tumor
408232|NCT01401868|recurrent|recurrent
408233|NCT01401868|advanced|advanced
408234|NCT01401868|metastatic|metastatic
408235|NCT01401855|Diagnosis|diagnosis
408236|NCT01401855|Fine Needle Aspiration Biopsy|fine needle aspiration biopsy
408237|NCT01401842|low back muscular strength and endurance|low back muscular strength and endurance
408238|NCT01401829|endometrial cancer|endometrial cancer
408239|NCT01401829|aerobic walking|aerobic walking
408240|NCT01401829|stretching/flexibility exercises|stretching/flexibility exercises
408241|NCT01401829|quality of life|quality of life
408242|NCT01401816|Adolescents|adolescents
408243|NCT01401816|Sexually Active|sexually active
408244|NCT01401816|Unprotected Sex|unprotected sex
408245|NCT01401816|Emergency Contraception|emergency contraception
408246|NCT01401803|periorbital|periorbital
408247|NCT01401803|glabella|glabella
408248|NCT01401803|ptosis|ptosis
408249|NCT01401803|eyelid|eyelid
408250|NCT01401803|brow|brow
408251|NCT01401790|Children|children
408252|NCT01401790|Adolescents|adolescents
408253|NCT01401790|Telehomecare|telehomecare
408254|NCT01401777|Kidney Tumors, Cryoablation, Biopsy|kidney tumors, cryoablation, biopsy
408255|NCT01401751|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
408256|NCT01401751|Artificial Pancreas|artificial pancreas
408257|NCT01401738|Shoulder Arthroscopic Surgery|shoulder arthroscopic surgery
408258|NCT01401725|venous thromboembolism|venous thromboembolism
408259|NCT01401725|thromboprophylaxis|thromboprophylaxis
408260|NCT01401725|anticoagulants|anticoagulants
408261|NCT01401725|hospitalized medical patients|hospitalized medical patients
408262|NCT01401725|electronic order sets|electronic order sets
408263|NCT01401725|decision support|decision support
408264|NCT01401725|knowledge translation|knowledge translation
408265|NCT01401725|patient safety|patient safety
408266|NCT01401712|ON-Q|on-q
408267|NCT01401712|epidural|epidural
408268|NCT01401712|analgesia|analgesia
408269|NCT01401699|Barrett's|barrett's
408270|NCT01401699|esophagus|esophagus
408271|NCT01401699|OCT|oct
408272|NCT01401699|imaging|imaging
408273|NCT01401673|Chronic Cough|chronic cough
408274|NCT01401673|Indantadol|indantadol
408275|NCT01401660|low back pain|low back pain
408276|NCT01401647|cardiac arrest|cardiac arrest
408277|NCT01401647|cardiopulmonary resuscitation|cardiopulmonary resuscitation
408278|NCT01401647|ventricular fibrillation|ventricular fibrillation
408279|NCT01401647|pulseless ventricular tachycardia|pulseless ventricular tachycardia
408280|NCT01401647|Non-traumatic Out of Hospital Cardiac Arrest (OOHCA)|non-traumatic out of hospital cardiac arrest (oohca)
408281|NCT01401634|Hyperglycemia Hydration|hyperglycemia hydration
408282|NCT01401621|behavioral economics|behavioral economics
408283|NCT01401621|nudge|nudge
408284|NCT01401621|scratch off|scratch off
408285|NCT01401621|blood pressure check|blood pressure check
408286|NCT01401621|cholesterol test|cholesterol test
408287|NCT01401608|VT|vt
408288|NCT01401608|ventricular tachycardia|ventricular tachycardia
408289|NCT01401608|ablation|ablation
408290|NCT01401608|magnetic navigation|magnetic navigation
408291|NCT01401608|robotic|robotic
408292|NCT01401582|health care|health care
408293|NCT01401582|dementia care|dementia care
408294|NCT01401582|caregiver support|caregiver support
408295|NCT01401582|epidemiological study|epidemiological study
408296|NCT01401569|Exercise,|exercise,
408297|NCT01401569|counseling,|counseling,
408298|NCT01401569|smoking cessation,|smoking cessation,
408299|NCT01401569|depressive disorders|depressive disorders
408300|NCT01401556|osteoporosis|osteoporosis
408301|NCT01401556|fracture|fracture
408302|NCT01401556|treatment|treatment
408303|NCT01401556|guidelines|guidelines
408304|NCT01401556|quality|quality
408305|NCT01401543|testosterone|testosterone
408306|NCT01401543|energy|energy
408307|NCT01401543|libido|libido
408308|NCT01401543|erectile function|erectile function
408309|NCT01401543|weak muscles|weak muscles
408310|NCT01401530|Neoplasms|neoplasms
408311|NCT01401530|Neoplasms by Histologic Type|neoplasms by histologic type
408312|NCT01401530|Lymphoma|lymphoma
408313|NCT01401530|Non-Hodgkin|non-hodgkin
408314|NCT01401530|T- Cell|t- cell
408315|NCT01401530|Lymphatic Diseases|lymphatic diseases
408316|NCT01401530|Lymphoproliferative Disorders|lymphoproliferative disorders
408317|NCT01401530|lmmune System Diseases|lmmune system diseases
408318|NCT01401530|lmmunoproliferative Disorders|lmmunoproliferative disorders
408319|NCT01401504|Anti-cancer|anti-cancer
408320|NCT01401504|ASP3026|asp3026
408321|NCT01401504|Anaplastic Lymphoma Kinase (ALK)|anaplastic lymphoma kinase (alk)
408322|NCT01401491|schizophrenia|schizophrenia
408323|NCT01401491|clozapine|clozapine
408324|NCT01401491|fluvoxamine|fluvoxamine
408325|NCT01401491|metabolic syndrome|metabolic syndrome
408326|NCT01401478|Secondary Hyperparathyroidism|secondary hyperparathyroidism
408327|NCT01401478|Chronic Renal Insufficiency|chronic renal insufficiency
408328|NCT01401465|perennial allergic rhinitis|perennial allergic rhinitis
408329|NCT01401465|PAR|par
408330|NCT01401452|Monoclonals|monoclonals
408331|NCT01401452|Moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
408332|NCT01401452|Psoriasis Area & Severity Index (PASI)|psoriasis area & severity index (pasi)
408333|NCT01401452|Adalimumab|adalimumab
408334|NCT01401452|Biological disease modifying anti-rheumatic drugs (BDMARD)|biological disease modifying anti-rheumatic drugs (bdmard)
408335|NCT01401452|Co-morbidities|co-morbidities
408336|NCT01401452|Antibodies|antibodies
408337|NCT01401452|Disease Life Quality Index (DLQI)|disease life quality index (dlqi)
408338|NCT01401439|cystic fibrosis|cystic fibrosis
408339|NCT01401439|body mass index|body mass index
408340|NCT01401439|fat free mass|fat free mass
408341|NCT01401439|Children with cystic fibrosis|children with cystic fibrosis
408342|NCT01401426|overweight|overweight
408343|NCT01401426|Obesity, Morbid|obesity, morbid
408344|NCT01401374|Vitiligo Vulgaris|vitiligo vulgaris
408345|NCT01401374|Autoimmunity|autoimmunity
408346|NCT01401374|Thyroid Disease|thyroid disease
408347|NCT01401296|Depression|depression
408348|NCT01401296|Online-Therapy|online-therapy
408349|NCT01401296|Deprexis|deprexis
408350|NCT01401296|Self-help|self-help
408351|NCT01401257|PXT3003|pxt3003
408352|NCT01401257|Charcot-Marie-Tooth Disease|charcot-marie-tooth disease
408353|NCT01401257|Hereditary Motor and Sensory Neuropathies|hereditary motor and sensory neuropathies
408354|NCT01401231|depression|depression
408355|NCT01401231|pregnancy|pregnancy
408356|NCT01401218|thoracic aortic surgery|thoracic aortic surgery
408357|NCT01401218|acute kidney injury|acute kidney injury
408559|NCT01400399|AJCC DCIS or T1- T2, N0|ajcc dcis or t1- t2, n0
408358|NCT01401205|shoulder arthroscopic surgery|shoulder arthroscopic surgery
408359|NCT01401205|dyspnea|dyspnea
408360|NCT01401205|airway diameter|airway diameter
408361|NCT01401192|thymidylate synthase|thymidylate synthase
408362|NCT01401179|Preterm Premature Rupture of Fetal Membranes|preterm premature rupture of fetal membranes
408363|NCT01401179|antibiotic therapy|antibiotic therapy
408364|NCT01401140|Coronary Artery Bypass|coronary artery bypass
408365|NCT01401140|Coronary Artery Surgery|coronary artery surgery
408366|NCT01401140|Coronary Artery Bypass Graft|coronary artery bypass graft
408367|NCT01401140|Coronary Revascularization|coronary revascularization
408368|NCT01401140|Cardiac microdialysis|cardiac microdialysis
408369|NCT01401140|Custodiol|custodiol
408370|NCT01401140|St Thomas|st thomas
408371|NCT01401140|Cardioplegic solutions|cardioplegic solutions
408372|NCT01401127|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
408373|NCT01401127|Exercise|exercise
408374|NCT01401127|Continuous Subcutaneous Insulin Infusion|continuous subcutaneous insulin infusion
408375|NCT01401127|CSII|csii
408376|NCT01401127|Insulin Pump Therapy|insulin pump therapy
408377|NCT01401114|Wellnara|wellnara
408378|NCT01401114|Postmenopausal osteoporosis|postmenopausal osteoporosis
408379|NCT01401101|mental health|mental health
408380|NCT01401101|PTSD|ptsd
408381|NCT01401101|primary care|primary care
408382|NCT01401101|quality improvement|quality improvement
408383|NCT01401101|collaborative care|collaborative care
408384|NCT01401088|patient with refractory glaucoma|patient with refractory glaucoma
408385|NCT01401075|Quality of Life|quality of life
408386|NCT01401075|QoL|qol
408387|NCT01401075|EORTC QLQ-C30|eortc qlq-c30
408388|NCT01401075|EORTC QLQ-STO22|eortc qlq-sto22
408389|NCT01401075|5-FU|5-fu
408390|NCT01401075|Viscum album|viscum album
408391|NCT01401062|metastatic breast cancer|metastatic breast cancer
408392|NCT01401062|TGF-beta|tgf-beta
408393|NCT01401062|fresolimumab|fresolimumab
408394|NCT01401062|monoclonal antibody|monoclonal antibody
408395|NCT01401062|radiation therapy|radiation therapy
408396|NCT01401062|abscopal response|abscopal response
408397|NCT01401049|Fospropofol|fospropofol
408398|NCT01401049|Propofol|propofol
408399|NCT01401049|Colonoscopy|colonoscopy
408400|NCT01401049|Lusedra|lusedra
408401|NCT01401036|acute myocardial infarction|acute myocardial infarction
408402|NCT01401036|stents|stents
408403|NCT01401036|angioplasty|angioplasty
408404|NCT01401036|thrombosis|thrombosis
408405|NCT01401010|neutropenia|neutropenia
408406|NCT01401010|doripenem|doripenem
408407|NCT01400997|Growth disorders|growth disorders
408408|NCT01400997|Saizen|saizen
408409|NCT01400997|Easypod|easypod
408410|NCT01400997|Growth hormone|growth hormone
408411|NCT01400997|Pediatric subject|pediatric subject
408412|NCT01400984|Growth disorders|growth disorders
408413|NCT01400984|Saizen|saizen
408414|NCT01400984|Easypod|easypod
408415|NCT01400984|Growth hormone|growth hormone
408416|NCT01400984|Pediatric subject|pediatric subject
408417|NCT01400971|Diabetes|diabetes
408418|NCT01400971|Insulin|insulin
408419|NCT01400971|Progression|progression
408420|NCT01400971|Patient Reported Measures|patient reported measures
408421|NCT01400971|Adherence|adherence
408422|NCT01400971|Heterogeneity|heterogeneity
408423|NCT01400971|Hypoglycemia|hypoglycemia
408424|NCT01400958|fatigue|fatigue
408425|NCT01400958|external beam radiation|external beam radiation
408426|NCT01400958|EBRT|ebrt
408427|NCT01400958|radiation therapy|radiation therapy
408428|NCT01400958|placebo|placebo
408429|NCT01400958|cognitive function|cognitive function
408430|NCT01400958|TMZ|tmz
408431|NCT01400958|Temozolomide|temozolomide
408432|NCT01400945|GERD|gerd
408433|NCT01400945|endoscopy|endoscopy
408434|NCT01400945|LA grade|la grade
408435|NCT01400945|heartburn|heartburn
408436|NCT01400932|inflammatory lesion|inflammatory lesion
408437|NCT01400932|Benzoyl peroxide (BPO)|benzoyl peroxide (bpo)
408438|NCT01400932|once daily|once daily
408439|NCT01400932|acne vulgaris|acne vulgaris
408440|NCT01400932|vehicle gel|vehicle gel
408441|NCT01400932|clindamycin (CLDM) 1%-BPO 3% gel|clindamycin (cldm) 1%-bpo 3% gel
408442|NCT01400932|non-inflammatory lesion|non-inflammatory lesion
408443|NCT01400919|Peripheral arterial disease|peripheral arterial disease
408444|NCT01400919|claudication|claudication
408445|NCT01400919|stent|stent
408446|NCT01400919|EverFlex|everflex
408447|NCT01400919|GPS|gps
408448|NCT01400919|Iliac Artery|iliac artery
408449|NCT01400893|Acute Renal Failure|acute renal failure
408450|NCT01400893|Acute kidney injury|acute kidney injury
408451|NCT01400893|Acute tubular necrosis|acute tubular necrosis
408452|NCT01400893|Continuous Renal Replacement Therapy|continuous renal replacement therapy
408453|NCT01400893|Severe sepsis|severe sepsis
408454|NCT01400893|Selective cytopheretic device|selective cytopheretic device
408455|NCT01400880|Maternal Fetal Monitoring|maternal fetal monitoring
408456|NCT01400867|Infections|infections
408457|NCT01400867|Pediatrics|pediatrics
408458|NCT01400867|Teflaro|teflaro
408459|NCT01400867|cephalosporin|cephalosporin
408460|NCT01400854|breakthrough cancer pain|breakthrough cancer pain
408461|NCT01400841|Aortic Insufficiency, Aortic Regurgitation, Aortic Valve Repair|aortic insufficiency, aortic regurgitation, aortic valve repair
408462|NCT01400815|smoking|smoking
408463|NCT01400815|smoking cessation|smoking cessation
408464|NCT01400815|quitting smoking|quitting smoking
408465|NCT01400776|Postmenopausal Women, Vaginal Dryness|postmenopausal women, vaginal dryness
408466|NCT01400763|focus of study|focus of study
408467|NCT01400750|cystic fibrosis- P aeruginosa- eradication-child|cystic fibrosis- p aeruginosa- eradication-child
408468|NCT01400737|ibuprofen|ibuprofen
408469|NCT01400737|prophylaxis|prophylaxis
408470|NCT01400737|VELBW|velbw
408471|NCT01400724|menopause|menopause
408472|NCT01400724|metabolic syndrome|metabolic syndrome
408473|NCT01400724|myo-inositol|myo-inositol
408474|NCT01400724|insulin resistance|insulin resistance
408475|NCT01400724|cocoa polyphenols|cocoa polyphenols
408476|NCT01400724|isoflavones|isoflavones
408477|NCT01400711|Fast-tract surgery, Enhanced recovery after surgery, multimodal surgery.|fast-tract surgery, enhanced recovery after surgery, multimodal surgery.
408478|NCT01400698|Intra-uterine growth retardation (IUGR)|intra-uterine growth retardation (iugr)
408479|NCT01400698|Saizen|saizen
408480|NCT01400698|Recombinant human growth hormone (r-hGH)|recombinant human growth hormone (r-hgh)
408481|NCT01400698|Final height|final height
408482|NCT01400698|Bone age|bone age
408483|NCT01400698|SGA (Small for Gestational Age)|sga (small for gestational age)
408484|NCT01400685|CLL|cll
408485|NCT01400685|Leukemia|leukemia
408486|NCT01400685|Untreated|untreated
408487|NCT01400685|B-CLL|b-cll
408488|NCT01400685|SLL|sll
408489|NCT01400672|Diffuse intrinsic pontine glioma|diffuse intrinsic pontine glioma
408490|NCT01400659|CSII|csii
408491|NCT01400659|prandial insulin requirements|prandial insulin requirements
408492|NCT01400659|bolus calculation|bolus calculation
408493|NCT01400659|dual-wave bolus|dual-wave bolus
408494|NCT01400646|Rivaroxaban|rivaroxaban
408495|NCT01400646|JNJ-39039039|jnj-39039039
408496|NCT01400646|BAY59-7939|bay59-7939
408497|NCT01400646|Warfarin|warfarin
408498|NCT01400646|Transition|transition
408499|NCT01400633|Myelodysplastic Syndrome|myelodysplastic syndrome
408500|NCT01400633|Dacogen|dacogen
408501|NCT01400633|decitabine|decitabine
408502|NCT01400633|epigenetic therapy|epigenetic therapy
408503|NCT01400633|hypomethylating agent|hypomethylating agent
408504|NCT01400620|oral mucositis|oral mucositis
408505|NCT01400620|chemoradiation|chemoradiation
408506|NCT01400620|head and neck cancer|head and neck cancer
408507|NCT01400607|cartilage|cartilage
408508|NCT01400607|knee surgery|knee surgery
408509|NCT01400607|cartilage injury|cartilage injury
408510|NCT01400607|knee pain|knee pain
408511|NCT01400607|cartilage repair|cartilage repair
408512|NCT01400607|cartilage damage|cartilage damage
408513|NCT01400607|cartilage lesion|cartilage lesion
408514|NCT01400607|cartilage defect|cartilage defect
408515|NCT01400607|articular cartilage lesion|articular cartilage lesion
408516|NCT01400607|articular cartilage defect|articular cartilage defect
408517|NCT01400607|juvenile|juvenile
408518|NCT01400607|cells|cells
408519|NCT01400607|ISTO Technologies|isto technologies
408520|NCT01400607|Neocartilage|neocartilage
408521|NCT01400607|RevaFlex|revaflex
408522|NCT01400594|Onychomycosis|onychomycosis
408523|NCT01400555|Prostate Cancer|prostate cancer
408524|NCT01400555|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
408525|NCT01400555|Abiraterone Acetate|abiraterone acetate
408526|NCT01400555|Docetaxel|docetaxel
408527|NCT01400555|Prednisone|prednisone
408528|NCT01400555|Dexamethasone|dexamethasone
408529|NCT01400542|Early Onset Alzheimer Disease|early onset alzheimer disease
408530|NCT01400542|Alzheimer Disease|alzheimer disease
408531|NCT01400542|Sleep Apnea Syndromes|sleep apnea syndromes
408532|NCT01400542|Obstructive Sleep Apnea Syndromes|obstructive sleep apnea syndromes
408533|NCT01400542|Cognitive functions|cognitive functions
408534|NCT01400542|Continuous Positive Airway Pressure (CPAP) treatment|continuous positive airway pressure (cpap) treatment
408535|NCT01400529|Osteoarthritis|osteoarthritis
408536|NCT01400529|knee|knee
408537|NCT01400529|hip|hip
408538|NCT01400529|population based|population based
408539|NCT01400516|Rheumatoid Arthritis|rheumatoid arthritis
408540|NCT01400516|Bone erosion|bone erosion
408541|NCT01400516|Osteopenia|osteopenia
408542|NCT01400503|Multicentric Castleman's Disease|multicentric castleman's disease
408543|NCT01400503|Multicentric|multicentric
408544|NCT01400503|Castleman|castleman
408545|NCT01400503|Siltuximab|siltuximab
408546|NCT01400503|Long term safety|long term safety
408547|NCT01400477|Drug Trial|drug trial
408548|NCT01400477|Smoking|smoking
408549|NCT01400477|Smoking Cessation|smoking cessation
408550|NCT01400477|Cognition|cognition
408551|NCT01400477|Mental Focus|mental focus
408552|NCT01400464|Giant Cell Arteritis|giant cell arteritis
408553|NCT01400464|prednisone|prednisone
408554|NCT01400464|pharmacokinetics|pharmacokinetics
408555|NCT01400438|Herceptin|herceptin
408556|NCT01400438|Breast cancer|breast cancer
408557|NCT01400438|Quality of life|quality of life
408558|NCT01400438|fatigue|fatigue
408560|NCT01400373|Hypothermia, induced|hypothermia, induced
408561|NCT01400373|Intra-arrest cooling|intra-arrest cooling
408562|NCT01400373|Cardiac arrest|cardiac arrest
408563|NCT01400373|Prehospital emergency care|prehospital emergency care
408564|NCT01400373|Emergency Medical Services|emergency medical services
408565|NCT01400360|cerebral vasospasm|cerebral vasospasm
408566|NCT01400360|subarachnoid hemorrhage|subarachnoid hemorrhage
408567|NCT01400360|transluminal balloon angioplasty|transluminal balloon angioplasty
408568|NCT01400360|intraarterial treatment|intraarterial treatment
408569|NCT01400347|Motor activity, lower extremity, physical exercise|motor activity, lower extremity, physical exercise
408570|NCT01400334|Ischemic Cardiomyopathy|ischemic cardiomyopathy
408571|NCT01400334|Sudden Cardiac Death|sudden cardiac death
408572|NCT01400334|Positron Emission Tomography|positron emission tomography
408573|NCT01400334|Hibernating Myocardium|hibernating myocardium
408574|NCT01400334|Denervated Myocardium|denervated myocardium
408575|NCT01400321|dental implant|dental implant
408576|NCT01400321|soft tissue maintenance|soft tissue maintenance
408577|NCT01400321|bone remodelling|bone remodelling
408578|NCT01400321|inclined atrophy|inclined atrophy
408579|NCT01400308|Methicillin Resistant Staphylococcus Aureus colonization.|methicillin resistant staphylococcus aureus colonization.
408580|NCT01400308|Methicillin Resistant Staphylococcus Aureus infection.|methicillin resistant staphylococcus aureus infection.
408581|NCT01400295|contrast-induced nephropathy|contrast-induced nephropathy
408582|NCT01400295|contrast medium|contrast medium
408583|NCT01400295|creatinine clearance|creatinine clearance
408584|NCT01400295|coronary angiography|coronary angiography
408585|NCT01400295|diabetes|diabetes
408586|NCT01400295|chronic kidney disease|chronic kidney disease
408587|NCT01400269|PACE|pace
408588|NCT01400256|diagnostic|diagnostic
408589|NCT01400243|Marijuana|marijuana
408590|NCT01400243|Drug withdrawal symptoms|drug withdrawal symptoms
408591|NCT01400243|Nicotine|nicotine
408592|NCT01400230|computed tomography|computed tomography
408593|NCT01400230|intravascular ultrasound|intravascular ultrasound
408594|NCT01400230|coronary stenosis|coronary stenosis
408595|NCT01400230|fractional flow reserve|fractional flow reserve
408596|NCT01400217|Primary Care|primary care
408597|NCT01400217|Particle size|particle size
408598|NCT01400217|beclomethasone dipropionate|beclomethasone dipropionate
408599|NCT01400217|Asthma Management|asthma management
408600|NCT01400217|Maintenance Therapy|maintenance therapy
408601|NCT01400217|Metered-Dose Inhaler|metered-dose inhaler
408602|NCT01400204|hangover|hangover
408603|NCT01400204|next day effects|next day effects
408604|NCT01400204|MDMA|mdma
408605|NCT01400204|Alcohol|alcohol
408606|NCT01400191|Metformin|metformin
408607|NCT01400191|Hypoglycemic Agents|hypoglycemic agents
408608|NCT01400191|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
408609|NCT01400191|Gluconeogenesis|gluconeogenesis
408610|NCT01400191|Pharmacodynamics|pharmacodynamics
408611|NCT01400191|Pharmacogenetics|pharmacogenetics
408612|NCT01400178|cochlear implant|cochlear implant
408613|NCT01400178|children|children
408614|NCT01400178|follow up|follow up
408615|NCT01400178|results|results
408616|NCT01400165|Therapeutic Equivalency|therapeutic equivalency
408617|NCT01400165|Human Experimentation|human experimentation
408618|NCT01400165|Bioequivalence|bioequivalence
408619|NCT01400165|Brand name|brand name
408620|NCT01400165|Generic|generic
408621|NCT01400165|Healthy volunteers|healthy volunteers
408622|NCT01400152|Hypothermia, body temperature regulation,thermal comfort, active warming, passive warming, prehospital trauma care|hypothermia, body temperature regulation,thermal comfort, active warming, passive warming, prehospital trauma care
408623|NCT01400139|Pain|pain
408624|NCT01400139|Nonmalignant pain|nonmalignant pain
408625|NCT01400139|Nonneuropathic Pain|nonneuropathic pain
408626|NCT01400139|Opioid|opioid
408627|NCT01400126|Ultrapure water,hemodialysis, CRP, blood pressure|ultrapure water,hemodialysis, crp, blood pressure
408628|NCT01400113|Acute Agitation|acute agitation
408629|NCT01400113|schizophrenia|schizophrenia
408630|NCT01400113|bipolar|bipolar
408631|NCT01400113|psychosis|psychosis
408632|NCT01400113|panss-ec|panss-ec
408633|NCT01400100|octreotide|octreotide
408634|NCT01400100|intraarterial|intraarterial
408635|NCT01400100|pancreatic hardness|pancreatic hardness
408636|NCT01400100|pancreatoduodenectomy|pancreatoduodenectomy
408637|NCT01400100|durometer|durometer
408638|NCT01400100|dynamometer|dynamometer
408639|NCT01400087|colonoscopy|colonoscopy
408640|NCT01400087|Lower Gastrointestinal Tract|lower gastrointestinal tract
408641|NCT01400087|Cecal intubation|cecal intubation
408642|NCT01400087|Cap-attached colonoscopy|cap-attached colonoscopy
408643|NCT01400087|Trainee|trainee
408644|NCT01400061|obesity, etiology, pathogenesis, treatment|obesity, etiology, pathogenesis, treatment
408645|NCT01400035|acute cerebral infarction, Vinpocetine|acute cerebral infarction, vinpocetine
408646|NCT01400022|lichen|lichen
408647|NCT01400022|sclerosus|sclerosus
408648|NCT01400022|genital|genital
408649|NCT01400022|vulvar|vulvar
408650|NCT01400022|UVA1|uva1
408651|NCT01400009|Statin|statin
408652|NCT01400009|HMG COA Reductase Inhibitor|hmg coa reductase inhibitor
408653|NCT01400009|myalgia|myalgia
408654|NCT01400009|vitamin D|vitamin d
408655|NCT01399996|probiotic|probiotic
408656|NCT01399996|microbiota|microbiota
408657|NCT01399996|transit time|transit time
408658|NCT01399996|immunity|immunity
408659|NCT01399996|immune function|immune function
408660|NCT01399996|constipation|constipation
408661|NCT01399996|bowel function|bowel function
408662|NCT01399983|six minute walk|six minute walk
408663|NCT01399970|Mobile Teledermatology|mobile teledermatology
408664|NCT01399970|Telemedicine|telemedicine
408665|NCT01399970|Acne|acne
408666|NCT01399957|Multiple Sclerosis|multiple sclerosis
408667|NCT01399957|Dalfampridine-ER|dalfampridine-er
408668|NCT01399957|Walking speed|walking speed
408669|NCT01399944|bitter taste|bitter taste
408670|NCT01399944|psychophysics|psychophysics
408671|NCT01399944|genetics|genetics
408672|NCT01399944|epigenetics|epigenetics
408673|NCT01399944|bitterness sensitivity|bitterness sensitivity
408674|NCT01399931|Early stage|early stage
408675|NCT01399918|Kidney|kidney
408676|NCT01399918|Everolimus|everolimus
408677|NCT01399918|Bevacizumab|bevacizumab
408678|NCT01399918|10-226|10-226
408679|NCT01399918|non-clear cell histology|non-clear cell histology
408680|NCT01399918|Advanced|advanced
408681|NCT01399905|Parkinson's disease|parkinson's disease
408682|NCT01399905|Levodopa|levodopa
408683|NCT01399905|Carbidopa|carbidopa
408684|NCT01399905|Blood brain barrier|blood brain barrier
408685|NCT01399879|Surface potential|surface potential
408686|NCT01399879|Electrical|electrical
408687|NCT01399879|Motion stabilization|motion stabilization
408688|NCT01399866|D-cycloserine|d-cycloserine
408689|NCT01399866|Smoking cues|smoking cues
408690|NCT01399866|Cognitive remediation|cognitive remediation
408691|NCT01399866|physiologic reactivity|physiologic reactivity
408692|NCT01399866|craving|craving
408693|NCT01399853|immunogenicity|immunogenicity
408694|NCT01399853|safety|safety
408695|NCT01399853|inactivated EV71 vaccine|inactivated ev71 vaccine
408696|NCT01399801|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
408697|NCT01399801|medically refractory heart failure patients|medically refractory heart failure patients
408698|NCT01399788|Bioequivalence|bioequivalence
408699|NCT01399788|Healthy Volunteers|healthy volunteers
408700|NCT01399775|Atrophy of Edentulous Alveolar Ridge|atrophy of edentulous alveolar ridge
408701|NCT01399775|Dental Prosthesis, Implant-Supported|dental prosthesis, implant-supported
408702|NCT01399775|Dental Implants, Single-Tooth|dental implants, single-tooth
408703|NCT01399762|stroke, acute|stroke, acute
408704|NCT01399762|mechanical recanalization|mechanical recanalization
408705|NCT01399762|interventional neuroradiology|interventional neuroradiology
408706|NCT01399762|clinical registry|clinical registry
408707|NCT01399749|Cartilage|cartilage
408708|NCT01399749|Articular|articular
408709|NCT01399749|Femoral|femoral
408710|NCT01399749|Knee|knee
408711|NCT01399749|Chondrocytes|chondrocytes
408712|NCT01399749|Adipose tissue-derived mesenchymal stem cells|adipose tissue-derived mesenchymal stem cells
408713|NCT01399736|PCI FFR STEMI MVD|pci ffr stemi mvd
408714|NCT01399736|FFR guided PCI in acute STEMI patients with MVD|ffr guided pci in acute stemi patients with mvd
408715|NCT01399723|Severe pneumonia|severe pneumonia
408716|NCT01399710|colorectal cancer|colorectal cancer
408717|NCT01399710|CT colonography|ct colonography
408718|NCT01399710|CAD|cad
408719|NCT01399671|depression|depression
408720|NCT01399671|vestibular|vestibular
408721|NCT01399658|Brachytherapy|brachytherapy
408722|NCT01399658|Gynecological cancer|gynecological cancer
408723|NCT01399645|Randomized trial|randomized trial
408724|NCT01399645|Open label|open label
408725|NCT01399645|Pilot study|pilot study
408726|NCT01399645|Single center|single center
408727|NCT01399606|Excessive Daytime Sleepiness (EDS)|excessive daytime sleepiness (eds)
408728|NCT01399606|Narcolepsy|narcolepsy
408729|NCT01399593|Antibody Mediated Rejection|antibody mediated rejection
408730|NCT01399593|AMR|amr
408731|NCT01399593|Acute Humoral Rejection|acute humoral rejection
408732|NCT01399593|AHR|ahr
408733|NCT01399593|Living Donor|living donor
408734|NCT01399593|Kidney Transplant|kidney transplant
408735|NCT01399580|endothelin receptor antagonists|endothelin receptor antagonists
408736|NCT01399567|pain|pain
408737|NCT01399567|depression|depression
408738|NCT01399567|nursing homes|nursing homes
408739|NCT01399567|diffusion of innovations|diffusion of innovations
408740|NCT01399567|clinical trial|clinical trial
408741|NCT01399541|Symptoms|symptoms
408742|NCT01399541|Symptoms cluster|symptoms cluster
408743|NCT01399541|Fatigue|fatigue
408744|NCT01399541|Depression|depression
408745|NCT01399541|Sleeplessness|sleeplessness
408746|NCT01399541|Social support|social support
408747|NCT01399541|Stigma|stigma
408748|NCT01399515|Retinitis pigmentosa|retinitis pigmentosa
408749|NCT01399515|Valproic acid|valproic acid
408750|NCT01399502|Depression|depression
408751|NCT01399502|Self Care|self care
408752|NCT01399489|Aerobic exercise|aerobic exercise
408753|NCT01399489|Moderate intensity|moderate intensity
408754|NCT01399489|Ambulatory blood pressure|ambulatory blood pressure
408854|NCT01399086|Metastatic|metastatic
408755|NCT01399489|Post exercise hypotension|post exercise hypotension
408756|NCT01399476|Achalasia|achalasia
408757|NCT01399463|Drug Eluting Stent, Drug Eluting Balloon, Fractional Flow Reserve, DES, DEB, FFR|drug eluting stent, drug eluting balloon, fractional flow reserve, des, deb, ffr
408758|NCT01399450|Schizophrenia, depressive symptom, paliperidone|schizophrenia, depressive symptom, paliperidone
408759|NCT01399437|Default Network|default network
408760|NCT01399437|Schizophrenia|schizophrenia
408761|NCT01399437|fMRI|fmri
408762|NCT01399437|Spatial Attention|spatial attention
408763|NCT01399437|Sentinel Function|sentinel function
408764|NCT01399424|Shigellosis|shigellosis
408765|NCT01399424|Safety and Immunogenicity|safety and immunogenicity
408766|NCT01399424|Conjugate Vaccine|conjugate vaccine
408767|NCT01399424|Shigella|shigella
408768|NCT01399424|Vaccine|vaccine
408769|NCT01399411|Self-Reported|self-reported
408770|NCT01399411|Farming|farming
408771|NCT01399411|Agriculture|agriculture
408772|NCT01399411|Disease Validation|disease validation
408773|NCT01399411|Autoimmune Disorders|autoimmune disorders
408774|NCT01399398|Brain Scan|brain scan
408775|NCT01399398|Kinetic Analysis|kinetic analysis
408776|NCT01399398|Healthy Subjects|healthy subjects
408777|NCT01399398|Healthy Volunteer|healthy volunteer
408778|NCT01399398|HV|hv
408779|NCT01399385|Arteriosclerosis|arteriosclerosis
408780|NCT01399385|Arteriosclerosis, Narrowing of Vessels|arteriosclerosis, narrowing of vessels
408781|NCT01399385|Endothelial Dysfunction|endothelial dysfunction
408782|NCT01399385|Hardening of the arteries|hardening of the arteries
408783|NCT01399385|Noninvasive Plaque Imaging|noninvasive plaque imaging
408784|NCT01399385|Cardiovascular Disease|cardiovascular disease
408785|NCT01399385|Heart Disease|heart disease
408786|NCT01399385|Healthy Volunteer|healthy volunteer
408787|NCT01399385|HV|hv
408788|NCT01399372|neurotoxicity|neurotoxicity
408789|NCT01399372|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
408790|NCT01399372|radiation toxicity|radiation toxicity
408791|NCT01399372|cognitive/functional effects|cognitive/functional effects
408792|NCT01399372|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
408793|NCT01399359|breast cancer|breast cancer
408794|NCT01399346|Insulin aspart|insulin aspart
408795|NCT01399346|Type 1 diabetes|type 1 diabetes
408796|NCT01399346|Glucose clamp|glucose clamp
408797|NCT01399346|Pharmacodynamics|pharmacodynamics
408798|NCT01399346|Pharmacokinetics|pharmacokinetics
408799|NCT01399346|Rapid Acting Insulin Analog|rapid acting insulin analog
408800|NCT01399333|PDCAAS|pdcaas
408801|NCT01399333|Bariatric patient|bariatric patient
408802|NCT01399320|Pilonidal disease|pilonidal disease
408803|NCT01399320|Excision|excision
408804|NCT01399320|cyanoacrylate|cyanoacrylate
408805|NCT01399307|Stem|stem
408806|NCT01399307|Cell|cell
408807|NCT01399307|Antria|antria
408808|NCT01399307|Adipose|adipose
408809|NCT01399307|Stromal|stromal
408810|NCT01399307|Vascular|vascular
408811|NCT01399307|Fraction|fraction
408812|NCT01399307|Shahram|shahram
408813|NCT01399307|Shah|shah
408814|NCT01399307|Rahimian|rahimian
408815|NCT01399294|Palliative Care|palliative care
408816|NCT01399294|Advanced Cancer|advanced cancer
408817|NCT01399294|Constipation|constipation
408818|NCT01399294|Traditional Chinese Medicine|traditional chinese medicine
408819|NCT01399294|Syndrome Distribution|syndrome distribution
408820|NCT01399281|juvenile idiopathic arthritis, biologics, methotrexate|juvenile idiopathic arthritis, biologics, methotrexate
408821|NCT01399268|Bilateral total knee replacement|bilateral total knee replacement
408822|NCT01399268|cytokine|cytokine
408823|NCT01399268|desmosine|desmosine
408824|NCT01399242|Disorder Related to Renal Transplantation|disorder related to renal transplantation
408825|NCT01399203|contrast-induced nephropathy|contrast-induced nephropathy
408826|NCT01399203|contrast medium|contrast medium
408827|NCT01399203|creatinine clearance|creatinine clearance
408828|NCT01399203|percutaneous coronary intervention|percutaneous coronary intervention
408829|NCT01399164|Vitamin B-12|vitamin b-12
408830|NCT01399151|Vitamin D|vitamin d
408831|NCT01399151|Immune function|immune function
408832|NCT01399138|Pre-diabetes|pre-diabetes
408833|NCT01399138|Metabolic syndrome|metabolic syndrome
408834|NCT01399138|Diabetes|diabetes
408835|NCT01399138|Hypertension|hypertension
408836|NCT01399138|Blueberries|blueberries
408837|NCT01399138|Anthocyanins|anthocyanins
408838|NCT01399138|Insulin sensitivity|insulin sensitivity
408839|NCT01399138|Insulin resistance|insulin resistance
408840|NCT01399125|Alzheimer's|alzheimer's
408841|NCT01399125|Rivastigmine|rivastigmine
408842|NCT01399125|Patch|patch
408843|NCT01399125|Dementia|dementia
408844|NCT01399112|Smoking Cessation|smoking cessation
408845|NCT01399112|First episode psychosis|first episode psychosis
408846|NCT01399112|Electronic Decision Support System|electronic decision support system
408847|NCT01399099|scar|scar
408848|NCT01399099|incision|incision
408849|NCT01399099|wound healing|wound healing
408850|NCT01399099|scarring|scarring
408851|NCT01399099|post-surgical|post-surgical
408852|NCT01399086|Cancer|cancer
408853|NCT01399086|Breast|breast
408855|NCT01399086|Hormonotherapy|hormonotherapy
408856|NCT01399073|stroke|stroke
408857|NCT01399073|neglect|neglect
408858|NCT01399073|hemianopsia|hemianopsia
408859|NCT01399073|virtual reality|virtual reality
408860|NCT01399060|Cough|cough
408861|NCT01399060|tobacco smoke exposure|tobacco smoke exposure
408862|NCT01399047|Batten Disease|batten disease
408863|NCT01399034|Epigenomics|epigenomics
408864|NCT01399034|DNA methylation|dna methylation
408865|NCT01399034|MicroRNA|microrna
408866|NCT01399034|Periodontitis|periodontitis
408867|NCT01399034|Inflammation|inflammation
408868|NCT01399034|Obesity|obesity
408869|NCT01399021|Parotidectomy|parotidectomy
408870|NCT01399021|Drain removal|drain removal
408871|NCT01399021|Timing|timing
408872|NCT01399021|Hematoma|hematoma
408873|NCT01399021|Surgical wound infection|surgical wound infection
408874|NCT01399008|Hyperuricemia|hyperuricemia
408875|NCT01398995|Type 1 Diabetes|type 1 diabetes
408876|NCT01398995|Exercise|exercise
408877|NCT01398995|continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
408878|NCT01398969|Randomized|randomized
408879|NCT01398969|Double Blind|double blind
408880|NCT01398969|Fecal Transplant|fecal transplant
408881|NCT01398969|Recurrent|recurrent
408882|NCT01398969|Clostridium difficile infection|clostridium difficile infection
408883|NCT01398969|CDI|cdi
408884|NCT01398969|HBT|hbt
408885|NCT01398969|Diarrhea|diarrhea
408886|NCT01398969|Frozen HBT|frozen hbt
408887|NCT01398969|Thawed HBT|thawed hbt
408888|NCT01398969|Fecal Enema|fecal enema
408889|NCT01398956|Levetiracetam|levetiracetam
408890|NCT01398956|Epilepsy|epilepsy
408891|NCT01398956|Generalized tonic-clonic seizures|generalized tonic-clonic seizures
408892|NCT01398943|flow-mediated dilation|flow-mediated dilation
408893|NCT01398943|arterial stiffness|arterial stiffness
408894|NCT01398943|intima-media thickness|intima-media thickness
408895|NCT01398943|pulse wave velocity|pulse wave velocity
408896|NCT01398943|dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
408897|NCT01398943|inflammatory markers|inflammatory markers
408898|NCT01398943|blood lipids|blood lipids
408899|NCT01398943|tetrahydrobiopterin|tetrahydrobiopterin
408900|NCT01398943|body mass index|body mass index
408901|NCT01398943|hemoglobin A1c|hemoglobin a1c
408902|NCT01398943|complete blood count|complete blood count
408903|NCT01398943|oxidative stress biomarkers|oxidative stress biomarkers
408904|NCT01398943|pulmonary function test|pulmonary function test
408905|NCT01398943|lung|lung
408906|NCT01398943|COPD|copd
408907|NCT01398930|acupuncture; knee osteoarthritis; adjunctive therapy; chronic pain; algometer; etoricoxib.|acupuncture; knee osteoarthritis; adjunctive therapy; chronic pain; algometer; etoricoxib.
408908|NCT01398917|psc|psc
408909|NCT01398917|dominant stricture|dominant stricture
408910|NCT01398904|BDD|bdd
408911|NCT01398878|Medical education, graduate|medical education, graduate
408912|NCT01398878|Patient care|patient care
408913|NCT01398878|Outcome assessment (Health care)|outcome assessment (health care)
408914|NCT01398878|Work schedule tolerance|work schedule tolerance
408915|NCT01398865|BDD|bdd
408916|NCT01398826|Type 1 Diabetes|type 1 diabetes
408917|NCT01398826|Exercise|exercise
408918|NCT01398826|Continuous glucose monitoring|continuous glucose monitoring
408919|NCT01398813|HED|hed
408920|NCT01398813|XLHED|xlhed
408921|NCT01398774|Pseudohypoparathyroidism|pseudohypoparathyroidism
408922|NCT01398774|Albright Hereditary Osteodystrophy|albright hereditary osteodystrophy
408923|NCT01398761|Continuity of patient care|continuity of patient care
408924|NCT01398761|Workflow|workflow
408925|NCT01398761|Quality of signout|quality of signout
408926|NCT01398761|Web based|web based
408927|NCT01398761|Handoffs|handoffs
408928|NCT01398761|Multi disciplinary|multi disciplinary
408929|NCT01398761|Written signout|written signout
408930|NCT01398761|Information science|information science
408931|NCT01398748|Parkinson's disease|parkinson's disease
408932|NCT01398748|Neuroprotection|neuroprotection
408933|NCT01398748|Glutathione|glutathione
408934|NCT01398748|Intranasal|intranasal
408935|NCT01398722|cardiac surgery|cardiac surgery
408936|NCT01398722|prognosis|prognosis
408937|NCT01398722|intensive insulin therapy|intensive insulin therapy
408938|NCT01398709|Cardiopulmonary Bypass|cardiopulmonary bypass
408939|NCT01398709|Prognosis|prognosis
408940|NCT01398709|Cardiac Surgery|cardiac surgery
408941|NCT01398709|Rewarming Rate|rewarming rate
408942|NCT01398696|Patient Information Leaflets|patient information leaflets
408943|NCT01398696|primary care|primary care
408944|NCT01398696|patient behaviour|patient behaviour
408945|NCT01398696|pharyngitis|pharyngitis
408946|NCT01398696|gastroenteritis|gastroenteritis
408947|NCT01398670|Type I Diabetes|type i diabetes
408948|NCT01398670|Wockhardt's Insulin analogue Lispro|wockhardt's insulin analogue lispro
408949|NCT01398670|Humalog®|humalog®
408950|NCT01398670|Humalog Mix|humalog mix
408951|NCT01398670|Wockhardt|wockhardt
408952|NCT01398670|Biosimilar|biosimilar
408953|NCT01398670|Phase 3|phase 3
408954|NCT01398657|localized|localized
408955|NCT01398657|High risk|high risk
408956|NCT01398657|Prostate Cancer|prostate cancer
408957|NCT01398657|Randomized|randomized
408958|NCT01398657|Cryotherapy|cryotherapy
408959|NCT01398657|Cryoablation|cryoablation
408960|NCT01398657|Adjuvant|adjuvant
408961|NCT01398657|Androgen Deprivation Therapy|androgen deprivation therapy
408962|NCT01398657|Hormone therapy|hormone therapy
408963|NCT01398657|ADT|adt
408964|NCT01398644|Phlebotomy|phlebotomy
408965|NCT01398644|Therapeutic erythrocytapheresis|therapeutic erythrocytapheresis
408966|NCT01398644|Hereditary Hemochromatosis|hereditary hemochromatosis
408967|NCT01398644|maintenance therapy|maintenance therapy
408968|NCT01398631|Risk scores|risk scores
408969|NCT01398631|ACS|acs
408970|NCT01398631|HEART-score|heart-score
408971|NCT01398618|latent tuberculosis infection|latent tuberculosis infection
408972|NCT01398618|tuberculosis|tuberculosis
408973|NCT01398618|interferon-gamma release assay|interferon-gamma release assay
408974|NCT01398618|preventive therapy|preventive therapy
408975|NCT01398618|9-month isoniazid|9-month isoniazid
408976|NCT01398618|4-month rifampin|4-month rifampin
408977|NCT01398605|Postmenopausal women|postmenopausal women
408978|NCT01398605|Physical activity|physical activity
408979|NCT01398605|Cardiovascular risks|cardiovascular risks
408980|NCT01398605|Cardiac function|cardiac function
408981|NCT01398605|Dose-response|dose-response
408982|NCT01398592|Diabetes mellitus Type two|diabetes mellitus type two
408983|NCT01398592|T2DM|t2dm
408984|NCT01398592|vildagliptin|vildagliptin
408985|NCT01398592|sitagliptin|sitagliptin
408986|NCT01398592|FPG|fpg
408987|NCT01398592|DPP-4|dpp-4
408988|NCT01398579|intestinal metaplasia|intestinal metaplasia
408989|NCT01398579|dysplasia|dysplasia
408990|NCT01398579|probe-based confocal endomicroscopy|probe-based confocal endomicroscopy
408991|NCT01398566|TBI|tbi
408992|NCT01398566|concussion|concussion
408993|NCT01398566|brain injury|brain injury
408994|NCT01398553|stroke|stroke
408995|NCT01398553|tbi|tbi
408996|NCT01398553|rehabilitation|rehabilitation
408997|NCT01398553|upper limb|upper limb
408998|NCT01398527|Long-Term Care|long-term care
408999|NCT01398527|Vitamin D|vitamin d
409000|NCT01398501|AML|aml
409001|NCT01398501|FLT3-ITD|flt3-itd
409002|NCT01398501|Stem cell transplant|stem cell transplant
409003|NCT01398488|Trough levels|trough levels
409004|NCT01398488|Education|education
409005|NCT01398488|Adherence|adherence
409006|NCT01398449|thoracic esophageal squamous cell carcinoma|thoracic esophageal squamous cell carcinoma
409007|NCT01398449|esophagectomy|esophagectomy
409008|NCT01398449|elective nodal irradiation|elective nodal irradiation
409009|NCT01398449|adjuvant chemotherapy|adjuvant chemotherapy
409010|NCT01398436|Central venous saturation|central venous saturation
409011|NCT01398436|Mixed venous saturation|mixed venous saturation
409012|NCT01398436|Right atrium|right atrium
409013|NCT01398436|Central Venous Catheter position|central venous catheter position
409014|NCT01398423|Hypertension|hypertension
409015|NCT01398423|Diabetes mellitis|diabetes mellitis
409016|NCT01398423|Nephropathy|nephropathy
409017|NCT01398423|Albuminuria|albuminuria
409018|NCT01398410|Rabeprazole|rabeprazole
409019|NCT01398410|proton pump inhibitor|proton pump inhibitor
409020|NCT01398410|Acetylsalicylic Acid|acetylsalicylic acid
409021|NCT01398410|Aspirin|aspirin
409022|NCT01398410|Gastric Ulcer|gastric ulcer
409023|NCT01398410|Duodenal Ulcer|duodenal ulcer
409024|NCT01398397|HED|hed
409025|NCT01398397|XLHED|xlhed
409026|NCT01398397|X-linked Hypohidrotic Ectodermal Dysplasia (XLHED)|x-linked hypohidrotic ectodermal dysplasia (xlhed)
409027|NCT01398384|ST Elevation MI|st elevation mi
409028|NCT01398384|STEMI|stemi
409029|NCT01398371|Heart failure|heart failure
409030|NCT01398371|Digoxin withdrawal|digoxin withdrawal
409031|NCT01398358|obesity|obesity
409032|NCT01398358|prevention|prevention
409033|NCT01398358|children|children
409034|NCT01398319|prevention|prevention
409035|NCT01398319|alcohol abuse|alcohol abuse
409036|NCT01398306|Angiogenesis Inhibitors|angiogenesis inhibitors
409037|NCT01398306|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
409038|NCT01398306|Neoplasms by Histologic Type|neoplasms by histologic type
409039|NCT01398306|Neoplasms|neoplasms
409040|NCT01398306|Adenocarcinoma|adenocarcinoma
409041|NCT01398306|Kidney Neoplasms|kidney neoplasms
409042|NCT01398306|Urologic Neoplasms|urologic neoplasms
409043|NCT01398306|Urogenital Neoplasms|urogenital neoplasms
409044|NCT01398306|Neoplasms by Site|neoplasms by site
409045|NCT01398306|Kidney Diseases|kidney diseases
409046|NCT01398306|Angiogenesis Inducing Agents|angiogenesis inducing agents
409047|NCT01398306|Biological Markers|biological markers
409048|NCT01398280|Rosacea|rosacea
409049|NCT01398280|Dermatology|dermatology
409050|NCT01398280|UCSD|ucsd
409051|NCT01398280|Skin disease|skin disease
409052|NCT01398254|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
409053|NCT01398254|Mortality|mortality
409054|NCT01398228|Quality of care|quality of care
409055|NCT01398228|Acute Coronary Syndromes (ACS)|acute coronary syndromes (acs)
409056|NCT01398215|umbilical hernia|umbilical hernia
409057|NCT01398215|ventral hernia|ventral hernia
409058|NCT01398202|Vitamin D status|vitamin d status
409059|NCT01398202|25-hydroxyvitamin D|25-hydroxyvitamin d
409060|NCT01398202|Vitamin D3|vitamin d3
409061|NCT01398202|RCT|rct
409062|NCT01398202|Bio-efficacy|bio-efficacy
409063|NCT01398189|clozapine|clozapine
409064|NCT01398189|PET|pet
409065|NCT01398189|schizophrenia|schizophrenia
409066|NCT01398189|schizoaffective disorder|schizoaffective disorder
409067|NCT01398176|gamma delta T cell|gamma delta t cell
409068|NCT01398176|proliferation|proliferation
409069|NCT01398163|probiotics|probiotics
409070|NCT01398163|digestive well-being|digestive well-being
409071|NCT01398163|fMRI|fmri
409072|NCT01398163|brain-gut axis|brain-gut axis
409073|NCT01398150|gamma delta T cell|gamma delta t cell
409074|NCT01398150|proliferation|proliferation
409075|NCT01398150|cytokine secretion|cytokine secretion
409076|NCT01398150|immune function|immune function
409077|NCT01398150|antioxidant status|antioxidant status
409078|NCT01398137|Ragweed allergy|ragweed allergy
409079|NCT01398124|early stage non-small cell lung cancer|early stage non-small cell lung cancer
409080|NCT01398124|non-small cell lung cancer|non-small cell lung cancer
409081|NCT01398085|Papillary thyroid carcinoma|papillary thyroid carcinoma
409082|NCT01398085|Follicular thyroid carcinoma|follicular thyroid carcinoma
409083|NCT01398085|Hurthle cell carcinoma of the thyroid|hurthle cell carcinoma of the thyroid
409084|NCT01398085|Iodine Radioisotopes|iodine radioisotopes
409085|NCT01398059|Sedentary Behavior|sedentary behavior
409086|NCT01398059|Cardiometabolic Risk|cardiometabolic risk
409087|NCT01398059|Pediatrics|pediatrics
409088|NCT01398046|dasatinib|dasatinib
409089|NCT01398046|betaine|betaine
409090|NCT01398046|betaine hydrochloride|betaine hydrochloride
409091|NCT01398046|pharmacokinetics|pharmacokinetics
409092|NCT01398046|healthy volunteer|healthy volunteer
409093|NCT01398033|infrapopliteal arteries|infrapopliteal arteries
409094|NCT01398033|In-stent stenosis|in-stent stenosis
409095|NCT01398033|long lesions|long lesions
409096|NCT01398033|drug-coated balloon|drug-coated balloon
409097|NCT01398020|Bowel Preparation|bowel preparation
409098|NCT01398020|Patient comfort|patient comfort
409099|NCT01398020|Bi-Peglyte|bi-peglyte
409100|NCT01397994|Nicorandil therapy in patients of chronic stable angina|nicorandil therapy in patients of chronic stable angina
409101|NCT01397968|partial onset seizures|partial onset seizures
409102|NCT01397968|treatment resistant|treatment resistant
409103|NCT01397968|partial epilepsy|partial epilepsy
409104|NCT01397955|Julina|julina
409105|NCT01397955|Postmenopausal osteoporosis|postmenopausal osteoporosis
409106|NCT01397942|Diet intervention|diet intervention
409107|NCT01397942|Type 2 diabetes|type 2 diabetes
409108|NCT01397942|Vegetables|vegetables
409109|NCT01397942|Phytochemicals|phytochemicals
409110|NCT01397916|CLL|cll
409111|NCT01397916|IDO|ido
409112|NCT01397903|antidepressant therapy, inadequate control, add-on therapy|antidepressant therapy, inadequate control, add-on therapy
409113|NCT01397890|Severe chronic obstructive pulmonary disease (COPD) patients|severe chronic obstructive pulmonary disease (copd) patients
409114|NCT01397877|endometrial cancer|endometrial cancer
409115|NCT01397877|BKM|bkm
409116|NCT01397877|monotherapy|monotherapy
409117|NCT01397877|metastatic|metastatic
409118|NCT01397877|initial treatment|initial treatment
409119|NCT01397864|Hereditary Angioedema|hereditary angioedema
409120|NCT01397864|HAE|hae
409121|NCT01397864|Angioedema|angioedema
409243|NCT01397305|Antineoplastic Agents|antineoplastic agents
409122|NCT01397864|Recombinant C1 Inhibitor|recombinant c1 inhibitor
409123|NCT01397864|rhC1INH|rhc1inh
409124|NCT01397864|registry|registry
409125|NCT01397838|Osteopenia|osteopenia
409126|NCT01397812|Rejection of the Heart Transplant|rejection of the heart transplant
409127|NCT01397812|Heart Transplant Rejection, an immune-mediated allograft injury|heart transplant rejection, an immune-mediated allograft injury
409128|NCT01397812|Non-cellular or humoral rejection in cardiac transplant recipients|non-cellular or humoral rejection in cardiac transplant recipients
409129|NCT01397812|Right ventricular endomyocardial biopsy to detect Heart transplant rejection|right ventricular endomyocardial biopsy to detect heart transplant rejection
409130|NCT01397799|Acute Myelogenous Leukemia|acute myelogenous leukemia
409131|NCT01397799|AML|aml
409132|NCT01397799|Refractory|refractory
409133|NCT01397799|Elderly|elderly
409134|NCT01397773|Hemodialysis|hemodialysis
409135|NCT01397773|peritoneal dialysis|peritoneal dialysis
409136|NCT01397773|chronic kidney disease|chronic kidney disease
409137|NCT01397773|inflammation|inflammation
409138|NCT01397773|carotis intima media thickness|carotis intima media thickness
409139|NCT01397760|DIFFICULT TO CONTROL ASTHMA|difficult to control asthma
409140|NCT01397760|OMALIZUMABE|omalizumabe
409141|NCT01397747|Cancer|cancer
409142|NCT01397747|Colorectal Cancer|colorectal cancer
409143|NCT01397747|Neoplasm|neoplasm
409144|NCT01397747|Colorectal Neoplasm|colorectal neoplasm
409145|NCT01397747|Intestinal Neoplasms|intestinal neoplasms
409146|NCT01397747|Gastrointestinal Neoplasms|gastrointestinal neoplasms
409147|NCT01397747|Digestive System Neoplasms|digestive system neoplasms
409148|NCT01397747|Neoplasms by Site|neoplasms by site
409149|NCT01397747|Neoplasms|neoplasms
409150|NCT01397747|Digestive System Diseases|digestive system diseases
409151|NCT01397747|Gastrointestinal Diseases|gastrointestinal diseases
409152|NCT01397747|Colonic Diseases|colonic diseases
409153|NCT01397747|Intestinal Diseases|intestinal diseases
409154|NCT01397747|Rectal Diseases|rectal diseases
409155|NCT01397734|CML|cml
409156|NCT01397734|Chronic myelogenous leukemia|chronic myelogenous leukemia
409157|NCT01397734|Chronic Myeloid leukemia|chronic myeloid leukemia
409158|NCT01397734|Arsenic|arsenic
409159|NCT01397734|Arsenic trioxide|arsenic trioxide
409160|NCT01397734|Imatinib|imatinib
409161|NCT01397734|Dasatinib|dasatinib
409162|NCT01397734|Nilotinib|nilotinib
409163|NCT01397734|TKI|tki
409164|NCT01397734|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
409165|NCT01397721|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
409166|NCT01397721|pulmonary vasculature|pulmonary vasculature
409167|NCT01397721|pulmonary hypertension|pulmonary hypertension
409168|NCT01397721|atherosclerosis|atherosclerosis
409169|NCT01397721|smokers|smokers
409170|NCT01397721|emphysema|emphysema
409171|NCT01397708|Melanoma|melanoma
409172|NCT01397708|Unresectable|unresectable
409173|NCT01397682|Comprehensive Geriatric Assessment|comprehensive geriatric assessment
409174|NCT01397682|Frail elderly|frail elderly
409175|NCT01397682|Italy/epidemiology|italy/epidemiology
409176|NCT01397682|Geriatric Health Service|geriatric health service
409177|NCT01397682|Polypharmacy|polypharmacy
409178|NCT01397682|Biological Markers|biological markers
409179|NCT01397682|Epidemiologic Research Design|epidemiologic research design
409180|NCT01397656|cardiac arrest|cardiac arrest
409181|NCT01397656|CPR|cpr
409182|NCT01397656|resuscitation|resuscitation
409183|NCT01397656|fatigue|fatigue
409184|NCT01397656|quality|quality
409185|NCT01397565|Cholecystectomy|cholecystectomy
409186|NCT01397565|Laparoscopy|laparoscopy
409187|NCT01397565|Minilaparoscopic surgery|minilaparoscopic surgery
409188|NCT01397565|Post-operative pain|post-operative pain
409189|NCT01397565|Recovery time|recovery time
409190|NCT01397526|Congenital heart disease|congenital heart disease
409191|NCT01397526|Cardiopulmonary bypass|cardiopulmonary bypass
409192|NCT01397526|Capillary leak|capillary leak
409193|NCT01397526|Colloid osmotic pressure|colloid osmotic pressure
409194|NCT01397526|Children|children
409195|NCT01397513|Fibrin network structure|fibrin network structure
409196|NCT01397513|Aspirin treatment|aspirin treatment
409197|NCT01397513|Platelet microparticles|platelet microparticles
409198|NCT01397487|morphometric parameters, embryo biopsy|morphometric parameters, embryo biopsy
409199|NCT01397474|peripheral perfusion|peripheral perfusion
409200|NCT01397474|critically ill patients|critically ill patients
409201|NCT01397474|fluid administration|fluid administration
409202|NCT01397448|Rabeprazole|rabeprazole
409203|NCT01397448|proton pump inhibitor|proton pump inhibitor
409204|NCT01397448|Acetylsalicylic Acid|acetylsalicylic acid
409205|NCT01397448|Aspirin|aspirin
409206|NCT01397448|Gastric Ulcer|gastric ulcer
409207|NCT01397448|Duodenal Ulcer|duodenal ulcer
409208|NCT01397435|Lysosomal diseases|lysosomal diseases
409209|NCT01397435|Magnetic resonance Spectroscopy|magnetic resonance spectroscopy
409210|NCT01397435|MRI|mri
409211|NCT01397422|Levodopa-induced dyskinesia|levodopa-induced dyskinesia
409212|NCT01397422|Parkinsonism|parkinsonism
409213|NCT01397370|Safety|safety
409214|NCT01397370|Tolerability|tolerability
409215|NCT01397370|Pharmacokinetics|pharmacokinetics
409216|NCT01397370|Pharmacodynamics|pharmacodynamics
409217|NCT01397357|Cardiac magnetic resonance|cardiac magnetic resonance
409218|NCT01397357|Myocardial Ischemia|myocardial ischemia
409219|NCT01397357|Coronary Artery Disease|coronary artery disease
409220|NCT01397357|suspected Myocardial Ischemia|suspected myocardial ischemia
409221|NCT01397344|People in the outpatient waiting room|people in the outpatient waiting room
409222|NCT01397331|inhalational anesthesia|inhalational anesthesia
409223|NCT01397331|intravenous anesthesia|intravenous anesthesia
409224|NCT01397331|cardiac surgery|cardiac surgery
409225|NCT01397318|TaiChi Exercise|taichi exercise
409226|NCT01397318|pregnant women|pregnant women
409227|NCT01397305|5,10-methylenetetrahydrofolate|5,10-methylenetetrahydrofolate
409228|NCT01397305|neoadjuvant therapy|neoadjuvant therapy
409229|NCT01397305|pemetrexed|pemetrexed
409230|NCT01397305|Neoplasms|neoplasms
409231|NCT01397305|Rectal Neoplasms|rectal neoplasms
409232|NCT01397305|Colorectal Neoplasms|colorectal neoplasms
409233|NCT01397305|Intestinal Neoplasms|intestinal neoplasms
409234|NCT01397305|Gastrointestinal Neoplasms|gastrointestinal neoplasms
409235|NCT01397305|Digestive System Neoplasms|digestive system neoplasms
409236|NCT01397305|Neoplasms by Site|neoplasms by site
409237|NCT01397305|Rectal Diseases|rectal diseases
409238|NCT01397305|Digestive System Diseases|digestive system diseases
409239|NCT01397305|Gastrointestinal Diseases|gastrointestinal diseases
409240|NCT01397305|Intestinal Diseases|intestinal diseases
409241|NCT01397305|Pharmacologic Actions|pharmacologic actions
409242|NCT01397305|Therapeutic Uses|therapeutic uses
409244|NCT01397305|Enzyme Inhibitors|enzyme inhibitors
409245|NCT01397305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
409246|NCT01397305|Folic Acid Antagonists|folic acid antagonists
409247|NCT01397305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic
409248|NCT01397305|Antimetabolites|antimetabolites
409249|NCT01397292|Bronchoscopy|bronchoscopy
409250|NCT01397292|Interventional Pulmonary|interventional pulmonary
409251|NCT01397292|Pleuroscopy|pleuroscopy
409252|NCT01397292|Tracheostomy|tracheostomy
409253|NCT01397279|type 2 diabetes|type 2 diabetes
409254|NCT01397279|insulin sensitivity|insulin sensitivity
409255|NCT01397279|hyperinsulinemic euglycemic clamp|hyperinsulinemic euglycemic clamp
409256|NCT01397266|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
409257|NCT01397266|Cocaine|cocaine
409258|NCT01397266|impulsivity|impulsivity
409259|NCT01397266|rating scale|rating scale
409260|NCT01397253|Automated Communication Tools|automated communication tools
409261|NCT01397253|Medication errors|medication errors
409262|NCT01397253|PCP communication|pcp communication
409263|NCT01397227|Malaria|malaria
409264|NCT01397227|Plasmodium falciparum|plasmodium falciparum
409265|NCT01397227|Vaccination|vaccination
409266|NCT01397227|Prophylaxis|prophylaxis
409267|NCT01397227|Adenovirus|adenovirus
409268|NCT01397188|PiCCO|picco
409269|NCT01397175|Coronary artery disease|coronary artery disease
409270|NCT01397175|Percutaneous coronary intervention|percutaneous coronary intervention
409271|NCT01397175|Drug-eluting stent|drug-eluting stent
409272|NCT01397149|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
409273|NCT01397149|Thrombocytopenia|thrombocytopenia
409274|NCT01397149|Alkylating agents|alkylating agents
409275|NCT01397149|Purine derivatives|purine derivatives
409276|NCT01397149|TPO receptor agonist|tpo receptor agonist
409277|NCT01397136|Human embryo|human embryo
409278|NCT01397136|Culture media|culture media
409279|NCT01397136|Cell-free DNA|cell-free dna
409280|NCT01397136|In vitro fertilization|in vitro fertilization
409281|NCT01397136|Infertility|infertility
409282|NCT01397123|BMI z-score|bmi z-score
409283|NCT01397123|children|children
409284|NCT01397123|overweight|overweight
409285|NCT01397123|school-based intervention|school-based intervention
409286|NCT01397123|trained teachers|trained teachers
409287|NCT01397123|fruit|fruit
409288|NCT01397123|vegetables|vegetables
409289|NCT01397123|Low nutrition energy dense foods|low nutrition energy dense foods
409290|NCT01397084|esomeprazole 20mg|esomeprazole 20mg
409291|NCT01397084|heartburn|heartburn
409292|NCT01397084|rabeprazole 10mg|rabeprazole 10mg
409293|NCT01397084|reflux esophagitis|reflux esophagitis
409294|NCT01397084|Phase IV|phase iv
409295|NCT01397071|Avocado, antioxidant|avocado, antioxidant
409296|NCT01397045|Lung|lung
409297|NCT01397045|Nodule|nodule
409298|NCT01397045|Rehabilitation|rehabilitation
409299|NCT01397045|VATS|vats
409300|NCT01397045|Thoracotomy|thoracotomy
409301|NCT01397032|attention bias modification treatment|attention bias modification treatment
409302|NCT01397032|cognitive bias modification|cognitive bias modification
409303|NCT01397032|attention training|attention training
409304|NCT01397032|social anxiety|social anxiety
409305|NCT01397019|Pancreatic cancer|pancreatic cancer
409306|NCT01397019|Chemotherapy|chemotherapy
409307|NCT01397019|Chemoradiotherapy|chemoradiotherapy
409308|NCT01397006|Fibromyalgia|fibromyalgia
409309|NCT01397006|pregabalin|pregabalin
409310|NCT01397006|Lyrica|lyrica
409311|NCT01396980|hemodialysis|hemodialysis
409312|NCT01396980|intensive care|intensive care
409313|NCT01396980|microcirculation|microcirculation
409314|NCT01396967|capsulorhexis|capsulorhexis
409315|NCT01396954|Liver cirrhosis|liver cirrhosis
409316|NCT01396954|Diabetes mellitus|diabetes mellitus
409317|NCT01396954|Hepatogenous diabetes|hepatogenous diabetes
409318|NCT01396954|Oral glucose tolerance test|oral glucose tolerance test
409319|NCT01396954|Insulin resistance.|insulin resistance.
409320|NCT01396941|Diabetes|diabetes
409321|NCT01396928|Low rectal adenocarcinoma|low rectal adenocarcinoma
409322|NCT01396915|Skeletal muscle lipid content|skeletal muscle lipid content
409323|NCT01396915|whole muscle volume|whole muscle volume
409324|NCT01396915|fasting glucose|fasting glucose
409325|NCT01396915|insulin|insulin
409326|NCT01396915|blood urea nitrogen|blood urea nitrogen
409327|NCT01396889|Upper Respiratory Tract Infections|upper respiratory tract infections
409328|NCT01396889|Echinacea|echinacea
409329|NCT01396889|viral infections|viral infections
409330|NCT01396876|Medical clown|medical clown
409331|NCT01396876|Pediatric emergency medicine|pediatric emergency medicine
409332|NCT01396876|Emergency procedures|emergency procedures
409333|NCT01396863|Renal dialysis|renal dialysis
409334|NCT01396863|Hemodiafiltration|hemodiafiltration
409335|NCT01396863|Hemodialysis|hemodialysis
409336|NCT01396863|MRI|mri
409337|NCT01396850|Psychotic Patients|psychotic patients
409338|NCT01396837|Diabetic Foot Ulcer|diabetic foot ulcer
409339|NCT01396837|Diabetic Ulcer|diabetic ulcer
409340|NCT01396837|Diabetic Wound|diabetic wound
409341|NCT01396837|Chronic Ulcer|chronic ulcer
409342|NCT01396837|Chronic Wound|chronic wound
409343|NCT01396837|Neuropathic Diabetic Foot Ulcer|neuropathic diabetic foot ulcer
409344|NCT01396837|Neuropathic DFU|neuropathic dfu
409345|NCT01396837|DFU|dfu
409346|NCT01396824|Malnutrition|malnutrition
409347|NCT01396824|Undernutrition|undernutrition
409348|NCT01396824|Nutrition Assessment|nutrition assessment
409349|NCT01396824|Nutritional Assessment|nutritional assessment
409350|NCT01396824|Nutritional Index|nutritional index
409351|NCT01396824|Prognostic Nutritional Index|prognostic nutritional index
409352|NCT01396824|Prognostic Nutritional Index (PNI)|prognostic nutritional index (pni)
409353|NCT01396824|Nutritional Status|nutritional status
409354|NCT01396824|Prognosis|prognosis
409355|NCT01396824|Heart Failure|heart failure
409356|NCT01396824|Cardiovascular Diseases|cardiovascular diseases
409357|NCT01396824|Body Composition|body composition
409358|NCT01396824|Body Weights and Measures|body weights and measures
409359|NCT01396811|Tinea Pedis|tinea pedis
409360|NCT01396811|Antifungal|antifungal
409361|NCT01396798|serious infections|serious infections
409362|NCT01396798|meningitis|meningitis
409363|NCT01396785|Tinea Pedis|tinea pedis
409364|NCT01396785|Antifungal|antifungal
409365|NCT01396772|prediabetes|prediabetes
409366|NCT01396772|diabetes prevention|diabetes prevention
409367|NCT01396772|adults|adults
409368|NCT01396772|lifestyle intervention|lifestyle intervention
409369|NCT01396772|Social Cognitive Theory|social cognitive theory
409370|NCT01396772|dietary intake|dietary intake
409371|NCT01396772|physical activity|physical activity
409372|NCT01396759|Bubble CPAP|bubble cpap
409373|NCT01396759|Humidified high flow|humidified high flow
409374|NCT01396759|Hypoxaemia|hypoxaemia
409375|NCT01396759|Nasal prong|nasal prong
409376|NCT01396759|Severe pneumonia|severe pneumonia
409377|NCT01396733|thyroid|thyroid
409378|NCT01396733|cancer|cancer
409379|NCT01396733|redifferentiation|redifferentiation
409380|NCT01396733|lipoic acid|lipoic acid
409381|NCT01396707|HER2|her2
409382|NCT01396707|Trastuzumab|trastuzumab
409383|NCT01396707|XELOX|xelox
409384|NCT01396707|PHASE 2|phase 2
409385|NCT01396681|resected pancreatic cancer|resected pancreatic cancer
409386|NCT01396668|locally advanced|locally advanced
409387|NCT01396655|breast cancer|breast cancer
409388|NCT01396655|neoadjuvant chemotherapy|neoadjuvant chemotherapy
409389|NCT01396655|molecular marker|molecular marker
409390|NCT01396655|FDG PET|fdg pet
409391|NCT01396655|locally advanced breast cancer|locally advanced breast cancer
409392|NCT01396642|Topical Emollient Therapy|topical emollient therapy
409393|NCT01396642|Emollient|emollient
409394|NCT01396642|Preterm|preterm
409395|NCT01396642|Hospital Acquired Infection|hospital acquired infection
409396|NCT01396629|cartridge IOL|cartridge iol
409397|NCT01396603|Optical Frequency Domain Imaging|optical frequency domain imaging
409398|NCT01396603|Optical Coherence Tomography|optical coherence tomography
409399|NCT01396603|Optical biopsy|optical biopsy
409400|NCT01396603|Comprehensive Microscopy|comprehensive microscopy
409401|NCT01396590|Central Nervous System|central nervous system
409402|NCT01396577|Central Nervous System|central nervous system
409403|NCT01396564|Type 2 diabetes|type 2 diabetes
409404|NCT01396564|Resistin|resistin
409405|NCT01396564|Inflammation|inflammation
409406|NCT01396564|Insulin Resistance|insulin resistance
409407|NCT01396551|Anchored Beacon Transponder|anchored beacon transponder
409408|NCT01396551|Anchored Transponder|anchored transponder
409409|NCT01396551|Lung cancer|lung cancer
409410|NCT01396551|Calypso system|calypso system
409411|NCT01396551|Realtime tracking|realtime tracking
409412|NCT01396538|anti-HBc alone ；occult HBV infection|anti-hbc alone ；occult hbv infection
409413|NCT01396525|Atherosclerosis|atherosclerosis
409414|NCT01396525|Peripheral artery disease|peripheral artery disease
409415|NCT01396525|Peripheral vascular disease|peripheral vascular disease
409416|NCT01396525|PAD|pad
409417|NCT01396525|Claudication|claudication
409418|NCT01396525|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
409419|NCT01396525|Stent|stent
409420|NCT01396525|PAOD|paod
409421|NCT01396525|PVD|pvd
409422|NCT01396512|Japanese Encephalitis|japanese encephalitis
409423|NCT01396512|Japanese Encephalitis Virus Disease|japanese encephalitis virus disease
409424|NCT01396512|IMOJEV™|imojev™
409425|NCT01396512|CD.JEVAX™|cd.jevax™
409426|NCT01396499|Leukemia|leukemia
409427|NCT01396499|Acute leukemias|acute leukemias
409428|NCT01396499|Relapsed/refractory leukemias|relapsed/refractory leukemias
409429|NCT01396499|Acute myelogenous leukemia|acute myelogenous leukemia
409430|NCT01396499|AML|aml
409431|NCT01396499|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
409432|NCT01396499|ALL|all
409433|NCT01396499|BKM120|bkm120
409434|NCT01396486|Omega-3 Fatty Acids|omega-3 fatty acids
409435|NCT01396486|Fish Oil|fish oil
409436|NCT01396486|Inositol|inositol
409437|NCT01396486|Natural supplements|natural supplements
409438|NCT01396486|Bipolar Spectrum Disorders|bipolar spectrum disorders
409439|NCT01396486|Mania|mania
409440|NCT01396486|Depression|depression
409441|NCT01396486|Children|children
409442|NCT01396473|afterschool|afterschool
409443|NCT01396473|accelerometers|accelerometers
409444|NCT01396473|plate waste|plate waste
409445|NCT01396473|policy|policy
409446|NCT01396473|environment|environment
409447|NCT01396460|respiratory quotient|respiratory quotient
409448|NCT01396460|fat oxidation|fat oxidation
409746|NCT01394939|Vaccinia|vaccinia
409449|NCT01396460|morbid obesity|morbid obesity
409450|NCT01396460|bariatric|bariatric
409451|NCT01396460|Bariatric Surgery|bariatric surgery
409452|NCT01396447|Bipolar I disorder|bipolar i disorder
409453|NCT01396447|Bipolar depression|bipolar depression
409454|NCT01396447|Depression|depression
409455|NCT01396447|Bipolar disorder|bipolar disorder
409456|NCT01396395|Nicorandil|nicorandil
409457|NCT01396395|Stable angina|stable angina
409458|NCT01396382|neuroendocrine|neuroendocrine
409459|NCT01396382|neuroendocrine carcinoma|neuroendocrine carcinoma
409460|NCT01396382|neuroendocrine tumor|neuroendocrine tumor
409461|NCT01396382|carcinoid|carcinoid
409462|NCT01396382|carcinoid tumor|carcinoid tumor
409463|NCT01396382|islet cell tumor|islet cell tumor
409464|NCT01396382|APUDoma|apudoma
409465|NCT01396382|Gallium|gallium
409466|NCT01396382|PET Scan|pet scan
409467|NCT01396343|Pediatric Multiple Sclerosis|pediatric multiple sclerosis
409468|NCT01396343|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
409469|NCT01396343|Clinically Isolated Syndrome|clinically isolated syndrome
409470|NCT01396343|Demyelinating Disease|demyelinating disease
409471|NCT01396317|PMR|pmr
409472|NCT01396317|POLYMYALGIA RHEUMATICA|polymyalgia rheumatica
409473|NCT01396317|Tocilizumab|tocilizumab
409474|NCT01396317|Hospital for Special Surgery|hospital for special surgery
409475|NCT01396317|HSS|hss
409476|NCT01396317|Robert Spiera|robert spiera
409477|NCT01396304|leg ulcer|leg ulcer
409478|NCT01396304|infection|infection
409479|NCT01396304|closure|closure
409480|NCT01396304|wound dressings|wound dressings
409481|NCT01396239|DMD|dmd
409482|NCT01396226|Atrial refractoriness|atrial refractoriness
409483|NCT01396226|cardiac electrophysiology|cardiac electrophysiology
409484|NCT01396226|IKACh|ikach
409485|NCT01396213|larazotide acetate|larazotide acetate
409486|NCT01396187|Type 2 diabetes|type 2 diabetes
409487|NCT01396187|safety|safety
409488|NCT01396187|multiple dose|multiple dose
409489|NCT01396187|intravenous|intravenous
409490|NCT01396174|breast cancer|breast cancer
409491|NCT01396174|breast tumor|breast tumor
409492|NCT01396161|Phase 1|phase 1
409493|NCT01396161|Multiple Doses|multiple doses
409494|NCT01396161|Safety|safety
409495|NCT01396161|Pharmacokinetics|pharmacokinetics
409496|NCT01396161|Pharmacodynamics|pharmacodynamics
409497|NCT01396161|Healthy Volunteers|healthy volunteers
409498|NCT01396161|Type 2 Diabetic Patients|type 2 diabetic patients
409499|NCT01396148|Children and young adults with GIST|children and young adults with gist
409500|NCT01396148|sunitinib malate|sunitinib malate
409501|NCT01396148|pharmacokinetics|pharmacokinetics
409502|NCT01396148|tumor response|tumor response
409503|NCT01396148|overall survival|overall survival
409504|NCT01396148|tumor KIT mutation status|tumor kit mutation status
409505|NCT01396135|Phase 1|phase 1
409506|NCT01396135|Pharmacokinetics|pharmacokinetics
409507|NCT01396135|Healthy|healthy
409508|NCT01396135|Japanese|japanese
409509|NCT01396135|Non-smokers|non-smokers
409510|NCT01396135|Major Depressive Disorder|major depressive disorder
409511|NCT01396135|CP-601|cp-601
409512|NCT01396135|927|927
409513|NCT01396096|Bariatric Surgery|bariatric surgery
409514|NCT01396083|Visual impairment|visual impairment
409515|NCT01396083|macular edema|macular edema
409516|NCT01396083|Central retinal vein occlusion|central retinal vein occlusion
409517|NCT01396083|Dexamethasone implant|dexamethasone implant
409518|NCT01396083|Ranibizumab|ranibizumab
409519|NCT01396057|Visual impairment|visual impairment
409520|NCT01396057|macular edema|macular edema
409521|NCT01396057|branch retinal vein occlusion|branch retinal vein occlusion
409522|NCT01396057|Dexamethasone implant|dexamethasone implant
409523|NCT01396057|Ranibizumab|ranibizumab
409524|NCT01396044|Quality improvement|quality improvement
409525|NCT01396044|Checklist|checklist
409526|NCT01396044|Critical care|critical care
409527|NCT01396044|Anti-bacterial agents|anti-bacterial agents
409528|NCT01396044|Mechanical ventilation|mechanical ventilation
409529|NCT01395966|with tubes|with tubes
409530|NCT01395953|Buspirone|buspirone
409531|NCT01395953|Buspar|buspar
409532|NCT01395953|Autism Spectrum Disorders|autism spectrum disorders
409533|NCT01395953|Pervasive Developmental Disorders|pervasive developmental disorders
409534|NCT01395953|Children|children
409535|NCT01395953|Adolescents|adolescents
409536|NCT01395953|Anxiety|anxiety
409537|NCT01395940|Gonadotropin-Releasing Hormone (GnRH) antagonist|gonadotropin-releasing hormone (gnrh) antagonist
409538|NCT01395927|Canagliflozin|canagliflozin
409539|NCT01395927|Rifampin|rifampin
409540|NCT01395927|Pharmacokinetics|pharmacokinetics
409541|NCT01395901|Prevention of Postoperative Nausea and Vomiting|prevention of postoperative nausea and vomiting
409542|NCT01395901|Palonosetron|palonosetron
409543|NCT01395901|Ondansetron|ondansetron
409544|NCT01395901|Pediatric|pediatric
409545|NCT01395836|Coronary Artery Bypass Grafting|coronary artery bypass grafting
409546|NCT01395836|Cardiology|cardiology
409547|NCT01395836|Cardiac Electrophysiology|cardiac electrophysiology
409548|NCT01395836|Cardiac Surgery|cardiac surgery
409549|NCT01395784|Oxycodone|oxycodone
409945|NCT01394081|Veterans|veterans
409550|NCT01395784|Opioid abuse|opioid abuse
409551|NCT01395771|Effect|effect
409552|NCT01395771|Phone call|phone call
409553|NCT01395771|Intervention|intervention
409554|NCT01395771|Promote|promote
409555|NCT01395771|HAART adherence|haart adherence
409556|NCT01395758|KRAS mutation|kras mutation
409557|NCT01395758|metastatic NSCLC|metastatic nsclc
409558|NCT01395745|SLE|sle
409559|NCT01395745|Lupus|lupus
409560|NCT01395745|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
409561|NCT01395745|Autoimmune Diseases|autoimmune diseases
409562|NCT01395745|A-623|a-623
409563|NCT01395745|Blisibimod|blisibimod
409564|NCT01395719|renal transplantation|renal transplantation
409565|NCT01395719|glomerular filtration rate|glomerular filtration rate
409566|NCT01395719|remote ischemic preconditioning|remote ischemic preconditioning
409567|NCT01395719|remote ischemic conditioning|remote ischemic conditioning
409568|NCT01395706|Malignant Neoplasm of Breast|malignant neoplasm of breast
409569|NCT01395706|Sentinel lymph node detection|sentinel lymph node detection
409570|NCT01395706|ICG fluorescence technique|icg fluorescence technique
409571|NCT01395706|Population of male and female patients with mamma carcinoma|population of male and female patients with mamma carcinoma
409572|NCT01395680|cancer adolescent|cancer adolescent
409573|NCT01395680|resilience|resilience
409574|NCT01395641|Aromatic Amino Acid Decarboxylase|aromatic amino acid decarboxylase
409575|NCT01395641|AADC|aadc
409576|NCT01395641|DDC|ddc
409577|NCT01395641|Gene Therapy|gene therapy
409578|NCT01395641|AAV2-AADC|aav2-aadc
409579|NCT01395641|Viral Vector|viral vector
409580|NCT01395641|Gene Transfer|gene transfer
409581|NCT01395641|Aromatic L-Amino Acid Decarboxylase Deficiency|aromatic l-amino acid decarboxylase deficiency
409582|NCT01395628|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
409583|NCT01395628|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
409584|NCT01395628|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
409585|NCT01395628|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
409586|NCT01395628|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
409587|NCT01395628|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
409588|NCT01395589|allergy|allergy
409589|NCT01395589|clinical trial|clinical trial
409590|NCT01395589|exacerbation|exacerbation
409591|NCT01395589|pediatrics|pediatrics
409592|NCT01395576|Genu recurvatum|genu recurvatum
409593|NCT01395576|Knee hyper extension|knee hyper extension
409594|NCT01395576|Orthosis|orthosis
409595|NCT01395576|Gait analysis|gait analysis
409596|NCT01395576|Post stroke|post stroke
409597|NCT01395524|Non-Cancer-Related Pain|non-cancer-related pain
409598|NCT01395524|Opioid-Induced Constipation.|opioid-induced constipation.
409599|NCT01395511|whiplash associated disorder,|whiplash associated disorder,
409600|NCT01395511|Intractable Traumatic Cervical Syndrome,|intractable traumatic cervical syndrome,
409601|NCT01395511|Acupuncture,|acupuncture,
409602|NCT01395511|Randomized controlled trial|randomized controlled trial
409603|NCT01395498|CMV|cmv
409604|NCT01395498|PCP|pcp
409605|NCT01395498|bronchoalveolar lavage|bronchoalveolar lavage
409606|NCT01395485|Amgen|amgen
409607|NCT01395485|Adolescent|adolescent
409608|NCT01395485|Single Dose|single dose
409609|NCT01395485|Safety|safety
409610|NCT01395485|Pharmacokinetics|pharmacokinetics
409611|NCT01395472|TBI|tbi
409612|NCT01395472|Acute physical exercise|acute physical exercise
409613|NCT01395472|Cognitive functions|cognitive functions
409614|NCT01395472|Mood|mood
409615|NCT01395459|screening|screening
409616|NCT01395459|cancer prevention|cancer prevention
409617|NCT01395459|IVR|ivr
409618|NCT01395433|Assessing the bioequivalence of escitalopram dosage forms|assessing the bioequivalence of escitalopram dosage forms
409620|NCT01395420|open label|open label
409621|NCT01395420|healthy male and female (post menopausal) volunteers|healthy male and female (post menopausal) volunteers
409622|NCT01395420|Pharmacokinetics|pharmacokinetics
409623|NCT01395420|CAZ104|caz104
409624|NCT01395420|Avibactam|avibactam
409625|NCT01395420|Ceftazidime|ceftazidime
409626|NCT01395420|open label, at least 2 different regimens, concentration of investigational product (IP), CAZ104, Avibactam, Ceftazidime, Cmax, tmax|open label, at least 2 different regimens, concentration of investigational product (ip), caz104, avibactam, ceftazidime, cmax, tmax
409627|NCT01395407|Brain|brain
409628|NCT01395407|Neoplasm|neoplasm
409629|NCT01395407|Neoplasm Metastasis|neoplasm metastasis
409630|NCT01395407|Radiosurgery|radiosurgery
409631|NCT01395394|Phenylketonuria|phenylketonuria
409632|NCT01395394|PKU|pku
409633|NCT01395394|tetrahydrobiopterin|tetrahydrobiopterin
409634|NCT01395394|sapropterin dihydrochloride|sapropterin dihydrochloride
409635|NCT01395394|BH4|bh4
409636|NCT01395394|Kuvan|kuvan
409637|NCT01395394|Oxidative stress|oxidative stress
409638|NCT01395368|subjective|subjective
409639|NCT01395368|unilateral|unilateral
409640|NCT01395368|bilateral|bilateral
409641|NCT01395368|non-pulsatile|non-pulsatile
409642|NCT01395368|6 month's duration or longer|6 month's duration or longer
409643|NCT01395355|binge eating|binge eating
410150|NCT01393093|HCC|hcc
409644|NCT01395355|loss of control eating|loss of control eating
409645|NCT01395355|eating in the absence of hunger|eating in the absence of hunger
409646|NCT01395355|emotional eating|emotional eating
409647|NCT01395342|Pregnant women|pregnant women
409648|NCT01395342|Pre-eclampsia|pre-eclampsia
409649|NCT01395342|Exercise|exercise
409650|NCT01395342|Hypertension, Pregnancy-Induced|hypertension, pregnancy-induced
409651|NCT01395342|Parturition|parturition
409652|NCT01395303|infarction|infarction
409653|NCT01395303|stroke|stroke
409654|NCT01395303|diabetes|diabetes
409655|NCT01395303|fracture|fracture
409656|NCT01395303|aortic stenosis|aortic stenosis
409657|NCT01395303|cancer|cancer
409658|NCT01395303|death|death
409659|NCT01395303|vitamin D|vitamin d
409660|NCT01395303|androgens|androgens
409661|NCT01395303|thyroid hormones|thyroid hormones
409662|NCT01395290|staphylococcus aureus|staphylococcus aureus
409663|NCT01395290|vitamin D|vitamin d
409664|NCT01395277|Nitric Oxide|nitric oxide
409665|NCT01395277|Vascular Function|vascular function
409666|NCT01395277|Aging|aging
409667|NCT01395277|Blood Pressure|blood pressure
409668|NCT01395277|Arterial Stiffness|arterial stiffness
409669|NCT01395277|Cardiovascular Disease|cardiovascular disease
409670|NCT01395277|Cerebral Blood Flow|cerebral blood flow
409671|NCT01395251|rheumatoid arthritis|rheumatoid arthritis
409672|NCT01395251|diagnosis|diagnosis
409673|NCT01395251|sensitivity|sensitivity
409674|NCT01395251|glucocorticoids|glucocorticoids
409675|NCT01395238|fathers|fathers
409676|NCT01395238|parenting|parenting
409677|NCT01395238|high-risk|high-risk
409678|NCT01395238|child maltreatment|child maltreatment
409679|NCT01395238|prevention|prevention
409680|NCT01395225|Fat Emulsifying|fat emulsifying
409681|NCT01395225|Radical Cystectomy|radical cystectomy
409682|NCT01395225|Pelvic Lymph Node Dissection|pelvic lymph node dissection
409683|NCT01395225|Pathological Lymph Node Processing|pathological lymph node processing
409684|NCT01395225|Bladder Cancer|bladder cancer
409685|NCT01395225|Transitional Cell Carcinoma|transitional cell carcinoma
409686|NCT01395225|Urothelial Cell Carcinoma|urothelial cell carcinoma
409687|NCT01395212|Cell-based cardiac regenerative therapy|cell-based cardiac regenerative therapy
409688|NCT01395212|Intramyocardial injections|intramyocardial injections
409689|NCT01395212|NOGA procedure|noga procedure
409690|NCT01395212|Acute myocardial infarction|acute myocardial infarction
409691|NCT01395199|Magnetic resonance imaging|magnetic resonance imaging
409692|NCT01395199|Thalassemia|thalassemia
409693|NCT01395199|Iron overload|iron overload
409694|NCT01395186|varicocele|varicocele
409695|NCT01395186|pain|pain
409696|NCT01395173|detection|detection
409697|NCT01395160|Attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
409698|NCT01395160|ADHD|adhd
409699|NCT01395160|Bipolar Disorder|bipolar disorder
409700|NCT01395160|Electrophysiological|electrophysiological
409701|NCT01395160|EEG|eeg
409702|NCT01395160|ERP|erp
409703|NCT01395160|Attention|attention
409704|NCT01395160|Motivation|motivation
409705|NCT01395160|Mood instability|mood instability
409706|NCT01395147|Drug Therapy|drug therapy
409707|NCT01395134|External branch of the superior laryngeal nerve,|external branch of the superior laryngeal nerve,
409708|NCT01395134|Recurrent laryngeal nerve,|recurrent laryngeal nerve,
409709|NCT01395134|Intraoperative neuromonitoring,|intraoperative neuromonitoring,
409710|NCT01395134|Thyroid surgery|thyroid surgery
409711|NCT01395121|c-KIT mutation|c-kit mutation
409712|NCT01395121|advanced disease|advanced disease
409713|NCT01395121|tyrosine kinase inhibitors|tyrosine kinase inhibitors
409714|NCT01395095|cardiac rehabilitation|cardiac rehabilitation
409715|NCT01395095|risk factor|risk factor
409716|NCT01395095|lifestyle|lifestyle
409717|NCT01395082|Myocarditis|myocarditis
409718|NCT01395082|Pericarditis|pericarditis
409719|NCT01395082|Vaccinia virus|vaccinia virus
409720|NCT01395082|ACAM2000®|acam2000®
409721|NCT01395082|Smallpox vaccine|smallpox vaccine
409722|NCT01395069|Post-cataract surgery|post-cataract surgery
409723|NCT01395069|macular edema|macular edema
409724|NCT01395056|breast neoplasm|breast neoplasm
409725|NCT01395056|Neoplasm Metastasis|neoplasm metastasis
409726|NCT01395056|Drug Therapy|drug therapy
409727|NCT01395043|Transversus Abdominis Plane catheter|transversus abdominis plane catheter
409728|NCT01395043|TAP catheter|tap catheter
409729|NCT01395030|Liver|liver
409730|NCT01395030|Cancer|cancer
409731|NCT01395017|Pancreatic cancer|pancreatic cancer
409732|NCT01395017|Dasatinib|dasatinib
409733|NCT01395017|chemotherapy|chemotherapy
409734|NCT01395017|Locally advanced|locally advanced
409735|NCT01394991|Epoetin alfa (EPREX, ERYPO)|epoetin alfa (eprex, erypo)
409736|NCT01394978|Pleural air leak|pleural air leak
409737|NCT01394978|Pulmonary resection|pulmonary resection
409738|NCT01394978|Open thoracotomy|open thoracotomy
409739|NCT01394965|ECG|ecg
409740|NCT01394965|Mapping|mapping
409741|NCT01394965|ecg mapping|ecg mapping
409742|NCT01394965|arrythmias|arrythmias
409743|NCT01394952|Cardiovascular disease|cardiovascular disease
409744|NCT01394952|Diabetes Mellitus|diabetes mellitus
409745|NCT01394952|Dulaglutide|dulaglutide
409747|NCT01394939|Vaccinia Virus|vaccinia virus
409748|NCT01394939|JX-594|jx-594
409749|NCT01394939|Jennerex|jennerex
409750|NCT01394939|Colorectal Carcinoma|colorectal carcinoma
409751|NCT01394939|Colorectal cancer|colorectal cancer
409752|NCT01394939|Colon Cancer|colon cancer
409753|NCT01394939|Rectal Cancer|rectal cancer
409754|NCT01394939|oncolytic virus|oncolytic virus
409755|NCT01394939|viral therapy|viral therapy
409756|NCT01394939|RAS mutant|ras mutant
409757|NCT01394939|Erbitux failure|erbitux failure
409758|NCT01394939|Oxaliplatin failure|oxaliplatin failure
409759|NCT01394939|FOLFOX failure|folfox failure
409760|NCT01394939|FOLFIRI failure|folfiri failure
409761|NCT01394939|Irinotecan failure|irinotecan failure
409762|NCT01394939|Pexa-Vec|pexa-vec
409763|NCT01394926|CE-U/S - Contrast-Enhanced U/S|ce-u/s - contrast-enhanced u/s
409764|NCT01394926|U/S - Ultrasound|u/s - ultrasound
409765|NCT01394926|Assess effectiveness|assess effectiveness
409767|NCT01394900|sexually transmitted infection|sexually transmitted infection
409768|NCT01394900|STI|sti
409769|NCT01394900|men who have sex with men|men who have sex with men
409770|NCT01394900|MSM|msm
409771|NCT01394900|couples|couples
409772|NCT01394900|African American|african american
409773|NCT01394900|Black|black
409774|NCT01394887|Metformin, inflammation|metformin, inflammation
409775|NCT01394887|resistin|resistin
409776|NCT01394887|impaired glucose tolerance|impaired glucose tolerance
409777|NCT01394887|children|children
409778|NCT01394874|osteoarthritis|osteoarthritis
409779|NCT01394874|exercise|exercise
409780|NCT01394861|Endoscopic Submucosal Dissection|endoscopic submucosal dissection
409781|NCT01394861|ESD|esd
409782|NCT01394861|EMR|emr
409783|NCT01394861|Early Gastric Cancer|early gastric cancer
409784|NCT01394861|Flexible Endoscopic Robotic System|flexible endoscopic robotic system
409785|NCT01394861|Master Slave Robot|master slave robot
409786|NCT01394861|Ease & Safety of ESD by Flexible Master Slave Robotic System|ease & safety of esd by flexible master slave robotic system
409787|NCT01394835|Patient after lung transplantation|patient after lung transplantation
409788|NCT01394809|osteoporosis|osteoporosis
409789|NCT01394809|wrist fracture|wrist fracture
409790|NCT01394809|mental practice|mental practice
409791|NCT01394809|mirror therapy|mirror therapy
409792|NCT01394809|immobilization|immobilization
409793|NCT01394809|elderly|elderly
409794|NCT01394783|Endotracheal intubation, Teaching, Videolaryngoscope|endotracheal intubation, teaching, videolaryngoscope
409795|NCT01394770|hypertension|hypertension
409796|NCT01394770|dialysis|dialysis
409797|NCT01394770|aliskiren|aliskiren
409798|NCT01394770|amlodipine|amlodipine
409799|NCT01394770|outcome|outcome
409800|NCT01394744|metal|metal
409801|NCT01394744|ion|ion
409802|NCT01394744|cytokine|cytokine
409803|NCT01394744|hip arthroplasty|hip arthroplasty
409804|NCT01394744|blood|blood
409805|NCT01394744|Assessment|assessment
409806|NCT01394744|cytokine profile|cytokine profile
409807|NCT01394718|analgesic adjunct|analgesic adjunct
409808|NCT01394718|acetaminophen|acetaminophen
409809|NCT01394718|spine fusion surgery|spine fusion surgery
409810|NCT01394718|opiate reduction|opiate reduction
409811|NCT01394718|pain management after elective surgical operation|pain management after elective surgical operation
409812|NCT01394705|patients at increased risk for atherosclerosis|patients at increased risk for atherosclerosis
409813|NCT01394692|intraoperative MRI|intraoperative mri
409814|NCT01394692|glioma surgery|glioma surgery
409815|NCT01394692|extent of resection|extent of resection
409816|NCT01394679|Lung Cancer|lung cancer
409817|NCT01394679|Recurrent Lung Cancer no treatment within 3 months|recurrent lung cancer no treatment within 3 months
409818|NCT01394653|YM060|ym060
409819|NCT01394653|ramosetron|ramosetron
409820|NCT01394653|orally-disintegrating tablet|orally-disintegrating tablet
409821|NCT01394653|OD tablet|od tablet
409822|NCT01394653|bioequivalence|bioequivalence
409823|NCT01394614|Cataplexy|cataplexy
409824|NCT01394614|MSLT|mslt
409825|NCT01394614|Hypocretin|hypocretin
409826|NCT01394614|HLA typing|hla typing
409827|NCT01394614|Polysomnography|polysomnography
409828|NCT01394614|A/H1N1 vaccine|a/h1n1 vaccine
409829|NCT01394601|Antipsychotics|antipsychotics
409830|NCT01394601|schizophrenia|schizophrenia
409831|NCT01394601|acute inpatient|acute inpatient
409832|NCT01394588|Cardiac Surgery|cardiac surgery
409833|NCT01394588|Perioperative Glucose Control|perioperative glucose control
409834|NCT01394575|breast cancer|breast cancer
409835|NCT01394575|radiotherapy|radiotherapy
409836|NCT01394575|simultaneous integrated boost|simultaneous integrated boost
409837|NCT01394575|tumor bed|tumor bed
409838|NCT01394575|IMRT|imrt
409839|NCT01394536|Post-operative|post-operative
409840|NCT01394536|post-op|post-op
409841|NCT01394536|nausea|nausea
409842|NCT01394536|vomiting|vomiting
409843|NCT01394510|insulin secretion|insulin secretion
409844|NCT01394510|beta-cell function|beta-cell function
409845|NCT01394510|oxidative stress|oxidative stress
409846|NCT01394510|type 2 diabetes|type 2 diabetes
409847|NCT01394497|Liver Transplantation|liver transplantation
409848|NCT01394497|Graft Survival|graft survival
409849|NCT01394497|Graft Rejection|graft rejection
409850|NCT01394497|Primary Graft Dysfunction|primary graft dysfunction
409851|NCT01394497|Tissue and Organ Harvesting|tissue and organ harvesting
409852|NCT01394497|Tissue and Organ Procurement|tissue and organ procurement
409853|NCT01394497|Tissue Donors|tissue donors
409854|NCT01394497|Cold Ischemia|cold ischemia
409855|NCT01394471|schizophrenia|schizophrenia
409856|NCT01394471|schizoaffective disorder|schizoaffective disorder
409857|NCT01394471|oxytocin|oxytocin
409858|NCT01394471|OT|ot
409859|NCT01394471|social cognition|social cognition
409860|NCT01394471|social functioning|social functioning
409861|NCT01394471|paranoia|paranoia
409862|NCT01394471|psychosis|psychosis
409863|NCT01394471|psychotic symptoms|psychotic symptoms
409864|NCT01394471|social deficits|social deficits
409865|NCT01394471|intranasal administration|intranasal administration
409866|NCT01394458|catheter related infection|catheter related infection
409867|NCT01394458|bacteremia|bacteremia
409868|NCT01394458|hemodialysis|hemodialysis
409869|NCT01394432|Endocardial Stem Cells Injection|endocardial stem cells injection
409870|NCT01394432|Percutaneous Coronary Intervention|percutaneous coronary intervention
409871|NCT01394393|obesity treatment|obesity treatment
409872|NCT01394393|evidence based intervention|evidence based intervention
409873|NCT01394393|cognitive behavioral treatment|cognitive behavioral treatment
409874|NCT01394393|virtual reality environments|virtual reality environments
409875|NCT01394380|sugar|sugar
409876|NCT01394380|sweetened beverages|sweetened beverages
409877|NCT01394380|hepatic steatosis|hepatic steatosis
409878|NCT01394380|visceral obesity|visceral obesity
409879|NCT01394380|metabolic syndrome|metabolic syndrome
409880|NCT01394367|respiratory therapy|respiratory therapy
409881|NCT01394367|exercise therapy|exercise therapy
409882|NCT01394367|oxygen uptake|oxygen uptake
409883|NCT01394367|quality of life|quality of life
409884|NCT01394367|right ventricular function|right ventricular function
409885|NCT01394367|severe pulmonary hypertension|severe pulmonary hypertension
409886|NCT01394354|Multiple Myeloma relapsed refractory|multiple myeloma relapsed refractory
409887|NCT01394341|Liraglutide|liraglutide
409888|NCT01394341|Uremia|uremia
409889|NCT01394341|Dialysis|dialysis
409890|NCT01394341|Type 2 diabetes mellitus|type 2 diabetes mellitus
409891|NCT01394341|Safety|safety
409892|NCT01394341|Efficacy|efficacy
409893|NCT01394328|Delirium|delirium
409894|NCT01394328|Dementia|dementia
409895|NCT01394328|Confusion Assessment Method|confusion assessment method
409896|NCT01394328|Elderly|elderly
409897|NCT01394315|diffuse optical tomography|diffuse optical tomography
409898|NCT01394315|response|response
409899|NCT01394315|neoadjuvant chemotherapy|neoadjuvant chemotherapy
409900|NCT01394315|breast cancer|breast cancer
409901|NCT01394302|Trigger Finger|trigger finger
409902|NCT01394289|Standardization|standardization
409903|NCT01394289|Immunotherapy|immunotherapy
409904|NCT01394289|Skin prick test|skin prick test
409905|NCT01394263|prostate cancer|prostate cancer
409906|NCT01394263|PSA|psa
409907|NCT01394263|testosterone suppression|testosterone suppression
409908|NCT01394250|Pain|pain
409909|NCT01394250|Anxiety|anxiety
409910|NCT01394250|IV Cannulation|iv cannulation
409911|NCT01394250|Topical Lidocaine|topical lidocaine
409912|NCT01394250|Buzzy|buzzy
409913|NCT01394250|Face, Legs, Activity, Crying, Consolability (FLACC) scale|face, legs, activity, crying, consolability (flacc) scale
409914|NCT01394250|Faces Pain Scale Revised (FPS-R)|faces pain scale revised (fps-r)
409915|NCT01394250|Child Rating of Anxiety Scale|child rating of anxiety scale
409916|NCT01394224|Healthy volunteers|healthy volunteers
409917|NCT01394224|Japanese|japanese
409918|NCT01394198|Osteopathic Manipulative Medicine (OMM)|osteopathic manipulative medicine (omm)
409919|NCT01394198|Neuromuscular Medicine (NMM)|neuromuscular medicine (nmm)
409920|NCT01394198|Somatic Dysfunction|somatic dysfunction
409921|NCT01394198|Correlational Study|correlational study
409922|NCT01394198|Endoscopy|endoscopy
409923|NCT01394185|marijuana|marijuana
409924|NCT01394185|dronabinol|dronabinol
409925|NCT01394185|pharmacotherapy|pharmacotherapy
409926|NCT01394172|Tidal Volume|tidal volume
409927|NCT01394172|Pediatric|pediatric
409928|NCT01394172|Difficult airway|difficult airway
409929|NCT01394172|Ventilation|ventilation
409930|NCT01394172|Airway management|airway management
409931|NCT01394159|passes required to establish diagnosis|passes required to establish diagnosis
409932|NCT01394146|phosphorus-based food additives|phosphorus-based food additives
409933|NCT01394146|phosphorus metabolism|phosphorus metabolism
409934|NCT01394133|HIV Infected Women|hiv infected women
409935|NCT01394120|Pancreas cancer|pancreas cancer
409936|NCT01394120|Targeted Therapy|targeted therapy
409937|NCT01394107|Thromboprophylaxis|thromboprophylaxis
409938|NCT01394107|Effect of LMWH on coagulation|effect of lmwh on coagulation
409939|NCT01394107|Pregnancy|pregnancy
409940|NCT01394107|Neuraxial anesthesia|neuraxial anesthesia
409941|NCT01394107|Spinal haematoma|spinal haematoma
409942|NCT01394094|Gum chewing|gum chewing
409943|NCT01394094|Bowel function|bowel function
409944|NCT01394094|benign gynecologic surgery|benign gynecologic surgery
409946|NCT01394081|Health Care Utilization|health care utilization
409947|NCT01394081|Rural Health|rural health
409948|NCT01394081|Patient Navigation|patient navigation
409949|NCT01394081|Motivational Interviewing|motivational interviewing
409950|NCT01394068|Selenium level|selenium level
409951|NCT01394068|Various blood values|various blood values
409952|NCT01394068|Duration of artificial respiration|duration of artificial respiration
409953|NCT01394068|Residence in ICU/ Hospital|residence in icu/ hospital
409954|NCT01394068|SOFA-Score|sofa-score
409955|NCT01394068|SAPS-Score|saps-score
409956|NCT01394055|Diabetes Mellitus Type 1 and 2|diabetes mellitus type 1 and 2
409957|NCT01394055|Delayed Gastric Emptying|delayed gastric emptying
409958|NCT01394055|Gastroparesis|gastroparesis
409959|NCT01394055|Gastrointestinal Motility Disorder|gastrointestinal motility disorder
409960|NCT01394042|Biopsy proven primary prostate cancer|biopsy proven primary prostate cancer
409961|NCT01394029|iron overload|iron overload
409962|NCT01394029|iron chelation|iron chelation
409963|NCT01394029|deferasirox|deferasirox
409964|NCT01394029|observational|observational
409965|NCT01394003|Advanced cancer|advanced cancer
409966|NCT01393977|Spinal Cord Injuries|spinal cord injuries
409967|NCT01393977|Stem Cell Transplantation|stem cell transplantation
409968|NCT01393977|Rehabilitation|rehabilitation
409969|NCT01393951|Recombinant Influenza hemagglutinin vaccine|recombinant influenza hemagglutinin vaccine
409970|NCT01393938|Mullerian Duct Anomaly|mullerian duct anomaly
409971|NCT01393938|3-dimensional Ultrasound|3-dimensional ultrasound
409972|NCT01393938|Magnetic Resonance Imaging|magnetic resonance imaging
409973|NCT01393912|crenolanib|crenolanib
409974|NCT01393912|radiation therapy|radiation therapy
409975|NCT01393912|malignant brain tumors|malignant brain tumors
409976|NCT01393912|pediatric|pediatric
409977|NCT01393899|tofacitinib|tofacitinib
409978|NCT01393899|Xeljanz|xeljanz
409979|NCT01393899|CP-690,550|cp-690,550
409980|NCT01393899|maintenance therapy|maintenance therapy
409981|NCT01393886|Obesity Surgery|obesity surgery
409982|NCT01393873|Obesity|obesity
409983|NCT01393873|Type 2 DM|type 2 dm
409984|NCT01393860|Diabetes|diabetes
409985|NCT01393860|aliskiren|aliskiren
409986|NCT01393860|hypertension|hypertension
409987|NCT01393860|renal impairment|renal impairment
409988|NCT01393847|Sickle Cell|sickle cell
409989|NCT01393847|Pain|pain
409990|NCT01393847|Genetics|genetics
409991|NCT01393847|Sickle Cell Disease|sickle cell disease
409992|NCT01393847|Healthy Volunteer|healthy volunteer
409993|NCT01393847|HV|hv
409994|NCT01393834|Delayed cord clamping|delayed cord clamping
409995|NCT01393834|Umbilical cord|umbilical cord
409996|NCT01393834|Preterm|preterm
409997|NCT01393834|Cord milking|cord milking
409998|NCT01393808|Type 2 diabetes|type 2 diabetes
409999|NCT01393808|Paricalcitol|paricalcitol
410000|NCT01393808|Proteinuria|proteinuria
410001|NCT01393808|Sodium intake|sodium intake
410002|NCT01393795|Pulmonary Hypertension|pulmonary hypertension
410003|NCT01393795|Pain|pain
410004|NCT01393782|high output shock|high output shock
410005|NCT01393782|distributive shock|distributive shock
410006|NCT01393782|warm shock|warm shock
410007|NCT01393782|septic shock|septic shock
410008|NCT01393782|pressor|pressor
410009|NCT01393782|angiotensin|angiotensin
410010|NCT01393782|ATII|atii
410011|NCT01393782|vasopressor|vasopressor
410012|NCT01393769|Retinoblastoma|retinoblastoma
410013|NCT01393769|RTB|rtb
410014|NCT01393769|Ocular tumour|ocular tumour
410015|NCT01393769|Melfalan|melfalan
410016|NCT01393769|Enucleation|enucleation
410017|NCT01393769|Tumor of the eye|tumor of the eye
410018|NCT01393769|Eye|eye
410019|NCT01393769|Ocular cancer|ocular cancer
410020|NCT01393769|Ocular chemotherapy|ocular chemotherapy
410021|NCT01393769|Ophthalmic artery|ophthalmic artery
410022|NCT01393769|Intra-arterial chemotherapy|intra-arterial chemotherapy
410023|NCT01393743|Central Nervous System|central nervous system
410024|NCT01393730|prostate|prostate
410025|NCT01393730|metastatic|metastatic
410026|NCT01393730|castrate resistant|castrate resistant
410027|NCT01393704|myomectomy|myomectomy
410028|NCT01393704|vasopressin|vasopressin
410029|NCT01393704|blood loss|blood loss
410030|NCT01393691|nighttime fears|nighttime fears
410031|NCT01393691|anxiety|anxiety
410032|NCT01393691|sleep|sleep
410033|NCT01393691|actigraphy|actigraphy
410034|NCT01393691|intervention|intervention
410035|NCT01393652|Pharmacokinetics Safety Tolerability Pharmacodynamics|pharmacokinetics safety tolerability pharmacodynamics
410036|NCT01393639|treatment of rheumatoid arthritis|treatment of rheumatoid arthritis
410037|NCT01393639|treatment of RA|treatment of ra
410038|NCT01393639|patients on methotrexate for rheumatoid arthritis|patients on methotrexate for rheumatoid arthritis
410039|NCT01393639|prednisone for rheumatoid arthritis|prednisone for rheumatoid arthritis
410040|NCT01393587|Oxidative Stress|oxidative stress
410041|NCT01393587|Laproscopy|laproscopy
410042|NCT01393561|Rhinitis|rhinitis
410043|NCT01393561|Common cold|common cold
410044|NCT01393561|Nasal symptoms|nasal symptoms
410045|NCT01393561|Children|children
410046|NCT01393548|Rhinitis|rhinitis
410047|NCT01393548|common cold|common cold
410048|NCT01393548|nasal symptoms|nasal symptoms
410049|NCT01393548|children|children
410050|NCT01393535|Adiponectin|adiponectin
410051|NCT01393535|Prognosis|prognosis
410052|NCT01393535|Cardiac Surgery|cardiac surgery
410053|NCT01393522|headache|headache
410054|NCT01393522|migraine|migraine
410055|NCT01393509|PU-H71|pu-h71
410056|NCT01393509|Solid Tumor|solid tumor
410057|NCT01393509|Lymphoma|lymphoma
410058|NCT01393509|11-041|11-041
410059|NCT01393509|incurable, locally advanced or metastatic solid tumor malignancy or lymphoma|incurable, locally advanced or metastatic solid tumor malignancy or lymphoma
410060|NCT01393496|prematurity|prematurity
410061|NCT01393496|anemia|anemia
410062|NCT01393496|transfusion|transfusion
410063|NCT01393483|esophagectomy|esophagectomy
410064|NCT01393483|endoscopy|endoscopy
410065|NCT01393483|biopsy|biopsy
410066|NCT01393483|Tissue mesothelin|tissue mesothelin
410067|NCT01393483|Serum mesothelin|serum mesothelin
410068|NCT01393483|11-037|11-037
410069|NCT01393470|HPV|hpv
410070|NCT01393470|Vaccine|vaccine
410071|NCT01393470|long-term efficacy|long-term efficacy
410072|NCT01393470|registry-based study|registry-based study
410073|NCT01393470|Evaluation of long-term HPV vaccine efficacy: a population-based, registry-based cohort study in Finland.|evaluation of long-term hpv vaccine efficacy: a population-based, registry-based cohort study in finland.
410074|NCT01393457|cocaine|cocaine
410075|NCT01393457|cognition|cognition
410076|NCT01393457|medication|medication
410077|NCT01393457|treatment|treatment
410078|NCT01393444|Electrocorticography|electrocorticography
410079|NCT01393444|Tetraplegia|tetraplegia
410080|NCT01393444|Spinal cord injury|spinal cord injury
410081|NCT01393444|Brainstem stroke|brainstem stroke
410082|NCT01393444|Neuroprosthetic|neuroprosthetic
410083|NCT01393444|Brain-computer interface|brain-computer interface
410084|NCT01393444|Direct brain interface|direct brain interface
410085|NCT01393444|Neural activity|neural activity
410086|NCT01393444|Motor cortex|motor cortex
410087|NCT01393431|Exhaled breath condensate pH|exhaled breath condensate ph
410088|NCT01393431|Predictive value of pH|predictive value of ph
410089|NCT01393418|Erythropoietin|erythropoietin
410090|NCT01393418|Cardiac Surgery|cardiac surgery
410091|NCT01393418|Renal Biomarker|renal biomarker
410092|NCT01393418|Acute Kidney Injury|acute kidney injury
410093|NCT01393418|Hypothermic Circulatory Arrest|hypothermic circulatory arrest
410094|NCT01393392|smoking cessation|smoking cessation
410095|NCT01393392|methadone treatment|methadone treatment
410096|NCT01393392|nicotine addiction|nicotine addiction
410097|NCT01393392|drug treatment|drug treatment
410098|NCT01393392|drug addiction|drug addiction
410099|NCT01393392|tobacco dependence|tobacco dependence
410100|NCT01393327|physical training|physical training
410101|NCT01393327|remaining post-operative pulmonary vascular changes|remaining post-operative pulmonary vascular changes
410102|NCT01393327|right ventricular pump function|right ventricular pump function
410103|NCT01393327|PEA|pea
410104|NCT01393301|Nicotine dependence|nicotine dependence
410105|NCT01393301|Smoking, cessation|smoking, cessation
410106|NCT01393301|Quitting|quitting
410107|NCT01393301|Anxiety symptoms|anxiety symptoms
410108|NCT01393301|Cognitive-behavioral therapy|cognitive-behavioral therapy
410109|NCT01393275|diabetes|diabetes
410110|NCT01393275|exercise|exercise
410111|NCT01393275|intervention|intervention
410112|NCT01393275|rehabilitation|rehabilitation
410113|NCT01393275|metabolic rate|metabolic rate
410114|NCT01393275|sport|sport
410115|NCT01393249|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
410116|NCT01393249|Pediatric|pediatric
410117|NCT01393249|Asparaginase|asparaginase
410118|NCT01393249|Pancreatitis|pancreatitis
410119|NCT01393223|Interstitial Cystitis|interstitial cystitis
410120|NCT01393223|Painful Bladder Syndrome|painful bladder syndrome
410121|NCT01393223|Bladder Pain Syndrome|bladder pain syndrome
410122|NCT01393223|Liposome|liposome
410124|NCT01393210|insulin sensitivity|insulin sensitivity
410125|NCT01393210|adipose tissue|adipose tissue
410126|NCT01393210|inflammation|inflammation
410127|NCT01393197|HCC|hcc
410128|NCT01393197|TACE|tace
410129|NCT01393184|Target therapy|target therapy
410130|NCT01393171|Anterior Vaginal Prolapse|anterior vaginal prolapse
410131|NCT01393171|Cystocele|cystocele
410132|NCT01393171|Pelvic Organ Prolapse|pelvic organ prolapse
410133|NCT01393145|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
410134|NCT01393145|salmeterol|salmeterol
410135|NCT01393145|fluticasone|fluticasone
410136|NCT01393145|formoterol|formoterol
410137|NCT01393145|FEV1|fev1
410138|NCT01393145|Moderate-to-severe|moderate-to-severe
410139|NCT01393132|Dry Eye|dry eye
410140|NCT01393132|Sjogren's Syndrome|sjogren's syndrome
410141|NCT01393132|Graft vs. Host Disease|graft vs. host disease
410142|NCT01393132|Rheumatoid arthritis|rheumatoid arthritis
410143|NCT01393132|Systemic lupus erythematosus|systemic lupus erythematosus
410144|NCT01393132|Scleroderma|scleroderma
410145|NCT01393106|HL|hl
410146|NCT01393106|idelalisib|idelalisib
410147|NCT01393106|CAL-101|cal-101
410148|NCT01393106|GS-1101|gs-1101
410149|NCT01393106|PI3K|pi3k
410151|NCT01393093|TACE|tace
410152|NCT01393080|nimotuzumab|nimotuzumab
410153|NCT01393080|non-small cell lung cancer|non-small cell lung cancer
410154|NCT01393080|chemotherapy|chemotherapy
410155|NCT01393067|cSEMS|csems
410156|NCT01393067|NEPS|neps
410157|NCT01393067|ERCP|ercp
410158|NCT01393067|biliary stricture|biliary stricture
410159|NCT01393067|biliary stenosis|biliary stenosis
410160|NCT01393067|liver transplantation|liver transplantation
410161|NCT01393054|Nigella sativa seed extract|nigella sativa seed extract
410162|NCT01393054|hypertension|hypertension
410163|NCT01393054|elderly|elderly
410164|NCT01393028|coronary artery disease|coronary artery disease
410165|NCT01393028|angina pectoris|angina pectoris
410166|NCT01393028|Stable chest pain complaints|stable chest pain complaints
410167|NCT01393015|automatic|automatic
410168|NCT01393015|automation|automation
410169|NCT01393015|oxygen|oxygen
410170|NCT01393015|weaning|weaning
410171|NCT01393015|COPD|copd
410172|NCT01393015|exacerbation|exacerbation
410173|NCT01393002|intensive care|intensive care
410174|NCT01393002|candidemia|candidemia
410175|NCT01393002|fungal infection|fungal infection
410176|NCT01392976|cancer|cancer
410177|NCT01392976|advanced|advanced
410178|NCT01392976|solid|solid
410179|NCT01392976|tumor|tumor
410180|NCT01392976|gemcitabine|gemcitabine
410181|NCT01392976|human equilibrative nucleoside transporter-1 (hENT1)|human equilibrative nucleoside transporter-1 (hent1)
410182|NCT01392976|CO-1.01|co-1.01
410183|NCT01392976|CO-101|co-101
410184|NCT01392976|CO101|co101
410185|NCT01392963|botox|botox
410186|NCT01392963|depression|depression
410187|NCT01392950|silicone hydrogel contact lenses for daily wear|silicone hydrogel contact lenses for daily wear
410188|NCT01392937|AIOL|aiol
410189|NCT01392937|multipurpose solution|multipurpose solution
410190|NCT01392937|silicone hydrogel lenses|silicone hydrogel lenses
410191|NCT01392937|The safety and efficacy of the All-in-One Light multipurpose care regimen by comparison with the Aquify care regimen|the safety and efficacy of the all-in-one light multipurpose care regimen by comparison with the aquify care regimen
410192|NCT01392911|Dose Ranging|dose ranging
410193|NCT01392911|Extended Early Bactericidal Activity|extended early bactericidal activity
410194|NCT01392911|Maximum tolerable dose|maximum tolerable dose
410195|NCT01392911|Pharmacokinetics|pharmacokinetics
410196|NCT01392911|Pulmonary Tuberculosis|pulmonary tuberculosis
410197|NCT01392911|Rifampicin|rifampicin
410198|NCT01392911|Rifafour|rifafour
410199|NCT01392911|Safety|safety
410200|NCT01392911|Tolerability|tolerability
410201|NCT01392911|Max Tolerable Dose|max tolerable dose
410202|NCT01392898|liraglutide|liraglutide
410203|NCT01392898|insulin|insulin
410204|NCT01392898|type 2 diabetes mellitus|type 2 diabetes mellitus
410205|NCT01392885|Schizophrenia|schizophrenia
410206|NCT01392885|Schizoaffective Disorder|schizoaffective disorder
410207|NCT01392885|Brain Health|brain health
410208|NCT01392885|Exercise|exercise
410209|NCT01392885|Mental Health|mental health
410210|NCT01392885|Poor memory|poor memory
410211|NCT01392872|Immunosuppressant|immunosuppressant
410212|NCT01392872|Quality of life|quality of life
410213|NCT01392872|Cognitive function|cognitive function
410214|NCT01392872|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
410215|NCT01392846|Coronary artery disease requiring drug eluting stents|coronary artery disease requiring drug eluting stents
410216|NCT01392833|iga nephropathy|iga nephropathy
410217|NCT01392833|chronic kidney disease|chronic kidney disease
410218|NCT01392833|proteinuria|proteinuria
410219|NCT01392833|steroids|steroids
410220|NCT01392833|azathioprine|azathioprine
410221|NCT01392820|Phase I|phase i
410222|NCT01392820|Japan|japan
410223|NCT01392820|Elderly|elderly
410224|NCT01392820|PK|pk
410225|NCT01392820|SAD|sad
410226|NCT01392820|MAD|mad
410227|NCT01392807|Phase 1|phase 1
410228|NCT01392807|volunteers with hepatic impairment|volunteers with hepatic impairment
410229|NCT01392807|pharmacokinetics|pharmacokinetics
410230|NCT01392807|NKTR-118|nktr-118
410231|NCT01392807|Child-Pugh scale|child-pugh scale
410232|NCT01392807|AUC|auc
410233|NCT01392807|Cmax|cmax
410234|NCT01392807|tmax|tmax
410235|NCT01392807|t1/2|t1/2
410236|NCT01392794|YM060|ym060
410237|NCT01392794|ramosetron|ramosetron
410238|NCT01392794|orally-disintegrating tablet|orally-disintegrating tablet
410239|NCT01392794|OD tablet|od tablet
410240|NCT01392794|bioequivalence|bioequivalence
410241|NCT01392781|PCOS|pcos
410242|NCT01392781|hsC-RP|hsc-rp
410243|NCT01392781|Lp-PLA2|lp-pla2
410244|NCT01392781|cardiovascular risk|cardiovascular risk
410245|NCT01392768|Epilepsy|epilepsy
410246|NCT01392768|Partial|partial
410247|NCT01392768|Seizures|seizures
410248|NCT01392768|Adjunctive|adjunctive
410249|NCT01392690|No condition|no condition
410250|NCT01392690|Primary prevention|primary prevention
410251|NCT01392690|Anxiety|anxiety
410252|NCT01392677|dapagliflozin|dapagliflozin
410253|NCT01392677|diabetes|diabetes
410254|NCT01392677|hyperglycaemia|hyperglycaemia
410255|NCT01392651|Urinary stress incontinence|urinary stress incontinence
410256|NCT01392651|TVT|tvt
410257|NCT01392638|Sildenafil|sildenafil
410258|NCT01392638|Nitric oxide synthase|nitric oxide synthase
410259|NCT01392638|Polymorphism|polymorphism
410260|NCT01392638|Hemodynamics|hemodynamics
410261|NCT01392625|Non ischemic dilated cardiomyopathy|non ischemic dilated cardiomyopathy
410262|NCT01392625|Dilated cardiomyopathy|dilated cardiomyopathy
410263|NCT01392625|Heart failure|heart failure
410264|NCT01392625|Cardiac Stem Cell Transplantation|cardiac stem cell transplantation
410265|NCT01392625|Stem Cells|stem cells
410266|NCT01392612|thrombosis|thrombosis
410267|NCT01392612|hypertension|hypertension
410268|NCT01392612|gender|gender
410269|NCT01392612|endothelium|endothelium
410270|NCT01392599|CRPS Type II|crps type ii
410271|NCT01392599|Pain|pain
410272|NCT01392599|Surgery|surgery
410273|NCT01392599|Regional Subcutaneous Venous Sympathectomy(RSVS)|regional subcutaneous venous sympathectomy(rsvs)
410274|NCT01392599|Sudeck|sudeck
410275|NCT01392599|Reflex sympathetic dystrophy (RSD)|reflex sympathetic dystrophy (rsd)
410276|NCT01392599|Causalgia|causalgia
410277|NCT01392599|Algodystrophy|algodystrophy
410278|NCT01392586|survival|survival
410279|NCT01392586|systemic therapy|systemic therapy
410280|NCT01392586|upfront surgery|upfront surgery
410281|NCT01392534|Hypertension|hypertension
410282|NCT01392534|Telmisartan|telmisartan
410283|NCT01392534|Hydrochlorothiazide|hydrochlorothiazide
410284|NCT01392534|Potassium|potassium
410285|NCT01392534|Glucose metabolism|glucose metabolism
410286|NCT01392534|Lipid metabolism|lipid metabolism
410287|NCT01392521|Safety|safety
410288|NCT01392521|Tolerability|tolerability
410289|NCT01392521|Pharmacokinetics|pharmacokinetics
410290|NCT01392495|Pulmonary arterial hypertension|pulmonary arterial hypertension
410291|NCT01392495|imatinib|imatinib
410292|NCT01392495|6MWD|6mwd
410293|NCT01392482|Schizophrenia|schizophrenia
410294|NCT01392482|Bipolar Disorder|bipolar disorder
410295|NCT01392469|Pulmonary arterial hypertension|pulmonary arterial hypertension
410296|NCT01392469|pulmonary vascular resistance|pulmonary vascular resistance
410297|NCT01392469|imatinib|imatinib
410298|NCT01392469|bosentan|bosentan
410299|NCT01392469|sildenafil|sildenafil
410300|NCT01392456|OHIP-EDENT, VALIDATION, OVERDENTURE, ROMANIAN|ohip-edent, validation, overdenture, romanian
410301|NCT01392443|INC424|inc424
410302|NCT01392443|Ruxolitinib|ruxolitinib
410303|NCT01392443|Myelofibrosis|myelofibrosis
410304|NCT01392443|MF|mf
410305|NCT01392430|Primary prophylaxis|primary prophylaxis
410306|NCT01392430|Secondary prophylaxis|secondary prophylaxis
410307|NCT01392430|Discontinuation|discontinuation
410308|NCT01392391|Stroke|stroke
410309|NCT01392391|Exercise|exercise
410310|NCT01392391|Protein synthesis|protein synthesis
410311|NCT01392391|Protein breakdown|protein breakdown
410312|NCT01392391|Muscle atrophy|muscle atrophy
410313|NCT01392391|Muscle phenotype|muscle phenotype
410314|NCT01392391|Inflammation|inflammation
410315|NCT01392391|Insulin resistance|insulin resistance
410316|NCT01392391|Fitness|fitness
410317|NCT01392378|Prevenar 13|prevenar 13
410318|NCT01392378|13vPnC|13vpnc
410319|NCT01392378|Antipyretic medication|antipyretic medication
410320|NCT01392378|Healthy subjects|healthy subjects
410321|NCT01392365|Crohn's disease|crohn's disease
410322|NCT01392365|Intestinal tuberculosis|intestinal tuberculosis
410323|NCT01392365|Diagnosis, Differential|diagnosis, differential
410324|NCT01392352|pazopanib|pazopanib
410325|NCT01392352|hypertension|hypertension
410326|NCT01392352|forearm blood flow|forearm blood flow
410327|NCT01392339|Obstructive Sleep Apnea|obstructive sleep apnea
410328|NCT01392339|CPAP|cpap
410329|NCT01392339|hypoxia|hypoxia
410330|NCT01392339|sleep|sleep
410331|NCT01392339|translational science|translational science
410332|NCT01392339|gene expression|gene expression
410333|NCT01392326|Psoriatic arthritis|psoriatic arthritis
410334|NCT01392326|PsA|psa
410335|NCT01392326|ACR|acr
410336|NCT01392326|CASPAR|caspar
410337|NCT01392313|carnitine, kidney|carnitine, kidney
410338|NCT01392287|Geriatric|geriatric
410339|NCT01392287|Older adults|older adults
410340|NCT01392287|Major Depressive Disorder|major depressive disorder
410341|NCT01392287|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
410342|NCT01392287|memantine hydrochloride|memantine hydrochloride
410343|NCT01392287|N-Acetylaspartylglutamate|n-acetylaspartylglutamate
410344|NCT01392287|NAAG|naag
410345|NCT01392287|Cognitive impairment|cognitive impairment
410346|NCT01392248|EEG|eeg
410347|NCT01392248|breast cancer surgery|breast cancer surgery
410348|NCT01392248|prediction|prediction
410349|NCT01392248|acute postoperative pain|acute postoperative pain
410350|NCT01392248|chronic pain|chronic pain
410351|NCT01392235|Recurrent and/or Metastatic Nasopharyngeal Carcinoma (NPC)|recurrent and/or metastatic nasopharyngeal carcinoma (npc)
410352|NCT01392222|focus group|focus group
410353|NCT01392222|11-108|11-108
410354|NCT01392209|BEVACIZUMAB|bevacizumab
410355|NCT01392209|HYPOFRACTIONATED STEREOTACTIC RADIOTHERAPY|hypofractionated stereotactic radiotherapy
410356|NCT01392209|Brain|brain
410357|NCT01392209|CNS|cns
410358|NCT01392209|anti-VEGF antibody|anti-vegf antibody
410359|NCT01392209|11-057|11-057
410360|NCT01392196|Renal Impairment|renal impairment
410361|NCT01392183|Kidney cancer|kidney cancer
410362|NCT01392183|Renal Cell Carcinoma|renal cell carcinoma
410363|NCT01392183|Poor-Risk Clear-Cell Renal Cell Carcinoma|poor-risk clear-cell renal cell carcinoma
410364|NCT01392183|RCC|rcc
410365|NCT01392183|Metastatic|metastatic
410366|NCT01392183|Locally advanced|locally advanced
410367|NCT01392183|Complete response|complete response
410368|NCT01392183|CR|cr
410369|NCT01392183|Partial Response|partial response
410370|NCT01392183|PR|pr
410371|NCT01392183|Overall survival|overall survival
410372|NCT01392183|OS|os
410373|NCT01392183|Time to progression|time to progression
410374|NCT01392183|TTP|ttp
410375|NCT01392183|Pazopanib|pazopanib
410376|NCT01392183|GW786034|gw786034
410377|NCT01392183|Temsirolimus|temsirolimus
410378|NCT01392183|CCI-779|cci-779
410379|NCT01392183|Torisel|torisel
410380|NCT01392183|Benadryl|benadryl
410381|NCT01392183|Diphenhydramine|diphenhydramine
410382|NCT01392183|TemPa|tempa
410383|NCT01392170|Leukemia|leukemia
410384|NCT01392170|Chronic Myeloid Leukemia|chronic myeloid leukemia
410385|NCT01392170|CML|cml
410386|NCT01392170|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors
410387|NCT01392170|TKI|tki
410388|NCT01392170|Complete cytogenetic remission|complete cytogenetic remission
410389|NCT01392170|CCyR|ccyr
410390|NCT01392170|Minimal residual disease|minimal residual disease
410391|NCT01392170|MRD|mrd
410392|NCT01392170|PEG-IFNa-2a|peg-ifna-2a
410393|NCT01392170|Pegasys|pegasys
410394|NCT01392170|Peginterferon Alpha-2a|peginterferon alpha-2a
410395|NCT01392170|Philadelphia chromosome (Ph)-positive|philadelphia chromosome (ph)-positive
410396|NCT01392170|BCR-ABL1-positive|bcr-abl1-positive
410397|NCT01392144|Radiation pneumonitis|radiation pneumonitis
410398|NCT01392144|RP|rp
410399|NCT01392144|Nitric oxide|nitric oxide
410400|NCT01392144|NO|no
410401|NCT01392144|Thoracic|thoracic
410402|NCT01392144|Esophagus cancer|esophagus cancer
410403|NCT01392144|Lung cancer|lung cancer
410404|NCT01392144|Radiation therapy|radiation therapy
410405|NCT01392144|radiotherapy|radiotherapy
410406|NCT01392144|RT|rt
410407|NCT01392144|XRT|xrt
410408|NCT01392144|Airway|airway
410409|NCT01392144|Alveolar|alveolar
410410|NCT01392144|Nitric oxide breath analyzer|nitric oxide breath analyzer
410411|NCT01392144|Questionnaires|questionnaires
410412|NCT01392131|Oncoxin|oncoxin
410413|NCT01392131|Safety of Oncoxin|safety of oncoxin
410414|NCT01392131|Therapeutic efficacy of Oncoxin|therapeutic efficacy of oncoxin
410415|NCT01392131|Improvement of quality of life with Oncoxin|improvement of quality of life with oncoxin
410416|NCT01392131|Survival benefit with Oncoxin|survival benefit with oncoxin
410417|NCT01392105|Mesenchymal stem cells|mesenchymal stem cells
410418|NCT01392105|Myocardial infarction|myocardial infarction
410419|NCT01392105|Left ventricular dysfunction|left ventricular dysfunction
410420|NCT01392092|Contingency Management|contingency management
410421|NCT01392092|Drug Self-Administration|drug self-administration
410422|NCT01392079|CLL|cll
410423|NCT01392079|17p deletion|17p deletion
410424|NCT01392079|refractory to fludarabine|refractory to fludarabine
410425|NCT01392079|subcutaneous alemtuzumab|subcutaneous alemtuzumab
410426|NCT01392079|CLL with 17p- or refractory to fludarabine|cll with 17p- or refractory to fludarabine
410427|NCT01392066|breast neoplasms|breast neoplasms
410428|NCT01392066|spouses/partners|spouses/partners
410429|NCT01392066|couples|couples
410430|NCT01392066|interpersonal relations|interpersonal relations
410431|NCT01392066|psychosocial adjustment|psychosocial adjustment
410432|NCT01392066|psychological adaptation|psychological adaptation
410433|NCT01392066|depression|depression
410434|NCT01392066|quality of life|quality of life
410435|NCT01392066|dyadic coping|dyadic coping
410436|NCT01392066|coping behavior|coping behavior
410437|NCT01392066|cohort|cohort
410438|NCT01392066|questionnaire|questionnaire
410439|NCT01392053|labor|labor
410440|NCT01392053|pain|pain
410441|NCT01392053|massage|massage
410442|NCT01392027|Pancreatic Cancer|pancreatic cancer
410443|NCT01392027|Chronic Pancreatitis|chronic pancreatitis
410444|NCT01392027|Diseases of the pancreas|diseases of the pancreas
410445|NCT01392014|malaria|malaria
410446|NCT01392014|DHP|dhp
410447|NCT01392014|PQ|pq
410448|NCT01392014|gametocytes|gametocytes
410449|NCT01391975|arteriovenous fistula|arteriovenous fistula
410450|NCT01391975|surveillance|surveillance
410451|NCT01391975|arterial stenosis|arterial stenosis
410452|NCT01391975|venous stenosis|venous stenosis
410453|NCT01391962|Pharmacodynamics|pharmacodynamics
410454|NCT01391962|VEGF Inhibitor|vegf inhibitor
410455|NCT01391962|Alveolar Soft Part Sarcoma|alveolar soft part sarcoma
410456|NCT01391962|Anti-Angiogenesis|anti-angiogenesis
410457|NCT01391962|Gene Expression Profiling|gene expression profiling
410458|NCT01391949|disability|disability
410459|NCT01391949|walking|walking
410460|NCT01391949|feedback|feedback
410461|NCT01391949|exercise|exercise
410462|NCT01391923|Lipolysis|lipolysis
410463|NCT01391923|Cryolipolysis|cryolipolysis
410464|NCT01391923|Fat Reduction|fat reduction
410465|NCT01391910|rhinosinusitis|rhinosinusitis
410466|NCT01391897|somatoform disorders|somatoform disorders
410467|NCT01391897|PTSD|ptsd
410468|NCT01391897|epigenetics|epigenetics
410469|NCT01391897|psychotherapy|psychotherapy
410470|NCT01391897|psychosomatics|psychosomatics
410471|NCT01391884|Incretin hormones|incretin hormones
410472|NCT01391884|GLP-1|glp-1
410473|NCT01391884|GIP|gip
410474|NCT01391884|Uremia|uremia
410475|NCT01391884|Dialysis|dialysis
410476|NCT01391858|Pregabalin|pregabalin
410477|NCT01391858|Postoperative pain|postoperative pain
410478|NCT01391858|Mastectomy|mastectomy
410479|NCT01391845|progesterone|progesterone
410480|NCT01391845|glycodelin-A|glycodelin-a
410481|NCT01391845|ulipristal acetate|ulipristal acetate
410482|NCT01391832|rTMS|rtms
410483|NCT01391832|PTSD|ptsd
410484|NCT01391832|Post Traumatic Stress Disorder|post traumatic stress disorder
410485|NCT01391832|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
410486|NCT01391832|combat related PTSD|combat related ptsd
410487|NCT01391832|OEF|oef
410488|NCT01391832|OIF|oif
410489|NCT01391832|Veterans|veterans
410490|NCT01391832|operation enduring freedom|operation enduring freedom
410491|NCT01391832|operation iraqi freedom|operation iraqi freedom
410492|NCT01391832|CPT|cpt
410493|NCT01391832|cognitive processing therapy|cognitive processing therapy
410494|NCT01391819|Brazil|brazil
410495|NCT01391819|Incidence|incidence
410496|NCT01391819|Dengue virus|dengue virus
410497|NCT01391819|Dengue|dengue
410498|NCT01391819|Dengue infection|dengue infection
410499|NCT01391806|Breast cancer|breast cancer
410500|NCT01391806|Preoperative breast MRI|preoperative breast mri
410501|NCT01391806|Breast-conserving surgery|breast-conserving surgery
410502|NCT01391806|Mastectomy|mastectomy
410503|NCT01391806|Prospective study|prospective study
410504|NCT01391793|Renal scarring|renal scarring
410505|NCT01391793|Dexamethasone|dexamethasone
410506|NCT01391793|Child|child
410507|NCT01391793|Corticosteroids|corticosteroids
410508|NCT01391793|Pediatric|pediatric
410509|NCT01391793|Urinary tract infection|urinary tract infection
410510|NCT01391793|Escherichia Coli Urinary Tract Infection|escherichia coli urinary tract infection
410511|NCT01391780|pelvic floor evaluation,|pelvic floor evaluation,
410512|NCT01391780|women,|women,
410513|NCT01391780|stress urinary incontinence;|stress urinary incontinence;
410514|NCT01391780|urgency urinary incontinence.|urgency urinary incontinence.
410515|NCT01391767|Ridge Preservation|ridge preservation
410516|NCT01391767|Dental Implant|dental implant
410517|NCT01391767|Histology|histology
410518|NCT01391754|child abuse|child abuse
410519|NCT01391741|Parkinson´s Disease|parkinson´s disease
410520|NCT01391741|Walking|walking
410521|NCT01391741|Exercise|exercise
410522|NCT01391741|Automaticity|automaticity
410523|NCT01391741|Dual Task|dual task
410524|NCT01391741|Visual Cues|visual cues
410525|NCT01391741|Cueing|cueing
410526|NCT01391741|Neuroplasticity|neuroplasticity
410527|NCT01391741|Gait analysis|gait analysis
410528|NCT01391715|Gastroesophageal reflux disease|gastroesophageal reflux disease
410529|NCT01391715|Proton pump inhibitor|proton pump inhibitor
410530|NCT01391715|standard dose|standard dose
410531|NCT01391715|Double dose|double dose
410532|NCT01391676|glaucoma|glaucoma
410533|NCT01391676|trabeculectomy|trabeculectomy
410534|NCT01391676|filtering bleb|filtering bleb
410535|NCT01391676|spectral domain optical coherence tomography|spectral domain optical coherence tomography
410536|NCT01391663|Drug Therapy|drug therapy
410538|NCT01391650|double-bundle|double-bundle
410539|NCT01391650|navigation system|navigation system
410540|NCT01391637|Long term follow-up|long term follow-up
410541|NCT01391637|HuCNS-SC cells|hucns-sc cells
410542|NCT01391637|human central nervous system stem cells|human central nervous system stem cells
410543|NCT01391624|chocolate|chocolate
410544|NCT01391624|craving|craving
410545|NCT01391624|addiction|addiction
410546|NCT01391624|compulsion|compulsion
410547|NCT01391598|fibromyalgia|fibromyalgia
410548|NCT01391598|intravenous lidocaine|intravenous lidocaine
410549|NCT01391598|substance P|substance p
410550|NCT01391598|interleukins|interleukins
410551|NCT01391585|Text|text
410552|NCT01391585|SMS|sms
410553|NCT01391585|diabetes|diabetes
410554|NCT01391585|self-monitoring|self-monitoring
410555|NCT01391585|self-management|self-management
410556|NCT01391585|adherence|adherence
410557|NCT01391572|thoracic esophageal squamous cell carcinoma|thoracic esophageal squamous cell carcinoma
410558|NCT01391572|esophagectomy|esophagectomy
410559|NCT01391572|radiation|radiation
410560|NCT01391572|tumor bed|tumor bed
410561|NCT01391572|elective nodal irradiation|elective nodal irradiation
410562|NCT01391559|breathing difficulty|breathing difficulty
410563|NCT01391520|Acute Kidney Injury|acute kidney injury
410564|NCT01391520|Contrast-Induced Nephropathy|contrast-induced nephropathy
410565|NCT01391520|Labile Iron|labile iron
410566|NCT01391520|Iron Chelation|iron chelation
410567|NCT01391520|Deferiprone|deferiprone
410954|NCT01389830|Latinos|latinos
410568|NCT01391507|Anti-beta1-receptor autoantibodies|anti-beta1-receptor autoantibodies
410569|NCT01391507|COR-1|cor-1
410570|NCT01391507|Heart failure|heart failure
410571|NCT01391494|Human Enterovirus 71 (EV71)|human enterovirus 71 (ev71)
410572|NCT01391494|Hand, Foot and Mouth Disease|hand, foot and mouth disease
410573|NCT01391494|Inactivated Vaccine|inactivated vaccine
410574|NCT01391494|Human Diploid cell|human diploid cell
410575|NCT01391494|Safety|safety
410576|NCT01391494|Immunogenicity|immunogenicity
410577|NCT01391494|Adverse reactions associated with vaccine|adverse reactions associated with vaccine
410578|NCT01391481|Perfluorocarbon|perfluorocarbon
410579|NCT01391481|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
410580|NCT01391481|Acute lung injury|acute lung injury
410581|NCT01391455|Inguinal hernia repair|inguinal hernia repair
410582|NCT01391455|Mesh|mesh
410583|NCT01391455|Groin pain|groin pain
410584|NCT01391455|Testicular pain|testicular pain
410585|NCT01391442|follow up of troop,|follow up of troop,
410586|NCT01391442|MRI, Echocardiography, Functional indices|mri, echocardiography, functional indices
410587|NCT01391416|Hyperhomocysteinemia|hyperhomocysteinemia
410588|NCT01391416|Chronic kidney disease|chronic kidney disease
410589|NCT01391403|Schizophrenia|schizophrenia
410590|NCT01391403|Risperidone|risperidone
410591|NCT01391403|Artemisinin|artemisinin
410592|NCT01391403|Toxoplasma|toxoplasma
410593|NCT01391403|Immune|immune
410594|NCT01391390|Tardive Dyskinesia|tardive dyskinesia
410595|NCT01391390|Schizophrenia|schizophrenia
410596|NCT01391390|Melatonin|melatonin
410597|NCT01391390|Oxidative Stress|oxidative stress
410598|NCT01391390|Antioxidant|antioxidant
410599|NCT01391377|HDL|hdl
410600|NCT01391377|High density Lipoprotein|high density lipoprotein
410601|NCT01391377|Peripheral arterial disease|peripheral arterial disease
410602|NCT01391377|Tredaptive|tredaptive
410603|NCT01391377|Niacin|niacin
410604|NCT01391377|Laropiprant|laropiprant
410605|NCT01391377|Plaque|plaque
410606|NCT01391377|Atherosclerosis|atherosclerosis
410607|NCT01391377|Lipid content|lipid content
410608|NCT01391351|carcinoma of the ovary, the fallopian tube or peritoneal serous-type advanced stage|carcinoma of the ovary, the fallopian tube or peritoneal serous-type advanced stage
410609|NCT01391351|chemotherapy with Taxol and Carboplatin|chemotherapy with taxol and carboplatin
410610|NCT01391351|predictors of therapeutic response|predictors of therapeutic response
410611|NCT01391351|serum miRNA|serum mirna
410612|NCT01391351|identification of polymorphisms or SNPs (Single Nucleotide Polymorphism)|identification of polymorphisms or snps (single nucleotide polymorphism)
410613|NCT01391338|Prostatitis|prostatitis
410614|NCT01391338|Chronic|chronic
410615|NCT01391338|Pelvic Pain|pelvic pain
410616|NCT01391338|NIH-CPSI|nih-cpsi
410617|NCT01391338|Pain domain score in NIH-CPSI|pain domain score in nih-cpsi
410618|NCT01391260|Locally Advanced NSCLC|locally advanced nsclc
410619|NCT01391260|EGFR Mutation Positive|egfr mutation positive
410620|NCT01391260|Radiotherapy combined Gefitinib|radiotherapy combined gefitinib
410621|NCT01391247|open angle glaucoma|open angle glaucoma
410622|NCT01391247|low tension glaucoma|low tension glaucoma
410623|NCT01391247|oximetry|oximetry
410624|NCT01391234|Metastatic bone disease|metastatic bone disease
410625|NCT01391234|Bone metastases|bone metastases
410626|NCT01391234|Radiation therapy|radiation therapy
410627|NCT01391234|TomoTherapy|tomotherapy
410628|NCT01391221|Depression|depression
410629|NCT01391221|Inflammation|inflammation
410630|NCT01391221|Cognition|cognition
410631|NCT01391221|Pain|pain
410632|NCT01391221|Allostatic load|allostatic load
410633|NCT01391208|Barrett's Esophagus with High Grade Dysplasia|barrett's esophagus with high grade dysplasia
410634|NCT01391208|Esophageal adenocarcinoma|esophageal adenocarcinoma
410635|NCT01391195|low level laser therapy|low level laser therapy
410636|NCT01391195|muscle performance|muscle performance
410637|NCT01391195|fatigue index|fatigue index
410638|NCT01391195|endurance training|endurance training
410639|NCT01391195|ventilatory threshold|ventilatory threshold
410640|NCT01391195|VO2Max|vo2max
410641|NCT01391195|VO2Peak|vo2peak
410642|NCT01391182|Epsilon Aminocaproic Acid|epsilon aminocaproic acid
410643|NCT01391182|blood loss|blood loss
410644|NCT01391182|total hip arthroplasty|total hip arthroplasty
410645|NCT01391182|reduction in blood transfusions|reduction in blood transfusions
410646|NCT01391182|Amicar|amicar
410647|NCT01391156|minoxidil|minoxidil
410648|NCT01391156|finasteride|finasteride
410649|NCT01391156|topical|topical
410650|NCT01391156|lotion|lotion
410651|NCT01391156|male pattern hair loss|male pattern hair loss
410652|NCT01391156|androgenetic alopecia|androgenetic alopecia
410653|NCT01391143|Prostate cancer|prostate cancer
410654|NCT01391143|Melanoma|melanoma
410655|NCT01391143|Renal cell carcinoma|renal cell carcinoma
410656|NCT01391143|Triple-negative breast cancer|triple-negative breast cancer
410657|NCT01391143|Head and neck cancer|head and neck cancer
410658|NCT01391143|Bladder cancer|bladder cancer
410659|NCT01391143|Non-small cell lung cancer|non-small cell lung cancer
410660|NCT01391143|Squamous cell carcinoma|squamous cell carcinoma
410661|NCT01391130|Cancer|cancer
410662|NCT01391130|Tumor|tumor
410663|NCT01391130|Metastasis|metastasis
410664|NCT01391117|TMC649128|tmc649128
410666|NCT01391117|TMC649128HPC1002|tmc649128hpc1002
410667|NCT01391117|Hepatitis C|hepatitis c
410668|NCT01391117|Hep C|hep c
410669|NCT01391104|Pulmonary Hypertension|pulmonary hypertension
410670|NCT01391104|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
410671|NCT01391104|Exercise|exercise
410672|NCT01391104|Six-minute walk test|six-minute walk test
410673|NCT01391104|sildenafil|sildenafil
410674|NCT01391078|glaucoma|glaucoma
410675|NCT01391078|IOP|iop
410676|NCT01391078|Sensimed Triggerfish|sensimed triggerfish
410677|NCT01391078|Goldmann Applanation Tonometry|goldmann applanation tonometry
410678|NCT01391078|fluctuation|fluctuation
410679|NCT01391078|comparison|comparison
410680|NCT01391065|Diffusion Weighted MRI|diffusion weighted mri
410681|NCT01391065|FLT PET|flt pet
410682|NCT01391065|F-Miso PET|f-miso pet
410683|NCT01391065|Image Guided Brachytherapy|image guided brachytherapy
410684|NCT01391065|Cervix|cervix
410685|NCT01391065|Postoperative Residual Disease/Postoperative recurrences|postoperative residual disease/postoperative recurrences
410686|NCT01391052|Intrauterine system|intrauterine system
410687|NCT01391052|reproductive age|reproductive age
410688|NCT01391052|menstrual bleeding|menstrual bleeding
410689|NCT01391039|Ductal Carcinoma In-situ|ductal carcinoma in-situ
410690|NCT01391039|Contrast Ultrasound|contrast ultrasound
410691|NCT01391039|Microinvasion|microinvasion
410692|NCT01391039|Elastography|elastography
410693|NCT01391026|Medical informatics|medical informatics
410694|NCT01391026|Health services accessibility|health services accessibility
410695|NCT01391013|Human immunodeficiency virus 1|human immunodeficiency virus 1
410696|NCT01391013|Acquired immunodeficiency syndrome|acquired immunodeficiency syndrome
410697|NCT01391013|Immunologic deficiency syndrome|immunologic deficiency syndrome
410698|NCT01391013|Darunavir/ritonavir|darunavir/ritonavir
410699|NCT01391013|Darunavir|darunavir
410700|NCT01391013|Ritonavir|ritonavir
410701|NCT01391013|Nucleoside reverse transcriptase inhibitors (NRTIs)|nucleoside reverse transcriptase inhibitors (nrtis)
410702|NCT01391013|Prezista|prezista
410703|NCT01391000|rotator cuff surgery|rotator cuff surgery
410704|NCT01391000|pain|pain
410705|NCT01391000|exercise therapy|exercise therapy
410706|NCT01390974|ACS|acs
410707|NCT01390974|PCI|pci
410708|NCT01390974|thienopyridines|thienopyridines
410709|NCT01390974|prasugrel therapy|prasugrel therapy
410710|NCT01390974|clopidogrel therapy|clopidogrel therapy
410711|NCT01390961|Allergic conjunctivitis|allergic conjunctivitis
410712|NCT01390935|guideline adherence|guideline adherence
410713|NCT01390935|systolic heart failure|systolic heart failure
410714|NCT01390909|epilepsy|epilepsy
410715|NCT01390909|anti-epileptic drug|anti-epileptic drug
410716|NCT01390909|polytherapy|polytherapy
410717|NCT01390909|adherence|adherence
410718|NCT01390909|Medicaid|medicaid
410719|NCT01390870|Enlarged prostate, 5-alpha-reductase inhibitor, alpha-blocker, adherence|enlarged prostate, 5-alpha-reductase inhibitor, alpha-blocker, adherence
410720|NCT01390818|MEK inhibitor (Pimasertib)|mek inhibitor (pimasertib)
410721|NCT01390818|PI3K/mTOR Inhibitor|pi3k/mtor inhibitor
410722|NCT01390818|Solid Tumor|solid tumor
410723|NCT01390818|Phase I|phase i
410724|NCT01390766|Antirejection|antirejection
410725|NCT01390740|Transthoracic echocardiography|transthoracic echocardiography
410726|NCT01390727|hypertension|hypertension
410727|NCT01390727|device-guided breathing|device-guided breathing
410728|NCT01390727|autonomic function|autonomic function
410729|NCT01390727|Resperate|resperate
410730|NCT01390714|Proton Pump Inhibitors|proton pump inhibitors
410731|NCT01390714|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
410732|NCT01390714|pharmacokinetics|pharmacokinetics
410733|NCT01390714|pharmacodynamics|pharmacodynamics
410734|NCT01390701|randomized|randomized
410735|NCT01390701|cross-over|cross-over
410736|NCT01390701|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
410737|NCT01390701|felodipin|felodipin
410738|NCT01390701|hypertension|hypertension
410739|NCT01390701|blood pressure|blood pressure
410740|NCT01390701|treatment|treatment
410741|NCT01390688|Brain-derived Neurotrophic factor|brain-derived neurotrophic factor
410742|NCT01390688|Low-grade inflammation|low-grade inflammation
410743|NCT01390688|Cognitive dysfunction|cognitive dysfunction
410744|NCT01390662|serum 25-hydroxyvitamin d,vitamin D supplement, depression,|serum 25-hydroxyvitamin d,vitamin d supplement, depression,
410745|NCT01390662|parathyroid hormone|parathyroid hormone
410746|NCT01390649|ITP|itp
410747|NCT01390636|Continuous Glucose Monitoring|continuous glucose monitoring
410748|NCT01390636|Type 1 Diabetes and an Eating Disorder|type 1 diabetes and an eating disorder
410749|NCT01390636|Eating Disorder Only|eating disorder only
410750|NCT01390623|Acute Uncomplicated Pyelonephritis|acute uncomplicated pyelonephritis
410751|NCT01390623|Short-term antibiotic|short-term antibiotic
410752|NCT01390623|Ceftriaxone|ceftriaxone
410753|NCT01390623|Cefixime|cefixime
410754|NCT01390623|Women|women
410755|NCT01390623|Efficacy|efficacy
410756|NCT01390610|Continuous Glucose Monitoring|continuous glucose monitoring
410757|NCT01390610|Self Monitored Blood Glucose|self monitored blood glucose
410758|NCT01390610|Type 2 Diabetes|type 2 diabetes
410759|NCT01390597|peripheral T-cell lymphoma|peripheral t-cell lymphoma
410760|NCT01390597|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
410761|NCT01390597|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
410762|NCT01390597|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
410763|NCT01390597|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
410764|NCT01390597|anaplastic large cell lymphoma|anaplastic large cell lymphoma
410765|NCT01390584|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
410766|NCT01390584|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
410767|NCT01390584|adult favorable prognosis Hodgkin lymphoma|adult favorable prognosis hodgkin lymphoma
410768|NCT01390584|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
410769|NCT01390584|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
410770|NCT01390584|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
410771|NCT01390584|adult unfavorable prognosis Hodgkin lymphoma|adult unfavorable prognosis hodgkin lymphoma
410772|NCT01390571|adult glioblastoma|adult glioblastoma
410773|NCT01390571|adult giant cell glioblastoma|adult giant cell glioblastoma
410774|NCT01390571|adult gliosarcoma|adult gliosarcoma
410775|NCT01390571|recurrent adult brain tumor|recurrent adult brain tumor
410776|NCT01390558|Down Syndrome|down syndrome
410777|NCT01390558|Orthotics|orthotics
410778|NCT01390558|Gait Analysis|gait analysis
410779|NCT01390545|Rheumatoid arthritis|rheumatoid arthritis
410780|NCT01390545|anti-CD20 antibody|anti-cd20 antibody
410781|NCT01390545|subcutaneous|subcutaneous
410782|NCT01390532|Left Ventricular Dyssynchrony|left ventricular dyssynchrony
410783|NCT01390532|Gated blood-pool|gated blood-pool
410784|NCT01390532|D-SPECT|d-spect
410785|NCT01390532|Pharmacological stress|pharmacological stress
410786|NCT01390532|NYHA III/IV|nyha iii/iv
410787|NCT01390532|LVEF < 35 %|lvef < 35 %
410788|NCT01390532|QRS > 120 ms|qrs > 120 ms
410789|NCT01390532|optimal medical treatment|optimal medical treatment
410790|NCT01390532|cardiac resynchronization therapy|cardiac resynchronization therapy
410791|NCT01390519|mRCC,|mrcc,
410792|NCT01390519|observational,|observational,
410793|NCT01390519|Afinitor,|afinitor,
410794|NCT01390519|everolimus,|everolimus,
410795|NCT01390519|2.line|2.line
410796|NCT01390506|cardiac arrest|cardiac arrest
410797|NCT01390506|resuscitation|resuscitation
410798|NCT01390506|neurological outcome|neurological outcome
410799|NCT01390493|neurofeedback, alpha, anorexia nervosa|neurofeedback, alpha, anorexia nervosa
410800|NCT01390480|vitamin D|vitamin d
410801|NCT01390480|Autoimmune disease|autoimmune disease
410802|NCT01390480|diabetes|diabetes
410803|NCT01390467|Paracetamol|paracetamol
410804|NCT01390467|Cognitive impact|cognitive impact
410805|NCT01390441|Rheumatoid arthritis|rheumatoid arthritis
410806|NCT01390441|RA|ra
410807|NCT01390441|Rituximab|rituximab
410808|NCT01390441|Rituxan|rituxan
410809|NCT01390441|MabThera|mabthera
410810|NCT01390441|Methotrexate|methotrexate
410811|NCT01390441|Rheumatrex|rheumatrex
410812|NCT01390441|Trexall|trexall
410813|NCT01390441|MK-8808|mk-8808
410814|NCT01390402|Alloreactive haploidentical NK cells|alloreactive haploidentical nk cells
410815|NCT01390402|Natural killer cells|natural killer cells
410816|NCT01390402|Stem Cell Transplantation|stem cell transplantation
410817|NCT01390402|Immune cells|immune cells
410818|NCT01390402|Chronic myelogenous leukemia|chronic myelogenous leukemia
410819|NCT01390402|CML|cml
410820|NCT01390402|Human leukocyte antigen|human leukocyte antigen
410821|NCT01390402|HLA|hla
410822|NCT01390402|Graft-vs-host disease|graft-vs-host disease
410823|NCT01390402|GVHD|gvhd
410824|NCT01390402|Antithymocyte globulin|antithymocyte globulin
410825|NCT01390402|ATG|atg
410826|NCT01390402|Thymoglobulin|thymoglobulin
410827|NCT01390402|Interleukin-2|interleukin-2
410828|NCT01390402|IL-2|il-2
410829|NCT01390402|Aldesleukin|aldesleukin
410830|NCT01390402|Proleukin|proleukin
410831|NCT01390402|Fludarabine|fludarabine
410832|NCT01390402|Fludarabine phosphate|fludarabine phosphate
410833|NCT01390402|Fludara|fludara
410834|NCT01390402|Tacrolimus|tacrolimus
410835|NCT01390402|Prograf|prograf
410836|NCT01390402|Busulfan|busulfan
410837|NCT01390402|Busulfex|busulfex
410838|NCT01390402|Myleran|myleran
410839|NCT01390402|Methotrexate|methotrexate
410840|NCT01390389|Geriatric bipolar depression|geriatric bipolar depression
410841|NCT01390389|MR Spectroscopy|mr spectroscopy
410842|NCT01390389|Coenzyme Q10|coenzyme q10
410843|NCT01390389|Mitochondrial Dysfunction|mitochondrial dysfunction
410844|NCT01390376|Schizophrenia|schizophrenia
410845|NCT01390376|NMDA|nmda
410846|NCT01390376|DAAOI|daaoi
410847|NCT01390376|Clozapine resistant schizophrenia|clozapine resistant schizophrenia
410848|NCT01390363|immunization|immunization
410849|NCT01390363|reminder systems|reminder systems
410850|NCT01390350|Schnitzler syndrome|schnitzler syndrome
410851|NCT01390350|autoinflammatory syndrome|autoinflammatory syndrome
410852|NCT01390337|AC220|ac220
410853|NCT01390337|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
410854|NCT01390337|De Novo Acute Myeloid Leukemia (AML)|de novo acute myeloid leukemia (aml)
410955|NCT01389830|Hispanic American|hispanic american
410855|NCT01390337|Newly diagnosed Acute Myeloid Leukemia (AML)|newly diagnosed acute myeloid leukemia (aml)
410856|NCT01390337|FMS-like tyrosine kinase (FLT3)|fms-like tyrosine kinase (flt3)
410857|NCT01390337|FMS-like tyrosine kinase (FLT3) Inhibitor|fms-like tyrosine kinase (flt3) inhibitor
410858|NCT01390337|Kinase|kinase
410859|NCT01390337|Kinase Inhibitor|kinase inhibitor
410860|NCT01390337|Pharmacokinetics|pharmacokinetics
410861|NCT01390337|ASP2689|asp2689
410862|NCT01390337|quizartinib|quizartinib
410863|NCT01390324|Migraine|migraine
410864|NCT01390324|Naratriptan|naratriptan
410865|NCT01390324|Naproxen|naproxen
410866|NCT01390298|chronic pain after knee replacement surgery|chronic pain after knee replacement surgery
410867|NCT01390272|Hypertension|hypertension
410868|NCT01390272|Telephone|telephone
410869|NCT01390272|Disease Management|disease management
410870|NCT01390272|Veterans|veterans
410871|NCT01390272|Pharmacists|pharmacists
410872|NCT01390272|Nurses|nurses
410873|NCT01390246|Pregnancy|pregnancy
410874|NCT01390246|Tobacco use disorder|tobacco use disorder
410875|NCT01390246|Smoking cessation|smoking cessation
410876|NCT01390246|Bupropion SR|bupropion sr
410877|NCT01390246|Zyban|zyban
410878|NCT01390233|Labor, obstetric|labor, obstetric
410879|NCT01390233|Labor, induced|labor, induced
410880|NCT01390220|Epilepsy|epilepsy
410881|NCT01390220|seizure clusters|seizure clusters
410882|NCT01390220|acute repetitive seizures|acute repetitive seizures
410883|NCT01390220|rescue treatment|rescue treatment
410884|NCT01390220|ARTEMIS|artemis
410885|NCT01390207|hCG triggering|hcg triggering
410886|NCT01390207|pregnancy|pregnancy
410887|NCT01390207|GnRH antagonist|gnrh antagonist
410888|NCT01390194|liver disease|liver disease
410889|NCT01390194|hepatocellular carcinoma|hepatocellular carcinoma
410890|NCT01390155|Electrocardiography|electrocardiography
410891|NCT01390155|Coronary Artery Disease|coronary artery disease
410892|NCT01390155|Atrial Fibrillation|atrial fibrillation
410893|NCT01390155|Heart Atria|heart atria
410894|NCT01390155|Coronary Circulation|coronary circulation
410895|NCT01390155|Ischemia|ischemia
410896|NCT01390116|gamma delta T cell|gamma delta t cell
410897|NCT01390116|natural killer cell|natural killer cell
410898|NCT01390116|proliferation|proliferation
410899|NCT01390116|cytokine secretion|cytokine secretion
410900|NCT01390116|Improvement in immune cell function in healthy humans|improvement in immune cell function in healthy humans
410901|NCT01390103|hip pain|hip pain
410902|NCT01390090|piriformis muscle|piriformis muscle
410903|NCT01390077|homogentisic acid|homogentisic acid
410904|NCT01390051|birth weight|birth weight
410905|NCT01390051|thrombosis|thrombosis
410906|NCT01390051|anticoagulant therapy|anticoagulant therapy
410907|NCT01390025|Influenza|influenza
410908|NCT01390025|Monoclonal antibody|monoclonal antibody
410909|NCT01389973|Diseases [C] - Digestive System Diseases [C06]|diseases [c] - digestive system diseases [c06]
410910|NCT01389973|primary biliary cirrhosis|primary biliary cirrhosis
410911|NCT01389973|ursodeoxycholic acid (UDCA)|ursodeoxycholic acid (udca)
410912|NCT01389973|STELARA|stelara
410913|NCT01389973|ustekinumab|ustekinumab
410914|NCT01389947|mesenteric ischemia|mesenteric ischemia
410915|NCT01389947|extracorporeal circulation|extracorporeal circulation
410916|NCT01389947|microcirculation|microcirculation
410917|NCT01389947|cardiac surgery|cardiac surgery
410918|NCT01389947|IFABP|ifabp
410919|NCT01389947|citrullinemia|citrullinemia
410920|NCT01389947|glycocalyx|glycocalyx
410921|NCT01389947|vascular occlusion test|vascular occlusion test
410922|NCT01389947|NIRS probe on thenar eminence|nirs probe on thenar eminence
410923|NCT01389934|levo-bupicaine|levo-bupicaine
410924|NCT01389934|Radical|radical
410925|NCT01389934|Mastectomy|mastectomy
410926|NCT01389921|lower urinary tract|lower urinary tract
410927|NCT01389921|sensory evoked potential|sensory evoked potential
410928|NCT01389921|contact heat evoked potential stimulation|contact heat evoked potential stimulation
410929|NCT01389921|electroencephalogram|electroencephalogram
410930|NCT01389921|cortical processing|cortical processing
410931|NCT01389921|bladder sensations|bladder sensations
410932|NCT01389921|lower urinary tract dysfunction|lower urinary tract dysfunction
410933|NCT01389921|overactive bladder|overactive bladder
410934|NCT01389895|Lupus|lupus
410935|NCT01389895|Cutaneous lupus|cutaneous lupus
410936|NCT01389882|mechanical ventilation|mechanical ventilation
410937|NCT01389882|diaphragm electrical activity|diaphragm electrical activity
410938|NCT01389882|pressure support|pressure support
410939|NCT01389869|Emotional tears|emotional tears
410940|NCT01389869|Postprandial plasma|postprandial plasma
410941|NCT01389869|Chemosignal|chemosignal
410942|NCT01389869|Obesity|obesity
410943|NCT01389869|Appetite|appetite
410944|NCT01389869|Food intake|food intake
410945|NCT01389856|Persistent pulmonary hypertension, newborn|persistent pulmonary hypertension, newborn
410946|NCT01389856|PPHN|pphn
410947|NCT01389843|Heart failure|heart failure
410948|NCT01389843|Registry|registry
410949|NCT01389843|Cohort|cohort
410950|NCT01389843|Heart Disease|heart disease
410951|NCT01389843|Cardiovascular Diseases|cardiovascular diseases
410952|NCT01389830|End of Life|end of life
410953|NCT01389830|EOL|eol
410956|NCT01389830|Medicare beneficiaries|medicare beneficiaries
410957|NCT01389830|stage III diagnosis|stage iii diagnosis
410958|NCT01389830|Breast cancer|breast cancer
410959|NCT01389830|Colorectal cancer|colorectal cancer
410960|NCT01389830|Prostate cancer|prostate cancer
410961|NCT01389830|Lung cancer|lung cancer
410962|NCT01389830|Cancer Prevention and Treatment Demonstration|cancer prevention and treatment demonstration
410963|NCT01389830|CPTD|cptd
410964|NCT01389804|transplant, pediatric|transplant, pediatric
410965|NCT01389791|muscle relaxation|muscle relaxation
410966|NCT01389791|magnesium sulfate|magnesium sulfate
410967|NCT01389791|rocuronium|rocuronium
410968|NCT01389739|continuity of care|continuity of care
410969|NCT01389739|interprofessional collaboration|interprofessional collaboration
410970|NCT01389726|custodial grandparents|custodial grandparents
410971|NCT01389726|kinship caregivers|kinship caregivers
410972|NCT01389726|grandparents raising grandchildren|grandparents raising grandchildren
410973|NCT01389726|grandmothers|grandmothers
410974|NCT01389726|grandchildren|grandchildren
410975|NCT01389726|psychological well-being|psychological well-being
410976|NCT01389713|ovarian reserve|ovarian reserve
410977|NCT01389713|ovarian stimulation|ovarian stimulation
410978|NCT01389713|clomifene citrate|clomifene citrate
410979|NCT01389713|high doses Follicle Stimulating Hormone (FSH)|high doses follicle stimulating hormone (fsh)
410980|NCT01389687|Poliomyelitis|poliomyelitis
410981|NCT01389687|Inactivated polio vaccine|inactivated polio vaccine
410982|NCT01389687|Polio|polio
410983|NCT01389687|Poliovirus|poliovirus
410984|NCT01389674|coronary stenosis|coronary stenosis
410985|NCT01389674|Angina pectoris|angina pectoris
410986|NCT01389674|left ventricular wall motion abnormalities|left ventricular wall motion abnormalities
410987|NCT01389661|Maxillary bone cysts|maxillary bone cysts
410988|NCT01389661|Cell therapy|cell therapy
410989|NCT01389661|Mesenchymal stem cells|mesenchymal stem cells
410990|NCT01389661|Autologous serum scaffold|autologous serum scaffold
410991|NCT01389648|adult|adult
410992|NCT01389635|Abdominoplasty|abdominoplasty
410993|NCT01389635|Epidural|epidural
410994|NCT01389622|Acupuncture|acupuncture
410995|NCT01389622|smoking cessation|smoking cessation
410996|NCT01389609|Bioequivalence|bioequivalence
410997|NCT01389609|Orally-disintegrating Tablet|orally-disintegrating tablet
410998|NCT01389596|safety|safety
410999|NCT01389596|efficacy|efficacy
411000|NCT01389596|partial onset seizures|partial onset seizures
411001|NCT01389596|pediatric|pediatric
411002|NCT01389596|pregabalin|pregabalin
411003|NCT01389596|placebo-controlled|placebo-controlled
411004|NCT01389596|double-blind|double-blind
411005|NCT01389583|GIST(Gastrointestinal stromal tumor)|gist(gastrointestinal stromal tumor)
411006|NCT01389583|HSP(Heat Shock Protein)|hsp(heat shock protein)
411007|NCT01389583|Biomarker|biomarker
411008|NCT01389557|malaria|malaria
411009|NCT01389557|DHP|dhp
411010|NCT01389557|PQ|pq
411011|NCT01389557|MST|mst
411012|NCT01389518|Symptomatic treatment|symptomatic treatment
411013|NCT01389518|Common Cold|common cold
411014|NCT01389518|flu syndrome|flu syndrome
411015|NCT01389505|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
411016|NCT01389505|Bevacizumab|bevacizumab
411017|NCT01389505|Panretinal Photocoagulation|panretinal photocoagulation
411018|NCT01389492|meat|meat
411019|NCT01389492|LDL|ldl
411020|NCT01389492|MDA|mda
411021|NCT01389466|Avian influenza|avian influenza
411022|NCT01389453|umbilical cord mesenchyma stem cell transplantation|umbilical cord mesenchyma stem cell transplantation
411023|NCT01389440|Resectable pancreatic adenocarcinoma|resectable pancreatic adenocarcinoma
411024|NCT01389440|Gemcitabine|gemcitabine
411025|NCT01389440|Erlotinib|erlotinib
411026|NCT01389440|Radiotherapy|radiotherapy
411027|NCT01389440|Neoadjuvant treatment|neoadjuvant treatment
411028|NCT01389414|cholangiocarcinoma|cholangiocarcinoma
411029|NCT01389414|biliary|biliary
411030|NCT01389414|gallbladder|gallbladder
411031|NCT01389414|intrahepatic|intrahepatic
411032|NCT01389414|extrahepatic|extrahepatic
411033|NCT01389401|Larynx|larynx
411034|NCT01389401|GERD|gerd
411035|NCT01389401|saliva|saliva
411036|NCT01389401|epidermal growth factor|epidermal growth factor
411037|NCT01389388|Carotid plaques|carotid plaques
411038|NCT01389388|inflammatory joint disease|inflammatory joint disease
411039|NCT01389388|statins|statins
411040|NCT01389388|inflammation|inflammation
411041|NCT01389388|lipoprotein components|lipoprotein components
411042|NCT01389375|Closure Device|closure device
411043|NCT01389375|Coronary Angiography|coronary angiography
411044|NCT01389362|Diabetes|diabetes
411045|NCT01389362|foot ulcer|foot ulcer
411046|NCT01389362|Chinese herbal medicine|chinese herbal medicine
411047|NCT01389349|tonsillectomy|tonsillectomy
411048|NCT01389349|adenotonsillectomy|adenotonsillectomy
411049|NCT01389349|acupuncture|acupuncture
411050|NCT01389349|children|children
411051|NCT01389349|postoperative pain|postoperative pain
411052|NCT01389349|postoperative nausea|postoperative nausea
411053|NCT01389336|Fibromyalgia Syndrome|fibromyalgia syndrome
411054|NCT01389336|Fibromyalgia|fibromyalgia
411055|NCT01389336|Ayurveda|ayurveda
411056|NCT01389336|Traditional Indian Medicine|traditional indian medicine
411057|NCT01389336|CAM|cam
411058|NCT01389336|Pain|pain
411059|NCT01389336|Chronic Widespread Pain|chronic widespread pain
411060|NCT01389297|alcohol dependence intervention|alcohol dependence intervention
411061|NCT01389297|Internet delivered intervention|internet delivered intervention
411062|NCT01389297|alcohol dependence treatment|alcohol dependence treatment
411063|NCT01389297|Internet delivered treatment|internet delivered treatment
411064|NCT01389284|Naproxen Sodium,|naproxen sodium,
411065|NCT01389284|dental pain|dental pain
411066|NCT01389271|Pulmonary hypertension|pulmonary hypertension
411067|NCT01389271|Inhaled iloprost|inhaled iloprost
411068|NCT01389271|Efficacy|efficacy
411069|NCT01389271|Safety|safety
411070|NCT01389271|Tolerability|tolerability
411071|NCT01389271|Survival|survival
411072|NCT01389271|NYHA class III and IV|nyha class iii and iv
411073|NCT01389219|Post partum|post partum
411074|NCT01389219|Neonate|neonate
411075|NCT01389219|community health care workers|community health care workers
411076|NCT01389193|ibudilast|ibudilast
411077|NCT01389193|migraine|migraine
411078|NCT01389193|glial cell|glial cell
411079|NCT01389154|diagnostic yield|diagnostic yield
411080|NCT01389154|Electromagnetic Tip Tracked|electromagnetic tip tracked
411081|NCT01389154|peripheral lung lesion|peripheral lung lesion
411082|NCT01389141|ovary|ovary
411083|NCT01389141|follicle|follicle
411084|NCT01389141|hormones|hormones
411085|NCT01389141|bone|bone
411086|NCT01389141|muscle|muscle
411087|NCT01389128|labor|labor
411088|NCT01389128|pain|pain
411089|NCT01389128|massage|massage
411090|NCT01389128|natural birth|natural birth
411091|NCT01389115|liver cirrhosis|liver cirrhosis
411092|NCT01389115|oxidative stress|oxidative stress
411093|NCT01389115|liver transplant|liver transplant
411094|NCT01389102|Postmenopause|postmenopause
411095|NCT01389102|Hot Flashes|hot flashes
411096|NCT01389102|Estradiol|estradiol
411097|NCT01389102|Polyestradiol phosphate|polyestradiol phosphate
411098|NCT01389102|Estradiol valerate|estradiol valerate
411099|NCT01389102|Estradiol 3-benzoate|estradiol 3-benzoate
411100|NCT01389102|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate
411101|NCT01389102|Estrogens|estrogens
411102|NCT01389102|Hormones|hormones
411103|NCT01389102|Hormones, Hormone Substitutes|hormones, hormone substitutes
411104|NCT01389102|Hormone Antagonists|hormone antagonists
411105|NCT01389089|edema reduction|edema reduction
411106|NCT01389089|ice|ice
411107|NCT01389089|multi-layer compression bandage|multi-layer compression bandage
411108|NCT01389089|A-V Impulse compression|a-v impulse compression
411109|NCT01389089|ankle|ankle
411110|NCT01389076|Previously Untreated, Advanced-Stage, Follicular Lymphoma|previously untreated, advanced-stage, follicular lymphoma
411111|NCT01389063|endothelial function|endothelial function
411112|NCT01389063|CCR5 receptor|ccr5 receptor
411113|NCT01389063|Maraviroc|maraviroc
411114|NCT01389063|Abacavir|abacavir
411115|NCT01389063|Flow Mediated Dilatation|flow mediated dilatation
411116|NCT01389063|EndoPAT|endopat
411117|NCT01389037|African American|african american
411118|NCT01389037|High blood pressure|high blood pressure
411119|NCT01389024|sickle cell disease|sickle cell disease
411120|NCT01389024|stroke|stroke
411121|NCT01389024|silent cerebral infarct|silent cerebral infarct
411122|NCT01389024|children|children
411123|NCT01389011|PI|pi
411124|NCT01389011|PVI|pvi
411125|NCT01389011|Interscalene block|interscalene block
411126|NCT01388998|fluid management|fluid management
411127|NCT01388998|fluid therapy|fluid therapy
411128|NCT01388998|dPP|dpp
411129|NCT01388998|difference in pulse pressure|difference in pulse pressure
411130|NCT01388998|PVI|pvi
411131|NCT01388998|pleth variability index|pleth variability index
411132|NCT01388998|external pressure applied on the caval vein|external pressure applied on the caval vein
411133|NCT01388985|Rabies|rabies
411134|NCT01388985|Vaccination|vaccination
411135|NCT01388985|Boostability|boostability
411136|NCT01388972|Community nutritional environment|community nutritional environment
411137|NCT01388972|Physical activity|physical activity
411138|NCT01388946|acute postoperative pain|acute postoperative pain
411139|NCT01388946|late pain|late pain
411140|NCT01388946|chronic pain|chronic pain
411141|NCT01388946|wound irrigation with local anesthetic|wound irrigation with local anesthetic
411142|NCT01388933|Crohn's Disease|crohn's disease
411143|NCT01388933|natural|natural
411144|NCT01388933|herbal|herbal
411145|NCT01388933|Kampo|kampo
411146|NCT01388933|inflammatory bowel disease|inflammatory bowel disease
411147|NCT01388933|Adult ages 18 to 75|adult ages 18 to 75
411148|NCT01388933|Male and female subjects|male and female subjects
411149|NCT01388920|COPD|copd
411150|NCT01388920|Muscle wasting|muscle wasting
411151|NCT01388907|myomectomy|myomectomy
411152|NCT01388907|adhesion prevention|adhesion prevention
411153|NCT01388907|pregnancy rate|pregnancy rate
411154|NCT01388881|reading difficulties|reading difficulties
411155|NCT01388868|infusion dose|infusion dose
411156|NCT01388868|vecuronium|vecuronium
411157|NCT01388868|motor evoked potential|motor evoked potential
411158|NCT01388868|neuromuscular blocking agent|neuromuscular blocking agent
411159|NCT01388855|Heart Failure|heart failure
411160|NCT01388855|Vitamin D|vitamin d
411161|NCT01388855|Pain|pain
411162|NCT01388855|Pilot Study|pilot study
411163|NCT01388855|RCT|rct
411164|NCT01388842|severe malaria|severe malaria
411165|NCT01388842|children|children
411166|NCT01388842|adjunctive treatment|adjunctive treatment
411167|NCT01388829|formulation comparison|formulation comparison
411168|NCT01388816|Randomized|randomized
411169|NCT01388816|Double-Blind|double-blind
411170|NCT01388816|Placebo Controlled|placebo controlled
411171|NCT01388816|Parallel Arm|parallel arm
411172|NCT01388816|Type II Hyperlipidemia|type ii hyperlipidemia
411173|NCT01388816|Cholesteryl Ester Transferase Protein Inhibitor|cholesteryl ester transferase protein inhibitor
411174|NCT01388816|CETP Inhibitor|cetp inhibitor
411175|NCT01388803|bronchial blocker|bronchial blocker
411176|NCT01388803|VATS|vats
411177|NCT01388790|Gastric Cancer|gastric cancer
411178|NCT01388790|Cetuximab|cetuximab
411179|NCT01388790|EMD271786|emd271786
411180|NCT01388790|TS-1|ts-1
411181|NCT01388790|Cisplatin|cisplatin
411182|NCT01388777|Breast Cancer|breast cancer
411183|NCT01388777|Breast Carcinoma|breast carcinoma
411184|NCT01388777|Cryoablation|cryoablation
411185|NCT01388777|The Visica 2™ Treatment System|the visica 2™ treatment system
411186|NCT01388777|Unifocal primary invasive ductal breast carcinoma|unifocal primary invasive ductal breast carcinoma
411187|NCT01388777|Cryoprobe|cryoprobe
411188|NCT01388764|L-arginine supplement study|l-arginine supplement study
411189|NCT01388751|Mallet Finger splinting|mallet finger splinting
411190|NCT01388738|Navigation Brain Stimulation (NEXSTIM)|navigation brain stimulation (nexstim)
411191|NCT01388738|cerebroprotective drug effectiveness|cerebroprotective drug effectiveness
411192|NCT01388738|acute ischemic stroke|acute ischemic stroke
411193|NCT01388725|sTREM-1|strem-1
411194|NCT01388725|sCD163|scd163
411195|NCT01388725|PCT|pct
411196|NCT01388725|CRP|crp
411197|NCT01388725|WBC count|wbc count
411198|NCT01388725|SOFA score|sofa score
411199|NCT01388725|SIRS|sirs
411200|NCT01388725|sepsis|sepsis
411201|NCT01388725|severity|severity
411202|NCT01388725|prognosis|prognosis
411203|NCT01388712|Probiotics|probiotics
411204|NCT01388712|constipation|constipation
411205|NCT01388712|children|children
411206|NCT01388699|Migraine with aura|migraine with aura
411207|NCT01388686|sepsis|sepsis
411208|NCT01388686|catheter|catheter
411209|NCT01388686|blood stream infection|blood stream infection
411210|NCT01388686|blood culture|blood culture
411211|NCT01388673|prior RYGB procedure|prior rygb procedure
411212|NCT01388673|regained weight over time|regained weight over time
411213|NCT01388673|dilated pouch and/or stoma|dilated pouch and/or stoma
411214|NCT01388660|Healthy|healthy
411215|NCT01388660|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
411216|NCT01388660|Pharmacokinetics|pharmacokinetics
411217|NCT01388647|Neoadjuvant Treatment|neoadjuvant treatment
411218|NCT01388647|HER-2 Positive Breast Cancer|her-2 positive breast cancer
411219|NCT01388634|Length of hospital stay|length of hospital stay
411220|NCT01388634|readmission|readmission
411221|NCT01388634|ventral hernia|ventral hernia
411222|NCT01388621|ovarian cancer|ovarian cancer
411223|NCT01388621|fallopian cancer|fallopian cancer
411224|NCT01388621|recurrent|recurrent
411225|NCT01388621|platinum-sensitive|platinum-sensitive
411226|NCT01388621|KRAS-Wildtype|kras-wildtype
411227|NCT01388608|rheumatoid arthritis|rheumatoid arthritis
411228|NCT01388608|etanercept|etanercept
411229|NCT01388608|step activity measure|step activity measure
411230|NCT01388582|contraceptives|contraceptives
411231|NCT01388582|hormonal|hormonal
411232|NCT01388582|breastfeeding|breastfeeding
411233|NCT01388582|infant weight|infant weight
411234|NCT01388569|stage IV melanoma|stage iv melanoma
411235|NCT01388556|exercise|exercise
411236|NCT01388556|Parkinson disease|parkinson disease
411237|NCT01388556|motor symptoms|motor symptoms
411238|NCT01388556|gait|gait
411239|NCT01388556|balance|balance
411240|NCT01388543|Pharmacokinetics|pharmacokinetics
411241|NCT01388543|Clinical Pharmacology|clinical pharmacology
411242|NCT01388543|Pharmacogenomics|pharmacogenomics
411243|NCT01388543|HIV|hiv
411244|NCT01388517|Pityriasis alba|pityriasis alba
411245|NCT01388517|Tacrolimus|tacrolimus
411246|NCT01388517|Calcitriol|calcitriol
411247|NCT01388517|Petrolatum|petrolatum
411248|NCT01388491|Contraception|contraception
411249|NCT01388491|Hemostasis|hemostasis
411250|NCT01388491|Blood Coagulation|blood coagulation
411251|NCT01388478|Safety|safety
411252|NCT01388478|Tolerability|tolerability
411253|NCT01388478|R(+)Pramipexole|r(+)pramipexole
411254|NCT01388478|Alzheimer's|alzheimer's
411255|NCT01388465|Adherence|adherence
411256|NCT01388465|Intervention|intervention
411257|NCT01388452|HIV|hiv
411258|NCT01388452|routine HIV testing|routine hiv testing
411259|NCT01388452|provider-initiated HIV testing and counseling|provider-initiated hiv testing and counseling
411260|NCT01388452|early infant diagnosis|early infant diagnosis
411261|NCT01388452|Africa South of the Sahara|africa south of the sahara
411262|NCT01388439|oseltamivir|oseltamivir
411263|NCT01388439|influenza|influenza
411264|NCT01388439|neonate|neonate
411265|NCT01388439|premature|premature
411266|NCT01388439|pharmacokinetics|pharmacokinetics
411267|NCT01388413|neurogenic bladder|neurogenic bladder
411268|NCT01388413|urinary tract infection|urinary tract infection
411269|NCT01388400|stroke|stroke
411270|NCT01388400|rehabilitation|rehabilitation
411271|NCT01388400|virtual reality|virtual reality
411272|NCT01388400|upper limb|upper limb
411273|NCT01388387|pharmacogenetics|pharmacogenetics
411274|NCT01388387|pharmacokinetics|pharmacokinetics
411275|NCT01388387|tacrolimus|tacrolimus
411276|NCT01388387|genetic polymorphism|genetic polymorphism
411277|NCT01388387|CYP3A5|cyp3a5
411278|NCT01388387|liver transplantation|liver transplantation
411279|NCT01388374|Delivery of Health Care|delivery of health care
411280|NCT01388374|Nurse Practitioners|nurse practitioners
411281|NCT01388374|Out of Hours Medical Care|out of hours medical care
411282|NCT01388374|Primary Health Care|primary health care
411283|NCT01388374|Emergency Medical Services|emergency medical services
411284|NCT01388348|benign prostatic hyperplasia (BPH)|benign prostatic hyperplasia (bph)
411285|NCT01388348|acoustic vibration|acoustic vibration
411286|NCT01388322|Pregnancy|pregnancy
411287|NCT01388322|Preeclampsia|preeclampsia
411288|NCT01388322|Placental insufficiency|placental insufficiency
411289|NCT01388283|prognostic marker|prognostic marker
411290|NCT01388270|Hemodialysis|hemodialysis
411291|NCT01388270|Anticoagulation|anticoagulation
411292|NCT01388270|Clotting|clotting
411293|NCT01388270|Coagulation|coagulation
411294|NCT01388270|dalteparin|dalteparin
411295|NCT01388270|Clotting in the extracorporeal system during HD|clotting in the extracorporeal system during hd
411296|NCT01388270|Antithrombogenic property of Evodial HD filter|antithrombogenic property of evodial hd filter
411297|NCT01388270|Anticoagulation during HD|anticoagulation during hd
411298|NCT01388257|Crohn Disease|crohn disease
411299|NCT01388257|Anoperineal fistula|anoperineal fistula
411300|NCT01388257|Anal fistula|anal fistula
411301|NCT01388257|Proctology|proctology
411302|NCT01388257|Drainage|drainage
411303|NCT01388257|Colorectal Surgery|colorectal surgery
411304|NCT01388257|Fistulotomy|fistulotomy
411305|NCT01388257|Plug|plug
411306|NCT01388257|Advancement flap|advancement flap
411307|NCT01388257|Glue|glue
411308|NCT01388257|Anti Tumor Necrosis Factor-alpha|anti tumor necrosis factor-alpha
411309|NCT01388257|Adalimumab|adalimumab
411310|NCT01388244|Screening|screening
411311|NCT01388244|Risk Assessment|risk assessment
411312|NCT01388244|Fractures|fractures
411313|NCT01388244|Absorptiometry, Photon|absorptiometry, photon
411314|NCT01388244|Fracture prevention|fracture prevention
411315|NCT01388244|Women|women
411316|NCT01388244|Patient prespective|patient prespective
411317|NCT01388231|social phobia, cognitive-behavioral therapy, treatment|social phobia, cognitive-behavioral therapy, treatment
411318|NCT01388218|Physical Activity|physical activity
411319|NCT01388218|Patient Reported Outcome (PRO)|patient reported outcome (pro)
411320|NCT01388218|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
411321|NCT01388218|Innovative Medicines Initiative - Joint Undertaking (IMI-JU)|innovative medicines initiative - joint undertaking (imi-ju)
411322|NCT01388205|Myopia|myopia
411323|NCT01388205|Outdoor activity|outdoor activity
411324|NCT01388205|Physical activity|physical activity
411325|NCT01388205|Randomized Controlled Trial|randomized controlled trial
411326|NCT01388205|Pedometer|pedometer
411327|NCT01388205|Behavior modification|behavior modification
411328|NCT01388205|Obesity|obesity
411329|NCT01388192|Pancreaticoduodenectomy|pancreaticoduodenectomy
411330|NCT01388192|diabetes|diabetes
411331|NCT01388192|sugar metabolism|sugar metabolism
411332|NCT01388179|Autism|autism
411333|NCT01388179|TMS|tms
411334|NCT01388153|Bioequivalence, acarbose, ODT|bioequivalence, acarbose, odt
411335|NCT01388140|dissociation|dissociation
411336|NCT01388140|psychosis|psychosis
411337|NCT01388140|trauma|trauma
411338|NCT01388140|parenting|parenting
411339|NCT01388140|executive functions|executive functions
411340|NCT01388114|Procalcitonin Measurement|procalcitonin measurement
411341|NCT01388101|LECT2|lect2
411342|NCT01388088|Hypertension|hypertension
411343|NCT01388088|Potassium|potassium
411344|NCT01388088|Blood-pressure|blood-pressure
411345|NCT01388075|induction|induction
411346|NCT01388075|CYP2C9|cyp2c9
411347|NCT01388075|Genetic variability|genetic variability
411348|NCT01388075|Expression|expression
411349|NCT01388062|influenza virus|influenza virus
411350|NCT01388049|EV71|ev71
411351|NCT01388036|heart rate|heart rate
411352|NCT01388023|SmellX|smellx
411353|NCT01388023|malodor|malodor
411354|NCT01388023|halitosis|halitosis
411355|NCT01388023|herbal formulation|herbal formulation
411356|NCT01388023|natural medicinals|natural medicinals
411357|NCT01388023|slow release delivery system|slow release delivery system
411358|NCT01388023|gingivitis|gingivitis
411359|NCT01388023|Bad Breath|bad breath
411360|NCT01388010|probiotics|probiotics
411361|NCT01388010|gastrointestinal well being|gastrointestinal well being
411362|NCT01388010|digestive symptoms|digestive symptoms
411363|NCT01388010|healthy population|healthy population
411364|NCT01387997|HPV|hpv
411365|NCT01387984|Type 2 diabetes mellitus|type 2 diabetes mellitus
411366|NCT01387984|Diabetic complications|diabetic complications
411367|NCT01387984|YKL-40|ykl-40
411368|NCT01387971|impression cytology|impression cytology
411369|NCT01387971|ocular surface disorders|ocular surface disorders
411370|NCT01387971|ocular surface cells' variation|ocular surface cells' variation
411371|NCT01387971|Limbal insufficiency|limbal insufficiency
411372|NCT01387958|Hepatitis C virus|hepatitis c virus
411373|NCT01387958|Chronically infected|chronically infected
411374|NCT01387958|treatment naive|treatment naive
411375|NCT01387958|non responders to prior therapy|non responders to prior therapy
411376|NCT01387945|Home blood pressure monitoring|home blood pressure monitoring
411377|NCT01387945|Patient activation|patient activation
411378|NCT01387945|Patient-centered care|patient-centered care
411379|NCT01387945|Community Health Aides|community health aides
411380|NCT01387945|Primary Health Care|primary health care
411381|NCT01387932|Hepatocellular carcinoma|hepatocellular carcinoma
411382|NCT01387932|TACE|tace
411383|NCT01387932|HepaSphere Microspheres|hepasphere microspheres
411384|NCT01387932|QuadraSphere Microspheres|quadrasphere microspheres
411385|NCT01387932|Doxorubicin|doxorubicin
411386|NCT01387919|Set time points during 48 hours of fasting|set time points during 48 hours of fasting
411387|NCT01387906|mild|mild
411388|NCT01387906|moderate|moderate
411389|NCT01387893|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
411390|NCT01387893|BPH|bph
411391|NCT01387893|Lower Urinary Tract Symptoms|lower urinary tract symptoms
411392|NCT01387893|LUTS|luts
411393|NCT01387893|Self-Administered Maneuver|self-administered maneuver
411394|NCT01387893|Symptomatic Relief|symptomatic relief
411395|NCT01387893|Digital Repetitive Infrapubic Pressure maneuver|digital repetitive infrapubic pressure maneuver
411396|NCT01387880|Metastatic colorectal cancer|metastatic colorectal cancer
411397|NCT01387880|Third line therapy|third line therapy
411398|NCT01387880|Fourth line therapy|fourth line therapy
411399|NCT01387880|KRAS mutation status|kras mutation status
411400|NCT01387880|Cetuximab|cetuximab
411401|NCT01387880|Everolimus|everolimus
411402|NCT01387880|Irinotecan|irinotecan
411403|NCT01387867|Exercise|exercise
411404|NCT01387867|Hip osteoarthritis|hip osteoarthritis
411405|NCT01387867|Randomized controlled trial|randomized controlled trial
411406|NCT01387841|yoga|yoga
411407|NCT01387841|chemotherapy|chemotherapy
411408|NCT01387841|nausea|nausea
411409|NCT01387841|vomiting|vomiting
411410|NCT01387828|Splenic artery|splenic artery
411411|NCT01387828|Aneurysm|aneurysm
411412|NCT01387828|laparoscopic|laparoscopic
411413|NCT01387828|Vascular reconstruction|vascular reconstruction
411414|NCT01387828|Splenectomy|splenectomy
411415|NCT01387815|Effectiveness|effectiveness
411416|NCT01387815|Psoriasis|psoriasis
411417|NCT01387815|Observational|observational
411418|NCT01387815|Prospective|prospective
411419|NCT01387815|Adalimumab|adalimumab
411420|NCT01387815|Traditional Systemic Agents|traditional systemic agents
411421|NCT01387815|Topical Agents|topical agents
411422|NCT01387815|Comparative|comparative
411423|NCT01387802|Assessing Effectiveness in Ankylosing Spondylitis|assessing effectiveness in ankylosing spondylitis
411424|NCT01387789|Product Surveillance|product surveillance
411425|NCT01387789|Postmarketing|postmarketing
411426|NCT01387750|Acute Pain|acute pain
411427|NCT01387750|Musculoskeletal Pain|musculoskeletal pain
411428|NCT01387750|Topical Analgesic|topical analgesic
411429|NCT01387737|TA-7284|ta-7284
411430|NCT01387737|JNJ-28431754|jnj-28431754
411431|NCT01387737|Canagliflozin|canagliflozin
411432|NCT01387737|Sodium Glucose Co-Transporter (SGLT2 inhibitor)|sodium glucose co-transporter (sglt2 inhibitor)
411433|NCT01387724|disseminated neuroblastoma|disseminated neuroblastoma
411434|NCT01387724|localized resectable neuroblastoma|localized resectable neuroblastoma
411435|NCT01387724|localized unresectable neuroblastoma|localized unresectable neuroblastoma
411436|NCT01387724|regional neuroblastoma|regional neuroblastoma
411437|NCT01387724|stage 4S neuroblastoma|stage 4s neuroblastoma
411438|NCT01387672|postmenopausal|postmenopausal
411439|NCT01387672|osteoporosis|osteoporosis
411440|NCT01387672|bone turnover|bone turnover
411441|NCT01387672|nitrate|nitrate
411442|NCT01387672|headache|headache
411443|NCT01387659|Myfortic|myfortic
411444|NCT01387659|Simulect|simulect
411445|NCT01387659|Steroids|steroids
411446|NCT01387659|Diabetes|diabetes
411447|NCT01387659|Transplant|transplant
411448|NCT01387659|Gastric emptying|gastric emptying
411449|NCT01387659|Gastric motility|gastric motility
411450|NCT01387646|STI, abuse, substance use, unintended pregnancy|sti, abuse, substance use, unintended pregnancy
411451|NCT01387633|Nursing care|nursing care
411452|NCT01387633|Diabetes mellitus|diabetes mellitus
411453|NCT01387633|Health Education|health education
411454|NCT01387633|Patient compliance|patient compliance
411455|NCT01387633|Social support|social support
411456|NCT01387633|Self-efficacy|self-efficacy
412622|NCT01382407|acne|acne
411457|NCT01387633|Adaptation strategy|adaptation strategy
411458|NCT01387620|Phacoemulsification|phacoemulsification
411459|NCT01387620|Corneal Edema|corneal edema
411460|NCT01387620|Corneal Endothelium|corneal endothelium
411461|NCT01387620|Viscoelastic Substances|viscoelastic substances
411462|NCT01387607|Pregabalin|pregabalin
411463|NCT01387607|fibromyalgia|fibromyalgia
411464|NCT01387594|Crohn's disease lumbar puncture anti-MAdCAM monoclonal antibody PF-00547659 Ulcerative Colitis|crohn's disease lumbar puncture anti-madcam monoclonal antibody pf-00547659 ulcerative colitis
411465|NCT01387555|liver cancer|liver cancer
411466|NCT01387555|liver tumor|liver tumor
411467|NCT01387555|advanced hcc|advanced hcc
411468|NCT01387555|hepatocellular cancer|hepatocellular cancer
411469|NCT01387555|Jennerex|jennerex
411470|NCT01387555|HCC|hcc
411471|NCT01387555|sorafenib|sorafenib
411472|NCT01387555|sorafenib failure|sorafenib failure
411473|NCT01387555|sorafenib intolerant|sorafenib intolerant
411474|NCT01387555|Nexavar|nexavar
411475|NCT01387555|Nexavar failure|nexavar failure
411476|NCT01387555|JX594|jx594
411477|NCT01387555|oncolytic virus|oncolytic virus
411478|NCT01387555|vaccinia|vaccinia
411479|NCT01387555|viral therapy|viral therapy
411480|NCT01387555|JX|jx
411481|NCT01387555|Biotherapeutics|biotherapeutics
411482|NCT01387555|HEP018|hep018
411483|NCT01387555|traverse|traverse
411484|NCT01387555|biologic|biologic
411485|NCT01387555|Pexa-Vec|pexa-vec
411486|NCT01387542|Schizophrenia|schizophrenia
411487|NCT01387542|Paliperidone Extended Release (ER)|paliperidone extended release (er)
411488|NCT01387542|INVEGA|invega
411489|NCT01387529|Reference Values|reference values
411490|NCT01387516|nicotine|nicotine
411491|NCT01387516|juveniles|juveniles
411492|NCT01387516|detention|detention
411493|NCT01387503|Hepatocellular Carcinoma|hepatocellular carcinoma
411494|NCT01387503|Liver Transplantation|liver transplantation
411495|NCT01387503|Downstaging|downstaging
411496|NCT01387503|Trans-arterial chemoembolization (TACE)|trans-arterial chemoembolization (tace)
411497|NCT01387503|Radiofrequency ablation (RFA)|radiofrequency ablation (rfa)
411498|NCT01387503|Liver resection|liver resection
411499|NCT01387503|Sorafenib|sorafenib
411500|NCT01387490|Mild Traumatic Brain Injury|mild traumatic brain injury
411501|NCT01387490|Telephone counseling|telephone counseling
411502|NCT01387477|hypoglycemia|hypoglycemia
411503|NCT01387477|lactate|lactate
411504|NCT01387477|glucose|glucose
411505|NCT01387477|ICU|icu
411506|NCT01387464|bromfenac concentrations|bromfenac concentrations
411507|NCT01387464|ISV-303|isv-303
411508|NCT01387464|Bromday|bromday
411509|NCT01387451|Brown adipose tissue|brown adipose tissue
411510|NCT01387451|Different regions|different regions
411511|NCT01387451|Chinese adults|chinese adults
411512|NCT01387438|Brown Adipose Tissue|brown adipose tissue
411513|NCT01387438|Cross sectional study|cross sectional study
411514|NCT01387438|Chinese Adults|chinese adults
411515|NCT01387438|Factor|factor
411516|NCT01387425|Smoking cessation of diabetic smoker|smoking cessation of diabetic smoker
411517|NCT01387412|genital warts|genital warts
411518|NCT01387412|HIV|hiv
411519|NCT01387412|MSM|msm
411520|NCT01387412|Peru|peru
411521|NCT01387412|HPV|hpv
411522|NCT01387399|ovarian cancer|ovarian cancer
411523|NCT01387399|recurrence|recurrence
411524|NCT01387399|platinum-sensitive recurrent ovarian cancer|platinum-sensitive recurrent ovarian cancer
411525|NCT01387399|HIPEC|hipec
411526|NCT01387399|intraperitoneal chemotherapy|intraperitoneal chemotherapy
411527|NCT01387399|hyperthermic intraperitoneal chemoperfusion|hyperthermic intraperitoneal chemoperfusion
411528|NCT01387399|cisplatin|cisplatin
411529|NCT01387373|breast cancer|breast cancer
411530|NCT01387373|metastatic|metastatic
411531|NCT01387373|liver metastases|liver metastases
411532|NCT01387373|intrahepatic|intrahepatic
411533|NCT01387373|chemotherapy|chemotherapy
411534|NCT01387360|Myopia|myopia
411535|NCT01387360|Hyperopia|hyperopia
411536|NCT01387360|Presbyopia|presbyopia
411537|NCT01387360|Pseudophakia|pseudophakia
411538|NCT01387360|LASIK|lasik
411539|NCT01387347|Thymosin beta 4|thymosin beta 4
411540|NCT01387347|Dry eye syndrome|dry eye syndrome
411541|NCT01387347|Dry eye|dry eye
411542|NCT01387334|resistive exercise|resistive exercise
411543|NCT01387334|Resistance Exercise Training Program|resistance exercise training program
411544|NCT01387334|Rubber Bands|rubber bands
411545|NCT01387334|Glycemic Control|glycemic control
411546|NCT01387334|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
411547|NCT01387321|Pi3K|pi3k
411548|NCT01387321|Advanced solid tumor|advanced solid tumor
411549|NCT01387308|Phase 1|phase 1
411550|NCT01387308|Healthy male volunteers|healthy male volunteers
411551|NCT01387308|pharmacokinetics|pharmacokinetics
411552|NCT01387308|fostamatinib|fostamatinib
411553|NCT01387308|Scientific Terminology: Bioavailability, R406 plasma AUC and C_maxR406 plasma AUC0-t, t1/2λz and t_max|scientific terminology: bioavailability, r406 plasma auc and c_maxr406 plasma auc0-t, t1/2λz and t_max
411554|NCT01387308|Laymen Terminology: Amount of R406 in blood|laymen terminology: amount of r406 in blood
411555|NCT01387295|breast cancer|breast cancer
411556|NCT01387295|liver metastases|liver metastases
411557|NCT01387295|intrahepatic chemotherapy|intrahepatic chemotherapy
411558|NCT01387256|abortion|abortion
411559|NCT01387256|mifepristone|mifepristone
411560|NCT01387256|misoprostol|misoprostol
411561|NCT01387256|with gestations > 63 days LMP|with gestations > 63 days lmp
411562|NCT01387243|behavior modification|behavior modification
411563|NCT01387243|overweight|overweight
411564|NCT01387243|orlistat|orlistat
411565|NCT01387230|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
411566|NCT01387230|long acting muscarinic antagonist|long acting muscarinic antagonist
411567|NCT01387217|GSK2018682|gsk2018682
411568|NCT01387217|First Time in Human|first time in human
411569|NCT01387217|Healthy Volunteer|healthy volunteer
411570|NCT01387204|MEK inhibitor|mek inhibitor
411571|NCT01387204|elimination|elimination
411572|NCT01387204|Phase 1|phase 1
411573|NCT01387204|GSK1120212|gsk1120212
411574|NCT01387204|cancer|cancer
411575|NCT01387204|Pharmacokinetics|pharmacokinetics
411576|NCT01387204|oncology|oncology
411577|NCT01387204|radiolabeled ADME|radiolabeled adme
411578|NCT01387178|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
411579|NCT01387178|cost and cost analysis|cost and cost analysis
411580|NCT01387178|bronchodilators|bronchodilators
411581|NCT01387178|healthcare utilization|healthcare utilization
411582|NCT01387178|fluticasone propionate/salmeterol|fluticasone propionate/salmeterol
411583|NCT01387178|tiotropium|tiotropium
411584|NCT01387165|Latin America|latin america
411585|NCT01387165|diabetes complications|diabetes complications
411586|NCT01387165|patient compliance|patient compliance
411587|NCT01387165|Diabetes mellitus, type 2|diabetes mellitus, type 2
411588|NCT01387165|health services accessibility|health services accessibility
411589|NCT01387152|chest pain|chest pain
411590|NCT01387152|myocardial perfusion scintigraphy|myocardial perfusion scintigraphy
411591|NCT01387152|nuclear stress testing|nuclear stress testing
411592|NCT01387152|low radiation dose|low radiation dose
411593|NCT01387139|Ketamine|ketamine
411594|NCT01387139|Propofol|propofol
411595|NCT01387139|Procedural Sedation and Analgesia|procedural sedation and analgesia
411596|NCT01387113|stroke|stroke
411597|NCT01387113|tPA|tpa
411598|NCT01387113|Thrombolysis|thrombolysis
411599|NCT01387113|rt-PA|rt-pa
411600|NCT01387113|Ischemic|ischemic
411601|NCT01387113|CTP|ctp
411602|NCT01387113|Imaging|imaging
411603|NCT01387113|CT Perfusion Imaging|ct perfusion imaging
411604|NCT01387113|Perfusion|perfusion
411605|NCT01387113|CTA|cta
411606|NCT01387113|CT Angiography|ct angiography
411607|NCT01387113|Acute ischemic stroke|acute ischemic stroke
411608|NCT01387113|Acute stroke therapy|acute stroke therapy
411609|NCT01387113|(AIS)|(ais)
411610|NCT01387100|supportive employment|supportive employment
411611|NCT01387100|vocational rehabilitation|vocational rehabilitation
411612|NCT01387087|ASP015K|asp015k
411613|NCT01387087|Healthy subjects|healthy subjects
411614|NCT01387087|Pharmacodynamics|pharmacodynamics
411615|NCT01387087|Maximum tolerated dose|maximum tolerated dose
411616|NCT01387061|liver resection|liver resection
411617|NCT01387061|hepatic resection|hepatic resection
411618|NCT01387061|intraoperative ultrasound|intraoperative ultrasound
411619|NCT01387048|acne vulgaris|acne vulgaris
411620|NCT01387048|late-type acne|late-type acne
411621|NCT01387048|Skinoren|skinoren
411622|NCT01387048|maintenance|maintenance
411623|NCT01387022|Antiretroviral treatment|antiretroviral treatment
411624|NCT01387022|Tenofovir|tenofovir
411625|NCT01387022|Drug resistance|drug resistance
411626|NCT01387022|Treatment outcome|treatment outcome
411627|NCT01386983|Enlarged prostate, 5-alpha-reductase inhibitor, alpha-blocker, acute urinary retention, surgery, early, costs|enlarged prostate, 5-alpha-reductase inhibitor, alpha-blocker, acute urinary retention, surgery, early, costs
411628|NCT01386983|benign prostatic hyperplasia|benign prostatic hyperplasia
411629|NCT01386970|Pharmacokinetics|pharmacokinetics
411630|NCT01386970|antiretroviral therapy|antiretroviral therapy
411631|NCT01386970|nucleoside analogs|nucleoside analogs
411632|NCT01386970|mitochondrial toxicity|mitochondrial toxicity
411633|NCT01386970|clinical pharmacology|clinical pharmacology
411634|NCT01386970|cellular pharmacology|cellular pharmacology
411635|NCT01386970|pharmacogenetics|pharmacogenetics
411636|NCT01386957|Nephrotic Syndrome|nephrotic syndrome
411637|NCT01386957|Steroid treatment|steroid treatment
411638|NCT01386957|Proteinuria|proteinuria
411639|NCT01386957|Child|child
411640|NCT01386944|Rotigotine|rotigotine
411641|NCT01386944|Neupro®|neupro®
411642|NCT01386944|Augmentation|augmentation
411643|NCT01386944|Restless Legs Syndrome|restless legs syndrome
411644|NCT01386944|Moderate to severe|moderate to severe
411645|NCT01386944|idiopathic|idiopathic
411646|NCT01386944|adults|adults
411647|NCT01386931|Biopsy, Fine-Needle|biopsy, fine-needle
411648|NCT01386931|Endoscopic Ultrasonography|endoscopic ultrasonography
411649|NCT01386931|cytopathology|cytopathology
411650|NCT01386918|Hallucinations|hallucinations
411651|NCT01386918|Schizophrenia|schizophrenia
411652|NCT01386905|Obesity|obesity
411653|NCT01386879|suction|suction
411654|NCT01386879|aspiration|aspiration
412623|NCT01382394|Sepsis|sepsis
411655|NCT01386879|general anesthesia|general anesthesia
411656|NCT01386879|intubation|intubation
411657|NCT01386879|endotracheal tube|endotracheal tube
411658|NCT01386879|respiratory complications|respiratory complications
411659|NCT01386866|AMG 706|amg 706
411660|NCT01386866|Motesanib|motesanib
411661|NCT01386866|Amgen|amgen
411662|NCT01386866|Phase 1|phase 1
411663|NCT01386853|Hyperlipidemia|hyperlipidemia
411664|NCT01386853|Pitavastatin|pitavastatin
411665|NCT01386853|Atorvastatin|atorvastatin
411666|NCT01386840|Efficacy of Treatment|efficacy of treatment
411667|NCT01386840|Severe|severe
411668|NCT01386840|home treatment|home treatment
411669|NCT01386840|treatment at hospital|treatment at hospital
411670|NCT01386827|Ixiaro|ixiaro
411671|NCT01386827|japanese encephalitis vaccine|japanese encephalitis vaccine
411672|NCT01386827|booster|booster
411673|NCT01386801|Diabetes|diabetes
411674|NCT01386801|Controls|controls
411675|NCT01386801|Biospecimen|biospecimen
411676|NCT01386788|Smoke, cyanide, closed space fires|smoke, cyanide, closed space fires
411677|NCT01386775|X-Linked Hypohidrotic Ectodermal Dysplasia|x-linked hypohidrotic ectodermal dysplasia
411678|NCT01386775|XLHED|xlhed
411679|NCT01386775|Hypohidrotic Ectodermal Dysplasia|hypohidrotic ectodermal dysplasia
411680|NCT01386775|HED|hed
411681|NCT01386762|paralysis|paralysis
411682|NCT01386762|paraplegia|paraplegia
411683|NCT01386762|obesity|obesity
411684|NCT01386749|Vibration treatment|vibration treatment
411685|NCT01386749|Fracture healing|fracture healing
411686|NCT01386749|Muscular function|muscular function
411687|NCT01386736|insulin resistance|insulin resistance
411688|NCT01386736|obesity|obesity
411689|NCT01386736|adolescence|adolescence
411690|NCT01386736|vitamin D supplementation|vitamin d supplementation
411691|NCT01386723|eltrombopag|eltrombopag
411692|NCT01386723|promacta|promacta
411693|NCT01386723|immune thrombocytopenia (ITP)|immune thrombocytopenia (itp)
411694|NCT01386710|GBM|gbm
411695|NCT01386710|AA|aa
411696|NCT01386710|AO|ao
411697|NCT01386710|Brain|brain
411698|NCT01386710|Tumors|tumors
411699|NCT01386710|Malignant|malignant
411700|NCT01386710|Glioblastoma|glioblastoma
411701|NCT01386710|Multiforme|multiforme
411702|NCT01386710|Anaplastic|anaplastic
411703|NCT01386710|Astrocytoma|astrocytoma
411704|NCT01386684|Prostate Cancer|prostate cancer
411705|NCT01386671|Type 2 Diabetes|type 2 diabetes
411706|NCT01386671|metformin glycinate|metformin glycinate
411707|NCT01386671|metabolic control|metabolic control
411708|NCT01386658|Efficacy|efficacy
411709|NCT01386658|Hereditary angioedema|hereditary angioedema
411710|NCT01386658|HAE|hae
411711|NCT01386658|Pediatric|pediatric
411712|NCT01386658|Children|children
411713|NCT01386658|Pharmacokinetics|pharmacokinetics
411714|NCT01386658|Safety|safety
411715|NCT01386658|Firazyr|firazyr
411716|NCT01386658|icatibant|icatibant
411717|NCT01386645|impaired glucose tolerance|impaired glucose tolerance
411718|NCT01386645|prediabetes|prediabetes
411719|NCT01386645|dietary glycemic index|dietary glycemic index
411720|NCT01386645|beta-cell function|beta-cell function
411721|NCT01386645|insulin secretion|insulin secretion
411722|NCT01386645|oxidative stress|oxidative stress
411723|NCT01386645|glycemic variability|glycemic variability
411724|NCT01386632|Stage III-IV Squamous Cell Carcinoma|stage iii-iv squamous cell carcinoma
411725|NCT01386593|Cytochrome|cytochrome
411726|NCT01386593|Phenotyping|phenotyping
411727|NCT01386593|Pharmacokinetics|pharmacokinetics
411728|NCT01386580|Brain Neoplasms|brain neoplasms
411729|NCT01386580|Neoplasm Metastasis|neoplasm metastasis
411730|NCT01386580|Neoplasms|neoplasms
411731|NCT01386580|Central Nervous System Neoplasms|central nervous system neoplasms
411732|NCT01386580|Nervous System Neoplasms|nervous system neoplasms
411733|NCT01386580|Neoplasms by Site|neoplasms by site
411734|NCT01386580|Brain Diseases|brain diseases
411735|NCT01386580|Central Nervous System Diseases|central nervous system diseases
411736|NCT01386580|Nervous System Diseases|nervous system diseases
411737|NCT01386580|Neoplastic Processes|neoplastic processes
411738|NCT01386580|Pathologic Processes|pathologic processes
411739|NCT01386567|hypogonadism|hypogonadism
411740|NCT01386567|low testosterone|low testosterone
411741|NCT01386567|low T|low t
411742|NCT01386554|H.P. Acthar Gel|h.p. acthar gel
411743|NCT01386554|Acthar|acthar
411744|NCT01386554|nephrotic syndrome|nephrotic syndrome
411745|NCT01386554|idiopathic membranous nephropathy|idiopathic membranous nephropathy
411746|NCT01386554|proteinuria|proteinuria
411747|NCT01386515|Adaptation|adaptation
411748|NCT01386515|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
411749|NCT01386515|Communication about Duchenne Muscular Dystrophy|communication about duchenne muscular dystrophy
411750|NCT01386515|Sibling|sibling
411751|NCT01386502|Solid Tumors|solid tumors
411752|NCT01386502|Monoclonal Antibody|monoclonal antibody
411753|NCT01386502|Peptide Vaccine|peptide vaccine
411754|NCT01386502|Toxicity|toxicity
411755|NCT01386502|PD-1 ligand|pd-1 ligand
411756|NCT01386502|Solid Tumor|solid tumor
411757|NCT01386502|Breast Cancer|breast cancer
411758|NCT01386502|Ovarian Cancer|ovarian cancer
411759|NCT01386502|Pancreatic Cancer|pancreatic cancer
411760|NCT01386502|Colon Cancer|colon cancer
411761|NCT01386502|Sarcoma|sarcoma
411762|NCT01386489|HIV-uninfected|hiv-uninfected
411763|NCT01386489|Mucosal Immunity|mucosal immunity
411764|NCT01386489|Kinetics|kinetics
411765|NCT01386489|Cytokines|cytokines
411766|NCT01386489|Chemokines|chemokines
411767|NCT01386489|Healthy Volunteer|healthy volunteer
411768|NCT01386489|HV|hv
411769|NCT01386476|5-HT1A Receptors|5-ht1a receptors
411770|NCT01386476|Blood Brain Barrier|blood brain barrier
411771|NCT01386476|Drug Resistance|drug resistance
411772|NCT01386476|Healthy Volunteer|healthy volunteer
411773|NCT01386476|HV|hv
411774|NCT01386437|Fungal Infection|fungal infection
411775|NCT01386437|Immunopathogenesis|immunopathogenesis
411776|NCT01386437|Genetics|genetics
411777|NCT01386437|Fungal Infections|fungal infections
411778|NCT01386437|Mucocutaneous Fungal Infection|mucocutaneous fungal infection
411779|NCT01386437|Invasive Fungal Infection|invasive fungal infection
411780|NCT01386424|Influenza|influenza
411781|NCT01386424|Human|human
411782|NCT01386424|Challenge Study|challenge study
411783|NCT01386424|Healthy Volunteer|healthy volunteer
411784|NCT01386424|HV|hv
411785|NCT01386411|Genetic testing|genetic testing
411786|NCT01386411|BRCA testing|brca testing
411787|NCT01386411|Ashkenazi descent|ashkenazi descent
411788|NCT01386411|11-086|11-086
411789|NCT01386398|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
411790|NCT01386398|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
411791|NCT01386398|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
411792|NCT01386398|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
411793|NCT01386398|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
411794|NCT01386398|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
411795|NCT01386398|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
411796|NCT01386398|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
411797|NCT01386372|Hyponatremia|hyponatremia
411798|NCT01386372|Vasopressin|vasopressin
411799|NCT01386372|Tolvaptan|tolvaptan
411800|NCT01386372|SIADH|siadh
411801|NCT01386346|gastroesophageal junction|gastroesophageal junction
411802|NCT01386346|GEJ|gej
411803|NCT01386346|esophageal|esophageal
411804|NCT01386346|esophagus|esophagus
411805|NCT01386333|Frontotemporal Dementia|frontotemporal dementia
411806|NCT01386333|oxytocin|oxytocin
411807|NCT01386333|Pick's disease|pick's disease
411808|NCT01386320|anaesthetic techniques, regional; surgery orthopaedic|anaesthetic techniques, regional; surgery orthopaedic
411809|NCT01386307|Pain|pain
411810|NCT01386307|Hospitalization|hospitalization
411811|NCT01386281|Julina|julina
411812|NCT01386281|Postmenopausal osteoporosis|postmenopausal osteoporosis
411813|NCT01386268|Kogenate FS|kogenate fs
411814|NCT01386268|Hemophilia A|hemophilia a
411815|NCT01386255|GERD|gerd
411816|NCT01386242|Colorectal Cancer|colorectal cancer
411817|NCT01386242|Novaferon|novaferon
411818|NCT01386229|hemodynamic stability|hemodynamic stability
411819|NCT01386229|etomidate|etomidate
411820|NCT01386229|ketamine|ketamine
411821|NCT01386229|coronary artery bypass surgery after induction of anesthesia, hemodynamic stability|coronary artery bypass surgery after induction of anesthesia, hemodynamic stability
411822|NCT01386216|Critical limb ischemia|critical limb ischemia
411823|NCT01386216|Peripheral vascular disease|peripheral vascular disease
411824|NCT01386216|platelet-rich plasma|platelet-rich plasma
411825|NCT01386203|lung cancer|lung cancer
411826|NCT01386203|biomarkers|biomarkers
411827|NCT01386203|breath|breath
411828|NCT01386203|early detection|early detection
411829|NCT01386190|preterm infant, body composition, exercise|preterm infant, body composition, exercise
411830|NCT01386177|MDMA|mdma
411831|NCT01386177|doxazosin|doxazosin
411832|NCT01386177|norepinephrine|norepinephrine
411833|NCT01386177|alpha1- receptor|alpha1- receptor
411834|NCT01386177|ecstasy|ecstasy
411835|NCT01386177|stimulants|stimulants
411836|NCT01386151|Moderate asthmatic, uncontrolled|moderate asthmatic, uncontrolled
411837|NCT01386138|HIV|hiv
411838|NCT01386138|HIV Risk|hiv risk
411839|NCT01386138|Sexually Transmitted Infections|sexually transmitted infections
411840|NCT01386138|Women|women
411841|NCT01386138|Pregnancy|pregnancy
411842|NCT01386138|Neonatal Health|neonatal health
411843|NCT01386138|Drug Use|drug use
411844|NCT01386138|Drug Treatment|drug treatment
411845|NCT01386138|Gender-specific Treatment|gender-specific treatment
411846|NCT01386138|Methamphetamine|methamphetamine
411847|NCT01386138|Opioids|opioids
411848|NCT01386138|Cocaine|cocaine
411849|NCT01386138|Injection Drugs|injection drugs
411850|NCT01386138|Stimulants|stimulants
411851|NCT01386138|Alcohol|alcohol
411852|NCT01386138|Mandrax|mandrax
411853|NCT01386138|Marijuana|marijuana
411854|NCT01386138|Nicotine|nicotine
411855|NCT01386086|Aripiprazole|aripiprazole
411856|NCT01386086|adjunctive therapy|adjunctive therapy
411857|NCT01386086|mood stabilizers|mood stabilizers
411858|NCT01386086|major depressive disorder|major depressive disorder
411859|NCT01386086|postpartum|postpartum
411860|NCT01386086|Augmentation therapy|augmentation therapy
411861|NCT01386086|resistant|resistant
411862|NCT01386060|Stress|stress
411863|NCT01386060|Mindfulness|mindfulness
411864|NCT01386060|Meditation|meditation
411865|NCT01386047|Clinical Prediction Rules|clinical prediction rules
411866|NCT01386047|Electronic Health Records|electronic health records
411867|NCT01386047|Walsh Clinical Prediction Rule|walsh clinical prediction rule
411868|NCT01386047|Heckerling Clinical Prediction Rule|heckerling clinical prediction rule
411869|NCT01386034|Nutrition, protein metabolism, stable isotopes, mass spectrometry, intestinal failure|nutrition, protein metabolism, stable isotopes, mass spectrometry, intestinal failure
411870|NCT01386021|allograft|allograft
411871|NCT01386021|coronary|coronary
411872|NCT01386021|patency|patency
411873|NCT01386021|morbidity|morbidity
411874|NCT01385969|overinflation of LMAs|overinflation of lmas
411875|NCT01385956|metastatic|metastatic
411876|NCT01385956|locally advanced|locally advanced
411877|NCT01385956|combination therapy|combination therapy
411878|NCT01385956|dose escalation|dose escalation
411879|NCT01385956|epithelial cancer|epithelial cancer
411880|NCT01385956|adenocarcinoma|adenocarcinoma
411881|NCT01385956|exocrine pancreas|exocrine pancreas
411882|NCT01385943|Reflectance Confocal Microscopy|reflectance confocal microscopy
411883|NCT01385943|Dermoscopy|dermoscopy
411884|NCT01385943|Clinical Photos|clinical photos
411885|NCT01385943|Telemedicine|telemedicine
411886|NCT01385930|Overweight|overweight
411887|NCT01385930|Obesity|obesity
411888|NCT01385930|lifestyle counseling|lifestyle counseling
411889|NCT01385917|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
411890|NCT01385917|strength and function tests|strength and function tests
411891|NCT01385917|MRI|mri
411892|NCT01385878|Microcoaxial phacoemulsification, 1.8mm, 2.2mm|microcoaxial phacoemulsification, 1.8mm, 2.2mm
411893|NCT01385852|CME|cme
411894|NCT01385852|OCT|oct
411895|NCT01385852|Optical coherence tomography|optical coherence tomography
411896|NCT01385852|macular thickness|macular thickness
411897|NCT01385839|Alopecia|alopecia
411898|NCT01385839|Hair transplantation|hair transplantation
411899|NCT01385839|Needle irritation|needle irritation
411900|NCT01385839|Medical needling|medical needling
411901|NCT01385826|Uveitis|uveitis
411902|NCT01385826|Juvenile arthritis|juvenile arthritis
411903|NCT01385826|Anti-tumor necrosis factor alpha monoclonal antibody|anti-tumor necrosis factor alpha monoclonal antibody
411904|NCT01385826|treatment|treatment
411905|NCT01385813|pre-eclampsia|pre-eclampsia
411906|NCT01385813|inflammatory markers|inflammatory markers
411907|NCT01385813|serological biobank|serological biobank
411908|NCT01385813|To assess whether the inflammatory markers could be useful|to assess whether the inflammatory markers could be useful
411909|NCT01385813|in order to identify pregnant women at risk to|in order to identify pregnant women at risk to
411910|NCT01385813|develop preeclampsia|develop preeclampsia
411911|NCT01385800|Grass allergy|grass allergy
411912|NCT01385800|Rhinoconjunctivitis|rhinoconjunctivitis
411913|NCT01385800|Environmental Exposure Unit|environmental exposure unit
411914|NCT01385800|Immunotherapy|immunotherapy
411915|NCT01385800|ToleroMune Grass|toleromune grass
411916|NCT01385787|Pediatric (ages 0-21 years)|pediatric (ages 0-21 years)
411917|NCT01385787|myeloablative HCT|myeloablative hct
411918|NCT01385787|PBMTC sites|pbmtc sites
411919|NCT01385774|Intermittent Claudication|intermittent claudication
411920|NCT01385774|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
411921|NCT01385774|Supervised Exercise Therapy|supervised exercise therapy
411922|NCT01385774|Peripheral Arterial Disease|peripheral arterial disease
411923|NCT01385761|Supraglottic airway devices|supraglottic airway devices
411924|NCT01385735|Parkinson Disease|parkinson disease
411925|NCT01385735|Emotion|emotion
411926|NCT01385735|mood|mood
411927|NCT01385735|executive function|executive function
411928|NCT01385709|Lithium|lithium
411929|NCT01385709|Sertraline|sertraline
411930|NCT01385683|Healthy volunteer|healthy volunteer
411931|NCT01385683|Pharmacokinetic|pharmacokinetic
411932|NCT01385683|pharmacodynamic|pharmacodynamic
411933|NCT01385683|Polymorphism, Genetic|polymorphism, genetic
411934|NCT01385670|Patent Foramen Ovale|patent foramen ovale
411935|NCT01385670|PFO|pfo
411936|NCT01385644|Mesenchymal stem cells|mesenchymal stem cells
411937|NCT01385644|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
411938|NCT01385631|ST-Segment Elevation Myocardial Infarction|st-segment elevation myocardial infarction
411939|NCT01385631|Intravascular ultrasound|intravascular ultrasound
411940|NCT01385631|IVUS|ivus
411941|NCT01385631|Optical coherence tomography|optical coherence tomography
411942|NCT01385631|OCT|oct
411943|NCT01385631|Ezetimibe|ezetimibe
411944|NCT01385631|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
411945|NCT01385631|Atorvastatin|atorvastatin
411946|NCT01385631|Randomized trial|randomized trial
411947|NCT01385631|Hypolipidemic Agents|hypolipidemic agents
411948|NCT01385631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
411949|NCT01385631|Pharmacologic Actions|pharmacologic actions
412820|NCT01381653|sexual risk|sexual risk
411950|NCT01385631|Enzyme Inhibitors|enzyme inhibitors
411951|NCT01385631|Lipid Regulating Agents|lipid regulating agents
411952|NCT01385631|Therapeutic Uses|therapeutic uses
411953|NCT01385592|Parkinson Disease|parkinson disease
411954|NCT01385592|L-dopa|l-dopa
411955|NCT01385592|Levodopa|levodopa
411956|NCT01385592|Dyskinesia|dyskinesia
411957|NCT01385592|Anti-Dyskinesia Agents|anti-dyskinesia agents
411958|NCT01385579|colorectal cancer screening|colorectal cancer screening
411959|NCT01385579|fecal occult blood testing (FOBT)|fecal occult blood testing (fobt)
411960|NCT01385579|vulnerable populations|vulnerable populations
411961|NCT01385579|community health center|community health center
411962|NCT01385540|Tinnitus, fMRI, task-based fMRI, attention network|tinnitus, fmri, task-based fmri, attention network
411963|NCT01385488|lymphedema|lymphedema
411964|NCT01385488|breast cancer|breast cancer
411965|NCT01385488|self care|self care
411966|NCT01385488|bioelectrical impedance|bioelectrical impedance
411967|NCT01385488|monitoring|monitoring
411968|NCT01385475|Resistance Training|resistance training
411969|NCT01385475|Physical Function|physical function
411970|NCT01385475|Older Adults|older adults
411971|NCT01385449|nerve block|nerve block
411972|NCT01385449|shoulder surgery|shoulder surgery
411973|NCT01385449|physical therapy|physical therapy
411974|NCT01385436|human papillomavirus (HPV)|human papillomavirus (hpv)
411975|NCT01385436|cervical cancer|cervical cancer
411976|NCT01385436|high grade cervical squamous intraepithelial lesion (HSIL)|high grade cervical squamous intraepithelial lesion (hsil)
411977|NCT01385423|acute myelogenous leukemia|acute myelogenous leukemia
411978|NCT01385423|natural killer cells|natural killer cells
411979|NCT01385423|haploidentical donor|haploidentical donor
411980|NCT01385410|breastfeeding exclusively|breastfeeding exclusively
411981|NCT01385397|Health system organization|health system organization
411982|NCT01385345|Vitamin D deficiency|vitamin d deficiency
411983|NCT01385345|Insulin resistance|insulin resistance
411984|NCT01385332|Metaphase II|metaphase ii
411985|NCT01385332|Ovarian stimulation|ovarian stimulation
411986|NCT01385332|Egg donors|egg donors
411987|NCT01385319|Bare metal stent|bare metal stent
411988|NCT01385319|zotarolimus eluting stent|zotarolimus eluting stent
411989|NCT01385319|triple anti-thrombotic therapy|triple anti-thrombotic therapy
411990|NCT01385319|high bleeding riskduration of dual anti-platelet therapy|high bleeding riskduration of dual anti-platelet therapy
411991|NCT01385293|BKM120|bkm120
411992|NCT01385293|prostate cancer|prostate cancer
411993|NCT01385293|metastatic castrate-resistant prostate cancer (mCRPC)|metastatic castrate-resistant prostate cancer (mcrpc)
411994|NCT01385254|very low birthweight|very low birthweight
411995|NCT01385254|premature|premature
411996|NCT01385254|sibling adjustment|sibling adjustment
411997|NCT01385254|preterm|preterm
411998|NCT01385241|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
411999|NCT01385241|Stigma|stigma
412000|NCT01385241|Safe disclosure of seropositive status|safe disclosure of seropositive status
412001|NCT01385241|HIV positive women|hiv positive women
412002|NCT01385241|Self-efficacy|self-efficacy
412003|NCT01385228|prostate cancer|prostate cancer
412004|NCT01385228|metastatic|metastatic
412005|NCT01385228|pazopanib|pazopanib
412006|NCT01385228|docetaxel|docetaxel
412007|NCT01385228|metastatic prostate cancer|metastatic prostate cancer
412008|NCT01385215|Vaccination|vaccination
412009|NCT01385215|Mucosal Immunity|mucosal immunity
412010|NCT01385215|Nasal Immunization|nasal immunization
412011|NCT01385202|Atrial Fibrillation|atrial fibrillation
412012|NCT01385202|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
412013|NCT01385189|Human Hookworm Vaccine Initiative|human hookworm vaccine initiative
412014|NCT01385189|HHVI|hhvi
412015|NCT01385189|Human Hookworm|human hookworm
412016|NCT01385189|Hookworm|hookworm
412017|NCT01385189|Hookworm Disease|hookworm disease
412018|NCT01385189|N. americanus|n. americanus
412019|NCT01385189|Soil-transmitted helminth infection|soil-transmitted helminth infection
412020|NCT01385189|Intestinal blood loss|intestinal blood loss
412021|NCT01385189|Iron deficiency anemia|iron deficiency anemia
412022|NCT01385176|Heart failure|heart failure
412023|NCT01385176|Congestive heart failure|congestive heart failure
412024|NCT01385176|New York Heart Association Class II-III|new york heart association class ii-iii
412025|NCT01385176|Vagal therapy|vagal therapy
412026|NCT01385176|Vagal nerve stimulation|vagal nerve stimulation
412027|NCT01385163|mental health|mental health
412028|NCT01385163|gender-based violence|gender-based violence
412029|NCT01385163|Africa|africa
412030|NCT01385150|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
412031|NCT01385150|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
412032|NCT01385150|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
412033|NCT01385150|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
412034|NCT01385150|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
412035|NCT01385150|adult acute basophilic leukemia|adult acute basophilic leukemia
412036|NCT01385150|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
412037|NCT01385150|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
412038|NCT01385150|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
412039|NCT01385150|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
412040|NCT01385150|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
412041|NCT01385150|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
412042|NCT01385150|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
412043|NCT01385150|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
412044|NCT01385150|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
412045|NCT01385137|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
412046|NCT01385137|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
412047|NCT01385137|stage I breast cancer|stage i breast cancer
412048|NCT01385137|stage II breast cancer|stage ii breast cancer
412049|NCT01385137|stage IIIA breast cancer|stage iiia breast cancer
412050|NCT01385137|pain|pain
412051|NCT01385137|arthralgia|arthralgia
412052|NCT01385124|Cannabidiol|cannabidiol
412053|NCT01385124|GVHD|gvhd
412054|NCT01385124|Allogeneic transplantation|allogeneic transplantation
412055|NCT01385124|Prophylaxis|prophylaxis
412056|NCT01385111|endobronchial ultrasound|endobronchial ultrasound
412057|NCT01385111|endoscopic ultrasound|endoscopic ultrasound
412058|NCT01385111|EBUS-TBNA|ebus-tbna
412059|NCT01385111|EUS-FNA|eus-fna
412060|NCT01385111|EUS-B-FNA|eus-b-fna
412061|NCT01385111|lung cancer|lung cancer
412062|NCT01385111|staging|staging
412063|NCT01385098|Vitamin D|vitamin d
412064|NCT01385098|Bariatric surgery|bariatric surgery
412065|NCT01385098|Roux-en Y surgery|roux-en y surgery
412066|NCT01385098|Gastric sleeve surgery|gastric sleeve surgery
412067|NCT01385098|Parathyroid Hormone|parathyroid hormone
412068|NCT01385085|Vitamin D|vitamin d
412069|NCT01385085|Sunlight|sunlight
412070|NCT01385085|Deficiency|deficiency
412071|NCT01385072|acute leukemia|acute leukemia
412072|NCT01385072|relapse|relapse
412073|NCT01385072|induction failure|induction failure
412074|NCT01385072|allogeneic transplantation|allogeneic transplantation
412075|NCT01385072|graft versus leukemia effect|graft versus leukemia effect
412076|NCT01385046|physical inactivity|physical inactivity
412077|NCT01385046|poor diet|poor diet
412078|NCT01385020|Red yeast rice|red yeast rice
412079|NCT01385020|Gemfibrozil|gemfibrozil
412080|NCT01385020|Drug-drug interaction|drug-drug interaction
412081|NCT01385020|Pharmacokinetics|pharmacokinetics
412082|NCT01385007|Rural|rural
412083|NCT01385007|Veterans|veterans
412084|NCT01385007|Dementia|dementia
412085|NCT01385007|Pain|pain
412086|NCT01385007|Aggression|aggression
412087|NCT01385007|residence in a VA designated rural area|residence in a va designated rural area
412088|NCT01385007|presence of a caregiver|presence of a caregiver
412089|NCT01384994|Colorectal Cancer|colorectal cancer
412090|NCT01384994|PARLIM|parlim
412091|NCT01384994|KRAS Wildtype|kras wildtype
412092|NCT01384994|Liver metastases|liver metastases
412093|NCT01384981|chronic obstructive pulmonary rehabilitation|chronic obstructive pulmonary rehabilitation
412094|NCT01384981|COPD|copd
412095|NCT01384981|non invasive ventilation|non invasive ventilation
412097|NCT01384981|exercise capacity|exercise capacity
412098|NCT01384981|pulmonary rehabilitation|pulmonary rehabilitation
412099|NCT01384968|nitrite|nitrite
412100|NCT01384968|exercise|exercise
412101|NCT01384968|cycling|cycling
412102|NCT01384955|scoliosis|scoliosis
412103|NCT01384955|physical therapy|physical therapy
412104|NCT01384955|long term outcome|long term outcome
412105|NCT01384955|pulmonary function|pulmonary function
412106|NCT01384955|physical fitness|physical fitness
412107|NCT01384955|health related quality of life|health related quality of life
412108|NCT01384955|psychopathology|psychopathology
412109|NCT01384942|Bereavement|bereavement
412110|NCT01384942|Grief|grief
412111|NCT01384942|Mourning|mourning
412112|NCT01384942|Loss|loss
412113|NCT01384942|Death|death
412114|NCT01384942|Meaning|meaning
412115|NCT01384942|Group|group
412116|NCT01384942|Counseling|counseling
412117|NCT01384942|Psychotherapy|psychotherapy
412118|NCT01384942|Uncomplicated|uncomplicated
412119|NCT01384942|Support|support
412120|NCT01384916|depression|depression
412121|NCT01384916|yoga|yoga
412122|NCT01384916|health education|health education
412123|NCT01384916|antidepressant|antidepressant
412124|NCT01384877|Pain|pain
412125|NCT01384877|Cancer|cancer
412126|NCT01384877|Lidocaine|lidocaine
412127|NCT01384877|Sodium Channel Blockers|sodium channel blockers
412128|NCT01384864|barrett's esophagus|barrett's esophagus
412129|NCT01384864|intraepithelial neoplasia|intraepithelial neoplasia
412130|NCT01384864|cross polarized reflectance examination|cross polarized reflectance examination
412131|NCT01384864|vital-dye enhanced fluorescence examination|vital-dye enhanced fluorescence examination
412132|NCT01384838|breast cancer|breast cancer
412133|NCT01384838|physical activity|physical activity
412134|NCT01384838|sports|sports
412135|NCT01384838|exercise|exercise
412136|NCT01384825|Multiple Sclerosis|multiple sclerosis
412137|NCT01384825|Other Neurodegenerative Diseases|other neurodegenerative diseases
412138|NCT01384825|Chronic CerebroSpinal Venous Insufficiency|chronic cerebrospinal venous insufficiency
412139|NCT01384825|Prevalence|prevalence
412140|NCT01384825|Case-control|case-control
412141|NCT01384773|Keratoconus|keratoconus
412142|NCT01384773|Ectasia|ectasia
412143|NCT01384773|UVA light|uva light
412144|NCT01384773|riboflavin|riboflavin
412145|NCT01384773|post-LASIK (laser in situ keratomileusis)|post-lasik (laser in situ keratomileusis)
412146|NCT01384773|pellucid marginal degeneration|pellucid marginal degeneration
412147|NCT01384773|irregular astigmatism|irregular astigmatism
412148|NCT01384721|Computed Tomography Coronary Angiography|computed tomography coronary angiography
412149|NCT01384721|Coronary Artery Disease|coronary artery disease
412150|NCT01384721|Prevalence Of Disease|prevalence of disease
412151|NCT01384721|Prognosis|prognosis
412152|NCT01384721|Risk Stratification|risk stratification
412153|NCT01384708|squamous cell cancer|squamous cell cancer
412154|NCT01384708|squamous cell neoplasia|squamous cell neoplasia
412155|NCT01384695|Barrett's esophagus|barrett's esophagus
412156|NCT01384695|confocal microendoscopy|confocal microendoscopy
412157|NCT01384617|distal pancreatectomy|distal pancreatectomy
412158|NCT01384617|pancreatic fistula|pancreatic fistula
412159|NCT01384617|pancreaticojejunostomy|pancreaticojejunostomy
412160|NCT01384617|Roux-en-Y anastomosis|roux-en-y anastomosis
412161|NCT01384617|stapling closure|stapling closure
412162|NCT01384604|Schizophrenia|schizophrenia
412163|NCT01384604|Schizoaffective disorder|schizoaffective disorder
412164|NCT01384604|Bipolar disorder|bipolar disorder
412165|NCT01384604|Psychosis|psychosis
412166|NCT01384604|Genetics|genetics
412167|NCT01384604|Phenotype|phenotype
412168|NCT01384591|oxidative stress|oxidative stress
412169|NCT01384591|blood flow|blood flow
412170|NCT01384591|antioxidant|antioxidant
412171|NCT01384591|muscle|muscle
412172|NCT01384591|elderly|elderly
412173|NCT01384552|normal weight|normal weight
412174|NCT01384552|overweight|overweight
412175|NCT01384552|dietary restraint|dietary restraint
412176|NCT01384552|package unit size|package unit size
412177|NCT01384552|food intake|food intake
412178|NCT01384539|chronic kidney disease|chronic kidney disease
412179|NCT01384539|vitamin D deficiency|vitamin d deficiency
412180|NCT01384526|hormone therapy|hormone therapy
412181|NCT01384526|ovarian aging|ovarian aging
412182|NCT01384526|ovarian reserve|ovarian reserve
412183|NCT01384526|fertility|fertility
412184|NCT01384526|breast cancer|breast cancer
412185|NCT01384513|Allogeneic HSCT|allogeneic hsct
412186|NCT01384513|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
412187|NCT01384487|Viewing and axial cross sectional imaging of ocular|viewing and axial cross sectional imaging of ocular
412188|NCT01384487|structures, including the anterior chamber|structures, including the anterior chamber
412189|NCT01384474|Crew Resource Management|crew resource management
412190|NCT01384474|Surgical safety checklist|surgical safety checklist
412191|NCT01384474|Postoperative complications|postoperative complications
412192|NCT01384448|stress echocardiography|stress echocardiography
412193|NCT01384448|coronary ct angiography|coronary ct angiography
412194|NCT01384435|Spinocerebellar degeneration (SCD)|spinocerebellar degeneration (scd)
412195|NCT01384435|Thyrotropin-Releasing Hormone (TRH)|thyrotropin-releasing hormone (trh)
412196|NCT01384422|methotrexate-refractory|methotrexate-refractory
412197|NCT01384383|Chronic Hepatitis C|chronic hepatitis c
412198|NCT01384383|IL28B CC Genotype|il28b cc genotype
412199|NCT01384383|Treatment naive|treatment naive
412200|NCT01384383|Peginterferon α-2a (PEG)|peginterferon α-2a (peg)
412201|NCT01384383|Genotype 1a/b|genotype 1a/b
412202|NCT01384383|GS 9451|gs 9451
412203|NCT01384383|GS 5885|gs 5885
412204|NCT01384383|Ribavirin (RBV)|ribavirin (rbv)
412205|NCT01384383|HCV NS5A inhibitor|hcv ns5a inhibitor
412206|NCT01384383|HCV NS3 protease inhibitor|hcv ns3 protease inhibitor
412207|NCT01384357|lymphadenopathy|lymphadenopathy
412208|NCT01384357|needle biopsy|needle biopsy
412209|NCT01384357|sonography|sonography
412210|NCT01384331|Implanon users|implanon users
412211|NCT01384331|Frequent bleeding|frequent bleeding
412212|NCT01384331|Prolonged bleeding|prolonged bleeding
412213|NCT01384331|Comparison of treatments|comparison of treatments
412214|NCT01384331|Placebo controlled|placebo controlled
412215|NCT01384331|Randomly allocated tretment|randomly allocated tretment
412216|NCT01384292|Cancer-Related Pain|cancer-related pain
412217|NCT01384292|Opioid-Induced Constipation|opioid-induced constipation
412219|NCT01384279|metformin|metformin
412220|NCT01384279|topiramate|topiramate
412221|NCT01384279|obesity|obesity
412222|NCT01384279|metabolic syndrome|metabolic syndrome
412223|NCT01384266|Intraocular Inflammation following routine Cataract Surgery|intraocular inflammation following routine cataract surgery
412224|NCT01384253|HER2+|her2+
412225|NCT01384253|HER-2 positive|her-2 positive
412226|NCT01384253|intraperitoneal|intraperitoneal
412227|NCT01384253|intra-abdominal|intra-abdominal
412228|NCT01384253|Lead 212|lead 212
412229|NCT01384253|Radio Immunotherapy|radio immunotherapy
412230|NCT01384253|Alpha particle|alpha particle
412231|NCT01384253|Antibodies|antibodies
412232|NCT01384253|Immunoglobulins|immunoglobulins
412233|NCT01384253|Antibodies, Monoclonal|antibodies, monoclonal
412234|NCT01384253|Immunologic Factors|immunologic factors
412235|NCT01384253|Physiological Effects of Drugs|physiological effects of drugs
412236|NCT01384253|Pharmacologic Actions|pharmacologic actions
412237|NCT01384253|RIT|rit
412238|NCT01384240|colon polyps|colon polyps
412239|NCT01384240|colonic dysplasia|colonic dysplasia
412240|NCT01384240|anal dysplasia|anal dysplasia
412241|NCT01384240|microendoscopy|microendoscopy
412242|NCT01384227|Barrett's esophagus|barrett's esophagus
412243|NCT01384227|in vivo imaging|in vivo imaging
412244|NCT01384227|image guide microscope|image guide microscope
412245|NCT01384201|intestinal metaplasia, gastric cancer|intestinal metaplasia, gastric cancer
412246|NCT01384175|Epidural Analgesia|epidural analgesia
412247|NCT01384175|OPCAB|opcab
412248|NCT01384175|PCEA|pcea
412249|NCT01384162|ALS|als
412250|NCT01384162|VEGF165|vegf165
412251|NCT01384162|Safety|safety
412252|NCT01384162|Intracerebroventricular|intracerebroventricular
412253|NCT01384162|Infusion|infusion
412254|NCT01384162|Implantable|implantable
412255|NCT01384149|intra ocular pressure|intra ocular pressure
412256|NCT01384149|open angle glaucoma|open angle glaucoma
412257|NCT01384149|selective laser trabeculoplasty|selective laser trabeculoplasty
412258|NCT01384149|external laser treatment|external laser treatment
412259|NCT01384123|stable pulmonary sarcoidosis with no change in medication during the last 3 months/|stable pulmonary sarcoidosis with no change in medication during the last 3 months/
412260|NCT01384110|Amylase|amylase
412261|NCT01384110|Glucosidase|glucosidase
412262|NCT01384110|Glycemic response|glycemic response
412263|NCT01384110|Sucrose|sucrose
412264|NCT01384110|Seaweed|seaweed
412265|NCT01384097|haemodynamic|haemodynamic
412266|NCT01384097|goal-directed therapy|goal-directed therapy
412267|NCT01384097|surgery|surgery
412268|NCT01384097|anaesthesia|anaesthesia
412269|NCT01384084|pelvic organ prolapse|pelvic organ prolapse
412270|NCT01384084|urinary incontinence|urinary incontinence
412271|NCT01384084|sacropexy|sacropexy
412272|NCT01384084|sling|sling
412273|NCT01384071|Low back pain|low back pain
412274|NCT01384071|Unstable shoes|unstable shoes
412275|NCT01384071|Gait|gait
412276|NCT01384071|Balance|balance
412277|NCT01384058|atherogenic lipoprotein|atherogenic lipoprotein
412278|NCT01384058|cardiovascular disease|cardiovascular disease
412279|NCT01384058|coronary artery disease|coronary artery disease
412280|NCT01384058|type 2 diabetes|type 2 diabetes
412281|NCT01384058|small, dense LDL|small, dense ldl
412282|NCT01384045|Type II Diabetes|type ii diabetes
412283|NCT01384045|Diabetes|diabetes
412284|NCT01384032|CVD, LDL-C, apoE, SFA, DHA|cvd, ldl-c, apoe, sfa, dha
412285|NCT01384019|ST-elevation myocardial infarction|st-elevation myocardial infarction
412286|NCT01384019|percutaneous coronary intervention|percutaneous coronary intervention
412287|NCT01384019|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
412288|NCT01384019|microvascular occlusion|microvascular occlusion
412289|NCT01384019|myocardial salvage|myocardial salvage
412290|NCT01384006|Pancreas transplantation|pancreas transplantation
412291|NCT01384006|extended donor criteria|extended donor criteria
412292|NCT01384006|organ survival|organ survival
412293|NCT01383993|Open-Label|open-label
412294|NCT01383993|Pharmacokinetics|pharmacokinetics
412295|NCT01383993|Intravenous to oral switch|intravenous to oral switch
412296|NCT01383993|Safety|safety
412297|NCT01383993|Voriconazole|voriconazole
412298|NCT01383993|Immunocompromise|immunocompromise
412299|NCT01383993|Children|children
412300|NCT01383993|High Risk For Systemic Fungal Infection|high risk for systemic fungal infection
412301|NCT01383980|Enteral Nutrition|enteral nutrition
412302|NCT01383980|Enteral Feeding|enteral feeding
412303|NCT01383980|nasogastric tubes|nasogastric tubes
412304|NCT01383980|gastrostomy tubes|gastrostomy tubes
412305|NCT01383980|jejunostomy tubes|jejunostomy tubes
412306|NCT01383954|Knee osteoarthritis|knee osteoarthritis
412307|NCT01383941|asthma|asthma
412308|NCT01383941|rhinitis|rhinitis
412309|NCT01383941|difficult-to-treat asthmatic|difficult-to-treat asthmatic
412310|NCT01383941|phenotypes|phenotypes
412311|NCT01383889|Physical exercise|physical exercise
412312|NCT01383889|Pregnancy|pregnancy
412313|NCT01383889|Fetal well being|fetal well being
412314|NCT01383876|cervical|cervical
412315|NCT01383876|laminectomy|laminectomy
412316|NCT01383876|fusion|fusion
412317|NCT01383876|neurological compression|neurological compression
412318|NCT01383876|spondylosis|spondylosis
412319|NCT01383850|preterm infants|preterm infants
412320|NCT01383850|nasal continuous positive airway pressure|nasal continuous positive airway pressure
412321|NCT01383850|heliox|heliox
412322|NCT01383850|bronchopulmonary dysplasia.|bronchopulmonary dysplasia.
412323|NCT01383837|HIV/STI|hiv/sti
412324|NCT01383837|Prevention|prevention
412325|NCT01383837|Adolescents|adolescents
412326|NCT01383837|Substance Use Disorders|substance use disorders
412327|NCT01383837|Family-based intervention|family-based intervention
412328|NCT01383824|Hip Replacement|hip replacement
412329|NCT01383824|Femoral Component|femoral component
412432|NCT01383304|Thromboxane B2|thromboxane b2
412330|NCT01383811|Treatment Resistant Depression|treatment resistant depression
412331|NCT01383811|Exercise|exercise
412332|NCT01383798|iron deficiency, physical performance, female athletes|iron deficiency, physical performance, female athletes
412333|NCT01383785|Primary PTCA|primary ptca
412334|NCT01383785|Thrombus Aspiration Catheter|thrombus aspiration catheter
412335|NCT01383785|Intracoronary Abciximab|intracoronary abciximab
412336|NCT01383772|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
412337|NCT01383772|Pan retinal photocoagulation|pan retinal photocoagulation
412338|NCT01383772|Multi-spot Photocoagulator|multi-spot photocoagulator
412339|NCT01383772|Visual field tests|visual field tests
412340|NCT01383759|BORTEZOMIB (VELCADE)|bortezomib (velcade)
412341|NCT01383759|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
412342|NCT01383759|DEXAMETHASONE|dexamethasone
412343|NCT01383759|MELPHALAN|melphalan
412344|NCT01383759|11-061|11-061
412345|NCT01383746|Cholangiocarcinoma|cholangiocarcinoma
412346|NCT01383746|RADIOEMBOLIZATION|radioembolization
412347|NCT01383746|tumor response|tumor response
412348|NCT01383746|progression-free survival|progression-free survival
412349|NCT01383746|safety|safety
412350|NCT01383746|second-line therapy|second-line therapy
412351|NCT01383720|Aortic Valve Stenosis|aortic valve stenosis
412352|NCT01383720|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
412353|NCT01383655|wheezy bronchitis|wheezy bronchitis
412354|NCT01383655|asthma|asthma
412355|NCT01383655|rhinovirus|rhinovirus
412356|NCT01383655|magnesium|magnesium
412357|NCT01383629|Vitrectomy|vitrectomy
412358|NCT01383629|Local anaesthesia|local anaesthesia
412359|NCT01383629|Counselling|counselling
412360|NCT01383629|Fear|fear
412361|NCT01383629|Visual perception|visual perception
412362|NCT01383616|osteoporosis|osteoporosis
412363|NCT01383616|vertebral compression fractures|vertebral compression fractures
412364|NCT01383603|Cat Allergy|cat allergy
412365|NCT01383603|Rhinoconjunctivitis|rhinoconjunctivitis
412366|NCT01383603|Immunotherapy|immunotherapy
412367|NCT01383603|Cat-PAD|cat-pad
412368|NCT01383590|Cat allergy|cat allergy
412369|NCT01383590|Rhinoconjunctivitis|rhinoconjunctivitis
412370|NCT01383590|Immunotherapy|immunotherapy
412371|NCT01383590|Cat-PAD|cat-pad
412372|NCT01383577|Hemorrhoids|hemorrhoids
412373|NCT01383577|Ligation|ligation
412374|NCT01383577|Pain|pain
412375|NCT01383577|Morbidity|morbidity
412376|NCT01383577|Patient Satisfaction|patient satisfaction
412377|NCT01383577|Cost-Benefit Analysis|cost-benefit analysis
412378|NCT01383551|Depression|depression
412379|NCT01383551|Marital relationship|marital relationship
412380|NCT01383551|Parental competence|parental competence
412381|NCT01383538|pancreas|pancreas
412382|NCT01383538|cancer|cancer
412383|NCT01383538|adenocarcinoma|adenocarcinoma
412384|NCT01383538|Oxaliplatin|oxaliplatin
412385|NCT01383538|Leucovorin|leucovorin
412386|NCT01383538|Irinotecan|irinotecan
412387|NCT01383538|5-FU|5-fu
412388|NCT01383538|IPI-926|ipi-926
412389|NCT01383525|SLT, LTP|slt, ltp
412390|NCT01383525|non contact|non contact
412391|NCT01383525|Trabeculoplasty|trabeculoplasty
412392|NCT01383525|Laser|laser
412393|NCT01383525|intraocular pressure|intraocular pressure
412394|NCT01383512|stroke|stroke
412395|NCT01383512|rehabilitation|rehabilitation
412396|NCT01383512|robotics|robotics
412397|NCT01383512|motor control|motor control
412398|NCT01383512|upper limb|upper limb
412399|NCT01383486|Self Selection Tria|self selection tria
412400|NCT01383473|cancer therapy|cancer therapy
412401|NCT01383473|school attendance|school attendance
412402|NCT01383473|cancer diagnosis|cancer diagnosis
412403|NCT01383473|perception|perception
412404|NCT01383460|Acute-on-chronic liver failure|acute-on-chronic liver failure
412405|NCT01383460|ACLF|aclf
412406|NCT01383460|cirrhosis|cirrhosis
412407|NCT01383460|acute hepatitis|acute hepatitis
412408|NCT01383421|Rheumatoid Arthritis|rheumatoid arthritis
412409|NCT01383421|Patient Support Program|patient support program
412410|NCT01383421|adalimumab|adalimumab
412411|NCT01383408|breath sample analysis|breath sample analysis
412412|NCT01383408|exhalation analysis|exhalation analysis
412413|NCT01383408|volatile organic compounds|volatile organic compounds
412414|NCT01383408|screening|screening
412415|NCT01383408|lung cancer|lung cancer
412416|NCT01383408|breast cancer|breast cancer
412417|NCT01383408|ovarian cancer|ovarian cancer
412418|NCT01383408|canine scent detection|canine scent detection
412419|NCT01383382|Heart Diseases|heart diseases
412420|NCT01383382|Cardiovascular Diseases|cardiovascular diseases
412421|NCT01383382|Acute Myocardial Infarction|acute myocardial infarction
412422|NCT01383382|Decision Making|decision making
412423|NCT01383382|Percutaneous Coronary Intervention|percutaneous coronary intervention
412424|NCT01383382|Informed Consent|informed consent
412425|NCT01383382|Quality of Care|quality of care
412426|NCT01383330|megesterol|megesterol
412427|NCT01383317|Remote Ischemic Preconditioning|remote ischemic preconditioning
412428|NCT01383317|Acute Pain|acute pain
412429|NCT01383304|Platelet aggregation|platelet aggregation
412430|NCT01383304|Aspirin|aspirin
412431|NCT01383304|Drug resistance|drug resistance
412433|NCT01383304|Pharmacologic Actions|pharmacologic actions
412434|NCT01383304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
412435|NCT01383291|pelvic floor prolapse|pelvic floor prolapse
412436|NCT01383291|prolift|prolift
412437|NCT01383291|IVS|ivs
412438|NCT01383291|Surgery|surgery
412439|NCT01383278|tobacco|tobacco
412440|NCT01383278|smoking|smoking
412441|NCT01383278|smoking cessation|smoking cessation
412442|NCT01383265|screening colonoscopy|screening colonoscopy
412443|NCT01383265|adenoma|adenoma
412444|NCT01383265|water method|water method
412445|NCT01383252|water method|water method
412446|NCT01383252|air method|air method
412447|NCT01383252|unsedated colonoscopy|unsedated colonoscopy
412448|NCT01383252|adenoma detection|adenoma detection
412449|NCT01383239|Rotator Cuff Tear Repair|rotator cuff tear repair
412450|NCT01383239|Rotator Cuff Tear Repair and postoperative treatment|rotator cuff tear repair and postoperative treatment
412451|NCT01383226|endosonography|endosonography
412452|NCT01383226|enlarged thoracic lymph adenopathies|enlarged thoracic lymph adenopathies
412453|NCT01383226|non-cancer patient|non-cancer patient
412454|NCT01383213|Acute Respiratory Failure|acute respiratory failure
412455|NCT01383213|Pneumonia|pneumonia
412456|NCT01383213|Continuous Positive Airway Pressure|continuous positive airway pressure
412457|NCT01383200|efficacy|efficacy
412458|NCT01383200|comfort|comfort
412459|NCT01383187|Deep Burn Trauma|deep burn trauma
412460|NCT01383187|Dermo-Epidermal Graft|dermo-epidermal graft
412461|NCT01383187|Platelet Rich Plasma Concentrate (PRP)|platelet rich plasma concentrate (prp)
412462|NCT01383187|Vancouver Scar Score|vancouver scar score
412463|NCT01383187|Scarring|scarring
412464|NCT01383187|Hypertrophic Scarring|hypertrophic scarring
412465|NCT01383174|Breast cancer|breast cancer
412466|NCT01383174|Latinas|latinas
412467|NCT01383174|Peer support counselor|peer support counselor
412468|NCT01383174|Spanish speaking|spanish speaking
412469|NCT01383174|Community based|community based
412470|NCT01383161|Curcumin|curcumin
412471|NCT01383161|Turmeric|turmeric
412472|NCT01383161|Memory|memory
412473|NCT01383161|Cognitive Impairment|cognitive impairment
412474|NCT01383161|Brain Imaging|brain imaging
412475|NCT01383161|Supplement|supplement
412476|NCT01383148|NSCLC|nsclc
412477|NCT01383135|Healthy volunteers|healthy volunteers
412478|NCT01383122|Pulsed electromagnetic field device|pulsed electromagnetic field device
412479|NCT01383122|Cesarean section|cesarean section
412480|NCT01383109|Mass Balance|mass balance
412481|NCT01383109|Accelerated Mass Spectrometry (AMS)|accelerated mass spectrometry (ams)
412482|NCT01383109|microdose|microdose
412483|NCT01383109|Focus of the study: ADME|focus of the study: adme
412484|NCT01383096|OZ439|oz439
412485|NCT01383096|Bioavailability|bioavailability
412486|NCT01383096|Food Effect|food effect
412487|NCT01383083|Pulmonary arterial hypertension|pulmonary arterial hypertension
412488|NCT01383083|Congenital heart disease|congenital heart disease
412489|NCT01383083|Eisenmenger physiology|eisenmenger physiology
412490|NCT01383070|Timely initiation of breast feeding|timely initiation of breast feeding
412491|NCT01383070|Exclusive breast feeding|exclusive breast feeding
412492|NCT01383070|Timely introduction of complimentary feeding|timely introduction of complimentary feeding
412493|NCT01383070|Breast Feeding, Exclusive|breast feeding, exclusive
412494|NCT01383070|Childbirth and the Puerperium|childbirth and the puerperium
412495|NCT01383044|Carvedilol|carvedilol
412496|NCT01383044|Banding ligation with Carvedilol|banding ligation with carvedilol
412497|NCT01383044|the efficacy & safety of combining EVL and carvedilol in prevention of first variceal bleeding|the efficacy & safety of combining evl and carvedilol in prevention of first variceal bleeding
412498|NCT01383031|laparoscopic cholecystectomy|laparoscopic cholecystectomy
412499|NCT01383031|single site|single site
412500|NCT01383031|randomized controlled trail|randomized controlled trail
412501|NCT01383018|Erectile Dysfunction (ED)|erectile dysfunction (ed)
412502|NCT01383018|Penile Implant|penile implant
412503|NCT01383018|Impotence|impotence
412504|NCT01383018|Penile Prosthesis|penile prosthesis
412505|NCT01383018|Registry|registry
412506|NCT01383005|Treatment satisfaction|treatment satisfaction
412507|NCT01383005|Adherence to treatment|adherence to treatment
412508|NCT01382992|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
412509|NCT01382992|erbB-1|erbb-1
412510|NCT01382979|Alcohol misuse prevention|alcohol misuse prevention
412511|NCT01382979|College students|college students
412512|NCT01382979|Intervention and control|intervention and control
412513|NCT01382966|sclerostin|sclerostin
412514|NCT01382966|arteriovenous fistula thrombosis|arteriovenous fistula thrombosis
412515|NCT01382966|carpal tunnel syndrome|carpal tunnel syndrome
412516|NCT01382966|echocardiography|echocardiography
412517|NCT01382953|Holter Monitor, Ambulatory Electrocardiography Monitoring|holter monitor, ambulatory electrocardiography monitoring
412518|NCT01382888|Haemodialysis|haemodialysis
412519|NCT01382888|Arteriovenous fistula|arteriovenous fistula
412520|NCT01382888|Severe chronic kidney disease|severe chronic kidney disease
412521|NCT01382888|Newly constructed primary arteriovenous fistulas in patients planned for haemodialysis|newly constructed primary arteriovenous fistulas in patients planned for haemodialysis
412621|NCT01382407|ERBITUX® (cetuximab)|erbitux® (cetuximab)
412522|NCT01382875|Multi-disciplinary management program|multi-disciplinary management program
412523|NCT01382875|Conventional care program|conventional care program
412524|NCT01382875|Balance Ability|balance ability
412525|NCT01382875|Quality of Life|quality of life
412526|NCT01382862|acute ischemic stroke|acute ischemic stroke
412527|NCT01382862|thrombolysis|thrombolysis
412528|NCT01382862|prehospital|prehospital
412529|NCT01382862|emergency medicine|emergency medicine
412530|NCT01382862|suspected acute stroke|suspected acute stroke
412531|NCT01382862|telemedicine|telemedicine
412532|NCT01382849|amyloid|amyloid
412533|NCT01382849|cerebral amyloid angiopathy|cerebral amyloid angiopathy
412534|NCT01382849|hemorrhages|hemorrhages
412535|NCT01382849|cerebral spot sign|cerebral spot sign
412536|NCT01382810|dry eye signs and symptoms|dry eye signs and symptoms
412537|NCT01382771|low back pain|low back pain
412538|NCT01382771|zygapophysial joint pain|zygapophysial joint pain
412539|NCT01382771|medial branch block|medial branch block
412540|NCT01382771|> 6 months duration|> 6 months duration
412541|NCT01382771|non-radicular|non-radicular
412542|NCT01382758|Near Infrared Spectroscopy (NIRS)|near infrared spectroscopy (nirs)
412543|NCT01382758|Acute kidney injury (AKI)|acute kidney injury (aki)
412544|NCT01382732|Pre-eclampsia|pre-eclampsia
412545|NCT01382732|Postpartum hemorrhage|postpartum hemorrhage
412546|NCT01382732|Carbetocin|carbetocin
412547|NCT01382732|Oxytocin|oxytocin
412548|NCT01382719|FSAD|fsad
412549|NCT01382719|HSDD|hsdd
412550|NCT01382719|female sexual dysfunction|female sexual dysfunction
412551|NCT01382719|FSD|fsd
412552|NCT01382719|Female Sexual Arousal Disorder|female sexual arousal disorder
412553|NCT01382719|Hypoactive Sexual Desire Disorder|hypoactive sexual desire disorder
412554|NCT01382693|Behavioral symptoms|behavioral symptoms
412555|NCT01382693|Long-term care|long-term care
412556|NCT01382667|mucositis|mucositis
412557|NCT01382667|dyspepsia|dyspepsia
412558|NCT01382667|chemotherapy|chemotherapy
412559|NCT01382667|GLP-2|glp-2
412560|NCT01382667|questionnaire|questionnaire
412561|NCT01382641|Cataract surgery|cataract surgery
412562|NCT01382628|Diabetes|diabetes
412563|NCT01382628|Ulcers|ulcers
412564|NCT01382628|Equinus Deformity|equinus deformity
412565|NCT01382628|Amputation|amputation
412566|NCT01382628|Achilles Tendon|achilles tendon
412567|NCT01382628|Limb Loss|limb loss
412568|NCT01382615|Multiple Myeloma|multiple myeloma
412569|NCT01382602|Urinary Incontinence, Stress|urinary incontinence, stress
412570|NCT01382602|Tissue Therapy (Cell Therapy)|tissue therapy (cell therapy)
412571|NCT01382602|Transplantation, Autologous|transplantation, autologous
412572|NCT01382589|vitiligo|vitiligo
412573|NCT01382589|depigmentation|depigmentation
412574|NCT01382589|phototherapy|phototherapy
412575|NCT01382589|non-segmental vitiligo|non-segmental vitiligo
412576|NCT01382576|polycystic ovary syndrome|polycystic ovary syndrome
412577|NCT01382576|chitotriosidase activity|chitotriosidase activity
412578|NCT01382563|Eosinophilic Gastrointestinal Disorders|eosinophilic gastrointestinal disorders
412579|NCT01382563|EGID|egid
412580|NCT01382563|Eosinophilic Esophagitis|eosinophilic esophagitis
412581|NCT01382563|Registry|registry
412582|NCT01382563|Eosinophils|eosinophils
412583|NCT01382563|Eosinophilia|eosinophilia
412584|NCT01382563|Eosinophilic enteropathy|eosinophilic enteropathy
412585|NCT01382563|Eosinophilic enteritis|eosinophilic enteritis
412586|NCT01382563|Eosinophilic gastritis|eosinophilic gastritis
412587|NCT01382563|Eosinophilic gastroenteritis|eosinophilic gastroenteritis
412588|NCT01382563|Eosinophilic gastroenteropathy|eosinophilic gastroenteropathy
412589|NCT01382550|antithrombin|antithrombin
412590|NCT01382550|venous thrombosis|venous thrombosis
412591|NCT01382550|thrombosis risk factors|thrombosis risk factors
412592|NCT01382550|thrombophilia|thrombophilia
412593|NCT01382537|Neck|neck
412594|NCT01382537|Chronic|chronic
412595|NCT01382537|Musculoskeletal|musculoskeletal
412596|NCT01382537|Shoulder|shoulder
412597|NCT01382524|PIV therapy|piv therapy
412598|NCT01382498|Endothelin-1 high sensitivity CRP|endothelin-1 high sensitivity crp
412599|NCT01382485|non union|non union
412600|NCT01382485|bone defect|bone defect
412601|NCT01382485|tibia non union|tibia non union
412602|NCT01382485|femur non union|femur non union
412603|NCT01382485|bone graft|bone graft
412604|NCT01382472|STEMI|stemi
412605|NCT01382472|PPCI|ppci
412606|NCT01382472|Statins|statins
412607|NCT01382472|Infarct size|infarct size
412608|NCT01382459|children|children
412609|NCT01382446|Trauma|trauma
412610|NCT01382446|Mechanical Ventilation|mechanical ventilation
412611|NCT01382446|Ventilator Associated Pneumonia|ventilator associated pneumonia
412612|NCT01382446|Oral Care|oral care
412613|NCT01382433|Chronic Cannabis Users|chronic cannabis users
412614|NCT01382433|negative symptoms|negative symptoms
412615|NCT01382433|cognitive electrophysiology functions|cognitive electrophysiology functions
412616|NCT01382420|subclinical cushing syndrome|subclinical cushing syndrome
412617|NCT01382420|hypercortisolism|hypercortisolism
412618|NCT01382420|adrenal incidentaloma|adrenal incidentaloma
412619|NCT01382420|adrenalectomy|adrenalectomy
412620|NCT01382407|skin rash reaction|skin rash reaction
412624|NCT01382394|heart failure|heart failure
412625|NCT01382394|BNP|bnp
412626|NCT01382394|IL-6|il-6
412627|NCT01382394|Procalcitonin|procalcitonin
412628|NCT01382394|Prognosis|prognosis
412629|NCT01382368|Post Pneumonectomy Patients|post pneumonectomy patients
412630|NCT01382368|IPF|ipf
412631|NCT01382368|COPD|copd
412632|NCT01382355|Kidney transplant|kidney transplant
412633|NCT01382355|Kidney/Pancreas transplant|kidney/pancreas transplant
412634|NCT01382355|Antibody|antibody
412635|NCT01382355|Monitoring|monitoring
412636|NCT01382342|Parkinson's disease|parkinson's disease
412637|NCT01382342|cognition|cognition
412638|NCT01382342|executive function|executive function
412639|NCT01382342|rasagiline|rasagiline
412640|NCT01382329|Prophylaxis of influenza infection caused by a pandemic influenza virus (H5N1)|prophylaxis of influenza infection caused by a pandemic influenza virus (h5n1)
412641|NCT01382316|12-step facilitation|12-step facilitation
412642|NCT01382316|Alcoholics Anonymous|alcoholics anonymous
412643|NCT01382316|Narcotics Anonymous|narcotics anonymous
412644|NCT01382316|AA|aa
412645|NCT01382316|Self-help|self-help
412646|NCT01382303|Type 2 Diabetes|type 2 diabetes
412647|NCT01382303|pentoxifylline|pentoxifylline
412648|NCT01382303|proteinuria|proteinuria
412649|NCT01382290|MRI|mri
412650|NCT01382290|Spine|spine
412651|NCT01382290|Diffusion|diffusion
412652|NCT01382264|Poorly controlled diabetes Type 2|poorly controlled diabetes type 2
412653|NCT01382264|Computer Assisted Decision Support|computer assisted decision support
412654|NCT01382264|Primary Care Providers|primary care providers
412655|NCT01382251|Activities of Daily Living|activities of daily living
412656|NCT01382251|Caregivers|caregivers
412657|NCT01382251|Ambulatory Surgical Procedures|ambulatory surgical procedures
412658|NCT01382238|dolutegravir|dolutegravir
412659|NCT01382238|pediatric|pediatric
412660|NCT01382238|granule formulation|granule formulation
412661|NCT01382238|GSK1349572|gsk1349572
412662|NCT01382238|HIV|hiv
412663|NCT01382225|Dry eyes|dry eyes
412664|NCT01382225|Ocular discomfort|ocular discomfort
412665|NCT01382212|Evaluate safety through the evaluation of the incidence of hypercalcemia in pediatric subjects|evaluate safety through the evaluation of the incidence of hypercalcemia in pediatric subjects
412666|NCT01382199|Antibiotic Associated Diarrhea in Adult Patients|antibiotic associated diarrhea in adult patients
412667|NCT01382186|Qualitative|qualitative
412668|NCT01382186|User, Computer Interface|user, computer interface
412669|NCT01382186|quantitative|quantitative
412670|NCT01382186|survey|survey
412671|NCT01382186|telemedicine|telemedicine
412672|NCT01382173|Knee injury|knee injury
412673|NCT01382173|Osteoarthritis|osteoarthritis
412674|NCT01382173|Anterior Cruciate Ligament injury|anterior cruciate ligament injury
412675|NCT01382173|Patellar dislocation|patellar dislocation
412676|NCT01382160|Rheumatoid arthritis|rheumatoid arthritis
412677|NCT01382160|adalimumab|adalimumab
412678|NCT01382160|pharmacokinetic-pharmacodynamic relationship|pharmacokinetic-pharmacodynamic relationship
412679|NCT01382160|immunogenicity|immunogenicity
412680|NCT01382160|Fc gamma receptors polymorphisms|fc gamma receptors polymorphisms
412681|NCT01382134|Platelet dysfunction|platelet dysfunction
412682|NCT01382134|Hemodilution|hemodilution
412683|NCT01382134|Mild hypothermia|mild hypothermia
412684|NCT01382134|NSAID|nsaid
412685|NCT01382134|Desmopressin|desmopressin
412686|NCT01382121|Peer modeling|peer modeling
412687|NCT01382121|Observational learning|observational learning
412688|NCT01382121|Obesity|obesity
412689|NCT01382121|Adolescents|adolescents
412690|NCT01382121|Maximum ventilatory oxygen|maximum ventilatory oxygen
412691|NCT01382121|Aerobic fitness|aerobic fitness
412692|NCT01382121|Health behaviour|health behaviour
412693|NCT01382095|ETEC|etec
412694|NCT01382095|Diarrhea|diarrhea
412695|NCT01382095|Vaccine|vaccine
412696|NCT01382082|cognitive function|cognitive function
412697|NCT01382082|memory|memory
412698|NCT01382082|attention|attention
412699|NCT01382082|breast cancer|breast cancer
412700|NCT01382082|lymphoma|lymphoma
412701|NCT01382069|androgen|androgen
412702|NCT01382069|male contraception|male contraception
412703|NCT01382069|dimethandrolone|dimethandrolone
412704|NCT01382069|healthy men|healthy men
412705|NCT01382056|Peripheral Artery Disease|peripheral artery disease
412706|NCT01382056|Pulses|pulses
412707|NCT01382056|Beans|beans
412708|NCT01382056|PAD|pad
412709|NCT01382043|percutaneous coronary angioplasty|percutaneous coronary angioplasty
412710|NCT01382043|zotarolimus-eluting stent|zotarolimus-eluting stent
412711|NCT01382043|sirolimus-eluting stent|sirolimus-eluting stent
412712|NCT01382043|biodegradable polymer|biodegradable polymer
412713|NCT01382043|biocompatible polymer|biocompatible polymer
412714|NCT01382030|Soft tissue sarcoma|soft tissue sarcoma
412715|NCT01382030|High-risk|high-risk
412716|NCT01382030|Neoadjuvant|neoadjuvant
412717|NCT01382030|Adjuvant|adjuvant
412718|NCT01382030|Chemotherapy|chemotherapy
412719|NCT01382030|Radiotherapy|radiotherapy
412720|NCT01382017|lacosamide|lacosamide
412721|NCT01382017|carbamazepine|carbamazepine
412722|NCT01382017|placebo|placebo
412821|NCT01381653|substance use|substance use
412723|NCT01382017|transcranial magnetic stimulation|transcranial magnetic stimulation
412724|NCT01382017|TMS|tms
412725|NCT01382017|motor cortex|motor cortex
412726|NCT01382017|sodium channel|sodium channel
412727|NCT01382017|inhibition|inhibition
412728|NCT01382017|threshold|threshold
412729|NCT01382004|Neglected diseases|neglected diseases
412730|NCT01382004|Children|children
412731|NCT01381991|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
412732|NCT01381991|Reflux esophagitis|reflux esophagitis
412733|NCT01381991|i-scan|i-scan
412734|NCT01381978|Nutritional status of scholars|nutritional status of scholars
412735|NCT01381978|Risk factors of obesity|risk factors of obesity
412736|NCT01381978|Socioeconomical status|socioeconomical status
412737|NCT01381978|Physical activity habits|physical activity habits
412738|NCT01381965|spectral-domain optical coherence tomography|spectral-domain optical coherence tomography
412739|NCT01381965|idiopathic macular hole|idiopathic macular hole
412740|NCT01381965|cone outer segment tips line|cone outer segment tips line
412741|NCT01381965|vitrectomy|vitrectomy
412742|NCT01381952|X-ray|x-ray
412743|NCT01381952|Image processing|image processing
412744|NCT01381952|Neuro angiography|neuro angiography
412745|NCT01381952|Radiation exposure|radiation exposure
412746|NCT01381939|Intrahepatic Cholestasis of Pregnancy|intrahepatic cholestasis of pregnancy
412747|NCT01381939|Induction of labor|induction of labor
412748|NCT01381939|Pregnancy|pregnancy
412749|NCT01381939|Caesarian section|caesarian section
412750|NCT01381939|Pruritus|pruritus
412751|NCT01381939|IUFD|iufd
412752|NCT01381926|Type 2 diabetes|type 2 diabetes
412753|NCT01381926|exenatide|exenatide
412754|NCT01381926|Byetta|byetta
412755|NCT01381913|Gastric cancer|gastric cancer
412756|NCT01381913|Chemoradiotherapy|chemoradiotherapy
412757|NCT01381913|Adjacent tissue invasion|adjacent tissue invasion
412758|NCT01381913|Feasibility trial|feasibility trial
412759|NCT01381900|Canagliflozin|canagliflozin
412760|NCT01381900|Placebo|placebo
412761|NCT01381900|Type 2 diabetes mellitus|type 2 diabetes mellitus
412762|NCT01381887|Canagliflozin|canagliflozin
412763|NCT01381887|Placebo|placebo
412764|NCT01381887|Type 2 diabetes mellitus|type 2 diabetes mellitus
412765|NCT01381874|Breast cancer|breast cancer
412766|NCT01381874|Abiraterone|abiraterone
412767|NCT01381874|Postmenopausal|postmenopausal
412768|NCT01381874|Metastatic|metastatic
412769|NCT01381848|Doripenem|doripenem
412770|NCT01381848|DORIPED1003|doriped1003
412771|NCT01381848|Intravenous|intravenous
412772|NCT01381848|Infection|infection
412773|NCT01381848|Colonization|colonization
412774|NCT01381848|Prophylaxis|prophylaxis
412775|NCT01381848|Pediatric|pediatric
412776|NCT01381848|Antibiotic|antibiotic
412777|NCT01381848|Pharmacokinetics|pharmacokinetics
412778|NCT01381835|TMC435-TiDP16-C126|tmc435-tidp16-c126
412779|NCT01381835|TMC435-C126|tmc435-c126
412780|NCT01381835|TMC435|tmc435
412782|NCT01381835|Hepatitis C|hepatitis c
412783|NCT01381835|Hep C|hep c
412784|NCT01381835|severe renal impairement|severe renal impairement
412785|NCT01381822|TH-302|th-302
412786|NCT01381822|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
412787|NCT01381822|RCC|rcc
412788|NCT01381822|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
412789|NCT01381822|GIST|gist
412790|NCT01381822|Phase 1|phase 1
412791|NCT01381822|Sunitinib|sunitinib
412792|NCT01381822|Pancreatic Neuroendocrine Tumors|pancreatic neuroendocrine tumors
412793|NCT01381822|PNET|pnet
412794|NCT01381809|Myelodysplastic Syndromes|myelodysplastic syndromes
412795|NCT01381809|Myeloproliferative Disorders|myeloproliferative disorders
412796|NCT01381809|Bone Marrow disease|bone marrow disease
412797|NCT01381809|Anemia|anemia
412798|NCT01381809|Epoetin Alfa|epoetin alfa
412799|NCT01381809|Eprex|eprex
412800|NCT01381809|Erypo|erypo
412801|NCT01381809|Erythropoiesis-stimulating agent|erythropoiesis-stimulating agent
412802|NCT01381783|topical anaesthesia|topical anaesthesia
412803|NCT01381783|Phacoemulsification|phacoemulsification
412804|NCT01381770|muscular lesions grade 2|muscular lesions grade 2
412805|NCT01381770|muscular lesions grade 3|muscular lesions grade 3
412806|NCT01381757|Extensively Drug-Resistant Tuberculosis|extensively drug-resistant tuberculosis
412807|NCT01381757|First-Line Antituberculous Drugs|first-line antituberculous drugs
412808|NCT01381757|Second-Line Antituberculous Drugs|second-line antituberculous drugs
412809|NCT01381757|Middlebrook Culture|middlebrook culture
412810|NCT01381757|Agar Proportion Method|agar proportion method
412811|NCT01381744|Yersinia pestis, vaccine, plague, Flagellin/F1/V, Parent Protocol of 15-0104|yersinia pestis, vaccine, plague, flagellin/f1/v, parent protocol of 15-0104
412812|NCT01381731|post PRK wound healing|post prk wound healing
412813|NCT01381718|childhood brain tumor|childhood brain tumor
412814|NCT01381718|neurotoxicity|neurotoxicity
412815|NCT01381718|fatigue|fatigue
412816|NCT01381718|cognitive/functional effects|cognitive/functional effects
412817|NCT01381718|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
412818|NCT01381705|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
412819|NCT01381705|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
412822|NCT01381653|HIV prevention|hiv prevention
412823|NCT01381653|intervention acceptability and feasibility|intervention acceptability and feasibility
412824|NCT01381653|young men who have sex with men|young men who have sex with men
412825|NCT01381640|paracetamol|paracetamol
412826|NCT01381640|healthy volunteer|healthy volunteer
412827|NCT01381640|pharmacoscintography|pharmacoscintography
412828|NCT01381627|EBUS-TBNA|ebus-tbna
412829|NCT01381627|Dexmedetomidine|dexmedetomidine
412830|NCT01381627|Precedex|precedex
412831|NCT01381627|Remifentanil|remifentanil
412832|NCT01381627|Ultiva|ultiva
412833|NCT01381627|Monitored Anesthesia Care|monitored anesthesia care
412834|NCT01381627|Sedation|sedation
412835|NCT01381627|Bronchoscopy|bronchoscopy
412836|NCT01381627|Lung cancer|lung cancer
412837|NCT01381627|Mediastinal node|mediastinal node
412838|NCT01381627|Cancer staging|cancer staging
412839|NCT01381627|Anesthesia|anesthesia
412840|NCT01381627|Remote location|remote location
412841|NCT01381614|retrospective database analysis|retrospective database analysis
412842|NCT01381614|economic burden|economic burden
412843|NCT01381601|retrospective database analysis|retrospective database analysis
412844|NCT01381601|economic burden|economic burden
412845|NCT01381575|HPV infection|hpv infection
412846|NCT01381575|Human Papillomavirus|human papillomavirus
412847|NCT01381575|Cervical cancer|cervical cancer
412848|NCT01381575|HPV-16|hpv-16
412849|NCT01381575|HPV-18|hpv-18
412850|NCT01381575|vaccine|vaccine
412851|NCT01381562|intra-abdominal infection|intra-abdominal infection
412852|NCT01381562|belly|belly
412853|NCT01381562|Gram-negative pathogen|gram-negative pathogen
412854|NCT01381562|abscess|abscess
412855|NCT01381562|peritonitis|peritonitis
412856|NCT01381549|Gram-negative|gram-negative
412857|NCT01381549|uropathogens|uropathogens
412858|NCT01381549|complicated lower urinary tract infection|complicated lower urinary tract infection
412859|NCT01381549|pyelonephritis|pyelonephritis
412860|NCT01381536|Anti Blys Antibody|anti blys antibody
412861|NCT01381523|resource utilization|resource utilization
412862|NCT01381523|naproxen sodium|naproxen sodium
412863|NCT01381523|cost and cost analysis|cost and cost analysis
412864|NCT01381523|triptan|triptan
412865|NCT01381523|migraine|migraine
412866|NCT01381510|Benign prostatic hyperplasia|benign prostatic hyperplasia
412867|NCT01381510|Adherence|adherence
412868|NCT01381510|Acute urinary retention|acute urinary retention
412869|NCT01381510|Enlarged prostate|enlarged prostate
412870|NCT01381510|5-alpha reductase inhibitor|5-alpha reductase inhibitor
412872|NCT01381510|Cost and cost analysis|cost and cost analysis
412873|NCT01381497|presenteeism|presenteeism
412874|NCT01381497|migraine disorders|migraine disorders
412875|NCT01381497|work productivity|work productivity
412876|NCT01381497|triptan|triptan
412877|NCT01381497|sumatriptan and naproxen sodium|sumatriptan and naproxen sodium
412878|NCT01381497|absenteeism|absenteeism
412879|NCT01381484|Periorbital wrinkles|periorbital wrinkles
412880|NCT01381484|Efficacy and safety|efficacy and safety
412881|NCT01381432|Antirejection|antirejection
412882|NCT01381419|pharmacokinetics|pharmacokinetics
412883|NCT01381419|safety|safety
412884|NCT01381419|positron emission tomography (PET)|positron emission tomography (pet)
412885|NCT01381419|single ascending dose|single ascending dose
412886|NCT01381393|osteoporosis|osteoporosis
412887|NCT01381393|ibandronate|ibandronate
412888|NCT01381380|myofascial pain|myofascial pain
412889|NCT01381380|trigger point injection|trigger point injection
412890|NCT01381380|manual therapy|manual therapy
412891|NCT01381367|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
412892|NCT01381367|Inhaled corticosteroid|inhaled corticosteroid
412893|NCT01381367|Pneumococcal vaccine|pneumococcal vaccine
412894|NCT01381367|Acute exacerbation|acute exacerbation
412895|NCT01381367|High-dose daily inhaled corticosteroid usage|high-dose daily inhaled corticosteroid usage
412896|NCT01381367|Efficacy of the PPSV23 pneumococcal vaccine|efficacy of the ppsv23 pneumococcal vaccine
412897|NCT01381354|Secondary Progressive Multiple Sclerosis, primary progressive multiple sclerosis|secondary progressive multiple sclerosis, primary progressive multiple sclerosis
412898|NCT01381328|HIV-1 infected patients|hiv-1 infected patients
412899|NCT01381328|RALTEGRAVIR regimen|raltegravir regimen
412900|NCT01381328|genotypic evaluations|genotypic evaluations
412901|NCT01381328|phenotypic evaluations|phenotypic evaluations
412902|NCT01381315|Sentinel lymph node biopsy|sentinel lymph node biopsy
412903|NCT01381315|Axillary lymph node dissection|axillary lymph node dissection
412904|NCT01381315|Prevention of lymphedema|prevention of lymphedema
412905|NCT01381302|Severity of disease|severity of disease
412906|NCT01381276|Vitamin A|vitamin a
412907|NCT01381250|Pathological gambling according to DSM and having gambled at least once the past month.|pathological gambling according to dsm and having gambled at least once the past month.
412908|NCT01381250|Being atleast 18 years old|being atleast 18 years old
412909|NCT01381237|Balance|balance
412910|NCT01381237|Postural|postural
412911|NCT01381237|Rehabilitation|rehabilitation
412912|NCT01381237|Therapy|therapy
412913|NCT01381237|computer-assisted|computer-assisted
412914|NCT01381237|Video Games|video games
412915|NCT01381237|Center of Pressure|center of pressure
412916|NCT01381224|low back pain|low back pain
412917|NCT01381224|lumbar|lumbar
412918|NCT01381224|injection|injection
412919|NCT01381224|lumbar pain|lumbar pain
412920|NCT01381211|Intermediate stage hepatocellular carcinoma|intermediate stage hepatocellular carcinoma
412921|NCT01381198|cerebral palsy|cerebral palsy
412922|NCT01381198|distal rectus femoris transfer|distal rectus femoris transfer
412923|NCT01381198|stiff knee gait pattern|stiff knee gait pattern
412924|NCT01381198|gait analysis|gait analysis
412925|NCT01381198|single event multilevel surgery|single event multilevel surgery
412926|NCT01381198|randomized trial|randomized trial
412927|NCT01381198|crouch gait|crouch gait
412928|NCT01381185|myocardial infarction|myocardial infarction
412929|NCT01381185|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
412930|NCT01381185|high platelet reactivity (HPR)|high platelet reactivity (hpr)
412931|NCT01381172|Heart Failure|heart failure
412932|NCT01381172|Congestive Heart Failure|congestive heart failure
412933|NCT01381172|Chronic heart disease|chronic heart disease
412934|NCT01381172|Cardiac contractility modulation|cardiac contractility modulation
412935|NCT01381172|CCM|ccm
412936|NCT01381172|CHF|chf
412937|NCT01381159|Adherence|adherence
412938|NCT01381159|Asthma Control|asthma control
412939|NCT01381159|Asthma Quality Of Life|asthma quality of life
412940|NCT01381159|Motivational Communication|motivational communication
412941|NCT01381159|Motivational Interviewing|motivational interviewing
412942|NCT01381146|criminal behavior|criminal behavior
412943|NCT01381146|substance abuse|substance abuse
412944|NCT01381146|HIV risk behavior|hiv risk behavior
412945|NCT01381146|criminogenic thinking|criminogenic thinking
412946|NCT01381146|shame|shame
412947|NCT01381146|guilt|guilt
412948|NCT01381146|empathy|empathy
412949|NCT01381146|jail inmates|jail inmates
412950|NCT01381146|restorative justice|restorative justice
412951|NCT01381146|Crime|crime
412952|NCT01381133|Substance abuse|substance abuse
412953|NCT01381133|Adolescent outpatient treatment|adolescent outpatient treatment
412954|NCT01381133|Continuing care|continuing care
412955|NCT01381133|Outcomes|outcomes
412956|NCT01381120|Flank Pain|flank pain
412957|NCT01381120|Lower Urinary Tract Symptoms|lower urinary tract symptoms
412958|NCT01381120|LUTS|luts
412959|NCT01381120|Urgency|urgency
412960|NCT01381120|Nocturia|nocturia
412961|NCT01381120|Frequency|frequency
412962|NCT01381120|Ureteroscopy|ureteroscopy
412963|NCT01381120|Kidney Stones|kidney stones
412964|NCT01381120|Stent|stent
412965|NCT01381120|Incontinence|incontinence
412966|NCT01381120|VESIcare|vesicare
412967|NCT01381120|Ureter|ureter
412968|NCT01381120|Urinary Bladder, Overactive|urinary bladder, overactive
412969|NCT01381120|OAB|oab
412970|NCT01381120|Overactive Bladder Syndrome|overactive bladder syndrome
412971|NCT01381094|anemia|anemia
412972|NCT01381094|chronic kidney disease|chronic kidney disease
412973|NCT01381094|CKD|ckd
412974|NCT01381094|chronic renal insufficiency|chronic renal insufficiency
412975|NCT01381094|renal impairment|renal impairment
412976|NCT01381094|erythropoietin|erythropoietin
412977|NCT01381094|safety|safety
412978|NCT01381094|efficacy|efficacy
412979|NCT01381094|tolerability|tolerability
412980|NCT01381094|pharmacokinetics|pharmacokinetics
412981|NCT01381081|knee osteoarthritis|knee osteoarthritis
412982|NCT01381081|comparing platelet-rich plasma|comparing platelet-rich plasma
412983|NCT01381081|intra-articular knee injections|intra-articular knee injections
412984|NCT01381068|ventilation|ventilation
412985|NCT01381068|end tidal carbon dioxide|end tidal carbon dioxide
412986|NCT01381068|hypercapnia|hypercapnia
412987|NCT01381068|hypocapnia|hypocapnia
412988|NCT01381068|positive pressure ventilation|positive pressure ventilation
412989|NCT01381068|neonates|neonates
412990|NCT01381068|delivery room resuscitation|delivery room resuscitation
412991|NCT01381055|Cutaneous leishmaniasis|cutaneous leishmaniasis
412992|NCT01381055|Pentoxifylline|pentoxifylline
412993|NCT01381055|Meglumine antimoniate|meglumine antimoniate
412994|NCT01381055|L. braziliensis|l. braziliensis
412995|NCT01381042|Brown Adipose Tissue|brown adipose tissue
412996|NCT01381042|Incidence|incidence
412997|NCT01381042|Factor|factor
412998|NCT01381042|Human|human
412999|NCT01381016|LH pulsatility|lh pulsatility
413000|NCT01381016|Obesity|obesity
413001|NCT01381016|Reproduction|reproduction
413002|NCT01381003|Chronic Granulomatous Disease|chronic granulomatous disease
413003|NCT01381003|Gene therapy|gene therapy
413004|NCT01381003|X-CGD|x-cgd
413005|NCT01381003|NADPH-oxidase|nadph-oxidase
413006|NCT01381003|gp91-phox|gp91-phox
413007|NCT01380977|crime|crime
413008|NCT01380977|substance abuse|substance abuse
413009|NCT01380977|HIV risk|hiv risk
413010|NCT01380977|criminogenic thinking|criminogenic thinking
413011|NCT01380977|shame|shame
413012|NCT01380977|guilt|guilt
413013|NCT01380977|restorative justice|restorative justice
413014|NCT01380977|victim impact group|victim impact group
413015|NCT01380964|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
413016|NCT01380964|biomarkers|biomarkers
413017|NCT01380964|transcriptomics|transcriptomics
413018|NCT01380964|mironics|mironics
413019|NCT01380964|proteomics|proteomics
413020|NCT01380951|liver cirrhosis|liver cirrhosis
413021|NCT01380951|chronic hepatitis B|chronic hepatitis b
413022|NCT01380951|antiviral therapy|antiviral therapy
413023|NCT01380951|telbivudine|telbivudine
413024|NCT01380938|genotypes 2 and 3|genotypes 2 and 3
413025|NCT01380938|combination treatment|combination treatment
413026|NCT01380938|individualized treatment|individualized treatment
413027|NCT01380912|breast cancer|breast cancer
413028|NCT01380912|mastectomy|mastectomy
413029|NCT01380912|methylprednisoloneacetate|methylprednisoloneacetate
413030|NCT01380912|seroma|seroma
413031|NCT01380912|numbers of punctures|numbers of punctures
413032|NCT01380899|Parkinson Disease|parkinson disease
413033|NCT01380899|Parkinsonian Disorders|parkinsonian disorders
413034|NCT01380899|Lewy Bodies|lewy bodies
413035|NCT01380899|alpha-Synuclein|alpha-synuclein
413036|NCT01380860|mesh|mesh
413037|NCT01380860|hernia|hernia
413038|NCT01380847|Kidney Transplantation|kidney transplantation
413039|NCT01380847|Allograft|allograft
413040|NCT01380847|Kidney failure|kidney failure
413041|NCT01380847|Chronic allograft nephropathy|chronic allograft nephropathy
413042|NCT01380847|Monitoring|monitoring
413043|NCT01380847|Urine|urine
413044|NCT01380834|paravertebral nerve blocks|paravertebral nerve blocks
413045|NCT01380834|laparoscopic cholecystectomy|laparoscopic cholecystectomy
413046|NCT01380821|clinical indication for myocardial SPECT|clinical indication for myocardial spect
413047|NCT01380821|suspected or known coronary artery disease|suspected or known coronary artery disease
413048|NCT01380795|non-small cell lung cancer carcinoma|non-small cell lung cancer carcinoma
413049|NCT01380795|circulating tumor cells|circulating tumor cells
413050|NCT01380795|EGFR|egfr
413051|NCT01380795|K-ras|k-ras
413052|NCT01380782|brain tumor|brain tumor
413053|NCT01380782|recurrent disease|recurrent disease
413054|NCT01380756|Amgen|amgen
413055|NCT01380756|Phase 1|phase 1
413056|NCT01380756|Clinical Trial|clinical trial
413057|NCT01380756|Aurora kinase inhibitor|aurora kinase inhibitor
413058|NCT01380756|Open label|open label
413059|NCT01380756|Oncology|oncology
413060|NCT01380756|Hematology|hematology
413061|NCT01380743|Pompe disease|pompe disease
413062|NCT01380730|Hypercholesterolemia|hypercholesterolemia
413063|NCT01380730|Proprotein convertase subtilisin/kexin type 9 (PCSK9)|proprotein convertase subtilisin/kexin type 9 (pcsk9)
413064|NCT01380704|Depression|depression
413065|NCT01380678|bevacizumab|bevacizumab
413066|NCT01380678|pterygium|pterygium
413067|NCT01380678|treatment|treatment
413068|NCT01380678|elevation|elevation
413069|NCT01380665|Prevena|prevena
413070|NCT01380665|Incision|incision
413071|NCT01380665|Management|management
413072|NCT01380665|System|system
413073|NCT01380665|total|total
413074|NCT01380665|knee|knee
413075|NCT01380665|hip|hip
413076|NCT01380665|replacement|replacement
413077|NCT01380665|Surgery|surgery
413078|NCT01380665|Negative|negative
413079|NCT01380665|Pressure|pressure
413080|NCT01380665|dressing|dressing
413081|NCT01380665|KCI|kci
413082|NCT01380652|COPD III/IV|copd iii/iv
413083|NCT01380652|Activity Monitoring|activity monitoring
413084|NCT01380652|SenseWear|sensewear
413085|NCT01380652|Vibration training|vibration training
413086|NCT01380652|Galileo|galileo
413087|NCT01380652|Pulmonary rehabilitation|pulmonary rehabilitation
413088|NCT01380639|COPD III/IV|copd iii/iv
413089|NCT01380639|6-Minutes-Walking-Distance|6-minutes-walking-distance
413090|NCT01380639|Vibration training|vibration training
413091|NCT01380639|Galileo|galileo
413092|NCT01380639|Pulmonary rehabilitation|pulmonary rehabilitation
413093|NCT01380626|alpha-1-antitrypsin-deficiency|alpha-1-antitrypsin-deficiency
413094|NCT01380626|COPD|copd
413095|NCT01380626|exercise training|exercise training
413096|NCT01380626|muscle biopsy|muscle biopsy
413097|NCT01380613|HIV|hiv
413098|NCT01380613|depression|depression
413099|NCT01380613|drug use,|drug use,
413100|NCT01380613|risk reduction|risk reduction
413101|NCT01380600|Vaccinia|vaccinia
413102|NCT01380600|Vaccinia Virus|vaccinia virus
413103|NCT01380600|JX-594|jx-594
413104|NCT01380600|Jennerex|jennerex
413105|NCT01380600|Colorectal Carcinoma|colorectal carcinoma
413106|NCT01380600|Colorectal cancer|colorectal cancer
413107|NCT01380600|Colon Cancer|colon cancer
413108|NCT01380600|Rectal Cancer|rectal cancer
413109|NCT01380600|Pexa-Vec|pexa-vec
413110|NCT01380587|ALL|all
413111|NCT01380587|XCL1|xcl1
413112|NCT01380587|Cytokines|cytokines
413113|NCT01380587|Prognosis|prognosis
413114|NCT01380574|atrial fibrillation|atrial fibrillation
413115|NCT01380574|cardioversion|cardioversion
413116|NCT01380574|stroke|stroke
413117|NCT01380574|thromboembolism|thromboembolism
413118|NCT01380561|asimadoline|asimadoline
413119|NCT01380561|pharmacokinetic|pharmacokinetic
413120|NCT01380561|excretion of 14C-derived radioactivity|excretion of 14c-derived radioactivity
413121|NCT01380561|metabolite profile|metabolite profile
413122|NCT01380561|14C-asimadoline|14c-asimadoline
413123|NCT01380561|metabolites|metabolites
413224|NCT01380093|recreational opioid use|recreational opioid use
413124|NCT01380561|single and multiple oral doses|single and multiple oral doses
413125|NCT01380535|Extracorporeal photopheresis therapy|extracorporeal photopheresis therapy
413126|NCT01380535|Methoxsalen|methoxsalen
413127|NCT01380535|UVADEX|uvadex
413128|NCT01380535|Chronic graft versus host disease (cGvHD): National Institute Health Consensus Criteria|chronic graft versus host disease (cgvhd): national institute health consensus criteria
413129|NCT01380522|Bioequivalence, single-dose, fed|bioequivalence, single-dose, fed
413130|NCT01380509|Bioequivalence, single-dose, fasting|bioequivalence, single-dose, fasting
413131|NCT01380496|bioequivalence|bioequivalence
413132|NCT01380496|doxycycline monohydrate|doxycycline monohydrate
413133|NCT01380496|fed|fed
413134|NCT01380483|bioequivalence|bioequivalence
413135|NCT01380483|doxycycline monohydrate|doxycycline monohydrate
413136|NCT01380483|fasting|fasting
413137|NCT01380470|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
413138|NCT01380470|Diagnosis differential|diagnosis differential
413139|NCT01380470|Dyspnea/classification|dyspnea/classification
413140|NCT01380470|Dyspnea/etiology|dyspnea/etiology
413141|NCT01380457|bioequivalence|bioequivalence
413142|NCT01380457|dronabinol|dronabinol
413143|NCT01380457|fasting|fasting
413144|NCT01380444|Intertrochanteric fracture|intertrochanteric fracture
413145|NCT01380444|Gamma3 intramedullary nail|gamma3 intramedullary nail
413146|NCT01380444|Sliding hip screw|sliding hip screw
413147|NCT01380431|bioequivalence, lisinopril, fed|bioequivalence, lisinopril, fed
413148|NCT01380418|Obesity|obesity
413149|NCT01380405|Inhalators|inhalators
413150|NCT01380405|Education|education
413151|NCT01380405|Primary care|primary care
413152|NCT01380392|Liver cancer|liver cancer
413153|NCT01380392|Uncertainty|uncertainty
413154|NCT01380392|Personality|personality
413155|NCT01380392|coping strategies|coping strategies
413156|NCT01380379|physical violence|physical violence
413157|NCT01380379|sexual violence|sexual violence
413158|NCT01380366|Malabsorption|malabsorption
413159|NCT01380353|Women undergoing total mastectomy|women undergoing total mastectomy
413160|NCT01380353|Breast cancer prevention|breast cancer prevention
413161|NCT01380340|Seniors|seniors
413162|NCT01380340|Driving|driving
413163|NCT01380340|Group work|group work
413164|NCT01380327|cockroach|cockroach
413165|NCT01380327|immunotherapy|immunotherapy
413166|NCT01380327|sublingual immunotherapy (SLIT)|sublingual immunotherapy (slit)
413167|NCT01380327|inner city asthma|inner city asthma
413168|NCT01380314|leishmaniasis|leishmaniasis
413169|NCT01380314|cutaneois leishmaniasis|cutaneois leishmaniasis
413170|NCT01380314|miltefosine|miltefosine
413171|NCT01380314|oral therapy|oral therapy
413172|NCT01380314|treatment|treatment
413173|NCT01380314|imiquimod|imiquimod
413174|NCT01380301|Leishmaniasis|leishmaniasis
413175|NCT01380301|Miltefosine|miltefosine
413176|NCT01380301|Antimony|antimony
413177|NCT01380301|Therapy|therapy
413178|NCT01380288|Alzheimer's disease|alzheimer's disease
413179|NCT01380288|rivastigmine patch|rivastigmine patch
413180|NCT01380288|white matter change|white matter change
413181|NCT01380275|recurrent, refractory, bone, soft tissue, sarcomas|recurrent, refractory, bone, soft tissue, sarcomas
413182|NCT01380262|Colorectal Cancer|colorectal cancer
413183|NCT01380262|Skin Rash|skin rash
413184|NCT01380262|Pre-emptive treatment|pre-emptive treatment
413185|NCT01380262|Doxycycline|doxycycline
413186|NCT01380262|Anti-EGFR antibody|anti-egfr antibody
413187|NCT01380262|Cetuximab|cetuximab
413188|NCT01380262|Panitumumab|panitumumab
413189|NCT01380249|Phase I|phase i
413190|NCT01380249|Phase I multiple doses|phase i multiple doses
413191|NCT01380249|PDM08|pdm08
413192|NCT01380249|Cancer Treatment|cancer treatment
413193|NCT01380249|Pharmacokinetics and Pharmacodynamics|pharmacokinetics and pharmacodynamics
413194|NCT01380249|Advanced Solid Tumors|advanced solid tumors
413195|NCT01380249|Prodimed|prodimed
413196|NCT01380210|Carbon dioxide intoxication|carbon dioxide intoxication
413197|NCT01380210|Diffusion weighted images(DWI)|diffusion weighted images(dwi)
413198|NCT01380197|pain|pain
413199|NCT01380197|sickle cell|sickle cell
413200|NCT01380197|nubain|nubain
413201|NCT01380197|morphine|morphine
413202|NCT01380197|acute chest|acute chest
413203|NCT01380197|side effects|side effects
413204|NCT01380184|Relapsed cancer|relapsed cancer
413205|NCT01380158|pessary|pessary
413206|NCT01380158|preterm birth|preterm birth
413207|NCT01380158|short cervix|short cervix
413208|NCT01380158|cervical incompetence|cervical incompetence
413209|NCT01380145|multiple myeloma|multiple myeloma
413210|NCT01380145|MAGE-A3|mage-a3
413211|NCT01380145|autologous stem cell transplant|autologous stem cell transplant
413212|NCT01380132|Fecal incontinence|fecal incontinence
413213|NCT01380132|Treatment|treatment
413214|NCT01380132|Surgery|surgery
413215|NCT01380119|sputum conversion|sputum conversion
413216|NCT01380119|liver biochemistry|liver biochemistry
413217|NCT01380119|weight loss|weight loss
413218|NCT01380119|quality of life|quality of life
413219|NCT01380106|Multiple myeloma|multiple myeloma
413220|NCT01380106|Relapsed|relapsed
413221|NCT01380106|Revlimid|revlimid
413222|NCT01380093|abuse potential|abuse potential
413223|NCT01380093|abuse liability|abuse liability
413225|NCT01380093|morphine|morphine
413226|NCT01380067|Inguinal hernia|inguinal hernia
413227|NCT01380067|Lateral umbilicus ligament|lateral umbilicus ligament
413228|NCT01380067|Recurrence|recurrence
413229|NCT01380054|Pulmonary Hypertension|pulmonary hypertension
413230|NCT01380054|Quality of life|quality of life
413231|NCT01380054|Coping|coping
413232|NCT01380054|Depression|depression
413233|NCT01380054|Anxiety|anxiety
413234|NCT01380054|Social support|social support
413235|NCT01380054|Control beliefs|control beliefs
413236|NCT01380041|Multiple sclerosisCerebrospinal fluidBiomarkerCytokineArray|multiple sclerosiscerebrospinal fluidbiomarkercytokinearray
413237|NCT01380028|chronic subdural hematomas|chronic subdural hematomas
413238|NCT01380028|corticosteroid|corticosteroid
413239|NCT01380028|treatment|treatment
413240|NCT01380028|neurosurgery|neurosurgery
413241|NCT01380028|recurrence, adjuvant|recurrence, adjuvant
413242|NCT01380015|osteoarthritis|osteoarthritis
413243|NCT01380015|spearmint|spearmint
413244|NCT01380015|rosmarinic acid|rosmarinic acid
413245|NCT01380002|care needs|care needs
413247|NCT01379976|cancer|cancer
413248|NCT01379976|non small cell lung cancer|non small cell lung cancer
413249|NCT01379976|Advanced or metastatic non small cell lung cancer|advanced or metastatic non small cell lung cancer
413250|NCT01379937|influenza|influenza
413251|NCT01379937|H5N1|h5n1
413252|NCT01379937|vaccine|vaccine
413253|NCT01379937|children|children
413254|NCT01379911|Satiety|satiety
413255|NCT01379911|Food intake|food intake
413256|NCT01379911|Yogurt|yogurt
413257|NCT01379898|Pheochromocytoma|pheochromocytoma
413258|NCT01379898|Doxazosin|doxazosin
413259|NCT01379898|Phenoxybenzamine|phenoxybenzamine
413260|NCT01379885|Pain|pain
413261|NCT01379885|immunization|immunization
413262|NCT01379885|distraction|distraction
413263|NCT01379885|hypnosis|hypnosis
413264|NCT01379885|injections|injections
413265|NCT01379885|anxiety|anxiety
413266|NCT01379872|Prostate|prostate
413267|NCT01379872|Head and Neck|head and neck
413268|NCT01379872|Anal|anal
413269|NCT01379846|Immunostimulation|immunostimulation
413270|NCT01379846|Haemophilus b conjugate vaccine|haemophilus b conjugate vaccine
413271|NCT01379846|HIB|hib
413272|NCT01379833|Chronic Inflammatory Demyelinating Polyneuropathy|chronic inflammatory demyelinating polyneuropathy
413273|NCT01379833|Neurotrophic corneal ulcer|neurotrophic corneal ulcer
413274|NCT01379820|NEONATAL RESPIRATORY FAILURE|neonatal respiratory failure
413275|NCT01379820|OROTRACHEAL cpap|orotracheal cpap
413276|NCT01379820|NASAL cpap|nasal cpap
413277|NCT01379820|MECHANICAL VENTILATION|mechanical ventilation
413278|NCT01379820|PNEUMOTHORAX|pneumothorax
413279|NCT01379820|COMPENSATION BAG|compensation bag
413280|NCT01379781|prevention|prevention
413281|NCT01379781|postpartum depression|postpartum depression
413282|NCT01379755|stability|stability
413283|NCT01379755|single-radius|single-radius
413284|NCT01379755|multi-radius|multi-radius
413285|NCT01379755|total knee arthroplasty|total knee arthroplasty
413286|NCT01379742|prostate cancer|prostate cancer
413287|NCT01379742|prostate brachytherapy|prostate brachytherapy
413288|NCT01379729|Type 1 Diabetes|type 1 diabetes
413289|NCT01379729|Transplantation|transplantation
413290|NCT01379729|Beta Cells|beta cells
413291|NCT01379729|Encapsulation|encapsulation
413292|NCT01379703|HIV-1 infected patients|hiv-1 infected patients
413293|NCT01379703|Protease inhibitor|protease inhibitor
413294|NCT01379703|Kaletra®|kaletra®
413295|NCT01379690|HbA1c|hba1c
413296|NCT01379677|Coronary Artery Disease|coronary artery disease
413297|NCT01379677|Myocardial perfusion imaging|myocardial perfusion imaging
413298|NCT01379677|Rubidium|rubidium
413299|NCT01379677|Technetium|technetium
413300|NCT01379664|Sevoflurane|sevoflurane
413301|NCT01379664|Isoflurane|isoflurane
413302|NCT01379664|volatile anesthetic|volatile anesthetic
413303|NCT01379664|duration of hospitalization|duration of hospitalization
413304|NCT01379651|Egg allergy,specific oral tolerance induction|egg allergy,specific oral tolerance induction
413305|NCT01379638|cardiopulmonary bypass|cardiopulmonary bypass
413306|NCT01379638|cardiac output|cardiac output
413307|NCT01379638|flow rate|flow rate
413308|NCT01379638|lactate|lactate
413309|NCT01379625|fatty acid oxidation|fatty acid oxidation
413310|NCT01379625|triheptanoin|triheptanoin
413311|NCT01379625|long-chain fatty acid oxidation disorders|long-chain fatty acid oxidation disorders
413312|NCT01379625|LCHADD|lchadd
413313|NCT01379625|VLCADD|vlcadd
413314|NCT01379625|CPT2|cpt2
413315|NCT01379625|TFP|tfp
413316|NCT01379612|Ultrasound elastography|ultrasound elastography
413317|NCT01379612|Rectal cancer|rectal cancer
413318|NCT01379612|Preoperative chemoradiation|preoperative chemoradiation
413319|NCT01379599|cocaine|cocaine
413320|NCT01379599|heroin|heroin
413321|NCT01379599|STIs|stis
413322|NCT01379599|HIV|hiv
413323|NCT01379599|brief motivational intervention|brief motivational intervention
413324|NCT01379599|voluntary testing and counseling|voluntary testing and counseling
413325|NCT01379586|ONO-4053|ono-4053
413326|NCT01379586|Healthy adult subjects|healthy adult subjects
413327|NCT01379586|First time in humans|first time in humans
413328|NCT01379573|hydroxychloroquine|hydroxychloroquine
413329|NCT01379573|Plaquenil|plaquenil
413330|NCT01379573|congenital heart block|congenital heart block
413331|NCT01379573|neonatal lupus|neonatal lupus
413332|NCT01379573|systemic lupus erythematosus|systemic lupus erythematosus
413333|NCT01379573|Sjogren's syndrome|sjogren's syndrome
413334|NCT01379573|autoantibodies|autoantibodies
413335|NCT01379573|SSA/Ro|ssa/ro
413336|NCT01379573|SSB/La|ssb/la
413337|NCT01379573|autoimmunity|autoimmunity
413338|NCT01379573|pregnancy|pregnancy
413339|NCT01379573|immunoglobulin|immunoglobulin
413340|NCT01379547|Procalcitonin|procalcitonin
413341|NCT01379547|sepsis|sepsis
413342|NCT01379547|ICU|icu
413343|NCT01379547|antibiotic|antibiotic
413344|NCT01379547|antibiotic duration|antibiotic duration
413345|NCT01379547|Antibiotic treatment duration|antibiotic treatment duration
413346|NCT01379534|Solid tumors,|solid tumors,
413347|NCT01379534|advanced endometrial cancer,|advanced endometrial cancer,
413348|NCT01379534|Endometrial Cancer,|endometrial cancer,
413349|NCT01379534|Second-line treatment,|second-line treatment,
413350|NCT01379534|VEGF,|vegf,
413351|NCT01379534|Neoplasms,|neoplasms,
413352|NCT01379534|Endometrial Neoplasms,|endometrial neoplasms,
413353|NCT01379534|Uterine Neoplasms,|uterine neoplasms,
413354|NCT01379534|Female Genital Neoplasms,|female genital neoplasms,
413355|NCT01379534|Cancer,|cancer,
413356|NCT01379534|Carcinoma,|carcinoma,
413357|NCT01379534|Uterine Diseases,|uterine diseases,
413358|NCT01379534|Female Genital Diseases,|female genital diseases,
413359|NCT01379534|Tumors,|tumors,
413360|NCT01379534|Oral Administration,|oral administration,
413361|NCT01379534|Capsules,|capsules,
413362|NCT01379534|Tablets,|tablets,
413363|NCT01379534|CHIR258,|chir258,
413364|NCT01379534|CHIR-258,|chir-258,
413365|NCT01379534|CHIR 258,|chir 258,
413366|NCT01379534|TKI258,|tki258,
413367|NCT01379534|TKI-258,|tki-258,
413368|NCT01379534|TKI 258|tki 258
413369|NCT01379521|Localised|localised
413370|NCT01379521|unresectable|unresectable
413371|NCT01379521|chemoembolization|chemoembolization
413372|NCT01379495|burns|burns
413373|NCT01379495|rehabilitation|rehabilitation
413374|NCT01379482|Peritoneal carcinomatosis from gastric cancer|peritoneal carcinomatosis from gastric cancer
413375|NCT01379469|Carbamazepine (Tegretol) use|carbamazepine (tegretol) use
413376|NCT01379469|severe liver disease|severe liver disease
413377|NCT01379469|alpha-1-antitrypsin deficiency|alpha-1-antitrypsin deficiency
413378|NCT01379443|Children|children
413379|NCT01379443|Rehabilitation|rehabilitation
413380|NCT01379443|Family Functioning|family functioning
413381|NCT01379443|Mental Health|mental health
413382|NCT01379443|Costs|costs
413383|NCT01379443|Integration|integration
413384|NCT01379430|Vaccine|vaccine
413385|NCT01379430|Immune response|immune response
413386|NCT01379417|Prematurity|prematurity
413387|NCT01379417|Nutrition|nutrition
413388|NCT01379417|Growth|growth
413389|NCT01379404|sepsis, fluid status, BIA, CVP|sepsis, fluid status, bia, cvp
413390|NCT01379391|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
413391|NCT01379391|Platelet Engraftment|platelet engraftment
413392|NCT01379391|TPO|tpo
413393|NCT01379365|wrinkle rhytid aging|wrinkle rhytid aging
413394|NCT01379352|liver transplantation|liver transplantation
413395|NCT01379352|vecuronium|vecuronium
413396|NCT01379339|Cabazitaxel|cabazitaxel
413397|NCT01379339|Cabazitaxel and Cisplatin|cabazitaxel and cisplatin
413398|NCT01379339|Phase I|phase i
413399|NCT01379339|PF Induction Chemotherapy|pf induction chemotherapy
413400|NCT01379339|Squamous Cell Carcinoma|squamous cell carcinoma
413401|NCT01379339|Head and Neck|head and neck
413402|NCT01379339|Sanofi-Aventis Oncology|sanofi-aventis oncology
413403|NCT01379339|Locally Advanced|locally advanced
413404|NCT01379313|laparoscopic gynecologic surgery|laparoscopic gynecologic surgery
413405|NCT01379313|gas exchange|gas exchange
413406|NCT01379313|inspiratory time|inspiratory time
413407|NCT01379313|expiratory time|expiratory time
413408|NCT01379313|I:E ratio|i:e ratio
413409|NCT01379300|Hemophilia B|hemophilia b
413410|NCT01379287|Iso-Fludelone|iso-fludelone
413411|NCT01379287|KOS-1803|kos-1803
413412|NCT01379287|Dose-Escalation|dose-escalation
413413|NCT01379287|10-202|10-202
413414|NCT01379274|MDS|mds
413415|NCT01379274|Low risk disease|low risk disease
413416|NCT01379274|IPSS|ipss
413417|NCT01379261|STEMI|stemi
413418|NCT01379261|primary PCI|primary pci
413419|NCT01379261|Hypothermia|hypothermia
413420|NCT01379261|Endovascular cooling|endovascular cooling
413421|NCT01379261|Cardiac MRI|cardiac mri
413422|NCT01379235|independent 65 years old and above|independent 65 years old and above
413423|NCT01379222|AAA|aaa
413424|NCT01379222|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
413425|NCT01379222|EVAR|evar
413426|NCT01379222|Endovascular aneurysm repair|endovascular aneurysm repair
413427|NCT01379209|AHSCT|ahsct
413428|NCT01379209|Bone Marrow Transplant|bone marrow transplant
413429|NCT01379209|Leukemia|leukemia
413430|NCT01379209|myelodysplastic syndrome|myelodysplastic syndrome
413431|NCT01379209|hematological malignancies|hematological malignancies
413432|NCT01379209|Graft-versus-host-disease|graft-versus-host-disease
413433|NCT01379209|GvHD|gvhd
413434|NCT01379209|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
413435|NCT01379209|Stem Cell|stem cell
413436|NCT01379209|Transplantation|transplantation
413437|NCT01379196|Graves Orbitopathy|graves orbitopathy
413438|NCT01379196|Macrolide antibiotics|macrolide antibiotics
413439|NCT01379196|Inflammation|inflammation
413440|NCT01379196|Clinical Activity Score|clinical activity score
413441|NCT01379183|Healthy|healthy
413442|NCT01379183|Men|men
413443|NCT01379183|Women|women
413444|NCT01379183|No known gastrointestinal disease|no known gastrointestinal disease
413445|NCT01379183|Aged between 18-70 years|aged between 18-70 years
413446|NCT01379170|brown adipose tissue|brown adipose tissue
413447|NCT01379170|mitochondrial dysfunction|mitochondrial dysfunction
413448|NCT01379170|insulin resistance|insulin resistance
413449|NCT01379157|Patients with ventilator-associated pneumonia|patients with ventilator-associated pneumonia
413450|NCT01379131|Manifestation|manifestation
413451|NCT01379131|Coronary Heart Disease|coronary heart disease
413452|NCT01379131|Myocardial infarction|myocardial infarction
413453|NCT01379131|Angina pectoris|angina pectoris
413454|NCT01379131|Unheralded|unheralded
413455|NCT01379131|General Practice Research Database|general practice research database
413456|NCT01379131|Myocardial Ischaemia National Audit Project|myocardial ischaemia national audit project
413457|NCT01379131|CALIBER|caliber
413458|NCT01379118|Total knee replacement|total knee replacement
413459|NCT01379105|Electromyography|electromyography
413460|NCT01379105|Muscle Stretching Exercises|muscle stretching exercises
413461|NCT01379105|Neuromuscular agents|neuromuscular agents
413462|NCT01379105|Sedentary Lifestyle|sedentary lifestyle
413463|NCT01379092|Radiography|radiography
413464|NCT01379092|Breast Specimen Imaging|breast specimen imaging
413465|NCT01379066|Mycobacterium tuberculosis|mycobacterium tuberculosis
413466|NCT01379066|Pulmonary tuberculosis|pulmonary tuberculosis
413467|NCT01379066|Electronic nose|electronic nose
413468|NCT01379066|Gas chromatography|gas chromatography
413469|NCT01379053|Staphylococcus aureus|staphylococcus aureus
413470|NCT01379053|Methicillin-resistant staphylococcus aureus|methicillin-resistant staphylococcus aureus
413471|NCT01379053|Nosocomial disease|nosocomial disease
413472|NCT01379053|Electronic nose|electronic nose
413473|NCT01379053|Gas chromatography|gas chromatography
413474|NCT01379040|Cystic Fibrosis|cystic fibrosis
413475|NCT01379040|Pseudomonas aeruginosa|pseudomonas aeruginosa
413476|NCT01379040|Volatile Organic Compounds|volatile organic compounds
413477|NCT01379040|Electronic nose|electronic nose
413478|NCT01379040|Gas Chromatography|gas chromatography
413479|NCT01379027|Depression|depression
413480|NCT01379027|Website intervention|website intervention
413481|NCT01379027|CBT|cbt
413482|NCT01379014|Decisional conflict|decisional conflict
413483|NCT01379014|Disclosure|disclosure
413484|NCT01379014|Mental Health history|mental health history
413485|NCT01379014|Mental health service users|mental health service users
413486|NCT01379014|Decision Aid Tool|decision aid tool
413487|NCT01379014|Vocational Specialists|vocational specialists
413488|NCT01379001|cholinergic function|cholinergic function
413489|NCT01379001|aging|aging
413490|NCT01379001|pharmacologic MRI|pharmacologic mri
413491|NCT01378949|pain score|pain score
413492|NCT01378936|criminal behavior|criminal behavior
413493|NCT01378936|substance abuse|substance abuse
413494|NCT01378936|HIV risk behavior|hiv risk behavior
413495|NCT01378936|criminogenic thinking|criminogenic thinking
413496|NCT01378936|shame|shame
413497|NCT01378936|guilt|guilt
413498|NCT01378936|empathy|empathy
413499|NCT01378936|jail inmates|jail inmates
413500|NCT01378936|restorative justice|restorative justice
413501|NCT01378936|crime|crime
413502|NCT01378923|Mindfulness|mindfulness
413503|NCT01378923|Values|values
413504|NCT01378923|Jail Inmates|jail inmates
413505|NCT01378923|Impulsivity|impulsivity
413506|NCT01378923|Substance Abuse|substance abuse
413507|NCT01378923|HIV risk behavior|hiv risk behavior
413508|NCT01378923|Anxiety|anxiety
413509|NCT01378923|Depression|depression
413510|NCT01378923|Criminogenic Thinking|criminogenic thinking
413511|NCT01378910|HIV|hiv
413512|NCT01378910|TROPISM|tropism
413513|NCT01378910|PBMC|pbmc
413514|NCT01378910|GENOTYPE|genotype
413515|NCT01378910|454 SEQUENCING|454 sequencing
413516|NCT01378897|bariatric surgery|bariatric surgery
413517|NCT01378897|gastric bypass surgery|gastric bypass surgery
413518|NCT01378884|Gastroparesis|gastroparesis
413519|NCT01378884|Domperidone|domperidone
413520|NCT01378884|Motilium|motilium
413521|NCT01378871|T Cell|t cell
413522|NCT01378871|T-Cell|t-cell
413523|NCT01378871|Leukemia|leukemia
413524|NCT01378871|Lymphoma|lymphoma
413525|NCT01378871|Leukemia/Lymphoma|leukemia/lymphoma
413526|NCT01378871|ATL|atl
413527|NCT01378858|Smoking|smoking
413528|NCT01378858|Substance-Related Disorders|substance-related disorders
413529|NCT01378858|medication adherence|medication adherence
413530|NCT01378858|Methadone|methadone
413531|NCT01378845|Morbus Raynaud|morbus raynaud
413532|NCT01378845|Ulcera Hands, Toes|ulcera hands, toes
413533|NCT01378845|Vasospastic disorder|vasospastic disorder
413534|NCT01378845|Raynaud's phenomenon|raynaud's phenomenon
413535|NCT01378832|Intra-abdominal abscess|intra-abdominal abscess
413536|NCT01378832|wound infection|wound infection
413537|NCT01378832|colorectal surgery|colorectal surgery
413538|NCT01378819|laparoscopic cholecystectomy|laparoscopic cholecystectomy
413539|NCT01378819|Postoperative pain|postoperative pain
413540|NCT01378806|overweight|overweight
413541|NCT01378806|obesity|obesity
413542|NCT01378806|adults|adults
413543|NCT01378806|children|children
413544|NCT01378793|Acupressure|acupressure
413545|NCT01378793|Insomnia|insomnia
413546|NCT01378793|Sleep Disorders|sleep disorders
413547|NCT01378780|Stroke|stroke
413548|NCT01378780|hypertension|hypertension
413549|NCT01378780|diet|diet
413550|NCT01378780|sodium|sodium
413551|NCT01378780|physical activity|physical activity
413552|NCT01378767|Dietary restriction|dietary restriction
413553|NCT01378767|oxidative stress|oxidative stress
413554|NCT01378767|fasting|fasting
413555|NCT01378754|hydrodilation|hydrodilation
413556|NCT01378754|general anesthetic|general anesthetic
413557|NCT01378741|delirium|delirium
413558|NCT01378741|cardiac surgery|cardiac surgery
413559|NCT01378741|postoperative sedation|postoperative sedation
413560|NCT01378728|Optical imaging|optical imaging
413561|NCT01378728|Fluorescence imaging|fluorescence imaging
413562|NCT01378728|Chronic and acute wounds|chronic and acute wounds
413563|NCT01378728|Wound bacteria|wound bacteria
413564|NCT01378728|Bacterial biofilms|bacterial biofilms
413565|NCT01378728|Pathogenic bacteria|pathogenic bacteria
413566|NCT01378728|Microorganisms|microorganisms
413567|NCT01378728|Wound infection|wound infection
413568|NCT01378728|Wound healing|wound healing
413569|NCT01378728|Treatment response assessment|treatment response assessment
413570|NCT01378715|coronary artery disease|coronary artery disease
413571|NCT01378715|percutaneous coronary intervention|percutaneous coronary intervention
413572|NCT01378715|statins|statins
413573|NCT01378715|periprocedural myocardial infarction|periprocedural myocardial infarction
413574|NCT01378702|Mistletoe|mistletoe
413575|NCT01378702|Anthroposophical medicine|anthroposophical medicine
413576|NCT01378663|Congenital cardiac surgery|congenital cardiac surgery
413577|NCT01378663|Postoperative pain management|postoperative pain management
413578|NCT01378650|Tinnitus|tinnitus
413579|NCT01378650|Medication therapy management|medication therapy management
413580|NCT01378650|Cilostazol|cilostazol
413581|NCT01378650|Antiplatelet agents|antiplatelet agents
413582|NCT01378637|Leg|leg
413583|NCT01378637|Robotic device|robotic device
413584|NCT01378637|AMES|ames
413585|NCT01378637|Stroke|stroke
413586|NCT01378637|Cerebrovascular Accident|cerebrovascular accident
413587|NCT01378637|Rehabilitation|rehabilitation
413588|NCT01378611|intractable childhood epilepsy|intractable childhood epilepsy
413589|NCT01378611|VNS|vns
413590|NCT01378611|immune system|immune system
413591|NCT01378598|erlotinib|erlotinib
413592|NCT01378598|educational intervention|educational intervention
413593|NCT01378598|direct care nurse|direct care nurse
413594|NCT01378585|DLBS1033|dlbs1033
413595|NCT01378585|safety|safety
413596|NCT01378585|fibrinolytic|fibrinolytic
413597|NCT01378585|fibrinogenolytic|fibrinogenolytic
413598|NCT01378585|antiplatelet|antiplatelet
413599|NCT01378572|ICD|icd
413600|NCT01378572|sudden cardiac death|sudden cardiac death
413601|NCT01378572|mapping|mapping
413602|NCT01378559|Penis prosthesis|penis prosthesis
413603|NCT01378559|Titan|titan
413604|NCT01378559|Satisfaction|satisfaction
413605|NCT01378559|Complications|complications
413606|NCT01378533|triple-negative breast cancer|triple-negative breast cancer
413607|NCT01378533|dose-dense|dose-dense
413608|NCT01378533|epirubicin and cyclophosphamide followed by paclitaxel（AC-T）|epirubicin and cyclophosphamide followed by paclitaxel（ac-t）
413609|NCT01378533|paclitaxel plus carboplatin（PC）|paclitaxel plus carboplatin（pc）
413610|NCT01378533|3 years DFS|3 years dfs
413611|NCT01378533|the tolerance|the tolerance
413612|NCT01378520|breathlessness|breathlessness
413613|NCT01378520|resistive load breathing|resistive load breathing
413614|NCT01378520|beta-endorphins|beta-endorphins
413615|NCT01378507|endoscopic submucosal dissection|endoscopic submucosal dissection
413616|NCT01378507|gastrointestinal neoplasm|gastrointestinal neoplasm
413617|NCT01378494|osteoporosis|osteoporosis
413618|NCT01378494|bone|bone
413619|NCT01378494|HIV|hiv
413620|NCT01378494|antiretrovirals|antiretrovirals
413621|NCT01378494|inflammation|inflammation
413622|NCT01378455|handwriting|handwriting
413623|NCT01378455|cerebral palsy|cerebral palsy
413624|NCT01378455|visual perception|visual perception
413625|NCT01378455|sensory function|sensory function
413626|NCT01378455|motor function|motor function
413627|NCT01378455|computerized handwriting programs|computerized handwriting programs
413628|NCT01378442|Cerebral palsy|cerebral palsy
413629|NCT01378442|bone density|bone density
413630|NCT01378442|bone strength|bone strength
413631|NCT01378429|Perennial Allergic Rhinitis|perennial allergic rhinitis
413632|NCT01378429|PAR|par
413633|NCT01378416|Acute myelogenous leukemia|acute myelogenous leukemia
413634|NCT01378416|myelodysplastic Syndrome|myelodysplastic syndrome
413635|NCT01378416|cancer|cancer
413636|NCT01378403|Schizophrenia|schizophrenia
413637|NCT01378403|Cognitive deficites|cognitive deficites
413638|NCT01378403|Degraded objects|degraded objects
413639|NCT01378403|Magnocellular pathway|magnocellular pathway
413640|NCT01378390|Complex perianal fistula|complex perianal fistula
413641|NCT01378390|Crohn disease|crohn disease
413642|NCT01378390|Adipose-derived stem cells|adipose-derived stem cells
413643|NCT01378390|Liposuction|liposuction
413644|NCT01378377|MEK inhibitor|mek inhibitor
413645|NCT01378377|Temsirolimus|temsirolimus
413646|NCT01378377|Solid Tumor|solid tumor
413647|NCT01378377|Phase I|phase i
413648|NCT01378377|Pimasertib|pimasertib
413649|NCT01378338|GERD|gerd
413650|NCT01378338|Comparison between ERD and NERD|comparison between erd and nerd
413651|NCT01378338|Rate of complete resolution|rate of complete resolution
413652|NCT01378338|rate of recurrence|rate of recurrence
413653|NCT01378338|QOL|qol
413654|NCT01378338|To investigate the frequency and related risk factors of recurrence, and quality of life in patients with GERD after treatment with PPI|to investigate the frequency and related risk factors of recurrence, and quality of life in patients with gerd after treatment with ppi
413655|NCT01378338|The aim of this study is to investigate the frequency and related risk factors of recurrence, and quality of life in patients with GERD after treatment with PPI|the aim of this study is to investigate the frequency and related risk factors of recurrence, and quality of life in patients with gerd after treatment with ppi
413656|NCT01378325|spinal|spinal
413657|NCT01378325|cesarean delivery|cesarean delivery
413658|NCT01378325|phenylephrine|phenylephrine
413659|NCT01378325|hypotension|hypotension
413660|NCT01378312|vaccine|vaccine
413661|NCT01378312|TB|tb
413662|NCT01378312|tuberculosis|tuberculosis
413663|NCT01378299|testosterone|testosterone
413664|NCT01378273|neuroprotection|neuroprotection
413665|NCT01378273|erythropoietin|erythropoietin
413666|NCT01378273|Epo|epo
413667|NCT01378273|ELGANs|elgans
413668|NCT01378273|preterm|preterm
413669|NCT01378273|neonate|neonate
413670|NCT01378260|Peripheral Arterial Disease|peripheral arterial disease
413671|NCT01378260|Claudication|claudication
413672|NCT01378260|Comparative Effectiveness Research|comparative effectiveness research
413673|NCT01378260|PAD Study|pad study
413674|NCT01378260|PAD|pad
413675|NCT01378260|atherosclerosis|atherosclerosis
413676|NCT01378260|Intermittent claudication|intermittent claudication
413677|NCT01378260|leg pain|leg pain
413678|NCT01378247|Heart Failure|heart failure
413679|NCT01378247|Family Nursing|family nursing
413680|NCT01378247|Health-Related Quality of Life|health-related quality of life
413681|NCT01378247|Heart Failure Clinic|heart failure clinic
413682|NCT01378221|vitamin D|vitamin d
413683|NCT01378221|cardiac surgery|cardiac surgery
413684|NCT01378221|inflammation|inflammation
413685|NCT01378221|immune system|immune system
413686|NCT01378221|age|age
413687|NCT01378208|Intermittent fasting|intermittent fasting
413688|NCT01378208|Meal frequency|meal frequency
413689|NCT01378208|body composition|body composition
413690|NCT01378208|cognitive function|cognitive function
413691|NCT01378208|glucose metabolism|glucose metabolism
413692|NCT01378195|Alzheimer's Disease|alzheimer's disease
413693|NCT01378195|Dementia|dementia
413694|NCT01378195|caregiving|caregiving
413695|NCT01378195|caregiver|caregiver
413696|NCT01378195|coping|coping
413697|NCT01378195|coping with caregiving|coping with caregiving
413698|NCT01378195|stress|stress
413699|NCT01378182|Transplantation,Stem Cell|transplantation,stem cell
413700|NCT01378182|Wilson's Disease|wilson's disease
413701|NCT01378169|SIRS|sirs
413702|NCT01378169|Sepsis|sepsis
413703|NCT01378169|Severe Sepsis|severe sepsis
413704|NCT01378169|Septic Shock|septic shock
413705|NCT01378169|Inflammatory processes|inflammatory processes
413706|NCT01378169|Cytokines|cytokines
413707|NCT01378169|HLA-DR|hla-dr
413708|NCT01378169|HLA type II|hla type ii
413709|NCT01378169|Chemokines|chemokines
413710|NCT01378169|TLR expression|tlr expression
413711|NCT01378169|mRNA expression in whole blood|mrna expression in whole blood
413712|NCT01378169|Bacterial DNA detection|bacterial dna detection
413713|NCT01378169|Prognosis factors|prognosis factors
413714|NCT01378169|Infection|infection
413715|NCT01378169|Diagnosis|diagnosis
413716|NCT01378156|Therapy for HIV Infection|therapy for hiv infection
413717|NCT01378156|Suppressive ART with no failures|suppressive art with no failures
413718|NCT01378156|Treatment interruption|treatment interruption
413719|NCT01378143|Colorectal Cancer|colorectal cancer
413720|NCT01378143|Pentamidine bis(2-hydroxyethanesulfonate)|pentamidine bis(2-hydroxyethanesulfonate)
413721|NCT01378143|OCZ103-OS|ocz103-os
413722|NCT01378143|Standard of Care|standard of care
413723|NCT01378130|CCS|ccs
413724|NCT01378130|CSC|csc
413725|NCT01378130|Subretinal Fluid|subretinal fluid
413726|NCT01378130|multimodal imaging|multimodal imaging
413727|NCT01378117|diabetes|diabetes
413728|NCT01378117|non critical care setting|non critical care setting
413729|NCT01378117|hyperglycemia|hyperglycemia
413730|NCT01378117|treatment|treatment
413731|NCT01378117|oral antidiabetic agents|oral antidiabetic agents
413732|NCT01378117|subcutaneous insulin|subcutaneous insulin
413733|NCT01378104|reducing dose of peginterferon|reducing dose of peginterferon
413734|NCT01378104|chronic hepatitis c|chronic hepatitis c
413735|NCT01378104|Koreans|koreans
413736|NCT01378104|IL28B polymorphism|il28b polymorphism
413737|NCT01378091|Androgen Independent Prostate Cancer|androgen independent prostate cancer
413738|NCT01378078|schizophrenia|schizophrenia
413739|NCT01378078|negative syndrome|negative syndrome
413740|NCT01378078|PANSS|panss
413741|NCT01378065|POP|pop
413742|NCT01378065|pelvic organ prolapse|pelvic organ prolapse
413743|NCT01378065|anterior prolapse|anterior prolapse
413744|NCT01378065|posterior prolapse|posterior prolapse
413745|NCT01378065|vaginal prolapse|vaginal prolapse
413746|NCT01378065|vaginal floor reconstruction|vaginal floor reconstruction
413747|NCT01378039|COPD|copd
413748|NCT01378039|Asthma|asthma
413749|NCT01378039|Pathophysiology|pathophysiology
413750|NCT01378039|Genetics|genetics
413751|NCT01378039|Phenotype|phenotype
413752|NCT01378039|Treatment response|treatment response
413753|NCT01378026|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
413754|NCT01378026|G72|g72
413755|NCT01378026|SNP|snp
413756|NCT01378013|Metabonomics|metabonomics
413757|NCT01378013|Systems biology|systems biology
413758|NCT01378013|Intelligent knife|intelligent knife
413759|NCT01378013|Colorectal cancer|colorectal cancer
413760|NCT01378013|NMR|nmr
413761|NCT01378013|Mass spectrometry|mass spectrometry
413762|NCT01377974|Leishmaniasis|leishmaniasis
413763|NCT01377974|Mucocutaneous Leishmaniasis|mucocutaneous leishmaniasis
413764|NCT01377974|Therapeutics|therapeutics
413765|NCT01377974|meglumine antimoniate|meglumine antimoniate
413766|NCT01377974|miltefosine|miltefosine
413767|NCT01377948|Anger|anger
413768|NCT01377948|Aggression|aggression
413769|NCT01377948|CBT|cbt
413770|NCT01377948|Videogame|videogame
413771|NCT01377948|biofeedback|biofeedback
413772|NCT01377909|chronic hepatitis C, interferon|chronic hepatitis c, interferon
413773|NCT01377883|Needle, Anxiety, Pain, Clowns|needle, anxiety, pain, clowns
413774|NCT01377870|multiple sclerosis mesenchymal stem cell intravenous injection|multiple sclerosis mesenchymal stem cell intravenous injection
413775|NCT01377844|Diabetes mellitus|diabetes mellitus
413776|NCT01377818|COPD|copd
413777|NCT01377818|Exercise trainig|exercise trainig
413778|NCT01377805|Multiple Sclerosis hydrocephalus|multiple sclerosis hydrocephalus
413779|NCT01377792|hypertonic saline|hypertonic saline
413780|NCT01377792|cystic fibrosis|cystic fibrosis
413781|NCT01377792|pulmonary inflammation|pulmonary inflammation
413782|NCT01377792|pulmonary exacerbation|pulmonary exacerbation
413783|NCT01377779|Oxiplex/AP gel|oxiplex/ap gel
413784|NCT01377779|Prevention of Asherman's syndrome|prevention of asherman's syndrome
413785|NCT01377779|Intra uterine adhesions|intra uterine adhesions
413786|NCT01377766|Bell's palsy|bell's palsy
413787|NCT01377766|psychological stress|psychological stress
413788|NCT01377766|personality factors|personality factors
413789|NCT01377766|psychological factors|psychological factors
413790|NCT01377753|Toxicity|toxicity
413791|NCT01377753|Thermal Ablation/Damage|thermal ablation/damage
413792|NCT01377753|Localized Prostate Cancer|localized prostate cancer
413793|NCT01377753|Laser Ablation|laser ablation
413794|NCT01377753|PSA Levels|psa levels
413795|NCT01377753|Prostate Cancer|prostate cancer
413796|NCT01377740|Lipolysis|lipolysis
413797|NCT01377740|Cryolipolysis|cryolipolysis
413798|NCT01377740|Fat Reduction|fat reduction
413799|NCT01377701|pituitary adenomas|pituitary adenomas
413800|NCT01377701|recovery of vision|recovery of vision
413801|NCT01377701|trans-sphenoidal surgery|trans-sphenoidal surgery
413802|NCT01377688|DKD|dkd
413803|NCT01377636|Isoproterenol|isoproterenol
413804|NCT01377636|Bispectral index (BIS)|bispectral index (bis)
413805|NCT01377636|electrophysiology studies (EPS)|electrophysiology studies (eps)
413806|NCT01377623|Spinal fusion|spinal fusion
413807|NCT01377623|Inflammatory response|inflammatory response
413808|NCT01377623|Inflammatory markers|inflammatory markers
413809|NCT01377623|Dexmedetomidine|dexmedetomidine
413810|NCT01377610|Outpatient detoxification|outpatient detoxification
413811|NCT01377610|Opioid dependence|opioid dependence
413812|NCT01377610|Naltrexone|naltrexone
413813|NCT01377610|Vivitrol|vivitrol
413814|NCT01377610|Buprenorphine|buprenorphine
413815|NCT01377597|retinal vein occlusion|retinal vein occlusion
413816|NCT01377597|branch retinal vein occlusion|branch retinal vein occlusion
413817|NCT01377597|central retinal vein occlusion|central retinal vein occlusion
413818|NCT01377597|visual impairment|visual impairment
413819|NCT01377597|macular edema|macular edema
413820|NCT01377597|ranibizumab|ranibizumab
413821|NCT01377584|Continuous Positive Airway Pressure|continuous positive airway pressure
413822|NCT01377584|Patient Compliance|patient compliance
413823|NCT01377584|Intervention Studies|intervention studies
413824|NCT01377584|Spouses|spouses
413825|NCT01377571|diarrhea|diarrhea
413826|NCT01377571|fever|fever
413827|NCT01377571|nausea|nausea
413828|NCT01377571|vomit|vomit
413829|NCT01377571|irritability|irritability
413830|NCT01377558|aerobic training|aerobic training
413831|NCT01377558|resistance training|resistance training
413832|NCT01377558|combination of aerobic and resistance training|combination of aerobic and resistance training
413833|NCT01377558|diabetes|diabetes
413834|NCT01377558|type 2 diabetes|type 2 diabetes
413835|NCT01377558|HbA1c|hba1c
413836|NCT01377558|endothelial dysfunction|endothelial dysfunction
413837|NCT01377558|inflammation markers|inflammation markers
413838|NCT01377558|Parodontitis|parodontitis
413839|NCT01377558|Exercise intervention|exercise intervention
413840|NCT01377558|training|training
413841|NCT01377545|Infraclavicular|infraclavicular
413842|NCT01377545|Nerve Block|nerve block
413843|NCT01377545|Needle|needle
413844|NCT01377545|Perineural Catheter|perineural catheter
413845|NCT01377545|Volunteer|volunteer
413846|NCT01377545|Upper Extremity Nerve Block|upper extremity nerve block
413847|NCT01377545|Sensation|sensation
413848|NCT01377545|Strength|strength
413849|NCT01377532|Pheochromocytoma|pheochromocytoma
413850|NCT01377532|Paraganglioma|paraganglioma
413851|NCT01377532|MIBG|mibg
413852|NCT01377532|131I-MIBG|131i-mibg
413853|NCT01377532|Resistant|resistant
413854|NCT01377532|Relapsed|relapsed
413855|NCT01377532|Treatment|treatment
413856|NCT01377532|UCSF|ucsf
413857|NCT01377532|Pediatric|pediatric
413858|NCT01377532|Adult|adult
413859|NCT01377532|Oncology|oncology
413860|NCT01377519|Fibroids|fibroids
413861|NCT01377519|Uterine|uterine
413862|NCT01377519|Focused Ultrasound|focused ultrasound
413863|NCT01377519|Magnetic Resonance focused ultrasound|magnetic resonance focused ultrasound
413864|NCT01377519|HIFU|hifu
413865|NCT01377519|NOninvasive|noninvasive
413866|NCT01377519|Treatment|treatment
413867|NCT01377506|behavioral weight control|behavioral weight control
413868|NCT01377506|lifestyle intervention|lifestyle intervention
413869|NCT01377506|memory training|memory training
413870|NCT01377506|cognitive training|cognitive training
413871|NCT01377506|community-based|community-based
413872|NCT01377493|chewing-gum|chewing-gum
413873|NCT01377493|enamel subsurface lesion|enamel subsurface lesion
413874|NCT01377493|calcium additives|calcium additives
413875|NCT01377493|fluoride|fluoride
413876|NCT01377493|in situ|in situ
413877|NCT01377467|Osteoporosis|osteoporosis
413878|NCT01377467|Osteopenia|osteopenia
413879|NCT01377467|Denosumab|denosumab
413880|NCT01377467|Transplantation|transplantation
413881|NCT01377467|Kidney|kidney
413882|NCT01377454|mTBI|mtbi
413883|NCT01377454|concussion|concussion
413884|NCT01377454|mild Traumatic Brain Injury|mild traumatic brain injury
413885|NCT01377454|balance|balance
413886|NCT01377454|sensors|sensors
413887|NCT01377441|Ibuprofen|ibuprofen
413888|NCT01377441|Cytokines|cytokines
413889|NCT01377441|Recovery|recovery
413890|NCT01377441|IV ibuprofen|iv ibuprofen
413891|NCT01377441|major surgery|major surgery
413892|NCT01377428|COPD|copd
413893|NCT01377428|Indacaterol|indacaterol
413894|NCT01377428|Formoterol|formoterol
413895|NCT01377415|arthroscopy|arthroscopy
413896|NCT01377415|shoulder surgery|shoulder surgery
413897|NCT01377415|subacromial|subacromial
413898|NCT01377415|continuous bupivacaine|continuous bupivacaine
413899|NCT01377389|Prostate cancer|prostate cancer
413900|NCT01377389|Castrate sensitive prostate carcinoma|castrate sensitive prostate carcinoma
413901|NCT01377389|Metastatic prostate carcinoma|metastatic prostate carcinoma
413902|NCT01377389|Androgen deprivation therapy|androgen deprivation therapy
413903|NCT01377389|ADT|adt
413904|NCT01377389|Prostate-specific antigen|prostate-specific antigen
413905|NCT01377389|PSA|psa
413906|NCT01377389|Ipilimumab|ipilimumab
413907|NCT01377389|Yervoy|yervoy
413908|NCT01377389|BMS-734016|bms-734016
413909|NCT01377389|MDX010|mdx010
413910|NCT01377389|Leuprolide|leuprolide
413911|NCT01377389|Lupron Depot|lupron depot
413912|NCT01377389|Leuprolide Acetate|leuprolide acetate
413913|NCT01377389|Goserelin|goserelin
413914|NCT01377389|Zoladex|zoladex
413915|NCT01377389|Degarelix|degarelix
413916|NCT01377389|Firmagon|firmagon
413917|NCT01377363|metastatic breast cancer|metastatic breast cancer
413918|NCT01377363|primary breast cancer|primary breast cancer
413919|NCT01377350|Heart failure|heart failure
413920|NCT01377350|monitoring|monitoring
413921|NCT01377337|cardiac arrest|cardiac arrest
413922|NCT01377337|cardiopulmonary resuscitation|cardiopulmonary resuscitation
413923|NCT01377337|(sodium) bicarbonate|(sodium) bicarbonate
413924|NCT01377337|return of spontaneous circulation|return of spontaneous circulation
413925|NCT01377337|outcome|outcome
413926|NCT01377324|Breast cancer|breast cancer
413927|NCT01377324|Fulvestrant|fulvestrant
413928|NCT01377324|FES|fes
413929|NCT01377324|PET|pet
413930|NCT01377324|Positron|positron
413931|NCT01377324|Emission|emission
413932|NCT01377324|Tomography|tomography
413933|NCT01377324|Fluoroestradiol|fluoroestradiol
413934|NCT01377324|FES-PET|fes-pet
413935|NCT01377324|Molecular Imaging|molecular imaging
413936|NCT01377324|Estrogen Receptor|estrogen receptor
413937|NCT01377311|limbal stem cell|limbal stem cell
413938|NCT01377311|amniotic membrane|amniotic membrane
413939|NCT01377311|ex vivo expansion of autologous limbal stem cell|ex vivo expansion of autologous limbal stem cell
413940|NCT01377311|unilateral limbal stem cell insufficiency|unilateral limbal stem cell insufficiency
413941|NCT01377285|chronic kidney disease|chronic kidney disease
413942|NCT01377285|pentoxifylline|pentoxifylline
413943|NCT01377285|angiotensin receptor blockers(ARB)|angiotensin receptor blockers(arb)
413944|NCT01377272|HIV/AIDS|hiv/aids
413945|NCT01377272|spatial epidemiology|spatial epidemiology
413946|NCT01377272|geographic information system|geographic information system
413947|NCT01377272|HIV-infection/Aids|hiv-infection/aids
413948|NCT01377259|changes|changes
413949|NCT01377259|tissue|tissue
413950|NCT01377259|oxygenation|oxygenation
413951|NCT01377259|saturation|saturation
413952|NCT01377259|between|between
413953|NCT01377259|upper|upper
413954|NCT01377259|lower|lower
413955|NCT01377259|extremities|extremities
413956|NCT01377259|patients|patients
413957|NCT01377259|Adverse Effect|adverse effect
413958|NCT01377259|Spinal and Epidural|spinal and epidural
413959|NCT01377246|Somatostatin.|somatostatin.
413960|NCT01377246|Polycystic kidney disease.|polycystic kidney disease.
413961|NCT01377246|Renal insufficiency.|renal insufficiency.
413962|NCT01377233|Schizophrenia|schizophrenia
413963|NCT01377233|Antipsychotic|antipsychotic
413964|NCT01377233|Zicronapine|zicronapine
413965|NCT01377233|Lu 31-310|lu 31-310
413966|NCT01377220|Hepatocellular carcinoma|hepatocellular carcinoma
413967|NCT01377220|Positron Emission Tomography/computed tomography (PET-CT)|positron emission tomography/computed tomography (pet-ct)
413968|NCT01377220|11C-Choline|11c-choline
413969|NCT01377220|alpha fetoprotein|alpha fetoprotein
413970|NCT01377220|Dynamic magnetic resonance imaging|dynamic magnetic resonance imaging
413971|NCT01377220|Abdomen computed tomography|abdomen computed tomography
413972|NCT01377220|Tumoral liver biopsy|tumoral liver biopsy
413973|NCT01377207|ST segment Elevation Myocardial Infarction|st segment elevation myocardial infarction
413974|NCT01377207|Optical Coherence Tomography|optical coherence tomography
413975|NCT01377207|Percutaneous Coronary Intervention|percutaneous coronary intervention
413976|NCT01377207|Thrombus hystopathology|thrombus hystopathology
413977|NCT01377207|Gender differences|gender differences
413978|NCT01377194|Depression|depression
413979|NCT01377194|Major Depressive Disorder|major depressive disorder
413980|NCT01377181|Inguinal hernia|inguinal hernia
413981|NCT01377181|Laparoscope|laparoscope
413982|NCT01377181|Lateral us ligament|lateral us ligament
413983|NCT01377181|Recurrence|recurrence
413984|NCT01377181|Pediatric|pediatric
413985|NCT01377181|unilateral inguinal hernia|unilateral inguinal hernia
413986|NCT01377155|basal insulin|basal insulin
413987|NCT01377155|hypoglycemia|hypoglycemia
413988|NCT01377155|diabetes mellitus type two|diabetes mellitus type two
413989|NCT01377142|Uterovaginal prolapse|uterovaginal prolapse
413990|NCT01377142|hysteropexy|hysteropexy
413991|NCT01377142|mesh|mesh
413992|NCT01377129|Residual Rotational Laxity|residual rotational laxity
413993|NCT01377103|heart failure|heart failure
413994|NCT01377103|hypogonadism|hypogonadism
413995|NCT01377103|testosterone|testosterone
413996|NCT01377077|vitiligo|vitiligo
413997|NCT01377077|piebaldism|piebaldism
413998|NCT01377077|punchgrafting|punchgrafting
413999|NCT01377077|minigrafting|minigrafting
414000|NCT01377077|stable for at least 12 months|stable for at least 12 months
414001|NCT01377064|HIV|hiv
414002|NCT01377064|physical activity|physical activity
414003|NCT01377064|cardiovascular disease risk|cardiovascular disease risk
414004|NCT01377051|COPD|copd
414005|NCT01377051|Inspiratory capacity|inspiratory capacity
414006|NCT01377051|Residual volume|residual volume
414007|NCT01377051|Total lung resistance|total lung resistance
414008|NCT01377051|Arterial Oxygen|arterial oxygen
414009|NCT01377038|Osteoarthritis|osteoarthritis
414010|NCT01377038|Chronic pain|chronic pain
414011|NCT01377038|Central pain|central pain
414012|NCT01377012|Rheumatoid Arthritis|rheumatoid arthritis
414014|NCT01377012|ACR|acr
414015|NCT01377012|inflammatory joints|inflammatory joints
414016|NCT01376999|Sterility|sterility
414017|NCT01376999|FSH-r|fsh-r
414018|NCT01376999|intrauterine insemination|intrauterine insemination
414019|NCT01376999|unexplained sterility|unexplained sterility
414020|NCT01376973|stress, temporomandibular disorders.|stress, temporomandibular disorders.
414021|NCT01376960|forefoot surgery|forefoot surgery
414022|NCT01376960|Ankle Block|ankle block
414023|NCT01376960|Popliteal Fossa Block|popliteal fossa block
414024|NCT01376947|IUD device insertion|iud device insertion
414025|NCT01376947|Nulliparous|nulliparous
414026|NCT01376947|Multiparous|multiparous
414027|NCT01376947|Pain|pain
414028|NCT01376934|hysteroscopy|hysteroscopy
414029|NCT01376934|saline solution|saline solution
414030|NCT01376934|carbon dioxide|carbon dioxide
414031|NCT01376934|compare two techniques in office hysteroscopy co2 and saline solution|compare two techniques in office hysteroscopy co2 and saline solution
414032|NCT01376921|Growth disorders|growth disorders
414033|NCT01376921|Saizen|saizen
414034|NCT01376921|Easypod|easypod
414035|NCT01376921|Growth hormone|growth hormone
414036|NCT01376921|Pediatric subject|pediatric subject
414037|NCT01376908|Phenylketonuria (PKU)|phenylketonuria (pku)
414038|NCT01376908|Kuvan® (Sapropterin)|kuvan® (sapropterin)
414039|NCT01376908|Phe-restricted diet|phe-restricted diet
414040|NCT01376908|Paediatric <4 years old|paediatric <4 years old
414041|NCT01376908|responders to BH4|responders to bh4
414042|NCT01376908|Phe tolerance|phe tolerance
414043|NCT01376895|Black MSM/W|black msm/w
414044|NCT01376895|HIV|hiv
414045|NCT01376882|Caffeine|caffeine
414046|NCT01376882|Withdrawal|withdrawal
414047|NCT01376882|Cognitive function|cognitive function
414048|NCT01376882|Mood|mood
414049|NCT01376882|Cerebral haemodynamics|cerebral haemodynamics
414050|NCT01376869|Hops|hops
414051|NCT01376869|Mood|mood
414052|NCT01376869|Cognitive Function|cognitive function
414053|NCT01376869|Bioavailability|bioavailability
414054|NCT01376869|Satiety|satiety
414055|NCT01376869|Blood Pressure|blood pressure
414056|NCT01376869|Heart rate|heart rate
414057|NCT01376856|mediastinal lymph node with false positive FDG PET/CT results in lung cancer staging|mediastinal lymph node with false positive fdg pet/ct results in lung cancer staging
414058|NCT01376843|latent tuberculosis in health care workers|latent tuberculosis in health care workers
414059|NCT01376830|COPD|copd
414060|NCT01376830|Exacerbations|exacerbations
414061|NCT01376830|Viruses|viruses
414062|NCT01376817|Severe acute pancreatitis|severe acute pancreatitis
414063|NCT01376817|total parenteral nutrition|total parenteral nutrition
414064|NCT01376817|fat emulsions|fat emulsions
414065|NCT01376817|omega 3 fatty acids|omega 3 fatty acids
414066|NCT01376791|Periodontal disease|periodontal disease
414067|NCT01376791|Atherosclerosis|atherosclerosis
414068|NCT01376791|Oral Pathogens|oral pathogens
414069|NCT01376791|Native Americans|native americans
414070|NCT01376791|Inflammatory cytokines|inflammatory cytokines
414071|NCT01376791|Microbial metagenomics|microbial metagenomics
414072|NCT01376778|Perinatology|perinatology
414073|NCT01376778|Cytomegalovirus immune globulin|cytomegalovirus immune globulin
414074|NCT01376778|Cytogam|cytogam
414075|NCT01376778|CMVIG infusions|cmvig infusions
414076|NCT01376765|SARS, coronavirus, vaccine, adjuvant, Alhydrogel®, severe acute respiratory syndrome|sars, coronavirus, vaccine, adjuvant, alhydrogel®, severe acute respiratory syndrome
414077|NCT01376739|Magnevist|magnevist
414078|NCT01376739|MR angiography|mr angiography
414079|NCT01376713|Melanoma|melanoma
414080|NCT01376687|Osteopathic Medicine|osteopathic medicine
414081|NCT01376687|Cervical Spine|cervical spine
414082|NCT01376687|Kinetics|kinetics
414083|NCT01376674|localised|localised
414084|NCT01376674|prostate cancer|prostate cancer
414085|NCT01376674|radiotherapy|radiotherapy
414086|NCT01376674|immunology|immunology
414087|NCT01376661|Prostate Cancer|prostate cancer
414088|NCT01376661|Active Surveillance|active surveillance
414089|NCT01376661|Low risk prostate cancer|low risk prostate cancer
414090|NCT01376635|Chronic Kidney Disease|chronic kidney disease
414091|NCT01376635|Autonomic Dysfunction|autonomic dysfunction
414092|NCT01376609|Stroke|stroke
414093|NCT01376609|Ischaemic Stroke|ischaemic stroke
414094|NCT01376609|Cerebral Infarction|cerebral infarction
414095|NCT01376609|Cerebrovascular Disorders|cerebrovascular disorders
414096|NCT01376609|Brain Diseases|brain diseases
414097|NCT01376609|Nervous System Diseases|nervous system diseases
414098|NCT01376609|Vascular Diseases|vascular diseases
414099|NCT01376609|Brain Infarction|brain infarction
414100|NCT01376609|Brain Ischemia|brain ischemia
414101|NCT01376609|mismatch|mismatch
414102|NCT01376609|PWI/DWI mismatch|pwi/dwi mismatch
414103|NCT01376609|ischaemic penumbra|ischaemic penumbra
414104|NCT01376609|image analysis|image analysis
414105|NCT01376596|Remission|remission
414106|NCT01376596|Psychosocial Functioning|psychosocial functioning
414107|NCT01376596|Symptoms reduction|symptoms reduction
414108|NCT01376583|Breast cancer|breast cancer
414109|NCT01376583|Exercise|exercise
414110|NCT01376583|Myokines|myokines
414111|NCT01376583|AMPK|ampk
414112|NCT01376570|HIV|hiv
414113|NCT01376570|Opiate dependence|opiate dependence
414114|NCT01376570|Opiate replacement therapy|opiate replacement therapy
414115|NCT01376570|Cocaine-related disorders|cocaine-related disorders
414116|NCT01376570|Risk Reduction Behavior|risk reduction behavior
414117|NCT01376570|Medication Adherence|medication adherence
414118|NCT01376570|Motivation|motivation
414119|NCT01376557|diabetes mellitus|diabetes mellitus
414120|NCT01376544|Neonate|neonate
414121|NCT01376544|Weaning|weaning
414122|NCT01376544|Assist control ventilation|assist control ventilation
414123|NCT01376544|Pressure support ventilation|pressure support ventilation
414124|NCT01376531|acute renal failure|acute renal failure
414125|NCT01376531|cerebrovascular autoregulation|cerebrovascular autoregulation
414126|NCT01376531|transcranial Doppler|transcranial doppler
414127|NCT01376531|continuous veno-venous hemodialysis|continuous veno-venous hemodialysis
414128|NCT01376518|acute respiratory distress syndrome|acute respiratory distress syndrome
414129|NCT01376518|acute lung injury|acute lung injury
414130|NCT01376518|cerebrovascular autoregulation|cerebrovascular autoregulation
414131|NCT01376518|transcranial Doppler|transcranial doppler
414132|NCT01376518|ventilation|ventilation
414133|NCT01376505|Vaccine Therapy|vaccine therapy
414134|NCT01376492|Schizophrenia|schizophrenia
414135|NCT01376492|Sleep disturbances|sleep disturbances
414136|NCT01376492|Quality of sleep|quality of sleep
414137|NCT01376492|Functioning level|functioning level
414138|NCT01376492|Antipsychotic therapy.|antipsychotic therapy.
414139|NCT01376479|HFMD|hfmd
414140|NCT01376479|EV71|ev71
414141|NCT01376479|Enterovirus|enterovirus
414142|NCT01376479|INV21|inv21
414143|NCT01376479|Encephalitis|encephalitis
414144|NCT01376466|acute appendicitis|acute appendicitis
414145|NCT01376466|diagnosis|diagnosis
414146|NCT01376466|computed tomography|computed tomography
414147|NCT01376453|External Radiation Therapy|external radiation therapy
414148|NCT01376453|Locally Advanced Rectal|locally advanced rectal
414149|NCT01376453|Adenocarcinoma|adenocarcinoma
414150|NCT01376440|three or more loss stools in 24 hours|three or more loss stools in 24 hours
414151|NCT01376414|dyspepsia|dyspepsia
414152|NCT01376414|abdominal|abdominal
414153|NCT01376414|pain|pain
414154|NCT01376414|helicobacter|helicobacter
414155|NCT01376414|pylori|pylori
414156|NCT01376414|[C06.405.748.398]|[c06.405.748.398]
414157|NCT01376414|[C06.405.748.586]|[c06.405.748.586]
414158|NCT01376414|[C06.405.748.586.698]|[c06.405.748.586.698]
414159|NCT01376414|[C06.405.748.586.849]|[c06.405.748.586.849]
414160|NCT01376388|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
414161|NCT01376388|Pharmacogenetics|pharmacogenetics
414162|NCT01376388|GSK573719/GW642444|gsk573719/gw642444
414163|NCT01376375|Acupuncture|acupuncture
414164|NCT01376375|Low Back Pain|low back pain
414165|NCT01376362|Cystoid Macular Edema|cystoid macular edema
414166|NCT01376362|Intermediate Uveitis|intermediate uveitis
414167|NCT01376362|Uveitis|uveitis
414168|NCT01376362|OCT|oct
414169|NCT01376362|Interferon-Gamma (IFN-Gamma)|interferon-gamma (ifn-gamma)
414170|NCT01376349|depression|depression
414171|NCT01376349|anxiety disorder|anxiety disorder
414172|NCT01376349|cognitive/functional effects|cognitive/functional effects
414173|NCT01376349|sexual dysfunction|sexual dysfunction
414174|NCT01376349|cancer survivor|cancer survivor
414175|NCT01376349|breast cancer|breast cancer
414176|NCT01376349|cervical cancer|cervical cancer
414177|NCT01376349|fallopian tube cancer|fallopian tube cancer
414178|NCT01376349|uterine sarcoma|uterine sarcoma
414179|NCT01376349|vaginal cancer|vaginal cancer
414180|NCT01376349|vulvar cancer|vulvar cancer
414181|NCT01376349|ovarian epithelial cancer|ovarian epithelial cancer
414182|NCT01376349|ovarian germ cell tumor|ovarian germ cell tumor
414183|NCT01376349|ovarian sarcoma|ovarian sarcoma
414184|NCT01376349|ovarian stromal cancer|ovarian stromal cancer
414185|NCT01376349|primary peritoneal cavity cancer|primary peritoneal cavity cancer
414186|NCT01376349|endometrial cancer|endometrial cancer
414187|NCT01376336|environmental health|environmental health
414188|NCT01376336|diarrhea|diarrhea
414189|NCT01376336|water|water
414190|NCT01376336|HIV|hiv
414191|NCT01376323|Safety|safety
414192|NCT01376323|Dose Ranging|dose ranging
414193|NCT01376323|Efficacy|efficacy
414194|NCT01376258|benign prostatic hyperplasia|benign prostatic hyperplasia
414195|NCT01376258|acute urinary retention|acute urinary retention
414196|NCT01376258|adherence|adherence
414197|NCT01376258|5-alpha reductase inhibitor|5-alpha reductase inhibitor
414198|NCT01376258|enlarged prostate|enlarged prostate
414199|NCT01376258|surgery|surgery
414200|NCT01376232|Anaemia|anaemia
414201|NCT01376232|Drug- Drug Interaction|drug- drug interaction
414202|NCT01376219|GINA|gina
414203|NCT01376219|direct / indirect costs|direct / indirect costs
414204|NCT01376219|exacerbations|exacerbations
414205|NCT01376219|European|european
414206|NCT01376219|asthma control|asthma control
414207|NCT01376219|Asthma Control Test (TM - QualityMetric Incorporated)|asthma control test (tm - qualitymetric incorporated)
414208|NCT01376102|osteoporosis|osteoporosis
414209|NCT01376102|ibandronate|ibandronate
414210|NCT01376089|Safety|safety
414211|NCT01376076|schizophrenia|schizophrenia
414212|NCT01376076|QTc|qtc
414213|NCT01376076|cardiac repolarization|cardiac repolarization
414214|NCT01376050|venous stasis ulcer|venous stasis ulcer
414215|NCT01376050|leg ulcer|leg ulcer
414216|NCT01376037|upper arm|upper arm
414217|NCT01376037|body contouring|body contouring
414218|NCT01376037|body shaping|body shaping
414219|NCT01376024|Carpometacarpal arthritis|carpometacarpal arthritis
414220|NCT01376024|Basal joint arthritis|basal joint arthritis
414221|NCT01376024|CMC arthritis|cmc arthritis
414222|NCT01376024|Osteoarthritis|osteoarthritis
414223|NCT01376011|quercetin|quercetin
414224|NCT01376011|brain blood flow|brain blood flow
414225|NCT01376011|aging|aging
414226|NCT01376011|memory|memory
414227|NCT01375998|YAZ|yaz
414228|NCT01375998|Dysmenorrhea|dysmenorrhea
414229|NCT01375972|biliary cancer|biliary cancer
414230|NCT01375972|systemic chemotherapy|systemic chemotherapy
414231|NCT01375972|S-1|s-1
414232|NCT01375972|gemcitabine|gemcitabine
414233|NCT01375972|cisplatin|cisplatin
414234|NCT01375959|resveratrol|resveratrol
414235|NCT01375959|glucose intolerance|glucose intolerance
414236|NCT01375959|insulin resistance|insulin resistance
414237|NCT01375959|endothelial function|endothelial function
414238|NCT01375946|Pharmacokinetic Profile (PK) and Safety|pharmacokinetic profile (pk) and safety
414239|NCT01375946|PK analysis of EE and LNG|pk analysis of ee and lng
414240|NCT01375933|Smoking|smoking
414241|NCT01375933|NicVAX|nicvax
414242|NCT01375933|Smoking vaccine|smoking vaccine
414243|NCT01375920|Depression|depression
414244|NCT01375920|Antiglucocorticoid|antiglucocorticoid
414245|NCT01375920|Anti-depressants|anti-depressants
414246|NCT01375907|blood cell counts|blood cell counts
414247|NCT01375907|BUN|bun
414248|NCT01375907|ALT|alt
414249|NCT01375907|AST|ast
414250|NCT01375907|diarrhea|diarrhea
414251|NCT01375907|fever|fever
414252|NCT01375907|vomit|vomit
414253|NCT01375907|nausea|nausea
414254|NCT01375907|loss of appetite|loss of appetite
414255|NCT01375907|irritability|irritability
414256|NCT01375881|HIV|hiv
414257|NCT01375881|darunavir|darunavir
414258|NCT01375881|ritonavir|ritonavir
414259|NCT01375881|Prezista|prezista
414261|NCT01375881|experienced|experienced
414262|NCT01375868|HPV|hpv
414263|NCT01375868|recurrent respiratory papillomatosis|recurrent respiratory papillomatosis
414264|NCT01375868|antibodies|antibodies
414265|NCT01375855|Late stent malapposition|late stent malapposition
414266|NCT01375855|stent thrombosis|stent thrombosis
414267|NCT01375855|IVUS|ivus
414268|NCT01375855|non-polimeric stent|non-polimeric stent
414269|NCT01375816|adenocarcinoma of the colon|adenocarcinoma of the colon
414270|NCT01375816|recurrent colon cancer|recurrent colon cancer
414271|NCT01375816|stage IV colon cancer|stage iv colon cancer
414272|NCT01375816|adenocarcinoma of the rectum|adenocarcinoma of the rectum
414273|NCT01375816|recurrent rectal cancer|recurrent rectal cancer
414274|NCT01375816|stage IV rectal cancer|stage iv rectal cancer
414275|NCT01375803|dietary fiber|dietary fiber
414276|NCT01375803|fiber|fiber
414277|NCT01375803|insulin sensitivity|insulin sensitivity
414278|NCT01375803|insulin resistance|insulin resistance
414279|NCT01375803|glucose metabolism|glucose metabolism
414280|NCT01375790|whole-body vibration|whole-body vibration
414281|NCT01375790|older people|older people
414282|NCT01375790|exercise|exercise
414283|NCT01375790|body balance|body balance
414284|NCT01375790|muscle performance|muscle performance
414285|NCT01375790|falls|falls
414286|NCT01375790|physiotherapy|physiotherapy
414287|NCT01375777|High cholesterol|high cholesterol
414288|NCT01375777|Proprotein convertase subtilisin/kexin type 9 (PCSK9)|proprotein convertase subtilisin/kexin type 9 (pcsk9)
414289|NCT01375777|Treatment for high cholesterol|treatment for high cholesterol
414290|NCT01375777|Lowering cholesterol|lowering cholesterol
414291|NCT01375777|Lowering high cholesterol|lowering high cholesterol
414292|NCT01375777|Hypercholesterolemia|hypercholesterolemia
414293|NCT01375764|Proprotein convertase subtilisin/kexin type 9 (PCSK9)|proprotein convertase subtilisin/kexin type 9 (pcsk9)
414294|NCT01375764|Cholesterol|cholesterol
414295|NCT01375764|High Cholesterol|high cholesterol
414296|NCT01375764|Raised Cholesterol|raised cholesterol
414297|NCT01375764|Elevated Cholesterol|elevated cholesterol
414298|NCT01375764|Statin intolerant|statin intolerant
414299|NCT01375764|Hypercholesterolemia|hypercholesterolemia
414300|NCT01375751|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
414301|NCT01375751|Proprotein convertase subtilisin/kexin type 9 (PCSK9)|proprotein convertase subtilisin/kexin type 9 (pcsk9)
414302|NCT01375738|Early gastric cancer|early gastric cancer
414303|NCT01375712|Hard or lumpy stools|hard or lumpy stools
414304|NCT01375712|Stool consistency|stool consistency
414305|NCT01375712|Stool frequency|stool frequency
414306|NCT01375712|Constipation related symptoms|constipation related symptoms
414307|NCT01375712|Constipation related quality of life|constipation related quality of life
414308|NCT01375699|Breast cancer|breast cancer
414309|NCT01375699|Gastrointestinal cancer|gastrointestinal cancer
414310|NCT01375699|Genitourinary cancer|genitourinary cancer
414311|NCT01375699|Sarcoma|sarcoma
414312|NCT01375699|Gynecologic cancer|gynecologic cancer
414313|NCT01375686|Diabetes|diabetes
414314|NCT01375673|Exercise|exercise
414315|NCT01375673|Heart Failure|heart failure
414316|NCT01375673|Mixed Effects Modeling|mixed effects modeling
414317|NCT01375660|Vitamin D|vitamin d
414318|NCT01375660|Glucose intolerance|glucose intolerance
414319|NCT01375660|African American men|african american men
414320|NCT01375647|Oral Vaccines|oral vaccines
414321|NCT01375647|Vaccine Responsiveness|vaccine responsiveness
414322|NCT01375647|Tropical Enteropathy|tropical enteropathy
414323|NCT01375634|Intubation|intubation
414324|NCT01375634|Gastrointestinal|gastrointestinal
414325|NCT01375621|Farming|farming
414326|NCT01375621|Antibiotic Resistant|antibiotic resistant
414327|NCT01375621|Bacteria|bacteria
414328|NCT01375608|Neutropenia|neutropenia
414329|NCT01375608|Hemaglobin|hemaglobin
414330|NCT01375608|Coagulation Disorders|coagulation disorders
414331|NCT01375608|Thrombocytosis|thrombocytosis
414332|NCT01375608|Red Blood Cells|red blood cells
414333|NCT01375608|Sickle Cell Disease|sickle cell disease
414334|NCT01375595|Working Memory|working memory
414335|NCT01375595|Repetitive TMS (rTMS)|repetitive tms (rtms)
414336|NCT01375595|Language|language
414337|NCT01375595|Healthy Volunteer|healthy volunteer
414338|NCT01375595|HV|hv
414339|NCT01375582|Dry Eye|dry eye
414340|NCT01375582|tear film|tear film
414341|NCT01375582|lipid|lipid
414342|NCT01375582|tear volume|tear volume
414343|NCT01375582|environmental chamber|environmental chamber
414344|NCT01375582|thermal imaging|thermal imaging
414345|NCT01375569|CD105|cd105
414346|NCT01375569|Monoclonal Antibody|monoclonal antibody
414347|NCT01375569|Anti-Angiogenic|anti-angiogenic
414348|NCT01375569|Chimeric|chimeric
414349|NCT01375569|Apoptosis|apoptosis
414350|NCT01375569|Liver Cancer|liver cancer
414351|NCT01375556|Alcohol Clamp|alcohol clamp
414352|NCT01375556|Pharmacogenetics|pharmacogenetics
414353|NCT01375556|Family History of Alcoholism|family history of alcoholism
414354|NCT01375556|Pharmacodynamics|pharmacodynamics
414355|NCT01375556|Healthy Volunteer|healthy volunteer
414356|NCT01375556|HV|hv
414357|NCT01375543|Gene Identification|gene identification
414358|NCT01375543|Genetics|genetics
414359|NCT01375543|Genetic Disorders|genetic disorders
414360|NCT01375530|Prevention|prevention
414361|NCT01375530|Vaccine|vaccine
414362|NCT01375530|Immunity|immunity
414363|NCT01375530|Evaluate|evaluate
414364|NCT01375530|Screen|screen
414365|NCT01375530|Healthy Volunteer|healthy volunteer
414366|NCT01375530|HV|hv
414367|NCT01375504|Obesity|obesity
414368|NCT01375504|Body Mass Index|body mass index
414369|NCT01375504|Mindfulness Training|mindfulness training
414370|NCT01375504|Attention and Interpretation Therapy|attention and interpretation therapy
414371|NCT01375491|doxycycline|doxycycline
414372|NCT01375491|insulin resistance|insulin resistance
414373|NCT01375491|obesity|obesity
414374|NCT01375491|inflammation|inflammation
414375|NCT01375439|Pregnancy|pregnancy
414376|NCT01375439|vulvovaginitis|vulvovaginitis
414377|NCT01375439|uterine cervicitis|uterine cervicitis
414378|NCT01375439|pregnancy outcome|pregnancy outcome
414379|NCT01375426|Non-severe pneumonia|non-severe pneumonia
414380|NCT01375426|Treatment failure|treatment failure
414381|NCT01375426|Double dose amoxicillin|double dose amoxicillin
414382|NCT01375426|Children|children
414383|NCT01375413|Parkinson's disease|parkinson's disease
414384|NCT01375413|Gait|gait
414385|NCT01375413|Rehabilitation|rehabilitation
414386|NCT01375413|Cognition|cognition
414387|NCT01375413|Freezing of gait|freezing of gait
414388|NCT01375400|aspirin|aspirin
414389|NCT01375400|platelet|platelet
414390|NCT01375387|Vimpat|vimpat
414391|NCT01375387|Pharmacokinetics|pharmacokinetics
414392|NCT01375387|Healthy Japanese male|healthy japanese male
414393|NCT01375387|Healthy Chinese male|healthy chinese male
414394|NCT01375374|Vimpat|vimpat
414395|NCT01375374|Partial seizures|partial seizures
414396|NCT01375374|Carbamazepine|carbamazepine
414397|NCT01375374|Hormone levels|hormone levels
414398|NCT01375374|Lipid levels|lipid levels
414399|NCT01375374|Lacosamide|lacosamide
414400|NCT01375361|albuterol|albuterol
414401|NCT01375348|Cognitive function|cognitive function
414402|NCT01375348|Experimental pain|experimental pain
414403|NCT01375335|Postoperative|postoperative
414404|NCT01375335|Dobutamine|dobutamine
414405|NCT01375335|Inotropes|inotropes
414406|NCT01375335|Stunning|stunning
414407|NCT01375335|Heart failure|heart failure
414408|NCT01375309|probiotics|probiotics
414409|NCT01375309|preterm infants|preterm infants
414410|NCT01375309|enteral feeding|enteral feeding
414411|NCT01375309|Bifidobacterium on enteral feeding|bifidobacterium on enteral feeding
414412|NCT01375270|diabetes|diabetes
414413|NCT01375270|incretin|incretin
414414|NCT01375270|beta-cell function|beta-cell function
414415|NCT01375270|glucolipotoxicity|glucolipotoxicity
414416|NCT01375270|glucagon-like peptide 1|glucagon-like peptide 1
414417|NCT01375270|glucose-dependent insulinotropic polypeptide|glucose-dependent insulinotropic polypeptide
414418|NCT01375244|bioequivalence|bioequivalence
414419|NCT01375244|lisinopril|lisinopril
414420|NCT01375244|fasting|fasting
414421|NCT01375205|atopic dermatitis|atopic dermatitis
414422|NCT01375205|skin care|skin care
414423|NCT01375179|Inflammatory Bowel disease|inflammatory bowel disease
414424|NCT01375179|Ulcerative colitis|ulcerative colitis
414425|NCT01375153|BNP administration|bnp administration
414426|NCT01375153|appetite|appetite
414427|NCT01375153|ghrelin|ghrelin
414428|NCT01375153|PYY|pyy
414429|NCT01375140|Myeloproliferative Diseases|myeloproliferative diseases
414430|NCT01375140|Myelofibrosis|myelofibrosis
414431|NCT01375140|Post essential thrombocythemia/polycythemia vera|post essential thrombocythemia/polycythemia vera
414432|NCT01375140|Ruxolitinib|ruxolitinib
414433|NCT01375140|INCB018424|incb018424
414434|NCT01375140|Lenalidomide|lenalidomide
414435|NCT01375140|CC-5013|cc-5013
414436|NCT01375140|Revlimid|revlimid
414437|NCT01375140|Prednisone|prednisone
414438|NCT01375140|Interactive Voice Response System|interactive voice response system
414439|NCT01375140|IVR|ivr
414440|NCT01375127|Observational|observational
414441|NCT01375127|clinical follow-up data|clinical follow-up data
414442|NCT01375114|Advanced Cancers|advanced cancers
414443|NCT01375114|Solid Tumors|solid tumors
414444|NCT01375114|Cancer related fatigue|cancer related fatigue
414445|NCT01375114|CRF|crf
414446|NCT01375114|Panax ginseng|panax ginseng
414447|NCT01375114|Placebo|placebo
414448|NCT01375114|Sugar pill|sugar pill
414449|NCT01375114|Functional Assessment of Chronic Illness Therapy-Fatigue|functional assessment of chronic illness therapy-fatigue
414450|NCT01375114|FACIT-F|facit-f
414451|NCT01375114|Quality of life|quality of life
414452|NCT01375114|QOL|qol
414453|NCT01375114|FACT-G|fact-g
414454|NCT01375114|Hospital Anxiety and Depression Inventory|hospital anxiety and depression inventory
414455|NCT01375114|Neurocognitive function|neurocognitive function
414456|NCT01375114|SDMT|sdmt
414457|NCT01375114|Global Symptom Evaluation|global symptom evaluation
414458|NCT01375114|GSE|gse
414459|NCT01375101|lichen planus|lichen planus
414460|NCT01375101|quercetin|quercetin
414461|NCT01375088|propolis|propolis
414462|NCT01375088|mucositis|mucositis
414463|NCT01375088|radiotherapy|radiotherapy
414464|NCT01375088|cancer|cancer
414465|NCT01375049|Cystic fibrosis|cystic fibrosis
414466|NCT01375049|CF|cf
414467|NCT01375049|PA|pa
414468|NCT01375049|Pseudomonas aeruginosa|pseudomonas aeruginosa
414469|NCT01375049|AZLI|azli
414470|NCT01375049|aztreonam|aztreonam
414471|NCT01375036|Cystic fibrosis|cystic fibrosis
414472|NCT01375036|PA|pa
414473|NCT01375036|Pseudomonas aeruginosa|pseudomonas aeruginosa
414474|NCT01375036|CF|cf
414475|NCT01375036|aztreonam|aztreonam
414476|NCT01375023|Allogenic Haematopoietic Cell Transplantation|allogenic haematopoietic cell transplantation
414477|NCT01375023|Total Lymphoid Irradiation|total lymphoid irradiation
414478|NCT01375023|Anti-Thymocyte Globulin|anti-thymocyte globulin
414479|NCT01375023|Triple Negative Breast Cancer|triple negative breast cancer
414480|NCT01375010|HIV|hiv
414481|NCT01375010|Postmenopausal women|postmenopausal women
414482|NCT01375010|Vitamin D|vitamin d
414483|NCT01374984|smallpox|smallpox
414484|NCT01374984|vaccination|vaccination
414485|NCT01374984|complications|complications
414486|NCT01374971|Rheumatoid Arthritis|rheumatoid arthritis
414487|NCT01374971|Cimzia|cimzia
414488|NCT01374971|Certolizumab Pegol|certolizumab pegol
414489|NCT01374971|Arthroscopic Synovial biopsy|arthroscopic synovial biopsy
414490|NCT01374971|Office Based Procedure|office based procedure
414491|NCT01374971|Biologic|biologic
414492|NCT01374971|Tumor Necrosis Factor (TNF)|tumor necrosis factor (tnf)
414493|NCT01374971|Anti-TNF|anti-tnf
414494|NCT01374932|Asthma|asthma
414495|NCT01374932|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
414496|NCT01374919|Intravenous iron|intravenous iron
414497|NCT01374919|ferumoxytol|ferumoxytol
414498|NCT01374919|iron deficiency anemia|iron deficiency anemia
414499|NCT01374919|Treatment of iron deficiency|treatment of iron deficiency
414500|NCT01374919|Intolerance of or ineffectiveness of oral iron|intolerance of or ineffectiveness of oral iron
414501|NCT01374906|SOM230|som230
414502|NCT01374906|Cushing's Disease|cushing's disease
414503|NCT01374906|Mean Urinary Free Cortisol|mean urinary free cortisol
414504|NCT01374906|Pasireotide|pasireotide
414505|NCT01374906|Pasireotide LAR|pasireotide lar
414506|NCT01374906|Pasireotide long-acting release|pasireotide long-acting release
414507|NCT01374906|secondary hypercortisolism|secondary hypercortisolism
414508|NCT01374906|secondary hypercorticism|secondary hypercorticism
414509|NCT01374906|Itsenko-Cushing disease|itsenko-cushing disease
414510|NCT01374906|increased secretion of adrenocorticotropic hormone (ACTH)|increased secretion of adrenocorticotropic hormone (acth)
414511|NCT01374906|hyperpituitarism|hyperpituitarism
414512|NCT01374893|Function, hospitalization, elderly|function, hospitalization, elderly
414513|NCT01374880|Heart failure|heart failure
414514|NCT01374880|Dyspnea|dyspnea
414515|NCT01374880|Heart disease|heart disease
414516|NCT01374880|Pulmonary disease|pulmonary disease
414517|NCT01374880|Natriuretic peptide|natriuretic peptide
414518|NCT01374880|Rehabilitation|rehabilitation
414519|NCT01374867|Cardiogenic shock|cardiogenic shock
414520|NCT01374867|Myocardial infarction|myocardial infarction
414521|NCT01374867|Low-output syndrome|low-output syndrome
414522|NCT01374867|Prognosis|prognosis
414523|NCT01374867|Biomarkers|biomarkers
414524|NCT01374867|Pathophysiology|pathophysiology
414525|NCT01374854|type 1 diabetes mellitus|type 1 diabetes mellitus
414526|NCT01374854|umbilical mesenchymal stem cell|umbilical mesenchymal stem cell
414527|NCT01374854|mononuclear cell|mononuclear cell
414528|NCT01374841|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
414529|NCT01374841|High-Risk Hematologic Neoplasms|high-risk hematologic neoplasms
414530|NCT01374841|Haploidentical Donors|haploidentical donors
414531|NCT01374841|Cyclophosphamide|cyclophosphamide
414532|NCT01374828|Toradol|toradol
414533|NCT01374828|Ketorolac|ketorolac
414534|NCT01374828|Normal saline|normal saline
414535|NCT01374828|Laparoscopic|laparoscopic
414536|NCT01374828|Postoperative pain control|postoperative pain control
414537|NCT01374828|Incisional analgesia|incisional analgesia
414538|NCT01374815|Children's diet quality|children's diet quality
414539|NCT01374815|Health-related social problems|health-related social problems
414540|NCT01374763|Naloxone|naloxone
414541|NCT01374763|Oxycodone|oxycodone
414542|NCT01374763|Constipation|constipation
414543|NCT01374763|Pain, postoperative|pain, postoperative
414544|NCT01374763|Physiological effects of drugs|physiological effects of drugs
414545|NCT01374763|Analgesics, Opioid|analgesics, opioid
414546|NCT01374724|Tobacco Use|tobacco use
414547|NCT01374724|Relapse Prevention|relapse prevention
414548|NCT01374724|Military|military
414549|NCT01374724|Smokeless Tobacco Use|smokeless tobacco use
414550|NCT01374724|Dual Use|dual use
414551|NCT01374711|Endotoxin|endotoxin
414552|NCT01374711|Inflammation|inflammation
414553|NCT01374711|Sepsis|sepsis
414554|NCT01374711|GM-CSF|gm-csf
414555|NCT01374711|IFN-y|ifn-y
414556|NCT01374698|PCI|pci
414557|NCT01374698|Aspirin|aspirin
414558|NCT01374698|Reload|reload
414559|NCT01374685|BRCA1|brca1
414560|NCT01374685|BRCA2|brca2
414561|NCT01374685|Breast Cancer|breast cancer
414562|NCT01374685|African American|african american
414563|NCT01374685|Women|women
414564|NCT01374659|124-I PET|124-i pet
414565|NCT01374659|FDG-PET|fdg-pet
414566|NCT01374659|PET/CT|pet/ct
414567|NCT01374659|recurrence|recurrence
414568|NCT01374659|differentiated thyroid carcinoma|differentiated thyroid carcinoma
414569|NCT01374659|diagnostic value|diagnostic value
414570|NCT01374646|Childhood Obesity|childhood obesity
414571|NCT01374646|Group Treatment|group treatment
414572|NCT01374646|Community-based Programs|community-based programs
414573|NCT01374633|Sevoflurane|sevoflurane
414574|NCT01374633|Brain injury|brain injury
414575|NCT01374633|Intra cranial pressure|intra cranial pressure
414576|NCT01374633|Sedation|sedation
414577|NCT01374633|Brain injury with initial Glasgow score less than 9|brain injury with initial glasgow score less than 9
414578|NCT01374620|Cancer|cancer
414579|NCT01374607|acute coronary syndrome|acute coronary syndrome
414580|NCT01374607|myocardial ischemia|myocardial ischemia
414581|NCT01374607|high-sensitivity cardiac troponin T|high-sensitivity cardiac troponin t
414582|NCT01374581|retreatment|retreatment
414583|NCT01374581|artemisinin-based combination|artemisinin-based combination
414584|NCT01374581|malaria|malaria
414585|NCT01374581|resistant|resistant
414586|NCT01374568|Type 2 diabetes|type 2 diabetes
414587|NCT01374568|sitagliptin|sitagliptin
414588|NCT01374568|Januvia|januvia
414589|NCT01374555|Coronary artery disease|coronary artery disease
414590|NCT01374542|Bronchoscopy|bronchoscopy
414591|NCT01374542|Thoracoscopy|thoracoscopy
414592|NCT01374516|Dengue Virus|dengue virus
414593|NCT01374516|Dengue fever|dengue fever
414594|NCT01374516|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
414595|NCT01374516|CYD dengue vaccine|cyd dengue vaccine
414596|NCT01374516|Flavivirus|flavivirus
414597|NCT01374516|Dengue Disease|dengue disease
414598|NCT01374490|HIV +|hiv +
414599|NCT01374490|HIV positive|hiv positive
414600|NCT01374490|HIV associated diarrhea|hiv associated diarrhea
414601|NCT01374490|AIDS|aids
414602|NCT01374490|Diarrhea|diarrhea
414603|NCT01374477|Preeclampsia in Adolescence|preeclampsia in adolescence
414604|NCT01374477|Adolescent|adolescent
414605|NCT01374477|Primipaternity|primipaternity
414606|NCT01374464|Interscalene brachial plexus nerve block|interscalene brachial plexus nerve block
414607|NCT01374464|Nerve block|nerve block
414608|NCT01374451|Pancreatic|pancreatic
414609|NCT01374451|Neuroendocrine tumors|neuroendocrine tumors
414610|NCT01374451|PNET|pnet
414611|NCT01374451|Pasireotide|pasireotide
414612|NCT01374451|Everolimus|everolimus
414613|NCT01374451|Advanced progressive pancreatic neuroendocrine tumor|advanced progressive pancreatic neuroendocrine tumor
414614|NCT01374438|Alzheimer's disease|alzheimer's disease
414615|NCT01374438|cognitive function|cognitive function
414616|NCT01374438|brain glucose utilization|brain glucose utilization
414617|NCT01374438|FDG-PET|fdg-pet
414618|NCT01374399|allogeneic stem cell transplantation|allogeneic stem cell transplantation
414619|NCT01374399|exercise|exercise
414620|NCT01374399|survival|survival
414621|NCT01374399|fatigue|fatigue
414622|NCT01374399|quality of life|quality of life
414623|NCT01374399|cancer|cancer
414624|NCT01374399|physical performance|physical performance
414625|NCT01374386|adolescent obesity|adolescent obesity
414626|NCT01374373|Chemotherapy|chemotherapy
414627|NCT01374373|Anemia|anemia
414628|NCT01374373|Epoetin alfa|epoetin alfa
414629|NCT01374373|Erythropoiesis stimulating agent (ESA)|erythropoiesis stimulating agent (esa)
414630|NCT01374360|PNH|pnh
414631|NCT01374360|Paroxysmal Nocturnal hemoglobinuria|paroxysmal nocturnal hemoglobinuria
414632|NCT01374360|Soliris|soliris
414633|NCT01374360|Eculizumab|eculizumab
414634|NCT01374308|NASVAC|nasvac
414635|NCT01374308|Pegylated Interferon-2b|pegylated interferon-2b
414636|NCT01374308|CHB|chb
414637|NCT01374269|NSAIDS (Nonsteroidal anti-inflammatory drugs)|nsaids (nonsteroidal anti-inflammatory drugs)
414638|NCT01374269|Exercise|exercise
414639|NCT01374269|Physiotherapy|physiotherapy
414640|NCT01374269|Subacute Low Back Pain|subacute low back pain
414641|NCT01374269|Pain|pain
414642|NCT01374269|Visual Analogue Scale|visual analogue scale
414643|NCT01374269|oswesrty|oswesrty
414644|NCT01374269|Roland Morris|roland morris
414645|NCT01374269|SF-36|sf-36
414646|NCT01374269|Quality of life|quality of life
414647|NCT01374256|carbapenem|carbapenem
414648|NCT01374256|sulbactam|sulbactam
414649|NCT01374256|Acinetobacter baumannii|acinetobacter baumannii
414650|NCT01374230|clinical outcomes|clinical outcomes
414651|NCT01374230|radiographic outcomes|radiographic outcomes
414652|NCT01374230|total knee arthroplasty|total knee arthroplasty
414653|NCT01374230|survivorship|survivorship
414654|NCT01374204|Epilepsy|epilepsy
414655|NCT01374204|Stigma|stigma
414656|NCT01374191|botox|botox
414657|NCT01374191|neuroma pain|neuroma pain
414658|NCT01374191|pain|pain
414659|NCT01374191|chronic pain|chronic pain
414660|NCT01374191|botulinum toxin|botulinum toxin
414661|NCT01374191|botulinum toxin A|botulinum toxin a
414662|NCT01374191|botox and pain|botox and pain
414663|NCT01374191|botox and neuroma|botox and neuroma
414664|NCT01374191|botox treatment|botox treatment
414665|NCT01374191|onabotulinum|onabotulinum
414666|NCT01374191|onabotulinum toxin|onabotulinum toxin
414667|NCT01374191|onabotulinum toxin type A|onabotulinum toxin type a
414668|NCT01374165|SCD|scd
414669|NCT01374152|stroke|stroke
414670|NCT01374152|upper extremity|upper extremity
414671|NCT01374152|rehabilitation|rehabilitation
414672|NCT01374152|perfetti|perfetti
414673|NCT01374139|Bosutinib|bosutinib
414674|NCT01374139|Bioequivalence and Food Effect Studies|bioequivalence and food effect studies
414675|NCT01374113|safinamide|safinamide
414676|NCT01374113|pharmacokinetics|pharmacokinetics
414677|NCT01374113|renal impairment|renal impairment
414678|NCT01374113|Moderate and Severe Renal Impairment|moderate and severe renal impairment
414679|NCT01374100|Qigong|qigong
414680|NCT01374100|Complementary Medicine|complementary medicine
414681|NCT01374100|Exercise|exercise
414682|NCT01374100|Traditional Chinese Medicine|traditional chinese medicine
414683|NCT01374100|Meditation|meditation
414684|NCT01374100|Standard Exercise|standard exercise
414685|NCT01374100|Chemotherapy|chemotherapy
414686|NCT01374100|Advanced cancer|advanced cancer
414687|NCT01374100|Quality of Life|quality of life
414688|NCT01374100|Functional Assessment of Cancer Therapy|functional assessment of cancer therapy
414689|NCT01374100|Hospital Anxiety and Depression Scale|hospital anxiety and depression scale
414690|NCT01374100|Anxiety|anxiety
414691|NCT01374100|Depression|depression
414692|NCT01374100|Cancer Nutrition-Rehabilitation Program|cancer nutrition-rehabilitation program
414693|NCT01374100|Edmonton Symptom Assessment Scale|edmonton symptom assessment scale
414694|NCT01374100|Simmonds Functional Assessment|simmonds functional assessment
414695|NCT01374087|Recurrent Prostate Carcinoma|recurrent prostate carcinoma
414696|NCT01374087|Brachytherapy|brachytherapy
414697|NCT01374087|Triptorelin|triptorelin
414698|NCT01374087|Hormone Therapy|hormone therapy
414699|NCT01374074|Barrett's Esophagus (BE)|barrett's esophagus (be)
414700|NCT01374074|Intestinal metaplasia|intestinal metaplasia
414701|NCT01374074|Gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
414702|NCT01374074|Racial Disparity|racial disparity
414703|NCT01374061|Emergency intubation|emergency intubation
414704|NCT01374061|Glide scope Ranger|glide scope ranger
414705|NCT01374061|Pre hospital|pre hospital
414706|NCT01374035|Health Service|health service
414707|NCT01374035|Coordination|coordination
414708|NCT01374035|Referral letters|referral letters
414709|NCT01374035|Mental Health|mental health
414710|NCT01374035|Adults|adults
414711|NCT01374022|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
414712|NCT01374022|Randomized Controlled Trial|randomized controlled trial
414713|NCT01374022|Respiration, Artificial|respiration, artificial
414714|NCT01373996|Invasive blood pressure monitoring|invasive blood pressure monitoring
414715|NCT01373996|Intensive care unit|intensive care unit
414716|NCT01373996|Wireless Technology|wireless technology
414717|NCT01373983|Neuropathic pain|neuropathic pain
414718|NCT01373983|Intrathecal analgesia|intrathecal analgesia
414719|NCT01373983|Ziconotide|ziconotide
414720|NCT01373983|Bolus|bolus
414721|NCT01373983|trauma|trauma
414722|NCT01373983|central|central
414723|NCT01373983|severe|severe
414724|NCT01373983|chronic|chronic
414725|NCT01373970|Functional Dyspepsia|functional dyspepsia
414726|NCT01373970|Protonpump inhibitor|protonpump inhibitor
414727|NCT01373970|Rebound Acid HyperSecretion|rebound acid hypersecretion
414728|NCT01373957|Acute Coronary Syndrome|acute coronary syndrome
414729|NCT01373957|antithrombotic management|antithrombotic management
414730|NCT01373957|STEMI|stemi
414731|NCT01373957|NSTE-ACS|nste-acs
414732|NCT01373944|MPI|mpi
414733|NCT01373944|SPECT|spect
414734|NCT01373944|Stress-Only|stress-only
414735|NCT01373944|Spectrum Dynamics Camera|spectrum dynamics camera
414736|NCT01373944|Anger|anger
414737|NCT01373918|cholestasis|cholestasis
414738|NCT01373918|neonates|neonates
414739|NCT01373918|parenteral nutrition|parenteral nutrition
414740|NCT01373918|gastrointestinal disorders|gastrointestinal disorders
414741|NCT01373905|ARDS|ards
414742|NCT01373905|PEEP|peep
414743|NCT01373905|Recruitment maneuver|recruitment maneuver
414744|NCT01373879|Vaccine|vaccine
414745|NCT01373879|Immune response|immune response
414746|NCT01373866|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
414747|NCT01373866|Neuronavigation|neuronavigation
414748|NCT01373866|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
414749|NCT01373866|Diffusion Tensor Imaging|diffusion tensor imaging
414750|NCT01373853|Lens Fragmentation|lens fragmentation
414751|NCT01373853|Cataract|cataract
414752|NCT01373853|Phacoemulsification|phacoemulsification
414753|NCT01373853|Femtosecond Laser|femtosecond laser
414754|NCT01373840|focal|focal
414755|NCT01373840|dystonia|dystonia
414756|NCT01373840|dopamine|dopamine
414757|NCT01373840|receptor|receptor
414758|NCT01373827|VASER|vaser
414759|NCT01373827|VASERShape|vasershape
414760|NCT01373827|MC1|mc1
414761|NCT01373827|ultrasound|ultrasound
414762|NCT01373801|Postpartum women, after surgical repair of vaginal and cervical lacerations|postpartum women, after surgical repair of vaginal and cervical lacerations
414763|NCT01373775|Heart failure|heart failure
414764|NCT01373775|Revisit|revisit
414765|NCT01373775|Emergency room|emergency room
414766|NCT01373762|Adherence|adherence
414767|NCT01373762|Motivation|motivation
414768|NCT01373762|Health-related fitness|health-related fitness
414769|NCT01373762|Exercise videogames|exercise videogames
414770|NCT01373762|Physical Activity|physical activity
414771|NCT01373749|PPHN|pphn
414772|NCT01373749|NO inhalation|no inhalation
414773|NCT01373749|Sildenafil|sildenafil
414774|NCT01373749|Treatment|treatment
414775|NCT01373749|Safety|safety
414776|NCT01373723|Uterine Cervical Neoplasms|uterine cervical neoplasms
414777|NCT01373723|cancer screening|cancer screening
414778|NCT01373723|Costs and Cost Analysis|costs and cost analysis
414779|NCT01373723|cost-effectiveness analysis|cost-effectiveness analysis
414780|NCT01373723|Clinical Trial|clinical trial
414781|NCT01373723|Primary Health Care|primary health care
414782|NCT01373710|Adverse Reaction to Trastuzumab Administered by intrathecal|adverse reaction to trastuzumab administered by intrathecal
414783|NCT01373697|Ibuprofen|ibuprofen
414784|NCT01373697|muscle pain|muscle pain
414785|NCT01373697|sprains|sprains
414786|NCT01373697|contusions|contusions
414787|NCT01373697|tendonitis|tendonitis
414788|NCT01373684|Chronic hepatitis B|chronic hepatitis b
414789|NCT01373684|HBeAg-negative|hbeag-negative
414790|NCT01373671|Mammography|mammography
414791|NCT01373671|Screening|screening
414792|NCT01373671|Diagnostic|diagnostic
414793|NCT01373632|significant stenosis (>70% of lumen stenosis)|significant stenosis (>70% of lumen stenosis)
414794|NCT01373632|epicardial coronary arteries|epicardial coronary arteries
414795|NCT01373632|clinical ischemic|clinical ischemic
414796|NCT01373619|Heart failure with normal ejection fraction|heart failure with normal ejection fraction
414797|NCT01373619|hemodialysis patients|hemodialysis patients
414798|NCT01373619|ivabradine|ivabradine
414799|NCT01373619|Echocardiography|echocardiography
414800|NCT01373619|NYHA class|nyha class
414801|NCT01373619|6-minutes walking test|6-minutes walking test
414802|NCT01373593|persistent postherniorrhaphy pain|persistent postherniorrhaphy pain
414803|NCT01373580|presbyopia|presbyopia
414804|NCT01373580|LASIK|lasik
414805|NCT01373580|loss of accommodation|loss of accommodation
414806|NCT01373580|Emmetrope|emmetrope
414807|NCT01373567|Plaque Psoriasis|plaque psoriasis
414808|NCT01373528|Sinonasal Budesonide|sinonasal budesonide
414809|NCT01373528|Endoscopic sinus surgery|endoscopic sinus surgery
414810|NCT01373528|Hypothalamic-Pituitary-Adrenal Axis Function|hypothalamic-pituitary-adrenal axis function
414811|NCT01373515|DCOne|dcone
414812|NCT01373515|DCP-001|dcp-001
414813|NCT01373515|Second complete remission of AML|second complete remission of aml
414814|NCT01373515|Relapse AML|relapse aml
414815|NCT01373489|type 2 diabetes|type 2 diabetes
414816|NCT01373489|nurse case management|nurse case management
414817|NCT01373489|telemedicine|telemedicine
414818|NCT01373476|Diabetic Retinopathy|diabetic retinopathy
414819|NCT01373476|Traditional Chinese medicine|traditional chinese medicine
414820|NCT01373476|Diabetic Eye Problems|diabetic eye problems
414821|NCT01373476|Retinal Disorders|retinal disorders
414822|NCT01373463|resectable|resectable
414823|NCT01373437|Ultrasonography|ultrasonography
414824|NCT01373437|US|us
414825|NCT01373437|Confirming|confirming
414826|NCT01373437|Confirmation|confirmation
414827|NCT01373437|Proper|proper
414828|NCT01373437|Position|position
414829|NCT01373437|Endotracheal tube|endotracheal tube
414830|NCT01373437|ETT|ett
414831|NCT01373437|Emergency department|emergency department
414832|NCT01373437|ED|ed
414833|NCT01373437|Applicability|applicability
414834|NCT01373437|Accuracy|accuracy
414835|NCT01373424|Observational study|observational study
414836|NCT01373424|Cross-sectional and Prospective study|cross-sectional and prospective study
414837|NCT01373424|Cohort and case-control study|cohort and case-control study
414838|NCT01373411|CABG|cabg
414839|NCT01373411|Ticagrelor|ticagrelor
415437|NCT01370967|human milk|human milk
414840|NCT01373411|Coronary Artery Bypass Surgery|coronary artery bypass surgery
414841|NCT01373398|bladder cancer|bladder cancer
414842|NCT01373398|EO9|eo9
414843|NCT01373398|Apaziquone|apaziquone
414844|NCT01373385|pediatric urology|pediatric urology
414845|NCT01373385|vesicoureteral reflux|vesicoureteral reflux
414846|NCT01373385|ureteral reimplant|ureteral reimplant
414847|NCT01373385|Deflux|deflux
414848|NCT01373372|functional dyspepsia|functional dyspepsia
414849|NCT01373372|GI|gi
414850|NCT01373359|Misoprostol, oxytocin, postpartum blood loss, hemoglobin|misoprostol, oxytocin, postpartum blood loss, hemoglobin
414851|NCT01373346|type II diabetes|type ii diabetes
414852|NCT01373346|Gastric cancer|gastric cancer
414853|NCT01373346|Long limb Roux-en Y|long limb roux-en y
414854|NCT01373320|Smoking cessation|smoking cessation
414855|NCT01373320|Cancer screening|cancer screening
414856|NCT01373320|Appalachia|appalachia
414857|NCT01373320|Group-randomized trial|group-randomized trial
414858|NCT01373320|Faith-placed|faith-placed
414859|NCT01373307|Overweight|overweight
414860|NCT01373307|obesity|obesity
414861|NCT01373307|Appalachian|appalachian
414862|NCT01373307|intergenerational|intergenerational
414863|NCT01373307|families|families
414864|NCT01373307|energy balance|energy balance
414865|NCT01373307|group-randomized trial|group-randomized trial
414866|NCT01373294|non-muscle-invasive|non-muscle-invasive
414867|NCT01373294|transitional cell|transitional cell
414868|NCT01373294|oral lenalidomide|oral lenalidomide
414869|NCT01373294|intravesical|intravesical
414870|NCT01373281|Dengue|dengue
414871|NCT01373281|Dengue fever|dengue fever
414872|NCT01373281|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
414873|NCT01373281|CYD dengue vaccine|cyd dengue vaccine
414874|NCT01373281|Flavivirus|flavivirus
414875|NCT01373255|Placenta accreta|placenta accreta
414876|NCT01373255|Internal iliac artery catheterization|internal iliac artery catheterization
414877|NCT01373255|Post partum bleeding|post partum bleeding
414878|NCT01373229|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
414879|NCT01373229|CLL|cll
414880|NCT01373203|Acute Lung Injury(ALI)|acute lung injury(ali)
414881|NCT01373190|epilepsy|epilepsy
414882|NCT01373190|thermography|thermography
414883|NCT01373164|Neoplasms|neoplasms
414884|NCT01373164|Neoplasm Metastasis|neoplasm metastasis
414885|NCT01373164|Pancreatic Cancer|pancreatic cancer
414886|NCT01373138|Bioequivalence|bioequivalence
414887|NCT01373138|Desloratadine and pseudoephedrine|desloratadine and pseudoephedrine
414888|NCT01373138|crossover|crossover
414889|NCT01373125|Barrett's Esophagus|barrett's esophagus
414890|NCT01373125|Intestinal metaplasia|intestinal metaplasia
414891|NCT01373125|Gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
414892|NCT01373125|Neosquamous epithelium|neosquamous epithelium
414893|NCT01373125|Radiofrequency ablation (RFA)|radiofrequency ablation (rfa)
414894|NCT01373112|arthroplasty|arthroplasty
414895|NCT01373112|knee replacement|knee replacement
414896|NCT01373112|Osteoarthritis|osteoarthritis
414897|NCT01373112|knee Infection|knee infection
414898|NCT01373112|Prosthetic Joint Infection|prosthetic joint infection
414899|NCT01373112|Complications; Arthroplasty, Infection or Inflammation|complications; arthroplasty, infection or inflammation
414900|NCT01373112|Complications; Arthroplasty|complications; arthroplasty
414901|NCT01373099|arthroplasty|arthroplasty
414902|NCT01373099|hip replacement|hip replacement
414903|NCT01373099|Osteoarthritis|osteoarthritis
414904|NCT01373099|knee Infection|knee infection
414905|NCT01373099|Prosthetic Joint Infection|prosthetic joint infection
414906|NCT01373099|Complications; Arthroplasty, Infection or Inflammation|complications; arthroplasty, infection or inflammation
414907|NCT01373099|Complications; Arthroplasty|complications; arthroplasty
414908|NCT01373086|Hypertension,|hypertension,
414909|NCT01373086|mild hypertension,|mild hypertension,
414910|NCT01373086|moderate hypertension,|moderate hypertension,
414911|NCT01373086|high blood pressure,|high blood pressure,
414912|NCT01373086|uncomplicated hypertension.|uncomplicated hypertension.
414913|NCT01373060|ASP1941|asp1941
414914|NCT01373060|ipragliflozin|ipragliflozin
414915|NCT01373060|plasma glucose|plasma glucose
414916|NCT01373060|urine glucose|urine glucose
414917|NCT01373047|liver metastases|liver metastases
414918|NCT01373047|immunotherapy|immunotherapy
414919|NCT01373047|regional therapy|regional therapy
414920|NCT01373047|T cells|t cells
414921|NCT01373008|Inhaled steroids|inhaled steroids
414922|NCT01373008|bronchopulmonary dysplasia|bronchopulmonary dysplasia
414923|NCT01373008|Infants with moderate to severe BPD|infants with moderate to severe bpd
414924|NCT01372995|critical care|critical care
414925|NCT01372995|nosocomial infection|nosocomial infection
414926|NCT01372995|antiAntimicrobial peptide expression|antiantimicrobial peptide expression
414927|NCT01372995|LL-37|ll-37
414928|NCT01372995|hBD-2|hbd-2
414929|NCT01372995|cathelicidin|cathelicidin
414930|NCT01372995|microbial peptide|microbial peptide
414931|NCT01372956|LDL-C, cholesterol, risk factor|ldl-c, cholesterol, risk factor
414932|NCT01372943|Clostridium difficile|clostridium difficile
414933|NCT01372943|recurrent|recurrent
414934|NCT01372943|infection|infection
414935|NCT01372930|Etanercept|etanercept
414936|NCT01372930|acute ST segment elevated myocardial infarction|acute st segment elevated myocardial infarction
414937|NCT01372930|percutaneous coronary intervention|percutaneous coronary intervention
414938|NCT01372930|myocardial reperfusion injury|myocardial reperfusion injury
414939|NCT01372904|Cisplatin|cisplatin
414940|NCT01372904|Hearing loss|hearing loss
414941|NCT01372904|Ototoxicity|ototoxicity
414942|NCT01372904|Intratympanic injection|intratympanic injection
414943|NCT01372904|Dexamethasone|dexamethasone
414944|NCT01372904|Steroids|steroids
414945|NCT01372904|Prevention|prevention
414946|NCT01372891|Contrast Induced Nephropathy|contrast induced nephropathy
414947|NCT01372891|percutaneous coronary interventions|percutaneous coronary interventions
414948|NCT01372878|Polyps|polyps
414949|NCT01372878|Capsule endoscopy|capsule endoscopy
414950|NCT01372878|Colonoscopy|colonoscopy
414951|NCT01372852|Diabetes mellitus|diabetes mellitus
414952|NCT01372839|Myocardial Infarction|myocardial infarction
414953|NCT01372839|Unstable Angina|unstable angina
414954|NCT01372826|Phase 1|phase 1
414955|NCT01372826|Pharmacokinetics|pharmacokinetics
414956|NCT01372826|NKTR-118|nktr-118
414957|NCT01372826|renal impairment|renal impairment
414958|NCT01372826|parallel study|parallel study
414959|NCT01372826|QTcF Interval|qtcf interval
414960|NCT01372826|AUC(0-t)|auc(0-t)
414961|NCT01372826|Cmax|cmax
414962|NCT01372826|tmax|tmax
414963|NCT01372813|Advanced Clear Cell Renal Cell Carcinoma|advanced clear cell renal cell carcinoma
414964|NCT01372813|Cancer|cancer
414965|NCT01372813|Renal|renal
414966|NCT01372813|Renal Cell Carcinoma|renal cell carcinoma
414967|NCT01372813|Kidney Cancer|kidney cancer
414968|NCT01372800|adiponectin|adiponectin
414969|NCT01372800|cardiovascular diseases|cardiovascular diseases
414970|NCT01372800|cerebrovascular diseases|cerebrovascular diseases
414971|NCT01372774|neurotoxicity|neurotoxicity
414972|NCT01372774|radiation toxicity|radiation toxicity
414973|NCT01372774|cognitive/functional effects|cognitive/functional effects
414974|NCT01372774|tumors metastatic to brain|tumors metastatic to brain
414975|NCT01372774|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
414976|NCT01372761|Obese|obese
414977|NCT01372761|Obesity|obesity
414978|NCT01372761|Overweight|overweight
414979|NCT01372748|cardiac arrest|cardiac arrest
414980|NCT01372748|cardiopulmonary resuscitation|cardiopulmonary resuscitation
414981|NCT01372735|pancreatic cancer|pancreatic cancer
414982|NCT01372735|intensity-modulated radiation therapy|intensity-modulated radiation therapy
414983|NCT01372735|intraoperative radiation therapy|intraoperative radiation therapy
414984|NCT01372722|treatment resistant|treatment resistant
414985|NCT01372709|abdominal|abdominal
414986|NCT01372709|aortic|aortic
414987|NCT01372709|aneurysm|aneurysm
414988|NCT01372683|Appetite|appetite
414989|NCT01372683|Satiety|satiety
414990|NCT01372683|Subjective energy|subjective energy
414991|NCT01372683|Oats|oats
414992|NCT01372670|Treating meal related anxiety|treating meal related anxiety
414993|NCT01372657|cataract|cataract
414994|NCT01372657|refraction|refraction
414995|NCT01372657|iol|iol
414996|NCT01372657|calculation|calculation
414997|NCT01372657|formula|formula
414998|NCT01372631|Reduction mammoplasty|reduction mammoplasty
414999|NCT01372631|mastectomy|mastectomy
415000|NCT01372631|partial mastectomy|partial mastectomy
415001|NCT01372631|lumpectomy|lumpectomy
415002|NCT01372631|breast conserving surgery|breast conserving surgery
415003|NCT01372631|breast cancer|breast cancer
415004|NCT01372605|Depression|depression
415005|NCT01372605|HIV|hiv
415006|NCT01372605|Adherence|adherence
415007|NCT01372605|Collaborative care|collaborative care
415008|NCT01372605|Measurement-Based Care|measurement-based care
415009|NCT01372553|Primary care|primary care
415010|NCT01372553|Family History|family history
415011|NCT01372553|Risk Stratification|risk stratification
415012|NCT01372553|Cancer|cancer
415013|NCT01372553|Thrombosis|thrombosis
415014|NCT01372540|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
415015|NCT01372540|MM|mm
415016|NCT01372540|Plasma Cell Leukemia|plasma cell leukemia
415017|NCT01372540|PCL|pcl
415018|NCT01372540|Arry-520|arry-520
415019|NCT01372540|Carfilzomib|carfilzomib
415020|NCT01372540|Dexamethasone|dexamethasone
415021|NCT01372540|Decadron|decadron
415022|NCT01372540|Filgrastim|filgrastim
415023|NCT01372540|G-CSF|g-csf
415024|NCT01372540|Neupogen|neupogen
415025|NCT01372527|medical informatics|medical informatics
415026|NCT01372527|health IT|health it
415027|NCT01372527|primary care|primary care
415028|NCT01372527|screening|screening
415029|NCT01372527|cervical cancer|cervical cancer
415030|NCT01372527|colorectal cancer|colorectal cancer
415031|NCT01372527|breast cancer|breast cancer
415032|NCT01372527|mammography|mammography
415033|NCT01372527|colonoscopy|colonoscopy
415034|NCT01372527|pap smear|pap smear
415035|NCT01372514|Thromboembolism|thromboembolism
415036|NCT01372514|Venous Thromboembolism|venous thromboembolism
415037|NCT01372514|Pulmonary Embolism|pulmonary embolism
415038|NCT01372501|Obesity|obesity
415039|NCT01372488|Suture self removal|suture self removal
415040|NCT01372488|non-absorbable sutures|non-absorbable sutures
415041|NCT01372475|Osteoarthritis|osteoarthritis
415042|NCT01372475|Knee|knee
415043|NCT01372475|Hyaluronan|hyaluronan
415044|NCT01372475|Hyaluronic Acid|hyaluronic acid
415045|NCT01372475|Viscoelastic|viscoelastic
415046|NCT01372475|Hydrogel|hydrogel
415047|NCT01372462|COPD|copd
415048|NCT01372462|Ventilator|ventilator
415049|NCT01372462|Constant work rate|constant work rate
415050|NCT01372449|Autism|autism
415051|NCT01372449|Psychopharmacology|psychopharmacology
415052|NCT01372449|Clinical Trial|clinical trial
415053|NCT01372449|Children|children
415054|NCT01372436|dental decay|dental decay
415055|NCT01372436|DMFT|dmft
415056|NCT01372436|Individual Caries Risk|individual caries risk
415057|NCT01372436|Risk factors|risk factors
415058|NCT01372410|Long acting muscarinic antagonist|long acting muscarinic antagonist
415059|NCT01372410|Tiotropium|tiotropium
415060|NCT01372410|Chronic Bronchitis|chronic bronchitis
415061|NCT01372410|Emphysema|emphysema
415062|NCT01372410|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
415063|NCT01372371|Vancomycin, Gentamycin|vancomycin, gentamycin
415064|NCT01372371|Local Powder Antibiotic's Efficacy in Controlling Post Surgical Infection|local powder antibiotic's efficacy in controlling post surgical infection
415065|NCT01372332|homonymous hemianopia|homonymous hemianopia
415066|NCT01372332|quality of life (QoL)|quality of life (qol)
415067|NCT01372332|visual exploration|visual exploration
415068|NCT01372332|on-road car driving|on-road car driving
415069|NCT01372332|driving simulator|driving simulator
415070|NCT01372332|useful field of view (UFOV)|useful field of view (ufov)
415071|NCT01372332|modified field of view (MAFOV)|modified field of view (mafov)
415072|NCT01372319|glaucoma|glaucoma
415073|NCT01372319|binocular visual field loss|binocular visual field loss
415074|NCT01372319|semi-automated kinetic perimetry (SKP)|semi-automated kinetic perimetry (skp)
415075|NCT01372319|quality of life (QoL)|quality of life (qol)
415076|NCT01372319|visual exploration|visual exploration
415077|NCT01372319|on-road car driving|on-road car driving
415078|NCT01372319|driving simulator|driving simulator
415079|NCT01372293|PCOS|pcos
415080|NCT01372293|oral contraceptive pill|oral contraceptive pill
415081|NCT01372293|polymorphisms|polymorphisms
415082|NCT01372267|Cognitive Behavioral Therapy|cognitive behavioral therapy
415083|NCT01372267|Chronic Pain|chronic pain
415084|NCT01372267|Substance Use Disorders|substance use disorders
415085|NCT01372267|Psychoeducational control group|psychoeducational control group
415086|NCT01372254|Cigarette Smoking|cigarette smoking
415087|NCT01372254|Drug Use|drug use
415088|NCT01372254|Depressed Mood|depressed mood
415089|NCT01372241|Papanicolaou test|papanicolaou test
415090|NCT01372241|Cervical cancer screening|cervical cancer screening
415091|NCT01372241|Randomized controlled trial|randomized controlled trial
415092|NCT01372241|Faith-placed|faith-placed
415093|NCT01372241|Appalachia|appalachia
415094|NCT01372228|hematopoietic stem cell Tx, chimerism, leukodystrophy|hematopoietic stem cell tx, chimerism, leukodystrophy
415095|NCT01372215|Breast mass|breast mass
415096|NCT01372215|Breast lesion|breast lesion
415097|NCT01372202|Operable|operable
415098|NCT01372202|Based on CHFR Methylation Status|based on chfr methylation status
415099|NCT01372202|Diagnostic Biopsies|diagnostic biopsies
415100|NCT01372189|molecular imaging|molecular imaging
415101|NCT01372189|epidermal growth factor receptor|epidermal growth factor receptor
415102|NCT01372189|colorectal neoplasia|colorectal neoplasia
415103|NCT01372189|confocal laser endomicroscopy|confocal laser endomicroscopy
415104|NCT01372176|Intensive care unit|intensive care unit
415105|NCT01372176|Critical illness|critical illness
415106|NCT01372176|Mortality|mortality
415107|NCT01372176|Reduced quality of life|reduced quality of life
415108|NCT01372176|Loss of lean body mass|loss of lean body mass
415109|NCT01372176|Loss of physical function|loss of physical function
415110|NCT01372176|Optimised nutritional support|optimised nutritional support
415111|NCT01372176|Early initiation of nutrition|early initiation of nutrition
415112|NCT01372176|Indirect calorimetry|indirect calorimetry
415113|NCT01372163|Phase 1|phase 1
415114|NCT01372163|Multiple Ascending Doses|multiple ascending doses
415115|NCT01372163|Safety|safety
415116|NCT01372163|Pharmacokinetics|pharmacokinetics
415117|NCT01372163|Healthy Volunteers|healthy volunteers
415118|NCT01372163|Type 2 Diabetic Patients|type 2 diabetic patients
415119|NCT01372150|major depressive disorder|major depressive disorder
415120|NCT01372150|MDD|mdd
415121|NCT01372150|depression|depression
415122|NCT01372137|NOX-H94|nox-h94
415123|NCT01372137|Hepcidin|hepcidin
415124|NCT01372137|Anemia|anemia
415125|NCT01372137|Inflammation|inflammation
415126|NCT01372124|Renal impairment|renal impairment
415127|NCT01372124|NOX-E36|nox-e36
415128|NCT01372111|Stg III or IVa Squamous Cell Carcinoma.|stg iii or iva squamous cell carcinoma.
415129|NCT01372111|Advanced|advanced
415130|NCT01372098|Domestic Violence|domestic violence
415131|NCT01372098|Spouse Abuse|spouse abuse
415132|NCT01372072|chronic respiratory hypercapnic failure|chronic respiratory hypercapnic failure
415839|NCT01369394|Tailoring|tailoring
415133|NCT01372046|technology transfer|technology transfer
415134|NCT01372046|skill development|skill development
415135|NCT01372046|organizational change|organizational change
415136|NCT01372033|drug treatment|drug treatment
415137|NCT01372033|substance abuse|substance abuse
415138|NCT01372033|offenders|offenders
415139|NCT01372033|high risk|high risk
415140|NCT01372020|Varicose ulcer|varicose ulcer
415141|NCT01372020|wound healing|wound healing
415142|NCT01372020|electrical stimulation|electrical stimulation
415143|NCT01372007|Rectal carcinoma|rectal carcinoma
415144|NCT01371994|Radical Robotic Arm|radical robotic arm
415145|NCT01371994|Post Prostatectomy Incontinence|post prostatectomy incontinence
415146|NCT01371994|Vesicare|vesicare
415147|NCT01371994|YM905|ym905
415148|NCT01371968|Alfentanil|alfentanil
415149|NCT01371968|optimal dose|optimal dose
415150|NCT01371968|laryngeal mask airway|laryngeal mask airway
415151|NCT01371955|diabetic nephropathy|diabetic nephropathy
415152|NCT01371955|CYBA|cyba
415153|NCT01371955|p22phox|p22phox
415154|NCT01371955|RAGE|rage
415155|NCT01371955|12LOX|12lox
415156|NCT01371955|genetic|genetic
415157|NCT01371955|Type 1 Diabetes Mellitus with Diabetic Dermatitis|type 1 diabetes mellitus with diabetic dermatitis
415158|NCT01371955|caucasian|caucasian
415159|NCT01371955|more than twenty years of diabetes duration|more than twenty years of diabetes duration
415160|NCT01371955|older than 18 years|older than 18 years
415161|NCT01371955|no nephropathy other than diabetic nephropathy|no nephropathy other than diabetic nephropathy
415162|NCT01371942|Colorectal cancer(CRC)|colorectal cancer(crc)
415163|NCT01371916|tuberculous meningitis|tuberculous meningitis
415164|NCT01371916|early secretory antigenic target 6|early secretory antigenic target 6
415165|NCT01371916|diagnosis|diagnosis
415166|NCT01371903|morphine|morphine
415167|NCT01371903|fentanyl|fentanyl
415168|NCT01371903|dilaudid|dilaudid
415169|NCT01371903|opioid|opioid
415170|NCT01371903|capnography|capnography
415171|NCT01371890|hemodialysis|hemodialysis
415172|NCT01371890|end-stage renal disease|end-stage renal disease
415173|NCT01371890|hypertension|hypertension
415174|NCT01371877|urticaria|urticaria
415175|NCT01371877|angioedema|angioedema
415176|NCT01371877|hive|hive
415177|NCT01371877|swelling|swelling
415178|NCT01371864|Congenital cardiac disease|congenital cardiac disease
415179|NCT01371864|Teamwork|teamwork
415180|NCT01371864|Communication|communication
415181|NCT01371864|Peri-operative|peri-operative
415182|NCT01371838|Community-Acquired Bacterial Pneumonia|community-acquired bacterial pneumonia
415183|NCT01371825|LIPA|lipa
415184|NCT01371825|Wolman Disease|wolman disease
415185|NCT01371825|Wolman Phenotype|wolman phenotype
415186|NCT01371825|Acid Lipase Deficiency|acid lipase deficiency
415187|NCT01371825|Acid Cholesteryl Hydrolase|acid cholesteryl hydrolase
415188|NCT01371825|Acid Lipase Disease Deficiency, type 2|acid lipase disease deficiency, type 2
415189|NCT01371825|Cholesteryl Ester Storage Disease (CESD)|cholesteryl ester storage disease (cesd)
415190|NCT01371825|Cholesteryl Ester Hydrolase Deficiency|cholesteryl ester hydrolase deficiency
415191|NCT01371825|Early Onset Lysosomal Acid Lipase Deficiency (Wolman Disease)|early onset lysosomal acid lipase deficiency (wolman disease)
415192|NCT01371825|LAL Deficiency|lal deficiency
415193|NCT01371825|Late Onset Lysosomal Acid Lipase Deficiency (CESD)|late onset lysosomal acid lipase deficiency (cesd)
415194|NCT01371825|Wolman Disease (early onset LAL Deficiency)|wolman disease (early onset lal deficiency)
415195|NCT01371825|Related Disorders:|related disorders:
415196|NCT01371825|Non-alcoholic Fatty Liver Disease (NAFLD)|non-alcoholic fatty liver disease (nafld)
415197|NCT01371825|Non-alcoholic Steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
415198|NCT01371825|Alcoholic Liver Disease|alcoholic liver disease
415199|NCT01371825|Cryptogenic Cirrhosis|cryptogenic cirrhosis
415200|NCT01371825|Niemann-Pick Disease (NPD) Type C|niemann-pick disease (npd) type c
415201|NCT01371825|Chanarin Dorfman Syndrome|chanarin dorfman syndrome
415202|NCT01371799|Schizophrenia|schizophrenia
415203|NCT01371786|Ciclesonide|ciclesonide
415204|NCT01371786|Allergic Rhinitis|allergic rhinitis
415205|NCT01371760|Multiple sclerosis|multiple sclerosis
415206|NCT01371760|Chronic cerebrospinal venous insufficiency|chronic cerebrospinal venous insufficiency
415207|NCT01371760|Percutaneous Transluminal Angioplasty (PTA)|percutaneous transluminal angioplasty (pta)
415208|NCT01371760|Internal jugular vein|internal jugular vein
415209|NCT01371760|Azygous vein|azygous vein
415210|NCT01371747|Hyperkalemia|hyperkalemia
415211|NCT01371747|Chronic Kidney Disease|chronic kidney disease
415212|NCT01371747|Treatment of Hyperkalemia|treatment of hyperkalemia
415213|NCT01371747|Hypertension|hypertension
415214|NCT01371747|Diabetic Nephropathy|diabetic nephropathy
415215|NCT01371734|Major Depressive Disorder|major depressive disorder
415216|NCT01371734|MDD|mdd
415217|NCT01371734|Depression|depression
415218|NCT01371721|Major Depressive Disorder|major depressive disorder
415219|NCT01371721|MDD|mdd
415220|NCT01371721|Depression|depression
415221|NCT01371708|Major Depressive Disorder|major depressive disorder
415222|NCT01371708|MDD|mdd
415223|NCT01371708|Depression|depression
415224|NCT01371695|IGF-II levels|igf-ii levels
415225|NCT01371669|Pulmonary arterial hypertension|pulmonary arterial hypertension
415226|NCT01371669|Chronic post embolic disease|chronic post embolic disease
415227|NCT01371669|Sleep hypoxemia|sleep hypoxemia
415228|NCT01371669|polysomnography|polysomnography
415229|NCT01371669|sleep apnea|sleep apnea
415230|NCT01371669|periodic respiration|periodic respiration
415231|NCT01371630|Leukemia|leukemia
415232|NCT01371630|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
415233|NCT01371630|ALL|all
415234|NCT01371630|pre-B, Philadelphia chromosome (Ph-) negative|pre-b, philadelphia chromosome (ph-) negative
415235|NCT01371630|Maximum tolerated dose|maximum tolerated dose
415236|NCT01371630|Inotuzumab Ozogamycin|inotuzumab ozogamycin
415237|NCT01371630|CMC-544|cmc-544
415238|NCT01371630|Vincristine|vincristine
415239|NCT01371630|Rituximab|rituximab
415240|NCT01371630|Rituxan|rituxan
415241|NCT01371630|Cyclophosphamide|cyclophosphamide
415242|NCT01371630|Cytoxan|cytoxan
415243|NCT01371630|Neosar|neosar
415244|NCT01371630|Dexamethasone|dexamethasone
415245|NCT01371630|Decadron|decadron
415246|NCT01371630|Mesna|mesna
415247|NCT01371630|Mesnex|mesnex
415248|NCT01371630|Pegfilgrastim|pegfilgrastim
415249|NCT01371630|Neulasta|neulasta
415250|NCT01371630|PEG-G-CSF|peg-g-csf
415251|NCT01371630|Ara-C|ara-c
415252|NCT01371630|Cytarabine|cytarabine
415253|NCT01371630|Cytosar|cytosar
415254|NCT01371630|DepoCyt|depocyt
415255|NCT01371630|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
415256|NCT01371630|6-Mercaptopurine|6-mercaptopurine
415257|NCT01371630|Mercaptopurine|mercaptopurine
415258|NCT01371630|Purinethol|purinethol
415259|NCT01371630|6-MP|6-mp
415260|NCT01371630|Methotrexate|methotrexate
415261|NCT01371630|Otrexup|otrexup
415262|NCT01371630|Rasuvo|rasuvo
415263|NCT01371630|Rheumatrex|rheumatrex
415264|NCT01371630|Trexall|trexall
415265|NCT01371630|Amethopterin|amethopterin
415266|NCT01371630|Methotrexate Sodium|methotrexate sodium
415267|NCT01371630|MTX|mtx
415268|NCT01371630|Oncovin|oncovin
415269|NCT01371630|Vincristine Sulfate|vincristine sulfate
415270|NCT01371630|Vincasar Pfs|vincasar pfs
415271|NCT01371630|Prednisone|prednisone
415272|NCT01371630|Deltasone|deltasone
415273|NCT01371630|Sterapred|sterapred
415274|NCT01371630|Rayos|rayos
415275|NCT01371630|Meticorten|meticorten
415276|NCT01371630|Citrovorum|citrovorum
415277|NCT01371630|Leucovorin|leucovorin
415278|NCT01371630|Wellcovorin|wellcovorin
415279|NCT01371630|Calcium Leucovorin|calcium leucovorin
415280|NCT01371630|Folinic Acid|folinic acid
415281|NCT01371630|Citrovorum Factor|citrovorum factor
415282|NCT01371617|IPI-926|ipi-926
415283|NCT01371617|926|926
415284|NCT01371617|Myelofibrosis|myelofibrosis
415285|NCT01371617|Hedgehog|hedgehog
415286|NCT01371617|Infinity Pharmaceuticals|infinity pharmaceuticals
415287|NCT01371617|Post Essential thrombocythemia|post essential thrombocythemia
415288|NCT01371617|Post Polycythemia vera|post polycythemia vera
415289|NCT01371604|Hepatitis C|hepatitis c
415290|NCT01371604|HCV|hcv
415291|NCT01371604|treatment-naive|treatment-naive
415292|NCT01371591|Bleeding|bleeding
415293|NCT01371591|gastrointestinal|gastrointestinal
415294|NCT01371591|hemorrhage|hemorrhage
415295|NCT01371591|ulcer|ulcer
415296|NCT01371591|varix|varix
415297|NCT01371591|varices|varices
415298|NCT01371591|ulcers|ulcers
415299|NCT01371591|GI|gi
415300|NCT01371591|stomach|stomach
415301|NCT01371591|esophagus|esophagus
415302|NCT01371591|duodenum|duodenum
415303|NCT01371591|melena|melena
415304|NCT01371591|hematemesis|hematemesis
415305|NCT01371591|coffee-ground|coffee-ground
415306|NCT01371578|Hepatitis C|hepatitis c
415307|NCT01371578|HCV|hcv
415308|NCT01371578|Rapid Virologic Response|rapid virologic response
415309|NCT01371578|Sustained Virologic Response|sustained virologic response
415310|NCT01371578|Direct Acting Antiviral|direct acting antiviral
415311|NCT01371578|Combination Therapy HCV RNA|combination therapy hcv rna
415312|NCT01371578|Polymerase inhibitor|polymerase inhibitor
415313|NCT01371578|Protease inhibitor|protease inhibitor
415314|NCT01371578|Treatment naïve|treatment naïve
415315|NCT01371578|GS-5885|gs-5885
415316|NCT01371578|GS-9190|gs-9190
415317|NCT01371578|Tegobuvir|tegobuvir
415318|NCT01371578|GS-9451|gs-9451
415319|NCT01371565|Cushing's Disease|cushing's disease
415320|NCT01371565|Cushing's Syndrome|cushing's syndrome
415321|NCT01371565|Cushings|cushings
415322|NCT01371565|Pituitary|pituitary
415323|NCT01371565|Ectopic ACTH secretion|ectopic acth secretion
415324|NCT01371539|Myopia|myopia
415325|NCT01371539|Presbyopia|presbyopia
415326|NCT01371513|Serum prostate specific antigen|serum prostate specific antigen
415327|NCT01371422|Paravertebral nerve blockade|paravertebral nerve blockade
415328|NCT01371422|Percutaneous nephrolithotomy/nephrolithotripsy|percutaneous nephrolithotomy/nephrolithotripsy
415329|NCT01371422|opioids|opioids
415330|NCT01371422|pain|pain
415331|NCT01371409|Stroke|stroke
415332|NCT01371409|TMS|tms
415333|NCT01371409|Paired Pulse|paired pulse
415334|NCT01371409|EEG|eeg
415335|NCT01371409|Motor Learning|motor learning
415336|NCT01371396|Metabolic syndrome|metabolic syndrome
415337|NCT01371396|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
415338|NCT01371396|Obesity Metabolism|obesity metabolism
415339|NCT01371396|Stable isotopes|stable isotopes
415340|NCT01371396|Dietary weight loss|dietary weight loss
415341|NCT01371370|low intensity resistance exercise training|low intensity resistance exercise training
415342|NCT01371370|hypocaloric diet|hypocaloric diet
415343|NCT01371370|prehypertension|prehypertension
415344|NCT01371370|hypertension|hypertension
415345|NCT01371370|obesity|obesity
415346|NCT01371370|arterial function|arterial function
415347|NCT01371370|arterial stiffness|arterial stiffness
415348|NCT01371370|pulse wave velocity|pulse wave velocity
415349|NCT01371370|autonomic function|autonomic function
415350|NCT01371370|endothelial function|endothelial function
415351|NCT01371370|adipocytokines|adipocytokines
415352|NCT01371357|Remethylation|remethylation
415353|NCT01371357|Human Subjects|human subjects
415354|NCT01371357|Clinical Trial|clinical trial
415355|NCT01371357|B-vitamin|b-vitamin
415356|NCT01371357|Creatine|creatine
415357|NCT01371344|Liver Transplantation|liver transplantation
415358|NCT01371344|Kidney Transplantation|kidney transplantation
415359|NCT01371344|Heart Transplantation|heart transplantation
415360|NCT01371344|Pharmacokinetics|pharmacokinetics
415361|NCT01371331|Kidney Transplantation|kidney transplantation
415362|NCT01371331|Pharmacokinetics|pharmacokinetics
415363|NCT01371331|Heart Transplantation|heart transplantation
415364|NCT01371331|Liver Transplantation|liver transplantation
415365|NCT01371318|diabetic foot ulcer|diabetic foot ulcer
415366|NCT01371318|amputation|amputation
415367|NCT01371318|wounds|wounds
415368|NCT01371318|diabetic foot|diabetic foot
415369|NCT01371318|diabetes complications|diabetes complications
415370|NCT01371292|Physical activity|physical activity
415371|NCT01371292|Transformational leadership|transformational leadership
415372|NCT01371292|Physical education|physical education
415373|NCT01371266|Glucose intolerance|glucose intolerance
415374|NCT01371266|Insulin resistance|insulin resistance
415375|NCT01371266|Insulin|insulin
415376|NCT01371266|metabolic syndrome|metabolic syndrome
415377|NCT01371266|honey|honey
415378|NCT01371266|Inflammation|inflammation
415379|NCT01371266|oxidative stress|oxidative stress
415380|NCT01371253|Nintendo wii|nintendo wii
415381|NCT01371253|postural balance|postural balance
415382|NCT01371253|muscle strength|muscle strength
415383|NCT01371253|elderly|elderly
415384|NCT01371240|pancreas cancer|pancreas cancer
415385|NCT01371240|MRI|mri
415386|NCT01371240|CT scan|ct scan
415387|NCT01371227|Multiple myeloma|multiple myeloma
415388|NCT01371227|Relapsed or refractory multiple myeloma|relapsed or refractory multiple myeloma
415389|NCT01371227|JNS002|jns002
415390|NCT01371227|Bortezomib|bortezomib
415391|NCT01371214|exercise|exercise
415392|NCT01371214|exercise movement techniques|exercise movement techniques
415393|NCT01371214|activities of daily living|activities of daily living
415395|NCT01371123|serum aluminum|serum aluminum
415396|NCT01371123|parenteral nutrition|parenteral nutrition
415397|NCT01371123|children|children
415398|NCT01371110|OCD|ocd
415399|NCT01371110|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
415400|NCT01371110|ketamine|ketamine
415401|NCT01371110|treatment|treatment
415402|NCT01371097|Barthel Index|barthel index
415403|NCT01371097|elderly hospitalised patients|elderly hospitalised patients
415404|NCT01371097|progressive resistance training|progressive resistance training
415405|NCT01371071|Clinically isolated syndrome (CIS)|clinically isolated syndrome (cis)
415406|NCT01371071|Multiple sclerosis (MS)|multiple sclerosis (ms)
415407|NCT01371071|Immunomodulatory therapy|immunomodulatory therapy
415408|NCT01371071|Prognostic markers|prognostic markers
415409|NCT01371071|MRI|mri
415410|NCT01371071|OCT|oct
415411|NCT01371058|high on-treatment platelet reactivity|high on-treatment platelet reactivity
415412|NCT01371058|percutaneous coronary intervention|percutaneous coronary intervention
415413|NCT01371058|stent thrombosis|stent thrombosis
415414|NCT01371045|Acromegaly|acromegaly
415415|NCT01371045|Growth Hormone|growth hormone
415416|NCT01371045|Carcinoid Syndrome|carcinoid syndrome
415417|NCT01371045|Somatostatin|somatostatin
415418|NCT01371019|Preterm Birth, Proteomics|preterm birth, proteomics
415419|NCT01370993|Hypoxemia|hypoxemia
415420|NCT01370993|Model|model
415421|NCT01370993|Bronchoscopes|bronchoscopes
415422|NCT01370993|Monitored anesthesia care|monitored anesthesia care
415423|NCT01370980|Medication Adherence|medication adherence
415424|NCT01370980|Patient Compliance|patient compliance
415425|NCT01370980|Patient Acceptance of Health Care|patient acceptance of health care
415426|NCT01370980|Administration, Oral|administration, oral
415427|NCT01370980|Cancer|cancer
415428|NCT01370980|Letrozol|letrozol
415429|NCT01370980|Exemestan|exemestan
415430|NCT01370980|Imatinib|imatinib
415431|NCT01370980|Sunitinib|sunitinib
415432|NCT01370980|Nilotinib|nilotinib
415433|NCT01370980|Everolimus|everolimus
415434|NCT01370980|Deferasirox|deferasirox
415435|NCT01370967|infant|infant
415436|NCT01370967|term birth|term birth
415438|NCT01370967|infant formula|infant formula
415439|NCT01370967|breast feeding|breast feeding
415440|NCT01370967|bottle feeding|bottle feeding
415441|NCT01370967|gastrointestinal tract|gastrointestinal tract
415442|NCT01370967|quality of life|quality of life
415443|NCT01370967|infant development|infant development
415444|NCT01370954|CerefolinNAC|cerefolinnac
415445|NCT01370954|early memory loss|early memory loss
415446|NCT01370954|pre-alzheimer's disease|pre-alzheimer's disease
415447|NCT01370954|cognitive function|cognitive function
415448|NCT01370954|folic acid|folic acid
415449|NCT01370954|folate|folate
415450|NCT01370954|L-methylfolate|l-methylfolate
415451|NCT01370954|vitamin B12|vitamin b12
415452|NCT01370954|methylcobalamin|methylcobalamin
415453|NCT01370954|N-acetylcysteine|n-acetylcysteine
415454|NCT01370954|NAC|nac
415455|NCT01370954|oxidative stress|oxidative stress
415456|NCT01370954|memory deficit|memory deficit
415457|NCT01370954|antioxidant|antioxidant
415458|NCT01370941|Chymosin|chymosin
415459|NCT01370941|24H urine calcium excretion|24h urine calcium excretion
415460|NCT01370941|Calcium absorption|calcium absorption
415461|NCT01370941|Intestinal Absorption of Calcium|intestinal absorption of calcium
415462|NCT01370928|Colonoscopy performance|colonoscopy performance
415463|NCT01370928|Pain|pain
415464|NCT01370928|Discomfort|discomfort
415465|NCT01370928|Screening|screening
415466|NCT01370928|Colorectal cancer|colorectal cancer
415467|NCT01370928|Colorectal cancer screening, diagnostics of adenomas|colorectal cancer screening, diagnostics of adenomas
415468|NCT01370915|postoperative pain, nasal septum surgery, pregabalin|postoperative pain, nasal septum surgery, pregabalin
415469|NCT01370876|Oxaliplatin|oxaliplatin
415470|NCT01370876|Head and Neck cancer|head and neck cancer
415471|NCT01370863|GERD|gerd
415472|NCT01370863|Gastroesophageal reflux disease|gastroesophageal reflux disease
415473|NCT01370863|SPD557|spd557
415474|NCT01370863|Proton pump inhibitors|proton pump inhibitors
415475|NCT01370850|Retina pathology|retina pathology
415476|NCT01370824|Diagnosis|diagnosis
415477|NCT01370824|Clinical|clinical
415478|NCT01370824|Punch biopsy|punch biopsy
415479|NCT01370824|Surgical excision|surgical excision
415480|NCT01370824|Histology|histology
415481|NCT01370824|Histopathology|histopathology
415482|NCT01370824|Observed agreement|observed agreement
415483|NCT01370824|Diagnostic value|diagnostic value
415484|NCT01370824|Accuracy|accuracy
415485|NCT01370824|Interobserver variability|interobserver variability
415486|NCT01370824|Intraobserver variability|intraobserver variability
415487|NCT01370811|oxybutynin|oxybutynin
415488|NCT01370811|clonidine|clonidine
415489|NCT01370811|OC Oral Solution|oc oral solution
415490|NCT01370811|sialorrhoea|sialorrhoea
415491|NCT01370811|Parkinson's disease|parkinson's disease
415492|NCT01370798|Severe hypospadias|severe hypospadias
415493|NCT01370798|local oestrogen|local oestrogen
415494|NCT01370798|promestriene|promestriene
415495|NCT01370798|Onlay-tube-onlay urethroplasty|onlay-tube-onlay urethroplasty
415496|NCT01370798|post-operative complications|post-operative complications
415497|NCT01370798|fistula dehiscence|fistula dehiscence
415498|NCT01370772|B CLL|b cll
415499|NCT01370772|Fist line treatment|fist line treatment
415500|NCT01370759|bowel prep|bowel prep
415501|NCT01370759|PillCam|pillcam
415502|NCT01370733|TMS,|tms,
415503|NCT01370733|MDD,|mdd,
415504|NCT01370733|Depression,|depression,
415505|NCT01370733|sTMS,|stms,
415506|NCT01370733|NEST,|nest,
415507|NCT01370733|NeoSync,|neosync,
415508|NCT01370733|EEG,|eeg,
415509|NCT01370733|synchronous,|synchronous,
415510|NCT01370733|non-invasive neuromodulation,|non-invasive neuromodulation,
415511|NCT01370733|transcranial magnetic stimulation,|transcranial magnetic stimulation,
415512|NCT01370733|antidepressant,|antidepressant,
415513|NCT01370720|IBS|ibs
415514|NCT01370720|mast cell activation|mast cell activation
415515|NCT01370720|low grade inflammation|low grade inflammation
415516|NCT01370720|visceral hyperalgesia|visceral hyperalgesia
415517|NCT01370668|functional remediation|functional remediation
415518|NCT01370668|psychoeducation|psychoeducation
415519|NCT01370668|neurocognition|neurocognition
415520|NCT01370629|atrial fibrillation|atrial fibrillation
415521|NCT01370629|cardioversion|cardioversion
415522|NCT01370616|Infection|infection
415523|NCT01370616|Diabetes complications|diabetes complications
415524|NCT01370616|Diabetes wound infection|diabetes wound infection
415525|NCT01370616|Soft tissue infection|soft tissue infection
415526|NCT01370616|Osteomyelitis|osteomyelitis
415527|NCT01370616|Diabetes mellitus|diabetes mellitus
415528|NCT01370577|Predictors for asthma control|predictors for asthma control
415529|NCT01370577|Asthma Exacerbation rate|asthma exacerbation rate
415530|NCT01370577|Mean frequency of PFT|mean frequency of pft
415531|NCT01370577|sputum assessments|sputum assessments
415532|NCT01370577|refill adherence(%)|refill adherence(%)
415533|NCT01370577|prescription persistence|prescription persistence
415534|NCT01370564|Heart failure|heart failure
415535|NCT01370564|Cardiac filling pressure|cardiac filling pressure
415536|NCT01370538|Heartburn|heartburn
415537|NCT01370525|Heartburn|heartburn
415538|NCT01370486|Lennox-Gastaut syndrome|lennox-gastaut syndrome
415539|NCT01370486|Epileptic encephalopathy|epileptic encephalopathy
415540|NCT01370486|Melatonin|melatonin
415541|NCT01370486|Tonic seizures|tonic seizures
415542|NCT01370486|Interictal discharges|interictal discharges
415543|NCT01370486|Quality of sleep|quality of sleep
415544|NCT01370473|Hyponatremia|hyponatremia
415545|NCT01370460|Tranexamic Acid|tranexamic acid
415546|NCT01370460|Blood transfusion|blood transfusion
415547|NCT01370460|Total knee arthroplasty|total knee arthroplasty
415548|NCT01370447|Leigh syndrome|leigh syndrome
415549|NCT01370447|MELAS|melas
415550|NCT01370447|Kearns-Sayre|kearns-sayre
415551|NCT01370447|Alper's|alper's
415552|NCT01370447|Inherited mitochondrial disease|inherited mitochondrial disease
415553|NCT01370447|Friedreich's ataxia|friedreich's ataxia
415554|NCT01370447|POLG1 deficiency|polg1 deficiency
415555|NCT01370434|MM|mm
415556|NCT01370408|Autologous stem cell transplant|autologous stem cell transplant
415557|NCT01370408|BEAM|beam
415558|NCT01370408|Oral busulfan|oral busulfan
415559|NCT01370408|Cyclophosphamide|cyclophosphamide
415560|NCT01370408|Etoposide|etoposide
415561|NCT01370408|Carboplatin|carboplatin
415562|NCT01370408|melphalan|melphalan
415563|NCT01370395|geriatrics|geriatrics
415564|NCT01370395|troponin|troponin
415565|NCT01370395|electrocardiography|electrocardiography
415566|NCT01370395|diagnosis|diagnosis
415567|NCT01370395|myocardial infarction|myocardial infarction
415568|NCT01370382|geriatrics|geriatrics
415569|NCT01370382|troponin|troponin
415570|NCT01370382|electrocardiography|electrocardiography
415571|NCT01370382|diagnosis|diagnosis
415572|NCT01370382|myocardial infarction|myocardial infarction
415573|NCT01370356|smoking reduction|smoking reduction
415574|NCT01370356|smoking cessation|smoking cessation
415575|NCT01370330|Neuroblastoma|neuroblastoma
415576|NCT01370330|MIBG|mibg
415577|NCT01370330|131I-MIBG|131i-mibg
415578|NCT01370330|Resistant|resistant
415579|NCT01370330|Relapsed|relapsed
415580|NCT01370330|Treatment|treatment
415581|NCT01370330|UCSF|ucsf
415582|NCT01370330|Pediatric|pediatric
415583|NCT01370330|Oncology|oncology
415584|NCT01370304|repetitive Transcranial Magnetic Stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
415585|NCT01370304|Depression|depression
415586|NCT01370304|Venlafaxine|venlafaxine
415587|NCT01370304|fMRI|fmri
415588|NCT01370291|rTMS|rtms
415589|NCT01370291|Risperidone|risperidone
415590|NCT01370278|Central airway obstruction|central airway obstruction
415591|NCT01370278|lumen obstruction|lumen obstruction
415592|NCT01370278|Sodium bicarbonate|sodium bicarbonate
415593|NCT01370278|Baking soda|baking soda
415594|NCT01370278|Normal saline|normal saline
415595|NCT01370278|Salt water|salt water
415596|NCT01370278|Airway stents|airway stents
415597|NCT01370278|Bronchoscopy|bronchoscopy
415598|NCT01370278|mucus obstruction|mucus obstruction
415599|NCT01370265|Regadenoson (Lexiscan)|regadenoson (lexiscan)
415600|NCT01370265|PET N-13 ammonia imaging|pet n-13 ammonia imaging
415601|NCT01370265|Myocardial Blood Flow (MBF)|myocardial blood flow (mbf)
415602|NCT01370265|Regadenoson Stress|regadenoson stress
415603|NCT01370252|ankle arthrodesis|ankle arthrodesis
415604|NCT01370252|pain|pain
415605|NCT01370252|arthroscopic technique|arthroscopic technique
415606|NCT01370252|ankle osteoarthritis|ankle osteoarthritis
415607|NCT01370239|monoclonal antibody|monoclonal antibody
415608|NCT01370239|Lewis|lewis
415609|NCT01370239|breast cancer|breast cancer
415610|NCT01370213|non-myeloablative haploidentical transplant|non-myeloablative haploidentical transplant
415611|NCT01370213|hematopoietic cell transplant|hematopoietic cell transplant
415612|NCT01370213|natural killer cells|natural killer cells
415613|NCT01370213|adoptive cellular therapy|adoptive cellular therapy
415614|NCT01370200|citrate|citrate
415615|NCT01370200|anticoagulation|anticoagulation
415616|NCT01370200|plasma exchange|plasma exchange
415617|NCT01370200|efficacy|efficacy
415618|NCT01370187|Bronchiolitis|bronchiolitis
415619|NCT01370187|Postbronchiolitis wheezing|postbronchiolitis wheezing
415620|NCT01370187|Montelukast|montelukast
415621|NCT01370174|Falls|falls
415622|NCT01370174|Balance|balance
415623|NCT01370174|Protective Stepping|protective stepping
415624|NCT01370174|Lateral Balance|lateral balance
415625|NCT01370174|Elderly|elderly
415626|NCT01370161|transjugular intrahepatic portosystemic shunt|transjugular intrahepatic portosystemic shunt
415627|NCT01370161|TIPS|tips
415628|NCT01370161|variceal bleeding|variceal bleeding
415629|NCT01370161|liver cirrhosis|liver cirrhosis
415630|NCT01370161|hepatitis B|hepatitis b
415631|NCT01370148|Pharmacokinetics|pharmacokinetics
415632|NCT01370148|Protein Binding|protein binding
415633|NCT01370148|Conivaptan|conivaptan
415634|NCT01370148|Vaprisol|vaprisol
415635|NCT01370148|Liver Disease|liver disease
415636|NCT01370148|YM087|ym087
415637|NCT01370135|neovascular glaucoma|neovascular glaucoma
415638|NCT01370135|rubeosis|rubeosis
415639|NCT01370135|anterior chamber|anterior chamber
415640|NCT01370135|intraocular|intraocular
415942|NCT01369030|vitamin B6|vitamin b6
415641|NCT01370135|intravitreal injections|intravitreal injections
415642|NCT01370135|Lucentis|lucentis
415643|NCT01370135|Ranibizumab|ranibizumab
415644|NCT01370135|short ans longterm effects|short ans longterm effects
415645|NCT01370135|best corrected visual acuity|best corrected visual acuity
415646|NCT01370135|gonioscopy|gonioscopy
415647|NCT01370135|BCVA|bcva
415648|NCT01370135|quality of life|quality of life
415649|NCT01370122|Women over the age of 20|women over the age of 20
415650|NCT01370083|Dysphagia|dysphagia
415651|NCT01370083|Viscosity|viscosity
415652|NCT01370083|Tongue|tongue
415653|NCT01370083|Pressure|pressure
415654|NCT01370057|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
415655|NCT01370057|Scoliosis|scoliosis
415656|NCT01370057|AIS|ais
415657|NCT01370057|Brace|brace
415658|NCT01370057|TLSO|tlso
415659|NCT01370044|Febrile Seizure|febrile seizure
415660|NCT01370044|Carbon Dioxide|carbon dioxide
415661|NCT01370044|Carbogen|carbogen
415662|NCT01370044|Respiratory Alkalosis|respiratory alkalosis
415663|NCT01370031|Asthma|asthma
415664|NCT01370031|PK|pk
415665|NCT01370031|Adults|adults
415666|NCT01370018|CD4 counts|cd4 counts
415667|NCT01369992|Metastatic Cancer|metastatic cancer
415668|NCT01369979|Lumped constant|lumped constant
415669|NCT01369979|FDG|fdg
415670|NCT01369979|PET|pet
415671|NCT01369966|Smoking Cessation|smoking cessation
415672|NCT01369966|Schizophrenic Smokers|schizophrenic smokers
415673|NCT01369966|fMRI|fmri
415674|NCT01369966|Neural Circuits|neural circuits
415675|NCT01369953|Civic Ideals/Social Norms|civic ideals/social norms
415676|NCT01369953|Genetic Counseling|genetic counseling
415677|NCT01369953|Genetic Disorders|genetic disorders
415678|NCT01369953|Genetic Testing|genetic testing
415679|NCT01369953|Whole Genome Sequencing|whole genome sequencing
415680|NCT01369940|Growth Discordancy|growth discordancy
415681|NCT01369940|Fetal Growth|fetal growth
415682|NCT01369940|Twin Growth|twin growth
415683|NCT01369927|Shigellosis|shigellosis
415684|NCT01369927|Safety and Immunogenicity|safety and immunogenicity
415685|NCT01369927|Conjugate Vaccine|conjugate vaccine
415686|NCT01369914|Graft-Versus-Host Disease|graft-versus-host disease
415687|NCT01369914|Natural History Study|natural history study
415688|NCT01369914|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
415689|NCT01369914|GVHD|gvhd
415690|NCT01369901|Exercise|exercise
415691|NCT01369901|Spinal Bulbar Muscular Atrophy|spinal bulbar muscular atrophy
415692|NCT01369901|Spinal and Bulbar Muscular Atrophy|spinal and bulbar muscular atrophy
415693|NCT01369901|SBMA|sbma
415694|NCT01369901|Motor Neuron Disease|motor neuron disease
415695|NCT01369888|Immunotherapy|immunotherapy
415696|NCT01369888|Cell Therapy|cell therapy
415697|NCT01369888|IL-15 Cytokine|il-15 cytokine
415698|NCT01369888|Melanoma|melanoma
415699|NCT01369888|Metastatic Melanoma|metastatic melanoma
415700|NCT01369888|Skin Cancer|skin cancer
415701|NCT01369875|Immunotherapy|immunotherapy
415702|NCT01369875|Cell Therapy|cell therapy
415703|NCT01369875|Metastatic Cancer|metastatic cancer
415704|NCT01369875|Melanoma|melanoma
415705|NCT01369875|Metastatic Melanoma|metastatic melanoma
415706|NCT01369875|Skin Cancer|skin cancer
415707|NCT01369862|live attenuated flu vaccines|live attenuated flu vaccines
415708|NCT01369862|influenza A (H1N1)|influenza a (h1n1)
415709|NCT01369862|intranasal application|intranasal application
415710|NCT01369862|replication-deficient influenza virus|replication-deficient influenza virus
415711|NCT01369836|Tafamidis|tafamidis
415712|NCT01369836|Pharmacokinetics|pharmacokinetics
415713|NCT01369836|TTR stabilization|ttr stabilization
415714|NCT01369823|HbA1c|hba1c
415715|NCT01369823|Paradigm 522/722 Infusion Pump|paradigm 522/722 infusion pump
415716|NCT01369823|Transmitter (MMT-7703WW)|transmitter (mmt-7703ww)
415717|NCT01369823|Sensor MMT-7002 (i.e. Glucose Sensor)|sensor mmt-7002 (i.e. glucose sensor)
415718|NCT01369823|Levels of HbA1c at enrollment higher than 7|levels of hba1c at enrollment higher than 7
415719|NCT01369810|Epidemiological|epidemiological
415720|NCT01369810|asthma|asthma
415721|NCT01369810|COPD|copd
415722|NCT01369810|reimbursement|reimbursement
415723|NCT01369810|switch|switch
415724|NCT01369810|outcomes associated with the change in reimbursement|outcomes associated with the change in reimbursement
415725|NCT01369797|UPSAV|upsav
415726|NCT01369797|autonomy|autonomy
415727|NCT01369797|the elderly of 75 years and older|the elderly of 75 years and older
415728|NCT01369784|Diffuse large B-cell Lymphoma|diffuse large b-cell lymphoma
415729|NCT01369784|R-IPI|r-ipi
415730|NCT01369771|Confocal microscopic findings|confocal microscopic findings
415731|NCT01369771|Ocular Hypertension|ocular hypertension
415732|NCT01369771|Open-Angle Glaucoma|open-angle glaucoma
415733|NCT01369771|Preservative-free eye drops|preservative-free eye drops
415734|NCT01369758|morcellator|morcellator
415735|NCT01369758|hysteroscope|hysteroscope
415736|NCT01369758|myomectomy|myomectomy
415737|NCT01369758|polypectomy|polypectomy
415738|NCT01369758|uterine fibroids|uterine fibroids
415739|NCT01369758|uterine polyps|uterine polyps
415740|NCT01369745|Rheumatoid Arthritis|rheumatoid arthritis
415943|NCT01369030|vitamin B12|vitamin b12
415741|NCT01369745|Moderate to severe|moderate to severe
415742|NCT01369719|Thalassemia|thalassemia
415743|NCT01369719|Iron overload|iron overload
415744|NCT01369719|transfusion|transfusion
415745|NCT01369719|osveral|osveral
415746|NCT01369719|desferal|desferal
415747|NCT01369706|electromagnetic interference|electromagnetic interference
415748|NCT01369706|hand-held metal detector|hand-held metal detector
415749|NCT01369706|pacemaker|pacemaker
415750|NCT01369706|cardioverter-defibrillator|cardioverter-defibrillator
415751|NCT01369693|smokeless tobacco|smokeless tobacco
415752|NCT01369693|Nicotine|nicotine
415753|NCT01369693|Cadmium|cadmium
415754|NCT01369693|lead|lead
415755|NCT01369693|Tobacco Specific Nitrosamines|tobacco specific nitrosamines
415756|NCT01369680|Ketamine|ketamine
415757|NCT01369680|Chronic pain|chronic pain
415758|NCT01369680|Children|children
415759|NCT01369680|Oral pain medication|oral pain medication
415760|NCT01369654|hysterectomy with Bilateral Salpingo Oophorectomy|hysterectomy with bilateral salpingo oophorectomy
415761|NCT01369654|Oophorectomy|oophorectomy
415762|NCT01369654|Gynecologic condition|gynecologic condition
415763|NCT01369641|cisplatin|cisplatin
415764|NCT01369641|STS|sts
415765|NCT01369641|sodium thiosulfate|sodium thiosulfate
415766|NCT01369641|Adults|adults
415767|NCT01369641|dose range of 80-120mg/m2|dose range of 80-120mg/m2
415768|NCT01369628|Open label|open label
415769|NCT01369628|Dose Escalating|dose escalating
415770|NCT01369628|Phase Ib|phase ib
415771|NCT01369615|Malignant pain|malignant pain
415772|NCT01369615|Nonmalignant pain|nonmalignant pain
415773|NCT01369615|Pain|pain
415774|NCT01369615|Pediatric|pediatric
415775|NCT01369615|Opioid|opioid
415776|NCT01369615|Moderate to severe|moderate to severe
415777|NCT01369589|Xerostomia|xerostomia
415778|NCT01369589|dry mouth|dry mouth
415779|NCT01369589|Sjogren's Syndrome|sjogren's syndrome
415780|NCT01369563|rhinitis|rhinitis
415781|NCT01369563|ciclesonide|ciclesonide
415782|NCT01369563|intermittent rhinitis|intermittent rhinitis
415783|NCT01369563|persistent rhinitis|persistent rhinitis
415784|NCT01369524|fluid responsiveness|fluid responsiveness
415785|NCT01369524|microcirculation|microcirculation
415786|NCT01369524|Intensive Care|intensive care
415787|NCT01369511|Disuse Atrophy|disuse atrophy
415788|NCT01369511|Muscle|muscle
415789|NCT01369511|Strength|strength
415790|NCT01369511|Arthroplasty|arthroplasty
415791|NCT01369511|Hip|hip
415792|NCT01369511|Joint Replacement|joint replacement
415793|NCT01369498|Hematology|hematology
415794|NCT01369498|Myelofibrosis|myelofibrosis
415795|NCT01369498|Thrombocythemia Myelofibrosis|thrombocythemia myelofibrosis
415796|NCT01369498|Bone Marrow Diseases|bone marrow diseases
415797|NCT01369498|Hematologic Diseases|hematologic diseases
415798|NCT01369498|Blood Diseases|blood diseases
415799|NCT01369498|Leukemia|leukemia
415800|NCT01369498|Blood Disorders|blood disorders
415801|NCT01369485|Urinary Incontinence|urinary incontinence
415802|NCT01369485|Overactive Bladder|overactive bladder
415803|NCT01369485|Frequency|frequency
415804|NCT01369485|Urgency|urgency
415805|NCT01369459|Comorbid|comorbid
415806|NCT01369459|ADHD|adhd
415807|NCT01369459|SUD|sud
415808|NCT01369459|ASU|asu
415809|NCT01369446|In vitro fertilization|in vitro fertilization
415810|NCT01369446|Assisted reproduction|assisted reproduction
415811|NCT01369446|Noninvasive imaging of embryos|noninvasive imaging of embryos
415812|NCT01369446|Time lapse imaging of embryos|time lapse imaging of embryos
415813|NCT01369446|Traditional morphological grading of embryos|traditional morphological grading of embryos
415814|NCT01369446|Prediction of blastocysts|prediction of blastocysts
415815|NCT01369433|tivozanib|tivozanib
415816|NCT01369420|locoregional cancer therapy|locoregional cancer therapy
415817|NCT01369420|pancreatic cancer|pancreatic cancer
415818|NCT01369420|unresectable pancreatic cancer|unresectable pancreatic cancer
415819|NCT01369420|pancreatic adenocarcinoma|pancreatic adenocarcinoma
415820|NCT01369420|locally advanced, unresectable pancreatic cancer|locally advanced, unresectable pancreatic cancer
415821|NCT01369420|pancreatic cancer tumor ablation|pancreatic cancer tumor ablation
415822|NCT01369420|NanoKnife tumor ablation for pancreatic cancer|nanoknife tumor ablation for pancreatic cancer
415823|NCT01369420|NanoKnife LEDC system tumor ablation|nanoknife ledc system tumor ablation
415824|NCT01369420|Non thermal ablation|non thermal ablation
415825|NCT01369420|Irreversible electroporation for pancreatic cancer treatment|irreversible electroporation for pancreatic cancer treatment
415826|NCT01369420|IRE for unresectable pancreatic cancer|ire for unresectable pancreatic cancer
415827|NCT01369407|Heart failure|heart failure
415828|NCT01369407|HF|hf
415829|NCT01369407|Heart Diseases|heart diseases
415830|NCT01369407|Cardiovascular Diseases|cardiovascular diseases
415831|NCT01369407|Heart Failure NYHA class III|heart failure nyha class iii
415832|NCT01369407|Advanced heart failure|advanced heart failure
415833|NCT01369407|Systolic Heart Failure|systolic heart failure
415834|NCT01369394|Measles|measles
415835|NCT01369394|Mumps|mumps
415836|NCT01369394|Rubella|rubella
415837|NCT01369394|MMR|mmr
415838|NCT01369394|Prevention|prevention
415840|NCT01369394|Persuasive communication|persuasive communication
415841|NCT01369394|Children|children
415842|NCT01369381|Cervical spine|cervical spine
415843|NCT01369381|Endotracheal intubation|endotracheal intubation
415844|NCT01369381|Laryngoscope|laryngoscope
415845|NCT01369381|Biomechanics|biomechanics
415846|NCT01369368|Acute myeloid leukemia|acute myeloid leukemia
415847|NCT01369368|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
415848|NCT01369368|Relapse|relapse
415849|NCT01369368|Disease stabilization, survival|disease stabilization, survival
415850|NCT01369355|Ustekinumab|ustekinumab
415851|NCT01369355|Stelara, Moderately to severely active Crohn's Disease|stelara, moderately to severely active crohn's disease
415852|NCT01369355|IBD, Crohn's|ibd, crohn's
415853|NCT01369355|UNITI|uniti
415854|NCT01369355|colitis|colitis
415855|NCT01369355|IL-12|il-12
415856|NCT01369355|IL-23|il-23
415857|NCT01369342|ustekinumab|ustekinumab
415858|NCT01369342|moderately to severely active Crohn's Disease|moderately to severely active crohn's disease
415859|NCT01369342|Stelara|stelara
415860|NCT01369342|IBD|ibd
415861|NCT01369342|colitis|colitis
415862|NCT01369342|crohn|crohn
415863|NCT01369342|UNITI|uniti
415864|NCT01369342|Crohn's|crohn's
415865|NCT01369329|ustekinumab|ustekinumab
415866|NCT01369329|moderately to severely active Crohn's Disease|moderately to severely active crohn's disease
415867|NCT01369329|tumor necrosis factor, Stelara|tumor necrosis factor, stelara
415868|NCT01369329|Crohn|crohn
415869|NCT01369329|Crohn's|crohn's
415870|NCT01369329|IBD|ibd
415871|NCT01369329|UNITI|uniti
415872|NCT01369303|HIV|hiv
415873|NCT01369290|Depression|depression
415874|NCT01369290|Antidepressant Medication|antidepressant medication
415875|NCT01369290|CBT|cbt
415876|NCT01369277|PF-04991532|pf-04991532
415877|NCT01369277|safety and tolerability|safety and tolerability
415878|NCT01369277|PK|pk
415879|NCT01369277|Japanese and Western population|japanese and western population
415880|NCT01369264|Repetitive Transcranial Magnetic Stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
415881|NCT01369264|Electroencephalography (EEG)|electroencephalography (eeg)
415882|NCT01369264|Magnetic Resonance Imaging|magnetic resonance imaging
415883|NCT01369264|Quantitative EEG (QEEG)|quantitative eeg (qeeg)
415884|NCT01369238|bee venom acupuncture|bee venom acupuncture
415885|NCT01369238|east west collaborative medicine|east west collaborative medicine
415886|NCT01369238|whiplash associated disorder|whiplash associated disorder
415887|NCT01369225|Randomized|randomized
415888|NCT01369225|Safety Study|safety study
415889|NCT01369225|Open Label|open label
415890|NCT01369199|Hepatitis B|hepatitis b
415891|NCT01369199|immune-tolerant hepatitis b|immune-tolerant hepatitis b
415892|NCT01369199|HBV|hbv
415893|NCT01369173|Healthy|healthy
415894|NCT01369147|SICU|sicu
415895|NCT01369147|calories|calories
415896|NCT01369147|TPN|tpn
415897|NCT01369147|tube feeding|tube feeding
415898|NCT01369147|Optimum Energy Dose in SICU|optimum energy dose in sicu
415899|NCT01369134|self-etch adhesive|self-etch adhesive
415900|NCT01369134|selective enamel etching|selective enamel etching
415901|NCT01369134|Adper Easy Bond|adper easy bond
415902|NCT01369134|Supreme Ultra|supreme ultra
415903|NCT01369134|Molar and premolar teeth|molar and premolar teeth
415904|NCT01369134|Adult|adult
415905|NCT01369134|Class I and II cavities|class i and ii cavities
415906|NCT01369121|peritumoral brain edema|peritumoral brain edema
415907|NCT01369121|edema|edema
415908|NCT01369121|malignant brain tumor|malignant brain tumor
415909|NCT01369121|brain tumor|brain tumor
415910|NCT01369121|dexamethasone|dexamethasone
415911|NCT01369121|Decadron|decadron
415912|NCT01369108|small Class I|small class i
415913|NCT01369108|molar and premolar|molar and premolar
415914|NCT01369108|low stress flowable composite|low stress flowable composite
415915|NCT01369108|adult|adult
415916|NCT01369108|Restoration|restoration
415917|NCT01369108|small caries lesions|small caries lesions
415918|NCT01369082|islet allograft function|islet allograft function
415919|NCT01369082|c-peptide production|c-peptide production
415920|NCT01369082|maintenance immunosuppressive medications|maintenance immunosuppressive medications
415921|NCT01369069|stroke|stroke
415922|NCT01369069|diabetes|diabetes
415923|NCT01369069|hyperglycemia|hyperglycemia
415924|NCT01369056|antiretroviral therapy, highly active|antiretroviral therapy, highly active
415925|NCT01369056|treatment adherence|treatment adherence
415926|NCT01369043|Vitamin E|vitamin e
415927|NCT01369043|Vitamin C|vitamin c
415928|NCT01369043|Exercise|exercise
415929|NCT01369043|Antioxidant|antioxidant
415930|NCT01369030|L-methylfolate|l-methylfolate
415931|NCT01369030|Deplin|deplin
415932|NCT01369030|depression|depression
415933|NCT01369030|antidepressant|antidepressant
415934|NCT01369030|combination therapy|combination therapy
415935|NCT01369030|augmentation|augmentation
415936|NCT01369030|folate|folate
415937|NCT01369030|folic acid|folic acid
415938|NCT01369030|homocysteine|homocysteine
415939|NCT01369030|methionine|methionine
415940|NCT01369030|MTHFR genotype|mthfr genotype
415941|NCT01369030|C677T mutation|c677t mutation
415944|NCT01369017|healthy volunteer|healthy volunteer
415945|NCT01369017|endotoxin|endotoxin
415946|NCT01369004|self-weighing|self-weighing
415947|NCT01369004|self-monitoring|self-monitoring
415948|NCT01369004|weight loss|weight loss
415949|NCT01369004|obesity|obesity
415950|NCT01368991|Coronary Artery Bypass Grafts|coronary artery bypass grafts
415951|NCT01368991|Sternal Closure|sternal closure
415952|NCT01368991|Biologic Bone cement|biologic bone cement
415953|NCT01368978|TIDM|tidm
415954|NCT01368952|Obstructive Sleep Apnea|obstructive sleep apnea
415955|NCT01368952|Prone positioning|prone positioning
415956|NCT01368952|Positional Treatment|positional treatment
415957|NCT01368952|Hypoxemia|hypoxemia
415958|NCT01368939|breast imaging|breast imaging
415959|NCT01368939|MBI|mbi
415960|NCT01368939|dose reduction|dose reduction
415961|NCT01368939|Tc-99m|tc-99m
415962|NCT01368939|imaging|imaging
415963|NCT01368939|cardiac|cardiac
415964|NCT01368900|Ultherapy™ Treatment|ultherapy™ treatment
415965|NCT01368900|Ulthera, Inc.|ulthera, inc.
415966|NCT01368900|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
415967|NCT01368887|psoriasis|psoriasis
415968|NCT01368887|scalp psoriasis|scalp psoriasis
415969|NCT01368861|infant|infant
415970|NCT01368861|immunizations|immunizations
415971|NCT01368861|pain|pain
415972|NCT01368861|pain management|pain management
415973|NCT01368861|vaccines|vaccines
415974|NCT01368861|analgesia|analgesia
415975|NCT01368848|AGMT|agmt
415976|NCT01368848|NSCLC|nsclc
415977|NCT01368848|non-small cell lung cancer|non-small cell lung cancer
415978|NCT01368848|bevacizumab|bevacizumab
415979|NCT01368848|Avastin|avastin
415980|NCT01368848|Cisplatin|cisplatin
415981|NCT01368848|Docetaxel|docetaxel
415982|NCT01368848|Taxotere|taxotere
415983|NCT01368848|Inoperable|inoperable
415984|NCT01368848|stages IIIB and IV|stages iiib and iv
415985|NCT01368809|Ambulatory surgery|ambulatory surgery
415986|NCT01368809|Pain management|pain management
415987|NCT01368809|Perioperative outcomes|perioperative outcomes
415988|NCT01368809|Fentanyl|fentanyl
415989|NCT01368809|Coughing during insertion of an LMA|coughing during insertion of an lma
415990|NCT01368809|Ambulatory surgery procedures|ambulatory surgery procedures
415991|NCT01368796|Vaccine|vaccine
415992|NCT01368796|Influenza vaccine|influenza vaccine
415993|NCT01368796|Adjuvanted Influenza vaccine|adjuvanted influenza vaccine
415994|NCT01368796|Intradermal Influenza vaccine|intradermal influenza vaccine
415995|NCT01368796|Seniors|seniors
415996|NCT01368796|Acceptability of vaccines|acceptability of vaccines
415997|NCT01368796|Influenza|influenza
415998|NCT01368757|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
415999|NCT01368757|CMML|cmml
416000|NCT01368757|Lenalidomide|lenalidomide
416001|NCT01368757|Revlimid|revlimid
416002|NCT01368744|Breast Neoplasms|breast neoplasms
416003|NCT01368744|Breast Diseases|breast diseases
416004|NCT01368705|Infants|infants
416005|NCT01368705|Nitrogen Balance|nitrogen balance
416006|NCT01368705|Cardiothoracic surgery|cardiothoracic surgery
416007|NCT01368705|Congenital heart disease|congenital heart disease
416008|NCT01368705|Malnutrition|malnutrition
416009|NCT01368692|subclavian vein catheterization success rate|subclavian vein catheterization success rate
416010|NCT01368679|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
416011|NCT01368679|Abdominal Aortic|abdominal aortic
416012|NCT01368666|Aortic valve replacement|aortic valve replacement
416013|NCT01368666|Aortic stenosis|aortic stenosis
416014|NCT01368666|Biological valve|biological valve
416015|NCT01368666|Sutureless valve|sutureless valve
416016|NCT01368666|Stented valve|stented valve
416017|NCT01368666|Aortic Valve Disease|aortic valve disease
416018|NCT01368653|Tobacco|tobacco
416019|NCT01368653|Smoking|smoking
416020|NCT01368653|Smoking Cessation|smoking cessation
416021|NCT01368653|Tobacco Dependence|tobacco dependence
416022|NCT01368653|Tobacco Use|tobacco use
416023|NCT01368653|Nicotine Dependence|nicotine dependence
416024|NCT01368627|Coronary Artery Disease|coronary artery disease
416025|NCT01368627|Restenosis|restenosis
416026|NCT01368627|Stent thrombosis|stent thrombosis
416027|NCT01368627|Coronary stents|coronary stents
416028|NCT01368627|Angioplasty|angioplasty
416029|NCT01368627|Drug Eluting Stents(DES)|drug eluting stents(des)
416030|NCT01368614|OHS|ohs
416031|NCT01368601|Lung Cancer|lung cancer
416032|NCT01368601|CPAP|cpap
416033|NCT01368601|PPC|ppc
416034|NCT01368601|lobectomy|lobectomy
416035|NCT01368601|One-lung ventilation|one-lung ventilation
416036|NCT01368588|adenocarcinoma of the prostate|adenocarcinoma of the prostate
416037|NCT01368588|stage I prostate cancer|stage i prostate cancer
416038|NCT01368588|stage IIA prostate cancer|stage iia prostate cancer
416039|NCT01368588|stage IIB prostate cancer|stage iib prostate cancer
416040|NCT01368588|stage III prostate cancer|stage iii prostate cancer
416041|NCT01368575|Ischemic|ischemic
416042|NCT01368575|Mitral|mitral
416043|NCT01368575|Valve|valve
416044|NCT01368575|Insufficiency|insufficiency
416045|NCT01368575|SVR|svr
416046|NCT01368549|Metanx|metanx
416047|NCT01368549|diabetes|diabetes
416048|NCT01368549|neuropathy|neuropathy
416049|NCT01368549|folic acid|folic acid
416050|NCT01368549|folate|folate
416051|NCT01368549|L-methylfolate|l-methylfolate
416052|NCT01368549|vitamin B6|vitamin b6
416053|NCT01368549|Pyridoxal 5'-phosphate|pyridoxal 5'-phosphate
416054|NCT01368549|vitamin B12|vitamin b12
416055|NCT01368549|methylcobalamin|methylcobalamin
416056|NCT01368549|DPN|dpn
416057|NCT01368536|High blood pressure|high blood pressure
416058|NCT01368536|diabetes|diabetes
416059|NCT01368523|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
416060|NCT01368523|chronic phase|chronic phase
416061|NCT01368523|accelerated phase|accelerated phase
416062|NCT01368523|blastic phase|blastic phase
416063|NCT01368523|nilotinib|nilotinib
416064|NCT01368510|obsessive-compulsive disorder (OCD)|obsessive-compulsive disorder (ocd)
416065|NCT01368510|cognitive-behavioral therapy (CBT)|cognitive-behavioral therapy (cbt)
416066|NCT01368510|magnetic resonance spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
416067|NCT01368510|glutamate|glutamate
416068|NCT01368510|cingulate gyrus|cingulate gyrus
416069|NCT01368471|STEMI|stemi
416070|NCT01368471|myocardial infarction|myocardial infarction
416071|NCT01368471|stent|stent
416072|NCT01368432|TBI|tbi
416073|NCT01368432|Depression|depression
416074|NCT01368432|Mood|mood
416075|NCT01368432|Behavior|behavior
416076|NCT01368419|Endostar|endostar
416077|NCT01368419|Radiotherapy|radiotherapy
416078|NCT01368419|Esophageal Cancer|esophageal cancer
416079|NCT01368406|schizophrenia|schizophrenia
416080|NCT01368406|weight gain|weight gain
416081|NCT01368406|intervention|intervention
416082|NCT01368380|Breast cancer|breast cancer
416083|NCT01368380|Partners|partners
416084|NCT01368380|Couples|couples
416085|NCT01368380|Attachment|attachment
416086|NCT01368380|Intervention|intervention
416087|NCT01368367|Burns|burns
416088|NCT01368354|Community Led Total Sanitation|community led total sanitation
416089|NCT01368354|Open Defecation|open defecation
416090|NCT01368354|Cysticercosis|cysticercosis
416091|NCT01368354|Soil transmitted helminths|soil transmitted helminths
416092|NCT01368354|Zambia|zambia
416093|NCT01368341|Antibiotics|antibiotics
416094|NCT01368341|General Practice|general practice
416095|NCT01368341|Erythema migrans|erythema migrans
416096|NCT01368341|Borrelia|borrelia
416097|NCT01368341|Ticks|ticks
416098|NCT01368328|Type 2 Diabetes|type 2 diabetes
416099|NCT01368328|Chromium|chromium
416100|NCT01368328|Insulin resistance|insulin resistance
416101|NCT01368302|attention bias modification treatment|attention bias modification treatment
416102|NCT01368302|cognitive bias modification|cognitive bias modification
416103|NCT01368302|attention training|attention training
416104|NCT01368302|anxiety|anxiety
416105|NCT01368276|Melanoma|melanoma
416106|NCT01368276|Stage IIIb, IIIc and IV Disease|stage iiib, iiic and iv disease
416107|NCT01368276|oncolytic|oncolytic
416108|NCT01368276|OncoVex|oncovex
416109|NCT01368276|OncoVEX^GM-CSF|oncovex^gm-csf
416110|NCT01368250|Aortic|aortic
416111|NCT01368250|Stenosis|stenosis
416112|NCT01368250|Valve|valve
416113|NCT01368250|VARC|varc
416114|NCT01368250|Transcatheter|transcatheter
416115|NCT01368250|Minimal-invasive|minimal-invasive
416116|NCT01368237|Computed tomography|computed tomography
416117|NCT01368237|Myocardial perfusion|myocardial perfusion
416118|NCT01368237|Coronary heart disease|coronary heart disease
416119|NCT01368224|Skin sensitivity|skin sensitivity
416120|NCT01368224|Trans-epidermal water loss|trans-epidermal water loss
416121|NCT01368224|Clinical score|clinical score
416122|NCT01368224|skin moisturization factors|skin moisturization factors
416123|NCT01368224|serum immune-regulatory cytokine|serum immune-regulatory cytokine
416124|NCT01368224|Evaluation of intestinal flora composition|evaluation of intestinal flora composition
416125|NCT01368211|Mirasol|mirasol
416126|NCT01368211|Thrombocytopenic|thrombocytopenic
416127|NCT01368211|Pathogen reduction|pathogen reduction
416128|NCT01368211|Platelets|platelets
416129|NCT01368211|Thromboelastography|thromboelastography
416130|NCT01368211|CCI|cci
416131|NCT01368211|Corrected Count Increment|corrected count increment
416132|NCT01368198|Ocular Emulsion|ocular emulsion
416133|NCT01368198|OPTIVE™ Lubricant|optive™ lubricant
416134|NCT01368198|Tear Film Break Up Time|tear film break up time
416135|NCT01368185|Essential hypertension Uric acid Retrospective Hyzaar|essential hypertension uric acid retrospective hyzaar
416136|NCT01368172|spinal cord injury|spinal cord injury
416137|NCT01368172|physical activity|physical activity
416138|NCT01368172|physical fitness|physical fitness
416139|NCT01368133|acromegaly|acromegaly
416140|NCT01368133|pituitary tumor|pituitary tumor
416141|NCT01368107|IL-7|il-7
416142|NCT01368107|metastatic breast cancer patients|metastatic breast cancer patients
416143|NCT01368107|lymphopenia|lymphopenia
416144|NCT01368094|Pancreaticoduodenectomy|pancreaticoduodenectomy
416145|NCT01368094|Drainage|drainage
416146|NCT01368094|Surgical site infection|surgical site infection
416147|NCT01368068|Perimenopause|perimenopause
416148|NCT01368068|Depression|depression
416149|NCT01368055|Proton Radiation, Prostate Cancer|proton radiation, prostate cancer
416150|NCT01368042|Quality of Life changes|quality of life changes
416400|NCT01366976|acetaminophen|acetaminophen
416151|NCT01368042|Secondary Hyperparathyroidism|secondary hyperparathyroidism
416152|NCT01368042|Chronic Kidney Disease|chronic kidney disease
416153|NCT01368042|Hemodialysis|hemodialysis
416154|NCT01368042|Paricalcitol intravenous treatment|paricalcitol intravenous treatment
416156|NCT01368029|Immune response|immune response
416157|NCT01368029|Influenza vaccine|influenza vaccine
416158|NCT01368029|Elderly|elderly
416159|NCT01368029|Healthy|healthy
416160|NCT01368029|Microbiome|microbiome
416161|NCT01368016|Smoking Cessation|smoking cessation
416162|NCT01368016|Nicotine Pharmacodynamics|nicotine pharmacodynamics
416163|NCT01368003|Castration resistant prostate cancer|castration resistant prostate cancer
416164|NCT01367990|alopecia|alopecia
416165|NCT01367990|hair loss|hair loss
416166|NCT01367990|prevention|prevention
416167|NCT01367990|radiotherapy|radiotherapy
416168|NCT01367990|head & neck cancer|head & neck cancer
416169|NCT01367990|radiodermatitis|radiodermatitis
416170|NCT01367990|radiation dermatitis|radiation dermatitis
416171|NCT01367990|radiation-induced alopecia|radiation-induced alopecia
416172|NCT01367977|Ehlers Danlos Syndrome|ehlers danlos syndrome
416173|NCT01367977|External Communicating Hydrocephalus|external communicating hydrocephalus
416174|NCT01367977|Dysautonomia|dysautonomia
416175|NCT01367977|Postural orthostatic tachycardia syndrome|postural orthostatic tachycardia syndrome
416176|NCT01367977|Chronic cerebrospinal venous insufficiency|chronic cerebrospinal venous insufficiency
416177|NCT01367964|Hypsarrhythmia|hypsarrhythmia
416178|NCT01367964|Spasms, Infantile|spasms, infantile
416179|NCT01367964|West Syndrome|west syndrome
416180|NCT01367951|unstable chest injury|unstable chest injury
416181|NCT01367951|flail chest|flail chest
416182|NCT01367951|chest wall injury|chest wall injury
416183|NCT01367951|rib fracture|rib fracture
416184|NCT01367938|Osteoarthritis|osteoarthritis
416185|NCT01367938|Total Knee Replacement|total knee replacement
416186|NCT01367938|Total Knee Arthroplasty|total knee arthroplasty
416187|NCT01367938|TKA|tka
416188|NCT01367938|Knee|knee
416189|NCT01367925|Osteoarthritis|osteoarthritis
416190|NCT01367925|Total Knee Replacement|total knee replacement
416191|NCT01367925|TKA|tka
416192|NCT01367925|Knee|knee
416193|NCT01367925|PS|ps
416194|NCT01367925|CS|cs
416195|NCT01367912|Luteal phase support|luteal phase support
416196|NCT01367912|estradiol supplementation|estradiol supplementation
416197|NCT01367912|IVF/ICSI|ivf/icsi
416198|NCT01367912|clinical pregnancy rate|clinical pregnancy rate
416199|NCT01367899|Safety|safety
416200|NCT01367899|Efficacy|efficacy
416201|NCT01367886|Urine proteomics|urine proteomics
416202|NCT01367886|overactive bladder|overactive bladder
416203|NCT01367860|spine surgery|spine surgery
416204|NCT01367860|low back pain|low back pain
416205|NCT01367860|herniated disk|herniated disk
416206|NCT01367847|Parenting|parenting
416207|NCT01367847|Parent-Child Relations|parent-child relations
416208|NCT01367847|Child Behavior|child behavior
416209|NCT01367834|Turner Syndrome|turner syndrome
416210|NCT01367834|growth hormone|growth hormone
416211|NCT01367834|brain development|brain development
416212|NCT01367821|Obstructive jaundice|obstructive jaundice
416213|NCT01367821|ERCP|ercp
416214|NCT01367821|Immune dysfunction|immune dysfunction
416215|NCT01367821|Endotoxin tolerance|endotoxin tolerance
416216|NCT01367821|Quorum sensing|quorum sensing
416217|NCT01367808|Buprenorphine|buprenorphine
416218|NCT01367808|Vorikonazole|vorikonazole
416219|NCT01367808|Posakonazole|posakonazole
416220|NCT01367808|Interactions|interactions
416221|NCT01367795|palliation|palliation
416222|NCT01367795|quality of life|quality of life
416223|NCT01367795|surgery|surgery
416224|NCT01367795|surgery; palliative|surgery; palliative
416225|NCT01367795|lifestyle|lifestyle
416226|NCT01367782|UPDRS|updrs
416227|NCT01367769|Deep vein thrombosis|deep vein thrombosis
416228|NCT01367769|superficial thrombophlebitis|superficial thrombophlebitis
416229|NCT01367769|contrast ultrasound|contrast ultrasound
416230|NCT01367743|myocardial infarction|myocardial infarction
416231|NCT01367743|epinephrine|epinephrine
416232|NCT01367743|norepinephrine|norepinephrine
416233|NCT01367743|cardiac output|cardiac output
416234|NCT01367730|osteopenia and osteoporosis|osteopenia and osteoporosis
416235|NCT01367717|Creatine|creatine
416236|NCT01367717|Creatinine|creatinine
416237|NCT01367717|Serum Creatinine|serum creatinine
416238|NCT01367717|Urine Creatinine|urine creatinine
416239|NCT01367717|Creatine Monohydrate|creatine monohydrate
416240|NCT01367717|Creatine Ethyl Ester|creatine ethyl ester
416241|NCT01367717|Acute Kidney Injury|acute kidney injury
416242|NCT01367717|Renal|renal
416243|NCT01367717|Kidney|kidney
416244|NCT01367704|gender-based violence|gender-based violence
416245|NCT01367704|intimate partner violence|intimate partner violence
416246|NCT01367704|relationship abuse|relationship abuse
416247|NCT01367704|sexual harassment|sexual harassment
416248|NCT01367704|sexual violence|sexual violence
416249|NCT01367691|CRT|crt
416250|NCT01367691|heart failure|heart failure
416251|NCT01367691|CMR|cmr
416252|NCT01367691|safety|safety
416253|NCT01367639|BRCA 1/2 Carriers|brca 1/2 carriers
416254|NCT01367639|IBSR|ibsr
416255|NCT01367639|The Work|the work
416256|NCT01367639|Randomized clinical trial|randomized clinical trial
416257|NCT01367613|Advanced medical illness|advanced medical illness
416258|NCT01367600|Advanced medical illness|advanced medical illness
416259|NCT01367574|Opioid-induced bowel dysfunction|opioid-induced bowel dysfunction
416260|NCT01367444|Stargardt's Disease|stargardt's disease
416261|NCT01367431|Xanthohumol|xanthohumol
416262|NCT01367431|Metabolic syndrome|metabolic syndrome
416263|NCT01367418|Analgesia: Thoracic epidural, patient controlled|analgesia: thoracic epidural, patient controlled
416264|NCT01367418|Surgery: Radical retropubic prostatectomy|surgery: radical retropubic prostatectomy
416265|NCT01367418|Immune system|immune system
416266|NCT01367418|Inflammation|inflammation
416267|NCT01367405|Surgical decompression|surgical decompression
416268|NCT01367405|conservative treatment|conservative treatment
416269|NCT01367405|incomplete spinal cord lesion|incomplete spinal cord lesion
416270|NCT01367405|recovery|recovery
416271|NCT01367379|Physician|physician
416272|NCT01367379|duty loading|duty loading
416273|NCT01367379|stress response|stress response
416274|NCT01367379|Physician with different amount of duty area|physician with different amount of duty area
416275|NCT01367366|malignant mediastinal lymphadenopathy|malignant mediastinal lymphadenopathy
416276|NCT01367366|positron emission tomography|positron emission tomography
416277|NCT01367366|endobronchial ultrasound|endobronchial ultrasound
416278|NCT01367366|transbronchial needle aspiration|transbronchial needle aspiration
416279|NCT01367327|Exercise|exercise
416280|NCT01367288|locally advanced breast cancer|locally advanced breast cancer
416281|NCT01367288|neoadjuvant chemotherapy|neoadjuvant chemotherapy
416282|NCT01367288|HER2-negative breast cancer|her2-negative breast cancer
416283|NCT01367288|stage IIb breast cancer|stage iib breast cancer
416284|NCT01367288|stage IIIa breast cancer|stage iiia breast cancer
416285|NCT01367288|Zoledronic acid|zoledronic acid
416286|NCT01367288|bisphosphonate|bisphosphonate
416287|NCT01367288|zometa|zometa
416288|NCT01367288|therapeutic response|therapeutic response
416289|NCT01367288|VEGF serum|vegf serum
416290|NCT01367288|tumors markers|tumors markers
416291|NCT01367288|neoangiogenesis|neoangiogenesis
416292|NCT01367288|apoptosis|apoptosis
416293|NCT01367288|proliferation|proliferation
416294|NCT01367288|disseminated tumors cells|disseminated tumors cells
416295|NCT01367288|gamma-delta T cells activation|gamma-delta t cells activation
416296|NCT01367275|colon|colon
416297|NCT01367275|Colorectum|colorectum
416298|NCT01367275|Colorectal Cancer|colorectal cancer
416299|NCT01367275|Plasma FGF|plasma fgf
416300|NCT01367275|Colorectal adenocarcinoma|colorectal adenocarcinoma
416301|NCT01367275|Bevacizumab|bevacizumab
416302|NCT01367275|Brivanib|brivanib
416303|NCT01367275|BMS-582664|bms-582664
416304|NCT01367275|Irinotecan|irinotecan
416305|NCT01367275|CPT-11|cpt-11
416306|NCT01367275|Camptosar|camptosar
416307|NCT01367275|Fibroblast Growth Factor|fibroblast growth factor
416308|NCT01367275|bFGF|bfgf
416309|NCT01367275|tyrosine kinase receptors|tyrosine kinase receptors
416310|NCT01367275|vascular endothelial growth factor receptors|vascular endothelial growth factor receptors
416311|NCT01367275|VEGFR|vegfr
416312|NCT01367275|fibroblast growth factor receptors|fibroblast growth factor receptors
416313|NCT01367275|FGFR|fgfr
416314|NCT01367262|Absorption|absorption
416315|NCT01367262|Distribution|distribution
416316|NCT01367262|Metabolism|metabolism
416317|NCT01367262|Excretion|excretion
416318|NCT01367249|cataract surgery|cataract surgery
416319|NCT01367223|inflammatory response|inflammatory response
416320|NCT01367223|parenteral nutrition|parenteral nutrition
416321|NCT01367223|glutamine|glutamine
416322|NCT01367223|amino acid|amino acid
416323|NCT01367223|pediatric|pediatric
416324|NCT01367223|intensive care|intensive care
416325|NCT01367223|systemic infection|systemic infection
416326|NCT01367223|abdominal surgery|abdominal surgery
416327|NCT01367223|polytraumatised|polytraumatised
416328|NCT01367223|mortality|mortality
416329|NCT01367223|mean stay in the intensive care unit|mean stay in the intensive care unit
416330|NCT01367223|occurrence of infections|occurrence of infections
416332|NCT01367210|AIDS|aids
416333|NCT01367210|Highly Active AntiRetroviral Therapy|highly active antiretroviral therapy
416334|NCT01367210|Simplification|simplification
416335|NCT01367210|Maraviroc|maraviroc
416336|NCT01367210|Darunavir|darunavir
416337|NCT01367210|Treatment experienced|treatment experienced
416338|NCT01367210|Tropism|tropism
416339|NCT01367197|exercise training|exercise training
416340|NCT01367197|atrial fibrillation|atrial fibrillation
416341|NCT01367184|VTE|vte
416342|NCT01367184|Inferior vena cava|inferior vena cava
416343|NCT01367184|Venous thrombo-embolism|venous thrombo-embolism
416344|NCT01367184|Outcome data|outcome data
416345|NCT01367184|IVC Filters|ivc filters
416346|NCT01367158|Meningococcal disease|meningococcal disease
416347|NCT01367158|vaccines|vaccines
416348|NCT01367158|adolescents|adolescents
416349|NCT01367158|prevention|prevention
416350|NCT01367158|Meningitis|meningitis
416351|NCT01367145|OMEGA-3 polyunsaturated fatty-acids|omega-3 polyunsaturated fatty-acids
416352|NCT01367145|Peripheral Arterial Disease|peripheral arterial disease
416353|NCT01367145|Endothelial Function|endothelial function
416354|NCT01367145|Inflammation|inflammation
416355|NCT01367145|Platelet Function|platelet function
416356|NCT01367132|ultrasound|ultrasound
416357|NCT01367132|first trimester|first trimester
416358|NCT01367132|umbilical cord|umbilical cord
416359|NCT01367119|Depression|depression
416360|NCT01367119|Electroconvulsive therapy|electroconvulsive therapy
416361|NCT01367119|Ketamine|ketamine
416362|NCT01367119|Methohexital|methohexital
416363|NCT01367106|offspring of 21-hydroxylase enzyme block|offspring of 21-hydroxylase enzyme block
416364|NCT01367093|BIOLOGICAL MARKERS|biological markers
416365|NCT01367093|INTENSIVE CARE UNIT|intensive care unit
416366|NCT01367093|MORTALITY|mortality
416367|NCT01367093|QUALITY OF LIFE|quality of life
416368|NCT01367093|CARDIOVASCULAR|cardiovascular
416369|NCT01367080|depression|depression
416370|NCT01367067|claustrophobia|claustrophobia
416371|NCT01367067|magnetic resonance imaging|magnetic resonance imaging
416372|NCT01367067|MRI|mri
416373|NCT01367067|anxiety|anxiety
416374|NCT01367067|anxious patients|anxious patients
416375|NCT01367067|phobic disorders|phobic disorders
416376|NCT01367067|anxiety disorders|anxiety disorders
416377|NCT01367067|mental disorders|mental disorders
416378|NCT01367054|Metformine|metformine
416379|NCT01367054|adverse events|adverse events
416380|NCT01367054|bioequivalence|bioequivalence
416381|NCT01367041|bone|bone
416382|NCT01367041|muscle electrical activity|muscle electrical activity
416383|NCT01367041|whole-body vibration|whole-body vibration
416384|NCT01367028|HER2-positive early breast cancer|her2-positive early breast cancer
416385|NCT01367015|Preterm|preterm
416386|NCT01367015|SGA|sga
416387|NCT01367015|AREDF|aredf
416388|NCT01367015|Early feeding|early feeding
416389|NCT01367015|Late feeding|late feeding
416390|NCT01367015|Feed intolerance|feed intolerance
416391|NCT01367015|Necrotizing enterocolitis|necrotizing enterocolitis
416392|NCT01367015|Days to achieve Full Feeds defined as 150 mL/kg|days to achieve full feeds defined as 150 ml/kg
416393|NCT01367002|Uterine serous papillary carcinoma|uterine serous papillary carcinoma
416394|NCT01367002|Type II endometrial cancer|type ii endometrial cancer
416395|NCT01367002|HER2/neu|her2/neu
416396|NCT01367002|Paclitaxel, Carboplatin, Trastuzumab|paclitaxel, carboplatin, trastuzumab
416397|NCT01366989|Total Ankle Arthroplasty|total ankle arthroplasty
416398|NCT01366976|oxidative stress|oxidative stress
416399|NCT01366976|cardiopulmonary bypass|cardiopulmonary bypass
416401|NCT01366976|hemolysis|hemolysis
416402|NCT01366963|postural tachycardia syndrome|postural tachycardia syndrome
416403|NCT01366963|brain fog|brain fog
416404|NCT01366963|cognitive dysfunction|cognitive dysfunction
416405|NCT01366937|vitamin B12|vitamin b12
416407|NCT01366937|14C|14c
416408|NCT01366937|fecal excretion|fecal excretion
416409|NCT01366924|protein turnover|protein turnover
416410|NCT01366924|whole body protein turnover|whole body protein turnover
416411|NCT01366924|essential amino acids|essential amino acids
416412|NCT01366924|leucine|leucine
416413|NCT01366911|stem cells|stem cells
416414|NCT01366911|QCT testing|qct testing
416415|NCT01366911|Bone density findings|bone density findings
416416|NCT01366911|mesenchymal stem cells|mesenchymal stem cells
416417|NCT01366885|Autism|autism
416418|NCT01366885|Pregnancy|pregnancy
416419|NCT01366885|Newborn siblings|newborn siblings
416420|NCT01366872|ankle|ankle
416421|NCT01366872|arthritis|arthritis
416422|NCT01366872|total ankle arthroplasty|total ankle arthroplasty
416423|NCT01366872|Agility LP,|agility lp,
416424|NCT01366859|Autism|autism
416425|NCT01366859|Children|children
416426|NCT01366859|Behavior|behavior
416427|NCT01366859|Glutathione|glutathione
416428|NCT01366859|Whey Protein|whey protein
416429|NCT01366859|Immunocal|immunocal
416430|NCT01366859|Antioxidant|antioxidant
416431|NCT01366846|Peanut|peanut
416432|NCT01366833|Dysphagia|dysphagia
416433|NCT01366833|Esophagus|esophagus
416434|NCT01366833|Cancer|cancer
416435|NCT01366833|Esophageal Cancer|esophageal cancer
416436|NCT01366794|Gut hormones|gut hormones
416437|NCT01366794|Insulin secretion|insulin secretion
416438|NCT01366781|Gut hormones|gut hormones
416439|NCT01366781|Insulin secretion|insulin secretion
416440|NCT01366768|Gut hormones|gut hormones
416441|NCT01366768|Insulin secretion|insulin secretion
416442|NCT01366768|Normal physiology|normal physiology
416443|NCT01366729|hemiplegia|hemiplegia
416444|NCT01366729|walking|walking
416445|NCT01366729|canes|canes
416446|NCT01366729|TheraTogs|theratogs
416447|NCT01366729|EMG|emg
416448|NCT01366729|balance|balance
416449|NCT01366729|Timed up and go|timed up and go
416450|NCT01366716|Contingency Management|contingency management
416451|NCT01366716|Cash|cash
416452|NCT01366716|Substance Abuse|substance abuse
416453|NCT01366716|Ethics|ethics
416454|NCT01366703|heart failure|heart failure
416455|NCT01366703|implantable loop recorder|implantable loop recorder
416456|NCT01366690|HIV|hiv
416457|NCT01366690|community health workers|community health workers
416458|NCT01366690|randomized trial|randomized trial
416459|NCT01366690|task shifting|task shifting
416460|NCT01366690|Uganda|uganda
416461|NCT01366690|retention|retention
416462|NCT01366690|operations research|operations research
416463|NCT01366690|implementation research|implementation research
416464|NCT01366664|Premature Ejaculation|premature ejaculation
416465|NCT01366664|Selective Serotonin Reuptake Inhibitor|selective serotonin reuptake inhibitor
416466|NCT01366664|Dapoxetine|dapoxetine
416467|NCT01366664|PRILIGY|priligy
416468|NCT01366664|Terazosin|terazosin
416469|NCT01366664|Pharmacodynamic|pharmacodynamic
416470|NCT01366664|Pharmacokinetic|pharmacokinetic
416471|NCT01366651|Doripenem|doripenem
416472|NCT01366651|DORIPED1002|doriped1002
416473|NCT01366651|Intravenous|intravenous
416474|NCT01366651|Pediatric|pediatric
416475|NCT01366651|Antibiotic|antibiotic
416476|NCT01366651|Meningitis|meningitis
416477|NCT01366638|Hepatitis C, Chronic|hepatitis c, chronic
416478|NCT01366638|TMC435|tmc435
416479|NCT01366638|Hepatitis C|hepatitis c
416480|NCT01366638|Hepatitis C virus|hepatitis c virus
416481|NCT01366638|Interferon Alfa-2b|interferon alfa-2b
416482|NCT01366638|Ribavirin|ribavirin
416483|NCT01366638|Viral ribonucleic acid|viral ribonucleic acid
416484|NCT01366625|hypertension, resistant|hypertension, resistant
416485|NCT01366625|obstructive sleep apnea|obstructive sleep apnea
416486|NCT01366625|renal denervation|renal denervation
416487|NCT01366625|continuous positive airway pressure therapy|continuous positive airway pressure therapy
416488|NCT01366612|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
416489|NCT01366612|AML|aml
416490|NCT01366612|CML|cml
416491|NCT01366612|MDS|mds
416492|NCT01366599|highly emetogenic chemotherapy|highly emetogenic chemotherapy
416493|NCT01366599|HEC|hec
416494|NCT01366599|moderately emetogenic chemotherapy|moderately emetogenic chemotherapy
416495|NCT01366599|MEC|mec
416496|NCT01366573|Pharmacokinetics|pharmacokinetics
416497|NCT01366573|mu-opioid receptors|mu-opioid receptors
416498|NCT01366573|Addiction|addiction
416499|NCT01366573|Pharmacodynamics|pharmacodynamics
416500|NCT01366573|Alcohol|alcohol
416501|NCT01366547|Bioavailability|bioavailability
416502|NCT01366547|Lamivudine|lamivudine
416503|NCT01366547|Dolutegravir|dolutegravir
416504|NCT01366547|integrase|integrase
416505|NCT01366547|Abacavir|abacavir
416506|NCT01366534|safety|safety
416507|NCT01366534|Vaccine|vaccine
416508|NCT01366534|Phase 1/2|phase 1/2
416509|NCT01366534|immunogenicity|immunogenicity
416510|NCT01366534|Malaria|malaria
416511|NCT01366534|efficacy|efficacy
416512|NCT01366534|sporozoite challenge|sporozoite challenge
416513|NCT01366495|Seek|seek
416514|NCT01366495|Test|test
416515|NCT01366495|Treat|treat
416516|NCT01366482|Peripheral arterial disease,|peripheral arterial disease,
416517|NCT01366482|claudication,|claudication,
416518|NCT01366482|atherectomy,|atherectomy,
416519|NCT01366482|plaque excision,|plaque excision,
416520|NCT01366482|drug-coated balloon|drug-coated balloon
416521|NCT01366482|drug-eluting balloon|drug-eluting balloon
416522|NCT01366469|coronary artery bypass grafting|coronary artery bypass grafting
416523|NCT01366469|coronary artery disease|coronary artery disease
416524|NCT01366469|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
416525|NCT01366456|Temperature Change|temperature change
416526|NCT01366456|Moxibustion|moxibustion
416527|NCT01366456|Warming effect|warming effect
416528|NCT01366443|ROM PLUS|rom plus
416529|NCT01366443|conventional clinical tests of rupture of membranes (ROM)|conventional clinical tests of rupture of membranes (rom)
416530|NCT01366443|speculum exam|speculum exam
416531|NCT01366443|visualization of leakage|visualization of leakage
416532|NCT01366443|pooling of amniotic fluid in the posterior fornix|pooling of amniotic fluid in the posterior fornix
416533|NCT01366443|nitrazine testing|nitrazine testing
416534|NCT01366443|ferning|ferning
416535|NCT01366430|BPPV(benign paroxysmal positional vertigo)|bppv(benign paroxysmal positional vertigo)
416536|NCT01366430|HC-BPPV(BPPV involving the horizontal semicircular canal)|hc-bppv(bppv involving the horizontal semicircular canal)
416537|NCT01366430|Nystagmus|nystagmus
416538|NCT01366430|Treatment outcome|treatment outcome
416539|NCT01366430|Horizontal Canal Benign Paroxysmal Positional Vertigo|horizontal canal benign paroxysmal positional vertigo
416540|NCT01366404|FFR|ffr
416541|NCT01366391|polycystic ovary syndrome|polycystic ovary syndrome
416542|NCT01366391|metformin|metformin
416543|NCT01366391|pharmacokinetic|pharmacokinetic
416544|NCT01366313|paracetamol|paracetamol
416545|NCT01366313|morphine|morphine
416546|NCT01366313|median effective dose|median effective dose
416547|NCT01366313|pain|pain
416548|NCT01366287|Relative bioavailability|relative bioavailability
416549|NCT01366287|food effect|food effect
416550|NCT01366287|tablet|tablet
416551|NCT01366287|suspension|suspension
416552|NCT01366287|single dose|single dose
416553|NCT01366287|crossover|crossover
416554|NCT01366287|healthy subjects|healthy subjects
416555|NCT01366274|Trauma|trauma
416556|NCT01366261|Flex-rigid pleuroscopy|flex-rigid pleuroscopy
416557|NCT01366261|pleural biopsy|pleural biopsy
416558|NCT01366261|pleural effusion|pleural effusion
416559|NCT01366261|safety|safety
416560|NCT01366261|thoracoscopy|thoracoscopy
416561|NCT01366222|asthma|asthma
416562|NCT01366209|Pirfenidone|pirfenidone
416563|NCT01366209|ASCEND|ascend
416564|NCT01366209|IPF|ipf
416565|NCT01366209|FVC|fvc
416566|NCT01366196|Orthopedic Procedures|orthopedic procedures
416567|NCT01366196|Spinal Fusions|spinal fusions
416568|NCT01366196|Pregabalin|pregabalin
416569|NCT01366196|Gamma-Aminobutyric Acid|gamma-aminobutyric acid
416570|NCT01366196|Analgesics|analgesics
416571|NCT01366196|Sensory System Agents|sensory system agents
416572|NCT01366196|Peripheral Nervous System Agents|peripheral nervous system agents
416573|NCT01366196|Physiological Effects of Drugs|physiological effects of drugs
416574|NCT01366196|Pharmacologic Actions|pharmacologic actions
416575|NCT01366196|Central Nervous System Agents|central nervous system agents
416576|NCT01366196|Therapeutic Uses|therapeutic uses
416577|NCT01366196|Anticonvulsants|anticonvulsants
416578|NCT01366196|GABA Agents|gaba agents
416579|NCT01366196|Neurotransmitter Agents|neurotransmitter agents
416580|NCT01366196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
416581|NCT01366170|childhood anaplastic large cell lymphoma|childhood anaplastic large cell lymphoma
416582|NCT01366157|childhood favorable prognosis Hodgkin lymphoma|childhood favorable prognosis hodgkin lymphoma
416583|NCT01366157|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
416584|NCT01366157|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
416585|NCT01366157|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
416586|NCT01366157|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
416587|NCT01366157|childhood lymphocyte depletion Hodgkin lymphoma|childhood lymphocyte depletion hodgkin lymphoma
416588|NCT01366157|childhood lymphocyte predominant Hodgkin lymphoma|childhood lymphocyte predominant hodgkin lymphoma
416589|NCT01366157|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
416590|NCT01366157|childhood nodular lymphocyte predominant Hodgkin lymphoma|childhood nodular lymphocyte predominant hodgkin lymphoma
416591|NCT01366157|childhood nodular sclerosis Hodgkin lymphoma|childhood nodular sclerosis hodgkin lymphoma
416592|NCT01366118|Rectal cancer, Chemoradiotherapy, target therapy|rectal cancer, chemoradiotherapy, target therapy
416593|NCT01366105|Wound healing|wound healing
416594|NCT01366105|Negative Pressure Wound Therapy|negative pressure wound therapy
416595|NCT01366105|V.A.C.|v.a.c.
416596|NCT01366105|Incision|incision
416597|NCT01366092|stem cell transplant|stem cell transplant
416598|NCT01366092|GVHD|gvhd
416599|NCT01366092|bone marrow transplant|bone marrow transplant
416600|NCT01366092|cord blood transplant|cord blood transplant
416601|NCT01366092|regulatory T cell|regulatory t cell
416602|NCT01366092|interleukin|interleukin
416603|NCT01366066|Stress incontinence|stress incontinence
416604|NCT01366066|urge incontinence|urge incontinence
416605|NCT01366066|overactive bladder syndrome|overactive bladder syndrome
416606|NCT01366066|vibration|vibration
416607|NCT01366066|nerve stimulation|nerve stimulation
416608|NCT01366053|Prostate Cancer|prostate cancer
416609|NCT01366053|Androgen Deprivation Therapy|androgen deprivation therapy
416610|NCT01366053|Agonist|agonist
416611|NCT01366053|Antagonist|antagonist
416612|NCT01366053|PSA Failure|psa failure
416613|NCT01366053|PSA Rise|psa rise
416614|NCT01366040|Patient Satisfaction|patient satisfaction
416615|NCT01366040|Multiple Sclerosis|multiple sclerosis
416616|NCT01366040|Autoinjector|autoinjector
416617|NCT01366040|Avonex|avonex
416618|NCT01366027|pseudobulbar affect|pseudobulbar affect
416619|NCT01366014|osteoarthritis|osteoarthritis
416620|NCT01366014|knee|knee
416621|NCT01366014|pain|pain
416622|NCT01366014|NSAID|nsaid
416623|NCT01366001|Opioid|opioid
416624|NCT01366001|Cocaine|cocaine
416625|NCT01366001|Dependence|dependence
416626|NCT01366001|Abuse|abuse
416627|NCT01366001|Intravenous|intravenous
416628|NCT01366001|Buprenorphine|buprenorphine
416629|NCT01365988|fMRI|fmri
416630|NCT01365988|Risk-Taking|risk-taking
416631|NCT01365988|Decision-Making|decision-making
416632|NCT01365988|Memory|memory
416633|NCT01365988|Resting-State Functional Connectivity|resting-state functional connectivity
416634|NCT01365975|Cohort Study|cohort study
416635|NCT01365975|Folinic Acid, peri-conception|folinic acid, peri-conception
416636|NCT01365975|Pediatric Leukemia|pediatric leukemia
416637|NCT01365975|Pediatric Cancer|pediatric cancer
416638|NCT01365962|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
416639|NCT01365962|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
416640|NCT01365962|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
416641|NCT01365962|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
416642|NCT01365962|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
416643|NCT01365949|Ewing sarcoma/peripheral primitive neuroectodermal tumor (PNET)|ewing sarcoma/peripheral primitive neuroectodermal tumor (pnet)
416644|NCT01365936|IVF|ivf
416645|NCT01365936|ICSI|icsi
416646|NCT01365936|OHSS|ohss
416647|NCT01365936|PCOS|pcos
416648|NCT01365936|recFSH|recfsh
416649|NCT01365936|HMG|hmg
416650|NCT01365897|Modafinil|modafinil
416651|NCT01365897|Memory|memory
416652|NCT01365897|Executive Functions|executive functions
416653|NCT01365897|Memory, Short-Term|memory, short-term
416654|NCT01365897|Attention|attention
416655|NCT01365897|University Students|university students
416656|NCT01365897|Stroop Effect|stroop effect
416657|NCT01365897|Digit Span|digit span
416658|NCT01365897|Backwards Digit Span|backwards digit span
416659|NCT01365897|Biber Cognitive Estimation Test|biber cognitive estimation test
416660|NCT01365871|prostate biopsy|prostate biopsy
416661|NCT01365871|pain|pain
416662|NCT01365845|Proton Radiation|proton radiation
416663|NCT01365845|Breast Cancer|breast cancer
416664|NCT01365819|Crystal meth dependence|crystal meth dependence
416665|NCT01365819|crystal meth|crystal meth
416666|NCT01365819|methamphetamine dependence|methamphetamine dependence
416667|NCT01365819|substance abuse|substance abuse
416668|NCT01365806|heart transplantation|heart transplantation
416669|NCT01365806|allograft rejection|allograft rejection
416670|NCT01365806|QT interval|qt interval
416671|NCT01365806|electrocardiogram (ECG)|electrocardiogram (ecg)
416672|NCT01365793|cerebral edema|cerebral edema
416673|NCT01365793|diabetic ketoacidosis|diabetic ketoacidosis
416674|NCT01365793|pediatric diabetes|pediatric diabetes
416675|NCT01365793|fluid therapy|fluid therapy
416676|NCT01365780|microcirculation, O2c|microcirculation, o2c
416677|NCT01365767|Crohn disease|crohn disease
416678|NCT01365767|Ultrasonography, contrast enhanced|ultrasonography, contrast enhanced
416679|NCT01365767|Elasticity Imaging Techniques|elasticity imaging techniques
416680|NCT01365767|Small intestine|small intestine
416681|NCT01365767|Magnetic Resonance Imaging|magnetic resonance imaging
416682|NCT01365767|CDAI|cdai
416683|NCT01365767|Calprotectin|calprotectin
416684|NCT01365767|IBD|ibd
416685|NCT01365767|Sonography|sonography
416686|NCT01365754|Lumbar degenerative disease|lumbar degenerative disease
416687|NCT01365741|PCI|pci
416688|NCT01365741|STEMI|stemi
416689|NCT01365741|Interventions|interventions
416690|NCT01365741|Heart disease|heart disease
416691|NCT01365741|Thrombocytic inhibition|thrombocytic inhibition
416692|NCT01365741|Cross-over study|cross-over study
416693|NCT01365741|Percutaneous coronary intervention|percutaneous coronary intervention
416694|NCT01365728|Femtosecond Laser|femtosecond laser
416695|NCT01365728|FS60|fs60
416696|NCT01365728|iFS|ifs
416697|NCT01365728|Intralase|intralase
416698|NCT01365728|Wavefront-guided LASIK|wavefront-guided lasik
416699|NCT01365728|IntraLASIK|intralasik
416700|NCT01365728|LASIK|lasik
416701|NCT01365728|Myopia|myopia
416702|NCT01365728|Nearsightedness|nearsightedness
416703|NCT01365715|Preoperative embolization|preoperative embolization
416704|NCT01365715|Transcatheter arterial embolization|transcatheter arterial embolization
416705|NCT01365715|Therapeutic angiography|therapeutic angiography
416706|NCT01365715|Embolization|embolization
416707|NCT01365715|Surgical blood loss|surgical blood loss
416708|NCT01365715|Spinal metastases|spinal metastases
416709|NCT01365715|Spinal neoplasms|spinal neoplasms
416710|NCT01365715|Vertebral metastases|vertebral metastases
416711|NCT01365715|metastatic spine surgery|metastatic spine surgery
416712|NCT01365715|Spinal surgery|spinal surgery
416713|NCT01365702|COPD|copd
416714|NCT01365702|tiotropium|tiotropium
416715|NCT01365702|tuberculous destroyed lung|tuberculous destroyed lung
416716|NCT01365676|Edema|edema
416717|NCT01365676|Depression|depression
416718|NCT01365676|Hot Flashes|hot flashes
416719|NCT01365676|Anxiety|anxiety
416720|NCT01365676|Irritability|irritability
416721|NCT01365676|PMS|pms
416722|NCT01365663|Hypercholesterolemia|hypercholesterolemia
416723|NCT01365663|LDL|ldl
416724|NCT01365663|HDL|hdl
416725|NCT01365663|apoB|apob
416726|NCT01365663|hyperlipidemia|hyperlipidemia
416727|NCT01365663|LNA-oligonucleotide|lna-oligonucleotide
416728|NCT01365637|safety|safety
416729|NCT01365637|tolerability|tolerability
416730|NCT01365637|pharmacokinetics|pharmacokinetics
416731|NCT01365637|PF-05089771|pf-05089771
416732|NCT01365598|malaria|malaria
416733|NCT01365598|uncomplicated malaria|uncomplicated malaria
416734|NCT01365598|gametocytocidal drug|gametocytocidal drug
416735|NCT01365598|gametocytocidal|gametocytocidal
416736|NCT01365598|gametocyte|gametocyte
416737|NCT01365598|primaquine|primaquine
416738|NCT01365598|transmission blocking|transmission blocking
416739|NCT01365598|malaria transmission|malaria transmission
416740|NCT01365598|sexual parasite|sexual parasite
416741|NCT01365598|sexual stage|sexual stage
416742|NCT01365598|Uganda|uganda
416743|NCT01365598|Africa|africa
416744|NCT01365585|Pulmonary arterial hypertension|pulmonary arterial hypertension
416745|NCT01365585|sildenafil citrate|sildenafil citrate
416746|NCT01365585|Revatio|revatio
416747|NCT01365572|Drug-eluting stent|drug-eluting stent
416748|NCT01365559|multiple myeloma|multiple myeloma
416749|NCT01365559|carfilzomib|carfilzomib
416750|NCT01365559|relapsed|relapsed
416751|NCT01365559|refractory|refractory
416752|NCT01365559|bortezomib|bortezomib
416753|NCT01365559|Oncotherapeutics|oncotherapeutics
416754|NCT01365533|Airway Inflammation|airway inflammation
416755|NCT01365533|Roflumilast|roflumilast
416756|NCT01365494|Rabies|rabies
416757|NCT01365494|rabies vaccines|rabies vaccines
416758|NCT01365494|post-exposure prophylaxis|post-exposure prophylaxis
416759|NCT01365481|Hypertension, pediatric|hypertension, pediatric
416760|NCT01365481|Hypertension with or without chronic kidney disease|hypertension with or without chronic kidney disease
416761|NCT01365468|RAD001,|rad001,
416762|NCT01365468|Everolimus,|everolimus,
416763|NCT01365468|Plexiform Neurofibroma,|plexiform neurofibroma,
416764|NCT01365468|Neurofibromatosis Type 1|neurofibromatosis type 1
416765|NCT01365455|Psoriasis|psoriasis
416766|NCT01365455|plaque|plaque
416767|NCT01365455|plaque-type psoriasis|plaque-type psoriasis
416768|NCT01365455|IL-17 blocker|il-17 blocker
416769|NCT01365455|subcutaneous|subcutaneous
416770|NCT01365455|psoriatic arthritis|psoriatic arthritis
416771|NCT01365455|injection|injection
416772|NCT01365455|AIN457|ain457
416773|NCT01365455|AIN457A|ain457a
416774|NCT01365455|secukinumab|secukinumab
416775|NCT01365442|Cholera|cholera
416776|NCT01365442|Vaccination|vaccination
416777|NCT01365442|Oral cholera vaccine|oral cholera vaccine
416778|NCT01365442|Mass vaccination|mass vaccination
416779|NCT01365442|Oral whole cell cholera vaccine|oral whole cell cholera vaccine
416780|NCT01365429|Lung Transplant, Transplantation Lung|lung transplant, transplantation lung
416781|NCT01365416|diabetes|diabetes
416782|NCT01365416|diabetes remission|diabetes remission
416783|NCT01365416|obesity|obesity
416784|NCT01365416|bariatric surgery|bariatric surgery
416785|NCT01365416|gene expression|gene expression
416786|NCT01365416|genetic variation|genetic variation
416787|NCT01365416|metabolomics|metabolomics
416788|NCT01365416|metabonomics|metabonomics
416789|NCT01365416|epigenetic variation|epigenetic variation
416790|NCT01365416|mutations|mutations
416791|NCT01365390|prospective|prospective
416792|NCT01365390|Incidence|incidence
416793|NCT01365390|otitis|otitis
416794|NCT01365390|observational|observational
416795|NCT01365390|Epidemiological|epidemiological
416796|NCT01365390|retrospective|retrospective
416797|NCT01365377|Anxiety|anxiety
416798|NCT01365377|Depression|depression
416799|NCT01365377|Post-traumatic stress disorders|post-traumatic stress disorders
416800|NCT01365377|Quality of life|quality of life
416801|NCT01365377|Family|family
416802|NCT01365377|ICU|icu
416803|NCT01365364|PLM|plm
416804|NCT01365364|dopamine|dopamine
416805|NCT01365364|physical exercise|physical exercise
416806|NCT01365338|schizophrenia fMRI cognition working memory ASL|schizophrenia fmri cognition working memory asl
416807|NCT01365312|Central line associated infection|central line associated infection
416808|NCT01365312|PICC associated infection|picc associated infection
416809|NCT01365312|Neonatal central line associated sepsis|neonatal central line associated sepsis
416810|NCT01365312|Central line colonization|central line colonization
416811|NCT01365312|Ethanol Lock|ethanol lock
416812|NCT01365286|asthma, chronic obstructive pulmonary disease, COPD, ivabradine, heart rate|asthma, chronic obstructive pulmonary disease, copd, ivabradine, heart rate
416813|NCT01365273|Split thickness skin grafts|split thickness skin grafts
416814|NCT01365273|Mepitel One|mepitel one
416815|NCT01365273|Bridal Veil and staples|bridal veil and staples
416816|NCT01365273|Pain|pain
416817|NCT01365247|Co-morbid substance disorders and PTSD|co-morbid substance disorders and ptsd
416818|NCT01365247|Trauma|trauma
416819|NCT01365247|Alcohol and other drug use disorders|alcohol and other drug use disorders
416820|NCT01365247|Treatment outcome|treatment outcome
416821|NCT01365247|Post-Traumatic Stress Disorder (PTSD)|post-traumatic stress disorder (ptsd)
416822|NCT01365247|Co-morbid Alcohol and other drug use disorders (AOD)|co-morbid alcohol and other drug use disorders (aod)
416823|NCT01365247|Behavioral Treatment|behavioral treatment
416824|NCT01365221|Acute Coronary Syndrome|acute coronary syndrome
416825|NCT01365221|Clopidogrel|clopidogrel
416826|NCT01365221|Prasugrel|prasugrel
416827|NCT01365195|opioid|opioid
416828|NCT01365195|Fentanyl|fentanyl
416829|NCT01365195|Anesthetic adjuvant|anesthetic adjuvant
416830|NCT01365195|Pain management|pain management
416831|NCT01365195|Perioperative outcomes|perioperative outcomes
416832|NCT01365195|Constipation|constipation
416833|NCT01365195|Ileus|ileus
416834|NCT01365195|Colorectal|colorectal
416835|NCT01365182|prostate cancer|prostate cancer
416836|NCT01365182|urinary incontinence|urinary incontinence
416837|NCT01365182|pelvic floor muscle exercise|pelvic floor muscle exercise
416838|NCT01365182|self-management|self-management
416839|NCT01365182|behavioral intervention|behavioral intervention
416840|NCT01365182|quality of life|quality of life
416841|NCT01365169|Cyberinfrastructure|cyberinfrastructure
416842|NCT01365169|CI|ci
416843|NCT01365169|CYCORE|cycore
416844|NCT01365169|Quality of Life|quality of life
416845|NCT01365169|QOL|qol
416846|NCT01365169|Head and Neck|head and neck
416847|NCT01365169|H&N|h&n
416848|NCT01365169|Carbon Monoxide|carbon monoxide
416849|NCT01365169|CO|co
416850|NCT01365169|Colorectal Cancer|colorectal cancer
417350|NCT01363128|HCVAD|hcvad
416851|NCT01365169|Oropharyngeal Cancer|oropharyngeal cancer
416852|NCT01365169|Laryngeal Cancer|laryngeal cancer
416853|NCT01365169|Hypopharyngeal Cancer|hypopharyngeal cancer
416854|NCT01365169|Nasopharyngeal Cancer|nasopharyngeal cancer
416855|NCT01365169|Smoker|smoker
416856|NCT01365169|Recent Smoking Cessation|recent smoking cessation
416857|NCT01365156|locally advanced cervical cancer|locally advanced cervical cancer
416858|NCT01365156|pretherapeutic para-aortic surgical staging|pretherapeutic para-aortic surgical staging
416859|NCT01365156|radiologic staging|radiologic staging
416860|NCT01365156|pretherapeutic surgical staging|pretherapeutic surgical staging
416861|NCT01365156|para-aortic metastatic disease|para-aortic metastatic disease
416862|NCT01365130|esophageal cancer|esophageal cancer
416863|NCT01365130|gastroesophageal cancer|gastroesophageal cancer
416864|NCT01365130|gastric cancer|gastric cancer
416865|NCT01365104|brain blood flow|brain blood flow
416866|NCT01365104|stroke|stroke
416867|NCT01365104|cerebrovascular|cerebrovascular
416868|NCT01365104|aging|aging
416869|NCT01365104|cerebrovascular hemodynamics|cerebrovascular hemodynamics
416870|NCT01365078|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
416871|NCT01365078|Stearidonic acid|stearidonic acid
416872|NCT01365078|Lipid metabolism|lipid metabolism
416873|NCT01365078|Serum triacylglycerol|serum triacylglycerol
416874|NCT01365052|Maximum Use Safety Trial|maximum use safety trial
416875|NCT01365039|contact lens|contact lens
416876|NCT01365026|Healthy Lifestyle|healthy lifestyle
416877|NCT01365026|Health promotion|health promotion
416878|NCT01365026|Counselling|counselling
416879|NCT01365026|Action Plan|action plan
416880|NCT01365026|Primary Health Care|primary health care
416881|NCT01365013|Lifestyle|lifestyle
416882|NCT01365013|Prediabetic State|prediabetic state
416883|NCT01365013|Patient Education|patient education
416884|NCT01365013|Primary Health Care|primary health care
416885|NCT01365000|Phase 1|phase 1
416886|NCT01365000|Pharmacokinetics|pharmacokinetics
416887|NCT01365000|NKTR-118|nktr-118
416888|NCT01365000|fasting or fed state|fasting or fed state
416889|NCT01365000|cross-over study|cross-over study
416890|NCT01365000|AUC(0-t)|auc(0-t)
416891|NCT01365000|Cmax|cmax
416892|NCT01365000|tmax|tmax
416893|NCT01365000|QTcF Interval|qtcf interval
416894|NCT01364987|transplant|transplant
416895|NCT01364987|ASP015K|asp015k
416896|NCT01364987|healthy subjects|healthy subjects
416897|NCT01364974|ASP015K|asp015k
416898|NCT01364974|Healthy subjects|healthy subjects
416899|NCT01364961|Resveratrol|resveratrol
416900|NCT01364961|FMD|fmd
416901|NCT01364961|PWV|pwv
416902|NCT01364961|HDL-cholesterol|hdl-cholesterol
416903|NCT01364961|Macrovasculature|macrovasculature
416904|NCT01364961|Microvasculature|microvasculature
416905|NCT01364948|Preterm|preterm
416906|NCT01364948|VLBW|vlbw
416907|NCT01364948|Coconut Oil application|coconut oil application
416908|NCT01364948|Trans epidermal water loss|trans epidermal water loss
416909|NCT01364948|Weight gain|weight gain
416910|NCT01364909|Sepsis|sepsis
416911|NCT01364909|Severe sepsis|severe sepsis
416912|NCT01364909|Septic shock|septic shock
416913|NCT01364909|Septicaemia|septicaemia
416914|NCT01364909|Bacteremia|bacteremia
416915|NCT01364896|Non-corticosteroid immunosuppressive agent|non-corticosteroid immunosuppressive agent
416916|NCT01364883|Vaccine|vaccine
416917|NCT01364883|Immune response|immune response
416918|NCT01364870|Knee OA|knee oa
416919|NCT01364870|TENS|tens
416920|NCT01364870|Total knee replacement|total knee replacement
416921|NCT01364870|Knee arthroplasty|knee arthroplasty
416922|NCT01364870|total unilateral knee replacement|total unilateral knee replacement
416923|NCT01364857|port wine stain of a limb|port wine stain of a limb
416924|NCT01364831|sleep time|sleep time
416925|NCT01364831|athletic performance|athletic performance
416926|NCT01364792|schizophrenia|schizophrenia
416927|NCT01364792|treatment|treatment
416928|NCT01364792|inflammation|inflammation
416929|NCT01364792|neuroinflammation|neuroinflammation
416930|NCT01364792|hippocampal|hippocampal
416931|NCT01364779|aspirin|aspirin
416932|NCT01364779|Chronic kidney disease|chronic kidney disease
416933|NCT01364753|Memory|memory
416934|NCT01364753|Aviation|aviation
416935|NCT01364714|ICU acquired weakness|icu acquired weakness
416936|NCT01364701|Erectile dysfunction|erectile dysfunction
416937|NCT01364701|combination therapy|combination therapy
416938|NCT01364701|Sildenafil|sildenafil
416939|NCT01364701|tadalafil|tadalafil
416940|NCT01364701|PDE5i|pde5i
416941|NCT01364701|No Conditions|no conditions
416942|NCT01364688|coronary calcification|coronary calcification
416943|NCT01364688|vascular calcification|vascular calcification
416944|NCT01364688|active vitamin D|active vitamin d
416945|NCT01364688|alfacalcidol|alfacalcidol
416946|NCT01364675|Impaired fasting glucose|impaired fasting glucose
416947|NCT01364675|Impaired glucose tolerance|impaired glucose tolerance
416948|NCT01364675|Pre-diabetes|pre-diabetes
416949|NCT01364675|Pre-hypertensives|pre-hypertensives
416950|NCT01364675|Cardiovascular events|cardiovascular events
416951|NCT01364662|Impulsive Aggression|impulsive aggression
416952|NCT01364662|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
416953|NCT01364662|ADHD|adhd
416954|NCT01364649|Sexual Dysfunction, Physiological|sexual dysfunction, physiological
416955|NCT01364649|Depressive Disorder, Major|depressive disorder, major
416956|NCT01364649|Depression|depression
416957|NCT01364649|Antidepressive Agents|antidepressive agents
416958|NCT01364649|Drug Therapy|drug therapy
416959|NCT01364636|1-Heart Failure|1-heart failure
416960|NCT01364636|2-Acute Heart Failure|2-acute heart failure
416961|NCT01364636|3-Acute Decompensated Heart Failure|3-acute decompensated heart failure
416962|NCT01364636|4-Worsening Renal Function|4-worsening renal function
416963|NCT01364636|5-Acute Kidney Injury|5-acute kidney injury
416964|NCT01364636|6-Cardiorenal Syndrome|6-cardiorenal syndrome
416965|NCT01364623|testosterone|testosterone
416966|NCT01364623|pharmacokinetics|pharmacokinetics
416967|NCT01364610|diagnosis|diagnosis
416968|NCT01364610|pH measurement|ph measurement
416969|NCT01364610|catheter|catheter
416970|NCT01364610|wireless|wireless
416971|NCT01364597|Brivaracetam|brivaracetam
416972|NCT01364597|Epilepsy|epilepsy
416973|NCT01364597|Child|child
416974|NCT01364597|Infant|infant
416975|NCT01364597|Adolescents|adolescents
416976|NCT01364571|Staphylococcus aureus|staphylococcus aureus
416977|NCT01364571|vaccine|vaccine
416978|NCT01364571|staphylococcal infection|staphylococcal infection
416979|NCT01364532|transulnar arterial access|transulnar arterial access
416980|NCT01364532|transradial arterial access|transradial arterial access
416981|NCT01364532|percutaneous coronary intervention|percutaneous coronary intervention
416982|NCT01364519|COPD|copd
416983|NCT01364506|Cardiovascular capacity|cardiovascular capacity
416984|NCT01364506|Water exercise|water exercise
416985|NCT01364506|Hydrokinetic Therapy|hydrokinetic therapy
416986|NCT01364506|Pregnancy|pregnancy
416987|NCT01364506|Perinatal outcomes|perinatal outcomes
416988|NCT01364493|HER2-positive|her2-positive
416989|NCT01364493|adenocarcinoma of the stomach or gastro-esophageal junction|adenocarcinoma of the stomach or gastro-esophageal junction
416990|NCT01364493|Inoperable|inoperable
416991|NCT01364493|locally advanced|locally advanced
416992|NCT01364493|recurrent|recurrent
416993|NCT01364493|metastatic|metastatic
416994|NCT01364480|Tetraplegia|tetraplegia
416995|NCT01364480|Spinal cord injury|spinal cord injury
416996|NCT01364480|Brainstem or spinal stroke|brainstem or spinal stroke
416997|NCT01364480|Neuroprosthetic|neuroprosthetic
416998|NCT01364480|Brain-machine interface|brain-machine interface
416999|NCT01364480|Brain-computer interface|brain-computer interface
417000|NCT01364480|Neural activity|neural activity
417001|NCT01364454|Colorectal Cancer Screening|colorectal cancer screening
417002|NCT01364454|Faecal Occult Blood test|faecal occult blood test
417003|NCT01364454|General Practitioners Involvement|general practitioners involvement
417004|NCT01364454|Patient's Participation|patient's participation
417005|NCT01364454|Reminder|reminder
417006|NCT01364441|ONO-2950|ono-2950
417007|NCT01364441|healthy adult subjects|healthy adult subjects
417008|NCT01364441|first in human|first in human
417009|NCT01364441|safety|safety
417010|NCT01364441|tolerability|tolerability
417011|NCT01364441|pharmacokinetics|pharmacokinetics
417013|NCT01364415|pasireotide|pasireotide
417014|NCT01364415|LAR|lar
417015|NCT01364415|NETs|nets
417016|NCT01364415|advanced neuroendocrine tumors|advanced neuroendocrine tumors
417017|NCT01364402|scheduled for PCI|scheduled for pci
417018|NCT01364389|Polymyalgia Rheumatica|polymyalgia rheumatica
417019|NCT01364389|Inflammatory Disease|inflammatory disease
417020|NCT01364389|Rheumatic Disease|rheumatic disease
417021|NCT01364376|Gastric Cancer|gastric cancer
417022|NCT01364363|Transplant|transplant
417023|NCT01364363|Allogeneic|allogeneic
417024|NCT01364363|Allogeneic transplant|allogeneic transplant
417025|NCT01364363|Unrelated donor transplant|unrelated donor transplant
417026|NCT01364363|MUD|mud
417027|NCT01364363|HSCT|hsct
417028|NCT01364363|Stem cell transplant|stem cell transplant
417029|NCT01364350|type 2 diabetes mellitus|type 2 diabetes mellitus
417030|NCT01364350|pediatrics|pediatrics
417031|NCT01364350|post-intervention study|post-intervention study
417032|NCT01364350|metformin|metformin
417033|NCT01364350|complications|complications
417034|NCT01364337|Hypertension|hypertension
417035|NCT01364324|tuberculosis|tuberculosis
417036|NCT01364324|pharmacokinetics|pharmacokinetics
417037|NCT01364324|first-line drugs|first-line drugs
417038|NCT01364324|gastrectomy|gastrectomy
417039|NCT01364311|Dry Eye Syndromes|dry eye syndromes
417040|NCT01364311|Dietary Supplements|dietary supplements
417041|NCT01364311|Vitamac® Tag and Nacht capsules|vitamac® tag and nacht capsules
417042|NCT01364311|Lutein|lutein
417043|NCT01364311|Vitamin C|vitamin c
417044|NCT01364311|Zinc|zinc
417045|NCT01364311|ginkgo biloba|ginkgo biloba
417046|NCT01364311|Flavinoids|flavinoids
417047|NCT01364311|Fishoil|fishoil
417048|NCT01364311|Zeaxanthin|zeaxanthin
417049|NCT01364311|Vitamin E|vitamin e
417050|NCT01364311|Copper|copper
417051|NCT01364311|Selen|selen
417052|NCT01364311|Alpha Lipon acid|alpha lipon acid
417053|NCT01364311|Break up time (BUT)|break up time (but)
417054|NCT01364311|Improvement of subjective symptoms of dry eye syndrome|improvement of subjective symptoms of dry eye syndrome
417055|NCT01364311|Visual Acuity|visual acuity
417056|NCT01364311|Tear film osmolarity|tear film osmolarity
417057|NCT01364311|OSI (Objective Scattering Index)|osi (objective scattering index)
417058|NCT01364311|Schirmer I test|schirmer i test
417059|NCT01364311|Staining of the cornea with fluorescein|staining of the cornea with fluorescein
417060|NCT01364311|Impression cytology|impression cytology
417061|NCT01364311|Tear cytokines/chemokines|tear cytokines/chemokines
417062|NCT01364311|Data from patient diary how often Hylo-Comod® eye drops were used|data from patient diary how often hylo-comod® eye drops were used
417063|NCT01364298|Gabapentin/B complex|gabapentin/b complex
417064|NCT01364298|Pregabalin|pregabalin
417065|NCT01364298|Pain|pain
417066|NCT01364298|Neuropathic|neuropathic
417067|NCT01364298|Gavindo|gavindo
417068|NCT01364298|Lyrica|lyrica
417069|NCT01364259|tic douloureux|tic douloureux
417070|NCT01364246|Progressive Multiple Sclerosis|progressive multiple sclerosis
417071|NCT01364246|neuromyelitis optica|neuromyelitis optica
417072|NCT01364246|Umbilical Cord Mesenchymal Stem Cell|umbilical cord mesenchymal stem cell
417073|NCT01364220|Additional relevant MeSH terms|additional relevant mesh terms
417074|NCT01364220|Stroke|stroke
417075|NCT01364220|Cerebral Infarction|cerebral infarction
417076|NCT01364220|Cerebrovascular Disorders|cerebrovascular disorders
417077|NCT01364220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
417078|NCT01364220|Magnetic Resonance Imaging|magnetic resonance imaging
417079|NCT01364220|Recurrence|recurrence
417080|NCT01364194|Post operative pain|post operative pain
417081|NCT01364194|Total knee replacement|total knee replacement
417082|NCT01364194|Total knee arthroplasty|total knee arthroplasty
417083|NCT01364194|Bupivacaine|bupivacaine
417084|NCT01364194|Periarticular injection|periarticular injection
417085|NCT01364194|Placebo|placebo
417086|NCT01364194|Morphine consumption|morphine consumption
417087|NCT01364181|Udenafil|udenafil
417088|NCT01364181|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
417089|NCT01364181|pulmonary hypertension|pulmonary hypertension
417090|NCT01364181|Phosphodiesterase 5 inhibitors|phosphodiesterase 5 inhibitors
417091|NCT01364181|Exercise|exercise
417092|NCT01364181|Dyspnea|dyspnea
417093|NCT01364129|Diabetes|diabetes
417094|NCT01364129|Diabetic Retinopathy Screening|diabetic retinopathy screening
417095|NCT01364129|Ophthalmic Telemedicine|ophthalmic telemedicine
417096|NCT01364129|Comparative Effectiveness Research|comparative effectiveness research
417097|NCT01364116|Pulse CO-Oximetry™|pulse co-oximetry™
417098|NCT01364116|children|children
417099|NCT01364116|noninvasive|noninvasive
417100|NCT01364103|pulse pressure variation|pulse pressure variation
417101|NCT01364103|systolic pressure variation|systolic pressure variation
417102|NCT01364103|central venous pressure|central venous pressure
417103|NCT01364103|aortic blood flow velocity variation|aortic blood flow velocity variation
417104|NCT01364103|pleth variability index|pleth variability index
417105|NCT01364090|hepatitis C|hepatitis c
417106|NCT01364090|treatment|treatment
417107|NCT01364090|injection drug users or receiving opiate substitution therapy|injection drug users or receiving opiate substitution therapy
417108|NCT01364077|Heart rate|heart rate
417109|NCT01364077|Dialysis|dialysis
417110|NCT01364077|ESRD|esrd
417111|NCT01364077|ivabradine|ivabradine
417112|NCT01363973|oropharyngeal dysphagia|oropharyngeal dysphagia
417113|NCT01363973|post-stroke|post-stroke
417114|NCT01363960|Incidence|incidence
417115|NCT01363960|neonatal care|neonatal care
417116|NCT01363960|retinopathy of prematurity|retinopathy of prematurity
417117|NCT01363960|risk factors|risk factors
417118|NCT01363934|Erythropoietin|erythropoietin
417119|NCT01363934|EPO-hFC|epo-hfc
417120|NCT01363921|CKD5|ckd5
417121|NCT01363921|dialysis|dialysis
417122|NCT01363921|high porous membranes|high porous membranes
417123|NCT01363921|micro-inflammation|micro-inflammation
417124|NCT01363908|Beta-Thalassemia|beta-thalassemia
417125|NCT01363908|Sickle Cell Anemia|sickle cell anemia
417126|NCT01363908|Transfusional iron overload|transfusional iron overload
417127|NCT01363908|Iron Overload|iron overload
417128|NCT01363908|Iron Chelation|iron chelation
417129|NCT01363895|atrial fibrillation|atrial fibrillation
417130|NCT01363895|catheter ablation|catheter ablation
417131|NCT01363895|percutaneous closure of LAA|percutaneous closure of laa
417132|NCT01363895|intervention|intervention
417133|NCT01363882|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
417134|NCT01363882|Noninvasive Ventilation|noninvasive ventilation
417135|NCT01363882|Respiratory Dysfunction|respiratory dysfunction
417136|NCT01363882|Positive Pressure Ventilation|positive pressure ventilation
417137|NCT01363869|hyperuricemia|hyperuricemia
417138|NCT01363869|gout|gout
417139|NCT01363869|uric acid|uric acid
417140|NCT01363869|xanthine oxidase inhibitor|xanthine oxidase inhibitor
417141|NCT01363869|green tea|green tea
417142|NCT01363869|catechins|catechins
417143|NCT01363869|antioxidant|antioxidant
417144|NCT01363856|first ever stroke|first ever stroke
417145|NCT01363843|neoadjuvant|neoadjuvant
417146|NCT01363843|chemo/radiation|chemo/radiation
417147|NCT01363843|rectal cancer|rectal cancer
417148|NCT01363843|rectum cancer|rectum cancer
417149|NCT01363843|colon cancer|colon cancer
417150|NCT01363843|colorectal cancer|colorectal cancer
417151|NCT01363830|Disc|disc
417152|NCT01363830|lumbar|lumbar
417153|NCT01363830|herniation|herniation
417154|NCT01363804|AV-951|av-951
417155|NCT01363804|Tivozanib|tivozanib
417156|NCT01363804|Healthy Subjects|healthy subjects
417157|NCT01363804|rifampin|rifampin
417158|NCT01363804|Pharmacokinetics|pharmacokinetics
417159|NCT01363791|Systematic review and meta-analysis|systematic review and meta-analysis
417160|NCT01363791|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
417161|NCT01363791|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
417162|NCT01363791|Clinical practice guidelines|clinical practice guidelines
417163|NCT01363791|Clinical trials|clinical trials
417164|NCT01363791|Dietary sugars|dietary sugars
417165|NCT01363791|Fructose|fructose
417166|NCT01363791|High fructose corn syrup|high fructose corn syrup
417167|NCT01363791|Fruit|fruit
417168|NCT01363791|Isocaloric|isocaloric
417169|NCT01363791|Hypercaloric|hypercaloric
417170|NCT01363791|Cardiometabolic risk factors|cardiometabolic risk factors
417171|NCT01363791|Triglycerides|triglycerides
417172|NCT01363791|Cholesterol|cholesterol
417173|NCT01363791|Glycemic control|glycemic control
417174|NCT01363791|Insulin resistance|insulin resistance
417175|NCT01363791|Body weight|body weight
417176|NCT01363791|Uric acid|uric acid
417177|NCT01363791|Blood pressure|blood pressure
417178|NCT01363791|Fatty liver|fatty liver
417179|NCT01363791|Fasting|fasting
417180|NCT01363791|Postprandial|postprandial
417181|NCT01363778|AV-951|av-951
417182|NCT01363778|Tivozanib|tivozanib
417183|NCT01363778|Healthy Subjects|healthy subjects
417184|NCT01363778|ketoconazole|ketoconazole
417185|NCT01363778|Pharmacokinetics|pharmacokinetics
417186|NCT01363765|diagnosis|diagnosis
417187|NCT01363765|polymerase chain reaction|polymerase chain reaction
417188|NCT01363765|sputum smear|sputum smear
417189|NCT01363765|stepped-wedge design|stepped-wedge design
417190|NCT01363765|cost-effectiveness|cost-effectiveness
417191|NCT01363765|Xpert MTB/Rif|xpert mtb/rif
417192|NCT01363752|Kidney|kidney
417193|NCT01363752|Transplant|transplant
417194|NCT01363752|Immunosuppression|immunosuppression
417195|NCT01363752|Kidney Failure, Acute|kidney failure, acute
417196|NCT01363752|Advagraf|advagraf
417197|NCT01363752|Tacrolimus|tacrolimus
417198|NCT01363752|Astagraf XL|astagraf xl
417199|NCT01363739|VEGF polymorphism Bevacizumab|vegf polymorphism bevacizumab
417200|NCT01363726|surveillance Rotavirus Gastroenteritis Children|surveillance rotavirus gastroenteritis children
417201|NCT01363726|< 5 years of age|< 5 years of age
417202|NCT01363726|southern Israel|southern israel
417203|NCT01363726|Signed informed concent|signed informed concent
417204|NCT01363674|Growth disorders|growth disorders
417205|NCT01363674|Saizen|saizen
417206|NCT01363674|Easypod|easypod
417207|NCT01363674|Growth hormone|growth hormone
417208|NCT01363674|Pediatric subject|pediatric subject
417209|NCT01363661|angina pectoris|angina pectoris
417210|NCT01363661|atherosclerosis|atherosclerosis
417211|NCT01363661|endothelial dysfunction|endothelial dysfunction
417212|NCT01363648|VCI-HS|vci-hs
417213|NCT01363648|stroke|stroke
417214|NCT01363648|choline alphoscerate|choline alphoscerate
417215|NCT01363635|severe sepsis/septic shock|severe sepsis/septic shock
417216|NCT01363635|organ failure|organ failure
417217|NCT01363635|AKI|aki
417218|NCT01363635|PMI|pmi
417219|NCT01363635|ALI|ali
417220|NCT01363635|Stroke|stroke
417221|NCT01363635|ICU death|icu death
417222|NCT01363622|Vaspin|vaspin
417223|NCT01363622|LGA|lga
417224|NCT01363622|SGA|sga
417225|NCT01363622|Insulin|insulin
417226|NCT01363622|Blood glucose|blood glucose
417227|NCT01363596|Infertility|infertility
417228|NCT01363596|Fertility|fertility
417229|NCT01363596|Reproductive Medicine|reproductive medicine
417230|NCT01363596|Pregnancy|pregnancy
417231|NCT01363596|Conception|conception
417232|NCT01363596|Miscarriage|miscarriage
417233|NCT01363596|Ovulation Detection|ovulation detection
417234|NCT01363596|Cervical Mucus|cervical mucus
417235|NCT01363596|IVF Alternative|ivf alternative
417236|NCT01363583|traumatic brain injury|traumatic brain injury
417237|NCT01363570|Macular Degeneration|macular degeneration
417238|NCT01363570|Age related macular degeneration|age related macular degeneration
417239|NCT01363570|Macula Risk|macula risk
417240|NCT01363570|Genetic test|genetic test
417241|NCT01363570|Anti-inflammatory|anti-inflammatory
417242|NCT01363570|Anti-vascular endothelial growth factor (Anti-VEGF)|anti-vascular endothelial growth factor (anti-vegf)
417243|NCT01363570|Lucentis|lucentis
417244|NCT01363570|Ranibizumab|ranibizumab
417245|NCT01363570|Vision loss|vision loss
417246|NCT01363557|Randomized|randomized
417247|NCT01363557|Brain Radiation Therapy|brain radiation therapy
417248|NCT01363557|Lung Cancer|lung cancer
417249|NCT01363557|Brain Metastasis|brain metastasis
417250|NCT01363557|Gefitinib|gefitinib
417251|NCT01363544|ADHD|adhd
417252|NCT01363544|neurofeedback|neurofeedback
417253|NCT01363544|exercise|exercise
417254|NCT01363544|neurophysiology|neurophysiology
417255|NCT01363531|Prescription|prescription
417256|NCT01363531|Antibiotic|antibiotic
417257|NCT01363531|Acute respiratory infections|acute respiratory infections
417258|NCT01363531|Satisfaction|satisfaction
417259|NCT01363531|Perception|perception
417260|NCT01363531|Pharyngitis and/or acute tonsillitis|pharyngitis and/or acute tonsillitis
417261|NCT01363531|Rhinosinusitis|rhinosinusitis
417262|NCT01363531|Acute bronchitis|acute bronchitis
417263|NCT01363531|Acute exacerbation of chronic obstructive pulmonary disease (mild to moderate)|acute exacerbation of chronic obstructive pulmonary disease (mild to moderate)
417264|NCT01363518|humerus|humerus
417265|NCT01363518|fracture|fracture
417266|NCT01363518|operative treatment|operative treatment
417267|NCT01363518|non-operative treatment|non-operative treatment
417268|NCT01363492|agalsidase alfa|agalsidase alfa
417269|NCT01363492|Replagal|replagal
417270|NCT01363492|Enzyme Replacement Therapy|enzyme replacement therapy
417271|NCT01363440|Diabetic Macular Edema|diabetic macular edema
417272|NCT01363440|Diabetic Retinopathy|diabetic retinopathy
417273|NCT01363414|Dry eye|dry eye
417274|NCT01363414|Ocular aberration|ocular aberration
417275|NCT01363401|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
417276|NCT01363401|ALS|als
417277|NCT01363401|Motor neuron disease|motor neuron disease
417278|NCT01363401|MND|mnd
417279|NCT01363401|HYNR-CS inj|hynr-cs inj
417280|NCT01363401|Autologous bone marrow derived stem cell|autologous bone marrow derived stem cell
417281|NCT01363401|Intrathecal injection|intrathecal injection
417282|NCT01363375|Plantar fascia|plantar fascia
417283|NCT01363375|Plantar fasciitis|plantar fasciitis
417284|NCT01363375|Foot orthosis|foot orthosis
417285|NCT01363375|Finite element analysis|finite element analysis
417286|NCT01363375|Gait analysis|gait analysis
417287|NCT01363375|Plantar pressure measurement|plantar pressure measurement
417288|NCT01363362|Selective Laser Trabeculoplasty|selective laser trabeculoplasty
417289|NCT01363362|pulsatile ocular blood flow|pulsatile ocular blood flow
417290|NCT01363336|Adalat|adalat
417291|NCT01363336|Hypertension|hypertension
417292|NCT01363336|Diabetes|diabetes
417293|NCT01363336|Chronic kidney disease|chronic kidney disease
417294|NCT01363297|Relapsed/Refractory Acute Lymphocytic Leukemia (ALL)|relapsed/refractory acute lymphocytic leukemia (all)
417295|NCT01363258|Elderly|elderly
417296|NCT01363258|Dementia|dementia
417297|NCT01363258|Care-resistant behavior|care-resistant behavior
417298|NCT01363258|Oral health|oral health
417299|NCT01363258|Long-term care|long-term care
417300|NCT01363245|cost effectiveness|cost effectiveness
417301|NCT01363245|behavioral health counseling|behavioral health counseling
417302|NCT01363232|BKM120|bkm120
417303|NCT01363232|MEK162|mek162
417304|NCT01363232|RAS RAF mutations|ras raf mutations
417305|NCT01363232|triple negative breast cancer|triple negative breast cancer
417306|NCT01363232|pancreatic cancer, ovarian cancer|pancreatic cancer, ovarian cancer
417307|NCT01363232|NSCLC progressed on EGFR TKI|nsclc progressed on egfr tki
417308|NCT01363232|PI3K inhibitor|pi3k inhibitor
417309|NCT01363232|MEK inhibitor|mek inhibitor
417310|NCT01363206|Melanoma|melanoma
417311|NCT01363206|GM-CSF|gm-csf
417312|NCT01363206|Ipilimumab|ipilimumab
417313|NCT01363206|Immunologic Response|immunologic response
417314|NCT01363193|Weight-based heparin dosing|weight-based heparin dosing
417315|NCT01363193|Obesity|obesity
417316|NCT01363193|Body Mass Index|body mass index
417317|NCT01363193|Venous thromboembolism|venous thromboembolism
417318|NCT01363193|Atrial fibrillation|atrial fibrillation
417319|NCT01363193|Lean body weight|lean body weight
417320|NCT01363193|Unfractionated heparin|unfractionated heparin
417321|NCT01363193|heparin|heparin
417322|NCT01363167|vitamin D|vitamin d
417323|NCT01363167|preterm infants|preterm infants
417324|NCT01363167|calcium|calcium
417325|NCT01363167|bone|bone
417326|NCT01363167|parathyroid hormone|parathyroid hormone
417327|NCT01363154|Children's Health|children's health
417328|NCT01363154|Pediatrics|pediatrics
417329|NCT01363154|Epilepsy|epilepsy
417330|NCT01363154|Photoparoxysmal|photoparoxysmal
417331|NCT01363154|Photosensitive|photosensitive
417332|NCT01363154|Music|music
417333|NCT01363154|Mozart|mozart
417334|NCT01363154|K-448|k-448
417335|NCT01363141|Cardiovascular Diseases|cardiovascular diseases
417336|NCT01363141|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
417337|NCT01363141|Abdominal Fat|abdominal fat
417338|NCT01363141|Atherogenic Dyslipidemia|atherogenic dyslipidemia
417339|NCT01363141|Hypertension|hypertension
417340|NCT01363141|Hyperglycemia|hyperglycemia
417341|NCT01363141|Insulin Resistance|insulin resistance
417342|NCT01363141|Thrombosis state|thrombosis state
417343|NCT01363128|Leukemia|leukemia
417344|NCT01363128|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
417345|NCT01363128|CD-20 Positive Acute Lymphoblastic Leukemia|cd-20 positive acute lymphoblastic leukemia
417346|NCT01363128|Any level of CD20 expression|any level of cd20 expression
417347|NCT01363128|Lymphoblastic lymphoma|lymphoblastic lymphoma
417348|NCT01363128|Central Venous Catheter|central venous catheter
417351|NCT01363128|Cyclophosphamide|cyclophosphamide
417352|NCT01363128|Cytoxan|cytoxan
417353|NCT01363128|Neosar|neosar
417354|NCT01363128|Mesna|mesna
417355|NCT01363128|Mesnex|mesnex
417356|NCT01363128|Doxorubicin|doxorubicin
417357|NCT01363128|Adriamycin|adriamycin
417358|NCT01363128|Rubex|rubex
417359|NCT01363128|Vincristine|vincristine
417360|NCT01363128|Dexamethasone|dexamethasone
417361|NCT01363128|Decadron|decadron
417362|NCT01363128|Ofatumumab|ofatumumab
417363|NCT01363128|Arzerra|arzerra
417364|NCT01363128|Methotrexate|methotrexate
417365|NCT01363128|Cytarabine|cytarabine
417366|NCT01363128|Ara-C|ara-c
417367|NCT01363128|Cytosar|cytosar
417368|NCT01363128|DepoCyt|depocyt
417369|NCT01363128|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
417370|NCT01363115|Body Weight|body weight
417371|NCT01363115|Dietary Supplement|dietary supplement
417372|NCT01363115|Calcium|calcium
417373|NCT01363115|Vitamin D|vitamin d
417374|NCT01363102|Muscle strength|muscle strength
417375|NCT01363102|functional mobility|functional mobility
417376|NCT01363102|outcome|outcome
417377|NCT01363102|intensive care unit|intensive care unit
417378|NCT01363102|quality of life|quality of life
417379|NCT01363037|HIV infections|hiv infections
417380|NCT01363037|Anti-HIV agents|anti-hiv agents
417381|NCT01363037|HIV-1|hiv-1
417382|NCT01363024|Solid Cancers|solid cancers
417383|NCT01363011|HIV-1|hiv-1
417384|NCT01363011|Treatment Naive|treatment naive
417385|NCT01363011|Treatment Experienced|treatment experienced
417386|NCT01362998|fentanyl, morphine, duramorph, Cesarean section, epidural|fentanyl, morphine, duramorph, cesarean section, epidural
417387|NCT01362959|Delirium|delirium
417388|NCT01362959|Psychomotor Agitation|psychomotor agitation
417389|NCT01362959|Substance Withdrawal Syndrome|substance withdrawal syndrome
417390|NCT01362959|Nicotine replacement therapy|nicotine replacement therapy
417391|NCT01362946|Conduct problems|conduct problems
417392|NCT01362946|callous-unemotional traits|callous-unemotional traits
417393|NCT01362946|disruptive behavior disorders|disruptive behavior disorders
417394|NCT01362933|PE|pe
417395|NCT01362933|DVT|dvt
417396|NCT01362933|SVT|svt
417397|NCT01362933|LMWH|lmwh
417398|NCT01362933|VKA|vka
417399|NCT01362933|international Venous Thromboembolism Recommendations|international venous thromboembolism recommendations
417400|NCT01362920|Sepsis|sepsis
417401|NCT01362920|Septic shock|septic shock
417402|NCT01362920|Procalcitonin|procalcitonin
417403|NCT01362920|PCT|pct
417404|NCT01362881|Early|early
417405|NCT01362881|Onset|onset
417406|NCT01362881|Scoliosis|scoliosis
417407|NCT01362868|Glaucoma|glaucoma
417408|NCT01362868|Triggerfish|triggerfish
417409|NCT01362868|Water drinking test|water drinking test
417410|NCT01362855|Advance Care Planning|advance care planning
417411|NCT01362855|End of life|end of life
417412|NCT01362855|Knowledge translation|knowledge translation
417413|NCT01362855|Goals of care|goals of care
417414|NCT01362855|Advance directive|advance directive
417415|NCT01362855|Lining will|lining will
417416|NCT01362842|Lung Cancer|lung cancer
417417|NCT01362842|Symptom distress|symptom distress
417418|NCT01362842|Post-operation|post-operation
417419|NCT01362842|Anxiety|anxiety
417420|NCT01362842|Depression|depression
417421|NCT01362842|Uncertainty|uncertainty
417422|NCT01362842|Fear of recurrence|fear of recurrence
417423|NCT01362842|Self-efficacy|self-efficacy
417424|NCT01362842|Needs|needs
417425|NCT01362803|Maximum Tolerated Dose|maximum tolerated dose
417426|NCT01362803|Pharmacokinetics|pharmacokinetics
417427|NCT01362803|Pharmacodynamics|pharmacodynamics
417428|NCT01362803|Response Rate|response rate
417429|NCT01362803|pain, quality of life and physical functioning|pain, quality of life and physical functioning
417430|NCT01362803|Neurofibromatosis Type 1|neurofibromatosis type 1
417432|NCT01362803|Plexiform Neurofibroma|plexiform neurofibroma
417433|NCT01362790|Immune Therapy|immune therapy
417434|NCT01362790|Immunotoxin|immunotoxin
417435|NCT01362790|T-Cell Depletion|t-cell depletion
417436|NCT01362790|Mesothelioma|mesothelioma
417437|NCT01362777|Obstructive Sleep Apnea/Hypopnea Syndrome|obstructive sleep apnea/hypopnea syndrome
417438|NCT01362777|Exercise training program|exercise training program
417439|NCT01362777|Inflammation|inflammation
417440|NCT01362777|Oxidative Stress|oxidative stress
417441|NCT01362777|Resistance to insulin|resistance to insulin
417442|NCT01362764|Abiraterone Acetate|abiraterone acetate
417443|NCT01362764|ZYTIGA|zytiga
417444|NCT01362738|Long-standing persistent atrial fibrillation|long-standing persistent atrial fibrillation
417445|NCT01362725|spinal cord stimulation|spinal cord stimulation
417446|NCT01362725|systolic heart failure|systolic heart failure
417447|NCT01362712|breast cancer|breast cancer
417448|NCT01362712|radiotherapy|radiotherapy
417449|NCT01362712|chemoradiotherapy|chemoradiotherapy
417450|NCT01362712|radiation|radiation
417451|NCT01362712|chemoradiation|chemoradiation
417452|NCT01362712|[F-18]|[f-18]
417453|NCT01362699|Alcoholism|alcoholism
417454|NCT01362699|Alcohol-Related Disorders|alcohol-related disorders
417455|NCT01362699|Substance-Related Disorders|substance-related disorders
417456|NCT01362699|Mental Disorders|mental disorders
417457|NCT01362699|Alcohol Dependence|alcohol dependence
417458|NCT01362699|JNJ-31001074|jnj-31001074
417459|NCT01362699|Bavisant|bavisant
417460|NCT01362686|diagnosis of Alzheimer's disease|diagnosis of alzheimer's disease
417461|NCT01362686|medication adherence|medication adherence
417462|NCT01362673|Phase 1|phase 1
417463|NCT01362673|Pharmacokinetics|pharmacokinetics
417464|NCT01362673|food effect|food effect
417465|NCT01362673|Healthy Japanese|healthy japanese
417466|NCT01362673|rheumatoid arthritis|rheumatoid arthritis
417467|NCT01362660|post-natal monitoring|post-natal monitoring
417468|NCT01362660|exposure in utero|exposure in utero
417469|NCT01362647|Muscle Relaxation|muscle relaxation
417470|NCT01362634|HIV/AIDS|hiv/aids
417471|NCT01362634|substance use|substance use
417472|NCT01362634|club drugs|club drugs
417473|NCT01362634|sexual risk|sexual risk
417474|NCT01362621|Allergic asthma|allergic asthma
417475|NCT01362621|Pediatrics|pediatrics
417476|NCT01362621|Exacerbations|exacerbations
417477|NCT01362621|Perennial aeroallergens|perennial aeroallergens
417478|NCT01362621|Inhaled corticosteroids|inhaled corticosteroids
417479|NCT01362608|Gout|gout
417480|NCT01362608|Inflammatory gout|inflammatory gout
417481|NCT01362608|acute gout|acute gout
417482|NCT01362595|leucine administration|leucine administration
417483|NCT01362595|red blood cell transfusion|red blood cell transfusion
417484|NCT01362595|Diamond Blackfan anemia|diamond blackfan anemia
417485|NCT01362582|Pancreatic cancer|pancreatic cancer
417486|NCT01362582|progression under chemotherapy|progression under chemotherapy
417487|NCT01362582|parenteral nutrition|parenteral nutrition
417488|NCT01362582|pancreatic adenocarcinoma|pancreatic adenocarcinoma
417489|NCT01362582|chemotherapy|chemotherapy
417490|NCT01362569|endotoxin|endotoxin
417491|NCT01362569|neutrophil function|neutrophil function
417492|NCT01362569|albumin function|albumin function
417493|NCT01362543|PTSD|ptsd
417494|NCT01362543|Depression|depression
417495|NCT01362543|Refugees|refugees
417496|NCT01362543|Trauma|trauma
417497|NCT01362517|Vaccination|vaccination
417498|NCT01362517|Immunisation|immunisation
417499|NCT01362517|Virus|virus
417500|NCT01362517|Diphtheria|diphtheria
417501|NCT01362517|Pertussis|pertussis
417502|NCT01362517|Tetanus|tetanus
417503|NCT01362517|Hepatitis B|hepatitis b
417504|NCT01362517|Haemophilus Influenzae|haemophilus influenzae
417505|NCT01362517|Immunity|immunity
417506|NCT01362504|Pro-adrenomedullin|pro-adrenomedullin
417507|NCT01362504|Neonatal sepsis|neonatal sepsis
417508|NCT01362504|Prognosis|prognosis
417509|NCT01362504|Sepsis marker|sepsis marker
417510|NCT01362504|Clinical sepsis|clinical sepsis
417511|NCT01362504|Proven sepsis|proven sepsis
417512|NCT01362491|Headache|headache
417513|NCT01362478|schizophrenia|schizophrenia
417514|NCT01362478|gene promoter|gene promoter
417515|NCT01362478|methylation|methylation
417516|NCT01362478|endophenotype|endophenotype
417517|NCT01362478|epigenetic|epigenetic
417518|NCT01362452|Leukemia|leukemia
417519|NCT01362452|Lymphoma|lymphoma
417520|NCT01362452|CD19-specific T cells|cd19-specific t cells
417521|NCT01362452|Umbilical cord blood transplantation|umbilical cord blood transplantation
417522|NCT01362452|B-Lineage Lymphoid Malignancies|b-lineage lymphoid malignancies
417523|NCT01362452|B-cell leukemia|b-cell leukemia
417524|NCT01362452|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
417525|NCT01362452|ALL|all
417526|NCT01362452|Biphenotypic Leukemia|biphenotypic leukemia
417527|NCT01362452|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
417528|NCT01362452|NHL|nhl
417529|NCT01362452|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
417530|NCT01362452|SLL|sll
417531|NCT01362452|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
417532|NCT01362452|CLL|cll
417533|NCT01362452|White blood cells|white blood cells
417534|NCT01362452|T cells|t cells
417535|NCT01362452|Melphalan|melphalan
417536|NCT01362452|Alkeran|alkeran
417537|NCT01362452|Thiotepa|thiotepa
417538|NCT01362452|Fludarabine|fludarabine
417539|NCT01362452|Fludarabine Phosphate|fludarabine phosphate
417540|NCT01362452|Fludara|fludara
417541|NCT01362452|ATG|atg
417542|NCT01362452|Antithymocyte Globulin|antithymocyte globulin
417543|NCT01362452|Thymoglobulin|thymoglobulin
417544|NCT01362452|Rituxan|rituxan
417545|NCT01362452|Rituximab|rituximab
417546|NCT01362452|Cyclophosphamide|cyclophosphamide
417547|NCT01362452|Cytoxan|cytoxan
417548|NCT01362452|Neosar|neosar
417549|NCT01362439|Schizophrenia|schizophrenia
417550|NCT01362439|Paliperidone|paliperidone
417551|NCT01362426|schizophrenia|schizophrenia
417552|NCT01362426|paliperidone palmitate|paliperidone palmitate
417553|NCT01362426|INVEGA SUSTENNA|invega sustenna
417554|NCT01362426|registries|registries
417555|NCT01362426|quality of healthcare|quality of healthcare
417556|NCT01362413|pseudarthrosis|pseudarthrosis
417557|NCT01362413|mineralization|mineralization
417558|NCT01362413|platelet-rich-plasma|platelet-rich-plasma
417559|NCT01362413|serum|serum
417560|NCT01362400|LUNG NEOPLASMS|lung neoplasms
417561|NCT01362400|LARGE CELL CARCINOMA|large cell carcinoma
417562|NCT01362400|SQUAMOUS CELL CARCINOMA|squamous cell carcinoma
417563|NCT01362387|Medical abortion|medical abortion
417564|NCT01362387|abortion follow-up|abortion follow-up
417565|NCT01362361|Second line colorectal cancer|second line colorectal cancer
417566|NCT01362348|Age-related Macular Degeneration|age-related macular degeneration
417567|NCT01362322|dTpa|dtpa
417568|NCT01362322|Boostrix|boostrix
417569|NCT01362309|Alcohol|alcohol
417570|NCT01362309|Cues|cues
417571|NCT01362309|Extinction|extinction
417572|NCT01362309|D-Cycloserine|d-cycloserine
417573|NCT01362296|NRAS|nras
417574|NCT01362296|docetaxel|docetaxel
417575|NCT01362296|NSCLC|nsclc
417576|NCT01362296|GSK1120212|gsk1120212
417577|NCT01362296|MEK inhibitor|mek inhibitor
417578|NCT01362296|targeted therapy|targeted therapy
417579|NCT01362296|KRAS|kras
417580|NCT01362296|BRAF|braf
417581|NCT01362270|Anxiolytics|anxiolytics
417582|NCT01362270|Sedatives|sedatives
417583|NCT01362270|Acupuncture Therapy|acupuncture therapy
417584|NCT01362244|Quality of Life|quality of life
417585|NCT01362244|Intranasal Steroids|intranasal steroids
417586|NCT01362244|Severe Nasal Polyposis|severe nasal polyposis
417587|NCT01362244|Polyp Relapse|polyp relapse
417588|NCT01362244|Endoscopic Polyp Score|endoscopic polyp score
417589|NCT01362244|Surgery|surgery
417590|NCT01362231|Fibrosis|fibrosis
417591|NCT01362231|Pulmonary Fibrosis|pulmonary fibrosis
417592|NCT01362231|Lung Diseases|lung diseases
417593|NCT01362231|Interstitial|interstitial
417594|NCT01362205|Severe Alcohol Withdrawal Delirium Tremens|severe alcohol withdrawal delirium tremens
417595|NCT01362192|Telangiectasis|telangiectasis
417596|NCT01362192|Spider Veins|spider veins
417597|NCT01362192|Excel V|excel v
417598|NCT01362192|Cutera|cutera
417599|NCT01362192|Laser|laser
417600|NCT01362192|Leg Veins|leg veins
417601|NCT01362192|Venulectasia|venulectasia
417602|NCT01362192|Lower Extremity veins|lower extremity veins
417603|NCT01362192|Laser light|laser light
417604|NCT01362192|KTP|ktp
417605|NCT01362192|532nm|532nm
417606|NCT01362179|malignant myeloid hematologic disorders|malignant myeloid hematologic disorders
417607|NCT01362179|filgrastim|filgrastim
417608|NCT01362179|long term incidence|long term incidence
417609|NCT01362179|donors who received and in those who did not receive filgrastim.|donors who received and in those who did not receive filgrastim.
417610|NCT01362166|Chinese medicine|chinese medicine
417611|NCT01362166|channel|channel
417612|NCT01362166|acupuncture|acupuncture
417613|NCT01362166|ZuSanLi|zusanli
417614|NCT01362166|XianGu|xiangu
417615|NCT01362166|frequency response|frequency response
417616|NCT01362166|resonance|resonance
417617|NCT01362166|male volunteer|male volunteer
417618|NCT01362166|aged within 20-35 years old|aged within 20-35 years old
417619|NCT01362153|Golimumab|golimumab
417620|NCT01362153|Simponi|simponi
417621|NCT01362153|Rheumatoid Arthritis|rheumatoid arthritis
417622|NCT01362153|PK|pk
417623|NCT01362153|PD|pd
417624|NCT01362140|Randomized|randomized
417625|NCT01362140|Darbepoetin alfa|darbepoetin alfa
417626|NCT01362140|Myelodysplastic Syndromes|myelodysplastic syndromes
417627|NCT01362140|Placebo-controlled|placebo-controlled
417628|NCT01362140|low risk MDS|low risk mds
417629|NCT01362140|intermediate-1 risk MDS|intermediate-1 risk mds
417630|NCT01362140|International Prognostic Scoring System|international prognostic scoring system
417631|NCT01362127|Histologically confirmed squamos cell carcinoma or adenocarcinoma of the esophagus and gastric cardia.Suitable for surgery.|histologically confirmed squamos cell carcinoma or adenocarcinoma of the esophagus and gastric cardia.suitable for surgery.
417632|NCT01362114|Hwa-byung|hwa-byung
417633|NCT01362114|Sihogayonggolmoryeo-tang|sihogayonggolmoryeo-tang
417634|NCT01362114|Anxiety|anxiety
417635|NCT01362101|cue reactivity|cue reactivity
417636|NCT01362101|physiologic activation|physiologic activation
417637|NCT01362101|craving|craving
417638|NCT01362101|smoking cues|smoking cues
417639|NCT01362101|Behavioral therapy|behavioral therapy
417640|NCT01362088|microcirculation|microcirculation
417641|NCT01362088|intensive care|intensive care
417642|NCT01362088|ultrafiltration|ultrafiltration
417643|NCT01362088|CVVH|cvvh
417644|NCT01362075|Shoulder Arthroplasty|shoulder arthroplasty
417645|NCT01362075|Local infiltration analgesia|local infiltration analgesia
417646|NCT01362049|Stabilization exercise|stabilization exercise
417647|NCT01362049|Physical therapy|physical therapy
417648|NCT01362049|Rehabilitation|rehabilitation
417649|NCT01362049|Movement System Impairment exercise|movement system impairment exercise
417650|NCT01362010|Acne|acne
417651|NCT01362010|Acne Vulgaris|acne vulgaris
417652|NCT01362010|Topical|topical
417653|NCT01362010|Minocycline|minocycline
417654|NCT01362010|Foam|foam
417655|NCT01362010|Phase II|phase ii
417656|NCT01361997|Antiseptics|antiseptics
417657|NCT01361997|Hemoculture contamination|hemoculture contamination
417658|NCT01361997|Anti-infecting agents, local|anti-infecting agents, local
417659|NCT01361984|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
417660|NCT01361984|COPD|copd
417661|NCT01361984|Emphysema|emphysema
417662|NCT01361984|Chronic Bronchitis|chronic bronchitis
417663|NCT01361984|Brovana|brovana
417664|NCT01361984|Serevent|serevent
417665|NCT01361971|Insulin resistance|insulin resistance
417666|NCT01361971|Inflammation|inflammation
417667|NCT01361971|Hypoxia|hypoxia
417669|NCT01361945|HER2+|her2+
417670|NCT01361945|Breast|breast
417671|NCT01361919|compressions|compressions
417672|NCT01361919|quality|quality
417673|NCT01361919|teaching method|teaching method
417674|NCT01361919|feedback|feedback
417675|NCT01361919|CPR performance - how well do students perform CPR when taught with feedback?|cpr performance - how well do students perform cpr when taught with feedback?
417676|NCT01361919|Cardiopulmonary resuscitation (CPR)|cardiopulmonary resuscitation (cpr)
417677|NCT01361906|Musculoskeletal and Neural Physiological Phenomena|musculoskeletal and neural physiological phenomena
417678|NCT01361906|Postural Balance|postural balance
417679|NCT01361906|Eye/hand coordination|eye/hand coordination
417680|NCT01361893|SIDS|sids
417681|NCT01361893|African American|african american
417682|NCT01361893|Infants|infants
417683|NCT01361893|Disparity|disparity
417684|NCT01361880|African American|african american
417685|NCT01361880|Anticipatory Guidance|anticipatory guidance
417686|NCT01361880|Health Promotion|health promotion
417687|NCT01361880|Infant Mortality|infant mortality
417688|NCT01361880|Injury Prevention|injury prevention
417689|NCT01361880|Nurses|nurses
417690|NCT01361880|Parent Education|parent education
417691|NCT01361880|sudden Infant Death Syndrome|sudden infant death syndrome
417692|NCT01361867|motor adaptation|motor adaptation
417693|NCT01361867|lower extremity motor learning|lower extremity motor learning
417694|NCT01361854|polysomnography|polysomnography
417695|NCT01361854|portable monitoring|portable monitoring
417696|NCT01361854|sleep|sleep
417697|NCT01361854|sleep disordered breathing|sleep disordered breathing
417698|NCT01361854|home based polysomnography|home based polysomnography
417699|NCT01361841|Latanoprost|latanoprost
417700|NCT01361841|bimatoprost|bimatoprost
417701|NCT01361841|travoprost|travoprost
417702|NCT01361841|non responders|non responders
417703|NCT01361828|Bevacizumab|bevacizumab
417704|NCT01361828|VEP|vep
417705|NCT01361828|ERG|erg
417706|NCT01361828|Optic nerve and retinal functions following intravitreal bevacizumab|optic nerve and retinal functions following intravitreal bevacizumab
417707|NCT01361815|Depression|depression
417708|NCT01361815|MDD|mdd
417709|NCT01361815|SSRIs|ssris
417710|NCT01361815|TMS|tms
417711|NCT01361789|Arthroscopic reconstruction|arthroscopic reconstruction
417712|NCT01361789|Anterior crucial ligament|anterior crucial ligament
417713|NCT01361789|Coxib|coxib
417714|NCT01361789|Dexamethasone|dexamethasone
417715|NCT01361776|immune response|immune response
417716|NCT01361776|TBE-vaccine|tbe-vaccine
417717|NCT01361776|elderly|elderly
417718|NCT01361776|additional doses|additional doses
417719|NCT01361763|Dabigatran|dabigatran
417720|NCT01361763|Microbleeds|microbleeds
417721|NCT01361763|Microthrombi|microthrombi
417722|NCT01361763|CADASIL|cadasil
417723|NCT01361763|Small Vessel Disease|small vessel disease
417724|NCT01361737|Preeclampsia|preeclampsia
417725|NCT01361737|serological bio-bank|serological bio-bank
417726|NCT01361737|adiponectin|adiponectin
417727|NCT01361737|suPAR|supar
417728|NCT01361724|Parkinson's disease|parkinson's disease
417729|NCT01361724|PD|pd
417730|NCT01361724|Exercise|exercise
417731|NCT01361724|Balance|balance
417732|NCT01361724|Mobility|mobility
417733|NCT01361698|recovery|recovery
417734|NCT01361698|illness management|illness management
417735|NCT01361698|rehabilitation|rehabilitation
417736|NCT01361698|mental illness|mental illness
417737|NCT01361698|psychosocial intervention|psychosocial intervention
417738|NCT01361698|Clinical recovery (increase in functioning, decrease in symptoms)|clinical recovery (increase in functioning, decrease in symptoms)
417739|NCT01361698|Personal recovery (Hope, optimism, living a fulfilling life)|personal recovery (hope, optimism, living a fulfilling life)
417740|NCT01361659|anginal complaints|anginal complaints
417741|NCT01361659|Lithotripsy|lithotripsy
417742|NCT01361659|no option patients|no option patients
417743|NCT01361633|d-cycloserine|d-cycloserine
417744|NCT01361633|geriatric|geriatric
417745|NCT01361633|neuropsychology|neuropsychology
417746|NCT01361633|cognition|cognition
417747|NCT01361633|cognitive-enhancer|cognitive-enhancer
417748|NCT01361633|aging|aging
417749|NCT01361633|neuropsychological functioning|neuropsychological functioning
417750|NCT01361620|genomic markers|genomic markers
417751|NCT01361620|aspirin resistance|aspirin resistance
417752|NCT01361607|Cancer pain|cancer pain
417753|NCT01361607|Opioid therapy|opioid therapy
417754|NCT01361607|Inadequate analgesia|inadequate analgesia
417755|NCT01361607|Optimized chronic opioid therapy|optimized chronic opioid therapy
417756|NCT01361594|Diabetes|diabetes
417757|NCT01361594|Coronary Artery Bypass Surgery|coronary artery bypass surgery
417758|NCT01361594|Glycemic control|glycemic control
417759|NCT01361594|Insulin infusion|insulin infusion
417760|NCT01361581|Acute renal failure|acute renal failure
417761|NCT01361581|Anticoagulation|anticoagulation
417762|NCT01361581|Citrate|citrate
417763|NCT01361581|Haemodiafiltration|haemodiafiltration
417764|NCT01361581|Haemofiltration|haemofiltration
417765|NCT01361581|Renal replacement therapy|renal replacement therapy
417766|NCT01361568|pain|pain
417767|NCT01361568|acute pain|acute pain
417768|NCT01361568|visceral pain|visceral pain
417769|NCT01361568|kappa agonist|kappa agonist
417770|NCT01361568|opioid analgesics|opioid analgesics
417771|NCT01361568|peripheral nervous system agents|peripheral nervous system agents
417772|NCT01361568|physiological effects of drugs|physiological effects of drugs
417773|NCT01361568|surgery|surgery
417774|NCT01361568|hysterectomy|hysterectomy
417775|NCT01361568|post-operative|post-operative
417776|NCT01361568|post-operative complications|post-operative complications
417777|NCT01361542|TNF|tnf
417778|NCT01361542|BMD|bmd
417779|NCT01361542|Ankylosing spondylitis|ankylosing spondylitis
417780|NCT01361542|bone health|bone health
417781|NCT01361542|Anti TNF therapy|anti tnf therapy
417782|NCT01361542|Disease activity|disease activity
417783|NCT01361529|dose escalation|dose escalation
417784|NCT01361516|Urolithiasis|urolithiasis
417785|NCT01361516|ESWL|eswl
417786|NCT01361516|Stone Fragmentation efficacy|stone fragmentation efficacy
417787|NCT01361516|Sedation|sedation
417788|NCT01361516|General Anaesthesia|general anaesthesia
417789|NCT01361503|Autism Spectrum Disorders|autism spectrum disorders
417790|NCT01361503|Pervasive Developmental Disorders|pervasive developmental disorders
417791|NCT01361503|Asperger's Syndrome|asperger's syndrome
417792|NCT01361503|Adolescents|adolescents
417793|NCT01361503|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
417794|NCT01361503|Diffusion Tensor Imaging|diffusion tensor imaging
417795|NCT01361477|General surgical ICU|general surgical icu
417796|NCT01361477|ICU Siamitra|icu siamitra
417797|NCT01361477|ICU Salad-Samung|icu salad-samung
417798|NCT01361477|Data registry|data registry
417799|NCT01361477|ICU refusal|icu refusal
417800|NCT01361477|ICU complications|icu complications
417801|NCT01361477|ICU resource utilization|icu resource utilization
417802|NCT01361477|Adverse events|adverse events
417803|NCT01361477|ICU readmission|icu readmission
417804|NCT01361451|parasternal electromyogram|parasternal electromyogram
417805|NCT01361451|neural respiratory drive|neural respiratory drive
417806|NCT01361451|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
417807|NCT01361451|respiratory physiology|respiratory physiology
417808|NCT01361451|Acute exacerbation|acute exacerbation
417809|NCT01361425|hypertension|hypertension
417810|NCT01361425|ultrasonography|ultrasonography
417811|NCT01361425|preeclampsia|preeclampsia
417812|NCT01361425|clinical trials|clinical trials
417813|NCT01361425|treatment|treatment
417814|NCT01361425|methyldopa|methyldopa
417815|NCT01361412|ragweed allergy|ragweed allergy
417816|NCT01361412|immunotherapy|immunotherapy
417817|NCT01361399|Sore Throat|sore throat
417818|NCT01361386|Long-term follow up|long-term follow up
417819|NCT01361386|Antithrombotic management patterns|antithrombotic management patterns
417820|NCT01361386|Acute Coronary Syndrome|acute coronary syndrome
417821|NCT01361386|Asia|asia
417822|NCT01361386|quality of life|quality of life
417823|NCT01361347|milk allergy|milk allergy
417824|NCT01361347|desensitization|desensitization
417825|NCT01361347|anaphylaxis|anaphylaxis
417826|NCT01361347|school-age|school-age
417827|NCT01361334|(other than AML M3)|(other than aml m3)
417828|NCT01361321|follow up|follow up
417829|NCT01361321|Guided bone regeneration|guided bone regeneration
417830|NCT01361321|Micro computerized tomography|micro computerized tomography
417831|NCT01361321|histological examination|histological examination
417832|NCT01361308|Menopause|menopause
417833|NCT01361308|Vasomotor Symptoms|vasomotor symptoms
417834|NCT01361308|Hot Flashes Perimenopause|hot flashes perimenopause
417835|NCT01361308|Climacteric Symptoms|climacteric symptoms
417836|NCT01361308|Mesafem|mesafem
417837|NCT01361308|Low-Dose Mesylate salt of Paroxetine (LDMP)|low-dose mesylate salt of paroxetine (ldmp)
417838|NCT01361295|Atrial fibrillation|atrial fibrillation
417839|NCT01361295|cerebral embolism|cerebral embolism
417840|NCT01361295|catheter ablation|catheter ablation
417841|NCT01361282|Total Corneal Power|total corneal power
417842|NCT01361282|Optical Coherence Tomography|optical coherence tomography
417843|NCT01361282|Descemet Stripping Endothelial Keratoplasty|descemet stripping endothelial keratoplasty
417844|NCT01361256|Macular Degeneration|macular degeneration
417845|NCT01361256|Visual Impairment|visual impairment
417846|NCT01361256|Implantable Telescope|implantable telescope
417847|NCT01361243|Pediatric Overweight|pediatric overweight
417848|NCT01361243|Pediatric Obesity|pediatric obesity
417849|NCT01361217|Fluoxetine|fluoxetine
417850|NCT01361217|CYP3A4|cyp3a4
417851|NCT01361217|CYP2D6|cyp2d6
417852|NCT01361217|CYP2C19|cyp2c19
417853|NCT01361217|Drug-Drug Interaction|drug-drug interaction
417854|NCT01361217|Multi-CYP Inhibition|multi-cyp inhibition
417855|NCT01361204|stress|stress
417856|NCT01361204|students|students
417857|NCT01361204|pharmacy practice|pharmacy practice
417858|NCT01361204|theanine|theanine
417859|NCT01361204|pharmacy training|pharmacy training
417860|NCT01361191|DLBCL|dlbcl
417861|NCT01361191|PET|pet
417862|NCT01361191|IPI|ipi
417863|NCT01361191|R-MegaCHOP|r-megachop
417864|NCT01361191|Autologous stem cell transplantation|autologous stem cell transplantation
417865|NCT01361165|Pediatric|pediatric
417866|NCT01361165|Data Analysis|data analysis
417867|NCT01361152|total knee arthroplasty|total knee arthroplasty
417868|NCT01361152|fixed-bearing|fixed-bearing
417869|NCT01361152|mobile-bearing|mobile-bearing
417870|NCT01361152|long-term|long-term
417871|NCT01361139|Chronic obstructive lung disease|chronic obstructive lung disease
417872|NCT01361139|Interstitial lung disease|interstitial lung disease
417873|NCT01361139|Asthma|asthma
417874|NCT01361139|Sarcoidosis|sarcoidosis
417875|NCT01361139|Pulmonary hypertension|pulmonary hypertension
417876|NCT01361139|Ultrasound|ultrasound
417877|NCT01361139|Doppler|doppler
417878|NCT01361139|Lung disease diagnosis|lung disease diagnosis
417879|NCT01361113|Renal Cell Carcinoma|renal cell carcinoma
417880|NCT01361113|RCC|rcc
417881|NCT01361113|Votrient|votrient
417882|NCT01361113|Pazopanib|pazopanib
417883|NCT01361113|Nephrectomy|nephrectomy
417884|NCT01361113|Neoadjuvant|neoadjuvant
417885|NCT01361113|Phase II|phase ii
417886|NCT01361113|LCCC 1028|lccc 1028
417887|NCT01361113|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
417888|NCT01361100|Otolaryngology|otolaryngology
417889|NCT01361087|TGF-B blood levels Atenolol vs, Losartan Study, NIH, NIHLB and NMF|tgf-b blood levels atenolol vs, losartan study, nih, nihlb and nmf
417890|NCT01361074|Virtual reality|virtual reality
417891|NCT01361074|Augmented reality|augmented reality
417892|NCT01361074|In vivo exposure|in vivo exposure
417893|NCT01361074|One session treatment|one session treatment
417894|NCT01361074|ICT|ict
417895|NCT01361074|Efficacy|efficacy
417896|NCT01361074|Specific phobia|specific phobia
417897|NCT01361074|Anxiety disorders|anxiety disorders
417898|NCT01361061|liver cirrhosis|liver cirrhosis
417899|NCT01361061|screening|screening
417900|NCT01361061|hepatocellular carcinoma|hepatocellular carcinoma
417901|NCT01361061|liver cancer markers: AFP, AFP-L3% and DCP|liver cancer markers: afp, afp-l3% and dcp
417902|NCT01361048|trichomonas|trichomonas
417903|NCT01361035|health literacy|health literacy
417904|NCT01361035|cancer screening|cancer screening
417905|NCT01361035|doctor-patient communication|doctor-patient communication
417906|NCT01361035|standardized patient|standardized patient
417907|NCT01361035|continuing medical education|continuing medical education
417908|NCT01360996|PCOS|pcos
417909|NCT01360970|hepatitis A vaccine|hepatitis a vaccine
417910|NCT01360970|TNF-alfa inhibitory drugs|tnf-alfa inhibitory drugs
417911|NCT01360970|Rheumatoid arthritis|rheumatoid arthritis
417912|NCT01360970|methotrexate|methotrexate
417913|NCT01360957|Obesity|obesity
417914|NCT01360944|PPT, topical, psoriasis|ppt, topical, psoriasis
417915|NCT01360931|Lung cancer|lung cancer
417916|NCT01360931|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
417917|NCT01360905|PTL|ptl
417918|NCT01360905|Multiples|multiples
417919|NCT01360892|Hepatitis B virus|hepatitis b virus
417920|NCT01360892|Hepatitis C virus|hepatitis c virus
417921|NCT01360892|Chronic hepatitis|chronic hepatitis
417922|NCT01360892|Liver chlorosis|liver chlorosis
417923|NCT01360892|Liver stiffness|liver stiffness
417924|NCT01360892|Liver fibrosis|liver fibrosis
417925|NCT01360879|Hepatitis B virus|hepatitis b virus
417926|NCT01360879|Hepatitis C virus|hepatitis c virus
417927|NCT01360879|Chronic hepatitis|chronic hepatitis
417928|NCT01360879|Liver cirrhosis|liver cirrhosis
417929|NCT01360879|Liver stiffness|liver stiffness
417930|NCT01360879|Liver fibrosis|liver fibrosis
417931|NCT01360866|OPC-34712|opc-34712
417932|NCT01360866|brexpiprazole|brexpiprazole
417933|NCT01360866|Major Depressive Disorder|major depressive disorder
417934|NCT01360866|Adjunctive Treatment|adjunctive treatment
417935|NCT01360853|pancreatic cancer|pancreatic cancer
417936|NCT01360853|gemcitabine|gemcitabine
417937|NCT01360853|ON 01910.Na|on 01910.na
417938|NCT01360853|rigosertib sodium|rigosertib sodium
417939|NCT01360840|Asymptomatic|asymptomatic
417940|NCT01360840|mildly symptomatic|mildly symptomatic
417941|NCT01360840|metastatic castrate-resistant prostate cancer|metastatic castrate-resistant prostate cancer
417942|NCT01360840|mCRPC|mcrpc
417943|NCT01360827|Safety|safety
417944|NCT01360827|tolerability|tolerability
417945|NCT01360827|maximum tolerated dose of EMD 1201081|maximum tolerated dose of emd 1201081
417946|NCT01360827|TLR9 agonists|tlr9 agonists
417947|NCT01360827|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
417948|NCT01360827|First line subjects|first line subjects
417949|NCT01360827|recurrent/metastatic|recurrent/metastatic
417950|NCT01360788|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
417951|NCT01360788|lung function|lung function
417952|NCT01360788|symptoms|symptoms
417953|NCT01360788|activity-related dyspnea|activity-related dyspnea
417954|NCT01360788|quadriceps muscle function|quadriceps muscle function
417955|NCT01360788|exercise capacity|exercise capacity
417956|NCT01360788|physical activity in daily life|physical activity in daily life
417957|NCT01360788|muscle biopsy|muscle biopsy
418052|NCT01360398|pathogen|pathogen
417958|NCT01360788|systemic inflammation|systemic inflammation
417959|NCT01360788|GOLD stage I|gold stage i
417960|NCT01360788|pulmonary function|pulmonary function
417961|NCT01360775|Nutritional status|nutritional status
417962|NCT01360775|Dependent patients|dependent patients
417963|NCT01360775|Nutritional educational intervention|nutritional educational intervention
417964|NCT01360775|Caregivers|caregivers
417965|NCT01360775|Clinical assay|clinical assay
417966|NCT01360762|Secondary prophylaxis|secondary prophylaxis
417967|NCT01360762|Visceral leishmaniasis|visceral leishmaniasis
417968|NCT01360762|Relapses|relapses
417969|NCT01360762|HIV co-infection|hiv co-infection
417970|NCT01360762|Pentamidine|pentamidine
417971|NCT01360762|Ethiopia|ethiopia
417972|NCT01360749|Pain management|pain management
417973|NCT01360749|Lidocaine|lidocaine
417974|NCT01360736|Suicide Prevention|suicide prevention
417975|NCT01360736|Suicide Attempt|suicide attempt
417976|NCT01360736|Suicide Ideation|suicide ideation
417977|NCT01360736|Randomized Controlled Trial|randomized controlled trial
417978|NCT01360736|Safety Planning|safety planning
417979|NCT01360710|male age 18-30 years old|male age 18-30 years old
417980|NCT01360710|presence of central obesity|presence of central obesity
417981|NCT01360710|no history of cardiovascular disease, depression|no history of cardiovascular disease, depression
417982|NCT01360710|not on any medication|not on any medication
417983|NCT01360697|Diabetes|diabetes
417984|NCT01360697|Structured care|structured care
417985|NCT01360671|PPHN|pphn
417986|NCT01360671|persistent pulmonary hypertension of the newborn|persistent pulmonary hypertension of the newborn
417987|NCT01360671|sildenafil|sildenafil
417988|NCT01360671|iv|iv
417989|NCT01360658|Intravenous immunoglobulins|intravenous immunoglobulins
417990|NCT01360658|Solar urticaria|solar urticaria
417991|NCT01360658|Minimal urticaria dose|minimal urticaria dose
417992|NCT01360658|Quality of life|quality of life
417993|NCT01360658|Safety|safety
417994|NCT01360645|OPC-34712|opc-34712
417995|NCT01360645|brexpiprazole|brexpiprazole
417996|NCT01360645|Major Depressive Disorder|major depressive disorder
417997|NCT01360645|Adjunctive Treatment|adjunctive treatment
417998|NCT01360632|OPC-34712|opc-34712
417999|NCT01360632|brexpiprazole|brexpiprazole
418000|NCT01360632|Major Depressive Disorder|major depressive disorder
418001|NCT01360632|Adjunctive Treatment|adjunctive treatment
418002|NCT01360619|To demonstrate that multifunction Keito is as effective, as safe and accurate as the predicate K014009 on its body fat measurement.|to demonstrate that multifunction keito is as effective, as safe and accurate as the predicate k014009 on its body fat measurement.
418003|NCT01360606|Liver|liver
418004|NCT01360606|Mets|mets
418005|NCT01360593|Pancreas|pancreas
418006|NCT01360567|green tea|green tea
418007|NCT01360567|EGCG|egcg
418008|NCT01360567|type 2 diabetes|type 2 diabetes
418009|NCT01360567|hyperlipidemia|hyperlipidemia
418010|NCT01360554|comparative study of PF-00299804 and Erlotinib|comparative study of pf-00299804 and erlotinib
418011|NCT01360554|Double-Blind Phase 3 trial of TKI|double-blind phase 3 trial of tki
418012|NCT01360541|Barrett oesophagus|barrett oesophagus
418013|NCT01360541|Low grade dysplasia|low grade dysplasia
418014|NCT01360541|Radiofrequency ablation|radiofrequency ablation
418015|NCT01360528|Folic acid replacement|folic acid replacement
418016|NCT01360528|Folic acid|folic acid
418017|NCT01360528|Preterm neonate|preterm neonate
418018|NCT01360515|esophagoscope|esophagoscope
418019|NCT01360515|esophageal disease|esophageal disease
418020|NCT01360515|gastroesophageal reflux|gastroesophageal reflux
418021|NCT01360515|esophageal varices|esophageal varices
418022|NCT01360502|capsule endoscopy|capsule endoscopy
418023|NCT01360502|cardiac pacemaker|cardiac pacemaker
418024|NCT01360502|implantable cardiac defibrillator|implantable cardiac defibrillator
418025|NCT01360476|hypertension|hypertension
418026|NCT01360476|left ventricular hypertrophy|left ventricular hypertrophy
418027|NCT01360476|Vitamin D|vitamin d
418028|NCT01360476|African-Americans|african-americans
418029|NCT01360463|drug abuse counseling|drug abuse counseling
418030|NCT01360463|HIV risk reduction counseling|hiv risk reduction counseling
418031|NCT01360463|HIV infection|hiv infection
418032|NCT01360463|injection drug users|injection drug users
418033|NCT01360463|AIDS|aids
418034|NCT01360450|opioid withdrawal|opioid withdrawal
418035|NCT01360450|Neonatal Pain, Agitation, and Sedation Scale (NPASS)|neonatal pain, agitation, and sedation scale (npass)
418036|NCT01360450|duraclon|duraclon
418037|NCT01360437|coronary angioplasty|coronary angioplasty
418038|NCT01360437|clopidogrel hyporesponsiveness|clopidogrel hyporesponsiveness
418039|NCT01360437|prasugrel|prasugrel
418040|NCT01360437|ticagrelor|ticagrelor
418041|NCT01360437|CAD|cad
418042|NCT01360437|ACS|acs
418043|NCT01360424|osteoporosis|osteoporosis
418044|NCT01360424|teriparatide|teriparatide
418045|NCT01360424|bone turnover|bone turnover
418046|NCT01360424|New forms of inherited low-turnover osteoporosis|new forms of inherited low-turnover osteoporosis
418047|NCT01360411|elastography|elastography
418048|NCT01360411|strain ratio|strain ratio
418049|NCT01360411|pancreas|pancreas
418050|NCT01360411|GI wall lesions|gi wall lesions
418051|NCT01360411|lymph nodes|lymph nodes
418053|NCT01360398|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
418054|NCT01360398|Acute Exacerbations of Chronic Obstructive Pulmonary Disease|acute exacerbations of chronic obstructive pulmonary disease
418055|NCT01360398|COPD|copd
418056|NCT01360398|respiratory|respiratory
418057|NCT01360398|AECOPD|aecopd
418058|NCT01360398|exacerbation|exacerbation
418059|NCT01360385|Central retinal rein occlusion|central retinal rein occlusion
418060|NCT01360385|Retinal oximetry|retinal oximetry
418061|NCT01360385|Oxymap Retinal Oximeter|oxymap retinal oximeter
418062|NCT01360385|Visual acuity|visual acuity
418063|NCT01360385|Central retinal thickness|central retinal thickness
418064|NCT01360372|Hydrogen breath test value and gastric residual volume measurements|hydrogen breath test value and gastric residual volume measurements
418065|NCT01360372|Tube feeding tolerance while taking a stable dose of opiate|tube feeding tolerance while taking a stable dose of opiate
418066|NCT01360359|low back pain|low back pain
418067|NCT01360359|core stabilization|core stabilization
418068|NCT01360359|trunk muscle exercises|trunk muscle exercises
418069|NCT01360359|physical therapy|physical therapy
418070|NCT01360359|RCT|rct
418071|NCT01360346|Enteral Sedation|enteral sedation
418072|NCT01360346|Intravenous Sedation|intravenous sedation
418073|NCT01360346|Critically ill ICU patient|critically ill icu patient
418074|NCT01360346|Conscious Sedation|conscious sedation
418075|NCT01360346|Deep Sedation|deep sedation
418076|NCT01360346|RASS|rass
418077|NCT01360346|CAM-ICU|cam-icu
418078|NCT01360346|VNR|vnr
418079|NCT01360346|BPS|bps
418080|NCT01360346|Propofol|propofol
418081|NCT01360346|Midazolam|midazolam
418082|NCT01360346|Hydroxyzine|hydroxyzine
418083|NCT01360346|Lorazepam|lorazepam
418084|NCT01360346|Melatonin|melatonin
418085|NCT01360333|Dehydration|dehydration
418086|NCT01360333|Hydration|hydration
418087|NCT01360320|Green tea|green tea
418088|NCT01360320|polyphenol|polyphenol
418089|NCT01360320|catechin|catechin
418090|NCT01360320|EGCG|egcg
418091|NCT01360320|Epigallocatechin gallate|epigallocatechin gallate
418092|NCT01360320|colorectal adenoma|colorectal adenoma
418093|NCT01360320|adenoma prevention|adenoma prevention
418094|NCT01360320|colon cancer prevention|colon cancer prevention
418095|NCT01360307|psychometric validation|psychometric validation
418096|NCT01360307|major depressive disorder|major depressive disorder
418097|NCT01360307|patient-reported outcome|patient-reported outcome
418098|NCT01360294|Asthma|asthma
418099|NCT01360294|Small airways disease|small airways disease
418100|NCT01360294|Questionnaire|questionnaire
418101|NCT01360281|Quadriceps strength|quadriceps strength
418102|NCT01360281|osteoarthritis rehabilitation|osteoarthritis rehabilitation
418103|NCT01360281|NMES|nmes
418104|NCT01360255|Hepatocellular Carcinoma|hepatocellular carcinoma
418105|NCT01360255|transarterial chemoembolisation|transarterial chemoembolisation
418106|NCT01360255|liver cancer markers: AFP, AFP-L3% and DCP|liver cancer markers: afp, afp-l3% and dcp
418107|NCT01360242|Acute STEMI|acute stemi
418108|NCT01360242|Thrombus aspiration|thrombus aspiration
418109|NCT01360242|Angioplasty|angioplasty
418110|NCT01360242|Primary Percutaneous Coronary Intervention|primary percutaneous coronary intervention
418111|NCT01360229|Parkinsons Disease|parkinsons disease
418112|NCT01360229|Fatigue|fatigue
418113|NCT01360216|Long-acting reversible contraception|long-acting reversible contraception
418114|NCT01360216|Intrauterine contraception|intrauterine contraception
418115|NCT01360216|Intrauterine devices|intrauterine devices
418116|NCT01360216|Single-rod implant|single-rod implant
418117|NCT01360216|Hormonal contraception|hormonal contraception
418118|NCT01360190|MDD|mdd
418119|NCT01360190|major depressive disorder|major depressive disorder
418120|NCT01360190|QEEG|qeeg
418121|NCT01360190|electroencephalograph|electroencephalograph
418122|NCT01360190|fluoxtine|fluoxtine
418123|NCT01360190|placebo|placebo
418124|NCT01360164|Human Umbilical Cord Mesenchymal Stem Cells|human umbilical cord mesenchymal stem cells
418125|NCT01360151|VEGF (Vascular endothelial growth factor)|vegf (vascular endothelial growth factor)
418126|NCT01360125|adult acute basophilic leukemia|adult acute basophilic leukemia
418127|NCT01360125|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
418128|NCT01360125|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
418129|NCT01360125|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
418130|NCT01360125|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
418131|NCT01360125|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
418132|NCT01360125|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
418133|NCT01360125|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
418134|NCT01360125|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
418135|NCT01360125|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
418136|NCT01360125|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
418137|NCT01360125|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
418138|NCT01360125|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
418331|NCT01359358|MRSA|mrsa
418139|NCT01360125|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
418140|NCT01360125|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
418141|NCT01360125|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
418142|NCT01360112|Mosquito|mosquito
418143|NCT01360112|Membrane|membrane
418144|NCT01360112|Feeding|feeding
418145|NCT01360112|Parasites|parasites
418146|NCT01360112|Infection|infection
418147|NCT01360112|Malaria|malaria
418148|NCT01360099|Atypical Hip Fracture|atypical hip fracture
418149|NCT01360099|Biosphosphonates|biosphosphonates
418150|NCT01360099|Subtrochanteric Hip Fracture|subtrochanteric hip fracture
418151|NCT01360099|Osteoporosis|osteoporosis
418152|NCT01360086|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
418153|NCT01360086|adenocarcinoma of the stomach|adenocarcinoma of the stomach
418154|NCT01360086|stage IB gastric cancer|stage ib gastric cancer
418155|NCT01360086|stage IIA gastric cancer|stage iia gastric cancer
418156|NCT01360086|stage IIB gastric cancer|stage iib gastric cancer
418157|NCT01360086|stage IIIA gastric cancer|stage iiia gastric cancer
418158|NCT01360086|stage IIIB gastric cancer|stage iiib gastric cancer
418159|NCT01360086|stage IIIC gastric cancer|stage iiic gastric cancer
418160|NCT01360073|MI|mi
418161|NCT01360073|low dose aspirin|low dose aspirin
418162|NCT01360073|PPI|ppi
418163|NCT01360073|epidemiology|epidemiology
418164|NCT01360073|Nonfatal MI and coronary death|nonfatal mi and coronary death
418165|NCT01360047|MI|mi
418166|NCT01360047|low dose aspirin|low dose aspirin
418167|NCT01360047|PPI|ppi
418168|NCT01360047|epidemiology|epidemiology
418169|NCT01360034|Obstetric labor, premature|obstetric labor, premature
418170|NCT01360034|Short cervix|short cervix
418171|NCT01360034|Nifedipine|nifedipine
418172|NCT01360034|Indomethacin|indomethacin
418173|NCT01360008|Cardiac arrhythmia|cardiac arrhythmia
418174|NCT01360008|Catheter ablation|catheter ablation
418175|NCT01360008|Cohort Study|cohort study
418176|NCT01360008|cryoballoon|cryoballoon
418177|NCT01360008|radiofrequency|radiofrequency
418178|NCT01359995|cytomegalovirus endotheliitis|cytomegalovirus endotheliitis
418179|NCT01359982|Advanced Solid Tumors|advanced solid tumors
418180|NCT01359982|Lymphomas|lymphomas
418181|NCT01359982|Safety|safety
418182|NCT01359982|Blood flow|blood flow
418183|NCT01359982|Nitric oxide|nitric oxide
418184|NCT01359982|Cancer|cancer
418185|NCT01359982|Dynamic contrast enhanced MRI (DCE-MRI)|dynamic contrast enhanced mri (dce-mri)
418186|NCT01359982|Contrast Enhanced Ultrasound (CEUS)|contrast enhanced ultrasound (ceus)
418187|NCT01359969|Hereditary Angioedema|hereditary angioedema
418188|NCT01359969|HAE|hae
418189|NCT01359969|Angioedema|angioedema
418190|NCT01359969|Recombinant C1 Inhibitor|recombinant c1 inhibitor
418191|NCT01359969|rhC1INH|rhc1inh
418192|NCT01359969|Pediatrics|pediatrics
418193|NCT01359943|Rheumatoid Arthritis|rheumatoid arthritis
418194|NCT01359943|RA|ra
418195|NCT01359943|secukinumab|secukinumab
418196|NCT01359943|AIN457|ain457
418197|NCT01359943|inflammatory joints|inflammatory joints
418198|NCT01359943|American College of Rheumatology|american college of rheumatology
418199|NCT01359943|ACR|acr
418200|NCT01359904|dialysate glucose|dialysate glucose
418201|NCT01359904|glycemic control|glycemic control
418202|NCT01359904|hypoglycemic episodes|hypoglycemic episodes
418203|NCT01359878|Postpartum haemorrhage|postpartum haemorrhage
418204|NCT01359878|Postpartum bleeding|postpartum bleeding
418205|NCT01359878|Postnatal bleeding|postnatal bleeding
418206|NCT01359878|Fibrinogen concentrate|fibrinogen concentrate
418207|NCT01359878|Transfusion|transfusion
418208|NCT01359878|Haemostatis|haemostatis
418209|NCT01359878|Thrombelastography|thrombelastography
418210|NCT01359865|Total hip arthroplasty|total hip arthroplasty
418211|NCT01359865|lumbar plexus block|lumbar plexus block
418212|NCT01359865|spinal anesthesia|spinal anesthesia
418213|NCT01359865|range of motion|range of motion
418214|NCT01359865|Anesthetic Technique|anesthetic technique
418215|NCT01359865|Post-operative Pain Scores|post-operative pain scores
418216|NCT01359852|JNJ-42491293|jnj-42491293
418217|NCT01359852|JNJ-40411813|jnj-40411813
418218|NCT01359852|Metabotropic glutamate subtype 2 receptor (mGlu2R)|metabotropic glutamate subtype 2 receptor (mglu2r)
418219|NCT01359852|Positive allosteric modulator (PAM)|positive allosteric modulator (pam)
418220|NCT01359852|positron emission tomography (PET)|positron emission tomography (pet)
418221|NCT01359826|Systemic Lupus Erythematosus|systemic lupus erythematosus
418222|NCT01359826|Widespread Pain|widespread pain
418223|NCT01359826|Fibromyalgia|fibromyalgia
418224|NCT01359826|Fatigue|fatigue
418225|NCT01359826|Pain|pain
418226|NCT01359826|Quality of Life|quality of life
418227|NCT01359800|HIV|hiv
418228|NCT01359800|HAART|haart
418229|NCT01359774|Energy|energy
418230|NCT01359774|Metabolism|metabolism
418231|NCT01359774|Spectroscopy|spectroscopy
418232|NCT01359761|Suicide|suicide
418233|NCT01359761|Cognitive Therapy|cognitive therapy
418234|NCT01359761|Inpatient|inpatient
418235|NCT01359761|Military|military
418332|NCT01359358|MLST|mlst
418333|NCT01359358|PFGE|pfge
418236|NCT01359748|Non Invasive Blood Pressure measurement study.|non invasive blood pressure measurement study.
418237|NCT01359735|Wound|wound
418238|NCT01359735|non-melanoma skin cancer|non-melanoma skin cancer
418239|NCT01359735|Mohs micrographic surgery|mohs micrographic surgery
418240|NCT01359735|Head or neck|head or neck
418241|NCT01359722|N-acetylcysteine|n-acetylcysteine
418242|NCT01359722|Myocardial Revascularization|myocardial revascularization
418243|NCT01359722|Acute Renal Failure|acute renal failure
418244|NCT01359722|Oxidative Stress|oxidative stress
418245|NCT01359696|solid cancers|solid cancers
418246|NCT01359670|Duchenne|duchenne
418247|NCT01359670|muscular dystrophy|muscular dystrophy
418248|NCT01359670|tadalafil|tadalafil
418249|NCT01359670|sildenafil|sildenafil
418250|NCT01359670|muscle ischemia|muscle ischemia
418251|NCT01359670|exercise|exercise
418252|NCT01359657|Relapsed|relapsed
418253|NCT01359657|Refractory|refractory
418254|NCT01359631|Chronic Cluster Headache|chronic cluster headache
418255|NCT01359618|Phase I|phase i
418256|NCT01359618|Safety|safety
418257|NCT01359618|tolerability|tolerability
418258|NCT01359618|healthy|healthy
418259|NCT01359618|major depressive disorder|major depressive disorder
418260|NCT01359618|thorough QT|thorough qt
418261|NCT01359618|maximum tolerated dose|maximum tolerated dose
418262|NCT01359618|elimination|elimination
418263|NCT01359618|heart electrical signal|heart electrical signal
418264|NCT01359605|ADME|adme
418265|NCT01359605|Healthy volunteers|healthy volunteers
418266|NCT01359592|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
418267|NCT01359592|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
418268|NCT01359592|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
418269|NCT01359592|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
418270|NCT01359592|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
418271|NCT01359579|renal impairment|renal impairment
418272|NCT01359579|phase 1|phase 1
418273|NCT01359579|healthy volunteers|healthy volunteers
418274|NCT01359540|Total Hip Arthroplasty|total hip arthroplasty
418275|NCT01359540|Bone Loss|bone loss
418276|NCT01359540|Femoral Remodeling|femoral remodeling
418277|NCT01359540|Bone mineral density|bone mineral density
418278|NCT01359540|THA|tha
418279|NCT01359540|DXA|dxa
418280|NCT01359540|DEXA|dexa
418281|NCT01359540|Dual Energy X-Ray Absorptiometry|dual energy x-ray absorptiometry
418282|NCT01359527|Total Hip Replacement|total hip replacement
418283|NCT01359527|Hip Resurfacing|hip resurfacing
418284|NCT01359527|Femoral Remodeling|femoral remodeling
418285|NCT01359527|Bone Loss|bone loss
418286|NCT01359527|Bone Mineral Density|bone mineral density
418287|NCT01359527|BMD|bmd
418288|NCT01359527|DXA|dxa
418289|NCT01359527|DEXA|dexa
418290|NCT01359527|THA|tha
418291|NCT01359501|patients receiving chemotherapy|patients receiving chemotherapy
418292|NCT01359488|Growth Hormone Deficiency|growth hormone deficiency
418293|NCT01359488|rhGH|rhgh
418294|NCT01359488|hGH|hgh
418295|NCT01359488|Versartis|versartis
418296|NCT01359488|AGHD|aghd
418297|NCT01359488|Hormones|hormones
418298|NCT01359488|Hormone substitute|hormone substitute
418299|NCT01359488|Endocrin System disease|endocrin system disease
418300|NCT01359488|Bone disease|bone disease
418301|NCT01359488|Bone disease, developmental|bone disease, developmental
418302|NCT01359488|Bone diseases|bone diseases
418303|NCT01359488|Musculoskeletal diseases|musculoskeletal diseases
418304|NCT01359488|Bone diseases, endocrine|bone diseases, endocrine
418305|NCT01359488|Metabolism diseases|metabolism diseases
418306|NCT01359488|Hypopituitarism|hypopituitarism
418307|NCT01359488|Pituitary disease|pituitary disease
418308|NCT01359488|Hypothalmic disease|hypothalmic disease
418309|NCT01359488|Brain disease|brain disease
418310|NCT01359488|Growth Hormone Releasing Hormone|growth hormone releasing hormone
418311|NCT01359488|Hormone replacement therapy|hormone replacement therapy
418312|NCT01359488|IGF-I|igf-i
418313|NCT01359488|IGFBP-3|igfbp-3
418314|NCT01359475|Acetal crowns|acetal crowns
418315|NCT01359475|Primary molars|primary molars
418316|NCT01359475|The retention of acetal crowns in primary dentition|the retention of acetal crowns in primary dentition
418317|NCT01359475|Color changes of acetal crowns|color changes of acetal crowns
418318|NCT01359462|hepatic cirrhosis patients with ascites|hepatic cirrhosis patients with ascites
418319|NCT01359449|Meningitis|meningitis
418320|NCT01359449|Meningococcal Infection|meningococcal infection
418321|NCT01359449|Menactra®|menactra®
418322|NCT01359449|MenC|menc
418323|NCT01359410|Pancreas adenocarcinoma|pancreas adenocarcinoma
418324|NCT01359410|Precancerous lesions of the pancreas (mucinous cystic neoplasms, IPMN)|precancerous lesions of the pancreas (mucinous cystic neoplasms, ipmn)
418325|NCT01359410|Pancreas neuroendocrine cancer|pancreas neuroendocrine cancer
418326|NCT01359397|Adenoca. stomach/gastr. Junct.|adenoca. stomach/gastr. junct.
418327|NCT01359384|severe primary immune deficieny|severe primary immune deficieny
418328|NCT01359371|Smoking Cessation|smoking cessation
418329|NCT01359371|Telephone|telephone
418330|NCT01359371|Hospital Volunteers|hospital volunteers
418334|NCT01359358|Resistance|resistance
418335|NCT01359358|isolated from colonization|isolated from colonization
418336|NCT01359345|NSF|nsf
418337|NCT01359345|ESRD|esrd
418338|NCT01359345|MRA|mra
418339|NCT01359345|MRI|mri
418340|NCT01359345|occurrence of NSF|occurrence of nsf
418341|NCT01359345|Use of Gadollinum|use of gadollinum
418342|NCT01359332|Convulsive status EPILEPTICUS|convulsive status epilepticus
418343|NCT01359332|hypothermia therapy|hypothermia therapy
418344|NCT01359332|(defined as continuous SEIZURING for longer than 5 min or three seizures|(defined as continuous seizuring for longer than 5 min or three seizures
418345|NCT01359332|not separated by recovery of normal consciousness|not separated by recovery of normal consciousness
418346|NCT01359332|or of the level of consciousness present before the|or of the level of consciousness present before the
418347|NCT01359332|seizures)|seizures)
418348|NCT01359319|Phase 1 Safety and Pharmacokinetic Study|phase 1 safety and pharmacokinetic study
418349|NCT01359306|Acute myocardial infarction|acute myocardial infarction
418350|NCT01359306|Right ventricular infarction|right ventricular infarction
418351|NCT01359306|Cardiovascular Magnetic Resonance|cardiovascular magnetic resonance
418352|NCT01359306|Prognosis|prognosis
418353|NCT01359280|HIV|hiv
418354|NCT01359280|AIDS|aids
418355|NCT01359280|Medication|medication
418356|NCT01359280|Adherence|adherence
418357|NCT01359241|dysglycemia|dysglycemia
418358|NCT01359241|diabetes|diabetes
418359|NCT01359241|closed loop insulin delivery|closed loop insulin delivery
418360|NCT01359228|Rosacea|rosacea
418361|NCT01359202|Stroke|stroke
418362|NCT01359202|ICH|ich
418363|NCT01359202|Intracerebral hemorrhage|intracerebral hemorrhage
418364|NCT01359202|acute stroke|acute stroke
418365|NCT01359202|rfVIIa|rfviia
418366|NCT01359202|Niastase|niastase
418367|NCT01359189|Suspected Primary Prostate Cancer|suspected primary prostate cancer
418368|NCT01359163|bioequivalence study|bioequivalence study
418369|NCT01359163|marketed vs reformulation tablets|marketed vs reformulation tablets
418370|NCT01359163|Femulen|femulen
418371|NCT01359137|Behavior|behavior
418372|NCT01359137|Drug users|drug users
418373|NCT01359137|Criminal Justice|criminal justice
418374|NCT01359137|Probation|probation
418375|NCT01359124|Osteoarthritis, Knee|osteoarthritis, knee
418376|NCT01359124|Exercise Therapies|exercise therapies
418377|NCT01359111|Intradermal injections|intradermal injections
418378|NCT01359111|Vaccination|vaccination
418379|NCT01359098|swimmer's ear|swimmer's ear
418380|NCT01359098|ear drops|ear drops
418381|NCT01359098|ear foam|ear foam
418382|NCT01359098|otic foam|otic foam
418383|NCT01359098|ear infection|ear infection
418384|NCT01359098|ear pain|ear pain
418385|NCT01359098|ear inflammation|ear inflammation
418386|NCT01359085|To compare postoperative pain relief by pregabalin versus ISBPB following arthroscopic rotator cuff repair|to compare postoperative pain relief by pregabalin versus isbpb following arthroscopic rotator cuff repair
418387|NCT01359085|To compare postoperative opioid consumption and opioid related AEs|to compare postoperative opioid consumption and opioid related aes
418388|NCT01359085|To compare patients recovery profile and patients satisfaction|to compare patients recovery profile and patients satisfaction
418389|NCT01359072|coping|coping
418390|NCT01359072|psychological distress|psychological distress
418391|NCT01359072|self-administered intervention|self-administered intervention
418392|NCT01359059|assess the beneficial effects of PGL administered either pre or post surgery|assess the beneficial effects of pgl administered either pre or post surgery
418393|NCT01359059|assess the satisfaction rate in the orthopedic oncologic patients|assess the satisfaction rate in the orthopedic oncologic patients
418394|NCT01359046|CAUTI|cauti
418395|NCT01359046|UTI|uti
418396|NCT01359033|Myocardial Infarction|myocardial infarction
418397|NCT01359033|UK|uk
418398|NCT01359033|Sweden|sweden
418399|NCT01359033|National audit registry|national audit registry
418400|NCT01359033|MINAP|minap
418401|NCT01359033|RIKS-HIA|riks-hia
418402|NCT01359020|Fever|fever
418403|NCT01359020|Ibuprofen|ibuprofen
418404|NCT01359020|Acetaminophen|acetaminophen
418405|NCT01359020|Dipyrone|dipyrone
418406|NCT01359007|Locally advanced unresectable adenocarcinoma of pancreas|locally advanced unresectable adenocarcinoma of pancreas
418407|NCT01359007|Borderline resectable adenocarcinoma of pancreas|borderline resectable adenocarcinoma of pancreas
418408|NCT01358994|metformin|metformin
418409|NCT01358994|type 2 diabetes|type 2 diabetes
418410|NCT01358994|e-GFR|e-gfr
418411|NCT01358994|creatinine|creatinine
418412|NCT01358994|lactic acidosis|lactic acidosis
418413|NCT01358955|mild cognitive impairment|mild cognitive impairment
418414|NCT01358955|cognitive therapy|cognitive therapy
418415|NCT01358955|prevention|prevention
418416|NCT01358916|antimicrobial resistance|antimicrobial resistance
418417|NCT01358916|antibiotic prescription|antibiotic prescription
418418|NCT01358916|primary health care|primary health care
418419|NCT01358916|cluster-randomized trial|cluster-randomized trial
418420|NCT01358890|over weight|over weight
418421|NCT01358890|obesity|obesity
418422|NCT01358838|Patients with either hypertrophic or atrophic scars|patients with either hypertrophic or atrophic scars
418423|NCT01358838|Efficacy of ablative 10600nm fractional laser therapy|efficacy of ablative 10600nm fractional laser therapy
418522|NCT01358409|Nebivolol|nebivolol
418424|NCT01358838|Laser therapy compared to no treatment of (part of) the scar|laser therapy compared to no treatment of (part of) the scar
418425|NCT01358825|Infanrix-IPV/Hib|infanrix-ipv/hib
418426|NCT01358825|Long-term follow up|long-term follow up
418427|NCT01358825|Persistence|persistence
418428|NCT01358825|Infanrix hexa|infanrix hexa
418429|NCT01358812|RAS Wild-Type|ras wild-type
418430|NCT01358812|BRAF Wild-Type|braf wild-type
418431|NCT01358799|Chlamydia trachomatis|chlamydia trachomatis
418432|NCT01358799|APTIMA Assay for Chlamydia trachomatis|aptima assay for chlamydia trachomatis
418433|NCT01358786|Quilting suture|quilting suture
418434|NCT01358786|seroma|seroma
418435|NCT01358786|Procedure|procedure
418436|NCT01358786|Surgery|surgery
418437|NCT01358773|Obesity|obesity
418438|NCT01358773|Therapy|therapy
418439|NCT01358773|Interdisciplinary|interdisciplinary
418440|NCT01358760|Vulvar/vaginal atrophy|vulvar/vaginal atrophy
418441|NCT01358760|Atrophic Vaginitis|atrophic vaginitis
418442|NCT01358760|Dehydroepiandrosterone|dehydroepiandrosterone
418443|NCT01358760|DHEA|dhea
418444|NCT01358760|Prasterone|prasterone
418445|NCT01358760|Vaginorm|vaginorm
418446|NCT01358760|Menopause|menopause
418447|NCT01358760|Intrarosa|intrarosa
418448|NCT01358734|AML|aml
418449|NCT01358734|elderly|elderly
418450|NCT01358734|acute myelogenous leukemia|acute myelogenous leukemia
418451|NCT01358734|vidaza|vidaza
418452|NCT01358734|azacitidine|azacitidine
418453|NCT01358734|elderly AML|elderly aml
418454|NCT01358734|revlimid|revlimid
418455|NCT01358734|lenalidomide|lenalidomide
418456|NCT01358695|Lateral Canthal Lines|lateral canthal lines
418457|NCT01358695|Crow's Feet|crow's feet
418458|NCT01358669|Denosumab|denosumab
418459|NCT01358669|Total Hip Arthroplasty|total hip arthroplasty
418460|NCT01358643|OEF/OIF|oef/oif
418461|NCT01358643|Physical Activity|physical activity
418462|NCT01358643|Preferences|preferences
418463|NCT01358630|Periodontitis|periodontitis
418464|NCT01358630|Vascular disease|vascular disease
418465|NCT01358630|Proinflammatory cytokines|proinflammatory cytokines
418466|NCT01358604|localized resectable neuroblastoma|localized resectable neuroblastoma
418467|NCT01358604|recurrent neuroblastoma|recurrent neuroblastoma
418468|NCT01358604|regional neuroblastoma|regional neuroblastoma
418469|NCT01358604|stage 4S neuroblastoma|stage 4s neuroblastoma
418470|NCT01358604|localized unresectable neuroblastoma|localized unresectable neuroblastoma
418471|NCT01358578|Psoriasis,|psoriasis,
418472|NCT01358578|inflammatory skin disease,|inflammatory skin disease,
418473|NCT01358578|scaly patches|scaly patches
418474|NCT01358578|Psoriasis|psoriasis
418475|NCT01358578|inflammatory skin disease|inflammatory skin disease
418476|NCT01358552|Neevo|neevo
418477|NCT01358552|Neevo DHA|neevo dha
418478|NCT01358552|L-methylfolate|l-methylfolate
418479|NCT01358552|anemia during pregnancy|anemia during pregnancy
418480|NCT01358552|folic acid|folic acid
418481|NCT01358552|vitamin B12|vitamin b12
418482|NCT01358552|prenatal vitamins|prenatal vitamins
418483|NCT01358552|hemoglobin|hemoglobin
418484|NCT01358552|iron deficiency|iron deficiency
418485|NCT01358552|Pregnancy|pregnancy
418486|NCT01358539|palliation|palliation
418487|NCT01358539|pain education|pain education
418488|NCT01358526|Low back pain|low back pain
418489|NCT01358526|Chronic pain|chronic pain
418490|NCT01358526|Opioid|opioid
418491|NCT01358526|Moderate to severe chronic low back pain|moderate to severe chronic low back pain
418492|NCT01358513|Positron Emission Tomography|positron emission tomography
418493|NCT01358513|Inflammation|inflammation
418494|NCT01358513|Calcification|calcification
418495|NCT01358500|opioid dependence|opioid dependence
418496|NCT01358500|tolerant|tolerant
418497|NCT01358500|dependent|dependent
418498|NCT01358487|Major depression|major depression
418499|NCT01358487|Cognitive Behavioral preventive intervention|cognitive behavioral preventive intervention
418500|NCT01358487|Mood Management|mood management
418501|NCT01358487|Self-help|self-help
418502|NCT01358487|Internet|internet
418503|NCT01358474|Parkinson disease|parkinson disease
418504|NCT01358474|idiopathic rapid eye movement sleep disorder|idiopathic rapid eye movement sleep disorder
418505|NCT01358474|Gaucher disease|gaucher disease
418506|NCT01358474|healthy volunteer|healthy volunteer
418507|NCT01358448|Treatment of childhood obesity|treatment of childhood obesity
418508|NCT01358422|Prospective observational study|prospective observational study
418509|NCT01358422|major adverse cardiac events (MACE)|major adverse cardiac events (mace)
418510|NCT01358422|clinically significant bleeding events|clinically significant bleeding events
418511|NCT01358422|Dual anti-platelet therapy|dual anti-platelet therapy
418512|NCT01358422|aspirin alone therapy|aspirin alone therapy
418513|NCT01358422|non-cardiac surgery|non-cardiac surgery
418514|NCT01358422|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
418515|NCT01358422|placement of a bare metal or drug eluting stent|placement of a bare metal or drug eluting stent
418516|NCT01358422|OBTAIN|obtain
418517|NCT01358422|Simon Howell|simon howell
418518|NCT01358422|ESA|esa
418519|NCT01358422|European Society of Anaesthesiology|european society of anaesthesiology
418520|NCT01358409|steatosis|steatosis
418521|NCT01358409|MR spectroscopy|mr spectroscopy
418523|NCT01358409|cardiac MRI|cardiac mri
418524|NCT01358396|Diabetic Macular Edema, Glycemic Control|diabetic macular edema, glycemic control
418525|NCT01358383|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
418526|NCT01358383|Pharmacokinetics|pharmacokinetics
418528|NCT01358383|fasting state|fasting state
418529|NCT01358383|Amount of VIMOVO in the blood|amount of vimovo in the blood
418530|NCT01358383|taken on empty stomach|taken on empty stomach
418531|NCT01358370|LAL Deficiency|lal deficiency
418532|NCT01358370|LIPA|lipa
418533|NCT01358370|Wolman disease|wolman disease
418534|NCT01358370|Wolman Phenotype|wolman phenotype
418535|NCT01358370|Early Onset LAL Deficiency|early onset lal deficiency
418536|NCT01358370|Acid Lipase Deficiency|acid lipase deficiency
418537|NCT01358357|Lurasidone|lurasidone
418538|NCT01358357|Latuda|latuda
418539|NCT01358357|Bipolar I|bipolar i
418540|NCT01358318|obesity|obesity
418541|NCT01358318|satiety|satiety
418542|NCT01358318|soy protein|soy protein
418543|NCT01358318|soy fiber|soy fiber
418544|NCT01358318|control appetite|control appetite
418545|NCT01358318|reduce food intake|reduce food intake
418546|NCT01358305|muscle|muscle
418547|NCT01358305|synthesis|synthesis
418548|NCT01358305|mTOR|mtor
418549|NCT01358305|antioxidant|antioxidant
418550|NCT01358305|inflammatory markers|inflammatory markers
418551|NCT01358305|soy protein|soy protein
418552|NCT01358305|whey|whey
418553|NCT01358305|casein|casein
418554|NCT01358292|Intramedullary tibia nailing|intramedullary tibia nailing
418555|NCT01358292|Anterior Knee Pain|anterior knee pain
418556|NCT01358292|Nail positioning|nail positioning
418557|NCT01358253|Rituximab|rituximab
418558|NCT01358253|HyperCVAD|hypercvad
418559|NCT01358240|Econazole Nitrate|econazole nitrate
418560|NCT01358240|Foam|foam
418561|NCT01358240|Quinnova|quinnova
418562|NCT01358240|Tinea Pedis|tinea pedis
418563|NCT01358214|Sub-urethral Sling|sub-urethral sling
418564|NCT01358214|Treatment Outcome|treatment outcome
418565|NCT01358214|Quality of Life|quality of life
418566|NCT01358201|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
418567|NCT01358188|Gaucher disease|gaucher disease
418568|NCT01358188|immunity|immunity
418569|NCT01358188|inflammation|inflammation
418570|NCT01358188|macrophage activation|macrophage activation
418571|NCT01358175|Ankylosing spondylitis|ankylosing spondylitis
418572|NCT01358175|AS|as
418573|NCT01358175|ASAS|asas
418574|NCT01358175|inflammatory back pain|inflammatory back pain
418575|NCT01358162|Tuberculosis|tuberculosis
418576|NCT01358136|Thyroidectomy|thyroidectomy
418577|NCT01358136|Mitochondria|mitochondria
418578|NCT01358123|liver cirrhosis|liver cirrhosis
418579|NCT01358123|portal hypertension|portal hypertension
418580|NCT01358123|survival|survival
418581|NCT01358123|von willebrand factor|von willebrand factor
418582|NCT01358123|hepatic venous pressure gradient|hepatic venous pressure gradient
418583|NCT01358110|palliative care|palliative care
418584|NCT01358110|cancer|cancer
418585|NCT01358110|emergency medicine|emergency medicine
418586|NCT01358110|end- of- life care|end- of- life care
418587|NCT01358097|Head and neck cancer|head and neck cancer
418588|NCT01358097|Oropharyngeal cancer|oropharyngeal cancer
418589|NCT01358097|Human papillomavirus|human papillomavirus
418590|NCT01358097|Squamous cell carcinoma|squamous cell carcinoma
418591|NCT01358097|Radiation treatment|radiation treatment
418592|NCT01358097|Chemotherapy|chemotherapy
418593|NCT01358097|Induction chemotherapy|induction chemotherapy
418594|NCT01358097|Immune status|immune status
418595|NCT01358097|Immune monitoring|immune monitoring
418596|NCT01358097|head and neck robotic surgery|head and neck robotic surgery
418597|NCT01358084|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
418598|NCT01358084|MPM|mpm
418599|NCT01358084|Maintenance treatment|maintenance treatment
418600|NCT01358084|NGR-hTNF|ngr-htnf
418601|NCT01358071|NGR-hTNF|ngr-htnf
418602|NCT01358071|Pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
418603|NCT01358071|Doxorubicin|doxorubicin
418604|NCT01358071|Platinum-resistant|platinum-resistant
418605|NCT01358071|Progression or recurrence Ovarian Cancer|progression or recurrence ovarian cancer
418606|NCT01358071|Ovarian Cancer|ovarian cancer
418607|NCT01358071|Advanced or metastatic|advanced or metastatic
418608|NCT01358058|Brain tumors|brain tumors
418609|NCT01358058|Radiation|radiation
418610|NCT01358058|Proton|proton
418611|NCT01358058|Gliomas|gliomas
418612|NCT01358045|Topical|topical
418613|NCT01358045|Diclofenac|diclofenac
418614|NCT01358045|Vitamin D3|vitamin d3
418615|NCT01358032|Fear of falling|fear of falling
418616|NCT01358032|Cognitive behavioral therapy|cognitive behavioral therapy
418617|NCT01358032|Randomized controlled trial|randomized controlled trial
418618|NCT01358032|Frailty|frailty
418619|NCT01358032|Accidental Falls|accidental falls
418620|NCT01358006|JNJ-40411813|jnj-40411813
418621|NCT01358006|Positron Emission Tomography (PET)|positron emission tomography (pet)
418622|NCT01358006|Serotonin-2A (5-HT2A) receptor antagonist|serotonin-2a (5-ht2a) receptor antagonist
418623|NCT01358006|Male Volunteers|male volunteers
418624|NCT01357993|Methylphenidate hydrochloride|methylphenidate hydrochloride
418625|NCT01357993|Concerta|concerta
418626|NCT01357993|Adults|adults
418627|NCT01357993|Attention-Deficit / Hyperactivity Disorder|attention-deficit / hyperactivity disorder
418628|NCT01357993|ADHD|adhd
418629|NCT01357993|Long term safety|long term safety
418630|NCT01357980|Detrusor Muscle Overactivity|detrusor muscle overactivity
418631|NCT01357954|Postural control|postural control
418632|NCT01357954|Targeted Training|targeted training
418633|NCT01357954|Gross motor function|gross motor function
418634|NCT01357954|Cerebral palsy|cerebral palsy
418635|NCT01357941|venous thromboembolism|venous thromboembolism
418636|NCT01357941|thromboembolism|thromboembolism
418637|NCT01357941|deep vein thrombosis|deep vein thrombosis
418638|NCT01357941|pulmonary embolism|pulmonary embolism
418639|NCT01357941|thromboprophylaxis|thromboprophylaxis
418640|NCT01357941|thrombosis|thrombosis
418641|NCT01357941|embolism and thrombosis|embolism and thrombosis
418642|NCT01357941|cardiovascular diseases|cardiovascular diseases
418643|NCT01357941|venous thrombosis|venous thrombosis
418644|NCT01357941|vascular diseases|vascular diseases
418645|NCT01357941|anticoagulants|anticoagulants
418646|NCT01357941|hematologic agents|hematologic agents
418647|NCT01357941|cardiovascular agents|cardiovascular agents
418648|NCT01357941|enoxaparin|enoxaparin
418649|NCT01357941|dalteparin|dalteparin
418650|NCT01357941|tinzaparin|tinzaparin
418651|NCT01357941|pregnancy complications|pregnancy complications
418652|NCT01357928|TEG|teg
418653|NCT01357928|Thromboelastography|thromboelastography
418654|NCT01357928|Coagulation|coagulation
418655|NCT01357915|Cytomegalovirus|cytomegalovirus
418656|NCT01357915|Vaccine|vaccine
418657|NCT01357889|pharmacokinetics|pharmacokinetics
418658|NCT01357889|pharmacodynamics|pharmacodynamics
418659|NCT01357889|GSK716155|gsk716155
418660|NCT01357889|albiglutide|albiglutide
418661|NCT01357863|Lapatinib|lapatinib
418662|NCT01357863|Observational Study|observational study
418663|NCT01357863|Trastuzumab|trastuzumab
418664|NCT01357863|Brazil|brazil
418665|NCT01357863|Metastatic Breast Cancer|metastatic breast cancer
418666|NCT01357837|Osteoarthritis, knee|osteoarthritis, knee
418667|NCT01357837|Analgesia|analgesia
418668|NCT01357837|Pain|pain
418669|NCT01357837|Painful|painful
418670|NCT01357824|Intubation|intubation
418671|NCT01357824|Sellick´s maneuver|sellick´s maneuver
418672|NCT01357824|aspiration|aspiration
418673|NCT01357824|[E05.497.578]|[e05.497.578]
418674|NCT01357811|Genz-112638|genz-112638
418675|NCT01357811|digoxin|digoxin
418676|NCT01357798|Headache|headache
418677|NCT01357798|Allodynia|allodynia
418678|NCT01357798|Botulinum Toxin Type A|botulinum toxin type a
418679|NCT01357785|Periodontal ligament stem cells|periodontal ligament stem cells
418680|NCT01357785|Periodontal regeneration|periodontal regeneration
418681|NCT01357785|Clinical trial|clinical trial
418682|NCT01357785|Deep intraosseous defects|deep intraosseous defects
418683|NCT01357746|Pulmonary arterial blood pressure doppler|pulmonary arterial blood pressure doppler
418684|NCT01357733|Diffuse, Large B-Cell, Lymphoma|diffuse, large b-cell, lymphoma
418685|NCT01357733|18F Fluorodeoxyglucose|18f fluorodeoxyglucose
418686|NCT01357733|Radionuclide-Emission Computed Tomography|radionuclide-emission computed tomography
418687|NCT01357720|Vaccination|vaccination
418688|NCT01357720|Immunisation|immunisation
418689|NCT01357720|Virus|virus
418690|NCT01357720|Diphtheria|diphtheria
418691|NCT01357720|Pertussis|pertussis
418692|NCT01357720|Tetanus|tetanus
418693|NCT01357720|Hepatitis B|hepatitis b
418694|NCT01357720|Haemophilus Influenzae|haemophilus influenzae
418695|NCT01357720|Immunity|immunity
418696|NCT01357694|psychotherapy|psychotherapy
418697|NCT01357694|depression|depression
418698|NCT01357694|anxiety|anxiety
418699|NCT01357694|surgical patients|surgical patients
418700|NCT01357681|Huntington Disease|huntington disease
418701|NCT01357681|Cognition|cognition
418702|NCT01357681|Motor|motor
418703|NCT01357681|Behaviour|behaviour
418704|NCT01357681|Functional Capacity|functional capacity
418705|NCT01357681|Quality of Life|quality of life
418706|NCT01357681|Biomarker|biomarker
418707|NCT01357681|MRI|mri
418708|NCT01357681|Huntingtin|huntingtin
418709|NCT01357681|EGCG|egcg
418710|NCT01357655|Myelogenous|myelogenous
418711|NCT01357655|Chronic|chronic
418712|NCT01357655|BCR-ABL Positive|bcr-abl positive
418713|NCT01357642|asthma|asthma
418714|NCT01357642|bronchial asthma|bronchial asthma
418715|NCT01357642|shortness of breath|shortness of breath
418716|NCT01357629|Vaccination follow-up|vaccination follow-up
418717|NCT01357616|Glaucoma|glaucoma
418718|NCT01357616|Open-angle glaucoma|open-angle glaucoma
418719|NCT01357616|Ocular hypertension|ocular hypertension
418720|NCT01357616|OAG|oag
418721|NCT01357616|OH|oh
418722|NCT01357590|aneurysm, penetrating ulcer, descending thoracic aorta|aneurysm, penetrating ulcer, descending thoracic aorta
418723|NCT01357577|PTSD|ptsd
418724|NCT01357577|Substance Use Disorders|substance use disorders
418725|NCT01357564|dementia|dementia
418726|NCT01357564|caregivers|caregivers
418727|NCT01357564|tailored activity|tailored activity
418728|NCT01357551|obesity|obesity
418729|NCT01357551|intervention studies|intervention studies
418730|NCT01357551|patient adherence|patient adherence
418731|NCT01357538|Bibrocathol|bibrocathol
418732|NCT01357538|eye ointment|eye ointment
418733|NCT01357538|blepharitis|blepharitis
418734|NCT01357538|eye lid|eye lid
418735|NCT01357525|Pancreas|pancreas
418736|NCT01357525|Resected|resected
418737|NCT01357512|prostate cancer diagnosis|prostate cancer diagnosis
418738|NCT01357512|magnetic resonance imaging|magnetic resonance imaging
418739|NCT01357512|prostate biopsy|prostate biopsy
418740|NCT01357486|Hepatocellular Carcinoma|hepatocellular carcinoma
418741|NCT01357486|CHILD B|child b
418742|NCT01357486|palliative management|palliative management
418743|NCT01357486|Sorafenib|sorafenib
418744|NCT01357486|Pravastatin|pravastatin
418745|NCT01357473|hormonal values|hormonal values
418746|NCT01357473|menstruations|menstruations
418747|NCT01357473|pregnancy|pregnancy
418748|NCT01357473|antagonist|antagonist
418749|NCT01357460|Emphysema|emphysema
418750|NCT01357460|alpha1 antitrypsin deficiency|alpha1 antitrypsin deficiency
418751|NCT01357460|endoscopic lung volume reduction|endoscopic lung volume reduction
418752|NCT01357447|Sjogren's syndrome|sjogren's syndrome
418753|NCT01357447|Cough|cough
418754|NCT01357408|without an indication for ICD or CRT|without an indication for icd or crt
418755|NCT01357408|left ventricular function greater than or equal to 40%|left ventricular function greater than or equal to 40%
418756|NCT01357395|Small Cell Lung Carcinoma|small cell lung carcinoma
418757|NCT01357382|low fat diet|low fat diet
418758|NCT01357382|low carbohydrate diet|low carbohydrate diet
418759|NCT01357369|bacteria infections|bacteria infections
418760|NCT01357343|Low back pain|low back pain
418761|NCT01357343|Chiropractic|chiropractic
418762|NCT01357343|Acupuncture|acupuncture
418763|NCT01357343|Integrated care|integrated care
418764|NCT01357330|locally advanced or metastatic|locally advanced or metastatic
418765|NCT01357317|Kidney disease|kidney disease
418766|NCT01357317|Hyperphosphatemia|hyperphosphatemia
418767|NCT01357317|Parathyroid hormone|parathyroid hormone
418768|NCT01357304|Group treatment|group treatment
418769|NCT01357304|Physical activity referral|physical activity referral
418770|NCT01357304|Type 2 diabetes|type 2 diabetes
418771|NCT01357304|Hypertension|hypertension
418772|NCT01357291|Behavior|behavior
418773|NCT01357291|Drug users|drug users
418774|NCT01357291|Inmates|inmates
418775|NCT01357278|osteoporosis|osteoporosis
418776|NCT01357278|exercise|exercise
418777|NCT01357278|intervention|intervention
418778|NCT01357278|rehabilitation|rehabilitation
418779|NCT01357278|bone mineral density|bone mineral density
418780|NCT01357278|muscle strength|muscle strength
418781|NCT01357265|Seasonal Influenza|seasonal influenza
418782|NCT01357265|vaccine|vaccine
418783|NCT01357252|Diabetes mellitus|diabetes mellitus
418784|NCT01357252|vildagliptin|vildagliptin
418785|NCT01357239|Fragile X Syndrome|fragile x syndrome
418786|NCT01357239|Martin-Bell Syndrome|martin-bell syndrome
418787|NCT01357239|Genetic Diseases|genetic diseases
418788|NCT01357239|X-Linked|x-linked
418789|NCT01357239|Escalante's syndrome|escalante's syndrome
418790|NCT01357226|measurement in two environments|measurement in two environments
418791|NCT01357213|Botulism, Clostridium|botulism, clostridium
418792|NCT01357187|Lumbar pathology|lumbar pathology
418793|NCT01357187|requiring elective lumbar interbody fusion|requiring elective lumbar interbody fusion
418794|NCT01357096|intervention|intervention
418795|NCT01357096|CABG or PTCA|cabg or ptca
418796|NCT01357083|Melatonin|melatonin
418797|NCT01357083|Periodicity|periodicity
418798|NCT01357083|Depressive disorder, major|depressive disorder, major
418799|NCT01357083|Serum|serum
418800|NCT01357083|Depression|depression
418801|NCT01357057|Medical records|medical records
418802|NCT01357057|Outcome scale|outcome scale
418803|NCT01357057|Biological biomarkers|biological biomarkers
418804|NCT01357044|Semen quality|semen quality
418805|NCT01357044|Plant extracts|plant extracts
418806|NCT01357031|Amitriptyline|amitriptyline
418807|NCT01357031|Placebo|placebo
418808|NCT01357031|Melatonin|melatonin
418809|NCT01357031|Migraine|migraine
418810|NCT01357031|Headache|headache
418811|NCT01357031|Drug therapy|drug therapy
418812|NCT01357031|Preventive treatment of migraine|preventive treatment of migraine
418813|NCT01357018|Ankylosing spondylitis|ankylosing spondylitis
418814|NCT01357018|Disease activity|disease activity
418815|NCT01357018|EQ-5D|eq-5d
418816|NCT01357018|Quality of life|quality of life
418817|NCT01357018|Rheumatoid arthritis|rheumatoid arthritis
418818|NCT01356992|non-inferiority phase III study|non-inferiority phase iii study
418819|NCT01356992|Low-Molecular Weight Heparin|low-molecular weight heparin
418820|NCT01356992|Versa® (enoxaparin - Eurofarma)|versa® (enoxaparin - eurofarma)
418821|NCT01356992|Clexane® (enoxaparin - Sanofi-Aventis)|clexane® (enoxaparin - sanofi-aventis)
418822|NCT01356992|Acute coronary syndrome without ST-segment elevation|acute coronary syndrome without st-segment elevation
418823|NCT01356979|Medical thoracoscopy|medical thoracoscopy
418824|NCT01356979|Pleural effusion|pleural effusion
418825|NCT01356979|Malignant pleural diseases|malignant pleural diseases
418826|NCT01356979|Tuberculous pleuritis|tuberculous pleuritis
418827|NCT01356979|Fibrinous pleuritis|fibrinous pleuritis
418828|NCT01356953|Aerobic Exercise|aerobic exercise
418829|NCT01356953|Blood Pressure|blood pressure
418830|NCT01356940|Ambulation|ambulation
418831|NCT01356927|long acting reversible contraception|long acting reversible contraception
418832|NCT01356927|medical abortion|medical abortion
418833|NCT01356927|DMPA|dmpa
418834|NCT01356927|etonogestrel implant|etonogestrel implant
418835|NCT01356927|Implanon|implanon
418836|NCT01356927|contraceptive continuation|contraceptive continuation
418837|NCT01356875|myelodysplastic syndrome|myelodysplastic syndrome
418838|NCT01356875|Transfusion|transfusion
418839|NCT01356875|Hydralazine|hydralazine
418840|NCT01356875|valproic acid|valproic acid
418841|NCT01356862|mastectomy|mastectomy
418842|NCT01356862|axillary node dissection|axillary node dissection
418843|NCT01356862|adjuvant or neoadjuvant|adjuvant or neoadjuvant
418844|NCT01356849|Endothelin Receptor Antagonists|endothelin receptor antagonists
418845|NCT01356849|Proteinuria|proteinuria
418846|NCT01356836|Coronary collateral development|coronary collateral development
418847|NCT01356836|monocyte subsets|monocyte subsets
418848|NCT01356836|collateralization|collateralization
418849|NCT01356823|Human Papilloma Virus 16|human papilloma virus 16
418850|NCT01356823|Human Papilloma Virus 18|human papilloma virus 18
418851|NCT01356823|vaccine|vaccine
418852|NCT01356823|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
418853|NCT01356823|cervical Cancer|cervical cancer
418854|NCT01356810|Delirium|delirium
418855|NCT01356810|Primary Prevention|primary prevention
418856|NCT01356810|Elderly|elderly
418857|NCT01356797|knee arthroscopy|knee arthroscopy
418858|NCT01356797|hyperbaric bupivacaine|hyperbaric bupivacaine
418859|NCT01356797|hypobaric levobupivacaine plus fentanyl|hypobaric levobupivacaine plus fentanyl
418860|NCT01356784|Sick-listed|sick-listed
418861|NCT01356784|Tailored physical activity|tailored physical activity
418862|NCT01356784|Patient education|patient education
418863|NCT01356784|Returning to work|returning to work
418864|NCT01356784|DK-Sønderborg Municipality|dk-sønderborg municipality
418865|NCT01356784|columna|columna
418866|NCT01356784|upper body|upper body
418867|NCT01356771|Risk Assessment|risk assessment
418868|NCT01356771|Intervention|intervention
418869|NCT01356745|premixed nitrous oxide and oxygen|premixed nitrous oxide and oxygen
418870|NCT01356745|acute pain|acute pain
418871|NCT01356745|prehospital setting|prehospital setting
418872|NCT01356732|mechanical ventilation|mechanical ventilation
418873|NCT01356732|Midazolam|midazolam
418874|NCT01356732|Ramsay|ramsay
418875|NCT01356732|Sufentanil|sufentanil
418876|NCT01356719|Tracheostomy|tracheostomy
418877|NCT01356719|adverse effects|adverse effects
418878|NCT01356719|Critical Care|critical care
418879|NCT01356719|standards|standards
418880|NCT01356719|safety|safety
418881|NCT01356706|liver metastases|liver metastases
418882|NCT01356706|colorectal cancer|colorectal cancer
418883|NCT01356706|surgery|surgery
418884|NCT01356706|prognosis|prognosis
418885|NCT01356693|Cough|cough
418886|NCT01356693|Common cold|common cold
418887|NCT01356693|Child|child
418888|NCT01356693|Adolescent|adolescent
418889|NCT01356680|Hodgkin Lymphoma|hodgkin lymphoma
418890|NCT01356680|intermediate stage|intermediate stage
418891|NCT01356680|PET|pet
418892|NCT01356667|American Indians|american indians
418893|NCT01356667|Native Americans|native americans
418894|NCT01356667|substance abuse|substance abuse
418895|NCT01356667|culture|culture
418896|NCT01356654|Stroke|stroke
418897|NCT01356654|TDCS|tdcs
418898|NCT01356654|Gait|gait
418899|NCT01356654|Balance|balance
418900|NCT01356654|loss of postural balance|loss of postural balance
418901|NCT01356641|Antibiotic treatment|antibiotic treatment
418902|NCT01356641|Non perforated appendicitis|non perforated appendicitis
418903|NCT01356641|Children|children
418904|NCT01356628|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
418905|NCT01356628|HCC|hcc
418906|NCT01356628|Liver Cancer|liver cancer
418907|NCT01356628|PD-0332991|pd-0332991
418908|NCT01356615|anticoagulation|anticoagulation
418909|NCT01356615|hemodialysis|hemodialysis
418910|NCT01356615|heparin|heparin
418911|NCT01356615|lipids|lipids
418912|NCT01356615|low molecular weight heparins|low molecular weight heparins
418913|NCT01356602|Gout|gout
418914|NCT01356602|arthritis|arthritis
418915|NCT01356602|gout flare|gout flare
418916|NCT01356602|acute gout|acute gout
418917|NCT01356602|gouty|gouty
418918|NCT01356602|rheumatic disease|rheumatic disease
418919|NCT01356602|uric acid|uric acid
418920|NCT01356563|hemodialysis|hemodialysis
418921|NCT01356563|pharmacist|pharmacist
418922|NCT01356563|medication-related problems|medication-related problems
418923|NCT01356563|compliance|compliance
418924|NCT01356511|Purpura, Thrombocytopenic, Idiopathic|purpura, thrombocytopenic, idiopathic
418925|NCT01356498|gout|gout
418926|NCT01356498|chronic gout|chronic gout
418927|NCT01356485|Sickle cell anemia|sickle cell anemia
418928|NCT01356485|Sickle cell disease|sickle cell disease
418929|NCT01356485|Sickling crisis|sickling crisis
418930|NCT01356485|Vaso-occlusive crisis|vaso-occlusive crisis
418931|NCT01356485|Carboxyhemoglobin|carboxyhemoglobin
418932|NCT01356485|Oxygen therapeutic|oxygen therapeutic
418933|NCT01356485|Hemoglobin solutions|hemoglobin solutions
418934|NCT01356485|Pegylated hemoglobin|pegylated hemoglobin
418935|NCT01356472|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
418936|NCT01356472|Pneumonia, Ventilator-Associated|pneumonia, ventilator-associated
418937|NCT01356472|linezolid|linezolid
418938|NCT01356472|imipenem/cilastatin|imipenem/cilastatin
418939|NCT01356459|Pressure ulcers|pressure ulcers
418940|NCT01356459|ICU|icu
418941|NCT01356459|Prevention|prevention
418942|NCT01356446|safety|safety
418943|NCT01356446|team|team
418944|NCT01356446|team performance|team performance
418945|NCT01356446|surgery|surgery
418946|NCT01356446|outcome|outcome
418947|NCT01356433|dialysis,inflammation,vitamin C|dialysis,inflammation,vitamin c
418948|NCT01356420|SLOS|slos
418949|NCT01356394|Obesity|obesity
418950|NCT01356394|Metabolic Syndrome|metabolic syndrome
418951|NCT01356394|Microalbuminuria|microalbuminuria
418952|NCT01356394|Chronic Kidney Disease|chronic kidney disease
418953|NCT01356381|Diabetes mellitus|diabetes mellitus
418954|NCT01356381|vildagliptin|vildagliptin
418955|NCT01356368|Lung cancer|lung cancer
418956|NCT01356355|Stent discomfort|stent discomfort
418957|NCT01356355|Herbmed plus|herbmed plus
418958|NCT01356355|Tolterodine|tolterodine
418959|NCT01356342|Influenza|influenza
418960|NCT01356342|Vaccine|vaccine
418961|NCT01356342|Immunogenicity|immunogenicity
418962|NCT01356329|Gynecologic malignancy ,major surgery|gynecologic malignancy ,major surgery
418963|NCT01356316|Influenza|influenza
418964|NCT01356316|Vaccine|vaccine
418965|NCT01356316|Immunogenicity|immunogenicity
418966|NCT01356303|Lung cancer|lung cancer
418967|NCT01356290|Medulloblastoma|medulloblastoma
418968|NCT01356290|Relapse|relapse
418969|NCT01356290|Children|children
418970|NCT01356290|antiangiogenic|antiangiogenic
418971|NCT01356290|metronomic|metronomic
418972|NCT01356290|intrathecal|intrathecal
418973|NCT01356277|renal|renal
418974|NCT01356277|allograft|allograft
418975|NCT01356277|immunosuppressive|immunosuppressive
418976|NCT01356277|immunosuppression|immunosuppression
418977|NCT01356277|adherence|adherence
418978|NCT01356277|medication|medication
418979|NCT01356277|compliance|compliance
418980|NCT01356264|colorectal cancer|colorectal cancer
418981|NCT01356264|colorectal surgery|colorectal surgery
418982|NCT01356264|prehabilitation|prehabilitation
418983|NCT01356264|surgical recovery|surgical recovery
418984|NCT01356264|exercise|exercise
418985|NCT01356264|referred for scheduled resection|referred for scheduled resection
418986|NCT01356251|Quality of life|quality of life
418987|NCT01356251|support group|support group
418988|NCT01356251|questionnaires|questionnaires
418989|NCT01356251|Internet-based support group|internet-based support group
418990|NCT01356251|11-066|11-066
418991|NCT01356225|pain following dental impaction surgery|pain following dental impaction surgery
418992|NCT01356199|Gonalgia|gonalgia
418993|NCT01356199|Quality of Life|quality of life
418994|NCT01356199|Dietary supplement|dietary supplement
418995|NCT01356199|Nutrition|nutrition
418996|NCT01356186|Suicide|suicide
418997|NCT01356186|Cognitive Therapy|cognitive therapy
418998|NCT01356186|Inpatient|inpatient
418999|NCT01356186|Military|military
419000|NCT01356173|solid cancers|solid cancers
419001|NCT01356160|Hepatitis C|hepatitis c
419002|NCT01356160|HCV|hcv
419003|NCT01356160|Rapid Virologic Response|rapid virologic response
419004|NCT01356160|Sustained Virologic Response|sustained virologic response
419005|NCT01356160|Direct Acting Antiviral|direct acting antiviral
419006|NCT01356160|Combination Therapy HCV RNA|combination therapy hcv rna
419007|NCT01356160|Protease inhibitor|protease inhibitor
419008|NCT01356160|Treatment naïve|treatment naïve
419009|NCT01356160|GS-5885|gs-5885
419010|NCT01356160|GS-9451|gs-9451
419011|NCT01356147|ventilator associated pulmonary infections|ventilator associated pulmonary infections
419012|NCT01356134|multiple sclerosis|multiple sclerosis
419013|NCT01356134|ehlers danlos syndrome|ehlers danlos syndrome
419014|NCT01356134|CCSVI|ccsvi
419015|NCT01356134|chronic cerebrospinal venous insufficiency|chronic cerebrospinal venous insufficiency
419016|NCT01356134|fundus|fundus
419017|NCT01356134|retina|retina
419018|NCT01356108|Conduit|conduit
419019|NCT01356108|Pulmonic|pulmonic
419020|NCT01356108|Stenosis|stenosis
419021|NCT01356108|Regurgitation|regurgitation
419022|NCT01356108|Dysfunctional|dysfunctional
419023|NCT01356095|Tuberculosis|tuberculosis
419024|NCT01356095|Treatment Adherence|treatment adherence
419025|NCT01356095|knowledge translation|knowledge translation
419026|NCT01356095|Educational outreach|educational outreach
419027|NCT01356069|BPD|bpd
419028|NCT01356069|MHS|mhs
419029|NCT01356069|heavy users|heavy users
419030|NCT01356069|sequential psychotherapy|sequential psychotherapy
419031|NCT01356004|severe resistant|severe resistant
419032|NCT01355991|Spinal Cord Injury|spinal cord injury
419033|NCT01355991|Tetraplegia|tetraplegia
419034|NCT01355991|Pulmonary Function|pulmonary function
419035|NCT01355991|Bronchodilator|bronchodilator
419036|NCT01355965|completed standard first line therapy|completed standard first line therapy
419037|NCT01355965|platinum based double regimen|platinum based double regimen
419038|NCT01355965|Progressive Disease|progressive disease
419039|NCT01355965|chosen not to pursue primary standard of care therapy|chosen not to pursue primary standard of care therapy
419040|NCT01355952|Obesity|obesity
419041|NCT01355952|Weight Loss|weight loss
419042|NCT01355952|Schizophrenia|schizophrenia
419043|NCT01355952|Alpha Lipoic Acid|alpha lipoic acid
419044|NCT01355939|Hernia|hernia
419045|NCT01355939|Adhesiolysis|adhesiolysis
419046|NCT01355939|Adhesions|adhesions
419047|NCT01355939|Intraperitoneal Mesh|intraperitoneal mesh
419048|NCT01355939|Abdominal Re-exploration|abdominal re-exploration
419049|NCT01355939|Mesh|mesh
419050|NCT01355939|Barrier-Coated Mesh|barrier-coated mesh
419051|NCT01355939|Non-Barrier-Coated Mesh|non-barrier-coated mesh
419052|NCT01355939|Laparoscopic Approach|laparoscopic approach
419053|NCT01355939|Open Approach|open approach
419054|NCT01355939|Abdominal Re-Exploration Surgery|abdominal re-exploration surgery
419055|NCT01355926|Flexible Fiber-based CO2 Laser|flexible fiber-based co2 laser
419056|NCT01355926|Monopolar Cautery|monopolar cautery
419057|NCT01355926|Oral Cavity Lesions|oral cavity lesions
419058|NCT01355926|Quality of life|quality of life
419059|NCT01355926|Assessing Pain|assessing pain
419060|NCT01355926|11-034|11-034
419061|NCT01355913|Myelodysplastic syndromes (MDS)|myelodysplastic syndromes (mds)
419062|NCT01355913|chromosmal aberrations|chromosmal aberrations
419063|NCT01355913|cytogenetics|cytogenetics
419064|NCT01355913|Fluorescence in situ hybridization (FISH)|fluorescence in situ hybridization (fish)
419065|NCT01355913|CD34+ cells|cd34+ cells
419066|NCT01355913|peripheral blood|peripheral blood
419067|NCT01355900|Total knee arthroplasty|total knee arthroplasty
419068|NCT01355900|Tourniquet|tourniquet
419069|NCT01355900|Blood loss|blood loss
419070|NCT01355900|Volume loading test|volume loading test
419071|NCT01355887|blood loss|blood loss
419072|NCT01355887|hepatectomy|hepatectomy
419073|NCT01355887|prospective study|prospective study
419074|NCT01355887|PTC|ptc
419075|NCT01355874|Internal Symptomatic Hemorrhoids|internal symptomatic hemorrhoids
419076|NCT01355861|sarcopenia|sarcopenia
419077|NCT01355861|aging|aging
419078|NCT01355861|rehabilitation|rehabilitation
419079|NCT01355861|exercise|exercise
419080|NCT01355848|Suicide|suicide
419081|NCT01355848|Brief Intervention|brief intervention
419082|NCT01355848|Youth|youth
419083|NCT01355848|Acute Medical Setting|acute medical setting
419084|NCT01355848|Readiness to Change|readiness to change
419085|NCT01355848|Suicidality|suicidality
419086|NCT01355835|Parkinson's disease|parkinson's disease
419087|NCT01355835|gait|gait
419088|NCT01355835|deep brain stimulation|deep brain stimulation
419089|NCT01355835|substantia nigra pars reticulata|substantia nigra pars reticulata
419090|NCT01355835|subthalamic nucleus|subthalamic nucleus
419091|NCT01355822|abortion|abortion
419092|NCT01355822|perinatal death|perinatal death
419093|NCT01355822|IUGR|iugr
419094|NCT01355822|preterm birth|preterm birth
419095|NCT01355822|placental abruption|placental abruption
419096|NCT01355822|preeclampsia|preeclampsia
419097|NCT01355809|Six-Minute Walk Test|six-minute walk test
419098|NCT01355757|shoulder arthroscopy|shoulder arthroscopy
419099|NCT01355757|24-week follow-up|24-week follow-up
419100|NCT01355757|quality of life|quality of life
419101|NCT01355757|rehabilitation achievement|rehabilitation achievement
419102|NCT01355757|rotator cuff repair|rotator cuff repair
419103|NCT01355744|humans|humans
419104|NCT01355744|insect bites|insect bites
419105|NCT01355731|Registered Nurse|registered nurse
419106|NCT01355731|Behaviors|behaviors
419107|NCT01355731|Attitudes|attitudes
419108|NCT01355692|DME|dme
419109|NCT01355692|Laser|laser
419110|NCT01355692|Selective laser therapy|selective laser therapy
419111|NCT01355692|photocoagulation|photocoagulation
419112|NCT01355666|pressure ulcers|pressure ulcers
419113|NCT01355666|stage 1|stage 1
419114|NCT01355666|stage 2|stage 2
419115|NCT01355666|stage 3|stage 3
419116|NCT01355666|stage 4|stage 4
419117|NCT01355666|wounds|wounds
419118|NCT01355666|sores|sores
419119|NCT01355666|infection|infection
419120|NCT01355666|bioburden|bioburden
419121|NCT01355666|bacterial contamination|bacterial contamination
419122|NCT01355666|bed linen|bed linen
419123|NCT01355666|sheets|sheets
419124|NCT01355666|underpad|underpad
419125|NCT01355666|skin assessment|skin assessment
419126|NCT01355666|microclimate|microclimate
419127|NCT01355666|shear|shear
419128|NCT01355666|friction|friction
419129|NCT01355666|moisture|moisture
419130|NCT01355666|fabrics|fabrics
419131|NCT01355666|long term care|long term care
419132|NCT01355666|nursing home|nursing home
419133|NCT01355666|decubitus ulcer|decubitus ulcer
419134|NCT01355666|bed ridden|bed ridden
419135|NCT01355666|anti-microbial|anti-microbial
419136|NCT01355653|heat|heat
419137|NCT01355653|device|device
419138|NCT01355653|safety|safety
419139|NCT01355653|performance|performance
419140|NCT01355653|heatwrap|heatwrap
419141|NCT01355653|elderly|elderly
419142|NCT01355653|overweight|overweight
419143|NCT01355640|heel lance|heel lance
419144|NCT01355640|pain|pain
419145|NCT01355640|newborn|newborn
419146|NCT01355627|CSF leaks|csf leaks
419147|NCT01355627|Skull base surgery|skull base surgery
419148|NCT01355627|pseudomeningocele|pseudomeningocele
419149|NCT01355627|TachoSil®|tachosil®
419150|NCT01355627|Prevention|prevention
419151|NCT01355627|post-operative|post-operative
419152|NCT01355614|Crohn's Disease|crohn's disease
419153|NCT01355614|Fistula|fistula
419154|NCT01355575|Microbiota|microbiota
419155|NCT01355575|Insulin resistance|insulin resistance
419156|NCT01355575|Bacterial endotoxin|bacterial endotoxin
419157|NCT01355575|Hepatic triglyceride|hepatic triglyceride
419158|NCT01355575|Inflammation|inflammation
419159|NCT01355549|Shoulder pain|shoulder pain
419160|NCT01355549|Rotator cuff disease|rotator cuff disease
419161|NCT01355549|Spinal cord injuries|spinal cord injuries
419162|NCT01355549|Platelet-rich plasma therapy|platelet-rich plasma therapy
419163|NCT01355549|Rehabilitation|rehabilitation
419164|NCT01355536|Preterm birth|preterm birth
419165|NCT01355536|Preterm labour|preterm labour
419166|NCT01355536|Polycystic Ovary Syndrome|polycystic ovary syndrome
419167|NCT01355536|PCOS|pcos
419168|NCT01355536|Diabetes Mellitus|diabetes mellitus
419169|NCT01355536|Hyperandrogenism|hyperandrogenism
419170|NCT01355536|Hirsutism|hirsutism
419171|NCT01355536|Ovarian cysts|ovarian cysts
419172|NCT01355536|Anti Muller Hormone|anti muller hormone
419173|NCT01355536|Hypertension|hypertension
419174|NCT01355523|Breast cancer surgery|breast cancer surgery
419175|NCT01355523|Melatonin|melatonin
419176|NCT01355523|Depression|depression
419177|NCT01355523|Anxiety|anxiety
419178|NCT01355523|Sleep disturbances|sleep disturbances
419179|NCT01355523|Cognitive function|cognitive function
419180|NCT01355471|rosacea|rosacea
419181|NCT01355458|rosacea|rosacea
419182|NCT01355419|Obstructive sleep apnea|obstructive sleep apnea
419183|NCT01355419|CPAP|cpap
419184|NCT01355419|actigraphy|actigraphy
419185|NCT01355419|sleep|sleep
419186|NCT01355419|physical activity|physical activity
419187|NCT01355406|FlexStent|flexstent
419188|NCT01355406|Superficial Femoral Artery or SFA|superficial femoral artery or sfa
419189|NCT01355406|Self Expanding Stent|self expanding stent
419190|NCT01355406|Stent|stent
419191|NCT01355406|Bare Metal Stent|bare metal stent
419192|NCT01355393|Breast Cancer|breast cancer
419193|NCT01355393|HER2+|her2+
419194|NCT01355393|Vaccine|vaccine
419195|NCT01355393|Stage II|stage ii
419196|NCT01355393|Stage III|stage iii
419197|NCT01355393|Stage IV|stage iv
419198|NCT01355380|Pulmonary arterial hypertension|pulmonary arterial hypertension
419199|NCT01355380|Inhaled iloprost|inhaled iloprost
419200|NCT01355380|Quality of life|quality of life
419201|NCT01355367|BAYA1040 CR|baya1040 cr
419202|NCT01355367|Nifedipine|nifedipine
419203|NCT01355367|Essential hypertension|essential hypertension
419204|NCT01355367|Japanese Patients|japanese patients
419205|NCT01355367|Phase III|phase iii
419206|NCT01355367|Extension study|extension study
419207|NCT01355354|Phase 1|phase 1
419208|NCT01355354|healthy volunteers|healthy volunteers
419209|NCT01355354|pharmacokinetics|pharmacokinetics
419210|NCT01355354|Rheumatoid arthritis|rheumatoid arthritis
419211|NCT01355354|RA, Fostamatinib|ra, fostamatinib
419212|NCT01355354|Digoxin, drug-drug interaction|digoxin, drug-drug interaction
419213|NCT01355354|Scientific terminology: Rheumatoid arthritis|scientific terminology: rheumatoid arthritis
419214|NCT01355354|Fostamatinib|fostamatinib
419215|NCT01355354|Digoxin|digoxin
419216|NCT01355354|drug-drug interaction|drug-drug interaction
419217|NCT01355354|Laymen terminology: Rheumatoid arthritis|laymen terminology: rheumatoid arthritis
419218|NCT01355354|Amount of Digoxin in blood|amount of digoxin in blood
419219|NCT01355341|RENAL CALCULI HERBMED PLUS|renal calculi herbmed plus
419220|NCT01355328|light|light
419221|NCT01355315|EECP|eecp
419222|NCT01355315|ischemic cardiomyopathy|ischemic cardiomyopathy
419223|NCT01355315|endothelin-1|endothelin-1
419224|NCT01355315|ischemia coronary artery diseases|ischemia coronary artery diseases
419225|NCT01355315|congestive heart failure not amenable to standard procedures|congestive heart failure not amenable to standard procedures
419226|NCT01355302|Cancer|cancer
419227|NCT01355302|Solid Tumors|solid tumors
419228|NCT01355302|Gastric|gastric
419229|NCT01355302|Phase I|phase i
419230|NCT01355302|Phase II|phase ii
419231|NCT01355289|Chronic Hepatitis C related|chronic hepatitis c related
419232|NCT01355276|Cinitapride|cinitapride
419233|NCT01355276|efficacy|efficacy
419234|NCT01355276|safety|safety
419235|NCT01355276|mild to moderate functional dyspepsia|mild to moderate functional dyspepsia
419236|NCT01355263|vitamin a|vitamin a
419237|NCT01355263|preschool children|preschool children
419238|NCT01355263|iron metabolic homeostasis|iron metabolic homeostasis
419239|NCT01355263|supplementation effect|supplementation effect
419240|NCT01355237|Complementary and alternative medicine (CAM)|complementary and alternative medicine (cam)
419241|NCT01355224|obesity|obesity
419242|NCT01355224|genetics|genetics
419243|NCT01355224|risk assessment|risk assessment
419244|NCT01355224|health behaviors|health behaviors
419245|NCT01355224|randomized controlled trial|randomized controlled trial
419246|NCT01355211|Altered Mental Status|altered mental status
419247|NCT01355211|non-convulsive seizure|non-convulsive seizure
419248|NCT01355211|status epilepticus|status epilepticus
419249|NCT01355211|electroencephalography|electroencephalography
419250|NCT01355185|Seed movement|seed movement
419251|NCT01355185|implants|implants
419252|NCT01355185|prostate brachytherapy|prostate brachytherapy
419253|NCT01355185|localized|localized
419254|NCT01355172|Influenza|influenza
419255|NCT01355172|Vaccine|vaccine
419256|NCT01355172|Immunogenicity|immunogenicity
419257|NCT01355159|Pregnancy|pregnancy
419258|NCT01355159|Folic Acid supplementation|folic acid supplementation
419259|NCT01355159|Preeclampsia|preeclampsia
419260|NCT01355146|Patients with proven Fabry's Disease|patients with proven fabry's disease
419261|NCT01355133|Urinary incontinence|urinary incontinence
419262|NCT01355133|Myoblasts|myoblasts
419263|NCT01355133|Muscle derived cells|muscle derived cells
419264|NCT01355133|Stem cells|stem cells
419265|NCT01355120|advanced ocular melanoma|advanced ocular melanoma
419266|NCT01355107|selenium level measurement|selenium level measurement
419267|NCT01355094|temporary abdomen closure|temporary abdomen closure
419268|NCT01355094|peritoneal vacuum therapy|peritoneal vacuum therapy
419269|NCT01355094|open abdomen|open abdomen
419270|NCT01355094|abdominal compartment syndrome|abdominal compartment syndrome
419271|NCT01355094|intra-abdominal sepsis|intra-abdominal sepsis
419272|NCT01355094|intra-abdominal hypertension|intra-abdominal hypertension
419273|NCT01355094|critical care|critical care
419274|NCT01355081|Drug Therapy|drug therapy
419275|NCT01355068|phenytoin|phenytoin
419276|NCT01355068|chewable tablets|chewable tablets
419277|NCT01355068|dilantin|dilantin
419278|NCT01355068|epanutin|epanutin
419279|NCT01355068|infatabs|infatabs
419280|NCT01355068|bioequivalence|bioequivalence
419281|NCT01355068|Partial seizure|partial seizure
419282|NCT01355068|Tonic-clonic seizure|tonic-clonic seizure
419283|NCT01355029|Stroke caregivers|stroke caregivers
419284|NCT01355029|Family Caregivers|family caregivers
419285|NCT01355029|Stroke|stroke
419286|NCT01355016|RSV|rsv
419287|NCT01354977|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
419288|NCT01354977|Glucose Metabolism Disorders|glucose metabolism disorders
419289|NCT01354977|Metabolic Diseases|metabolic diseases
419290|NCT01354977|Diabetes Mellitus|diabetes mellitus
419291|NCT01354977|Endocrin System Diseases|endocrin system diseases
419292|NCT01354977|Resveratrol|resveratrol
419293|NCT01354977|Therapeutic Uses|therapeutic uses
419294|NCT01354964|Glucose Metabolism Disorders|glucose metabolism disorders
419295|NCT01354964|Insulin Resistance|insulin resistance
419296|NCT01354964|Endocrine System|endocrine system
419297|NCT01354964|Vitamin D|vitamin d
419298|NCT01354951|Focal Brachytherapy|focal brachytherapy
419299|NCT01354951|Endorectal coil MRI|endorectal coil mri
419300|NCT01354951|Quality of Life|quality of life
419301|NCT01354951|11-056|11-056
419302|NCT01354938|Bronchitis|bronchitis
419303|NCT01354925|Diabetes type 2|diabetes type 2
419304|NCT01354925|Fasting|fasting
419305|NCT01354925|Ramadan|ramadan
419306|NCT01354925|Insulin analogues|insulin analogues
419307|NCT01354912|mycobacterial infection|mycobacterial infection
419308|NCT01354912|culture|culture
419309|NCT01354912|ct scan|ct scan
419310|NCT01354886|in-vitro fertilization|in-vitro fertilization
419311|NCT01354886|reproductive disorder|reproductive disorder
419312|NCT01354873|Colonoscopy|colonoscopy
419313|NCT01354873|Colon Polyps|colon polyps
419314|NCT01354860|knee osteoarthritis|knee osteoarthritis
419315|NCT01354847|extracorporeal circulation|extracorporeal circulation
419316|NCT01354847|platelet dysfunction|platelet dysfunction
419317|NCT01354847|Multiplate electrode aggregometry analyses|multiplate electrode aggregometry analyses
419318|NCT01354847|Multiplate|multiplate
419319|NCT01354821|Aorta|aorta
419320|NCT01354821|Aneurysm|aneurysm
419321|NCT01354821|endovascular|endovascular
419322|NCT01354821|stent-graft|stent-graft
419323|NCT01354808|Cilostazol|cilostazol
419324|NCT01354808|Platelet|platelet
419325|NCT01354808|Inflammation|inflammation
419326|NCT01354808|Myonecrosis|myonecrosis
419327|NCT01354795|EUS FNA|eus fna
419328|NCT01354795|stylet|stylet
419329|NCT01354795|suction|suction
419330|NCT01354782|Pharmacokinetic|pharmacokinetic
419331|NCT01354782|Roflumilast|roflumilast
419332|NCT01354756|sleep apnea|sleep apnea
419333|NCT01354756|polysomnography|polysomnography
419334|NCT01354756|obesity|obesity
419335|NCT01354756|bariatric surgery|bariatric surgery
419336|NCT01354743|atrophy|atrophy
419337|NCT01354743|rhytids|rhytids
419338|NCT01354743|glabellar|glabellar
419339|NCT01354743|periorbital|periorbital
419340|NCT01354730|incidence|incidence
419341|NCT01354730|nature|nature
419342|NCT01354730|seriousness|seriousness
419343|NCT01354730|ADRs|adrs
419344|NCT01354730|vaccination|vaccination
419345|NCT01354704|deep veinous thrombosis|deep veinous thrombosis
419346|NCT01354704|enoxaparin|enoxaparin
419347|NCT01354691|Alzheimer's Disease|alzheimer's disease
419348|NCT01354691|Dementia|dementia
419349|NCT01354691|Memory Loss|memory loss
419350|NCT01354691|Cognitive Impairment|cognitive impairment
419351|NCT01354691|Brain Diseases|brain diseases
419352|NCT01354691|Central Nervous System Diseases|central nervous system diseases
419353|NCT01354691|Nervous System Diseases|nervous system diseases
419354|NCT01354691|Neurodegenerative Diseases|neurodegenerative diseases
419355|NCT01354691|Delirium, Dementia, Amnestic, Cognitive Disorders|delirium, dementia, amnestic, cognitive disorders
419356|NCT01354691|Mental Disorders|mental disorders
419357|NCT01354691|Depression|depression
419358|NCT01354691|Anxiety|anxiety
419359|NCT01354678|heart failure|heart failure
419360|NCT01354678|bone marrow mononuclear cells|bone marrow mononuclear cells
419361|NCT01354665|Multiple sclerosis|multiple sclerosis
419362|NCT01354665|Interferon beta-1b|interferon beta-1b
419363|NCT01354665|Fatigue|fatigue
419364|NCT01354665|Depression|depression
419365|NCT01354652|lactic acidosis|lactic acidosis
419366|NCT01354652|entecavir|entecavir
419367|NCT01354652|lamivudine|lamivudine
419368|NCT01354626|Hepatic fat accumulation|hepatic fat accumulation
419369|NCT01354626|Dietary protein|dietary protein
419370|NCT01354626|NAFLD|nafld
419371|NCT01354600|Obesity|obesity
419372|NCT01354600|Appetite|appetite
419373|NCT01354600|Hormones|hormones
419374|NCT01354600|Exercise|exercise
419375|NCT01354600|Body Weight|body weight
419376|NCT01354587|immunodeficiency|immunodeficiency
419377|NCT01354574|energy metabolism|energy metabolism
419378|NCT01354574|lipids|lipids
419379|NCT01354574|lipoproteins|lipoproteins
419380|NCT01354574|satiety|satiety
419381|NCT01354574|glycemic load|glycemic load
419382|NCT01354574|insulin|insulin
419383|NCT01354561|respiratory physiotherapy|respiratory physiotherapy
419384|NCT01354561|cardiac autonomic modulation|cardiac autonomic modulation
419385|NCT01354561|paediatric patients|paediatric patients
419386|NCT01354548|Trismus|trismus
419387|NCT01354548|Cancer|cancer
419388|NCT01354548|Radiotherapy|radiotherapy
419389|NCT01354548|Quality of life|quality of life
419390|NCT01354535|periprosthetic|periprosthetic
419391|NCT01354535|femur fractures|femur fractures
419392|NCT01354535|Vancouver B1|vancouver b1
419393|NCT01354509|Normothermia|normothermia
419394|NCT01354509|fever control|fever control
419395|NCT01354509|Outcome study|outcome study
419396|NCT01354496|Healthy Volunteers|healthy volunteers
419397|NCT01354496|Bioavailability|bioavailability
419398|NCT01354483|spinal cord injury|spinal cord injury
419399|NCT01354483|umbilical cord blood mononuclear cell|umbilical cord blood mononuclear cell
419400|NCT01354483|lithium carbonate|lithium carbonate
419401|NCT01354470|Meth|meth
419402|NCT01354470|Methamphetamine Addiction|methamphetamine addiction
419403|NCT01354470|Methamphetamine Treatment|methamphetamine treatment
419404|NCT01354470|Modafinil|modafinil
419405|NCT01354457|Patient with relapsing or refractory CD22+B-acute lymphoblastic leukemia (ALL)|patient with relapsing or refractory cd22+b-acute lymphoblastic leukemia (all)
419406|NCT01354444|Memory problems|memory problems
419407|NCT01354444|Alzheimer's Disease|alzheimer's disease
419408|NCT01354431|Advanced/Metastatic|advanced/metastatic
419409|NCT01354431|clear cell component|clear cell component
419410|NCT01354392|Relapsed or refractory|relapsed or refractory
419411|NCT01354392|Large B-Cell|large b-cell
419412|NCT01354392|Diffuse|diffuse
419413|NCT01354340|Cholesterol|cholesterol
419414|NCT01354340|LDL-cholesterol|ldl-cholesterol
419415|NCT01354340|Coronary artery disease|coronary artery disease
419416|NCT01354340|Red yeast rice|red yeast rice
419417|NCT01354340|Plants extract|plants extract
419418|NCT01354340|Cholesterol excess|cholesterol excess
419419|NCT01354340|Delivery of Health Care|delivery of health care
419420|NCT01354327|Delivery of Health Care|delivery of health care
419421|NCT01354327|Cholesterol|cholesterol
419422|NCT01354327|LDL-cholesterol|ldl-cholesterol
419423|NCT01354327|Coronary artery disease|coronary artery disease
419424|NCT01354327|Red yeast rice|red yeast rice
419425|NCT01354327|Plants extract|plants extract
419426|NCT01354327|Cholesterol excess|cholesterol excess
419428|NCT01354314|Neurocognitive impairment|neurocognitive impairment
419429|NCT01354314|Memory|memory
419430|NCT01354314|Dementia|dementia
419431|NCT01354314|CSF marker|csf marker
419432|NCT01354314|Functional assessment|functional assessment
419433|NCT01354314|MRS|mrs
419434|NCT01354314|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
419435|NCT01354314|Arterial spin labeling|arterial spin labeling
419436|NCT01354314|SSRI|ssri
419437|NCT01354301|kidney transplantation|kidney transplantation
419438|NCT01354301|thymoglobulin|thymoglobulin
419439|NCT01354301|everolimus|everolimus
419440|NCT01354288|Diabetes|diabetes
419441|NCT01354288|Children|children
419442|NCT01354288|Disease management|disease management
419443|NCT01354288|Ketosis|ketosis
419444|NCT01354288|Hypoglycemia|hypoglycemia
419445|NCT01354288|Parents|parents
419446|NCT01354288|Education|education
419447|NCT01354275|PCOS|pcos
419448|NCT01354275|IVF/ICSI|ivf/icsi
419449|NCT01354275|Clinical Pregnancy rates|clinical pregnancy rates
419450|NCT01354275|GnRH Antagonist|gnrh antagonist
419451|NCT01354275|GnRH Agonist|gnrh agonist
419452|NCT01354262|Diabetes|diabetes
419453|NCT01354262|Vitamin D deficiency|vitamin d deficiency
419454|NCT01354262|Hemoglobin A1c|hemoglobin a1c
419455|NCT01354249|preoperative fasting|preoperative fasting
419456|NCT01354249|insulin resistance|insulin resistance
419457|NCT01354249|carbohydrates|carbohydrates
419458|NCT01354249|whey protein|whey protein
419459|NCT01354249|inflammatory response|inflammatory response
419460|NCT01354223|silicone hydrogel contact lens|silicone hydrogel contact lens
419461|NCT01354223|SHCL|shcl
419462|NCT01354223|stenfilcon A|stenfilcon a
419463|NCT01354223|ocufilcon B|ocufilcon b
419464|NCT01354223|daily disposable|daily disposable
419465|NCT01354223|substantial equivalence|substantial equivalence
419466|NCT01354223|CooperVision ClearSight™ 1 Day SCL|coopervision clearsight™ 1 day scl
419467|NCT01354210|Patient Adherence|patient adherence
419468|NCT01354210|HIV|hiv
419469|NCT01354197|Adverse events|adverse events
419470|NCT01354197|Mortality|mortality
419471|NCT01354197|Readmission|readmission
419472|NCT01354197|Surgical intensive care unit|surgical intensive care unit
419473|NCT01354171|active surveillance|active surveillance
419474|NCT01354171|low risk prostate cancer|low risk prostate cancer
419475|NCT01354132|schizophrenia|schizophrenia
419476|NCT01354132|schizoaffective|schizoaffective
419477|NCT01354132|schizophreniform|schizophreniform
419478|NCT01354132|early schizophrenia spectrum psychosis|early schizophrenia spectrum psychosis
419479|NCT01354106|Skin condition after wear|skin condition after wear
419480|NCT01354093|MacTel|mactel
419481|NCT01354093|Macular telangiectasia type 2|macular telangiectasia type 2
419482|NCT01354080|constipation|constipation
419483|NCT01354080|massage|massage
419484|NCT01354080|tensegrity|tensegrity
419485|NCT01354067|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
419486|NCT01354067|Lung Diseases, Obstructive|lung diseases, obstructive
419487|NCT01354067|Single Limb|single limb
419488|NCT01354067|Elastic Resistance|elastic resistance
419489|NCT01354067|Resistance Training|resistance training
419490|NCT01354067|Minor Muscle Mass|minor muscle mass
419491|NCT01354067|Local muscle training|local muscle training
419492|NCT01354054|Knee OA|knee oa
419493|NCT01354054|TENS|tens
419494|NCT01354041|fear and health worries about cancer recurrence|fear and health worries about cancer recurrence
419495|NCT01354028|premature infant|premature infant
419496|NCT01354028|massage therapy|massage therapy
419497|NCT01354028|sleep induction|sleep induction
419498|NCT01354028|relaxation|relaxation
419499|NCT01354015|Diabetes|diabetes
419500|NCT01354015|Technology|technology
419501|NCT01354002|human biological samples|human biological samples
419502|NCT01354002|tissue banking|tissue banking
419503|NCT01353989|hepatitis A|hepatitis a
419504|NCT01353989|vaccination|vaccination
419505|NCT01353989|elderly|elderly
419506|NCT01353989|protection to hepatitis A after vaccination|protection to hepatitis a after vaccination
419507|NCT01353976|Econazole Nitrate|econazole nitrate
419508|NCT01353976|Foam|foam
419509|NCT01353976|Quinnova|quinnova
419510|NCT01353976|Tinea Pedis|tinea pedis
419511|NCT01353950|Costimulatory molecules|costimulatory molecules
419512|NCT01353950|Cystic Fibrosis|cystic fibrosis
419513|NCT01353950|Biomarkers|biomarkers
419514|NCT01353937|wound healing|wound healing
419515|NCT01353924|Allergy|allergy
419516|NCT01353924|Vaccine|vaccine
419517|NCT01353924|rBet v 1|rbet v 1
419518|NCT01353924|Prevention|prevention
419519|NCT01353885|Primary Osteoarthritis, Hip|primary osteoarthritis, hip
419520|NCT01353885|Total Hip Arthroplasty|total hip arthroplasty
419521|NCT01353885|Anterior Approach|anterior approach
419522|NCT01353885|Posterior Approach|posterior approach
419523|NCT01353885|Anterolateral Approach|anterolateral approach
419524|NCT01353885|Cohort Study|cohort study
419525|NCT01353885|Outcomes, Complication Rate|outcomes, complication rate
419526|NCT01353885|Outcomes, Quality of Life|outcomes, quality of life
419527|NCT01353872|Fatigue|fatigue
419528|NCT01353872|Tennis|tennis
419529|NCT01353872|Nutrition|nutrition
419530|NCT01353872|Tournament simulation|tournament simulation
419531|NCT01353872|Delivery of Health Care|delivery of health care
419532|NCT01353846|oocyte donation program|oocyte donation program
419533|NCT01353846|natural cycle|natural cycle
419534|NCT01353846|hormone replacement therapy|hormone replacement therapy
419535|NCT01353820|Midly hypercholesterolemic subjects|midly hypercholesterolemic subjects
419536|NCT01353820|Probiotic|probiotic
419537|NCT01353820|Cholesterol lowering|cholesterol lowering
419538|NCT01353820|Dairy|dairy
419539|NCT01353807|Fish oil|fish oil
419540|NCT01353807|Pregnancy|pregnancy
419541|NCT01353807|RCT|rct
419542|NCT01353807|Birth weight|birth weight
419543|NCT01353807|Gestational age|gestational age
419544|NCT01353807|Asthma and allergies|asthma and allergies
419545|NCT01353807|Metabolic syndrome|metabolic syndrome
419546|NCT01353807|Obesity|obesity
419547|NCT01353794|SORAFENIB|sorafenib
419548|NCT01353794|RENAL CELL CARCINOMA|renal cell carcinoma
419549|NCT01353794|TYROSINE KINASE INHIBITOR|tyrosine kinase inhibitor
419550|NCT01353794|OBSERVATIONAL STUDY|observational study
419551|NCT01353781|Phase 1|phase 1
419552|NCT01353781|advanced solid tumor|advanced solid tumor
419553|NCT01353781|AKT|akt
419554|NCT01353781|Ascending|ascending
419555|NCT01353781|Japanese|japanese
419556|NCT01353768|Influenza|influenza
419557|NCT01353755|specific immunotherapy|specific immunotherapy
419558|NCT01353755|SIT|sit
419559|NCT01353729|12-lead ECG|12-lead ecg
419560|NCT01353729|cardiac repolarization|cardiac repolarization
419561|NCT01353729|QTc|qtc
419562|NCT01353729|influenza|influenza
419563|NCT01353729|GR121167|gr121167
419564|NCT01353729|zanamivir|zanamivir
419565|NCT01353703|Infanrix hexa™|infanrix hexa™
419566|NCT01353703|Primary vaccination|primary vaccination
419567|NCT01353703|India|india
419568|NCT01353703|combination vaccine|combination vaccine
419569|NCT01353703|infants|infants
419570|NCT01353690|Cell Therapy|cell therapy
419571|NCT01353690|Heart Failure|heart failure
419572|NCT01353690|Heart Disease|heart disease
419573|NCT01353690|Myocardial Infarction|myocardial infarction
419574|NCT01353690|Myocardial Ischemia|myocardial ischemia
419575|NCT01353690|Autologous|autologous
419576|NCT01353690|Muscle-derived Cell|muscle-derived cell
419577|NCT01353677|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
419578|NCT01353677|QOL|qol
419579|NCT01353664|rollover protocol|rollover protocol
419580|NCT01353664|romidepsin|romidepsin
419581|NCT01353664|Gloucester Pharmaceuticals|gloucester pharmaceuticals
419582|NCT01353664|Celgene Corporation|celgene corporation
419583|NCT01353664|continuing treatment|continuing treatment
419584|NCT01353638|Peritoneal dialysis|peritoneal dialysis
419585|NCT01353638|Alanyl-Glutamine-Dipeptide|alanyl-glutamine-dipeptide
419586|NCT01353638|Heat shock protein|heat shock protein
419587|NCT01353638|Peritoneal cells|peritoneal cells
419588|NCT01353638|functional maintenance of the peritoneal membrane|functional maintenance of the peritoneal membrane
419589|NCT01353625|Neoplasm|neoplasm
419590|NCT01353625|Malignancy|malignancy
419591|NCT01353625|Carcinoma|carcinoma
419592|NCT01353625|Lymphoma|lymphoma
419593|NCT01353625|Leukemia|leukemia
419594|NCT01353625|Multiple myeloma|multiple myeloma
419595|NCT01353625|mTOR kinase inhibitor|mtor kinase inhibitor
419596|NCT01353625|Castration-resistant prostate cancer|castration-resistant prostate cancer
419597|NCT01353625|Hormone-resistant prostate cancer|hormone-resistant prostate cancer
419598|NCT01353625|Diffuse Large B-cell lymphoma|diffuse large b-cell lymphoma
419599|NCT01353599|Spinal Cord Injury|spinal cord injury
419600|NCT01353599|Tetraplegia|tetraplegia
419601|NCT01353599|Pulmonary Function|pulmonary function
419602|NCT01353573|Brain Neoplasms|brain neoplasms
419603|NCT01353573|Neoplasm Metastasis|neoplasm metastasis
419604|NCT01353573|Neoplasms|neoplasms
419605|NCT01353560|integrative medicine|integrative medicine
419606|NCT01353560|barriers to utilization|barriers to utilization
419607|NCT01353560|communication|communication
419608|NCT01353534|Immunogenicity and Safety|immunogenicity and safety
419609|NCT01353521|complex renal cysts|complex renal cysts
419610|NCT01353521|Contrast enhanced ultrasound|contrast enhanced ultrasound
419611|NCT01353508|Sodium excretion,|sodium excretion,
419612|NCT01353508|LCZ696|lcz696
419613|NCT01353495|Diabetic Foot Ulcers|diabetic foot ulcers
419614|NCT01353482|mesothelioma|mesothelioma
419615|NCT01353482|vorinostat|vorinostat
419616|NCT01353456|Ambulation|ambulation
419617|NCT01353456|Side effects|side effects
419618|NCT01353456|Serum sCD40L|serum scd40l
419619|NCT01353456|Bowel function|bowel function
419620|NCT01353456|Postoperative pain|postoperative pain
419621|NCT01353443|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
419622|NCT01353443|AAA|aaa
419623|NCT01353430|IBMPFD - Inclusion Body Myopathy associated with|ibmpfd - inclusion body myopathy associated with
419624|NCT01353430|Paget's disease of bone and Frontotemporal Dementia|paget's disease of bone and frontotemporal dementia
419625|NCT01353430|VCP gene - Valosin-containing protein gene|vcp gene - valosin-containing protein gene
419626|NCT01353417|Grafting, kidney|grafting, kidney
419627|NCT01353417|Transplantation, kidney|transplantation, kidney
419628|NCT01353391|Diabetes|diabetes
419629|NCT01353391|MiTy|mity
419630|NCT01353391|Metformin in Women|metformin in women
419631|NCT01353391|Type 2 Diabetes Pregnancy|type 2 diabetes pregnancy
419632|NCT01353378|dexmedetomidine|dexmedetomidine
419633|NCT01353378|emergence delirium|emergence delirium
419634|NCT01353378|sevoflurane anesthesia|sevoflurane anesthesia
419635|NCT01353378|preschool children|preschool children
419636|NCT01353378|oral maxillofacial surgery|oral maxillofacial surgery
419637|NCT01353352|Evaluation|evaluation
419638|NCT01353352|C-Spine|c-spine
419639|NCT01353352|Nursing|nursing
419640|NCT01353352|Clinical Decision Rule|clinical decision rule
419641|NCT01353339|Kidney Transplant|kidney transplant
419642|NCT01353339|BK Polyomavirus Infection|bk polyomavirus infection
419643|NCT01353326|non-inflammatory degenerative joint disease|non-inflammatory degenerative joint disease
419644|NCT01353326|hip resurfacing|hip resurfacing
419645|NCT01353326|bone mineral density|bone mineral density
419646|NCT01353326|cemented|cemented
419647|NCT01353326|cementless|cementless
419648|NCT01353313|NICHD Neonatal Research Network|nichd neonatal research network
419649|NCT01353313|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
419650|NCT01353313|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
419651|NCT01353313|Prematurity|prematurity
419652|NCT01353313|Mechanical ventilation|mechanical ventilation
419653|NCT01353313|Intubation|intubation
419654|NCT01353313|Neurodevelopmental impairment|neurodevelopmental impairment
419655|NCT01353300|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
419656|NCT01353300|cystic nephroma|cystic nephroma
419657|NCT01353300|neuroblastoma|neuroblastoma
419658|NCT01353300|childhood medulloblastoma|childhood medulloblastoma
419659|NCT01353300|childhood hepatoblastoma|childhood hepatoblastoma
419660|NCT01353300|stromal predominant Wilms tumor|stromal predominant wilms tumor
419661|NCT01353300|hereditary Wilms tumor|hereditary wilms tumor
419788|NCT01352884|Metastatic|metastatic
419662|NCT01353300|pleuropulmonary blastoma|pleuropulmonary blastoma
419663|NCT01353287|Transcatheter Aortic Valve Intervention (TAVI)|transcatheter aortic valve intervention (tavi)
419664|NCT01353287|Live case transmission|live case transmission
419665|NCT01353261|Platelet reactivity|platelet reactivity
419666|NCT01353248|Hepatitis C|hepatitis c
419667|NCT01353248|HCV|hcv
419668|NCT01353248|Rapid Virologic Response|rapid virologic response
419669|NCT01353248|Sustained Virologic Response|sustained virologic response
419670|NCT01353248|Direct Acting Antiviral|direct acting antiviral
419671|NCT01353248|Combination Therapy|combination therapy
419672|NCT01353248|HCV RNA|hcv rna
419673|NCT01353248|Polymerase inhibitor|polymerase inhibitor
419674|NCT01353248|Protease inhibitor|protease inhibitor
419675|NCT01353248|Treatment naïve|treatment naïve
419676|NCT01353248|GS-5885|gs-5885
419677|NCT01353248|GS-9451|gs-9451
419678|NCT01353248|Tegobuvir|tegobuvir
419679|NCT01353235|COPD|copd
419680|NCT01353235|acute respiratory failure|acute respiratory failure
419681|NCT01353235|mechanical ventilation|mechanical ventilation
419682|NCT01353235|non invasive ventilation|non invasive ventilation
419683|NCT01353235|steroids|steroids
419684|NCT01353222|Bladder cancer|bladder cancer
419685|NCT01353222|Renal pelvis cancer|renal pelvis cancer
419686|NCT01353222|Ureteral cancer|ureteral cancer
419687|NCT01353222|Urethral cancer|urethral cancer
419688|NCT01353222|Bladder|bladder
419689|NCT01353222|Renal pelvis|renal pelvis
419690|NCT01353222|Ureter|ureter
419691|NCT01353222|Urethra|urethra
419692|NCT01353222|Immune therapy|immune therapy
419693|NCT01353222|Immunotherapy|immunotherapy
419694|NCT01353222|Vaccine|vaccine
419695|NCT01353222|Dendritic cells|dendritic cells
419696|NCT01353222|Antigen-presenting cells|antigen-presenting cells
419697|NCT01353222|Antigen presenting cells|antigen presenting cells
419698|NCT01353222|Cancer vaccine|cancer vaccine
419699|NCT01353222|Urothelial carcinoma|urothelial carcinoma
419700|NCT01353222|Urothelial neoplasms|urothelial neoplasms
419701|NCT01353222|Neoplasms by site|neoplasms by site
419702|NCT01353222|Neoplasms|neoplasms
419703|NCT01353196|carotid|carotid
419704|NCT01353196|atherosclerosis|atherosclerosis
419705|NCT01353196|cognitive function|cognitive function
419706|NCT01353183|biopsies, enteric nervous system, biomarker|biopsies, enteric nervous system, biomarker
419707|NCT01353170|Serum calcium|serum calcium
419708|NCT01353170|Dialysate|dialysate
419709|NCT01353170|Mass balance|mass balance
419710|NCT01353170|Blood pressure|blood pressure
419711|NCT01353157|cytokine|cytokine
419712|NCT01353157|cardiac surgery|cardiac surgery
419713|NCT01353157|clinical scoring system|clinical scoring system
419714|NCT01353144|aspirin|aspirin
419715|NCT01353144|peptic ulcer|peptic ulcer
419716|NCT01353131|electrocardiogram,|electrocardiogram,
419717|NCT01353131|cardiac magnetic resonance|cardiac magnetic resonance
419718|NCT01353131|heart failure|heart failure
419719|NCT01353131|sudden cardiac death|sudden cardiac death
419720|NCT01353131|ECG scoring|ecg scoring
419721|NCT01353131|Delayed enhancement|delayed enhancement
419722|NCT01353118|diabetes|diabetes
419723|NCT01353118|bariatric surgery|bariatric surgery
419724|NCT01353118|Roux-en-y gastric bypass|roux-en-y gastric bypass
419725|NCT01353118|retinopathy|retinopathy
419726|NCT01353118|neuropathy|neuropathy
419727|NCT01353118|nephropathy|nephropathy
419728|NCT01353105|cystic fibrosis|cystic fibrosis
419729|NCT01353105|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
419730|NCT01353105|pulmonary fibrosis|pulmonary fibrosis
419731|NCT01353092|Randomized Controlled Trial|randomized controlled trial
419732|NCT01353092|Major depression|major depression
419733|NCT01353092|Hamilton|hamilton
419734|NCT01353092|PEMF|pemf
419735|NCT01353066|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
419736|NCT01353066|BMI 30.0-34.9 kg/m2|bmi 30.0-34.9 kg/m2
419737|NCT01353053|Immunosuppression|immunosuppression
419738|NCT01353053|Cytomegalovirus|cytomegalovirus
419739|NCT01353053|Renal Transplant|renal transplant
419740|NCT01353053|Atrophy/interstitial|atrophy/interstitial
419741|NCT01353053|Conversion of tacrolimus everolimus|conversion of tacrolimus everolimus
419742|NCT01353014|Nutrigenomics|nutrigenomics
419743|NCT01353014|Diet|diet
419744|NCT01353014|Nutrition|nutrition
419745|NCT01353001|Intervention Studies|intervention studies
419746|NCT01353001|Magnetic Resonance Imaging|magnetic resonance imaging
419747|NCT01353001|C-Reactive Protein|c-reactive protein
419748|NCT01352988|C17.300.475|c17.300.475
419749|NCT01352988|C17.800.480|c17.800.480
419750|NCT01352975|Age Related Macular Degeneration (AMD)|age related macular degeneration (amd)
419751|NCT01352975|Dark Adaptation|dark adaptation
419752|NCT01352975|Age Related Macular Degeneration|age related macular degeneration
419753|NCT01352975|AMD|amd
419754|NCT01352962|Dose Limiting Toxicity|dose limiting toxicity
419755|NCT01352962|Urethra Cancer|urethra cancer
419756|NCT01352962|Carcinoma of the Bladder|carcinoma of the bladder
419757|NCT01352962|Cancer of the Renal Pelvis|cancer of the renal pelvis
419758|NCT01352962|Ureter Cancer|ureter cancer
419759|NCT01352962|Urethral Cancer|urethral cancer
419760|NCT01352962|Solid Tumor|solid tumor
419761|NCT01352962|Pancreatic Cancer|pancreatic cancer
419762|NCT01352962|Ovarian Cancer|ovarian cancer
419763|NCT01352962|Non-Small Cell Lung Cancer|non-small cell lung cancer
419764|NCT01352949|Anthropometry|anthropometry
419765|NCT01352949|Stereophotogrammetry|stereophotogrammetry
419766|NCT01352949|Torso|torso
419767|NCT01352949|Spinal Deformity|spinal deformity
419768|NCT01352949|Chest Wall Deformity|chest wall deformity
419769|NCT01352949|Overweight|overweight
419770|NCT01352949|Obese|obese
419771|NCT01352949|Healthy Volunteer|healthy volunteer
419772|NCT01352949|HV|hv
419773|NCT01352936|nephrotoxicity|nephrotoxicity
419774|NCT01352936|hospital cost|hospital cost
419775|NCT01352936|Staphylococcus aureus|staphylococcus aureus
419776|NCT01352936|bacteremia|bacteremia
419777|NCT01352936|vancomycin|vancomycin
419778|NCT01352936|teicoplanin|teicoplanin
419779|NCT01352923|PEAR1 gene|pear1 gene
419780|NCT01352923|whether and how PEAR 1 modulate intracellular signaling pathways relevant for platelet function|whether and how pear 1 modulate intracellular signaling pathways relevant for platelet function
419781|NCT01352897|Cholesterol|cholesterol
419782|NCT01352897|rosuvastatin|rosuvastatin
419783|NCT01352897|retrospective|retrospective
419784|NCT01352884|Cancer|cancer
419785|NCT01352884|Carcinoma|carcinoma
419786|NCT01352884|Tumor|tumor
419787|NCT01352884|Solid tumor|solid tumor
419789|NCT01352884|Melanoma|melanoma
419790|NCT01352871|Immunity, Innate|immunity, innate
419791|NCT01352871|Attention|attention
419792|NCT01352871|Concentration|concentration
419793|NCT01352858|Arthritis|arthritis
419795|NCT01352858|Auto-immune disorders|auto-immune disorders
419796|NCT01352832|Chronic NSAID use|chronic nsaid use
419797|NCT01352806|accuracy of identifying intralaminar space|accuracy of identifying intralaminar space
419798|NCT01352793|phase 3 safety study|phase 3 safety study
419799|NCT01352793|5700 healthy subjects|5700 healthy subjects
419800|NCT01352793|3 vaccine doses at month 0|3 vaccine doses at month 0
419801|NCT01352793|2|2
419802|NCT01352793|and 6|and 6
419803|NCT01352793|control HAV/saline/HAV|control hav/saline/hav
419804|NCT01352780|motivational interviewing|motivational interviewing
419805|NCT01352780|psoriasis|psoriasis
419806|NCT01352780|self management|self management
419807|NCT01352767|insulin injection|insulin injection
419808|NCT01352754|Hip fracture|hip fracture
419809|NCT01352754|Troponin T|troponin t
419810|NCT01352754|myocardial infarction|myocardial infarction
419811|NCT01352741|low back pain|low back pain
419812|NCT01352741|neuropathic|neuropathic
419813|NCT01352741|pain assessment|pain assessment
419814|NCT01352741|centrally acting tapentadol pregabalin|centrally acting tapentadol pregabalin
419815|NCT01352741|severe chronic|severe chronic
419816|NCT01352728|Unresectable|unresectable
419817|NCT01352689|CKD-828|ckd-828
419818|NCT01352689|Hypertension|hypertension
419819|NCT01352689|Primary Hypertension|primary hypertension
419820|NCT01352689|Healthy Volunteer|healthy volunteer
419821|NCT01352689|S-Amlodipine|s-amlodipine
419822|NCT01352689|Telmisartan|telmisartan
419823|NCT01352689|Amlodipine|amlodipine
419824|NCT01352689|Pharmacokinetic|pharmacokinetic
419825|NCT01352689|Phase 1|phase 1
419826|NCT01352676|renal colic|renal colic
419827|NCT01352676|flank pain|flank pain
419828|NCT01352676|back pain|back pain
419829|NCT01352663|Type I Diabetes|type i diabetes
419830|NCT01352663|Wockhardt|wockhardt
419831|NCT01352663|Insulin Analogue|insulin analogue
419832|NCT01352650|leukemia|leukemia
419833|NCT01352637|Traumatic Event|traumatic event
419834|NCT01352637|Trauma Survivor|trauma survivor
419835|NCT01352637|Exposure Therapy|exposure therapy
419836|NCT01352637|PTSD DCS|ptsd dcs
419837|NCT01352637|Virtual Reality Exposure|virtual reality exposure
419838|NCT01352637|Veteran|veteran
419839|NCT01352637|Combat-related PTSD|combat-related ptsd
419840|NCT01352611|Tactile Defensiveness|tactile defensiveness
419841|NCT01352611|Autistic Disorder|autistic disorder
419842|NCT01352598|prostate cancer|prostate cancer
419843|NCT01352598|stereotactic radiotherapy|stereotactic radiotherapy
419844|NCT01352572|Antidepressant Response|antidepressant response
420551|NCT01349634|goiter|goiter
419845|NCT01352572|Signal Transduction|signal transduction
419846|NCT01352572|Lymphocyte|lymphocyte
419847|NCT01352572|Biomarkers|biomarkers
419848|NCT01352572|Depressed Patients|depressed patients
419849|NCT01352572|Antidepressant Drug Adverse Reaction|antidepressant drug adverse reaction
419850|NCT01352559|Pharmacogenomics|pharmacogenomics
419851|NCT01352559|Prediction of Antidepressant Response|prediction of antidepressant response
419852|NCT01352559|Depressed Patients|depressed patients
419853|NCT01352559|biomarkers|biomarkers
419854|NCT01352559|phenotype|phenotype
419855|NCT01352559|Antidepressant Response|antidepressant response
419856|NCT01352559|Adverse Reaction to Drug|adverse reaction to drug
419857|NCT01352546|vaginismus|vaginismus
419858|NCT01352546|painful sex|painful sex
419859|NCT01352546|painful intercourse|painful intercourse
419860|NCT01352546|dyspareunia|dyspareunia
419861|NCT01352546|inability to have intercourse|inability to have intercourse
419862|NCT01352546|inability to consummate marriage|inability to consummate marriage
419863|NCT01352546|vaginal spasm|vaginal spasm
419864|NCT01352546|"hitting a wall"|"hitting a wall"
419865|NCT01352546|pain during sex|pain during sex
419866|NCT01352546|pain during intercourse|pain during intercourse
419867|NCT01352546|burning with intercourse|burning with intercourse
419868|NCT01352520|systemic therapy|systemic therapy
419869|NCT01352520|cutaneous anaplastic large T cell lymphoma|cutaneous anaplastic large t cell lymphoma
419870|NCT01352520|ALCL|alcl
419871|NCT01352520|lymphomatoid papulosis|lymphomatoid papulosis
419872|NCT01352520|LyP|lyp
419873|NCT01352520|mycosis fungoides|mycosis fungoides
419874|NCT01352520|MF|mf
419875|NCT01352520|SGN-35 (brentuximab vedotin)|sgn-35 (brentuximab vedotin)
419876|NCT01352520|skin lymphomas|skin lymphomas
419877|NCT01352520|CD30-positive lymphoproliferative disorders|cd30-positive lymphoproliferative disorders
419878|NCT01352520|tumor lymphocytes|tumor lymphocytes
419879|NCT01352520|cutaneous lymphomas|cutaneous lymphomas
419880|NCT01352520|CD30+ expression|cd30+ expression
419881|NCT01352520|Hematologic Disorder|hematologic disorder
419882|NCT01352520|Lymphoma|lymphoma
419883|NCT01352494|locally advanced breast cancer|locally advanced breast cancer
419884|NCT01352494|docetaxel|docetaxel
419885|NCT01352494|gemcitabine|gemcitabine
419886|NCT01352481|Speech sound development|speech sound development
419887|NCT01352468|ADHD|adhd
419888|NCT01352468|cognitive training|cognitive training
419889|NCT01352455|Hemodialysis|hemodialysis
419890|NCT01352455|Pediatric|pediatric
419891|NCT01352455|Outcomes|outcomes
419892|NCT01352455|Comparative Effectiveness|comparative effectiveness
419893|NCT01352455|End Stage Renal Disease|end stage renal disease
419894|NCT01352442|Presbyopia|presbyopia
419895|NCT01352442|Accommodation|accommodation
419896|NCT01352442|Near visual acuity|near visual acuity
419897|NCT01352442|LASIK|lasik
419898|NCT01352429|adult|adult
419899|NCT01352429|histologically confirmed|histologically confirmed
419900|NCT01352416|Suppress Atrial Fibrillation|suppress atrial fibrillation
419901|NCT01352416|heart bypass surgery|heart bypass surgery
419902|NCT01352416|heart valve surgery|heart valve surgery
419903|NCT01352403|obesity|obesity
419904|NCT01352403|bariatric surgery|bariatric surgery
419905|NCT01352403|gastric bypass|gastric bypass
419906|NCT01352403|life style intervention|life style intervention
419907|NCT01352403|cardiac function|cardiac function
419908|NCT01352390|behavioral economics|behavioral economics
419909|NCT01352390|nudge|nudge
419910|NCT01352390|artwork|artwork
419911|NCT01352390|Pap smear|pap smear
419912|NCT01352390|Blood pressure check|blood pressure check
419913|NCT01352390|Cholesterol test|cholesterol test
419914|NCT01352390|Fasting plasma glucose test|fasting plasma glucose test
419915|NCT01352364|Physiotherapy.|physiotherapy.
419916|NCT01352364|Deafness.|deafness.
419917|NCT01352364|Postural balance.|postural balance.
419918|NCT01352364|Motor skills.|motor skills.
419919|NCT01352351|Breast feeding Exclusive|breast feeding exclusive
419920|NCT01352351|Initiation of breastfeeding|initiation of breastfeeding
419921|NCT01352338|REPEAT|repeat
419922|NCT01352338|multiple myeloma|multiple myeloma
419923|NCT01352338|revlimid|revlimid
419924|NCT01352338|lenalidomide|lenalidomide
419925|NCT01352338|cyclophosphamide|cyclophosphamide
419926|NCT01352338|endoxan|endoxan
419927|NCT01352338|prednisone|prednisone
419928|NCT01352338|lenalidomide refractory|lenalidomide refractory
419929|NCT01352312|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
419930|NCT01352312|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
419931|NCT01352312|B-cell|b-cell
419932|NCT01352312|leukemia|leukemia
419933|NCT01352312|lymphoma|lymphoma
419934|NCT01352312|bendamustine|bendamustine
419935|NCT01352312|pentostatin|pentostatin
419936|NCT01352312|ofatumumab|ofatumumab
419937|NCT01352312|NHL|nhl
419938|NCT01352312|CLL|cll
419939|NCT01352299|Macintosh laryngoscope blade|macintosh laryngoscope blade
419940|NCT01352299|MacCoy laryngoscope blade|maccoy laryngoscope blade
419941|NCT01352299|Miller laryngoscope blade|miller laryngoscope blade
419942|NCT01352299|TrueView laryngoscope|trueview laryngoscope
419943|NCT01352286|Multiple myeloma|multiple myeloma
419944|NCT01352286|Autologous stem cell transplantation|autologous stem cell transplantation
419945|NCT01352286|Received initial treatment previously|received initial treatment previously
419946|NCT01352273|advanced Solid tumors|advanced solid tumors
419947|NCT01352273|harboring RAS|harboring ras
419948|NCT01352273|harboring BRAFV600E|harboring brafv600e
419949|NCT01352260|Near Infrared Spectroscopy|near infrared spectroscopy
419950|NCT01352260|Neuromonitoring|neuromonitoring
419951|NCT01352260|Aortic Arch Replacement|aortic arch replacement
419952|NCT01352221|iron deficiency|iron deficiency
419953|NCT01352221|anaemia|anaemia
419954|NCT01352221|inflammatory bowel disease|inflammatory bowel disease
419955|NCT01352221|Crohn's Disease|crohn's disease
419956|NCT01352208|ASP9521|asp9521
419957|NCT01352208|Castrate Resistant Prostate Cancer|castrate resistant prostate cancer
419958|NCT01352208|Phase 1/2|phase 1/2
419959|NCT01352195|Forever Free|forever free
419960|NCT01352143|Neonates|neonates
419961|NCT01352130|Postoperative nausea and vomiting|postoperative nausea and vomiting
419962|NCT01352130|Ondansetron|ondansetron
419963|NCT01352130|Granisetron|granisetron
419964|NCT01352130|QTc interval|qtc interval
419965|NCT01352104|Externalizing Problem Behaviour in Preschoolers|externalizing problem behaviour in preschoolers
419966|NCT01352091|breast cancer|breast cancer
419967|NCT01352091|adjuvant endocrine therapy|adjuvant endocrine therapy
419968|NCT01352091|AI|ai
419969|NCT01352091|Zoladex|zoladex
419970|NCT01352078|Non healing ulcer|non healing ulcer
419971|NCT01352078|Wound|wound
419972|NCT01352078|Hidradenitis suppurativa|hidradenitis suppurativa
419973|NCT01352078|Acne Inversa|acne inversa
419974|NCT01352078|Hidradenitis|hidradenitis
419975|NCT01352065|Pharmacokinetics|pharmacokinetics
419976|NCT01352065|Exercise performance|exercise performance
419977|NCT01352065|Athletes|athletes
419978|NCT01352052|chronic widespread pain|chronic widespread pain
419979|NCT01352052|fibromyalgia|fibromyalgia
419980|NCT01352052|outcome assessment|outcome assessment
419981|NCT01352052|functional ability|functional ability
419982|NCT01352052|AMPS|amps
419983|NCT01352052|rehabilitation|rehabilitation
419984|NCT01352039|Heparin Sodium|heparin sodium
419985|NCT01352039|Thromboprophylaxis|thromboprophylaxis
419986|NCT01352039|Hip Fracture Surgery.|hip fracture surgery.
419987|NCT01352013|Fibromyalgia|fibromyalgia
419988|NCT01352013|Omega-3|omega-3
419989|NCT01352013|Chronic Pain|chronic pain
419990|NCT01352013|Fatigue|fatigue
419991|NCT01352013|Mood|mood
419992|NCT01352013|docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
419993|NCT01352013|eicosapentaenoic acid (EPA)|eicosapentaenoic acid (epa)
419994|NCT01352000|self help|self help
419995|NCT01352000|smoking cessation|smoking cessation
419996|NCT01352000|cancer prevention|cancer prevention
419997|NCT01351987|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
419998|NCT01351974|breast cancer|breast cancer
419999|NCT01351974|sentinel lymph node biopsy|sentinel lymph node biopsy
420000|NCT01351974|axillary recurrence|axillary recurrence
420001|NCT01351961|Hypertension|hypertension
420002|NCT01351961|Cognitive function|cognitive function
420003|NCT01351948|Immune response|immune response
420004|NCT01351935|non-hodgkin's lymphoma|non-hodgkin's lymphoma
420005|NCT01351935|lymphoma|lymphoma
420006|NCT01351935|leukemia|leukemia
420007|NCT01351935|chronic lymphocytic leukemia|chronic lymphocytic leukemia
420008|NCT01351935|b-cell malignancies|b-cell malignancies
420009|NCT01351935|Btk inhibitor|btk inhibitor
420010|NCT01351935|Phase 1b|phase 1b
420011|NCT01351935|Avila Therapeutics|avila therapeutics
420012|NCT01351935|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
420013|NCT01351883|immunomodulating diet|immunomodulating diet
420014|NCT01351883|postoperative infection|postoperative infection
420015|NCT01351857|Type 1 Diabetes|type 1 diabetes
420016|NCT01351857|17 to 20 years of age|17 to 20 years of age
420017|NCT01351844|Aromatase inhibitor|aromatase inhibitor
420018|NCT01351844|Arthralgia Syndrome|arthralgia syndrome
420019|NCT01351844|Exercise|exercise
420020|NCT01351831|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
420021|NCT01351831|Resistance training|resistance training
420022|NCT01351831|Physical Therapy Modalities|physical therapy modalities
420023|NCT01351831|Randomized Controlled Trial|randomized controlled trial
420024|NCT01351805|vitamin D|vitamin d
420025|NCT01351805|omega-3 fatty acid|omega-3 fatty acid
420026|NCT01351805|fish oil|fish oil
420027|NCT01351805|prevention|prevention
420028|NCT01351805|trial|trial
420029|NCT01351805|autoimmune disease|autoimmune disease
420030|NCT01351805|rheumatoid arthritis|rheumatoid arthritis
420031|NCT01351805|psoriasis|psoriasis
420032|NCT01351805|systemic inflammation|systemic inflammation
420033|NCT01351805|Interleukin-6|interleukin-6
420034|NCT01351805|C-reactive peptide|c-reactive peptide
420035|NCT01351805|tumor necrosis factor|tumor necrosis factor
420036|NCT01351805|osteoarthritis|osteoarthritis
420037|NCT01351779|Intraocular pressure|intraocular pressure
420038|NCT01351779|Contact lens sensor|contact lens sensor
420039|NCT01351779|Optic disc hemorrhage|optic disc hemorrhage
420040|NCT01351766|Behavioral Activation|behavioral activation
420041|NCT01351753|Obesity|obesity
420042|NCT01351753|Metabolic Syndrome X|metabolic syndrome x
420043|NCT01351753|Hypertension|hypertension
420044|NCT01351753|Dyslipidemia|dyslipidemia
420045|NCT01351753|Impaired glucose tolerance|impaired glucose tolerance
420047|NCT01351740|Anti-HIV Agents|anti-hiv agents
420048|NCT01351740|HIV Protease Inhibitors|hiv protease inhibitors
420049|NCT01351727|seniors|seniors
420050|NCT01351727|seizures|seizures
420051|NCT01351727|epilepsy|epilepsy
420052|NCT01351727|quality of life|quality of life
420053|NCT01351714|D3 resection|d3 resection
420054|NCT01351714|right colectomy|right colectomy
420055|NCT01351714|MDCT angiography|mdct angiography
420056|NCT01351714|lymphadenectomy|lymphadenectomy
420057|NCT01351714|safe|safe
420058|NCT01351714|right colon|right colon
420059|NCT01351714|preoperative|preoperative
420060|NCT01351701|Diabetic foot|diabetic foot
420061|NCT01351701|Bacteriological epidemiology|bacteriological epidemiology
420062|NCT01351701|Wagner's Grading|wagner's grading
420063|NCT01351701|eastern India|eastern india
420064|NCT01351688|Phase 1|phase 1
420065|NCT01351688|Metastatic|metastatic
420066|NCT01351688|Castration resistant|castration resistant
420067|NCT01351688|Prostate cancer|prostate cancer
420068|NCT01351688|Androgen receptor|androgen receptor
420069|NCT01351688|Down regulation|down regulation
420070|NCT01351688|Japanese|japanese
420071|NCT01351675|Chronic kidney disease|chronic kidney disease
420072|NCT01351675|Type 2 diabetes|type 2 diabetes
420073|NCT01351675|Diabetic nephropathy|diabetic nephropathy
420074|NCT01351662|Lupus|lupus
420075|NCT01351662|stress|stress
420076|NCT01351649|exercise|exercise
420077|NCT01351649|adolescent|adolescent
420078|NCT01351649|intervention|intervention
420079|NCT01351649|female|female
420080|NCT01351649|counseling|counseling
420081|NCT01351636|chronic kidney disease|chronic kidney disease
420082|NCT01351636|hypertension|hypertension
420083|NCT01351623|PR-171 (CARFILZOMIB)|pr-171 (carfilzomib)
420084|NCT01351623|Chemotherapy|chemotherapy
420085|NCT01351623|10-228|10-228
420086|NCT01351610|Critical Limb Ischemia|critical limb ischemia
420087|NCT01351610|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
420088|NCT01351610|Peripheral Artery Disease|peripheral artery disease
420089|NCT01351610|Peripheral Vascular Disease|peripheral vascular disease
420090|NCT01351610|Stem Cell Therapy|stem cell therapy
420091|NCT01351610|Mesenchymal Stem Cells|mesenchymal stem cells
420092|NCT01351597|recurrent breast cancer|recurrent breast cancer
420093|NCT01351597|metastatic breast cancer|metastatic breast cancer
420094|NCT01351597|docetaxel|docetaxel
420095|NCT01351597|oxaliplatin|oxaliplatin
420096|NCT01351584|Breast Cancer|breast cancer
420097|NCT01351584|Advanced Breast Cancer|advanced breast cancer
420098|NCT01351584|Epidemiology|epidemiology
420099|NCT01351584|Registry|registry
420100|NCT01351584|Health Services Research|health services research
420101|NCT01351584|Germany|germany
420102|NCT01351584|Palliative Treatment|palliative treatment
420103|NCT01351584|Adjuvant Drug Therapy|adjuvant drug therapy
420104|NCT01351584|Nutrition Assessment|nutrition assessment
420105|NCT01351584|Physical Activity|physical activity
420106|NCT01351519|Glioma|glioma
420107|NCT01351519|Glioblastoma|glioblastoma
420108|NCT01351519|Glioblastoma Multiforme|glioblastoma multiforme
420109|NCT01351519|Astrocytoma|astrocytoma
420110|NCT01351519|Brain Tumor|brain tumor
420111|NCT01351506|Body weight|body weight
420112|NCT01351506|Body mass index|body mass index
420113|NCT01351506|Weight change|weight change
420114|NCT01351506|ICU outcomes|icu outcomes
420115|NCT01351493|pressure sore|pressure sore
420116|NCT01351493|nitric oxide|nitric oxide
420117|NCT01351480|Auto-immune Disease|auto-immune disease
420118|NCT01351480|Arthritis|arthritis
420119|NCT01351480|Rheumatoid Arthritis|rheumatoid arthritis
420120|NCT01351467|Parkinson's|parkinson's
420121|NCT01351467|genetic|genetic
420122|NCT01351467|online|online
420123|NCT01351467|GWAS|gwas
420124|NCT01351467|genome wide association|genome wide association
420125|NCT01351454|Depression|depression
420126|NCT01351454|Substance Use|substance use
420127|NCT01351454|HIV Medication Adherence|hiv medication adherence
420128|NCT01351454|Behavioral Activation|behavioral activation
420129|NCT01351441|Geriatric|geriatric
420130|NCT01351441|Pharmacoeconomics|pharmacoeconomics
420131|NCT01351441|Health Literacy|health literacy
420132|NCT01351441|Adherence|adherence
420133|NCT01351428|Non invasive cardiac output monitor|non invasive cardiac output monitor
420134|NCT01351428|NICOM|nicom
420135|NCT01351428|Hypertension|hypertension
420136|NCT01351428|Pregnancy|pregnancy
420137|NCT01351428|Pre-Eclampsia|pre-eclampsia
420138|NCT01351402|Massage|massage
420139|NCT01351402|Rest|rest
420140|NCT01351389|Brief|brief
420141|NCT01351389|Alcohol|alcohol
420142|NCT01351389|Intervention|intervention
420143|NCT01351389|Sex|sex
420144|NCT01351389|Risk|risk
420145|NCT01351376|Lymphedema, Low Level Laser, Breast Cancer|lymphedema, low level laser, breast cancer
420146|NCT01351363|Arthroscopic shoulder surgery|arthroscopic shoulder surgery
420147|NCT01351363|Pain threshold|pain threshold
420148|NCT01351350|Solid tumor, mTORC1/2 inhibitors, HER2|solid tumor, mtorc1/2 inhibitors, her2
420149|NCT01351337|Diffusion tensor imaging, Glioma, Intraoperative monitoring, Pyramidal tract, Subcortical|diffusion tensor imaging, glioma, intraoperative monitoring, pyramidal tract, subcortical
420150|NCT01351337|stimulation, Tractography|stimulation, tractography
420151|NCT01351324|Endothelial function|endothelial function
420152|NCT01351324|Non-esterified fatty acids|non-esterified fatty acids
420153|NCT01351324|Insulin sensitivity|insulin sensitivity
420154|NCT01351311|treatment|treatment
420155|NCT01351311|exercise|exercise
420156|NCT01351311|resistance training|resistance training
420157|NCT01351311|swiss ball|swiss ball
420158|NCT01351311|functional capacity|functional capacity
420159|NCT01351259|Mechanical ventilation|mechanical ventilation
420160|NCT01351259|Intubation|intubation
420161|NCT01351259|Cuff pressure|cuff pressure
420162|NCT01351259|Microaspiration|microaspiration
420163|NCT01351246|Program Evaluation|program evaluation
420164|NCT01351246|ADHD|adhd
420165|NCT01351233|Cataract|cataract
420166|NCT01351220|CRC screening|crc screening
420167|NCT01351220|Prevention and early detection of CRC|prevention and early detection of crc
420168|NCT01351220|Filipino|filipino
420169|NCT01351220|Dissemination|dissemination
420170|NCT01351194|Hepatocellular Carcinoma|hepatocellular carcinoma
420171|NCT01351194|RFA|rfa
420172|NCT01351194|HR|hr
420173|NCT01351181|Diabetes|diabetes
420174|NCT01351168|Parkinson's disease|parkinson's disease
420175|NCT01351168|zolpidem|zolpidem
420176|NCT01351155|acute respiratory failure|acute respiratory failure
420177|NCT01351155|noninvasive ventilation|noninvasive ventilation
420178|NCT01351129|formulation comparison|formulation comparison
420179|NCT01351116|brachytherapy|brachytherapy
420180|NCT01351116|external beam radiation|external beam radiation
420181|NCT01351116|high dose rate intraluminal brachytherapy|high dose rate intraluminal brachytherapy
420182|NCT01351116|lung cancer|lung cancer
420183|NCT01351116|quality of life|quality of life
420184|NCT01351116|radiation treatment|radiation treatment
420185|NCT01351116|bronchus|bronchus
420186|NCT01351103|LGK974|lgk974
420187|NCT01351103|pancreatic adenocarcinoma|pancreatic adenocarcinoma
420188|NCT01351103|BRAF mutant colorectal cancer|braf mutant colorectal cancer
420189|NCT01351103|RNF43 mutation|rnf43 mutation
420190|NCT01351103|RSPO fusion|rspo fusion
420191|NCT01351103|melanoma|melanoma
420192|NCT01351103|triple negative breast cancer|triple negative breast cancer
420193|NCT01351103|PDR001|pdr001
420194|NCT01351103|immunotherapy|immunotherapy
420195|NCT01351103|head and neck scc|head and neck scc
420196|NCT01351103|cervical scc|cervical scc
420197|NCT01351103|esophageal scc|esophageal scc
420198|NCT01351103|lung scc|lung scc
420199|NCT01351077|Developmental Delay|developmental delay
420200|NCT01351064|ADHD|adhd
420201|NCT01351012|Canola oil|canola oil
420202|NCT01351012|High oleic canola oil|high oleic canola oil
420203|NCT01351012|Flax oil|flax oil
420204|NCT01351012|ALA|ala
420205|NCT01351012|DHA|dha
420206|NCT01351012|Metabolic syndrome|metabolic syndrome
420207|NCT01351012|Cardiovascular disease|cardiovascular disease
420208|NCT01351012|Endothelial function|endothelial function
420209|NCT01351012|FADS1|fads1
420210|NCT01351012|Gut microbiome|gut microbiome
420211|NCT01351012|Body composition|body composition
420212|NCT01351012|Psychosocial status|psychosocial status
420213|NCT01351012|Cholesterol|cholesterol
420214|NCT01351012|Lipids|lipids
420215|NCT01351012|Lipoproteins|lipoproteins
420216|NCT01351012|Inflammation|inflammation
420217|NCT01351012|Lipid peroxidation|lipid peroxidation
420218|NCT01350999|Drug Therapy|drug therapy
420219|NCT01350986|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
420220|NCT01350973|Drug Therapy|drug therapy
420221|NCT01350960|hypercholesterolemia|hypercholesterolemia
420222|NCT01350960|hyperlipidemia|hyperlipidemia
420223|NCT01350960|LDL|ldl
420224|NCT01350960|HDL|hdl
420225|NCT01350960|PCSK9|pcsk9
420226|NCT01350960|LNA-oligonucleotide|lna-oligonucleotide
420227|NCT01350947|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
420228|NCT01350947|CMML|cmml
420229|NCT01350921|phase 1|phase 1
420230|NCT01350921|ticagrelor|ticagrelor
420231|NCT01350921|venlafaxine|venlafaxine
420232|NCT01350895|Polycystic ovarian syndrome (PCOS)|polycystic ovarian syndrome (pcos)
420233|NCT01350882|kidney transplantation|kidney transplantation
420234|NCT01350882|acute humoral rejection|acute humoral rejection
420235|NCT01350882|rituximab|rituximab
420236|NCT01350856|Uncomplicated P. falciparum malaria|uncomplicated p. falciparum malaria
420237|NCT01350843|Men|men
420238|NCT01350843|Orange Juice|orange juice
420239|NCT01350843|Cholesterol|cholesterol
420240|NCT01350843|Obesity|obesity
420241|NCT01350830|inguinal hernia|inguinal hernia
420242|NCT01350830|groin hernia|groin hernia
420243|NCT01350830|chronic pain|chronic pain
420244|NCT01350830|mesh repair|mesh repair
420245|NCT01350804|Rheumatoid Arthritis|rheumatoid arthritis
420246|NCT01350804|RA|ra
420247|NCT01350804|ACR|acr
420248|NCT01350804|inflammatory joints|inflammatory joints
420249|NCT01350778|Coronary artery disease requiring drug eluting stents|coronary artery disease requiring drug eluting stents
420250|NCT01350765|Birth asphyxia|birth asphyxia
420251|NCT01350765|Low birth weight|low birth weight
420252|NCT01350765|neonatal sepsis|neonatal sepsis
420253|NCT01350765|mortality|mortality
420254|NCT01350765|community based interventions|community based interventions
420255|NCT01350752|cost effectiveness|cost effectiveness
420256|NCT01350752|provider knowledge|provider knowledge
420257|NCT01350752|schools|schools
420258|NCT01350726|Cirrhosis|cirrhosis
420259|NCT01350726|Hepatic Carcinoma|hepatic carcinoma
420260|NCT01350713|skin|skin
420261|NCT01350713|burn|burn
420262|NCT01350713|povidone iodine|povidone iodine
420263|NCT01350713|cold water|cold water
420264|NCT01350700|QOL|qol
420265|NCT01350687|Calcium Phosphore|calcium phosphore
420266|NCT01350687|Renagel|renagel
420267|NCT01350674|mediastinal tuberculosis|mediastinal tuberculosis
420268|NCT01350674|endoscopy|endoscopy
420269|NCT01350674|EBUS|ebus
420270|NCT01350674|tuberculous lymphadenopathy|tuberculous lymphadenopathy
420271|NCT01350674|endobronchial ultrasound|endobronchial ultrasound
420272|NCT01350661|Asthma|asthma
420273|NCT01350661|Questionnaires|questionnaires
420274|NCT01350648|Viral Hepatitis|viral hepatitis
420275|NCT01350648|Prospective Cohort|prospective cohort
420276|NCT01350648|Hepatocellular Carcinoma|hepatocellular carcinoma
420277|NCT01350648|HIV-HCV Co-Infection|hiv-hcv co-infection
420278|NCT01350648|HIV-HBV Co-Infection|hiv-hbv co-infection
420279|NCT01350648|Hepatitis B|hepatitis b
420280|NCT01350648|Hepatitis C|hepatitis c
420281|NCT01350648|Hepatitis|hepatitis
420282|NCT01350635|Specific Immunotherapy|specific immunotherapy
420283|NCT01350635|Grass pollen vaccine|grass pollen vaccine
420284|NCT01350635|Allergy|allergy
420285|NCT01350635|Grass Pollen Allergy|grass pollen allergy
420286|NCT01350622|pain management|pain management
420287|NCT01350609|essential hypertension, blood pressure, nifedipine, candesartan, FDC|essential hypertension, blood pressure, nifedipine, candesartan, fdc
420288|NCT01350596|Bioequivalence Study|bioequivalence study
420289|NCT01350596|Ibuprofen|ibuprofen
420290|NCT01350596|Alivium|alivium
420291|NCT01350583|tumor related pain|tumor related pain
420292|NCT01350570|acupuncture|acupuncture
420293|NCT01350570|loperamide|loperamide
420294|NCT01350570|functional diarrhea|functional diarrhea
420295|NCT01350570|IBS|ibs
420296|NCT01350557|Elderly|elderly
420297|NCT01350557|Hip fracture|hip fracture
420298|NCT01350557|Intervention program|intervention program
420299|NCT01350544|HIV|hiv
420300|NCT01350544|Adherence|adherence
420301|NCT01350544|African American/Black|african american/black
420302|NCT01350544|Disparities|disparities
420303|NCT01350531|Obesity|obesity
420304|NCT01350531|African American adolescents|african american adolescents
420305|NCT01350531|Motivation|motivation
420306|NCT01350518|Intra-Abdominal Fat|intra-abdominal fat
420307|NCT01350518|Metabolic Syndrome|metabolic syndrome
420308|NCT01350518|Hepatic steatosis|hepatic steatosis
420309|NCT01350505|Postural Balance|postural balance
420310|NCT01350505|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
420311|NCT01350492|pain|pain
420312|NCT01350492|brain imaging|brain imaging
420313|NCT01350492|exercise|exercise
420314|NCT01350479|Cross infection|cross infection
420315|NCT01350479|Long term care|long term care
420316|NCT01350466|Chronic rhinosinusitis|chronic rhinosinusitis
420317|NCT01350453|CIT|cit
420318|NCT01350453|Stroke|stroke
420319|NCT01350427|leucine supplementation|leucine supplementation
420320|NCT01350427|BCCA supplementation|bcca supplementation
420321|NCT01350427|resistance exercise-induced muscle remodeling|resistance exercise-induced muscle remodeling
420322|NCT01350401|Melanoma|melanoma
420323|NCT01350401|Cell Therapy|cell therapy
420324|NCT01350401|T Cell Therapy|t cell therapy
420325|NCT01350401|NY-ESO-1|ny-eso-1
420326|NCT01350401|Immuno-oncology|immuno-oncology
420327|NCT01350401|Metastatic|metastatic
420328|NCT01350401|Previously treated|previously treated
420329|NCT01350401|T Cell Receptor|t cell receptor
420330|NCT01350388|Chronic Kidney Disease|chronic kidney disease
420331|NCT01350388|Diabetes|diabetes
420332|NCT01350388|Febuxostat|febuxostat
420333|NCT01350388|Inflammation|inflammation
420334|NCT01350388|Hyperuricemia|hyperuricemia
420335|NCT01350362|tideglusib|tideglusib
420336|NCT01350362|Alzheimer|alzheimer
420337|NCT01350362|NP-12|np-12
420338|NCT01350362|NP031112|np031112
420339|NCT01350362|ARGO|argo
420340|NCT01350362|Noscira|noscira
420341|NCT01350349|Depression|depression
420342|NCT01350349|Dementia|dementia
420343|NCT01350349|Geriatrics|geriatrics
420344|NCT01350310|Heart failure|heart failure
420345|NCT01350310|Dilated cardiomyopathy|dilated cardiomyopathy
420346|NCT01350310|Stem cells|stem cells
420347|NCT01350297|tetraplegia|tetraplegia
420348|NCT01350297|reinnervation|reinnervation
420349|NCT01350297|phrenic nerve|phrenic nerve
420350|NCT01350284|Antioxidants|antioxidants
420351|NCT01350284|Glucose Intolerance prevention and control|glucose intolerance prevention and control
420352|NCT01350284|Diabetes Mellitus prevention and control|diabetes mellitus prevention and control
420353|NCT01350271|Hookworm|hookworm
420354|NCT01350271|Necator americanus|necator americanus
420355|NCT01350271|Mebendazole|mebendazole
420356|NCT01350258|allogeneic HSCT|allogeneic hsct
420357|NCT01350258|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
420358|NCT01350245|Acute Myeloid Leukemia|acute myeloid leukemia
420359|NCT01350245|Myelodysplastic Syndromes|myelodysplastic syndromes
420360|NCT01350245|Biphenotypic Leukemia|biphenotypic leukemia
420361|NCT01350245|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
420362|NCT01350245|Chronic Myeloid Leukemia|chronic myeloid leukemia
420363|NCT01350245|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
420364|NCT01350245|Plasma Cell Neoplasms|plasma cell neoplasms
420365|NCT01350245|Lymphoma|lymphoma
420366|NCT01350245|Hodgkin's Disease|hodgkin's disease
420367|NCT01350245|Aplastic Anemia|aplastic anemia
420368|NCT01350245|Hematopoietic stem cell transplant (HSCT)|hematopoietic stem cell transplant (hsct)
420369|NCT01350245|myeloablative haploidentical HSCT|myeloablative haploidentical hsct
420370|NCT01350245|graft versus host disease (GVHD)|graft versus host disease (gvhd)
420371|NCT01350232|sickle cell|sickle cell
420372|NCT01350232|SS disease|ss disease
420373|NCT01350232|SC disease|sc disease
420374|NCT01350232|S-thalassemia|s-thalassemia
420375|NCT01350232|transplant|transplant
420376|NCT01350232|bone marrow transplant|bone marrow transplant
420377|NCT01350232|stem cell transplant|stem cell transplant
420378|NCT01350232|matched sibling|matched sibling
420379|NCT01350232|haploidentical|haploidentical
420380|NCT01350232|hemoglobinopathy|hemoglobinopathy
420381|NCT01350232|anemia|anemia
420382|NCT01350232|desensitization|desensitization
420383|NCT01350219|Cord blood stem cells|cord blood stem cells
420384|NCT01350219|Immune modulation|immune modulation
420385|NCT01350219|Stem cell educator|stem cell educator
420386|NCT01350219|Autoimmunity|autoimmunity
420387|NCT01350219|Islet beta cell regeneration|islet beta cell regeneration
420388|NCT01350219|Type 1 diabetes|type 1 diabetes
420389|NCT01350206|Carcinoma,Hepatocellular|carcinoma,hepatocellular
420390|NCT01350206|Liver Neoplasms|liver neoplasms
420391|NCT01350206|Therapeutic|therapeutic
420392|NCT01350206|Chemoembolization,|chemoembolization,
420393|NCT01350206|TACE|tace
420394|NCT01350206|hepatic resection|hepatic resection
420395|NCT01350193|Manuka Honey|manuka honey
420396|NCT01350193|Irrigation|irrigation
420397|NCT01350193|Endoscopic Sinus Surgery|endoscopic sinus surgery
420398|NCT01350180|biochemical failure|biochemical failure
420399|NCT01350180|hormonal therapy|hormonal therapy
420400|NCT01350167|Hepatocellular Carcinoma|hepatocellular carcinoma
420401|NCT01350167|Liver Cancer|liver cancer
420402|NCT01350167|Ultrasound|ultrasound
420403|NCT01350167|Computed Tomography|computed tomography
420404|NCT01350167|Alpha fetoprotein|alpha fetoprotein
420405|NCT01350167|Cirrhosis|cirrhosis
420406|NCT01350167|Screening|screening
420407|NCT01350167|Advanced Liver Disease|advanced liver disease
420408|NCT01350154|clinical trial|clinical trial
420409|NCT01350154|sildenafil|sildenafil
420410|NCT01350154|revatio|revatio
420411|NCT01350154|muscular dystrophy|muscular dystrophy
420412|NCT01350154|adult|adult
420413|NCT01350154|nNOS|nnos
420414|NCT01350141|Hypercholesterolemia|hypercholesterolemia
420415|NCT01350141|dyslipidemia|dyslipidemia
420416|NCT01350141|high cholesterol|high cholesterol
420417|NCT01350141|LDL|ldl
420418|NCT01350141|antibody|antibody
420419|NCT01350141|PCSK9|pcsk9
420420|NCT01350141|PF-04950615|pf-04950615
420421|NCT01350141|RN316|rn316
420422|NCT01350128|COPD|copd
420423|NCT01350115|Basal Cell Carcinoma|basal cell carcinoma
420424|NCT01350115|Gorlin Syndrome,|gorlin syndrome,
420425|NCT01350115|Gorlin-Goltz Syndrome,|gorlin-goltz syndrome,
420426|NCT01350115|Basal Cell Nevus Syndrome,|basal cell nevus syndrome,
420427|NCT01350115|Nevoid Basal Cell Carcinoma Syndrome,|nevoid basal cell carcinoma syndrome,
420428|NCT01350115|Basal Cell Carcinoma Nevus Syndrome|basal cell carcinoma nevus syndrome
420429|NCT01350115|Smo inhibitor,|smo inhibitor,
420430|NCT01350115|Hedgehog pathway inhibitor|hedgehog pathway inhibitor
420431|NCT01350115|BCCs|bccs
420432|NCT01350102|Adult|adult
420433|NCT01350089|energy drinks|energy drinks
420434|NCT01350089|alcohol intoxication|alcohol intoxication
420435|NCT01350076|intraoperative fluid|intraoperative fluid
420436|NCT01350076|pediatric|pediatric
420437|NCT01350076|goal directed therapy|goal directed therapy
420438|NCT01350076|pediatric with major abdominal surgery|pediatric with major abdominal surgery
420439|NCT01350076|ASA less than or equal to 3|asa less than or equal to 3
420440|NCT01350076|Duration of surgery less than 2 hours|duration of surgery less than 2 hours
420441|NCT01350076|Body weight more than or equal to 15 kg|body weight more than or equal to 15 kg
420442|NCT01350063|water|water
420443|NCT01350063|tubewell|tubewell
420444|NCT01350063|diarrhea|diarrhea
420445|NCT01350063|chlorination|chlorination
420446|NCT01350063|safe storage|safe storage
420447|NCT01350050|topical pharyngeal anesthesia|topical pharyngeal anesthesia
420448|NCT01350050|articaine|articaine
420449|NCT01350037|patient-controlled sedation|patient-controlled sedation
420450|NCT01350037|propofol|propofol
420451|NCT01350037|alfentanil|alfentanil
420452|NCT01350037|remifentanil|remifentanil
420453|NCT01350037|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
420454|NCT01350024|Conjunctival Mullerectomy|conjunctival mullerectomy
420455|NCT01350024|Blepharoptosis|blepharoptosis
420456|NCT01350024|Ptosis surgery|ptosis surgery
420457|NCT01350024|Pain Control|pain control
420458|NCT01350011|Nicotine Replacement Therapy|nicotine replacement therapy
420459|NCT01350011|Buprenorphine|buprenorphine
420460|NCT01350011|Varenicline|varenicline
420461|NCT01350011|Smoking Cessation|smoking cessation
420462|NCT01350011|Addiction|addiction
420463|NCT01350011|The Innovative System (IS) Treatment|the innovative system (is) treatment
420464|NCT01350011|The Standard Treatment Control (STC)|the standard treatment control (stc)
420465|NCT01349985|Naltrexone|naltrexone
420466|NCT01349985|problem drinking|problem drinking
420467|NCT01349985|medication adherence|medication adherence
420468|NCT01349985|adherence|adherence
420469|NCT01349985|smartphone|smartphone
420470|NCT01349920|biological markers|biological markers
420471|NCT01349920|endoscopy|endoscopy
420472|NCT01349920|gastrointestinal|gastrointestinal
420473|NCT01349881|Eflornithine/sulindac prevention trial|eflornithine/sulindac prevention trial
420474|NCT01349868|COPD|copd
420475|NCT01349829|Hepatitis A|hepatitis a
420476|NCT01349829|Vaccination|vaccination
420477|NCT01349829|Immunity|immunity
420478|NCT01349816|COPD|copd
420479|NCT01349803|COPD|copd
420480|NCT01349790|ITP|itp
420481|NCT01349790|Primary immune thrombocytopenia|primary immune thrombocytopenia
420482|NCT01349777|antiplatelet therapy post drug eluting stents|antiplatelet therapy post drug eluting stents
420483|NCT01349764|vitamin D replacement|vitamin d replacement
420484|NCT01349764|Urolithiasis|urolithiasis
420485|NCT01349764|deficiency|deficiency
420486|NCT01349764|insufficiency|insufficiency
420487|NCT01349751|abdominal incision|abdominal incision
420488|NCT01349751|hyperbaric|hyperbaric
420489|NCT01349751|isobaric|isobaric
420490|NCT01349751|levobupivacaine|levobupivacaine
420491|NCT01349751|spinal anaesthesia|spinal anaesthesia
420492|NCT01349725|Safety|safety
420493|NCT01349699|endotoxemia|endotoxemia
420494|NCT01349699|inflammation|inflammation
420495|NCT01349699|iron|iron
420496|NCT01349699|iron chelation|iron chelation
420497|NCT01349699|cytokines|cytokines
420498|NCT01349686|Food|food
420499|NCT01349686|Fluids|fluids
420500|NCT01349686|Labor|labor
420501|NCT01349673|Open-label|open-label
420502|NCT01349673|Proctitis|proctitis
420503|NCT01349673|Proctosigmoiditis|proctosigmoiditis
420504|NCT01349673|Ulcerative|ulcerative
420505|NCT01349673|Salix|salix
420506|NCT01349673|Budesonide foam|budesonide foam
420507|NCT01349673|Budesonide|budesonide
420508|NCT01349673|Rectal|rectal
420509|NCT01349673|Gastrointestinal|gastrointestinal
420510|NCT01349673|Colitis|colitis
420511|NCT01349673|UC|uc
420512|NCT01349673|UP|up
420513|NCT01349673|UPS|ups
420514|NCT01349673|Additional relevant MeSH terms:|additional relevant mesh terms:
420515|NCT01349673|Proctocolitis|proctocolitis
420516|NCT01349673|Ulcer|ulcer
420517|NCT01349673|Colitis, Ulcerative|colitis, ulcerative
420518|NCT01349673|Gastroenteritis|gastroenteritis
420519|NCT01349673|Gastrointestinal Diseases|gastrointestinal diseases
420520|NCT01349673|Digestive System Diseases|digestive system diseases
420521|NCT01349673|Rectal Diseases|rectal diseases
420522|NCT01349673|Intestinal Diseases|intestinal diseases
420523|NCT01349673|Colonic Diseases|colonic diseases
420524|NCT01349673|Sigmoid Diseases|sigmoid diseases
420525|NCT01349673|Pathologic Processes|pathologic processes
420526|NCT01349673|Inflammatory Bowel Diseases|inflammatory bowel diseases
420527|NCT01349673|Bronchodilator Agents|bronchodilator agents
420528|NCT01349673|Autonomic Agents|autonomic agents
420529|NCT01349673|Peripheral Nervous System Agents|peripheral nervous system agents
420530|NCT01349673|Physiological Effects of Drugs|physiological effects of drugs
420531|NCT01349673|Pharmacologic Actions|pharmacologic actions
420532|NCT01349673|Anti-Asthmatic Agents|anti-asthmatic agents
420533|NCT01349673|Respiratory System Agents|respiratory system agents
420534|NCT01349673|Therapeutic Uses|therapeutic uses
420535|NCT01349673|Glucocorticoids|glucocorticoids
420536|NCT01349673|Hormones|hormones
420537|NCT01349673|Hormones, Hormone Substitutes and Hormone Antagonists|hormones, hormone substitutes and hormone antagonists
420538|NCT01349673|Anti-inflammatory Agents|anti-inflammatory agents
420539|NCT01349660|Glioblastoma multiforme|glioblastoma multiforme
420540|NCT01349660|GBM|gbm
420541|NCT01349660|Bevacizumab|bevacizumab
420542|NCT01349660|PI3K Pathway|pi3k pathway
420543|NCT01349660|BKM120|bkm120
420544|NCT01349647|FUCOSYL-GM1-KLH|fucosyl-gm1-klh
420545|NCT01349647|GLOBO H-KLH CONJUGATE|globo h-klh conjugate
420546|NCT01349647|OPT-821|opt-821
420547|NCT01349647|POLYSIALIC ACID - KLH|polysialic acid - klh
420548|NCT01349647|Vaccine|vaccine
420549|NCT01349647|08-095|08-095
420550|NCT01349634|iodine|iodine
420552|NCT01349634|cretinism|cretinism
420553|NCT01349634|child nutrition|child nutrition
420554|NCT01349634|cognition|cognition
420555|NCT01349621|Abnormal Pap results|abnormal pap results
420556|NCT01349621|Colposcopy|colposcopy
420557|NCT01349608|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
420558|NCT01349608|Motivational Interviewing|motivational interviewing
420559|NCT01349608|Health Coaching|health coaching
420560|NCT01349608|Physical Activity|physical activity
420561|NCT01349582|flow diversion|flow diversion
420562|NCT01349582|endovascular treatment|endovascular treatment
420563|NCT01349582|symptomatic aneurysm|symptomatic aneurysm
420564|NCT01349582|cavernous carotid aneurysm|cavernous carotid aneurysm
420565|NCT01349582|ophthalmic aneurysm|ophthalmic aneurysm
420566|NCT01349582|vertebral aneurysm|vertebral aneurysm
420567|NCT01349556|cancer|cancer
420568|NCT01349556|chemotherapy|chemotherapy
420569|NCT01349556|EGFR inhibitors|egfr inhibitors
420570|NCT01349556|tretinoin|tretinoin
420571|NCT01349556|EGFRi drug rash|egfri drug rash
420572|NCT01349543|Respiratory syncytial virus|respiratory syncytial virus
420573|NCT01349543|RSV|rsv
420574|NCT01349543|Immunology|immunology
420575|NCT01349543|Viral infection|viral infection
420576|NCT01349543|Bronchiolitis|bronchiolitis
420577|NCT01349543|Viral challenge|viral challenge
420578|NCT01349543|Viral lung disease|viral lung disease
420579|NCT01349530|Usual medical care|usual medical care
420580|NCT01349530|Anticoagulation by VKAs: COUMADINE® & PREVISCAN®|anticoagulation by vkas: coumadine® & previscan®
420581|NCT01349530|Anticoagulation clinic care, CREATIF|anticoagulation clinic care, creatif
420582|NCT01349517|health-related quality of life(HRQL)|health-related quality of life(hrql)
420583|NCT01349517|Esophageal Cancer|esophageal cancer
420584|NCT01349491|Atrial Fibrillation|atrial fibrillation
420585|NCT01349491|Ranolazine|ranolazine
420586|NCT01349478|paraplegia|paraplegia
420587|NCT01349478|tetraplegia|tetraplegia
420588|NCT01349478|passive gait training|passive gait training
420589|NCT01349478|O2 consumption|o2 consumption
420590|NCT01349478|exercise capacity|exercise capacity
420591|NCT01349478|CVD risk factors|cvd risk factors
420592|NCT01349478|spasticity|spasticity
420593|NCT01349478|pain|pain
420594|NCT01349478|bladder, bowel|bladder, bowel
420595|NCT01349478|well being|well being
420596|NCT01349465|Hepatitis C|hepatitis c
420597|NCT01349465|Hepatitis|hepatitis
420598|NCT01349465|TMC435|tmc435
420599|NCT01349465|Liver disease|liver disease
420600|NCT01349465|Virus Infection|virus infection
420601|NCT01349452|Conjunctivitis, Viral|conjunctivitis, viral
420602|NCT01349452|Adenoviridae Infections|adenoviridae infections
420603|NCT01349452|Ganciclovir|ganciclovir
420604|NCT01349452|Adenovirus Keratoconjunctivitis|adenovirus keratoconjunctivitis
420605|NCT01349452|Treatment of viral conjunctivitis|treatment of viral conjunctivitis
420606|NCT01349426|Lung resection|lung resection
420607|NCT01349426|Parenchymal pneumostasis, haemostasis|parenchymal pneumostasis, haemostasis
420608|NCT01349426|Fissure closure|fissure closure
420609|NCT01349426|Automatic staplers,LigaSure, Force Triad Generator|automatic staplers,ligasure, force triad generator
420610|NCT01349426|Bipolar fusion|bipolar fusion
420611|NCT01349426|Procedure cost|procedure cost
420612|NCT01349413|Functional dyspepsia|functional dyspepsia
420613|NCT01349413|symptom response|symptom response
420614|NCT01349413|postprandial fullness|postprandial fullness
420615|NCT01349413|gastroesophageal reflux disease|gastroesophageal reflux disease
420616|NCT01349413|acid suppression|acid suppression
420617|NCT01349400|asymptomatic|asymptomatic
420618|NCT01349400|minimally symptomatic|minimally symptomatic
420619|NCT01349348|Tolvaptan treatment to ascites and hepatic cirrhosis|tolvaptan treatment to ascites and hepatic cirrhosis
420620|NCT01349322|stage IA breast cancer|stage ia breast cancer
420621|NCT01349322|stage IB breast cancer|stage ib breast cancer
420622|NCT01349322|stage II breast cancer|stage ii breast cancer
420623|NCT01349322|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
420624|NCT01349322|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
420625|NCT01349322|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
420626|NCT01349322|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
420627|NCT01349322|ductal breast carcinoma in situ|ductal breast carcinoma in situ
420628|NCT01349309|Prophylactic Swallowing Exercises|prophylactic swallowing exercises
420629|NCT01349309|Head and Neck Cancer|head and neck cancer
420630|NCT01349309|Dysphagia|dysphagia
420631|NCT01349296|Solid Tumors|solid tumors
420632|NCT01349283|Hepatitis B Vaccine|hepatitis b vaccine
420633|NCT01349283|Hepatitis B Virus|hepatitis b virus
420634|NCT01349283|Antigen|antigen
420635|NCT01349283|Antibody|antibody
420636|NCT01349283|Vaccination|vaccination
420637|NCT01349270|chronic inflammatory demyelinating polyneuropathy|chronic inflammatory demyelinating polyneuropathy
420638|NCT01349270|immunoglobulin|immunoglobulin
420639|NCT01349270|prednisone|prednisone
420640|NCT01349257|Asthmatic patients|asthmatic patients
420641|NCT01349244|hydronephrosis|hydronephrosis
420642|NCT01349244|CT|ct
420643|NCT01349244|POC US|poc us
420644|NCT01349231|obsessive-compulsive disorder|obsessive-compulsive disorder
420645|NCT01349231|ketamine|ketamine
420646|NCT01349231|glutamate|glutamate
420647|NCT01349218|Potassium|potassium
420648|NCT01349218|Infants|infants
420649|NCT01349218|Heel Stick|heel stick
420650|NCT01349218|Less than or equal to 6 months of age|less than or equal to 6 months of age
420651|NCT01349218|IV catheter blood samples|iv catheter blood samples
420652|NCT01349218|perioperatively|perioperatively
420653|NCT01349218|elective surgical procedures|elective surgical procedures
420654|NCT01349205|OSA|osa
420655|NCT01349205|Caffeine|caffeine
420656|NCT01349205|Tonsillectomy|tonsillectomy
420657|NCT01349205|Adenoidectomy|adenoidectomy
420658|NCT01349205|Sleep Study|sleep study
420659|NCT01349192|MRSA|mrsa
420660|NCT01349192|Cystic Fibrosis|cystic fibrosis
420661|NCT01349192|Early Infection|early infection
420662|NCT01349192|Treatment|treatment
420663|NCT01349179|Hip|hip
420664|NCT01349179|Arthroplasty|arthroplasty
420665|NCT01349179|Metal on metal|metal on metal
420666|NCT01349179|operated on 2002|operated on 2002
420667|NCT01349166|Obesity|obesity
420668|NCT01349166|Type 2 diabetes|type 2 diabetes
420669|NCT01349166|glucose intolerance|glucose intolerance
420670|NCT01349166|Physical Activity|physical activity
420671|NCT01349166|Inflammation|inflammation
420672|NCT01349166|HPA axis|hpa axis
420673|NCT01349166|Cytokines|cytokines
420674|NCT01349153|Physical Activity|physical activity
420675|NCT01349153|Young Adults|young adults
420676|NCT01349153|Cancer Survivors|cancer survivors
420677|NCT01349127|Vitamin D|vitamin d
420678|NCT01349127|Cholecalciferol|cholecalciferol
420679|NCT01349127|Nutrient requirements|nutrient requirements
420680|NCT01349127|Randomised Controlled Trial|randomised controlled trial
420681|NCT01349127|Lactation|lactation
420682|NCT01349127|pregnancy|pregnancy
420683|NCT01349127|Cord blood|cord blood
420684|NCT01349127|Human milk|human milk
420685|NCT01349127|serum 25-hydroxyvitamin D|serum 25-hydroxyvitamin d
420686|NCT01349127|deficiency|deficiency
420687|NCT01349127|insufficiency|insufficiency
420688|NCT01349127|nutrition|nutrition
420689|NCT01349114|aliskiren|aliskiren
420690|NCT01349114|endothelial function|endothelial function
420691|NCT01349114|hypertension|hypertension
420692|NCT01349101|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
420693|NCT01349101|HSCT|hsct
420694|NCT01349101|allogeneic marrow transplantation|allogeneic marrow transplantation
420695|NCT01349101|cyclophosphamide|cyclophosphamide
420696|NCT01349101|graft-versus-host disease|graft-versus-host disease
420697|NCT01349101|GVHD|gvhd
420698|NCT01349088|breast cancer|breast cancer
420699|NCT01349088|metastatic breast cancer|metastatic breast cancer
420700|NCT01349088|stage IV breast cancer|stage iv breast cancer
420701|NCT01349088|motesanib|motesanib
420702|NCT01349088|ixabepilone|ixabepilone
420703|NCT01349088|capecitabine|capecitabine
420704|NCT01349075|Unresectable|unresectable
420705|NCT01349075|Hepatocellular Carcinoma|hepatocellular carcinoma
420706|NCT01349075|TheraSphere|therasphere
420707|NCT01349075|Yttrium-90|yttrium-90
420708|NCT01349062|Prolonged Viral Suppression|prolonged viral suppression
420709|NCT01349062|HIV Infections|hiv infections
420710|NCT01349049|AML|aml
420711|NCT01349049|relapsed|relapsed
420712|NCT01349049|refractory|refractory
420713|NCT01349036|GBM|gbm
420714|NCT01349036|Glioblastoma|glioblastoma
420715|NCT01349036|brain cancer|brain cancer
420716|NCT01349023|energy content|energy content
420717|NCT01349023|energy density|energy density
420718|NCT01349023|energy intake|energy intake
420719|NCT01349023|pre-portioned entrees|pre-portioned entrees
420720|NCT01349010|hyperlipidemia|hyperlipidemia
420721|NCT01348997|cancer|cancer
420722|NCT01348997|cancer survivors|cancer survivors
420723|NCT01348997|internet|internet
420724|NCT01348997|depression|depression
420725|NCT01348997|anxiety|anxiety
420726|NCT01348984|postoperative|postoperative
420727|NCT01348984|pain score|pain score
420728|NCT01348984|morphine consumption|morphine consumption
420729|NCT01348971|sodium nitrate|sodium nitrate
420730|NCT01348971|coronary artery bypass surgery|coronary artery bypass surgery
420731|NCT01348971|ischemia-reperfusion|ischemia-reperfusion
420732|NCT01348971|myocardial injury|myocardial injury
420733|NCT01348958|Patello femoral|patello femoral
420734|NCT01348958|osteoarthritis|osteoarthritis
420735|NCT01348958|arthroplasty|arthroplasty
420736|NCT01348945|Partial tear ACL|partial tear acl
420737|NCT01348945|Stump preserved ACL surgery|stump preserved acl surgery
420738|NCT01348932|asthma|asthma
420739|NCT01348932|Chitinase 3-like 1 (CHI3L1)|chitinase 3-like 1 (chi3l1)
420740|NCT01348932|YKL-40|ykl-40
420741|NCT01348932|single nucleotide polymorphism(SNP)|single nucleotide polymorphism(snp)
420742|NCT01348932|Real time PCR|real time pcr
420743|NCT01348932|gene|gene
420744|NCT01348919|Cancer|cancer
420745|NCT01348919|Multiple myeloma|multiple myeloma
420746|NCT01348919|CEP-18770|cep-18770
420747|NCT01348919|Lenalidomide|lenalidomide
420748|NCT01348919|Dexamethasone|dexamethasone
420749|NCT01348906|cardiopulmonary bypass|cardiopulmonary bypass
420750|NCT01348893|Mental health|mental health
420751|NCT01348893|Education|education
420752|NCT01348893|Mind Body Therapies|mind body therapies
420753|NCT01348880|drug-drug interaction|drug-drug interaction
420754|NCT01348867|Diabetes|diabetes
420755|NCT01348867|Structured Care|structured care
420756|NCT01348854|astigmatism|astigmatism
420757|NCT01348841|community wound care|community wound care
420758|NCT01348841|systematic wound team referral|systematic wound team referral
420759|NCT01348841|Advanced in-home nurse wound training|advanced in-home nurse wound training
420760|NCT01348828|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
420761|NCT01348828|Fenestrated|fenestrated
420762|NCT01348828|Renal Stent|renal stent
420763|NCT01348828|Juxtarenal|juxtarenal
420764|NCT01348828|Pararenal|pararenal
420765|NCT01348828|Endologix|endologix
420766|NCT01348828|Renal|renal
420767|NCT01348802|Knowledge Translation|knowledge translation
420768|NCT01348802|Push-out Evidence|push-out evidence
420769|NCT01348802|Technology-Based Knowledge Translation|technology-based knowledge translation
420770|NCT01348802|Pain|pain
420771|NCT01348802|Interdisciplinary|interdisciplinary
420772|NCT01348802|Physician|physician
420773|NCT01348802|Rehabilitation|rehabilitation
420774|NCT01348802|Nursing|nursing
420775|NCT01348802|Knowledge Uptake|knowledge uptake
420776|NCT01348789|Hair removal|hair removal
420777|NCT01348789|Hair Clearance|hair clearance
420778|NCT01348789|Epilation|epilation
420779|NCT01348776|hair reduction|hair reduction
420780|NCT01348776|hair removal|hair removal
420781|NCT01348776|hair clearance|hair clearance
420782|NCT01348750|PTSD|ptsd
420783|NCT01348750|Healing Touch|healing touch
420784|NCT01348750|Guided Imagery|guided imagery
420785|NCT01348750|Military|military
420786|NCT01348750|Complementary Medicine|complementary medicine
420787|NCT01348737|Phase 1|phase 1
420788|NCT01348737|healthy volunteers|healthy volunteers
420789|NCT01348737|double-blind|double-blind
420790|NCT01348737|placebo-controlled|placebo-controlled
420791|NCT01348737|AZD3839|azd3839
420792|NCT01348737|pharmacokinetics|pharmacokinetics
420793|NCT01348737|Alzheimer's Disease|alzheimer's disease
420794|NCT01348724|Radioactive carbon|radioactive carbon
420795|NCT01348724|Absorption|absorption
420796|NCT01348724|Distribution|distribution
420797|NCT01348724|Metabolism|metabolism
420798|NCT01348724|Excretion|excretion
420799|NCT01348724|Healthy Volunteers|healthy volunteers
420800|NCT01348711|Pre-eclampsia|pre-eclampsia
420801|NCT01348698|Adrenal Cancer|adrenal cancer
420802|NCT01348698|Pheochromocytoma|pheochromocytoma
420803|NCT01348698|Functioning Tumor|functioning tumor
420804|NCT01348698|Nonfunctioning Tumor|nonfunctioning tumor
420805|NCT01348698|Gene Expression|gene expression
420806|NCT01348698|Adrenal Tumor|adrenal tumor
420807|NCT01348672|Age related macular degeneration|age related macular degeneration
420808|NCT01348672|Glaucoma|glaucoma
420809|NCT01348672|Diabetic retinopathy|diabetic retinopathy
420810|NCT01348672|Retinal oxygen saturation|retinal oxygen saturation
420811|NCT01348672|Blood flow|blood flow
420812|NCT01348672|Vascular function|vascular function
420813|NCT01348672|High resolution imaging|high resolution imaging
420814|NCT01348659|Hypertonic saline|hypertonic saline
420815|NCT01348659|Extracellular fluid|extracellular fluid
420816|NCT01348659|cardiopulmonary bypass|cardiopulmonary bypass
420817|NCT01348646|Smoking|smoking
420818|NCT01348646|Adolescence|adolescence
420819|NCT01348646|Brief intervention|brief intervention
420820|NCT01348633|Doppler SD-OCT Blood Flow Technology|doppler sd-oct blood flow technology
420821|NCT01348633|Retinal and choroidal blood flow|retinal and choroidal blood flow
420822|NCT01348633|Canon Laser Blood Flowmeter|canon laser blood flowmeter
420823|NCT01348620|single port cholecystectomy|single port cholecystectomy
420824|NCT01348607|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
420825|NCT01348607|sleep disorders|sleep disorders
420826|NCT01348607|fatigue|fatigue
420827|NCT01348607|childhood craniopharyngioma|childhood craniopharyngioma
420828|NCT01348594|Vitamin D|vitamin d
420829|NCT01348594|In vitro Fertilization|in vitro fertilization
420830|NCT01348581|Adult|adult
420831|NCT01348581|Aged|aged
420832|NCT01348581|Aged, 80 and over|aged, 80 and over
420833|NCT01348581|Bandages|bandages
420834|NCT01348581|Biological Dressings|biological dressings
420835|NCT01348581|Chronic Disease|chronic disease
420836|NCT01348581|Collagen|collagen
420837|NCT01348581|Epithelium|epithelium
420838|NCT01348581|Extracellular Matrix|extracellular matrix
420839|NCT01348581|Fibroblasts|fibroblasts
420840|NCT01348581|Granulation Tissue|granulation tissue
420841|NCT01348581|Humans|humans
420842|NCT01348581|Leg Ulcer|leg ulcer
420843|NCT01348581|Middle Aged|middle aged
420844|NCT01348581|Prospective Studies|prospective studies
420845|NCT01348581|Soft Tissue Injuries|soft tissue injuries
420846|NCT01348581|Treatment Outcome|treatment outcome
420847|NCT01348581|Varicose Ulcer|varicose ulcer
420848|NCT01348581|Wound Healing|wound healing
420849|NCT01348581|Wounds and Injuries|wounds and injuries
420850|NCT01348555|COPD|copd
421046|NCT01347684|elavil|elavil
420851|NCT01348542|Chronic Insomnia|chronic insomnia
420852|NCT01348542|Short Sleep Duration|short sleep duration
420853|NCT01348542|Trazodone|trazodone
420854|NCT01348542|Cognitive Behavioral Therapy|cognitive behavioral therapy
420855|NCT01348542|Efficacy|efficacy
420856|NCT01348529|OCD|ocd
420857|NCT01348529|CBT|cbt
420858|NCT01348529|Reducing OCD symptoms|reducing ocd symptoms
420859|NCT01348516|HIV|hiv
420860|NCT01348490|PMF|pmf
420861|NCT01348490|PPV-MF|ppv-mf
420862|NCT01348490|PET-MF|pet-mf
420863|NCT01348477|inguinal|inguinal
420864|NCT01348477|hernia|hernia
420865|NCT01348477|pain|pain
420866|NCT01348477|inguinodynia|inguinodynia
420867|NCT01348477|mesh|mesh
420868|NCT01348464|appendectomy|appendectomy
420869|NCT01348464|appendicitis|appendicitis
420870|NCT01348464|laparoscopic surgery|laparoscopic surgery
420871|NCT01348451|Human spinal cord derived neural stem cell transplantation|human spinal cord derived neural stem cell transplantation
420872|NCT01348451|ALS|als
420873|NCT01348438|high risk|high risk
420874|NCT01348438|surgical valve replacement|surgical valve replacement
420875|NCT01348425|PAD|pad
420876|NCT01348412|non resectable metastases|non resectable metastases
420877|NCT01348412|liver of colic or rectal origin|liver of colic or rectal origin
420878|NCT01348412|after failure of the conventional treatments|after failure of the conventional treatments
420879|NCT01348399|Coronary artery disease requiring drug eluting stents|coronary artery disease requiring drug eluting stents
420880|NCT01348386|Potassium hydroxide.|potassium hydroxide.
420881|NCT01348386|Molluscum Contagiosum|molluscum contagiosum
420882|NCT01348373|drug eluting stents|drug eluting stents
420883|NCT01348334|Sling surgery|sling surgery
420884|NCT01348334|synthetic meshes|synthetic meshes
420885|NCT01348334|ultrapromesh®|ultrapromesh®
420886|NCT01348334|mix mesh|mix mesh
420887|NCT01348334|incontinence|incontinence
420888|NCT01348334|The Ultrapromesh® synthetic sling procedures have lower complications incidence and higher success rates than the other synthetic slings in 3-year follow-up.|the ultrapromesh® synthetic sling procedures have lower complications incidence and higher success rates than the other synthetic slings in 3-year follow-up.
420889|NCT01348308|Late diagnosed HIV-1 infected patients|late diagnosed hiv-1 infected patients
420890|NCT01348308|AIDS-defining events|aids-defining events
420891|NCT01348308|Immune restoration|immune restoration
420892|NCT01348295|Mechanical ventilation|mechanical ventilation
420893|NCT01348295|Children|children
420894|NCT01348295|Neonates|neonates
420895|NCT01348295|Pediatric intensive care|pediatric intensive care
420896|NCT01348282|Neurocognitive Impairment|neurocognitive impairment
420897|NCT01348282|Controlled Randomized Trial|controlled randomized trial
420898|NCT01348282|Coadjunctive Treatments|coadjunctive treatments
420899|NCT01348282|Lithium; Rivastigmine|lithium; rivastigmine
420900|NCT01348282|Antiretroviral Therapy|antiretroviral therapy
420901|NCT01348282|HIV Infection|hiv infection
420902|NCT01348269|bone marrow edema|bone marrow edema
420903|NCT01348269|Aclasta|aclasta
420904|NCT01348256|colorectal carcinoma|colorectal carcinoma
420905|NCT01348256|resectable hepatic metastasis|resectable hepatic metastasis
420906|NCT01348256|adjuvant treatment|adjuvant treatment
420907|NCT01348256|dendritic cells|dendritic cells
420908|NCT01348230|Premature prolonged rupture of membranes|premature prolonged rupture of membranes
420909|NCT01348230|Premature labor|premature labor
420910|NCT01348230|Uromodulin|uromodulin
420911|NCT01348230|Glycosylation|glycosylation
420912|NCT01348217|unoperated cancers|unoperated cancers
420913|NCT01348217|oesophagus|oesophagus
420914|NCT01348217|radiochemotherapy|radiochemotherapy
420915|NCT01348217|with and without increased doses|with and without increased doses
420916|NCT01348204|Cystic Fibrosis|cystic fibrosis
420917|NCT01348191|Thyrotrophin|thyrotrophin
420918|NCT01348191|Pregnancy|pregnancy
420919|NCT01348191|Human myometrium|human myometrium
420920|NCT01348191|Relaxation|relaxation
420921|NCT01348191|Contractility|contractility
420922|NCT01348152|Gastric Emptying|gastric emptying
420923|NCT01348139|Asthma|asthma
420924|NCT01348139|patients|patients
420925|NCT01348139|lung function|lung function
420926|NCT01348126|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
420927|NCT01348126|NSCLC|nsclc
420928|NCT01348126|Lung cancer|lung cancer
420929|NCT01348113|Alcohol Use Disorders Identification Test|alcohol use disorders identification test
420930|NCT01348113|alcohol dependence|alcohol dependence
420931|NCT01348113|Alcohol problem|alcohol problem
420932|NCT01348100|Schizophrenia|schizophrenia
420933|NCT01348100|Iloperidone|iloperidone
420934|NCT01348100|Depot|depot
420935|NCT01348100|Injection|injection
420936|NCT01348087|Fragile X Syndrome|fragile x syndrome
420937|NCT01348087|Martin-Bell Syndrome|martin-bell syndrome
420938|NCT01348087|Genetic Diseases|genetic diseases
420939|NCT01348087|X-Linked|x-linked
420940|NCT01348087|Escalante's syndrome|escalante's syndrome
420941|NCT01348074|warfarin|warfarin
420942|NCT01348074|surgery|surgery
420943|NCT01348074|management|management
420944|NCT01348074|thromboembolism|thromboembolism
420945|NCT01348074|bleeding|bleeding
420946|NCT01348061|Alzheimers Disease|alzheimers disease
420947|NCT01348061|Progressive Supranuclear Palsy|progressive supranuclear palsy
420948|NCT01348061|CSF|csf
420949|NCT01348061|Cerebrospinal Fluid|cerebrospinal fluid
420950|NCT01348061|Biomarker|biomarker
420951|NCT01348061|Heavy Water|heavy water
420952|NCT01348061|Cargo proteins|cargo proteins
420953|NCT01348048|palliative care|palliative care
420954|NCT01348048|end-of-life care|end-of-life care
420955|NCT01348048|randomized clinical trial|randomized clinical trial
420956|NCT01348048|quality of life|quality of life
420957|NCT01348048|needs assessment|needs assessment
420958|NCT01348048|patient satisfaction|patient satisfaction
420959|NCT01348048|cost-effectiveness|cost-effectiveness
420960|NCT01348048|Screening|screening
420961|NCT01348035|Autosomal Dominant Polycystic Kidney Disease.|autosomal dominant polycystic kidney disease.
420962|NCT01348035|Arginine vasopressin|arginine vasopressin
420963|NCT01348035|Total Kidney Volume|total kidney volume
420964|NCT01348035|Glomerular Filtration Rate|glomerular filtration rate
420965|NCT01348009|Gastric cancer|gastric cancer
420966|NCT01348009|First-line therapy|first-line therapy
420967|NCT01348009|Tesetaxel|tesetaxel
420968|NCT01348009|Taxane|taxane
420969|NCT01348009|Capecitabine|capecitabine
420970|NCT01348009|Oral fluoropyrimidine|oral fluoropyrimidine
420971|NCT01348009|Cisplatin|cisplatin
420972|NCT01348009|Platinum|platinum
420973|NCT01347996|AML|aml
420974|NCT01347996|Leukemia|leukemia
420975|NCT01347996|Acute Myeloid Leukemia|acute myeloid leukemia
420976|NCT01347996|Minimal Residual Disease|minimal residual disease
420977|NCT01347996|Ceplene|ceplene
420978|NCT01347996|Histamine|histamine
420979|NCT01347996|interleukin 2|interleukin 2
420980|NCT01347983|RA|ra
420981|NCT01347970|childhood cancer survivor|childhood cancer survivor
420982|NCT01347970|CHF|chf
420983|NCT01347970|risk of congestive heart failure|risk of congestive heart failure
420984|NCT01347944|MORE|more
420985|NCT01347944|Monitoring Revlimid|monitoring revlimid
420986|NCT01347944|Myelodysplastic Syndrome|myelodysplastic syndrome
420987|NCT01347944|Transfusion-dependent anemia|transfusion-dependent anemia
420988|NCT01347944|5q deletion|5q deletion
420989|NCT01347944|lenalidomide|lenalidomide
420990|NCT01347918|Fluorine MRI, small intestinal transit and motor activity|fluorine mri, small intestinal transit and motor activity
420991|NCT01347892|Talar injury|talar injury
420992|NCT01347892|ankle|ankle
420993|NCT01347892|lesion|lesion
420994|NCT01347892|defect|defect
420995|NCT01347892|cartilage repair|cartilage repair
420996|NCT01347879|Acne vulgaris|acne vulgaris
420997|NCT01347879|PDT|pdt
420998|NCT01347866|Advanced metastatic cancer (solid tumors)|advanced metastatic cancer (solid tumors)
420999|NCT01347866|PI3K|pi3k
421000|NCT01347866|mTOR|mtor
421001|NCT01347866|MEK|mek
421002|NCT01347840|Obesity Gastric Bypass Roux en Y|obesity gastric bypass roux en y
421003|NCT01347827|Coronary artery bypass surgery|coronary artery bypass surgery
421004|NCT01347827|Oximetry|oximetry
421005|NCT01347827|Brain metabolism|brain metabolism
421006|NCT01347814|Domperidone|domperidone
421007|NCT01347814|gastric emptying|gastric emptying
421008|NCT01347814|obesity|obesity
421009|NCT01347814|diabetes mellitus|diabetes mellitus
421010|NCT01347814|Domperidone/pharmacology|domperidone/pharmacology
421011|NCT01347814|Pharmacologic Actions|pharmacologic actions
421012|NCT01347814|Physiological Effects of Drugs|physiological effects of drugs
421013|NCT01347814|Gastrointestinal Agents|gastrointestinal agents
421014|NCT01347814|Humans|humans
421015|NCT01347801|GLP-1|glp-1
421016|NCT01347801|Inflammation|inflammation
421017|NCT01347801|Glucose|glucose
421018|NCT01347788|Prostate cancer|prostate cancer
421019|NCT01347788|Castration Resistant|castration resistant
421020|NCT01347788|Bone Metastases|bone metastases
421021|NCT01347775|Renal failure|renal failure
421022|NCT01347775|Respiratory muscles|respiratory muscles
421023|NCT01347775|Resistance training|resistance training
421024|NCT01347762|cannabis dependence|cannabis dependence
421025|NCT01347762|marijuana dependence|marijuana dependence
421026|NCT01347762|cannabis use disorders|cannabis use disorders
421027|NCT01347762|cannabis withdrawal|cannabis withdrawal
421028|NCT01347762|nabilone|nabilone
421029|NCT01347749|Meditation|meditation
421030|NCT01347749|Mindfulness|mindfulness
421031|NCT01347749|Compassion|compassion
421032|NCT01347749|Group Psychotherapy|group psychotherapy
421033|NCT01347749|Emotional Regulation|emotional regulation
421034|NCT01347749|fMRI|fmri
421035|NCT01347710|Coronary Artery Disease.|coronary artery disease.
421036|NCT01347710|Positron Emission Tomography Myocardial Perfusion Imaging.|positron emission tomography myocardial perfusion imaging.
421037|NCT01347710|Single Positron Emission Computed Tomography.|single positron emission computed tomography.
421038|NCT01347710|Flurpiridaz F18 Injection.|flurpiridaz f18 injection.
421039|NCT01347697|rectal neoplasms|rectal neoplasms
421040|NCT01347697|reconstructive surgical procedure|reconstructive surgical procedure
421041|NCT01347697|bioprosthesis|bioprosthesis
421042|NCT01347697|surgical flaps|surgical flaps
421043|NCT01347697|locomotion|locomotion
421044|NCT01347697|lesser pelvis|lesser pelvis
421045|NCT01347684|headache|headache
421047|NCT01347684|splints|splints
421048|NCT01347684|physical therapy|physical therapy
421049|NCT01347684|behavioral therapy|behavioral therapy
421050|NCT01347671|analgesia|analgesia
421051|NCT01347671|analgesics|analgesics
421052|NCT01347671|pain|pain
421053|NCT01347671|chronic pain|chronic pain
421054|NCT01347671|neuropathic pain|neuropathic pain
421055|NCT01347658|etravirine|etravirine
421056|NCT01347658|Echinacea purpurea|echinacea purpurea
421057|NCT01347658|interaction|interaction
421058|NCT01347645|locally advanced|locally advanced
421059|NCT01347645|metastatic colon|metastatic colon
421060|NCT01347645|rectal cancer|rectal cancer
421061|NCT01347632|Bacterial Vaginosis|bacterial vaginosis
421062|NCT01347632|Vaginal discharge|vaginal discharge
421063|NCT01347632|Vaginal infections|vaginal infections
421064|NCT01347619|Comparative Effectiveness Research Summary Guide (CERSG)|comparative effectiveness research summary guide (cersg)
421065|NCT01347619|anti-psychotic use|anti-psychotic use
421066|NCT01347619|Nursing Home|nursing home
421067|NCT01347619|Long-term care|long-term care
421068|NCT01347619|Qualitative assessment of influences on CERSG adoption in NH|qualitative assessment of influences on cersg adoption in nh
421069|NCT01347619|Development of toolkit of CERSG-based products for NHs|development of toolkit of cersg-based products for nhs
421070|NCT01347619|Evaluation of 3 implementation strategies of the toolkit|evaluation of 3 implementation strategies of the toolkit
421071|NCT01347606|thyroid|thyroid
421072|NCT01347606|secure|secure
421073|NCT01347606|surgery|surgery
421074|NCT01347606|methylene|methylene
421075|NCT01347606|blue|blue
421076|NCT01347593|ceftizoxime|ceftizoxime
421077|NCT01347593|Cesarean|cesarean
421078|NCT01347593|post caesarean febrile morbidity|post caesarean febrile morbidity
421079|NCT01347580|Heart attack|heart attack
421080|NCT01347580|heart disease|heart disease
421081|NCT01347580|cardiovascular disease|cardiovascular disease
421082|NCT01347580|stroke|stroke
421083|NCT01347580|reperfusion|reperfusion
421084|NCT01347580|pre hospital settings|pre hospital settings
421085|NCT01347580|ticagrelor|ticagrelor
421086|NCT01347580|Percutaneous Coronary Intervention|percutaneous coronary intervention
421087|NCT01347567|Fingerstick BNP test|fingerstick bnp test
421088|NCT01347567|Home Health Management System|home health management system
421089|NCT01347567|Acute Decompensated Heart Failure|acute decompensated heart failure
421090|NCT01347567|Hospital Readmission|hospital readmission
421091|NCT01347567|Prevention|prevention
421092|NCT01347554|drug-eluting stent|drug-eluting stent
421093|NCT01347554|everolimus|everolimus
421094|NCT01347554|zotarolimus|zotarolimus
421095|NCT01347554|myocardial ischemia|myocardial ischemia
421096|NCT01347554|cardiovascular diseases|cardiovascular diseases
421097|NCT01347554|MACE|mace
421098|NCT01347554|safety|safety
421099|NCT01347541|PTSD|ptsd
421100|NCT01347528|Medication adherence|medication adherence
421101|NCT01347528|Heart failure|heart failure
421102|NCT01347528|Telemonitoring|telemonitoring
421103|NCT01347528|Determinants of adherence|determinants of adherence
421104|NCT01347515|Phenol-enriched olive oil|phenol-enriched olive oil
421105|NCT01347515|bioavailability|bioavailability
421106|NCT01347515|bioactivity|bioactivity
421107|NCT01347489|gender|gender
421108|NCT01347476|prostate-specific antigen|prostate-specific antigen
421109|NCT01347476|radical prostatectomy|radical prostatectomy
421110|NCT01347450|Flavonoids|flavonoids
421111|NCT01347450|cacao|cacao
421112|NCT01347450|lipid peroxidation|lipid peroxidation
421113|NCT01347450|plasma|plasma
421114|NCT01347437|HIV|hiv
421115|NCT01347437|antiretroviral medication|antiretroviral medication
421116|NCT01347437|adherence|adherence
421117|NCT01347437|adolescent|adolescent
421118|NCT01347424|NSCLC|nsclc
421119|NCT01347424|NPC|npc
421120|NCT01347398|Sleep apnoea|sleep apnoea
421121|NCT01347398|Diagnosis|diagnosis
421122|NCT01347398|Blood pressure|blood pressure
421123|NCT01347398|Body mass index|body mass index
421124|NCT01347398|Breath analysis|breath analysis
421125|NCT01347385|Fibroids|fibroids
421126|NCT01347385|Laparoscopic myomectomy|laparoscopic myomectomy
421127|NCT01347385|Barbed suture|barbed suture
421128|NCT01347372|peer support|peer support
421129|NCT01347372|peer mentoring|peer mentoring
421130|NCT01347372|peer counselling|peer counselling
421131|NCT01347372|arthritis|arthritis
421132|NCT01347372|chronic disease|chronic disease
421133|NCT01347372|inflammatory arthritis|inflammatory arthritis
421134|NCT01347372|early inflammatory arthritis|early inflammatory arthritis
421135|NCT01347372|rheumatoid arthritis|rheumatoid arthritis
421136|NCT01347359|Peer support|peer support
421137|NCT01347359|Peer mentoring|peer mentoring
421138|NCT01347359|Peer counselling|peer counselling
421139|NCT01347359|Arthritis|arthritis
421140|NCT01347359|Inflammatory arthritis|inflammatory arthritis
421141|NCT01347359|Early inflammatory arthritis|early inflammatory arthritis
421142|NCT01347359|Rheumatoid arthritis|rheumatoid arthritis
421143|NCT01347359|Chronic disease|chronic disease
421144|NCT01347346|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
421145|NCT01347346|Primary immune deficiency|primary immune deficiency
421146|NCT01347346|ex vivo gene therapy|ex vivo gene therapy
421147|NCT01347346|hematopoietic stem cells|hematopoietic stem cells
421148|NCT01347333|liver metastases|liver metastases
421149|NCT01347333|stereotactic radiotherapy|stereotactic radiotherapy
421150|NCT01347320|Prostate cancer|prostate cancer
421151|NCT01347320|preoperative staging|preoperative staging
421152|NCT01347320|MRI|mri
421153|NCT01347320|Free surgical margins|free surgical margins
421154|NCT01347307|stereotactic radiotherapy|stereotactic radiotherapy
421155|NCT01347307|spinal metastases|spinal metastases
421156|NCT01347307|vertebral metastases|vertebral metastases
421157|NCT01347307|benign spinal tumors|benign spinal tumors
421158|NCT01347281|Cancer of the Head and Neck|cancer of the head and neck
421159|NCT01347281|[18F]HX4|[18f]hx4
421160|NCT01347281|hypoxia|hypoxia
421161|NCT01347281|PET|pet
421162|NCT01347281|phase II trial|phase ii trial
421163|NCT01347268|coasting|coasting
421164|NCT01347268|withdrawing GnRH agonist|withdrawing gnrh agonist
421165|NCT01347268|GnRH antagonist|gnrh antagonist
421166|NCT01347268|IVF|ivf
421167|NCT01347242|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
421168|NCT01347242|Primary immune deficiency|primary immune deficiency
421169|NCT01347242|ex vivo gene therapy|ex vivo gene therapy
421170|NCT01347242|hematopoietic stem cells|hematopoietic stem cells
421171|NCT01347229|Glaucoma|glaucoma
421172|NCT01347229|Triggerfish|triggerfish
421173|NCT01347229|body position|body position
421174|NCT01347216|Drug treatment|drug treatment
421175|NCT01347216|Treatment pathways|treatment pathways
421176|NCT01347216|Clinical routine|clinical routine
421177|NCT01347216|Registry|registry
421178|NCT01347216|Treatment outcomes|treatment outcomes
421179|NCT01347216|Endothelin receptor antagonist|endothelin receptor antagonist
421180|NCT01347216|Phosphodiesterase-V inhibitor|phosphodiesterase-v inhibitor
421181|NCT01347216|Prostanoid|prostanoid
421182|NCT01347216|Sildenafil|sildenafil
421183|NCT01347216|Bosentan|bosentan
421184|NCT01347216|Macitentan|macitentan
421185|NCT01347216|Sitaxentan|sitaxentan
421186|NCT01347216|Ambrisentan|ambrisentan
421187|NCT01347216|Imatinib|imatinib
421188|NCT01347216|Epoprostenol|epoprostenol
421189|NCT01347216|Treprostinil|treprostinil
421190|NCT01347216|Iloprost|iloprost
421191|NCT01347216|Infusion pump|infusion pump
421192|NCT01347216|Riociguat|riociguat
421193|NCT01347216|soluble guanylate cyclase stimulator|soluble guanylate cyclase stimulator
421194|NCT01347216|Quality of life|quality of life
421195|NCT01347216|Patient-related outcomes|patient-related outcomes
421196|NCT01347216|Economic model|economic model
421197|NCT01347216|Adverse event|adverse event
421198|NCT01347216|Safety|safety
421199|NCT01347216|Combination therapy|combination therapy
421200|NCT01347216|Internet|internet
421201|NCT01347216|Europe|europe
421202|NCT01347216|Australia|australia
421203|NCT01347216|Japan|japan
421204|NCT01347216|Eisenmenger|eisenmenger
421205|NCT01347216|Adults|adults
421206|NCT01347216|Children|children
421207|NCT01347216|Selexipag|selexipag
421208|NCT01347203|phase I|phase i
421209|NCT01347203|healthy volunteers|healthy volunteers
421210|NCT01347203|crossover study|crossover study
421211|NCT01347203|pharmacokinetics|pharmacokinetics
421212|NCT01347203|pharmacodynamics|pharmacodynamics
421213|NCT01347190|Cystic Fibrosis|cystic fibrosis
421214|NCT01347164|bisexual|bisexual
421215|NCT01347164|HIV prevention|hiv prevention
421216|NCT01347151|Glide scope|glide scope
421217|NCT01347151|Pentax|pentax
421218|NCT01347151|C spine movement|c spine movement
421219|NCT01347138|Screening|screening
421220|NCT01347138|depression|depression
421221|NCT01347138|case management|case management
421222|NCT01347125|DHF (diastolic heart failure)|dhf (diastolic heart failure)
421223|NCT01347125|HFNEF (heart failure with normal ejection fraction|hfnef (heart failure with normal ejection fraction
421224|NCT01347112|smoking|smoking
421225|NCT01347112|tobacco dependence|tobacco dependence
421226|NCT01347112|alcohol dependence|alcohol dependence
421227|NCT01347099|CBT|cbt
421228|NCT01347099|OCD|ocd
421229|NCT01347099|Internet|internet
421230|NCT01347099|Reduce symptom burden|reduce symptom burden
421231|NCT01347073|Urea Cycle Disorder|urea cycle disorder
421232|NCT01347073|UCD|ucd
421233|NCT01347073|GT4P|gt4p
421234|NCT01347073|Buphenyl|buphenyl
421235|NCT01347073|hyperammonemia|hyperammonemia
421236|NCT01347073|sodium phenylbutyrate|sodium phenylbutyrate
421237|NCT01347060|Asthma|asthma
421238|NCT01347060|treatment|treatment
421239|NCT01347060|Advair and inhaled corticosteroids|advair and inhaled corticosteroids
421240|NCT01347060|Medicare|medicare
421241|NCT01347060|Outcomes|outcomes
421242|NCT01347060|costs|costs
421243|NCT01347047|Amyloidosis|amyloidosis
421244|NCT01347047|Known or Suspected|known or suspected
421245|NCT01347034|radiation|radiation
421246|NCT01347034|neoadjuvant|neoadjuvant
421247|NCT01347034|intratumoral|intratumoral
421248|NCT01347034|autologous|autologous
421249|NCT01347034|dendritic cells|dendritic cells
421250|NCT01347021|vaginal colpopexy sacrospinous|vaginal colpopexy sacrospinous
421251|NCT01347021|vaginal colpopexy uterosacral|vaginal colpopexy uterosacral
421252|NCT01347008|Sildenafil|sildenafil
421253|NCT01347008|Endothelial Progenitor Cells|endothelial progenitor cells
421254|NCT01347008|Laser Doppler Imaging|laser doppler imaging
421255|NCT01346982|Darunavir|darunavir
421256|NCT01346982|Silimarine|silimarine
421257|NCT01346982|interaction|interaction
421258|NCT01346969|Skin scarring|skin scarring
421259|NCT01346969|cicatrix|cicatrix
421260|NCT01346969|breast scar|breast scar
421261|NCT01346956|Cigarette|cigarette
421262|NCT01346956|Smoking|smoking
421263|NCT01346956|Cardiovascular Effects|cardiovascular effects
421264|NCT01346956|2D Echocardiography|2d echocardiography
421265|NCT01346956|Doppler|doppler
421266|NCT01346943|Abdominal Aortic Aneurysms, AAA|abdominal aortic aneurysms, aaa
421267|NCT01346930|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
421268|NCT01346930|IPF|ipf
421269|NCT01346930|pulmonary fibrosis|pulmonary fibrosis
421270|NCT01346917|Colorectal cancer|colorectal cancer
421271|NCT01346917|Laparoscopic surgery|laparoscopic surgery
421272|NCT01346917|Postoperative ileus|postoperative ileus
421273|NCT01346917|Lidocaine|lidocaine
421274|NCT01346917|Early oral feeding|early oral feeding
421275|NCT01346878|Ultra deep sequencing|ultra deep sequencing
421276|NCT01346878|Virological failure|virological failure
421277|NCT01346878|Salvage antiretroviral therapy|salvage antiretroviral therapy
421278|NCT01346865|triple anti-platelet therapy|triple anti-platelet therapy
421279|NCT01346865|dual antiplatelet therapy|dual antiplatelet therapy
421280|NCT01346865|DES|des
421281|NCT01346865|Coronary Artery Disease|coronary artery disease
421282|NCT01346852|pediatrics|pediatrics
421283|NCT01346852|Medicaid|medicaid
421284|NCT01346852|asthma|asthma
421285|NCT01346852|outcomes|outcomes
421286|NCT01346852|asthma medication ratio|asthma medication ratio
421287|NCT01346839|Diagnostic delay|diagnostic delay
421288|NCT01346839|Prevention|prevention
421289|NCT01346839|Diagnostic errors|diagnostic errors
421290|NCT01346826|Crohn's disease|crohn's disease
421291|NCT01346826|Ulcerative colitis|ulcerative colitis
421292|NCT01346826|Infliximab|infliximab
421293|NCT01346826|Infusion reaction|infusion reaction
421294|NCT01346813|Newborns|newborns
421295|NCT01346813|Premature|premature
421296|NCT01346813|Pain|pain
421297|NCT01346813|Pain assessment|pain assessment
421298|NCT01346813|Painful Procedures|painful procedures
421299|NCT01346813|Stressful Procedures|stressful procedures
421300|NCT01346813|Endotracheal Intubation|endotracheal intubation
421301|NCT01346813|Analgesia|analgesia
421302|NCT01346813|Sedation|sedation
421303|NCT01346813|Longterm effects of pain|longterm effects of pain
421304|NCT01346813|Epidemiology|epidemiology
421305|NCT01346787|carfilzomib|carfilzomib
421306|NCT01346787|dexamethasone|dexamethasone
421307|NCT01346787|cyclophosphamide|cyclophosphamide
421308|NCT01346787|multiple myeloma|multiple myeloma
421309|NCT01346787|newly diagnosed|newly diagnosed
421310|NCT01346774|cystitis|cystitis
421311|NCT01346774|pyelonephritis|pyelonephritis
421312|NCT01346774|bladder infection|bladder infection
421313|NCT01346774|kidney infection|kidney infection
421314|NCT01346761|Genetic Counseling|genetic counseling
421315|NCT01346761|Genetic Counseling Interventions|genetic counseling interventions
421316|NCT01346761|Genetic Testing|genetic testing
421317|NCT01346761|BRCA1 gene|brca1 gene
421318|NCT01346761|BRCA2 gene|brca2 gene
421319|NCT01346761|Risk Communication|risk communication
421320|NCT01346748|vasospasm prevention|vasospasm prevention
421321|NCT01346735|Ventilator associated pneumonia|ventilator associated pneumonia
421322|NCT01346735|Catheter related blood stream infection|catheter related blood stream infection
421323|NCT01346735|Catheter associated urinary tract infection|catheter associated urinary tract infection
421324|NCT01346735|ICU-related infections (VAP, CAUTI and CRBSI)|icu-related infections (vap, cauti and crbsi)
421325|NCT01346735|India|india
421326|NCT01346709|Operative surgical procedures|operative surgical procedures
421327|NCT01346709|Postoperative pulmonary complications (PPC)|postoperative pulmonary complications (ppc)
421328|NCT01346709|Epidemiological Study|epidemiological study
421329|NCT01346709|ARISCAT score|ariscat score
421330|NCT01346709|Risk Score|risk score
421331|NCT01346709|Europe|europe
421332|NCT01346709|PERISCOPE|periscope
421333|NCT01346709|observational study|observational study
421334|NCT01346709|Mild respiratory failure|mild respiratory failure
421335|NCT01346709|Severe respiratory failure|severe respiratory failure
421336|NCT01346709|acute lung injury (ALI)|acute lung injury (ali)
421337|NCT01346709|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
421338|NCT01346709|Suspected pulmonary infection|suspected pulmonary infection
421339|NCT01346709|Pulmonary infiltrate|pulmonary infiltrate
421340|NCT01346709|Pleural effusion|pleural effusion
421341|NCT01346709|Atelectasis|atelectasis
421342|NCT01346709|Pneumothorax|pneumothorax
421343|NCT01346709|Bronchospasm|bronchospasm
421344|NCT01346709|Aspiration Pneumonitis|aspiration pneumonitis
421345|NCT01346709|Cardiopulmonary edema|cardiopulmonary edema
421346|NCT01346709|Prospective Evaluation|prospective evaluation
421531|NCT01345825|gait analysis|gait analysis
421347|NCT01346709|nonobstetric in-hospital surgical procedure|nonobstetric in-hospital surgical procedure
421348|NCT01346709|general or regional anaesthesia|general or regional anaesthesia
421349|NCT01346709|continued 7-day period recruitment|continued 7-day period recruitment
421350|NCT01346670|Red yeast rice|red yeast rice
421351|NCT01346670|Lovastatin|lovastatin
421352|NCT01346670|Bioavailability|bioavailability
421353|NCT01346657|Nifidipine|nifidipine
421354|NCT01346657|red yeast rice|red yeast rice
421355|NCT01346657|drug-drug interaction|drug-drug interaction
421356|NCT01346644|Probiotic|probiotic
421357|NCT01346644|infant nutrition|infant nutrition
421358|NCT01346644|safety|safety
421359|NCT01346644|infections|infections
421360|NCT01346618|bone age|bone age
421361|NCT01346618|children|children
421362|NCT01346618|x-ray|x-ray
421363|NCT01346618|ultrasound|ultrasound
421364|NCT01346618|ultrasound based method|ultrasound based method
421365|NCT01346618|safe|safe
421366|NCT01346618|valid|valid
421367|NCT01346618|reproducable|reproducable
421368|NCT01346605|Cardiac CT, heart disease|cardiac ct, heart disease
421369|NCT01346592|Adjuvanted Trivalent Subunit Influenza Vaccine|adjuvanted trivalent subunit influenza vaccine
421370|NCT01346592|vaccine|vaccine
421371|NCT01346592|influenza|influenza
421372|NCT01346592|adjuvant|adjuvant
421373|NCT01346592|MF-59|mf-59
421374|NCT01346592|pediatric|pediatric
421375|NCT01346579|stage IA breast cancer|stage ia breast cancer
421376|NCT01346579|stage IB breast cancer|stage ib breast cancer
421377|NCT01346579|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
421378|NCT01346566|Cionni Ring|cionni ring
421379|NCT01346566|In-the-bag IOL|in-the-bag iol
421380|NCT01346566|Subluxated lenses|subluxated lenses
421381|NCT01346566|Intraoperative Performance|intraoperative performance
421382|NCT01346566|Postoperative Outcome|postoperative outcome
421383|NCT01346553|Chronic Venous Insufficiency (CVI)|chronic venous insufficiency (cvi)
421384|NCT01346527|diabetes|diabetes
421385|NCT01346527|pregnancy|pregnancy
421386|NCT01346527|left ventricular dysfunction|left ventricular dysfunction
421387|NCT01346527|neonatal|neonatal
421388|NCT01346527|lipid|lipid
421389|NCT01346527|lipotoxicity|lipotoxicity
421390|NCT01346527|neurodevelopment|neurodevelopment
421391|NCT01346514|Homeless Persons|homeless persons
421392|NCT01346514|Housing|housing
421393|NCT01346514|Case Management|case management
421394|NCT01346514|Veterans|veterans
421395|NCT01346514|Substance Related Disorders|substance related disorders
421396|NCT01346514|Mental Disorders|mental disorders
421397|NCT01346514|Social Adjustment|social adjustment
421398|NCT01346501|Rheumatoid arthritis|rheumatoid arthritis
421399|NCT01346488|Rheumatoid arthritis|rheumatoid arthritis
421400|NCT01346449|Obesity|obesity
421401|NCT01346423|Sick leave|sick leave
421402|NCT01346423|musculoskeletal pain|musculoskeletal pain
421403|NCT01346423|return to work|return to work
421404|NCT01346423|multidisciplinary intervention|multidisciplinary intervention
421405|NCT01346423|randomised controlled trial|randomised controlled trial
421406|NCT01346410|pancreatic cancer|pancreatic cancer
421407|NCT01346397|rejection|rejection
421408|NCT01346397|survival|survival
421409|NCT01346397|alemtuzumab|alemtuzumab
421410|NCT01346397|cyclosporine|cyclosporine
421411|NCT01346397|tacrolimus|tacrolimus
421412|NCT01346384|intracuff pressure|intracuff pressure
421413|NCT01346384|laryngeal tube|laryngeal tube
421414|NCT01346384|nitrous oxide|nitrous oxide
421415|NCT01346371|Allergic|allergic
421416|NCT01346371|conjunctivitis|conjunctivitis
421417|NCT01346371|Allergic conjunctivitis|allergic conjunctivitis
421418|NCT01346358|Advanced Solid Tumors|advanced solid tumors
421419|NCT01346345|Recession|recession
421420|NCT01346319|dose escalating|dose escalating
421421|NCT01346293|Tetanus|tetanus
421422|NCT01346293|Diphtheria|diphtheria
421423|NCT01346293|Pertussis|pertussis
421424|NCT01346293|DTap-IPV|dtap-ipv
421425|NCT01346293|DAPTACEL®|daptacel®
421426|NCT01346293|VARIVAX®|varivax®
421427|NCT01346280|Adherence to Evidence-Based Guidelines|adherence to evidence-based guidelines
421428|NCT01346280|Multidisciplinary Care|multidisciplinary care
421429|NCT01346280|Patient Experiences|patient experiences
421430|NCT01346280|Quality of Care Outcomes|quality of care outcomes
421431|NCT01346267|nausea and vomiting|nausea and vomiting
421432|NCT01346267|unspecified childhood solid tumor|unspecified childhood solid tumor
421433|NCT01346267|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
421434|NCT01346267|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
421435|NCT01346267|childhood central nervous system germinoma|childhood central nervous system germinoma
421436|NCT01346267|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
421437|NCT01346267|childhood central nervous system teratoma|childhood central nervous system teratoma
421438|NCT01346267|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
421439|NCT01346267|childhood mixed glioma|childhood mixed glioma
421440|NCT01346267|childhood oligodendroglioma|childhood oligodendroglioma
421441|NCT01346267|untreated childhood brain stem glioma|untreated childhood brain stem glioma
421442|NCT01346267|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
421443|NCT01346267|untreated childhood visual pathway glioma|untreated childhood visual pathway glioma
421444|NCT01346267|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
421445|NCT01346267|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
421446|NCT01346267|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
421447|NCT01346267|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
421448|NCT01346267|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
421449|NCT01346267|untreated childhood cerebral astrocytoma|untreated childhood cerebral astrocytoma
421450|NCT01346267|untreated childhood subependymal giant cell astrocytoma|untreated childhood subependymal giant cell astrocytoma
421451|NCT01346267|childhood ependymoblastoma|childhood ependymoblastoma
421452|NCT01346267|untreated childhood medulloblastoma|untreated childhood medulloblastoma
421453|NCT01346267|untreated childhood pineoblastoma|untreated childhood pineoblastoma
421454|NCT01346267|childhood choroid plexus tumor|childhood choroid plexus tumor
421455|NCT01346267|childhood craniopharyngioma|childhood craniopharyngioma
421456|NCT01346267|childhood supratentorial ependymoma|childhood supratentorial ependymoma
421457|NCT01346267|childhood supratentorial primitive neuroectodermal tumor|childhood supratentorial primitive neuroectodermal tumor
421458|NCT01346267|childhood medulloepithelioma|childhood medulloepithelioma
421459|NCT01346267|childhood infratentorial ependymoma|childhood infratentorial ependymoma
421460|NCT01346267|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
421461|NCT01346267|childhood meningioma|childhood meningioma
421462|NCT01346254|after|after
421463|NCT01346241|Panic|panic
421464|NCT01346241|Anxiety|anxiety
421465|NCT01346228|Panic|panic
421466|NCT01346228|Panic Disorder|panic disorder
421467|NCT01346228|Anxiety|anxiety
421468|NCT01346215|heparin|heparin
421469|NCT01346215|renal insufficiency, chronic|renal insufficiency, chronic
421470|NCT01346215|extracorporeal dialysis|extracorporeal dialysis
421471|NCT01346215|fibrinolytic agents|fibrinolytic agents
421472|NCT01346215|anticoagulants|anticoagulants
421473|NCT01346215|aPTT|aptt
421474|NCT01346202|multi-modal pain therapy, chronic pain|multi-modal pain therapy, chronic pain
421475|NCT01346189|Cardiovascular Disease|cardiovascular disease
421476|NCT01346163|Schizophrenia|schizophrenia
421477|NCT01346163|Cognitive Impairment|cognitive impairment
421478|NCT01346163|Electrophysiology|electrophysiology
421479|NCT01346163|H3 receptor antagonist|h3 receptor antagonist
421480|NCT01346137|ovulation|ovulation
421481|NCT01346137|unruptured luteinized follicle|unruptured luteinized follicle
421482|NCT01346137|meloxicam|meloxicam
421483|NCT01346124|radiation|radiation
421484|NCT01346124|IMRT|imrt
421485|NCT01346124|IMPT|impt
421486|NCT01346098|diabetes|diabetes
421487|NCT01346098|islet transplantation|islet transplantation
421488|NCT01346098|pancreas|pancreas
421489|NCT01346098|pancreatectomy|pancreatectomy
421490|NCT01346085|islet transplantation|islet transplantation
421491|NCT01346085|brittle diabetes|brittle diabetes
421492|NCT01346085|type 1 diabetes|type 1 diabetes
421493|NCT01346072|tolvaptan|tolvaptan
421494|NCT01346072|copeptin|copeptin
421495|NCT01346072|heart failure|heart failure
421496|NCT01346072|vasopressin antagonist|vasopressin antagonist
421497|NCT01346059|Clostridium|clostridium
421498|NCT01346059|Colitis|colitis
421499|NCT01346059|Intracolonic vancomycin|intracolonic vancomycin
421500|NCT01346059|psuedomembranous colitis|psuedomembranous colitis
421501|NCT01346046|Type 2 Diabetes|type 2 diabetes
421502|NCT01346046|Adults 18 years and older|adults 18 years and older
421503|NCT01346046|Taking Control of Your Diabetes Health Fair|taking control of your diabetes health fair
421504|NCT01346033|Type 2 Diabetes|type 2 diabetes
421505|NCT01346033|Adults 18 years and older|adults 18 years and older
421506|NCT01346033|Taking Control of Your Diabetes Health Fair|taking control of your diabetes health fair
421507|NCT01345968|anemia|anemia
421508|NCT01345968|transfusion|transfusion
421509|NCT01345968|intravenous ferric carboxymaltose|intravenous ferric carboxymaltose
421510|NCT01345929|cUTI|cuti
421511|NCT01345890|swallowing|swallowing
421512|NCT01345890|stroke|stroke
421513|NCT01345890|aspiration|aspiration
421514|NCT01345890|human|human
421515|NCT01345890|electrical stimulation|electrical stimulation
421516|NCT01345890|post stroke dysphagia|post stroke dysphagia
421517|NCT01345877|burn injury|burn injury
421518|NCT01345877|cold pressor test|cold pressor test
421519|NCT01345877|gender|gender
421520|NCT01345877|pain|pain
421521|NCT01345877|pain sensitivity|pain sensitivity
421522|NCT01345877|pain prediction|pain prediction
421523|NCT01345877|psychometrics|psychometrics
421524|NCT01345877|quantitative sensory testing|quantitative sensory testing
421525|NCT01345864|attention cognition memory problem solving scopolamine challenge|attention cognition memory problem solving scopolamine challenge
421526|NCT01345825|osteoarthrosis|osteoarthrosis
421527|NCT01345825|unicompartmental knee replacement|unicompartmental knee replacement
421528|NCT01345825|knee|knee
421529|NCT01345825|resistance training|resistance training
421530|NCT01345825|Muscle power|muscle power
421532|NCT01345825|gait|gait
421533|NCT01345825|physiotherapy|physiotherapy
421534|NCT01345825|Gyro sensor|gyro sensor
421535|NCT01345812|ART|art
421536|NCT01345812|IVF|ivf
421537|NCT01345812|Timelapse|timelapse
421538|NCT01345799|Crohn's Disease Activity Index|crohn's disease activity index
421539|NCT01345799|Crohn's Disease|crohn's disease
421540|NCT01345799|Inflammatory Bowel Disease|inflammatory bowel disease
421541|NCT01345760|Basal Cell Carcinoma|basal cell carcinoma
421542|NCT01345760|Squamous Cell Carcinoma|squamous cell carcinoma
421543|NCT01345760|Actinic Keratosis|actinic keratosis
421544|NCT01345760|microRNA|microrna
421545|NCT01345760|Dicer|dicer
421546|NCT01345760|Drosha|drosha
421547|NCT01345760|RISC|risc
421548|NCT01345760|microprocessor complex|microprocessor complex
421549|NCT01345760|Argonaute|argonaute
421550|NCT01345760|DGCR8|dgcr8
421551|NCT01345760|TARBP|tarbp
421552|NCT01345747|laryngeal tube suction|laryngeal tube suction
421553|NCT01345747|gynecology|gynecology
421554|NCT01345747|laparoscopic surgery|laparoscopic surgery
421555|NCT01345721|Meningococcal|meningococcal
421556|NCT01345721|ACWY|acwy
421557|NCT01345721|Conjugate Vaccine|conjugate vaccine
421558|NCT01345721|Meningitis|meningitis
421559|NCT01345721|Toddlers|toddlers
421560|NCT01345721|Children|children
421561|NCT01345721|Persistence|persistence
421562|NCT01345721|Boost|boost
421563|NCT01345708|Low dose rituximab|low dose rituximab
421564|NCT01345708|WAIHA|waiha
421565|NCT01345708|CHD|chd
421566|NCT01345695|Childhood diarrhea|childhood diarrhea
421567|NCT01345695|childhood pneumonia|childhood pneumonia
421568|NCT01345695|telemedicine|telemedicine
421569|NCT01345695|cluster|cluster
421570|NCT01345695|treatment-control trial|treatment-control trial
421571|NCT01345656|Chronic Heart Failure|chronic heart failure
421572|NCT01345643|Transfusion|transfusion
421573|NCT01345643|Hemoglobin level|hemoglobin level
421574|NCT01345630|Double-blind|double-blind
421575|NCT01345630|comparative|comparative
421576|NCT01345630|trial|trial
421577|NCT01345630|maraviroc|maraviroc
421578|NCT01345630|versus|versus
421579|NCT01345630|emtricitabine/tenofovir|emtricitabine/tenofovir
421580|NCT01345630|both with darunavir/ritonavir|both with darunavir/ritonavir
421581|NCT01345630|antiretroviral-naive|antiretroviral-naive
421582|NCT01345630|Ccr5 tropic|ccr5 tropic
421583|NCT01345630|Hiv 1|hiv 1
421584|NCT01345630|patients.|patients.
421585|NCT01345591|BTI|bti
421586|NCT01345591|Craniomaxillofacial (CMF) Battle-injured (BI)|craniomaxillofacial (cmf) battle-injured (bi)
421587|NCT01345591|Facial Trauma|facial trauma
421588|NCT01345591|Fat Grafts|fat grafts
421589|NCT01345591|Autogenous Fat Transfers (AFT)|autogenous fat transfers (aft)
421590|NCT01345591|Wounded warriors|wounded warriors
421591|NCT01345578|Urea Cycle Disorders|urea cycle disorders
421592|NCT01345578|Carbamoyl-Phosphate Synthase I Deficiency Disease|carbamoyl-phosphate synthase i deficiency disease
421593|NCT01345578|Citrullinemia|citrullinemia
421594|NCT01345578|Ornithine Carbamoyltransferase Deficiency Disease|ornithine carbamoyltransferase deficiency disease
421595|NCT01345578|Crigler-Najjar Syndrome|crigler-najjar syndrome
421596|NCT01345565|fulminant hepatic failure|fulminant hepatic failure
421597|NCT01345552|Oligo mets|oligo mets
421598|NCT01345552|Oligometastatic disease|oligometastatic disease
421599|NCT01345539|Oligo mets|oligo mets
421600|NCT01345539|Oligometastatic disease|oligometastatic disease
421601|NCT01345513|Genomic Analysis|genomic analysis
421602|NCT01345513|Sequencing|sequencing
421603|NCT01345513|Genetic|genetic
421604|NCT01345513|Biopsy|biopsy
421605|NCT01345513|Solid tumors|solid tumors
421606|NCT01345500|Overweight|overweight
421607|NCT01345500|Obese|obese
421608|NCT01345500|Type 2 Diabetic|type 2 diabetic
421609|NCT01345500|Diabetes|diabetes
421610|NCT01345500|Weight loss|weight loss
421611|NCT01345500|Physical activity|physical activity
421612|NCT01345500|Diet|diet
421613|NCT01345500|Prepackaged meals|prepackaged meals
421614|NCT01345487|appetite|appetite
421615|NCT01345487|protein|protein
421616|NCT01345487|legumes|legumes
421617|NCT01345487|meat|meat
421618|NCT01345448|Glaucoma|glaucoma
421619|NCT01345448|Brimonidine|brimonidine
421620|NCT01345448|Transdermal|transdermal
421621|NCT01345435|telemonitoring|telemonitoring
421622|NCT01345435|usual care|usual care
421623|NCT01345435|telemedicine|telemedicine
421624|NCT01345435|telehealth|telehealth
421625|NCT01345435|home care|home care
421626|NCT01345435|Health Care Quality|health care quality
421627|NCT01345435|Access|access
421628|NCT01345435|Evaluation|evaluation
421629|NCT01345409|Musculoskeletal pain|musculoskeletal pain
421630|NCT01345409|Chronic pain|chronic pain
421631|NCT01345409|Acupuncture|acupuncture
421632|NCT01345409|Chiropractic|chiropractic
421633|NCT01345396|Asthma|asthma
421634|NCT01345396|Health education|health education
421635|NCT01345396|Pregnancy|pregnancy
421636|NCT01345383|smoking|smoking
421637|NCT01345383|bronchoscopy|bronchoscopy
421638|NCT01345383|cough|cough
421639|NCT01345370|Glioblastoma|glioblastoma
421640|NCT01345357|Solid tumors|solid tumors
421641|NCT01345357|mantle cell lymphoma|mantle cell lymphoma
421642|NCT01345357|Gemcitabine|gemcitabine
421643|NCT01345357|Cisplatin|cisplatin
421644|NCT01345357|Cancer|cancer
421645|NCT01345357|Neoplasms|neoplasms
421646|NCT01345357|Antineoplastic agents|antineoplastic agents
421647|NCT01345318|Crohn's Disease|crohn's disease
421648|NCT01345318|safety|safety
421649|NCT01345318|efficacy|efficacy
421650|NCT01345318|pharmacokinetics|pharmacokinetics
421651|NCT01345318|pharmacodynamics|pharmacodynamics
421652|NCT01345318|Crohn's Disease Activity Index (CDAI)|crohn's disease activity index (cdai)
421653|NCT01345305|Sturge-Weber Syndrome|sturge-weber syndrome
421654|NCT01345305|Biomarkers|biomarkers
421655|NCT01345305|Quantitative EEG|quantitative eeg
421656|NCT01345305|Transcranial Doppler Ultrasound|transcranial doppler ultrasound
421657|NCT01345305|Medical Rehabilitation Scales|medical rehabilitation scales
421658|NCT01345305|Optical Coherence Tomography|optical coherence tomography
421659|NCT01345266|Pharyngometry|pharyngometry
421660|NCT01345266|Novel Dry Powder Inhaler|novel dry powder inhaler
421661|NCT01345266|HRCT|hrct
421662|NCT01345266|Inhalation Profiles|inhalation profiles
421663|NCT01345253|SLEDAI|sledai
421664|NCT01345253|Asia|asia
421665|NCT01345253|placebo|placebo
421666|NCT01345253|BLys|blys
421667|NCT01345253|PGA|pga
421668|NCT01345253|BILAG|bilag
421669|NCT01345253|systemic lupus erythematosus|systemic lupus erythematosus
421670|NCT01345253|SELENA|selena
421671|NCT01345253|Lupus|lupus
421672|NCT01345253|SRI|sri
421673|NCT01345253|efficacy|efficacy
421674|NCT01345253|B cell|b cell
421675|NCT01345253|SLE Flare Index|sle flare index
421676|NCT01345253|belimumab|belimumab
421677|NCT01345253|safety|safety
421678|NCT01345253|phase III|phase iii
421679|NCT01345253|B lymphocyte|b lymphocyte
421680|NCT01345240|Africa|africa
421681|NCT01345240|Plasmodium falciparum|plasmodium falciparum
421682|NCT01345240|Malaria vaccine|malaria vaccine
421683|NCT01345240|hepatitis B|hepatitis b
421684|NCT01345240|EPI|epi
421685|NCT01345227|Type 1 diabetes|type 1 diabetes
421686|NCT01345227|islet transplantation|islet transplantation
421687|NCT01345227|autotransplantation|autotransplantation
421688|NCT01345214|ONO-7746|ono-7746
421689|NCT01345214|Chemotherapy Induced Thrombocytopenia|chemotherapy induced thrombocytopenia
421690|NCT01345214|Thrombocytopenia|thrombocytopenia
421691|NCT01345201|Phase 1|phase 1
421692|NCT01345201|dose escalation|dose escalation
421693|NCT01345201|histologically confirmed|histologically confirmed
421694|NCT01345201|malignancy metastatic|malignancy metastatic
421695|NCT01345175|rectal|rectal
421696|NCT01345175|colon|colon
421697|NCT01345175|PLACEBO|placebo
421698|NCT01345175|RIFAXIMIN|rifaximin
421699|NCT01345175|metronidazole|metronidazole
421700|NCT01345175|11-045|11-045
421701|NCT01345162|Herniotomy|herniotomy
421702|NCT01345149|Obesity|obesity
421703|NCT01345149|Pregnancy|pregnancy
421704|NCT01345149|Intervention|intervention
421705|NCT01345149|Diet|diet
421706|NCT01345149|Physical activity|physical activity
421707|NCT01345136|Neurofibromatosis Type 2|neurofibromatosis type 2
421708|NCT01345136|Vestibular schwannoma|vestibular schwannoma
421709|NCT01345136|Hearing|hearing
421710|NCT01345110|dementia|dementia
421711|NCT01345110|mild cognitive impairment|mild cognitive impairment
421712|NCT01345110|prevalence|prevalence
421713|NCT01345110|incidence|incidence
421714|NCT01345110|elderly|elderly
421715|NCT01345110|longitudinal study|longitudinal study
421716|NCT01345110|population study|population study
421717|NCT01345097|short, metaphyseal-fitting femoral stem|short, metaphyseal-fitting femoral stem
421718|NCT01345097|cementless anatomical femoral stem|cementless anatomical femoral stem
421719|NCT01345097|young patient|young patient
421720|NCT01345097|elderly patient|elderly patient
421721|NCT01345071|Rheumatoid Arthritis|rheumatoid arthritis
421722|NCT01345071|Pregnancy|pregnancy
421723|NCT01345071|Anti-TNF|anti-tnf
421724|NCT01345071|Preconceptional counselling|preconceptional counselling
421725|NCT01345071|Disease activity|disease activity
421726|NCT01345058|Epilepsy|epilepsy
421727|NCT01345058|antiepileptic drug|antiepileptic drug
421728|NCT01345058|polytherapy|polytherapy
421729|NCT01345045|Diabetic Asymmetric Polyneuropathy|diabetic asymmetric polyneuropathy
421730|NCT01345045|Symmetric Diabetic Proximal Motor Neuropathy|symmetric diabetic proximal motor neuropathy
421731|NCT01345045|Diabetic Mononeuropathy Simplex,|diabetic mononeuropathy simplex,
421732|NCT01345045|Diabetic Autonomic Neuropathy,|diabetic autonomic neuropathy,
421733|NCT01345045|Diabetic Amyotrophy|diabetic amyotrophy
421734|NCT01345045|Mononeuropathy|mononeuropathy
421735|NCT01345045|Diabetic Neuropathy|diabetic neuropathy
421736|NCT01345045|Asymmetric Diabetic Proximal Motor Neuropathy|asymmetric diabetic proximal motor neuropathy
421737|NCT01345045|Diabetic Polyneuropathy|diabetic polyneuropathy
421738|NCT01345045|Painful|painful
421739|NCT01345045|Diabetic Mononeuropathy|diabetic mononeuropathy
421740|NCT01345045|Neuralgia|neuralgia
421741|NCT01345019|zoledronic acid|zoledronic acid
421742|NCT01345019|hematologic malignancies|hematologic malignancies
421743|NCT01345019|SRE|sre
421744|NCT01345019|skeletal-related event|skeletal-related event
421745|NCT01345019|blood cancer|blood cancer
421746|NCT01345019|lytic bone lesions|lytic bone lesions
421747|NCT01345019|bone metastases|bone metastases
421748|NCT01345019|myeloma|myeloma
421749|NCT01345019|fractures|fractures
421750|NCT01345019|spinal cord compression|spinal cord compression
421751|NCT01345019|radiation to bone|radiation to bone
421752|NCT01345019|surgery to bone|surgery to bone
421753|NCT01345019|bisphosphonates|bisphosphonates
421754|NCT01345019|Neoplasms, Plasma Cell|neoplasms, plasma cell
421755|NCT01345019|Paraproteinemias|paraproteinemias
421756|NCT01345019|Neoplasms|neoplasms
421757|NCT01345019|Neoplasm Metastasis|neoplasm metastasis
421758|NCT01345019|Bone Neoplasms|bone neoplasms
421759|NCT01345019|Bone Marrow Diseases|bone marrow diseases
421760|NCT01345019|Blood Protein Disorders|blood protein disorders
421761|NCT01345019|Hematologic Diseases|hematologic diseases
421762|NCT01345019|multiple myeloma|multiple myeloma
421763|NCT01345019|denosumab|denosumab
421764|NCT01345019|Neoplastic Processes|neoplastic processes
421765|NCT01345019|Bone Diseases|bone diseases
421766|NCT01345019|Diphosphonates|diphosphonates
421767|NCT01345019|Bone Density Conservation Agents|bone density conservation agents
421768|NCT01345006|juvenile macular dystrophy|juvenile macular dystrophy
421769|NCT01345006|SMD|smd
421770|NCT01345006|fundus flavimaculatus|fundus flavimaculatus
421771|NCT01344993|Dry AMD|dry amd
421772|NCT01344993|Geographic atrophy|geographic atrophy
421773|NCT01344941|Vaccine response|vaccine response
421774|NCT01344941|Human Lymphocytes|human lymphocytes
421775|NCT01344915|Patella|patella
421776|NCT01344915|Knee|knee
421777|NCT01344915|Brace|brace
421778|NCT01344876|multiple myeloma [MM]|multiple myeloma [mm]
421779|NCT01344876|non-Hodgkin lymphoma [NHL]|non-hodgkin lymphoma [nhl]
421780|NCT01344876|acute myeloid leukemia [AML]|acute myeloid leukemia [aml]
421781|NCT01344876|acute lymphoid leukemia [ALL]|acute lymphoid leukemia [all]
421782|NCT01344876|chronic myeloid leukemia [CML]|chronic myeloid leukemia [cml]
421783|NCT01344824|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
421784|NCT01344824|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
421785|NCT01344824|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
421786|NCT01344824|adenocarcinoma of the lung|adenocarcinoma of the lung
421787|NCT01344824|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
421788|NCT01344824|large cell lung cancer|large cell lung cancer
421789|NCT01344811|telemonitoring|telemonitoring
421790|NCT01344811|usual care|usual care
421791|NCT01344811|telehealth|telehealth
421792|NCT01344811|home care|home care
421793|NCT01344811|Health Care Quality|health care quality
421794|NCT01344811|Access|access
421795|NCT01344811|Evaluation|evaluation
421796|NCT01344798|limb girdle muscular dystrophy type 2C|limb girdle muscular dystrophy type 2c
421797|NCT01344798|gamma-sarcoglycanopathy|gamma-sarcoglycanopathy
421798|NCT01344798|gene therapy|gene therapy
421799|NCT01344798|AAV vector|aav vector
421800|NCT01344798|neuromuscular disease|neuromuscular disease
421801|NCT01344798|orphan disease|orphan disease
421802|NCT01344785|Intertrochanteric Fractures|intertrochanteric fractures
421803|NCT01344785|Intramedullary nailing|intramedullary nailing
421804|NCT01344785|Hip function|hip function
421805|NCT01344785|Pain|pain
421806|NCT01344772|femoral neck fracture|femoral neck fracture
421807|NCT01344772|total hip arthroplasty|total hip arthroplasty
421808|NCT01344772|internal fixation|internal fixation
421809|NCT01344759|Obstructive Sleep Apnea|obstructive sleep apnea
421810|NCT01344759|MRI|mri
421811|NCT01344759|Pediatrics|pediatrics
421812|NCT01344759|Dexmedetomidine|dexmedetomidine
421813|NCT01344759|Propofol|propofol
421814|NCT01344759|Anesthesia|anesthesia
421815|NCT01344746|sleep-disordered breathing|sleep-disordered breathing
421816|NCT01344733|Major Depressive Disorder|major depressive disorder
421817|NCT01344733|MDD|mdd
421818|NCT01344720|Low Back Pain|low back pain
421819|NCT01344720|Etoricoxib|etoricoxib
421820|NCT01344720|Oxycodone|oxycodone
421821|NCT01344707|Hematologic Malignancies|hematologic malignancies
421822|NCT01344707|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
421823|NCT01344707|Acute Lymphocytic Leukemia (ALL)|acute lymphocytic leukemia (all)
421824|NCT01344707|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
421825|NCT01344707|Multiple Myeloma (MM)|multiple myeloma (mm)
421826|NCT01344707|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
421827|NCT01344707|Malignant Lymphomas|malignant lymphomas
421828|NCT01344707|Histone Deacetylase (HDAC)|histone deacetylase (hdac)
421829|NCT01344707|4SC-202|4sc-202
421830|NCT01344707|Phase I|phase i
421831|NCT01344694|Epicardial fat|epicardial fat
421832|NCT01344694|Visceral fat|visceral fat
421833|NCT01344694|atherosclerosis|atherosclerosis
421834|NCT01344694|coronary computed tomography angiography|coronary computed tomography angiography
421835|NCT01344694|Carotid Doppler ultrasound|carotid doppler ultrasound
421836|NCT01344668|Diabetes|diabetes
421837|NCT01344642|HIV|hiv
421838|NCT01344642|RNA|rna
421839|NCT01344616|computer-based behavioral support|computer-based behavioral support
421938|NCT01344200|Celecoxib|celecoxib
421840|NCT01344603|cardiac surgery|cardiac surgery
421841|NCT01344603|cardiac anesthesia|cardiac anesthesia
421842|NCT01344603|epidural|epidural
421843|NCT01344590|central line associated blood stream infections|central line associated blood stream infections
421844|NCT01344577|Buccal Plate Augmentation technique|buccal plate augmentation technique
421845|NCT01344577|socket preservation|socket preservation
421846|NCT01344577|porcine biomaterial|porcine biomaterial
421847|NCT01344564|Prostate cancer|prostate cancer
421848|NCT01344564|Hormone therapy|hormone therapy
421849|NCT01344564|Testosterone measures|testosterone measures
421850|NCT01344538|ginger|ginger
421851|NCT01344538|Zingiber officinale|zingiber officinale
421852|NCT01344538|Cancer Risk Reductive|cancer risk reductive
421853|NCT01344538|Eicosanoids|eicosanoids
421854|NCT01344538|Colorectal Cancer|colorectal cancer
421855|NCT01344538|Inflammation|inflammation
421856|NCT01344525|obesity therapy|obesity therapy
421857|NCT01344525|metabolic syndrome|metabolic syndrome
421858|NCT01344525|gastrointestinal tract|gastrointestinal tract
421859|NCT01344525|microbiota|microbiota
421860|NCT01344525|metabolomics|metabolomics
421861|NCT01344525|micronutrients|micronutrients
421862|NCT01344525|outcome|outcome
421863|NCT01344525|sustainability|sustainability
421864|NCT01344512|Pharmacokinetic|pharmacokinetic
421865|NCT01344512|Population|population
421866|NCT01344512|Children|children
421867|NCT01344512|Ceftazidime|ceftazidime
421868|NCT01344512|Ciprofloxacin|ciprofloxacin
421869|NCT01344512|Voriconazole|voriconazole
421870|NCT01344512|Pediatric|pediatric
421871|NCT01344499|women|women
421872|NCT01344499|laparoscopic subtotal hysterectomy|laparoscopic subtotal hysterectomy
421873|NCT01344486|women undergoing laparoscopic surgery|women undergoing laparoscopic surgery
421874|NCT01344473|Remineralisation|remineralisation
421875|NCT01344473|White Spot Lesions|white spot lesions
421876|NCT01344473|Orthodontic treatment|orthodontic treatment
421877|NCT01344473|Tooth Mousse creme|tooth mousse creme
421878|NCT01344473|Casein Phosphopeptide|casein phosphopeptide
421879|NCT01344460|magnetic resonance angiography (MRA) of the renal arteries|magnetic resonance angiography (mra) of the renal arteries
421880|NCT01344447|Supra-aortic vascular disease|supra-aortic vascular disease
421881|NCT01344447|MRA|mra
421882|NCT01344447|CTA|cta
421883|NCT01344447|Males and females aged 18 years or older|males and females aged 18 years or older
421884|NCT01344447|Stroke|stroke
421885|NCT01344447|Transient Ischemic Attack (TIA)|transient ischemic attack (tia)
421886|NCT01344421|Movement capture system|movement capture system
421887|NCT01344421|Movement analysis|movement analysis
421888|NCT01344421|Hip dysplasia|hip dysplasia
421889|NCT01344421|Hip pain|hip pain
421890|NCT01344421|Quality of life|quality of life
421891|NCT01344421|Physical function|physical function
421892|NCT01344408|Dizziness|dizziness
421893|NCT01344408|rehabilitation|rehabilitation
421894|NCT01344408|geriatric|geriatric
421895|NCT01344408|IT-technology|it-technology
421896|NCT01344382|Adolescent|adolescent
421897|NCT01344382|Parent|parent
421898|NCT01344382|Substance Abuse|substance abuse
421899|NCT01344382|Parent Training|parent training
421900|NCT01344382|Community Reinforcement and Family Training|community reinforcement and family training
421901|NCT01344382|CRAFT|craft
421902|NCT01344382|Community Reinforcement Approach|community reinforcement approach
421903|NCT01344382|Addiction|addiction
421904|NCT01344382|Family Intervention|family intervention
421905|NCT01344369|Healthy Subjects|healthy subjects
421906|NCT01344369|Bioequivalence|bioequivalence
421907|NCT01344356|stereotactic radiosurgery|stereotactic radiosurgery
421908|NCT01344356|head and neck tumors|head and neck tumors
421909|NCT01344356|squamous cell carcinoma of head and neck|squamous cell carcinoma of head and neck
421910|NCT01344330|Colon cancer|colon cancer
421911|NCT01344330|Prevention|prevention
421912|NCT01344330|Cruciferous vegetables|cruciferous vegetables
421913|NCT01344330|Histone status|histone status
421914|NCT01344304|aprepitant therapy|aprepitant therapy
421915|NCT01344304|fosaprepitant therapy|fosaprepitant therapy
421916|NCT01344304|5HT3-receptor antagonist|5ht3-receptor antagonist
421917|NCT01344304|dexamethasone|dexamethasone
421918|NCT01344304|colorectal cancer|colorectal cancer
421919|NCT01344304|FOLFOX|folfox
421920|NCT01344304|XELOX|xelox
421921|NCT01344304|SOX|sox
421922|NCT01344291|hyperprolactinoma|hyperprolactinoma
421923|NCT01344291|turmeric|turmeric
421924|NCT01344291|amenorrhea|amenorrhea
421925|NCT01344265|B-type natriuretic peptide|b-type natriuretic peptide
421926|NCT01344265|global end diastolic volume|global end diastolic volume
421927|NCT01344239|aortic aneurysm|aortic aneurysm
421928|NCT01344239|ischemia/reperfusion|ischemia/reperfusion
421929|NCT01344239|preconditioning|preconditioning
421930|NCT01344239|pulmonary injury|pulmonary injury
421931|NCT01344239|intestinal injury|intestinal injury
421932|NCT01344226|steroid responder|steroid responder
421933|NCT01344213|Pregabalin|pregabalin
421934|NCT01344213|Celecoxib|celecoxib
421935|NCT01344213|Intrathecal morphine|intrathecal morphine
421936|NCT01344213|Total knee arthroplasty|total knee arthroplasty
421937|NCT01344200|Pharmacokinetics|pharmacokinetics
421939|NCT01344200|Pediatric|pediatric
421940|NCT01344200|Peds QL|peds ql
421941|NCT01344200|CYP2C9|cyp2c9
421942|NCT01344174|Acute-on-chronic liver failure|acute-on-chronic liver failure
421943|NCT01344174|HBV|hbv
421944|NCT01344174|Dexamethasone|dexamethasone
421945|NCT01344174|Prognosis|prognosis
421946|NCT01344161|Vitamin D|vitamin d
421947|NCT01344161|Metabolic profile|metabolic profile
421948|NCT01344161|Overweight|overweight
421949|NCT01344161|Obesity|obesity
421950|NCT01344148|Anti- TB|anti- tb
421951|NCT01344148|HAART|haart
421952|NCT01344148|choice of the right moment|choice of the right moment
421953|NCT01344135|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
421954|NCT01344135|Muscular Atrophy|muscular atrophy
421955|NCT01344135|Nutritional rehabilitation|nutritional rehabilitation
421956|NCT01344135|Counselling|counselling
421957|NCT01344096|Gaucher disease|gaucher disease
421958|NCT01344096|Thrombocytopathy|thrombocytopathy
421959|NCT01344096|Imiglucerase|imiglucerase
421960|NCT01344070|innovator formulations|innovator formulations
421961|NCT01344070|generic formulations|generic formulations
421962|NCT01344070|bioequivalence|bioequivalence
421963|NCT01344070|interchangeability|interchangeability
421964|NCT01344070|inter-patch variation|inter-patch variation
421965|NCT01344070|quality of generic drug formulations on the market|quality of generic drug formulations on the market
421966|NCT01344070|Interchangeability between marketed generic formulations|interchangeability between marketed generic formulations
421967|NCT01344070|prevalence of large intrasubject variability despite average bioequivalence|prevalence of large intrasubject variability despite average bioequivalence
421968|NCT01344070|Causes of large intrasubject variability|causes of large intrasubject variability
421969|NCT01344057|Seasonal Influenza, vaccine|seasonal influenza, vaccine
421970|NCT01344044|Brain-Computer Interface|brain-computer interface
421971|NCT01344018|adult angiosarcoma|adult angiosarcoma
421972|NCT01344018|adult fibrosarcoma|adult fibrosarcoma
421973|NCT01344018|adult leiomyosarcoma|adult leiomyosarcoma
421974|NCT01344018|adult liposarcoma|adult liposarcoma
421975|NCT01344018|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
421976|NCT01344018|adult malignant mesenchymoma|adult malignant mesenchymoma
421977|NCT01344018|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
421978|NCT01344018|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
421979|NCT01344018|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
421980|NCT01344005|non-small cell lung cancer|non-small cell lung cancer
421981|NCT01344005|small cell lung cancer|small cell lung cancer
421982|NCT01344005|tobacco use disorder|tobacco use disorder
421983|NCT01343992|Embryo transfer|embryo transfer
421984|NCT01343992|Implantation rate|implantation rate
421985|NCT01343992|Pregnancy rate|pregnancy rate
421986|NCT01343992|bedrest|bedrest
421987|NCT01343992|neutral|neutral
421988|NCT01343992|benevolent|benevolent
421989|NCT01343992|deterious|deterious
421990|NCT01343992|implantation|implantation
421991|NCT01343992|gestation rates|gestation rates
421992|NCT01343953|severe aplastic anemia|severe aplastic anemia
421993|NCT01343953|cord blood transplantation|cord blood transplantation
421994|NCT01343940|RCT|rct
421995|NCT01343940|randomized block repeated measures design|randomized block repeated measures design
421996|NCT01343940|efficacy trial|efficacy trial
421997|NCT01343940|high risk population|high risk population
421998|NCT01343927|Chronic low back pain|chronic low back pain
421999|NCT01343927|Community health center|community health center
422000|NCT01343927|Yoga|yoga
422001|NCT01343927|Physical therapy|physical therapy
422002|NCT01343927|Minority populations|minority populations
422003|NCT01343927|Health education|health education
422004|NCT01343862|moderate traumatic brain injury|moderate traumatic brain injury
422005|NCT01343862|brain contusion|brain contusion
422006|NCT01343849|breast cancer|breast cancer
422007|NCT01343849|auto antibodies|auto antibodies
422008|NCT01343836|autologous tenocytes|autologous tenocytes
422009|NCT01343836|cell therapy|cell therapy
422010|NCT01343836|eccentric exercises|eccentric exercises
422011|NCT01343810|Mindfulness-Based Stress Reduction|mindfulness-based stress reduction
422012|NCT01343810|Meditation|meditation
422013|NCT01343810|Psychological stress|psychological stress
422014|NCT01343810|Sleep quality|sleep quality
422015|NCT01343810|Cardiovascular disease|cardiovascular disease
422016|NCT01343810|Inflammation|inflammation
422017|NCT01343797|Glycemic index|glycemic index
422018|NCT01343797|Insulinemic index|insulinemic index
422019|NCT01343797|Fructo-oligosaccharide syrup|fructo-oligosaccharide syrup
422020|NCT01343797|Fructose syrup|fructose syrup
422021|NCT01343797|Aged between eighteen and fifty years old|aged between eighteen and fifty years old
422022|NCT01343797|BMI between nineteen and twenty five kg/m²|bmi between nineteen and twenty five kg/m²
422023|NCT01343797|Non diabetic or pre-diabetic|non diabetic or pre-diabetic
422024|NCT01343797|Without liver, renal or gastro-intestinal disorder|without liver, renal or gastro-intestinal disorder
422025|NCT01343797|Non-smoker|non-smoker
422026|NCT01343784|Voiding trial|voiding trial
422027|NCT01343784|sling|sling
422028|NCT01343784|post-operative assessment|post-operative assessment
422029|NCT01343784|urinary retention|urinary retention
422030|NCT01343771|Anorexia Nervosa (AN)|anorexia nervosa (an)
422031|NCT01343771|bone density|bone density
422032|NCT01343771|DHEA|dhea
422033|NCT01343771|estrogen therapy|estrogen therapy
422034|NCT01343771|eating disorder|eating disorder
422035|NCT01343693|DDD|ddd
422036|NCT01343693|Deformity|deformity
422037|NCT01343693|Tumor|tumor
422038|NCT01343693|Fracture|fracture
422039|NCT01343693|Cervical|cervical
422040|NCT01343667|GORE Neuro Protection System|gore neuro protection system
422041|NCT01343667|GORE Flow Reversal System|gore flow reversal system
422042|NCT01343667|carotid artery stenosis|carotid artery stenosis
422043|NCT01343667|embolic protection device|embolic protection device
422044|NCT01343667|reverse flow|reverse flow
422045|NCT01343667|proximal occlusion device|proximal occlusion device
422046|NCT01343667|GNPS|gnps
422047|NCT01343667|Parodi|parodi
422048|NCT01343667|EMPiRE|empire
422049|NCT01343667|distal embolization|distal embolization
422050|NCT01343667|minimizing risks of CAS|minimizing risks of cas
422051|NCT01343667|PAES|paes
422052|NCT01343667|embolic filter|embolic filter
422053|NCT01343654|HIV medication adherence|hiv medication adherence
422054|NCT01343654|drug use|drug use
422055|NCT01343654|rural|rural
422056|NCT01343654|nonadherence to HIV medications|nonadherence to hiv medications
422057|NCT01343641|Kidney Disease|kidney disease
422058|NCT01343641|Chronic Kidney Disease|chronic kidney disease
422059|NCT01343641|Growth Hormone|growth hormone
422060|NCT01343628|Alcohol, atomoxetine, Strattera, alcohol dependence, alcoholism|alcohol, atomoxetine, strattera, alcohol dependence, alcoholism
422061|NCT01343602|stroke|stroke
422062|NCT01343602|Constraint Induced Movement Therapy|constraint induced movement therapy
422063|NCT01343602|participation|participation
422064|NCT01343602|Physical Therapy|physical therapy
422065|NCT01343602|Occupational Therapy|occupational therapy
422066|NCT01343563|Depression|depression
422067|NCT01343563|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
422068|NCT01343563|EEG|eeg
422069|NCT01343563|Trigeminal Nerve Stimulation|trigeminal nerve stimulation
422070|NCT01343550|Borderline Personality Disorder|borderline personality disorder
422071|NCT01343550|Borderline Personality|borderline personality
422072|NCT01343550|Borderline|borderline
422073|NCT01343537|Brain Bleed|brain bleed
422074|NCT01343537|SAH|sah
422075|NCT01343537|Vasospasm|vasospasm
422076|NCT01343524|cystic fibrosis|cystic fibrosis
422077|NCT01343524|spirometry|spirometry
422078|NCT01343524|PFT's|pft's
422079|NCT01343524|pulmonary function test|pulmonary function test
422080|NCT01343511|Autism|autism
422081|NCT01343511|human cord blood mononuclear cells|human cord blood mononuclear cells
422082|NCT01343511|human umbilical cord mesenchymal stem cells|human umbilical cord mesenchymal stem cells
422083|NCT01343498|Solid Tumor Malignancy|solid tumor malignancy
422084|NCT01343498|Advanced Solid Tumors|advanced solid tumors
422085|NCT01343498|BEZ235|bez235
422086|NCT01343498|mTOR Inhibitor|mtor inhibitor
422087|NCT01343485|Human papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
422088|NCT01343485|Gardasil vaccine|gardasil vaccine
422089|NCT01343472|Behavior|behavior
422090|NCT01343472|Drug users|drug users
422091|NCT01343459|Hypofractionated Whole breast irradiation|hypofractionated whole breast irradiation
422092|NCT01343459|Hypofractionated Whole breast irradiation long term results|hypofractionated whole breast irradiation long term results
422093|NCT01343459|Breast conserving therapy|breast conserving therapy
422094|NCT01343459|IORT with electrons in breast cancer|iort with electrons in breast cancer
422095|NCT01343459|IOERT as anticipated Boost|ioert as anticipated boost
422096|NCT01343459|IOERT and hypofractionated whole breast irradiation|ioert and hypofractionated whole breast irradiation
422097|NCT01343446|Sleep impairment, Coping Style, Diabetes Mellitus|sleep impairment, coping style, diabetes mellitus
422098|NCT01343433|Delirium|delirium
422099|NCT01343433|Intensive Care Unit Syndrome|intensive care unit syndrome
422100|NCT01343433|Bright light therapy|bright light therapy
422101|NCT01343433|Intensive Care Unit|intensive care unit
422102|NCT01343420|Skin tests|skin tests
422103|NCT01343420|Dog Hair|dog hair
422104|NCT01343420|Allergy Extract|allergy extract
422105|NCT01343394|Autologous|autologous
422106|NCT01343394|Stem Cells|stem cells
422107|NCT01343394|Hearing Loss|hearing loss
422108|NCT01343394|Children|children
422109|NCT01343381|Heparin|heparin
422110|NCT01343381|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
422111|NCT01343381|Anti-coagulation efficacy|anti-coagulation efficacy
422112|NCT01343368|Post-menarchal|post-menarchal
422113|NCT01343355|Tropical Spastic Paraparesis|tropical spastic paraparesis
422114|NCT01343355|HAM|ham
422115|NCT01343355|TSP|tsp
422116|NCT01343342|omega-3|omega-3
422117|NCT01343342|PUFA|pufa
422118|NCT01343342|fatty acids|fatty acids
422119|NCT01343342|cardiovascular disease|cardiovascular disease
422120|NCT01343342|gene expression|gene expression
422121|NCT01343329|Traumatic Brain Injury|traumatic brain injury
422122|NCT01343329|Dysautonomia|dysautonomia
422123|NCT01343329|Brain Injury|brain injury
422124|NCT01343329|Sympathetic hyperactivity|sympathetic hyperactivity
422125|NCT01343316|Enteral Feeds|enteral feeds
422126|NCT01343316|Supplemental Feeds|supplemental feeds
422127|NCT01343316|Transpyloric Tube|transpyloric tube
422128|NCT01343316|Nasogastric Tube|nasogastric tube
422129|NCT01343303|Osteoarthritis, knee|osteoarthritis, knee
422130|NCT01343303|knee pain|knee pain
422131|NCT01343303|pain measurement|pain measurement
422132|NCT01343290|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
422133|NCT01343290|Pharmacokinetic|pharmacokinetic
422134|NCT01343290|Oral Bioavailability|oral bioavailability
422135|NCT01343290|Food effect|food effect
422136|NCT01343277|Advanced Liposarcoma or Leiomyosarcoma|advanced liposarcoma or leiomyosarcoma
422137|NCT01343277|Trabectedin|trabectedin
422138|NCT01343277|Yondelis|yondelis
422139|NCT01343277|Dacarbazine|dacarbazine
422140|NCT01343277|Anthracycline|anthracycline
422141|NCT01343277|L-sarcoma|l-sarcoma
422142|NCT01343264|Radical Pleurectomy|radical pleurectomy
422143|NCT01343264|Pleurectomy/decortication|pleurectomy/decortication
422144|NCT01343264|Cisplatin|cisplatin
422145|NCT01343264|Pemetrexed|pemetrexed
422146|NCT01343264|Radiation|radiation
422147|NCT01343251|dialysis|dialysis
422148|NCT01343251|HeRO graft|hero graft
422149|NCT01343251|catheter|catheter
422150|NCT01343251|chronic renal failure|chronic renal failure
422151|NCT01343251|end stage renal disease|end stage renal disease
422152|NCT01343251|renal insufficiency|renal insufficiency
422153|NCT01343238|obesity|obesity
422154|NCT01343238|diet|diet
422155|NCT01343238|exercise|exercise
422156|NCT01343225|African american vitamin d bone density|african american vitamin d bone density
422157|NCT01343225|African American male or female treatment naive|african american male or female treatment naive
422158|NCT01343212|hepatocellular carcinoma|hepatocellular carcinoma
422159|NCT01343212|stiffness|stiffness
422160|NCT01343186|Peginterferon|peginterferon
422161|NCT01343186|Healthy subject|healthy subject
422162|NCT01343186|Pharmacokinetics|pharmacokinetics
422163|NCT01343186|Pharmacodynamics|pharmacodynamics
422164|NCT01343186|Safety|safety
422165|NCT01343173|Leukemia|leukemia
422166|NCT01343173|Adult Chronic|adult chronic
422167|NCT01343173|Myeloid|myeloid
422168|NCT01343147|Hyperthermia|hyperthermia
422169|NCT01343147|Microwave diathermy|microwave diathermy
422170|NCT01343147|Hot packs|hot packs
422171|NCT01343147|Pain|pain
422172|NCT01343147|Physical function|physical function
422173|NCT01343134|Retina|retina
422174|NCT01343134|Rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
422175|NCT01343134|Macular detachment|macular detachment
422176|NCT01343134|Spectral domain OCT|spectral domain oct
422177|NCT01343134|Microperimetry|microperimetry
422178|NCT01343121|Radiotherapy|radiotherapy
422179|NCT01343121|GemX Chemoradiotherapy|gemx chemoradiotherapy
422180|NCT01343121|Bladder Cancer|bladder cancer
422181|NCT01343108|Emotional Labor|emotional labor
422182|NCT01343108|Burnout|burnout
422183|NCT01343108|Job Satisfaction|job satisfaction
422184|NCT01343108|Emotional Intelligence|emotional intelligence
422185|NCT01343108|Job stress|job stress
422186|NCT01343108|Job involvement|job involvement
422187|NCT01343095|ICU Delirium|icu delirium
422188|NCT01343095|Delirium|delirium
422189|NCT01343095|Sleep Quality|sleep quality
422190|NCT01343095|Sleep Efficiency|sleep efficiency
422191|NCT01343095|ICU Noise|icu noise
422192|NCT01343095|Noise Reduction|noise reduction
422193|NCT01343095|Earplugs|earplugs
422194|NCT01343095|Noise Canceling Headphones|noise canceling headphones
422195|NCT01343069|safety|safety
422196|NCT01343069|team|team
422197|NCT01343069|team performance|team performance
422198|NCT01343069|surgery|surgery
422199|NCT01343069|outcome|outcome
422200|NCT01343056|Diabetes Self Management Education (DSME)|diabetes self management education (dsme)
422201|NCT01343056|Diabetes|diabetes
422202|NCT01343056|Self Management Support (SMS)|self management support (sms)
422203|NCT01343043|Sarcoma|sarcoma
422204|NCT01343043|Cell Therapy|cell therapy
422205|NCT01343043|T Cell Therapy|t cell therapy
422206|NCT01343043|NY-ESO-1|ny-eso-1
422207|NCT01343043|Immuno-oncology|immuno-oncology
422208|NCT01343043|Metastatic|metastatic
422209|NCT01343043|Previously treated|previously treated
422210|NCT01343043|T Cell Receptor|t cell receptor
422211|NCT01343017|Anaesthesia|anaesthesia
422212|NCT01343017|Pulmonary gas exchange|pulmonary gas exchange
422213|NCT01343017|Functional residual capacity|functional residual capacity
422214|NCT01343017|Cardiac output|cardiac output
422215|NCT01343017|Sevoflurane|sevoflurane
422216|NCT01343004|BA058|ba058
422217|NCT01343004|abaloparatide|abaloparatide
422218|NCT01343004|Abaloparatide-SC|abaloparatide-sc
422219|NCT01343004|osteoporosis|osteoporosis
422220|NCT01343004|postmenopausal|postmenopausal
422221|NCT01343004|bone loss|bone loss
422222|NCT01343004|ACTIVE|active
422223|NCT01343004|fracture|fracture
422224|NCT01342991|Haemorrhoids|haemorrhoids
422225|NCT01342991|Haemorrhoidectomy|haemorrhoidectomy
422226|NCT01342991|Laser Haemorrhoidectomy|laser haemorrhoidectomy
422227|NCT01342991|Milligan-Morgan Haemorrhoidectomy|milligan-morgan haemorrhoidectomy
422228|NCT01342991|Open Haemorrhoidectomy|open haemorrhoidectomy
422229|NCT01342978|HPV|hpv
422230|NCT01342978|HNSCC|hnscc
422231|NCT01342952|pulmonary arterial hypertension|pulmonary arterial hypertension
422232|NCT01342952|pediatrics|pediatrics
422233|NCT01342939|Monogenetic diabetes|monogenetic diabetes
422234|NCT01342939|Diabetes mellitus|diabetes mellitus
422235|NCT01342926|age-related macular degeneration|age-related macular degeneration
422236|NCT01342926|geographic atrophy|geographic atrophy
422237|NCT01342926|dry AMD|dry amd
422238|NCT01342900|tissue oxygenation|tissue oxygenation
422239|NCT01342900|higk risk surgery|higk risk surgery
422240|NCT01342900|high risk patient|high risk patient
422241|NCT01342900|postoperative complications|postoperative complications
422242|NCT01342874|inositol|inositol
422243|NCT01342874|gestational diabetes mellitus|gestational diabetes mellitus
422244|NCT01342874|obstetric adverse outcomes|obstetric adverse outcomes
422245|NCT01342861|protein supplementation|protein supplementation
422246|NCT01342861|caloric intake|caloric intake
422247|NCT01342861|breakfast|breakfast
422248|NCT01342861|transthyretin (prealbumin)|transthyretin (prealbumin)
422249|NCT01342861|albumin|albumin
422250|NCT01342861|Length of stay|length of stay
422251|NCT01342848|NSTE-ACS|nste-acs
422252|NCT01342848|PCI|pci
422253|NCT01342848|Thrombus Aspiration|thrombus aspiration
422254|NCT01342848|IVUS|ivus
422255|NCT01342848|Periprocedural Myocardial Infarction|periprocedural myocardial infarction
422256|NCT01342835|propofol|propofol
422257|NCT01342835|sevoflurane|sevoflurane
422258|NCT01342835|postoperative pain|postoperative pain
422259|NCT01342835|children|children
422260|NCT01342822|Heart disease|heart disease
422261|NCT01342822|Coronary Revascularization|coronary revascularization
422262|NCT01342809|Depression|depression
422263|NCT01342809|Hopelessness|hopelessness
422264|NCT01342809|Suicidal ideation|suicidal ideation
422265|NCT01342796|Cell mediated immunity|cell mediated immunity
422266|NCT01342796|cell mediated immune response|cell mediated immune response
422267|NCT01342796|Children|children
422268|NCT01342796|adjuvanted|adjuvanted
422269|NCT01342783|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
422270|NCT01342783|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
422271|NCT01342783|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
422272|NCT01342783|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
422273|NCT01342783|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
422274|NCT01342783|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
422275|NCT01342744|Cardiovascular risk factors|cardiovascular risk factors
422276|NCT01342731|Tigecycline|tigecycline
422277|NCT01342731|A.baumannii|a.baumannii
422278|NCT01342731|Drug safety|drug safety
422279|NCT01342718|Irritable bowel syndrome|irritable bowel syndrome
422280|NCT01342718|Herbal medicine|herbal medicine
422281|NCT01342718|Probiotics|probiotics
422282|NCT01342679|chronic myeloid leukemia|chronic myeloid leukemia
422283|NCT01342679|dasatinib|dasatinib
422284|NCT01342679|complete molecular response|complete molecular response
422285|NCT01342666|High density lipoprotein cholesterol|high density lipoprotein cholesterol
422286|NCT01342666|Tomato|tomato
422287|NCT01342666|Lycopene|lycopene
422288|NCT01342666|Hypoalphalipoproteinemia|hypoalphalipoproteinemia
422289|NCT01342666|Dyslipidemia|dyslipidemia
422290|NCT01342653|Peritoneal|peritoneal
422291|NCT01342653|Carcinomatosis|carcinomatosis
422292|NCT01342653|Gastric|gastric
422293|NCT01342653|Cancer|cancer
422294|NCT01342653|NIPS|nips
422295|NCT01342653|HIPEC|hipec
422296|NCT01342627|Renal Carcinoma|renal carcinoma
422297|NCT01342627|Metastatic|metastatic
422298|NCT01342627|Sorafenib|sorafenib
422299|NCT01342627|Elderly|elderly
422300|NCT01342614|Hypertension|hypertension
422301|NCT01342614|Insulin Resistance|insulin resistance
422302|NCT01342614|Hyperinsulinemia|hyperinsulinemia
422303|NCT01342614|Metformin|metformin
422304|NCT01342614|Fosinopril|fosinopril
422305|NCT01342588|Pedicle screws|pedicle screws
422306|NCT01342588|safety|safety
422307|NCT01342575|ACDF|acdf
422308|NCT01342549|Alcohol Use Disorders|alcohol use disorders
422309|NCT01342549|Traumatic Brain Injury|traumatic brain injury
422310|NCT01342549|Mood and Anxiety Disorders|mood and anxiety disorders
422311|NCT01342536|Depression|depression
422312|NCT01342523|Smoking Cessation|smoking cessation
422313|NCT01342523|Smoking|smoking
422314|NCT01342523|Nicotine|nicotine
422315|NCT01342510|Intravenous Anesthesia|intravenous anesthesia
422316|NCT01342510|General Anesthesia|general anesthesia
422317|NCT01342497|diabetic foot ulcer|diabetic foot ulcer
422318|NCT01342471|Physical activity intervention|physical activity intervention
422319|NCT01342471|walking|walking
422320|NCT01342471|TV|tv
422321|NCT01342471|sedentary|sedentary
422322|NCT01342458|Knee osteoarthritis|knee osteoarthritis
422323|NCT01342458|Shoes|shoes
422324|NCT01342458|Gait|gait
422325|NCT01342458|Biomechanics|biomechanics
422326|NCT01342432|low back pain|low back pain
422327|NCT01342432|balance reeducation|balance reeducation
422328|NCT01342432|pain|pain
422329|NCT01342432|function|function
422330|NCT01342367|Prostate cancer|prostate cancer
422331|NCT01342367|Quality of Life|quality of life
422332|NCT01342354|Pancreatic Cancer|pancreatic cancer
422333|NCT01342354|Stereotactic Radiation|stereotactic radiation
422334|NCT01342328|Sleep disruption|sleep disruption
422335|NCT01342328|Sleep hygiene|sleep hygiene
422336|NCT01342328|Sedative agents and sleep|sedative agents and sleep
422337|NCT01342328|Electroencephalography|electroencephalography
422338|NCT01342328|REM sleep|rem sleep
422339|NCT01342328|Magnetoencephalography|magnetoencephalography
422340|NCT01342315|Tinea Cruris, antifungal|tinea cruris, antifungal
422341|NCT01342302|Breast Cancer|breast cancer
422342|NCT01342302|Couples|couples
422343|NCT01342302|Distress|distress
422344|NCT01342302|Online Support|online support
422345|NCT01342302|e-health|e-health
422346|NCT01342302|Intervention|intervention
422347|NCT01342302|Relationships|relationships
422348|NCT01342289|Nonmyeloablative|nonmyeloablative
422349|NCT01342289|Allogeneic|allogeneic
422350|NCT01342289|Bone Marrow Transplant (BMT)|bone marrow transplant (bmt)
422351|NCT01342289|Tacrolimus|tacrolimus
422352|NCT01342289|Cyclophosphamide|cyclophosphamide
422353|NCT01342276|Heart failure|heart failure
422354|NCT01342276|Self-management|self-management
422355|NCT01342276|Telehealth|telehealth
422356|NCT01342276|Internet|internet
422357|NCT01342263|Chronic disease management|chronic disease management
422358|NCT01342263|Ischemic heart disease|ischemic heart disease
422359|NCT01342263|Heart failure|heart failure
422360|NCT01342263|Chronic kidney disease|chronic kidney disease
422361|NCT01342263|Diabetes|diabetes
422362|NCT01342263|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
422363|NCT01342263|Telehealth|telehealth
422364|NCT01342263|Internet|internet
422365|NCT01342250|Decompensated Liver Cirrhosis|decompensated liver cirrhosis
422366|NCT01342250|Umbilical Cord Mesenchymal Stem Cells|umbilical cord mesenchymal stem cells
422367|NCT01342237|Brain tumors|brain tumors
422368|NCT01342237|Stem cell transplantation|stem cell transplantation
422369|NCT01342237|topotecan|topotecan
422370|NCT01342237|thiotepa|thiotepa
422371|NCT01342237|carboplatin|carboplatin
422372|NCT01342237|melphalan|melphalan
422373|NCT01342237|etoposide|etoposide
422374|NCT01342224|pancreatic|pancreatic
422375|NCT01342224|cancer|cancer
422376|NCT01342224|adenocarcinoma|adenocarcinoma
422377|NCT01342224|vaccine|vaccine
422378|NCT01342211|PF-04950615|pf-04950615
422379|NCT01342211|RN316|rn316
422380|NCT01342198|pregabalin|pregabalin
422381|NCT01342198|pharmacokinetics|pharmacokinetics
422382|NCT01342198|bioavailability|bioavailability
422383|NCT01342198|bioequivalence|bioequivalence
422384|NCT01342185|Medical ozone therapy|medical ozone therapy
422385|NCT01342185|chronic hepatitis B|chronic hepatitis b
422386|NCT01342172|Bladder Cancer|bladder cancer
422387|NCT01342172|Urothelial Cancer|urothelial cancer
422388|NCT01342172|Chemotherapy|chemotherapy
422389|NCT01342172|First-line|first-line
422390|NCT01342172|Metastatic|metastatic
422391|NCT01342159|bevacizumab, diabetic macular edema, triamcinolone|bevacizumab, diabetic macular edema, triamcinolone
422392|NCT01342146|pegylated Somatropin|pegylated somatropin
422393|NCT01342146|PEG-GH|peg-gh
422394|NCT01342146|Growth hormone|growth hormone
422395|NCT01342146|PEG-rhGH|peg-rhgh
422396|NCT01342146|Growth hormone deficiency (GHD)|growth hormone deficiency (ghd)
422397|NCT01342146|Phase 2 study|phase 2 study
422398|NCT01342120|atypical antipsychotics|atypical antipsychotics
422399|NCT01342120|quetiapine|quetiapine
422400|NCT01342107|Contact Lenses|contact lenses
422401|NCT01342107|Contact Lens Care|contact lens care
422402|NCT01342107|Multi-Purpose Solution Wettability|multi-purpose solution wettability
422403|NCT01342107|Myopia|myopia
422404|NCT01342094|Primary open angle glaucoma or ocular hypertension|primary open angle glaucoma or ocular hypertension
422405|NCT01342081|Primary open angle glaucoma or ocular hypertension|primary open angle glaucoma or ocular hypertension
422406|NCT01342068|Thoracic outlet syndrome|thoracic outlet syndrome
422407|NCT01342068|Osteopathic medicine|osteopathic medicine
422408|NCT01342068|Osteopathic Manual Manipulations|osteopathic manual manipulations
422409|NCT01342068|OMT|omt
422410|NCT01342068|Wright's Test|wright's test
422411|NCT01342068|Adson's Test|adson's test
422412|NCT01342068|Halstead's Maneuver|halstead's maneuver
422413|NCT01342068|TOS|tos
422414|NCT01342068|Vascular Sonography|vascular sonography
422415|NCT01342042|diabetes|diabetes
422416|NCT01342042|rRE-4|rre-4
422417|NCT01342042|exenatide|exenatide
422418|NCT01342042|metformin|metformin
422419|NCT01342042|CSPC ZhongQi|cspc zhongqi
422420|NCT01342029|Microvascular Coronary Dysfunction (MCD)|microvascular coronary dysfunction (mcd)
422421|NCT01342016|prograf|prograf
422422|NCT01342016|nephritis|nephritis
422423|NCT01342016|leflunomide|leflunomide
422424|NCT01342016|immunosuppressant|immunosuppressant
422425|NCT01342003|HCV infection|hcv infection
422426|NCT01342003|genotype 1a|genotype 1a
422427|NCT01342003|genotype 1 b|genotype 1 b
422428|NCT01341990|Contact Lenses|contact lenses
422924|NCT01339871|Pazopanib|pazopanib
422429|NCT01341990|Contact Lens Care|contact lens care
422430|NCT01341990|Multi-Purpose Solution|multi-purpose solution
422431|NCT01341977|Contact Lenses|contact lenses
422432|NCT01341977|Contact Lens Care|contact lens care
422433|NCT01341977|Multi-Purpose Solution|multi-purpose solution
422434|NCT01341964|Clopidogrel|clopidogrel
422435|NCT01341964|Aspirin|aspirin
422436|NCT01341964|Interaction|interaction
422437|NCT01341951|liver failure, Acute|liver failure, acute
422438|NCT01341938|Smokeless Tobacco Use|smokeless tobacco use
422439|NCT01341925|childhood depression|childhood depression
422440|NCT01341899|Type 1 diabetes|type 1 diabetes
422441|NCT01341899|stem cell|stem cell
422442|NCT01341899|C-peptide|c-peptide
422443|NCT01341899|Immune function|immune function
422444|NCT01341886|differentiated thyroid cancer|differentiated thyroid cancer
422445|NCT01341886|THS suppression|ths suppression
422446|NCT01341886|metformin|metformin
422447|NCT01341834|Nasopharyngeal carcinoma, antiangiogenesis, HDACi, mTOR, Phase Ib|nasopharyngeal carcinoma, antiangiogenesis, hdaci, mtor, phase ib
422448|NCT01341821|Leadership Style|leadership style
422449|NCT01341821|Team Climate|team climate
422450|NCT01341808|Crohn's disease|crohn's disease
422451|NCT01341808|Ulcerative colitis|ulcerative colitis
422452|NCT01341808|Hepatitis A|hepatitis a
422453|NCT01341808|vaccine|vaccine
422454|NCT01341795|Newly diagnosed type 2 diabetes patients|newly diagnosed type 2 diabetes patients
422455|NCT01341782|Secondary hyperparathyroidism|secondary hyperparathyroidism
422456|NCT01341782|Paricalcitol|paricalcitol
422457|NCT01341782|Hemodialysis|hemodialysis
422458|NCT01341782|Maxacalcitol|maxacalcitol
422459|NCT01341756|Gastric Cancer|gastric cancer
422460|NCT01341756|Radiotherapy|radiotherapy
422461|NCT01341756|palliation|palliation
422462|NCT01341756|bleeding|bleeding
422463|NCT01341756|pain|pain
422464|NCT01341756|obstruction|obstruction
422465|NCT01341743|chronic hepatitis B|chronic hepatitis b
422466|NCT01341743|inadequate response|inadequate response
422467|NCT01341743|NUC therapy|nuc therapy
422468|NCT01341730|Atherosclerosis|atherosclerosis
422469|NCT01341730|Pioglitazone|pioglitazone
422470|NCT01341730|Atorvastatin|atorvastatin
422471|NCT01341730|PET CT|pet ct
422472|NCT01341717|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
422473|NCT01341717|Sitagliptin|sitagliptin
422474|NCT01341717|Insulin|insulin
422475|NCT01341704|malaria|malaria
422476|NCT01341704|vaccine|vaccine
422477|NCT01341704|clinical trials|clinical trials
422478|NCT01341704|proof of concept|proof of concept
422479|NCT01341704|efficacy|efficacy
422480|NCT01341691|chronic kidney disease|chronic kidney disease
422481|NCT01341691|K2CG chewing gum|k2cg chewing gum
422482|NCT01341691|phosphorus|phosphorus
422483|NCT01341691|saliva|saliva
422484|NCT01341678|chronic kidney disease|chronic kidney disease
422485|NCT01341678|phosphorus|phosphorus
422486|NCT01341678|circadian rhythm|circadian rhythm
422487|NCT01341678|saliva|saliva
422488|NCT01341665|hyponatremia|hyponatremia
422489|NCT01341665|SIADH|siadh
422490|NCT01341665|copeptin|copeptin
422491|NCT01341639|combination vaccine|combination vaccine
422492|NCT01341639|diphtheria|diphtheria
422493|NCT01341639|pertussis|pertussis
422494|NCT01341639|tetanus|tetanus
422495|NCT01341639|hepatitis B|hepatitis b
422496|NCT01341639|Hep B|hep b
422497|NCT01341639|Haemophilus influenzae b|haemophilus influenzae b
422498|NCT01341639|Hib|hib
422499|NCT01341639|polio|polio
422500|NCT01341639|poliovirus|poliovirus
422501|NCT01341626|delinquency|delinquency
422502|NCT01341626|drug use|drug use
422503|NCT01341626|HIV risk behavior|hiv risk behavior
422504|NCT01341626|economic costs|economic costs
422505|NCT01341600|Clopidogrel|clopidogrel
422506|NCT01341600|Pharmacogenetics|pharmacogenetics
422507|NCT01341600|Platelets|platelets
422508|NCT01341600|Healthy Subjects|healthy subjects
422509|NCT01341587|SMBG (self monitoring of blood glucose)|smbg (self monitoring of blood glucose)
422510|NCT01341587|diabetes|diabetes
422511|NCT01341587|mobile technology|mobile technology
422512|NCT01341574|spatial neglect|spatial neglect
422513|NCT01341574|stroke|stroke
422514|NCT01341548|Nasal|nasal
422515|NCT01341548|Cluster Headache|cluster headache
422516|NCT01341548|Episodic Cluster|episodic cluster
422517|NCT01341548|Headache|headache
422518|NCT01341548|Phase 3|phase 3
422519|NCT01341548|Civamide|civamide
422520|NCT01341548|TRPV-1 Receptor|trpv-1 receptor
422521|NCT01341509|Surgical Treatment of Insertional Achilles Tendinopathy|surgical treatment of insertional achilles tendinopathy
422522|NCT01341496|Metastatic Cancer|metastatic cancer
422523|NCT01341496|Cancer Vaccine|cancer vaccine
422524|NCT01341496|Immunotherapy|immunotherapy
422525|NCT01341496|Chest Metastases|chest metastases
422526|NCT01341496|Sarcoma|sarcoma
422527|NCT01341496|Melanoma|melanoma
422528|NCT01341483|erectile dysfunction|erectile dysfunction
422529|NCT01341483|internal pudendal artery|internal pudendal artery
422530|NCT01341483|erection|erection
422531|NCT01341483|coronary artery disease|coronary artery disease
422532|NCT01341483|peripheral atherosclerotic disease|peripheral atherosclerotic disease
422533|NCT01341431|Parkinson disease|parkinson disease
422534|NCT01341431|Bee venom|bee venom
422535|NCT01341431|Motor fluctuations|motor fluctuations
422536|NCT01341431|Disease progression|disease progression
422537|NCT01341418|tibia|tibia
422538|NCT01341418|suprapatellar|suprapatellar
422539|NCT01341392|Drug-Drug interaction between the CKD-501 and Amlodipine|drug-drug interaction between the ckd-501 and amlodipine
422540|NCT01341379|Ureagenesis|ureagenesis
422541|NCT01341379|Urea cycle|urea cycle
422542|NCT01341379|Inborn errors of metabolism|inborn errors of metabolism
422543|NCT01341366|Laparoscopic surgery|laparoscopic surgery
422544|NCT01341340|Stent|stent
422545|NCT01341340|Infrapopliteal|infrapopliteal
422546|NCT01341340|Tibial|tibial
422547|NCT01341340|Limb Salvage|limb salvage
422548|NCT01341327|Left Main|left main
422549|NCT01341314|joint pain|joint pain
422550|NCT01341314|stiffness|stiffness
422551|NCT01341301|allogeneic stem cell transplant|allogeneic stem cell transplant
422552|NCT01341301|TJU 2 Step|tju 2 step
422553|NCT01341301|HSCT|hsct
422554|NCT01341301|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
422555|NCT01341288|prostate cancer|prostate cancer
422556|NCT01341288|EUCLIDIAN|euclidian
422557|NCT01341288|Endo-Uro Computed Lattice for Intratumoral Delivery, Implantation, Ablation with Nanosensing|endo-uro computed lattice for intratumoral delivery, implantation, ablation with nanosensing
422558|NCT01341288|robot|robot
422559|NCT01341288|brachytherapy|brachytherapy
422560|NCT01341288|seed implantation|seed implantation
422561|NCT01341275|hepatitis B vaccine|hepatitis b vaccine
422562|NCT01341275|duration of protection|duration of protection
422563|NCT01341275|adolescent immunization|adolescent immunization
422564|NCT01341275|anamnestic response|anamnestic response
422565|NCT01341275|booster dose|booster dose
422566|NCT01341275|Immunity to hepatitis B as measured by anti-HBSAg titers|immunity to hepatitis b as measured by anti-hbsag titers
422567|NCT01341262|autologous stem cell transplantation|autologous stem cell transplantation
422568|NCT01341262|thalidomide|thalidomide
422569|NCT01341262|induction therapy|induction therapy
422570|NCT01341236|VLBW|vlbw
422571|NCT01341236|IUGR|iugr
422572|NCT01341236|NIRS|nirs
422573|NCT01341236|enteral nutrition|enteral nutrition
422574|NCT01341236|superior mesenteric artery doppler|superior mesenteric artery doppler
422575|NCT01341210|Patients Satisfaction|patients satisfaction
422576|NCT01341210|Decision Making|decision making
422577|NCT01341210|Informed Consent|informed consent
422578|NCT01341197|Fecal immunochemical test|fecal immunochemical test
422579|NCT01341197|Guaiac fecal occult blood test|guaiac fecal occult blood test
422580|NCT01341197|Helicobacter pylori stool antigen test|helicobacter pylori stool antigen test
422581|NCT01341197|Mass screening|mass screening
422582|NCT01341197|Bidirectional endoscopy|bidirectional endoscopy
422583|NCT01341184|rifabutin|rifabutin
422584|NCT01341184|rifampin|rifampin
422585|NCT01341184|TMC207|tmc207
422586|NCT01341184|tuberculosis|tuberculosis
422587|NCT01341171|tamoxifen|tamoxifen
422588|NCT01341171|aromatase inhibitors|aromatase inhibitors
422589|NCT01341171|breast cancer|breast cancer
422590|NCT01341171|platelets|platelets
422591|NCT01341158|Malignatn Melanoma|malignatn melanoma
422592|NCT01341145|hypertension|hypertension
422593|NCT01341145|aerobic exercise|aerobic exercise
422594|NCT01341145|relaxation|relaxation
422595|NCT01341145|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
422596|NCT01341145|magnetic resonance spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
422597|NCT01341145|brain health|brain health
422598|NCT01341132|HCC|hcc
422599|NCT01341132|Hepatocellular Carcinoma|hepatocellular carcinoma
422600|NCT01341132|MRI|mri
422601|NCT01341132|Liver|liver
422602|NCT01341106|chronic hepatitis B|chronic hepatitis b
422603|NCT01341106|liver fibrosis|liver fibrosis
422604|NCT01341106|treatment with Entecavir|treatment with entecavir
422605|NCT01341080|Balance|balance
422606|NCT01341080|Postural impairment|postural impairment
422607|NCT01341080|Falls|falls
422608|NCT01341080|Parkinson Disease|parkinson disease
422609|NCT01341054|mucositis|mucositis
422610|NCT01341054|chamomilla|chamomilla
422611|NCT01341054|therapeutics|therapeutics
422612|NCT01341028|weight loss|weight loss
422613|NCT01341028|appetite|appetite
422614|NCT01341028|ghrelin|ghrelin
422615|NCT01341028|PYY|pyy
422616|NCT01341028|GLP-1|glp-1
422617|NCT01341028|insulin|insulin
422618|NCT01341028|laparoscopic|laparoscopic
422619|NCT01341028|Roux-en-Y gastric bypass|roux-en-y gastric bypass
422620|NCT01341028|gastric fundus resection|gastric fundus resection
422621|NCT01341002|Postoperative Care|postoperative care
422622|NCT01341002|red blood cell transfusion|red blood cell transfusion
422623|NCT01341002|venous oxygen saturation|venous oxygen saturation
422624|NCT01340989|women undergoing laparoscopic surgery for: hysterectomy, colpopexy, endometriosis, adhesions or myomas|women undergoing laparoscopic surgery for: hysterectomy, colpopexy, endometriosis, adhesions or myomas
422625|NCT01340976|Cancer Related Anemia|cancer related anemia
422626|NCT01340963|Chagas heart disease|chagas heart disease
422627|NCT01340963|ventricular tachycardia|ventricular tachycardia
422925|NCT01339871|Vorinostat|vorinostat
422628|NCT01340963|atrial fibrillation|atrial fibrillation
422629|NCT01340963|stroke|stroke
422630|NCT01340963|cardiac death|cardiac death
422631|NCT01340963|signal averaged electrocardiogram|signal averaged electrocardiogram
422632|NCT01340950|Prevention|prevention
422633|NCT01340950|Anti-Retroviral Agents|anti-retroviral agents
422634|NCT01340950|Neuropsychological Tests|neuropsychological tests
422635|NCT01340937|Diphtheria|diphtheria
422636|NCT01340937|Tetanus|tetanus
422637|NCT01340937|Whooping Cough (pertussis)|whooping cough (pertussis)
422638|NCT01340937|Poliomyelitis|poliomyelitis
422639|NCT01340937|Hepatitis B infection|hepatitis b infection
422640|NCT01340937|Haemophilus influenzae type b infection|haemophilus influenzae type b infection
422641|NCT01340924|Gestational diabetes|gestational diabetes
422642|NCT01340924|Type 2 diabetes|type 2 diabetes
422643|NCT01340898|meningococcal conjugate vaccine|meningococcal conjugate vaccine
422644|NCT01340898|serogroups A,C, W-135 or Y|serogroups a,c, w-135 or y
422645|NCT01340898|meningococcal diseases|meningococcal diseases
422646|NCT01340898|Immunogenicity|immunogenicity
422647|NCT01340898|Neisseria meningitidis|neisseria meningitidis
422648|NCT01340898|co-administration|co-administration
422649|NCT01340898|routine vaccines|routine vaccines
422650|NCT01340885|attention|attention
422651|NCT01340885|mild cognitive impairment|mild cognitive impairment
422652|NCT01340885|dementia|dementia
422653|NCT01340872|iron deficiency|iron deficiency
422654|NCT01340872|anaemia|anaemia
422655|NCT01340872|inflammatory bowel disease|inflammatory bowel disease
422656|NCT01340872|ulcerative colitis|ulcerative colitis
422657|NCT01340859|Suicide|suicide
422658|NCT01340859|Cognitive Therapy|cognitive therapy
422659|NCT01340859|Inpatient|inpatient
422660|NCT01340859|Military|military
422661|NCT01340846|gemfibrozil|gemfibrozil
422662|NCT01340846|BRAF|braf
422663|NCT01340846|Drug Interactions|drug interactions
422664|NCT01340846|GSK2118436|gsk2118436
422665|NCT01340846|warfarin|warfarin
422666|NCT01340846|ketoconazole|ketoconazole
422667|NCT01340846|BRAF inhibitor|braf inhibitor
422668|NCT01340846|oncology|oncology
422669|NCT01340846|BRAF positive tumor|braf positive tumor
422670|NCT01340833|GSK2118436|gsk2118436
422671|NCT01340833|BRAF inhibitor|braf inhibitor
422672|NCT01340833|BRAF-mutation positive tumor|braf-mutation positive tumor
422673|NCT01340833|Oncology|oncology
422674|NCT01340833|absolute bioavailability|absolute bioavailability
422675|NCT01340833|microtracer|microtracer
422676|NCT01340781|inpatients|inpatients
422677|NCT01340781|medical|medical
422678|NCT01340781|polysomnogram|polysomnogram
422679|NCT01340781|questionnaires|questionnaires
422680|NCT01340768|Glucose metabolism disorders Metabolic diseases Peptidase inhibitors|glucose metabolism disorders metabolic diseases peptidase inhibitors
422681|NCT01340755|Rectal cancer|rectal cancer
422682|NCT01340742|Remote ischemic preconditioning|remote ischemic preconditioning
422683|NCT01340742|Abdominal surgery|abdominal surgery
422684|NCT01340742|Perioperative complications|perioperative complications
422685|NCT01340729|melanoma|melanoma
422686|NCT01340729|TPI 287|tpi 287
422687|NCT01340729|tumor recurrence|tumor recurrence
422688|NCT01340729|tumor progression|tumor progression
422689|NCT01340729|novel taxane analog|novel taxane analog
422690|NCT01340703|optic disc pit|optic disc pit
422691|NCT01340703|retinal detachment|retinal detachment
422692|NCT01340703|retinoschisis|retinoschisis
422693|NCT01340703|vitrectomy|vitrectomy
422694|NCT01340703|posterior vitreous detachment|posterior vitreous detachment
422695|NCT01340690|ADHD|adhd
422696|NCT01340690|children|children
422697|NCT01340690|adolescents|adolescents
422698|NCT01340690|Polyunsaturated Fatty Acids|polyunsaturated fatty acids
422699|NCT01340690|ADHDRS - IV|adhdrs - iv
422700|NCT01340677|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
422701|NCT01340677|Pharmacokinetic|pharmacokinetic
422702|NCT01340677|Dose proportionality|dose proportionality
422703|NCT01340664|Canagliflozin|canagliflozin
422704|NCT01340664|Placebo|placebo
422705|NCT01340664|Metformin|metformin
422706|NCT01340664|Hemoglobin A1c|hemoglobin a1c
422707|NCT01340664|Type 2 diabetes mellitus|type 2 diabetes mellitus
422708|NCT01340651|myelofibrosis|myelofibrosis
422709|NCT01340651|myeloproliferative neoplasms|myeloproliferative neoplasms
422710|NCT01340651|PMF|pmf
422711|NCT01340651|PET-MF|pet-mf
422712|NCT01340651|PPV-MF|ppv-mf
422713|NCT01340638|Seal pressure|seal pressure
422714|NCT01340638|Cookgas|cookgas
422715|NCT01340638|AirQ|airq
422716|NCT01340638|LMA|lma
422717|NCT01340638|supraglottic device|supraglottic device
422718|NCT01340625|Healthy Subjects|healthy subjects
422719|NCT01340612|large aneurysm|large aneurysm
422720|NCT01340612|wide-necked aneurysm|wide-necked aneurysm
422721|NCT01340612|recurring aneurysm|recurring aneurysm
422722|NCT01340586|PHARMACOKINETIC|pharmacokinetic
422723|NCT01340586|NOS|nos
422724|NCT01340573|Chronic Hepatitis C|chronic hepatitis c
422725|NCT01340573|pegylated interferon|pegylated interferon
422726|NCT01340573|PegIntron Pen|pegintron pen
422727|NCT01340573|Ribavirin|ribavirin
422825|NCT01340131|Primary Hypertension|primary hypertension
422728|NCT01340560|Endometrium, local injury, implantation, pregnancy, in vitro fertilization|endometrium, local injury, implantation, pregnancy, in vitro fertilization
422729|NCT01340547|Phase I|phase i
422730|NCT01340547|Safety|safety
422731|NCT01340547|PK|pk
422732|NCT01340547|ECG QTc|ecg qtc
422733|NCT01340547|Efficacy|efficacy
422734|NCT01340547|Palifosfamide-tris|palifosfamide-tris
422735|NCT01340547|non-randomized|non-randomized
422736|NCT01340534|Surgical wound infection|surgical wound infection
422737|NCT01340534|Oxygen|oxygen
422738|NCT01340534|Cesarean|cesarean
422739|NCT01340521|Pituitary Hormone Response|pituitary hormone response
422740|NCT01340521|Clomiphene Citrate|clomiphene citrate
422741|NCT01340521|Follicle Stimulating Hormone|follicle stimulating hormone
422742|NCT01340521|Luteinizing Hormone|luteinizing hormone
422743|NCT01340508|Pathological complete response|pathological complete response
422744|NCT01340508|Intensity modulated radiotherapy|intensity modulated radiotherapy
422745|NCT01340508|Rectal cancer|rectal cancer
422746|NCT01340495|Breast Cancer|breast cancer
422747|NCT01340495|Mastectomy|mastectomy
422748|NCT01340482|XLH|xlh
422749|NCT01340469|nosocomial infections|nosocomial infections
422750|NCT01340469|necrotizing enterocolitis|necrotizing enterocolitis
422751|NCT01340469|preterm infants|preterm infants
422752|NCT01340469|ver low birth weight|ver low birth weight
422753|NCT01340469|probiotics|probiotics
422754|NCT01340456|4beta-OHcholesterol|4beta-ohcholesterol
422755|NCT01340456|Midazolam|midazolam
422756|NCT01340456|CYP3A4|cyp3a4
422757|NCT01340456|Enzyme induction|enzyme induction
422758|NCT01340456|Drug metabolism|drug metabolism
422759|NCT01340430|her2 positive breast cancer|her2 positive breast cancer
422760|NCT01340430|her2 positive non operable breast cancer|her2 positive non operable breast cancer
422761|NCT01340430|her2 positive locally advanced breast cancer|her2 positive locally advanced breast cancer
422762|NCT01340430|neoadjuvant trastuzumab|neoadjuvant trastuzumab
422763|NCT01340430|pathologic complete response|pathologic complete response
422764|NCT01340417|melatonin|melatonin
422765|NCT01340417|preterm|preterm
422766|NCT01340417|deficiency|deficiency
422767|NCT01340417|neuroprotection|neuroprotection
422768|NCT01340391|cast, radius fracture|cast, radius fracture
422769|NCT01340378|neonatal surgery|neonatal surgery
422770|NCT01340378|Blalock-Taussig shunt|blalock-taussig shunt
422771|NCT01340339|Jaundice|jaundice
422772|NCT01340339|Hyperbilirubinemia|hyperbilirubinemia
422773|NCT01340339|Phototherapy and Super-LED Fluorescent lamps|phototherapy and super-led fluorescent lamps
422774|NCT01340326|Post myocardial infarction ventricular remodeling|post myocardial infarction ventricular remodeling
422775|NCT01340326|valsartan|valsartan
422776|NCT01340313|caudal block, children, ultrasound, urological surgery|caudal block, children, ultrasound, urological surgery
422777|NCT01340300|Colorectal|colorectal
422778|NCT01340300|Breast|breast
422779|NCT01340300|Insulin|insulin
422780|NCT01340300|Exercise|exercise
422781|NCT01340287|Plant sterol|plant sterol
422782|NCT01340287|Hypercholesterolemia|hypercholesterolemia
422783|NCT01340287|diet|diet
422784|NCT01340287|dairy|dairy
422785|NCT01340287|isoprostanes|isoprostanes
422786|NCT01340287|Midly hypercholesterolemic subjects|midly hypercholesterolemic subjects
422787|NCT01340274|Community Reinforcement and Family Training|community reinforcement and family training
422788|NCT01340274|Concerned Significant Others|concerned significant others
422789|NCT01340274|Identified Problem Gambler|identified problem gambler
422790|NCT01340274|Therapeutics|therapeutics
422791|NCT01340261|Pediatric|pediatric
422792|NCT01340261|Chronic Pain|chronic pain
422793|NCT01340248|food effect|food effect
422794|NCT01340248|pharmacokinetics|pharmacokinetics
422795|NCT01340248|healthy male volunteers|healthy male volunteers
422796|NCT01340222|Preterm labour|preterm labour
422797|NCT01340222|monocyte|monocyte
422798|NCT01340222|lymphocyte|lymphocyte
422799|NCT01340222|MCP-1|mcp-1
422800|NCT01340222|Treg Lymphocytes|treg lymphocytes
422801|NCT01340222|biologic markers|biologic markers
422802|NCT01340222|immunology|immunology
422803|NCT01340222|HLA-DR|hla-dr
422804|NCT01340222|Th17|th17
422805|NCT01340183|Phase I|phase i
422806|NCT01340183|safety|safety
422807|NCT01340183|tolerability|tolerability
422808|NCT01340183|pharmacokinetics|pharmacokinetics
422809|NCT01340183|AZD5099|azd5099
422810|NCT01340183|volunteers|volunteers
422811|NCT01340183|safety of the drug AZD5099|safety of the drug azd5099
422812|NCT01340183|blood and urine levels of AZD5099|blood and urine levels of azd5099
422813|NCT01340183|single intravenous doses|single intravenous doses
422814|NCT01340183|healthy volunteers|healthy volunteers
422815|NCT01340157|Fexinidazole|fexinidazole
422816|NCT01340157|Phase I|phase i
422817|NCT01340157|Bioavailability study|bioavailability study
422818|NCT01340157|Food effect|food effect
422819|NCT01340157|Human African Trypanosomiasis|human african trypanosomiasis
422820|NCT01340144|total knee replacement|total knee replacement
422821|NCT01340144|patellar crepitus|patellar crepitus
422822|NCT01340144|Replacement of knee joint|replacement of knee joint
422823|NCT01340131|CKD-828|ckd-828
422824|NCT01340131|Hypertension|hypertension
422826|NCT01340131|Healthy Volunteer|healthy volunteer
422827|NCT01340131|S-Amlodipine|s-amlodipine
422828|NCT01340131|Telmisartan|telmisartan
422829|NCT01340131|Amlodipine|amlodipine
422830|NCT01340131|Pharmacokinetic|pharmacokinetic
422831|NCT01340131|Phase 1|phase 1
422832|NCT01340118|Asthma|asthma
422833|NCT01340118|FEF25-75|fef25-75
422834|NCT01340118|exhaled nitric oxide|exhaled nitric oxide
422835|NCT01340118|inhaled corticosteroid|inhaled corticosteroid
422836|NCT01340118|children|children
422837|NCT01340105|Microwave ablation|microwave ablation
422838|NCT01340105|Radiofrequency ablation|radiofrequency ablation
422839|NCT01340105|Randomised controlled trial|randomised controlled trial
422840|NCT01340092|Family Navigator|family navigator
422841|NCT01340092|Autistic Disorder|autistic disorder
422842|NCT01340092|Early Intervention|early intervention
422843|NCT01340092|Developmental Disabilities|developmental disabilities
422844|NCT01340092|Child Development Disorders|child development disorders
422845|NCT01340079|diabetes mellitus, non-insulin dependent|diabetes mellitus, non-insulin dependent
422846|NCT01340066|urinary incontinence|urinary incontinence
422847|NCT01340066|stress incontinence|stress incontinence
422848|NCT01340066|urge incontinence|urge incontinence
422849|NCT01340066|mixed incontinence|mixed incontinence
422850|NCT01340040|Phase I|phase i
422851|NCT01340040|cancer|cancer
422852|NCT01340040|solid tumours|solid tumours
422853|NCT01340040|advanced solid malignancies|advanced solid malignancies
422854|NCT01340040|dose escalation|dose escalation
422855|NCT01340040|Insulin like growth factor|insulin like growth factor
422856|NCT01340040|Japanese|japanese
422857|NCT01340027|Overactive bladder (OAB)|overactive bladder (oab)
422858|NCT01340027|Frequency|frequency
422859|NCT01340027|Micturition|micturition
422860|NCT01340027|Urgency|urgency
422861|NCT01340027|Urinary incontinence|urinary incontinence
422862|NCT01340027|Urgency incontinence|urgency incontinence
422863|NCT01340027|YM178|ym178
422864|NCT01340014|Glaucoma|glaucoma
422865|NCT01340014|Intraocular pressure|intraocular pressure
422866|NCT01340014|Tonometry, ocular|tonometry, ocular
422867|NCT01340001|Dementia with Lewy bodies|dementia with lewy bodies
422868|NCT01340001|Nucleus basalis of Meynert|nucleus basalis of meynert
422869|NCT01340001|Deep brain stimulation|deep brain stimulation
422870|NCT01339988|Stem-cells|stem-cells
422871|NCT01339988|Transplantation|transplantation
422872|NCT01339988|Busulfex|busulfex
422873|NCT01339988|Cyclophosphamide|cyclophosphamide
422874|NCT01339988|Total-Body-Ittadiation|total-body-ittadiation
422875|NCT01339975|Renal Cell Carcinoma|renal cell carcinoma
422876|NCT01339975|Nephrectomy|nephrectomy
422877|NCT01339975|Antiangiogenics|antiangiogenics
422878|NCT01339975|Chemokines|chemokines
422879|NCT01339975|Prognostic value|prognostic value
422880|NCT01339975|Carcinoma|carcinoma
422881|NCT01339975|Carcinoma, Renal Cell|carcinoma, renal cell
422882|NCT01339975|Kidney Neoplasms|kidney neoplasms
422883|NCT01339975|Kidney Diseases|kidney diseases
422884|NCT01339975|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
422885|NCT01339975|Neoplasms by Histologic Type|neoplasms by histologic type
422886|NCT01339975|Neoplasms|neoplasms
422887|NCT01339975|Adenocarcinoma|adenocarcinoma
422888|NCT01339975|Urologic Neoplasms|urologic neoplasms
422889|NCT01339975|Urogenital Neoplasms|urogenital neoplasms
422890|NCT01339975|Neoplasms by Site|neoplasms by site
422891|NCT01339975|Urologic Diseases|urologic diseases
422892|NCT01339975|Adjuvants, Immunologic|adjuvants, immunologic
422893|NCT01339975|Physiological Effects of Drugs|physiological effects of drugs
422894|NCT01339975|Pharmacologic Actions|pharmacologic actions
422895|NCT01339975|Biomarkers|biomarkers
422896|NCT01339975|Targeted therapies|targeted therapies
422897|NCT01339975|Surgery|surgery
422898|NCT01339962|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
422899|NCT01339949|AMD|amd
422900|NCT01339949|wet AMD|wet amd
422901|NCT01339949|Macular Degeneration|macular degeneration
422902|NCT01339949|wet Age-related Macular Degeneration|wet age-related macular degeneration
422903|NCT01339949|Age-Related Macular Degeneration|age-related macular degeneration
422904|NCT01339949|IRay|iray
422905|NCT01339949|radiation|radiation
422906|NCT01339949|Oraya|oraya
422907|NCT01339949|Oraya Therapeutics, Inc|oraya therapeutics, inc
422908|NCT01339949|Low-voltage stereotactic radiosurgery|low-voltage stereotactic radiosurgery
422909|NCT01339949|radiosurgery|radiosurgery
422910|NCT01339949|x-ray|x-ray
422911|NCT01339949|Lucentis|lucentis
422912|NCT01339949|external beam radiation|external beam radiation
422913|NCT01339923|Meningococcal disease|meningococcal disease
422914|NCT01339923|Vaccines|vaccines
422915|NCT01339923|intercalated administration|intercalated administration
422916|NCT01339910|Acute Myelogenous Leukemia|acute myelogenous leukemia
422917|NCT01339910|Myelodysplastic Syndrome|myelodysplastic syndrome
422918|NCT01339897|N6022, GSNORi|n6022, gsnori
422919|NCT01339884|Friedreich ataxia|friedreich ataxia
422920|NCT01339884|Resveratrol|resveratrol
422921|NCT01339884|Frataxin|frataxin
422922|NCT01339884|Cardiomyopathy|cardiomyopathy
422923|NCT01339884|Oxidative stress|oxidative stress
422926|NCT01339871|Advanced Malignancies|advanced malignancies
422927|NCT01339845|Cholera vaccine|cholera vaccine
422928|NCT01339845|Behaviour change intervention|behaviour change intervention
422929|NCT01339845|Cost effectiveness and cost-benefit|cost effectiveness and cost-benefit
422930|NCT01339845|Prevention of cholera|prevention of cholera
422931|NCT01339845|Control of Cholera|control of cholera
422932|NCT01339845|Vaccination|vaccination
422933|NCT01339806|mTBI|mtbi
422934|NCT01339806|Concussion|concussion
422935|NCT01339793|corporate social responsibility|corporate social responsibility
422936|NCT01339793|social identity theory|social identity theory
422937|NCT01339793|stakeholder theory|stakeholder theory
422938|NCT01339793|organizational commitment|organizational commitment
422939|NCT01339793|organizational performance|organizational performance
422940|NCT01339767|Autism|autism
422941|NCT01339767|Language Acquisition|language acquisition
422942|NCT01339767|Language Development|language development
422943|NCT01339767|Toddlers|toddlers
422944|NCT01339754|recurrent pancreatic cancer|recurrent pancreatic cancer
422945|NCT01339754|stage IV pancreatic cancer|stage iv pancreatic cancer
422946|NCT01339754|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
422947|NCT01339741|Psoriasis Vulgaris|psoriasis vulgaris
422948|NCT01339741|Vitamin D Deficiency|vitamin d deficiency
422949|NCT01339741|Vitamin D Insufficiency|vitamin d insufficiency
422950|NCT01339741|Vitamin D Supplement|vitamin d supplement
422951|NCT01339741|Psoriasis Area and Severity Index (PASI Score)|psoriasis area and severity index (pasi score)
422952|NCT01339741|Dermatologic Life Qualify Index (DLQI)|dermatologic life qualify index (dlqi)
422953|NCT01339715|Ryodoraku|ryodoraku
422954|NCT01339715|Heart Rate Variability|heart rate variability
422955|NCT01339715|Traditional medicine|traditional medicine
422956|NCT01339715|Autonomic Nervous System|autonomic nervous system
422957|NCT01339715|Acupuncture|acupuncture
422958|NCT01339715|Far Infrared Ray|far infrared ray
422959|NCT01339715|CV12 Acupoint|cv12 acupoint
422960|NCT01339702|Traumatic Brain Injury|traumatic brain injury
422961|NCT01339702|TBI|tbi
422962|NCT01339702|Head Trauma|head trauma
422963|NCT01339702|Acute Traumatic Brain Injury|acute traumatic brain injury
422964|NCT01339702|Trauma, Brain|trauma, brain
422965|NCT01339689|PTSD|ptsd
422966|NCT01339689|Posttraumatic Stress Disorder|posttraumatic stress disorder
422967|NCT01339689|pharmacotherapy|pharmacotherapy
422968|NCT01339689|ganaxolone|ganaxolone
422969|NCT01339676|Vitamin D|vitamin d
422970|NCT01339676|Multiple Sclerosis|multiple sclerosis
422971|NCT01339676|MRI|mri
422972|NCT01339676|Randomised Trial|randomised trial
422973|NCT01339676|Finland|finland
422974|NCT01339650|Solid Tumor|solid tumor
422975|NCT01339650|BRCA 1 and BRCA 2 Mutations|brca 1 and brca 2 mutations
422976|NCT01339650|Breast Cancer 1|breast cancer 1
422977|NCT01339650|Breast Cancer 2|breast cancer 2
422978|NCT01339650|High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancers|high grade serous ovarian, fallopian tube, or primary peritoneal cancers
422979|NCT01339650|Solid Tumors|solid tumors
422980|NCT01339637|Impaired Glucose Tolerance|impaired glucose tolerance
422981|NCT01339637|Diabetes Risk Factors|diabetes risk factors
422982|NCT01339637|Dark Skin|dark skin
422983|NCT01339624|analgesia|analgesia
422984|NCT01339624|renal colic|renal colic
422985|NCT01339624|ketorolac|ketorolac
422986|NCT01339624|nasal fentanyl|nasal fentanyl
422987|NCT01339624|morphine.|morphine.
422988|NCT01339624|treatment of acute renal colic|treatment of acute renal colic
422989|NCT01339611|quality of life|quality of life
422990|NCT01339611|medical adherence|medical adherence
422991|NCT01339611|warfarin|warfarin
422992|NCT01339611|Health education|health education
422993|NCT01339572|autologous transplantation|autologous transplantation
422994|NCT01339572|peripheral stem cell mobilization|peripheral stem cell mobilization
422995|NCT01339559|Epilepsy|epilepsy
422996|NCT01339559|Brivaracetam|brivaracetam
422997|NCT01339559|Partial Onset Seizures|partial onset seizures
422998|NCT01339559|Adjunctive treatment|adjunctive treatment
422999|NCT01339546|ecologic|ecologic
423000|NCT01339546|cross sectional|cross sectional
423001|NCT01339546|trend analysis|trend analysis
423002|NCT01339533|ALI|ali
423003|NCT01339533|ARDS|ards
423004|NCT01339481|Orencia|orencia
423005|NCT01339481|Abatacept|abatacept
423006|NCT01339481|Rheumatoid Arthritis|rheumatoid arthritis
423007|NCT01339481|Infusion|infusion
423008|NCT01339468|advagraf|advagraf
423009|NCT01339468|prograf|prograf
423010|NCT01339468|living donor liver transplantation|living donor liver transplantation
423011|NCT01339468|FK506|fk506
423012|NCT01339468|Immunosuppressant|immunosuppressant
423013|NCT01339455|Neuromyelitis Optica|neuromyelitis optica
423014|NCT01339455|NMO|nmo
423015|NCT01339455|Devic's Disease|devic's disease
423016|NCT01339455|Stem Cell Transplant|stem cell transplant
423017|NCT01339429|wound|wound
423018|NCT01339429|negative pressure wound therapy|negative pressure wound therapy
423019|NCT01339429|non-powered negative pressure wound therapy|non-powered negative pressure wound therapy
423020|NCT01339390|Obesity|obesity
423021|NCT01339390|Veteran|veteran
423022|NCT01339390|Self Care|self care
423215|NCT01338701|Acupuncture|acupuncture
423023|NCT01339390|Patient Education|patient education
423024|NCT01339390|Peer Group|peer group
423025|NCT01339377|Ozone|ozone
423026|NCT01339377|Oxygen|oxygen
423027|NCT01339377|Oxygen-Ozone|oxygen-ozone
423028|NCT01339377|AO-1000|ao-1000
423029|NCT01339377|ActiveO|activeo
423030|NCT01339377|Herniated Disc|herniated disc
423031|NCT01339377|Disc|disc
423032|NCT01339377|Lumbar|lumbar
423033|NCT01339351|breast cancer|breast cancer
423034|NCT01339351|social connection|social connection
423035|NCT01339325|Laparo-endoscopic single site cholecystectomy|laparo-endoscopic single site cholecystectomy
423036|NCT01339325|Quality of Life|quality of life
423037|NCT01339325|Postoperative Pain|postoperative pain
423038|NCT01339325|Cosmetics|cosmetics
423039|NCT01339325|Complication|complication
423040|NCT01339312|Rabies|rabies
423041|NCT01339312|Rabies virus|rabies virus
423042|NCT01339312|Purified Vero Rabies Vaccine - Serum Free|purified vero rabies vaccine - serum free
423043|NCT01339299|COS|cos
423044|NCT01339299|ART|art
423045|NCT01339299|Infertility|infertility
423046|NCT01339273|TAP block|tap block
423047|NCT01339273|Laparoscopic hemicolectomy|laparoscopic hemicolectomy
423048|NCT01339273|Laparoscopic anterior resection|laparoscopic anterior resection
423049|NCT01339273|laparoscopic colonic resection|laparoscopic colonic resection
423050|NCT01339247|Bioequivalence|bioequivalence
423051|NCT01339247|Paroxetine reference/test|paroxetine reference/test
423052|NCT01339247|healthy volunteers|healthy volunteers
423053|NCT01339247|Fed condition|fed condition
423054|NCT01339234|treadmill exercise|treadmill exercise
423055|NCT01339234|rehabilitation|rehabilitation
423056|NCT01339234|progressive multiple sclerosis|progressive multiple sclerosis
423057|NCT01339234|functional ability|functional ability
423058|NCT01339234|quality of life|quality of life
423059|NCT01339234|fatigue|fatigue
423060|NCT01339221|Observational|observational
423061|NCT01339221|Rotarix™|rotarix™
423062|NCT01339221|post-marketing|post-marketing
423063|NCT01339208|Type 2 Diabetes|type 2 diabetes
423064|NCT01339195|Dementia|dementia
423065|NCT01339195|Alzheimer disease|alzheimer disease
423066|NCT01339195|stroke|stroke
423067|NCT01339195|cognitive impairment|cognitive impairment
423068|NCT01339182|somatropin|somatropin
423070|NCT01339182|PD|pd
423071|NCT01339182|male|male
423072|NCT01339182|pharmacokinetics|pharmacokinetics
423073|NCT01339182|pharmacodynamics|pharmacodynamics
423074|NCT01339182|safety|safety
423075|NCT01339169|YF476|yf476
423076|NCT01339169|Hypergastrinaemia|hypergastrinaemia
423077|NCT01339169|netazepide|netazepide
423078|NCT01339169|gastric carcinoids|gastric carcinoids
423079|NCT01339156|Safety|safety
423080|NCT01339156|Tolerability|tolerability
423081|NCT01339156|Food Effect|food effect
423082|NCT01339156|Pharmacokinetics|pharmacokinetics
423083|NCT01339143|Vildagliptin|vildagliptin
423084|NCT01339130|Alzheimer disease|alzheimer disease
423085|NCT01339130|Stroke|stroke
423086|NCT01339130|Frontotemporal Lobar Degeneration|frontotemporal lobar degeneration
423087|NCT01339130|Lewy Body Dementia|lewy body dementia
423088|NCT01339130|Huntington Disease|huntington disease
423089|NCT01339130|mild cognitive impairment|mild cognitive impairment
423090|NCT01339130|vascular injury|vascular injury
423091|NCT01339130|Parkinson's disease|parkinson's disease
423092|NCT01339117|irritable bowel syndrome|irritable bowel syndrome
423093|NCT01339117|children|children
423094|NCT01339117|chronic abdominal pain|chronic abdominal pain
423095|NCT01339117|recurrent abdominal pain|recurrent abdominal pain
423096|NCT01339104|Cardiovascular safety|cardiovascular safety
423097|NCT01339078|Biliary strictures|biliary strictures
423098|NCT01339078|liver transplantation|liver transplantation
423099|NCT01339065|ketamine|ketamine
423100|NCT01339065|inflammatory|inflammatory
423101|NCT01339065|pro inflammatory|pro inflammatory
423102|NCT01339065|pro inflammatory markers IL-6 and IL-1beta|pro inflammatory markers il-6 and il-1beta
423103|NCT01339052|BKM120|bkm120
423104|NCT01339052|Brain tumor|brain tumor
423105|NCT01339039|AMD3100|amd3100
423106|NCT01339039|plerixafor|plerixafor
423107|NCT01339039|Mozobil|mozobil
423108|NCT01339039|bevacizumab|bevacizumab
423109|NCT01339026|Acute coronary syndrome|acute coronary syndrome
423110|NCT01339026|Platelet reactivity|platelet reactivity
423111|NCT01339026|Clopidogrel|clopidogrel
423112|NCT01339026|Percutaneous coronary intervention|percutaneous coronary intervention
423113|NCT01339013|Quantification|quantification
423114|NCT01339013|ventilatory requirements|ventilatory requirements
423115|NCT01339013|charcoal filter|charcoal filter
423116|NCT01339000|Colorectal Cancer|colorectal cancer
423117|NCT01339000|Breast Cancer|breast cancer
423118|NCT01339000|Immunization|immunization
423119|NCT01339000|Immunocompromised Host|immunocompromised host
423120|NCT01339000|Bladder Cancer|bladder cancer
423121|NCT01339000|Colon Cancer|colon cancer
423122|NCT01338987|FLT|flt
423123|NCT01338987|Lupron|lupron
423124|NCT01338987|Thymic Renewal|thymic renewal
423125|NCT01338987|Stem Cell Transplant|stem cell transplant
423126|NCT01338987|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
423127|NCT01338987|Acute Myelogenous Leukemia|acute myelogenous leukemia
423128|NCT01338987|Myelodyplastic Syndrome|myelodyplastic syndrome
423129|NCT01338974|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
423130|NCT01338974|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
423131|NCT01338974|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
423132|NCT01338974|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
423133|NCT01338974|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
423134|NCT01338974|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
423135|NCT01338974|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
423136|NCT01338974|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
423137|NCT01338974|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
423138|NCT01338974|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
423139|NCT01338974|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
423140|NCT01338974|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
423141|NCT01338974|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
423142|NCT01338974|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
423143|NCT01338974|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
423144|NCT01338974|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
423145|NCT01338961|Cardiopulmonary Bypass|cardiopulmonary bypass
423146|NCT01338961|Hypothermia|hypothermia
423147|NCT01338961|Normothermia|normothermia
423148|NCT01338961|Troponin I|troponin i
423149|NCT01338961|Bleeding|bleeding
423150|NCT01338935|CW 002|cw 002
423151|NCT01338935|Phase I trial|phase i trial
423152|NCT01338935|safety|safety
423153|NCT01338935|efficacy|efficacy
423154|NCT01338935|pharmacokinetics|pharmacokinetics
423155|NCT01338935|estimated dose|estimated dose
423156|NCT01338935|Neuromuscular Blocking Agents|neuromuscular blocking agents
423157|NCT01338935|Treatment Effectiveness|treatment effectiveness
423158|NCT01338935|Drug Antagonism|drug antagonism
423159|NCT01338909|prasugrel|prasugrel
423160|NCT01338909|clopidogrel|clopidogrel
423161|NCT01338909|primary percutaneous coronary intervention|primary percutaneous coronary intervention
423162|NCT01338909|high platelet reactivity|high platelet reactivity
423163|NCT01338896|Rotigotine|rotigotine
423164|NCT01338896|Neupro|neupro
423165|NCT01338883|HIV-1 Infection|hiv-1 infection
423166|NCT01338883|CCR5-tropic|ccr5-tropic
423167|NCT01338883|Anti-retroviral naive|anti-retroviral naive
423168|NCT01338870|Phase 2|phase 2
423169|NCT01338870|safety and efficacy study with PF-04991532|safety and efficacy study with pf-04991532
423170|NCT01338870|Type 2 diabetes|type 2 diabetes
423171|NCT01338857|neurofibromatosis1 (NF1)|neurofibromatosis1 (nf1)
423172|NCT01338857|Recurrent or progressive optic pathway gliomas (OPG)|recurrent or progressive optic pathway gliomas (opg)
423173|NCT01338857|Recurrent or progressive low-grade glioma|recurrent or progressive low-grade glioma
423174|NCT01338857|sorafenib|sorafenib
423175|NCT01338857|low-grade astrocytoma|low-grade astrocytoma
423176|NCT01338844|Poor oocyte quality|poor oocyte quality
423177|NCT01338844|IVF failure|ivf failure
423178|NCT01338831|prostate cancer,|prostate cancer,
423179|NCT01338831|breast cancer,|breast cancer,
423180|NCT01338831|prolactin,|prolactin,
423181|NCT01338831|prolactin receptor|prolactin receptor
423182|NCT01338831|uterine leiomyoma|uterine leiomyoma
423183|NCT01338818|Attention Deficit /Hyperactivity Disorder,|attention deficit /hyperactivity disorder,
423184|NCT01338818|hyperactivity|hyperactivity
423185|NCT01338805|Partial onset seizure|partial onset seizure
423186|NCT01338805|seizure frequency|seizure frequency
423187|NCT01338805|nervous system diseases|nervous system diseases
423188|NCT01338805|central nervous system diseases|central nervous system diseases
423189|NCT01338805|CNS|cns
423190|NCT01338805|brain diseases|brain diseases
423191|NCT01338805|neurologic manifestations|neurologic manifestations
423192|NCT01338805|adjunctive treatment|adjunctive treatment
423193|NCT01338805|AEDs|aeds
423194|NCT01338805|antiepileptic drug|antiepileptic drug
423195|NCT01338779|Tolerance|tolerance
423196|NCT01338779|Renal|renal
423197|NCT01338779|Allograft|allograft
423198|NCT01338779|B Cell Signature|b cell signature
423199|NCT01338766|spondylolisthesis|spondylolisthesis
423200|NCT01338766|lumbar spinal stenosis|lumbar spinal stenosis
423201|NCT01338753|breast|breast
423202|NCT01338753|cancer|cancer
423203|NCT01338753|Pharmacogenomics|pharmacogenomics
423204|NCT01338753|bevacizumab|bevacizumab
423205|NCT01338740|Chrohn's disease|chrohn's disease
423206|NCT01338740|Moderate to severely active Crohn's disease patients|moderate to severely active crohn's disease patients
423207|NCT01338714|HBV carrier|hbv carrier
423208|NCT01338714|HBV DNA title|hbv dna title
423209|NCT01338714|Chinese Medicine|chinese medicine
423210|NCT01338714|Liver function|liver function
423211|NCT01338714|RHD-1|rhd-1
423212|NCT01338701|TBI|tbi
423213|NCT01338701|Headaches|headaches
423214|NCT01338701|Military|military
423216|NCT01338701|Walter Reed Army Medical Center|walter reed army medical center
423217|NCT01338701|Fort Belvoir Community Hospital|fort belvoir community hospital
423218|NCT01338675|Chronic granulomatous disease|chronic granulomatous disease
423219|NCT01338675|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
423220|NCT01338662|Parkinson`s disease|parkinson`s disease
423221|NCT01338649|Parkinson's disease|parkinson's disease
423222|NCT01338649|Daytime somnolence|daytime somnolence
423223|NCT01338649|Sleepiness|sleepiness
423224|NCT01338649|Light therapy|light therapy
423225|NCT01338636|Exercise-induced pulmonary arterial hypertension (EIPAH)|exercise-induced pulmonary arterial hypertension (eipah)
423226|NCT01338636|Pulmonary arterial hypertension (PAH)|pulmonary arterial hypertension (pah)
423227|NCT01338636|ambrisentan|ambrisentan
423228|NCT01338636|Advanced cardiopulmonary exercise test (CPET)|advanced cardiopulmonary exercise test (cpet)
423229|NCT01338623|bioequivalence|bioequivalence
423230|NCT01338623|tansulosine|tansulosine
423231|NCT01338610|Ocular discomfort|ocular discomfort
423232|NCT01338597|thyroidectomy|thyroidectomy
423233|NCT01338597|invasiveness|invasiveness
423234|NCT01338584|Pelvic floor muscle training|pelvic floor muscle training
423235|NCT01338584|Post prostatectomy|post prostatectomy
423236|NCT01338584|Early regaining of urinary continence|early regaining of urinary continence
423237|NCT01338584|Positive improvement in quality of life|positive improvement in quality of life
423238|NCT01338571|stool fatty acid|stool fatty acid
423239|NCT01338532|Hip osteoarthritis|hip osteoarthritis
423240|NCT01338532|Exercise|exercise
423241|NCT01338532|Patient Education|patient education
423242|NCT01338532|Total Hip Replacement|total hip replacement
423243|NCT01338506|Military|military
423244|NCT01338506|Posttraumatic Stress Disorder|posttraumatic stress disorder
423245|NCT01338506|PTSD|ptsd
423246|NCT01338506|PostTraumatic Stress Disorders|posttraumatic stress disorders
423247|NCT01338506|Combat|combat
423248|NCT01338506|Psychological Treatment|psychological treatment
423249|NCT01338506|Psychotherapy|psychotherapy
423250|NCT01338506|Trauma|trauma
423251|NCT01338506|Posttraumatic Stress|posttraumatic stress
423252|NCT01338506|Prolonged Exposure|prolonged exposure
423253|NCT01338506|Exposure therapy|exposure therapy
423254|NCT01338506|Behavior Therapy|behavior therapy
423255|NCT01338506|Cognitive Behavior Therapy|cognitive behavior therapy
423256|NCT01338506|Stress Disorders|stress disorders
423257|NCT01338506|Drug Abuse|drug abuse
423258|NCT01338506|Drug Dependence|drug dependence
423259|NCT01338506|Alcohol Abuse|alcohol abuse
423260|NCT01338506|Alcohol Dependence|alcohol dependence
423261|NCT01338506|Substance Use Disorders|substance use disorders
423262|NCT01338506|Alcoholism|alcoholism
423263|NCT01338480|trauma|trauma
423264|NCT01338480|surgery|surgery
423265|NCT01338480|informed consent|informed consent
423266|NCT01338467|Glaucoma|glaucoma
423267|NCT01338467|Refractory glaucoma|refractory glaucoma
423268|NCT01338467|Cyclocoagulation|cyclocoagulation
423269|NCT01338467|High Intensity Focused Ultrasound|high intensity focused ultrasound
423270|NCT01338441|Drug induced QT prolongation|drug induced qt prolongation
423271|NCT01338428|rape|rape
423272|NCT01338428|sexual assault|sexual assault
423273|NCT01338428|intervention|intervention
423274|NCT01338428|female university students|female university students
423275|NCT01338415|pediatric|pediatric
423276|NCT01338415|pulmonary arterial hypertension|pulmonary arterial hypertension
423277|NCT01338415|bosentan|bosentan
423278|NCT01338415|Tracleer|tracleer
423279|NCT01338363|acid suppressing drugs|acid suppressing drugs
423280|NCT01338363|pharmacoepidemiology|pharmacoepidemiology
423281|NCT01338363|children|children
423282|NCT01338350|safety|safety
423283|NCT01338350|tolerability|tolerability
423284|NCT01338350|pharmacokinetics|pharmacokinetics
423285|NCT01338350|pharmacodynamics|pharmacodynamics
423286|NCT01338350|AZD5423|azd5423
423287|NCT01338350|Japanese|japanese
423288|NCT01338337|Low risk International Prognostic Scoring System (IPSS) (0 or Int-1)|low risk international prognostic scoring system (ipss) (0 or int-1)
423289|NCT01338337|Patients who have not responded to previous treatment with erythropoietin (EPO)|patients who have not responded to previous treatment with erythropoietin (epo)
423290|NCT01338337|Eastern Cooperative Oncology Group (ECOG) score ≤ 3|eastern cooperative oncology group (ecog) score ≤ 3
423291|NCT01338324|Biomarker|biomarker
423292|NCT01338324|Pharmacokinetics|pharmacokinetics
423293|NCT01338324|Villous|villous
423294|NCT01338324|Simvastatin|simvastatin
423295|NCT01338324|Celiac disease|celiac disease
423296|NCT01338298|Schizophrenia|schizophrenia
423297|NCT01338298|Symptomatic Hyperprolactinemia|symptomatic hyperprolactinemia
423298|NCT01338298|Hormone|hormone
423299|NCT01338298|Menstrual|menstrual
423300|NCT01338285|Industry Hygiene|industry hygiene
423301|NCT01338285|Molecular Epidemiology|molecular epidemiology
423302|NCT01338285|Cancer Susceptability|cancer susceptability
423303|NCT01338285|Genotoxocity|genotoxocity
423304|NCT01338285|FISH|fish
423305|NCT01338142|postmenopausal|postmenopausal
423306|NCT01338142|women|women
423307|NCT01338142|absorption|absorption
423308|NCT01338142|calcium|calcium
423309|NCT01338142|amorphous calcium|amorphous calcium
423310|NCT01338129|vitamin c|vitamin c
423311|NCT01338129|ascorbic acid|ascorbic acid
423312|NCT01338129|ankle fracture|ankle fracture
423313|NCT01338129|crps|crps
423314|NCT01338129|rds|rds
423315|NCT01338129|crps prevention|crps prevention
423316|NCT01338116|computerized decision support system|computerized decision support system
423317|NCT01338116|PCR|pcr
423318|NCT01338116|antibiotic treatment|antibiotic treatment
423319|NCT01338103|Pemphigus|pemphigus
423320|NCT01338103|Rituximab|rituximab
423321|NCT01338103|Cylex|cylex
423322|NCT01338090|VEGF imaging|vegf imaging
423323|NCT01338090|neuroendocrine tumors|neuroendocrine tumors
423324|NCT01338090|biomarker|biomarker
423325|NCT01338090|mTOR inhibition|mtor inhibition
423326|NCT01338077|Alginate|alginate
423327|NCT01338077|Gastroesophageal reflux disease|gastroesophageal reflux disease
423328|NCT01338064|Silicosis|silicosis
423329|NCT01338051|Community based participatory research|community based participatory research
423330|NCT01338025|HIV|hiv
423331|NCT01338025|Bridging|bridging
423332|NCT01338025|Strategy|strategy
423333|NCT01338012|metastatic castrate resistant prostate cancer|metastatic castrate resistant prostate cancer
423334|NCT01338012|prostate cancer|prostate cancer
423335|NCT01338012|prostate|prostate
423336|NCT01338012|immune therapy|immune therapy
423337|NCT01338012|immunotherapy|immunotherapy
423338|NCT01338012|vaccine|vaccine
423339|NCT01338012|dendritic cells|dendritic cells
423340|NCT01338012|antigen-presenting cells|antigen-presenting cells
423341|NCT01338012|antigen presenting cells|antigen presenting cells
423342|NCT01338012|cancer vaccine|cancer vaccine
423343|NCT01338012|prostatic adenocarcinoma|prostatic adenocarcinoma
423344|NCT01338012|Sipuleucel-T|sipuleucel-t
423345|NCT01338012|castration resistant prostate cancer (CRPC)|castration resistant prostate cancer (crpc)
423346|NCT01338012|booster|booster
423347|NCT01338012|retreatment|retreatment
423348|NCT01338012|immune memory|immune memory
423349|NCT01338012|immune response|immune response
423350|NCT01337986|Multiple Sclerosis|multiple sclerosis
423351|NCT01337986|Optic Neuritis|optic neuritis
423352|NCT01337986|Ampyra|ampyra
423353|NCT01337986|Dalfampridine|dalfampridine
423354|NCT01337986|Fampridine|fampridine
423355|NCT01337986|Remote Optic Neuritis|remote optic neuritis
423356|NCT01337986|Contrast Sensitivity|contrast sensitivity
423357|NCT01337986|Treatment|treatment
423358|NCT01337973|violence|violence
423359|NCT01337973|aggression|aggression
423360|NCT01337973|Substance-Related Disorders|substance-related disorders
423361|NCT01337973|Alcohol-Related Disorders|alcohol-related disorders
423362|NCT01337973|Drug-Related Disorders|drug-related disorders
423363|NCT01337960|Stroke|stroke
423364|NCT01337960|Robotics|robotics
423365|NCT01337960|Neurorehabilitation|neurorehabilitation
423366|NCT01337947|Type 1 diabetes|type 1 diabetes
423367|NCT01337947|adolescents|adolescents
423368|NCT01337947|exercise|exercise
423369|NCT01337947|vascular function|vascular function
423370|NCT01337934|Septic shock|septic shock
423371|NCT01337934|Sepsis|sepsis
423372|NCT01337934|Albumin|albumin
423373|NCT01337934|Lactated Ringer|lactated ringer
423374|NCT01337908|depression|depression
423375|NCT01337908|quality of life|quality of life
423376|NCT01337908|disability|disability
423377|NCT01337895|Dairy|dairy
423378|NCT01337895|obesity|obesity
423379|NCT01337895|overweight|overweight
423380|NCT01337895|weight loss|weight loss
423381|NCT01337895|adults|adults
423382|NCT01337882|Air Pollution|air pollution
423383|NCT01337882|Diesel exhaust|diesel exhaust
423384|NCT01337882|Biodiesel exhaust|biodiesel exhaust
423385|NCT01337882|Vascular function|vascular function
423386|NCT01337882|Fibrinolysis|fibrinolysis
423387|NCT01337882|Acute vascular and endothelial responses|acute vascular and endothelial responses
423388|NCT01337869|Bascom Procedure, Limberg, Pilonidal Disease|bascom procedure, limberg, pilonidal disease
423389|NCT01337856|time-effectiveness|time-effectiveness
423390|NCT01337856|hand hygiene protocols|hand hygiene protocols
423391|NCT01337843|Chronic low back pain|chronic low back pain
423392|NCT01337843|cognitive behavioral pain management|cognitive behavioral pain management
423393|NCT01337843|coping|coping
423394|NCT01337843|mindfulness|mindfulness
423395|NCT01337843|physical activity|physical activity
423396|NCT01337843|Back Pain Lower Back Chronic|back pain lower back chronic
423397|NCT01337830|smoking|smoking
423398|NCT01337830|smokeless|smokeless
423399|NCT01337830|aversion|aversion
423400|NCT01337830|nicotine|nicotine
423401|NCT01337830|nicotine replacement|nicotine replacement
423402|NCT01337817|smoking|smoking
423403|NCT01337817|smokeless|smokeless
423404|NCT01337817|aversion|aversion
423405|NCT01337817|nicotine|nicotine
423406|NCT01337817|nicotine replacement|nicotine replacement
423407|NCT01337791|chronic hepatitis B|chronic hepatitis b
423408|NCT01337791|hepatitis B virus|hepatitis b virus
423409|NCT01337791|perinatal transmission|perinatal transmission
423410|NCT01337791|Telbivudine|telbivudine
423411|NCT01337778|gender based violence|gender based violence
423412|NCT01337778|maternal and child health|maternal and child health
423413|NCT01337778|women|women
423414|NCT01337778|India|india
423415|NCT01337765|BEZ235,|bez235,
423416|NCT01337765|MEK162|mek162
423417|NCT01337765|RAS RAF mutations,|ras raf mutations,
423418|NCT01337765|triple negative breast cancer|triple negative breast cancer
423419|NCT01337765|pancreatic cancer,|pancreatic cancer,
423420|NCT01337765|NSCLC progressed on EGFR TKI|nsclc progressed on egfr tki
423421|NCT01337765|PI3K/mTOR inhibitor,|pi3k/mtor inhibitor,
423422|NCT01337765|MEK inhibitor|mek inhibitor
423423|NCT01337765|Advanced and selected solid tumors|advanced and selected solid tumors
423424|NCT01337752|multiple myeloma|multiple myeloma
423425|NCT01337752|renal insufficiency|renal insufficiency
423426|NCT01337752|untreated multiple myeloma|untreated multiple myeloma
423427|NCT01337739|Hysteroscopic Surgery|hysteroscopic surgery
423428|NCT01337739|Dexmedetomidine|dexmedetomidine
423429|NCT01337739|Sedation|sedation
423430|NCT01337739|Opioids|opioids
423431|NCT01337726|Depression|depression
423432|NCT01337726|Heart Failure|heart failure
423433|NCT01337726|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
423434|NCT01337726|Quality of Life|quality of life
423435|NCT01337726|Functional Impairment|functional impairment
423436|NCT01337713|Anxiety, GAD, Massage|anxiety, gad, massage
423437|NCT01337700|ASD|asd
423438|NCT01337700|Autism|autism
423439|NCT01337700|Autism Spectrum Disorder|autism spectrum disorder
423440|NCT01337700|Asperger Syndrome|asperger syndrome
423441|NCT01337700|Asperger|asperger
423442|NCT01337700|PDD|pdd
423443|NCT01337700|PDD-NOS|pdd-nos
423444|NCT01337687|Autism|autism
423445|NCT01337687|Autism Spectrum Disorders|autism spectrum disorders
423446|NCT01337687|Oxytocin|oxytocin
423447|NCT01337687|Hollander|hollander
423448|NCT01337687|ASD|asd
423449|NCT01337687|Asperger Syndrome|asperger syndrome
423450|NCT01337687|Asperger|asperger
423451|NCT01337661|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
423452|NCT01337661|COPD|copd
423453|NCT01337661|Acute Exacerbation of COPD|acute exacerbation of copd
423454|NCT01337661|AECOPD|aecopd
423455|NCT01337648|Fecal biomarkers|fecal biomarkers
423456|NCT01337648|Radiation biodosimetry|radiation biodosimetry
423457|NCT01337648|Total-body irradiation (TBI)|total-body irradiation (tbi)
423458|NCT01337648|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
423459|NCT01337648|Gene expression profiles|gene expression profiles
423460|NCT01337648|Fecal metabolites|fecal metabolites
423461|NCT01337609|Depression|depression
423462|NCT01337609|Irritable Bowel Syndrome|irritable bowel syndrome
423463|NCT01337609|Probiotic|probiotic
423464|NCT01337609|Bacillus Coagulans|bacillus coagulans
423465|NCT01337596|pain|pain
423466|NCT01337596|neuropathic pain|neuropathic pain
423467|NCT01337596|headaches|headaches
423468|NCT01337583|HIV Infections|hiv infections
423469|NCT01337583|Anti-HIV agents|anti-hiv agents
423470|NCT01337583|HIV-1|hiv-1
423471|NCT01337570|HIV Infections|hiv infections
423472|NCT01337570|Anti-HIV agents|anti-hiv agents
423473|NCT01337570|HIV-1|hiv-1
423474|NCT01337557|Allergic conjunctivitis|allergic conjunctivitis
423475|NCT01337544|HAPLOIDENTICAL STEM CELL TRANSPLANTATION|haploidentical stem cell transplantation
423476|NCT01337544|NK CELL|nk cell
423477|NCT01337544|IL-15|il-15
423478|NCT01337531|Ovarian Response in PCOS|ovarian response in pcos
423479|NCT01337531|pregnancy rate in PCOS|pregnancy rate in pcos
423480|NCT01337531|miscarriage rate in PCOS|miscarriage rate in pcos
423481|NCT01337518|Prostate Specific Antigen|prostate specific antigen
423482|NCT01337518|Castration Resistant Prostate Cancer|castration resistant prostate cancer
423483|NCT01337518|Adenocarcinoma|adenocarcinoma
423484|NCT01337518|Androgen Receptor|androgen receptor
423485|NCT01337518|Metastases|metastases
423486|NCT01337505|INNO-206|inno-206
423487|NCT01337505|Phase 1|phase 1
423488|NCT01337505|DOXO-EMCH|doxo-emch
423489|NCT01337505|Advanced solid tumors|advanced solid tumors
423490|NCT01337492|Hepatocellular Carcinoma|hepatocellular carcinoma
423491|NCT01337492|Orthotopic Liver Transplant|orthotopic liver transplant
423492|NCT01337466|Phase I|phase i
423493|NCT01337466|FIAU|fiau
423494|NCT01337466|Fialuridine|fialuridine
423495|NCT01337466|Biodistribution|biodistribution
423496|NCT01337466|Dosimetry|dosimetry
423497|NCT01337466|Prosthetic|prosthetic
423498|NCT01337466|Joint|joint
423499|NCT01337466|Infection|infection
423500|NCT01337466|PET-CT|pet-ct
423501|NCT01337453|botulinum toxin|botulinum toxin
423502|NCT01337453|flu like symptoms|flu like symptoms
423503|NCT01337453|frequency of FLS|frequency of fls
423504|NCT01337453|Botox|botox
423505|NCT01337440|Ursodeoxycholic Acid|ursodeoxycholic acid
423506|NCT01337440|sitagliptin|sitagliptin
423507|NCT01337440|bile acids|bile acids
423508|NCT01337440|GLP-1|glp-1
423509|NCT01337427|multiple sclerosis|multiple sclerosis
423510|NCT01337427|relapsing|relapsing
423511|NCT01337427|MS|ms
423512|NCT01337427|injectable|injectable
423513|NCT01337427|subcutaneous|subcutaneous
423514|NCT01337427|SC|sc
423515|NCT01337427|PEGylated|pegylated
423516|NCT01337427|interferon|interferon
423517|NCT01337427|PEG|peg
423518|NCT01337427|OCT|oct
423519|NCT01337427|Optical Coherence Tomography|optical coherence tomography
423520|NCT01337414|age-related macular degeneration|age-related macular degeneration
423521|NCT01337414|screening|screening
423522|NCT01337414|monitoring|monitoring
423523|NCT01337414|diagnosis|diagnosis
423524|NCT01337414|dry or non-neovascular age-related macular degeneration (high risk, intermediate, geographic atrophy or AREDS grade 3/4 AMD)|dry or non-neovascular age-related macular degeneration (high risk, intermediate, geographic atrophy or areds grade 3/4 amd)
423525|NCT01337401|Cediranib|cediranib
423526|NCT01337401|ASPS|asps
423527|NCT01337401|Sarcoma|sarcoma
423528|NCT01337362|Diabetes|diabetes
423529|NCT01337362|Hypoglycaemia|hypoglycaemia
423530|NCT01337362|EEG|eeg
423531|NCT01337362|Thermography|thermography
423532|NCT01337362|Hypoglycaemia-associated autonomic failure|hypoglycaemia-associated autonomic failure
423533|NCT01337362|QTc interval|qtc interval
423534|NCT01337362|Hypoglycemic alarm device|hypoglycemic alarm device
423535|NCT01337362|Hormone response|hormone response
423536|NCT01337349|Pentoxifylline|pentoxifylline
423537|NCT01337349|Chronic Congestive Heart Failure|chronic congestive heart failure
423538|NCT01337349|Left Systolic Function|left systolic function
423539|NCT01337349|Biomarkers|biomarkers
423540|NCT01337323|allergic rhinitis, allergies, concomitant medications, allergy symptoms|allergic rhinitis, allergies, concomitant medications, allergy symptoms
423541|NCT01337310|Advanced solid tumors|advanced solid tumors
423542|NCT01337297|crack cocaine|crack cocaine
423543|NCT01337297|addiction|addiction
423544|NCT01337297|tDCS|tdcs
423545|NCT01337297|ERP|erp
423546|NCT01337297|P300|p300
423547|NCT01337297|attention|attention
423548|NCT01337297|inhibitory control|inhibitory control
423549|NCT01337297|working memory|working memory
423550|NCT01337271|artificial, ventilation|artificial, ventilation
423551|NCT01337271|mechanical ventilation|mechanical ventilation
423552|NCT01337271|weaning|weaning
423553|NCT01337258|cost effectiveness|cost effectiveness
423554|NCT01337258|dutasteride|dutasteride
423555|NCT01337258|elevated risk population|elevated risk population
423556|NCT01337258|Prostate cancer|prostate cancer
423557|NCT01337258|prevention|prevention
423558|NCT01337245|Envenomation|envenomation
423559|NCT01337245|Coral Snake|coral snake
423560|NCT01337245|Antivenom|antivenom
423561|NCT01337245|Micrurus fulvius|micrurus fulvius
423562|NCT01337232|language development disorders|language development disorders
423563|NCT01337232|learning disorders|learning disorders
423564|NCT01337232|sentences|sentences
423565|NCT01337232|syntax|syntax
423566|NCT01337232|school-age|school-age
423567|NCT01337232|language|language
423568|NCT01337219|cystic fibrosis|cystic fibrosis
423569|NCT01337219|bioequivalence|bioequivalence
423570|NCT01337219|pharmacokinetic|pharmacokinetic
423571|NCT01337219|sputum|sputum
423572|NCT01337219|plasma|plasma
423573|NCT01337206|Esophageal Stenosis|esophageal stenosis
423574|NCT01337206|Esopageal Strictures|esopageal strictures
423575|NCT01337206|Esophageal Dysphagia|esophageal dysphagia
423576|NCT01337193|stress urinary incontinence|stress urinary incontinence
423577|NCT01337193|exercise|exercise
423578|NCT01337193|pelvic floor muscles|pelvic floor muscles
423579|NCT01337193|biofeedback|biofeedback
423580|NCT01337193|rehabilitative ultrasound imaging|rehabilitative ultrasound imaging
423581|NCT01337180|lung function|lung function
423582|NCT01337180|respiratory symptoms|respiratory symptoms
423583|NCT01337180|dust|dust
423584|NCT01337180|inflammation|inflammation
423585|NCT01337180|prospective|prospective
423586|NCT01337167|Diphtheria|diphtheria
423587|NCT01337167|Tetanus|tetanus
423588|NCT01337167|Whooping Cough (pertussis)|whooping cough (pertussis)
423589|NCT01337167|Poliomyelitis|poliomyelitis
423590|NCT01337167|Hepatitis B infection|hepatitis b infection
423591|NCT01337167|Haemophilus influenzae type b infection|haemophilus influenzae type b infection
423592|NCT01337154|NSCLC|nsclc
423593|NCT01337154|non-small cell lung cancer|non-small cell lung cancer
423594|NCT01337154|tamibarotene|tamibarotene
423595|NCT01337141|Telemedicine|telemedicine
423596|NCT01337141|Type 1 diabetes|type 1 diabetes
423597|NCT01337141|Metabolic control optimisation|metabolic control optimisation
423598|NCT01337141|Health care costs|health care costs
423599|NCT01337141|Intervention study|intervention study
423600|NCT01337141|Access to internet|access to internet
423601|NCT01337115|Postoperative pain|postoperative pain
423602|NCT01337115|Knee arthroplasty|knee arthroplasty
423603|NCT01337115|Peripheral nerve blocks|peripheral nerve blocks
423604|NCT01337115|Sciatic nerve block|sciatic nerve block
423605|NCT01337115|Femoral nerve block|femoral nerve block
423606|NCT01337102|Lung Cancer|lung cancer
423607|NCT01337102|Stage 3b|stage 3b
423608|NCT01337102|Stage 4|stage 4
423609|NCT01337102|First Line Chemotherapy Treatment|first line chemotherapy treatment
423610|NCT01337102|Quality Of Life|quality of life
423611|NCT01337102|Palliative Care|palliative care
423612|NCT01337102|Randomized|randomized
423613|NCT01337102|Lung Cancer Scale|lung cancer scale
423614|NCT01337089|Cancer pain|cancer pain
423615|NCT01337089|Opioid therapy|opioid therapy
423616|NCT01337089|Inadequate analgesia|inadequate analgesia
423617|NCT01337089|Optimized chronic opioid therapy|optimized chronic opioid therapy
423618|NCT01337063|Adverse drug events|adverse drug events
423619|NCT01337050|Hepatocellular Carcinoma|hepatocellular carcinoma
423620|NCT01337050|Advanced/Metastatic solid tumors|advanced/metastatic solid tumors
423621|NCT01337037|video-assisted thoracic surgery|video-assisted thoracic surgery
423622|NCT01337037|Lung cancer|lung cancer
423623|NCT01337037|lobectomy|lobectomy
423624|NCT01337024|HRV|hrv
423625|NCT01337024|NDO|ndo
423626|NCT01337024|BoNT/A,|bont/a,
423627|NCT01337024|adverse effects|adverse effects
423628|NCT01337011|Chronic Ischemic Cardiomyopathy|chronic ischemic cardiomyopathy
423629|NCT01336998|necrotizing enterocolitis|necrotizing enterocolitis
423630|NCT01336998|arginine supplementation|arginine supplementation
423631|NCT01336998|calprotectin|calprotectin
423632|NCT01336985|Chemoembolization|chemoembolization
423633|NCT01336985|Hepatic Metastases|hepatic metastases
423634|NCT01336985|Irinotecan|irinotecan
423635|NCT01336985|Drug Eluding Beads|drug eluding beads
423636|NCT01336985|Colorectal Cancer|colorectal cancer
423637|NCT01336985|Liver Cancer|liver cancer
423638|NCT01336985|Hepatic Cancer|hepatic cancer
423639|NCT01336985|Melanoma|melanoma
423640|NCT01336959|Acute Kidney Injury|acute kidney injury
423641|NCT01336959|Cardiopulmonary Bypass|cardiopulmonary bypass
423642|NCT01336959|CABG|cabg
423643|NCT01336959|Cardiac Surgery|cardiac surgery
423644|NCT01336946|lifestyle|lifestyle
423645|NCT01336946|mental disorder|mental disorder
423646|NCT01336907|CNV|cnv
423647|NCT01336907|AMD|amd
423648|NCT01336907|Wet-treated CNV|wet-treated cnv
423649|NCT01336894|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
423650|NCT01336894|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
423651|NCT01336855|HIV|hiv
423652|NCT01336855|Observational|observational
423653|NCT01336855|Pathogenesis|pathogenesis
423654|NCT01336855|Immunology|immunology
423655|NCT01336855|Virology|virology
423656|NCT01336855|Control|control
423657|NCT01336855|Healthy control|healthy control
423658|NCT01336855|Men who have sex with men|men who have sex with men
423659|NCT01336842|panobinostat|panobinostat
423660|NCT01336842|cisplatin|cisplatin
423661|NCT01336842|pemetrexed|pemetrexed
423662|NCT01336842|dose escalation|dose escalation
423663|NCT01336829|Hepatitis C|hepatitis c
423664|NCT01336829|HIV|hiv
423665|NCT01336829|TMC125IFD1001|tmc125ifd1001
423666|NCT01336829|TMC125|tmc125
423667|NCT01336829|Intelence|intelence
423668|NCT01336829|etravirine|etravirine
423669|NCT01336829|ETR|etr
423670|NCT01336829|TMC278|tmc278
423671|NCT01336829|telaprevir|telaprevir
423672|NCT01336829|TVR|tvr
423673|NCT01336829|VX-950|vx-950
423674|NCT01336829|healthy volunteers|healthy volunteers
423675|NCT01336829|crossover|crossover
423676|NCT01336816|smoking|smoking
423677|NCT01336816|smokeless|smokeless
423678|NCT01336816|aversion|aversion
423679|NCT01336816|nicotine|nicotine
423680|NCT01336816|nicotine replacement|nicotine replacement
423681|NCT01336790|Lymphatic disease|lymphatic disease
423682|NCT01336790|Lymphedema|lymphedema
423683|NCT01336790|Lymphangiomatosis|lymphangiomatosis
423684|NCT01336790|Lymphangiectasia|lymphangiectasia
423685|NCT01336790|Protein-losing enteropathy|protein-losing enteropathy
423686|NCT01336790|Vascular Anomalies|vascular anomalies
423687|NCT01336777|obesity|obesity
423688|NCT01336777|adipocyte differentiation|adipocyte differentiation
423689|NCT01336777|inflammation|inflammation
423690|NCT01336777|insulin resistance|insulin resistance
423691|NCT01336777|visceral fat|visceral fat
423692|NCT01336777|regional fat depots|regional fat depots
423693|NCT01336764|driving distress|driving distress
423694|NCT01336764|veterans|veterans
423695|NCT01336764|OEF/OIF|oef/oif
423696|NCT01336738|Phase 2|phase 2
423697|NCT01336738|safety and efficacy study with PF-04991532|safety and efficacy study with pf-04991532
423698|NCT01336738|Type 2 diabetes|type 2 diabetes
423699|NCT01336725|Morbid obesity|morbid obesity
423700|NCT01336725|Patient education|patient education
423701|NCT01336712|CML|cml
423702|NCT01336712|CLL|cll
423703|NCT01336712|AML|aml
423704|NCT01336712|ALL|all
423705|NCT01336712|MDS|mds
423706|NCT01336712|HD|hd
423707|NCT01336712|NHL|nhl
423708|NCT01336712|MFB|mfb
423709|NCT01336712|P.vera|p.vera
423710|NCT01336712|Essential Thrombocytosis|essential thrombocytosis
423711|NCT01336699|shigellosis, vaccine, Shigella sonnei, WRSs2, WRSs3|shigellosis, vaccine, shigella sonnei, wrss2, wrss3
423712|NCT01336673|Glucophage XR|glucophage xr
423713|NCT01336673|Tolerability|tolerability
423714|NCT01336660|Effectiveness|effectiveness
423715|NCT01336660|New Antivenom|new antivenom
423716|NCT01336660|North Africa and Middle East Scorpio Envenomation|north africa and middle east scorpio envenomation
423717|NCT01336634|BRAF V600E|braf v600e
423718|NCT01336634|trametinib|trametinib
423719|NCT01336634|dabrafenib|dabrafenib
423720|NCT01336634|GSK2118436|gsk2118436
423721|NCT01336634|GSK1120212|gsk1120212
423722|NCT01336634|Oncology|oncology
423723|NCT01336634|Non-Small Cell Lung Cancer|non-small cell lung cancer
423724|NCT01336621|Partial-onset seizures|partial-onset seizures
423725|NCT01336621|retigabine IR|retigabine ir
423726|NCT01336621|Open Label Extension|open label extension
423727|NCT01336621|GW582892|gw582892
423728|NCT01336621|Epilepsy|epilepsy
423729|NCT01336595|total knee arthroplasty|total knee arthroplasty
423730|NCT01336595|oxidized zirconium|oxidized zirconium
423731|NCT01336595|genesis II|genesis ii
423732|NCT01336595|femoral component|femoral component
423733|NCT01336595|cobalt chrome|cobalt chrome
423734|NCT01336582|suitable candidate|suitable candidate
423735|NCT01336582|single agent docetaxel therapy|single agent docetaxel therapy
423736|NCT01336582|Advanced Solid Tumor|advanced solid tumor
423737|NCT01336569|Primary Open-Angle Glaucoma|primary open-angle glaucoma
423738|NCT01336569|Ocular Hypertension|ocular hypertension
423739|NCT01336569|Pigment Dispersion Glaucoma|pigment dispersion glaucoma
423740|NCT01336569|IOP|iop
423741|NCT01336556|Oral appliance|oral appliance
423742|NCT01336556|Continuous positive airway pressure|continuous positive airway pressure
423743|NCT01336556|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
423744|NCT01336556|Snore|snore
423745|NCT01336543|Non small cell lung cancer|non small cell lung cancer
423746|NCT01336543|Inoperable Stage III|inoperable stage iii
423747|NCT01336543|Inoperable|inoperable
423748|NCT01336543|Stage III|stage iii
423749|NCT01336530|Oesophageal pain|oesophageal pain
423750|NCT01336530|Radiotherapy|radiotherapy
423751|NCT01336530|Combined radio-chemotherapy|combined radio-chemotherapy
423752|NCT01336530|Oesophageal symptoms|oesophageal symptoms
423753|NCT01336517|Stroke|stroke
423754|NCT01336517|Hemiplegia|hemiplegia
423755|NCT01336517|AFO|afo
423756|NCT01336517|Gait|gait
423757|NCT01336478|NK|nk
423758|NCT01336478|natural killer|natural killer
423759|NCT01336478|immunotherapy|immunotherapy
423760|NCT01336478|leukemia|leukemia
423761|NCT01336478|hematological malignancies|hematological malignancies
423762|NCT01336478|stem cell transplantation|stem cell transplantation
423763|NCT01336478|adoptive therapy|adoptive therapy
423764|NCT01336439|Bruxism|bruxism
423765|NCT01336439|Polysomnography|polysomnography
423766|NCT01336439|Botulinum toxin type A|botulinum toxin type a
423767|NCT01336439|Masseter muscle|masseter muscle
423768|NCT01336439|Temporal muscle|temporal muscle
423769|NCT01336426|Peripheral Artery Disease|peripheral artery disease
423770|NCT01336426|PAD|pad
423771|NCT01336413|brain injuries, traumatic|brain injuries, traumatic
423772|NCT01336413|pregnenolone|pregnenolone
423773|NCT01336413|Veteran|veteran
423774|NCT01336413|OEF/OIF|oef/oif
423775|NCT01336413|neurosteroid|neurosteroid
423776|NCT01336413|allopregnanolone|allopregnanolone
423777|NCT01336400|Single cell haplotyping|single cell haplotyping
423778|NCT01336400|Preimplantation genetic diagnosis|preimplantation genetic diagnosis
423779|NCT01336361|Palliative Care|palliative care
423780|NCT01336361|Physical Therapy|physical therapy
423781|NCT01336361|Functionally Dependent Elderly|functionally dependent elderly
423782|NCT01336348|Prasugrel|prasugrel
423783|NCT01336348|Tirofiban|tirofiban
423784|NCT01336348|Clopidogrel|clopidogrel
423785|NCT01336348|glycoprotein IIa/IIIa inhibitors|glycoprotein iia/iiia inhibitors
423786|NCT01336348|P2Y12 blockers|p2y12 blockers
423787|NCT01336335|sleep apnea, obstructive|sleep apnea, obstructive
423788|NCT01336335|sympathetic nerve activity|sympathetic nerve activity
423789|NCT01336335|treatment|treatment
423790|NCT01336322|beta-cell function|beta-cell function
423791|NCT01336322|insulin resistance|insulin resistance
423792|NCT01336309|Yoga|yoga
423793|NCT01336283|COPD|copd
423794|NCT01336283|Exercise Training|exercise training
423795|NCT01336270|Melanoma|melanoma
423796|NCT01336270|NK cells|nk cells
423797|NCT01336270|T lymphocytes|t lymphocytes
423798|NCT01336270|macrophages|macrophages
423799|NCT01336257|Decision Support Techniques|decision support techniques
423800|NCT01336257|Electronic Health Records|electronic health records
423801|NCT01336257|Reminder Systems|reminder systems
423802|NCT01336257|Early Detection of Cancer|early detection of cancer
423803|NCT01336257|Mammography|mammography
423804|NCT01336257|Women|women
423805|NCT01336244|Safety|safety
423806|NCT01336244|Tolerability|tolerability
423807|NCT01336244|Pharmacokinetics|pharmacokinetics
423808|NCT01336231|quality of life|quality of life
423809|NCT01336231|cognitive functions|cognitive functions
423810|NCT01336231|antiangiogenic agents|antiangiogenic agents
423811|NCT01336231|kidney cancer|kidney cancer
423812|NCT01336231|metastatic|metastatic
423813|NCT01336218|Phase 1|phase 1
423814|NCT01336218|healthy volunteers|healthy volunteers
423815|NCT01336218|Rheumatoid arthritis|rheumatoid arthritis
423816|NCT01336218|RA|ra
423817|NCT01336218|Fostamatinib|fostamatinib
423818|NCT01336218|Rifampicin|rifampicin
423819|NCT01336218|drug-drug interaction|drug-drug interaction
423820|NCT01336218|Pharmacokinetics|pharmacokinetics
423821|NCT01336218|Amount of Rifampicin in blood|amount of rifampicin in blood
423822|NCT01336205|Non-Cancer-Related Pain|non-cancer-related pain
424125|NCT01334905|YM178|ym178
423823|NCT01336205|Opioid-Induced Constipation|opioid-induced constipation
423824|NCT01336192|Advanced NSCLC|advanced nsclc
423825|NCT01336192|Maintenance therapy|maintenance therapy
423826|NCT01336192|Gemcitabine|gemcitabine
423827|NCT01336179|gingivitis|gingivitis
423828|NCT01336179|dental plaque|dental plaque
423829|NCT01336179|oral hygiene|oral hygiene
423830|NCT01336179|toothbrush|toothbrush
423831|NCT01336179|chewing sticks|chewing sticks
423832|NCT01336166|H1N1|h1n1
423833|NCT01336166|Vaccine|vaccine
423834|NCT01336166|Immunogenicity|immunogenicity
423835|NCT01336166|Safety|safety
423836|NCT01336153|Safety|safety
423837|NCT01336153|Efficacy|efficacy
423838|NCT01336153|MLC601|mlc601
423839|NCT01336153|motor recovery|motor recovery
423840|NCT01336140|regadenoson|regadenoson
423841|NCT01336140|chronic kidney disease|chronic kidney disease
423842|NCT01336140|renal failure|renal failure
423843|NCT01336140|lexiscan|lexiscan
423844|NCT01336140|aminophylline|aminophylline
423845|NCT01336140|SPECT|spect
423846|NCT01336140|Myocardial Perfusion Imaging|myocardial perfusion imaging
423847|NCT01336140|pharmacologic stress test|pharmacologic stress test
423848|NCT01336140|Patients with stage IV or V chronic kidney disease being assessed with nuclear stress testing of the heart using the stress agent regadenoson (Lexiscan ®)|patients with stage iv or v chronic kidney disease being assessed with nuclear stress testing of the heart using the stress agent regadenoson (lexiscan ®)
423849|NCT01336127|Occupational Therapy|occupational therapy
423850|NCT01336127|Parkinson's Disease|parkinson's disease
423851|NCT01336127|Effectiveness|effectiveness
423852|NCT01336127|RCT|rct
423853|NCT01336127|Activities of daily living|activities of daily living
423854|NCT01336127|Participation|participation
423855|NCT01336127|Caregiver's Burden|caregiver's burden
423856|NCT01336127|Economic evaluation|economic evaluation
423857|NCT01336101|PAD|pad
423858|NCT01336101|SFA|sfa
423859|NCT01336088|dyskinesia|dyskinesia
423860|NCT01336088|Parkinson's disease|parkinson's disease
423861|NCT01336075|Percutaneous radiofrequency catheter ablation|percutaneous radiofrequency catheter ablation
423862|NCT01336075|Mini invasive thoracoscopic radiofrequency ablation|mini invasive thoracoscopic radiofrequency ablation
423863|NCT01336062|advanced|advanced
423864|NCT01336062|resistant to prior chemotherapy|resistant to prior chemotherapy
423865|NCT01336010|Hepatitis C|hepatitis c
423866|NCT01336010|Acute Hepatitis C|acute hepatitis c
423867|NCT01336010|Early chronic Hepatitis C|early chronic hepatitis c
423868|NCT01335997|Low-density lipoprotein|low-density lipoprotein
423869|NCT01335997|LDL|ldl
423870|NCT01335997|High-density lipoprotein|high-density lipoprotein
423871|NCT01335997|HDL|hdl
423872|NCT01335997|Niacin|niacin
423873|NCT01335997|Lipid modifying therapy|lipid modifying therapy
423874|NCT01335997|Cholesterol|cholesterol
423875|NCT01335997|High cholesterol|high cholesterol
423876|NCT01335997|Triglycerides|triglycerides
423877|NCT01335984|telemonitoring|telemonitoring
423878|NCT01335984|usual care|usual care
423879|NCT01335984|telemedicine|telemedicine
423880|NCT01335984|telehealth|telehealth
423881|NCT01335984|home care|home care
423882|NCT01335984|Health Care Quality|health care quality
423883|NCT01335984|Access|access
423884|NCT01335984|Evaluation|evaluation
423885|NCT01335971|COPD|copd
423886|NCT01335971|Nrf2|nrf2
423887|NCT01335971|Sulforaphane|sulforaphane
423888|NCT01335945|Cryoablation|cryoablation
423889|NCT01335945|Cryotherapy|cryotherapy
423890|NCT01335945|Cryosurgery|cryosurgery
423891|NCT01335945|Pancreas|pancreas
423892|NCT01335945|Pancreatic Cancer|pancreatic cancer
423893|NCT01335945|Celiac Plexus|celiac plexus
423894|NCT01335945|Pain|pain
423895|NCT01335945|Abdominal pain|abdominal pain
423896|NCT01335932|Acute Lung Injury|acute lung injury
423897|NCT01335932|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
423898|NCT01335932|Respiratory Failure|respiratory failure
423899|NCT01335932|Cytomegalovirus seropositive|cytomegalovirus seropositive
423900|NCT01335932|Infection|infection
423901|NCT01335932|Intravenous Ganciclovir|intravenous ganciclovir
423902|NCT01335932|Non-immunocompromised|non-immunocompromised
423903|NCT01335932|Valganciclovir|valganciclovir
423904|NCT01335919|Hemoglobin|hemoglobin
423905|NCT01335919|Monitoring, Physiologic|monitoring, physiologic
423906|NCT01335919|Blood Gas Monitoring, Transcutaneous|blood gas monitoring, transcutaneous
423907|NCT01335906|Cancer Screening Tests|cancer screening tests
423908|NCT01335906|Early Diagnosis of Cancer|early diagnosis of cancer
423909|NCT01335906|Mammography|mammography
423910|NCT01335906|Informed Consent|informed consent
423911|NCT01335906|Consent Forms|consent forms
423912|NCT01335893|Imaging|imaging
423913|NCT01335893|Indocyanine Green|indocyanine green
423914|NCT01335893|Lung Cancer|lung cancer
423915|NCT01335893|Lung Neoplasms|lung neoplasms
423916|NCT01335893|Preliminary Study|preliminary study
423917|NCT01335880|Obesity|obesity
423918|NCT01335880|Heart Disease|heart disease
423919|NCT01335880|Seniors|seniors
423920|NCT01335880|Elderly|elderly
423921|NCT01335880|Chronic Disease|chronic disease
423922|NCT01335880|Prevention|prevention
423923|NCT01335854|Apnea-hypopnea index|apnea-hypopnea index
423924|NCT01335854|Continuous positive airway pressure|continuous positive airway pressure
423925|NCT01335854|CPAP adherence|cpap adherence
423926|NCT01335828|Echography|echography
423927|NCT01335828|Elastography|elastography
423928|NCT01335828|Thyroid nodules|thyroid nodules
423929|NCT01335828|Needles punction|needles punction
423930|NCT01335828|Thyroid surgery|thyroid surgery
423931|NCT01335828|Patients with thyroids nodules|patients with thyroids nodules
423932|NCT01335802|Abortion, Spontaneous|abortion, spontaneous
423933|NCT01335802|Pre-eclampsia|pre-eclampsia
423934|NCT01335802|Gestational hypertension|gestational hypertension
423935|NCT01335802|Pregnancy Complications|pregnancy complications
423936|NCT01335802|Subclinical hypothyroidism|subclinical hypothyroidism
423937|NCT01335802|Thyroperoxidase antibodies (TPOab)|thyroperoxidase antibodies (tpoab)
423938|NCT01335802|Mitochondrial dysfunction|mitochondrial dysfunction
423939|NCT01335789|marijuana|marijuana
423940|NCT01335789|substance abuse|substance abuse
423941|NCT01335789|drug abuse|drug abuse
423942|NCT01335789|marijuana dependence|marijuana dependence
423943|NCT01335789|drug addiction|drug addiction
423944|NCT01335776|Mindfulness-Based Stress Reduction|mindfulness-based stress reduction
423945|NCT01335776|Cognitive Behavior Therapy|cognitive behavior therapy
423946|NCT01335776|Actigraphy|actigraphy
423947|NCT01335776|Noninferiority|noninferiority
423948|NCT01335776|MBSR|mbsr
423949|NCT01335776|CBT-I|cbt-i
423950|NCT01335763|HbA1c|hba1c
423951|NCT01335763|Multicentre before-after design|multicentre before-after design
423952|NCT01335763|Glycemic control|glycemic control
423953|NCT01335763|Community pharmacists|community pharmacists
423954|NCT01335750|corneal staining|corneal staining
423955|NCT01335698|Pediatric|pediatric
423956|NCT01335685|Drug Therapy|drug therapy
423957|NCT01335672|Myocardial infarction|myocardial infarction
423958|NCT01335672|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
423959|NCT01335672|General Practice Research Database|general practice research database
423960|NCT01335672|Myocardial Ischaemia National Audit Project|myocardial ischaemia national audit project
423961|NCT01335672|CALIBER|caliber
423962|NCT01335659|FFR|ffr
423963|NCT01335659|IVUS|ivus
423964|NCT01335659|QCA|qca
423965|NCT01335633|MS|ms
423966|NCT01335633|Neuropsychological tests|neuropsychological tests
423967|NCT01335607|HCV|hcv
423968|NCT01335607|Hepatitis C Virus|hepatitis c virus
423969|NCT01335594|Sleep apnea, obstructive|sleep apnea, obstructive
423970|NCT01335594|Deglutition Disorders|deglutition disorders
423971|NCT01335594|Manometry|manometry
423972|NCT01335594|Endoscopy|endoscopy
423973|NCT01335568|Hepatocyte|hepatocyte
423974|NCT01335568|Scaffold|scaffold
423975|NCT01335568|Matrix|matrix
423976|NCT01335568|Liver cirrhosis|liver cirrhosis
423977|NCT01335568|Liver insufficiency|liver insufficiency
423978|NCT01335529|HCV infection|hcv infection
423979|NCT01335529|HIV-1 infection|hiv-1 infection
423980|NCT01335503|gluten|gluten
423981|NCT01335451|AZD5213|azd5213
423982|NCT01335451|safety|safety
423983|NCT01335451|pharmacokinetics|pharmacokinetics
423984|NCT01335451|single dose|single dose
423985|NCT01335451|repeated dose|repeated dose
423986|NCT01335451|young|young
423987|NCT01335451|elderly|elderly
423988|NCT01335451|Japanese|japanese
423989|NCT01335451|healthy subject|healthy subject
423990|NCT01335438|total knee arthroplasty|total knee arthroplasty
423991|NCT01335438|cemented|cemented
423992|NCT01335438|cementless|cementless
423993|NCT01335438|fixation|fixation
423994|NCT01335438|posterior stabilized|posterior stabilized
423995|NCT01335438|cruciate retaining|cruciate retaining
423996|NCT01335425|Language problems|language problems
423997|NCT01335425|childhood epilepsy|childhood epilepsy
423998|NCT01335425|bening (rolandic) epilepsy (of childhood) with centro temporal spikes|bening (rolandic) epilepsy (of childhood) with centro temporal spikes
423999|NCT01335425|brain maturation|brain maturation
424000|NCT01335425|structral connectivity|structral connectivity
424001|NCT01335425|functional connectivity|functional connectivity
424002|NCT01335399|Newly Diagnosed|newly diagnosed
424003|NCT01335399|Previously Untreated|previously untreated
424004|NCT01335373|Vaginal candidiasis|vaginal candidiasis
424005|NCT01335373|Bacterial vaginosis (also known as non-specific, or Gardnerellosis, or anaerobic vaginosis)|bacterial vaginosis (also known as non-specific, or gardnerellosis, or anaerobic vaginosis)
424006|NCT01335373|Trichomonal vaginitis|trichomonal vaginitis
424007|NCT01335373|Vaginitis due to mixed infection|vaginitis due to mixed infection
424008|NCT01335360|nevirapine|nevirapine
424009|NCT01335360|pharmacokinetics|pharmacokinetics
424010|NCT01335347|Influenza|influenza
424011|NCT01335347|pandemic|pandemic
424012|NCT01335347|avian influenza|avian influenza
424013|NCT01335347|H5N1|h5n1
424014|NCT01335347|flu|flu
424015|NCT01335334|Effectiveness|effectiveness
424016|NCT01335334|eradication|eradication
424017|NCT01335334|Asymptomatic|asymptomatic
424018|NCT01335321|viscosupplementation|viscosupplementation
424019|NCT01335321|intra-articular injection|intra-articular injection
424020|NCT01335321|hyaluronic acid|hyaluronic acid
424021|NCT01335321|osteoarthritis|osteoarthritis
424022|NCT01335321|knee|knee
424023|NCT01335308|Pediatric Obesity|pediatric obesity
424024|NCT01335308|Motivational Interviewing|motivational interviewing
424025|NCT01335308|Overweight|overweight
424026|NCT01335308|Behavior Change|behavior change
424027|NCT01335295|Flavocoxid|flavocoxid
424028|NCT01335295|Duchenne muscular dystrophy|duchenne muscular dystrophy
424029|NCT01335295|pilot study|pilot study
424030|NCT01335256|Phase I, dose escalation, kinase inhibitor, cyclin-dependent kinase inhibitor, target therapy, small molecule|phase i, dose escalation, kinase inhibitor, cyclin-dependent kinase inhibitor, target therapy, small molecule
424031|NCT01335243|Orthopedic Procedures|orthopedic procedures
424032|NCT01335243|Spine|spine
424033|NCT01335243|Interbody fusion|interbody fusion
424034|NCT01335243|Arthrodesis|arthrodesis
424035|NCT01335243|Lumbar Vertebrae|lumbar vertebrae
424036|NCT01335243|CT Scan|ct scan
424037|NCT01335243|Spine balance|spine balance
424038|NCT01335243|Instrumented fusion|instrumented fusion
424039|NCT01335243|Posterior fusion|posterior fusion
424040|NCT01335243|Degenerative spine|degenerative spine
424041|NCT01335243|painful|painful
424042|NCT01335230|HIV|hiv
424043|NCT01335230|HCV|hcv
424044|NCT01335230|Hepatitis C|hepatitis c
424045|NCT01335230|HIV and Hepatitis C coinfection|hiv and hepatitis c coinfection
424046|NCT01335230|HIV/HCV|hiv/hcv
424047|NCT01335217|Depression|depression
424048|NCT01335217|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
424049|NCT01335217|Trigeminal Nerve Stimulation|trigeminal nerve stimulation
424050|NCT01335217|Post Traumatic Stress Disorder|post traumatic stress disorder
424051|NCT01335204|Castration-resistant prostate cancer|castration-resistant prostate cancer
424052|NCT01335204|Prostate Cancer|prostate cancer
424053|NCT01335204|JEVTANA|jevtana
424054|NCT01335204|Cabazitaxel|cabazitaxel
424055|NCT01335204|Bavituximab|bavituximab
424057|NCT01335191|vaccine|vaccine
424058|NCT01335191|lipopeptide|lipopeptide
424059|NCT01335191|Tat|tat
424060|NCT01335191|TUTI-16|tuti-16
424061|NCT01335191|THYMON|thymon
424062|NCT01335178|Tobacco smoke exposure|tobacco smoke exposure
424063|NCT01335178|Secondhand smoke exposure|secondhand smoke exposure
424064|NCT01335178|Passive smoking|passive smoking
424065|NCT01335178|Child health|child health
424066|NCT01335178|Prevention|prevention
424067|NCT01335178|Tobacco control|tobacco control
424068|NCT01335178|Motivational Interviewing|motivational interviewing
424069|NCT01335178|Air quality|air quality
424070|NCT01335178|Pilot Study|pilot study
424071|NCT01335165|PNH|pnh
424072|NCT01335152|stress|stress
424073|NCT01335152|depression|depression
424074|NCT01335152|anxiety|anxiety
424075|NCT01335152|web|web
424076|NCT01335152|internet|internet
424077|NCT01335152|coping|coping
424078|NCT01335139|sublingual immunotherapy|sublingual immunotherapy
424079|NCT01335139|subcutaneous immunotherapy|subcutaneous immunotherapy
424080|NCT01335126|Artificial tears|artificial tears
424081|NCT01335100|Functional outcome|functional outcome
424082|NCT01335100|Quality of life|quality of life
424083|NCT01335100|Global Positioning System (GPS)|global positioning system (gps)
424084|NCT01335100|Advanced tracking technologies|advanced tracking technologies
424085|NCT01335100|Time-space activity.|time-space activity.
424086|NCT01335100|walking speed|walking speed
424087|NCT01335100|distances|distances
424088|NCT01335100|number of walking events and destinations|number of walking events and destinations
424089|NCT01335087|sleep apnea|sleep apnea
424090|NCT01335087|secondary prevention|secondary prevention
424091|NCT01335087|cardiovascular endpoint|cardiovascular endpoint
424092|NCT01335061|Hemophilia B|hemophilia b
424093|NCT01335061|on-demand|on-demand
424094|NCT01335061|prophylaxis|prophylaxis
424095|NCT01335061|nonacog alfa|nonacog alfa
424096|NCT01335061|BeneFIX|benefix
424097|NCT01335061|FIX|fix
424098|NCT01335048|Clopidogrel|clopidogrel
424099|NCT01335048|Statins|statins
424100|NCT01335048|Platelet reactivity|platelet reactivity
424101|NCT01335048|Point-of-care platelet function test|point-of-care platelet function test
424102|NCT01335035|Iron metabolism,|iron metabolism,
424103|NCT01335035|Allogenetic Hematopoietic Stem Cell Transplant,|allogenetic hematopoietic stem cell transplant,
424104|NCT01335035|haematological diseases|haematological diseases
424105|NCT01335009|melanoma|melanoma
424106|NCT01335009|malignant|malignant
424107|NCT01335009|metastatic|metastatic
424108|NCT01334983|cancer|cancer
424109|NCT01334983|function|function
424110|NCT01334983|fatigue|fatigue
424111|NCT01334983|late stage|late stage
424112|NCT01334983|metastases|metastases
424113|NCT01334983|quality of life|quality of life
424114|NCT01334983|functional decline in cancer|functional decline in cancer
424115|NCT01334944|Pain|pain
424116|NCT01334944|Fever|fever
424117|NCT01334931|Exposure to Ionizing Radiation|exposure to ionizing radiation
424118|NCT01334931|Occupational Exposure to Radiation|occupational exposure to radiation
424119|NCT01334918|pharmacologic stress|pharmacologic stress
424120|NCT01334918|Coronary Artery Disease (CAD)|coronary artery disease (cad)
424121|NCT01334918|regadenoson|regadenoson
424122|NCT01334918|ischemia|ischemia
424123|NCT01334905|Overactive Bladder|overactive bladder
424124|NCT01334905|Urinary incontinence|urinary incontinence
424126|NCT01334905|mirabegron|mirabegron
424127|NCT01334905|Food effect|food effect
424128|NCT01334879|radiation|radiation
424129|NCT01334879|retinopathy|retinopathy
424130|NCT01334879|anti-VEGF|anti-vegf
424131|NCT01334879|eye|eye
424132|NCT01334866|Minimally invasive coronary surgery|minimally invasive coronary surgery
424133|NCT01334866|Coronary artery bypass grafting|coronary artery bypass grafting
424134|NCT01334866|MICS CABG|mics cabg
424135|NCT01334840|Cardiovascular risk|cardiovascular risk
424136|NCT01334840|Cholecystokinin|cholecystokinin
424137|NCT01334840|Gallbladder emptying|gallbladder emptying
424138|NCT01334840|Lipid absorption|lipid absorption
424139|NCT01334840|Postprandial triacylglycerols|postprandial triacylglycerols
424140|NCT01334840|Sodium-bicarbonated mineral water|sodium-bicarbonated mineral water
424141|NCT01334827|topical microbicide|topical microbicide
424142|NCT01334827|primary prevention|primary prevention
424143|NCT01334827|HIV|hiv
424144|NCT01334827|AIDS|aids
424145|NCT01334827|drug delivery systems|drug delivery systems
424146|NCT01334801|aortic stenosis|aortic stenosis
424147|NCT01334801|von Willebrand factor|von willebrand factor
424148|NCT01334801|mitral valve replacement|mitral valve replacement
424149|NCT01334801|aortic valve replacement|aortic valve replacement
424150|NCT01334801|prosthetic valve dysfunction|prosthetic valve dysfunction
424151|NCT01334801|brain natriuretic peptide|brain natriuretic peptide
424152|NCT01334801|mitral valve regurgitation|mitral valve regurgitation
424153|NCT01334801|aortic valve regurgitation|aortic valve regurgitation
424154|NCT01334801|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
424155|NCT01334801|tricuspid insufficiency|tricuspid insufficiency
424156|NCT01334788|sleep deprivation|sleep deprivation
424157|NCT01334788|sleep restriction|sleep restriction
424158|NCT01334775|Inguinal hernia|inguinal hernia
424159|NCT01334775|Postoperative pain|postoperative pain
424160|NCT01334775|Surgical mesh|surgical mesh
424161|NCT01334762|minimal to mild endometriosis|minimal to mild endometriosis
424162|NCT01334762|letrozole|letrozole
424163|NCT01334762|clomiphene citrate|clomiphene citrate
424164|NCT01334762|IUI|iui
424165|NCT01334749|Stroke|stroke
424166|NCT01334749|Dementia|dementia
424167|NCT01334749|Dementia, Vascular|dementia, vascular
424168|NCT01334749|Alzheimer's Disease|alzheimer's disease
424169|NCT01334749|Intracranial Hemorrhage|intracranial hemorrhage
424170|NCT01334749|Brain Ischemia|brain ischemia
424171|NCT01334736|smoking cessation|smoking cessation
424172|NCT01334736|contingency management|contingency management
424173|NCT01334736|spirometry|spirometry
424174|NCT01334736|lung age|lung age
424175|NCT01334723|Benign prostatic hyperplasia, enlarged prostate, 5-alpha-reductase inhibitor, adherence, surgery, acute urinary retention|benign prostatic hyperplasia, enlarged prostate, 5-alpha-reductase inhibitor, adherence, surgery, acute urinary retention
424176|NCT01334710|Liver cancer|liver cancer
424177|NCT01334697|Cardiotrophin-1|cardiotrophin-1
424178|NCT01334697|CT-1|ct-1
424179|NCT01334684|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
424180|NCT01334684|Metformin Efficacy|metformin efficacy
424181|NCT01334684|Gene Expression Profiles|gene expression profiles
424182|NCT01334684|Personalized Medicine|personalized medicine
424183|NCT01334671|ST-elevation myocardial infarction(STEMI)|st-elevation myocardial infarction(stemi)
424184|NCT01334671|emergency percutaneous coronary intervention(PCI)|emergency percutaneous coronary intervention(pci)
424185|NCT01334671|lipitor or Atorvastatin|lipitor or atorvastatin
424186|NCT01334658|Corneal endothelium|corneal endothelium
424187|NCT01334658|Cataract surgery|cataract surgery
424188|NCT01334658|Irrigation solutions intraocular|irrigation solutions intraocular
424189|NCT01334658|Phacoemulsification|phacoemulsification
424190|NCT01334645|Copeptin|copeptin
424191|NCT01334645|Troponin|troponin
424192|NCT01334645|Diagnosis|diagnosis
424193|NCT01334645|Chest pain|chest pain
424194|NCT01334645|Acute Coronary Syndrome|acute coronary syndrome
424195|NCT01334645|Acute Myocardial Infarction|acute myocardial infarction
424196|NCT01334645|Unstable Angina|unstable angina
424197|NCT01334632|Electrophysiological study|electrophysiological study
424198|NCT01334632|Nerve block|nerve block
424199|NCT01334632|Analgesia, patient-controlled|analgesia, patient-controlled
424200|NCT01334632|Shoulder surgery|shoulder surgery
424201|NCT01334619|Anesthetic techniques,regional|anesthetic techniques,regional
424202|NCT01334619|Drug delivery,volume|drug delivery,volume
424203|NCT01334619|Anesthetic, local: ropivacaine|anesthetic, local: ropivacaine
424204|NCT01334606|diabetes|diabetes
424205|NCT01334606|pen needle|pen needle
424206|NCT01334606|basal insulin|basal insulin
424207|NCT01334606|long-acting insulin|long-acting insulin
424208|NCT01334554|African American|african american
424209|NCT01334554|Women|women
424210|NCT01334554|Metabolic Syndrome|metabolic syndrome
424211|NCT01334554|Endothelial function|endothelial function
424212|NCT01334554|Sildenafil citrate|sildenafil citrate
424213|NCT01334528|Deployment Acquired Mild Traumatic Brain Injury|deployment acquired mild traumatic brain injury
424214|NCT01334528|Persistent Post-Concussive Symptoms|persistent post-concussive symptoms
424215|NCT01334528|Repeated measures|repeated measures
424216|NCT01334502|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
424508|NCT01333332|Pancreas|pancreas
424217|NCT01334502|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
424218|NCT01334502|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
424219|NCT01334502|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
424220|NCT01334489|Monochorionic pregnancy|monochorionic pregnancy
424221|NCT01334489|Twin to twin transfusion syndrome|twin to twin transfusion syndrome
424222|NCT01334489|Cervical pessary|cervical pessary
424223|NCT01334489|Cervical lenght|cervical lenght
424224|NCT01334476|Data Repository|data repository
424225|NCT01334476|Facilitate Recruitment of Participants for Ongoing and Future Research|facilitate recruitment of participants for ongoing and future research
424226|NCT01334450|Improvement of ADAS-COG|improvement of adas-cog
424227|NCT01334437|blood test|blood test
424228|NCT01334437|ovarian cancer|ovarian cancer
424229|NCT01334437|Associated Auto Antibodies|associated auto antibodies
424230|NCT01334424|Robot assisted laparoscopic radical prostatectomy|robot assisted laparoscopic radical prostatectomy
424231|NCT01334424|Hypoperfusion reperfusion injury,|hypoperfusion reperfusion injury,
424232|NCT01334424|Propofol|propofol
424233|NCT01334424|oxidative stress|oxidative stress
424234|NCT01334398|Traumatic Brain Injury|traumatic brain injury
424235|NCT01334372|suicide|suicide
424236|NCT01334372|veterans|veterans
424237|NCT01334372|assessment|assessment
424238|NCT01334372|CAMS|cams
424239|NCT01334359|physical activity|physical activity
424240|NCT01334359|fitness|fitness
424241|NCT01334359|brain health|brain health
424242|NCT01334359|cognition|cognition
424243|NCT01334359|scholastic achievement|scholastic achievement
424244|NCT01334359|preadolescent children|preadolescent children
424245|NCT01334346|Running|running
424246|NCT01334346|Footwear|footwear
424247|NCT01334346|Injury incidence|injury incidence
424248|NCT01334346|injury risk|injury risk
424249|NCT01334346|pain|pain
424250|NCT01334333|kidney transplant|kidney transplant
424251|NCT01334333|tacrolimus|tacrolimus
424252|NCT01334333|medication adherence|medication adherence
424253|NCT01334333|depression|depression
424254|NCT01334333|neuropsychological|neuropsychological
424255|NCT01334333|cognition|cognition
424256|NCT01334333|Self-efficacy|self-efficacy
424257|NCT01334333|everyday problem solving|everyday problem solving
424258|NCT01334320|oral squamous cell carcinoma|oral squamous cell carcinoma
424259|NCT01334320|elective neck dissection|elective neck dissection
424260|NCT01334320|"watchful waiting"|"watchful waiting"
424261|NCT01334320|survival benefit|survival benefit
424262|NCT01334320|recurrence rate|recurrence rate
424263|NCT01334307|Emphysema|emphysema
424264|NCT01334307|RePneu|repneu
424265|NCT01334294|CNV|cnv
424266|NCT01334294|AMD|amd
424267|NCT01334281|Panel Reactive Antibody (PRA)|panel reactive antibody (pra)
424268|NCT01334281|Sensitization|sensitization
424269|NCT01334281|Organ Transplant|organ transplant
424270|NCT01334268|In-stent Late Lumen Loss (LLL)|in-stent late lumen loss (lll)
424271|NCT01334268|TARGET VESSEL FAILURE (TVF)|target vessel failure (tvf)
424272|NCT01334268|MYOCARDIAL INFARCTION (MI)|myocardial infarction (mi)
424273|NCT01334268|TARGET VESSEL REVASCULARIZATION (TVR)|target vessel revascularization (tvr)
424274|NCT01334268|TARGET LESION REVASCULARIZATION (TLR)|target lesion revascularization (tlr)
424275|NCT01334268|TARGET LESION FAILURE (TLF)|target lesion failure (tlf)
424276|NCT01334268|STENT THROMBOSIS|stent thrombosis
424277|NCT01334268|RESTENOTIC LESION|restenotic lesion
424278|NCT01334268|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
424279|NCT01334268|REAL-WORLD|real-world
424280|NCT01334268|THE RANDOMIZED CONTROLLED TRIAL|the randomized controlled trial
424281|NCT01334255|Pigment epithelial detachment|pigment epithelial detachment
424282|NCT01334255|Exudative age-related macular degeneration|exudative age-related macular degeneration
424283|NCT01334255|Polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
424284|NCT01334242|Pharmacodynamics|pharmacodynamics
424285|NCT01334229|sitagliptin|sitagliptin
424286|NCT01334229|diabetes|diabetes
424287|NCT01334229|apolipoprotein B48 and B100|apolipoprotein b48 and b100
424288|NCT01334216|smoking|smoking
424289|NCT01334216|quitting|quitting
424290|NCT01334216|tobacco|tobacco
424291|NCT01334216|Parental|parental
424292|NCT01334203|Chronic angina|chronic angina
424293|NCT01334203|Angina pectoris|angina pectoris
424294|NCT01334203|Coronary artery disease|coronary artery disease
424295|NCT01334203|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
424297|NCT01334190|AE adverse event|ae adverse event
424298|NCT01334190|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
424299|NCT01334190|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
424300|NCT01334190|ART antiretroviral therapy|art antiretroviral therapy
424301|NCT01334190|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
424302|NCT01334190|DCF data collection forms|dcf data collection forms
424303|NCT01334190|DMC Data Monitoring Committee|dmc data monitoring committee
424304|NCT01334190|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
424305|NCT01334190|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
424306|NCT01334190|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
424509|NCT01333332|Radiation|radiation
424307|NCT01334190|ICH International Conference of Harmonisation|ich international conference of harmonisation
424308|NCT01334190|IND Investigational New Drug Application|ind investigational new drug application
424309|NCT01334190|IRB Institutional Review Board|irb institutional review board
424310|NCT01334190|IU international units|iu international units
424311|NCT01334190|mg milligram(s)|mg milligram(s)
424312|NCT01334190|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
424313|NCT01334190|PCR polymerase chain reaction|pcr polymerase chain reaction
424314|NCT01334190|SAE serious adverse event|sae serious adverse event
424315|NCT01334190|µg microgram|µg microgram
424316|NCT01334190|ULN upper limit of the normal range|uln upper limit of the normal range
424317|NCT01334190|WB Western Blot|wb western blot
424318|NCT01334190|post-marketing monitoring|post-marketing monitoring
424319|NCT01334190|safety|safety
424320|NCT01334190|efficacy|efficacy
424321|NCT01334190|acceptability|acceptability
424322|NCT01334164|substance use disorder|substance use disorder
424323|NCT01334164|offenders|offenders
424324|NCT01334164|reentry|reentry
424325|NCT01334164|HIV risk behavior|hiv risk behavior
424326|NCT01334164|recidivism|recidivism
424327|NCT01334138|hypertension|hypertension
424328|NCT01334138|sodium|sodium
424329|NCT01334138|diet|diet
424330|NCT01334125|Double Diabetes|double diabetes
424331|NCT01334125|Type 1 diabetes|type 1 diabetes
424332|NCT01334125|Type 2 diabetes|type 2 diabetes
424333|NCT01334125|Obesity|obesity
424334|NCT01334125|Acanthosis nigricans|acanthosis nigricans
424335|NCT01334125|Diabetes associated autoantibodies|diabetes associated autoantibodies
424336|NCT01334112|Hepatocellular Carcinoma|hepatocellular carcinoma
424337|NCT01334112|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
424338|NCT01334112|Liver Cancer|liver cancer
424339|NCT01334112|Axitinib|axitinib
424340|NCT01334112|AG-013736|ag-013736
424341|NCT01334086|AML|aml
424342|NCT01334073|Phase I|phase i
424343|NCT01334073|Axitinib|axitinib
424344|NCT01334073|Everolimus|everolimus
424345|NCT01334073|Maximum tolerated dose (MTD)|maximum tolerated dose (mtd)
424346|NCT01334073|solid tumor|solid tumor
424347|NCT01334073|Renal cell cancer (RCC)|renal cell cancer (rcc)
424348|NCT01334073|Pharmacokinetics (PK/PD)|pharmacokinetics (pk/pd)
424349|NCT01334021|Genomic Testing|genomic testing
424350|NCT01334021|Genetic Testing|genetic testing
424351|NCT01334021|HER2 Negative|her2 negative
424352|NCT01334021|Primary Invasive Breast Cancer|primary invasive breast cancer
424353|NCT01334021|Stage I|stage i
424354|NCT01334021|Stage II|stage ii
424355|NCT01334021|Stage III|stage iii
424356|NCT01334021|Registry|registry
424357|NCT01334021|Biopsy|biopsy
424358|NCT01334021|Tumor sampling|tumor sampling
424359|NCT01334008|Circulating tumor DNA|circulating tumor dna
424360|NCT01334008|Choroidal Melanoma|choroidal melanoma
424361|NCT01333995|Peer counselling|peer counselling
424362|NCT01333995|Infant|infant
424363|NCT01333995|Intervention|intervention
424364|NCT01333995|breastfeeding|breastfeeding
424365|NCT01333995|complementary feeding|complementary feeding
424366|NCT01333995|stunting|stunting
424367|NCT01333982|Neonatal Sepsis|neonatal sepsis
424368|NCT01333982|Evaluation|evaluation
424369|NCT01333982|Bangladesh|bangladesh
424370|NCT01333982|Drying|drying
424371|NCT01333982|Wrapping|wrapping
424372|NCT01333982|Bathing|bathing
424373|NCT01333943|Total Knee Replacement|total knee replacement
424374|NCT01333943|Regional Anesthesia|regional anesthesia
424375|NCT01333943|Quadriceps|quadriceps
424376|NCT01333943|Muscle Strength|muscle strength
424377|NCT01333943|Muscle Strength Dynamometer|muscle strength dynamometer
424378|NCT01333943|Quadriceps muscle strength after regional anesthesia for TKA|quadriceps muscle strength after regional anesthesia for tka
424379|NCT01333930|immunological effects|immunological effects
424380|NCT01333930|Active O2|active o2
424381|NCT01333930|strenuous exercise|strenuous exercise
424382|NCT01333930|procedures|procedures
424383|NCT01333930|pharmacodynamic parameters|pharmacodynamic parameters
424384|NCT01333930|blood sampling scheme|blood sampling scheme
424385|NCT01333917|Curcumin|curcumin
424386|NCT01333917|Colorectal Cancer|colorectal cancer
424387|NCT01333917|GWAS|gwas
424388|NCT01333865|Memantine|memantine
424389|NCT01333865|Namenda|namenda
424390|NCT01333865|Autism Spectrum Disorders|autism spectrum disorders
424391|NCT01333865|Pervasive Developmental Disorders|pervasive developmental disorders
424392|NCT01333865|Adults|adults
424393|NCT01333852|head and neck cancer|head and neck cancer
424394|NCT01333852|paclitaxel|paclitaxel
424395|NCT01333852|metformin|metformin
424396|NCT01333852|squamous cell carcinoma|squamous cell carcinoma
424397|NCT01333839|CABG surgery|cabg surgery
424398|NCT01333839|exercise intervention|exercise intervention
424399|NCT01333839|insulin sensitivity|insulin sensitivity
424400|NCT01333839|muscle mass|muscle mass
424401|NCT01333813|immune response|immune response
424402|NCT01333813|Engerix-B™Kinder|engerix-b™kinder
424403|NCT01333813|Persistence|persistence
424404|NCT01333813|challenge dose|challenge dose
424405|NCT01333787|dietary fiber|dietary fiber
424406|NCT01333787|clinical trial|clinical trial
424407|NCT01333787|constipation|constipation
424408|NCT01333787|children|children
424409|NCT01333774|Diabetes|diabetes
424410|NCT01333774|Acarbose|acarbose
424411|NCT01333774|Diet|diet
424412|NCT01333774|Compliance|compliance
424413|NCT01333774|Advising|advising
424414|NCT01333761|right to left cardiac shunt finding|right to left cardiac shunt finding
424415|NCT01333748|breast cancer|breast cancer
424416|NCT01333748|ovarian cancer|ovarian cancer
424417|NCT01333748|BRCA 1 and BRCA 2|brca 1 and brca 2
424418|NCT01333735|cognitive functions|cognitive functions
424419|NCT01333735|quality of life|quality of life
424420|NCT01333735|breast cancer|breast cancer
424421|NCT01333735|chemotherapy|chemotherapy
424422|NCT01333735|ages patients|ages patients
424423|NCT01333709|locally advanced rectal carcinoma|locally advanced rectal carcinoma
424424|NCT01333709|Tailored treatment strategy|tailored treatment strategy
424425|NCT01333709|MRI volumetry|mri volumetry
424426|NCT01333709|Early tumor response|early tumor response
424427|NCT01333696|Squamous cell carcinoma of head and neck|squamous cell carcinoma of head and neck
424428|NCT01333696|Pemetrexed|pemetrexed
424429|NCT01333683|tinnitus|tinnitus
424430|NCT01333683|hearing loss|hearing loss
424431|NCT01333683|arterial hypertension|arterial hypertension
424432|NCT01333683|ototoxicity|ototoxicity
424433|NCT01333657|sTREM-1|strem-1
424434|NCT01333657|sepsis|sepsis
424435|NCT01333657|SIRS|sirs
424436|NCT01333657|blood|blood
424437|NCT01333657|urine|urine
424438|NCT01333657|diagnosis|diagnosis
424439|NCT01333657|prognosis|prognosis
424440|NCT01333644|HIV Infection|hiv infection
424441|NCT01333644|Endothelial function|endothelial function
424442|NCT01333644|Cardiovascular Disease|cardiovascular disease
424443|NCT01333644|Inflammation|inflammation
424444|NCT01333644|Antiretroviral medication|antiretroviral medication
424445|NCT01333644|Treatment naive|treatment naive
424446|NCT01333644|Treatment experienced|treatment experienced
424447|NCT01333631|Locally advanced unresectable pancreatic cancer|locally advanced unresectable pancreatic cancer
424448|NCT01333618|Filter Tilt|filter tilt
424449|NCT01333618|Preventional efficiency|preventional efficiency
424450|NCT01333618|Günther Tulip filter|günther tulip filter
424451|NCT01333618|Transfemoral Approach|transfemoral approach
424452|NCT01333605|Hodgkin lymphoma|hodgkin lymphoma
424453|NCT01333605|Chemotherapy|chemotherapy
424454|NCT01333605|IGEV|igev
424455|NCT01333605|Autologous stem cell transplantation|autologous stem cell transplantation
424456|NCT01333592|Type 2 diabetes|type 2 diabetes
424457|NCT01333592|HbA1c|hba1c
424458|NCT01333592|Long-term study|long-term study
424459|NCT01333553|birthmark|birthmark
424460|NCT01333540|constipation|constipation
424461|NCT01333540|opioid induced|opioid induced
424462|NCT01333514|diabetes|diabetes
424463|NCT01333514|prandial|prandial
424464|NCT01333514|insulin|insulin
424465|NCT01333514|aspart|aspart
424466|NCT01333514|carbohydrate|carbohydrate
424467|NCT01333514|inpatient|inpatient
424468|NCT01333514|novolog|novolog
424469|NCT01333501|Multiple sclerosis|multiple sclerosis
424470|NCT01333501|cognitive symptoms|cognitive symptoms
424471|NCT01333501|relapsing-remitting multiple sclerosis (RRMS)|relapsing-remitting multiple sclerosis (rrms)
424472|NCT01333501|fingolimod|fingolimod
424473|NCT01333501|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
424474|NCT01333488|Traumatic|traumatic
424475|NCT01333488|Brain|brain
424476|NCT01333488|Injury|injury
424477|NCT01333475|Targeted Therapy|targeted therapy
424478|NCT01333475|KRAS Mutation|kras mutation
424479|NCT01333475|Metastatic Colorectal Cancer|metastatic colorectal cancer
424480|NCT01333475|Colorectal Cancer|colorectal cancer
424481|NCT01333449|Decitabine|decitabine
424482|NCT01333449|MDS, myelodysplastic syndrome|mds, myelodysplastic syndrome
424483|NCT01333449|prospective open label, phaseII|prospective open label, phaseii
424484|NCT01333449|Allogeneic Hematopoietic cell transplant|allogeneic hematopoietic cell transplant
424485|NCT01333423|Breast Cancer|breast cancer
424486|NCT01333423|Metastatic Triple Negative|metastatic triple negative
424487|NCT01333423|ER/PR/HER2 negative|er/pr/her2 negative
424488|NCT01333423|Locally advanced|locally advanced
424489|NCT01333423|Stage IV|stage iv
424490|NCT01333423|Metastatic|metastatic
424491|NCT01333423|Seliciclib|seliciclib
424492|NCT01333423|Liposomal Doxorubicin|liposomal doxorubicin
424493|NCT01333423|Doxil|doxil
424494|NCT01333423|Doxorubicin Hydrochloride (Liposomal)|doxorubicin hydrochloride (liposomal)
424495|NCT01333410|vitiligo|vitiligo
424496|NCT01333410|tacrolimus|tacrolimus
424497|NCT01333410|mometasone furoate|mometasone furoate
424498|NCT01333371|Distal Radius|distal radius
424499|NCT01333371|Volar locked plating|volar locked plating
424500|NCT01333371|Cost Effectiveness|cost effectiveness
424501|NCT01333371|Randomization|randomization
424502|NCT01333371|Outcomes|outcomes
424503|NCT01333358|Relapsing|relapsing
424504|NCT01333358|remitting|remitting
424505|NCT01333345|Cataract replacement surgery|cataract replacement surgery
424506|NCT01333345|implantation|implantation
424507|NCT01333345|EC-3 IOL|ec-3 iol
424510|NCT01333319|liver transplantation|liver transplantation
424511|NCT01333319|acute kidney injury|acute kidney injury
424512|NCT01333306|tDCS|tdcs
424513|NCT01333306|cognitive training|cognitive training
424514|NCT01333293|mastocytosis|mastocytosis
424515|NCT01333293|omalizumab|omalizumab
424516|NCT01333267|Endocrine System Diseases|endocrine system diseases
424517|NCT01333267|MusculoSkeletal System Disease|musculoskeletal system disease
424518|NCT01333267|Hormones|hormones
424519|NCT01333267|Postmenopausal Women|postmenopausal women
424520|NCT01333267|Bone metabolism|bone metabolism
424521|NCT01333267|Physiologic Properties|physiologic properties
424522|NCT01333267|African-Americans|african-americans
424523|NCT01333254|urinary tract infections|urinary tract infections
424524|NCT01333254|urinary catheterisation|urinary catheterisation
424525|NCT01333241|Hispanic Americans|hispanic americans
424526|NCT01333241|Cardiovascular disease|cardiovascular disease
424527|NCT01333241|Obesity|obesity
424528|NCT01333241|Intervention|intervention
424529|NCT01333215|Suicide, Attempted|suicide, attempted
424530|NCT01333215|Cognitive Symptoms|cognitive symptoms
424531|NCT01333202|Fresh lime|fresh lime
424532|NCT01333202|nicotine gum|nicotine gum
424533|NCT01333202|smoking cessation|smoking cessation
424534|NCT01333202|craving|craving
424535|NCT01333189|total knee arthroplasty|total knee arthroplasty
424536|NCT01333189|osteoarthritis|osteoarthritis
424537|NCT01333189|biomechanics|biomechanics
424538|NCT01333189|gait|gait
424539|NCT01333176|Type 2 Diabetes|type 2 diabetes
424540|NCT01333176|Hb A1c screening for diabetes in aboriginals|hb a1c screening for diabetes in aboriginals
424541|NCT01333150|Temporomandibular disorders|temporomandibular disorders
424542|NCT01333150|Orofacial pain|orofacial pain
424543|NCT01333137|Triple negative breast cancer|triple negative breast cancer
424544|NCT01333124|Preoperative chemoradiotherapy with Gemcitabine|preoperative chemoradiotherapy with gemcitabine
424545|NCT01333098|anxiety|anxiety
424546|NCT01333098|older adult|older adult
424547|NCT01333098|memory|memory
424548|NCT01333098|cognitive|cognitive
424549|NCT01333098|Saint Louis|saint louis
424550|NCT01333098|treatment|treatment
424551|NCT01333098|Non-dementia cognitive impairment in older adults with anxiety disorders.|non-dementia cognitive impairment in older adults with anxiety disorders.
424552|NCT01333085|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
424553|NCT01333085|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
424554|NCT01333085|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
424555|NCT01333085|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
424556|NCT01333085|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
424557|NCT01333085|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
424558|NCT01333085|tongue cancer|tongue cancer
424559|NCT01333072|Autistic Disorder|autistic disorder
424560|NCT01333059|Sedation|sedation
424561|NCT01333059|Cycling|cycling
424562|NCT01333059|Pediatric|pediatric
424563|NCT01333046|Hodgkin Lymphoma|hodgkin lymphoma
424564|NCT01333046|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
424565|NCT01333046|CTL|ctl
424566|NCT01333033|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
424567|NCT01333033|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
424568|NCT01333033|stage IB esophageal cancer|stage ib esophageal cancer
424569|NCT01333033|stage IIA esophageal cancer|stage iia esophageal cancer
424570|NCT01333033|stage IIB esophageal cancer|stage iib esophageal cancer
424571|NCT01333033|stage IIIA esophageal cancer|stage iiia esophageal cancer
424572|NCT01333033|stage IIIB esophageal cancer|stage iiib esophageal cancer
424573|NCT01333033|stage IIIC esophageal cancer|stage iiic esophageal cancer
424574|NCT01333020|emulsion|emulsion
424575|NCT01333020|protein|protein
424576|NCT01333020|cross-linking|cross-linking
424577|NCT01333020|gastric emptying|gastric emptying
424578|NCT01332955|Hepatitis C, Chronic|hepatitis c, chronic
424579|NCT01332955|HIV Infection|hiv infection
424580|NCT01332955|Telaprevir|telaprevir
424581|NCT01332955|Peginterferon alfa-2a|peginterferon alfa-2a
424582|NCT01332955|Ribavirin|ribavirin
424583|NCT01332955|Pharmacokinetic|pharmacokinetic
424584|NCT01332955|Pharmacogenetic|pharmacogenetic
424585|NCT01332955|Previous peginterferon-ribavirin regimen failure|previous peginterferon-ribavirin regimen failure
424586|NCT01332942|Anemia|anemia
424587|NCT01332929|brain radiation therapy|brain radiation therapy
424588|NCT01332929|Bevacizumab|bevacizumab
424589|NCT01332929|brain metastasis|brain metastasis
424590|NCT01332929|solid tumor|solid tumor
424591|NCT01332916|No metastatic breast cancer|no metastatic breast cancer
424592|NCT01332916|cognitive troubles|cognitive troubles
424593|NCT01332916|adjuvant chemotherapy|adjuvant chemotherapy
424594|NCT01332890|Drug interaction|drug interaction
424595|NCT01332890|revaprazan|revaprazan
424596|NCT01332890|Itopride HCI|itopride hci
424597|NCT01332877|Obesity|obesity
424598|NCT01332877|Weight loss|weight loss
424599|NCT01332877|Ghrelin|ghrelin
424600|NCT01332877|Satiety|satiety
424601|NCT01332877|Hunger|hunger
424602|NCT01332864|headache|headache
424603|NCT01332864|migraine|migraine
424604|NCT01332864|cephalgia|cephalgia
424605|NCT01332864|osteopathic manipulative treatment|osteopathic manipulative treatment
424606|NCT01332851|child welfare|child welfare
424607|NCT01332851|child protective services|child protective services
424608|NCT01332851|child abuse|child abuse
424609|NCT01332851|child neglect|child neglect
424610|NCT01332851|infant|infant
424611|NCT01332851|parenting|parenting
424612|NCT01332825|olfaction|olfaction
424613|NCT01332825|smell dysfunction|smell dysfunction
424614|NCT01332812|Dexamethasone|dexamethasone
424615|NCT01332812|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
424616|NCT01332812|General Anesthesia|general anesthesia
424617|NCT01332812|neuropsychological tests|neuropsychological tests
424618|NCT01332799|cardiovascular disease|cardiovascular disease
424619|NCT01332799|kidney transplantation|kidney transplantation
424620|NCT01332786|AML|aml
424621|NCT01332760|ergonomics|ergonomics
424622|NCT01332760|workplace|workplace
424623|NCT01332760|occupational|occupational
424624|NCT01332760|tool|tool
424625|NCT01332760|dental|dental
424626|NCT01332760|dentist|dentist
424627|NCT01332747|TC|tc
424628|NCT01332747|TG|tg
424629|NCT01332747|HDL|hdl
424630|NCT01332747|LDL|ldl
424631|NCT01332747|VLDL|vldl
424632|NCT01332734|microcirculation|microcirculation
424633|NCT01332734|SDF|sdf
424634|NCT01332734|magnesium sulfate|magnesium sulfate
424635|NCT01332721|TRC105|trc105
424636|NCT01332721|CD105|cd105
424637|NCT01332721|Endoglin|endoglin
424638|NCT01332721|Solid Tumors|solid tumors
424639|NCT01332721|Avastin|avastin
424640|NCT01332721|Bevacizumab|bevacizumab
424641|NCT01332708|high complex carbohydrates|high complex carbohydrates
424642|NCT01332708|hypocaloric diet|hypocaloric diet
424643|NCT01332708|cholinergic status|cholinergic status
424644|NCT01332708|overweight|overweight
424645|NCT01332708|obese|obese
424646|NCT01332695|tremor|tremor
424647|NCT01332695|WHIGET|whiget
424648|NCT01332695|Fahn Tolosa Marin Scale|fahn tolosa marin scale
424649|NCT01332682|head and neck cancer|head and neck cancer
424650|NCT01332682|resistance training|resistance training
424651|NCT01332682|nutrition counseling|nutrition counseling
424652|NCT01332682|pharyngeal or laryngeal cancer|pharyngeal or laryngeal cancer
424653|NCT01332669|hepatocellular carcinoma|hepatocellular carcinoma
424654|NCT01332669|chemoembolization|chemoembolization
424655|NCT01332669|drug eluting beads|drug eluting beads
424656|NCT01332669|HCC|hcc
424657|NCT01332669|Liver cancer|liver cancer
424658|NCT01332669|Korea|korea
424659|NCT01332643|Preimplantation Genetic Diagnosis|preimplantation genetic diagnosis
424660|NCT01332643|recurrent pregnancy loss|recurrent pregnancy loss
424661|NCT01332643|infertility|infertility
424662|NCT01332643|genetic screening|genetic screening
424663|NCT01332643|trisomy 21|trisomy 21
424664|NCT01332643|Down syndrome|down syndrome
424665|NCT01332630|Breast cancer|breast cancer
424666|NCT01332630|Brain metastases|brain metastases
424667|NCT01332630|TPI 287|tpi 287
424668|NCT01332630|Computed Tomography|computed tomography
424669|NCT01332630|CT|ct
424670|NCT01332630|Magnetic Resonance Imaging|magnetic resonance imaging
424671|NCT01332630|MRI|mri
424672|NCT01332617|Multiple Myeloma|multiple myeloma
424673|NCT01332617|Simvastatin|simvastatin
424674|NCT01332617|Zoledronic|zoledronic
424675|NCT01332617|Bortezomib|bortezomib
424676|NCT01332617|Bendamustine|bendamustine
424677|NCT01332617|Methylprednisolone|methylprednisolone
424678|NCT01332591|STEMI, primary PCI, non-infarct, non-culprit lesion, CABG|stemi, primary pci, non-infarct, non-culprit lesion, cabg
424679|NCT01332565|GSK1349572|gsk1349572
424680|NCT01332565|pharmacokinetics|pharmacokinetics
424681|NCT01332565|Japanese|japanese
424682|NCT01332565|HIV|hiv
424683|NCT01332552|pharmacokinetics|pharmacokinetics
424684|NCT01332552|First administration to human|first administration to human
424685|NCT01332552|antiviral activity|antiviral activity
424686|NCT01332552|safety|safety
424687|NCT01332552|hepatitis C|hepatitis c
424688|NCT01332526|FFT|fft
424689|NCT01332526|inflammation|inflammation
424690|NCT01332526|lipid metabolism|lipid metabolism
424691|NCT01332526|hyperuricemia|hyperuricemia
424692|NCT01332526|Agents Affecting Uric Acid Metabolism|agents affecting uric acid metabolism
424693|NCT01332513|Healthy Volunteers|healthy volunteers
424694|NCT01332500|Triptans|triptans
424695|NCT01332500|Migraine|migraine
424696|NCT01332487|5-alpha-reductase inhibitor|5-alpha-reductase inhibitor
424697|NCT01332487|prostate surgery|prostate surgery
424698|NCT01332487|alpha-blocker|alpha-blocker
424699|NCT01332487|enlarged prostate|enlarged prostate
424700|NCT01332487|acute urinary retention|acute urinary retention
424701|NCT01332487|Benign prostatic hyperplasia|benign prostatic hyperplasia
424702|NCT01332474|Botox|botox
424703|NCT01332474|JCP|jcp
424704|NCT01332448|Xenical|xenical
424705|NCT01332448|Alli|alli
424706|NCT01332448|safety|safety
424707|NCT01332448|meta-analysis|meta-analysis
424708|NCT01332448|liver-function test|liver-function test
424709|NCT01332448|Roche|roche
424710|NCT01332448|orlistat|orlistat
424711|NCT01332435|Enlarged prostate, 5-alpha-reductase inhibitor, alpha-blocker, early, costs|enlarged prostate, 5-alpha-reductase inhibitor, alpha-blocker, early, costs
424712|NCT01332370|Retrospective|retrospective
424713|NCT01332370|Type 2 Diabetes|type 2 diabetes
424714|NCT01332370|Cost Analysis|cost analysis
424715|NCT01332370|Rosiglitazone|rosiglitazone
424716|NCT01332370|Sitagliptin|sitagliptin
424717|NCT01332357|fluticasone/propionate salmeterol combination|fluticasone/propionate salmeterol combination
424718|NCT01332357|hospitalization|hospitalization
424719|NCT01332357|emergency department|emergency department
424720|NCT01332357|asthma|asthma
424721|NCT01332344|fluticasone propionate/salmeterol combination|fluticasone propionate/salmeterol combination
424722|NCT01332344|Asthma|asthma
424723|NCT01332344|inhaled corticosteroids|inhaled corticosteroids
424724|NCT01332344|outcomes|outcomes
424725|NCT01332331|pulmonary arterial hypertension|pulmonary arterial hypertension
424726|NCT01332331|pediatric|pediatric
424727|NCT01332292|inhalation profiles|inhalation profiles
424728|NCT01332292|pharmacokinetics|pharmacokinetics
424729|NCT01332292|pharyngometry|pharyngometry
424730|NCT01332292|asthma|asthma
424731|NCT01332292|pediatric subjects|pediatric subjects
424732|NCT01332292|GW685698|gw685698
424733|NCT01332292|Fluticasone furoate|fluticasone furoate
424734|NCT01332292|safety|safety
424735|NCT01332266|Cancer|cancer
424736|NCT01332266|head and neck|head and neck
424737|NCT01332266|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
424738|NCT01332266|phase I|phase i
424739|NCT01332266|phase II|phase ii
424740|NCT01332253|Tonsillectomy, Pediatric|tonsillectomy, pediatric
424741|NCT01332240|staging|staging
424742|NCT01332240|endosonography|endosonography
424743|NCT01332240|lung cancer|lung cancer
424744|NCT01332240|stage III|stage iii
424745|NCT01332214|Phase 1|phase 1
424746|NCT01332214|healthy male volunteers|healthy male volunteers
424747|NCT01332214|dose escalation|dose escalation
424748|NCT01332214|pharmacokinetics|pharmacokinetics
424749|NCT01332214|Single Ascending Dose|single ascending dose
424750|NCT01332214|AZD2820 Cmax|azd2820 cmax
424751|NCT01332214|tmax|tmax
424752|NCT01332214|t1/2λz|t1/2λz
424753|NCT01332201|Advagraf|advagraf
424754|NCT01332201|Heart|heart
424755|NCT01332201|Lung|lung
424756|NCT01332201|Pancreas|pancreas
424757|NCT01332201|Transplant|transplant
424758|NCT01332201|Immunosuppression|immunosuppression
424759|NCT01332201|Pharmacokinetics|pharmacokinetics
424760|NCT01332162|Hypertrophic Obstructive Cardiomyopathy (HOCM)|hypertrophic obstructive cardiomyopathy (hocm)
424761|NCT01332162|Pacing|pacing
424762|NCT01332149|Diabetic Neuropathies|diabetic neuropathies
424763|NCT01332149|Pain|pain
424764|NCT01332149|Efficacy of pregabalin|efficacy of pregabalin
424765|NCT01332149|Placebo controlled|placebo controlled
424766|NCT01332110|Footwear|footwear
424767|NCT01332110|Motion Analysis|motion analysis
424768|NCT01332110|Running Injury|running injury
424769|NCT01332097|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
424770|NCT01332097|Exacerbation|exacerbation
424771|NCT01332097|Pulmonary Inflammation|pulmonary inflammation
424772|NCT01332084|SOTI|soti
424773|NCT01332084|tolerance|tolerance
424774|NCT01332084|desensitization|desensitization
424775|NCT01332084|challenge test|challenge test
424776|NCT01332084|HA wheat cereals|ha wheat cereals
424777|NCT01332071|Metformin|metformin
424778|NCT01332071|Rosiglitazone|rosiglitazone
424779|NCT01332071|Healthy volunteers|healthy volunteers
424780|NCT01332071|Avandamet|avandamet
424781|NCT01332071|Fed conditions|fed conditions
424782|NCT01332071|Bioequivalence|bioequivalence
424783|NCT01332058|Peripheral arterial disease|peripheral arterial disease
424784|NCT01332058|Walking|walking
424785|NCT01332058|Motivational Interviewing|motivational interviewing
424786|NCT01332032|cost effectiveness|cost effectiveness
424787|NCT01332032|screening mammography|screening mammography
424788|NCT01332032|repeat mammography|repeat mammography
424789|NCT01332032|telephone counseling|telephone counseling
424790|NCT01332032|computerized reminders|computerized reminders
424791|NCT01332032|compliance|compliance
424792|NCT01332019|Subcutaneous|subcutaneous
424793|NCT01332019|Extension|extension
424794|NCT01332019|Interferon|interferon
424795|NCT01332019|MS|ms
424796|NCT01332019|PEGylated|pegylated
424797|NCT01332019|Injectable|injectable
424798|NCT01332019|SC|sc
424799|NCT01332019|PEG|peg
424800|NCT01332019|peginterferon beta-1a|peginterferon beta-1a
424801|NCT01332019|Relapsing|relapsing
424802|NCT01331993|Phase 1|phase 1
424803|NCT01331993|crossover|crossover
424804|NCT01331993|bioequivalence|bioequivalence
424805|NCT01331993|naproxen|naproxen
424806|NCT01331993|esomeprazole|esomeprazole
424807|NCT01331993|vimovo|vimovo
424808|NCT01331993|healthy volunteers|healthy volunteers
424809|NCT01331980|cystic fibrosis|cystic fibrosis
424810|NCT01331980|bone|bone
424811|NCT01331967|pioglitazone|pioglitazone
424812|NCT01331967|optical coherence tomography|optical coherence tomography
424813|NCT01331967|microRNA|microrna
424814|NCT01331967|neointima|neointima
424815|NCT01331967|major adverse cardiovascular event|major adverse cardiovascular event
424816|NCT01331941|AMG 386|amg 386
424817|NCT01331941|Pharmacokinetic|pharmacokinetic
424818|NCT01331941|Renal Impairment|renal impairment
424819|NCT01331928|Sequential chemotherapy, gastric cancer|sequential chemotherapy, gastric cancer
424820|NCT01331915|Metastatic Melanoma|metastatic melanoma
424821|NCT01331915|Safety|safety
424822|NCT01331915|Theravac vaccine|theravac vaccine
424823|NCT01331915|HLA-A2 typing|hla-a2 typing
424824|NCT01331915|Tyrosinase.A2 gene expression|tyrosinase.a2 gene expression
424825|NCT01331902|Adenosine|adenosine
424826|NCT01331902|Nicorandil|nicorandil
424827|NCT01331902|Fractional Flow Reserve|fractional flow reserve
424828|NCT01331902|Maximal Hyperemia|maximal hyperemia
424829|NCT01331889|transfusion|transfusion
424830|NCT01331889|liver transplantation|liver transplantation
424831|NCT01331889|potassium|potassium
424832|NCT01331876|Cognitive and Behavioral Therapy|cognitive and behavioral therapy
424833|NCT01331863|Bronchial disease|bronchial disease
424834|NCT01331863|Lung cancer surgery|lung cancer surgery
424835|NCT01331863|Aorta/aortic Allograft|aorta/aortic allograft
424836|NCT01331863|homograft|homograft
424837|NCT01331863|Tracheal disease|tracheal disease
424838|NCT01331863|Benign|benign
424839|NCT01331863|Malignant|malignant
424840|NCT01331824|Bladder Cancer|bladder cancer
424841|NCT01331824|Urothelial Cancer|urothelial cancer
424842|NCT01331824|Chemotherapy|chemotherapy
424843|NCT01331824|Second-line|second-line
424844|NCT01331824|Metastatic|metastatic
424845|NCT01331811|HIV|hiv
424846|NCT01331811|Tuberculosis|tuberculosis
424847|NCT01331811|Diagnosis|diagnosis
424848|NCT01331811|Pediatrics|pediatrics
424849|NCT01331811|Asia|asia
424850|NCT01331811|Africa|africa
424851|NCT01331798|Abdominoplasty|abdominoplasty
424852|NCT01331785|paracentesis|paracentesis
424853|NCT01331785|ascites|ascites
424854|NCT01331785|hypotension|hypotension
424855|NCT01331772|Breast cancer|breast cancer
424856|NCT01331772|Adapted Physical activity|adapted physical activity
424857|NCT01331772|Nutrition|nutrition
424858|NCT01331772|Assessment|assessment
424859|NCT01331772|Patient education|patient education
424860|NCT01331759|Burnout|burnout
424861|NCT01331759|Subthreshold Disorder|subthreshold disorder
424862|NCT01331707|drug-eluting stent|drug-eluting stent
424863|NCT01331707|Zotarolimus|zotarolimus
424864|NCT01331707|Everolimus|everolimus
424865|NCT01331707|all comers population|all comers population
424866|NCT01331707|target vessel failure|target vessel failure
424867|NCT01331707|coronary artery disease|coronary artery disease
424868|NCT01331681|Diabetic Macular Edema (DME)|diabetic macular edema (dme)
424869|NCT01331681|VEGF Trap-Eye|vegf trap-eye
424870|NCT01331681|Best-corrected visual acuity (BCVA)|best-corrected visual acuity (bcva)
424871|NCT01331642|Lymphatic Diseases|lymphatic diseases
424872|NCT01331642|Metabolism, Inborn Errors|metabolism, inborn errors
424873|NCT01331642|Genetic Diseases, Inborn|genetic diseases, inborn
424874|NCT01331642|Lipidoses|lipidoses
424875|NCT01331642|Lipid Metabolism, Inborn Errors|lipid metabolism, inborn errors
424876|NCT01331642|Metabolic Diseases|metabolic diseases
424877|NCT01331642|Lipid Metabolism Disorders|lipid metabolism disorders
424878|NCT01331629|breast cancer|breast cancer
424879|NCT01331629|fatigue|fatigue
424880|NCT01331629|quality of life|quality of life
424881|NCT01331629|art-therapie|art-therapie
424882|NCT01331629|adjuvant radiotherapy|adjuvant radiotherapy
424883|NCT01331616|Prospective study|prospective study
424884|NCT01331616|Glioblastoma|glioblastoma
424885|NCT01331616|Avastin|avastin
424886|NCT01331616|Visual Evoked Potential|visual evoked potential
424887|NCT01331616|Optic neuropathy|optic neuropathy
424888|NCT01331616|Chemo-radiotherapy|chemo-radiotherapy
424889|NCT01331603|MDS|mds
424890|NCT01331603|primary myelofibrosis|primary myelofibrosis
424891|NCT01331603|low+high risk MDS patients|low+high risk mds patients
424892|NCT01331603|patients|patients
424893|NCT01331577|Healthy|healthy
424894|NCT01331577|Primary Prevention|primary prevention
424895|NCT01331577|Stress|stress
424896|NCT01331577|Kinesiology|kinesiology
424897|NCT01331577|cognitive behavioural therapy|cognitive behavioural therapy
424898|NCT01331577|Prevention|prevention
424899|NCT01331564|Pregnancy|pregnancy
424900|NCT01331564|Postpartum|postpartum
424901|NCT01331564|Weight gain|weight gain
424902|NCT01331564|Weight retention|weight retention
424903|NCT01331564|Behavior|behavior
424904|NCT01331564|Electronic Media|electronic media
424905|NCT01331564|Randomized Clinical Trial|randomized clinical trial
424906|NCT01331551|Inflammatory Bowel disease|inflammatory bowel disease
424907|NCT01331538|temporomandibular dysfunction|temporomandibular dysfunction
424908|NCT01331538|posture|posture
424909|NCT01331525|Small cell lung cancer|small cell lung cancer
424910|NCT01331525|Chemotherapy|chemotherapy
424911|NCT01331525|Immunotherapy|immunotherapy
424912|NCT01331525|CTLA-4|ctla-4
424913|NCT01331525|Ipilimumab|ipilimumab
424914|NCT01331512|Clinical Geriatrics|clinical geriatrics
424915|NCT01331512|Biomechanics|biomechanics
424916|NCT01331512|Epidemiology|epidemiology
424917|NCT01331512|Decline in Ambulation|decline in ambulation
424918|NCT01331499|Blood loss|blood loss
424919|NCT01331499|transfusions|transfusions
424920|NCT01331499|instrumented spinal fusion|instrumented spinal fusion
424921|NCT01331486|Prehypertension|prehypertension
424922|NCT01331486|Mild hypertension|mild hypertension
424923|NCT01331486|Flow mediated dilation|flow mediated dilation
424924|NCT01331486|Hawthorn|hawthorn
424925|NCT01331473|Carotid Artery|carotid artery
424926|NCT01331473|Stenting|stenting
424927|NCT01331473|CAS|cas
424928|NCT01331473|proximal protection|proximal protection
424929|NCT01331460|HIV|hiv
424930|NCT01331460|HIV risk|hiv risk
424931|NCT01331460|Sexually Transmitted Diseases|sexually transmitted diseases
424932|NCT01331460|Drug Use|drug use
424933|NCT01331460|Women|women
424934|NCT01331460|Drug Treatment|drug treatment
424935|NCT01331460|opioids|opioids
424936|NCT01331460|injection drug use|injection drug use
424937|NCT01331460|stimulants|stimulants
424938|NCT01331460|gender-specific treatment|gender-specific treatment
424939|NCT01331395|Infertility|infertility
424940|NCT01331395|IVF|ivf
424941|NCT01331395|Acupuncture|acupuncture
424942|NCT01331382|Resveratrol|resveratrol
424943|NCT01331382|Piperine|piperine
424944|NCT01331382|Cerebral blood flow|cerebral blood flow
424945|NCT01331382|Near- infrared spectroscopy|near- infrared spectroscopy
424946|NCT01331382|Bioavailability|bioavailability
424947|NCT01331369|adherence|adherence
424948|NCT01331369|compliance|compliance
424949|NCT01331369|persistence|persistence
424950|NCT01331369|drop out|drop out
424951|NCT01331369|abandon|abandon
424952|NCT01331356|Chronic proctalgia|chronic proctalgia
424953|NCT01331356|Botulinum toxin type A|botulinum toxin type a
424954|NCT01331356|Ganglion Impar|ganglion impar
424955|NCT01331356|Perineal pain|perineal pain
424956|NCT01331356|Pudendal neuralgia|pudendal neuralgia
424957|NCT01331356|Refractory chronic proctalgia|refractory chronic proctalgia
424958|NCT01331343|Diabetes|diabetes
424959|NCT01331343|Glycemic Control|glycemic control
424960|NCT01331343|Continuous Glucose Monitoring|continuous glucose monitoring
424961|NCT01331330|Depressive Disorder|depressive disorder
424962|NCT01331330|Unipolar|unipolar
424963|NCT01331330|Implantable Stimulation Electrodes|implantable stimulation electrodes
424964|NCT01331317|Cardiovascular disease and mortality|cardiovascular disease and mortality
424965|NCT01331317|Plasma NTproBNP|plasma ntprobnp
424966|NCT01331317|UAER|uaer
424967|NCT01331304|Bipolar disorder|bipolar disorder
424968|NCT01331304|Comparative effectiveness trial|comparative effectiveness trial
424969|NCT01331304|Lithium|lithium
424970|NCT01331304|Quetiapine|quetiapine
424971|NCT01331291|bosutinib|bosutinib
424972|NCT01331291|SKI-606|ski-606
424973|NCT01331278|total joint replacement|total joint replacement
424974|NCT01331278|knee|knee
424975|NCT01331265|perceived lactose intolerance|perceived lactose intolerance
424976|NCT01331265|calcium/dairy consumption|calcium/dairy consumption
424977|NCT01331265|specific health outcomes|specific health outcomes
424978|NCT01331239|Cushing Disease|cushing disease
424979|NCT01331239|LCI699|lci699
424980|NCT01331239|Pituitary Gland|pituitary gland
424981|NCT01331239|Adrenocorticotropic Hormone|adrenocorticotropic hormone
424982|NCT01331213|Pregabalin|pregabalin
424983|NCT01331213|Irritable Bowel Syndrome|irritable bowel syndrome
424984|NCT01331213|motor|motor
424985|NCT01331213|sensation|sensation
424986|NCT01331213|colon|colon
424987|NCT01331213|human|human
424988|NCT01331200|ischemic stroke|ischemic stroke
424989|NCT01331200|tissue plasminogen activator|tissue plasminogen activator
424990|NCT01331200|early mobilization|early mobilization
424991|NCT01331200|patient safety|patient safety
424992|NCT01331200|length of stay|length of stay
424993|NCT01331187|Echocardiography|echocardiography
424994|NCT01331187|Heart failure|heart failure
424995|NCT01331187|Ultrasonography|ultrasonography
424996|NCT01331187|pocket-size device|pocket-size device
424997|NCT01331187|Aorta|aorta
424998|NCT01331187|Education|education
424999|NCT01331174|knee|knee
425000|NCT01331174|osteoarthritis|osteoarthritis
425001|NCT01331174|physical therapy|physical therapy
425002|NCT01331174|pulsed short wave|pulsed short wave
425003|NCT01331161|shingles vaccine|shingles vaccine
425004|NCT01331161|immune responses|immune responses
425005|NCT01331148|sickle cell disease|sickle cell disease
425006|NCT01331148|vitamin D|vitamin d
425007|NCT01331148|pediatrics|pediatrics
425008|NCT01331148|pain|pain
425009|NCT01331135|pediatrics|pediatrics
425010|NCT01331135|sirolimus|sirolimus
425011|NCT01331135|relapse|relapse
425012|NCT01331109|Fibromyalgia|fibromyalgia
425013|NCT01331109|Pediatric Fibromyalgia|pediatric fibromyalgia
425014|NCT01331109|Adolescent Fibromyalgia|adolescent fibromyalgia
425015|NCT01331109|milnacipran|milnacipran
425016|NCT01331109|Savella|savella
425017|NCT01331109|loss of therapeutic response|loss of therapeutic response
425018|NCT01331109|Forest Research Institute|forest research institute
425019|NCT01331109|Pain|pain
425020|NCT01331109|Fatigue|fatigue
425021|NCT01331109|Serotonin Norepinephrine Reuptake Inhibitors|serotonin norepinephrine reuptake inhibitors
425022|NCT01331096|thyroid gland resection surgery|thyroid gland resection surgery
425023|NCT01331096|total intravenous anesthesia|total intravenous anesthesia
425024|NCT01331070|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
425025|NCT01331057|Bilingualism|bilingualism
425026|NCT01331057|Language|language
425027|NCT01331057|Evaluation transcultural|evaluation transcultural
425028|NCT01331057|Intra Familial Relationship|intra familial relationship
425029|NCT01331057|Transmissions mother|transmissions mother
425030|NCT01331057|Tongue french|tongue french
425031|NCT01331057|Language tamil|language tamil
425032|NCT01331057|Language arabic|language arabic
425033|NCT01331057|Language soninke|language soninke
425034|NCT01331057|Language cultural|language cultural
425035|NCT01331057|Affiliations crossbreeding|affiliations crossbreeding
425036|NCT01331044|RUTF|rutf
425037|NCT01331044|Severe Acute Malnutrition|severe acute malnutrition
425038|NCT01331044|Children|children
425039|NCT01331044|Body composition|body composition
425040|NCT01331044|Microbiota|microbiota
425041|NCT01331044|Short Chain Fatty Acid|short chain fatty acid
425042|NCT01331044|Acceptability of RUTF|acceptability of rutf
425043|NCT01331044|Edema free 15 percent weight gain|edema free 15 percent weight gain
425044|NCT01331044|Changes in body composition|changes in body composition
425045|NCT01331044|Gut microbiota|gut microbiota
425046|NCT01331044|Genome wide association|genome wide association
425047|NCT01331031|temporomandibular disorder|temporomandibular disorder
425048|NCT01331031|adolescents|adolescents
425049|NCT01331005|Macular Edema|macular edema
425050|NCT01331005|Non steroidal anti-inflammatories|non steroidal anti-inflammatories
425051|NCT01330992|Circadian rhythms|circadian rhythms
425052|NCT01330992|Melatonin|melatonin
425053|NCT01330992|Ocular light exposure|ocular light exposure
425054|NCT01330992|Darkness Exposure|darkness exposure
425055|NCT01330992|Performance|performance
425056|NCT01330992|Alertness|alertness
425057|NCT01330979|Intraocular pressure|intraocular pressure
425058|NCT01330966|surgically unresectable chondrosarcoma|surgically unresectable chondrosarcoma
425059|NCT01330953|Anemia|anemia
425060|NCT01330940|Kidney stones|kidney stones
425061|NCT01330940|Calcium|calcium
425062|NCT01330940|citrate|citrate
425063|NCT01330927|VA106483|va106483
425064|NCT01330927|Nocturia|nocturia
425065|NCT01330927|Benign Prostatic Hypertrophy|benign prostatic hypertrophy
425066|NCT01330927|BPH|bph
425067|NCT01330927|Elderly|elderly
425068|NCT01330927|Males|males
425069|NCT01330927|Nocturnal voids|nocturnal voids
425070|NCT01330927|Anti-diuretic|anti-diuretic
425071|NCT01330914|Obesity, Morbid|obesity, morbid
425072|NCT01330914|Bariatric Surgery|bariatric surgery
425073|NCT01330914|Gastric Bypass|gastric bypass
425074|NCT01330914|Calcium Metabolism Disorders|calcium metabolism disorders
425075|NCT01330914|Vitamin D|vitamin d
425076|NCT01330914|Bone Density|bone density
425077|NCT01330914|Body Composition|body composition
425078|NCT01330914|Weight Loss|weight loss
425079|NCT01330888|war|war
425080|NCT01330888|religion|religion
425081|NCT01330888|caregiver|caregiver
425082|NCT01330888|combat stress disorder|combat stress disorder
425083|NCT01330862|patient outcomes|patient outcomes
425084|NCT01330849|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
425085|NCT01330849|School|school
425086|NCT01330849|Behavioral Intervention|behavioral intervention
425087|NCT01330849|RCT|rct
425088|NCT01330823|pancreatic carcinoma|pancreatic carcinoma
425089|NCT01330823|L-Carnitine|l-carnitine
425090|NCT01330823|quality of life|quality of life
425091|NCT01330823|survival|survival
425092|NCT01330823|malnutrition|malnutrition
425093|NCT01330823|cancer cachexia|cancer cachexia
425094|NCT01330823|fatigue|fatigue
425095|NCT01330810|Pharmacokinetics|pharmacokinetics
425096|NCT01330810|Dietary Supplements|dietary supplements
425097|NCT01330810|Curcumin|curcumin
425098|NCT01330797|Cataract|cataract
425099|NCT01330797|Intravitreal|intravitreal
425100|NCT01330797|Ranibizumab|ranibizumab
425101|NCT01330797|LOCS III|locs iii
425102|NCT01330758|Phase I|phase i
425103|NCT01330758|Healthy male and non-fertile female volunteers|healthy male and non-fertile female volunteers
425104|NCT01330758|Bioavailability|bioavailability
425105|NCT01330758|AZD8931|azd8931
425106|NCT01330745|cardiopulmonary bypass|cardiopulmonary bypass
425107|NCT01330745|mesenteric|mesenteric
425108|NCT01330745|microcirculatory function|microcirculatory function
425109|NCT01330732|SPINESCAN®|spinescan®
425110|NCT01330732|kyphosis|kyphosis
425111|NCT01330719|Periodontitis|periodontitis
425112|NCT01330706|Skin Diseases [C17.800]|skin diseases [c17.800]
425113|NCT01330706|Nail Diseases [C17.800.529]|nail diseases [c17.800.529]
425114|NCT01330706|Nails, Ingrown [C17.800.529.406]|nails, ingrown [c17.800.529.406]
425115|NCT01330693|ADHD|adhd
425116|NCT01330693|Atomoxetine|atomoxetine
425117|NCT01330693|Biomarker|biomarker
425118|NCT01330680|coffee|coffee
425119|NCT01330680|caffeine|caffeine
425120|NCT01330680|blood pressure|blood pressure
425121|NCT01330680|nutrigenetics|nutrigenetics
425122|NCT01330680|gene polymorphisms|gene polymorphisms
425123|NCT01330680|Acute Cardiovascular and Neuropsychologic Effects|acute cardiovascular and neuropsychologic effects
425124|NCT01330667|Hyperbilirubinemia|hyperbilirubinemia
425125|NCT01330667|Breastfeeding|breastfeeding
425126|NCT01330667|Limited Formula|limited formula
425127|NCT01330654|Intermediate risk of adverse cardiac event|intermediate risk of adverse cardiac event
425128|NCT01330654|Undergoing laparoscopic surgical procedure|undergoing laparoscopic surgical procedure
425129|NCT01330654|Age forty to seventy five|age forty to seventy five
425130|NCT01330641|Tendonitis|tendonitis
425131|NCT01330641|Rotator Cuff|rotator cuff
425132|NCT01330641|Shoulder|shoulder
425133|NCT01330641|Injection|injection
425134|NCT01330628|peripheral arterial disease|peripheral arterial disease
425135|NCT01330628|in stent restenosis|in stent restenosis
425136|NCT01330628|peripheral vascular disease|peripheral vascular disease
425137|NCT01330615|EMLA|emla
425138|NCT01330615|plantar warts|plantar warts
425139|NCT01330615|cryotherapy|cryotherapy
425140|NCT01330589|Percutaneous coronary intervention|percutaneous coronary intervention
425141|NCT01330589|Clopidogrel|clopidogrel
425142|NCT01330589|St. John's Wort|st. john's wort
425143|NCT01330589|CYP 2C19 loss-of-function allele|cyp 2c19 loss-of-function allele
425144|NCT01330576|Hypothermia|hypothermia
425145|NCT01330576|cooling|cooling
425146|NCT01330576|necrotizing enterocolitis|necrotizing enterocolitis
425147|NCT01330576|NEC|nec
425148|NCT01330576|neonates|neonates
425149|NCT01330576|preterm|preterm
425150|NCT01330563|Drug-Drug interaction between the CKD-501 and ketoconazole|drug-drug interaction between the ckd-501 and ketoconazole
425151|NCT01330550|High fiber sugar free biscuit|high fiber sugar free biscuit
425152|NCT01330550|pre-diabetics|pre-diabetics
425153|NCT01330537|perceptual development|perceptual development
425154|NCT01330537|topological perception theory|topological perception theory
425155|NCT01330537|familiarization/novelty preference method|familiarization/novelty preference method
425156|NCT01330537|Discriminate a disk and a ring (topologically different),|discriminate a disk and a ring (topologically different),
425157|NCT01330537|Discriminate a disk and a triangle (geometrically different)|discriminate a disk and a triangle (geometrically different)
425158|NCT01330537|Detect a change in the number of holes|detect a change in the number of holes
425159|NCT01330537|Detect the size of the hole|detect the size of the hole
425160|NCT01330511|Newborn infant|newborn infant
425161|NCT01330511|Congenital hydronephrosis|congenital hydronephrosis
425162|NCT01330511|Postnatal imaging evaluation|postnatal imaging evaluation
425163|NCT01330511|Diagnostic algorithm|diagnostic algorithm
425164|NCT01330498|Longitudinal assessment of biomarkers|longitudinal assessment of biomarkers
425165|NCT01330498|duration of natalizumab|duration of natalizumab
425166|NCT01330498|stratification of risk for PML|stratification of risk for pml
425167|NCT01330472|Alprazolam|alprazolam
425168|NCT01330472|Xanax|xanax
425169|NCT01330472|Bioequivalence|bioequivalence
425170|NCT01330472|Panic disorder with or without agoraphobia.|panic disorder with or without agoraphobia.
425171|NCT01330459|Pain during first trimester surgical abortion|pain during first trimester surgical abortion
425172|NCT01330446|Head and Neck Cancer|head and neck cancer
425173|NCT01330446|HNC|hnc
425174|NCT01330446|Fatigue|fatigue
425175|NCT01330446|Patient-Reported Fatigue|patient-reported fatigue
425176|NCT01330446|Fatigue-Symptom Intervention|fatigue-symptom intervention
425177|NCT01330446|Postoperative Radiation Therapy|postoperative radiation therapy
425178|NCT01330446|Postoperative Chemoradiation Therapy|postoperative chemoradiation therapy
425179|NCT01330446|Armodafinil|armodafinil
425180|NCT01330446|Nuvigil|nuvigil
425181|NCT01330446|Placebo|placebo
425182|NCT01330446|Sugar Pill|sugar pill
425183|NCT01330446|Questionnaires|questionnaires
425184|NCT01330446|Surveys|surveys
425185|NCT01330394|Alcoholism|alcoholism
425186|NCT01330394|Lesch's typology|lesch's typology
425187|NCT01330394|tDCS|tdcs
425188|NCT01330394|ERP|erp
425189|NCT01330394|P300|p300
425190|NCT01330394|FAB|fab
425191|NCT01330394|MMSE|mmse
425192|NCT01330394|Cognitive tasks|cognitive tasks
425193|NCT01330368|Systemic Lupus Erythematosus|systemic lupus erythematosus
425194|NCT01330368|SLE|sle
425195|NCT01330368|Lupus|lupus
425196|NCT01330368|children with SLE|children with sle
425197|NCT01330355|Ocular infections, bacterial|ocular infections, bacterial
425198|NCT01330329|Obesity|obesity
425199|NCT01330329|Weight loss|weight loss
425200|NCT01330329|Exercise|exercise
425201|NCT01330329|Intervention studies|intervention studies
425202|NCT01330303|Bioequivalence|bioequivalence
425203|NCT01330303|Healthy volunteers|healthy volunteers
425204|NCT01330303|tamsulosin hydrochloride|tamsulosin hydrochloride
425205|NCT01330303|Fed administration|fed administration
425206|NCT01330290|Rotigotine|rotigotine
425207|NCT01330290|Neupro®|neupro®
425208|NCT01330290|Parkinson|parkinson
425209|NCT01330290|Treatment preference|treatment preference
425210|NCT01330290|Care-giving|care-giving
425211|NCT01330277|Metabolic Diseases|metabolic diseases
425212|NCT01330277|Biomarker|biomarker
425213|NCT01330277|Mucopolysaccharidosis II|mucopolysaccharidosis ii
425214|NCT01330277|Lysosomal Storage Diseases|lysosomal storage diseases
425215|NCT01330277|Morbus Hunter|morbus hunter
425216|NCT01330277|Mucopolysaccharidoses|mucopolysaccharidoses
425217|NCT01330264|Intracranial Pressure (ICP) Monitoring|intracranial pressure (icp) monitoring
425218|NCT01330264|Admission to Intensive Care Unit (ICU)|admission to intensive care unit (icu)
425219|NCT01330238|Low back pain|low back pain
425220|NCT01330238|Modic changes|modic changes
425221|NCT01330238|Vertebral endplate signal changes|vertebral endplate signal changes
425222|NCT01330238|Efficacy|efficacy
425223|NCT01330238|Zoledronic acid|zoledronic acid
425224|NCT01330238|Bisphosphonates|bisphosphonates
425225|NCT01330238|RCT|rct
425226|NCT01330199|Healthy|healthy
425227|NCT01330199|Female|female
425228|NCT01330199|Volunteer|volunteer
425229|NCT01330160|stroke|stroke
425230|NCT01330160|Brain ischemia|brain ischemia
425231|NCT01330160|Intracranial hemorrhage|intracranial hemorrhage
425232|NCT01330160|Dementia, Vascular|dementia, vascular
425233|NCT01330160|Alzheimer's disease|alzheimer's disease
425234|NCT01330147|HPV|hpv
425235|NCT01330147|oral cancer|oral cancer
425236|NCT01330147|oropharyngeal cancer|oropharyngeal cancer
425237|NCT01330147|tonsillectomy|tonsillectomy
425238|NCT01330134|procedural|procedural
425239|NCT01330121|Adherence with discharge diabetes medications|adherence with discharge diabetes medications
425240|NCT01330121|Diabeted mellitus type 2 greater than one year|diabeted mellitus type 2 greater than one year
425241|NCT01330121|Patient with provider and prescriptions filled within CCHS|patient with provider and prescriptions filled within cchs
425242|NCT01330108|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
425243|NCT01330108|PAH|pah
425244|NCT01330108|WHO Group 1|who group 1
425245|NCT01330095|Bifidobacterium bifidum|bifidobacterium bifidum
425246|NCT01330095|Very low birth weight infant|very low birth weight infant
425247|NCT01330095|Enteral feeding|enteral feeding
425248|NCT01330095|Growth|growth
425249|NCT01330095|amount of enteral feeding|amount of enteral feeding
425250|NCT01330082|Photodynamic therapy|photodynamic therapy
425251|NCT01330082|Light-emitting diode|light-emitting diode
425252|NCT01330082|toluidine blue|toluidine blue
425253|NCT01330082|scaling and root planing|scaling and root planing
425254|NCT01330056|Laryngeal and pharyngeal preservation, survivals|laryngeal and pharyngeal preservation, survivals
425255|NCT01330043|smoking cessation intervention|smoking cessation intervention
425256|NCT01330017|Seasonal allergies|seasonal allergies
425257|NCT01329991|RA|ra
425258|NCT01329991|Methotrexate|methotrexate
425259|NCT01329978|Hepatitis C|hepatitis c
425260|NCT01329978|HCV|hcv
425261|NCT01329978|Chronic Hepatitis C|chronic hepatitis c
425262|NCT01329965|Cardiovascular disease|cardiovascular disease
425263|NCT01329965|Inflammation|inflammation
425264|NCT01329965|LPS|lps
425265|NCT01329965|Endotoxin|endotoxin
425266|NCT01329939|Asthma|asthma
425267|NCT01329939|Obesity|obesity
425268|NCT01329939|Pediatric|pediatric
425269|NCT01329939|Inflammation|inflammation
425270|NCT01329939|Leukotriene|leukotriene
425271|NCT01329939|Montelukast|montelukast
425272|NCT01329926|Parkinson's disease|parkinson's disease
425273|NCT01329926|Neural stem cells|neural stem cells
425274|NCT01329900|Chemotherapy|chemotherapy
425275|NCT01329900|Stem Cell Collection|stem cell collection
425276|NCT01329900|Ofatumumab|ofatumumab
425277|NCT01329900|Arzerra|arzerra
425278|NCT01329900|Ifosfamide|ifosfamide
425279|NCT01329900|Ifex|ifex
425280|NCT01329900|Etoposide|etoposide
425281|NCT01329900|VePesid|vepesid
425282|NCT01329900|Mesna|mesna
425283|NCT01329900|Mesnex|mesnex
425284|NCT01329900|G-CSF|g-csf
425285|NCT01329900|Filgrastim|filgrastim
425286|NCT01329900|Neupogen|neupogen
425287|NCT01329900|Apheresis|apheresis
425288|NCT01329887|microcirculation|microcirculation
425289|NCT01329887|SDF|sdf
425290|NCT01329887|ketanserin|ketanserin
425291|NCT01329887|severe sepsis|severe sepsis
425292|NCT01329861|chronic back pain|chronic back pain
425293|NCT01329861|internet based treatment|internet based treatment
425294|NCT01329861|pain management programme|pain management programme
425295|NCT01329861|cognitive behavioural therapy|cognitive behavioural therapy
425296|NCT01329861|minimal therapist contact|minimal therapist contact
425297|NCT01329848|Accommodation|accommodation
425298|NCT01329848|Reading|reading
425299|NCT01329848|Autorefraction|autorefraction
425300|NCT01329822|type 2 diabetes|type 2 diabetes
425301|NCT01329822|overweight|overweight
425302|NCT01329809|metastatic colorectal cancer|metastatic colorectal cancer
425303|NCT01329809|colon cancer|colon cancer
425304|NCT01329809|liver metastasis|liver metastasis
425305|NCT01329809|Pexa-vec|pexa-vec
425306|NCT01329809|JX-594|jx-594
425307|NCT01329796|dysmenorrhea,|dysmenorrhea,
425308|NCT01329796|pelvic pain|pelvic pain
425309|NCT01329796|dyspareunia|dyspareunia
425310|NCT01329796|endometriosis|endometriosis
425311|NCT01329770|Neurodevelopmental disability|neurodevelopmental disability
425312|NCT01329770|Hyperactivity|hyperactivity
425313|NCT01329770|Anxiety|anxiety
425314|NCT01329770|Cognitive problems|cognitive problems
425315|NCT01329770|Behavioural symptoms|behavioural symptoms
425316|NCT01329770|Fragile X syndrome|fragile x syndrome
425317|NCT01329770|Autism|autism
425318|NCT01329770|inherited Genetic condition|inherited genetic condition
425319|NCT01329757|Spinal Cord Injury|spinal cord injury
425320|NCT01329757|Growth Hormone|growth hormone
425321|NCT01329757|Trauma|trauma
425322|NCT01329757|Incomplete|incomplete
425323|NCT01329757|ASIA|asia
425324|NCT01329744|HIV lipodystrophy|hiv lipodystrophy
425325|NCT01329731|white spot lesion|white spot lesion
425326|NCT01329731|initial caries|initial caries
425327|NCT01329731|fluoride|fluoride
425328|NCT01329731|amine fluoride|amine fluoride
425329|NCT01329731|orthodontics|orthodontics
425330|NCT01329731|remineralization|remineralization
425331|NCT01329731|brackets|brackets
425332|NCT01329718|Stability of the Septin 9 biomarker|stability of the septin 9 biomarker
425333|NCT01329718|Epi Pro Colon Test|epi pro colon test
425334|NCT01329718|CRC|crc
425335|NCT01329692|RYGB|rygb
425336|NCT01329692|Intervention|intervention
425337|NCT01329692|follow-up|follow-up
425338|NCT01329692|standard-of-care|standard-of-care
425339|NCT01329692|Back on Track program|back on track program
425340|NCT01329692|poor weight loss|poor weight loss
425341|NCT01329692|morbidly obese|morbidly obese
425342|NCT01329666|Primary Hyperparathyroidism|primary hyperparathyroidism
425343|NCT01329666|Endocrinology|endocrinology
425344|NCT01329666|Hypercalcemia|hypercalcemia
425345|NCT01329666|Vitamin D deficiency|vitamin d deficiency
425346|NCT01329666|Parathyroid Hormone|parathyroid hormone
425347|NCT01329666|Osteoporosis|osteoporosis
425348|NCT01329666|Bone Density|bone density
425349|NCT01329666|Vitamin D repletion|vitamin d repletion
425350|NCT01329666|Vitamin D Supplements|vitamin d supplements
425351|NCT01329653|cerebral blood volume|cerebral blood volume
425352|NCT01329653|aging|aging
425353|NCT01329653|exercise|exercise
425354|NCT01329640|Metronimic chemotherapy|metronimic chemotherapy
425355|NCT01329640|Locally Advanced HER2-positive Breast Cancer|locally advanced her2-positive breast cancer
425356|NCT01329601|cognitive training|cognitive training
425357|NCT01329601|Alzheimer disease|alzheimer disease
425358|NCT01329601|tertiary prevention|tertiary prevention
425359|NCT01329588|Female sex workers|female sex workers
425360|NCT01329588|West Africa|west africa
425361|NCT01329588|Presumptive treatment|presumptive treatment
425362|NCT01329588|Sexually transmitted infections|sexually transmitted infections
425363|NCT01329575|endoluminal ultrasound|endoluminal ultrasound
425364|NCT01329575|Mediastinal LN invasion|mediastinal ln invasion
425365|NCT01329562|Menstrual migraine|menstrual migraine
425366|NCT01329562|Menstrually-related migraine|menstrually-related migraine
425367|NCT01329562|Treximet|treximet
425368|NCT01329562|CGRP|cgrp
425369|NCT01329562|calcitonin gene-related peptide|calcitonin gene-related peptide
425370|NCT01329536|Alzheimer's Disease|alzheimer's disease
425371|NCT01329536|Agitation|agitation
425372|NCT01329536|Genetics|genetics
425373|NCT01329536|Apolipoprotein|apolipoprotein
425374|NCT01329536|ApoE4|apoe4
425375|NCT01329523|Dementia|dementia
425376|NCT01329523|Insulin-like growth factor|insulin-like growth factor
425377|NCT01329523|IGF|igf
425378|NCT01329523|APO E4|apo e4
425379|NCT01329523|Genetics|genetics
425380|NCT01329510|ADHD|adhd
425381|NCT01329510|Adult|adult
425382|NCT01329484|Alzheimer|alzheimer
425383|NCT01329484|Dementia|dementia
425384|NCT01329484|Computer|computer
425385|NCT01329484|Cognitive training|cognitive training
425386|NCT01329484|Reminiscence therapy|reminiscence therapy
425387|NCT01329458|FLL|fll
425388|NCT01329458|CEUS|ceus
425389|NCT01329458|SonoVue|sonovue
425390|NCT01329458|HCC|hcc
425391|NCT01329458|Liver metastases|liver metastases
425392|NCT01329458|Hemangiomas|hemangiomas
425393|NCT01329458|FNH|fnh
425394|NCT01329445|Cartilage repair|cartilage repair
425395|NCT01329445|Articular cartilage defects|articular cartilage defects
425396|NCT01329432|surfactant|surfactant
425397|NCT01329432|intubation|intubation
425398|NCT01329432|spontaneous breathing|spontaneous breathing
425399|NCT01329432|bronchopulmonary dysplasia|bronchopulmonary dysplasia
425400|NCT01329406|Osteoarthritis (OA)|osteoarthritis (oa)
425401|NCT01329406|Milnacipran|milnacipran
425402|NCT01329406|Serotonin-norepinephrine reuptake inhibitor (SNRI)|serotonin-norepinephrine reuptake inhibitor (snri)
425403|NCT01329406|Knee pain|knee pain
425404|NCT01329393|Disability|disability
425405|NCT01329393|Social Security|social security
425406|NCT01329393|Representative Payee|representative payee
425407|NCT01329380|Ankylosing Spondylitis|ankylosing spondylitis
425408|NCT01329367|EVASYON|evasyon
425409|NCT01329367|GENOI|genoi
425410|NCT01329367|antioxidants|antioxidants
425411|NCT01329367|legume|legume
425412|NCT01329367|fish|fish
425413|NCT01329354|Follicular lymphoma|follicular lymphoma
425414|NCT01329354|Follicular non-Hodgkin´s lymphoma|follicular non-hodgkin´s lymphoma
425415|NCT01329354|Autologous effector lymphocytes|autologous effector lymphocytes
425416|NCT01329354|Cell Therapy|cell therapy
425417|NCT01329354|Maintenance therapy|maintenance therapy
425418|NCT01329354|Rituximab|rituximab
425419|NCT01329341|PTSD|ptsd
425420|NCT01329341|Service Dogs|service dogs
425421|NCT01329328|whole-body vibration|whole-body vibration
425422|NCT01329328|radiofrequency|radiofrequency
425423|NCT01329328|hormonal status|hormonal status
425424|NCT01329328|muscular strength|muscular strength
425425|NCT01329328|balance|balance
425426|NCT01329276|COPD|copd
425427|NCT01329276|Symbicort|symbicort
425428|NCT01329276|Turbohaler|turbohaler
425429|NCT01329276|Computational Fluid Dynamics|computational fluid dynamics
425430|NCT01329276|Functional Imaging|functional imaging
425431|NCT01329276|Budesonide|budesonide
425432|NCT01329276|Formoterol|formoterol
425433|NCT01329263|menthol cigarettes|menthol cigarettes
425434|NCT01329250|Tuberculosis|tuberculosis
425435|NCT01329250|Moxifloxacin|moxifloxacin
425436|NCT01329250|Pharmacokinetics|pharmacokinetics
425437|NCT01329250|Safety|safety
425438|NCT01329237|drug-eluting stent|drug-eluting stent
425439|NCT01329237|coronary endothelial function|coronary endothelial function
425440|NCT01329237|coronary imaging|coronary imaging
425441|NCT01329224|acetylsalicylic acid resistance|acetylsalicylic acid resistance
425442|NCT01329211|Gastroparesis|gastroparesis
425443|NCT01329211|Quality of Life|quality of life
425444|NCT01329198|tourette|tourette
425445|NCT01329198|tourette's|tourette's
425446|NCT01329198|TS|ts
425447|NCT01329198|tourette syndrome|tourette syndrome
425448|NCT01329198|tourette's syndrome|tourette's syndrome
425449|NCT01329185|EBV Viremia in posttransplant kidney recipients|ebv viremia in posttransplant kidney recipients
425450|NCT01329185|CMV viremia in posttransplant kidney recipients|cmv viremia in posttransplant kidney recipients
425451|NCT01329172|PUFA|pufa
425452|NCT01329172|Cystic Fibrosis|cystic fibrosis
425453|NCT01329172|Nasal brushing|nasal brushing
425454|NCT01329172|Mucins|mucins
425455|NCT01329172|Mucin production|mucin production
425456|NCT01329159|High altitude|high altitude
425457|NCT01329159|respiratory function|respiratory function
425458|NCT01329159|cardiorespiratory health|cardiorespiratory health
425459|NCT01329159|indoor pollution|indoor pollution
425460|NCT01329146|pulse pressure variation|pulse pressure variation
425461|NCT01329146|preload dependency|preload dependency
425462|NCT01329146|one-lung ventilation|one-lung ventilation
425463|NCT01329146|thoracic surgery|thoracic surgery
425464|NCT01329133|Deep brain stimulation (DBS)|deep brain stimulation (dbs)
425465|NCT01329133|Obsessive compulsive disorder|obsessive compulsive disorder
425466|NCT01329133|ventral striatum|ventral striatum
425467|NCT01329133|subthalamic nucleus|subthalamic nucleus
425468|NCT01329107|Rehabilitation|rehabilitation
425469|NCT01329107|Enhanced Recovery|enhanced recovery
425470|NCT01329107|Health related Qouality of Life|health related qouality of life
425471|NCT01329107|Patient outcomes|patient outcomes
425472|NCT01329094|Severe mental illness|severe mental illness
425473|NCT01329094|physical activity|physical activity
425474|NCT01329094|evaluation|evaluation
425475|NCT01329081|Rehabilitation|rehabilitation
425476|NCT01329081|Strength training|strength training
425477|NCT01329081|Long-term effect|long-term effect
425478|NCT01329081|Activity and participation after fast-track knee arthroplasty|activity and participation after fast-track knee arthroplasty
425479|NCT01329068|breast cancer|breast cancer
425480|NCT01329042|Potassium sodium citrate|potassium sodium citrate
425481|NCT01329042|stone recurrence|stone recurrence
425482|NCT01329042|ESWL|eswl
425483|NCT01329042|PCNL|pcnl
425484|NCT01329042|Hypocitraturia|hypocitraturia
425485|NCT01329042|intervention|intervention
425486|NCT01329029|COPD|copd
425487|NCT01329029|Roflumilast|roflumilast
425488|NCT01329029|Daxas|daxas
425489|NCT01329016|Pregnancy|pregnancy
425490|NCT01329016|Glyburide|glyburide
425491|NCT01329016|Metformin|metformin
425492|NCT01329016|Pharmacokinetics|pharmacokinetics
425493|NCT01329016|Pharmacodynamics|pharmacodynamics
425494|NCT01329003|Silicosis|silicosis
425495|NCT01328990|IPTc|iptc
425496|NCT01328990|malaria|malaria
425497|NCT01328990|children|children
425498|NCT01328990|pharmacokinetics|pharmacokinetics
425499|NCT01328990|amodiaquiane|amodiaquiane
425500|NCT01328990|sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
425501|NCT01328964|pediatric|pediatric
425502|NCT01328964|asthma|asthma
425503|NCT01328964|outcomes|outcomes
425504|NCT01328964|inhaled cortcosteroids|inhaled cortcosteroids
425505|NCT01328938|Pegfilgrastim|pegfilgrastim
425506|NCT01328938|neutropenia|neutropenia
425507|NCT01328925|Rotavirus|rotavirus
425508|NCT01328925|Viral gastroenteritis|viral gastroenteritis
425509|NCT01328925|Gastroenteritis|gastroenteritis
425510|NCT01328912|ischemic preconditioning|ischemic preconditioning
425511|NCT01328912|cardiac surgery|cardiac surgery
425512|NCT01328912|vascular surgery|vascular surgery
425513|NCT01328899|Emphysema|emphysema
425514|NCT01328899|COPD|copd
425515|NCT01328899|RePneu|repneu
425516|NCT01328886|omalizumab|omalizumab
425517|NCT01328886|allergic asthma|allergic asthma
425518|NCT01328886|pediatric patients|pediatric patients
425519|NCT01328873|Pulmonary infiltrates|pulmonary infiltrates
425520|NCT01328873|stem cell transplant|stem cell transplant
425521|NCT01328873|leukemia|leukemia
425522|NCT01328860|Autologous|autologous
425523|NCT01328860|Stem Cells|stem cells
425524|NCT01328860|Spinal Cord Injury|spinal cord injury
425525|NCT01328860|Children|children
425526|NCT01328834|Nephritis, Lupus|nephritis, lupus
425527|NCT01328834|Tacrolimus|tacrolimus
425528|NCT01328821|Safety|safety
425529|NCT01328821|Tolerability|tolerability
425530|NCT01328821|Pharmacokinetics|pharmacokinetics
425531|NCT01328821|Healthy volunteers|healthy volunteers
425532|NCT01328808|Acetaminophen|acetaminophen
425533|NCT01328808|Preterm Infants|preterm infants
425534|NCT01328795|Cardiogoniometry|cardiogoniometry
425535|NCT01328795|Chest Pain Unit|chest pain unit
425536|NCT01328795|ST-elevation|st-elevation
425537|NCT01328795|Troponin|troponin
425538|NCT01328795|Catheter intervention|catheter intervention
425539|NCT01328795|Fast Track|fast track
425540|NCT01328782|elbow fracture|elbow fracture
425541|NCT01328782|supracondylar elbow fracture|supracondylar elbow fracture
425542|NCT01328782|elbow|elbow
425543|NCT01328782|fracture|fracture
425544|NCT01328782|pain management|pain management
425545|NCT01328782|pediatric|pediatric
425546|NCT01328769|uric acid|uric acid
425547|NCT01328769|febuxostat|febuxostat
425548|NCT01328769|hypertension|hypertension
425549|NCT01328769|intra-renal renin-angiotensin system|intra-renal renin-angiotensin system
425550|NCT01328769|renal plasma flow|renal plasma flow
425551|NCT01328769|angiotensin II|angiotensin ii
425552|NCT01328756|ADHD|adhd
425553|NCT01328730|significant stenosis (>70% of lumen stenosis)|significant stenosis (>70% of lumen stenosis)
425554|NCT01328730|epicardial coronary arteries.|epicardial coronary arteries.
425555|NCT01328704|Iron deficiency|iron deficiency
425556|NCT01328704|Vitamin D deficiency|vitamin d deficiency
425557|NCT01328704|Anemia|anemia
425558|NCT01328704|Athletes|athletes
425559|NCT01328704|Triathletes|triathletes
425560|NCT01328704|Triathlon|triathlon
425561|NCT01328691|Carcinoma, Renal Cell|carcinoma, renal cell
425562|NCT01328691|thrombus|thrombus
425563|NCT01328691|body mass index|body mass index
425564|NCT01328691|grade|grade
425565|NCT01328678|Alopecia Areata|alopecia areata
425566|NCT01328678|Vitamin D|vitamin d
425567|NCT01328678|Parathyroid|parathyroid
425568|NCT01328678|Calcium|calcium
425569|NCT01328652|LPR|lpr
425570|NCT01328652|LTH|lth
425571|NCT01328639|Collaborative care|collaborative care
425572|NCT01328639|Diabetes management|diabetes management
425573|NCT01328639|Depression management|depression management
425574|NCT01328639|Primary care|primary care
425575|NCT01328626|Safety|safety
425576|NCT01328626|Maximum Tolerated Dose|maximum tolerated dose
425577|NCT01328626|Pharmacokinetics|pharmacokinetics
425578|NCT01328626|ABT-199|abt-199
425579|NCT01328626|Preliminary Efficacy|preliminary efficacy
425580|NCT01328626|Cancer|cancer
425581|NCT01328626|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
425582|NCT01328626|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
425583|NCT01328613|BDNF|bdnf
425584|NCT01328613|Homeosis|homeosis
425585|NCT01328613|Women|women
425586|NCT01328613|Childbirth|childbirth
425587|NCT01328613|Major Depressive Disorder|major depressive disorder
425588|NCT01328600|Placenta|placenta
425589|NCT01328600|Pregnancy|pregnancy
425590|NCT01328600|Hypertension|hypertension
425591|NCT01328600|Supplementation|supplementation
425592|NCT01328600|Antibody|antibody
425593|NCT01328587|Eltrombopag|eltrombopag
425594|NCT01328587|Aplastic Anemia|aplastic anemia
425595|NCT01328587|Aplastic Anemia Treatment|aplastic anemia treatment
425596|NCT01328587|Moderate Aplastic Anemia|moderate aplastic anemia
425597|NCT01328587|Moderate Aplastic Anemia Treatment|moderate aplastic anemia treatment
425598|NCT01328574|Progression-Free Survival|progression-free survival
425599|NCT01328574|Carcinoma of the Bladder|carcinoma of the bladder
425600|NCT01328574|Cancer of the Renal Pelvis|cancer of the renal pelvis
425601|NCT01328574|Ureter Cancer|ureter cancer
425602|NCT01328574|Survival|survival
425603|NCT01328574|Bladder Cancer|bladder cancer
425604|NCT01328574|Renal Pelvis Cancer|renal pelvis cancer
425605|NCT01328574|Urothelial Cancer|urothelial cancer
425606|NCT01328561|Arginine|arginine
425607|NCT01328561|Oxytocin|oxytocin
425608|NCT01328561|Vasopressin|vasopressin
425609|NCT01328561|Placebo|placebo
425610|NCT01328561|Analgesia|analgesia
425611|NCT01328561|Healthy Volunteer|healthy volunteer
425612|NCT01328561|HV|hv
425613|NCT01328548|varicella-zoster virus|varicella-zoster virus
425614|NCT01328548|vaccine|vaccine
425615|NCT01328548|T-cell|t-cell
425616|NCT01328548|genes|genes
425617|NCT01328548|frail elderly|frail elderly
425618|NCT01328548|immunosenescence|immunosenescence
425619|NCT01328548|immune and genetic correlates of response to zoster vaccine in the elderly|immune and genetic correlates of response to zoster vaccine in the elderly
425620|NCT01328509|Zinc|zinc
425621|NCT01328496|Hematologic Malignancies|hematologic malignancies
425622|NCT01328496|Umbilical Cord Blood transplantation|umbilical cord blood transplantation
425623|NCT01328496|Hematopoietic Cell Transplantation|hematopoietic cell transplantation
425624|NCT01328483|Neonates|neonates
425625|NCT01328483|Intrapartum Oropharyngeal Suctioning|intrapartum oropharyngeal suctioning
425626|NCT01328483|Meconium Aspiration Syndrome|meconium aspiration syndrome
425627|NCT01328470|platelet|platelet
425628|NCT01328470|cilostazol|cilostazol
425629|NCT01328470|clopidogrel|clopidogrel
425630|NCT01328470|chronic kidney disease|chronic kidney disease
425631|NCT01328457|Leishmaniasis, Visceral|leishmaniasis, visceral
425632|NCT01328457|kala-azar|kala-azar
425633|NCT01328457|Paromomycin|paromomycin
425634|NCT01328457|Bangladesh|bangladesh
425635|NCT01328457|Injections, Intramuscular|injections, intramuscular
425636|NCT01328457|Treatment Outcome|treatment outcome
425637|NCT01328457|Patient compliance|patient compliance
425638|NCT01328457|Medication adherence|medication adherence
425639|NCT01328457|Drug toxicity|drug toxicity
425640|NCT01328431|Tobacco Use Cessation|tobacco use cessation
425641|NCT01328431|Smoking Cessation|smoking cessation
425642|NCT01328431|Nicotine Replacement Therapy|nicotine replacement therapy
425643|NCT01328431|Brief Intervention|brief intervention
425644|NCT01328418|Lengthening|lengthening
425645|NCT01328392|LPR|lpr
425646|NCT01328392|GERD|gerd
425647|NCT01328366|Quality of Life|quality of life
425648|NCT01328366|Psychosocial factors|psychosocial factors
425649|NCT01328353|triage|triage
425650|NCT01328353|aprn|aprn
425651|NCT01328353|telehealth|telehealth
425652|NCT01328353|CCHCN|cchcn
425653|NCT01328353|advanced practice nurse|advanced practice nurse
425654|NCT01328353|improve family quality of life|improve family quality of life
425655|NCT01328353|reduce unplanned use of health care services|reduce unplanned use of health care services
425656|NCT01328353|telehealth triage intervention|telehealth triage intervention
425657|NCT01328340|muscle power, exercise, aging|muscle power, exercise, aging
425658|NCT01328301|gait|gait
425659|NCT01328301|hemiplegia|hemiplegia
425660|NCT01328301|treadmill|treadmill
425661|NCT01328301|physiotherapy|physiotherapy
425662|NCT01328301|rehabilitation|rehabilitation
425663|NCT01328288|HIV related adverse events|hiv related adverse events
425664|NCT01328288|Immunological failure|immunological failure
425665|NCT01328288|virological failure|virological failure
425666|NCT01328288|quality of life|quality of life
425667|NCT01328288|depression|depression
425668|NCT01328288|genotypic resistance|genotypic resistance
425669|NCT01328275|HIV related adverse events|hiv related adverse events
425670|NCT01328275|immunological failure|immunological failure
425671|NCT01328275|virological failure|virological failure
425672|NCT01328275|quality of life|quality of life
425673|NCT01328275|depression|depression
425674|NCT01328275|genotypic resistance|genotypic resistance
425675|NCT01328262|Hemoglobins|hemoglobins
425676|NCT01328249|Breast Cancer|breast cancer
425677|NCT01328249|HER2-normal Stage I to III invasive breast cancer|her2-normal stage i to iii invasive breast cancer
425678|NCT01328236|Bortezomib|bortezomib
425679|NCT01328236|PCL|pcl
425680|NCT01328223|Hepatocellular carcinoma|hepatocellular carcinoma
425681|NCT01328223|radiotherapy|radiotherapy
425682|NCT01328223|sorafenib|sorafenib
425683|NCT01328210|metabolic syndrome|metabolic syndrome
425684|NCT01328210|Phlebotomy|phlebotomy
425685|NCT01328210|blood letting|blood letting
425686|NCT01328210|hypertension|hypertension
425687|NCT01328210|insulin sensitivity|insulin sensitivity
425688|NCT01328197|Treovance|treovance
425689|NCT01328197|aneurysm|aneurysm
425690|NCT01328197|AAA|aaa
425691|NCT01328158|Kaletra, Lopinavir (LPV)/Ritonavir (RTV), Human Immunodeficiency Virus (HIV) infection|kaletra, lopinavir (lpv)/ritonavir (rtv), human immunodeficiency virus (hiv) infection
425692|NCT01328132|Liver|liver
425693|NCT01328132|transplant|transplant
425694|NCT01328132|albumin|albumin
425695|NCT01328067|MRgFus|mrgfus
425696|NCT01328067|Uterine Fibroids|uterine fibroids
425697|NCT01328067|Pelvic Pain|pelvic pain
425698|NCT01328067|Quality of Life|quality of life
425699|NCT01328067|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
425700|NCT01328054|cancer|cancer
425701|NCT01328054|cardiac repolarization|cardiac repolarization
425702|NCT01328054|Holter monitor|holter monitor
425703|NCT01328054|pharmacokinetics|pharmacokinetics
425704|NCT01328054|GW572016|gw572016
425705|NCT01328054|lapatinib|lapatinib
425706|NCT01328054|QTc interval|qtc interval
425707|NCT01328054|safety|safety
425708|NCT01328054|ECG|ecg
425709|NCT01328041|GSK1349572|gsk1349572
425710|NCT01328041|resistance to raltegravir or elvitegravir|resistance to raltegravir or elvitegravir
425711|NCT01328041|Integrase inhibitor|integrase inhibitor
425712|NCT01328041|ART-experienced|art-experienced
425713|NCT01328041|dolutegravir|dolutegravir
425714|NCT01328028|Invasive cervical cancer|invasive cervical cancer
425715|NCT01328028|Human papillomavirus|human papillomavirus
425716|NCT01328015|hyperhidrosis|hyperhidrosis
425717|NCT01328015|oxybutynin|oxybutynin
425718|NCT01328015|plantar sweating|plantar sweating
425719|NCT01328015|compensatory sweating|compensatory sweating
425720|NCT01328002|Fibromyalgia|fibromyalgia
425721|NCT01328002|Pediatric Fibromyalgia|pediatric fibromyalgia
425722|NCT01328002|Adolescent Fibromyalgia|adolescent fibromyalgia
425723|NCT01328002|milnacipran|milnacipran
425724|NCT01328002|Savella|savella
425725|NCT01328002|loss of therapeutic response|loss of therapeutic response
425726|NCT01328002|Forest Research Institute|forest research institute
425727|NCT01328002|Pain|pain
425728|NCT01328002|Fatigue|fatigue
425729|NCT01328002|Serotonin Norepinephrine Reuptake Inhibitors|serotonin norepinephrine reuptake inhibitors
425730|NCT01328002|Randomized Withdrawal|randomized withdrawal
425731|NCT01327989|Solitaire FR Device|solitaire fr device
425732|NCT01327989|Mechanical Thrombectomy|mechanical thrombectomy
425733|NCT01327989|Recanalization|recanalization
425734|NCT01327989|Brain artery recanalization|brain artery recanalization
425735|NCT01327989|Neurovascular intervention|neurovascular intervention
425736|NCT01327989|Interventional Neuroradiology|interventional neuroradiology
425737|NCT01327989|STAR|star
425738|NCT01327989|Acute Ischemic Stroke|acute ischemic stroke
425739|NCT01327976|Obesity|obesity
425740|NCT01327976|Bariatric surgery|bariatric surgery
425741|NCT01327976|Excess weight loss|excess weight loss
425742|NCT01327976|Vagus nerve|vagus nerve
425743|NCT01327976|Vagal blocking|vagal blocking
425744|NCT01327976|vBloc Therapy|vbloc therapy
425745|NCT01327963|Gastroesophageal reflux disease|gastroesophageal reflux disease
425746|NCT01327963|GERD|gerd
425747|NCT01327963|Heartburn|heartburn
425748|NCT01327963|Reflux|reflux
425749|NCT01327963|Regurgitation|regurgitation
425750|NCT01327963|Hoarseness|hoarseness
425751|NCT01327963|Cough|cough
425752|NCT01327950|Percutaneous treatment|percutaneous treatment
425753|NCT01327950|Superficial Femoral Artery lesions|superficial femoral artery lesions
425754|NCT01327950|EPIC Nitinol Vascular Stent System|epic nitinol vascular stent system
425755|NCT01327911|Mactel|mactel
425756|NCT01327911|Macular Telangiectasia Type 2|macular telangiectasia type 2
425757|NCT01327898|MSM|msm
425758|NCT01327898|HIV/AIDS|hiv/aids
425759|NCT01327898|sexual risk|sexual risk
425760|NCT01327898|substance use|substance use
425761|NCT01327872|Idiopathic Thrombocytopenia Purpura(ITP)|idiopathic thrombocytopenia purpura(itp)
425762|NCT01327872|Acute and Chronic Thrombocytopenia Associated with Chronic Liver Disease|acute and chronic thrombocytopenia associated with chronic liver disease
425763|NCT01327872|TLD|tld
425764|NCT01327846|Cardiovascular Death|cardiovascular death
425765|NCT01327846|Myocardial Infarction|myocardial infarction
425766|NCT01327846|Stroke|stroke
425767|NCT01327846|Canakinumab|canakinumab
425768|NCT01327846|IL-1B|il-1b
425769|NCT01327846|hsCRP|hscrp
425770|NCT01327820|Oxygen consumption|oxygen consumption
425771|NCT01327820|Aortic Aneurysm|aortic aneurysm
425772|NCT01327820|Peripheral Arterial Disease|peripheral arterial disease
425773|NCT01327807|Registries|registries
425774|NCT01327807|Cystinosis|cystinosis
425775|NCT01327807|Nephropathic Cystinosis|nephropathic cystinosis
425776|NCT01327807|Renal Fanconi Syndrome|renal fanconi syndrome
425777|NCT01327807|Cystine|cystine
425778|NCT01327807|Kidney|kidney
425779|NCT01327807|Rare Diseases|rare diseases
425780|NCT01327794|recurrent pancreatic cancer|recurrent pancreatic cancer
425781|NCT01327794|stage III pancreatic cancer|stage iii pancreatic cancer
425782|NCT01327794|stage IV pancreatic cancer|stage iv pancreatic cancer
425783|NCT01327768|Stroke,|stroke,
425784|NCT01327768|Stem Cell,|stem cell,
425785|NCT01327768|Olfactory Ensheathing Cells,|olfactory ensheathing cells,
425786|NCT01327768|Intracerebral Implantation of Olfactory Ensheathing Cells.|intracerebral implantation of olfactory ensheathing cells.
425787|NCT01327755|Selenium|selenium
425788|NCT01327755|HIV/ AIDS|hiv/ aids
425789|NCT01327755|CD4 counts|cd4 counts
425790|NCT01327755|Antiretroviral therapy|antiretroviral therapy
425791|NCT01327742|Relay|relay
425792|NCT01327742|Thoracic|thoracic
425793|NCT01327742|Aneurysm|aneurysm
425794|NCT01327729|pegylated interferon|pegylated interferon
425795|NCT01327729|interferon|interferon
425796|NCT01327729|HCV|hcv
425797|NCT01327729|genotype 4|genotype 4
425798|NCT01327703|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
425799|NCT01327703|Cystic Fibrosis|cystic fibrosis
425800|NCT01327703|Steatorrhea|steatorrhea
425801|NCT01327703|Malabsorption|malabsorption
425802|NCT01327703|Malnutrition|malnutrition
425803|NCT01327677|pain management|pain management
425804|NCT01327677|opioid analgesic therapy|opioid analgesic therapy
425805|NCT01327677|safety|safety
425806|NCT01327677|craniotomy|craniotomy
425807|NCT01327664|Quiescent uveitis|quiescent uveitis
425808|NCT01327664|intermediate uveitis|intermediate uveitis
425809|NCT01327664|panuveitis|panuveitis
425810|NCT01327664|posterior uveitis|posterior uveitis
425811|NCT01327664|uveitis|uveitis
425812|NCT01327651|Drug Administration Schedule|drug administration schedule
425813|NCT01327651|Nucleoside Reverse Transcriptase Inhibitors|nucleoside reverse transcriptase inhibitors
425814|NCT01327651|Pharmacokinetics|pharmacokinetics
425815|NCT01327625|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
425816|NCT01327625|Graft versus host disease|graft versus host disease
425817|NCT01327625|Bronchiolitis obliterans|bronchiolitis obliterans
425818|NCT01327625|Azithromycin|azithromycin
425921|NCT01327261|benserazide|benserazide
425819|NCT01327625|N-acetylcystein|n-acetylcystein
425820|NCT01327625|Fluticasone|fluticasone
425821|NCT01327625|Inhaled steroid|inhaled steroid
425822|NCT01327612|AMG 655|amg 655
425823|NCT01327612|AMG 479|amg 479
425824|NCT01327612|Apoptosis|apoptosis
425825|NCT01327612|Monoclonal Antibody|monoclonal antibody
425826|NCT01327612|Tumor Necrosis Factor|tumor necrosis factor
425827|NCT01327612|Insulin-like Growth Factor|insulin-like growth factor
425828|NCT01327612|Bevacizumab|bevacizumab
425829|NCT01327612|Modified FOLFOX6|modified folfox6
425830|NCT01327612|mFOLFOX6|mfolfox6
425831|NCT01327612|FOLFOX|folfox
425832|NCT01327612|Lymphoma|lymphoma
425833|NCT01327612|Trail Receptor|trail receptor
425834|NCT01327612|ganitumab|ganitumab
425835|NCT01327612|conatumumab|conatumumab
425836|NCT01327599|Open-angle glaucoma|open-angle glaucoma
425837|NCT01327599|Ocular hypertension|ocular hypertension
425838|NCT01327599|Pigment dispersion glaucoma|pigment dispersion glaucoma
425839|NCT01327599|Intraocular pressure|intraocular pressure
425840|NCT01327586|disability|disability
425841|NCT01327586|substance abuse|substance abuse
425842|NCT01327586|cocaine abuse|cocaine abuse
425843|NCT01327586|dual diagnosis|dual diagnosis
425844|NCT01327586|representative payee|representative payee
425845|NCT01327586|HIV risk reduction|hiv risk reduction
425846|NCT01327573|chronic kidney allograft injury|chronic kidney allograft injury
425847|NCT01327573|complement protein|complement protein
425848|NCT01327573|eculizumab|eculizumab
425849|NCT01327573|Kidney transplantation|kidney transplantation
425850|NCT01327560|hemodialysis patients|hemodialysis patients
425851|NCT01327560|sleep quality|sleep quality
425852|NCT01327560|restless legs syndrome|restless legs syndrome
425853|NCT01327560|excessive daytime sleepiness|excessive daytime sleepiness
425854|NCT01327560|sleep apnea syndrome|sleep apnea syndrome
425855|NCT01327547|HIV coinfection|hiv coinfection
425856|NCT01327547|maraviroc|maraviroc
425857|NCT01327547|CCR5 blocker|ccr5 blocker
425858|NCT01327547|entry inhibitor|entry inhibitor
425859|NCT01327547|liver disease|liver disease
425860|NCT01327547|viral hepatitis|viral hepatitis
425861|NCT01327534|STEMI|stemi
425862|NCT01327534|clopidogrel|clopidogrel
425863|NCT01327534|prasugrel|prasugrel
425864|NCT01327534|platelet reactivity index|platelet reactivity index
425865|NCT01327534|ST resolution|st resolution
425866|NCT01327495|Androgen replacement in men|androgen replacement in men
425867|NCT01327482|Raltegravir|raltegravir
425868|NCT01327482|Pharmacokinetics|pharmacokinetics
425869|NCT01327456|health literacy|health literacy
425870|NCT01327456|self-management|self-management
425871|NCT01327456|inhaler technique|inhaler technique
425872|NCT01327443|NAFLD|nafld
425873|NCT01327443|NASH|nash
425874|NCT01327443|Weight loss|weight loss
425875|NCT01327443|Exercise|exercise
425876|NCT01327443|NAS scores|nas scores
425877|NCT01327443|Mitochondrial dysfunction|mitochondrial dysfunction
425878|NCT01327430|glycerophosphates|glycerophosphates
425879|NCT01327430|sphingomyelins|sphingomyelins
425880|NCT01327417|Depression|depression
425881|NCT01327404|Depression|depression
425882|NCT01327404|Diabetes Mellitus|diabetes mellitus
425883|NCT01327391|on line hemodiafiltration|on line hemodiafiltration
425884|NCT01327391|tolerance|tolerance
425885|NCT01327391|quality of life|quality of life
425886|NCT01327391|cardiovascular risk|cardiovascular risk
425887|NCT01327391|Hemodialysis patients|hemodialysis patients
425888|NCT01327365|significant coronary artery disease|significant coronary artery disease
425889|NCT01327365|PCI|pci
425890|NCT01327365|radial approach|radial approach
425891|NCT01327365|women|women
425892|NCT01327365|bifurcation lesion|bifurcation lesion
425893|NCT01327365|ostial lesion|ostial lesion
425894|NCT01327365|7 Fr guiding catheter|7 fr guiding catheter
425895|NCT01327365|percutaneous coronary intervention|percutaneous coronary intervention
425896|NCT01327352|lupus|lupus
425897|NCT01327326|Pain modulation|pain modulation
425898|NCT01327326|Experimental pain|experimental pain
425899|NCT01327313|alpha v integrin|alpha v integrin
425900|NCT01327313|antibody|antibody
425901|NCT01327313|solid tumor|solid tumor
425902|NCT01327313|Japanese|japanese
425903|NCT01327313|EMD525797|emd525797
425904|NCT01327300|Irritable Bowel Syndrome|irritable bowel syndrome
425905|NCT01327300|Irritable Bowel Syndrome Treatment|irritable bowel syndrome treatment
425906|NCT01327300|Mesalamine|mesalamine
425907|NCT01327300|Anti-inflammatory drugs|anti-inflammatory drugs
425908|NCT01327300|5-ASA drugs|5-asa drugs
425909|NCT01327300|Apriso ™|apriso ™
425910|NCT01327287|thoracic epidural|thoracic epidural
425911|NCT01327287|blunt|blunt
425912|NCT01327287|blunt thoracic injury|blunt thoracic injury
425913|NCT01327274|Pectus excavatum|pectus excavatum
425914|NCT01327274|Chest wall deformity|chest wall deformity
425915|NCT01327274|Magnetic Mini-Mover Procedure|magnetic mini-mover procedure
425916|NCT01327274|Pectus Severity Index|pectus severity index
425917|NCT01327274|pediatric medical device|pediatric medical device
425918|NCT01327274|magnetic alteration|magnetic alteration
425919|NCT01327274|sunken chest|sunken chest
425920|NCT01327261|levodopa|levodopa
425922|NCT01327261|bioequivalence|bioequivalence
425923|NCT01327261|pharmacokinetics|pharmacokinetics
425924|NCT01327261|A Single - Dose|a single - dose
425925|NCT01327261|Randomized- Sequence|randomized- sequence
425926|NCT01327261|Open -Label Crossover Study|open -label crossover study
425927|NCT01327248|Bronchiolitis obliterans|bronchiolitis obliterans
425928|NCT01327248|HRCT|hrct
425929|NCT01327248|Sputum|sputum
425930|NCT01327248|Blood|blood
425931|NCT01327248|Inflammation|inflammation
425932|NCT01327248|adaptive immune system|adaptive immune system
425933|NCT01327248|innate immune system|innate immune system
425934|NCT01327222|age-related macular degeneration|age-related macular degeneration
425935|NCT01327222|bevacizumab|bevacizumab
425936|NCT01327196|dementia|dementia
425937|NCT01327196|cardiovascular risk|cardiovascular risk
425938|NCT01327196|elderly|elderly
425939|NCT01327196|aging|aging
425940|NCT01327196|older 65-100 years|older 65-100 years
425941|NCT01327157|Facial Paralysis / rehabilitation.|facial paralysis / rehabilitation.
425942|NCT01327157|Dental Occlusion.|dental occlusion.
425943|NCT01327157|Occlusal Adjustment.|occlusal adjustment.
425944|NCT01327157|Malocclusion / therapy.|malocclusion / therapy.
425945|NCT01327092|Injury|injury
425946|NCT01327092|Injury Prevention|injury prevention
425947|NCT01327092|Cincinnati Home Injury Prevention|cincinnati home injury prevention
425948|NCT01327092|Injury Hazards|injury hazards
425949|NCT01327092|Modifiable Injury Hazards|modifiable injury hazards
425950|NCT01327092|CHIP|chip
425951|NCT01327092|Literacy Promotion|literacy promotion
425952|NCT01327092|Reduce exposure to injury hazards|reduce exposure to injury hazards
425953|NCT01327092|preventable and medically attended injury|preventable and medically attended injury
425954|NCT01327092|young children|young children
425955|NCT01327079|NICU|nicu
425956|NCT01327079|Methadone|methadone
425957|NCT01327079|neonates|neonates
425958|NCT01327066|QTc|qtc
425959|NCT01327066|ECG Effects|ecg effects
425960|NCT01327053|locally advanced basal cell carcinoma,|locally advanced basal cell carcinoma,
425961|NCT01327053|metastatic basal cell carcinoma|metastatic basal cell carcinoma
425962|NCT01327040|light|light
425963|NCT01327040|melatonin|melatonin
425964|NCT01327040|circadian|circadian
425965|NCT01327040|delayed sleep phase disorder|delayed sleep phase disorder
425966|NCT01327040|circadian light sensitivity|circadian light sensitivity
425967|NCT01327040|circadian timing system|circadian timing system
425968|NCT01327027|vasopressin|vasopressin
425969|NCT01327027|antisocial|antisocial
425970|NCT01327027|affiliation|affiliation
425971|NCT01327014|Hyperlipidemia|hyperlipidemia
425972|NCT01327014|Cholesterol|cholesterol
425973|NCT01327014|Lipids|lipids
425974|NCT01327014|Lipoproteins|lipoproteins
425975|NCT01327014|XueZhiKang|xuezhikang
425976|NCT01327014|Botanical|botanical
425977|NCT01327001|Asthma bronchiale, fixed combination|asthma bronchiale, fixed combination
425978|NCT01326988|Spinal anesthesia|spinal anesthesia
425979|NCT01326988|ultrasound|ultrasound
425980|NCT01326988|real-time|real-time
425981|NCT01326975|infant, premature|infant, premature
425982|NCT01326975|infant, very low birth weight|infant, very low birth weight
425983|NCT01326975|diaphragm|diaphragm
425984|NCT01326975|apnea|apnea
425985|NCT01326975|continuous positive airway pressure|continuous positive airway pressure
425986|NCT01326936|Online education|online education
425987|NCT01326936|Medical education|medical education
425988|NCT01326936|Substance abuse training|substance abuse training
425989|NCT01326936|Drug abuse training|drug abuse training
425990|NCT01326923|Head|head
425991|NCT01326923|Neck|neck
425992|NCT01326923|Locally advanced|locally advanced
425993|NCT01326923|Squamous Cell|squamous cell
425994|NCT01326923|Hypopharynx|hypopharynx
425995|NCT01326923|Larynx|larynx
425996|NCT01326923|Oral Cavity|oral cavity
425997|NCT01326923|Base of Tongue|base of tongue
425998|NCT01326923|Tonsil|tonsil
425999|NCT01326923|Neck lymph node|neck lymph node
426000|NCT01326923|Resection|resection
426001|NCT01326910|Eczema|eczema
426002|NCT01326884|aortic aneurysm|aortic aneurysm
426003|NCT01326884|iliac aneurysm|iliac aneurysm
426004|NCT01326884|endovascular procedures|endovascular procedures
426005|NCT01326871|cancer|cancer
426006|NCT01326871|immunotherapy|immunotherapy
426007|NCT01326871|immunochemotherapy|immunochemotherapy
426008|NCT01326871|combinational therapy|combinational therapy
426009|NCT01326871|targeted|targeted
426010|NCT01326871|metastatic|metastatic
426011|NCT01326871|muscle invasive|muscle invasive
426012|NCT01326871|interleukin-2|interleukin-2
426013|NCT01326871|cisplatin|cisplatin
426014|NCT01326871|gemcitabine|gemcitabine
426015|NCT01326871|antitumor|antitumor
426016|NCT01326871|TCR|tcr
426017|NCT01326871|T-cell receptor|t-cell receptor
426018|NCT01326871|p53|p53
426019|NCT01326871|p53 gene|p53 gene
426020|NCT01326871|p53 tumor supressor protein|p53 tumor supressor protein
426021|NCT01326871|urothelial cancer|urothelial cancer
426022|NCT01326871|bladder cancer|bladder cancer
426023|NCT01326871|renal pelvis cancer|renal pelvis cancer
426024|NCT01326871|ureters cancer|ureters cancer
426025|NCT01326871|urethra cancer|urethra cancer
426026|NCT01326871|HLA-A2 positive|hla-a2 positive
426027|NCT01326871|HLA-A*0201/p53 aa264-272|hla-a*0201/p53 aa264-272
426028|NCT01326871|HLA complex|hla complex
426029|NCT01326871|Muscle Invasive or Metastatic|muscle invasive or metastatic
426030|NCT01326858|Ocular discomfort|ocular discomfort
426031|NCT01326858|AL-4943A Ophthalmic Solution|al-4943a ophthalmic solution
426032|NCT01326845|Gastrointestinal adverse events,|gastrointestinal adverse events,
426033|NCT01326845|myelodysplastic syndrome,|myelodysplastic syndrome,
426034|NCT01326845|transfusional iron overload diarrhea,|transfusional iron overload diarrhea,
426035|NCT01326845|constipation abdominal pain,|constipation abdominal pain,
426036|NCT01326845|vomiting|vomiting
426037|NCT01326832|THA|tha
426038|NCT01326819|Near infrared spectroscopy|near infrared spectroscopy
426039|NCT01326819|Skin pigmentation|skin pigmentation
426040|NCT01326819|Regional oxygen saturation|regional oxygen saturation
426041|NCT01326806|Parent-based intervention|parent-based intervention
426042|NCT01326806|Sexual risk behavior|sexual risk behavior
426043|NCT01326806|Adolescents|adolescents
426044|NCT01326793|telepsychiatry|telepsychiatry
426045|NCT01326793|MDD|mdd
426046|NCT01326793|Depression|depression
426047|NCT01326793|Major Depressive Disorder|major depressive disorder
426048|NCT01326793|Skype|skype
426049|NCT01326793|college|college
426050|NCT01326793|university|university
426051|NCT01326780|Acne|acne
426052|NCT01326780|Irritation|irritation
426053|NCT01326780|Safety|safety
426054|NCT01326780|Sebum|sebum
426055|NCT01326741|clonal mast cell disorder|clonal mast cell disorder
426056|NCT01326741|exercise-induced anaphylaxis|exercise-induced anaphylaxis
426057|NCT01326741|hypotension|hypotension
426058|NCT01326728|Relapse|relapse
426059|NCT01326728|Hematologic Malignancy|hematologic malignancy
426060|NCT01326728|Allogeneic|allogeneic
426061|NCT01326728|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
426062|NCT01326728|Leukemia|leukemia
426063|NCT01326728|Lymphoma|lymphoma
426064|NCT01326728|Hodgkin Lymphoma|hodgkin lymphoma
426065|NCT01326715|Multiple Sclerosis|multiple sclerosis
426066|NCT01326715|MRI|mri
426067|NCT01326715|Manganese Enhanced MRI|manganese enhanced mri
426068|NCT01326715|Optic Neuritis|optic neuritis
426069|NCT01326715|Healthy Volunteer|healthy volunteer
426070|NCT01326676|Polypill|polypill
426071|NCT01326676|Red Heart Pill|red heart pill
426072|NCT01326676|Cardiovascular disease|cardiovascular disease
426073|NCT01326676|Secondary prevention|secondary prevention
426074|NCT01326676|carotid intima media thickness|carotid intima media thickness
426075|NCT01326663|Veterans|veterans
426076|NCT01326663|TBI|tbi
426077|NCT01326663|Alcoholism|alcoholism
426078|NCT01326663|Mood|mood
426079|NCT01326650|vitamin D, mortality, event-free survival, heart failure|vitamin d, mortality, event-free survival, heart failure
426080|NCT01326637|primary health care|primary health care
426081|NCT01326637|aged|aged
426082|NCT01326624|heart failure|heart failure
426083|NCT01326624|ventricular dysfunction|ventricular dysfunction
426084|NCT01326624|sudden death|sudden death
426085|NCT01326624|sudden cardiac arrest|sudden cardiac arrest
426086|NCT01326624|ventricular tachycardia|ventricular tachycardia
426087|NCT01326624|ventricular fibrillation|ventricular fibrillation
426088|NCT01326624|wearable defibrillator|wearable defibrillator
426089|NCT01326611|Chronic lung disease|chronic lung disease
426090|NCT01326611|Clarithromycin|clarithromycin
426091|NCT01326611|Ureaplasma urealyticum|ureaplasma urealyticum
426092|NCT01326598|V Go™|v go™
426093|NCT01326598|Type 2 Diabetes|type 2 diabetes
426094|NCT01326598|Insulin|insulin
426095|NCT01326598|Oral Anti Hypoglycemic Drugs|oral anti hypoglycemic drugs
426096|NCT01326585|Scleral Buckling|scleral buckling
426097|NCT01326585|Dexamethasone|dexamethasone
426098|NCT01326585|Post-operative Nausea and Vomiting|post-operative nausea and vomiting
426099|NCT01326572|HIV|hiv
426100|NCT01326572|Pulmonary disease|pulmonary disease
426101|NCT01326572|emphysema|emphysema
426102|NCT01326572|COPD|copd
426103|NCT01326559|induction chemotherapy|induction chemotherapy
426104|NCT01326559|docetaxel|docetaxel
426105|NCT01326559|cisplatin|cisplatin
426106|NCT01326559|fluorouracil|fluorouracil
426107|NCT01326559|cetuximab|cetuximab
426108|NCT01326559|intensity-modulated radiotherapy|intensity-modulated radiotherapy
426109|NCT01326546|Therapeutic HBV Vaccine|therapeutic hbv vaccine
426110|NCT01326546|Chronic Hepatitis B|chronic hepatitis b
426111|NCT01326546|HBeAg positive|hbeag positive
426112|NCT01326533|pre-diabetes|pre-diabetes
426113|NCT01326533|hydroxychloroquine|hydroxychloroquine
426114|NCT01326533|frequently sampled intravenous glucose tolerance testing|frequently sampled intravenous glucose tolerance testing
426115|NCT01326533|insulin resistance|insulin resistance
426116|NCT01326533|insulin secretion|insulin secretion
426117|NCT01326533|glucose tolerance|glucose tolerance
426118|NCT01326507|pulmonary embolism|pulmonary embolism
426119|NCT01326507|Heart-type fatty acid-binding protein|heart-type fatty acid-binding protein
426120|NCT01326507|cardiac biomarkers|cardiac biomarkers
426121|NCT01326507|risk stratification|risk stratification
426517|NCT01324817|Respiration|respiration
426122|NCT01326494|Upper Respiratory Tract Infection|upper respiratory tract infection
426123|NCT01326494|Asthma|asthma
426124|NCT01326494|URTI induced exacerbation of Asthma|urti induced exacerbation of asthma
426125|NCT01326481|TRC105|trc105
426126|NCT01326481|Breast Cancer|breast cancer
426127|NCT01326481|CD105|cd105
426128|NCT01326481|Endoglin|endoglin
426129|NCT01326481|TRACON Pharma|tracon pharma
426130|NCT01326481|Roswell Park Cancer Institute|roswell park cancer institute
426131|NCT01326481|Department of Defense|department of defense
426132|NCT01326468|head and neck cancer|head and neck cancer
426133|NCT01326468|temsirolimus|temsirolimus
426134|NCT01326468|cetuximab|cetuximab
426135|NCT01326468|cisplatin|cisplatin
426136|NCT01326468|radiation therapy|radiation therapy
426137|NCT01326455|transradial|transradial
426138|NCT01326455|angiogram|angiogram
426139|NCT01326455|device|device
426140|NCT01326455|Care of the radial artery post transradial angiogram|care of the radial artery post transradial angiogram
426141|NCT01326442|weight loss|weight loss
426142|NCT01326442|overweight|overweight
426143|NCT01326442|body composition|body composition
426144|NCT01326442|visceral obesity|visceral obesity
426145|NCT01326442|insulin|insulin
426146|NCT01326442|glucose tolerance|glucose tolerance
426147|NCT01326442|cholesterol|cholesterol
426148|NCT01326442|hypertriglyceridemia|hypertriglyceridemia
426149|NCT01326429|Sodium|sodium
426150|NCT01326429|Hyponatremia|hyponatremia
426151|NCT01326429|Hypernatremia|hypernatremia
426152|NCT01326429|Emergency department|emergency department
426153|NCT01326416|obesity|obesity
426154|NCT01326416|metabolic syndrome|metabolic syndrome
426155|NCT01326416|leucine|leucine
426156|NCT01326416|arginine|arginine
426157|NCT01326416|physical activity|physical activity
426158|NCT01326403|proximal|proximal
426159|NCT01326403|hip|hip
426160|NCT01326403|fractures|fractures
426161|NCT01326338|Diarrhea|diarrhea
426162|NCT01326325|Cancer|cancer
426163|NCT01326325|Refractory pain|refractory pain
426164|NCT01326325|Uncontrolled pain|uncontrolled pain
426165|NCT01326325|Ketamine|ketamine
426166|NCT01326286|Comparative Effectiveness Research|comparative effectiveness research
426167|NCT01326286|Prostatectomy|prostatectomy
426168|NCT01326286|radiotherapy|radiotherapy
426169|NCT01326286|quality of life|quality of life
426170|NCT01326273|CMV|cmv
426171|NCT01326273|cytomegalovirus|cytomegalovirus
426172|NCT01326273|autologous|autologous
426173|NCT01326273|leukemia|leukemia
426174|NCT01326273|hematological malignancies|hematological malignancies
426175|NCT01326273|stem cell transplantation|stem cell transplantation
426176|NCT01326273|CMV reactivation|cmv reactivation
426177|NCT01326273|adoptive therapy|adoptive therapy
426178|NCT01326260|resuscitation|resuscitation
426179|NCT01326260|trauma|trauma
426180|NCT01326260|THAM|tham
426181|NCT01326260|colloids|colloids
426182|NCT01326260|crystalloids|crystalloids
426183|NCT01326234|Smoking|smoking
426184|NCT01326234|Motivation|motivation
426185|NCT01326234|Cessation|cessation
426186|NCT01326221|Truvada|truvada
426187|NCT01326221|tenofovir|tenofovir
426188|NCT01326221|emtricitabine|emtricitabine
426189|NCT01326221|Pharmacokinetics|pharmacokinetics
426190|NCT01326221|Healthy Volunteers|healthy volunteers
426191|NCT01326208|electrical impedance tomography|electrical impedance tomography
426192|NCT01326208|positive end-expiratory pressure|positive end-expiratory pressure
426193|NCT01326208|regional ventilation delay index|regional ventilation delay index
426194|NCT01326195|HIV Prevention|hiv prevention
426195|NCT01326195|Dating Violence|dating violence
426196|NCT01326195|Females|females
426197|NCT01326195|Romantic relationships|romantic relationships
426198|NCT01326195|Adolescents|adolescents
426199|NCT01326195|Sexuality|sexuality
426200|NCT01326195|Underserved youth|underserved youth
426201|NCT01326182|asthma|asthma
426202|NCT01326182|depression|depression
426203|NCT01326182|Latino|latino
426204|NCT01326169|Alcohol|alcohol
426205|NCT01326169|brief intervention|brief intervention
426206|NCT01326169|injuries|injuries
426207|NCT01326156|Osteoarthritis|osteoarthritis
426208|NCT01326156|Knee|knee
426209|NCT01326156|Knee cap|knee cap
426210|NCT01326156|Patella|patella
426211|NCT01326156|Patellofemoral|patellofemoral
426212|NCT01326143|MRD|mrd
426213|NCT01326143|Narval|narval
426214|NCT01326143|Oral appliance|oral appliance
426215|NCT01326143|Obstructive Sleep apnea|obstructive sleep apnea
426216|NCT01326143|OSAH|osah
426217|NCT01326143|OSA treatment|osa treatment
426218|NCT01326130|Integrated care network|integrated care network
426219|NCT01326130|Chronic care model|chronic care model
426220|NCT01326130|Health services research|health services research
426221|NCT01326117|gastroparesis|gastroparesis
426222|NCT01326117|gastric emptying|gastric emptying
426223|NCT01326117|diabetes|diabetes
426224|NCT01326117|Stomach Diseases|stomach diseases
426225|NCT01326117|Gastrointestinal Diseases|gastrointestinal diseases
426226|NCT01326117|Digestive System Diseases|digestive system diseases
426518|NCT01324817|Breathing|breathing
426227|NCT01326117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors
426228|NCT01326117|Neurologic Manifestations|neurologic manifestations
426229|NCT01326117|Paralysis|paralysis
426230|NCT01326117|Signs and Symptoms|signs and symptoms
426231|NCT01326117|Pharmacologic Actions|pharmacologic actions
426232|NCT01326104|Medulloblastoma|medulloblastoma
426233|NCT01326104|Primitive Neuroectodermal Tumor|primitive neuroectodermal tumor
426234|NCT01326091|Lumbar fusion surgery|lumbar fusion surgery
426235|NCT01326078|sedation|sedation
426236|NCT01326078|children|children
426237|NCT01326078|leukemia|leukemia
426238|NCT01326078|bone marrow biopsy|bone marrow biopsy
426239|NCT01326013|Stool|stool
426240|NCT01326013|Feces|feces
426241|NCT01326013|Gastrointestinal|gastrointestinal
426242|NCT01326013|Pathogen|pathogen
426243|NCT01326013|Panel|panel
426244|NCT01326013|xTAG GPP|xtag gpp
426245|NCT01326013|Infectious colitis|infectious colitis
426246|NCT01326013|Gastroenteritis|gastroenteritis
426247|NCT01326013|Detection|detection
426248|NCT01325987|Type 2 diabetes|type 2 diabetes
426249|NCT01325987|Vitamin D deficiency|vitamin d deficiency
426250|NCT01325987|Glycemic control|glycemic control
426251|NCT01325974|Malaria|malaria
426252|NCT01325974|Plasmodium falciparum|plasmodium falciparum
426253|NCT01325974|Diagnosis|diagnosis
426254|NCT01325974|Rapid diagnostic test|rapid diagnostic test
426255|NCT01325974|malaria transmission|malaria transmission
426256|NCT01325961|prostate, cervical and anal canal cancers with pelvic lymph node irradiation|prostate, cervical and anal canal cancers with pelvic lymph node irradiation
426257|NCT01325948|COPD|copd
426258|NCT01325935|Coronary Artery Disease|coronary artery disease
426259|NCT01325935|Coronary Disease|coronary disease
426260|NCT01325935|Myocardial Ischemia|myocardial ischemia
426261|NCT01325935|Heart Disease|heart disease
426262|NCT01325935|Cardiovascular Disease|cardiovascular disease
426263|NCT01325935|Arteriosclerosis|arteriosclerosis
426264|NCT01325935|Arterial Occlusive Disease|arterial occlusive disease
426265|NCT01325935|Vascular Disease|vascular disease
426266|NCT01325935|Clopidogrel|clopidogrel
426267|NCT01325935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
426268|NCT01325896|Multiple Mieloma, PEG-Intron|multiple mieloma, peg-intron
426269|NCT01325870|cardiopulmonary resuscitation|cardiopulmonary resuscitation
426270|NCT01325818|Coronary Artery Disease|coronary artery disease
426271|NCT01325818|Coronary Disease|coronary disease
426272|NCT01325818|Dyslipidemia|dyslipidemia
426273|NCT01325818|Stable Angina Pectoris|stable angina pectoris
426274|NCT01325818|Heart Diseases|heart diseases
426275|NCT01325818|Cardiovascular Diseases|cardiovascular diseases
426276|NCT01325818|Arteriosclerosis|arteriosclerosis
426277|NCT01325818|Arterial Occlusive Diseases|arterial occlusive diseases
426278|NCT01325818|Vascular Diseases Pravastatin|vascular diseases pravastatin
426279|NCT01325818|Rosuvastatin|rosuvastatin
426280|NCT01325818|Anticholesteremic Agents|anticholesteremic agents
426281|NCT01325818|Antilipemic Agents|antilipemic agents
426282|NCT01325818|Antimetabolites|antimetabolites
426283|NCT01325818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
426284|NCT01325818|Pharmacologic Actions|pharmacologic actions
426285|NCT01325818|Therapeutic Uses|therapeutic uses
426286|NCT01325818|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
426287|NCT01325805|Miscarriage|miscarriage
426288|NCT01325805|Recurrent Pregnancy Loss|recurrent pregnancy loss
426289|NCT01325805|Obesity|obesity
426290|NCT01325805|Overweight|overweight
426291|NCT01325805|Diet|diet
426292|NCT01325792|Complex ventral incisional hernia repair|complex ventral incisional hernia repair
426293|NCT01325792|reapproximation of the rectus abdominis muscle|reapproximation of the rectus abdominis muscle
426294|NCT01325792|retrorectus or intraperitoneal placement technique|retrorectus or intraperitoneal placement technique
426295|NCT01325792|mobility for midline fascial closure|mobility for midline fascial closure
426296|NCT01325779|deep venous thrombosis|deep venous thrombosis
426297|NCT01325779|DVT|dvt
426298|NCT01325779|enoxaparin|enoxaparin
426299|NCT01325779|heparin|heparin
426300|NCT01325779|surgical intensive care|surgical intensive care
426301|NCT01325766|Cystic Fibrosis|cystic fibrosis
426302|NCT01325766|Yoga|yoga
426303|NCT01325701|PCI-32765|pci-32765
426304|NCT01325701|Lymphoma, B-Cell|lymphoma, b-cell
426305|NCT01325701|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
426306|NCT01325701|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
426307|NCT01325701|Germinal Center B-Cell|germinal center b-cell
426308|NCT01325701|Activated B-Cell|activated b-cell
426309|NCT01325688|PEP005|pep005
426310|NCT01325688|Peplin|peplin
426311|NCT01325688|sBCC|sbcc
426312|NCT01325675|Atrial fibrillation|atrial fibrillation
426313|NCT01325675|Motor activity|motor activity
426314|NCT01325649|rectal cancer|rectal cancer
426315|NCT01325649|MRI|mri
426316|NCT01325649|selective preoperative radiochemotherapy|selective preoperative radiochemotherapy
426317|NCT01325649|involvement of circumferential resection margin|involvement of circumferential resection margin
426318|NCT01325649|locoregional recurrence rate|locoregional recurrence rate
426319|NCT01325636|Allogenic haematopoietic stem cell transplant|allogenic haematopoietic stem cell transplant
426320|NCT01325636|Cytomegalovirus or Adenovirus infection|cytomegalovirus or adenovirus infection
426321|NCT01325636|Graft versus Host|graft versus host
426322|NCT01325623|Automatic Magnet Mode (AMM)|automatic magnet mode (amm)
426323|NCT01325623|Vagal Nerve Stimulation|vagal nerve stimulation
426324|NCT01325610|vitamin D|vitamin d
426325|NCT01325610|kidney|kidney
426326|NCT01325610|renal|renal
426327|NCT01325597|Heart failure|heart failure
426328|NCT01325597|Electric stimulation|electric stimulation
426329|NCT01325597|Breathing exercises|breathing exercises
426330|NCT01325571|prograf|prograf
426331|NCT01325571|immunosuppressant|immunosuppressant
426332|NCT01325558|cancer|cancer
426333|NCT01325558|tissue factor|tissue factor
426334|NCT01325558|solid tumor|solid tumor
426335|NCT01325558|ovarian cancer|ovarian cancer
426336|NCT01325558|breast cancer|breast cancer
426337|NCT01325558|non-small cell lung cancer|non-small cell lung cancer
426338|NCT01325558|colon cancer|colon cancer
426339|NCT01325558|pancreatic cancer|pancreatic cancer
426340|NCT01325558|head and neck cancer|head and neck cancer
426341|NCT01325558|prostate cancer|prostate cancer
426342|NCT01325558|soft-tissue sarcoma|soft-tissue sarcoma
426343|NCT01325558|metastatic|metastatic
426344|NCT01325558|gemcitabine|gemcitabine
426345|NCT01325558|anti-tumor|anti-tumor
426346|NCT01325558|venous thromboembolism|venous thromboembolism
426347|NCT01325545|Stroke|stroke
426348|NCT01325545|Atrial Fibrillation|atrial fibrillation
426349|NCT01325532|depression|depression
426350|NCT01325532|Major Depressive Disorder|major depressive disorder
426351|NCT01325532|MDD|mdd
426352|NCT01325532|Cranial Electrical Stimulation|cranial electrical stimulation
426353|NCT01325532|CES|ces
426354|NCT01325506|Prostatectomy|prostatectomy
426355|NCT01325493|opioid tolerance|opioid tolerance
426356|NCT01325493|hyperalgesia|hyperalgesia
426357|NCT01325493|scoliosis|scoliosis
426358|NCT01325493|pupillometry|pupillometry
426359|NCT01325480|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
426360|NCT01325480|Pacing|pacing
426361|NCT01325480|His Bundle|his bundle
426362|NCT01325467|coronary artery disease|coronary artery disease
426363|NCT01325467|high frequency QRS analysis|high frequency qrs analysis
426364|NCT01325467|ischemia|ischemia
426365|NCT01325467|exercise testing|exercise testing
426366|NCT01325467|diagnosis of coronary artery disease|diagnosis of coronary artery disease
426367|NCT01325454|Pleural effusion|pleural effusion
426368|NCT01325454|angiogenic cytokine|angiogenic cytokine
426369|NCT01325454|fibrinolytic activity|fibrinolytic activity
426370|NCT01325441|BBI608|bbi608
426371|NCT01325415|Phase 1|phase 1
426372|NCT01325415|healthy male volunteers|healthy male volunteers
426373|NCT01325415|cross-over study|cross-over study
426374|NCT01325415|NKTR-118|nktr-118
426375|NCT01325402|Radioligand|radioligand
426376|NCT01325402|Alzheimers disease|alzheimers disease
426377|NCT01325402|Maximum Diagnostic Mass|maximum diagnostic mass
426378|NCT01325402|Beta amyloid|beta amyloid
426379|NCT01325376|overweight|overweight
426380|NCT01325376|obesity|obesity
426381|NCT01325363|Schizophrenia|schizophrenia
426382|NCT01325363|Novel metaphor|novel metaphor
426383|NCT01325298|Keratoconus|keratoconus
426384|NCT01325298|Ectasia|ectasia
426385|NCT01325298|cross linking|cross linking
426386|NCT01325298|collagen cross linking|collagen cross linking
426387|NCT01325298|corneal crosslinking|corneal crosslinking
426388|NCT01325298|corneal diseases|corneal diseases
426389|NCT01325298|eye diseases|eye diseases
426390|NCT01325285|Intraocular pressure|intraocular pressure
426391|NCT01325285|Hypercapnia|hypercapnia
426392|NCT01325285|Hyperoxia|hyperoxia
426393|NCT01325285|Rebreathing circuit|rebreathing circuit
426394|NCT01325272|otoacoustic emissions in newborns|otoacoustic emissions in newborns
426395|NCT01325246|ventral hernia|ventral hernia
426396|NCT01325246|repair|repair
426397|NCT01325246|clinical|clinical
426398|NCT01325246|reoperation|reoperation
426399|NCT01325233|Astragulus polysaccharides|astragulus polysaccharides
426400|NCT01325233|Hemorrhagic stroke|hemorrhagic stroke
426401|NCT01325207|Breast Cancer|breast cancer
426402|NCT01325194|DLBCL|dlbcl
426403|NCT01325194|FL grade 3B|fl grade 3b
426404|NCT01325194|high risk|high risk
426405|NCT01325194|CNS prophylaxis|cns prophylaxis
426406|NCT01325194|chemoimmunotherapy|chemoimmunotherapy
426407|NCT01325181|Chronic central serous chorioretinopathy|chronic central serous chorioretinopathy
426408|NCT01325181|Ranibizumab|ranibizumab
426409|NCT01325181|Photodynamic therapy|photodynamic therapy
426410|NCT01325168|PTSD|ptsd
426411|NCT01325168|empathy|empathy
426412|NCT01325168|oxytocin|oxytocin
426413|NCT01325155|Air Pollution|air pollution
426414|NCT01325155|particulate matter|particulate matter
426415|NCT01325155|cardiovascular Disease|cardiovascular disease
426416|NCT01325142|Osteonecrosis of the Jaw (ONJ)|osteonecrosis of the jaw (onj)
426417|NCT01325129|ESIN|esin
426418|NCT01325129|Clavicular Fracture|clavicular fracture
426419|NCT01325129|Dislocation|dislocation
426420|NCT01325129|Children|children
426421|NCT01325129|Adolescents|adolescents
426422|NCT01325116|STEMI|stemi
426519|NCT01324817|Rate|rate
426423|NCT01325116|Medication Adherence|medication adherence
426424|NCT01325116|Quality Improvement|quality improvement
426425|NCT01325103|Spinal cord injury|spinal cord injury
426426|NCT01325103|Mesenchymal stem cells|mesenchymal stem cells
426427|NCT01325103|Bone marrow|bone marrow
426428|NCT01325090|neuropathic pain due to thoracotomy|neuropathic pain due to thoracotomy
426429|NCT01325090|Neuropathic Pain Due to Thoracoscopy|neuropathic pain due to thoracoscopy
426430|NCT01325077|Nurse-based, acute pain service, pediatric, postoperative,|nurse-based, acute pain service, pediatric, postoperative,
426431|NCT01325077|pain|pain
426432|NCT01325064|Carotid Artery Diseases|carotid artery diseases
426433|NCT01325064|Blood Pressure|blood pressure
426434|NCT01325064|Blood Pressure Monitoring, Ambulatory|blood pressure monitoring, ambulatory
426435|NCT01325064|Peripheral Vascular Diseases|peripheral vascular diseases
426436|NCT01325064|Retinal Vessels|retinal vessels
426437|NCT01325051|raltegravir|raltegravir
426438|NCT01325051|pharmacokinetics|pharmacokinetics
426439|NCT01325051|healthy|healthy
426440|NCT01325051|male|male
426441|NCT01325051|volunteers|volunteers
426442|NCT01325051|gastrointestinal|gastrointestinal
426443|NCT01325051|tract|tract
426444|NCT01325038|resting metabolic rate|resting metabolic rate
426445|NCT01325025|Metachromatic Leukodystrophy|metachromatic leukodystrophy
426446|NCT01325025|Demyelinating Diseases|demyelinating diseases
426447|NCT01325025|Magnetic Resonance Imaging|magnetic resonance imaging
426448|NCT01325025|Diffusion Tensor Imaging|diffusion tensor imaging
426449|NCT01325025|Relaxometry|relaxometry
426450|NCT01325025|Spectroscopy|spectroscopy
426451|NCT01325025|Longitudinal Studies|longitudinal studies
426452|NCT01325012|Pain|pain
426453|NCT01325012|Surgery|surgery
426454|NCT01325012|Catheter|catheter
426455|NCT01325012|Nerve Block|nerve block
426456|NCT01325012|Popliteal|popliteal
426457|NCT01325012|Subgluteal|subgluteal
426458|NCT01325012|Sciatic|sciatic
426459|NCT01325012|UCSD|ucsd
426460|NCT01325012|Moderate-to-severe pain|moderate-to-severe pain
426461|NCT01325012|Perineural Catheter|perineural catheter
426462|NCT01325012|Orthopedic Surgery|orthopedic surgery
426463|NCT01325012|foot surgery surgery|foot surgery surgery
426464|NCT01325012|sciatic perineural catheter|sciatic perineural catheter
426465|NCT01325012|age =>18|age =>18
426466|NCT01324999|Sarcoidosis Associated Pulmonary Hypertension|sarcoidosis associated pulmonary hypertension
426467|NCT01324986|extraesophageal symptoms of gastroesophageal reflux disease|extraesophageal symptoms of gastroesophageal reflux disease
426468|NCT01324973|Medical Informatics|medical informatics
426469|NCT01324973|Therapy, Computer-Assisted|therapy, computer-assisted
426470|NCT01324973|Health Education|health education
426471|NCT01324973|Diet|diet
426472|NCT01324973|Exercise|exercise
426473|NCT01324960|IPSS|ipss
426474|NCT01324960|High risk|high risk
426475|NCT01324960|Azacitidine|azacitidine
426476|NCT01324960|Ceplene|ceplene
426477|NCT01324947|Myeloma|myeloma
426478|NCT01324947|Multiple Myeloma|multiple myeloma
426479|NCT01324947|Relapsed Multiple Myeloma|relapsed multiple myeloma
426480|NCT01324947|Relapsed and Refractory Multiple Myeloma|relapsed and refractory multiple myeloma
426481|NCT01324947|Refractory Myeloma|refractory myeloma
426482|NCT01324947|Resistant Multiple Myeloma|resistant multiple myeloma
426483|NCT01324947|Treatment-resistant Multiple Myeloma|treatment-resistant multiple myeloma
426484|NCT01324947|Pomalidomide|pomalidomide
426485|NCT01324947|Lenalidomide-resistant|lenalidomide-resistant
426486|NCT01324947|Bortezomib-resistant|bortezomib-resistant
426487|NCT01324947|Companion|companion
426488|NCT01324934|acute rejection|acute rejection
426489|NCT01324934|chronic rejection|chronic rejection
426490|NCT01324934|subclinical rejection|subclinical rejection
426491|NCT01324934|renal transplantation|renal transplantation
426492|NCT01324934|steroid-free|steroid-free
426493|NCT01324934|kidney transplantation|kidney transplantation
426494|NCT01324895|Small intestinal bacterial overgrowth syndrome (SIBO)|small intestinal bacterial overgrowth syndrome (sibo)
426495|NCT01324895|bacterial overgrowth syndrome|bacterial overgrowth syndrome
426496|NCT01324895|Small Bowel Bacterial Overgrowth Syndrome (SBBOS)|small bowel bacterial overgrowth syndrome (sbbos)
426497|NCT01324895|14-Co2 D-Xylose Breath Testing|14-co2 d-xylose breath testing
426498|NCT01324895|Antibiotics|antibiotics
426499|NCT01324895|Prokinteics|prokinteics
426500|NCT01324895|Prokinetic Agents|prokinetic agents
426501|NCT01324882|colonoscopy|colonoscopy
426502|NCT01324869|KH902|kh902
426503|NCT01324869|Diabetic macular Edema|diabetic macular edema
426504|NCT01324869|Intravitreal injection|intravitreal injection
426505|NCT01324869|Multiple injections|multiple injections
426506|NCT01324869|20 patients|20 patients
426507|NCT01324869|0.5mg/eye/time|0.5mg/eye/time
426508|NCT01324856|pancreatic cancer|pancreatic cancer
426509|NCT01324856|periampulary cancer|periampulary cancer
426510|NCT01324856|pancreaticogastro vs pancreaticojejuno anastomosis|pancreaticogastro vs pancreaticojejuno anastomosis
426511|NCT01324843|Safety and Tolerability|safety and tolerability
426512|NCT01324843|Intradermal Electroporation|intradermal electroporation
426513|NCT01324817|Non-Contact|non-contact
426514|NCT01324817|Radar|radar
426515|NCT01324817|Doppler|doppler
426516|NCT01324817|Respiratory|respiratory
426520|NCT01324817|Frequency|frequency
426521|NCT01324817|Respiratory Mechanics|respiratory mechanics
426522|NCT01324817|Respiratory Rate Measurement|respiratory rate measurement
426523|NCT01324817|Apnea|apnea
426524|NCT01324817|Sleep Apnea|sleep apnea
426525|NCT01324804|postoperative wound healing|postoperative wound healing
426526|NCT01324778|Edentulism in the Upper Jaw|edentulism in the upper jaw
426527|NCT01324765|Women|women
426528|NCT01324765|PTSD|ptsd
426529|NCT01324765|Group Therapy|group therapy
426530|NCT01324765|Incarceration|incarceration
426531|NCT01324752|Drug-drug interaction|drug-drug interaction
426532|NCT01324752|Pharmacokinetics|pharmacokinetics
426533|NCT01324752|PA21|pa21
426534|NCT01324726|Bacterial colonization|bacterial colonization
426535|NCT01324726|Extended spectrum beta lactamase producing organisms|extended spectrum beta lactamase producing organisms
426536|NCT01324687|Telemedicine|telemedicine
426537|NCT01324687|Geriatrics|geriatrics
426538|NCT01324674|Common Mental Disorder|common mental disorder
426539|NCT01324674|Efficacy of Bach´s flower remedy|efficacy of bach´s flower remedy
426540|NCT01324674|Spiritual well-being|spiritual well-being
426541|NCT01324648|Guided self-help|guided self-help
426542|NCT01324648|Telephone delivery|telephone delivery
426543|NCT01324648|Cognitive behavior therapy|cognitive behavior therapy
426544|NCT01324648|Bibliotherapy|bibliotherapy
426545|NCT01324635|glioma|glioma
426546|NCT01324635|meningioma|meningioma
426547|NCT01324635|brain metastasis|brain metastasis
426548|NCT01324635|stereotactic|stereotactic
426549|NCT01324635|radiotherapy|radiotherapy
426550|NCT01324635|radiosurgery|radiosurgery
426551|NCT01324622|Spinal Cord Diseases|spinal cord diseases
426552|NCT01324622|Myelopathy|myelopathy
426553|NCT01324622|Myeloradiculopathy|myeloradiculopathy
426554|NCT01324622|Laminectomy|laminectomy
426555|NCT01324622|Laminoplasty|laminoplasty
426556|NCT01324609|choroidal nevus|choroidal nevus
426557|NCT01324609|vitrectomy|vitrectomy
426558|NCT01324596|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
426559|NCT01324596|Bortezomib|bortezomib
426560|NCT01324596|R-CHOP|r-chop
426561|NCT01324596|Molecular profiling|molecular profiling
426562|NCT01324596|Chemotherapy|chemotherapy
426563|NCT01324570|Pain|pain
426564|NCT01324570|Opioid|opioid
426565|NCT01324570|Analgesia|analgesia
426566|NCT01324570|Moderate to severe pain|moderate to severe pain
426567|NCT01324557|Continuous glucose monitoring|continuous glucose monitoring
426568|NCT01324557|CAPD patients|capd patients
426569|NCT01324557|Insulin pump|insulin pump
426570|NCT01324544|Acute Pain|acute pain
426571|NCT01324544|Opioid|opioid
426572|NCT01324544|Analgesia|analgesia
426573|NCT01324531|Bankart repair|bankart repair
426574|NCT01324531|remplissage|remplissage
426575|NCT01324531|Hill-Sachs defect|hill-sachs defect
426576|NCT01324531|shoulder instability|shoulder instability
426577|NCT01324531|anterior shoulder instability|anterior shoulder instability
426578|NCT01324492|phase Ib,|phase ib,
426579|NCT01324492|RAD001,|rad001,
426580|NCT01324492|advanced pulmonary neuroendocrine tumor|advanced pulmonary neuroendocrine tumor
426581|NCT01324479|Non-small cell lung cancer,|non-small cell lung cancer,
426582|NCT01324479|hepatocellular,|hepatocellular,
426583|NCT01324479|gastric,|gastric,
426584|NCT01324479|renal cell,|renal cell,
426585|NCT01324479|c-MET,|c-met,
426586|NCT01324479|refractory,|refractory,
426587|NCT01324479|glioblastoma,|glioblastoma,
426588|NCT01324479|breast,|breast,
426589|NCT01324479|nasopharyngeal,|nasopharyngeal,
426590|NCT01324479|confirmed evidence of c-MET dysregulation|confirmed evidence of c-met dysregulation
426591|NCT01324453|Acute Myocardial Infarction|acute myocardial infarction
426592|NCT01324453|STEMI|stemi
426593|NCT01324453|Post Conditioning|post conditioning
426594|NCT01324453|Primary Percutaneous Coronary Intervention|primary percutaneous coronary intervention
426595|NCT01324440|Bacterial Vaccines|bacterial vaccines
426596|NCT01324440|Staphylococcus Aureus|staphylococcus aureus
426597|NCT01324440|Adjuvanted Vaccine|adjuvanted vaccine
426598|NCT01324427|Telemedicine|telemedicine
426599|NCT01324427|Virtual Medical Visit|virtual medical visit
426600|NCT01324427|Quality of Life|quality of life
426601|NCT01324427|11-022|11-022
426602|NCT01324401|Peanut Allergy|peanut allergy
426603|NCT01324401|Peanut Hypersensitivity|peanut hypersensitivity
426604|NCT01324362|FP|fp
426605|NCT01324362|Asthma|asthma
426606|NCT01324362|Sont|sont
426607|NCT01324362|FSC|fsc
426608|NCT01324362|BHR|bhr
426609|NCT01324349|Hepatic|hepatic
426610|NCT01324349|Topical Hemostat|topical hemostat
426611|NCT01324336|ALL|all
426612|NCT01324336|acute lymphoblastic leukemia|acute lymphoblastic leukemia
426613|NCT01324336|6-Mercaptopurine|6-mercaptopurine
426614|NCT01324336|Pediatric|pediatric
426615|NCT01324323|ROMI-001|romi-001
426616|NCT01324323|romi|romi
426617|NCT01324323|Romidepsin|romidepsin
426618|NCT01324323|Istodax|istodax
426619|NCT01324323|advanced malignancy|advanced malignancy
426620|NCT01324323|PK|pk
426621|NCT01324323|pharmacokinetics|pharmacokinetics
426622|NCT01324310|ROMI-001|romi-001
426623|NCT01324310|romi|romi
426624|NCT01324310|Romidepsin|romidepsin
426625|NCT01324310|Istodax|istodax
426626|NCT01324310|advanced malignancy|advanced malignancy
426627|NCT01324310|PK|pk
426628|NCT01324310|pharmacokinetics|pharmacokinetics
426629|NCT01324297|Diagnostic Techniques and Procedures|diagnostic techniques and procedures
426630|NCT01324297|Sensitivity and Specificity|sensitivity and specificity
426631|NCT01324297|Skin Tests|skin tests
426632|NCT01324297|Biological Markers|biological markers
426633|NCT01324284|Lubiprostone|lubiprostone
426634|NCT01324284|Bowel preparation regime|bowel preparation regime
426635|NCT01324271|Tympanostomy tube placement|tympanostomy tube placement
426636|NCT01324258|pancreatic cancer (combination with gemcitabine)|pancreatic cancer (combination with gemcitabine)
426637|NCT01324258|Non-small cell lung cancer (combination with gemcitabine)|non-small cell lung cancer (combination with gemcitabine)
426638|NCT01324258|solid tumors (single agent)|solid tumors (single agent)
426639|NCT01324258|MEK inhibitor|mek inhibitor
426640|NCT01324258|GSK1120212|gsk1120212
426641|NCT01324258|biliary cancer (combination with gemcitabine)|biliary cancer (combination with gemcitabine)
426642|NCT01324258|urothelial cancer (combination with gemcitabine)|urothelial cancer (combination with gemcitabine)
426643|NCT01324245|Salt|salt
426644|NCT01324245|Balance|balance
426645|NCT01324245|Renin Angiotensin System|renin angiotensin system
426646|NCT01324245|Fenoldopam\blood Pressure|fenoldopam\blood pressure
426647|NCT01324245|Sodium|sodium
426648|NCT01324219|nursing staff|nursing staff
426649|NCT01324219|residents|residents
426650|NCT01324206|Whole-Body|whole-body
426651|NCT01324206|Development|development
426652|NCT01324206|Exposure|exposure
426653|NCT01324206|Magnetic|magnetic
426654|NCT01324206|Resonance|resonance
426655|NCT01324180|ALL|all
426656|NCT01324180|Relapsed|relapsed
426657|NCT01324180|Refractory|refractory
426658|NCT01324167|schizophrenia|schizophrenia
426659|NCT01324167|schizoaffective disorder|schizoaffective disorder
426660|NCT01324141|Anal Cancer|anal cancer
426661|NCT01324141|Radioprotector|radioprotector
426662|NCT01324141|Topical|topical
426663|NCT01324141|Radiation|radiation
426664|NCT01324141|Dermatitis|dermatitis
426665|NCT01324128|PA21|pa21
426666|NCT01324128|Phosphate Binder|phosphate binder
426667|NCT01324115|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
426668|NCT01324102|Neoplasms|neoplasms
426669|NCT01324089|Resveratrol|resveratrol
426670|NCT01324089|Piperine|piperine
426671|NCT01324076|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
426672|NCT01324076|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
426673|NCT01324076|advanced adult primary liver cancer|advanced adult primary liver cancer
426674|NCT01324063|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
426675|NCT01324037|suspected upper extremity deep vein thrombosis|suspected upper extremity deep vein thrombosis
426676|NCT01324037|diagnostic algorithm|diagnostic algorithm
426677|NCT01324024|Menopause|menopause
426678|NCT01324024|Aging|aging
426679|NCT01324024|Memory|memory
426680|NCT01324024|Women|women
426681|NCT01323998|enlarged prostate|enlarged prostate
426682|NCT01323998|Benign prostatic hyperplasia|benign prostatic hyperplasia
426683|NCT01323998|alpha-blocker|alpha-blocker
426684|NCT01323998|5-alpha-reductase inhibitor|5-alpha-reductase inhibitor
426685|NCT01323972|Malaria|malaria
426686|NCT01323972|Plasmodium falciparum|plasmodium falciparum
426687|NCT01323959|BoostrixTM Polio|boostrixtm polio
426688|NCT01323959|dTpa-IPV|dtpa-ipv
426689|NCT01323959|booster|booster
426690|NCT01323946|H5N1|h5n1
426691|NCT01323946|influenza infection|influenza infection
426692|NCT01323946|Influenza vaccine GSK1562902A|influenza vaccine gsk1562902a
426693|NCT01323933|Solid tumors|solid tumors
426694|NCT01323933|Oncology|oncology
426695|NCT01323933|Cancer|cancer
426696|NCT01323920|Stem Cell Transplant|stem cell transplant
426697|NCT01323920|Allogeneic Transplant|allogeneic transplant
426698|NCT01323920|Donors|donors
426699|NCT01323907|Total Parenteral Nutrition-induced Cholestasis|total parenteral nutrition-induced cholestasis
426700|NCT01323907|Omegaven|omegaven
426701|NCT01323907|liver disease|liver disease
426702|NCT01323907|Cholestasis|cholestasis
426703|NCT01323907|Fat emulsions|fat emulsions
426704|NCT01323881|theta burst stimulation, stroke, motor, plasticity|theta burst stimulation, stroke, motor, plasticity
426705|NCT01323842|renal colic|renal colic
426706|NCT01323842|hydronephrosis|hydronephrosis
426707|NCT01323842|abdominal aortic aneurysm|abdominal aortic aneurysm
426708|NCT01323842|ultrasound|ultrasound
426709|NCT01323842|emergency medicine|emergency medicine
426710|NCT01323842|urolithiasis|urolithiasis
426711|NCT01323829|High Tone Pelvic Floor Dysfunction|high tone pelvic floor dysfunction
426712|NCT01323829|Botulinum toxin type A|botulinum toxin type a
426713|NCT01323829|EMG|emg
426714|NCT01323803|Eosinophilic Esophagitis|eosinophilic esophagitis
426715|NCT01323790|Non-Cancer-Related Pain|non-cancer-related pain
426716|NCT01323790|Opioid-Induced Constipation|opioid-induced constipation
426717|NCT01323777|Cataracts|cataracts
426718|NCT01323777|Intraocular lens|intraocular lens
426719|NCT01323777|Multifocal|multifocal
426720|NCT01323777|Toric|toric
426721|NCT01323777|Astigmatism|astigmatism
426722|NCT01323777|Presbyopia|presbyopia
426723|NCT01323764|Hydrocephalus|hydrocephalus
426724|NCT01323764|CSF shunts|csf shunts
426725|NCT01323764|Normal Pressure Hydrocephalus|normal pressure hydrocephalus
426726|NCT01323764|NPH|nph
426727|NCT01323764|ShuntCheck|shuntcheck
426728|NCT01323764|Shunt Malfunction|shunt malfunction
426729|NCT01323764|Suspected shunt malfunction in adult hydrocephalus patients|suspected shunt malfunction in adult hydrocephalus patients
426730|NCT01323738|Psychoeducation|psychoeducation
426731|NCT01323738|Group Control|group control
426732|NCT01323725|Team-based financial incentives|team-based financial incentives
426733|NCT01323725|Smoking cessation|smoking cessation
426734|NCT01323712|CKD|ckd
426735|NCT01323712|LV mass|lv mass
426736|NCT01323712|Vitamin D|vitamin d
426737|NCT01323712|LV function|lv function
426738|NCT01323699|Parkinson Disease|parkinson disease
426739|NCT01323699|Anxiety|anxiety
426740|NCT01323699|Depression|depression
426741|NCT01323647|IPV|ipv
426742|NCT01323647|PoliorixTM|poliorixtm
426743|NCT01323647|China|china
426744|NCT01323608|Thalassemia|thalassemia
426745|NCT01323608|hypercalciuria|hypercalciuria
426746|NCT01323608|vitamin D|vitamin d
426747|NCT01323608|To conduct a pilot study to determine the effect of various doses of|to conduct a pilot study to determine the effect of various doses of
426748|NCT01323608|vitamin D supplementation on vitamin D stores and their association with calcium excretion|vitamin d supplementation on vitamin d stores and their association with calcium excretion
426749|NCT01323595|Pain control|pain control
426750|NCT01323595|testicular sperm extraction|testicular sperm extraction
426751|NCT01323595|sperm|sperm
426752|NCT01323582|Gastroparesis|gastroparesis
426753|NCT01323582|Gastroparesis Treatment|gastroparesis treatment
426754|NCT01323582|Gastric Emptying|gastric emptying
426755|NCT01323582|Prokinetic Agents|prokinetic agents
426756|NCT01323582|Macrolides|macrolides
426757|NCT01323582|Erythromycin|erythromycin
426758|NCT01323582|Azithromycin|azithromycin
426759|NCT01323582|Erythromycin Cardiac Side-effects|erythromycin cardiac side-effects
426760|NCT01323582|Erythromycin drug interactions|erythromycin drug interactions
426761|NCT01323582|AZI|azi
426762|NCT01323569|Sativex|sativex
426763|NCT01323569|Cannabinoids|cannabinoids
426764|NCT01323569|Abuse potential|abuse potential
426765|NCT01323569|Addiction|addiction
426766|NCT01323556|Panic disorder|panic disorder
426767|NCT01323556|agoraphobia|agoraphobia
426768|NCT01323556|panic attacks|panic attacks
426769|NCT01323556|exposure based learning|exposure based learning
426770|NCT01323556|interoceptive exposure exercises|interoceptive exposure exercises
426771|NCT01323556|fear augmentation|fear augmentation
426772|NCT01323556|in vivo exposure|in vivo exposure
426773|NCT01323543|Back Pain,|back pain,
426774|NCT01323543|Back Pains, Low|back pains, low
426775|NCT01323543|Low Back Pains|low back pains
426776|NCT01323543|Pain, Low Back|pain, low back
426777|NCT01323543|Pains, Low Back|pains, low back
426778|NCT01323543|Lumbago|lumbago
426779|NCT01323543|Lower Back Pain|lower back pain
426780|NCT01323543|Back Pain, Lower|back pain, lower
426781|NCT01323543|Back Pains, Lower|back pains, lower
426782|NCT01323543|Lower Back Pains|lower back pains
426783|NCT01323543|Pain, Lower Back|pain, lower back
426784|NCT01323543|Pains, Lower Back|pains, lower back
426785|NCT01323543|Low Back Ache|low back ache
426786|NCT01323543|Ache, Low Back|ache, low back
426787|NCT01323543|Aches, Low Back|aches, low back
426788|NCT01323543|Back Ache, Low|back ache, low
426789|NCT01323543|Back Aches, Low|back aches, low
426790|NCT01323543|Low Back Aches|low back aches
426791|NCT01323543|Low Backache|low backache
426792|NCT01323543|Backache, Low|backache, low
426793|NCT01323543|Backaches, Low|backaches, low
426794|NCT01323543|Low Backaches|low backaches
426795|NCT01323543|Low Back Pain, Recurrent|low back pain, recurrent
426796|NCT01323543|Recurrent Low Back Pain|recurrent low back pain
426797|NCT01323543|Low Back Pain, Postural|low back pain, postural
426798|NCT01323543|Postural Low Back Pain|postural low back pain
426799|NCT01323543|Low Back Pain, Mechanical|low back pain, mechanical
426800|NCT01323543|Mechanical Low Back Pain|mechanical low back pain
426801|NCT01323543|Low Back Pain, Posterior Compartment|low back pain, posterior compartment
426802|NCT01323530|metastatic breast cancer|metastatic breast cancer
426803|NCT01323517|skin|skin
426804|NCT01323517|DACTINOMYCIN|dactinomycin
426805|NCT01323517|MDX-010 (Ipilimumab)|mdx-010 (ipilimumab)
426806|NCT01323517|MELPHALAN|melphalan
426807|NCT01323517|Isolated Limb Infusion|isolated limb infusion
426808|NCT01323517|10-101|10-101
426809|NCT01323504|Stage 5 arteritis|stage 5 arteritis
426810|NCT01323504|Stage 6 arteritis|stage 6 arteritis
426811|NCT01323504|rutherford classification|rutherford classification
426812|NCT01323491|smoking cessation|smoking cessation
426813|NCT01323491|nicotine replacement therapy|nicotine replacement therapy
426814|NCT01323491|routine smokers|routine smokers
426815|NCT01323478|Depressive Disorder|depressive disorder
426816|NCT01323478|Depression|depression
426817|NCT01323478|Depressive Disorder, Major|depressive disorder, major
426923|NCT01323088|Liver fat|liver fat
426818|NCT01323478|Mood Disorders|mood disorders
426819|NCT01323478|Mental Disorders|mental disorders
426820|NCT01323478|Behavioural Symptoms|behavioural symptoms
426821|NCT01323465|Sativex|sativex
426822|NCT01323465|Cytochrome P450|cytochrome p450
426823|NCT01323465|Pharmacokinetics|pharmacokinetics
426824|NCT01323465|Cannabinoids|cannabinoids
426825|NCT01323465|ketoconazole|ketoconazole
426826|NCT01323465|omeprazole|omeprazole
426827|NCT01323465|rifampicin|rifampicin
426828|NCT01323452|entecavir|entecavir
426829|NCT01323452|hepatitis B|hepatitis b
426830|NCT01323439|Patients presenting with an intracranial aneurysm|patients presenting with an intracranial aneurysm
426831|NCT01323426|urinary incontinence, stress|urinary incontinence, stress
426832|NCT01323426|autologous|autologous
426833|NCT01323413|stroke|stroke
426834|NCT01323413|penumbra|penumbra
426835|NCT01323413|determinants|determinants
426836|NCT01323413|CT perfusion|ct perfusion
426837|NCT01323400|GIST|gist
426838|NCT01323400|Resistant|resistant
426839|NCT01323400|Pazopanib|pazopanib
426840|NCT01323400|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
426841|NCT01323400|Best supportive care|best supportive care
426842|NCT01323400|Progression-free survival|progression-free survival
426843|NCT01323400|Overall survival|overall survival
426844|NCT01323400|Objective response rate|objective response rate
426845|NCT01323400|Best response|best response
426846|NCT01323400|Tolerance profile|tolerance profile
426847|NCT01323374|Fibromyalgia|fibromyalgia
426848|NCT01323374|FMS|fms
426849|NCT01323374|droxidopa|droxidopa
426850|NCT01323374|pain|pain
426851|NCT01323361|inflammation|inflammation
426852|NCT01323361|laparoscopy|laparoscopy
426853|NCT01323361|hernia|hernia
426854|NCT01323361|incisional|incisional
426855|NCT01323361|trauma|trauma
426856|NCT01323348|Diabetes|diabetes
426857|NCT01323348|Diabetes Education|diabetes education
426858|NCT01323348|Diabetic Retinopathy|diabetic retinopathy
426859|NCT01323348|HbA1c|hba1c
426860|NCT01323335|Uric Acid|uric acid
426861|NCT01323335|Rasburicase|rasburicase
426862|NCT01323335|Inflammatory Markers|inflammatory markers
426863|NCT01323322|Health Disparities|health disparities
426864|NCT01323322|Diversity|diversity
426865|NCT01323322|Socioeconomic Status|socioeconomic status
426866|NCT01323322|Epidemiology|epidemiology
426867|NCT01323309|Supportive Psychotherapy|supportive psychotherapy
426868|NCT01323309|Therapy|therapy
426869|NCT01323309|11-021|11-021
426870|NCT01323296|Myocardial infarction|myocardial infarction
426871|NCT01323296|Magnetic resonance|magnetic resonance
426872|NCT01323296|Nanoparticle|nanoparticle
426873|NCT01323296|Iron|iron
426874|NCT01323296|Inflammation|inflammation
426875|NCT01323283|Omega-3|omega-3
426876|NCT01323283|physical activity|physical activity
426877|NCT01323283|children|children
426878|NCT01323283|obesity|obesity
426879|NCT01323283|sedentary|sedentary
426880|NCT01323283|accelerometry|accelerometry
426881|NCT01323283|BMI|bmi
426882|NCT01323283|fatty acids|fatty acids
426883|NCT01323283|inflammatory markers|inflammatory markers
426884|NCT01323283|intervention|intervention
426885|NCT01323283|randomized|randomized
426886|NCT01323283|double blind|double blind
426887|NCT01323270|Healthy adolescents|healthy adolescents
426888|NCT01323257|TMC435-TiDP16-C115|tmc435-tidp16-c115
426889|NCT01323257|TMC435-C115|tmc435-c115
426890|NCT01323257|TMC435|tmc435
426891|NCT01323257|HCV|hcv
426892|NCT01323257|Hepatitis C|hepatitis c
426893|NCT01323257|Hep C|hep c
426894|NCT01323257|healthy volunteers|healthy volunteers
426895|NCT01323244|TMC435-TiDP16-C213|tmc435-tidp16-c213
426896|NCT01323244|TMC435-C213|tmc435-c213
426897|NCT01323244|TMC435|tmc435
426898|NCT01323244|HCV|hcv
426899|NCT01323244|Hepatitis C|hepatitis c
426900|NCT01323231|XY-Zone|xy-zone
426901|NCT01323231|school drop-out risk|school drop-out risk
426902|NCT01323231|protective factors|protective factors
426903|NCT01323231|truancy|truancy
426904|NCT01323218|Obstructive sleep apnea-hypopnea syndrome|obstructive sleep apnea-hypopnea syndrome
426905|NCT01323218|OSAHS|osahs
426906|NCT01323218|Vitamin D|vitamin d
426907|NCT01323205|JNJ-40411813|jnj-40411813
426908|NCT01323192|Concerta|concerta
426909|NCT01323192|Adults|adults
426910|NCT01323192|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
426911|NCT01323192|ADHD|adhd
426912|NCT01323192|Methylphenidate hydrochloride|methylphenidate hydrochloride
426913|NCT01323179|Postoperative pain|postoperative pain
426914|NCT01323179|Postoperative opioid requirements|postoperative opioid requirements
426915|NCT01323166|rectal cancer|rectal cancer
426916|NCT01323140|hypogonadism, testosterone, transdermal system|hypogonadism, testosterone, transdermal system
426917|NCT01323114|type 2 diabetes mellitus|type 2 diabetes mellitus
426918|NCT01323114|non-morbidly obese|non-morbidly obese
426919|NCT01323114|laparoscopic duodenal exclusion|laparoscopic duodenal exclusion
426920|NCT01323088|Childhood obesity|childhood obesity
426921|NCT01323088|Visceral fat|visceral fat
426922|NCT01323088|Insulin resistance|insulin resistance
426924|NCT01323088|Skeletal muscle lipid|skeletal muscle lipid
426925|NCT01323088|Regular exercise|regular exercise
426926|NCT01323062|chemotherapy naive|chemotherapy naive
426927|NCT01323062|stage IV non squamous non small cell lung cancer|stage iv non squamous non small cell lung cancer
426928|NCT01323062|Phase 1b|phase 1b
426929|NCT01323062|Bavituximab|bavituximab
426930|NCT01323062|Chimeric 3G4|chimeric 3g4
426931|NCT01323062|U of North Carolina at Chapel Hill|u of north carolina at chapel hill
426932|NCT01323049|extubation strategy|extubation strategy
426933|NCT01323010|asthma|asthma
426934|NCT01323010|albuterol|albuterol
426935|NCT01323010|metered dose inhalers|metered dose inhalers
426936|NCT01322984|ASD|asd
426937|NCT01322984|Startle|startle
426938|NCT01322971|Bacterial Vaginosis|bacterial vaginosis
426939|NCT01322971|Infertility|infertility
426940|NCT01322971|Miscarriage|miscarriage
426941|NCT01322971|Metronidazole|metronidazole
426942|NCT01322958|bedside ultrasound|bedside ultrasound
426943|NCT01322932|Medication Adherence|medication adherence
426944|NCT01322932|HIV Infection|hiv infection
426945|NCT01322932|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination [Substance Name]|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination [substance name]
426946|NCT01322932|efavirenz|efavirenz
426947|NCT01322932|emtricitabine|emtricitabine
426948|NCT01322932|Patient Satisfaction|patient satisfaction
426949|NCT01322932|tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
426950|NCT01322919|PresbyLASIK|presbylasik
426951|NCT01322919|Presbyopia|presbyopia
426952|NCT01322919|LASIK|lasik
426953|NCT01322919|Supracor|supracor
426954|NCT01322919|refractive|refractive
426955|NCT01322919|Myopia|myopia
426956|NCT01322919|Hyperopia|hyperopia
426957|NCT01322906|ABMLF|abmlf
426958|NCT01322906|Allogenic Bone marrow Mesenchymal Stem Cells|allogenic bone marrow mesenchymal stem cells
426959|NCT01322906|Liver Failure|liver failure
426960|NCT01322906|Transplantation|transplantation
426961|NCT01322893|Metastatic breast cancer|metastatic breast cancer
426962|NCT01322893|Circulating tumour cells|circulating tumour cells
426963|NCT01322893|CTC|ctc
426964|NCT01322893|Prognostic factors|prognostic factors
426965|NCT01322893|Treatment response|treatment response
426966|NCT01322880|domestic violence|domestic violence
426967|NCT01322867|bioequivalence study|bioequivalence study
426968|NCT01322867|alprazolam|alprazolam
426969|NCT01322867|frontal|frontal
426970|NCT01322854|IMRT|imrt
426971|NCT01322854|Integrated boost|integrated boost
426972|NCT01322854|adjuvant radiotherapy|adjuvant radiotherapy
426973|NCT01322854|breast cancer|breast cancer
426974|NCT01322854|breast conserving surgery|breast conserving surgery
426975|NCT01322841|CHICA|chica
426976|NCT01322841|clinical decision support|clinical decision support
426977|NCT01322828|Bicep|bicep
426978|NCT01322828|Tendon|tendon
426979|NCT01322828|Distal|distal
426980|NCT01322828|Ruptures|ruptures
426981|NCT01322828|Randomized|randomized
426982|NCT01322828|Surgery|surgery
426983|NCT01322815|colon cancer|colon cancer
426984|NCT01322815|metastatic|metastatic
426985|NCT01322815|vaccine|vaccine
426986|NCT01322802|Ovarian Cancer|ovarian cancer
426987|NCT01322802|Vaccine|vaccine
426988|NCT01322802|Stage III|stage iii
426989|NCT01322802|Stage IV|stage iv
426990|NCT01322802|Remission|remission
426991|NCT01322789|Diabetes mellitus|diabetes mellitus
426992|NCT01322789|Stem cells|stem cells
426993|NCT01322789|Autologous stem cell transplantation|autologous stem cell transplantation
426994|NCT01322789|Autoimmune diseases|autoimmune diseases
426995|NCT01322776|Mantle Cell Lymphoma|mantle cell lymphoma
426996|NCT01322776|Recurrent|recurrent
426997|NCT01322776|Bortezomib|bortezomib
426998|NCT01322776|Combination Treatment|combination treatment
426999|NCT01322737|resection|resection
427000|NCT01322737|open|open
427001|NCT01322737|laparoscopic|laparoscopic
427002|NCT01322737|benign|benign
427003|NCT01322737|malignant|malignant
427004|NCT01322737|disease|disease
427005|NCT01322737|colon|colon
427006|NCT01322737|gastric|gastric
427007|NCT01322724|colonoscopy|colonoscopy
427008|NCT01322724|colon cancer screening|colon cancer screening
427009|NCT01322724|patient discomfort scores|patient discomfort scores
427010|NCT01322724|sedation medication requirements|sedation medication requirements
427011|NCT01322724|water insertion method|water insertion method
427012|NCT01322711|Thromboxane|thromboxane
427013|NCT01322711|Aspirin|aspirin
427014|NCT01322711|Atorvastatin|atorvastatin
427015|NCT01322711|Platelet activation|platelet activation
427016|NCT01322711|Thrombin Activation|thrombin activation
427017|NCT01322711|Oxidative stress|oxidative stress
427018|NCT01322698|ICU|icu
427019|NCT01322685|Tuberculosis|tuberculosis
427020|NCT01322685|Lung cancer|lung cancer
427021|NCT01322672|Anesthetic Agents|anesthetic agents
427022|NCT01322672|POCD|pocd
427023|NCT01322672|Delirium|delirium
427024|NCT01322672|Cognitive Testing|cognitive testing
427025|NCT01322672|Aging|aging
427026|NCT01322672|Surgery|surgery
427027|NCT01322672|fMRI|fmri
427424|NCT01321008|XRT|xrt
427028|NCT01322672|Diffusion Tensor Imaging|diffusion tensor imaging
427029|NCT01322672|White Matter|white matter
427030|NCT01322659|Mechanical ventilation|mechanical ventilation
427031|NCT01322659|Weaning|weaning
427032|NCT01322659|Noninvasive ventilation|noninvasive ventilation
427033|NCT01322659|Acute respiratory failure|acute respiratory failure
427034|NCT01322659|Helmet|helmet
427035|NCT01322646|ADHD|adhd
427036|NCT01322646|Driving|driving
427037|NCT01322646|Behavior modification|behavior modification
427038|NCT01322633|Pantoprazole|pantoprazole
427039|NCT01322633|proton pump inhibitor|proton pump inhibitor
427040|NCT01322633|gastric cancer|gastric cancer
427041|NCT01322633|digestive system cancer|digestive system cancer
427042|NCT01322633|cancer|cancer
427043|NCT01322607|Exercise|exercise
427044|NCT01322607|Rehabilitation|rehabilitation
427045|NCT01322607|Stroke|stroke
427046|NCT01322594|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
427047|NCT01322594|COPD|copd
427048|NCT01322581|Plasmodium Falciparum|plasmodium falciparum
427049|NCT01322581|Genome-Wide Expression|genome-wide expression
427050|NCT01322581|Antibody Profiling by Protein Microarray|antibody profiling by protein microarray
427051|NCT01322581|Multiplex Cytokine Analysis|multiplex cytokine analysis
427052|NCT01322581|Children and Adults|children and adults
427053|NCT01322581|Malaria|malaria
427054|NCT01322568|Aging|aging
427055|NCT01322568|Gene|gene
427056|NCT01322568|Environment|environment
427057|NCT01322568|Inflammation|inflammation
427058|NCT01322568|Iceland|iceland
427059|NCT01322555|PBR28|pbr28
427060|NCT01322555|Positron Emission Tomography (PET)|positron emission tomography (pet)
427061|NCT01322555|Propofol|propofol
427062|NCT01322555|Autism|autism
427063|NCT01322555|Immune Response|immune response
427064|NCT01322555|Autism Spectrum Disorders|autism spectrum disorders
427065|NCT01322555|ASD|asd
427066|NCT01322555|Healthy Volunteer|healthy volunteer
427067|NCT01322555|HV|hv
427068|NCT01322529|nulliparity|nulliparity
427069|NCT01322529|pregnant women|pregnant women
427070|NCT01322529|pregnancy outcomes|pregnancy outcomes
427071|NCT01322529|pregnancy complications|pregnancy complications
427072|NCT01322490|PROSTVAC|prostvac
427073|NCT01322490|metastatic|metastatic
427074|NCT01322490|prostate cancer|prostate cancer
427075|NCT01322490|castrate-resistant|castrate-resistant
427076|NCT01322490|vaccine|vaccine
427077|NCT01322490|immunotherapy|immunotherapy
427078|NCT01322490|Phase 3|phase 3
427079|NCT01322477|Identification of treatment efficacy in patients with advanced HCC by PET/CT F18-FDG|identification of treatment efficacy in patients with advanced hcc by pet/ct f18-fdg
427080|NCT01322464|Sativex|sativex
427081|NCT01322464|bio-availability|bio-availability
427082|NCT01322464|cannabinoid|cannabinoid
427083|NCT01322464|pharmacokinetics|pharmacokinetics
427084|NCT01322451|Safety|safety
427085|NCT01322451|Tolerability|tolerability
427086|NCT01322451|Pharmacokinetics|pharmacokinetics
427087|NCT01322438|healthy volunteers|healthy volunteers
427088|NCT01322438|rifampin|rifampin
427089|NCT01322438|pharmacokinetics|pharmacokinetics
427090|NCT01322438|single dose|single dose
427091|NCT01322412|Adapted physical activity|adapted physical activity
427092|NCT01322412|breast cancer|breast cancer
427093|NCT01322399|low back pain|low back pain
427094|NCT01322399|chronic pain|chronic pain
427095|NCT01322399|manual therapy|manual therapy
427096|NCT01322399|Structural Integration|structural integration
427098|NCT01322386|BA|ba
427099|NCT01322373|Alzheimer's disease|alzheimer's disease
427100|NCT01322373|magnetoencephalography|magnetoencephalography
427101|NCT01322373|MEG|meg
427102|NCT01322373|SNI|sni
427103|NCT01322347|End Stage Renal Disease|end stage renal disease
427104|NCT01322347|Hemodialysis|hemodialysis
427105|NCT01322347|SFP|sfp
427106|NCT01322347|Hemodialysis-dependent chronic renal failure|hemodialysis-dependent chronic renal failure
427107|NCT01322334|Snoring|snoring
427108|NCT01322334|Sleep apnea|sleep apnea
427109|NCT01322334|Pharyngeal muscle tone|pharyngeal muscle tone
427110|NCT01322321|ACZ885|acz885
427111|NCT01322321|diabetes|diabetes
427112|NCT01322321|type 1|type 1
427113|NCT01322321|C-peptide|c-peptide
427114|NCT01322308|lupus|lupus
427115|NCT01322308|HDL particles|hdl particles
427116|NCT01322308|endothelial function|endothelial function
427117|NCT01322308|pioglitazone|pioglitazone
427118|NCT01322243|Anxiety|anxiety
427119|NCT01322243|Metabolic state|metabolic state
427120|NCT01322243|Stress|stress
427121|NCT01322230|Instructional Design|instructional design
427122|NCT01322230|Online learning module|online learning module
427123|NCT01322230|Surgical education|surgical education
427124|NCT01322217|Medication adherence|medication adherence
427125|NCT01322217|Substance use|substance use
427126|NCT01322217|Sexual risk behaviors|sexual risk behaviors
427127|NCT01322204|codeine, neonates, pediatric pharmacology|codeine, neonates, pediatric pharmacology
427128|NCT01322191|pain, pain management, pediatrics, morphine pharmacokinetics|pain, pain management, pediatrics, morphine pharmacokinetics
427129|NCT01322178|cetuximab|cetuximab
427130|NCT01322178|colorectal carcinoma|colorectal carcinoma
427131|NCT01322165|Marfan syndrome|marfan syndrome
427132|NCT01322165|Turner syndrome|turner syndrome
427133|NCT01322165|Bicuspid aortic valve|bicuspid aortic valve
427134|NCT01322165|Ehlers-Danlos Syndrome|ehlers-danlos syndrome
427135|NCT01322165|Loeys-Dietz syndrome|loeys-dietz syndrome
427136|NCT01322165|Aneurysm|aneurysm
427137|NCT01322165|Genetic|genetic
427138|NCT01322165|aortic|aortic
427139|NCT01322165|thoracic|thoracic
427140|NCT01322165|mutation|mutation
427141|NCT01322165|dissection|dissection
427142|NCT01322152|metastases|metastases
427143|NCT01322152|neoplasm|neoplasm
427144|NCT01322139|Sativex|sativex
427145|NCT01322139|Cannabinoid|cannabinoid
427146|NCT01322139|Electrocardiogram|electrocardiogram
427147|NCT01322139|QT interval|qt interval
427148|NCT01322113|BIPOLAR|bipolar
427149|NCT01322113|MANIA|mania
427150|NCT01322113|DEPRESSION|depression
427151|NCT01322100|Brain Metastases, CNS Metastases|brain metastases, cns metastases
427152|NCT01322087|Nutrition|nutrition
427153|NCT01322087|new energy dense food concept|new energy dense food concept
427154|NCT01322074|Acute postoperative pain|acute postoperative pain
427155|NCT01322074|systemic inflammation|systemic inflammation
427156|NCT01322074|CRP|crp
427157|NCT01322074|IL6|il6
427158|NCT01322061|Gallbladder removal|gallbladder removal
427159|NCT01322061|acute cholecystitis|acute cholecystitis
427160|NCT01322061|Laparoscopic cholecestectomy|laparoscopic cholecestectomy
427161|NCT01322048|Sympathetic Hyperactivity|sympathetic hyperactivity
427162|NCT01322048|Traumatic Brain Injury|traumatic brain injury
427163|NCT01322048|Agitation|agitation
427164|NCT01322048|Severe TBI|severe tbi
427165|NCT01322048|TBI|tbi
427166|NCT01322048|Catecholamines|catecholamines
427167|NCT01322048|Heart rate variability|heart rate variability
427168|NCT01322048|Adrenergic alpha-Agonists|adrenergic alpha-agonists
427169|NCT01322048|Adrenergic beta-Antagonists|adrenergic beta-antagonists
427170|NCT01322048|Cognitive Impairment|cognitive impairment
427171|NCT01322022|Autism|autism
427172|NCT01322022|Autism Spectrum Disorders|autism spectrum disorders
427173|NCT01322022|Sleep Problems|sleep problems
427174|NCT01322022|Sleep Disturbances|sleep disturbances
427175|NCT01322022|Interventions|interventions
427176|NCT01322009|Children|children
427177|NCT01322009|Brain injury|brain injury
427178|NCT01322009|Trauma|trauma
427179|NCT01321996|PET/CT|pet/ct
427180|NCT01321996|68Ga-DOTANOC|68ga-dotanoc
427181|NCT01321996|IPF|ipf
427182|NCT01321996|NSIP|nsip
427183|NCT01321996|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
427184|NCT01321931|Smoking Cessation|smoking cessation
427185|NCT01321931|Nicotine pharmacokinetics|nicotine pharmacokinetics
427186|NCT01321892|HRME|hrme
427187|NCT01321892|High-resolution microendoscope|high-resolution microendoscope
427188|NCT01321892|Optical imaging technology|optical imaging technology
427189|NCT01321892|Non-invasive fluorescence and reflectance imaging|non-invasive fluorescence and reflectance imaging
427190|NCT01321892|Upper aerodigestive tract|upper aerodigestive tract
427191|NCT01321892|Cancer surgery|cancer surgery
427192|NCT01321892|Squamous cell carcinoma|squamous cell carcinoma
427193|NCT01321892|Oral cavity|oral cavity
427194|NCT01321892|Oropharynx|oropharynx
427195|NCT01321892|Larynx|larynx
427196|NCT01321892|Hypopharynx|hypopharynx
427197|NCT01321892|Squamous cell carcinoma of the oral cavity, oropharynx, larynx, and/or hypopharynx|squamous cell carcinoma of the oral cavity, oropharynx, larynx, and/or hypopharynx
427198|NCT01321879|Gram Positive Bloodstream Infections|gram positive bloodstream infections
427199|NCT01321879|Sepsis|sepsis
427200|NCT01321879|Staphylococcus aureus|staphylococcus aureus
427201|NCT01321879|Enterococci|enterococci
427202|NCT01321879|Streptococci|streptococci
427203|NCT01321879|Pneumococci|pneumococci
427204|NCT01321879|Corynebacterium|corynebacterium
427205|NCT01321879|Propionibacterium or Bacillus species|propionibacterium or bacillus species
427206|NCT01321879|Telavancin|telavancin
427207|NCT01321879|Vibativ|vibativ
427208|NCT01321866|Angioplasty|angioplasty
427209|NCT01321866|cutting balloon|cutting balloon
427210|NCT01321853|Home health care|home health care
427211|NCT01321853|Medication Management|medication management
427212|NCT01321853|Cognitive impairment|cognitive impairment
427213|NCT01321853|Medication adherence|medication adherence
427214|NCT01321853|Older adults|older adults
427215|NCT01321853|Care Coordination management|care coordination management
427216|NCT01321840|Endometriosis|endometriosis
427217|NCT01321840|pain|pain
427218|NCT01321840|sart|sart
427219|NCT01321840|autonomic nervous system|autonomic nervous system
427220|NCT01321840|fMRI|fmri
427221|NCT01321840|perfusion|perfusion
427222|NCT01321840|connectivity|connectivity
427223|NCT01321840|hypnotherapy|hypnotherapy
427224|NCT01321840|traditional Chinese medicine|traditional chinese medicine
427225|NCT01321827|ABPA|abpa
427226|NCT01321814|Hyperacusis|hyperacusis
427227|NCT01321814|Personality|personality
427228|NCT01321814|Comorbidity|comorbidity
427229|NCT01321814|Treatment|treatment
427230|NCT01321814|Cognitive behavioral therapy|cognitive behavioral therapy
427231|NCT01321801|Pregabalin|pregabalin
427232|NCT01321801|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
427233|NCT01321801|Postoperative pain|postoperative pain
427234|NCT01321801|Opioid consumption|opioid consumption
427235|NCT01321788|thromboprophylaxis|thromboprophylaxis
427236|NCT01321788|pregnancy|pregnancy
427237|NCT01321788|post-cesarian section|post-cesarian section
427238|NCT01321762|Prolapse|prolapse
427239|NCT01321762|Childbirth|childbirth
427240|NCT01321762|Pregnancy|pregnancy
427241|NCT01321749|ischemic cerebral vascular disease|ischemic cerebral vascular disease
427242|NCT01321749|stroke secondary prevention|stroke secondary prevention
427243|NCT01321749|remote ischemic preconditioning|remote ischemic preconditioning
427244|NCT01321736|dietary fiber|dietary fiber
427245|NCT01321736|enteral nutrition|enteral nutrition
427246|NCT01321736|laxation|laxation
427247|NCT01321723|Osteoporosis|osteoporosis
427248|NCT01321723|Bone Diseases, Metabolic|bone diseases, metabolic
427249|NCT01321723|Bone Diseases|bone diseases
427250|NCT01321723|Bone Density Conservation Agents|bone density conservation agents
427251|NCT01321710|sleep hygiene|sleep hygiene
427252|NCT01321710|actigraphy|actigraphy
427253|NCT01321710|maternal|maternal
427254|NCT01321710|infant|infant
427255|NCT01321710|postpartum period|postpartum period
427256|NCT01321710|immunization|immunization
427257|NCT01321710|acetaminophen|acetaminophen
427258|NCT01321697|Being seen in the Winthrop P. Rockefeller Cancer Institute for vulvar|being seen in the winthrop p. rockefeller cancer institute for vulvar
427259|NCT01321697|cancer requiring lymph node evaluation for the ipsilateral or contralateral|cancer requiring lymph node evaluation for the ipsilateral or contralateral
427260|NCT01321697|groin|groin
427261|NCT01321671|pregabalin|pregabalin
427262|NCT01321671|pharmacokinetics|pharmacokinetics
427263|NCT01321671|bioavailability|bioavailability
427264|NCT01321671|bioequivalence|bioequivalence
427265|NCT01321658|Geriatric Assessment|geriatric assessment
427266|NCT01321658|Perioperative Care|perioperative care
427267|NCT01321658|Colorectal Neoplasms|colorectal neoplasms
427268|NCT01321658|Frail Elderly|frail elderly
427269|NCT01321645|Acne Vulgaris|acne vulgaris
427270|NCT01321645|Homoeopathy|homoeopathy
427271|NCT01321645|Homeopathy|homeopathy
427272|NCT01321645|Azadirachta Indica|azadirachta indica
427273|NCT01321632|Acne Vulgaris|acne vulgaris
427274|NCT01321632|Homoeopathy|homoeopathy
427275|NCT01321632|Zingiber officinalis|zingiber officinalis
427276|NCT01321619|Chronic venous insufficiency|chronic venous insufficiency
427277|NCT01321619|Hemorrhoidal syndrome|hemorrhoidal syndrome
427278|NCT01321619|Varicell|varicell
427279|NCT01321606|infection|infection
427280|NCT01321606|probiotics|probiotics
427281|NCT01321567|rabeprazole sodium|rabeprazole sodium
427282|NCT01321567|refractory reflux esophagitis|refractory reflux esophagitis
427283|NCT01321541|non-hodgkin lymphoma|non-hodgkin lymphoma
427284|NCT01321541|DLBCL|dlbcl
427285|NCT01321541|relapsed|relapsed
427286|NCT01321541|aggressive NHL|aggressive nhl
427287|NCT01321541|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
427288|NCT01321541|Rituximab|rituximab
427289|NCT01321541|Rituxan|rituxan
427290|NCT01321541|Pixantrone|pixantrone
427291|NCT01321541|NHL|nhl
427292|NCT01321541|non hodgkin's lymphoma|non hodgkin's lymphoma
427293|NCT01321541|de novo DLBCL|de novo dlbcl
427294|NCT01321541|DLBCL transformed from Indolent Lymphoma|dlbcl transformed from indolent lymphoma
427295|NCT01321541|Follicular Grade 3 Lymphoma|follicular grade 3 lymphoma
427296|NCT01321502|treatment of herpes|treatment of herpes
427297|NCT01321489|Phase III|phase iii
427298|NCT01321489|Sildenafil Citrate Tablet Sublingual|sildenafil citrate tablet sublingual
427299|NCT01321489|Erectile dysfunction|erectile dysfunction
427300|NCT01321437|Melanoma|melanoma
427301|NCT01321437|Axitinib|axitinib
427302|NCT01321437|Anti-angiogenesis|anti-angiogenesis
427303|NCT01321437|Neoadjuvant Melanoma|neoadjuvant melanoma
427304|NCT01321424|Dry Eye|dry eye
427305|NCT01321424|Tear Osmolarity|tear osmolarity
427306|NCT01321424|Meibomain Gland Disease|meibomain gland disease
427307|NCT01321424|Aqueous Dificiency|aqueous dificiency
427308|NCT01321424|Tear film abnormality|tear film abnormality
427309|NCT01321411|Respiratory Muscle Blood Flow|respiratory muscle blood flow
427310|NCT01321411|Work of Breathing|work of breathing
427311|NCT01321411|Near Infrared Spectroscopy|near infrared spectroscopy
427312|NCT01321398|High Frequency Oscillation|high frequency oscillation
427313|NCT01321398|Oscillation|oscillation
427314|NCT01321398|HFO|hfo
427315|NCT01321398|Transpulmonary pressure|transpulmonary pressure
427316|NCT01321385|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
427317|NCT01321385|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
427318|NCT01321385|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
427319|NCT01321385|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
427320|NCT01321385|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
427321|NCT01321385|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
427322|NCT01321385|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
427323|NCT01321385|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
427324|NCT01321385|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
427325|NCT01321385|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
427326|NCT01321385|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
427327|NCT01321346|Relapse|relapse
427328|NCT01321346|Lymphoblastic|lymphoblastic
427329|NCT01321346|Leukemia|leukemia
427330|NCT01321346|Panobinostat|panobinostat
427331|NCT01321346|LBH589|lbh589
427332|NCT01321346|Refractory|refractory
427333|NCT01321346|Hodgkin's|hodgkin's
427334|NCT01321346|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
427335|NCT01321346|Lymphoma|lymphoma
427336|NCT01321346|Myelogenous|myelogenous
427337|NCT01321346|Acute|acute
427338|NCT01321346|Childhood|childhood
427339|NCT01321346|Pediatric|pediatric
427340|NCT01321346|ALL|all
427341|NCT01321346|AML|aml
427342|NCT01321346|NHL|nhl
427343|NCT01321346|HD|hd
427344|NCT01321333|thoracic spinal cord injury|thoracic spinal cord injury
427345|NCT01321333|spinal cord injury thoracic|spinal cord injury thoracic
427346|NCT01321333|sub-acute spinal cord injury|sub-acute spinal cord injury
427347|NCT01321333|human neural stem cells|human neural stem cells
427348|NCT01321333|stem cells|stem cells
427349|NCT01321333|stem cells transplant|stem cells transplant
427350|NCT01321333|stem cells transplant spinal cord injury|stem cells transplant spinal cord injury
427351|NCT01321320|ICUAP|icuap
427352|NCT01321320|Critical illness|critical illness
427353|NCT01321320|Muscle wasting|muscle wasting
427354|NCT01321320|ICU|icu
427355|NCT01321307|Aphtostomatitis|aphtostomatitis
427356|NCT01321307|Mucositis|mucositis
427357|NCT01321307|Mouth sores|mouth sores
427358|NCT01321307|Natural|natural
427359|NCT01321307|Herbal|herbal
427360|NCT01321281|Osteoarthritis|osteoarthritis
427361|NCT01321268|orange peel skin|orange peel skin
427362|NCT01321268|cellulite|cellulite
427363|NCT01321255|Myocardial Infarction|myocardial infarction
427364|NCT01321255|Treatment Adherence|treatment adherence
427365|NCT01321242|Resting heart rate|resting heart rate
427366|NCT01321242|Stable Angina|stable angina
427367|NCT01321242|Hypertension|hypertension
427368|NCT01321242|beta-blockers|beta-blockers
427369|NCT01321229|Sleep apnea|sleep apnea
427370|NCT01321229|NIHSS scale|nihss scale
427371|NCT01321229|FIM scale|fim scale
427372|NCT01321229|FUGL-MEYER scale|fugl-meyer scale
427373|NCT01321216|rotavirus|rotavirus
427374|NCT01321216|gastroenteritis|gastroenteritis
427375|NCT01321216|children|children
427376|NCT01321216|Pediatric|pediatric
427377|NCT01321216|dehydration|dehydration
427378|NCT01321216|vaccine|vaccine
427379|NCT01321203|carbon dioxide insufflation|carbon dioxide insufflation
427380|NCT01321177|Schizophrenia|schizophrenia
427381|NCT01321177|Schizoaffective Disorder|schizoaffective disorder
427382|NCT01321177|Schizophreniform Disorder|schizophreniform disorder
427383|NCT01321177|Brief Psychotic Disorder|brief psychotic disorder
427384|NCT01321177|Psychotic Disorder NOS|psychotic disorder nos
427385|NCT01321177|First Episode|first episode
427386|NCT01321151|Mild Brain Injury|mild brain injury
427387|NCT01321151|Concussions|concussions
427388|NCT01321151|Resveratrol|resveratrol
427389|NCT01321151|Boxers|boxers
427390|NCT01321151|ImPACT|impact
427391|NCT01321151|MRI|mri
427392|NCT01321138|Electrophysiological study|electrophysiological study
427393|NCT01321138|Nerve block|nerve block
427394|NCT01321138|Analgesia, Patient-Controlled|analgesia, patient-controlled
427395|NCT01321138|Anterior cruciate ligament|anterior cruciate ligament
427396|NCT01321125|Antiseptics|antiseptics
427397|NCT01321125|Administration cutaneously|administration cutaneously
427398|NCT01321125|Chlorine compounds|chlorine compounds
427399|NCT01321125|Anti-infecting agents, local|anti-infecting agents, local
427400|NCT01321112|Conversion|conversion
427401|NCT01321112|Mycophenolate mofetil|mycophenolate mofetil
427402|NCT01321112|Calcineurin inhibitors|calcineurin inhibitors
427403|NCT01321112|Liver transplantation|liver transplantation
427404|NCT01321112|Gene expression|gene expression
427405|NCT01321099|Iron absorption|iron absorption
427406|NCT01321099|Complementary food fortificant|complementary food fortificant
427407|NCT01321099|Young children|young children
427408|NCT01321086|PAD|pad
427409|NCT01321060|severe acute pancreatitis|severe acute pancreatitis
427410|NCT01321060|acute fluid collection|acute fluid collection
427411|NCT01321060|catheter drainage|catheter drainage
427412|NCT01321060|repeated aspiration|repeated aspiration
427413|NCT01321047|sedation|sedation
427414|NCT01321047|benzodiazepine|benzodiazepine
427415|NCT01321047|opioid|opioid
427416|NCT01321047|propofol|propofol
427417|NCT01321034|Lipoprotein (a)|lipoprotein (a)
427418|NCT01321034|LPA|lpa
427419|NCT01321034|Niacin|niacin
427420|NCT01321034|Kringle IV-2 repeats|kringle iv-2 repeats
427421|NCT01321008|NK cell lymphoma-nasal type|nk cell lymphoma-nasal type
427422|NCT01321008|Stage I/II|stage i/ii
427423|NCT01321008|Radiation therapy|radiation therapy
427425|NCT01321008|chemotherapy|chemotherapy
427426|NCT01321008|CHOP|chop
427427|NCT01321008|Cyclophosphamide|cyclophosphamide
427428|NCT01321008|Cytoxan|cytoxan
427429|NCT01321008|Neosar|neosar
427430|NCT01321008|Adriamycin|adriamycin
427431|NCT01321008|Doxorubicin|doxorubicin
427432|NCT01321008|Rubex|rubex
427433|NCT01321008|Vincristine|vincristine
427434|NCT01321008|Oncovin|oncovin
427435|NCT01321008|Prednisone|prednisone
427436|NCT01320995|Second degree vaginal tear|second degree vaginal tear
427437|NCT01320995|Perineal ultrasound|perineal ultrasound
427438|NCT01320995|Anal incontinence|anal incontinence
427439|NCT01320982|Schizophrenia|schizophrenia
427440|NCT01320982|schizoaffective disorder|schizoaffective disorder
427441|NCT01320969|mindfulness, fear conditioning|mindfulness, fear conditioning
427442|NCT01320956|hypnosis|hypnosis
427443|NCT01320956|HYPNOANALGESIA|hypnoanalgesia
427444|NCT01320956|surgery|surgery
427445|NCT01320956|children|children
427446|NCT01320956|anxiety|anxiety
427447|NCT01320956|morphine|morphine
427448|NCT01320956|pain|pain
427449|NCT01320956|A-VAS|a-vas
427450|NCT01320956|orthopaedics|orthopaedics
427451|NCT01320956|osteotomy|osteotomy
427452|NCT01320956|tenotomy|tenotomy
427453|NCT01320956|arthrodesis|arthrodesis
427454|NCT01320956|spinal column surgery|spinal column surgery
427455|NCT01320943|stopping oral antiviral therapy|stopping oral antiviral therapy
427456|NCT01320943|HBsAg loss|hbsag loss
427457|NCT01320943|seroconversion|seroconversion
427458|NCT01320943|restarting oral antiviral therapy|restarting oral antiviral therapy
427459|NCT01320930|Effect of Pulmonary rehabilitation.|effect of pulmonary rehabilitation.
427460|NCT01320930|Exercise capacity|exercise capacity
427461|NCT01320930|Quality of life|quality of life
427462|NCT01320917|obesity|obesity
427463|NCT01320917|contraceptives hormonal|contraceptives hormonal
427464|NCT01320917|levonorgestrel-releasing intrauterine device|levonorgestrel-releasing intrauterine device
427465|NCT01320917|cardiovascular risk|cardiovascular risk
427466|NCT01320904|Closed Kinetic Chain|closed kinetic chain
427467|NCT01320904|NMES|nmes
427468|NCT01320904|Knee Osteoarthritis|knee osteoarthritis
427469|NCT01320891|general anaesthesia for major abdominal surgery|general anaesthesia for major abdominal surgery
427470|NCT01320878|pulmonary hypertension|pulmonary hypertension
427471|NCT01320852|Transplant|transplant
427472|NCT01320826|colonoscopy|colonoscopy
427473|NCT01320826|primary care physicians|primary care physicians
427474|NCT01320826|quality assurance|quality assurance
427475|NCT01320813|da vinci robot|da vinci robot
427476|NCT01320813|Thyroidectomy|thyroidectomy
427477|NCT01320787|Brain|brain
427478|NCT01320787|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
427479|NCT01320787|Locally advanced breast cancer|locally advanced breast cancer
427480|NCT01320787|Estrogen receptor|estrogen receptor
427481|NCT01320787|ER|er
427482|NCT01320787|Progesterone receptor|progesterone receptor
427483|NCT01320787|PR|pr
427484|NCT01320787|Negative for ErbB2|negative for erbb2
427485|NCT01320787|Malignant tumor of the central nervous system|malignant tumor of the central nervous system
427486|NCT01320787|CNS|cns
427487|NCT01320761|Formulation Comparison|formulation comparison
427488|NCT01320748|Abstinence from alcohol|abstinence from alcohol
427489|NCT01320748|Substance Abuse and Mental Health Services|substance abuse and mental health services
427490|NCT01320748|Social Support|social support
427491|NCT01320748|Psychosocial Support Systems|psychosocial support systems
427492|NCT01320748|Psychological support|psychological support
427493|NCT01320748|Cognitive Support|cognitive support
427494|NCT01320748|Emotional Support|emotional support
427495|NCT01320748|Mental Support|mental support
427496|NCT01320748|Psychosocial Support|psychosocial support
427497|NCT01320748|Intervention Studies|intervention studies
427498|NCT01320748|Prevention & control|prevention & control
427499|NCT01320748|Preventive therapy|preventive therapy
427500|NCT01320748|Treatment|treatment
427501|NCT01320748|Therapy|therapy
427502|NCT01320748|Magnetic Resonance Imaging|magnetic resonance imaging
427503|NCT01320748|fMRI|fmri
427504|NCT01320748|Imaging|imaging
427505|NCT01320748|Magnetic Resonance Imaging, Functional|magnetic resonance imaging, functional
427506|NCT01320748|MRI Scans|mri scans
427507|NCT01320748|MRI, Functional|mri, functional
427508|NCT01320748|Clinical Protocols|clinical protocols
427509|NCT01320748|Protocols, Treatment|protocols, treatment
427510|NCT01320748|Drug Abuse Treatment Center|drug abuse treatment center
427511|NCT01320748|Substance Abuse Treatment Center|substance abuse treatment center
427512|NCT01320735|Lucrin Depot|lucrin depot
427513|NCT01320735|intermittent adjuvant regimen|intermittent adjuvant regimen
427514|NCT01320735|advanced prostate cancer|advanced prostate cancer
427515|NCT01320735|Leuprorelin|leuprorelin
427516|NCT01320722|renin angiotensin system|renin angiotensin system
427517|NCT01320722|vitamin D|vitamin d
427518|NCT01320722|uric acid|uric acid
427519|NCT01320722|allopurinol|allopurinol
427520|NCT01320722|probenecid|probenecid
427521|NCT01320722|endothelial function|endothelial function
427522|NCT01320709|Emergency contraception|emergency contraception
427523|NCT01320709|Contraception|contraception
427524|NCT01320670|pharmacoresistance|pharmacoresistance
427525|NCT01320657|Self-ligating|self-ligating
427526|NCT01320657|orthodontic|orthodontic
427527|NCT01320657|appliance|appliance
427528|NCT01320657|expansion|expansion
427529|NCT01320657|dental inclination|dental inclination
427530|NCT01320657|Expansion and inclination changes arising with orthodontic treatment|expansion and inclination changes arising with orthodontic treatment
427531|NCT01320644|Uterine prolapse|uterine prolapse
427532|NCT01320644|vaginal prolapse|vaginal prolapse
427533|NCT01320644|mesh erosion|mesh erosion
427534|NCT01320644|urinary incontinence|urinary incontinence
427535|NCT01320644|bowel symptoms|bowel symptoms
427536|NCT01320631|uterine prolapse|uterine prolapse
427537|NCT01320631|vaginal prolapse|vaginal prolapse
427538|NCT01320618|uterine prolapse|uterine prolapse
427539|NCT01320618|vaginal prolapse|vaginal prolapse
427540|NCT01320618|mesh erosion|mesh erosion
427541|NCT01320618|urinary incontinence|urinary incontinence
427542|NCT01320618|bowel symptoms|bowel symptoms
427543|NCT01320592|Patient must have histologically or cytologically-confirmed metastatic|patient must have histologically or cytologically-confirmed metastatic
427544|NCT01320592|breast cancer|breast cancer
427545|NCT01320592|Any ER, PR or Her2 status is allowed.|any er, pr or her2 status is allowed.
427546|NCT01320592|Tumor must express Retinoblastoma (Rb) protein, defined as|tumor must express retinoblastoma (rb) protein, defined as
427547|NCT01320592|any measurable staining by immunohistochemistry on the invasive tumor component|any measurable staining by immunohistochemistry on the invasive tumor component
427548|NCT01320592|<3 prior cyttoxic chemotherapy regimens for metastatic disease.|<3 prior cyttoxic chemotherapy regimens for metastatic disease.
427549|NCT01320592|Performance status of 0-1 on the ECOG Performance Scale and life expectancy > 3 months.|performance status of 0-1 on the ecog performance scale and life expectancy > 3 months.
427550|NCT01320592|Patient must have evaluable disease. Measureable disease is not required.|patient must have evaluable disease. measureable disease is not required.
427551|NCT01320592|The subject has adequate organ function|the subject has adequate organ function
427552|NCT01320579|atopic dermatitis|atopic dermatitis
427553|NCT01320579|cis-urocanic acid|cis-urocanic acid
427554|NCT01320566|Polymeric Lung Volume Reduction (PLVR)|polymeric lung volume reduction (plvr)
427555|NCT01320566|Bolilogic Lung Volume Reduction (BLVR)|bolilogic lung volume reduction (blvr)
427556|NCT01320566|AeriSeal|aeriseal
427557|NCT01320566|treatment|treatment
427558|NCT01320566|device|device
427559|NCT01320566|breathing|breathing
427560|NCT01320566|COPD|copd
427561|NCT01320566|emphysema|emphysema
427562|NCT01320566|heterogeneous|heterogeneous
427563|NCT01320566|homogeneous|homogeneous
427564|NCT01320566|Pathologic Processes|pathologic processes
427565|NCT01320566|Respiratory Tract Diseases|respiratory tract diseases
427566|NCT01320566|Lung Diseases|lung diseases
427567|NCT01320566|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
427568|NCT01320527|dietary supplement|dietary supplement
427569|NCT01320527|cognition|cognition
427570|NCT01320527|mood|mood
427571|NCT01320527|Alzheimer's disease|alzheimer's disease
427572|NCT01320527|memory loss|memory loss
427573|NCT01320501|Lung Cancer|lung cancer
427574|NCT01320488|Breast Cancer|breast cancer
427575|NCT01320475|thoracic epidural analgesia|thoracic epidural analgesia
427576|NCT01320475|epidural opioid|epidural opioid
427577|NCT01320475|ketamine|ketamine
427578|NCT01320475|adverse effect|adverse effect
427579|NCT01320462|Smoking|smoking
427580|NCT01320462|quit|quit
427581|NCT01320462|surgery|surgery
427582|NCT01320462|anesthesia|anesthesia
427583|NCT01320462|champix|champix
427584|NCT01320449|EPO|epo
427585|NCT01320449|Proteomics|proteomics
427586|NCT01320449|Carbohydrate metabolism|carbohydrate metabolism
427587|NCT01320449|Fat metabolism|fat metabolism
427588|NCT01320449|Protein metabolism|protein metabolism
427589|NCT01320436|Ulcerative colitis|ulcerative colitis
427590|NCT01320436|Curcumin|curcumin
427591|NCT01320423|Intracerebral Haemorrhage|intracerebral haemorrhage
427592|NCT01320384|ALI|ali
427593|NCT01320371|barbed sutures|barbed sutures
427594|NCT01320371|knotted sutures|knotted sutures
427595|NCT01320371|total knee arthroplasty|total knee arthroplasty
427596|NCT01320371|knee surgery|knee surgery
427597|NCT01320358|Patient compliance|patient compliance
427598|NCT01320358|ECMPS-IEM|ecmps-iem
427599|NCT01320358|transplantation|transplantation
427600|NCT01320358|renal maintenance|renal maintenance
427601|NCT01320358|Proteus|proteus
427602|NCT01320345|Diabetes Mellitus|diabetes mellitus
427603|NCT01320345|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
427604|NCT01320345|Retinopathy|retinopathy
427605|NCT01320345|Diabetic Nephropathy|diabetic nephropathy
427606|NCT01320345|Fenofibrate|fenofibrate
427607|NCT01320332|Ulcerative colitis|ulcerative colitis
427608|NCT01320332|ASP3291|asp3291
427609|NCT01320293|Moderate to Severe Chronic plaque type psoriasis|moderate to severe chronic plaque type psoriasis
427610|NCT01320280|Prostate cancer, BIBW 2992 (Afatinib) , HER inhibitor|prostate cancer, bibw 2992 (afatinib) , her inhibitor
427611|NCT01320267|Resectable right colon cancer|resectable right colon cancer
427612|NCT01320254|Palliative treatment|palliative treatment
427613|NCT01320254|Panitumumab|panitumumab
427614|NCT01320254|Cisplatin|cisplatin
427615|NCT01320254|Cisplatinum|cisplatinum
427616|NCT01320254|Gemcitabine|gemcitabine
427617|NCT01320254|Vectibix|vectibix
427618|NCT01320228|Obesity|obesity
427619|NCT01320228|orlistat|orlistat
427620|NCT01320228|fat excretion|fat excretion
427621|NCT01320228|fiber|fiber
427622|NCT01320228|dairy calcium|dairy calcium
427623|NCT01320215|da Vinci Robot|da vinci robot
427624|NCT01320215|uterine prolapse|uterine prolapse
427625|NCT01320215|vaginal prolapse|vaginal prolapse
427626|NCT01320215|sacrohysteropexy|sacrohysteropexy
427627|NCT01320202|End Stage Renal Disease|end stage renal disease
427628|NCT01320202|Hemodialysis|hemodialysis
427629|NCT01320202|SFP|sfp
427630|NCT01320202|Hemodialysis-dependent chronic renal failure|hemodialysis-dependent chronic renal failure
427631|NCT01320189|Energy intake|energy intake
427632|NCT01320189|Protein requirement|protein requirement
427633|NCT01320189|Satiety|satiety
427634|NCT01320189|Protein leverage hypothesis|protein leverage hypothesis
427635|NCT01320150|persistent postsurgical pain (PPP)|persistent postsurgical pain (ppp)
427636|NCT01320137|Immunological assay|immunological assay
427637|NCT01320137|Birch allergy|birch allergy
427638|NCT01320124|Contractures|contractures
427639|NCT01320124|Total knee arthroplasty|total knee arthroplasty
427640|NCT01320124|Tissue bank|tissue bank
427641|NCT01320124|Osteoarthritis|osteoarthritis
427642|NCT01320124|Gene expressions|gene expressions
427643|NCT01320111|progression free survival|progression free survival
427644|NCT01320111|paclitaxel|paclitaxel
427645|NCT01320111|sorafenib|sorafenib
427646|NCT01320111|metastatic breast cancer|metastatic breast cancer
427647|NCT01320098|Attention|attention
427648|NCT01320098|Behavior Problems|behavior problems
427649|NCT01320098|Compliance|compliance
427650|NCT01320098|Evaluation|evaluation
427651|NCT01320098|Preschool|preschool
427652|NCT01320098|ADHD|adhd
427653|NCT01320098|Overactive|overactive
427654|NCT01320098|Inattentive|inattentive
427655|NCT01320098|Attention Deficit Hyperactivity Disorder in Preschoolers|attention deficit hyperactivity disorder in preschoolers
427656|NCT01320085|Metastatic melanoma,|metastatic melanoma,
427657|NCT01320085|BRAF-mutant,|braf-mutant,
427658|NCT01320085|NRAS-mutant|nras-mutant
427659|NCT01320072|aspirin|aspirin
427660|NCT01320072|asthma|asthma
427661|NCT01320072|diagnosis|diagnosis
427662|NCT01320072|prostaglandins|prostaglandins
427663|NCT01320072|leukotrienes|leukotrienes
427664|NCT01320059|18F-Fluoro-PEG6-IPQA|18f-fluoro-peg6-ipqa
427665|NCT01320059|Radioactive Imaging Solution|radioactive imaging solution
427666|NCT01320059|Non-Small Cell Lung Cancer|non-small cell lung cancer
427667|NCT01320059|Positron Emission Tomography|positron emission tomography
427668|NCT01320059|PET Scan|pet scan
427669|NCT01320059|CT|ct
427670|NCT01320059|Computed Tomography|computed tomography
427671|NCT01320046|Urinary Incontinence|urinary incontinence
427672|NCT01320046|Vulvar pruritus|vulvar pruritus
427673|NCT01320046|Vulvar contact dermatitis|vulvar contact dermatitis
427674|NCT01320033|acne vulgaris|acne vulgaris
427675|NCT01320033|inflammatory lesions|inflammatory lesions
427676|NCT01320020|Cancer|cancer
427677|NCT01320020|Neoplasm|neoplasm
427678|NCT01320020|Carcinoma|carcinoma
427679|NCT01320020|intravenous|intravenous
427680|NCT01320020|Monoclonal Antibody|monoclonal antibody
427681|NCT01320020|Removab|removab
427682|NCT01319994|glucocorticoid|glucocorticoid
427683|NCT01319981|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
427684|NCT01319981|ALL|all
427685|NCT01319981|Lymphoblastic lymphoma|lymphoblastic lymphoma
427686|NCT01319981|Cytoxan|cytoxan
427687|NCT01319981|Neosar|neosar
427688|NCT01319981|Mesnex|mesnex
427689|NCT01319981|Liposomal Vincristine|liposomal vincristine
427690|NCT01319981|Vincristine Sulfate Liposomes Injection|vincristine sulfate liposomes injection
427691|NCT01319981|Marqibo|marqibo
427692|NCT01319981|Dexamethasone|dexamethasone
427693|NCT01319981|Adriamycin|adriamycin
427694|NCT01319981|Rubex|rubex
427695|NCT01319981|Cytarabine|cytarabine
427696|NCT01319981|Cytosar|cytosar
427697|NCT01319981|DepoCyt|depocyt
427698|NCT01319981|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
427699|NCT01319981|Imatinib Mesylate|imatinib mesylate
427700|NCT01319981|Gleevec|gleevec
427701|NCT01319981|ST1571|st1571
427702|NCT01319981|NSC-716051|nsc-716051
427703|NCT01319981|Filgrastim|filgrastim
427704|NCT01319981|Neupogen|neupogen
427705|NCT01319968|Postpartum dyspareunia|postpartum dyspareunia
427706|NCT01319968|Vaginal atrophy|vaginal atrophy
427707|NCT01319955|Pneumonia|pneumonia
427708|NCT01319955|Influenza|influenza
427709|NCT01319955|Child|child
427710|NCT01319955|Respiratory|respiratory
427711|NCT01319955|Pathogen|pathogen
427712|NCT01319942|Radiotherapy|radiotherapy
427713|NCT01319942|Sorafenib|sorafenib
427714|NCT01319942|Treatment outcome|treatment outcome
427715|NCT01319929|Osteoarthritis, knee pain, osteoarthritic knee pain|osteoarthritis, knee pain, osteoarthritic knee pain
427716|NCT01319903|sepsis|sepsis
427717|NCT01319903|inflammation|inflammation
427718|NCT01319903|complement|complement
427719|NCT01319903|immune system|immune system
427720|NCT01319890|all histologic subtypes|all histologic subtypes
427721|NCT01319890|benign|benign
427722|NCT01319890|malignant|malignant
427723|NCT01319864|leukemia|leukemia
427724|NCT01319851|bone marrow transplant|bone marrow transplant
427725|NCT01319851|sickle cell disease|sickle cell disease
427726|NCT01319851|thalassemia|thalassemia
427727|NCT01319851|Glanzmann thrombasthenia|glanzmann thrombasthenia
427728|NCT01319851|Wiskott-Aldrich syndrome|wiskott-aldrich syndrome
427729|NCT01319851|chronic-granulomatous disease|chronic-granulomatous disease
427730|NCT01319851|severe congenital neutropenia|severe congenital neutropenia
427731|NCT01319851|leukocyte adhesion deficiency|leukocyte adhesion deficiency
427732|NCT01319851|Schwachman-Diamond syndrome|schwachman-diamond syndrome
427733|NCT01319851|Diamond-Blackfan anemia|diamond-blackfan anemia
427734|NCT01319851|Fanconi anemia|fanconi anemia
427735|NCT01319851|dyskeratosis-congenita|dyskeratosis-congenita
427736|NCT01319851|Chediak-Higashi syndrome|chediak-higashi syndrome
427737|NCT01319851|severe aplastic anemia|severe aplastic anemia
427738|NCT01319838|neuroblastoma|neuroblastoma
427739|NCT01319838|isotretinoin|isotretinoin
427740|NCT01319812|Vascular intervention|vascular intervention
427741|NCT01319812|Endovascular|endovascular
427742|NCT01319812|Peripheral stent|peripheral stent
427743|NCT01319799|Embolism|embolism
427744|NCT01319799|Nervous system|nervous system
427745|NCT01319799|Aorta|aorta
427746|NCT01319799|Valves|valves
427747|NCT01319799|Ultrasonics|ultrasonics
427748|NCT01319786|Hypertension|hypertension
427749|NCT01319786|Microvascular function|microvascular function
427750|NCT01319760|STEMI|stemi
427751|NCT01319747|atrial|atrial
427752|NCT01319747|fibrillation|fibrillation
427753|NCT01319747|pvi|pvi
427754|NCT01319747|vats|vats
427755|NCT01319747|ablation|ablation
427756|NCT01319734|Vitamin C|vitamin c
427757|NCT01319734|Oxidative stress|oxidative stress
427758|NCT01319734|Type 2DM|type 2dm
427759|NCT01319721|Amniotic membrane|amniotic membrane
427760|NCT01319721|Limbal conjunctival autograft|limbal conjunctival autograft
427761|NCT01319721|Limbal|limbal
427762|NCT01319721|Conjunctival|conjunctival
427763|NCT01319721|Mitomycin C|mitomycin c
427764|NCT01319721|Recurrent pterygium|recurrent pterygium
427765|NCT01319721|Pterygium|pterygium
427766|NCT01319708|ovarian stimulation|ovarian stimulation
427767|NCT01319708|climiphene citrate|climiphene citrate
427768|NCT01319708|Gonadotropin-Releasing Hormone agonists/antagonists|gonadotropin-releasing hormone agonists/antagonists
427769|NCT01319708|Follicle Stimulating Hormone|follicle stimulating hormone
427770|NCT01319695|corifollitropin alfa|corifollitropin alfa
427771|NCT01319695|FSH ovarian stimulation|fsh ovarian stimulation
427772|NCT01319695|IVF|ivf
427773|NCT01319682|Pain|pain
427774|NCT01319682|Preemptive|preemptive
427775|NCT01319682|Lidocaine|lidocaine
427776|NCT01319682|Intravenous|intravenous
427777|NCT01319682|Lumbar fusion|lumbar fusion
427778|NCT01319656|Chronic diseases|chronic diseases
427779|NCT01319656|Primary care|primary care
427780|NCT01319656|Rehabilitation|rehabilitation
427781|NCT01319656|Chronic Care Model|chronic care model
427782|NCT01319656|Patient centered medical home|patient centered medical home
427783|NCT01319643|Oxygen|oxygen
427784|NCT01319643|Hyperoxia|hyperoxia
427785|NCT01319643|Intensive care unit|intensive care unit
427786|NCT01319643|Mortality|mortality
427787|NCT01319643|Organ dysfunction|organ dysfunction
427788|NCT01319643|Postoperative care|postoperative care
427789|NCT01319630|sepsis|sepsis
427790|NCT01319630|microcirculation|microcirculation
427791|NCT01319630|saline|saline
427792|NCT01319630|crystalloid|crystalloid
427793|NCT01319630|colloid|colloid
427794|NCT01319630|albumin|albumin
427795|NCT01319630|hydroxyethyl starch|hydroxyethyl starch
427796|NCT01319578|chronic kidney disease|chronic kidney disease
427797|NCT01319578|phosphorus|phosphorus
427798|NCT01319578|phosphate|phosphate
427799|NCT01319578|saliva|saliva
427800|NCT01319578|K2CG|k2cg
427801|NCT01319578|medical food|medical food
427802|NCT01319578|chitosan|chitosan
427803|NCT01319565|Young TIL|young til
427804|NCT01319565|Metastatic Melanoma|metastatic melanoma
427805|NCT01319565|Immunotherapy|immunotherapy
427806|NCT01319565|Adoptive Cell Therapy|adoptive cell therapy
427807|NCT01319565|Skin Cancer|skin cancer
427808|NCT01319552|red blood cells|red blood cells
427809|NCT01319552|transfusion|transfusion
427810|NCT01319552|storage|storage
427811|NCT01319552|sickle cell disease|sickle cell disease
427812|NCT01319552|β-thalassemia|β-thalassemia
427813|NCT01319552|hemoglobin-associated iron|hemoglobin-associated iron
427814|NCT01319526|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
427815|NCT01319526|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
427816|NCT01319526|HIV infection|hiv infection
427817|NCT01319500|Drug Utilization|drug utilization
427818|NCT01319500|Oral Contraceptives|oral contraceptives
427819|NCT01319474|Deep vein thrombosis|deep vein thrombosis
427820|NCT01319474|Pulmonary embolism|pulmonary embolism
427821|NCT01319474|Ultrasound|ultrasound
427822|NCT01319474|Pregnancy|pregnancy
427823|NCT01319461|Osteoarthritis|osteoarthritis
427824|NCT01319461|Hyalgan|hyalgan
427825|NCT01319448|Sickle cell disease|sickle cell disease
427826|NCT01319448|Malaria|malaria
427827|NCT01319448|Intermittent Preventive Treatment (IPT)|intermittent preventive treatment (ipt)
427828|NCT01319448|prophylaxis|prophylaxis
427829|NCT01319435|Ciprofloxacin|ciprofloxacin
427830|NCT01319435|Neonates|neonates
427831|NCT01319435|Gram negative infection|gram negative infection
427832|NCT01319422|myeloma|myeloma
427833|NCT01319422|multiple myeloma|multiple myeloma
427834|NCT01319422|pomalidomide|pomalidomide
427835|NCT01319422|immunomodulatory|immunomodulatory
427836|NCT01319409|Anterior cruciate ligament surgery|anterior cruciate ligament surgery
427837|NCT01319409|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
427838|NCT01319409|Single bundle anterior cruciate ligament reconstruction|single bundle anterior cruciate ligament reconstruction
427839|NCT01319409|Double bundle anterior cruciate ligament reconstruction|double bundle anterior cruciate ligament reconstruction
427840|NCT01319409|Randomized clinical trial|randomized clinical trial
427841|NCT01319396|breathing rate|breathing rate
427842|NCT01319383|HIV-1 Infection|hiv-1 infection
427843|NCT01319383|HIV RNA <50 copies/mL|hiv rna <50 copies/ml
427844|NCT01319383|Stable ART|stable art
427845|NCT01319383|Resting CD4+ T cells|resting cd4+ t cells
427846|NCT01319383|Leukapheresis|leukapheresis
427847|NCT01319383|Vorinostat|vorinostat
427848|NCT01319383|HIV RNA expression|hiv rna expression
427849|NCT01319383|PK visits|pk visits
427850|NCT01319331|diabetes|diabetes
427851|NCT01319331|type 1 diabetes|type 1 diabetes
427852|NCT01319331|AAT|aat
427853|NCT01319331|Alpha-1 Antitrypsin|alpha-1 antitrypsin
427854|NCT01319279|Pharmacokinetics|pharmacokinetics
427855|NCT01319279|Hydrocodone|hydrocodone
427856|NCT01319279|Extended Release|extended release
427857|NCT01319279|Hepatic impairment|hepatic impairment
427858|NCT01319266|hydrocodone|hydrocodone
427859|NCT01319266|extended release|extended release
427860|NCT01319266|pharmacokinetics|pharmacokinetics
427861|NCT01319266|renal impairment|renal impairment
427862|NCT01319253|Cystic Fibrosis|cystic fibrosis
427863|NCT01319253|Pseudomonas aeruginosa|pseudomonas aeruginosa
427864|NCT01319227|Periprosthetic bone remodeling|periprosthetic bone remodeling
427865|NCT01319227|Stress shielding|stress shielding
427866|NCT01319227|Short femoral stem|short femoral stem
427867|NCT01319227|Porous Titanium Construct|porous titanium construct
427868|NCT01319227|Polyethylene wear|polyethylene wear
427869|NCT01319214|cocaine addiction treatment craving|cocaine addiction treatment craving
427870|NCT01319188|Age-related macular degeneration|age-related macular degeneration
427871|NCT01319188|ranibizumab|ranibizumab
427872|NCT01319188|acute thromboembolic events|acute thromboembolic events
427873|NCT01319188|coronary artery disease|coronary artery disease
427874|NCT01319188|cerebrovascular disease|cerebrovascular disease
427875|NCT01319175|hip flexion strength training|hip flexion strength training
427876|NCT01319175|elastic bands|elastic bands
427877|NCT01319175|external resistance|external resistance
427878|NCT01319162|PCOS|pcos
427879|NCT01319149|molecular methods|molecular methods
427880|NCT01319136|new infusion test method|new infusion test method
427881|NCT01319136|reference method|reference method
427882|NCT01319136|cerebrospinal fluid dynamics|cerebrospinal fluid dynamics
427883|NCT01319123|dressing for venous leg ulcers|dressing for venous leg ulcers
427884|NCT01319110|Cardiac Arrest|cardiac arrest
427885|NCT01319110|Post Cardiac Arrest|post cardiac arrest
427886|NCT01319110|CoQ10|coq10
427887|NCT01319110|Ubiquinone|ubiquinone
427888|NCT01319110|Post Arrest|post arrest
427889|NCT01319097|Reduction on local soft tissue edema|reduction on local soft tissue edema
427890|NCT01319058|obstructive sleep apnea|obstructive sleep apnea
427891|NCT01319058|Tonsillectomy|tonsillectomy
427892|NCT01319058|Tonsillotomy|tonsillotomy
427893|NCT01319058|Inflammation|inflammation
427894|NCT01319058|Pain|pain
427895|NCT01319058|Post tonsillectomy bleeding|post tonsillectomy bleeding
427896|NCT01319045|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
427897|NCT01319045|Congenital Heart Disease|congenital heart disease
427898|NCT01319045|Eisenmenger's Syndrome|eisenmenger's syndrome
427899|NCT01319045|Prostacyclin|prostacyclin
427900|NCT01319045|Iloprost|iloprost
427901|NCT01319019|lung function|lung function
427902|NCT01319019|bronchodilator|bronchodilator
427903|NCT01319019|COPD, dose response, dosing interval, efficacy, safety, PD, PK|copd, dose response, dosing interval, efficacy, safety, pd, pk
427904|NCT01319006|relative bioavailability|relative bioavailability
427905|NCT01318993|GSK1605786A; Inflammatory Bowel Disease; Crohn's disease; long-term treatment; quality of life; CCR9 antagonist|gsk1605786a; inflammatory bowel disease; crohn's disease; long-term treatment; quality of life; ccr9 antagonist
427906|NCT01318980|ADME|adme
427907|NCT01318980|IV radiolabelled|iv radiolabelled
427908|NCT01318980|pharmacokinetics|pharmacokinetics
427909|NCT01318967|Renal blood flow|renal blood flow
427910|NCT01318967|Regional renal blood flow|regional renal blood flow
427911|NCT01318967|MRI|mri
427912|NCT01318941|Ophthalmology, age-related macular degeneration, Diabetic Macular Edema, Retinal Vein Occlusion, ranibizumab|ophthalmology, age-related macular degeneration, diabetic macular edema, retinal vein occlusion, ranibizumab
427913|NCT01318941|Ophthalmology|ophthalmology
427914|NCT01318941|Age-related macular degeneration|age-related macular degeneration
427915|NCT01318941|Diabetic Macular Edema|diabetic macular edema
427916|NCT01318941|Retinal Vein Occlusion|retinal vein occlusion
427917|NCT01318941|LUMINOUS|luminous
427918|NCT01318941|Ranibizumab|ranibizumab
427919|NCT01318928|Periodontitis|periodontitis
427920|NCT01318928|antibiotics|antibiotics
427921|NCT01318928|treatment period|treatment period
427922|NCT01318928|microbiology|microbiology
427923|NCT01318915|Kidney transplantation|kidney transplantation
427924|NCT01318915|Living donor transplant|living donor transplant
427925|NCT01318915|Graft rejection|graft rejection
427926|NCT01318915|Graft loss|graft loss
427927|NCT01318915|Induction with rituximab and ATG|induction with rituximab and atg
427928|NCT01318915|Immunosuppression (IS)|immunosuppression (is)
427929|NCT01318889|Dexpanthenol|dexpanthenol
427930|NCT01318889|Radiotherapy|radiotherapy
427931|NCT01318889|chemotherapy|chemotherapy
427932|NCT01318889|Mucositis|mucositis
427933|NCT01318876|influenza|influenza
427934|NCT01318876|vaccine safety|vaccine safety
427935|NCT01318876|adverse events|adverse events
427936|NCT01318876|health care workers|health care workers
427937|NCT01318863|aged matched normal control samples|aged matched normal control samples
427938|NCT01318850|schizophrenia|schizophrenia
427939|NCT01318850|cognitive remediation|cognitive remediation
427940|NCT01318850|fMRI|fmri
427941|NCT01318837|OABSS|oabss
427942|NCT01318837|IPSS|ipss
427943|NCT01318837|PPBC|ppbc
427944|NCT01318837|Solifenacin|solifenacin
427945|NCT01318824|Neonatal Respiratory Failure|neonatal respiratory failure
427946|NCT01318824|Newborn Infant|newborn infant
427947|NCT01318824|BiPAP|bipap
427948|NCT01318824|NIPPV|nippv
427949|NCT01318811|Heparin|heparin
427950|NCT01318811|CRRT|crrt
427951|NCT01318811|Continuous renal replacement therapy|continuous renal replacement therapy
427952|NCT01318811|CVVHD|cvvhd
427953|NCT01318811|Anticoagulation|anticoagulation
427954|NCT01318798|Development|development
427955|NCT01318798|Pre- and intra-operative predictors|pre- and intra-operative predictors
427956|NCT01318798|Acute renal failure|acute renal failure
427957|NCT01318798|Liver Surgery|liver surgery
427958|NCT01318798|Prediction score|prediction score
427959|NCT01318798|Validation|validation
427960|NCT01318798|Clinical consequences|clinical consequences
427961|NCT01318798|Decision curve analysis|decision curve analysis
427962|NCT01318798|predictors of acute renal failure after liver resection|predictors of acute renal failure after liver resection
427963|NCT01318785|secondary arm-lymphedema|secondary arm-lymphedema
427964|NCT01318785|breast cancer related arm-lymphedema|breast cancer related arm-lymphedema
427965|NCT01318746|change of potassium amount, circadian and day-to-day variability|change of potassium amount, circadian and day-to-day variability
427966|NCT01318733|Rosacea|rosacea
427967|NCT01318720|Neck Pain|neck pain
427968|NCT01318720|Thrust Manipulation|thrust manipulation
427969|NCT01318720|Non-Thrust Manipulation|non-thrust manipulation
427970|NCT01318707|Severe Hemophilia A|severe hemophilia a
427971|NCT01318707|Hemophilia A Patients|hemophilia a patients
427972|NCT01318707|Serum collection vs a method of added FVIII to blood samples|serum collection vs a method of added fviii to blood samples
427973|NCT01318694|Chronic hepatitis C|chronic hepatitis c
427974|NCT01318694|Cyclophilin inhibitor|cyclophilin inhibitor
427975|NCT01318681|driving, memory, cognition|driving, memory, cognition
427976|NCT01318668|fmri smoking vaccination mood|fmri smoking vaccination mood
427977|NCT01318655|Phase I|phase i
427978|NCT01318655|Japan|japan
427979|NCT01318655|SAD|sad
427980|NCT01318655|MAD|mad
427981|NCT01318642|Adenocarcinoma|adenocarcinoma
427982|NCT01318642|pancreas|pancreas
427983|NCT01318642|pancreatic cancer|pancreatic cancer
427984|NCT01318642|local|local
427985|NCT01318642|unresectable|unresectable
427986|NCT01318642|stage II|stage ii
427987|NCT01318642|stage III|stage iii
427988|NCT01318616|hip adduction strength training|hip adduction strength training
427989|NCT01318616|Improvement in adductor strength|improvement in adductor strength
427990|NCT01318590|Pancreatitis, Chronic|pancreatitis, chronic
427991|NCT01318590|Abdominal Pain|abdominal pain
427992|NCT01318590|Celiac bloc|celiac bloc
427993|NCT01318590|Endosonography|endosonography
427994|NCT01318564|Type II Diabetes|type ii diabetes
427995|NCT01318564|Unit dose packaging devices|unit dose packaging devices
427996|NCT01318564|Metformin|metformin
427997|NCT01318564|Lisinopril|lisinopril
427998|NCT01318564|Enalapril|enalapril
427999|NCT01318564|Atorvastatin|atorvastatin
428000|NCT01318564|Lipitor|lipitor
428001|NCT01318564|Simvastatin|simvastatin
428002|NCT01318564|Aspirin|aspirin
428003|NCT01318564|Questionnaires|questionnaires
428004|NCT01318551|Anemia|anemia
428005|NCT01318538|Substance use disorders, Gender differences, women, treatment outcomes, group therapy|substance use disorders, gender differences, women, treatment outcomes, group therapy
428006|NCT01318499|cataract|cataract
428007|NCT01318499|inflammation|inflammation
428008|NCT01318499|pain|pain
428009|NCT01318499|inflammatory cells|inflammatory cells
428010|NCT01318499|aqueous flare|aqueous flare
428011|NCT01318473|cancer|cancer
428012|NCT01318460|coronary artery disease|coronary artery disease
428013|NCT01318460|levosimendan|levosimendan
428014|NCT01318460|coronary artery bypass grafting|coronary artery bypass grafting
428015|NCT01318460|cardiac surgery|cardiac surgery
428016|NCT01318447|Hepatic metastases|hepatic metastases
428017|NCT01318447|Liver metastases|liver metastases
428018|NCT01318447|Colorectal cancer|colorectal cancer
428019|NCT01318447|Colorectal adenocarcinoma|colorectal adenocarcinoma
428020|NCT01318447|Accuray|accuray
428021|NCT01318447|CyberKnife|cyberknife
428022|NCT01318434|Outpatient|outpatient
428023|NCT01318421|Relapsing forms of secondary progressive multiple sclerosis (SPMS)or relapsing-remitting multiple sclerosis (RRMS)|relapsing forms of secondary progressive multiple sclerosis (spms)or relapsing-remitting multiple sclerosis (rrms)
428024|NCT01318356|Q fever|q fever
428025|NCT01318356|Cognitive behavioral therapy|cognitive behavioral therapy
428026|NCT01318356|Doxycycline|doxycycline
428027|NCT01318356|Fatigue|fatigue
428028|NCT01318356|Coxiella|coxiella
428029|NCT01318343|Cryolipolysis|cryolipolysis
428030|NCT01318343|Abdominal Fat|abdominal fat
428031|NCT01318343|Adipose Tissue|adipose tissue
428032|NCT01318343|Fat Reduction|fat reduction
428033|NCT01318343|Non Invasive|non invasive
428034|NCT01318304|innate immunity|innate immunity
428035|NCT01318304|HIV|hiv
428036|NCT01318304|pregnancy|pregnancy
428037|NCT01318304|vaginal immunity|vaginal immunity
428038|NCT01318291|IVF|ivf
428039|NCT01318291|Drop out|drop out
428040|NCT01318278|Hypotension|hypotension
428041|NCT01318278|Low blood pressure|low blood pressure
428042|NCT01318278|Neonate|neonate
428043|NCT01318278|Dopamine|dopamine
428044|NCT01318278|Vasopressin|vasopressin
428045|NCT01318278|Extremely Low Birth Weight Infant|extremely low birth weight infant
428046|NCT01318265|drug interactions|drug interactions
428047|NCT01318265|ketoconazole|ketoconazole
428048|NCT01318265|pharmacokinetics|pharmacokinetics
428049|NCT01318265|human volunteers|human volunteers
428050|NCT01318252|Elevated IOP|elevated iop
428051|NCT01318226|postherpetic neuralgia|postherpetic neuralgia
428052|NCT01318226|shingles|shingles
428053|NCT01318226|analgesia|analgesia
428054|NCT01318226|neuropathic pain|neuropathic pain
428055|NCT01318213|VRE|vre
428056|NCT01318213|MRSA|mrsa
428057|NCT01318200|Primary liver cancer|primary liver cancer
428058|NCT01318200|Hepatocellular carcinoma|hepatocellular carcinoma
428059|NCT01318200|CyberKnife|cyberknife
428060|NCT01318200|Accuray|accuray
428061|NCT01318200|TACE|tace
428062|NCT01318200|Transarterial chemoembolization|transarterial chemoembolization
428063|NCT01318187|renal colic|renal colic
428064|NCT01318187|paracetamol|paracetamol
428065|NCT01318187|morphine|morphine
428066|NCT01318187|emergency department|emergency department
428067|NCT01318174|Pulmonary embolism|pulmonary embolism
428068|NCT01318174|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
428069|NCT01318161|Epidural analgesia|epidural analgesia
428070|NCT01318161|Patient controlled analgesia|patient controlled analgesia
428071|NCT01318161|Colorectal cancer|colorectal cancer
428072|NCT01318161|Morbidity|morbidity
428073|NCT01318161|Mortality|mortality
428074|NCT01318148|Echinocandins|echinocandins
428075|NCT01318148|Caspofungin|caspofungin
428076|NCT01318148|Pharmacokinetics|pharmacokinetics
428077|NCT01318148|Prophylaxis|prophylaxis
428078|NCT01318148|Antifungal|antifungal
428079|NCT01318148|Aspergillosis|aspergillosis
428080|NCT01318148|Acute Leucemia|acute leucemia
428081|NCT01318135|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
428082|NCT01318135|Diabetes Mellitus|diabetes mellitus
428083|NCT01318135|Drug Therapy|drug therapy
428084|NCT01318122|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
428085|NCT01318122|Diabetes Mellitus|diabetes mellitus
428086|NCT01318122|Drug Therapy|drug therapy
428087|NCT01318109|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
428088|NCT01318109|Diabetes Mellitus|diabetes mellitus
428089|NCT01318109|Drug Therapy|drug therapy
428090|NCT01318096|safety|safety
428091|NCT01318096|efficacy|efficacy
428092|NCT01318096|raltegravir|raltegravir
428093|NCT01318096|HBV/HIV co-infection|hbv/hiv co-infection
428094|NCT01318083|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
428095|NCT01318083|Diabetes Mellitus|diabetes mellitus
428096|NCT01318083|Drug Therapy|drug therapy
428097|NCT01318070|Diabetes Mellitus - Type2|diabetes mellitus - type2
428098|NCT01318070|Diabetes Mellitus|diabetes mellitus
428099|NCT01318070|Drug Therapy|drug therapy
428100|NCT01318057|Pharmacogenetics|pharmacogenetics
428101|NCT01318057|Warfarin|warfarin
428102|NCT01318057|Personalized Medicine|personalized medicine
428103|NCT01318057|Puerto Ricans|puerto ricans
428104|NCT01318057|Physiogenomics|physiogenomics
428105|NCT01318057|Hispanics|hispanics
428106|NCT01318057|Anticoagulants|anticoagulants
428107|NCT01318057|Cardiovascular|cardiovascular
428108|NCT01318057|Deep Vein Thrombosis with or without Pulmonary Embolism|deep vein thrombosis with or without pulmonary embolism
428109|NCT01318057|Cardiac Valvular Replacement|cardiac valvular replacement
428110|NCT01318044|thiopental|thiopental
428111|NCT01318044|propofol|propofol
428112|NCT01318044|sedation|sedation
428113|NCT01318044|MRI|mri
428114|NCT01318031|DDI|ddi
428115|NCT01318031|Healthy Volunteers|healthy volunteers
428116|NCT01318018|depression|depression
428117|NCT01318018|bispectral index|bispectral index
428118|NCT01318018|electroconvulsive therapy|electroconvulsive therapy
428119|NCT01318018|magnetic seizure therapy|magnetic seizure therapy
428120|NCT01317992|Medication overuse headache|medication overuse headache
428121|NCT01317992|ibudilast|ibudilast
428122|NCT01317992|glia|glia
428123|NCT01317940|Leukemia|leukemia
428124|NCT01317940|ALL|all
428125|NCT01317940|Vitamin D|vitamin d
428126|NCT01317940|Bone Density|bone density
428127|NCT01317940|Body Fat|body fat
428128|NCT01317940|Obesity|obesity
428129|NCT01317940|Adipose|adipose
428130|NCT01317927|belionstat|belionstat
428131|NCT01317927|warfarin|warfarin
428132|NCT01317927|hematological malignancy|hematological malignancy
428133|NCT01317927|solid tumors|solid tumors
428134|NCT01317927|PK/PD study|pk/pd study
428135|NCT01317901|follicular lymphoma|follicular lymphoma
428136|NCT01317901|small lymphocytic lymphoma|small lymphocytic lymphoma
428137|NCT01317901|marginal zone lymphoma|marginal zone lymphoma
428138|NCT01317901|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
428139|NCT01317901|indolent lymphoma|indolent lymphoma
428140|NCT01317888|high grade gliomas of the brain|high grade gliomas of the brain
428141|NCT01317888|anti-body treatment|anti-body treatment
428142|NCT01317888|survival|survival
428143|NCT01317862|labor induction, transcervical foley catheter, prostaglandin|labor induction, transcervical foley catheter, prostaglandin
428144|NCT01317849|folic acid|folic acid
428145|NCT01317849|B vitamins|b vitamins
428146|NCT01317849|secondary prevention|secondary prevention
428147|NCT01317849|stroke|stroke
428148|NCT01317849|randomized controlled trial|randomized controlled trial
428149|NCT01317849|homocysteine|homocysteine
428150|NCT01317836|pancreatic cystic lesion|pancreatic cystic lesion
428151|NCT01317836|PET|pet
428152|NCT01317836|PET-CT|pet-ct
428153|NCT01317836|diagnosis|diagnosis
428154|NCT01317823|Multiparas, Bishop score, Cervical length, Cervical ripening|multiparas, bishop score, cervical length, cervical ripening
428155|NCT01317810|Overactive Bladder (OAB)|overactive bladder (oab)
428156|NCT01317810|Observational|observational
428157|NCT01317810|Registry|registry
428158|NCT01317797|Rheumatoid Arthritis|rheumatoid arthritis
428159|NCT01317797|MT203|mt203
428160|NCT01317797|Human IgG1 monoclonal antibody|human igg1 monoclonal antibody
428161|NCT01317797|GM-CSF monoclonal antibody|gm-csf monoclonal antibody
428162|NCT01317784|diagnosis screening|diagnosis screening
428163|NCT01317784|HIV serodiagnosis|hiv serodiagnosis
428164|NCT01317784|HCV antibodies|hcv antibodies
428165|NCT01317784|serologic tests|serologic tests
428166|NCT01317784|Bedside testing|bedside testing
428167|NCT01317784|diagnostic test kits|diagnostic test kits
428168|NCT01317784|syphilis serodiagnosis|syphilis serodiagnosis
428169|NCT01317771|Proximal Biceps Pathology|proximal biceps pathology
428170|NCT01317758|influenza, vaccine, H5N1|influenza, vaccine, h5n1
428171|NCT01317745|H5N1, vaccine, influenza|h5n1, vaccine, influenza
428172|NCT01317732|Energy expenditure, physical activity, accelerometer, magnetometer, monitoring|energy expenditure, physical activity, accelerometer, magnetometer, monitoring
428173|NCT01317719|Rupture of Distal Bicep Tendon|rupture of distal bicep tendon
428174|NCT01317706|Bishop score, Cervical length, Cervical ripening, Labor induction|bishop score, cervical length, cervical ripening, labor induction
428175|NCT01317693|LI-ESWT|li-eswt
428176|NCT01317693|Erectile Dysfunction|erectile dysfunction
428177|NCT01317693|ED|ed
428178|NCT01317693|Shock waves|shock waves
428179|NCT01317693|Therapy|therapy
428180|NCT01317680|Erectile Dysfunction|erectile dysfunction
428181|NCT01317680|ED|ed
428182|NCT01317680|PDE5 inhibitors|pde5 inhibitors
428183|NCT01317680|LI-ESWT|li-eswt
428184|NCT01317667|Ricin|ricin
428185|NCT01317667|RVEc|rvec
428186|NCT01317654|Tuberculosis meningitis|tuberculosis meningitis
428187|NCT01317628|tobacco smoke, intervention program|tobacco smoke, intervention program
428188|NCT01317615|Large cell carcinoma,|large cell carcinoma,
428189|NCT01317615|Lung cancer,|lung cancer,
428190|NCT01317615|Neuroendocrine Tumors,|neuroendocrine tumors,
428191|NCT01317615|RAD001|rad001
428192|NCT01317602|Atrial Fibrillation|atrial fibrillation
428193|NCT01317602|AF|af
428194|NCT01317589|Pain|pain
428195|NCT01317589|Cancer of Head and Neck|cancer of head and neck
428196|NCT01317589|methadone|methadone
428197|NCT01317589|Fentanyl|fentanyl
428198|NCT01317576|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
428199|NCT01317576|Exercise|exercise
428200|NCT01317563|asthma|asthma
428201|NCT01317563|obesity|obesity
428202|NCT01317563|nutrition|nutrition
428203|NCT01317563|antioxidant|antioxidant
428204|NCT01317550|Non-Small Cell Lung Cancer|non-small cell lung cancer
428205|NCT01317550|NSCLC|nsclc
428206|NCT01317550|Symptoms|symptoms
428207|NCT01317550|Concurrent Chemoradiation|concurrent chemoradiation
428208|NCT01317550|CXRT|cxrt
428209|NCT01317550|Fatigue|fatigue
428210|NCT01317550|Pain|pain
428211|NCT01317550|Disturbed Sleep|disturbed sleep
428212|NCT01317550|Lack of Appetite|lack of appetite
428213|NCT01317550|Drowsiness|drowsiness
428214|NCT01317550|Armodafinil|armodafinil
428215|NCT01317550|Nuvigil|nuvigil
428216|NCT01317550|Minocycline|minocycline
428217|NCT01317550|Dynacin|dynacin
428218|NCT01317550|Minocin|minocin
428219|NCT01317550|Minocin PAC|minocin pac
428220|NCT01317550|Myrac|myrac
428221|NCT01317550|Solodyn|solodyn
428222|NCT01317550|Placebo|placebo
428223|NCT01317537|personal health records|personal health records
428224|NCT01317524|Milk|milk
428225|NCT01317524|Homogenization|homogenization
428226|NCT01317524|Postprandial hyperlipidemia|postprandial hyperlipidemia
428227|NCT01317524|Postprandial inflammation|postprandial inflammation
428228|NCT01317524|Overweight|overweight
428229|NCT01317498|ART|art
428230|NCT01317498|antiretroviral|antiretroviral
428231|NCT01317498|treatment|treatment
428232|NCT01317498|Vietnam|vietnam
428233|NCT01317498|Asia|asia
428234|NCT01317498|viral load|viral load
428235|NCT01317485|diverticulitis|diverticulitis
428236|NCT01317485|perforation|perforation
428237|NCT01317485|sigmoidectomy|sigmoidectomy
428238|NCT01317485|sigmoid resection|sigmoid resection
428239|NCT01317485|lavage|lavage
428240|NCT01317485|laparoscopic|laparoscopic
428241|NCT01317485|wash-out|wash-out
428242|NCT01317485|rinsing|rinsing
428243|NCT01317485|hartmann|hartmann
428244|NCT01317485|end-colostomy|end-colostomy
428245|NCT01317485|primary anastomosis|primary anastomosis
428246|NCT01317472|laryngopharyngeal reflux, acid reflux, throat reflux|laryngopharyngeal reflux, acid reflux, throat reflux
428247|NCT01317459|Self management|self management
428248|NCT01317459|Diabetes type one|diabetes type one
428249|NCT01317459|Empowerment|empowerment
428250|NCT01317459|Intrinsic motivation|intrinsic motivation
428251|NCT01317446|gingivitis index|gingivitis index
428252|NCT01317446|plaque index|plaque index
428253|NCT01317446|discoloration index|discoloration index
428254|NCT01317446|mouth rinse|mouth rinse
428255|NCT01317446|amine fluoride/stannous fluoride|amine fluoride/stannous fluoride
428256|NCT01317446|clinical trial|clinical trial
428257|NCT01317433|Metastatic Colorectal Cancer|metastatic colorectal cancer
428258|NCT01317433|K-RAS wild-type|k-ras wild-type
428259|NCT01317433|FOLFIRI|folfiri
428260|NCT01317433|Cetuximab|cetuximab
428261|NCT01317407|postoperative delirium|postoperative delirium
428262|NCT01317394|non-albicans candidemia|non-albicans candidemia
428263|NCT01317368|Postoperative analgesic treatment|postoperative analgesic treatment
428264|NCT01317368|TAP block|tap block
428265|NCT01317368|Prostatectomy|prostatectomy
428266|NCT01317368|Double blinded randomized clinical trial|double blinded randomized clinical trial
428267|NCT01317355|Cancer|cancer
428268|NCT01317355|Symptom burden|symptom burden
428269|NCT01317355|Symptom cluster|symptom cluster
428270|NCT01317355|Distress|distress
428271|NCT01317355|Pain|pain
428272|NCT01317355|Fatigue|fatigue
428273|NCT01317355|Sleep disorder|sleep disorder
428274|NCT01317355|HRQoL|hrqol
428275|NCT01317342|liver transplantation|liver transplantation
428276|NCT01317342|machine liver perfusion|machine liver perfusion
428277|NCT01317342|extended criteria liver grafts|extended criteria liver grafts
428278|NCT01317342|donation after cardiac death|donation after cardiac death
428279|NCT01317342|hypothermic machine liver perfusion|hypothermic machine liver perfusion
428280|NCT01317342|liver reperfusion injury|liver reperfusion injury
428281|NCT01317303|paired associative stimulation|paired associative stimulation
428282|NCT01317303|theta burst stimulation|theta burst stimulation
428283|NCT01317303|transcranial magnetic stimulation|transcranial magnetic stimulation
428284|NCT01317303|neuroplasticity|neuroplasticity
428285|NCT01317303|healthy controls|healthy controls
428286|NCT01317290|Conversion of ALA|conversion of ala
428287|NCT01317277|interventions|interventions
428288|NCT01317277|technology|technology
428289|NCT01317277|drug abuse|drug abuse
428290|NCT01317277|methamphetamine|methamphetamine
428291|NCT01317264|β-glucan|β-glucan
428292|NCT01317264|cholesterol|cholesterol
428293|NCT01317264|bile acids|bile acids
428294|NCT01317264|blood glucose|blood glucose
428295|NCT01317264|appetite|appetite
428296|NCT01317251|Obesity prevention|obesity prevention
428297|NCT01317251|appetite regulation|appetite regulation
428298|NCT01317251|hyperlipidemia|hyperlipidemia
428299|NCT01317238|Smallpox vaccine efficacy|smallpox vaccine efficacy
428300|NCT01317225|Progesterone|progesterone
428301|NCT01317225|Obstetric labor, premature|obstetric labor, premature
428302|NCT01317225|Short cervix|short cervix
428303|NCT01317212|Glioblastoma multiforme|glioblastoma multiforme
428304|NCT01317212|Carboplatin|carboplatin
428305|NCT01317212|Convection-enhanced delivery|convection-enhanced delivery
428306|NCT01317199|Rising psa|rising psa
428307|NCT01317186|FGF 23|fgf 23
428308|NCT01317186|ADMA|adma
428309|NCT01317186|chronic kidney disease|chronic kidney disease
428310|NCT01317186|Ca-P metabolism disorder|ca-p metabolism disorder
428311|NCT01317173|Chronic kidney disease progression|chronic kidney disease progression
428312|NCT01317173|FGF 23|fgf 23
428313|NCT01317173|Klotho|klotho
428314|NCT01317160|Achilles Tendon|achilles tendon
428315|NCT01317160|Immobilization|immobilization
428316|NCT01317160|Wound Healing|wound healing
428317|NCT01317160|Intermittent Pneumatic Compression|intermittent pneumatic compression
428318|NCT01317160|Ultrasonography|ultrasonography
428319|NCT01317160|Microdialysis|microdialysis
428320|NCT01317147|pharmacokinetics|pharmacokinetics
428321|NCT01317147|serotonin reuptake inhibitors|serotonin reuptake inhibitors
428322|NCT01317147|gastric bypass|gastric bypass
428323|NCT01317147|depression|depression
428324|NCT01317147|bioavailability|bioavailability
428325|NCT01317147|drug absorption|drug absorption
428326|NCT01317147|area under curve|area under curve
428327|NCT01317134|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
428328|NCT01317134|Prognostic factors|prognostic factors
428329|NCT01317134|Signal transduction|signal transduction
428330|NCT01317134|Genetics|genetics
428331|NCT01317121|Patients with a first episode of schizophrenia|patients with a first episode of schizophrenia
428332|NCT01317121|Subjects at risk for psychosis|subjects at risk for psychosis
428333|NCT01317108|node-negative|node-negative
428334|NCT01317095|Rigid fixation|rigid fixation
428335|NCT01317095|Sternal closure|sternal closure
428336|NCT01317095|Open heart surgery|open heart surgery
428337|NCT01317082|Postoperative Nausea & Vomiting.|postoperative nausea & vomiting.
428338|NCT01317017|Psoriasis|psoriasis
428339|NCT01317004|Multiple sclerosis|multiple sclerosis
428340|NCT01317004|Fingolimod|fingolimod
428341|NCT01317004|Disease Modifying Therapy|disease modifying therapy
428342|NCT01317004|TSQM-9|tsqm-9
428343|NCT01316991|chewing gum|chewing gum
428344|NCT01316991|appetite|appetite
428345|NCT01316991|hunger|hunger
428346|NCT01316991|satiety|satiety
428347|NCT01316991|metabolic|metabolic
428348|NCT01316991|nutrition|nutrition
428349|NCT01316991|gut peptide hormones|gut peptide hormones
428350|NCT01316991|psychological phenomena and processes|psychological phenomena and processes
428351|NCT01316965|Postoperative delirium|postoperative delirium
428352|NCT01316965|elderly|elderly
428353|NCT01316965|prevention|prevention
428354|NCT01316965|stepped wedge design|stepped wedge design
428355|NCT01316965|healthcare workers|healthcare workers
428356|NCT01316952|carvedilol|carvedilol
428357|NCT01316952|propranolol|propranolol
428358|NCT01316952|hypersensitivity reactions|hypersensitivity reactions
428359|NCT01316952|beta- blockers|beta- blockers
428360|NCT01316952|Coreg|coreg
428361|NCT01316939|Crohn's disease, oral CCR9 antagonist, placebo-controlled, maintenance of remission, 52-week treatment, quality of life|crohn's disease, oral ccr9 antagonist, placebo-controlled, maintenance of remission, 52-week treatment, quality of life
428362|NCT01316926|fast condition|fast condition
428363|NCT01316926|Paroxetine reference/test|paroxetine reference/test
428364|NCT01316926|healthy volunteers|healthy volunteers
428365|NCT01316926|Bioequivalence|bioequivalence
428366|NCT01316913|tiotropium|tiotropium
428367|NCT01316913|long-acting muscarinic antagonist|long-acting muscarinic antagonist
428368|NCT01316913|COPD|copd
428369|NCT01316913|long-acting beta agonist|long-acting beta agonist
428370|NCT01316900|long-acting muscarinic antagonist|long-acting muscarinic antagonist
428371|NCT01316900|tiotropium|tiotropium
428372|NCT01316900|COPD|copd
428373|NCT01316900|long-acting beta agonist|long-acting beta agonist
428374|NCT01316887|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
428375|NCT01316887|COPD|copd
428376|NCT01316887|nDPI|ndpi
428377|NCT01316887|long-acting beta agonist|long-acting beta agonist
428378|NCT01316887|long-acting muscarinic antagonist|long-acting muscarinic antagonist
428379|NCT01316887|tolerability|tolerability
428380|NCT01316887|safety|safety
428381|NCT01316874|Valrubicin|valrubicin
428382|NCT01316874|CIS|cis
428383|NCT01316874|AD 32, BCG-refractory CIS|ad 32, bcg-refractory cis
428384|NCT01316874|Carcinoma in situ (CIS) previously treated with BCG|carcinoma in situ (cis) previously treated with bcg
428385|NCT01316848|AV-951|av-951
428386|NCT01316848|tivozanib|tivozanib
428387|NCT01316848|healthy Subjects|healthy subjects
428388|NCT01316848|food Effect|food effect
428389|NCT01316848|pharmacokinetics|pharmacokinetics
428390|NCT01316835|retrospective,sitagliptin, glycemia control,real world|retrospective,sitagliptin, glycemia control,real world
428391|NCT01316822|CSF1R|csf1r
428392|NCT01316822|M-CSF|m-csf
428393|NCT01316822|CSF-1|csf-1
428394|NCT01316822|c-FMS|c-fms
428395|NCT01316822|Tumor-associated macrophage|tumor-associated macrophage
428396|NCT01316822|Macrophage-Colony Stimulating Factor-1|macrophage-colony stimulating factor-1
428397|NCT01316822|Receptor tyrosine kinase inhibitor|receptor tyrosine kinase inhibitor
428398|NCT01316822|Tumor cell-induced osteolysis|tumor cell-induced osteolysis
428399|NCT01316809|Brain|brain
428400|NCT01316809|Tumor|tumor
428401|NCT01316809|Recurrent|recurrent
428402|NCT01316809|Surgery|surgery
428403|NCT01316809|Radiation|radiation
428404|NCT01316809|Glioma|glioma
428405|NCT01316809|Brain Tumor|brain tumor
428406|NCT01316809|Glioblastoma Multiforme|glioblastoma multiforme
428407|NCT01316809|Astrocytoma|astrocytoma
428408|NCT01316809|Brainstem Glioma|brainstem glioma
428409|NCT01316796|Sickle Cell Disease|sickle cell disease
428410|NCT01316796|Hemolysis|hemolysis
428411|NCT01316796|Anemia|anemia
428412|NCT01316796|Nitric Oxide|nitric oxide
428413|NCT01316796|Blood Flow|blood flow
428414|NCT01316796|Leg Ulcer|leg ulcer
428415|NCT01316796|Sickle Cell Anemia|sickle cell anemia
428416|NCT01316796|Thalassemia|thalassemia
428417|NCT01316796|Hemolytic Blood Disorder|hemolytic blood disorder
428418|NCT01316783|Africans|africans
428419|NCT01316783|Obesity|obesity
428420|NCT01316783|Diabetes|diabetes
428421|NCT01316783|Heart Disease|heart disease
428422|NCT01316783|Genetic|genetic
428423|NCT01316783|African Descent|african descent
428424|NCT01316783|Cardiovascular Disease|cardiovascular disease
428425|NCT01316770|Xerostomia|xerostomia
428426|NCT01316770|Sj(SqrRoot)(Delta)gren s Syndrome|sj(sqrroot)(delta)gren s syndrome
428427|NCT01316770|Interventional Study|interventional study
428428|NCT01316770|Sjogren Syndrome|sjogren syndrome
428429|NCT01316770|Dry Mouth|dry mouth
428430|NCT01316744|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
428431|NCT01316744|anxiety disorder|anxiety disorder
428432|NCT01316744|depression|depression
428433|NCT01316744|pain|pain
428434|NCT01316744|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
428435|NCT01316744|neuropathy|neuropathy
428436|NCT01316744|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
428437|NCT01316744|acute undifferentiated leukemia|acute undifferentiated leukemia
428438|NCT01316744|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
428439|NCT01316744|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
428440|NCT01316744|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
428441|NCT01316744|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
428763|NCT01316081|childhood obesity|childhood obesity
428442|NCT01316744|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
428443|NCT01316744|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
428444|NCT01316744|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
428445|NCT01316744|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
428446|NCT01316744|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
428447|NCT01316744|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
428448|NCT01316744|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
428449|NCT01316744|mast cell leukemia|mast cell leukemia
428450|NCT01316744|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
428451|NCT01316744|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
428452|NCT01316744|prolymphocytic leukemia|prolymphocytic leukemia
428453|NCT01316744|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
428454|NCT01316744|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
428455|NCT01316744|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
428456|NCT01316744|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
428457|NCT01316744|refractory hairy cell leukemia|refractory hairy cell leukemia
428458|NCT01316744|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
428459|NCT01316744|secondary acute myeloid leukemia|secondary acute myeloid leukemia
428460|NCT01316744|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
428461|NCT01316744|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
428462|NCT01316744|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
428463|NCT01316744|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
428464|NCT01316744|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
428465|NCT01316744|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
428466|NCT01316744|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
428467|NCT01316744|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
428468|NCT01316744|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
428469|NCT01316744|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
428470|NCT01316744|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
428471|NCT01316744|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
428472|NCT01316744|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
428473|NCT01316744|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
428474|NCT01316744|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
428475|NCT01316744|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
428476|NCT01316744|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
428477|NCT01316744|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
428478|NCT01316744|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
428479|NCT01316744|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
428480|NCT01316744|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
428481|NCT01316744|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
428482|NCT01316744|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
428715|NCT01316211|Back Ache|back ache
428483|NCT01316744|anaplastic large cell lymphoma|anaplastic large cell lymphoma
428484|NCT01316744|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
428485|NCT01316744|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
428486|NCT01316744|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
428487|NCT01316744|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
428488|NCT01316744|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
428489|NCT01316744|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
428490|NCT01316744|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
428491|NCT01316744|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
428492|NCT01316744|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
428493|NCT01316744|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
428494|NCT01316744|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
428495|NCT01316744|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
428496|NCT01316744|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
428497|NCT01316744|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
428498|NCT01316744|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
428499|NCT01316744|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
428500|NCT01316744|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
428501|NCT01316744|splenic marginal zone lymphoma|splenic marginal zone lymphoma
428502|NCT01316744|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
428503|NCT01316744|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
428504|NCT01316744|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
428505|NCT01316744|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
428506|NCT01316744|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
428507|NCT01316744|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
428508|NCT01316744|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
428509|NCT01316744|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
428510|NCT01316744|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
428511|NCT01316744|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
428512|NCT01316744|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
428513|NCT01316744|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
428514|NCT01316744|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
428515|NCT01316744|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
428516|NCT01316744|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
428517|NCT01316744|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
428518|NCT01316744|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
428519|NCT01316744|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
428520|NCT01316744|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
428521|NCT01316744|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
428522|NCT01316744|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
428523|NCT01316744|stage I mantle cell lymphoma|stage i mantle cell lymphoma
428524|NCT01316744|stage I marginal zone lymphoma|stage i marginal zone lymphoma
428525|NCT01316744|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
428526|NCT01316744|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
428527|NCT01316744|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
428528|NCT01316744|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
428529|NCT01316744|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
428530|NCT01316744|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
428531|NCT01316744|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
428764|NCT01316081|hepcidin|hepcidin
428532|NCT01316744|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
428533|NCT01316744|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
428534|NCT01316744|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
428535|NCT01316744|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
428536|NCT01316744|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
428537|NCT01316744|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
428538|NCT01316744|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
428539|NCT01316744|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
428540|NCT01316744|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
428541|NCT01316744|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
428542|NCT01316744|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
428543|NCT01316744|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
428544|NCT01316744|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
428545|NCT01316744|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
428546|NCT01316744|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
428547|NCT01316744|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
428548|NCT01316744|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
428549|NCT01316744|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
428550|NCT01316744|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
428551|NCT01316744|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
428552|NCT01316744|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
428553|NCT01316744|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
428554|NCT01316744|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
428555|NCT01316744|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
428556|NCT01316744|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
428557|NCT01316744|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
428558|NCT01316744|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
428559|NCT01316744|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
428560|NCT01316744|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
428561|NCT01316744|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
428562|NCT01316744|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
428563|NCT01316744|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
428564|NCT01316744|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
428565|NCT01316744|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
428566|NCT01316744|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
428567|NCT01316744|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
428568|NCT01316744|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
428569|NCT01316744|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
428570|NCT01316744|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
428571|NCT01316744|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
428572|NCT01316744|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
428573|NCT01316744|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
428574|NCT01316744|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
428575|NCT01316744|intraocular lymphoma|intraocular lymphoma
428576|NCT01316744|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
428577|NCT01316744|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
428578|NCT01316744|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
428579|NCT01316744|chronic eosinophilic leukemia|chronic eosinophilic leukemia
428580|NCT01316744|chronic neutrophilic leukemia|chronic neutrophilic leukemia
428581|NCT01316744|primary myelofibrosis|primary myelofibrosis
428582|NCT01316744|essential thrombocythemia|essential thrombocythemia
428583|NCT01316744|polycythemia vera|polycythemia vera
428584|NCT01316744|extramedullary plasmacytoma|extramedullary plasmacytoma
428585|NCT01316744|isolated plasmacytoma of bone|isolated plasmacytoma of bone
428586|NCT01316744|stage I multiple myeloma|stage i multiple myeloma
428587|NCT01316744|stage II multiple myeloma|stage ii multiple myeloma
428588|NCT01316744|stage III multiple myeloma|stage iii multiple myeloma
428589|NCT01316744|primary systemic amyloidosis|primary systemic amyloidosis
428590|NCT01316744|refractory multiple myeloma|refractory multiple myeloma
428591|NCT01316744|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
428592|NCT01316744|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
428593|NCT01316744|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
428594|NCT01316744|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
428595|NCT01316718|IBS|ibs
428596|NCT01316718|diarrhoea|diarrhoea
428597|NCT01316679|HCC|hcc
428598|NCT01316679|Liver Disease without HCC|liver disease without hcc
428599|NCT01316666|orthostatic hypotension|orthostatic hypotension
428600|NCT01316666|Multiple System Atrophy|multiple system atrophy
428601|NCT01316666|Pure Autonomic Failure|pure autonomic failure
428602|NCT01316666|Parkinson's Disease|parkinson's disease
428603|NCT01316627|Body Dysmorphic Disorder (BDD)|body dysmorphic disorder (bdd)
428604|NCT01316627|Cognitive Behavior Therapy (CBT)|cognitive behavior therapy (cbt)
428605|NCT01316627|Obsessive Compulsive Disorder (OCD)|obsessive compulsive disorder (ocd)
428606|NCT01316627|Mirror Retraining|mirror retraining
428607|NCT01316627|Crooked Mirror Externalization Therapy|crooked mirror externalization therapy
428608|NCT01316614|Fine-Needle Aspiration|fine-needle aspiration
428609|NCT01316614|Stylet|stylet
428610|NCT01316614|Solid Mass|solid mass
428611|NCT01316614|Endoscopic Ultrasound (EUS)|endoscopic ultrasound (eus)
428612|NCT01316588|recolonization|recolonization
428613|NCT01316588|Plastic adhesive drape|plastic adhesive drape
428716|NCT01316211|Ache, Back|ache, back
428614|NCT01316588|microbial sealant|microbial sealant
428615|NCT01316588|SSI|ssi
428616|NCT01316588|bacterial growth|bacterial growth
428617|NCT01316575|Continuous Positive Airway Pressure|continuous positive airway pressure
428618|NCT01316575|Postoperative Complications|postoperative complications
428619|NCT01316575|Respiratory Insufficiency|respiratory insufficiency
428620|NCT01316575|Colorectal Surgery|colorectal surgery
428621|NCT01316549|fludarabine|fludarabine
428622|NCT01316549|pharmacokinetics|pharmacokinetics
428623|NCT01316549|pediatric|pediatric
428624|NCT01316549|allogeneic|allogeneic
428625|NCT01316549|hematopoietic cell transplantation|hematopoietic cell transplantation
428626|NCT01316536|pain, agitation, music|pain, agitation, music
428627|NCT01316523|Lenalidomide|lenalidomide
428628|NCT01316523|Rituximab|rituximab
428629|NCT01316523|untreated indolent Non-Hodgkin's Lymphoma|untreated indolent non-hodgkin's lymphoma
428630|NCT01316510|Probiotic|probiotic
428631|NCT01316510|bifidobacteria|bifidobacteria
428632|NCT01316510|intestinal motility|intestinal motility
428633|NCT01316497|Acute kidney injury|acute kidney injury
428634|NCT01316497|Ischemic preconditioning|ischemic preconditioning
428635|NCT01316497|Congenital heart defects|congenital heart defects
428636|NCT01316497|Cardiac surgical procedures|cardiac surgical procedures
428637|NCT01316497|Infant|infant
428638|NCT01316497|Child|child
428639|NCT01316484|Cognitive Debriefing|cognitive debriefing
428640|NCT01316471|Chronic Pain|chronic pain
428641|NCT01316471|Abdominal Pain|abdominal pain
428642|NCT01316471|Headache|headache
428643|NCT01316471|Adolescents|adolescents
428644|NCT01316471|Internet Interventions|internet interventions
428645|NCT01316471|Behavioral Interventions|behavioral interventions
428646|NCT01316458|Prostate cancer,|prostate cancer,
428647|NCT01316458|radical prostatectomy,|radical prostatectomy,
428648|NCT01316458|PSA rise|psa rise
428649|NCT01316445|Electroencephalography|electroencephalography
428650|NCT01316445|Benzodiazepines|benzodiazepines
428651|NCT01316445|Midazolam|midazolam
428652|NCT01316432|Cenderitide|cenderitide
428653|NCT01316432|CD-NP|cd-np
428654|NCT01316432|Natriuretic peptide|natriuretic peptide
428655|NCT01316432|Heart failure|heart failure
428656|NCT01316432|Chronic heart failure|chronic heart failure
428657|NCT01316432|HF|hf
428658|NCT01316432|CHF|chf
428659|NCT01316406|safety|safety
428660|NCT01316406|efficacy|efficacy
428661|NCT01316406|treatment|treatment
428662|NCT01316406|PPES|ppes
428663|NCT01316406|Palmar-Plantar Erythrodysesthesia Syndrome|palmar-plantar erythrodysesthesia syndrome
428664|NCT01316406|Hand-foot syndrome|hand-foot syndrome
428665|NCT01316406|capecitabine|capecitabine
428666|NCT01316393|xerostomia, saliva, mucoprotection, oral health|xerostomia, saliva, mucoprotection, oral health
428667|NCT01316367|Health Promotion Education|health promotion education
428668|NCT01316367|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
428669|NCT01316367|Cardiovascular Risk Factors|cardiovascular risk factors
428670|NCT01316367|Spain|spain
428671|NCT01316354|Arabinoxylan|arabinoxylan
428672|NCT01316354|Beta glucan|beta glucan
428673|NCT01316354|Whole grain|whole grain
428674|NCT01316354|Dietary fibre|dietary fibre
428675|NCT01316354|Metabolic syndrome|metabolic syndrome
428676|NCT01316354|Glycemic index|glycemic index
428677|NCT01316354|Satiety|satiety
428678|NCT01316328|toxicity after single shot partial breast irradiation (SSPBI)|toxicity after single shot partial breast irradiation (sspbi)
428679|NCT01316302|Social Anxiety Disorder|social anxiety disorder
428680|NCT01316302|Social Phobia|social phobia
428681|NCT01316302|SAD|sad
428682|NCT01316289|tibial fractures|tibial fractures
428683|NCT01316289|pilon|pilon
428684|NCT01316289|pilon fractures|pilon fractures
428685|NCT01316289|tibial plafond|tibial plafond
428686|NCT01316289|reduction quality|reduction quality
428687|NCT01316289|anatomical reduction|anatomical reduction
428688|NCT01316289|functional outcome|functional outcome
428689|NCT01316289|ankle joint|ankle joint
428690|NCT01316276|Cystic Fibrosis|cystic fibrosis
428691|NCT01316276|Respiratory Infections|respiratory infections
428692|NCT01316276|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
428693|NCT01316276|CFTR|cftr
428694|NCT01316276|Anti-bacterial Agent|anti-bacterial agent
428695|NCT01316250|chronic myelogenous leukemia|chronic myelogenous leukemia
428696|NCT01316250|nilotinib|nilotinib
428697|NCT01316250|complete cytogenetic response|complete cytogenetic response
428698|NCT01316250|imatinib mesylate|imatinib mesylate
428699|NCT01316237|Hepatitis C|hepatitis c
428700|NCT01316237|HCV|hcv
428701|NCT01316237|HCV RNA|hcv rna
428702|NCT01316237|Polymerase inhibitor|polymerase inhibitor
428703|NCT01316237|Treatment naïve|treatment naïve
428704|NCT01316237|GS-6620|gs-6620
428705|NCT01316224|Psoriasis|psoriasis
428706|NCT01316224|Incidence|incidence
428707|NCT01316224|Quality of Life|quality of life
428708|NCT01316224|Psoriatic Arthritis|psoriatic arthritis
428709|NCT01316224|Prevalence|prevalence
428710|NCT01316211|Back Pains|back pains
428711|NCT01316211|Pain, Back|pain, back
428712|NCT01316211|Pains, Back|pains, back
428713|NCT01316211|Backache|backache
428714|NCT01316211|Backaches|backaches
428717|NCT01316211|Aches, Back|aches, back
428718|NCT01316211|Back Aches|back aches
428719|NCT01316211|Back Pain without Radiation|back pain without radiation
428720|NCT01316211|Vertebrogenic Pain Syndrome|vertebrogenic pain syndrome
428721|NCT01316211|Pain Syndrome, Vertebrogenic|pain syndrome, vertebrogenic
428722|NCT01316211|Pain Syndromes, Vertebrogenic|pain syndromes, vertebrogenic
428723|NCT01316211|Syndrome, Vertebrogenic Pain|syndrome, vertebrogenic pain
428724|NCT01316211|Syndromes, Vertebrogenic Pain|syndromes, vertebrogenic pain
428725|NCT01316211|Vertebrogenic Pain Syndromes|vertebrogenic pain syndromes
428726|NCT01316211|Back Pain with Radiation|back pain with radiation
428727|NCT01316211|Stenosis, spinal|stenosis, spinal
428728|NCT01316211|Caudal stenosis|caudal stenosis
428729|NCT01316211|Spondylopathy|spondylopathy
428730|NCT01316211|Spondylopathies|spondylopathies
428731|NCT01316211|Low back pain|low back pain
428732|NCT01316211|Lower back pain|lower back pain
428733|NCT01316198|human study|human study
428734|NCT01316198|AMD|amd
428735|NCT01316198|lutein|lutein
428736|NCT01316198|zeaxanthin|zeaxanthin
428737|NCT01316198|optical density|optical density
428738|NCT01316185|Hepatitis D|hepatitis d
428739|NCT01316185|HDV|hdv
428740|NCT01316185|Hepatitis|hepatitis
428741|NCT01316172|consultation|consultation
428742|NCT01316146|Hodgkin's Lymphoma|hodgkin's lymphoma
428743|NCT01316146|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
428744|NCT01316146|Lymphoma|lymphoma
428745|NCT01316146|T lymphocytes|t lymphocytes
428746|NCT01316133|Tacrolimus|tacrolimus
428747|NCT01316133|Prograf|prograf
428748|NCT01316133|FK506|fk506
428749|NCT01316133|Proteinuria|proteinuria
428750|NCT01316133|Calcineurin inhibitor|calcineurin inhibitor
428751|NCT01316120|Self-collected vaginal samples|self-collected vaginal samples
428752|NCT01316120|HPV|hpv
428753|NCT01316120|HPV self-obtained sample|hpv self-obtained sample
428754|NCT01316120|HPV specimen transport medium|hpv specimen transport medium
428755|NCT01316107|ASP1941|asp1941
428756|NCT01316107|Diabetes mellitus|diabetes mellitus
428757|NCT01316107|nateglinide|nateglinide
428758|NCT01316107|long-term safety|long-term safety
428759|NCT01316094|Renal impairment|renal impairment
428760|NCT01316094|ASP1941|asp1941
428761|NCT01316094|Pharmacokinetics|pharmacokinetics
428762|NCT01316081|antioxidant supplementation|antioxidant supplementation
428765|NCT01316081|iron status|iron status
428766|NCT01316081|oxidative stress|oxidative stress
428767|NCT01316081|inflammation|inflammation
428768|NCT01316068|diabetic nephropathy|diabetic nephropathy
428769|NCT01316068|albuminuria|albuminuria
428770|NCT01316068|type 2 diabetes|type 2 diabetes
428771|NCT01316068|sulodexide|sulodexide
428772|NCT01316042|Puberty|puberty
428773|NCT01316042|Hormones|hormones
428774|NCT01316029|Laying-on-of-hands|laying-on-of-hands
428775|NCT01316029|Therapeutic touch|therapeutic touch
428776|NCT01316029|cross-sectional study|cross-sectional study
428777|NCT01316029|healing environment|healing environment
428778|NCT01316029|safety and effectiveness|safety and effectiveness
428779|NCT01316029|optimal condition for the intervention|optimal condition for the intervention
428780|NCT01316016|obesity|obesity
428781|NCT01316016|glucose intolerance|glucose intolerance
428782|NCT01316016|cholesterol|cholesterol
428783|NCT01316016|blood pressure|blood pressure
428784|NCT01316003|cone outer segment tips line|cone outer segment tips line
428785|NCT01316003|Optical coherence tomography|optical coherence tomography
428786|NCT01315990|Phase IV Study|phase iv study
428787|NCT01315990|Metastatic Colorectal Cancer (mCRC|metastatic colorectal cancer (mcrc
428788|NCT01315990|Cetuximab (Erbitux)|cetuximab (erbitux)
428789|NCT01315990|first-line treatment|first-line treatment
428790|NCT01315990|acneiform follicular exanthema|acneiform follicular exanthema
428791|NCT01315990|rash|rash
428792|NCT01315990|vitamin K1|vitamin k1
428793|NCT01315977|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
428794|NCT01315977|Antioxidant oxidant balance|antioxidant oxidant balance
428795|NCT01315977|Activation of Antioxidant Response Element|activation of antioxidant response element
428796|NCT01315964|cholesterol|cholesterol
428797|NCT01315964|plant sterols|plant sterols
428798|NCT01315964|atherosclerosis|atherosclerosis
428799|NCT01315964|arterial stiffness|arterial stiffness
428800|NCT01315951|Non scalp Seborrheic Dermatitis|non scalp seborrheic dermatitis
428801|NCT01315925|Acute myeloid leukemia|acute myeloid leukemia
428802|NCT01315925|invasive fungal infection|invasive fungal infection
428803|NCT01315925|Aspergillosis|aspergillosis
428804|NCT01315925|candidiasis|candidiasis
428805|NCT01315912|clomiphene citrate|clomiphene citrate
428806|NCT01315912|infertility|infertility
428807|NCT01315912|letrozole|letrozole
428808|NCT01315899|Raynaud's phenomenon|raynaud's phenomenon
428809|NCT01315899|Systemic sclerosis|systemic sclerosis
428810|NCT01315886|sublingual|sublingual
428811|NCT01315886|fentanyl|fentanyl
428812|NCT01315886|titration|titration
428813|NCT01315886|conversion|conversion
428814|NCT01315886|breakthrough cancer pain|breakthrough cancer pain
428815|NCT01315886|pain intensity difference|pain intensity difference
428817|NCT01315886|Edmonton Symptom Assessment System|edmonton symptom assessment system
428818|NCT01315886|ESAS|esas
428819|NCT01315873|myeloma|myeloma
428820|NCT01315873|multiple myeloma|multiple myeloma
428821|NCT01315873|relapsed myeloma|relapsed myeloma
428822|NCT01315873|refractory myeloma|refractory myeloma
428823|NCT01315860|Low Back Pain|low back pain
428824|NCT01315860|Pregnancy|pregnancy
428825|NCT01315860|Biomechanics|biomechanics
428826|NCT01315821|Saccharomyces boulardii|saccharomyces boulardii
428827|NCT01315821|necrotizing enterocolitis|necrotizing enterocolitis
428828|NCT01315795|polycystic liver disease|polycystic liver disease
428829|NCT01315782|Sepsis|sepsis
428830|NCT01315782|Severe sepsis|severe sepsis
428831|NCT01315782|Septic shock|septic shock
428832|NCT01315782|Alveolar dead space|alveolar dead space
428833|NCT01315782|Multi-organ failure|multi-organ failure
428834|NCT01315730|stuttering|stuttering
428835|NCT01315730|haptic|haptic
428836|NCT01315730|feedback|feedback
428837|NCT01315730|fluency|fluency
428838|NCT01315691|Cystic Fibrosis|cystic fibrosis
428839|NCT01315691|Respiratory Infections|respiratory infections
428840|NCT01315691|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
428841|NCT01315691|Amikacin|amikacin
428842|NCT01315691|Anti-bacterial agents|anti-bacterial agents
428843|NCT01315678|Cystic Fibrosis|cystic fibrosis
428844|NCT01315678|Respiratory Infections|respiratory infections
428845|NCT01315678|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
428846|NCT01315678|CFTR|cftr
428847|NCT01315678|Amikacin|amikacin
428848|NCT01315678|Anti-bacterial Agents|anti-bacterial agents
428849|NCT01315665|broccoli sprouts|broccoli sprouts
428850|NCT01315665|sulforaphane|sulforaphane
428851|NCT01315665|triterpenoid|triterpenoid
428852|NCT01315665|Nrf2 activation|nrf2 activation
428853|NCT01315665|cystic fibrosis|cystic fibrosis
428854|NCT01315665|healthy volunteers|healthy volunteers
428855|NCT01315665|anti-inflammatory|anti-inflammatory
428856|NCT01315652|1 Rheumatoid arthritis|1 rheumatoid arthritis
428857|NCT01315652|2 Education|2 education
428858|NCT01315652|3 Co-morbidities|3 co-morbidities
428859|NCT01315652|4 Nurse|4 nurse
428860|NCT01315639|Dementia|dementia
428861|NCT01315639|Cognitive impairment|cognitive impairment
428862|NCT01315639|Memory impairment|memory impairment
428863|NCT01315639|Mild Cognitive Impairment|mild cognitive impairment
428864|NCT01315639|Cerebrospinal fluid|cerebrospinal fluid
428865|NCT01315639|Plasma|plasma
428866|NCT01315639|Biomarker|biomarker
428867|NCT01315639|Longitudinal|longitudinal
428868|NCT01315639|Abeta peptide amyloid, saPP alpha|abeta peptide amyloid, sapp alpha
428869|NCT01315639|Oculomotor impairment|oculomotor impairment
428870|NCT01315626|Bronchiectasis|bronchiectasis
428871|NCT01315626|pulmonary exacerbations|pulmonary exacerbations
428872|NCT01315626|pulmonary infections|pulmonary infections
428873|NCT01315574|Glaucoma|glaucoma
428874|NCT01315574|Xalatan|xalatan
428875|NCT01315574|Travatan Z|travatan z
428876|NCT01315574|Latanoprost|latanoprost
428877|NCT01315574|Travoprost|travoprost
428878|NCT01315574|Dry Eye|dry eye
428879|NCT01315561|acute low back pain|acute low back pain
428880|NCT01315561|motion stlye acupuncture treatment|motion stlye acupuncture treatment
428881|NCT01315561|disability|disability
428882|NCT01315561|MSAT|msat
428883|NCT01315548|Contrast enhanced harmonic endoscopic ultrasound|contrast enhanced harmonic endoscopic ultrasound
428884|NCT01315548|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
428885|NCT01315548|Chronic pancreatitis|chronic pancreatitis
428886|NCT01315535|Mandibular Advancement|mandibular advancement
428887|NCT01315535|Oral Appliance|oral appliance
428888|NCT01315535|TMD|tmd
428889|NCT01315522|Stents|stents
428890|NCT01315522|Endoscopy|endoscopy
428891|NCT01315522|Cholangiopancreatography|cholangiopancreatography
428892|NCT01315522|Endoscopic Retrograde|endoscopic retrograde
428893|NCT01315509|Severe mental illness|severe mental illness
428894|NCT01315509|Dental measures|dental measures
428895|NCT01315509|Resistant depression|resistant depression
428896|NCT01315496|Human Immunoglobulin G|human immunoglobulin g
428897|NCT01315496|Sepsis|sepsis
428898|NCT01315496|Septic shock|septic shock
428899|NCT01315483|Breast cancer|breast cancer
428900|NCT01315483|survivors|survivors
428901|NCT01315483|weight lose|weight lose
428902|NCT01315483|dietary pattern|dietary pattern
428903|NCT01315470|improving pregnancy rate and endometrial thickness|improving pregnancy rate and endometrial thickness
428904|NCT01315457|alemtuzumab, infection, prophylaxis, treatment|alemtuzumab, infection, prophylaxis, treatment
428905|NCT01315431|Solid tumor malignancy, excluding lymphoma|solid tumor malignancy, excluding lymphoma
428906|NCT01315418|Probiotic - Lactobacillus casei DN-114 001 - dairy product -|probiotic - lactobacillus casei dn-114 001 - dairy product -
428907|NCT01315418|infections - firemen|infections - firemen
428908|NCT01315418|Common infectious diseases, occuring in healthy subjects,|common infectious diseases, occuring in healthy subjects,
428909|NCT01315418|including upper respiratory tract infections (defined as|including upper respiratory tract infections (defined as
428910|NCT01315418|rhinopharyngitis, sore throat, sinusitis and otitis)|rhinopharyngitis, sore throat, sinusitis and otitis)
428911|NCT01315418|lower respiratory tract infections (defined as bronchitis|lower respiratory tract infections (defined as bronchitis
429008|NCT01314976|Children|children
428912|NCT01315418|pneumopathy and flu and flu-like syndromes)|pneumopathy and flu and flu-like syndromes)
428913|NCT01315418|gastrointestinal tract infection defined as gastroenteritis|gastrointestinal tract infection defined as gastroenteritis
428914|NCT01315405|Emotional facial expression|emotional facial expression
428915|NCT01315405|Apathy|apathy
428916|NCT01315405|Mirror neurons|mirror neurons
428917|NCT01315379|Prolonged Exposure|prolonged exposure
428918|NCT01315379|CBT|cbt
428919|NCT01315379|PTSD|ptsd
428920|NCT01315379|Mild Traumatic Brain Injury|mild traumatic brain injury
428921|NCT01315379|Post Concussive Syndrome|post concussive syndrome
428922|NCT01315366|Vitamin D|vitamin d
428923|NCT01315366|Elderly|elderly
428924|NCT01315366|Cardiovascular profile|cardiovascular profile
428925|NCT01315366|Insulin resistance|insulin resistance
428926|NCT01315366|Gene polymorphisms|gene polymorphisms
428927|NCT01315327|Tourette's Disorder, Obsessive-Compulsive Disorder, tics|tourette's disorder, obsessive-compulsive disorder, tics
428928|NCT01315314|Glucose degradation products|glucose degradation products
428929|NCT01315314|Inflammation|inflammation
428930|NCT01315314|Endothelial dysfunction|endothelial dysfunction
428931|NCT01315314|Soluble adhesion molecules|soluble adhesion molecules
428932|NCT01315314|Peritoneal dialysis|peritoneal dialysis
428933|NCT01315301|Efavirenz|efavirenz
428934|NCT01315301|Rifampicin|rifampicin
428935|NCT01315301|HAART|haart
428936|NCT01315301|Anti Tuberculosis|anti tuberculosis
428937|NCT01315288|Medical decision making|medical decision making
428938|NCT01315288|Asymptomatic Carotid Stenosis|asymptomatic carotid stenosis
428939|NCT01315275|visual impairment|visual impairment
428940|NCT01315275|macular edema|macular edema
428941|NCT01315275|ranibizumab|ranibizumab
428942|NCT01315275|visual impairment due to macular edema|visual impairment due to macular edema
428943|NCT01315262|Sildenafil 100|sildenafil 100
428944|NCT01315262|restoring erectile function after radical prostatectomy|restoring erectile function after radical prostatectomy
428945|NCT01315249|QVA149|qva149
428946|NCT01315249|indacaterol|indacaterol
428947|NCT01315249|NVA237|nva237
428948|NCT01315249|COPD|copd
428949|NCT01315249|fluticasone/salmeterol|fluticasone/salmeterol
428950|NCT01315210|Fibromyalgia|fibromyalgia
428951|NCT01315210|Fatigue|fatigue
428952|NCT01315210|D-Ribose|d-ribose
428953|NCT01315197|Low back Pain|low back pain
428954|NCT01315184|Interactive Voice Response|interactive voice response
428955|NCT01315184|Computer-based Treatment|computer-based treatment
428956|NCT01315184|Opioid Agonist|opioid agonist
428957|NCT01315184|Buprenorphine|buprenorphine
428958|NCT01315184|Methadone|methadone
428959|NCT01315171|medium chain triglycerides|medium chain triglycerides
428960|NCT01315171|hypoglycemia|hypoglycemia
428961|NCT01315171|cognitive function|cognitive function
428962|NCT01315171|functional MRI|functional mri
428963|NCT01315158|Obstructive Sleep Apnea|obstructive sleep apnea
428964|NCT01315158|Body Mass Index|body mass index
428965|NCT01315132|Myeloablative Hematopoietic Stem Cell Transplant|myeloablative hematopoietic stem cell transplant
428966|NCT01315132|Cyclophosphamide tolerization|cyclophosphamide tolerization
428967|NCT01315132|2 Step Approach|2 step approach
428968|NCT01315132|Hematological malignancies|hematological malignancies
428969|NCT01315132|leukemia|leukemia
428970|NCT01315132|lymphoma|lymphoma
428971|NCT01315132|multiple myeloma|multiple myeloma
428972|NCT01315132|Hodgkin's Disease|hodgkin's disease
428973|NCT01315093|In Vitro Fertilisation|in vitro fertilisation
428974|NCT01315093|poor responders|poor responders
428975|NCT01315080|mammillary fistula|mammillary fistula
428976|NCT01315080|triamcinolone|triamcinolone
428977|NCT01315080|ultrasound management|ultrasound management
428978|NCT01315080|percutaneous treatment|percutaneous treatment
428979|NCT01315067|kidney transplantation|kidney transplantation
428980|NCT01315067|acute rejection|acute rejection
428981|NCT01315067|diagnosis|diagnosis
428982|NCT01315067|urine analysis|urine analysis
428983|NCT01315067|urinary peptides|urinary peptides
428984|NCT01315067|mass spectrometry|mass spectrometry
428985|NCT01315067|allograft biopsy|allograft biopsy
428986|NCT01315067|pathology|pathology
428987|NCT01315067|diagnostic study|diagnostic study
428988|NCT01315054|IDUs|idus
428989|NCT01315054|high risk behaviors|high risk behaviors
428990|NCT01315054|HIV|hiv
428991|NCT01315054|MMT dosage and retention|mmt dosage and retention
428992|NCT01315054|psychosocial services|psychosocial services
428993|NCT01315028|mania|mania
428994|NCT01315028|hypomania|hypomania
428995|NCT01315028|bipolar affective disorder|bipolar affective disorder
428996|NCT01315028|psychological intervention|psychological intervention
428997|NCT01315028|cognitive therapy|cognitive therapy
428998|NCT01315015|Breast cancer|breast cancer
428999|NCT01315015|Breast neoplasm|breast neoplasm
429000|NCT01315015|Magnetic Resonance Imaging|magnetic resonance imaging
429001|NCT01315015|Breast density|breast density
429002|NCT01315015|Early detection of cancer|early detection of cancer
429003|NCT01315015|Cancer screening test|cancer screening test
429004|NCT01315015|Secondary prevention|secondary prevention
429005|NCT01315002|nicotine|nicotine
429006|NCT01315002|schizophrenia|schizophrenia
429007|NCT01315002|endophenotype|endophenotype
429009|NCT01314976|parasite|parasite
429010|NCT01314976|intestinal|intestinal
429011|NCT01314976|treatment|treatment
429013|NCT01314937|preschool-age children|preschool-age children
429014|NCT01314937|soil-transmitted helminths|soil-transmitted helminths
429015|NCT01314937|growth|growth
429016|NCT01314937|development|development
429017|NCT01314937|deworming|deworming
429018|NCT01314924|Hypertension|hypertension
429019|NCT01314924|Endothelial dysfunction|endothelial dysfunction
429020|NCT01314924|Vascular stiffness|vascular stiffness
429021|NCT01314924|Use of one or two antihypertensive drugs|use of one or two antihypertensive drugs
429022|NCT01314911|H1N1|h1n1
429023|NCT01314911|Complications|complications
429024|NCT01314911|PCR|pcr
429025|NCT01314911|Seasonal Influenza|seasonal influenza
429026|NCT01314911|Viral Shedding|viral shedding
429027|NCT01314898|Single dose|single dose
429028|NCT01314898|cross-over|cross-over
429029|NCT01314898|active-control|active-control
429030|NCT01314898|placebo control|placebo control
429031|NCT01314898|antimineralocorticoid activity|antimineralocorticoid activity
429032|NCT01314885|Healthy|healthy
429033|NCT01314872|Overactive bladder|overactive bladder
429034|NCT01314872|MK-4618|mk-4618
429035|NCT01314872|tolterodine|tolterodine
429036|NCT01314859|Nifedipine|nifedipine
429037|NCT01314859|Obstetric Labor|obstetric labor
429038|NCT01314859|Premature|premature
429039|NCT01314859|Tocolysis|tocolysis
429040|NCT01314833|Luminal A|luminal a
429041|NCT01314833|Luminal B|luminal b
429042|NCT01314833|Her-2 overexpression|her-2 overexpression
429043|NCT01314833|DFS|dfs
429044|NCT01314833|DDFS|ddfs
429045|NCT01314833|OS|os
429046|NCT01314820|Knee|knee
429047|NCT01314820|Osteoarthritis|osteoarthritis
429048|NCT01314820|Effusion.|effusion.
429049|NCT01314807|COPD|copd
429050|NCT01314781|Overactive Bladder|overactive bladder
429051|NCT01314781|urinary frequency|urinary frequency
429052|NCT01314755|Head and Neck neoplasm|head and neck neoplasm
429053|NCT01314755|Nutrition|nutrition
429054|NCT01314755|Carcinoma|carcinoma
429055|NCT01314755|Infection|infection
429056|NCT01314755|Post-operative|post-operative
429057|NCT01314755|Surgery|surgery
429058|NCT01314755|Immune-enhancing|immune-enhancing
429059|NCT01314742|neonates|neonates
429060|NCT01314742|mechanical ventilation|mechanical ventilation
429061|NCT01314742|oral care|oral care
429062|NCT01314742|duration of mechanical ventilation|duration of mechanical ventilation
429063|NCT01314742|feasibility|feasibility
429064|NCT01314742|ventilator-associated pneumonia|ventilator-associated pneumonia
429065|NCT01314729|Orthodontic fixed retainer|orthodontic fixed retainer
429066|NCT01314729|fiber-reinforced-composite retainer|fiber-reinforced-composite retainer
429067|NCT01314729|composite-wire retainer|composite-wire retainer
429068|NCT01314690|obesity|obesity
429069|NCT01314690|low calorie diet|low calorie diet
429070|NCT01314690|intestinal microbiota|intestinal microbiota
429071|NCT01314690|inflammation (systemic and in adipose tissue)|inflammation (systemic and in adipose tissue)
429072|NCT01314690|fat mass|fat mass
429073|NCT01314690|Impact of nutritional transition on intestinal microbiota|impact of nutritional transition on intestinal microbiota
429074|NCT01314690|relation between food intake, clinical parameters and intestinal microbiota|relation between food intake, clinical parameters and intestinal microbiota
429075|NCT01314664|Non-Muscle Invasive Bladder Cancer|non-muscle invasive bladder cancer
429076|NCT01314664|CIS|cis
429077|NCT01314664|BCG Refractory|bcg refractory
429078|NCT01314651|Migraine Disorders|migraine disorders
429079|NCT01314651|Chronic migraine|chronic migraine
429080|NCT01314651|Insomnia|insomnia
429081|NCT01314651|Behavioral sleep management|behavioral sleep management
429082|NCT01314612|Insomnia|insomnia
429083|NCT01314612|group psychotherapy|group psychotherapy
429084|NCT01314612|nightmares|nightmares
429085|NCT01314612|PTSD|ptsd
429086|NCT01314612|posttraumatic stress disorder|posttraumatic stress disorder
429087|NCT01314612|Veterans|veterans
429088|NCT01314612|cognitive-behavioral intervention|cognitive-behavioral intervention
429089|NCT01314599|Leukemia|leukemia
429090|NCT01314599|lurbinectedin|lurbinectedin
429091|NCT01314599|PM01183|pm01183
429092|NCT01314599|Pharma Mar|pharma mar
429093|NCT01314599|Acute Leukemia in Relapse and Primary Refractory|acute leukemia in relapse and primary refractory
429094|NCT01314586|hypercholesterolemia|hypercholesterolemia
429095|NCT01314586|postmenopause|postmenopause
429096|NCT01314586|secoisolariciresinol diglucoside|secoisolariciresinol diglucoside
429097|NCT01314586|flaxseed|flaxseed
429098|NCT01314586|lignans|lignans
429099|NCT01314586|enterolactone|enterolactone
429100|NCT01314586|enterodiol|enterodiol
429101|NCT01314586|serum cholesterol|serum cholesterol
429102|NCT01314586|LDL cholesterol|ldl cholesterol
429103|NCT01314573|High intensity exercise training|high intensity exercise training
429104|NCT01314573|Vascular health|vascular health
429105|NCT01314573|Endothelial function|endothelial function
429106|NCT01314573|Circulating angiogenic cells|circulating angiogenic cells
429107|NCT01314573|endothelial progenitor cells|endothelial progenitor cells
429108|NCT01314573|Aerobic capacity|aerobic capacity
429109|NCT01314573|Arterial stiffness|arterial stiffness
429110|NCT01314573|Traditional and emerging cardiovascular disease risk factors|traditional and emerging cardiovascular disease risk factors
429111|NCT01314560|Lowe syndrome|lowe syndrome
429112|NCT01314560|OCRL|ocrl
429113|NCT01314560|Haemostasis|haemostasis
429114|NCT01314560|Bleeding Disorders|bleeding disorders
429115|NCT01314560|Platelet Function Tests|platelet function tests
429116|NCT01314547|Environment|environment
429117|NCT01314547|spondylarthritis|spondylarthritis
429118|NCT01314547|vasculitis|vasculitis
429119|NCT01314547|stress|stress
429120|NCT01314547|life event|life event
429121|NCT01314547|vaccine|vaccine
429122|NCT01314534|Kabuki syndrome|kabuki syndrome
429123|NCT01314534|Genetic|genetic
429124|NCT01314534|CGH-array|cgh-array
429125|NCT01314521|Suicide|suicide
429126|NCT01314521|Depression|depression
429127|NCT01314521|Adolescents|adolescents
429128|NCT01314508|pre-pubertal children|pre-pubertal children
429129|NCT01314508|pre-transplant|pre-transplant
429130|NCT01314508|not treated with growth hormone for at least 3 months|not treated with growth hormone for at least 3 months
429131|NCT01314495|Alopecia Areata|alopecia areata
429132|NCT01314482|Neuropathic pain|neuropathic pain
429133|NCT01314482|Minocycline|minocycline
429134|NCT01314469|Quality of life in patients with macular edema compared to patients without macular edema.|quality of life in patients with macular edema compared to patients without macular edema.
429135|NCT01314456|Prostate biopsy|prostate biopsy
429136|NCT01314456|Trans-rectal ultrasound|trans-rectal ultrasound
429137|NCT01314456|Prostate cancer|prostate cancer
429138|NCT01314443|smoking cessation|smoking cessation
429139|NCT01314443|gamma-tocopherol|gamma-tocopherol
429140|NCT01314443|nicotine-replacement therapy|nicotine-replacement therapy
429141|NCT01314443|oxidative stress|oxidative stress
429142|NCT01314417|Uveitis|uveitis
429143|NCT01314417|Macular Edema|macular edema
429144|NCT01314417|Methotrexate|methotrexate
429145|NCT01314404|Human papillomavirus|human papillomavirus
429146|NCT01314404|Prevalence|prevalence
429147|NCT01314404|Knowledge Attitude and Practice|knowledge attitude and practice
429148|NCT01314404|Willingness to Participate|willingness to participate
429149|NCT01314404|Vaccine|vaccine
429151|NCT01314391|stage I Wilms tumor|stage i wilms tumor
429152|NCT01314391|stage II Wilms tumor|stage ii wilms tumor
429153|NCT01314391|stage III Wilms tumor|stage iii wilms tumor
429154|NCT01314391|stage IV Wilms tumor|stage iv wilms tumor
429155|NCT01314391|stage V Wilms tumor|stage v wilms tumor
429156|NCT01314391|renal failure|renal failure
429157|NCT01314378|Mindfulness|mindfulness
429158|NCT01314378|Cognitive behavioral therapy|cognitive behavioral therapy
429159|NCT01314378|Smoking|smoking
429160|NCT01314378|Impulsivity|impulsivity
429161|NCT01314378|Inhibitory Control|inhibitory control
429162|NCT01314326|Optical Coherence Tomography|optical coherence tomography
429163|NCT01314326|Glaucoma|glaucoma
429164|NCT01314326|Advanced Imaging|advanced imaging
429165|NCT01314313|SAPIEN XT|sapien xt
429166|NCT01314313|SAPIEN 3|sapien 3
429167|NCT01314313|Transfemoral|transfemoral
429168|NCT01314313|Transapical|transapical
429169|NCT01314313|Transaortic|transaortic
429170|NCT01314313|NovaFlex|novaflex
429171|NCT01314313|TAVI|tavi
429172|NCT01314313|Aortic Stenosis|aortic stenosis
429173|NCT01314313|THV|thv
429174|NCT01314313|Aortic Valve|aortic valve
429175|NCT01314313|Transcatheter Heart Valve|transcatheter heart valve
429176|NCT01314313|tAVR|tavr
429177|NCT01314300|Child, adolescent, young adult|child, adolescent, young adult
429178|NCT01314300|Plaster|plaster
429179|NCT01314300|Lidocaine|lidocaine
429180|NCT01314287|Anaesthesia|anaesthesia
429181|NCT01314287|pulmonary complications|pulmonary complications
429182|NCT01314287|Atelectasis|atelectasis
429183|NCT01314274|Epistaxis|epistaxis
429184|NCT01314274|Osler|osler
429185|NCT01314274|Weber|weber
429186|NCT01314274|Rendu|rendu
429187|NCT01314274|HHT|hht
429188|NCT01314274|Hereditary haemorrhagic telangiectasia|hereditary haemorrhagic telangiectasia
429189|NCT01314248|airway sealing pressure|airway sealing pressure
429190|NCT01314248|fiberoptic assessment|fiberoptic assessment
429191|NCT01314248|ease and time for successful insertion|ease and time for successful insertion
429192|NCT01314248|incidence of gastric insufflation|incidence of gastric insufflation
429193|NCT01314248|complications were also evaluated|complications were also evaluated
429194|NCT01314235|anticoagulation with ASS|anticoagulation with ass
429195|NCT01314235|anticoagulation with clopidogrel|anticoagulation with clopidogrel
429196|NCT01314209|dexmedetomidine|dexmedetomidine
429197|NCT01314209|pharmacokinetics|pharmacokinetics
429198|NCT01314209|critical illness|critical illness
429199|NCT01314209|continuous renal replacement therapy|continuous renal replacement therapy
429200|NCT01314196|biceps|biceps
429201|NCT01314196|resistance training|resistance training
429202|NCT01314196|rehabilitation|rehabilitation
429203|NCT01314196|impact syndrome|impact syndrome
429204|NCT01314183|Knee|knee
429205|NCT01314183|Physical Therapy|physical therapy
429206|NCT01314183|Exercise|exercise
429207|NCT01314170|Implant, glaucoma, refractory glaucoma.|implant, glaucoma, refractory glaucoma.
429208|NCT01314157|low back pain|low back pain
429209|NCT01314157|pain|pain
429210|NCT01314157|incapacity|incapacity
429211|NCT01314157|life quality|life quality
429212|NCT01314157|rehabilitation|rehabilitation
429213|NCT01314144|axillary clearance|axillary clearance
429214|NCT01314144|wound infiltration|wound infiltration
429215|NCT01314144|wound infusion|wound infusion
429216|NCT01314144|local anaesthetic wound infusion|local anaesthetic wound infusion
429217|NCT01314118|abiraterone acetate|abiraterone acetate
429218|NCT01314118|prednisone|prednisone
429219|NCT01314118|zytiga|zytiga
429220|NCT01314092|crohn's disease|crohn's disease
429221|NCT01314092|fistula|fistula
429222|NCT01314092|complex|complex
429223|NCT01314079|Crohn's fistula|crohn's fistula
429224|NCT01314079|Autologous adipose derived stem cell|autologous adipose derived stem cell
429225|NCT01314053|Daptomycin|daptomycin
429226|NCT01314053|Serious Gram-positive Infections|serious gram-positive infections
429227|NCT01314040|Dietary protein|dietary protein
429228|NCT01314040|Biomarkers|biomarkers
429229|NCT01314040|filtration rate|filtration rate
429230|NCT01314040|urinary acid excretion|urinary acid excretion
429231|NCT01314014|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
429232|NCT01314014|Lymphoma, Low Grade|lymphoma, low grade
429233|NCT01314014|Lymphoma, Intermediate Grade|lymphoma, intermediate grade
429234|NCT01314014|Lymphoma, High Grade|lymphoma, high grade
429235|NCT01314014|Lymphoma, B Cell|lymphoma, b cell
429236|NCT01314001|Tobacco, Smoking, Varenicline, Nicotine Patch|tobacco, smoking, varenicline, nicotine patch
429237|NCT01313988|dose-response study|dose-response study
429238|NCT01313988|blood lipid profile|blood lipid profile
429239|NCT01313988|plant sterols|plant sterols
429240|NCT01313988|fish oil|fish oil
429241|NCT01313975|Electrolyte disturbances|electrolyte disturbances
429242|NCT01313975|Fluid balance|fluid balance
429243|NCT01313975|subarachnoid hemorrhage|subarachnoid hemorrhage
429244|NCT01313975|traumatic brain injury|traumatic brain injury
429245|NCT01313975|Cerebral salt wasting|cerebral salt wasting
429246|NCT01313975|SIADH|siadh
429247|NCT01313975|Diabetes insipidus|diabetes insipidus
429248|NCT01313962|antiviral|antiviral
429249|NCT01313962|intranasal|intranasal
429250|NCT01313962|influenza|influenza
429251|NCT01313949|Diabetes|diabetes
429252|NCT01313949|Peer Support|peer support
429253|NCT01313949|Structured Care|structured care
429254|NCT01313936|Neuroblastoma|neuroblastoma
429255|NCT01313936|MIBG|mibg
429256|NCT01313936|131I-MIBG|131i-mibg
429257|NCT01313936|Irinotecan|irinotecan
429258|NCT01313936|Vincristine|vincristine
429259|NCT01313936|Resistant|resistant
429260|NCT01313936|Relapsed|relapsed
429261|NCT01313936|Treatment|treatment
429262|NCT01313936|UCSF|ucsf
429263|NCT01313936|Pediatric|pediatric
429264|NCT01313936|Oncology|oncology
429265|NCT01313923|Pemphigus|pemphigus
429266|NCT01313910|HIV|hiv
429267|NCT01313910|diarrhea|diarrhea
429268|NCT01313897|Multiple Myeloma|multiple myeloma
429269|NCT01313832|ventricular septal defect|ventricular septal defect
429270|NCT01313832|remote ischemic preconditioning|remote ischemic preconditioning
429271|NCT01313832|pulmonary hypertension|pulmonary hypertension
429272|NCT01313832|infant with ventricular septal defect and pulmonary hypertension|infant with ventricular septal defect and pulmonary hypertension
429273|NCT01313819|Freezing|freezing
429274|NCT01313806|dementia|dementia
429275|NCT01313806|memory loss|memory loss
429276|NCT01313806|cognitive decline|cognitive decline
429277|NCT01313793|Bioequivalence (BE) Study|bioequivalence (be) study
429278|NCT01313793|Healthy Volunteers|healthy volunteers
429279|NCT01313780|cancer related pain|cancer related pain
429280|NCT01313767|spasticity|spasticity
429281|NCT01313767|upperlimb|upperlimb
429282|NCT01313767|Botulinum toxin|botulinum toxin
429283|NCT01313754|Skin closure|skin closure
429284|NCT01313754|dermabond|dermabond
429285|NCT01313754|vicryl|vicryl
429286|NCT01313754|monocryl|monocryl
429287|NCT01313754|Suburethral sling|suburethral sling
429288|NCT01313754|Transobturator Sling|transobturator sling
429289|NCT01313754|Pain|pain
429290|NCT01313754|Discomfort|discomfort
429291|NCT01313754|Skin irritation|skin irritation
429292|NCT01313728|Acne|acne
429293|NCT01313728|Irritation|irritation
429294|NCT01313715|Safety|safety
429295|NCT01313715|Immunogenicity|immunogenicity
429296|NCT01313715|inactivated EV71 vaccine|inactivated ev71 vaccine
429297|NCT01313702|polypill, compliance, cardiovascular disease|polypill, compliance, cardiovascular disease
429298|NCT01313689|Safety|safety
429299|NCT01313689|Refractory|refractory
429300|NCT01313689|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
429301|NCT01313689|Oncology|oncology
429302|NCT01313689|Ofatumumab|ofatumumab
429303|NCT01313689|Efficacy|efficacy
429304|NCT01313676|COPD|copd
429305|NCT01313676|Cardiovascular disease|cardiovascular disease
429306|NCT01313676|Novel Dry Powder Inhaler|novel dry powder inhaler
429307|NCT01313676|Survival|survival
429308|NCT01313663|GW786034|gw786034
429309|NCT01313663|non-small cell lung cancer|non-small cell lung cancer
429310|NCT01313663|NSCLC|nsclc
429311|NCT01313663|pemetrexed|pemetrexed
429312|NCT01313663|pazopanib|pazopanib
429313|NCT01313650|long-acting beta agonist|long-acting beta agonist
429314|NCT01313650|anticholinergic|anticholinergic
429315|NCT01313637|anticholinergic|anticholinergic
429316|NCT01313637|long-acting beta agonist|long-acting beta agonist
429317|NCT01313598|Patients with solid tumors|patients with solid tumors
429318|NCT01313598|Treatment-refractory|treatment-refractory
429319|NCT01313585|Primary care|primary care
429320|NCT01313585|asthma management|asthma management
429321|NCT01313585|inhaler device|inhaler device
429322|NCT01313585|maintenance therapy|maintenance therapy
429323|NCT01313585|reliever therapy|reliever therapy
429324|NCT01313585|Easibreathe salbutamol|easibreathe salbutamol
429325|NCT01313572|Coronary Artery Disease|coronary artery disease
429326|NCT01313572|Myocardial Perfusion Imaging|myocardial perfusion imaging
429327|NCT01313559|Castrate Resistant|castrate resistant
429328|NCT01313559|Chemotherapy Naive|chemotherapy naive
429329|NCT01313559|Prostate Cancer|prostate cancer
429330|NCT01313559|SOM230|som230
429331|NCT01313559|Everolimus|everolimus
429332|NCT01313546|Femoral nerve block|femoral nerve block
429333|NCT01313546|total knee arthroplasty|total knee arthroplasty
429334|NCT01313533|Atherosclerosis of Autologous Vein Bypass Graft|atherosclerosis of autologous vein bypass graft
429335|NCT01313507|Primary Immunodeficiency Disease|primary immunodeficiency disease
429336|NCT01313507|PID|pid
429337|NCT01313494|COPD|copd
429338|NCT01313494|Roflumilast|roflumilast
429339|NCT01313494|FEV1|fev1
429340|NCT01313494|China|china
429341|NCT01313481|Older persons|older persons
429342|NCT01313481|Exercise|exercise
429343|NCT01313481|Balance|balance
429344|NCT01313468|NEAT|neat
429345|NCT01313468|maximal oxygen uptake|maximal oxygen uptake
429346|NCT01313468|stroke volume|stroke volume
429347|NCT01313455|Oligomenorrhea|oligomenorrhea
429348|NCT01313455|Adrenal Hyperplasia|adrenal hyperplasia
429349|NCT01313455|Obesity|obesity
429350|NCT01313455|Hyperandrogenism|hyperandrogenism
429351|NCT01313455|Polycystic Ovarian Syndrome|polycystic ovarian syndrome
429352|NCT01313455|PCOS|pcos
429353|NCT01313455|Polycystic Ovary|polycystic ovary
429354|NCT01313455|Healthy Volunteer|healthy volunteer
429355|NCT01313455|HV|hv
429356|NCT01313442|Gut Microbiota|gut microbiota
429357|NCT01313442|Analysis of immune subsets with regard to their function|analysis of immune subsets with regard to their function
429358|NCT01313442|Samples|samples
429359|NCT01313442|Gastrointestinal Cancer|gastrointestinal cancer
429360|NCT01313442|Gastrointestinal Tract Cancer|gastrointestinal tract cancer
429361|NCT01313429|Metastatic Cancer|metastatic cancer
429362|NCT01313429|Cancer Vaccine|cancer vaccine
429363|NCT01313429|Immunotherapy|immunotherapy
429364|NCT01313429|Adjuvant Therapy|adjuvant therapy
429365|NCT01313429|Chest Metastases|chest metastases
429366|NCT01313429|Cancer|cancer
429367|NCT01313429|Melanoma|melanoma
429368|NCT01313429|Lung Cancer|lung cancer
429369|NCT01313429|Sarcoma|sarcoma
429370|NCT01313416|Adjuvant Therapy|adjuvant therapy
429371|NCT01313416|Recombinant Monoclonal Antibody|recombinant monoclonal antibody
429372|NCT01313416|Adenocarcinoma of the Pancreas|adenocarcinoma of the pancreas
429373|NCT01313416|Vaccination|vaccination
429374|NCT01313416|PD-1 Receptor|pd-1 receptor
429375|NCT01313416|Pancreas Cancer|pancreas cancer
429376|NCT01313416|Pancreatic Cancer|pancreatic cancer
429377|NCT01313403|5-HT1A Receptors|5-ht1a receptors
429378|NCT01313403|Major Depression|major depression
429379|NCT01313403|PET Imaging|pet imaging
429380|NCT01313403|Depression|depression
429381|NCT01313403|Healthy Volunteer|healthy volunteer
429382|NCT01313403|HV|hv
429383|NCT01313390|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
429384|NCT01313390|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
429385|NCT01313390|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
429386|NCT01313390|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
429387|NCT01313390|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
429388|NCT01313390|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
429389|NCT01313390|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
429390|NCT01313390|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
429391|NCT01313390|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
429392|NCT01313390|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
429393|NCT01313390|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
429394|NCT01313390|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
429395|NCT01313390|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
429396|NCT01313390|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
429397|NCT01313390|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
429582|NCT01312532|Total knee arthroplasty|total knee arthroplasty
429398|NCT01313390|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
429399|NCT01313390|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
429400|NCT01313390|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
429401|NCT01313390|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
429402|NCT01313390|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
429403|NCT01313390|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
429404|NCT01313390|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
429405|NCT01313390|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
429406|NCT01313390|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
429407|NCT01313390|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
429408|NCT01313390|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
429409|NCT01313390|recurrent salivary gland cancer|recurrent salivary gland cancer
429410|NCT01313390|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
429411|NCT01313390|stage III salivary gland cancer|stage iii salivary gland cancer
429412|NCT01313390|stage IV salivary gland cancer|stage iv salivary gland cancer
429413|NCT01313390|tongue cancer|tongue cancer
429414|NCT01313377|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
429415|NCT01313377|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
429416|NCT01313377|liver and intrahepatic biliary tract cancer|liver and intrahepatic biliary tract cancer
429417|NCT01313377|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
429418|NCT01313377|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
429419|NCT01313377|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
429420|NCT01313377|localized gallbladder cancer|localized gallbladder cancer
429421|NCT01313325|hippotherapy|hippotherapy
429422|NCT01313325|neuromuscular disorders|neuromuscular disorders
429423|NCT01313325|balance deficits|balance deficits
429424|NCT01313325|participation|participation
429425|NCT01313286|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
429426|NCT01313260|Refractory partial epilepsies|refractory partial epilepsies
429427|NCT01313247|Paracetamol|paracetamol
429428|NCT01313247|opioids|opioids
429429|NCT01313247|cancer pain|cancer pain
429430|NCT01313221|plaque psoriasis|plaque psoriasis
429431|NCT01313221|moderate|moderate
429432|NCT01313221|severe|severe
429433|NCT01313221|etanercept|etanercept
429434|NCT01313221|Enbrel|enbrel
429435|NCT01313221|topical|topical
429436|NCT01313208|RA|ra
429437|NCT01313208|Enbrel|enbrel
429438|NCT01313208|DMARD|dmard
429439|NCT01313208|Joint Count|joint count
429440|NCT01313208|Rheumatoid Arthritis|rheumatoid arthritis
429441|NCT01313208|Etanercept|etanercept
429442|NCT01313208|disease modifying anti-rheumatic drug|disease modifying anti-rheumatic drug
429443|NCT01313169|Electronic medical record reminders, Panel management|electronic medical record reminders, panel management
429444|NCT01313156|Metabolic Syndrome, Syndrome X, MetS,|metabolic syndrome, syndrome x, mets,
429445|NCT01313156|Type 2 Diabetes|type 2 diabetes
429446|NCT01313143|AOP200704, Esmolol, Pharmacokinetics, Pharmacodynamics|aop200704, esmolol, pharmacokinetics, pharmacodynamics
429447|NCT01313130|traumatic brain injury|traumatic brain injury
429448|NCT01313130|post traumatic stress disorder|post traumatic stress disorder
429449|NCT01313130|Diffusion tensor imaging|diffusion tensor imaging
429450|NCT01313130|resting state functional connectivity|resting state functional connectivity
429451|NCT01313130|genetic factors|genetic factors
429452|NCT01313117|chemotherapy|chemotherapy
429453|NCT01313117|peripheral neuropathy|peripheral neuropathy
429454|NCT01313117|paclitaxel|paclitaxel
429455|NCT01313117|breast cancer|breast cancer
429456|NCT01313078|Ovarian Cancer|ovarian cancer
429457|NCT01313078|Fallopian Tube Cancer|fallopian tube cancer
429458|NCT01313078|Primary Peritoneal Cancer|primary peritoneal cancer
429459|NCT01313078|Relapsed or Refractory|relapsed or refractory
429460|NCT01313078|Pegaspargase|pegaspargase
429461|NCT01313078|Pegylated L-Asparaginase|pegylated l-asparaginase
429462|NCT01313065|VX15/2503|vx15/2503
429463|NCT01313065|Semaphorin 4D|semaphorin 4d
429464|NCT01313065|SEMA4D|sema4d
429465|NCT01313065|CD100|cd100
429466|NCT01313065|safety|safety
429467|NCT01313065|tolerability|tolerability
429468|NCT01313065|pharmacokinetics|pharmacokinetics
429469|NCT01313065|pharmacodynamics|pharmacodynamics
429470|NCT01313065|advanced solid tumors|advanced solid tumors
429471|NCT01313052|Psychotic|psychotic
429472|NCT01313052|Criminal|criminal
429473|NCT01313039|Breast Cancer|breast cancer
429474|NCT01313039|ER-negative|er-negative
429475|NCT01313039|Allred Score|allred score
429476|NCT01313026|Percutaneous nerve evaluation|percutaneous nerve evaluation
429477|NCT01313026|Transanal irrigation|transanal irrigation
429478|NCT01313026|Low anterior resection syndrome|low anterior resection syndrome
429479|NCT01313000|fat, transfer, autologous fat transfer, bicep|fat, transfer, autologous fat transfer, bicep
429480|NCT01312948|Obstructive sleep apnea|obstructive sleep apnea
429481|NCT01312948|OSA|osa
429482|NCT01312948|CPAP|cpap
429483|NCT01312948|CPAP mask|cpap mask
429484|NCT01312948|Non-invasive ventilation|non-invasive ventilation
429485|NCT01312948|NIV|niv
429486|NCT01312935|Percutaneous Coronary Intervention|percutaneous coronary intervention
429487|NCT01312935|Heparin|heparin
429488|NCT01312935|Angioplasty|angioplasty
429489|NCT01312935|LMWH|lmwh
429490|NCT01312909|smoking cessation in adolescents|smoking cessation in adolescents
429491|NCT01312857|colon|colon
429492|NCT01312857|rectal|rectal
429493|NCT01312857|liver|liver
429494|NCT01312857|AMG 954 (Panitumumab)|amg 954 (panitumumab)
429495|NCT01312857|DEXAMETHASONE|dexamethasone
429496|NCT01312857|FLOXURIDINE|floxuridine
429497|NCT01312857|FLUOROURACIL|fluorouracil
429498|NCT01312857|IRINOTECAN (CPT-11) CAMPTOSAR|irinotecan (cpt-11) camptosar
429499|NCT01312857|LEUCOVORIN|leucovorin
429500|NCT01312857|10-137|10-137
429501|NCT01312831|cobalamin|cobalamin
429502|NCT01312831|B12|b12
429503|NCT01312831|homocysteine|homocysteine
429504|NCT01312831|MMA|mma
429505|NCT01312831|holotranscobalamin|holotranscobalamin
429506|NCT01312831|Eligen|eligen
429507|NCT01312805|asthma|asthma
429508|NCT01312805|clinical decision support|clinical decision support
429509|NCT01312805|CHICA|chica
429510|NCT01312792|Severe Pneumonia|severe pneumonia
429511|NCT01312792|Pneumonia|pneumonia
429512|NCT01312792|ARI|ari
429513|NCT01312792|IMCI|imci
429514|NCT01312792|Modified IMCI|modified imci
429515|NCT01312792|1st level Health facilities|1st level health facilities
429516|NCT01312792|Children|children
429517|NCT01312792|Operational Research|operational research
429518|NCT01312792|Bangladesh|bangladesh
429519|NCT01312792|Treatment of Severe Pneumonia|treatment of severe pneumonia
429520|NCT01312779|Mitral Valve Replacement|mitral valve replacement
429521|NCT01312779|23mm CEP|23mm cep
429522|NCT01312779|Magna|magna
429523|NCT01312740|obesity|obesity
429524|NCT01312740|dietary treatment|dietary treatment
429525|NCT01312740|high protein diet|high protein diet
429526|NCT01312740|Low glycaemic index|low glycaemic index
429527|NCT01312740|adipocytes|adipocytes
429528|NCT01312740|fat mass|fat mass
429529|NCT01312740|systemic inflammatory markers|systemic inflammatory markers
429530|NCT01312740|improvement of complications|improvement of complications
429531|NCT01312740|effect on weight loss|effect on weight loss
429532|NCT01312727|Tubulointerstitial renal diseases|tubulointerstitial renal diseases
429533|NCT01312727|Hereditary renal diseases|hereditary renal diseases
429534|NCT01312727|Uromodulin|uromodulin
429535|NCT01312727|Renin gene|renin gene
429536|NCT01312714|Hemodialysis|hemodialysis
429537|NCT01312714|Peritoneal dialysis|peritoneal dialysis
429538|NCT01312714|Vitamin D Deficiency|vitamin d deficiency
429539|NCT01312714|blood pressure|blood pressure
429540|NCT01312714|arterial stiffness|arterial stiffness
429541|NCT01312714|Heart function|heart function
429542|NCT01312714|Renin-angiotensin system|renin-angiotensin system
429543|NCT01312714|Calcium|calcium
429544|NCT01312714|FGF-23|fgf-23
429545|NCT01312714|Brain natriuretic peptide|brain natriuretic peptide
429546|NCT01312701|cancer|cancer
429547|NCT01312701|immunomonitoring|immunomonitoring
429548|NCT01312701|CD247 -zeta chain|cd247 -zeta chain
429549|NCT01312701|chronic inflamation|chronic inflamation
429550|NCT01312701|anticancertherapy|anticancertherapy
429551|NCT01312688|Early Goal Directed Hemodunamic Therapy in Sepsis|early goal directed hemodunamic therapy in sepsis
429552|NCT01312675|severe sepsis|severe sepsis
429553|NCT01312675|mechanical ventilation|mechanical ventilation
429554|NCT01312610|orange juice|orange juice
429555|NCT01312610|cognitive function|cognitive function
429556|NCT01312610|flavonoids|flavonoids
429557|NCT01312610|flavanones|flavanones
429558|NCT01312597|Flavonoid|flavonoid
429559|NCT01312597|Cognitive performance|cognitive performance
429560|NCT01312597|Cognitive function|cognitive function
429561|NCT01312597|Executive function|executive function
429562|NCT01312597|fMRI|fmri
429563|NCT01312597|Cerebral blood flow|cerebral blood flow
429564|NCT01312597|Acute|acute
429565|NCT01312584|Flavanol|flavanol
429566|NCT01312584|Cocoa|cocoa
429567|NCT01312584|Vascular function|vascular function
429568|NCT01312584|Absorption|absorption
429569|NCT01312584|Metabolism|metabolism
429570|NCT01312584|Alkalisation|alkalisation
429571|NCT01312558|obstructive sleep apnoea/hypopnoea syndrome|obstructive sleep apnoea/hypopnoea syndrome
429572|NCT01312558|Mediterranean diet|mediterranean diet
429573|NCT01312558|exercise|exercise
429574|NCT01312558|weight loss|weight loss
429575|NCT01312558|continuous positive airway pressure|continuous positive airway pressure
429576|NCT01312558|lipid peroxidation|lipid peroxidation
429577|NCT01312545|orbital implant|orbital implant
429578|NCT01312545|evisceration|evisceration
429579|NCT01312545|economic|economic
429580|NCT01312545|polyethylene|polyethylene
429581|NCT01312545|porous|porous
429583|NCT01312532|Fixed-bearing|fixed-bearing
429584|NCT01312532|Mobile-bearing|mobile-bearing
429585|NCT01312519|Bone marrow biopsy of iliac crest|bone marrow biopsy of iliac crest
429586|NCT01312506|metastatic|metastatic
429587|NCT01312506|melanoma|melanoma
429588|NCT01312506|CNS|cns
429589|NCT01312493|Head and neck cancer|head and neck cancer
429590|NCT01312493|Phase II|phase ii
429591|NCT01312493|Locally advanced|locally advanced
429592|NCT01312493|Panitumumab|panitumumab
429593|NCT01312493|Vectibix|vectibix
429594|NCT01312493|Lineberger|lineberger
429595|NCT01312493|Radiation Therapy|radiation therapy
429596|NCT01312493|Intensity modulated radiation therapy (IMRT)|intensity modulated radiation therapy (imrt)
429597|NCT01312493|Stage III to IVB|stage iii to ivb
429598|NCT01312480|Tobacco|tobacco
429599|NCT01312480|Tobacco Prevention|tobacco prevention
429600|NCT01312480|Tobacco Cessation|tobacco cessation
429601|NCT01312480|5A's Model|5a's model
429602|NCT01312480|Adolescence|adolescence
429603|NCT01312480|Media Use|media use
429604|NCT01312454|intravitreal injection|intravitreal injection
429605|NCT01312454|intraocular pressure|intraocular pressure
429606|NCT01312454|open-angle glaucoma|open-angle glaucoma
429607|NCT01312454|ocular hypertension|ocular hypertension
429608|NCT01312441|Vitamin D|vitamin d
429609|NCT01312441|Ergocalciferol|ergocalciferol
429610|NCT01312415|total knee arthroplasty|total knee arthroplasty
429611|NCT01312415|total knee replacement|total knee replacement
429612|NCT01312415|local infiltration analgesia|local infiltration analgesia
429613|NCT01312415|intra-articular local anaesthesia|intra-articular local anaesthesia
429614|NCT01312415|patients undergoing total knee arthroplasty (total knee replacement)|patients undergoing total knee arthroplasty (total knee replacement)
429615|NCT01312363|Alzheimer's disease|alzheimer's disease
429616|NCT01312363|Rivastigmine|rivastigmine
429617|NCT01312363|Patch|patch
429618|NCT01312363|Tolerability|tolerability
429619|NCT01312350|neoadjuvant chemotherapy|neoadjuvant chemotherapy
429620|NCT01312350|definitive chemoradiation therapy|definitive chemoradiation therapy
429621|NCT01312350|head and neck cancer|head and neck cancer
429622|NCT01312350|base of tongue|base of tongue
429623|NCT01312350|Locally advanced|locally advanced
429624|NCT01312337|gefitinib|gefitinib
429625|NCT01312337|EGFR mutation negative|egfr mutation negative
429626|NCT01312337|NSCLC|nsclc
429627|NCT01312324|neoadjuvant chemotherapy|neoadjuvant chemotherapy
429628|NCT01312324|thymic cancer|thymic cancer
429629|NCT01312311|nasopharyngeal cancer|nasopharyngeal cancer
429630|NCT01312311|weekly docetaxel|weekly docetaxel
429631|NCT01312311|cisplatin|cisplatin
429632|NCT01312298|Arthritis|arthritis
429633|NCT01312298|General anaesthesia|general anaesthesia
429634|NCT01312298|Spinal anaesthesia|spinal anaesthesia
429635|NCT01312285|osteoarthritis|osteoarthritis
429636|NCT01312285|painful hips|painful hips
429637|NCT01312272|Schizophrenia|schizophrenia
429638|NCT01312272|Social Intelligence|social intelligence
429639|NCT01312272|Perception, Social|perception, social
429640|NCT01312272|Oxytocin|oxytocin
429641|NCT01312259|Painful Bladder Syndrome|painful bladder syndrome
429642|NCT01312259|Interstitial Cystitis|interstitial cystitis
429643|NCT01312259|Pelvic Floor dysfunction|pelvic floor dysfunction
429644|NCT01312259|Fecal incontinence|fecal incontinence
429645|NCT01312259|Constipation|constipation
429646|NCT01312259|Sexual dysfunction|sexual dysfunction
429647|NCT01312259|Dyspareunia|dyspareunia
429648|NCT01312259|Vulvodynia|vulvodynia
429649|NCT01312246|vessel ligation|vessel ligation
429650|NCT01312246|colon resection|colon resection
429651|NCT01312207|tractional retinoschisis|tractional retinoschisis
429652|NCT01312207|traction retinal detachment|traction retinal detachment
429653|NCT01312194|Periapical Periodontitis|periapical periodontitis
429654|NCT01312194|Dental Pulp Necrosis|dental pulp necrosis
429655|NCT01312194|Root canal Therapy|root canal therapy
429656|NCT01312194|Adolescent|adolescent
429657|NCT01312181|Technology based intervention|technology based intervention
429658|NCT01312181|HIV primary care clinic|hiv primary care clinic
429659|NCT01312181|Brief behavioral intervention|brief behavioral intervention
429660|NCT01312181|Drug abuse|drug abuse
429661|NCT01312168|Cardiovascular disease|cardiovascular disease
429662|NCT01312168|Continuous positive airway pressure|continuous positive airway pressure
429663|NCT01312168|Endothelium|endothelium
429664|NCT01312168|Vascular function|vascular function
429665|NCT01312168|Inflammation|inflammation
429666|NCT01312168|Sleep Apnea|sleep apnea
429667|NCT01312168|Obstructive|obstructive
429668|NCT01312155|endotracheal|endotracheal
429669|NCT01312155|intubation|intubation
429670|NCT01312155|video|video
429671|NCT01312155|time|time
429672|NCT01312129|Alcohol|alcohol
429673|NCT01312129|Sulfasalazine|sulfasalazine
429674|NCT01312116|Internet treatment|internet treatment
429675|NCT01312116|GAD|gad
429676|NCT01312116|guided self-help|guided self-help
429677|NCT01312103|Safety Planning|safety planning
429678|NCT01312090|Weight loss|weight loss
429679|NCT01312090|brown adipose tissue|brown adipose tissue
429680|NCT01312090|white adipose tissue|white adipose tissue
429681|NCT01312090|muscle, metabolism|muscle, metabolism
429682|NCT01312090|cold exposure|cold exposure
429683|NCT01312077|total hip arthroplasty|total hip arthroplasty
429684|NCT01312077|total hip replacement|total hip replacement
429685|NCT01312077|local infiltration analgesia|local infiltration analgesia
429686|NCT01312077|wound infusion|wound infusion
429687|NCT01312077|patients undergoing total hip replacement (total hip arthroplasty)|patients undergoing total hip replacement (total hip arthroplasty)
429688|NCT01312064|rituximab|rituximab
429689|NCT01312064|everolimus|everolimus
429690|NCT01312038|Eustachian tube|eustachian tube
429691|NCT01312038|otitis|otitis
429692|NCT01312038|middle-ear pressure|middle-ear pressure
429693|NCT01312038|simethicone|simethicone
429694|NCT01312012|hepatitis B virus,mother-infant transmission, nucleoside analog,pregnant women|hepatitis b virus,mother-infant transmission, nucleoside analog,pregnant women
429695|NCT01311999|latent tuberculosis, renal failure, dialysis, interferon-gamma release assay|latent tuberculosis, renal failure, dialysis, interferon-gamma release assay
429696|NCT01311986|atopic dermatitis|atopic dermatitis
429697|NCT01311986|nummular eczema|nummular eczema
429698|NCT01311986|chemokines|chemokines
429699|NCT01311973|Chronic kidney disease, phosphorus, salivary phosphorus|chronic kidney disease, phosphorus, salivary phosphorus
429700|NCT01311960|pterygium|pterygium
429701|NCT01311960|recurrent pterygium|recurrent pterygium
429702|NCT01311960|bevacizumab|bevacizumab
429703|NCT01311960|VEGF|vegf
429704|NCT01311960|anti-VEGF|anti-vegf
429705|NCT01311947|Chronic hepatitis B|chronic hepatitis b
429706|NCT01311947|Peginterferon alfa-2a|peginterferon alfa-2a
429707|NCT01311921|enterovirus 71, host genetics, social, behavior, environmental factors|enterovirus 71, host genetics, social, behavior, environmental factors
429708|NCT01311908|Pancreaticoduodenectomy|pancreaticoduodenectomy
429709|NCT01311908|Roux-en-Y reconstruction|roux-en-y reconstruction
429710|NCT01311908|Reflux esophagitis|reflux esophagitis
429711|NCT01311895|acute|acute
429712|NCT01311895|pain|pain
429713|NCT01311895|emergency department|emergency department
429714|NCT01311895|hydromorphone|hydromorphone
429715|NCT01311856|Behavioral intervention|behavioral intervention
429716|NCT01311856|Exercise|exercise
429717|NCT01311856|Physical Assessment|physical assessment
429718|NCT01311856|Questionnaire|questionnaire
429719|NCT01311856|Survey|survey
429720|NCT01311856|Telephone counseling|telephone counseling
429721|NCT01311856|Internet interventions|internet interventions
429722|NCT01311856|Overweight cancer survivors|overweight cancer survivors
429723|NCT01311856|Exercise and weight management program|exercise and weight management program
429724|NCT01311791|Left ventricular augmentation|left ventricular augmentation
429725|NCT01311791|Left ventricular restoration|left ventricular restoration
429726|NCT01311765|Postoperative peritonitis|postoperative peritonitis
429727|NCT01311765|Intra-abdominal infection|intra-abdominal infection
429728|NCT01311765|Surgery|surgery
429729|NCT01311765|Laparotomy|laparotomy
429730|NCT01311765|Nosocomial infection|nosocomial infection
429731|NCT01311765|Antibiotic therapy|antibiotic therapy
429732|NCT01311765|Duration of treatment|duration of treatment
429733|NCT01311765|Multidrug resistant bacteria|multidrug resistant bacteria
429734|NCT01311752|human papillomavirus|human papillomavirus
429735|NCT01311752|follow up|follow up
429736|NCT01311739|Pharmacokinetics|pharmacokinetics
429737|NCT01311713|cancer|cancer
429738|NCT01311713|tumors|tumors
429739|NCT01311713|PARP|parp
429740|NCT01311700|Ischemia|ischemia
429741|NCT01311700|Reperfusion|reperfusion
429742|NCT01311700|Myocardial infarction|myocardial infarction
429743|NCT01311700|Beta blockers|beta blockers
429744|NCT01311700|Metoprolol|metoprolol
429745|NCT01311700|Acute myocardial infarction|acute myocardial infarction
429746|NCT01311700|Necrosis|necrosis
429747|NCT01311700|Salvaged Myocardium|salvaged myocardium
429748|NCT01311687|Myeloma|myeloma
429749|NCT01311687|Multiple Myeloma|multiple myeloma
429750|NCT01311687|Relapsed Multiple Myeloma|relapsed multiple myeloma
429751|NCT01311687|Relapsed and Refractory Multiple Myeloma|relapsed and refractory multiple myeloma
429752|NCT01311687|Refractory Myeloma|refractory myeloma
429753|NCT01311687|Resistant Multiple Myeloma|resistant multiple myeloma
429754|NCT01311687|Treatment-resistant Multiple Myeloma|treatment-resistant multiple myeloma
429755|NCT01311687|Pomalidomide|pomalidomide
429756|NCT01311687|Lenalidomide-resistant|lenalidomide-resistant
429757|NCT01311687|Bortezomib-resistant|bortezomib-resistant
429758|NCT01311648|recombinant factor VIII|recombinant factor viii
429759|NCT01311648|pediatric use|pediatric use
429760|NCT01311635|Phase 1|phase 1
429761|NCT01311635|bioavailability study|bioavailability study
429762|NCT01311635|AZD1981|azd1981
429763|NCT01311635|tablets|tablets
429764|NCT01311635|To study the relative bioavailability of single dose AZD1981 via three different tablets|to study the relative bioavailability of single dose azd1981 via three different tablets
429765|NCT01311635|To compare the bioavailability between three different AZD1981 tablets|to compare the bioavailability between three different azd1981 tablets
429766|NCT01311622|drug-drug interaction|drug-drug interaction
429767|NCT01311622|Phase 1|phase 1
429768|NCT01311622|healthy subjects|healthy subjects
429769|NCT01311622|warfarin|warfarin
429770|NCT01311622|Rheumatoid arthritis|rheumatoid arthritis
429771|NCT01311622|RA|ra
429772|NCT01311622|fostamatinib open-label|fostamatinib open-label
429773|NCT01311622|pharmacokinetics|pharmacokinetics
429774|NCT01311622|pharmacodynamics|pharmacodynamics
429775|NCT01311622|level of Warfarin in the blood|level of warfarin in the blood
429776|NCT01311609|Systane, Dry Eye|systane, dry eye
429777|NCT01311596|icons in clinic or office for patients with Autism|icons in clinic or office for patients with autism
429778|NCT01311583|Self-care|self-care
429779|NCT01311583|Teach Back|teach back
429780|NCT01311557|Tetanus|tetanus
429781|NCT01311557|Diphtheria|diphtheria
429782|NCT01311557|Pertussis|pertussis
429783|NCT01311557|Tdap vaccine|tdap vaccine
429784|NCT01311557|Adacel®|adacel®
429785|NCT01311531|Fracture|fracture
429786|NCT01311531|Radius|radius
429787|NCT01311531|Surgery|surgery
429788|NCT01311531|Osteosynthesis|osteosynthesis
429789|NCT01311518|Thymosin Beta 4|thymosin beta 4
429790|NCT01311518|Thymosin β4 (Tβ4) Injectable Solution|thymosin β4 (tβ4) injectable solution
429791|NCT01311518|RGN-352|rgn-352
429792|NCT01311505|bioequivalence; rifampicin|bioequivalence; rifampicin
429793|NCT01311492|Alzheimer's Disease|alzheimer's disease
429794|NCT01311492|exercise|exercise
429795|NCT01311492|physical activity|physical activity
429796|NCT01311492|intervention|intervention
429797|NCT01311479|Osteopathic Manipulation|osteopathic manipulation
429798|NCT01311479|Interstitial Cystitis|interstitial cystitis
429799|NCT01311479|Sacroiliac Joint Dysfunction|sacroiliac joint dysfunction
429800|NCT01311466|Liver transplantation|liver transplantation
429801|NCT01311466|Overall survival|overall survival
429802|NCT01311440|RCT|rct
429803|NCT01311440|modified Atkins diet|modified atkins diet
429804|NCT01311440|epilepsy|epilepsy
429805|NCT01311440|adults|adults
429806|NCT01311440|ketogenic diet|ketogenic diet
429807|NCT01311401|2 diabetes mellitus,Circassians, High fasting glucose|2 diabetes mellitus,circassians, high fasting glucose
429808|NCT01311388|cancer|cancer
429809|NCT01311375|spinal,, bone, cord injury, lipid,antioxidant|spinal,, bone, cord injury, lipid,antioxidant
429810|NCT01311362|Steady-state|steady-state
429811|NCT01311362|Ambrisentan|ambrisentan
429812|NCT01311362|St. Johns Wort|st. johns wort
429813|NCT01311349|Susceptibility of tigecycline|susceptibility of tigecycline
429814|NCT01311349|Drug Resistance, Bacterial|drug resistance, bacterial
429815|NCT01311336|Pegfilgrastim|pegfilgrastim
429816|NCT01311336|Loratadine|loratadine
429817|NCT01311336|Myalgia/arthralgia|myalgia/arthralgia
429818|NCT01311323|Multivessel Coronary Artery Disease|multivessel coronary artery disease
429819|NCT01311323|Left Main Narrowing|left main narrowing
429820|NCT01311323|Percutaneous Coronary Intervention|percutaneous coronary intervention
429821|NCT01311323|Coronary Artery Bypass Grafting|coronary artery bypass grafting
429822|NCT01311323|Drug-Eluting Stent|drug-eluting stent
429823|NCT01311310|troponin, open heart surgery, children|troponin, open heart surgery, children
429824|NCT01311284|Nasotracheal intubation|nasotracheal intubation
429825|NCT01311284|Macintosh laryngoscope|macintosh laryngoscope
429826|NCT01311284|Airtraq|airtraq
429827|NCT01311284|McGrath|mcgrath
429828|NCT01311284|Manikin|manikin
429829|NCT01311284|airway management|airway management
429830|NCT01311271|Stroke|stroke
429831|NCT01311271|Cerebrovascular disease|cerebrovascular disease
429832|NCT01311271|hemiplegia|hemiplegia
429833|NCT01311271|Transcranial magnetic stimulation|transcranial magnetic stimulation
429834|NCT01311271|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
429835|NCT01311271|rTMS|rtms
429836|NCT01311271|rehabilitation|rehabilitation
429837|NCT01311271|Upper Extremity|upper extremity
429838|NCT01311258|AML|aml
429839|NCT01311258|MDS|mds
429840|NCT01311245|Risky drinking|risky drinking
429841|NCT01311245|Brief intervention|brief intervention
429842|NCT01311245|Computer-generated feedback|computer-generated feedback
429843|NCT01311245|Stage-tailored|stage-tailored
429844|NCT01311245|Non-stage-tailored|non-stage-tailored
429845|NCT01311232|rituximab, lymphoma, hepatitis B virus|rituximab, lymphoma, hepatitis b virus
429846|NCT01311206|knee osteoarthritis|knee osteoarthritis
429847|NCT01311206|isokinetic knee extensor strength|isokinetic knee extensor strength
429848|NCT01311206|quadriceps volume|quadriceps volume
429849|NCT01311206|symptomatic knee osteoarthritis|symptomatic knee osteoarthritis
429850|NCT01311193|Circadian rhythms|circadian rhythms
429851|NCT01311193|Sleep-wake cycles|sleep-wake cycles
429852|NCT01311193|Melatonin|melatonin
429853|NCT01311193|Borderline Personality Disorder|borderline personality disorder
429854|NCT01311193|Light therapy|light therapy
429855|NCT01311167|Dexamethasone|dexamethasone
429856|NCT01311167|Sodium|sodium
429857|NCT01311154|carriers|carriers
429858|NCT01311154|resistant Enterobacteriaceae|resistant enterobacteriaceae
429859|NCT01311154|AMR|amr
429860|NCT01311154|antibiotic|antibiotic
429861|NCT01311128|Blood pressure|blood pressure
429862|NCT01311128|Heart rate|heart rate
429863|NCT01311128|Cardiac output|cardiac output
429864|NCT01311128|Critical care|critical care
429865|NCT01311128|Perioperative care|perioperative care
429866|NCT01311102|Pain score|pain score
429867|NCT01311102|IUD placement|iud placement
430069|NCT01310244|phase I|phase i
429868|NCT01311076|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
429869|NCT01311076|Insulin|insulin
429870|NCT01311076|Glucose|glucose
429871|NCT01311076|Drug Therapy|drug therapy
429872|NCT01311050|Metastatic Colorectal Cancer|metastatic colorectal cancer
429873|NCT01311037|Premenopausal Women with Advanced Breast Cancer|premenopausal women with advanced breast cancer
429874|NCT01311024|Children|children
429875|NCT01311024|Pneumococcal Vaccines|pneumococcal vaccines
429876|NCT01311011|Critical Limb Ischemia|critical limb ischemia
429877|NCT01310998|Schizophrenia|schizophrenia
429878|NCT01310998|high intensity exercise|high intensity exercise
429879|NCT01310998|interval training exercise|interval training exercise
429880|NCT01310985|Rectal Cancer|rectal cancer
429881|NCT01310972|Adjuvant Colon Cancer|adjuvant colon cancer
429882|NCT01310959|Aplastic Anemia Marrow Failure Syndrome|aplastic anemia marrow failure syndrome
429883|NCT01310946|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
429884|NCT01310894|Prostatic Disease|prostatic disease
429885|NCT01310894|Genital Neoplasm,male|genital neoplasm,male
429886|NCT01310894|Urogenital neoplasm|urogenital neoplasm
429887|NCT01310894|Genital disease,male|genital disease,male
429888|NCT01310894|Male urogenital disease|male urogenital disease
429889|NCT01310894|Neoplasms|neoplasms
429890|NCT01310894|Neoplasms by site|neoplasms by site
429891|NCT01310894|Prostatic neoplasm|prostatic neoplasm
429892|NCT01310894|Carcinoma|carcinoma
429893|NCT01310881|Neurogenesis|neurogenesis
429894|NCT01310881|hippocampal stem cells|hippocampal stem cells
429895|NCT01310881|depression|depression
429896|NCT01310881|stroke|stroke
429897|NCT01310868|adult giant cell glioblastoma|adult giant cell glioblastoma
429898|NCT01310868|adult gliosarcoma|adult gliosarcoma
429899|NCT01310868|adult glioblastoma|adult glioblastoma
429900|NCT01310855|adult giant cell glioblastoma|adult giant cell glioblastoma
429901|NCT01310855|adult glioblastoma|adult glioblastoma
429902|NCT01310855|adult gliosarcoma|adult gliosarcoma
429903|NCT01310855|recurrent adult brain tumor|recurrent adult brain tumor
429904|NCT01310842|Smoker|smoker
429905|NCT01310842|Smoking Cessation|smoking cessation
429906|NCT01310842|Social Determinants|social determinants
429907|NCT01310842|Environmental Effects|environmental effects
429908|NCT01310842|Individual-level effects|individual-level effects
429909|NCT01310842|Nicotine patch|nicotine patch
429910|NCT01310842|Smart Phone|smart phone
429911|NCT01310842|SP|sp
429912|NCT01310842|Global Positioning System|global positioning system
429913|NCT01310842|GPS|gps
429914|NCT01310842|Questionnaires|questionnaires
429915|NCT01310842|Saliva samples|saliva samples
429916|NCT01310829|Genetic counselor|genetic counselor
429917|NCT01310829|Genetic counseling degree program|genetic counseling degree program
429918|NCT01310829|Genetic counseling students|genetic counseling students
429919|NCT01310829|Virtual reality-based intervention|virtual reality-based intervention
429920|NCT01310829|VR|vr
429921|NCT01310829|Genetic counseling|genetic counseling
429922|NCT01310829|hereditary cancers|hereditary cancers
429923|NCT01310829|Questionnaires|questionnaires
429924|NCT01310829|Physiological measurements|physiological measurements
429925|NCT01310829|Skin sensors|skin sensors
429926|NCT01310816|malignant neoplasms of the bone|malignant neoplasms of the bone
429927|NCT01310816|bone sarcoma|bone sarcoma
429928|NCT01310803|Urinary Bladder Neoplasms|urinary bladder neoplasms
429929|NCT01310803|Neoplasms|neoplasms
429930|NCT01310803|Urologic Neoplasms|urologic neoplasms
429931|NCT01310803|Urogenital Neoplasms|urogenital neoplasms
429932|NCT01310803|Neoplasms by Site|neoplasms by site
429933|NCT01310803|Urinary Bladder Diseases|urinary bladder diseases
429934|NCT01310803|Urologic Diseases|urologic diseases
429935|NCT01310803|TURBT|turbt
429936|NCT01310803|Valstar|valstar
429937|NCT01310790|septic shock|septic shock
429938|NCT01310790|lactic acid clearance|lactic acid clearance
429939|NCT01310790|ScVO2|scvo2
429940|NCT01310777|Open-Angle glaucoma|open-angle glaucoma
429941|NCT01310777|Ocular Hypertension|ocular hypertension
429942|NCT01310777|OAG|oag
429943|NCT01310777|OHT|oht
429944|NCT01310764|Intraocular pressure|intraocular pressure
429945|NCT01310764|Trabeculectomy|trabeculectomy
429946|NCT01310764|Mitomycin C|mitomycin c
429947|NCT01310764|Bevacizumab|bevacizumab
429948|NCT01310738|Visceral leishmaniasis|visceral leishmaniasis
429949|NCT01310738|Leishmania infantum|leishmania infantum
429950|NCT01310738|Leishmania chagasi|leishmania chagasi
429951|NCT01310725|CABG|cabg
429952|NCT01310725|LIMA|lima
429953|NCT01310725|saphenous vein|saphenous vein
429954|NCT01310725|radial artery|radial artery
429955|NCT01310712|hyperhidrosis|hyperhidrosis
429956|NCT01310712|oxybutynin|oxybutynin
429957|NCT01310699|Colonoscopy|colonoscopy
429958|NCT01310699|Diagnostic imaging|diagnostic imaging
429959|NCT01310699|Colorectal Neoplasm|colorectal neoplasm
429960|NCT01310699|Tandem Colonoscopy|tandem colonoscopy
429961|NCT01310699|Flat Polyp|flat polyp
429962|NCT01310699|Nonpolypoid|nonpolypoid
429963|NCT01310699|Flat and Depressed Lesions|flat and depressed lesions
429964|NCT01310699|Primary Prevention|primary prevention
429965|NCT01310699|Endoscopy|endoscopy
429966|NCT01310686|wet AMD anti-VEGF|wet amd anti-vegf
429967|NCT01310686|Genetic analysis of patients with Wet AMD who have not responded fully to anti-VEGF treatments|genetic analysis of patients with wet amd who have not responded fully to anti-vegf treatments
429968|NCT01310673|Gout|gout
429969|NCT01310673|Allopurinol|allopurinol
429970|NCT01310673|Acute gout|acute gout
429971|NCT01310647|estradiol|estradiol
429972|NCT01310647|testosterone|testosterone
429973|NCT01310647|combined oral contraceptive|combined oral contraceptive
429974|NCT01310647|low responders|low responders
429975|NCT01310647|ICSI|icsi
429976|NCT01310634|Neonates|neonates
429977|NCT01310634|Parenting|parenting
429978|NCT01310634|Anxiety|anxiety
429979|NCT01310634|Depression|depression
429980|NCT01310621|Neonate|neonate
429981|NCT01310621|Meconium aspiration syndrome|meconium aspiration syndrome
429982|NCT01310621|surfactant lung lavage|surfactant lung lavage
429983|NCT01310608|Atherosclerosis aorta|atherosclerosis aorta
429984|NCT01310608|A-View|a-view
429985|NCT01310608|Distal ascending aorta|distal ascending aorta
429986|NCT01310608|Transoesophageal echocardiography|transoesophageal echocardiography
429987|NCT01310608|CABG|cabg
429988|NCT01310608|Cerebral embolisation|cerebral embolisation
429989|NCT01310595|Musculoskeletal manipulations|musculoskeletal manipulations
429990|NCT01310595|Proprioception|proprioception
429991|NCT01310595|Postural balance|postural balance
429992|NCT01310582|Sevoflurane|sevoflurane
429993|NCT01310582|Desflurane|desflurane
429994|NCT01310569|PCOS, Skinfold thickness, HOMA-IR|pcos, skinfold thickness, homa-ir
429995|NCT01310556|OGTT|ogtt
429996|NCT01310556|coronary artery disease|coronary artery disease
429997|NCT01310543|Teenage pregnancy|teenage pregnancy
429998|NCT01310543|Adolescent|adolescent
429999|NCT01310543|Sexual health|sexual health
430000|NCT01310543|Youth development|youth development
430001|NCT01310530|Breast Cancer|breast cancer
430002|NCT01310530|Partial Breast|partial breast
430003|NCT01310530|Proton Beam|proton beam
430004|NCT01310517|Angiogram|angiogram
430005|NCT01310517|Injected Contrast|injected contrast
430006|NCT01310517|Heart Function|heart function
430007|NCT01310517|contrast dye|contrast dye
430008|NCT01310478|Recombinant human endostatin|recombinant human endostatin
430009|NCT01310478|Metastatic colorectal cancer|metastatic colorectal cancer
430010|NCT01310478|DLT|dlt
430011|NCT01310478|MTD|mtd
430012|NCT01310478|Pharmacokinetics|pharmacokinetics
430013|NCT01310452|diabetes, basal insulin, metformin, liver fat, visceral fat|diabetes, basal insulin, metformin, liver fat, visceral fat
430014|NCT01310426|Anal Sphincter injury|anal sphincter injury
430015|NCT01310426|Fecal Incontinence|fecal incontinence
430016|NCT01310413|Influenza|influenza
430017|NCT01310413|H5N1|h5n1
430018|NCT01310413|Pandemic|pandemic
430019|NCT01310400|Influenza|influenza
430020|NCT01310400|Virus|virus
430021|NCT01310400|Vaccination|vaccination
430022|NCT01310400|Immunisation|immunisation
430023|NCT01310387|Lung cancer|lung cancer
430024|NCT01310387|Cancer pain|cancer pain
430025|NCT01310387|Opioid|opioid
430026|NCT01310374|influenza vaccine|influenza vaccine
430027|NCT01310374|immune response|immune response
430028|NCT01310374|dynamic changes|dynamic changes
430029|NCT01310361|Pharyngitis|pharyngitis
430030|NCT01310361|Group A β-hemolytic Streptococci|group a β-hemolytic streptococci
430031|NCT01310361|Exudate|exudate
430032|NCT01310361|Erythema Penicillin|erythema penicillin
430033|NCT01310361|Amoxicillin|amoxicillin
430034|NCT01310348|Bone|bone
430035|NCT01310348|Muscle strength|muscle strength
430036|NCT01310348|whole-body vibration|whole-body vibration
430037|NCT01310335|sclerostin|sclerostin
430038|NCT01310335|whole-body vibration|whole-body vibration
430039|NCT01310322|Phase I|phase i
430040|NCT01310322|Healthy male volunteers|healthy male volunteers
430041|NCT01310322|mild asthmatics|mild asthmatics
430042|NCT01310322|pharmacokinetics|pharmacokinetics
430043|NCT01310322|Bioavailability and AUC|bioavailability and auc
430044|NCT01310322|Level of AZD5423 in your blood|level of azd5423 in your blood
430045|NCT01310309|Stents|stents
430046|NCT01310309|Drug-eluting Stent|drug-eluting stent
430047|NCT01310309|Angioplasty|angioplasty
430048|NCT01310309|Coronary Artery stenosis|coronary artery stenosis
430049|NCT01310309|Coronary Artery Stent Restenosis|coronary artery stent restenosis
430050|NCT01310309|Stent Thrombosis|stent thrombosis
430051|NCT01310296|Phase 1|phase 1
430052|NCT01310296|Normal Healthy Volunteers|normal healthy volunteers
430053|NCT01310296|Mass Balance|mass balance
430054|NCT01310296|ADME|adme
430055|NCT01310296|Absolute Bioavailability|absolute bioavailability
430056|NCT01310283|dental caries|dental caries
430057|NCT01310283|children|children
430058|NCT01310283|mutans streptococci|mutans streptococci
430059|NCT01310283|lactobacilli|lactobacilli
430060|NCT01310283|cariogenic bacteria|cariogenic bacteria
430061|NCT01310244|Phase 1/2|phase 1/2
430062|NCT01310244|MTD|mtd
430063|NCT01310244|stage IV|stage iv
430064|NCT01310244|NSCLC|nsclc
430065|NCT01310244|chemo-naive|chemo-naive
430066|NCT01310244|Mixed-cell dose escalation|mixed-cell dose escalation
430067|NCT01310244|lung cancer|lung cancer
430068|NCT01310244|non-small-cell|non-small-cell
430070|NCT01310244|Belinostat|belinostat
430071|NCT01310244|Carboplatin|carboplatin
430072|NCT01310244|Paclitaxel|paclitaxel
430073|NCT01310244|adenocarcinoma|adenocarcinoma
430074|NCT01310244|PXD-101|pxd-101
430075|NCT01310231|Metastatic Breast Cancer|metastatic breast cancer
430076|NCT01310231|Metformin|metformin
430077|NCT01310218|orthopedics, carpal tunnel syndrome, postoperative care|orthopedics, carpal tunnel syndrome, postoperative care
430078|NCT01310205|HCV|hcv
430079|NCT01310205|Genotype 1|genotype 1
430080|NCT01310205|relapsers|relapsers
430081|NCT01310205|non cirrhotic|non cirrhotic
430082|NCT01310205|Chronic Hepatitis C|chronic hepatitis c
430083|NCT01310179|gene therapy|gene therapy
430084|NCT01310179|advanced solid tumors|advanced solid tumors
430085|NCT01310179|Head and Neck cancer|head and neck cancer
430086|NCT01310179|intratumoral therapy|intratumoral therapy
430087|NCT01310166|Multiple sclerosis|multiple sclerosis
430088|NCT01310166|RRMS|rrms
430089|NCT01310166|relapsing-remitting|relapsing-remitting
430090|NCT01310166|fingolimod|fingolimod
430091|NCT01310166|biomarkers|biomarkers
430092|NCT01310140|Metabolic Syndrome|metabolic syndrome
430093|NCT01310140|Insulin Resistance|insulin resistance
430094|NCT01310140|Massachusetts General Hospital|massachusetts general hospital
430095|NCT01310140|Major Depressive Disorder|major depressive disorder
430096|NCT01310140|Major Depressive Disorder with Psychotic Features|major depressive disorder with psychotic features
430097|NCT01310140|Cortisol|cortisol
430098|NCT01310140|Dexamethasone Suppression Test|dexamethasone suppression test
430099|NCT01310127|NSAID|nsaid
430100|NCT01310127|Ocular Inflammation|ocular inflammation
430101|NCT01310127|bromfenac|bromfenac
430102|NCT01310114|Human Placenta-Derived Cells|human placenta-derived cells
430103|NCT01310114|Stem cells|stem cells
430104|NCT01310114|Stroke|stroke
430105|NCT01310114|PDA001|pda001
430106|NCT01310114|Celgene|celgene
430107|NCT01310114|cenplacel-L|cenplacel-l
430108|NCT01310101|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
430109|NCT01310101|Refractory|refractory
430110|NCT01310101|Relapse|relapse
430111|NCT01310101|Ofatumumab|ofatumumab
430112|NCT01310101|Dexamethasone|dexamethasone
430113|NCT01310088|Childhood|childhood
430114|NCT01310088|Child|child
430115|NCT01310088|adolescent|adolescent
430116|NCT01310088|central blood pressure|central blood pressure
430117|NCT01310088|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
430118|NCT01310088|ABPM|abpm
430119|NCT01310088|clinic blood pressure|clinic blood pressure
430120|NCT01310088|pulse wave velocity|pulse wave velocity
430121|NCT01310088|PWV|pwv
430122|NCT01310088|Pulse cave analysis|pulse cave analysis
430123|NCT01310088|PWA|pwa
430124|NCT01310088|heart rate variability|heart rate variability
430125|NCT01310088|HRV|hrv
430126|NCT01310088|Echocardiography|echocardiography
430127|NCT01310088|Urine microalbuminuria|urine microalbuminuria
430128|NCT01310088|blood samples|blood samples
430129|NCT01310075|Mastectomy|mastectomy
430130|NCT01310075|Bioprosthetic Mesh|bioprosthetic mesh
430131|NCT01310075|Breast Reconstruction|breast reconstruction
430132|NCT01310075|Tissue Expander|tissue expander
430133|NCT01310075|Alloderm|alloderm
430134|NCT01310075|Surgimend|surgimend
430135|NCT01310062|hepatocellular carcinoma|hepatocellular carcinoma
430136|NCT01310062|microarray|microarray
430137|NCT01310062|gene expression profiling|gene expression profiling
430138|NCT01310062|biomarkers|biomarkers
430139|NCT01310049|Exploratory study in healthy subjects|exploratory study in healthy subjects
430140|NCT01310023|Conditions and diagnoses potentially related to perinatal exposure to antiretroviral medications|conditions and diagnoses potentially related to perinatal exposure to antiretroviral medications
430141|NCT01309997|Imatinib|imatinib
430142|NCT01309997|Rituximab|rituximab
430143|NCT01309997|Chronic Graft-vs-Host Disease|chronic graft-vs-host disease
430144|NCT01309984|Monitored anesthesia care|monitored anesthesia care
430145|NCT01309971|Assessment|assessment
430146|NCT01309971|Questionable Caries|questionable caries
430147|NCT01309958|Dental Caries|dental caries
430148|NCT01309958|Intervention|intervention
430149|NCT01309958|Non-invasive treatment for early caries|non-invasive treatment for early caries
430150|NCT01309919|intrauterine device|intrauterine device
430151|NCT01309919|Mirena|mirena
430152|NCT01309919|levonorgestrel intrauterine system|levonorgestrel intrauterine system
430153|NCT01309919|postpartum contraception|postpartum contraception
430154|NCT01309893|Contact lens|contact lens
430155|NCT01309880|Contact lens|contact lens
430156|NCT01309854|Phase 1|phase 1
430157|NCT01309854|healthy volunteers|healthy volunteers
430158|NCT01309854|pharmacokinetics|pharmacokinetics
430159|NCT01309854|Rheumatoid arthritis|rheumatoid arthritis
430160|NCT01309854|RA|ra
430161|NCT01309854|fostamatinib|fostamatinib
430162|NCT01309854|pioglitazone|pioglitazone
430163|NCT01309854|drug-drug interaction|drug-drug interaction
430164|NCT01309841|Non-Cancer-Related Pain, Opioid-Induced Constipation|non-cancer-related pain, opioid-induced constipation
430165|NCT01309828|Renal Insufficiency|renal insufficiency
430166|NCT01309828|Kidney Diseases|kidney diseases
430167|NCT01309828|Hypertension|hypertension
430168|NCT01309828|Drug Therapy|drug therapy
430169|NCT01309815|neoplasms|neoplasms
430170|NCT01309815|existentialism|existentialism
430171|NCT01309815|existential concerns|existential concerns
430172|NCT01309815|Meaning making|meaning making
430173|NCT01309815|early palliative phase|early palliative phase
430174|NCT01309815|elderly|elderly
430175|NCT01309802|botox|botox
430176|NCT01309802|raynaud's|raynaud's
430177|NCT01309802|botulinum toxin|botulinum toxin
430178|NCT01309802|botulinum toxin A|botulinum toxin a
430179|NCT01309802|raynaud's disease|raynaud's disease
430180|NCT01309802|raynaud's syndrome|raynaud's syndrome
430181|NCT01309802|raynaud's phenomenon|raynaud's phenomenon
430182|NCT01309802|ischemic digits|ischemic digits
430183|NCT01309802|ischemia|ischemia
430184|NCT01309802|botox treatment|botox treatment
430185|NCT01309802|onabotulinum|onabotulinum
430186|NCT01309802|onabotulinum toxin|onabotulinum toxin
430187|NCT01309802|onabotulinum toxin type A|onabotulinum toxin type a
430188|NCT01309789|Antibodies, Monoclonal|antibodies, monoclonal
430189|NCT01309789|Antibody-Drug Conjugate|antibody-drug conjugate
430190|NCT01309789|Antigens, CD30|antigens, cd30
430191|NCT01309789|Drug Therapy|drug therapy
430192|NCT01309789|Hematologic Diseases|hematologic diseases
430193|NCT01309789|Lymphoma|lymphoma
430194|NCT01309789|monomethyl auristatin E|monomethyl auristatin e
430195|NCT01309789|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
430196|NCT01309789|Lymphoma, T-cell|lymphoma, t-cell
430197|NCT01309789|Lymphoma, NK-cell|lymphoma, nk-cell
430198|NCT01309737|Xeljanz|xeljanz
430199|NCT01309737|tofacitinib|tofacitinib
430200|NCT01309737|Jak-inhibitor|jak-inhibitor
430201|NCT01309737|oral treatment|oral treatment
430202|NCT01309737|chronic|chronic
430203|NCT01309737|severe|severe
430204|NCT01309737|moderate|moderate
430205|NCT01309737|Pruritus|pruritus
430206|NCT01309737|Itch|itch
430207|NCT01309737|DLQI|dlqi
430208|NCT01309737|treatment|treatment
430209|NCT01309737|safety|safety
430210|NCT01309737|efficacy|efficacy
430211|NCT01309737|CP-690,550|cp-690,550
430212|NCT01309737|Plaque Psoriasis|plaque psoriasis
430213|NCT01309737|Psoriasis Vulgaris|psoriasis vulgaris
430214|NCT01309724|Hypotension|hypotension
430215|NCT01309724|Fluid|fluid
430216|NCT01309711|MRI|mri
430217|NCT01309711|Biomarkers|biomarkers
430218|NCT01309711|Neonatal encephalopathy|neonatal encephalopathy
430219|NCT01309711|Therapeutic hypothermia|therapeutic hypothermia
430220|NCT01309698|Drug interaction|drug interaction
430221|NCT01309685|Cognition|cognition
430222|NCT01309685|Smoking|smoking
430223|NCT01309685|Nicotine|nicotine
430224|NCT01309685|Varenicline|varenicline
430225|NCT01309685|Withdrawal|withdrawal
430226|NCT01309672|adenocarcinoma of the prostate|adenocarcinoma of the prostate
430227|NCT01309672|hormone-resistant prostate cancer|hormone-resistant prostate cancer
430228|NCT01309672|stage IV prostate cancer|stage iv prostate cancer
430229|NCT01309672|recurrent prostate cancer|recurrent prostate cancer
430230|NCT01309659|Anemia|anemia
430231|NCT01309659|Unexplained anemia|unexplained anemia
430232|NCT01309659|elderly|elderly
430233|NCT01309659|geriatric|geriatric
430234|NCT01309659|older adults|older adults
430235|NCT01309659|UAE|uae
430236|NCT01309659|over 65|over 65
430237|NCT01309659|iron|iron
430238|NCT01309659|pactte|pactte
430239|NCT01309659|pactee|pactee
430240|NCT01309659|aging|aging
430241|NCT01309659|aged|aged
430242|NCT01309659|old|old
430243|NCT01309659|older|older
430244|NCT01309646|Primary vaccination|primary vaccination
430245|NCT01309646|combination vaccine|combination vaccine
430246|NCT01309646|South Korea|south korea
430247|NCT01309633|locally advanced|locally advanced
430248|NCT01309633|metastatic|metastatic
430249|NCT01309620|zinc, oxidative stress, vascular indices, type 2 diabetes|zinc, oxidative stress, vascular indices, type 2 diabetes
430250|NCT01309581|depression|depression
430251|NCT01309581|electroconvulsive therapy|electroconvulsive therapy
430252|NCT01309581|ketamine|ketamine
430253|NCT01309581|antidepressant|antidepressant
430254|NCT01309555|Growth disorders|growth disorders
430255|NCT01309555|Saizen|saizen
430256|NCT01309555|easypod™|easypod™
430257|NCT01309555|Growth hormone|growth hormone
430258|NCT01309555|Pediatric subject|pediatric subject
430259|NCT01309542|major depressive disorder|major depressive disorder
430260|NCT01309542|desvenlafaxine|desvenlafaxine
430261|NCT01309542|antidepressant|antidepressant
430262|NCT01309529|general thoracic surgery|general thoracic surgery
430263|NCT01309529|epidural analgesia|epidural analgesia
430264|NCT01309529|postoperative retention of urine|postoperative retention of urine
430265|NCT01309529|postoperative urinary tract infection|postoperative urinary tract infection
430266|NCT01309529|catheter associated urinary tract infection|catheter associated urinary tract infection
430267|NCT01309516|Postnatal depression|postnatal depression
430268|NCT01309516|Maternal depression|maternal depression
430269|NCT01309516|Psychosocial intervention|psychosocial intervention
430270|NCT01309490|high eIF4E expression|high eif4e expression
430271|NCT01309490|solid tumor cancer|solid tumor cancer
430272|NCT01309477|Refractory Nephrotic Syndrome|refractory nephrotic syndrome
430273|NCT01309477|Tacrolimus|tacrolimus
430274|NCT01309451|diabetic macular edema|diabetic macular edema
430275|NCT01309451|DME|dme
430276|NCT01309438|Healthy|healthy
430277|NCT01309438|Renal Insufficiency|renal insufficiency
430278|NCT01309438|Rivaroxaban (BAY 59-7939, JNJ-39039039)|rivaroxaban (bay 59-7939, jnj-39039039)
430279|NCT01309438|Erythromycin|erythromycin
430280|NCT01309438|Pharmacokinetic|pharmacokinetic
430281|NCT01309438|Pharmacodynamic|pharmacodynamic
430282|NCT01309425|tapentadol|tapentadol
430283|NCT01309425|NUCYNTA|nucynta
430284|NCT01309425|CG5503|cg5503
430285|NCT01309425|R331333|r331333
430286|NCT01309425|pharmacokinetics|pharmacokinetics
430287|NCT01309425|healthy volunteer|healthy volunteer
430288|NCT01309412|Relapsed or refractory multiple myeloma|relapsed or refractory multiple myeloma
430289|NCT01309412|CNTO 328|cnto 328
430290|NCT01309412|siltuximab|siltuximab
430291|NCT01309412|bortezomib|bortezomib
430292|NCT01309412|dexamethasone|dexamethasone
430293|NCT01309399|bone formation rate|bone formation rate
430294|NCT01309399|total hip arthroplasty|total hip arthroplasty
430295|NCT01309386|Tapentadol|tapentadol
430296|NCT01309386|Tumor related pain|tumor related pain
430297|NCT01309386|Opioid|opioid
430298|NCT01309386|Cancer related pain|cancer related pain
430299|NCT01309386|Morphine|morphine
430300|NCT01309373|Schizophrenia|schizophrenia
430301|NCT01309373|Schizoaffective Disorder|schizoaffective disorder
430302|NCT01309373|Remission|remission
430303|NCT01309373|Psychosocial|psychosocial
430304|NCT01309373|Symtomatic|symtomatic
430305|NCT01309373|Integration|integration
430306|NCT01309373|Schizoaffective|schizoaffective
430307|NCT01309373|Adherence|adherence
430308|NCT01309360|ultrasound|ultrasound
430309|NCT01309360|methaemoglobin|methaemoglobin
430310|NCT01309360|prilocaine|prilocaine
430311|NCT01309360|regional anesthesia|regional anesthesia
430312|NCT01309360|ASA risk groups I-II|asa risk groups i-ii
430313|NCT01309360|adult outpatients|adult outpatients
430314|NCT01309360|surgical spectrum covered procedures|surgical spectrum covered procedures
430315|NCT01309360|distal forearm|distal forearm
430316|NCT01309360|hand|hand
430317|NCT01309347|prosthetic socket, residual limb volume fluctuation|prosthetic socket, residual limb volume fluctuation
430318|NCT01309334|MRI|mri
430319|NCT01309334|PET-scan|pet-scan
430320|NCT01309334|multiple myeloma|multiple myeloma
430321|NCT01309334|prognosis|prognosis
430322|NCT01309334|pharmacoeconomic analysis|pharmacoeconomic analysis
430323|NCT01309321|Perinatal|perinatal
430324|NCT01309321|Handwashing|handwashing
430325|NCT01309321|Neonatal|neonatal
430326|NCT01309321|Morbidity|morbidity
430327|NCT01309321|Mortality|mortality
430328|NCT01309321|Primiparous|primiparous
430329|NCT01309321|Health behavior|health behavior
430330|NCT01309321|Developing countries|developing countries
430331|NCT01309321|Sepsis|sepsis
430332|NCT01309321|Omphalitis|omphalitis
430333|NCT01309321|Infectious disease|infectious disease
430334|NCT01309321|Bangladesh|bangladesh
430335|NCT01309308|cervical length|cervical length
430336|NCT01309308|sweeping the membranes|sweeping the membranes
430337|NCT01309256|distal gastrectomy|distal gastrectomy
430338|NCT01309256|Robotic gastrectomy|robotic gastrectomy
430339|NCT01309256|registry|registry
430340|NCT01309256|learning curve|learning curve
430341|NCT01309256|cost-effectiveness|cost-effectiveness
430342|NCT01309256|quality of life|quality of life
430343|NCT01309256|acute inflammatory reaction|acute inflammatory reaction
430344|NCT01309256|Robotic and laparoscopic surgery|robotic and laparoscopic surgery
430345|NCT01309243|HIV|hiv
430346|NCT01309243|HIV-1|hiv-1
430347|NCT01309243|Antiretroviral Treatment-Naïve|antiretroviral treatment-naïve
430348|NCT01309230|Stage III|stage iii
430349|NCT01309230|Stage IV|stage iv
430350|NCT01309230|epithelial ovarian cancer|epithelial ovarian cancer
430351|NCT01309230|ovarian cancer|ovarian cancer
430352|NCT01309230|Adjuvant|adjuvant
430353|NCT01309230|immunotherapy|immunotherapy
430354|NCT01309204|open-angle glaucoma|open-angle glaucoma
430355|NCT01309204|ocular hypertension|ocular hypertension
430356|NCT01309204|OAG|oag
430357|NCT01309204|OHT|oht
430358|NCT01309191|Androgenetic Alopecia|androgenetic alopecia
430359|NCT01309191|Minoxidil|minoxidil
430360|NCT01309191|Microarray|microarray
430361|NCT01309165|stroke|stroke
430362|NCT01309165|cognition|cognition
430363|NCT01309165|cognitive strategies|cognitive strategies
430364|NCT01309165|motor skill acquisition|motor skill acquisition
430365|NCT01309165|participation|participation
430366|NCT01309152|cefazolin|cefazolin
430367|NCT01309152|microdialysis|microdialysis
430368|NCT01309152|morbid obesity|morbid obesity
430369|NCT01309152|pharmacokinetics|pharmacokinetics
430370|NCT01309126|Colorectal Cancer|colorectal cancer
430371|NCT01309126|KRAS Wild Type|kras wild type
430372|NCT01309126|Imprime PGG|imprime pgg
430373|NCT01309126|Cetuximab|cetuximab
430374|NCT01309126|Phase 3|phase 3
430375|NCT01309126|Efficacy|efficacy
430376|NCT01309126|Safety|safety
430478|NCT01308606|Hep C|hep c
430377|NCT01309126|Recurrent or Progressive KRAS Wild Type Colorectal Cancer|recurrent or progressive kras wild type colorectal cancer
430378|NCT01309087|Gene Expression|gene expression
430379|NCT01309087|Lung Cancer|lung cancer
430380|NCT01309087|Smoking|smoking
430381|NCT01309074|Anxiety|anxiety
430382|NCT01309074|Epilepsy|epilepsy
430383|NCT01309048|bone metastasis|bone metastasis
430384|NCT01309048|Patients with bone metastasis|patients with bone metastasis
430385|NCT01309035|Prothesis fixation|prothesis fixation
430386|NCT01309035|Bloodlessness|bloodlessness
430387|NCT01309022|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
430388|NCT01309022|T1D|t1d
430389|NCT01309022|T1DM|t1dm
430390|NCT01309022|Islets of Langerhans Transplantation|islets of langerhans transplantation
430391|NCT01309022|Pancreatic Islets Transplantation|pancreatic islets transplantation
430392|NCT01309022|Islet Transplant|islet transplant
430393|NCT01309022|Tacrolimus|tacrolimus
430394|NCT01309022|Sirolimus|sirolimus
430395|NCT01309022|Mycophenolate mofetil|mycophenolate mofetil
430396|NCT01309022|Mycophenolic acid|mycophenolic acid
430397|NCT01309009|Infantile Colic|infantile colic
430398|NCT01309009|Tachykinin antagonist|tachykinin antagonist
430399|NCT01309009|Nepadutant|nepadutant
430400|NCT01308996|alveolar ridge augmentation|alveolar ridge augmentation
430401|NCT01308996|edentulous ridge|edentulous ridge
430402|NCT01308996|alveolar ridge defect|alveolar ridge defect
430403|NCT01308996|posterior mandible defect|posterior mandible defect
430404|NCT01308996|bone morphogenic protein|bone morphogenic protein
430405|NCT01308996|osseointegration|osseointegration
430406|NCT01308983|Prehypertension|prehypertension
430407|NCT01308983|Flow mediated dilation|flow mediated dilation
430408|NCT01308983|Pulse wave velocity|pulse wave velocity
430409|NCT01308983|carotid compliance|carotid compliance
430410|NCT01308983|Prehypertension and amiloride|prehypertension and amiloride
430411|NCT01308944|invasive epithelial ovarian cancer,|invasive epithelial ovarian cancer,
430412|NCT01308944|primary peritoneal carcinoma,|primary peritoneal carcinoma,
430413|NCT01308944|fallopian tube cancer|fallopian tube cancer
430414|NCT01308931|Contraception|contraception
430415|NCT01308931|IUD|iud
430416|NCT01308931|Essure|essure
430417|NCT01308931|Tubal ligation|tubal ligation
430418|NCT01308931|Anti-Mullerian hormone|anti-mullerian hormone
430419|NCT01308918|Thoracic surgery|thoracic surgery
430420|NCT01308918|Double lumen tube intubation|double lumen tube intubation
430421|NCT01308918|GlideScope|glidescope
430422|NCT01308918|Stylet|stylet
430423|NCT01308905|Neuroblastoma|neuroblastoma
430424|NCT01308879|Contextualized Feedback System (CFS)|contextualized feedback system (cfs)
430425|NCT01308879|Mental health outcomes|mental health outcomes
430426|NCT01308879|Quality improvement|quality improvement
430427|NCT01308879|Feedback|feedback
430428|NCT01308879|Clinical trial|clinical trial
430429|NCT01308866|cardiovascular diseases|cardiovascular diseases
430430|NCT01308866|patient education|patient education
430431|NCT01308866|primary health care|primary health care
430432|NCT01308866|consumer participation|consumer participation
430433|NCT01308866|decision aids|decision aids
430434|NCT01308840|Unresectable|unresectable
430435|NCT01308840|metastatic|metastatic
430436|NCT01308840|biliary tract|biliary tract
430437|NCT01308840|gallbladder cancer|gallbladder cancer
430438|NCT01308827|Children 28 days to 36 months of age with suspected pneumococcal disease|children 28 days to 36 months of age with suspected pneumococcal disease
430439|NCT01308814|Perimenopause|perimenopause
430440|NCT01308814|Menopause|menopause
430441|NCT01308814|Depression|depression
430442|NCT01308814|Cardiovascular health|cardiovascular health
430443|NCT01308801|fibromyalgia|fibromyalgia
430444|NCT01308801|pain|pain
430445|NCT01308801|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
430446|NCT01308801|rehabilitation exercise|rehabilitation exercise
430447|NCT01308801|quality of life|quality of life
430448|NCT01308788|glaucoma blood flow|glaucoma blood flow
430449|NCT01308775|SIS.NET|sis.net
430450|NCT01308736|tobacco|tobacco
430451|NCT01308736|nicotine|nicotine
430452|NCT01308736|cigarette smoking|cigarette smoking
430453|NCT01308710|endothelial function|endothelial function
430454|NCT01308710|lipids|lipids
430455|NCT01308710|pediatrics|pediatrics
430456|NCT01308697|Flail|flail
430457|NCT01308697|Chest|chest
430458|NCT01308671|coronary artery disease|coronary artery disease
430459|NCT01308671|varenicline|varenicline
430460|NCT01308671|clopidogrel|clopidogrel
430461|NCT01308658|TMC114-C176|tmc114-c176
430462|NCT01308658|TMC114|tmc114
430463|NCT01308658|DRV|drv
430464|NCT01308658|HIV|hiv
430465|NCT01308658|Healthy volunteers|healthy volunteers
430466|NCT01308645|SBP Injection|sbp injection
430467|NCT01308645|HCC|hcc
430468|NCT01308632|glioblastoma|glioblastoma
430469|NCT01308632|temozolamide|temozolamide
430470|NCT01308632|radiotherapy|radiotherapy
430471|NCT01308632|TMZ|tmz
430472|NCT01308632|irinotecan|irinotecan
430473|NCT01308606|TMC435-TiDP16-C116|tmc435-tidp16-c116
430474|NCT01308606|TMC435-C116|tmc435-c116
430475|NCT01308606|TMC435|tmc435
430476|NCT01308606|HCV|hcv
430477|NCT01308606|Hepatitis C|hepatitis c
430479|NCT01308606|healthy volunteers|healthy volunteers
430480|NCT01308554|TAP block|tap block
430481|NCT01308554|Pain|pain
430482|NCT01308554|Obesity|obesity
430483|NCT01308554|Surgery|surgery
430484|NCT01308554|Laparoscopic gastric bypass|laparoscopic gastric bypass
430485|NCT01308528|Venous Thromboembolism|venous thromboembolism
430486|NCT01308515|knee|knee
430487|NCT01308515|osteoarthritis|osteoarthritis
430488|NCT01308515|joint|joint
430489|NCT01308515|replacement|replacement
430490|NCT01308515|knee surgery|knee surgery
430491|NCT01308502|laryngopharyngeal reflux|laryngopharyngeal reflux
430492|NCT01308502|LPR|lpr
430493|NCT01308502|GERD|gerd
430494|NCT01308502|gastroesophageal reflux|gastroesophageal reflux
430495|NCT01308502|nasopharyngeal probe|nasopharyngeal probe
430496|NCT01308463|elbow long-term Survivorship|elbow long-term survivorship
430622|NCT01307904|Blood glucose|blood glucose
430497|NCT01308463|Study participant Discovery Elbow Multi-center Study who|study participant discovery elbow multi-center study who
430498|NCT01308463|consent for the Discovery Elbow Long-term SurvivorshipStudy|consent for the discovery elbow long-term survivorshipstudy
430499|NCT01308450|ADHD Normative Control Group|adhd normative control group
430500|NCT01308424|Herpes Labialis|herpes labialis
430501|NCT01308424|Herpes Simplex|herpes simplex
430502|NCT01308424|Herpes|herpes
430503|NCT01308411|Asthma|asthma
430504|NCT01308411|Inhaled Corticosteroids|inhaled corticosteroids
430505|NCT01308411|Exhaled Nitric oxide|exhaled nitric oxide
430506|NCT01308411|Airways inflammation|airways inflammation
430507|NCT01308411|Step down|step down
430508|NCT01308411|Predicting response|predicting response
430509|NCT01308372|cardiovascular risk|cardiovascular risk
430510|NCT01308372|France|france
430511|NCT01308372|General practice|general practice
430512|NCT01308372|Primary prevention|primary prevention
430513|NCT01308372|Non treated patients|non treated patients
430514|NCT01308359|fetal movement|fetal movement
430515|NCT01308346|Bioabsorbable|bioabsorbable
430516|NCT01308346|Coronary Stent|coronary stent
430517|NCT01308346|Everolimus|everolimus
430518|NCT01308346|drug eluting stents|drug eluting stents
430519|NCT01308346|stents|stents
430520|NCT01308346|angioplasty|angioplasty
430521|NCT01308346|coronary artery disease|coronary artery disease
430522|NCT01308346|total coronary occlusion|total coronary occlusion
430523|NCT01308346|coronary artery restenosis|coronary artery restenosis
430524|NCT01308346|stent thrombosis|stent thrombosis
430525|NCT01308346|myocardial ischemia|myocardial ischemia
430526|NCT01308346|coronary artery stenosis|coronary artery stenosis
430527|NCT01308307|Non-cycloplegic photorefraction|non-cycloplegic photorefraction
430528|NCT01308307|cycloplegic refraction,|cycloplegic refraction,
430529|NCT01308307|Amblyopia|amblyopia
430530|NCT01308294|Melanoma|melanoma
430531|NCT01308294|Stage II-IV|stage ii-iv
430532|NCT01308294|Immunotherapy|immunotherapy
430533|NCT01308294|Vaccination|vaccination
430534|NCT01308294|HLA class I and II tumor-specific peptides|hla class i and ii tumor-specific peptides
430535|NCT01308294|IMP321|imp321
430536|NCT01308294|Montanide ISA-51 VG|montanide isa-51 vg
430537|NCT01308268|STH|sth
430538|NCT01308268|Soil-transmitted Helminthiasis|soil-transmitted helminthiasis
430539|NCT01308268|mass drug administration|mass drug administration
430540|NCT01308229|Bifurcation|bifurcation
430541|NCT01308229|Dedicated|dedicated
430542|NCT01308229|Drug-eluting stent|drug-eluting stent
430543|NCT01308229|Angioplasty|angioplasty
430544|NCT01308229|Coronary artery disease|coronary artery disease
430545|NCT01308229|Coronary artery stenosis|coronary artery stenosis
430546|NCT01308216|Transcranial Laser Therapy|transcranial laser therapy
430547|NCT01308216|Hemiplegia|hemiplegia
430548|NCT01308216|Rehabilitation|rehabilitation
430549|NCT01308216|Physiotherapy|physiotherapy
430550|NCT01308216|Ischemic stroke|ischemic stroke
430551|NCT01308190|Preoperative chemoradiotherapy|preoperative chemoradiotherapy
430552|NCT01308190|Transanal endoscopic microsurgery|transanal endoscopic microsurgery
430553|NCT01308190|Rectal Cancer|rectal cancer
430554|NCT01308190|T2-T3s-N0|t2-t3s-n0
430555|NCT01308164|Type 1 diabetes|type 1 diabetes
430556|NCT01308164|Insulin Pump Therapy|insulin pump therapy
430557|NCT01308151|CBT, self harm, depression, cultural adaptation, Pakistan|cbt, self harm, depression, cultural adaptation, pakistan
430558|NCT01308138|Physical Activity|physical activity
430559|NCT01308138|pathology|pathology
430560|NCT01308138|Physical Deconditioning|physical deconditioning
430561|NCT01308125|Stable Angina|stable angina
430562|NCT01308125|Coronary artery disease|coronary artery disease
430563|NCT01308125|PCI|pci
430564|NCT01308125|Reperfusion|reperfusion
430565|NCT01308125|Myocardial Infarction|myocardial infarction
430566|NCT01308125|collateral flow pressure index|collateral flow pressure index
430567|NCT01308125|CFpI|cfpi
430568|NCT01308125|pressure controlled intermittent coronary sinus occlusion|pressure controlled intermittent coronary sinus occlusion
430569|NCT01308125|PICSO|picso
430570|NCT01308112|Iron|iron
430571|NCT01308112|Plasmodium|plasmodium
430572|NCT01308112|Malaria|malaria
430573|NCT01308112|Pregnancy|pregnancy
430574|NCT01308112|Kenya|kenya
430575|NCT01308099|POTS|pots
430576|NCT01308099|Vascular Endothelial Function|vascular endothelial function
430577|NCT01308086|Cancer|cancer
430578|NCT01308086|colorectal cancer|colorectal cancer
430579|NCT01308086|adjuvant chemotherapy|adjuvant chemotherapy
430580|NCT01308086|capecitabine|capecitabine
430581|NCT01308086|oxaliplatin|oxaliplatin
430582|NCT01308086|5 fluorouracil|5 fluorouracil
430583|NCT01308060|Canthal lines|canthal lines
430584|NCT01308034|non GIST sarcomas|non gist sarcomas
430585|NCT01308034|sunitinib|sunitinib
430586|NCT01308034|radiotherapy|radiotherapy
430587|NCT01308034|dose escalation|dose escalation
430588|NCT01308021|Rhinoconjunctivitis|rhinoconjunctivitis
430589|NCT01308021|Allergy|allergy
430590|NCT01308021|Grass pollen|grass pollen
430591|NCT01308021|Hypersensitivity|hypersensitivity
430592|NCT01308021|Immune system disorder|immune system disorder
430593|NCT01308008|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
430594|NCT01308008|Mobility Limitation|mobility limitation
430595|NCT01307995|GDM|gdm
430596|NCT01307995|incretin effect|incretin effect
430597|NCT01307995|gestation|gestation
430598|NCT01307995|reversibility|reversibility
430599|NCT01307982|Gastroesophageal Reflux|gastroesophageal reflux
430600|NCT01307982|Nervous System Diseases|nervous system diseases
430601|NCT01307982|Fundoplication|fundoplication
430602|NCT01307982|Enteral Nutrition|enteral nutrition
430603|NCT01307969|liposomes|liposomes
430604|NCT01307969|ropivacaine|ropivacaine
430605|NCT01307969|dental anesthesia|dental anesthesia
430606|NCT01307969|dentistry|dentistry
430607|NCT01307943|MBSR|mbsr
430608|NCT01307943|adolescent|adolescent
430609|NCT01307943|mental health|mental health
430610|NCT01307930|Echinocandin|echinocandin
430611|NCT01307930|Obesity|obesity
430612|NCT01307930|Pharmacokinetics|pharmacokinetics
430613|NCT01307930|Pharmacodynamics|pharmacodynamics
430614|NCT01307930|Fungal infection|fungal infection
430615|NCT01307917|diabetes mellitus|diabetes mellitus
430616|NCT01307917|diabetic nephropathy|diabetic nephropathy
430617|NCT01307917|vascular endothelial dysfunction|vascular endothelial dysfunction
430618|NCT01307917|flavonoids|flavonoids
430619|NCT01307917|flow-mediated dilation|flow-mediated dilation
430620|NCT01307904|Glycemic index|glycemic index
430621|NCT01307904|Dates|dates
430623|NCT01307891|Triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
430624|NCT01307891|Metastatic breast cancer|metastatic breast cancer
430625|NCT01307891|Tigatuzumab (CS-1008)|tigatuzumab (cs-1008)
430626|NCT01307891|Abraxane (ABI-007)|abraxane (abi-007)
430627|NCT01307891|HER-2-neu negative|her-2-neu negative
430628|NCT01307891|ER negative, PR negative|er negative, pr negative
430629|NCT01307865|midface volume loss|midface volume loss
430630|NCT01307865|aging of midface|aging of midface
430631|NCT01307865|sculptra|sculptra
430632|NCT01307865|sculptra aesthetic|sculptra aesthetic
430633|NCT01307865|poly-L-lactic acid|poly-l-lactic acid
430634|NCT01307852|Fiber optic radiation detectors|fiber optic radiation detectors
430635|NCT01307852|Enhanced endorectal balloon|enhanced endorectal balloon
430636|NCT01307852|Radiation treatment|radiation treatment
430637|NCT01307852|Radiotherapy|radiotherapy
430638|NCT01307852|External beam radiation|external beam radiation
430639|NCT01307852|Dosimetry|dosimetry
430640|NCT01307839|labor|labor
430641|NCT01307839|epidural|epidural
430642|NCT01307826|massage|massage
430643|NCT01307826|shoulder|shoulder
430644|NCT01307826|pain|pain
430645|NCT01307826|range of motion|range of motion
430646|NCT01307826|restricted range of motion|restricted range of motion
430647|NCT01307813|colon distal|colon distal
430648|NCT01307813|surgical resection|surgical resection
430649|NCT01307787|exercise|exercise
430650|NCT01307787|education|education
430651|NCT01307787|self-management|self-management
430652|NCT01307787|rehabilitation|rehabilitation
430653|NCT01307774|parental acceptability of HPV vaccine|parental acceptability of hpv vaccine
430654|NCT01307761|fine needle aspiration; predictor; ultrasonography; thyroid cancer|fine needle aspiration; predictor; ultrasonography; thyroid cancer
430655|NCT01307748|aromatherapy|aromatherapy
430656|NCT01307748|stress|stress
430657|NCT01307748|older adults|older adults
430658|NCT01307748|stress-related change|stress-related change
430659|NCT01307735|myocarditis|myocarditis
430660|NCT01307735|edema|edema
430661|NCT01307735|hyperemia|hyperemia
430662|NCT01307735|fibrosis|fibrosis
430663|NCT01307735|necrosis|necrosis
430664|NCT01307735|cardiovascular magnetic resonance imaging|cardiovascular magnetic resonance imaging
430665|NCT01307722|left atrial distensibility|left atrial distensibility
430666|NCT01307722|advanced chronic heart failure|advanced chronic heart failure
430667|NCT01307722|decompensation|decompensation
430668|NCT01307722|rehospitalization|rehospitalization
430669|NCT01307722|prognosis|prognosis
430670|NCT01307722|all-cause mortality|all-cause mortality
430671|NCT01307722|heart failure with hospitalization|heart failure with hospitalization
430672|NCT01307722|the duration of hospitalization|the duration of hospitalization
430673|NCT01307696|Umbilical Hernia Repair|umbilical hernia repair
430674|NCT01307696|PVP Mesh|pvp mesh
430675|NCT01307683|Pregnancy|pregnancy
430676|NCT01307683|Overweight|overweight
430677|NCT01307683|Obese|obese
430678|NCT01307683|Stress|stress
430679|NCT01307683|Mindfulness|mindfulness
430680|NCT01307657|clopidogrel|clopidogrel
430681|NCT01307657|platelet|platelet
430682|NCT01307657|platelet function test|platelet function test
430683|NCT01307657|healthy|healthy
430684|NCT01307657|Platelet function tests|platelet function tests
430685|NCT01307644|Overweight|overweight
430686|NCT01307644|Obesity|obesity
430687|NCT01307644|Rural Health|rural health
430688|NCT01307644|Weight Loss|weight loss
430689|NCT01307644|Weight Maintenance|weight maintenance
430690|NCT01307644|Rural Middle Aged and Older Women|rural middle aged and older women
430691|NCT01307644|Web Intervention Weight Loss|web intervention weight loss
430692|NCT01307644|Class I, II, & III obese (BMI 28 to 45)|class i, ii, & iii obese (bmi 28 to 45)
430693|NCT01307605|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
430694|NCT01307605|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
430695|NCT01307605|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
430696|NCT01307605|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
430697|NCT01307605|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
430698|NCT01307605|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
430699|NCT01307605|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
430700|NCT01307605|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
430701|NCT01307605|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
430702|NCT01307605|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
430703|NCT01307605|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
430704|NCT01307605|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
430705|NCT01307592|peripheral T-cell lymphoma|peripheral t-cell lymphoma
430706|NCT01307592|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
430707|NCT01307592|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
430708|NCT01307592|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
430709|NCT01307592|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
430710|NCT01307514|DIABETES|diabetes
430711|NCT01307514|PHARMACOKINETICS|pharmacokinetics
430712|NCT01307514|PHARMACODYNAMICS|pharmacodynamics
430713|NCT01307514|INSULIN|insulin
430714|NCT01307501|Cryoablation|cryoablation
430715|NCT01307501|Cryotherapy|cryotherapy
430716|NCT01307501|Cryosurgery|cryosurgery
430717|NCT01307501|Metastatic|metastatic
430718|NCT01307501|Lung|lung
430719|NCT01307501|Pleura|pleura
430720|NCT01307501|Tumors|tumors
430722|NCT01307488|AIDS|aids
430723|NCT01307488|Atazanavir|atazanavir
430724|NCT01307488|Simplification|simplification
430725|NCT01307475|Chronic Post-Traumatic Stress Disorder|chronic post-traumatic stress disorder
430726|NCT01307475|Delayed Onset Post-Traumatic Stress Disorder|delayed onset post-traumatic stress disorder
430727|NCT01307475|Post-Traumatic Neuroses|post-traumatic neuroses
430728|NCT01307475|Posttraumatic Neuroses|posttraumatic neuroses
430729|NCT01307475|Post-Traumatic Stress Disorders|post-traumatic stress disorders
430730|NCT01307475|Posttraumatic Stress Disorders|posttraumatic stress disorders
430731|NCT01307475|PTSD|ptsd
430732|NCT01307475|Post TraumaticStress Disorder|post traumaticstress disorder
430733|NCT01307475|Endogenous Depression|endogenous depression
430734|NCT01307475|Neurotic Depression|neurotic depression
430735|NCT01307475|Depressive Syndrome|depressive syndrome
430736|NCT01307475|Melancholia|melancholia
430737|NCT01307475|Depressive Neurosis|depressive neurosis
430738|NCT01307475|Unipolar Depression|unipolar depression
430739|NCT01307475|Depressive Symptoms|depressive symptoms
430740|NCT01307475|Emotional Depression|emotional depression
430741|NCT01307475|Quality of Life|quality of life
430742|NCT01307449|pneumococcal vaccine|pneumococcal vaccine
430743|NCT01307449|immune responses|immune responses
430744|NCT01307436|Hepatitis A Vaccine|hepatitis a vaccine
430745|NCT01307436|Combined Vaccines|combined vaccines
430746|NCT01307436|DTP Vaccine|dtp vaccine
430747|NCT01307436|MMR Vaccine|mmr vaccine
430748|NCT01307423|psoriasis|psoriasis
430749|NCT01307423|Arthritis|arthritis
430750|NCT01307423|Psoriatic Arthritis|psoriatic arthritis
430751|NCT01307423|inflammation|inflammation
430752|NCT01307423|skin condition|skin condition
430753|NCT01307423|inflammatory cells|inflammatory cells
430754|NCT01307423|apremilast|apremilast
430755|NCT01307423|CC-10004|cc-10004
430756|NCT01307423|phosphodiesterase type 4|phosphodiesterase type 4
430757|NCT01307410|Patients with type 2 diabetes and participated in 3B Study|patients with type 2 diabetes and participated in 3b study
430758|NCT01307384|Total Hip Arthroplasty|total hip arthroplasty
430759|NCT01307384|Total Hip Replacement (THR)|total hip replacement (thr)
430760|NCT01307384|Primary Hip Arthroplasty|primary hip arthroplasty
430761|NCT01307384|THA|tha
430762|NCT01307384|THR|thr
430763|NCT01307371|Bone Marrow Mononuclear cells;|bone marrow mononuclear cells;
430764|NCT01307371|Diabetes;|diabetes;
430765|NCT01307371|ST-segment Elevation Myocardial Infarction;|st-segment elevation myocardial infarction;
430766|NCT01307371|Percutaneous Coronary Intervention;|percutaneous coronary intervention;
430767|NCT01307371|Left Ventricular Function|left ventricular function
430768|NCT01307332|Multiple Sclerosis|multiple sclerosis
430769|NCT01307332|MS|ms
430770|NCT01307332|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
430771|NCT01307332|RRMS|rrms
430772|NCT01307332|Alemtuzumab|alemtuzumab
430773|NCT01307332|Demyelination|demyelination
430774|NCT01307332|Remyelination|remyelination
430775|NCT01307332|Tolerogenic|tolerogenic
430776|NCT01307332|T cells|t cells
430777|NCT01307332|Demyelinating Autoimmune Diseases, CNS|demyelinating autoimmune diseases, cns
430778|NCT01307332|Autoimmune Diseases of the Nervous System|autoimmune diseases of the nervous system
430779|NCT01307332|Nervous System Diseases|nervous system diseases
430780|NCT01307332|Demyelinating Diseases|demyelinating diseases
430781|NCT01307332|Autoimmune Diseases|autoimmune diseases
430782|NCT01307332|Immune System Diseases|immune system diseases
430783|NCT01307319|Allergies|allergies
430784|NCT01307319|Hayfever|hayfever
430785|NCT01307306|Thermal injury|thermal injury
430786|NCT01307306|Chemical Burn|chemical burn
430787|NCT01307306|Flame Burn|flame burn
430788|NCT01307280|Behavioral Weight Management Intervention|behavioral weight management intervention
430789|NCT01307280|weight loss|weight loss
430790|NCT01307280|cost-effective analysis|cost-effective analysis
430791|NCT01307280|high blood pressure|high blood pressure
430792|NCT01307280|randomized clinical trial|randomized clinical trial
430793|NCT01307280|behavioral interventions|behavioral interventions
430794|NCT01307280|physical activity|physical activity
430795|NCT01307280|dietary change|dietary change
430796|NCT01307280|obesity|obesity
430797|NCT01307267|Phase 1|phase 1
430798|NCT01307267|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
430799|NCT01307267|Advanced malignancies|advanced malignancies
430800|NCT01307241|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
430801|NCT01307241|prognostic factor|prognostic factor
430802|NCT01307241|pharmacogenetics.|pharmacogenetics.
430803|NCT01307228|Knowledge translation|knowledge translation
430804|NCT01307228|Policymakers|policymakers
430805|NCT01307228|Health systems|health systems
430806|NCT01307215|TAP block|tap block
430807|NCT01307215|incision pain|incision pain
430808|NCT01307215|total hysterectomy|total hysterectomy
430809|NCT01307202|knee|knee
430810|NCT01307202|arthroplasty|arthroplasty
430811|NCT01307202|postoperative pain|postoperative pain
430812|NCT01307202|gabapentin|gabapentin
430813|NCT01307189|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
430814|NCT01307189|Exercise|exercise
430815|NCT01307189|Endurance shuttle walking test|endurance shuttle walking test
430816|NCT01307189|Bronchodilation|bronchodilation
430817|NCT01307189|Tiotropium|tiotropium
430818|NCT01307176|ataxia|ataxia
430819|NCT01307176|exercise|exercise
430820|NCT01307176|training|training
430821|NCT01307176|cerebellar|cerebellar
430822|NCT01307176|rehabilitation|rehabilitation
430823|NCT01307163|saliva|saliva
430824|NCT01307163|liver transplantation|liver transplantation
430825|NCT01307163|children|children
430826|NCT01307163|In this prospective study 60 subjects will be examined|in this prospective study 60 subjects will be examined
430827|NCT01307163|children and adolescents|children and adolescents
430828|NCT01307163|after a successful liver transplantation|after a successful liver transplantation
430829|NCT01307163|informed consent forms signed be the examinees parents|informed consent forms signed be the examinees parents
430830|NCT01307150|Atopic Dermatitis|atopic dermatitis
430831|NCT01307150|Dead Sea|dead sea
430832|NCT01307150|Climatotherapy|climatotherapy
430833|NCT01307150|SCORAD|scorad
430834|NCT01307124|safety and efficacy|safety and efficacy
430835|NCT01307124|low dose LPV/r|low dose lpv/r
430836|NCT01307124|standard dose LPV/r|standard dose lpv/r
430837|NCT01307124|HIV infected children|hiv infected children
430838|NCT01307111|Misoprostol|misoprostol
430839|NCT01307111|IUD insertion|iud insertion
430840|NCT01307111|Nulliparous Women|nulliparous women
430841|NCT01307111|Contraception|contraception
430842|NCT01307111|Family Planning|family planning
430843|NCT01307111|IUD insertion in nulliparous women|iud insertion in nulliparous women
430844|NCT01307098|Enzyme Replacement Therapy (ERT)|enzyme replacement therapy (ert)
430845|NCT01307098|Lysosomal Storage Disease|lysosomal storage disease
430846|NCT01307098|Late Onset Lysosomal Acid Lipase (LAL) Deficiency|late onset lysosomal acid lipase (lal) deficiency
430847|NCT01307098|Acid cholesteryl ester hydrolase deficiency, type 2|acid cholesteryl ester hydrolase deficiency, type 2
430848|NCT01307098|Acid lipase disease|acid lipase disease
430849|NCT01307098|Cholesterol ester hydrolase deficiency|cholesterol ester hydrolase deficiency
430850|NCT01307098|LAL Deficiency|lal deficiency
430851|NCT01307098|LIPA Deficiency|lipa deficiency
430852|NCT01307098|Wolman disease|wolman disease
430853|NCT01307085|remote ischemic preconditioning|remote ischemic preconditioning
430854|NCT01307085|lung injury|lung injury
430855|NCT01307085|pulmonary resection|pulmonary resection
430856|NCT01307072|periodic examinations, compliance|periodic examinations, compliance
430857|NCT01307059|Growth disorders|growth disorders
430858|NCT01307059|Saizen|saizen
430859|NCT01307059|Easypod|easypod
430860|NCT01307059|Growth hormone|growth hormone
430861|NCT01307059|Pediatric subject|pediatric subject
430862|NCT01307046|Essential hypertension|essential hypertension
430863|NCT01307046|Uncontrolled hypertension|uncontrolled hypertension
430864|NCT01307046|Antihypertensive agents|antihypertensive agents
430865|NCT01307046|Blood pressure|blood pressure
430866|NCT01307033|Essential hypertension|essential hypertension
430867|NCT01307033|Uncontrolled hypertension|uncontrolled hypertension
430868|NCT01307033|Antihypertensive agents|antihypertensive agents
430869|NCT01307033|Blood pressure|blood pressure
430870|NCT01307020|Moderate to severe pain|moderate to severe pain
430871|NCT01307020|Postoperative pain|postoperative pain
430872|NCT01307020|Analgesics|analgesics
430873|NCT01307020|Dexketoprofen|dexketoprofen
430874|NCT01307020|Tramadol|tramadol
430875|NCT01306994|Exercise Test|exercise test
430876|NCT01306994|Bicycle Ergometry Test|bicycle ergometry test
430877|NCT01306994|Stress Test|stress test
430878|NCT01306981|Diabetes Mellitus|diabetes mellitus
430879|NCT01306981|Diabetes Complications|diabetes complications
430880|NCT01306981|Retinal Diseases|retinal diseases
430881|NCT01306981|Endothelial Growth Factors|endothelial growth factors
430882|NCT01306981|Monoclonal Antibodies|monoclonal antibodies
430883|NCT01306981|Ranibizumab|ranibizumab
430884|NCT01306981|Vitrectomy|vitrectomy
430885|NCT01306981|Vitreoretinal Surgery|vitreoretinal surgery
430886|NCT01306968|mild tramatic brain injury|mild tramatic brain injury
430887|NCT01306968|mTBI|mtbi
430888|NCT01306968|hyperbaric oxygen|hyperbaric oxygen
430889|NCT01306968|post concussive symptoms|post concussive symptoms
430890|NCT01306968|active duty military|active duty military
430891|NCT01306968|veterans|veterans
430892|NCT01306955|retinal vasculitis|retinal vasculitis
430893|NCT01306955|posterior uveitis|posterior uveitis
430894|NCT01306955|methylprednisolone|methylprednisolone
430895|NCT01306942|HER2 positive breast cancer|her2 positive breast cancer
430896|NCT01306942|first line treatment|first line treatment
430897|NCT01306942|Dasatinib|dasatinib
430898|NCT01306942|SRC kinase|src kinase
430899|NCT01306942|Trastuzumab resistance|trastuzumab resistance
430900|NCT01306929|Huntington Disease.|huntington disease.
430901|NCT01306916|thyroid disease, hyperthyroidism|thyroid disease, hyperthyroidism
430902|NCT01306903|Minimizing Cardiopulmonary Bypass MECC damage organ failure|minimizing cardiopulmonary bypass mecc damage organ failure
430903|NCT01306877|hemorrhoid|hemorrhoid
430904|NCT01306877|hemorrhoid stapler|hemorrhoid stapler
430905|NCT01306864|Endoscopic Hemostasis|endoscopic hemostasis
430906|NCT01306864|Peptic Ulcer|peptic ulcer
430907|NCT01306864|Recurrent Bleeding|recurrent bleeding
430908|NCT01306864|Injection Therapy|injection therapy
430909|NCT01306864|Thermal Probe|thermal probe
430910|NCT01306851|fibrin glue|fibrin glue
430911|NCT01306851|anastomotic leak|anastomotic leak
430912|NCT01306851|gastrointestinal high risk anastomosis|gastrointestinal high risk anastomosis
430913|NCT01306838|Short bowel syndrome|short bowel syndrome
430914|NCT01306838|Necrotizing enterocolitis|necrotizing enterocolitis
430915|NCT01306838|Small intestine perforation|small intestine perforation
430916|NCT01306838|Enterostomy|enterostomy
430917|NCT01306838|Intralipid|intralipid
430918|NCT01306838|Microlipid|microlipid
430919|NCT01306838|Fish oil|fish oil
430920|NCT01306825|Daptomycin|daptomycin
430921|NCT01306825|Bone disease,infectious|bone disease,infectious
430922|NCT01306825|Osteomyelitis|osteomyelitis
430923|NCT01306825|Diabetic foot|diabetic foot
430924|NCT01306825|Staphylococcus aureus|staphylococcus aureus
430925|NCT01306812|Adolescent|adolescent
430926|NCT01306812|Alcohol|alcohol
430927|NCT01306812|Criminology|criminology
430928|NCT01306812|Genes|genes
430929|NCT01306812|Environment|environment
430930|NCT01306812|Mono amine Oxidase|mono amine oxidase
430931|NCT01306812|Serotonin|serotonin
430932|NCT01306812|Social Support|social support
430933|NCT01306799|Barrett's Esophagus|barrett's esophagus
430934|NCT01306799|Erosive Esophagitis|erosive esophagitis
430935|NCT01306799|Proton Pump Inhibitor (PPI)|proton pump inhibitor (ppi)
430936|NCT01306799|Bone|bone
430937|NCT01306799|Bone Density|bone density
430938|NCT01306799|GERD|gerd
430939|NCT01306799|ulcer prophylaxis|ulcer prophylaxis
430940|NCT01306773|Influenza A|influenza a
430941|NCT01306773|convalescent plasma|convalescent plasma
430942|NCT01306773|death|death
430943|NCT01306760|depression|depression
430944|NCT01306760|electroconvulsive therapy|electroconvulsive therapy
430945|NCT01306760|ketamine|ketamine
430946|NCT01306747|Chronic pain|chronic pain
430947|NCT01306747|Stanford chronic pain self-management programme|stanford chronic pain self-management programme
430948|NCT01306747|Patient education|patient education
430949|NCT01306734|Extracorporeal circulation|extracorporeal circulation
430950|NCT01306734|Deep Hypothermic Circulatory Arrest|deep hypothermic circulatory arrest
430951|NCT01306734|aortic aneurism|aortic aneurism
430952|NCT01306734|neurological injury|neurological injury
430953|NCT01306734|inflammation|inflammation
430954|NCT01306734|coagulation|coagulation
430955|NCT01306708|Adhesive Capsulitis|adhesive capsulitis
430956|NCT01306708|Shoulder|shoulder
430957|NCT01306708|SPADI|spadi
430958|NCT01306695|Dementia|dementia
430959|NCT01306695|Depressive symptoms|depressive symptoms
430960|NCT01306695|Caregiver Burden|caregiver burden
430961|NCT01306695|Hispanic|hispanic
430962|NCT01306695|Latino|latino
430963|NCT01306695|Intervention|intervention
430964|NCT01306695|Geriatric Depression Scale|geriatric depression scale
430965|NCT01306695|Zarit Caregiver Burden Scale|zarit caregiver burden scale
430966|NCT01306656|Endocrinology|endocrinology
430967|NCT01306656|Metabolic Bone Disease|metabolic bone disease
430968|NCT01306656|Primary Hyperparathyroidism|primary hyperparathyroidism
430969|NCT01306656|PHPT|phpt
430970|NCT01306656|Vitamin D Deficiency|vitamin d deficiency
430971|NCT01306656|Bone Mineral Density|bone mineral density
430972|NCT01306656|Hyper-calcemia|hyper-calcemia
430973|NCT01306643|Indolent Non-Hodgkin's Lymphoma|indolent non-hodgkin's lymphoma
430974|NCT01306643|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
430975|NCT01306643|iNHL|inhl
430976|NCT01306643|NHL|nhl
430977|NCT01306643|CAL-101|cal-101
430978|NCT01306643|PI3K|pi3k
430979|NCT01306643|Phosphatidylinositol 3-kinase|phosphatidylinositol 3-kinase
430980|NCT01306643|Follicular Lymphoma (FL)|follicular lymphoma (fl)
430981|NCT01306643|Small Lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
430982|NCT01306643|Marginal Zone Lymphoma (MZL)|marginal zone lymphoma (mzl)
430983|NCT01306630|AV-951|av-951
430984|NCT01306630|tivozanib|tivozanib
430985|NCT01306630|capecitabine (Xeloda®)|capecitabine (xeloda®)
430986|NCT01306604|Genetic Diseases|genetic diseases
430987|NCT01306604|Lipidoses|lipidoses
430988|NCT01306604|Lipid Metabolism|lipid metabolism
430989|NCT01306604|Lysosomal Storage Diseases|lysosomal storage diseases
430990|NCT01306604|Metabolic Diseases|metabolic diseases
430991|NCT01306604|Lipid Metabolism Disorders|lipid metabolism disorders
430992|NCT01306591|neovascular age-related macular degeneration|neovascular age-related macular degeneration
430993|NCT01306591|Bevacizumab|bevacizumab
430994|NCT01306591|Multicenter Randomized Study|multicenter randomized study
430995|NCT01306578|Guillain Barre syndrome|guillain barre syndrome
430996|NCT01306578|IVIG|ivig
430997|NCT01306578|Plasma exchange|plasma exchange
430998|NCT01306565|Unstable angina|unstable angina
430999|NCT01306565|NSTMI|nstmi
431000|NCT01306565|Statin|statin
431001|NCT01306565|Atorvastatin|atorvastatin
431002|NCT01306552|Tobacco use|tobacco use
431003|NCT01306552|Adolescents|adolescents
431004|NCT01306552|Primary prevention|primary prevention
431005|NCT01306552|Program effectiveness|program effectiveness
431006|NCT01306552|Parental component|parental component
431007|NCT01306539|deep brain stimulation|deep brain stimulation
431008|NCT01306539|subthalamic nucleus|subthalamic nucleus
431009|NCT01306526|Thin-cap fibroatheroma|thin-cap fibroatheroma
431010|NCT01306526|Vulnerable plaque|vulnerable plaque
431011|NCT01306526|Coronary artery disease|coronary artery disease
431012|NCT01306526|Obstructive sleep apnea|obstructive sleep apnea
431013|NCT01306526|Intravascular Ultrasound|intravascular ultrasound
431014|NCT01306513|emphysema|emphysema
431015|NCT01306513|lung volume reduction surgery|lung volume reduction surgery
431016|NCT01306513|mesenchymal stromal cells|mesenchymal stromal cells
431017|NCT01306500|Gastric lavage|gastric lavage
431018|NCT01306500|Neonate|neonate
431019|NCT01306500|Meconium stained amniotic fluid|meconium stained amniotic fluid
431020|NCT01306500|Feeding problems|feeding problems
431021|NCT01306487|macular hole|macular hole
431022|NCT01306474|CD4/CD25 Tr cell,TNF,IFN-γ,IL-2|cd4/cd25 tr cell,tnf,ifn-γ,il-2
431023|NCT01306448|constipation|constipation
431024|NCT01306448|gastro|gastro
431025|NCT01306448|vibrating capsule|vibrating capsule
431026|NCT01306448|safety|safety
431027|NCT01306435|Osteoarthritis|osteoarthritis
431028|NCT01306435|Low Power Laser Therapy|low power laser therapy
431029|NCT01306435|Exercise|exercise
431030|NCT01306435|Knee|knee
431031|NCT01306422|hoodia gordonii|hoodia gordonii
431032|NCT01306422|energy intake|energy intake
431033|NCT01306422|food intake|food intake
431034|NCT01306422|efficacy|efficacy
431035|NCT01306422|body weight|body weight
431036|NCT01306422|functional food|functional food
431037|NCT01306422|plant extract|plant extract
431038|NCT01306422|safety|safety
431039|NCT01306422|steroid glycosides|steroid glycosides
431040|NCT01306422|tolerability|tolerability
431041|NCT01306409|anemia|anemia
431042|NCT01306409|kidney disease|kidney disease
431043|NCT01306396|NAFLD|nafld
431044|NCT01306396|metabolic syndrome|metabolic syndrome
431045|NCT01306396|children|children
431046|NCT01306396|fructose|fructose
431047|NCT01306383|SODIS|sodis
431048|NCT01306383|waterborne|waterborne
431049|NCT01306383|Disease|disease
431050|NCT01306383|Diarrhoea|diarrhoea
431051|NCT01306383|dysentery|dysentery
431052|NCT01306370|primary knee arthroplasty|primary knee arthroplasty
431053|NCT01306370|fibrin glue|fibrin glue
431054|NCT01306370|tranexamic acid|tranexamic acid
431055|NCT01306370|topic|topic
431056|NCT01306357|Turner's syndrome|turner's syndrome
431057|NCT01306357|somatropin|somatropin
431058|NCT01306357|human growth hormone deficiency|human growth hormone deficiency
431466|NCT01304810|NicVAX|nicvax
431059|NCT01306344|Qualitative Research|qualitative research
431060|NCT01306344|Interview, Psychological|interview, psychological
431061|NCT01306344|Patients|patients
431062|NCT01306344|Nurses|nurses
431063|NCT01306344|Physicians|physicians
431064|NCT01306305|Influenza|influenza
431065|NCT01306305|Virus|virus
431066|NCT01306305|Vaccination|vaccination
431067|NCT01306305|Immunisation|immunisation
431068|NCT01306292|Pulmonary hypertension|pulmonary hypertension
431069|NCT01306292|Right heart Catheterization|right heart catheterization
431070|NCT01306279|Cystic Fibrosis|cystic fibrosis
431071|NCT01306279|Infection|infection
431072|NCT01306279|Pulmonary exacerbation|pulmonary exacerbation
431073|NCT01306279|Hypermutators|hypermutators
431074|NCT01306279|Bacterial diversity|bacterial diversity
431075|NCT01306279|Quorum sensing|quorum sensing
431076|NCT01306266|active duty|active duty
431077|NCT01306266|blast induced|blast induced
431078|NCT01306266|headache|headache
431079|NCT01306253|Influenza|influenza
431080|NCT01306253|Virus|virus
431081|NCT01306253|Vaccination|vaccination
431082|NCT01306253|Immunisation|immunisation
431083|NCT01306240|Infant newborn|infant newborn
431084|NCT01306240|Infant preterm|infant preterm
431085|NCT01306240|Acute respiratory distress syndrome|acute respiratory distress syndrome
431086|NCT01306240|surfactant|surfactant
431087|NCT01306240|Hyaline Membrane disease|hyaline membrane disease
431088|NCT01306240|Newborn acute respiratory distress syndrome (ARDS)|newborn acute respiratory distress syndrome (ards)
431089|NCT01306227|Infant, newborn|infant, newborn
431090|NCT01306227|Infant, preterm|infant, preterm
431091|NCT01306227|Thyroid|thyroid
431092|NCT01306227|Outcome|outcome
431093|NCT01306227|Newborns less than 32 weeks of gestation|newborns less than 32 weeks of gestation
431094|NCT01306227|TSH < 20 mIU/L and a FT4 < 0.80 ng/dL|tsh < 20 miu/l and a ft4 < 0.80 ng/dl
431095|NCT01306201|Hospital Setting|hospital setting
431096|NCT01306188|metastatic cancer|metastatic cancer
431097|NCT01306188|lymphopenia|lymphopenia
431098|NCT01306188|T cell receptor diversity|t cell receptor diversity
431099|NCT01306149|biochemical parameters|biochemical parameters
431100|NCT01306149|mineral metabolism|mineral metabolism
431101|NCT01306149|protein-bound uremic retention solutes|protein-bound uremic retention solutes
431102|NCT01306149|incident PD patients|incident pd patients
431103|NCT01306136|Posttraumatic stress disorder|posttraumatic stress disorder
431104|NCT01306136|Prolonged exposure|prolonged exposure
431105|NCT01306136|Cognitive behavior therapy|cognitive behavior therapy
431106|NCT01306123|bioavailability|bioavailability
431107|NCT01306123|pharmacokinetics|pharmacokinetics
431108|NCT01306123|cyanocobalamin|cyanocobalamin
431109|NCT01306123|intranasal|intranasal
431110|NCT01306123|intramuscular|intramuscular
431111|NCT01306110|Liver fibrosis|liver fibrosis
431112|NCT01306110|diabetes|diabetes
431113|NCT01306110|Fibroscan|fibroscan
431114|NCT01306110|Fibrotest|fibrotest
431115|NCT01306110|noninvasive fibrosis biomarkers|noninvasive fibrosis biomarkers
431116|NCT01306097|Zinc Supplement|zinc supplement
431117|NCT01306097|Diarrhea|diarrhea
431118|NCT01306097|Sever Diarrhea|sever diarrhea
431119|NCT01306084|Respiratory Infections|respiratory infections
431120|NCT01306084|Norovirus|norovirus
431121|NCT01306084|Adenovirus|adenovirus
431122|NCT01306084|Viral Infection|viral infection
431123|NCT01306084|Respiratory Viruses|respiratory viruses
431124|NCT01306058|Hepatocellular Carcinoma|hepatocellular carcinoma
431125|NCT01306058|TRC105|trc105
431126|NCT01306058|Sorafenib|sorafenib
431127|NCT01306058|Liver Cancer|liver cancer
431128|NCT01306058|Monoclonal Antibody|monoclonal antibody
431129|NCT01306045|AZD6244|azd6244
431130|NCT01306045|MK-2206|mk-2206
431131|NCT01306045|Lapatinib|lapatinib
431132|NCT01306045|Erlotinib|erlotinib
431133|NCT01306045|Sunitinib|sunitinib
431134|NCT01306045|Lung Cancer|lung cancer
431135|NCT01306045|Thymic Cancer|thymic cancer
431136|NCT01306045|Small Cell Lung Cancer|small cell lung cancer
431137|NCT01306045|Non-Small Cell Lung Cancer|non-small cell lung cancer
431138|NCT01306032|PARP Inhibitor|parp inhibitor
431139|NCT01306032|BRCA Mutations|brca mutations
431140|NCT01306032|DNA Damage Repair|dna damage repair
431141|NCT01306032|Pharmacodynamics|pharmacodynamics
431142|NCT01306032|Metronomic Cyclophosphamide|metronomic cyclophosphamide
431143|NCT01306032|Ovarian Cancer|ovarian cancer
431144|NCT01306032|Breast Cancer|breast cancer
431145|NCT01306032|Fallopian Tube Cancer|fallopian tube cancer
431146|NCT01306032|Peritoneal Cancer|peritoneal cancer
431147|NCT01306019|X-Linked Severe Combined Immunodeficiency (XSCID)|x-linked severe combined immunodeficiency (xscid)
431148|NCT01306019|Gene Transfer|gene transfer
431149|NCT01306019|Peripheral Blood Stem Cells|peripheral blood stem cells
431150|NCT01306019|Common Gamma Chain (GC), Immune Reconstitution|common gamma chain (gc), immune reconstitution
431151|NCT01306019|Immune Reconstitution|immune reconstitution
431152|NCT01306019|X-Linked Severe Combined Immunodeficiency|x-linked severe combined immunodeficiency
431153|NCT01306019|SCID|scid
431154|NCT01306006|Mortality|mortality
431155|NCT01306006|Vaccines|vaccines
431156|NCT01305954|Breast|breast
431157|NCT01305954|Cancer|cancer
431158|NCT01305954|Breast Cancer|breast cancer
431159|NCT01305954|New Diagnosis|new diagnosis
431160|NCT01305954|Treatment|treatment
431161|NCT01305954|Chemotherapy|chemotherapy
431162|NCT01305954|Blood|blood
431163|NCT01305954|Blood Draw|blood draw
431164|NCT01305954|Lab Draw|lab draw
431165|NCT01305954|Gene|gene
431166|NCT01305954|Gene Therapy|gene therapy
431167|NCT01305954|Geriatric|geriatric
431168|NCT01305954|Oncology|oncology
431169|NCT01305954|Muss|muss
431171|NCT01305954|North Carolina Cancer Hospital|north carolina cancer hospital
431172|NCT01305954|Initial Treatment|initial treatment
431173|NCT01305954|CBC|cbc
431174|NCT01305941|everolimus|everolimus
431175|NCT01305941|trastuzumab|trastuzumab
431176|NCT01305941|vinorelbine|vinorelbine
431177|NCT01305941|RAD001|rad001
431178|NCT01305941|Breast Cancer|breast cancer
431179|NCT01305941|Herceptin|herceptin
431180|NCT01305941|Navelbine|navelbine
431181|NCT01305941|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
431182|NCT01305941|Brain Metastases|brain metastases
431183|NCT01305915|single-session group|single-session group
431184|NCT01305915|psychoeducational intervention|psychoeducational intervention
431185|NCT01305889|Depression|depression
431186|NCT01305889|Cerebral perfusion|cerebral perfusion
431187|NCT01305889|Brain derived neurotropic factor|brain derived neurotropic factor
431188|NCT01305889|Problem Solving Therapy|problem solving therapy
431189|NCT01305889|Sertraline|sertraline
431190|NCT01305876|yoga|yoga
431191|NCT01305876|emotional behavioral disorder|emotional behavioral disorder
431192|NCT01305876|intervention|intervention
431193|NCT01305876|school|school
431194|NCT01305876|meditation|meditation
431195|NCT01305876|focus: yoga intervention in students with emotional behavioral disorders in an urban school|focus: yoga intervention in students with emotional behavioral disorders in an urban school
431196|NCT01305863|Peripheral Vascular Disease (PVD)|peripheral vascular disease (pvd)
431197|NCT01305850|Aliskiren|aliskiren
431198|NCT01305850|Losartan|losartan
431199|NCT01305850|Peritoneal membrane dysfunction|peritoneal membrane dysfunction
431200|NCT01305837|multiple sclerosis|multiple sclerosis
431201|NCT01305837|methylprednisolone|methylprednisolone
431202|NCT01305837|osteopontin|osteopontin
431203|NCT01305837|inflammation|inflammation
431204|NCT01305837|demyelinating|demyelinating
431205|NCT01305824|arteriovenous fistula|arteriovenous fistula
431206|NCT01305824|AVF|avf
431207|NCT01305824|hemodialysis|hemodialysis
431208|NCT01305824|vascular access|vascular access
431209|NCT01305824|dialysis|dialysis
431210|NCT01305824|fistula|fistula
431211|NCT01305824|PRT-201|prt-201
431212|NCT01305824|vonapanitase|vonapanitase
431213|NCT01305824|kidney|kidney
431214|NCT01305824|renal|renal
431215|NCT01305811|Complex Medical Illness|complex medical illness
431216|NCT01305811|Gulf War Illness|gulf war illness
431217|NCT01305811|Veteran|veteran
431218|NCT01305798|Biometric Screenings|biometric screenings
431219|NCT01305798|Active Choice|active choice
431220|NCT01305798|Behavioral Economics|behavioral economics
431221|NCT01305798|Default|default
431222|NCT01305772|SCCHN|scchn
431223|NCT01305772|untreated|untreated
431224|NCT01305772|Stage III or IVa-b (M0)|stage iii or iva-b (m0)
431225|NCT01305759|Total knee arthroplasty|total knee arthroplasty
431226|NCT01305759|Total hip arthroplasty|total hip arthroplasty
431227|NCT01305759|Peri acetabular osteotomy|peri acetabular osteotomy
431228|NCT01305759|Social class|social class
431229|NCT01305759|Health related quality of life|health related quality of life
431230|NCT01305746|SLE|sle
431231|NCT01305746|Lupus|lupus
431232|NCT01305746|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
431233|NCT01305746|A-623|a-623
431234|NCT01305746|Autoimmune Diseases|autoimmune diseases
431235|NCT01305746|Blisibimod|blisibimod
431236|NCT01305733|Pain relief|pain relief
431237|NCT01305720|mydriatic|mydriatic
431238|NCT01305720|NIRS|nirs
431239|NCT01305720|preterm|preterm
431240|NCT01305720|eye drops|eye drops
431241|NCT01305720|cerebral|cerebral
431242|NCT01305720|mesenteric oxygenation|mesenteric oxygenation
431243|NCT01305707|Consolidation ECT|consolidation ect
431244|NCT01305707|Pharmacotherapy|pharmacotherapy
431245|NCT01305707|Efficacy|efficacy
431246|NCT01305707|Depression|depression
431247|NCT01305707|Prevention|prevention
431248|NCT01305707|Electroconvulsive therapy|electroconvulsive therapy
431249|NCT01305707|Drug therapy|drug therapy
431250|NCT01305668|COPD|copd
431251|NCT01305668|Emphysema phenotype|emphysema phenotype
431252|NCT01305655|Drug: Glucarpidase|drug: glucarpidase
431253|NCT01305642|Postnatal development|postnatal development
431254|NCT01305642|Breast milk fortification|breast milk fortification
431255|NCT01305642|Composition of breast milk|composition of breast milk
431256|NCT01305629|HIV|hiv
431257|NCT01305629|Medication Adherence|medication adherence
431258|NCT01305629|Substance Use|substance use
431259|NCT01305629|Older adults|older adults
431260|NCT01305629|Treatment|treatment
431261|NCT01305616|Open angle Glaucoma|open angle glaucoma
431874|NCT01303081|Work-site|work-site
431262|NCT01305616|Yellow-tinted intraocular lens|yellow-tinted intraocular lens
431263|NCT01305616|Short-wavelength Automated Perimetry (SWAP)|short-wavelength automated perimetry (swap)
431264|NCT01305616|Standard Automated Perimetry (SAP)|standard automated perimetry (sap)
431265|NCT01305616|cataract|cataract
431266|NCT01305590|HIV|hiv
431267|NCT01305590|AIDS|aids
431268|NCT01305590|Medication Adherence|medication adherence
431269|NCT01305590|Commitment Devices|commitment devices
431270|NCT01305590|Behavioral Economics|behavioral economics
431271|NCT01305564|Pulmonary embolism (PE)|pulmonary embolism (pe)
431272|NCT01305564|Deep vein thrombosis (DVT)|deep vein thrombosis (dvt)
431273|NCT01305564|Vena cava|vena cava
431274|NCT01305564|Vena cava filter|vena cava filter
431275|NCT01305564|Inferior vena cava|inferior vena cava
431276|NCT01305564|Venous thromboembolic disease (VTED)|venous thromboembolic disease (vted)
431277|NCT01305525|SCS|scs
431278|NCT01305525|St. Jude Medical|st. jude medical
431279|NCT01305525|Neuromodulation|neuromodulation
431280|NCT01305512|Solid|solid
431281|NCT01305512|Tumor|tumor
431282|NCT01305512|Taxane|taxane
431283|NCT01305499|AML|aml
431284|NCT01305447|smoking cessation|smoking cessation
431285|NCT01305447|exercise maintenance|exercise maintenance
431286|NCT01305447|preventing relapse|preventing relapse
431287|NCT01305447|weight gain|weight gain
431288|NCT01305447|group-mediated cognitive behavioural therapy|group-mediated cognitive behavioural therapy
431289|NCT01305434|diabetes mellitus type 2|diabetes mellitus type 2
431290|NCT01305434|mulberry leaf extract|mulberry leaf extract
431291|NCT01305434|post prandial blood glucose|post prandial blood glucose
431292|NCT01305421|ICU|icu
431293|NCT01305421|muscle strength|muscle strength
431294|NCT01305421|mechanical ventilation|mechanical ventilation
431295|NCT01305421|weaning|weaning
431296|NCT01305408|Bipolar I Disorder|bipolar i disorder
431297|NCT01305395|Cardiac Allograft Vasculopathy in Heart Transplant|cardiac allograft vasculopathy in heart transplant
431298|NCT01305382|Cardiac Allograft Vasculopathy|cardiac allograft vasculopathy
431299|NCT01305369|ASTHMA|asthma
431300|NCT01305369|PLATELET RECEPTOR P2Y12|platelet receptor p2y12
431301|NCT01305369|PRASUGREL|prasugrel
431302|NCT01305369|INFLAMMATION|inflammation
431303|NCT01305356|degenerative joint disease|degenerative joint disease
431304|NCT01305356|DJD|djd
431305|NCT01305356|joint fusion|joint fusion
431306|NCT01305356|hindfoot|hindfoot
431307|NCT01305356|congenital deformity|congenital deformity
431308|NCT01305356|osteoarthritis|osteoarthritis
431309|NCT01305356|rheumatoid arthritis|rheumatoid arthritis
431310|NCT01305356|post-traumatic arthritis|post-traumatic arthritis
431311|NCT01305356|ankylosing spondylitis|ankylosing spondylitis
431312|NCT01305356|Augment(tm) Injectable Bone Graft|augment(tm) injectable bone graft
431313|NCT01305356|autologous bone graft|autologous bone graft
431314|NCT01305356|autogenous bone graft|autogenous bone graft
431315|NCT01305356|beta-TCP|beta-tcp
431316|NCT01305356|bovine collagen|bovine collagen
431317|NCT01305356|rhPDGF(bb)|rhpdgf(bb)
431318|NCT01305343|Spinal Deformity|spinal deformity
431319|NCT01305343|Scoliosis|scoliosis
431320|NCT01305343|Neurologic complications|neurologic complications
431321|NCT01305330|small renal mass|small renal mass
431322|NCT01305330|active surveillance|active surveillance
431323|NCT01305330|kidney mass|kidney mass
431324|NCT01305330|kidney tumour|kidney tumour
431325|NCT01305317|Statin|statin
431326|NCT01305291|dietary fiber|dietary fiber
431327|NCT01305291|satiety response|satiety response
431328|NCT01305291|hunger|hunger
431329|NCT01305291|CCK|cck
431330|NCT01305291|PYY|pyy
431331|NCT01305291|ghrelin|ghrelin
431332|NCT01305291|GIP|gip
431333|NCT01305291|GLP-1|glp-1
431334|NCT01305278|Balance|balance
431335|NCT01305278|Rehabilitation|rehabilitation
431336|NCT01305278|Vestibular|vestibular
431337|NCT01305265|sore throat|sore throat
431338|NCT01305265|dysphagia|dysphagia
431339|NCT01305265|hoarseness|hoarseness
431340|NCT01305265|post operative|post operative
431341|NCT01305265|endotracheal intubation|endotracheal intubation
431342|NCT01305239|Observational|observational
431343|NCT01305239|epidemiological|epidemiological
431344|NCT01305239|cohort|cohort
431345|NCT01305239|cross-sectional|cross-sectional
431346|NCT01305239|prospective|prospective
431347|NCT01305239|multicenter|multicenter
431348|NCT01305239|survey|survey
431349|NCT01305239|France.|france.
431350|NCT01305226|THR 100|thr 100
431351|NCT01305174|Common Iliac Artery and External Iliac Artery|common iliac artery and external iliac artery
431352|NCT01305161|1Allergy|1allergy
431353|NCT01305161|2 Neuromuscular blockers|2 neuromuscular blockers
431354|NCT01305148|warfarin|warfarin
431355|NCT01305148|genetic testing|genetic testing
431356|NCT01305148|personalized medicine|personalized medicine
431357|NCT01305148|anti-coagulants|anti-coagulants
431358|NCT01305148|coumadin|coumadin
431359|NCT01305135|myelodysplastic syndrome, azacitidine, idarubicin|myelodysplastic syndrome, azacitidine, idarubicin
431360|NCT01305122|Glioma|glioma
431361|NCT01305122|Neurocognitive functions|neurocognitive functions
431362|NCT01305096|heart rate variability|heart rate variability
431363|NCT01305096|oxygen uptake|oxygen uptake
431364|NCT01305096|heart rate recovery|heart rate recovery
431365|NCT01305096|perceived stress|perceived stress
431366|NCT01305096|sleep|sleep
431367|NCT01305096|blood pressure|blood pressure
431368|NCT01305096|body mass index|body mass index
431369|NCT01305096|body weight|body weight
431370|NCT01305096|hand grip strength|hand grip strength
431371|NCT01305096|sleep quality|sleep quality
431372|NCT01305096|subjective health complaints|subjective health complaints
431373|NCT01305096|blood lipids|blood lipids
431374|NCT01305096|salivary cortisol|salivary cortisol
431375|NCT01305096|blood sugar|blood sugar
431376|NCT01305096|HbA1C|hba1c
431377|NCT01305096|Adiponectin|adiponectin
431378|NCT01305096|Leptin|leptin
431379|NCT01305096|Adipolipoproteins|adipolipoproteins
431380|NCT01305096|blood proteins|blood proteins
431381|NCT01305096|cytokines|cytokines
431382|NCT01305096|insomnia|insomnia
431383|NCT01305096|sleeplessness|sleeplessness
431384|NCT01305096|yoga|yoga
431385|NCT01305070|Standard balloon angioplasty|standard balloon angioplasty
431386|NCT01305070|POBA|poba
431387|NCT01305070|Angioplasty with paclitaxel-eluting balloon|angioplasty with paclitaxel-eluting balloon
431388|NCT01305070|Superficial femoral artery|superficial femoral artery
431389|NCT01305057|dry skin condition|dry skin condition
431390|NCT01305044|tai chi|tai chi
431391|NCT01305044|elderly cancer survivor|elderly cancer survivor
431392|NCT01305044|mind body intervention|mind body intervention
431393|NCT01305031|Asphyxia|asphyxia
431394|NCT01305031|Resuscitation|resuscitation
431395|NCT01305031|Room Air|room air
431396|NCT01305018|Branched-chain amino acids|branched-chain amino acids
431397|NCT01305018|Leucine|leucine
431398|NCT01305018|Muscle damage|muscle damage
431399|NCT01305018|Inflammation|inflammation
431400|NCT01305018|supplementation|supplementation
431401|NCT01305018|resistance exercise-induced|resistance exercise-induced
431402|NCT01305005|blood flow|blood flow
431403|NCT01304992|Dietary protein|dietary protein
431404|NCT01304992|Lupin protein|lupin protein
431405|NCT01304992|Cholesterol metabolism|cholesterol metabolism
431406|NCT01304992|Protein metabolism|protein metabolism
431407|NCT01304992|Hypercholesterolemia|hypercholesterolemia
431408|NCT01304992|Protein-enriched drinks|protein-enriched drinks
431409|NCT01304979|acupuncture|acupuncture
431410|NCT01304979|auricular acu-therapy|auricular acu-therapy
431411|NCT01304979|gua sha therapy|gua sha therapy
431412|NCT01304979|low back 'spine fusion'|low back 'spine fusion'
431413|NCT01304979|post surgical pain|post surgical pain
431414|NCT01304979|post surgical recovery|post surgical recovery
431415|NCT01304979|Pain and recovery from 'spine fusion' surgery|pain and recovery from 'spine fusion' surgery
431416|NCT01304966|RRP|rrp
431417|NCT01304966|HPV|hpv
431418|NCT01304953|General anaesthetics|general anaesthetics
431419|NCT01304953|gynaecological laparoscopy|gynaecological laparoscopy
431420|NCT01304953|anaesthetic i.v.|anaesthetic i.v.
431421|NCT01304953|propofol|propofol
431422|NCT01304953|anaesthetic volatile|anaesthetic volatile
431423|NCT01304953|evoflurane|evoflurane
431424|NCT01304953|antiemetics|antiemetics
431425|NCT01304953|reopisetron|reopisetron
431426|NCT01304953|postoperative pain|postoperative pain
431427|NCT01304940|Stress|stress
431428|NCT01304940|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
431429|NCT01304940|Stress Disorders, Traumatic|stress disorders, traumatic
431430|NCT01304927|Reproduction|reproduction
431431|NCT01304927|Sex hormones|sex hormones
431432|NCT01304927|Glucose metabolism|glucose metabolism
431433|NCT01304927|Bone metabolism|bone metabolism
431434|NCT01304927|Calcium|calcium
431435|NCT01304927|Sperm|sperm
431436|NCT01304927|testis|testis
431437|NCT01304927|bone|bone
431438|NCT01304927|endocrinology|endocrinology
431439|NCT01304914|Respiratory tract infections|respiratory tract infections
431440|NCT01304914|Gastrointestinal tract infections|gastrointestinal tract infections
431441|NCT01304914|Pediatrics|pediatrics
431442|NCT01304914|Specimen collection|specimen collection
431443|NCT01304901|Acute asthma|acute asthma
431444|NCT01304901|Children|children
431445|NCT01304901|Montelukast|montelukast
431446|NCT01304901|Emergency room|emergency room
431447|NCT01304888|Food consumption|food consumption
431448|NCT01304875|Fabry disease|fabry disease
431449|NCT01304875|alpha-galactosidase deficiency|alpha-galactosidase deficiency
431450|NCT01304875|exercise|exercise
431451|NCT01304875|pulmonary|pulmonary
431452|NCT01304849|Hodgkin's Lymphoma|hodgkin's lymphoma
431453|NCT01304849|PET CT scan|pet ct scan
431454|NCT01304849|Escalated BEACOPP|escalated beacopp
431455|NCT01304849|ABVD|abvd
431456|NCT01304849|Response adapted therapy|response adapted therapy
431457|NCT01304836|Kidney|kidney
431458|NCT01304836|Diabetes Mellitus|diabetes mellitus
431459|NCT01304836|Transplant|transplant
431460|NCT01304836|Immunosuppression|immunosuppression
431461|NCT01304823|T1R2/T1R3|t1r2/t1r3
431462|NCT01304823|gastric emptying|gastric emptying
431463|NCT01304823|gut|gut
431464|NCT01304823|lactisole|lactisole
431465|NCT01304823|nutrient sensing|nutrient sensing
431467|NCT01304810|Smoking cessation|smoking cessation
431468|NCT01304797|MM302|mm302
431469|NCT01304797|Breast Cancer|breast cancer
431470|NCT01304797|Locally advanced/unresectable|locally advanced/unresectable
431471|NCT01304797|metastatic|metastatic
431472|NCT01304784|Solid tumors|solid tumors
431473|NCT01304784|Failed at least one line of standard therapy|failed at least one line of standard therapy
431474|NCT01304771|Safety|safety
431475|NCT01304771|AKSB|aksb
431476|NCT01304771|probiotic|probiotic
431477|NCT01304771|synbiotic|synbiotic
431478|NCT01304771|enterococcus|enterococcus
431479|NCT01304771|Saccharomyces|saccharomyces
431480|NCT01304771|elderly|elderly
431481|NCT01304771|influenza|influenza
431482|NCT01304771|vaccine|vaccine
431483|NCT01304771|immune|immune
431484|NCT01304771|response|response
431485|NCT01304693|AMD|amd
431486|NCT01304693|Wet AMD|wet amd
431487|NCT01304693|Exudative|exudative
431488|NCT01304693|CNV|cnv
431489|NCT01304667|Vulvar cancer|vulvar cancer
431490|NCT01304667|Radiotherapy|radiotherapy
431491|NCT01304667|Chemotherapy|chemotherapy
431492|NCT01304654|acute lung injury|acute lung injury
431493|NCT01304654|respiratory distress syndrome|respiratory distress syndrome
431494|NCT01304654|neoplasms|neoplasms
431495|NCT01304654|child|child
431496|NCT01304641|Dyslipidemia|dyslipidemia
431497|NCT01304641|Cardiovascular|cardiovascular
431499|NCT01304628|asthma|asthma
431500|NCT01304615|Overweight|overweight
431501|NCT01304615|Obesity|obesity
431502|NCT01304615|Young Adults|young adults
431503|NCT01304615|Energy Density|energy density
431504|NCT01304615|Culinary Skills|culinary skills
431505|NCT01304615|Physical Activity|physical activity
431506|NCT01304615|Consumption of Self-made Meals|consumption of self-made meals
431507|NCT01304615|Family History of diabetes|family history of diabetes
431508|NCT01304602|colorectal cancer|colorectal cancer
431509|NCT01304602|BKM120|bkm120
431510|NCT01304602|irinotecan|irinotecan
431511|NCT01304589|provoked vestibulodynia|provoked vestibulodynia
431512|NCT01304589|vulvodynia|vulvodynia
431513|NCT01304589|PVD|pvd
431514|NCT01304576|stroke|stroke
431515|NCT01304576|parietal lesions|parietal lesions
431516|NCT01304550|non-invasive|non-invasive
431517|NCT01304550|hemoglobin|hemoglobin
431518|NCT01304524|CIN 2/3 or CIN 3|cin 2/3 or cin 3
431519|NCT01304524|Cervical cancer|cervical cancer
431520|NCT01304524|Papillomavirus|papillomavirus
431521|NCT01304485|Recurrent Prostate Carcinoma|recurrent prostate carcinoma
431522|NCT01304485|sodium acetate c11|sodium acetate c11
431523|NCT01304485|PET|pet
431524|NCT01304485|prostate cancer|prostate cancer
431525|NCT01304485|rising PSA|rising psa
431526|NCT01304485|PSA recurrence|psa recurrence
431527|NCT01304485|biochemical recurrence|biochemical recurrence
431528|NCT01304472|coronary angioplasty|coronary angioplasty
431529|NCT01304472|clopidogrel resistance|clopidogrel resistance
431530|NCT01304472|prasugrel|prasugrel
431531|NCT01304446|Nutritional support|nutritional support
431532|NCT01304446|Cancer|cancer
431533|NCT01304446|Malnutrition|malnutrition
431534|NCT01304446|Child|child
431535|NCT01304446|Adolescent|adolescent
431536|NCT01304446|pediatric|pediatric
431537|NCT01304420|Juvenile idiopathic arthritis|juvenile idiopathic arthritis
431538|NCT01304420|Ultrasonography|ultrasonography
431539|NCT01304420|Cartilage|cartilage
431540|NCT01304420|Cartilage biomarkers|cartilage biomarkers
431541|NCT01304420|Bone biomarkers|bone biomarkers
431542|NCT01304407|Rothmund-Thomson Syndrome|rothmund-thomson syndrome
431543|NCT01304407|Calcium absorption|calcium absorption
431544|NCT01304407|Bone density|bone density
431545|NCT01304394|Parenteral Nutrition|parenteral nutrition
431546|NCT01304394|Multi Chamber Bag|multi chamber bag
431547|NCT01304381|Heart failure|heart failure
431548|NCT01304381|Palliative care|palliative care
431549|NCT01304381|Integrated care|integrated care
431550|NCT01304368|Hyperthermia, Induced|hyperthermia, induced
431551|NCT01304368|Randomized Controlled Trial|randomized controlled trial
431552|NCT01304368|Neck Pain|neck pain
431553|NCT01304368|Sensory Thresholds|sensory thresholds
431554|NCT01304368|Pain Measurements|pain measurements
431555|NCT01304355|IBS|ibs
431556|NCT01304355|Cognition|cognition
431557|NCT01304355|Kynurenine Pathway|kynurenine pathway
431558|NCT01304355|Gastrointestinal|gastrointestinal
431559|NCT01304342|Propofol|propofol
431560|NCT01304342|remifentanil|remifentanil
431561|NCT01304342|fentanyl|fentanyl
431562|NCT01304342|ERCP|ercp
431563|NCT01304342|Quality of sedation|quality of sedation
431564|NCT01304342|recovery|recovery
431565|NCT01304342|satisfaction|satisfaction
431566|NCT01304342|respiratory depression|respiratory depression
431567|NCT01304303|solid|solid
431568|NCT01304303|tumor|tumor
431569|NCT01304303|taxane|taxane
431570|NCT01304303|platinum|platinum
431571|NCT01304290|inflammatory process|inflammatory process
431572|NCT01304290|hyperglycaemia|hyperglycaemia
431573|NCT01304290|inflammatory cytokine response|inflammatory cytokine response
431574|NCT01304290|organ survival|organ survival
431575|NCT01304290|hyperinsulinemic clamp|hyperinsulinemic clamp
431576|NCT01304277|Replagal|replagal
431577|NCT01304264|glaucoma, ocular, blood flow, fluctuations|glaucoma, ocular, blood flow, fluctuations
431578|NCT01304251|short-term fasting|short-term fasting
431579|NCT01304251|adjuvant chemotherapy|adjuvant chemotherapy
431580|NCT01304251|toxicity|toxicity
431581|NCT01304251|side-effects|side-effects
431582|NCT01304238|Retrospective evaluation of patients with acute Heparin-induced Thrombocytopenia type II treated with Fondaparinux|retrospective evaluation of patients with acute heparin-induced thrombocytopenia type ii treated with fondaparinux
431583|NCT01304225|diabetic retinopathy|diabetic retinopathy
431584|NCT01304225|photocoagulation|photocoagulation
431585|NCT01304225|PASCAL laser|pascal laser
431586|NCT01304212|total knee arthroplasty|total knee arthroplasty
431587|NCT01304212|intraarticular infiltration|intraarticular infiltration
431588|NCT01304212|femoral block|femoral block
431589|NCT01304199|Cancer survivor|cancer survivor
431590|NCT01304199|Neoplasms|neoplasms
431591|NCT01304199|Treatments|treatments
431592|NCT01304199|Physical status|physical status
431593|NCT01304199|Psychosocial status|psychosocial status
431594|NCT01304199|Survivorship survey|survivorship survey
431595|NCT01304199|Survivorship care|survivorship care
431596|NCT01304199|Research|research
431597|NCT01304199|Cancer patient|cancer patient
431598|NCT01304186|Health literacy|health literacy
431599|NCT01304186|HIV|hiv
431600|NCT01304186|Medication Adherence|medication adherence
431601|NCT01304186|IMB Model|imb model
431602|NCT01304173|BCG|bcg
431603|NCT01304173|refractory|refractory
431604|NCT01304173|NMIBC|nmibc
431605|NCT01304173|CIS|cis
431606|NCT01304173|non-muscle invasive|non-muscle invasive
431607|NCT01304160|pancreatic cancer|pancreatic cancer
431608|NCT01304160|stereotactic body radiotherapy|stereotactic body radiotherapy
431609|NCT01304160|radiation|radiation
431610|NCT01304160|gemcitabine|gemcitabine
431611|NCT01304160|locally advanced|locally advanced
431612|NCT01304147|ketamine|ketamine
431613|NCT01304147|depression|depression
431614|NCT01304147|treatment resistance|treatment resistance
431615|NCT01304147|intranasal, antidepressant|intranasal, antidepressant
431616|NCT01304147|glutamate|glutamate
431617|NCT01304147|NMDA receptor|nmda receptor
431618|NCT01304121|Bone tumors|bone tumors
431619|NCT01304121|Bioactive glass|bioactive glass
431620|NCT01304121|Autogenous bone grafting|autogenous bone grafting
431621|NCT01304121|Allogeneic bone grafting|allogeneic bone grafting
431622|NCT01304121|PET imaging|pet imaging
431623|NCT01304108|Venous Thromboembolism|venous thromboembolism
431624|NCT01304108|Delivery of Health Care|delivery of health care
431625|NCT01304108|Quality Improvement|quality improvement
431626|NCT01304108|Evidence-Based Practice|evidence-based practice
431627|NCT01304095|Coronary Artery Disease, Angina, Metabolic Syndrome|coronary artery disease, angina, metabolic syndrome
431628|NCT01304082|pain pH local anesthetics|pain ph local anesthetics
431629|NCT01304069|Pharmacokinetics|pharmacokinetics
431630|NCT01304069|Pharmacodynamics|pharmacodynamics
431631|NCT01304056|Ventilatory physiology|ventilatory physiology
431632|NCT01304043|ovarian tumors|ovarian tumors
431633|NCT01304043|rare ovarian tumors|rare ovarian tumors
431634|NCT01304043|germinal tumors|germinal tumors
431635|NCT01304043|sexual cords tumors|sexual cords tumors
431636|NCT01304043|observatory|observatory
431637|NCT01304043|forum|forum
431638|NCT01304030|Empathy|empathy
431639|NCT01304017|rehabilitation|rehabilitation
431640|NCT01304017|stroke|stroke
431641|NCT01304017|intervention|intervention
431642|NCT01304017|physical activity|physical activity
431643|NCT01304017|participation|participation
431644|NCT01304004|Obesity|obesity
431645|NCT01304004|Yogurt|yogurt
431646|NCT01304004|Proteins|proteins
431647|NCT01304004|Fibres|fibres
431648|NCT01304004|Women|women
431649|NCT01304004|Satiety|satiety
431650|NCT01303952|cold agglutinin disease|cold agglutinin disease
431651|NCT01303952|hemolysis|hemolysis
431652|NCT01303952|eculizumab|eculizumab
431653|NCT01303952|terminal complement inhibition|terminal complement inhibition
431654|NCT01303939|Glaucoma|glaucoma
431655|NCT01303939|MRI Brain Scan|mri brain scan
431656|NCT01303939|Voxel-Based Morphometry|voxel-based morphometry
431657|NCT01303926|QoL|qol
431658|NCT01303926|EQ5D score|eq5d score
431659|NCT01303926|cisplatin pemetrexed|cisplatin pemetrexed
431660|NCT01303926|carboplatin paclitaxel bevacizumab|carboplatin paclitaxel bevacizumab
431661|NCT01303926|maintenance|maintenance
431662|NCT01303913|COPD|copd
431663|NCT01303913|Oxygen desaturation|oxygen desaturation
431664|NCT01303913|Walking test|walking test
431665|NCT01303900|Haemophilia|haemophilia
431666|NCT01303900|Cardiovascular disease|cardiovascular disease
431667|NCT01303900|Cardiovascular disease risk factors|cardiovascular disease risk factors
431668|NCT01303900|Prospective|prospective
431669|NCT01303900|QRISK2|qrisk2
431670|NCT01303900|Hypertension|hypertension
431671|NCT01303900|Hypercholesterolaemia|hypercholesterolaemia
431672|NCT01303900|Diabetes|diabetes
431673|NCT01303900|Obesity|obesity
431674|NCT01303887|PACIFICO|pacifico
431675|NCT01303887|Follicular Lymphoma|follicular lymphoma
431676|NCT01303887|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
431677|NCT01303887|Rituximab|rituximab
431678|NCT01303887|R-CVP|r-cvp
431679|NCT01303887|R-FC|r-fc
431680|NCT01303887|Older|older
431681|NCT01303874|Rheumatoid arthritis|rheumatoid arthritis
431682|NCT01303874|Inflammatory arthritis|inflammatory arthritis
431683|NCT01303874|Undifferentiated arthritis|undifferentiated arthritis
431684|NCT01303874|Etanercept|etanercept
431685|NCT01303874|Combination Therapy|combination therapy
431686|NCT01303861|Nicotine addiction|nicotine addiction
431687|NCT01303861|Cigarette smoking|cigarette smoking
431688|NCT01303861|Smoking cessation|smoking cessation
431689|NCT01303861|Zyban|zyban
431690|NCT01303861|Chantix|chantix
431691|NCT01303861|Nicotine patches|nicotine patches
431692|NCT01303861|Nicotrol Inhaler|nicotrol inhaler
431693|NCT01303861|varenicline|varenicline
431694|NCT01303861|bupropion|bupropion
431695|NCT01303848|Blood lactate|blood lactate
431696|NCT01303848|Lipid transfer proteins|lipid transfer proteins
431697|NCT01303848|Lactate|lactate
431698|NCT01303848|PLTP|pltp
431699|NCT01303848|CETP|cetp
431700|NCT01303848|PPARs|ppars
431701|NCT01303848|CLOCk|clock
431702|NCT01303848|Bal1|bal1
431703|NCT01303835|malignant glioma|malignant glioma
431704|NCT01303835|glioblastoma multiforme|glioblastoma multiforme
431705|NCT01303835|quality of life|quality of life
431706|NCT01303835|naltrexone|naltrexone
431707|NCT01303809|Perioperative care|perioperative care
431708|NCT01303809|Fast-track|fast-track
431709|NCT01303809|Enhanced Recovery After Surgery|enhanced recovery after surgery
431710|NCT01303809|ERAS|eras
431711|NCT01303809|Obesity|obesity
431712|NCT01303809|Bariatric surgery|bariatric surgery
431713|NCT01303809|Laparoscopic Sleeve Gastrectomy|laparoscopic sleeve gastrectomy
431714|NCT01303796|AML|aml
431715|NCT01303783|Nifedipine GITS|nifedipine gits
431716|NCT01303783|Candesartan|candesartan
431717|NCT01303783|mild to moderate Hypertension|mild to moderate hypertension
431718|NCT01303783|Combination therapy|combination therapy
431719|NCT01303770|Multiple Sclerosis|multiple sclerosis
431720|NCT01303770|Cognitive impairment|cognitive impairment
431721|NCT01303770|Self-management programs|self-management programs
431722|NCT01303770|Occupational Therapy|occupational therapy
431723|NCT01303770|Rehabilitation|rehabilitation
431724|NCT01303757|obesity|obesity
431725|NCT01303731|Spinal anesthesia|spinal anesthesia
431726|NCT01303731|Cesarean section|cesarean section
431727|NCT01303731|Marcaine Spinal 0.5% Heavy minidose|marcaine spinal 0.5% heavy minidose
431728|NCT01303731|Fentanyl|fentanyl
431729|NCT01303731|Local Anesthetics|local anesthetics
431730|NCT01303718|LV Dysfunction|lv dysfunction
431731|NCT01303718|Heart Failure|heart failure
431732|NCT01303705|progressive metastatic prostate cancer|progressive metastatic prostate cancer
431733|NCT01303705|cancer of the prostate|cancer of the prostate
431734|NCT01303705|prostate cancer|prostate cancer
431735|NCT01303692|bone mineral loss|bone mineral loss
431736|NCT01303692|prostate cancer|prostate cancer
431737|NCT01303692|GnRH agonist alone vs. GnRH agonist plus anti-androgen combination|gnrh agonist alone vs. gnrh agonist plus anti-androgen combination
431738|NCT01303679|First line metastatic breast cancer|first line metastatic breast cancer
431739|NCT01303679|Positive estrogen receptors|positive estrogen receptors
431740|NCT01303679|Negative HER2 receptors|negative her2 receptors
431741|NCT01303679|At least stable disease after 4 months of paclitaxel-bevcizumab induction chemotheray|at least stable disease after 4 months of paclitaxel-bevcizumab induction chemotheray
431742|NCT01303653|endoscopic tissue closure,|endoscopic tissue closure,
431743|NCT01303653|gastro-gastric fistulas,|gastro-gastric fistulas,
431744|NCT01303653|gastrointestinal perforations|gastrointestinal perforations
431745|NCT01303640|Coronary stent|coronary stent
431746|NCT01303627|Remifentanil|remifentanil
431747|NCT01303627|Laryngeal mask airway removal|laryngeal mask airway removal
431748|NCT01303627|Hemodynamic changing|hemodynamic changing
431749|NCT01303627|Infusion|infusion
431750|NCT01303627|Ureterorenoscopy|ureterorenoscopy
431751|NCT01303614|hysterosalpingography|hysterosalpingography
431752|NCT01303614|prilocaine|prilocaine
431753|NCT01303614|local anaesthetic|local anaesthetic
431754|NCT01303614|pain relief|pain relief
431755|NCT01303614|gynecological pathology|gynecological pathology
431756|NCT01303601|Olanzapine|olanzapine
431757|NCT01303601|Monotherapy|monotherapy
431758|NCT01303601|bipolar Ⅰ depression|bipolar ⅰ depression
431759|NCT01303588|elderly patients|elderly patients
431760|NCT01303575|Adolescents|adolescents
431761|NCT01303575|Youth|youth
431762|NCT01303575|Sexual Health|sexual health
431763|NCT01303575|Sex Education|sex education
431764|NCT01303575|Pregnancy Prevention|pregnancy prevention
431765|NCT01303575|Abstinence Education|abstinence education
431766|NCT01303575|HIV|hiv
431767|NCT01303575|Human Immunodeficiency Virus|human immunodeficiency virus
431768|NCT01303575|STI|sti
431769|NCT01303575|Chlamydia|chlamydia
431770|NCT01303575|Gonorrhea|gonorrhea
431771|NCT01303575|Sexually Transmitted Infections|sexually transmitted infections
431772|NCT01303575|American Indian|american indian
431773|NCT01303575|Alaska Native|alaska native
431774|NCT01303575|Native American|native american
431775|NCT01303575|Internet-Based|internet-based
431776|NCT01303575|Computer-based Education|computer-based education
431777|NCT01303575|Computer-based learning|computer-based learning
431778|NCT01303562|oat|oat
431779|NCT01303562|barley|barley
431780|NCT01303562|whole grain|whole grain
431781|NCT01303562|bioavailability|bioavailability
431782|NCT01303562|phytochemical|phytochemical
431783|NCT01303549|Liver transplantation|liver transplantation
431784|NCT01303549|Hepatic transplant|hepatic transplant
431785|NCT01303549|Antifungal prophylaxis|antifungal prophylaxis
431786|NCT01303549|Anidulafungin|anidulafungin
431787|NCT01303549|Liposomal Amphotericin B|liposomal amphotericin b
431788|NCT01303523|LMWH|lmwh
431789|NCT01303523|heparin|heparin
431790|NCT01303523|immobilization|immobilization
431791|NCT01303523|anticoagulant prophylaxis|anticoagulant prophylaxis
431792|NCT01303523|leg injuries|leg injuries
431793|NCT01303523|thromboembolism|thromboembolism
431794|NCT01303510|Influenza|influenza
431795|NCT01303510|Virus|virus
431796|NCT01303510|Vaccination|vaccination
431797|NCT01303510|Immunisation|immunisation
431798|NCT01303497|Angiosarcoma|angiosarcoma
431799|NCT01303497|Paclitaxel|paclitaxel
431800|NCT01303497|bevacizumab|bevacizumab
431801|NCT01303471|pain assessment|pain assessment
431802|NCT01303471|anesthesia|anesthesia
431803|NCT01303471|analgesia|analgesia
431804|NCT01303471|opioid|opioid
431805|NCT01303471|HRV|hrv
431806|NCT01303471|APV|apv
431807|NCT01303471|autonomic nervous system (ANS)|autonomic nervous system (ans)
431808|NCT01303471|pupil size|pupil size
431809|NCT01303458|community resource|community resource
431810|NCT01303458|well-child care visit|well-child care visit
431811|NCT01303458|low-income|low-income
431812|NCT01303432|Joint discomfort|joint discomfort
431813|NCT01303432|Functional Food|functional food
431814|NCT01303432|Joint function|joint function
431815|NCT01303432|Mobilee|mobilee
431816|NCT01303419|mammography|mammography
431817|NCT01303406|randomized withdrawal|randomized withdrawal
431818|NCT01303406|idebenone|idebenone
431819|NCT01303406|friedreich's ataxia|friedreich's ataxia
431820|NCT01303406|Miconos|miconos
431821|NCT01303406|Patient reported outcome|patient reported outcome
431822|NCT01303406|ICARS|icars
431823|NCT01303393|Patient education. Patient discharge. Needs assessment.|patient education. patient discharge. needs assessment.
431824|NCT01303380|Hyper IgD syndrome|hyper igd syndrome
431825|NCT01303380|canakinumab|canakinumab
431826|NCT01303380|HIDS|hids
431827|NCT01303380|mevalonate kinase deficiency|mevalonate kinase deficiency
431828|NCT01303380|MKD|mkd
431829|NCT01303367|Dementia|dementia
431830|NCT01303367|behavioral and psychological symptoms of dementia|behavioral and psychological symptoms of dementia
431831|NCT01303354|Epidural, Transforaminal, Steroid Injection, Dexamethasone|epidural, transforaminal, steroid injection, dexamethasone
431832|NCT01303315|C19 246 300|c19 246 300
431833|NCT01303302|C19 246 300|c19 246 300
431834|NCT01303289|Total Enteral Nutrition|total enteral nutrition
431835|NCT01303289|Severe insufficient nutrition|severe insufficient nutrition
431836|NCT01303289|T-Diet plus Standard|t-diet plus standard
431837|NCT01303289|Lipidic profile|lipidic profile
431838|NCT01303289|Quality of life|quality of life
431839|NCT01303276|retinal vein occlusion|retinal vein occlusion
431840|NCT01303276|anti-VEGF|anti-vegf
431841|NCT01303276|blood flow|blood flow
431842|NCT01303263|efficiency|efficiency
431843|NCT01303263|cost-awareness|cost-awareness
431844|NCT01303263|hospitals|hospitals
431845|NCT01303263|graduate medical education|graduate medical education
431846|NCT01303250|goal-directed fluid optimization|goal-directed fluid optimization
431847|NCT01303250|hemodynamic optimization|hemodynamic optimization
431848|NCT01303250|crystalloid|crystalloid
431849|NCT01303250|colloid|colloid
431850|NCT01303237|LA SCCHN|la scchn
431851|NCT01303237|Cetuximab|cetuximab
431852|NCT01303237|RT|rt
431853|NCT01303237|PMS|pms
431854|NCT01303224|Irritable Bowel Syndrome|irritable bowel syndrome
431855|NCT01303224|Colon, irritable|colon, irritable
431856|NCT01303224|Bowel disease|bowel disease
431857|NCT01303211|Meningococcal serogroup A conjugate vaccine|meningococcal serogroup a conjugate vaccine
431858|NCT01303211|Vaccine efficacy|vaccine efficacy
431859|NCT01303211|Serogroup A meningococcal diseases|serogroup a meningococcal diseases
431860|NCT01303198|CPAP|cpap
431861|NCT01303198|APAP|apap
431862|NCT01303198|sleep apnea|sleep apnea
431863|NCT01303185|Psoriatic Nail|psoriatic nail
431864|NCT01303185|Pulsed dye laser|pulsed dye laser
431865|NCT01303159|Cholangiocarcinoma|cholangiocarcinoma
431866|NCT01303159|Pancreatic Cancer|pancreatic cancer
431867|NCT01303159|Radiofrequency|radiofrequency
431868|NCT01303159|Ablation|ablation
431869|NCT01303146|Metachromatic Leukodystrophy|metachromatic leukodystrophy
431870|NCT01303146|Enzyme replacement therapy|enzyme replacement therapy
431871|NCT01303146|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
431872|NCT01303133|beta amyloid, Down Syndrome, Alzheimer's Disease|beta amyloid, down syndrome, alzheimer's disease
431873|NCT01303081|Smoking Cessation|smoking cessation
431875|NCT01303081|Incentives|incentives
431876|NCT01303081|Health Behavior|health behavior
431877|NCT01303081|Smoking|smoking
431878|NCT01303068|CF|cf
431879|NCT01303055|Pancreatic beta Cell|pancreatic beta cell
431880|NCT01303055|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
431881|NCT01303055|Glucose Metabolism Disorders|glucose metabolism disorders
431882|NCT01303055|Metabolic Diseases|metabolic diseases
431883|NCT01303055|Endocrine System Diseases|endocrine system diseases
431884|NCT01303055|Metformin|metformin
431885|NCT01303055|Hypoglycemic Agents|hypoglycemic agents
431886|NCT01303055|Physiological Effects of Drugs|physiological effects of drugs
431887|NCT01303055|Pharmacologic Actions|pharmacologic actions
431888|NCT01303055|hemoglobin A1c protein, human|hemoglobin a1c protein, human
431889|NCT01303055|Oral Glucose Tolerance Test|oral glucose tolerance test
431890|NCT01303042|insulin LISPRO|insulin lispro
431891|NCT01303042|Insulin therapy|insulin therapy
431892|NCT01303042|hemoglobin A1c protein, human|hemoglobin a1c protein, human
431893|NCT01303042|Blood Glucose Self-Monitoring|blood glucose self-monitoring
431894|NCT01303042|Quality of Life|quality of life
431895|NCT01303042|Hypoglycemia|hypoglycemia
431896|NCT01303042|Diabetes Mellitus|diabetes mellitus
431897|NCT01303042|1,5-Anhydroglucitol|1,5-anhydroglucitol
431898|NCT01303029|Pancreatic cancer|pancreatic cancer
431899|NCT01303029|gemcitabine|gemcitabine
431900|NCT01303029|erlotinib|erlotinib
431901|NCT01303029|capecitabine|capecitabine
431902|NCT01302990|Influenza|influenza
431903|NCT01302990|Respiratory disease|respiratory disease
431904|NCT01302990|Prevention|prevention
431905|NCT01302977|Congenital diaphragmatic hernia|congenital diaphragmatic hernia
431906|NCT01302977|Fetal anomalies|fetal anomalies
431907|NCT01302964|Autistic Disorder|autistic disorder
431908|NCT01302964|Asperger's Disorder|asperger's disorder
431909|NCT01302964|Pervasive Developmental Disorder|pervasive developmental disorder
431910|NCT01302951|pharmacokinetics|pharmacokinetics
431911|NCT01302951|liver resection|liver resection
431912|NCT01302938|Double-blind|double-blind
431913|NCT01302938|Placebo-controlled|placebo-controlled
431914|NCT01302938|frequency|frequency
431915|NCT01302938|urgency|urgency
431916|NCT01302938|web-based|web-based
431917|NCT01302938|incontinence|incontinence
431918|NCT01302938|methodology|methodology
431919|NCT01302938|ediary|ediary
431920|NCT01302938|safety|safety
431921|NCT01302938|efficacy|efficacy
431922|NCT01302938|tolerability ER|tolerability er
431923|NCT01302938|overactive bladder|overactive bladder
431924|NCT01302912|ocular adnexal lymphomas|ocular adnexal lymphomas
431925|NCT01302886|High risk Smoldering multiple myeloma,|high risk smoldering multiple myeloma,
431926|NCT01302886|BHQ880,|bhq880,
431927|NCT01302886|MM|mm
431928|NCT01302873|Tinnitus|tinnitus
431929|NCT01302873|AMPA Receptor antagonist|ampa receptor antagonist
431930|NCT01302860|Cryopyrin-associated periodic syndromes (CAPS)|cryopyrin-associated periodic syndromes (caps)
431931|NCT01302860|Familial Cold Autoinflammatory Syndrome (FCAS)|familial cold autoinflammatory syndrome (fcas)
431932|NCT01302860|Muckle-Wells Syndrome (MWS) or Neonatal Onset Multisystem Inflammatory Disease (NOMID)|muckle-wells syndrome (mws) or neonatal onset multisystem inflammatory disease (nomid)
431933|NCT01302860|children|children
431934|NCT01302860|systemic autoinflammatory disease|systemic autoinflammatory disease
431935|NCT01302860|CIAS-1 gene|cias-1 gene
431936|NCT01302860|NALP-3|nalp-3
431937|NCT01302860|NLRP3|nlrp3
431938|NCT01302860|ACZ885|acz885
431939|NCT01302860|Ilaris|ilaris
431940|NCT01302860|human monoclonal anti-human interleukin-1 beta (IL-beta)|human monoclonal anti-human interleukin-1 beta (il-beta)
431941|NCT01302860|antibody|antibody
431942|NCT01302860|autosomal dominant|autosomal dominant
431943|NCT01302860|familial autoinflammatory syndrome|familial autoinflammatory syndrome
431944|NCT01302847|Integrase Inhibitors|integrase inhibitors
431945|NCT01302847|Infant|infant
431946|NCT01302847|Child|child
431947|NCT01302847|Adolescent|adolescent
431948|NCT01302834|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
431949|NCT01302834|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
431950|NCT01302834|human papilloma virus infection|human papilloma virus infection
431951|NCT01302821|breast - male|breast - male
431952|NCT01302821|breast - female|breast - female
431953|NCT01302821|metastatic|metastatic
431954|NCT01302821|invasive|invasive
431955|NCT01302808|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
431956|NCT01302808|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
431957|NCT01302808|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
431958|NCT01302808|malignant pleural effusion|malignant pleural effusion
431959|NCT01302808|adenocarcinoma of the lung|adenocarcinoma of the lung
431960|NCT01302808|adenosquamous cell lung cancer|adenosquamous cell lung cancer
431961|NCT01302808|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
431962|NCT01302808|large cell lung cancer|large cell lung cancer
431963|NCT01302808|squamous cell lung cancer|squamous cell lung cancer
431964|NCT01302795|Interleukin 1 beta|interleukin 1 beta
431965|NCT01302795|Canakinumab|canakinumab
431966|NCT01302795|autoinflammatory syndrome|autoinflammatory syndrome
431967|NCT01302782|Altitude|altitude
431968|NCT01302782|Glucose|glucose
431969|NCT01302769|Acute Sore Throat|acute sore throat
431970|NCT01302769|Ear Acupuncture|ear acupuncture
431971|NCT01302756|gestational diabetes|gestational diabetes
431972|NCT01302756|gestational hypertension|gestational hypertension
431973|NCT01302756|folic acid|folic acid
431974|NCT01302743|Diabetes|diabetes
431975|NCT01302743|Metformin|metformin
431976|NCT01302743|Cinnamon|cinnamon
431977|NCT01302730|ankylosing spondylitis|ankylosing spondylitis
431978|NCT01302730|spondylarthritis|spondylarthritis
431979|NCT01302730|inflammatory back pain|inflammatory back pain
431980|NCT01302730|seronegative|seronegative
431981|NCT01302717|Left ventricular pacing|left ventricular pacing
431982|NCT01302704|Vitamin D|vitamin d
431983|NCT01302704|Proton Pump Inhibitors|proton pump inhibitors
431984|NCT01302691|Essential hypertension|essential hypertension
431985|NCT01302691|Uncontrolled hypertension|uncontrolled hypertension
431986|NCT01302691|Antihypertensive agents|antihypertensive agents
431987|NCT01302691|Blood pressure|blood pressure
431988|NCT01302652|acromegaly|acromegaly
431989|NCT01302652|growth hormone|growth hormone
431990|NCT01302652|growth hormone deficiency|growth hormone deficiency
431991|NCT01302626|NSCLC|nsclc
431992|NCT01302626|SCLC|sclc
431993|NCT01302626|lung cancer|lung cancer
431994|NCT01302626|RNA|rna
431995|NCT01302626|DNA|dna
431996|NCT01302626|imaging|imaging
431997|NCT01302626|genomics|genomics
431998|NCT01302626|proteomics|proteomics
431999|NCT01302626|predictive model|predictive model
432000|NCT01302626|prospective study|prospective study
432001|NCT01302613|rectal cancer|rectal cancer
432002|NCT01302574|T1R2/T1R3|t1r2/t1r3
432003|NCT01302574|gastric emptying|gastric emptying
432005|NCT01302574|lactisole|lactisole
432006|NCT01302574|nutrient sensing|nutrient sensing
432007|NCT01302561|adults|adults
432008|NCT01302561|fiber|fiber
432009|NCT01302561|cold|cold
432010|NCT01302561|flu|flu
432011|NCT01302561|immune function|immune function
432012|NCT01302561|microbiota|microbiota
432013|NCT01302548|Abscess|abscess
432014|NCT01302548|Wound Irrigation|wound irrigation
432015|NCT01302548|Wound Debridement|wound debridement
432016|NCT01302548|Wound Healing|wound healing
432017|NCT01302548|Incision and drainage|incision and drainage
432018|NCT01302548|Chlorhexidine|chlorhexidine
432019|NCT01302535|Yoga|yoga
432020|NCT01302535|Hypertension|hypertension
432021|NCT01302535|Quality of Life|quality of life
432022|NCT01302535|Primary Health Care|primary health care
432023|NCT01302509|Nutritional support.|nutritional support.
432024|NCT01302509|Cancer.|cancer.
432025|NCT01302509|Malnutrition.|malnutrition.
432026|NCT01302509|Child.|child.
432027|NCT01302509|Adolescent|adolescent
432028|NCT01302496|Previously Treated|previously treated
432029|NCT01302496|Unresectable|unresectable
432030|NCT01302496|Stage III or IV Melanoma|stage iii or iv melanoma
432031|NCT01302470|biventricular pacing|biventricular pacing
432032|NCT01302457|Thermal Burn Trauma|thermal burn trauma
432033|NCT01302444|treprostinil|treprostinil
432034|NCT01302444|pulmonary hypertension, tadalafil|pulmonary hypertension, tadalafil
432035|NCT01302431|experimental|experimental
432036|NCT01302431|intervention|intervention
432037|NCT01302431|nurse-led|nurse-led
432038|NCT01302431|nurse specialist|nurse specialist
432039|NCT01302431|multiple sclerosis|multiple sclerosis
432040|NCT01302431|support of caregivers|support of caregivers
432041|NCT01302418|Respiratory Virus|respiratory virus
432042|NCT01302418|Influenza|influenza
432043|NCT01302418|RSV|rsv
432044|NCT01302418|Parainfluenza|parainfluenza
432045|NCT01302418|Metapneumovirus|metapneumovirus
432046|NCT01302418|Rhinovirus|rhinovirus
432047|NCT01302418|Coxsackie virus|coxsackie virus
432048|NCT01302418|Echo virus|echo virus
432049|NCT01302418|Adenovirus|adenovirus
432050|NCT01302418|Coronavirus|coronavirus
432051|NCT01302418|Bocavirus|bocavirus
432052|NCT01302405|Advanced solid tumor|advanced solid tumor
432053|NCT01302405|cancer|cancer
432054|NCT01302405|phase 1|phase 1
432055|NCT01302405|pancreatic cancer|pancreatic cancer
432056|NCT01302405|colon cancer|colon cancer
432057|NCT01302405|unresectable neoplastic disease|unresectable neoplastic disease
432058|NCT01302405|Progressive cancer|progressive cancer
432059|NCT01302405|metastatic solid tumor|metastatic solid tumor
432060|NCT01302379|Obesity|obesity
432061|NCT01302379|Survival|survival
432062|NCT01302379|Weight loss|weight loss
432063|NCT01302379|Metformin|metformin
432064|NCT01302379|Biological markers|biological markers
432065|NCT01302366|multiple myeloma|multiple myeloma
432066|NCT01302366|myeloma|myeloma
432067|NCT01302366|asymptomatic myeloma|asymptomatic myeloma
432068|NCT01302366|smoldering myeloma|smoldering myeloma
432069|NCT01302366|Asymptomatic (smoldering) myeloma|asymptomatic (smoldering) myeloma
432070|NCT01302353|Phase I trial|phase i trial
432071|NCT01302353|Emulsified Isoflurane|emulsified isoflurane
432072|NCT01302353|Health volunteer|health volunteer
432073|NCT01302340|Dementia|dementia
432074|NCT01302340|Alzheimer|alzheimer
432075|NCT01302340|Cannabis|cannabis
432076|NCT01302340|THC|thc
432077|NCT01302340|Behavioral Disturbances|behavioral disturbances
432078|NCT01302340|Neuropsychiatric Inventory|neuropsychiatric inventory
432079|NCT01302327|Wolfram syndrome|wolfram syndrome
432080|NCT01302327|Diabetes mellitus|diabetes mellitus
432081|NCT01302327|Exenatide|exenatide
432082|NCT01302327|GLP-1 analog|glp-1 analog
432083|NCT01302327|beta cell function|beta cell function
432084|NCT01302301|endolumenal myotomy, per oral endoscopic myotomy|endolumenal myotomy, per oral endoscopic myotomy
432085|NCT01302288|endolumenal myotomy, per oral endoscopic myotomy|endolumenal myotomy, per oral endoscopic myotomy
432086|NCT01302275|neuropathic pain|neuropathic pain
432087|NCT01302275|oxcarbazepine|oxcarbazepine
432088|NCT01302275|pain mechanism|pain mechanism
432089|NCT01302262|Smoking-induced dopamine release|smoking-induced dopamine release
432090|NCT01302262|[11C]-(+)-PHNO PET Study|[11c]-(+)-phno pet study
432091|NCT01302249|Glaucoma|glaucoma
432092|NCT01302249|Intraocular pressure|intraocular pressure
432093|NCT01302249|Ocular hypertension|ocular hypertension
432094|NCT01302236|Elderly|elderly
432095|NCT01302236|Early stage chronic kidney disease|early stage chronic kidney disease
432096|NCT01302236|Hypertension|hypertension
432097|NCT01302236|Eplerenone|eplerenone
432098|NCT01302223|burns|burns
432099|NCT01302223|Growth Factors, Combined Defect of|growth factors, combined defect of
432100|NCT01302223|inflammation|inflammation
432101|NCT01302223|Cytokine Storm|cytokine storm
432102|NCT01302210|MRSA|mrsa
432103|NCT01302210|Cluster Randomized Trial|cluster randomized trial
432104|NCT01302210|Infection Control Intervention|infection control intervention
432105|NCT01302197|Stroke|stroke
432106|NCT01302197|Body Composition|body composition
432107|NCT01302197|Glucose Tolerance|glucose tolerance
432108|NCT01302171|dilated cardiomyopathy|dilated cardiomyopathy
432109|NCT01302171|adult stem cells|adult stem cells
432110|NCT01302171|bone marrow progenitor cells|bone marrow progenitor cells
432111|NCT01302171|bone marrow stem cells|bone marrow stem cells
432112|NCT01302171|autologous|autologous
432113|NCT01302171|granulocyte-colony stimulating factor|granulocyte-colony stimulating factor
432114|NCT01302171|intracoronary injection|intracoronary injection
432115|NCT01302171|left ventricular function|left ventricular function
432116|NCT01302171|To determine if patient's own bone marrow derived stem cells can be used to improve cardiac function|to determine if patient's own bone marrow derived stem cells can be used to improve cardiac function
432117|NCT01302158|Drug-Drug interaction|drug-drug interaction
432118|NCT01302158|ASP1941|asp1941
432119|NCT01302158|Glimepiride|glimepiride
432120|NCT01302158|Healthy subjects|healthy subjects
432121|NCT01302145|pharmacokinetics|pharmacokinetics
432122|NCT01302145|metformin|metformin
432123|NCT01302145|Drug to drug interaction|drug to drug interaction
432124|NCT01302145|ASP1941|asp1941
432125|NCT01302132|Mass Balance|mass balance
432126|NCT01302132|ASP1941|asp1941
432127|NCT01302132|Pharmacokinetics|pharmacokinetics
432128|NCT01302119|Onychomycosis|onychomycosis
432129|NCT01302119|nail fungus|nail fungus
432130|NCT01302119|toenail fungus|toenail fungus
432131|NCT01302119|fungal nail|fungal nail
432132|NCT01302119|hyperkeratosis|hyperkeratosis
432133|NCT01302119|nail infection|nail infection
432134|NCT01302119|nail treatment|nail treatment
432135|NCT01302119|toenail infection|toenail infection
432136|NCT01302119|toenail treatment|toenail treatment
432137|NCT01302119|foot dermatoses|foot dermatoses
432138|NCT01302119|fungal culture|fungal culture
432139|NCT01302119|onycholysis|onycholysis
432140|NCT01302119|podiatrist|podiatrist
432141|NCT01302119|podiatry|podiatry
432142|NCT01302119|subungual|subungual
432143|NCT01302119|tinea unguium|tinea unguium
432144|NCT01302119|antifungal|antifungal
432145|NCT01302119|anti-fungal|anti-fungal
432146|NCT01302119|dermatologist|dermatologist
432147|NCT01302119|dermatology|dermatology
432148|NCT01302119|dermatophyte|dermatophyte
432149|NCT01302119|distal subungual onychomycosis|distal subungual onychomycosis
432150|NCT01302119|yellow nail|yellow nail
432151|NCT01302119|thick nail|thick nail
432152|NCT01302119|brittle nail|brittle nail
432153|NCT01302119|crumbling nail|crumbling nail
432154|NCT01302119|discolored nail|discolored nail
432155|NCT01302119|weak nail|weak nail
432156|NCT01302106|Myelodysplastic Syndromes|myelodysplastic syndromes
432157|NCT01302106|Clofarabine|clofarabine
432158|NCT01302106|Low Dose Cytarabine|low dose cytarabine
432159|NCT01302106|Poor risk MDS|poor risk mds
432160|NCT01302080|prospective|prospective
432161|NCT01302080|cohort|cohort
432162|NCT01302080|sertraline|sertraline
432163|NCT01302080|long-term impact|long-term impact
432164|NCT01302080|cognition|cognition
432165|NCT01302080|emotional and physical development|emotional and physical development
432166|NCT01302080|pubertal maturation|pubertal maturation
432167|NCT01302054|Bladder Overactive|bladder overactive
432168|NCT01302054|Overactive urinary bladder|overactive urinary bladder
432169|NCT01302054|Overactive Bladder|overactive bladder
432170|NCT01302041|bone turnover|bone turnover
432171|NCT01302041|hormone-naïve|hormone-naïve
432172|NCT01302041|prostate specific antigen|prostate specific antigen
432173|NCT01302041|Prostate Cancer|prostate cancer
432174|NCT01302028|Renal Impairment|renal impairment
432175|NCT01302028|ASP1941|asp1941
432176|NCT01302028|Pharmacokinetics|pharmacokinetics
432177|NCT01302002|Breast Cancer|breast cancer
432178|NCT01302002|Metformin|metformin
432179|NCT01302002|Pre-Surgery|pre-surgery
432180|NCT01301989|Sleep|sleep
432181|NCT01301989|Children|children
432182|NCT01301989|Disparities|disparities
432183|NCT01301989|Minority|minority
432184|NCT01301989|Urban|urban
432185|NCT01301976|nutritional state|nutritional state
432186|NCT01301976|nutrients intake|nutrients intake
432187|NCT01301976|ulcerative colitis|ulcerative colitis
432188|NCT01301950|Arthroplasties, Knee Replacement|arthroplasties, knee replacement
432189|NCT01301950|Arthroplasties, Replacement, Knee|arthroplasties, replacement, knee
432190|NCT01301950|Arthroplasty, Knee Replacement|arthroplasty, knee replacement
432191|NCT01301950|Knee Replacement Arthroplasties|knee replacement arthroplasties
432192|NCT01301950|Knee Replacement Arthroplasty|knee replacement arthroplasty
432193|NCT01301950|Knee Replacement, Total|knee replacement, total
432194|NCT01301950|Replacement Arthroplasties, Knee|replacement arthroplasties, knee
432195|NCT01301950|Replacement Arthroplasty, Knee|replacement arthroplasty, knee
432196|NCT01301950|Replacement, Total Knee|replacement, total knee
432197|NCT01301950|Total Knee Replacement|total knee replacement
432198|NCT01301937|Mucosal Leishmaniasis|mucosal leishmaniasis
432199|NCT01301937|Leishmania braziliensis|leishmania braziliensis
432200|NCT01301937|Meglumine Antimoniate|meglumine antimoniate
432201|NCT01301937|Treatment Effectiveness|treatment effectiveness
432202|NCT01301937|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
432203|NCT01301924|Leishmaniasis Cutaneous|leishmaniasis cutaneous
432204|NCT01301924|Leishmania braziliensis|leishmania braziliensis
432205|NCT01301924|Meglumine Antimoniate|meglumine antimoniate
432206|NCT01301924|Treatment Effectiveness|treatment effectiveness
432207|NCT01301924|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
432208|NCT01301911|Breast cancer, Advanced|breast cancer, advanced
432209|NCT01301911|Cipatinib|cipatinib
432210|NCT01301911|phase I|phase i
432211|NCT01301911|HER2 positive or uncertain advanced breast cancer|her2 positive or uncertain advanced breast cancer
432212|NCT01301898|Hunter syndrome|hunter syndrome
432213|NCT01301898|MPS II|mps ii
432214|NCT01301898|Idursulfase|idursulfase
432215|NCT01301885|endometriosis|endometriosis
432216|NCT01301885|dysmenorrhea|dysmenorrhea
432217|NCT01301885|infertility|infertility
432218|NCT01301885|biomarker|biomarker
432219|NCT01301885|drug target|drug target
432220|NCT01301859|older adults|older adults
432221|NCT01301859|adherence|adherence
432222|NCT01301859|antidepressant|antidepressant
432223|NCT01301859|depression|depression
432224|NCT01301833|insulin resistance|insulin resistance
432225|NCT01301820|maintenance treatment|maintenance treatment
432226|NCT01301820|Disease free survival|disease free survival
432227|NCT01301807|Relapsed/refractory multiple myeloma|relapsed/refractory multiple myeloma
432228|NCT01301807|RRMM|rrmm
432229|NCT01301807|Carfilzomib|carfilzomib
432230|NCT01301807|Panobinostat|panobinostat
432231|NCT01301807|LBH589B|lbh589b
432232|NCT01301794|Hypertriglyceridemia|hypertriglyceridemia
432233|NCT01301794|Fish oil|fish oil
432234|NCT01301794|Omega 3 fatty acids|omega 3 fatty acids
432235|NCT01301768|Dietary Intervention|dietary intervention
432236|NCT01301768|Pregnancy Jail|pregnancy jail
432237|NCT01301768|Iodine Deficiency|iodine deficiency
432238|NCT01301768|Iodine Nutrition|iodine nutrition
432239|NCT01301768|Dietary Habits|dietary habits
432240|NCT01301768|Urinary Iodine|urinary iodine
432241|NCT01301768|Pregnancy|pregnancy
432242|NCT01301768|Group Education|group education
432243|NCT01301768|Cluster Randomized Trial|cluster randomized trial
432244|NCT01301768|Primary Health Care|primary health care
432245|NCT01301703|rheumatoid pertussis tetanus|rheumatoid pertussis tetanus
432246|NCT01301690|neck mass|neck mass
432247|NCT01301690|ultrasound|ultrasound
432249|NCT01301690|BMVC|bmvc
432368|NCT01301053|hypoglycemia|hypoglycemia
432250|NCT01301664|The bone marrow-derived mesenchymal stem cells (BMMSCs) were obtained from redundant bone marrow from drilling during the joint replacement surgery.|the bone marrow-derived mesenchymal stem cells (bmmscs) were obtained from redundant bone marrow from drilling during the joint replacement surgery.
432251|NCT01301664|The synovial-derived mesenchymal stem cells (SMSCs) were isolated from synovial membranes in the joint replacement surgery.|the synovial-derived mesenchymal stem cells (smscs) were isolated from synovial membranes in the joint replacement surgery.
432252|NCT01301664|Cartilage slices were obtained from discard cartilage in the joint replacement surgery.|cartilage slices were obtained from discard cartilage in the joint replacement surgery.
432253|NCT01301651|Virtual Reality|virtual reality
432254|NCT01301651|Balance|balance
432255|NCT01301651|Parkinson's disease|parkinson's disease
432256|NCT01301651|Dual Task|dual task
432257|NCT01301625|MitraClip|mitraclip
432258|NCT01301625|mitral regurgitation (MR)|mitral regurgitation (mr)
432259|NCT01301625|mitral valve insufficiency|mitral valve insufficiency
432260|NCT01301625|percutaneous mitral valve repair|percutaneous mitral valve repair
432359|NCT01301079|Ketamine|ketamine
432261|NCT01301625|congestive heart failure|congestive heart failure
432262|NCT01301612|carcinoma or adenocarcinoma or uterine cervix adenosquamous carcinoma|carcinoma or adenocarcinoma or uterine cervix adenosquamous carcinoma
432263|NCT01301599|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
432264|NCT01301599|alpha blocker|alpha blocker
432265|NCT01301599|5-alpha reductase inhibitor|5-alpha reductase inhibitor
432266|NCT01301599|combination therapy|combination therapy
432267|NCT01301560|Asymptomatic brain metastasis|asymptomatic brain metastasis
432268|NCT01301560|NSCLC|nsclc
432269|NCT01301560|GKS|gks
432270|NCT01301534|abdominal aortic aneurysm|abdominal aortic aneurysm
432271|NCT01301521|Pre-Diabetes|pre-diabetes
432272|NCT01301521|cinnamon|cinnamon
432273|NCT01301508|atopic dermatitis|atopic dermatitis
432274|NCT01301495|Esophageal Cancer, Malignant, Dysphagia, Esophagus, Cancer|esophageal cancer, malignant, dysphagia, esophagus, cancer
432275|NCT01301482|Acute Sore Throat|acute sore throat
432276|NCT01301482|Ear Acupuncture|ear acupuncture
432277|NCT01301456|Phase 1|phase 1
432278|NCT01301456|Type 2 Diabetes|type 2 diabetes
432279|NCT01301456|CVX-096|cvx-096
432280|NCT01301443|Age Related Macular Degeneration|age related macular degeneration
432281|NCT01301430|Progressive glioblastoma multiforme|progressive glioblastoma multiforme
432282|NCT01301430|Recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
432283|NCT01301430|Oncolytic virus|oncolytic virus
432284|NCT01301417|Compression Anastomosis|compression anastomosis
432285|NCT01301404|Postoperative nausea and vomiting (PONV)|postoperative nausea and vomiting (ponv)
432286|NCT01301404|Spinal morphine|spinal morphine
432287|NCT01301404|Total knee replacement (TKR)|total knee replacement (tkr)
432288|NCT01301404|blood sugar|blood sugar
432289|NCT01301404|carbohydrate drink|carbohydrate drink
432290|NCT01301391|B3 and C malignant thymoma|b3 and c malignant thymoma
432291|NCT01301365|autonomic response|autonomic response
432292|NCT01301352|Critical Care|critical care
432293|NCT01301352|Intubation, gastrointestinal|intubation, gastrointestinal
432294|NCT01301352|Child|child
432295|NCT01301352|Infant|infant
432296|NCT01301352|Adolescent|adolescent
432297|NCT01301352|Continuous positive airway pressure|continuous positive airway pressure
432298|NCT01301352|Enteral Nutrition|enteral nutrition
432299|NCT01301339|Pre-Diabetes|pre-diabetes
432300|NCT01301339|Diabetes|diabetes
432301|NCT01301339|cardiovascular risks|cardiovascular risks
432302|NCT01301326|retinal arterial macroaneurysm|retinal arterial macroaneurysm
432303|NCT01301326|laser treatment|laser treatment
432304|NCT01301313|Acute heart failure|acute heart failure
432305|NCT01301313|Children|children
432306|NCT01301313|Levosimendan|levosimendan
432307|NCT01301313|Inotropic treatment|inotropic treatment
432308|NCT01301274|hyponatremia|hyponatremia
432309|NCT01301274|maintenance solutions|maintenance solutions
432310|NCT01301274|pediatrics|pediatrics
432311|NCT01301261|Sugammadex|sugammadex
432312|NCT01301261|entropy|entropy
432313|NCT01301261|bispectral index|bispectral index
432314|NCT01301261|blood pressure|blood pressure
432315|NCT01301261|heart rate|heart rate
432316|NCT01301261|oxygenation|oxygenation
432317|NCT01301261|end-tidal CO2|end-tidal co2
432318|NCT01301261|hemodynamics|hemodynamics
432319|NCT01301261|general anesthesia|general anesthesia
432320|NCT01301248|locally advanced,|locally advanced,
432321|NCT01301248|unresectable,|unresectable,
432322|NCT01301248|head and neck squamous cell carcinoma,|head and neck squamous cell carcinoma,
432323|NCT01301248|stage III/IV|stage iii/iv
432324|NCT01301235|Mitochondria|mitochondria
432325|NCT01301222|octreotide|octreotide
432326|NCT01301222|pancreatic fistula|pancreatic fistula
432327|NCT01301222|soft pancreas|soft pancreas
432328|NCT01301222|pancreatoduodenectomy|pancreatoduodenectomy
432329|NCT01301196|sedentary behaviour|sedentary behaviour
432330|NCT01301196|diabetes|diabetes
432331|NCT01301196|structured education|structured education
432332|NCT01301196|18-30 years olds|18-30 years olds
432333|NCT01301196|family history of T2DM or CVD|family history of t2dm or cvd
432334|NCT01301196|BMI ≥ 25 (≥23 for south Asians)|bmi ≥ 25 (≥23 for south asians)
432335|NCT01301183|Anorexia Nervosa|anorexia nervosa
432336|NCT01301183|Estrogen|estrogen
432337|NCT01301183|Teenagers|teenagers
432338|NCT01301183|IGF-1|igf-1
432339|NCT01301170|Neck pain|neck pain
432340|NCT01301170|Dry Needling|dry needling
432341|NCT01301170|Manual Therapy|manual therapy
432342|NCT01301170|Manipulation|manipulation
432343|NCT01301144|Tuberculosis|tuberculosis
432344|NCT01301144|Urea Breath Test|urea breath test
432345|NCT01301118|Transplantation Infection|transplantation infection
432346|NCT01301118|Wound of skin|wound of skin
432347|NCT01301118|Burns|burns
432348|NCT01301118|Graft Loss|graft loss
432349|NCT01301118|Infection|infection
432350|NCT01301105|pain regulation|pain regulation
432351|NCT01301105|social stress|social stress
432352|NCT01301105|affect|affect
432353|NCT01301105|attention|attention
432354|NCT01301105|brain|brain
432355|NCT01301105|immune|immune
432356|NCT01301105|endocrine|endocrine
432357|NCT01301079|Remifentanil|remifentanil
432358|NCT01301079|Hyperalgesia|hyperalgesia
432360|NCT01301079|Von Frey's filament|von frey's filament
432361|NCT01301079|Algometer|algometer
432362|NCT01301079|Interleukines|interleukines
432363|NCT01301079|Opioid-induced hyperalgesia|opioid-induced hyperalgesia
432364|NCT01301053|hyperglycemia and increased mortality in the ICU|hyperglycemia and increased mortality in the icu
432365|NCT01301053|hypoglycemia and increased mortality in the ICU|hypoglycemia and increased mortality in the icu
432366|NCT01301053|glucose variability and increased mortality in the ICU|glucose variability and increased mortality in the icu
432367|NCT01301053|Continuous Glucose Monitoring (CGM) and hypoglycemia|continuous glucose monitoring (cgm) and hypoglycemia
432369|NCT01301053|reducing ICU mortality|reducing icu mortality
432370|NCT01301040|breast cancer, elderly, early cardiac toxicity|breast cancer, elderly, early cardiac toxicity
432371|NCT01301027|End stage renal disease|end stage renal disease
432372|NCT01301027|Hemodialysis|hemodialysis
432373|NCT01301027|Pioglitazone|pioglitazone
432374|NCT01301027|Adipokines|adipokines
432375|NCT01301014|accuracy, anterior cruciate ligament, diagnostic value, examination, knee, Lachman test, sensitivity, specificity|accuracy, anterior cruciate ligament, diagnostic value, examination, knee, lachman test, sensitivity, specificity
432376|NCT01301001|Vulvodynia|vulvodynia
432377|NCT01300988|HIV infection|hiv infection
432378|NCT01300988|Neurokinin-1 receptor antagonist|neurokinin-1 receptor antagonist
432379|NCT01300988|CCR5 expression|ccr5 expression
432380|NCT01300988|Treatment Naive|treatment naive
432381|NCT01300975|Leishmaniasis|leishmaniasis
432382|NCT01300975|intralesional antimony|intralesional antimony
432383|NCT01300975|cryotherapy|cryotherapy
432384|NCT01300962|Xeloda|xeloda
432385|NCT01300962|Capecitabine|capecitabine
432386|NCT01300962|BKM120|bkm120
432387|NCT01300962|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
432388|NCT01300962|Metastatic|metastatic
432389|NCT01300962|BYL719 Breast Cancer|byl719 breast cancer
432390|NCT01300949|Contrast Sensitivity|contrast sensitivity
432391|NCT01300949|Pelli-Robson Test|pelli-robson test
432392|NCT01300923|Fragile X Syndrome|fragile x syndrome
432393|NCT01300923|Acamprosate|acamprosate
432394|NCT01300910|Adult Males|adult males
432395|NCT01300910|Circumcision|circumcision
432396|NCT01300910|HIV prevention|hiv prevention
432397|NCT01300910|Device|device
432398|NCT01300910|Shang Ring|shang ring
432399|NCT01300897|cortical function, motor evoked potential responses|cortical function, motor evoked potential responses
432400|NCT01300845|Oxygen mask|oxygen mask
432401|NCT01300845|Oxygen cannula|oxygen cannula
432402|NCT01300845|Humidification|humidification
432403|NCT01300845|Oxygen therapy|oxygen therapy
432404|NCT01300845|Intensive Care Unit|intensive care unit
432405|NCT01300832|Surgery|surgery
432406|NCT01300832|Deep Vein Thrombosis|deep vein thrombosis
432407|NCT01300832|Preoperative|preoperative
432408|NCT01300819|Rotigotine|rotigotine
432409|NCT01300819|Neupro®|neupro®
432410|NCT01300819|Non-motor symptoms|non-motor symptoms
432411|NCT01300806|HIV|hiv
432412|NCT01300806|harmful substance use|harmful substance use
432413|NCT01300793|V-RICE|v-rice
432414|NCT01300793|Relapsed NHL|relapsed nhl
432415|NCT01300793|Primary Refractory NHL|primary refractory nhl
432416|NCT01300780|bleaching agent|bleaching agent
432417|NCT01300780|tooth bleaching|tooth bleaching
432418|NCT01300780|sensibility|sensibility
432419|NCT01300754|Osgood-Schlatter|osgood-schlatter
432420|NCT01300754|Tendinosis|tendinosis
432421|NCT01300754|Apophysitis|apophysitis
432422|NCT01300754|Enthesopathy|enthesopathy
432423|NCT01300754|Dextrose.|dextrose.
432424|NCT01300728|Intravenous immunotherapy|intravenous immunotherapy
432425|NCT01300728|Conversion to Alzheimer Disease|conversion to alzheimer disease
432426|NCT01300715|zygapophysial joint|zygapophysial joint
432427|NCT01300715|facet joint|facet joint
432428|NCT01300715|low back pain|low back pain
432429|NCT01300715|radiofrequency|radiofrequency
432430|NCT01300715|neurotomy|neurotomy
432431|NCT01300689|HPV|hpv
432432|NCT01300689|MSM|msm
432433|NCT01300689|Vaccine|vaccine
432434|NCT01300689|China|china
432435|NCT01300676|Tualang honey|tualang honey
432436|NCT01300676|HRT|hrt
432437|NCT01300676|safety profiles|safety profiles
432438|NCT01300676|cardiovascular parameters|cardiovascular parameters
432439|NCT01300676|hormonal levels|hormonal levels
432440|NCT01300676|bone changes|bone changes
432441|NCT01300676|postmenopausal women|postmenopausal women
432442|NCT01300650|Heart failure|heart failure
432443|NCT01300650|Inflammation|inflammation
432444|NCT01300650|Interleukin-1|interleukin-1
432445|NCT01300650|Cardiopulmonary exercise|cardiopulmonary exercise
432446|NCT01300637|schizophrenia|schizophrenia
432447|NCT01300637|clozapine|clozapine
432448|NCT01300637|metabolic dysregulation|metabolic dysregulation
432449|NCT01300637|metformin|metformin
432450|NCT01300624|Aphasia|aphasia
432451|NCT01300624|therapy|therapy
432452|NCT01300624|treatment|treatment
432453|NCT01300624|verbs|verbs
432454|NCT01300624|sentences|sentences
432455|NCT01300611|Double Cord Blood Transplantation|double cord blood transplantation
432456|NCT01300611|Neutrophil Engraftment|neutrophil engraftment
432457|NCT01300611|Platelet Engraftment|platelet engraftment
432560|NCT01300156|refractory|refractory
432458|NCT01300611|Immune Reconstitution|immune reconstitution
432459|NCT01300611|Mucositis|mucositis
432460|NCT01300585|Breast|breast
432461|NCT01300585|Cancer|cancer
432462|NCT01300559|efficacy|efficacy
432463|NCT01300559|hemoglobin|hemoglobin
432464|NCT01300559|spine|spine
432465|NCT01300546|Frequent migraine|frequent migraine
432466|NCT01300546|Migraine transformation|migraine transformation
432467|NCT01300546|Migraine|migraine
432468|NCT01300546|Treximet|treximet
432469|NCT01300546|Naproxen|naproxen
432470|NCT01300546|Sumatriptan|sumatriptan
432471|NCT01300533|Cancer|cancer
432472|NCT01300533|Neoplasms|neoplasms
432473|NCT01300533|Solid Tumor|solid tumor
432474|NCT01300533|Ovarian Cancer|ovarian cancer
432475|NCT01300533|Lung Cancer|lung cancer
432476|NCT01300533|Non-Small Cell Lung Cancer|non-small cell lung cancer
432477|NCT01300533|Pancreatic Cancer|pancreatic cancer
432478|NCT01300533|Breast Cancer|breast cancer
432479|NCT01300533|Endometrial Cancer|endometrial cancer
432480|NCT01300533|Melanoma|melanoma
432481|NCT01300533|Prostate Cancer|prostate cancer
432482|NCT01300533|Skin Cancer|skin cancer
432483|NCT01300533|Head and Neck Cancer|head and neck cancer
432484|NCT01300533|Solid Malignancies|solid malignancies
432485|NCT01300520|Fluoroscopy|fluoroscopy
432486|NCT01300520|Femoral fracture|femoral fracture
432487|NCT01300520|Tibial fracture|tibial fracture
432488|NCT01300520|Spinal Fusion|spinal fusion
432489|NCT01300507|stent thrombosis|stent thrombosis
432490|NCT01300507|intra coronary imaging|intra coronary imaging
432491|NCT01300507|blood platelet function testing|blood platelet function testing
432492|NCT01300494|bifurcation lesion|bifurcation lesion
432493|NCT01300494|optimal viewing angle|optimal viewing angle
432494|NCT01300494|automated software|automated software
432495|NCT01300468|advanced/metastatic solid tumors|advanced/metastatic solid tumors
432496|NCT01300455|Insomnia|insomnia
432497|NCT01300455|obstructive sleep apnea|obstructive sleep apnea
432498|NCT01300455|orexin receptor antagonist|orexin receptor antagonist
432499|NCT01300442|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
432500|NCT01300442|diaphragm|diaphragm
432501|NCT01300442|electrical stimulation|electrical stimulation
432502|NCT01300442|pulmonary rehabilitation|pulmonary rehabilitation
432503|NCT01300429|core biopsy|core biopsy
432504|NCT01300429|Resistance to Crizotinib|resistance to crizotinib
432505|NCT01300429|Non-small Cell Lung Cancer|non-small cell lung cancer
432506|NCT01300429|11-014|11-014
432507|NCT01300416|Kidney transplantation|kidney transplantation
432508|NCT01300416|mycophenolate sodium|mycophenolate sodium
432509|NCT01300416|EC-MPS|ec-mps
432510|NCT01300416|Health Related Quality of Life|health related quality of life
432511|NCT01300416|GI symptoms|gi symptoms
432512|NCT01300416|Immunosuppressants|immunosuppressants
432513|NCT01300416|HRQL|hrql
432514|NCT01300416|PGWB|pgwb
432515|NCT01300416|GIQLI|giqli
432516|NCT01300390|liver transplant|liver transplant
432517|NCT01300390|end-stage liver disease|end-stage liver disease
432518|NCT01300390|cirrhosis|cirrhosis
432519|NCT01300377|Post-operative pain|post-operative pain
432520|NCT01300377|pain|pain
432521|NCT01300377|pacemaker|pacemaker
432522|NCT01300377|defibrillator|defibrillator
432523|NCT01300377|post-operative narcotic use|post-operative narcotic use
432524|NCT01300377|local anesthesia|local anesthesia
432525|NCT01300351|Advanced breast cancer|advanced breast cancer
432526|NCT01300351|metastatic breast cancer|metastatic breast cancer
432527|NCT01300338|Diabetes|diabetes
432528|NCT01300325|Bronchiolitis, 3% Hypertonic Saline Solution|bronchiolitis, 3% hypertonic saline solution
432529|NCT01300312|eperisone|eperisone
432530|NCT01300312|diclofenac|diclofenac
432531|NCT01300312|low back pain|low back pain
432532|NCT01300299|lung cancer|lung cancer
432533|NCT01300299|radiation|radiation
432534|NCT01300299|stereotactic|stereotactic
432535|NCT01300273|Diabetic nephropathy|diabetic nephropathy
432536|NCT01300273|Podocyte|podocyte
432537|NCT01300273|Low Protein Diet|low protein diet
432538|NCT01300273|Ketoanalogs|ketoanalogs
432539|NCT01300234|tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
432540|NCT01300234|chronic hepatitis B|chronic hepatitis b
432541|NCT01300234|adefovir dipivoxil|adefovir dipivoxil
432542|NCT01300221|Three dimension echocardiography|three dimension echocardiography
432543|NCT01300221|Congenital heart disease|congenital heart disease
432544|NCT01300221|Z-score|z-score
432545|NCT01300208|cutaneous lupus erythematosus|cutaneous lupus erythematosus
432546|NCT01300208|subacute lupus erythematosus|subacute lupus erythematosus
432547|NCT01300208|discoid lupus erythematosus|discoid lupus erythematosus
432548|NCT01300208|lupus|lupus
432549|NCT01300195|VATS|vats
432550|NCT01300195|standardized surgery|standardized surgery
432551|NCT01300195|persistent pain|persistent pain
432552|NCT01300182|ACLR|aclr
432553|NCT01300169|Suicide|suicide
432554|NCT01300169|Assessment|assessment
432555|NCT01300169|Intervention|intervention
432556|NCT01300169|CAMS|cams
432557|NCT01300156|Hodgkin's disease|hodgkin's disease
432558|NCT01300156|lymphoma|lymphoma
432559|NCT01300156|Relapsed|relapsed
432561|NCT01300130|neurological development|neurological development
432562|NCT01300130|preterm infants|preterm infants
432563|NCT01300130|fatty acid status|fatty acid status
432564|NCT01300117|cardiac surgery|cardiac surgery
432565|NCT01300117|adamts13|adamts13
432566|NCT01300117|TTP|ttp
432567|NCT01300117|extracorporeal circulation|extracorporeal circulation
432568|NCT01300117|Heart-Lung Machine|heart-lung machine
432569|NCT01300104|prostate cancer progression|prostate cancer progression
432570|NCT01300104|active surveillance|active surveillance
432571|NCT01300104|whole grain rye|whole grain rye
432572|NCT01300104|exercise|exercise
432573|NCT01300104|insulin sensitivity|insulin sensitivity
432574|NCT01300104|quality of life|quality of life
432575|NCT01300091|Shoulder|shoulder
432576|NCT01300091|Pain|pain
432577|NCT01300091|Range of Motion|range of motion
432578|NCT01300091|Disability Evaluation|disability evaluation
432579|NCT01300091|Function|function
432580|NCT01300091|Sick Leave|sick leave
432581|NCT01300091|Primary Health Care|primary health care
432582|NCT01300091|Visual Analog Scale|visual analog scale
432583|NCT01300091|Visual Analog Pain Scale|visual analog pain scale
432584|NCT01300091|The American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form|the american shoulder and elbow surgeons standardized shoulder assessment form
432585|NCT01300078|Hot Flashes|hot flashes
432586|NCT01300078|Hot Flushes|hot flushes
432587|NCT01300078|Vasomotor Symptoms|vasomotor symptoms
432588|NCT01300078|Menopausal Symptoms|menopausal symptoms
432589|NCT01300052|psoriasis|psoriasis
432590|NCT01300039|nephrolithiasis|nephrolithiasis
432591|NCT01300039|urolithiasis|urolithiasis
432592|NCT01300039|hyperoxaluria|hyperoxaluria
432593|NCT01300039|Helicobacter pylori|helicobacter pylori
432594|NCT01300026|Low intermediate grade B cell Lymphoma|low intermediate grade b cell lymphoma
432595|NCT01300026|Non-cutaneous T-cell NHL|non-cutaneous t-cell nhl
432596|NCT01300026|Mantle Cell Lymphoma|mantle cell lymphoma
432597|NCT01300026|PI3K delta|pi3k delta
432598|NCT01300026|Lymphoid|lymphoid
432599|NCT01300026|NHL|nhl
432600|NCT01300026|MCL|mcl
432601|NCT01300026|Hematologic|hematologic
432602|NCT01300026|CLL|cll
432603|NCT01300026|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
432604|NCT01300013|Intravenous|intravenous
432605|NCT01300013|IV|iv
432606|NCT01300013|Left Ventricular Systolic Dysfunction|left ventricular systolic dysfunction
432607|NCT01300013|Hospitalized|hospitalized
432608|NCT01300013|Acute heart failure|acute heart failure
432609|NCT01300013|Heart failure|heart failure
432610|NCT01300013|Left ventricular ejection fraction|left ventricular ejection fraction
432611|NCT01300013|pharmacokinetics|pharmacokinetics
432612|NCT01300013|Pharmacodynamics|pharmacodynamics
432613|NCT01300013|Dyspnea|dyspnea
432614|NCT01300013|hospitalization|hospitalization
432615|NCT01300013|In-patient|in-patient
432616|NCT01300013|Omecamtiv mecarbil|omecamtiv mecarbil
432617|NCT01300013|Double-blind|double-blind
432618|NCT01300013|Randomized|randomized
432619|NCT01300013|Placebo-controlled|placebo-controlled
432620|NCT01299987|Keywords provided by University Hospital Mannheim:|keywords provided by university hospital mannheim:
432621|NCT01299987|Intraoperative Radiotherapy|intraoperative radiotherapy
432622|NCT01299987|Early Breast Cancer|early breast cancer
432623|NCT01299987|Elderly Patients|elderly patients
432624|NCT01299974|Family-centered|family-centered
432625|NCT01299974|teaching|teaching
432626|NCT01299974|residents|residents
432627|NCT01299974|family faculty|family faculty
432628|NCT01299961|Rheumatoid Arthritis|rheumatoid arthritis
432629|NCT01299961|Subcutaneous Abatacept|subcutaneous abatacept
432630|NCT01299961|Ultrasound|ultrasound
432631|NCT01299948|HIV|hiv
432632|NCT01299948|AIDS|aids
432633|NCT01299948|CD4|cd4
432634|NCT01299948|progression|progression
432635|NCT01299948|immune activation|immune activation
432636|NCT01299935|stress reduction|stress reduction
432637|NCT01299935|Transcendental Meditation technique|transcendental meditation technique
432638|NCT01299935|secondary prevention of coronary heart disease|secondary prevention of coronary heart disease
432639|NCT01299922|Lupus nephritis|lupus nephritis
432640|NCT01299922|Therapy|therapy
432641|NCT01299922|Cyclosporin|cyclosporin
432642|NCT01299922|Mycophenolic acid|mycophenolic acid
432643|NCT01299909|Mindfulness Training for Smokers|mindfulness training for smokers
432644|NCT01299909|Smoking|smoking
432645|NCT01299909|Smoking cessation|smoking cessation
432646|NCT01299909|Addiction|addiction
432647|NCT01299909|behavioral intervention|behavioral intervention
432648|NCT01299909|Nicotine|nicotine
432649|NCT01299909|Tobacco|tobacco
432650|NCT01299909|Mindfulness|mindfulness
432651|NCT01299909|Meditation|meditation
432652|NCT01299909|MBSR|mbsr
432653|NCT01299909|Mindfulness Based Stress Reduction|mindfulness based stress reduction
432654|NCT01299909|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
432655|NCT01299909|MBCT|mbct
432656|NCT01299909|Mindfulness Based Relapse Prevention|mindfulness based relapse prevention
432657|NCT01299909|MBRP|mbrp
432658|NCT01299909|Mindfulness Training|mindfulness training
432659|NCT01299909|Nicotine Patch|nicotine patch
432660|NCT01299909|Quit Line|quit line
432661|NCT01299909|Phone counseling|phone counseling
432662|NCT01299909|Freedom from Smoking|freedom from smoking
432663|NCT01299896|Cigarette Smoking|cigarette smoking
432664|NCT01299896|Smoking, Tobacco|smoking, tobacco
432665|NCT01299896|Tobacco Smoking|tobacco smoking
432666|NCT01299896|Smoking Cessation|smoking cessation
432667|NCT01299896|Tobacco Dependence|tobacco dependence
432668|NCT01299883|Cancer|cancer
432669|NCT01299883|CVD|cvd
432670|NCT01299883|African American|african american
432671|NCT01299883|Health Education Intervention|health education intervention
432672|NCT01299883|Intervention RCT|intervention rct
432673|NCT01299883|Study focus is to examine the influence of health education regarding either CVD or CVD and cancer on health behaviors.|study focus is to examine the influence of health education regarding either cvd or cvd and cancer on health behaviors.
432674|NCT01299857|pemphigus|pemphigus
432675|NCT01299857|Mabthéra (R)|mabthéra (r)
432676|NCT01299857|B lymphocytes|b lymphocytes
432677|NCT01299857|desmogleines|desmogleines
432678|NCT01299844|Type 2 Diabetes|type 2 diabetes
432679|NCT01299818|central pain|central pain
432680|NCT01299818|spine surgey|spine surgey
432681|NCT01299818|outcome|outcome
432682|NCT01299818|patients undergo spinal surgery|patients undergo spinal surgery
432683|NCT01299805|Drug Therapy|drug therapy
432684|NCT01299805|pharmacodynamic|pharmacodynamic
432685|NCT01299792|spinal cord injury|spinal cord injury
432686|NCT01299792|urodynamics|urodynamics
432687|NCT01299792|ultrasound|ultrasound
432688|NCT01299792|neurogenic bladder dysfunction|neurogenic bladder dysfunction
432689|NCT01299779|hyponatremia|hyponatremia
432690|NCT01299779|PEG-SD|peg-sd
432691|NCT01299779|PEG-ELS|peg-els
432692|NCT01299766|Mild Cognitive Impairment|mild cognitive impairment
432693|NCT01299766|Memory|memory
432694|NCT01299727|Recombinant Human Heparan N-Sulfatase (rhHNS)|recombinant human heparan n-sulfatase (rhhns)
432695|NCT01299727|Sanfilippo Syndrome Type A (MPS IIIA)|sanfilippo syndrome type a (mps iiia)
432696|NCT01299727|Lysosomal storage disease (LSD)|lysosomal storage disease (lsd)
432697|NCT01299727|Mucopolysaccharidosis (MPS) III|mucopolysaccharidosis (mps) iii
432698|NCT01299714|Human Papilloma Virus|human papilloma virus
432699|NCT01299714|vaccine|vaccine
432700|NCT01299714|stress|stress
432701|NCT01299714|cervical cancer|cervical cancer
432702|NCT01299714|GARDASIL|gardasil
432703|NCT01299701|Advanced or metastatic cancer|advanced or metastatic cancer
432704|NCT01299701|refractory|refractory
432705|NCT01299701|core phase|core phase
432706|NCT01299701|extension phase|extension phase
432707|NCT01299701|dose escalation|dose escalation
432708|NCT01299701|standard chemotherapy|standard chemotherapy
432709|NCT01299701|docetaxel|docetaxel
432710|NCT01299701|paclitaxel|paclitaxel
432711|NCT01299701|carboplatin|carboplatin
432712|NCT01299701|safety|safety
432713|NCT01299701|tolerability|tolerability
432714|NCT01299675|MR conditional|mr conditional
432715|NCT01299649|CAD|cad
432716|NCT01299636|PM060184|pm060184
432717|NCT01299636|Phase I|phase i
432718|NCT01299636|Pharma Mar|pharma mar
432719|NCT01299623|breast cancer|breast cancer
432720|NCT01299623|breast cancer prevention|breast cancer prevention
432721|NCT01299623|African American women|african american women
432722|NCT01299610|Atopic Dermatitis|atopic dermatitis
432723|NCT01299610|GW870086X|gw870086x
432724|NCT01299610|TIS|tis
432725|NCT01299610|IGA|iga
432726|NCT01299597|repeat dose|repeat dose
432727|NCT01299597|statins|statins
432728|NCT01299597|safety and tolerability|safety and tolerability
432729|NCT01299597|drug interaction|drug interaction
432730|NCT01299597|sb649868|sb649868
432731|NCT01299597|healthy male subjects|healthy male subjects
432732|NCT01299597|pharmacokinetics|pharmacokinetics
432733|NCT01299558|pharmacokinetics|pharmacokinetics
432734|NCT01299558|GW642444|gw642444
432735|NCT01299558|absolute bioavailability|absolute bioavailability
432736|NCT01299558|healthy subjects|healthy subjects
432737|NCT01299558|fluticasone furoate|fluticasone furoate
432738|NCT01299558|GW685698|gw685698
432739|NCT01299545|Rheumatoid Arthritis|rheumatoid arthritis
432740|NCT01299545|Anti TNF|anti tnf
432741|NCT01299545|Infliximab|infliximab
432742|NCT01299545|Methotrexate|methotrexate
432743|NCT01299545|DMARDs|dmards
432744|NCT01299545|Gene expression biomarkers|gene expression biomarkers
432745|NCT01299519|obesity|obesity
432746|NCT01299519|weight loss|weight loss
432747|NCT01299519|insulin resistance|insulin resistance
432748|NCT01299506|soft tissue sarcoma|soft tissue sarcoma
432749|NCT01299506|trabectedin|trabectedin
432750|NCT01299506|Netherlands|netherlands
432751|NCT01299493|carcinoma|carcinoma
432752|NCT01299493|colorectal cancer|colorectal cancer
432753|NCT01299493|community health centers|community health centers
432754|NCT01299493|cluster-randomized|cluster-randomized
432755|NCT01299493|health behavior|health behavior
432756|NCT01299480|Healthy adolescents|healthy adolescents
432757|NCT01299467|Asthma|asthma
432758|NCT01299467|duration of action|duration of action
432759|NCT01299467|allergen challenge|allergen challenge
432760|NCT01299428|CEREBRAL OXYGENATION|cerebral oxygenation
432761|NCT01299428|HYPERNATREMİA|hypernatremia
432762|NCT01299428|NEWBORN|newborn
432763|NCT01299428|NA VALUES|na values
432764|NCT01299415|ASA404,|asa404,
432765|NCT01299415|Phase I,|phase i,
432766|NCT01299415|Oncology,|oncology,
432767|NCT01299415|CYP1A2,|cyp1a2,
432768|NCT01299415|fluvoxamine,|fluvoxamine,
432769|NCT01299415|drug drug interaction,|drug drug interaction,
432770|NCT01299415|Novartis,|novartis,
432771|NCT01299415|Antisoma|antisoma
432772|NCT01299389|Paliperidone palmitate|paliperidone palmitate
432773|NCT01299389|Schizophrenia|schizophrenia
432774|NCT01299376|Essential hypertension|essential hypertension
432775|NCT01299376|Antihypertensive agents|antihypertensive agents
432776|NCT01299376|Blood pressure|blood pressure
432777|NCT01299376|Uncontrolled hypertension|uncontrolled hypertension
432778|NCT01299363|Prolapse|prolapse
432779|NCT01299363|Pain with intercourse|pain with intercourse
432780|NCT01299363|Dyspareunia|dyspareunia
432781|NCT01299363|Post operative pain|post operative pain
432782|NCT01299350|Heart failure|heart failure
432783|NCT01299350|Nt-proBNP|nt-probnp
432785|NCT01299311|insulin sensitivity|insulin sensitivity
432786|NCT01299285|Absorption|absorption
432787|NCT01299285|Distribution|distribution
432788|NCT01299285|Metabolism|metabolism
432789|NCT01299285|Excretion|excretion
432790|NCT01299285|Mass balance|mass balance
432791|NCT01299285|Metabolic profile|metabolic profile
432792|NCT01299285|Radiolabeled study|radiolabeled study
432793|NCT01299285|14C|14c
432794|NCT01299259|Text message reminders|text message reminders
432795|NCT01299259|Pelvic inflammatory disease|pelvic inflammatory disease
432796|NCT01299259|PID|pid
432797|NCT01299259|Primary care follow-up|primary care follow-up
432798|NCT01299259|Emergency department care|emergency department care
432799|NCT01299259|Discharge instructions|discharge instructions
432800|NCT01299246|Diabetic Foot|diabetic foot
432801|NCT01299246|non-invasive DFP assessment tools|non-invasive dfp assessment tools
432802|NCT01299246|early detection of DFP|early detection of dfp
432803|NCT01299220|Erlotinib|erlotinib
432804|NCT01299220|Acitretin|acitretin
432805|NCT01299220|Rash|rash
432806|NCT01299220|Dermatology|dermatology
432807|NCT01299220|Oncology|oncology
432808|NCT01299207|Stents|stents
432809|NCT01299207|Drug-Eluting Stents|drug-eluting stents
432810|NCT01299207|Stent Thrombosis|stent thrombosis
432811|NCT01299207|Bleeding|bleeding
432812|NCT01299207|Dual-Antiplatelet Therapy|dual-antiplatelet therapy
432813|NCT01299194|BRONCHIECTASIS|bronchiectasis
432814|NCT01299194|PSEUDOMONAS AERUGINOSA|pseudomonas aeruginosa
432815|NCT01299194|STATIN|statin
432816|NCT01299194|OUTCOME|outcome
432817|NCT01299181|Bronchiectasis|bronchiectasis
432818|NCT01299181|Outcome|outcome
432819|NCT01299181|Statin therapy|statin therapy
432820|NCT01299168|global gene expression|global gene expression
432821|NCT01299168|molecular diagnostic classifiers|molecular diagnostic classifiers
432822|NCT01299155|Intraocular Lens|intraocular lens
432823|NCT01299155|Presbyopia Correcting IOL|presbyopia correcting iol
432824|NCT01299142|Influenza|influenza
432825|NCT01299142|antibodies|antibodies
432826|NCT01299142|monoclonal|monoclonal
432827|NCT01299142|virus|virus
432828|NCT01299129|Uveitis|uveitis
432829|NCT01299129|Cystoid macular edema|cystoid macular edema
432830|NCT01299129|microperimetry|microperimetry
432831|NCT01299129|functional visual acuity|functional visual acuity
432832|NCT01299129|intravitreal triamcinolone|intravitreal triamcinolone
432833|NCT01299116|AE-adverse event|ae-adverse event
432834|NCT01299116|FDA-(U.S.) Food and Drug Administration|fda-(u.s.) food and drug administration
432835|NCT01299116|GCP-Good Clinical Practice guidelines|gcp-good clinical practice guidelines
432836|NCT01299116|ICH-International Committee on Harmonisation|ich-international committee on harmonisation
432837|NCT01299116|IRB-Institutional Review Board|irb-institutional review board
432838|NCT01299116|IU-International units|iu-international units
432839|NCT01299116|mg-milligram(s)|mg-milligram(s)
432840|NCT01299116|mm3-cubic millimeter(s)|mm3-cubic millimeter(s)
432841|NCT01299116|LARC-Long-Acting reversible contraception|larc-long-acting reversible contraception
432842|NCT01299116|PPCNC-Planned Parenthood of North Carolina|ppcnc-planned parenthood of north carolina
432843|NCT01299116|SAE-serious adverse event|sae-serious adverse event
432844|NCT01299116|SARC-Short-Acting reversible contraception|sarc-short-acting reversible contraception
432845|NCT01299116|µg-microgram|µg-microgram
432846|NCT01299116|ULN-upper limit of the normal range|uln-upper limit of the normal range
432847|NCT01299116|SubQ-subcutaneous|subq-subcutaneous
432848|NCT01299103|wrinkle|wrinkle
432849|NCT01299103|rhytide|rhytide
432850|NCT01299090|wrinkles|wrinkles
432851|NCT01299090|rhytides|rhytides
432852|NCT01299077|Lumbar disc degenerative disease|lumbar disc degenerative disease
432853|NCT01299077|Methycobal|methycobal
432854|NCT01299064|mindfulness-based intervention|mindfulness-based intervention
432855|NCT01299064|symptoms reduction|symptoms reduction
432856|NCT01299064|mental health|mental health
432857|NCT01299051|Weight Management|weight management
432858|NCT01299051|Employee Health|employee health
432859|NCT01299038|Crestor|crestor
432860|NCT01299038|TFBP|tfbp
432861|NCT01299038|rosuvastatin|rosuvastatin
432862|NCT01299025|balance|balance
432863|NCT01299025|walking|walking
432864|NCT01298999|Barrett's Esophagus|barrett's esophagus
432865|NCT01298999|Esophageal Adenocarcinoma|esophageal adenocarcinoma
432866|NCT01298999|GERD|gerd
432867|NCT01298999|Acid Reflux|acid reflux
432868|NCT01298986|atrial fibrillation ablation procedures|atrial fibrillation ablation procedures
432869|NCT01298960|Poor Ovarian response in IVF|poor ovarian response in ivf
432870|NCT01298960|Metaphase II oocytes|metaphase ii oocytes
432871|NCT01298960|Pregnancy Rate|pregnancy rate
432872|NCT01298960|Growth Hormone|growth hormone
432873|NCT01298947|Photoablative Atherectomy|photoablative atherectomy
432874|NCT01298947|Paclitaxel-Coated Balloon|paclitaxel-coated balloon
432875|NCT01298947|Instent Femoro-popliteal Obstructions|instent femoro-popliteal obstructions
432876|NCT01298921|Headache|headache
432877|NCT01298921|Cluster Headache|cluster headache
432878|NCT01298921|Oxygen Therapy|oxygen therapy
432879|NCT01298908|varicose veins, oedema|varicose veins, oedema
432880|NCT01298895|optical components|optical components
432881|NCT01298895|pseudoexfoliation|pseudoexfoliation
432882|NCT01298895|cataract|cataract
432883|NCT01298895|LENSTAR® LS 900®|lenstar® ls 900®
432884|NCT01298882|Type 2 diabetes mellitus|type 2 diabetes mellitus
432885|NCT01298882|Overweight|overweight
432886|NCT01298882|Obesity|obesity
432887|NCT01298869|CKD|ckd
432888|NCT01298869|HPV infection|hpv infection
432889|NCT01298869|HPV vaccine|hpv vaccine
432890|NCT01298869|antibodies titer|antibodies titer
432891|NCT01298856|hydrotherapy|hydrotherapy
432892|NCT01298856|chronic ankle instability|chronic ankle instability
432893|NCT01298856|ankle taping|ankle taping
432894|NCT01298843|Confirmed or Suspected Infections|confirmed or suspected infections
432895|NCT01298817|Obesity|obesity
432896|NCT01298817|Aging|aging
432897|NCT01298817|Soy|soy
432898|NCT01298817|Weight Loss|weight loss
432899|NCT01298817|Ectopic Fat|ectopic fat
432900|NCT01298778|chronic pain post delivery|chronic pain post delivery
432901|NCT01298778|postpartum depression|postpartum depression
432902|NCT01298778|tailored pain management|tailored pain management
432903|NCT01298765|buccal soluble film|buccal soluble film
432904|NCT01298739|asthma control level , ACQ|asthma control level , acq
432905|NCT01298726|PHARMACEUTICAL SERVICES|pharmaceutical services
432906|NCT01298726|DIABETES MELLITUS|diabetes mellitus
432907|NCT01298713|Hormonoresistance|hormonoresistance
432908|NCT01298713|tamoxifen|tamoxifen
432909|NCT01298713|Previously received anti-aromatase treatment|previously received anti-aromatase treatment
432910|NCT01298713|mTor inhibitor|mtor inhibitor
432911|NCT01298687|open-angle glaucoma|open-angle glaucoma
432912|NCT01298687|ocular hypertension|ocular hypertension
432913|NCT01298687|divided dose|divided dose
432914|NCT01298661|Exercise Test|exercise test
432915|NCT01298661|Reproducibility of Results|reproducibility of results
432916|NCT01298661|Mortality|mortality
432917|NCT01298648|Crohn's Disease|crohn's disease
432918|NCT01298635|Primary angle-closure glaucoma|primary angle-closure glaucoma
432919|NCT01298635|cataract|cataract
432920|NCT01298635|trabeculectomy|trabeculectomy
432921|NCT01298635|phacotrabeculectomy|phacotrabeculectomy
432922|NCT01298609|Fibromyalgia|fibromyalgia
432923|NCT01298609|Occipital Nerve Stimulation|occipital nerve stimulation
432924|NCT01298570|Metastatic Colorectal Cancer|metastatic colorectal cancer
432925|NCT01298570|K-RAS mutation|k-ras mutation
432926|NCT01298570|BRAF mutation|braf mutation
432927|NCT01298570|Regorafenib|regorafenib
432928|NCT01298570|BAY 73-4506|bay 73-4506
432929|NCT01298570|FOLFIRI|folfiri
432930|NCT01298570|Irinotecan|irinotecan
432931|NCT01298570|5-FU|5-fu
432932|NCT01298570|Leucovorin|leucovorin
432933|NCT01298570|Placebo|placebo
432934|NCT01298570|Phase II|phase ii
432935|NCT01298570|Multi-Center|multi-center
432936|NCT01298570|Randomized|randomized
432937|NCT01298570|Lineberger|lineberger
432938|NCT01298570|North Carolina Cancer Hospital|north carolina cancer hospital
432939|NCT01298570|UNC|unc
432940|NCT01298557|Traumatic brain injury|traumatic brain injury
432941|NCT01298557|Post-concussive symptoms|post-concussive symptoms
432942|NCT01298557|Brain imaging|brain imaging
432943|NCT01298557|Neurocognitive testing|neurocognitive testing
432944|NCT01298544|Vaccine|vaccine
432945|NCT01298544|Prevenar|prevenar
432946|NCT01298544|Pneumococcal disease|pneumococcal disease
432947|NCT01298531|Etanercept|etanercept
432948|NCT01298531|Axial Spondyloarthritis|axial spondyloarthritis
432949|NCT01298531|NSAIDs sparing effect|nsaids sparing effect
432950|NCT01298518|multiple dose study in type 2 diabetes patients|multiple dose study in type 2 diabetes patients
432951|NCT01298505|Phase 1 multiple dose safety toleration fexofenadine|phase 1 multiple dose safety toleration fexofenadine
432952|NCT01298492|Active Crohn's disease|active crohn's disease
432953|NCT01298492|Anti-TNF Refractory|anti-tnf refractory
432954|NCT01298492|Immunosuppressant Refractory|immunosuppressant refractory
432955|NCT01298479|volume delivery|volume delivery
432956|NCT01298466|identification|identification
432957|NCT01298466|chronic|chronic
432958|NCT01298466|neuropathic|neuropathic
432959|NCT01298466|low back pain|low back pain
432960|NCT01298466|primary care|primary care
432961|NCT01298466|pregabalin|pregabalin
432962|NCT01298414|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
432963|NCT01298401|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
432964|NCT01298401|stage IIB pancreatic cancer|stage iib pancreatic cancer
432965|NCT01298401|stage III pancreatic cancer|stage iii pancreatic cancer
432966|NCT01298388|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
432967|NCT01298388|cancer survivor|cancer survivor
432968|NCT01298388|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
432969|NCT01298388|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
432970|NCT01298388|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
432971|NCT01298388|non-T, non-B childhood acute lymphoblastic leukemia|non-t, non-b childhood acute lymphoblastic leukemia
432972|NCT01298388|non-T, non-B, cALLa positive childhood acute lymphoblastic leukemia|non-t, non-b, calla positive childhood acute lymphoblastic leukemia
432973|NCT01298388|non-T, non-B, cALLa negative childhood acute lymphoblastic leukemia|non-t, non-b, calla negative childhood acute lymphoblastic leukemia
432974|NCT01298388|non-T, non-B, cALLa positive, pre-B childhood acute lymphoblastic leukemia|non-t, non-b, calla positive, pre-b childhood acute lymphoblastic leukemia
432975|NCT01298388|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
432976|NCT01298375|Metabolic flexibility|metabolic flexibility
432977|NCT01298375|Mitochondrial function|mitochondrial function
432978|NCT01298375|Human primary myoblasts|human primary myoblasts
432979|NCT01298375|Lipid metabolism|lipid metabolism
432980|NCT01298336|Mycobacterium Xenopi Pulmonary Infection|mycobacterium xenopi pulmonary infection
432981|NCT01298336|Clarithromycin|clarithromycin
432982|NCT01298336|Moxifloxacin|moxifloxacin
432983|NCT01298323|Medullary Thyroid Cancer|medullary thyroid cancer
432984|NCT01298323|Locally advanced|locally advanced
432985|NCT01298323|Metastatic|metastatic
432986|NCT01298323|Vandetanib|vandetanib
432987|NCT01298323|Patient Outreach|patient outreach
432988|NCT01298310|Morton's neuroma, QST measurements|morton's neuroma, qst measurements
432989|NCT01298297|Buprenorphine, acute pain, analgesia|buprenorphine, acute pain, analgesia
432990|NCT01298284|Variceal bleeding|variceal bleeding
432991|NCT01298284|portal hypertension|portal hypertension
432992|NCT01298284|hepatocelluar carcinoma|hepatocelluar carcinoma
432993|NCT01298284|endoscopic variceal ligation|endoscopic variceal ligation
432994|NCT01298284|non-selective beta-blocker|non-selective beta-blocker
432995|NCT01298284|rebleeding|rebleeding
432996|NCT01298271|gastric variceal bleeding|gastric variceal bleeding
432997|NCT01298271|primaryprevention|primaryprevention
432998|NCT01298271|cyanoacrylate injection|cyanoacrylate injection
432999|NCT01298271|non-selective beta-blocker|non-selective beta-blocker
433000|NCT01298245|diabetes|diabetes
433001|NCT01298245|diabetic retinopathy|diabetic retinopathy
433002|NCT01298245|Chinese|chinese
433003|NCT01298245|gene|gene
433004|NCT01298245|associations|associations
433005|NCT01298206|A/H1N1 Influenza|a/h1n1 influenza
433006|NCT01298206|swine flu|swine flu
433007|NCT01298206|virus disease|virus disease
433008|NCT01298206|Avian flu|avian flu
433009|NCT01298193|Early-stage breast cancer patients|early-stage breast cancer patients
433010|NCT01298180|Prader-Willi Syndrome|prader-willi syndrome
433011|NCT01298180|Growth Hormone Deficiency|growth hormone deficiency
433012|NCT01298167|Cyanoacrylate|cyanoacrylate
433013|NCT01298167|Fast Absorbing Gut|fast absorbing gut
433014|NCT01298167|Mohs Surgery|mohs surgery
433015|NCT01298167|Epidermal closure method|epidermal closure method
433016|NCT01298154|Food intake|food intake
433017|NCT01298154|Blood glucose|blood glucose
433018|NCT01298154|Pulses|pulses
433019|NCT01298154|Protein|protein
433020|NCT01298141|Replagal|replagal
433021|NCT01298141|Enzyme Replacement Therapy|enzyme replacement therapy
433022|NCT01298141|agalsidase alfa|agalsidase alfa
433023|NCT01298115|chronic kidney disease|chronic kidney disease
433024|NCT01298115|dialysis|dialysis
433025|NCT01298115|pre dialysis education|pre dialysis education
433026|NCT01298115|transplantation|transplantation
433027|NCT01298115|conservative care|conservative care
433028|NCT01298102|kidney|kidney
433029|NCT01298102|transplantation|transplantation
433030|NCT01298102|haemodialysis|haemodialysis
433031|NCT01298102|vaccination|vaccination
433032|NCT01298102|influenza H1N1 2009|influenza h1n1 2009
433033|NCT01298089|Flap|flap
433034|NCT01298089|LASIK|lasik
433035|NCT01298089|Corneal|corneal
433036|NCT01298076|Diabetes|diabetes
433037|NCT01298076|Retinopathy|retinopathy
433038|NCT01298076|Macular oedema|macular oedema
433039|NCT01298076|Laser|laser
433040|NCT01298076|Photocoagulation|photocoagulation
433041|NCT01298076|Fovea|fovea
433042|NCT01298076|Steroid|steroid
433043|NCT01298076|Bevacizumab|bevacizumab
433044|NCT01298076|Intravitreal|intravitreal
433045|NCT01298037|Immunology, Hepatitis B, HBV|immunology, hepatitis b, hbv
433046|NCT01298024|Achilles tendon rupture|achilles tendon rupture
433047|NCT01298024|Non-surgical treatment|non-surgical treatment
433048|NCT01298024|Exercise|exercise
433049|NCT01298024|Neuromuscular training|neuromuscular training
433050|NCT01298011|operable|operable
433051|NCT01298011|pancreas|pancreas
433052|NCT01298011|Abraxane|abraxane
433053|NCT01298011|Gemcitabine|gemcitabine
433054|NCT01298011|Preoperative|preoperative
433055|NCT01298011|potentially|potentially
433056|NCT01298011|Pancreatic Cancer|pancreatic cancer
433057|NCT01297985|Serious mental illness|serious mental illness
433058|NCT01297985|Psychiatric disability|psychiatric disability
433059|NCT01297985|Mental health peer-led|mental health peer-led
433060|NCT01297985|Mental illness education|mental illness education
433061|NCT01297985|Illness self-management|illness self-management
433062|NCT01297972|Aplastic Anemia|aplastic anemia
433063|NCT01297972|Mesenchymal Stem Cells|mesenchymal stem cells
433064|NCT01297959|Surgical Wound Infection|surgical wound infection
433065|NCT01297959|Therapeutic Enzyme System|therapeutic enzyme system
433066|NCT01297959|Singlet Oxygen|singlet oxygen
433067|NCT01297959|Peroxidase|peroxidase
433068|NCT01297959|Glucose Oxidase|glucose oxidase
433069|NCT01297959|Colorectal surgery|colorectal surgery
433070|NCT01297959|Incisional Surgical Site Infections (SSI)|incisional surgical site infections (ssi)
433071|NCT01297959|Anti-infective Agents, Local|anti-infective agents, local
433072|NCT01297959|Clinical Trial, Phase III|clinical trial, phase iii
433073|NCT01297933|parenteral nutrition associated liver disease|parenteral nutrition associated liver disease
433074|NCT01297933|cholestasis|cholestasis
433075|NCT01297933|short bowel syndrome|short bowel syndrome
433076|NCT01297933|Omegaven|omegaven
433077|NCT01297920|Open-Angle Glaucoma|open-angle glaucoma
433078|NCT01297920|Ocular Hypertension|ocular hypertension
433079|NCT01297920|Brinzolamide|brinzolamide
433080|NCT01297920|Brimonidine|brimonidine
433081|NCT01297920|Intraocular pressure|intraocular pressure
433082|NCT01297907|Crohn's Disease|crohn's disease
433083|NCT01297907|Bronchial hyper reactivity|bronchial hyper reactivity
433084|NCT01297907|Fractional exhaled NO|fractional exhaled no
433085|NCT01297907|Methacholine Challenge Test|methacholine challenge test
433086|NCT01297907|Pediatric Crohn's Disease Activity Index|pediatric crohn's disease activity index
433087|NCT01297907|To determine the frequency of bronchial hyperreactivity in pediatric patients followed and treated for Crohn disease|to determine the frequency of bronchial hyperreactivity in pediatric patients followed and treated for crohn disease
433088|NCT01297894|A. baumannii|a. baumannii
433089|NCT01297894|colistin|colistin
433090|NCT01297894|fosfomycin|fosfomycin
433091|NCT01297881|Caucasian outpatients|caucasian outpatients
433092|NCT01297881|undiagnosed respiratory symptoms|undiagnosed respiratory symptoms
433093|NCT01297881|dyspnea|dyspnea
433094|NCT01297881|cough|cough
433095|NCT01297881|sputum|sputum
433096|NCT01297829|ibuprofen|ibuprofen
433097|NCT01297829|postoperative narcotics|postoperative narcotics
433098|NCT01297829|visual analog pain scale|visual analog pain scale
433099|NCT01297829|inguinal hernia repair|inguinal hernia repair
433100|NCT01297829|umbilical hernia repair|umbilical hernia repair
433101|NCT01297790|Cough|cough
433102|NCT01297790|Inhalational cough challenges|inhalational cough challenges
433103|NCT01297790|Cough reflex sensitivity|cough reflex sensitivity
433104|NCT01297790|Chronic cough.|chronic cough.
433105|NCT01297777|Mast cell|mast cell
433106|NCT01297777|Mastocytosis|mastocytosis
433107|NCT01297777|Mast cell disease|mast cell disease
433108|NCT01297738|diet manipulation|diet manipulation
433109|NCT01297738|serotonin|serotonin
433110|NCT01297738|dopamine|dopamine
433111|NCT01297738|insulin sensitivity|insulin sensitivity
433112|NCT01297725|Cesarean section|cesarean section
433113|NCT01297725|Cesarean section[*methods]|cesarean section[*methods]
433114|NCT01297725|Fascia [*surgery]|fascia [*surgery]
433115|NCT01297725|Randomized Controlled Trial|randomized controlled trial
433116|NCT01297725|Abdominal Wall [*surgery]|abdominal wall [*surgery]
433117|NCT01297725|Pain, postoperative|pain, postoperative
433118|NCT01297725|Surgical wound infection|surgical wound infection
433119|NCT01297712|screening colonoscopy|screening colonoscopy
433120|NCT01297712|adenoma|adenoma
433121|NCT01297712|hyperplastic polyp|hyperplastic polyp
433122|NCT01297712|differential diagnosis|differential diagnosis
433123|NCT01297699|Graves´ orbitopathy|graves´ orbitopathy
433124|NCT01297699|Graves´ ophthalmopathy|graves´ ophthalmopathy
433125|NCT01297699|Thyroid eye disease|thyroid eye disease
433126|NCT01297699|Thyroid-associated ophthalmopathy|thyroid-associated ophthalmopathy
433127|NCT01297699|Tocilizumab|tocilizumab
433128|NCT01297699|EUGOGO|eugogo
433129|NCT01297699|CAS|cas
433130|NCT01297686|Chronic plantar fasciitis|chronic plantar fasciitis
433131|NCT01297686|Workplace injury|workplace injury
433132|NCT01297686|Foot and Ankle Disability Index|foot and ankle disability index
433133|NCT01297686|Ultrasound measure of disease severity|ultrasound measure of disease severity
433134|NCT01297673|vesico-ureteral reflux|vesico-ureteral reflux
433135|NCT01297673|neurogenic bladder dysfunction|neurogenic bladder dysfunction
433136|NCT01297673|spinal cord injury|spinal cord injury
433137|NCT01297660|neurogenic detrusor overactivity|neurogenic detrusor overactivity
433138|NCT01297660|detrusor sphincter dyssynergia|detrusor sphincter dyssynergia
433139|NCT01297660|compliance|compliance
433140|NCT01297660|video urodynamic|video urodynamic
433141|NCT01297660|spinal cord injury|spinal cord injury
433242|NCT01297296|akinesis|akinesis
433142|NCT01297647|urinary tract infection|urinary tract infection
433143|NCT01297647|urodynamics|urodynamics
433144|NCT01297647|spinal cord injury|spinal cord injury
433145|NCT01297634|Botulinum toxin type A|botulinum toxin type a
433146|NCT01297634|Hyperfunctional forehead lines|hyperfunctional forehead lines
433147|NCT01297634|Randomized controlled trial|randomized controlled trial
433148|NCT01297634|Double-blinded trial|double-blinded trial
433149|NCT01297634|Electromyogram (EMG)|electromyogram (emg)
433150|NCT01297634|Electromyographic activity|electromyographic activity
433151|NCT01297634|Frontal Area|frontal area
433152|NCT01297621|breast hypertrophy|breast hypertrophy
433153|NCT01297621|physical activity|physical activity
433154|NCT01297621|sexuality|sexuality
433155|NCT01297621|patient satisfaction|patient satisfaction
433156|NCT01297595|relative bioavailability|relative bioavailability
433157|NCT01297595|pharmacokinetics|pharmacokinetics
433158|NCT01297595|crizotinib|crizotinib
433159|NCT01297595|oral liquid formulation|oral liquid formulation
433160|NCT01297595|formulated capsule|formulated capsule
433161|NCT01297582|ONO-6950|ono-6950
433162|NCT01297582|Healthy Adult Subjects|healthy adult subjects
433163|NCT01297569|Diabetic macular edema|diabetic macular edema
433164|NCT01297569|Macular edema|macular edema
433165|NCT01297569|DME|dme
433166|NCT01297569|Diabetic retinopathy|diabetic retinopathy
433167|NCT01297569|Diabetic eye disease|diabetic eye disease
433168|NCT01297569|anti-VEGF|anti-vegf
433169|NCT01297569|ranibizumab|ranibizumab
433170|NCT01297569|Lucentis|lucentis
433171|NCT01297556|Irritable Bowel Syndrome|irritable bowel syndrome
433172|NCT01297543|Induction chemotherapy|induction chemotherapy
433173|NCT01297543|Re-induction chemotherapy|re-induction chemotherapy
433174|NCT01297543|Consolidation chemotherapy|consolidation chemotherapy
433175|NCT01297543|Leukemia|leukemia
433176|NCT01297543|Myelodysplasia|myelodysplasia
433177|NCT01297530|Phase I|phase i
433178|NCT01297530|Dose Escalation|dose escalation
433179|NCT01297530|Hypoxia inducible factor 1 alpha|hypoxia inducible factor 1 alpha
433180|NCT01297530|Neoplasms|neoplasms
433181|NCT01297517|AOG|aog
433182|NCT01297517|OHT|oht
433183|NCT01297517|Open-Angle Glaucoma|open-angle glaucoma
433184|NCT01297517|Ocular Hypertension|ocular hypertension
433185|NCT01297504|palivizumab|palivizumab
433186|NCT01297504|lower respiratory tract infection|lower respiratory tract infection
433187|NCT01297504|Respiratory syncytial virus|respiratory syncytial virus
433188|NCT01297504|usage patterns|usage patterns
433189|NCT01297491|NSCLC|nsclc
433190|NCT01297491|PI3K|pi3k
433191|NCT01297465|Ovulation Induction|ovulation induction
433192|NCT01297465|Ovarian Stimulation|ovarian stimulation
433193|NCT01297465|Reproductive Technique, Assisted|reproductive technique, assisted
433194|NCT01297465|Assisted Reproductive Technics|assisted reproductive technics
433195|NCT01297465|Assisted Reproductive Technique|assisted reproductive technique
433196|NCT01297465|Reproductive Technology, Assisted|reproductive technology, assisted
433197|NCT01297452|BKM120|bkm120
433198|NCT01297452|CARBOPLATIN|carboplatin
433199|NCT01297452|TAXOL (PACLITAXEL)|taxol (paclitaxel)
433200|NCT01297452|Chemotherapy|chemotherapy
433201|NCT01297452|10-192|10-192
433202|NCT01297439|shoulder dystocia,|shoulder dystocia,
433203|NCT01297439|Mac Roberts' maneuver,|mac roberts' maneuver,
433204|NCT01297439|pushing maneuver|pushing maneuver
433205|NCT01297413|allogeneic|allogeneic
433206|NCT01297413|adult|adult
433207|NCT01297413|stem|stem
433208|NCT01297413|cells|cells
433209|NCT01297413|stroke|stroke
433210|NCT01297413|ischemic|ischemic
433211|NCT01297400|Burns, Partial Thickness Burns|burns, partial thickness burns
433212|NCT01297387|Diabetic Patients|diabetic patients
433213|NCT01297387|Critical Limb Ischemia|critical limb ischemia
433214|NCT01297387|Revascularization|revascularization
433215|NCT01297374|Obesity|obesity
433216|NCT01297348|Lybrel|lybrel
433217|NCT01297348|levonorgestrel|levonorgestrel
433218|NCT01297348|ethinyl estradiol|ethinyl estradiol
433219|NCT01297348|venus thromboembolism (VTE)|venus thromboembolism (vte)
433220|NCT01297348|oral contraceptives (OC)|oral contraceptives (oc)
433221|NCT01297348|safety|safety
433222|NCT01297348|database study|database study
433223|NCT01297348|case-control study|case-control study
433224|NCT01297335|intrathecal|intrathecal
433225|NCT01297335|clonidine|clonidine
433226|NCT01297335|poorly|poorly
433227|NCT01297335|controlled|controlled
433228|NCT01297335|hypertension|hypertension
433229|NCT01297322|vascular closure system|vascular closure system
433230|NCT01297322|manual compression|manual compression
433231|NCT01297322|femoral arteriotomy|femoral arteriotomy
433232|NCT01297322|percutaneous endovascular procedures|percutaneous endovascular procedures
433233|NCT01297309|PTH 1-84|pth 1-84
433234|NCT01297309|Hypoparathyroidism|hypoparathyroidism
433235|NCT01297309|Parathyroid Hormone 1-84|parathyroid hormone 1-84
433236|NCT01297309|NPSP558|npsp558
433237|NCT01297296|heart failure|heart failure
433238|NCT01297296|percutaneous|percutaneous
433239|NCT01297296|interventional cardiology|interventional cardiology
433240|NCT01297296|apical remodeling|apical remodeling
433241|NCT01297296|LV dilatation|lv dilatation
433243|NCT01297296|dyskinesis|dyskinesis
433244|NCT01297296|myocardial infarction|myocardial infarction
433245|NCT01297283|Heart failure|heart failure
433246|NCT01297283|Cardiac resynchronization|cardiac resynchronization
433247|NCT01297283|Leadless ECG|leadless ecg
433248|NCT01297283|Follow-up|follow-up
433249|NCT01297244|AV-951|av-951
433250|NCT01297244|Tivozanib|tivozanib
433251|NCT01297244|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
433252|NCT01297244|RCC|rcc
433253|NCT01297244|Biomarkers|biomarkers
433254|NCT01297231|fibroglandular tissue|fibroglandular tissue
433255|NCT01297231|tamoxifen|tamoxifen
433256|NCT01297231|MRI|mri
433257|NCT01297231|Background Parenchymal Enhancement|background parenchymal enhancement
433258|NCT01297231|10-217|10-217
433259|NCT01297218|Alzheimer, Mesenchymal Stem Cells, Umbilical Cord Blood|alzheimer, mesenchymal stem cells, umbilical cord blood
433260|NCT01297205|Human Umbilical Cord Blood Derived Mesenchymal Stem Cells|human umbilical cord blood derived mesenchymal stem cells
433261|NCT01297205|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
433262|NCT01297205|Premature infants|premature infants
433263|NCT01297192|YM178|ym178
433264|NCT01297192|Mirabegron|mirabegron
433265|NCT01297192|DDI|ddi
433266|NCT01297192|Phase I|phase i
433267|NCT01297192|Solifenacin|solifenacin
433268|NCT01297192|Pharmacokinetics|pharmacokinetics
433269|NCT01297192|Pharmacokinetics of mirabegron|pharmacokinetics of mirabegron
433270|NCT01297179|Pharmacokinetics|pharmacokinetics
433271|NCT01297179|Oral contraceptives|oral contraceptives
433272|NCT01297179|Drug interactions|drug interactions
433273|NCT01297179|Pharmacokinetics of mirabegron|pharmacokinetics of mirabegron
433274|NCT01297153|Congenital Cataract|congenital cataract
433275|NCT01297153|Children younger than 2 years|children younger than 2 years
433276|NCT01297153|Aphakia|aphakia
433277|NCT01297153|Primary IOL Implantation|primary iol implantation
433278|NCT01297140|Psychiatry|psychiatry
433279|NCT01297140|Behaviour|behaviour
433280|NCT01297140|Alzheimer's|alzheimer's
433281|NCT01297140|Personality|personality
433282|NCT01297088|Proof of Mechanism|proof of mechanism
433283|NCT01297088|Phase I|phase i
433284|NCT01297088|Neoplasm|neoplasm
433285|NCT01297088|Inflammation|inflammation
433286|NCT01297075|Health Services Research|health services research
433287|NCT01297075|Chronic Care|chronic care
433288|NCT01297075|Outreach Visits|outreach visits
433289|NCT01297075|Primary care|primary care
433290|NCT01297075|chronic disease management|chronic disease management
433291|NCT01297062|Diabetes|diabetes
433292|NCT01297062|exenatide|exenatide
433293|NCT01297062|Amylin|amylin
433294|NCT01297062|Lilly|lilly
433295|NCT01297062|QT interval|qt interval
433296|NCT01297049|Diabetes|diabetes
433297|NCT01297049|obesity|obesity
433298|NCT01297049|behavior therapy|behavior therapy
433299|NCT01297049|self management|self management
433300|NCT01297036|Pharmacokinetics|pharmacokinetics
433301|NCT01297036|Bioequivalence|bioequivalence
433302|NCT01297036|Donepezil|donepezil
433303|NCT01297023|calcium phosphate|calcium phosphate
433304|NCT01297023|vitamin d3|vitamin d3
433305|NCT01297023|bone metabolism|bone metabolism
433306|NCT01297023|human study|human study
433307|NCT01297010|Nausea and Vomiting|nausea and vomiting
433308|NCT01297010|Vomiting|vomiting
433309|NCT01297010|Postoperative|postoperative
433310|NCT01297010|Anesthesia|anesthesia
433311|NCT01296997|calcium phosphate|calcium phosphate
433312|NCT01296997|incretins|incretins
433313|NCT01296997|human study|human study
433314|NCT01296984|Rectal cancer|rectal cancer
433315|NCT01296984|APR|apr
433316|NCT01296958|Taenia solium|taenia solium
433317|NCT01296958|cysticercosis|cysticercosis
433318|NCT01296958|neurocysticercosis|neurocysticercosis
433319|NCT01296919|Chronic rhinosinusitis|chronic rhinosinusitis
433320|NCT01296919|Histopathology|histopathology
433321|NCT01296919|Infundibulum|infundibulum
433322|NCT01296919|Lamina propria|lamina propria
433323|NCT01296919|Uncinate process|uncinate process
433324|NCT01296906|Reminder/recall messages|reminder/recall messages
433325|NCT01296906|reminders|reminders
433326|NCT01296906|recall|recall
433327|NCT01296906|immunizations|immunizations
433328|NCT01296906|immunization information systems|immunization information systems
433329|NCT01296906|effectiveness of reminder/recall|effectiveness of reminder/recall
433330|NCT01296906|population-based reminder/recall|population-based reminder/recall
433331|NCT01296867|Laser ablation algorithms|laser ablation algorithms
433332|NCT01296867|Excimer laser|excimer laser
433333|NCT01296867|Refractive correction|refractive correction
433334|NCT01296867|Corneal Asphericity Adjustment|corneal asphericity adjustment
433335|NCT01296854|spa therapy|spa therapy
433336|NCT01296841|telemedicine|telemedicine
433337|NCT01296841|remote consultation|remote consultation
433338|NCT01296841|telehealth|telehealth
433339|NCT01296841|ehealth|ehealth
433340|NCT01296841|image archiving|image archiving
433341|NCT01296841|inflammatory bowel disease|inflammatory bowel disease
433342|NCT01296815|Kaposi sarcoma|kaposi sarcoma
433343|NCT01296815|HIV|hiv
433344|NCT01296815|Bevacizumab|bevacizumab
433345|NCT01296802|Ecstasy|ecstasy
433346|NCT01296802|MDMA|mdma
433347|NCT01296802|Serotonin|serotonin
433348|NCT01296802|Neurotoxicity|neurotoxicity
433349|NCT01296802|dexfenfluramine|dexfenfluramine
433350|NCT01296802|Positron emission tomography|positron emission tomography
433351|NCT01296802|altanserin|altanserin
433352|NCT01296802|5-HT2A receptor|5-ht2a receptor
433353|NCT01296776|exercise|exercise
433354|NCT01296776|whole-body electromyostimulation|whole-body electromyostimulation
433355|NCT01296776|bone mineral density|bone mineral density
433356|NCT01296776|falls|falls
433357|NCT01296776|physical fitness|physical fitness
433358|NCT01296776|pain|pain
433359|NCT01296763|Irinotecan|irinotecan
433360|NCT01296763|Cisplatin|cisplatin
433361|NCT01296763|Carboplatin|carboplatin
433362|NCT01296763|Mitomycin-C|mitomycin-c
433363|NCT01296763|Olaparib|olaparib
433364|NCT01296763|AZD2281|azd2281
433365|NCT01296711|Rheumatoid arthritis|rheumatoid arthritis
433366|NCT01296711|CDP6038|cdp6038
433367|NCT01296711|Interleukin-6|interleukin-6
433368|NCT01296698|Smoking Cessation|smoking cessation
433369|NCT01296698|Tobacco Use Disorder|tobacco use disorder
433370|NCT01296685|cardiovascular surgical procedure|cardiovascular surgical procedure
433371|NCT01296672|Finasteride|finasteride
433372|NCT01296672|Placebo|placebo
433373|NCT01296672|Prostate cancer|prostate cancer
433374|NCT01296672|Prostate Specific Antigen (PSA)|prostate specific antigen (psa)
433375|NCT01296672|Men at intermediate risk of prostate cancer|men at intermediate risk of prostate cancer
433376|NCT01296672|Men scheduled for prostate biopsy|men scheduled for prostate biopsy
433377|NCT01296659|sarcoma|sarcoma
433378|NCT01296659|Ridaforolimus|ridaforolimus
433379|NCT01296659|soft tissue sarcoma|soft tissue sarcoma
433380|NCT01296659|unresectable sarcoma|unresectable sarcoma
433381|NCT01296646|Alcohol|alcohol
433382|NCT01296646|Alcoholics|alcoholics
433383|NCT01296646|Substance Abuse|substance abuse
433384|NCT01296646|Alcohol Abuse|alcohol abuse
433385|NCT01296646|Alcohol Addiction|alcohol addiction
433386|NCT01296633|health literacy|health literacy
433387|NCT01296633|patient education|patient education
433388|NCT01296633|medication adherence|medication adherence
433389|NCT01296633|patient/provider communication|patient/provider communication
433390|NCT01296633|Diabetes Mellitus|diabetes mellitus
433391|NCT01296607|Pharmacodynamics|pharmacodynamics
433392|NCT01296607|Pharmacokinetics|pharmacokinetics
433393|NCT01296607|Urocortin 2|urocortin 2
433394|NCT01296607|Urocortin 3|urocortin 3
433395|NCT01296607|Reproducibility|reproducibility
433396|NCT01296607|Onset/ Offset|onset/ offset
433397|NCT01296607|Forearm blood flow|forearm blood flow
433398|NCT01296607|Plethysmography|plethysmography
433399|NCT01296607|Heart Failure|heart failure
433400|NCT01296581|Cancer|cancer
433401|NCT01296581|Tumors|tumors
433402|NCT01296581|VEGFR|vegfr
433403|NCT01296581|PDGFR|pdgfr
433404|NCT01296568|metastatic solid tumors|metastatic solid tumors
433405|NCT01296568|Malignant/M-Neoplasm|malignant/m-neoplasm
433406|NCT01296568|Pancreas NOS|pancreas nos
433407|NCT01296568|Absorption|absorption
433408|NCT01296568|Distribution|distribution
433409|NCT01296568|Metabolism|metabolism
433410|NCT01296568|Excretion|excretion
433411|NCT01296568|Mass balance|mass balance
433412|NCT01296568|Metabolic profile|metabolic profile
433413|NCT01296568|Radiolabeled study|radiolabeled study
433414|NCT01296516|Women|women
433415|NCT01296516|Postpartum|postpartum
433416|NCT01296516|GDM|gdm
433417|NCT01296503|Multiple Myeloma|multiple myeloma
433418|NCT01296503|Treatment|treatment
433419|NCT01296503|Maintenance|maintenance
433420|NCT01296503|Thalidomide|thalidomide
433421|NCT01296490|oxidative stress, physical exercise, fitness level|oxidative stress, physical exercise, fitness level
433422|NCT01296477|Asthma|asthma
433423|NCT01296477|ASTHMA IQ tool|asthma iq tool
433424|NCT01296477|Asthma Control Test (ACT)|asthma control test (act)
433425|NCT01296477|EPR-3 Guidelines, Exacerbations|epr-3 guidelines, exacerbations
433426|NCT01296464|Parkinson's Disease|parkinson's disease
433427|NCT01296464|Motor response|motor response
433428|NCT01296464|Wearing-off|wearing-off
433429|NCT01296451|Hepatitis C|hepatitis c
433430|NCT01296451|vaccine|vaccine
433431|NCT01296451|Adenovirus|adenovirus
433432|NCT01296451|MVA|mva
433433|NCT01296451|chronic infection|chronic infection
433434|NCT01296451|interferon|interferon
433435|NCT01296451|ribavirin|ribavirin
433436|NCT01296425|Growth disorders|growth disorders
433437|NCT01296425|Saizen|saizen
433438|NCT01296425|Easypod|easypod
433439|NCT01296425|Growth hormone|growth hormone
433440|NCT01296425|Pediatric subject|pediatric subject
433441|NCT01296399|in stent restenosis|in stent restenosis
433442|NCT01296399|bare metal stent|bare metal stent
433443|NCT01296399|drug eluting stent|drug eluting stent
433444|NCT01296399|de novo lesion|de novo lesion
433445|NCT01296373|HIV-1|hiv-1
433446|NCT01296373|immune|immune
433447|NCT01296373|restoration|restoration
433448|NCT01296373|observational|observational
433449|NCT01296360|immune response|immune response
433450|NCT01296360|IC51-325|ic51-325
433548|NCT01295892|menopause|menopause
433451|NCT01296360|Japanese Encephalitis|japanese encephalitis
433452|NCT01296360|Intercell AG|intercell ag
433453|NCT01296347|Ketamine|ketamine
433454|NCT01296347|Thoracotomy|thoracotomy
433455|NCT01296347|VATS|vats
433456|NCT01296347|Pain|pain
433457|NCT01296334|opioids|opioids
433458|NCT01296334|analgesia|analgesia
433459|NCT01296334|secondary hyperalgesia|secondary hyperalgesia
433460|NCT01296334|quantitative sensory testing|quantitative sensory testing
433461|NCT01296334|inflammatory injury|inflammatory injury
433462|NCT01296308|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
433463|NCT01296308|Diabetic Neuropathy|diabetic neuropathy
433464|NCT01296308|Complementary Medicine|complementary medicine
433465|NCT01296308|Alternative Medicine|alternative medicine
433466|NCT01296308|Integrative Medicine|integrative medicine
433467|NCT01296308|Quality of Life|quality of life
433468|NCT01296308|Quantitative Sensory Testing|quantitative sensory testing
433469|NCT01296295|smoking cessation advice|smoking cessation advice
433470|NCT01296295|spirometry|spirometry
433471|NCT01296295|primary health care|primary health care
433472|NCT01296269|social cognition|social cognition
433473|NCT01296269|oxytocin|oxytocin
433474|NCT01296269|vasopressin|vasopressin
433475|NCT01296269|decision making|decision making
433476|NCT01296269|social decision making|social decision making
433477|NCT01296256|Bendamustine|bendamustine
433478|NCT01296256|Conditioning Therapy|conditioning therapy
433479|NCT01296256|Autologous Stem Cell Transplant|autologous stem cell transplant
433480|NCT01296256|Aggressive Non Hodgkin's Lymphoma|aggressive non hodgkin's lymphoma
433481|NCT01296243|Castration-resistant prostate cancer|castration-resistant prostate cancer
433482|NCT01296243|Tesetaxel|tesetaxel
433483|NCT01296243|Taxanes|taxanes
433484|NCT01296243|Chemotherapy-naive|chemotherapy-naive
433485|NCT01296243|Chemotherapy-exposed|chemotherapy-exposed
433486|NCT01296243|Progressive, metastatic castration-resistant prostate cancer|progressive, metastatic castration-resistant prostate cancer
433487|NCT01296217|Patients with infiltrant prostatic carcinoma|patients with infiltrant prostatic carcinoma
433488|NCT01296165|Travel|travel
433489|NCT01296165|Spread|spread
433490|NCT01296165|Antibiotic resistance|antibiotic resistance
433491|NCT01296139|Non-Cutaneous Malignancy|non-cutaneous malignancy
433492|NCT01296139|Prostatectomy|prostatectomy
433493|NCT01296139|Metastatic Prostate Cancer|metastatic prostate cancer
433494|NCT01296139|Imaging Study|imaging study
433495|NCT01296139|Magnetic Resonance Imaging|magnetic resonance imaging
433496|NCT01296139|Prostate Cancer|prostate cancer
433497|NCT01296126|Post Traumatic Stress Disorder (PTSD)|post traumatic stress disorder (ptsd)
433498|NCT01296126|MRI|mri
433499|NCT01296126|TBI|tbi
433500|NCT01296126|Traumatic Brain Injury|traumatic brain injury
433501|NCT01296126|Post Traumatic Stress Disorder|post traumatic stress disorder
433502|NCT01296126|PTSD|ptsd
433503|NCT01296100|impaired glucose tolerance|impaired glucose tolerance
433504|NCT01296100|nutrition|nutrition
433505|NCT01296100|physical activity|physical activity
433506|NCT01296087|Asthma|asthma
433507|NCT01296087|Mild to Moderate Asthma|mild to moderate asthma
433508|NCT01296074|monocyte|monocyte
433509|NCT01296074|cardiopulmonary bypass|cardiopulmonary bypass
433510|NCT01296074|cardiac surgery|cardiac surgery
433511|NCT01296061|Dialysis|dialysis
433512|NCT01296061|Renal Transplantation|renal transplantation
433513|NCT01296061|Failure of allograft|failure of allograft
433514|NCT01296048|weight|weight
433515|NCT01296048|body fat|body fat
433516|NCT01296048|total body water|total body water
433517|NCT01296048|bone mass|bone mass
433518|NCT01296048|muscle mass|muscle mass
433519|NCT01296035|recurrent ovarian cancer|recurrent ovarian cancer
433520|NCT01296035|platinum-refractory ovarian cancer|platinum-refractory ovarian cancer
433521|NCT01296022|Heart rhythm disturbances|heart rhythm disturbances
433522|NCT01296022|Implantable cardiac defibrillator|implantable cardiac defibrillator
433523|NCT01296009|embryonic implantation|embryonic implantation
433524|NCT01296009|endometrial receptivity|endometrial receptivity
433525|NCT01296009|traditional Chinese medicines|traditional chinese medicines
433526|NCT01296009|in vitro fertilization-embryo transfer|in vitro fertilization-embryo transfer
433527|NCT01296009|pregnant rate|pregnant rate
433528|NCT01295970|Surgery of the brain|surgery of the brain
433529|NCT01295970|Radiosurgery|radiosurgery
433530|NCT01295970|Brain Metastasis|brain metastasis
433531|NCT01295944|Chemotherapy|chemotherapy
433532|NCT01295944|Brain Tumor|brain tumor
433533|NCT01295944|Spinal Cord Tumor|spinal cord tumor
433534|NCT01295944|Malignancy|malignancy
433535|NCT01295944|Neurologic|neurologic
433536|NCT01295931|Near-infrared|near-infrared
433537|NCT01295931|NIR|nir
433538|NCT01295931|Indocyanine green|indocyanine green
433539|NCT01295931|ICG|icg
433540|NCT01295931|Melanoma|melanoma
433541|NCT01295931|Fluorescent dyes|fluorescent dyes
433542|NCT01295931|Lymph nodes|lymph nodes
433543|NCT01295931|Experimental camera|experimental camera
433544|NCT01295918|probiotic|probiotic
433545|NCT01295918|AAD|aad
433546|NCT01295918|Lactobacillus reuteri|lactobacillus reuteri
433547|NCT01295918|diarrhea|diarrhea
433549|NCT01295892|obesity|obesity
433550|NCT01295892|capillary|capillary
433551|NCT01295892|microcirculation|microcirculation
433552|NCT01295892|estrogen|estrogen
433553|NCT01295892|Microvascular Function|microvascular function
433554|NCT01295879|Vitamin D insufficiency|vitamin d insufficiency
433555|NCT01295866|chronic nasal inflammation|chronic nasal inflammation
433556|NCT01295866|nasal nitric oxide|nasal nitric oxide
433557|NCT01295866|atopy|atopy
433558|NCT01295827|Melanoma|melanoma
433559|NCT01295827|Carcinoma|carcinoma
433560|NCT01295827|Cancer|cancer
433561|NCT01295827|Advanced cancer|advanced cancer
433562|NCT01295827|Metastatic cancer|metastatic cancer
433563|NCT01295827|Metastatic melanoma|metastatic melanoma
433564|NCT01295827|PD-1|pd-1
433565|NCT01295827|PD1|pd1
433566|NCT01295814|Interstitial cystitis|interstitial cystitis
433567|NCT01295814|Humira|humira
433568|NCT01295814|Adalimumab|adalimumab
433569|NCT01295801|Linezolid|linezolid
433570|NCT01295801|Vitamin B6|vitamin b6
433571|NCT01295801|Linezolid-associated cytopenias|linezolid-associated cytopenias
433572|NCT01295775|diabetic retinopathy|diabetic retinopathy
433573|NCT01295775|sulodexide|sulodexide
433574|NCT01295775|hard exudates|hard exudates
433575|NCT01295775|microaneurysms|microaneurysms
433576|NCT01295775|hemorrhages|hemorrhages
433577|NCT01295775|intraretinal microvascular abnormalities|intraretinal microvascular abnormalities
433578|NCT01295762|Children|children
433579|NCT01295762|Cancer|cancer
433580|NCT01295762|Immunomonitoring|immunomonitoring
433581|NCT01295762|Prognostic/Predictive Factors|prognostic/predictive factors
433582|NCT01295762|Immunotherapy|immunotherapy
433583|NCT01295749|cardiac arrest|cardiac arrest
433584|NCT01295749|No Flow|no flow
433585|NCT01295749|Emergency|emergency
433586|NCT01295749|Nurse|nurse
433587|NCT01295749|laryngeal Tube|laryngeal tube
433588|NCT01295736|scleroderma|scleroderma
433589|NCT01295736|digital|digital
433590|NCT01295736|ulcer|ulcer
433591|NCT01295723|Breast cancer|breast cancer
433592|NCT01295723|Radiation therapy|radiation therapy
433593|NCT01295723|Mobetron|mobetron
433594|NCT01295723|IOERT|ioert
433595|NCT01295723|IORT|iort
433596|NCT01295723|Hypofractionated radiation therapy|hypofractionated radiation therapy
433597|NCT01295723|Partial breast radiation|partial breast radiation
433598|NCT01295710|adult acute myeloid leukemia|adult acute myeloid leukemia
433599|NCT01295710|adult acute lymphoid leukemia|adult acute lymphoid leukemia
433600|NCT01295710|adult myelodysplastic syndrome|adult myelodysplastic syndrome
433601|NCT01295710|allogenic stem cell transplantation|allogenic stem cell transplantation
433602|NCT01295710|unrelated donor|unrelated donor
433603|NCT01295710|GVHD|gvhd
433604|NCT01295710|US-ATG-F (Anti-human-T-lymphocyte Immune Globulin, Rabbit)|us-atg-f (anti-human-t-lymphocyte immune globulin, rabbit)
433605|NCT01295697|Patients with non-CNS or CNS tumors|patients with non-cns or cns tumors
433606|NCT01295697|Pediatric patients with Relapsed/Refractory Solid Tumors|pediatric patients with relapsed/refractory solid tumors
433607|NCT01295684|cranberry|cranberry
433608|NCT01295684|cardiovascular|cardiovascular
433609|NCT01295684|adhesion|adhesion
433610|NCT01295684|polyphenol|polyphenol
433611|NCT01295658|cancer|cancer
433612|NCT01295658|cancer survivorship|cancer survivorship
433613|NCT01295658|psychosocial needs|psychosocial needs
433614|NCT01295658|cancer experience|cancer experience
433615|NCT01295658|metastatic breast cancer|metastatic breast cancer
433616|NCT01295658|breast cancer|breast cancer
433617|NCT01295658|caregiver|caregiver
433618|NCT01295645|Stem Cell Transplant|stem cell transplant
433619|NCT01295645|Hemorrhagic Cystitis|hemorrhagic cystitis
433620|NCT01295645|Bladder inflammation|bladder inflammation
433621|NCT01295645|Frequent urination|frequent urination
433622|NCT01295645|Pain|pain
433623|NCT01295645|Polyomavirus hominis type I|polyomavirus hominis type i
433624|NCT01295645|BK virus|bk virus
433625|NCT01295645|BKV|bkv
433626|NCT01295645|Cidofovir|cidofovir
433627|NCT01295645|Vistide|vistide
433628|NCT01295632|Recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
433629|NCT01295632|Hormone resistant prostate cancer|hormone resistant prostate cancer
433630|NCT01295632|Relapsed ovarian carcinoma|relapsed ovarian carcinoma
433631|NCT01295632|Refractory ovarian carcinoma|refractory ovarian carcinoma
433632|NCT01295632|Refractory breast cancer|refractory breast cancer
433633|NCT01295632|Relapsed breast cancer|relapsed breast cancer
433634|NCT01295619|Dura|dura
433635|NCT01295619|Sealant|sealant
433636|NCT01295619|Cranial|cranial
433637|NCT01295619|Craniotomy|craniotomy
433638|NCT01295619|CSF leakage|csf leakage
433639|NCT01295619|CSF leakage following cranial surgery|csf leakage following cranial surgery
433640|NCT01295606|cefazolin|cefazolin
433641|NCT01295606|prophylaxis|prophylaxis
433642|NCT01295606|pharmacokinetics|pharmacokinetics
433643|NCT01295606|newborn|newborn
433644|NCT01295593|CLL previously treated|cll previously treated
433645|NCT01295567|ischemia reperfusion injury|ischemia reperfusion injury
433646|NCT01295567|CABG|cabg
433647|NCT01295567|dipyridamole|dipyridamole
433648|NCT01295567|HS-troponin-I|hs-troponin-i
433649|NCT01295554|Peripheral arterial disease, MRA|peripheral arterial disease, mra
433650|NCT01295541|ICU LOS|icu los
433651|NCT01295541|Progressive Mobility|progressive mobility
433652|NCT01295541|Deconditioning|deconditioning
433653|NCT01295528|blood pressure|blood pressure
433654|NCT01295528|heart rate|heart rate
433655|NCT01295515|HIV|hiv
433656|NCT01295515|Replication|replication
433657|NCT01295515|Antiretroviral|antiretroviral
433658|NCT01295515|Interferon|interferon
433659|NCT01295515|Reservoirs|reservoirs
433660|NCT01295476|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
433661|NCT01295476|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
433662|NCT01295476|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
433663|NCT01295476|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
433664|NCT01295476|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
433665|NCT01295476|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
433666|NCT01295463|sexual dysfunction|sexual dysfunction
433667|NCT01295463|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
433668|NCT01295463|infertility|infertility
433669|NCT01295463|colon cancer|colon cancer
433670|NCT01295463|male breast cancer|male breast cancer
433671|NCT01295463|breast cancer|breast cancer
433672|NCT01295463|germ cell tumor|germ cell tumor
433673|NCT01295463|ovarian sarcoma|ovarian sarcoma
433674|NCT01295463|uterine sarcoma|uterine sarcoma
433675|NCT01295463|chronic lymphocytic leukemia|chronic lymphocytic leukemia
433676|NCT01295463|osteosarcoma|osteosarcoma
433677|NCT01295463|chronic myelogenous leukemia|chronic myelogenous leukemia
433678|NCT01295463|non-Hodgkin lymphoma|non-hodgkin lymphoma
433679|NCT01295463|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
433680|NCT01295463|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
433681|NCT01295463|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
433682|NCT01295463|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
433683|NCT01295463|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
433684|NCT01295463|mast cell leukemia|mast cell leukemia
433685|NCT01295463|hairy cell leukemia|hairy cell leukemia
433686|NCT01295463|prolymphocytic leukemia|prolymphocytic leukemia
433687|NCT01295463|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
433688|NCT01295463|adult acute myeloid leukemia|adult acute myeloid leukemia
433689|NCT01295463|adult Hodgkin lymphoma|adult hodgkin lymphoma
433690|NCT01295463|adult T-cell leukemia/lymphoma|adult t-cell leukemia/lymphoma
433691|NCT01295463|small intestine lymphoma|small intestine lymphoma
433692|NCT01295463|anaplastic large cell lymphoma|anaplastic large cell lymphoma
433693|NCT01295463|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
433694|NCT01295463|mycosis fungoides/Sezary syndrome|mycosis fungoides/sezary syndrome
433695|NCT01295463|intraocular lymphoma|intraocular lymphoma
433696|NCT01295463|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
433697|NCT01295463|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
433698|NCT01295463|noncutaneous extranodal lymphoma|noncutaneous extranodal lymphoma
433699|NCT01295463|secondary acute myeloid leukemia|secondary acute myeloid leukemia
433700|NCT01295463|acute undifferentiated leukemia|acute undifferentiated leukemia
433701|NCT01295463|central nervous system leukemia|central nervous system leukemia
433702|NCT01295463|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
433703|NCT01295463|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
433704|NCT01295463|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
433705|NCT01295463|Kaposi sarcoma|kaposi sarcoma
433706|NCT01295463|adult soft tissue sarcoma|adult soft tissue sarcoma
433707|NCT01295463|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
433708|NCT01295463|secondary central nervous system Hodgkin lymphoma|secondary central nervous system hodgkin lymphoma
433709|NCT01295463|cutaneous lymphoma|cutaneous lymphoma
433710|NCT01295463|adult non-Hodgkin lymphoma|adult non-hodgkin lymphoma
433711|NCT01295450|Phase III|phase iii
433712|NCT01295450|Apevinat BC|apevinat bc
433713|NCT01295450|Lack of appetite|lack of appetite
433714|NCT01295437|inguinal hernia, Lichtenstein hernioplasty, chronic pain|inguinal hernia, lichtenstein hernioplasty, chronic pain
433715|NCT01295424|Cardiac Arrest|cardiac arrest
433716|NCT01295424|Intensive Care Unit|intensive care unit
433717|NCT01295424|Emergency Medical Service|emergency medical service
433718|NCT01295385|type 2 diabetes|type 2 diabetes
433719|NCT01295385|Cardiovascular diseases|cardiovascular diseases
433720|NCT01295385|coronary syndrome have abnormalities of glucidic metabolism|coronary syndrome have abnormalities of glucidic metabolism
433721|NCT01295372|Schizophrenia|schizophrenia
433722|NCT01295372|Antipsychotic|antipsychotic
433723|NCT01295372|Risperidone|risperidone
433724|NCT01295372|Lu 31-130|lu 31-130
433725|NCT01295359|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
433726|NCT01295359|Walking|walking
433727|NCT01295359|Hospital|hospital
433728|NCT01295359|Exercise Tolerance|exercise tolerance
433729|NCT01295359|Physical Therapy|physical therapy
433730|NCT01295320|Herpes Zoster|herpes zoster
433731|NCT01295320|vaccine|vaccine
433732|NCT01295320|safety|safety
433733|NCT01295320|immunogenicity|immunogenicity
433734|NCT01295307|acute myeloid leukemia|acute myeloid leukemia
433735|NCT01295307|relapsed|relapsed
433736|NCT01295307|refractory|refractory
433737|NCT01295307|Relapsed or refractory AML|relapsed or refractory aml
433738|NCT01295294|Uterine Hemorrhage|uterine hemorrhage
433739|NCT01295294|Contraception|contraception
433740|NCT01295294|Contraceptive Methods|contraceptive methods
433741|NCT01295294|Intrauterine devices|intrauterine devices
433742|NCT01295294|Mirena|mirena
433743|NCT01295268|Vulvar pain|vulvar pain
433744|NCT01295268|Vulvodynia|vulvodynia
433745|NCT01295268|Vestibulodynia|vestibulodynia
433746|NCT01295268|Vulvar vestibulitis|vulvar vestibulitis
433747|NCT01295255|Allergic rhinitis|allergic rhinitis
433748|NCT01295255|Psychological status|psychological status
433749|NCT01295255|Asthma|asthma
433750|NCT01295255|Aeroallergen|aeroallergen
433751|NCT01295242|HPV|hpv
433752|NCT01295242|Cervical Cancer|cervical cancer
433753|NCT01295216|prehypertension|prehypertension
433754|NCT01295216|blood pressure|blood pressure
433755|NCT01295216|mobile technology|mobile technology
433756|NCT01295216|Latin America|latin america
433757|NCT01295216|behavioral change|behavioral change
433758|NCT01295216|healthy lifestyles|healthy lifestyles
433759|NCT01295216|mHealth|mhealth
433760|NCT01295177|wound healing|wound healing
433761|NCT01295177|diabetes mellitus|diabetes mellitus
433762|NCT01295164|keratoconus, wave-front sensing technology, aberrometer|keratoconus, wave-front sensing technology, aberrometer
433763|NCT01295138|Constipation|constipation
433764|NCT01295138|Caesarean section|caesarean section
433765|NCT01295138|Abdominal Pain|abdominal pain
433766|NCT01295138|Nausea|nausea
433767|NCT01295138|Vomiting|vomiting
433768|NCT01295125|Infected ventral hernia|infected ventral hernia
433769|NCT01295125|Contaminated incisional hernia|contaminated incisional hernia
433770|NCT01295099|scar formation|scar formation
433771|NCT01295099|5-FU|5-fu
433772|NCT01295099|genetic link|genetic link
433773|NCT01295099|psychological impact|psychological impact
433774|NCT01295099|social impact|social impact
433775|NCT01295086|Adenocarcinoma of the gastro-esophageal|adenocarcinoma of the gastro-esophageal
433776|NCT01295086|Her2|her2
433777|NCT01295086|Dose finding|dose finding
433778|NCT01295086|Taxotere (Docetaxel)|taxotere (docetaxel)
433779|NCT01295086|Eloxatin (Oxaliplatin)|eloxatin (oxaliplatin)
433780|NCT01295086|Xeloda (Capecitabine)|xeloda (capecitabine)
433781|NCT01295086|Herceptin (Trastuzumab)|herceptin (trastuzumab)
433782|NCT01295073|Trientine|trientine
433783|NCT01295073|Cataract surgery|cataract surgery
433784|NCT01295073|Macular Edema|macular edema
433785|NCT01295060|Acromegaly|acromegaly
433786|NCT01295060|Octreotide|octreotide
433787|NCT01295060|IGF-1|igf-1
433788|NCT01295060|Growth Hormone|growth hormone
433789|NCT01295060|Implant|implant
433790|NCT01295060|Hydrogel|hydrogel
433791|NCT01295047|Marfan Syndrome|marfan syndrome
433792|NCT01295047|Large arterial function|large arterial function
433793|NCT01295047|LV function|lv function
433794|NCT01295047|atenolol|atenolol
433795|NCT01295047|perindopril|perindopril
433796|NCT01295047|verapamil|verapamil
433797|NCT01295047|central arterial pressure|central arterial pressure
433798|NCT01295034|HIV|hiv
433799|NCT01295034|combination antiretroviral therapy|combination antiretroviral therapy
433800|NCT01295034|vitamin D|vitamin d
433801|NCT01295034|low bone density|low bone density
433802|NCT01295021|The prevalence of sympathetic overactivity in hypertensive patients.|the prevalence of sympathetic overactivity in hypertensive patients.
433803|NCT01295008|Fabry disease|fabry disease
433804|NCT01295008|Male pattern baldness|male pattern baldness
433805|NCT01295008|Alopecia|alopecia
433806|NCT01295008|GLA gene mutation|gla gene mutation
433807|NCT01295008|Alpha-galactosidase A|alpha-galactosidase a
433808|NCT01294995|short term consumption|short term consumption
433809|NCT01294995|Chinese liquor|chinese liquor
433810|NCT01294995|serum lipids|serum lipids
433811|NCT01294995|uric acid|uric acid
433812|NCT01294995|inflammation biomarkers|inflammation biomarkers
433813|NCT01294982|OAB|oab
433814|NCT01294982|Over Active Bladder|over active bladder
433815|NCT01294982|overactive bladder|overactive bladder
433816|NCT01294982|Urinary Urge Incontinence|urinary urge incontinence
433817|NCT01294982|Urinary Incontinence|urinary incontinence
433818|NCT01294969|Allergic conjunctivitis|allergic conjunctivitis
433819|NCT01294956|Dry eye|dry eye
433820|NCT01294956|artificial tears|artificial tears
433821|NCT01294956|corneal staining|corneal staining
433822|NCT01294943|Intensive Care Units|intensive care units
433823|NCT01294943|Biofilms|biofilms
433824|NCT01294943|Tongue|tongue
433825|NCT01294943|Infection|infection
433826|NCT01294943|Pneumonia/Aspiration|pneumonia/aspiration
433827|NCT01294930|hip fracture|hip fracture
433828|NCT01294930|mortality|mortality
433829|NCT01294930|complications|complications
433830|NCT01294904|Hormone|hormone
433831|NCT01294904|Sperm|sperm
433832|NCT01294904|Chronic kidney disease|chronic kidney disease
433833|NCT01294891|Rheology|rheology
433834|NCT01294891|Sickle cell|sickle cell
433835|NCT01294891|Paroxysmal nocturnal hemoglobinuria|paroxysmal nocturnal hemoglobinuria
433836|NCT01294891|contrast ultrasound|contrast ultrasound
433837|NCT01294878|anti-IgE treatment|anti-ige treatment
433838|NCT01294878|interstitial cystitis/bladder pain syndrome|interstitial cystitis/bladder pain syndrome
433839|NCT01294878|omalizumab|omalizumab
433840|NCT01294865|Sepsis|sepsis
433841|NCT01294865|late-onset|late-onset
433842|NCT01294865|suPAR|supar
433843|NCT01294852|prophylactic|prophylactic
433844|NCT01294852|surfactant|surfactant
433845|NCT01294852|premature|premature
433846|NCT01294852|mechanical ventilation|mechanical ventilation
433847|NCT01294852|mortality|mortality
433848|NCT01294852|morbidities|morbidities
433849|NCT01294839|sinus-node dysfunction|sinus-node dysfunction
433850|NCT01294839|RVOTs pacing|rvots pacing
433851|NCT01294839|RVA pacing|rva pacing
433852|NCT01294826|Colorectal Neoplasms|colorectal neoplasms
433853|NCT01294826|Intestinal Neoplasms|intestinal neoplasms
433854|NCT01294826|Gastrointestinal Neoplasms|gastrointestinal neoplasms
433855|NCT01294826|Digestive System Neoplasms|digestive system neoplasms
433856|NCT01294826|Neoplasms by Site|neoplasms by site
433857|NCT01294826|Neoplasms|neoplasms
433858|NCT01294826|Digestive System Diseases|digestive system diseases
433859|NCT01294826|Gastrointestinal Diseases|gastrointestinal diseases
433860|NCT01294826|Colonic Diseases|colonic diseases
433861|NCT01294826|Intestinal Diseases|intestinal diseases
433862|NCT01294826|Rectal Diseases|rectal diseases
433863|NCT01294826|Cetuximab|cetuximab
433864|NCT01294826|HSP90 Heat-Shock Proteins|hsp90 heat-shock proteins
433865|NCT01294826|EGFR protein, human|egfr protein, human
433866|NCT01294813|Electric Impedance Tomography (EIT)|electric impedance tomography (eit)
433867|NCT01294813|Ventilation|ventilation
433868|NCT01294813|Bronchoscopy|bronchoscopy
433869|NCT01294813|Lung Impedance|lung impedance
433870|NCT01294813|Recruitment|recruitment
433871|NCT01294800|Parkinson's disease|parkinson's disease
433872|NCT01294787|COPD|copd
433873|NCT01294787|QVA149|qva149
433874|NCT01294787|tiotropium|tiotropium
433875|NCT01294787|exercise|exercise
433876|NCT01294787|exercise tolerance|exercise tolerance
433877|NCT01294787|combination bronchodilator|combination bronchodilator
433878|NCT01294787|moderate to severe COPD|moderate to severe copd
433879|NCT01294774|Lupus erythematosus|lupus erythematosus
433880|NCT01294774|skin lupus|skin lupus
433881|NCT01294761|HIV-1|hiv-1
433882|NCT01294761|AIDS|aids
433883|NCT01294761|Clinical Trials, Randomized|clinical trials, randomized
433884|NCT01294748|Coronary Artery Disease|coronary artery disease
433885|NCT01294748|Drug-eluting Stent|drug-eluting stent
433886|NCT01294748|Sirolimus|sirolimus
433887|NCT01294735|Temozolomide|temozolomide
433888|NCT01294735|glioblastoma multiforme|glioblastoma multiforme
433889|NCT01294735|melanoma|melanoma
433890|NCT01294735|advanced neoplasm|advanced neoplasm
433891|NCT01294722|Rheumatoid Arthritis|rheumatoid arthritis
433892|NCT01294722|anti-TNF α|anti-tnf α
433893|NCT01294709|angina pectoris|angina pectoris
433894|NCT01294709|coronary artery disease|coronary artery disease
433895|NCT01294709|calcitonin gene-related peptide|calcitonin gene-related peptide
433896|NCT01294709|exercise tolerance,|exercise tolerance,
433897|NCT01294696|Osteoarthritis|osteoarthritis
433898|NCT01294696|Standard of care|standard of care
433899|NCT01294683|Low-density lipoprotein|low-density lipoprotein
433900|NCT01294683|LDL|ldl
433901|NCT01294683|High-density lipoprotein|high-density lipoprotein
433902|NCT01294683|HDL|hdl
433903|NCT01294683|Niacin|niacin
433904|NCT01294683|Lipid modifying therapy|lipid modifying therapy
433905|NCT01294683|Cholesterol|cholesterol
433906|NCT01294683|High cholesterol|high cholesterol
433907|NCT01294683|Triglycerides|triglycerides
433908|NCT01294683|Mixed Dyslipidemia|mixed dyslipidemia
433909|NCT01294670|ETOPOSIDE (VP-16)|etoposide (vp-16)
433910|NCT01294670|SAHA (SUBEROYLANILIDE HYDROXAMIC ACID) (Vorinostat)|saha (suberoylanilide hydroxamic acid) (vorinostat)
433911|NCT01294670|Pediatric|pediatric
433912|NCT01294670|10-096|10-096
433913|NCT01294670|POETIC|poetic
433914|NCT01294670|phase II component: the population will be restricted to relapsed/refractory sarcomas.|phase ii component: the population will be restricted to relapsed/refractory sarcomas.
433915|NCT01294657|Obesity|obesity
433916|NCT01294657|Cancer Risk|cancer risk
433917|NCT01294657|African Americans|african americans
433918|NCT01294657|Diet|diet
433919|NCT01294657|Physical Activity|physical activity
433920|NCT01294631|Canagliflozin|canagliflozin
433921|NCT01294631|JNJ-28431754|jnj-28431754
433922|NCT01294631|Hydrochlorothiazide|hydrochlorothiazide
433923|NCT01294631|Pharmacokinetic|pharmacokinetic
433924|NCT01294631|Pharmacodynamic|pharmacodynamic
433925|NCT01294618|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
433926|NCT01294618|nilotinib|nilotinib
433927|NCT01294618|pegylated interferon|pegylated interferon
433928|NCT01294618|BCR-ABL Philadelphia chromosome|bcr-abl philadelphia chromosome
434025|NCT01294215|14024|14024
434026|NCT01294202|GIST|gist
433929|NCT01294618|Hematologic, cytogenetic and molecular response rates and kinetics will be studied in addition to the safety of the combination|hematologic, cytogenetic and molecular response rates and kinetics will be studied in addition to the safety of the combination
433930|NCT01294605|DTPa|dtpa
433931|NCT01294605|Td|td
433932|NCT01294605|IPV|ipv
433933|NCT01294579|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
433934|NCT01294579|Ofatumumab|ofatumumab
433935|NCT01294579|Relapsed|relapsed
433936|NCT01294579|Rituximab|rituximab
433937|NCT01294579|Bendamustine|bendamustine
433938|NCT01294566|safety|safety
433939|NCT01294566|motilin agonist|motilin agonist
433940|NCT01294566|single dose|single dose
433941|NCT01294566|ascending dose|ascending dose
433942|NCT01294566|GSK1322888|gsk1322888
433943|NCT01294566|migrating motor complex|migrating motor complex
433944|NCT01294566|tolerability|tolerability
433945|NCT01294566|FTIH|ftih
433946|NCT01294566|gastric emptying|gastric emptying
433947|NCT01294527|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
433948|NCT01294527|cardiac pacing|cardiac pacing
433949|NCT01294527|electrical stimulation|electrical stimulation
433950|NCT01294527|bi-ventricular pacing|bi-ventricular pacing
433951|NCT01294514|Respiratory Rate|respiratory rate
433952|NCT01294501|Medication administration|medication administration
433953|NCT01294501|Medication errors|medication errors
433954|NCT01294501|Health Literacy|health literacy
433955|NCT01294501|Pediatric Emergency Department|pediatric emergency department
433956|NCT01294501|Web-based education|web-based education
433957|NCT01294488|PCIT|pcit
433958|NCT01294488|Child Maltreatment Prevention|child maltreatment prevention
433959|NCT01294488|Practitioner Fidelity|practitioner fidelity
433960|NCT01294462|acute coronary syndrome|acute coronary syndrome
433961|NCT01294462|coronary disease|coronary disease
433962|NCT01294462|coronary artery disease|coronary artery disease
433963|NCT01294436|Phase3|phase3
433964|NCT01294436|Clinical trial|clinical trial
433965|NCT01294436|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
433966|NCT01294423|Phase3|phase3
433967|NCT01294423|Clinical trial|clinical trial
433968|NCT01294423|Type2 Diabetes Mellitus|type2 diabetes mellitus
433969|NCT01294397|Amgen|amgen
433970|NCT01294397|Phase 1|phase 1
433971|NCT01294397|Postmenopausal|postmenopausal
433972|NCT01294397|Osteopenia|osteopenia
433973|NCT01294397|Rheumatoid|rheumatoid
433974|NCT01294397|Bone Mineral Density|bone mineral density
433975|NCT01294397|Arthritis|arthritis
433976|NCT01294397|Pharmacokinetics|pharmacokinetics
433977|NCT01294397|Osteoporosis|osteoporosis
433978|NCT01294371|Lucrin Depot|lucrin depot
433979|NCT01294371|genital endometriosis|genital endometriosis
433980|NCT01294371|6 months therapy|6 months therapy
433981|NCT01294358|Pancreatic Cancer|pancreatic cancer
433982|NCT01294358|Regional Therapy|regional therapy
433983|NCT01294358|Selective Arterial Infusion|selective arterial infusion
433984|NCT01294358|Locally Advanced Disease|locally advanced disease
433985|NCT01294345|Birth Defects|birth defects
433986|NCT01294345|Genomics|genomics
433987|NCT01294345|Congenital Malformations|congenital malformations
433988|NCT01294332|Cognition|cognition
433989|NCT01294332|TBI|tbi
433990|NCT01294332|Mood|mood
433991|NCT01294332|Aerobic Exercise Training|aerobic exercise training
433992|NCT01294332|Cardiorespiratory Fitness|cardiorespiratory fitness
433993|NCT01294332|Traumatic Brain Injury|traumatic brain injury
433994|NCT01294319|Cortical Resistance|cortical resistance
433995|NCT01294319|ACTH|acth
433996|NCT01294319|Glucocorticoid|glucocorticoid
433997|NCT01294319|Mifepristone|mifepristone
433998|NCT01294319|SPIRONOLACTONE|spironolactone
433999|NCT01294319|Exercise|exercise
434000|NCT01294319|Hypothalamic-Pituitary-Adrenal Axis|hypothalamic-pituitary-adrenal axis
434001|NCT01294319|Healthy Volunteer|healthy volunteer
434002|NCT01294319|HV|hv
434003|NCT01294280|Stage I Non-Small Cell Lung Cancer|stage i non-small cell lung cancer
434004|NCT01294280|Stage II Non-Small Cell Lung Cancer|stage ii non-small cell lung cancer
434005|NCT01294267|Ventricular Tachycardia|ventricular tachycardia
434006|NCT01294267|Radio Frequency Ablation|radio frequency ablation
434007|NCT01294267|Percutaneous Left Ventricular Assist Device|percutaneous left ventricular assist device
434008|NCT01294267|Hemodynamic Management|hemodynamic management
434009|NCT01294267|Interventional Cardiac Procedure|interventional cardiac procedure
434010|NCT01294267|Mechanical Cardiac Assistance|mechanical cardiac assistance
434011|NCT01294267|Intra-Aortic Balloon Pump|intra-aortic balloon pump
434012|NCT01294267|Coronary Intervention|coronary intervention
434013|NCT01294267|Impella 2.5|impella 2.5
434014|NCT01294267|Circulation Support system|circulation support system
434015|NCT01294254|wound reepithelialization|wound reepithelialization
434016|NCT01294241|Epidermolysis bullosa|epidermolysis bullosa
434017|NCT01294241|Wound healing|wound healing
434018|NCT01294241|Epithelialization|epithelialization
434019|NCT01294215|BAYA1040|baya1040
434020|NCT01294215|Nifedipine|nifedipine
434021|NCT01294215|Essential hypertension|essential hypertension
434022|NCT01294215|Japanese Patients|japanese patients
434023|NCT01294215|Phase III|phase iii
434024|NCT01294215|combination study|combination study
434027|NCT01294202|Gastrointestinal Stromal Tumor|gastrointestinal stromal tumor
434028|NCT01294202|unresectable|unresectable
434029|NCT01294202|metastatic|metastatic
434030|NCT01294202|AT13387|at13387
434031|NCT01294202|Astex|astex
434032|NCT01294202|Gleevec|gleevec
434033|NCT01294202|Imatinib|imatinib
434034|NCT01294189|end-of-life decisions, critical care, advance directive|end-of-life decisions, critical care, advance directive
434035|NCT01294176|Optic Neuritis|optic neuritis
434036|NCT01294176|Lipoic Acid|lipoic acid
434037|NCT01294176|Multiple Sclerosis|multiple sclerosis
434038|NCT01294176|Antioxidant|antioxidant
434039|NCT01294176|OCT|oct
434040|NCT01294176|Acute|acute
434041|NCT01294163|Xenon|xenon
434042|NCT01294163|Sevoflurane|sevoflurane
434043|NCT01294163|Propofol|propofol
434044|NCT01294163|Total intravenous anaesthesia|total intravenous anaesthesia
434045|NCT01294163|Anaesthesia|anaesthesia
434046|NCT01294163|Coronary artery disease|coronary artery disease
434047|NCT01294163|Coronary artery bypass graft|coronary artery bypass graft
434048|NCT01294137|frail|frail
434049|NCT01294137|elderly|elderly
434050|NCT01294137|hospitalized|hospitalized
434051|NCT01294137|sleep apnea|sleep apnea
434052|NCT01294137|oximetry|oximetry
434053|NCT01294111|Fatigue|fatigue
434054|NCT01294111|Quality of life|quality of life
434055|NCT01294111|Elderly|elderly
434056|NCT01294098|Femoral Fractures|femoral fractures
434057|NCT01294098|Pediatrics|pediatrics
434058|NCT01294098|Pain, Postoperative|pain, postoperative
434059|NCT01294072|curcumin|curcumin
434060|NCT01294072|plant exosomes|plant exosomes
434061|NCT01294072|malignant colon tissue|malignant colon tissue
434062|NCT01294059|Fibromyalgia|fibromyalgia
434063|NCT01294059|Hyperalgesia|hyperalgesia
434064|NCT01294059|Pain|pain
434065|NCT01294059|Central Sensitization|central sensitization
434066|NCT01294046|Episodic migraine headache|episodic migraine headache
434067|NCT01294020|Transplant|transplant
434068|NCT01294020|Liver|liver
434069|NCT01294020|Tacrolimus|tacrolimus
434070|NCT01294020|Kidney|kidney
434071|NCT01294020|Heart|heart
434072|NCT01294020|Lung|lung
434073|NCT01294020|Immunosuppression|immunosuppression
434074|NCT01294020|Advagraf|advagraf
434075|NCT01294020|Pharmacokinetics|pharmacokinetics
434076|NCT01293994|Chronic Pain, Genetic Variation, Opioid Medications, Pain|chronic pain, genetic variation, opioid medications, pain
434077|NCT01293968|Aphthous Stomatitis|aphthous stomatitis
434078|NCT01293968|Ibuprofen|ibuprofen
434079|NCT01293968|treatment efficacy|treatment efficacy
434080|NCT01293955|cartilage|cartilage
434081|NCT01293955|knee osteoarthritis|knee osteoarthritis
434082|NCT01293955|protective effect|protective effect
434083|NCT01293942|unresectable liver-only metastases in colorectal cancer|unresectable liver-only metastases in colorectal cancer
434084|NCT01293916|pediatric|pediatric
434085|NCT01293916|femur|femur
434086|NCT01293916|femoral|femoral
434087|NCT01293916|fracture|fracture
434088|NCT01293916|spica|spica
434089|NCT01293916|cast|cast
434090|NCT01293916|diaphyseal|diaphyseal
434091|NCT01293916|single|single
434092|NCT01293916|double|double
434093|NCT01293916|patient age 2 to 6 years old|patient age 2 to 6 years old
434094|NCT01293903|Immunomodulation|immunomodulation
434095|NCT01293890|adherence|adherence
434096|NCT01293890|medication|medication
434097|NCT01293890|exacerbations|exacerbations
434098|NCT01293890|hospital admission|hospital admission
434099|NCT01293877|Laparoscopy|laparoscopy
434100|NCT01293877|obesity|obesity
434101|NCT01293877|gastric|gastric
434102|NCT01293877|restrictive|restrictive
434103|NCT01293864|structural analysis, diffusible proteins, glycosaminoglycans|structural analysis, diffusible proteins, glycosaminoglycans
434104|NCT01293851|Biomarkers|biomarkers
434105|NCT01293851|Gene Expression|gene expression
434106|NCT01293851|Neuropathic Pain|neuropathic pain
434107|NCT01293851|Neurotoxicity|neurotoxicity
434108|NCT01293851|Chemotherapy|chemotherapy
434109|NCT01293851|Peripheral Neuropathic Pain|peripheral neuropathic pain
434110|NCT01293851|Cancer|cancer
434111|NCT01293838|Adolescents|adolescents
434112|NCT01293838|Anxiety Disorder|anxiety disorder
434113|NCT01293838|Cipralex|cipralex
434114|NCT01293838|Social Phobia|social phobia
434115|NCT01293838|Separation Anxiety Disorder|separation anxiety disorder
434116|NCT01293838|Panic Disorder|panic disorder
434117|NCT01293838|Generalized Anxiety Disorder|generalized anxiety disorder
434118|NCT01293838|physiological arousal|physiological arousal
434119|NCT01293838|stress response|stress response
434120|NCT01293838|salivary cortisol|salivary cortisol
434121|NCT01293838|salivary alpha-amylase|salivary alpha-amylase
434122|NCT01293838|heart rate variability|heart rate variability
434123|NCT01293799|Randomized|randomized
434124|NCT01293799|Peritoneal dialysis|peritoneal dialysis
434125|NCT01293799|Peritonitis|peritonitis
434126|NCT01293799|Primary prevention|primary prevention
434127|NCT01293799|Quality control|quality control
434128|NCT01293799|Self care|self care
434129|NCT01293799|Kidney failure, chronic|kidney failure, chronic
434130|NCT01293786|magnesium|magnesium
434331|NCT01292954|polyphenols|polyphenols
434131|NCT01293786|kidney transplantation|kidney transplantation
434132|NCT01293786|hypomagnesemia|hypomagnesemia
434133|NCT01293773|Randomized controlled trial|randomized controlled trial
434134|NCT01293773|Drug-eluting Stent|drug-eluting stent
434135|NCT01293773|Multicenter study|multicenter study
434136|NCT01293760|intrauterine device|intrauterine device
434137|NCT01293760|contraception|contraception
434138|NCT01293747|Estrogen|estrogen
434139|NCT01293747|Progesterone|progesterone
434140|NCT01293747|Microspheres|microspheres
434141|NCT01293747|Menopause|menopause
434142|NCT01293747|Pharmacokinetics|pharmacokinetics
434143|NCT01293734|bronchial asthma|bronchial asthma
434144|NCT01293734|cold type|cold type
434145|NCT01293734|heat type|heat type
434146|NCT01293734|Asthenia type|asthenia type
434147|NCT01293734|TCM syndrome|tcm syndrome
434148|NCT01293734|symptoms|symptoms
434149|NCT01293734|physical signs|physical signs
434150|NCT01293721|Bone Mineral Density|bone mineral density
434151|NCT01293721|Vibration|vibration
434152|NCT01293721|Rehabilitation|rehabilitation
434153|NCT01293721|Fracture healing rate|fracture healing rate
434154|NCT01293708|Octogenarians|octogenarians
434155|NCT01293708|HRQOL|hrqol
434156|NCT01293708|mortality|mortality
434157|NCT01293708|prospective observational|prospective observational
434158|NCT01293708|Elderly|elderly
434159|NCT01293695|hot flashes|hot flashes
434160|NCT01293695|post menopausal women|post menopausal women
434161|NCT01293695|skin conductance monitors|skin conductance monitors
434162|NCT01293695|hypnosis|hypnosis
434163|NCT01293695|hypnotizability|hypnotizability
434164|NCT01293669|Type 2 Diabetes|type 2 diabetes
434165|NCT01293669|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
434166|NCT01293604|Barley|barley
434167|NCT01293604|Oats|oats
434168|NCT01293604|Whole grains|whole grains
434169|NCT01293604|Cardiovascular disease|cardiovascular disease
434170|NCT01293604|adults not taking lipid-lowering or glucoregulatory medications.|adults not taking lipid-lowering or glucoregulatory medications.
434171|NCT01293591|Garlic|garlic
434172|NCT01293591|Cancer biomarkers|cancer biomarkers
434173|NCT01293591|Gene expression|gene expression
434174|NCT01293591|Oxidative stress|oxidative stress
434175|NCT01293591|DNA damage|dna damage
434176|NCT01293578|Decision Aids|decision aids
434177|NCT01293578|Shared Medical Decision Making|shared medical decision making
434178|NCT01293578|Patient Education|patient education
434179|NCT01293578|Endocrine System Diseases|endocrine system diseases
434180|NCT01293578|Glucose Metabolism Disorders|glucose metabolism disorders
434181|NCT01293578|Metabolic Diseases|metabolic diseases
434182|NCT01293565|X-Linked Hypohidrotic Ectodermal Dysplasia|x-linked hypohidrotic ectodermal dysplasia
434183|NCT01293565|Hypohidrotic Ectodermal Dysplasia|hypohidrotic ectodermal dysplasia
434184|NCT01293565|XLHED|xlhed
434185|NCT01293565|HED|hed
434186|NCT01293539|Retinoblastoma|retinoblastoma
434187|NCT01293539|intra-arterial chemotherapy|intra-arterial chemotherapy
434188|NCT01293539|angiography|angiography
434189|NCT01293526|Heart failure|heart failure
434190|NCT01293526|echocardiography|echocardiography
434191|NCT01293513|Only patients with Acute or Primary HIV infection will be studied|only patients with acute or primary hiv infection will be studied
434192|NCT01293500|SIRS|sirs
434193|NCT01293500|shock|shock
434194|NCT01293500|sepsis|sepsis
434195|NCT01293500|pediatric|pediatric
434196|NCT01293500|inter-facility transport|inter-facility transport
434197|NCT01293500|specialized transport|specialized transport
434198|NCT01293500|NIRS monitoring|nirs monitoring
434199|NCT01293487|Phase 1|phase 1
434200|NCT01293487|Osteopenia|osteopenia
434201|NCT01293487|RN564|rn564
434202|NCT01293448|Esophagectomy|esophagectomy
434203|NCT01293448|Barrett's Esophagus|barrett's esophagus
434204|NCT01293435|Community Acquired Pneumonia (CAP)|community acquired pneumonia (cap)
434205|NCT01293435|Complicated Skin and Skin Structures Infections (cSSSI)|complicated skin and skin structures infections (csssi)
434206|NCT01293435|Complicated Skin and Soft Tissues Infections (cSSTI)|complicated skin and soft tissues infections (cssti)
434207|NCT01293435|Antibiotics|antibiotics
434208|NCT01293435|Infection management|infection management
434209|NCT01293435|Use of Resources|use of resources
434210|NCT01293435|MRSA|mrsa
434211|NCT01293435|PRSP|prsp
434212|NCT01293422|PXR, glucose, cholesterol|pxr, glucose, cholesterol
434213|NCT01293396|insulin aspart 30|insulin aspart 30
434214|NCT01293396|insulin aspart 70|insulin aspart 70
434215|NCT01293396|insulin aspart|insulin aspart
434216|NCT01293396|postprandial glucose and lipid metabolism|postprandial glucose and lipid metabolism
434217|NCT01293396|consecutive mixed meals|consecutive mixed meals
434218|NCT01293344|Cardiovascular diseases|cardiovascular diseases
434219|NCT01293344|Controlled nutritional intervention|controlled nutritional intervention
434220|NCT01293344|Sex differences|sex differences
434221|NCT01293344|Women|women
434222|NCT01293344|Men|men
434223|NCT01293344|Cardiovascular risk|cardiovascular risk
434224|NCT01293344|Lipid profile|lipid profile
434225|NCT01293344|Blood pressure|blood pressure
434226|NCT01293344|Insulin sensitivity|insulin sensitivity
434227|NCT01293344|Inflammatory markers|inflammatory markers
434228|NCT01293344|Endothelial function|endothelial function
434229|NCT01293344|Oxidative stress|oxidative stress
434230|NCT01293331|Dengue Fever Fever Seroprevalence|dengue fever fever seroprevalence
434231|NCT01293318|Copeptin|copeptin
434232|NCT01293318|Vasopressin|vasopressin
434233|NCT01293318|antidiuretic hormone (ADH)|antidiuretic hormone (adh)
434234|NCT01293305|osteoarthritis|osteoarthritis
434235|NCT01293292|Osteoporosis|osteoporosis
434236|NCT01293292|Forsteo|forsteo
434237|NCT01293292|Teriparatide|teriparatide
434238|NCT01293279|HCV viral genotypes|hcv viral genotypes
434239|NCT01293279|host genotypes|host genotypes
434240|NCT01293279|IL28B|il28b
434241|NCT01293279|ITPA|itpa
434242|NCT01293279|RNA|rna
434243|NCT01293279|China|china
434244|NCT01293266|Propofol|propofol
434245|NCT01293266|Metabolic Acidosis|metabolic acidosis
434246|NCT01293266|Pediatric Cardiology|pediatric cardiology
434247|NCT01293266|Anesthesia|anesthesia
434248|NCT01293227|Wrist Fracture|wrist fracture
434249|NCT01293214|limb transplantation|limb transplantation
434250|NCT01293214|limb allotransplantation|limb allotransplantation
434251|NCT01293214|hand transplantation|hand transplantation
434252|NCT01293214|hand allotransplantation|hand allotransplantation
434253|NCT01293214|hand amputation|hand amputation
434254|NCT01293214|leg transplantation|leg transplantation
434255|NCT01293201|SAR|sar
434256|NCT01293201|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
434257|NCT01293188|Aortic Valve Replacement|aortic valve replacement
434258|NCT01293188|Bioprosthetic|bioprosthetic
434259|NCT01293175|whole grains|whole grains
434260|NCT01293175|polyphenols|polyphenols
434261|NCT01293175|overweight|overweight
434262|NCT01293175|bioavailability|bioavailability
434263|NCT01293175|antioxidant status|antioxidant status
434264|NCT01293175|inflammation|inflammation
434265|NCT01293162|Metabolic syndrome|metabolic syndrome
434266|NCT01293162|Cardiovascular risk|cardiovascular risk
434267|NCT01293149|knee, reconstructive surgery|knee, reconstructive surgery
434268|NCT01293149|femoral nerve block|femoral nerve block
434269|NCT01293136|knee|knee
434270|NCT01293136|reconstructive surgery|reconstructive surgery
434271|NCT01293136|femoral nerve block|femoral nerve block
434272|NCT01293123|HIV|hiv
434273|NCT01293123|raltegravir|raltegravir
434274|NCT01293123|cerebrospinal fluid|cerebrospinal fluid
434275|NCT01293110|urodynamics|urodynamics
434276|NCT01293110|neurogenic lower urinary tract dysfunction|neurogenic lower urinary tract dysfunction
434277|NCT01293110|neurological disease/injury|neurological disease/injury
434278|NCT01293084|mucociliary clearance|mucociliary clearance
434279|NCT01293084|children|children
434280|NCT01293084|cystic fibrosis|cystic fibrosis
434281|NCT01293084|hypertonic saline|hypertonic saline
434282|NCT01293071|Antibiotic rotation|antibiotic rotation
434283|NCT01293071|Cycling|cycling
434284|NCT01293071|Mixing|mixing
434285|NCT01293071|Gram-negative|gram-negative
434286|NCT01293071|EU|eu
434287|NCT01293071|Multi center|multi center
434288|NCT01293071|Multi Centre|multi centre
434289|NCT01293071|Cluster randomized trial|cluster randomized trial
434290|NCT01293071|Cross over|cross over
434291|NCT01293058|opioid|opioid
434292|NCT01293058|overdose|overdose
434293|NCT01293058|naloxone|naloxone
434294|NCT01293058|intranasal|intranasal
434295|NCT01293045|Osteoporosis|osteoporosis
434296|NCT01293045|Postmenopausal women|postmenopausal women
434297|NCT01293045|Functional food|functional food
434298|NCT01293045|Hydrolysed collagen|hydrolysed collagen
434299|NCT01293045|Bone metabolism|bone metabolism
434300|NCT01293045|Bone marker of resorption|bone marker of resorption
434301|NCT01293045|Bone marker of formation|bone marker of formation
434302|NCT01293032|Estrogen Receptor Positive|estrogen receptor positive
434303|NCT01293032|Progesterone Receptor Positive|progesterone receptor positive
434304|NCT01293032|HER2/Neu Negative|her2/neu negative
434305|NCT01293032|Breast Cancer|breast cancer
434306|NCT01293019|Complementary and alternative medicine|complementary and alternative medicine
434307|NCT01293019|Osteopathic treatment|osteopathic treatment
434308|NCT01293006|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
434309|NCT01292980|sDTI|sdti
434310|NCT01292980|Pressure ulcers|pressure ulcers
434311|NCT01292980|Therapy surfaces|therapy surfaces
434312|NCT01292980|Mattresses|mattresses
434313|NCT01292980|Deep Tissue Injury|deep tissue injury
434314|NCT01292980|pressure ulcer treatment|pressure ulcer treatment
434315|NCT01292967|Flavanol|flavanol
434316|NCT01292967|cocoa|cocoa
434317|NCT01292967|maltitol|maltitol
434318|NCT01292967|absorption|absorption
434319|NCT01292967|metabolism|metabolism
434320|NCT01292967|chocolate|chocolate
434321|NCT01292967|food matrix|food matrix
434322|NCT01292967|bioavailability|bioavailability
434323|NCT01292954|blueberries|blueberries
434324|NCT01292954|vascular function|vascular function
434325|NCT01292954|FMD|fmd
434326|NCT01292954|Blood pressure|blood pressure
434327|NCT01292954|Laser Doppler|laser doppler
434328|NCT01292954|pharmacokinetics|pharmacokinetics
434329|NCT01292954|absorption|absorption
434330|NCT01292954|metabolism|metabolism
434332|NCT01292954|flavonoids|flavonoids
434333|NCT01292928|Atherosclerosis, Superficial Femoral Artery (SFA), Proximal Popliteal Artery (PPA), lower extremities, Stenting|atherosclerosis, superficial femoral artery (sfa), proximal popliteal artery (ppa), lower extremities, stenting
434334|NCT01292915|Re-bleeding, NVUGIB|re-bleeding, nvugib
434335|NCT01292889|Seasonal Affective Disorder|seasonal affective disorder
434336|NCT01292889|Major Depressive Disorder|major depressive disorder
434337|NCT01292889|Depression|depression
434338|NCT01292889|Winter Blues|winter blues
434339|NCT01292876|MTURR|mturr
434340|NCT01292876|ECM|ecm
434341|NCT01292876|Muscle Loss|muscle loss
434342|NCT01292876|Tendon|tendon
434343|NCT01292876|Tendon Repair|tendon repair
434344|NCT01292876|Muscle Repair|muscle repair
434345|NCT01292876|Soft Tissue Repair|soft tissue repair
434346|NCT01292876|Scaffold|scaffold
434347|NCT01292876|Extracellular Matrix|extracellular matrix
434348|NCT01292863|Peritoneal dialysis|peritoneal dialysis
434349|NCT01292863|Biocompatible dialysis fluid|biocompatible dialysis fluid
434350|NCT01292850|Topical|topical
434351|NCT01292850|Skin|skin
434352|NCT01292850|sterility|sterility
434353|NCT01292850|ethylchloride|ethylchloride
434354|NCT01292850|ethyl|ethyl
434355|NCT01292850|chloride|chloride
434356|NCT01292850|spray|spray
434357|NCT01292837|Levetiracetam|levetiracetam
434358|NCT01292837|Epilepsy|epilepsy
434359|NCT01292837|Generalized tonic-clonic seizures|generalized tonic-clonic seizures
434360|NCT01292824|Hepatitis C virus|hepatitis c virus
434361|NCT01292824|Entry|entry
434362|NCT01292824|Scavenger receptor-BI|scavenger receptor-bi
434363|NCT01292824|High density lipoprotein|high density lipoprotein
434364|NCT01292824|Liver transplantation|liver transplantation
434365|NCT01292811|Spinal Cord Injury|spinal cord injury
434366|NCT01292811|Functional Electrical Stimulation|functional electrical stimulation
434367|NCT01292811|Hand function|hand function
434368|NCT01292811|Tetraplegia|tetraplegia
434369|NCT01292798|Diabetes|diabetes
434371|NCT01292798|Edema|edema
434372|NCT01292798|Retina|retina
434373|NCT01292772|breast cancer|breast cancer
434374|NCT01292772|bilateral mastectomy|bilateral mastectomy
434375|NCT01292772|immediate breast reconstruction|immediate breast reconstruction
434376|NCT01292772|locally advanced unilateral breast cancer|locally advanced unilateral breast cancer
434377|NCT01292772|bilateral mastectomy for prophylaxis|bilateral mastectomy for prophylaxis
434378|NCT01292759|stroke volume|stroke volume
434379|NCT01292759|cardiac output|cardiac output
434380|NCT01292759|validation|validation
434381|NCT01292733|Women with increased risk for developing ovarian cancer|women with increased risk for developing ovarian cancer
434382|NCT01292733|Women diagnosed with reproductive cancer|women diagnosed with reproductive cancer
434383|NCT01292733|Women with relatives who have had ovarian or breast cancer|women with relatives who have had ovarian or breast cancer
434384|NCT01292720|vitamin D deficiency, vitamin D insufficiency, heart failure|vitamin d deficiency, vitamin d insufficiency, heart failure
434385|NCT01292707|malaria|malaria
434386|NCT01292707|rdt|rdt
434387|NCT01292707|fever|fever
434388|NCT01292707|treatment|treatment
434389|NCT01292694|supine hypertension|supine hypertension
434390|NCT01292694|autonomic failure|autonomic failure
434391|NCT01292694|angiotensin|angiotensin
434392|NCT01292694|losartan|losartan
434393|NCT01292694|captopril|captopril
434394|NCT01292681|colorectal cancer|colorectal cancer
434395|NCT01292681|FDG-PET-CT|fdg-pet-ct
434396|NCT01292681|MRS,|mrs,
434397|NCT01292681|DCE-MRI|dce-mri
434398|NCT01292681|DWI|dwi
434399|NCT01292681|colorectal cancer with histologically proven distant metastases|colorectal cancer with histologically proven distant metastases
434400|NCT01292642|cognitive behavioral therapy|cognitive behavioral therapy
434401|NCT01292642|nicotine dependence|nicotine dependence
434402|NCT01292642|cannabis dependence|cannabis dependence
434403|NCT01292642|smoking cessation|smoking cessation
434404|NCT01292642|nicotine replacement therapy|nicotine replacement therapy
434405|NCT01292629|intraocular lens|intraocular lens
434406|NCT01292629|IOL|iol
434407|NCT01292629|cataract|cataract
434408|NCT01292629|Hoya|hoya
434409|NCT01292629|surgical|surgical
434410|NCT01292629|optics|optics
434411|NCT01292629|ocular|ocular
434412|NCT01292629|visual acuity|visual acuity
434413|NCT01292577|Schizophrenia|schizophrenia
434414|NCT01292577|Schizoaffective Disorder|schizoaffective disorder
434415|NCT01292577|Cannabis|cannabis
434416|NCT01292577|Alcohol|alcohol
434417|NCT01292577|Substance Misuse|substance misuse
434418|NCT01292577|Cognition|cognition
434419|NCT01292577|Psychosocial Treatment|psychosocial treatment
434420|NCT01292577|Cognitive Enhancement Therapy|cognitive enhancement therapy
434421|NCT01292577|Personal Therapy|personal therapy
434422|NCT01292577|Treatment as Usual|treatment as usual
434423|NCT01292551|single ventricle physiology|single ventricle physiology
434424|NCT01292551|Fontan procedure|fontan procedure
434425|NCT01292525|Withdrawal of Tacrolimus and renal graft|withdrawal of tacrolimus and renal graft
434426|NCT01292525|renal allograft|renal allograft
434427|NCT01292525|stable renal function|stable renal function
434428|NCT01292512|Bereavement management|bereavement management
434429|NCT01292512|Complicated grief|complicated grief
434430|NCT01292499|psychotherapy|psychotherapy
434431|NCT01292499|psychoeducation|psychoeducation
434432|NCT01292499|depression|depression
434433|NCT01292447|Pain measurement|pain measurement
434434|NCT01292447|Intrauterine devices|intrauterine devices
434435|NCT01292447|Lidocaine|lidocaine
434436|NCT01292434|Diet|diet
434437|NCT01292434|Obesity|obesity
434438|NCT01292434|Child Preschool|child preschool
434439|NCT01292434|Treatment Outcome|treatment outcome
434440|NCT01292434|Body Mass Index|body mass index
434441|NCT01292434|Intervention Studies|intervention studies
434442|NCT01292434|Randomized Controlled Trial|randomized controlled trial
434443|NCT01292434|Child Day Care Centers|child day care centers
434444|NCT01292434|Schools Nursery|schools nursery
434445|NCT01292434|Child Care|child care
434446|NCT01292408|autophagy|autophagy
434447|NCT01292408|hydroxychloroquine|hydroxychloroquine
434448|NCT01292408|hypoxia|hypoxia
434449|NCT01292408|proven invasive adenocarcinoma of the breast: tumors are found to be ER negative (<10% ER pos cells)|proven invasive adenocarcinoma of the breast: tumors are found to be er negative (<10% er pos cells)
434450|NCT01292395|dietary supplement|dietary supplement
434451|NCT01292395|protein metabolism|protein metabolism
434452|NCT01292395|bone turnover|bone turnover
434453|NCT01292382|Elderly|elderly
434454|NCT01292382|Memory|memory
434455|NCT01292382|Cognition|cognition
434456|NCT01292382|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
434457|NCT01292369|breath test|breath test
434458|NCT01292369|colon cancer|colon cancer
434459|NCT01292369|breast cancer|breast cancer
434460|NCT01292343|third molars|third molars
434461|NCT01292343|triclosan|triclosan
434462|NCT01292343|toothpaste|toothpaste
434463|NCT01292343|dry socket|dry socket
434464|NCT01292343|wound infection|wound infection
434465|NCT01292330|liver Tumor|liver tumor
434466|NCT01292317|NGAL|ngal
434467|NCT01292317|neutrophil gelatinase-associated Lipocalin|neutrophil gelatinase-associated lipocalin
434468|NCT01292317|contrast media nephropathy|contrast media nephropathy
434469|NCT01292317|CIN|cin
434470|NCT01292317|volume expansion|volume expansion
434471|NCT01292317|acute kidney injury|acute kidney injury
434472|NCT01292317|contrast media|contrast media
434473|NCT01292304|Cirrhotic|cirrhotic
434474|NCT01292304|Tolvaptan|tolvaptan
434475|NCT01292304|v2 receptor antagonist|v2 receptor antagonist
434476|NCT01292291|stage I prostate cancer|stage i prostate cancer
434477|NCT01292291|stage IIA prostate cancer|stage iia prostate cancer
434478|NCT01292291|stage IIB prostate cancer|stage iib prostate cancer
434479|NCT01292278|subarachnoid hemorrhage|subarachnoid hemorrhage
434480|NCT01292278|cerebral vasospasm|cerebral vasospasm
434481|NCT01292278|neuropeptide Y|neuropeptide y
434482|NCT01292278|spontaneous|spontaneous
434483|NCT01292278|aneurysmal|aneurysmal
434484|NCT01292265|Arthritis|arthritis
434485|NCT01292265|Joint pain|joint pain
434486|NCT01292265|Inflammation|inflammation
434487|NCT01292265|Rheumatoid Arthritis|rheumatoid arthritis
434488|NCT01292239|Hepatitis C, Chronic|hepatitis c, chronic
434489|NCT01292239|Hepatitis C|hepatitis c
434490|NCT01292239|Hepatitis C virus|hepatitis c virus
434491|NCT01292239|Interferon Alfa-2a|interferon alfa-2a
434492|NCT01292239|Ribavirin|ribavirin
434493|NCT01292239|Viral RNA|viral rna
434494|NCT01292213|Chronic cough|chronic cough
434495|NCT01292213|Haemophilus influenzae|haemophilus influenzae
434496|NCT01292200|Chinese women|chinese women
434497|NCT01292200|Mammography|mammography
434498|NCT01292200|Breast Cancer|breast cancer
434499|NCT01292187|Osteoporosis|osteoporosis
434500|NCT01292187|Osteopenia|osteopenia
434501|NCT01292187|Osteoporosis, Postmenopausal|osteoporosis, postmenopausal
434502|NCT01292187|Bone Diseases, Metabolic|bone diseases, metabolic
434503|NCT01292187|Bone Diseases|bone diseases
434504|NCT01292187|Musculoskeletal Diseases|musculoskeletal diseases
434505|NCT01292187|Salmon calcitonin|salmon calcitonin
434506|NCT01292187|Calcitonin|calcitonin
434507|NCT01292174|HIV prevention|hiv prevention
434508|NCT01292161|Hepatitis C|hepatitis c
434509|NCT01292161|Silymarin|silymarin
434510|NCT01292161|Quality of life|quality of life
434511|NCT01292148|resuscitation, hypothermia|resuscitation, hypothermia
434512|NCT01292135|Lymphoma, B-Cell|lymphoma, b-cell
434513|NCT01292135|Leukemia, Lymphoid|leukemia, lymphoid
434514|NCT01292135|Leukemia, B-Cell|leukemia, b-cell
434515|NCT01292135|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
434516|NCT01292122|Wounds|wounds
434517|NCT01292122|Grafts|grafts
434518|NCT01292122|Wound Healing|wound healing
434519|NCT01292122|Cell Therapy|cell therapy
434520|NCT01292122|Split-thickness skin graft donor site wound|split-thickness skin graft donor site wound
434521|NCT01292109|endoscopy|endoscopy
434522|NCT01292109|colonoscopy|colonoscopy
434523|NCT01292109|preparation for surgery|preparation for surgery
434524|NCT01292096|homelessness|homelessness
434525|NCT01292096|substance use|substance use
434526|NCT01292096|frequent hospitalization|frequent hospitalization
434527|NCT01292096|frequent users of health services|frequent users of health services
434625|NCT01291758|Veterans|veterans
434528|NCT01292096|enhanced care management|enhanced care management
434529|NCT01292096|coordination services p|coordination services p
434530|NCT01292096|high risk for frequent hospitalization|high risk for frequent hospitalization
434531|NCT01292070|Fel d 1 protein, Felis domesticus|fel d 1 protein, felis domesticus
434532|NCT01292070|Injections, Intradermal|injections, intradermal
434533|NCT01292057|Alcohol|alcohol
434534|NCT01292057|Aripiprazole|aripiprazole
434535|NCT01292057|Impulsivity|impulsivity
434536|NCT01292057|Alcoholism|alcoholism
434537|NCT01292057|drinking|drinking
434538|NCT01292057|treatment|treatment
434539|NCT01292057|craving|craving
434540|NCT01292057|brain imaging|brain imaging
434541|NCT01292057|genetics|genetics
434542|NCT01292044|elastography|elastography
434543|NCT01292044|cytology|cytology
434544|NCT01292031|VAP|vap
434545|NCT01292031|MDR-GNB|mdr-gnb
434546|NCT01292031|colistin|colistin
434547|NCT01292031|meropenem|meropenem
434548|NCT01292018|Management of dyslipidemia in Type 2 Diabetes Mellitus adult patients in India|management of dyslipidemia in type 2 diabetes mellitus adult patients in india
434549|NCT01292018|Dyslipidemia control rates in Type 2 diabetic Mellitus patients|dyslipidemia control rates in type 2 diabetic mellitus patients
434550|NCT01292005|pancreatitis|pancreatitis
434551|NCT01292005|pancreatic necrosis|pancreatic necrosis
434552|NCT01292005|severe acute pancreatitis (SAP)|severe acute pancreatitis (sap)
434553|NCT01292005|Alcoholic pancreatitis|alcoholic pancreatitis
434554|NCT01292005|gallstone pancreatitis|gallstone pancreatitis
434555|NCT01291992|Non-convulsive seizures|non-convulsive seizures
434556|NCT01291992|Cardiac Surgery|cardiac surgery
434557|NCT01291992|Postop|postop
434558|NCT01291992|24 hour EEG Monitoring|24 hour eeg monitoring
434559|NCT01291979|Pain|pain
434560|NCT01291979|Preemptive|preemptive
434561|NCT01291979|Lidocaine|lidocaine
434562|NCT01291979|Intravenous|intravenous
434563|NCT01291979|Tonsillectomy|tonsillectomy
434564|NCT01291966|medication errors|medication errors
434565|NCT01291966|Patient Compliance|patient compliance
434566|NCT01291966|patient safety|patient safety
434567|NCT01291966|polypharmacy|polypharmacy
434568|NCT01291953|atrial fibrillation|atrial fibrillation
434569|NCT01291953|screening|screening
434570|NCT01291953|prevention|prevention
434571|NCT01291953|case finding|case finding
434572|NCT01291953|primary care|primary care
434573|NCT01291927|Periampullary carcinoma|periampullary carcinoma
434574|NCT01291927|Pancreas-sparing Duodenectomy|pancreas-sparing duodenectomy
434575|NCT01291927|pancreaticoduodenectomy|pancreaticoduodenectomy
434576|NCT01291927|lymphadenectomy|lymphadenectomy
434577|NCT01291914|Osteoarthritis|osteoarthritis
434578|NCT01291914|knee|knee
434579|NCT01291914|intra-articular|intra-articular
434580|NCT01291914|safety|safety
434581|NCT01291914|efficacy|efficacy
434582|NCT01291914|pharmacokinetics|pharmacokinetics
434583|NCT01291914|pain|pain
434584|NCT01291901|pain|pain
434585|NCT01291901|cancer|cancer
434586|NCT01291901|malignancy|malignancy
434587|NCT01291901|intractable|intractable
434588|NCT01291901|gene therapy|gene therapy
434589|NCT01291901|enkephalin|enkephalin
434590|NCT01291901|opioid|opioid
434591|NCT01291875|Type 2 Diabetes mellitus|type 2 diabetes mellitus
434592|NCT01291875|Periodontal Disease|periodontal disease
434593|NCT01291875|metabolic control|metabolic control
434594|NCT01291875|periodontal treatment|periodontal treatment
434595|NCT01291875|inflammatory markers|inflammatory markers
434596|NCT01291849|nasal surgery|nasal surgery
434597|NCT01291849|endoscopic sinus surgery|endoscopic sinus surgery
434598|NCT01291849|septoplasty|septoplasty
434599|NCT01291849|Cough|cough
434600|NCT01291836|Acute Kidney Injury (AKI)|acute kidney injury (aki)
434601|NCT01291836|Acute Decompensated Heart Failure (ADHF)|acute decompensated heart failure (adhf)
434602|NCT01291836|Neutrophil Gelatinase Associated Lipocalin (NGAL)|neutrophil gelatinase associated lipocalin (ngal)
434603|NCT01291836|biomarker|biomarker
434604|NCT01291823|gefitinib|gefitinib
434605|NCT01291823|radiation|radiation
434606|NCT01291823|esophageal cancer|esophageal cancer
434607|NCT01291797|congenital heart disease|congenital heart disease
434608|NCT01291797|neurodevelopmental outcome|neurodevelopmental outcome
434609|NCT01291797|AEEG|aeeg
434610|NCT01291797|sleep wake cycles|sleep wake cycles
434611|NCT01291784|monoclonal antibody|monoclonal antibody
434612|NCT01291771|End stage renal disease|end stage renal disease
434613|NCT01291771|myocardial microvascular disease|myocardial microvascular disease
434614|NCT01291771|cardiorenal syndrome|cardiorenal syndrome
434615|NCT01291771|coronary flow reserve|coronary flow reserve
434616|NCT01291771|index of microvascular resistance|index of microvascular resistance
434617|NCT01291771|Patients with end stage renal disease scheduled or not for kidney or kidney + pancreatic transplantation|patients with end stage renal disease scheduled or not for kidney or kidney + pancreatic transplantation
434618|NCT01291758|Persian Gulf War|persian gulf war
434619|NCT01291758|Gulf War Syndrome|gulf war syndrome
434620|NCT01291758|GWI|gwi
434621|NCT01291758|Gulf War Illness|gulf war illness
434622|NCT01291758|Exercise|exercise
434623|NCT01291758|Chronic Fatigue|chronic fatigue
434624|NCT01291758|Fibromyalgia|fibromyalgia
434626|NCT01291758|Irritable Bowel Syndrome|irritable bowel syndrome
434627|NCT01291758|Migraine headaches|migraine headaches
434628|NCT01291758|Neuropathy|neuropathy
434629|NCT01291719|closed loop glucose control|closed loop glucose control
434630|NCT01291719|intensive care glucose control|intensive care glucose control
434631|NCT01291706|Transcranial Doppler|transcranial doppler
434632|NCT01291706|Mild and moderate Traumatic Brain Injury|mild and moderate traumatic brain injury
434633|NCT01291706|Neurological deterioration|neurological deterioration
434634|NCT01291706|Brain CT scan|brain ct scan
434635|NCT01291693|Hazardous drinking|hazardous drinking
434636|NCT01291693|general hospital|general hospital
434637|NCT01291693|brief intervention|brief intervention
434638|NCT01291693|Motivational Interviewing|motivational interviewing
434639|NCT01291693|computer-generated feedback|computer-generated feedback
434640|NCT01291693|stage-tailored|stage-tailored
434641|NCT01291693|delivery channel|delivery channel
434642|NCT01291680|Pregnancy|pregnancy
434643|NCT01291680|Chronic pain|chronic pain
434644|NCT01291680|Fibromyalgia|fibromyalgia
434645|NCT01291654|PDA|pda
434646|NCT01291654|Paracetamol|paracetamol
434647|NCT01291654|Indomethacin|indomethacin
434648|NCT01291654|Ibuprofen|ibuprofen
434649|NCT01291641|Hyperlipidemias|hyperlipidemias
434650|NCT01291641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
434651|NCT01291641|Probucol|probucol
434652|NCT01291641|Cilostazol|cilostazol
434653|NCT01291628|Capecitabine|capecitabine
434654|NCT01291628|Hand and foot syndrome|hand and foot syndrome
434655|NCT01291628|Socks|socks
434656|NCT01291628|Copper|copper
434657|NCT01291628|Toxicity|toxicity
434658|NCT01291602|NXL104|nxl104
434659|NCT01291602|ceftazidime|ceftazidime
434660|NCT01291602|CAZ104|caz104
434661|NCT01291602|Healthy Japanese volunteers|healthy japanese volunteers
434662|NCT01291602|Phase 1|phase 1
434663|NCT01291602|Single and Multiple Dose Study|single and multiple dose study
434664|NCT01291589|HIV-infected|hiv-infected
434665|NCT01291589|MSM|msm
434666|NCT01291589|HIV prevention|hiv prevention
434667|NCT01291576|Deep infiltrating endometriosis|deep infiltrating endometriosis
434668|NCT01291576|Rectal endometriosis|rectal endometriosis
434669|NCT01291576|Colorectal resection|colorectal resection
434670|NCT01291576|Nodule excision|nodule excision
434671|NCT01291576|Rectal shaving|rectal shaving
434672|NCT01291576|Functional outcomes|functional outcomes
434673|NCT01291576|Constipation|constipation
434674|NCT01291563|TMC207TBC1003|tmc207tbc1003
434675|NCT01291563|TMC207|tmc207
434676|NCT01291563|M.Tuberculosis|m.tuberculosis
434677|NCT01291563|TBC|tbc
434678|NCT01291563|Moxifloxacin|moxifloxacin
434679|NCT01291563|ECG|ecg
434680|NCT01291563|QT/QTc|qt/qtc
434681|NCT01291563|Healthy volunteers|healthy volunteers
434682|NCT01291550|Detecting volatile biomarkers using breath sample|detecting volatile biomarkers using breath sample
434683|NCT01291537|Advanced|advanced
434684|NCT01291537|Severe form|severe form
434685|NCT01291524|pregabalin|pregabalin
434686|NCT01291524|pharmacokinetics|pharmacokinetics
434687|NCT01291524|bioavailability|bioavailability
434688|NCT01291524|bioequivalence|bioequivalence
434689|NCT01291511|Schizophrenia|schizophrenia
434690|NCT01291511|Mental Disorders|mental disorders
434691|NCT01291511|Antipsychotic Agents|antipsychotic agents
434692|NCT01291511|Iloperdione|iloperdione
434693|NCT01291511|Relapse Prevention|relapse prevention
434694|NCT01291498|Primary Parathyroid Adenomas|primary parathyroid adenomas
434695|NCT01291485|HIV|hiv
434696|NCT01291485|Medication adherence|medication adherence
434697|NCT01291485|computer-based intervention|computer-based intervention
434698|NCT01291472|ketorolac|ketorolac
434699|NCT01291472|pain|pain
434700|NCT01291472|pregnancy|pregnancy
434701|NCT01291472|non-pregnant state|non-pregnant state
434702|NCT01291459|HIV|hiv
434703|NCT01291459|naive patients|naive patients
434704|NCT01291459|maraviroc|maraviroc
434705|NCT01291459|raltegravir|raltegravir
434706|NCT01291446|Intestinal gas production|intestinal gas production
434707|NCT01291446|Intestinal microbiota|intestinal microbiota
434708|NCT01291407|Combined Modality|combined modality
434709|NCT01291407|Gastric Cancer|gastric cancer
434710|NCT01291407|Radiation Therapy|radiation therapy
434711|NCT01291407|S-1|s-1
434712|NCT01291394|Growth disorders|growth disorders
434713|NCT01291394|Saizen|saizen
434714|NCT01291394|Easypod|easypod
434715|NCT01291394|Growth hormone|growth hormone
434716|NCT01291394|Pediatric subject|pediatric subject
434717|NCT01291381|allergic rhinitis|allergic rhinitis
434718|NCT01291381|peripheral tolerance|peripheral tolerance
434719|NCT01291381|regulatory T cells|regulatory t cells
434720|NCT01291381|specific immunotherapy|specific immunotherapy
434721|NCT01291381|Tr1 cells|tr1 cells
434722|NCT01291368|Sedation|sedation
434723|NCT01291368|Delirium|delirium
434724|NCT01291368|PTSD|ptsd
434725|NCT01291368|Depression|depression
434726|NCT01291368|Anxiety|anxiety
434727|NCT01291368|HRQoL|hrqol
434728|NCT01291368|CAM-ICU|cam-icu
434729|NCT01291368|RASS|rass
434730|NCT01291368|SF-36|sf-36
434731|NCT01291368|ICU-memory tool|icu-memory tool
434732|NCT01291368|Antipsychotic Agents|antipsychotic agents
434733|NCT01291368|Mobilization|mobilization
434734|NCT01291368|ICU-nursing|icu-nursing
434735|NCT01291368|ICU|icu
434736|NCT01291368|intensive care|intensive care
434737|NCT01291368|critical care|critical care
434738|NCT01291368|critical care nursing|critical care nursing
434739|NCT01291355|Maternal position|maternal position
434740|NCT01291355|Occipitoposterior position|occipitoposterior position
434741|NCT01291355|Labor|labor
434742|NCT01291355|Dystocia|dystocia
434743|NCT01291355|Fetal presentation Abnormalities|fetal presentation abnormalities
434744|NCT01291342|Pregnancy|pregnancy
434745|NCT01291342|Preeclampsia|preeclampsia
434746|NCT01291342|Volatile biomarkers|volatile biomarkers
434747|NCT01291342|Chemical sensors|chemical sensors
434748|NCT01291342|Nanomaterials|nanomaterials
434749|NCT01291342|Nanosensors|nanosensors
434750|NCT01291342|NA-NOSE|na-nose
434751|NCT01291329|stem cell|stem cell
434752|NCT01291329|acute ST-Elevation Myocardial Infarction|acute st-elevation myocardial infarction
434753|NCT01291303|Non invasive ventilation|non invasive ventilation
434754|NCT01291303|acute exacerbation of COPD|acute exacerbation of copd
434755|NCT01291303|optimized ventilation|optimized ventilation
434756|NCT01291290|rAAA|raaa
434757|NCT01291290|Platelets|platelets
434758|NCT01291290|TEG|teg
434759|NCT01291290|Massive bleeding|massive bleeding
434760|NCT01291290|Coagulopathy|coagulopathy
434761|NCT01291277|gastrointestinal hemorrhage|gastrointestinal hemorrhage
434762|NCT01291277|esophageal varices|esophageal varices
434763|NCT01291277|gastrointestinal endoscopy|gastrointestinal endoscopy
434764|NCT01291277|ligation|ligation
434765|NCT01291264|Chlamydia trachomatis|chlamydia trachomatis
434766|NCT01291264|Neisseria gonorrhoeae|neisseria gonorrhoeae
434767|NCT01291264|Sexually Transmitted Diseases|sexually transmitted diseases
434768|NCT01291238|learning disability|learning disability
434769|NCT01291238|blood lipids|blood lipids
434770|NCT01291238|cardio metabolic risk factors|cardio metabolic risk factors
434771|NCT01291238|upper secondary school for learning disability students|upper secondary school for learning disability students
434772|NCT01291238|adolescents|adolescents
434773|NCT01291238|cardio respiratory fitness|cardio respiratory fitness
434774|NCT01291238|absorptiometry photos|absorptiometry photos
434775|NCT01291225|playgrounds|playgrounds
434776|NCT01291225|farms|farms
434777|NCT01291225|injury prevention|injury prevention
434778|NCT01291225|safety knowledge, attitudes and practices|safety knowledge, attitudes and practices
434779|NCT01291225|safe play|safe play
434780|NCT01291225|rural|rural
434781|NCT01291212|In Vitro Fertilization|in vitro fertilization
434782|NCT01291212|Testosterone|testosterone
434783|NCT01291212|Ovarian Stimulation|ovarian stimulation
434784|NCT01291212|Luteinizing Hormone|luteinizing hormone
434785|NCT01291199|double-blind placebo controlled cross-over study|double-blind placebo controlled cross-over study
434786|NCT01291186|spinal anesthesia|spinal anesthesia
434787|NCT01291186|intrathecal bupivacaine|intrathecal bupivacaine
434788|NCT01291186|median effective dose|median effective dose
434789|NCT01291186|height|height
434790|NCT01291147|pain|pain
434791|NCT01291147|anaesthetic|anaesthetic
434792|NCT01291121|Age related macular degeneration|age related macular degeneration
434793|NCT01291121|Intravitreal ranibizumab|intravitreal ranibizumab
434794|NCT01291121|Intravitreal expansile gas injection|intravitreal expansile gas injection
434795|NCT01291082|Breast cancer|breast cancer
434796|NCT01291082|metastasis|metastasis
434797|NCT01291082|bone|bone
434798|NCT01291082|diffusion MRI|diffusion mri
434799|NCT01291069|Fontan|fontan
434800|NCT01291069|Tadalafil|tadalafil
434801|NCT01291069|Exercise performance|exercise performance
434802|NCT01291056|Clomiphene citrate|clomiphene citrate
434803|NCT01291056|Mood symptoms|mood symptoms
434804|NCT01291056|Infertility|infertility
434805|NCT01291056|Superovulation|superovulation
434806|NCT01291056|Effects of clomiphene on mood|effects of clomiphene on mood
434807|NCT01291043|Shiatsu|shiatsu
434808|NCT01291043|Fibromyalgia|fibromyalgia
434809|NCT01291043|Pain|pain
434810|NCT01291043|Quality of sleep|quality of sleep
434811|NCT01291043|Balance|balance
434812|NCT01291043|Quality of life|quality of life
434813|NCT01291017|Advanced stage|advanced stage
434814|NCT01290952|off-pump|off-pump
434815|NCT01290952|bypass|bypass
434816|NCT01290952|coronary artery surgery|coronary artery surgery
434817|NCT01290939|adult glioblastoma|adult glioblastoma
434818|NCT01290939|recurrent adult brain tumor|recurrent adult brain tumor
434819|NCT01290939|Cognition Disorders|cognition disorders
434820|NCT01290939|functional defects|functional defects
434821|NCT01290926|advanced chemorefractory colorectal cancer|advanced chemorefractory colorectal cancer
434822|NCT01290926|sorafenib|sorafenib
434823|NCT01290926|capecitabine|capecitabine
434824|NCT01290926|FDG-PET|fdg-pet
434825|NCT01290926|early metabolic response|early metabolic response
434826|NCT01290913|peanut allergy|peanut allergy
434827|NCT01290913|Xolair|xolair
434828|NCT01290900|NXL104|nxl104
434829|NCT01290900|CAZ104|caz104
434830|NCT01290900|Ceftazidime|ceftazidime
434831|NCT01290900|CXL104|cxl104
434832|NCT01290900|Ceftaroline|ceftaroline
434833|NCT01290900|Healthy Male Volunteers|healthy male volunteers
434834|NCT01290900|Phase 1|phase 1
434835|NCT01290900|OT|ot
434836|NCT01290900|Single Dose Study|single dose study
434837|NCT01290874|Asthma|asthma
434838|NCT01290874|Blacks|blacks
434839|NCT01290874|LABA|laba
434840|NCT01290874|Tiotropium|tiotropium
434841|NCT01290874|Spiriva|spiriva
434842|NCT01290874|African American|african american
434843|NCT01290874|Serevent|serevent
434844|NCT01290874|salmeterol|salmeterol
434845|NCT01290874|Foradil|foradil
434846|NCT01290874|formoterol|formoterol
434847|NCT01290874|Advair|advair
434848|NCT01290874|Symbicort|symbicort
434849|NCT01290874|Dulera|dulera
434850|NCT01290861|Huntington's Disease|huntington's disease
434851|NCT01290861|Cognitive Battery|cognitive battery
434852|NCT01290861|Cognitive Testing|cognitive testing
434853|NCT01290861|Cognition|cognition
434854|NCT01290861|pre-manifest Huntington's Disease|pre-manifest huntington's disease
434855|NCT01290848|pediatrics|pediatrics
434856|NCT01290848|Health Promotion Campaign|health promotion campaign
434857|NCT01290848|Community events|community events
434858|NCT01290835|Stereotactic radiotherapy|stereotactic radiotherapy
434859|NCT01290835|CyberKnife following lumpectomy|cyberknife following lumpectomy
434860|NCT01290835|Breast cancer|breast cancer
434861|NCT01290822|Biventricular pacing|biventricular pacing
434862|NCT01290822|Dilated Cardiomyopathy|dilated cardiomyopathy
434863|NCT01290822|Ischemic Cardiomyopathy|ischemic cardiomyopathy
434864|NCT01290822|Congestive heart failure|congestive heart failure
434865|NCT01290822|Cardiac allograft|cardiac allograft
434866|NCT01290822|Cardiac surgery|cardiac surgery
434867|NCT01290822|AVD|avd
434868|NCT01290822|VVD|vvd
434869|NCT01290822|LV pacing site|lv pacing site
434870|NCT01290822|pacing optimization|pacing optimization
434871|NCT01290809|Prophylactic Cranial Irradiation|prophylactic cranial irradiation
434872|NCT01290809|lung cancer|lung cancer
434873|NCT01290783|mCRC|mcrc
434874|NCT01290783|CRC|crc
434875|NCT01290783|colorectal|colorectal
434876|NCT01290783|irinotecan|irinotecan
434877|NCT01290783|Hyaluronic acid|hyaluronic acid
434878|NCT01290783|Hyaluronan|hyaluronan
434879|NCT01290770|obesity|obesity
434880|NCT01290770|men|men
434881|NCT01290770|TFPI|tfpi
434882|NCT01290770|Lipoprotein(a)|lipoprotein(a)
434883|NCT01290770|Lp(a)|lp(a)
434884|NCT01290770|Tissue Factor pathway inhibitor|tissue factor pathway inhibitor
434885|NCT01290770|aspirin|aspirin
434886|NCT01290744|leprosy|leprosy
434887|NCT01290744|ENL|enl
434888|NCT01290744|clofazimine|clofazimine
434889|NCT01290731|Hepatitis C, Chronic|hepatitis c, chronic
434890|NCT01290731|Hepatitis C virus|hepatitis c virus
434891|NCT01290731|Interferon Alfa-2a|interferon alfa-2a
434892|NCT01290731|Ribavirin|ribavirin
434893|NCT01290731|Viral RNA|viral rna
434894|NCT01290705|Knee|knee
434895|NCT01290705|Anterior Cruciate Ligament|anterior cruciate ligament
434896|NCT01290705|Pain|pain
434897|NCT01290705|Patella|patella
434898|NCT01290705|Exercise Therapy|exercise therapy
434899|NCT01290692|Brain Neoplasms|brain neoplasms
434900|NCT01290692|Central Nervous System Neoplasms|central nervous system neoplasms
434901|NCT01290692|Brain Diseases|brain diseases
434902|NCT01290692|Neoplasms|neoplasms
434903|NCT01290692|Nervous System Neoplasms|nervous system neoplasms
434904|NCT01290692|Glioblastoma|glioblastoma
434905|NCT01290692|Astrocytoma|astrocytoma
434906|NCT01290692|Nervous System Diseases|nervous system diseases
434907|NCT01290692|Central Nervous System Diseases|central nervous system diseases
434908|NCT01290692|Glioma|glioma
434909|NCT01290692|Recurrent astrocytoma|recurrent astrocytoma
434910|NCT01290692|Recurrent glioma|recurrent glioma
434911|NCT01290692|Cancer vaccine|cancer vaccine
434912|NCT01290692|Immunotherapy|immunotherapy
434913|NCT01290692|Killer T cells|killer t cells
434914|NCT01290692|Activated T cells|activated t cells
434915|NCT01290692|GM-CSF|gm-csf
434916|NCT01290692|Activated lymphocytes|activated lymphocytes
434917|NCT01290679|Hepatitis C|hepatitis c
434918|NCT01290679|TMC435|tmc435
434919|NCT01290679|HCV|hcv
434920|NCT01290679|Hep C|hep c
434921|NCT01290679|genotype 1|genotype 1
434922|NCT01290601|malaria|malaria
434923|NCT01290601|Plasmodium vivax|plasmodium vivax
434924|NCT01290601|adults|adults
434925|NCT01290601|treatment|treatment
434926|NCT01290601|tafenoquine|tafenoquine
434927|NCT01290562|SBRT|sbrt
434928|NCT01290562|spinal Metastases|spinal metastases
434929|NCT01290562|Paraspinal Metastases|paraspinal metastases
434930|NCT01290562|spinal Metastases and SBRT|spinal metastases and sbrt
434931|NCT01290562|Paraspinal Metastases and SBRT|paraspinal metastases and sbrt
434932|NCT01290536|Liver metastases|liver metastases
434933|NCT01290510|tendinopathy|tendinopathy
434934|NCT01290510|hyaluronan|hyaluronan
434935|NCT01290510|tendon|tendon
434936|NCT01290510|hyaluronic acid|hyaluronic acid
435038|NCT01290120|B-ALL|b-all
434937|NCT01290484|Lymphatic malformation, vascular malformation|lymphatic malformation, vascular malformation
434938|NCT01290458|Eccentric training|eccentric training
434939|NCT01290458|Free radicals|free radicals
434940|NCT01290458|Antioxidant supplements|antioxidant supplements
434941|NCT01290458|Training adaptations|training adaptations
434942|NCT01290458|Lipid profile|lipid profile
434943|NCT01290445|varenicline|varenicline
434944|NCT01290445|smoking|smoking
434945|NCT01290445|smoking cessation|smoking cessation
434946|NCT01290445|cohort study|cohort study
434947|NCT01290445|drug safety|drug safety
434948|NCT01290445|prospective study|prospective study
434949|NCT01290432|female fertility|female fertility
434950|NCT01290432|ovarian reserve|ovarian reserve
434951|NCT01290432|oocyte quality|oocyte quality
434952|NCT01290432|oocyte quantity|oocyte quantity
434953|NCT01290432|antimullerian hormone|antimullerian hormone
434954|NCT01290432|AMH|amh
434955|NCT01290432|dietary supplements|dietary supplements
434956|NCT01290432|inofolic plus|inofolic plus
434957|NCT01290432|myoinositol|myoinositol
434958|NCT01290432|folic acid|folic acid
434959|NCT01290419|RSV|rsv
434960|NCT01290406|Endometrial cancer,|endometrial cancer,
434961|NCT01290406|uterine cancer,|uterine cancer,
434962|NCT01290406|PI3K,|pi3k,
434963|NCT01290406|mTOR,|mtor,
434964|NCT01290406|targeted therapy|targeted therapy
434965|NCT01290393|vaccine|vaccine
434966|NCT01290393|Spontaneous abortions|spontaneous abortions
434967|NCT01290393|Human papillomavirus|human papillomavirus
434968|NCT01290393|HPV|hpv
434969|NCT01290393|Cervarix|cervarix
434970|NCT01290393|pregnancy|pregnancy
434971|NCT01290380|Solid tumor malignancies,|solid tumor malignancies,
434972|NCT01290380|simvastatin,|simvastatin,
434973|NCT01290380|caffeine,|caffeine,
434974|NCT01290380|omeprazole and diclofenac,|omeprazole and diclofenac,
434975|NCT01290380|ASA404,|asa404,
434976|NCT01290380|PK data|pk data
434977|NCT01290367|Chronic Lumbar Back Pain|chronic lumbar back pain
434978|NCT01290367|Low back pain|low back pain
434979|NCT01290367|Back pain|back pain
434980|NCT01290367|Degenerative Disc Disease|degenerative disc disease
434981|NCT01290367|Injection of Degenerated Lumbar Disc|injection of degenerated lumbar disc
434982|NCT01290367|Stem Cells|stem cells
434983|NCT01290367|Adult Stem Cells|adult stem cells
434984|NCT01290367|Allogeneic Mesenchymal Precursor cells (MPCs)|allogeneic mesenchymal precursor cells (mpcs)
434985|NCT01290367|Mesoblast|mesoblast
434986|NCT01290354|Brain penetration|brain penetration
434987|NCT01290354|positron emission tomography|positron emission tomography
434988|NCT01290354|Lapatinib|lapatinib
434989|NCT01290341|fungal infection|fungal infection
434990|NCT01290341|athlete foot|athlete foot
434991|NCT01290328|anemia|anemia
434992|NCT01290328|kidney transplant|kidney transplant
434993|NCT01290328|alloimmunity|alloimmunity
434994|NCT01290289|Labor|labor
434995|NCT01290289|Epidural|epidural
434996|NCT01290289|Combined spinal epidural|combined spinal epidural
434997|NCT01290289|pethidine|pethidine
434998|NCT01290276|Ondansetron|ondansetron
434999|NCT01290276|Methylphenidate|methylphenidate
435000|NCT01290263|Glioblastoma|glioblastoma
435001|NCT01290263|GBM|gbm
435002|NCT01290263|Brain Tumor|brain tumor
435003|NCT01290263|Glioma|glioma
435004|NCT01290237|vancomycin|vancomycin
435005|NCT01290237|loading dose|loading dose
435006|NCT01290237|pharmacokinetic|pharmacokinetic
435007|NCT01290237|pediatric|pediatric
435008|NCT01290237|Methicillin-Resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
435009|NCT01290237|Serious infection with Gram positive bacteria|serious infection with gram positive bacteria
435010|NCT01290211|maraviroc|maraviroc
435011|NCT01290211|fosamprenavir|fosamprenavir
435012|NCT01290211|drug interaction|drug interaction
435013|NCT01290211|pharmacokinetics|pharmacokinetics
435014|NCT01290211|HIV|hiv
435015|NCT01290211|AIDS|aids
435016|NCT01290211|CCR5|ccr5
435017|NCT01290211|protease inhibitor|protease inhibitor
435018|NCT01290198|epoxy-eicosatrienoic acid|epoxy-eicosatrienoic acid
435019|NCT01290198|Laser Doppler|laser doppler
435020|NCT01290198|Endothelium derived hyperpolarizing factor|endothelium derived hyperpolarizing factor
435021|NCT01290198|cutaneous microcirculation|cutaneous microcirculation
435022|NCT01290198|post-occlusive hyperaemia|post-occlusive hyperaemia
435023|NCT01290198|thermal hyperemia|thermal hyperemia
435024|NCT01290198|intradermal microdialysis|intradermal microdialysis
435025|NCT01290198|fluconazole|fluconazole
435026|NCT01290185|Arthroplasty|arthroplasty
435027|NCT01290185|Pharmacol Nerve Block|pharmacol nerve block
435028|NCT01290172|Liver transplant|liver transplant
435029|NCT01290172|portal hypertension|portal hypertension
435030|NCT01290159|tolerance to heat|tolerance to heat
435031|NCT01290146|Heart Failure|heart failure
435032|NCT01290146|Levosimendan|levosimendan
435033|NCT01290146|Inotropic agents|inotropic agents
435034|NCT01290146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors
435035|NCT01290146|Vasodilators|vasodilators
435036|NCT01290146|Diuretics|diuretics
435037|NCT01290120|Burkitt Lymphoma|burkitt lymphoma
435039|NCT01290120|Adult patients|adult patients
435040|NCT01290107|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
435041|NCT01290107|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
435042|NCT01290081|Tuberculosis|tuberculosis
435043|NCT01290081|Injecting drug users|injecting drug users
435044|NCT01290081|Case management|case management
435045|NCT01290068|Intraocular Lens|intraocular lens
435046|NCT01290055|yellow fever|yellow fever
435047|NCT01290055|vaccine|vaccine
435048|NCT01290055|memory T cells|memory t cells
435049|NCT01290029|pediatric|pediatric
435050|NCT01290029|CKD|ckd
435051|NCT01290029|dialysis|dialysis
435052|NCT01290029|paediatric|paediatric
435053|NCT01290016|randomized controlled trial|randomized controlled trial
435054|NCT01290016|children|children
435055|NCT01290016|obesity|obesity
435056|NCT01290016|nutrition|nutrition
435057|NCT01290016|exercise|exercise
435058|NCT01290003|Antibacterial agents|antibacterial agents
435059|NCT01290003|Neonate|neonate
435060|NCT01290003|Meconium stained amniotic fluid|meconium stained amniotic fluid
435061|NCT01290003|Neonatal sepsis|neonatal sepsis
435062|NCT01289977|Sandfly|sandfly
435063|NCT01289977|leishmaniasis|leishmaniasis
435064|NCT01289977|immune response|immune response
435065|NCT01289977|individuals age 18-50|individuals age 18-50
435066|NCT01289951|HIV|hiv
435067|NCT01289951|VHC|vhc
435068|NCT01289951|Advanced hepatic cirrhosis|advanced hepatic cirrhosis
435069|NCT01289951|Pharmacokinetic|pharmacokinetic
435070|NCT01289951|Raltegravir|raltegravir
435071|NCT01289938|pharmacokinetic|pharmacokinetic
435072|NCT01289938|pharmacogenetic|pharmacogenetic
435073|NCT01289938|Metoclopramide|metoclopramide
435074|NCT01289938|Diphenhydramine|diphenhydramine
435075|NCT01289938|CYP2D6 polymorphisms|cyp2d6 polymorphisms
435076|NCT01289925|dietary supplement|dietary supplement
435077|NCT01289925|selenium|selenium
435078|NCT01289925|healthy volunteer|healthy volunteer
435079|NCT01289925|Johns Hopkins|johns hopkins
435080|NCT01289925|older|older
435081|NCT01289925|aging|aging
435082|NCT01289925|geriatrics|geriatrics
435083|NCT01289925|baltimore|baltimore
435084|NCT01289925|mineral|mineral
435085|NCT01289925|over 70|over 70
435086|NCT01289912|Tuberous Sclerosis Complex|tuberous sclerosis complex
435087|NCT01289912|Autism|autism
435088|NCT01289912|Neurocognition|neurocognition
435089|NCT01289912|RAD001|rad001
435090|NCT01289912|Everolimus|everolimus
435091|NCT01289912|Afinitor|afinitor
435092|NCT01289912|TSC|tsc
435093|NCT01289899|BR-A-657|br-a-657
435094|NCT01289899|Fimasartan|fimasartan
435095|NCT01289899|multiple-dose|multiple-dose
435096|NCT01289899|pharmacokinetic|pharmacokinetic
435097|NCT01289899|pharmacodynamic|pharmacodynamic
435098|NCT01289899|safety|safety
435099|NCT01289886|single-dose|single-dose
435100|NCT01289886|pharmacokinetic|pharmacokinetic
435101|NCT01289886|pharmacodynamic|pharmacodynamic
435102|NCT01289886|safety|safety
435103|NCT01289847|Primary Immune Deficiency Disorders|primary immune deficiency disorders
435104|NCT01289847|Common Variable Immunodeficiency|common variable immunodeficiency
435105|NCT01289847|X-linked agammaglobulinemia|x-linked agammaglobulinemia
435106|NCT01289847|Hyper-IgM syndrome|hyper-igm syndrome
435107|NCT01289847|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
435108|NCT01289847|Immunoglobulins|immunoglobulins
435109|NCT01289847|Bacterial Infections|bacterial infections
435110|NCT01289834|RSA|rsa
435111|NCT01289834|Bone Cement|bone cement
435112|NCT01289808|Glucose|glucose
435113|NCT01289808|analgesic|analgesic
435114|NCT01289808|newborns|newborns
435115|NCT01289795|Stroke|stroke
435116|NCT01289795|Cerebral Infarction|cerebral infarction
435117|NCT01289795|Cerebrovascular Disorders|cerebrovascular disorders
435118|NCT01289795|Brain Diseases|brain diseases
435119|NCT01289795|Central Nervous System Diseases|central nervous system diseases
435120|NCT01289782|Hepatitis C|hepatitis c
435121|NCT01289782|TMC435|tmc435
435122|NCT01289782|HCV|hcv
435123|NCT01289782|Hep C|hep c
435124|NCT01289782|Genotype 1|genotype 1
435125|NCT01289756|pharmacokinetic|pharmacokinetic
435126|NCT01289756|clomiphene|clomiphene
435127|NCT01289756|CYP2D6 polymorphisms|cyp2d6 polymorphisms
435128|NCT01289756|inhibition of CYP2D6 and CYP3A4|inhibition of cyp2d6 and cyp3a4
435129|NCT01289743|ankylosing spondylitis|ankylosing spondylitis
435130|NCT01289743|atanercept|atanercept
435131|NCT01289743|therapy|therapy
435132|NCT01289743|magnetic resonance imaging|magnetic resonance imaging
435133|NCT01289730|undifferentiated spondyloarthritis|undifferentiated spondyloarthritis
435134|NCT01289730|etanercept|etanercept
435135|NCT01289730|therapy|therapy
435136|NCT01289730|magnetic resonance imaging|magnetic resonance imaging
435137|NCT01289717|biomarkers|biomarkers
435138|NCT01289717|proteogenomic profiling|proteogenomic profiling
435139|NCT01289717|acute rejection|acute rejection
435140|NCT01289717|chronic allograft nephropathy/interstitial fibrosis and tubular atrophy|chronic allograft nephropathy/interstitial fibrosis and tubular atrophy
435141|NCT01289704|Charcot−Marie−Tooth disease,|charcot−marie−tooth disease,
435142|NCT01289704|CMT1A,|cmt1a,
435143|NCT01289704|rehabilitation,|rehabilitation,
435144|NCT01289704|treadmill,|treadmill,
435145|NCT01289704|stretching,|stretching,
435146|NCT01289704|proprioception,|proprioception,
435147|NCT01289704|Randomised Controlled Trial.|randomised controlled trial.
435148|NCT01289691|One Lung Ventilation|one lung ventilation
435149|NCT01289691|Atelectasis|atelectasis
435150|NCT01289691|Oxygenation|oxygenation
435151|NCT01289678|acute myelogenous leukemia|acute myelogenous leukemia
435152|NCT01289678|interleukin-2|interleukin-2
435153|NCT01289665|lubricating|lubricating
435154|NCT01289665|gel|gel
435155|NCT01289665|speculum|speculum
435156|NCT01289665|Pain, Pelvic|pain, pelvic
435157|NCT01289665|Examination, Gynecological|examination, gynecological
435158|NCT01289652|Acute hepatitis C (HCV)|acute hepatitis c (hcv)
435159|NCT01289652|Human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
435160|NCT01289639|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
435161|NCT01289639|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
435162|NCT01289639|insulin resistance|insulin resistance
435163|NCT01289639|pioglitazone|pioglitazone
435164|NCT01289639|fenofibrate|fenofibrate
435165|NCT01289626|Calciphylaxis, dialysis|calciphylaxis, dialysis
435166|NCT01289613|Bispectral Index|bispectral index
435167|NCT01289613|Anesthesia|anesthesia
435168|NCT01289613|Asymmetry|asymmetry
435169|NCT01289587|Diabetes|diabetes
435170|NCT01289587|Physical activity|physical activity
435171|NCT01289587|Body composition|body composition
435172|NCT01289587|Aerobic fitness|aerobic fitness
435173|NCT01289587|Metabolic control|metabolic control
435174|NCT01289574|androgen receptor degradation enhancer|androgen receptor degradation enhancer
435175|NCT01289548|remote ischaemic preconditioning|remote ischaemic preconditioning
435176|NCT01289548|kidney transplantation|kidney transplantation
435177|NCT01289535|Influenza vaccine|influenza vaccine
435178|NCT01289535|immune response|immune response
435179|NCT01289535|elderly|elderly
435180|NCT01289522|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
435181|NCT01289522|recurrent or metastatic|recurrent or metastatic
435182|NCT01289522|first line chemotherapy|first line chemotherapy
435183|NCT01289522|cetuximab|cetuximab
435184|NCT01289522|docetaxel|docetaxel
435185|NCT01289522|cisplatin|cisplatin
435186|NCT01289522|antineoplastic agents|antineoplastic agents
435187|NCT01289522|First Line Palliative Treatment|first line palliative treatment
435188|NCT01289496|Ribavirin|ribavirin
435189|NCT01289496|Pegasys|pegasys
435190|NCT01289496|Hepatitis|hepatitis
435191|NCT01289483|awake fiberoptic intubation (AFI)|awake fiberoptic intubation (afi)
435192|NCT01289483|difficult airway|difficult airway
435193|NCT01289483|fospropofol|fospropofol
435194|NCT01289470|NIRS Technology|nirs technology
435195|NCT01289470|Cardiovascular surgery|cardiovascular surgery
435196|NCT01289470|valvular surgery with cardiopulmonary bypass|valvular surgery with cardiopulmonary bypass
435197|NCT01289457|Acute Myelogenous Leukemia|acute myelogenous leukemia
435198|NCT01289457|AML|aml
435199|NCT01289457|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
435200|NCT01289457|MDS|mds
435201|NCT01289457|Relapsed|relapsed
435202|NCT01289457|Refractory|refractory
435203|NCT01289457|Clofarabine|clofarabine
435204|NCT01289457|Clofarex|clofarex
435205|NCT01289457|Clolar|clolar
435206|NCT01289457|Idarubicin|idarubicin
435207|NCT01289457|Idamycin|idamycin
435208|NCT01289457|Cytarabine|cytarabine
435209|NCT01289457|Ara-C|ara-c
435210|NCT01289457|Cytosar|cytosar
435211|NCT01289457|DepoCyt|depocyt
435212|NCT01289457|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
435213|NCT01289444|palliative care|palliative care
435214|NCT01289444|AIDS|aids
435215|NCT01289444|adolescents|adolescents
435216|NCT01289444|quality of life|quality of life
435217|NCT01289444|adherence|adherence
435218|NCT01289444|spiritual|spiritual
435219|NCT01289444|threat appraisal|threat appraisal
435220|NCT01289444|treatment congruence|treatment congruence
435221|NCT01289444|treatment preferences|treatment preferences
435222|NCT01289444|dialysis|dialysis
435223|NCT01289444|hospitalization|hospitalization
435224|NCT01289444|communication|communication
435225|NCT01289444|family intervention|family intervention
435226|NCT01289444|Family Centered Advance Care Planning|family centered advance care planning
435227|NCT01289444|decision making|decision making
435228|NCT01289444|advance care planning|advance care planning
435229|NCT01289444|end of life|end of life
435230|NCT01289418|H1N1|h1n1
435231|NCT01289418|vaccine safety|vaccine safety
435232|NCT01289418|adverse events|adverse events
435233|NCT01289418|health care workers|health care workers
435234|NCT01289405|obstructive sleep apnea|obstructive sleep apnea
435235|NCT01289405|oropharyngeal exercises|oropharyngeal exercises
435236|NCT01289405|speech therapy|speech therapy
435237|NCT01289392|Obstructive Sleep Apnea|obstructive sleep apnea
435238|NCT01289392|CPAP|cpap
435239|NCT01289392|Oral appliance|oral appliance
435240|NCT01289392|Aerobic exercise|aerobic exercise
435241|NCT01289392|Resistance training|resistance training
435242|NCT01289379|pneumoperitoneum|pneumoperitoneum
435243|NCT01289379|laparoscopy|laparoscopy
435244|NCT01289379|HFJV|hfjv
435245|NCT01289379|cardiovascular|cardiovascular
435246|NCT01289379|Symptomatic|symptomatic
435247|NCT01289353|triple negative|triple negative
435248|NCT01289353|breast cancer|breast cancer
435249|NCT01289353|adjuvant therapy|adjuvant therapy
435250|NCT01289353|Carboplatin|carboplatin
435251|NCT01289353|chemotherapy|chemotherapy
435252|NCT01289353|radiation therapy|radiation therapy
435253|NCT01289353|chemo-radiotherapy|chemo-radiotherapy
435254|NCT01289353|accelerated radiotherapy|accelerated radiotherapy
435255|NCT01289340|wound healing|wound healing
435256|NCT01289340|pain|pain
435257|NCT01289340|burn|burn
435258|NCT01289314|total laparoscopic hysterectomy|total laparoscopic hysterectomy
435259|NCT01289314|laparoscopic supracervical hysterectomy|laparoscopic supracervical hysterectomy
435260|NCT01289301|renal transplantation|renal transplantation
435261|NCT01289301|polyoma BK virus infection|polyoma bk virus infection
435262|NCT01289301|everolimus|everolimus
435263|NCT01289301|calcineurin inhibitor|calcineurin inhibitor
435264|NCT01289301|mTOR inhibitor|mtor inhibitor
435265|NCT01289288|colorectal cancer screening|colorectal cancer screening
435266|NCT01289288|Chinese Americans|chinese americans
435267|NCT01289288|patients nonadherent with CRC Screening|patients nonadherent with crc screening
435268|NCT01289275|tobacco cessation|tobacco cessation
435269|NCT01289275|smoking cessation|smoking cessation
435270|NCT01289275|telephone|telephone
435271|NCT01289275|self-help|self-help
435272|NCT01289275|smoking abstinence|smoking abstinence
435273|NCT01289275|tobacco use disorder|tobacco use disorder
435274|NCT01289275|hospital|hospital
435275|NCT01289275|cardiopulmonary diseases|cardiopulmonary diseases
435276|NCT01289275|disparity|disparity
435277|NCT01289262|Cesarean section|cesarean section
435278|NCT01289262|Kerr incision|kerr incision
435279|NCT01289262|Purse string suturing in CS|purse string suturing in cs
435280|NCT01289262|Continuous locked suturing in CS|continuous locked suturing in cs
435281|NCT01289249|meropenem|meropenem
435282|NCT01289249|child|child
435283|NCT01289249|bacterial infection|bacterial infection
435284|NCT01289249|treatment evaluation|treatment evaluation
435285|NCT01289236|Shoulder Pain|shoulder pain
435286|NCT01289223|Indolent B-cell NHL, bendamustine, rituximab, progression-free survival|indolent b-cell nhl, bendamustine, rituximab, progression-free survival
435287|NCT01289210|B cell|b cell
435288|NCT01289210|lymphoma|lymphoma
435289|NCT01289184|Occupational Health Hazards|occupational health hazards
435290|NCT01289184|Air Pollution|air pollution
435291|NCT01289184|Photocopiers|photocopiers
435292|NCT01289184|Other Specified Personal Exposures|other specified personal exposures
435293|NCT01289184|History Presenting Hazards to Health|history presenting hazards to health
435294|NCT01289171|The efficacy, tolerability and safety of 15% glycolic acid lotion for treatment of diffuse flat warts among HIV+ children were investigated|the efficacy, tolerability and safety of 15% glycolic acid lotion for treatment of diffuse flat warts among hiv+ children were investigated
435295|NCT01289158|malonic and methylmalonic aciduria|malonic and methylmalonic aciduria
435296|NCT01289158|malonyl-coenzyme A decarboxylase|malonyl-coenzyme a decarboxylase
435297|NCT01289158|MLYCD|mlycd
435298|NCT01289145|Action Planning|action planning
435299|NCT01289145|Positive Outcome Expectancies|positive outcome expectancies
435300|NCT01289145|Randomized Controlled Trial|randomized controlled trial
435301|NCT01289145|Stages of change|stages of change
435302|NCT01289145|Health behavior|health behavior
435303|NCT01289145|Motivation|motivation
435304|NCT01289132|Drug Therapy|drug therapy
435305|NCT01289119|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
435306|NCT01289119|Drug Therapy|drug therapy
435307|NCT01289106|Hepatitis B vaccine|hepatitis b vaccine
435308|NCT01289106|HIV infection|hiv infection
435309|NCT01289106|Modified HBV vaccine dose|modified hbv vaccine dose
435310|NCT01289106|Modified HBV vaccine schedule|modified hbv vaccine schedule
435311|NCT01289093|inguinal hernia|inguinal hernia
435312|NCT01289093|incisional hernia|incisional hernia
435313|NCT01289093|quality of life|quality of life
435314|NCT01289093|disease-specific|disease-specific
435315|NCT01289080|Schizophrenia|schizophrenia
435316|NCT01289080|psychiatric disorders|psychiatric disorders
435317|NCT01289080|renal failure|renal failure
435318|NCT01289067|Metastatic|metastatic
435319|NCT01289067|Castration Resistant|castration resistant
435320|NCT01289067|Prostate Cancer|prostate cancer
435321|NCT01289054|Female|female
435322|NCT01289054|Pregnancy|pregnancy
435323|NCT01289054|Hematologic Pregnancy|hematologic pregnancy
435324|NCT01289054|Complications|complications
435325|NCT01289054|Registry|registry
435326|NCT01289054|Pregnant Registry|pregnant registry
435327|NCT01289054|CML|cml
435328|NCT01289054|GIST|gist
435329|NCT01289054|Gleevec|gleevec
435330|NCT01289054|Tasigna|tasigna
435331|NCT01289054|Glivec|glivec
435332|NCT01289054|Pregnancy Exposure|pregnancy exposure
435333|NCT01289041|Advanced endometrial cancer|advanced endometrial cancer
435334|NCT01289041|PI3K pathway|pi3k pathway
435335|NCT01289041|second-line treatment|second-line treatment
435336|NCT01289028|GIST|gist
435337|NCT01289028|Imatinib|imatinib
435338|NCT01289028|Sunitinib|sunitinib
435339|NCT01289028|Gastrointestinal|gastrointestinal
435340|NCT01289028|Stromal|stromal
435341|NCT01289028|Tumors|tumors
435342|NCT01289015|fungal infection|fungal infection
435343|NCT01289015|athlete foot|athlete foot
435344|NCT01288989|Advanced Solid Tumors|advanced solid tumors
435345|NCT01288976|Mitral Valve|mitral valve
435346|NCT01288976|Mitral Regurgitation|mitral regurgitation
435347|NCT01288976|MitraClip|mitraclip
435348|NCT01288976|Mitral Valve Surgery|mitral valve surgery
435349|NCT01288976|Mitral Valve Insufficiency or Mitral Regurgitation|mitral valve insufficiency or mitral regurgitation
435350|NCT01288963|melanoma|melanoma
435351|NCT01288963|IL-2|il-2
435352|NCT01288963|Aldesleukin|aldesleukin
435353|NCT01288950|BCG vaccine|bcg vaccine
435354|NCT01288950|Vitamin D|vitamin d
435355|NCT01288950|Cholecalciferol|cholecalciferol
435356|NCT01288950|Tuberculosis|tuberculosis
435357|NCT01288937|Milnacipran|milnacipran
435358|NCT01288937|Idiopathic Peripheral Neuropathy|idiopathic peripheral neuropathy
435359|NCT01288937|Diabetic neuropathy|diabetic neuropathy
435360|NCT01288937|Neuropathic pain|neuropathic pain
435361|NCT01288911|Metastatic|metastatic
435362|NCT01288911|MDV3100|mdv3100
435363|NCT01288911|Prostate|prostate
435364|NCT01288911|progressive|progressive
435365|NCT01288911|Cancer|cancer
435366|NCT01288911|enzalutamide|enzalutamide
435367|NCT01288898|ASP1941|asp1941
435368|NCT01288898|Diabetes Mellitus|diabetes mellitus
435369|NCT01288898|Multiple ascending doses|multiple ascending doses
435370|NCT01288898|Healthy subjects|healthy subjects
435371|NCT01288885|ASP1941|asp1941
435372|NCT01288885|Diabetes Mellitus|diabetes mellitus
435373|NCT01288885|First in Men|first in men
435374|NCT01288872|Praziquantal, Schistosomiasis, pregnant women, Philippines|praziquantal, schistosomiasis, pregnant women, philippines
435375|NCT01288859|polyphenols|polyphenols
435376|NCT01288859|curcumin|curcumin
435377|NCT01288859|bioavailability|bioavailability
435378|NCT01288859|cocoa|cocoa
435379|NCT01288846|medication list|medication list
435380|NCT01288846|changes in medication|changes in medication
435381|NCT01288846|prescription medication|prescription medication
435382|NCT01288833|Colonoscopy|colonoscopy
435383|NCT01288833|Diagnostic Imaging|diagnostic imaging
435384|NCT01288833|Colorectal Neoplasm|colorectal neoplasm
435385|NCT01288833|Primary Prevention|primary prevention
435386|NCT01288833|Cost and Cost Analysis|cost and cost analysis
435387|NCT01288833|Endoscopy|endoscopy
435388|NCT01288807|Fibromyalgia|fibromyalgia
435389|NCT01288807|pain|pain
435390|NCT01288794|Cirrhosis|cirrhosis
435391|NCT01288794|Uncomplicated ascites|uncomplicated ascites
435392|NCT01288794|Refractory ascites|refractory ascites
435393|NCT01288794|Chronic albumin treatment|chronic albumin treatment
435394|NCT01288781|High Altitude Headache; intra-cranial pressure; hypoxia|high altitude headache; intra-cranial pressure; hypoxia
435395|NCT01288768|Meniscal injury|meniscal injury
435396|NCT01288768|Knee arthroscopy|knee arthroscopy
435397|NCT01288768|Middleaged|middleaged
435398|NCT01288768|Functional outcome|functional outcome
435399|NCT01288755|TMC278-TiDP6-C153|tmc278-tidp6-c153
435400|NCT01288755|TMC278-C153|tmc278-c153
435401|NCT01288755|TMC278|tmc278
435402|NCT01288755|HIV|hiv
435403|NCT01288742|TMC435-TiDP16-C108|tmc435-tidp16-c108
435404|NCT01288742|TMC435-C108|tmc435-c108
435405|NCT01288742|TMC435|tmc435
435406|NCT01288742|HPC|hpc
435407|NCT01288742|HCV|hcv
435408|NCT01288742|Hepatitis C|hepatitis c
435409|NCT01288716|ASD|asd
435410|NCT01288716|Autism|autism
435411|NCT01288716|Asperger Syndrome|asperger syndrome
435412|NCT01288703|urinary incontinence|urinary incontinence
435413|NCT01288690|Refugees|refugees
435414|NCT01288690|Trauma|trauma
435415|NCT01288690|Narrative|narrative
435416|NCT01288690|Exposure|exposure
435417|NCT01288690|Middle East|middle east
435418|NCT01288690|Therapy|therapy
435419|NCT01288677|Healthy volunteer|healthy volunteer
435420|NCT01288677|TMC649128HPC1001|tmc649128hpc1001
435421|NCT01288677|TMC649128|tmc649128
435422|NCT01288677|HCV|hcv
435423|NCT01288677|Hepatitis C|hepatitis c
435424|NCT01288677|healthy volunteers|healthy volunteers
435425|NCT01288677|Phase I trial|phase i trial
435426|NCT01288664|Lupus Nephritis|lupus nephritis
435427|NCT01288664|Tacrolimus|tacrolimus
435428|NCT01288664|Induction Phase|induction phase
435429|NCT01288651|Pulmonary arterial hypertension|pulmonary arterial hypertension
435430|NCT01288651|Iron deficiency|iron deficiency
435431|NCT01288651|Exercise|exercise
435432|NCT01288638|Polycystic Ovary Syndrome|polycystic ovary syndrome
435433|NCT01288638|Metabolic Syndrome|metabolic syndrome
435434|NCT01288638|Pulse|pulse
435435|NCT01288638|Lifestyle Intervention|lifestyle intervention
435436|NCT01288638|Aerobic Exercise|aerobic exercise
435437|NCT01288638|Diet|diet
435438|NCT01288625|Identify whether Cytofos can reduce the incidence and duration of HNC patients' oral mucositis caused by radiotherapy.|identify whether cytofos can reduce the incidence and duration of hnc patients' oral mucositis caused by radiotherapy.
435439|NCT01288612|Barrett's Esophagus|barrett's esophagus
435440|NCT01288599|Laparoscopy|laparoscopy
435441|NCT01288599|Randomized|randomized
435442|NCT01288599|Single port access|single port access
435443|NCT01288599|Adnexal disease|adnexal disease
435444|NCT01288599|LESS|less
435445|NCT01288586|Post Traumatic Arthritis|post traumatic arthritis
435446|NCT01288586|Rheumatoid Arthritis|rheumatoid arthritis
435447|NCT01288586|Osteoarthritis|osteoarthritis
435448|NCT01288560|medical imaging|medical imaging
435449|NCT01288560|heart failure|heart failure
435450|NCT01288560|morbidity and mortality|morbidity and mortality
435451|NCT01288560|PET/CT,CMR,SPECT, echo, coronary angiography|pet/ct,cmr,spect, echo, coronary angiography
435452|NCT01288560|knowledge translation|knowledge translation
435453|NCT01288560|cost effectiveness|cost effectiveness
435454|NCT01288560|quality of life|quality of life
435455|NCT01288560|prospective comparative effectiveness randomized clinical trial|prospective comparative effectiveness randomized clinical trial
435456|NCT01288547|cognition|cognition
435457|NCT01288547|attention|attention
435458|NCT01288547|methylxanthine|methylxanthine
435459|NCT01288521|kidney transplantation|kidney transplantation
435460|NCT01288521|tacrolimus|tacrolimus
435461|NCT01288521|P-glycoprotein|p-glycoprotein
435462|NCT01288521|ABCB1|abcb1
435463|NCT01288521|genotyping|genotyping
435464|NCT01288482|Methacholine challenge|methacholine challenge
435465|NCT01288482|nebulizer|nebulizer
435466|NCT01288482|English-Wright|english-wright
435467|NCT01288482|AeroEclipse II|aeroeclipse ii
435468|NCT01288469|10020603|10020603
435469|NCT01288456|medical device, space-occupying device|medical device, space-occupying device
435470|NCT01288430|Heat shock protein 90|heat shock protein 90
435471|NCT01288430|Advanced solid tumors|advanced solid tumors
435472|NCT01288430|Non-small cell lung carcinoma|non-small cell lung carcinoma
435473|NCT01288430|Epidermal growth factor receptor|epidermal growth factor receptor
435474|NCT01288430|Tyrosine kinase inhibitor acquired resistance|tyrosine kinase inhibitor acquired resistance
435475|NCT01288430|Non-small cell lung carcinoma with acquired resistance to erlotinib, gefitinib, afatinib or others.|non-small cell lung carcinoma with acquired resistance to erlotinib, gefitinib, afatinib or others.
435476|NCT01288417|HIV infections|hiv infections
435477|NCT01288417|HCV infections|hcv infections
435478|NCT01288417|interaction|interaction
435479|NCT01288417|pharmacokinetics|pharmacokinetics
435480|NCT01288417|raltegravir|raltegravir
435481|NCT01288417|boceprevir|boceprevir
435482|NCT01288404|Bevacizumab, impending recurrent pterygium|bevacizumab, impending recurrent pterygium
435483|NCT01288378|fungal infection|fungal infection
435484|NCT01288378|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
435485|NCT01288378|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
435486|NCT01288378|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
435487|NCT01288378|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
435488|NCT01288378|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
435489|NCT01288378|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
435490|NCT01288378|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
435491|NCT01288378|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
435492|NCT01288378|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
435493|NCT01288378|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
435494|NCT01288378|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
435495|NCT01288378|secondary acute myeloid leukemia|secondary acute myeloid leukemia
435496|NCT01288365|heart failure|heart failure
435497|NCT01288365|preserved ejection fraction|preserved ejection fraction
435498|NCT01288352|early treatment|early treatment
435499|NCT01288352|rhythm control|rhythm control
435500|NCT01288352|atrial fibrillation|atrial fibrillation
435501|NCT01288352|cardiovascular complications|cardiovascular complications
435502|NCT01288313|human milk|human milk
435503|NCT01288313|polyunsaturated fatty acids|polyunsaturated fatty acids
435504|NCT01288313|linolenic acid|linolenic acid
435505|NCT01288313|rapeseed oil|rapeseed oil
435506|NCT01288287|Certolizumab pegol|certolizumab pegol
435507|NCT01288287|Cimzia®|cimzia®
435508|NCT01288274|Contraception|contraception
435509|NCT01288274|Family planning|family planning
435510|NCT01288274|Task Shifting|task shifting
435511|NCT01288274|Community based distribution|community based distribution
435512|NCT01288274|Ethiopia|ethiopia
435513|NCT01288274|DMPA|dmpa
435514|NCT01288248|Airway|airway
435515|NCT01288248|Airway laryngeal mask|airway laryngeal mask
435516|NCT01288248|Endotracheal tube|endotracheal tube
435517|NCT01288248|Respiration artificial|respiration artificial
435518|NCT01288248|Laryngospasm|laryngospasm
435519|NCT01288248|Safety of airway laryngeal mask|safety of airway laryngeal mask
435520|NCT01288235|proton radiotherapy|proton radiotherapy
435521|NCT01288222|acute myelogenous leukemia|acute myelogenous leukemia
435522|NCT01288222|hematopoietic cell transplantation|hematopoietic cell transplantation
435523|NCT01288222|unrelated donor|unrelated donor
435524|NCT01288209|Hepatitis C, Chronic|hepatitis c, chronic
435525|NCT01288209|Hepatitis C|hepatitis c
435526|NCT01288209|Hepatitis C virus|hepatitis c virus
435527|NCT01288209|Interferon Alfa-2a|interferon alfa-2a
435528|NCT01288209|Ribavirin|ribavirin
435529|NCT01288209|Viral RNA|viral rna
435530|NCT01288196|CNTO 6785|cnto 6785
435531|NCT01288196|Intravenous|intravenous
435532|NCT01288196|Subcutaneous|subcutaneous
435533|NCT01288196|Pharmacokinetics|pharmacokinetics
435534|NCT01288196|Immunogenicity|immunogenicity
435535|NCT01288196|Safety|safety
435536|NCT01288196|Tolerability|tolerability
435537|NCT01288183|tobacco|tobacco
435538|NCT01288183|smoking|smoking
435539|NCT01288183|tDCS|tdcs
435540|NCT01288183|DLPFC|dlpfc
435541|NCT01288170|cystic fibrosis, bioequivalence, pharmacokinetic, sputum, plasma|cystic fibrosis, bioequivalence, pharmacokinetic, sputum, plasma
435542|NCT01288157|healthy|healthy
435543|NCT01288157|adult|adult
435544|NCT01288157|Chinese|chinese
435545|NCT01288157|male|male
435546|NCT01288157|Simponi|simponi
435547|NCT01288157|CNTO 148|cnto 148
435548|NCT01288144|Screening|screening
435549|NCT01288144|Gestational diabetes mellitus|gestational diabetes mellitus
435550|NCT01288131|Anti-r-HuEpo antibody|anti-r-huepo antibody
435551|NCT01288131|Anti-r-HuEpo associated PRCA|anti-r-huepo associated prca
435552|NCT01288131|Treatment|treatment
435553|NCT01288131|Absolute reticulocyte count|absolute reticulocyte count
435554|NCT01288105|drug-eluting stents|drug-eluting stents
435555|NCT01288105|noncardiac surgery|noncardiac surgery
435556|NCT01288092|Metastatic breast cancer|metastatic breast cancer
435557|NCT01288092|HER2 negative|her2 negative
435558|NCT01288092|HR positive|hr positive
435559|NCT01288092|PI3K pathway|pi3k pathway
435560|NCT01288092|no more than 2 prior lines of chemotherapy|no more than 2 prior lines of chemotherapy
435561|NCT01288092|Metastatic Breast Cancer(MBC)|metastatic breast cancer(mbc)
435562|NCT01288079|Major Depressive Disorder|major depressive disorder
435563|NCT01288079|MDD|mdd
435564|NCT01288079|Monotherapy|monotherapy
435565|NCT01288079|Inadequate Response to Antidepressant Therapy|inadequate response to antidepressant therapy
435566|NCT01288066|Shoulder|shoulder
435567|NCT01288066|Total arthroplasty|total arthroplasty
435568|NCT01288066|Hemiarthroplasty|hemiarthroplasty
435569|NCT01288066|Resurfacing|resurfacing
435570|NCT01288066|Glenoid|glenoid
435571|NCT01288066|Constant score|constant score
435572|NCT01288040|stroke|stroke
435573|NCT01288040|treadmill|treadmill
435574|NCT01288040|walking|walking
435575|NCT01288040|hemiparesis|hemiparesis
435576|NCT01288040|training|training
435577|NCT01288014|immune response|immune response
435578|NCT01288014|varicella zoster virus (VZV)|varicella zoster virus (vzv)
435579|NCT01288014|cytokine levels|cytokine levels
435580|NCT01288014|immunization|immunization
435581|NCT01287975|Stroke Rehabilitation|stroke rehabilitation
435582|NCT01287975|Brain Computer Interface|brain computer interface
435583|NCT01287975|Upper Limb Rehabilitation|upper limb rehabilitation
435584|NCT01287975|EEG-based Motor Imagery|eeg-based motor imagery
435585|NCT01287975|Robotic Rehabilitation|robotic rehabilitation
435586|NCT01287975|Haptic Knob|haptic knob
435587|NCT01287962|Apatinib|apatinib
435588|NCT01287962|Non-small Cell Lung Cancer|non-small cell lung cancer
435589|NCT01287962|VEGFR TKIs|vegfr tkis
435590|NCT01287949|Diphtheria|diphtheria
435591|NCT01287949|Tetanus|tetanus
435592|NCT01287949|Poliomyelitis|poliomyelitis
435593|NCT01287949|Pertussis (acellular)|pertussis (acellular)
435594|NCT01287949|Biological/vaccine|biological/vaccine
435595|NCT01287936|Chronic Stroke|chronic stroke
435596|NCT01287936|Stable Stroke|stable stroke
435597|NCT01287923|Hematology|hematology
435598|NCT01287923|Secondary lymphoid organs|secondary lymphoid organs
435599|NCT01287910|Cardiac|cardiac
435600|NCT01287910|Angina|angina
435601|NCT01287910|Chest pain|chest pain
435602|NCT01287897|Crohn's Disease|crohn's disease
435603|NCT01287897|safety|safety
435604|NCT01287897|efficacy|efficacy
435605|NCT01287897|pharmacokinetics|pharmacokinetics
435606|NCT01287897|pharmacodynamics|pharmacodynamics
435607|NCT01287897|Crohn's Disease Activity Index (CDAI)|crohn's disease activity index (cdai)
435608|NCT01287884|ABG|abg
435609|NCT01287884|VBG|vbg
435610|NCT01287884|pH|ph
435611|NCT01287884|pCO2|pco2
435612|NCT01287871|Cervical Cancer Screening|cervical cancer screening
435613|NCT01287845|Prostate cancer|prostate cancer
435614|NCT01287845|Neoplasm|neoplasm
435615|NCT01287845|Diagnostic Imaging|diagnostic imaging
435616|NCT01287845|PET (Positron Emission Tomography) -tracer|pet (positron emission tomography) -tracer
435617|NCT01287845|PET-diagnosis|pet-diagnosis
435618|NCT01287832|Methicillin-resistant|methicillin-resistant
435619|NCT01287832|Staphylococcus aureus|staphylococcus aureus
435620|NCT01287806|ulinastatin|ulinastatin
435621|NCT01287806|inhalation injury|inhalation injury
435622|NCT01287780|Humans|humans
435623|NCT01287780|Prostheses and Implants|prostheses and implants
435624|NCT01287780|Gentamicin administration and dosage|gentamicin administration and dosage
435625|NCT01287780|Surgical sponges|surgical sponges
435626|NCT01287780|Treatment outcomes|treatment outcomes
435627|NCT01287767|Dementia|dementia
435628|NCT01287767|Depression|depression
435629|NCT01287767|Burden of care|burden of care
435630|NCT01287767|Psychosocial intervention|psychosocial intervention
435631|NCT01287767|Family home care|family home care
435632|NCT01287702|early feeding|early feeding
435633|NCT01287702|varices bleeding|varices bleeding
435634|NCT01287702|to evaluate impact of early feeding on early rebleeding after ligation of varices|to evaluate impact of early feeding on early rebleeding after ligation of varices
435635|NCT01287689|Non-interventional trial|non-interventional trial
435636|NCT01287689|immunodeficiency|immunodeficiency
435637|NCT01287689|outcome study, registry|outcome study, registry
435638|NCT01287689|long-term outcomes, drug utilization|long-term outcomes, drug utilization
435639|NCT01287689|effectiveness, treatment patterns|effectiveness, treatment patterns
435640|NCT01287689|patient characteristics under real life conditions|patient characteristics under real life conditions
435641|NCT01287689|factors for treatment success|factors for treatment success
435642|NCT01287689|long-term tolerability|long-term tolerability
435643|NCT01287689|quality of life|quality of life
435644|NCT01287637|Rectal cancer|rectal cancer
435645|NCT01287637|Temporary ileostomy|temporary ileostomy
435646|NCT01287637|Ealy reversal|ealy reversal
435647|NCT01287637|Morbidity|morbidity
435648|NCT01287637|Mortality|mortality
435649|NCT01287637|Quality of life|quality of life
435650|NCT01287637|Economic effect|economic effect
435651|NCT01287624|triple negative breast cancer|triple negative breast cancer
435652|NCT01287624|fine line chemotherapy|fine line chemotherapy
435653|NCT01287611|Cesarean section|cesarean section
435654|NCT01287611|Kerr incision|kerr incision
435655|NCT01287611|Purse string suturing in C/S|purse string suturing in c/s
435656|NCT01287611|Continuous locked suturing in C/S|continuous locked suturing in c/s
435657|NCT01287598|Phase I|phase i
435658|NCT01287598|Probe substrate|probe substrate
435659|NCT01287598|target therapy|target therapy
435660|NCT01287598|small molecule|small molecule
435661|NCT01287598|pharmacokinetics|pharmacokinetics
435662|NCT01287585|Hepatocellular carcinoma|hepatocellular carcinoma
435663|NCT01287585|Arginine|arginine
435664|NCT01287585|Arginine deiminase|arginine deiminase
435665|NCT01287585|ADI-PEG 20|adi-peg 20
435666|NCT01287572|TcCO2|tcco2
435667|NCT01287572|sedation|sedation
435668|NCT01287572|procedure|procedure
435669|NCT01287572|PICU|picu
435670|NCT01287559|NEC|nec
435671|NCT01287559|Premature Infant|premature infant
435672|NCT01287533|Rheumatoid arthritis|rheumatoid arthritis
435673|NCT01287533|Glucocorticoid induced osteoporosis|glucocorticoid induced osteoporosis
435674|NCT01287533|Vertebral fracture|vertebral fracture
435675|NCT01287507|VLBW, NEC, Late onset sepsis|vlbw, nec, late onset sepsis
435676|NCT01287494|elderly|elderly
435677|NCT01287494|care management|care management
435678|NCT01287494|primary care|primary care
435679|NCT01287481|Fibromyalgia|fibromyalgia
435680|NCT01287481|Behavioral interventions|behavioral interventions
435681|NCT01287481|Psychological interventions|psychological interventions
435682|NCT01287468|phytomedicines|phytomedicines
435683|NCT01287468|breast cancer|breast cancer
435684|NCT01287468|stromal fibroblasts|stromal fibroblasts
435685|NCT01287468|MDSCs|mdscs
435686|NCT01287468|functional mechanism|functional mechanism
435687|NCT01287455|Asthma|asthma
435688|NCT01287455|Vitamin D|vitamin d
435689|NCT01287455|airway reactivity|airway reactivity
435690|NCT01287455|metacholine challenge test|metacholine challenge test
435691|NCT01287429|Ultrasonography|ultrasonography
435692|NCT01287416|Suicide Intervention|suicide intervention
435693|NCT01287416|Applied Suicide Intervention Skills Training (ASIST)|applied suicide intervention skills training (asist)
435694|NCT01287416|Resilience Retreat|resilience retreat
435695|NCT01287416|First Nations|first nations
435696|NCT01287416|Suicide Intervention and Response Inventory (SIRI)|suicide intervention and response inventory (siri)
435697|NCT01287403|Cereals|cereals
435698|NCT01287403|Alkylresorcinols|alkylresorcinols
435699|NCT01287403|Betaine|betaine
435700|NCT01287403|Phenolics|phenolics
435701|NCT01287403|Plasma and urine cereal phytochemicals|plasma and urine cereal phytochemicals
435702|NCT01287390|squamous cell carcinoma|squamous cell carcinoma
435703|NCT01287390|oral cavity|oral cavity
435704|NCT01287390|oropharynx|oropharynx
435705|NCT01287390|hypopharynx|hypopharynx
435706|NCT01287390|larynx|larynx
435707|NCT01287377|tobacco cessation|tobacco cessation
435708|NCT01287377|smoking cessation|smoking cessation
435709|NCT01287377|nicotine|nicotine
435710|NCT01287377|counseling|counseling
435711|NCT01287377|telephone|telephone
435712|NCT01287377|self-help|self-help
435713|NCT01287377|smoking abstinence|smoking abstinence
435714|NCT01287377|tobacco use disorder|tobacco use disorder
435715|NCT01287377|nicotine replacement therapy|nicotine replacement therapy
435716|NCT01287364|perennial allergic rhinitis|perennial allergic rhinitis
435717|NCT01287364|PAR|par
435718|NCT01287351|Real-world|real-world
435719|NCT01287351|observational|observational
435720|NCT01287351|Fluticasone propionate|fluticasone propionate
435721|NCT01287351|Metred dose inhaler|metred dose inhaler
435722|NCT01287351|Extra-fine hydrofluoroalkane|extra-fine hydrofluoroalkane
435723|NCT01287351|Asthma management|asthma management
435724|NCT01287351|Inhaled corticosteroids|inhaled corticosteroids
435725|NCT01287351|Beclomethasone dipropionate|beclomethasone dipropionate
435726|NCT01287351|USA|usa
435727|NCT01287325|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
435728|NCT01287325|Cough|cough
435729|NCT01287325|DNK333|dnk333
435730|NCT01287312|We will treat children age 1 month to 20 years with recurrent TEF after surgical failure|we will treat children age 1 month to 20 years with recurrent tef after surgical failure
435731|NCT01287299|pregnancy|pregnancy
435732|NCT01287299|obesity|obesity
435733|NCT01287299|diet glycemic load|diet glycemic load
435734|NCT01287299|body composition|body composition
435735|NCT01287299|body fat|body fat
435736|NCT01287299|gestational weight gain|gestational weight gain
435737|NCT01287299|insulin resistance|insulin resistance
435738|NCT01287286|Cancers|cancers
435739|NCT01287286|Antrodia cinnamomea|antrodia cinnamomea
435740|NCT01287286|Chemotherapy|chemotherapy
435741|NCT01287286|Gastrointestinal Disorder|gastrointestinal disorder
435742|NCT01287273|frozen-thawed|frozen-thawed
435743|NCT01287273|IVF|ivf
435744|NCT01287273|incubation|incubation
435745|NCT01287273|pregnancy rate|pregnancy rate
435746|NCT01287273|Pregnancy rate of frozen-thawed embryos of IVF treatments|pregnancy rate of frozen-thawed embryos of ivf treatments
435747|NCT01287260|BAYA1040_Nifedipine|baya1040_nifedipine
435748|NCT01287260|Nifedipine|nifedipine
435749|NCT01287260|Essential hypertension|essential hypertension
435750|NCT01287260|Japanese Patients|japanese patients
435751|NCT01287260|Phase III|phase iii
435752|NCT01287260|13176|13176
435753|NCT01287247|Cervical dystonia|cervical dystonia
435754|NCT01287247|Blepharospasm|blepharospasm
435755|NCT01287208|Physical activity|physical activity
435756|NCT01287208|Accelerometer|accelerometer
435757|NCT01287208|Steps|steps
435758|NCT01287208|Medical residents|medical residents
435759|NCT01287195|Ulcerative Colitis|ulcerative colitis
435760|NCT01287195|Inflammatory Bowel Disease|inflammatory bowel disease
435761|NCT01287182|Asymptomatic Myocardial Ischemic patients|asymptomatic myocardial ischemic patients
435762|NCT01287169|Bisphenol A|bisphenol a
435763|NCT01287156|Recruitment|recruitment
435764|NCT01287156|TBI|tbi
435765|NCT01287156|Screening|screening
435766|NCT01287156|Traumatic Brain Injury|traumatic brain injury
435767|NCT01287143|Fever|fever
435768|NCT01287143|Signs and Symptoms|signs and symptoms
435769|NCT01287143|Febrile Assessment Tool (FAST)|febrile assessment tool (fast)
435770|NCT01287130|Antibodies|antibodies
435771|NCT01287130|Pharmacokinetics|pharmacokinetics
435772|NCT01287130|Kinase Inhibitors|kinase inhibitors
435773|NCT01287130|Colon Cancer|colon cancer
435774|NCT01287130|K-Ras|k-ras
435775|NCT01287130|Colorectal Cancer|colorectal cancer
435776|NCT01287130|Solid Tumor|solid tumor
435777|NCT01287104|Leukemia/Lymphoma|leukemia/lymphoma
435778|NCT01287104|Hematologic Malignacies|hematologic malignacies
435779|NCT01287104|Leukemia|leukemia
435780|NCT01287104|Lymphoma|lymphoma
435781|NCT01287104|Ewing Sarcoma|ewing sarcoma
435782|NCT01287104|Rhabdomyosarcoma|rhabdomyosarcoma
435783|NCT01287104|Neuroblastoma|neuroblastoma
435784|NCT01287104|Healthy Donor|healthy donor
435785|NCT01287078|Chronic GVHD of the Lung|chronic gvhd of the lung
435786|NCT01287078|Peripheral Blood Stem Cell Transplant|peripheral blood stem cell transplant
435787|NCT01287078|Inhaled Cyclosporine|inhaled cyclosporine
435788|NCT01287078|Graft-Versus-Host Disease|graft-versus-host disease
435789|NCT01287078|GVHD|gvhd
435790|NCT01287078|Bronchiolitis Obliterans|bronchiolitis obliterans
435791|NCT01287078|Lung|lung
435792|NCT01287065|Fluticasone furoate|fluticasone furoate
435793|NCT01287065|Vilanterol|vilanterol
435794|NCT01287065|Efficacy|efficacy
435795|NCT01287065|FEV1|fev1
435796|NCT01287065|FF/VI Inhalation powder|ff/vi inhalation powder
435797|NCT01287052|Migraine|migraine
435798|NCT01287052|Pediatric|pediatric
435799|NCT01287052|Adolescent|adolescent
435800|NCT01287052|Nitrous Oxide|nitrous oxide
435801|NCT01287026|MRI Catheterization|mri catheterization
435802|NCT01287026|Right Heart Catheterization|right heart catheterization
435803|NCT01287026|Pulmonary Artery Catheterization|pulmonary artery catheterization
435804|NCT01287026|MRI Safety|mri safety
435805|NCT01287026|Jugular Vein Catheterization|jugular vein catheterization
435806|NCT01287026|Heart Catheterization|heart catheterization
435807|NCT01287026|Heart Disease|heart disease
435808|NCT01287026|Cardiovascular Disease|cardiovascular disease
435809|NCT01287013|Image Guided Procedures|image guided procedures
435810|NCT01287013|Xperguide CT|xperguide ct
435811|NCT01287013|Electromagnetic Tracking|electromagnetic tracking
435812|NCT01287013|Navigation|navigation
435813|NCT01287013|Image Guided Procedure|image guided procedure
435814|NCT01287013|Cancer|cancer
435815|NCT01287013|Granuloma|granuloma
435816|NCT01287000|Respiratory Health Outcomes|respiratory health outcomes
435817|NCT01287000|Petroleum|petroleum
435818|NCT01287000|Dispersant(s)|dispersant(s)
435819|NCT01287000|Oil Spill|oil spill
435820|NCT01287000|Longitudinal Study|longitudinal study
435821|NCT01286987|BRCA1 Protein|brca1 protein
435822|NCT01286987|BRCA2 Protein|brca2 protein
435823|NCT01286961|Bowel preparation|bowel preparation
435824|NCT01286961|Polyethylene glycols|polyethylene glycols
435825|NCT01286961|Colonoscopy|colonoscopy
435826|NCT01286961|Outpatient|outpatient
435827|NCT01286948|LNG gel|lng gel
435828|NCT01286948|oral LNG|oral lng
435829|NCT01286948|follicle rupture|follicle rupture
435830|NCT01286948|intra-vaginal administration|intra-vaginal administration
435831|NCT01286948|growth of the leading follicle|growth of the leading follicle
435832|NCT01286948|preovulatory peak of serum luteinizing hormone|preovulatory peak of serum luteinizing hormone
435833|NCT01286948|characteristics of the cervical mucus|characteristics of the cervical mucus
435834|NCT01286948|serum levels of estradiol (E2) and progesterone (P)|serum levels of estradiol (e2) and progesterone (p)
435835|NCT01286935|Parkinson's Disease|parkinson's disease
435836|NCT01286935|PD|pd
435837|NCT01286935|Levodopa|levodopa
435838|NCT01286935|Patients with idiopathic Parkinson's Disease with motor fluctuations,|patients with idiopathic parkinson's disease with motor fluctuations,
435839|NCT01286922|diabetes|diabetes
435840|NCT01286922|exercise|exercise
435841|NCT01286922|insulin resistance|insulin resistance
435842|NCT01286922|interval training|interval training
435843|NCT01286922|physical activity|physical activity
435844|NCT01286909|Metabolic|metabolic
435845|NCT01286896|advanced solid tumors|advanced solid tumors
435846|NCT01286883|stem cell markers|stem cell markers
435847|NCT01286883|prognostic markers|prognostic markers
435848|NCT01286883|metastatic colorectal cancer|metastatic colorectal cancer
435849|NCT01286883|circulating tumor cells|circulating tumor cells
435850|NCT01286883|tumor microenvironment|tumor microenvironment
435851|NCT01286883|colorectal cancer|colorectal cancer
435852|NCT01286883|advanced colorectal cancer|advanced colorectal cancer
435853|NCT01286870|Primary Breast Reconstruction|primary breast reconstruction
435854|NCT01286831|Accelerator Mass Spectrometry (AMS)|accelerator mass spectrometry (ams)
435855|NCT01286831|Beta-2 agonist|beta-2 agonist
435856|NCT01286831|Absorption, Distribution, Metabolism and Excretion (ADME)|absorption, distribution, metabolism and excretion (adme)
435857|NCT01286831|Radiolabel|radiolabel
435858|NCT01286818|Colon Cancer|colon cancer
435859|NCT01286818|Rectal Cancer|rectal cancer
435860|NCT01286766|unresectable|unresectable
435861|NCT01286766|locally advanced|locally advanced
435862|NCT01286740|HIV-1|hiv-1
435863|NCT01286740|HIV|hiv
435864|NCT01286740|Treatment Experienced|treatment experienced
435865|NCT01286701|Bioequivalence|bioequivalence
435866|NCT01286701|crossover|crossover
435867|NCT01286701|Terbinafine hydrochloride|terbinafine hydrochloride
435868|NCT01286701|fed|fed
435869|NCT01286688|Bioequivalence|bioequivalence
435870|NCT01286688|crossover|crossover
435871|NCT01286688|Terbinafine hydrochloride|terbinafine hydrochloride
435872|NCT01286688|Fasting|fasting
435873|NCT01286675|ASCT|asct
435874|NCT01286675|G-CSF|g-csf
435875|NCT01286662|gardner syndrome|gardner syndrome
435876|NCT01286662|colorectal carcinoma|colorectal carcinoma
435877|NCT01286662|desmoid tumor|desmoid tumor
435878|NCT01286662|resection|resection
435879|NCT01286662|colon|colon
435880|NCT01286649|Alopecia|alopecia
435881|NCT01286649|Alopecia, Androgenetic|alopecia, androgenetic
435882|NCT01286649|Androgenetic Alopecia|androgenetic alopecia
435883|NCT01286636|artificial neural network|artificial neural network
435884|NCT01286610|vibration|vibration
435885|NCT01286610|ICU|icu
435886|NCT01286610|blood pressure|blood pressure
435887|NCT01286610|intracranial pressure|intracranial pressure
435888|NCT01286610|infection|infection
435889|NCT01286610|indirect calorimetry|indirect calorimetry
435890|NCT01286597|lactose intolerance|lactose intolerance
435891|NCT01286597|DNA sequencing|dna sequencing
435892|NCT01286597|psychosocial factors|psychosocial factors
435893|NCT01286597|irritable bowel syndrome|irritable bowel syndrome
435894|NCT01286597|visceral hypersensitivity|visceral hypersensitivity
435895|NCT01286584|varenicline|varenicline
435896|NCT01286584|alcohol|alcohol
435897|NCT01286584|placebo|placebo
435898|NCT01286584|smoking cessation|smoking cessation
435899|NCT01286545|Ankylosing spondylitis|ankylosing spondylitis
435900|NCT01286545|Infliximab|infliximab
435901|NCT01286545|Radiographic progression|radiographic progression
435902|NCT01286532|Asthma, Asthma in Children|asthma, asthma in children
435903|NCT01286519|pharmacokinetics|pharmacokinetics
435904|NCT01286506|Pulse pressure variation|pulse pressure variation
435905|NCT01286506|Continuous venovenous hemodialysis|continuous venovenous hemodialysis
435906|NCT01286506|Volume status|volume status
435907|NCT01286506|Critical care|critical care
435908|NCT01286493|HIV|hiv
435909|NCT01286493|booster|booster
435910|NCT01286493|rabies|rabies
435911|NCT01286493|immune response|immune response
435912|NCT01286480|Health Care Transition|health care transition
435913|NCT01286480|Adolescent|adolescent
435914|NCT01286467|PF-04449913|pf-04449913
435915|NCT01286467|Hedgehog Inhibitor|hedgehog inhibitor
435916|NCT01286467|Solid tumor|solid tumor
435917|NCT01286467|Pharmacokinetics|pharmacokinetics
435918|NCT01286467|Safety|safety
435919|NCT01286467|Pharmacodynamics|pharmacodynamics
435920|NCT01286454|BIOAVAILABILITY|bioavailability
435921|NCT01286454|FOOD EFFECT|food effect
435922|NCT01286441|Verruca vulgaris|verruca vulgaris
435923|NCT01286428|liver|liver
435924|NCT01286428|cancer|cancer
435925|NCT01286428|tumor|tumor
435926|NCT01286428|ablation|ablation
435927|NCT01286428|Pathfinder|pathfinder
435928|NCT01286415|Posttraumatic Stress Disorder|posttraumatic stress disorder
435929|NCT01286415|Cognitive Processing Therapy|cognitive processing therapy
435930|NCT01286415|combat|combat
435931|NCT01286415|military|military
435932|NCT01286415|CPT|cpt
435933|NCT01286415|group therapy|group therapy
435934|NCT01286402|Smoking cessation during pregnancy|smoking cessation during pregnancy
435935|NCT01286402|bupropion|bupropion
435936|NCT01286389|Mild cognitive impairment|mild cognitive impairment
435937|NCT01286389|Dementia|dementia
435938|NCT01286389|Obesity|obesity
435939|NCT01286389|Overweight|overweight
435940|NCT01286389|diet|diet
435941|NCT01286389|caloric restriction|caloric restriction
435942|NCT01286389|body composition|body composition
435943|NCT01286389|weight loss|weight loss
435944|NCT01286376|Symbiotics|symbiotics
435945|NCT01286376|Fiber|fiber
435946|NCT01286376|Constipation|constipation
435947|NCT01286363|Bite force|bite force
435948|NCT01286363|Dental occlusion|dental occlusion
435949|NCT01286363|Face|face
435950|NCT01286363|Mastication|mastication
435951|NCT01286363|Morphology|morphology
435952|NCT01286350|motivational interviewing|motivational interviewing
435953|NCT01286350|problem solving skills training|problem solving skills training
435954|NCT01286350|family communication|family communication
435955|NCT01286350|social support|social support
435956|NCT01286350|adolescents|adolescents
435957|NCT01286337|axilla|axilla
435958|NCT01286337|surgery|surgery
435959|NCT01286337|technique|technique
435960|NCT01286337|bipolar vessel sealing|bipolar vessel sealing
435961|NCT01286324|Matricaria|matricaria
435962|NCT01286324|Chamomile|chamomile
435963|NCT01286324|Herb|herb
435964|NCT01286324|Insomnia|insomnia
435965|NCT01286311|Health Education|health education
435966|NCT01286311|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
435967|NCT01286311|Hypolipidemic Agents/therapeutic use|hypolipidemic agents/therapeutic use
435968|NCT01286311|Patient Education as Topic|patient education as topic
435969|NCT01286298|diode laser|diode laser
435970|NCT01286298|gingival enlargement|gingival enlargement
435971|NCT01286298|gingival overgrowth|gingival overgrowth
435972|NCT01286298|gingival hyperplasia|gingival hyperplasia
435973|NCT01286298|orthodontics|orthodontics
435974|NCT01286285|influenza|influenza
435975|NCT01286285|acute respiratory infections|acute respiratory infections
435976|NCT01286285|paediatric|paediatric
435977|NCT01286285|intensive care units|intensive care units
435978|NCT01286285|epidemiology|epidemiology
435979|NCT01286259|HIV|hiv
435980|NCT01286259|HAART suppressed|haart suppressed
435981|NCT01286259|Disulfiram|disulfiram
435982|NCT01286259|Antabuse|antabuse
435983|NCT01286259|Latent reservoir|latent reservoir
435984|NCT01286259|Eradication|eradication
435985|NCT01286259|Cure|cure
435986|NCT01286246|Progesterone|progesterone
435987|NCT01286246|Randomized controlled trial|randomized controlled trial
435988|NCT01286233|fatigue|fatigue
435989|NCT01286233|sleep disorders|sleep disorders
435990|NCT01286233|depression|depression
435991|NCT01286233|stage IA breast cancer|stage ia breast cancer
435992|NCT01286233|stage IB breast cancer|stage ib breast cancer
435993|NCT01286233|stage II breast cancer|stage ii breast cancer
435994|NCT01286233|stage IIIA breast cancer|stage iiia breast cancer
435995|NCT01286207|Migraine headache|migraine headache
435996|NCT01286181|COPD|copd
435997|NCT01286181|Biofeedback|biofeedback
435998|NCT01286181|Dyspnea|dyspnea
435999|NCT01286181|Quality of life|quality of life
436000|NCT01286181|Stress|stress
436001|NCT01286168|Bilateral breast mastectomy|bilateral breast mastectomy
436002|NCT01286168|Immediate tissue expanders reconstruction|immediate tissue expanders reconstruction
436003|NCT01286155|Barrett's esophagus|barrett's esophagus
436004|NCT01286155|gastroesophageal reflux disease|gastroesophageal reflux disease
436005|NCT01286155|GERD|gerd
436006|NCT01286142|Prospective, Observational Safety Study|prospective, observational safety study
436007|NCT01286116|heart failure|heart failure
436008|NCT01286116|percutaneous|percutaneous
436009|NCT01286116|interventional cardiology|interventional cardiology
436010|NCT01286116|apical remodeling|apical remodeling
436011|NCT01286116|LV dilatation|lv dilatation
436012|NCT01286116|akinesis|akinesis
436013|NCT01286116|dyskinesis|dyskinesis
436014|NCT01286116|myocardial infarction|myocardial infarction
436015|NCT01286103|Canagliflozin|canagliflozin
436016|NCT01286103|Pharmacokinetics|pharmacokinetics
436017|NCT01286103|Pharmacodynamics|pharmacodynamics
436018|NCT01286090|Cisapride (PREPULSID)|cisapride (prepulsid)
436019|NCT01286090|Placebo|placebo
436020|NCT01286090|Diabetes mellitus|diabetes mellitus
436021|NCT01286090|Diabetic gastroparesis|diabetic gastroparesis
436022|NCT01286077|Multiple Myeloma|multiple myeloma
436023|NCT01286077|bortezomib|bortezomib
436024|NCT01286077|hematology|hematology
436025|NCT01286077|bone marrow cancer|bone marrow cancer
436026|NCT01286077|Myeloma-related bone disease|myeloma-related bone disease
436027|NCT01286077|bone mineral density|bone mineral density
436028|NCT01286077|bone markers|bone markers
436029|NCT01286064|adenocarcinoma,|adenocarcinoma,
436030|NCT01286064|colorectal tumors,|colorectal tumors,
436031|NCT01286064|endogenous porphyrins,|endogenous porphyrins,
436032|NCT01286064|fluorescence,|fluorescence,
436033|NCT01286064|tumor markers.|tumor markers.
436034|NCT01286051|ovulation induction, GnRH|ovulation induction, gnrh
436035|NCT01286038|platelets|platelets
436036|NCT01286025|medical education|medical education
436037|NCT01286025|problem-based learning|problem-based learning
436038|NCT01286025|interactive tutorial|interactive tutorial
436039|NCT01286012|End Stage Renal Disease, Hemodialysis, SFP|end stage renal disease, hemodialysis, sfp
436040|NCT01285986|Graft patency|graft patency
436041|NCT01285986|Limb salvage|limb salvage
436042|NCT01285960|Uterine fibroids|uterine fibroids
436043|NCT01285960|MRgFUS|mrgfus
436044|NCT01285960|ExAblate|exablate
436045|NCT01285960|Focused Ultrasound|focused ultrasound
436046|NCT01285960|Symptomatic uterine fibroids|symptomatic uterine fibroids
436047|NCT01285947|pain experience|pain experience
436048|NCT01285947|energy devices|energy devices
436049|NCT01285947|Ulthera|ulthera
436050|NCT01285947|Thermage|thermage
436051|NCT01285947|VBeam|vbeam
436052|NCT01285921|hippocampal|hippocampal
436053|NCT01285921|vestibular test|vestibular test
436054|NCT01285908|Baroreceptor|baroreceptor
436055|NCT01285908|Norepinephrine|norepinephrine
436056|NCT01285908|Orthostatic Hypotension|orthostatic hypotension
436057|NCT01285908|Sympathetic Nervous System|sympathetic nervous system
436058|NCT01285908|Blood Pressure|blood pressure
436059|NCT01285895|Lung and heart transplantations|lung and heart transplantations
436060|NCT01285895|Mucoviscidosis|mucoviscidosis
436061|NCT01285895|Educational needs|educational needs
436062|NCT01285882|Lung transplantations|lung transplantations
436063|NCT01285882|Representations|representations
436064|NCT01285882|Mucoviscidosis|mucoviscidosis
436065|NCT01285869|Pneumonia|pneumonia
436066|NCT01285869|Intervention Studies|intervention studies
436067|NCT01285869|Aged|aged
436068|NCT01285869|Aged, 80 and over|aged, 80 and over
436069|NCT01285869|Geriatric Assessment|geriatric assessment
436070|NCT01285856|patients|patients
436071|NCT01285856|illicit consumption of psychotropic agents and alcohol|illicit consumption of psychotropic agents and alcohol
436072|NCT01285856|buprenorphine|buprenorphine
436073|NCT01285856|methadone|methadone
436074|NCT01285830|Infants|infants
436075|NCT01285830|Probiotics|probiotics
436076|NCT01285830|Prevention|prevention
436077|NCT01285830|Lactobacillus reuteri|lactobacillus reuteri
436078|NCT01285830|Eczema|eczema
436079|NCT01285830|IgE|ige
436080|NCT01285830|Sensitization|sensitization
436081|NCT01285830|Microbiota|microbiota
436082|NCT01285830|Chemokines|chemokines
436083|NCT01285791|morbid obesity|morbid obesity
436084|NCT01285791|intra-abdominal visceral fat|intra-abdominal visceral fat
436085|NCT01285791|gastric bypass|gastric bypass
436086|NCT01285791|sleeve gastrectomy|sleeve gastrectomy
436087|NCT01285791|gastric banding|gastric banding
436088|NCT01285791|visceral fat|visceral fat
436089|NCT01285778|Anal squamous cell carcinoma|anal squamous cell carcinoma
436090|NCT01285778|panitumumab|panitumumab
436091|NCT01285778|chemoradiation|chemoradiation
436092|NCT01285778|anal cancer|anal cancer
436093|NCT01285778|GEMCAD-09-02|gemcad-09-02
436094|NCT01285739|Pulmonary Disease, Chronic Obstructive.|pulmonary disease, chronic obstructive.
436095|NCT01285739|Tracheostomy.|tracheostomy.
436096|NCT01285739|Invasive Mechanical Ventilation.|invasive mechanical ventilation.
436097|NCT01285739|Non-Invasive Mechanical Ventilation.|non-invasive mechanical ventilation.
436098|NCT01285726|Peritoneal dialysis|peritoneal dialysis
436099|NCT01285726|Hydration status|hydration status
436100|NCT01285726|Residual renal function|residual renal function
436101|NCT01285726|Bioimpedance spectroscopy|bioimpedance spectroscopy
436102|NCT01285726|Body composition monitor|body composition monitor
436103|NCT01285713|Dehydration|dehydration
436104|NCT01285713|Gastroenteritis|gastroenteritis
436105|NCT01285713|Dehydration in Gastroenteritis|dehydration in gastroenteritis
436106|NCT01285687|Tonsillectomy|tonsillectomy
436107|NCT01285687|Post-Operative Pain|post-operative pain
436108|NCT01285687|Acupuncture|acupuncture
436109|NCT01285674|cisplatin|cisplatin
436110|NCT01285674|ototoxicity|ototoxicity
436111|NCT01285674|intratympanic steroids|intratympanic steroids
436112|NCT01285661|Deep venous thrombosis|deep venous thrombosis
436113|NCT01285661|Pulmonary embolism|pulmonary embolism
436114|NCT01285661|Ultrasonography|ultrasonography
436115|NCT01285661|D-dimer|d-dimer
436116|NCT01285661|Venous thromboembolism|venous thromboembolism
436117|NCT01285661|Bleeding|bleeding
436118|NCT01285648|chest tubes,|chest tubes,
436119|NCT01285648|Continuous Positive Airway Pressure,|continuous positive airway pressure,
436120|NCT01285648|lung resection, thoracic surgery,|lung resection, thoracic surgery,
436121|NCT01285648|noninvasive ventilation,|noninvasive ventilation,
436122|NCT01285648|postoperative|postoperative
436123|NCT01285622|Surgery; gynecological|surgery; gynecological
436124|NCT01285622|Stroke volume|stroke volume
436125|NCT01285596|Pharmacokinetics|pharmacokinetics
436126|NCT01285596|Cardiography|cardiography
436127|NCT01285596|Impedance|impedance
436128|NCT01285596|Age groups|age groups
436129|NCT01285596|Gender Identity|gender identity
436130|NCT01285583|Amyotrophoc Lateral Sclerosis|amyotrophoc lateral sclerosis
436131|NCT01285583|TRO19622|tro19622
436132|NCT01285583|Olesoxime|olesoxime
436133|NCT01285583|Trophos|trophos
436134|NCT01285557|Gastric Cancer , S-1, Phase 3|gastric cancer , s-1, phase 3
436135|NCT01285544|statins|statins
436136|NCT01285544|cholesterol|cholesterol
436137|NCT01285544|hypercholesterolemia|hypercholesterolemia
436138|NCT01285544|atorvastatin|atorvastatin
436139|NCT01285544|Dyslipidemia in cardiovascular disease (KoLipinon)|dyslipidemia in cardiovascular disease (kolipinon)
436140|NCT01285531|lumbar puncture|lumbar puncture
436141|NCT01285531|Compass|compass
436142|NCT01285531|pressure transducer|pressure transducer
436143|NCT01285531|manometry|manometry
436144|NCT01285531|The focus of the study is to improve lumbar puncture(LP)success, reduce the number of LP attempts, reduce the number of traumatic attempts.|the focus of the study is to improve lumbar puncture(lp)success, reduce the number of lp attempts, reduce the number of traumatic attempts.
436145|NCT01285518|Type 2 diabetes|type 2 diabetes
436146|NCT01285518|intravenous|intravenous
436147|NCT01285518|single dose|single dose
436148|NCT01285505|alprazolam|alprazolam
436149|NCT01285505|sublingual|sublingual
436150|NCT01285505|bioequivalence|bioequivalence
436151|NCT01285492|COPD|copd
436152|NCT01285492|QVA149|qva149
436153|NCT01285492|NVA237|nva237
436154|NCT01285492|indacaterol|indacaterol
436155|NCT01285492|combination bronchodilator|combination bronchodilator
436156|NCT01285479|Fingolimod|fingolimod
436157|NCT01285479|FTY720|fty720
436158|NCT01285479|Gilenya|gilenya
436159|NCT01285479|Multiple sclerosis|multiple sclerosis
436160|NCT01285479|MS|ms
436161|NCT01285479|Safety|safety
436162|NCT01285479|Pregnancy|pregnancy
436163|NCT01285479|Pregnancy outcomes|pregnancy outcomes
436164|NCT01285466|Cancer|cancer
436165|NCT01285466|BEZ235|bez235
436166|NCT01285466|BKM120|bkm120
436167|NCT01285466|paclitaxel|paclitaxel
436168|NCT01285466|trastuzumab|trastuzumab
436169|NCT01285453|ASA404,|asa404,
436170|NCT01285453|vadimezan,|vadimezan,
436171|NCT01285453|docetaxel|docetaxel
436172|NCT01285440|breast|breast
436173|NCT01285440|biopsy|biopsy
436174|NCT01285440|suspicious lesion|suspicious lesion
436175|NCT01285440|molecular breast imaging|molecular breast imaging
436176|NCT01285427|DNA, sequencing|dna, sequencing
436177|NCT01285427|Identification and definition of Class I and II Human Leukocyte Antigens (HLA)|identification and definition of class i and ii human leukocyte antigens (hla)
436178|NCT01285414|Glioblastoma|glioblastoma
436179|NCT01285414|Brain Neoplasms|brain neoplasms
436180|NCT01285414|Brain Cancer|brain cancer
436181|NCT01285414|Verubulin|verubulin
436182|NCT01285401|Multiple Sclerosis|multiple sclerosis
436183|NCT01285401|Rebif|rebif
436184|NCT01285401|VigantOL® oil|vigantol® oil
436185|NCT01285401|Vitamin D|vitamin d
436186|NCT01285401|Add-on treatment|add-on treatment
436187|NCT01285388|Safety|safety
436188|NCT01285388|Tolerability|tolerability
436189|NCT01285388|Pharmacokinetic|pharmacokinetic
436190|NCT01285362|Fatty Liver Disease|fatty liver disease
436191|NCT01285362|Hepatic Steatosis|hepatic steatosis
436192|NCT01285362|Docosahexaenoic Acid|docosahexaenoic acid
436193|NCT01285362|Eicosapentanoic Acid|eicosapentanoic acid
436194|NCT01285362|Omega-3 Fatty Acids|omega-3 fatty acids
436195|NCT01285362|Elevated Transaminases|elevated transaminases
436196|NCT01285362|Fish oil supplements|fish oil supplements
436197|NCT01285349|HIV, STI, condom use, drug use,|hiv, sti, condom use, drug use,
436198|NCT01285336|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
436199|NCT01285336|DNA repair system|dna repair system
436200|NCT01285336|polymorphism|polymorphism
436201|NCT01285336|susceptibility|susceptibility
436202|NCT01285336|copy number variation (CNV)|copy number variation (cnv)
436203|NCT01285310|Rheumatoid, Arthritis|rheumatoid, arthritis
436204|NCT01285297|Transmyocardial revascularization (TMR)|transmyocardial revascularization (tmr)
436205|NCT01285297|Bone marrow aspirate concentrate (BMAC)|bone marrow aspirate concentrate (bmac)
436206|NCT01285297|Angina|angina
436207|NCT01285284|Colonoscopy|colonoscopy
436208|NCT01285284|Music|music
436209|NCT01285284|Tolerance|tolerance
436210|NCT01285284|Pain|pain
436211|NCT01285284|Anxiety|anxiety
436212|NCT01285284|Dose of sedative drugs administered during the procedure|dose of sedative drugs administered during the procedure
436213|NCT01285271|xenon|xenon
436214|NCT01285271|sevoflurane|sevoflurane
436215|NCT01285271|cardiac anesthesia|cardiac anesthesia
436216|NCT01285271|CABG|cabg
436217|NCT01285271|Bypass surgery|bypass surgery
436218|NCT01285258|Peripartum|peripartum
436219|NCT01285258|hysterectomy|hysterectomy
436220|NCT01285258|placenta accreta|placenta accreta
436221|NCT01285258|mortality|mortality
436222|NCT01285245|insulin sensitivity|insulin sensitivity
437007|NCT01281319|mycoplasma|mycoplasma
436223|NCT01285245|interleukin-1 receptor antagonist|interleukin-1 receptor antagonist
436224|NCT01285245|inflammation|inflammation
436225|NCT01285245|hyperglycemia-induced insulin resistance|hyperglycemia-induced insulin resistance
436226|NCT01285219|Granulocyte colony-stimulating factor , recombinant|granulocyte colony-stimulating factor , recombinant
436227|NCT01285219|Polyethylene glycols|polyethylene glycols
436228|NCT01285219|Neutropenia|neutropenia
436229|NCT01285219|Drug therapy, combination|drug therapy, combination
436230|NCT01285193|hypertension|hypertension
436231|NCT01285193|high blood pressure|high blood pressure
436232|NCT01285193|treatment|treatment
436233|NCT01285193|breath control|breath control
436234|NCT01285193|breathing exercise|breathing exercise
436235|NCT01285193|audio CD|audio cd
436236|NCT01285180|COPD|copd
436237|NCT01285180|Quality of life|quality of life
436238|NCT01285180|sociodemographic data|sociodemographic data
436239|NCT01285180|cost-of-illness data|cost-of-illness data
436240|NCT01285180|roflumilast|roflumilast
436241|NCT01285180|Daxas|daxas
436242|NCT01285167|COPD|copd
436243|NCT01285167|Quality of life|quality of life
436244|NCT01285167|lung function|lung function
436245|NCT01285167|spirometry|spirometry
436246|NCT01285167|roflumilast|roflumilast
436247|NCT01285167|Daxas|daxas
436248|NCT01285167|severe COPD|severe copd
436249|NCT01285154|Hip dysplasia|hip dysplasia
436250|NCT01285154|Triple Osteotomy|triple osteotomy
436251|NCT01285154|Femoral Head Coverage|femoral head coverage
436252|NCT01285154|Femoral Head Medialization|femoral head medialization
436253|NCT01285141|HIV Infections|hiv infections
436254|NCT01285141|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
436255|NCT01285115|Generalized anxiety disorder|generalized anxiety disorder
436256|NCT01285115|Jingji-zhengchong|jingji-zhengchong
436257|NCT01285115|Gamisoyosan|gamisoyosan
436258|NCT01285115|anxiety|anxiety
436259|NCT01285063|overweight|overweight
436260|NCT01285063|obesity|obesity
436261|NCT01285063|physical fitness|physical fitness
436262|NCT01285063|kinder garden|kinder garden
436263|NCT01285063|preschool|preschool
436264|NCT01285050|HIV|hiv
436265|NCT01285050|Human immunodeficiency virus|human immunodeficiency virus
436266|NCT01285050|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
436267|NCT01285050|AIDS Virus|aids virus
436268|NCT01285050|Immunodeficiency Virus, Human|immunodeficiency virus, human
436269|NCT01285050|Virus, Human Immunodeficiency|virus, human immunodeficiency
436270|NCT01285050|Hepatitis C|hepatitis c
436271|NCT01285050|Hepatitis C, chronic|hepatitis c, chronic
436272|NCT01285050|Hepatitis C virus|hepatitis c virus
436273|NCT01285050|Hepatitis C antibodies|hepatitis c antibodies
436274|NCT01285050|Hepatitis C antigens|hepatitis c antigens
436275|NCT01285024|total hip arthroplasty|total hip arthroplasty
436276|NCT01285024|transfusion|transfusion
436277|NCT01285024|hemostat|hemostat
436278|NCT01285011|arthrodesis|arthrodesis
436279|NCT01285011|PIP joint|pip joint
436280|NCT01284998|forefoot deformities|forefoot deformities
436281|NCT01284998|basal osteotomy|basal osteotomy
436282|NCT01284959|cognitive function|cognitive function
436283|NCT01284959|subjective experiences|subjective experiences
436284|NCT01284959|neuroleptic-induced deficit syndrome|neuroleptic-induced deficit syndrome
436285|NCT01284959|paliperidone extended-release|paliperidone extended-release
436286|NCT01284959|risperidone|risperidone
436287|NCT01284946|PCT sporadic or familial|pct sporadic or familial
436288|NCT01284946|Skin fragility and bullae lesions|skin fragility and bullae lesions
436289|NCT01284946|non-transfusion iron overload|non-transfusion iron overload
436290|NCT01284933|Stroke|stroke
436291|NCT01284933|Ischemic Attack, Transient|ischemic attack, transient
436292|NCT01284933|Magnetic Resonance Imaging|magnetic resonance imaging
436293|NCT01284933|Carotid Arteries|carotid arteries
436294|NCT01284933|Carotid Artery Plaque|carotid artery plaque
436295|NCT01284933|Atherosclerosis|atherosclerosis
436296|NCT01284920|MDV3100|mdv3100
436297|NCT01284920|Response Evaluation Criteria in Solid Tumor (RECIST)|response evaluation criteria in solid tumor (recist)
436298|NCT01284920|docetaxel|docetaxel
436299|NCT01284920|PSA level|psa level
436300|NCT01284907|Asthma|asthma
436301|NCT01284907|Asthma therapy|asthma therapy
436302|NCT01284907|Randomized controlled trial|randomized controlled trial
436303|NCT01284907|children|children
436304|NCT01284894|Dysphagia|dysphagia
436305|NCT01284894|Conventional manometry|conventional manometry
436306|NCT01284894|High resolution manometry|high resolution manometry
436307|NCT01284881|MRA|mra
436308|NCT01284881|compliance|compliance
436309|NCT01284881|OSAHS|osahs
436310|NCT01284868|Mechanisms of Pharmacological Action|mechanisms of pharmacological action
436311|NCT01284868|Pharmacodynamics|pharmacodynamics
436312|NCT01284868|Pharmacokinetics|pharmacokinetics
436313|NCT01284855|neurotoxic envenoming (WHO ICD-10 T63.0)|neurotoxic envenoming (who icd-10 t63.0)
436314|NCT01284842|sleep-deprivation|sleep-deprivation
436315|NCT01284842|virtual reality|virtual reality
436316|NCT01284842|residency|residency
436317|NCT01284842|performance|performance
436318|NCT01284816|severely obese patients|severely obese patients
436319|NCT01284803|patients|patients
436320|NCT01284803|moderate depression|moderate depression
436321|NCT01284777|cancerology|cancerology
436322|NCT01284777|genetic|genetic
436323|NCT01284764|Endoscopy|endoscopy
436324|NCT01284764|Gastrectomy|gastrectomy
436325|NCT01284764|Stomach neoplasms|stomach neoplasms
436326|NCT01284738|TM|tm
436327|NCT01284738|TI|ti
436328|NCT01284738|MP|mp
436329|NCT01284712|treatment by bleedings|treatment by bleedings
436330|NCT01284699|Parkinson|parkinson
436331|NCT01284699|contraindication to Intracerebral electrode implantation|contraindication to intracerebral electrode implantation
436332|NCT01284699|Gamma Knife radiosurgery|gamma knife radiosurgery
436333|NCT01284686|Pathophysiology|pathophysiology
436334|NCT01284686|Parkinson|parkinson
436335|NCT01284686|neuronal oscillations|neuronal oscillations
436336|NCT01284673|Cord blood stem|cord blood stem
436337|NCT01284673|neonatal asphyxia|neonatal asphyxia
436338|NCT01284647|Chronic Erosive Gastritis|chronic erosive gastritis
436339|NCT01284647|Teprenone|teprenone
436340|NCT01284647|Sucralfate|sucralfate
436341|NCT01284634|Cannabidiol|cannabidiol
436342|NCT01284634|Fatty liver|fatty liver
436343|NCT01284634|Diabetes|diabetes
436344|NCT01284634|Body fat|body fat
436345|NCT01284608|Observational|observational
436346|NCT01284608|prospective|prospective
436347|NCT01284608|metabolic changes|metabolic changes
436348|NCT01284608|metabolic syndrome|metabolic syndrome
436349|NCT01284608|diabetes|diabetes
436350|NCT01284608|prostatic cancer|prostatic cancer
436351|NCT01284608|risk fracture|risk fracture
436352|NCT01284595|Radioactive carbon|radioactive carbon
436353|NCT01284595|Absorption|absorption
436354|NCT01284595|Distribution|distribution
436355|NCT01284595|Metabolism|metabolism
436356|NCT01284595|Excretion|excretion
436357|NCT01284595|Healthy Volunteers|healthy volunteers
436358|NCT01284582|CETP|cetp
436359|NCT01284582|Vaccine|vaccine
436360|NCT01284582|Cholesterol|cholesterol
436361|NCT01284582|Inhibition|inhibition
436362|NCT01284556|partial onset seizures|partial onset seizures
436363|NCT01284530|Epilepsy|epilepsy
436364|NCT01284530|Pediatrics|pediatrics
436365|NCT01284530|Young Adults|young adults
436366|NCT01284517|Bipolar I Depression|bipolar i depression
436367|NCT01284517|Lurasidone|lurasidone
436368|NCT01284517|Latuda|latuda
436369|NCT01284491|Breast reduction|breast reduction
436370|NCT01284491|PlasmaBlade|plasmablade
436371|NCT01284491|Electrosurgery|electrosurgery
436372|NCT01284491|PEAK Surgical|peak surgical
436373|NCT01284491|Medtronic Advanced Energy|medtronic advanced energy
436374|NCT01284491|Medtronic|medtronic
436375|NCT01284478|pseudophakic cystoid macular edema, diabetic macular edema, Irvine Gass Syndrome, cataract surgery, ozurdex, dexamethasone|pseudophakic cystoid macular edema, diabetic macular edema, irvine gass syndrome, cataract surgery, ozurdex, dexamethasone
436376|NCT01284465|Type 2 diabetes self-management|type 2 diabetes self-management
436377|NCT01284465|Minority women|minority women
436378|NCT01284465|Barriers to diabetes self-management|barriers to diabetes self-management
436379|NCT01284452|Septic shock|septic shock
436380|NCT01284452|Severe sepsis|severe sepsis
436381|NCT01284452|Acute lung injury|acute lung injury
436382|NCT01284452|Acute respiratory distress syndrome|acute respiratory distress syndrome
436383|NCT01284452|ARDS|ards
436384|NCT01284426|Chronic urticaria|chronic urticaria
436385|NCT01284426|Natural course|natural course
436386|NCT01284426|Remission|remission
436387|NCT01284400|heart failure|heart failure
436388|NCT01284400|disease management|disease management
436389|NCT01284387|Mild to moderate Alzheimer's disease|mild to moderate alzheimer's disease
436390|NCT01284387|immunization|immunization
436391|NCT01284387|amyloid imaging|amyloid imaging
436392|NCT01284387|injection|injection
436393|NCT01284387|vaccine|vaccine
436394|NCT01284374|HPV Vaccines|hpv vaccines
436395|NCT01284374|Attitude to Health|attitude to health
436396|NCT01284374|Decision Making|decision making
436397|NCT01284374|Qualitative Research|qualitative research
436398|NCT01284361|intermittent catheter|intermittent catheter
436399|NCT01284361|preference|preference
436400|NCT01284348|Chemotherapy induced anemia|chemotherapy induced anemia
436401|NCT01284348|Non-small cell lung cancer|non-small cell lung cancer
436402|NCT01284335|Advanced solid tumors|advanced solid tumors
436403|NCT01284335|Unresectable|unresectable
436404|NCT01284335|Metastatic|metastatic
436405|NCT01284335|Limited treatment options|limited treatment options
436406|NCT01284335|Measurable or nonmeasurable disease|measurable or nonmeasurable disease
436407|NCT01284309|Intraocular Pressure (IOP)|intraocular pressure (iop)
436408|NCT01284309|YM178|ym178
436409|NCT01284283|Arthrosis|arthrosis
436410|NCT01284283|Rheumatoid Arthrosis|rheumatoid arthrosis
436411|NCT01284283|Arthritic Joint|arthritic joint
436412|NCT01284283|Rheumatoid Arthritis|rheumatoid arthritis
436413|NCT01284283|Osteoarthritis|osteoarthritis
436414|NCT01284283|Total Ankle Replacement|total ankle replacement
436415|NCT01284270|Cardiac MRI|cardiac mri
436416|NCT01284270|Plaque|plaque
436417|NCT01284257|EC-MPS|ec-mps
436418|NCT01284257|MMF|mmf
436419|NCT01284257|kidney transplant|kidney transplant
436420|NCT01284257|outcomes|outcomes
436421|NCT01284257|mycophenolate sodium|mycophenolate sodium
436422|NCT01284257|mycophenolic acid (MPA)|mycophenolic acid (mpa)
436423|NCT01284244|Urinary Incontinence, Stress|urinary incontinence, stress
436424|NCT01284244|pessary|pessary
436425|NCT01284244|conservative management|conservative management
436426|NCT01284231|MEDI-565, gastrointestinal adenocarcinomas, carcinoembryonic antigen, bispecific T-cell engager|medi-565, gastrointestinal adenocarcinomas, carcinoembryonic antigen, bispecific t-cell engager
436427|NCT01284205|non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
436428|NCT01284205|superficial bladder cancer|superficial bladder cancer
436429|NCT01284192|B-cell Lymphoma|b-cell lymphoma
436430|NCT01284192|Advanced Malignancies|advanced malignancies
436431|NCT01284192|Anaplastic Lymphoma Kinase (ALK)|anaplastic lymphoma kinase (alk)
436432|NCT01284192|ASP3026|asp3026
436433|NCT01284192|Solid Tumor|solid tumor
436434|NCT01284179|Functional Chest Pain|functional chest pain
436435|NCT01284179|Functional GI Disorders|functional gi disorders
436436|NCT01284179|Home Hypnotherapy|home hypnotherapy
436437|NCT01284153|respiratory gating|respiratory gating
436438|NCT01284153|prone radiotherapy|prone radiotherapy
436439|NCT01284153|breast cancer|breast cancer
436440|NCT01284140|Critical illness|critical illness
436441|NCT01284140|Sleep|sleep
436442|NCT01284140|Polysomnography|polysomnography
436443|NCT01284140|Respiratory failure|respiratory failure
436444|NCT01284140|Circadian rhythm|circadian rhythm
436445|NCT01284140|Sedation|sedation
436446|NCT01284127|superficial siderosis|superficial siderosis
436447|NCT01284114|Elderly chronic kidney disease|elderly chronic kidney disease
436448|NCT01284114|Hypertension|hypertension
436449|NCT01284114|Aliskiren|aliskiren
436450|NCT01284088|Male Circumcision|male circumcision
436451|NCT01284088|HIV Prevention|hiv prevention
436452|NCT01284088|Medical Device|medical device
436453|NCT01284062|Active Ulcerative Colitis|active ulcerative colitis
436454|NCT01284062|Phase 2A|phase 2a
436455|NCT01284062|Double-blind|double-blind
436456|NCT01284062|Randomized|randomized
436457|NCT01284062|PK/PD Biomarker Study|pk/pd biomarker study
436458|NCT01284049|Home Parenteral Nutrition|home parenteral nutrition
436459|NCT01284049|Intralipid 20%®|intralipid 20%®
436460|NCT01284049|OMEGAVEN 10%®|omegaven 10%®
436461|NCT01284049|Liver diseases|liver diseases
436462|NCT01284036|Healthy subject|healthy subject
436463|NCT01284036|safety|safety
436464|NCT01284036|PK study|pk study
436465|NCT01284036|healthy volunteers|healthy volunteers
436466|NCT01284023|near infrared spectroscopy|near infrared spectroscopy
436467|NCT01284023|acute compartment syndrome|acute compartment syndrome
436468|NCT01284010|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
436469|NCT01283997|Multiple Myeloma|multiple myeloma
436470|NCT01283997|Neuropathy|neuropathy
436471|NCT01283997|Peripheral Nerve Function|peripheral nerve function
436472|NCT01283997|Touch Detection Threshold|touch detection threshold
436473|NCT01283997|Nerve Damage|nerve damage
436474|NCT01283997|Thalidomide|thalidomide
436475|NCT01283997|Bortezomib|bortezomib
436476|NCT01283997|Velcade|velcade
436477|NCT01283997|Minocycline|minocycline
436478|NCT01283997|Dynacin|dynacin
436479|NCT01283997|Minocin|minocin
436480|NCT01283997|Minocin PAC|minocin pac
436481|NCT01283997|Myrac|myrac
436482|NCT01283997|Solodyn|solodyn
436483|NCT01283984|Safety|safety
436484|NCT01283984|tolerability|tolerability
436485|NCT01283984|healthy|healthy
436486|NCT01283984|inhaled|inhaled
436487|NCT01283984|respiratory disease|respiratory disease
436488|NCT01283958|Iloprost, Eisenmenger's syndrome|iloprost, eisenmenger's syndrome
436489|NCT01283945|VEGFRs|vegfrs
436490|NCT01283945|FGFR1|fgfr1
436491|NCT01283945|angiogenesis|angiogenesis
436492|NCT01283906|Mucositis|mucositis
436493|NCT01283906|Head and Neck Cancer|head and neck cancer
436494|NCT01283906|Squamous Cell Cancer|squamous cell cancer
436495|NCT01283906|Chemotherapy|chemotherapy
436496|NCT01283906|Radiation Therapy|radiation therapy
436497|NCT01283906|Oral Rinse|oral rinse
436498|NCT01283880|kidney|kidney
436499|NCT01283880|transplantation|transplantation
436500|NCT01283880|metabolic acidosis|metabolic acidosis
436501|NCT01283880|renal tubular acidosis|renal tubular acidosis
436502|NCT01283880|nephrocalcinosis|nephrocalcinosis
436503|NCT01283815|Laparoscopy|laparoscopy
436504|NCT01283815|Drainage|drainage
436505|NCT01283815|Appendectomy|appendectomy
436506|NCT01283789|breast|breast
436507|NCT01283789|cancer|cancer
436508|NCT01283789|metastatic|metastatic
436509|NCT01283789|metastasis|metastasis
436510|NCT01283763|Cervical Intraepithelial Neoplasia, Imiquimod, conization|cervical intraepithelial neoplasia, imiquimod, conization
436511|NCT01283750|care coordination|care coordination
436512|NCT01283750|dementia care|dementia care
436513|NCT01283750|intervention|intervention
436514|NCT01283750|unmet needs|unmet needs
436515|NCT01283750|community|community
436516|NCT01283750|older adults|older adults
436517|NCT01283750|caregiver|caregiver
436518|NCT01283737|Osteochondritis Dissecans|osteochondritis dissecans
436519|NCT01283737|OCD|ocd
436520|NCT01283737|Mosaicplasty|mosaicplasty
436521|NCT01283737|Demineralised Bone Matrix|demineralised bone matrix
436522|NCT01283737|DBX|dbx
436523|NCT01283737|DBX Putty|dbx putty
436524|NCT01283724|Endometriosis|endometriosis
436525|NCT01283724|DEXA|dexa
436526|NCT01283724|Adolescent|adolescent
436527|NCT01283724|Safety|safety
436528|NCT01283724|Efficacy|efficacy
436529|NCT01283724|Post-menarche|post-menarche
436530|NCT01283711|wrinkles reduction|wrinkles reduction
436531|NCT01283711|rhytides reduction|rhytides reduction
436532|NCT01283711|RF treatment|rf treatment
436533|NCT01283698|psoriasis|psoriasis
436534|NCT01283698|topical|topical
436535|NCT01283698|PPT|ppt
436536|NCT01283685|Exercise, Physical|exercise, physical
436537|NCT01283672|Whole grains|whole grains
436538|NCT01283672|Barley|barley
436539|NCT01283672|Oats|oats
436540|NCT01283672|Cardiovascular disease|cardiovascular disease
436541|NCT01283672|Postprandial lipid metabolism|postprandial lipid metabolism
436542|NCT01283672|Endothelial function|endothelial function
436543|NCT01283672|Risk of cardiovascular disease in healthy men and women|risk of cardiovascular disease in healthy men and women
436544|NCT01283659|computed tomographic angiography|computed tomographic angiography
436545|NCT01283659|coronary angiogram|coronary angiogram
436546|NCT01283659|cost effectiveness|cost effectiveness
436547|NCT01283659|QoL|qol
436548|NCT01283659|Heart failure|heart failure
436549|NCT01283659|diagnostic accuracy|diagnostic accuracy
436550|NCT01283659|prospective comparative effectiveness randomized clinical trial|prospective comparative effectiveness randomized clinical trial
436551|NCT01283633|neuromodulation|neuromodulation
436552|NCT01283633|remote presence robotics|remote presence robotics
436553|NCT01283620|stroke|stroke
436554|NCT01283620|extremity, upper|extremity, upper
436555|NCT01283607|in vitro fertilization|in vitro fertilization
436556|NCT01283607|e-health|e-health
436557|NCT01283607|cognitive behavioral therapy|cognitive behavioral therapy
436558|NCT01283607|psychosocial risk profile|psychosocial risk profile
436559|NCT01283607|emotional maladjustment|emotional maladjustment
436560|NCT01283568|PMS, climacteric, depression|pms, climacteric, depression
436561|NCT01283555|Microbicide, Applicator, Safety|microbicide, applicator, safety
436562|NCT01283542|Non-functioning pituitary adenoma,|non-functioning pituitary adenoma,
436563|NCT01283542|pasireotide LAR,|pasireotide lar,
436564|NCT01283542|tumor volume|tumor volume
436565|NCT01283529|Intrathoracal blood volume|intrathoracal blood volume
436566|NCT01283529|Cardiac output|cardiac output
436567|NCT01283529|Children|children
436568|NCT01283516|ALK inhibitor,|alk inhibitor,
436569|NCT01283516|NSCLC,|nsclc,
436570|NCT01283516|LDK378,|ldk378,
436571|NCT01283516|ceritinib,|ceritinib,
436572|NCT01283516|genetic abnormalities|genetic abnormalities
436573|NCT01283503|PI3K,|pi3k,
436574|NCT01283503|Advanced solid tumor|advanced solid tumor
436575|NCT01283490|topical anesthetic, sonophoresis|topical anesthetic, sonophoresis
436576|NCT01283477|Caesarean Delivery|caesarean delivery
436577|NCT01283477|Pruritis|pruritis
436578|NCT01283477|Intrathecal Morphine|intrathecal morphine
436579|NCT01283477|Acupuncture At LI11|acupuncture at li11
436580|NCT01283464|Retinol|retinol
436581|NCT01283464|Tretinoin|tretinoin
436582|NCT01283451|near-infrared spectroscopy|near-infrared spectroscopy
436583|NCT01283425|MiniMed Paradigm insulin pump|minimed paradigm insulin pump
436584|NCT01283425|insulin Lispro|insulin lispro
436585|NCT01283425|Insulin Aspart|insulin aspart
436586|NCT01283425|Quick-set infusion set|quick-set infusion set
436587|NCT01283412|Delirium|delirium
436588|NCT01283412|Dexmedetomidine|dexmedetomidine
436589|NCT01283412|Adult Patients|adult patients
436590|NCT01283412|Elective Major Surgery|elective major surgery
436591|NCT01283412|General Anesthesia|general anesthesia
436592|NCT01283360|MSM|msm
436593|NCT01283360|HIV negative|hiv negative
436594|NCT01283360|microbicide|microbicide
436595|NCT01283360|prevention|prevention
436596|NCT01283347|Parkinson's disease|parkinson's disease
436597|NCT01283334|Head and Neck Cancer|head and neck cancer
436598|NCT01283334|Recurrent Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)|recurrent metastatic squamous cell carcinoma of the head and neck (scchn)
436599|NCT01283321|Hemostasis|hemostasis
436600|NCT01283321|Cardiopulmonary bypass (heart-lung machine)|cardiopulmonary bypass (heart-lung machine)
436601|NCT01283321|Fibrinogen|fibrinogen
436602|NCT01283321|platelet|platelet
436603|NCT01283308|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
436604|NCT01283308|India|india
436605|NCT01283308|Prevention & Control|prevention & control
436606|NCT01283308|Lifestyle Intervention|lifestyle intervention
436607|NCT01283308|Translational Research|translational research
436608|NCT01283269|Rehabilitation|rehabilitation
436609|NCT01283269|Cognitive Intervention|cognitive intervention
436610|NCT01283269|Prevention|prevention
436611|NCT01283243|ARFI Imaging|arfi imaging
436612|NCT01283243|Normal values|normal values
436613|NCT01283243|HIV infection|hiv infection
436614|NCT01283230|ARFI imaging|arfi imaging
436615|NCT01283230|normal values|normal values
436616|NCT01283230|chronic liver disease|chronic liver disease
436617|NCT01283230|liver donors|liver donors
436618|NCT01283230|kidney donors|kidney donors
436619|NCT01283191|substance use|substance use
436620|NCT01283191|drug use|drug use
436621|NCT01283191|drug abuse|drug abuse
436622|NCT01283191|exercise|exercise
436623|NCT01283191|physical activity|physical activity
436624|NCT01283178|squamous cell carcinoma of the paranasal sinus and nasal cavity|squamous cell carcinoma of the paranasal sinus and nasal cavity
436625|NCT01283165|health education|health education
436626|NCT01283165|Polyparasitism|polyparasitism
436627|NCT01283165|school based deworming program|school based deworming program
436628|NCT01283165|integrated control of parasites|integrated control of parasites
436629|NCT01283152|Hepatic Encephalopathy|hepatic encephalopathy
436630|NCT01283152|HE|he
436631|NCT01283152|Cirrhosis|cirrhosis
436632|NCT01283152|PSE|pse
436633|NCT01283152|Portosystemic Encephalopathy|portosystemic encephalopathy
436634|NCT01283152|Hepatic coma|hepatic coma
436635|NCT01283152|AMS|ams
436636|NCT01283152|Altered mental status|altered mental status
436637|NCT01283152|Complications of cirrhosis|complications of cirrhosis
436638|NCT01283152|Chronic liver disease|chronic liver disease
436639|NCT01283139|SLE|sle
436640|NCT01283139|Systemic Lupus Erythematosus|systemic lupus erythematosus
436641|NCT01283139|Sifalimumab|sifalimumab
436642|NCT01283139|MEDI-545|medi-545
436643|NCT01283126|Hypoglycemia, cognitive function|hypoglycemia, cognitive function
436644|NCT01283113|Visceral Fat|visceral fat
436645|NCT01283113|Waist Circumference|waist circumference
436646|NCT01283113|Bioelectrical Impedance|bioelectrical impedance
436647|NCT01283113|Metabolic Syndrome|metabolic syndrome
436648|NCT01283113|Obesity|obesity
436649|NCT01283113|Type 2 Diabetes|type 2 diabetes
436650|NCT01283100|HIV, GSK2248761, GSK1349572, drug interaction, pharmacokinetics|hiv, gsk2248761, gsk1349572, drug interaction, pharmacokinetics
436651|NCT01283087|TNS|tns
436652|NCT01283087|Spinal anesthesia|spinal anesthesia
436653|NCT01283087|Lidocaine|lidocaine
436654|NCT01283048|Kidney Cancer|kidney cancer
436655|NCT01283048|Avastin|avastin
436656|NCT01283022|Pharmacokinetics|pharmacokinetics
436657|NCT01283022|Misoprostol Vaginal Insert|misoprostol vaginal insert
436658|NCT01283022|Induction of labor|induction of labor
436659|NCT01283022|Cervical Ripening|cervical ripening
436660|NCT01283022|Rate of Cesarean section|rate of cesarean section
436661|NCT01283009|pneumoniae|pneumoniae
436662|NCT01282996|Mechanical ventilation|mechanical ventilation
436663|NCT01282996|Postoperative pulmonary complications|postoperative pulmonary complications
436664|NCT01282996|Positive end-expiratory pressure|positive end-expiratory pressure
436665|NCT01282996|Protective lung ventilation|protective lung ventilation
436666|NCT01282996|Alveolar recruitment maneuver|alveolar recruitment maneuver
436667|NCT01282996|General anesthesia|general anesthesia
436668|NCT01282996|Abdominal surgery|abdominal surgery
436669|NCT01282983|fiber|fiber
436670|NCT01282983|orange juice|orange juice
436671|NCT01282983|digestive symptom|digestive symptom
436672|NCT01282944|physical activity in adults 65 or older|physical activity in adults 65 or older
436673|NCT01282931|Women|women
436674|NCT01282931|Stage IV|stage iv
436675|NCT01282931|Metastatic|metastatic
436676|NCT01282931|Breast Cancer|breast cancer
436677|NCT01282931|Progressed|progressed
436678|NCT01282931|Progression|progression
436679|NCT01282918|ICD|icd
436680|NCT01282918|DF Test|df test
436681|NCT01282918|intra-operative DF testing|intra-operative df testing
436682|NCT01282918|VT|vt
436683|NCT01282892|Visceral fat|visceral fat
436684|NCT01282892|fatty liver|fatty liver
436685|NCT01282892|atherosclerosis|atherosclerosis
436686|NCT01282892|coronary computed tomography angiography|coronary computed tomography angiography
436687|NCT01282879|Itraconazole oral solution|itraconazole oral solution
436688|NCT01282879|invasive fungal infections|invasive fungal infections
436689|NCT01282879|prophylaxis|prophylaxis
436690|NCT01282879|Graft vs Host Disease|graft vs host disease
436691|NCT01282879|transplantation|transplantation
436692|NCT01282853|peptic ulcer|peptic ulcer
436693|NCT01282853|hemorrhage|hemorrhage
436694|NCT01282853|rapid urease test|rapid urease test
436695|NCT01282853|urea breath test|urea breath test
436696|NCT01282840|LUTS|luts
436697|NCT01282814|Bioequivalence|bioequivalence
436698|NCT01282814|Healthy Subjects|healthy subjects
436699|NCT01282801|Bioequivalence|bioequivalence
436700|NCT01282801|Healthy Subjects|healthy subjects
436701|NCT01282788|infant nutrition|infant nutrition
436702|NCT01282788|complementary feeding|complementary feeding
436703|NCT01282788|malnutrition|malnutrition
436704|NCT01282788|stunting of growth|stunting of growth
436705|NCT01282775|overweight|overweight
436706|NCT01282775|obesity|obesity
436707|NCT01282775|worksite|worksite
436708|NCT01282762|Prevention of Hepatitis B infection.|prevention of hepatitis b infection.
436709|NCT01282762|End Stage Renal Disease|end stage renal disease
436710|NCT01282762|Hepatitis B vaccination|hepatitis b vaccination
436711|NCT01282762|Hepatitis B virus (HBV)|hepatitis b virus (hbv)
436712|NCT01282749|Overweight|overweight
436713|NCT01282749|Obesity|obesity
436714|NCT01282749|African American|african american
436715|NCT01282749|Women|women
436716|NCT01282749|Translational|translational
436717|NCT01282749|Faith based|faith based
436718|NCT01282749|Community based participatory research|community based participatory research
436719|NCT01282736|eating disorder|eating disorder
436720|NCT01282736|binge eating|binge eating
436721|NCT01282684|Safety|safety
436722|NCT01282684|Tolerability|tolerability
436723|NCT01282684|Pharmacokinetics|pharmacokinetics
436724|NCT01282684|PLX5622|plx5622
436725|NCT01282671|breathing exercises|breathing exercises
436726|NCT01282671|cardiac surgery|cardiac surgery
436727|NCT01282671|lung function|lung function
436728|NCT01282671|postoperative complication|postoperative complication
436729|NCT01282671|positive expiratory pressure|positive expiratory pressure
436730|NCT01282658|CPT-11,pharmacogenomics,colorectal cancer|cpt-11,pharmacogenomics,colorectal cancer
436731|NCT01282645|Cranial defect|cranial defect
436732|NCT01282645|PSI|psi
436733|NCT01282645|patient specific implant|patient specific implant
436734|NCT01282645|PEEK|peek
436735|NCT01282645|polyether ether ketone|polyether ether ketone
436736|NCT01282645|craniectomy|craniectomy
436737|NCT01282645|craniotomy|craniotomy
436738|NCT01282632|depression|depression
436739|NCT01282632|treatment resistant depression|treatment resistant depression
436740|NCT01282632|unipolar|unipolar
436741|NCT01282632|non- psychotic major depression|non- psychotic major depression
436742|NCT01282632|add-on to a serotonin type antidepressants|add-on to a serotonin type antidepressants
436743|NCT01282632|risperidone|risperidone
436744|NCT01282632|olanzapine|olanzapine
436745|NCT01282632|double blind comparison|double blind comparison
436746|NCT01282632|randomized|randomized
436747|NCT01282606|Chemonucleolysis|chemonucleolysis
436748|NCT01282606|Lumbar Vertebrae|lumbar vertebrae
436749|NCT01282606|Hernia|hernia
436750|NCT01282593|TEL/ALM1_positive ALL relapses|tel/alm1_positive all relapses
436751|NCT01282580|Women at high risk of developing breast cancer|women at high risk of developing breast cancer
436752|NCT01282541|Tearing, Epiphora, Botulinum Toxin A|tearing, epiphora, botulinum toxin a
436753|NCT01282502|rectal cancer|rectal cancer
436754|NCT01282502|chemotherapy|chemotherapy
436755|NCT01282502|chemoradiation|chemoradiation
436756|NCT01282476|DLBCL (Diffuse Large B Cell Lymphoma)|dlbcl (diffuse large b cell lymphoma)
436757|NCT01282476|Panobinostat|panobinostat
436758|NCT01282476|LBH589 (Panobinostat)|lbh589 (panobinostat)
436759|NCT01282476|LBH-589 (Panobinostat)|lbh-589 (panobinostat)
436760|NCT01282476|HDAC inhibitor (Histone deacetylase inhibitor)|hdac inhibitor (histone deacetylase inhibitor)
436761|NCT01282476|DAC inhibitor (deacetylase inhibitor)|dac inhibitor (deacetylase inhibitor)
436762|NCT01282476|deacetylase inhibitor|deacetylase inhibitor
436763|NCT01282476|lymphoma|lymphoma
436764|NCT01282463|Carcinoma, Renal Cell|carcinoma, renal cell
436765|NCT01282450|Radiotherapy|radiotherapy
436766|NCT01282450|NSCLC|nsclc
436767|NCT01282424|indolent Non-Hodgkin Lymphoma|indolent non-hodgkin lymphoma
436768|NCT01282424|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
436769|NCT01282424|iNHL|inhl
436770|NCT01282424|NHL|nhl
436771|NCT01282424|GS-1101|gs-1101
436772|NCT01282424|CAL-101|cal-101
436773|NCT01282424|PI3K|pi3k
436774|NCT01282424|Phosphatidylinositol 3-kinase|phosphatidylinositol 3-kinase
436775|NCT01282424|Follicular Lymphoma (FL)|follicular lymphoma (fl)
436776|NCT01282424|Small lymphocytic lymphoma (SLL)|small lymphocytic lymphoma (sll)
436777|NCT01282424|Lymphoplasmacytoid lymphoma (LPL)|lymphoplasmacytoid lymphoma (lpl)
436778|NCT01282424|Marginal zone lymphoma (MZL)|marginal zone lymphoma (mzl)
436779|NCT01282372|Ankylosing spondylitis|ankylosing spondylitis
436780|NCT01282372|Sleep|sleep
436781|NCT01282372|Psoriatic arthritis|psoriatic arthritis
436782|NCT01282372|Work Productivity|work productivity
436783|NCT01282372|Rheumatoid Arthritis|rheumatoid arthritis
436784|NCT01282359|Educational asthma program|educational asthma program
436785|NCT01282359|Clusters analysis study|clusters analysis study
436786|NCT01282359|Asthma Control Test|asthma control test
436787|NCT01282346|Glaucoma shunt|glaucoma shunt
436788|NCT01282346|Ocular implant|ocular implant
436789|NCT01282346|Gold|gold
436790|NCT01282346|Trabeculectomy|trabeculectomy
436791|NCT01282320|Randomized Controlled Trial|randomized controlled trial
436792|NCT01282320|Clinical Tria|clinical tria
436793|NCT01282320|Postmenopause|postmenopause
436794|NCT01282320|Hot-flashes|hot-flashes
436795|NCT01282320|Quality of life|quality of life
436796|NCT01282320|Physical Fitness|physical fitness
436797|NCT01282307|Guided Self-Determination|guided self-determination
436798|NCT01282307|Improving insight|improving insight
436799|NCT01282307|Autonomy-supportive problem solving intervention|autonomy-supportive problem solving intervention
436800|NCT01282307|Evaluate the effects of the method Guided Self-Determination|evaluate the effects of the method guided self-determination
436801|NCT01282307|Improving insight in patients diagnosed with schizophrenia|improving insight in patients diagnosed with schizophrenia
436802|NCT01282281|Bipolar Disorder|bipolar disorder
436803|NCT01282281|Youth|youth
436804|NCT01282281|Adults|adults
436805|NCT01282281|Endocrine-metabolic changes|endocrine-metabolic changes
436806|NCT01282268|fragile X syndrome|fragile x syndrome
436807|NCT01282268|autism spectrum disorder|autism spectrum disorder
436808|NCT01282242|acute stroke, IV rt-PA, Activase, Alteplase|acute stroke, iv rt-pa, activase, alteplase
436809|NCT01282229|LANAP, Laser dentistry|lanap, laser dentistry
436810|NCT01282203|General surgery|general surgery
436811|NCT01282203|General anesthesia|general anesthesia
436812|NCT01282203|Inhalation anesthesia|inhalation anesthesia
436813|NCT01282203|Sevorane|sevorane
436814|NCT01282203|Sevoflurane|sevoflurane
436815|NCT01282190|dyslipidemia, motivational interview, prevention|dyslipidemia, motivational interview, prevention
436816|NCT01282177|surveillance, safety , tolerability , vaccine|surveillance, safety , tolerability , vaccine
436817|NCT01282164|glucagon stimulation test|glucagon stimulation test
436818|NCT01282164|insulin tolerance test|insulin tolerance test
436819|NCT01282164|growth hormone deficiency|growth hormone deficiency
436820|NCT01282164|hypothalamic-pituitary disorders|hypothalamic-pituitary disorders
436821|NCT01282151|NSCLC|nsclc
436822|NCT01282151|Non Squamous cell|non squamous cell
436823|NCT01282151|Docetaxel|docetaxel
436824|NCT01282151|Pemetrexed|pemetrexed
436825|NCT01282138|Allergic conjunctivitis|allergic conjunctivitis
436826|NCT01282125|general population|general population
436827|NCT01282125|prevalence|prevalence
436828|NCT01282125|Norway|norway
436829|NCT01282099|all children entering the PICU eligible for enrollment|all children entering the picu eligible for enrollment
436830|NCT01282099|age range: neonate to 16 years|age range: neonate to 16 years
436831|NCT01282086|Sevorane|sevorane
436832|NCT01282086|Sevoflurane|sevoflurane
436833|NCT01282086|General anesthesia|general anesthesia
436834|NCT01282086|Inhalation anesthesia|inhalation anesthesia
436835|NCT01282086|General surgery|general surgery
436836|NCT01282073|Idiopathic membranous nephropathy|idiopathic membranous nephropathy
436837|NCT01282073|Mycophenolate mofetil|mycophenolate mofetil
436838|NCT01282073|Proteinuria|proteinuria
436839|NCT01282073|Renal function|renal function
436840|NCT01282060|HBA1C|hba1c
436841|NCT01282060|DIABETES-RELATED COMPLICATIONS|diabetes-related complications
436842|NCT01282060|GLYCAEMIC BALANCE|glycaemic balance
436843|NCT01282047|Lenalidomide|lenalidomide
436844|NCT01282047|Kaposi|kaposi
436845|NCT01282047|HIV|hiv
436846|NCT01282047|efficacy|efficacy
436847|NCT01282047|safety|safety
436848|NCT01282034|CHONDRAL|chondral
436849|NCT01282034|OSTEOCHONDRAL|osteochondral
436850|NCT01282021|RBC Antigens|rbc antigens
436851|NCT01282021|Molecular Typing|molecular typing
436852|NCT01282021|Ethiopian Sub-Populations|ethiopian sub-populations
436853|NCT01282021|Immunohematology|immunohematology
436854|NCT01282021|Immune Response|immune response
436855|NCT01282008|Online Surveys|online surveys
436856|NCT01282008|Tobacco Corrective Statements|tobacco corrective statements
436857|NCT01282008|Message Testing|message testing
436858|NCT01282008|Focus Groups|focus groups
436859|NCT01281995|Biologic Samples|biologic samples
436860|NCT01281995|Hydrocortisone|hydrocortisone
436861|NCT01281995|Laboratory Research Specimens|laboratory research specimens
436862|NCT01281995|Glucocorticoids|glucocorticoids
436863|NCT01281995|Immune Modulation|immune modulation
436864|NCT01281995|Healthy Volunteer|healthy volunteer
436865|NCT01281995|HV|hv
436866|NCT01281982|Imaging|imaging
436867|NCT01281982|Gliomas|gliomas
436868|NCT01281982|Pet Scan|pet scan
436869|NCT01281982|Blood Brain Barrier|blood brain barrier
436870|NCT01281982|P-Glycoprotein|p-glycoprotein
436871|NCT01281982|Brain Tumor|brain tumor
436872|NCT01281982|Glioma|glioma
436873|NCT01281982|Glioblastoma Multiforme|glioblastoma multiforme
436874|NCT01281982|Astrocytoma|astrocytoma
436875|NCT01281969|Placebo Controlled|placebo controlled
436876|NCT01281969|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
436877|NCT01281969|Children and Adolescents|children and adolescents
436878|NCT01281969|Intravenous Immunoglobulin|intravenous immunoglobulin
436879|NCT01281969|PANDAS|pandas
436880|NCT01281956|Epilepsy|epilepsy
436881|NCT01281956|Drug Trial|drug trial
436882|NCT01281956|Serotonin|serotonin
436883|NCT01281956|Serotonin 1A Receptor|serotonin 1a receptor
436884|NCT01281956|Temporal Lobe Epilepsy|temporal lobe epilepsy
436885|NCT01281956|Partial Epilepsy|partial epilepsy
436886|NCT01281930|Superficial abscess|superficial abscess
436887|NCT01281930|packing material|packing material
436888|NCT01281930|wick|wick
436889|NCT01281930|incision and drainage|incision and drainage
436890|NCT01281917|velcade|velcade
436891|NCT01281917|temsirolimus|temsirolimus
436892|NCT01281917|non-hodgkins lymphoma|non-hodgkins lymphoma
436893|NCT01281891|Drug: Morphine intrathecal|drug: morphine intrathecal
436894|NCT01281891|Pain: Postoperative|pain: postoperative
436895|NCT01281891|Surgery: Total hip arthroplasty|surgery: total hip arthroplasty
436896|NCT01281878|primary hyperoxaluria|primary hyperoxaluria
436897|NCT01281878|Pyridoxal-phosphate|pyridoxal-phosphate
436898|NCT01281839|Hepatitis C|hepatitis c
436899|NCT01281839|TMC435|tmc435
436900|NCT01281839|HCV|hcv
436901|NCT01281839|Hep C|hep c
436902|NCT01281839|Genotype 1|genotype 1
436903|NCT01281813|TMC114IFD3001|tmc114ifd3001
436904|NCT01281813|TMC114|tmc114
436905|NCT01281813|HIV|hiv
436906|NCT01281813|Darunavir|darunavir
436907|NCT01281813|PREZISTA|prezista
436908|NCT01281787|FAP= post-surgery atrial fibrillation|fap= post-surgery atrial fibrillation
437008|NCT01281319|ureaplasma|ureaplasma
436909|NCT01281787|ACEI= angiotensin converting enzyme-inhibitors|acei= angiotensin converting enzyme-inhibitors
436910|NCT01281787|ARBs= angiotensin II receptor blockers|arbs= angiotensin ii receptor blockers
436911|NCT01281787|NT-proBNP= brain natriuretic peptide|nt-probnp= brain natriuretic peptide
436912|NCT01281748|acute exacerbation of COPD|acute exacerbation of copd
436913|NCT01281735|treatment outcome|treatment outcome
436914|NCT01281735|side effects|side effects
436915|NCT01281735|Protein Kinase Inhibitors|protein kinase inhibitors
436916|NCT01281735|pediatrics|pediatrics
436917|NCT01281722|healthy adults|healthy adults
436918|NCT01281722|melanoma|melanoma
436919|NCT01281696|Breast cancer|breast cancer
436920|NCT01281696|CNS metastasis|cns metastasis
436921|NCT01281696|Brain metastasis|brain metastasis
436922|NCT01281696|Leptomeningeal metastasis|leptomeningeal metastasis
436923|NCT01281696|Bevacizumab|bevacizumab
436924|NCT01281696|Etoposide|etoposide
436925|NCT01281696|Cisplatin|cisplatin
436926|NCT01281670|H reflex; muscle activation; rate of force development; whole body vibration|h reflex; muscle activation; rate of force development; whole body vibration
436927|NCT01281657|Fingolimod|fingolimod
436928|NCT01281657|FTY720|fty720
436929|NCT01281657|Relapsing forms of multiple sclerosis|relapsing forms of multiple sclerosis
436930|NCT01281657|Multiple sclerosis|multiple sclerosis
436931|NCT01281657|MS|ms
436932|NCT01281657|Safety|safety
436933|NCT01281657|Efficacy|efficacy
436934|NCT01281644|Keratosis pilaris (KP)|keratosis pilaris (kp)
436935|NCT01281631|ALS|als
436936|NCT01281618|Barrett's esophagus|barrett's esophagus
436937|NCT01281605|Type 2 diabetes|type 2 diabetes
436938|NCT01281605|Basal insulin|basal insulin
436939|NCT01281605|Insulin detemir|insulin detemir
436940|NCT01281605|Insulin titration algorithm|insulin titration algorithm
436941|NCT01281579|Pharmacokinetics|pharmacokinetics
436942|NCT01281579|Pharmacodynamics|pharmacodynamics
436943|NCT01281579|Canagliflozin|canagliflozin
436944|NCT01281566|Cisapride (Prepulsid)|cisapride (prepulsid)
436945|NCT01281566|Feeding intolerance|feeding intolerance
436946|NCT01281566|Enteral feeding|enteral feeding
436947|NCT01281566|Nasogastric tube|nasogastric tube
436948|NCT01281566|Neonate|neonate
436949|NCT01281553|Cisapride (PREPULSID)|cisapride (prepulsid)
436950|NCT01281553|Placebo|placebo
436951|NCT01281553|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
436952|NCT01281553|Gastro-oesophageal Reflux Disease (GORD)|gastro-oesophageal reflux disease (gord)
436953|NCT01281540|Cisapride ( PREPULSID )|cisapride ( prepulsid )
436954|NCT01281540|Placebo|placebo
436955|NCT01281540|Idiopathic|idiopathic
436956|NCT01281540|Stomach Diseases|stomach diseases
436957|NCT01281540|Stomach|stomach
436958|NCT01281527|Paliperidone palmitate|paliperidone palmitate
436959|NCT01281527|Schizophrenia|schizophrenia
436960|NCT01281527|Intramuscular injection|intramuscular injection
436961|NCT01281501|Dyspepsia|dyspepsia
436962|NCT01281501|Emergency treatment|emergency treatment
436963|NCT01281501|Pantoprazole|pantoprazole
436964|NCT01281501|Antacid|antacid
436965|NCT01281501|Pain measurement|pain measurement
436966|NCT01281475|Angelman syndrome|angelman syndrome
436967|NCT01281475|Levodopa|levodopa
436968|NCT01281475|Carbidopa|carbidopa
436969|NCT01281475|L-dopa|l-dopa
436970|NCT01281462|complicated Urinary Tract Infection|complicated urinary tract infection
436971|NCT01281462|Acute Pyelonephritis|acute pyelonephritis
436972|NCT01281436|childhood|childhood
436973|NCT01281436|overweight|overweight
436974|NCT01281436|obesity|obesity
436975|NCT01281436|Health information technology|health information technology
436976|NCT01281436|HeartSmartKids|heartsmartkids
436977|NCT01281436|Motivational Interviewing|motivational interviewing
436978|NCT01281410|respiratory muscles|respiratory muscles
436979|NCT01281410|hematopoetic stem cell transplantation|hematopoetic stem cell transplantation
436980|NCT01281410|inspiratory muscle training|inspiratory muscle training
436981|NCT01281397|cardiac surgery|cardiac surgery
436982|NCT01281397|aggregometry|aggregometry
436983|NCT01281397|thromboelastometry|thromboelastometry
436984|NCT01281397|platelet function|platelet function
436985|NCT01281397|bleeding|bleeding
436986|NCT01281397|antiplatelet therapy|antiplatelet therapy
436987|NCT01281384|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
436988|NCT01281384|echocardiography|echocardiography
436989|NCT01281384|heart failure|heart failure
436990|NCT01281384|imaging|imaging
436991|NCT01281384|cost effectiveness|cost effectiveness
436992|NCT01281384|quality of life|quality of life
436993|NCT01281384|definitive diagnosis|definitive diagnosis
436994|NCT01281384|prospective comparative effectiveness randomized clinical trial|prospective comparative effectiveness randomized clinical trial
436995|NCT01281358|Premature infants|premature infants
436996|NCT01281358|Motor Development|motor development
436998|NCT01281345|candida|candida
436999|NCT01281345|epidemiology|epidemiology
437000|NCT01281345|blood stream infection|blood stream infection
437001|NCT01281345|candidemia|candidemia
437002|NCT01281332|menopause|menopause
437003|NCT01281332|hot flash|hot flash
437004|NCT01281332|quality of life|quality of life
437005|NCT01281319|preterm labor|preterm labor
437006|NCT01281319|PROM|prom
437009|NCT01281319|high risk pregnancy|high risk pregnancy
437010|NCT01281306|hypertension|hypertension
437011|NCT01281306|blood pressure|blood pressure
437012|NCT01281306|LCZ696|lcz696
437013|NCT01281306|dual-acting|dual-acting
437014|NCT01281306|neprilysin|neprilysin
437015|NCT01281306|nep inhibitor|nep inhibitor
437016|NCT01281306|vasopeptidase|vasopeptidase
437017|NCT01281306|angiotensin receptor|angiotensin receptor
437018|NCT01281306|angiotensin receptor neprilysin inhibitor (ARNi)|angiotensin receptor neprilysin inhibitor (arni)
437019|NCT01281293|V-COMPAS; Vagus Nerve Stimulation Clinical Outcomes;|v-compas; vagus nerve stimulation clinical outcomes;
437020|NCT01281280|PuLsE 2, Drug-resistant Epilepsy Partial-onset Seizures|pulse 2, drug-resistant epilepsy partial-onset seizures
437021|NCT01281267|facial transplantation|facial transplantation
437022|NCT01281267|face transplantation|face transplantation
437023|NCT01281267|composite tissue allotransplantation|composite tissue allotransplantation
437024|NCT01281267|VCA|vca
437025|NCT01281267|composite tissue allograft|composite tissue allograft
437026|NCT01281267|facial allograft|facial allograft
437027|NCT01281254|Fallopian tube cancer|fallopian tube cancer
437028|NCT01281254|Primary peritoneal cancer|primary peritoneal cancer
437029|NCT01281254|AMG386|amg386
437030|NCT01281254|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
437031|NCT01281254|Recurrent epithelial ovarian cancer|recurrent epithelial ovarian cancer
437032|NCT01281241|MTWA|mtwa
437033|NCT01281241|mechanical alternans|mechanical alternans
437034|NCT01281228|Exenatide|exenatide
437035|NCT01281228|Type 2 diabetes mellitus|type 2 diabetes mellitus
437036|NCT01281228|Incretin hormones|incretin hormones
437037|NCT01281228|GLP-1 agonist|glp-1 agonist
437038|NCT01281228|Satiety|satiety
437039|NCT01281228|Reward|reward
437040|NCT01281215|Pharmaceutical Education|pharmaceutical education
437041|NCT01281215|Rational Drug Use|rational drug use
437042|NCT01281215|Asthma|asthma
437043|NCT01281202|Cocaine|cocaine
437044|NCT01281202|Cocaine Addiction Treatment|cocaine addiction treatment
437045|NCT01281202|Cocaine Treatment|cocaine treatment
437046|NCT01281202|Vigabatrin|vigabatrin
437047|NCT01281202|CPP-109|cpp-109
437048|NCT01281202|Catalyst|catalyst
437049|NCT01281202|National Institute on Drug Abuse|national institute on drug abuse
437050|NCT01281189|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
437051|NCT01281189|ALS|als
437052|NCT01281189|Motor Neurone Disease|motor neurone disease
437053|NCT01281137|stage IA breast cancer|stage ia breast cancer
437054|NCT01281137|stage IB breast cancer|stage ib breast cancer
437055|NCT01281137|stage II breast cancer|stage ii breast cancer
437056|NCT01281137|stage IIIA breast cancer|stage iiia breast cancer
437057|NCT01281098|High Risk Proliferative Diabetic Retinopathy|high risk proliferative diabetic retinopathy
437058|NCT01281098|Diabetes Mellitus Type I, Type II|diabetes mellitus type i, type ii
437059|NCT01281098|Pegaptanib|pegaptanib
437060|NCT01281098|Panretinal Photocoagulation|panretinal photocoagulation
437061|NCT01281085|Shoulder|shoulder
437062|NCT01281085|Outcome treatment|outcome treatment
437063|NCT01281085|Validation Studies|validation studies
437064|NCT01281085|Biomechanics|biomechanics
437065|NCT01281033|primary PCI|primary pci
437066|NCT01281033|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
437067|NCT01281033|thrombus aspiration|thrombus aspiration
437068|NCT01281020|Glaucoma|glaucoma
437069|NCT01281020|Adherence|adherence
437070|NCT01281020|Fixed combination therapy|fixed combination therapy
437071|NCT01281007|Herpes Simplex Virus|herpes simplex virus
437072|NCT01280994|Lung Disease|lung disease
437073|NCT01280994|Pulmonary Disease|pulmonary disease
437074|NCT01280994|Diagnostic Imaging|diagnostic imaging
437075|NCT01280994|MRI|mri
437076|NCT01280981|Menorrhagia|menorrhagia
437077|NCT01280981|Heavy Menstrual Bleeding|heavy menstrual bleeding
437078|NCT01280981|Lysteda|lysteda
437079|NCT01280955|Plerixafor and Allogeneic Myeloablative Stem Cell Transplant|plerixafor and allogeneic myeloablative stem cell transplant
437080|NCT01280942|clinical deterioration|clinical deterioration
437081|NCT01280942|detection algorithms|detection algorithms
437082|NCT01280942|automated warning systems|automated warning systems
437083|NCT01280929|High Risk Proliferative Diabetic Retinopathy|high risk proliferative diabetic retinopathy
437084|NCT01280929|Ranibizumab|ranibizumab
437085|NCT01280929|Panretinal Photocoagulation|panretinal photocoagulation
437086|NCT01280903|Osteoarthritis, Knee|osteoarthritis, knee
437087|NCT01280903|Hypertension|hypertension
437088|NCT01280903|Exercise|exercise
437089|NCT01280903|Physical activity|physical activity
437090|NCT01280903|Self Efficacy|self efficacy
437091|NCT01280903|Patient Compliance|patient compliance
437092|NCT01280903|Aged|aged
437093|NCT01280890|Dementia|dementia
437094|NCT01280890|Nursing home|nursing home
437095|NCT01280890|Person-centred Care|person-centred care
437096|NCT01280890|Staff training|staff training
437097|NCT01280877|optic neuropathy|optic neuropathy
437098|NCT01280877|visual field|visual field
437099|NCT01280877|electric stimulation|electric stimulation
437100|NCT01280877|alternating current|alternating current
437101|NCT01280877|perimetry|perimetry
437102|NCT01280851|Living renal donor|living renal donor
437103|NCT01280851|Magnetic Resonance Imaging|magnetic resonance imaging
437104|NCT01280851|Renal vascular anatomy|renal vascular anatomy
437105|NCT01280851|Renal function|renal function
437106|NCT01280812|mobile phone|mobile phone
437107|NCT01280812|physical activity|physical activity
437108|NCT01280812|women|women
437109|NCT01280812|maintenance|maintenance
437110|NCT01280812|health promotion|health promotion
437111|NCT01280812|prevention|prevention
437112|NCT01280799|Anorexia Nervosa|anorexia nervosa
437113|NCT01280799|Adolescents|adolescents
437114|NCT01280799|Family Treatment|family treatment
437115|NCT01280799|Eating Disorder|eating disorder
437116|NCT01280799|Acceptance and Commitment Therapy|acceptance and commitment therapy
437117|NCT01280786|AML|aml
437118|NCT01280786|leukemia|leukemia
437119|NCT01280786|relapsed or refractory AML|relapsed or refractory aml
437120|NCT01280773|weaning, mechanical ventilation|weaning, mechanical ventilation
437121|NCT01280747|Prior authorization|prior authorization
437122|NCT01280747|Fibromyalgia|fibromyalgia
437123|NCT01280747|Painful Diabetic Peripheral Neuropathy|painful diabetic peripheral neuropathy
437124|NCT01280747|Policy|policy
437125|NCT01280747|Real World Data|real world data
437126|NCT01280734|melatonin|melatonin
437127|NCT01280734|circadin|circadin
437128|NCT01280734|zolpidem|zolpidem
437129|NCT01280734|body sway|body sway
437130|NCT01280734|postural instability|postural instability
437131|NCT01280708|Urology|urology
437132|NCT01280708|Nephrology|nephrology
437133|NCT01280708|Renal and pancreas transplantation|renal and pancreas transplantation
437134|NCT01280708|Data base|data base
437135|NCT01280708|Epidemiology|epidemiology
437136|NCT01280695|Type 2|type 2
437137|NCT01280695|Diabetes Mellitus|diabetes mellitus
437138|NCT01280695|Diabetes|diabetes
437139|NCT01280695|High blood sugar|high blood sugar
437140|NCT01280695|Blood sugar|blood sugar
437141|NCT01280695|Blood glucose|blood glucose
437142|NCT01280695|Glucose|glucose
437143|NCT01280682|type 1 diabetes|type 1 diabetes
437144|NCT01280682|age|age
437145|NCT01280682|course of disease|course of disease
437146|NCT01280682|autoantibodies|autoantibodies
437147|NCT01280682|C-peptide levels|c-peptide levels
437148|NCT01280669|Non-infectious|non-infectious
437149|NCT01280669|Uveitis|uveitis
437150|NCT01280669|Panuveitis|panuveitis
437151|NCT01280643|stage IVA colon cancer|stage iva colon cancer
437152|NCT01280643|stage IVA rectal cancer|stage iva rectal cancer
437153|NCT01280643|stage IVB colon cancer|stage ivb colon cancer
437154|NCT01280643|stage IVB rectal cancer|stage ivb rectal cancer
437155|NCT01280630|ACS: Acute coronary syndrome Retrospective Registry|acs: acute coronary syndrome retrospective registry
437156|NCT01280617|Renal Transplant|renal transplant
437157|NCT01280617|Thymoglubulin|thymoglubulin
437158|NCT01280591|Naproxen sodium|naproxen sodium
437159|NCT01280591|Diphenhydramine|diphenhydramine
437160|NCT01280578|Migraine|migraine
437161|NCT01280565|non-resectable or metastatic stage 3 or stage 4 melanoma carrying a mutation in the juxta membrane domain of c-kit|non-resectable or metastatic stage 3 or stage 4 melanoma carrying a mutation in the juxta membrane domain of c-kit
437162|NCT01280552|Glioblastoma Multiforme|glioblastoma multiforme
437163|NCT01280539|Multiple Sclerosis|multiple sclerosis
437164|NCT01280539|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
437165|NCT01280539|Cortical Excitability|cortical excitability
437166|NCT01280487|ZSTK474|zstk474
437167|NCT01280487|PI3K inhibitor|pi3k inhibitor
437168|NCT01280474|depression during pregnancy|depression during pregnancy
437169|NCT01280474|postpartum depression|postpartum depression
437170|NCT01280474|pregnancy outcomes|pregnancy outcomes
437171|NCT01280474|newborn development|newborn development
437172|NCT01280474|paternal psychopathology|paternal psychopathology
437173|NCT01280461|Pneumonia|pneumonia
437174|NCT01280448|Lung Cancer|lung cancer
437175|NCT01280448|Tobacco Smoking|tobacco smoking
437176|NCT01280448|gene polymorphism|gene polymorphism
437177|NCT01280435|Online Discourse|online discourse
437178|NCT01280435|e-Learning|e-learning
437179|NCT01280435|Biopsy|biopsy
437180|NCT01280435|Virtual Pathologic Section|virtual pathologic section
437181|NCT01280422|ROCDR|rocdr
437182|NCT01280396|metabolic|metabolic
437183|NCT01280396|SGAs|sgas
437184|NCT01280396|clozapine|clozapine
437185|NCT01280383|non-invasive ventilation|non-invasive ventilation
437186|NCT01280383|diaphragm|diaphragm
437187|NCT01280383|electrical activity|electrical activity
437188|NCT01280383|neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
437189|NCT01280383|critically ill patients|critically ill patients
437190|NCT01280370|Incisional hernia repair|incisional hernia repair
437191|NCT01280357|Fetal Heart Rate (FHR)|fetal heart rate (fhr)
437192|NCT01280357|Uterine Activity (UA)|uterine activity (ua)
437193|NCT01280357|Labor & Delivery|labor & delivery
437194|NCT01280331|Bunionectomy|bunionectomy
437195|NCT01280305|schizophrenia|schizophrenia
437196|NCT01280305|schizoaffective disorder|schizoaffective disorder
437197|NCT01280292|central hypothyroidism, hypopituitarism, eltroxin|central hypothyroidism, hypopituitarism, eltroxin
437295|NCT01279889|cardiac output|cardiac output
437296|NCT01279889|blood pressure|blood pressure
437198|NCT01280279|Behavior modification, Behavior therapy, Nocturia, Polyuria, Quality of life|behavior modification, behavior therapy, nocturia, polyuria, quality of life
437199|NCT01280266|Pathological Conditions|pathological conditions
437200|NCT01280266|Signs and Symptoms|signs and symptoms
437201|NCT01280266|Blood circulation|blood circulation
437202|NCT01280253|Predictor|predictor
437203|NCT01280253|outcome|outcome
437204|NCT01280253|biochemical|biochemical
437205|NCT01280240|anemia|anemia
437206|NCT01280240|cancer|cancer
437207|NCT01280240|CIA|cia
437208|NCT01280227|Symptom management|symptom management
437209|NCT01280227|Symptom assessment|symptom assessment
437210|NCT01280227|Patient satisfaction|patient satisfaction
437211|NCT01280227|Patient-provider communication|patient-provider communication
437212|NCT01280201|Neuroendocrine Tumors|neuroendocrine tumors
437213|NCT01280201|Pazopanib|pazopanib
437214|NCT01280201|GETNE|getne
437215|NCT01280201|Biomarkers|biomarkers
437216|NCT01280188|Diabetes|diabetes
437217|NCT01280175|BDP|bdp
437218|NCT01280175|Formoterol|formoterol
437219|NCT01280175|pMDI|pmdi
437220|NCT01280175|Aerochamber Plus|aerochamber plus
437221|NCT01280175|Charcoal|charcoal
437222|NCT01280162|Plasmodium falciparum, Plasmodium vivax|plasmodium falciparum, plasmodium vivax
437223|NCT01280149|substance P|substance p
437224|NCT01280149|allergic rhinitis|allergic rhinitis
437225|NCT01280149|allergen immunotherapy|allergen immunotherapy
437226|NCT01280136|HIV|hiv
437227|NCT01280136|Sexually Transmitted Diseases|sexually transmitted diseases
437228|NCT01280136|Pregnancy Prevention|pregnancy prevention
437229|NCT01280136|Abstinence Education|abstinence education
437230|NCT01280136|Adolescents|adolescents
437231|NCT01280136|Sexual Health|sexual health
437232|NCT01280123|Parkinson's Disease|parkinson's disease
437233|NCT01280123|Biomarkers|biomarkers
437234|NCT01280110|dry eye|dry eye
437235|NCT01280110|pseudophakia|pseudophakia
437236|NCT01280110|cornea|cornea
437237|NCT01280110|lubricating drop|lubricating drop
437238|NCT01280110|BAK|bak
437239|NCT01280110|blood aqueous barrier|blood aqueous barrier
437240|NCT01280110|blood-retina barrier|blood-retina barrier
437241|NCT01280097|Intensive care unit delirium|intensive care unit delirium
437242|NCT01280097|Sleep disruption|sleep disruption
437243|NCT01280097|Sleep hygiene|sleep hygiene
437244|NCT01280097|Early mobilization in the Intensive care unit|early mobilization in the intensive care unit
437245|NCT01280097|Sedative agents and sleep|sedative agents and sleep
437246|NCT01280097|Circadian rhythm|circadian rhythm
437247|NCT01280097|Cognitive disorder|cognitive disorder
437248|NCT01280097|Electroencephalography (EEG) to measure sleep|electroencephalography (eeg) to measure sleep
437249|NCT01280097|Confusion Assessment Method in the Intensive Care Unit|confusion assessment method in the intensive care unit
437250|NCT01280097|Immune function|immune function
437251|NCT01280097|REM sleep|rem sleep
437252|NCT01280084|neonate activity|neonate activity
437253|NCT01280084|labour analgesia|labour analgesia
437254|NCT01280032|intraoperative radiotherapy|intraoperative radiotherapy
437255|NCT01280032|kyphoplasty|kyphoplasty
437256|NCT01280032|spinal metastases|spinal metastases
437257|NCT01280019|functional residual capacity|functional residual capacity
437258|NCT01280019|electrical impedance tomography|electrical impedance tomography
437259|NCT01280019|inflammatory parameters|inflammatory parameters
437260|NCT01280006|Obstructive Sleep Apnea|obstructive sleep apnea
437261|NCT01280006|Hypoxia|hypoxia
437262|NCT01280006|Sleep|sleep
437263|NCT01280006|Blood Pressure|blood pressure
437264|NCT01280006|Hypertension|hypertension
437265|NCT01280006|Myocardial Infarction|myocardial infarction
437266|NCT01280006|Stroke|stroke
437267|NCT01280006|Ventilation|ventilation
437268|NCT01280006|Brain|brain
437269|NCT01280006|Cerebral Blood Flow|cerebral blood flow
437270|NCT01280006|Renal Blood Flow|renal blood flow
437271|NCT01279980|ERAS|eras
437272|NCT01279980|Local anaesthetic wound catheter|local anaesthetic wound catheter
437273|NCT01279980|Painbuster|painbuster
437274|NCT01279980|Epidural|epidural
437275|NCT01279980|colorectal surgery|colorectal surgery
437276|NCT01279980|enhanced recovery program|enhanced recovery program
437277|NCT01279967|Pleural Mesothelioma|pleural mesothelioma
437278|NCT01279967|ADI-PEG 20|adi-peg 20
437279|NCT01279928|paediatric and adolescent population|paediatric and adolescent population
437280|NCT01279928|nailfold capillaroscopy|nailfold capillaroscopy
437281|NCT01279928|laser Doppler flowmetry|laser doppler flowmetry
437282|NCT01279928|retinal vessel calibre|retinal vessel calibre
437283|NCT01279928|retinal vessel fractal analysis|retinal vessel fractal analysis
437284|NCT01279928|24 hour Ambulatory Blood Pressure Monitoring|24 hour ambulatory blood pressure monitoring
437285|NCT01279915|ASP0456|asp0456
437286|NCT01279915|Pharmacokinetics|pharmacokinetics
437287|NCT01279915|safety|safety
437288|NCT01279915|tolerability|tolerability
437289|NCT01279902|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
437290|NCT01279902|rituximab|rituximab
437291|NCT01279902|CHOP|chop
437292|NCT01279902|abbreviated therapy|abbreviated therapy
437293|NCT01279889|hypotension|hypotension
437294|NCT01279889|cesarean delivery|cesarean delivery
437297|NCT01279889|plethysmography variability index|plethysmography variability index
437298|NCT01279863|Pneumonia|pneumonia
437299|NCT01279863|Cough|cough
437300|NCT01279863|Shortness of breath|shortness of breath
437301|NCT01279863|VRI|vri
437302|NCT01279850|Lyrica|lyrica
437303|NCT01279850|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
437304|NCT01279850|Safety|safety
437305|NCT01279850|Neuropathic Pain|neuropathic pain
437306|NCT01279850|Post Marketing Surveillance|post marketing surveillance
437307|NCT01279837|swallowing disorders|swallowing disorders
437308|NCT01279837|swallowing therapy|swallowing therapy
437309|NCT01279837|head neck cancer|head neck cancer
437310|NCT01279837|oropharyngeal dysphagia|oropharyngeal dysphagia
437311|NCT01279824|swallowing, treatment, stroke,rehabilitation|swallowing, treatment, stroke,rehabilitation
437312|NCT01279811|spinal cord injury, CSF, biomarkers, CSF pressure|spinal cord injury, csf, biomarkers, csf pressure
437313|NCT01279798|Lung Cancer|lung cancer
437314|NCT01279798|NSCLC|nsclc
437315|NCT01279798|stage III or IV NSCLC|stage iii or iv nsclc
437316|NCT01279785|Molecular Imaging|molecular imaging
437317|NCT01279785|PSMA|psma
437318|NCT01279785|adenocarcinoma|adenocarcinoma
437319|NCT01279785|prostatectomy|prostatectomy
437320|NCT01279759|Anterior Cruciate Ligament Reconstruction Predictive Factors|anterior cruciate ligament reconstruction predictive factors
437321|NCT01279759|Function Downstairs walking Step time Symmetry|function downstairs walking step time symmetry
437322|NCT01279746|DVT Ultrasound compression Hypoxia Pulmonary Emboli|dvt ultrasound compression hypoxia pulmonary emboli
437323|NCT01279746|Occult DVT in hypoxic patients|occult dvt in hypoxic patients
437324|NCT01279733|microarray|microarray
437325|NCT01279720|Adenosine deaminase deficiency|adenosine deaminase deficiency
437326|NCT01279720|Gene therapy|gene therapy
437327|NCT01279694|newly-diagnosed multiple myeloma.|newly-diagnosed multiple myeloma.
437328|NCT01279681|neurotoxicity|neurotoxicity
437329|NCT01279681|cognitive/functional effects|cognitive/functional effects
437330|NCT01279681|stage IVA colon cancer|stage iva colon cancer
437331|NCT01279681|stage IVA rectal cancer|stage iva rectal cancer
437332|NCT01279681|stage IVB colon cancer|stage ivb colon cancer
437333|NCT01279681|stage IVB rectal cancer|stage ivb rectal cancer
437334|NCT01279681|recurrent colon cancer|recurrent colon cancer
437335|NCT01279681|recurrent rectal cancer|recurrent rectal cancer
437336|NCT01279668|Montelukast|montelukast
437337|NCT01279668|Persistent cough|persistent cough
437338|NCT01279668|Adults|adults
437339|NCT01279668|Double-blind randomised placebo controlled trial|double-blind randomised placebo controlled trial
437340|NCT01279642|Catheterization, Peripheral|catheterization, peripheral
437341|NCT01279642|Ultrasonography, Interventional|ultrasonography, interventional
437342|NCT01279642|Nursing|nursing
437343|NCT01279642|Pediatric|pediatric
437344|NCT01279629|chronic plaque psoriasis|chronic plaque psoriasis
437345|NCT01279629|To evaluate the efficacy of the drugs under study for treating chronic plaque psoriasis|to evaluate the efficacy of the drugs under study for treating chronic plaque psoriasis
437346|NCT01279616|sickle cell|sickle cell
437347|NCT01279616|stem cell transplant|stem cell transplant
437348|NCT01279603|Cancer|cancer
437349|NCT01279590|Hyperlipidemia|hyperlipidemia
437350|NCT01279590|Dyslipidemia|dyslipidemia
437351|NCT01279590|Metabolic diseases|metabolic diseases
437352|NCT01279590|Lipid metabolism disorders|lipid metabolism disorders
437353|NCT01279590|Hyperlipoproteinemia Type IIa|hyperlipoproteinemia type iia
437354|NCT01279590|Hyperlipoproteinemia Type IIb|hyperlipoproteinemia type iib
437355|NCT01279590|Hypercholesterolemia, Autosomal Dominant|hypercholesterolemia, autosomal dominant
437356|NCT01279590|Hypercholesterolemia, Autosomal Dominant, Type B|hypercholesterolemia, autosomal dominant, type b
437357|NCT01279590|Frederickson Type IIa|frederickson type iia
437358|NCT01279590|Frederickson Type IIb Hyperlipidemia|frederickson type iib hyperlipidemia
437359|NCT01279577|Crohn´s disease|crohn´s disease
437360|NCT01279577|Trichuris suis|trichuris suis
437361|NCT01279577|randomized|randomized
437362|NCT01279577|placebo|placebo
437363|NCT01279577|induction of remission|induction of remission
437364|NCT01279577|porcine whipworm|porcine whipworm
437365|NCT01279564|Endotracheal intubation and its outcomes|endotracheal intubation and its outcomes
437366|NCT01279538|Kidney Transplantation|kidney transplantation
437367|NCT01279538|Pharmacokinetics|pharmacokinetics
437368|NCT01279538|Pharmacology|pharmacology
437369|NCT01279538|ASKP1240|askp1240
437370|NCT01279525|Falls|falls
437371|NCT01279525|Prevention|prevention
437372|NCT01279525|Elderly|elderly
437373|NCT01279512|Metformin Acarbose pco infertility overweight|metformin acarbose pco infertility overweight
437374|NCT01279499|Morbid obesity|morbid obesity
437375|NCT01279499|Sevoflurane|sevoflurane
437376|NCT01279499|Propofol|propofol
437377|NCT01279499|Remifentanyl|remifentanyl
437378|NCT01279499|BIS|bis
437379|NCT01279499|Cardiovascular stability|cardiovascular stability
437380|NCT01279499|Recovery scores|recovery scores
437381|NCT01279499|Drug consumption|drug consumption
437382|NCT01279486|Pregnancy,|pregnancy,
437383|NCT01279473|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
437384|NCT01279473|CML|cml
437385|NCT01279473|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
437386|NCT01279473|Philadelphia Chromosome Positive, ph+ ALL|philadelphia chromosome positive, ph+ all
437387|NCT01279473|Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)|acute lymphoblastic leukemia (philadelphia chromosome positive)
437388|NCT01279460|chronic kidney disease|chronic kidney disease
437389|NCT01279460|CKD|ckd
437390|NCT01279460|pulse wave velocity|pulse wave velocity
437391|NCT01279460|PWV|pwv
437392|NCT01279447|infrapatellar nerve|infrapatellar nerve
437393|NCT01279447|saphenous nerve|saphenous nerve
437394|NCT01279447|knee arthroscopy|knee arthroscopy
437395|NCT01279447|nerve block|nerve block
437396|NCT01279408|Palliative treatment|palliative treatment
437397|NCT01279408|advanced non-small cell lung cancer|advanced non-small cell lung cancer
437398|NCT01279408|Patients with Asymptomatic Centrally Located Advance NSCLC who are palliative|patients with asymptomatic centrally located advance nsclc who are palliative
437399|NCT01279395|atherosclerosis|atherosclerosis
437400|NCT01279395|cholesterol|cholesterol
437401|NCT01279395|cyclooxygenase|cyclooxygenase
437402|NCT01279395|gene expression|gene expression
437403|NCT01279395|lipid metabolism|lipid metabolism
437404|NCT01279382|Symptoms|symptoms
437405|NCT01279382|Psychological status|psychological status
437406|NCT01279382|Hypnotherapy|hypnotherapy
437407|NCT01279382|Relaxation training|relaxation training
437408|NCT01279369|Pregnancy|pregnancy
437409|NCT01279369|Trauma|trauma
437410|NCT01279369|Placental Abruption|placental abruption
437411|NCT01279369|Fetal fibronectin|fetal fibronectin
437412|NCT01279356|Liver diseases|liver diseases
437413|NCT01279356|Volatile organic compounds|volatile organic compounds
437414|NCT01279356|Inflammation|inflammation
437415|NCT01279356|Oxidative stress|oxidative stress
437416|NCT01279356|non-invasive tests|non-invasive tests
437417|NCT01279343|labor induction|labor induction
437418|NCT01279343|foley bulb|foley bulb
437419|NCT01279343|misoprostol|misoprostol
437420|NCT01279330|Colorectal Cancer|colorectal cancer
437421|NCT01279330|Screening|screening
437422|NCT01279330|General Practitioner|general practitioner
437423|NCT01279330|Fecal Occult Blood Tests|fecal occult blood tests
437424|NCT01279304|breast cancer|breast cancer
437425|NCT01279304|locoregional recurrence rate|locoregional recurrence rate
437426|NCT01279304|neoadjuvant chemotherapy and surgery|neoadjuvant chemotherapy and surgery
437427|NCT01279304|radiotherapy|radiotherapy
437428|NCT01279304|risk model|risk model
437429|NCT01279304|overall survival|overall survival
437430|NCT01279304|relapse free survival|relapse free survival
437431|NCT01279304|cT1-2cN0-1 breast cancer|ct1-2cn0-1 breast cancer
437432|NCT01279291|advanced solid tumor|advanced solid tumor
437433|NCT01279291|Ovarian cancer|ovarian cancer
437434|NCT01279291|Primary peritoneal cancer|primary peritoneal cancer
437435|NCT01279291|Fallopian tube cancer|fallopian tube cancer
437436|NCT01279278|Colorectal Cancer|colorectal cancer
437437|NCT01279278|Screening|screening
437438|NCT01279278|General Practitioner|general practitioner
437439|NCT01279278|Fecal Occult Blood Tests|fecal occult blood tests
437440|NCT01279265|Lactobacillus|lactobacillus
437441|NCT01279265|Probiotic|probiotic
437442|NCT01279265|Crying time|crying time
437443|NCT01279265|Fecal microbiota|fecal microbiota
437444|NCT01279265|Calprotectin|calprotectin
437445|NCT01279265|Colic|colic
437446|NCT01279265|Infant Crying|infant crying
437447|NCT01279265|Barr Diary|barr diary
437448|NCT01279265|Breath Hydrogen|breath hydrogen
437449|NCT01279265|Clinical Design|clinical design
437450|NCT01279239|Poly Trauma|poly trauma
437451|NCT01279239|Metabonomics|metabonomics
437452|NCT01279239|NMR|nmr
437453|NCT01279239|MOF|mof
437454|NCT01279200|letrozole|letrozole
437455|NCT01279200|ovulation monitoring|ovulation monitoring
437456|NCT01279200|pregnancy rate|pregnancy rate
437457|NCT01279187|dental|dental
437458|NCT01279187|implant|implant
437459|NCT01279174|Hip, arthrosis|hip, arthrosis
437460|NCT01279161|overweight, obesity, children, insulin, pump therapy, FTO|overweight, obesity, children, insulin, pump therapy, fto
437461|NCT01279148|biopsy guidance|biopsy guidance
437462|NCT01279148|tracking device|tracking device
437463|NCT01279135|IGRT,Postoperative, Cervix, Late toxicity, Bowel|igrt,postoperative, cervix, late toxicity, bowel
437464|NCT01279109|gestational weight gain|gestational weight gain
437465|NCT01279096|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
437466|NCT01279096|relapse|relapse
437467|NCT01279096|childhood|childhood
437468|NCT01279096|clofarabine|clofarabine
437469|NCT01279070|Schizophrenia|schizophrenia
437470|NCT01279070|Cognitive remediation|cognitive remediation
437471|NCT01279070|Group training|group training
437472|NCT01279070|Executive function|executive function
437473|NCT01279070|Social functioning|social functioning
437474|NCT01279057|Rhinitis, allergic, seasonal, fluticasone furoate, equivalence|rhinitis, allergic, seasonal, fluticasone furoate, equivalence
437475|NCT01279044|HIV|hiv
437476|NCT01279044|MSM|msm
437477|NCT01279044|SUMSM|sumsm
437478|NCT01279018|Persistent postsurgical pain|persistent postsurgical pain
437479|NCT01279018|breast cancer|breast cancer
437480|NCT01279018|postmastectomy pain syndrome|postmastectomy pain syndrome
437481|NCT01279018|neuropathic pain|neuropathic pain
437482|NCT01279005|MSM|msm
437483|NCT01279005|focus group|focus group
437484|NCT01279005|HIV|hiv
437485|NCT01279005|risk-taking|risk-taking
437486|NCT01279005|risk-denial|risk-denial
437487|NCT01279005|signature on inform consent, willing to participate, MSM either HIV positive or negative, age 20-50 years old|signature on inform consent, willing to participate, msm either hiv positive or negative, age 20-50 years old
437488|NCT01278992|fatigue|fatigue
437489|NCT01278992|adaptogen|adaptogen
437490|NCT01278992|Rhodiola rosea|rhodiola rosea
437491|NCT01278979|obstetric|obstetric
437492|NCT01278979|perineal tear|perineal tear
437493|NCT01278979|perineal injury|perineal injury
437494|NCT01278979|diagnosis|diagnosis
437495|NCT01278966|Epilepsy|epilepsy
437496|NCT01278966|Diet|diet
437497|NCT01278966|the Modified Atkins Diet|the modified atkins diet
437498|NCT01278966|Ketogenic diet|ketogenic diet
437499|NCT01278953|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
437500|NCT01278953|atrial fibrillation|atrial fibrillation
437501|NCT01278953|radiofrequency ablation|radiofrequency ablation
437502|NCT01278953|pulmonary vein isolation|pulmonary vein isolation
437503|NCT01278953|ablation catheter|ablation catheter
437504|NCT01278953|RF|rf
437505|NCT01278953|contact force sensing|contact force sensing
437506|NCT01278953|contact force|contact force
437507|NCT01278953|contact force assisted ablation|contact force assisted ablation
437508|NCT01278927|exercise|exercise
437509|NCT01278927|stress management|stress management
437510|NCT01278927|post transplant|post transplant
437511|NCT01278927|physical and emotional relaxation|physical and emotional relaxation
437512|NCT01278901|helicobacter pylori|helicobacter pylori
437513|NCT01278901|urease test|urease test
437514|NCT01278901|13C-UBT|13c-ubt
437515|NCT01278901|the focus of the study is to evaluate a possible effect of PPI therapy on Helicobacter pylori diagnostic tests|the focus of the study is to evaluate a possible effect of ppi therapy on helicobacter pylori diagnostic tests
437516|NCT01278888|Lung cancer|lung cancer
437517|NCT01278888|Pain|pain
437518|NCT01278888|Quality of life|quality of life
437519|NCT01278888|Economy|economy
437520|NCT01278875|High density lipoproteins|high density lipoproteins
437521|NCT01278875|Acute coronary syndromes|acute coronary syndromes
437522|NCT01278875|Cellular cholesterol efflux|cellular cholesterol efflux
437523|NCT01278875|HDL: proteomics|hdl: proteomics
437524|NCT01278875|Nitric Acid production|nitric acid production
437525|NCT01278862|Crowns|crowns
437526|NCT01278862|posterior teeth|posterior teeth
437527|NCT01278862|CAD CAM crowns|cad cam crowns
437528|NCT01278862|digital veneer system|digital veneer system
437529|NCT01278862|Lava|lava
437530|NCT01278862|clinical|clinical
437531|NCT01278849|Advanced or metastatic cancer,|advanced or metastatic cancer,
437532|NCT01278849|refractory,|refractory,
437533|NCT01278849|core phase,|core phase,
437534|NCT01278849|extension phase,|extension phase,
437535|NCT01278849|dose escalation,|dose escalation,
437536|NCT01278849|standard chemotherapy,|standard chemotherapy,
437537|NCT01278849|pharmacokinetics,|pharmacokinetics,
437538|NCT01278849|doctaxel,|doctaxel,
437539|NCT01278849|paclitaxel,|paclitaxel,
437540|NCT01278849|carboplatin,|carboplatin,
437541|NCT01278849|safety,|safety,
437542|NCT01278849|tolerability,|tolerability,
437543|NCT01278849|hepatic impairment|hepatic impairment
437544|NCT01278836|Flap|flap
437545|NCT01278836|leg defect|leg defect
437546|NCT01278836|reconstruction|reconstruction
437547|NCT01278836|tissue|tissue
437548|NCT01278823|obesity|obesity
437549|NCT01278823|type 2 diabetes|type 2 diabetes
437550|NCT01278810|Icaritin,|icaritin,
437551|NCT01278810|ERa36|era36
437552|NCT01278784|Dry eye syndromes|dry eye syndromes
437553|NCT01278784|Chitosan-N-Acetylcysteine|chitosan-n-acetylcysteine
437554|NCT01278771|CHD|chd
437555|NCT01278758|Advanced or metastatic cancer,|advanced or metastatic cancer,
437556|NCT01278758|refractory,|refractory,
437557|NCT01278758|core phase,|core phase,
437558|NCT01278758|extension phase,|extension phase,
437559|NCT01278758|dose escalation,|dose escalation,
437560|NCT01278758|standard chemotherapy,|standard chemotherapy,
437561|NCT01278758|doctaxel,|doctaxel,
437562|NCT01278758|paclitaxel,|paclitaxel,
437563|NCT01278758|carboplatin,|carboplatin,
437564|NCT01278758|safety,|safety,
437565|NCT01278758|tolerability|tolerability
437566|NCT01278745|cardiac allograft vasculopathy (CAV)|cardiac allograft vasculopathy (cav)
437567|NCT01278745|prevention|prevention
437568|NCT01278745|cardiac transplantation|cardiac transplantation
437569|NCT01278745|rituximab|rituximab
437570|NCT01278732|arterial hypertension|arterial hypertension
437571|NCT01278719|Antrochoanal polyp|antrochoanal polyp
437572|NCT01278719|Ethmoidal polyp|ethmoidal polyp
437573|NCT01278719|Recurrence|recurrence
437574|NCT01278719|Risk factors|risk factors
437575|NCT01278719|Environmental factors|environmental factors
437576|NCT01278719|Gene expression|gene expression
437577|NCT01278719|Micro array|micro array
437578|NCT01278719|Mutation|mutation
437579|NCT01278693|Renal failure, hemodialysis, dyslipidemia, L-carnitine.|renal failure, hemodialysis, dyslipidemia, l-carnitine.
437580|NCT01278680|Behavioral economics|behavioral economics
437581|NCT01278680|Incentives|incentives
437582|NCT01278680|Health|health
437583|NCT01278667|ADHD|adhd
437584|NCT01278667|Memory|memory
437585|NCT01278667|Social|social
437586|NCT01278667|Emotion|emotion
437587|NCT01278667|Methylphenidate|methylphenidate
437588|NCT01278641|Fibromyalgia|fibromyalgia
437589|NCT01278641|Widespread pain|widespread pain
437590|NCT01278641|Fatigue|fatigue
437591|NCT01278641|Physical exercise|physical exercise
437592|NCT01278602|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
437593|NCT01278602|Chemotherapy|chemotherapy
437594|NCT01278602|R-ESHAP|r-eshap
437595|NCT01278602|Autologous stem cell transplantation|autologous stem cell transplantation
437596|NCT01278576|Muscle spasticity|muscle spasticity
437597|NCT01278576|Stroke|stroke
437598|NCT01278576|Botulinum Toxins|botulinum toxins
437599|NCT01278576|Lower extremity|lower extremity
437600|NCT01278576|Ankle|ankle
437601|NCT01278563|Low Glycemic Index Diet|low glycemic index diet
437602|NCT01278537|elderly|elderly
437603|NCT01278537|cancer surgery|cancer surgery
437604|NCT01278537|quality of life|quality of life
437605|NCT01278537|empowerment|empowerment
437606|NCT01278537|shared-decision|shared-decision
437607|NCT01278524|Delirium|delirium
437608|NCT01278524|Analgosedation|analgosedation
437609|NCT01278524|ICU|icu
437610|NCT01278524|Pain|pain
437611|NCT01278524|Implementation|implementation
437612|NCT01278511|Canadian C-Spine Rule|canadian c-spine rule
437613|NCT01278511|Prehospital Emergency Care|prehospital emergency care
437614|NCT01278511|Cervical Spine Injuries|cervical spine injuries
437615|NCT01278511|Cervical Spine Fractures|cervical spine fractures
437616|NCT01278511|Emergency Medicine Undergraduates|emergency medicine undergraduates
437617|NCT01278498|Escitalopram|escitalopram
437618|NCT01278498|Depression|depression
437619|NCT01278498|Stroke|stroke
437620|NCT01278485|Diabetes complications|diabetes complications
437621|NCT01278472|cholecystectomy|cholecystectomy
437622|NCT01278472|laparoscopic|laparoscopic
437623|NCT01278472|single-port|single-port
437624|NCT01278472|gallstones|gallstones
437625|NCT01278459|endothelial function|endothelial function
437626|NCT01278459|cardiovascular|cardiovascular
437627|NCT01278446|Cow's Milk Allergy|cow's milk allergy
437628|NCT01278446|CMA|cma
437629|NCT01278433|Polio|polio
437630|NCT01278433|Poliovirus|poliovirus
437631|NCT01278433|IMOVAX Polio™|imovax polio™
437632|NCT01278420|Visual outcomes with bilateral implantation of Tecnis MF and ReSTOR IOLs Six months post cataract surgery|visual outcomes with bilateral implantation of tecnis mf and restor iols six months post cataract surgery
437633|NCT01278407|DLB|dlb
437634|NCT01278407|Dementia with Lewy bodies|dementia with lewy bodies
437635|NCT01278407|Lewy Body Disease|lewy body disease
437636|NCT01278407|Dementia|dementia
437637|NCT01278407|E2020|e2020
437638|NCT01278407|Donepezil|donepezil
437639|NCT01278407|Aricept|aricept
437640|NCT01278394|Onychomycosis|onychomycosis
437641|NCT01278394|Fungal Nail|fungal nail
437642|NCT01278381|pancreas, pancreaticoduodenectomy, major complications|pancreas, pancreaticoduodenectomy, major complications
437643|NCT01278368|pancreatic cancer, neoadjuvant chemotherapy|pancreatic cancer, neoadjuvant chemotherapy
437644|NCT01278355|pain|pain
437645|NCT01278355|acupuncture|acupuncture
437646|NCT01278342|Sandostatin LAR|sandostatin lar
437647|NCT01278342|High Dose|high dose
437648|NCT01278342|GH-receptor antagonist|gh-receptor antagonist
437649|NCT01278342|combination with dopamine-agonist|combination with dopamine-agonist
437650|NCT01278342|acromegalic patients|acromegalic patients
437651|NCT01278342|octreotide acetate|octreotide acetate
437652|NCT01278342|Somavert|somavert
437653|NCT01278342|Dostinex|dostinex
437654|NCT01278342|pegvisomant|pegvisomant
437655|NCT01278342|cabergoline|cabergoline
437656|NCT01278342|not adequately controlled|not adequately controlled
437657|NCT01278342|active acromegaly|active acromegaly
437658|NCT01278329|Music|music
437659|NCT01278329|Foetal learning|foetal learning
437660|NCT01278329|Brazelton Neonatal Behavioral Assessment Scale|brazelton neonatal behavioral assessment scale
437661|NCT01278316|PTSD|ptsd
437662|NCT01278316|TBI|tbi
437663|NCT01278316|Cognition|cognition
437664|NCT01278316|Cognitive Training|cognitive training
437665|NCT01278303|Coarctation|coarctation
437666|NCT01278303|Aorta|aorta
437667|NCT01278290|Triptorelin acetate|triptorelin acetate
437668|NCT01278290|precocious puberty|precocious puberty
437669|NCT01278290|premature thelarche|premature thelarche
437670|NCT01278290|GnRH analog|gnrh analog
437671|NCT01278290|Diagnostic validation study|diagnostic validation study
437672|NCT01278277|Stargardt disease|stargardt disease
437673|NCT01278277|macula|macula
437674|NCT01278277|electroretinogram|electroretinogram
437675|NCT01278277|saffron|saffron
437676|NCT01278264|Transversus abdominis plane block|transversus abdominis plane block
437677|NCT01278264|Ultrasound guided|ultrasound guided
437678|NCT01278264|Abdominoplasty|abdominoplasty
437679|NCT01278238|Hypotension|hypotension
437680|NCT01278238|Caesarean section|caesarean section
437681|NCT01278238|Spinal anaesthesia|spinal anaesthesia
437682|NCT01278238|Lower limb compression / wrapping|lower limb compression / wrapping
437683|NCT01278238|Phenylephrine|phenylephrine
437684|NCT01278225|Neurofeedback|neurofeedback
437685|NCT01278225|Neural Function|neural function
437686|NCT01278225|Neuromodulation|neuromodulation
437687|NCT01278225|Chemotherapy-Induced Neuropathic Pain|chemotherapy-induced neuropathic pain
437688|NCT01278225|Electroencephalogram|electroencephalogram
437689|NCT01278225|EEG|eeg
437690|NCT01278225|Biofeedback|biofeedback
437691|NCT01278225|BF|bf
437692|NCT01278225|Quality of Life|quality of life
437693|NCT01278225|QOL|qol
437694|NCT01278225|Pain Quality Assessment Scale|pain quality assessment scale
437695|NCT01278225|PQAS|pqas
437696|NCT01278225|Brief Symptom Inventory|brief symptom inventory
437697|NCT01278225|BSI|bsi
437698|NCT01278225|Sleep Disturbances|sleep disturbances
437699|NCT01278225|Fatigue|fatigue
437700|NCT01278225|Questionnaires|questionnaires
437701|NCT01278212|breast cancer|breast cancer
437702|NCT01278212|breast neoplasm|breast neoplasm
437703|NCT01278212|breast tumor|breast tumor
437704|NCT01278212|radiotherapy|radiotherapy
437705|NCT01278212|radiation|radiation
437706|NCT01278212|accelerated|accelerated
437707|NCT01278212|lumpectomy|lumpectomy
437708|NCT01278199|Bronchial Artery Embolization|bronchial artery embolization
437709|NCT01278199|Non-severe Hemoptysis|non-severe hemoptysis
437710|NCT01278199|Bleeding mild-to-moderate abundance|bleeding mild-to-moderate abundance
437711|NCT01278199|Volume ranging from 100 ml to 200 ml|volume ranging from 100 ml to 200 ml
437712|NCT01278186|Coronary stenosis|coronary stenosis
437713|NCT01278186|Bifurcation|bifurcation
437714|NCT01278186|Drug-eluting balloon|drug-eluting balloon
437715|NCT01278186|Drug-eluting stent|drug-eluting stent
437716|NCT01278186|Angiographic follow-up|angiographic follow-up
437717|NCT01278186|Late Lumen Loss|late lumen loss
437718|NCT01278186|Restenosis|restenosis
437719|NCT01278173|Vigabatrin-associated vision change|vigabatrin-associated vision change
437720|NCT01278173|Adult refractory complex partial seizures|adult refractory complex partial seizures
437721|NCT01278173|CPS|cps
437722|NCT01278173|Epilepsy|epilepsy
437723|NCT01278173|Seizures|seizures
437724|NCT01278173|Brain diseases|brain diseases
437725|NCT01278173|Central Nervous System Diseases|central nervous system diseases
437726|NCT01278173|Nervous System Diseases|nervous system diseases
437727|NCT01278173|Neurologic Manifestations|neurologic manifestations
437728|NCT01278173|Enzyme Inhibitors|enzyme inhibitors
437729|NCT01278173|GABA Agents|gaba agents
437730|NCT01278147|cancer|cancer
437731|NCT01278147|fatigue program education|fatigue program education
437732|NCT01278121|Obesity|obesity
437733|NCT01278121|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
437734|NCT01278121|Cardiovascular diseases|cardiovascular diseases
437735|NCT01278108|Safety|safety
437736|NCT01278108|Tolerability|tolerability
437737|NCT01278108|Pharmacokinetics|pharmacokinetics
437738|NCT01278095|Safety|safety
437739|NCT01278095|Tolerability|tolerability
437740|NCT01278095|Pharmacokinetics|pharmacokinetics
437741|NCT01278082|Randomized|randomized
437742|NCT01278082|double-blind|double-blind
437743|NCT01278082|Placebo-controlled|placebo-controlled
437744|NCT01278082|budesonide|budesonide
437745|NCT01278082|collagenous colitis|collagenous colitis
437746|NCT01278082|acute treatment|acute treatment
437747|NCT01278082|maintaining remission|maintaining remission
437748|NCT01278069|Acute myeloid Leukemia|acute myeloid leukemia
437749|NCT01278069|Myeloid Sarcoma|myeloid sarcoma
437750|NCT01278069|Extramedullary Acute myeloid Leukemia|extramedullary acute myeloid leukemia
437751|NCT01278069|18FDG-PET-CT|18fdg-pet-ct
437752|NCT01278056|Non-alcoholic steatohepatitis (NASH) and increased iron storage / disturbed distribution|non-alcoholic steatohepatitis (nash) and increased iron storage / disturbed distribution
437753|NCT01278043|Antiplatelet|antiplatelet
437754|NCT01278043|Percutaneous Coronary Intervention|percutaneous coronary intervention
437755|NCT01278043|Coronary artery disease|coronary artery disease
437756|NCT01278043|Antiplatelet Response, Interval Variability & Events in Percutaneous Coronary Intervention|antiplatelet response, interval variability & events in percutaneous coronary intervention
437757|NCT01278017|nontyphoidal salmonellae|nontyphoidal salmonellae
437758|NCT01278017|enterocolitis|enterocolitis
437759|NCT01278017|ceftriaxone|ceftriaxone
437760|NCT01278004|Adult cancer patients with chemotherapy-induced painful peripheral neuropathy|adult cancer patients with chemotherapy-induced painful peripheral neuropathy
437761|NCT01277991|Bioequivalence|bioequivalence
437762|NCT01277991|healthy volunteer study|healthy volunteer study
437763|NCT01277991|Rheumatoid Arthritis|rheumatoid arthritis
437764|NCT01277978|Caesarean section|caesarean section
437765|NCT01277978|Cardiovascular effects|cardiovascular effects
437766|NCT01277978|Postpartum hemorrhage|postpartum hemorrhage
437767|NCT01277978|Carbetocin|carbetocin
437768|NCT01277978|Oxytocin|oxytocin
437769|NCT01277965|Algorithm basal insulin|algorithm basal insulin
437770|NCT01277965|physical activity|physical activity
437771|NCT01277965|Type 1 diabetes|type 1 diabetes
437772|NCT01277965|Insulin pump treatment|insulin pump treatment
437773|NCT01277952|Traumatic Brain Injury|traumatic brain injury
437774|NCT01277952|DBS|dbs
437775|NCT01277926|Breast Cancer|breast cancer
437776|NCT01277926|Hormone Receptor Positive, Advanced Breast Cancer|hormone receptor positive, advanced breast cancer
437777|NCT01277913|diabetes|diabetes
437778|NCT01277913|vitamin D|vitamin d
437779|NCT01277913|bone density|bone density
437780|NCT01277913|children|children
437781|NCT01277887|Smoking|smoking
437782|NCT01277887|Nicotine|nicotine
437783|NCT01277887|Nicotine polacrilex|nicotine polacrilex
437784|NCT01277887|Nicotine replacement|nicotine replacement
437785|NCT01277861|Desflurane, Fentanyl, Airway responses|desflurane, fentanyl, airway responses
437786|NCT01277848|PLAC1|plac1
437787|NCT01277848|pregnant|pregnant
437788|NCT01277848|first prenatal visit|first prenatal visit
437789|NCT01277848|pre-eclampsia|pre-eclampsia
437790|NCT01277835|video-assisted|video-assisted
437791|NCT01277835|thoracic surgery|thoracic surgery
437792|NCT01277835|VATS|vats
437793|NCT01277835|lidocaine infusion|lidocaine infusion
437794|NCT01277835|VATS procedures|vats procedures
437795|NCT01277822|Hypertension|hypertension
437796|NCT01277822|Uncontrolled hypertension|uncontrolled hypertension
437797|NCT01277822|High blood pressure|high blood pressure
437798|NCT01277822|Uncontrolled high blood pressure|uncontrolled high blood pressure
437799|NCT01277822|Untreated high blood pressure|untreated high blood pressure
437800|NCT01277822|Untreated hypertension|untreated hypertension
437801|NCT01277822|Essential hypertension|essential hypertension
437802|NCT01277809|Long term care|long term care
437803|NCT01277809|Aging|aging
437804|NCT01277809|Accidental Falls|accidental falls
437805|NCT01277809|Muscle Weakness|muscle weakness
437806|NCT01277809|Gait|gait
437807|NCT01277809|Physical Fitness|physical fitness
437808|NCT01277809|Muscle Strength|muscle strength
437809|NCT01277809|Postural Balance|postural balance
437810|NCT01277809|Activities of Daily Living|activities of daily living
437811|NCT01277809|Body Weight|body weight
437812|NCT01277809|Blood Pressure|blood pressure
437813|NCT01277809|Depression|depression
437814|NCT01277809|Behavior|behavior
437815|NCT01277809|Dementia|dementia
437816|NCT01277770|Thymoglobulin|thymoglobulin
437817|NCT01277770|Kidney Transplant Recipients|kidney transplant recipients
437818|NCT01277770|Steroid-Free|steroid-free
437819|NCT01277770|Immunosuppression|immunosuppression
437820|NCT01277744|Desmoplastic small round cell tumor|desmoplastic small round cell tumor
437821|NCT01277744|DSRCT|dsrct
437822|NCT01277744|Hyperthermic peritoneal perfusion|hyperthermic peritoneal perfusion
437823|NCT01277744|HIPEC|hipec
437824|NCT01277744|Complete abdominal tumor excision|complete abdominal tumor excision
437825|NCT01277744|Extensive abdominal disease|extensive abdominal disease
437826|NCT01277744|Non-carcinoma tumors|non-carcinoma tumors
437827|NCT01277744|Abdominal cavity|abdominal cavity
437828|NCT01277744|Cisplatin|cisplatin
437829|NCT01277744|Platinol-AQ|platinol-aq
437830|NCT01277744|Platinol|platinol
437831|NCT01277744|CDDP|cddp
437832|NCT01277744|Diffuse peritoneal tumor|diffuse peritoneal tumor
437833|NCT01277744|Retroperitoneal tumor|retroperitoneal tumor
437834|NCT01277744|Ovarian germ cell|ovarian germ cell
437835|NCT01277744|Wilms' tumor|wilms' tumor
437836|NCT01277705|Booster vaccination|booster vaccination
437837|NCT01277692|First administration to human, safety, pharmacokinetics, healthy subjects, antiviral activity, hepatitis C patients|first administration to human, safety, pharmacokinetics, healthy subjects, antiviral activity, hepatitis c patients
437838|NCT01277679|lung water measures|lung water measures
437839|NCT01277679|pulmonary edema|pulmonary edema
437840|NCT01277679|MRI|mri
437841|NCT01277679|heart failure|heart failure
437842|NCT01277666|Crohn's disease|crohn's disease
437843|NCT01277666|capsule|capsule
437844|NCT01277666|GSK1605786A|gsk1605786a
437845|NCT01277666|quality of life|quality of life
437846|NCT01277666|inflammatory bowel disease|inflammatory bowel disease
437847|NCT01277666|oral therapy|oral therapy
437848|NCT01277653|Hepatocellular carcinoma|hepatocellular carcinoma
437849|NCT01277640|male tolerance|male tolerance
437850|NCT01277640|HIV-1|hiv-1
437851|NCT01277640|microbicide|microbicide
437852|NCT01277640|dapivirine|dapivirine
437854|NCT01277627|HIV|hiv
437855|NCT01277627|Nevirapine|nevirapine
437856|NCT01277627|HCV viral load|hcv viral load
437857|NCT01277627|Efavirenz|efavirenz
437858|NCT01277627|Protease inhibitors|protease inhibitors
437859|NCT01277614|lifestyle|lifestyle
437860|NCT01277614|diet|diet
437861|NCT01277614|exercise|exercise
437862|NCT01277601|Chronic Hepatitis B|chronic hepatitis b
437863|NCT01277601|Hep B|hep b
437864|NCT01277601|Non cirrhotic|non cirrhotic
437865|NCT01277601|Tenofovir disoproxil fumarate (TDF)|tenofovir disoproxil fumarate (tdf)
437866|NCT01277601|Peginterferon α-2a (Peg-IFN)|peginterferon α-2a (peg-ifn)
437867|NCT01277588|fetal scalp sampling|fetal scalp sampling
437868|NCT01277588|experience questionnaire|experience questionnaire
437869|NCT01277575|stroke|stroke
437870|NCT01277575|aphasia|aphasia
437871|NCT01277575|language|language
437872|NCT01277562|Breast Cancer|breast cancer
437873|NCT01277562|Prostate Cancer|prostate cancer
437874|NCT01277562|Osteopenia|osteopenia
437875|NCT01277562|Osteoporosis|osteoporosis
437876|NCT01277562|Secondary causes of bone loss|secondary causes of bone loss
437877|NCT01277549|Leukapheresis|leukapheresis
437878|NCT01277549|Hematopoetic Stem Cell Mobilization|hematopoetic stem cell mobilization
437879|NCT01277510|dialysis|dialysis
437880|NCT01277510|sensipar|sensipar
437881|NCT01277510|mimpara|mimpara
437882|NCT01277510|hemodialysis|hemodialysis
437883|NCT01277510|peritoneal dialysis|peritoneal dialysis
437884|NCT01277510|renal|renal
437885|NCT01277510|parathyroid hormone|parathyroid hormone
437886|NCT01277510|pediatric|pediatric
437887|NCT01277497|Chronic kidney disease|chronic kidney disease
437888|NCT01277497|Phosphate binder|phosphate binder
437889|NCT01277497|Sevelamer carbonate|sevelamer carbonate
437890|NCT01277497|Calcium acetate|calcium acetate
437891|NCT01277497|Vascular calcification|vascular calcification
437892|NCT01277497|Endothelial Dysfunction|endothelial dysfunction
437893|NCT01277484|decitabine|decitabine
437894|NCT01277484|dose|dose
437895|NCT01277484|schedule|schedule
437896|NCT01277484|safety|safety
437897|NCT01277484|allogeneic stem cell transplantation|allogeneic stem cell transplantation
437898|NCT01277471|meal frequency|meal frequency
437899|NCT01277471|type two diabetes|type two diabetes
437900|NCT01277458|HIV|hiv
437901|NCT01277458|MSM|msm
437902|NCT01277458|Ethnicity|ethnicity
437903|NCT01277445|gut microbiome|gut microbiome
437904|NCT01277445|prebiotics|prebiotics
437905|NCT01277445|immunological status|immunological status
437906|NCT01277445|fructans|fructans
437907|NCT01277432|Diabetes|diabetes
437908|NCT01277432|Depression|depression
437909|NCT01277406|Colorectal Carcinoma|colorectal carcinoma
437910|NCT01277406|Resminostat|resminostat
437911|NCT01277406|HDAC|hdac
437912|NCT01277406|4SC-201|4sc-201
437913|NCT01277406|Phase I|phase i
437914|NCT01277406|Phase II|phase ii
437915|NCT01277393|Enteral nutrition feeding|enteral nutrition feeding
437916|NCT01277380|H1N1 Influenza virus|h1n1 influenza virus
437917|NCT01277380|swine flu|swine flu
437918|NCT01277380|Real Time RT-PCR|real time rt-pcr
437919|NCT01277367|Obesity|obesity
437920|NCT01277367|Sedentary|sedentary
437921|NCT01277367|Physical activity|physical activity
437922|NCT01277367|exercise|exercise
437923|NCT01277367|incentives|incentives
437924|NCT01277354|Cognitive Processing Therapy (CPT)|cognitive processing therapy (cpt)
437925|NCT01277315|ALS|als
437926|NCT01277315|Anakinra|anakinra
437927|NCT01277315|Kineret|kineret
437928|NCT01277315|Progressive Muscular Atrophy|progressive muscular atrophy
437929|NCT01277315|PMA|pma
437930|NCT01277315|Safety Trial|safety trial
437931|NCT01277315|Tolerability Trial|tolerability trial
437932|NCT01277289|dexamethasone|dexamethasone
437933|NCT01277289|ery-dex|ery-dex
437934|NCT01277289|Chron's disease|chron's disease
437935|NCT01277289|CD|cd
437936|NCT01277276|Medical tool|medical tool
437937|NCT01277263|Breast Cancer|breast cancer
437938|NCT01277250|Hospitalized adults|hospitalized adults
437939|NCT01277250|Tobacco users|tobacco users
437940|NCT01277250|Smokers|smokers
437941|NCT01277250|Smoking cessation|smoking cessation
437942|NCT01277250|Web-based|web-based
437943|NCT01277250|Transition coach|transition coach
437944|NCT01277237|Non alcoholic fatty liver disease|non alcoholic fatty liver disease
437945|NCT01277224|physical activity|physical activity
437946|NCT01277224|obesity|obesity
437947|NCT01277224|adiposity|adiposity
437948|NCT01277224|children|children
437949|NCT01277224|blood lipids|blood lipids
437950|NCT01277224|blood pressure|blood pressure
437951|NCT01277224|randomized controlled trials|randomized controlled trials
437952|NCT01277211|Contraception|contraception
437953|NCT01277211|NuvaRing|nuvaring
437954|NCT01277198|kidney calculi|kidney calculi
437955|NCT01277198|ureteral calculi|ureteral calculi
437956|NCT01277198|cystoscopes|cystoscopes
437957|NCT01277198|laparoscopes|laparoscopes
437958|NCT01277185|calcium|calcium
437959|NCT01277185|healthy|healthy
437960|NCT01277185|Mexican-American adolescents|mexican-american adolescents
437961|NCT01277185|camp|camp
437962|NCT01277185|girls|girls
437963|NCT01277185|boys|boys
437964|NCT01277185|bone|bone
437965|NCT01277172|DLBCL|dlbcl
437966|NCT01277172|pharmacokinetics|pharmacokinetics
437967|NCT01277172|pharmacodynamics|pharmacodynamics
437968|NCT01277172|Rituximab|rituximab
437969|NCT01277172|LymphomaLymphoma|lymphomalymphoma
437970|NCT01277172|Non-HodgkinLymphoma|non-hodgkinlymphoma
437971|NCT01277172|B-CellLymphoma|b-celllymphoma
437972|NCT01277172|Large B-Cell|large b-cell
437973|NCT01277172|Disorders Lymphatic Diseases|disorders lymphatic diseases
437974|NCT01277172|Immunoproliferative Disorders|immunoproliferative disorders
437975|NCT01277172|Antineoplastic Agents|antineoplastic agents
437976|NCT01277172|Adverse Effects|adverse effects
437977|NCT01277159|Analgesia|analgesia
437978|NCT01277159|Duration|duration
437979|NCT01277159|Popliteal Fossa Nerve Block|popliteal fossa nerve block
437980|NCT01277159|Dexamethasone|dexamethasone
437981|NCT01277159|Buprenorphine|buprenorphine
437982|NCT01277159|Additives|additives
437983|NCT01277159|Ankle surgery|ankle surgery
437984|NCT01277146|Phase 1|phase 1
437985|NCT01277146|dose escalation|dose escalation
437986|NCT01277146|histologically confirmed|histologically confirmed
437987|NCT01277146|malignancy metastatic|malignancy metastatic
437988|NCT01277107|PSG|psg
437989|NCT01277107|LPS|lps
437990|NCT01277107|TST|tst
437991|NCT01277107|WASO|waso
437992|NCT01277107|Subjects With Insomnia characterized by both Difficulty in Falling Asleep and Staying Asleep|subjects with insomnia characterized by both difficulty in falling asleep and staying asleep
437993|NCT01277081|Paracetamol|paracetamol
437994|NCT01277081|Common cold|common cold
437995|NCT01277068|obese patients|obese patients
437996|NCT01277068|TRL|trl
437997|NCT01277068|the bariatric surgery|the bariatric surgery
437998|NCT01277042|Safety|safety
437999|NCT01277042|HPV vaccine|hpv vaccine
438000|NCT01277042|Immune response|immune response
438001|NCT01277042|Human papillomavirus|human papillomavirus
438002|NCT01277042|China|china
438003|NCT01277016|Amyloidosis|amyloidosis
438004|NCT01277016|Bortezomib|bortezomib
438005|NCT01276977|Migraine|migraine
438006|NCT01276977|Acute Migraine|acute migraine
438007|NCT01276977|Headache|headache
438008|NCT01276964|menses|menses
438009|NCT01276964|quantitative determination of menstrual losses|quantitative determination of menstrual losses
438010|NCT01276964|kinetic definition of menses|kinetic definition of menses
438011|NCT01276951|Cocoa|cocoa
438012|NCT01276951|Chocolate|chocolate
438013|NCT01276951|Endothelial disfunction|endothelial disfunction
438014|NCT01276951|Cardiovascular disease|cardiovascular disease
438015|NCT01276951|Blood Pressure|blood pressure
438016|NCT01276951|Hypertension|hypertension
438017|NCT01276938|Breast cancer|breast cancer
438018|NCT01276938|Intra Operative Radiation Therapy|intra operative radiation therapy
438019|NCT01276938|Toxicity|toxicity
438020|NCT01276925|Hip arthroplasty|hip arthroplasty
438021|NCT01276925|Peripheral nervous blockade|peripheral nervous blockade
438022|NCT01276925|Postoperative|postoperative
438023|NCT01276925|Pain|pain
438024|NCT01276925|Ropivacaine|ropivacaine
438025|NCT01276899|Breast Cancer|breast cancer
438026|NCT01276899|Triple negative breast cancer|triple negative breast cancer
438027|NCT01276899|ERnegative, PRnegative and Her2negative|ernegative, prnegative and her2negative
438028|NCT01276899|Taxanes|taxanes
438029|NCT01276899|Metastases|metastases
438030|NCT01276899|Biomarkers|biomarkers
438031|NCT01276899|Resistance|resistance
438032|NCT01276899|Biobanking|biobanking
438033|NCT01276899|Breast cancer with unresectable metastases to the liver|breast cancer with unresectable metastases to the liver
438034|NCT01276899|Breast cancer with unresectable metastases to the skin|breast cancer with unresectable metastases to the skin
438035|NCT01276899|Breast cancer with unresectable metastases to the lymph node|breast cancer with unresectable metastases to the lymph node
438036|NCT01276899|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
438037|NCT01276886|Left sided acute diverticulitis diagnosed clinically by the presence of abdominal pain, leukocytosis (>11x109) and/or fever >38°C, confirmed by imaging.|left sided acute diverticulitis diagnosed clinically by the presence of abdominal pain, leukocytosis (>11x109) and/or fever >38°c, confirmed by imaging.
438038|NCT01276886|CT criteria: localized thickening (≥4 mm) of the colonic wall and signs of inflammation of the pericolic fat, abscess and/or extraluminal air and/or contrast.|ct criteria: localized thickening (≥4 mm) of the colonic wall and signs of inflammation of the pericolic fat, abscess and/or extraluminal air and/or contrast.
438039|NCT01276886|US criteria: bowel wall thickening (>4 mm), diverticular inflammation, pericolic fat edema, intramural or pericolic inflammatory mass, intramural fistula.|us criteria: bowel wall thickening (>4 mm), diverticular inflammation, pericolic fat edema, intramural or pericolic inflammatory mass, intramural fistula.
438040|NCT01276886|WSCE criteria: segmental luminal narrowing and a tethered mucosa with or without a mass effect or extravasation of contrast and/or extraluminal air.|wsce criteria: segmental luminal narrowing and a tethered mucosa with or without a mass effect or extravasation of contrast and/or extraluminal air.
438041|NCT01276873|Artificial Respiration|artificial respiration
438042|NCT01276873|Suction|suction
438043|NCT01276873|Pain|pain
438044|NCT01276873|Nursing|nursing
438045|NCT01276873|Neonatology|neonatology
438046|NCT01276860|Obstructive Sleep Apnea|obstructive sleep apnea
438047|NCT01276860|Pediatric Obstructive Sleep Apnea|pediatric obstructive sleep apnea
438048|NCT01276860|OSA|osa
438049|NCT01276860|PVT|pvt
438050|NCT01276860|Psychomotor Vigilance Testing|psychomotor vigilance testing
438051|NCT01276860|Psychomotor Vigilance Task|psychomotor vigilance task
438052|NCT01276847|psoriasis|psoriasis
438053|NCT01276847|Ustekinumab|ustekinumab
438054|NCT01276847|Stelara|stelara
438055|NCT01276847|Etanercept|etanercept
438056|NCT01276847|Enbrel|enbrel
438057|NCT01276821|Bronchiolitis|bronchiolitis
438058|NCT01276821|L-Epinephrine|l-epinephrine
438059|NCT01276821|3% Hypertonic Saline|3% hypertonic saline
438060|NCT01276821|Clinical Severity Score|clinical severity score
438061|NCT01276808|Magnetic navigation, percutaneous coronary intervention|magnetic navigation, percutaneous coronary intervention
438062|NCT01276769|Triple Negative Breast Cancer|triple negative breast cancer
438063|NCT01276769|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
438064|NCT01276769|Platinum|platinum
438065|NCT01276730|Advanced cervical cancer|advanced cervical cancer
438066|NCT01276730|India|india
438067|NCT01276691|Vascular function|vascular function
438068|NCT01276691|Inflammation|inflammation
438069|NCT01276691|Oxidative stress|oxidative stress
438070|NCT01276691|Hemostatic balance|hemostatic balance
438071|NCT01276691|Aspirin|aspirin
438072|NCT01276691|Firefighting|firefighting
438073|NCT01276678|CAD|cad
438074|NCT01276665|Bladder cancer|bladder cancer
438075|NCT01276665|urinary diversion|urinary diversion
438076|NCT01276665|Postoperative Complications|postoperative complications
438077|NCT01276665|Fluid Therapy|fluid therapy
438078|NCT01276665|Norepinephrine|norepinephrine
438079|NCT01276652|Polysomnography|polysomnography
438080|NCT01276652|Circadian rhythmicity|circadian rhythmicity
438081|NCT01276639|Xeljanz|xeljanz
438082|NCT01276639|tofacitinib|tofacitinib
438083|NCT01276639|chronic|chronic
438084|NCT01276639|Pruritus|pruritus
438085|NCT01276639|Itch|itch
438086|NCT01276639|DLQI|dlqi
438087|NCT01276639|severe|severe
438088|NCT01276639|moderate|moderate
438089|NCT01276639|treatment|treatment
438090|NCT01276639|safety|safety
438091|NCT01276639|efficacy|efficacy
438092|NCT01276639|CP-690,550|cp-690,550
438093|NCT01276639|Plaque Psoriasis|plaque psoriasis
438094|NCT01276639|Psoriasis Vulgaris|psoriasis vulgaris
438095|NCT01276639|Jax-inhibitor|jax-inhibitor
438096|NCT01276639|Oral Treatment|oral treatment
438097|NCT01276613|Resectable Adenocarcinoma of the Pancreas|resectable adenocarcinoma of the pancreas
438098|NCT01276613|Gemcitabine|gemcitabine
438099|NCT01276613|Gemcitabine Hydrochloride|gemcitabine hydrochloride
438100|NCT01276613|Gemzar|gemzar
438101|NCT01276587|sickle cell disease|sickle cell disease
438102|NCT01276587|children|children
438103|NCT01276587|vitamin D|vitamin d
438104|NCT01276587|safety|safety
438105|NCT01276574|PET/CT|pet/ct
438106|NCT01276574|Ovarian cancer|ovarian cancer
438107|NCT01276574|HE4|he4
438108|NCT01276561|laparoscopy|laparoscopy
438109|NCT01276561|splenectomy|splenectomy
438110|NCT01276561|single site|single site
438111|NCT01276561|trial|trial
438112|NCT01276522|Schnitzler syndrome|schnitzler syndrome
438113|NCT01276522|IL-1 beta|il-1 beta
438114|NCT01276522|Canakinumab|canakinumab
438115|NCT01276522|Ilaris|ilaris
438116|NCT01276522|Treatment|treatment
438117|NCT01276522|Efficacy|efficacy
438118|NCT01276522|Safety|safety
438119|NCT01276509|Crohn's disease Safety Efficacy Pharmacokinetics Pharmacodynamics Crohn's Disease Activity Index (CDAI)|crohn's disease safety efficacy pharmacokinetics pharmacodynamics crohn's disease activity index (cdai)
438120|NCT01276483|GIST|gist
438121|NCT01276483|Response Monitoring|response monitoring
438122|NCT01276483|Functional Magnetic Imaging|functional magnetic imaging
438123|NCT01276483|Positron Emission Tomography|positron emission tomography
438124|NCT01276483|Computer Tomography|computer tomography
438125|NCT01276470|Adult and Pediatric Autoimmune Disease|adult and pediatric autoimmune disease
438126|NCT01276470|Antibody|antibody
438127|NCT01276470|Autoimmune Diseases|autoimmune diseases
438128|NCT01276470|Autoimmunity Pathogenesis|autoimmunity pathogenesis
438129|NCT01276470|Environmental Risk Factors|environmental risk factors
438130|NCT01276470|Myositis|myositis
438131|NCT01276457|immunosuppression|immunosuppression
438132|NCT01276457|kidney transplantation|kidney transplantation
438133|NCT01276457|everolimus|everolimus
438134|NCT01276457|safety|safety
438135|NCT01276444|valve repair|valve repair
438136|NCT01276444|postoperative period|postoperative period
438137|NCT01276444|goal-directed therapy|goal-directed therapy
438138|NCT01276444|pulmonary artery catheter|pulmonary artery catheter
438139|NCT01276444|transpulmonary thermodilution|transpulmonary thermodilution
438140|NCT01276444|central venous oxygen saturation|central venous oxygen saturation
438141|NCT01276392|regional and systemical anticoagulation|regional and systemical anticoagulation
438142|NCT01276392|continuous renal replacement therapy|continuous renal replacement therapy
438143|NCT01276392|multiplate|multiplate
438144|NCT01276392|rotational thrombelastometry|rotational thrombelastometry
438145|NCT01276379|colorectal cancer|colorectal cancer
438146|NCT01276379|advanced|advanced
438147|NCT01276379|metastatic|metastatic
438148|NCT01276379|KRAS|kras
438149|NCT01276379|biomarkers (BRAF, IGF1P/MMp7,PI3K-PTEN)|biomarkers (braf, igf1p/mmp7,pi3k-pten)
438150|NCT01276379|cetuximab|cetuximab
438151|NCT01276366|Heel lance|heel lance
438152|NCT01276366|Premature|premature
438153|NCT01276366|Breast milk|breast milk
438154|NCT01276353|Alzheimer Disease|alzheimer disease
438155|NCT01276353|Dementia|dementia
438156|NCT01276353|Delirium|delirium
438157|NCT01276353|Amnestic|amnestic
438158|NCT01276353|Cognitive Disorders|cognitive disorders
438159|NCT01276353|Donepezil|donepezil
438160|NCT01276353|Brain Diseases|brain diseases
438161|NCT01276353|Central Nervous System Diseases|central nervous system diseases
438162|NCT01276353|Nervous System Diseases|nervous system diseases
438163|NCT01276353|Tauopathies|tauopathies
438164|NCT01276353|Neurodegenerative Diseases|neurodegenerative diseases
438165|NCT01276353|Mental Disorders|mental disorders
438166|NCT01276353|Cholinesterase Inhibitors|cholinesterase inhibitors
438167|NCT01276353|Enzy|enzy
438168|NCT01276340|Urinary Incontinence|urinary incontinence
438169|NCT01276340|Urinary stress incontinence|urinary stress incontinence
438170|NCT01276340|Urinary urge incontinence|urinary urge incontinence
438171|NCT01276340|Women|women
438172|NCT01276340|electrical stimulation|electrical stimulation
438173|NCT01276340|KEAT stimulator|keat stimulator
438174|NCT01276340|quality of life|quality of life
438175|NCT01276314|SCAR|scar
438176|NCT01276314|anti-TNF-a|anti-tnf-a
438177|NCT01276275|Acute coronary syndrome, thienopyridine, epidemiology|acute coronary syndrome, thienopyridine, epidemiology
438178|NCT01276262|Phase 1, healthy female volunteers, oral contraceptive, pharmacokinetics, Rheumatoid arthritis, RA, fostamatinib|phase 1, healthy female volunteers, oral contraceptive, pharmacokinetics, rheumatoid arthritis, ra, fostamatinib
438179|NCT01276249|Aptus Endosystem|aptus endosystem
438180|NCT01276249|EndoStaple|endostaple
438181|NCT01276249|Endograft|endograft
438182|NCT01276249|Stent Graft|stent graft
438183|NCT01276249|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
438184|NCT01276249|Heli-FX|heli-fx
438185|NCT01276249|EndoAnchor|endoanchor
438186|NCT01276236|Kaposi's Sarcoma|kaposi's sarcoma
438187|NCT01276236|Maraviroc|maraviroc
438188|NCT01276236|CCR5|ccr5
438189|NCT01276236|HIV|hiv
438190|NCT01276223|Dry eye|dry eye
438191|NCT01276223|ocular discomfort|ocular discomfort
438192|NCT01276197|hypertension|hypertension
438193|NCT01276197|healthcare disparities|healthcare disparities
438194|NCT01276197|minority health|minority health
438195|NCT01276197|health behavior|health behavior
438196|NCT01276184|HPV Vaccine|hpv vaccine
438197|NCT01276184|HPV vaccination|hpv vaccination
438198|NCT01276184|SMS|sms
438199|NCT01276184|Text Message|text message
438200|NCT01276184|Gardasil|gardasil
438201|NCT01276145|pudendal artery disease|pudendal artery disease
438202|NCT01276145|erectile dysfunction|erectile dysfunction
438203|NCT01276145|coronary angiography|coronary angiography
438204|NCT01276145|coronary disease|coronary disease
438205|NCT01276145|cardiac|cardiac
438206|NCT01276132|percutaneous coronary artery intervention|percutaneous coronary artery intervention
438207|NCT01276132|coronary disease|coronary disease
438208|NCT01276119|CDP6038|cdp6038
438209|NCT01276119|single-dose|single-dose
438210|NCT01276119|pharmacokinetics|pharmacokinetics
438211|NCT01276119|healthy subjects|healthy subjects
438212|NCT01276106|AC-201|ac-201
438213|NCT01276106|Interleukin 1 inhibitor|interleukin 1 inhibitor
438214|NCT01276093|Atrial fibrillation|atrial fibrillation
438215|NCT01276093|PVI ablation|pvi ablation
438216|NCT01276093|Elderly patients|elderly patients
438217|NCT01276093|Efficacy|efficacy
438218|NCT01276041|MAB 2C4 (PERTUZUMAB)|mab 2c4 (pertuzumab)
438219|NCT01276041|MAB HER 2 (HERCEPTIN) (TRASTUZUMAB)|mab her 2 (herceptin) (trastuzumab)
438220|NCT01276041|TAXOL (PACLITAXEL)|taxol (paclitaxel)
438221|NCT01276041|10-142|10-142
438222|NCT01276041|Stage IV HER2 (+) breast cancer|stage iv her2 (+) breast cancer
438223|NCT01276028|Acupuncture|acupuncture
438224|NCT01276028|Hot Flashes|hot flashes
438225|NCT01276028|Menopause|menopause
438226|NCT01276028|Vasomotor Symptoms|vasomotor symptoms
438227|NCT01276015|BoNT-A-botulinum neurotoxin type A|bont-a-botulinum neurotoxin type a
438228|NCT01276015|CMAP-compound muscle action potential|cmap-compound muscle action potential
438229|NCT01276015|CP-cerebral palsy|cp-cerebral palsy
438230|NCT01276015|LG-lateral gastrocnemius|lg-lateral gastrocnemius
438231|NCT01276015|MG-medial gastrocnemius|mg-medial gastrocnemius
438232|NCT01276015|TA-tibialis anterior|ta-tibialis anterior
438233|NCT01276015|PROMS-passive range of movement|proms-passive range of movement
438234|NCT01276015|MAS-modified Ashworth scale|mas-modified ashworth scale
438235|NCT01276015|EVGS-Edinburgh visual gait scale|evgs-edinburgh visual gait scale
438236|NCT01276015|GMF-CS-gross motor function classification system|gmf-cs-gross motor function classification system
438237|NCT01276002|disrupted duct|disrupted duct
438238|NCT01276002|pancreatic pseudocysts|pancreatic pseudocysts
438239|NCT01275976|C1-esterase inhibitor|c1-esterase inhibitor
438240|NCT01275976|Systemic inflammation|systemic inflammation
438242|NCT01275976|Trauma|trauma
438243|NCT01275976|Multiple Organ Dysfunction Syndrome|multiple organ dysfunction syndrome
438244|NCT01275976|Cytokines|cytokines
438245|NCT01275963|Echocardiography|echocardiography
438246|NCT01275963|Strain imaging|strain imaging
438247|NCT01275963|Ventricular Dysfunction|ventricular dysfunction
438248|NCT01275963|Cardiomyopathy|cardiomyopathy
438249|NCT01275963|Longitudinal left ventricular function|longitudinal left ventricular function
438250|NCT01275950|Tobacco vendor|tobacco vendor
438251|NCT01275950|students|students
438252|NCT01275950|knowledge|knowledge
438253|NCT01275950|attitude|attitude
438254|NCT01275950|practice|practice
438255|NCT01275950|direct advertisements|direct advertisements
438256|NCT01275950|surrogate advertisements|surrogate advertisements
438257|NCT01275924|Syndesmosis|syndesmosis
438258|NCT01275924|Injury|injury
438259|NCT01275924|Ankle|ankle
438260|NCT01275924|Fracture|fracture
438261|NCT01275898|NIRS|nirs
438262|NCT01275898|cerebral oxygenation|cerebral oxygenation
438263|NCT01275885|cholecalciferol|cholecalciferol
438264|NCT01275885|infant|infant
438265|NCT01275885|bone mineral density|bone mineral density
438266|NCT01275872|guided imagery|guided imagery
438267|NCT01275872|progressive muscle relaxation|progressive muscle relaxation
438268|NCT01275872|complimentary and alternative medicine|complimentary and alternative medicine
438269|NCT01275872|quality of life|quality of life
438270|NCT01275872|stress|stress
438271|NCT01275872|pain|pain
438272|NCT01275872|anxiety|anxiety
438273|NCT01275859|Neoadjuvant|neoadjuvant
438274|NCT01275859|Letrozole|letrozole
438275|NCT01275859|Lapatinib|lapatinib
438276|NCT01275859|Postmenopausal|postmenopausal
438277|NCT01275846|heart failure|heart failure
438278|NCT01275846|congestive heart failure|congestive heart failure
438279|NCT01275846|telemedicine|telemedicine
438280|NCT01275833|Implantable ICD|implantable icd
438281|NCT01275833|First Degree AV block|first degree av block
438282|NCT01275820|diabetes, insulin, blood sugar|diabetes, insulin, blood sugar
438283|NCT01275807|climacteric, climacteric syndrome|climacteric, climacteric syndrome
438284|NCT01275794|Type 2 Diabetes|type 2 diabetes
438285|NCT01275781|Phase 1|phase 1
438286|NCT01275781|healthy male volunteers|healthy male volunteers
438287|NCT01275781|radioactivity|radioactivity
438288|NCT01275781|excretion|excretion
438289|NCT01275781|metabolism|metabolism
438290|NCT01275781|AZD9742|azd9742
438291|NCT01275781|amount of radioactive AZD9742 in urine, feces, and vomitus (if appropriate)|amount of radioactive azd9742 in urine, feces, and vomitus (if appropriate)
438292|NCT01275768|radio-frequency ablation|radio-frequency ablation
438293|NCT01275768|Malignant jaundice|malignant jaundice
438294|NCT01275755|opioid therapy|opioid therapy
438295|NCT01275755|constipation|constipation
438296|NCT01275755|chronic noncancer pain|chronic noncancer pain
438297|NCT01275755|mu opioid receptor antagonist|mu opioid receptor antagonist
438298|NCT01275755|ADL5945|adl5945
438299|NCT01275755|Opioid Induced Constipation|opioid induced constipation
438300|NCT01275742|Heart failure|heart failure
438301|NCT01275742|Depression|depression
438302|NCT01275742|Depressive symptoms|depressive symptoms
438303|NCT01275742|Cognitive therapy|cognitive therapy
438304|NCT01275742|Hospitalization|hospitalization
438305|NCT01275742|Quality of life|quality of life
438306|NCT01275729|Renal Replacement Therapy|renal replacement therapy
438307|NCT01275729|Diuretics|diuretics
438308|NCT01275729|Biomarkers|biomarkers
438309|NCT01275729|Renal Insufficiency|renal insufficiency
438310|NCT01275729|Furosemide|furosemide
438311|NCT01275729|Therapeutic Uses|therapeutic uses
438312|NCT01275729|Physiological Effects of Drugs|physiological effects of drugs
438313|NCT01275729|Biological Markers|biological markers
438314|NCT01275716|Patient Education|patient education
438315|NCT01275716|coronary artery disease|coronary artery disease
438316|NCT01275716|Impact of Coronary Images Used During Patient Education on Coronary Artery Disease and Subsequent Lifestyle Modifications.|impact of coronary images used during patient education on coronary artery disease and subsequent lifestyle modifications.
438317|NCT01275703|To determine the utility of a noninvasive method of measuring cardiac output during exercise testing in patients with PH|to determine the utility of a noninvasive method of measuring cardiac output during exercise testing in patients with ph
438318|NCT01275690|cardiac|cardiac
438319|NCT01275690|pulmonary hypertension|pulmonary hypertension
438320|NCT01275690|To determine the accuracy of a noninvasive method of measuring cardiac output as compared to the standard invasive approach in patients with PH|to determine the accuracy of a noninvasive method of measuring cardiac output as compared to the standard invasive approach in patients with ph
438321|NCT01275651|adenocarcinoma of the prostate|adenocarcinoma of the prostate
438322|NCT01275651|recurrent prostate cancer|recurrent prostate cancer
438323|NCT01275638|cortisol, prednisolone, adrenal insufficiency, sepsis|cortisol, prednisolone, adrenal insufficiency, sepsis
438324|NCT01275625|maraviroc|maraviroc
438325|NCT01275625|naive|naive
438326|NCT01275625|hiv|hiv
438327|NCT01275625|zidovudine|zidovudine
438328|NCT01275625|lamivudine|lamivudine
438329|NCT01275625|combivir|combivir
438330|NCT01275625|Clade A|clade a
438331|NCT01275612|Mesenchymal Stromal Cells|mesenchymal stromal cells
438332|NCT01275612|Solid tumors|solid tumors
438333|NCT01275612|Cisplatin therapy|cisplatin therapy
438334|NCT01275612|Acute kidney injury|acute kidney injury
438335|NCT01275586|NF1|nf1
438336|NCT01275586|plexiform neurofibromas|plexiform neurofibromas
438337|NCT01275586|nilotinib|nilotinib
438338|NCT01275586|Tasigna|tasigna
438339|NCT01275573|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
438340|NCT01275573|pain threshold|pain threshold
438341|NCT01275573|Parkinson's disease|parkinson's disease
438342|NCT01275573|Pain threshold in Parkinson's disease|pain threshold in parkinson's disease
438343|NCT01275547|Patient controlled analgesia|patient controlled analgesia
438344|NCT01275547|Morphine|morphine
438345|NCT01275547|S-Ketamine intranasal|s-ketamine intranasal
438346|NCT01275547|Midazolam intranasal|midazolam intranasal
438347|NCT01275534|Stem cell transplantation|stem cell transplantation
438348|NCT01275534|Symptom experience|symptom experience
438349|NCT01275534|Late effects|late effects
438350|NCT01275534|Self-management|self-management
438351|NCT01275508|Subjects with active Crohn's disease|subjects with active crohn's disease
438352|NCT01275508|Safety and tolerability of FITC-Adalimumab|safety and tolerability of fitc-adalimumab
438353|NCT01275508|Intestinal topical application|intestinal topical application
438354|NCT01275495|Stroke|stroke
438355|NCT01275495|Family Caregivers|family caregivers
438356|NCT01275495|Cerebrovascular Accident|cerebrovascular accident
438357|NCT01275495|Carers|carers
438358|NCT01275495|Care Givers|care givers
438359|NCT01275495|Depression|depression
438360|NCT01275495|Life change events|life change events
438361|NCT01275495|Family health|family health
438362|NCT01275495|Quality of life|quality of life
438363|NCT01275495|Cost|cost
438364|NCT01275495|Intervention studies|intervention studies
438365|NCT01275495|Clinical trial|clinical trial
438366|NCT01275482|Latent Myofascial trigger point.|latent myofascial trigger point.
438367|NCT01275482|Transverse friction massage|transverse friction massage
438368|NCT01275482|Local twitch response|local twitch response
438369|NCT01275482|Effectiveness|effectiveness
438370|NCT01275469|Impaired Glucose tolerance|impaired glucose tolerance
438371|NCT01275469|OGTT|ogtt
438372|NCT01275469|PPARs|ppars
438373|NCT01275456|allergen provocation|allergen provocation
438374|NCT01275456|environmental challenge|environmental challenge
438375|NCT01275456|allergen chamber|allergen chamber
438376|NCT01275456|house dust mite|house dust mite
438377|NCT01275456|immunotherapy|immunotherapy
438378|NCT01275443|HIV|hiv
438379|NCT01275430|central venous catheters|central venous catheters
438380|NCT01275430|peripherally inserted central catheters (PICC_|peripherally inserted central catheters (picc_
438381|NCT01275430|Electrocardiography (ECG)|electrocardiography (ecg)
438382|NCT01275430|intravascular ECG|intravascular ecg
438383|NCT01275430|Tip Positioning System|tip positioning system
438384|NCT01275417|Acupuncture|acupuncture
438385|NCT01275404|Erectile Dysfunction|erectile dysfunction
438386|NCT01275404|focus group|focus group
438387|NCT01275404|Quality of Life|quality of life
438388|NCT01275404|10-204|10-204
438389|NCT01275391|Tobacco use|tobacco use
438390|NCT01275391|Alcohol abuse|alcohol abuse
438391|NCT01275391|Drug abuse|drug abuse
438392|NCT01275391|Substance use|substance use
438393|NCT01275391|Prevention|prevention
438394|NCT01275391|Brief intervention|brief intervention
438395|NCT01275391|Screening|screening
438396|NCT01275391|Adolescents|adolescents
438397|NCT01275365|Mobility Limitation|mobility limitation
438398|NCT01275365|Low Protein Intake|low protein intake
438399|NCT01275365|Older Men|older men
438400|NCT01275365|Testosterone|testosterone
438401|NCT01275352|left ventricular hypertrophy|left ventricular hypertrophy
438402|NCT01275352|heart failure|heart failure
438403|NCT01275339|Aortic valve stenosis|aortic valve stenosis
438404|NCT01275339|Tadalafil|tadalafil
438405|NCT01275339|Phosphodiesterase inhibitors|phosphodiesterase inhibitors
438406|NCT01275339|Hypertension, pulmonary|hypertension, pulmonary
438407|NCT01275339|Hypertrophy, left ventricular|hypertrophy, left ventricular
438408|NCT01275326|Indoor Air Quality|indoor air quality
438409|NCT01275326|Infectious Aerosols|infectious aerosols
438410|NCT01275313|Pressure ulcers|pressure ulcers
438411|NCT01275313|wheelchairs|wheelchairs
438412|NCT01275313|wheelchair functional capacity|wheelchair functional capacity
438413|NCT01275313|custom-fitted wheelchair|custom-fitted wheelchair
438414|NCT01275287|Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis|anti-neutrophil cytoplasmic antibody-associated vasculitis
438415|NCT01275287|Complement Activation|complement activation
438416|NCT01275274|ANCA|anca
438417|NCT01275274|Vasculitis|vasculitis
438418|NCT01275274|Pauci-immune vasculitis|pauci-immune vasculitis
438419|NCT01275261|Stroke|stroke
438420|NCT01275261|Urinary Tract Infection|urinary tract infection
438421|NCT01275248|OCD|ocd
438422|NCT01275248|Obsessive Compulsive Disorder|obsessive compulsive disorder
438423|NCT01275222|GIST|gist
438424|NCT01275222|everolimus|everolimus
438425|NCT01275222|mTOR|mtor
438426|NCT01275222|Imatinib resistant|imatinib resistant
438427|NCT01275222|Imatinib-refractory/resistant gastrointestinal stromal tumors|imatinib-refractory/resistant gastrointestinal stromal tumors
438428|NCT01275209|HCD122|hcd122
438429|NCT01275209|Lucatumumab|lucatumumab
438430|NCT01275209|CD40|cd40
438431|NCT01275209|Follicular Lymphoma|follicular lymphoma
438432|NCT01275209|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
438433|NCT01275209|Antibody|antibody
438434|NCT01275196|Newly diagnosed,|newly diagnosed,
438435|NCT01275196|Ph+ chronic myeloid leukemia,|ph+ chronic myeloid leukemia,
438436|NCT01275196|CML-CP|cml-cp
438437|NCT01275183|HNSCC|hnscc
438438|NCT01275183|SCC|scc
438439|NCT01275183|head and neck|head and neck
438440|NCT01275183|squamous cell|squamous cell
438441|NCT01275183|nasopharyngeal|nasopharyngeal
438442|NCT01275157|Absorption|absorption
438443|NCT01275157|Distribution|distribution
438444|NCT01275157|Metabolism|metabolism
438445|NCT01275157|Excretion|excretion
438446|NCT01275157|Mass balance|mass balance
438447|NCT01275157|Metabolic profile|metabolic profile
438448|NCT01275157|Radiolabeled study|radiolabeled study
438449|NCT01275157|14C|14c
438450|NCT01275131|Insulin analog|insulin analog
438451|NCT01275131|Type 1 diabetes mellitus|type 1 diabetes mellitus
438452|NCT01275131|Pharmacokinetic|pharmacokinetic
438453|NCT01275131|Glucodynamic|glucodynamic
438454|NCT01275131|Phase 1|phase 1
438455|NCT01275092|robotic-assisted PCI|robotic-assisted pci
438456|NCT01275092|coronary intervention|coronary intervention
438457|NCT01275092|CorPath PRECISE|corpath precise
438458|NCT01275092|PCI|pci
438459|NCT01275079|tonsillectomy|tonsillectomy
438460|NCT01275079|nasalance|nasalance
438461|NCT01275079|tonsil volume|tonsil volume
438462|NCT01275079|Thai|thai
438463|NCT01275079|adult|adult
438464|NCT01275066|Mucopolysaccharidosis IV type A|mucopolysaccharidosis iv type a
438465|NCT01275066|MPS IV Type A|mps iv type a
438466|NCT01275066|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
438467|NCT01275066|MPS IVA|mps iva
438468|NCT01275066|Morquio A Syndrome|morquio a syndrome
438469|NCT01275066|Lysosomal Storage Disorder|lysosomal storage disorder
438470|NCT01275066|LSD|lsd
438471|NCT01275066|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
438472|NCT01275066|N-acetylgalactosamine-6-sulfate sulfatase|n-acetylgalactosamine-6-sulfate sulfatase
438473|NCT01275066|galactose-6-sulfatase|galactose-6-sulfatase
438474|NCT01275066|GALNS|galns
438475|NCT01275066|enzyme replacement therapy|enzyme replacement therapy
438476|NCT01275066|ERT|ert
438477|NCT01275053|Leptin|leptin
438478|NCT01275053|In Vivo|in vivo
438479|NCT01275053|Diabetic|diabetic
438480|NCT01275053|Obese|obese
438481|NCT01275053|Lean|lean
438482|NCT01275040|diabetes|diabetes
438483|NCT01275040|mobile screening|mobile screening
438484|NCT01275040|complications|complications
438485|NCT01275040|primary care|primary care
438486|NCT01275040|specialised care|specialised care
438487|NCT01275040|quality of care|quality of care
438488|NCT01275027|diabetes|diabetes
438489|NCT01275027|blood sugar|blood sugar
438490|NCT01275027|insulin|insulin
438491|NCT01275027|nutritional supplement|nutritional supplement
438492|NCT01275027|nutraceutical|nutraceutical
438493|NCT01275014|TMJ|tmj
438494|NCT01275014|corticosteroids|corticosteroids
438495|NCT01275014|osteoarthritis|osteoarthritis
438496|NCT01275014|arthrocentesis|arthrocentesis
438497|NCT01275014|pain|pain
438498|NCT01275001|brain|brain
438499|NCT01275001|brain development|brain development
438500|NCT01275001|MRI|mri
438501|NCT01275001|preschool children|preschool children
438502|NCT01275001|cortical mantle thickness|cortical mantle thickness
438503|NCT01275001|hippocampal volume|hippocampal volume
438504|NCT01274988|Opiate dependence|opiate dependence
438505|NCT01274988|Deep brain stimulation|deep brain stimulation
438506|NCT01274988|Nucleus accumbens|nucleus accumbens
438507|NCT01274949|LI-ESWT|li-eswt
438508|NCT01274949|Erectile Dysfunction|erectile dysfunction
438509|NCT01274949|Radical Prostatectomy|radical prostatectomy
438510|NCT01274949|Non PDE5 inhibitor responders|non pde5 inhibitor responders
438511|NCT01274949|Shock wave|shock wave
438512|NCT01274923|Erectile dysfunction|erectile dysfunction
438513|NCT01274923|Low Intensity Shock Wave|low intensity shock wave
438514|NCT01274910|Fish Oil|fish oil
438515|NCT01274910|Knee|knee
438516|NCT01274910|Analgetics|analgetics
438517|NCT01274897|Meningococcal|meningococcal
438518|NCT01274897|ACWY-CRM|acwy-crm
438519|NCT01274897|Conjugate Vaccine|conjugate vaccine
438520|NCT01274897|Meningitis|meningitis
438521|NCT01274897|Adolescents|adolescents
438522|NCT01274897|Persistence|persistence
438523|NCT01274897|Adults|adults
438524|NCT01274884|Acromioclavicular|acromioclavicular
438525|NCT01274884|Injury|injury
438526|NCT01274884|Dislocation|dislocation
438527|NCT01274884|Surgery|surgery
438528|NCT01274871|Thoracotomy|thoracotomy
438529|NCT01274871|Chronic Pain|chronic pain
438530|NCT01274871|persistent post-surgical pain|persistent post-surgical pain
438531|NCT01274858|persistent pain|persistent pain
438532|NCT01274858|neuropathic pain|neuropathic pain
438533|NCT01274858|Thoracotomy|thoracotomy
438534|NCT01274858|Chronic Pain|chronic pain
438535|NCT01274845|Meconium aspiration syndrome|meconium aspiration syndrome
438536|NCT01274845|Heliox|heliox
438537|NCT01274845|Mechanical ventilation|mechanical ventilation
438538|NCT01274845|Newborn|newborn
438539|NCT01274832|Parkinson|parkinson
438540|NCT01274832|DBS of STN|dbs of stn
438541|NCT01274832|PD|pd
438542|NCT01274832|Deep Brain stimulation of STN|deep brain stimulation of stn
438543|NCT01274832|Early treatment|early treatment
438544|NCT01274819|delirium|delirium
438545|NCT01274819|confusion|confusion
438546|NCT01274806|breast cancer|breast cancer
438547|NCT01274806|physical therapy|physical therapy
438548|NCT01274806|massage|massage
438549|NCT01274806|core stability|core stability
438550|NCT01274793|functional constipation|functional constipation
438551|NCT01274793|functional diarrhea|functional diarrhea
438552|NCT01274793|acupuncture|acupuncture
438553|NCT01274754|neuroprotection|neuroprotection
438554|NCT01274754|erythromycin|erythromycin
438555|NCT01274754|neurocognitive assessment|neurocognitive assessment
438556|NCT01274741|Posttraumatic stress disorder|posttraumatic stress disorder
438557|NCT01274741|Substance use disorder|substance use disorder
438558|NCT01274741|Treatment efficacy|treatment efficacy
438559|NCT01274741|Randomized trial|randomized trial
438560|NCT01274728|Acute myocardial infarction|acute myocardial infarction
438561|NCT01274728|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
438562|NCT01274728|Drug-eluting balloon|drug-eluting balloon
438563|NCT01274728|Bivalirudin|bivalirudin
438564|NCT01274715|Behavioral health coaching|behavioral health coaching
438565|NCT01274715|Diabetes|diabetes
438566|NCT01274715|Emotional health|emotional health
438567|NCT01274702|History of|history of
438568|NCT01274702|Patients|patients
438569|NCT01274702|acute|acute
438570|NCT01274689|lagophthalmos|lagophthalmos
438571|NCT01274689|parotis tumor|parotis tumor
438572|NCT01274689|m. orbicularis oculi paresis|m. orbicularis oculi paresis
438573|NCT01274676|stenting|stenting
438574|NCT01274676|carotid plaque|carotid plaque
438575|NCT01274676|stenosis|stenosis
438576|NCT01274676|angioplasty|angioplasty
438577|NCT01274663|Single Ascending Dose|single ascending dose
438578|NCT01274663|Phase 1|phase 1
438579|NCT01274663|Safety and Tolerability|safety and tolerability
438580|NCT01274663|PK|pk
438581|NCT01274663|Healthy Subjects|healthy subjects
438582|NCT01274637|postpartum|postpartum
438583|NCT01274637|low molecular weight heparin|low molecular weight heparin
438584|NCT01274637|venous thromboembolism|venous thromboembolism
438585|NCT01274637|prophylaxis|prophylaxis
438586|NCT01274637|Dalteparin Sodium|dalteparin sodium
438587|NCT01274624|Colorectal|colorectal
438588|NCT01274624|Cancer|cancer
438589|NCT01274624|REOLYSIN®|reolysin®
438590|NCT01274624|Chemotherapy|chemotherapy
438591|NCT01274624|FOLFIRI|folfiri
438592|NCT01274624|Reovirus|reovirus
438593|NCT01274624|Oncolytic virus|oncolytic virus
438594|NCT01274624|Fluorouracil|fluorouracil
438595|NCT01274624|Irinotecan|irinotecan
438596|NCT01274624|Leucovorin|leucovorin
438597|NCT01274624|Bevacizumab|bevacizumab
438598|NCT01274611|sweating|sweating
438599|NCT01274611|sweat|sweat
438600|NCT01274611|underarm|underarm
438601|NCT01274611|axillary|axillary
438602|NCT01274611|hyperhidrosis|hyperhidrosis
438603|NCT01274611|botox|botox
438604|NCT01274611|liposuction|liposuction
438605|NCT01274611|suction-curettage|suction-curettage
438606|NCT01274611|suction|suction
438607|NCT01274611|curettage|curettage
438608|NCT01274598|Probiotics|probiotics
438609|NCT01274598|Safety|safety
438610|NCT01274598|Elderly|elderly
438611|NCT01274598|Lactobacillus|lactobacillus
438612|NCT01274598|LGG|lgg
438613|NCT01274559|MK-0524A/ER|mk-0524a/er
438614|NCT01274559|Hypercholesterolemia|hypercholesterolemia
438615|NCT01274559|Dyslipidemia|dyslipidemia
438616|NCT01274559|Niacin|niacin
438617|NCT01274559|Laropiprant|laropiprant
438618|NCT01274533|ATLL|atll
438619|NCT01274520|ECD liver transplant allografts|ecd liver transplant allografts
438620|NCT01274520|Hypothermic machine perfusion|hypothermic machine perfusion
438621|NCT01274520|Cold storage preservation|cold storage preservation
438622|NCT01274520|liver transplant|liver transplant
438623|NCT01274520|portable bypass system|portable bypass system
438624|NCT01274520|machine perfusion preservation|machine perfusion preservation
438625|NCT01274520|extended criteria liver|extended criteria liver
438626|NCT01274507|Asthma|asthma
438627|NCT01274507|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
438628|NCT01274507|Healthy|healthy
438629|NCT01274507|Longitudinal Study|longitudinal study
438630|NCT01274507|Bronchoscopy|bronchoscopy
438631|NCT01274494|Hypertension|hypertension
438632|NCT01274481|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
438633|NCT01274481|Acute Lung Injury|acute lung injury
438634|NCT01274481|pulmonary hypertension|pulmonary hypertension
438635|NCT01274481|oxygenation|oxygenation
438636|NCT01274481|lung mechanics|lung mechanics
438637|NCT01274481|gas exchange|gas exchange
438638|NCT01274455|Gene therapy|gene therapy
438639|NCT01274455|pancreatic carcinoma|pancreatic carcinoma
438640|NCT01274455|gemcitabine|gemcitabine
438641|NCT01274455|endoscopic ultrasound|endoscopic ultrasound
438642|NCT01274442|dental implant|dental implant
438643|NCT01274429|Peanut allergy|peanut allergy
438644|NCT01274429|Immunotherapy|immunotherapy
438645|NCT01274429|OIT|oit
438646|NCT01274416|Anorexia Nervosa|anorexia nervosa
438647|NCT01274416|Eating Disorder|eating disorder
438648|NCT01274416|Treatment|treatment
438649|NCT01274416|Acceptance and Commitment Therapy|acceptance and commitment therapy
438650|NCT01274416|Separated Family Treatment|separated family treatment
438651|NCT01274403|Multiple Myeloma|multiple myeloma
438652|NCT01274403|Elderly patients|elderly patients
438653|NCT01274390|Cardiac Surgery|cardiac surgery
438654|NCT01274390|Red Blood Cell|red blood cell
438655|NCT01274390|Transfusion|transfusion
438656|NCT01274390|Oxygen Saturation|oxygen saturation
438657|NCT01274390|Microvascular Flow|microvascular flow
438658|NCT01274377|nonmyeloablative allogeneic stem cell transplantation|nonmyeloablative allogeneic stem cell transplantation
438659|NCT01274377|cytomegalovirus|cytomegalovirus
438660|NCT01274377|donor lymphocyte infusions|donor lymphocyte infusions
438661|NCT01274377|cytotoxic T lymphocyte|cytotoxic t lymphocyte
438662|NCT01274364|Diabetes|diabetes
438663|NCT01274364|Structured Care|structured care
438664|NCT01274351|First line treatment|first line treatment
438665|NCT01274351|newly diagnosed|newly diagnosed
438765|NCT01273909|Breast Cancer|breast cancer
438666|NCT01274351|Philadelphia chromosome positive|philadelphia chromosome positive
438667|NCT01274351|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
438668|NCT01274351|Ph+|ph+
438669|NCT01274351|CML-CP|cml-cp
438670|NCT01274351|major molecular response|major molecular response
438671|NCT01274351|Social risk|social risk
438672|NCT01274325|asthma|asthma
438673|NCT01274312|Somato-sensory reflex arch|somato-sensory reflex arch
438674|NCT01274312|Spinal cord injury|spinal cord injury
438675|NCT01274312|Xiao Procedure|xiao procedure
438676|NCT01274299|Infants|infants
438677|NCT01274299|morphometry|morphometry
438678|NCT01274299|face|face
438679|NCT01274299|3D|3d
438680|NCT01274286|hospital accreditation|hospital accreditation
438681|NCT01274286|patient-centered|patient-centered
438682|NCT01274286|healthcare quality index|healthcare quality index
438683|NCT01274286|documentary analysis|documentary analysis
438684|NCT01274286|meta analysis|meta analysis
438685|NCT01274273|Bevacizumab|bevacizumab
438686|NCT01274273|interleukin-2|interleukin-2
438687|NCT01274273|interferon-alpha|interferon-alpha
438688|NCT01274260|child|child
438689|NCT01274260|infant|infant
438690|NCT01274260|lung injury|lung injury
438691|NCT01274260|inflammation|inflammation
438692|NCT01274260|pneumonia|pneumonia
438693|NCT01274260|ventilator|ventilator
438694|NCT01274247|Tongue-tie|tongue-tie
438695|NCT01274247|Ankyloglossia|ankyloglossia
438696|NCT01274234|EPC capturing sirolimus eluting COMBO stent|epc capturing sirolimus eluting combo stent
438697|NCT01274234|Optical coherence tomography (OCT)|optical coherence tomography (oct)
438698|NCT01274234|Early neointimal healing and stent coverage|early neointimal healing and stent coverage
438699|NCT01274234|Late neointimal thickness, neointimal area, and lumen loss|late neointimal thickness, neointimal area, and lumen loss
438700|NCT01274208|Gaucher disease, Hepatitis C , Glucocerebroside immunity|gaucher disease, hepatitis c , glucocerebroside immunity
438701|NCT01274195|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
438702|NCT01274156|Erectile dysfunction|erectile dysfunction
438703|NCT01274156|Low Intensity Shock Wave|low intensity shock wave
438704|NCT01274143|Colorectal|colorectal
438705|NCT01274143|Cancer|cancer
438706|NCT01274143|Colon|colon
438707|NCT01274143|Rectal|rectal
438708|NCT01274143|Behavioral Intervention|behavioral intervention
438709|NCT01274143|Screening|screening
438710|NCT01274143|Motivational Interviewing|motivational interviewing
438711|NCT01274143|Extended Parallel Process Model|extended parallel process model
438712|NCT01274143|Implementation Intentions|implementation intentions
438713|NCT01274143|Family CARE|family care
438714|NCT01274117|Chronic renal failure|chronic renal failure
438715|NCT01274117|Basilic vein transposition fistula|basilic vein transposition fistula
438716|NCT01274104|statin-related myalgia|statin-related myalgia
438717|NCT01274104|high cholesterol|high cholesterol
438718|NCT01274091|Gene-diet interaction|gene-diet interaction
438719|NCT01274091|PPARgamma gene|ppargamma gene
438720|NCT01274091|Pro12Ala|pro12ala
438721|NCT01274091|Fatty acids|fatty acids
438722|NCT01274091|Dietary modification|dietary modification
438723|NCT01274091|Insulin sensitivity|insulin sensitivity
438724|NCT01274091|Glucose metabolism|glucose metabolism
438725|NCT01274078|inflammation|inflammation
438726|NCT01274078|lipids|lipids
438727|NCT01274078|CRP|crp
438728|NCT01274065|psychiatry|psychiatry
438729|NCT01274065|psychiatric illness|psychiatric illness
438730|NCT01274065|developmental disability|developmental disability
438731|NCT01274065|mental health|mental health
438732|NCT01274065|medication burden|medication burden
438733|NCT01274052|Gestational diabetes mellitus|gestational diabetes mellitus
438734|NCT01274052|Meal test|meal test
438735|NCT01274052|Incretin hormones|incretin hormones
438736|NCT01274052|Glucagon-like peptide-1 (GLP-1)|glucagon-like peptide-1 (glp-1)
438737|NCT01274052|Glucose-dependent insulinotropic polypeptide|glucose-dependent insulinotropic polypeptide
438738|NCT01274052|Insulin|insulin
438739|NCT01274052|C-peptide|c-peptide
438740|NCT01274052|Glucagon|glucagon
438741|NCT01274026|phenylketonuria|phenylketonuria
438742|NCT01274026|PKU|pku
438743|NCT01274026|phenylalanine|phenylalanine
438744|NCT01274026|neurotransmitters|neurotransmitters
438745|NCT01274026|gene|gene
438746|NCT01274026|Kuvan|kuvan
438747|NCT01274026|sapropterin|sapropterin
438748|NCT01274013|Hepatitis C|hepatitis c
438749|NCT01274013|Chronic Hepatitis C|chronic hepatitis c
438750|NCT01274013|Vitamin D|vitamin d
438751|NCT01274013|Vitamin D deficiency|vitamin d deficiency
438752|NCT01274000|diarrhea|diarrhea
438753|NCT01274000|IBS|ibs
438754|NCT01274000|Colonic disease|colonic disease
438755|NCT01274000|YM060|ym060
438756|NCT01274000|Ramosetron|ramosetron
438757|NCT01273974|intradermal influenza vaccine|intradermal influenza vaccine
438758|NCT01273974|hemodialysis patients|hemodialysis patients
438759|NCT01273935|Aspirin, Acute Cerebrovascular Ischemia, Platelet Function|aspirin, acute cerebrovascular ischemia, platelet function
438760|NCT01273922|NDV-3|ndv-3
438761|NCT01273922|vaccine|vaccine
438762|NCT01273922|Staphylococcus aureus|staphylococcus aureus
438763|NCT01273922|MRSA|mrsa
438764|NCT01273922|Candida|candida
438766|NCT01273909|BRACA1/2 Genotype|braca1/2 genotype
438767|NCT01273909|Acquired Lymphedema|acquired lymphedema
438768|NCT01273909|Congenital Lymphedema|congenital lymphedema
438769|NCT01273896|STA-9090|sta-9090
438770|NCT01273896|advanced breast cancer|advanced breast cancer
438771|NCT01273896|10-145|10-145
438772|NCT01273883|hearing|hearing
438773|NCT01273883|magnesium|magnesium
438774|NCT01273870|hemodialysis|hemodialysis
438775|NCT01273870|high-flux-dialyzer|high-flux-dialyzer
438776|NCT01273870|performance|performance
438777|NCT01273870|blood compatibility|blood compatibility
438778|NCT01273857|Cardiac progenitor cells|cardiac progenitor cells
438779|NCT01273857|Cell therapy|cell therapy
438780|NCT01273857|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
438781|NCT01273857|Single Ventricle|single ventricle
438782|NCT01273857|Norwood|norwood
438783|NCT01273857|Sano modification|sano modification
438784|NCT01273857|Glenn|glenn
438785|NCT01273857|Fontan|fontan
438786|NCT01273844|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
438787|NCT01273844|amyloidosis|amyloidosis
438788|NCT01273844|Bortezomib|bortezomib
438789|NCT01273831|intraocular pressure, anesthesia,cisatracurium,atracurium.|intraocular pressure, anesthesia,cisatracurium,atracurium.
438790|NCT01273818|inguinal hernia|inguinal hernia
438791|NCT01273818|infection prophylaxis|infection prophylaxis
438792|NCT01273818|topical gentamicin|topical gentamicin
438793|NCT01273805|metastatic pancreatic cancer|metastatic pancreatic cancer
438794|NCT01273805|hydroxychloroquine|hydroxychloroquine
438795|NCT01273779|sepsis|sepsis
438796|NCT01273779|talactoferrin|talactoferrin
438797|NCT01273779|lactoferrin|lactoferrin
438798|NCT01273779|recombinant human lactoferrin|recombinant human lactoferrin
438799|NCT01273753|End-stage renal disease|end-stage renal disease
438800|NCT01273753|Hemodialysis|hemodialysis
438801|NCT01273753|Bioimpedance analysis|bioimpedance analysis
438802|NCT01273753|Blood volume monitoring|blood volume monitoring
438803|NCT01273740|PTFE bypass|ptfe bypass
438804|NCT01273740|femoro-popliteal|femoro-popliteal
438805|NCT01273740|femoro-crural|femoro-crural
438806|NCT01273740|popliteal arteries|popliteal arteries
438807|NCT01273740|crural arteries|crural arteries
438808|NCT01273740|external support|external support
438809|NCT01273740|crtical limb ischemia|crtical limb ischemia
438810|NCT01273727|epiretinal membrane|epiretinal membrane
438811|NCT01273727|macular pucker|macular pucker
438812|NCT01273727|cellophane maculopathy|cellophane maculopathy
438813|NCT01273727|macular edema|macular edema
438814|NCT01273727|retinal edema|retinal edema
438815|NCT01273727|ozurdex|ozurdex
438816|NCT01273727|dexamethasone|dexamethasone
438817|NCT01273727|intravitreal implant|intravitreal implant
438818|NCT01273714|benign thyroid disease|benign thyroid disease
438819|NCT01273714|incidental thyroid cancer|incidental thyroid cancer
438820|NCT01273714|recurrent goiter|recurrent goiter
438821|NCT01273714|revision thyroid surgery|revision thyroid surgery
438822|NCT01273701|amphetamine|amphetamine
438823|NCT01273701|methamphetamine|methamphetamine
438824|NCT01273701|psychosocial intervention|psychosocial intervention
438825|NCT01273701|contingency management|contingency management
438826|NCT01273701|slow prosecution|slow prosecution
438827|NCT01273701|substance use disorder|substance use disorder
438828|NCT01273688|pain|pain
438829|NCT01273688|elbow|elbow
438830|NCT01273688|tendinopathy|tendinopathy
438831|NCT01273675|Hypertension|hypertension
438832|NCT01273675|Primary disease|primary disease
438833|NCT01273662|HCC|hcc
438834|NCT01273649|muscle activation|muscle activation
438835|NCT01273649|ACL reconstruction|acl reconstruction
438836|NCT01273649|cryotherapy|cryotherapy
438837|NCT01273649|TENS|tens
438838|NCT01273636|Endometrial hyperplasia|endometrial hyperplasia
438839|NCT01273636|Hysterectomy|hysterectomy
438840|NCT01273636|Endometrial carcinoma|endometrial carcinoma
438841|NCT01273623|PAD, Peripheral Arterial Disease, Calcium, Atherectomy, Jetstream|pad, peripheral arterial disease, calcium, atherectomy, jetstream
438842|NCT01273610|Breast Neoplasms|breast neoplasms
438843|NCT01273610|HER2 protein, human|her2 protein, human
438844|NCT01273610|Geriatric Health Services|geriatric health services
438845|NCT01273610|Antineoplastic Agents, Combined|antineoplastic agents, combined
438846|NCT01273610|Geriatric Assessment|geriatric assessment
438847|NCT01273610|Pharmacokinetics|pharmacokinetics
438848|NCT01273610|Toxicity|toxicity
438849|NCT01273610|Patient Adherence|patient adherence
438850|NCT01273597|Parathyroid hormone,Kidney failure, chronic,Hyperparathyroidism, secondary|parathyroid hormone,kidney failure, chronic,hyperparathyroidism, secondary
438851|NCT01273584|Metformin, obese, pregnancy, gestational diabetes|metformin, obese, pregnancy, gestational diabetes
438852|NCT01273571|Canagliflozin|canagliflozin
438853|NCT01273571|Metformin (GLUCOPHAGE IR)|metformin (glucophage ir)
438854|NCT01273571|Pharmacokinetics|pharmacokinetics
438855|NCT01273571|Pharmacodynamics|pharmacodynamics
438856|NCT01273558|Canagliflozin|canagliflozin
438857|NCT01273558|Renal threshold for glucose|renal threshold for glucose
438858|NCT01273558|Pharmacodynamics|pharmacodynamics
438859|NCT01273545|Dapoxetine hydrochloride (PRILIGY)|dapoxetine hydrochloride (priligy)
438860|NCT01273545|Premature ejaculation|premature ejaculation
438861|NCT01273532|tapentadol|tapentadol
438862|NCT01273532|NUCYNTA|nucynta
438863|NCT01273532|CG5503|cg5503
438864|NCT01273532|R331333|r331333
438865|NCT01273532|pharmacokinetics|pharmacokinetics
438866|NCT01273532|healthy volunteer|healthy volunteer
438867|NCT01273519|Ankylosing|ankylosing
438868|NCT01273519|Rheumatoid|rheumatoid
438869|NCT01273519|Antibodies|antibodies
438870|NCT01273519|Arthritis|arthritis
438871|NCT01273519|Pain|pain
438872|NCT01273519|Antirheumatic Agents|antirheumatic agents
438873|NCT01273519|Psoriatic|psoriatic
438874|NCT01273519|Spondylitis|spondylitis
438875|NCT01273519|Monoclonals|monoclonals
438876|NCT01273506|tapentadol|tapentadol
438877|NCT01273506|NUCYNTA|nucynta
438878|NCT01273506|CG5503|cg5503
438879|NCT01273506|R331333|r331333
438880|NCT01273506|pharmacokinetics|pharmacokinetics
438881|NCT01273506|healthy volunteer|healthy volunteer
438882|NCT01273493|Trabectedin, YONDELIS|trabectedin, yondelis
438883|NCT01273493|Antineoplastic Agents|antineoplastic agents
438884|NCT01273493|Solid tumors|solid tumors
438885|NCT01273493|Locally advanced or metastatic disease|locally advanced or metastatic disease
438886|NCT01273493|Chemotherapy|chemotherapy
438887|NCT01273493|Pharmacokinetics|pharmacokinetics
438888|NCT01273493|Hepatic Dysfunction|hepatic dysfunction
438889|NCT01273480|Trabectedin, YONDELIS|trabectedin, yondelis
438890|NCT01273480|Rifampin (RIFADIN)|rifampin (rifadin)
438891|NCT01273480|Antineoplastic Agents|antineoplastic agents
438892|NCT01273480|Solid tumors|solid tumors
438893|NCT01273480|Locally advanced or metastatic disease|locally advanced or metastatic disease
438894|NCT01273480|Chemotherapy|chemotherapy
438895|NCT01273480|Pharmacokinetics|pharmacokinetics
438896|NCT01273467|Ischemic Cerebral Infarction|ischemic cerebral infarction
438897|NCT01273467|Stroke|stroke
438898|NCT01273467|CNTO0007|cnto0007
438899|NCT01273467|42037788|42037788
438900|NCT01273454|Open-label|open-label
438901|NCT01273454|Non-interventional|non-interventional
438902|NCT01273454|OROS hydromorphone|oros hydromorphone
438903|NCT01273454|Korean cancer patients|korean cancer patients
438904|NCT01273415|hormone receptor-positive breast cancer|hormone receptor-positive breast cancer
438905|NCT01273415|nomogram|nomogram
438906|NCT01273415|Ki67|ki67
438907|NCT01273415|Effects of Chemotherapy|effects of chemotherapy
438908|NCT01273402|colorectal cancer|colorectal cancer
438909|NCT01273402|TF2 (Recombinant, humanized Tri-Fab bsMAb composed of 2 humanized MN-14 anti-CEA Fab x and one 679 anti-HSG Fab)|tf2 (recombinant, humanized tri-fab bsmab composed of 2 humanized mn-14 anti-cea fab x and one 679 anti-hsg fab)
438910|NCT01273402|IMP288 (DOTA-di-HSG hapten-peptide for 111In/90Y labeling)|imp288 (dota-di-hsg hapten-peptide for 111in/90y labeling)
438911|NCT01273389|Lupus nephritis|lupus nephritis
438912|NCT01273389|CNTO 136|cnto 136
438913|NCT01273389|Sirukumab|sirukumab
438914|NCT01273389|Kidney diseases|kidney diseases
438915|NCT01273389|Proteinuria|proteinuria
438916|NCT01273389|Glomerulonephritis|glomerulonephritis
438918|NCT01273376|Depression|depression
438919|NCT01273376|Major Depression|major depression
438920|NCT01273363|Asthma|asthma
438921|NCT01273363|Asthma in Children|asthma in children
438922|NCT01273350|internal carotid artery|internal carotid artery
438923|NCT01273350|common carotid artery|common carotid artery
438924|NCT01273350|bruit|bruit
438925|NCT01273350|tia|tia
438926|NCT01273337|Stroke|stroke
438927|NCT01273337|Ischemia|ischemia
438928|NCT01273337|Ischemic Stroke|ischemic stroke
438929|NCT01273337|Middle Cerebral Artery|middle cerebral artery
438930|NCT01273337|MCA|mca
438931|NCT01273337|Stem Cells|stem cells
438932|NCT01273337|Stem Cell|stem cell
438933|NCT01273337|Autologous Bone Marrow|autologous bone marrow
438934|NCT01273337|Ipsilateral MCA|ipsilateral mca
438935|NCT01273324|Osteoarthritis|osteoarthritis
438936|NCT01273311|Brain Aging|brain aging
438937|NCT01273311|Diabetes|diabetes
438938|NCT01273311|Aging|aging
438939|NCT01273311|Obesity|obesity
438940|NCT01273311|CARDIA|cardia
438941|NCT01273298|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
438942|NCT01273298|exercise|exercise
438943|NCT01273298|dynamic hyperinflation|dynamic hyperinflation
438944|NCT01273298|cardioselective beta blockers|cardioselective beta blockers
438945|NCT01273272|Cognitive Behavior Therapy|cognitive behavior therapy
438946|NCT01273272|Early dementia, Alzheimer type|early dementia, alzheimer type
438947|NCT01273259|Hypertension, pulmonary|hypertension, pulmonary
438948|NCT01273259|DHEA|dhea
438949|NCT01273259|six-minute walk test|six-minute walk test
438950|NCT01273259|pulmonary arterial pressure|pulmonary arterial pressure
438951|NCT01273220|Epidemiology|epidemiology
438952|NCT01273220|Epidemiologic Survey|epidemiologic survey
438953|NCT01273220|Alcohol|alcohol
438954|NCT01273207|Peripheral Blood Stem Cell Transplant|peripheral blood stem cell transplant
438955|NCT01273207|Inhaled Cyclosporine|inhaled cyclosporine
438956|NCT01273207|Graft-Versus-Host Disease|graft-versus-host disease
438957|NCT01273207|Bone Marrow Transplant|bone marrow transplant
438958|NCT01273207|Lung Transplantation|lung transplantation
438959|NCT01273207|Bronchiolitis Obliterans|bronchiolitis obliterans
438960|NCT01273207|Graft Versus Host Disease|graft versus host disease
438961|NCT01273194|Palliative Care|palliative care
438962|NCT01273194|Survey|survey
438963|NCT01273194|Quality of Life|quality of life
438964|NCT01273194|Attitudes|attitudes
438965|NCT01273194|Pediatric Cancer|pediatric cancer
438966|NCT01273181|Immunotherapy|immunotherapy
438967|NCT01273181|Gene Therapy|gene therapy
438968|NCT01273181|Metastatic Cancer|metastatic cancer
438969|NCT01273181|Clinical Response|clinical response
438970|NCT01273181|Metastatic Melanoma|metastatic melanoma
438971|NCT01273181|Metastatic Renal Cell Cancer|metastatic renal cell cancer
438972|NCT01273168|Pharmacokinetics|pharmacokinetics
438973|NCT01273168|Advanced Cancer|advanced cancer
438974|NCT01273168|Cytochrome P 450|cytochrome p 450
438975|NCT01273168|Selective Estrogen Receptor Modulator|selective estrogen receptor modulator
438976|NCT01273168|Tamoxifen Metabolite|tamoxifen metabolite
438977|NCT01273168|Gynecologic Cancer|gynecologic cancer
438978|NCT01273168|Breast Cancer|breast cancer
438979|NCT01273168|Desmoid Tumor|desmoid tumor
438980|NCT01273168|Endometrial Cancer|endometrial cancer
438981|NCT01273168|Ovarian Cancer|ovarian cancer
438982|NCT01273168|Uterine Cancer|uterine cancer
438983|NCT01273168|Fallopian Tube Cancer|fallopian tube cancer
438984|NCT01273168|Peritoneal Cancer|peritoneal cancer
438985|NCT01273155|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
438986|NCT01273155|Liver Dysfunction|liver dysfunction
438987|NCT01273155|Pharmacokinetics|pharmacokinetics
438988|NCT01273155|UGT1A1 Polymorphisms|ugt1a1 polymorphisms
438989|NCT01273155|Solid Tumor|solid tumor
438990|NCT01273155|Cancer|cancer
438991|NCT01273155|Lymphoma|lymphoma
438992|NCT01273142|Human Immunodeficiency Virus, liver toxicity, hapatitis co-infection|human immunodeficiency virus, liver toxicity, hapatitis co-infection
438993|NCT01273129|Neurosurgery|neurosurgery
438994|NCT01273129|Childhood Epilepsy|childhood epilepsy
438995|NCT01273129|Epilepsy|epilepsy
438996|NCT01273129|Frontal Lobe Epilepsy|frontal lobe epilepsy
438997|NCT01273129|Temporal Lobe Epilepsy|temporal lobe epilepsy
438998|NCT01273116|frailty|frailty
438999|NCT01273116|integrated care|integrated care
439000|NCT01273116|hospital|hospital
439001|NCT01273116|geriatrics|geriatrics
439002|NCT01273116|hospital-wide intervention|hospital-wide intervention
439003|NCT01273090|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
439004|NCT01273090|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
439005|NCT01273090|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
439006|NCT01273090|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
439007|NCT01273090|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
439008|NCT01273090|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
439009|NCT01273090|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
439010|NCT01273090|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
439011|NCT01273090|recurrent childhood anaplastic astrocytoma|recurrent childhood anaplastic astrocytoma
439012|NCT01273090|recurrent childhood anaplastic oligoastrocytoma|recurrent childhood anaplastic oligoastrocytoma
439013|NCT01273090|recurrent childhood anaplastic oligodendroglioma|recurrent childhood anaplastic oligodendroglioma
439014|NCT01273090|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
439015|NCT01273090|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
439016|NCT01273090|recurrent childhood diffuse astrocytoma|recurrent childhood diffuse astrocytoma
439017|NCT01273090|recurrent childhood fibrillary astrocytoma|recurrent childhood fibrillary astrocytoma
439018|NCT01273090|recurrent childhood gemistocytic astrocytoma|recurrent childhood gemistocytic astrocytoma
439019|NCT01273090|recurrent childhood giant cell glioblastoma|recurrent childhood giant cell glioblastoma
439020|NCT01273090|recurrent childhood glioblastoma|recurrent childhood glioblastoma
439021|NCT01273090|recurrent childhood gliomatosis cerebri|recurrent childhood gliomatosis cerebri
439022|NCT01273090|recurrent childhood gliosarcoma|recurrent childhood gliosarcoma
439023|NCT01273090|recurrent childhood oligoastrocytoma|recurrent childhood oligoastrocytoma
439024|NCT01273090|recurrent childhood oligodendroglioma|recurrent childhood oligodendroglioma
439025|NCT01273090|recurrent childhood pilocytic astrocytoma|recurrent childhood pilocytic astrocytoma
439026|NCT01273090|recurrent childhood pilomyxoid astrocytoma|recurrent childhood pilomyxoid astrocytoma
439027|NCT01273090|recurrent childhood pleomorphic xanthoastrocytoma|recurrent childhood pleomorphic xanthoastrocytoma
439028|NCT01273090|recurrent childhood protoplasmic astrocytoma|recurrent childhood protoplasmic astrocytoma
439029|NCT01273090|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
439030|NCT01273090|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
439031|NCT01273090|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
439032|NCT01273090|childhood pineal parenchymal tumor|childhood pineal parenchymal tumor
439033|NCT01273090|recurrent childhood central nervous system embryonal tumor|recurrent childhood central nervous system embryonal tumor
439034|NCT01273090|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
439035|NCT01273090|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
439120|NCT01272661|breastfeeding|breastfeeding
439036|NCT01273090|childhood central nervous system germinoma|childhood central nervous system germinoma
439037|NCT01273090|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
439038|NCT01273090|childhood central nervous system teratoma|childhood central nervous system teratoma
439039|NCT01273090|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
439040|NCT01273090|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
439041|NCT01273090|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
439042|NCT01273090|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
439043|NCT01273090|childhood nodular lymphocyte predominant Hodgkin lymphoma|childhood nodular lymphocyte predominant hodgkin lymphoma
439044|NCT01273090|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
439045|NCT01273090|childhood Burkitt lymphoma|childhood burkitt lymphoma
439046|NCT01273090|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
439047|NCT01273090|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
439048|NCT01273090|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
439049|NCT01273090|hepatosplenic T-cell lymphoma|hepatosplenic t-cell lymphoma
439050|NCT01273090|intraocular lymphoma|intraocular lymphoma
439051|NCT01273090|noncutaneous extranodal lymphoma|noncutaneous extranodal lymphoma
439052|NCT01273090|peripheral T-cell lymphoma|peripheral t-cell lymphoma
439053|NCT01273090|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
439054|NCT01273090|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
439055|NCT01273090|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
439056|NCT01273090|small intestine lymphoma|small intestine lymphoma
439057|NCT01273077|Rotavirus|rotavirus
439058|NCT01273077|Rotarix|rotarix
439059|NCT01273064|HCV|hcv
439060|NCT01273064|Null Responders|null responders
439061|NCT01273051|Rectal Cancer|rectal cancer
439062|NCT01273051|Radiochemotherapy|radiochemotherapy
439063|NCT01273051|TEM|tem
439064|NCT01273051|Organ preservation|organ preservation
439065|NCT01273025|pharmacokinetic|pharmacokinetic
439066|NCT01273025|lime powder regimen|lime powder regimen
439067|NCT01273025|kidney stone|kidney stone
439068|NCT01273025|Oxidative stress|oxidative stress
439069|NCT01273012|probiotic|probiotic
439070|NCT01273012|cost-effectiveness|cost-effectiveness
439071|NCT01273012|diarrhea|diarrhea
439072|NCT01273012|children|children
439073|NCT01273012|Sum of the monetary cost of the hospitalization|sum of the monetary cost of the hospitalization
439074|NCT01272999|Acute otitis media|acute otitis media
439075|NCT01272999|Prevnar 13|prevnar 13
439076|NCT01272999|Streptococcus pneumoniae|streptococcus pneumoniae
439077|NCT01272986|Determination of the level of oxidised LDL by measuring the level of IgG in Blood|determination of the level of oxidised ldl by measuring the level of igg in blood
439078|NCT01272960|Contraception|contraception
439079|NCT01272960|Postnatal care|postnatal care
439080|NCT01272947|Blunt soft tissue injury/contusion|blunt soft tissue injury/contusion
439081|NCT01272934|Ankle Sprain, soft tissue injury|ankle sprain, soft tissue injury
439082|NCT01272895|OCT images|oct images
439083|NCT01272895|Stent strut coverage|stent strut coverage
439084|NCT01272895|Endothelialization|endothelialization
439085|NCT01272895|Neointimal thickness, area and hyperplasia|neointimal thickness, area and hyperplasia
439086|NCT01272895|Stent malapposition|stent malapposition
439087|NCT01272830|total joint arthroplasty|total joint arthroplasty
439088|NCT01272830|synovitis|synovitis
439089|NCT01272830|ALVAL (Aseptic Lymphocyte-Dominant Vasculitis-Associated Lesion)|alval (aseptic lymphocyte-dominant vasculitis-associated lesion)
439090|NCT01272830|osteolysis|osteolysis
439091|NCT01272830|periprosthetic metallosis|periprosthetic metallosis
439092|NCT01272817|Nonmyeloablative transplant|nonmyeloablative transplant
439093|NCT01272817|Allogeneic transplant|allogeneic transplant
439094|NCT01272817|Transplant|transplant
439095|NCT01272804|Pharmacokinetics PK Pharmacodynamics PD T2DM Phase 1 Type 2 diabetes mellitus safety and tolerability|pharmacokinetics pk pharmacodynamics pd t2dm phase 1 type 2 diabetes mellitus safety and tolerability
439096|NCT01272791|metastatic stage IV pancreatic cancer|metastatic stage iv pancreatic cancer
439098|NCT01272765|weight loss|weight loss
439099|NCT01272765|weight management|weight management
439100|NCT01272765|anti-psychotic medication|anti-psychotic medication
439101|NCT01272765|Zyprexa|zyprexa
439102|NCT01272765|Seroquel|seroquel
439103|NCT01272765|Risperdal|risperdal
439104|NCT01272752|obesity|obesity
439105|NCT01272752|weight loss|weight loss
439106|NCT01272752|weight management|weight management
439107|NCT01272752|anti-psychotic medication|anti-psychotic medication
439108|NCT01272752|nutriceutical|nutriceutical
439109|NCT01272739|obesity|obesity
439110|NCT01272739|weight loss|weight loss
439111|NCT01272739|weight management|weight management
439112|NCT01272739|overweight|overweight
439113|NCT01272739|nutriceutical|nutriceutical
439114|NCT01272687|Parkinson Disease|parkinson disease
439115|NCT01272687|Parkinsonian Disorders|parkinsonian disorders
439116|NCT01272687|Brain Diseases|brain diseases
439117|NCT01272687|Central Nervous System Diseases|central nervous system diseases
439118|NCT01272687|Nervous System Diseases|nervous system diseases
439119|NCT01272687|Neurodegenerative Diseases|neurodegenerative diseases
439121|NCT01272661|low-income|low-income
439122|NCT01272661|high-risk|high-risk
439123|NCT01272661|African-American|african-american
439124|NCT01272661|health disparity|health disparity
439125|NCT01272648|Rehabilitation|rehabilitation
439126|NCT01272648|Coping|coping
439127|NCT01272648|Prostate cancer|prostate cancer
439128|NCT01272648|Nursing|nursing
439129|NCT01272648|Physiotherapy|physiotherapy
439130|NCT01272648|Pelvic floor exercises|pelvic floor exercises
439131|NCT01272648|Motivational Interviewing|motivational interviewing
439132|NCT01272635|Asthma|asthma
439133|NCT01272635|Wheezing|wheezing
439134|NCT01272635|Respiratory Tract Illness|respiratory tract illness
439135|NCT01272635|Azythromycin|azythromycin
439136|NCT01272635|Prednisolone|prednisolone
439137|NCT01272635|Preschool-age|preschool-age
439138|NCT01272622|Quality of life|quality of life
439139|NCT01272622|Endocrinology|endocrinology
439140|NCT01272622|Oncology|oncology
439141|NCT01272622|Hypothalamus|hypothalamus
439142|NCT01272622|Irradiation|irradiation
439143|NCT01272622|Neurosurgery|neurosurgery
439144|NCT01272622|Pediatric Brain tumors|pediatric brain tumors
439145|NCT01272622|Randomized trial|randomized trial
439146|NCT01272596|Multiple Sclerosis|multiple sclerosis
439147|NCT01272596|Visual Contrast Acuity|visual contrast acuity
439148|NCT01272596|Visual Contrast Sensitivity|visual contrast sensitivity
439149|NCT01272596|Sloan Charts|sloan charts
439150|NCT01272583|Type 1 diabetes|type 1 diabetes
439151|NCT01272583|DPP-4 inhibitor|dpp-4 inhibitor
439152|NCT01272583|Glucagon|glucagon
439153|NCT01272570|breast|breast
439154|NCT01272570|oral|oral
439155|NCT01272570|cancer|cancer
439156|NCT01272557|HCC|hcc
439157|NCT01272544|Dental caries|dental caries
439158|NCT01272544|Epidemiology|epidemiology
439159|NCT01272544|Gingivitis|gingivitis
439160|NCT01272544|Oral health|oral health
439161|NCT01272531|pharmacogenetics|pharmacogenetics
439162|NCT01272531|bipolar disorders|bipolar disorders
439163|NCT01272531|affective disorders|affective disorders
439164|NCT01272531|mood disorders|mood disorders
439165|NCT01272531|pharmacologic actions|pharmacologic actions
439166|NCT01272531|psychotropic drugs|psychotropic drugs
439167|NCT01272531|antimanic agents|antimanic agents
439168|NCT01272531|antidepressant agents|antidepressant agents
439169|NCT01272531|lithium|lithium
439170|NCT01272531|lithium carbonate|lithium carbonate
439171|NCT01272531|Lithobid|lithobid
439172|NCT01272531|Eskalith|eskalith
439173|NCT01272531|divalproex|divalproex
439174|NCT01272531|divalproex sodium|divalproex sodium
439175|NCT01272531|Depakote|depakote
439176|NCT01272531|valproate|valproate
439177|NCT01272518|chaos theory heart rate variability mania bipolar disorder|chaos theory heart rate variability mania bipolar disorder
439178|NCT01272479|hemodialysis|hemodialysis
439179|NCT01272479|hepatitis C|hepatitis c
439180|NCT01272479|inflammation|inflammation
439181|NCT01272479|iron stores|iron stores
439182|NCT01272479|prohepcidin|prohepcidin
439183|NCT01272466|multiple myeloma|multiple myeloma
439184|NCT01272466|vaccination|vaccination
439185|NCT01272466|antiapoptotic proteins|antiapoptotic proteins
439186|NCT01272466|proteasome inhibition|proteasome inhibition
439187|NCT01272453|coronary artery disease|coronary artery disease
439188|NCT01272453|CT scan|ct scan
439189|NCT01272453|coronary angiography|coronary angiography
439190|NCT01272453|chest pain|chest pain
439191|NCT01272453|aortic aneurysm|aortic aneurysm
439192|NCT01272453|pulmonary embolism|pulmonary embolism
439193|NCT01272440|PEG-asparaginase|peg-asparaginase
439194|NCT01272440|children|children
439195|NCT01272440|pharmacokinetics|pharmacokinetics
439196|NCT01272440|antibodies|antibodies
439197|NCT01272440|acute lymphoblastic leukaemia|acute lymphoblastic leukaemia
439198|NCT01272440|adverse effects|adverse effects
439199|NCT01272414|Eyelid retraction|eyelid retraction
439200|NCT01272414|Botulinum Toxins|botulinum toxins
439201|NCT01272388|Aortic valve stenosis|aortic valve stenosis
439202|NCT01272388|Tadalafil|tadalafil
439203|NCT01272388|Phosphodiesterase inhibitors|phosphodiesterase inhibitors
439204|NCT01272388|Hypertension, pulmonary|hypertension, pulmonary
439205|NCT01272388|Hypertrophy, left ventricular|hypertrophy, left ventricular
439206|NCT01272362|Indacaterol|indacaterol
439207|NCT01272362|COPD|copd
439208|NCT01272362|LABA|laba
439209|NCT01272362|Reversibility|reversibility
439210|NCT01272349|spinal cord injury|spinal cord injury
439211|NCT01272349|walking|walking
439212|NCT01272349|low oxygen|low oxygen
439213|NCT01272349|air|air
439214|NCT01272349|strength|strength
439215|NCT01272336|spinal cord injury, low oxygen, strength, motor control|spinal cord injury, low oxygen, strength, motor control
439216|NCT01272323|Cat allergy|cat allergy
439217|NCT01272323|Rhinoconjunctivitis|rhinoconjunctivitis
439218|NCT01272310|Chronic Hepatitis C|chronic hepatitis c
439219|NCT01272310|Combination Therapy|combination therapy
439220|NCT01272310|Hydroxychloroquine|hydroxychloroquine
439221|NCT01272310|Pegylated Interferon Alpha-2a|pegylated interferon alpha-2a
439222|NCT01272310|Ribavirin|ribavirin
439322|NCT01271959|Chemotherapy|chemotherapy
439223|NCT01272310|Chronic Hepatitis C Genotype 1 infected adult subjects|chronic hepatitis c genotype 1 infected adult subjects
439224|NCT01272297|LI-ESWT|li-eswt
439225|NCT01272297|Erectile Dysfunction|erectile dysfunction
439226|NCT01272297|Non PDE5 inhibitor responders|non pde5 inhibitor responders
439227|NCT01272297|Shock wave|shock wave
439228|NCT01272284|Female|female
439229|NCT01272284|Stress urinary incontinence|stress urinary incontinence
439230|NCT01272284|Mini sling|mini sling
439231|NCT01272284|Single incision sling|single incision sling
439232|NCT01272284|Urinary incontinence|urinary incontinence
439233|NCT01272284|Mixed urinary incontinence|mixed urinary incontinence
439234|NCT01272284|Additional relevant MeSH terms:|additional relevant mesh terms:
439235|NCT01272284|Stress|stress
439236|NCT01272284|Urinary Incontinence, Stress|urinary incontinence, stress
439237|NCT01272284|Pathological Processes|pathological processes
439238|NCT01272284|Urination Disorders|urination disorders
439239|NCT01272284|Urological Disorders|urological disorders
439240|NCT01272284|Urological Manifestations|urological manifestations
439241|NCT01272284|Signs and Symptoms|signs and symptoms
439242|NCT01272271|Contact lens|contact lens
439243|NCT01272271|Infection|infection
439244|NCT01272271|Cornea|cornea
439245|NCT01272245|Acute Myelogenous Leukemia|acute myelogenous leukemia
439246|NCT01272245|AML|aml
439247|NCT01272245|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
439248|NCT01272245|MDS|mds
439249|NCT01272245|Omacetaxine|omacetaxine
439250|NCT01272245|Cytarabine|cytarabine
439251|NCT01272245|ARA-C|ara-c
439252|NCT01272245|Cytosar|cytosar
439253|NCT01272245|DepoCyt|depocyt
439254|NCT01272245|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
439255|NCT01272180|Safety|safety
439256|NCT01272180|Immunogenicity|immunogenicity
439257|NCT01272180|Vaccine|vaccine
439258|NCT01272180|Meningococcal|meningococcal
439259|NCT01272180|Seroresponse|seroresponse
439260|NCT01272167|Post-menopausal women|post-menopausal women
439261|NCT01272167|Grapefruit juice|grapefruit juice
439262|NCT01272167|Naringin|naringin
439263|NCT01272167|Vascular protection|vascular protection
439264|NCT01272167|Bone metabolism|bone metabolism
439265|NCT01272154|Cerebellum|cerebellum
439266|NCT01272154|Cortical plasticity|cortical plasticity
439267|NCT01272154|Sensorimotor adaptation|sensorimotor adaptation
439268|NCT01272154|Dystonia|dystonia
439269|NCT01272154|Cerebral Palsy|cerebral palsy
439270|NCT01272154|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
439271|NCT01272154|and|and
439272|NCT01272141|Metastatic breast cancer|metastatic breast cancer
439273|NCT01272141|Triple negative breast cancer|triple negative breast cancer
439274|NCT01272141|Estrogen receptor (ER)/progesterone receptor (PR)/human epidermal growth factor receptor 2 (HER2)-negative breast cancer|estrogen receptor (er)/progesterone receptor (pr)/human epidermal growth factor receptor 2 (her2)-negative breast cancer
439275|NCT01272115|Climacteric stage|climacteric stage
439276|NCT01272115|Integrative health care model|integrative health care model
439277|NCT01272115|Empowerment approach|empowerment approach
439278|NCT01272115|Primary care services|primary care services
439279|NCT01272076|Age Related Macular Degeneration|age related macular degeneration
439280|NCT01272076|Geographic Atrophy|geographic atrophy
439281|NCT01272076|Imaging|imaging
439282|NCT01272076|OCT|oct
439283|NCT01272063|Drusen|drusen
439284|NCT01272063|Dry AMD|dry amd
439285|NCT01272063|OCT|oct
439286|NCT01272063|Imaging|imaging
439287|NCT01272050|adenocarcinoma of the prostate|adenocarcinoma of the prostate
439288|NCT01272050|recurrent prostate cancer|recurrent prostate cancer
439289|NCT01272050|stage IIA prostate cancer|stage iia prostate cancer
439290|NCT01272050|stage IIB prostate cancer|stage iib prostate cancer
439291|NCT01272050|stage III prostate cancer|stage iii prostate cancer
439292|NCT01272024|clinical trial|clinical trial
439293|NCT01272024|symptom education|symptom education
439294|NCT01272024|advanced cancer|advanced cancer
439295|NCT01272011|Respiration|respiration
439296|NCT01272011|Spinal cord injuries|spinal cord injuries
439297|NCT01272011|Walking recovery|walking recovery
439298|NCT01271998|antibiotic|antibiotic
439299|NCT01271998|healthy subjects|healthy subjects
439300|NCT01271998|pharmacokinetics|pharmacokinetics
439301|NCT01271985|Cardiovascular Diseases|cardiovascular diseases
439302|NCT01271985|Drug Combinations|drug combinations
439303|NCT01271985|prevention and control|prevention and control
439304|NCT01271985|Aspirin|aspirin
439305|NCT01271985|Antihypertensive Agents|antihypertensive agents
439306|NCT01271985|Antilipemic Agents|antilipemic agents
439307|NCT01271959|Ovarian|ovarian
439308|NCT01271959|Fallopian Tube|fallopian tube
439309|NCT01271959|Peritoneal|peritoneal
439310|NCT01271959|Uterine Neoplasms|uterine neoplasms
439311|NCT01271959|Vulva|vulva
439312|NCT01271959|Endometrial|endometrial
439313|NCT01271959|Cervical|cervical
439314|NCT01271959|Lung|lung
439315|NCT01271959|Carcinoid|carcinoid
439316|NCT01271959|Sarcoma|sarcoma
439317|NCT01271959|Mesothelioma|mesothelioma
439318|NCT01271959|Adenocarcinoma|adenocarcinoma
439319|NCT01271959|Colorectal|colorectal
439320|NCT01271959|Breast|breast
439321|NCT01271959|Assay|assay
439323|NCT01271959|Recurrent|recurrent
439324|NCT01271959|Refractory|refractory
439325|NCT01271959|Persistent|persistent
439326|NCT01271959|Chemoresponse|chemoresponse
439327|NCT01271933|fibromyalgia|fibromyalgia
439328|NCT01271933|pain|pain
439329|NCT01271933|pregabalin|pregabalin
439330|NCT01271933|Lyrica|lyrica
439331|NCT01271920|Trastuzumab-refractory|trastuzumab-refractory
439332|NCT01271920|advanced HER2-positive breast cancer,|advanced her2-positive breast cancer,
439333|NCT01271920|Hsp90,|hsp90,
439334|NCT01271920|2nd or 3rd line treatment|2nd or 3rd line treatment
439335|NCT01271907|Skin Cancer|skin cancer
439336|NCT01271907|Malignancy|malignancy
439337|NCT01271907|Immunotherapy|immunotherapy
439338|NCT01271907|Melanoma Peptides|melanoma peptides
439339|NCT01271907|Melanoma|melanoma
439340|NCT01271907|Metastatic Melanoma|metastatic melanoma
439341|NCT01271894|HIV|hiv
439342|NCT01271894|efavirenz|efavirenz
439343|NCT01271894|pharmacokinetic|pharmacokinetic
439344|NCT01271881|Hemodialysis|hemodialysis
439345|NCT01271881|Fistula|fistula
439346|NCT01271881|Angiograph|angiograph
439347|NCT01271881|Angiogram|angiogram
439348|NCT01271881|Adult patients who are currently receiving hemodialysis treatment via an AV vascular graft or fistula located in the upper extremity|adult patients who are currently receiving hemodialysis treatment via an av vascular graft or fistula located in the upper extremity
439349|NCT01271868|Recombinant Factor IX|recombinant factor ix
439350|NCT01271855|Belladonna|belladonna
439351|NCT01271855|Opium|opium
439352|NCT01271855|Suppository|suppository
439353|NCT01271829|Avocados|avocados
439354|NCT01271829|Satiety|satiety
439355|NCT01271829|Feeding study|feeding study
439356|NCT01271816|genetics|genetics
439357|NCT01271816|sudden death|sudden death
439358|NCT01271816|monitoring|monitoring
439359|NCT01271816|loop recorder|loop recorder
439360|NCT01271816|cardiomyopathy|cardiomyopathy
439361|NCT01271790|Hepatitis C|hepatitis c
439362|NCT01271790|HCV|hcv
439363|NCT01271790|Rapid Virologic Response|rapid virologic response
439364|NCT01271790|Sustained Virologic Response|sustained virologic response
439365|NCT01271790|Direct Acting Antiviral|direct acting antiviral
439366|NCT01271790|Combination Therapy|combination therapy
439367|NCT01271790|HCV RNA|hcv rna
439368|NCT01271790|Polymerase inhibitor|polymerase inhibitor
439369|NCT01271790|Protease inhibitor|protease inhibitor
439370|NCT01271790|Treatment naïve|treatment naïve
439371|NCT01271790|GS-9190|gs-9190
439372|NCT01271790|GS-9451|gs-9451
439373|NCT01271777|Pre-diabetes|pre-diabetes
439374|NCT01271777|Clamp technique|clamp technique
439375|NCT01271777|PPARs|ppars
439376|NCT01271777|Insulin resistance|insulin resistance
439377|NCT01271751|Atherogenic-dyslipidaemia|atherogenic-dyslipidaemia
439378|NCT01271751|PPARs|ppars
439379|NCT01271738|Breast Cancer|breast cancer
439380|NCT01271738|Tumors or cancer of the human breast|tumors or cancer of the human breast
439381|NCT01271738|Breast Tumors|breast tumors
439382|NCT01271738|Cancer of Breast|cancer of breast
439383|NCT01271738|Cancer of the Breast|cancer of the breast
439384|NCT01271738|Human Mammary Carcinoma|human mammary carcinoma
439385|NCT01271738|Neoplasms, Breast|neoplasms, breast
439386|NCT01271712|Gastrointestinal stromal cancer|gastrointestinal stromal cancer
439387|NCT01271712|GIST|gist
439388|NCT01271712|multikinase inhibitor|multikinase inhibitor
439389|NCT01271699|Fabry Disease|fabry disease
439390|NCT01271699|Fabry´s Disease|fabry´s disease
439391|NCT01271699|Anderson-Fabry Disease|anderson-fabry disease
439392|NCT01271699|Multiple Sclerosis|multiple sclerosis
439393|NCT01271660|muscle cramp|muscle cramp
439394|NCT01271660|liver cirrhosis|liver cirrhosis
439395|NCT01271660|pregabalin|pregabalin
439396|NCT01271647|osteopenia,chinese herb|osteopenia,chinese herb
439397|NCT01271634|cross-transmission|cross-transmission
439398|NCT01271634|offending vessel|offending vessel
439399|NCT01271621|Airtraq, Intraocular pressure|airtraq, intraocular pressure
439400|NCT01271608|Accident prevention|accident prevention
439401|NCT01271608|Blood-borne pathogens|blood-borne pathogens
439402|NCT01271608|Protective devices.|protective devices.
439403|NCT01271608|Needlestick injuries|needlestick injuries
439404|NCT01271608|Injections subcutaneous|injections subcutaneous
439405|NCT01271608|Injections intradermal|injections intradermal
439406|NCT01271595|acupuncture|acupuncture
439407|NCT01271595|autonomic nervous system|autonomic nervous system
439408|NCT01271595|seasonal allergic rhinitis|seasonal allergic rhinitis
439409|NCT01271582|Colorecatal cancer|colorecatal cancer
439410|NCT01271582|Gastric cancer|gastric cancer
439411|NCT01271582|Irinotecan|irinotecan
439412|NCT01271582|UGT1A1|ugt1a1
439413|NCT01271582|Neutropenia|neutropenia
439414|NCT01271556|COPD|copd
439415|NCT01271556|LABA|laba
439416|NCT01271556|salmeterol|salmeterol
439417|NCT01271543|Comparison of hemodynamic|comparison of hemodynamic
439418|NCT01271543|endotracheal intubation|endotracheal intubation
439419|NCT01271543|changes induced by|changes induced by
439420|NCT01271543|performed|performed
439421|NCT01271543|the aid of the SOS|the aid of the sos
439422|NCT01271543|as compared to the Macintosh Laryngoscope|as compared to the macintosh laryngoscope
439423|NCT01271530|Late Effects of Polio|late effects of polio
439424|NCT01271530|Cardiovascular Fitness|cardiovascular fitness
439425|NCT01271530|Fatigue|fatigue
439426|NCT01271530|Energy cost of Walking|energy cost of walking
439427|NCT01271530|Pain|pain
439428|NCT01271517|Basal insulin|basal insulin
439429|NCT01271517|long acting insulin analogs|long acting insulin analogs
439430|NCT01271517|metabolic control|metabolic control
439431|NCT01271517|HbA1c|hba1c
439432|NCT01271517|C-peptide|c-peptide
439433|NCT01271517|IGF-I|igf-i
439434|NCT01271517|GH|gh
439435|NCT01271517|IGFBP|igfbp
439436|NCT01271504|Cancer|cancer
439437|NCT01271504|liver|liver
439438|NCT01271504|hepatocellular carcinoma|hepatocellular carcinoma
439439|NCT01271504|phase I|phase i
439440|NCT01271504|phase II|phase ii
439441|NCT01271491|Pediatric|pediatric
439442|NCT01271478|inflammation|inflammation
439443|NCT01271478|telmisartan|telmisartan
439444|NCT01271478|captopril|captopril
439445|NCT01271478|hemodialysis|hemodialysis
439446|NCT01271426|Polypoidal Choroidal Vasculopathy|polypoidal choroidal vasculopathy
439447|NCT01271426|Ranibizumab|ranibizumab
439448|NCT01271400|Infertility treatments|infertility treatments
439449|NCT01271400|Frozen embryo transfers (FET).|frozen embryo transfers (fet).
439450|NCT01271400|IVF.|ivf.
439451|NCT01271400|ART.|art.
439452|NCT01271400|Cryopreservation|cryopreservation
439453|NCT01271400|Slow-Freeze|slow-freeze
439454|NCT01271400|Freeze / thaw survival rates|freeze / thaw survival rates
439455|NCT01271400|Blastocyst formation|blastocyst formation
439456|NCT01271400|Pregnancy|pregnancy
439457|NCT01271387|Liver disease|liver disease
439458|NCT01271387|pharmacokinetics|pharmacokinetics
439459|NCT01271374|African American|african american
439460|NCT01271374|Hypertension|hypertension
439461|NCT01271374|Cardiometabolic Syndrome|cardiometabolic syndrome
439462|NCT01271361|thrombus aspiration|thrombus aspiration
439463|NCT01271361|Drug-Eluting Stent|drug-eluting stent
439464|NCT01271361|optical frequency domain imaging (OFDI)|optical frequency domain imaging (ofdi)
439465|NCT01271335|CTO|cto
439466|NCT01271335|Angioplasty|angioplasty
439467|NCT01271335|PCI|pci
439468|NCT01271322|PET|pet
439469|NCT01271322|response evaluation|response evaluation
439470|NCT01271322|neoadjuvant|neoadjuvant
439471|NCT01271322|radiochemotherapy|radiochemotherapy
439472|NCT01271322|adenocarcinoma of the esophagogastric junction|adenocarcinoma of the esophagogastric junction
439473|NCT01271322|esophageal carcinoma|esophageal carcinoma
439474|NCT01271322|evaluation of preoperative (radio)-chemotherapy in patients with adenocarcinomas of the oesophagogastric junction|evaluation of preoperative (radio)-chemotherapy in patients with adenocarcinomas of the oesophagogastric junction
439475|NCT01271296|Addison Disease|addison disease
439476|NCT01271296|Pharmacokinetics|pharmacokinetics
439477|NCT01271296|Hormone Replacement Therapy|hormone replacement therapy
439478|NCT01271296|cortisone acetate|cortisone acetate
439479|NCT01271296|Quality of Life|quality of life
439480|NCT01271270|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
439481|NCT01271270|Palomid 529|palomid 529
439482|NCT01271270|Age Related Macular Degeneration|age related macular degeneration
439483|NCT01271270|AMD|amd
439484|NCT01271257|misoprostol, pharmacokinetics|misoprostol, pharmacokinetics
439485|NCT01271231|periodontal treatment, diabetes, glycemia, glycated hemoglobin|periodontal treatment, diabetes, glycemia, glycated hemoglobin
439486|NCT01271205|pneumonia|pneumonia
439487|NCT01271205|RDW|rdw
439488|NCT01271205|mortality|mortality
439489|NCT01271205|prognostic factor|prognostic factor
439490|NCT01271192|local recurrent rectal cancer|local recurrent rectal cancer
439491|NCT01271192|surgical resection|surgical resection
439492|NCT01271192|adjuvant therapy|adjuvant therapy
439493|NCT01271179|orthotopic liver transplantation|orthotopic liver transplantation
439494|NCT01271179|preservation solution|preservation solution
439495|NCT01271179|peribiliary plexus|peribiliary plexus
439496|NCT01271179|nonanastomotic biliary strictures|nonanastomotic biliary strictures
439497|NCT01271179|primary non-function|primary non-function
439498|NCT01271166|Colorectal,|colorectal,
439499|NCT01271166|Cancer|cancer
439500|NCT01271153|Septic shock|septic shock
439501|NCT01271127|radiation therapy|radiation therapy
439502|NCT01271127|coronary artery disease|coronary artery disease
439503|NCT01271127|Hodgkin Lymphoma|hodgkin lymphoma
439504|NCT01271101|Non-ST-elevated acute coronary syndromes (NSTE-ACS)|non-st-elevated acute coronary syndromes (nste-acs)
439505|NCT01271101|anticoagulation|anticoagulation
439506|NCT01271088|ototoxicity|ototoxicity
439507|NCT01271088|aminoglycoside|aminoglycoside
439508|NCT01271088|vancomycine|vancomycine
439509|NCT01271088|peritoneal dialysis|peritoneal dialysis
439510|NCT01271088|peritonitis|peritonitis
439511|NCT01271075|urticaria|urticaria
439512|NCT01271075|bilastine|bilastine
439513|NCT01271062|Resolvment of Diabetes Mellitus, Type 2|resolvment of diabetes mellitus, type 2
439514|NCT01271062|gastric bypass|gastric bypass
439515|NCT01271036|Lubricating Agents|lubricating agents
439516|NCT01271036|Personal Lubricant|personal lubricant
439517|NCT01270984|Imatinib mesylate|imatinib mesylate
439518|NCT01270984|Pharmacokinetics|pharmacokinetics
439624|NCT01270646|Mapping|mapping
439519|NCT01270984|Healthy volunteers|healthy volunteers
439520|NCT01270971|Onychomycosis|onychomycosis
439521|NCT01270971|nail fungus|nail fungus
439522|NCT01270971|toenail fungus|toenail fungus
439523|NCT01270971|fungal nail|fungal nail
439524|NCT01270971|hyperkeratosis|hyperkeratosis
439525|NCT01270971|nail infection|nail infection
439526|NCT01270971|nail treatment|nail treatment
439527|NCT01270971|toenail infection|toenail infection
439528|NCT01270971|toenail treatment|toenail treatment
439529|NCT01270971|foot dermatoses|foot dermatoses
439530|NCT01270971|fungal culture|fungal culture
439531|NCT01270971|onycholysis|onycholysis
439532|NCT01270971|podiatrist|podiatrist
439533|NCT01270971|podiatry|podiatry
439534|NCT01270971|subungual|subungual
439535|NCT01270971|tinea unguium|tinea unguium
439536|NCT01270971|antifungal|antifungal
439537|NCT01270971|anti-fungal|anti-fungal
439538|NCT01270971|dermatologist|dermatologist
439539|NCT01270971|dermatology|dermatology
439540|NCT01270971|dermatophyte|dermatophyte
439541|NCT01270971|distal subungual onychomycosis|distal subungual onychomycosis
439542|NCT01270971|yellow nail|yellow nail
439543|NCT01270971|thick nail|thick nail
439544|NCT01270971|brittle nail|brittle nail
439545|NCT01270971|crumbling nail|crumbling nail
439546|NCT01270971|discolored nail|discolored nail
439547|NCT01270971|weak nail|weak nail
439548|NCT01270958|AVY-REG00108VN|avy-reg00108vn
439549|NCT01270906|Neoplasms|neoplasms
439550|NCT01270906|Cancer|cancer
439551|NCT01270906|Tumors|tumors
439552|NCT01270906|Administration|administration
439553|NCT01270906|oral|oral
439554|NCT01270906|CHIR258|chir258
439555|NCT01270906|CHIR-258|chir-258
439556|NCT01270906|CHIR 258|chir 258
439557|NCT01270906|TKI258|tki258
439558|NCT01270906|TKI-258|tki-258
439559|NCT01270906|TKI 258|tki 258
439560|NCT01270906|dose finding|dose finding
439561|NCT01270893|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
439562|NCT01270893|GIST|gist
439563|NCT01270893|Nilotinib|nilotinib
439564|NCT01270893|AMN107|amn107
439565|NCT01270893|Tasigna|tasigna
439566|NCT01270867|Ischemia|ischemia
439567|NCT01270867|Stroke|stroke
439568|NCT01270867|Ischemic Stroke|ischemic stroke
439569|NCT01270867|Mechanical Thrombectomy|mechanical thrombectomy
439570|NCT01270867|Brain|brain
439571|NCT01270867|Brain clot|brain clot
439572|NCT01270867|Cerebrovascular disease|cerebrovascular disease
439573|NCT01270867|Recanalization|recanalization
439574|NCT01270867|Revascularization|revascularization
439575|NCT01270854|Normal saline|normal saline
439576|NCT01270854|Plasmalyte|plasmalyte
439577|NCT01270854|Intravenous fluid|intravenous fluid
439578|NCT01270854|Traumatic injury|traumatic injury
439579|NCT01270854|Fluid resuscitation|fluid resuscitation
439580|NCT01270828|Control Release Pregabalin in Post Herpetic Neuralgia|control release pregabalin in post herpetic neuralgia
439581|NCT01270815|pregabalin|pregabalin
439582|NCT01270815|pharmacokinetics|pharmacokinetics
439583|NCT01270815|bioavailability|bioavailability
439584|NCT01270815|bioequivalence|bioequivalence
439585|NCT01270802|Endothelial function|endothelial function
439586|NCT01270802|Vitamin D|vitamin d
439587|NCT01270802|Efavirenz|efavirenz
439588|NCT01270802|Raltegravir|raltegravir
439589|NCT01270789|beta-cell function|beta-cell function
439590|NCT01270789|GLP-1 analogue|glp-1 analogue
439591|NCT01270789|diabetes|diabetes
439592|NCT01270776|Randomized Controlled Trial|randomized controlled trial
439593|NCT01270776|Chlorhexidine|chlorhexidine
439594|NCT01270776|Infant, Premature|infant, premature
439595|NCT01270763|Obesity|obesity
439596|NCT01270763|physical fitness|physical fitness
439597|NCT01270763|cholesterol levels|cholesterol levels
439598|NCT01270763|genetics|genetics
439599|NCT01270763|weight loss|weight loss
439600|NCT01270750|ENDOTHELIN RECEPTOR ANTAGONIST|endothelin receptor antagonist
439601|NCT01270750|BOSENTAN|bosentan
439602|NCT01270750|SECONDARY PULMONARY HYPERTENSION|secondary pulmonary hypertension
439603|NCT01270750|RHEUMATOID FEVER|rheumatoid fever
439604|NCT01270750|CONGESTIVE HEART FAILURE|congestive heart failure
439605|NCT01270750|SECONDARY PULMONARY HYPERTENSION DUE TO MITRAL STENOSIS|secondary pulmonary hypertension due to mitral stenosis
439606|NCT01270711|compliance study|compliance study
439607|NCT01270711|effectiveness study|effectiveness study
439608|NCT01270711|hyperprolactinemia|hyperprolactinemia
439609|NCT01270711|Parkinson's disease|parkinson's disease
439610|NCT01270711|retrospective cohort study|retrospective cohort study
439611|NCT01270698|colorectal cancer|colorectal cancer
439612|NCT01270672|MDMA|mdma
439613|NCT01270672|carvedilol|carvedilol
439614|NCT01270672|norepinephrine|norepinephrine
439615|NCT01270672|alpha - beta receptor|alpha - beta receptor
439616|NCT01270672|Ecstasy|ecstasy
439617|NCT01270672|stimulant|stimulant
439618|NCT01270659|Fentanyl buccal tablet|fentanyl buccal tablet
439619|NCT01270646|Cardiac insufficiency|cardiac insufficiency
439620|NCT01270646|Invasive procedure|invasive procedure
439621|NCT01270646|Heart Failure|heart failure
439622|NCT01270646|Noninvasive procedure|noninvasive procedure
439623|NCT01270646|Congestive Heart Failure|congestive heart failure
439625|NCT01270646|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
439626|NCT01270646|Open study|open study
439627|NCT01270646|Cardiac Pacings, Artificial|cardiac pacings, artificial
439628|NCT01270646|Hemodynamics|hemodynamics
439629|NCT01270620|elderly obese|elderly obese
439630|NCT01270581|transient tachypnea of the newborn|transient tachypnea of the newborn
439631|NCT01270581|high flow nasal cannula|high flow nasal cannula
439632|NCT01270581|bubble nasal|bubble nasal
439633|NCT01270581|continuous positive airway pressure|continuous positive airway pressure
439634|NCT01270568|positive psychology|positive psychology
439635|NCT01270568|cardiovascular disease|cardiovascular disease
439636|NCT01270542|Traction Retinal Detachment (PDR)|traction retinal detachment (pdr)
439637|NCT01270542|Proliferative Diabetic Retinopathy (PDR)|proliferative diabetic retinopathy (pdr)
439638|NCT01270529|Physical Activity|physical activity
439639|NCT01270529|Physical Performance|physical performance
439640|NCT01270529|Physical Functioning|physical functioning
439641|NCT01270529|CKD|ckd
439642|NCT01270529|ESRD|esrd
439643|NCT01270529|Transplant Recipients|transplant recipients
439644|NCT01270516|diaphragm|diaphragm
439645|NCT01270516|limb muscle|limb muscle
439646|NCT01270516|EPA|epa
439647|NCT01270516|HMB|hmb
439648|NCT01270516|ICU patients|icu patients
439649|NCT01270503|Meningitis|meningitis
439650|NCT01270503|Meningococcal disease|meningococcal disease
439651|NCT01270503|Menactra®|menactra®
439652|NCT01270490|candidemia|candidemia
439653|NCT01270490|candida sepsis|candida sepsis
439654|NCT01270490|invasive fungal disease|invasive fungal disease
439655|NCT01270477|Frost injury|frost injury
439656|NCT01270451|Weight maintenance|weight maintenance
439657|NCT01270451|Group counseling|group counseling
439658|NCT01270451|Prevention of diseases|prevention of diseases
439659|NCT01270425|systemic sclerosis|systemic sclerosis
439660|NCT01270425|hashimoto thyroiditis|hashimoto thyroiditis
439661|NCT01270425|thyroid nodules|thyroid nodules
439662|NCT01270412|Osteoarthritis|osteoarthritis
439663|NCT01270412|PRP|prp
439664|NCT01270412|PRGF|prgf
439665|NCT01270412|Hyaluronic acid|hyaluronic acid
439666|NCT01270386|NSCLC|nsclc
439667|NCT01270386|apatinib|apatinib
439668|NCT01270386|phase II|phase ii
439669|NCT01270386|lung|lung
439670|NCT01270386|cancer|cancer
439671|NCT01270373|neoadjuvant therapy|neoadjuvant therapy
439672|NCT01270373|drug therapy|drug therapy
439673|NCT01270321|Thyroid Cancer|thyroid cancer
439674|NCT01270308|Bioequivalence|bioequivalence
439675|NCT01270308|two way crossover|two way crossover
439676|NCT01270295|Receptor for advanced glycation end products (RAGE)|receptor for advanced glycation end products (rage)
439677|NCT01270295|Soluble RAGE (sRAGE)|soluble rage (srage)
439678|NCT01270295|Endogenous secretory RAGE (esRAGE)|endogenous secretory rage (esrage)
439679|NCT01270295|High-mobility group box-1 protein (HMGB-1)|high-mobility group box-1 protein (hmgb-1)
439680|NCT01270295|Extracellular newly-identified RAGE-binding protein (EN-RAGE or S100A12)|extracellular newly-identified rage-binding protein (en-rage or s100a12)
439681|NCT01270295|Advanced glycation endproducts (AGEs)|advanced glycation endproducts (ages)
439682|NCT01270295|Pentosidine|pentosidine
439683|NCT01270295|N--carboxymethyllysine|n--carboxymethyllysine
439684|NCT01270295|Acute lung injury (ALI)|acute lung injury (ali)
439685|NCT01270295|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
439686|NCT01270295|Alveolar epithelium|alveolar epithelium
439687|NCT01270295|Mechanical ventilation|mechanical ventilation
439688|NCT01270295|Intensive Care Unit (ICU)|intensive care unit (icu)
439689|NCT01270269|Asthenia|asthenia
439690|NCT01270269|Muscle Weakness|muscle weakness
439691|NCT01270269|Brain Injuries|brain injuries
439692|NCT01270269|Critical Illness|critical illness
439693|NCT01270269|Critical Illness Myoneuropathy|critical illness myoneuropathy
439694|NCT01270269|Rehabilitation|rehabilitation
439695|NCT01270269|Sepsis|sepsis
439696|NCT01270269|Respiratory Failure|respiratory failure
439697|NCT01270269|Delirium|delirium
439698|NCT01270269|Over-sedation|over-sedation
439699|NCT01270269|Immobility|immobility
439700|NCT01270269|Aging|aging
439701|NCT01270269|Signs and Symptoms|signs and symptoms
439702|NCT01270269|Muscular Diseases|muscular diseases
439703|NCT01270269|Musculoskeletal Diseases|musculoskeletal diseases
439704|NCT01270269|Neuromuscular Manifestations|neuromuscular manifestations
439705|NCT01270269|Neurologic Manifestations|neurologic manifestations
439706|NCT01270269|Pathologic Processes|pathologic processes
439707|NCT01270269|Brain Diseases|brain diseases
439708|NCT01270269|Central Nervous System Diseases|central nervous system diseases
439709|NCT01270269|Craniocerebral Trauma|craniocerebral trauma
439710|NCT01270269|Trauma, Nervous System|trauma, nervous system
439711|NCT01270269|Wounds and Injuries|wounds and injuries
439712|NCT01270269|Disorders of Environmental Origin|disorders of environmental origin
439713|NCT01270256|allergy|allergy
439714|NCT01270230|HIV Prevention Intervention|hiv prevention intervention
439715|NCT01270230|African American Men who have Sex with Men|african american men who have sex with men
439716|NCT01270217|Automobile driving|automobile driving
439717|NCT01270217|Driving under the influence|driving under the influence
439718|NCT01270217|Interview, psychological|interview, psychological
439719|NCT01270217|Brief intervention|brief intervention
439720|NCT01270217|Brief motivational interview|brief motivational interview
439721|NCT01270204|Dysphagia|dysphagia
439722|NCT01270204|Swallowing Problems|swallowing problems
439723|NCT01270204|Dynamic Fluoroscopic Swallow Study|dynamic fluoroscopic swallow study
439724|NCT01270204|Aspiration|aspiration
439725|NCT01270204|Regurgitation|regurgitation
439726|NCT01270204|Acid Reflux|acid reflux
439727|NCT01270191|Exenatide, Beta-Cell Function, Glycemic Control|exenatide, beta-cell function, glycemic control
439728|NCT01270191|in Newly Diagnosed Type 2 Diabetic Patients|in newly diagnosed type 2 diabetic patients
439729|NCT01270165|lamivudine|lamivudine
439730|NCT01270165|telbivudine|telbivudine
439731|NCT01270165|adefovir|adefovir
439732|NCT01270165|lamivudine resistance|lamivudine resistance
439733|NCT01270152|ascorbic acid|ascorbic acid
439734|NCT01270152|catheterization central venous|catheterization central venous
439735|NCT01270152|nursing care|nursing care
439736|NCT01270139|nanoparticles|nanoparticles
439737|NCT01270139|mesenchymal stem cell|mesenchymal stem cell
439738|NCT01270139|plasmonics|plasmonics
439739|NCT01270139|atherosclerosis|atherosclerosis
439740|NCT01270139|IVUS|ivus
439741|NCT01270139|stenting|stenting
439742|NCT01270126|optic neuropathy|optic neuropathy
439743|NCT01270126|alternating current stimulation|alternating current stimulation
439744|NCT01270126|vision recovery|vision recovery
439745|NCT01270126|restoration|restoration
439746|NCT01270126|plasticity|plasticity
439747|NCT01270087|Rheumatoid arthritis, cardiovascular disease, adalimumab|rheumatoid arthritis, cardiovascular disease, adalimumab
439748|NCT01270074|double blind placebo controlled randomised clinical trial|double blind placebo controlled randomised clinical trial
439749|NCT01270074|azithromycin|azithromycin
439750|NCT01270074|infant|infant
439751|NCT01270074|pediatric|pediatric
439752|NCT01270074|cystic fibrosis|cystic fibrosis
439753|NCT01270074|bronchiectasis|bronchiectasis
439754|NCT01270061|HIV testing|hiv testing
439755|NCT01270061|black Africans|black africans
439756|NCT01270061|immigrants|immigrants
439757|NCT01270061|health screening|health screening
439758|NCT01270048|Hwa-byung, Bunsimgi-eum(Fenxinqiyin)|hwa-byung, bunsimgi-eum(fenxinqiyin)
439759|NCT01269996|type 2 diabetes mellitus|type 2 diabetes mellitus
439760|NCT01269996|JUBILEE Study|jubilee study
439761|NCT01269996|Janumet|janumet
439762|NCT01269996|Lantus|lantus
439763|NCT01269983|low back pain|low back pain
439764|NCT01269983|fascial manipulation|fascial manipulation
439765|NCT01269983|physioterapy|physioterapy
439766|NCT01269983|physical activity|physical activity
439767|NCT01269957|halitosis|halitosis
439768|NCT01269957|pediatric dentistry|pediatric dentistry
439769|NCT01269957|mouth breathing|mouth breathing
439770|NCT01269944|osteoarthritis|osteoarthritis
439771|NCT01269944|knee|knee
439772|NCT01269944|high wedge tibial osteotomy|high wedge tibial osteotomy
439773|NCT01269944|dGEMRIC|dgemric
439774|NCT01269931|endobronchial ultrasound|endobronchial ultrasound
439775|NCT01269931|bronchoscopy|bronchoscopy
439776|NCT01269931|education|education
439777|NCT01269931|interventional bronchoscopy|interventional bronchoscopy
439778|NCT01269931|simulation|simulation
439779|NCT01269918|Craniotomy, pain relief|craniotomy, pain relief
439780|NCT01269918|Adult solid neoplasm|adult solid neoplasm
439781|NCT01269892|diarrhea, lactose, milk, weight, acute.|diarrhea, lactose, milk, weight, acute.
439782|NCT01269879|epicondylitis|epicondylitis
439783|NCT01269879|pain|pain
439784|NCT01269879|tendon|tendon
439785|NCT01269866|Lupus Pain|lupus pain
439786|NCT01269866|Lupus|lupus
439787|NCT01269866|Pain|pain
439788|NCT01269866|Systemic Lupus Erythematosus|systemic lupus erythematosus
439789|NCT01269866|Duloxetine|duloxetine
439790|NCT01269866|Cymbalta|cymbalta
439791|NCT01269853|GBM|gbm
439792|NCT01269853|AA|aa
439793|NCT01269853|AO|ao
439794|NCT01269853|Brain|brain
439795|NCT01269853|Tumors|tumors
439796|NCT01269853|Malignant|malignant
439797|NCT01269853|Glioblastoma|glioblastoma
439798|NCT01269853|Multiforme|multiforme
439799|NCT01269853|Anaplastic|anaplastic
439800|NCT01269853|Astrocytoma|astrocytoma
439801|NCT01269827|inflammation|inflammation
439802|NCT01269827|pentoxifylline|pentoxifylline
439803|NCT01269827|hemodialysis|hemodialysis
439804|NCT01269814|Gastrointestinal bleeding|gastrointestinal bleeding
439805|NCT01269814|Emergency endoscopy|emergency endoscopy
439806|NCT01269814|Rockall Risk Scoring System|rockall risk scoring system
439807|NCT01269801|BOTOX|botox
439808|NCT01269801|JUVEDERM|juvederm
439809|NCT01269801|Prospective|prospective
439810|NCT01269801|Open Label|open label
439811|NCT01269801|Randomized|randomized
439812|NCT01269801|Crossover Study|crossover study
439813|NCT01269788|non-erosive reflux disease|non-erosive reflux disease
439814|NCT01269788|heartburn|heartburn
439815|NCT01269788|functional|functional
439816|NCT01269788|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation
439817|NCT01269788|Proton Pump Inhibitors|proton pump inhibitors
439818|NCT01269762|Red yeast rice|red yeast rice
439819|NCT01269762|Lovastatin|lovastatin
440023|NCT01269034|diabetes|diabetes
439820|NCT01269762|Drug-drug interaction|drug-drug interaction
439821|NCT01269762|Pharmacokinetics|pharmacokinetics
439822|NCT01269749|Hyperthyroidism|hyperthyroidism
439823|NCT01269749|Antithyroid drugs|antithyroid drugs
439824|NCT01269749|Cancer|cancer
439825|NCT01269749|Dosimetry|dosimetry
439826|NCT01269749|Children|children
439827|NCT01269736|electrocardiographic monitoring|electrocardiographic monitoring
439828|NCT01269736|arrhythmia|arrhythmia
439829|NCT01269736|myocardial ischemia|myocardial ischemia
439830|NCT01269723|Smoking|smoking
439831|NCT01269723|influenza|influenza
439832|NCT01269723|influenza vaccine|influenza vaccine
439833|NCT01269710|Second Generation Antipsychotics|second generation antipsychotics
439834|NCT01269710|Schizophrenia|schizophrenia
439835|NCT01269710|Schizoaffective|schizoaffective
439836|NCT01269710|Schizophreniform|schizophreniform
439837|NCT01269710|Psychosis NOS|psychosis nos
439838|NCT01269710|Mood Disorders|mood disorders
439839|NCT01269710|Weight|weight
439840|NCT01269710|Autism|autism
439841|NCT01269697|AMD|amd
439842|NCT01269697|food supplementation|food supplementation
439843|NCT01269697|macular pigments|macular pigments
439844|NCT01269697|luthéine|luthéine
439845|NCT01269697|zéaxanthine|zéaxanthine
439846|NCT01269697|visual acuity|visual acuity
439847|NCT01269697|prevention|prevention
439848|NCT01269697|genetique risk|genetique risk
439849|NCT01269684|Kidney|kidney
439850|NCT01269684|renal|renal
439851|NCT01269684|transplantation|transplantation
439852|NCT01269684|tacrolimus|tacrolimus
439853|NCT01269684|everolimus|everolimus
439854|NCT01269684|stable allograft recipients|stable allograft recipients
439855|NCT01269671|Functional Abdominal Pain|functional abdominal pain
439856|NCT01269671|Irritable Bowel Syndrome|irritable bowel syndrome
439857|NCT01269671|IBS|ibs
439858|NCT01269671|Functional Dyspepsia|functional dyspepsia
439859|NCT01269671|Melatonin|melatonin
439860|NCT01269671|Simethicone|simethicone
439861|NCT01269671|Peppermint Oil|peppermint oil
439862|NCT01269671|mentharil|mentharil
439863|NCT01269671|functional bowel disorders|functional bowel disorders
439864|NCT01269671|quality of life|quality of life
439865|NCT01269645|Cancer|cancer
439866|NCT01269645|Clinical trials|clinical trials
439867|NCT01269632|teenagers to adult transition|teenagers to adult transition
439868|NCT01269632|comparison|comparison
439869|NCT01269619|back pain|back pain
439870|NCT01269619|posture|posture
439871|NCT01269619|lumbar support|lumbar support
439872|NCT01269619|dynamic support|dynamic support
439873|NCT01269593|PET Scan|pet scan
439874|NCT01269593|124I-PUH71|124i-puh71
439875|NCT01269593|10-139|10-139
439876|NCT01269567|RectalNeoplasms|rectalneoplasms
439877|NCT01269567|Colorectal Neoplasms|colorectal neoplasms
439878|NCT01269567|Intestinal Neoplasms|intestinal neoplasms
439879|NCT01269567|Gastrointestinal Neoplasms|gastrointestinal neoplasms
439880|NCT01269567|Digestive System Neoplasms|digestive system neoplasms
439881|NCT01269567|Neoplasms by Site|neoplasms by site
439882|NCT01269567|Digestive System Diseases|digestive system diseases
439883|NCT01269567|Gastrointestinal Diseases|gastrointestinal diseases
439884|NCT01269567|Intestinal Diseases|intestinal diseases
439885|NCT01269567|Rectal Diseases|rectal diseases
439886|NCT01269554|diarrhea|diarrhea
439887|NCT01269554|Guinea-Bissau|guinea-bissau
439888|NCT01269554|Finland|finland
439889|NCT01269554|Children|children
439890|NCT01269554|Adults|adults
439891|NCT01269554|Intestinal pathogens|intestinal pathogens
439892|NCT01269554|Bacteria|bacteria
439893|NCT01269554|Virus|virus
439894|NCT01269554|Parasites|parasites
439895|NCT01269528|Palivizumab|palivizumab
439896|NCT01269528|Airway Hyperreactivity|airway hyperreactivity
439897|NCT01269528|EBC|ebc
439898|NCT01269528|MCT|mct
439899|NCT01269515|Cox-2 inhibitor|cox-2 inhibitor
439900|NCT01269515|HIV|hiv
439901|NCT01269515|immune activation|immune activation
439902|NCT01269515|immune modulating|immune modulating
439903|NCT01269515|progression markers|progression markers
439904|NCT01269515|vaccine|vaccine
439905|NCT01269489|quality of life|quality of life
439906|NCT01269489|general Slovenian population|general slovenian population
439907|NCT01269489|EORTC QLQ C30|eortc qlq c30
439908|NCT01269463|Attention deficit|attention deficit
439909|NCT01269463|Hyperactivity|hyperactivity
439910|NCT01269463|Impulsivity|impulsivity
439911|NCT01269463|Inattention|inattention
439912|NCT01269450|second trimester vaginal bleeding|second trimester vaginal bleeding
439913|NCT01269450|late abortion|late abortion
439914|NCT01269450|preterm birth|preterm birth
439915|NCT01269450|progesterone|progesterone
439916|NCT01269437|mild to moderate asthma|mild to moderate asthma
439917|NCT01269424|adult giant cell glioblastoma|adult giant cell glioblastoma
439918|NCT01269424|adult glioblastoma|adult glioblastoma
439919|NCT01269424|adult gliosarcoma|adult gliosarcoma
439920|NCT01269385|Imprime PGG|imprime pgg
439921|NCT01269372|polyps|polyps
439922|NCT01269372|capsule endoscopy|capsule endoscopy
439923|NCT01269372|colonoscopy|colonoscopy
439924|NCT01269346|Locally recurrent|locally recurrent
440125|NCT01268540|IOL|iol
439925|NCT01269346|metastatic HER2Positive breast cancer|metastatic her2positive breast cancer
439926|NCT01269307|Anesthesia|anesthesia
439927|NCT01269307|Pain|pain
439928|NCT01269307|Procedural sedation|procedural sedation
439929|NCT01269307|Airway/Anesthesia/Analgesia|airway/anesthesia/analgesia
439930|NCT01269294|Hepatitis C|hepatitis c
439931|NCT01269294|TMC435-TiDP16-C117|tmc435-tidp16-c117
439932|NCT01269294|TMC435-C117|tmc435-c117
439933|NCT01269294|TMC435|tmc435
439934|NCT01269294|HCV|hcv
439935|NCT01269294|Moxifloxacin|moxifloxacin
439936|NCT01269294|ECG|ecg
439937|NCT01269294|QT|qt
439938|NCT01269294|QTc|qtc
439939|NCT01269281|Bioequivalence|bioequivalence
439940|NCT01269281|two way crossover|two way crossover
439941|NCT01269242|coronary restenosis|coronary restenosis
439942|NCT01269242|angioplasty|angioplasty
439943|NCT01269242|stent|stent
439944|NCT01269242|MCP-1/CCL2|mcp-1/ccl2
439945|NCT01269242|MCP-3/CCL7|mcp-3/ccl7
439946|NCT01269203|multiple myeloma|multiple myeloma
439947|NCT01269203|MM|mm
439948|NCT01269203|maintenance therapy|maintenance therapy
439949|NCT01269203|lenalidomide|lenalidomide
439950|NCT01269203|bone marrow transplantation|bone marrow transplantation
439951|NCT01269203|auto-HSCT|auto-hsct
439952|NCT01269203|Autologous Hematopoietic Stem Cell Transplantation|autologous hematopoietic stem cell transplantation
439953|NCT01269203|NF-kB inhibition|nf-kb inhibition
439954|NCT01269203|reducing symptoms|reducing symptoms
439955|NCT01269203|maintenance chemotherapy|maintenance chemotherapy
439956|NCT01269203|inflammatory cytokines|inflammatory cytokines
439957|NCT01269203|nuclear factor kappa B|nuclear factor kappa b
439958|NCT01269203|NF-kB|nf-kb
439959|NCT01269203|interleukin|interleukin
439960|NCT01269203|IL-6|il-6
439961|NCT01269203|tumor necrosis factor|tumor necrosis factor
439962|NCT01269203|TNF-a|tnf-a
439963|NCT01269203|NF-kB activation levels|nf-kb activation levels
439964|NCT01269190|oral mucosa in vivo|oral mucosa in vivo
439965|NCT01269190|Wide-Field In Vivo Imaging|wide-field in vivo imaging
439966|NCT01269190|High Resolution In Vivo Imaging|high resolution in vivo imaging
439967|NCT01269190|Oral Neoplasia|oral neoplasia
439968|NCT01269190|Topical Fluorescent Dyes|topical fluorescent dyes
439969|NCT01269190|contrast dye|contrast dye
439970|NCT01269190|oral dysplasia|oral dysplasia
439971|NCT01269190|Proflavine|proflavine
439972|NCT01269190|oral lesions|oral lesions
439973|NCT01269190|surgical resection|surgical resection
439974|NCT01269190|High Resolution Microendoscope|high resolution microendoscope
439975|NCT01269190|HRME|hrme
439976|NCT01269190|Identafi 3000|identafi 3000
439977|NCT01269190|Multispectral Digital Microscope|multispectral digital microscope
439978|NCT01269190|MDM|mdm
439979|NCT01269190|Portable Screening System|portable screening system
439980|NCT01269190|PS2|ps2
439981|NCT01269177|ACPE|acpe
439982|NCT01269177|Acute respiratory failure|acute respiratory failure
439983|NCT01269177|Non invasive ventilation|non invasive ventilation
439984|NCT01269177|acute cardiogenic pulmonary edema|acute cardiogenic pulmonary edema
439985|NCT01269164|Face Transplant|face transplant
439986|NCT01269164|Facial Transplantation|facial transplantation
439987|NCT01269164|Composite Facial Allograft Transplantation|composite facial allograft transplantation
439988|NCT01269151|Age-Related Macular Degeneration|age-related macular degeneration
439989|NCT01269151|Retinal Function|retinal function
439990|NCT01269151|multifocal-ERG|multifocal-erg
439991|NCT01269151|Electroretinography|electroretinography
439992|NCT01269151|microperimetry|microperimetry
439993|NCT01269151|Lucentis|lucentis
439994|NCT01269151|Ranibizumab|ranibizumab
439995|NCT01269151|longterm effects|longterm effects
439996|NCT01269151|best corrected visual acuity|best corrected visual acuity
439997|NCT01269151|BCVA|bcva
439998|NCT01269138|Inherited Factor VII deficiency|inherited factor vii deficiency
439999|NCT01269138|Inhibitor development in Factor VII deficiency|inhibitor development in factor vii deficiency
440000|NCT01269138|Bleeding in Factor VII Deficiency|bleeding in factor vii deficiency
440001|NCT01269138|Surgery in Factor VII deficiency|surgery in factor vii deficiency
440002|NCT01269138|Prophylaxis in Factor VII Deficiency|prophylaxis in factor vii deficiency
440003|NCT01269125|cytokines|cytokines
440004|NCT01269125|endometriosis|endometriosis
440005|NCT01269125|fertilization rate|fertilization rate
440006|NCT01269125|follicular fluid|follicular fluid
440007|NCT01269125|pregnancy rate|pregnancy rate
440008|NCT01269099|hypokalemia|hypokalemia
440009|NCT01269099|intravenous patient controlled analgesia|intravenous patient controlled analgesia
440010|NCT01269086|Primary Heath Care|primary heath care
440011|NCT01269086|Preventive Medicine|preventive medicine
440012|NCT01269086|Adolescent Health Services|adolescent health services
440013|NCT01269086|Spouses|spouses
440014|NCT01269086|Family|family
440015|NCT01269086|Family Practice|family practice
440016|NCT01269073|Obstructive Sleep Apnea|obstructive sleep apnea
440017|NCT01269060|Colorectal Cancer, laparoscopic surgery|colorectal cancer, laparoscopic surgery
440018|NCT01269047|type 1 diabetes|type 1 diabetes
440019|NCT01269047|Symlin|symlin
440020|NCT01269047|Byetta|byetta
440021|NCT01269047|CGMS iPro|cgms ipro
440022|NCT01269034|Type 1 diabetes Milletus|type 1 diabetes milletus
440024|NCT01269034|healthy controls|healthy controls
440025|NCT01269034|exenatide|exenatide
440026|NCT01269034|byetta|byetta
440027|NCT01269021|MMF treatment IgA Nephropathy (IgAN)|mmf treatment iga nephropathy (igan)
440028|NCT01269008|Closed loop|closed loop
440029|NCT01269008|type 1 diabetes|type 1 diabetes
440030|NCT01269008|Symlin|symlin
440031|NCT01269008|Byetta|byetta
440032|NCT01269008|diabetes|diabetes
440033|NCT01269008|insulin|insulin
440034|NCT01269008|insulin pump|insulin pump
440035|NCT01268995|NODAT|nodat
440036|NCT01268995|kidney transplantation|kidney transplantation
440037|NCT01268995|beta cell function|beta cell function
440038|NCT01268995|insulin|insulin
440039|NCT01268995|Tacrolimus|tacrolimus
440040|NCT01268995|Cyclosporine A|cyclosporine a
440041|NCT01268982|socket preservation|socket preservation
440042|NCT01268982|alveolar ridge augmentation|alveolar ridge augmentation
440043|NCT01268969|pilonidal disease PND|pilonidal disease pnd
440044|NCT01268943|rectal neoplasms|rectal neoplasms
440045|NCT01268943|aged|aged
440046|NCT01268943|radiotherapy|radiotherapy
440047|NCT01268943|drug therapy|drug therapy
440048|NCT01268943|dose-escalation|dose-escalation
440049|NCT01268943|capecitabine|capecitabine
440050|NCT01268930|ovarian reserve|ovarian reserve
440051|NCT01268930|endometrioma excision|endometrioma excision
440052|NCT01268930|hemostatic matrix|hemostatic matrix
440053|NCT01268930|bipolar electrocoagulation|bipolar electrocoagulation
440054|NCT01268930|thermal injury|thermal injury
440055|NCT01268917|coronary artery disease|coronary artery disease
440056|NCT01268917|off-pump coronary artery bypass|off-pump coronary artery bypass
440057|NCT01268917|aspirin|aspirin
440058|NCT01268891|Azilect|azilect
440059|NCT01268891|Motor fluctuations|motor fluctuations
440060|NCT01268891|Parkinson´s Disease|parkinson´s disease
440061|NCT01268891|Rasagiline|rasagiline
440062|NCT01268878|effect of febrile neutropenia resulting chemotherapy by TPF|effect of febrile neutropenia resulting chemotherapy by tpf
440063|NCT01268865|Acoustic Radiation Force Impulse (ARFI)|acoustic radiation force impulse (arfi)
440064|NCT01268865|Virtual Touch Quantification (VTQ)|virtual touch quantification (vtq)
440065|NCT01268865|liver stiffness measurement (LSM)|liver stiffness measurement (lsm)
440066|NCT01268865|liver fibrosis|liver fibrosis
440067|NCT01268865|cirrhosis|cirrhosis
440068|NCT01268865|hepatitis B|hepatitis b
440069|NCT01268865|hepatitis C|hepatitis c
440070|NCT01268839|TMC278, rilpivirine, efavirenz, healthy volunteer|tmc278, rilpivirine, efavirenz, healthy volunteer
440071|NCT01268800|AML|aml
440072|NCT01268800|Induction|induction
440073|NCT01268761|Ovarian hyperstimulation syndrome (OHSS)|ovarian hyperstimulation syndrome (ohss)
440074|NCT01268761|GnRH antagonist|gnrh antagonist
440075|NCT01268761|Ascitis.|ascitis.
440076|NCT01268748|single site surgery|single site surgery
440077|NCT01268748|laparoscopic surgery|laparoscopic surgery
440078|NCT01268748|pain|pain
440079|NCT01268748|nausea|nausea
440080|NCT01268735|Dysfunctional Tear Syndrome|dysfunctional tear syndrome
440081|NCT01268735|Dry Eye|dry eye
440082|NCT01268735|LIPCOF|lipcof
440083|NCT01268735|Hydroxypropyl-guar|hydroxypropyl-guar
440084|NCT01268722|Nitinol Stent|nitinol stent
440085|NCT01268722|Balloon angioplasty|balloon angioplasty
440086|NCT01268722|Chronic total occlusions|chronic total occlusions
440087|NCT01268722|Femoropopliteal|femoropopliteal
440088|NCT01268696|diabetes|diabetes
440089|NCT01268696|obesity|obesity
440090|NCT01268696|hypertension|hypertension
440091|NCT01268696|dyslipidemia|dyslipidemia
440092|NCT01268683|Ischemic stroke|ischemic stroke
440093|NCT01268657|PTSD|ptsd
440094|NCT01268657|Fear of Falling|fear of falling
440095|NCT01268657|Older Adults|older adults
440096|NCT01268657|Injurious Falls|injurious falls
440097|NCT01268657|Exposure Therapy|exposure therapy
440098|NCT01268644|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
440099|NCT01268631|Fibromyalgia|fibromyalgia
440100|NCT01268631|Pain modulation|pain modulation
440101|NCT01268618|IBS|ibs
440102|NCT01268618|Diarrhea|diarrhea
440103|NCT01268618|Dyspepsia|dyspepsia
440104|NCT01268605|Dental caries|dental caries
440105|NCT01268605|Resin based composite|resin based composite
440106|NCT01268605|Hypersensitivity|hypersensitivity
440107|NCT01268605|Teeth|teeth
440108|NCT01268605|Dentistry|dentistry
440109|NCT01268605|Practice-based research network|practice-based research network
440110|NCT01268592|fertility preservation|fertility preservation
440111|NCT01268592|oocyte cryopreservation|oocyte cryopreservation
440112|NCT01268592|vitrification|vitrification
440113|NCT01268592|egg freezing|egg freezing
440114|NCT01268592|fertility preservation in female cancer patients|fertility preservation in female cancer patients
440115|NCT01268579|ribavirin|ribavirin
440116|NCT01268579|VIRAZOLE|virazole
440117|NCT01268579|tonsil|tonsil
440118|NCT01268579|base of tongue|base of tongue
440119|NCT01268579|squamous cell carcinoma|squamous cell carcinoma
440120|NCT01268579|10-218|10-218
440121|NCT01268566|Glioblastoma|glioblastoma
440122|NCT01268553|pulmonary arterial hypertension|pulmonary arterial hypertension
440123|NCT01268553|inhaled prostacyclin|inhaled prostacyclin
440124|NCT01268540|intraocular lens|intraocular lens
440126|NCT01268540|cataract|cataract
440127|NCT01268540|refractive astigmatism|refractive astigmatism
440128|NCT01268540|Aspheric|aspheric
440129|NCT01268540|Toric|toric
440130|NCT01268540|Hoya|hoya
440131|NCT01268540|Surgical|surgical
440132|NCT01268540|Optics|optics
440133|NCT01268540|visual acuity|visual acuity
440134|NCT01268527|Psoriasis vulgaris|psoriasis vulgaris
440135|NCT01268514|Complex|complex
440136|NCT01268514|Abdominal Wall Reconstruction|abdominal wall reconstruction
440137|NCT01268514|AWR|awr
440138|NCT01268514|Hernia|hernia
440139|NCT01268475|Bronchiectasis|bronchiectasis
440140|NCT01268475|Quality of Life|quality of life
440141|NCT01268475|Respiratory Function Tests|respiratory function tests
440142|NCT01268475|Exercise Test|exercise test
440143|NCT01268449|Tinnitus|tinnitus
440144|NCT01268449|Low power laser|low power laser
440145|NCT01268423|Percutaneous tracheostomy|percutaneous tracheostomy
440146|NCT01268423|Swallowing dysfunction|swallowing dysfunction
440147|NCT01268423|Mechanical ventilation|mechanical ventilation
440148|NCT01268423|Intensive Care|intensive care
440149|NCT01268410|Acute respiratory failure|acute respiratory failure
440150|NCT01268410|Acute lung injury|acute lung injury
440151|NCT01268410|Acute respiratory distress syndrome|acute respiratory distress syndrome
440152|NCT01268410|Mechanical Ventilation|mechanical ventilation
440153|NCT01268410|Non-Invasive Ventilation|non-invasive ventilation
440154|NCT01268397|elderly|elderly
440155|NCT01268397|wrist fracture|wrist fracture
440156|NCT01268397|fracture of the distal radius|fracture of the distal radius
440157|NCT01268397|volar plate|volar plate
440158|NCT01268397|plaster cast|plaster cast
440159|NCT01268384|pancreatic cancer|pancreatic cancer
440160|NCT01268384|neoadjuvant chemotherapy|neoadjuvant chemotherapy
440161|NCT01268384|gemcitabine|gemcitabine
440162|NCT01268384|capecitabine|capecitabine
440163|NCT01268371|Coronary artery disease|coronary artery disease
440164|NCT01268371|Stent|stent
440165|NCT01268345|blood glucose|blood glucose
440166|NCT01268332|Placebo IVR as a delivery method|placebo ivr as a delivery method
440167|NCT01268319|Myocardial Infarction|myocardial infarction
440168|NCT01268319|percutaneous coronary intervention|percutaneous coronary intervention
440169|NCT01268319|embolization|embolization
440170|NCT01268319|necrotic core|necrotic core
440171|NCT01268319|vulnerable plaque|vulnerable plaque
440172|NCT01268319|coronary plaque rupture|coronary plaque rupture
440173|NCT01268306|contact lens|contact lens
440174|NCT01268306|corneal staining|corneal staining
440175|NCT01268306|fluorescein staining|fluorescein staining
440176|NCT01268306|preservatives|preservatives
440177|NCT01268306|keratitis|keratitis
440178|NCT01268306|punctate keratopathy|punctate keratopathy
440179|NCT01268306|superficial punctate keratopathy|superficial punctate keratopathy
440180|NCT01268306|SPK|spk
440181|NCT01268293|Cancer|cancer
440182|NCT01268254|wine|wine
440183|NCT01268254|aging|aging
440184|NCT01268254|atherosclerosis|atherosclerosis
440185|NCT01268254|telomere|telomere
440186|NCT01268254|tomography|tomography
440187|NCT01268254|coronary vessels|coronary vessels
440188|NCT01268241|Fabry Disease|fabry disease
440189|NCT01268241|Fabry´s Disease|fabry´s disease
440190|NCT01268241|Anderson-Fabry Disease|anderson-fabry disease
440191|NCT01268228|intracoronary ECG|intracoronary ecg
440192|NCT01268228|coronary bifurcation stenosis|coronary bifurcation stenosis
440193|NCT01268228|side branch compromise|side branch compromise
440194|NCT01268228|Periprocedural myonecrosis during coronary bifurcation lesion stenting assessed with ic ECG|periprocedural myonecrosis during coronary bifurcation lesion stenting assessed with ic ecg
440195|NCT01268215|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
440196|NCT01268215|Budesonide|budesonide
440197|NCT01268215|Infasurf|infasurf
440198|NCT01268202|cutaneous radioinduced fibrosis|cutaneous radioinduced fibrosis
440199|NCT01268189|burn wound|burn wound
440200|NCT01268189|management with oxygen|management with oxygen
440201|NCT01268176|Vitamin D|vitamin d
440202|NCT01268176|vitamin D deficiency|vitamin d deficiency
440203|NCT01268176|vitamin D absorption|vitamin d absorption
440204|NCT01268163|Docetaxel|docetaxel
440205|NCT01268163|Phase I|phase i
440206|NCT01268163|Pharmacokinetic|pharmacokinetic
440207|NCT01268163|Bioequivalence|bioequivalence
440208|NCT01268137|MDD|mdd
440209|NCT01268137|DBS|dbs
440210|NCT01268124|Japanese|japanese
440211|NCT01268111|vitamin D deficiency, insulin sensitivity|vitamin d deficiency, insulin sensitivity
440212|NCT01268098|Hypoparathyroidism, rhPTH[1-84], NPSP558|hypoparathyroidism, rhpth[1-84], npsp558
440213|NCT01268085|Radiation Safety|radiation safety
440214|NCT01268085|Computerized Physician Order Entry|computerized physician order entry
440215|NCT01268085|Decision Support|decision support
440216|NCT01268085|Cat Scans|cat scans
440217|NCT01268072|COPD|copd
440218|NCT01268059|Non-small cell lung cancer|non-small cell lung cancer
440219|NCT01268059|NSCLC|nsclc
440220|NCT01268046|aging|aging
440221|NCT01268046|postmenopausal women|postmenopausal women
440222|NCT01268046|estrogen|estrogen
440223|NCT01268046|memory|memory
440224|NCT01268033|rituximab|rituximab
440225|NCT01268033|idiopathic nephrotic syndrome|idiopathic nephrotic syndrome
440226|NCT01268033|minimal change disease|minimal change disease
440227|NCT01268033|focal and segmental glomerulosclerosis|focal and segmental glomerulosclerosis
440228|NCT01268020|Alzheimer|alzheimer
440229|NCT01268020|AD|ad
440230|NCT01267994|Steroid|steroid
440231|NCT01267994|Steroid-Resistant|steroid-resistant
440232|NCT01267994|Autoimmune Inner Ear Disease|autoimmune inner ear disease
440233|NCT01267994|Immune Mediated Hearing Loss|immune mediated hearing loss
440234|NCT01267994|Sudden Sensorineural Hearing Loss|sudden sensorineural hearing loss
440235|NCT01267994|Meniere's Disease|meniere's disease
440236|NCT01267994|Autoimmune|autoimmune
440237|NCT01267994|Hearing|hearing
440238|NCT01267981|Small bowel|small bowel
440239|NCT01267981|video-capsule endoscopy|video-capsule endoscopy
440240|NCT01267981|gastrointestinal bleeding|gastrointestinal bleeding
440241|NCT01267981|polyethylene glycol|polyethylene glycol
440242|NCT01267968|pharmacokinetics|pharmacokinetics
440243|NCT01267968|bronchoalveolar lavage|bronchoalveolar lavage
440244|NCT01267968|GSK2251052|gsk2251052
440245|NCT01267968|pulmonary|pulmonary
440246|NCT01267968|healthy volunteer|healthy volunteer
440247|NCT01267968|antimicrobial|antimicrobial
440248|NCT01267942|Adenotonsillectomy.|adenotonsillectomy.
440249|NCT01267929|Children with cerebral palsy|children with cerebral palsy
440250|NCT01267929|Gross Motor Function Measure|gross motor function measure
440251|NCT01267929|Imitative learning|imitative learning
440252|NCT01267929|Mirror neuron|mirror neuron
440253|NCT01267929|Action observation|action observation
440254|NCT01267929|Conventional physical therapy|conventional physical therapy
440255|NCT01267916|intrinsic positive end-expiratory pressure|intrinsic positive end-expiratory pressure
440256|NCT01267916|obesity|obesity
440257|NCT01267916|ventilator setting|ventilator setting
440258|NCT01267916|respiratory rate|respiratory rate
440259|NCT01267903|Vaccines Adverse Reaction|vaccines adverse reaction
440260|NCT01267890|ethics|ethics
440261|NCT01267890|law|law
440262|NCT01267890|surrogate|surrogate
440263|NCT01267890|conflict|conflict
440264|NCT01267877|U.S. Preventive Services Task Force|u.s. preventive services task force
440265|NCT01267877|Patient attitude|patient attitude
440266|NCT01267877|Mammogram|mammogram
440267|NCT01267877|Guideline|guideline
440268|NCT01267864|migraine|migraine
440269|NCT01267864|emergency|emergency
440270|NCT01267864|metoclopramide|metoclopramide
440271|NCT01267864|ketorolac|ketorolac
440272|NCT01267864|valproate|valproate
440273|NCT01267851|gynecologic disease|gynecologic disease
440274|NCT01267838|Coronary artery disease|coronary artery disease
440275|NCT01267838|Restenosis|restenosis
440276|NCT01267838|Stent thrombosis|stent thrombosis
440277|NCT01267825|Disc herniation|disc herniation
440278|NCT01267825|Lumbosacral radiculopathy|lumbosacral radiculopathy
440279|NCT01267825|Corticosteroids|corticosteroids
440280|NCT01267786|Oxidotic stress|oxidotic stress
440281|NCT01267773|depression|depression
440282|NCT01267773|conduct problems|conduct problems
440283|NCT01267760|dialysis|dialysis
440284|NCT01267760|hemodialysis|hemodialysis
440285|NCT01267760|Effect of recycled low-volume dialysate on dialysis efficacy|effect of recycled low-volume dialysate on dialysis efficacy
440286|NCT01267747|Atrial fibrillation|atrial fibrillation
440287|NCT01267747|Atrial Flutter|atrial flutter
440288|NCT01267747|Primary Aldosteronism|primary aldosteronism
440289|NCT01267747|Aldosterone Producing Adenoma|aldosterone producing adenoma
440290|NCT01267734|Everolimus|everolimus
440291|NCT01267734|Zotarolimus|zotarolimus
440292|NCT01267734|Cilostazol|cilostazol
440293|NCT01267734|Clopidogrel|clopidogrel
440294|NCT01267721|heart surgery|heart surgery
440295|NCT01267695|Gastrointestinal Stromal Tumor|gastrointestinal stromal tumor
440296|NCT01267695|Imatinib mesylate|imatinib mesylate
440297|NCT01267695|Perioperative therapy|perioperative therapy
440298|NCT01267682|Delirium|delirium
440299|NCT01267682|Dementia|dementia
440300|NCT01267682|Non-pharmacological Intervention|non-pharmacological intervention
440301|NCT01267682|Post-acute care|post-acute care
440302|NCT01267669|Variceal bleeding|variceal bleeding
440303|NCT01267669|Endoscopic therapy|endoscopic therapy
440304|NCT01267669|Band ligation|band ligation
440305|NCT01267669|Somatostatin|somatostatin
440306|NCT01267669|Vasoactive drugs|vasoactive drugs
440307|NCT01267669|Octreotide|octreotide
440308|NCT01267643|Alefacept|alefacept
440309|NCT01267643|Amevive|amevive
440310|NCT01267643|Aplastic Anemia|aplastic anemia
440311|NCT01267643|Moderate to Severe Aplastic Anemia|moderate to severe aplastic anemia
440312|NCT01267630|Delirium of Mixed Origin|delirium of mixed origin
440313|NCT01267630|Subacute Delirium|subacute delirium
440314|NCT01267630|Mental Disorders, Organic|mental disorders, organic
440315|NCT01267630|Organic Brain Syndrome, Nonpsychotic|organic brain syndrome, nonpsychotic
440316|NCT01267630|Organic Mental Disorders|organic mental disorders
440317|NCT01267630|Organic Mental Disorders, Psychotic|organic mental disorders, psychotic
440318|NCT01267630|Psychoses, Traumatic|psychoses, traumatic
440319|NCT01267630|Cognition Disorder|cognition disorder
440320|NCT01267630|Confusion state|confusion state
440321|NCT01267630|Disorientation|disorientation
440322|NCT01267617|hemodialysis|hemodialysis
440323|NCT01267617|hypotension|hypotension
440324|NCT01267617|circulatory stress|circulatory stress
440325|NCT01267617|photo-plethysmography|photo-plethysmography
440326|NCT01267578|Epitope peptide, CTL, Esophageal cancer, Vaccination|epitope peptide, ctl, esophageal cancer, vaccination
440327|NCT01267565|ventilator-acquired pneumonia|ventilator-acquired pneumonia
440328|NCT01267565|prevention|prevention
440330|NCT01267565|tracheal aspiration|tracheal aspiration
440331|NCT01267565|microaspiration|microaspiration
440332|NCT01267552|Breast cancer|breast cancer
440333|NCT01267552|Surgery|surgery
440334|NCT01267552|Complications|complications
440335|NCT01267552|Drainage|drainage
440336|NCT01267552|Seroma|seroma
440337|NCT01267539|Suan Zao Ren Tang, climacteric, PSQI, WHOQOL-BREF|suan zao ren tang, climacteric, psqi, whoqol-bref
440338|NCT01267526|Growth disorders|growth disorders
440339|NCT01267526|Saizen|saizen
440340|NCT01267526|Easypod|easypod
440341|NCT01267526|Growth hormone|growth hormone
440342|NCT01267526|Pediatric subject|pediatric subject
440343|NCT01267513|oxygen saturation|oxygen saturation
440344|NCT01267513|pulse rate|pulse rate
440345|NCT01267513|tachycardia|tachycardia
440346|NCT01267513|bradycardia|bradycardia
440347|NCT01267513|hypoxia|hypoxia
440348|NCT01267487|Heparin|heparin
440349|NCT01267487|Protamine|protamine
440350|NCT01267487|Cardiopulmonary Bypass|cardiopulmonary bypass
440351|NCT01267487|Titration|titration
440352|NCT01267474|School children|school children
440353|NCT01267474|Sugar intake|sugar intake
440354|NCT01267474|Nutritional education program|nutritional education program
440355|NCT01267461|To asses the biological actions of insulin analogs in primary tumor cells|to asses the biological actions of insulin analogs in primary tumor cells
440356|NCT01267448|Diabetes Mellitus Type2.|diabetes mellitus type2.
440357|NCT01267448|Severe Hyperglycemia - blood glucose levels >300mg/dl.|severe hyperglycemia - blood glucose levels >300mg/dl.
440358|NCT01267435|Arthroscopy, Anterior Cruciate Ligament, Tibial Tunnel.|arthroscopy, anterior cruciate ligament, tibial tunnel.
440359|NCT01267422|Leber's Hereditary Optic Neuropathy,11778 LHON mutation,|leber's hereditary optic neuropathy,11778 lhon mutation,
440360|NCT01267422|rAAV2-ND4,triamcinolone acetonide|raav2-nd4,triamcinolone acetonide
440361|NCT01267409|Mapping the emotional territories of the STN|mapping the emotional territories of the stn
440362|NCT01267409|Identifying the emotional spectral signature of the STN single unit activity|identifying the emotional spectral signature of the stn single unit activity
440363|NCT01267409|Manipulating emotional processing of PD patients by high and low frequency stimulation|manipulating emotional processing of pd patients by high and low frequency stimulation
440364|NCT01267409|Affecting long-term emotional states of the PD patients|affecting long-term emotional states of the pd patients
440365|NCT01267396|Bioequivalence|bioequivalence
440366|NCT01267396|Sertraline|sertraline
440367|NCT01267396|crossover|crossover
440368|NCT01267383|Bioequivalence|bioequivalence
440369|NCT01267383|Sertraline|sertraline
440370|NCT01267383|crossover|crossover
440371|NCT01267370|clinical trial|clinical trial
440372|NCT01267370|dietary fiber|dietary fiber
440373|NCT01267370|constipation|constipation
440374|NCT01267370|children|children
440375|NCT01267357|Serous Papillary Endometrial Cancer|serous papillary endometrial cancer
440376|NCT01267357|Endometrioid endometrial cancer|endometrioid endometrial cancer
440377|NCT01267357|biomarkers|biomarkers
440378|NCT01267357|P16|p16
440379|NCT01267357|P53|p53
440380|NCT01267357|Prognosis|prognosis
440381|NCT01267344|biliary tract cancer|biliary tract cancer
440382|NCT01267344|BTC|btc
440383|NCT01267344|cetuximaba|cetuximaba
440384|NCT01267331|Old Myocardial Infarction|old myocardial infarction
440385|NCT01267331|Stem Cell Therapy|stem cell therapy
440386|NCT01267331|Coronary Artery Bypass Grafting|coronary artery bypass grafting
440387|NCT01267331|Coronary Artery Disease|coronary artery disease
440388|NCT01267318|Gastric juice|gastric juice
440389|NCT01267318|Stomach|stomach
440390|NCT01267318|GI|gi
440391|NCT01267318|Gastric juice samples with presence of blood.|gastric juice samples with presence of blood.
440392|NCT01267305|esophagectomy|esophagectomy
440393|NCT01267305|lung resection|lung resection
440394|NCT01267305|venous thromboembolism|venous thromboembolism
440395|NCT01267305|low molecular weight heparin|low molecular weight heparin
440396|NCT01267305|chest drainage|chest drainage
440397|NCT01267305|TEG|teg
440398|NCT01267292|cocaine dependence|cocaine dependence
440399|NCT01267292|psychopharmacology|psychopharmacology
440400|NCT01267292|attentional bias|attentional bias
440401|NCT01267292|risky decision making|risky decision making
440402|NCT01267292|buspirone|buspirone
440403|NCT01267292|methylphenidate|methylphenidate
440404|NCT01267227|Hyperlipidemia|hyperlipidemia
440405|NCT01267227|Cholesterol|cholesterol
440406|NCT01267227|Blood Pressure|blood pressure
440407|NCT01267227|Oxidative Stress|oxidative stress
440408|NCT01267227|Pterostilbene|pterostilbene
440409|NCT01267227|Blueberry|blueberry
440410|NCT01267227|Grape Extract|grape extract
440411|NCT01267201|Single dose bioavailability study of methylprednisolone powder for oral suspension (4mg/mL) versus methylprednisolone tablet (32 mg)|single dose bioavailability study of methylprednisolone powder for oral suspension (4mg/ml) versus methylprednisolone tablet (32 mg)
440412|NCT01267162|CHB|chb
440413|NCT01267149|superficial vertical perioral lines|superficial vertical perioral lines
440414|NCT01267149|superficial horizontal and lateral canthal lines|superficial horizontal and lateral canthal lines
440415|NCT01267149|correct moderate to severe facial wrinkles and folds|correct moderate to severe facial wrinkles and folds
440416|NCT01267136|Tonsillectomy|tonsillectomy
440417|NCT01267136|Pain|pain
440418|NCT01267136|Pediatric|pediatric
440419|NCT01267136|Opioids|opioids
440420|NCT01267136|Tramadol|tramadol
440421|NCT01267136|Codeine|codeine
440422|NCT01267097|Pediatric Obesity|pediatric obesity
440423|NCT01267097|Treatment|treatment
440424|NCT01267097|Cognitive Behavioural Therapy|cognitive behavioural therapy
440425|NCT01267097|Psychoeducation|psychoeducation
440426|NCT01267097|Canada|canada
440427|NCT01267084|Trabectedin (YONDELIS)|trabectedin (yondelis)
440428|NCT01267084|Ketoconazole|ketoconazole
440429|NCT01267084|Antineoplastic Agents|antineoplastic agents
440430|NCT01267084|Solid tumors|solid tumors
440431|NCT01267084|Locally advanced or metastatic disease|locally advanced or metastatic disease
440432|NCT01267084|Chemotherapy|chemotherapy
440433|NCT01267084|Pharmacokinetics|pharmacokinetics
440434|NCT01267071|Entero-test|entero-test
440435|NCT01267071|Phase I|phase i
440436|NCT01267071|GSK962040|gsk962040
440437|NCT01267071|i.v. microtracer|i.v. microtracer
440438|NCT01267071|radioactivity|radioactivity
440439|NCT01267071|pharmacokinetics|pharmacokinetics
440440|NCT01267071|healthy volunteer|healthy volunteer
440441|NCT01267058|Booster vaccination|booster vaccination
440442|NCT01267045|Persian Gulf Syndrome|persian gulf syndrome
440443|NCT01267045|Pain|pain
440444|NCT01267045|Fatigue|fatigue
440445|NCT01267045|Attention|attention
440446|NCT01267045|Meditation|meditation
440447|NCT01267019|social cognition|social cognition
440448|NCT01267019|training intervention|training intervention
440449|NCT01266993|Immunogenicity|immunogenicity
440450|NCT01266993|Persistence|persistence
440451|NCT01266993|Safety|safety
440452|NCT01266993|Conjugate vaccine|conjugate vaccine
440453|NCT01266993|Meningococcal vaccine|meningococcal vaccine
440454|NCT01266980|cortisol|cortisol
440455|NCT01266980|renal impairment|renal impairment
440456|NCT01266980|serum potassium|serum potassium
440457|NCT01266980|pharmacokinetics|pharmacokinetics
440458|NCT01266980|Fluticasone furoate|fluticasone furoate
440459|NCT01266980|heart rate|heart rate
440460|NCT01266967|GSK2118436|gsk2118436
440461|NCT01266967|Metastatic melanoma to the brain|metastatic melanoma to the brain
440462|NCT01266967|Brain metastases|brain metastases
440463|NCT01266967|Braf mutation|braf mutation
440464|NCT01266967|Brain neoplasm|brain neoplasm
440465|NCT01266967|BRAF inhibitor|braf inhibitor
440466|NCT01266954|Cancer|cancer
440467|NCT01266954|18F FDG|18f fdg
440468|NCT01266954|PK|pk
440469|NCT01266954|PET|pet
440470|NCT01266954|Positron Emission Tomography|positron emission tomography
440471|NCT01266954|PD|pd
440472|NCT01266954|AKT Inhibitor|akt inhibitor
440473|NCT01266954|GSK2141795|gsk2141795
440474|NCT01266941|pharmacokinetics|pharmacokinetics
440475|NCT01266941|hepatic impairment|hepatic impairment
440476|NCT01266941|heart rate|heart rate
440477|NCT01266941|serum potassium|serum potassium
440478|NCT01266941|serum cortisol|serum cortisol
440479|NCT01266941|GW642444M|gw642444m
440480|NCT01266941|Fluticasone furoate (GW685698)|fluticasone furoate (gw685698)
440481|NCT01266915|SCLE|scle
440482|NCT01266915|CLE|cle
440483|NCT01266915|DLE|dle
440484|NCT01266902|HIV-1 Infection|hiv-1 infection
440485|NCT01266902|HIV-1|hiv-1
440486|NCT01266902|HIV|hiv
440487|NCT01266902|TMC278-TiDP6-C222|tmc278-tidp6-c222
440488|NCT01266902|TMC278-C222|tmc278-c222
440489|NCT01266902|TMC278|tmc278
440490|NCT01266902|Rilpivirine|rilpivirine
440491|NCT01266889|preterm infant,cerebral oxygenation, intracranial haemorrhagia|preterm infant,cerebral oxygenation, intracranial haemorrhagia
440492|NCT01266863|Hospital-acquired pneumonia|hospital-acquired pneumonia
440493|NCT01266863|E test|e test
440494|NCT01266863|Antibiogram|antibiogram
440495|NCT01266863|Bronchoalveolar lavage|bronchoalveolar lavage
440496|NCT01266850|vaccine, rotavirus, gastroenteritis, infants|vaccine, rotavirus, gastroenteritis, infants
440497|NCT01266837|metastatic renal cell carcinoma|metastatic renal cell carcinoma
440498|NCT01266837|biomarker|biomarker
440499|NCT01266837|Everolimus|everolimus
440500|NCT01266824|Pain|pain
440501|NCT01266824|Retinopathy of Prematurity|retinopathy of prematurity
440502|NCT01266824|Neonates|neonates
440503|NCT01266811|dexamethasone|dexamethasone
440504|NCT01266811|Siltuximab|siltuximab
440505|NCT01266811|CNTO 328|cnto 328
440506|NCT01266811|IL-6|il-6
440507|NCT01266811|Monoclonal Antibody|monoclonal antibody
440508|NCT01266811|Multiple Myeloma|multiple myeloma
440509|NCT01266811|Relapsed or Refractory|relapsed or refractory
440510|NCT01266811|Velcade|velcade
440511|NCT01266811|bortezomib|bortezomib
440512|NCT01266798|Health literacy, participation|health literacy, participation
440513|NCT01266785|crohn's|crohn's
440514|NCT01266785|Infliximab|infliximab
440721|NCT01266044|Dry mouth|dry mouth
440515|NCT01266785|Inflammatory bowel disease|inflammatory bowel disease
440516|NCT01266785|digestive tract|digestive tract
440517|NCT01266785|Interleukin|interleukin
440518|NCT01266772|asthma; children; montelukast; treatment; exacerbation|asthma; children; montelukast; treatment; exacerbation
440519|NCT01266759|Menorrhagia|menorrhagia
440520|NCT01266759|Vaginal ring|vaginal ring
440521|NCT01266759|Norethisterone Acetate|norethisterone acetate
440522|NCT01266746|gas tamponade,|gas tamponade,
440523|NCT01266746|macular hole,|macular hole,
440524|NCT01266746|macular hole retinal detachment,|macular hole retinal detachment,
440525|NCT01266746|optical coherence tomography|optical coherence tomography
440526|NCT01266733|fibromyalgia, non pharmacological intervention|fibromyalgia, non pharmacological intervention
440527|NCT01266720|pancreatic cancer|pancreatic cancer
440528|NCT01266720|peptide vaccine|peptide vaccine
440529|NCT01266720|VEGFR|vegfr
440530|NCT01266720|gemcitabine|gemcitabine
440531|NCT01266707|Hepatocellular carcinoma|hepatocellular carcinoma
440532|NCT01266707|peptide vaccine|peptide vaccine
440533|NCT01266707|VEGFR|vegfr
440534|NCT01266694|Pericardial effusion|pericardial effusion
440535|NCT01266694|Cardiac surgery|cardiac surgery
440536|NCT01266694|Tamponade|tamponade
440537|NCT01266694|colchicine|colchicine
440538|NCT01266668|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
440539|NCT01266668|Breast|breast
440540|NCT01266668|Rituximab|rituximab
440541|NCT01266642|Breast cancer|breast cancer
440542|NCT01266642|Early invasive breast cancer|early invasive breast cancer
440543|NCT01266642|Ductal carcinoma in situ of the breast|ductal carcinoma in situ of the breast
440544|NCT01266642|Tis|tis
440545|NCT01266642|T1|t1
440546|NCT01266642|T2|t2
440547|NCT01266642|N0|n0
440548|NCT01266642|N1mic|n1mic
440549|NCT01266642|N1a|n1a
440550|NCT01266642|Lumpectomy|lumpectomy
440551|NCT01266642|Hypofractionated whole breast irradiation|hypofractionated whole breast irradiation
440552|NCT01266642|HF-WBI|hf-wbi
440553|NCT01266642|Conventionally fractionated whole breast irradiation|conventionally fractionated whole breast irradiation
440554|NCT01266642|CF-WBI|cf-wbi
440555|NCT01266642|Radiation therapy|radiation therapy
440556|NCT01266642|Radiotherapy|radiotherapy
440557|NCT01266629|small bowel|small bowel
440558|NCT01266616|Interleukin-12|interleukin-12
440559|NCT01266616|Electroporation|electroporation
440560|NCT01266616|HIV Therapeutic Vaccine|hiv therapeutic vaccine
440561|NCT01266603|Metastatic Melanoma|metastatic melanoma
440562|NCT01266603|Unresectable Melanoma|unresectable melanoma
440563|NCT01266603|HDIL-2|hdil-2
440564|NCT01266603|Interleukin-2|interleukin-2
440565|NCT01266603|IL-2|il-2
440566|NCT01266603|Aldesleukin|aldesleukin
440567|NCT01266603|Proleukin|proleukin
440568|NCT01266603|recMAGE-A3 + AS15|recmage-a3 + as15
440569|NCT01266603|ASCI|asci
440570|NCT01266603|recMAGE-A3|recmage-a3
440571|NCT01266603|Recombinant MAGE-A3 protein|recombinant mage-a3 protein
440572|NCT01266603|recMAGE-A3 + AS15 ASCI|recmage-a3 + as15 asci
440573|NCT01266603|MAGE-A3|mage-a3
440574|NCT01266603|MAGE-A3 ASCI|mage-a3 asci
440575|NCT01266577|Brain Metabolism|brain metabolism
440576|NCT01266577|Neurochemistry|neurochemistry
440577|NCT01266577|Magnetic Resonance Imaging|magnetic resonance imaging
440578|NCT01266577|Mental Illness|mental illness
440579|NCT01266577|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
440580|NCT01266577|Healthy Volunteer|healthy volunteer
440581|NCT01266577|HV|hv
440582|NCT01266551|Antireflux procedure|antireflux procedure
440583|NCT01266551|Gastroesophageal reflux|gastroesophageal reflux
440584|NCT01266551|Infant sleep position|infant sleep position
440585|NCT01266551|pH monitoring|ph monitoring
440586|NCT01266499|Klebsiella , pneumonia, carbapenem-hydrolyzing lactamase, carbapenem-resistant Klebsiella (KPC), eradication,|klebsiella , pneumonia, carbapenem-hydrolyzing lactamase, carbapenem-resistant klebsiella (kpc), eradication,
440587|NCT01266486|Breast cancer|breast cancer
440588|NCT01266486|Pharmacodynamics|pharmacodynamics
440589|NCT01266486|AMPK|ampk
440590|NCT01266486|PET Scan|pet scan
440591|NCT01266473|Adults|adults
440592|NCT01266434|moderate persistent asthma|moderate persistent asthma
440593|NCT01266434|Inhaled corticosteroids|inhaled corticosteroids
440594|NCT01266421|DNG|dng
440595|NCT01266421|Anemia|anemia
440596|NCT01266421|Depression|depression
440597|NCT01266408|Drospirenone|drospirenone
440598|NCT01266408|Dienogest|dienogest
440599|NCT01266408|Metafolin|metafolin
440600|NCT01266408|Folic acid|folic acid
440601|NCT01266408|Safety|safety
440602|NCT01266395|morning symptoms COPD|morning symptoms copd
440603|NCT01266369|mastocytosis|mastocytosis
440604|NCT01266369|D816V|d816v
440605|NCT01266369|handicaps|handicaps
440606|NCT01266356|Minor Traumatic Brain Injury|minor traumatic brain injury
440607|NCT01266356|Translation|translation
440608|NCT01266343|Glaucoma|glaucoma
440609|NCT01266343|anterior chamber paracentesis|anterior chamber paracentesis
440610|NCT01266343|conventional Mannitol infusion|conventional mannitol infusion
440611|NCT01266330|dairy|dairy
440612|NCT01266330|inflammation|inflammation
440613|NCT01266330|reactive oxygen species|reactive oxygen species
440614|NCT01266330|oxidative stress|oxidative stress
440615|NCT01266330|body composition|body composition
440616|NCT01266291|Tuberous sclerosis|tuberous sclerosis
440617|NCT01266291|TS|ts
440618|NCT01266291|Seizures|seizures
440619|NCT01266278|shoulder injuries|shoulder injuries
440620|NCT01266265|pulmonary arterial hypertension|pulmonary arterial hypertension
440621|NCT01266265|PAH|pah
440622|NCT01266265|treprostinil sodium|treprostinil sodium
440623|NCT01266265|Tyvaso|tyvaso
440624|NCT01266265|inhalation|inhalation
440625|NCT01266265|Ventavis|ventavis
440626|NCT01266265|iloprost|iloprost
440627|NCT01266265|prostacyclin|prostacyclin
440628|NCT01266265|epoprostenol sodium|epoprostenol sodium
440629|NCT01266265|Flolan|flolan
440630|NCT01266265|Veletri|veletri
440631|NCT01266265|subcutaneous and intravenous prostacyclin analogue|subcutaneous and intravenous prostacyclin analogue
440632|NCT01266265|Remodulin|remodulin
440633|NCT01266265|oral ERA|oral era
440634|NCT01266265|bosentan|bosentan
440635|NCT01266265|Tracleer|tracleer
440636|NCT01266265|ambrisentan|ambrisentan
440637|NCT01266265|Letairis|letairis
440638|NCT01266265|oral PDE5 inhibitors|oral pde5 inhibitors
440639|NCT01266265|sildenafil|sildenafil
440640|NCT01266265|Revatio|revatio
440641|NCT01266265|tadalafil|tadalafil
440642|NCT01266265|Adcirca|adcirca
440643|NCT01266265|Opsumit|opsumit
440644|NCT01266265|macitentan|macitentan
440645|NCT01266265|Adempas|adempas
440646|NCT01266265|riociguat|riociguat
440647|NCT01266265|Orenitram|orenitram
440648|NCT01266265|oral treprostinil|oral treprostinil
440649|NCT01266252|neonates|neonates
440650|NCT01266252|single organ respiratory failure|single organ respiratory failure
440651|NCT01266239|Bifurcation lesion, drug-eluting stent, symmetric expansion|bifurcation lesion, drug-eluting stent, symmetric expansion
440652|NCT01266226|Rotator cuff tears|rotator cuff tears
440653|NCT01266226|ACP|acp
440654|NCT01266213|fulvestrant|fulvestrant
440655|NCT01266213|anastrozole|anastrozole
440656|NCT01266213|goserelin|goserelin
440657|NCT01266213|tamoxifen|tamoxifen
440658|NCT01266213|premenopausal|premenopausal
440659|NCT01266213|hormone receptor positive|hormone receptor positive
440660|NCT01266200|microcirculation|microcirculation
440661|NCT01266200|vertebral fracture|vertebral fracture
440662|NCT01266200|inflammation|inflammation
440663|NCT01266200|minimal-invasive surgery|minimal-invasive surgery
440664|NCT01266187|FOLFOX|folfox
440665|NCT01266187|liver metastasis|liver metastasis
440666|NCT01266187|cetuximab|cetuximab
440667|NCT01266174|CIAS|cias
440668|NCT01266174|Cognition|cognition
440669|NCT01266174|Schizophrenia|schizophrenia
440670|NCT01266174|Eltoprazine|eltoprazine
440671|NCT01266161|dental pain|dental pain
440672|NCT01266161|multiple dose|multiple dose
440673|NCT01266161|ibuprofen|ibuprofen
440674|NCT01266161|third molar extraction|third molar extraction
440675|NCT01266135|Interstitial Lung Disease|interstitial lung disease
440676|NCT01266135|Usual Interstitial Pneumonia|usual interstitial pneumonia
440677|NCT01266135|Fibrosis,|fibrosis,
440678|NCT01266135|Pulmonary Fibrosis,|pulmonary fibrosis,
440679|NCT01266135|Respiratory Disease,|respiratory disease,
440680|NCT01266135|Interstitial Lung Disease,|interstitial lung disease,
440681|NCT01266135|Biological Therapy,|biological therapy,
440682|NCT01266135|Therapeutic Uses,|therapeutic uses,
440683|NCT01266122|HIV|hiv
440684|NCT01266122|Psychosocial problems|psychosocial problems
440685|NCT01266122|MSM|msm
440686|NCT01266122|India|india
440687|NCT01266109|Substance Use|substance use
440688|NCT01266109|Delinquency|delinquency
440689|NCT01266109|Juvenile Drug Court|juvenile drug court
440690|NCT01266109|Contingency Management|contingency management
440691|NCT01266109|Family Engagement|family engagement
440692|NCT01266096|124I-cRGDY-PEG-dots|124i-crgdy-peg-dots
440693|NCT01266096|Pet scan|pet scan
440694|NCT01266096|10-155|10-155
440695|NCT01266096|melanoma|melanoma
440696|NCT01266096|brain|brain
440697|NCT01266083|MONTANIDE ISA 51|montanide isa 51
440698|NCT01266083|WT1 PEPTIDE SPECIFIC T CELLS|wt1 peptide specific t cells
440699|NCT01266083|vaccine|vaccine
440700|NCT01266083|10-143|10-143
440701|NCT01266070|VHL|vhl
440702|NCT01266070|Hemangioblastoma|hemangioblastoma
440703|NCT01266070|Tumor of the central nervous system|tumor of the central nervous system
440704|NCT01266070|TKI258|tki258
440705|NCT01266057|Advanced Malignancies|advanced malignancies
440706|NCT01266057|Metastatic cancers|metastatic cancers
440707|NCT01266057|Sirolimus|sirolimus
440708|NCT01266057|Hydroxychloroquine|hydroxychloroquine
440709|NCT01266057|Vorinostat|vorinostat
440710|NCT01266057|Plaquenil|plaquenil
440711|NCT01266057|Rapamune|rapamune
440712|NCT01266057|Saha|saha
440713|NCT01266057|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
440714|NCT01266057|MSK-390|msk-390
440715|NCT01266057|Zolinza|zolinza
440716|NCT01266044|Radiation-induced xerostomia|radiation-induced xerostomia
440717|NCT01266044|Acupuncture|acupuncture
440718|NCT01266044|Oropharyngeal cancer|oropharyngeal cancer
440719|NCT01266044|Radiation Therapy|radiation therapy
440720|NCT01266044|IMRT|imrt
440722|NCT01266031|Glioblastoma Multiforme|glioblastoma multiforme
440723|NCT01266018|small cell lung cancer|small cell lung cancer
440724|NCT01266018|SCLC|sclc
440725|NCT01266018|ADI-PEG 20|adi-peg 20
440726|NCT01266018|arginine deiminase pegylated|arginine deiminase pegylated
440727|NCT01266005|HBe Ag(-) Chronic Hepatitis B|hbe ag(-) chronic hepatitis b
440728|NCT01265992|Secondary hyperparathyroidism|secondary hyperparathyroidism
440729|NCT01265992|Mineral and Bone Disorder (CKD-MBD)|mineral and bone disorder (ckd-mbd)
440730|NCT01265992|Chronic Kidney Disease|chronic kidney disease
440731|NCT01265979|advanced|advanced
440732|NCT01265979|metastatic|metastatic
440733|NCT01265979|gastro-intestinal|gastro-intestinal
440734|NCT01265979|stromal|stromal
440735|NCT01265979|GIST|gist
440736|NCT01265979|regorafenib|regorafenib
440737|NCT01265966|Moderate Sedation|moderate sedation
440738|NCT01265966|Sedation, Deep|sedation, deep
440739|NCT01265953|cancer prevention|cancer prevention
440740|NCT01265953|isothiocyanate|isothiocyanate
440741|NCT01265953|sulforaphane|sulforaphane
440742|NCT01265940|bladder cancer|bladder cancer
440743|NCT01265940|urothelial cancer|urothelial cancer
440744|NCT01265940|metastatic urothelial cancer|metastatic urothelial cancer
440745|NCT01265940|advanced urothelial cancer|advanced urothelial cancer
440746|NCT01265927|Breast Cancer|breast cancer
440747|NCT01265927|Breast Tumors|breast tumors
440748|NCT01265927|Cancer of Breast|cancer of breast
440749|NCT01265927|Cancer of the Breast|cancer of the breast
440750|NCT01265927|Genes, HER-2|genes, her-2
440751|NCT01265927|Genes, HER2|genes, her2
440752|NCT01265901|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
440753|NCT01265901|First line|first line
440754|NCT01265901|Eligible for sunitinib|eligible for sunitinib
440755|NCT01265888|PAH|pah
440756|NCT01265888|PH IPF|ph ipf
440757|NCT01265875|Chronic Pancreatitis|chronic pancreatitis
440758|NCT01265862|Tracheal intubation|tracheal intubation
440759|NCT01265862|Supraglottic airway devices|supraglottic airway devices
440760|NCT01265862|Patients undergoing general anesthesia|patients undergoing general anesthesia
440761|NCT01265836|Dyslipidemia Treatment and Cardiovascular Outcomes|dyslipidemia treatment and cardiovascular outcomes
440762|NCT01265823|Humira|humira
440763|NCT01265823|Adalimumab|adalimumab
440764|NCT01265823|Plaque Psoriasis|plaque psoriasis
440765|NCT01265810|stomatitis|stomatitis
440766|NCT01265810|targeted therapy|targeted therapy
440767|NCT01265810|Caphosol|caphosol
440768|NCT01265810|mouthrinses|mouthrinses
440769|NCT01265771|Arrhythmia|arrhythmia
440770|NCT01265771|Children|children
440771|NCT01265758|Atrial fibrillation|atrial fibrillation
440772|NCT01265758|Cardiac arrhythmia|cardiac arrhythmia
440773|NCT01265758|ECG|ecg
440774|NCT01265758|Telemonitoring|telemonitoring
440775|NCT01265758|Telemetry|telemetry
440776|NCT01265758|Holter|holter
440777|NCT01265745|Phase I|phase i
440778|NCT01265732|Phase 1|phase 1
440779|NCT01265732|relative bioavailability|relative bioavailability
440780|NCT01265732|healthy volunteers|healthy volunteers
440781|NCT01265732|pharmacokinetics|pharmacokinetics
440782|NCT01265732|suspension|suspension
440783|NCT01265732|dispersion|dispersion
440784|NCT01265719|Prospective|prospective
440785|NCT01265719|non-interventional|non-interventional
440786|NCT01265719|longitudinal|longitudinal
440787|NCT01265719|cohort study|cohort study
440788|NCT01265706|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
440789|NCT01265680|Blood Transfusion|blood transfusion
440790|NCT01265680|Heart surgery|heart surgery
440791|NCT01265680|Erythropoietin|erythropoietin
440792|NCT01265680|HRE|hre
440793|NCT01265667|Psoriasis|psoriasis
440794|NCT01265667|Plaque psoriasis|plaque psoriasis
440795|NCT01265654|Advanced Breast Cancer|advanced breast cancer
440796|NCT01265654|Hormonal Treatment|hormonal treatment
440797|NCT01265615|chronic allograft nephropathy|chronic allograft nephropathy
440798|NCT01265615|stem-progenitor cells|stem-progenitor cells
440799|NCT01265615|cardiorenal syndrome|cardiorenal syndrome
440800|NCT01265615|calcitriol|calcitriol
440801|NCT01265615|paricalcitol|paricalcitol
440802|NCT01265615|cholecalciferol|cholecalciferol
440803|NCT01265615|cardiac repair|cardiac repair
440804|NCT01265615|renal repair|renal repair
440805|NCT01265602|Actinic Keratosis|actinic keratosis
440806|NCT01265602|AK|ak
440807|NCT01265602|NMSC|nmsc
440808|NCT01265589|RDS|rds
440809|NCT01265589|Infant, newborn|infant, newborn
440810|NCT01265589|Vitamin A|vitamin a
440811|NCT01265589|Surfactant|surfactant
440812|NCT01265563|silymarin|silymarin
440813|NCT01265563|glutathione|glutathione
440814|NCT01265563|diabetic nephropathies|diabetic nephropathies
440815|NCT01265563|oxidative stress|oxidative stress
440816|NCT01265563|N-acetylcysteine|n-acetylcysteine
440817|NCT01265563|protein tholation|protein tholation
440818|NCT01265537|Transplant|transplant
440819|NCT01265537|Tacrolimus|tacrolimus
440820|NCT01265537|Diabetes after transplant|diabetes after transplant
440821|NCT01265537|Acute rejection prevention|acute rejection prevention
440822|NCT01265537|New onset diabetes after transplant|new onset diabetes after transplant
440823|NCT01265511|Hepatitis C|hepatitis c
440824|NCT01265511|SCY-635|scy-635
440825|NCT01265511|Ribavirin|ribavirin
440826|NCT01265511|Interferon|interferon
440827|NCT01265498|Farnesoid X Receptor|farnesoid x receptor
440828|NCT01265498|FXR|fxr
440829|NCT01265498|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
440830|NCT01265498|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
440831|NCT01265498|NAFLD|nafld
440832|NCT01265498|NASH|nash
440833|NCT01265498|obeticholic acid|obeticholic acid
440834|NCT01265472|Translocator Protein|translocator protein
440835|NCT01265472|Basal Cell Carcinoma|basal cell carcinoma
440836|NCT01265472|Squamous Cell Carcinoma|squamous cell carcinoma
440837|NCT01265472|Malignancy|malignancy
440838|NCT01265446|Sore throat, upper respiratory tract infection, lozenge with lidocaine and cetylpyridinium chloride.|sore throat, upper respiratory tract infection, lozenge with lidocaine and cetylpyridinium chloride.
440839|NCT01265433|GM-CSF|gm-csf
440840|NCT01265433|MONTANIDE ISA 51|montanide isa 51
440841|NCT01265433|WT1 PEPTIDE SPECIFIC T CELLS|wt1 peptide specific t cells
440842|NCT01265433|Vaccine|vaccine
440843|NCT01265433|10-134|10-134
440844|NCT01265420|Dupuytren|dupuytren
440845|NCT01265420|Dupuytren's Disease|dupuytren's disease
440846|NCT01265407|Children|children
440847|NCT01265407|Hemoglobinopathies|hemoglobinopathies
440848|NCT01265407|Epidemiology|epidemiology
440849|NCT01265407|Malaria|malaria
440850|NCT01265394|Amyloid|amyloid
440851|NCT01265394|Magnetic resonance imaging|magnetic resonance imaging
440852|NCT01265394|Positron Emission Tomography|positron emission tomography
440853|NCT01265394|Standard uptake value ratios|standard uptake value ratios
440854|NCT01265394|Healthy Subjects|healthy subjects
440855|NCT01265381|Cohort|cohort
440856|NCT01265381|Radiation|radiation
440857|NCT01265381|Thyroid Cancer|thyroid cancer
440858|NCT01265368|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
440859|NCT01265368|Tumor Vaccine|tumor vaccine
440860|NCT01265368|Cell-based Therapy|cell-based therapy
440861|NCT01265342|Bronchial Spasm|bronchial spasm
440862|NCT01265342|Respiratory Tract Infections|respiratory tract infections
440863|NCT01265342|Viral wheezing|viral wheezing
440864|NCT01265342|Child, Preschool|child, preschool
440865|NCT01265342|Beclomethasone|beclomethasone
440866|NCT01265342|Italy|italy
440867|NCT01265342|Physicians, Primary Care|physicians, primary care
440868|NCT01265342|Pediatrics|pediatrics
440869|NCT01265316|Cardiac arrest, CPR, pediatric|cardiac arrest, cpr, pediatric
440870|NCT01265303|ablation, cardiac arrhythmia, atrial fibrillation, telemonitoring, telemetry|ablation, cardiac arrhythmia, atrial fibrillation, telemonitoring, telemetry
440871|NCT01265290|Cardiac arrhythmia|cardiac arrhythmia
440872|NCT01265290|Cardiogenic syncope|cardiogenic syncope
440873|NCT01265290|Pediatrics|pediatrics
440874|NCT01265290|Children|children
440875|NCT01265277|sudden infant death syndrome|sudden infant death syndrome
440876|NCT01265277|SIDS|sids
440877|NCT01265277|infant|infant
440878|NCT01265277|licensed day care|licensed day care
440879|NCT01265277|sleep patterns|sleep patterns
440880|NCT01265277|stress levels|stress levels
440881|NCT01265264|Gout|gout
440882|NCT01265264|hyperuricemia|hyperuricemia
440883|NCT01265264|arthritis|arthritis
440884|NCT01265264|joint diseases|joint diseases
440885|NCT01265264|allopurinol|allopurinol
440886|NCT01265251|Normal Pressure Hydrocephalus|normal pressure hydrocephalus
440887|NCT01265251|Neuropsychological Test|neuropsychological test
440888|NCT01265251|Assessment of cognitive disorders/dementia|assessment of cognitive disorders/dementia
440889|NCT01265251|Neuropsychological assessment|neuropsychological assessment
440890|NCT01265238|Spastic equinovarus foot|spastic equinovarus foot
440891|NCT01265238|Stroke|stroke
440892|NCT01265238|Neurotomy|neurotomy
440893|NCT01265238|Tendon surgery|tendon surgery
440894|NCT01265225|breast cancer stages 0-II|breast cancer stages 0-ii
440895|NCT01265199|AML|aml
440896|NCT01265186|Sedation|sedation
440897|NCT01265186|BIS|bis
440898|NCT01265186|aEEG|aeeg
440899|NCT01265186|Neonatal Pain and Sedation Scale|neonatal pain and sedation scale
440900|NCT01265186|neonate|neonate
440901|NCT01265186|newborn|newborn
440902|NCT01265173|SBP|sbp
440903|NCT01265173|liver cirrhosis|liver cirrhosis
440904|NCT01265173|antibiotics|antibiotics
440905|NCT01265134|the elders|the elders
440906|NCT01265134|falling|falling
440907|NCT01265134|loss balance|loss balance
440908|NCT01265121|Acromegaly|acromegaly
440909|NCT01265121|Insulin resistance|insulin resistance
440910|NCT01265121|Euglycemic Clamp|euglycemic clamp
440911|NCT01265121|Somatostatin analogues|somatostatin analogues
440912|NCT01265095|VRE|vre
440913|NCT01265069|Helicobacter pylori|helicobacter pylori
440914|NCT01265069|concomitant therapy|concomitant therapy
440915|NCT01265069|high dose dual therapy|high dose dual therapy
440916|NCT01265069|antibiotic resistance|antibiotic resistance
440917|NCT01265043|oral health|oral health
440918|NCT01265043|oral hygiene|oral hygiene
440919|NCT01265043|bacteria|bacteria
440920|NCT01265043|quality of life|quality of life
440921|NCT01265043|Clinical oral health in patients following acute stroke|clinical oral health in patients following acute stroke
440922|NCT01265043|Oral opportunistic pathogens in patients following acute stroke|oral opportunistic pathogens in patients following acute stroke
440923|NCT01265043|Oral health-related quality of life in patients following acute stroke|oral health-related quality of life in patients following acute stroke
440924|NCT01265030|Desmoid Tumor|desmoid tumor
440925|NCT01265030|Sirolimus|sirolimus
440926|NCT01265030|Surgically-Resectable Desmoid Tumor|surgically-resectable desmoid tumor
440927|NCT01265017|type 1 diabetes|type 1 diabetes
440928|NCT01265017|pregnancy|pregnancy
440929|NCT01265017|insulin requirement|insulin requirement
440930|NCT01265004|Functional outcome|functional outcome
440931|NCT01264991|Sham|sham
440932|NCT01264991|Meniscus tear|meniscus tear
440933|NCT01264991|Meniscectomy|meniscectomy
440934|NCT01264978|COPD|copd
440935|NCT01264978|Rehabilitation|rehabilitation
440936|NCT01264978|Neuromuscular stimulation|neuromuscular stimulation
440937|NCT01264978|Quadriceps muscle|quadriceps muscle
440938|NCT01264978|Magnetic stimulation|magnetic stimulation
440939|NCT01264965|Pain|pain
440940|NCT01264965|Analgesia|analgesia
440941|NCT01264965|Cognitive impairment|cognitive impairment
440942|NCT01264965|Randomized controlled trial|randomized controlled trial
440943|NCT01264965|Physical function|physical function
440944|NCT01264952|Liver metastases of colorectal cancer|liver metastases of colorectal cancer
440945|NCT01264952|Bleomycin|bleomycin
440946|NCT01264952|Electrochemotherapy|electrochemotherapy
440947|NCT01264900|Psychotherapy|psychotherapy
440948|NCT01264900|Cognitive Behavioral Therapy|cognitive behavioral therapy
440949|NCT01264900|Aggression|aggression
440950|NCT01264900|fMRI|fmri
440951|NCT01264900|Behavioral Intervention|behavioral intervention
440952|NCT01264887|analgesia|analgesia
440953|NCT01264887|analgesics|analgesics
440954|NCT01264887|chronic pain|chronic pain
440955|NCT01264887|tumour related pain|tumour related pain
440956|NCT01264887|chronic malignant tumor-related pain|chronic malignant tumor-related pain
440957|NCT01264861|Evaluate dopamine and serotonin activity in the brain at 3 doses of Safinamide|evaluate dopamine and serotonin activity in the brain at 3 doses of safinamide
440958|NCT01264848|multiple sclerosis|multiple sclerosis
440959|NCT01264848|venous insufficiency|venous insufficiency
440960|NCT01264822|Rabeprazole Sodium|rabeprazole sodium
440961|NCT01264822|Helicobacter pylori|helicobacter pylori
440962|NCT01264822|stomach neoplasms|stomach neoplasms
440963|NCT01264809|diabetes|diabetes
440964|NCT01264796|Korean American, type 2 diabetes, culturally tailored|korean american, type 2 diabetes, culturally tailored
440965|NCT01264770|Rheumatoid Arthritis|rheumatoid arthritis
440967|NCT01264770|fostamatinib|fostamatinib
440968|NCT01264757|pedometer|pedometer
440969|NCT01264757|accelerometer|accelerometer
440970|NCT01264757|moderate-to-vigorous physical activity|moderate-to-vigorous physical activity
440971|NCT01264757|adult|adult
440972|NCT01264757|randomized trial|randomized trial
440973|NCT01264744|Bladder cancer|bladder cancer
440974|NCT01264744|Chromosomal aberrations|chromosomal aberrations
440975|NCT01264744|FISH|fish
440976|NCT01264744|Urine sample|urine sample
440977|NCT01264731|melanoma|melanoma
440978|NCT01264731|peptide vaccine|peptide vaccine
440979|NCT01264731|aldara|aldara
440980|NCT01264731|imiquimod|imiquimod
440981|NCT01264731|immunotherapy|immunotherapy
440982|NCT01264718|minority health|minority health
440983|NCT01264718|child|child
440984|NCT01264718|Medicaid|medicaid
440985|NCT01264705|Cirrhosis|cirrhosis
440986|NCT01264705|GI Cancer|gi cancer
440987|NCT01264705|Hepatitis|hepatitis
440988|NCT01264705|Oncology|oncology
440989|NCT01264679|Iron deficiency anemia|iron deficiency anemia
440990|NCT01264679|Feraheme|feraheme
440991|NCT01264679|ferumoxytol|ferumoxytol
440992|NCT01264679|chronic kidney disease|chronic kidney disease
440993|NCT01264679|CKD|ckd
440994|NCT01264679|pediatric|pediatric
440995|NCT01264679|dialysis-dependent|dialysis-dependent
440996|NCT01264679|nondialysis-dependent|nondialysis-dependent
440997|NCT01264666|Chinese tea flavor liquor|chinese tea flavor liquor
440998|NCT01264666|postprandial|postprandial
440999|NCT01264666|uric acid|uric acid
441000|NCT01264666|high-sensitive C-reactive protein|high-sensitive c-reactive protein
441001|NCT01264653|cataract|cataract
441002|NCT01264640|Brain-derived neurotrophic factor (BDNF)|brain-derived neurotrophic factor (bdnf)
441003|NCT01264640|Platelets|platelets
441004|NCT01264640|Aspirin|aspirin
441005|NCT01264640|Clopidogrel|clopidogrel
441006|NCT01264627|Hypertension|hypertension
441007|NCT01264627|Blood pressure|blood pressure
441008|NCT01264627|Breathing|breathing
441009|NCT01264627|PetCO2|petco2
441010|NCT01264627|Stress|stress
441011|NCT01264614|exercise|exercise
441012|NCT01264614|neuropsychological|neuropsychological
441013|NCT01264614|dementia|dementia
441014|NCT01264614|Alzheimer's Disease|alzheimer's disease
441015|NCT01264614|mild cognitive impairment|mild cognitive impairment
441016|NCT01264614|strength|strength
441017|NCT01264614|MCI|mci
441018|NCT01264614|AD|ad
441019|NCT01264614|EEG|eeg
441020|NCT01264614|neurophysiological|neurophysiological
441021|NCT01264614|growth factor|growth factor
441022|NCT01264614|cognitive decline|cognitive decline
441023|NCT01264614|executive function|executive function
441024|NCT01264601|Anaphylaxis to Egg|anaphylaxis to egg
441025|NCT01264601|Severe Egg Allergy|severe egg allergy
441026|NCT01264575|spinal anesthesia|spinal anesthesia
441027|NCT01264575|intrathecal bupivacaine|intrathecal bupivacaine
441028|NCT01264575|epinephrine|epinephrine
441029|NCT01264575|ED50|ed50
441030|NCT01264575|ED95|ed95
441031|NCT01264562|chemotherapy, adjuvant|chemotherapy, adjuvant
441032|NCT01264562|adverse effects|adverse effects
441033|NCT01264562|breast neoplasms|breast neoplasms
441034|NCT01264562|cognition disorders|cognition disorders
441035|NCT01264562|Stress Disorders, post-traumatic|stress disorders, post-traumatic
441036|NCT01264562|cortisol|cortisol
441037|NCT01264549|ischemic stroke|ischemic stroke
441038|NCT01264549|stroke-associated infections|stroke-associated infections
441039|NCT01264549|biomarkers|biomarkers
441040|NCT01264549|PCT|pct
441041|NCT01264549|immune and infection parameters|immune and infection parameters
441042|NCT01264536|lactoferrin|lactoferrin
441043|NCT01264536|sepsis|sepsis
441044|NCT01264536|neonates|neonates
441045|NCT01264536|prevention|prevention
441046|NCT01264536|infections|infections
441047|NCT01264523|chrononutrition|chrononutrition
441048|NCT01264523|moderately high protein|moderately high protein
441049|NCT01264523|glycemic index|glycemic index
441050|NCT01264523|type-2 diabetes|type-2 diabetes
441051|NCT01264523|overweight|overweight
441052|NCT01264523|obesity|obesity
441053|NCT01264523|weight management|weight management
441054|NCT01264510|conductive hearing loss|conductive hearing loss
441055|NCT01264510|mixed hearing loss|mixed hearing loss
441056|NCT01264510|unilateral deafness|unilateral deafness
441057|NCT01264510|implanted with Baha|implanted with baha
441058|NCT01264510|conductive or mixed hearing loss implanted with a Baha or|conductive or mixed hearing loss implanted with a baha or
441059|NCT01264510|unilateral deafness implanted with a Baha|unilateral deafness implanted with a baha
441060|NCT01264484|Advantage|advantage
441061|NCT01264484|Non-interventional|non-interventional
441062|NCT01264484|Post market release study|post market release study
441063|NCT01264484|Germany|germany
441064|NCT01264484|Treated with Advantage prosthetic heart valve|treated with advantage prosthetic heart valve
441065|NCT01264471|Gulf War Syndrome|gulf war syndrome
441066|NCT01264471|Gulf War Illness|gulf war illness
441067|NCT01264471|Mitochondrial defects|mitochondrial defects
441068|NCT01264471|Mitochondrial disorders|mitochondrial disorders
441069|NCT01264471|Persian Gulf Syndrome|persian gulf syndrome
441070|NCT01264445|HIV|hiv
441071|NCT01264328|Head and neck cancer, panitumumab, TTCC-2009-03|head and neck cancer, panitumumab, ttcc-2009-03
441072|NCT01264315|Lenalidomide|lenalidomide
441073|NCT01264315|Tandem Autologous-Allogeneic Transplant|tandem autologous-allogeneic transplant
441074|NCT01264302|Bioequivalence|bioequivalence
441075|NCT01264302|Finasteride|finasteride
441076|NCT01264302|crossover|crossover
441077|NCT01264289|Bioequivalence|bioequivalence
441078|NCT01264289|Finasteride|finasteride
441079|NCT01264289|crossover|crossover
441080|NCT01264276|ROP|rop
441081|NCT01264276|Retinopathy of Prematurity|retinopathy of prematurity
441082|NCT01264276|Telemedicine|telemedicine
441083|NCT01264263|cIMT|cimt
441084|NCT01264263|hs CRP (C-reactive protein)|hs crp (c-reactive protein)
441085|NCT01264263|DM (Diabetic Mellitus)|dm (diabetic mellitus)
441086|NCT01264263|Korea|korea
441087|NCT01264263|Corelation between cIMT (carotid intima media thickness)|corelation between cimt (carotid intima media thickness)
441088|NCT01264263|Cardio Vascular risk in Diabetic Mellitus|cardio vascular risk in diabetic mellitus
441089|NCT01264250|Safety|safety
441090|NCT01264250|Tolerability|tolerability
441091|NCT01264250|pharmacokinetics|pharmacokinetics
441092|NCT01264250|drug metabolism|drug metabolism
441093|NCT01264237|Postherpetic neuralgia|postherpetic neuralgia
441094|NCT01264237|Neuropathic pain|neuropathic pain
441095|NCT01264237|Etoricoxib|etoricoxib
441096|NCT01264211|Efficacy of Diacerein|efficacy of diacerein
441097|NCT01264211|Safety of Diacerein|safety of diacerein
441098|NCT01264211|Carry-over effect of Diacerein|carry-over effect of diacerein
441099|NCT01264172|Functional outcome|functional outcome
441100|NCT01264172|Microcirculation|microcirculation
441101|NCT01264172|Inflammatory response|inflammatory response
441102|NCT01264159|Developing acute heart failure|developing acute heart failure
441103|NCT01264146|hyperbaric oxygen therapy|hyperbaric oxygen therapy
441104|NCT01264146|calcaneal fracture|calcaneal fracture
441105|NCT01264146|calcaneal plating|calcaneal plating
441106|NCT01264146|wound infection|wound infection
441107|NCT01264146|microcirculation|microcirculation
441108|NCT01264120|Obesity|obesity
441109|NCT01264120|Bariatric surgery|bariatric surgery
441110|NCT01264120|Health Psychology|health psychology
441111|NCT01264081|Lapatinib|lapatinib
441112|NCT01264081|Melanoma|melanoma
441113|NCT01264081|ERBB4 Mutation|erbb4 mutation
441114|NCT01264081|Malignant Melanoma|malignant melanoma
441115|NCT01264081|Skin Cancer|skin cancer
441116|NCT01264068|Suan-Tsao-Jen-Tang ,Jia-Wey-Shiau-Yau-San,metabolomics,menopause|suan-tsao-jen-tang ,jia-wey-shiau-yau-san,metabolomics,menopause
441217|NCT01263678|Coaching|coaching
441117|NCT01264055|Rare Diseases of Airways|rare diseases of airways
441118|NCT01264055|Bronchiectasis|bronchiectasis
441119|NCT01264055|Idiopathic Bronchiectasis|idiopathic bronchiectasis
441120|NCT01264055|Chronic Cough|chronic cough
441121|NCT01264055|Nontuberculous Mycobacteriam Infection|nontuberculous mycobacteriam infection
441122|NCT01264042|Iron Supplementation,|iron supplementation,
441123|NCT01264042|week 24 to 28 at study day|week 24 to 28 at study day
441124|NCT01264029|Well-Being|well-being
441125|NCT01264029|Tai Chi|tai chi
441126|NCT01264029|Obesity|obesity
441127|NCT01264029|Mindfulness|mindfulness
441128|NCT01264029|Meditation|meditation
441129|NCT01264029|Overweight|overweight
441130|NCT01264003|inguinal hernia, antibiotic, prophylaxis|inguinal hernia, antibiotic, prophylaxis
441131|NCT01263990|hemodynamic monitoring systems|hemodynamic monitoring systems
441132|NCT01263990|stroke volume|stroke volume
441133|NCT01263977|septic shock|septic shock
441134|NCT01263977|goal directed volume therapy|goal directed volume therapy
441135|NCT01263977|outcome|outcome
441136|NCT01263964|ischemic stroke|ischemic stroke
441137|NCT01263964|troponin elevation|troponin elevation
441138|NCT01263964|transient apical ballooning|transient apical ballooning
441139|NCT01263964|acute coronary syndrome|acute coronary syndrome
441140|NCT01263964|troponin elevation,|troponin elevation,
441141|NCT01263964|culprit lesion on coronary angiogram,|culprit lesion on coronary angiogram,
441142|NCT01263964|troponin elevation and stroke localisation (temporal lobe?)|troponin elevation and stroke localisation (temporal lobe?)
441143|NCT01263951|Differentiated metastatic thyroid cancer|differentiated metastatic thyroid cancer
441145|NCT01263938|monocytes|monocytes
441146|NCT01263938|CD16+|cd16+
441147|NCT01263938|statins|statins
441148|NCT01263938|mcp1|mcp1
441149|NCT01263938|inflammation|inflammation
441150|NCT01263925|Alprostadil|alprostadil
441151|NCT01263925|Prostaglandin E1|prostaglandin e1
441152|NCT01263925|Prostavasin®|prostavasin®
441153|NCT01263925|PAOD|paod
441154|NCT01263912|Polyunsaturated fatty acids|polyunsaturated fatty acids
441155|NCT01263912|Cognitive development|cognitive development
441156|NCT01263912|Growth|growth
441157|NCT01263912|Infection|infection
441158|NCT01263899|Lymphoid malignancies|lymphoid malignancies
441159|NCT01263899|Hodgkin lymphoma|hodgkin lymphoma
441160|NCT01263899|Mantle Cell Lymphoma|mantle cell lymphoma
441161|NCT01263899|Indolent Lymphoma|indolent lymphoma
441162|NCT01263899|SB1518|sb1518
441163|NCT01263847|Dietary Supplement: Galactooligosaccharide|dietary supplement: galactooligosaccharide
441164|NCT01263834|Trabeculectomy|trabeculectomy
441165|NCT01263834|bevacizumab|bevacizumab
441166|NCT01263834|intraocular pressure|intraocular pressure
441167|NCT01263821|glioma|glioma
441168|NCT01263821|biologic imaging|biologic imaging
441169|NCT01263821|magnetic resonance spectroscopy|magnetic resonance spectroscopy
441170|NCT01263821|magnetic resonance imaging|magnetic resonance imaging
441171|NCT01263821|perfusion imaging|perfusion imaging
441172|NCT01263821|diffusion imaging|diffusion imaging
441173|NCT01263821|functional magnetic resonance imaging|functional magnetic resonance imaging
441174|NCT01263821|radiation therapy|radiation therapy
441175|NCT01263821|intensity modulated radiation therapy|intensity modulated radiation therapy
441176|NCT01263808|Indacaterol|indacaterol
441177|NCT01263808|Moxifloxacin|moxifloxacin
441178|NCT01263782|Non-Small Cell Lung Cancer|non-small cell lung cancer
441179|NCT01263782|NSCLL|nscll
441180|NCT01263782|Nonsquamous cell|nonsquamous cell
441181|NCT01263782|Metastatic disease|metastatic disease
441182|NCT01263782|Cixutumumab|cixutumumab
441183|NCT01263782|IMC-A12|imc-a12
441184|NCT01263782|Carboplatin|carboplatin
441185|NCT01263782|Paraplatin|paraplatin
441186|NCT01263782|Pemetrexed|pemetrexed
441187|NCT01263782|LY231514|ly231514
441188|NCT01263782|Alimta|alimta
441189|NCT01263782|MTA|mta
441190|NCT01263782|Multitargeted Antifolate|multitargeted antifolate
441191|NCT01263782|NSC-698037|nsc-698037
441192|NCT01263782|Bevacizumab|bevacizumab
441193|NCT01263782|Avastin|avastin
441194|NCT01263782|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
441195|NCT01263782|rhuMAb-VEGF|rhumab-vegf
441196|NCT01263769|Locally advanced clear cell renal cell carcinoma|locally advanced clear cell renal cell carcinoma
441197|NCT01263769|AG-013736|ag-013736
441198|NCT01263769|Axitinib|axitinib
441199|NCT01263769|Radical nephrectomy|radical nephrectomy
441200|NCT01263756|Driving|driving
441201|NCT01263756|Autism Spectrum Disorders|autism spectrum disorders
441202|NCT01263756|ASD|asd
441203|NCT01263756|Attention Deficits|attention deficits
441204|NCT01263756|Adults|adults
441205|NCT01263756|Adolescents|adolescents
441206|NCT01263756|Pervasive Developmental Disorders|pervasive developmental disorders
441207|NCT01263743|Stage 1 hypertension|stage 1 hypertension
441208|NCT01263717|HIV|hiv
441209|NCT01263717|lipodystrophy|lipodystrophy
441210|NCT01263717|tesamorelin|tesamorelin
441211|NCT01263717|Egrifta|egrifta
441212|NCT01263717|growth hormone releasing hormone|growth hormone releasing hormone
441213|NCT01263691|AVA|ava
441214|NCT01263691|AV7909|av7909
441215|NCT01263691|Anthrax vaccine|anthrax vaccine
441216|NCT01263678|Decisional Conflict|decisional conflict
441218|NCT01263678|Decisional Regret|decisional regret
441219|NCT01263665|stent-graft|stent-graft
441220|NCT01263665|superficial femoral artery|superficial femoral artery
441221|NCT01263665|SFA|sfa
441222|NCT01263665|peripheral artery disease|peripheral artery disease
441223|NCT01263665|PAD|pad
441224|NCT01263652|Pain|pain
441225|NCT01263652|intramuscular|intramuscular
441226|NCT01263652|oral|oral
441227|NCT01263652|spine|spine
441228|NCT01263652|preference|preference
441229|NCT01263639|patient satisfaction|patient satisfaction
441230|NCT01263639|patient-physician relationship|patient-physician relationship
441231|NCT01263639|orthopaedic trauma|orthopaedic trauma
441232|NCT01263626|Cough|cough
441233|NCT01263626|Chronic Cough|chronic cough
441234|NCT01263626|Reflux|reflux
441235|NCT01263600|Hepatitis B|hepatitis b
441236|NCT01263600|HBV|hbv
441237|NCT01263600|Pediatric|pediatric
441238|NCT01263587|Hepatitis B|hepatitis b
441239|NCT01263587|HBV|hbv
441240|NCT01263587|Cohort Study|cohort study
441241|NCT01263574|Catheter related infections prevention/control|catheter related infections prevention/control
441242|NCT01263574|Anti infective agents|anti infective agents
441243|NCT01263574|Catheter related infections prevention|catheter related infections prevention
441244|NCT01263561|glaucoma|glaucoma
441245|NCT01263561|filtration surgery|filtration surgery
441246|NCT01263561|trabeculectomy|trabeculectomy
441247|NCT01263561|ExPRESS shunt|express shunt
441248|NCT01263522|primary prevention|primary prevention
441249|NCT01263522|endurance|endurance
441250|NCT01263522|cardiovascular risk factors|cardiovascular risk factors
441251|NCT01263522|training|training
441252|NCT01263522|exercise|exercise
441253|NCT01263522|non-responder|non-responder
441254|NCT01263509|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
441255|NCT01263509|Diabetes Mellitus|diabetes mellitus
441256|NCT01263509|Drug Therapy|drug therapy
441257|NCT01263496|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
441258|NCT01263496|Diabetes Mellitus|diabetes mellitus
441259|NCT01263496|Drug Therapy|drug therapy
441260|NCT01263483|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
441261|NCT01263483|Diabetes Mellitus|diabetes mellitus
441262|NCT01263483|Drug Therapy|drug therapy
441263|NCT01263470|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
441264|NCT01263470|Diabetes Mellitus|diabetes mellitus
441265|NCT01263470|Drug Therapy|drug therapy
441266|NCT01263457|Growth disorders|growth disorders
441267|NCT01263457|Saizen|saizen
441268|NCT01263457|EasypodTM|easypodtm
441269|NCT01263457|Growth hormone|growth hormone
441270|NCT01263457|Pediatric subject|pediatric subject
441271|NCT01263444|AZARGA®|azarga®
441272|NCT01263444|Open angle glaucoma|open angle glaucoma
441273|NCT01263444|Prostaglandin Therapy|prostaglandin therapy
441274|NCT01263431|Hemorrhoidectomy, haemorrhoidal dearterialisation, anopexy|hemorrhoidectomy, haemorrhoidal dearterialisation, anopexy
441275|NCT01263418|Follicular Lymphoma|follicular lymphoma
441276|NCT01263418|Marginal Zone Lymphoma|marginal zone lymphoma
441277|NCT01263418|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
441278|NCT01263418|Elderly|elderly
441279|NCT01263418|Newly Diagnosed|newly diagnosed
441280|NCT01263418|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
441281|NCT01263418|University of North Carolina|university of north carolina
441282|NCT01263418|Ofatumumab|ofatumumab
441283|NCT01263418|Arzerra|arzerra
441284|NCT01263418|Phase 2|phase 2
441285|NCT01263418|Geriatric|geriatric
441286|NCT01263418|Lymphoma|lymphoma
441287|NCT01263405|Sarcoma|sarcoma
441288|NCT01263392|Neurogenic bladder|neurogenic bladder
441289|NCT01263392|Spina bifida|spina bifida
441290|NCT01263392|Intermittent catheterization|intermittent catheterization
441291|NCT01263392|Urinary tract infections|urinary tract infections
441292|NCT01263379|gene transfer|gene transfer
441293|NCT01263366|Radiodermatitis|radiodermatitis
441294|NCT01263366|Prevention|prevention
441295|NCT01263366|Radiotherapy|radiotherapy
441296|NCT01263366|Breast|breast
441297|NCT01263366|Radiation Dermatitis|radiation dermatitis
441298|NCT01263353|Carcinoid tumor,|carcinoid tumor,
441299|NCT01263353|Gastroenteropancreatic Neuroendocrine Tumors,|gastroenteropancreatic neuroendocrine tumors,
441300|NCT01263353|Pulmonary Neuroendocrine Tumors,|pulmonary neuroendocrine tumors,
441301|NCT01263353|pasireotide LAR,|pasireotide lar,
441302|NCT01263353|SOM230 LAR,|som230 lar,
441303|NCT01263353|everolimus,|everolimus,
441304|NCT01263353|RAD001,|rad001,
441305|NCT01263353|Advanced Neuroendocrine Tumor,|advanced neuroendocrine tumor,
441306|NCT01263353|Gastroenteropancreatic System|gastroenteropancreatic system
441307|NCT01263340|COPD|copd
441308|NCT01263340|observational study|observational study
441309|NCT01263340|prevalence|prevalence
441310|NCT01263340|characterisation|characterisation
441311|NCT01263327|human papillomavirus vaccine|human papillomavirus vaccine
441312|NCT01263314|Hypertension|hypertension
441313|NCT01263301|subclavian steal|subclavian steal
441314|NCT01263301|carotid duplex|carotid duplex
441315|NCT01263301|subclavian stenosis|subclavian stenosis
441316|NCT01263301|hemodialysis with vascular access in the upper limbs|hemodialysis with vascular access in the upper limbs
441317|NCT01263301|the focus of this study is to see if duplex can be used as an tool to differentiate the different causes of subclavian steal syndromes|the focus of this study is to see if duplex can be used as an tool to differentiate the different causes of subclavian steal syndromes
441318|NCT01263275|depression|depression
441319|NCT01263275|direct current stimulation|direct current stimulation
441320|NCT01263275|alternative electrode montage|alternative electrode montage
441321|NCT01263262|Surgical site infection|surgical site infection
441322|NCT01263262|Corneal toxicity|corneal toxicity
441323|NCT01263262|Ototoxicity|ototoxicity
441324|NCT01263262|Povidone-iodine|povidone-iodine
441325|NCT01263262|Chlorhexidine-alcohol|chlorhexidine-alcohol
441326|NCT01263249|Femoral|femoral
441327|NCT01263249|Nerve Block|nerve block
441328|NCT01263249|Anterior|anterior
441329|NCT01263249|Posterior|posterior
441330|NCT01263249|Continuous Infusion|continuous infusion
441331|NCT01263249|Perineural Catheter|perineural catheter
441332|NCT01263249|Volunteer|volunteer
441333|NCT01263249|Lower Extremity Nerve Blocks|lower extremity nerve blocks
441334|NCT01263236|Depression|depression
441335|NCT01263210|Recurrent acute otitis media|recurrent acute otitis media
441336|NCT01263210|Conjugate pneumococcal vaccine|conjugate pneumococcal vaccine
441337|NCT01263210|Ventilation tube treatment|ventilation tube treatment
441338|NCT01263210|Nasopharyngeal flora|nasopharyngeal flora
441339|NCT01263184|shoulder|shoulder
441340|NCT01263184|strength|strength
441341|NCT01263184|quality of life|quality of life
441342|NCT01263171|adenocarcinoma of the rectum|adenocarcinoma of the rectum
441343|NCT01263171|stage IIIB rectal cancer|stage iiib rectal cancer
441344|NCT01263171|stage IIIC rectal cancer|stage iiic rectal cancer
441345|NCT01263158|randomised controlled trial|randomised controlled trial
441346|NCT01263158|nulliparous women|nulliparous women
441347|NCT01263158|slow labour progress|slow labour progress
441348|NCT01263158|prolonged labour|prolonged labour
441349|NCT01263158|oxytocin augmentation|oxytocin augmentation
441350|NCT01263158|operative delivery|operative delivery
441351|NCT01263158|childbirth experience|childbirth experience
441352|NCT01263132|Polyneuropathy|polyneuropathy
441353|NCT01263132|Diabetes Mellitus|diabetes mellitus
441354|NCT01263132|Diabetic peripheral neuropathy|diabetic peripheral neuropathy
441355|NCT01263080|mirtazapine|mirtazapine
441356|NCT01263080|folic acid|folic acid
441357|NCT01263080|schizophrenia|schizophrenia
441358|NCT01263067|Posttraumatic Stress Disorder|posttraumatic stress disorder
441359|NCT01263067|PTSD|ptsd
441360|NCT01263067|Car Accident|car accident
441361|NCT01263067|Auto Accident|auto accident
441362|NCT01263067|Lifespan Integration|lifespan integration
441363|NCT01263054|Back Pain|back pain
441364|NCT01263054|Low Back Pain|low back pain
441365|NCT01263054|Discogenic Back Pain|discogenic back pain
441366|NCT01263041|Glutamine, NEC, L-arginine,Preterm,Sepsis|glutamine, nec, l-arginine,preterm,sepsis
441367|NCT01263015|GSK1349572|gsk1349572
441368|NCT01263015|Abacavir/Lamivudine|abacavir/lamivudine
441369|NCT01263015|Treatment-naive|treatment-naive
441370|NCT01263015|HIV Infection|hiv infection
441371|NCT01263015|Dolutegravir|dolutegravir
441372|NCT01263015|integrase inhibitor|integrase inhibitor
441373|NCT01263015|Atripla|atripla
441374|NCT01262989|Bioequivalence|bioequivalence
441375|NCT01262989|Tamsulosin|tamsulosin
441376|NCT01262989|Healthy volunteers|healthy volunteers
441377|NCT01262989|Fast conditions|fast conditions
441378|NCT01262976|Tuberculosis vaccine|tuberculosis vaccine
441379|NCT01262963|GSK2118436|gsk2118436
441380|NCT01262963|BRAF inhibitor|braf inhibitor
441381|NCT01262963|BRAF positive tumor|braf positive tumor
441382|NCT01262963|ADME|adme
441383|NCT01262963|Oncology|oncology
441384|NCT01262937|confocal, biliary, esophagus|confocal, biliary, esophagus
441385|NCT01262924|Booster vaccination|booster vaccination
441386|NCT01262898|tolerability|tolerability
441387|NCT01262898|pharmacokinetics|pharmacokinetics
441388|NCT01262898|13 C oral breath test|13 c oral breath test
441389|NCT01262898|Type I and II Diabetes mellitus|type i and ii diabetes mellitus
441390|NCT01262898|gastroparesis|gastroparesis
441391|NCT01262898|gut motility|gut motility
441392|NCT01262898|phase II|phase ii
441393|NCT01262898|pharmacodynamics|pharmacodynamics
441394|NCT01262898|repeat dose|repeat dose
441395|NCT01262898|gastric emptying|gastric emptying
441396|NCT01262898|symptoms|symptoms
441397|NCT01262898|GSK962040|gsk962040
441398|NCT01262885|pharmacokinetics|pharmacokinetics
441399|NCT01262885|tolerability|tolerability
441400|NCT01262885|single dose|single dose
441401|NCT01262885|antibiotics|antibiotics
441402|NCT01262885|repeat dose|repeat dose
441403|NCT01262885|GSK2251052|gsk2251052
441404|NCT01262885|safety|safety
441405|NCT01262872|Haemophilus influenzae|haemophilus influenzae
441406|NCT01262872|Streptococcus pneumoniae|streptococcus pneumoniae
441407|NCT01262872|The Gambia|the gambia
441408|NCT01262872|immunogenicity|immunogenicity
441409|NCT01262872|nasopharyngeal carriage|nasopharyngeal carriage
441410|NCT01262872|infants|infants
441411|NCT01262872|safety|safety
441412|NCT01262872|Pneumococcal vaccine|pneumococcal vaccine
441413|NCT01262872|children|children
441414|NCT01262846|HIV|hiv
441415|NCT01262846|Flu vaccination|flu vaccination
441416|NCT01262846|HIV infected individuals|hiv infected individuals
441417|NCT01262846|Fluzone SD|fluzone sd
441418|NCT01262846|Fluzone HD|fluzone hd
441419|NCT01262820|Pazopanib|pazopanib
441420|NCT01262820|Non Squamous Non Small Cell Lung Cancer|non squamous non small cell lung cancer
441421|NCT01262820|After Progress on first line therapy|after progress on first line therapy
441422|NCT01262820|Using Bevacizumab|using bevacizumab
441423|NCT01262807|fracture|fracture
441424|NCT01262807|radius|radius
441425|NCT01262807|adult|adult
441426|NCT01262807|range of motion|range of motion
441427|NCT01262794|Healthy volunteers|healthy volunteers
441428|NCT01262794|Japanese|japanese
441429|NCT01262781|neonatal adiposity|neonatal adiposity
441430|NCT01262781|metabolic syndrome|metabolic syndrome
441431|NCT01262781|fructose|fructose
441432|NCT01262781|maternal diet|maternal diet
441433|NCT01262768|Nutrition|nutrition
441434|NCT01262768|Obesity|obesity
441435|NCT01262768|Parent|parent
441436|NCT01262768|Portion Size Estimation|portion size estimation
441437|NCT01262768|Accuracy|accuracy
441438|NCT01262755|GERD|gerd
441439|NCT01262755|IBS|ibs
441440|NCT01262755|Minority|minority
441441|NCT01262742|pregnancy|pregnancy
441442|NCT01262742|postpartum hemorrhage|postpartum hemorrhage
441443|NCT01262742|Cesarean delivery|cesarean delivery
441444|NCT01262742|carbetocin|carbetocin
441445|NCT01262729|xenon inhalation|xenon inhalation
441446|NCT01262729|therapeutical hypothermia|therapeutical hypothermia
441447|NCT01262729|patients after cardiopulmonary resuscitation|patients after cardiopulmonary resuscitation
441448|NCT01262729|efficacy|efficacy
441449|NCT01262729|safety|safety
441450|NCT01262716|Chest wall progression breast cancer|chest wall progression breast cancer
441451|NCT01262716|PDT|pdt
441452|NCT01262716|Photofrin|photofrin
441453|NCT01262716|Photosensitizer|photosensitizer
441454|NCT01262690|First-in-human (FIH)|first-in-human (fih)
441455|NCT01262690|Single Ascending Dose (SAD) Study|single ascending dose (sad) study
441456|NCT01262690|TAM-163|tam-163
441457|NCT01262690|PF-05230901|pf-05230901
441458|NCT01262690|Cachexia|cachexia
441459|NCT01262677|Partial epilepsy|partial epilepsy
441460|NCT01262677|partial seizures|partial seizures
441461|NCT01262677|epilepsy|epilepsy
441462|NCT01262677|seizures|seizures
441463|NCT01262677|adjunctive therapy|adjunctive therapy
441464|NCT01262677|intervention|intervention
441465|NCT01262677|controlled-release|controlled-release
441466|NCT01262677|placebo-controlled|placebo-controlled
441467|NCT01262677|seizure|seizure
441468|NCT01262664|Advanced prostate cancer|advanced prostate cancer
441469|NCT01262664|Castrate-Resistant Prostate Cancer|castrate-resistant prostate cancer
441470|NCT01262664|Prohibitin-TP01|prohibitin-tp01
441471|NCT01262651|Cancer pain|cancer pain
441472|NCT01262651|Opioid therapy|opioid therapy
441473|NCT01262651|Inadequate analgesia|inadequate analgesia
441474|NCT01262651|Optimized chronic opioid therapy|optimized chronic opioid therapy
441475|NCT01262625|stable angina|stable angina
441476|NCT01262625|recurrent chest pain|recurrent chest pain
441477|NCT01262625|chest pain|chest pain
441478|NCT01262625|angina equivalent|angina equivalent
441479|NCT01262625|diagnosis|diagnosis
441480|NCT01262625|coronary artery disease|coronary artery disease
441481|NCT01262612|cediranib|cediranib
441482|NCT01262612|malignant ascites|malignant ascites
441483|NCT01262612|malignant pleural effusion|malignant pleural effusion
441484|NCT01262599|Breast and abdomen morbidities after TRAM flap surgery|breast and abdomen morbidities after tram flap surgery
441485|NCT01262599|TRAM flap surgery|tram flap surgery
441486|NCT01262599|Post-mastectomy breast reconstructive surgery|post-mastectomy breast reconstructive surgery
441487|NCT01262586|Type II Diabetes Mellitus|type ii diabetes mellitus
441488|NCT01262586|Vildagliptin|vildagliptin
441489|NCT01262586|Glimepiride|glimepiride
441490|NCT01262586|Continuous glucose monitoring|continuous glucose monitoring
441491|NCT01262560|pain|pain
441492|NCT01262560|dysphagia|dysphagia
441493|NCT01262560|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
441494|NCT01262560|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
441495|NCT01262560|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
441496|NCT01262560|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
441497|NCT01262560|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
441498|NCT01262560|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
441499|NCT01262560|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
441500|NCT01262560|extensive stage small cell lung cancer|extensive stage small cell lung cancer
441501|NCT01262560|limited stage small cell lung cancer|limited stage small cell lung cancer
441502|NCT01262560|recurrent small cell lung cancer|recurrent small cell lung cancer
441503|NCT01262560|esophagitis|esophagitis
441504|NCT01262534|Psoriasis|psoriasis
441505|NCT01262534|comorbidities, associated treatment, quality of life|comorbidities, associated treatment, quality of life
441506|NCT01262521|Dietary nitrate|dietary nitrate
441507|NCT01262508|autonomic nervous system|autonomic nervous system
441508|NCT01262482|adenocarcinoma|adenocarcinoma
441509|NCT01262482|gastric|gastric
441510|NCT01262482|gastroesophageal junction|gastroesophageal junction
441511|NCT01262482|Relapsed|relapsed
441512|NCT01262482|sorafenib|sorafenib
441513|NCT01262482|oxaliplatin|oxaliplatin
441514|NCT01262443|Atrial flutter|atrial flutter
441515|NCT01262430|Osteoarthritis|osteoarthritis
441516|NCT01262417|colorectal cancer|colorectal cancer
441517|NCT01262417|two stage surgery for the resection of hepatic metastases|two stage surgery for the resection of hepatic metastases
441518|NCT01262417|resorbable barrier membrane|resorbable barrier membrane
441519|NCT01262417|abdominal and peri-hepatic adhesion|abdominal and peri-hepatic adhesion
441520|NCT01262391|Overactive bladder|overactive bladder
441521|NCT01262391|Pediatric|pediatric
441522|NCT01262391|Pharmacokinetics|pharmacokinetics
441523|NCT01262391|Single-dose|single-dose
441524|NCT01262391|Solifenacin suspension|solifenacin suspension
441525|NCT01262365|Lupus|lupus
441526|NCT01262365|Monoclonal antibody|monoclonal antibody
441527|NCT01262365|B-Cell immunotherapy|b-cell immunotherapy
441528|NCT01262365|Epratuzumab|epratuzumab
441529|NCT01262339|Primary focal hyperhidrosis|primary focal hyperhidrosis
441530|NCT01262339|interdermal injections|interdermal injections
441531|NCT01262339|iontophoresis|iontophoresis
441532|NCT01262339|BTX-A|btx-a
441533|NCT01262300|Immunosenescence|immunosenescence
441534|NCT01262300|Shingles|shingles
441535|NCT01262300|Vitamin D|vitamin d
441536|NCT01262300|Varicella Zoster Virus|varicella zoster virus
441537|NCT01262300|Vaccine|vaccine
441538|NCT01262300|Immune Response|immune response
441539|NCT01262300|Geriatrics|geriatrics
441540|NCT01262287|Randomized Trial|randomized trial
441541|NCT01262287|Medication for Heavy Drinking|medication for heavy drinking
441542|NCT01262287|Dutasteride Treatment|dutasteride treatment
441543|NCT01262261|opioid dependence|opioid dependence
441544|NCT01262261|opioid addiction|opioid addiction
441545|NCT01262261|buprenorphine|buprenorphine
441546|NCT01262261|implant|implant
441547|NCT01262261|methadone|methadone
441548|NCT01262261|heroin|heroin
441549|NCT01262261|suboxone|suboxone
441550|NCT01262261|opioid pain medication|opioid pain medication
441551|NCT01262261|opioid withdrawal|opioid withdrawal
441552|NCT01262248|small colorectal polyps|small colorectal polyps
441553|NCT01262248|narrow band imaging|narrow band imaging
441554|NCT01262248|vascularization|vascularization
441555|NCT01262248|computer-based classification|computer-based classification
441556|NCT01262235|Solid tumor|solid tumor
441557|NCT01262235|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
441558|NCT01262235|Hodgkin's Disease|hodgkin's disease
441559|NCT01262235|Neuroendocrine tumors (NET)|neuroendocrine tumors (net)
441560|NCT01262235|Adrenocortical carcinoma (ACC)|adrenocortical carcinoma (acc)
441561|NCT01262235|Carcinoid|carcinoid
441562|NCT01262222|Predictive Value For Postoperative Cardiac Events|predictive value for postoperative cardiac events
441563|NCT01262222|Endothelial Dysfunction|endothelial dysfunction
441564|NCT01262222|10-206|10-206
441565|NCT01262209|Vision loss|vision loss
441566|NCT01262209|Chronic glaucoma|chronic glaucoma
441567|NCT01262209|Low vision rehabilitation|low vision rehabilitation
441568|NCT01262196|Trauma|trauma
441569|NCT01262196|Hemorrhage|hemorrhage
441570|NCT01262196|Hemorrhagic shock|hemorrhagic shock
441571|NCT01262196|Lactic acidosis|lactic acidosis
441572|NCT01262196|Oxygen carriers|oxygen carriers
441573|NCT01262196|Oxygen therapeutics|oxygen therapeutics
441574|NCT01262196|Hemoglobin solutions|hemoglobin solutions
441575|NCT01262196|Red cell substitutes|red cell substitutes
441576|NCT01262196|PEG-hemoglobin|peg-hemoglobin
441577|NCT01262183|oesophagus cancer|oesophagus cancer
441578|NCT01262183|chemoradiotherapy|chemoradiotherapy
441579|NCT01262183|panitumumab|panitumumab
441580|NCT01262183|irresectable|irresectable
441581|NCT01262170|dietary supplement|dietary supplement
441582|NCT01262170|nutraceutical|nutraceutical
441583|NCT01262157|Erectile dysfunction|erectile dysfunction
441584|NCT01262157|PDE5 Inhibitor|pde5 inhibitor
441585|NCT01262157|Low intensity shock wave therapy.|low intensity shock wave therapy.
441586|NCT01262144|Cervical Cancer|cervical cancer
441587|NCT01262144|PET CT|pet ct
441588|NCT01262144|SUV Max|suv max
441589|NCT01262131|Fibromyalgia|fibromyalgia
441590|NCT01262131|Pain associated with Fibromyalgia|pain associated with fibromyalgia
441591|NCT01262118|Cholesterol metabolism|cholesterol metabolism
441592|NCT01262118|Cholesterol flux|cholesterol flux
441593|NCT01262118|Rheumatoid Arthritis|rheumatoid arthritis
441594|NCT01262118|Tasocitinib|tasocitinib
441595|NCT01262118|CP-690|cp-690
441596|NCT01262118|550|550
441597|NCT01262105|CFU|cfu
441598|NCT01262105|surgery site|surgery site
441599|NCT01262092|opioid dependent|opioid dependent
441600|NCT01262092|detoxification|detoxification
441601|NCT01262092|buprenorphine|buprenorphine
441602|NCT01262092|suboxone|suboxone
441603|NCT01262092|opiate|opiate
441604|NCT01262079|influenza|influenza
441605|NCT01262079|healthy volunteer|healthy volunteer
441606|NCT01262079|immunity|immunity
441607|NCT01262079|antibody|antibody
441608|NCT01262079|blood sample|blood sample
441609|NCT01262066|hypertension|hypertension
441610|NCT01262066|stress reduction|stress reduction
441611|NCT01262053|Computerized Physician Order Entry|computerized physician order entry
441612|NCT01262053|CPOE|cpoe
441613|NCT01262053|Wrong Patient|wrong patient
441614|NCT01262053|Juxtaposition|juxtaposition
441615|NCT01262053|Patient Safety|patient safety
441616|NCT01262053|Medical Errors|medical errors
441617|NCT01262040|NBI|nbi
441618|NCT01262040|ENDOMETRIUM|endometrium
441619|NCT01262040|FALLOPIAN TUBE|fallopian tube
441620|NCT01262040|OVARY|ovary
441621|NCT01262040|PERITONEUM|peritoneum
441622|NCT01262040|Surgery|surgery
441623|NCT01262040|Lung|lung
441624|NCT01262040|Pancreatic|pancreatic
441625|NCT01262040|Esophageal|esophageal
441626|NCT01262040|thorascopic|thorascopic
441627|NCT01262040|laparoscopic|laparoscopic
441628|NCT01262040|robotic|robotic
441629|NCT01262040|10-180|10-180
441630|NCT01262027|Metastatic inflammatory breast cancer|metastatic inflammatory breast cancer
441631|NCT01262027|Stage IV disease|stage iv disease
441632|NCT01262027|HER2-negative|her2-negative
441633|NCT01262027|Dovitinib|dovitinib
441634|NCT01262027|TKI258|tki258
441635|NCT01262014|platinum|platinum
441636|NCT01262014|resistant|resistant
441637|NCT01262014|advanced|advanced
441638|NCT01262014|ovarian|ovarian
441639|NCT01262014|cancer|cancer
441640|NCT01261975|Ocular Surgery|ocular surgery
441641|NCT01261975|Intraocular Lens|intraocular lens
441642|NCT01261962|Humoral immunity|humoral immunity
441643|NCT01261962|Neutrophil function|neutrophil function
441644|NCT01261962|Gene expression|gene expression
441645|NCT01261949|Tinnitus|tinnitus
441646|NCT01261949|chronic subjective tinnitus|chronic subjective tinnitus
441647|NCT01261949|transcranial magnetic stimulation|transcranial magnetic stimulation
441648|NCT01261949|sensation disorders|sensation disorders
441649|NCT01261949|hearing disorders|hearing disorders
441650|NCT01261936|Menorrhagia|menorrhagia
441651|NCT01261936|Congenital Bleeding Disorders(CBDs)|congenital bleeding disorders(cbds)
441652|NCT01261936|Diagnosis and treatment of menorrhagia in CBDs|diagnosis and treatment of menorrhagia in cbds
441653|NCT01261897|Adductor-Canal-Blockade|adductor-canal-blockade
441654|NCT01261897|postoperative pain|postoperative pain
441655|NCT01261897|US-guided nerve block|us-guided nerve block
441656|NCT01261897|total knee arthroplasty|total knee arthroplasty
441657|NCT01261884|Pregnancy|pregnancy
441658|NCT01261884|Exercise|exercise
441659|NCT01261884|Hypertension|hypertension
441660|NCT01261884|Preeclampsia|preeclampsia
441661|NCT01261884|Resistance exercise|resistance exercise
441662|NCT01261858|Sternal closure|sternal closure
441663|NCT01261858|Coronary artery bypass grafting|coronary artery bypass grafting
441664|NCT01261858|Biologic bone cement|biologic bone cement
441665|NCT01261845|Delivery of Health Care|delivery of health care
441666|NCT01261845|Equity in Health Services|equity in health services
441667|NCT01261845|Ethnic Groups|ethnic groups
441668|NCT01261845|Health Services Research|health services research
441669|NCT01261845|Health Surveys|health surveys
441670|NCT01261845|Immigration|immigration
441671|NCT01261845|Referral and Consultation|referral and consultation
441672|NCT01261845|Resource Allocation|resource allocation
441673|NCT01261845|Social Justice|social justice
441674|NCT01261845|Vulnerable Populations|vulnerable populations
441675|NCT01261832|Acute Myocardial Infarction|acute myocardial infarction
441676|NCT01261832|Percutaneous coronary intervention|percutaneous coronary intervention
441677|NCT01261819|cystoscopy, minimally invasive hysterectomy|cystoscopy, minimally invasive hysterectomy
441678|NCT01261793|Lupus|lupus
441679|NCT01261793|Monoclonal antibody|monoclonal antibody
441680|NCT01261793|B-Cell immunotherapy|b-cell immunotherapy
441681|NCT01261793|Epratuzumab|epratuzumab
441682|NCT01261780|neuropathy,paraneoplastic|neuropathy,paraneoplastic
441683|NCT01261780|paraneoplastic peripheral neuropathy|paraneoplastic peripheral neuropathy
441684|NCT01261780|pain|pain
441685|NCT01261780|hyperalgesia|hyperalgesia
441686|NCT01261754|Metastatic Prostate Adenocarcinoma|metastatic prostate adenocarcinoma
441687|NCT01261728|Gemcitabine|gemcitabine
441688|NCT01261728|Cisplatin|cisplatin
441689|NCT01261728|Bladder|bladder
441690|NCT01261728|radical nephroureterectomy|radical nephroureterectomy
441691|NCT01261728|ureterectomy|ureterectomy
441692|NCT01261728|10-208|10-208
441693|NCT01261702|Magnesium sulphate|magnesium sulphate
441694|NCT01261702|Post Pulmonary Resection|post pulmonary resection
441695|NCT01261702|Pain|pain
441696|NCT01261689|Epidural analgesia|epidural analgesia
441697|NCT01261689|Instrumental delivery|instrumental delivery
441698|NCT01261689|Maternal outcome|maternal outcome
441699|NCT01261689|Neonatal outcome|neonatal outcome
441700|NCT01261676|caesarean section|caesarean section
441701|NCT01261676|labour, obstetric|labour, obstetric
441702|NCT01261676|implementation guidelines|implementation guidelines
441703|NCT01261676|quality indicators|quality indicators
441704|NCT01261650|widespread chronic pain, transcranial direct current stimulation, fibromyalgia|widespread chronic pain, transcranial direct current stimulation, fibromyalgia
441705|NCT01261637|cesarean, pain, transversus abdominus plane block|cesarean, pain, transversus abdominus plane block
441706|NCT01261624|poly JIA|poly jia
441707|NCT01261598|Positron-Emission Tomography|positron-emission tomography
441708|NCT01261598|PET Scan|pet scan
441709|NCT01261598|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
441710|NCT01261598|Radiation Oncology|radiation oncology
441711|NCT01261598|SUV|suv
441712|NCT01261585|Positron-Emission Tomography|positron-emission tomography
441713|NCT01261585|PET Scan|pet scan
441714|NCT01261585|FDG|fdg
441715|NCT01261585|FLT|flt
441716|NCT01261585|FMISO|fmiso
441717|NCT01261585|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
441718|NCT01261585|chemo-Radiation Oncology|chemo-radiation oncology
441719|NCT01261585|SUV|suv
441720|NCT01261572|ASP3550|asp3550
441721|NCT01261572|Degarelix|degarelix
441722|NCT01261572|Prostate cancer|prostate cancer
441723|NCT01261572|Prostatic neoplasms|prostatic neoplasms
441724|NCT01261559|Computed tomography|computed tomography
441725|NCT01261559|Radiation dose|radiation dose
441726|NCT01261559|Dose reduction|dose reduction
441727|NCT01261559|Breast displacement|breast displacement
441728|NCT01261559|Chrysalis device|chrysalis device
441729|NCT01261559|Image quality|image quality
441730|NCT01261546|pleural effusion, empyema, corticoids, dexamethasone|pleural effusion, empyema, corticoids, dexamethasone
441731|NCT01261533|vitreous body substitute|vitreous body substitute
441732|NCT01261533|foldable capsular vitreous body|foldable capsular vitreous body
441733|NCT01261507|lung neoplasm nodule image processing computer-assisted|lung neoplasm nodule image processing computer-assisted
441734|NCT01261494|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
441735|NCT01261494|Glucose Metabolism Disorders|glucose metabolism disorders
441736|NCT01261494|Metabolic Diseases|metabolic diseases
441737|NCT01261494|Cardiovascular Diseases|cardiovascular diseases
441738|NCT01261494|PPARs|ppars
441739|NCT01261494|OGTT|ogtt
441740|NCT01261481|Bioavailability|bioavailability
441741|NCT01261468|Chronic pain|chronic pain
441742|NCT01261468|Electric Stimulation Therapy|electric stimulation therapy
441743|NCT01261468|Neurologic Examination|neurologic examination
441744|NCT01261442|distal symmetric polyneuropathy|distal symmetric polyneuropathy
441745|NCT01261442|diabetic peripheral neuropathy|diabetic peripheral neuropathy
441746|NCT01261442|posterior tibial nerve|posterior tibial nerve
441747|NCT01261442|regional anesthesia|regional anesthesia
441748|NCT01261442|nerve conduction study|nerve conduction study
441749|NCT01261429|Pigmented villonodular synovitis|pigmented villonodular synovitis
441750|NCT01261429|tenosynovial giant cell tumour|tenosynovial giant cell tumour
441751|NCT01261429|nilotinib|nilotinib
441752|NCT01261416|seizures|seizures
441753|NCT01261416|epilepsy|epilepsy
441754|NCT01261416|neonatal|neonatal
441755|NCT01261416|levetiracetam|levetiracetam
441756|NCT01261403|Human Placenta-Derived Cells|human placenta-derived cells
441757|NCT01261390|Sleep Apnea|sleep apnea
441758|NCT01261390|Heart Disease|heart disease
441759|NCT01261390|Risk factors for heart disease|risk factors for heart disease
441760|NCT01261377|COPD, obstructive sleep apnea, OSA, BPAP, CPAP|copd, obstructive sleep apnea, osa, bpap, cpap
441761|NCT01261364|GeneSight|genesight
441762|NCT01261364|Assurex|assurex
441763|NCT01261364|AssureRx|assurerx
441764|NCT01261351|Pre eclampsia|pre eclampsia
441765|NCT01261351|Endogenous thrombin potential|endogenous thrombin potential
441766|NCT01261338|PCBs|pcbs
441767|NCT01261338|Olestra|olestra
441768|NCT01261325|Epilepsy|epilepsy
441769|NCT01261325|Brivaracetam|brivaracetam
441770|NCT01261325|Partial Onset Seizures|partial onset seizures
441771|NCT01261325|Adjunctive treatment|adjunctive treatment
441772|NCT01261312|SGI-110|sgi-110
441773|NCT01261312|DNA Hypomethylating Agent|dna hypomethylating agent
441774|NCT01261312|Intermediate 1, Intermediate 2, CMML or High Risk MDS|intermediate 1, intermediate 2, cmml or high risk mds
441775|NCT01261312|AML|aml
441776|NCT01261299|Phase 0 Clinical trial|phase 0 clinical trial
441777|NCT01261299|Human microdosing trial|human microdosing trial
441778|NCT01261299|Drug resistance, neoplasm|drug resistance, neoplasm
441779|NCT01261299|Carcinoma, Non-small cell lung|carcinoma, non-small cell lung
441780|NCT01261299|Urinary Bladder Neoplasm|urinary bladder neoplasm
441781|NCT01261299|Individualized Medicine|individualized medicine
441782|NCT01261299|Carboplatin|carboplatin
441783|NCT01261299|Carboplatin-DNA adducts|carboplatin-dna adducts
441784|NCT01261286|inflammation|inflammation
441785|NCT01261286|receptor downregulation|receptor downregulation
441786|NCT01261286|reduced response|reduced response
441787|NCT01261286|calcium channels|calcium channels
441788|NCT01261286|PK-PD relationship|pk-pd relationship
441789|NCT01261273|PCI|pci
441790|NCT01261273|observational registry|observational registry
441791|NCT01261260|uridine|uridine
441792|NCT01261260|gamma-amino butyric acid|gamma-amino butyric acid
441793|NCT01261260|Magnetic Resonance Imaging|magnetic resonance imaging
441794|NCT01261260|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
441795|NCT01261260|Proton Echo-Planar Spectroscopic Imaging|proton echo-planar spectroscopic imaging
441796|NCT01261234|Carotid Artery Disease|carotid artery disease
441797|NCT01261234|Carotid Artery Stenting|carotid artery stenting
441798|NCT01261234|In stent restenosis|in stent restenosis
441799|NCT01261234|Cardiovascular event|cardiovascular event
441800|NCT01261234|Intima Media Thickness|intima media thickness
441801|NCT01261208|HIV, AIDS, Helicobacter pylori|hiv, aids, helicobacter pylori
441802|NCT01261182|Malnutrition|malnutrition
441803|NCT01261182|School feeding|school feeding
441804|NCT01261182|Infant nutrition|infant nutrition
441805|NCT01261182|Mother's nutrition|mother's nutrition
441806|NCT01261182|Fortified food|fortified food
441807|NCT01261182|Anemia|anemia
441808|NCT01261182|Cluster randomized controlled trials|cluster randomized controlled trials
441809|NCT01261182|Effectiveness|effectiveness
441810|NCT01261182|Impact evaluation studies|impact evaluation studies
441811|NCT01261182|Uganda|uganda
441812|NCT01261169|Mycophenolate sodium (Myfortic®)|mycophenolate sodium (myfortic®)
441813|NCT01261169|Corticosteroid-refractory autoimmune Uveitis|corticosteroid-refractory autoimmune uveitis
441814|NCT01261130|Human Hookworm Vaccine Initiative|human hookworm vaccine initiative
441815|NCT01261130|HHVI|hhvi
441816|NCT01261130|Human Hookworm|human hookworm
441817|NCT01261130|Hookworm|hookworm
441818|NCT01261130|Hookworm Disease|hookworm disease
441819|NCT01261130|N. americanus|n. americanus
441820|NCT01261130|Soil-transmitted helminth infection|soil-transmitted helminth infection
441821|NCT01261130|Intestinal blood loss|intestinal blood loss
441822|NCT01261130|Iron deficiency anemia|iron deficiency anemia
441823|NCT01261117|Patent ductus arteriosis|patent ductus arteriosis
441824|NCT01261117|İbuprofen|ibuprofen
441825|NCT01261117|Extremely Low Birth Weigh infant|extremely low birth weigh infant
441826|NCT01261104|hearing loss|hearing loss
441827|NCT01261104|handicap|handicap
441828|NCT01261104|counseling|counseling
441829|NCT01261091|Neurocritical Care|neurocritical care
441830|NCT01261091|Ischemic Stroke|ischemic stroke
441831|NCT01261091|Intracerebral Hemorrhage|intracerebral hemorrhage
441832|NCT01261091|Subarachnoid Hemorrhage|subarachnoid hemorrhage
441833|NCT01261091|Tracheostomy|tracheostomy
441834|NCT01261091|Tracheotomy|tracheotomy
441835|NCT01261091|Percutaneous Dilatative Tracheostomy|percutaneous dilatative tracheostomy
441836|NCT01261091|Weaning|weaning
441837|NCT01261091|Ventilation|ventilation
441838|NCT01261078|intrathecal epinephrine|intrathecal epinephrine
441839|NCT01261078|duration of anesthesia|duration of anesthesia
441840|NCT01261078|quality of anesthesia|quality of anesthesia
441841|NCT01261078|intrathecal fentanyl|intrathecal fentanyl
441842|NCT01261065|beta blockers|beta blockers
441843|NCT01261065|heart failure|heart failure
441844|NCT01261065|contractility|contractility
441845|NCT01261065|remodeling|remodeling
441846|NCT01261052|glucose sensors|glucose sensors
441847|NCT01261052|artificial pancreas|artificial pancreas
441848|NCT01261052|Diabetes Mellitus|diabetes mellitus
441849|NCT01261013|Keratoconus|keratoconus
441850|NCT01261013|intrastromal corneal ring segment|intrastromal corneal ring segment
441851|NCT01261013|To evaluate the visual and refractive outcomes of intrastromal corneal ring segment in keratoconic eyes at different stages|to evaluate the visual and refractive outcomes of intrastromal corneal ring segment in keratoconic eyes at different stages
441852|NCT01261000|Acromegaly|acromegaly
441853|NCT01260987|Moderate to severe actinic keratoses|moderate to severe actinic keratoses
441854|NCT01260987|Difficult to treat nodular basal cell carcinomas|difficult to treat nodular basal cell carcinomas
441855|NCT01260974|Invasive fungal infections|invasive fungal infections
441856|NCT01260974|Liver Transplantation|liver transplantation
441857|NCT01260974|Organ Transplantation|organ transplantation
441858|NCT01260974|Mycoses|mycoses
441859|NCT01260974|Fungus Diseases|fungus diseases
441860|NCT01260974|Antifungal Agents|antifungal agents
441861|NCT01260974|Invasive Mycosis|invasive mycosis
441862|NCT01260948|Bioequivalence|bioequivalence
441863|NCT01260948|Healthy Subjects|healthy subjects
441864|NCT01260935|GERD|gerd
441865|NCT01260935|laparoscopic surgery|laparoscopic surgery
441866|NCT01260935|gastroesophageal|gastroesophageal
441867|NCT01260935|reflux|reflux
441868|NCT01260922|Bioequivalence|bioequivalence
441869|NCT01260922|Healthy Subjects|healthy subjects
441870|NCT01260896|Bioequivalence|bioequivalence
441871|NCT01260896|Healthy Subjects|healthy subjects
441872|NCT01260883|ketorolac pharmacokinetics|ketorolac pharmacokinetics
441873|NCT01260883|ketorolac stereo-isomers|ketorolac stereo-isomers
441874|NCT01260883|infants|infants
441875|NCT01260883|postoperative analgesia|postoperative analgesia
441876|NCT01260883|safety|safety
441877|NCT01260857|Spirinolactone|spirinolactone
441878|NCT01260857|Hydroflumethiazide|hydroflumethiazide
441879|NCT01260857|Hypertension|hypertension
441880|NCT01260857|Filipinos|filipinos
441881|NCT01260857|Diabetes mellitus|diabetes mellitus
441882|NCT01260857|Proteinuria|proteinuria
441883|NCT01260831|BedsidePEWS|bedsidepews
441884|NCT01260831|Intensive Care|intensive care
441885|NCT01260818|Tranexamic Acid|tranexamic acid
441886|NCT01260805|bioequivalence|bioequivalence
441887|NCT01260805|study|study
441888|NCT01260805|ethinylestradiol|ethinylestradiol
441889|NCT01260805|gestodene|gestodene
441890|NCT01260740|Traumatic Brain Injury|traumatic brain injury
441891|NCT01260740|Explicit Learning|explicit learning
441892|NCT01260740|Primary Motor Cortex|primary motor cortex
441893|NCT01260740|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
441894|NCT01260740|Implicit Learning|implicit learning
441895|NCT01260740|Healthy Volunteer|healthy volunteer
441896|NCT01260740|HV|hv
441897|NCT01260727|HIV Preventive Vaccine|hiv preventive vaccine
441898|NCT01260675|phase 1 study|phase 1 study
441899|NCT01260675|volunteers|volunteers
441900|NCT01260662|Deep Procedural Sedation|deep procedural sedation
441901|NCT01260662|Propofol|propofol
441902|NCT01260662|Ketamine|ketamine
441903|NCT01260662|Emergency Department|emergency department
441904|NCT01260662|Monitoring|monitoring
441905|NCT01260662|Capnography|capnography
441906|NCT01260662|Procedural Sedation in the Emergency Department|procedural sedation in the emergency department
441907|NCT01260649|Electroconvulsive treatment|electroconvulsive treatment
441908|NCT01260649|ketamine|ketamine
441909|NCT01260649|Major Depression|major depression
441910|NCT01260649|Treatment-resistant Major Depressive Disorder|treatment-resistant major depressive disorder
441911|NCT01260623|asthma|asthma
441912|NCT01260623|pharmacokinetics|pharmacokinetics
441913|NCT01260623|prednisone|prednisone
441914|NCT01260623|prednisolone|prednisolone
441915|NCT01260623|asthma exacerbation|asthma exacerbation
441916|NCT01260623|pharmacokinetic profile|pharmacokinetic profile
441917|NCT01260610|Hepatitis B, Tenofovir, Telbivudine|hepatitis b, tenofovir, telbivudine
441918|NCT01260597|smoking|smoking
441919|NCT01260597|quit line re-enrollment and IVR systems|quit line re-enrollment and ivr systems
441920|NCT01260584|thienopyridine|thienopyridine
441921|NCT01260584|antiplatelet|antiplatelet
441922|NCT01260584|prasugrel|prasugrel
441923|NCT01260584|clopidogrel|clopidogrel
441924|NCT01260571|blackheads and pimples|blackheads and pimples
441925|NCT01260571|Acne vulgaris grade II|acne vulgaris grade ii
441926|NCT01260532|Autoimmune thyroid disease|autoimmune thyroid disease
441927|NCT01260506|Relapsed Glioblastoma Multiforme, GBM|relapsed glioblastoma multiforme, gbm
441928|NCT01260493|very frail|very frail
441929|NCT01260493|case manager|case manager
441930|NCT01260493|integrated care|integrated care
441931|NCT01260493|multiprofessional|multiprofessional
441932|NCT01260493|intervention|intervention
441933|NCT01260480|Carcinoma, non-small-cell lung|carcinoma, non-small-cell lung
441934|NCT01260480|Head and neck neoplasms|head and neck neoplasms
441935|NCT01260480|Diagnostic imaging|diagnostic imaging
441936|NCT01260467|recurrent|recurrent
441937|NCT01260454|Qutenza|qutenza
441938|NCT01260454|Capsaicin|capsaicin
441939|NCT01260454|Remodulin|remodulin
441940|NCT01260454|Treprostinil|treprostinil
441941|NCT01260428|hypoxia|hypoxia
441942|NCT01260428|O2 diffusion and convection|o2 diffusion and convection
441943|NCT01260428|cardiac output|cardiac output
441944|NCT01260428|PEEP|peep
441945|NCT01260428|Effects of hypoxia|effects of hypoxia
441946|NCT01260415|colorectal cancer|colorectal cancer
441947|NCT01260415|liver metastases|liver metastases
441948|NCT01260415|panitumumab|panitumumab
441949|NCT01260415|FOLFOX|folfox
441950|NCT01260415|Colorectal cancer with liver metastases|colorectal cancer with liver metastases
441951|NCT01260402|heart failure|heart failure
441952|NCT01260402|Cardiomyopathy, dilated|cardiomyopathy, dilated
441953|NCT01260402|Coronary disease|coronary disease
441954|NCT01260402|Cardiac Pacing, Artificial|cardiac pacing, artificial
441955|NCT01260402|cardiac resynchronization therapy|cardiac resynchronization therapy
441956|NCT01260402|Hemodynamics|hemodynamics
441957|NCT01260402|Randomized Controlled Trials|randomized controlled trials
441958|NCT01260402|Open Study|open study
441959|NCT01260389|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
441960|NCT01260389|COPD|copd
441961|NCT01260376|VLDL-TG|vldl-tg
441962|NCT01260376|Metabolism|metabolism
441963|NCT01260376|Exercise|exercise
441964|NCT01260376|Free Fatty Acids|free fatty acids
441965|NCT01260350|PSI-7977|psi-7977
441966|NCT01260350|Sofosbuvir|sofosbuvir
441967|NCT01260350|GS-7977|gs-7977
441968|NCT01260350|GS-5885|gs-5885
441969|NCT01260350|GS-9669|gs-9669
441971|NCT01260350|ribavirin|ribavirin
441972|NCT01260350|RBV|rbv
441973|NCT01260350|Pegylated Interferon|pegylated interferon
441974|NCT01260350|PEG-IFN|peg-ifn
441975|NCT01260350|Chronic Hepatitis C Infection|chronic hepatitis c infection
441976|NCT01260350|HCV|hcv
441977|NCT01260350|Hepatitis|hepatitis
441978|NCT01260350|Genotype 1|genotype 1
441979|NCT01260350|Genotype 2|genotype 2
441980|NCT01260350|Genotype 3|genotype 3
441981|NCT01260350|GT 1|gt 1
441982|NCT01260350|GT 2|gt 2
441983|NCT01260350|GT 3|gt 3
441984|NCT01260350|Hemophilia|hemophilia
441985|NCT01260337|Weight loss|weight loss
441986|NCT01260337|Type 2 Diabetes|type 2 diabetes
441987|NCT01260337|Behavior Modification|behavior modification
441988|NCT01260337|portion control|portion control
441989|NCT01260324|Phosphodiesterase type 5 inhibitors|phosphodiesterase type 5 inhibitors
441990|NCT01260324|non-arteritic anterior ischemic optic neuropathy|non-arteritic anterior ischemic optic neuropathy
441991|NCT01260324|descriptive epidemiology study|descriptive epidemiology study
441992|NCT01260311|Observational|observational
441993|NCT01260298|MC1 VASER VASERShape|mc1 vaser vasershape
441994|NCT01260272|Cardiovascular|cardiovascular
442289|NCT01259063|GEMCITABINE|gemcitabine
441995|NCT01260272|Risk Factors|risk factors
441996|NCT01260272|Cardiovascular Disease|cardiovascular disease
441997|NCT01260272|Glucose|glucose
441998|NCT01260272|Blood Pressure|blood pressure
441999|NCT01260272|BMI|bmi
442000|NCT01260272|Weight|weight
442001|NCT01260272|Waist Circumference|waist circumference
442002|NCT01260259|Pediatric|pediatric
442003|NCT01260259|Cardiac|cardiac
442004|NCT01260259|Surgery|surgery
442005|NCT01260259|Cardiopulmonary|cardiopulmonary
442006|NCT01260259|Bypass|bypass
442007|NCT01260259|Myocardial|myocardial
442008|NCT01260259|Kidney|kidney
442009|NCT01260259|Lung|lung
442010|NCT01260259|Injury|injury
442011|NCT01260233|smoking cessation|smoking cessation
442012|NCT01260233|complications|complications
442013|NCT01260233|cigarettes|cigarettes
442014|NCT01260233|preoperative|preoperative
442015|NCT01260233|perioperative|perioperative
442016|NCT01260233|surgery|surgery
442017|NCT01260233|education|education
442018|NCT01260233|nicotine replacement therapy|nicotine replacement therapy
442019|NCT01260207|Acute Coronary Syndrome|acute coronary syndrome
442020|NCT01260207|Interactive Voice Response Technology|interactive voice response technology
442021|NCT01260207|Best Practice Guidelines|best practice guidelines
442022|NCT01260207|Compliance|compliance
442023|NCT01260207|Health Care Utilization|health care utilization
442024|NCT01260168|Cancer|cancer
442025|NCT01260168|Colorectal Cancer|colorectal cancer
442026|NCT01260168|Neoplasm|neoplasm
442027|NCT01260168|Colorectal Neoplasm|colorectal neoplasm
442028|NCT01260168|Intestinal Neoplasms|intestinal neoplasms
442029|NCT01260168|Gastrointestinal Neoplasms|gastrointestinal neoplasms
442030|NCT01260168|Digestive System Neoplasms|digestive system neoplasms
442031|NCT01260168|Neoplasms by Site|neoplasms by site
442032|NCT01260168|Neoplasms|neoplasms
442033|NCT01260168|Digestive System Diseases|digestive system diseases
442034|NCT01260168|Gastrointestinal Diseases|gastrointestinal diseases
442035|NCT01260168|Colonic Diseases|colonic diseases
442036|NCT01260168|Intestinal Diseases|intestinal diseases
442037|NCT01260168|Rectal Diseases|rectal diseases
442038|NCT01260129|BPH|bph
442039|NCT01260129|silodosin|silodosin
442040|NCT01260116|Efficacy,safety,ziprasidone,depressive symptoms ,schizophrenia|efficacy,safety,ziprasidone,depressive symptoms ,schizophrenia
442041|NCT01260103|Optic pathway glioma, recurrent|optic pathway glioma, recurrent
442042|NCT01260103|Optic pathway glioma, progressive|optic pathway glioma, progressive
442043|NCT01260103|Temozolomide|temozolomide
442044|NCT01260103|Temodar|temodar
442045|NCT01260103|TMZ|tmz
442046|NCT01260103|Antineoplastons|antineoplastons
442047|NCT01260103|ANP therapy|anp therapy
442048|NCT01260103|Atengenal (A10)|atengenal (a10)
442049|NCT01260103|Astugenal (AS2-1)|astugenal (as2-1)
442050|NCT01260090|Minimally conscious states|minimally conscious states
442051|NCT01260090|Persistently vegetative states|persistently vegetative states
442052|NCT01260090|Traumatic brain injury|traumatic brain injury
442053|NCT01260064|Appendicitis|appendicitis
442054|NCT01260064|Open appendectomy|open appendectomy
442055|NCT01260064|Laparoscopic appendectomy|laparoscopic appendectomy
442056|NCT01260064|Endoclip|endoclip
442057|NCT01260064|Intracorporeal suture|intracorporeal suture
442058|NCT01260064|Quality-of-life|quality-of-life
442059|NCT01260038|Non Small Cell Lung Cancer|non small cell lung cancer
442060|NCT01260038|observational study|observational study
442061|NCT01260038|EGFR mutation analysis|egfr mutation analysis
442062|NCT01260038|EGFR mutation status|egfr mutation status
442063|NCT01260038|testing turn around time|testing turn around time
442064|NCT01260025|Tolerability|tolerability
442065|NCT01260025|Pharmacokinetics|pharmacokinetics
442066|NCT01260025|Endostatin|endostatin
442067|NCT01260025|antiangiogenesis|antiangiogenesis
442068|NCT01260025|cancer|cancer
442069|NCT01260012|Schistosoma mansoni|schistosoma mansoni
442070|NCT01260012|Schistosomiasis|schistosomiasis
442071|NCT01260012|periportal fibrosis|periportal fibrosis
442072|NCT01260012|antioxidant|antioxidant
442073|NCT01260012|fibrosis reversal|fibrosis reversal
442074|NCT01259999|malnutrition|malnutrition
442075|NCT01259999|oleic-acid|oleic-acid
442076|NCT01259999|micronutrient supplement|micronutrient supplement
442077|NCT01259999|old peoples home|old peoples home
442078|NCT01259986|Vitiligo|vitiligo
442079|NCT01259986|Laser|laser
442080|NCT01259986|Segmental vitiligo|segmental vitiligo
442081|NCT01259986|Acral vitiligo|acral vitiligo
442082|NCT01259973|Pharmacogenetics|pharmacogenetics
442083|NCT01259973|Antipsychotics|antipsychotics
442084|NCT01259973|Extrapyramidal Symptoms|extrapyramidal symptoms
442085|NCT01259947|headache|headache
442086|NCT01259947|migraine|migraine
442087|NCT01259947|medicinal plant|medicinal plant
442088|NCT01259947|essential oil|essential oil
442089|NCT01259947|phytotherapy|phytotherapy
442090|NCT01259934|Randomized Phase III trial|randomized phase iii trial
442091|NCT01259934|Adjuvant therapy|adjuvant therapy
442092|NCT01259934|Interferon|interferon
442093|NCT01259934|Melanoma|melanoma
442094|NCT01259921|EEG biofeedback|eeg biofeedback
442095|NCT01259921|neurofeedback|neurofeedback
442096|NCT01259921|PTSD|ptsd
442097|NCT01259921|Affect Regulation|affect regulation
442098|NCT01259921|Chronic Trauma|chronic trauma
442099|NCT01259908|laparoscopic aortic surgery|laparoscopic aortic surgery
442100|NCT01259908|aorto-iliac occlusive disease|aorto-iliac occlusive disease
442101|NCT01259882|Pharmacokinetics Safety Tolerability Pharmacodynamics|pharmacokinetics safety tolerability pharmacodynamics
442102|NCT01259856|Polycythemia vera|polycythemia vera
442103|NCT01259856|Essential thrombocythemia|essential thrombocythemia
442104|NCT01259856|Hydroxyurea|hydroxyurea
442105|NCT01259856|PEGASYS|pegasys
442106|NCT01259856|Pegylated Interferon Alfa-2a|pegylated interferon alfa-2a
442107|NCT01259843|Acute aortic syndrome|acute aortic syndrome
442108|NCT01259830|fast-track|fast-track
442109|NCT01259830|colon or rectal surgery|colon or rectal surgery
442110|NCT01259830|pain relief|pain relief
442111|NCT01259817|Polycythemia Vera|polycythemia vera
442112|NCT01259817|Essential Thrombocythemia|essential thrombocythemia
442113|NCT01259817|Hydroxyurea Resistant|hydroxyurea resistant
442114|NCT01259817|Abdominal Vein Thrombosis|abdominal vein thrombosis
442115|NCT01259817|PEGASYS|pegasys
442116|NCT01259804|peanut|peanut
442117|NCT01259804|food allergy|food allergy
442118|NCT01259804|anaphylaxis|anaphylaxis
442119|NCT01259804|immunotherapy|immunotherapy
442120|NCT01259778|Growth disorders|growth disorders
442121|NCT01259778|Saizen|saizen
442122|NCT01259778|easypod™|easypod™
442123|NCT01259778|Growth hormone|growth hormone
442124|NCT01259778|Pediatric subject|pediatric subject
442125|NCT01259765|llama antibody|llama antibody
442126|NCT01259765|rotavirus diarrhoea|rotavirus diarrhoea
442127|NCT01259765|children|children
442128|NCT01259752|Trauma|trauma
442129|NCT01259752|ankle sprain|ankle sprain
442130|NCT01259752|emergency|emergency
442131|NCT01259752|compression stocking|compression stocking
442132|NCT01259739|trained cyclists|trained cyclists
442133|NCT01259739|no medications|no medications
442134|NCT01259739|no diseases|no diseases
442135|NCT01259739|non-smokers|non-smokers
442136|NCT01259726|Diarrhea|diarrhea
442137|NCT01259726|Clostridium difficile|clostridium difficile
442138|NCT01259726|Clostridium infections|clostridium infections
442139|NCT01259726|Signs and Symptoms Digestive|signs and symptoms digestive
442140|NCT01259726|Bacterial Infections|bacterial infections
442141|NCT01259726|Pharmacologic Actions|pharmacologic actions
442142|NCT01259713|Ambisome|ambisome
442143|NCT01259713|ALL|all
442144|NCT01259713|invasive fungal infection|invasive fungal infection
442145|NCT01259713|prophylaxis|prophylaxis
442146|NCT01259713|liposomal amphotericin B|liposomal amphotericin b
442147|NCT01259713|Invasive fungal infection prophylaxis|invasive fungal infection prophylaxis
442148|NCT01259700|High blood pressure|high blood pressure
442149|NCT01259700|Primary care|primary care
442150|NCT01259700|Cardiovascular disease prevention|cardiovascular disease prevention
442151|NCT01259700|Salt reduction|salt reduction
442152|NCT01259687|Electrocardiogram|electrocardiogram
442153|NCT01259687|Arterial line waveform|arterial line waveform
442154|NCT01259687|Cardiac output|cardiac output
442155|NCT01259674|Pediatric|pediatric
442156|NCT01259674|children|children
442157|NCT01259674|acute cough|acute cough
442158|NCT01259674|treatment|treatment
442159|NCT01259674|syrup|syrup
442160|NCT01259674|protective natural extracts|protective natural extracts
442161|NCT01259661|physical activity|physical activity
442162|NCT01259661|metabolic syndrome|metabolic syndrome
442163|NCT01259661|postmenopausal women|postmenopausal women
442164|NCT01259661|exercise training|exercise training
442165|NCT01259648|remifentanil|remifentanil
442166|NCT01259648|anesthesia induction|anesthesia induction
442167|NCT01259648|reactional tachycardia|reactional tachycardia
442168|NCT01259635|Parkinson's disease|parkinson's disease
442169|NCT01259635|freezing of gait|freezing of gait
442170|NCT01259609|Diabetic Macular Edema|diabetic macular edema
442171|NCT01259609|Ciliary Body|ciliary body
442172|NCT01259609|Ultrasound Biomicroscopy|ultrasound biomicroscopy
442173|NCT01259609|Vitrectomy|vitrectomy
442174|NCT01259596|anxiety|anxiety
442175|NCT01259596|rural|rural
442176|NCT01259596|elderly|elderly
442177|NCT01259544|CP-Chronic Pancreatitis|cp-chronic pancreatitis
442178|NCT01259544|DPT-Di peptide breath test|dpt-di peptide breath test
442179|NCT01259544|ePFT- Endoscopic pancreatic function test|epft- endoscopic pancreatic function test
442180|NCT01259531|strong|strong
442181|NCT01259531|silodosin|silodosin
442182|NCT01259531|benign prostatic hyperplasia|benign prostatic hyperplasia
442183|NCT01259531|BPH|bph
442184|NCT01259531|lower urinary tract symptoms associated with severe BPH|lower urinary tract symptoms associated with severe bph
442185|NCT01259505|no number|no number
442186|NCT01259492|Attention Deficit /Hyperactivity Disorder, hyperactivity|attention deficit /hyperactivity disorder, hyperactivity
442187|NCT01259479|Solid Tumors|solid tumors
442188|NCT01259479|Maximum Tolerated Dose|maximum tolerated dose
442189|NCT01259479|Parmacokinetics|parmacokinetics
442190|NCT01259479|Pharmacogenomics|pharmacogenomics
442191|NCT01259479|Satraplatin|satraplatin
442192|NCT01259479|Cancer|cancer
442193|NCT01259479|Solid Tumor|solid tumor
442194|NCT01259479|Brain Tumor|brain tumor
442195|NCT01259466|Smoking cessation|smoking cessation
442196|NCT01259466|Overweight|overweight
442197|NCT01259466|Obesity|obesity
442198|NCT01259466|Internet treatment|internet treatment
442199|NCT01259453|Hepatitis B vaccination|hepatitis b vaccination
442200|NCT01259453|Syringe exchange programs|syringe exchange programs
442201|NCT01259453|Injection drug users|injection drug users
442202|NCT01259453|Hepatitis B prevention through vaccination|hepatitis b prevention through vaccination
442203|NCT01259440|Telemedicine|telemedicine
442204|NCT01259440|continuous positive airway pressure|continuous positive airway pressure
442205|NCT01259440|treatment adherence|treatment adherence
442206|NCT01259427|Mental Disorders|mental disorders
442207|NCT01259427|Psychotic Disorders|psychotic disorders
442208|NCT01259427|Schizophrenia|schizophrenia
442209|NCT01259427|Stigmatization|stigmatization
442210|NCT01259427|Mood Disorders|mood disorders
442211|NCT01259427|Schizophrenia and Disorders with Psychotic Feature|schizophrenia and disorders with psychotic feature
442212|NCT01259414|Carcinoma,Hepatocellular|carcinoma,hepatocellular
442213|NCT01259414|Liver Neoplasms|liver neoplasms
442214|NCT01259414|Survival analysis|survival analysis
442215|NCT01259414|treatment outcome|treatment outcome
442216|NCT01259414|administration drugs|administration drugs
442217|NCT01259414|Chemoembolization,|chemoembolization,
442218|NCT01259414|TACE|tace
442219|NCT01259414|polyvinyl alcohol|polyvinyl alcohol
442220|NCT01259414|water-soluble contrast mesium|water-soluble contrast mesium
442221|NCT01259414|iopamidol|iopamidol
442222|NCT01259414|lipiodol|lipiodol
442223|NCT01259414|distilled water|distilled water
442224|NCT01259401|Sleep|sleep
442225|NCT01259401|Rehabilitation|rehabilitation
442226|NCT01259401|Behavior therapy|behavior therapy
442227|NCT01259401|Insomnia|insomnia
442228|NCT01259388|Multiple sclerosis|multiple sclerosis
442229|NCT01259388|Lithium|lithium
442230|NCT01259349|cataract,|cataract,
442231|NCT01259349|phacoemulsification,|phacoemulsification,
442232|NCT01259349|one percent ultrasound|one percent ultrasound
442233|NCT01259349|endothelial cell density|endothelial cell density
442234|NCT01259336|Itraconazole|itraconazole
442235|NCT01259336|chronic cavitary pulmonary aspergillosis|chronic cavitary pulmonary aspergillosis
442236|NCT01259336|Aspergillosis|aspergillosis
442237|NCT01259336|fungal ball|fungal ball
442238|NCT01259336|mycetoma|mycetoma
442239|NCT01259336|efficacy|efficacy
442240|NCT01259336|safety|safety
442241|NCT01259310|fertility|fertility
442242|NCT01259310|women|women
442243|NCT01259310|epilepsy|epilepsy
442244|NCT01259310|pregnancy|pregnancy
442245|NCT01259310|seizures|seizures
442246|NCT01259310|seizure frequency|seizure frequency
442247|NCT01259310|ovulation|ovulation
442248|NCT01259310|menstruation|menstruation
442249|NCT01259310|hormones|hormones
442250|NCT01259310|progesterone|progesterone
442251|NCT01259297|Aliskiren|aliskiren
442252|NCT01259297|Elderly|elderly
442253|NCT01259297|Major Cardiovascular Events|major cardiovascular events
442254|NCT01259297|Effect of aliskiren-based regimen on major CV events (composite of CV death, non-fatal MI, non-fatal stroke and significant heart failure) in the elderly|effect of aliskiren-based regimen on major cv events (composite of cv death, non-fatal mi, non-fatal stroke and significant heart failure) in the elderly
442255|NCT01259284|Breast cancer|breast cancer
442256|NCT01259284|Colorectal cancer|colorectal cancer
442257|NCT01259284|Genitourinary cancer|genitourinary cancer
442258|NCT01259284|Head and neck cancers|head and neck cancers
442259|NCT01259284|Lung cancer|lung cancer
442260|NCT01259284|Melanoma|melanoma
442261|NCT01259284|Sarcoma|sarcoma
442262|NCT01259284|Atorvastatin|atorvastatin
442263|NCT01259284|Lipitor|lipitor
442264|NCT01259284|Fish Oil supplement|fish oil supplement
442265|NCT01259284|Placebo|placebo
442266|NCT01259258|varicocele, methylene blue, varicocelectomy, hydrocele,|varicocele, methylene blue, varicocelectomy, hydrocele,
442267|NCT01259245|Chronic obstructive pulmonary disease COPD|chronic obstructive pulmonary disease copd
442268|NCT01259245|pulmonary rehabilitation program PRP|pulmonary rehabilitation program prp
442269|NCT01259245|Tai chi|tai chi
442270|NCT01259219|HIV|hiv
442271|NCT01259219|Completion of TB treamtment|completion of tb treamtment
442272|NCT01259206|Calcaneal Spur, Diabetic Obese Patients|calcaneal spur, diabetic obese patients
442273|NCT01259193|Hepatocellular Carcinoma|hepatocellular carcinoma
442274|NCT01259193|Sorafenib|sorafenib
442275|NCT01259193|Zoledronic Acid|zoledronic acid
442276|NCT01259193|toxic reaction|toxic reaction
442277|NCT01259180|acupuncture|acupuncture
442278|NCT01259167|JOBA, Low Back Pain, Physical Exercise|joba, low back pain, physical exercise
442279|NCT01259141|macrolide- resistant Mycoplasma pneumoniae,|macrolide- resistant mycoplasma pneumoniae,
442280|NCT01259141|Mycoplasm pneumonia antibiotic therapy|mycoplasm pneumonia antibiotic therapy
442281|NCT01259115|Healthy subjects|healthy subjects
442282|NCT01259115|Opioid|opioid
442283|NCT01259115|Transdermal|transdermal
442284|NCT01259102|Healthy subjects|healthy subjects
442285|NCT01259102|Opioid|opioid
442286|NCT01259102|Transdermal|transdermal
442287|NCT01259089|Adenocarcinoma of the Lung|adenocarcinoma of the lung
442288|NCT01259089|Non-small Cell Lung Cancer|non-small cell lung cancer
442290|NCT01259063|RAD001(EVEROLIMUS)|rad001(everolimus)
442291|NCT01259063|urinary|urinary
442292|NCT01259063|BCG-Refractory|bcg-refractory
442293|NCT01259063|Intravesical|intravesical
442294|NCT01259063|10-165|10-165
442295|NCT01259050|ALS treatment|als treatment
442296|NCT01259050|Zinc|zinc
442297|NCT01259050|Copper|copper
442298|NCT01259050|BMAA|bmaa
442299|NCT01259050|ALS|als
442300|NCT01259037|Elastography|elastography
442301|NCT01259037|Cutaneous|cutaneous
442302|NCT01259037|Imaging|imaging
442303|NCT01259024|hepatocellular carcinoma|hepatocellular carcinoma
442304|NCT01259024|chemoembolization|chemoembolization
442305|NCT01259024|transarterial chemoembolization|transarterial chemoembolization
442306|NCT01259024|liver cancer|liver cancer
442307|NCT01259024|doxorubicin|doxorubicin
442308|NCT01259024|drug-eluting beads|drug-eluting beads
442309|NCT01259024|LC Bead|lc bead
442310|NCT01259011|end stage renal disease|end stage renal disease
442311|NCT01259011|dialysis|dialysis
442312|NCT01259011|end of life decision making|end of life decision making
442313|NCT01259011|surrogate psychological morbidities|surrogate psychological morbidities
442314|NCT01258985|Knee|knee
442315|NCT01258985|Knee osteoarthritis|knee osteoarthritis
442316|NCT01258985|osteoarthritis|osteoarthritis
442317|NCT01258985|Knee pain|knee pain
442318|NCT01258985|Tai Chi|tai chi
442319|NCT01258985|Physical Therapy|physical therapy
442320|NCT01258985|mind-body exercise|mind-body exercise
442321|NCT01258972|Bifurcation lesions|bifurcation lesions
442322|NCT01258959|Ultrasound, retrobulbar, parabulbar, ophthalmic surgery.|ultrasound, retrobulbar, parabulbar, ophthalmic surgery.
442323|NCT01258946|epicardial adipose pcos|epicardial adipose pcos
442324|NCT01258933|Leukemia|leukemia
442325|NCT01258933|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
442326|NCT01258933|CLL|cll
442327|NCT01258933|Lymphoma|lymphoma
442328|NCT01258933|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
442329|NCT01258933|SLL|sll
442330|NCT01258933|Ofatumumab|ofatumumab
442331|NCT01258920|Schizophrenia|schizophrenia
442332|NCT01258920|Paliperidone palmitate|paliperidone palmitate
442333|NCT01258920|Intramascular Injection|intramascular injection
442334|NCT01258907|BI-204|bi-204
442335|NCT01258868|Mesothelioma|mesothelioma
442336|NCT01258868|Esophageal Cancer|esophageal cancer
442337|NCT01258868|Lung Cancer|lung cancer
442338|NCT01258868|Thoracic Malignancies|thoracic malignancies
442339|NCT01258868|Tumor Cell Vaccine|tumor cell vaccine
442340|NCT01258842|Influenza|influenza
442341|NCT01258842|Prevention|prevention
442342|NCT01258842|Probiotic|probiotic
442343|NCT01258829|Heart Failure Cardiac Resynchronisation Therapy|heart failure cardiac resynchronisation therapy
442344|NCT01258816|Acute Myeloid Leukaemia (AML)|acute myeloid leukaemia (aml)
442345|NCT01258816|Pharmacokinetics|pharmacokinetics
442346|NCT01258816|Elacytarabine|elacytarabine
442347|NCT01258816|CP-4055|cp-4055
442348|NCT01258803|asthma|asthma
442349|NCT01258803|children|children
442350|NCT01258803|persistent|persistent
442351|NCT01258790|TS|ts
442352|NCT01258790|tics|tics
442353|NCT01258790|tourette|tourette
442354|NCT01258777|Healthy volunteers|healthy volunteers
442355|NCT01258777|Japanese male|japanese male
442356|NCT01258777|Caucasian male|caucasian male
442357|NCT01258777|Simponi|simponi
442358|NCT01258764|hypertension|hypertension
442359|NCT01258764|Blood Pressure control|blood pressure control
442360|NCT01258764|hypertension treatment|hypertension treatment
442361|NCT01258764|antihypertensive|antihypertensive
442362|NCT01258764|N of 1 study|n of 1 study
442363|NCT01258751|Healthy Volunteers|healthy volunteers
442364|NCT01258738|Early ankylosing spondylitis (SpA) study; efficacy and safety and health out comes|early ankylosing spondylitis (spa) study; efficacy and safety and health out comes
442365|NCT01258725|amnioinfusion, severe idiopahic oligohydramnios|amnioinfusion, severe idiopahic oligohydramnios
442366|NCT01258673|Fimasartan|fimasartan
442367|NCT01258673|Fimasartan/Hydrochlorothiazide combination|fimasartan/hydrochlorothiazide combination
442368|NCT01258647|infant nutrition|infant nutrition
442369|NCT01258647|complementary feeding|complementary feeding
442370|NCT01258647|malnutrition|malnutrition
442371|NCT01258647|stunting of growth|stunting of growth
442372|NCT01258634|Osteosarcoma|osteosarcoma
442373|NCT01258634|Surgically Resectable High Grade Osteosarcoma|surgically resectable high grade osteosarcoma
442374|NCT01258634|Lung Metastases Only|lung metastases only
442375|NCT01258621|distal pancreatectomy, laparoscopy, learning curve|distal pancreatectomy, laparoscopy, learning curve
442376|NCT01258608|advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
442377|NCT01258608|Mapatumumab|mapatumumab
442378|NCT01258608|HGS1012|hgs1012
442379|NCT01258608|sorafenib|sorafenib
442380|NCT01258595|Influenza|influenza
442381|NCT01258595|Trivalent Inactivated Influenza Vaccine|trivalent inactivated influenza vaccine
442382|NCT01258595|High-Dose Trivalent Inactivated Influenza Vaccine|high-dose trivalent inactivated influenza vaccine
442383|NCT01258595|Influenza vaccines|influenza vaccines
442384|NCT01258582|HIV|hiv
442385|NCT01258582|Testing|testing
442386|NCT01258582|HIV Seronegativity|hiv seronegativity
442387|NCT01258569|laparoscopic|laparoscopic
442388|NCT01258569|colon|colon
442389|NCT01258569|resection|resection
442390|NCT01258569|Entereg|entereg
442391|NCT01258543|Global osteopathic evaluation|global osteopathic evaluation
442392|NCT01258543|Non-specific back pain|non-specific back pain
442393|NCT01258543|Inter-examiner reliability|inter-examiner reliability
442394|NCT01258530|influenza, bioequivalence, oseltamivir, Tamiflu, over-encapsulation|influenza, bioequivalence, oseltamivir, tamiflu, over-encapsulation
442395|NCT01258517|RDS|rds
442396|NCT01258517|surfactant|surfactant
442397|NCT01258517|cerebral oxygenation|cerebral oxygenation
442398|NCT01258517|near infrared spectroscopy|near infrared spectroscopy
442399|NCT01258504|Steady-state|steady-state
442400|NCT01258504|Bosentan|bosentan
442401|NCT01258504|St. Johns Wort|st. johns wort
442402|NCT01258478|NSCLC, rehabilitation, CPET, lung resection|nsclc, rehabilitation, cpet, lung resection
442403|NCT01258465|Communication|communication
442404|NCT01258465|Pivotal Response Training|pivotal response training
442405|NCT01258465|Picture Exchange Communication System|picture exchange communication system
442406|NCT01258439|HIV|hiv
442407|NCT01258439|cardiovascular disease|cardiovascular disease
442408|NCT01258439|post prandial lipids|post prandial lipids
442409|NCT01258439|ritonavir|ritonavir
442410|NCT01258439|darunavir|darunavir
442411|NCT01258439|raltegravir|raltegravir
442412|NCT01258439|arterial stiffness|arterial stiffness
442413|NCT01258439|tonometry|tonometry
442414|NCT01258413|Cervical Cancer|cervical cancer
442415|NCT01258413|Radical hysterectomy, Laparoscopic|radical hysterectomy, laparoscopic
442416|NCT01258413|Overall survival|overall survival
442417|NCT01258413|Disease-free five-years survival|disease-free five-years survival
442418|NCT01258374|Pharmacokinetics, raltegravir, darunavir, NRTI sparing regimen|pharmacokinetics, raltegravir, darunavir, nrti sparing regimen
442419|NCT01258361|preoperative fasting|preoperative fasting
442420|NCT01258296|Postoperative pain|postoperative pain
442421|NCT01258296|Breast reconstruction|breast reconstruction
442422|NCT01258296|Abdominal flap breast reconstruction|abdominal flap breast reconstruction
442423|NCT01258257|Aneurysm|aneurysm
442424|NCT01258257|Subarachnoid hemorrhage|subarachnoid hemorrhage
442425|NCT01258257|Lumbar drain|lumbar drain
442426|NCT01258257|Cerebral vasospasm|cerebral vasospasm
442427|NCT01258257|Cerebral Ventricles|cerebral ventricles
442428|NCT01258257|Cerebrospinal Fluid|cerebrospinal fluid
442429|NCT01258257|Prospective Studies|prospective studies
442430|NCT01258257|Drainage/methods*|drainage/methods*
442431|NCT01258257|Humans|humans
442432|NCT01258257|Subarachnoid Hemorrhage/cerebrospinal fluid*|subarachnoid hemorrhage/cerebrospinal fluid*
442433|NCT01258257|Subarachnoid Hemorrhage/complications*|subarachnoid hemorrhage/complications*
442434|NCT01258257|Subarachnoid Space/surgery*|subarachnoid space/surgery*
442435|NCT01258257|Vasospasm, Intracranial/etiology|vasospasm, intracranial/etiology
442436|NCT01258257|Vasospasm, Intracranial/surgery*|vasospasm, intracranial/surgery*
442437|NCT01258244|Out-of-Hospital Cardiac Arrest, OHCA|out-of-hospital cardiac arrest, ohca
442438|NCT01258205|Amgen|amgen
442439|NCT01258205|AMG 139|amg 139
442440|NCT01258205|Crohn's Disease|crohn's disease
442441|NCT01258192|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
442442|NCT01258192|neoadjuvant chemotherapy|neoadjuvant chemotherapy
442443|NCT01258192|albumin-bound paclitaxel|albumin-bound paclitaxel
442444|NCT01258192|cisplatin|cisplatin
442445|NCT01258153|Infantile Colic|infantile colic
442446|NCT01258153|tachykinin antagonist|tachykinin antagonist
442447|NCT01258153|Nepadutant|nepadutant
442448|NCT01258140|CT angiography|ct angiography
442449|NCT01258140|radiation dose|radiation dose
442450|NCT01258140|contrast medium|contrast medium
442451|NCT01258127|Pemetrexed|pemetrexed
442452|NCT01258127|Vinorelbine|vinorelbine
442453|NCT01258127|Carboplatin|carboplatin
442454|NCT01258114|Overweight|overweight
442455|NCT01258114|Obesity|obesity
442456|NCT01258114|Balneotherapy|balneotherapy
442457|NCT01258114|Spa Therapy|spa therapy
442458|NCT01258114|balneology|balneology
442459|NCT01258114|hydrotherapy|hydrotherapy
442460|NCT01258114|SF 12|sf 12
442461|NCT01258114|Nutritional counselling|nutritional counselling
442462|NCT01258114|Zelen double consent|zelen double consent
442463|NCT01258114|Lifestyle modification program|lifestyle modification program
442464|NCT01258114|IMC|imc
442465|NCT01258088|psoriasis|psoriasis
442466|NCT01258075|type 2 diabetes mellitus|type 2 diabetes mellitus
442467|NCT01258075|blood glucose|blood glucose
442468|NCT01258075|anti-diabetic|anti-diabetic
442469|NCT01258075|bile acid sequestrant|bile acid sequestrant
442470|NCT01258075|colesevelam HCl|colesevelam hcl
442471|NCT01258075|oral suspension|oral suspension
442472|NCT01258075|pediatric|pediatric
442473|NCT01258075|add-on therapy|add-on therapy
442474|NCT01258075|add-on to metformin|add-on to metformin
442475|NCT01258075|metformin|metformin
442476|NCT01258075|adolescent|adolescent
442477|NCT01258075|lipid|lipid
442478|NCT01258049|Plasmodium infections|plasmodium infections
442479|NCT01258049|Remittent fever|remittent fever
442480|NCT01258049|Artemether|artemether
442481|NCT01258049|Artemesinins|artemesinins
442482|NCT01258049|Quinine|quinine
442483|NCT01258049|Malaria|malaria
442484|NCT01258049|Protozoan infections|protozoan infections
442485|NCT01258049|sublingual drug delivery|sublingual drug delivery
442486|NCT01258049|Parasitic disease|parasitic disease
442487|NCT01258049|Antiprotozoan agents|antiprotozoan agents
442488|NCT01258036|Bone microarchitecture|bone microarchitecture
442489|NCT01258036|Bone mineral density|bone mineral density
442490|NCT01258036|Bone markers|bone markers
442491|NCT01258036|hereditary determinism|hereditary determinism
442492|NCT01258010|Red blood cell transfusion|red blood cell transfusion
442493|NCT01258010|Neurosurgery|neurosurgery
442494|NCT01258010|Orthopedic surgery|orthopedic surgery
442495|NCT01258010|Tranexamic acid|tranexamic acid
442496|NCT01258010|Surgical blood loss|surgical blood loss
442497|NCT01257997|No specific experimental conditions|no specific experimental conditions
442498|NCT01257971|Cholesterol|cholesterol
442499|NCT01257971|HMG-CoA reductase inhibitor|hmg-coa reductase inhibitor
442500|NCT01257971|cardiovascular risk|cardiovascular risk
442501|NCT01257971|LDLl|ldll
442502|NCT01257958|Vitamin D, 19 nor Vitamin D, Multiple Sclerosis|vitamin d, 19 nor vitamin d, multiple sclerosis
442503|NCT01257932|Breast Cancer|breast cancer
442504|NCT01257906|acne|acne
442505|NCT01257906|Ziana|ziana
442506|NCT01257906|clindamycin|clindamycin
442507|NCT01257906|tretinoin|tretinoin
442508|NCT01257893|migraine|migraine
442509|NCT01257893|chronic migraine|chronic migraine
442510|NCT01257893|migraine with aura|migraine with aura
442511|NCT01257893|migraine without aura|migraine without aura
442512|NCT01257893|aspirin|aspirin
442513|NCT01257893|platelets|platelets
442514|NCT01257880|Migraine|migraine
442515|NCT01257880|Migraine with Aura|migraine with aura
442516|NCT01257880|Aura|aura
442517|NCT01257880|Patent Foramen Ovale|patent foramen ovale
442518|NCT01257880|Platelets|platelets
442519|NCT01257880|Sleep Apnea|sleep apnea
442520|NCT01257880|Cognitive Function|cognitive function
442521|NCT01257867|Brain-derived neurotrophic factor|brain-derived neurotrophic factor
442522|NCT01257867|Oxidative stress|oxidative stress
442523|NCT01257867|Neurogenesis|neurogenesis
442524|NCT01257867|Lithium|lithium
442525|NCT01257867|Lithia water|lithia water
442526|NCT01257854|busulfan|busulfan
442527|NCT01257854|pharmacogenetic|pharmacogenetic
442528|NCT01257854|pharmacokinetic|pharmacokinetic
442529|NCT01257854|toxicity|toxicity
442530|NCT01257854|survival|survival
442531|NCT01257841|Fasting|fasting
442532|NCT01257841|Gut hormones|gut hormones
442533|NCT01257841|Inflammatory Cytokines|inflammatory cytokines
442534|NCT01257815|Diabetes mellitus|diabetes mellitus
442535|NCT01257815|Diabetic retinopathy|diabetic retinopathy
442536|NCT01257815|Macular oedema|macular oedema
442537|NCT01257815|Visual acuity|visual acuity
442538|NCT01257789|laparoscopic gastric bypass|laparoscopic gastric bypass
442539|NCT01257789|learning curve|learning curve
442540|NCT01257789|complications|complications
442541|NCT01257789|operative time|operative time
442542|NCT01257776|Critical Limb Ischemia (CLI)|critical limb ischemia (cli)
442543|NCT01257776|Diabetes|diabetes
442544|NCT01257776|Mesenchymal Stem Cells|mesenchymal stem cells
442545|NCT01257776|Regenerative Therapy|regenerative therapy
442546|NCT01257763|needles/adverse effects|needles/adverse effects
442547|NCT01257763|administration, cutaneous|administration, cutaneous
442548|NCT01257763|erythema|erythema
442549|NCT01257763|pain measurement|pain measurement
442550|NCT01257763|Safety|safety
442551|NCT01257763|Microstructure Transdermal System|microstructure transdermal system
442552|NCT01257750|corneal neovascularization|corneal neovascularization
442553|NCT01257750|pazopanib|pazopanib
442554|NCT01257750|votrient|votrient
442555|NCT01257750|rosacea|rosacea
442556|NCT01257737|Urea Cycle Disorders|urea cycle disorders
442557|NCT01257737|GT4P|gt4p
442558|NCT01257737|HPN-100|hpn-100
442559|NCT01257737|Sodium Phenylbutyrate (NaPBA)|sodium phenylbutyrate (napba)
442560|NCT01257737|Glyceryl tri-(4-phenylbutyrate)|glyceryl tri-(4-phenylbutyrate)
442561|NCT01257737|Phenylbutyrate|phenylbutyrate
442562|NCT01257737|Hyperion|hyperion
442563|NCT01257737|BUPHENYL|buphenyl
442564|NCT01257737|hyperammonemia|hyperammonemia
442565|NCT01257724|Knowledge translation|knowledge translation
442566|NCT01257724|Community based organizations|community based organizations
442567|NCT01257724|HIV/AIDS|hiv/aids
442568|NCT01257711|Gastric Cancer|gastric cancer
442569|NCT01257711|Gastrectomy|gastrectomy
442570|NCT01257711|Billroth 2|billroth 2
442571|NCT01257711|Roux-en-Y|roux-en-y
442572|NCT01257698|Vitrectomy|vitrectomy
442573|NCT01257698|Gas bubble|gas bubble
442574|NCT01257698|Retinal detachment|retinal detachment
442575|NCT01257698|Macular hole|macular hole
442576|NCT01257698|Aqueous suppressant|aqueous suppressant
442577|NCT01257672|acute gastroenteritis|acute gastroenteritis
442578|NCT01257672|vomiting|vomiting
442579|NCT01257672|ondansetron|ondansetron
442580|NCT01257672|domperidon|domperidon
442581|NCT01257672|symptomatic treatment|symptomatic treatment
442582|NCT01257659|Rectocele|rectocele
442583|NCT01257659|Trans anal STARR resection|trans anal starr resection
442584|NCT01257659|Transvaginal repair|transvaginal repair
442585|NCT01257633|da Vinci surgical robot|da vinci surgical robot
442586|NCT01257633|laryngeal cancer|laryngeal cancer
442587|NCT01257620|Inflammatory Bowel Disease|inflammatory bowel disease
442588|NCT01257620|Coeliac Disease|coeliac disease
442589|NCT01257594|Gliomas|gliomas
442590|NCT01257594|Erlotinib|erlotinib
442591|NCT01257594|Glioblastoma|glioblastoma
442592|NCT01257594|GBM|gbm
442593|NCT01257594|Gliosarcoma|gliosarcoma
442594|NCT01257594|Glioma|glioma
442595|NCT01257581|ALS|als
442596|NCT01257581|Lou Gehrig's Disease|lou gehrig's disease
442597|NCT01257581|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
442598|NCT01257581|Creatine|creatine
442599|NCT01257581|Tamoxifen|tamoxifen
442600|NCT01257581|Selection Design|selection design
442601|NCT01257542|randomized|randomized
442602|NCT01257542|parallel|parallel
442603|NCT01257542|double-blind|double-blind
442604|NCT01257542|placebo-controlled|placebo-controlled
442605|NCT01257542|cough|cough
442606|NCT01257542|efficacy|efficacy
442607|NCT01257542|safety|safety
442608|NCT01257542|dextromethorphan|dextromethorphan
442609|NCT01257529|pregabalin|pregabalin
442610|NCT01257529|pharmacokinetics|pharmacokinetics
442611|NCT01257529|bioavailability|bioavailability
442612|NCT01257529|bioequivalence|bioequivalence
442613|NCT01257516|pregabalin|pregabalin
442614|NCT01257516|pharmacokinetics|pharmacokinetics
442615|NCT01257516|bioavailability|bioavailability
442616|NCT01257516|bioequivalence|bioequivalence
442617|NCT01257503|children|children
442618|NCT01257503|upper respiratory tract infections|upper respiratory tract infections
442619|NCT01257503|homeopathy|homeopathy
442620|NCT01257477|Diarrhea|diarrhea
442621|NCT01257477|IBS|ibs
442622|NCT01257477|Irritable Bowel Syndrome|irritable bowel syndrome
442623|NCT01257464|CFRD|cfrd
442624|NCT01257464|sitagliptin|sitagliptin
442625|NCT01257464|cystic fibrosis-related diabetes|cystic fibrosis-related diabetes
442626|NCT01257464|incretins|incretins
442627|NCT01257464|hyperglycemia|hyperglycemia
442628|NCT01257464|GIP|gip
442629|NCT01257464|GLP-1|glp-1
442630|NCT01257451|Type 2 Diabetes Mellitus, Vildagliptin, Elderly Patients|type 2 diabetes mellitus, vildagliptin, elderly patients
442631|NCT01257412|Phase III|phase iii
442632|NCT01257412|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
442633|NCT01257412|inadequate glycaemic control|inadequate glycaemic control
442634|NCT01257360|RAS-Wildtype|ras-wildtype
442635|NCT01257360|Radiotherapy|radiotherapy
442636|NCT01257360|Neoadjuvant treatment|neoadjuvant treatment
442637|NCT01257347|Medication adherence|medication adherence
442638|NCT01257347|clinical inertia|clinical inertia
442639|NCT01257347|treatment intensification|treatment intensification
442640|NCT01257347|quality of care|quality of care
442641|NCT01257334|type 2 diabetes|type 2 diabetes
442642|NCT01257308|lung cancer|lung cancer
442643|NCT01257295|dietary fiber|dietary fiber
442644|NCT01257295|energy intake|energy intake
442645|NCT01257295|appetite|appetite
442646|NCT01257295|satiety hormones|satiety hormones
442647|NCT01257295|glucose|glucose
442648|NCT01257295|gastric emptying|gastric emptying
442649|NCT01257269|Thrombotic thrombocytopenic purpura|thrombotic thrombocytopenic purpura
442650|NCT01257269|ADAMTS13|adamts13
442651|NCT01257269|Von Willebrand factor|von willebrand factor
442652|NCT01257269|Von Willebrand factor cleaving protease|von willebrand factor cleaving protease
442653|NCT01257269|Thrombocytopenia|thrombocytopenia
442654|NCT01257269|Hemolytic anemia|hemolytic anemia
442655|NCT01257256|infertile patients|infertile patients
442656|NCT01257243|cough|cough
442657|NCT01257243|symptoms|symptoms
442658|NCT01257243|cold|cold
442659|NCT01257243|flu|flu
442660|NCT01257217|Intraocular Lens|intraocular lens
442661|NCT01257217|Presbyopia|presbyopia
442662|NCT01257217|multifocal|multifocal
442663|NCT01257191|Vehicle Emissions|vehicle emissions
442664|NCT01257191|Diesel Exhaust|diesel exhaust
442665|NCT01257165|Automobile driving|automobile driving
442666|NCT01257165|Zopiclone|zopiclone
442667|NCT01257165|Drug safety|drug safety
442668|NCT01257165|Traffic accidents|traffic accidents
442669|NCT01257139|To evaluate a geriatric scale designed to help with treatment|to evaluate a geriatric scale designed to help with treatment
442670|NCT01257139|allocation to dual-agent therapy based on platinum or to|allocation to dual-agent therapy based on platinum or to
442671|NCT01257139|single-agent chemotherapy in elderly subjects with advancedstage|single-agent chemotherapy in elderly subjects with advancedstage
442672|NCT01257139|NSCLC, based on the time to failure in the two arms|nsclc, based on the time to failure in the two arms
442673|NCT01257126|Upper respiratory tract infections|upper respiratory tract infections
442674|NCT01257126|diclofenac potassium|diclofenac potassium
442675|NCT01257126|nimesulide|nimesulide
442676|NCT01257126|fever|fever
442677|NCT01257126|pain|pain
442678|NCT01257113|shoulder pain|shoulder pain
442679|NCT01257113|shoulder impingement|shoulder impingement
442680|NCT01257113|rotatorcuff pathology|rotatorcuff pathology
442681|NCT01257113|supervised exercise|supervised exercise
442682|NCT01257113|homebased exercise|homebased exercise
442683|NCT01257100|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
442684|NCT01257100|Epstein-Barr Virus|epstein-barr virus
442685|NCT01257100|NPC|npc
442686|NCT01257087|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
442687|NCT01257087|Obesity|obesity
442688|NCT01257087|Bariatric Surgery|bariatric surgery
442689|NCT01257087|Glycaemic control|glycaemic control
442690|NCT01257087|Microvascular complications|microvascular complications
442691|NCT01257087|Intensive|intensive
442692|NCT01257087|Conservative|conservative
442693|NCT01257074|Herpes Simplex|herpes simplex
442694|NCT01257061|Dermatitis|dermatitis
442695|NCT01257061|Dermatitis, Atopic|dermatitis, atopic
442696|NCT01257048|Oxygen enhanced magnetic resonance imaging|oxygen enhanced magnetic resonance imaging
442697|NCT01257048|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
442698|NCT01257048|method evaluation|method evaluation
442699|NCT01257035|Rectum cancer|rectum cancer
442701|NCT01257035|18F-FAZA-PET/CT|18f-faza-pet/ct
442702|NCT01257035|Radiotherapy|radiotherapy
442703|NCT01257035|Chemoradiotherapy|chemoradiotherapy
442704|NCT01257022|Prevention|prevention
442705|NCT01257022|HIV|hiv
442706|NCT01257022|Substance use|substance use
442707|NCT01257022|Hispanic|hispanic
442708|NCT01257022|Adolescents|adolescents
442709|NCT01257022|Unsafe sexual behavior|unsafe sexual behavior
442710|NCT01257022|Behavioral intervention|behavioral intervention
442711|NCT01257009|sympathetic activity|sympathetic activity
442712|NCT01257009|chronic kidney disease|chronic kidney disease
442713|NCT01257009|atorvastatin|atorvastatin
442714|NCT01257009|lipitor|lipitor
442715|NCT01256983|Sleep quality|sleep quality
442716|NCT01256983|Daytime Sleepiness|daytime sleepiness
442717|NCT01256944|PCOS|pcos
442718|NCT01256944|DM|dm
442719|NCT01256944|Hypertension|hypertension
442720|NCT01256944|CVD|cvd
442721|NCT01256931|2009 H1N1 influenza vaccine, organ transplant patients,|2009 h1n1 influenza vaccine, organ transplant patients,
442722|NCT01256931|booster with Fluarix|booster with fluarix
442723|NCT01256918|cataract|cataract
442724|NCT01256918|phacoemulsification|phacoemulsification
442725|NCT01256918|phacochop|phacochop
442726|NCT01256918|phacotip|phacotip
442727|NCT01256879|cimetidine|cimetidine
442728|NCT01256879|pharmacokinetics|pharmacokinetics
442729|NCT01256879|formulation|formulation
442730|NCT01256866|Dexmedetomidine|dexmedetomidine
442731|NCT01256866|Midazolam|midazolam
442732|NCT01256866|Sedation|sedation
442733|NCT01256866|Mechanical ventilation|mechanical ventilation
442734|NCT01256866|Critically ill patients|critically ill patients
442735|NCT01256853|histologically confirmed EBV+ NPC patients|histologically confirmed ebv+ npc patients
442736|NCT01256827|age-related macular degeneration|age-related macular degeneration
442737|NCT01256827|ranibizumab|ranibizumab
442738|NCT01256827|geographic atrophy|geographic atrophy
442739|NCT01256827|ANCHOR Study|anchor study
442740|NCT01256827|MARINA Study|marina study
442741|NCT01256814|HIV/AIDS|hiv/aids
442742|NCT01256814|Adult|adult
442743|NCT01256814|Behavioral Intervention|behavioral intervention
442744|NCT01256814|Sleep|sleep
442745|NCT01256814|Physical Activity|physical activity
442746|NCT01256801|Metastatic Breast Neoplasms|metastatic breast neoplasms
442747|NCT01256801|Gene Expression Profiling|gene expression profiling
442748|NCT01256801|immunotherapy|immunotherapy
442749|NCT01256788|viscosupplementation|viscosupplementation
442750|NCT01256788|meniscus tear|meniscus tear
442751|NCT01256788|degenerative joint disease|degenerative joint disease
442752|NCT01256775|atherosclerosis|atherosclerosis
442753|NCT01256775|carotid intima-media thickness|carotid intima-media thickness
442754|NCT01256775|intermittent claudication|intermittent claudication
442755|NCT01256775|Nitric Oxide / NO|nitric oxide / no
442756|NCT01256762|imetelstat|imetelstat
442757|NCT01256762|imetelstat sodium|imetelstat sodium
442758|NCT01256762|GRN163L|grn163l
442759|NCT01256762|telomerase inhibitor|telomerase inhibitor
442760|NCT01256762|telomerase inhibition|telomerase inhibition
442761|NCT01256762|metastatic breast cancer|metastatic breast cancer
442762|NCT01256762|locally recurrent breast cancer|locally recurrent breast cancer
442763|NCT01256762|Bevacizumab|bevacizumab
442764|NCT01256762|Paclitaxel|paclitaxel
442765|NCT01256762|Avastin|avastin
442766|NCT01256762|Taxol|taxol
442767|NCT01256762|HER-2-negative|her-2-negative
442768|NCT01256762|First-Line Chemotherapy|first-line chemotherapy
442769|NCT01256762|Second-Line Chemotherapy|second-line chemotherapy
442770|NCT01256723|drug eluting stent (DES)|drug eluting stent (des)
442771|NCT01256723|unprotected left main coronary artery (ULMCA)|unprotected left main coronary artery (ulmca)
442772|NCT01256684|Vulvar/vaginal atrophy|vulvar/vaginal atrophy
442773|NCT01256684|Atrophic Vaginitis|atrophic vaginitis
442774|NCT01256684|Dehydroepiandrosterone|dehydroepiandrosterone
442775|NCT01256684|DHEA|dhea
442776|NCT01256684|Prasterone|prasterone
442777|NCT01256684|Vaginorm|vaginorm
442778|NCT01256684|Menopause|menopause
442779|NCT01256684|Intrarosa|intrarosa
442780|NCT01256671|Vulvar/Vaginal Atrophy|vulvar/vaginal atrophy
442781|NCT01256671|Atrophic Vaginitis|atrophic vaginitis
442782|NCT01256671|Dehydroepiandrosterone|dehydroepiandrosterone
442783|NCT01256671|DHEA|dhea
442784|NCT01256671|Prasterone|prasterone
442785|NCT01256671|Vaginorm|vaginorm
442786|NCT01256671|Menopause|menopause
442787|NCT01256671|Intrarosa|intrarosa
442788|NCT01256658|P. falciparum|p. falciparum
442789|NCT01256658|malaria|malaria
442790|NCT01256658|asymptomatic carriers|asymptomatic carriers
442791|NCT01256658|bed-nets|bed-nets
442792|NCT01256658|ITN-insecticide-treated net|itn-insecticide-treated net
442793|NCT01256658|idiopathic trigeminal neuralgia|idiopathic trigeminal neuralgia
442794|NCT01256658|RDT-Rapid diagnostic test|rdt-rapid diagnostic test
442795|NCT01256645|weaning|weaning
442796|NCT01256645|mechanical ventilation|mechanical ventilation
442797|NCT01256645|blood transfusion|blood transfusion
442798|NCT01256645|spontaneous breathing trials|spontaneous breathing trials
442799|NCT01256619|Marvelon|marvelon
442800|NCT01256619|PMS|pms
442801|NCT01256619|serum Lipids|serum lipids
442802|NCT01256593|Lyrica|lyrica
442803|NCT01256593|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
442804|NCT01256593|Safety|safety
442805|NCT01256593|Neuropathic Pain|neuropathic pain
442806|NCT01256593|Post Marketing Surveillance|post marketing surveillance
442807|NCT01256554|Stereotactic Radiosurgery|stereotactic radiosurgery
442808|NCT01256554|SSRS|ssrs
442809|NCT01256554|Radiation|radiation
442810|NCT01256554|Radiotherapy|radiotherapy
442811|NCT01256554|Metastatic Epidural Spinal Cord Compression|metastatic epidural spinal cord compression
442812|NCT01256554|MESCC|mescc
442813|NCT01256528|Invasive breast carcinoma|invasive breast carcinoma
442814|NCT01256528|Breast reconstruction|breast reconstruction
442815|NCT01256528|Mastectomy|mastectomy
442816|NCT01256528|Breast cancer|breast cancer
442817|NCT01256528|Delayed-delayed breast reconstruction|delayed-delayed breast reconstruction
442818|NCT01256528|Post-mastectomy radiation therapy|post-mastectomy radiation therapy
442819|NCT01256515|Healthy adults aged 50 or older|healthy adults aged 50 or older
442820|NCT01256489|KPro|kpro
442821|NCT01256489|Keratoprosthesis|keratoprosthesis
442822|NCT01256489|Stevens-Johnson Syndrome|stevens-johnson syndrome
442823|NCT01256489|Infliximab|infliximab
442824|NCT01256489|Corneal Blindness|corneal blindness
442825|NCT01256450|buccal soluble film|buccal soluble film
442826|NCT01256450|enriched enrollment|enriched enrollment
442827|NCT01256450|randomized withdrawal|randomized withdrawal
442828|NCT01256437|Acneiform eruption|acneiform eruption
442829|NCT01256437|papulopustular|papulopustular
442830|NCT01256437|EGFR|egfr
442831|NCT01256437|cetuximab|cetuximab
442832|NCT01256437|erlotinib|erlotinib
442833|NCT01256437|gefitinib|gefitinib
442834|NCT01256437|panitumumab|panitumumab
442835|NCT01256437|eruption secondary to treatment with either cetuximab|eruption secondary to treatment with either cetuximab
442836|NCT01256424|CIN|cin
442837|NCT01256411|hypertension|hypertension
442838|NCT01256411|blood pressure|blood pressure
442839|NCT01256411|LCZ696|lcz696
442840|NCT01256411|dual-acting|dual-acting
442841|NCT01256411|neprilysin|neprilysin
442842|NCT01256411|nep inhibitor|nep inhibitor
442843|NCT01256411|vasopeptidase|vasopeptidase
442844|NCT01256411|angiotensin receptor|angiotensin receptor
442845|NCT01256411|angiotensin receptor neprilysin inhibitor (ARNi)|angiotensin receptor neprilysin inhibitor (arni)
442846|NCT01256372|Cardiac surgery|cardiac surgery
442847|NCT01256372|Acute kidney injury|acute kidney injury
442848|NCT01256346|Premature|premature
442849|NCT01256346|baby|baby
442850|NCT01256346|heart rate|heart rate
442851|NCT01256346|resuscitation|resuscitation
442852|NCT01256307|Obstructive Sleep Apnea/Hypopnea Syndrome|obstructive sleep apnea/hypopnea syndrome
442853|NCT01256307|Exercise training program|exercise training program
442854|NCT01256307|Inflammation|inflammation
442855|NCT01256307|Oxidative Stress|oxidative stress
442856|NCT01256307|Insulin resistance|insulin resistance
442857|NCT01256294|Renal transplant|renal transplant
442858|NCT01256294|kidney transplant|kidney transplant
442859|NCT01256294|immunosuppressive therapy|immunosuppressive therapy
442860|NCT01256294|anti-rejection medication|anti-rejection medication
442861|NCT01256294|pharmacokinetics|pharmacokinetics
442862|NCT01256294|tacrolimus|tacrolimus
442863|NCT01256281|Sickle Cell Disease|sickle cell disease
442864|NCT01256281|Pain|pain
442865|NCT01256281|Vasoocclusion|vasoocclusion
442866|NCT01256281|Nerve Block|nerve block
442867|NCT01256281|Regional Anesthesia|regional anesthesia
442868|NCT01256268|metastatic|metastatic
442869|NCT01256268|recurrent|recurrent
442870|NCT01256268|Solid Cancer|solid cancer
442871|NCT01256255|transplant|transplant
442872|NCT01256255|influenza infection|influenza infection
442873|NCT01256242|tendon|tendon
442874|NCT01256242|shoulder|shoulder
442875|NCT01256242|rotator cuff|rotator cuff
442876|NCT01256242|Glenohumeral|glenohumeral
442877|NCT01256229|deafness|deafness
442878|NCT01256229|hearing loss|hearing loss
442879|NCT01256229|developmental delay|developmental delay
442880|NCT01256229|mental retardation|mental retardation
442881|NCT01256216|Arthritis|arthritis
442882|NCT01256216|Osteoarthritis|osteoarthritis
442883|NCT01256216|Arthroplasty|arthroplasty
442884|NCT01256203|PDT|pdt
442885|NCT01256203|Porfimer sodium|porfimer sodium
442886|NCT01256203|Phototoxicity|phototoxicity
442887|NCT01256203|Sunscreen|sunscreen
442888|NCT01256177|Bipolar Depression|bipolar depression
442889|NCT01256177|Mental disease,|mental disease,
442890|NCT01256164|fibrin sealants|fibrin sealants
442891|NCT01256164|hemostatics|hemostatics
442892|NCT01256164|time to hemostasis|time to hemostasis
442893|NCT01256151|Bioequivalence|bioequivalence
442894|NCT01256151|sublingual|sublingual
442895|NCT01256151|alprazolam|alprazolam
442896|NCT01256151|pharmacokinetics|pharmacokinetics
442897|NCT01256138|Allogene MSCs|allogene mscs
442898|NCT01256138|transplantation|transplantation
442899|NCT01256138|chronic liver diseases|chronic liver diseases
442900|NCT01256138|portal vein|portal vein
442901|NCT01256125|allogene MSCs|allogene mscs
442902|NCT01256125|transplantation|transplantation
442903|NCT01256125|chronic liver diseases|chronic liver diseases
442904|NCT01256125|peripheral vein|peripheral vein
442905|NCT01256112|obesity|obesity
442906|NCT01256112|behavioral intervention|behavioral intervention
442907|NCT01256112|family based|family based
442908|NCT01256112|weight loss|weight loss
442909|NCT01256099|Self-help treatment|self-help treatment
442910|NCT01256099|Internet treatment|internet treatment
442911|NCT01256099|CBT|cbt
442912|NCT01256099|Prevention|prevention
442913|NCT01256099|Comorbidity|comorbidity
442914|NCT01256060|Autism Spectrum disorder|autism spectrum disorder
442915|NCT01256060|Oxytocin|oxytocin
442916|NCT01256060|Clinical Trial|clinical trial
442917|NCT01256060|Children|children
442918|NCT01256060|Pharmacology|pharmacology
442919|NCT01256047|immunonutrition|immunonutrition
442920|NCT01256047|hepatectomy|hepatectomy
442921|NCT01256047|Th1|th1
442922|NCT01256047|Th2|th2
442923|NCT01256034|immunonutrition|immunonutrition
442924|NCT01256034|pancreaticoduodenectomy|pancreaticoduodenectomy
442925|NCT01256034|Th1|th1
442926|NCT01256034|Th2|th2
442927|NCT01256008|Breast Cancer|breast cancer
442928|NCT01256008|Depression|depression
442929|NCT01256008|Anxiety|anxiety
442930|NCT01256008|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
442931|NCT01255995|PXF|pxf
442932|NCT01255982|Bipolar depression|bipolar depression
442933|NCT01255982|subsyndromal symptoms|subsyndromal symptoms
442934|NCT01255982|functioning|functioning
442935|NCT01255982|cognitive function|cognitive function
442936|NCT01255969|Dialysis|dialysis
442937|NCT01255969|Physical exercise|physical exercise
442938|NCT01255969|Clinical Trial|clinical trial
442939|NCT01255969|Quality of Life|quality of life
442940|NCT01255969|Performance|performance
442941|NCT01255969|Fitness|fitness
442942|NCT01255969|Cardiovascular Mortality|cardiovascular mortality
442943|NCT01255969|Vascular access|vascular access
442944|NCT01255956|restenosis|restenosis
442945|NCT01255956|ISR|isr
442946|NCT01255956|in-stent restenosis|in-stent restenosis
442947|NCT01255956|drug eluting stent|drug eluting stent
442948|NCT01255956|rapamycin eluting stent|rapamycin eluting stent
442949|NCT01255956|paclitaxel eluting balloon catheter|paclitaxel eluting balloon catheter
442950|NCT01255943|MRSA|mrsa
442951|NCT01255943|bloodstream infections|bloodstream infections
442952|NCT01255943|hemodialysis|hemodialysis
442953|NCT01255930|Pregnant Women|pregnant women
442954|NCT01255930|Sonographic Textures|sonographic textures
442955|NCT01255917|Tio identify role of NGF in pain in CP|tio identify role of ngf in pain in cp
442956|NCT01255917|Identify biomarkers related to progression of CP|identify biomarkers related to progression of cp
442957|NCT01255891|high risk localized adenocarcinoma of the prostate|high risk localized adenocarcinoma of the prostate
442958|NCT01255878|Sleep bruxism|sleep bruxism
442959|NCT01255878|Gabapentine|gabapentine
442960|NCT01255878|Occlusal splint|occlusal splint
442961|NCT01255878|Polysomnography|polysomnography
442962|NCT01255865|Thermometry|thermometry
442963|NCT01255865|Deep Tissue Temperature|deep tissue temperature
442964|NCT01255865|Core Temperature|core temperature
442965|NCT01255865|Body Temperature|body temperature
442966|NCT01255865|Rectal Temperature|rectal temperature
442967|NCT01255865|Oral Temperature|oral temperature
442968|NCT01255852|atorvastatin|atorvastatin
442969|NCT01255852|intracranial artery stenting|intracranial artery stenting
442970|NCT01255852|restenosis|restenosis
442971|NCT01255839|double-balloon|double-balloon
442972|NCT01255839|balloon catheter|balloon catheter
442973|NCT01255839|prostaglandin|prostaglandin
442974|NCT01255839|minprostin|minprostin
442975|NCT01255839|induction of labour|induction of labour
442976|NCT01255839|fetal outcome|fetal outcome
442977|NCT01255826|Preterm|preterm
442978|NCT01255826|Neonates|neonates
442979|NCT01255826|Delivery room|delivery room
442980|NCT01255826|Resuscitation|resuscitation
442981|NCT01255826|Ventilation|ventilation
442982|NCT01255826|Neopuff|neopuff
442983|NCT01255826|CPAP|cpap
442984|NCT01255813|Chronic Cluster Headache|chronic cluster headache
442985|NCT01255787|Major Depressive Disorder|major depressive disorder
442986|NCT01255787|Depression|depression
442987|NCT01255787|Melancholia|melancholia
442988|NCT01255787|Drug Therapy|drug therapy
442989|NCT01255774|subfoveal CNV|subfoveal cnv
443188|NCT01254903|Radiation|radiation
442990|NCT01255774|Wet (Exudative) AMD|wet (exudative) amd
442991|NCT01255774|macular degeneration|macular degeneration
442992|NCT01255761|Certolizumab Pegol|certolizumab pegol
442993|NCT01255761|Cimzia|cimzia
442994|NCT01255761|Rheumatoid Arthritis|rheumatoid arthritis
442995|NCT01255761|CDAI|cdai
442996|NCT01255761|RAPID3|rapid3
442997|NCT01255748|cancer, proton, radiation|cancer, proton, radiation
442998|NCT01255735|pediatrics|pediatrics
442999|NCT01255735|voice|voice
443000|NCT01255735|voice therapy|voice therapy
443001|NCT01255735|vocal therapy|vocal therapy
443002|NCT01255735|hoarseness|hoarseness
443003|NCT01255722|iodinated contrast media, coronary artery disease|iodinated contrast media, coronary artery disease
443004|NCT01255709|Asthma|asthma
443005|NCT01255709|shortness of breath|shortness of breath
443006|NCT01255709|wheezing|wheezing
443007|NCT01255696|Celiac Disease|celiac disease
443008|NCT01255696|Coeliac Disease|coeliac disease
443009|NCT01255696|Celiac Sprue|celiac sprue
443010|NCT01255696|Keliakia Disease|keliakia disease
443011|NCT01255683|Chronic|chronic
443012|NCT01255683|Sinusitis|sinusitis
443013|NCT01255683|Steroid|steroid
443014|NCT01255683|treatment|treatment
443015|NCT01255670|Peritonsillar Abscess|peritonsillar abscess
443016|NCT01255670|Quinsy|quinsy
443017|NCT01255670|Penicillin|penicillin
443018|NCT01255670|Metronidazole|metronidazole
443019|NCT01255670|Recurrence|recurrence
443020|NCT01255605|Intermittent preventive treatment with sulfadoxin-pyrimethamine|intermittent preventive treatment with sulfadoxin-pyrimethamine
443021|NCT01255605|in Bobo-Dioulasso peri-urban areas, 5 years after its implementation|in bobo-dioulasso peri-urban areas, 5 years after its implementation
443022|NCT01255605|Burkina Faso.|burkina faso.
443023|NCT01255592|Bronchiectasis|bronchiectasis
443024|NCT01255592|Neutrophil|neutrophil
443025|NCT01255592|Respiratory disease|respiratory disease
443026|NCT01255592|Sputum|sputum
443027|NCT01255579|asthma|asthma
443028|NCT01255579|small airways|small airways
443029|NCT01255579|inhaled corticosteroids|inhaled corticosteroids
443030|NCT01255540|Coronary heart disease in patients over|coronary heart disease in patients over
443031|NCT01255540|80 years of age.|80 years of age.
443032|NCT01255488|Search engine|search engine
443033|NCT01255488|Clinical decision-making|clinical decision-making
443034|NCT01255488|Research abstracts|research abstracts
443035|NCT01255488|Full-text manuscripts|full-text manuscripts
443036|NCT01255488|Family Nurse Practitioners|family nurse practitioners
443037|NCT01255462|AMD,|amd,
443038|NCT01255462|ARMD,|armd,
443039|NCT01255462|Age-related Macular Degeneration,|age-related macular degeneration,
443040|NCT01255462|Eye Disease,|eye disease,
443041|NCT01255462|Wet AMD,|wet amd,
443042|NCT01255462|Neovascular AMD,|neovascular amd,
443043|NCT01255462|Choroidal Neovascular Membrane,|choroidal neovascular membrane,
443044|NCT01255462|Choroidal Neovascularization,|choroidal neovascularization,
443045|NCT01255462|Drusen,|drusen,
443046|NCT01255462|Geographic Atrophy,|geographic atrophy,
443047|NCT01255462|Complement,|complement,
443048|NCT01255462|C5,|c5,
443049|NCT01255462|Antibody|antibody
443050|NCT01255449|Forced oscillation technique|forced oscillation technique
443051|NCT01255449|Respiratory input impedance|respiratory input impedance
443052|NCT01255449|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
443053|NCT01255449|Obliterative bronchiolitis|obliterative bronchiolitis
443054|NCT01255423|Ankle sprain, soft tissue injury|ankle sprain, soft tissue injury
443055|NCT01255397|male infertility|male infertility
443056|NCT01255397|natural cycle IVF|natural cycle ivf
443057|NCT01255397|in-vitro fertilization|in-vitro fertilization
443058|NCT01255397|intrauterine inseminatio|intrauterine inseminatio
443059|NCT01255371|HIV|hiv
443060|NCT01255371|Second line antiretroviral treatment|second line antiretroviral treatment
443061|NCT01255371|Sub saharian Africa|sub saharian africa
443062|NCT01255371|Generic|generic
443063|NCT01255358|Ataxia Teleangiectasia|ataxia teleangiectasia
443064|NCT01255358|AT|at
443065|NCT01255358|Ery-Dex|ery-dex
443066|NCT01255358|Dexamethasone|dexamethasone
443067|NCT01255358|Dexamethasone sodium phosphate|dexamethasone sodium phosphate
443068|NCT01255345|Physiotherapy|physiotherapy
443069|NCT01255345|Multidisciplinary Pain Centers|multidisciplinary pain centers
443070|NCT01255345|Pain measurements|pain measurements
443071|NCT01255345|Physical activity|physical activity
443072|NCT01255345|Quality of life|quality of life
443074|NCT01255319|MDS|mds
443075|NCT01255306|Rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
443076|NCT01255306|Pars plana vitrectomy|pars plana vitrectomy
443077|NCT01255306|Silicone oil|silicone oil
443078|NCT01255306|Retinal nerve fibre layer|retinal nerve fibre layer
443079|NCT01255293|Retinal detachment|retinal detachment
443080|NCT01255293|Proliferative vitreoretinopathy|proliferative vitreoretinopathy
443081|NCT01255293|Diabetic retinopathy|diabetic retinopathy
443082|NCT01255293|Vitrectomy|vitrectomy
443083|NCT01255293|Silicone oil|silicone oil
443084|NCT01255280|Crystal methamphetamine abuse|crystal methamphetamine abuse
443085|NCT01255280|Crystal methamphetamine dependence|crystal methamphetamine dependence
443086|NCT01255280|Sexual risk behavior|sexual risk behavior
443087|NCT01255280|Men who have sex with men (MSM)|men who have sex with men (msm)
443088|NCT01255280|Behavioral activation|behavioral activation
443089|NCT01255267|Acute coronary syndrome and chronic coronary artery disease patients|acute coronary syndrome and chronic coronary artery disease patients
443090|NCT01255254|he effect of gingival scaling on Metabolic control|he effect of gingival scaling on metabolic control
443091|NCT01255241|Lower Limbs Deformities|lower limbs deformities
443092|NCT01255241|kinetics|kinetics
443093|NCT01255241|kinematics|kinematics
443094|NCT01255241|gait|gait
443095|NCT01255241|energy expenditure|energy expenditure
443096|NCT01255228|obesity|obesity
443097|NCT01255228|body composition|body composition
443098|NCT01255228|adipocyte-derived cytokine|adipocyte-derived cytokine
443099|NCT01255228|low glycemic index|low glycemic index
443100|NCT01255215|malaria|malaria
443101|NCT01255215|children|children
443102|NCT01255202|preeclampsia|preeclampsia
443103|NCT01255202|toxemia|toxemia
443104|NCT01255202|twin|twin
443105|NCT01255202|pregnancy|pregnancy
443106|NCT01255202|pp13|pp13
443107|NCT01255202|prediction|prediction
443108|NCT01255202|kongo red|kongo red
443109|NCT01255189|NIRS|nirs
443110|NCT01255176|Infant|infant
443111|NCT01255176|Physical Therapy|physical therapy
443112|NCT01255163|Alzheimer's|alzheimer's
443113|NCT01255163|Brain insulin resistance|brain insulin resistance
443114|NCT01255163|Diabetes|diabetes
443115|NCT01255150|Genetic Ancestry Analysis|genetic ancestry analysis
443116|NCT01255150|Molecular Profiling|molecular profiling
443117|NCT01255150|Smoking Status|smoking status
443118|NCT01255150|Wood Smoke Exposure|wood smoke exposure
443119|NCT01255150|EGFR Mutation Analysis|egfr mutation analysis
443120|NCT01255150|Non Small Cell Lung Cancer|non small cell lung cancer
443121|NCT01255137|Selective VEGF Inhibitor|selective vegf inhibitor
443122|NCT01255137|Clinical Activity|clinical activity
443123|NCT01255137|Response Rate|response rate
443124|NCT01255137|Measurable Disease|measurable disease
443125|NCT01255137|Biological Markers|biological markers
443126|NCT01255137|Adrenocortical Cancer|adrenocortical cancer
443127|NCT01255111|Chronic respiratory failure|chronic respiratory failure
443128|NCT01255111|Noninvasive ventilation|noninvasive ventilation
443129|NCT01255111|Patient-ventilator interactions|patient-ventilator interactions
443130|NCT01255111|Sleep|sleep
443131|NCT01255111|Sleep fragmentation|sleep fragmentation
443132|NCT01255085|Obesity|obesity
443133|NCT01255085|Food intake regulation|food intake regulation
443134|NCT01255085|blood glucose regulation|blood glucose regulation
443135|NCT01255085|protein|protein
443136|NCT01255085|fiber|fiber
443137|NCT01255085|pulses|pulses
443138|NCT01255085|yellow peas|yellow peas
443139|NCT01255072|TMS|tms
443140|NCT01255072|elderly|elderly
443141|NCT01255072|depression|depression
443142|NCT01255072|neuronavegation|neuronavegation
443143|NCT01255072|neurocognition|neurocognition
443144|NCT01255059|Genome-wide association studies(GWAS)|genome-wide association studies(gwas)
443145|NCT01255059|Single nucleotide polymorphism(SNP)|single nucleotide polymorphism(snp)
443146|NCT01255059|Lung cancer|lung cancer
443147|NCT01255033|perioperative surgery|perioperative surgery
443148|NCT01255033|regional oxygenation|regional oxygenation
443149|NCT01255033|hypoxemia|hypoxemia
443150|NCT01255033|brain hypoxemia|brain hypoxemia
443151|NCT01255033|spectroscopy, near-infrared|spectroscopy, near-infrared
443152|NCT01255020|α-Keto Acid|α-keto acid
443153|NCT01255020|Restricted Protein Diet|restricted protein diet
443154|NCT01255020|Residual Renal Function|residual renal function
443155|NCT01255007|Colorectal|colorectal
443156|NCT01255007|liver|liver
443157|NCT01255007|metastases|metastases
443158|NCT01255007|Primovist|primovist
443159|NCT01255007|MRI|mri
443160|NCT01255007|CT|ct
443161|NCT01255007|cancer|cancer
443162|NCT01255007|resection|resection
443163|NCT01255007|MDCT|mdct
443164|NCT01255007|Diffusion|diffusion
443165|NCT01255007|Weighted|weighted
443166|NCT01255007|3T|3t
443167|NCT01254994|hepatitis B|hepatitis b
443168|NCT01254994|acute on chronic liver failure (ACHBLF)|acute on chronic liver failure (achblf)
443169|NCT01254994|entecavir|entecavir
443170|NCT01254994|treatment|treatment
443171|NCT01254994|predicting|predicting
443172|NCT01254981|Percutaneous coronary intervention|percutaneous coronary intervention
443173|NCT01254981|DES|des
443174|NCT01254981|Angina pectoris|angina pectoris
443175|NCT01254981|Stent|stent
443176|NCT01254968|blood flow in the middle cerebral artery of brain|blood flow in the middle cerebral artery of brain
443177|NCT01254955|2009 H1N1 influenza vaccine, organ transplant patients|2009 h1n1 influenza vaccine, organ transplant patients
443178|NCT01254942|exercise|exercise
443179|NCT01254942|hip fractures|hip fractures
443180|NCT01254942|rehabilitation|rehabilitation
443181|NCT01254942|aged|aged
443182|NCT01254942|aged 80 and over|aged 80 and over
443183|NCT01254929|Cancer|cancer
443184|NCT01254929|Bone metastases|bone metastases
443185|NCT01254916|Chronic Rhinosinusitis|chronic rhinosinusitis
443186|NCT01254916|Sinonasal Outcome test 22|sinonasal outcome test 22
443187|NCT01254903|Stereotactic Radiosurgery|stereotactic radiosurgery
443189|NCT01254903|Radiotherapy|radiotherapy
443190|NCT01254903|Metastatic Epidural Spinal Cord Compression|metastatic epidural spinal cord compression
443191|NCT01254903|MESCC|mescc
443192|NCT01254890|Relapsed Acute Leukemia|relapsed acute leukemia
443193|NCT01254890|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
443194|NCT01254890|CMML|cmml
443195|NCT01254890|Myelodysplastic Syndrome|myelodysplastic syndrome
443197|NCT01254890|Acute myeloid leukemia|acute myeloid leukemia
443198|NCT01254890|AML|aml
443199|NCT01254890|5-azacitidine|5-azacitidine
443200|NCT01254890|Azacitidine|azacitidine
443201|NCT01254890|5-aza|5-aza
443202|NCT01254890|Vidaza|vidaza
443203|NCT01254890|5-AZC|5-azc
443204|NCT01254890|AZA-CR|aza-cr
443205|NCT01254890|Ladakamycin|ladakamycin
443206|NCT01254890|NSC-102816|nsc-102816
443207|NCT01254890|Sorafenib|sorafenib
443208|NCT01254890|Nexavar|nexavar
443209|NCT01254890|BAY43-9006|bay43-9006
443210|NCT01254877|HIV|hiv
443211|NCT01254864|Castrate resistant prostate cancer|castrate resistant prostate cancer
443212|NCT01254864|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
443213|NCT01254864|Sunitinib Malate|sunitinib malate
443214|NCT01254864|SUO11248|suo11248
443215|NCT01254864|Sutent|sutent
443216|NCT01254864|BMS-354825|bms-354825
443217|NCT01254864|Sprycel|sprycel
443218|NCT01254851|discharge criteria, gynecologic surgery, post-op ambulation|discharge criteria, gynecologic surgery, post-op ambulation
443219|NCT01254825|Adductor Canal Block (ACB)|adductor canal block (acb)
443220|NCT01254825|Diagnostic Knee Arthroscopy|diagnostic knee arthroscopy
443221|NCT01254825|Saphenous nerve|saphenous nerve
443222|NCT01254825|Pain|pain
443223|NCT01254825|Ultrasound block|ultrasound block
443224|NCT01254812|pulmonary function|pulmonary function
443225|NCT01254812|BD-TAP-block|bd-tap-block
443226|NCT01254786|VATS|vats
443227|NCT01254786|one lung ventilation|one lung ventilation
443228|NCT01254786|continuous positive pressure ventilation|continuous positive pressure ventilation
443229|NCT01254786|high frequency positive pressure ventilation|high frequency positive pressure ventilation
443230|NCT01254721|Acute bipolar mania|acute bipolar mania
443231|NCT01254721|Seroquel XR|seroquel xr
443232|NCT01254721|Seroquel XR plus lithium|seroquel xr plus lithium
443233|NCT01254721|Quetiapine fumarate|quetiapine fumarate
443234|NCT01254695|Idiopathic Fecal Incontinence|idiopathic fecal incontinence
443235|NCT01254695|Fecal Incontinence|fecal incontinence
443236|NCT01254695|Sacral Nerve Stimulation|sacral nerve stimulation
443237|NCT01254695|Sacral Nerve Neuromodulation|sacral nerve neuromodulation
443238|NCT01254682|wrist|wrist
443239|NCT01254682|joint|joint
443240|NCT01254682|arthroscopy|arthroscopy
443241|NCT01254682|hyaluronan|hyaluronan
443242|NCT01254682|hyaluronic acid|hyaluronic acid
443243|NCT01254682|Necessity of Arthroscopic surgery|necessity of arthroscopic surgery
443244|NCT01254669|Haitian girls, African American girls|haitian girls, african american girls
443245|NCT01254669|Brief Negotiated Interview|brief negotiated interview
443246|NCT01254669|cognitive behavioral intervention|cognitive behavioral intervention
443247|NCT01254669|HPV vaccine|hpv vaccine
443248|NCT01254669|cervical cancer|cervical cancer
443249|NCT01254643|Papillomavirus vaccines|papillomavirus vaccines
443250|NCT01254643|Uterine cervical cancer|uterine cervical cancer
443251|NCT01254643|Human Papilloma Virus infections|human papilloma virus infections
443252|NCT01254630|Herpes zoster|herpes zoster
443253|NCT01254630|vaccine|vaccine
443254|NCT01254630|herpes-zoster-related complications|herpes-zoster-related complications
443255|NCT01254630|immunocompromised|immunocompromised
443256|NCT01254630|herpes zoster-associated pain|herpes zoster-associated pain
443257|NCT01254630|solid tumor malignancy|solid tumor malignancy
443258|NCT01254630|hematologic malignancy|hematologic malignancy
443259|NCT01254604|Tafluprost|tafluprost
443260|NCT01254604|Glaucoma|glaucoma
443261|NCT01254604|Ocular Hypertension|ocular hypertension
443262|NCT01254604|Timolol|timolol
443263|NCT01254604|Eye Disorder|eye disorder
443264|NCT01254604|Preservative-Free|preservative-free
443265|NCT01254604|Prostaglandin Analogue|prostaglandin analogue
443266|NCT01254591|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
443267|NCT01254591|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
443268|NCT01254591|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
443269|NCT01254591|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
443270|NCT01254591|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
443271|NCT01254591|stage I colon cancer|stage i colon cancer
443272|NCT01254591|stage IIA colon cancer|stage iia colon cancer
443273|NCT01254591|stage IIB colon cancer|stage iib colon cancer
443274|NCT01254591|stage IIC colon cancer|stage iic colon cancer
443275|NCT01254591|stage IIIA colon cancer|stage iiia colon cancer
443276|NCT01254591|stage I rectal cancer|stage i rectal cancer
443277|NCT01254591|stage IIA rectal cancer|stage iia rectal cancer
443278|NCT01254591|stage IIB rectal cancer|stage iib rectal cancer
443279|NCT01254591|stage IIC rectal cancer|stage iic rectal cancer
443280|NCT01254591|stage IIIA rectal cancer|stage iiia rectal cancer
443281|NCT01254591|stage IA breast cancer|stage ia breast cancer
443282|NCT01254591|stage IB breast cancer|stage ib breast cancer
443283|NCT01254591|stage II breast cancer|stage ii breast cancer
443284|NCT01254591|stage IIIA breast cancer|stage iiia breast cancer
443285|NCT01254591|stage IIIB breast cancer|stage iiib breast cancer
443286|NCT01254591|stage I esophageal cancer|stage i esophageal cancer
443287|NCT01254591|stage II esophageal cancer|stage ii esophageal cancer
443288|NCT01254591|stage III esophageal cancer|stage iii esophageal cancer
443289|NCT01254591|stage I hypopharyngeal cancer|stage i hypopharyngeal cancer
443290|NCT01254591|stage II hypopharyngeal cancer|stage ii hypopharyngeal cancer
443291|NCT01254591|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
443292|NCT01254591|stage I laryngeal cancer|stage i laryngeal cancer
443293|NCT01254591|stage II laryngeal cancer|stage ii laryngeal cancer
443294|NCT01254591|stage III laryngeal cancer|stage iii laryngeal cancer
443295|NCT01254591|stage I lip and oral cavity cancer|stage i lip and oral cavity cancer
443296|NCT01254591|stage II lip and oral cavity cancer|stage ii lip and oral cavity cancer
443297|NCT01254591|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
443298|NCT01254591|stage I nasopharyngeal cancer|stage i nasopharyngeal cancer
443299|NCT01254591|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
443300|NCT01254591|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
443301|NCT01254591|stage I oropharyngeal cancer|stage i oropharyngeal cancer
443302|NCT01254591|stage II oropharyngeal cancer|stage ii oropharyngeal cancer
443303|NCT01254591|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
443304|NCT01254591|stage I paranasal sinus and nasal cavity cancer|stage i paranasal sinus and nasal cavity cancer
443305|NCT01254591|stage II paranasal sinus and nasal cavity cancer|stage ii paranasal sinus and nasal cavity cancer
443306|NCT01254591|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
443307|NCT01254591|stage I salivary gland cancer|stage i salivary gland cancer
443308|NCT01254591|stage II salivary gland cancer|stage ii salivary gland cancer
443309|NCT01254591|stage III salivary gland cancer|stage iii salivary gland cancer
443310|NCT01254591|tongue cancer|tongue cancer
443311|NCT01254565|Clinical Trial, Phase 2|clinical trial, phase 2
443312|NCT01254565|Renal Dialysis|renal dialysis
443313|NCT01254565|Secondary Hyperparathyroidism|secondary hyperparathyroidism
443314|NCT01254565|Parathyroid hormone|parathyroid hormone
443315|NCT01254539|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
443316|NCT01254539|Bone marrow|bone marrow
443317|NCT01254539|Stem cells|stem cells
443318|NCT01254539|Autologous|autologous
443319|NCT01254539|Safety|safety
443320|NCT01254513|Metastatic Prostate cancer|metastatic prostate cancer
443321|NCT01254513|Elderly patients|elderly patients
443322|NCT01254513|Vulnerable and Frail (SIOG classification)|vulnerable and frail (siog classification)
443323|NCT01254513|castration-resistant|castration-resistant
443324|NCT01254500|patients with brain lesions|patients with brain lesions
443325|NCT01254474|Depolarization, tissue|depolarization, tissue
443326|NCT01254474|Repolarization, tissue|repolarization, tissue
443327|NCT01254474|Cardiac Arrhythmias|cardiac arrhythmias
443328|NCT01254474|Action potentials, monophasic|action potentials, monophasic
443329|NCT01254474|Mapping, Catheter|mapping, catheter
443330|NCT01254474|Cardiac activation|cardiac activation
443331|NCT01254461|Phase 1|phase 1
443332|NCT01254461|Drug-Drug interaction|drug-drug interaction
443333|NCT01254461|pravastatin|pravastatin
443334|NCT01254461|AZD1981|azd1981
443335|NCT01254461|The pharmacokinetics resulting from AZD1981 and pravastatin interaction|the pharmacokinetics resulting from azd1981 and pravastatin interaction
443336|NCT01254461|The effects of taking a combination of AZD1981 and pravastatin|the effects of taking a combination of azd1981 and pravastatin
443337|NCT01254448|Alzheimer's Disease|alzheimer's disease
443338|NCT01254435|Colonoscopy|colonoscopy
443339|NCT01254435|Positioning in colonoscopy|positioning in colonoscopy
443340|NCT01254435|Quality control|quality control
443341|NCT01254422|Dengue fever|dengue fever
443342|NCT01254422|Dengue hemorrhagic fever|dengue hemorrhagic fever
443343|NCT01254422|CYD dengue vaccine|cyd dengue vaccine
443344|NCT01254409|pulmonary, fibrosis|pulmonary, fibrosis
443345|NCT01254396|Bioavailability Food Effect Oral Dissolving Tablet (ODT)|bioavailability food effect oral dissolving tablet (odt)
443346|NCT01254383|Bioequivalence Oral Dissolving Tablet|bioequivalence oral dissolving tablet
443347|NCT01254357|Burns|burns
443348|NCT01254357|Trauma|trauma
443349|NCT01254357|Outcomes|outcomes
443350|NCT01254357|Quality of Life|quality of life
443351|NCT01254344|Colorectal surgery|colorectal surgery
443352|NCT01254318|hematological malignancy|hematological malignancy
443353|NCT01254318|fungal infection|fungal infection
443354|NCT01254318|leukemia|leukemia
443355|NCT01254305|Depression|depression
443356|NCT01254305|Fatigue|fatigue
443357|NCT01254305|Major Depressive Disorder|major depressive disorder
443358|NCT01254266|morbid obesity|morbid obesity
443359|NCT01254266|adolescents|adolescents
443360|NCT01254266|inpatient treatment|inpatient treatment
443361|NCT01254253|percutaneous coronary intervention|percutaneous coronary intervention
443362|NCT01254253|chronic total occlusion|chronic total occlusion
443363|NCT01254253|coronary angiography|coronary angiography
443364|NCT01254253|single photon emission CT|single photon emission ct
443365|NCT01254253|Multislice coronary CT angiography|multislice coronary ct angiography
443366|NCT01254227|Cardiac iron overload,|cardiac iron overload,
443367|NCT01254227|deferasirox,|deferasirox,
443368|NCT01254227|deferoxamine|deferoxamine
443369|NCT01254214|Mindfulness|mindfulness
443370|NCT01254214|Quality of life|quality of life
443371|NCT01254214|Transplantation|transplantation
443372|NCT01254214|Renal disease|renal disease
443373|NCT01254188|Chronic myeloid leukemia,|chronic myeloid leukemia,
443374|NCT01254188|CML,|cml,
443375|NCT01254188|nilotinib,|nilotinib,
443376|NCT01254188|myelogenous,|myelogenous,
443377|NCT01254188|Philadelphia chromosome|philadelphia chromosome
443378|NCT01254162|Oily Skin|oily skin
443379|NCT01254162|Sebum|sebum
443380|NCT01254123|Glucagon Like Peptide-1|glucagon like peptide-1
443381|NCT01254123|Exenatide|exenatide
443382|NCT01254123|myocardial infarction|myocardial infarction
443383|NCT01254123|MRI|mri
443384|NCT01254123|PCI|pci
443385|NCT01254084|Herbal medicine; Type 2 diabetes; Gynostemma pentaphyllum Tea; Insulin sensitivity;|herbal medicine; type 2 diabetes; gynostemma pentaphyllum tea; insulin sensitivity;
443386|NCT01254071|GI198745|gi198745
443387|NCT01254071|Tamsulosin hydrochloride|tamsulosin hydrochloride
443388|NCT01254071|Dutasteride|dutasteride
443389|NCT01254071|food effect|food effect
443390|NCT01254071|healthy male subjects|healthy male subjects
443391|NCT01254071|north-east Asian ancestry|north-east asian ancestry
443392|NCT01254071|Bioequivalence|bioequivalence
443393|NCT01254071|cross-over design|cross-over design
443394|NCT01254071|Pilot bioequivalence|pilot bioequivalence
443395|NCT01254032|CAT|cat
443396|NCT01254032|COPD|copd
443397|NCT01254019|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
443398|NCT01254019|DMD|dmd
443399|NCT01254019|968|968
443400|NCT01254019|GSK|gsk
443401|NCT01254019|Duchenne|duchenne
443402|NCT01253993|Disruptive Behavior Disorders, Substance abuse,|disruptive behavior disorders, substance abuse,
443403|NCT01253993|Iowa Gambling Task, Decision Making.|iowa gambling task, decision making.
443404|NCT01253980|pneumonitis|pneumonitis
443405|NCT01253980|paraffin|paraffin
443406|NCT01253980|kerosene|kerosene
443407|NCT01253967|Gastroenteritis|gastroenteritis
443408|NCT01253967|Hospital surveillance|hospital surveillance
443409|NCT01253967|Rotavirus gastroenteritis|rotavirus gastroenteritis
443410|NCT01253954|invasive candida infection|invasive candida infection
443411|NCT01253941|COPD, Intensive Resistive Breathing, Cytokine IL6,|copd, intensive resistive breathing, cytokine il6,
443412|NCT01253928|body composition|body composition
443413|NCT01253928|insulin sensitivity|insulin sensitivity
443414|NCT01253928|protein metabolism|protein metabolism
443415|NCT01253928|pioglitazone|pioglitazone
443416|NCT01253889|Functional echocardiography|functional echocardiography
443417|NCT01253889|oral glucose|oral glucose
443418|NCT01253889|neonatal stress|neonatal stress
443419|NCT01253863|Clinical Examination, Accuracy, Hand, Tendon, Injury.|clinical examination, accuracy, hand, tendon, injury.
443420|NCT01253850|hiv|hiv
443421|NCT01253850|antiretroviral|antiretroviral
443422|NCT01253850|adherence|adherence
443423|NCT01253850|adolescent|adolescent
443424|NCT01253837|L19|l19
443425|NCT01253837|antibody|antibody
443426|NCT01253837|monoclonal|monoclonal
443427|NCT01253837|tumor targeting|tumor targeting
443428|NCT01253837|TNFa|tnfa
443429|NCT01253837|colorectal cancer|colorectal cancer
443430|NCT01253837|Phase I: Patients with relapsed or refractory locally advanced or metastatic solid tumors not amenable to standard systemic therapy.|phase i: patients with relapsed or refractory locally advanced or metastatic solid tumors not amenable to standard systemic therapy.
443431|NCT01253837|Phase II: Patients with relapsed or refractory locally advanced or metastatic colorectal cancer not amenable to standard systemic therapy.|phase ii: patients with relapsed or refractory locally advanced or metastatic colorectal cancer not amenable to standard systemic therapy.
443432|NCT01253824|NPC-01|npc-01
443433|NCT01253824|IKH-01|ikh-01
443434|NCT01253824|Pharmacodynamics|pharmacodynamics
443435|NCT01253824|Norethisterone|norethisterone
443436|NCT01253824|Ethinyl Estradiol|ethinyl estradiol
443437|NCT01253824|Estradiol|estradiol
443438|NCT01253824|Progesterone|progesterone
443439|NCT01253824|FSH|fsh
443440|NCT01253824|LH|lh
443441|NCT01253798|exercise|exercise
443442|NCT01253798|hydrotherapy|hydrotherapy
443443|NCT01253759|Transpupillary thermotherapy|transpupillary thermotherapy
443444|NCT01253759|Choroidal melanoma|choroidal melanoma
443445|NCT01253759|ICG-Photodynamic therapy|icg-photodynamic therapy
443446|NCT01253746|NTD|ntd
443447|NCT01253746|open NTD|open ntd
443448|NCT01253746|spina bifida|spina bifida
443449|NCT01253746|anencephaly|anencephaly
443450|NCT01253746|closed NTD|closed ntd
443451|NCT01253746|lipomeningocele|lipomeningocele
443452|NCT01253746|tethered cord.|tethered cord.
443453|NCT01253733|Cystic Fibrosis|cystic fibrosis
443454|NCT01253733|Inflammatory Bowel Disease|inflammatory bowel disease
443455|NCT01253733|Type 1 Diabetes|type 1 diabetes
443456|NCT01253733|Chronic Disease Management|chronic disease management
443457|NCT01253733|SMS|sms
443458|NCT01253733|Text messages|text messages
443459|NCT01253733|Internet|internet
443460|NCT01253733|Healthcare Interactions|healthcare interactions
443461|NCT01253720|obesity|obesity
443462|NCT01253720|text messages|text messages
443463|NCT01253720|internet|internet
443464|NCT01253720|cancer|cancer
443465|NCT01253720|overweight|overweight
443466|NCT01253707|Solid Tumors|solid tumors
443467|NCT01253707|C-met inhibitor|c-met inhibitor
443468|NCT01253694|Diabetes|diabetes
443469|NCT01253694|edema|edema
443470|NCT01253694|ranibizumab|ranibizumab
443471|NCT01253694|bevacizumab|bevacizumab
443472|NCT01253694|refractory|refractory
443473|NCT01253681|AMG 386|amg 386
443474|NCT01253681|Ovarian Cancer|ovarian cancer
443475|NCT01253655|Healthy Volunteers|healthy volunteers
443476|NCT01253629|Fragile X Syndrome|fragile x syndrome
443477|NCT01253629|Martin-Bell Syndrome|martin-bell syndrome
443478|NCT01253629|Genetic Diseases|genetic diseases
443479|NCT01253629|X-Linked|x-linked
443480|NCT01253603|Asthma|asthma
443481|NCT01253590|atrial fibrillation|atrial fibrillation
443482|NCT01253590|ECG monitor|ecg monitor
443483|NCT01253590|Blood pressure device|blood pressure device
443484|NCT01253590|Remote Cardiac Monitoring|remote cardiac monitoring
443485|NCT01253551|VX-950HEP1001|vx-950hep1001
443486|NCT01253551|hepatitis|hepatitis
443487|NCT01253551|telaprevir|telaprevir
443488|NCT01253551|raltegravir|raltegravir
443489|NCT01253551|crossover|crossover
443490|NCT01253551|healthy volunteers|healthy volunteers
443491|NCT01253551|VX-950.|vx-950.
443492|NCT01253525|Adenocarcinoma|adenocarcinoma
443493|NCT01253525|Gastroesophageal Junction|gastroesophageal junction
443494|NCT01253512|Ischemic Stroke|ischemic stroke
443495|NCT01253512|Thrombolysis|thrombolysis
443496|NCT01253486|expressive writing|expressive writing
443497|NCT01253486|cardiac rehabilitation|cardiac rehabilitation
443498|NCT01253473|COPD|copd
443499|NCT01253460|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
443500|NCT01253460|CLL|cll
443501|NCT01253460|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
443502|NCT01253460|SLL|sll
443503|NCT01253460|Cyclophosphamide|cyclophosphamide
443504|NCT01253460|Rituximab|rituximab
443505|NCT01253460|Sapacitabine|sapacitabine
443506|NCT01253460|Cytoxan|cytoxan
443507|NCT01253460|Neosar|neosar
443508|NCT01253460|Rituxan|rituxan
443509|NCT01253434|Transdermal Administration|transdermal administration
443510|NCT01253421|MDD|mdd
443511|NCT01253421|Major Depressive Disorder|major depressive disorder
443512|NCT01253421|Amisulpride|amisulpride
443513|NCT01253408|anandamide|anandamide
443514|NCT01253408|cannabinoid|cannabinoid
443515|NCT01253408|fatty acid amide hydrolase|fatty acid amide hydrolase
443516|NCT01253408|gastric|gastric
443517|NCT01253408|motility|motility
443518|NCT01253408|small bowel|small bowel
443519|NCT01253395|Exercise|exercise
443520|NCT01253395|Pain|pain
443521|NCT01253369|pazopanib|pazopanib
443522|NCT01253317|Rett Syndrome|rett syndrome
443523|NCT01253317|IGF-1|igf-1
443524|NCT01253317|Increlex|increlex
443525|NCT01253317|Mecasermin|mecasermin
443526|NCT01253317|IGF1|igf1
443527|NCT01253317|MECP2|mecp2
443528|NCT01253317|RTT|rtt
443529|NCT01253252|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
443530|NCT01253252|Prosthesis|prosthesis
443531|NCT01253252|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
443532|NCT01253252|Positron-emission Tomography|positron-emission tomography
443533|NCT01253252|Spiral computed tomography|spiral computed tomography
443534|NCT01253252|Biological markers|biological markers
443535|NCT01253239|Visual outcomes|visual outcomes
443536|NCT01253239|Patient satisfaction|patient satisfaction
443537|NCT01253213|Prostate cancer|prostate cancer
443538|NCT01253213|Ultrasound molecular imaging|ultrasound molecular imaging
443539|NCT01253213|Contrast agent|contrast agent
443540|NCT01253213|BR55|br55
443541|NCT01253213|VEGFR2|vegfr2
443542|NCT01253200|Type 1 Atrial Flutter|type 1 atrial flutter
443543|NCT01253200|Typical Atrial Flutter|typical atrial flutter
443544|NCT01253200|Arrhythmias, Cardiac|arrhythmias, cardiac
443545|NCT01253200|Heart Diseases|heart diseases
443546|NCT01253200|Cardiovascular Diseases|cardiovascular diseases
443547|NCT01253161|advanced|advanced
443548|NCT01253161|metastatic|metastatic
443549|NCT01253161|unresectable|unresectable
443550|NCT01253161|carcinoma|carcinoma
443551|NCT01253161|gastrointestinal tract|gastrointestinal tract
443552|NCT01253161|lungs|lungs
443553|NCT01253161|colon|colon
443554|NCT01253161|liver|liver
443555|NCT01253161|rectum|rectum
443556|NCT01253161|small intestine|small intestine
443557|NCT01253161|stomach|stomach
443558|NCT01253161|pancreatic|pancreatic
443559|NCT01253148|Liver|liver
443560|NCT01253148|Bile Duct|bile duct
443561|NCT01253135|Fibrin, white petrolatum, wound healing|fibrin, white petrolatum, wound healing
443562|NCT01253096|Interleukin|interleukin
443564|NCT01253096|monoclonal|monoclonal
443565|NCT01253096|antibody|antibody
443566|NCT01253096|cytokine|cytokine
443567|NCT01253096|metastatic|metastatic
443568|NCT01253096|melanoma|melanoma
443569|NCT01253096|tumor targeting|tumor targeting
443570|NCT01253096|intratumoral|intratumoral
443665|NCT01252810|NYHA New York Heart Association|nyha new york heart association
443666|NCT01252810|PCI Percutaneous coronary intervention|pci percutaneous coronary intervention
443571|NCT01253096|Malignant melanoma with presence of injectable soft-tissue metastases either in clinical stage III or stage IV without visceral metastases.|malignant melanoma with presence of injectable soft-tissue metastases either in clinical stage iii or stage iv without visceral metastases.
443572|NCT01253083|Mobility|mobility
443573|NCT01253083|Developmental Delay|developmental delay
443574|NCT01253083|Cerebral Palsy|cerebral palsy
443575|NCT01253083|Early Walking|early walking
443576|NCT01253083|Postural Control|postural control
443577|NCT01253057|cleaning staff|cleaning staff
443578|NCT01253057|antineoplastic agents|antineoplastic agents
443579|NCT01253044|OEF/OIF|oef/oif
443580|NCT01253044|Veterans|veterans
443581|NCT01253044|Psychotherapy|psychotherapy
443582|NCT01253031|hearing loss|hearing loss
443583|NCT01253031|aging|aging
443584|NCT01253031|short term memory|short term memory
443585|NCT01253031|attentional blink|attentional blink
443586|NCT01253018|stroke|stroke
443587|NCT01253018|robotics|robotics
443588|NCT01253018|upper extremity rehabilitation|upper extremity rehabilitation
443589|NCT01252992|Extrapulmonary|extrapulmonary
443590|NCT01252992|Tuberculosis|tuberculosis
443591|NCT01252992|Paradoxical reaction|paradoxical reaction
443592|NCT01252992|Risk factors|risk factors
443593|NCT01252992|Incidence|incidence
443594|NCT01252992|CT scan|ct scan
443595|NCT01252992|Natural history|natural history
443596|NCT01252992|Immune system phenomena|immune system phenomena
443597|NCT01252992|Immune markers|immune markers
443598|NCT01252992|Gene Expression Profiling|gene expression profiling
443599|NCT01252979|MELAS|melas
443600|NCT01252979|Ketones|ketones
443601|NCT01252979|Medium Chain Triglycerides|medium chain triglycerides
443602|NCT01252979|MCT oil|mct oil
443603|NCT01252979|Mitochondrial Disorder|mitochondrial disorder
443604|NCT01252979|Heteroplasmy|heteroplasmy
443605|NCT01252979|3243AG|3243ag
443606|NCT01252979|Subject is informed and given ample opportunity to consider his/her participation and has given his/her written consent.|subject is informed and given ample opportunity to consider his/her participation and has given his/her written consent.
443607|NCT01252979|Subject is willing and able to comply with all trial requirements.|subject is willing and able to comply with all trial requirements.
443608|NCT01252979|Subject harbors the 3243 A>G mtDNA mutation at a level detectable in blood.|subject harbors the 3243 a>g mtdna mutation at a level detectable in blood.
443609|NCT01252979|Female subjects of child-bearing potential must not be pregnant.|female subjects of child-bearing potential must not be pregnant.
443610|NCT01252979|Subjects must not have Diabetes Mellitus.|subjects must not have diabetes mellitus.
443611|NCT01252966|Tobacco|tobacco
443612|NCT01252966|Smoking|smoking
443613|NCT01252966|Cognition|cognition
443614|NCT01252966|Behavioral Training|behavioral training
443615|NCT01252966|Relapse|relapse
443616|NCT01252953|vascular disease|vascular disease
443617|NCT01252953|lipids|lipids
443618|NCT01252953|cholesteryl ester transfer protein (CETP) inhibition|cholesteryl ester transfer protein (cetp) inhibition
443619|NCT01252953|anacetrapib|anacetrapib
443620|NCT01252940|HIV-1|hiv-1
443621|NCT01252940|HIV|hiv
443622|NCT01252940|Treatment Experienced|treatment experienced
443623|NCT01252914|Open angle|open angle
443624|NCT01252914|Glaucoma|glaucoma
443625|NCT01252914|Surgery|surgery
443626|NCT01252914|Ocular Hypertension|ocular hypertension
443627|NCT01252914|Eye Diseases|eye diseases
443628|NCT01252901|WT1|wt1
443629|NCT01252901|Wilms Tumor|wilms tumor
443630|NCT01252901|Denys-Drash Syndrome|denys-drash syndrome
443631|NCT01252901|Nephrotic Syndrome|nephrotic syndrome
443632|NCT01252901|Proteinuria|proteinuria
443633|NCT01252888|Open angle|open angle
443634|NCT01252888|Glaucoma|glaucoma
443635|NCT01252888|Surgery|surgery
443636|NCT01252888|Glaucoma Open-Angle|glaucoma open-angle
443637|NCT01252888|Ocular Hypertension|ocular hypertension
443638|NCT01252888|Eye Diseases|eye diseases
443639|NCT01252875|LDL-C|ldl-c
443640|NCT01252875|Cholesterol|cholesterol
443641|NCT01252875|Stroke|stroke
443642|NCT01252875|Transient ischemic attack|transient ischemic attack
443643|NCT01252875|Statin|statin
443644|NCT01252875|Lipid lowering therapy|lipid lowering therapy
443645|NCT01252862|Open angle|open angle
443646|NCT01252862|Glaucoma|glaucoma
443647|NCT01252862|Surgery|surgery
443648|NCT01252862|Ocular Hypertension|ocular hypertension
443649|NCT01252862|eye diseases|eye diseases
443650|NCT01252849|Open angle|open angle
443651|NCT01252849|Glaucoma|glaucoma
443652|NCT01252849|surgery|surgery
443653|NCT01252849|Glaucoma, Open-Angle|glaucoma, open-angle
443654|NCT01252849|Ocular Hypertension|ocular hypertension
443655|NCT01252849|Eye Diseases|eye diseases
443656|NCT01252823|Hemodialysis|hemodialysis
443657|NCT01252823|Cardiac Arrhythmia|cardiac arrhythmia
443658|NCT01252823|Cardiac Death|cardiac death
443659|NCT01252823|Implantable Loop Recorder|implantable loop recorder
443660|NCT01252810|CATH Catheterization|cath catheterization
443661|NCT01252810|CI-AKI Contrast-induced acute kidney injury|ci-aki contrast-induced acute kidney injury
443662|NCT01252810|DM Diabetes mellitus|dm diabetes mellitus
443663|NCT01252810|eGFR Estimated glomerular filtration rate|egfr estimated glomerular filtration rate
443664|NCT01252810|MDRD Modification of Diet in Renal Disease|mdrd modification of diet in renal disease
443667|NCT01252810|SCr Serum creatinine|scr serum creatinine
443668|NCT01252797|brain metastases|brain metastases
443669|NCT01252784|higher risk MDS|higher risk mds
443670|NCT01252771|phosphorus|phosphorus
443671|NCT01252771|dialysis|dialysis
443672|NCT01252771|PhosLo|phoslo
443673|NCT01252732|ABSSSI|absssi
443674|NCT01252732|Skin Infection|skin infection
443675|NCT01252732|Abscess|abscess
443676|NCT01252719|ABSSSI|absssi
443677|NCT01252719|Skin Infection|skin infection
443678|NCT01252719|Abscess|abscess
443679|NCT01252706|brief intervention|brief intervention
443680|NCT01252706|alcohol|alcohol
443681|NCT01252706|nicotine|nicotine
443682|NCT01252706|drug abuse|drug abuse
443683|NCT01252654|Lasik|lasik
443684|NCT01252654|Femtosecond Laser|femtosecond laser
443685|NCT01252654|Visumax|visumax
443686|NCT01252654|IntraLase|intralase
443687|NCT01252654|Myopia|myopia
443688|NCT01252654|Myopic Patients undergoing LASIK|myopic patients undergoing lasik
443690|NCT01252628|CRC|crc
443691|NCT01252628|SCCHN|scchn
443692|NCT01252628|PX-866|px-866
443693|NCT01252628|Cetuximab|cetuximab
443694|NCT01252628|ERBITUX|erbitux
443695|NCT01252628|Colon|colon
443696|NCT01252628|Head and Neck|head and neck
443697|NCT01252628|Colorectal cancer|colorectal cancer
443698|NCT01252628|Squamous cell carcinoma|squamous cell carcinoma
443699|NCT01252628|PI-3K|pi-3k
443700|NCT01252628|PI3 kinase|pi3 kinase
443701|NCT01252628|PI3K|pi3k
443702|NCT01252615|ICD|icd
443703|NCT01252615|HF|hf
443704|NCT01252615|cardiac arrest|cardiac arrest
443705|NCT01252615|VF|vf
443706|NCT01252615|cardiac arrhythmias|cardiac arrhythmias
443707|NCT01252602|breastfeeding, EPDS, prenatal depression|breastfeeding, epds, prenatal depression
443708|NCT01252589|Chronic Myeloid Leukemia|chronic myeloid leukemia
443709|NCT01252589|Quality of Life|quality of life
443710|NCT01252589|Symptoms|symptoms
443711|NCT01252589|Patient-Reported outcomes|patient-reported outcomes
443712|NCT01252589|Questionnaire|questionnaire
443713|NCT01252576|FSFI|fsfi
443714|NCT01252576|female sexual function|female sexual function
443715|NCT01252576|italian validation|italian validation
443716|NCT01252563|ENTER10|enter10
443717|NCT01252563|Hypertension|hypertension
443718|NCT01252563|Japanese|japanese
443719|NCT01252563|Norvasc 10mg|norvasc 10mg
443720|NCT01252563|Post Marketing surveillance|post marketing surveillance
443721|NCT01252550|IBS|ibs
443722|NCT01252550|GI|gi
443723|NCT01252550|QOL|qol
443724|NCT01252550|Pathophysiology|pathophysiology
443725|NCT01252550|Gut microbiota|gut microbiota
443726|NCT01252550|Danone|danone
443727|NCT01252550|Activia|activia
443728|NCT01252550|Probiotics|probiotics
443729|NCT01252537|HIV|hiv
443730|NCT01252537|Tuberculosis|tuberculosis
443731|NCT01252537|Immunosuppression|immunosuppression
443732|NCT01252537|ART|art
443733|NCT01252537|Ethiopia|ethiopia
443734|NCT01252537|Primary health care|primary health care
443735|NCT01252524|diabetes mellitus|diabetes mellitus
443736|NCT01252524|fiber|fiber
443737|NCT01252524|glycemic control|glycemic control
443738|NCT01252524|calcium polycarbophil|calcium polycarbophil
443739|NCT01252511|Malabsorption after RYGB|malabsorption after rygb
443740|NCT01252511|Fat Malabsorption and maldigestion|fat malabsorption and maldigestion
443741|NCT01252511|Obesity surgery|obesity surgery
443742|NCT01252511|Bariatric surgery|bariatric surgery
443743|NCT01252498|Cancer of the head and neck|cancer of the head and neck
443744|NCT01252498|Radiotherapy|radiotherapy
443745|NCT01252498|Prostaglandins|prostaglandins
443746|NCT01252485|AML|aml
443747|NCT01252485|Registry study|registry study
443748|NCT01252485|Biology and Outcome|biology and outcome
443749|NCT01252485|Higher Risk MDS|higher risk mds
443750|NCT01252472|Flomax|flomax
443751|NCT01252472|Floppy iris Syndrome|floppy iris syndrome
443752|NCT01252472|Tamsulosin|tamsulosin
443753|NCT01252459|AA-PET|aa-pet
443754|NCT01252459|T1-Gd-MRI|t1-gd-mri
443755|NCT01252459|re-irradiation|re-irradiation
443756|NCT01252459|recurrent glioma|recurrent glioma
443757|NCT01252446|ICD 10|icd 10
443758|NCT01252446|Attention-Deficit-Hyperactivity-Disorder (ADHD)|attention-deficit-hyperactivity-disorder (adhd)
443759|NCT01252446|Comorbidity|comorbidity
443760|NCT01252446|Social-demographic profile|social-demographic profile
443761|NCT01252420|Distal Vein Thrombosis|distal vein thrombosis
443762|NCT01252420|Proximal Vein Thrombosis|proximal vein thrombosis
443763|NCT01252420|Pulmonary Embolism|pulmonary embolism
443764|NCT01252420|Post-thrombotic syndrome|post-thrombotic syndrome
443765|NCT01252420|Limited duration treatment|limited duration treatment
443766|NCT01252407|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
443767|NCT01252407|Sympathetic nervous system|sympathetic nervous system
443768|NCT01252407|Parasympathetic nervous system|parasympathetic nervous system
443769|NCT01252407|heart rate|heart rate
443770|NCT01252342|Oxytocin|oxytocin
443771|NCT01252342|Intramyometrial|intramyometrial
443772|NCT01252329|high risk cutaneous squamous cell carcinoma|high risk cutaneous squamous cell carcinoma
443773|NCT01252329|selective neck dissection|selective neck dissection
443774|NCT01252329|elective lymph node management|elective lymph node management
443775|NCT01252329|clinical nodal observation|clinical nodal observation
443776|NCT01252303|Obesity, weight loss, meal replacements|obesity, weight loss, meal replacements
443777|NCT01252264|biorepository|biorepository
443778|NCT01252264|genetics|genetics
443779|NCT01252264|craniofacial|craniofacial
443780|NCT01252264|cleft lip|cleft lip
443781|NCT01252264|cleft palate|cleft palate
443782|NCT01252251|PASIREOTIDE (SOM230)|pasireotide (som230)
443783|NCT01252251|RAD001 (EVEROLIMUS)|rad001 (everolimus)
443784|NCT01252251|eye|eye
443785|NCT01252251|10-123|10-123
443786|NCT01252225|Chronic Cough|chronic cough
443787|NCT01252225|Lidocaine|lidocaine
443788|NCT01252212|HIV, antiretroviral, adherence, SMS, cell phone|hiv, antiretroviral, adherence, sms, cell phone
443789|NCT01252199|Shigamabs|shigamabs
443790|NCT01252199|Monoclonal|monoclonal
443791|NCT01252199|Antibodies|antibodies
443792|NCT01252199|Shiga|shiga
443793|NCT01252199|Toxin|toxin
443794|NCT01252199|E.coli|e.coli
443795|NCT01252199|HUS|hus
443796|NCT01252199|Bloody|bloody
443797|NCT01252199|Diarrhea|diarrhea
443798|NCT01252186|Contraception|contraception
443799|NCT01252186|Hemostasis|hemostasis
443800|NCT01252186|Blood Coagulation|blood coagulation
443801|NCT01252173|endotracheal|endotracheal
443802|NCT01252173|intubation|intubation
443803|NCT01252173|tracheal|tracheal
443804|NCT01252173|pressure|pressure
443805|NCT01252173|cufflator|cufflator
443806|NCT01252160|Neuralgia, Postherpetic|neuralgia, postherpetic
443807|NCT01252160|QUTENZA|qutenza
443808|NCT01252134|Soft Contact lens|soft contact lens
443809|NCT01252134|Multi-purpose solution|multi-purpose solution
443810|NCT01252134|Wettability|wettability
443811|NCT01252121|Dry Eye|dry eye
443812|NCT01252121|Ocular Retention Time|ocular retention time
443813|NCT01252108|Helicobacter pylori|helicobacter pylori
443814|NCT01252108|peptic ulcer disease|peptic ulcer disease
443815|NCT01252108|stomach ulcers|stomach ulcers
443816|NCT01252108|gastric cancer|gastric cancer
443818|NCT01252095|Phase I|phase i
443819|NCT01252095|Progen|progen
443820|NCT01252095|antimetastatic|antimetastatic
443821|NCT01252095|antiangiogenic|antiangiogenic
443822|NCT01252095|advanced cancer patients|advanced cancer patients
443823|NCT01252095|solid tumors|solid tumors
443824|NCT01252095|solid tumours|solid tumours
443825|NCT01252082|metabolic control|metabolic control
443826|NCT01252082|fasting plasma glucose|fasting plasma glucose
443827|NCT01252082|glycated hemoglobin|glycated hemoglobin
443828|NCT01252043|cholestasis|cholestasis
443829|NCT01252043|children|children
443830|NCT01252030|CAD, physical activity, rehabilitation, prevention|cad, physical activity, rehabilitation, prevention
443831|NCT01252004|Left ventricular ballooning|left ventricular ballooning
443832|NCT01251978|Choroidal melanoma|choroidal melanoma
443833|NCT01251978|Ranibizumab|ranibizumab
443834|NCT01251978|Transpupillary Thermotherapy|transpupillary thermotherapy
443835|NCT01251978|CSTIP|cstip
443836|NCT01251978|Indocyanine Green|indocyanine green
443837|NCT01251965|Relapsed Acute Leukemia|relapsed acute leukemia
443838|NCT01251965|Acute myeloid leukemia|acute myeloid leukemia
443839|NCT01251965|AML|aml
443840|NCT01251965|Acute lymphocytic leukemia|acute lymphocytic leukemia
443841|NCT01251965|ALL|all
443842|NCT01251965|Ruxolitinib|ruxolitinib
443843|NCT01251965|Jakafi|jakafi
443844|NCT01251965|INC424|inc424
443845|NCT01251965|INCB018424|incb018424
443846|NCT01251926|Bevacizumab|bevacizumab
443847|NCT01251926|Camptothecin|camptothecin
443848|NCT01251926|EZN-2208|ezn-2208
443849|NCT01251926|Anti-Angiogenesis|anti-angiogenesis
443850|NCT01251926|Advanced Cancer|advanced cancer
443851|NCT01251926|Cancer|cancer
443852|NCT01251926|Solid Tumor|solid tumor
443853|NCT01251913|Tissue Harvest|tissue harvest
443854|NCT01251913|Hospice|hospice
443855|NCT01251913|Autopsy|autopsy
443856|NCT01251913|Crainiotomy|crainiotomy
443857|NCT01251913|Brain Tumor|brain tumor
443858|NCT01251913|Glioma|glioma
443859|NCT01251913|Astrocytoma|astrocytoma
443860|NCT01251900|Triple Negative Disease|triple negative disease
443861|NCT01251900|BRCA1|brca1
443862|NCT01251900|BRCA2|brca2
443863|NCT01251900|Hispanic/Latino|hispanic/latino
443864|NCT01251900|Breast Cancer|breast cancer
443865|NCT01251887|Lipids|lipids
443866|NCT01251887|Obesity|obesity
443867|NCT01251887|Omega-3 Fatty Acids|omega-3 fatty acids
443868|NCT01251887|Overweight|overweight
443869|NCT01251848|Sitaxentan|sitaxentan
443870|NCT01251848|ritonavir|ritonavir
443871|NCT01251848|drug interaction|drug interaction
443872|NCT01251848|pharmacokinetics|pharmacokinetics
443873|NCT01251835|Sitaxsentan|sitaxsentan
443874|NCT01251835|Rifampin|rifampin
443875|NCT01251835|Drug Interaction|drug interaction
443876|NCT01251835|Pharmacokinetics|pharmacokinetics
443877|NCT01251809|Asparaginase|asparaginase
443878|NCT01251809|ALL|all
443879|NCT01251783|term babies|term babies
443880|NCT01251770|Hyponatremia|hyponatremia
443881|NCT01251770|Water-Electrolyte Imbalance|water-electrolyte imbalance
443882|NCT01251757|diabetes|diabetes
443883|NCT01251757|cardiovascular disease|cardiovascular disease
443884|NCT01251757|randomized clinical trial|randomized clinical trial
443885|NCT01251757|medication adherence|medication adherence
443886|NCT01251757|health information technology|health information technology
443887|NCT01251757|adult|adult
443888|NCT01251757|telephone calls|telephone calls
443889|NCT01251757|IVR|ivr
443890|NCT01251744|Pregnancy|pregnancy
443891|NCT01251744|Congenital|congenital
443892|NCT01251744|Cytomegalovirus infection|cytomegalovirus infection
443893|NCT01251718|Donepezil hydrochloride|donepezil hydrochloride
443894|NCT01251718|Alzheimer's Disease|alzheimer's disease
443895|NCT01251705|Cornea|cornea
443896|NCT01251705|SL OCT|sl oct
443897|NCT01251705|Spectral OCT Cornea modul|spectral oct cornea modul
443898|NCT01251705|ultrasound pachymetry|ultrasound pachymetry
443899|NCT01251705|Pentacam|pentacam
443900|NCT01251692|Corneal erosions|corneal erosions
443901|NCT01251692|PTK|ptk
443902|NCT01251679|handwashing|handwashing
443903|NCT01251679|masks|masks
443904|NCT01251679|infectious disease transmission|infectious disease transmission
443905|NCT01251666|Colorectal cancer|colorectal cancer
443906|NCT01251666|Screening|screening
443907|NCT01251666|Average-risk population|average-risk population
443908|NCT01251666|faecal occult blood tests|faecal occult blood tests
443909|NCT01251640|pancreatic cancer,|pancreatic cancer,
443910|NCT01251640|MEK-inhibitor|mek-inhibitor
443911|NCT01251627|Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, Decitabine|myelodysplastic syndromes, chronic myelomonocytic leukemia, decitabine
443912|NCT01251614|Randomized|randomized
443913|NCT01251614|Double-blind|double-blind
443914|NCT01251614|Chronic plaque psoriasis|chronic plaque psoriasis
443915|NCT01251614|Pediatric|pediatric
443916|NCT01251588|Cartilage legions|cartilage legions
443917|NCT01251588|Symptomatic focal cartilage defects|symptomatic focal cartilage defects
443918|NCT01251588|Microfracture|microfracture
443919|NCT01251588|MACI|maci
443920|NCT01251588|Autologous chondrocyte|autologous chondrocyte
443921|NCT01251549|ReWalk|rewalk
443922|NCT01251549|Paraplegia|paraplegia
443923|NCT01251549|Spinal Cord Injuries (SCI)|spinal cord injuries (sci)
443924|NCT01251536|colorectal cancer|colorectal cancer
443925|NCT01251536|K-Ras wildtype|k-ras wildtype
443926|NCT01251536|first line metastatic|first line metastatic
443927|NCT01251536|standard cetuximab + FOLFIRI|standard cetuximab + folfiri
443928|NCT01251536|dose escalation cetuximab|dose escalation cetuximab
443929|NCT01251523|Asthma|asthma
443930|NCT01251471|major depressive disorder|major depressive disorder
443931|NCT01251471|MDD|mdd
443932|NCT01251471|imaging genetics|imaging genetics
443933|NCT01251471|pharmacoMRI|pharmacomri
443934|NCT01251432|otitis media|otitis media
443935|NCT01251432|Eustachian tube|eustachian tube
443936|NCT01251432|allergy|allergy
443937|NCT01251432|gastroesophageal reflux|gastroesophageal reflux
443938|NCT01251432|tympanostomy tube|tympanostomy tube
443939|NCT01251419|Generic Medication|generic medication
443940|NCT01251419|Brand Name Medication|brand name medication
443941|NCT01251419|Conversion Rates|conversion rates
443942|NCT01251419|Social Proximity|social proximity
443943|NCT01251419|Behavioral Economics|behavioral economics
443944|NCT01251406|Stable|stable
443945|NCT01251406|Chronic Heart Failure|chronic heart failure
443946|NCT01251406|Systolic|systolic
443947|NCT01251393|Cocaine|cocaine
443948|NCT01251393|crack|crack
443949|NCT01251393|treatment|treatment
443950|NCT01251393|dependence|dependence
443951|NCT01251393|biperiden|biperiden
443952|NCT01251341|inflammation|inflammation
443953|NCT01251341|immune system|immune system
443954|NCT01251341|cytokines|cytokines
443955|NCT01251341|meditation|meditation
443956|NCT01251341|compassion|compassion
443957|NCT01251341|attention|attention
443958|NCT01251315|Glutathione|glutathione
443959|NCT01251315|Antioxidant|antioxidant
443960|NCT01251315|Free radical|free radical
443961|NCT01251315|Oxidative stress|oxidative stress
443962|NCT01251315|N-Acetyl Cysteine|n-acetyl cysteine
443963|NCT01251315|Glutathione precursor|glutathione precursor
443964|NCT01251302|Corus CAD|corus cad
443965|NCT01251302|Age/Sex/Gene Expression Score|age/sex/gene expression score
443966|NCT01251302|Molecular Genetics|molecular genetics
443967|NCT01251302|Atherosclerosis|atherosclerosis
443968|NCT01251302|ASGES|asges
443969|NCT01251302|Gene Expression|gene expression
443970|NCT01251302|GES|ges
443971|NCT01251302|CAD|cad
443972|NCT01251302|CVD|cvd
443973|NCT01251302|CHD|chd
443974|NCT01251302|Clinical Utility|clinical utility
443975|NCT01251302|Precision Medicine|precision medicine
443976|NCT01251302|Coronary Artery Disease|coronary artery disease
443977|NCT01251302|Angina Pectoris|angina pectoris
443978|NCT01251302|Chest Pain|chest pain
443979|NCT01251302|Cardiovascular Disease|cardiovascular disease
443980|NCT01251302|Coronary Heart Disease|coronary heart disease
443981|NCT01251302|IMPACT|impact
443982|NCT01251302|IMPACT-CARD|impact-card
443983|NCT01251263|headaches|headaches
443984|NCT01251263|migraines|migraines
443985|NCT01251263|breakthrough bleeding|breakthrough bleeding
443986|NCT01251263|breakthrough spotting|breakthrough spotting
443987|NCT01251263|menstrually associated migraines|menstrually associated migraines
443988|NCT01251263|breakthrough bleeding or breakthrough spotting|breakthrough bleeding or breakthrough spotting
443989|NCT01251224|asthma|asthma
443990|NCT01251224|mouse allergen|mouse allergen
443991|NCT01251224|environmental intervention|environmental intervention
443992|NCT01251211|BOTULINUM TOXIN|botulinum toxin
443993|NCT01251211|NEUROPATHIC PAIN|neuropathic pain
443994|NCT01251211|RANDOMIZED CONTROLLED TRIAL|randomized controlled trial
443995|NCT01251185|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
443996|NCT01251185|Heart Failure|heart failure
443997|NCT01251185|Congestive Heart Failure|congestive heart failure
443998|NCT01251185|Non-invasive|non-invasive
443999|NCT01251185|Device Trial|device trial
444000|NCT01251185|NYHA (New York Heart Association)|nyha (new york heart association)
444001|NCT01251185|Ischemic cardiomyopathy|ischemic cardiomyopathy
444002|NCT01251185|Ischemia|ischemia
444003|NCT01251185|Myocardial contractility|myocardial contractility
444004|NCT01251159|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
444005|NCT01251159|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
444006|NCT01251159|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
444007|NCT01251159|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
444008|NCT01251159|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
444009|NCT01251159|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
444010|NCT01251159|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
444011|NCT01251159|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
444012|NCT01251159|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
444013|NCT01251159|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
444014|NCT01251159|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
444015|NCT01251159|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
444016|NCT01251159|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
444017|NCT01251159|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
444018|NCT01251159|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
444019|NCT01251146|Hypertension|hypertension
444020|NCT01251146|Bisoprolol|bisoprolol
444021|NCT01251146|Atenolol|atenolol
444022|NCT01251133|Communicable Diseases|communicable diseases
444023|NCT01251133|Infection|infection
444024|NCT01251133|Influenza|influenza
444025|NCT01251133|Orthomyxoviridae Infections|orthomyxoviridae infections
444026|NCT01251133|RNA Virus Infections|rna virus infections
444027|NCT01251133|Virus Diseases|virus diseases
444028|NCT01251133|Respiratory Tract Infections|respiratory tract infections
444029|NCT01251133|Respiratory Tract Diseases|respiratory tract diseases
444030|NCT01251107|Hodgkin lymphoma|hodgkin lymphoma
444031|NCT01251107|ABVD|abvd
444032|NCT01251107|BEACOPP|beacopp
444033|NCT01251107|Salvage high dose chemotherapy|salvage high dose chemotherapy
444034|NCT01251094|Dementia|dementia
444035|NCT01251094|Parkinson's|parkinson's
444036|NCT01251094|impairment|impairment
444037|NCT01251094|Dementia Registry for Parkinson's Disease|dementia registry for parkinson's disease
444038|NCT01251081|high volume hemofiltration|high volume hemofiltration
444039|NCT01251081|sepsis|sepsis
444040|NCT01251081|acute kidney injury|acute kidney injury
444041|NCT01251081|survival|survival
444042|NCT01251068|anemic preterms, cerebral oxygenation,somatic oxygenation, blood transfusion|anemic preterms, cerebral oxygenation,somatic oxygenation, blood transfusion
444043|NCT01251055|N-methyl-D-aspartate receptor|n-methyl-d-aspartate receptor
444044|NCT01251055|glycine transporter|glycine transporter
444045|NCT01251055|schizophrenia|schizophrenia
444046|NCT01251016|Type 2 diabetes mellitus|type 2 diabetes mellitus
444047|NCT01251016|Y-Roux gastric bypass|y-roux gastric bypass
444048|NCT01251016|Gut hormones|gut hormones
444049|NCT01251016|Gene expression|gene expression
444050|NCT01251016|Surgery|surgery
444051|NCT01251003|Traumatic Brain Injury|traumatic brain injury
444052|NCT01251003|TBI|tbi
444053|NCT01251003|Pediatric|pediatric
444054|NCT01251003|Chronic|chronic
444055|NCT01250990|Niacin|niacin
444056|NCT01250990|HDL|hdl
444057|NCT01250990|Reverse cholesterol transport|reverse cholesterol transport
444058|NCT01250977|Non-treatment seeking smokers, reporting consumption of at least|non-treatment seeking smokers, reporting consumption of at least
444059|NCT01250977|10 cigarettes per day for at least the past 6 months|10 cigarettes per day for at least the past 6 months
444060|NCT01250951|Iron Overload|iron overload
444061|NCT01250951|hemotranfusion|hemotranfusion
444062|NCT01250951|deferasirox|deferasirox
444063|NCT01250951|ferritin|ferritin
444064|NCT01250951|Rare anemia|rare anemia
444065|NCT01250951|Transfusional Iron Overload|transfusional iron overload
444066|NCT01250938|autism|autism
444067|NCT01250938|autism spectrum disorders|autism spectrum disorders
444068|NCT01250938|pervasive developmental disorders|pervasive developmental disorders
444069|NCT01250938|intervention|intervention
444070|NCT01250938|low-income|low-income
444071|NCT01250938|underserved populations|underserved populations
444072|NCT01250938|underrepresented populations|underrepresented populations
444073|NCT01250925|Contact lens|contact lens
444074|NCT01250925|Lens care|lens care
444075|NCT01250912|Ablation|ablation
444076|NCT01250912|Arrythmia|arrythmia
444077|NCT01250912|Imaging|imaging
444078|NCT01250899|HIV|hiv
444079|NCT01250899|Vitamin D|vitamin d
444080|NCT01250899|HAART|haart
444081|NCT01250860|Manual therapy|manual therapy
444082|NCT01250860|DoboMed exercise|dobomed exercise
444083|NCT01250860|Spirometric test|spirometric test
444084|NCT01250847|ARMS|arms
444085|NCT01250847|Ultra High Risk|ultra high risk
444086|NCT01250847|Quetiapine|quetiapine
444087|NCT01250847|Verbal memory|verbal memory
444088|NCT01250821|Infertility|infertility
444089|NCT01250821|Anovulation|anovulation
444090|NCT01250821|Ovulation induction|ovulation induction
444091|NCT01250795|Prevention|prevention
444092|NCT01250782|Glutamine, trauma patients, infections, mortality|glutamine, trauma patients, infections, mortality
444093|NCT01250769|dental|dental
444094|NCT01250769|dentist|dentist
444095|NCT01250769|plaque|plaque
444096|NCT01250769|IP Cleaning|ip cleaning
444097|NCT01250756|vaccine|vaccine
444098|NCT01250756|pneumococcal conjugate|pneumococcal conjugate
444099|NCT01250743|genotype 1|genotype 1
444100|NCT01250730|PK profile in Japanese healthy male volunteers|pk profile in japanese healthy male volunteers
444101|NCT01250717|prostatectomy|prostatectomy
444102|NCT01250717|docetaxel|docetaxel
444103|NCT01250704|Neuromyotonia, Isaac's syndrome; Peripheral nerve hyperexcitability; Myokymia; Potassium channelopathy|neuromyotonia, isaac's syndrome; peripheral nerve hyperexcitability; myokymia; potassium channelopathy
444104|NCT01250691|pneumonia|pneumonia
444105|NCT01250691|ICU|icu
444106|NCT01250691|isolation room|isolation room
444107|NCT01250691|clinical epidemiology|clinical epidemiology
444108|NCT01250691|infection control|infection control
444109|NCT01250678|multiple sclerosis|multiple sclerosis
444110|NCT01250678|cognitive impairment|cognitive impairment
444111|NCT01250678|natalizumab|natalizumab
444112|NCT01250678|SDMT|sdmt
444113|NCT01250665|multiple sclerosis|multiple sclerosis
444114|NCT01250665|cognitive impairment|cognitive impairment
444115|NCT01250665|interferon-beta 1b|interferon-beta 1b
444116|NCT01250665|corpus callosum index|corpus callosum index
444117|NCT01250652|Chronic urticaria|chronic urticaria
444118|NCT01250652|Urticaria|urticaria
444119|NCT01250652|Antihistamine|antihistamine
444120|NCT01250639|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
444121|NCT01250639|non-aboriginal Taiwanese|non-aboriginal taiwanese
444122|NCT01250639|Genome-wide association study|genome-wide association study
444123|NCT01250626|Inulin|inulin
444124|NCT01250626|childhood GFR formula|childhood gfr formula
444125|NCT01250587|Open label|open label
444126|NCT01250587|dose-finding Phase 1 study|dose-finding phase 1 study
444127|NCT01250574|CD64|cd64
444128|NCT01250574|Procalcitonin|procalcitonin
444129|NCT01250561|gabapentin|gabapentin
444130|NCT01250561|valacyclovir|valacyclovir
444131|NCT01250561|phn|phn
444132|NCT01250561|shingles|shingles
444133|NCT01250548|Rheumatoid arthritis|rheumatoid arthritis
444134|NCT01250548|RA|ra
444135|NCT01250548|Active rheumatoid arthritis|active rheumatoid arthritis
444136|NCT01250535|Drug drug interactions|drug drug interactions
444137|NCT01250535|Warfarin|warfarin
444138|NCT01250535|Anticoagulants|anticoagulants
444139|NCT01250535|Lovastatin|lovastatin
444140|NCT01250535|Statins|statins
444141|NCT01250535|CYP4F2|cyp4f2
444142|NCT01250535|Vitamin K|vitamin k
444143|NCT01250509|Obesity|obesity
444144|NCT01250509|Mindfulness based stress reduction|mindfulness based stress reduction
444145|NCT01250509|Mindful eating|mindful eating
444146|NCT01250509|Stress|stress
444147|NCT01250509|Overnutrition|overnutrition
444148|NCT01250509|Nutrition Disorders|nutrition disorders
444149|NCT01250509|Overweight|overweight
444150|NCT01250509|Body Weight|body weight
444151|NCT01250509|Signs and Symptoms|signs and symptoms
444152|NCT01250496|regadenoson|regadenoson
444153|NCT01250496|lexiscan|lexiscan
444154|NCT01250496|aminophylline|aminophylline
444155|NCT01250496|SPECT|spect
444156|NCT01250496|Myocardial Perfusion Imaging|myocardial perfusion imaging
444157|NCT01250496|pharmacologic stress test|pharmacologic stress test
444158|NCT01250483|prostate|prostate
444159|NCT01250483|prostate-specific antigen|prostate-specific antigen
444160|NCT01250483|benign prostatic hyperplasia|benign prostatic hyperplasia
444161|NCT01250483|adrenergic alpha-Antagonists|adrenergic alpha-antagonists
444162|NCT01250444|Inspiratory Muscle Training|inspiratory muscle training
444163|NCT01250444|Hypertension|hypertension
444164|NCT01250444|Breathing Exercises|breathing exercises
444165|NCT01250444|Cardiac Rehabilitation|cardiac rehabilitation
444166|NCT01250418|Bispectral Index|bispectral index
444167|NCT01250418|Ketamine|ketamine
444168|NCT01250392|Active choice|active choice
444169|NCT01250392|Nurse visits|nurse visits
444170|NCT01250392|Behavioral economics|behavioral economics
444559|NCT01248637|hypoxia|hypoxia
444171|NCT01250366|Safety and Pharmacokinetics|safety and pharmacokinetics
444172|NCT01250353|ocular surface reconstruction|ocular surface reconstruction
444173|NCT01250353|conjunctival healing|conjunctival healing
444174|NCT01250353|pterygium|pterygium
444175|NCT01250353|latex biomembrane|latex biomembrane
444176|NCT01250353|pterygium surgery|pterygium surgery
444177|NCT01250340|Diabetes|diabetes
444178|NCT01250340|Isoprostanes|isoprostanes
444179|NCT01250340|Thromboxane|thromboxane
444180|NCT01250340|Aspirin|aspirin
444181|NCT01250327|right ventricular outflow tract|right ventricular outflow tract
444182|NCT01250327|endovascular valve insertion|endovascular valve insertion
444183|NCT01250327|economic evaluation|economic evaluation
444184|NCT01250327|valved stent|valved stent
444185|NCT01250314|osteoporosis|osteoporosis
444186|NCT01250314|men|men
444187|NCT01250314|bone micro-architecture|bone micro-architecture
444188|NCT01250314|bone markers|bone markers
444189|NCT01250301|Smoking Cessation|smoking cessation
444190|NCT01250301|Tobacco Dependence|tobacco dependence
444191|NCT01250301|De-nicotinised cigarettes|de-nicotinised cigarettes
444192|NCT01250288|Health Information Technology|health information technology
444193|NCT01250288|Health Records, Personal|health records, personal
444194|NCT01250288|Hospital Information Systems|hospital information systems
444195|NCT01250288|Patient Access to Records|patient access to records
444196|NCT01250288|Medical Records|medical records
444197|NCT01250288|Medical Record Systems, Computerized|medical record systems, computerized
444198|NCT01250275|Canola Oil|canola oil
444199|NCT01250275|Peripheral Arterial Disease|peripheral arterial disease
444200|NCT01250275|Peripheral Vascular Disease|peripheral vascular disease
444201|NCT01250275|PAD|pad
444202|NCT01250262|low back pain|low back pain
444203|NCT01250262|obese|obese
444204|NCT01250262|fear avoidance|fear avoidance
444205|NCT01250262|disability and low back pain|disability and low back pain
444206|NCT01250262|chronic low back pain in obese older adults|chronic low back pain in obese older adults
444207|NCT01250249|To compare Safety and Reactogenecity of BCG vaccine of Green Signal Biopharma Private Limited with BCG vaccine of serum institute of India limited|to compare safety and reactogenecity of bcg vaccine of green signal biopharma private limited with bcg vaccine of serum institute of india limited
444208|NCT01250236|brimonidine|brimonidine
444209|NCT01250236|alpha-2 adrenoceptor|alpha-2 adrenoceptor
444210|NCT01250236|cornea|cornea
444211|NCT01250236|corneal thickness|corneal thickness
444212|NCT01250223|Lymphoma, Follicular|lymphoma, follicular
444213|NCT01250223|Prognosis|prognosis
444214|NCT01250223|Progression-Free Survival|progression-free survival
444215|NCT01250223|Outcome|outcome
444216|NCT01250223|International Cooperation|international cooperation
444217|NCT01250223|Data Collection|data collection
444218|NCT01250223|Prospective studies|prospective studies
444219|NCT01250223|Rare Diseases|rare diseases
444220|NCT01250210|contraception|contraception
444221|NCT01250210|pregnancy prevention|pregnancy prevention
444222|NCT01250197|Normal Volunteers|normal volunteers
444223|NCT01250184|Myofascial pain|myofascial pain
444224|NCT01250184|Trigger points.|trigger points.
444225|NCT01250184|Lidocaine injection.|lidocaine injection.
444226|NCT01250184|Physical therapy|physical therapy
444227|NCT01250171|Dry eye|dry eye
444228|NCT01250171|IL17/ IL-1β|il17/ il-1β
444229|NCT01250171|Biologic|biologic
444230|NCT01250158|Liver Percutaneous Isolated Localized Perfusion|liver percutaneous isolated localized perfusion
444231|NCT01250158|PILP|pilp
444232|NCT01250158|Isolated Hepatic Perfusion|isolated hepatic perfusion
444233|NCT01250158|IHP|ihp
444234|NCT01250158|Liver metastases|liver metastases
444235|NCT01250158|Unresectable liver metastases of different etiologies|unresectable liver metastases of different etiologies
444236|NCT01250132|Traumatic brain injury|traumatic brain injury
444237|NCT01250132|Paediatrics|paediatrics
444238|NCT01250132|Hypopituitarism|hypopituitarism
444239|NCT01250106|probiotics|probiotics
444240|NCT01250106|prevention|prevention
444241|NCT01250106|dietary intervention|dietary intervention
444242|NCT01250106|insulin resistance|insulin resistance
444243|NCT01250106|obesity|obesity
444244|NCT01250106|type 2 diabetes|type 2 diabetes
444245|NCT01250015|colorectal cancer|colorectal cancer
444246|NCT01250015|consent|consent
444247|NCT01250015|screening|screening
444248|NCT01250002|Pain|pain
444249|NCT01250002|MQOR 40|mqor 40
444250|NCT01250002|Lidocaine|lidocaine
444251|NCT01250002|Gynecologic|gynecologic
444252|NCT01250002|Surgery|surgery
444253|NCT01250002|Laparoscopic|laparoscopic
444254|NCT01249989|Physical Activity|physical activity
444255|NCT01249989|Sedentary Lifestyle|sedentary lifestyle
444256|NCT01249989|Diet|diet
444257|NCT01249989|Health Behavior|health behavior
444258|NCT01249976|blood culture|blood culture
444259|NCT01249976|central venous catheter|central venous catheter
444260|NCT01249976|acridine orange leucocyte cytospin test|acridine orange leucocyte cytospin test
444261|NCT01249976|semi-quantitative skin culture|semi-quantitative skin culture
444262|NCT01249963|acute pancreatitis|acute pancreatitis
444263|NCT01249963|enteral nutrition|enteral nutrition
444264|NCT01249963|nutritional status|nutritional status
444265|NCT01249963|pancreas|pancreas
444266|NCT01249963|T-Diet plus Atémpero|t-diet plus atémpero
444267|NCT01249950|Morbid obesity|morbid obesity
444268|NCT01249950|teenagers|teenagers
444269|NCT01249950|co-morbidities|co-morbidities
444270|NCT01249950|bariatric surgery|bariatric surgery
444271|NCT01249950|epidemiology|epidemiology
444272|NCT01249937|Macular Degeneration|macular degeneration
444273|NCT01249937|Age-related macular degeneration|age-related macular degeneration
444274|NCT01249937|Anti-inflammatory|anti-inflammatory
444275|NCT01249937|Anti-vascular endothelial growth factor (Anti-VEGF)|anti-vascular endothelial growth factor (anti-vegf)
444276|NCT01249937|Lucentis|lucentis
444277|NCT01249937|Ranibizumab|ranibizumab
444278|NCT01249937|Kenalog|kenalog
444279|NCT01249937|Triamcinolone Acetonide|triamcinolone acetonide
444280|NCT01249937|Vision loss|vision loss
444281|NCT01249924|Obstructive sleep apnea (OSA), continuous positive airway pressure(CPAP), surgery, anesthesia|obstructive sleep apnea (osa), continuous positive airway pressure(cpap), surgery, anesthesia
444282|NCT01249911|Infants|infants
444283|NCT01249898|Fracture in the Scaphoid fractures|fracture in the scaphoid fractures
444284|NCT01249885|pacifier sucking|pacifier sucking
444285|NCT01249885|children|children
444286|NCT01249885|occlusion|occlusion
444287|NCT01249885|drooling|drooling
444288|NCT01249872|open gastric by-pass|open gastric by-pass
444289|NCT01249872|super morbidly obese patients|super morbidly obese patients
444290|NCT01249872|postoperative thoracic epidural analgesia|postoperative thoracic epidural analgesia
444291|NCT01249872|different drug regimens (morphine and levobupivacaine)|different drug regimens (morphine and levobupivacaine)
444292|NCT01249872|Lung function tests|lung function tests
444293|NCT01249872|Postoperative Bowel recovery|postoperative bowel recovery
444294|NCT01249872|Postoperative Ambulation|postoperative ambulation
444295|NCT01249859|stomach disease|stomach disease
444296|NCT01249859|signet ring cell carcinoma|signet ring cell carcinoma
444297|NCT01249859|chemotherapy|chemotherapy
444298|NCT01249859|Prognostic|prognostic
444299|NCT01249833|Influenza|influenza
444300|NCT01249833|Cognition|cognition
444301|NCT01249833|Attention|attention
444302|NCT01249833|Simple Reaction Time|simple reaction time
444303|NCT01249833|Alertness|alertness
444304|NCT01249833|Calmness|calmness
444305|NCT01249833|Contentment|contentment
444306|NCT01249833|Mood|mood
444307|NCT01249820|anidulafungin|anidulafungin
444308|NCT01249820|antifungal prophylaxis|antifungal prophylaxis
444309|NCT01249820|allogeneic haematopoietic stem cell transplant|allogeneic haematopoietic stem cell transplant
444310|NCT01249820|myeloablative chemotherapy|myeloablative chemotherapy
444311|NCT01249820|AML-MDS|aml-mds
444312|NCT01249820|pharmacokinetics|pharmacokinetics
444313|NCT01249807|Cancer Screening|cancer screening
444314|NCT01249807|health service utilization model|health service utilization model
444315|NCT01249807|quality of health life|quality of health life
444316|NCT01249794|NIV|niv
444317|NCT01249794|non invasive ventilation|non invasive ventilation
444318|NCT01249794|cardiac surgery|cardiac surgery
444319|NCT01249794|continuous positive airway pressure|continuous positive airway pressure
444320|NCT01249768|Prospective study|prospective study
444321|NCT01249768|diagnostic accuracy|diagnostic accuracy
444322|NCT01249768|CSF|csf
444323|NCT01249768|MRI|mri
444324|NCT01249742|diabetes mellitus|diabetes mellitus
444325|NCT01249742|adolescent|adolescent
444326|NCT01249742|online intervention|online intervention
444327|NCT01249742|psychosocial|psychosocial
444328|NCT01249742|quality of life|quality of life
444329|NCT01249729|Magnetic Resonance Imaging, 3D reconstructed image|magnetic resonance imaging, 3d reconstructed image
444330|NCT01249716|follow-up home visit|follow-up home visit
444331|NCT01249716|Geriatric Disorder|geriatric disorder
444332|NCT01249716|rehabilitation|rehabilitation
444333|NCT01249690|Bortezomib,Thalidomide,bone metabolites|bortezomib,thalidomide,bone metabolites
444334|NCT01249677|type 2 diabetes|type 2 diabetes
444335|NCT01249677|first phase insulin secretion|first phase insulin secretion
444336|NCT01249677|beta-cell rest|beta-cell rest
444337|NCT01249677|basal insulin|basal insulin
444338|NCT01249664|sham-controlled|sham-controlled
444339|NCT01249664|pathologic myopia|pathologic myopia
444340|NCT01249664|mCNV|mcnv
444341|NCT01249664|choroidal neovascularization|choroidal neovascularization
444342|NCT01249664|intravitreal injection|intravitreal injection
444343|NCT01249664|vision loss|vision loss
444344|NCT01249664|macular damage|macular damage
444345|NCT01249651|Patients, Single|patients, single
444346|NCT01249638|Bevacizumab|bevacizumab
444347|NCT01249638|Capecitabine|capecitabine
444348|NCT01249638|Irinotecan|irinotecan
444349|NCT01249638|mCRC|mcrc
444350|NCT01249625|Influenza|influenza
444351|NCT01249625|H1N1|h1n1
444352|NCT01249625|Respiratory protection|respiratory protection
444353|NCT01249625|N95 respirator|n95 respirator
444354|NCT01249625|Medical mask|medical mask
444355|NCT01249625|Personal protective equipment|personal protective equipment
444356|NCT01249625|Facial protective equipment|facial protective equipment
444357|NCT01249625|Pandemic planning|pandemic planning
444358|NCT01249612|Knee joint icing|knee joint icing
444359|NCT01249612|knee-extension strength|knee-extension strength
444660|NCT01248143|Glucose|glucose
444360|NCT01249599|Takotsubo Syndrome|takotsubo syndrome
444361|NCT01249599|apical balooning syndrome|apical balooning syndrome
444362|NCT01249599|stress-cardiomyopathy|stress-cardiomyopathy
444363|NCT01249599|endothelial function|endothelial function
444364|NCT01249599|sympathetic nervous activity|sympathetic nervous activity
444365|NCT01249599|platelet adhesion|platelet adhesion
444366|NCT01249599|arterial compliance|arterial compliance
444367|NCT01249573|fascia therapy|fascia therapy
444368|NCT01249573|transcutaneous fibrolysis|transcutaneous fibrolysis
444369|NCT01249573|acute ankle distortion|acute ankle distortion
444370|NCT01249495|leg ulcer|leg ulcer
444371|NCT01249495|wound therapy|wound therapy
444372|NCT01249495|Pro-inflammatory interleukins|pro-inflammatory interleukins
444373|NCT01249482|Helicobacter pylori|helicobacter pylori
444374|NCT01249482|reflux|reflux
444375|NCT01249482|acid rebound|acid rebound
444376|NCT01249391|Hand|hand
444377|NCT01249391|osteoarthritis|osteoarthritis
444378|NCT01249391|splint|splint
444379|NCT01249391|pain|pain
444380|NCT01249391|deformity|deformity
444381|NCT01249391|function|function
444382|NCT01249378|Nutrition|nutrition
444383|NCT01249378|Lipid|lipid
444384|NCT01249378|Digestion|digestion
444385|NCT01249378|Endotoxemia|endotoxemia
444386|NCT01249378|Inflammation|inflammation
444387|NCT01249378|Metabolism|metabolism
444388|NCT01249378|Stable Isotope|stable isotope
444389|NCT01249378|Obesity|obesity
444390|NCT01249365|medically significant conditions|medically significant conditions
444391|NCT01249365|cervical neoplasia|cervical neoplasia
444392|NCT01249365|serious adverse events (SAEs)|serious adverse events (saes)
444393|NCT01249365|HPV vaccine|hpv vaccine
444394|NCT01249352|Esophageal Cancer|esophageal cancer
444395|NCT01249352|Nimotuzumab|nimotuzumab
444396|NCT01249352|EF024|ef024
444397|NCT01249352|EF024-201|ef024-201
444398|NCT01249339|smokeless tobacco|smokeless tobacco
444399|NCT01249339|Nicotine|nicotine
444400|NCT01249339|Cadmium|cadmium
444401|NCT01249339|lead|lead
444402|NCT01249339|Tobacco Specific Nitrosamines|tobacco specific nitrosamines
444403|NCT01249326|Morbid obesity,|morbid obesity,
444404|NCT01249326|Bariatric surgery, by-pass, sleeve gastrectomy,|bariatric surgery, by-pass, sleeve gastrectomy,
444405|NCT01249326|Nitrogen balance,|nitrogen balance,
444406|NCT01249326|Protein requirement,|protein requirement,
444407|NCT01249326|Weight loss|weight loss
444408|NCT01249326|Muscle wasting, muscle disability|muscle wasting, muscle disability
444409|NCT01249313|Risk|risk
444410|NCT01249313|outcome|outcome
444411|NCT01249300|Dysphagia caused by cerebral vascular accidents|dysphagia caused by cerebral vascular accidents
444412|NCT01249287|stroke|stroke
444413|NCT01249287|stem cell|stem cell
444414|NCT01249274|cocaine abuse|cocaine abuse
444415|NCT01249274|cocaine dependence|cocaine dependence
444416|NCT01249274|postpartum period|postpartum period
444417|NCT01249261|Postmenopausal Women|postmenopausal women
444418|NCT01249261|Osteoporosis|osteoporosis
444419|NCT01249248|Heart rate variability|heart rate variability
444420|NCT01249248|Autonomic dysfunction|autonomic dysfunction
444421|NCT01249248|Exercise|exercise
444422|NCT01249248|Sports|sports
444423|NCT01249248|Competition|competition
444424|NCT01249248|Athletes|athletes
444425|NCT01249209|obesity|obesity
444426|NCT01249209|adults|adults
444427|NCT01249209|lifestyle intervention|lifestyle intervention
444428|NCT01249209|effect after two years treatment for lifestyle change - morbid obesity adults|effect after two years treatment for lifestyle change - morbid obesity adults
444429|NCT01249183|Diphtheria|diphtheria
444430|NCT01249183|Tetanus|tetanus
444431|NCT01249183|Pertussis (acellular, component)|pertussis (acellular, component)
444432|NCT01249183|Diphteria|diphteria
444433|NCT01249183|Biological / vaccine|biological / vaccine
444434|NCT01249170|Communication skills|communication skills
444435|NCT01249157|MRI|mri
444436|NCT01249157|PEM|pem
444437|NCT01249157|10-189|10-189
444438|NCT01249144|Intraocular Lens (IOL)|intraocular lens (iol)
444439|NCT01249144|Quarter Diopter|quarter diopter
444440|NCT01249144|Biaspheric|biaspheric
444441|NCT01249105|MK-2206|mk-2206
444442|NCT01249105|GBM|gbm
444443|NCT01249092|biliary cirrhosis|biliary cirrhosis
444444|NCT01249066|AMP-activated protein kinase|amp-activated protein kinase
444445|NCT01249066|lung adenocarcinomas|lung adenocarcinomas
444446|NCT01249066|Prognosis|prognosis
444447|NCT01249066|Observation study|observation study
444448|NCT01249053|OPA1|opa1
444449|NCT01249053|lung adenocarcinomas|lung adenocarcinomas
444450|NCT01249053|Prognosis|prognosis
444451|NCT01249053|Expression of optic atrophy type 1 (OPA1) protein in lung adenocarcinoma|expression of optic atrophy type 1 (opa1) protein in lung adenocarcinoma
444452|NCT01249040|Frozen shoulder|frozen shoulder
444453|NCT01249040|pain scale|pain scale
444454|NCT01249040|range of motion(ROM)|range of motion(rom)
444455|NCT01249040|muscle strength|muscle strength
444456|NCT01249040|shoulder arthrography|shoulder arthrography
444457|NCT01249027|Drug eluting stents|drug eluting stents
444458|NCT01249027|Stents|stents
444459|NCT01249027|China|china
444460|NCT01249027|DES|des
444461|NCT01249027|XIENCE V EECSS|xience v eecss
444462|NCT01249001|pediatrics|pediatrics
444463|NCT01249001|nausea|nausea
444464|NCT01249001|vomiting|vomiting
444465|NCT01249001|chemotherapy|chemotherapy
444466|NCT01249001|antiemetic|antiemetic
444467|NCT01248988|Pneumococcal vaccine|pneumococcal vaccine
444468|NCT01248988|Safety|safety
444469|NCT01248988|Synflorix|synflorix
444470|NCT01248988|Pneumococcal diseases|pneumococcal diseases
444471|NCT01248975|asthma|asthma
444472|NCT01248975|GSK2190915|gsk2190915
444473|NCT01248962|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
444474|NCT01248962|CARBOPLATIN|carboplatin
444475|NCT01248962|DEXAMETHASONE|dexamethasone
444476|NCT01248962|GEMCITABINE|gemcitabine
444477|NCT01248962|LIPODOX(LIPOSOMAL DOXORUBICIN)|lipodox(liposomal doxorubicin)
444478|NCT01248962|MONTELUKAST (SINGULAR)|montelukast (singular)
444479|NCT01248962|TAXOL (PACLITAXEL|taxol (paclitaxel
444480|NCT01248962|Fallopian Tubes|fallopian tubes
444481|NCT01248962|10-184|10-184
444482|NCT01248949|Advanced solid tumors|advanced solid tumors
444483|NCT01248949|Advanced recurrent ovarian tumors|advanced recurrent ovarian tumors
444484|NCT01248949|MEDI3617|medi3617
444485|NCT01248949|Ang2|ang2
444486|NCT01248949|Ovarian cancer|ovarian cancer
444487|NCT01248949|Malignant glioma|malignant glioma
444488|NCT01248923|relapsed multiple myeloma|relapsed multiple myeloma
444489|NCT01248923|plasma cell dyscrasia|plasma cell dyscrasia
444490|NCT01248923|plasmacytoma|plasmacytoma
444491|NCT01248923|kinesin spindle protein|kinesin spindle protein
444492|NCT01248923|anti-mitotic|anti-mitotic
444493|NCT01248884|combination vaccine|combination vaccine
444494|NCT01248884|Primary vaccination|primary vaccination
444495|NCT01248871|renal|renal
444496|NCT01248871|transplantation|transplantation
444497|NCT01248871|Volatile|volatile
444498|NCT01248871|anesthetic|anesthetic
444499|NCT01248845|Mechanical ventilation|mechanical ventilation
444500|NCT01248845|Electrical diaphragmatic activity|electrical diaphragmatic activity
444501|NCT01248832|tobacco cessation|tobacco cessation
444502|NCT01248832|smoking cessation|smoking cessation
444503|NCT01248832|telephone|telephone
444504|NCT01248832|self-help|self-help
444505|NCT01248832|smoking abstinence|smoking abstinence
444506|NCT01248832|tobacco use disorder|tobacco use disorder
444507|NCT01248832|disparity|disparity
444508|NCT01248819|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
444509|NCT01248819|Nebulization|nebulization
444510|NCT01248819|Ropivacaine|ropivacaine
444511|NCT01248806|Lung nodule|lung nodule
444512|NCT01248806|Screening|screening
444513|NCT01248806|Spiral low - dose computed tomography|spiral low - dose computed tomography
444514|NCT01248806|Lung cancer|lung cancer
444515|NCT01248793|Ankylosing Sponylitis, injection, golimumab, simponi|ankylosing sponylitis, injection, golimumab, simponi
444516|NCT01248780|Rheumatoid Arthritis|rheumatoid arthritis
444517|NCT01248780|injection|injection
444518|NCT01248780|golimumab|golimumab
444519|NCT01248780|simponi|simponi
444520|NCT01248767|Pathological gambling|pathological gambling
444521|NCT01248767|"at risk gambling"|"at risk gambling"
444522|NCT01248767|cohort|cohort
444523|NCT01248767|cognitive distortions|cognitive distortions
444524|NCT01248767|impulsivity|impulsivity
444525|NCT01248767|psychiatric comorbidities|psychiatric comorbidities
444526|NCT01248767|gambling trajectory|gambling trajectory
444527|NCT01248767|gambling practice evolution|gambling practice evolution
444528|NCT01248767|addiction|addiction
444529|NCT01248754|Neurosurgery|neurosurgery
444530|NCT01248754|Neuronavigation|neuronavigation
444531|NCT01248754|Positron emission tomography|positron emission tomography
444532|NCT01248754|FDOPA|fdopa
444533|NCT01248741|prostate cancer|prostate cancer
444534|NCT01248741|interstitial radiation,|interstitial radiation,
444535|NCT01248741|brachytherapy|brachytherapy
444536|NCT01248728|Autism Spectrum Disorder|autism spectrum disorder
444537|NCT01248728|Clinical Trial|clinical trial
444538|NCT01248728|Omega-3 Fatty Acids|omega-3 fatty acids
444539|NCT01248728|Toddlers|toddlers
444540|NCT01248715|pneumonia, bacterial|pneumonia, bacterial
444541|NCT01248715|pneumonia, viral|pneumonia, viral
444542|NCT01248715|respiratory tract infections|respiratory tract infections
444543|NCT01248715|oseltamivir, therapeutic use|oseltamivir, therapeutic use
444544|NCT01248702|Myocardial Infarction|myocardial infarction
444545|NCT01248702|Heart Failure|heart failure
444546|NCT01248702|Sudden Cardiac Death|sudden cardiac death
444547|NCT01248702|Critical Pathways|critical pathways
444548|NCT01248676|cancer radiation patient education|cancer radiation patient education
444549|NCT01248663|pancreatic cancer|pancreatic cancer
444550|NCT01248663|pylorus-preserving pancreaticoduodenectomy|pylorus-preserving pancreaticoduodenectomy
444551|NCT01248663|delayed gastric emptying|delayed gastric emptying
444552|NCT01248663|reconstruction|reconstruction
444553|NCT01248650|Safety evaluation|safety evaluation
444554|NCT01248650|Pharmacokinetic analysis|pharmacokinetic analysis
444555|NCT01248637|pancreas|pancreas
444556|NCT01248637|pancreatic cancer|pancreatic cancer
444557|NCT01248637|pancreatic tumor|pancreatic tumor
444558|NCT01248637|pimonidazole|pimonidazole
444560|NCT01248637|whipple's resection|whipple's resection
444561|NCT01248624|Palliative Care|palliative care
444562|NCT01248624|Quality of Life|quality of life
444563|NCT01248624|Satisfaction with Care|satisfaction with care
444564|NCT01248611|pain|pain
444565|NCT01248611|adverse effects|adverse effects
444566|NCT01248611|safety|safety
444567|NCT01248611|feasibility|feasibility
444568|NCT01248585|Symptom Control|symptom control
444569|NCT01248572|Cataract|cataract
444570|NCT01248572|Biaspheric intraocular lens|biaspheric intraocular lens
444571|NCT01248572|Uniplanar intraocular lens|uniplanar intraocular lens
444572|NCT01248572|Effective lens position|effective lens position
444573|NCT01248546|Breast cancer|breast cancer
444574|NCT01248546|Computer-aided detection|computer-aided detection
444575|NCT01248546|Mammography screening|mammography screening
444576|NCT01248546|Digital breast tomosynthesis|digital breast tomosynthesis
444577|NCT01248533|Abdominal aortic aneurysm, atherosclerosis|abdominal aortic aneurysm, atherosclerosis
444578|NCT01248520|Pregnancy|pregnancy
444579|NCT01248520|Influenza Vaccination|influenza vaccination
444580|NCT01248507|COPD|copd
444581|NCT01248481|Acarbose/Glucobay®|acarbose/glucobay®
444582|NCT01248481|Basal insulin|basal insulin
444583|NCT01248481|PPG (Postprandial Glycaemia)|ppg (postprandial glycaemia)
444584|NCT01248468|Pain, Migraine|pain, migraine
444585|NCT01248455|Monoclonal Antibody|monoclonal antibody
444586|NCT01248455|NK Cell Mediated Killing|nk cell mediated killing
444587|NCT01248455|Response Rate|response rate
444588|NCT01248455|Pharmacokinetics|pharmacokinetics
444589|NCT01248455|Biological Activity|biological activity
444590|NCT01248455|Smoldering Multiple Myeloma|smoldering multiple myeloma
444591|NCT01248455|SMM|smm
444592|NCT01248442|Vitamin D Deficiency|vitamin d deficiency
444593|NCT01248442|Autoimmune disease|autoimmune disease
444594|NCT01248442|Diabetes|diabetes
444595|NCT01248429|thyrosine kinase inhibitor|thyrosine kinase inhibitor
444596|NCT01248429|phosphokinase creatinin|phosphokinase creatinin
444597|NCT01248429|myalgia|myalgia
444598|NCT01248416|Aromatase|aromatase
444599|NCT01248416|Growth|growth
444600|NCT01248416|Letrozole|letrozole
444601|NCT01248416|Anastrozole|anastrozole
444602|NCT01248416|GH|gh
444603|NCT01248416|Children|children
444604|NCT01248416|Puberty|puberty
444605|NCT01248403|RAD001|rad001
444606|NCT01248403|Paclitaxel|paclitaxel
444607|NCT01248403|gastric cancer|gastric cancer
444608|NCT01248403|advanced gastric or esophagogastric junction cancer|advanced gastric or esophagogastric junction cancer
444609|NCT01248390|traumatic brain injury|traumatic brain injury
444610|NCT01248390|post-concussion|post-concussion
444611|NCT01248377|Cephalosporins|cephalosporins
444612|NCT01248377|Drug hypersensitivity|drug hypersensitivity
444613|NCT01248351|aspirin, clopidogrel, pharmacodynamics, platelet transfusion|aspirin, clopidogrel, pharmacodynamics, platelet transfusion
444614|NCT01248299|Chemotherapy|chemotherapy
444615|NCT01248299|Best Supportive Care|best supportive care
444616|NCT01248286|Diabetes|diabetes
444617|NCT01248286|Prediabetes|prediabetes
444618|NCT01248286|Prevention|prevention
444619|NCT01248286|Whole grain|whole grain
444620|NCT01248286|Advanced glycation end products|advanced glycation end products
444621|NCT01248286|Insulin sensitivity|insulin sensitivity
444622|NCT01248273|GLOBO H-KLH CONJUGATE|globo h-klh conjugate
444623|NCT01248273|MUC-1 KLH|muc-1 klh
444624|NCT01248273|QS-21|qs-21
444625|NCT01248273|TF(C)-KLH|tf(c)-klh
444626|NCT01248273|TN(C)-KLH|tn(c)-klh
444627|NCT01248273|Immunization|immunization
444628|NCT01248273|Vaccine|vaccine
444629|NCT01248273|09-184|09-184
444630|NCT01248260|Fetal body size|fetal body size
444631|NCT01248260|Fetal brain size|fetal brain size
444632|NCT01248260|Folic acid|folic acid
444633|NCT01248247|Non small cell lung cancer|non small cell lung cancer
444634|NCT01248247|Biopsy accessible tumor|biopsy accessible tumor
444635|NCT01248247|Stage IIIB non small cell lung cancer|stage iiib non small cell lung cancer
444636|NCT01248247|Stage IV non small cell lung cancer|stage iv non small cell lung cancer
444637|NCT01248234|elderly|elderly
444638|NCT01248234|hypertensive|hypertensive
444639|NCT01248234|anesthesia|anesthesia
444640|NCT01248221|Breath test|breath test
444641|NCT01248221|Dyspepsia|dyspepsia
444642|NCT01248221|Gastric Emptying|gastric emptying
444643|NCT01248221|Gastroparesis|gastroparesis
444644|NCT01248208|egg allergy|egg allergy
444645|NCT01248208|influenza vaccine|influenza vaccine
444646|NCT01248195|Schizophrenia|schizophrenia
444647|NCT01248195|Schizophreniform disorder|schizophreniform disorder
444648|NCT01248195|Schizoaffective disorder|schizoaffective disorder
444649|NCT01248195|Imaging|imaging
444650|NCT01248195|Prognosis|prognosis
444651|NCT01248195|Treatment guidelines|treatment guidelines
444652|NCT01248195|Pharmacogenetics|pharmacogenetics
444653|NCT01248182|acetabular fracture|acetabular fracture
444654|NCT01248182|pelvic ring injury|pelvic ring injury
444655|NCT01248143|Green Tea|green tea
444656|NCT01248143|Fermented papaya preparation|fermented papaya preparation
444657|NCT01248143|Diabetes|diabetes
444658|NCT01248143|Cardiovascular diseases|cardiovascular diseases
444659|NCT01248143|Atherosclerotic plaques|atherosclerotic plaques
444661|NCT01248143|Dietary supplements and functional foods|dietary supplements and functional foods
444662|NCT01248130|Omega-3 Fatty Acid|omega-3 fatty acid
444663|NCT01248130|Autism Spectrum Disorders|autism spectrum disorders
444664|NCT01248130|Pervasive Developmental Disorders|pervasive developmental disorders
444665|NCT01248130|Children|children
444666|NCT01248130|Cognitive Functioning|cognitive functioning
444667|NCT01248117|PCV|pcv
444668|NCT01248117|polypoidal|polypoidal
444669|NCT01248117|choroidal|choroidal
444670|NCT01248117|vasculopathy|vasculopathy
444671|NCT01248104|Cardiac Surgery|cardiac surgery
444672|NCT01248104|Antifibrinolytic agents|antifibrinolytic agents
444673|NCT01248104|Blood transfusion|blood transfusion
444674|NCT01248104|epsilon aminocaproic acid|epsilon aminocaproic acid
444675|NCT01248104|tranexamic acid|tranexamic acid
444676|NCT01248091|IUD, Insertion, Decrease, Pain|iud, insertion, decrease, pain
444677|NCT01248078|elective cesarean section|elective cesarean section
444678|NCT01248078|antibiotic prophylaxis|antibiotic prophylaxis
444679|NCT01248078|cefazoline|cefazoline
444680|NCT01248078|wound infection|wound infection
444681|NCT01248065|Asthma|asthma
444682|NCT01248065|Vitamin D|vitamin d
444683|NCT01248065|Corticosteroids|corticosteroids
444684|NCT01248065|Treatment failure|treatment failure
444685|NCT01248039|Muscle strength, functional performance, joint replacement|muscle strength, functional performance, joint replacement
444686|NCT01248026|Cardiovascular disease|cardiovascular disease
444687|NCT01248026|Buttermilk|buttermilk
444688|NCT01248026|Blood lipids|blood lipids
444689|NCT01248026|Cholesterol absorption|cholesterol absorption
444690|NCT01248026|Cholesterol synthesis|cholesterol synthesis
444691|NCT01248000|Hodgkin lymphoma|hodgkin lymphoma
444692|NCT01248000|FDG-PET|fdg-pet
444693|NCT01248000|prognostic factor|prognostic factor
444694|NCT01248000|clinical trial|clinical trial
444695|NCT01247987|IVF, assisted reproduction, embryo transfer|ivf, assisted reproduction, embryo transfer
444696|NCT01247974|Coronary Artery Bypass Grafting|coronary artery bypass grafting
444697|NCT01247974|New Onset Postoperative Atrial Fibrillation|new onset postoperative atrial fibrillation
444698|NCT01247948|pedicle screw of fixation operation|pedicle screw of fixation operation
444699|NCT01247948|spine surgery|spine surgery
444700|NCT01247948|navigation assisted|navigation assisted
444701|NCT01247935|Pain|pain
444702|NCT01247935|Acupuncture|acupuncture
444703|NCT01247935|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
444704|NCT01247935|Colonoscopy|colonoscopy
444705|NCT01247922|Pediatric Ependymoma|pediatric ependymoma
444706|NCT01247922|Ependymoma|ependymoma
444707|NCT01247922|Erlotinib|erlotinib
444708|NCT01247922|Tarceva|tarceva
444709|NCT01247883|Phase 1|phase 1
444710|NCT01247883|relative bioavailability|relative bioavailability
444711|NCT01247883|healthy volunteers|healthy volunteers
444712|NCT01247883|pharmacokinetics|pharmacokinetics
444713|NCT01247883|solution|solution
444714|NCT01247883|tablet|tablet
444715|NCT01247870|Chronic obstructive pulmonary disease, COPD, metformin|chronic obstructive pulmonary disease, copd, metformin
444716|NCT01247857|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
444717|NCT01247857|Nebulization|nebulization
444718|NCT01247857|Ropivacaine|ropivacaine
444719|NCT01247844|adult Males|adult males
444720|NCT01247844|circumcision|circumcision
444721|NCT01247844|HIV prevention|hiv prevention
444722|NCT01247844|device|device
444723|NCT01247831|glaucoma, selective laser trabeculoplasty, ocular rigidity|glaucoma, selective laser trabeculoplasty, ocular rigidity
444724|NCT01247805|Bioequivalence|bioequivalence
444725|NCT01247805|Powder for oral suspention|powder for oral suspention
444726|NCT01247792|sepsis|sepsis
444727|NCT01247792|organ failure|organ failure
444728|NCT01247792|end-of-life decisions|end-of-life decisions
444729|NCT01247792|patient-centered communication|patient-centered communication
444730|NCT01247779|gynecology|gynecology
444731|NCT01247779|oncology|oncology
444732|NCT01247779|coelioscopy|coelioscopy
444733|NCT01247779|robot|robot
444734|NCT01247779|morbidity|morbidity
444735|NCT01247727|Heart rate variability|heart rate variability
444736|NCT01247727|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
444737|NCT01247714|T-Diet plus Diabet NP|t-diet plus diabet np
444738|NCT01247714|Diabetic|diabetic
444739|NCT01247714|Enteral Nutrition|enteral nutrition
444740|NCT01247714|Glycaemic response|glycaemic response
444741|NCT01247714|Metabolic Syndrome|metabolic syndrome
444742|NCT01247714|Insulin resistance|insulin resistance
444743|NCT01247714|Lipidic profile|lipidic profile
444744|NCT01247701|UCB|ucb
444745|NCT01247701|Umbilical Cord Blood|umbilical cord blood
444746|NCT01247701|Transplant|transplant
444747|NCT01247701|Umbilical Cord Blood Transplant|umbilical cord blood transplant
444748|NCT01247701|Cord Blood Stem Cell Transplantation|cord blood stem cell transplantation
444749|NCT01247701|Pediatric|pediatric
444750|NCT01247701|Myeloid Hematological Malignancies|myeloid hematological malignancies
444751|NCT01247701|Busulfan|busulfan
444752|NCT01247701|Cytoxan|cytoxan
444753|NCT01247701|Cyclophosphamide|cyclophosphamide
444754|NCT01247701|Fludarabine|fludarabine
444755|NCT01247688|Lymphoid|lymphoid
444756|NCT01247688|hematologic malignancy|hematologic malignancy
444757|NCT01247688|UCB|ucb
444758|NCT01247688|Umbilical Cord Blood Transplant|umbilical cord blood transplant
444759|NCT01247688|Total Body Irradiation|total body irradiation
444760|NCT01247688|Cytoxan|cytoxan
444761|NCT01247688|Cyclophosphamide|cyclophosphamide
444762|NCT01247688|Fludarabine|fludarabine
444763|NCT01247662|Autism spectrum disorder|autism spectrum disorder
444764|NCT01247662|Social Responsiveness Scale|social responsiveness scale
444765|NCT01247662|Childhood Asperger's Syndrome Test|childhood asperger's syndrome test
444766|NCT01247662|Adult Autism Spectrum Quotient|adult autism spectrum quotient
444767|NCT01247662|psychometric|psychometric
444768|NCT01247649|Continuous glucose monitoring system|continuous glucose monitoring system
444769|NCT01247649|Non invasive|non invasive
444770|NCT01247649|Type 1 diabetes|type 1 diabetes
444771|NCT01247649|Dielectric spectroscopy|dielectric spectroscopy
444772|NCT01247636|HLRQ|hlrq
444773|NCT01247636|Elderly|elderly
444774|NCT01247636|Balance|balance
444775|NCT01247636|Mobility|mobility
444776|NCT01247636|Fear of falling|fear of falling
444777|NCT01247623|Non-resectable, advanced malignant melanoma.|non-resectable, advanced malignant melanoma.
444778|NCT01247597|Thyroid Cancer|thyroid cancer
444779|NCT01247597|Germline DICER1 Mutation|germline dicer1 mutation
444780|NCT01247597|MicroRNA Biogenesis|microrna biogenesis
444781|NCT01247597|Pleuropulmonary Blastoma|pleuropulmonary blastoma
444782|NCT01247597|PPB|ppb
444783|NCT01247584|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
444784|NCT01247584|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
444785|NCT01247584|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
444786|NCT01247584|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
444787|NCT01247584|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
444788|NCT01247584|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
444789|NCT01247584|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
444790|NCT01247584|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
444791|NCT01247558|Metanx®|metanx®
444792|NCT01247558|diabetes|diabetes
444793|NCT01247558|neuropathy|neuropathy
444794|NCT01247558|peripheral neurological disorder|peripheral neurological disorder
444795|NCT01247558|peripheral circulation disorder|peripheral circulation disorder
444796|NCT01247558|folic acid|folic acid
444797|NCT01247558|folate|folate
444798|NCT01247558|L-methylfolate|l-methylfolate
444799|NCT01247558|vitamin B6|vitamin b6
444800|NCT01247558|Pyridoxal 5'-phosphate|pyridoxal 5'-phosphate
444801|NCT01247558|vitamin B12|vitamin b12
444802|NCT01247558|methylcobalamin|methylcobalamin
444803|NCT01247545|Remote ischemic preconditioning|remote ischemic preconditioning
444804|NCT01247545|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
444805|NCT01247545|Cardioprotection|cardioprotection
444806|NCT01247545|Clinical Outcomes|clinical outcomes
444807|NCT01247532|Cancer|cancer
444808|NCT01247532|Fatigue|fatigue
444809|NCT01247532|Mindfulness|mindfulness
444810|NCT01247532|Meditation|meditation
444811|NCT01247532|Neoplasms|neoplasms
444812|NCT01247506|microRNA|microrna
444813|NCT01247493|fludarabine|fludarabine
444814|NCT01247493|AML|aml
444815|NCT01247493|Efficacy|efficacy
444816|NCT01247493|tolerability|tolerability
444817|NCT01247454|CVD|cvd
444818|NCT01247454|primary prevention|primary prevention
444819|NCT01247454|ASA|asa
444820|NCT01247454|physician behavioral change|physician behavioral change
444821|NCT01247454|Patient behavioral change|patient behavioral change
444822|NCT01247441|All breast cancer patients who were diagnosed or managed in NUH will be included into this registry|all breast cancer patients who were diagnosed or managed in nuh will be included into this registry
444823|NCT01247428|Coronary Artery Disease|coronary artery disease
444824|NCT01247428|Drug-eluting Stent|drug-eluting stent
444825|NCT01247428|Sirolimus|sirolimus
444826|NCT01247415|anaphylaxis|anaphylaxis
444827|NCT01247415|allergy|allergy
444828|NCT01247415|IgE mediated|ige mediated
444829|NCT01247415|ORS|ors
444830|NCT01247415|oculorespiratory syndrome|oculorespiratory syndrome
444831|NCT01247415|Allergic-like reactions|allergic-like reactions
444832|NCT01247415|H1N1|h1n1
444833|NCT01247415|Arepanrix|arepanrix
444834|NCT01247402|peripheral arterial disease|peripheral arterial disease
444835|NCT01247402|in-stent restenosis|in-stent restenosis
444836|NCT01247402|drug eluting balloon|drug eluting balloon
444837|NCT01247389|laparoscopy|laparoscopy
444838|NCT01247389|colon resection|colon resection
444839|NCT01247389|incisional hernia|incisional hernia
444840|NCT01247376|inflammation|inflammation
444841|NCT01247376|arthroscopy|arthroscopy
444842|NCT01247376|knee|knee
444843|NCT01247376|microdialysis|microdialysis
444844|NCT01247363|Diabetes glucokinase safety|diabetes glucokinase safety
444845|NCT01247311|Vitamin D|vitamin d
444846|NCT01247311|pulse wave velocity|pulse wave velocity
444847|NCT01247298|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
444848|NCT01247298|Trans-Arterial Chemobolizaion (TACE)|trans-arterial chemobolizaion (tace)
445034|NCT01246388|Steatosis|steatosis
444849|NCT01247298|Radiation Induced Liver Disease (RILD)|radiation induced liver disease (rild)
444850|NCT01247298|Stereotactic Body Radiation Therapy (SBRT)|stereotactic body radiation therapy (sbrt)
444851|NCT01247285|Bioequivalence|bioequivalence
444852|NCT01247285|Healthy Subjects|healthy subjects
444853|NCT01247272|Bioequivalence|bioequivalence
444854|NCT01247272|Healthy Subjects|healthy subjects
444855|NCT01247259|allergic rhinitis|allergic rhinitis
444856|NCT01247259|immunotherapy|immunotherapy
444857|NCT01247259|sublingual|sublingual
444858|NCT01247246|Oral Mucositis|oral mucositis
444859|NCT01247246|Head and Neck|head and neck
444860|NCT01247246|Head and Neck Neoplasms|head and neck neoplasms
444861|NCT01247246|Mucositis|mucositis
444862|NCT01247246|Stomatitis|stomatitis
444863|NCT01247246|Neoplasms by Site|neoplasms by site
444864|NCT01247246|Neoplasms|neoplasms
444865|NCT01247246|Gastroenteritis|gastroenteritis
444866|NCT01247246|Gastrointestinal Diseases|gastrointestinal diseases
444867|NCT01247246|Digestive System Diseases|digestive system diseases
444868|NCT01247246|Mouth Diseases|mouth diseases
444869|NCT01247246|Stomatognathic Diseases|stomatognathic diseases
444870|NCT01247246|SCV-07|scv-07
444871|NCT01247233|breast cancer|breast cancer
444872|NCT01247233|Accelerated Partial Breast Irradiation|accelerated partial breast irradiation
444873|NCT01247233|invasive cancer|invasive cancer
444874|NCT01247233|Hypofractionated Irradiation|hypofractionated irradiation
444875|NCT01247233|Lumpectomy|lumpectomy
444876|NCT01247220|Macular Edema|macular edema
444877|NCT01247220|Branch retinal vein occlusion|branch retinal vein occlusion
444878|NCT01247220|Ranibizumab|ranibizumab
444879|NCT01247207|Duchenne muscular dystrophy|duchenne muscular dystrophy
444880|NCT01247207|Becker muscular dystrophy|becker muscular dystrophy
444881|NCT01247207|Nonsense mutation|nonsense mutation
444882|NCT01247207|Premature stop codon|premature stop codon
444883|NCT01247207|DMD|dmd
444884|NCT01247207|BMD|bmd
444885|NCT01247207|nmDBMD|nmdbmd
444886|NCT01247207|DBMD|dbmd
444887|NCT01247207|Ataluren|ataluren
444888|NCT01247207|PTC124|ptc124
444889|NCT01247194|hepatitis C|hepatitis c
444890|NCT01247194|NS5A|ns5a
444891|NCT01247194|HCV RNA|hcv rna
444892|NCT01247181|compliance|compliance
444893|NCT01247181|observance|observance
444894|NCT01247181|mobile phone|mobile phone
444895|NCT01247181|SMS|sms
444896|NCT01247181|text message|text message
444897|NCT01247181|ARV|arv
444898|NCT01247181|HAART|haart
444899|NCT01247181|AIDS|aids
444900|NCT01247168|Refractory|refractory
444901|NCT01247168|Solid tumors|solid tumors
444902|NCT01247168|Cancer|cancer
444903|NCT01247142|invasive pulmonary aspergillosis|invasive pulmonary aspergillosis
444904|NCT01247142|exhaled breath condensate|exhaled breath condensate
444905|NCT01247129|Superficial inferior epigastric artery flap, delay phenomenon|superficial inferior epigastric artery flap, delay phenomenon
444906|NCT01247103|healthy volunteers|healthy volunteers
444907|NCT01247103|safety|safety
444908|NCT01247103|tolerability|tolerability
444909|NCT01247090|hypertension|hypertension
444910|NCT01247090|end stage renal disease|end stage renal disease
444911|NCT01247090|vasopressin|vasopressin
444912|NCT01247090|Arginine Vasopressin|arginine vasopressin
444913|NCT01247090|AVP|avp
444914|NCT01247090|Pitressin®|pitressin®
444915|NCT01247077|selenium|selenium
444916|NCT01247077|neuropsychological testing|neuropsychological testing
444917|NCT01247077|autoantibodies|autoantibodies
444918|NCT01247064|Bronchiolitis|bronchiolitis
444919|NCT01247064|Hypertonic Saline|hypertonic saline
444920|NCT01247051|priming|priming
444921|NCT01247051|cardiac surgery|cardiac surgery
444922|NCT01247051|cardio pulmonary bypass|cardio pulmonary bypass
444923|NCT01247051|precoating|precoating
444924|NCT01246999|Influenza|influenza
444925|NCT01246999|A/California/7/2009-like (2009 H1N1)|a/california/7/2009-like (2009 h1n1)
444926|NCT01246999|A/Perth/16/2009-like (H3N2)|a/perth/16/2009-like (h3n2)
444927|NCT01246999|B/Brisbane/60/2008-like (B/Victoria lineage)|b/brisbane/60/2008-like (b/victoria lineage)
444928|NCT01246973|Oral Curcumin|oral curcumin
444929|NCT01246973|Radiation Dermatitis|radiation dermatitis
444930|NCT01246973|Breast Cancer Patients|breast cancer patients
444931|NCT01246960|cancer|cancer
444932|NCT01246960|stomach|stomach
444933|NCT01246960|esophagus|esophagus
444934|NCT01246960|gastroesophageal|gastroesophageal
444935|NCT01246947|Moderate Tricuspid Valve Regurgitation|moderate tricuspid valve regurgitation
444936|NCT01246947|Tricuspid Valve Repair|tricuspid valve repair
444937|NCT01246947|Mitral Value Surgery|mitral value surgery
444938|NCT01246921|Vitiligo, repigmentation, satisfaction|vitiligo, repigmentation, satisfaction
444939|NCT01246908|TRD|trd
444940|NCT01246895|Cartilage repair|cartilage repair
444941|NCT01246895|Cartilage|cartilage
444942|NCT01246895|Knee|knee
444943|NCT01246895|Knee Pain|knee pain
444944|NCT01246895|Microfracture|microfracture
444945|NCT01246895|Arthroscopy|arthroscopy
444946|NCT01246895|Bone Marrow Stimulation|bone marrow stimulation
444947|NCT01246895|Chondrogenesis|chondrogenesis
444948|NCT01246895|Scaffold|scaffold
444949|NCT01246895|Chitosan|chitosan
444950|NCT01246895|Articular Cartilage Repair|articular cartilage repair
444951|NCT01246882|Stroke, gait, walking, disability|stroke, gait, walking, disability
444952|NCT01246882|wireless inertial sensing|wireless inertial sensing
444953|NCT01246882|mobile health|mobile health
444954|NCT01246869|brain, cancer,glioblastoma multiforme, meningioma, glioma|brain, cancer,glioblastoma multiforme, meningioma, glioma
444955|NCT01246856|Cardiotoxicity|cardiotoxicity
444956|NCT01246856|Breast cancer treatment|breast cancer treatment
444957|NCT01246856|MIBG scintigraphy|mibg scintigraphy
444958|NCT01246856|Strain Echocardiography|strain echocardiography
444959|NCT01246856|patients who have been treated with TAC one year previously|patients who have been treated with tac one year previously
444960|NCT01246843|sunitinib|sunitinib
444961|NCT01246843|sorafenib|sorafenib
444962|NCT01246843|cognitive functioning|cognitive functioning
444963|NCT01246817|Carcinoma, Renal Cell|carcinoma, renal cell
444964|NCT01246817|temsirolimus|temsirolimus
444965|NCT01246817|FLT-PET|flt-pet
444966|NCT01246817|FDG-PET|fdg-pet
444967|NCT01246817|Adult patients with metastatic RCC (any histology and any MSKCC prognostic score), with documented|adult patients with metastatic rcc (any histology and any mskcc prognostic score), with documented
444968|NCT01246817|progressive disease after more than two prior systemic treatments with any of the following: cytokines (±|progressive disease after more than two prior systemic treatments with any of the following: cytokines (±
444969|NCT01246817|chemotherapy), sunitinib, sorafenib, or bevacizumab (± IFN).|chemotherapy), sunitinib, sorafenib, or bevacizumab (± ifn).
444970|NCT01246804|HIV infections|hiv infections
444971|NCT01246804|interaction|interaction
444972|NCT01246804|pharmacokinetics|pharmacokinetics
444973|NCT01246791|NPC-01|npc-01
444974|NCT01246791|Pharmacokinetics|pharmacokinetics
444975|NCT01246791|Healthy female volunteer|healthy female volunteer
444976|NCT01246791|Norethisterone|norethisterone
444977|NCT01246791|Ethinyl Estradiol|ethinyl estradiol
444978|NCT01246765|Atypical Antipsychotics and pregnancy|atypical antipsychotics and pregnancy
444979|NCT01246765|Pregnancy|pregnancy
444980|NCT01246765|Medication use during pregnancy|medication use during pregnancy
444981|NCT01246752|AML, Leukemia|aml, leukemia
444982|NCT01246752|Acute Myeloid Leukemia|acute myeloid leukemia
444983|NCT01246752|HSCT|hsct
444984|NCT01246752|Stem Cell Transplantation|stem cell transplantation
444985|NCT01246752|Tx|tx
444986|NCT01246752|Chemotherapy|chemotherapy
444987|NCT01246739|mild hypercortisolism|mild hypercortisolism
444988|NCT01246739|adrenal tumour|adrenal tumour
444989|NCT01246739|surgical procedures, elective|surgical procedures, elective
444990|NCT01246739|indication|indication
444991|NCT01246726|cancer, breast, radiotherapy, boost|cancer, breast, radiotherapy, boost
444992|NCT01246713|acetaminophen|acetaminophen
444993|NCT01246713|excipients|excipients
444994|NCT01246700|Parkinson's disease|parkinson's disease
444995|NCT01246700|Randomized single-blind crossover trial|randomized single-blind crossover trial
444996|NCT01246700|Sensory Attention Focused Exercise|sensory attention focused exercise
444997|NCT01246674|function, hip muscle strength, hip replacement, hip pain,|function, hip muscle strength, hip replacement, hip pain,
444998|NCT01246609|acid base balance|acid base balance
444999|NCT01246609|Percutaneous Lithotripsy|percutaneous lithotripsy
445000|NCT01246583|Multi Site|multi site
445001|NCT01246583|Randomized|randomized
445002|NCT01246583|Placebo Controlled|placebo controlled
445003|NCT01246583|Double Blind|double blind
445004|NCT01246583|Parallel Group|parallel group
445005|NCT01246583|chronic plaque psoriasis|chronic plaque psoriasis
445006|NCT01246583|topical treatment|topical treatment
445007|NCT01246583|skin diseases|skin diseases
445008|NCT01246583|papulosquamous|papulosquamous
445009|NCT01246570|exercise|exercise
445010|NCT01246570|heart|heart
445011|NCT01246570|coronary disease|coronary disease
445012|NCT01246570|rehabilitation|rehabilitation
445013|NCT01246557|Patients with Chronic Lymphatic Leukemia relapsing or resistant to treatment|patients with chronic lymphatic leukemia relapsing or resistant to treatment
445014|NCT01246544|Patient Safety|patient safety
445015|NCT01246544|The Helsinki Declaration on Patient Safety in Anaesthesiology|the helsinki declaration on patient safety in anaesthesiology
445016|NCT01246544|Helsinki Declaration on Patient Safety|helsinki declaration on patient safety
445017|NCT01246544|European Board of Anaesthesiology (EBA)|european board of anaesthesiology (eba)
445018|NCT01246544|European Society of Anaesthesiology (ESA)|european society of anaesthesiology (esa)
445019|NCT01246531|Urolithiasis|urolithiasis
445020|NCT01246531|Renal calculi|renal calculi
445021|NCT01246531|Aging|aging
445022|NCT01246531|Osteoporosis|osteoporosis
445023|NCT01246518|distal subungual onychomycosis|distal subungual onychomycosis
445024|NCT01246466|Persistent Atrial Fibrillation, Longstanding Persistent Atrial Fibrillation, Ablation, catheter ablation|persistent atrial fibrillation, longstanding persistent atrial fibrillation, ablation, catheter ablation
445025|NCT01246427|Adjuvant hormonal therapy|adjuvant hormonal therapy
445026|NCT01246427|Homeopathic treatment|homeopathic treatment
445027|NCT01246427|Hot flashes|hot flashes
445028|NCT01246427|Quality of life|quality of life
445029|NCT01246427|Hot flash score|hot flash score
445030|NCT01246414|Asthma|asthma
445031|NCT01246414|Exhaled breath condensates|exhaled breath condensates
445032|NCT01246414|Cytokines|cytokines
445033|NCT01246388|Fibrosis|fibrosis
445035|NCT01246388|Liver biopsy|liver biopsy
445036|NCT01246388|Elastography|elastography
445037|NCT01246388|MRI|mri
445038|NCT01246349|Motivational Interviewing|motivational interviewing
445039|NCT01246349|Child and Adolescent Self-Efficacy|child and adolescent self-efficacy
445040|NCT01246349|Health Behaviours|health behaviours
445041|NCT01246336|Parkinson's disease, Parkinsonism|parkinson's disease, parkinsonism
445042|NCT01246336|Biomarkers|biomarkers
445043|NCT01246336|Exhaled breath|exhaled breath
445044|NCT01246336|Nanothechnology|nanothechnology
445045|NCT01246323|Visual analogue scale|visual analogue scale
445046|NCT01246323|pain level|pain level
445047|NCT01246323|analgesia|analgesia
445048|NCT01246323|combined anesthesia|combined anesthesia
445049|NCT01246284|Alopecia areata|alopecia areata
445050|NCT01246284|Intralesional|intralesional
445051|NCT01246284|Triamcinolone acetonide|triamcinolone acetonide
445052|NCT01246284|Concentration|concentration
445053|NCT01246258|primary ciliary dyskinesia|primary ciliary dyskinesia
445054|NCT01246258|otolith|otolith
445055|NCT01246258|vestibular tests|vestibular tests
445056|NCT01246245|PIN SITE INFECTION AFTER EXTERNAL FIXATION|pin site infection after external fixation
445057|NCT01246219|Idiopathic Short stature|idiopathic short stature
445058|NCT01246219|Self Image|self image
445059|NCT01246219|GH therapy|gh therapy
445060|NCT01246219|Psychological distress|psychological distress
445061|NCT01246206|● Non-Hodgkin lymphoma,|● non-hodgkin lymphoma,
445062|NCT01246206|● Hodgkin disease,|● hodgkin disease,
445063|NCT01246206|● Acute Myelogenous or Acute Lymphocytic Leukemia|● acute myelogenous or acute lymphocytic leukemia
445064|NCT01246206|● Myelodysplastic Syndromes,|● myelodysplastic syndromes,
445065|NCT01246206|● Chronic Myelogenous Leukemia|● chronic myelogenous leukemia
445066|NCT01246206|● Multiple Myeloma|● multiple myeloma
445067|NCT01246206|● Chronic Lymphocytic Leukemia|● chronic lymphocytic leukemia
445068|NCT01246206|● Myelofibrosis and other myeloproliferative disorders;|● myelofibrosis and other myeloproliferative disorders;
445069|NCT01246193|CKD-828|ckd-828
445070|NCT01246193|Hypertension|hypertension
445071|NCT01246193|Primary Hypertension|primary hypertension
445072|NCT01246193|Healthy Volunteer|healthy volunteer
445073|NCT01246193|S-Amlodipine|s-amlodipine
445074|NCT01246193|Telmisartan|telmisartan
445075|NCT01246193|Amlodipine|amlodipine
445076|NCT01246193|Pharmacokinetic|pharmacokinetic
445077|NCT01246193|Phase 1|phase 1
445078|NCT01246180|Skin, microcirculation; ASIC, pressure ulcer|skin, microcirculation; asic, pressure ulcer
445079|NCT01246167|Proximal humerus fracture|proximal humerus fracture
445080|NCT01246167|conservative|conservative
445081|NCT01246167|locking plate|locking plate
445082|NCT01246167|Philos|philos
445083|NCT01246167|Hemiprosthesis|hemiprosthesis
445084|NCT01246154|ASTHMA|asthma
445085|NCT01246141|tricuspid valve regurgitation|tricuspid valve regurgitation
445086|NCT01246141|replacement|replacement
445087|NCT01246141|repair|repair
445088|NCT01246141|outcomes|outcomes
445089|NCT01246128|Nicotinic Acetylcholine Receptors|nicotinic acetylcholine receptors
445090|NCT01246128|Schizophrenia Smokers|schizophrenia smokers
445091|NCT01246128|PET Imaging|pet imaging
445092|NCT01246102|Targeted Therapy|targeted therapy
445093|NCT01246102|HER2 Positive Cancer|her2 positive cancer
445094|NCT01246102|Cancer|cancer
445095|NCT01246102|Solid Tumor|solid tumor
445096|NCT01246102|Breast Cancer|breast cancer
445097|NCT01246089|Ranibizumab|ranibizumab
445098|NCT01246089|Myopia|myopia
445099|NCT01246089|Complications|complications
445100|NCT01246089|Neovascularization|neovascularization
445101|NCT01246089|OCT|oct
445102|NCT01246050|Heart Failure|heart failure
445103|NCT01246050|Outcome Assessment|outcome assessment
445104|NCT01246050|Congestive Heart Failure|congestive heart failure
445105|NCT01246037|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
445106|NCT01246037|Beta-blocker|beta-blocker
445107|NCT01246037|Adrenergic Receptor Antagonist|adrenergic receptor antagonist
445108|NCT01245998|Thrombophlebitis|thrombophlebitis
445109|NCT01245998|Venous thrombosis|venous thrombosis
445110|NCT01245998|Pulmonary embolism|pulmonary embolism
445111|NCT01245998|Anticoagulants|anticoagulants
445112|NCT01245998|Low-Molecular-Weight Heparin|low-molecular-weight heparin
445113|NCT01245985|SCCHN|scchn
445114|NCT01245985|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
445115|NCT01245985|oropharyngeal carcinoma|oropharyngeal carcinoma
445116|NCT01245985|hypopharyngeal carcinoma|hypopharyngeal carcinoma
445117|NCT01245985|laryngeal carcinoma|laryngeal carcinoma
445118|NCT01245972|pulsed dye laser|pulsed dye laser
445119|NCT01245972|PDL|pdl
445120|NCT01245972|basal cell carcinoma|basal cell carcinoma
445121|NCT01245972|squamous cell carcinoma|squamous cell carcinoma
445122|NCT01245972|BCC|bcc
445123|NCT01245972|SCC|scc
445124|NCT01245972|594nM laser|594nm laser
445125|NCT01245959|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
445126|NCT01245959|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
445127|NCT01245959|Induction chemotherapy|induction chemotherapy
445128|NCT01245959|Clinical trial|clinical trial
445129|NCT01245946|Acne moderate|acne moderate
445130|NCT01245946|Photodynamic Therapy|photodynamic therapy
445131|NCT01245946|Topical retinoids|topical retinoids
445132|NCT01245946|Antimicrobial agents|antimicrobial agents
445133|NCT01245933|COPD|copd
445134|NCT01245933|register|register
445135|NCT01245933|comorbidities|comorbidities
445136|NCT01245933|systemic inflammation|systemic inflammation
445137|NCT01245920|Dental implant|dental implant
445138|NCT01245920|Alveolar bone|alveolar bone
445139|NCT01245920|Clinical attachment Level|clinical attachment level
445140|NCT01245907|Hot flashes|hot flashes
445141|NCT01245907|Menopause|menopause
445142|NCT01245907|HRQoL|hrqol
445143|NCT01245907|Applied relaxation|applied relaxation
445144|NCT01245907|Insomnia|insomnia
445145|NCT01245907|Women's knowledge|women's knowledge
445146|NCT01245894|Index of microcirculatory resistance|index of microcirculatory resistance
445147|NCT01245894|Fractional Flow Reserve|fractional flow reserve
445148|NCT01245881|controlled trial|controlled trial
445149|NCT01245881|fractional photothermolysis|fractional photothermolysis
445150|NCT01245881|laser surgery|laser surgery
445151|NCT01245881|melasma|melasma
445152|NCT01245881|pigment disorder|pigment disorder
445153|NCT01245868|Spinal anaesthesia|spinal anaesthesia
445154|NCT01245868|Bupivacaine|bupivacaine
445155|NCT01245868|Lidocaine|lidocaine
445156|NCT01245868|Duration of blockade|duration of blockade
445157|NCT01245855|Prostaglandin E1|prostaglandin e1
445158|NCT01245855|percutaneous coronary intervention|percutaneous coronary intervention
445159|NCT01245855|Cardiac troponin T|cardiac troponin t
445160|NCT01245855|Creatine kinase-MB|creatine kinase-mb
445161|NCT01245829|Cross Infection|cross infection
445162|NCT01245829|Nosocomial Infection|nosocomial infection
445163|NCT01245829|Healthcare Acquired Infection|healthcare acquired infection
445164|NCT01245829|Hospital Paperwork|hospital paperwork
445165|NCT01245829|Observation Charts|observation charts
445166|NCT01245829|Critical Care|critical care
445167|NCT01245829|Contamination|contamination
445168|NCT01245816|colon polyps|colon polyps
445169|NCT01245803|rosuvastatin|rosuvastatin
445170|NCT01245803|angioplasty|angioplasty
445171|NCT01245803|acute coronary syndrome|acute coronary syndrome
445172|NCT01245790|Phase 1|phase 1
445173|NCT01245790|healthy volunteers|healthy volunteers
445174|NCT01245790|volunteers with renal impairment|volunteers with renal impairment
445175|NCT01245790|pharmacokinetics|pharmacokinetics
445176|NCT01245790|Rheumatoid arthritis|rheumatoid arthritis
445178|NCT01245790|fostamatinib|fostamatinib
445179|NCT01245790|Patients|patients
445180|NCT01245777|RLS|rls
445181|NCT01245777|Pregnancy|pregnancy
445182|NCT01245777|Iron Deficiency|iron deficiency
445183|NCT01245777|Anaemia|anaemia
445184|NCT01245764|Cervical cancer|cervical cancer
445185|NCT01245764|vulvar cancer|vulvar cancer
445186|NCT01245764|vaginal cancer|vaginal cancer
445187|NCT01245764|genital warts|genital warts
445188|NCT01245764|human papillomavirus|human papillomavirus
445189|NCT01245751|Shingles|shingles
445190|NCT01245751|Vaccine|vaccine
445191|NCT01245712|Adenocarcinoma of the breast|adenocarcinoma of the breast
445192|NCT01245712|Lumpectomy|lumpectomy
445193|NCT01245712|Stage 0 breast cancer|stage 0 breast cancer
445194|NCT01245712|Stage I breast cancer|stage i breast cancer
445195|NCT01245712|Stage II breast cancer|stage ii breast cancer
445196|NCT01245712|Accelerated partial breast irradiation|accelerated partial breast irradiation
445197|NCT01245712|APBI|apbi
445198|NCT01245699|Cardiac arrest, CPR, quality improvement|cardiac arrest, cpr, quality improvement
445199|NCT01245686|Diet interventions|diet interventions
445200|NCT01245686|Physical activity interventions|physical activity interventions
445201|NCT01245686|Medication adherence|medication adherence
445202|NCT01245686|Tailored interventions|tailored interventions
445203|NCT01245673|Advanced Disease|advanced disease
445204|NCT01245673|MAGE-A3 Immunizations with Hiltonol|mage-a3 immunizations with hiltonol
445205|NCT01245673|Vaccine-Primed Autologous T-Cells|vaccine-primed autologous t-cells
445206|NCT01245673|Lenalidomide Maintenance|lenalidomide maintenance
445207|NCT01245660|Phase 0|phase 0
445208|NCT01245660|Bladder carcinoma|bladder carcinoma
445209|NCT01245660|egf pathway|egf pathway
445210|NCT01245660|infiltrative bladder carcinoma|infiltrative bladder carcinoma
445211|NCT01245660|cystectomy|cystectomy
445212|NCT01245660|LAPATINIB|lapatinib
445213|NCT01245647|women|women
445214|NCT01245647|HIV|hiv
445215|NCT01245647|alcohol|alcohol
445216|NCT01245647|medication|medication
445217|NCT01245647|adherence|adherence
445218|NCT01245647|acceptability|acceptability
445219|NCT01245621|palliative care|palliative care
445220|NCT01245621|end of life care|end of life care
445221|NCT01245621|quality of life|quality of life
445222|NCT01245621|caregivers|caregivers
445223|NCT01245608|Atorvastatin|atorvastatin
445224|NCT01245608|Aspirin|aspirin
445225|NCT01245608|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
445226|NCT01245608|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
445227|NCT01245608|antihypertensive agents|antihypertensive agents
445228|NCT01245595|Acute Kidney Injury (AKI)|acute kidney injury (aki)
445229|NCT01245595|Cardiopulmonary bypass (CPB)|cardiopulmonary bypass (cpb)
445436|NCT01244633|Efficacy|efficacy
445230|NCT01245530|Alzheimer disease|alzheimer disease
445231|NCT01245517|hyperphosphatemia or malnutrition|hyperphosphatemia or malnutrition
445232|NCT01245478|Surgical Procedures, Elective|surgical procedures, elective
445233|NCT01245452|Rheumatoid arthritis|rheumatoid arthritis
445234|NCT01245452|Tocilizumab|tocilizumab
445235|NCT01245452|Cardiorespiratory endurance|cardiorespiratory endurance
445236|NCT01245426|Asthma|asthma
445237|NCT01245426|GW870086|gw870086
445238|NCT01245426|Efficacy|efficacy
445239|NCT01245426|FEV1|fev1
445240|NCT01245413|Stoma|stoma
445241|NCT01245413|adhesive|adhesive
445242|NCT01245413|warm|warm
445243|NCT01245413|moist|moist
445244|NCT01245413|cycling|cycling
445245|NCT01245413|men|men
445246|NCT01245413|peel-value|peel-value
445247|NCT01245413|healthy men 50-70 years old|healthy men 50-70 years old
445248|NCT01245413|men with colostoma, above 18 years|men with colostoma, above 18 years
445249|NCT01245400|Z-Lig|z-lig
445250|NCT01245400|allograft|allograft
445251|NCT01245400|ACL|acl
445252|NCT01245400|Anterior Cruciate Ligament|anterior cruciate ligament
445253|NCT01245400|ACLR|aclr
445254|NCT01245400|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
445255|NCT01245400|EU|eu
445256|NCT01245400|European Union|european union
445257|NCT01245400|S. Africa|s. africa
445258|NCT01245400|Reconstruction of ruptured anterior cruciate ligaments|reconstruction of ruptured anterior cruciate ligaments
445259|NCT01245387|prospective|prospective
445260|NCT01245387|observational|observational
445261|NCT01245387|Phase 4|phase 4
445262|NCT01245387|non-interventional|non-interventional
445263|NCT01245387|open-label|open-label
445264|NCT01245361|Undifferentiated Arthritis|undifferentiated arthritis
445265|NCT01245361|Rheumatoid Arthritis|rheumatoid arthritis
445266|NCT01245361|Infliximab|infliximab
445267|NCT01245348|Schizophrenia|schizophrenia
445268|NCT01245348|Bipolar Disorder|bipolar disorder
445269|NCT01245348|atypical antipsychotic|atypical antipsychotic
445270|NCT01245348|adherence|adherence
445271|NCT01245348|cost effectiveness|cost effectiveness
445272|NCT01245348|pharmacogenetics|pharmacogenetics
445273|NCT01245348|mental illness|mental illness
445274|NCT01245348|SULT4A1|sult4a1
445275|NCT01245335|CLI|cli
445276|NCT01245335|Critical Limb Ischemia|critical limb ischemia
445277|NCT01245335|PAOD|paod
445278|NCT01245335|Peripheral Arterial Disease|peripheral arterial disease
445279|NCT01245335|Stem Cells|stem cells
445280|NCT01245335|Limb amputation|limb amputation
445281|NCT01245335|Leg ulcers|leg ulcers
445282|NCT01245322|treatment, lactobacilli|treatment, lactobacilli
445283|NCT01245296|Umbilical cord|umbilical cord
445284|NCT01245296|cord clamping|cord clamping
445285|NCT01245296|iron|iron
445286|NCT01245296|Ferritin|ferritin
445287|NCT01245296|newborn|newborn
445288|NCT01245296|jaundice|jaundice
445289|NCT01245296|infant|infant
445290|NCT01245296|development|development
445291|NCT01245296|infections|infections
445292|NCT01245283|knee|knee
445293|NCT01245283|osteoarthritis|osteoarthritis
445294|NCT01245283|pain|pain
445295|NCT01245283|function|function
445296|NCT01245283|impairment|impairment
445297|NCT01245270|anthocyanin|anthocyanin
445298|NCT01245270|blaeberries|blaeberries
445299|NCT01245270|bilberries|bilberries
445300|NCT01245270|blueberries|blueberries
445301|NCT01245270|mirtoselect|mirtoselect
445302|NCT01245270|glucose AUC|glucose auc
445303|NCT01245257|Inflammation|inflammation
445304|NCT01245257|Urea Synthesis|urea synthesis
445305|NCT01245257|Catabolism|catabolism
445306|NCT01245257|Nitrogen balance|nitrogen balance
445307|NCT01245231|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
445308|NCT01245179|sickle cell anemia|sickle cell anemia
445309|NCT01245179|sickle cell thalassemia|sickle cell thalassemia
445310|NCT01245179|HDAC inhibitor|hdac inhibitor
445311|NCT01245179|hemoglobin F|hemoglobin f
445312|NCT01245179|sickle beta thalassemia|sickle beta thalassemia
445313|NCT01245179|Fetal Hemoglobin|fetal hemoglobin
445314|NCT01245153|Urinary incontinence, Pelvic floor muscle training|urinary incontinence, pelvic floor muscle training
445315|NCT01245140|Palmo-Plantar Pustolosis|palmo-plantar pustolosis
445316|NCT01245127|Schnitzler syndrome|schnitzler syndrome
445317|NCT01245101|HIV raltegravir intensification replication activation|hiv raltegravir intensification replication activation
445318|NCT01245088|Crohn's disease|crohn's disease
445319|NCT01245088|chondroitin sulfate|chondroitin sulfate
445320|NCT01245062|MEK inhibitor|mek inhibitor
445321|NCT01245062|Cancer|cancer
445322|NCT01245062|Metastatic Melanoma|metastatic melanoma
445323|NCT01245062|BRAF mutant metastatic melanoma|braf mutant metastatic melanoma
445324|NCT01245062|GSK1120212|gsk1120212
445325|NCT01245049|MMR|mmr
445326|NCT01245049|dTpa-IPV|dtpa-ipv
445327|NCT01245049|Boostrix Polio|boostrix polio
445328|NCT01245049|Repevax|repevax
445329|NCT01245049|Priorix|priorix
445330|NCT01245036|Sarcoidosis|sarcoidosis
445331|NCT01245036|Tuberculosis|tuberculosis
445332|NCT01245010|Metabolic Syndrome|metabolic syndrome
445333|NCT01245010|Water|water
445334|NCT01245010|Obesity|obesity
445335|NCT01245010|Clinical trial|clinical trial
445336|NCT01245010|Prevention|prevention
445337|NCT01244997|Partial edentulism|partial edentulism
445338|NCT01244997|Bone atrophy|bone atrophy
445339|NCT01244997|Bone healing|bone healing
445340|NCT01244984|asthma|asthma
445341|NCT01244984|Fluticasone furoate|fluticasone furoate
445342|NCT01244984|GW642444|gw642444
445343|NCT01244958|Active rheumatoid arthritis|active rheumatoid arthritis
445344|NCT01244958|leflunomide|leflunomide
445345|NCT01244958|rituximab|rituximab
445346|NCT01244958|inadequate clinical response to leflunomide|inadequate clinical response to leflunomide
445347|NCT01244945|Functional Constipation|functional constipation
445348|NCT01244945|Functional Foods|functional foods
445349|NCT01244945|Probiotics|probiotics
445350|NCT01244945|Lactobacillus reuteri|lactobacillus reuteri
445351|NCT01244906|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
445352|NCT01244906|Acute Myelogenous Leukemia|acute myelogenous leukemia
445353|NCT01244906|Myelodysplastic Syndrome|myelodysplastic syndrome
445354|NCT01244906|Myelofibrosis|myelofibrosis
445355|NCT01244906|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
445356|NCT01244906|Acute Lymphoblastic Lymphoma|acute lymphoblastic lymphoma
445357|NCT01244906|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
445358|NCT01244906|Prolymphocytic Leukemia|prolymphocytic leukemia
445359|NCT01244906|Low-grade non-Hodgkin's Lymphoma|low-grade non-hodgkin's lymphoma
445360|NCT01244906|Mantle Cell Lymphoma|mantle cell lymphoma
445361|NCT01244906|Hodgkin Lymphoma|hodgkin lymphoma
445362|NCT01244906|Myeloma|myeloma
445363|NCT01244880|PF-02545920|pf-02545920
445364|NCT01244880|ketamine|ketamine
445365|NCT01244880|fMRI|fmri
445366|NCT01244880|associative Learning|associative learning
445367|NCT01244854|chronic mental disorders|chronic mental disorders
445368|NCT01244854|cardiovascular disease|cardiovascular disease
445369|NCT01244854|behavior change|behavior change
445370|NCT01244841|ST elevation acute myocardial infarction|st elevation acute myocardial infarction
445371|NCT01244841|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
445372|NCT01244841|Discharge|discharge
445373|NCT01244841|Health status|health status
445374|NCT01244841|Quality of care|quality of care
445375|NCT01244815|Bi-polar I disorder|bi-polar i disorder
445376|NCT01244815|antipsychotic|antipsychotic
445377|NCT01244815|serotonin|serotonin
445378|NCT01244815|dopamine|dopamine
445379|NCT01244815|noradrenalin|noradrenalin
445380|NCT01244815|histamine|histamine
445381|NCT01244815|pediatric|pediatric
445382|NCT01244802|yellow fever vaccine|yellow fever vaccine
445383|NCT01244789|endometrial cancer|endometrial cancer
445384|NCT01244789|chemotherapy|chemotherapy
445385|NCT01244789|carboplatin|carboplatin
445386|NCT01244789|paclitaxel|paclitaxel
445387|NCT01244789|Stage 1 & 2|stage 1 & 2
445388|NCT01244789|node-negative|node-negative
445389|NCT01244789|intermediate risk|intermediate risk
445390|NCT01244789|high risk|high risk
445391|NCT01244763|Kidney|kidney
445392|NCT01244763|Chronic Kidney Disease|chronic kidney disease
445393|NCT01244763|CKD|ckd
445394|NCT01244763|Renal|renal
445395|NCT01244763|Anemia|anemia
445396|NCT01244763|Oral anemia treatment|oral anemia treatment
445397|NCT01244763|Hemoglobin levels|hemoglobin levels
445398|NCT01244763|Erythropoietin|erythropoietin
445399|NCT01244763|Blood count|blood count
445400|NCT01244763|Predialysis|predialysis
445401|NCT01244763|Pre-dialysis|pre-dialysis
445402|NCT01244763|Hb|hb
445403|NCT01244763|Non-dialysis|non-dialysis
445404|NCT01244750|Chronic Phase - Chronic Myeloid Leukemia|chronic phase - chronic myeloid leukemia
445405|NCT01244737|Brain neoplasms|brain neoplasms
445406|NCT01244737|Children|children
445407|NCT01244737|Positron-Emission Tomography|positron-emission tomography
445408|NCT01244737|18F-FLT|18f-flt
445409|NCT01244711|Major Depression|major depression
445410|NCT01244711|Generalized Anxiety Disorder|generalized anxiety disorder
445411|NCT01244711|Benzodiazepine|benzodiazepine
445412|NCT01244711|Quetiapine|quetiapine
445413|NCT01244698|Surgical Site Infection, Breast Reconstruction, Antibiotics|surgical site infection, breast reconstruction, antibiotics
445414|NCT01244685|bowel resection|bowel resection
445415|NCT01244685|Deltex CardioQ Probe|deltex cardioq probe
445416|NCT01244685|fluid management|fluid management
445417|NCT01244672|Hemorrhoids|hemorrhoids
445418|NCT01244672|THD|thd
445419|NCT01244672|Ferguson|ferguson
445420|NCT01244659|Tacrolimus|tacrolimus
445421|NCT01244659|Immunosuppressive Agents|immunosuppressive agents
445422|NCT01244659|Kidney transplantation|kidney transplantation
445423|NCT01244646|Diabetes Mellitus|diabetes mellitus
445424|NCT01244646|Type 2|type 2
445425|NCT01244646|DMT2|dmt2
445426|NCT01244646|T2DM|t2dm
445427|NCT01244646|metformin|metformin
445428|NCT01244646|sulfonylurea|sulfonylurea
445429|NCT01244646|hypoglycemia|hypoglycemia
445430|NCT01244646|weight|weight
445431|NCT01244646|quality of life|quality of life
445432|NCT01244646|compliance|compliance
445433|NCT01244633|Tourette's|tourette's
445434|NCT01244633|Ecopipam|ecopipam
445435|NCT01244633|Dopamine receptors|dopamine receptors
445437|NCT01244633|Safety|safety
445438|NCT01244633|Adults|adults
445439|NCT01244620|A pharmacokinetic drug-drug interaction study between sitaxsentan and tadalafil and between sitaxsentan and sildenafil at the steady-state|a pharmacokinetic drug-drug interaction study between sitaxsentan and tadalafil and between sitaxsentan and sildenafil at the steady-state
445440|NCT01244594|Spinal Cord Injury|spinal cord injury
445441|NCT01244594|Cycling|cycling
445442|NCT01244594|Functional Electrical Stimulation|functional electrical stimulation
445443|NCT01244581|middle ear effusion|middle ear effusion
445444|NCT01244581|amoxicillin-clavulanate|amoxicillin-clavulanate
445445|NCT01244581|tympanometry|tympanometry
445446|NCT01244568|Prostate Cancer|prostate cancer
445447|NCT01244568|Decision support interventions (DESI)|decision support interventions (desi)
445448|NCT01244568|Comparative Effectiveness Research (CER)|comparative effectiveness research (cer)
445449|NCT01244542|Schizophrenia|schizophrenia
445450|NCT01244542|DSM IV criteria|dsm iv criteria
445451|NCT01244542|Pain insensitivity|pain insensitivity
445452|NCT01244542|Painful perception|painful perception
445453|NCT01244542|Opioid receptors|opioid receptors
445454|NCT01244490|ADHD|adhd
445455|NCT01244477|Stress Disorders, Post Traumatic|stress disorders, post traumatic
445456|NCT01244477|Trust|trust
445457|NCT01244477|functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
445458|NCT01244464|Poliomyelitis|poliomyelitis
445459|NCT01244464|IMOVAX POLIO™|imovax polio™
445460|NCT01244464|Polio|polio
445461|NCT01244451|CLL|cll
445462|NCT01244451|relapsed|relapsed
445463|NCT01244451|refractory|refractory
445464|NCT01244451|Bendamustine|bendamustine
445465|NCT01244451|Ofatumumab|ofatumumab
445466|NCT01244438|endometrial cancer|endometrial cancer
445467|NCT01244438|FGFR2 mutations|fgfr2 mutations
445468|NCT01244412|Fundus photography|fundus photography
445469|NCT01244399|inositol|inositol
445470|NCT01244399|caffeine|caffeine
445471|NCT01244399|NTDs|ntds
445472|NCT01244386|Computed tomography|computed tomography
445473|NCT01244386|Iterative reconstruction|iterative reconstruction
445474|NCT01244386|Automatic tube current modulation|automatic tube current modulation
445475|NCT01244386|Crohn's disease|crohn's disease
445476|NCT01244386|Inflammatory bowel disease|inflammatory bowel disease
445477|NCT01244386|Radiation dose optimization|radiation dose optimization
445478|NCT01244386|C reactive protein|c reactive protein
445479|NCT01244373|Best-corrected visual acuity|best-corrected visual acuity
445480|NCT01244373|posterior capsule opacification|posterior capsule opacification
445481|NCT01244373|QUATRIX® Aspheric Evolutive pre-loaded|quatrix® aspheric evolutive pre-loaded
445482|NCT01244360|resveratrol|resveratrol
445483|NCT01244360|insulin|insulin
445484|NCT01244360|inflammation|inflammation
445485|NCT01244360|cognition|cognition
445486|NCT01244360|metabolism|metabolism
445487|NCT01244347|folic acid|folic acid
445488|NCT01244347|malformations|malformations
445489|NCT01244347|prevention|prevention
445490|NCT01244334|cataract surgery, vision, corneal edema, retinal thickness|cataract surgery, vision, corneal edema, retinal thickness
445491|NCT01244321|End stage heart failure|end stage heart failure
445492|NCT01244321|heart transplantation|heart transplantation
445493|NCT01244321|Ventricular assist device|ventricular assist device
445494|NCT01244321|Patients with end stage heart failure|patients with end stage heart failure
445495|NCT01244321|awaiting heart transplantation|awaiting heart transplantation
445496|NCT01244308|Phrenic nerve stimulation|phrenic nerve stimulation
445497|NCT01244308|LV pacing configuration|lv pacing configuration
445498|NCT01244308|CRT|crt
445499|NCT01244308|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
445500|NCT01244308|Heart failure|heart failure
445501|NCT01244295|Grief|grief
445502|NCT01244295|Bereavement|bereavement
445503|NCT01244295|Psychotherapy|psychotherapy
445504|NCT01244295|Randomized controlled trial|randomized controlled trial
445505|NCT01244295|Treatment study|treatment study
445506|NCT01244282|brain imaging|brain imaging
445507|NCT01244269|Parkinson's disease|parkinson's disease
445508|NCT01244269|Methylphenidate|methylphenidate
445509|NCT01244269|Non motor symptoms|non motor symptoms
445510|NCT01244269|Postural control|postural control
445511|NCT01244243|stroke|stroke
445512|NCT01244243|rehabilitation|rehabilitation
445513|NCT01244204|vitamin D deficiency|vitamin d deficiency
445514|NCT01244204|tuberculin sin test|tuberculin sin test
445515|NCT01244204|immunity|immunity
445516|NCT01244204|tuberculosis|tuberculosis
445517|NCT01244191|Non squamous, non-small-cell lung cancer|non squamous, non-small-cell lung cancer
445518|NCT01244191|Epidermal growth factor receptor, wild type|epidermal growth factor receptor, wild type
445519|NCT01244191|c-Met inhibitor|c-met inhibitor
445520|NCT01244178|Sepsis|sepsis
445521|NCT01244178|Insulin|insulin
445522|NCT01244139|BIIB033|biib033
445523|NCT01244139|Multiple Sclerosis|multiple sclerosis
445524|NCT01244139|anti-LINGO-1 antibody|anti-lingo-1 antibody
445525|NCT01244139|Relapsing Remitting MS|relapsing remitting ms
445526|NCT01244139|remyelination|remyelination
445527|NCT01244139|myelin repair|myelin repair
445528|NCT01244139|Multiple ascending dose|multiple ascending dose
445529|NCT01244139|Secondary progessive MS|secondary progessive ms
445530|NCT01244126|otitis media|otitis media
445531|NCT01244126|recurrent ear infections (otitis media)|recurrent ear infections (otitis media)
445532|NCT01244100|Food-effects PK study in healthy subjects.|food-effects pk study in healthy subjects.
445533|NCT01244087|Inquiry-based stress reduction|inquiry-based stress reduction
445534|NCT01244087|Quality of life|quality of life
445535|NCT01244087|breast cancer|breast cancer
445536|NCT01244048|n3 LC-PUFA, yoghurt, inflammatory markers|n3 lc-pufa, yoghurt, inflammatory markers
445537|NCT01244035|High blood pressure|high blood pressure
445538|NCT01244022|Colorectal cancer|colorectal cancer
445539|NCT01244022|Surgical stress response|surgical stress response
445540|NCT01244022|interleukins|interleukins
445541|NCT01244009|Poly (ADP-ribose) polymerase (PARP) inhibitor|poly (adp-ribose) polymerase (parp) inhibitor
445542|NCT01243996|Patent ductus arteriosus, ibuprofen, preterm infants|patent ductus arteriosus, ibuprofen, preterm infants
445543|NCT01243970|Spinal anaesthesia|spinal anaesthesia
445544|NCT01243970|phenylephrine|phenylephrine
445545|NCT01243970|ephedrine|ephedrine
445546|NCT01243970|ECG changes|ecg changes
445547|NCT01243970|Caesarean delivery|caesarean delivery
445548|NCT01243970|Myocardial ischaemia|myocardial ischaemia
445549|NCT01243970|Cardiac output|cardiac output
445550|NCT01243970|hypotension|hypotension
445551|NCT01243944|INCB018424|incb018424
445552|NCT01243931|Phototherapeutic keratectomy|phototherapeutic keratectomy
445553|NCT01243931|Optical coherence tomography|optical coherence tomography
445554|NCT01243931|Corneal opacity|corneal opacity
445555|NCT01243931|Corneal dystrophy|corneal dystrophy
445556|NCT01243918|Acute respiratory failure|acute respiratory failure
445557|NCT01243918|Oxygen therapy delivery systems|oxygen therapy delivery systems
445558|NCT01243918|Non invasive ventilation|non invasive ventilation
445559|NCT01243918|High concentration mask|high concentration mask
445560|NCT01243918|Hypoxemic pneumonia|hypoxemic pneumonia
445561|NCT01243879|fasting|fasting
445562|NCT01243879|starvation|starvation
445563|NCT01243879|calorie restriction|calorie restriction
445564|NCT01243879|fMRI|fmri
445565|NCT01243840|Central aortic pressure|central aortic pressure
445566|NCT01243840|Aortic pulse wave velocity|aortic pulse wave velocity
445567|NCT01243840|Aortic PWV using a single pressure recording|aortic pwv using a single pressure recording
445568|NCT01243840|Vascular aging|vascular aging
445569|NCT01243840|Left ventricular hypertrophy|left ventricular hypertrophy
445570|NCT01243840|Left ventricular diastolic function|left ventricular diastolic function
445571|NCT01243827|Hypertension, carvedilol, bisoprolol, central pulse pressure, pulse pressure amplification, reflection magnitude, LV mass index, LV diastolic function|hypertension, carvedilol, bisoprolol, central pulse pressure, pulse pressure amplification, reflection magnitude, lv mass index, lv diastolic function
445572|NCT01243814|hyaluronate|hyaluronate
445573|NCT01243814|hyaluronic acid|hyaluronic acid
445574|NCT01243814|viscosupplementation|viscosupplementation
445575|NCT01243801|chronic pain|chronic pain
445576|NCT01243801|persistent postsurgical pain|persistent postsurgical pain
445577|NCT01243801|hyperalgesia|hyperalgesia
445578|NCT01243801|ketamine|ketamine
445579|NCT01243801|quantitative sensory testing|quantitative sensory testing
445580|NCT01243788|COPD|copd
445581|NCT01243788|Seretide|seretide
445582|NCT01243788|Combivent|combivent
445583|NCT01243788|effect and safety|effect and safety
445584|NCT01243788|Twelve weeks|twelve weeks
445585|NCT01243775|NSCLC|nsclc
445586|NCT01243762|Colorectal cancer|colorectal cancer
445587|NCT01243762|Solid tumors|solid tumors
445588|NCT01243762|Ovarian cancer|ovarian cancer
445589|NCT01243762|Fallopian tube cancer|fallopian tube cancer
445590|NCT01243762|Primary peritoneal cancer|primary peritoneal cancer
445591|NCT01243749|Target Vessel Revascularization (TVR)|target vessel revascularization (tvr)
445592|NCT01243749|Target Lesion Revascularization (TLR)|target lesion revascularization (tlr)
445593|NCT01243749|Myocardial Infarction (MI)|myocardial infarction (mi)
445594|NCT01243749|Target Vessel Failure (TVF)|target vessel failure (tvf)
445595|NCT01243749|Target Lesion Failure (TLF)|target lesion failure (tlf)
445596|NCT01243749|Stent Thrombosis|stent thrombosis
445597|NCT01243749|Restenotic Lesion|restenotic lesion
445598|NCT01243749|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
445599|NCT01243749|Real-world|real-world
445600|NCT01243736|anemic|anemic
445601|NCT01243736|bleeding|bleeding
445602|NCT01243736|blood in stool|blood in stool
445603|NCT01243736|abdomen pain|abdomen pain
445604|NCT01243736|Gastrointestinal bleeding|gastrointestinal bleeding
445605|NCT01243736|capsule endoscopy (CE)|capsule endoscopy (ce)
445606|NCT01243723|Dyschesia treatment|dyschesia treatment
445607|NCT01243723|Inconfort related to dyschesia|inconfort related to dyschesia
445608|NCT01243723|Quality of life|quality of life
445609|NCT01243723|Bowel function index|bowel function index
445610|NCT01243697|Desogestrel|desogestrel
445611|NCT01243697|Chemosensitivity|chemosensitivity
445612|NCT01243684|Spinal cord|spinal cord
445613|NCT01243684|cervical spondylosis|cervical spondylosis
445614|NCT01243684|myelopathy|myelopathy
445615|NCT01243671|Behçet's, intestinal|behçet's, intestinal
445616|NCT01243658|Oxytocin|oxytocin
445617|NCT01243658|BPD|bpd
445618|NCT01243658|Borderline|borderline
445619|NCT01243632|malignant pleural mesothelioma|malignant pleural mesothelioma
445620|NCT01243632|chemotherapy|chemotherapy
445621|NCT01243632|gemcitabine|gemcitabine
445622|NCT01243632|cisplatin|cisplatin
445623|NCT01243632|long infusion|long infusion
445624|NCT01243619|PET|pet
445625|NCT01243619|CT|ct
445626|NCT01243619|radiotherapy|radiotherapy
445627|NCT01243606|Anxiety|anxiety
445628|NCT01243606|Depression|depression
445629|NCT01243606|Obsessive Compulsive Disorder|obsessive compulsive disorder
445630|NCT01243606|Panic Disorder|panic disorder
445631|NCT01243606|Generalized Anxiety Disorder|generalized anxiety disorder
445632|NCT01243606|Social Anxiety Disorder|social anxiety disorder
445633|NCT01243606|Transdiagnostic Treatment|transdiagnostic treatment
445634|NCT01243606|CBT|cbt
445635|NCT01243593|pediatrics|pediatrics
445636|NCT01243593|anesthesia|anesthesia
445637|NCT01243593|pyeloplasty|pyeloplasty
445638|NCT01243593|Transversus Abdominis Plane Block|transversus abdominis plane block
445639|NCT01243593|Regional Anesthesia|regional anesthesia
445640|NCT01243580|PK and safety|pk and safety
445641|NCT01243580|Pharmacokinetic profile (PK) and safety|pharmacokinetic profile (pk) and safety
445642|NCT01243554|Exercise training|exercise training
445643|NCT01243554|Pregnancy|pregnancy
445644|NCT01243554|Obesity|obesity
445645|NCT01243528|Malnutrition|malnutrition
445646|NCT01243528|Infection|infection
445647|NCT01243528|Neurological|neurological
445648|NCT01243515|Central Venous Pressure|central venous pressure
445649|NCT01243515|Kidney Diseases|kidney diseases
445650|NCT01243515|Chronic Kidney Disease|chronic kidney disease
445651|NCT01243515|Healthy Subjects|healthy subjects
445652|NCT01243515|Non-Invasive Monitor|non-invasive monitor
445653|NCT01243489|CML|cml
445654|NCT01243489|compliance|compliance
445655|NCT01243489|compliance supporting measures|compliance supporting measures
445656|NCT01243489|complete cytogenetic response|complete cytogenetic response
445657|NCT01243489|mayor molecular remission|mayor molecular remission
445658|NCT01243489|Philadelphia chromosome|philadelphia chromosome
445659|NCT01243489|BCR-ABL|bcr-abl
445660|NCT01243489|Imatinib|imatinib
445661|NCT01243489|tyrosine kinase inhibitor|tyrosine kinase inhibitor
445662|NCT01243489|smart blister|smart blister
445663|NCT01243476|myelodysplastic syndrome|myelodysplastic syndrome
445664|NCT01243476|5q deletion|5q deletion
445665|NCT01243476|anemia|anemia
445666|NCT01243476|lenalidomide|lenalidomide
445667|NCT01243476|red blood cells transfusion|red blood cells transfusion
445668|NCT01243437|plague, ciprofloxacin|plague, ciprofloxacin
445669|NCT01243411|Peyronie's Disease, penile plaque, penile curvature|peyronie's disease, penile plaque, penile curvature
445670|NCT01243398|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
445671|NCT01243398|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
445672|NCT01243398|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
445673|NCT01243398|recurrent esophageal cancer|recurrent esophageal cancer
445674|NCT01243398|stage IA esophageal cancer|stage ia esophageal cancer
445675|NCT01243398|stage IB esophageal cancer|stage ib esophageal cancer
445676|NCT01243398|stage IIA esophageal cancer|stage iia esophageal cancer
445677|NCT01243398|stage IIB esophageal cancer|stage iib esophageal cancer
445678|NCT01243398|stage IIIA esophageal cancer|stage iiia esophageal cancer
445679|NCT01243398|stage IIIB esophageal cancer|stage iiib esophageal cancer
445680|NCT01243398|stage IIIC esophageal cancer|stage iiic esophageal cancer
445681|NCT01243398|stage IV esophageal cancer|stage iv esophageal cancer
445682|NCT01243385|adenocarcinoma of the prostate|adenocarcinoma of the prostate
445683|NCT01243385|hormone-resistant prostate cancer|hormone-resistant prostate cancer
445684|NCT01243385|stage III prostate cancer|stage iii prostate cancer
445685|NCT01243385|stage IV prostate cancer|stage iv prostate cancer
445686|NCT01243385|recurrent prostate cancer|recurrent prostate cancer
445687|NCT01243372|recurrent colon cancer|recurrent colon cancer
445688|NCT01243372|stage IIIA colon cancer|stage iiia colon cancer
445689|NCT01243372|stage IIIB colon cancer|stage iiib colon cancer
445690|NCT01243372|stage IIIC colon cancer|stage iiic colon cancer
445691|NCT01243372|stage IVA colon cancer|stage iva colon cancer
445692|NCT01243372|stage IVB colon cancer|stage ivb colon cancer
445693|NCT01243372|recurrent rectal cancer|recurrent rectal cancer
445694|NCT01243372|stage III rectal cancer|stage iii rectal cancer
445695|NCT01243372|stage IV rectal cancer|stage iv rectal cancer
445696|NCT01243346|Gastrointestinal Stromal Tumor|gastrointestinal stromal tumor
445697|NCT01243346|PDGFR Inhibitor|pdgfr inhibitor
445698|NCT01243346|Crenolanib (CP-868,596)|crenolanib (cp-868,596)
445699|NCT01243281|hepatitis B|hepatitis b
445700|NCT01243281|HBeAg|hbeag
445701|NCT01243281|pegylated interferon|pegylated interferon
445702|NCT01243281|entecavir|entecavir
445703|NCT01243255|hypercholesterolemia|hypercholesterolemia
445704|NCT01243255|low density lipoprotein|low density lipoprotein
445705|NCT01243255|undertreatment of hypercholesterolemia|undertreatment of hypercholesterolemia
445706|NCT01243242|ADHD,Adults,MG01CI,METADOXINE|adhd,adults,mg01ci,metadoxine
445707|NCT01243216|Pregnancy|pregnancy
445708|NCT01243216|Labor|labor
445709|NCT01243216|Epidural Analgesia|epidural analgesia
445710|NCT01243216|Epidural Anesthesia|epidural anesthesia
445711|NCT01243216|Spinal Anesthesia|spinal anesthesia
445712|NCT01243216|Ultrasound|ultrasound
445713|NCT01243216|Neuraxial Analgesia|neuraxial analgesia
445714|NCT01243216|Neuraxial Anesthesia|neuraxial anesthesia
445715|NCT01243216|Cesarean delivery|cesarean delivery
445716|NCT01243203|Smoking, surgery, Anesthesia, quit|smoking, surgery, anesthesia, quit
445717|NCT01243190|leukemia|leukemia
445718|NCT01243190|small lymphocytic leukemia|small lymphocytic leukemia
445719|NCT01243190|SLL|sll
445720|NCT01243190|CLL|cll
445721|NCT01243190|ofatumumab|ofatumumab
445722|NCT01243190|untreated|untreated
445723|NCT01243190|early stage|early stage
445724|NCT01243190|high-risk|high-risk
445725|NCT01243177|Lacosamide|lacosamide
445726|NCT01243177|Vimpat®|vimpat®
445727|NCT01243177|Epilepsy|epilepsy
445728|NCT01243177|Monotherapy|monotherapy
445729|NCT01243177|Velocity|velocity
445730|NCT01243164|confidence|confidence
445731|NCT01243164|wheelchair performance|wheelchair performance
445732|NCT01243151|Hypercholesterolemia|hypercholesterolemia
445733|NCT01243151|Dyslipidemia|dyslipidemia
445734|NCT01243151|LDL|ldl
445735|NCT01243151|High Cholesterol|high cholesterol
445736|NCT01243151|Japanese Volunteers|japanese volunteers
445737|NCT01243151|PF-04950615|pf-04950615
445738|NCT01243151|RN316|rn316
445739|NCT01243138|Cross-sectional|cross-sectional
445740|NCT01243138|epidemiological study|epidemiological study
445741|NCT01243138|to evaluate the prevalence of CV risk factors in patients attending general practice in AfME region|to evaluate the prevalence of cv risk factors in patients attending general practice in afme region
445742|NCT01243125|Blockage|blockage
445743|NCT01243125|Encrustation|encrustation
445744|NCT01243125|Catheter|catheter
445745|NCT01243125|Spinal Cord Injury|spinal cord injury
445746|NCT01243125|SCI|sci
445747|NCT01243086|Macular Degeneration|macular degeneration
445748|NCT01243086|Age-related macular degeneration|age-related macular degeneration
445749|NCT01243086|Anti-inflammatory|anti-inflammatory
445750|NCT01243086|Anti-vascular endothelial growth factor (Anti-VEGF)|anti-vascular endothelial growth factor (anti-vegf)
445751|NCT01243086|Lucentis|lucentis
445752|NCT01243086|Ranibizumab|ranibizumab
445753|NCT01243086|OZURDEX|ozurdex
445754|NCT01243086|Dexamethasone|dexamethasone
445755|NCT01243086|Vision loss|vision loss
445756|NCT01243073|imetelstat|imetelstat
445757|NCT01243073|imetelstat sodium|imetelstat sodium
445758|NCT01243073|GRN163L|grn163l
445759|NCT01243073|telomerase inhibitor|telomerase inhibitor
445760|NCT01243073|telomerase|telomerase
445761|NCT01243073|essential thrombocytosis|essential thrombocytosis
445762|NCT01243073|essential thrombocythemia|essential thrombocythemia
445763|NCT01243073|ET|et
445764|NCT01243073|polycythemia vera|polycythemia vera
445765|NCT01243073|PV|pv
445766|NCT01243060|Sleep Aid|sleep aid
445767|NCT01243047|Second line treatment for metastatic colorectal cancer|second line treatment for metastatic colorectal cancer
445768|NCT01243008|Lyme disease|lyme disease
445769|NCT01243008|Borreliosis|borreliosis
445770|NCT01243008|Azithromycin|azithromycin
445771|NCT01242982|5. metacarpal fracture/fractures|5. metacarpal fracture/fractures
445772|NCT01242982|subcapital|subcapital
445773|NCT01242982|shaft|shaft
445774|NCT01242982|closed|closed
445775|NCT01242956|stroke|stroke
445776|NCT01242956|video-based training|video-based training
445777|NCT01242956|rehabilitation|rehabilitation
445778|NCT01242943|I131|i131
445779|NCT01242943|L19|l19
445780|NCT01242943|antibody|antibody
445781|NCT01242943|monoclonal|monoclonal
445782|NCT01242943|tumour targeting|tumour targeting
445783|NCT01242943|radioimmunotherapy|radioimmunotherapy
445784|NCT01242943|cancer|cancer
445785|NCT01242930|imetelstat|imetelstat
445786|NCT01242930|imetelstat sodium|imetelstat sodium
445787|NCT01242930|GRN163L|grn163l
445788|NCT01242930|telomerase inhibitor|telomerase inhibitor
445789|NCT01242930|telomerase inhibition|telomerase inhibition
445790|NCT01242930|multiple myeloma|multiple myeloma
445791|NCT01242930|myeloma|myeloma
445792|NCT01242930|myeloma progenitor cells|myeloma progenitor cells
445793|NCT01242904|dialysis solutions|dialysis solutions
445794|NCT01242904|renal replacement therapy|renal replacement therapy
445795|NCT01242904|peritoneal dialysis|peritoneal dialysis
445796|NCT01242904|bimodal solution|bimodal solution
445797|NCT01242904|glucose sparing therapy|glucose sparing therapy
445798|NCT01242891|Ventricular Assist Device|ventricular assist device
445799|NCT01242891|Pediatric Ventricular Assist Device|pediatric ventricular assist device
445800|NCT01242878|HbSS|hbss
445801|NCT01242878|Sickle cell anemia|sickle cell anemia
445802|NCT01242878|HbSC|hbsc
445803|NCT01242878|HbSbetathalassemia|hbsbetathalassemia
445804|NCT01242878|Hemoglobinopathy|hemoglobinopathy
445805|NCT01242878|Hemoglobinopathies|hemoglobinopathies
445806|NCT01242865|Stress|stress
445807|NCT01242865|Anxiety|anxiety
445808|NCT01242865|Resilience|resilience
445809|NCT01242865|Mindfulness|mindfulness
445810|NCT01242865|Quality of Life|quality of life
445811|NCT01242865|Stress Management|stress management
445812|NCT01242852|Hysteroscopy|hysteroscopy
445813|NCT01242852|infertility|infertility
445814|NCT01242852|subfertility|subfertility
445912|NCT01242345|Hypoxemia|hypoxemia
445815|NCT01242852|intrauterine abnormalities|intrauterine abnormalities
445816|NCT01242852|intracavitary pathology|intracavitary pathology
445817|NCT01242852|IVF|ivf
445818|NCT01242852|ICSI|icsi
445819|NCT01242852|in vitro fertilization|in vitro fertilization
445820|NCT01242852|intracytoplasmic sperm injection|intracytoplasmic sperm injection
445821|NCT01242839|CACICOL20|cacicol20
445822|NCT01242813|TNF-receptor associated periodic syndrome|tnf-receptor associated periodic syndrome
445823|NCT01242813|fevers|fevers
445824|NCT01242813|rashes|rashes
445825|NCT01242813|musculoskeletal and abdominal pain|musculoskeletal and abdominal pain
445826|NCT01242813|periorbital edema|periorbital edema
445827|NCT01242813|TNFR1|tnfr1
445828|NCT01242800|male breast cancer|male breast cancer
445829|NCT01242800|stage IV breast cancer|stage iv breast cancer
445830|NCT01242787|Chronic hepatitis B|chronic hepatitis b
445831|NCT01242787|LB80380|lb80380
445832|NCT01242787|treatment-naive|treatment-naive
445833|NCT01242787|entecavir|entecavir
445834|NCT01242787|Extension|extension
445835|NCT01242774|AML|aml
445836|NCT01242774|bone marrow|bone marrow
445837|NCT01242774|abnormal blast cells of myeloid|abnormal blast cells of myeloid
445838|NCT01242774|acute leukemia|acute leukemia
445839|NCT01242774|cytogenetic abnormalities|cytogenetic abnormalities
445840|NCT01242774|HDACi|hdaci
445841|NCT01242761|Accuracy of diagnostic ultrasound based in community or as part of a specialist hospital-based service|accuracy of diagnostic ultrasound based in community or as part of a specialist hospital-based service
445842|NCT01242735|Obsessive Compulsive Disorder|obsessive compulsive disorder
445843|NCT01242735|OCD|ocd
445844|NCT01242735|Exercise|exercise
445845|NCT01242735|Aerobic Exercise|aerobic exercise
445846|NCT01242722|Heart failure|heart failure
445847|NCT01242722|auto threshold|auto threshold
445848|NCT01242722|pacing|pacing
445849|NCT01242722|CRT-D recipients|crt-d recipients
445850|NCT01242722|Left Ventricular (LV) evoked response signals|left ventricular (lv) evoked response signals
445851|NCT01242696|Drug Eluting Stents|drug eluting stents
445852|NCT01242696|Observational|observational
445853|NCT01242696|All-Comers|all-comers
445854|NCT01242657|Tobacco Use Cessation|tobacco use cessation
445855|NCT01242657|Youth Tobacco Use|youth tobacco use
445856|NCT01242657|Physical Activity|physical activity
445857|NCT01242657|Smoking Cessation Intervention|smoking cessation intervention
445858|NCT01242618|nasal cartilage diseases|nasal cartilage diseases
445859|NCT01242605|unresectable|unresectable
445860|NCT01242605|advanced|advanced
445861|NCT01242566|Temozolomide|temozolomide
445862|NCT01242566|Elderly|elderly
445863|NCT01242566|Glioblastoma|glioblastoma
445864|NCT01242566|Karnofsky performance score (KPS)|karnofsky performance score (kps)
445865|NCT01242540|Pain|pain
445866|NCT01242540|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
445867|NCT01242527|dyslipidemia|dyslipidemia
445868|NCT01242527|hyperlipidemia|hyperlipidemia
445869|NCT01242527|omega-3 carboxylic acid|omega-3 carboxylic acid
445870|NCT01242514|Rheumatoid Arthritis|rheumatoid arthritis
445871|NCT01242514|OSKIRA|oskira
445872|NCT01242514|Fostamatinib|fostamatinib
445873|NCT01242501|Prevention|prevention
445874|NCT01242501|Counseling|counseling
445875|NCT01242501|Behavioral interventions|behavioral interventions
445876|NCT01242501|HIV risk reduction|hiv risk reduction
445877|NCT01242488|Rheumatoid Arthritis|rheumatoid arthritis
445878|NCT01242488|CDP6038|cdp6038
445879|NCT01242488|Interleukin-6|interleukin-6
445880|NCT01242488|Tocilizumab|tocilizumab
445881|NCT01242475|tuberculosis|tuberculosis
445882|NCT01242475|rdESAT-6|rdesat-6
445883|NCT01242475|CFP-10|cfp-10
445884|NCT01242475|skin test|skin test
445885|NCT01242475|diagnostic test|diagnostic test
445886|NCT01242462|Conventional mechanical ventilation|conventional mechanical ventilation
445887|NCT01242462|Mid-frequency ventilation|mid-frequency ventilation
445888|NCT01242462|Respiratory Distress Syndrome|respiratory distress syndrome
445889|NCT01242462|Preterm Newborn Infant|preterm newborn infant
445890|NCT01242462|Mean Airway Pressure|mean airway pressure
445891|NCT01242462|Mean Arterial Pressure|mean arterial pressure
445892|NCT01242462|Mean Peak Inspiratory Pressure|mean peak inspiratory pressure
445893|NCT01242449|Breast cancer|breast cancer
445894|NCT01242449|Metastatic|metastatic
445895|NCT01242449|HER2 positive|her2 positive
445896|NCT01242449|vinorelbine|vinorelbine
445897|NCT01242436|Ovarian Cancer|ovarian cancer
445898|NCT01242436|Peritoneal Metastasis|peritoneal metastasis
445899|NCT01242436|Whole body diffusion MRI|whole body diffusion mri
445900|NCT01242436|therapy|therapy
445901|NCT01242423|musculoskeletal shockwave therapy|musculoskeletal shockwave therapy
445902|NCT01242410|Short cervix|short cervix
445903|NCT01242410|Preterm birth|preterm birth
445904|NCT01242410|Cervical pessary|cervical pessary
445905|NCT01242410|Twins|twins
445906|NCT01242371|Schizophrenia|schizophrenia
445907|NCT01242371|Schizoaffective|schizoaffective
445908|NCT01242371|Probiotic supplements|probiotic supplements
445909|NCT01242371|Gliadin|gliadin
445910|NCT01242371|Casein|casein
445911|NCT01242358|hypoxaemia - capnography - integrated pulmonary index - PEG|hypoxaemia - capnography - integrated pulmonary index - peg
445913|NCT01242345|Capnography|capnography
445914|NCT01242345|Integrated pulmonary index|integrated pulmonary index
445915|NCT01242345|Sedation|sedation
445916|NCT01242345|Propofol|propofol
445917|NCT01242345|Safety|safety
445918|NCT01242332|perioperative|perioperative
445919|NCT01242332|pregabalin|pregabalin
445920|NCT01242332|arthroscopic anterior cruciate ligament reconstruction|arthroscopic anterior cruciate ligament reconstruction
445921|NCT01242332|postoperative pain management|postoperative pain management
445922|NCT01242319|quality improvement|quality improvement
445923|NCT01242319|implementation trials|implementation trials
445924|NCT01242319|cholesterol guidelines|cholesterol guidelines
445925|NCT01242319|patient activation|patient activation
445926|NCT01242306|endothelial dysfunction acetylcholine bms ses|endothelial dysfunction acetylcholine bms ses
445927|NCT01242280|Acute variceal bleeding|acute variceal bleeding
445928|NCT01242280|Massive bleeding|massive bleeding
445929|NCT01242280|Liver Cirrhosis|liver cirrhosis
445930|NCT01242280|Esophageal tamponade|esophageal tamponade
445931|NCT01242280|Esophageal stent|esophageal stent
445932|NCT01242267|multiple myeloma|multiple myeloma
445933|NCT01242267|transplant|transplant
445934|NCT01242267|Multiple myeloma patients undergoing transplant|multiple myeloma patients undergoing transplant
445935|NCT01242254|KH902|kh902
445936|NCT01242254|age-related macular degeneration|age-related macular degeneration
445937|NCT01242254|choroidal neovascularization|choroidal neovascularization
445938|NCT01242254|intravitreal injection|intravitreal injection
445939|NCT01242254|multiple injections|multiple injections
445940|NCT01242241|Propofol|propofol
445941|NCT01242241|Childhood obesity|childhood obesity
445942|NCT01242241|Pharmacodynamics|pharmacodynamics
445943|NCT01242228|ASP1941|asp1941
445944|NCT01242228|Diabetes mellitus|diabetes mellitus
445945|NCT01242228|Dipeptidyl peptidase-4 inhibitor|dipeptidyl peptidase-4 inhibitor
445946|NCT01242228|DPP-4 inhibitor|dpp-4 inhibitor
445947|NCT01242228|long-term safety|long-term safety
445948|NCT01242215|ASP1941|asp1941
445949|NCT01242215|Diabetes mellitus|diabetes mellitus
445950|NCT01242215|sulfonylurea|sulfonylurea
445951|NCT01242202|ASP1941|asp1941
445952|NCT01242202|Diabetes mellitus|diabetes mellitus
445953|NCT01242202|alpha glucosidase inhibitor|alpha glucosidase inhibitor
445954|NCT01242202|long-term safety|long-term safety
445955|NCT01242150|Acute Respiratory Failure|acute respiratory failure
445956|NCT01242150|Continuous Positive Airway Pressure|continuous positive airway pressure
445957|NCT01242150|Infants|infants
445958|NCT01242150|Helmet|helmet
445959|NCT01242111|Mucopolysaccharidosis IV type A|mucopolysaccharidosis iv type a
445960|NCT01242111|MPS IV Type A|mps iv type a
445961|NCT01242111|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
445962|NCT01242111|MPS IVA|mps iva
445963|NCT01242111|Morquio A Syndrome|morquio a syndrome
445964|NCT01242111|Lysosomal Storage Disorder|lysosomal storage disorder
445965|NCT01242111|LSD|lsd
445966|NCT01242111|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
445967|NCT01242111|N-acetylgalactosamine-6-sulfate sulfatase|n-acetylgalactosamine-6-sulfate sulfatase
445968|NCT01242111|galactose-6-sulfatase|galactose-6-sulfatase
445969|NCT01242111|GALNS|galns
445970|NCT01242111|enzyme replacement therapy|enzyme replacement therapy
445971|NCT01242111|ERT|ert
445972|NCT01242098|Asthma|asthma
445973|NCT01242098|Combination therapy|combination therapy
445974|NCT01242098|Primary care management|primary care management
445975|NCT01242098|Switch|switch
445976|NCT01242098|ICS/LABA|ics/laba
445977|NCT01242098|Fostair|fostair
445978|NCT01242098|Seretide|seretide
445979|NCT01242085|alignment|alignment
445980|NCT01242072|malignancy|malignancy
445981|NCT01242072|etoposide and carboplatin|etoposide and carboplatin
445982|NCT01242072|non small cell lung cancer|non small cell lung cancer
445983|NCT01242072|small cell lung cancer|small cell lung cancer
445984|NCT01242072|testicular cancer|testicular cancer
445985|NCT01242072|thymoma|thymoma
445986|NCT01242072|ovarian cancer|ovarian cancer
445987|NCT01242072|osteosarcoma|osteosarcoma
445988|NCT01242059|Obesity|obesity
445989|NCT01242059|Food intake regulation|food intake regulation
445990|NCT01242059|blood glucose regulation|blood glucose regulation
445991|NCT01242059|protein|protein
445992|NCT01242059|fiber|fiber
445993|NCT01242059|pulses|pulses
445994|NCT01242059|yellow peas|yellow peas
445995|NCT01242046|female sexual arousal|female sexual arousal
445996|NCT01242033|red raspberries|red raspberries
445997|NCT01242033|post-prandial|post-prandial
445998|NCT01242033|oxidative stress|oxidative stress
445999|NCT01242033|antioxidants|antioxidants
446000|NCT01242033|polyphenols|polyphenols
446001|NCT01242033|vitamin C|vitamin c
446002|NCT01242033|acute dietary intervention|acute dietary intervention
446003|NCT01242007|Myotonic dystrophy|myotonic dystrophy
446004|NCT01242007|Steinert's disease|steinert's disease
446005|NCT01241981|Breast|breast
446006|NCT01241981|Cancer|cancer
446007|NCT01241981|Digital|digital
446008|NCT01241981|Mammography|mammography
446009|NCT01241981|Tomosynthesis|tomosynthesis
446010|NCT01241968|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
446011|NCT01241968|Myocardial Ischemia|myocardial ischemia
446012|NCT01241968|Refractory Angina|refractory angina
446013|NCT01241955|CPR|cpr
446014|NCT01241942|Lung Transplant|lung transplant
446015|NCT01241942|Emphysema|emphysema
446016|NCT01241942|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
446017|NCT01241942|Cystic Fibrosis|cystic fibrosis
446018|NCT01241942|Pulmonary Fibrosis|pulmonary fibrosis
446019|NCT01241942|Bronchiectasis|bronchiectasis
446020|NCT01241942|Sarcoidosis|sarcoidosis
446021|NCT01241942|Pulmonary Hypertension|pulmonary hypertension
446022|NCT01241942|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
446023|NCT01241929|advanced cancer|advanced cancer
446024|NCT01241916|elbow, splint|elbow, splint
446025|NCT01241903|Platelet activation|platelet activation
446026|NCT01241903|platelet leukocyte aggregates|platelet leukocyte aggregates
446027|NCT01241890|Cystic Fibrosis|cystic fibrosis
446028|NCT01241890|Children|children
446029|NCT01241890|Exhaled Breath Condensate|exhaled breath condensate
446030|NCT01241890|Non-invasive Inflammatory Markers|non-invasive inflammatory markers
446031|NCT01241890|Volatile Organic Compounds|volatile organic compounds
446032|NCT01241890|Home monitoring|home monitoring
446033|NCT01241890|Quality of life|quality of life
446034|NCT01241838|Heart failure|heart failure
446035|NCT01241838|Left ventricular hypertrophy|left ventricular hypertrophy
446036|NCT01241838|Diastolic dysfunction|diastolic dysfunction
446037|NCT01241825|capsule endoscopy|capsule endoscopy
446038|NCT01241825|chewing gum|chewing gum
446039|NCT01241825|small bowel transit time|small bowel transit time
446040|NCT01241812|knee|knee
446041|NCT01241812|osteoarthritis|osteoarthritis
446042|NCT01241799|endoscopic ultrasound guided fine needle aspiration (EUS-FNA)|endoscopic ultrasound guided fine needle aspiration (eus-fna)
446043|NCT01241799|pancreatic biopsy|pancreatic biopsy
446044|NCT01241799|randomized|randomized
446045|NCT01241799|single blind|single blind
446046|NCT01241799|fine needle aspiration (FNA) adequacy|fine needle aspiration (fna) adequacy
446047|NCT01241799|fine needle aspiration (FNA) accuracy|fine needle aspiration (fna) accuracy
446048|NCT01241786|chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
446049|NCT01241786|small lymphocytic lymphoma (SLL)|small lymphocytic lymphoma (sll)
446050|NCT01241773|TMC435-TiDP16-C123|tmc435-tidp16-c123
446051|NCT01241773|TMC435-C123|tmc435-c123
446052|NCT01241773|TMC435|tmc435
446053|NCT01241773|HCV|hcv
446054|NCT01241773|Hepatitis C|hepatitis c
446055|NCT01241760|Genotype 1 chronic hepatitis C|genotype 1 chronic hepatitis c
446056|NCT01241760|VX-950-C211|vx-950-c211
446057|NCT01241760|VX-950|vx-950
446058|NCT01241760|IL28B|il28b
446059|NCT01241760|Telaprevir|telaprevir
446060|NCT01241760|Hepatitis C|hepatitis c
446061|NCT01241760|BID|bid
446062|NCT01241760|Q8h|q8h
446063|NCT01241760|SOC|soc
446064|NCT01241734|Diffuse Large B cell Lymphoma|diffuse large b cell lymphoma
446065|NCT01241721|Breast Diseases|breast diseases
446066|NCT01241721|Breast Neoplasms|breast neoplasms
446067|NCT01241721|Neoplasms|neoplasms
446068|NCT01241695|Oral nutritional supplement, diabetes mellitus type 2, glycaemic control|oral nutritional supplement, diabetes mellitus type 2, glycaemic control
446069|NCT01241695|Oral nutritional supplement (Food for special medical purposes)|oral nutritional supplement (food for special medical purposes)
446070|NCT01241682|Mesothelioma|mesothelioma
446071|NCT01241682|Dendritic cells|dendritic cells
446072|NCT01241682|Cyclophosphamide|cyclophosphamide
446073|NCT01241682|Tumor lysate-loaded|tumor lysate-loaded
446074|NCT01241682|Immunotherapy|immunotherapy
446075|NCT01241656|Prostate cancer|prostate cancer
446076|NCT01241656|Decision support intervention (DESI)|decision support intervention (desi)
446077|NCT01241656|Shared medical appointments (SMA)|shared medical appointments (sma)
446078|NCT01241656|Comparative effectiveness research (CER)|comparative effectiveness research (cer)
446079|NCT01241643|interleukin-7|interleukin-7
446080|NCT01241643|immune-based therapies|immune-based therapies
446081|NCT01241643|HIV|hiv
446082|NCT01241643|infectious disease|infectious disease
446083|NCT01241643|immune non-responders|immune non-responders
446084|NCT01241630|Somato-sensory reflex arch|somato-sensory reflex arch
446085|NCT01241630|Spinal cord injury|spinal cord injury
446086|NCT01241630|Xiao Procedure|xiao procedure
446087|NCT01241617|Lung disease|lung disease
446088|NCT01241617|Lobectomy|lobectomy
446089|NCT01241617|Pulmonary resection|pulmonary resection
446090|NCT01241591|CP-690,550|cp-690,550
446091|NCT01241591|Etanercept|etanercept
446092|NCT01241591|Moderate|moderate
446093|NCT01241591|Severe|severe
446094|NCT01241591|Chronic|chronic
446095|NCT01241591|Plaque|plaque
446096|NCT01241591|Psoriasis|psoriasis
446097|NCT01241591|Efficacy|efficacy
446098|NCT01241591|Safety|safety
446099|NCT01241591|Tofacitinib|tofacitinib
446100|NCT01241591|Xeljanz|xeljanz
446101|NCT01241591|OPT Compare|opt compare
446102|NCT01241591|OPT|opt
446103|NCT01241591|head-to-head|head-to-head
446104|NCT01241591|non-inferiority|non-inferiority
446105|NCT01241591|Psoriasis vulgaris|psoriasis vulgaris
446106|NCT01241591|short-term|short-term
446107|NCT01241591|Itch|itch
446108|NCT01241591|Pruritus|pruritus
446109|NCT01241591|Plaque psoriasis|plaque psoriasis
446110|NCT01241591|DLQI|dlqi
446111|NCT01241578|Obesity|obesity
446112|NCT01241578|Behavior Therapy|behavior therapy
446113|NCT01241578|Lifestyle|lifestyle
446114|NCT01241578|Technology|technology
446115|NCT01241578|Cellular Phone|cellular phone
446116|NCT01241565|lung cancer|lung cancer
446117|NCT01241565|lobectomy|lobectomy
446118|NCT01241565|wedge resection|wedge resection
446119|NCT01241552|Clostridium difficile|clostridium difficile
446120|NCT01241552|recurrent Clostridium difficile|recurrent clostridium difficile
446121|NCT01241552|vancomycin|vancomycin
446122|NCT01241552|metronidazole|metronidazole
446123|NCT01241552|monoclonal antibody|monoclonal antibody
446124|NCT01241552|Clostridium difficile infection (CDI)|clostridium difficile infection (cdi)
446125|NCT01241526|COPD|copd
446126|NCT01241526|COMET|comet
446127|NCT01241526|Disease management|disease management
446128|NCT01241513|glutathione|glutathione
446129|NCT01241513|redox status|redox status
446130|NCT01241513|carotid body chemosensitivity|carotid body chemosensitivity
446131|NCT01241513|ventilation|ventilation
446132|NCT01241500|Myelodysplastic syndromes|myelodysplastic syndromes
446133|NCT01241500|MDS|mds
446134|NCT01241487|Hypertension, Valsartan/Amlodipine,|hypertension, valsartan/amlodipine,
446135|NCT01241461|Advanced Cancer|advanced cancer
446136|NCT01241461|Metastatic Cancer|metastatic cancer
446137|NCT01241461|p70s6 inhibitor|p70s6 inhibitor
446138|NCT01241448|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
446139|NCT01241422|Asthma|asthma
446140|NCT01241422|Mild asthma|mild asthma
446141|NCT01241422|Singulair|singulair
446142|NCT01241422|JNJ 40929837|jnj 40929837
446143|NCT01241422|Montelukast|montelukast
446144|NCT01241409|Healthy|healthy
446145|NCT01241409|Sprinkle Capsule Formulation|sprinkle capsule formulation
446146|NCT01241409|Rabeprazole sodium|rabeprazole sodium
446147|NCT01241409|Pharmacokinetics|pharmacokinetics
446148|NCT01241409|Bioequivalence|bioequivalence
446149|NCT01241409|Safety|safety
446150|NCT01241396|Multiple Myeloma|multiple myeloma
446151|NCT01241396|observational|observational
446152|NCT01241396|survey|survey
446153|NCT01241396|non-interventional|non-interventional
446154|NCT01241396|international|international
446155|NCT01241396|epidemiology|epidemiology
446156|NCT01241396|treatment|treatment
446157|NCT01241396|routine clinical practice|routine clinical practice
446158|NCT01241396|retrospective|retrospective
446159|NCT01241396|prospective|prospective
446160|NCT01241383|Scleroderma renal crisis|scleroderma renal crisis
446161|NCT01241383|angiotensin converting enzyme inhibitors|angiotensin converting enzyme inhibitors
446162|NCT01241383|bosentan|bosentan
446163|NCT01241383|endothelin receptor antagonist|endothelin receptor antagonist
446164|NCT01241370|Retinal endothelia dysfunction|retinal endothelia dysfunction
446165|NCT01241370|Type 2 diabetes mellitus|type 2 diabetes mellitus
446166|NCT01241370|Insulin-resistance|insulin-resistance
446167|NCT01241370|micro-lightguide spectrophotometry|micro-lightguide spectrophotometry
446168|NCT01241370|laserdopplerfluxmetry|laserdopplerfluxmetry
446169|NCT01241357|Iron|iron
446170|NCT01241357|Iron overload|iron overload
446171|NCT01241357|Hepatic iron concentration|hepatic iron concentration
446172|NCT01241357|High-temperature superconductivity|high-temperature superconductivity
446173|NCT01241357|Magnetic susceptibility|magnetic susceptibility
446174|NCT01241357|Susceptometer|susceptometer
446176|NCT01241344|Hematopoeitic Stem cell Transplant|hematopoeitic stem cell transplant
446177|NCT01241344|HSCT|hsct
446178|NCT01241331|moderate to severe facial acne vulgaris|moderate to severe facial acne vulgaris
446179|NCT01241318|neonate|neonate
446180|NCT01241318|omphalitis|omphalitis
446181|NCT01241318|neonatal mortality|neonatal mortality
446182|NCT01241318|maternal health|maternal health
446183|NCT01241318|umbilical cord infection|umbilical cord infection
446184|NCT01241305|Vasculitis|vasculitis
446185|NCT01241305|CSS|css
446186|NCT01241305|EGPA|egpa
446187|NCT01241305|GCA|gca
446188|NCT01241305|GPA|gpa
446189|NCT01241305|WG|wg
446190|NCT01241305|MPA|mpa
446191|NCT01241305|PAN|pan
446192|NCT01241305|TAK|tak
446193|NCT01241279|cataract surgery|cataract surgery
446194|NCT01241279|intraocular lens|intraocular lens
446195|NCT01241266|Peptic Ulcer Bleeding|peptic ulcer bleeding
446196|NCT01241266|high risk|high risk
446197|NCT01241266|None-Interventional Study|none-interventional study
446198|NCT01241266|he proportion of peptic ulcer bleeding patients who are at high risk (Forrest Ia-IIb)|he proportion of peptic ulcer bleeding patients who are at high risk (forrest ia-iib)
446199|NCT01241253|legumes|legumes
446200|NCT01241253|glycemic response|glycemic response
446201|NCT01241253|glucose|glucose
446202|NCT01241253|type 2 diabetes mellitus|type 2 diabetes mellitus
446203|NCT01241227|liver fibrosis|liver fibrosis
446204|NCT01241227|survival|survival
446205|NCT01241227|transient elastography|transient elastography
446206|NCT01241214|Seasonal allergic rhinitis|seasonal allergic rhinitis
446207|NCT01241214|SAR|sar
446208|NCT01241214|Allergic rhinitis|allergic rhinitis
446209|NCT01241214|Allergies|allergies
446210|NCT01241201|intestinal health|intestinal health
446211|NCT01241201|probiotics|probiotics
446212|NCT01241201|inflammation|inflammation
446213|NCT01241201|biomarkers|biomarkers
446214|NCT01241188|tuberculosis|tuberculosis
446215|NCT01241188|rdESAT-6|rdesat-6
446216|NCT01241188|CFP-10|cfp-10
446217|NCT01241188|skin test|skin test
446218|NCT01241188|diagnostic test|diagnostic test
446219|NCT01241175|IOP|iop
446220|NCT01241175|ophthalmic anesthesia|ophthalmic anesthesia
446221|NCT01241175|magnesium sulfate|magnesium sulfate
446222|NCT01241162|Neuroblastoma|neuroblastoma
446223|NCT01241162|Ewings sarcoma|ewings sarcoma
446224|NCT01241162|osteogenic sarcoma|osteogenic sarcoma
446225|NCT01241162|rhabdomyosarcoma|rhabdomyosarcoma
446226|NCT01241162|synovial sarcoma|synovial sarcoma
446227|NCT01241162|high-risk|high-risk
446228|NCT01241162|relapsed|relapsed
446229|NCT01241162|children|children
446230|NCT01241149|Nissen fundoplication|nissen fundoplication
446231|NCT01241149|non-acid reflux disease|non-acid reflux disease
446232|NCT01241149|anti-reflux surgery|anti-reflux surgery
446233|NCT01241136|pilonidal disease, cystectomy, recurrence|pilonidal disease, cystectomy, recurrence
446234|NCT01241123|return of bowel function, post-operative, colon surgery|return of bowel function, post-operative, colon surgery
446235|NCT01241110|PID, Ofloxacin, Azitromicine, Metronidazole|pid, ofloxacin, azitromicine, metronidazole
446236|NCT01241097|endothelial function|endothelial function
446237|NCT01241097|statins|statins
446238|NCT01241097|ezetimibe|ezetimibe
446239|NCT01241097|pleiotropism|pleiotropism
446240|NCT01241084|asthmatic children|asthmatic children
446241|NCT01241071|Lumbar region|lumbar region
446242|NCT01241071|Pain|pain
446243|NCT01241071|Fascia|fascia
446244|NCT01241071|Electromyography|electromyography
446245|NCT01241071|Goniometry|goniometry
446246|NCT01241058|pediatrics, crohn's disease, disease course, therapy|pediatrics, crohn's disease, disease course, therapy
446247|NCT01241032|DA-8159|da-8159
446248|NCT01241032|Udenafil|udenafil
446249|NCT01241032|Alcohol|alcohol
446250|NCT01241019|asphyxia neonatorum, hypothermia, neuroprotection|asphyxia neonatorum, hypothermia, neuroprotection
446251|NCT01241006|Relapse|relapse
446252|NCT01241006|Corticosteroids|corticosteroids
446253|NCT01240993|parenting intervention|parenting intervention
446254|NCT01240993|mother-child relations|mother-child relations
446255|NCT01240993|substance abuse|substance abuse
446256|NCT01240993|attachment|attachment
446257|NCT01240993|child development|child development
446258|NCT01240967|Phase 1|phase 1
446259|NCT01240967|healthy volunteers|healthy volunteers
446260|NCT01240967|volunteers with renal impairment|volunteers with renal impairment
446261|NCT01240967|pharmacokinetics|pharmacokinetics
446262|NCT01240967|TC-5214|tc-5214
446263|NCT01240954|Rhinitis|rhinitis
446264|NCT01240954|Allergic|allergic
446265|NCT01240954|Immunotherapy|immunotherapy
446266|NCT01240915|safety efficacy MultiStem(r) moderate to severe Ulcerative Colitis|safety efficacy multistem(r) moderate to severe ulcerative colitis
446267|NCT01240902|Valvular Heart Disease|valvular heart disease
446268|NCT01240902|Critical Aortic Stenosis|critical aortic stenosis
446269|NCT01240902|Severe Aortic Stenosis|severe aortic stenosis
446270|NCT01240902|High Risk|high risk
446271|NCT01240902|Aortic Valve Replacement|aortic valve replacement
446272|NCT01240889|Ragweed allergies|ragweed allergies
446273|NCT01240889|acoustic rhinometry|acoustic rhinometry
446274|NCT01240889|nasal allergen challenge|nasal allergen challenge
446275|NCT01240876|Sciatica|sciatica
446276|NCT01240876|Pain|pain
446277|NCT01240863|osteoarthritis|osteoarthritis
446278|NCT01240863|low back pain|low back pain
446279|NCT01240863|Moderate to Severe Pain|moderate to severe pain
446280|NCT01240850|Retroperitoneal fibrosis|retroperitoneal fibrosis
446281|NCT01240850|Inflammatory aneurysms|inflammatory aneurysms
446282|NCT01240850|Methotrexate|methotrexate
446283|NCT01240850|Prednisone|prednisone
446284|NCT01240850|Aorta|aorta
446285|NCT01240837|glycaemic index|glycaemic index
446286|NCT01240837|arenga pinnata sugar|arenga pinnata sugar
446287|NCT01240837|palm sugar|palm sugar
446288|NCT01240837|diabetes|diabetes
446289|NCT01240824|bladder cancer|bladder cancer
446290|NCT01240824|urothelial carcinoma|urothelial carcinoma
446291|NCT01240824|transitional cell carcinoma bladder|transitional cell carcinoma bladder
446292|NCT01240824|ureter|ureter
446293|NCT01240811|intrauterine device|intrauterine device
446294|NCT01240811|IUD|iud
446295|NCT01240811|levonorgestrel|levonorgestrel
446296|NCT01240811|copper|copper
446297|NCT01240811|CD4|cd4
446298|NCT01240811|CCR5|ccr5
446299|NCT01240811|microflora|microflora
446300|NCT01240798|Depression|depression
446301|NCT01240798|Anxiety|anxiety
446302|NCT01240798|Coronary disease|coronary disease
446303|NCT01240785|gestational diabetes|gestational diabetes
446304|NCT01240785|metformin|metformin
446305|NCT01240785|insulin|insulin
446306|NCT01240772|Haemorrhoids, Surgery, Cost-effectiveness, Morbidity, Risk assessment,RCT, Stapled haemorrhoidopexy, Doppler-guided, Haemorrhoidal artery ligation, Outcome|haemorrhoids, surgery, cost-effectiveness, morbidity, risk assessment,rct, stapled haemorrhoidopexy, doppler-guided, haemorrhoidal artery ligation, outcome
446307|NCT01240759|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
446308|NCT01240759|Metformin|metformin
446309|NCT01240746|Influenza|influenza
446310|NCT01240746|Quadrivalent Influenza Vaccine|quadrivalent influenza vaccine
446311|NCT01240746|Trivalent Influenza Vaccine|trivalent influenza vaccine
446312|NCT01240746|Influenza viruses|influenza viruses
446313|NCT01240746|Fluzone®|fluzone®
446314|NCT01240720|I131|i131
446315|NCT01240720|F16|f16
446316|NCT01240720|antibody|antibody
446317|NCT01240720|monoclonal|monoclonal
446318|NCT01240720|tumor targeting|tumor targeting
446319|NCT01240720|radioimmunotherapy|radioimmunotherapy
446320|NCT01240720|lymphoma, breast and lung cancer|lymphoma, breast and lung cancer
446321|NCT01240720|Patients with different cancer types|patients with different cancer types
446322|NCT01240694|Lupus|lupus
446323|NCT01240694|SLE|sle
446324|NCT01240681|Locally Advanced Breast Cancer (LABC)|locally advanced breast cancer (labc)
446325|NCT01240681|neoadjuvant chemotherapy|neoadjuvant chemotherapy
446326|NCT01240681|Fluorothymidine Positron Emission Tomography (FLT PET)|fluorothymidine positron emission tomography (flt pet)
446327|NCT01240681|Blood Oxygen Level Dependent Magnetic Resonance Imaging (BOLD MRI)|blood oxygen level dependent magnetic resonance imaging (bold mri)
446328|NCT01240681|tumor response|tumor response
446329|NCT01240681|mastectomy|mastectomy
446330|NCT01240668|Hyponatremia|hyponatremia
446331|NCT01240668|Euvolemia|euvolemia
446332|NCT01240668|Hypervolemia|hypervolemia
446333|NCT01240668|Euvolemic|euvolemic
446334|NCT01240668|Hypervolemic|hypervolemic
446335|NCT01240655|LCL161|lcl161
446336|NCT01240655|solid tumors|solid tumors
446337|NCT01240655|paclitaxel|paclitaxel
446338|NCT01240642|Advanced or metastatic cancer|advanced or metastatic cancer
446339|NCT01240642|refractory|refractory
446340|NCT01240642|core phase|core phase
446341|NCT01240642|extension phase|extension phase
446342|NCT01240642|dose escalation|dose escalation
446343|NCT01240642|standard chemotherapy|standard chemotherapy
446344|NCT01240642|doctaxel|doctaxel
446345|NCT01240642|paclitaxel|paclitaxel
446346|NCT01240642|carboplatin|carboplatin
446347|NCT01240642|safety|safety
446348|NCT01240642|tolerability|tolerability
446349|NCT01240616|Nicotine|nicotine
446350|NCT01240616|Mecamylamine|mecamylamine
446351|NCT01240616|Attention|attention
446352|NCT01240616|fMRI|fmri
446353|NCT01240616|Default Network|default network
446354|NCT01240616|Healthy Volunteer|healthy volunteer
446355|NCT01240616|HV|hv
446356|NCT01240603|Artemisinin|artemisinin
446357|NCT01240603|Malaria|malaria
446358|NCT01240603|Drug Resistance|drug resistance
446359|NCT01240603|Hemoglobin E|hemoglobin e
446360|NCT01240590|Anaplastic Thyroid Cancer|anaplastic thyroid cancer
446361|NCT01240590|Crolibulin|crolibulin
446362|NCT01240590|Solid Tumors|solid tumors
446363|NCT01240590|ATC|atc
446364|NCT01240577|IPdR|ipdr
446365|NCT01240577|Pharmacokinetics|pharmacokinetics
446366|NCT01240577|Early Phase I|early phase i
446367|NCT01240577|Cancer|cancer
446368|NCT01240577|Solid Tumor|solid tumor
446369|NCT01240577|Lymphoma|lymphoma
446370|NCT01240551|Imaging|imaging
446371|NCT01240551|Bone Metastasis|bone metastasis
446372|NCT01240551|Bone Scan|bone scan
446373|NCT01240551|Radiopharmaceutical|radiopharmaceutical
446374|NCT01240551|Pet Scan|pet scan
446375|NCT01240551|Prostate Cancer|prostate cancer
446376|NCT01240525|graft versus host disease|graft versus host disease
446377|NCT01240525|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
446378|NCT01240525|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
446379|NCT01240525|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
446380|NCT01240525|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
446381|NCT01240525|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
446382|NCT01240525|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
446383|NCT01240525|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
446384|NCT01240525|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
446385|NCT01240525|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
446386|NCT01240525|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
446387|NCT01240525|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
446388|NCT01240525|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
446389|NCT01240525|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
446390|NCT01240525|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
446391|NCT01240525|Hodgkin's lymphoma|hodgkin's lymphoma
446392|NCT01240525|Chronic (Pro-)lymphocytic leukaemia|chronic (pro-)lymphocytic leukaemia
446393|NCT01240525|Plasma cell myeloma|plasma cell myeloma
446394|NCT01240525|Acute myeloid leukaemia|acute myeloid leukaemia
446395|NCT01240525|Acute lymphoblastic leukaemia|acute lymphoblastic leukaemia
446396|NCT01240525|Myelodysplastic syndrome|myelodysplastic syndrome
446397|NCT01240525|Chronic myelomonocytic leukaemia|chronic myelomonocytic leukaemia
446398|NCT01240499|Weight management|weight management
446399|NCT01240499|New weight paradigm|new weight paradigm
446400|NCT01240499|Overweight women|overweight women
446401|NCT01240499|Eating behaviors|eating behaviors
446402|NCT01240499|Appetite ratings|appetite ratings
446602|NCT01239641|ablation|ablation
446403|NCT01240499|Blood lipids|blood lipids
446404|NCT01240486|IRIS|iris
446405|NCT01240486|HIV|hiv
446406|NCT01240486|Immune|immune
446407|NCT01240486|Reconstitution|reconstitution
446408|NCT01240486|Inflammatory|inflammatory
446409|NCT01240486|Syndrome|syndrome
446410|NCT01240473|kala azar|kala azar
446411|NCT01240473|visceral leishmaniasis|visceral leishmaniasis
446412|NCT01240473|diagnosis|diagnosis
446413|NCT01240473|drug resistance|drug resistance
446414|NCT01240473|Therapeutics|therapeutics
446415|NCT01240473|Capacity Building|capacity building
446416|NCT01240447|NSCLC|nsclc
446417|NCT01240447|lung cancer, small-cell|lung cancer, small-cell
446418|NCT01240447|advanced lung cancer|advanced lung cancer
446419|NCT01240434|trocar hernia closure laparoscopy|trocar hernia closure laparoscopy
446420|NCT01240421|Metastatic breast cancer with no other treatment options|metastatic breast cancer with no other treatment options
446421|NCT01240395|Multiple chemical sensitivities|multiple chemical sensitivities
446423|NCT01240395|Mindfulness-based cognitive therapy|mindfulness-based cognitive therapy
446424|NCT01240395|MBCT|mbct
446425|NCT01240369|VEGFC|vegfc
446426|NCT01240369|CTTN|cttn
446427|NCT01240369|miR326|mir326
446428|NCT01240369|ESCC|escc
446429|NCT01240369|NSCLC|nsclc
446430|NCT01240356|transcranial doppler|transcranial doppler
446431|NCT01240356|sonothrombolysis|sonothrombolysis
446432|NCT01240356|ultrasound|ultrasound
446433|NCT01240356|stroke|stroke
446434|NCT01240343|Biobank|biobank
446435|NCT01240343|Genetics|genetics
446436|NCT01240330|Deep Vein Thrombosis|deep vein thrombosis
446437|NCT01240330|Effects of compression therapy|effects of compression therapy
446438|NCT01240330|Peak Flow Velocity|peak flow velocity
446439|NCT01240317|expert system|expert system
446440|NCT01240317|decision support system|decision support system
446441|NCT01240317|human patient simulator|human patient simulator
446442|NCT01240317|anesthesia|anesthesia
446443|NCT01240291|glutamine|glutamine
446444|NCT01240291|trauma|trauma
446445|NCT01240291|alanyl-glutamine|alanyl-glutamine
446446|NCT01240265|Vitamin D deficiency|vitamin d deficiency
446447|NCT01240265|Rickets|rickets
446448|NCT01240265|Infant|infant
446449|NCT01240265|Nutrition|nutrition
446450|NCT01240252|diabetes|diabetes
446451|NCT01240252|insulin resistance|insulin resistance
446452|NCT01240239|Pre anesthesia consultation|pre anesthesia consultation
446453|NCT01240239|telemedicine|telemedicine
446454|NCT01240213|Vitamin D|vitamin d
446455|NCT01240213|lifestyle intervention|lifestyle intervention
446456|NCT01240213|postmenopausal women|postmenopausal women
446457|NCT01240200|diabetes|diabetes
446458|NCT01240200|elderly|elderly
446459|NCT01240200|insulin injections|insulin injections
446460|NCT01240187|epilepsy|epilepsy
446461|NCT01240174|Antibiotic|antibiotic
446462|NCT01240174|Antimicrobial|antimicrobial
446463|NCT01240174|Prescribing|prescribing
446464|NCT01240174|Cough|cough
446465|NCT01240174|Acute Bronchitis|acute bronchitis
446466|NCT01240161|Glioblastoma multiforme|glioblastoma multiforme
446467|NCT01240161|FLT|flt
446468|NCT01240161|PET|pet
446469|NCT01240148|Allodynia|allodynia
446470|NCT01240148|hyperalgesia|hyperalgesia
446471|NCT01240148|paresthesia|paresthesia
446472|NCT01240135|Contact Lens Wear|contact lens wear
446473|NCT01240135|Contact Lens Solution|contact lens solution
446474|NCT01240135|Multi-purpose disinfecting solution|multi-purpose disinfecting solution
446475|NCT01240135|Myopia|myopia
446476|NCT01240122|Corneal staining and comfort evaluation in normal, habitual contact lens wearers.|corneal staining and comfort evaluation in normal, habitual contact lens wearers.
446477|NCT01240096|Functional dyspepsia|functional dyspepsia
446478|NCT01240096|Weight loss|weight loss
446479|NCT01240096|Mirtazapine|mirtazapine
446480|NCT01240083|Depression|depression
446481|NCT01240083|Transcranial magnetic stimulation|transcranial magnetic stimulation
446482|NCT01240083|Thetaburst Stimulation|thetaburst stimulation
446483|NCT01240083|Alternative treatment methods|alternative treatment methods
446484|NCT01240070|diabetes,|diabetes,
446485|NCT01240070|cardiovascular|cardiovascular
446486|NCT01240070|risk factor|risk factor
446487|NCT01240070|cardiovascular event|cardiovascular event
446488|NCT01240070|intervention|intervention
446489|NCT01240057|Isolated Congenital Diaphragmatic Hernia|isolated congenital diaphragmatic hernia
446490|NCT01240057|Fetal Surgery|fetal surgery
446491|NCT01240057|Pulmonary Hypoplasia|pulmonary hypoplasia
446492|NCT01240044|Newborn Pain|newborn pain
446493|NCT01240044|Respiratory Physiotherapy|respiratory physiotherapy
446494|NCT01240044|Neonatal intensive care unit|neonatal intensive care unit
446495|NCT01240031|Malnutrition|malnutrition
446496|NCT01240031|Nutritional Risk|nutritional risk
446497|NCT01240031|Intake|intake
446498|NCT01240031|Food sensory|food sensory
446499|NCT01240031|Nutritional therapy|nutritional therapy
446500|NCT01240031|Energy|energy
446501|NCT01240031|Protein|protein
446502|NCT01240031|Handgrip strength|handgrip strength
446503|NCT01240031|Reaction time|reaction time
446504|NCT01240031|Quality of Life|quality of life
446505|NCT01239979|coronary artery disease|coronary artery disease
446506|NCT01239966|Acute Respiratory Distress syndrome|acute respiratory distress syndrome
446507|NCT01239966|Acute renal Failure|acute renal failure
446508|NCT01239953|In-stent restenosis|in-stent restenosis
446509|NCT01239953|Drug-eluting balloon|drug-eluting balloon
446510|NCT01239953|Drug-eluting stent|drug-eluting stent
446511|NCT01239953|Angiography|angiography
446512|NCT01239953|Minimal lumen diameter|minimal lumen diameter
446513|NCT01239940|In-stent restenosis|in-stent restenosis
446514|NCT01239940|Drug-eluting balloon|drug-eluting balloon
446515|NCT01239940|Drug-eluting stent|drug-eluting stent
446516|NCT01239940|Angiography|angiography
446517|NCT01239940|Minimal lumen diameter|minimal lumen diameter
446518|NCT01239927|diverticulitis|diverticulitis
446519|NCT01239927|hartmann|hartmann
446520|NCT01239927|anastomosis|anastomosis
446521|NCT01239914|drug eluting stent|drug eluting stent
446522|NCT01239914|coronary artery disease|coronary artery disease
446523|NCT01239914|Korean registry|korean registry
446524|NCT01239901|sickle cell disease|sickle cell disease
446525|NCT01239901|sickle cell anemia|sickle cell anemia
446526|NCT01239901|sickled cells|sickled cells
446527|NCT01239901|blood vessel|blood vessel
446528|NCT01239901|iron overload|iron overload
446529|NCT01239888|Depression|depression
446530|NCT01239888|Treatment resistant depression|treatment resistant depression
446531|NCT01239888|Oxytocin|oxytocin
446532|NCT01239888|Estrogen Modulators|estrogen modulators
446533|NCT01239888|HPA axis|hpa axis
446534|NCT01239888|Mental Disorders|mental disorders
446535|NCT01239888|Estrogens|estrogens
446536|NCT01239888|Tibolone|tibolone
446537|NCT01239888|Estrogen Receptor Modulators|estrogen receptor modulators
446538|NCT01239888|Androgens|androgens
446539|NCT01239888|Hormones|hormones
446540|NCT01239888|Hormone Substitutes|hormone substitutes
446541|NCT01239888|Physiological Effects of Drugs|physiological effects of drugs
446542|NCT01239888|Pharmacologic Actions|pharmacologic actions
446543|NCT01239888|Hormone Antagonists|hormone antagonists
446544|NCT01239888|Bone Density Conservation Agents|bone density conservation agents
446545|NCT01239888|Estrogen Antagonists|estrogen antagonists
446546|NCT01239862|pulmonary, silicosis, chronic and accelerated silicosis, autologous transplantation|pulmonary, silicosis, chronic and accelerated silicosis, autologous transplantation
446547|NCT01239862|bone marrow cells, stem cells, cell therapy|bone marrow cells, stem cells, cell therapy
446548|NCT01239849|Diabetes Mellitus, Hypercholesterolemia|diabetes mellitus, hypercholesterolemia
446549|NCT01239836|urinary incontinence, self-management, cost, self-efficacy, continence promotion|urinary incontinence, self-management, cost, self-efficacy, continence promotion
446550|NCT01239823|osteoarthritis|osteoarthritis
446551|NCT01239823|whole body vibration|whole body vibration
446552|NCT01239823|mobility|mobility
446553|NCT01239823|rehabilitation|rehabilitation
446554|NCT01239810|hyaluronic acid|hyaluronic acid
446555|NCT01239810|cartilage|cartilage
446556|NCT01239810|T2 mapping|t2 mapping
446557|NCT01239810|quantitative|quantitative
446558|NCT01239810|MRI|mri
446559|NCT01239810|volume|volume
446560|NCT01239784|pediatrics|pediatrics
446561|NCT01239784|Heart Defects|heart defects
446562|NCT01239784|Neurodevelopmental deficit|neurodevelopmental deficit
446563|NCT01239784|Neurodevelopmental Rehabilitation|neurodevelopmental rehabilitation
446564|NCT01239771|Safety|safety
446565|NCT01239771|tolerability|tolerability
446566|NCT01239771|healthy|healthy
446567|NCT01239771|stable disease|stable disease
446568|NCT01239771|oral|oral
446569|NCT01239771|tablet|tablet
446570|NCT01239745|Hormone adjuvant treatment of early breast cancer with aromatase inhibitors following 2-3 years of tamoxifen|hormone adjuvant treatment of early breast cancer with aromatase inhibitors following 2-3 years of tamoxifen
446571|NCT01239719|Allergic dermatitis|allergic dermatitis
446572|NCT01239693|Stunting|stunting
446573|NCT01239693|Growth failure|growth failure
446574|NCT01239693|Malnutrition|malnutrition
446575|NCT01239693|Lipid based nutrient supplement|lipid based nutrient supplement
446576|NCT01239693|LNS|lns
446577|NCT01239693|Prevention|prevention
446578|NCT01239693|Malawi|malawi
446579|NCT01239693|Sub-Saharan Africa|sub-saharan africa
446580|NCT01239693|Dietary supplementation|dietary supplementation
446581|NCT01239693|Efficacy|efficacy
446582|NCT01239693|Pregnancy|pregnancy
446583|NCT01239693|Infancy|infancy
446584|NCT01239693|Newborn|newborn
446585|NCT01239680|hemorrhagic shock|hemorrhagic shock
446586|NCT01239680|glutamine|glutamine
446587|NCT01239680|trauma resuscitation|trauma resuscitation
446588|NCT01239680|department of defense|department of defense
446589|NCT01239680|trauma|trauma
446590|NCT01239667|Health related quality of Life, Self Care behavior, activities of daily living|health related quality of life, self care behavior, activities of daily living
446591|NCT01239654|acute|acute
446592|NCT01239654|coronary|coronary
446593|NCT01239654|syndrome|syndrome
446594|NCT01239654|everolimus|everolimus
446595|NCT01239654|zotarolimus|zotarolimus
446596|NCT01239654|optical|optical
446597|NCT01239654|coherence|coherence
446598|NCT01239654|tomography|tomography
446599|NCT01239641|Uterine Fibroids|uterine fibroids
446600|NCT01239641|Myoectomy|myoectomy
446601|NCT01239641|High Intensity Focused Ultrasound|high intensity focused ultrasound
446603|NCT01239602|changes in cortical excitability in subjects with chronic stroke after stem cell therapy|changes in cortical excitability in subjects with chronic stroke after stem cell therapy
446604|NCT01239589|Patients admitted as for an acute bipolar manic episode|patients admitted as for an acute bipolar manic episode
446605|NCT01239589|Description of management patterns and hospital stay in patients admitted for acute bipolar manic episode and treated with either quetiapine IR or quetiapine XR|description of management patterns and hospital stay in patients admitted for acute bipolar manic episode and treated with either quetiapine ir or quetiapine xr
446606|NCT01239563|kidney transplantation|kidney transplantation
446607|NCT01239563|donation after cardiac death|donation after cardiac death
446608|NCT01239563|ischemia-reperfusion injury|ischemia-reperfusion injury
446609|NCT01239563|thymoglobulin|thymoglobulin
446610|NCT01239563|steroid avoidance|steroid avoidance
446611|NCT01239563|lymphocyte|lymphocyte
446612|NCT01239550|Insulin|insulin
446613|NCT01239550|Detemir|detemir
446614|NCT01239550|Dopamine, brain,neurotransmitter|dopamine, brain,neurotransmitter
446615|NCT01239550|Diabetes|diabetes
446616|NCT01239550|Obesity|obesity
446617|NCT01239550|Neurotransmitters|neurotransmitters
446618|NCT01239524|breast reconstruction, latissimus dorsi flap, thoracodorsal nerve, skeletal muscle disuse, breast MRI|breast reconstruction, latissimus dorsi flap, thoracodorsal nerve, skeletal muscle disuse, breast mri
446619|NCT01239485|Pediatric refractory or relapsed acute leukemia|pediatric refractory or relapsed acute leukemia
446620|NCT01239472|chronic allograft nephropathy|chronic allograft nephropathy
446621|NCT01239472|cytokines|cytokines
446622|NCT01239472|kidney transplant|kidney transplant
446623|NCT01239472|calcineurin inhibitors withdrawn|calcineurin inhibitors withdrawn
446624|NCT01239446|Hodgkin lymphoma|hodgkin lymphoma
446625|NCT01239446|mediastinal irradiation|mediastinal irradiation
446626|NCT01239446|Coronary Artery Disease|coronary artery disease
446627|NCT01239394|NHL|nhl
446628|NCT01239394|ofatumumab|ofatumumab
446629|NCT01239381|proton radiation|proton radiation
446630|NCT01239381|stereotactic body radiotherapy|stereotactic body radiotherapy
446631|NCT01239381|SBRT|sbrt
446632|NCT01239368|Multiple Myeloma|multiple myeloma
446633|NCT01239368|High Risk|high risk
446634|NCT01239368|Newly Diagnosed|newly diagnosed
446635|NCT01239368|Adoptive Immunotherapy|adoptive immunotherapy
446636|NCT01239368|Autologous|autologous
446637|NCT01239329|Complex multiple disabilities|complex multiple disabilities
446638|NCT01239329|Malnutrition|malnutrition
446639|NCT01239277|muscle|muscle
446640|NCT01239277|FSR|fsr
446641|NCT01239277|protein|protein
446642|NCT01239277|carbohydrate|carbohydrate
446643|NCT01239277|leucine|leucine
446644|NCT01239251|GlowCap|glowcap
446645|NCT01239251|adjuvant endocrine therapy|adjuvant endocrine therapy
446646|NCT01239238|asthma|asthma
446647|NCT01239238|children|children
446648|NCT01239238|home monitoring|home monitoring
446649|NCT01239238|exhaled breath condensate|exhaled breath condensate
446650|NCT01239238|non-invasive inflammatory markers|non-invasive inflammatory markers
446651|NCT01239238|volatile organic compounds|volatile organic compounds
446652|NCT01239225|Patients undergoing coronary angiography|patients undergoing coronary angiography
446653|NCT01239212|seizures|seizures
446654|NCT01239212|neonate|neonate
446655|NCT01239212|levetiracetam|levetiracetam
446656|NCT01239212|Epilepsy|epilepsy
446657|NCT01239212|central nervous system diseases|central nervous system diseases
446658|NCT01239212|anticonvulsants|anticonvulsants
446659|NCT01239199|Infants|infants
446660|NCT01239199|Exhaled Nitric Oxide|exhaled nitric oxide
446661|NCT01239199|Asthma|asthma
446662|NCT01239199|Tobacco smoke exposure|tobacco smoke exposure
446663|NCT01239199|environment|environment
446664|NCT01239186|methylation|methylation
446665|NCT01239186|micro array|micro array
446666|NCT01239186|locus H19|locus h19
446667|NCT01239186|male infertility|male infertility
446668|NCT01239173|Posttraumatic stress disorder|posttraumatic stress disorder
446669|NCT01239173|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
446670|NCT01239173|Amygdala|amygdala
446671|NCT01239173|emotion regulation|emotion regulation
446672|NCT01239173|memory|memory
446673|NCT01239160|lymphedema|lymphedema
446674|NCT01239160|pneumatic compression device|pneumatic compression device
446675|NCT01239160|randomised clinical trial|randomised clinical trial
446676|NCT01239160|volume reduction|volume reduction
446677|NCT01239147|weight maintenance|weight maintenance
446678|NCT01239134|Malignant melanoma|malignant melanoma
446679|NCT01239134|Metastatic|metastatic
446680|NCT01239134|Unresectable|unresectable
446681|NCT01239134|Stage III or Stage IV|stage iii or stage iv
446682|NCT01239134|Solid tumor|solid tumor
446683|NCT01239121|drug toxicity|drug toxicity
446684|NCT01239121|drug interactions|drug interactions
446685|NCT01239121|electronic health records|electronic health records
446686|NCT01239121|medical errors|medical errors
446687|NCT01239043|Meningitis|meningitis
446688|NCT01239043|Meningococcal Meningitis|meningococcal meningitis
446689|NCT01239043|Meningococcal Infections|meningococcal infections
446690|NCT01239043|Menactra®|menactra®
446691|NCT01239043|Menomune®|menomune®
446692|NCT01239043|Meningococcal vaccine|meningococcal vaccine
446693|NCT01239030|inattention|inattention
446694|NCT01239030|impulsivity|impulsivity
446695|NCT01239030|hyperactivity|hyperactivity
446696|NCT01239030|ADHD|adhd
446697|NCT01239004|dyslipidemia|dyslipidemia
446698|NCT01239004|hyperlipidemia|hyperlipidemia
446699|NCT01239004|hyperglycemia|hyperglycemia
446700|NCT01239004|impaired fasting glucose|impaired fasting glucose
446701|NCT01238978|Diabetes mellitus, vildagliptin, hypoglycemia, elderly|diabetes mellitus, vildagliptin, hypoglycemia, elderly
446702|NCT01238952|solid tumors|solid tumors
446703|NCT01238952|breast cancer|breast cancer
446704|NCT01238952|triple negative breast cancer|triple negative breast cancer
446705|NCT01238952|HER2 negative|her2 negative
446706|NCT01238952|ER negative|er negative
446707|NCT01238952|PR negative|pr negative
446708|NCT01238939|solid tumors|solid tumors
446709|NCT01238939|colorectal cancer|colorectal cancer
446710|NCT01238926|Oxidative stress|oxidative stress
446711|NCT01238926|Parkinson's disease|parkinson's disease
446712|NCT01238926|Homocysteine|homocysteine
446713|NCT01238926|Glutathione|glutathione
446714|NCT01238926|B vitamins|b vitamins
446715|NCT01238887|Satiety|satiety
446716|NCT01238887|Food Intake|food intake
446717|NCT01238887|Weight Loss|weight loss
446718|NCT01238887|Oxidative Stress|oxidative stress
446719|NCT01238887|botanicals|botanicals
446720|NCT01238887|Garcinia Cambogia-derived hydroxycitric acid|garcinia cambogia-derived hydroxycitric acid
446721|NCT01238861|Asthma|asthma
446722|NCT01238861|Benralizumab|benralizumab
446723|NCT01238861|MEDI-563|medi-563
446724|NCT01238848|Hypertonic|hypertonic
446725|NCT01238848|Saline|saline
446726|NCT01238848|Bronchiolitis|bronchiolitis
446727|NCT01238848|Efficacy|efficacy
446728|NCT01238835|Sapien XT Valve|sapien xt valve
446729|NCT01238835|Valvular Heart Disease|valvular heart disease
446730|NCT01238835|Aortic Stenosis|aortic stenosis
446731|NCT01238835|Heart Valve Therapy|heart valve therapy
446732|NCT01238835|Transapical|transapical
446733|NCT01238835|Transcatheter|transcatheter
446734|NCT01238809|Compliance|compliance
446735|NCT01238809|France|france
446736|NCT01238796|telavancin|telavancin
446737|NCT01238796|Pharmacokinetics|pharmacokinetics
446738|NCT01238796|Severe renal disease|severe renal disease
446739|NCT01238796|VIBATIV®|vibativ®
446740|NCT01238796|ASP9809|asp9809
446741|NCT01238770|Ovarian cancer|ovarian cancer
446742|NCT01238757|Prospective Studies|prospective studies
446743|NCT01238757|Humans, pediatric|humans, pediatric
446744|NCT01238757|Positive-Pressure Respiration/methods*|positive-pressure respiration/methods*
446745|NCT01238757|Respiration, Artificial/methods*|respiration, artificial/methods*
446746|NCT01238757|Intensive Care|intensive care
446747|NCT01238757|Intensive Care Units/statistics & numerical data*|intensive care units/statistics & numerical data*
446748|NCT01238757|Respiration, Artificial/statistics & numerical data*|respiration, artificial/statistics & numerical data*
446749|NCT01238757|Patients/statistics & numerical data*|patients/statistics & numerical data*
446750|NCT01238757|Prevalence|prevalence
446751|NCT01238757|Respiratory Muscles/innervation|respiratory muscles/innervation
446752|NCT01238757|Child|child
446753|NCT01238757|Child, Preschool|child, preschool
446754|NCT01238757|Infant|infant
446755|NCT01238757|Infant, Newborn|infant, newborn
446756|NCT01238757|Intensive Care Units, Pediatric|intensive care units, pediatric
446757|NCT01238757|Respiratory Rate*|respiratory rate*
446758|NCT01238731|Valve replacement|valve replacement
446759|NCT01238731|pulmonary hypertension|pulmonary hypertension
446760|NCT01238731|long term follow up|long term follow up
446761|NCT01238718|lidocaine|lidocaine
446762|NCT01238718|anesthetic depth|anesthetic depth
446763|NCT01238718|hemodynamics|hemodynamics
446764|NCT01238718|rapid sequence induction|rapid sequence induction
446765|NCT01238718|BIS|bis
446766|NCT01238705|Hypertension|hypertension
446767|NCT01238705|Antihypertensive Agents|antihypertensive agents
446768|NCT01238705|Combination|combination
446769|NCT01238705|Sexual Dysfunction|sexual dysfunction
446770|NCT01238705|Oxidative Stress|oxidative stress
446771|NCT01238692|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
446772|NCT01238692|DLBCL|dlbcl
446773|NCT01238692|Relapsed B-cell lymphoma|relapsed b-cell lymphoma
446774|NCT01238692|Refractory B-cell lymphoma|refractory b-cell lymphoma
446775|NCT01238692|B-cell Lymphoma|b-cell lymphoma
446776|NCT01238692|Panobinostat|panobinostat
446777|NCT01238692|LBH589|lbh589
446778|NCT01238692|Rituximab|rituximab
446779|NCT01238692|Histone Deacetylase Inhibitors|histone deacetylase inhibitors
446780|NCT01238679|safety|safety
446781|NCT01238679|tolerability|tolerability
446782|NCT01238679|pharmacokinetics|pharmacokinetics
446783|NCT01238679|healthy volunteers|healthy volunteers
446784|NCT01238666|liver|liver
446785|NCT01238666|cancer|cancer
446786|NCT01238666|tumor|tumor
446787|NCT01238666|ablation|ablation
446788|NCT01238666|Pathfinder|pathfinder
446789|NCT01238653|liver|liver
446790|NCT01238653|cancer|cancer
446791|NCT01238653|tumor|tumor
446792|NCT01238653|Pathfinder|pathfinder
446793|NCT01238640|Smoking Cessation|smoking cessation
446794|NCT01238640|Nicotine|nicotine
446900|NCT01238250|16p11.2|16p11.2
446795|NCT01238627|Smoking Cessation|smoking cessation
446796|NCT01238627|Nicotine pharmacokinetics|nicotine pharmacokinetics
446797|NCT01238614|maternal depression|maternal depression
446798|NCT01238614|clinical decision support|clinical decision support
446799|NCT01238601|Breast augmentation|breast augmentation
446800|NCT01238575|Pervasive Developmental Disorders|pervasive developmental disorders
446802|NCT01238575|PDD-NOS|pdd-nos
446803|NCT01238575|Autistic Disorder|autistic disorder
446804|NCT01238575|Autism|autism
446805|NCT01238575|Asperger's Disorder|asperger's disorder
446806|NCT01238575|Hyperactivity|hyperactivity
446807|NCT01238575|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
446808|NCT01238575|ADHD|adhd
446809|NCT01238575|Medication|medication
446810|NCT01238575|Drug|drug
446811|NCT01238575|Guanfacine|guanfacine
446812|NCT01238575|Intuniv|intuniv
446813|NCT01238575|Placebo|placebo
446814|NCT01238575|Methylphenidate|methylphenidate
446815|NCT01238562|cancer patient|cancer patient
446816|NCT01238562|chemotherapy|chemotherapy
446817|NCT01238562|carboplatin|carboplatin
446818|NCT01238562|taxol|taxol
446819|NCT01238562|cyclophosphamide|cyclophosphamide
446820|NCT01238562|pharmorubicin|pharmorubicin
446821|NCT01238549|Spinal Cord Injuries|spinal cord injuries
446822|NCT01238549|Quality of Life|quality of life
446823|NCT01238536|Epidural Steroid Injection|epidural steroid injection
446824|NCT01238536|Low Back Pain|low back pain
446825|NCT01238536|Spinal Stenosis|spinal stenosis
446826|NCT01238536|Elderly|elderly
446827|NCT01238523|tibia|tibia
446828|NCT01238523|shaft|shaft
446829|NCT01238523|fracture|fracture
446830|NCT01238523|children|children
446831|NCT01238497|SAPIEN XT™|sapien xt™
446832|NCT01238497|Transfemoral|transfemoral
446833|NCT01238497|NovaFlex|novaflex
446834|NCT01238497|NovaFlex+|novaflex+
446835|NCT01238497|NF|nf
446836|NCT01238497|NF+|nf+
446837|NCT01238497|Transapical|transapical
446838|NCT01238497|Transaortic|transaortic
446839|NCT01238497|Ascendra2|ascendra2
446840|NCT01238497|Ascendra+|ascendra+
446841|NCT01238497|Asc+|asc+
446842|NCT01238497|aortic stenosis|aortic stenosis
446843|NCT01238497|aortic valve|aortic valve
446844|NCT01238497|Transcatheter Heart Valve|transcatheter heart valve
446845|NCT01238497|THV|thv
446846|NCT01238484|Ankle Equinus|ankle equinus
446847|NCT01238484|Ankle contracture|ankle contracture
446848|NCT01238484|Diabetes Mellitus|diabetes mellitus
446849|NCT01238484|Dynasplint|dynasplint
446850|NCT01238484|AFD|afd
446851|NCT01238471|retinopathy of prematurity|retinopathy of prematurity
446852|NCT01238471|Propranolol|propranolol
446853|NCT01238471|Vascular endothelial growth factor|vascular endothelial growth factor
446854|NCT01238471|premature infant|premature infant
446855|NCT01238458|[18F]AV-45 PET amyloid binding imaging|[18f]av-45 pet amyloid binding imaging
446856|NCT01238458|Alzheimer's disease|alzheimer's disease
446857|NCT01238458|mild cognitive impartment,|mild cognitive impartment,
446858|NCT01238445|Pediatric|pediatric
446859|NCT01238432|Pediatric|pediatric
446860|NCT01238432|Polymorphism, Genetic|polymorphism, genetic
446861|NCT01238432|Adrenergic beta-Agonists|adrenergic beta-agonists
446862|NCT01238406|Type 1 diabetes|type 1 diabetes
446863|NCT01238406|Closed loop|closed loop
446864|NCT01238406|Artificial Pancreas|artificial pancreas
446865|NCT01238380|Monogenic diabetes|monogenic diabetes
446866|NCT01238380|HNF1A|hnf1a
446867|NCT01238380|HNF4A|hnf4a
446868|NCT01238380|GCK|gck
446869|NCT01238380|genetic testing|genetic testing
446870|NCT01238380|health economic model|health economic model
446871|NCT01238354|Weight Loss|weight loss
446872|NCT01238354|Social support|social support
446873|NCT01238341|Pancreatobiliary disease in patients with altered gastric anatomy.|pancreatobiliary disease in patients with altered gastric anatomy.
446874|NCT01238328|Mucopolysaccharidosis|mucopolysaccharidosis
446875|NCT01238328|HSCT|hsct
446876|NCT01238315|Batten's disease|batten's disease
446877|NCT01238315|INCL|incl
446878|NCT01238315|LINCL|lincl
446879|NCT01238315|Neuronal Ceroid Lipofuscinosis|neuronal ceroid lipofuscinosis
446880|NCT01238315|NCL|ncl
446881|NCT01238289|peer education|peer education
446882|NCT01238289|diabetes|diabetes
446883|NCT01238289|randomized|randomized
446884|NCT01238289|trial|trial
446885|NCT01238276|soft tissue infection|soft tissue infection
446886|NCT01238276|wound infection|wound infection
446887|NCT01238276|cellulitis|cellulitis
446888|NCT01238276|foot ulcer|foot ulcer
446889|NCT01238276|Diabetes|diabetes
446890|NCT01238276|antibiotics|antibiotics
446891|NCT01238276|cefazolin|cefazolin
446892|NCT01238276|cephazolin|cephazolin
446893|NCT01238276|Ancef|ancef
446894|NCT01238276|Kefzol|kefzol
446895|NCT01238276|subcutaneous fluid administration|subcutaneous fluid administration
446896|NCT01238276|ultrasound|ultrasound
446897|NCT01238276|MRSA|mrsa
446898|NCT01238276|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
446899|NCT01238263|Atopic dermatitis, autologous serum skin testing, IgE autoantibodies|atopic dermatitis, autologous serum skin testing, ige autoantibodies
446901|NCT01238250|16p11.2 del|16p11.2 del
446902|NCT01238250|16p11.2 deletion|16p11.2 deletion
446903|NCT01238250|16p11.2 dup|16p11.2 dup
446904|NCT01238250|16p11.2 duplication|16p11.2 duplication
446905|NCT01238250|chromosome 16|chromosome 16
446906|NCT01238250|chromosome 16p|chromosome 16p
446907|NCT01238250|chromosome 16p11|chromosome 16p11
446908|NCT01238250|chromosome 16p11.2|chromosome 16p11.2
446909|NCT01238250|1q21.1|1q21.1
446910|NCT01238250|1q21.1 del|1q21.1 del
446911|NCT01238250|1q21.1 deletion|1q21.1 deletion
446912|NCT01238250|1q21.1 dup|1q21.1 dup
446913|NCT01238250|1q21.1 duplication|1q21.1 duplication
446914|NCT01238250|chromosome 1|chromosome 1
446915|NCT01238250|chromosome 1q|chromosome 1q
446916|NCT01238250|chromosome 1q21|chromosome 1q21
446917|NCT01238250|chromosome 1q21.1|chromosome 1q21.1
446918|NCT01238250|genetic mutation|genetic mutation
446919|NCT01238250|genetic variant|genetic variant
446920|NCT01238250|gene variant|gene variant
446921|NCT01238250|autism|autism
446922|NCT01238250|ADNP|adnp
446923|NCT01238250|ANKRD11|ankrd11
446924|NCT01238250|ARID1B|arid1b
446925|NCT01238250|ASXL3|asxl3
446926|NCT01238250|ACTL6B|actl6b
446927|NCT01238250|AHDC1|ahdc1
446928|NCT01238250|BAF190|baf190
446929|NCT01238250|ANK2|ank2
446930|NCT01238250|ASH1L|ash1l
446931|NCT01238250|BCL11A|bcl11a
446932|NCT01238250|CHD2|chd2
446933|NCT01238250|CHD8|chd8
446934|NCT01238250|CTNNB1|ctnnb1
446935|NCT01238250|CUL3|cul3
446936|NCT01238250|DST|dst
446937|NCT01238250|DYRK1A|dyrk1a
446938|NCT01238250|FOXP1|foxp1
446939|NCT01238250|GRIN2B|grin2b
446940|NCT01238250|KDM6B|kdm6b
446941|NCT01238250|KMT2E|kmt2e
446942|NCT01238250|MBD5|mbd5
446943|NCT01238250|MED13L|med13l
446944|NCT01238250|PTEN|pten
446945|NCT01238250|REST|rest
446946|NCT01238250|SCN2A|scn2a
446947|NCT01238250|SMARCC1|smarcc1
446948|NCT01238250|SMARCC2|smarcc2
446949|NCT01238250|SYNGAP1|syngap1
446950|NCT01238250|HIVEP2|hivep2
446951|NCT01238250|HNRNPH2|hnrnph2
446952|NCT01238250|PPP2R5D|ppp2r5d
446953|NCT01238250|CHAMP1|champ1
446954|NCT01238250|CSNK2A1|csnk2a1
446955|NCT01238250|CTBP1|ctbp1
446956|NCT01238250|DDX3X|ddx3x
446957|NCT01238250|DNMT3A|dnmt3a
446958|NCT01238250|DSCAM|dscam
446959|NCT01238250|GRIN2A|grin2a
446960|NCT01238250|KAT6A|kat6a
446961|NCT01238250|KATNAL2|katnal2
446962|NCT01238250|KDM5B|kdm5b
446963|NCT01238250|KMT2C|kmt2c
446964|NCT01238250|KMT5B|kmt5b
446965|NCT01238250|SUV420H1|suv420h1
446966|NCT01238250|PACS1|pacs1
446967|NCT01238250|PBRM1|pbrm1
446968|NCT01238250|PTCHD1|ptchd1
446969|NCT01238250|PURA|pura
446970|NCT01238250|SETBP1|setbp1
446971|NCT01238250|SETD5|setd5
446972|NCT01238250|SMARCA4|smarca4
446973|NCT01238250|STXBP1|stxbp1
446974|NCT01238250|TBR1|tbr1
446975|NCT01238237|Glioblastoma Multiforme|glioblastoma multiforme
446976|NCT01238237|Anaplastic Astrocytoma|anaplastic astrocytoma
446977|NCT01238237|High Grade Glial Neoplasms|high grade glial neoplasms
446978|NCT01238237|Brain Tumor|brain tumor
446979|NCT01238237|EGFR|egfr
446980|NCT01238237|Epidermal Growth Factor Receptor|epidermal growth factor receptor
446981|NCT01238237|EGFRvIII|egfrviii
446982|NCT01238224|Insulin resistance|insulin resistance
446983|NCT01238224|Phosphodiesterase-5 inhibition|phosphodiesterase-5 inhibition
446984|NCT01238224|Microdialysis|microdialysis
446985|NCT01238224|Type 2 diabetes|type 2 diabetes
446986|NCT01238224|Endothelial dysfunction|endothelial dysfunction
446987|NCT01238224|Oral hypoglycaemic agents|oral hypoglycaemic agents
446988|NCT01238185|oral leukoplakia|oral leukoplakia
446989|NCT01238172|stage I prostate cancer|stage i prostate cancer
446990|NCT01238172|stage IIB prostate cancer|stage iib prostate cancer
446991|NCT01238172|stage IIA prostate cancer|stage iia prostate cancer
446992|NCT01238172|adenocarcinoma of the prostate|adenocarcinoma of the prostate
446993|NCT01238159|Natural killer cell|natural killer cell
446994|NCT01238159|T cell|t cell
446995|NCT01238159|Lymphoma|lymphoma
446996|NCT01238159|Radiation|radiation
446997|NCT01238159|Chemotherapy|chemotherapy
446998|NCT01238120|Cancer|cancer
446999|NCT01238120|Cognitive difficulties|cognitive difficulties
447000|NCT01238107|Cachexia|cachexia
447001|NCT01238107|Cancer|cancer
447002|NCT01238094|colorectal cancer|colorectal cancer
447003|NCT01238094|simvastatin|simvastatin
447004|NCT01238094|second-line chemotherapy|second-line chemotherapy
447005|NCT01238081|Cystic fibrosis|cystic fibrosis
447006|NCT01238055|advanced gastric cancer|advanced gastric cancer
447007|NCT01238055|sunitinib|sunitinib
447008|NCT01238055|docetaxel|docetaxel
447009|NCT01238055|fluoropyrimidine platinum based chemotherapy|fluoropyrimidine platinum based chemotherapy
447010|NCT01238029|Dose finding study|dose finding study
447011|NCT01238029|Combination|combination
447012|NCT01237990|liver|liver
447013|NCT01237990|cancer|cancer
447014|NCT01237990|tumor|tumor
447118|NCT01237613|Rupture|rupture
447119|NCT01237613|Tendon|tendon
447015|NCT01237951|Autologous Hematopoietic-Cell Support|autologous hematopoietic-cell support
447016|NCT01237951|Stem Cell Transplant|stem cell transplant
447017|NCT01237951|Busulfan|busulfan
447018|NCT01237951|Myleran|myleran
447019|NCT01237951|Busulfex|busulfex
447020|NCT01237951|Gemcitabine|gemcitabine
447021|NCT01237951|Gemzar|gemzar
447022|NCT01237951|Melphalan|melphalan
447023|NCT01237951|Alkeran|alkeran
447024|NCT01237951|Decadron|decadron
447025|NCT01237951|Dexamethasone|dexamethasone
447026|NCT01237951|G-CSF|g-csf
447027|NCT01237951|Filgrastim|filgrastim
447028|NCT01237951|Neupogen|neupogen
447029|NCT01237925|Sunburn|sunburn
447030|NCT01237925|Dexchlorpheniramine|dexchlorpheniramine
447031|NCT01237925|Gel|gel
447032|NCT01237925|Cream|cream
447033|NCT01237899|Kidney|kidney
447034|NCT01237899|Renal|renal
447035|NCT01237886|spontaneous breathing trial|spontaneous breathing trial
447036|NCT01237886|heart rate variability|heart rate variability
447037|NCT01237886|respiratory rate variability|respiratory rate variability
447038|NCT01237873|Aliskiren|aliskiren
447039|NCT01237873|Amlodipine|amlodipine
447040|NCT01237873|Essential hypertension|essential hypertension
447041|NCT01237873|Long term|long term
447042|NCT01237860|Foot drop|foot drop
447043|NCT01237860|Thigh muscle weakness|thigh muscle weakness
447044|NCT01237860|Upper Motor Neuron injury or disease|upper motor neuron injury or disease
447045|NCT01237847|inflammatory bowel disease|inflammatory bowel disease
447046|NCT01237847|IBD|ibd
447047|NCT01237847|Crohn's disease|crohn's disease
447048|NCT01237847|ulcerative colitis|ulcerative colitis
447049|NCT01237847|adolescent|adolescent
447050|NCT01237808|AML|aml
447051|NCT01237808|NPM1 Mutation|npm1 mutation
447052|NCT01237808|elderly patients (>60 years)|elderly patients (>60 years)
447053|NCT01237808|unfit for intensive chemotherapy|unfit for intensive chemotherapy
447054|NCT01237795|Chloramine T|chloramine t
447055|NCT01237795|Complete Denture|complete denture
447056|NCT01237795|Dental Plaque Index|dental plaque index
447057|NCT01237795|Dentifrice|dentifrice
447058|NCT01237795|Denture Bases|denture bases
447059|NCT01237795|Denture Cleansers|denture cleansers
447060|NCT01237795|Edentulous Mouth|edentulous mouth
447061|NCT01237795|Fluorosurfactant|fluorosurfactant
447062|NCT01237795|Oral Health|oral health
447063|NCT01237795|Toothpaste|toothpaste
447064|NCT01237782|Candida|candida
447065|NCT01237782|Complete Denture|complete denture
447066|NCT01237782|Dental Plaque Index|dental plaque index
447067|NCT01237782|Denture Bases|denture bases
447068|NCT01237782|Denture Cleansers|denture cleansers
447069|NCT01237782|Edentulous Mouth|edentulous mouth
447070|NCT01237782|Mutans Streptococci|mutans streptococci
447071|NCT01237782|Oral Health|oral health
447072|NCT01237782|Propolis|propolis
447073|NCT01237782|Streptococcus mutans|streptococcus mutans
447074|NCT01237769|vitamin D|vitamin d
447075|NCT01237769|Metabolic syndrome|metabolic syndrome
447076|NCT01237769|Hypertension|hypertension
447077|NCT01237769|Dyslipidemia|dyslipidemia
447078|NCT01237769|Dysglycemia|dysglycemia
447079|NCT01237769|Inflammation|inflammation
447080|NCT01237756|pediatric anesthesia|pediatric anesthesia
447081|NCT01237756|endotracheal tube|endotracheal tube
447082|NCT01237756|electrical impedance tomography|electrical impedance tomography
447083|NCT01237756|misplacement|misplacement
447084|NCT01237756|endobronchial|endobronchial
447085|NCT01237743|Embolism|embolism
447086|NCT01237743|Nervous system|nervous system
447087|NCT01237743|Aorta|aorta
447088|NCT01237743|Valves|valves
447089|NCT01237743|Ultrasonics|ultrasonics
447090|NCT01237730|percutaneous endoscopic gastrostomy|percutaneous endoscopic gastrostomy
447091|NCT01237730|peristomal wound infection|peristomal wound infection
447092|NCT01237730|prophylactic antibiotics|prophylactic antibiotics
447093|NCT01237717|hypertension|hypertension
447094|NCT01237691|drug use|drug use
447095|NCT01237691|drug arrests|drug arrests
447096|NCT01237691|incarceration|incarceration
447097|NCT01237678|Immunogen|immunogen
447098|NCT01237678|Lung|lung
447099|NCT01237678|Small Cell Lung Cancer|small cell lung cancer
447100|NCT01237678|Carboplatin|carboplatin
447101|NCT01237678|ADC|adc
447102|NCT01237665|locally resectable advanced adenocarcinoma of the rectum|locally resectable advanced adenocarcinoma of the rectum
447103|NCT01237652|Isolated Systolic Hypertension|isolated systolic hypertension
447104|NCT01237652|Perioperative Myocardial Ischemia|perioperative myocardial ischemia
447105|NCT01237652|Perioperative Cardiovascular adverse events|perioperative cardiovascular adverse events
447106|NCT01237639|Red Cells|red cells
447107|NCT01237639|Transfusion|transfusion
447108|NCT01237639|Trigger|trigger
447109|NCT01237639|Threshold|threshold
447110|NCT01237639|Hematopoietic Stem cell Transplantation|hematopoietic stem cell transplantation
447111|NCT01237626|Driving|driving
447112|NCT01237626|Aging|aging
447113|NCT01237626|Older drivers|older drivers
447114|NCT01237626|Medical Fitness to drive|medical fitness to drive
447115|NCT01237626|Health Status|health status
447116|NCT01237626|At-fault collisions|at-fault collisions
447117|NCT01237613|Achilles|achilles
447120|NCT01237613|Artelon|artelon
447121|NCT01237600|Ocular surface damage|ocular surface damage
447122|NCT01237600|Limbal deficiency|limbal deficiency
447123|NCT01237600|Cultivated corneal epithelial stem cell transplantation|cultivated corneal epithelial stem cell transplantation
447124|NCT01237587|Adolescents|adolescents
447125|NCT01237587|Juvenile Primary Fibromyalgia Syndrome|juvenile primary fibromyalgia syndrome
447126|NCT01237574|Liver Diseases|liver diseases
447127|NCT01237574|Alcoholic|alcoholic
447128|NCT01237574|Metabolic Diseases|metabolic diseases
447129|NCT01237574|cohort|cohort
447130|NCT01237574|liver disease|liver disease
447131|NCT01237561|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
447132|NCT01237561|COPD Guidelines|copd guidelines
447133|NCT01237561|Patient Activation|patient activation
447134|NCT01237561|Lung Age|lung age
447135|NCT01237548|water pipe smoking|water pipe smoking
447136|NCT01237548|acute effect|acute effect
447137|NCT01237548|Endothelial|endothelial
447138|NCT01237548|healthy adults who smoke narghile|healthy adults who smoke narghile
447139|NCT01237535|Unexplained infertility|unexplained infertility
447140|NCT01237535|Insemination|insemination
447141|NCT01237535|Luteal phase support|luteal phase support
447142|NCT01237535|Ovarian stimulation|ovarian stimulation
447143|NCT01237522|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
447144|NCT01237522|Metabolic Clearance Rate|metabolic clearance rate
447145|NCT01237522|Pharmacokinetics|pharmacokinetics
447146|NCT01237522|Pharmacogenetics|pharmacogenetics
447147|NCT01237509|EEG|eeg
447148|NCT01237509|Sleep|sleep
447149|NCT01237509|device|device
447150|NCT01237509|diabetes|diabetes
447151|NCT01237509|hypoglycemia|hypoglycemia
447152|NCT01237483|reirradiation with Erbitux|reirradiation with erbitux
447153|NCT01237483|HNSCC|hnscc
447154|NCT01237483|local recurrent inoperable Squamous Cell Cancer of the Head and Neck|local recurrent inoperable squamous cell cancer of the head and neck
447155|NCT01237470|inguinal hernia|inguinal hernia
447156|NCT01237470|hernia recurrence|hernia recurrence
447157|NCT01237470|no mesh techniques|no mesh techniques
447158|NCT01237470|Desarda technique|desarda technique
447159|NCT01237444|Lopinavir/ritonavir plus 3TC as a dual therapy regimen.|lopinavir/ritonavir plus 3tc as a dual therapy regimen.
447160|NCT01237431|Water drinking|water drinking
447161|NCT01237431|osmoreceptors|osmoreceptors
447162|NCT01237431|autonomic failure|autonomic failure
447163|NCT01237431|syncope|syncope
447164|NCT01237431|blood pressure|blood pressure
447165|NCT01237431|liver transplant|liver transplant
447166|NCT01237405|osteoarthritis|osteoarthritis
447167|NCT01237405|nuclear medicine|nuclear medicine
447168|NCT01237405|macrophages|macrophages
447169|NCT01237392|wound debridement|wound debridement
447170|NCT01237392|requiring debridement|requiring debridement
447171|NCT01237366|HIV/AIDS|hiv/aids
447172|NCT01237366|Methamphetamine|methamphetamine
447173|NCT01237366|Trauma|trauma
447174|NCT01237340|Adult Growth Hormone Deficiency (AGHD)|adult growth hormone deficiency (aghd)
447175|NCT01237340|immunogenicity|immunogenicity
447176|NCT01237340|growth hormone|growth hormone
447177|NCT01237340|antibodies|antibodies
447178|NCT01237340|GH biomarkers|gh biomarkers
447179|NCT01237340|IGF-I|igf-i
447180|NCT01237327|Metastatic Breast Cancer|metastatic breast cancer
447181|NCT01237327|Advanced|advanced
447182|NCT01237327|Postmenopausal|postmenopausal
447183|NCT01237327|Exemestane vs Megestrol|exemestane vs megestrol
447184|NCT01237314|type 2 diabetes|type 2 diabetes
447185|NCT01237314|metformin|metformin
447186|NCT01237314|glargine|glargine
447187|NCT01237314|exenatide|exenatide
447188|NCT01237314|glycemic impact of food|glycemic impact of food
447189|NCT01237314|continuous glucose monitoring|continuous glucose monitoring
447190|NCT01237301|Type 2 Diabetes|type 2 diabetes
447191|NCT01237301|Continuous Glucose Monitoring|continuous glucose monitoring
447192|NCT01237275|Pharmacogenomics|pharmacogenomics
447193|NCT01237275|Prediction of Antidepressant Response|prediction of antidepressant response
447194|NCT01237275|Depressed Patients|depressed patients
447195|NCT01237262|psoriasis|psoriasis
447196|NCT01237262|immune infiltrate|immune infiltrate
447197|NCT01237262|dendritic cells|dendritic cells
447198|NCT01237262|cytokine expression|cytokine expression
447199|NCT01237249|Multiple Myeloma|multiple myeloma
447200|NCT01237249|Velcade|velcade
447201|NCT01237249|Revlimid|revlimid
447202|NCT01237236|Advanced solid tumor|advanced solid tumor
447203|NCT01237236|lymphoma|lymphoma
447204|NCT01237223|Aliskiren|aliskiren
447205|NCT01237223|Amlodipine|amlodipine
447206|NCT01237223|Essential hypertension|essential hypertension
447207|NCT01237210|Parkinson's Disease|parkinson's disease
447208|NCT01237210|PD|pd
447209|NCT01237210|magnetic resonance spectroscopy|magnetic resonance spectroscopy
447210|NCT01237184|initial dental implant stability|initial dental implant stability
447211|NCT01237184|maxillary sinus proximity|maxillary sinus proximity
447212|NCT01237184|bicortical fixation|bicortical fixation
447213|NCT01237171|Brachytherapy|brachytherapy
447214|NCT01237171|Lung Brachytherapy|lung brachytherapy
447215|NCT01237171|NSCLC|nsclc
447216|NCT01237171|Sub-lobar resection|sub-lobar resection
447217|NCT01237158|GAD1,|gad1,
447218|NCT01237158|GAD67,|gad67,
447219|NCT01237158|bipolar,|bipolar,
447220|NCT01237158|GABA,|gaba,
447221|NCT01237158|Glutamate,|glutamate,
447222|NCT01237158|Reelin,|reelin,
447223|NCT01237158|Rln,|rln,
447224|NCT01237158|Spectroscopy|spectroscopy
447225|NCT01237158|euthymic bipolar I patients|euthymic bipolar i patients
447226|NCT01237145|pigeon|pigeon
447227|NCT01237145|bird fancier|bird fancier
447228|NCT01237145|extrinsic allergic alveolitis|extrinsic allergic alveolitis
447229|NCT01237145|BAL|bal
447230|NCT01237145|broncho-alveolar lavage|broncho-alveolar lavage
447231|NCT01237145|elispot|elispot
447232|NCT01237145|antigen|antigen
447233|NCT01237106|PCOS|pcos
447234|NCT01237106|IVM|ivm
447235|NCT01237106|Polycystic ovarian syndrome|polycystic ovarian syndrome
447236|NCT01237106|In Vitro Maturation|in vitro maturation
447237|NCT01237106|IVF|ivf
447238|NCT01237093|Fish Diet|fish diet
447239|NCT01237093|Meat Diet|meat diet
447240|NCT01237093|Biomarkers|biomarkers
447241|NCT01237093|Stable Isotopes|stable isotopes
447242|NCT01237093|Dietary Intake|dietary intake
447243|NCT01237067|PARP inhibitor, womens's cancers, relapsed, recurrent|parp inhibitor, womens's cancers, relapsed, recurrent
447244|NCT01237067|Ovarian, breast, endometrial, cervical|ovarian, breast, endometrial, cervical
447245|NCT01237067|Carboplatin|carboplatin
447246|NCT01237067|BRCA 1 and BRCA 2|brca 1 and brca 2
447247|NCT01237067|Breast Cancer|breast cancer
447248|NCT01237067|Ovarian Cancer|ovarian cancer
447249|NCT01237067|Uterine Cancer|uterine cancer
447250|NCT01237067|Cervical Cancer|cervical cancer
447251|NCT01237067|Peritoneal Cancer|peritoneal cancer
447252|NCT01237067|Endometrial Cancer|endometrial cancer
447253|NCT01237067|Fallopian Tube Cancer|fallopian tube cancer
447254|NCT01237054|18-FDG PET/CT|18-fdg pet/ct
447255|NCT01237054|Abnormal Plasma Cells|abnormal plasma cells
447256|NCT01237054|Serum Free Light-Chain Abnormality|serum free light-chain abnormality
447257|NCT01237054|Serum M-Protein|serum m-protein
447258|NCT01237054|DCE-MRI|dce-mri
447259|NCT01237054|Multiple Myeloma|multiple myeloma
447260|NCT01237054|Smoldering Multiple Myeloma|smoldering multiple myeloma
447261|NCT01237054|SMM|smm
447262|NCT01237054|MM|mm
447263|NCT01237041|Child|child
447264|NCT01237041|Body Fat|body fat
447265|NCT01237041|Niacin|niacin
447266|NCT01237041|Growth Hormone|growth hormone
447267|NCT01237041|Obesity|obesity
447268|NCT01237041|Growth Hormones|growth hormones
447269|NCT01237041|Short Stature|short stature
447270|NCT01237041|Children|children
447271|NCT01237015|Neonate|neonate
447272|NCT01237015|Oral feeding|oral feeding
447273|NCT01237015|Nasal CPAP|nasal cpap
447274|NCT01237015|Sucking|sucking
447275|NCT01237015|Swallowing|swallowing
447276|NCT01237015|Breathing|breathing
447277|NCT01237002|Liver ischemia; Pringle time|liver ischemia; pringle time
447278|NCT01236989|anatomical resection|anatomical resection
447279|NCT01236989|non-anatomical resection|non-anatomical resection
447280|NCT01236989|IOUS-guided finger compression|ious-guided finger compression
447281|NCT01236963|Clinical trial|clinical trial
447282|NCT01236963|Prevention mouthrinse|prevention mouthrinse
447283|NCT01236963|Dental Floss|dental floss
447284|NCT01236950|Clinical Trial|clinical trial
447285|NCT01236950|Prevention Mouthrinse|prevention mouthrinse
447286|NCT01236937|CT, lung nodule biopsy, Respiration Gated, Lung Cancer|ct, lung nodule biopsy, respiration gated, lung cancer
447287|NCT01236911|Calcium , TBI,complications, days in hospital|calcium , tbi,complications, days in hospital
447288|NCT01236898|N-acetylneuraminic acid,|n-acetylneuraminic acid,
447289|NCT01236898|pharmacokinetics|pharmacokinetics
447290|NCT01236898|hIBM|hibm
447291|NCT01236872|Nitrate|nitrate
447292|NCT01236872|Nitrite|nitrite
447293|NCT01236872|Vegetable|vegetable
447294|NCT01236872|Aortic stiffness|aortic stiffness
447295|NCT01236859|Gabapentin|gabapentin
447296|NCT01236859|prophylaxis|prophylaxis
447297|NCT01236859|incidence of pruritus|incidence of pruritus
447298|NCT01236859|intrathecal morphine|intrathecal morphine
447299|NCT01236846|Vitamin D fortification|vitamin d fortification
447300|NCT01236846|Yogurt Drink|yogurt drink
447301|NCT01236846|Efficacy|efficacy
447302|NCT01236833|Lactated Ringer's Solution|lactated ringer's solution
447303|NCT01236833|Isotonic Solution|isotonic solution
447304|NCT01236833|Intestinal Disease|intestinal disease
447305|NCT01236833|Feeding Intolerance|feeding intolerance
447306|NCT01236833|Necrotizing Enterocolitis|necrotizing enterocolitis
447307|NCT01236833|Newborn|newborn
447308|NCT01236833|Premature Infant|premature infant
447310|NCT01236820|LDL|ldl
447311|NCT01236820|Cardiovascular disease|cardiovascular disease
447312|NCT01236820|Chronic kidney disease|chronic kidney disease
447313|NCT01236820|Hemodialysis|hemodialysis
447314|NCT01236807|Adenosine|adenosine
447315|NCT01236807|Magnetic Resonance Imaging|magnetic resonance imaging
447316|NCT01236807|MR perfusion|mr perfusion
447317|NCT01236807|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
447318|NCT01236807|FFR|ffr
447319|NCT01236807|Pressure wire|pressure wire
447320|NCT01236807|Coronary Disease|coronary disease
447321|NCT01236807|Heart Diseases|heart diseases
447322|NCT01236807|Cardiovascular Diseases|cardiovascular diseases
447323|NCT01236807|Arteriosclerosis|arteriosclerosis
447324|NCT01236781|breast cancer|breast cancer
447325|NCT01236781|screening|screening
447326|NCT01236781|diagnostics|diagnostics
447327|NCT01236781|diagnosis|diagnosis
447328|NCT01236781|high-risk|high-risk
447329|NCT01236781|breast neoplasms|breast neoplasms
447330|NCT01236781|digital mammography|digital mammography
447331|NCT01236781|mammography|mammography
447332|NCT01236781|tomosynthesis|tomosynthesis
447333|NCT01236781|dense breasts|dense breasts
447334|NCT01236781|radiation dose|radiation dose
447335|NCT01236781|comparison|comparison
447336|NCT01236781|Hologic|hologic
447337|NCT01236781|Pennsylvania|pennsylvania
447338|NCT01236781|Philadelphia|philadelphia
447339|NCT01236781|breast study|breast study
447340|NCT01236781|mammo|mammo
447341|NCT01236781|tomo|tomo
447342|NCT01236781|mammary|mammary
447343|NCT01236768|Contraceptive|contraceptive
447344|NCT01236755|children|children
447345|NCT01236755|corneal reshaping|corneal reshaping
447346|NCT01236755|myopia|myopia
447347|NCT01236755|myopia progression|myopia progression
447348|NCT01236755|orthokeratology|orthokeratology
447349|NCT01236742|children|children
447350|NCT01236742|corneal reshaping|corneal reshaping
447351|NCT01236742|myopia|myopia
447352|NCT01236742|myopia progression|myopia progression
447353|NCT01236742|orthokeratology|orthokeratology
447354|NCT01236729|knee replacement|knee replacement
447355|NCT01236729|disability|disability
447356|NCT01236729|older people|older people
447357|NCT01236716|squamous cell carcinoma of lung|squamous cell carcinoma of lung
447358|NCT01236716|Albumin bound paclitaxel|albumin bound paclitaxel
447359|NCT01236716|chemotherapy|chemotherapy
447360|NCT01236703|SIRS|sirs
447361|NCT01236703|Sepsis|sepsis
447362|NCT01236703|hematological infection score|hematological infection score
447363|NCT01236690|Transcatheter arterial embolization|transcatheter arterial embolization
447364|NCT01236690|Cinobufacin injection|cinobufacin injection
447365|NCT01236690|hepatoma|hepatoma
447366|NCT01236677|Pathogen|pathogen
447367|NCT01236664|memory training|memory training
447368|NCT01236664|mnemonics|mnemonics
447369|NCT01236664|cognition|cognition
447370|NCT01236664|work|work
447371|NCT01236638|Primary Myelofibrosis|primary myelofibrosis
447372|NCT01236638|Post-Polycythemia Vera|post-polycythemia vera
447373|NCT01236638|Post-Essential Thrombocythemia|post-essential thrombocythemia
447374|NCT01236638|CYT387|cyt387
447375|NCT01236625|Tissue Adhesions|tissue adhesions
447376|NCT01236625|Adhesiolysis|adhesiolysis
447377|NCT01236625|Inadvertent enterotomy|inadvertent enterotomy
447378|NCT01236625|Prospective cohort study|prospective cohort study
447379|NCT01236625|Quality of life|quality of life
447380|NCT01236612|Plasmodium|plasmodium
447381|NCT01236612|falciparum|falciparum
447382|NCT01236612|malaria|malaria
447383|NCT01236612|chloroquine|chloroquine
447384|NCT01236612|immunity|immunity
447385|NCT01236599|preterm infant, thermoregulation, polyethylene bag|preterm infant, thermoregulation, polyethylene bag
447386|NCT01236586|Maximum Tolerated Dose|maximum tolerated dose
447387|NCT01236586|Toxicity|toxicity
447388|NCT01236586|Pharmacokinetics|pharmacokinetics
447389|NCT01236586|NOTCH Signaling Pathway|notch signaling pathway
447390|NCT01236586|Expression of JAGGED 1 and 2|expression of jagged 1 and 2
447391|NCT01236586|Cancer|cancer
447392|NCT01236586|Solid Tumor|solid tumor
447393|NCT01236586|Brain Tumor|brain tumor
447394|NCT01236586|Wilms Tumor|wilms tumor
447395|NCT01236586|Osteosarcoma|osteosarcoma
447396|NCT01236586|Lymphoma|lymphoma
447397|NCT01236573|Gene Therapy|gene therapy
447398|NCT01236573|Immunotherapy|immunotherapy
447399|NCT01236573|Adoptive Cell Therapy|adoptive cell therapy
447400|NCT01236573|Metastatic Melanoma|metastatic melanoma
447401|NCT01236534|Multiple Sclerosis|multiple sclerosis
447402|NCT01236534|Constipation|constipation
447403|NCT01236534|Multiple Sclerosis Associated Constipation|multiple sclerosis associated constipation
447404|NCT01236521|Back pain|back pain
447405|NCT01236521|Care Management|care management
447406|NCT01236521|Pain|pain
447407|NCT01236521|Patient outcomes|patient outcomes
447408|NCT01236521|Patient-center Care|patient-center care
447409|NCT01236521|Primary care|primary care
447410|NCT01236508|White Matter Hyperintensity|white matter hyperintensity
447411|NCT01236508|Stroke|stroke
447412|NCT01236508|Carotid Artery Plaque Inflammation|carotid artery plaque inflammation
447413|NCT01236508|FDG PET|fdg pet
447414|NCT01236508|MRI|mri
447415|NCT01236508|TIA|tia
447416|NCT01236495|thoracotomy|thoracotomy
447417|NCT01236495|postoperative pain|postoperative pain
447418|NCT01236495|spinal morphine|spinal morphine
447419|NCT01236482|Pregnancy|pregnancy
447420|NCT01236482|Postpartum hemorrhage|postpartum hemorrhage
447421|NCT01236482|Uterine tone|uterine tone
447422|NCT01236482|Oxytocin|oxytocin
447423|NCT01236482|Ergometrine|ergometrine
447424|NCT01236482|Pharmacokinetic-pharmacodynamic analysis|pharmacokinetic-pharmacodynamic analysis
447425|NCT01236469|Aortic Valve|aortic valve
447426|NCT01236456|chronic inflammatory demyelinating polyneuropathy|chronic inflammatory demyelinating polyneuropathy
447427|NCT01236456|cyclophosphamide|cyclophosphamide
447428|NCT01236456|autoimmune|autoimmune
447429|NCT01236430|Hyperlipidemia|hyperlipidemia
447430|NCT01236430|statin|statin
447431|NCT01236430|Ezetimibe|ezetimibe
447432|NCT01236430|Zetia|zetia
447433|NCT01236430|Atorvastatin|atorvastatin
447434|NCT01236430|Lipitor|lipitor
447435|NCT01236391|Pharmacyclics|pharmacyclics
447436|NCT01236391|Mantle|mantle
447437|NCT01236391|Mantle Cell|mantle cell
447438|NCT01236391|Lymphoma|lymphoma
447439|NCT01236391|Non-Hodgkins|non-hodgkins
447440|NCT01236391|Bortezomib|bortezomib
447441|NCT01236391|Velcade|velcade
447442|NCT01236391|Naive|naive
447443|NCT01236391|PCYC|pcyc
447444|NCT01236378|Organ Transplants|organ transplants
447445|NCT01236378|Anti-Rejection Therapy|anti-rejection therapy
447446|NCT01236378|Pharmacokinetics|pharmacokinetics
447447|NCT01236365|Type 1 diabetes|type 1 diabetes
447448|NCT01236365|Children|children
447449|NCT01236365|Statins|statins
447450|NCT01236365|Hypercholesterolemia|hypercholesterolemia
447451|NCT01236365|Lipoproteins|lipoproteins
447452|NCT01236365|C reactive protein|c reactive protein
447453|NCT01236365|Continuous glucose monitors|continuous glucose monitors
447454|NCT01236365|Adolescence|adolescence
447455|NCT01236365|Abdominal magnetic resonance imaging|abdominal magnetic resonance imaging
447456|NCT01236365|Toll like receptors|toll like receptors
447457|NCT01236365|Receptors of advanced glycation end products|receptors of advanced glycation end products
447458|NCT01236365|Nutrition|nutrition
447459|NCT01236352|Advanced Cancer, Various, NOS|advanced cancer, various, nos
447460|NCT01236313|TEE|tee
447461|NCT01236313|Cardiac Surgery|cardiac surgery
447462|NCT01236313|Pulse Pressure|pulse pressure
447463|NCT01236300|Pancreatic cysts|pancreatic cysts
447464|NCT01236274|Myocardial Infarction|myocardial infarction
447465|NCT01236274|Antipsychotic agents|antipsychotic agents
447466|NCT01236274|Self-controlled case series method|self-controlled case series method
447467|NCT01236274|General Practice Research Database|general practice research database
447468|NCT01236274|Myocardial Ischaemia National Audit Project|myocardial ischaemia national audit project
447469|NCT01236274|CALIBER|caliber
447470|NCT01236261|Fungemia, fungal infection, susceptibility, antifungal|fungemia, fungal infection, susceptibility, antifungal
447471|NCT01236248|drugs|drugs
447472|NCT01236248|youth|youth
447473|NCT01236248|parent|parent
447474|NCT01236248|computer|computer
447475|NCT01236248|prevention|prevention
447476|NCT01236222|commuter cycling|commuter cycling
447477|NCT01236222|fitness|fitness
447478|NCT01236222|metabolic syndrome|metabolic syndrome
447479|NCT01236222|children|children
447480|NCT01236196|pain|pain
447481|NCT01236196|chronic pain|chronic pain
447482|NCT01236196|cognitive therapy|cognitive therapy
447483|NCT01236196|telehealth|telehealth
447484|NCT01236183|manual skill|manual skill
447485|NCT01236183|anesthesia residents|anesthesia residents
447486|NCT01236170|Amputees|amputees
447487|NCT01236170|spinal cord injuries|spinal cord injuries
447488|NCT01236170|quality of life|quality of life
447489|NCT01236170|satisfaction|satisfaction
447490|NCT01236170|healthcare disparities|healthcare disparities
447491|NCT01236170|wheelchairs|wheelchairs
447492|NCT01236157|Cardiology|cardiology
447493|NCT01236144|Myeloid|myeloid
447494|NCT01236144|Leukaemia|leukaemia
447495|NCT01236144|Acute|acute
447496|NCT01236144|Myelodysplastic|myelodysplastic
447497|NCT01236144|Pilot|pilot
447498|NCT01236144|Cardiff|cardiff
447499|NCT01236144|Haematology|haematology
447500|NCT01236144|Burnett|burnett
447501|NCT01236144|AC220|ac220
447502|NCT01236144|Plerixafor|plerixafor
447503|NCT01236144|Ganetespib|ganetespib
447504|NCT01236092|resolution of low back pain|resolution of low back pain
447505|NCT01236092|show measurable improvement in disc measurement|show measurable improvement in disc measurement
447506|NCT01236092|conservative therapy vs. surgery in resolving low back pain|conservative therapy vs. surgery in resolving low back pain
447507|NCT01236066|Rotavirus Gastroenteritis|rotavirus gastroenteritis
447508|NCT01236066|Rotarix|rotarix
447509|NCT01236066|RotaTeq|rotateq
447510|NCT01236066|Gastroenteritis|gastroenteritis
447511|NCT01236053|renal cancer|renal cancer
447512|NCT01236053|pancreatic cancer|pancreatic cancer
447513|NCT01236053|epidemiology|epidemiology
447514|NCT01236053|renal cell carcinoma|renal cell carcinoma
447515|NCT01236053|nervous system cancer|nervous system cancer
447516|NCT01236053|lung cancer|lung cancer
447517|NCT01236053|breast cancer|breast cancer
447518|NCT01236053|case-control|case-control
447519|NCT01236053|GPRD|gprd
447520|NCT01236053|Gapabentin|gapabentin
447521|NCT01236053|cancer|cancer
447522|NCT01236053|anal cancer|anal cancer
447523|NCT01236053|bone and joint cancer|bone and joint cancer
447524|NCT01236053|renal pelvis cancer|renal pelvis cancer
447525|NCT01236053|penis cancer|penis cancer
447526|NCT01236053|stomach cancer|stomach cancer
447527|NCT01236053|bladder cancer|bladder cancer
447528|NCT01236040|H5N1|h5n1
447529|NCT01236040|Influenza|influenza
447530|NCT01236040|Pandemic|pandemic
447531|NCT01236001|Lacosamide|lacosamide
447532|NCT01236001|Vimpat®|vimpat®
447533|NCT01235975|Neisseria meningitidis|neisseria meningitidis
447534|NCT01235975|Meningococcal Vaccines|meningococcal vaccines
447535|NCT01235975|serogroups A,C, W-135 or Y|serogroups a,c, w-135 or y
447536|NCT01235975|meningococcal diseases|meningococcal diseases
447537|NCT01235975|meningococcal conjugate vaccine|meningococcal conjugate vaccine
447538|NCT01235975|Immunogenicity|immunogenicity
447539|NCT01235962|anti-angiogenic agent|anti-angiogenic agent
447540|NCT01235962|renal cell carcinoma|renal cell carcinoma
447541|NCT01235962|pazopanib|pazopanib
447542|NCT01235962|adjuvant therapy|adjuvant therapy
447543|NCT01235962|VEGFR inhibitor|vegfr inhibitor
447544|NCT01235949|Pneumococcal vaccine|pneumococcal vaccine
447545|NCT01235949|Immunogenicity|immunogenicity
447546|NCT01235949|Safety|safety
447547|NCT01235949|Fever|fever
447548|NCT01235949|Primary vaccination|primary vaccination
447549|NCT01235949|Booster vaccination|booster vaccination
447550|NCT01235949|Pneumococcal disease|pneumococcal disease
447551|NCT01235949|Prophylactic antipyretic|prophylactic antipyretic
447552|NCT01235936|anemia|anemia
447553|NCT01235936|chronic kidney disease|chronic kidney disease
447554|NCT01235936|CKD|ckd
447555|NCT01235936|chronic renal insufficiency|chronic renal insufficiency
447556|NCT01235936|renal impairment|renal impairment
447557|NCT01235936|erythropoietin|erythropoietin
447558|NCT01235936|safety|safety
447559|NCT01235936|efficacy|efficacy
447560|NCT01235936|tolerability|tolerability
447561|NCT01235936|pharmacokinetics|pharmacokinetics
447562|NCT01235923|anemia|anemia
447563|NCT01235923|transfusions|transfusions
447564|NCT01235923|erythropoiesis|erythropoiesis
447565|NCT01235923|neonate|neonate
447566|NCT01235923|preterm|preterm
447567|NCT01235910|Hypertension|hypertension
447568|NCT01235910|Cardiac transplantation|cardiac transplantation
447569|NCT01235910|Aliskiren|aliskiren
447570|NCT01235910|Cyclosporine|cyclosporine
447571|NCT01235897|Neoplasms|neoplasms
447572|NCT01235897|Paclitaxel|paclitaxel
447573|NCT01235897|Trastuzumab|trastuzumab
447574|NCT01235884|gaseous colic, regurgitation and of constipation|gaseous colic, regurgitation and of constipation
447575|NCT01235871|Safety|safety
447576|NCT01235871|Tolerability|tolerability
447577|NCT01235871|SB1578|sb1578
447578|NCT01235858|Epidural analgesia|epidural analgesia
447579|NCT01235858|Epidural anesthesia labor|epidural anesthesia labor
447580|NCT01235858|Aseptic technique|aseptic technique
447581|NCT01235858|gown|gown
447582|NCT01235858|no gown|no gown
447583|NCT01235832|cholesterol|cholesterol
447584|NCT01235832|triglycerides|triglycerides
447585|NCT01235832|low-density lipoprotein|low-density lipoprotein
447586|NCT01235832|high-density lipoprotein|high-density lipoprotein
447587|NCT01235832|reverse cholesterol transport|reverse cholesterol transport
447588|NCT01235819|type 1 diabetes|type 1 diabetes
447589|NCT01235819|exenatide|exenatide
447590|NCT01235819|sitagliptin|sitagliptin
447591|NCT01235806|scaphoid|scaphoid
447592|NCT01235806|MRI|mri
447593|NCT01235806|ESAOTE|esaote
447594|NCT01235793|Relapsed|relapsed
447595|NCT01235793|Refractory|refractory
447596|NCT01235793|Primary Central Nervous System B-cell Lymphoma|primary central nervous system b-cell lymphoma
447597|NCT01235793|Autologous Stem Cell Transplant|autologous stem cell transplant
447598|NCT01235793|Temozolomide|temozolomide
447599|NCT01235793|B-Cell Lymphoma|b-cell lymphoma
447600|NCT01235793|RBEAM|rbeam
447601|NCT01235793|Conditioning Regimen|conditioning regimen
447602|NCT01235780|corneal hysteresis, ocular response analyzer|corneal hysteresis, ocular response analyzer
447603|NCT01235767|birth weight|birth weight
447604|NCT01235767|prematurity|prematurity
447605|NCT01235767|gestational age|gestational age
447606|NCT01235767|low birth weight|low birth weight
447607|NCT01235767|pregnancy|pregnancy
447608|NCT01235767|nutrition|nutrition
447609|NCT01235767|Vietnam|vietnam
447610|NCT01235754|testosterone|testosterone
447611|NCT01235754|hypoactive sexual desire disorder|hypoactive sexual desire disorder
447612|NCT01235754|menopause|menopause
447613|NCT01235741|Pramlintide|pramlintide
447614|NCT01235741|Metreleptin|metreleptin
447615|NCT01235741|Obesity|obesity
447616|NCT01235741|Amylin|amylin
447617|NCT01235741|Takeda|takeda
447618|NCT01235715|osteoarthritis|osteoarthritis
447619|NCT01235715|total knee replacement|total knee replacement
447620|NCT01235702|high blood pressure, hypertension, African Americans, perceived stress|high blood pressure, hypertension, african americans, perceived stress
447621|NCT01235676|obesity|obesity
447622|NCT01235676|lifestyle|lifestyle
447623|NCT01235676|pregnancy|pregnancy
447624|NCT01235676|newborn infant|newborn infant
447625|NCT01235663|obesity, insulin resistance|obesity, insulin resistance
447626|NCT01235637|COMFORT B score|comfort b score
447627|NCT01235637|Bis score|bis score
447628|NCT01235624|Autosomal dominant retinitis pigmentosa|autosomal dominant retinitis pigmentosa
447629|NCT01235624|Rare disease|rare disease
447630|NCT01235624|Genetics|genetics
447631|NCT01235598|Cimzia®|cimzia®
447632|NCT01235598|CDP870|cdp870
447633|NCT01235598|CZP|czp
447634|NCT01235598|Certolizumab Pegol|certolizumab pegol
447635|NCT01235598|Rheumatoid Arthritis|rheumatoid arthritis
447636|NCT01235598|MRI|mri
447637|NCT01235572|Acute myeloid leukemia with multilineage dysplasia following myelodysplastic syndrome|acute myeloid leukemia with multilineage dysplasia following myelodysplastic syndrome
447638|NCT01235572|Adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
447639|NCT01235572|Adult acute basophilic leukemia|adult acute basophilic leukemia
447640|NCT01235572|De|de
447641|NCT01235572|novo myelodysplastic syndromes|novo myelodysplastic syndromes
447642|NCT01235572|Secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
447643|NCT01235572|Untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
447644|NCT01235546|Pregnancy|pregnancy
447645|NCT01235546|Cesarean section|cesarean section
447646|NCT01235546|Antibiotic|antibiotic
447647|NCT01235546|Infections|infections
447648|NCT01235533|late-life depression|late-life depression
447649|NCT01235533|recurrence of depression|recurrence of depression
447650|NCT01235533|cognition|cognition
447651|NCT01235533|N-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
447652|NCT01235481|pulmonary rehabilitation|pulmonary rehabilitation
447653|NCT01235481|exercise therapy|exercise therapy
447654|NCT01235481|chronic lung disease|chronic lung disease
447655|NCT01235481|self-efficacy|self-efficacy
447656|NCT01235468|umbilical cord blood|umbilical cord blood
447657|NCT01235468|ex vivo expansion|ex vivo expansion
447658|NCT01235468|engraftment|engraftment
447659|NCT01235468|GVHD|gvhd
447660|NCT01235455|Multiple Sclerosis|multiple sclerosis
447661|NCT01235455|Adherence|adherence
447662|NCT01235455|Interferon beta-1b|interferon beta-1b
447663|NCT01235455|Coping styles|coping styles
447664|NCT01235442|Psoriasis|psoriasis
447665|NCT01235442|Topical|topical
447666|NCT01235442|etanercept|etanercept
447667|NCT01235442|clobetasol propionate|clobetasol propionate
447668|NCT01235429|Diabetes|diabetes
447669|NCT01235429|Behavioral intervention|behavioral intervention
447670|NCT01235429|diabetes self-management|diabetes self-management
447671|NCT01235429|Native Hawaiians|native hawaiians
447672|NCT01235429|health disparities|health disparities
447673|NCT01235403|Epilepsy treatment.|epilepsy treatment.
447674|NCT01235403|Anti-epileptic drugs|anti-epileptic drugs
447675|NCT01235403|Seizures|seizures
447676|NCT01235390|Postmenopausal women|postmenopausal women
447677|NCT01235390|walnuts|walnuts
447678|NCT01235377|prescribing patterns|prescribing patterns
447679|NCT01235377|thiazide|thiazide
447680|NCT01235377|chlorthalidone|chlorthalidone
447681|NCT01235377|hydrochlorothiazide|hydrochlorothiazide
447682|NCT01235377|target dose|target dose
447683|NCT01235377|cluster randomized trial|cluster randomized trial
447684|NCT01235364|Foley catheter|foley catheter
447685|NCT01235364|induction|induction
447686|NCT01235364|labour|labour
447687|NCT01235364|skin conductance|skin conductance
447688|NCT01235364|visual analogue scale|visual analogue scale
447689|NCT01235364|mechanical method|mechanical method
447690|NCT01235351|Myocardial infarction|myocardial infarction
447691|NCT01235351|Percutaneous coronary intervention|percutaneous coronary intervention
447692|NCT01235351|Clopidogrel|clopidogrel
447693|NCT01235351|Genetics|genetics
447694|NCT01235351|Platelet Function|platelet function
447695|NCT01235325|vitamin K|vitamin k
447696|NCT01235325|supplementation|supplementation
447697|NCT01235325|bone health indices|bone health indices
447698|NCT01235325|adult|adult
447699|NCT01235325|Crohn's disease|crohn's disease
447700|NCT01235286|remote ischemic preconditioning, free flap, microcirculation|remote ischemic preconditioning, free flap, microcirculation
447701|NCT01235260|REGRANEX (becaplermin)|regranex (becaplermin)
447702|NCT01235260|Platelet-derived growth factor BB|platelet-derived growth factor bb
447703|NCT01235260|Cancer|cancer
447704|NCT01235260|Cancer incidence|cancer incidence
447705|NCT01235260|Cancer mortality|cancer mortality
447706|NCT01235260|Lower Extremity Diabetic Neuropathic Ulcer|lower extremity diabetic neuropathic ulcer
447707|NCT01235234|Dry eye disease|dry eye disease
447708|NCT01235234|KCS|kcs
447709|NCT01235234|Aqueous Deficient Dry Eye|aqueous deficient dry eye
447710|NCT01235208|Overweight|overweight
447711|NCT01235208|Obesity|obesity
447712|NCT01235208|Metabolic syndrome|metabolic syndrome
447713|NCT01235208|Diet|diet
447714|NCT01235208|Carbohydrate|carbohydrate
447715|NCT01235208|Low glycemic index|low glycemic index
447716|NCT01235208|Eurodiet|eurodiet
447717|NCT01235195|bioequivalence study|bioequivalence study
447718|NCT01235195|sertraline 50 mg|sertraline 50 mg
447719|NCT01235195|capsules vs tablets|capsules vs tablets
447720|NCT01235182|acute dyspnea|acute dyspnea
447721|NCT01235182|prehospital emergency setting|prehospital emergency setting
447722|NCT01235182|differential diagnosis|differential diagnosis
447723|NCT01235182|ultrasound|ultrasound
447724|NCT01235182|NT-proBNP|nt-probnp
447725|NCT01235156|Premature ventricular contraction|premature ventricular contraction
447823|NCT01234649|type 2 diabetes mellitus|type 2 diabetes mellitus
448207|NCT01232920|uveitis|uveitis
447726|NCT01235156|Frequent premature ventricular contraction, with or without a short array of non-sustained ventricular tachycardia|frequent premature ventricular contraction, with or without a short array of non-sustained ventricular tachycardia
447727|NCT01235143|incidence|incidence
447728|NCT01235143|emergence agitation|emergence agitation
447729|NCT01235143|sevoflurane|sevoflurane
447730|NCT01235143|desflurane|desflurane
447731|NCT01235143|ambulatory pediatric surgery|ambulatory pediatric surgery
447732|NCT01235117|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
447733|NCT01235091|HIV prevention|hiv prevention
447734|NCT01235091|substance abuse|substance abuse
447735|NCT01235091|high risk behaviors|high risk behaviors
447736|NCT01235091|peer intervention|peer intervention
447737|NCT01235065|airway management|airway management
447738|NCT01235065|trauma|trauma
447739|NCT01235065|intubation|intubation
447740|NCT01235052|Head and neck neoplasms|head and neck neoplasms
447741|NCT01235052|Positron Emission Tomography|positron emission tomography
447742|NCT01235052|F18 fluoromisonidazole|f18 fluoromisonidazole
447743|NCT01235026|Obesity|obesity
447744|NCT01235026|Type-2 Diabetes|type-2 diabetes
447745|NCT01235026|Metabolic syndrome|metabolic syndrome
447746|NCT01235026|Low grade inflammation|low grade inflammation
447747|NCT01235026|Metabolic endotoxinemia|metabolic endotoxinemia
447748|NCT01235026|Insulin resistance|insulin resistance
447749|NCT01235026|Lipopolysaccharide|lipopolysaccharide
447750|NCT01235026|LPS-binding protein|lps-binding protein
447751|NCT01235026|sCD14|scd14
447752|NCT01235026|Synbiotic|synbiotic
447753|NCT01235026|Oligofructose|oligofructose
447754|NCT01235026|Bifidobacterium animalis subsp. lactis Bb12|bifidobacterium animalis subsp. lactis bb12
447755|NCT01235026|probiotic|probiotic
447756|NCT01235026|Prebiotic|prebiotic
447757|NCT01235013|HIV-1 infection|hiv-1 infection
447758|NCT01235013|Maraviroc|maraviroc
447759|NCT01235013|CD4 lymphocyte count|cd4 lymphocyte count
447760|NCT01235000|Influenza vaccines|influenza vaccines
447761|NCT01235000|Infant|infant
447762|NCT01235000|Dose-Response relationship, immunologic|dose-response relationship, immunologic
447763|NCT01235000|Prime-boost response|prime-boost response
447764|NCT01234987|Cancer|cancer
447765|NCT01234987|Breast Cancer|breast cancer
447766|NCT01234987|Colon cancer|colon cancer
447767|NCT01234987|Lung Cancer|lung cancer
447768|NCT01234974|multiple myeloma|multiple myeloma
447769|NCT01234948|Halitosis|halitosis
447770|NCT01234948|VSC|vsc
447771|NCT01234948|Periodontitis|periodontitis
447772|NCT01234948|Gingivitis|gingivitis
447773|NCT01234948|Putative periodontal pathogens|putative periodontal pathogens
447774|NCT01234948|Real-time PCR|real-time pcr
447775|NCT01234909|Missed immunizations|missed immunizations
447776|NCT01234896|Smoking Cessation, Nicotine pharmacokinetics|smoking cessation, nicotine pharmacokinetics
447777|NCT01234883|dehydration|dehydration
447778|NCT01234883|gastroenteritis|gastroenteritis
447779|NCT01234870|Myocardial Perfusion Imaging|myocardial perfusion imaging
447780|NCT01234870|Magnetic Resonance Imaging|magnetic resonance imaging
447781|NCT01234857|mTOR|mtor
447782|NCT01234857|breast cancer|breast cancer
447783|NCT01234857|estrogen receptor positive|estrogen receptor positive
447784|NCT01234844|pet-therapy|pet-therapy
447785|NCT01234844|guinea-pigs|guinea-pigs
447786|NCT01234844|rehabilitation|rehabilitation
447787|NCT01234844|elderly|elderly
447788|NCT01234831|MRSA|mrsa
447789|NCT01234831|colonization|colonization
447790|NCT01234831|nucleic acid amplification|nucleic acid amplification
447791|NCT01234831|chromogenic agar|chromogenic agar
447792|NCT01234818|Endometrial hyperplasia|endometrial hyperplasia
447793|NCT01234818|LNG-IUS|lng-ius
447794|NCT01234792|Smoking Cessation, Nicotine pharmacokinetics|smoking cessation, nicotine pharmacokinetics
447795|NCT01234753|Adults with CHD|adults with chd
447796|NCT01234753|GUCH|guch
447797|NCT01234753|Congenital heart disease|congenital heart disease
447798|NCT01234753|Computer-based education|computer-based education
447799|NCT01234753|Nursing|nursing
447800|NCT01234740|Los Angeles|los angeles
447801|NCT01234727|diabetes, SMBG, glucose testing systems, accuracy|diabetes, smbg, glucose testing systems, accuracy
447802|NCT01234714|Fatty Liver|fatty liver
447803|NCT01234714|Liver|liver
447804|NCT01234714|Magnetic Resonance Imaging|magnetic resonance imaging
447805|NCT01234714|Surgery|surgery
447806|NCT01234701|Liver|liver
447807|NCT01234701|Neoplasms|neoplasms
447808|NCT01234701|Magnetic Resonance Imaging|magnetic resonance imaging
447809|NCT01234701|Surgery|surgery
447810|NCT01234701|Pathology|pathology
447811|NCT01234688|Exercise Tolerance|exercise tolerance
447812|NCT01234688|Physical Endurance|physical endurance
447813|NCT01234675|Fibromyalgia|fibromyalgia
447814|NCT01234675|Sleep disorders|sleep disorders
447815|NCT01234675|Forest Laboratories|forest laboratories
447816|NCT01234675|Milnacipran|milnacipran
447817|NCT01234662|Elective cesarean sections|elective cesarean sections
447818|NCT01234662|Postoperative pain level|postoperative pain level
447819|NCT01234662|Spinal anesthesia|spinal anesthesia
447820|NCT01234662|Combined spinal epidural anesthesia|combined spinal epidural anesthesia
447821|NCT01234662|Epidural catheter|epidural catheter
447822|NCT01234649|gestational diabetes mellitus|gestational diabetes mellitus
447824|NCT01234649|metabolic dysfunction|metabolic dysfunction
447825|NCT01234649|impaired fasting glucose|impaired fasting glucose
447826|NCT01234649|impaired glucose tolerance|impaired glucose tolerance
447827|NCT01234649|incretin mimetic|incretin mimetic
447828|NCT01234636|Platelets|platelets
447829|NCT01234636|Platelet aggregation|platelet aggregation
447830|NCT01234636|Platelet activation|platelet activation
447831|NCT01234636|Platelet function|platelet function
447832|NCT01234636|Light transmission aggregometry|light transmission aggregometry
447833|NCT01234636|Flow cytometry|flow cytometry
447834|NCT01234636|Platelet function analyzer-100 (PFA-100)|platelet function analyzer-100 (pfa-100)
447835|NCT01234636|Linoleic acid, conjugated|linoleic acid, conjugated
447836|NCT01234636|cis9, trans11 conjugated linoleic acid|cis9, trans11 conjugated linoleic acid
447837|NCT01234636|dietary supplement|dietary supplement
447838|NCT01234636|short-term intervention|short-term intervention
447839|NCT01234623|Umbilical cord serum, eyedrops, GVHD, SS-I, corneal healing|umbilical cord serum, eyedrops, gvhd, ss-i, corneal healing
447840|NCT01234610|Exercise|exercise
447841|NCT01234610|Aortic aneurysm|aortic aneurysm
447842|NCT01234610|Feasibility|feasibility
447843|NCT01234610|Vascular disease|vascular disease
447844|NCT01234571|Pulmonary hypertension|pulmonary hypertension
447845|NCT01234571|Remodulin (Treprostenil sodium)|remodulin (treprostenil sodium)
447846|NCT01234571|End-stage renal disease|end-stage renal disease
447847|NCT01234571|Hemo-dialysis|hemo-dialysis
447848|NCT01234558|depression|depression
447849|NCT01234558|NMDA antagonist|nmda antagonist
447850|NCT01234558|treatment resistant|treatment resistant
447851|NCT01234519|ureter cancer|ureter cancer
447852|NCT01234519|renal pelvis cancer|renal pelvis cancer
447853|NCT01234519|bladder cancer|bladder cancer
447854|NCT01234519|urethra|urethra
447855|NCT01234506|long term care|long term care
447856|NCT01234506|lignans|lignans
447857|NCT01234506|oxidative stress|oxidative stress
447858|NCT01234506|inflammation|inflammation
447859|NCT01234506|aging|aging
447860|NCT01234506|dementia|dementia
447861|NCT01234506|postural balance|postural balance
447862|NCT01234506|depression|depression
447863|NCT01234506|muscle weakness|muscle weakness
447864|NCT01234506|quality of life|quality of life
447865|NCT01234506|pain|pain
447866|NCT01234493|ankle; fracture; syndesmosis;|ankle; fracture; syndesmosis;
447867|NCT01234467|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
447868|NCT01234467|Elderly|elderly
447869|NCT01234467|Newly Diagnosed|newly diagnosed
447870|NCT01234467|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
447871|NCT01234467|University of North Carolina|university of north carolina
447872|NCT01234467|Bendamustine|bendamustine
447873|NCT01234467|Rituximab|rituximab
447874|NCT01234467|Rituxan|rituxan
447875|NCT01234467|Treanda|treanda
447876|NCT01234467|Phase 2|phase 2
447877|NCT01234467|Geriatric|geriatric
447878|NCT01234467|Lymphoma|lymphoma
447879|NCT01234428|laparoscopy|laparoscopy
447880|NCT01234428|adjustable gastric banding|adjustable gastric banding
447881|NCT01234428|morbid obesity|morbid obesity
447882|NCT01234428|esophageal motility|esophageal motility
447883|NCT01234428|esophageal dilatation|esophageal dilatation
447884|NCT01234415|nasal|nasal
447885|NCT01234415|septum|septum
447886|NCT01234415|reconstruction|reconstruction
447887|NCT01234402|Breast Cancer|breast cancer
447888|NCT01234363|Renal allograft|renal allograft
447889|NCT01234363|kidney|kidney
447890|NCT01234363|fibrosis|fibrosis
447891|NCT01234363|elastography|elastography
447892|NCT01234363|elasticity|elasticity
447893|NCT01234337|Breast Cancer|breast cancer
447894|NCT01234337|HER2-neu|her2-neu
447895|NCT01234324|Stomach Neoplasms|stomach neoplasms
447896|NCT01234324|Gastroesophageal Junction Neoplasms|gastroesophageal junction neoplasms
447897|NCT01234324|gastric cancer|gastric cancer
447898|NCT01234324|cancer of the gastroesophageal junction|cancer of the gastroesophageal junction
447899|NCT01234285|sepsis|sepsis
447900|NCT01234285|septic shock|septic shock
447901|NCT01234285|anticoagulation|anticoagulation
447902|NCT01234285|intensive care unit|intensive care unit
447903|NCT01234272|patients with|patients with
447904|NCT01234272|undergoing|undergoing
447905|NCT01234272|gastrectomy|gastrectomy
447906|NCT01234259|Wrinkles|wrinkles
447907|NCT01234259|rhytides|rhytides
447908|NCT01234259|Cellulite|cellulite
447909|NCT01234259|circumference reduction|circumference reduction
447910|NCT01234246|Colorectal cancer|colorectal cancer
447911|NCT01234246|Sexual function|sexual function
447912|NCT01234246|Sexual dysfunction|sexual dysfunction
447913|NCT01234246|Quality of (sexual) life|quality of (sexual) life
447914|NCT01234246|Partners|partners
447915|NCT01234246|Body image|body image
447916|NCT01234246|Anxiety (state and trait)|anxiety (state and trait)
447917|NCT01234246|Depressive symptoms|depressive symptoms
447918|NCT01234246|Personality|personality
447919|NCT01234233|hypothermia, accidental|hypothermia, accidental
447920|NCT01234233|prewarming|prewarming
447921|NCT01234233|body temperature monitoring|body temperature monitoring
447922|NCT01234233|preoperative warming|preoperative warming
448206|NCT01232933|PICC|picc
447923|NCT01234233|sublingual temperature assessment|sublingual temperature assessment
447924|NCT01234233|tympanic temperature assessment|tympanic temperature assessment
447925|NCT01234220|Aldosterone|aldosterone
447926|NCT01234220|Primary Aldosteronism|primary aldosteronism
447927|NCT01234220|Aldosterone Producing Adenoma (APA)|aldosterone producing adenoma (apa)
447928|NCT01234220|Idiopathic Adrenal Hyperplasia (IHA)|idiopathic adrenal hyperplasia (iha)
447929|NCT01234220|Adrenal Venous Sampling|adrenal venous sampling
447930|NCT01234207|Progressive addition lenses|progressive addition lenses
447931|NCT01234207|Customized free-form|customized free-form
447932|NCT01234207|Presbyopia|presbyopia
447933|NCT01234207|Bifocals|bifocals
447934|NCT01234207|Subjective assessment|subjective assessment
447935|NCT01234207|Visual performance|visual performance
447936|NCT01234207|Visual acuity|visual acuity
447937|NCT01234207|Amsler grid|amsler grid
447938|NCT01234194|Composite Variability Index|composite variability index
447939|NCT01234194|Bispectral Index|bispectral index
447940|NCT01234194|Electromyography|electromyography
447941|NCT01234194|Nociception|nociception
447942|NCT01234194|Pain|pain
447943|NCT01234155|Exercise|exercise
447944|NCT01234155|Diabetes|diabetes
447945|NCT01234155|Obesity|obesity
447946|NCT01234155|Insulin Sensitivity|insulin sensitivity
447947|NCT01234155|Insulin Secretion|insulin secretion
447948|NCT01234155|Beta-cell Function|beta-cell function
447949|NCT01234155|Glycemic Control|glycemic control
447950|NCT01234155|GIP|gip
447951|NCT01234155|GLP-1|glp-1
447952|NCT01234142|varenicline transdermal percutaneous transcutaneous transdermal delivery system patch|varenicline transdermal percutaneous transcutaneous transdermal delivery system patch
447953|NCT01234129|multiple myeloma|multiple myeloma
447954|NCT01234129|stem cell transplant|stem cell transplant
447955|NCT01234129|zoledronic acid|zoledronic acid
447956|NCT01234116|Post exposure prophylaxis|post exposure prophylaxis
447957|NCT01234116|Health Care Workers|health care workers
447958|NCT01234103|sexually transmitted infection|sexually transmitted infection
447959|NCT01234103|sexual risk|sexual risk
447960|NCT01234103|HIV|hiv
447961|NCT01234103|young adults|young adults
447962|NCT01234103|cognitive-behavioral intervention|cognitive-behavioral intervention
447963|NCT01234090|Aphasia|aphasia
447964|NCT01234090|Quality of Life|quality of life
447965|NCT01234077|scheduled for a polysomnogram (overnight sleep study)|scheduled for a polysomnogram (overnight sleep study)
447966|NCT01234064|Symptomatic Venous Thromboembolism|symptomatic venous thromboembolism
447967|NCT01234064|Graduated Compression Stockings|graduated compression stockings
447968|NCT01234064|Randomized Controlled Trial|randomized controlled trial
447969|NCT01234064|Noncardiac Surgery|noncardiac surgery
447970|NCT01234038|Non-small cell lung cancer|non-small cell lung cancer
447971|NCT01234025|Castrate-Resistant Prostate Cancer|castrate-resistant prostate cancer
447972|NCT01234012|melanoma|melanoma
447973|NCT01234012|breast cancer|breast cancer
447974|NCT01234012|ovarian cancer|ovarian cancer
447975|NCT01234012|prostate cancer|prostate cancer
447976|NCT01234012|esophageal cancer|esophageal cancer
447977|NCT01234012|uterine cancer|uterine cancer
447978|NCT01234012|sarcoma|sarcoma
447979|NCT01234012|NY-ESO-1|ny-eso-1
447980|NCT01233999|Scleroderma|scleroderma
447981|NCT01233999|Raynaud's Syndrome|raynaud's syndrome
447982|NCT01233986|Acute Ischemic Stroke|acute ischemic stroke
447983|NCT01233986|Atherosclerosis|atherosclerosis
447984|NCT01233986|Apolipoprotein B48|apolipoprotein b48
447985|NCT01233973|nursing home|nursing home
447986|NCT01233973|advance care planning|advance care planning
447987|NCT01233960|Crohn's Disease|crohn's disease
447988|NCT01233960|Adult Stem Cell Therapy|adult stem cell therapy
447989|NCT01233960|inflammation of the gastrointestinal tract|inflammation of the gastrointestinal tract
447990|NCT01233934|Insect bites|insect bites
447991|NCT01233934|Dexchlorpheniramine|dexchlorpheniramine
447992|NCT01233934|Gel|gel
447993|NCT01233934|Cream|cream
447994|NCT01233882|Renal impairment|renal impairment
447995|NCT01233882|healthy volunteers|healthy volunteers
447996|NCT01233869|Bosutinib|bosutinib
447997|NCT01233869|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
447998|NCT01233856|ADHD|adhd
447999|NCT01233843|induction chemotherapy|induction chemotherapy
448000|NCT01233843|followed by irradiation and concurrent Erbitux, or radiochemotherapy|followed by irradiation and concurrent erbitux, or radiochemotherapy
448001|NCT01233830|safety, tolerability, pharmacokinetics, AZD2423, Japanese|safety, tolerability, pharmacokinetics, azd2423, japanese
448002|NCT01233817|Spinal muscular atrophy|spinal muscular atrophy
448003|NCT01233817|Neuromuscular disorder|neuromuscular disorder
448004|NCT01233817|Progressive strength training|progressive strength training
448005|NCT01233817|Children|children
448006|NCT01233804|influenza vaccination rates|influenza vaccination rates
448007|NCT01233791|high tone pelvic floor dysfunction|high tone pelvic floor dysfunction
448008|NCT01233791|levator pain|levator pain
448009|NCT01233791|dyspareunia|dyspareunia
448010|NCT01233778|Cardiovascular disease|cardiovascular disease
448011|NCT01233778|Omega-3 fatty acids|omega-3 fatty acids
448012|NCT01233778|Inflammation|inflammation
448013|NCT01233778|Endothelial function|endothelial function
448014|NCT01233778|Canola oil|canola oil
448015|NCT01233765|Periodontitis|periodontitis
448016|NCT01233765|Neutrophil|neutrophil
448017|NCT01233765|Inflammation|inflammation
448018|NCT01233752|systemic morphine analgesia|systemic morphine analgesia
448019|NCT01233752|pharmacogenetics|pharmacogenetics
448020|NCT01233752|pharmacokinetics|pharmacokinetics
448021|NCT01233739|rhizarthrosis|rhizarthrosis
448022|NCT01233739|Chondroitin sulfate|chondroitin sulfate
448023|NCT01233739|Placebo|placebo
448024|NCT01233726|Critical illness|critical illness
448025|NCT01233726|Hyperglycemia|hyperglycemia
448026|NCT01233726|Mechanical Ventilation|mechanical ventilation
448027|NCT01233726|Enteral nutrition|enteral nutrition
448028|NCT01233726|T-Diet plus Diabet IR|t-diet plus diabet ir
448029|NCT01233726|Malnutrition|malnutrition
448030|NCT01233726|Insulin resistance|insulin resistance
448031|NCT01233726|Metabolic stress|metabolic stress
448032|NCT01233713|Emergency Surgery|emergency surgery
448033|NCT01233713|Bowel perforation|bowel perforation
448034|NCT01233713|Diverticulitis|diverticulitis
448035|NCT01233713|Neoplasms|neoplasms
448036|NCT01233713|Postoperative Complications|postoperative complications
448037|NCT01233713|Randomized Controlled Trial|randomized controlled trial
448038|NCT01233700|living donation|living donation
448039|NCT01233700|organ donation|organ donation
448040|NCT01233700|psychological adaptation|psychological adaptation
448041|NCT01233700|mental health|mental health
448042|NCT01233700|physical well-being|physical well-being
448043|NCT01233700|interpersonal relations|interpersonal relations
448044|NCT01233700|quality of life|quality of life
448045|NCT01233700|psychosocial factors|psychosocial factors
448046|NCT01233687|Recurrent|recurrent
448047|NCT01233687|progressive|progressive
448048|NCT01233687|advanced|advanced
448049|NCT01233648|heart failure|heart failure
448050|NCT01233648|CRT-D|crt-d
448051|NCT01233609|retinitis pigmentosa|retinitis pigmentosa
448052|NCT01233609|valproic acid|valproic acid
448053|NCT01233609|visual field|visual field
448054|NCT01233596|congenital nasolacrimal duct obstruction|congenital nasolacrimal duct obstruction
448055|NCT01233596|monocanalicular intubation|monocanalicular intubation
448056|NCT01233596|bicanalicular intubation|bicanalicular intubation
448057|NCT01233596|complications|complications
448058|NCT01233583|Regulatory T-cells, psoriasis, IL-10.|regulatory t-cells, psoriasis, il-10.
448059|NCT01233570|Cutaneous Crohns Disease|cutaneous crohns disease
448060|NCT01233570|Topical Tacrolimus|topical tacrolimus
448061|NCT01233570|Protopic|protopic
448062|NCT01233570|Metastatic Crohns Disease|metastatic crohns disease
448063|NCT01233570|Pyoderma Gangrenosum|pyoderma gangrenosum
448064|NCT01233570|Granulomatous chelitis|granulomatous chelitis
448065|NCT01233570|Oral crohns disease|oral crohns disease
448066|NCT01233570|Perianal crohns disease|perianal crohns disease
448067|NCT01233544|Colorectal carcinoma|colorectal carcinoma
448068|NCT01233544|Liver metastases|liver metastases
448069|NCT01233544|Stereotactic body radiation therapy|stereotactic body radiation therapy
448070|NCT01233544|Radiofrequency ablation|radiofrequency ablation
448071|NCT01233518|CCTA Coronary Artery Disease CAD|ccta coronary artery disease cad
448072|NCT01233492|adult glioblastoma|adult glioblastoma
448073|NCT01233492|adult giant cell glioblastoma|adult giant cell glioblastoma
448074|NCT01233492|adult gliosarcoma|adult gliosarcoma
448075|NCT01233479|untreated childhood medulloblastoma|untreated childhood medulloblastoma
448076|NCT01233479|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
448077|NCT01233479|untreated childhood cerebral astrocytoma|untreated childhood cerebral astrocytoma
448078|NCT01233479|untreated childhood brain stem glioma|untreated childhood brain stem glioma
448079|NCT01233479|childhood medulloepithelioma|childhood medulloepithelioma
448080|NCT01233479|childhood infratentorial ependymoma|childhood infratentorial ependymoma
448081|NCT01233479|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
448082|NCT01233479|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
448083|NCT01233414|Pervasive Developmental Disorder|pervasive developmental disorder
448084|NCT01233414|Autism|autism
448085|NCT01233414|Children|children
448086|NCT01233414|Behavior Therapy|behavior therapy
448087|NCT01233414|Aggression|aggression
448088|NCT01233414|Tantrums|tantrums
448089|NCT01233414|Noncompliance|noncompliance
448090|NCT01233401|Pertussis, Vaccination, Adult|pertussis, vaccination, adult
448091|NCT01233375|cancer|cancer
448092|NCT01233375|metastatic|metastatic
448093|NCT01233375|pancreatic|pancreatic
448094|NCT01233375|pancreas|pancreas
448095|NCT01233375|adenocarcinoma|adenocarcinoma
448096|NCT01233375|gemcitabine|gemcitabine
448097|NCT01233375|human equilibrative nucleoside transporter-1 (hENT1)|human equilibrative nucleoside transporter-1 (hent1)
448098|NCT01233375|CO-1.01|co-1.01
448099|NCT01233375|CO-101|co-101
448100|NCT01233375|CO101|co101
448101|NCT01233375|Stage 4|stage 4
448102|NCT01233375|Stage IV|stage iv
448103|NCT01233375|Gemcitabine-Refractory|gemcitabine-refractory
448104|NCT01233375|Second-Line Therapy|second-line therapy
448105|NCT01233362|Cholera|cholera
448106|NCT01233362|Vaccine|vaccine
448107|NCT01233362|Kolkata|kolkata
448108|NCT01233362|West Bengal|west bengal
448109|NCT01233362|India|india
448110|NCT01233362|Immunogenicity|immunogenicity
448111|NCT01233362|Vaccination Schedules|vaccination schedules
448112|NCT01233349|overweight|overweight
448113|NCT01233349|obesity|obesity
448114|NCT01233349|weight loss|weight loss
448115|NCT01233349|body fat|body fat
448116|NCT01233349|waist circumference|waist circumference
448117|NCT01233349|satiety|satiety
448118|NCT01233336|ACS,|acs,
448119|NCT01233336|HGF,|hgf,
448120|NCT01233336|myocardial infarction|myocardial infarction
448121|NCT01233336|markers of myocardial injury|markers of myocardial injury
448122|NCT01233336|acute coronary syndrome (ACS)|acute coronary syndrome (acs)
448123|NCT01233336|prognostic factors in patients with ACS|prognostic factors in patients with acs
448124|NCT01233323|Phrenic nerve stimulation|phrenic nerve stimulation
448125|NCT01233323|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
448126|NCT01233323|Heart Failure|heart failure
448127|NCT01233323|Heart Diseases|heart diseases
448128|NCT01233310|Crohn's Disease|crohn's disease
448129|NCT01233297|wheeze|wheeze
448130|NCT01233297|infections|infections
448131|NCT01233271|algorithm|algorithm
448132|NCT01233271|tight glycemic control|tight glycemic control
448133|NCT01233271|glucose control|glucose control
448134|NCT01233271|intensive care|intensive care
448135|NCT01233271|insulin|insulin
448136|NCT01233271|ICU|icu
448137|NCT01233258|Haemophilia treatment|haemophilia treatment
448138|NCT01233258|rFVIII|rfviii
448139|NCT01233245|Multiple Sclerosis|multiple sclerosis
448140|NCT01233245|Adherence|adherence
448141|NCT01233245|Interferon beta-1b|interferon beta-1b
448142|NCT01233245|Coping Styles|coping styles
448143|NCT01233232|Chronic Obstructive Pulmonary Disease, Neutrophil, Respiratory Disease|chronic obstructive pulmonary disease, neutrophil, respiratory disease
448144|NCT01233219|systemic morphine analgesia|systemic morphine analgesia
448145|NCT01233219|pharmacogenetics|pharmacogenetics
448146|NCT01233219|pharmacokinetics|pharmacokinetics
448147|NCT01233206|PCOS|pcos
448148|NCT01233206|Polycystic ovary syndrome|polycystic ovary syndrome
448149|NCT01233206|Cancelled cycles|cancelled cycles
448150|NCT01233206|OHSS|ohss
448151|NCT01233206|Infertility|infertility
448152|NCT01233193|Home blood pressure measurement|home blood pressure measurement
448153|NCT01233193|Pharmaceutical Services|pharmaceutical services
448154|NCT01233193|Medication adherence|medication adherence
448155|NCT01233193|hypertension management|hypertension management
448156|NCT01233193|Blood Pressure|blood pressure
448157|NCT01233180|neck pain|neck pain
448158|NCT01233180|massage|massage
448159|NCT01233180|hyperthermia, induced|hyperthermia, induced
448160|NCT01233180|touch perception|touch perception
448161|NCT01233180|randomized controlled trial|randomized controlled trial
448162|NCT01233167|dual antiplatelet therapy|dual antiplatelet therapy
448163|NCT01233167|sirolimus drug-eluting stent|sirolimus drug-eluting stent
448164|NCT01233167|major adverse cardiac events|major adverse cardiac events
448165|NCT01233167|bleeding|bleeding
448166|NCT01233141|peripheral artery disease stage IV (Fontaine's classification) or stage 5 and 6 (Rutherford's classification|peripheral artery disease stage iv (fontaine's classification) or stage 5 and 6 (rutherford's classification
448167|NCT01233102|liver Cirrhosis|liver cirrhosis
448168|NCT01233102|Mesenchymal stem cells|mesenchymal stem cells
448169|NCT01233102|Hepatic artery infusion|hepatic artery infusion
448170|NCT01233102|Intravenous infusion|intravenous infusion
448171|NCT01233089|Myopia|myopia
448172|NCT01233089|contact lenses|contact lenses
448173|NCT01233089|children|children
448174|NCT01233063|behavior change|behavior change
448175|NCT01233063|physical activity|physical activity
448176|NCT01233063|nutrition|nutrition
448177|NCT01233063|fruits and vegetables|fruits and vegetables
448178|NCT01233063|saturated fat|saturated fat
448179|NCT01233063|trans fat|trans fat
448180|NCT01233063|added sugars|added sugars
448181|NCT01233063|email|email
448182|NCT01233063|web|web
448183|NCT01233063|obesity|obesity
448184|NCT01233063|aging|aging
448185|NCT01233050|undergoing elective colon and /or rectal surgical procedures involving an abdominal incision|undergoing elective colon and /or rectal surgical procedures involving an abdominal incision
448186|NCT01233024|Adult|adult
448187|NCT01233024|Women|women
448188|NCT01233024|Dietary Fiber|dietary fiber
448189|NCT01233024|Satiety Response|satiety response
448190|NCT01233024|Food Intake|food intake
448191|NCT01233011|Intubating laryngeal airway|intubating laryngeal airway
448192|NCT01233011|Pediatric|pediatric
448193|NCT01233011|Observational study|observational study
448194|NCT01232998|Patient Satisfaction|patient satisfaction
448195|NCT01232985|Atopic Dermatitis|atopic dermatitis
448196|NCT01232985|Pruritus|pruritus
448197|NCT01232972|vitrification|vitrification
448198|NCT01232972|egg freezing|egg freezing
448199|NCT01232972|oocyte cryopreservation|oocyte cryopreservation
448200|NCT01232972|female fertility potential|female fertility potential
448201|NCT01232972|fertility preservation|fertility preservation
448202|NCT01232972|Fertility preservation, female|fertility preservation, female
448203|NCT01232959|Gallbladder removal|gallbladder removal
448204|NCT01232946|Diabetes|diabetes
448205|NCT01232946|Myocardial metabolism|myocardial metabolism
448208|NCT01232920|antimetabolite|antimetabolite
448209|NCT01232920|immunosuppressive|immunosuppressive
448210|NCT01232920|clinical trial|clinical trial
448211|NCT01232907|Spinal Cord Injury (SCI)|spinal cord injury (sci)
448212|NCT01232894|indacaterol|indacaterol
448213|NCT01232894|COPD|copd
448214|NCT01232894|Long-acting beta2-agonist (LABA)|long-acting beta2-agonist (laba)
448215|NCT01232868|Innate immunity|innate immunity
448216|NCT01232868|Adaptive immunity|adaptive immunity
448217|NCT01232868|Slu shot|slu shot
448218|NCT01232868|Elderly|elderly
448219|NCT01232855|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
448220|NCT01232855|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
448221|NCT01232855|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
448222|NCT01232855|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
448223|NCT01232855|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
448224|NCT01232855|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
448225|NCT01232855|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
448226|NCT01232842|adult acute myeloid leukemia|adult acute myeloid leukemia
448227|NCT01232842|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
448228|NCT01232803|Rectal Microbicides|rectal microbicides
448229|NCT01232803|Tenofovir|tenofovir
448230|NCT01232803|Rectal use|rectal use
448231|NCT01232803|Rectal mucosal damage|rectal mucosal damage
448232|NCT01232790|Schizophrenia|schizophrenia
448233|NCT01232790|working memory|working memory
448234|NCT01232790|N-Acetylcysteine|n-acetylcysteine
448235|NCT01232777|Retinopathy of Prematurity|retinopathy of prematurity
448236|NCT01232777|Bevacizumab|bevacizumab
448237|NCT01232777|Avastin|avastin
448238|NCT01232777|Vascular Endothelial Growth Factor|vascular endothelial growth factor
448239|NCT01232751|health|health
448240|NCT01232751|women|women
448241|NCT01232725|BSID III|bsid iii
448242|NCT01232725|Human Milk|human milk
448243|NCT01232725|Donor Human Milk|donor human milk
448244|NCT01232725|Preterm infant|preterm infant
448245|NCT01232725|Breastfeeding|breastfeeding
448246|NCT01232712|MUC1|muc1
448247|NCT01232712|ImMucin|immucin
448248|NCT01232712|Vaccine|vaccine
448249|NCT01232712|Multiple Myeloma|multiple myeloma
448250|NCT01232699|obesity|obesity
448251|NCT01232699|weight loss|weight loss
448252|NCT01232699|internet treatment|internet treatment
448253|NCT01232699|motivational interviewing|motivational interviewing
448254|NCT01232686|Communicable Diseases|communicable diseases
448255|NCT01232686|Epidemiology|epidemiology
448256|NCT01232686|Population surveillance|population surveillance
448257|NCT01232686|Computerized Medical Record|computerized medical record
448258|NCT01232686|Data collection|data collection
448259|NCT01232673|Critical Limb Ischemia|critical limb ischemia
448260|NCT01232673|Bone-Marrow Aspiration Concentrate|bone-marrow aspiration concentrate
448261|NCT01232673|Diabetes Mellitus|diabetes mellitus
448262|NCT01232673|Major Amputation|major amputation
448263|NCT01232647|osteoporosis|osteoporosis
448264|NCT01232647|vitamin K|vitamin k
448265|NCT01232647|BONE MINERAL DENSITY|bone mineral density
448266|NCT01232647|BIOCHEMICAL MARKERS OF BONE TURNOVER|biochemical markers of bone turnover
448267|NCT01232634|pediatrics|pediatrics
448268|NCT01232634|haemophilia|haemophilia
448269|NCT01232634|ultrasound|ultrasound
448270|NCT01232634|MRI|mri
448271|NCT01232634|arthropathy|arthropathy
448272|NCT01232608|Coronary Artery Disease|coronary artery disease
448273|NCT01232608|Atherosclerosis.|atherosclerosis.
448274|NCT01232608|Diabetes Mellitus, type 2|diabetes mellitus, type 2
448275|NCT01232608|Exercise|exercise
448276|NCT01232608|HbA1c|hba1c
448277|NCT01232608|Carotid Atherosclerotic Disease|carotid atherosclerotic disease
448278|NCT01232608|Inflammation|inflammation
448279|NCT01232595|Clostridium difficile,|clostridium difficile,
448280|NCT01232595|C. difficile,|c. difficile,
448281|NCT01232595|CDI,|cdi,
448282|NCT01232595|Clostridium difficile-associated disease,|clostridium difficile-associated disease,
448283|NCT01232595|CDAD,|cdad,
448284|NCT01232595|pseudomembranous colitis,|pseudomembranous colitis,
448285|NCT01232595|PMC,|pmc,
448286|NCT01232595|antibiotic-associated diarrhea|antibiotic-associated diarrhea
448287|NCT01232582|Lower back pain, Facets joints Osteoarthritis|lower back pain, facets joints osteoarthritis
448288|NCT01232556|inotuzumab ozogamicin|inotuzumab ozogamicin
448289|NCT01232556|aggressive Non-Hodgkin lymphoma|aggressive non-hodgkin lymphoma
448290|NCT01232556|diffuse large b-cell lymphoma|diffuse large b-cell lymphoma
448291|NCT01232556|relapsed/refractory lymphoma|relapsed/refractory lymphoma
448292|NCT01232543|Atopic Dermatitis|atopic dermatitis
448293|NCT01232530|Malria, ACT, Safety, Efficacy, pregarnancy|malria, act, safety, efficacy, pregarnancy
448294|NCT01232504|Allo-HSCT|allo-hsct
448295|NCT01232504|rhGM-CSF|rhgm-csf
448296|NCT01232504|Systemic fungal infection (SFI)|systemic fungal infection (sfi)
448297|NCT01232478|Cystic Fibrosis|cystic fibrosis
448298|NCT01232478|Adherence|adherence
448299|NCT01232478|Problem-Solving|problem-solving
448300|NCT01232478|Adolescents|adolescents
448301|NCT01232478|Education|education
448302|NCT01232478|Skills Remediation|skills remediation
448303|NCT01232465|sperm DNA integrity|sperm dna integrity
448304|NCT01232465|Toluidine blue assay (TBA)|toluidine blue assay (tba)
448305|NCT01232465|IVF outcome|ivf outcome
448306|NCT01232452|lung cancer|lung cancer
448307|NCT01232452|advanced|advanced
448308|NCT01232452|non-small cell|non-small cell
448309|NCT01232413|Thorough QT (TQT)|thorough qt (tqt)
448310|NCT01232413|ASP1941|asp1941
448311|NCT01232400|subarachnoid hemorrhage|subarachnoid hemorrhage
448312|NCT01232400|esmolol|esmolol
448313|NCT01232400|cardiac function|cardiac function
448314|NCT01232400|cardiac electrophysiology|cardiac electrophysiology
448315|NCT01232387|Fetomaternal hemorrhage|fetomaternal hemorrhage
448316|NCT01232387|neonatal anemia|neonatal anemia
448317|NCT01232387|perinatal epidemiology|perinatal epidemiology
448318|NCT01232387|Kleihauer-Betke|kleihauer-betke
448319|NCT01232387|flow cytometry|flow cytometry
448320|NCT01232374|Nimotuzumab|nimotuzumab
448321|NCT01232374|local advanced esophageal squamous cell carcinoma|local advanced esophageal squamous cell carcinoma
448322|NCT01232374|chemo-irradiation|chemo-irradiation
448323|NCT01232361|ADHD|adhd
448324|NCT01232361|HIV|hiv
448325|NCT01232361|Pharmacokinetics|pharmacokinetics
448326|NCT01232348|bronchial asthma|bronchial asthma
448327|NCT01232348|Symbicort|symbicort
448328|NCT01232335|bronchial asthma|bronchial asthma
448329|NCT01232335|Symbicort|symbicort
448330|NCT01232335|long term use,|long term use,
448331|NCT01232322|bronchial asthma|bronchial asthma
448332|NCT01232322|Pulmicort Respules|pulmicort respules
448333|NCT01232322|long term use|long term use
448334|NCT01232322|pediatrics|pediatrics
448335|NCT01232309|Arterial Health|arterial health
448336|NCT01232309|Fiber|fiber
448337|NCT01232309|Chitin-glucan|chitin-glucan
448338|NCT01232309|oxidized LDL|oxidized ldl
448339|NCT01232296|Hepatocellular Carcinoma|hepatocellular carcinoma
448340|NCT01232296|HCC|hcc
448341|NCT01232296|Liver cancer|liver cancer
448342|NCT01232296|Child Pugh A|child pugh a
448343|NCT01232296|HCC Stage C|hcc stage c
448344|NCT01232257|Chronic kidney disease|chronic kidney disease
448345|NCT01232257|Chronic kidney failure|chronic kidney failure
448346|NCT01232257|End stage kidney disease|end stage kidney disease
448347|NCT01232257|End stage renal disease|end stage renal disease
448348|NCT01232257|Hydrogen sulfide|hydrogen sulfide
448349|NCT01232257|N-acetylcysteine|n-acetylcysteine
448350|NCT01232257|Acetylcysteine|acetylcysteine
448351|NCT01232244|Incretin hormones|incretin hormones
448352|NCT01232244|Glucagon|glucagon
448353|NCT01232244|Satiety|satiety
448354|NCT01232244|Hunger|hunger
448355|NCT01232244|Energy expenditure|energy expenditure
448356|NCT01232231|methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
448357|NCT01232231|decolonization|decolonization
448358|NCT01232231|random allocation|random allocation
448359|NCT01232231|outpatient|outpatient
448360|NCT01232218|Cerebral Vascular Accident|cerebral vascular accident
448361|NCT01232218|Stroke|stroke
448362|NCT01232218|Hemiplegic|hemiplegic
448363|NCT01232218|Shoulder pain|shoulder pain
448364|NCT01232218|range of motion|range of motion
448365|NCT01232218|scapula|scapula
448366|NCT01232218|mobilization|mobilization
448367|NCT01232205|antioxidant supplementation|antioxidant supplementation
448368|NCT01232205|preeclampsia|preeclampsia
448369|NCT01232153|chest tube|chest tube
448370|NCT01232153|preoxygenation|preoxygenation
448371|NCT01232153|NIV|niv
448372|NCT01232153|out-of-hospital|out-of-hospital
448373|NCT01232153|patients needing tracheal chest tube managed by Medical Mobile Emergency rescue services|patients needing tracheal chest tube managed by medical mobile emergency rescue services
448374|NCT01232140|COPD|copd
448375|NCT01232140|exacerbation|exacerbation
448376|NCT01232140|antibiotic treatment|antibiotic treatment
448377|NCT01232140|CRP|crp
448378|NCT01232140|sputum|sputum
448379|NCT01232140|inflammation|inflammation
448380|NCT01232101|covered, uncovered, palliative treatment, stent|covered, uncovered, palliative treatment, stent
448381|NCT01232088|drug labelling|drug labelling
448382|NCT01232088|standardized drug syringe labelling|standardized drug syringe labelling
448383|NCT01232088|European ICU|european icu
448384|NCT01232075|Letrozole ,Clomiphene citrate , IUI,unexplained infertility|letrozole ,clomiphene citrate , iui,unexplained infertility
448385|NCT01232062|breast neoplasm|breast neoplasm
448386|NCT01232062|Neoplasm Metastasis|neoplasm metastasis
448387|NCT01232062|Drug Therapy|drug therapy
448388|NCT01232049|healthy volunteers|healthy volunteers
448389|NCT01232036|healthy volunteers|healthy volunteers
448390|NCT01232023|Indobufen|indobufen
448391|NCT01232023|healthy volunteers|healthy volunteers
448392|NCT01232010|SK-3530|sk-3530
448393|NCT01232010|renal impairment|renal impairment
448394|NCT01232010|healthy volunteers|healthy volunteers
448395|NCT01231997|Udenafil|udenafil
448396|NCT01231997|DA-8159|da-8159
448397|NCT01231997|renal impairment|renal impairment
448398|NCT01231997|healthy volunteers|healthy volunteers
448399|NCT01231984|diabetes|diabetes
448400|NCT01231984|obesity|obesity
448401|NCT01231984|hypoglycemia|hypoglycemia
448402|NCT01231984|hyperglycemia|hyperglycemia
448403|NCT01231984|pen needle|pen needle
448404|NCT01231971|amyloid|amyloid
448405|NCT01231971|plaques|plaques
448406|NCT01231971|neuroimaging|neuroimaging
448407|NCT01231971|biomarkers|biomarkers
448408|NCT01231971|cognition disorder|cognition disorder
448409|NCT01231971|early detection|early detection
448410|NCT01231971|Amnestic MCI|amnestic mci
448411|NCT01231971|pre-dementia|pre-dementia
448412|NCT01231971|dementia|dementia
448413|NCT01231971|Alzheimer's disease|alzheimer's disease
448414|NCT01231971|tau|tau
448415|NCT01231958|Puerto Rican; CVD; Hispanic; health disparities; allostatic load; diet|puerto rican; cvd; hispanic; health disparities; allostatic load; diet
448416|NCT01231945|Cervical Cancer|cervical cancer
448417|NCT01231945|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
448418|NCT01231945|Cervical Intraepithelial Neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
448419|NCT01231932|Fatigue|fatigue
448420|NCT01231932|Cancer|cancer
448421|NCT01231932|Cancer Therapy|cancer therapy
448422|NCT01231932|Cancer Treatment|cancer treatment
448423|NCT01231932|Gene Expression Patterns|gene expression patterns
448424|NCT01231893|human, spinal cord injury, olfactory ensheathing cells, transplantation|human, spinal cord injury, olfactory ensheathing cells, transplantation
448425|NCT01231880|Malaria|malaria
448426|NCT01231867|Coronary Heart Disease|coronary heart disease
448427|NCT01231867|Acute Coronary Syndrome|acute coronary syndrome
448428|NCT01231867|Drug interactions|drug interactions
448429|NCT01231867|Clopidogrel|clopidogrel
448430|NCT01231867|Proton Pump Inhibitors|proton pump inhibitors
448431|NCT01231867|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
448432|NCT01231854|atopic hand dermatitis|atopic hand dermatitis
448433|NCT01231854|Chronic hand dermatitis|chronic hand dermatitis
448434|NCT01231828|sleep|sleep
448435|NCT01231828|cirrhosis|cirrhosis
448436|NCT01231828|encephalopathy|encephalopathy
448437|NCT01231828|simulated driving|simulated driving
448438|NCT01231828|sleep disorders|sleep disorders
448439|NCT01231815|Heart transplantation|heart transplantation
448440|NCT01231789|cardiac surgery|cardiac surgery
448441|NCT01231789|RIPC|ripc
448442|NCT01231789|brain injury|brain injury
448443|NCT01231776|cardiopulmonary bypass|cardiopulmonary bypass
448444|NCT01231776|sleep|sleep
448445|NCT01231776|acupuncture|acupuncture
448446|NCT01231763|HIV prevention|hiv prevention
448447|NCT01231763|Vaginal film|vaginal film
448448|NCT01231763|Microbicide|microbicide
448449|NCT01231763|Administration, intravaginal|administration, intravaginal
448450|NCT01231737|Prophylasy|prophylasy
448451|NCT01231737|recurrent urinary tract infection|recurrent urinary tract infection
448452|NCT01231737|prulifloxacin|prulifloxacin
448453|NCT01231737|phosphomycin|phosphomycin
448454|NCT01231711|depression|depression
448455|NCT01231711|post traumatic stress syndrome|post traumatic stress syndrome
448456|NCT01231711|functional status|functional status
448457|NCT01231711|veteran|veteran
448458|NCT01231711|military|military
448459|NCT01231711|stigma|stigma
448460|NCT01231711|mental health self-efficacy|mental health self-efficacy
448461|NCT01231698|septic shock|septic shock
448462|NCT01231698|esmolol|esmolol
448463|NCT01231698|tachycardia|tachycardia
448464|NCT01231698|betablockers|betablockers
448465|NCT01231685|Liver fibrosis|liver fibrosis
448466|NCT01231685|HIV|hiv
448467|NCT01231685|Hepatitis C Virus|hepatitis c virus
448468|NCT01231685|Coinfection|coinfection
448469|NCT01231659|RAD001 (Everolimus)|rad001 (everolimus)
448470|NCT01231659|Letrozole|letrozole
448471|NCT01231659|Breast cancer|breast cancer
448472|NCT01231659|Metastatic Breast cancer|metastatic breast cancer
448473|NCT01231659|Estrogen receptor positive|estrogen receptor positive
448474|NCT01231659|Failure of Tamoxifen|failure of tamoxifen
448475|NCT01231659|Anastrozole or Examestane|anastrozole or examestane
448476|NCT01231646|Folate Receptor Autoantibodies|folate receptor autoantibodies
448477|NCT01231646|Epilepsy|epilepsy
448478|NCT01231646|Psychiatric conditions|psychiatric conditions
448479|NCT01231633|Macular Edema|macular edema
448480|NCT01231633|Central Retinal Vein Occlusion|central retinal vein occlusion
448481|NCT01231620|Seasonal Influenza|seasonal influenza
448482|NCT01231620|Pandemic|pandemic
448483|NCT01231620|Orthomyxoviridae Infections|orthomyxoviridae infections
448484|NCT01231620|Influenza|influenza
448485|NCT01231620|Influenza A Virus, H1N1 Subtype|influenza a virus, h1n1 subtype
448486|NCT01231620|Enzyme Inhibitors|enzyme inhibitors
448487|NCT01231620|Influenza, seasonal|influenza, seasonal
448488|NCT01231620|Respiratory Tract Diseases|respiratory tract diseases
448489|NCT01231620|Zanamivir|zanamivir
448490|NCT01231620|Pharmacologic Actions|pharmacologic actions
448491|NCT01231620|Antiviral Agents|antiviral agents
448492|NCT01231620|Anti-Infective Agents|anti-infective agents
448493|NCT01231620|H1N1|h1n1
448494|NCT01231620|Neuraminidase inhibitor|neuraminidase inhibitor
448495|NCT01231620|Influenza B virus|influenza b virus
448496|NCT01231594|BRAF Inhibitor|braf inhibitor
448497|NCT01231594|Cancer|cancer
448498|NCT01231594|Safety|safety
448499|NCT01231594|GSK2118436|gsk2118436
448791|NCT01230281|Antioxidant|antioxidant
448500|NCT01231594|BRAF mutation positive tumors|braf mutation positive tumors
448501|NCT01231568|food effect; high fat meal|food effect; high fat meal
448502|NCT01231568|GSK2118436|gsk2118436
448503|NCT01231568|pharmacokinetic|pharmacokinetic
448504|NCT01231568|particle size|particle size
448505|NCT01231568|BRAF inhibitor|braf inhibitor
448506|NCT01231568|BRAF positive tumor|braf positive tumor
448507|NCT01231555|antiretroviral|antiretroviral
448508|NCT01231555|HAART|haart
448509|NCT01231555|NNRTI|nnrti
448510|NCT01231555|emtricitabine|emtricitabine
448511|NCT01231555|Sexually Transmitted Disease|sexually transmitted disease
448512|NCT01231555|antiretroviral therapy (ART)-naive adults|antiretroviral therapy (art)-naive adults
448513|NCT01231555|Immunologic Deficiency Syndrome|immunologic deficiency syndrome
448514|NCT01231555|tenofovir|tenofovir
448515|NCT01231555|abacavir|abacavir
448516|NCT01231555|Retroviridae Infections|retroviridae infections
448517|NCT01231555|GSK2248761|gsk2248761
448518|NCT01231555|lamivudine|lamivudine
448519|NCT01231555|Acquired ImmunoDeficiency Syndrome (AIDS)|acquired immunodeficiency syndrome (aids)
448520|NCT01231555|HIV infection|hiv infection
448521|NCT01231555|efavirenz|efavirenz
448522|NCT01231542|GSK1349572|gsk1349572
448523|NCT01231542|pharmacokinetics|pharmacokinetics
448524|NCT01231542|dolutegravir|dolutegravir
448525|NCT01231542|integrase|integrase
448526|NCT01231542|rifabutin|rifabutin
448527|NCT01231542|rifampin|rifampin
448528|NCT01231516|ART-experienced|art-experienced
448529|NCT01231516|Integrase inhibitor|integrase inhibitor
448530|NCT01231516|Raltegravir|raltegravir
448531|NCT01231516|GSK1349572|gsk1349572
448532|NCT01231516|Integrase inhibitor naive|integrase inhibitor naive
448533|NCT01231503|Africa|africa
448534|NCT01231503|malaria vaccine|malaria vaccine
448535|NCT01231503|schedule|schedule
448536|NCT01231503|EPI|epi
448537|NCT01231503|Plasmodium falciparum|plasmodium falciparum
448538|NCT01231477|anaesthetic techniques, inhalation|anaesthetic techniques, inhalation
448539|NCT01231477|sevoflurane|sevoflurane
448540|NCT01231477|Cytokines|cytokines
448541|NCT01231477|Immune response|immune response
448542|NCT01231464|safety|safety
448543|NCT01231464|efficacy|efficacy
448544|NCT01231464|placebo|placebo
448545|NCT01231464|allergic rhinitis|allergic rhinitis
448546|NCT01231464|fluticasone furoate|fluticasone furoate
448547|NCT01231451|HIV Infection|hiv infection
448548|NCT01231438|Renal failure stage 3B|renal failure stage 3b
448549|NCT01231425|Back pain|back pain
448550|NCT01231425|cervicalgia|cervicalgia
448551|NCT01231425|dorsalgia|dorsalgia
448552|NCT01231425|lumbalgia|lumbalgia
448553|NCT01231425|acupuncture|acupuncture
448554|NCT01231386|Female Breast Cancer|female breast cancer
448555|NCT01231386|miRNA expression|mirna expression
448556|NCT01231386|Neoadjuvant/Adjuvant Treatment|neoadjuvant/adjuvant treatment
448557|NCT01231386|Locally and Inflammatory Breast Cancer|locally and inflammatory breast cancer
448558|NCT01231373|varicose veins|varicose veins
448559|NCT01231360|claudication|claudication
448560|NCT01231360|peripheral artery disease|peripheral artery disease
448561|NCT01231360|PAD|pad
448562|NCT01231347|pancreas|pancreas
448563|NCT01231347|gemcitabine|gemcitabine
448564|NCT01231347|metastatic|metastatic
448565|NCT01231347|jaundice|jaundice
448566|NCT01231321|Adalimumab added to inadequate standard anti-rheumatic therapy in patients with active Rheumatoid Arthritis|adalimumab added to inadequate standard anti-rheumatic therapy in patients with active rheumatoid arthritis
448567|NCT01231256|Quality of life|quality of life
448568|NCT01231256|preventive health consultation|preventive health consultation
448569|NCT01231256|General practice|general practice
448570|NCT01231256|resources|resources
448571|NCT01231256|life style|life style
448572|NCT01231243|tooth bleaching, bleaching agent, hydrogen peroxide|tooth bleaching, bleaching agent, hydrogen peroxide
448573|NCT01231230|asthma, corticosteroids, bronchodilator, airway blood flow|asthma, corticosteroids, bronchodilator, airway blood flow
448574|NCT01231204|Breast Cancer|breast cancer
448575|NCT01231204|Mastectomy|mastectomy
448576|NCT01231204|UCSD|ucsd
448577|NCT01231204|Surgery|surgery
448578|NCT01231204|PVB Catheter|pvb catheter
448579|NCT01231204|Paravertebral Catheter|paravertebral catheter
448580|NCT01231204|Breast Pain|breast pain
448581|NCT01231204|Mastectomy Pain|mastectomy pain
448582|NCT01231204|Postoperative Pain|postoperative pain
448583|NCT01231139|Brain Injury|brain injury
448584|NCT01231139|Temperature|temperature
448585|NCT01231139|Paracetamol|paracetamol
448586|NCT01231139|Phase 2|phase 2
448587|NCT01231139|TBI|tbi
448588|NCT01231126|Induced labor|induced labor
448589|NCT01231126|Misoprostol|misoprostol
448590|NCT01231126|Postpartum blood|postpartum blood
448591|NCT01231126|Erythrocyte indices|erythrocyte indices
448592|NCT01231126|Vaginal delivery|vaginal delivery
448593|NCT01231113|malaria,|malaria,
448594|NCT01231113|pregnancy,|pregnancy,
448595|NCT01231113|dihydroartemisinin-piperaquine,|dihydroartemisinin-piperaquine,
448596|NCT01231113|efficacy,|efficacy,
448597|NCT01231113|safety,|safety,
448598|NCT01231113|Ghana|ghana
448599|NCT01231087|energy expenditure|energy expenditure
448600|NCT01231087|morbid obesity|morbid obesity
448601|NCT01231087|bariatric surgery|bariatric surgery
448602|NCT01231087|nutritional follow-up|nutritional follow-up
448603|NCT01231074|obesity|obesity
448604|NCT01231074|weight gain|weight gain
448605|NCT01231074|metformin|metformin
448606|NCT01231074|psychotropic drugs|psychotropic drugs
448607|NCT01231061|spine metastasis|spine metastasis
448608|NCT01231061|SBRT|sbrt
448609|NCT01231061|Radiosurgery|radiosurgery
448610|NCT01231035|acute cardiac syndrome|acute cardiac syndrome
448611|NCT01231035|stent thrombosis|stent thrombosis
448612|NCT01231035|platelet function|platelet function
448613|NCT01231035|antiplatelet therapy|antiplatelet therapy
448614|NCT01231022|breast neoplasm|breast neoplasm
448615|NCT01231022|Neoplasm Metastasis|neoplasm metastasis
448616|NCT01231022|Stem Cells|stem cells
448617|NCT01231022|Drug-Induced Liver Injury|drug-induced liver injury
448618|NCT01230996|cervical adenocarcinoma|cervical adenocarcinoma
448619|NCT01230996|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
448620|NCT01230996|cervical squamous cell carcinoma|cervical squamous cell carcinoma
448621|NCT01230996|stage IB cervical cancer|stage ib cervical cancer
448622|NCT01230996|stage IIA cervical cancer|stage iia cervical cancer
448623|NCT01230996|stage IIB cervical cancer|stage iib cervical cancer
448624|NCT01230996|stage III cervical cancer|stage iii cervical cancer
448625|NCT01230996|stage IVA cervical cancer|stage iva cervical cancer
448626|NCT01230983|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
448627|NCT01230983|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
448628|NCT01230983|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
448629|NCT01230983|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
448630|NCT01230983|cardiac toxicity|cardiac toxicity
448631|NCT01230957|Clostridium difficile infection|clostridium difficile infection
448632|NCT01230957|Diarrhea|diarrhea
448633|NCT01230957|Pseudomembranous colitis|pseudomembranous colitis
448634|NCT01230957|Clostridium Difficile Toxoid Vaccine|clostridium difficile toxoid vaccine
448635|NCT01230957|ACAM-CDIFF™ vaccine|acam-cdiff™ vaccine
448636|NCT01230944|GERD|gerd
448637|NCT01230944|LNF|lnf
448638|NCT01230944|CNF|cnf
448639|NCT01230944|Laparoscopic Nissen fundoplication|laparoscopic nissen fundoplication
448640|NCT01230944|Open Nissen fundoplication|open nissen fundoplication
448641|NCT01230944|Antireflux surgery|antireflux surgery
448642|NCT01230931|Acetabulum|acetabulum
448643|NCT01230931|Fracture|fracture
448644|NCT01230931|Hemostatis|hemostatis
448645|NCT01230931|Vitagel|vitagel
448646|NCT01230931|Fibrin sealant|fibrin sealant
448647|NCT01230918|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
448648|NCT01230918|Acute Coronary Syndrome|acute coronary syndrome
448649|NCT01230918|Myocardial Fibrosis|myocardial fibrosis
448650|NCT01230918|Fibrogenesis|fibrogenesis
448651|NCT01230918|Intimal Hyperplasia|intimal hyperplasia
448652|NCT01230918|Sudden Death|sudden death
448653|NCT01230918|avB3 Integrin Expression|avb3 integrin expression
448654|NCT01230905|Androgen Suppression Therapy|androgen suppression therapy
448655|NCT01230905|Hormonal Toxicity|hormonal toxicity
448656|NCT01230905|Quantitative PET|quantitative pet
448657|NCT01230905|Myocardial blood flow|myocardial blood flow
448658|NCT01230905|Coronary blood flow reserve|coronary blood flow reserve
448659|NCT01230905|Endothelial dysfunction|endothelial dysfunction
448660|NCT01230905|Coronary Artery Disease|coronary artery disease
448661|NCT01230879|Aging lung|aging lung
448662|NCT01230879|Airway remodeling|airway remodeling
448663|NCT01230879|Airway segmentation|airway segmentation
448664|NCT01230879|Chest CT|chest ct
448665|NCT01230866|Proton Radiation Prostate Cancer|proton radiation prostate cancer
448666|NCT01230840|fiber|fiber
448667|NCT01230840|calcium|calcium
448668|NCT01230840|magnesium|magnesium
448669|NCT01230827|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
448670|NCT01230827|golimumab|golimumab
448671|NCT01230827|juvenile arthritis|juvenile arthritis
448672|NCT01230827|GO KIDS|go kids
448673|NCT01230827|anti TNF alpha medications|anti tnf alpha medications
448674|NCT01230827|juvenile psoriatic arthritis|juvenile psoriatic arthritis
448675|NCT01230814|Bacterial vaginosis, metronidazole, miconazole, vulvovaginal candidiasis, trichomonas vaginalis, women, Kenya|bacterial vaginosis, metronidazole, miconazole, vulvovaginal candidiasis, trichomonas vaginalis, women, kenya
448676|NCT01230788|ALL|all
448677|NCT01230788|Leukemia|leukemia
448678|NCT01230788|Rituximab|rituximab
448679|NCT01230788|Pediatrics|pediatrics
448680|NCT01230762|Dapoxetine, Orgasmic disorder|dapoxetine, orgasmic disorder
448681|NCT01230762|Premature ejaculation|premature ejaculation
448682|NCT01230762|Sexual dysfunction|sexual dysfunction
448683|NCT01230762|Sexual intercourse|sexual intercourse
448684|NCT01230762|Ejaculation|ejaculation
448685|NCT01230762|Erectile Dysfunction|erectile dysfunction
448686|NCT01230749|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
448687|NCT01230749|Diabetes Mellitus|diabetes mellitus
448688|NCT01230749|Hyperglycemia|hyperglycemia
448689|NCT01230749|JNJ-41443532|jnj-41443532
448690|NCT01230749|Pioglitazone|pioglitazone
448691|NCT01230749|Placebo|placebo
448692|NCT01230697|Advanced|advanced
448693|NCT01230697|hepatocarcinoma|hepatocarcinoma
448694|NCT01230684|CEUS|ceus
448695|NCT01230684|Endoleaks|endoleaks
448696|NCT01230684|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
448697|NCT01230658|prophylactic enoxaparin|prophylactic enoxaparin
448698|NCT01230658|Roux en Y gastric bypass surgery|roux en y gastric bypass surgery
448699|NCT01230632|assisted reproduction technology|assisted reproduction technology
448700|NCT01230632|Metabolic risk factors|metabolic risk factors
448701|NCT01230632|In Vitro Fertilisation|in vitro fertilisation
448702|NCT01230606|Percutaneous Intervention|percutaneous intervention
448703|NCT01230606|Percutaneous Coronary Intervention|percutaneous coronary intervention
448704|NCT01230606|Catheterization|catheterization
448705|NCT01230606|Coronary Catheterization|coronary catheterization
448706|NCT01230606|Same day Discharge|same day discharge
448707|NCT01230606|Next Day Discharge|next day discharge
448708|NCT01230606|Patient Satisfaction|patient satisfaction
448709|NCT01230606|Multi-Center|multi-center
448710|NCT01230606|Randomized|randomized
448711|NCT01230606|Low-risk PCI|low-risk pci
448712|NCT01230606|BlindedClosure device|blindedclosure device
448713|NCT01230606|Vascular closure device|vascular closure device
448714|NCT01230580|Protease Inhibitors|protease inhibitors
448715|NCT01230580|RNA virus infections|rna virus infections
448716|NCT01230580|Virus diseases|virus diseases
448717|NCT01230580|Sexually Transmitted Diseases viral|sexually transmitted diseases viral
448718|NCT01230580|Immune system diseases|immune system diseases
448719|NCT01230580|Anti-infective Agents|anti-infective agents
448720|NCT01230580|Drug resistance|drug resistance
448721|NCT01230567|Problem wounds|problem wounds
448722|NCT01230567|Non healing wounds|non healing wounds
448723|NCT01230567|BCC|bcc
448724|NCT01230567|SCC|scc
448725|NCT01230567|Vasculitis|vasculitis
448726|NCT01230554|contact lens|contact lens
448727|NCT01230541|Semen characteristics|semen characteristics
448728|NCT01230541|Erectile Dysfunction|erectile dysfunction
448729|NCT01230515|Oncology Pain Management in outpatient hospice setting|oncology pain management in outpatient hospice setting
448730|NCT01230502|immunosuppression|immunosuppression
448731|NCT01230502|anti-rejection|anti-rejection
448732|NCT01230502|immune tolerance|immune tolerance
448733|NCT01230476|Locally advanced nasopharyngeal carcinoma|locally advanced nasopharyngeal carcinoma
448734|NCT01230476|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
448735|NCT01230476|Chemoradiation|chemoradiation
448736|NCT01230476|Cetuximab|cetuximab
448737|NCT01230463|Pain, Postoperative|pain, postoperative
448738|NCT01230463|Ketorolac|ketorolac
448739|NCT01230463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
448740|NCT01230463|Intraoperative Care|intraoperative care
448741|NCT01230450|urodynamic urinary incontinence, sub-urethral tape|urodynamic urinary incontinence, sub-urethral tape
448742|NCT01230437|montelukast|montelukast
448743|NCT01230437|asthma|asthma
448744|NCT01230437|allergic rhinitis|allergic rhinitis
448745|NCT01230437|nasal epithelial cells|nasal epithelial cells
448746|NCT01230437|inflammatory mediators|inflammatory mediators
448747|NCT01230424|OA|oa
448748|NCT01230424|Knee arthritis|knee arthritis
448749|NCT01230424|MRI|mri
448750|NCT01230424|Steroid|steroid
448751|NCT01230411|Episodic migraine|episodic migraine
448752|NCT01230385|lersivirine|lersivirine
448753|NCT01230385|UK-453|uk-453
448754|NCT01230385|061|061
448755|NCT01230385|safety|safety
448756|NCT01230385|tolerability|tolerability
448757|NCT01230385|pharmacokinetics|pharmacokinetics
448758|NCT01230385|HIV|hiv
448759|NCT01230385|non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
448760|NCT01230385|NNRTI|nnrti
448761|NCT01230359|Autism|autism
448762|NCT01230359|Children|children
448763|NCT01230359|ASD|asd
448764|NCT01230359|Vitamin B6|vitamin b6
448765|NCT01230359|Magnesium|magnesium
448766|NCT01230320|Cost estimates|cost estimates
448767|NCT01230320|Complete Denture|complete denture
448768|NCT01230320|Dental Economics|dental economics
448769|NCT01230320|Dental Impression Technique|dental impression technique
448770|NCT01230320|Denture Retention|denture retention
448771|NCT01230320|Edentulous|edentulous
448772|NCT01230320|Edentulism|edentulism
448773|NCT01230320|Oral Health-Related Quality of Life|oral health-related quality of life
448774|NCT01230320|Patient Acceptance of Health Care|patient acceptance of health care
448775|NCT01230320|Patient Satisfaction|patient satisfaction
448776|NCT01230320|Quality of Health Care|quality of health care
448777|NCT01230320|Quality of Life|quality of life
448778|NCT01230307|Vitamin D|vitamin d
448779|NCT01230307|Systolic failure|systolic failure
448780|NCT01230307|Genomics|genomics
448781|NCT01230307|Biomarkers|biomarkers
448782|NCT01230307|Exercise|exercise
448783|NCT01230307|Quality of Life|quality of life
448784|NCT01230294|echocardiography of the right heart|echocardiography of the right heart
448785|NCT01230294|3D 4D echocardiography|3d 4d echocardiography
448786|NCT01230294|strain measurement|strain measurement
448787|NCT01230294|chronic heart failure|chronic heart failure
448788|NCT01230294|pulmonary hypertension|pulmonary hypertension
448789|NCT01230281|C3G|c3g
448790|NCT01230281|Oxidative stress|oxidative stress
448792|NCT01230281|Black bean|black bean
448793|NCT01230268|C3G|c3g
448794|NCT01230268|Oxidative stress|oxidative stress
448795|NCT01230268|Antioxidant|antioxidant
448796|NCT01230268|Mulberry|mulberry
448797|NCT01230255|intra-abdominal pressure|intra-abdominal pressure
448798|NCT01230255|intra-abdominal hypertension|intra-abdominal hypertension
448799|NCT01230255|abdominal compartment syndrome|abdominal compartment syndrome
448800|NCT01230255|open abdomen|open abdomen
448801|NCT01230255|percutaneous|percutaneous
448802|NCT01230242|Mirena|mirena
448803|NCT01230242|postplacental intrauterine device|postplacental intrauterine device
448804|NCT01230242|postpartum insertion|postpartum insertion
448805|NCT01230229|Intermittent claudication|intermittent claudication
448806|NCT01230229|Superficial femoral artery|superficial femoral artery
448807|NCT01230229|Stenting|stenting
448808|NCT01230229|Medical treatment|medical treatment
448809|NCT01230229|Quality of life|quality of life
448810|NCT01230216|coronary artery disease|coronary artery disease
448811|NCT01230216|hypertension|hypertension
448812|NCT01230190|infants|infants
448813|NCT01230190|adaptive immunology|adaptive immunology
448814|NCT01230190|atopic dermatitis|atopic dermatitis
448815|NCT01230190|probiotics|probiotics
448816|NCT01230151|Deep Brain Stimulation|deep brain stimulation
448817|NCT01230151|DBS|dbs
448818|NCT01230151|Parkinson's disease|parkinson's disease
448819|NCT01230151|PD|pd
448820|NCT01230151|Patients who have a preexisting Deep Brain Stimulation (DBS) system for the treatment of Parkinson's disease (PD)|patients who have a preexisting deep brain stimulation (dbs) system for the treatment of parkinson's disease (pd)
448821|NCT01230125|Inflammation|inflammation
448822|NCT01230125|Pain|pain
448823|NCT01230125|Ocular surgery|ocular surgery
448824|NCT01230099|Critical Illness|critical illness
448825|NCT01230099|Mechanical Ventilation|mechanical ventilation
448826|NCT01230099|Palliative Care|palliative care
448827|NCT01230099|Caregivers|caregivers
448828|NCT01230086|ICD|icd
448829|NCT01230086|DFT-testing|dft-testing
448830|NCT01230073|ICD|icd
448831|NCT01230073|Home-Monitoring|home-monitoring
448832|NCT01230073|Quality of life|quality of life
448833|NCT01230060|ocular surgery|ocular surgery
448834|NCT01230060|phacoemulsification|phacoemulsification
448835|NCT01230047|depression|depression
448836|NCT01230047|anxiety|anxiety
448837|NCT01230047|psychoeducation|psychoeducation
448838|NCT01230047|self-help|self-help
448839|NCT01230047|psychosocial|psychosocial
448840|NCT01230034|Imidapril, Ramipril, Hypertension, Type 2 diabetes mellitus, Microalbuminuria|imidapril, ramipril, hypertension, type 2 diabetes mellitus, microalbuminuria
448841|NCT01230008|primary mediastinal lymphoma|primary mediastinal lymphoma
448842|NCT01230008|radiotherapy|radiotherapy
448843|NCT01230008|chemotherapy|chemotherapy
448844|NCT01230008|rituximab|rituximab
448845|NCT01229969|falls, balance problems, gaming systems, balance assessments|falls, balance problems, gaming systems, balance assessments
448846|NCT01229956|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
448847|NCT01229956|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
448848|NCT01229956|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
448849|NCT01229930|cervical adenocarcinoma|cervical adenocarcinoma
448850|NCT01229930|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
448851|NCT01229930|cervical squamous cell carcinoma|cervical squamous cell carcinoma
448852|NCT01229930|recurrent cervical cancer|recurrent cervical cancer
448853|NCT01229930|stage IVB cervical cancer|stage ivb cervical cancer
448854|NCT01229930|stage IVA cervical cancer|stage iva cervical cancer
448855|NCT01229891|vitamin D fortification|vitamin d fortification
448856|NCT01229891|yogurt drink|yogurt drink
448857|NCT01229891|type 2 diabetes|type 2 diabetes
448858|NCT01229891|efficacy|efficacy
448859|NCT01229852|Fibromyalgia|fibromyalgia
448860|NCT01229852|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
448861|NCT01229852|Pain|pain
448862|NCT01229839|Carcinoma,Hepatocellular|carcinoma,hepatocellular
448863|NCT01229839|Liver Neoplasms|liver neoplasms
448864|NCT01229839|Therapeutic|therapeutic
448865|NCT01229839|Chemoembolization,|chemoembolization,
448866|NCT01229839|TACE|tace
448867|NCT01229839|pharmacokinetics|pharmacokinetics
448868|NCT01229839|Iodized Oil/administration & dosage|iodized oil/administration & dosage
448869|NCT01229839|polyvinyl alcohol|polyvinyl alcohol
448870|NCT01229839|Humans|humans
448871|NCT01229826|Uterine fibroids|uterine fibroids
448872|NCT01229826|Uterine leiomyomas|uterine leiomyomas
448873|NCT01229826|MR Elastography|mr elastography
448874|NCT01229826|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
448875|NCT01229826|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
448876|NCT01229813|Untreated|untreated
448877|NCT01229813|First line|first line
448878|NCT01229813|Chemotherapy|chemotherapy
448879|NCT01229813|Maintenance treatment|maintenance treatment
448880|NCT01229813|KRAS wt|kras wt
448881|NCT01229813|KRAS mutated|kras mutated
448882|NCT01229813|Anti-angiogenetic treatment|anti-angiogenetic treatment
448883|NCT01229813|Metronomic capecitabine|metronomic capecitabine
448884|NCT01229813|bevacizumab|bevacizumab
448885|NCT01229813|erlotinib|erlotinib
448886|NCT01229813|Translational research|translational research
448887|NCT01229800|Polyethylene Glycol, Sodium Phosphate, Bowel preparation, Efficacy|polyethylene glycol, sodium phosphate, bowel preparation, efficacy
448888|NCT01229787|asthma|asthma
448889|NCT01229787|allergies|allergies
448890|NCT01229787|obesity|obesity
448891|NCT01229761|HIV|hiv
448892|NCT01229761|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
448893|NCT01229761|Breast Feeding|breast feeding
448894|NCT01229761|Infant Mortality|infant mortality
448895|NCT01229761|Morbidity|morbidity
448896|NCT01229761|Botswana|botswana
448897|NCT01229761|Africa|africa
448898|NCT01229761|Infectious disease transmission, vertical|infectious disease transmission, vertical
448899|NCT01229761|adverse drug event|adverse drug event
448900|NCT01229735|levetiracetam|levetiracetam
448901|NCT01229735|topiramate|topiramate
448902|NCT01229735|epilepsy|epilepsy
448903|NCT01229735|partial seizures|partial seizures
448904|NCT01229722|adherence|adherence
448905|NCT01229722|reminders|reminders
448906|NCT01229722|text messages|text messages
448907|NCT01229722|SMS|sms
448908|NCT01229722|mHealth|mhealth
448909|NCT01229709|Tinnitus|tinnitus
448910|NCT01229709|Mindfulness|mindfulness
448911|NCT01229709|MBSR|mbsr
448912|NCT01229709|Mindfulness Based Stress Reduction|mindfulness based stress reduction
448913|NCT01229709|MBTR|mbtr
448914|NCT01229696|Popliteal|popliteal
448915|NCT01229696|UCSD|ucsd
448916|NCT01229696|Postoperative pain|postoperative pain
448917|NCT01229696|Foot surgery|foot surgery
448918|NCT01229696|Ankle surgery|ankle surgery
448919|NCT01229696|Popliteal Catheter|popliteal catheter
448920|NCT01229696|Popliteal Nerve Block|popliteal nerve block
448921|NCT01229696|Lower extremity surgery|lower extremity surgery
448922|NCT01229696|Bifurcation|bifurcation
448923|NCT01229696|Catheter Insertion Site|catheter insertion site
448924|NCT01229683|UCSD|ucsd
448925|NCT01229683|Perineural Nerve Block|perineural nerve block
448926|NCT01229683|Shoulder Surgery|shoulder surgery
448927|NCT01229683|Pain|pain
448928|NCT01229683|Grip Strength|grip strength
448929|NCT01229683|Sensation|sensation
448930|NCT01229683|Interscalene Nerve Block|interscalene nerve block
448931|NCT01229670|Heart failure|heart failure
448932|NCT01229670|Hemorheology|hemorheology
448933|NCT01229670|Atherothrombosis|atherothrombosis
448934|NCT01229670|Angiogenesis|angiogenesis
448935|NCT01229657|Reopening of macular hole;|reopening of macular hole;
448936|NCT01229657|Visual acuity;|visual acuity;
448937|NCT01229657|Phacoemulsification cataract surgery;|phacoemulsification cataract surgery;
448938|NCT01229657|Vitrectomy|vitrectomy
448939|NCT01229644|Glioma|glioma
448940|NCT01229644|Brain Cancer|brain cancer
448941|NCT01229644|Recurrent glioma|recurrent glioma
448942|NCT01229644|Low grade glioma|low grade glioma
448943|NCT01229644|PDGFR Inhibitor|pdgfr inhibitor
448944|NCT01229644|Crenolanib (CP-868,596)|crenolanib (cp-868,596)
448945|NCT01229644|Neo-adjuvant Therapy|neo-adjuvant therapy
448946|NCT01229631|Periodontitis|periodontitis
448947|NCT01229631|Dietary supplementation|dietary supplementation
448948|NCT01229618|Prostate Cancer|prostate cancer
448949|NCT01229592|infection|infection
448950|NCT01229592|catheter|catheter
448951|NCT01229592|bacteriaemia|bacteriaemia
448952|NCT01229592|ethanol|ethanol
448953|NCT01229579|poliomyelitis|poliomyelitis
448954|NCT01229579|OPV|opv
448955|NCT01229579|zinc supplement|zinc supplement
448956|NCT01229579|diarrhea|diarrhea
448957|NCT01229579|placebo|placebo
448958|NCT01229579|double blind randomized control trial|double blind randomized control trial
448959|NCT01229579|elemental zinc|elemental zinc
448960|NCT01229579|seroconversion|seroconversion
448961|NCT01229579|bOPV|bopv
448962|NCT01229579|infants|infants
448963|NCT01229579|immunity|immunity
448964|NCT01229527|Colonoscopy|colonoscopy
448965|NCT01229527|Remifentanil|remifentanil
448966|NCT01229527|Sedation|sedation
448967|NCT01229514|Children|children
448968|NCT01229514|before|before
448969|NCT01229514|the age of 2 years|the age of 2 years
448970|NCT01229475|Atrial fibrillation|atrial fibrillation
448971|NCT01229475|recurrence|recurrence
448972|NCT01229475|repeat procedure|repeat procedure
448973|NCT01229475|linear ablation|linear ablation
448974|NCT01229475|stepwise approach|stepwise approach
448975|NCT01229449|Dental pain|dental pain
448976|NCT01229449|Ibuprofen|ibuprofen
448977|NCT01229449|Acetaminophen|acetaminophen
448978|NCT01229449|Nurofen Plus®|nurofen plus®
448979|NCT01229449|Panadeine® Extra|panadeine® extra
448980|NCT01229436|Dupuytren's|dupuytren's
448981|NCT01229436|treatment|treatment
448982|NCT01229436|injection|injection
448983|NCT01229436|recovery|recovery
448984|NCT01229436|health care resources|health care resources
448985|NCT01229397|Influenza|influenza
448986|NCT01229397|Virus|virus
448987|NCT01229397|Vaccination|vaccination
448988|NCT01229397|Immunisation|immunisation
448989|NCT01229371|Influenza|influenza
448990|NCT01229371|Virus|virus
448991|NCT01229371|Vaccination|vaccination
448992|NCT01229371|Immunisation|immunisation
448993|NCT01229358|vascular surgery|vascular surgery
448994|NCT01229358|wound infection|wound infection
448995|NCT01229358|wound complication|wound complication
448996|NCT01229332|Motor fluctuations levodopa pharmacokinetics carbidopa solution continuous|motor fluctuations levodopa pharmacokinetics carbidopa solution continuous
448997|NCT01229319|actinic keratosis, keratocytic lesion, keratoses, cryotherapy, imiquimod|actinic keratosis, keratocytic lesion, keratoses, cryotherapy, imiquimod
448998|NCT01229293|Mechanical muscle function|mechanical muscle function
448999|NCT01229293|Muscle strength|muscle strength
449000|NCT01229293|Hip replacement|hip replacement
449001|NCT01229293|Osteoarthritis|osteoarthritis
449002|NCT01229293|Hip arthroplasty|hip arthroplasty
449003|NCT01229280|Bioequivalence|bioequivalence
449004|NCT01229280|Darifenacin|darifenacin
449005|NCT01229280|Healthy volunteers|healthy volunteers
449006|NCT01229280|Postprandial|postprandial
449007|NCT01229267|Herpes zoster|herpes zoster
449008|NCT01229267|vaccine|vaccine
449009|NCT01229267|herpes zoster-related complications|herpes zoster-related complications
449010|NCT01229267|immunocompromised|immunocompromised
449011|NCT01229267|autologous hematopoietic cell transplants|autologous hematopoietic cell transplants
449012|NCT01229254|Betrixaban|betrixaban
449013|NCT01229254|MK-4448|mk-4448
449014|NCT01229254|nonvalvular atrial fibrillation|nonvalvular atrial fibrillation
449015|NCT01229241|local anesthetic|local anesthetic
449016|NCT01229241|epidural|epidural
449017|NCT01229241|pharmacokinetics|pharmacokinetics
449018|NCT01229241|plasmatic concentration|plasmatic concentration
449019|NCT01229241|epidural continuous infusion|epidural continuous infusion
449020|NCT01229202|trabeculectomy|trabeculectomy
449021|NCT01229202|glaucoma surgery|glaucoma surgery
449022|NCT01229202|bevacizumab|bevacizumab
449023|NCT01229202|Vascular Endothelial Growth Inhibitor|vascular endothelial growth inhibitor
449024|NCT01229202|glaucoma|glaucoma
449025|NCT01229189|Vitamin D|vitamin d
449026|NCT01229189|Effectiveness|effectiveness
449027|NCT01229189|Pregnant women and their neonates|pregnant women and their neonates
449028|NCT01229163|Motivational Incentive|motivational incentive
449029|NCT01229163|Automation|automation
449030|NCT01229163|Contingency Management|contingency management
449031|NCT01229163|Counseling Adherance|counseling adherance
449032|NCT01229150|Kinase Signal Transduction Pathway|kinase signal transduction pathway
449033|NCT01229150|Tumor Mutational Analysis|tumor mutational analysis
449034|NCT01229150|Tissue Immunohistochemistry|tissue immunohistochemistry
449035|NCT01229150|MIB-1 (Ki-67) Rate|mib-1 (ki-67) rate
449036|NCT01229150|PERK Level|perk level
449037|NCT01229150|Lung Cancer|lung cancer
449038|NCT01229150|Non-Small Cell Lung Cancer|non-small cell lung cancer
449039|NCT01229124|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
449040|NCT01229085|Psoriasis, mometasone, salicylic acid.|psoriasis, mometasone, salicylic acid.
449041|NCT01229072|Safety|safety
449042|NCT01229072|Non-inferiority|non-inferiority
449043|NCT01229059|FFA|ffa
449044|NCT01229059|insulin resistance|insulin resistance
449045|NCT01229059|mitochondria|mitochondria
449046|NCT01229046|presumed sepsis|presumed sepsis
449047|NCT01229033|Atrial fibrillation|atrial fibrillation
449048|NCT01229033|ablation|ablation
449049|NCT01229033|atrial flutter|atrial flutter
449050|NCT01229020|Emphysema|emphysema
449051|NCT01229020|COPD|copd
449052|NCT01229020|lung sounds|lung sounds
449053|NCT01229020|vibration response imaging|vibration response imaging
449054|NCT01229007|Hemophilia A|hemophilia a
449055|NCT01229007|Children|children
449056|NCT01228994|smoking cessation treatment|smoking cessation treatment
449057|NCT01228994|baclofen|baclofen
449058|NCT01228994|Smoking cessation counselling|smoking cessation counselling
449059|NCT01228968|obesity|obesity
449060|NCT01228942|ovarian cancer|ovarian cancer
449061|NCT01228942|fallopian tube cancer|fallopian tube cancer
449062|NCT01228942|primary peritoneal cancer|primary peritoneal cancer
449063|NCT01228929|Dry Eye|dry eye
449064|NCT01228929|Non-invasive instruments|non-invasive instruments
449065|NCT01228929|MGD|mgd
449066|NCT01228929|Environment|environment
449067|NCT01228929|Thermal Imaging|thermal imaging
449068|NCT01228916|tobacco|tobacco
449069|NCT01228916|smoking|smoking
449070|NCT01228916|secondhand smoke|secondhand smoke
449071|NCT01228903|uric acid kidney disease endothelial dysfunction|uric acid kidney disease endothelial dysfunction
449072|NCT01228851|Parkinson's Disease|parkinson's disease
449073|NCT01228851|Rehabilitation|rehabilitation
449074|NCT01228851|Balance|balance
449075|NCT01228851|Exercise|exercise
449076|NCT01228851|Parkinson's disease with balance deficits|parkinson's disease with balance deficits
449077|NCT01228851|H&Y 2.5-3|h&y 2.5-3
449078|NCT01228838|postherpetic neuralgia|postherpetic neuralgia
449079|NCT01228838|PHN|phn
449080|NCT01228838|capsaicin|capsaicin
449081|NCT01228838|herpes zoster|herpes zoster
449082|NCT01228838|shingles|shingles
449083|NCT01228838|analgesics|analgesics
449084|NCT01228838|neuropathy|neuropathy
449085|NCT01228825|Cardiac surgery|cardiac surgery
449086|NCT01228825|Cardiopulmonary bypass|cardiopulmonary bypass
449087|NCT01228825|Antibiotic prophylaxis|antibiotic prophylaxis
449088|NCT01228825|Cefuroxime|cefuroxime
449089|NCT01228812|Rheumatoid arthritis, physical activity|rheumatoid arthritis, physical activity
449090|NCT01228799|trabeculectomy,|trabeculectomy,
449091|NCT01228799|canaloplasty,|canaloplasty,
449092|NCT01228799|glaucoma surgery|glaucoma surgery
449093|NCT01228799|non-penetrating surgery|non-penetrating surgery
449094|NCT01228786|VDR, CaSR, PTH, Cyclin D1, Ki67, PCNA|vdr, casr, pth, cyclin d1, ki67, pcna
449095|NCT01228773|Cancer Survivors, Fatigue, web-based, tailored program|cancer survivors, fatigue, web-based, tailored program
449096|NCT01228760|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
449097|NCT01228760|ASG-5ME|asg-5me
449098|NCT01228760|Pharmacokinetics of ASG-5ME|pharmacokinetics of asg-5me
449099|NCT01228747|Levetiracetam|levetiracetam
449100|NCT01228747|epilepsy|epilepsy
449101|NCT01228747|generalized tonic-clonic|generalized tonic-clonic
449102|NCT01228734|Metastatic colorectal cancer|metastatic colorectal cancer
449103|NCT01228734|RAS wild type|ras wild type
449104|NCT01228734|Cetuximab|cetuximab
449105|NCT01228734|First line treatment|first line treatment
449106|NCT01228734|First occurrence of metastatic colorectal cancer in Chinese subjects with RAS wildtype|first occurrence of metastatic colorectal cancer in chinese subjects with ras wildtype
449107|NCT01228734|status|status
449108|NCT01228708|Implementation strategy|implementation strategy
449109|NCT01228708|Chronic disease management programme|chronic disease management programme
449110|NCT01228708|COPD|copd
449111|NCT01228695|steroids|steroids
449112|NCT01228695|patients treated with systemic steroids|patients treated with systemic steroids
449113|NCT01228682|Sodium|sodium
449114|NCT01228682|SIADH|siadh
449115|NCT01228682|Hyponatremia|hyponatremia
449116|NCT01228682|Vasopressin|vasopressin
449117|NCT01228682|Salt|salt
449118|NCT01228682|Water|water
449119|NCT01228656|Psoriasis|psoriasis
449120|NCT01228643|Pancreatic enzymes.|pancreatic enzymes.
449121|NCT01228643|To evaluate the efficacy of drugs in chronic renal failure|to evaluate the efficacy of drugs in chronic renal failure
449122|NCT01228630|rhinitis, loratadine, coated pill|rhinitis, loratadine, coated pill
449123|NCT01228617|Smoking Cessation|smoking cessation
449124|NCT01228617|Nicotine pharmacokinetics|nicotine pharmacokinetics
449125|NCT01228604|open label|open label
449126|NCT01228604|Ritalin®|ritalin®
449127|NCT01228604|ADHD|adhd
449128|NCT01228578|Multivitamins|multivitamins
449129|NCT01228578|HIV/AIDS|hiv/aids
449130|NCT01228578|Immune reconstitution|immune reconstitution
449131|NCT01228578|Weight Gain|weight gain
449132|NCT01228578|Quality of Life|quality of life
449133|NCT01228565|Head and neck carcinoma treated by radiotherapy plus erbitux|head and neck carcinoma treated by radiotherapy plus erbitux
449134|NCT01228552|Acute Migraine Treatment|acute migraine treatment
449135|NCT01228552|Migraine Treatment|migraine treatment
449136|NCT01228552|Migraine|migraine
449137|NCT01228552|Headache|headache
449138|NCT01228552|Treatment|treatment
449139|NCT01228539|PTSD|ptsd
449140|NCT01228539|Anger|anger
449141|NCT01228539|Aggression|aggression
449142|NCT01228539|Military|military
449143|NCT01228487|Oxidative Dysbalance|oxidative dysbalance
449144|NCT01228487|Oxidative Stress|oxidative stress
449145|NCT01228487|Biomarker|biomarker
449146|NCT01228461|Hodgkin Lymphoma Survivors|hodgkin lymphoma survivors
449147|NCT01228461|Adolescent and Young Adults|adolescent and young adults
449148|NCT01228448|external beam proton radiotherapy|external beam proton radiotherapy
449149|NCT01228448|PET|pet
449150|NCT01228435|NSCLC|nsclc
449151|NCT01228435|IPI-504|ipi-504
449152|NCT01228435|ALK translocation|alk translocation
449153|NCT01228435|Hsp90 inhibitor|hsp90 inhibitor
449154|NCT01228422|Will be studied 24 subjects divided Research and 2 parallel groups|will be studied 24 subjects divided research and 2 parallel groups
449155|NCT01228422|The treatment is a dose of 3MUI of alpha interferon 2nd|the treatment is a dose of 3mui of alpha interferon 2nd
449156|NCT01228422|There will be collection of blood at times: 0, 2, 4, 6, 8, 10, 12, 16, 24, 36, 48, 72 and 96 hours.|there will be collection of blood at times: 0, 2, 4, 6, 8, 10, 12, 16, 24, 36, 48, 72 and 96 hours.
449157|NCT01228422|The volunteers will be hospitalized 24 hours.|the volunteers will be hospitalized 24 hours.
449158|NCT01228422|Will be measured labels the AUC, Tmax, Cmax, neopterin and beta2-microglobulin|will be measured labels the auc, tmax, cmax, neopterin and beta2-microglobulin
449159|NCT01228409|Psoriasis|psoriasis
449160|NCT01228409|phototherapy|phototherapy
449161|NCT01228409|soriatane|soriatane
449162|NCT01228409|acitretin|acitretin
449163|NCT01228409|retinoid-related adverse events|retinoid-related adverse events
449164|NCT01228396|bladder|bladder
449165|NCT01228396|optic neuritis|optic neuritis
449166|NCT01228396|secondary progressive multiple sclerosis|secondary progressive multiple sclerosis
449167|NCT01228396|AIMSPRO|aimspro
449168|NCT01228396|hyperimmune caprine serum|hyperimmune caprine serum
449169|NCT01228396|hyperimmune goat serum|hyperimmune goat serum
449170|NCT01228383|Monoclonal antibody|monoclonal antibody
449171|NCT01228383|Rabies|rabies
449172|NCT01228383|Post-exposure prophylaxis|post-exposure prophylaxis
449173|NCT01228370|sildosin|sildosin
449174|NCT01228370|neurogenic bladder|neurogenic bladder
449175|NCT01228370|voiding dysfunction|voiding dysfunction
449176|NCT01228357|Pharmacogenomics|pharmacogenomics
449177|NCT01228357|Depressed Patients|depressed patients
449178|NCT01228344|Artemether-lumefantrine|artemether-lumefantrine
449179|NCT01228344|demographics|demographics
449180|NCT01228344|malaria|malaria
449181|NCT01228331|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
449182|NCT01228331|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
449183|NCT01228318|HAART|haart
449184|NCT01228318|Antiresorptive drugs|antiresorptive drugs
449185|NCT01228318|HIV/AIDS|hiv/aids
449186|NCT01228318|Bone loss|bone loss
449187|NCT01228305|ventricular septal defect|ventricular septal defect
449188|NCT01228305|atrioventricular septal defect|atrioventricular septal defect
449189|NCT01228305|oxidative stress|oxidative stress
449190|NCT01228305|cardiopulmonary bypass|cardiopulmonary bypass
449191|NCT01228305|acetaminophen|acetaminophen
449192|NCT01228305|hemolysis|hemolysis
449193|NCT01228305|acute kidney injury|acute kidney injury
449194|NCT01228305|Congenital heart disease undergoing cardiopulmonary bypass|congenital heart disease undergoing cardiopulmonary bypass
449195|NCT01228292|Anticoagulation|anticoagulation
449196|NCT01228292|Intensive Care Medicine|intensive care medicine
449197|NCT01228292|Hemodialysis|hemodialysis
449198|NCT01228292|Critical Ill Patients|critical ill patients
449199|NCT01228279|Peritoneal Dialysis|peritoneal dialysis
449200|NCT01228279|Dialysis Solutions|dialysis solutions
449201|NCT01228279|Artificial Kidney|artificial kidney
449202|NCT01228279|Renal Replacement Therapy|renal replacement therapy
449203|NCT01228279|Renal Dialysis|renal dialysis
449204|NCT01228279|Sympathetic Nervous System|sympathetic nervous system
449205|NCT01228279|Leptin|leptin
449206|NCT01228279|Icodextrin|icodextrin
449207|NCT01228266|Multiple Sclerosis|multiple sclerosis
449208|NCT01228240|Diabetes mellitus, type 2, Metformin, Generic, Efficacy|diabetes mellitus, type 2, metformin, generic, efficacy
449209|NCT01228227|Myonecrosis|myonecrosis
449210|NCT01228227|Percutaneous Angioplasty|percutaneous angioplasty
449211|NCT01228227|Myocardial Infarction|myocardial infarction
449212|NCT01228188|FTMH|ftmh
449213|NCT01228188|PPV|ppv
449214|NCT01228188|inverted ILM repositioning|inverted ilm repositioning
449215|NCT01228149|glaucoma|glaucoma
449216|NCT01228149|trabeculectomy|trabeculectomy
449217|NCT01228149|intraocular pressure|intraocular pressure
449218|NCT01228136|Adenotonsillectomy|adenotonsillectomy
449219|NCT01228136|Tranexamic acid|tranexamic acid
449220|NCT01228136|Blood loss|blood loss
449221|NCT01228136|Postoperative hemorrhage|postoperative hemorrhage
449222|NCT01228084|sulforaphane|sulforaphane
449223|NCT01228084|broccoli sprout extract (BSE)|broccoli sprout extract (bse)
449224|NCT01228084|prostate cancer|prostate cancer
449225|NCT01228084|recurrent prostate cancer|recurrent prostate cancer
449226|NCT01228084|phase II|phase ii
449227|NCT01228071|testosterone deficiency|testosterone deficiency
449228|NCT01228071|hypogonadism|hypogonadism
449229|NCT01228058|Trauma|trauma
449230|NCT01228058|Coagulopathy|coagulopathy
449231|NCT01228058|Coagulopathy in adult trauma patients|coagulopathy in adult trauma patients
449232|NCT01228045|Patients with histologically proved adenocarcinoma of advanced gastric cancer|patients with histologically proved adenocarcinoma of advanced gastric cancer
449233|NCT01228019|Usual practice re-examination|usual practice re-examination
449234|NCT01228006|Reduction of stress and fatigue|reduction of stress and fatigue
449235|NCT01227993|Central Serous Chorioretinopathy|central serous chorioretinopathy
449236|NCT01227993|Finasteride|finasteride
449237|NCT01227993|Proscar|proscar
449238|NCT01227993|Retinal Eye Disease|retinal eye disease
449239|NCT01227980|Addiction|addiction
449240|NCT01227980|Alcohol|alcohol
449241|NCT01227980|Alcohol Treatment|alcohol treatment
449242|NCT01227980|Alcoholics|alcoholics
449243|NCT01227980|Alcohol Dependence|alcohol dependence
449244|NCT01227980|Anxiety Disorder|anxiety disorder
449245|NCT01227980|Alcoholism|alcoholism
449246|NCT01227967|Adaptive Design|adaptive design
449247|NCT01227967|At Risk|at risk
449248|NCT01227967|H1N1|h1n1
449249|NCT01227967|Synergy|synergy
449250|NCT01227967|TCAD|tcad
449251|NCT01227954|cognitive/functional effects|cognitive/functional effects
449252|NCT01227954|tumors metastatic to brain|tumors metastatic to brain
449253|NCT01227954|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
449254|NCT01227941|advanced solid tumors|advanced solid tumors
449255|NCT01227941|ovarian cancer|ovarian cancer
449256|NCT01227941|pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
449257|NCT01227941|Doxil|doxil
449258|NCT01227941|Caelyx|caelyx
449259|NCT01227928|tyrosine kinase inhibitors|tyrosine kinase inhibitors
449260|NCT01227928|Primary Peritoneal Carcinoma|primary peritoneal carcinoma
449261|NCT01227928|primary peritoneal cancer|primary peritoneal cancer
449262|NCT01227928|ovarian cancer|ovarian cancer
449263|NCT01227928|Fallopian Tube Cancer|fallopian tube cancer
449264|NCT01227928|gynecologic cancer|gynecologic cancer
449265|NCT01227928|anti-angiogenesis|anti-angiogenesis
449266|NCT01227928|pazopanib|pazopanib
449267|NCT01227915|SIGNS AND SYMPTOMS OF ACUTE BACTERIAL CONJUNCTIVITIS|signs and symptoms of acute bacterial conjunctivitis
449268|NCT01227902|Seizures|seizures
449269|NCT01227902|retigabine IR|retigabine ir
449270|NCT01227902|GW582892|gw582892
449271|NCT01227902|Epilepsy|epilepsy
449272|NCT01227902|Open label, flexible dose|open label, flexible dose
449273|NCT01227902|Partial-onset seizures|partial-onset seizures
449274|NCT01227889|Metastatic melanoma|metastatic melanoma
449275|NCT01227889|melanoma|melanoma
449276|NCT01227889|BRAF mutant|braf mutant
449277|NCT01227889|Advanced melanoma|advanced melanoma
449278|NCT01227876|Control of postoperative inflammation in cataract surgery by phacoemulsification|control of postoperative inflammation in cataract surgery by phacoemulsification
449279|NCT01227863|SIGNS AND SYMPTOMS OF ACUTE BACTERIAL CONJUNCTIVITIS|signs and symptoms of acute bacterial conjunctivitis
449280|NCT01227850|Leptin|leptin
449281|NCT01227850|IGF1|igf1
449282|NCT01227850|Refeeding Index|refeeding index
449283|NCT01227850|Hypophosphataemia|hypophosphataemia
449284|NCT01227850|Primary focus of the study was to detemine whether the 'Refeeding Index', could reliably predict,that the refeeding syndrome would occur|primary focus of the study was to detemine whether the 'refeeding index', could reliably predict,that the refeeding syndrome would occur
449285|NCT01227837|omega 3|omega 3
449286|NCT01227837|CRT_AICD|crt_aicd
449287|NCT01227837|congestive heart failure|congestive heart failure
449288|NCT01227837|CHF|chf
449289|NCT01227824|integrase inhibitor|integrase inhibitor
449290|NCT01227824|HIV Infection|hiv infection
449291|NCT01227824|raltegravir|raltegravir
449292|NCT01227824|GSK1349572|gsk1349572
449293|NCT01227811|Darifenacin|darifenacin
449294|NCT01227811|Bioequivalence|bioequivalence
449295|NCT01227811|Healthy volunteers|healthy volunteers
449296|NCT01227811|Postprandial|postprandial
449297|NCT01227798|influenza A, H1N1|influenza a, h1n1
449298|NCT01227772|gastric cancer vaccine|gastric cancer vaccine
449299|NCT01227772|OTSGC-A24|otsgc-a24
449300|NCT01227772|A Phase I/IIa study|a phase i/iia study
449301|NCT01227772|HLA-A24-positive|hla-a24-positive
449302|NCT01227746|Advanced gastro-intestinal stromal tumors|advanced gastro-intestinal stromal tumors
449303|NCT01227720|Smoking Cessation, Nicotine pharmacokinetics|smoking cessation, nicotine pharmacokinetics
449304|NCT01227694|Cell therapy|cell therapy
449305|NCT01227694|Regenerative therapy|regenerative therapy
449306|NCT01227694|Advance therapy|advance therapy
449307|NCT01227694|Bone marrow|bone marrow
449308|NCT01227694|Mesenchymal stem cell|mesenchymal stem cell
449309|NCT01227694|Autologous|autologous
449310|NCT01227694|Interventional clinical trial|interventional clinical trial
449311|NCT01227694|Osteoarthrosis|osteoarthrosis
449312|NCT01227694|Osteoarthritis|osteoarthritis
449313|NCT01227694|Knee|knee
449314|NCT01227655|Parkinson|parkinson
449315|NCT01227655|PD|pd
449316|NCT01227655|Wearing-off|wearing-off
449317|NCT01227655|Levodopa/DDCI|levodopa/ddci
449318|NCT01227642|Prostate Cancer|prostate cancer
449319|NCT01227642|Prostate brachytherapy|prostate brachytherapy
449320|NCT01227642|Ultrasound treatment planning|ultrasound treatment planning
449321|NCT01227616|Iron deficiency anemia (IDA), Feraheme, ferumoxytol, chronic kidney disease (CKD), hemodialysis, magnetic resonance imaging (MRI)|iron deficiency anemia (ida), feraheme, ferumoxytol, chronic kidney disease (ckd), hemodialysis, magnetic resonance imaging (mri)
449322|NCT01227603|Bioequivalence|bioequivalence
449323|NCT01227603|Nifedipine|nifedipine
449324|NCT01227603|Candesartan|candesartan
449325|NCT01227603|FDC|fdc
449326|NCT01227590|Herbal medicine|herbal medicine
449327|NCT01227590|African Potato|african potato
449328|NCT01227590|Hypoxis obtusa|hypoxis obtusa
449329|NCT01227590|Drug interaction|drug interaction
449330|NCT01227590|HIV Infections|hiv infections
449331|NCT01227590|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
449332|NCT01227590|Healthy Subjects|healthy subjects
449333|NCT01227590|Anti-retroviral Agents|anti-retroviral agents
449334|NCT01227590|Lopinavir|lopinavir
449335|NCT01227590|Ritonavir|ritonavir
449336|NCT01227577|CML|cml
449337|NCT01227577|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
449338|NCT01227577|Leukemia|leukemia
449339|NCT01227577|CML-CP|cml-cp
449340|NCT01227577|Nilotinib|nilotinib
449341|NCT01227564|Early Alzheimer's disease|early alzheimer's disease
449342|NCT01227564|active immunization|active immunization
449343|NCT01227564|amyloid imaging|amyloid imaging
449344|NCT01227551|Melanoma|melanoma
449345|NCT01227551|CALM|calm
449346|NCT01227538|Beta cell reserve, urinary C peptide|beta cell reserve, urinary c peptide
449347|NCT01227512|Hyponatremia|hyponatremia
449348|NCT01227512|Dilutional Hyponatremia|dilutional hyponatremia
449349|NCT01227512|Euvolemic Hyponatremia|euvolemic hyponatremia
449350|NCT01227512|Hypervolemic Hyponatremia|hypervolemic hyponatremia
449351|NCT01227512|Fluid Restriction|fluid restriction
449352|NCT01227512|Tolvaptan|tolvaptan
449353|NCT01227486|Intubation, intratracheal|intubation, intratracheal
449354|NCT01227486|Ultrasonography|ultrasonography
449355|NCT01227486|Auscultation|auscultation
449356|NCT01227486|Capnography|capnography
449357|NCT01227486|Obesity|obesity
449358|NCT01227473|prediabetes|prediabetes
449359|NCT01227473|African Americans|african americans
449360|NCT01227473|mindfulness|mindfulness
449361|NCT01227473|behavioral|behavioral
449362|NCT01227473|diabetes|diabetes
450230|NCT01223235|MUC-1 KLH|muc-1 klh
449363|NCT01227460|Type 1 diabetes, Sitagliptin|type 1 diabetes, sitagliptin
449364|NCT01227434|Glioblastoma|glioblastoma
449365|NCT01227434|Gliosarcoma|gliosarcoma
449366|NCT01227434|Anaplastic astrocytoma|anaplastic astrocytoma
449367|NCT01227434|Malignant astrocytoma NOS|malignant astrocytoma nos
449368|NCT01227434|Malignant glioma|malignant glioma
449369|NCT01227434|GBM|gbm
449370|NCT01227421|influenza|influenza
449371|NCT01227408|Patients with confirmed breast cancer for neoadjuvant chemotherapy|patients with confirmed breast cancer for neoadjuvant chemotherapy
449372|NCT01227395|HIV|hiv
449373|NCT01227395|Post Marketing Surveillance|post marketing surveillance
449374|NCT01227369|Bisphosphonates|bisphosphonates
449375|NCT01227369|OPSAT-Q|opsat-q
449376|NCT01227356|Chronic myeloid leukemia, imatinib, interferon|chronic myeloid leukemia, imatinib, interferon
449377|NCT01227343|Gender differences|gender differences
449378|NCT01227343|nicotine|nicotine
449379|NCT01227343|cigarette smoking habits|cigarette smoking habits
449380|NCT01227343|behavior changes|behavior changes
449381|NCT01227317|Dyspnea|dyspnea
449382|NCT01227317|Mortality|mortality
449383|NCT01227291|Glaucoma|glaucoma
449384|NCT01227291|IOP|iop
449385|NCT01227291|siRNAs|sirnas
449386|NCT01227291|RNAi|rnai
449387|NCT01227291|beta inhibitor|beta inhibitor
449388|NCT01227278|Benralizumab|benralizumab
449389|NCT01227278|MEDI-563|medi-563
449390|NCT01227278|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
449391|NCT01227226|Dry eye|dry eye
449392|NCT01227187|Hemodialysis|hemodialysis
449393|NCT01227187|Anticoagulation|anticoagulation
449394|NCT01227187|Xigris|xigris
449395|NCT01227187|PTT|ptt
449396|NCT01227174|propofol only|propofol only
449397|NCT01227174|safety and efficacy|safety and efficacy
449398|NCT01227161|ASA I-II children between the age 0-7|asa i-ii children between the age 0-7
449399|NCT01227161|general anesthesia|general anesthesia
449400|NCT01227148|critical care, glycemic control, insulin, nitrogen balance|critical care, glycemic control, insulin, nitrogen balance
449401|NCT01227135|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
449402|NCT01227135|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
449403|NCT01227122|NGAL plasmatic level|ngal plasmatic level
449404|NCT01227122|Preoperative KIDNEY FAILURE, CHRONIC|preoperative kidney failure, chronic
449405|NCT01227122|Postoperative KIDNEY FAILURE, ACUTE|postoperative kidney failure, acute
449406|NCT01227122|Cardiac Surgery Procedures|cardiac surgery procedures
449407|NCT01227109|Infections|infections
449408|NCT01227109|Cancer|cancer
449409|NCT01227109|Procalcitonin|procalcitonin
449410|NCT01227109|C reactive protein|c reactive protein
449411|NCT01227096|electroacupuncture pediatric cardioprotection|electroacupuncture pediatric cardioprotection
449412|NCT01227083|AQLQ and cAQOL|aqlq and caqol
449413|NCT01227070|Asthma, hospitalization, children, exhaled nitric oxide, lung function, breath condensate, cysteinyl leukotrienes|asthma, hospitalization, children, exhaled nitric oxide, lung function, breath condensate, cysteinyl leukotrienes
449414|NCT01227057|exposure therapy|exposure therapy
449415|NCT01227057|case management|case management
449416|NCT01227057|older adults|older adults
449417|NCT01227057|cognitive rehabilitation|cognitive rehabilitation
449418|NCT01227044|Substance Abuse Counseling|substance abuse counseling
449419|NCT01227044|Adherence (medication)|adherence (medication)
449420|NCT01227044|Alcohol Abuse|alcohol abuse
449421|NCT01227044|Highly Active Antiretroviral Therapy (HAART)|highly active antiretroviral therapy (haart)
449422|NCT01227044|Naltrexone|naltrexone
449423|NCT01227044|Vivitrol|vivitrol
449425|NCT01227031|Genetic susceptibility of androgenetic alopecia|genetic susceptibility of androgenetic alopecia
449426|NCT01227031|Genetic difference in Finasteride response|genetic difference in finasteride response
449427|NCT01227005|Transfusion|transfusion
449428|NCT01227005|Whole Blood|whole blood
449429|NCT01227005|Trauma|trauma
449430|NCT01227005|Coagulopathy|coagulopathy
449431|NCT01227005|Component Therapy|component therapy
449432|NCT01227005|Civilian|civilian
449433|NCT01227005|Military|military
449434|NCT01226992|Clostridium difficile|clostridium difficile
449435|NCT01226992|Fecal Transplant|fecal transplant
449436|NCT01226992|Recurrent Diarrhea|recurrent diarrhea
449437|NCT01226992|Abdominal distension/bloating|abdominal distension/bloating
449438|NCT01226992|Fever|fever
449439|NCT01226979|rectal cancer|rectal cancer
449440|NCT01226979|high dose endorectal brachytherapy|high dose endorectal brachytherapy
449441|NCT01226953|Haemophilus influenzae type b (Hib)|haemophilus influenzae type b (hib)
449442|NCT01226953|Vaccine|vaccine
449443|NCT01226953|Anti-PRP antibody|anti-prp antibody
449444|NCT01226914|EVICEL, Fibrin Sealant, Thyroidectomy|evicel, fibrin sealant, thyroidectomy
449445|NCT01226901|Poly (ADP-ribose) polymerase (PARP) inhibitor|poly (adp-ribose) polymerase (parp) inhibitor
449446|NCT01226901|tumor|tumor
449447|NCT01226901|cancer|cancer
449448|NCT01226888|brown adipose tissue|brown adipose tissue
449449|NCT01226888|androgen deprivation therapy|androgen deprivation therapy
449450|NCT01226875|SWL|swl
449451|NCT01226875|kidney stones|kidney stones
449452|NCT01226875|renal calculi|renal calculi
449453|NCT01226862|Stroke|stroke
449454|NCT01226862|Telemedicine|telemedicine
449455|NCT01226862|Telestroke|telestroke
449456|NCT01226849|diffuse large B-cell lymphoma relapse refractory|diffuse large b-cell lymphoma relapse refractory
449457|NCT01226836|Pulmonary Rehabilitation|pulmonary rehabilitation
449458|NCT01226823|cholestasis|cholestasis
449459|NCT01226823|pregnancy|pregnancy
449460|NCT01226823|ursodeoxycholic acid|ursodeoxycholic acid
449461|NCT01226823|ICP|icp
449462|NCT01226797|Chronic HCV infection|chronic hcv infection
449463|NCT01226797|raised ALT|raised alt
449464|NCT01226797|transaminitis|transaminitis
449465|NCT01226797|HCV infection|hcv infection
449466|NCT01226771|hepatitis V virus|hepatitis v virus
449467|NCT01226771|genotype 1|genotype 1
449468|NCT01226771|ribavirin|ribavirin
449469|NCT01226771|interferon|interferon
449470|NCT01226771|Alternative ribavirin dosing|alternative ribavirin dosing
449471|NCT01226758|Safety|safety
449472|NCT01226758|Tolerability|tolerability
449473|NCT01226758|Efficacy|efficacy
449474|NCT01226758|Influenza|influenza
449475|NCT01226758|Flu|flu
449476|NCT01226758|Virus|virus
449477|NCT01226758|Vaccine|vaccine
449478|NCT01226745|Multiple sclerosis|multiple sclerosis
449479|NCT01226745|ONO-4641|ono-4641
449480|NCT01226745|MSC2430913A|msc2430913a
449481|NCT01226745|Efficacy|efficacy
449482|NCT01226732|Solid tumor|solid tumor
449483|NCT01226732|Capecitabine|capecitabine
449484|NCT01226732|Hsp90 inhibitor AUY922|hsp90 inhibitor auy922
449485|NCT01226719|liver-only metastatic KRAS wild-type colorectal cancer|liver-only metastatic kras wild-type colorectal cancer
449486|NCT01226719|Panitumumab|panitumumab
449487|NCT01226719|Oxaliplatin|oxaliplatin
449488|NCT01226719|Irinotecan|irinotecan
449489|NCT01226719|Leucovorin|leucovorin
449490|NCT01226719|5-Fluorouracil|5-fluorouracil
449491|NCT01226706|Urinary incontinence, urge|urinary incontinence, urge
449492|NCT01226706|detrusor hyperreflexia|detrusor hyperreflexia
449493|NCT01226706|detrusor instability|detrusor instability
449494|NCT01226706|non-neurogenic|non-neurogenic
449495|NCT01226706|Female Urogenital Diseases and Pregnancy Complications|female urogenital diseases and pregnancy complications
449496|NCT01226706|Female Urogenital Diseases|female urogenital diseases
449497|NCT01226706|Urologic Diseases|urologic diseases
449498|NCT01226706|Urination Disorders|urination disorders
449499|NCT01226706|Urinary Incontinence|urinary incontinence
449500|NCT01226693|pharmacokinetic|pharmacokinetic
449501|NCT01226693|single dose bioequivalence study|single dose bioequivalence study
449502|NCT01226693|balanced incomplete block design|balanced incomplete block design
449503|NCT01226693|PH-797804|ph-797804
449504|NCT01226693|P38 kinase inhibitor|p38 kinase inhibitor
449505|NCT01226680|Dry Eye|dry eye
449506|NCT01226680|Schirmer test|schirmer test
449507|NCT01226680|corneal staining|corneal staining
449508|NCT01226680|OSDI|osdi
449509|NCT01226680|OCI|oci
449510|NCT01226667|fibromyalgia|fibromyalgia
449511|NCT01226667|lyrica|lyrica
449512|NCT01226667|pregabalin|pregabalin
449513|NCT01226654|Quantitative Imaging of Multiple Sclerosis|quantitative imaging of multiple sclerosis
449514|NCT01226641|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
449515|NCT01226641|SCORE|score
449516|NCT01226641|Telemedicine|telemedicine
449517|NCT01226641|Arterial blood pressure|arterial blood pressure
449518|NCT01226641|Daily physical activity|daily physical activity
449519|NCT01226628|Macular degeneration|macular degeneration
449520|NCT01226628|Age-related macular degeneration|age-related macular degeneration
449521|NCT01226628|Cell therapy|cell therapy
449522|NCT01226628|CNTO 2476|cnto 2476
449523|NCT01226628|Human umbilical tissue-derived cells|human umbilical tissue-derived cells
449524|NCT01226628|hUTC|hutc
449525|NCT01226628|Geographic Atrophy|geographic atrophy
449526|NCT01226628|Subretinal|subretinal
449527|NCT01226628|Visual Acuity|visual acuity
449528|NCT01226615|Chondroitin sulphate|chondroitin sulphate
449529|NCT01226615|Knee osteoarthritis|knee osteoarthritis
449530|NCT01226615|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
449531|NCT01226602|Ticagrelor|ticagrelor
449532|NCT01226602|Healthy|healthy
449533|NCT01226602|Coronary flow velocity|coronary flow velocity
449534|NCT01226602|Adenosine|adenosine
449535|NCT01226589|Cancer cancer|cancer cancer
449536|NCT01226589|MRS|mrs
449537|NCT01226589|Treatment response|treatment response
449538|NCT01226589|Histologically confirmed diagnosed Breast cancer.|histologically confirmed diagnosed breast cancer.
449539|NCT01226589|Patient is 18 years or older.|patient is 18 years or older.
449540|NCT01226589|Karnofsky performance score is equal to or greater than 70.|karnofsky performance score is equal to or greater than 70.
449541|NCT01226589|No previously irradiated or recurrent breast.|no previously irradiated or recurrent breast.
449542|NCT01226589|No contraindication to MRS/MRI.|no contraindication to mrs/mri.
449543|NCT01226576|MRgFUS|mrgfus
449544|NCT01226576|Prostate Cancer|prostate cancer
449545|NCT01226576|Low-Intermediate Risk Prostate Cancer|low-intermediate risk prostate cancer
449546|NCT01226576|Localized Prostate Cancer|localized prostate cancer
449547|NCT01226576|InSightec|insightec
449548|NCT01226576|ExAblate|exablate
449549|NCT01226563|STEMI|stemi
449550|NCT01226563|Acute Myocardial Infarction|acute myocardial infarction
449551|NCT01226563|Congestive Heart Failure|congestive heart failure
449552|NCT01226563|Left Ventricular Remodeling|left ventricular remodeling
449553|NCT01226563|Devices, Medical|devices, medical
449554|NCT01226550|hyperthermic intraoperative peritoneal chemotherapy (HIPEC)|hyperthermic intraoperative peritoneal chemotherapy (hipec)
449555|NCT01226550|Irinotecan|irinotecan
449556|NCT01226550|Pharmacokinetics|pharmacokinetics
449557|NCT01226550|peritoneal carcinomatosis (PC)|peritoneal carcinomatosis (pc)
449558|NCT01226537|Taurine,Diabetes mellitus,oxidative stress,glycemic control|taurine,diabetes mellitus,oxidative stress,glycemic control
449559|NCT01226498|Blood Transfusion, Autologous|blood transfusion, autologous
449560|NCT01226498|Blood Preservation/adverse effects|blood preservation/adverse effects
449561|NCT01226498|Blood Transfusion/adverse effects|blood transfusion/adverse effects
449562|NCT01226498|Endothelium, Vascular/physiopathology|endothelium, vascular/physiopathology
449563|NCT01226498|Inflammation Mediators|inflammation mediators
449564|NCT01226485|Cancer|cancer
449565|NCT01226485|Terminal|terminal
449566|NCT01226485|Solid Tumor|solid tumor
449567|NCT01226485|End Stage|end stage
449568|NCT01226485|Metastatic|metastatic
449569|NCT01226472|PTCL|ptcl
449570|NCT01226472|CTCL|ctcl
449571|NCT01226472|MF|mf
449572|NCT01226472|SS|ss
449573|NCT01226459|Female Pattern Baldness|female pattern baldness
449574|NCT01226433|AE adverse event|ae adverse event
449575|NCT01226433|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
449576|NCT01226433|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
449577|NCT01226433|ART antiretroviral therapy|art antiretroviral therapy
449578|NCT01226433|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
449579|NCT01226433|DCF data collection forms|dcf data collection forms
449580|NCT01226433|DMC Data Monitoring Committee|dmc data monitoring committee
449581|NCT01226433|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
449582|NCT01226433|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
449583|NCT01226433|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
449584|NCT01226433|ICH International Conference of Harmonisation|ich international conference of harmonisation
449585|NCT01226433|IND Investigational New Drug Application|ind investigational new drug application
449586|NCT01226433|IRB Institutional Review Board|irb institutional review board
449587|NCT01226433|IU International units|iu international units
449588|NCT01226433|mg milligram(s)|mg milligram(s)
449589|NCT01226433|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
449590|NCT01226433|PCR polymerase chain reaction|pcr polymerase chain reaction
449591|NCT01226433|SAE serious adverse event|sae serious adverse event
449592|NCT01226433|µg microgram|µg microgram
449593|NCT01226433|ULN upper limit of the normal range|uln upper limit of the normal range
449594|NCT01226433|WB Western Blot|wb western blot
449595|NCT01226420|GVHD|gvhd
449596|NCT01226420|Alefacept|alefacept
449597|NCT01226420|Amevive|amevive
449598|NCT01226407|Solid Tumour|solid tumour
449599|NCT01226394|peritoneal carcinomatosis|peritoneal carcinomatosis
449600|NCT01226394|HIPEC|hipec
449601|NCT01226394|controlled clinical trial|controlled clinical trial
449602|NCT01226381|Paracetamol and setrons|paracetamol and setrons
449603|NCT01226381|No disease, healthy volunteers|no disease, healthy volunteers
449604|NCT01226368|HIV, HPV, cervical-vaginal smear|hiv, hpv, cervical-vaginal smear
449605|NCT01226342|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
449606|NCT01226329|Minority Groups|minority groups
449607|NCT01226329|Decision Making|decision making
449608|NCT01226329|Patient Participation|patient participation
449609|NCT01226329|Mental Health Services|mental health services
449610|NCT01226329|retention|retention
449611|NCT01226329|attendance|attendance
449612|NCT01226329|patient activation|patient activation
449613|NCT01226329|Hispanic Americans|hispanic americans
449614|NCT01226329|patient-provider communication|patient-provider communication
449615|NCT01226316|Advanced solid malignancy,PIK3CA mutated,AKT1 mutated, PTEN mutation, PTEN alteration, metastatic,ER+,breast,ovarian,endometrial,AZD5363,AKT inhibitor,|advanced solid malignancy,pik3ca mutated,akt1 mutated, pten mutation, pten alteration, metastatic,er+,breast,ovarian,endometrial,azd5363,akt inhibitor,
449616|NCT01226290|uterine fibroid RF ablation|uterine fibroid rf ablation
449617|NCT01226290|intrauterine ultrasound|intrauterine ultrasound
449618|NCT01226290|VizAblate|vizablate
449619|NCT01226264|Uterine cervical cancer|uterine cervical cancer
449620|NCT01226264|diffusion-weighted MRI|diffusion-weighted mri
449621|NCT01226264|recurrence|recurrence
449622|NCT01226251|oral malodour|oral malodour
449623|NCT01226251|halitosis|halitosis
449624|NCT01226251|Subjects consulting a bad breath clinic|subjects consulting a bad breath clinic
449625|NCT01226225|Patients with recent coronary event|patients with recent coronary event
449626|NCT01226212|Older people|older people
449627|NCT01226212|Synbiotic|synbiotic
449628|NCT01226212|Prebiotic|prebiotic
449629|NCT01226212|Probiotic|probiotic
449630|NCT01226212|Bacteria|bacteria
449631|NCT01226212|Immune|immune
449632|NCT01226186|Knee replacement|knee replacement
449633|NCT01226186|Pain control|pain control
449634|NCT01226186|Self medication|self medication
449635|NCT01226173|Prospective screening of blood donors.|prospective screening of blood donors.
449636|NCT01226147|Lupus Nephritis|lupus nephritis
449637|NCT01226147|SLE|sle
449638|NCT01226147|retinoid|retinoid
449639|NCT01226147|tamibarotene|tamibarotene
449640|NCT01226134|Functional Dyspepsia|functional dyspepsia
449641|NCT01226134|Itopride|itopride
449642|NCT01226134|Gastric Emptying|gastric emptying
449643|NCT01226134|Gastric Accommodation|gastric accommodation
449644|NCT01226134|Dyspeptic Symptoms|dyspeptic symptoms
449645|NCT01226121|dupuytren|dupuytren
449646|NCT01226121|dupuytren's|dupuytren's
449647|NCT01226095|Osteoarthritis|osteoarthritis
449648|NCT01226095|Pain|pain
449649|NCT01226095|Morning stiffness|morning stiffness
449650|NCT01226069|superficial phlebitis|superficial phlebitis
449651|NCT01226069|cannula-related vein inflammation|cannula-related vein inflammation
449652|NCT01226069|Glycerine magnesium sulphate|glycerine magnesium sulphate
449653|NCT01226069|Hirudoid cream|hirudoid cream
449654|NCT01226069|Nursing|nursing
449655|NCT01226056|advanced solid tumors|advanced solid tumors
449656|NCT01226056|Sorafenib (Nexavar®)|sorafenib (nexavar®)
449657|NCT01226056|RAD001 (everolimus)|rad001 (everolimus)
449658|NCT01226056|tumor molecular targets|tumor molecular targets
449659|NCT01226030|Advanced Solid Tumors|advanced solid tumors
449660|NCT01226017|Oxytocin|oxytocin
449661|NCT01226017|Animal Assisted therapy|animal assisted therapy
449662|NCT01226017|Farm animals|farm animals
449663|NCT01226017|Healthy nursing students|healthy nursing students
449664|NCT01226004|radiosurgery|radiosurgery
449665|NCT01226004|prostate|prostate
449666|NCT01226004|cancer|cancer
449667|NCT01226004|early|early
449668|NCT01226004|intermediate|intermediate
449669|NCT01226004|CyberKnife|cyberknife
449670|NCT01225991|Pain, Fatigue, Geriatric, Rheumatoid Arthritis, Milnacipran|pain, fatigue, geriatric, rheumatoid arthritis, milnacipran
449671|NCT01225978|Genetic Information|genetic information
449672|NCT01225978|Variant Updates|variant updates
449673|NCT01225978|Information Technology|information technology
449674|NCT01225978|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
449675|NCT01225978|Hearing Loss|hearing loss
449676|NCT01225978|Oncology|oncology
449677|NCT01225965|Particulate Matter induced inflammation of the lung|particulate matter induced inflammation of the lung
449678|NCT01225952|phacoemulsification|phacoemulsification
449679|NCT01225952|intraocular lens|intraocular lens
449680|NCT01225939|Type 2 diabetes mellitus|type 2 diabetes mellitus
449681|NCT01225939|Healthy|healthy
449682|NCT01225926|Intraocular Lens|intraocular lens
449683|NCT01225926|Toric|toric
449684|NCT01225913|asthma|asthma
449685|NCT01225913|lung function|lung function
449686|NCT01225913|inflammation|inflammation
449687|NCT01225874|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
449688|NCT01225874|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
449689|NCT01225874|non-T, non-B, cALLa positive, pre-B childhood acute lymphoblastic leukemia|non-t, non-b, calla positive, pre-b childhood acute lymphoblastic leukemia
449690|NCT01225809|AD01 follow-up extension|ad01 follow-up extension
449691|NCT01225796|Bicarbonate|bicarbonate
449692|NCT01225796|Chronic allograft nephropathy|chronic allograft nephropathy
449693|NCT01225796|Urinary TGF-beta|urinary tgf-beta
449694|NCT01225796|Urinary acid excretion|urinary acid excretion
449695|NCT01225770|green tea|green tea
449696|NCT01225770|gargling|gargling
449697|NCT01225770|prophylaxis|prophylaxis
449698|NCT01225770|influenza|influenza
449699|NCT01225770|Respiratory Tract Infections|respiratory tract infections
449700|NCT01225770|high school students|high school students
449701|NCT01225757|Echocardiography|echocardiography
449702|NCT01225757|HIPEC|hipec
449703|NCT01225692|Brain Injury|brain injury
449704|NCT01225692|Head Trauma|head trauma
449705|NCT01225692|Trauma Systems|trauma systems
449706|NCT01225692|Head Injury Guideline|head injury guideline
449707|NCT01225692|Time to Tertiary Care|time to tertiary care
449708|NCT01225679|Congenital Central Hypoventilation Syndrome|congenital central hypoventilation syndrome
449709|NCT01225679|Phox2B gene|phox2b gene
449710|NCT01225679|invasive ventilation|invasive ventilation
449711|NCT01225679|genetics|genetics
449712|NCT01225679|late-onset|late-onset
449713|NCT01225679|sleep|sleep
449714|NCT01225679|central sleep apnea|central sleep apnea
449715|NCT01225666|MOD-4023|mod-4023
449716|NCT01225666|Growth Hormone Deficient Adults|growth hormone deficient adults
449717|NCT01225666|Phase II|phase ii
449718|NCT01225653|Latanoprost|latanoprost
449719|NCT01225653|vasodilation|vasodilation
449720|NCT01225653|diabetic retinopathy|diabetic retinopathy
449721|NCT01225640|Tuberculosis|tuberculosis
449722|NCT01225640|EBA|eba
449723|NCT01225640|WBA|wba
449724|NCT01225627|Chronic disease management|chronic disease management
449725|NCT01225627|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
449726|NCT01225627|Discharge planning|discharge planning
449727|NCT01225627|Discharge coordinator|discharge coordinator
449728|NCT01225614|Home ventilation|home ventilation
449729|NCT01225614|Myotonic dystrophy type 1 (DM1)|myotonic dystrophy type 1 (dm1)
449730|NCT01225575|large cartilage defects|large cartilage defects
449731|NCT01225575|knee joint|knee joint
449732|NCT01225575|femoral condyle, tibia, trochlear, retropatellar|femoral condyle, tibia, trochlear, retropatellar
449733|NCT01225562|Heart attack|heart attack
449734|NCT01225562|Heart Disease|heart disease
449735|NCT01225562|Acute coronary syndrome|acute coronary syndrome
449736|NCT01225562|ACS|acs
449737|NCT01225562|Cardiovascular Disease|cardiovascular disease
449738|NCT01225549|Allergen Challenge|allergen challenge
449739|NCT01225549|Asthma|asthma
449740|NCT01225549|Inhaled selective glucocorticoid receptor agonist (iSEGRA)|inhaled selective glucocorticoid receptor agonist (isegra)
449741|NCT01225536|BRAF mutations|braf mutations
449742|NCT01225510|recurrent glioblastoma multiforme (GBM)|recurrent glioblastoma multiforme (gbm)
449743|NCT01225510|CVX-060|cvx-060
449744|NCT01225510|PF-04856884|pf-04856884
449745|NCT01225510|phase 2|phase 2
449746|NCT01225510|open-label|open-label
449747|NCT01225510|bevacizumab|bevacizumab
449748|NCT01225510|anti-angiogenic|anti-angiogenic
449749|NCT01225497|Randomized|randomized
449750|NCT01225497|Pilot study|pilot study
449751|NCT01225497|VISA-A|visa-a
449752|NCT01225497|VAS|vas
449753|NCT01225484|Knee arthroplasty, perioperative analgesia|knee arthroplasty, perioperative analgesia
449754|NCT01225471|novel epitope peptide|novel epitope peptide
449755|NCT01225471|CTL|ctl
449756|NCT01225471|advanced prostate cancer|advanced prostate cancer
449757|NCT01225458|Elderly patients|elderly patients
449758|NCT01225458|renal insufficiency|renal insufficiency
449759|NCT01225458|systematized gerontologic evaluation|systematized gerontologic evaluation
449760|NCT01225419|Plerixafor|plerixafor
449761|NCT01225419|Hematopoietic Stem Cell Transplant mobilization|hematopoietic stem cell transplant mobilization
449762|NCT01225419|children|children
449763|NCT01225406|Third line ARV therapy|third line arv therapy
449764|NCT01225406|HIV RNA|hiv rna
449765|NCT01225406|Absolute CD4+ T cell count|absolute cd4+ t cell count
449766|NCT01225406|serious adverse events (SAEs)|serious adverse events (saes)
449767|NCT01225406|Drug resistance|drug resistance
449768|NCT01225380|Hepatitis C|hepatitis c
449769|NCT01225380|HCV|hcv
449770|NCT01225380|Rapid Virologic Response|rapid virologic response
449771|NCT01225380|Sustained Virologic Response|sustained virologic response
449772|NCT01225380|Direct Acting Antiviral|direct acting antiviral
449773|NCT01225380|Combination Therapy|combination therapy
449774|NCT01225380|HCV RNA|hcv rna
449775|NCT01225380|Polymerase inhibitor|polymerase inhibitor
449776|NCT01225380|Protease inhibitor|protease inhibitor
449777|NCT01225380|Treatment naïve|treatment naïve
449778|NCT01225380|GS-9190|gs-9190
449779|NCT01225380|GS-9256|gs-9256
449780|NCT01225354|Cheek|cheek
449781|NCT01225354|Cheek flattening|cheek flattening
449782|NCT01225354|Malar deficiency|malar deficiency
449783|NCT01225354|Filler|filler
449784|NCT01225341|HSV-1|hsv-1
449785|NCT01225341|Herpes labialis|herpes labialis
449786|NCT01225341|Cold sores|cold sores
449787|NCT01225341|Fever blisters|fever blisters
449788|NCT01225289|Multiple Sclerosis|multiple sclerosis
449789|NCT01225289|Vitamin A|vitamin a
449790|NCT01225289|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
449791|NCT01225289|Th1 Cells|th1 cells
449792|NCT01225289|Th2 Cells|th2 cells
449793|NCT01225276|CIDP|cidp
449794|NCT01225276|IVIG|ivig
449795|NCT01225263|Migraine disorders|migraine disorders
449796|NCT01225263|Headache|headache
449797|NCT01225263|Simvastatin|simvastatin
449798|NCT01225263|Vitamin D|vitamin d
449799|NCT01225250|Caudal septal extension graft|caudal septal extension graft
449800|NCT01225250|Primary rhinoplasty|primary rhinoplasty
449801|NCT01225250|Secondary rhinoplasty|secondary rhinoplasty
449802|NCT01225237|diarrhea|diarrhea
449803|NCT01225237|IBS|ibs
449804|NCT01225237|Colonic disease|colonic disease
449805|NCT01225237|YM060|ym060
449806|NCT01225224|ASP015K|asp015k
449807|NCT01225224|Ethnic difference|ethnic difference
449808|NCT01225198|Vitamins|vitamins
449809|NCT01225198|Minerals|minerals
449810|NCT01225185|neurological complications|neurological complications
449811|NCT01225185|brain blood flow autoregulation|brain blood flow autoregulation
449812|NCT01225159|tight glycemic control|tight glycemic control
449813|NCT01225159|cardiac surgery|cardiac surgery
449814|NCT01225146|Ischemic|ischemic
449815|NCT01225146|Central|central
449816|NCT01225146|Retinal|retinal
449817|NCT01225146|Vein|vein
449818|NCT01225146|Occlusion|occlusion
449819|NCT01225146|Ranibizumab|ranibizumab
449820|NCT01225146|Lucentis|lucentis
449821|NCT01225146|CRVO|crvo
449822|NCT01225146|ISCRVO|iscrvo
449823|NCT01225133|Osteoarthritis, Osteoarthrosis, Arthritis, Arthrosis|osteoarthritis, osteoarthrosis, arthritis, arthrosis
449824|NCT01225107|Burns|burns
449825|NCT01225107|Infections|infections
449826|NCT01225107|Cranberry|cranberry
449827|NCT01225094|AAA|aaa
449828|NCT01225094|abdominal aortic aneurysm|abdominal aortic aneurysm
449829|NCT01225094|acute kidney injury|acute kidney injury
449830|NCT01225094|ischemia-reperfusion|ischemia-reperfusion
449831|NCT01225081|ASP1941|asp1941
449832|NCT01225081|Diabetes mellitus|diabetes mellitus
449833|NCT01225081|pioglitazone|pioglitazone
449834|NCT01225042|infectious diarrhea|infectious diarrhea
449835|NCT01225042|probiotics|probiotics
449836|NCT01225042|prevention|prevention
449837|NCT01225042|dietary intervention|dietary intervention
449838|NCT01225042|E. coli infection|e. coli infection
449839|NCT01225042|intestinal infection|intestinal infection
449840|NCT01225042|intestinal resistance|intestinal resistance
449841|NCT01225029|premature birth|premature birth
449842|NCT01225029|late preterm birth|late preterm birth
449843|NCT01225029|respiratory distress of the newborn|respiratory distress of the newborn
449844|NCT01225029|Transient tachypnea of the newborn|transient tachypnea of the newborn
449845|NCT01225003|gliomas|gliomas
449846|NCT01225003|magnetic resonance|magnetic resonance
449847|NCT01225003|diffusion kurtosis imaging|diffusion kurtosis imaging
449848|NCT01225003|MR spectroscopy|mr spectroscopy
449849|NCT01225003|grading|grading
449850|NCT01224990|gastro-intestinal tumor|gastro-intestinal tumor
449851|NCT01224990|accurate staging|accurate staging
449852|NCT01224990|whole-body diffusion weighted MRI|whole-body diffusion weighted mri
449853|NCT01224990|non-invasive|non-invasive
449854|NCT01224925|carious exposure|carious exposure
449855|NCT01224925|pulp capping|pulp capping
449856|NCT01224925|MTA|mta
449857|NCT01224925|Dycal|dycal
449858|NCT01224912|Insomnia|insomnia
449859|NCT01224912|Intervention|intervention
449860|NCT01224912|Self-help|self-help
449861|NCT01224912|Internet|internet
449862|NCT01224899|Heart Failure|heart failure
449863|NCT01224899|Sympathetic Nervous System|sympathetic nervous system
449864|NCT01224899|Sympathectomy|sympathectomy
449865|NCT01224899|Adrenergic beta-Antagonists|adrenergic beta-antagonists
449866|NCT01224899|Ventricular Dysfunction, Left|ventricular dysfunction, left
449867|NCT01224886|Aging|aging
449868|NCT01224886|Insulin resistance|insulin resistance
449869|NCT01224886|Ectopic lipids|ectopic lipids
449870|NCT01224886|Obesity|obesity
449871|NCT01224886|Exercise|exercise
449872|NCT01224886|Physical activity|physical activity
449873|NCT01224886|Oxidative capacity|oxidative capacity
449874|NCT01224886|Diabetes|diabetes
449875|NCT01224886|Metabolic syndrome|metabolic syndrome
449876|NCT01224873|breast cancer|breast cancer
449877|NCT01224873|bone metastasis|bone metastasis
449878|NCT01224873|comparison of diagnostic methods|comparison of diagnostic methods
449879|NCT01224873|bone scintigraphy|bone scintigraphy
449880|NCT01224873|fluoride PET/CT|fluoride pet/ct
449881|NCT01224873|FDG-PET/CT|fdg-pet/ct
449882|NCT01224860|Telmisartan|telmisartan
449883|NCT01224860|Losartan|losartan
449884|NCT01224860|Renal transplant|renal transplant
449885|NCT01224847|AMD|amd
449886|NCT01224847|Intravitreal Injection|intravitreal injection
449887|NCT01224847|Anesthesia|anesthesia
449888|NCT01224834|Ragweed, allergy, sublingual immunotherapy|ragweed, allergy, sublingual immunotherapy
449889|NCT01224821|iodine I 131 tositumomab|iodine i 131 tositumomab
449890|NCT01224821|anti-B1 Antibody|anti-b1 antibody
449891|NCT01224821|Bexxar|bexxar
449892|NCT01224821|radioimmunotherapy|radioimmunotherapy
449893|NCT01224821|tositumomab|tositumomab
449894|NCT01224808|von Willebrand Disease|von willebrand disease
449895|NCT01224795|uncomplicated influenza|uncomplicated influenza
449896|NCT01224782|Zemplar capsules|zemplar capsules
449897|NCT01224782|Chronic kidney disease (CKD) stage 3 or 4|chronic kidney disease (ckd) stage 3 or 4
449898|NCT01224782|Secondary hyperparathyroidism (SHPT)|secondary hyperparathyroidism (shpt)
449899|NCT01224782|Postmarketing observational study (PMOS)|postmarketing observational study (pmos)
449900|NCT01224756|Tonsillitis|tonsillitis
449901|NCT01224756|Pharyngitis|pharyngitis
449902|NCT01224756|Sore Throat|sore throat
449903|NCT01224756|Drug Therapy|drug therapy
449904|NCT01224717|Osteoporosis|osteoporosis
449905|NCT01224704|Hypertonic Saline Infusion|hypertonic saline infusion
449906|NCT01224704|Water Deprivation|water deprivation
449907|NCT01224704|Thirst|thirst
449908|NCT01224704|Water/Electrolytes Homeostasis|water/electrolytes homeostasis
449909|NCT01224704|Obesity|obesity
449910|NCT01224691|Respiratory Syncytial Virus|respiratory syncytial virus
449911|NCT01224691|TGF Beta|tgf beta
449912|NCT01224691|RSV|rsv
449913|NCT01224691|Asthma|asthma
449914|NCT01224691|Healthy Volunteer|healthy volunteer
449915|NCT01224678|breast cancer|breast cancer
449916|NCT01224665|stage II bladder cancer|stage ii bladder cancer
449917|NCT01224665|stage III bladder cancer|stage iii bladder cancer
449918|NCT01224665|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
449919|NCT01224652|gastric cancer|gastric cancer
449920|NCT01224652|paclitaxel|paclitaxel
449921|NCT01224652|irinotecan|irinotecan
449922|NCT01224639|dengue fever|dengue fever
449923|NCT01224639|live attenuated tetravalent dengue vaccine|live attenuated tetravalent dengue vaccine
449924|NCT01224639|TDV|tdv
449925|NCT01224639|Drug therapy|drug therapy
449926|NCT01224626|VRE|vre
449927|NCT01224626|Japanese|japanese
449928|NCT01224626|Post Marketing Surveillance|post marketing surveillance
449929|NCT01224600|lower limbs|lower limbs
449930|NCT01224600|Arterial Diseases|arterial diseases
449931|NCT01224587|Imaging technique|imaging technique
449932|NCT01224587|gastric transport through the gut|gastric transport through the gut
449933|NCT01224574|atrial fribrillation, cardiovascular events, aging, D-dimer|atrial fribrillation, cardiovascular events, aging, d-dimer
449934|NCT01224561|Thinness|thinness
449935|NCT01224561|Leanness|leanness
449936|NCT01224561|healthy volunteers|healthy volunteers
449937|NCT01224561|Lipid metabolism disorder|lipid metabolism disorder
449938|NCT01224548|vegan|vegan
449939|NCT01224548|diet|diet
449940|NCT01224548|diabetes|diabetes
449941|NCT01224548|overweight|overweight
449942|NCT01224548|workplace|workplace
449943|NCT01224548|nutrition|nutrition
449944|NCT01224548|diabetes and/or overweight|diabetes and/or overweight
449945|NCT01224535|Complementary foods|complementary foods
449946|NCT01224535|Amaranth|amaranth
449947|NCT01224535|Food Based approaches|food based approaches
449948|NCT01224535|Iron Deficiency anemia|iron deficiency anemia
449949|NCT01224535|Arid Areas|arid areas
449950|NCT01224535|Africa|africa
449951|NCT01224522|Randomized Controlled Trial|randomized controlled trial
449952|NCT01224522|Total Knee Arthroplasty|total knee arthroplasty
449953|NCT01224522|Patient Matched Cutting Blocks|patient matched cutting blocks
449954|NCT01224509|Cervix|cervix
449955|NCT01224509|EP3 receptors|ep3 receptors
449956|NCT01224509|Mifepristone|mifepristone
449957|NCT01224509|Prostaglandin|prostaglandin
449958|NCT01224509|Receptors|receptors
449959|NCT01224509|Steroids|steroids
449960|NCT01224496|Chronic cytopenic haematological diseases|chronic cytopenic haematological diseases
449961|NCT01224496|Chinese herbal concoction|chinese herbal concoction
449962|NCT01224496|Supportive management|supportive management
449963|NCT01224444|colon polyps|colon polyps
449964|NCT01224444|adenoma resection|adenoma resection
449965|NCT01224444|colon cancer screening|colon cancer screening
449966|NCT01224444|colonoscopy|colonoscopy
449967|NCT01224431|pain|pain
449968|NCT01224431|lidocaine|lidocaine
449969|NCT01224431|lumbar puncture|lumbar puncture
449970|NCT01224431|j-tip|j-tip
449971|NCT01224418|Tacrolimus|tacrolimus
449972|NCT01224418|Prograf|prograf
449973|NCT01224418|Calcinurin inhibitor|calcinurin inhibitor
449974|NCT01224418|Rheumatoid arthritis(RA)|rheumatoid arthritis(ra)
449975|NCT01224392|colorectal cancer|colorectal cancer
449976|NCT01224392|colorectal neoplasms|colorectal neoplasms
449977|NCT01224392|radiotherapy|radiotherapy
449978|NCT01224392|chemoradiotherapy|chemoradiotherapy
449979|NCT01224392|T3-4 rectal cancer|t3-4 rectal cancer
449980|NCT01224379|Lumbar spine|lumbar spine
449981|NCT01224379|fusion|fusion
449982|NCT01224379|adjacent instability|adjacent instability
449983|NCT01224379|topping-off.|topping-off.
449984|NCT01224366|Add-on to insulin|add-on to insulin
449985|NCT01224327|Liver cirrhosis|liver cirrhosis
449986|NCT01224327|Radiology|radiology
449987|NCT01224327|Mesenchymal Stem Cells|mesenchymal stem cells
449988|NCT01224327|Umbilical Cord|umbilical cord
449989|NCT01224314|Haemodynamics|haemodynamics
449990|NCT01224314|Hypotension|hypotension
449991|NCT01224314|Potassium|potassium
449992|NCT01224314|Haemodialysis|haemodialysis
449993|NCT01224314|Dialysis fluids|dialysis fluids
449994|NCT01224301|seasonal influenza vaccine|seasonal influenza vaccine
449995|NCT01224301|school-based clinics|school-based clinics
449996|NCT01224301|economic analysis of school based influenza vaccine delivery|economic analysis of school based influenza vaccine delivery
449997|NCT01224301|pediatric influenza vaccine rates|pediatric influenza vaccine rates
449998|NCT01224301|Influenza vaccine information for parents|influenza vaccine information for parents
449999|NCT01224288|RCC|rcc
450000|NCT01224288|Kidney cancer|kidney cancer
450001|NCT01224288|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
450002|NCT01224288|mRCC|mrcc
450003|NCT01224288|Dynamic contrast enhanced CT|dynamic contrast enhanced ct
450004|NCT01224288|DCE-CT|dce-ct
450005|NCT01224288|Tumor perfusion|tumor perfusion
450006|NCT01224275|group based care|group based care
450007|NCT01224275|antenatal care|antenatal care
450008|NCT01224275|parents satisfaction|parents satisfaction
450009|NCT01224275|Antenatal care´s organization and patient satisfaction|antenatal care´s organization and patient satisfaction
450010|NCT01224262|influenza vaccine|influenza vaccine
450011|NCT01224262|seasonal influenza|seasonal influenza
450012|NCT01224262|novel vaccine|novel vaccine
450013|NCT01224262|flu|flu
450014|NCT01224249|Selenium|selenium
450015|NCT01224249|Selenoprotein P|selenoprotein p
450016|NCT01224249|Fish|fish
450017|NCT01224249|Shellfish|shellfish
450018|NCT01224249|Bioavailability|bioavailability
450019|NCT01224223|asthma|asthma
450020|NCT01224210|portopulmonary hypertension|portopulmonary hypertension
450021|NCT01224210|portal hypertension|portal hypertension
450022|NCT01224210|esophageal or gastric varices|esophageal or gastric varices
450023|NCT01224210|right heart catheterization|right heart catheterization
450024|NCT01224210|transpulmonary gradient|transpulmonary gradient
450025|NCT01224210|Endothelin Receptor Antagonist|endothelin receptor antagonist
450026|NCT01224210|Ambrisentan|ambrisentan
450027|NCT01224210|Letairis|letairis
450028|NCT01224210|pulmonary hemodynamics|pulmonary hemodynamics
450029|NCT01224197|TMC435HPC1004|tmc435hpc1004
450030|NCT01224197|TMC435|tmc435
450031|NCT01224197|HCV|hcv
450032|NCT01224197|Hepatitis C|hepatitis c
450033|NCT01224197|Healthy Chinese volunteer|healthy chinese volunteer
450034|NCT01224184|HIV|hiv
450133|NCT01223560|Artificial pancreas|artificial pancreas
450035|NCT01224184|Sexually Transmitted Diseases|sexually transmitted diseases
450036|NCT01224184|Substance Abuse Detection|substance abuse detection
450037|NCT01224184|Randomized Controlled Trial|randomized controlled trial
450038|NCT01224132|Atopic dermatitis, probiotic, SCORAD index, prick tests, cytokines|atopic dermatitis, probiotic, scorad index, prick tests, cytokines
450039|NCT01224119|foot ankle arthritis bone graft|foot ankle arthritis bone graft
450040|NCT01224054|Tolerance alimentary|tolerance alimentary
450041|NCT01224054|Morbid obesity|morbid obesity
450042|NCT01224054|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
450043|NCT01224041|Tacrolimus|tacrolimus
450044|NCT01224041|Prograf|prograf
450045|NCT01224041|Calcinurin inhibitor|calcinurin inhibitor
450046|NCT01224041|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
450047|NCT01224028|Tacrolimus|tacrolimus
450048|NCT01224028|Prograf|prograf
450049|NCT01224028|Calcinurin inhibitor|calcinurin inhibitor
450050|NCT01224028|Albuminurea|albuminurea
450051|NCT01224028|Proteinurea|proteinurea
450052|NCT01224028|FK506|fk506
450053|NCT01224002|Cross-Sectional|cross-sectional
450054|NCT01224002|Observational|observational
450055|NCT01224002|Comparative|comparative
450056|NCT01224002|Retrospective|retrospective
450057|NCT01224002|Feasibility|feasibility
450058|NCT01224002|Dental Decay|dental decay
450059|NCT01224002|Drug Abuse|drug abuse
450060|NCT01224002|Survey|survey
450061|NCT01223989|overweight|overweight
450062|NCT01223989|obesity|obesity
450063|NCT01223989|bread|bread
450064|NCT01223989|hypocaloric diet|hypocaloric diet
450065|NCT01223976|latent tuberculosis psoriasis arthritis TST QTF|latent tuberculosis psoriasis arthritis tst qtf
450066|NCT01223976|Screening of latent tuberculosis in psoriasis|screening of latent tuberculosis in psoriasis
450067|NCT01223963|Macrolane|macrolane
450068|NCT01223963|Retrospective|retrospective
450069|NCT01223924|cancer|cancer
450070|NCT01223898|CML,|cml,
450071|NCT01223898|nilotinib,|nilotinib,
450072|NCT01223898|midazolam|midazolam
450073|NCT01223859|Radiofrequency, ablation, RFA, RFTA, RFITT, soft palate.|radiofrequency, ablation, rfa, rfta, rfitt, soft palate.
450074|NCT01223833|breast cancer|breast cancer
450075|NCT01223833|postmenopausal|postmenopausal
450076|NCT01223833|aromatase inhibitors|aromatase inhibitors
450077|NCT01223833|tamoxifen|tamoxifen
450078|NCT01223833|arthralgia|arthralgia
450079|NCT01223833|IGF-I|igf-i
450080|NCT01223833|BMI|bmi
450081|NCT01223833|grip strength|grip strength
450082|NCT01223807|COPD, diaphragm, rehabilitation|copd, diaphragm, rehabilitation
450083|NCT01223794|Fall|fall
450084|NCT01223794|all in surgical & Medical in-patient|all in surgical & medical in-patient
450085|NCT01223781|Freezing|freezing
450086|NCT01223781|biofeedback|biofeedback
450087|NCT01223781|motor learning|motor learning
450088|NCT01223781|freezing of gait in PD|freezing of gait in pd
450089|NCT01223755|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
450090|NCT01223755|Sirolimus|sirolimus
450091|NCT01223755|Renal insufficiency|renal insufficiency
450092|NCT01223729|Acetyl-L-carnitine;|acetyl-l-carnitine;
450093|NCT01223729|Minimal hepatic encephalopathy;|minimal hepatic encephalopathy;
450094|NCT01223729|Quality of life;|quality of life;
450095|NCT01223729|Depression.|depression.
450096|NCT01223716|amblyopia treatment|amblyopia treatment
450097|NCT01223716|neural plasticity|neural plasticity
450098|NCT01223716|perceptual learning|perceptual learning
450099|NCT01223716|vision therapy|vision therapy
450100|NCT01223716|spatial vision|spatial vision
450101|NCT01223716|video games|video games
450102|NCT01223716|occlusion therapy|occlusion therapy
450103|NCT01223703|n-3 PUFAs|n-3 pufas
450104|NCT01223703|Heart Failure|heart failure
450105|NCT01223703|Dilated cardiomyopathy|dilated cardiomyopathy
450106|NCT01223703|Ejection Fraction|ejection fraction
450107|NCT01223703|Exercise Capacity|exercise capacity
450108|NCT01223690|sepsis|sepsis
450109|NCT01223690|infection|infection
450110|NCT01223690|bacteremia|bacteremia
450111|NCT01223690|clarithromycin|clarithromycin
450112|NCT01223664|ABMSC|abmsc
450113|NCT01223664|Allogenic bone marrow mesenchymal stem cells|allogenic bone marrow mesenchymal stem cells
450114|NCT01223664|Liver cirrhosis|liver cirrhosis
450115|NCT01223664|Transplantation|transplantation
450116|NCT01223651|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
450117|NCT01223651|Continuous Glucose Monitoring System|continuous glucose monitoring system
450118|NCT01223651|Accuracy|accuracy
450119|NCT01223651|Altitude|altitude
450120|NCT01223638|Congenital hypothyroidism(CH)|congenital hypothyroidism(ch)
450121|NCT01223638|Hearing loss among children with CH|hearing loss among children with ch
450122|NCT01223612|Diabetes Mellitus|diabetes mellitus
450123|NCT01223612|Diabetes Complications|diabetes complications
450124|NCT01223612|Retinal Diseases|retinal diseases
450125|NCT01223612|Edema|edema
450126|NCT01223612|Endothelial Growth Factors|endothelial growth factors
450127|NCT01223612|Monoclonal Antibodies|monoclonal antibodies
450128|NCT01223612|Ranibizumab|ranibizumab
450129|NCT01223612|Laser therapy|laser therapy
450130|NCT01223599|pilonidal disease|pilonidal disease
450131|NCT01223599|natal cleft|natal cleft
450132|NCT01223599|limberg flap|limberg flap
450134|NCT01223560|Model predictive control|model predictive control
450135|NCT01223560|Virtual patient|virtual patient
450136|NCT01223547|Carbohydrate counting|carbohydrate counting
450137|NCT01223547|Insulin bolus calculation|insulin bolus calculation
450138|NCT01223534|Tuberculosis|tuberculosis
450139|NCT01223534|Latent tuberculosis infection|latent tuberculosis infection
450140|NCT01223534|Tuberculin skin test|tuberculin skin test
450141|NCT01223534|Interferon-gamma release assays|interferon-gamma release assays
450142|NCT01223534|Contact-tracing study|contact-tracing study
450143|NCT01223521|Contraception|contraception
450144|NCT01223521|Abortion|abortion
450145|NCT01223521|First trimester|first trimester
450146|NCT01223521|Intrauterine device|intrauterine device
450147|NCT01223482|Miscarriage|miscarriage
450148|NCT01223482|Karyotyping|karyotyping
450149|NCT01223482|Genetic testing|genetic testing
450150|NCT01223469|Atrial Fibrillation|atrial fibrillation
450151|NCT01223469|Supraventricular Tachycardia|supraventricular tachycardia
450152|NCT01223469|Contact Force|contact force
450153|NCT01223469|RF Ablation|rf ablation
450154|NCT01223469|Radiofrequency|radiofrequency
450155|NCT01223469|Pulmonary Vein Isolation|pulmonary vein isolation
450156|NCT01223469|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
450157|NCT01223456|Saxagliptin|saxagliptin
450158|NCT01223456|type 2 diabetes|type 2 diabetes
450159|NCT01223456|clinical practice|clinical practice
450160|NCT01223443|Coronary Artery Bypass Grafting|coronary artery bypass grafting
450161|NCT01223443|Drug Eluting Stent|drug eluting stent
450162|NCT01223443|Saphenous Vein Graft|saphenous vein graft
450163|NCT01223430|septic shock|septic shock
450164|NCT01223430|shock reversal|shock reversal
450165|NCT01223430|ICU|icu
450166|NCT01223430|traditional Chinese medicine|traditional chinese medicine
450167|NCT01223404|nicotine|nicotine
450168|NCT01223404|mecamylamine|mecamylamine
450169|NCT01223404|attention|attention
450170|NCT01223404|default network|default network
450171|NCT01223404|fMRI|fmri
450172|NCT01223391|orthostatic|orthostatic
450173|NCT01223391|abdominal compression|abdominal compression
450174|NCT01223365|moderate to severe pain|moderate to severe pain
450175|NCT01223365|diabetic peripheral neuropathy|diabetic peripheral neuropathy
450176|NCT01223365|postherpetic neuralgia|postherpetic neuralgia
450177|NCT01223365|traumatic injury|traumatic injury
450178|NCT01223365|complex regional pain syndrome|complex regional pain syndrome
450179|NCT01223365|back pain|back pain
450180|NCT01223365|neck pain|neck pain
450181|NCT01223365|osteoarthritis|osteoarthritis
450182|NCT01223365|rheumatoid arthritis|rheumatoid arthritis
450183|NCT01223352|pulmonary arterial hypertension|pulmonary arterial hypertension
450184|NCT01223352|children|children
450185|NCT01223352|pediatric|pediatric
450186|NCT01223352|bosentan|bosentan
450187|NCT01223339|Ertugliflozin|ertugliflozin
450188|NCT01223339|Japanese and Western population|japanese and western population
450189|NCT01223339|pharmacokinetics|pharmacokinetics
450190|NCT01223339|pharmacodynamics|pharmacodynamics
450191|NCT01223326|Acetylcysteine|acetylcysteine
450192|NCT01223313|Contraception|contraception
450193|NCT01223313|Woman's Condom|woman's condom
450194|NCT01223313|Female Condom|female condom
450195|NCT01223313|Condom|condom
450196|NCT01223287|NICHD Neonatal Research Network|nichd neonatal research network
450197|NCT01223287|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
450198|NCT01223287|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
450199|NCT01223287|Prematurity|prematurity
450200|NCT01223287|Mechanical ventilation|mechanical ventilation
450201|NCT01223287|Chronic Lung Disease (CLD)|chronic lung disease (cld)
450202|NCT01223274|NICHD Neonatal Research Network|nichd neonatal research network
450203|NCT01223274|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
450204|NCT01223274|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
450205|NCT01223274|Prematurity|prematurity
450206|NCT01223274|Mechanical ventilation|mechanical ventilation
450207|NCT01223274|Positive-Pressure Ventilation|positive-pressure ventilation
450208|NCT01223274|Surfactant|surfactant
450209|NCT01223274|Intubation|intubation
450210|NCT01223274|Pulse oximetry|pulse oximetry
450211|NCT01223274|Oxygen saturation|oxygen saturation
450212|NCT01223261|NICHD Neonatal Research Network|nichd neonatal research network
450213|NCT01223261|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
450214|NCT01223261|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
450215|NCT01223261|Prematurity|prematurity
450216|NCT01223261|Laparotomy|laparotomy
450217|NCT01223261|Drainage|drainage
450218|NCT01223261|Isolated intestinal perforation|isolated intestinal perforation
450219|NCT01223261|Focal intestinal performation|focal intestinal performation
450220|NCT01223248|radiation|radiation
450221|NCT01223248|Hypofractionated Image- Guided|hypofractionated image- guided
450222|NCT01223248|IGIMRT|igimrt
450223|NCT01223248|RT|rt
450224|NCT01223248|10-154|10-154
450225|NCT01223235|FALLOPIAN TUBE|fallopian tube
450226|NCT01223235|OVARY|ovary
450227|NCT01223235|PERITONEUM|peritoneum
450228|NCT01223235|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
450229|NCT01223235|GLOBO H-KLH CONJUGATE|globo h-klh conjugate
450231|NCT01223235|OPT-821|opt-821
450232|NCT01223235|TF (C) - KLH|tf (c) - klh
450233|NCT01223235|TN(C)-KLH|tn(c)-klh
450234|NCT01223235|10-099|10-099
450235|NCT01223222|Uncomplicated skin infections|uncomplicated skin infections
450236|NCT01223222|Impetigo|impetigo
450237|NCT01223222|Gram-negative|gram-negative
450238|NCT01223222|Diagnosis of uncomplicated, Gram-positive, skin infection. This may include patients with mild eczema/dermatoses such as atopic dermatitis.|diagnosis of uncomplicated, gram-positive, skin infection. this may include patients with mild eczema/dermatoses such as atopic dermatitis.
450239|NCT01223222|Gram-positive organisms which in the opinion of the investigator are causative for infection of the lesion(s),|gram-positive organisms which in the opinion of the investigator are causative for infection of the lesion(s),
450240|NCT01223209|Cancer|cancer
450241|NCT01223209|Carcinoma|carcinoma
450242|NCT01223209|Curative surgery|curative surgery
450243|NCT01223209|Curative surgery for carcinoma at least three months and not more than 5 years prior to treatment start|curative surgery for carcinoma at least three months and not more than 5 years prior to treatment start
450244|NCT01223196|Type 2 Diabetes, Thiazolidinediones, TIMP-3, TACE, TNF-a,|type 2 diabetes, thiazolidinediones, timp-3, tace, tnf-a,
450245|NCT01223196|insulin resistance|insulin resistance
450246|NCT01223183|cystic fibrosis|cystic fibrosis
450247|NCT01223183|nuclear medicine|nuclear medicine
450248|NCT01223183|aerosol|aerosol
450249|NCT01223183|nebulizer|nebulizer
450250|NCT01223170|Tailoring|tailoring
450251|NCT01223170|Cardiac rehabilitation|cardiac rehabilitation
450252|NCT01223170|Internet based intervention|internet based intervention
450253|NCT01223170|Exercise|exercise
450254|NCT01223170|Cardiovascular Disease rehabilitation|cardiovascular disease rehabilitation
450255|NCT01223157|obesity|obesity
450256|NCT01223157|endocannabinoids|endocannabinoids
450257|NCT01223144|Cognition|cognition
450258|NCT01223144|orbitofrontal cortex|orbitofrontal cortex
450259|NCT01223144|Iowa Gambling Task|iowa gambling task
450260|NCT01223144|facial emotion recognition|facial emotion recognition
450261|NCT01223118|Oocyte|oocyte
450262|NCT01223118|vitrification|vitrification
450263|NCT01223118|IVF|ivf
450264|NCT01223118|PGD|pgd
450265|NCT01223118|embryo biopsy|embryo biopsy
450266|NCT01223105|slow freeze|slow freeze
450267|NCT01223105|cryopreservation|cryopreservation
450268|NCT01223105|vitrification|vitrification
450269|NCT01223105|oocyte preservation|oocyte preservation
450270|NCT01223092|IVF|ivf
450271|NCT01223092|infertility|infertility
450272|NCT01223092|DNA|dna
450273|NCT01223079|r-hFSH|r-hfsh
450274|NCT01223079|r-hLH|r-hlh
450275|NCT01223066|Macrolane|macrolane
450276|NCT01223053|Sprain|sprain
450277|NCT01223053|Strain|strain
450278|NCT01223053|Pain|pain
450279|NCT01223053|Ankle Pain|ankle pain
450280|NCT01223053|Knee Pain|knee pain
450281|NCT01223053|Wrist Pain|wrist pain
450282|NCT01223053|Hand Pain|hand pain
450283|NCT01223027|Dovitinib|dovitinib
450284|NCT01223027|TKI|tki
450285|NCT01223027|Renal cell cancer|renal cell cancer
450286|NCT01223027|RCC|rcc
450287|NCT01223027|mRCC|mrcc
450288|NCT01223014|Radioactive|radioactive
450289|NCT01223014|ADME|adme
450290|NCT01223014|Neuropathic pain|neuropathic pain
450291|NCT01223001|Depression|depression
450292|NCT01223001|Traumatic brain injury|traumatic brain injury
450293|NCT01223001|Duloxetine|duloxetine
450294|NCT01223001|Cymbalta|cymbalta
450295|NCT01223001|impaired cognitive function|impaired cognitive function
450296|NCT01222975|risperidone fasting study|risperidone fasting study
450297|NCT01222936|LBH581|lbh581
450298|NCT01222936|Panobinostat|panobinostat
450299|NCT01222936|Small Cell Lung Carcinoma|small cell lung carcinoma
450300|NCT01222923|Risperidone fed study|risperidone fed study
450301|NCT01222910|Valacyclovir hydrochloride fasting study|valacyclovir hydrochloride fasting study
450302|NCT01222897|Valacyclovir hydrochloride fed study|valacyclovir hydrochloride fed study
450303|NCT01222871|Treatment|treatment
450304|NCT01222858|Obesity|obesity
450305|NCT01222858|Primary Care|primary care
450306|NCT01222858|Internet|internet
450307|NCT01222858|Technology|technology
450308|NCT01222858|Behavior Modification|behavior modification
450309|NCT01222819|Febrile neutropenia|febrile neutropenia
450310|NCT01222819|growth factors|growth factors
450311|NCT01222819|leukemia|leukemia
450312|NCT01222806|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
450313|NCT01222806|Cocaine|cocaine
450314|NCT01222806|Cue-Induced Craving|cue-induced craving
450315|NCT01222806|Repetitive TMS (rTMS)|repetitive tms (rtms)
450316|NCT01222806|Cocaine Craving|cocaine craving
450317|NCT01222793|High Weight Gain Liability (HWLA)|high weight gain liability (hwla)
450318|NCT01222793|Antipsychotic|antipsychotic
450319|NCT01222793|Obesity|obesity
450320|NCT01222793|Low Weight Gain|low weight gain
450321|NCT01222793|Schizophrenia|schizophrenia
450322|NCT01222793|Food Craving|food craving
450323|NCT01222780|Hematologic Malignancies|hematologic malignancies
450324|NCT01222780|Vincristine Sulfate|vincristine sulfate
450325|NCT01222780|Maximum Tolerated Dose|maximum tolerated dose
450326|NCT01222780|Pharmacokinetics|pharmacokinetics
450327|NCT01222780|Solid Tumors|solid tumors
450328|NCT01222780|Cancer|cancer
450329|NCT01222780|Pediatrics|pediatrics
450330|NCT01222780|Sarcoma|sarcoma
450331|NCT01222780|Wilms Tumor|wilms tumor
450332|NCT01222780|Leukemia|leukemia
450333|NCT01222780|Lymphoma|lymphoma
450334|NCT01222780|Brain Tumor|brain tumor
450335|NCT01222767|EFT|eft
450336|NCT01222767|PNET|pnet
450337|NCT01222767|EOE|eoe
450338|NCT01222754|Newly Diagnosed|newly diagnosed
450339|NCT01222754|DIPG|dipg
450340|NCT01222754|CC 5013|cc 5013
450341|NCT01222754|Radiation Therapy|radiation therapy
450342|NCT01222754|Lenalidomide|lenalidomide
450343|NCT01222754|XRT|xrt
450344|NCT01222754|Brain Tumor|brain tumor
450345|NCT01222754|Glioma|glioma
450346|NCT01222754|Pediatrics|pediatrics
450347|NCT01222741|AIRE- Autoimmune Regulator Gene|aire- autoimmune regulator gene
450348|NCT01222741|APECED- Autoimmune Polyendocrinopathy-Candidiasis Ectodermal Dystrophy|apeced- autoimmune polyendocrinopathy-candidiasis ectodermal dystrophy
450349|NCT01222741|CGD (Chronic Granulomatous Disease)|cgd (chronic granulomatous disease)
450350|NCT01222741|CMC- Chronic Mucocutaneous Candidiasis|cmc- chronic mucocutaneous candidiasis
450351|NCT01222728|PET Imaging|pet imaging
450352|NCT01222728|Vestibular Schwannoma|vestibular schwannoma
450353|NCT01222728|Neurofibromatosis|neurofibromatosis
450354|NCT01222728|Neurofibromatosis Type 2|neurofibromatosis type 2
450355|NCT01222728|NF2|nf2
450356|NCT01222702|CDIFF|cdiff
450357|NCT01222702|CDAD|cdad
450358|NCT01222702|CDI|cdi
450359|NCT01222702|Clostridium difficile infection|clostridium difficile infection
450360|NCT01222676|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
450361|NCT01222676|stage II bladder cancer|stage ii bladder cancer
450362|NCT01222676|stage III bladder cancer|stage iii bladder cancer
450363|NCT01222676|stage IV bladder cancer|stage iv bladder cancer
450364|NCT01222663|peritonitis|peritonitis
450365|NCT01222663|septic shock|septic shock
450366|NCT01222663|hemoperfusion|hemoperfusion
450367|NCT01222663|Polymyxin B|polymyxin b
450368|NCT01222663|endotoxin|endotoxin
450369|NCT01222650|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
450370|NCT01222650|I-PSS|i-pss
450371|NCT01222650|α1A-AR antagonist|α1a-ar antagonist
450372|NCT01222637|advanced solid cancers|advanced solid cancers
450373|NCT01222637|metastatic solid cancers|metastatic solid cancers
450374|NCT01222624|advanced solid malignancies|advanced solid malignancies
450375|NCT01222611|HIV|hiv
450376|NCT01222611|HCV|hcv
450377|NCT01222611|HIV/HCV|hiv/hcv
450378|NCT01222611|Coinfection|coinfection
450379|NCT01222611|Fosamprenavir|fosamprenavir
450380|NCT01222585|Metronidazole|metronidazole
450381|NCT01222585|Neonate|neonate
450382|NCT01222585|Premature|premature
450383|NCT01222585|Sepsis|sepsis
450384|NCT01222585|Necrotizing enterocolitis|necrotizing enterocolitis
450385|NCT01222572|radiation therapy|radiation therapy
450386|NCT01222572|stereotactic radiotherapy|stereotactic radiotherapy
450387|NCT01222572|stereotactic boost|stereotactic boost
450388|NCT01222559|Cartilage defects|cartilage defects
450389|NCT01222559|Knee joint|knee joint
450390|NCT01222559|Femoral Condyle|femoral condyle
450391|NCT01222507|tinnitus|tinnitus
450392|NCT01222507|cognition|cognition
450393|NCT01222507|brain processing speed|brain processing speed
450394|NCT01222507|Brain Fitness Program|brain fitness program
450395|NCT01222507|Posit Science|posit science
450396|NCT01222494|Child Psychiatry|child psychiatry
450397|NCT01222494|Obesity|obesity
450398|NCT01222494|Antipsychotic|antipsychotic
450399|NCT01222481|Head and Neck Cancer|head and neck cancer
450400|NCT01222481|Functional Status|functional status
450401|NCT01222481|Cognitive Status|cognitive status
450402|NCT01222481|Neurocognitive Assessments|neurocognitive assessments
450403|NCT01222481|Performance-based Assessments|performance-based assessments
450404|NCT01222481|Cancer|cancer
450405|NCT01222481|Function|function
450406|NCT01222481|Cognition|cognition
450407|NCT01222481|Quality of Life|quality of life
450408|NCT01222468|Spasticity, Spinal Cord Injury|spasticity, spinal cord injury
450409|NCT01222455|Phase 1|phase 1
450410|NCT01222455|Healthy volunteers|healthy volunteers
450411|NCT01222455|Volunteers with hepatic impairment|volunteers with hepatic impairment
450412|NCT01222455|Pharmacokinetics|pharmacokinetics
450413|NCT01222455|Fostamatinib|fostamatinib
450414|NCT01222442|Respiratory disease|respiratory disease
450415|NCT01222442|Bronchiolitis|bronchiolitis
450416|NCT01222442|Emphysema|emphysema
450417|NCT01222442|Lung disease causing persistent narrowing of the airways|lung disease causing persistent narrowing of the airways
450418|NCT01222390|Breast Cancer Reconstruction|breast cancer reconstruction
450419|NCT01222390|Tissue Expander|tissue expander
450420|NCT01222390|3-D Camera|3-d camera
450421|NCT01222390|Breast Reconstruction|breast reconstruction
450422|NCT01222390|Crescentric|crescentric
450423|NCT01222390|Expander Profile|expander profile
450424|NCT01222390|Fill-Volume|fill-volume
450425|NCT01222390|Lower Pole|lower pole
450426|NCT01222390|Upper Pole|upper pole
450427|NCT01222390|Acellular Dermis|acellular dermis
450428|NCT01222390|3-D Imaging|3-d imaging
450429|NCT01222364|NICHD Neonatal Research Network|nichd neonatal research network
450430|NCT01222364|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
450431|NCT01222364|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
450432|NCT01222364|Prematurity|prematurity
450433|NCT01222351|Alzheimer's disease|alzheimer's disease
450434|NCT01222351|Positron emission tomography|positron emission tomography
450435|NCT01222351|Biomarker|biomarker
450436|NCT01222351|Plasma Aβ|plasma aβ
450437|NCT01222351|Brain amyloid plaque load|brain amyloid plaque load
450438|NCT01222338|Mycobacterium|mycobacterium
450439|NCT01222338|MDR-TB|mdr-tb
450440|NCT01222338|XDR-TB|xdr-tb
450441|NCT01222338|HIV|hiv
450442|NCT01222338|HCV|hcv
450443|NCT01222325|kidney calculi|kidney calculi
450444|NCT01222325|urolithiasis|urolithiasis
450445|NCT01222325|urologic surgical procedures|urologic surgical procedures
450446|NCT01222325|extracorporeal shockwave lithotripsy|extracorporeal shockwave lithotripsy
450447|NCT01222312|advanced NSCLC|advanced nsclc
450448|NCT01222312|oxaliplatin|oxaliplatin
450449|NCT01222312|cisplatin|cisplatin
450450|NCT01222312|docetaxel|docetaxel
450451|NCT01222312|locally advanced or metastatic non small cell lung cancer (stage IIIB-IV)|locally advanced or metastatic non small cell lung cancer (stage iiib-iv)
450452|NCT01222286|Smoldering Multiple Myeloma|smoldering multiple myeloma
450453|NCT01222273|cystic fibrosis|cystic fibrosis
450454|NCT01222273|Allergic bronchopulmonary aspergillosis|allergic bronchopulmonary aspergillosis
450455|NCT01222273|A. fumigatus|a. fumigatus
450456|NCT01222273|Immune response|immune response
450457|NCT01222260|Amyloidosis|amyloidosis
450458|NCT01222260|Dexamethasone|dexamethasone
450459|NCT01222260|Bendamustine|bendamustine
450460|NCT01222260|Relapsed AL Amyloidosis|relapsed al amyloidosis
450461|NCT01222247|Betamethasone|betamethasone
450462|NCT01222247|Celestone|celestone
450463|NCT01222247|Steroids|steroids
450464|NCT01222247|Perinatology|perinatology
450465|NCT01222221|adult gliosarcoma|adult gliosarcoma
450466|NCT01222221|adult giant cell glioblastoma|adult giant cell glioblastoma
450467|NCT01222221|adult glioblastoma|adult glioblastoma
450468|NCT01222208|Bowel resection|bowel resection
450469|NCT01222195|Myelodysplastic Syndrome|myelodysplastic syndrome
450470|NCT01222195|Red cell transfusion independence|red cell transfusion independence
450471|NCT01222195|Darbepoetin alfa|darbepoetin alfa
450472|NCT01222195|Lenalidomide|lenalidomide
450473|NCT01222195|CC-5013|cc-5013
450474|NCT01222195|Revlimid|revlimid
450475|NCT01222195|Aranesp|aranesp
450476|NCT01222195|Erythropoietin|erythropoietin
450477|NCT01222195|Erythropoiesis Stimulating Protein|erythropoiesis stimulating protein
450478|NCT01222182|low density lipoprotein (LDL) cholesterol|low density lipoprotein (ldl) cholesterol
450479|NCT01222182|statin|statin
450480|NCT01222182|dose equivalent|dose equivalent
450481|NCT01222182|Hypercholesterolemia (defined by LDL guidelines)|hypercholesterolemia (defined by ldl guidelines)
450482|NCT01222169|Anesthesia|anesthesia
450483|NCT01222169|Children|children
450484|NCT01222169|Larynx|larynx
450485|NCT01222156|Cardiac arrhythmias|cardiac arrhythmias
450486|NCT01222156|Catheter ablation|catheter ablation
450487|NCT01222156|Electrophysiology|electrophysiology
450488|NCT01222156|Magnetic|magnetic
450489|NCT01222156|Mapping|mapping
450490|NCT01222156|Remote navigation|remote navigation
450491|NCT01222143|AML|aml
450492|NCT01222143|NOVE-HiDAC|nove-hidac
450493|NCT01222143|Nilotinib|nilotinib
450494|NCT01222130|HIV|hiv
450495|NCT01222130|Infant infection|infant infection
450496|NCT01222130|Diagnosis|diagnosis
450497|NCT01222130|Non-virological algorithm|non-virological algorithm
450498|NCT01222117|Acute Limb Ischemia|acute limb ischemia
450499|NCT01222104|vascular closure|vascular closure
450500|NCT01222104|Angio-Seal|angio-seal
450501|NCT01222104|Interventional radiology|interventional radiology
450502|NCT01222104|femoral artery|femoral artery
450503|NCT01222078|newly diagnosed type 1 diabetes mellitus|newly diagnosed type 1 diabetes mellitus
450504|NCT01222078|re-treatment|re-treatment
450505|NCT01222078|intravenous otelixizumab|intravenous otelixizumab
450506|NCT01222078|beta-cell preservation|beta-cell preservation
450507|NCT01222065|Glaucoma|glaucoma
450508|NCT01222065|Neurotubules|neurotubules
450509|NCT01222065|Birefringence|birefringence
450510|NCT01222065|Retinal Nerve Fiber Layer (RNFL)|retinal nerve fiber layer (rnfl)
450511|NCT01222052|high risk breast cancer|high risk breast cancer
450512|NCT01222052|low risk breast cancer|low risk breast cancer
450513|NCT01222052|uPA|upa
450514|NCT01222052|urokinase-type plasminogen activator|urokinase-type plasminogen activator
450515|NCT01222052|PAI|pai
450516|NCT01222052|plasminogen activator inhibitor-type|plasminogen activator inhibitor-type
450517|NCT01222039|Graft versus host disease|graft versus host disease
450518|NCT01222039|Mesenchymal stem cell|mesenchymal stem cell
450519|NCT01222039|Allogeneic mesenchymal stem cell|allogeneic mesenchymal stem cell
450520|NCT01222039|Adipose tissue|adipose tissue
450521|NCT01222039|Allotransplant|allotransplant
450522|NCT01222039|Allogenic|allogenic
450523|NCT01222039|Mesenchymal Stem Cells|mesenchymal stem cells
450524|NCT01222039|Immune System Diseases|immune system diseases
450525|NCT01222039|Chronic|chronic
450526|NCT01222039|Expanded|expanded
450527|NCT01222026|Primary Hyperparathyroidism|primary hyperparathyroidism
450528|NCT01222026|Osteopenia|osteopenia
450529|NCT01222026|Osteoporosis|osteoporosis
450530|NCT01221987|Human papillomavirus|human papillomavirus
450531|NCT01221987|neoplasia|neoplasia
450532|NCT01221974|Hydrosalpinx or infertility|hydrosalpinx or infertility
450533|NCT01221961|Major spine surgery|major spine surgery
450534|NCT01221961|Hemoglobin|hemoglobin
450535|NCT01221961|Blood transfusion|blood transfusion
450536|NCT01221948|Deep Brain Stimulation|deep brain stimulation
450537|NCT01221948|Parkinson's Disease|parkinson's disease
450538|NCT01221935|retrospective chart review study|retrospective chart review study
450539|NCT01221935|desvenlafaxine utilization|desvenlafaxine utilization
450540|NCT01221935|psychiatrists and primary care physicians|psychiatrists and primary care physicians
450541|NCT01221935|treatment of major depressive disorder|treatment of major depressive disorder
450542|NCT01221909|bleeding|bleeding
450543|NCT01221909|dacryocystorhinostomy|dacryocystorhinostomy
450544|NCT01221909|operative duration|operative duration
450545|NCT01221896|Localization of a parathyroid adenoma in patients with primary hyperparathyroidism.|localization of a parathyroid adenoma in patients with primary hyperparathyroidism.
450546|NCT01221883|Posttraumatic Stress|posttraumatic stress
450547|NCT01221883|Prevention|prevention
450548|NCT01221883|Diazepam|diazepam
450549|NCT01221870|Metastatic breast cancer|metastatic breast cancer
450550|NCT01221870|First-line therapy|first-line therapy
450551|NCT01221870|Tesetaxel|tesetaxel
450552|NCT01221870|Oral taxane|oral taxane
450553|NCT01221857|Double Umbilical Cord Blood Stem Cell Transplantation|double umbilical cord blood stem cell transplantation
450554|NCT01221857|Hematological Malignancies|hematological malignancies
450555|NCT01221857|HLA Mismatched Donors|hla mismatched donors
450556|NCT01221857|Cord Blood Transplantation|cord blood transplantation
450557|NCT01221844|Lactoferrin|lactoferrin
450558|NCT01221844|Pregnancy|pregnancy
450559|NCT01221844|Hereditary Thrombophilia|hereditary thrombophilia
450560|NCT01221844|Iron deficiency|iron deficiency
450561|NCT01221844|Iron deficiency anemia|iron deficiency anemia
450562|NCT01221818|Inflammatory Bowel Disease|inflammatory bowel disease
450563|NCT01221805|deep venous thrombosis|deep venous thrombosis
450564|NCT01221805|pulmonary embolism|pulmonary embolism
450565|NCT01221805|venous thromboembolism|venous thromboembolism
450566|NCT01221805|D-dimer|d-dimer
450567|NCT01221805|Wells score|wells score
450568|NCT01221805|Wells clinical pretest probability|wells clinical pretest probability
450569|NCT01221792|PTSD|ptsd
450570|NCT01221792|Anxiety|anxiety
450571|NCT01221792|Trauma|trauma
450572|NCT01221792|Assault|assault
450573|NCT01221792|Victim|victim
450574|NCT01221792|Witness|witness
450575|NCT01221792|Post Traumatic Stress Disorder|post traumatic stress disorder
450576|NCT01221792|Combat veteran|combat veteran
450577|NCT01221792|Flashbacks|flashbacks
450578|NCT01221792|Nightmares|nightmares
450579|NCT01221792|Sleep Disturbance|sleep disturbance
450580|NCT01221792|Hyperarousal|hyperarousal
450581|NCT01221792|Numbness|numbness
450582|NCT01221792|Avoidance|avoidance
450583|NCT01221779|Intensive language therapy|intensive language therapy
450584|NCT01221779|Anomia|anomia
450585|NCT01221779|Magnetic Resonance Imaging|magnetic resonance imaging
450586|NCT01221766|adnexal|adnexal
450587|NCT01221766|hair and nail|hair and nail
450588|NCT01221766|chronic graft vs host disease|chronic graft vs host disease
450589|NCT01221766|children|children
450590|NCT01221753|SSCHN|sschn
450591|NCT01221753|HPV|hpv
450592|NCT01221753|IMRT|imrt
450593|NCT01221740|To show that patients with greater pain sensitivity|to show that patients with greater pain sensitivity
450594|NCT01221740|will show greater improvement in their symptoms|will show greater improvement in their symptoms
450595|NCT01221740|(self-reported pain intensity, mood, sleep, and|(self-reported pain intensity, mood, sleep, and
450596|NCT01221740|quality of life) than those with lower pain|quality of life) than those with lower pain
450597|NCT01221740|sensitivity, based on QST, after taking milnacipran.|sensitivity, based on qst, after taking milnacipran.
450598|NCT01221740|To compare outcome differences|to compare outcome differences
450599|NCT01221740|(pain intensity, mood, activity interference,|(pain intensity, mood, activity interference,
450600|NCT01221740|sleep, and side effects) with those patients|sleep, and side effects) with those patients
450601|NCT01221740|who are either taking or not taking opioids for|who are either taking or not taking opioids for
450602|NCT01221740|their pain 10 weeks after being prescribed milnacipran.|their pain 10 weeks after being prescribed milnacipran.
450603|NCT01221740|To show that patients who are older, male,|to show that patients who are older, male,
450604|NCT01221740|with more medical comorbidities, greater disability,|with more medical comorbidities, greater disability,
450605|NCT01221740|and longer pain duration will report less improvement|and longer pain duration will report less improvement
450606|NCT01221740|(pain, mood, sleep, health-related quality of life)|(pain, mood, sleep, health-related quality of life)
450607|NCT01221740|and treatment satisfaction while taking milnacipran|and treatment satisfaction while taking milnacipran
450608|NCT01221740|compared with others without such characteristics.|compared with others without such characteristics.
450609|NCT01221740|identify patients back or neck pain|identify patients back or neck pain
450610|NCT01221740|greater 6 months|greater 6 months
450611|NCT01221740|QST|qst
450612|NCT01221740|10 weeks|10 weeks
450613|NCT01221740|milnacipran|milnacipran
450614|NCT01221740|pain intensity|pain intensity
450615|NCT01221740|mood|mood
450616|NCT01221740|activity|activity
450617|NCT01221740|interference|interference
450618|NCT01221740|sleep|sleep
450619|NCT01221740|side effects|side effects
450620|NCT01221740|age|age
450621|NCT01221740|gender|gender
450622|NCT01221740|medical comorbidities|medical comorbidities
450623|NCT01221740|pain diagnosis|pain diagnosis
450624|NCT01221740|pain duration|pain duration
450625|NCT01221740|disability status|disability status
450626|NCT01221727|Amgen|amgen
450627|NCT01221727|Phase 1|phase 1
450628|NCT01221727|Postmenopausal|postmenopausal
450629|NCT01221727|Osteoporosis|osteoporosis
450630|NCT01221714|nutritional supplements|nutritional supplements
450631|NCT01221714|supplements|supplements
450632|NCT01221714|vitamins|vitamins
450633|NCT01221714|omega-3|omega-3
450634|NCT01221714|Amerisciences|amerisciences
450635|NCT01221714|Carlos Montesinos|carlos montesinos
450636|NCT01221701|depression|depression
450637|NCT01221701|psychological treatments|psychological treatments
450638|NCT01221701|Cognitive Behavioral Therapy|cognitive behavioral therapy
450639|NCT01221701|child social/emotional functioning|child social/emotional functioning
450640|NCT01221701|parenting|parenting
450641|NCT01221701|home visitation|home visitation
450642|NCT01221688|Sentinel lymph node biopsy (SLNB)|sentinel lymph node biopsy (slnb)
450643|NCT01221688|large operable breast cancer|large operable breast cancer
450644|NCT01221688|neoadjuvant chemotherapy|neoadjuvant chemotherapy
450645|NCT01221688|patients with large operable breast cancer after neoadjuvant chemotherapy (NAC)|patients with large operable breast cancer after neoadjuvant chemotherapy (nac)
450646|NCT01221675|Small Cell Lung Cancer or CEA-expressing Non Small Cell Lung Carcinoma (NSCLC)|small cell lung cancer or cea-expressing non small cell lung carcinoma (nsclc)
450647|NCT01221675|Radio Immunotherapy|radio immunotherapy
450648|NCT01221675|Lutetium|lutetium
450649|NCT01221675|patient ≥ 18 years of age with CEA-positive SCLC in partial response|patient ≥ 18 years of age with cea-positive sclc in partial response
450650|NCT01221675|or who failed at least two lines of standard radiation and/or chemotherapy|or who failed at least two lines of standard radiation and/or chemotherapy
450651|NCT01221675|or Patients with histologic diagnosis of NSCLC|or patients with histologic diagnosis of nsclc
450652|NCT01221662|Siwu tang|siwu tang
450653|NCT01221662|brain hypoperfusion|brain hypoperfusion
450654|NCT01221662|cognition function|cognition function
450655|NCT01221623|Peyronie's Disease|peyronie's disease
450656|NCT01221623|penile plaque|penile plaque
450657|NCT01221623|penile curvature|penile curvature
450658|NCT01221610|Stenosis|stenosis
450659|NCT01221610|Occlusions|occlusions
450660|NCT01221610|SFA|sfa
450661|NCT01221610|PTA|pta
450662|NCT01221610|POBA|poba
450663|NCT01221610|DRB|drb
450664|NCT01221597|Peyronie's Disease|peyronie's disease
450665|NCT01221597|penile plaque|penile plaque
450666|NCT01221597|penile curvature|penile curvature
450667|NCT01221584|Dyslipidaemia|dyslipidaemia
450668|NCT01221584|LDL-C goals|ldl-c goals
450669|NCT01221584|guidelines|guidelines
450670|NCT01221571|Phase I|phase i
450671|NCT01221571|Dose escalation|dose escalation
450672|NCT01221571|AFM 13|afm 13
450673|NCT01221571|Natural killer cell|natural killer cell
450674|NCT01221545|Diabetes Mellitus|diabetes mellitus
450675|NCT01221519|Phase I|phase i
450676|NCT01221519|Bioavailability|bioavailability
450677|NCT01221519|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
450678|NCT01221519|Diabetic treatment|diabetic treatment
450679|NCT01221519|Metformin|metformin
450680|NCT01221519|High blood sugar|high blood sugar
450681|NCT01221506|unresectable|unresectable
450682|NCT01221506|metastatic|metastatic
450683|NCT01221506|clear cell renal carcinoma|clear cell renal carcinoma
450684|NCT01221493|solitary pulmonary nodules|solitary pulmonary nodules
450685|NCT01221493|transbronchial lung biopsy|transbronchial lung biopsy
450686|NCT01221493|endobronchial ultrasound|endobronchial ultrasound
450687|NCT01221454|ABMSC|abmsc
450688|NCT01221454|Allogenic bone marrow mesenchymal stem cells|allogenic bone marrow mesenchymal stem cells
450689|NCT01221454|Liver Failure|liver failure
450690|NCT01221454|Transplantation|transplantation
450691|NCT01221441|Cartilage|cartilage
450692|NCT01221441|Knee|knee
450693|NCT01221441|Osteoarthritis|osteoarthritis
450694|NCT01221428|Ulcerative colitis|ulcerative colitis
450695|NCT01221428|Mesenchymal Stem Cells|mesenchymal stem cells
450696|NCT01221428|Umbilical Cord|umbilical cord
450697|NCT01221389|hemorrhage|hemorrhage
450698|NCT01221389|plasma|plasma
450699|NCT01221389|coagulopathy|coagulopathy
450700|NCT01221389|trauma|trauma
450701|NCT01221363|Life style disease|life style disease
450702|NCT01221363|Obesity|obesity
450703|NCT01221363|Sedentary behaviour|sedentary behaviour
450704|NCT01221363|Cardiovascular biomarkers|cardiovascular biomarkers
450705|NCT01221350|Asthma|asthma
450706|NCT01221350|Allergic rhinitis|allergic rhinitis
450707|NCT01221350|Respiratory disease|respiratory disease
450708|NCT01221350|Allergy|allergy
450709|NCT01221350|Lipoic acid|lipoic acid
450710|NCT01221350|Thioctic acid|thioctic acid
450711|NCT01221350|Antioxidant|antioxidant
450712|NCT01221350|Oxidative stress|oxidative stress
450713|NCT01221311|stenosis|stenosis
450714|NCT01221311|bile duct|bile duct
450715|NCT01221311|chronic pancreatitis|chronic pancreatitis
450716|NCT01221311|postoperative|postoperative
450717|NCT01221311|post-liver transplant|post-liver transplant
450718|NCT01221285|Cockroach|cockroach
450719|NCT01221285|Immunotherapy|immunotherapy
450720|NCT01221285|Subcutaneous immunotherapy|subcutaneous immunotherapy
450721|NCT01221285|Inner city asthma|inner city asthma
450722|NCT01221272|SPECT MPI|spect mpi
450723|NCT01221246|Acute Middle Cerebral Artery Ischemic Stroke within 18 hours|acute middle cerebral artery ischemic stroke within 18 hours
450724|NCT01221207|diabetic foot ulcers|diabetic foot ulcers
450725|NCT01221207|casting|casting
450726|NCT01221207|wound care|wound care
450727|NCT01221194|diabetes|diabetes
450728|NCT01221194|foot ulcer prevention|foot ulcer prevention
450729|NCT01221194|therapeutic stockings|therapeutic stockings
450730|NCT01221181|Dense deposit disease|dense deposit disease
450731|NCT01221181|C3 nephropathy|c3 nephropathy
450732|NCT01221181|Eculizumab|eculizumab
450733|NCT01221168|prostate|prostate
450734|NCT01221168|cancer|cancer
450735|NCT01221168|genetic|genetic
450736|NCT01221168|epidemiology|epidemiology
450737|NCT01221168|susceptibility|susceptibility
450738|NCT01221155|Musculoskeletal|musculoskeletal
450739|NCT01221142|Hypothermia, ICH|hypothermia, ich
450740|NCT01221129|zinc|zinc
450741|NCT01221129|reticulocyte|reticulocyte
450742|NCT01221129|PBMC|pbmc
450743|NCT01221129|whole blood|whole blood
450744|NCT01221129|transcriptome|transcriptome
450745|NCT01221129|microarray|microarray
450746|NCT01221116|coronary artery disease,|coronary artery disease,
450747|NCT01221116|aortic stenosis,|aortic stenosis,
450748|NCT01221116|heart failure|heart failure
450749|NCT01221103|Dexamethasone|dexamethasone
450750|NCT01221103|Ofatumumab|ofatumumab
450751|NCT01221103|Bendamustine|bendamustine
450752|NCT01221103|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
450753|NCT01221103|Non-Hodgkin lymphoma|non-hodgkin lymphoma
450754|NCT01221090|Type 2 diabetes|type 2 diabetes
450755|NCT01221090|Health disparities|health disparities
450756|NCT01221090|Central Texas|central texas
450757|NCT01221090|PDA|pda
450758|NCT01221090|CDSMP|cdsmp
450759|NCT01221077|NSCLC|nsclc
450760|NCT01221077|Non-small cell lung cancer|non-small cell lung cancer
450761|NCT01221077|OSI-906|osi-906
450762|NCT01221077|IGF-IR|igf-ir
450763|NCT01221077|Tarceva|tarceva
450764|NCT01221077|Erlotinib|erlotinib
450765|NCT01221077|Epidermal Growth Factor Receptor|epidermal growth factor receptor
450766|NCT01221077|EGFR|egfr
450767|NCT01221077|Chemonaive|chemonaive
450768|NCT01221077|Activating mutations|activating mutations
450769|NCT01221064|Breast cancer|breast cancer
450770|NCT01221064|Axillary clearance|axillary clearance
450771|NCT01221064|lymphorrhoea|lymphorrhoea
450772|NCT01221051|third stage of labor,oxytocics, postpartum hemorrhage,|third stage of labor,oxytocics, postpartum hemorrhage,
450773|NCT01221025|Parecoxib;|parecoxib;
450774|NCT01221025|emergence delirium;|emergence delirium;
450775|NCT01221025|postoperative pain;|postoperative pain;
450776|NCT01221025|elderly patients;|elderly patients;
450777|NCT01221025|abdominal surgery|abdominal surgery
450778|NCT01221025|Parecoxib on emergence agitation and postoperative pain|parecoxib on emergence agitation and postoperative pain
450779|NCT01220999|Clinical trial|clinical trial
450780|NCT01220999|CS-1008 mAb|cs-1008 mab
450781|NCT01220999|monoclonal antibody CS-1008|monoclonal antibody cs-1008
450782|NCT01220999|Positron-Emission Tomography|positron-emission tomography
450783|NCT01220999|Pharmacokinetics|pharmacokinetics
450784|NCT01220999|Pharmacodynamics|pharmacodynamics
450785|NCT01220999|apoptosis|apoptosis
450786|NCT01220999|caspases|caspases
450787|NCT01220986|Liver regeneration|liver regeneration
450788|NCT01220986|Innate immune response|innate immune response
450789|NCT01220973|stage IV prostate cancer|stage iv prostate cancer
450790|NCT01220973|stage III prostate cancer|stage iii prostate cancer
450791|NCT01220973|recurrent prostate cancer|recurrent prostate cancer
450792|NCT01220973|stage IIB prostate cancer|stage iib prostate cancer
450793|NCT01220973|stage IIA prostate cancer|stage iia prostate cancer
450794|NCT01220960|art therapy|art therapy
450795|NCT01220960|breast cancer|breast cancer
450796|NCT01220960|women|women
450797|NCT01220960|young women|young women
450798|NCT01220960|older women|older women
450799|NCT01220960|quality of life|quality of life
450800|NCT01220960|meaning making|meaning making
450801|NCT01220960|support group|support group
450802|NCT01220960|art making|art making
450803|NCT01220960|art symbols|art symbols
450804|NCT01220908|LVRS (Lung Volume Reduction Surgery)|lvrs (lung volume reduction surgery)
450805|NCT01220908|LVRC (Lung Volume Reduction Coil)|lvrc (lung volume reduction coil)
450806|NCT01220908|Emphysema|emphysema
450807|NCT01220908|coil|coil
450808|NCT01220908|RePneu|repneu
450809|NCT01220895|Adoptive cellular therapy|adoptive cellular therapy
450810|NCT01220895|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
450811|NCT01220882|Slipped capital femoral epiphysis|slipped capital femoral epiphysis
450812|NCT01220856|Islet transplantation|islet transplantation
450813|NCT01220856|Type 1 diabetes mellitus|type 1 diabetes mellitus
450814|NCT01220843|chronic renal failure|chronic renal failure
450815|NCT01220843|FGF23|fgf23
450816|NCT01220843|Sevelamer carbonate|sevelamer carbonate
450817|NCT01220830|Multiple sclerosis|multiple sclerosis
450818|NCT01220830|RFQMR|rfqmr
450819|NCT01220830|Cytotron|cytotron
450820|NCT01220830|EDSS|edss
450821|NCT01220830|QOL assessment with FAMS|qol assessment with fams
450822|NCT01220817|prostate|prostate
450823|NCT01220817|cancer|cancer
450824|NCT01220817|psa|psa
450825|NCT01220817|psadt|psadt
450826|NCT01220817|pomegranate|pomegranate
450827|NCT01220817|POMx|pomx
450828|NCT01220791|methylprednisolone|methylprednisolone
450829|NCT01220791|IVF|ivf
450830|NCT01220791|progesterone|progesterone
450831|NCT01220791|corticosteroid|corticosteroid
450832|NCT01220791|late follicular phase|late follicular phase
450833|NCT01220791|pregnancy rates|pregnancy rates
450834|NCT01220765|hypoxemia|hypoxemia
450835|NCT01220765|capnography|capnography
450836|NCT01220765|sedation|sedation
450837|NCT01220752|IMRT|imrt
450838|NCT01220752|carbon ion therapy|carbon ion therapy
450839|NCT01220752|paranasal sinus|paranasal sinus
450840|NCT01220752|nasal cavity|nasal cavity
450841|NCT01220752|adenocarcinoma|adenocarcinoma
450842|NCT01220752|squamous cell carcinoma|squamous cell carcinoma
450843|NCT01220739|ischemic stroke|ischemic stroke
450844|NCT01220739|transcranial laser|transcranial laser
450845|NCT01220739|tissue plasminogen activator|tissue plasminogen activator
450846|NCT01220739|therapy|therapy
450847|NCT01220726|OAB|oab
450848|NCT01220713|Traumatic Brain Injury|traumatic brain injury
450849|NCT01220713|Veterans|veterans
450850|NCT01220713|Hyperbaric Oxygen Treatment|hyperbaric oxygen treatment
450851|NCT01220713|OEF/OIF|oef/oif
450852|NCT01220713|Post-Concussive Symptoms|post-concussive symptoms
450853|NCT01220713|Blast Exposure|blast exposure
450854|NCT01220687|Prematurity|prematurity
450855|NCT01220687|Oxygen exposure|oxygen exposure
450856|NCT01220687|Nitric Oxide|nitric oxide
450857|NCT01220674|neuropsychological assessment|neuropsychological assessment
450858|NCT01220674|cognitive impairment|cognitive impairment
450859|NCT01220674|computer-aided diagnostic tool|computer-aided diagnostic tool
450860|NCT01220661|Colorectal Surgery|colorectal surgery
450861|NCT01220661|Surgical Wound Infection|surgical wound infection
450862|NCT01220661|Laparoscopy|laparoscopy
450863|NCT01220661|Anti-Bacterial Agents|anti-bacterial agents
450864|NCT01220648|Chronic myeloid leukemia|chronic myeloid leukemia
450865|NCT01220648|interferon alfa|interferon alfa
450866|NCT01220648|nilotinib|nilotinib
450867|NCT01220648|combination|combination
450868|NCT01220648|CML|cml
450869|NCT01220648|Philadelphia chromosome positive (Ph+) chronic myeloid leukemia patients in chronic phase (CML-CP) after switch from previous CML treatment|philadelphia chromosome positive (ph+) chronic myeloid leukemia patients in chronic phase (cml-cp) after switch from previous cml treatment
450870|NCT01220635|Depressive Symptoms|depressive symptoms
450871|NCT01220635|Depression prevention|depression prevention
450872|NCT01220635|Adolescents|adolescents
450873|NCT01220635|School-Based Services|school-based services
450874|NCT01220635|Health Behavior|health behavior
450875|NCT01220622|Stroke|stroke
450876|NCT01220622|Mild cognitive impairment|mild cognitive impairment
450877|NCT01220622|Nimodipine|nimodipine
450878|NCT01220583|stage I salivary gland cancer|stage i salivary gland cancer
450879|NCT01220583|stage II salivary gland cancer|stage ii salivary gland cancer
450880|NCT01220583|stage III salivary gland cancer|stage iii salivary gland cancer
450881|NCT01220583|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
450882|NCT01220583|salivary gland adenocarcinoma|salivary gland adenocarcinoma
450883|NCT01220583|stage IVA salivary gland cancer|stage iva salivary gland cancer
450884|NCT01220583|stage IVB salivary gland cancer|stage ivb salivary gland cancer
450885|NCT01220583|stage IVC salivary gland cancer|stage ivc salivary gland cancer
450886|NCT01220570|breast cancer|breast cancer
450887|NCT01220570|ridaforolimus|ridaforolimus
450888|NCT01220570|ridaforolimus/dalotuzumab combination therapy|ridaforolimus/dalotuzumab combination therapy
450889|NCT01220557|Diabetes mellitus, education, self management|diabetes mellitus, education, self management
450890|NCT01220531|DiGeorge Anomaly|digeorge anomaly
450891|NCT01220531|Thymus Transplantation|thymus transplantation
450892|NCT01220531|DiGeorge Syndrome|digeorge syndrome
450893|NCT01220531|Athymia|athymia
450894|NCT01220531|Low T cell numbers|low t cell numbers
450895|NCT01220531|Immunoreconstitution|immunoreconstitution
450896|NCT01220531|Immunodeficiency|immunodeficiency
450897|NCT01220531|Complete DiGeorge|complete digeorge
450898|NCT01220531|Typical DiGeorge|typical digeorge
450899|NCT01220531|Atypical DiGeorge|atypical digeorge
450900|NCT01220531|Complete DiGeorge Anomaly|complete digeorge anomaly
450901|NCT01220505|scoliosis|scoliosis
450902|NCT01220505|kyphosis|kyphosis
450903|NCT01220505|spinal deformity|spinal deformity
450904|NCT01220505|curvature|curvature
450905|NCT01220505|lordosis|lordosis
450906|NCT01220492|liver cirrhosis|liver cirrhosis
450907|NCT01220492|mesenchymal stem cells|mesenchymal stem cells
450908|NCT01220492|ascites|ascites
450909|NCT01220492|serum albumin|serum albumin
450910|NCT01220479|Type 1 Diabetes, Bone mineral density, Growth|type 1 diabetes, bone mineral density, growth
450911|NCT01220479|Cardiovascular diseases, Exercise, Training,|cardiovascular diseases, exercise, training,
450912|NCT01220479|Child, Adolescent|child, adolescent
450913|NCT01220440|ADHD|adhd
450914|NCT01220440|Children|children
450915|NCT01220440|Methylphenidate|methylphenidate
450916|NCT01220440|Dextroamphetamine|dextroamphetamine
450917|NCT01220440|Placebo|placebo
450918|NCT01220440|Crossover|crossover
450919|NCT01220440|Double Blind|double blind
450920|NCT01220440|Neuropsychological tests|neuropsychological tests
450921|NCT01220440|Behavioural Questionnaires|behavioural questionnaires
450922|NCT01220427|high-risk prostate cancer|high-risk prostate cancer
450923|NCT01220427|radical prostatectomy|radical prostatectomy
450924|NCT01220427|micro-RNA|micro-rna
450925|NCT01220401|Nightmare|nightmare
450926|NCT01220401|PTSD|ptsd
450927|NCT01220401|Posttraumatic stress disorder|posttraumatic stress disorder
450928|NCT01220401|Suicide|suicide
450929|NCT01220401|Exposure Relaxation Rescription Therapy|exposure relaxation rescription therapy
450930|NCT01220401|Sleep|sleep
450931|NCT01220388|Aldosterone|aldosterone
450932|NCT01220388|L-lysine|l-lysine
450933|NCT01220388|Cortisol|cortisol
450934|NCT01220388|Adrenal glands|adrenal glands
450935|NCT01220375|Mobilization of autologous peripheral blood progenitor cells PBPC|mobilization of autologous peripheral blood progenitor cells pbpc
450936|NCT01220375|Autologous stem cell mobilization|autologous stem cell mobilization
450937|NCT01220375|Multiple Myeloma|multiple myeloma
450938|NCT01220375|Plerixafor|plerixafor
450939|NCT01220362|Analgesia, Epidural|analgesia, epidural
450940|NCT01220362|Urodynamics|urodynamics
450941|NCT01220362|Urinary Retention|urinary retention
450942|NCT01220284|solid tumors|solid tumors
450943|NCT01220284|oral treatment|oral treatment
450944|NCT01220284|platinum compound|platinum compound
450945|NCT01220284|vinca alkaloid|vinca alkaloid
450946|NCT01220284|drug combination|drug combination
450947|NCT01220271|Glioma|glioma
450948|NCT01220271|Glioblastoma|glioblastoma
450949|NCT01220245|endoluminal|endoluminal
450950|NCT01220245|surgical|surgical
450951|NCT01220245|bypass|bypass
450952|NCT01220245|patency|patency
450953|NCT01220245|quality of life|quality of life
450954|NCT01220245|multicentre|multicentre
450955|NCT01220245|RCT|rct
450956|NCT01220245|superficial femoral artery|superficial femoral artery
450957|NCT01220245|vascular patency|vascular patency
450958|NCT01220232|Lersivirine|lersivirine
450959|NCT01220232|UK-453|uk-453
450960|NCT01220232|061|061
450961|NCT01220232|NNRTI|nnrti
450962|NCT01220232|Abacavir|abacavir
450963|NCT01220232|Lamivudine|lamivudine
450964|NCT01220232|Combivir|combivir
450965|NCT01220232|Pharmacokinetics|pharmacokinetics
450966|NCT01220232|Drug Interaction|drug interaction
450967|NCT01220232|HIV|hiv
450968|NCT01220232|AIDS|aids
450969|NCT01220219|pregabalin|pregabalin
450970|NCT01220219|pharmacokinetics|pharmacokinetics
450971|NCT01220219|bioavailability|bioavailability
450972|NCT01220219|bioequivalence|bioequivalence
450973|NCT01220206|ED|ed
450974|NCT01220206|POMx|pomx
450975|NCT01220206|Pomegranate|pomegranate
450976|NCT01220206|Erectile dysfunction|erectile dysfunction
450977|NCT01220180|epilepsy|epilepsy
450978|NCT01220180|neuropathic pain|neuropathic pain
450979|NCT01220180|fibromyalgia|fibromyalgia
450980|NCT01220180|post-market surveillance|post-market surveillance
450981|NCT01220180|prospective observational|prospective observational
450982|NCT01220154|ovarian|ovarian
450983|NCT01220154|cancer|cancer
450984|NCT01220154|fallopian tube|fallopian tube
450985|NCT01220154|peritoneal|peritoneal
450986|NCT01220154|intraperitoneal|intraperitoneal
450987|NCT01220154|bevacizumab|bevacizumab
450988|NCT01220154|carboplatin|carboplatin
450989|NCT01220154|paclitaxel|paclitaxel
450990|NCT01220154|chemo-naive|chemo-naive
450991|NCT01220128|WT1|wt1
450992|NCT01220128|neoadjuvant|neoadjuvant
450993|NCT01220128|tumor antigen|tumor antigen
450994|NCT01220128|immunotherapy|immunotherapy
450995|NCT01220128|breast cancer|breast cancer
450996|NCT01220128|adult|adult
450997|NCT01220115|sickle cell disease|sickle cell disease
450998|NCT01220115|iron over load|iron over load
450999|NCT01220102|acne|acne
451000|NCT01220102|Epiduo|epiduo
451001|NCT01220102|adapalene/ benzoyl peroxide|adapalene/ benzoyl peroxide
451002|NCT01220089|obesity|obesity
451003|NCT01220089|weight loss|weight loss
451004|NCT01220076|Tamoxifen,|tamoxifen,
451005|NCT01220076|Breat Cancer|breat cancer
451006|NCT01220076|Pharmacogenetic|pharmacogenetic
451007|NCT01220076|non metastatic breast cancer, HR +|non metastatic breast cancer, hr +
451008|NCT01220063|RSHF|rshf
451009|NCT01220063|Irinotecan|irinotecan
451010|NCT01220063|Colorectal Cancer|colorectal cancer
451011|NCT01220063|metastases|metastases
451012|NCT01220050|Paricalcitol|paricalcitol
451013|NCT01220050|Renal transplant|renal transplant
451014|NCT01220050|Secondary Hyperparathyroidism|secondary hyperparathyroidism
451015|NCT01220011|Fetoscopic Laser surgery|fetoscopic laser surgery
451016|NCT01220011|Stage 1 Twin - twin transfusion syndrome|stage 1 twin - twin transfusion syndrome
451017|NCT01219998|Postoperative Complications|postoperative complications
451018|NCT01219998|Acute Kidney Failure|acute kidney failure
451019|NCT01219998|Peritoneal Dialysis|peritoneal dialysis
451020|NCT01219998|NGAL|ngal
451021|NCT01219985|positron emission tomography / computed tomography|positron emission tomography / computed tomography
451022|NCT01219985|18F-fluoro-2-deoxyglucose|18f-fluoro-2-deoxyglucose
451023|NCT01219985|liver neoplasm|liver neoplasm
451024|NCT01219985|respiratory motion|respiratory motion
451025|NCT01219972|Bone marrow transplant|bone marrow transplant
451026|NCT01219972|Pulmonary complications|pulmonary complications
451027|NCT01219959|ESRD|esrd
451028|NCT01219959|Diabetes|diabetes
451029|NCT01219959|CAPD|capd
451030|NCT01219946|Chronic Obstructive Pulmonary Disease, symptoms|chronic obstructive pulmonary disease, symptoms
451031|NCT01219920|Metastatic colorectal cancer|metastatic colorectal cancer
451032|NCT01219920|Phase III|phase iii
451033|NCT01219920|FOLFOXIRI|folfoxiri
451034|NCT01219920|FOLFIRI|folfiri
451035|NCT01219894|Coronary Disease|coronary disease
451036|NCT01219894|Stent|stent
451037|NCT01219894|Healing|healing
451038|NCT01219894|Anti-platelet therapy|anti-platelet therapy
451039|NCT01219881|desflurane|desflurane
451040|NCT01219881|sevoflurane|sevoflurane
451041|NCT01219855|Parathyroid Diseases|parathyroid diseases
451042|NCT01219855|Renal Insufficiency|renal insufficiency
451043|NCT01219855|Kidney Failure, Chronic|kidney failure, chronic
451044|NCT01219855|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
451045|NCT01219855|Vitamin D|vitamin d
451046|NCT01219855|Hyperparathyroidism|hyperparathyroidism
451047|NCT01219855|Kidney Diseases|kidney diseases
451048|NCT01219855|Kidney Failure|kidney failure
451049|NCT01219855|Renal Insufficiency, Chronic|renal insufficiency, chronic
451050|NCT01219842|Intermittent claudication|intermittent claudication
451051|NCT01219842|Health Related Quality of Life|health related quality of life
451052|NCT01219842|Walking performance|walking performance
451053|NCT01219842|Daily walking capacity|daily walking capacity
451054|NCT01219829|Pancreatic intraepithelial neoplasia (PanIN)|pancreatic intraepithelial neoplasia (panin)
451055|NCT01219829|Pancreatic Cancer|pancreatic cancer
451056|NCT01219829|Recurrence of pancreatic cancer|recurrence of pancreatic cancer
451057|NCT01219829|Field Effect|field effect
451058|NCT01219829|Genetic mutations in pancreatic cancer|genetic mutations in pancreatic cancer
451059|NCT01219816|efficacy of Chemo-immunotherapy|efficacy of chemo-immunotherapy
451060|NCT01219803|Dose-Response Relationship, type 2 diabetes,TCM|dose-response relationship, type 2 diabetes,tcm
451061|NCT01219790|Patients with painful vertebral metastases with a prostate cancer with an indication of analgesic treatment.|patients with painful vertebral metastases with a prostate cancer with an indication of analgesic treatment.
451062|NCT01219777|bevacizumab|bevacizumab
451063|NCT01219777|paclitaxel|paclitaxel
451064|NCT01219777|carboplatin|carboplatin
451065|NCT01219777|ovarian|ovarian
451066|NCT01219777|cancer|cancer
451067|NCT01219777|fallopian tube|fallopian tube
451068|NCT01219777|primary peritoneal|primary peritoneal
451069|NCT01219764|Helicobacter pylori infection|helicobacter pylori infection
451070|NCT01219764|quadruple therapy|quadruple therapy
451071|NCT01219764|Amoxicillin|amoxicillin
451072|NCT01219764|Metronidazole|metronidazole
451073|NCT01219764|Clarithromycin|clarithromycin
451074|NCT01219764|Rabeprazole|rabeprazole
451075|NCT01219738|Asthma, airway blood flow, budesonide, glucocorticosteroid.|asthma, airway blood flow, budesonide, glucocorticosteroid.
451076|NCT01219725|Body composition|body composition
451077|NCT01219725|Endothelial function|endothelial function
451078|NCT01219725|Lipoprotein profile|lipoprotein profile
451079|NCT01219725|Inflammatory markers|inflammatory markers
451080|NCT01219725|Aerobic capacity|aerobic capacity
451081|NCT01219725|Thrombotic markers|thrombotic markers
451082|NCT01219725|Arterial stiffness|arterial stiffness
451083|NCT01219725|Cardiac function|cardiac function
451084|NCT01219725|Traditional and emerging cardiovascular disease risk factors|traditional and emerging cardiovascular disease risk factors
451085|NCT01219712|NT-proBNP|nt-probnp
451086|NCT01219712|non-cardiac surgery|non-cardiac surgery
451087|NCT01219712|left ventricular dysfunction|left ventricular dysfunction
451088|NCT01219712|cardiac complications|cardiac complications
451089|NCT01219699|advanced solid tumors|advanced solid tumors
451090|NCT01219699|mutation|mutation
451091|NCT01219699|amplification|amplification
451092|NCT01219699|wild type|wild type
451093|NCT01219699|PIK3CA gene|pik3ca gene
451094|NCT01219699|dose-escalation|dose-escalation
451095|NCT01219699|estrogen receptor positive breast cancer|estrogen receptor positive breast cancer
451096|NCT01219686|unipolar depression, escitalopram, pindolol|unipolar depression, escitalopram, pindolol
451097|NCT01219673|Epithelial carcinoma|epithelial carcinoma
451098|NCT01219673|Oropharynx|oropharynx
451099|NCT01219673|Larynx|larynx
451100|NCT01219673|Symptom-management|symptom-management
451101|NCT01219673|Chemoradiation|chemoradiation
451102|NCT01219673|Placebo|placebo
451103|NCT01219673|Armodafinil|armodafinil
451104|NCT01219673|Nuvigil|nuvigil
451105|NCT01219673|Bupropion|bupropion
451106|NCT01219673|Wellbutrin|wellbutrin
451107|NCT01219673|Wellbutrin SR|wellbutrin sr
451108|NCT01219673|Zyban|zyban
451109|NCT01219673|Minocycline|minocycline
451110|NCT01219673|Dynacin|dynacin
451111|NCT01219673|Minocin|minocin
451112|NCT01219673|Minocin PAC|minocin pac
451113|NCT01219673|Myrac|myrac
451114|NCT01219673|Solodyn|solodyn
451115|NCT01219660|sleep|sleep
451116|NCT01219660|apnea|apnea
451117|NCT01219647|Multiple Sclerosis|multiple sclerosis
451118|NCT01219647|Exercise|exercise
451119|NCT01219647|Cognition|cognition
451120|NCT01219621|Symphony DR 2550,|symphony dr 2550,
451121|NCT01219621|Dual Chamber Pacemaker,|dual chamber pacemaker,
451122|NCT01219621|Sorin,|sorin,
451123|NCT01219621|Ela Medical,|ela medical,
451124|NCT01219621|DDD Mode,|ddd mode,
451125|NCT01219621|AAIsafeR2 mode,|aaisafer2 mode,
451126|NCT01219621|AV-Conduction,|av-conduction,
451127|NCT01219621|Reducing Ventricular Pacing,|reducing ventricular pacing,
451128|NCT01219621|Congestive Heart Failure,|congestive heart failure,
451129|NCT01219621|Cardiac Function,|cardiac function,
451130|NCT01219621|Atrial Arrhythmia,|atrial arrhythmia,
451131|NCT01219621|Atrial Fibrillation,|atrial fibrillation,
451132|NCT01219621|Atrial and Ventricular Hemodynamics,|atrial and ventricular hemodynamics,
451133|NCT01219621|Long AV-delays.|long av-delays.
451134|NCT01219621|Ventricular Function,|ventricular function,
451135|NCT01219621|Implantation,|implantation,
451136|NCT01219595|Urinary Tract Infection|urinary tract infection
451137|NCT01219595|UTI|uti
451138|NCT01219582|Diabetes Mellitus Type-2|diabetes mellitus type-2
451139|NCT01219582|Acarbose|acarbose
451140|NCT01219582|Metformin|metformin
451141|NCT01219582|Drug Therapy, Combination|drug therapy, combination
451142|NCT01219569|blindness|blindness
451143|NCT01219569|ischemic optic neuropathy|ischemic optic neuropathy
451144|NCT01219556|Hypertension|hypertension
451145|NCT01219556|Antihypertensive Agents|antihypertensive agents
451146|NCT01219556|Drug Therapy, Combination|drug therapy, combination
451147|NCT01219556|Olmesartan Medoxomil|olmesartan medoxomil
451148|NCT01219556|Hydrochlorothiazide|hydrochlorothiazide
451149|NCT01219543|Advanced solid malignancies|advanced solid malignancies
451150|NCT01219543|Child-Pugh A to B7 advanced hepatocellular carcinoma|child-pugh a to b7 advanced hepatocellular carcinoma
451151|NCT01219543|EGFR and/or ROS mutant NSCLC|egfr and/or ros mutant nsclc
451152|NCT01219543|Non-smokers with lung metastasis|non-smokers with lung metastasis
451153|NCT01219543|Gastric cancer|gastric cancer
451154|NCT01219543|Solid tumour|solid tumour
451155|NCT01219543|AZD1480|azd1480
451156|NCT01219543|JAK1/JAK2 kinase inhibitor|jak1/jak2 kinase inhibitor
451157|NCT01219530|gestational carrier|gestational carrier
451158|NCT01219530|intended parent|intended parent
451159|NCT01219517|IVF|ivf
451160|NCT01219517|embryo biopsy|embryo biopsy
451161|NCT01219517|DNA fingerprinting|dna fingerprinting
451162|NCT01219517|SNP|snp
451163|NCT01219504|PGD|pgd
451164|NCT01219504|IVF|ivf
451165|NCT01219491|egg donor|egg donor
451166|NCT01219491|recipients|recipients
451167|NCT01219491|donor characteristics|donor characteristics
451168|NCT01219478|To investigate the relationship between retinal thickness (RT) and metabolic risks (MRs) in patients without retinal lesion|to investigate the relationship between retinal thickness (rt) and metabolic risks (mrs) in patients without retinal lesion
451169|NCT01219465|Diabetes Mellitus|diabetes mellitus
451170|NCT01219465|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
451171|NCT01219465|mesenchymal stem cells|mesenchymal stem cells
451172|NCT01219465|Umbilical cord|umbilical cord
451173|NCT01219452|Dilated Cardiomyopathy|dilated cardiomyopathy
451174|NCT01219452|Umbilical cord|umbilical cord
451175|NCT01219452|Mesenchymal stem cells|mesenchymal stem cells
451176|NCT01219452|Children|children
451177|NCT01219439|discarded pathological specimens|discarded pathological specimens
451178|NCT01219439|discarded media|discarded media
451179|NCT01219439|IVF|ivf
451180|NCT01219426|Gambling|gambling
451181|NCT01219426|cognitive distortions|cognitive distortions
451182|NCT01219426|assessment tool|assessment tool
451183|NCT01219426|validation|validation
451184|NCT01219426|French|french
451185|NCT01219413|aliskiren|aliskiren
451186|NCT01219413|renin inhibitor|renin inhibitor
451187|NCT01219413|proteinuria|proteinuria
451188|NCT01219413|chronic kidney diseases|chronic kidney diseases
451189|NCT01219413|ACE inhibitor|ace inhibitor
451190|NCT01219400|DPP-4|dpp-4
451191|NCT01219400|GLP-1|glp-1
451192|NCT01219400|Glucagon|glucagon
451193|NCT01219400|Catecholamines|catecholamines
451194|NCT01219400|Counterregulation|counterregulation
451195|NCT01219400|Insulin-treatment|insulin-treatment
451196|NCT01219400|Type 2 diabetes|type 2 diabetes
451197|NCT01219387|AMH|amh
451198|NCT01219387|inhibin B|inhibin b
451199|NCT01219387|infertility|infertility
451200|NCT01219374|egg donor|egg donor
451201|NCT01219361|Donated embryos|donated embryos
451202|NCT01219348|IDO enzyme|ido enzyme
451203|NCT01219348|Vaccination trial|vaccination trial
451204|NCT01219348|Immunotherapy|immunotherapy
451205|NCT01219348|NSCLC, stage III_IV|nsclc, stage iii_iv
451206|NCT01219348|Indeolamine 2,3 dioxygenase = IDO|indeolamine 2,3 dioxygenase = ido
451207|NCT01219335|IVF|ivf
451208|NCT01219322|general endotracheal anesthesia|general endotracheal anesthesia
451209|NCT01219322|ASA I or II|asa i or ii
451210|NCT01219309|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
451211|NCT01219309|Omega 3/6 fatty acids|omega 3/6 fatty acids
451212|NCT01219309|Developmental coordination disorder|developmental coordination disorder
451213|NCT01219309|Reading/writing difficulties.|reading/writing difficulties.
451214|NCT01219296|infertility|infertility
451215|NCT01219296|IVF|ivf
451216|NCT01219283|PGD|pgd
451217|NCT01219283|IVF|ivf
451218|NCT01219270|Radiocontrast media,|radiocontrast media,
451219|NCT01219270|hyponatremia|hyponatremia
451220|NCT01219257|SpA|spa
451221|NCT01219257|Anti-TNF alpha treatment|anti-tnf alpha treatment
451222|NCT01219257|Ultrasonography|ultrasonography
451223|NCT01219257|Synovitis|synovitis
451224|NCT01219257|Enthesitis|enthesitis
451225|NCT01219244|memory|memory
451226|NCT01219244|diet|diet
451227|NCT01219244|elderly|elderly
451228|NCT01219244|cognition|cognition
451229|NCT01219244|prevention|prevention
451230|NCT01219244|lifestyle|lifestyle
451231|NCT01219231|Exercise|exercise
451232|NCT01219231|elderly|elderly
451233|NCT01219231|cognition|cognition
451234|NCT01219231|prevention|prevention
451235|NCT01219231|cognitive decline|cognitive decline
451236|NCT01219231|Lifestyle|lifestyle
451237|NCT01219218|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
451238|NCT01219218|Myocardial Ischemia|myocardial ischemia
451239|NCT01219218|Refractory Angina|refractory angina
451240|NCT01219205|macular edema secondary to retinal benous occlusion|macular edema secondary to retinal benous occlusion
451241|NCT01219179|Extremely Low Birth Weight Infants|extremely low birth weight infants
451242|NCT01219179|Hypernatremia|hypernatremia
451243|NCT01219179|Enteral Sterile Water Feeds|enteral sterile water feeds
451244|NCT01219153|Letrozole ,IVF, poor responders , GnRH antagonist|letrozole ,ivf, poor responders , gnrh antagonist
451245|NCT01219140|POMx|pomx
451246|NCT01219140|Osteopenia|osteopenia
451247|NCT01219140|postmenopausal women|postmenopausal women
451248|NCT01219140|Pomegranate|pomegranate
451249|NCT01219127|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
451250|NCT01219114|Daptomycin|daptomycin
451251|NCT01219114|endocarditis|endocarditis
451252|NCT01219114|complicated skin and skin structure infection|complicated skin and skin structure infection
451253|NCT01219101|Ethinyl estradiol|ethinyl estradiol
451254|NCT01219101|Polycystic ovary syndrome|polycystic ovary syndrome
451255|NCT01219101|Intrauterine insemination|intrauterine insemination
451256|NCT01219049|Diet|diet
451257|NCT01219049|Fibromyalgia|fibromyalgia
451258|NCT01219049|Pain|pain
451259|NCT01219049|Drug|drug
451260|NCT01219049|Amino-acid|amino-acid
451261|NCT01219049|Fatigue|fatigue
451262|NCT01219036|Asthma|asthma
451263|NCT01219036|Non-adherence|non-adherence
451264|NCT01219036|Fractional exhaled nitric oxide|fractional exhaled nitric oxide
451265|NCT01219023|Hand foot syndrome|hand foot syndrome
451266|NCT01219023|Palmar Plantar Erythrodysesthesia|palmar plantar erythrodysesthesia
451267|NCT01219023|chemotherapy|chemotherapy
451268|NCT01219023|Sunitinib|sunitinib
451269|NCT01219023|Capecitebine|capecitebine
451270|NCT01219023|Sildenafil|sildenafil
451271|NCT01219010|Monoclonal Gammopathy of Undetermined Significance|monoclonal gammopathy of undetermined significance
451272|NCT01219010|Smoldering Multiple Myeloma|smoldering multiple myeloma
451273|NCT01219010|Indolent Multiple Myeloma|indolent multiple myeloma
451274|NCT01219010|QT|qt
451275|NCT01219010|Siltuximab|siltuximab
451276|NCT01219010|CNTO 328|cnto 328
451277|NCT01219010|IL-6|il-6
451278|NCT01219010|Monoclonal Antibody|monoclonal antibody
451279|NCT01218997|Alcoholism|alcoholism
451280|NCT01218997|Alcohol dependence|alcohol dependence
451281|NCT01218984|Opiate Dependence|opiate dependence
451282|NCT01218971|Alcohol Dependence|alcohol dependence
451283|NCT01218958|Alcoholism|alcoholism
451284|NCT01218932|primaquine|primaquine
451285|NCT01218932|chloroquine|chloroquine
451286|NCT01218932|pharmacokinetic|pharmacokinetic
451287|NCT01218932|interactions|interactions
451288|NCT01218906|Dengue Fever Fever Dengue Infection|dengue fever fever dengue infection
451289|NCT01218867|Clinical Response|clinical response
451290|NCT01218867|Metastatic Cancer|metastatic cancer
451291|NCT01218867|Immunotherapy|immunotherapy
451292|NCT01218867|Adoptive Cell Therapy|adoptive cell therapy
451293|NCT01218867|Metastatic Melanoma|metastatic melanoma
451294|NCT01218854|Biopsy|biopsy
451295|NCT01218854|Surgical Navigation|surgical navigation
451296|NCT01218854|Image-guided Therapy|image-guided therapy
451297|NCT01218854|CT- Guided Biopsy|ct- guided biopsy
451298|NCT01218854|Cancer|cancer
451299|NCT01218841|Fish oil|fish oil
451300|NCT01218841|Omega-3 fatty acids|omega-3 fatty acids
451301|NCT01218841|Parenteral lipid emulsions|parenteral lipid emulsions
451302|NCT01218841|Immune response|immune response
451303|NCT01218841|Surgery|surgery
451304|NCT01218828|Contrast|contrast
451305|NCT01218828|nephropathy|nephropathy
451306|NCT01218828|cardiac catheterization|cardiac catheterization
451307|NCT01218828|angiography|angiography
451308|NCT01218828|percutaneous coronary intervention is|percutaneous coronary intervention is
451309|NCT01218802|HIV|hiv
451310|NCT01218802|Heart Disease|heart disease
451311|NCT01218802|Bone Density|bone density
451312|NCT01218789|Blindness|blindness
451313|NCT01218789|Eye Diseases|eye diseases
451314|NCT01218789|Nap Disorders|nap disorders
451315|NCT01218789|Circadian Rhythm Disorders|circadian rhythm disorders
451316|NCT01218789|Sleep disorders|sleep disorders
451317|NCT01218789|Circadian Rhythm Sleep Disorders|circadian rhythm sleep disorders
451318|NCT01218789|Dyssomnias|dyssomnias
451319|NCT01218789|Nervous System Diseases|nervous system diseases
451320|NCT01218776|Acute Coronary Syndrome, Eastern Europe, Therapies|acute coronary syndrome, eastern europe, therapies
451321|NCT01218763|Cardiac Event recorder|cardiac event recorder
451322|NCT01218763|Sensitivity|sensitivity
451323|NCT01218763|Efficacy|efficacy
451324|NCT01218750|DDME, ppV, ILM peeling, bevacizumab injection|ddme, ppv, ilm peeling, bevacizumab injection
451325|NCT01218685|Immunocompromised patients|immunocompromised patients
451326|NCT01218685|Safety of pandemic influenza A (H1N1)vaccine|safety of pandemic influenza a (h1n1)vaccine
451327|NCT01218685|Immunogenicity of pandemic influenza A (H1N1)vaccine|immunogenicity of pandemic influenza a (h1n1)vaccine
451328|NCT01218672|BPH|bph
451329|NCT01218672|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
451330|NCT01218659|Fabry Disease|fabry disease
451331|NCT01218646|Influenza|influenza
451332|NCT01218646|Quadrivalent Inactivated Influenza Vaccine|quadrivalent inactivated influenza vaccine
451333|NCT01218646|Trivalent Inactivated Influenza Vaccine|trivalent inactivated influenza vaccine
451334|NCT01218646|Influenza viruses|influenza viruses
451335|NCT01218607|Heart Septal Defects, Atrial|heart septal defects, atrial
451336|NCT01218607|Pulmonary Circulation|pulmonary circulation
451337|NCT01218607|Ventricular Function, Right|ventricular function, right
451338|NCT01218607|Echocardiography, Stress|echocardiography, stress
451339|NCT01218607|Ergometry|ergometry
451340|NCT01218607|Tissue Doppler Imaging|tissue doppler imaging
451341|NCT01218594|Stage III|stage iii
451342|NCT01218594|Unresectable|unresectable
451343|NCT01218594|Non-small cell lung cancer|non-small cell lung cancer
451344|NCT01218581|Adenomyosis, letrozole, GnRH-a|adenomyosis, letrozole, gnrh-a
451345|NCT01218555|kidney cancer|kidney cancer
451346|NCT01218555|adenoidcystic cancer|adenoidcystic cancer
451347|NCT01218542|Secondary brain malignancies|secondary brain malignancies
451348|NCT01218542|RapidArc|rapidarc
451349|NCT01218542|Volumetric modulated arc therapy|volumetric modulated arc therapy
451350|NCT01218529|Brain metastases from lung and breast tumors|brain metastases from lung and breast tumors
451351|NCT01218490|surgery|surgery
451352|NCT01218490|ovarian cancer|ovarian cancer
451353|NCT01218490|lymphadectomy|lymphadectomy
451354|NCT01218477|Leukemia|leukemia
451355|NCT01218477|(Chronic Myeloid Leukemia-Chronic Phase and Advanced)|(chronic myeloid leukemia-chronic phase and advanced)
451356|NCT01218464|Liver Failure|liver failure
451357|NCT01218464|Mesenchymal Stem Cells|mesenchymal stem cells
451358|NCT01218464|Model for End-Stage Liver Disease|model for end-stage liver disease
451359|NCT01218464|Ascite|ascite
451360|NCT01218464|Serum Albumin|serum albumin
451361|NCT01218425|dopamine|dopamine
451362|NCT01218425|EEG|eeg
451363|NCT01218425|episodic memory|episodic memory
451364|NCT01218425|contingent negative variation|contingent negative variation
451365|NCT01218425|response preparation|response preparation
451366|NCT01218425|levodopa|levodopa
451367|NCT01218425|methylphenidate|methylphenidate
451368|NCT01218412|Physical Activity|physical activity
451369|NCT01218412|Motivational Interviewing|motivational interviewing
451370|NCT01218412|Web-based|web-based
451371|NCT01218412|Physician Referral|physician referral
451372|NCT01218399|Asthma|asthma
451373|NCT01218386|ICSI|icsi
451374|NCT01218386|GnRH antagonists|gnrh antagonists
451375|NCT01218386|planning|planning
451376|NCT01218373|older people|older people
451377|NCT01218373|living independently at home|living independently at home
451378|NCT01218360|Crohn's disease|crohn's disease
451379|NCT01218360|standard-of-care|standard-of-care
451380|NCT01218360|Crohn Disease|crohn disease
451381|NCT01218360|Active Crohn's Disease|active crohn's disease
451382|NCT01218347|OATP1B1|oatp1b1
451383|NCT01218347|rosuvastatin|rosuvastatin
451384|NCT01218321|antiepileptic drugs|antiepileptic drugs
451385|NCT01218321|mitochondria|mitochondria
451386|NCT01218308|Influenza|influenza
451387|NCT01218295|COPD|copd
451388|NCT01218295|inspiratory muscles training|inspiratory muscles training
451389|NCT01218282|COPD|copd
451390|NCT01218282|home exercise training|home exercise training
451391|NCT01218269|anastomoses|anastomoses
451392|NCT01218256|diabetes mellitus|diabetes mellitus
451393|NCT01218256|type 2 diabetes|type 2 diabetes
451394|NCT01218256|T2DM|t2dm
451395|NCT01218256|resistance training|resistance training
451396|NCT01218256|hypertrophy training|hypertrophy training
451397|NCT01218256|endurance training|endurance training
451398|NCT01218243|Acupuncture|acupuncture
451399|NCT01218243|Mild and moderate BPH|mild and moderate bph
451400|NCT01218230|Pegaptanib, myopic CNVM, intravitreal anti-VEGF|pegaptanib, myopic cnvm, intravitreal anti-vegf
451401|NCT01218217|TB|tb
451402|NCT01218217|Tuberculosis|tuberculosis
451403|NCT01218217|EBA|eba
451404|NCT01218217|Pulmonary|pulmonary
451405|NCT01218217|Early Bactericidal Activity|early bactericidal activity
451406|NCT01218204|Pharmacodynamics|pharmacodynamics
451407|NCT01218204|Lipids|lipids
451408|NCT01218204|Dyslipidemia|dyslipidemia
451409|NCT01218204|Safety|safety
451410|NCT01218204|GSK1292263|gsk1292263
451411|NCT01218204|Ezetimibe|ezetimibe
451412|NCT01218204|Statin|statin
451413|NCT01218204|Pharmacokinetics|pharmacokinetics
451414|NCT01218204|Tolerability|tolerability
451415|NCT01218204|Atorvastatin|atorvastatin
451416|NCT01218191|subarachnoid hemorrhage|subarachnoid hemorrhage
451417|NCT01218191|scintigraphy|scintigraphy
451418|NCT01218191|neurocardiogenic injury|neurocardiogenic injury
451419|NCT01218178|acute myocardial infarction|acute myocardial infarction
451420|NCT01218178|acute kidney injury|acute kidney injury
451421|NCT01218178|contrast induced nephropathy|contrast induced nephropathy
451422|NCT01218178|primary PCI|primary pci
451423|NCT01218178|sodium-bicarbonate|sodium-bicarbonate
451424|NCT01218178|N-acetylcysteine|n-acetylcysteine
451425|NCT01218165|Healthy Eldery People|healthy eldery people
451426|NCT01218152|NF1|nf1
451427|NCT01218152|MPNST|mpnst
451428|NCT01218152|plasma|plasma
451429|NCT01218152|microarray CGH|microarray cgh
451430|NCT01218139|neurofibroma|neurofibroma
451431|NCT01218139|MPNST|mpnst
451432|NCT01218139|array CGH|array cgh
451433|NCT01218139|sequencing|sequencing
451434|NCT01218113|Human Immunodeficiency Virus (HIV)-1|human immunodeficiency virus (hiv)-1
451435|NCT01218113|safety|safety
451436|NCT01218113|vaccine|vaccine
451437|NCT01218113|immunogenicity|immunogenicity
451438|NCT01218113|reactogenicity|reactogenicity
451439|NCT01218113|HIV infection|hiv infection
451440|NCT01218087|Positional Head Shape Deformity|positional head shape deformity
451441|NCT01218074|bleeding|bleeding
451442|NCT01218074|blood sparing procedure|blood sparing procedure
451443|NCT01218074|desmopressin|desmopressin
451444|NCT01218074|aggregometry|aggregometry
451445|NCT01218074|thromboelastography|thromboelastography
451446|NCT01218061|Pre-diabetes|pre-diabetes
451447|NCT01218061|Type 2 diabetes|type 2 diabetes
451448|NCT01218061|Biomarkers|biomarkers
451449|NCT01218061|Cohort|cohort
451450|NCT01218061|Diabetes Risk Score|diabetes risk score
451451|NCT01218048|Carcinoma|carcinoma
451452|NCT01218048|Head and Neck|head and neck
451453|NCT01218048|Cetuximab|cetuximab
451454|NCT01218048|Locally Advanced Head and Neck Squamous Cell Carcinoma|locally advanced head and neck squamous cell carcinoma
451455|NCT01218035|Hip osteoarthritis|hip osteoarthritis
451456|NCT01218035|Bisphophonate therapy|bisphophonate therapy
451457|NCT01218035|Zoledronic acid|zoledronic acid
451458|NCT01218035|Radiostereometric analysis|radiostereometric analysis
451459|NCT01218035|Osteoporosis|osteoporosis
451460|NCT01218009|asthma|asthma
451461|NCT01218009|dry powder inhaler|dry powder inhaler
451462|NCT01218009|short-acting beta2-agonist|short-acting beta2-agonist
451463|NCT01218009|SABA|saba
451464|NCT01218009|bronchoconstriction|bronchoconstriction
451465|NCT01218009|bronchodilation|bronchodilation
451466|NCT01218009|bronchodilator|bronchodilator
451467|NCT01218009|metered dose inhaler|metered dose inhaler
451468|NCT01217996|working memory intervention|working memory intervention
451469|NCT01217996|memory impairment|memory impairment
451470|NCT01217996|cognitive late effects|cognitive late effects
451471|NCT01217996|Childhood Cancer Survivors|childhood cancer survivors
451472|NCT01217970|methamphetamine|methamphetamine
451473|NCT01217970|dependence|dependence
451474|NCT01217970|stimulant|stimulant
451475|NCT01217970|amphetamine|amphetamine
451476|NCT01217970|los angeles|los angeles
451477|NCT01217970|meth|meth
451478|NCT01217970|speed|speed
451479|NCT01217970|crank|crank
451480|NCT01217970|abuse|abuse
451481|NCT01217957|Drug therapy|drug therapy
451482|NCT01217944|Pathologic myopia|pathologic myopia
451483|NCT01217944|PM|pm
451484|NCT01217944|choroidal neovascularization|choroidal neovascularization
451485|NCT01217944|CNV|cnv
451486|NCT01217944|ranibizumab|ranibizumab
451487|NCT01217944|verteporfin PDT|verteporfin pdt
451488|NCT01217931|Renal Cell Carcinoma|renal cell carcinoma
451489|NCT01217931|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
451490|NCT01217931|Clear cell component|clear cell component
451491|NCT01217931|RCC|rcc
451492|NCT01217931|Bevacizumab|bevacizumab
451493|NCT01217931|Everolimus|everolimus
451494|NCT01217931|Pazopanib|pazopanib
451495|NCT01217931|GW786034|gw786034
451496|NCT01217931|Avastin|avastin
451497|NCT01217931|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
451498|NCT01217931|rhuMAb-VEGF|rhumab-vegf
451499|NCT01217931|Afinitor|afinitor
451500|NCT01217931|RAD001|rad001
451501|NCT01217918|PH-797804|ph-797804
451502|NCT01217918|Japanese|japanese
451503|NCT01217918|Phase 1|phase 1
451504|NCT01217918|multiple dose study|multiple dose study
451505|NCT01217905|Phase 1|phase 1
451506|NCT01217905|Type 2 diabetes|type 2 diabetes
451507|NCT01217905|obesity|obesity
451508|NCT01217905|Japanese healthy volunteer|japanese healthy volunteer
451509|NCT01217905|AZD7687|azd7687
451510|NCT01217892|Type 2 diabetes|type 2 diabetes
451511|NCT01217892|metformin treated|metformin treated
451512|NCT01217892|inadequate control|inadequate control
451513|NCT01217892|metformin treatment alone|metformin treatment alone
451514|NCT01217879|Cough|cough
451515|NCT01217879|Telmisartan|telmisartan
451516|NCT01217879|Bradykinin|bradykinin
451517|NCT01217879|Tolerability|tolerability
451518|NCT01217866|laparoscopic|laparoscopic
451519|NCT01217866|vaginal|vaginal
451520|NCT01217866|hysterectomy|hysterectomy
451521|NCT01217840|Adolescents, Vitamin D|adolescents, vitamin d
451522|NCT01217788|Generalized Social Phobia|generalized social phobia
451523|NCT01217788|Social Anxiety Disorder|social anxiety disorder
451524|NCT01217788|Social Phobia|social phobia
451525|NCT01217788|Phobic Disorders|phobic disorders
451526|NCT01217788|Phobias|phobias
451527|NCT01217775|PMDD, Premenstrual, Dysphoria, Mood Swings, Bloating.|pmdd, premenstrual, dysphoria, mood swings, bloating.
451528|NCT01217762|Oraya|oraya
451529|NCT01217762|Oraya Therapeutics, Inc.|oraya therapeutics, inc.
451530|NCT01217762|low voltage stereotactic radiosurgery|low voltage stereotactic radiosurgery
451531|NCT01217762|radiosurgery|radiosurgery
451532|NCT01217762|radiotherapy|radiotherapy
451533|NCT01217762|IRay|iray
451534|NCT01217762|AMD|amd
451535|NCT01217762|Macular Degeneration|macular degeneration
451536|NCT01217762|Wet AMD|wet amd
451537|NCT01217762|xray|xray
451538|NCT01217762|radiation|radiation
451539|NCT01217762|x ray|x ray
451540|NCT01217762|external beam radiation|external beam radiation
451541|NCT01217762|Ranibizumab|ranibizumab
451542|NCT01217762|Lucentis|lucentis
451543|NCT01217723|Acute leukemia (myeloid,lymphoid,or biphenotypic)|acute leukemia (myeloid,lymphoid,or biphenotypic)
451544|NCT01217723|Chronic myeloid leukemia|chronic myeloid leukemia
451545|NCT01217723|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
451546|NCT01217723|Lymphoma|lymphoma
451547|NCT01217723|Myelodysplastic syndrome|myelodysplastic syndrome
451548|NCT01217723|Myeloproliferative disorder|myeloproliferative disorder
451549|NCT01217710|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
451550|NCT01217710|Physical Activity|physical activity
451551|NCT01217710|Self Management|self management
451552|NCT01217710|Exercise|exercise
451553|NCT01217710|Technology|technology
451554|NCT01217710|Motivational Interviewing|motivational interviewing
451555|NCT01217697|Metastatic Castration-Resistant Prostate Cancer (CRPC)|metastatic castration-resistant prostate cancer (crpc)
451556|NCT01217697|Abiraterone Acetate|abiraterone acetate
451557|NCT01217671|Pulmonary, Emphysema|pulmonary, emphysema
451558|NCT01217671|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
451559|NCT01217658|Randomized Trial|randomized trial
451560|NCT01217658|Infant Colic|infant colic
451561|NCT01217658|Abusive Head Trauma|abusive head trauma
451562|NCT01217658|Shaken Baby Syndrome|shaken baby syndrome
451563|NCT01217645|Major depression disorder|major depression disorder
451564|NCT01217632|Connective tissue growth factor (CTGF)|connective tissue growth factor (ctgf)
451565|NCT01217632|human IgG1 monoclonal antibody|human igg1 monoclonal antibody
451566|NCT01217619|neoadjuvant treatment|neoadjuvant treatment
451567|NCT01217593|mastectomy|mastectomy
451568|NCT01217593|breast cancer|breast cancer
451569|NCT01217593|breast surgery|breast surgery
451570|NCT01217580|c-section|c-section
451571|NCT01217580|cesarean section|cesarean section
451572|NCT01217580|TAP block|tap block
451573|NCT01217580|pain|pain
451574|NCT01217580|pain after delivery|pain after delivery
451575|NCT01217580|pain after C-section|pain after c-section
451576|NCT01217580|pain after C-section delivery|pain after c-section delivery
451577|NCT01217580|pain after cesarean delivery|pain after cesarean delivery
451578|NCT01217580|pain after cesarean|pain after cesarean
451579|NCT01217567|cicatrix|cicatrix
451580|NCT01217567|cesarean section|cesarean section
451581|NCT01217567|sutures|sutures
451582|NCT01217567|surgical staples|surgical staples
451583|NCT01217567|postoperative pain|postoperative pain
451584|NCT01217567|Infection|infection
451585|NCT01217554|Low Back Pain|low back pain
451586|NCT01217554|Disability|disability
451587|NCT01217554|Kinematic measures|kinematic measures
451588|NCT01217541|Dementia|dementia
451589|NCT01217541|BPSD|bpsd
451590|NCT01217541|Quality of Life|quality of life
451591|NCT01217541|Person-centred care|person-centred care
451592|NCT01217541|Job satisfaction|job satisfaction
451593|NCT01217541|Nursing home|nursing home
451594|NCT01217541|Primary care|primary care
451595|NCT01217528|ICD|icd
451596|NCT01217528|CRTD|crtd
451597|NCT01217528|Sudden cardiac death|sudden cardiac death
451598|NCT01217528|Device settings|device settings
451599|NCT01217528|Patients who received ICD/CRTD for primary prevention of sudden cardiac death|patients who received icd/crtd for primary prevention of sudden cardiac death
451600|NCT01217502|Aged|aged
451601|NCT01217502|Homes for the aged|homes for the aged
451602|NCT01217502|Self management|self management
451603|NCT01217502|Personal autonomy|personal autonomy
451604|NCT01217502|Disease management|disease management
451605|NCT01217502|Self efficacy|self efficacy
451606|NCT01217502|Participation|participation
451607|NCT01217489|breast|breast
451608|NCT01217489|cancer|cancer
451609|NCT01217489|diagnosis|diagnosis
451610|NCT01217489|electrical|electrical
451611|NCT01217489|non-invasive|non-invasive
451612|NCT01217489|mammography|mammography
451613|NCT01217476|Diabetic foot|diabetic foot
451614|NCT01217476|Neuropathic|neuropathic
451615|NCT01217476|Wound|wound
451616|NCT01217476|Growth factor|growth factor
451617|NCT01217463|Diabetic foot|diabetic foot
451618|NCT01217463|Neuropathic|neuropathic
451619|NCT01217463|Wound|wound
451620|NCT01217463|Growth factor|growth factor
451621|NCT01217424|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
451622|NCT01217424|pain|pain
451623|NCT01217424|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
451744|NCT01216813|gastric cancer|gastric cancer
451624|NCT01217398|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
451625|NCT01217398|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
451626|NCT01217398|iris melanoma|iris melanoma
451627|NCT01217398|metastatic intraocular melanoma|metastatic intraocular melanoma
451628|NCT01217398|stage IV intraocular melanoma|stage iv intraocular melanoma
451629|NCT01217385|stage IIIA breast cancer|stage iiia breast cancer
451630|NCT01217385|stage IIIB breast cancer|stage iiib breast cancer
451631|NCT01217385|stage IIIC breast cancer|stage iiic breast cancer
451632|NCT01217372|Recurrent idiopathic calcium oxalate nephrolithiasis.|recurrent idiopathic calcium oxalate nephrolithiasis.
451633|NCT01217333|Telephones|telephones
451634|NCT01217333|Community-Based Participatory Research|community-based participatory research
451635|NCT01217333|Participation, Patient|participation, patient
451636|NCT01217333|Rural health services|rural health services
451637|NCT01217320|rheumatology|rheumatology
451638|NCT01217320|creatine supplementation|creatine supplementation
451639|NCT01217320|quality of life|quality of life
451640|NCT01217320|strength|strength
451641|NCT01217320|juvenile systemic lupus erythematosus|juvenile systemic lupus erythematosus
451642|NCT01217320|juvenile dermatomyositis|juvenile dermatomyositis
451643|NCT01217307|Metformin|metformin
451644|NCT01217307|ST elevation myocardial infarction (STEMI)|st elevation myocardial infarction (stemi)
451645|NCT01217307|Coronary artery disease|coronary artery disease
451646|NCT01217307|Heart failure|heart failure
451647|NCT01217307|Diabetes|diabetes
451648|NCT01217294|anaesthetic techniques, regional|anaesthetic techniques, regional
451649|NCT01217294|analgesia, post-operative|analgesia, post-operative
451650|NCT01217294|fascia iliaca compartment block|fascia iliaca compartment block
451651|NCT01217294|ultrasound guided|ultrasound guided
451652|NCT01217294|surgery, orthopaedic|surgery, orthopaedic
451653|NCT01217281|CKD, Renal, Chronic Kidney Disease, Periodontitis, Perio|ckd, renal, chronic kidney disease, periodontitis, perio
451654|NCT01217255|Hemophilia|hemophilia
451655|NCT01217255|Burden of Illness|burden of illness
451656|NCT01217255|Pediatric|pediatric
451657|NCT01217255|Quality of Life|quality of life
451658|NCT01217255|Disability|disability
451659|NCT01217255|Participation|participation
451660|NCT01217242|cerebral palsy|cerebral palsy
451661|NCT01217242|walking activity|walking activity
451662|NCT01217242|physical activity|physical activity
451663|NCT01217242|participation|participation
451664|NCT01217242|activity performance|activity performance
451665|NCT01217242|activity capacity|activity capacity
451666|NCT01217229|Hodgkin Lymphoma|hodgkin lymphoma
451667|NCT01217216|Breast Cancer|breast cancer
451668|NCT01217216|Weight loss|weight loss
451669|NCT01217216|Group Intervention|group intervention
451670|NCT01217216|Telephone Intervention|telephone intervention
451671|NCT01217177|Cervical cancer,|cervical cancer,
451672|NCT01217177|radiotherapy,|radiotherapy,
451673|NCT01217177|chemotherapy,|chemotherapy,
451674|NCT01217177|rad001,|rad001,
451675|NCT01217177|everolimus|everolimus
451676|NCT01217164|nutrition|nutrition
451677|NCT01217164|very low birth weight|very low birth weight
451678|NCT01217164|premature|premature
451679|NCT01217151|Hemodynamic Monitoring|hemodynamic monitoring
451680|NCT01217151|Goal-Directed Therapy|goal-directed therapy
451681|NCT01217138|Anaphylaxis, autoinjector, design, epinephrine|anaphylaxis, autoinjector, design, epinephrine
451682|NCT01217125|tuberousclerosis, angiomyolipoma, rapamycin|tuberousclerosis, angiomyolipoma, rapamycin
451683|NCT01217112|Dyslipidemias|dyslipidemias
451684|NCT01217112|Diabetes|diabetes
451685|NCT01217112|Liver Fat|liver fat
451686|NCT01217112|Body Fat|body fat
451687|NCT01217099|refractory mycoplasma pneumoniae pneumonia|refractory mycoplasma pneumoniae pneumonia
451688|NCT01217060|Adenocarcinoma|adenocarcinoma
451689|NCT01217060|Squamous cell carcinoma|squamous cell carcinoma
451690|NCT01217060|Thoracic esophagus|thoracic esophagus
451691|NCT01217060|Gastroesophageal junction|gastroesophageal junction
452581|NCT01213173|chest pain|chest pain
451692|NCT01217060|Chemoradiotherapy|chemoradiotherapy
451693|NCT01217060|Esophagectomy|esophagectomy
451694|NCT01217060|5-Fluorouracil|5-fluorouracil
451695|NCT01217060|Docetaxel|docetaxel
451696|NCT01217060|Radiation|radiation
451697|NCT01217060|Radiotherapy|radiotherapy
451698|NCT01217060|XRT|xrt
451699|NCT01217060|IMRT|imrt
451700|NCT01217060|Taxotere|taxotere
451701|NCT01217060|Adrucil|adrucil
451702|NCT01217060|Efudex|efudex
451703|NCT01217060|Dexamethasone|dexamethasone
451704|NCT01217060|Decadron|decadron
451705|NCT01217047|Spinal cord injury|spinal cord injury
451706|NCT01217047|Functional electrical stimulation|functional electrical stimulation
451707|NCT01217047|Rehabilitation|rehabilitation
451708|NCT01217047|Growth factors|growth factors
451709|NCT01217047|Cytokines|cytokines
451710|NCT01217034|Transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
451711|NCT01217034|TACE|tace
451712|NCT01217034|sorafenib|sorafenib
451713|NCT01217034|Time to untreatable progression|time to untreatable progression
451714|NCT01217034|TTUP|ttup
451715|NCT01217008|Spinal Cord Injury|spinal cord injury
451716|NCT01217008|GRNOPC1|grnopc1
451717|NCT01216995|Heart Attack|heart attack
451718|NCT01216995|Regenerative Cells|regenerative cells
451719|NCT01216995|Stem Cells|stem cells
451720|NCT01216982|Mood Disorders|mood disorders
451721|NCT01216982|Depression|depression
451722|NCT01216982|Combat Disorders|combat disorders
451723|NCT01216982|Stress Disorders|stress disorders
451724|NCT01216982|Fatty Acids, Omega-3|fatty acids, omega-3
451725|NCT01216982|Military Personnel|military personnel
451726|NCT01216982|Docosahexaenoic Acids/*therapeutic use|docosahexaenoic acids/*therapeutic use
451727|NCT01216982|Eicosapentaenoic Acid/*therapeutic use|eicosapentaenoic acid/*therapeutic use
451728|NCT01216956|extended release nicotinic acid|extended release nicotinic acid
451729|NCT01216956|non esterified fatty acid (NEFA)|non esterified fatty acid (nefa)
451730|NCT01216956|insulin resistance|insulin resistance
451731|NCT01216956|Cholesteryl ester transfer protein (CETP)|cholesteryl ester transfer protein (cetp)
451732|NCT01216956|High density lipoprotein cholesterol|high density lipoprotein cholesterol
451733|NCT01216891|Schizophrenia|schizophrenia
451734|NCT01216891|Schizoaffective Disorder|schizoaffective disorder
451735|NCT01216891|Schizophreniform Disorder|schizophreniform disorder
451736|NCT01216891|Delusional Disorder|delusional disorder
451737|NCT01216891|Psychosis|psychosis
451738|NCT01216891|First episode|first episode
451739|NCT01216865|Diabetic foot|diabetic foot
451740|NCT01216865|critical limb ischemia|critical limb ischemia
451741|NCT01216865|mesenchymal stem cells|mesenchymal stem cells
451742|NCT01216865|umbilical cord|umbilical cord
451743|NCT01216813|esophageal cancer|esophageal cancer
451745|NCT01216813|cervical cancer|cervical cancer
451746|NCT01216813|fallopian tube cancer|fallopian tube cancer
451747|NCT01216813|ovarian epithelial cancer|ovarian epithelial cancer
451748|NCT01216813|ovarian germ cell tumor|ovarian germ cell tumor
451749|NCT01216813|ovarian sarcoma|ovarian sarcoma
451750|NCT01216813|ovarian stromal cancer|ovarian stromal cancer
451751|NCT01216813|endometrial cancer|endometrial cancer
451752|NCT01216813|uterine sarcoma|uterine sarcoma
451753|NCT01216813|vaginal cancer|vaginal cancer
451754|NCT01216813|vulvar cancer|vulvar cancer
451755|NCT01216813|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
451756|NCT01216800|ototoxicity|ototoxicity
451757|NCT01216800|radiation toxicity|radiation toxicity
451758|NCT01216800|stage I salivary gland cancer|stage i salivary gland cancer
451759|NCT01216800|stage II salivary gland cancer|stage ii salivary gland cancer
451760|NCT01216800|stage III salivary gland cancer|stage iii salivary gland cancer
451761|NCT01216761|Bacteremia|bacteremia
451762|NCT01216761|Blood culture|blood culture
451763|NCT01216761|Contamination|contamination
451764|NCT01216761|Antiseptic agents|antiseptic agents
451765|NCT01216748|airway blood flow|airway blood flow
451766|NCT01216748|albuterol|albuterol
451767|NCT01216748|acidosis|acidosis
451768|NCT01216748|alkalosis|alkalosis
451769|NCT01216735|smokers|smokers
451770|NCT01216735|inhaled corticosteroids|inhaled corticosteroids
451771|NCT01216735|brachial flow|brachial flow
451772|NCT01216735|airway blood flow|airway blood flow
451773|NCT01216735|albuterol|albuterol
451774|NCT01216735|spirometry|spirometry
451775|NCT01216735|endothelial dysfunction|endothelial dysfunction
451776|NCT01216722|Muscle Wasting|muscle wasting
451777|NCT01216722|Strengthening|strengthening
451778|NCT01216722|Liver Disease|liver disease
451779|NCT01216722|Transplant|transplant
451780|NCT01216709|Infant|infant
451781|NCT01216709|Dietary Supplements|dietary supplements
451782|NCT01216709|Food, Fortified|food, fortified
451783|NCT01216709|Iron Absorption|iron absorption
451784|NCT01216696|ipilimumab|ipilimumab
451785|NCT01216696|melanoma|melanoma
451786|NCT01216696|NY-ESO-1|ny-eso-1
451787|NCT01216683|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
451788|NCT01216683|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
451789|NCT01216683|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
451790|NCT01216683|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
451791|NCT01216683|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
451792|NCT01216683|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
451793|NCT01216683|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
451794|NCT01216683|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
451795|NCT01216683|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
451796|NCT01216683|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
451797|NCT01216683|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
451798|NCT01216683|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
451799|NCT01216670|Reveal® XT|reveal® xt
451800|NCT01216670|Acute Heart Failure|acute heart failure
451801|NCT01216670|Low Ejection Fraction|low ejection fraction
451802|NCT01216670|Reveal® XT implanted|reveal® xt implanted
451803|NCT01216657|melanoma|melanoma
451804|NCT01216657|sunitinib|sunitinib
451805|NCT01216644|gastric cancer|gastric cancer
451806|NCT01216644|perioperative|perioperative
451807|NCT01216644|FLOT|flot
451808|NCT01216644|ECF|ecf
451809|NCT01216644|pathological complete remission|pathological complete remission
451810|NCT01216644|locally advanced resectable adenocarcinoma of the esophagogastric juction or the stomach|locally advanced resectable adenocarcinoma of the esophagogastric juction or the stomach
451811|NCT01216631|seronegative|seronegative
451812|NCT01216631|oligoarthritis|oligoarthritis
451813|NCT01216631|infliximab|infliximab
451814|NCT01216631|intraarticular|intraarticular
451815|NCT01216618|MiniMed paradigm insulin pumps|minimed paradigm insulin pumps
451816|NCT01216618|insulin Lispro|insulin lispro
451817|NCT01216618|Insulin Asprt.|insulin asprt.
451818|NCT01216592|COPD|copd
451819|NCT01216592|Airway inflammation|airway inflammation
451820|NCT01216592|Symptoms|symptoms
451821|NCT01216592|Lung function|lung function
451822|NCT01216592|Correlation|correlation
451823|NCT01216553|Bronchiolitis|bronchiolitis
451824|NCT01216553|Infants|infants
451825|NCT01216553|Nebulized Inhalation|nebulized inhalation
451826|NCT01216553|RSV|rsv
451827|NCT01216553|Oxygen|oxygen
451828|NCT01216540|vancomycin|vancomycin
451829|NCT01216540|nephrotoxicity|nephrotoxicity
451830|NCT01216540|length of stay|length of stay
451831|NCT01216540|costs|costs
451832|NCT01216527|Stage IIB or III squamous cell esophageal carcinoma.|stage iib or iii squamous cell esophageal carcinoma.
451833|NCT01216514|chronic inflammatory bowel diseases|chronic inflammatory bowel diseases
451834|NCT01216514|crohn disease|crohn disease
451835|NCT01216514|hemorrhagic rectocolitis|hemorrhagic rectocolitis
451836|NCT01216514|immunological markers|immunological markers
451837|NCT01216514|serological markers|serological markers
451838|NCT01216514|ANCA|anca
451839|NCT01216514|ASCA|asca
451840|NCT01216488|Forearm surgery|forearm surgery
451841|NCT01216488|Hand surgery|hand surgery
451842|NCT01216488|Anesthesia|anesthesia
451843|NCT01216462|Acute Coronary Syndrome|acute coronary syndrome
451844|NCT01216449|Citalopram|citalopram
451845|NCT01216449|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
451846|NCT01216449|fMRI|fmri
451847|NCT01216449|Pharmacokinetics|pharmacokinetics
451848|NCT01216449|Pharmacodynamics|pharmacodynamics
451849|NCT01216449|Amygdala|amygdala
451850|NCT01216449|Elderly|elderly
451851|NCT01216436|melanoma|melanoma
451852|NCT01216436|immunotherapy|immunotherapy
451853|NCT01216436|dendritic cell|dendritic cell
451854|NCT01216436|GITR-ligand|gitr-ligand
451855|NCT01216436|CTLA-4|ctla-4
451856|NCT01216423|Patent Foramen Ovale|patent foramen ovale
451857|NCT01216423|Pulmonary embolism|pulmonary embolism
451858|NCT01216423|Stroke|stroke
451859|NCT01216410|Nausea|nausea
451860|NCT01216410|Vomiting|vomiting
451861|NCT01216371|carcinoma|carcinoma
451862|NCT01216371|metastases|metastases
451863|NCT01216371|renal|renal
451864|NCT01216371|lung|lung
451865|NCT01216358|Headache|headache
451866|NCT01216358|Contraception|contraception
451867|NCT01216319|Biodesign|biodesign
451868|NCT01216319|Nipple Reconstruction|nipple reconstruction
451869|NCT01216319|Breast Cancer|breast cancer
451870|NCT01216319|Mastectomy|mastectomy
451871|NCT01216306|Obesity|obesity
451872|NCT01216306|Physical Activity|physical activity
451873|NCT01216306|Sedentary Activity|sedentary activity
451874|NCT01216306|Television viewing|television viewing
451875|NCT01216306|Latino|latino
451876|NCT01216306|Hispanic|hispanic
451877|NCT01216306|Preschool|preschool
451878|NCT01216306|School|school
451879|NCT01216306|Head Start|head start
451880|NCT01216293|Drug Therapy|drug therapy
451881|NCT01216280|Natura-alpha|natura-alpha
451882|NCT01216280|ulcerative colitis|ulcerative colitis
451883|NCT01216280|cytokines|cytokines
451884|NCT01216280|Th1|th1
451885|NCT01216280|Th17|th17
451886|NCT01216267|chromogranin A|chromogranin a
451887|NCT01216267|neuroendocrine|neuroendocrine
451888|NCT01216267|carcinoid|carcinoid
452582|NCT01213173|heart rate|heart rate
451889|NCT01216267|Proton Pump Inhibitor|proton pump inhibitor
451890|NCT01216254|breast cancer|breast cancer
451891|NCT01216254|stage 2|stage 2
451892|NCT01216254|breast conserving therapy|breast conserving therapy
451893|NCT01216254|sentinel lymph node dissection|sentinel lymph node dissection
451894|NCT01216254|high frequency electrocoagulation|high frequency electrocoagulation
451895|NCT01216202|Rectal cancer|rectal cancer
451896|NCT01216202|Preoperative radiotherapy|preoperative radiotherapy
451897|NCT01216202|Pelvic surgery|pelvic surgery
451898|NCT01216202|Sexual function|sexual function
451899|NCT01216202|Wellbeing|wellbeing
451900|NCT01216202|Hormone levels|hormone levels
451901|NCT01216202|Spermatogenesis|spermatogenesis
451902|NCT01216189|Rectal cancer|rectal cancer
451903|NCT01216189|Preoperative radiotherapy|preoperative radiotherapy
451904|NCT01216189|Pelvic surgery|pelvic surgery
451905|NCT01216189|Sexual function|sexual function
451906|NCT01216189|Wellbeing|wellbeing
451907|NCT01216189|Hormone levels|hormone levels
451908|NCT01216176|Breast Cancer|breast cancer
451909|NCT01216176|Postmenopausal|postmenopausal
451910|NCT01216176|Metastatic Phase I ONLY|metastatic phase i only
451911|NCT01216176|AZD0530|azd0530
451912|NCT01216176|Anastrozole|anastrozole
451913|NCT01216176|Phase I for metastatic disease|phase i for metastatic disease
451914|NCT01216176|Phase II for newly diagnosed breast cancer|phase ii for newly diagnosed breast cancer
451915|NCT01216176|Pharmacokinetic|pharmacokinetic
451916|NCT01216176|PK|pk
451917|NCT01216176|Hormone Receptor|hormone receptor
451918|NCT01216176|Estrogen Receptor|estrogen receptor
451919|NCT01216176|Progesterone Receptor|progesterone receptor
451920|NCT01216176|ER+|er+
451921|NCT01216176|PR+|pr+
451922|NCT01216176|HER negative|her negative
451923|NCT01216176|Aromatase Inhibitors|aromatase inhibitors
451924|NCT01216163|Pain following third molar extraction (wisdom tooth)|pain following third molar extraction (wisdom tooth)
451925|NCT01216150|antifibrinolytic drug|antifibrinolytic drug
451926|NCT01216150|coronary surgery|coronary surgery
451927|NCT01216150|hemorrhage|hemorrhage
451928|NCT01216150|aspirin|aspirin
451929|NCT01216150|clopidogrel|clopidogrel
451930|NCT01216137|Multiple Sclerosis|multiple sclerosis
451931|NCT01216137|Fatigue|fatigue
451932|NCT01216137|Balance|balance
451933|NCT01216137|Upright Postural Control|upright postural control
451934|NCT01216137|Dizziness|dizziness
451935|NCT01216124|triple negative local advanced breast cancer(TNLABC),neoadjuvant chemotherapy|triple negative local advanced breast cancer(tnlabc),neoadjuvant chemotherapy
451936|NCT01216111|triple negative breast cancer，local recurrence,distant metastasis|triple negative breast cancer，local recurrence,distant metastasis
451937|NCT01216098|Intrapartum|intrapartum
451938|NCT01216098|Clinical trial|clinical trial
451939|NCT01216098|Perinatal|perinatal
451940|NCT01216098|Doula|doula
451941|NCT01216098|VBAC|vbac
451942|NCT01216098|Perinatal Outcomes|perinatal outcomes
451943|NCT01216072|Relapsing Forms of Multiple Sclerosis|relapsing forms of multiple sclerosis
451944|NCT01216072|Disease Modifying Therapy|disease modifying therapy
451945|NCT01216072|fingolimod|fingolimod
451946|NCT01216072|Patient Reported Outcomes|patient reported outcomes
451947|NCT01216059|adherence|adherence
451948|NCT01216059|text message|text message
451949|NCT01216059|reminder|reminder
451950|NCT01216059|adolescents|adolescents
451951|NCT01216033|Breast cancer|breast cancer
451952|NCT01216033|Diagnostics|diagnostics
451953|NCT01216033|HER2|her2
451954|NCT01216033|Imaging|imaging
451955|NCT01216033|Metastases|metastases
451956|NCT01216033|SPECT|spect
451957|NCT01216033|Imaging of metastases|imaging of metastases
451958|NCT01216020|Head and Neck Cancer|head and neck cancer
451959|NCT01216020|Radiotherapy|radiotherapy
451960|NCT01216020|Cetuximab|cetuximab
451961|NCT01216020|Cisplatin|cisplatin
451962|NCT01216007|Plasma|plasma
451963|NCT01216007|bupivacaine|bupivacaine
451964|NCT01216007|concentration|concentration
451965|NCT01216007|caudal|caudal
451966|NCT01216007|epidural|epidural
451967|NCT01216007|TIVA|tiva
451968|NCT01216007|Inhalational|inhalational
451969|NCT01216007|anesthesia|anesthesia
451970|NCT01216007|Caudal epidural|caudal epidural
451971|NCT01215981|influenza vaccine|influenza vaccine
451972|NCT01215955|Type 2 Diabetes|type 2 diabetes
451973|NCT01215955|Insulin|insulin
451974|NCT01215955|Algorithms|algorithms
451975|NCT01215955|Blood glucose levels|blood glucose levels
451976|NCT01215942|Rheumatoid Arthritis|rheumatoid arthritis
451977|NCT01215929|methamphetamine withdrawal|methamphetamine withdrawal
451978|NCT01215929|mood|mood
451979|NCT01215929|retention|retention
451980|NCT01215929|sleep|sleep
451981|NCT01215916|Solid tumors|solid tumors
451982|NCT01215890|Crohn's disease|crohn's disease
451983|NCT01215890|Low bone mineral density|low bone mineral density
451984|NCT01215890|inflammatory bowel disease|inflammatory bowel disease
451985|NCT01215890|bisphosphonate|bisphosphonate
451986|NCT01215877|Bladder cancer|bladder cancer
451987|NCT01215877|Previously treated patients|previously treated patients
451988|NCT01215877|Tesetaxel|tesetaxel
451989|NCT01215877|Oral taxane|oral taxane
451990|NCT01215864|metastatic tumors|metastatic tumors
451991|NCT01215864|refractory tumors|refractory tumors
451992|NCT01215864|recurrent tumors|recurrent tumors
451993|NCT01215851|Tuberculosis|tuberculosis
451994|NCT01215851|EBA|eba
451995|NCT01215851|TMC207|tmc207
451996|NCT01215851|pretomanid|pretomanid
451997|NCT01215851|Early Bactericidal Activity|early bactericidal activity
451998|NCT01215851|Pulmonary Tuberculosis|pulmonary tuberculosis
452000|NCT01215851|bedaquiline|bedaquiline
452001|NCT01215851|pyrazinamide|pyrazinamide
452002|NCT01215851|moxifloxacin|moxifloxacin
452003|NCT01215851|ethambutol|ethambutol
452004|NCT01215851|rifafour|rifafour
452005|NCT01215838|HCC|hcc
452006|NCT01215838|hepatocellular carcinoma|hepatocellular carcinoma
452007|NCT01215838|Eovist|eovist
452008|NCT01215838|MR|mr
452009|NCT01215838|MRI|mri
452010|NCT01215838|magnetic resonance|magnetic resonance
452011|NCT01215825|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
452012|NCT01215825|systemic steroid|systemic steroid
452013|NCT01215799|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
452014|NCT01215799|HRPC|hrpc
452015|NCT01215760|peripheral nerve injury|peripheral nerve injury
452016|NCT01215760|sensory reeducation|sensory reeducation
452017|NCT01215760|brain plasticity|brain plasticity
452018|NCT01215760|training with a mirror|training with a mirror
452019|NCT01215760|rehabilitation|rehabilitation
452020|NCT01215747|Kiacta for AA amyloidosis|kiacta for aa amyloidosis
452021|NCT01215721|Incontinence|incontinence
452022|NCT01215721|Robotic Prostatectomy|robotic prostatectomy
452023|NCT01215721|Prostate Cancer|prostate cancer
452024|NCT01215708|Kidney calculi|kidney calculi
452025|NCT01215708|Lithotripsy|lithotripsy
452026|NCT01215708|Calcium channel blockers|calcium channel blockers
452027|NCT01215708|Adrenergic alpha-antagonists.|adrenergic alpha-antagonists.
452028|NCT01215695|Intubation, Endotracheal|intubation, endotracheal
452029|NCT01215695|Endotracheal Intubation, adverse events|endotracheal intubation, adverse events
452030|NCT01215682|infections|infections
452031|NCT01215682|immune system|immune system
452032|NCT01215682|vitamin D|vitamin d
452033|NCT01215682|sport|sport
452034|NCT01215682|children|children
452035|NCT01215669|Influenza|influenza
452036|NCT01215669|Influenza Virus Vaccines|influenza virus vaccines
452037|NCT01215669|Intradermal Injections|intradermal injections
452038|NCT01215643|Chronic hepatitis C genotype 2|chronic hepatitis c genotype 2
452039|NCT01215643|Chronic hepatitis C genotype 3|chronic hepatitis c genotype 3
452040|NCT01215643|Cyclophilin inhibitor|cyclophilin inhibitor
452041|NCT01215630|Veins|veins
452042|NCT01215630|Exercise tests|exercise tests
452043|NCT01215630|maximal oxygen uptake|maximal oxygen uptake
452044|NCT01215630|VO2max|vo2max
452045|NCT01215617|Randomized controlled study|randomized controlled study
452046|NCT01215617|Exercise training|exercise training
452047|NCT01215617|Lung function|lung function
452048|NCT01215617|Heart function|heart function
452049|NCT01215604|elderly patients|elderly patients
452050|NCT01215604|acute infection|acute infection
452051|NCT01215604|translation initiation factors|translation initiation factors
452052|NCT01215604|eIF4E|eif4e
452053|NCT01215604|eIF4G|eif4g
452054|NCT01215591|Neonatal|neonatal
452055|NCT01215591|Nasal CPAP|nasal cpap
452056|NCT01215591|Randomized controlled trial|randomized controlled trial
452057|NCT01215591|Weaning|weaning
452058|NCT01215578|Neuroendocrine Tumors|neuroendocrine tumors
452059|NCT01215578|Neuroectodermal Tumors|neuroectodermal tumors
452060|NCT01215578|Neoplasms, Germ Cell and Embryonal|neoplasms, germ cell and embryonal
452061|NCT01215578|Neoplasms by Histologic Type|neoplasms by histologic type
452062|NCT01215578|Neoplasms|neoplasms
452063|NCT01215578|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
452064|NCT01215578|Neoplasms, Nerve Tissue|neoplasms, nerve tissue
452065|NCT01215578|Pancreatic Neoplasms|pancreatic neoplasms
452066|NCT01215578|Digestive System Neoplasms|digestive system neoplasms
452067|NCT01215578|Neoplasms by Site|neoplasms by site
452068|NCT01215578|Endocrine Gland Neoplasms|endocrine gland neoplasms
452069|NCT01215578|Adenoma, Islet Cell|adenoma, islet cell
452070|NCT01215578|Adenocarcinoma|adenocarcinoma
452071|NCT01215578|Carcinoma|carcinoma
452072|NCT01215578|Adenoma|adenoma
452073|NCT01215578|Digestive System Diseases|digestive system diseases
452074|NCT01215578|Pancreatic Diseases|pancreatic diseases
452075|NCT01215578|Endocrine System Diseases|endocrine system diseases
452076|NCT01215578|Sunitinib|sunitinib
452077|NCT01215578|Antineoplastic Agents|antineoplastic agents
452078|NCT01215578|Therapeutic Uses|therapeutic uses
452079|NCT01215578|Pharmacologic Actions|pharmacologic actions
452080|NCT01215578|Angiogenesis Inhibitors|angiogenesis inhibitors
452081|NCT01215578|Angiogenesis Modulating Agents|angiogenesis modulating agents
452082|NCT01215578|Growth Substances|growth substances
452083|NCT01215578|Physiological Effects of Drugs|physiological effects of drugs
452084|NCT01215578|Growth Inhibitors|growth inhibitors
452085|NCT01215565|Carcinoma, Hepatocellular|carcinoma, hepatocellular
452086|NCT01215565|Carcinoma|carcinoma
452087|NCT01215565|Fibrosis|fibrosis
452088|NCT01215565|Liver Neoplasms|liver neoplasms
452089|NCT01215565|Pathologic Processes|pathologic processes
452090|NCT01215565|Digestive System Neoplasms|digestive system neoplasms
452091|NCT01215565|Neoplasms by Site|neoplasms by site
452092|NCT01215565|Neoplasms|neoplasms
452093|NCT01215565|Liver Diseases|liver diseases
452094|NCT01215565|Adenocarcinoma|adenocarcinoma
452095|NCT01215565|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
452096|NCT01215565|Neoplasms by Histologic Type|neoplasms by histologic type
452097|NCT01215565|Sunitinib|sunitinib
452098|NCT01215565|Antineoplastic Agents|antineoplastic agents
452099|NCT01215565|Therapeutic Uses|therapeutic uses
452100|NCT01215565|Pharmacologic Actions|pharmacologic actions
452101|NCT01215565|Angiogenesis Inhibitors|angiogenesis inhibitors
452102|NCT01215565|Angiogenesis Modulating Agents|angiogenesis modulating agents
452103|NCT01215565|Growth Substances|growth substances
452104|NCT01215565|Physiological Effects of Drugs|physiological effects of drugs
452105|NCT01215565|Growth Inhibitors|growth inhibitors
452106|NCT01215500|solid tumor cancer|solid tumor cancer
452107|NCT01215500|epithelial carcinoma|epithelial carcinoma
452108|NCT01215487|CML Predictive Study|cml predictive study
452109|NCT01215461|Neonatal mortality|neonatal mortality
452110|NCT01215461|Preterm birth|preterm birth
452111|NCT01215461|Low gestational age|low gestational age
452112|NCT01215461|VLBW|vlbw
452113|NCT01215448|Fatigue|fatigue
452114|NCT01215448|Quality of life|quality of life
452115|NCT01215448|Lifestyle|lifestyle
452116|NCT01215448|Complementary medicine|complementary medicine
452117|NCT01215422|Surgical procedures|surgical procedures
452118|NCT01215422|Intubation|intubation
452119|NCT01215422|Anesthesiologist|anesthesiologist
452120|NCT01215422|Laryngoscope|laryngoscope
452121|NCT01215422|Videolaryngoscope|videolaryngoscope
452122|NCT01215409|Levitra|levitra
452123|NCT01215409|Erectile dysfunction|erectile dysfunction
452124|NCT01215409|Taiwan|taiwan
452125|NCT01215396|Branched Chain Amino Acids|branched chain amino acids
452126|NCT01215396|Mental Performance|mental performance
452127|NCT01215396|Muscular Performance|muscular performance
452128|NCT01215396|Central Fatigue Theory|central fatigue theory
452129|NCT01215383|HDL|hdl
452130|NCT01215383|psychiatric patients|psychiatric patients
452131|NCT01215383|psychiatric patients before and during antipsychotic therapy|psychiatric patients before and during antipsychotic therapy
452132|NCT01215357|Pathological Gambling|pathological gambling
452133|NCT01215357|ecopipam|ecopipam
452134|NCT01215357|Dopamine|dopamine
452135|NCT01215331|Gestational Diabetes Mellitus|gestational diabetes mellitus
452136|NCT01215331|Treatment|treatment
452137|NCT01215331|Insulin|insulin
452138|NCT01215331|Metformin|metformin
452139|NCT01215331|Glyburide|glyburide
452140|NCT01215305|Gastroesophageal Reflux Disease, extraesophageal symptoms|gastroesophageal reflux disease, extraesophageal symptoms
452141|NCT01215292|testosterone|testosterone
452142|NCT01215292|acyline|acyline
452143|NCT01215292|ketoconazole|ketoconazole
452144|NCT01215292|dutasteride|dutasteride
452145|NCT01215292|anastrazole|anastrazole
452146|NCT01215292|Intratesticular hormone concentration|intratesticular hormone concentration
452147|NCT01215279|Respiratory disease|respiratory disease
452148|NCT01215279|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
452149|NCT01215266|Bladder cancer|bladder cancer
452150|NCT01215266|Chemotherapy|chemotherapy
452151|NCT01215266|Urothelium cancer|urothelium cancer
452152|NCT01215253|Sudden Death|sudden death
452153|NCT01215253|Ranolazine|ranolazine
452154|NCT01215253|Heart failure|heart failure
452155|NCT01215253|Ventricular tachycardia|ventricular tachycardia
452156|NCT01215253|Ventricular fibrillation|ventricular fibrillation
452157|NCT01215253|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
452158|NCT01215214|metabolite profiles|metabolite profiles
452159|NCT01215214|pharmacokinetics|pharmacokinetics
452160|NCT01215214|CYP3A|cyp3a
452161|NCT01215214|metabolomics|metabolomics
452162|NCT01215201|Periodontal maintenance|periodontal maintenance
452163|NCT01215201|≥5mm probing depth|≥5mm probing depth
452164|NCT01215201|bleeding on probing and/or suppuration|bleeding on probing and/or suppuration
452165|NCT01215188|Invasive pneumococcal disease|invasive pneumococcal disease
452166|NCT01215188|Pneumonia|pneumonia
452167|NCT01215188|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
452168|NCT01215175|Pneumococcal disease|pneumococcal disease
452169|NCT01215149|HIV|hiv
452170|NCT01215110|Bedaquiline|bedaquiline
452171|NCT01215110|Sirturo|sirturo
452172|NCT01215110|Early Bactericidal Activity|early bactericidal activity
452173|NCT01215110|EBA|eba
452174|NCT01215110|Pulmonary Tuberculosis|pulmonary tuberculosis
452175|NCT01215110|TMC207|tmc207
452176|NCT01215084|Human Volunteers|human volunteers
452177|NCT01215071|Lymphadenectomy|lymphadenectomy
452178|NCT01215071|Extension|extension
452179|NCT01215071|Bladder cancer|bladder cancer
452180|NCT01215058|Compliance, France|compliance, france
452181|NCT01215058|Gastrointestinal bleeding ulcer or symptomatic ulcer with NSAID|gastrointestinal bleeding ulcer or symptomatic ulcer with nsaid
452182|NCT01215045|AcrySof ReSTOR Aspheric +4|acrysof restor aspheric +4
452183|NCT01215032|castration-resistant prostate cancer|castration-resistant prostate cancer
452184|NCT01215032|insulin levels|insulin levels
452185|NCT01215032|metformin|metformin
452186|NCT01215019|traumatic brain injury|traumatic brain injury
452187|NCT01214993|GSK1349572|gsk1349572
452188|NCT01214993|para-aminohippurate|para-aminohippurate
452189|NCT01214993|iohexol|iohexol
452190|NCT01214980|Low-frequency ultrasound|low-frequency ultrasound
452191|NCT01214980|Wound healing|wound healing
452192|NCT01214980|Split thickness wound healing|split thickness wound healing
452193|NCT01214980|Skin graft donor site healing|skin graft donor site healing
452194|NCT01214967|risk factors for maternal depression|risk factors for maternal depression
452195|NCT01214954|Total Hip Replacement|total hip replacement
452196|NCT01214954|Rehabilitation|rehabilitation
452197|NCT01214954|Resistance training|resistance training
452198|NCT01214928|vitamin D|vitamin d
452199|NCT01214928|cholecalciferol|cholecalciferol
452200|NCT01214928|hemodialysis|hemodialysis
452201|NCT01214928|randomized controlled trial|randomized controlled trial
452202|NCT01214928|pilot|pilot
452203|NCT01214889|Diphtheria|diphtheria
452204|NCT01214889|Tetanus|tetanus
452205|NCT01214889|Pertussis|pertussis
452206|NCT01214889|Haemophilus influenzae type B|haemophilus influenzae type b
452207|NCT01214889|Poliomyelitis|poliomyelitis
452208|NCT01214889|PENTAXIM™|pentaxim™
452209|NCT01214889|TETRAXIM™|tetraxim™
452210|NCT01214863|Toric Intraocular Lens (IOL)|toric intraocular lens (iol)
452211|NCT01214850|Meningococcal vaccines|meningococcal vaccines
452212|NCT01214850|Meningococcal B|meningococcal b
452213|NCT01214850|Meningococcal ACWY serogroups|meningococcal acwy serogroups
452214|NCT01214837|Meningococcal|meningococcal
452215|NCT01214837|ACWY|acwy
452216|NCT01214837|Conjugate Vaccine|conjugate vaccine
452217|NCT01214837|Meningitis|meningitis
452218|NCT01214837|Infants|infants
452219|NCT01214837|Persistence|persistence
452220|NCT01214824|Diabetes|diabetes
452221|NCT01214824|Continuous Glucose Monitoring|continuous glucose monitoring
452222|NCT01214811|The change in signs of inflammation/local infection|the change in signs of inflammation/local infection
452223|NCT01214811|To evaluate the comfort, conformability,|to evaluate the comfort, conformability,
452224|NCT01214811|Pain during wear|pain during wear
452225|NCT01214798|sesamoid displacement,|sesamoid displacement,
452226|NCT01214798|metacarpophalangeal joint,|metacarpophalangeal joint,
452227|NCT01214798|radial condylar ridge of the metacarpal head.|radial condylar ridge of the metacarpal head.
452228|NCT01214772|pregnancy|pregnancy
452229|NCT01214772|heparin|heparin
452230|NCT01214772|fertilization|fertilization
452231|NCT01214759|HIV|hiv
452232|NCT01214759|prevention|prevention
452233|NCT01214759|prophylaxis|prophylaxis
452234|NCT01214759|Raltegravir|raltegravir
452235|NCT01214759|Truvada|truvada
452236|NCT01214746|Statin|statin
452237|NCT01214746|L-NMMA|l-nmma
452238|NCT01214746|Healthy subjects|healthy subjects
452239|NCT01214746|Nephrology|nephrology
452240|NCT01214707|Exercise/No active Treatment|exercise/no active treatment
452241|NCT01214694|TBI|tbi
452242|NCT01214694|intracranial edema|intracranial edema
452243|NCT01214694|brain edema|brain edema
452244|NCT01214694|craniocerebral trauma|craniocerebral trauma
452245|NCT01214694|head injury|head injury
452246|NCT01214694|brain hemorrhage, traumatic|brain hemorrhage, traumatic
452247|NCT01214694|subdural hematoma|subdural hematoma
452248|NCT01214694|brain concussion|brain concussion
452249|NCT01214694|head injuries, closed|head injuries, closed
452250|NCT01214694|epidural hematoma|epidural hematoma
452251|NCT01214694|extra-axial hemorrhage|extra-axial hemorrhage
452252|NCT01214694|cortical contusion|cortical contusion
452253|NCT01214694|Additional relevant MeSH terms:|additional relevant mesh terms:
452254|NCT01214694|Nervous System Diseases|nervous system diseases
452255|NCT01214694|Wounds and Injuries|wounds and injuries
452256|NCT01214694|Disorders of Environmental Origin|disorders of environmental origin
452257|NCT01214694|Central Nervous System Diseases|central nervous system diseases
452258|NCT01214694|Trauma, Nervous System|trauma, nervous system
452259|NCT01214694|Brain Diseases|brain diseases
452260|NCT01214694|Brain Injuries|brain injuries
452261|NCT01214681|Biomarkers|biomarkers
452262|NCT01214681|Colorectal cancer|colorectal cancer
452263|NCT01214681|Resistant starch|resistant starch
452264|NCT01214681|Polydextrose|polydextrose
452265|NCT01214681|Non-digestible carbohydrate|non-digestible carbohydrate
452266|NCT01214655|Acute Myelogenous Leukemia|acute myelogenous leukemia
452267|NCT01214655|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
452268|NCT01214655|Chronic Myelogenous Leukemia,Blast Crisis|chronic myelogenous leukemia,blast crisis
452269|NCT01214642|Advanced Cancer|advanced cancer
452270|NCT01214642|Cancer|cancer
452271|NCT01214629|Advanced Cancer|advanced cancer
452272|NCT01214629|Metastatic Cancer|metastatic cancer
452273|NCT01214629|Cancer|cancer
452274|NCT01214603|Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Acute|acute myelogenous leukemia, acute myeloid leukemia, acute
452275|NCT01214603|Leukemia, Leukemia|leukemia, leukemia
452276|NCT01214577|PEP005|pep005
452277|NCT01214577|Peplin|peplin
452278|NCT01214577|Photo-damage|photo-damage
452279|NCT01214564|PEP005|pep005
452280|NCT01214564|Peplin|peplin
452583|NCT01213160|Phase I|phase i
452281|NCT01214564|Seborrhoeic Keratosis|seborrhoeic keratosis
452282|NCT01214538|Vaccine pneumococcal natural history Acute otitis media|vaccine pneumococcal natural history acute otitis media
452283|NCT01214525|Meatal stenosis|meatal stenosis
452284|NCT01214525|Meatotomy|meatotomy
452285|NCT01214525|Uroflow|uroflow
452286|NCT01214525|Postvoid residual|postvoid residual
452287|NCT01214499|Refractory angina|refractory angina
452288|NCT01214499|Transmyocardial revascularization|transmyocardial revascularization
452289|NCT01214499|Stem cells|stem cells
452290|NCT01214499|Diffuse coronary disease not amenable to percutaneous coronary intervention, and angina, despite proper medical treatment|diffuse coronary disease not amenable to percutaneous coronary intervention, and angina, despite proper medical treatment
452291|NCT01214486|HIV|hiv
452292|NCT01214486|RAL|ral
452293|NCT01214486|Raltegravir|raltegravir
452294|NCT01214486|Isentress|isentress
452295|NCT01214486|Pharmacokinetics|pharmacokinetics
452296|NCT01214473|Clinical sepsis|clinical sepsis
452297|NCT01214473|Pneumonia|pneumonia
452298|NCT01214473|Diarrhea|diarrhea
452299|NCT01214473|Probiotics|probiotics
452300|NCT01214473|Synbiotics|synbiotics
452301|NCT01214460|MET|met
452302|NCT01214447|Hemodialysis|hemodialysis
452303|NCT01214447|Inflammation|inflammation
452304|NCT01214447|Malnutrition|malnutrition
452305|NCT01214447|Phase Angle|phase angle
452306|NCT01214434|Cradle Cap|cradle cap
452307|NCT01214434|Infantile seborrheic Dermatitis|infantile seborrheic dermatitis
452308|NCT01214421|Kidney Disease|kidney disease
452309|NCT01214421|ADPKD|adpkd
452310|NCT01214421|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
452311|NCT01214421|Adult Polycystic Kidney Disease|adult polycystic kidney disease
452312|NCT01214395|haemodialysis|haemodialysis
452313|NCT01214395|peritoneal dialysis|peritoneal dialysis
452314|NCT01214382|Gastric Bypass|gastric bypass
452315|NCT01214382|Bariatric Surgery|bariatric surgery
452316|NCT01214382|Sertraline|sertraline
452317|NCT01214382|Zoloft|zoloft
452318|NCT01214382|Pharmacokinetic|pharmacokinetic
452319|NCT01214369|intraosseous injection|intraosseous injection
452320|NCT01214369|X-tip|x-tip
452321|NCT01214369|PDL injection|pdl injection
452322|NCT01214369|Supplementary Injection|supplementary injection
452323|NCT01214356|diabetes|diabetes
452324|NCT01214356|kidney disease|kidney disease
452325|NCT01214356|vitamin D|vitamin d
452326|NCT01214343|sorafenib|sorafenib
452327|NCT01214343|Hepatic intraarterial infusion chemotherapy|hepatic intraarterial infusion chemotherapy
452328|NCT01214343|HAIC|haic
452329|NCT01214343|Low dose FP|low dose fp
452330|NCT01214343|cisplatin|cisplatin
452331|NCT01214343|fluorouracil|fluorouracil
452332|NCT01214330|cervical cancer|cervical cancer
452333|NCT01214317|multiple sclerosis|multiple sclerosis
452334|NCT01214317|mitoxantrone|mitoxantrone
452335|NCT01214317|plasmapheresis|plasmapheresis
452336|NCT01214317|induction therapy|induction therapy
452337|NCT01214304|Colposcopy|colposcopy
452338|NCT01214291|fractures|fractures
452339|NCT01214291|prostate cancer|prostate cancer
452340|NCT01214291|androgen deprivation therapy|androgen deprivation therapy
452341|NCT01214278|bioavailability|bioavailability
452342|NCT01214278|marine n-3 fatty acids|marine n-3 fatty acids
452343|NCT01214278|EPA|epa
452344|NCT01214278|DHA|dha
452345|NCT01214252|Repair of patients' abdominal wall defects|repair of patients' abdominal wall defects
452346|NCT01214187|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
452347|NCT01214187|IPF|ipf
452348|NCT01214187|pulmonary fibrosis|pulmonary fibrosis
452349|NCT01214187|carbon monoxide|carbon monoxide
452350|NCT01214174|cataract|cataract
452351|NCT01214174|inflammation|inflammation
452352|NCT01214161|IUD|iud
452353|NCT01214161|Lidocaine gel|lidocaine gel
452354|NCT01214135|Mental disorder|mental disorder
452355|NCT01214135|antipsychotic treatment|antipsychotic treatment
452356|NCT01214122|Phase 1|phase 1
452357|NCT01214122|Drug-Drug interaction|drug-drug interaction
452358|NCT01214122|warfarin|warfarin
452359|NCT01214122|AZD9668|azd9668
452360|NCT01214122|resulting from AZD9668 and Warfarin interaction|resulting from azd9668 and warfarin interaction
452361|NCT01214122|pharmacokinetics|pharmacokinetics
452362|NCT01214122|pharmacodynamics|pharmacodynamics
452363|NCT01214096|Chronic Heart failure|chronic heart failure
452364|NCT01214096|rhNRG-1|rhnrg-1
452365|NCT01214096|MRI|mri
452366|NCT01214083|N-acetylcysteine|n-acetylcysteine
452367|NCT01214083|naltrexone|naltrexone
452368|NCT01214070|Visual Perception|visual perception
452369|NCT01214070|Vision, Ocular|vision, ocular
452370|NCT01214070|Neuronal Plasticity|neuronal plasticity
452371|NCT01214057|chronic rhinosinusitis|chronic rhinosinusitis
452372|NCT01214057|endoscopic sinus surgery|endoscopic sinus surgery
452373|NCT01214057|TIVA|tiva
452374|NCT01214057|surgical field visualization|surgical field visualization
452375|NCT01214031|Confocal laser endomicroscope|confocal laser endomicroscope
452376|NCT01214031|Adenomatous polyps|adenomatous polyps
452377|NCT01214031|Colonoscopy|colonoscopy
452378|NCT01214005|nicotine|nicotine
452379|NCT01214005|reinforcement|reinforcement
452380|NCT01214005|craving|craving
452381|NCT01214005|relapse|relapse
452382|NCT01213966|Acute uncomplicated Plasmodium Falciparum malaria|acute uncomplicated plasmodium falciparum malaria
452383|NCT01213966|Blood stage Plasmodium Vivax malaria|blood stage plasmodium vivax malaria
452384|NCT01213953|Vertebral disc, mesenchymal stem cell.|vertebral disc, mesenchymal stem cell.
452385|NCT01213914|Burns|burns
452386|NCT01213914|Hemofiltration|hemofiltration
452387|NCT01213914|Vasopressins|vasopressins
452388|NCT01213914|Kidney Failure Acute|kidney failure acute
452389|NCT01213914|Shock, Septic|shock, septic
452390|NCT01213901|Insulin absorption|insulin absorption
452391|NCT01213901|Insulin injection technique|insulin injection technique
452392|NCT01213888|Diabetic retinopathy|diabetic retinopathy
452393|NCT01213888|pan-retinal photocoagulation|pan-retinal photocoagulation
452394|NCT01213888|macular edema|macular edema
452395|NCT01213875|heart failure|heart failure
452396|NCT01213875|nursing|nursing
452397|NCT01213875|home based intervention|home based intervention
452398|NCT01213875|cost|cost
452399|NCT01213875|efficacy|efficacy
452400|NCT01213862|Home Based education|home based education
452401|NCT01213862|Knowledge of Disease|knowledge of disease
452402|NCT01213862|Self-Care Skills|self-care skills
452403|NCT01213862|Quality of Life|quality of life
452404|NCT01213862|Heart Failure|heart failure
452405|NCT01213862|Randomized Clinical Trial|randomized clinical trial
452406|NCT01213836|Stable schizophrenia|stable schizophrenia
452407|NCT01213836|cognitive functioning|cognitive functioning
452408|NCT01213823|invasive candidiasis|invasive candidiasis
452409|NCT01213823|candidemia|candidemia
452410|NCT01213823|severe hepatic injury|severe hepatic injury
452411|NCT01213823|echinocandins|echinocandins
452412|NCT01213823|anidulafungin|anidulafungin
452413|NCT01213823|caspofungin|caspofungin
452414|NCT01213823|micafungin|micafungin
452415|NCT01213810|HIV|hiv
452416|NCT01213810|VZV (Varicella zoster Virus)|vzv (varicella zoster virus)
452417|NCT01213810|vaccine|vaccine
452418|NCT01213810|T cell|t cell
452419|NCT01213810|immunogenicity|immunogenicity
452420|NCT01213810|safety|safety
452421|NCT01213797|Suicide|suicide
452422|NCT01213771|Preoperative|preoperative
452423|NCT01213771|Intervention|intervention
452424|NCT01213771|Support|support
452425|NCT01213771|Care|care
452426|NCT01213758|liver function|liver function
452427|NCT01213758|galactose|galactose
452428|NCT01213758|18-F-deoxy-galactose|18-f-deoxy-galactose
452429|NCT01213758|PET/CT|pet/ct
452430|NCT01213758|stereotactic body radiation therapy|stereotactic body radiation therapy
452431|NCT01213758|SBRT|sbrt
452432|NCT01213745|lung|lung
452433|NCT01213745|cancer|cancer
452434|NCT01213745|quality of life|quality of life
452435|NCT01213732|L19, antibody, monoclonal, tumor targeting, TNFa, ILP, melanoma|l19, antibody, monoclonal, tumor targeting, tnfa, ilp, melanoma
452436|NCT01213719|betaine, creatine, strength|betaine, creatine, strength
452437|NCT01213706|airway blood flow|airway blood flow
452438|NCT01213706|albuterol|albuterol
452439|NCT01213706|Whole Body Periodic Acceleration (WBPA)|whole body periodic acceleration (wbpa)
452440|NCT01213706|Nitric Oxide|nitric oxide
452441|NCT01213706|Endothelial Dysfunction|endothelial dysfunction
452442|NCT01213693|COPD|copd
452443|NCT01213693|Bacteria|bacteria
452444|NCT01213693|Virus|virus
452445|NCT01213693|Inhaled Corticosteroids|inhaled corticosteroids
452446|NCT01213680|Inflammatory Bowel Disease, IBD|inflammatory bowel disease, ibd
452447|NCT01213654|Lung cancer|lung cancer
452448|NCT01213654|VATS Lobectomy|vats lobectomy
452449|NCT01213641|Cryopyrin-associated periodic syndromes(CAPS)|cryopyrin-associated periodic syndromes(caps)
452450|NCT01213641|CIAS1 protein|cias1 protein
452451|NCT01213641|NLRP3 protein|nlrp3 protein
452452|NCT01213641|human cryopyrin protein|human cryopyrin protein
452453|NCT01213641|Familial Cold Autoinflammatory Syndrome(FCAS)|familial cold autoinflammatory syndrome(fcas)
452454|NCT01213641|Muckle-Wells Syndrome(MWS)|muckle-wells syndrome(mws)
452455|NCT01213641|Neonatal Onset Multisystem Inflammatory disease(NOMID)|neonatal onset multisystem inflammatory disease(nomid)
452456|NCT01213641|NALP3|nalp3
452457|NCT01213641|canakinumab|canakinumab
452458|NCT01213641|Interleukin-1(IL-1)|interleukin-1(il-1)
452459|NCT01213628|abdominal surgery|abdominal surgery
452460|NCT01213628|hypothermia|hypothermia
452461|NCT01213628|wound desiccation|wound desiccation
452462|NCT01213628|warming|warming
452463|NCT01213602|Trauma patients|trauma patients
452464|NCT01213589|descending|descending
452465|NCT01213589|thoracic|thoracic
452466|NCT01213589|aortic|aortic
452467|NCT01213589|dissection|dissection
452468|NCT01213589|Valiant|valiant
452469|NCT01213589|Medtronic|medtronic
452470|NCT01213589|Type B|type b
452471|NCT01213589|VIRTUE|virtue
452472|NCT01213589|stent|stent
452473|NCT01213576|Lymphatic filariasis|lymphatic filariasis
452474|NCT01213576|microfilaria|microfilaria
452475|NCT01213576|Albendazole|albendazole
452476|NCT01213576|ivermectin|ivermectin
452477|NCT01213576|human immunodeficiency|human immunodeficiency
452478|NCT01213563|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
452479|NCT01213537|Heart failure|heart failure
452480|NCT01213524|nicotine|nicotine
452481|NCT01213524|craving|craving
452482|NCT01213524|dual-diagnosis|dual-diagnosis
452483|NCT01213524|comorbidity|comorbidity
452484|NCT01213511|coronary artery disease; coronary artery bypass grafting; cardiopulmonary bypass; minimal extracorporeal circulation|coronary artery disease; coronary artery bypass grafting; cardiopulmonary bypass; minimal extracorporeal circulation
452485|NCT01213498|Nephrology|nephrology
452486|NCT01213498|Atorvastatin|atorvastatin
452487|NCT01213498|L-NMMA|l-nmma
452488|NCT01213498|NO|no
452489|NCT01213472|ASCI|asci
452490|NCT01213472|melanoma|melanoma
452491|NCT01213472|tumor antigen|tumor antigen
452492|NCT01213472|unresectable|unresectable
452493|NCT01213472|progressive|progressive
452494|NCT01213472|NY-ESO-1|ny-eso-1
452495|NCT01213472|adult|adult
452496|NCT01213472|cancer-testis antigen|cancer-testis antigen
452497|NCT01213472|Immunotherapy|immunotherapy
452498|NCT01213459|Human papillomavirus|human papillomavirus
452499|NCT01213446|Von Willebrand Disease|von willebrand disease
452500|NCT01213420|Donor sites after wound closure|donor sites after wound closure
452501|NCT01213407|Dendritic cell|dendritic cell
452502|NCT01213407|Cancer vaccine|cancer vaccine
452503|NCT01213407|Anti-tumor immune therapy|anti-tumor immune therapy
452504|NCT01213407|Interleukine-12|interleukine-12
452505|NCT01213407|Individualised autologous therapy|individualised autologous therapy
452506|NCT01213407|Brain cancer|brain cancer
452507|NCT01213407|Temozolomide|temozolomide
452508|NCT01213407|Radiotherapy|radiotherapy
452509|NCT01213407|Irradiation|irradiation
452510|NCT01213407|High-grade glioma|high-grade glioma
452511|NCT01213407|Advanced therapy medicinal product ATMP|advanced therapy medicinal product atmp
452512|NCT01213407|Somatic cell therapy|somatic cell therapy
452513|NCT01213407|Leukocyte apheresis|leukocyte apheresis
452514|NCT01213407|Neurosurgery|neurosurgery
452515|NCT01213407|Neurooncology|neurooncology
452516|NCT01213407|Neurology|neurology
452517|NCT01213407|Immunology|immunology
452518|NCT01213407|Tumor immunology|tumor immunology
452519|NCT01213407|Transfusion medicine|transfusion medicine
452520|NCT01213407|Monocyte|monocyte
452521|NCT01213407|Killer cell|killer cell
452522|NCT01213407|Cytotoxic T-cell|cytotoxic t-cell
452523|NCT01213407|Cytotoxic T-lymphocyte|cytotoxic t-lymphocyte
452524|NCT01213394|Framingham score|framingham score
452525|NCT01213394|kidney transplant|kidney transplant
452526|NCT01213394|immunosuppression|immunosuppression
452527|NCT01213394|cardiovascular disease|cardiovascular disease
452528|NCT01213394|CellCept|cellcept
452529|NCT01213394|mycophenolate mofetil|mycophenolate mofetil
452530|NCT01213355|Randomized|randomized
452531|NCT01213355|double-blind|double-blind
452532|NCT01213355|placebo-controlled|placebo-controlled
452533|NCT01213355|5-way crossover|5-way crossover
452534|NCT01213355|single oral administrations of PF 05212377|single oral administrations of pf 05212377
452535|NCT01213355|scopolamine induced deficits in healthy subjects|scopolamine induced deficits in healthy subjects
452536|NCT01213342|dry eye disease|dry eye disease
452537|NCT01213316|HIV|hiv
452538|NCT01213316|antiretroviral|antiretroviral
452539|NCT01213316|human immunodeficiency virus|human immunodeficiency virus
452540|NCT01213316|Raltegravir|raltegravir
452541|NCT01213316|Adults with HIV-1 infection|adults with hiv-1 infection
452542|NCT01213303|cardiovascular risk|cardiovascular risk
452543|NCT01213303|metabolic syndrome|metabolic syndrome
452544|NCT01213303|fatty acids|fatty acids
452545|NCT01213303|oxysterols|oxysterols
452546|NCT01213303|antioxidants|antioxidants
452547|NCT01213303|oxidative stress|oxidative stress
452548|NCT01213290|Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA)|endoscopic ultrasound-guided fine-needle aspiration (eus-fna)
452549|NCT01213290|Stylet|stylet
452550|NCT01213277|Diabetes Mellitus|diabetes mellitus
452551|NCT01213277|HbA1c|hba1c
452552|NCT01213277|Glycation Rate|glycation rate
452553|NCT01213277|Fructosamine|fructosamine
452554|NCT01213264|neuromuscular blockade, NMBA, sugammadex, Bridion, TOF,|neuromuscular blockade, nmba, sugammadex, bridion, tof,
452555|NCT01213238|Liver metastasis|liver metastasis
452556|NCT01213238|hepatic arterial infusion|hepatic arterial infusion
452557|NCT01213238|HAI|hai
452558|NCT01213238|Eloxatin|eloxatin
452559|NCT01213238|Xeloda|xeloda
452560|NCT01213238|Avastin|avastin
452561|NCT01213238|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
452562|NCT01213238|rhuMAb-VEGF|rhumab-vegf
452563|NCT01213238|Oxaliplatin|oxaliplatin
452564|NCT01213238|Capecitabine|capecitabine
452565|NCT01213238|Bevacizumab|bevacizumab
452566|NCT01213225|Elderly|elderly
452567|NCT01213225|Hospitalization|hospitalization
452568|NCT01213225|Geriatrics|geriatrics
452569|NCT01213225|Mortality|mortality
452570|NCT01213225|Readmission|readmission
452571|NCT01213225|Length of Stay|length of stay
452572|NCT01213212|Caloric restriction|caloric restriction
452573|NCT01213212|type 2 diabetes|type 2 diabetes
452574|NCT01213212|abdominal obesity|abdominal obesity
452575|NCT01213212|renal disease|renal disease
452576|NCT01213186|stem cell|stem cell
452577|NCT01213186|hiv|hiv
452578|NCT01213186|CD4|cd4
452579|NCT01213186|immune activation|immune activation
452580|NCT01213173|angina pectoris|angina pectoris
452584|NCT01213160|cancer|cancer
452585|NCT01213160|solid tumours|solid tumours
452586|NCT01213160|advanced solid malignancies|advanced solid malignancies
452587|NCT01213160|dose escalation|dose escalation
452588|NCT01213160|FGFR TKI|fgfr tki
452589|NCT01213160|Japanese|japanese
452590|NCT01213147|Pregnancy|pregnancy
452591|NCT01213147|Clomiphene Citrate|clomiphene citrate
452592|NCT01213147|Fertilization|fertilization
452593|NCT01213147|Buserelin|buserelin
452594|NCT01213134|Medical Education|medical education
452595|NCT01213134|Resident Training|resident training
452596|NCT01213134|Portfolio|portfolio
452597|NCT01213121|bipolar depression|bipolar depression
452598|NCT01213121|heart rate variability|heart rate variability
452599|NCT01213121|cardio-respiratory coupling|cardio-respiratory coupling
452600|NCT01213121|electroencephalography|electroencephalography
452601|NCT01213108|Örebro prevention program|örebro prevention program
452602|NCT01213108|Youth drinking|youth drinking
452603|NCT01213095|Lymphoma|lymphoma
452604|NCT01213095|B-Cell|b-cell
452605|NCT01213095|Marginal Zone|marginal zone
452606|NCT01213095|Rituximab|rituximab
452607|NCT01213082|Exudative Age-related Macular Degeneration|exudative age-related macular degeneration
452608|NCT01213082|Proton beam irradiation|proton beam irradiation
452609|NCT01213082|ranibizumab|ranibizumab
452610|NCT01213082|bevacizumab|bevacizumab
452611|NCT01213082|anti-VEGF therapy|anti-vegf therapy
452612|NCT01213056|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
452613|NCT01213056|Chronic Headache Pain|chronic headache pain
452614|NCT01213056|Randomized Controlled Trial.|randomized controlled trial.
452615|NCT01213043|emphysema|emphysema
452616|NCT01213043|alpha 1-antitrypsin|alpha 1-antitrypsin
452617|NCT01213043|alpha 1-antitrypsin deficiency (AATD)|alpha 1-antitrypsin deficiency (aatd)
452618|NCT01213043|alpha 1-proteinase inhibitor (Alpha-1 PI)|alpha 1-proteinase inhibitor (alpha-1 pi)
452619|NCT01213030|HX4|hx4
452620|NCT01213030|[F-18]HX4|[f-18]hx4
452621|NCT01213030|FMISO|fmiso
452622|NCT01213030|[F-18]FMISO|[f-18]fmiso
452623|NCT01213030|Solitary Tumor|solitary tumor
452624|NCT01213030|Hypoxia|hypoxia
452625|NCT01213017|Certolizumab pegol|certolizumab pegol
452626|NCT01213017|Magnetic Resonance Imaging|magnetic resonance imaging
452627|NCT01213017|Rheumatoid Arthritis|rheumatoid arthritis
452628|NCT01213017|RAPID 3|rapid 3
452629|NCT01213004|gastro-esophageal junction|gastro-esophageal junction
452630|NCT01213004|lung|lung
452631|NCT01213004|abdominal|abdominal
452632|NCT01213004|cone-beam CT (CBCT)|cone-beam ct (cbct)
452633|NCT01213004|10-146|10-146
452634|NCT01212991|Progressive Metastatic Prostate Cancer|progressive metastatic prostate cancer
452635|NCT01212978|Aging|aging
452636|NCT01212978|Endothelium,Vascular|endothelium,vascular
452637|NCT01212978|Arterial Remodeling|arterial remodeling
452638|NCT01212978|Ventricular Vascular Coupling|ventricular vascular coupling
452639|NCT01212978|Nitric Oxide|nitric oxide
452640|NCT01212978|Walking|walking
452641|NCT01212978|Software|software
452642|NCT01212965|Selenium|selenium
452643|NCT01212965|Lymphatic Malformations|lymphatic malformations
452644|NCT01212965|Adolescents|adolescents
452645|NCT01212939|Dead pulps and open root ends|dead pulps and open root ends
452646|NCT01212939|Patients who have teeth with dead pulp and open root ends|patients who have teeth with dead pulp and open root ends
452647|NCT01212900|Atherosclerosis|atherosclerosis
452648|NCT01212900|Cardiovascular Disease|cardiovascular disease
452649|NCT01212900|Cardiac MRI|cardiac mri
452650|NCT01212900|Cardiac CT|cardiac ct
452651|NCT01212900|Cholesterol|cholesterol
452652|NCT01212887|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
452653|NCT01212887|recurrent colon cancer|recurrent colon cancer
452654|NCT01212887|stage IIIA colon cancer|stage iiia colon cancer
452655|NCT01212887|stage IIIB colon cancer|stage iiib colon cancer
452656|NCT01212887|stage IIIC colon cancer|stage iiic colon cancer
452657|NCT01212887|stage IV colon cancer|stage iv colon cancer
452658|NCT01212887|stage IVB colon cancer|stage ivb colon cancer
452659|NCT01212887|recurrent rectal cancer|recurrent rectal cancer
452660|NCT01212887|stage IIIA rectal cancer|stage iiia rectal cancer
452661|NCT01212887|stage IIIB rectal cancer|stage iiib rectal cancer
452662|NCT01212887|stage IIIC rectal cancer|stage iiic rectal cancer
452663|NCT01212887|stage IVA rectal cancer|stage iva rectal cancer
452664|NCT01212887|stage IVB rectal cancer|stage ivb rectal cancer
452665|NCT01212887|recurrent gastric cancer|recurrent gastric cancer
452666|NCT01212887|stage IV gastric cancer|stage iv gastric cancer
452667|NCT01212887|recurrent pancreatic cancer|recurrent pancreatic cancer
452668|NCT01212887|stage III pancreatic cancer|stage iii pancreatic cancer
452669|NCT01212887|stage IV pancreatic cancer|stage iv pancreatic cancer
452670|NCT01212887|recurrent breast cancer|recurrent breast cancer
452671|NCT01212887|stage IIIC breast cancer|stage iiic breast cancer
452672|NCT01212887|stage IV breast cancer|stage iv breast cancer
452673|NCT01212887|extensive stage small cell lung cancer|extensive stage small cell lung cancer
452674|NCT01212887|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
452675|NCT01212887|recurrent small cell lung cancer|recurrent small cell lung cancer
452676|NCT01212887|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
452677|NCT01212887|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
452678|NCT01212887|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
452679|NCT01212887|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
452680|NCT01212887|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
452681|NCT01212887|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
452682|NCT01212887|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
452683|NCT01212887|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
452684|NCT01212887|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
452685|NCT01212887|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
452686|NCT01212887|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
452687|NCT01212887|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
452688|NCT01212887|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
452689|NCT01212848|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
452690|NCT01212848|Suicidal ideation|suicidal ideation
452691|NCT01212835|Obesity|obesity
452692|NCT01212835|gastroesophageal reflux disease|gastroesophageal reflux disease
452693|NCT01212835|Morbid obesity|morbid obesity
452694|NCT01212835|esophagitis|esophagitis
452695|NCT01212835|GERD|gerd
452696|NCT01212835|silastic ring|silastic ring
452697|NCT01212835|Gastric bypass|gastric bypass
452698|NCT01212796|allogeneic stem cell transplantation|allogeneic stem cell transplantation
452699|NCT01212783|depression|depression
452700|NCT01212783|psychological treatments|psychological treatments
452701|NCT01212783|Cognitive Behavioral Therapy|cognitive behavioral therapy
452702|NCT01212783|child development|child development
452703|NCT01212783|parenting|parenting
452704|NCT01212783|home visitation|home visitation
452705|NCT01212770|Psoriatic Arthritis|psoriatic arthritis
452706|NCT01212770|Psoriasis|psoriasis
452707|NCT01212770|Arthritis|arthritis
452708|NCT01212770|inflammation|inflammation
452709|NCT01212770|skin condition|skin condition
452710|NCT01212770|inflammatory cells|inflammatory cells
452711|NCT01212770|apremilast|apremilast
452712|NCT01212770|CC-10004|cc-10004
452713|NCT01212770|phosphodiesterase type 4|phosphodiesterase type 4
452714|NCT01212757|Psoriasis|psoriasis
452715|NCT01212757|Arthritis|arthritis
452716|NCT01212757|Psoriatic Arthritis|psoriatic arthritis
452717|NCT01212757|inflammation|inflammation
452718|NCT01212757|skin condition|skin condition
452719|NCT01212757|inflammatory cells|inflammatory cells
452720|NCT01212757|apremilast|apremilast
452721|NCT01212757|CC-10004|cc-10004
452722|NCT01212757|phosphodiesterase type 4|phosphodiesterase type 4
452723|NCT01212744|PEG PAL; PKU; injection;|peg pal; pku; injection;
452724|NCT01212731|Patients with malignancies of the skull base or patients with low grade glioma who require radiotherapy.|patients with malignancies of the skull base or patients with low grade glioma who require radiotherapy.
452725|NCT01212718|Colorectal Cancer|colorectal cancer
452726|NCT01212718|non resectable metastasis|non resectable metastasis
452727|NCT01212718|reference lesion|reference lesion
452728|NCT01212718|biopsy|biopsy
452729|NCT01212718|thymidylate synthase quantitation|thymidylate synthase quantitation
452730|NCT01212679|nerve growth factor|nerve growth factor
452731|NCT01212679|traumatic brain injury|traumatic brain injury
452732|NCT01212679|intranasal|intranasal
452733|NCT01212679|prognosis|prognosis
452734|NCT01212679|neurological function|neurological function
452735|NCT01212666|Adductor Canal Block (ACB)|adductor canal block (acb)
452736|NCT01212666|Anterior Cruciate Ligament (ACL) Reconstruction|anterior cruciate ligament (acl) reconstruction
452737|NCT01212666|Saphenous nerve|saphenous nerve
452738|NCT01212666|Pain|pain
452739|NCT01212666|Ultrasound block|ultrasound block
452740|NCT01212653|Ankylosing Spondylitis|ankylosing spondylitis
452741|NCT01212653|Golimumab|golimumab
452742|NCT01212653|Simponi|simponi
452743|NCT01212653|Anti-TNF alpha|anti-tnf alpha
452744|NCT01212653|EPCs|epcs
452745|NCT01212653|Vascular stiffness|vascular stiffness
452746|NCT01212640|Transfusion, distress|transfusion, distress
452747|NCT01212627|Non-Small Cell Lung Cancer|non-small cell lung cancer
452748|NCT01212601|safety|safety
452749|NCT01212601|efficacy|efficacy
452750|NCT01212601|Chinese patients|chinese patients
452751|NCT01212601|practice|practice
452752|NCT01212588|BPD|bpd
452753|NCT01212588|Borderline|borderline
452754|NCT01212588|personality disorder|personality disorder
452755|NCT01212588|mifepristone|mifepristone
452756|NCT01212575|Mental disorder|mental disorder
452757|NCT01212575|Antipsychotic treatment|antipsychotic treatment
452758|NCT01212562|basal cell carcinoma|basal cell carcinoma
452759|NCT01212562|cryosurgery|cryosurgery
452760|NCT01212562|imiquimod|imiquimod
452761|NCT01212562|immunocryosurgery|immunocryosurgery
452762|NCT01212549|basal cell carcinoma|basal cell carcinoma
452763|NCT01212549|cryosurgery|cryosurgery
452764|NCT01212549|imiquimod|imiquimod
452765|NCT01212549|immunocryosurgery|immunocryosurgery
452766|NCT01212536|children|children
452767|NCT01212536|intubation|intubation
452768|NCT01212536|laryngoscope|laryngoscope
452769|NCT01212523|propofol|propofol
452770|NCT01212523|isoflurane|isoflurane
452771|NCT01212523|pulmonary hypertension|pulmonary hypertension
452772|NCT01212523|congenital heart disease|congenital heart disease
452773|NCT01212510|metastatic colorectal cancer|metastatic colorectal cancer
452774|NCT01212510|circulating tumor markers|circulating tumor markers
452775|NCT01212510|circulating tumor cell|circulating tumor cell
452776|NCT01212510|circulating tumor DNA|circulating tumor dna
452777|NCT01212510|marker's kinetic|marker's kinetic
452778|NCT01212497|mindfulness|mindfulness
452779|NCT01212497|meditation|meditation
452780|NCT01212497|training|training
452781|NCT01212497|coaching|coaching
452782|NCT01212497|virtual coach|virtual coach
452783|NCT01212471|Sign and symptoms of dry eye disease|sign and symptoms of dry eye disease
452784|NCT01212458|gesunde Probanden|gesunde probanden
452785|NCT01212432|Gram positive infection and CRRT|gram positive infection and crrt
452786|NCT01212406|Organ rejection|organ rejection
452787|NCT01212406|Lung transplantation|lung transplantation
452788|NCT01212406|Bronchiolitis Obliterans|bronchiolitis obliterans
452789|NCT01212406|Vitamin D|vitamin d
452790|NCT01212406|Prevention|prevention
452791|NCT01212393|venous thromboembolism disease|venous thromboembolism disease
452792|NCT01212393|emergency|emergency
452793|NCT01212393|prevention|prevention
452794|NCT01212393|thromboprophylaxis|thromboprophylaxis
452795|NCT01212393|medical|medical
452796|NCT01212393|hosptitalization|hosptitalization
452797|NCT01212393|health care risks|health care risks
452798|NCT01212380|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
452799|NCT01212380|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
452800|NCT01212380|Prolymphocytic Leukemia|prolymphocytic leukemia
452801|NCT01212367|Gene transfer|gene transfer
452802|NCT01212367|Immunology|immunology
452803|NCT01212367|Cancer|cancer
452804|NCT01212354|intensity modulated radiotherapy|intensity modulated radiotherapy
452805|NCT01212354|selective dose escalation|selective dose escalation
452806|NCT01212354|hypoxia|hypoxia
452807|NCT01212354|head cancer|head cancer
452808|NCT01212354|neck cancer|neck cancer
452809|NCT01212341|Allogenetic NK cells|allogenetic nk cells
452810|NCT01212341|Lymphomas|lymphomas
452811|NCT01212341|Solid tumors|solid tumors
452812|NCT01212328|T2DM|t2dm
452813|NCT01212328|Decision support software|decision support software
452814|NCT01212328|care coordinator|care coordinator
452815|NCT01212315|Wound infection|wound infection
452816|NCT01212315|SSI|ssi
452817|NCT01212315|Suture|suture
452818|NCT01212302|Clopidogrel|clopidogrel
452819|NCT01212302|ASA|asa
452820|NCT01212302|Low Response|low response
452821|NCT01212302|Resistance|resistance
452822|NCT01212263|PCOS|pcos
452823|NCT01212263|Clomiphene resistance|clomiphene resistance
452824|NCT01212263|ovulation induction|ovulation induction
452825|NCT01212263|low dose uFSH|low dose ufsh
452826|NCT01212263|uFSH step-up protocol|ufsh step-up protocol
452827|NCT01212237|glioma|glioma
452828|NCT01212237|meningioma|meningioma
452829|NCT01212237|anaplastic astrocytoma|anaplastic astrocytoma
452830|NCT01212211|Hyponatremia; Sodium level|hyponatremia; sodium level
452831|NCT01212211|Falls|falls
452832|NCT01212211|Gait|gait
452833|NCT01212211|elderly|elderly
452834|NCT01212185|oxytocin|oxytocin
452835|NCT01212185|alcohol withdrawal|alcohol withdrawal
452836|NCT01212185|lorazepam|lorazepam
452837|NCT01212185|alcoholism|alcoholism
452838|NCT01212185|intranasal administration|intranasal administration
452839|NCT01212185|CIWA-Ar|ciwa-ar
452840|NCT01212172|Hair removal|hair removal
452841|NCT01212172|Laser|laser
452842|NCT01212172|Diode laser|diode laser
452843|NCT01212159|Internet based monitoring system|internet based monitoring system
452844|NCT01212146|Artichokes|artichokes
452845|NCT01212146|Constipation|constipation
452846|NCT01212146|Functional Foods|functional foods
452847|NCT01212146|Prebiotics|prebiotics
452848|NCT01212146|Probiotics|probiotics
452849|NCT01212120|Diabetic foot|diabetic foot
452850|NCT01212107|Advanced cancer|advanced cancer
452851|NCT01212107|Metastatic cancer|metastatic cancer
452852|NCT01212107|Oncology|oncology
452853|NCT01212094|Rituximab|rituximab
452854|NCT01212094|Multiple Sclerosis|multiple sclerosis
452855|NCT01212094|Intrathecal|intrathecal
452856|NCT01212094|MS|ms
452857|NCT01212094|Secondary-Progressive Multiple Sclerosis|secondary-progressive multiple sclerosis
452858|NCT01212094|SP-MS|sp-ms
452859|NCT01212081|Virtual Reality|virtual reality
452860|NCT01212081|Schizophrenia|schizophrenia
452861|NCT01212081|Cannabis|cannabis
452862|NCT01212081|Assessment|assessment
452863|NCT01212081|Craving|craving
452864|NCT01212068|MEG|meg
452865|NCT01212068|Epilepsy|epilepsy
452866|NCT01212068|Brain Imaging|brain imaging
452867|NCT01212068|Brain Scan|brain scan
452868|NCT01212068|Auditory Processing|auditory processing
452869|NCT01212068|Auditory Perceptual Disorder|auditory perceptual disorder
452870|NCT01212055|PBSC Collection|pbsc collection
452871|NCT01212055|Immunodeficiency|immunodeficiency
452872|NCT01212055|Spectra Apheresis System|spectra apheresis system
452873|NCT01212055|Stem Cell Mobilization|stem cell mobilization
452874|NCT01212055|Leukapheresis|leukapheresis
452875|NCT01212042|Pneumonia|pneumonia
452876|NCT01212042|Pulmonary Pathogens|pulmonary pathogens
452877|NCT01212042|HIV|hiv
452878|NCT01212042|Immunocompromised Host|immunocompromised host
452879|NCT01212042|Respiratory Infection|respiratory infection
452880|NCT01212042|Mycobacteria|mycobacteria
452881|NCT01212029|Near Infrared|near infrared
452882|NCT01212029|Optical Imaging|optical imaging
452883|NCT01212029|Brain Imaging|brain imaging
452884|NCT01212029|Healthy Volunteer|healthy volunteer
452885|NCT01212029|HV|hv
452886|NCT01212016|Eosinophilic Esophagitis|eosinophilic esophagitis
452887|NCT01212016|Eosinophilic Gastroenteritis|eosinophilic gastroenteritis
452888|NCT01212016|Peanut Allergy|peanut allergy
452889|NCT01212016|T Cell|t cell
452890|NCT01212016|IgE|ige
452891|NCT01212016|Food Allergy|food allergy
452892|NCT01212003|Mycobacterium Tuberculosis|mycobacterium tuberculosis
452893|NCT01212003|Active Tuberculosis|active tuberculosis
452894|NCT01212003|Latent Tuberculosis|latent tuberculosis
452895|NCT01212003|Tuberculosis|tuberculosis
452896|NCT01212003|TB|tb
452897|NCT01211990|Pediatric|pediatric
452898|NCT01211990|Children|children
452899|NCT01211990|Cancer|cancer
452900|NCT01211990|Bone Marrow Transplant|bone marrow transplant
452901|NCT01211977|Muckle Wells Syndrome|muckle wells syndrome
452902|NCT01211977|Autoinflammatory|autoinflammatory
452903|NCT01211977|Interleukin-1|interleukin-1
452904|NCT01211951|Dry eye syndromes|dry eye syndromes
452905|NCT01211951|Corneal diseases|corneal diseases
452906|NCT01211951|Conjunctival diseases|conjunctival diseases
452907|NCT01211938|phase II/III|phase ii/iii
452908|NCT01211938|upper aerodigestive tract carcinoma|upper aerodigestive tract carcinoma
452909|NCT01211938|re irradiation|re irradiation
452910|NCT01211938|Recurrent or second upper aerodigestive tract carcinoma|recurrent or second upper aerodigestive tract carcinoma
452911|NCT01211925|unreconstructable peripheral arterial disease|unreconstructable peripheral arterial disease
452912|NCT01211912|Fetal movement|fetal movement
452913|NCT01211912|Fetal breathing|fetal breathing
452914|NCT01211912|Acetaminophen|acetaminophen
452915|NCT01211899|polymorphism,|polymorphism,
452916|NCT01211899|plasminogen activator inhibitor,|plasminogen activator inhibitor,
452917|NCT01211899|disseminated intravascular coagulation,|disseminated intravascular coagulation,
452918|NCT01211886|Brain natriuretic peptide|brain natriuretic peptide
452919|NCT01211886|Cardio-renal syndrome|cardio-renal syndrome
452920|NCT01211873|CNS|cns
452921|NCT01211873|Contrast Agent|contrast agent
452922|NCT01211873|MRI|mri
452923|NCT01211873|Dotarem|dotarem
452924|NCT01211873|Magnevist|magnevist
452925|NCT01211860|DCCR|dccr
452926|NCT01211860|Diazoxide Chonline Controlled-Release Tablet = DCCR|diazoxide chonline controlled-release tablet = dccr
452927|NCT01211860|Hypertriglyceridemia|hypertriglyceridemia
452928|NCT01211860|Triglycerides|triglycerides
452929|NCT01211860|Pharmacokinetics|pharmacokinetics
452930|NCT01211847|triglycerides|triglycerides
452931|NCT01211847|Apo B|apo b
452932|NCT01211847|non-HDL|non-hdl
452933|NCT01211847|statin|statin
452934|NCT01211847|fenofibrate|fenofibrate
452935|NCT01211795|Migraine|migraine
452936|NCT01211795|Prevention|prevention
452937|NCT01211795|Treatment|treatment
452938|NCT01211795|Ketoprofen|ketoprofen
452939|NCT01211795|Trigeminal nerve|trigeminal nerve
452940|NCT01211782|Alzheimer's disease|alzheimer's disease
452941|NCT01211782|AD|ad
452942|NCT01211782|AC-1204|ac-1204
452943|NCT01211782|ketogenic|ketogenic
452944|NCT01211782|ketosis|ketosis
452945|NCT01211769|PUFAs|pufas
452946|NCT01211769|Alcoholism|alcoholism
452947|NCT01211769|Treatment|treatment
452948|NCT01211769|Effectiveness|effectiveness
452949|NCT01211743|SILS|sils
452950|NCT01211743|Oxidative Stress|oxidative stress
452951|NCT01211743|8-epiPGF2a|8-epipgf2a
452952|NCT01211743|SILS vs standard laparoscopic cholecystectomy|sils vs standard laparoscopic cholecystectomy
452953|NCT01211730|Liver|liver
452954|NCT01211730|transplantation|transplantation
452955|NCT01211730|Glucose|glucose
452956|NCT01211730|Hyperglycemia|hyperglycemia
452957|NCT01211730|Insulin|insulin
452958|NCT01211730|Rejection|rejection
452959|NCT01211730|Hypoglycemia|hypoglycemia
452960|NCT01211717|Branched Chained Amino Acids|branched chained amino acids
452961|NCT01211717|Delayed Onset Muscle Soreness|delayed onset muscle soreness
452962|NCT01211717|Diabetes|diabetes
452963|NCT01211717|Muscle Damage|muscle damage
452964|NCT01211704|Bipolar, Alcoholism|bipolar, alcoholism
452965|NCT01211691|Hematologic|hematologic
452966|NCT01211691|Leukemia|leukemia
452967|NCT01211691|Malignancies|malignancies
452968|NCT01211691|Myeloproliferative Neoplasms|myeloproliferative neoplasms
452969|NCT01211665|IVMP|ivmp
452970|NCT01211665|corticosteroids|corticosteroids
452971|NCT01211665|IRIS|iris
452972|NCT01211665|Progressive Multifocal Leukoencephalopathy|progressive multifocal leukoencephalopathy
452973|NCT01211665|Immune reconstitution inflammatory syndrome|immune reconstitution inflammatory syndrome
452974|NCT01211665|PML|pml
452975|NCT01211652|Compliance|compliance
452976|NCT01211652|France|france
452977|NCT01211652|Self-administered questionnaire to patients|self-administered questionnaire to patients
452978|NCT01211613|Manipulation|manipulation
452979|NCT01211613|Chiropractic|chiropractic
452980|NCT01211613|Low Back Pain|low back pain
452981|NCT01211600|Staples|staples
452982|NCT01211600|Sutures|sutures
452983|NCT01211600|Wound infections|wound infections
452984|NCT01211600|Cosmesis|cosmesis
452985|NCT01211600|Aesthetic appearance of skin incision|aesthetic appearance of skin incision
452986|NCT01211587|Parkinson's Disease|parkinson's disease
452987|NCT01211587|Cognition|cognition
452988|NCT01211587|Safinamide|safinamide
452989|NCT01211587|Phase 2|phase 2
452990|NCT01211587|Non-demented patients|non-demented patients
452991|NCT01211587|Levodopa|levodopa
452992|NCT01211587|Dopamine agonist|dopamine agonist
452993|NCT01211535|Soft contact lenses|soft contact lenses
452994|NCT01211535|Multi-purpose Solution|multi-purpose solution
452995|NCT01211522|Delirium|delirium
452996|NCT01211522|Intensive care|intensive care
452997|NCT01211522|Mechanical ventilation|mechanical ventilation
452998|NCT01211522|Antipsychotic|antipsychotic
452999|NCT01211522|Haloperidol|haloperidol
453000|NCT01211522|Ziprasidone|ziprasidone
453001|NCT01211522|Randomized|randomized
453002|NCT01211522|Placebo|placebo
453003|NCT01211522|Sepsis|sepsis
453004|NCT01211522|Sedation|sedation
453005|NCT01211522|Long-term cognitive impairment|long-term cognitive impairment
453006|NCT01211509|montelukast|montelukast
453007|NCT01211509|cysteinyl leukotriene|cysteinyl leukotriene
453008|NCT01211509|lung transplantation|lung transplantation
453009|NCT01211509|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
453010|NCT01211496|functional testing|functional testing
453011|NCT01211496|resistance training|resistance training
453012|NCT01211496|velocity training|velocity training
453013|NCT01211496|elderly|elderly
453014|NCT01211496|geriatric|geriatric
453015|NCT01211496|knee|knee
453017|NCT01211496|leg strength|leg strength
453018|NCT01211483|Lung cancer|lung cancer
453019|NCT01211470|MRSA|mrsa
453020|NCT01211470|ABSSSI|absssi
453021|NCT01211470|Staphylococcus aureus|staphylococcus aureus
453022|NCT01211444|Obstructive Sleep Apnea|obstructive sleep apnea
453023|NCT01211444|OSA|osa
453024|NCT01211444|Hypoglossal nerve stimulation|hypoglossal nerve stimulation
453025|NCT01211444|Sleep apnea|sleep apnea
453026|NCT01211431|cesarean section|cesarean section
453027|NCT01211431|pain|pain
453028|NCT01211431|ropivacain|ropivacain
453029|NCT01211431|diclofena|diclofena
453030|NCT01211431|morphine|morphine
453031|NCT01211405|MDMA|mdma
453032|NCT01211405|Psychotherapy|psychotherapy
453033|NCT01211405|Veterans|veterans
453034|NCT01211405|Posttraumatic Stress Disorder|posttraumatic stress disorder
453035|NCT01211379|colorectal cancer screening|colorectal cancer screening
453036|NCT01211379|primary care|primary care
453037|NCT01211379|health disparities|health disparities
453038|NCT01211366|cell saver|cell saver
453039|NCT01211366|allogeneic RBCs|allogeneic rbcs
453040|NCT01211366|washed cells|washed cells
453041|NCT01211366|PRBC transfusion|prbc transfusion
453042|NCT01211353|Alcohol|alcohol
453043|NCT01211353|Brief Intervention|brief intervention
453044|NCT01211353|Personalized Feedback|personalized feedback
453045|NCT01211353|Veterans|veterans
453046|NCT01211340|Hospice|hospice
453047|NCT01211340|Caregivers|caregivers
453048|NCT01211340|Interdisciplinary Team|interdisciplinary team
453049|NCT01211340|Pain management|pain management
453050|NCT01211314|hypertension|hypertension
453051|NCT01211314|Fixed combination|fixed combination
453052|NCT01211314|lercanidipine|lercanidipine
453053|NCT01211314|enalapril|enalapril
453054|NCT01211314|Blood Pressure Monitoring, Ambulatory|blood pressure monitoring, ambulatory
453055|NCT01211301|obesity|obesity
453056|NCT01211301|overweight|overweight
453057|NCT01211301|weight loss|weight loss
453058|NCT01211301|randomized controlled trial|randomized controlled trial
453059|NCT01211301|Medifast|medifast
453060|NCT01211288|HIV|hiv
453061|NCT01211288|Implant|implant
453062|NCT01211288|Crown|crown
453063|NCT01211275|mesothelioma|mesothelioma
453064|NCT01211275|chemotherapy|chemotherapy
453065|NCT01211275|translational research|translational research
453066|NCT01211275|axitinib|axitinib
453067|NCT01211262|Melanoma|melanoma
453068|NCT01211262|Phase I|phase i
453069|NCT01211262|Biologic|biologic
453070|NCT01211249|Methotrexate-refractory|methotrexate-refractory
453071|NCT01211223|Chronic periodontitis|chronic periodontitis
453072|NCT01211223|Metronidazole plus Amoxicillin|metronidazole plus amoxicillin
453073|NCT01211223|Mechanical periodontal therapy|mechanical periodontal therapy
453074|NCT01211223|Scaling and Root Planning|scaling and root planning
453075|NCT01211223|Periodontal treatment|periodontal treatment
453076|NCT01211210|rectal cancer|rectal cancer
453077|NCT01211210|neoadjuvant therapy|neoadjuvant therapy
453078|NCT01211210|oxaliplatin|oxaliplatin
453079|NCT01211210|radiation|radiation
453080|NCT01211184|Hip surgery|hip surgery
453081|NCT01211184|Metabolism|metabolism
453082|NCT01211184|Glucose|glucose
453083|NCT01211184|Body fluids|body fluids
453084|NCT01211184|Complications|complications
453085|NCT01211171|Cough|cough
453086|NCT01211171|Telmisartan|telmisartan
453087|NCT01211171|Bradykinin|bradykinin
453088|NCT01211171|Tolerability|tolerability
453089|NCT01211158|emergency department|emergency department
453090|NCT01211158|procedural sedation|procedural sedation
453091|NCT01211158|ketofol|ketofol
453092|NCT01211158|ketamine|ketamine
453093|NCT01211158|propofol|propofol
453094|NCT01211158|conscious sedation|conscious sedation
453095|NCT01211145|Migraine|migraine
453096|NCT01211145|Headache|headache
453097|NCT01211145|Pain|pain
453098|NCT01211145|Efficacy|efficacy
453099|NCT01211145|Adolescents|adolescents
453100|NCT01211132|Colon polyps|colon polyps
453101|NCT01211132|Adenoma detection|adenoma detection
453102|NCT01211132|Cap|cap
453103|NCT01211132|Standard|standard
453104|NCT01211132|Colon Cancer|colon cancer
453105|NCT01211106|Treatment|treatment
453106|NCT01211106|PTSD|ptsd
453107|NCT01211106|Addiction|addiction
453108|NCT01211093|vibration|vibration
453109|NCT01211093|muscle|muscle
453110|NCT01211093|cerebrovascular accident|cerebrovascular accident
453111|NCT01211093|exercise|exercise
453112|NCT01211093|rehabilitation|rehabilitation
453113|NCT01211080|infancy hemangioma|infancy hemangioma
453114|NCT01211080|propranolol|propranolol
453115|NCT01211080|study design|study design
453116|NCT01211080|side effects|side effects
453117|NCT01211080|safety|safety
453118|NCT01211067|Inguinal hernia|inguinal hernia
453119|NCT01211067|Inguinal ring|inguinal ring
453120|NCT01211067|Histology|histology
453121|NCT01211067|Hernioplasty|hernioplasty
453122|NCT01211067|Lichtenstein|lichtenstein
453123|NCT01211041|Candida albicans, fungemia , prognostic factor|candida albicans, fungemia , prognostic factor
453124|NCT01211028|Critical leg ischemia|critical leg ischemia
453125|NCT01211028|Adipose derived Stroma/Stem Cells|adipose derived stroma/stem cells
453126|NCT01211028|Autologous|autologous
453127|NCT01211028|Angiogenesis|angiogenesis
453128|NCT01211002|Radiotherapy|radiotherapy
453129|NCT01211002|rh-endostatin|rh-endostatin
453130|NCT01211002|chemotherapy|chemotherapy
453131|NCT01211002|NSCLC|nsclc
453132|NCT01210976|levosimendan|levosimendan
453133|NCT01210976|CABG|cabg
453134|NCT01210976|AVR|avr
453135|NCT01210950|distraction|distraction
453136|NCT01210950|osteogenesis|osteogenesis
453137|NCT01210950|limb length discrepancy|limb length discrepancy
453138|NCT01210950|callus|callus
453139|NCT01210937|Internal Carotid Artery Stenosis|internal carotid artery stenosis
453140|NCT01210937|Carotid Endarterectomy|carotid endarterectomy
453141|NCT01210937|Stroke|stroke
453142|NCT01210937|Cerebrovascular|cerebrovascular
453143|NCT01210937|Atherosclerosis|atherosclerosis
453144|NCT01210924|children|children
453145|NCT01210924|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
453146|NCT01210924|antiretroviral therapy|antiretroviral therapy
453147|NCT01210924|China|china
453148|NCT01210924|Mortality|mortality
453149|NCT01210911|pancreatic cancer|pancreatic cancer
453150|NCT01210911|metformin|metformin
453151|NCT01210911|MAPK pathway|mapk pathway
453152|NCT01210911|PI3K/Akt pathway|pi3k/akt pathway
453153|NCT01210911|gemcitabine|gemcitabine
453154|NCT01210898|Influenza|influenza
453155|NCT01210898|Trivalent|trivalent
453156|NCT01210898|Adjuvanted|adjuvanted
453157|NCT01210898|Vaccine|vaccine
453158|NCT01210898|Children|children
453159|NCT01210885|Meningococcal Disease|meningococcal disease
453160|NCT01210885|Vaccines|vaccines
453161|NCT01210885|Adolescents|adolescents
453162|NCT01210872|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
453163|NCT01210872|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
453164|NCT01210872|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
453165|NCT01210872|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
453166|NCT01210872|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
453167|NCT01210872|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
453168|NCT01210872|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
453169|NCT01210872|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
453170|NCT01210872|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
453171|NCT01210872|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
453172|NCT01210872|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
453173|NCT01210872|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
453174|NCT01210872|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
453175|NCT01210872|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
453176|NCT01210872|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
453177|NCT01210872|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
453178|NCT01210872|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
453179|NCT01210872|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
453180|NCT01210872|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
453181|NCT01210872|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
453182|NCT01210872|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
453183|NCT01210872|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
453184|NCT01210872|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
453185|NCT01210872|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
453186|NCT01210872|tongue cancer|tongue cancer
453187|NCT01210859|detrusitol|detrusitol
453188|NCT01210859|overactive|overactive
453189|NCT01210859|bladder|bladder
453190|NCT01210859|ureteral|ureteral
453191|NCT01210859|stents|stents
453192|NCT01210846|AV-951|av-951
453193|NCT01210846|tivozanib|tivozanib
453194|NCT01210846|QTc|qtc
453195|NCT01210846|advanced solid tumors|advanced solid tumors
453196|NCT01210846|pharmacokinetics|pharmacokinetics
453197|NCT01210833|Finger Fractures|finger fractures
453198|NCT01210833|Tendon Injuries|tendon injuries
453199|NCT01210833|Soft Tissue Injuries|soft tissue injuries
453200|NCT01210781|All indication for deep brain stimulation (DBS)|all indication for deep brain stimulation (dbs)
453201|NCT01210768|Phase II|phase ii
453202|NCT01210768|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
453203|NCT01210768|Adjuvant Chemotherapy|adjuvant chemotherapy
453204|NCT01210768|Breast Cancer|breast cancer
453205|NCT01210755|Antithrombotics|antithrombotics
453206|NCT01210755|Haemostatics|haemostatics
453207|NCT01210755|Antidote|antidote
453208|NCT01210729|stroke|stroke
453209|NCT01210729|mechanical recanalization|mechanical recanalization
453210|NCT01210729|self-expanding stent|self-expanding stent
453211|NCT01210729|Solitaire|solitaire
453212|NCT01210716|Therapeutic plasma exchange|therapeutic plasma exchange
453213|NCT01210716|Autoimmune diseases|autoimmune diseases
453214|NCT01210716|Kidney transplant|kidney transplant
453215|NCT01210716|Hematologic disorders|hematologic disorders
453216|NCT01210716|Monoclonal gammopathy|monoclonal gammopathy
453217|NCT01210716|Neurologic disorders|neurologic disorders
453218|NCT01210703|Acoustic Pharyngometry|acoustic pharyngometry
453219|NCT01210703|CPAP|cpap
453220|NCT01210703|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
453221|NCT01210690|Levetiracetam|levetiracetam
453222|NCT01210690|Keppra® Oral Solution|keppra® oral solution
453223|NCT01210690|Keppra® in Children|keppra® in children
453224|NCT01210677|Cardiac Sarcoidosis|cardiac sarcoidosis
453225|NCT01210677|Sarcoidosis|sarcoidosis
453226|NCT01210664|Diabetes|diabetes
453227|NCT01210664|Treg|treg
453228|NCT01210651|Yoga|yoga
453229|NCT01210651|Major Depression|major depression
453230|NCT01210651|Self-Efficacy|self-efficacy
453231|NCT01210651|Self-Esteem|self-esteem
453232|NCT01210651|Hatha yoga|hatha yoga
453233|NCT01210651|mind-body therapies|mind-body therapies
453234|NCT01210651|depression|depression
453235|NCT01210625|Constipation|constipation
453236|NCT01210599|Back Pain|back pain
453237|NCT01210599|Bisphosphonate|bisphosphonate
453238|NCT01210599|Pamidronate|pamidronate
453239|NCT01210599|Bone Pain|bone pain
453240|NCT01210573|Heart Failure|heart failure
453241|NCT01210573|Heart-Assist Devices|heart-assist devices
453242|NCT01210573|Left Ventricular Assist Device|left ventricular assist device
453243|NCT01210560|Kidney Disease|kidney disease
453244|NCT01210560|Polycystic Kidney Disease|polycystic kidney disease
453245|NCT01210521|Asthmatic Patients|asthmatic patients
453246|NCT01210521|Vitamin D|vitamin d
453247|NCT01210521|Steroid Resistant Asthmatic Patients|steroid resistant asthmatic patients
453248|NCT01210521|cholecalciferol|cholecalciferol
453249|NCT01210508|Cancer patients with metastases to the spinal column|cancer patients with metastases to the spinal column
453250|NCT01210495|Hepatocellular Carcinoma|hepatocellular carcinoma
453251|NCT01210482|Torisel|torisel
453252|NCT01210482|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
453253|NCT01210469|elderly|elderly
453254|NCT01210469|postural balance|postural balance
453255|NCT01210469|musculoskeletal equilibrium|musculoskeletal equilibrium
453256|NCT01210469|posture|posture
453257|NCT01210469|muscle strength|muscle strength
453258|NCT01210469|muscle stretching exercises|muscle stretching exercises
453259|NCT01210456|Chronic Kidney Disease|chronic kidney disease
453260|NCT01210456|Contrast Media|contrast media
453261|NCT01210456|Acute Kidney Injury|acute kidney injury
453262|NCT01210456|N-Acetylcysteine|n-acetylcysteine
453263|NCT01210456|Bicarbonate|bicarbonate
453264|NCT01210443|sitaxentan sodium pulmonary hypertension|sitaxentan sodium pulmonary hypertension
453265|NCT01210430|Postural Tachycardia Syndrome|postural tachycardia syndrome
453266|NCT01210430|Orthostatic Intolerance|orthostatic intolerance
453267|NCT01210430|Reactive Oxygen Species|reactive oxygen species
453268|NCT01210430|Oxidative Stress|oxidative stress
453269|NCT01210430|Angiotensin II|angiotensin ii
453270|NCT01210430|Nitric Oxide|nitric oxide
453271|NCT01210430|Blood Flow|blood flow
453272|NCT01210430|POTS|pots
453273|NCT01210430|Ascorbic Acid|ascorbic acid
453274|NCT01210430|Vitamin C|vitamin c
453275|NCT01210430|Losartan|losartan
453276|NCT01210417|Trauma|trauma
453277|NCT01210417|Hypovolemia|hypovolemia
453278|NCT01210417|Hemorrhage|hemorrhage
453279|NCT01210417|Out of hospital trauma|out of hospital trauma
453280|NCT01210404|Drug interaction with methadone.|drug interaction with methadone.
453281|NCT01210378|NSCLC|nsclc
453282|NCT01210378|Nitroglycerin|nitroglycerin
453283|NCT01210378|Tumour perfusion|tumour perfusion
453284|NCT01210378|Hypoxia|hypoxia
453285|NCT01210378|Toxicity|toxicity
453286|NCT01210378|Phase II|phase ii
453287|NCT01210378|HX4|hx4
453288|NCT01210365|CHF functional class II|chf functional class ii
453289|NCT01210365|Patients with CHF|patients with chf
453290|NCT01210365|Patients with CHF functional class II (NYHA) of any etiology|patients with chf functional class ii (nyha) of any etiology
453291|NCT01210352|surgical pain|surgical pain
453292|NCT01210352|acute pain|acute pain
453293|NCT01210352|Acute Post Surgical Pain|acute post surgical pain
453294|NCT01210339|phase 1|phase 1
453295|NCT01210339|cross-over|cross-over
453296|NCT01210339|drug-drug Interaction|drug-drug interaction
453297|NCT01210339|esomeprazole|esomeprazole
453298|NCT01210339|acetylsalicylic acid|acetylsalicylic acid
453299|NCT01210339|clopidogrel|clopidogrel
453300|NCT01210339|healthy volunteers|healthy volunteers
453301|NCT01210339|cardiovascular disease|cardiovascular disease
453302|NCT01210339|patients with acid associated gastrointestinal symptoms|patients with acid associated gastrointestinal symptoms
453303|NCT01210326|TESE|tese
453304|NCT01210326|TESA|tesa
453305|NCT01210326|non obstructive|non obstructive
453306|NCT01210326|azoospermi|azoospermi
453307|NCT01210313|physical activity|physical activity
453308|NCT01210300|caesarean section|caesarean section
453309|NCT01210300|vaginal birth after caesarean section|vaginal birth after caesarean section
453310|NCT01210300|repeat caesarean section|repeat caesarean section
453311|NCT01210300|childbirth expectation|childbirth expectation
453312|NCT01210300|childbirth experience|childbirth experience
453313|NCT01210287|hepatitis B virus reactivation|hepatitis b virus reactivation
453314|NCT01210287|HBsAg negative|hbsag negative
453315|NCT01210287|HBcAb positive|hbcab positive
453316|NCT01210287|lymphoma|lymphoma
453317|NCT01210287|rituximab|rituximab
453318|NCT01210261|OSA|osa
453319|NCT01210261|CPAP|cpap
453320|NCT01210261|APAP|apap
453321|NCT01210261|SPAP|spap
453322|NCT01210261|Obstructive Sleep Apnea|obstructive sleep apnea
453323|NCT01210261|Sleep Apnea|sleep apnea
453324|NCT01210235|colorectal cancer screening|colorectal cancer screening
453325|NCT01210235|preventive health|preventive health
453326|NCT01210235|primary care|primary care
453327|NCT01210209|Ewing sarcoma|ewing sarcoma
453328|NCT01210209|Ewing sarcoma/peripheral primitive neuroectodermal tumor (PNET)|ewing sarcoma/peripheral primitive neuroectodermal tumor (pnet)
453329|NCT01210196|Fabry|fabry
453330|NCT01210183|Dextrose|dextrose
453331|NCT01210183|Cartilage|cartilage
453332|NCT01210183|Regeneration|regeneration
453333|NCT01210170|asthma,|asthma,
453334|NCT01210170|inhaled corticosteroids,|inhaled corticosteroids,
453335|NCT01210170|airway blood flow,|airway blood flow,
453336|NCT01210170|mometasone,|mometasone,
453337|NCT01210170|albuterol|albuterol
453338|NCT01210170|spirometry|spirometry
453339|NCT01210144|Infertility|infertility
453340|NCT01210144|Gonal-f|gonal-f
453341|NCT01210144|gene expression|gene expression
453342|NCT01210144|Assisted Reproductive Technologies|assisted reproductive technologies
453343|NCT01210144|Follitropin alfa|follitropin alfa
453344|NCT01210144|endometrium|endometrium
453345|NCT01210131|Toxicity|toxicity
453346|NCT01210131|Progression|progression
453347|NCT01210131|Survival|survival
453348|NCT01210131|SCLC|sclc
453349|NCT01210118|Pregnancy|pregnancy
453350|NCT01210118|Smoking cessation|smoking cessation
453351|NCT01210118|Cognitive-Behavioural interventions|cognitive-behavioural interventions
453352|NCT01210105|intubation|intubation
453353|NCT01210105|video laryngoscopes|video laryngoscopes
453354|NCT01210079|opioid-induced hyperalgesia|opioid-induced hyperalgesia
453355|NCT01210079|methadone|methadone
453356|NCT01210079|gabapentin|gabapentin
453357|NCT01210079|opioid addiction|opioid addiction
453358|NCT01210066|inflammation|inflammation
453359|NCT01210066|opioid-induced hyperalgesia|opioid-induced hyperalgesia
453360|NCT01210066|bupenorphine|bupenorphine
453361|NCT01210066|prescription opioid abuse|prescription opioid abuse
453362|NCT01210053|Non-Small Cell Lung Cancer|non-small cell lung cancer
453363|NCT01210040|Pregnancy|pregnancy
453364|NCT01210040|Iron deficiency|iron deficiency
453365|NCT01210040|Iron supplementation|iron supplementation
453366|NCT01210040|Burkina Faso|burkina faso
453495|NCT01209377|no focus|no focus
453367|NCT01210014|Recurrent aphthous stomatitis|recurrent aphthous stomatitis
453368|NCT01210014|treatment|treatment
453369|NCT01210014|zinc sulphate|zinc sulphate
453370|NCT01209975|blood flow|blood flow
453371|NCT01209975|glaucoma|glaucoma
453372|NCT01209975|SLT|slt
453373|NCT01209936|Body Fat|body fat
453374|NCT01209936|Total body water|total body water
453375|NCT01209923|Percent body fat|percent body fat
453376|NCT01209923|Body Composition|body composition
453377|NCT01209923|Stayhealthy|stayhealthy
453378|NCT01209897|Smoking|smoking
453379|NCT01209871|Lymphoplasmacytic Lymphoma|lymphoplasmacytic lymphoma
453380|NCT01209871|Recombinant DNA|recombinant dna
453381|NCT01209871|Fusion DNA Vaccine|fusion dna vaccine
453382|NCT01209871|Waldenström macroglobulinemia|waldenström macroglobulinemia
453383|NCT01209858|epilepsy|epilepsy
453384|NCT01209845|depression|depression
453385|NCT01209845|suicide ideation|suicide ideation
453386|NCT01209845|emergency department|emergency department
453387|NCT01209845|ketamine|ketamine
453388|NCT01209832|Metastatic Tumors|metastatic tumors
453389|NCT01209832|Lymphoma|lymphoma
453390|NCT01209819|Bone Mineral Density|bone mineral density
453391|NCT01209819|Adults|adults
453392|NCT01209780|seasonal influenza, vaccine|seasonal influenza, vaccine
453393|NCT01209767|Cellulite|cellulite
453394|NCT01209767|Cryolipolysis|cryolipolysis
453395|NCT01209767|Zeltiq|zeltiq
453396|NCT01209767|Subcision|subcision
453397|NCT01209754|Pregnancy|pregnancy
453398|NCT01209754|Chemoprophylactic Exposure|chemoprophylactic exposure
453399|NCT01209754|Mother|mother
453400|NCT01209754|Infant|infant
453401|NCT01209754|malformations|malformations
453402|NCT01209754|HIV|hiv
453403|NCT01209728|insomnia|insomnia
453404|NCT01209728|insomniacs|insomniacs
453405|NCT01209728|simulated driving|simulated driving
453406|NCT01209728|alcohol|alcohol
453407|NCT01209728|ethanol|ethanol
453408|NCT01209715|airway blood flow,|airway blood flow,
453409|NCT01209715|COPD,|copd,
453410|NCT01209715|endothelial dysfunction|endothelial dysfunction
453411|NCT01209715|inhaled corticosteroids|inhaled corticosteroids
453412|NCT01209676|melanoma, with advanced unresectable|melanoma, with advanced unresectable
453413|NCT01209663|General Surgery|general surgery
453414|NCT01209663|Emergency treatment|emergency treatment
453415|NCT01209663|Postoperative care|postoperative care
453416|NCT01209663|Intermediate care unit|intermediate care unit
453417|NCT01209663|High dependency unit|high dependency unit
453418|NCT01209663|Mortality|mortality
453419|NCT01209637|stable coronary artery disease|stable coronary artery disease
453420|NCT01209637|significant coronary stenosis|significant coronary stenosis
453421|NCT01209624|prospective|prospective
453422|NCT01209624|non-interventional|non-interventional
453423|NCT01209624|observational|observational
453424|NCT01209624|multi-center|multi-center
453425|NCT01209624|long-term|long-term
453426|NCT01209598|soft tissue|soft tissue
453427|NCT01209598|Palbociclib (PD0332991)|palbociclib (pd0332991)
453428|NCT01209598|10-094|10-094
453429|NCT01209572|energy expenditure|energy expenditure
453430|NCT01209572|heart rate|heart rate
453431|NCT01209572|accelerometry|accelerometry
453432|NCT01209572|body temperature|body temperature
453433|NCT01209572|heat flow galvanic response of skin|heat flow galvanic response of skin
453434|NCT01209546|Bronchiectasis|bronchiectasis
453435|NCT01209546|Pulmonary function|pulmonary function
453436|NCT01209546|Respiratory muscle strength|respiratory muscle strength
453437|NCT01209546|Respiratory secretions|respiratory secretions
453438|NCT01209533|Asthma|asthma
453439|NCT01209520|Lung Cancer|lung cancer
453440|NCT01209520|Non-Small Cell Lung Carcinoma|non-small cell lung carcinoma
453441|NCT01209520|NSCLC|nsclc
453442|NCT01209520|Methylation Analysis|methylation analysis
453443|NCT01209520|Hypermethylation|hypermethylation
453444|NCT01209520|Targeted Genes|targeted genes
453445|NCT01209520|Tumorigenesis|tumorigenesis
453446|NCT01209520|Tumor Supressor Genes|tumor supressor genes
453447|NCT01209507|Adrenal suppression|adrenal suppression
453448|NCT01209507|Chemotherapy fatigue|chemotherapy fatigue
453449|NCT01209507|Quality of life|quality of life
453450|NCT01209494|sudden cardiac death|sudden cardiac death
453451|NCT01209494|implantable cardioverter defibrillator|implantable cardioverter defibrillator
453452|NCT01209494|ventricular arrhythmias|ventricular arrhythmias
453453|NCT01209494|genetic syndromes|genetic syndromes
453454|NCT01209494|calcium metabolism|calcium metabolism
453455|NCT01209494|ventricular repolarization|ventricular repolarization
453456|NCT01209494|ECG|ecg
453457|NCT01209494|T wave|t wave
453458|NCT01209494|programmed electrical stimulation|programmed electrical stimulation
453459|NCT01209494|alternans|alternans
453460|NCT01209494|late potentials|late potentials
453461|NCT01209494|risk stratification|risk stratification
453462|NCT01209481|fruits|fruits
453463|NCT01209481|vegetables|vegetables
453464|NCT01209481|primary health care|primary health care
453465|NCT01209481|nutritional education|nutritional education
453466|NCT01209455|Acetylcysteine|acetylcysteine
453467|NCT01209455|Adverse effects|adverse effects
453468|NCT01209455|Acetaminophen|acetaminophen
453469|NCT01209455|Anaphylactoid reactions|anaphylactoid reactions
453470|NCT01209442|Glioblastoma|glioblastoma
453471|NCT01209442|Multiforme|multiforme
453472|NCT01209429|Calorie restriction|calorie restriction
453473|NCT01209429|GH/IGF-I axis|gh/igf-i axis
453474|NCT01209429|STATb5|statb5
453475|NCT01209429|SIRT1|sirt1
453476|NCT01209429|Intracellular signaling peptides and proteins|intracellular signaling peptides and proteins
453477|NCT01209429|Fasting|fasting
453478|NCT01209429|Growth hormone|growth hormone
453479|NCT01209429|IGF-1|igf-1
453480|NCT01209416|ghrelin|ghrelin
453481|NCT01209416|metabolism|metabolism
453482|NCT01209416|type 2 diabetes|type 2 diabetes
453483|NCT01209416|insulin resistance|insulin resistance
453484|NCT01209403|Dialysis|dialysis
453485|NCT01209403|Malnutrition|malnutrition
453486|NCT01209403|Insulin-Like Growth Factor I|insulin-like growth factor i
453487|NCT01209403|Insulin-Like Growth Factor Binding Protein 1|insulin-like growth factor binding protein 1
453488|NCT01209403|Inflammation|inflammation
453489|NCT01209390|osteochondral|osteochondral
453490|NCT01209390|regenerative|regenerative
453491|NCT01209390|repair|repair
453492|NCT01209390|cartilage lesion|cartilage lesion
453493|NCT01209377|standard|standard
453494|NCT01209377|fixed|fixed
453496|NCT01209377|EMDR treatment with bilateral stimulation via eye movement|emdr treatment with bilateral stimulation via eye movement
453497|NCT01209377|EMDR treatment with fixed eyes|emdr treatment with fixed eyes
453498|NCT01209377|Trauma exposition without external stimulus|trauma exposition without external stimulus
453499|NCT01209364|comparative|comparative
453500|NCT01209364|randomized|randomized
453501|NCT01209364|double-blind|double-blind
453502|NCT01209364|non-inferior|non-inferior
453503|NCT01209364|knee OA|knee oa
453504|NCT01209351|Pharmacokinetics|pharmacokinetics
453505|NCT01209351|Pharmacodynamics|pharmacodynamics
453506|NCT01209351|teduglutide|teduglutide
453507|NCT01209325|human papilloma virus infection|human papilloma virus infection
453508|NCT01209325|anal cancer|anal cancer
453509|NCT01209325|penile cancer|penile cancer
453510|NCT01209325|HIV infection|hiv infection
453511|NCT01209299|recurrent melanoma|recurrent melanoma
453512|NCT01209299|stage IIIC melanoma|stage iiic melanoma
453513|NCT01209299|stage IV melanoma|stage iv melanoma
453514|NCT01209286|Blinatumomab|blinatumomab
453515|NCT01209286|B-ALL|b-all
453516|NCT01209286|adult ALL|adult all
453517|NCT01209286|relapsed ALL|relapsed all
453518|NCT01209286|refractory ALL|refractory all
453519|NCT01209286|Leukemia|leukemia
453520|NCT01209286|ALL|all
453521|NCT01209286|Lymphatic diseases|lymphatic diseases
453522|NCT01209286|Lymphoproliferative disorders|lymphoproliferative disorders
453523|NCT01209286|bispecific antibody|bispecific antibody
453524|NCT01209286|anti-CD19|anti-cd19
453525|NCT01209286|Immunotherapeutic treatment|immunotherapeutic treatment
453526|NCT01209273|Quality of Life|quality of life
453527|NCT01209273|Automated Peritoneal Dialysis|automated peritoneal dialysis
453528|NCT01209273|Continuous Ambulatory Peritoneal Dialysis|continuous ambulatory peritoneal dialysis
453529|NCT01209273|End Stage Renal Disease|end stage renal disease
453530|NCT01209260|Transseptal Puncture|transseptal puncture
453531|NCT01209260|Radiofrequency Energy|radiofrequency energy
453532|NCT01209260|Left Atrium Access|left atrium access
453533|NCT01209260|Left Atrial Catheterization|left atrial catheterization
453534|NCT01209260|Ablation|ablation
453535|NCT01209260|Transseptal Catheterization|transseptal catheterization
453536|NCT01209260|Electrocautery|electrocautery
453537|NCT01209260|Catheter Ablation|catheter ablation
453538|NCT01209260|Atrial Fibrillation|atrial fibrillation
453539|NCT01209247|Fluoroquinolone -resistance|fluoroquinolone -resistance
453540|NCT01209247|Commensal flora|commensal flora
453541|NCT01209247|Emergence of resistance|emergence of resistance
453542|NCT01209234|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
453543|NCT01209234|MRSA|mrsa
453544|NCT01209195|Ovarian cancer|ovarian cancer
453545|NCT01209195|HER-2 negative breast cancer|her-2 negative breast cancer
453546|NCT01209195|Breast cancer|breast cancer
453547|NCT01209195|Fallopian tube cancer|fallopian tube cancer
453548|NCT01209169|Kidney Renal|kidney renal
453549|NCT01209117|formulation|formulation
453550|NCT01209117|bioavailability|bioavailability
453551|NCT01209117|pharmacokinetics|pharmacokinetics
453552|NCT01209117|GSK2248761|gsk2248761
453553|NCT01209104|omeprazole|omeprazole
453554|NCT01209104|proton pump inhibitor|proton pump inhibitor
453555|NCT01209104|COPD|copd
453556|NCT01209104|CXCR2 inhibitor|cxcr2 inhibitor
453557|NCT01209104|bioavailability|bioavailability
453558|NCT01209104|food-effect|food-effect
453559|NCT01209078|methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
453560|NCT01209078|linezolid|linezolid
453561|NCT01209078|repeat dose|repeat dose
453562|NCT01209078|GSK1322322|gsk1322322
453563|NCT01209065|integrase|integrase
453564|NCT01209065|fosamprenavir|fosamprenavir
453565|NCT01209065|ritonavir|ritonavir
453566|NCT01209065|GSK1349572|gsk1349572
453567|NCT01209052|COPD|copd
453568|NCT01209052|CXCR2 inhibitor|cxcr2 inhibitor
453569|NCT01209039|Schizophrenia|schizophrenia
453570|NCT01209039|PET|pet
453571|NCT01209026|Fluticasone furoate (GW685698)|fluticasone furoate (gw685698)
453572|NCT01209026|moxifloxacin|moxifloxacin
453573|NCT01209026|QTc|qtc
453574|NCT01209026|GW642444|gw642444
453575|NCT01209026|pharmacokinetics|pharmacokinetics
453576|NCT01209013|PDT|pdt
453577|NCT01209013|porfimer sodium|porfimer sodium
453578|NCT01209013|BE|be
453579|NCT01209000|Focal and Segmental Glomerulosclerosis|focal and segmental glomerulosclerosis
453580|NCT01209000|Focal & Segmental Glomerulosclerosis|focal & segmental glomerulosclerosis
453581|NCT01209000|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
453582|NCT01209000|FSGS|fsgs
453583|NCT01209000|Minimal change disease|minimal change disease
453584|NCT01209000|MCD|mcd
453585|NCT01209000|Membranous Nephropathy|membranous nephropathy
453586|NCT01209000|MN|mn
453587|NCT01209000|Nephrotic Syndrome|nephrotic syndrome
453588|NCT01209000|Neph Syndrome|neph syndrome
453589|NCT01209000|NEPTUNE|neptune
453590|NCT01209000|NephCure|nephcure
453591|NCT01209000|Halpin|halpin
453592|NCT01208974|Breast Cancer|breast cancer
453593|NCT01208974|Nipple Area Complex|nipple area complex
453594|NCT01208974|Mastectomy|mastectomy
453595|NCT01208974|Radiation Therapy|radiation therapy
453596|NCT01208974|Nipple-Sparing|nipple-sparing
453597|NCT01208974|Breast Reconstruction|breast reconstruction
453598|NCT01208961|Eicosapentaenoic Acid|eicosapentaenoic acid
453599|NCT01208961|Docosahexaenoic Acid|docosahexaenoic acid
453600|NCT01208961|Hypertriglyceridemia|hypertriglyceridemia
453601|NCT01208961|Omega-3 acid ethyl esters|omega-3 acid ethyl esters
453602|NCT01208961|Omega-3 carboxylic acids|omega-3 carboxylic acids
453603|NCT01208961|Epanova|epanova
453604|NCT01208961|Lovaza|lovaza
453605|NCT01208961|bioavailability|bioavailability
453606|NCT01208961|pharmacokinetics|pharmacokinetics
453607|NCT01208961|low-fat meal|low-fat meal
453608|NCT01208961|high-fat meal|high-fat meal
453609|NCT01208948|macular edema|macular edema
453610|NCT01208948|diabetes mellitus|diabetes mellitus
453611|NCT01208948|prevention alpha lipoic acid|prevention alpha lipoic acid
453612|NCT01208935|Randomized|randomized
453613|NCT01208935|Double blind|double blind
453614|NCT01208935|double-dummy|double-dummy
453615|NCT01208935|placebo-controlled|placebo-controlled
453616|NCT01208896|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
453617|NCT01208896|Reduced-intensity conditioning|reduced-intensity conditioning
453618|NCT01208896|Chemosensitive relapsed follicular lymphoma|chemosensitive relapsed follicular lymphoma
453745|NCT01208311|Alcoholic cirrhosis|alcoholic cirrhosis
453746|NCT01208311|hepatitis c cirrhosis|hepatitis c cirrhosis
453619|NCT01208883|Primary non-operated squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx and larynx.|primary non-operated squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx and larynx.
453620|NCT01208831|Advanced tumors|advanced tumors
453621|NCT01208831|hedgehog|hedgehog
453622|NCT01208831|smoothened inhibitor|smoothened inhibitor
453623|NCT01208792|Auto antibodies|auto antibodies
453624|NCT01208792|Target antigens|target antigens
453625|NCT01208792|2D-immunoblot|2d-immunoblot
453626|NCT01208792|Reactive oxygen species|reactive oxygen species
453627|NCT01208792|Pulmonary arterial hypertension|pulmonary arterial hypertension
453628|NCT01208792|Systemic sclerosis|systemic sclerosis
453629|NCT01208792|Human immunodeficiency virus infection|human immunodeficiency virus infection
453630|NCT01208792|Porto pulmonary hypertension|porto pulmonary hypertension
453631|NCT01208792|Congenital heart defect|congenital heart defect
453632|NCT01208792|Systemic lupus erythematosus|systemic lupus erythematosus
453633|NCT01208792|Mixed connective tissue disease|mixed connective tissue disease
453634|NCT01208792|Sjögren's syndrome|sjögren's syndrome
453635|NCT01208779|Compliance|compliance
453636|NCT01208779|HR+ breast cancer|hr+ breast cancer
453637|NCT01208779|epidemiology|epidemiology
453638|NCT01208766|Multiple Myeloma (Kahler's disease)|multiple myeloma (kahler's disease)
453639|NCT01208753|Safety|safety
453640|NCT01208753|Tolerability|tolerability
453641|NCT01208753|Pharmacokinetics|pharmacokinetics
453642|NCT01208740|Gonadotropins|gonadotropins
453643|NCT01208740|infertility|infertility
453644|NCT01208740|IVF|ivf
453645|NCT01208740|metformin|metformin
453646|NCT01208740|PCOS|pcos
453647|NCT01208740|poor prognosis|poor prognosis
453648|NCT01208740|poor responder|poor responder
453649|NCT01208727|Myocardial infarction|myocardial infarction
453650|NCT01208727|Postconditioning|postconditioning
453651|NCT01208727|Microvascular obstruction|microvascular obstruction
453652|NCT01208727|No reflow|no reflow
453653|NCT01208727|MRI|mri
453654|NCT01208714|Renal artery stenosis|renal artery stenosis
453655|NCT01208714|Atherosclerosis|atherosclerosis
453656|NCT01208714|Arterial hypertension|arterial hypertension
453657|NCT01208714|Percutaneous renal angioplasty|percutaneous renal angioplasty
453658|NCT01208714|Stenting|stenting
453659|NCT01208701|Atorvastatin|atorvastatin
453660|NCT01208701|L-NMMA|l-nmma
453661|NCT01208701|NO|no
453662|NCT01208701|Nephrology|nephrology
453663|NCT01208701|Diabetes Mellitus|diabetes mellitus
453664|NCT01208688|Spinal Cord Injuries|spinal cord injuries
453665|NCT01208662|Lenalidomide|lenalidomide
453666|NCT01208662|Bortezomib|bortezomib
453667|NCT01208662|Dexamethasone|dexamethasone
453668|NCT01208662|Stem Cell Transplant|stem cell transplant
453669|NCT01208662|Myeloma|myeloma
453670|NCT01208662|Multiple Myeloma|multiple myeloma
453671|NCT01208649|exenatide|exenatide
453672|NCT01208649|hepatic steatosis|hepatic steatosis
453673|NCT01208649|insulin resistance|insulin resistance
453674|NCT01208649|insulin sensitizers|insulin sensitizers
453675|NCT01208649|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
453676|NCT01208649|- GLP1-Analog|- glp1-analog
453677|NCT01208636|Vitamin D deficiency|vitamin d deficiency
453678|NCT01208636|Sun|sun
453679|NCT01208636|Genetics|genetics
453680|NCT01208584|functional MRI,primary motor cortex,spinal cord injury|functional mri,primary motor cortex,spinal cord injury
453681|NCT01208571|Harmful use|harmful use
453682|NCT01208571|Hazardous use|hazardous use
453683|NCT01208571|Dependence|dependence
453684|NCT01208558|Blood pressure|blood pressure
453685|NCT01208558|Cereals|cereals
453686|NCT01208558|Diet Therapy|diet therapy
453687|NCT01208558|Dietary carbohydrates|dietary carbohydrates
453688|NCT01208558|Dietary fiber|dietary fiber
453689|NCT01208558|Exercise Therapy|exercise therapy
453690|NCT01208558|Food|food
453691|NCT01208558|Glucose intolerance|glucose intolerance
453692|NCT01208558|Lifestyle|lifestyle
453693|NCT01208558|Physiotherapy|physiotherapy
453694|NCT01208558|Stroke|stroke
453695|NCT01208558|TIA|tia
453696|NCT01208558|Waist circumference|waist circumference
453697|NCT01208558|Weight loss|weight loss
453698|NCT01208545|taxol|taxol
453699|NCT01208545|vincristine|vincristine
453700|NCT01208545|oxaliplatin|oxaliplatin
453701|NCT01208545|chemotherapy|chemotherapy
453702|NCT01208545|nerve degeneration|nerve degeneration
453703|NCT01208545|nerve conduction|nerve conduction
453704|NCT01208545|cancer|cancer
453705|NCT01208545|nerve conduction studies|nerve conduction studies
453706|NCT01208519|Drug resistance, Microbial|drug resistance, microbial
453707|NCT01208519|Methicillin-Resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
453708|NCT01208519|ESBL|esbl
453709|NCT01208519|Colonisation|colonisation
453710|NCT01208519|Screening|screening
453711|NCT01208519|Gram-negative|gram-negative
453712|NCT01208493|prematurity|prematurity
453713|NCT01208493|enteral feeding|enteral feeding
453714|NCT01208493|proteins|proteins
453715|NCT01208493|formula|formula
453716|NCT01208480|stage II breast cancer|stage ii breast cancer
453717|NCT01208480|stage IIIA breast cancer|stage iiia breast cancer
453718|NCT01208480|stage IIIB breast cancer|stage iiib breast cancer
453719|NCT01208480|stage IIIC breast cancer|stage iiic breast cancer
453720|NCT01208480|triple-negative breast cancer|triple-negative breast cancer
453721|NCT01208428|Depression|depression
453722|NCT01208415|Zenith aortoiliac aneurysm|zenith aortoiliac aneurysm
453723|NCT01208415|iliac aneurysm|iliac aneurysm
453724|NCT01208415|branch|branch
453725|NCT01208415|connections|connections
453726|NCT01208415|endovascular graft|endovascular graft
453727|NCT01208415|graft-iliac bifurcation|graft-iliac bifurcation
453728|NCT01208415|Aneurysm|aneurysm
453729|NCT01208415|Vascular Diseases|vascular diseases
453730|NCT01208415|Cardiovascular Diseases|cardiovascular diseases
453731|NCT01208363|Iron fortification|iron fortification
453732|NCT01208363|polyphenols|polyphenols
453733|NCT01208363|NaFeEDTA|nafeedta
453734|NCT01208363|cowpea|cowpea
453735|NCT01208363|school feeding program|school feeding program
453736|NCT01208350|Weight Loss|weight loss
453737|NCT01208350|Motivation|motivation
453738|NCT01208350|Workplace|workplace
453739|NCT01208350|Web platform|web platform
453740|NCT01208337|Rejection|rejection
453741|NCT01208324|Cognitive difficulties|cognitive difficulties
453742|NCT01208324|memory impairment|memory impairment
453743|NCT01208324|mood changes|mood changes
453744|NCT01208324|brain activation|brain activation
453747|NCT01208311|cirrhosis|cirrhosis
453748|NCT01208298|Cold Sore Patch|cold sore patch
453749|NCT01208272|Body Mass Index|body mass index
453750|NCT01208272|Bulimia/therapy|bulimia/therapy
453751|NCT01208272|Comorbidity|comorbidity
453752|NCT01208272|Interpersonal Relations|interpersonal relations
453753|NCT01208272|Psychotherapy/methods|psychotherapy/methods
453754|NCT01208259|Body Mass Index|body mass index
453755|NCT01208259|Bulimia/therapy|bulimia/therapy
453756|NCT01208259|Comorbidity|comorbidity
453757|NCT01208259|Interpersonal Relations|interpersonal relations
453758|NCT01208259|Psychotherapy/methods|psychotherapy/methods
453759|NCT01208233|Phase 2 Ischemic stroke Safety and efficacy|phase 2 ischemic stroke safety and efficacy
453760|NCT01208220|Collagenase Santyl|collagenase santyl
453761|NCT01208220|Enzymatic debridement|enzymatic debridement
453762|NCT01208220|maintenance debridement|maintenance debridement
453763|NCT01208220|VAC|vac
453764|NCT01208220|NPWT|npwt
453765|NCT01208194|Advanced colorectal carcinoma|advanced colorectal carcinoma
453766|NCT01208194|Maintenance therapy|maintenance therapy
453767|NCT01208194|Immunomodulator|immunomodulator
453768|NCT01208168|toenail fungus|toenail fungus
453769|NCT01208168|onychomycosis|onychomycosis
453770|NCT01208168|nail infection|nail infection
453771|NCT01208155|Phase 1|phase 1
453772|NCT01208155|Healthy|healthy
453773|NCT01208155|pharmacokinetics|pharmacokinetics
453774|NCT01208155|Fostamatinib|fostamatinib
453775|NCT01208142|toe walker|toe walker
453776|NCT01208142|Pediatric toe walking|pediatric toe walking
453777|NCT01208142|ankle flexion|ankle flexion
453778|NCT01208129|toenail fungus|toenail fungus
453779|NCT01208129|onychomycosis|onychomycosis
453780|NCT01208129|nail infection|nail infection
453781|NCT01208116|Atherosclerosis|atherosclerosis
453782|NCT01208116|Prognosis|prognosis
453783|NCT01208116|Flow-mediated dilatation|flow-mediated dilatation
453784|NCT01208116|Brachial-ankle pulse wave velocity|brachial-ankle pulse wave velocity
453785|NCT01208116|Carotid Intimal-Medial Thickness|carotid intimal-medial thickness
453786|NCT01208116|coronary artery calcification score|coronary artery calcification score
453787|NCT01208116|Ankle-brachial index|ankle-brachial index
453788|NCT01208103|Cancer|cancer
453789|NCT01208103|Small bowel|small bowel
453790|NCT01208103|Ampulla of Vater|ampulla of vater
453791|NCT01208103|CAPOX Chemotherapy|capox chemotherapy
453792|NCT01208103|Bevacizumab|bevacizumab
453793|NCT01208103|Capecitabine|capecitabine
453794|NCT01208103|Oxaliplatin|oxaliplatin
453795|NCT01208103|Xeloda|xeloda
453796|NCT01208103|Eloxatin|eloxatin
453797|NCT01208103|Avastin|avastin
453798|NCT01208103|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
453799|NCT01208103|rhuMab-VEGF|rhumab-vegf
453800|NCT01208090|psoriasis|psoriasis
453801|NCT01208090|chronic plaque psoriasis|chronic plaque psoriasis
453802|NCT01208090|Moderate to severe chronic plaque psoriasis|moderate to severe chronic plaque psoriasis
453803|NCT01208077|ED hemodynamic profiles|ed hemodynamic profiles
453804|NCT01208077|patients treated under current clinical standards|patients treated under current clinical standards
453805|NCT01208077|Acute CHF|acute chf
453806|NCT01208077|Stroke syndromes|stroke syndromes
453807|NCT01208077|Systemic infection|systemic infection
453808|NCT01208064|adenocarcinoma of the lung|adenocarcinoma of the lung
453809|NCT01208064|adenosquamous cell lung cancer|adenosquamous cell lung cancer
453810|NCT01208064|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
453811|NCT01208064|large cell lung cancer|large cell lung cancer
453812|NCT01208064|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
453813|NCT01208064|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
453814|NCT01208064|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
453815|NCT01208025|Plaque|plaque
453816|NCT01208025|Imaging|imaging
453817|NCT01208012|Diabetes Mellitus treatment Metformin|diabetes mellitus treatment metformin
453818|NCT01207999|Human papillomavirus|human papillomavirus
453819|NCT01207960|dental phobia|dental phobia
453820|NCT01207960|psychotherapy|psychotherapy
453821|NCT01207960|eye movement desensitization and reprocessing - EMDR|eye movement desensitization and reprocessing - emdr
453822|NCT01207960|efficacy|efficacy
453823|NCT01207960|wait-list control|wait-list control
453824|NCT01207947|Vardenafil|vardenafil
453825|NCT01207947|Erectile dysfunction|erectile dysfunction
453826|NCT01207947|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors
453827|NCT01207947|Combination use with alpha-blockers|combination use with alpha-blockers
453828|NCT01207934|diabetes|diabetes
453829|NCT01207934|obesity|obesity
453830|NCT01207908|DMD|dmd
453831|NCT01207908|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
453832|NCT01207908|Insulin like growth factor|insulin like growth factor
453833|NCT01207908|6 minute walk test|6 minute walk test
453834|NCT01207869|Bronchopulmonary dysplasia (BPD)|bronchopulmonary dysplasia (bpd)
453835|NCT01207869|Extremely premature infant|extremely premature infant
453836|NCT01207869|Mesenchymal stem cells (MSCs)|mesenchymal stem cells (mscs)
453837|NCT01207869|umbilical cord|umbilical cord
453838|NCT01207856|Multiple sclerosis|multiple sclerosis
453839|NCT01207856|functional MRI|functional mri
453840|NCT01207856|cognitive rehabilitation|cognitive rehabilitation
453841|NCT01207856|ecological evaluation|ecological evaluation
453842|NCT01207856|neuroplasticity|neuroplasticity
453843|NCT01207843|Computed tomography|computed tomography
453844|NCT01207830|Obesity|obesity
453845|NCT01207817|a light flash in each eye for a total of 48 measurements|a light flash in each eye for a total of 48 measurements
453846|NCT01207804|Obesity|obesity
453847|NCT01207791|drug abuse|drug abuse
453848|NCT01207791|emergency department|emergency department
453849|NCT01207791|brief intervention|brief intervention
453850|NCT01207791|motivational interviewing|motivational interviewing
453851|NCT01207791|SBIRT|sbirt
453852|NCT01207778|brain|brain
453853|NCT01207778|development|development
453854|NCT01207778|erythropoietin|erythropoietin
453855|NCT01207778|neuroprotection|neuroprotection
453856|NCT01207778|MRI|mri
453857|NCT01207765|Multiple Myeloma|multiple myeloma
453858|NCT01207765|Zevalin|zevalin
453859|NCT01207752|dry eye, meibomian gland dysfunction, tear film break up time|dry eye, meibomian gland dysfunction, tear film break up time
453860|NCT01207739|Prolonged antibiotic treatment in Lyme disease|prolonged antibiotic treatment in lyme disease
453861|NCT01207739|Doxycycline|doxycycline
453862|NCT01207739|Clarithromycin|clarithromycin
453863|NCT01207739|Hydroxychloroquine|hydroxychloroquine
453864|NCT01207700|post discharge intervention|post discharge intervention
453865|NCT01207700|adherence|adherence
453866|NCT01207700|compliance|compliance
453867|NCT01207700|community health worker|community health worker
453868|NCT01207674|Pathological gambling|pathological gambling
453869|NCT01207674|"at risk gambling"|"at risk gambling"
453870|NCT01207674|gambling practice evolution|gambling practice evolution
453871|NCT01207674|psychiatric comorbidities|psychiatric comorbidities
453872|NCT01207674|gambling trajectory|gambling trajectory
453873|NCT01207674|cognitive distortions|cognitive distortions
453874|NCT01207674|ADHD|adhd
453875|NCT01207674|addiction|addiction
453876|NCT01207674|recourse to care|recourse to care
453877|NCT01207661|Mesenchymal cells|mesenchymal cells
453878|NCT01207661|osteoarthritis|osteoarthritis
453879|NCT01207661|intra articular injection|intra articular injection
453880|NCT01207648|Interferon beta 1a|interferon beta 1a
453881|NCT01207648|Autoimmune Diseases|autoimmune diseases
453882|NCT01207648|Demyelinating Diseases|demyelinating diseases
453883|NCT01207648|Immune System Diseases|immune system diseases
453884|NCT01207648|Immunologic Factors|immunologic factors
453885|NCT01207648|Nervous System Diseases|nervous system diseases
453886|NCT01207648|Physiological Effects of Drugs|physiological effects of drugs
453887|NCT01207648|Demyelinating Autoimmune Diseases, CNS|demyelinating autoimmune diseases, cns
453888|NCT01207648|Autoimmune Diseases of the Nervous System|autoimmune diseases of the nervous system
453889|NCT01207648|Retrospective Cohort Study|retrospective cohort study
453890|NCT01207635|Cancer|cancer
453891|NCT01207635|Arimidex|arimidex
453892|NCT01207609|Obesity|obesity
453893|NCT01207609|Morbid Obesity|morbid obesity
453894|NCT01207609|Bariatric Surgery|bariatric surgery
453895|NCT01207609|Laparoscopic Gastric Plication|laparoscopic gastric plication
453896|NCT01207596|Pain|pain
453897|NCT01207596|Neuropathy|neuropathy
453898|NCT01207596|Neuropathic Pain|neuropathic pain
453899|NCT01207596|Hydromorphone|hydromorphone
453900|NCT01207583|vaccine|vaccine
453901|NCT01207583|infant|infant
453902|NCT01207583|healthy subjects|healthy subjects
453903|NCT01207570|flexibility|flexibility
453904|NCT01207570|muscle|muscle
453905|NCT01207570|stretching|stretching
453906|NCT01207570|cerebral palsy|cerebral palsy
453907|NCT01207570|developmental|developmental
453908|NCT01207557|Healthcare personnel|healthcare personnel
453909|NCT01207557|influenza|influenza
453910|NCT01207557|immunization|immunization
453911|NCT01207557|flu|flu
453912|NCT01207557|vaccine|vaccine
453913|NCT01207544|motor|motor
453914|NCT01207544|balance|balance
453915|NCT01207544|developmental|developmental
453916|NCT01207544|physiotherapy|physiotherapy
453917|NCT01207531|sepsis|sepsis
453918|NCT01207531|miRNA|mirna
453919|NCT01207518|influenza|influenza
453920|NCT01207518|immunization|immunization
453921|NCT01207518|healthcare personnel|healthcare personnel
453922|NCT01207505|bipolar disorder|bipolar disorder
453923|NCT01207505|depression|depression
453924|NCT01207505|mania|mania
453925|NCT01207505|emotion regulation|emotion regulation
453926|NCT01207505|dialectical behavior therapy|dialectical behavior therapy
453927|NCT01207505|group therapy|group therapy
453928|NCT01207505|mindfulness|mindfulness
453929|NCT01207492|nilotinib|nilotinib
453930|NCT01207453|Arthritis, Rheumatoid|arthritis, rheumatoid
453931|NCT01207453|Milnacipran|milnacipran
453932|NCT01207453|Pain|pain
453933|NCT01207440|CML|cml
453934|NCT01207440|ALL|all
453935|NCT01207440|PH|ph
453936|NCT01207440|ponatinib|ponatinib
453937|NCT01207440|Ph+ALL|ph+all
453938|NCT01207440|T315I mutation|t315i mutation
453939|NCT01207440|Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia|philadelphia chromosome positive acute lymphoblastic leukemia
453940|NCT01207427|opioid therapy|opioid therapy
453941|NCT01207427|constipation|constipation
453942|NCT01207427|chronic noncancer pain|chronic noncancer pain
453943|NCT01207427|mu opioid receptor antagonist|mu opioid receptor antagonist
453944|NCT01207427|ADL5945|adl5945
453945|NCT01207414|Schizophrenia|schizophrenia
453946|NCT01207414|iloperidone|iloperidone
453947|NCT01207414|switch|switch
453948|NCT01207414|gradual switch|gradual switch
453949|NCT01207414|immediate switch|immediate switch
453950|NCT01207401|intrauterine device|intrauterine device
453951|NCT01207401|local anesthetic|local anesthetic
453952|NCT01207388|Blinatumomab|blinatumomab
453953|NCT01207388|MRD|mrd
453954|NCT01207388|B-ALL|b-all
453955|NCT01207388|Minimal residual disease|minimal residual disease
453956|NCT01207388|adult ALL|adult all
453957|NCT01207388|Leukemia|leukemia
453958|NCT01207388|ALL|all
453959|NCT01207388|Lymphatic diseases|lymphatic diseases
453960|NCT01207388|Lymphoproliferative disorders|lymphoproliferative disorders
453961|NCT01207388|bispecific antibody|bispecific antibody
453962|NCT01207388|anti-CD19|anti-cd19
453963|NCT01207388|Immunotherapeutic treatment|immunotherapeutic treatment
453964|NCT01207375|memory|memory
453965|NCT01207375|learning|learning
453966|NCT01207375|Traumatic Brain Injury|traumatic brain injury
453967|NCT01207375|cognition|cognition
453968|NCT01207375|treatment|treatment
453969|NCT01207375|therapy|therapy
454359|NCT01205529|Genotype|genotype
453970|NCT01207349|Type 2 diabetes|type 2 diabetes
453971|NCT01207349|Secondary prevention|secondary prevention
453972|NCT01207349|Physical activity|physical activity
453973|NCT01207349|Nutritional education|nutritional education
453974|NCT01207349|HbA1c|hba1c
453975|NCT01207349|Reunion island|reunion island
453976|NCT01207349|diabetic patients, both female and male, age >=18 years, able to practise a physical activity, in Saint Pierre (GHSR) and Saint Denis (CHD)|diabetic patients, both female and male, age >=18 years, able to practise a physical activity, in saint pierre (ghsr) and saint denis (chd)
453977|NCT01207336|stroke|stroke
453978|NCT01207336|rehabilitation|rehabilitation
453979|NCT01207336|transcranial direct current stimulation|transcranial direct current stimulation
453980|NCT01207336|nerve stimulation|nerve stimulation
453981|NCT01207310|smoking|smoking
453982|NCT01207310|smoking of 10 cigarettes per day|smoking of 10 cigarettes per day
453983|NCT01207297|Lupus nephritis|lupus nephritis
453984|NCT01207297|tacrolimus|tacrolimus
453985|NCT01207297|cyclophosphamide|cyclophosphamide
453986|NCT01207271|depression|depression
453987|NCT01207271|community mental health|community mental health
453988|NCT01207271|treatment|treatment
453989|NCT01207271|psychotherapy|psychotherapy
453990|NCT01207271|mediators|mediators
453991|NCT01207258|Motivational Interviewing|motivational interviewing
453992|NCT01207258|Brief Intervention|brief intervention
453993|NCT01207258|Intimate Partner Violence|intimate partner violence
453994|NCT01207258|Domestic Violence|domestic violence
453995|NCT01207258|Alcohol Abuse|alcohol abuse
453996|NCT01207245|Cystic fibrosis|cystic fibrosis
453997|NCT01207245|Tobramycin|tobramycin
453998|NCT01207245|Pharmacokinetics|pharmacokinetics
453999|NCT01207245|Toxicity|toxicity
454000|NCT01207232|seasonal influenza|seasonal influenza
454001|NCT01207232|behavioral economics|behavioral economics
454002|NCT01207232|implementation intentions|implementation intentions
454003|NCT01207232|planning prompt|planning prompt
454004|NCT01207232|nudge|nudge
454005|NCT01207219|psychosis|psychosis
454006|NCT01207219|yoga|yoga
454007|NCT01207219|aerobic exercise|aerobic exercise
454008|NCT01207219|memory|memory
454009|NCT01207219|attention|attention
454010|NCT01207219|neuro cognition|neuro cognition
454011|NCT01207206|Patient suffering from severe cancer pain despite the opioid treatment|patient suffering from severe cancer pain despite the opioid treatment
454012|NCT01207206|Opiate tolerance suspected on the basis of rapid escalation in opiate dose|opiate tolerance suspected on the basis of rapid escalation in opiate dose
454013|NCT01207206|Severe opiate side effects|severe opiate side effects
454014|NCT01207193|bone cyst bone defect mesenchymal cell|bone cyst bone defect mesenchymal cell
454015|NCT01207180|emergency medicine|emergency medicine
454016|NCT01207180|primary care physicians|primary care physicians
454017|NCT01207141|Liver Transplantation|liver transplantation
454018|NCT01207141|Thymoglobulin|thymoglobulin
454019|NCT01207141|Rejection|rejection
454020|NCT01207102|Breast cancer|breast cancer
454021|NCT01207102|Triple negative|triple negative
454022|NCT01207089|Safety|safety
454023|NCT01207089|tolerability|tolerability
454025|NCT01207089|healthy|healthy
454026|NCT01207089|overweight|overweight
454027|NCT01207089|obese|obese
454028|NCT01207076|CD45+ disease|cd45+ disease
454029|NCT01207063|Radiotherapy|radiotherapy
454030|NCT01207063|NSCLC|nsclc
454031|NCT01207063|Stage II-III non-small cell lung cancer|stage ii-iii non-small cell lung cancer
454032|NCT01207050|sleep disorders|sleep disorders
454033|NCT01207050|traumatic brain injury|traumatic brain injury
454034|NCT01207024|knee arthrosis|knee arthrosis
454035|NCT01207024|obesity|obesity
454036|NCT01207024|MRI|mri
454037|NCT01207024|bariatric surgery|bariatric surgery
454038|NCT01206998|preterm labor|preterm labor
454039|NCT01206998|progesterone|progesterone
454040|NCT01206998|tocolysis|tocolysis
454041|NCT01206998|cervical length|cervical length
454042|NCT01206985|Paracetamol|paracetamol
454043|NCT01206985|per-oral mucosa PMB|per-oral mucosa pmb
454044|NCT01206985|No disease, healthy volunteers|no disease, healthy volunteers
454045|NCT01206972|venous thromboembolism|venous thromboembolism
454046|NCT01206972|prevention|prevention
454047|NCT01206972|orthopaedic surgery|orthopaedic surgery
454048|NCT01206959|BP|bp
454049|NCT01206946|Respiratory distress|respiratory distress
454050|NCT01206946|Antenatal steroids|antenatal steroids
454051|NCT01206946|late preterm|late preterm
454052|NCT01206933|HIV/HCV Coinfection|hiv/hcv coinfection
454053|NCT01206933|Tat Protein|tat protein
454054|NCT01206933|HCV|hcv
454055|NCT01206920|HIV|hiv
454056|NCT01206920|AIDS|aids
454057|NCT01206920|Co-morbidities|co-morbidities
454058|NCT01206907|sickle cell anemia|sickle cell anemia
454059|NCT01206907|juvenile rheumatoid arthritis|juvenile rheumatoid arthritis
454060|NCT01206907|burn victim|burn victim
454061|NCT01206907|cancer|cancer
454062|NCT01206907|Chronic pain of malignant or non-malignant etiology|chronic pain of malignant or non-malignant etiology
454063|NCT01206894|lung cancer|lung cancer
454064|NCT01206894|chest wall invasion|chest wall invasion
454065|NCT01206894|transthoracic ultrasound|transthoracic ultrasound
454066|NCT01206881|breast cancer|breast cancer
454067|NCT01206881|neoadjuvant|neoadjuvant
454068|NCT01206881|liposomal doxorubicin|liposomal doxorubicin
454069|NCT01206881|PET scan|pet scan
454070|NCT01206868|kidney, transplantation, surgery, complications, lymphocele, fluid collections.|kidney, transplantation, surgery, complications, lymphocele, fluid collections.
454071|NCT01206855|MIST Therapy|mist therapy
454072|NCT01206842|functional capacity|functional capacity
454073|NCT01206842|training|training
454074|NCT01206842|neurocognition|neurocognition
454075|NCT01206829|Hearing Impaired Persons|hearing impaired persons
454076|NCT01206829|Tinnitus|tinnitus
454077|NCT01206829|Life Change Events|life change events
454078|NCT01206829|Adaptation, Psychological|adaptation, psychological
454079|NCT01206829|Rehabilitation, Vocational|rehabilitation, vocational
454080|NCT01206829|Cognitive Therapy|cognitive therapy
454081|NCT01206829|Avoidance Learning|avoidance learning
454082|NCT01206829|Escape Reaction|escape reaction
454083|NCT01206803|ovarian stimulation|ovarian stimulation
454084|NCT01206803|recombinant FSH|recombinant fsh
454085|NCT01206803|GnRH-antagonist|gnrh-antagonist
454086|NCT01206803|corifollitropin alfa|corifollitropin alfa
454087|NCT01206790|PTSD|ptsd
454088|NCT01206790|Narrative Exposure Therapy|narrative exposure therapy
454089|NCT01206790|torture victims|torture victims
454090|NCT01206790|immune system|immune system
454091|NCT01206777|Hypersensitivity Reactions|hypersensitivity reactions
454092|NCT01206777|B-cell malignancies|b-cell malignancies
454093|NCT01206764|RCC,|rcc,
454094|NCT01206764|mTOR pathway,|mtor pathway,
454095|NCT01206764|angiogenesis,|angiogenesis,
454096|NCT01206764|PFS,|pfs,
454097|NCT01206764|partial response [PR] + complete response [CR])|partial response [pr] + complete response [cr])
454098|NCT01206764|metastatic recurrent renal cell carcinoma|metastatic recurrent renal cell carcinoma
454099|NCT01206764|metastatic unresectable renal cell carcinoma|metastatic unresectable renal cell carcinoma
454100|NCT01206725|Diabetes type 2|diabetes type 2
454101|NCT01206725|exercise|exercise
454102|NCT01206725|tissue Doppler velocity|tissue doppler velocity
454103|NCT01206712|Diabetes Mellitus Type 2|diabetes mellitus type 2
454104|NCT01206712|insulin glargine|insulin glargine
454105|NCT01206712|Metformin|metformin
454106|NCT01206686|seasonal influenza|seasonal influenza
454107|NCT01206686|behavioral economics|behavioral economics
454108|NCT01206686|nudge|nudge
454109|NCT01206686|implementations intentions|implementations intentions
454110|NCT01206686|vaccination|vaccination
454111|NCT01206621|dyspnea|dyspnea
454112|NCT01206621|COPD|copd
454113|NCT01206621|CHF|chf
454114|NCT01206621|asthma|asthma
454115|NCT01206608|Breast augmentation|breast augmentation
454116|NCT01206608|Pain|pain
454117|NCT01206608|Analgesia|analgesia
454118|NCT01206595|Postoperative Pain|postoperative pain
454119|NCT01206595|Bunionectomy|bunionectomy
454120|NCT01206595|Analgesia|analgesia
454121|NCT01206569|glomerulonephritis|glomerulonephritis
454122|NCT01206569|systemic lupus erythematosus|systemic lupus erythematosus
454123|NCT01206556|HUMAN PAPILLOMA VIRUS|human papilloma virus
454124|NCT01206556|HPV|hpv
454125|NCT01206543|Craniopharyngioma|craniopharyngioma
454126|NCT01206543|Surgery|surgery
454127|NCT01206543|Intraoperative imaging|intraoperative imaging
454128|NCT01206543|Rate of total removal|rate of total removal
454129|NCT01206530|histologically documented|histologically documented
454130|NCT01206530|advanced|advanced
454131|NCT01206530|metastatic|metastatic
454132|NCT01206530|adenocarcinoma|adenocarcinoma
454133|NCT01206530|colon|colon
454134|NCT01206530|rectum|rectum
454135|NCT01206517|asenapine|asenapine
454136|NCT01206517|pediatric schizophrenia|pediatric schizophrenia
454137|NCT01206517|bipolar I disorder|bipolar i disorder
454138|NCT01206504|West Nile virus|west nile virus
454139|NCT01206504|WNV|wnv
454140|NCT01206504|Encephalitis|encephalitis
454141|NCT01206504|Meningitis|meningitis
454142|NCT01206504|Acute Flaccid Paralysis|acute flaccid paralysis
454143|NCT01206504|Monoclonal Antibody|monoclonal antibody
454144|NCT01206504|WNND|wnnd
454145|NCT01206504|West Nile Neuroinvasive Disease|west nile neuroinvasive disease
454146|NCT01206504|Accidental Exposure to West Nile Virus|accidental exposure to west nile virus
454147|NCT01206452|Atrial Fibrillation; Ablation|atrial fibrillation; ablation
454148|NCT01206426|Urothelial, cancer, cisplatin, neoadjuvant, chemotherapy, germline|urothelial, cancer, cisplatin, neoadjuvant, chemotherapy, germline
454149|NCT01206413|overweight; treatment; women|overweight; treatment; women
454150|NCT01206400|eugonadal, testosterone|eugonadal, testosterone
454151|NCT01206374|Vitiligo Vulgaris|vitiligo vulgaris
454152|NCT01206361|Real world|real world
454153|NCT01206361|observational|observational
454154|NCT01206361|retrospective|retrospective
454155|NCT01206361|database analysis|database analysis
454156|NCT01206348|Acne|acne
454157|NCT01206335|Cancer Cachexia|cancer cachexia
454158|NCT01206335|Anorexia|anorexia
454159|NCT01206335|Advanced Malignancies|advanced malignancies
454160|NCT01206335|Weight Loss|weight loss
454161|NCT01206335|Fatigue|fatigue
454162|NCT01206335|Karnofsky|karnofsky
454163|NCT01206335|C-Reactive Protein|c-reactive protein
454164|NCT01206335|Simmonds Functional Assessment|simmonds functional assessment
454360|NCT01205503|chemobrain|chemobrain
454165|NCT01206322|diabetes, blood flow, brain perfusion, cognitive function|diabetes, blood flow, brain perfusion, cognitive function
454166|NCT01206309|Graft vs Host Disease|graft vs host disease
454167|NCT01206309|Allogeneic Hematopoietic Cell Transplantation|allogeneic hematopoietic cell transplantation
454168|NCT01206309|Bone Marrow Transplantation|bone marrow transplantation
454169|NCT01206309|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
454170|NCT01206309|Umbilical Cord Blood Stem Cell Transplantation|umbilical cord blood stem cell transplantation
454171|NCT01206296|Adjuvant|adjuvant
454172|NCT01206296|Intraperitoneal|intraperitoneal
454173|NCT01206296|Gemcitabine|gemcitabine
454174|NCT01206296|Pancreas|pancreas
454175|NCT01206296|Adenocarcinoma|adenocarcinoma
454176|NCT01206283|traumatic brain injury|traumatic brain injury
454177|NCT01206283|subarachnoid hemorrhage|subarachnoid hemorrhage
454178|NCT01206283|secondary brain ischemia|secondary brain ischemia
454179|NCT01206283|microdialysis|microdialysis
454180|NCT01206283|modified Lund concept|modified lund concept
454181|NCT01206283|cerebral perfusion pressure|cerebral perfusion pressure
454182|NCT01206283|intracranial pressure|intracranial pressure
454183|NCT01206270|Klinefelter|klinefelter
454184|NCT01206270|Leydig|leydig
454185|NCT01206270|Testicular Tumor|testicular tumor
454186|NCT01206270|LH|lh
454187|NCT01206270|Infertility|infertility
454188|NCT01206257|Survey|survey
454189|NCT01206257|Angiography|angiography
454190|NCT01206257|ADR|adr
454191|NCT01206257|Image quality|image quality
454192|NCT01206244|dry eye|dry eye
454193|NCT01206244|tear meniscus|tear meniscus
454194|NCT01206244|tear osmolarity|tear osmolarity
454195|NCT01206231|Standard daily practice in managing patients with hypercholesterolemia|standard daily practice in managing patients with hypercholesterolemia
454196|NCT01206218|Gastric Cancer, BRCA1|gastric cancer, brca1
454197|NCT01206205|De novo Multiple Myeloma|de novo multiple myeloma
454198|NCT01206205|Bortezomib|bortezomib
454199|NCT01206205|Lenalidomide|lenalidomide
454200|NCT01206205|induction therapy|induction therapy
454201|NCT01206205|consolidation therapy|consolidation therapy
454202|NCT01206205|maintenance therapy|maintenance therapy
454203|NCT01206205|High dose therapy|high dose therapy
454204|NCT01206205|frontline therapy including new drugs and high dose therapy|frontline therapy including new drugs and high dose therapy
454205|NCT01206192|Intimate Terrorism|intimate terrorism
454206|NCT01206192|Situational couple violence|situational couple violence
454207|NCT01206192|Mental health|mental health
454208|NCT01206192|Chinese|chinese
454209|NCT01206192|Women|women
454210|NCT01206179|nonunion fracture bone formation pain relief|nonunion fracture bone formation pain relief
454211|NCT01206166|Randomized trial|randomized trial
454212|NCT01206166|Parental nutrition|parental nutrition
454213|NCT01206166|Enteral nutrition|enteral nutrition
454214|NCT01206166|Intensive care unit|intensive care unit
454215|NCT01206166|BMI < 25 or ≥ 35|bmi < 25 or ≥ 35
454216|NCT01206114|2009 H1N1 influenza|2009 h1n1 influenza
454217|NCT01206114|vaccination|vaccination
454218|NCT01206114|pandemic|pandemic
454219|NCT01206114|effectiveness|effectiveness
454220|NCT01206075|Beta Thalassemia Major|beta thalassemia major
454221|NCT01206075|Hematopoietic Stem Cell Mobilization|hematopoietic stem cell mobilization
454222|NCT01206075|Gene Transfer Techniques|gene transfer techniques
454223|NCT01206062|blood pressure|blood pressure
454224|NCT01206062|antihypertensive|antihypertensive
454225|NCT01206062|systolic|systolic
454226|NCT01206062|diastolic|diastolic
454227|NCT01206062|heart failure|heart failure
454228|NCT01206062|myocardial infarction|myocardial infarction
454229|NCT01206062|stroke|stroke
454230|NCT01206062|chronic kidney disease|chronic kidney disease
454231|NCT01206062|dementia|dementia
454232|NCT01206062|cognitive decline|cognitive decline
454233|NCT01206049|Cholangiocarcinoma|cholangiocarcinoma
454234|NCT01206049|Inoperable|inoperable
454235|NCT01206049|KRAS mutation|kras mutation
454236|NCT01206049|Biological treatment|biological treatment
454237|NCT01206049|Combination chemotherapy|combination chemotherapy
454238|NCT01206049|Monoclonal antibody|monoclonal antibody
454239|NCT01206036|castration|castration
454240|NCT01206036|prostate cancer|prostate cancer
454241|NCT01206036|castration resistant prostate cancer|castration resistant prostate cancer
454242|NCT01206036|PSA|psa
454243|NCT01206036|Docetaxel|docetaxel
454244|NCT01206036|Temsirolimus|temsirolimus
454245|NCT01206036|disease progression free survival|disease progression free survival
454247|NCT01206036|dose escalation|dose escalation
454248|NCT01206023|Multiple Sclerosis|multiple sclerosis
454249|NCT01206023|Breath|breath
454250|NCT01206023|Diagnosis|diagnosis
454251|NCT01206023|Discrimination MS/healthy subj. via exhaled breath samples|discrimination ms/healthy subj. via exhaled breath samples
454252|NCT01206010|Tobacco Dependence|tobacco dependence
454253|NCT01206010|Smoking cessation|smoking cessation
454254|NCT01206010|Varenicline|varenicline
454255|NCT01206010|Tailored dosing|tailored dosing
454256|NCT01205997|magnesium|magnesium
454257|NCT01205997|fentanyl|fentanyl
454258|NCT01205997|intrathecal|intrathecal
454259|NCT01205997|pain|pain
454260|NCT01205984|Chronic rhinosinusitis|chronic rhinosinusitis
454261|NCT01205984|Computed tomography scan|computed tomography scan
454262|NCT01205984|Methylprednisolone|methylprednisolone
454263|NCT01205971|Motivational interviewing|motivational interviewing
454264|NCT01205971|Community-based multimodal intervention|community-based multimodal intervention
454265|NCT01205971|Dental Health Advocates|dental health advocates
454266|NCT01205971|Prevention of ECC|prevention of ecc
454267|NCT01205971|Randomized clinical trial|randomized clinical trial
454268|NCT01205958|Cervical pain|cervical pain
454269|NCT01205958|Neck pain|neck pain
454270|NCT01205958|western medicine|western medicine
454271|NCT01205958|oriental medicine|oriental medicine
454272|NCT01205958|acupuncture|acupuncture
454273|NCT01205958|needle|needle
454274|NCT01205945|Aortic aneurysm, abdominal|aortic aneurysm, abdominal
454275|NCT01205945|Screening|screening
454276|NCT01205945|Mortality|mortality
454277|NCT01205932|venous thromboembolism|venous thromboembolism
454278|NCT01205932|prevention|prevention
454279|NCT01205932|othopaedic surgery|othopaedic surgery
454280|NCT01205919|Tinnitus|tinnitus
454281|NCT01205919|Internet Training|internet training
454282|NCT01205919|Cognitive-Behavior Therapy|cognitive-behavior therapy
454283|NCT01205919|CBT|cbt
454284|NCT01205906|Tinnitus|tinnitus
454285|NCT01205906|Internet Training|internet training
454286|NCT01205906|Cognitive-Behavior Therapy|cognitive-behavior therapy
454287|NCT01205906|CBT|cbt
454288|NCT01205880|combination treatment|combination treatment
454289|NCT01205880|topical corticosteroid|topical corticosteroid
454290|NCT01205880|vitamin D analogue|vitamin d analogue
454291|NCT01205880|clobex|clobex
454292|NCT01205880|vectical|vectical
454293|NCT01205880|clobetasol|clobetasol
454294|NCT01205880|calcitriol|calcitriol
454295|NCT01205867|Butyrylcholinesterase deficiency|butyrylcholinesterase deficiency
454296|NCT01205867|tolerability|tolerability
454297|NCT01205867|safety|safety
454298|NCT01205867|AZD8848|azd8848
454299|NCT01205867|pharmacokinetics|pharmacokinetics
454300|NCT01205867|pharmacodynamics|pharmacodynamics
454301|NCT01205867|BChE deficient subjects and matched control subject|bche deficient subjects and matched control subject
454302|NCT01205854|rheumatoid arthritis|rheumatoid arthritis
454303|NCT01205854|ultrasonography|ultrasonography
454304|NCT01205854|remission|remission
454305|NCT01205854|imaging remission|imaging remission
454306|NCT01205854|tight control|tight control
454307|NCT01205854|treat to target|treat to target
454308|NCT01205841|Ottawa Ankle and Foot Rules|ottawa ankle and foot rules
454309|NCT01205841|Buffalo Rule|buffalo rule
454310|NCT01205841|Bernese Ankle Rules|bernese ankle rules
454311|NCT01205841|Low Risk Exam|low risk exam
454312|NCT01205841|Malleolar Zone Algorithm|malleolar zone algorithm
454313|NCT01205841|Clinical decision rule|clinical decision rule
454314|NCT01205841|Ankle injury|ankle injury
454315|NCT01205841|Ankle sprain|ankle sprain
454316|NCT01205841|Inversion trauma|inversion trauma
454317|NCT01205828|liver cancer|liver cancer
454318|NCT01205828|hepatocellular|hepatocellular
454319|NCT01205828|temozolomide|temozolomide
454320|NCT01205828|veliparib|veliparib
454321|NCT01205802|patency, hepatic venous congestion, liver transplantation|patency, hepatic venous congestion, liver transplantation
454322|NCT01205789|Drug eluting stents|drug eluting stents
454323|NCT01205789|Stents|stents
454324|NCT01205789|Angioplasty|angioplasty
454325|NCT01205789|Left Main Coronary Artery Disease|left main coronary artery disease
454326|NCT01205776|Drug eluting stents|drug eluting stents
454327|NCT01205776|Stents|stents
454328|NCT01205776|Unprotected Left Main Coronary Artery Disease|unprotected left main coronary artery disease
454329|NCT01205776|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
454330|NCT01205737|DLBCL|dlbcl
454331|NCT01205737|pharmacokinetics|pharmacokinetics
454332|NCT01205737|pharmacodynamics|pharmacodynamics
454333|NCT01205711|recurrent colon cancer|recurrent colon cancer
454334|NCT01205711|stage IV colon cancer|stage iv colon cancer
454335|NCT01205711|recurrent rectal cancer|recurrent rectal cancer
454336|NCT01205711|stage IV rectal cancer|stage iv rectal cancer
454337|NCT01205672|Endometrium|endometrium
454338|NCT01205672|Gynecologic malignancy|gynecologic malignancy
454339|NCT01205672|Endometrial adenocarcinoma|endometrial adenocarcinoma
454340|NCT01205672|Insulin/glucose metabolism|insulin/glucose metabolism
454341|NCT01205672|Metformin|metformin
454342|NCT01205646|prostate cancer|prostate cancer
454343|NCT01205646|metastatic|metastatic
454344|NCT01205646|zoledronate|zoledronate
454345|NCT01205646|zometa|zometa
454346|NCT01205633|neurodegenerative disease|neurodegenerative disease
454347|NCT01205633|neurovascular disease|neurovascular disease
454348|NCT01205633|fatigue|fatigue
454349|NCT01205633|Hubbard Foundation|hubbard foundation
454350|NCT01205633|angioplasty|angioplasty
454351|NCT01205620|CABG|cabg
454352|NCT01205607|traumatic brain injury|traumatic brain injury
454353|NCT01205594|CABG surgery|cabg surgery
454354|NCT01205581|Fluzone|fluzone
454355|NCT01205581|Trivalent Influenza Vaccine|trivalent influenza vaccine
454356|NCT01205555|intra uterine insemination|intra uterine insemination
454357|NCT01205529|Atrial Fibrillation|atrial fibrillation
454358|NCT01205529|ST elevation|st elevation
454361|NCT01205503|Oxidative Stress|oxidative stress
454362|NCT01205503|Mesna|mesna
454363|NCT01205477|Anserine bursitis|anserine bursitis
454364|NCT01205464|Persistent symptoms|persistent symptoms
454365|NCT01205464|Doxycycline|doxycycline
454366|NCT01205464|Placebo|placebo
454367|NCT01205464|Neuroborreliosis|neuroborreliosis
454368|NCT01205451|GSK1358820|gsk1358820
454369|NCT01205451|upper limb|upper limb
454370|NCT01205451|spasticity|spasticity
454371|NCT01205451|post-stroke|post-stroke
454372|NCT01205438|SLE|sle
454373|NCT01205438|Systemic Lupus Erythematosis|systemic lupus erythematosis
454374|NCT01205438|Lupus|lupus
454375|NCT01205438|autoimmune disease|autoimmune disease
454376|NCT01205438|LY2127399|ly2127399
454377|NCT01205438|Immune System Disease|immune system disease
454378|NCT01205425|Computed coronary angiography|computed coronary angiography
454379|NCT01205425|Stent implantation|stent implantation
454380|NCT01205425|IVUS|ivus
454381|NCT01205386|CTO|cto
454382|NCT01205386|peripheral artery occlusive disease|peripheral artery occlusive disease
454383|NCT01205386|PAOD|paod
454384|NCT01205386|SFA|sfa
454385|NCT01205386|superficial femoral artery|superficial femoral artery
454386|NCT01205360|Analgesia, labour;|analgesia, labour;
454387|NCT01205360|Analgesic techniques, epidural;|analgesic techniques, epidural;
454388|NCT01205360|Drug delivery, intermittent bolus;|drug delivery, intermittent bolus;
454389|NCT01205360|Anesthetics local, Bupivacaine;|anesthetics local, bupivacaine;
454390|NCT01205360|Analgesics opioid, Fentanyl;|analgesics opioid, fentanyl;
454391|NCT01205347|Statin|statin
454392|NCT01205347|Myocardial infarction|myocardial infarction
454393|NCT01205347|Insulin sensitivity|insulin sensitivity
454394|NCT01205334|Glioblastoma multiforme|glioblastoma multiforme
454395|NCT01205334|GBM|gbm
454396|NCT01205334|Brain Cancer|brain cancer
454397|NCT01205334|CTL|ctl
454398|NCT01205321|Neoplasm|neoplasm
454399|NCT01205321|PET/CT diagnosis|pet/ct diagnosis
454400|NCT01205321|PET tracer|pet tracer
454401|NCT01205308|Plant stanols|plant stanols
454402|NCT01205308|type 1 diabetes|type 1 diabetes
454403|NCT01205308|sterol metabolism|sterol metabolism
454404|NCT01205308|cholesterol|cholesterol
454405|NCT01205295|hip|hip
454406|NCT01205295|shoulder|shoulder
454407|NCT01205295|mental disorders|mental disorders
454408|NCT01205295|anxiety|anxiety
454409|NCT01205295|concern|concern
454410|NCT01205295|efficacy of treatment|efficacy of treatment
454411|NCT01205282|ASD|asd
454412|NCT01205269|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
454413|NCT01205269|safety|safety
454414|NCT01205269|inhalation|inhalation
454415|NCT01205269|long-acting muscarinic receptor antagonist (LAMA)|long-acting muscarinic receptor antagonist (lama)
454416|NCT01205256|Methadone pharmacokinetics in adolescents|methadone pharmacokinetics in adolescents
454417|NCT01205243|Abacavir|abacavir
454418|NCT01205243|post-marketing surveillance|post-marketing surveillance
454419|NCT01205230|Esomeprazole|esomeprazole
454420|NCT01205230|Pharmacogenetics|pharmacogenetics
454421|NCT01205230|Pharmacokinetics|pharmacokinetics
454422|NCT01205230|Ketoconazole|ketoconazole
454423|NCT01205230|Pazopanib|pazopanib
454424|NCT01205230|Drug Interaction|drug interaction
454425|NCT01205230|Safety|safety
454426|NCT01205230|Solid Tumors|solid tumors
454427|NCT01205217|lapatinib|lapatinib
454428|NCT01205217|epirubicin|epirubicin
454429|NCT01205217|cyclophosphamide|cyclophosphamide
454430|NCT01205217|trastuzumab|trastuzumab
454431|NCT01205217|paclitaxel|paclitaxel
454432|NCT01205217|neoadjuvant therapy|neoadjuvant therapy
454433|NCT01205217|Breast Cancer|breast cancer
454434|NCT01205204|Clonidine|clonidine
454435|NCT01205204|Fentanyl|fentanyl
454436|NCT01205204|Bupivacaine|bupivacaine
454437|NCT01205204|Spinal Anesthesia|spinal anesthesia
454438|NCT01205204|Lower Segment Caesarian Section|lower segment caesarian section
454439|NCT01205191|Cognitive behavioural therapy|cognitive behavioural therapy
454440|NCT01205191|Anxiety|anxiety
454441|NCT01205191|Primary care|primary care
454442|NCT01205191|Effectiveness trial|effectiveness trial
454443|NCT01205191|Cell-phone supported therapy|cell-phone supported therapy
454444|NCT01205152|Hypophosphatasia|hypophosphatasia
454445|NCT01205152|HPP|hpp
454446|NCT01205152|Bone disease|bone disease
454447|NCT01205152|Soft bones|soft bones
454448|NCT01205152|Low alkaline phosphatase|low alkaline phosphatase
454449|NCT01205152|Genetic metabolic disorder|genetic metabolic disorder
454450|NCT01205152|Alkaline phosphatase|alkaline phosphatase
454451|NCT01205152|Tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
454452|NCT01205152|Rickets|rickets
454453|NCT01205152|Osteomalacia|osteomalacia
454454|NCT01205139|TMC435-TiDP16-C114|tmc435-tidp16-c114
454455|NCT01205139|TMC435-C114|tmc435-c114
454456|NCT01205139|TMC435|tmc435
454457|NCT01205139|HCV|hcv
454458|NCT01205139|Hepatitis C|hepatitis c
454459|NCT01205126|Pain|pain
454460|NCT01205126|Hydromorphone hydrochloride|hydromorphone hydrochloride
454461|NCT01205126|Oxycodone hydrochloride|oxycodone hydrochloride
454462|NCT01205100|Gastrointestinal Diseases|gastrointestinal diseases
454463|NCT01205100|Irritable Bowel Syndrome|irritable bowel syndrome
454464|NCT01205100|Behavioral Research|behavioral research
454465|NCT01205100|Biofeedback|biofeedback
454466|NCT01205074|Patients with chronic liver disease and cirrhosis|patients with chronic liver disease and cirrhosis
454467|NCT01205035|Idiopathic Parafoveal Telangiectasia|idiopathic parafoveal telangiectasia
454468|NCT01205035|Macular Telangiectasia|macular telangiectasia
454469|NCT01205035|Macula Lutea/pathology|macula lutea/pathology
454470|NCT01205035|Retinal Diseases/pathology|retinal diseases/pathology
454471|NCT01205035|Retinal Pigments/metabolism|retinal pigments/metabolism
454472|NCT01205035|Telangiectasis/metabolism|telangiectasis/metabolism
454473|NCT01205035|Telangiectasis/pathology|telangiectasis/pathology
454474|NCT01205009|in-vitro fertilization|in-vitro fertilization
454475|NCT01205009|poor responders|poor responders
454476|NCT01205009|human chorionic gonadotropin|human chorionic gonadotropin
454477|NCT01205009|Fertility Agents, Female|fertility agents, female
454478|NCT01204996|monoclonal antibody|monoclonal antibody
454479|NCT01204996|solid tumor|solid tumor
454480|NCT01204996|chemotherapy|chemotherapy
454481|NCT01204996|standard of care|standard of care
454482|NCT01204983|very low birth weight infant|very low birth weight infant
454483|NCT01204983|donor human milk|donor human milk
454484|NCT01204970|Confocal Laser Scanning Microendoscopy|confocal laser scanning microendoscopy
454485|NCT01204970|Small airways|small airways
454486|NCT01204970|COPD|copd
454487|NCT01204970|Lung transplantation|lung transplantation
454488|NCT01204957|Homocysteine|homocysteine
454489|NCT01204957|Insulin-like growth factor|insulin-like growth factor
454610|NCT01204723|cannabis|cannabis
454490|NCT01204957|Insulin-like growth factor binding protein|insulin-like growth factor binding protein
454491|NCT01204957|Serum estrogen|serum estrogen
454492|NCT01204957|Urinary phytoestrogens|urinary phytoestrogens
454493|NCT01204957|Thyroid hormones|thyroid hormones
454494|NCT01204931|reflux|reflux
454495|NCT01204931|gastroesophageal reflux disease|gastroesophageal reflux disease
454496|NCT01204931|GERD|gerd
454498|NCT01204918|Depression|depression
454499|NCT01204918|Treatment refractory|treatment refractory
454500|NCT01204918|Glutamate|glutamate
454501|NCT01204918|Riluzole|riluzole
454502|NCT01204918|Major depressive disorder|major depressive disorder
454503|NCT01204918|psychopharmacology|psychopharmacology
454504|NCT01204918|rilutek|rilutek
454505|NCT01204905|HIV-1|hiv-1
454506|NCT01204905|CD4|cd4
454507|NCT01204905|Viral Load|viral load
454508|NCT01204905|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
454509|NCT01204866|Allergic-Like Reaction|allergic-like reaction
454510|NCT01204866|Selected Formulation Components|selected formulation components
454511|NCT01204853|sitaxentan sodium hypertension|sitaxentan sodium hypertension
454512|NCT01204840|in vitro fertilization|in vitro fertilization
454513|NCT01204840|IVF|ivf
454514|NCT01204840|poor responder|poor responder
454515|NCT01204840|growth hormone|growth hormone
454516|NCT01204840|Poor responders to in vitro fertilization treatments|poor responders to in vitro fertilization treatments
454517|NCT01204827|Patients with chronic HBeAg negative hepatitis B virus infection treated with Sebivo (Telbivudine)|patients with chronic hbeag negative hepatitis b virus infection treated with sebivo (telbivudine)
454518|NCT01204814|HIV|hiv
454519|NCT01204814|Drug resistance|drug resistance
454520|NCT01204814|mutations|mutations
454521|NCT01204814|ARV's|arv's
454522|NCT01204801|Cancer|cancer
454523|NCT01204801|Breast Cancer|breast cancer
454524|NCT01204801|Breast Tumor|breast tumor
454525|NCT01204801|Breast Neoplasm|breast neoplasm
454526|NCT01204801|Neoplasms by Site|neoplasms by site
454527|NCT01204801|Neoplasms|neoplasms
454528|NCT01204801|Breast Diseases|breast diseases
454529|NCT01204801|Breast Conserving Surgery|breast conserving surgery
454530|NCT01204801|Breast Conservation|breast conservation
454531|NCT01204801|Partial Mastectomy|partial mastectomy
454532|NCT01204801|Lumpectomy|lumpectomy
454533|NCT01204801|Mastectomy|mastectomy
454534|NCT01204801|Surgery|surgery
454535|NCT01204801|Neoadjuvant Therapy|neoadjuvant therapy
454536|NCT01204801|Primary Therapy|primary therapy
454537|NCT01204801|Neoadjuvant Systemic Therapy|neoadjuvant systemic therapy
454538|NCT01204801|Thermotherapy|thermotherapy
454539|NCT01204801|Fever Therapy|fever therapy
454540|NCT01204801|Hot Temperature|hot temperature
454541|NCT01204801|Hyperthermia|hyperthermia
454542|NCT01204801|Hyperthermia, Therapeutic|hyperthermia, therapeutic
454543|NCT01204801|Hyperthermia, Local|hyperthermia, local
454544|NCT01204801|Hyperthermia, Induced|hyperthermia, induced
454545|NCT01204801|Therapeutic Hyperthermia|therapeutic hyperthermia
454546|NCT01204801|Microwave|microwave
454547|NCT01204801|Focused Microwave|focused microwave
454548|NCT01204801|Focused Microwave Thermotherapy|focused microwave thermotherapy
454549|NCT01204801|Minimally Invasive|minimally invasive
454550|NCT01204801|Doxorubicin|doxorubicin
454551|NCT01204801|Epirubicin|epirubicin
454552|NCT01204801|Epidoxirubicin|epidoxirubicin
454553|NCT01204801|Immunosuppresive Agent|immunosuppresive agent
454554|NCT01204801|Immunologic Factors|immunologic factors
454555|NCT01204801|Physiological Effects of Drugs|physiological effects of drugs
454556|NCT01204801|Chemotherapy|chemotherapy
454557|NCT01204801|Drug Therapy|drug therapy
454558|NCT01204801|Pharmalogic Actions|pharmalogic actions
454559|NCT01204801|Antirheumatic Agents|antirheumatic agents
454560|NCT01204801|Therapeutic Uses|therapeutic uses
454561|NCT01204801|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
454562|NCT01204801|Alkylating Agents|alkylating agents
454563|NCT01204801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
454564|NCT01204801|Antineoplastic Agents|antineoplastic agents
454565|NCT01204801|Myeloblative Agonists|myeloblative agonists
454566|NCT01204801|Antibiotics, Antineoplastic|antibiotics, antineoplastic
454567|NCT01204801|Anthracycline Agents|anthracycline agents
454568|NCT01204788|Acute myelogenous leukemia|acute myelogenous leukemia
454569|NCT01204788|AML|aml
454570|NCT01204788|Undifferentiated and bi-phenotypic leukemia|undifferentiated and bi-phenotypic leukemia
454571|NCT01204788|High-risk myelodysplastic syndrome|high-risk myelodysplastic syndrome
454572|NCT01204788|Chronic myelogenous leukemia|chronic myelogenous leukemia
454573|NCT01204788|Infection|infection
454574|NCT01204788|Radiated Prophylactic White Cell Transfusions|radiated prophylactic white cell transfusions
454575|NCT01204788|Therapeutic Radiated White Cell Transfusion|therapeutic radiated white cell transfusion
454576|NCT01204788|prophylactic antibiotics|prophylactic antibiotics
454577|NCT01204749|AMGEN|amgen
454578|NCT01204749|AMG 386|amg 386
454579|NCT01204749|Angiogenesis Inhibitors|angiogenesis inhibitors
454580|NCT01204749|Fallopian Tube Cancer|fallopian tube cancer
454581|NCT01204749|Primary Peritoneal Cancer|primary peritoneal cancer
454582|NCT01204749|Paclitaxel|paclitaxel
454583|NCT01204749|Ovarian Cancer|ovarian cancer
454584|NCT01204749|TRINOVA-1|trinova-1
454585|NCT01204736|tendon transfer|tendon transfer
454586|NCT01204736|elbow|elbow
454587|NCT01204723|Marijuana Abuse|marijuana abuse
454588|NCT01204723|Nicotine Dependence|nicotine dependence
454589|NCT01204723|Nicotine Withdrawal|nicotine withdrawal
454590|NCT01204723|neurokinin Receptor|neurokinin receptor
454591|NCT01204723|NK1 Receptor antagonist|nk1 receptor antagonist
454592|NCT01204723|Substance P|substance p
454593|NCT01204723|Recurrence|recurrence
454594|NCT01204723|Substance Withdrawal Syndrome|substance withdrawal syndrome
454595|NCT01204723|Substance-Related Disorders|substance-related disorders
454596|NCT01204723|Disorders of Environmental Origin|disorders of environmental origin
454597|NCT01204723|Mental Disorders|mental disorders
454598|NCT01204723|Disease Attributes|disease attributes
454599|NCT01204723|Pathologic Processes|pathologic processes
454600|NCT01204723|Tetrahydrocannabinol|tetrahydrocannabinol
454601|NCT01204723|Therapeutic Uses|therapeutic uses
454602|NCT01204723|Psychotropic Drugs|psychotropic drugs
454603|NCT01204723|Analgesics, Non-Narcotic|analgesics, non-narcotic
454604|NCT01204723|Analgesics|analgesics
454605|NCT01204723|Sensory System Agents|sensory system agents
454606|NCT01204723|Peripheral Nervous System Agents|peripheral nervous system agents
454607|NCT01204723|Neurotransmitter Agents|neurotransmitter agents
454608|NCT01204723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
454609|NCT01204723|Narcotic Antagonists|narcotic antagonists
454611|NCT01204710|Prostate Cancer|prostate cancer
454612|NCT01204684|dendritic cells|dendritic cells
454613|NCT01204684|glioma|glioma
454614|NCT01204684|vaccine|vaccine
454615|NCT01204684|glioma of WHO Grade III or IV|glioma of who grade iii or iv
454616|NCT01204671|influenza infection|influenza infection
454617|NCT01204671|GSK Biologicals influenza vaccine GSK2321138A|gsk biologicals influenza vaccine gsk2321138a
454618|NCT01204658|Haemophilus influenzae|haemophilus influenzae
454619|NCT01204658|Streptococcus pneumoniae|streptococcus pneumoniae
454620|NCT01204658|immunogenicity|immunogenicity
454621|NCT01204658|Pneumococcal vaccine|pneumococcal vaccine
454622|NCT01204658|infants|infants
454623|NCT01204658|safety|safety
454624|NCT01204619|peritoneal dialysis|peritoneal dialysis
454625|NCT01204567|HLRQ|hlrq
454626|NCT01204567|elderly|elderly
454627|NCT01204567|aerobic fitness|aerobic fitness
454628|NCT01204567|cognitive capacity|cognitive capacity
454629|NCT01204554|perforator flaps|perforator flaps
454630|NCT01204541|Non-exudative age-related macular degeneration|non-exudative age-related macular degeneration
454631|NCT01204528|Dysfunction in CKD|dysfunction in ckd
454632|NCT01204515|IBS|ibs
454633|NCT01204515|irritable bowel syndrome|irritable bowel syndrome
454634|NCT01204515|abdominal pain|abdominal pain
454635|NCT01204515|urgency|urgency
454636|NCT01204515|bloating|bloating
454637|NCT01204515|diarrhea|diarrhea
454638|NCT01204515|constipation|constipation
454639|NCT01204502|Gene therapy|gene therapy
454640|NCT01204502|Haploidentical|haploidentical
454641|NCT01204502|Bone marrow transplant|bone marrow transplant
454642|NCT01204502|Graft versus host disease|graft versus host disease
454643|NCT01204502|haploidentical stem cell transplantation|haploidentical stem cell transplantation
454644|NCT01204502|T-cell suicide gene therapy|t-cell suicide gene therapy
454645|NCT01204450|recurrent childhood brain tumor|recurrent childhood brain tumor
454646|NCT01204450|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
454647|NCT01204450|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
454743|NCT01204099|docetaxel|docetaxel
454744|NCT01204099|NSCLC|nsclc
454648|NCT01204450|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
454649|NCT01204450|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
454650|NCT01204450|recurrent neuroblastoma|recurrent neuroblastoma
454651|NCT01204450|recurrent osteosarcoma|recurrent osteosarcoma
454652|NCT01204450|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
454653|NCT01204437|adjuvant chemotherapy|adjuvant chemotherapy
454654|NCT01204437|primary carcinoma|primary carcinoma
454655|NCT01204437|elderly non frail patients|elderly non frail patients
454656|NCT01204437|EC|ec
454657|NCT01204437|CMF|cmf
454658|NCT01204437|Capecitabine|capecitabine
454659|NCT01204437|Nab-Paclitaxel|nab-paclitaxel
454660|NCT01204424|minimal invasive|minimal invasive
454661|NCT01204424|sinus floor augmentation|sinus floor augmentation
454662|NCT01204424|sinuslift|sinuslift
454663|NCT01204424|dental implants|dental implants
454664|NCT01204411|Efficacy|efficacy
454665|NCT01204411|Safety|safety
454666|NCT01204411|Artesunate-amodiaquine|artesunate-amodiaquine
454667|NCT01204411|Malaria|malaria
454668|NCT01204411|Plasmodium falciparum|plasmodium falciparum
454669|NCT01204411|Malnutrition|malnutrition
454670|NCT01204385|Non-typeable Haemophilus Influenzae|non-typeable haemophilus influenzae
454671|NCT01204385|Acute Otitis Media|acute otitis media
454672|NCT01204385|Streptococcus Pneumoniae|streptococcus pneumoniae
454673|NCT01204385|etiology|etiology
454674|NCT01204372|Metastatic pancreatic adenocarcinoma|metastatic pancreatic adenocarcinoma
454675|NCT01204372|First-line chemotherapy|first-line chemotherapy
454676|NCT01204372|Combination chemotherapy|combination chemotherapy
454677|NCT01204372|Targeted agents|targeted agents
454678|NCT01204346|adolescents|adolescents
454679|NCT01204346|MBT|mbt
454680|NCT01204346|depression|depression
454681|NCT01204346|emerging personality disorder|emerging personality disorder
454682|NCT01204333|Cerebral venous and sinus thrombosis|cerebral venous and sinus thrombosis
454683|NCT01204333|Cerebral venous thrombosis|cerebral venous thrombosis
454684|NCT01204333|Sinus Thrombosis, Intracranial|sinus thrombosis, intracranial
454685|NCT01204333|Endovascular thrombolysis|endovascular thrombolysis
454686|NCT01204333|Thrombolysis|thrombolysis
454687|NCT01204333|Thrombectomy|thrombectomy
454688|NCT01204320|Restenosis|restenosis
454689|NCT01204320|POBA|poba
454690|NCT01204320|Stenting|stenting
454691|NCT01204320|Paclitaxel|paclitaxel
454692|NCT01204281|Proportional Assist Ventilation plus|proportional assist ventilation plus
454693|NCT01204281|Acute respiratory failure|acute respiratory failure
454694|NCT01204281|Mechanical ventilation|mechanical ventilation
454695|NCT01204268|cerebral ischemia|cerebral ischemia
454696|NCT01204268|sevoflurane preconditioning|sevoflurane preconditioning
454697|NCT01204268|intracranial aneurysm surgery|intracranial aneurysm surgery
454698|NCT01204255|healthy, no evidence of disease|healthy, no evidence of disease
454699|NCT01204242|Breast Cancer|breast cancer
454700|NCT01204229|Alcohol Consumption|alcohol consumption
454701|NCT01204229|Social Anxiety|social anxiety
454702|NCT01204229|Depression|depression
454703|NCT01204229|Brief Intervention|brief intervention
454704|NCT01204229|Motivational Interviewing|motivational interviewing
454705|NCT01204229|Cognitive Behavioral Therapy|cognitive behavioral therapy
454706|NCT01204229|Sub-Clinical Social Anxiety|sub-clinical social anxiety
454707|NCT01204229|Sub-Clinical Depression|sub-clinical depression
454708|NCT01204216|Hemoglobin A1c|hemoglobin a1c
454709|NCT01204216|HbA1c|hba1c
454710|NCT01204216|glycated serum proteins|glycated serum proteins
454711|NCT01204216|fructosamine|fructosamine
454712|NCT01204216|glycated albumin|glycated albumin
454713|NCT01204216|glycation gap|glycation gap
454714|NCT01204203|mesothelioma|mesothelioma
454715|NCT01204203|zoledronic acid|zoledronic acid
454716|NCT01204203|zometa|zometa
454717|NCT01204203|bisphosphonate therapy|bisphosphonate therapy
454718|NCT01204203|CT scan|ct scan
454719|NCT01204203|PET scan|pet scan
454720|NCT01204190|Administration|administration
454721|NCT01204190|Cutaneous|cutaneous
454722|NCT01204177|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
454723|NCT01204177|MEK inhibitor|mek inhibitor
454724|NCT01204177|Sorafenib|sorafenib
454725|NCT01204177|Disease control rate (DCR)|disease control rate (dcr)
454726|NCT01204177|Safety|safety
454727|NCT01204164|AML|aml
454728|NCT01204164|ALL|all
454729|NCT01204164|MDS|mds
454730|NCT01204164|CML in blast crisis|cml in blast crisis
454731|NCT01204164|Multiple Myeloma|multiple myeloma
454732|NCT01204164|Carfilzomib refractory|carfilzomib refractory
454733|NCT01204138|RA, treatment, TNF, cytokines|ra, treatment, tnf, cytokines
454734|NCT01204112|Drug-Drug Interaction|drug-drug interaction
454735|NCT01204112|Tasocitinib (CP-690|tasocitinib (cp-690
454736|NCT01204112|550)|550)
454737|NCT01204112|Rifampin|rifampin
454738|NCT01204112|Healthy Volunteers|healthy volunteers
454739|NCT01204099|PX-866|px-866
454740|NCT01204099|Non small cell lung cancer|non small cell lung cancer
454741|NCT01204099|solid tumors|solid tumors
454742|NCT01204099|Squamous cell cancer of the head and neck|squamous cell cancer of the head and neck
454745|NCT01204099|taxotere|taxotere
454746|NCT01204099|SCCHN|scchn
454747|NCT01204099|PI-3K|pi-3k
454748|NCT01204099|PI3 kinase|pi3 kinase
454749|NCT01204099|PI3K|pi3k
454750|NCT01204086|Major Depressive Disorder|major depressive disorder
454751|NCT01204086|Antidepressants|antidepressants
454752|NCT01204086|Pharmacogenetics|pharmacogenetics
454753|NCT01204086|venlafaxine|venlafaxine
454754|NCT01204086|fluoxetine|fluoxetine
454755|NCT01204060|Nasal Allergen Lipopolysaccharide Inflammation Asthma|nasal allergen lipopolysaccharide inflammation asthma
454756|NCT01204034|COPD|copd
454757|NCT01204034|Formoterol|formoterol
454758|NCT01204034|Beclomethasone Dipropionate|beclomethasone dipropionate
454759|NCT01204034|Computational Fluid Dynamics|computational fluid dynamics
454760|NCT01204034|Functional Imaging|functional imaging
454761|NCT01204034|Central and Peripheral Airways|central and peripheral airways
454762|NCT01204034|BODE index|bode index
454763|NCT01204034|COPD Assessment Test (CAT)|copd assessment test (cat)
454764|NCT01204034|Borg CR10 scale|borg cr10 scale
454765|NCT01204021|Stress|stress
454766|NCT01204021|loneliness|loneliness
454767|NCT01204021|social isolation|social isolation
454768|NCT01204021|autonomic activity|autonomic activity
454769|NCT01204021|inflammation|inflammation
454770|NCT01204021|Perceived social isolation|perceived social isolation
454771|NCT01204021|Chronic stress|chronic stress
454772|NCT01203982|CIMT|cimt
454773|NCT01203982|IVUS-VH|ivus-vh
454774|NCT01203982|Coronary artery disease|coronary artery disease
454775|NCT01203956|AutoAdjust|autoadjust
454776|NCT01203956|SmartFlex|smartflex
454777|NCT01203956|Apnea Hypopnea Index|apnea hypopnea index
454778|NCT01203956|Patient reported outcomes|patient reported outcomes
454779|NCT01203943|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
454780|NCT01203943|Pulmonary Fibrosis|pulmonary fibrosis
454781|NCT01203943|Fibrosis|fibrosis
454782|NCT01203943|Interstitial Lung Disease|interstitial lung disease
454783|NCT01203943|Lung Diseases, Interstitial|lung diseases, interstitial
454784|NCT01203943|CC-930|cc-930
454785|NCT01203930|CLL|cll
454786|NCT01203930|SLL|sll
454787|NCT01203930|GS-1101|gs-1101
454788|NCT01203930|CAL-101|cal-101
454789|NCT01203930|Phosphatidylinositol 3-kinase (PI3K)|phosphatidylinositol 3-kinase (pi3k)
454790|NCT01203930|Rituximab|rituximab
454791|NCT01203930|Rituxan|rituxan
454792|NCT01203917|Gefitinib|gefitinib
454793|NCT01203917|EGFR TKI|egfr tki
454794|NCT01203917|efficacy|efficacy
454795|NCT01203917|Caucasian patients|caucasian patients
454796|NCT01203917|EGFR mutation positive advanced NSCLC|egfr mutation positive advanced nsclc
454797|NCT01203917|safety|safety
454798|NCT01203904|bronchial asthma, Pulmicort, long term use, pediatrics|bronchial asthma, pulmicort, long term use, pediatrics
454799|NCT01203891|SPECT|spect
454800|NCT01203891|Imaging|imaging
454801|NCT01203891|Healthy brain|healthy brain
454802|NCT01203891|regional cerebral blood flow|regional cerebral blood flow
454803|NCT01203878|Imiquimod|imiquimod
454804|NCT01203878|Photodynamic therapy|photodynamic therapy
454805|NCT01203878|Actinic keratoses|actinic keratoses
454806|NCT01203878|Sequential therapy|sequential therapy
454807|NCT01203878|Therapeutic uses|therapeutic uses
454808|NCT01203865|Fibromyalgia|fibromyalgia
454809|NCT01203865|Fatigue|fatigue
454810|NCT01203852|hypertension|hypertension
454811|NCT01203852|antihypertensive drug|antihypertensive drug
454812|NCT01203852|pharmacogenetics|pharmacogenetics
454813|NCT01203852|genetics|genetics
454814|NCT01203852|blood pressure|blood pressure
454815|NCT01203852|glucose|glucose
454816|NCT01203839|stage 1 breast cancer|stage 1 breast cancer
454817|NCT01203839|invasive ductal breast|invasive ductal breast
454818|NCT01203839|Partial Breast Irradiation (PBI)|partial breast irradiation (pbi)
454819|NCT01203839|radiation|radiation
454820|NCT01203839|10-114|10-114
454821|NCT01203826|Hypophosphatasia|hypophosphatasia
454822|NCT01203826|HPP|hpp
454823|NCT01203826|Bone Disease|bone disease
454824|NCT01203826|Soft Bones|soft bones
454825|NCT01203826|Low Alkaline Phosphatase|low alkaline phosphatase
454826|NCT01203826|genetic metabolic disorder|genetic metabolic disorder
454827|NCT01203826|alkaline phosphatase|alkaline phosphatase
454828|NCT01203826|tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
454829|NCT01203826|rickets|rickets
454830|NCT01203826|osteomalacia|osteomalacia
454831|NCT01203813|Chronic kidney disease|chronic kidney disease
454832|NCT01203813|Quality improvement|quality improvement
454833|NCT01203813|Self management support|self management support
454834|NCT01203813|Electronic health records|electronic health records
454835|NCT01203813|Clinical decision support|clinical decision support
454836|NCT01203813|Electronic reminders|electronic reminders
454837|NCT01203813|Patient outreach|patient outreach
454838|NCT01203787|Hepatocellular Carcinoma|hepatocellular carcinoma
454839|NCT01203787|HCC|hcc
454840|NCT01203787|Liver Cancer|liver cancer
454841|NCT01203774|Diabetes|diabetes
454842|NCT01203761|loneliness|loneliness
454843|NCT01203735|Non-small-cell lung cancer|non-small-cell lung cancer
454844|NCT01203735|Valproic acid|valproic acid
454845|NCT01203735|Chemotherapy|chemotherapy
454846|NCT01203735|Radiotherapy|radiotherapy
454847|NCT01203722|Reduced intensity|reduced intensity
454848|NCT01203722|partially HLA mismatched allogeneic BMT|partially hla mismatched allogeneic bmt
454849|NCT01203722|Acute leukemias|acute leukemias
454850|NCT01203722|Chronic leukemias|chronic leukemias
454851|NCT01203722|Myelodysplasia|myelodysplasia
454852|NCT01203722|Lymphomas|lymphomas
454853|NCT01203722|Unrelated or non-first-degree related donors|unrelated or non-first-degree related donors
454854|NCT01203709|lupus|lupus
454855|NCT01203709|nephritis|nephritis
454856|NCT01203709|glomerulonephritis|glomerulonephritis
454857|NCT01203709|nephropathy|nephropathy
454858|NCT01203709|refractory|refractory
454859|NCT01203696|Clopidogrel|clopidogrel
454860|NCT01203696|Platelet reactivity|platelet reactivity
454861|NCT01203696|Amlodipine|amlodipine
454862|NCT01203683|depression|depression
454863|NCT01203670|Glomerular filtration rate (GFR)|glomerular filtration rate (gfr)
454864|NCT01203670|Aspartate Amino Transferase (ASAT)|aspartate amino transferase (asat)
454865|NCT01203670|Alanine Amino transferase (ALAT)|alanine amino transferase (alat)
454866|NCT01203670|gamma Glutamyl transpeptidase (gamma GT)|gamma glutamyl transpeptidase (gamma gt)
454867|NCT01203670|Lipase|lipase
454868|NCT01203670|Amylase|amylase
454869|NCT01203657|exercise|exercise
454870|NCT01203657|physical activity|physical activity
454871|NCT01203657|tai chi|tai chi
454872|NCT01203644|Postoperative pain|postoperative pain
454873|NCT01203644|Analgesia|analgesia
454874|NCT01203618|Resectable, non-functioning pituitary adenoma|resectable, non-functioning pituitary adenoma
454875|NCT01203618|Pituitary tumor|pituitary tumor
454876|NCT01203618|Pituitary adenoma|pituitary adenoma
454877|NCT01203618|Pituitary macroadenoma|pituitary macroadenoma
454878|NCT01203605|Operative surgical procedures|operative surgical procedures
454879|NCT01203605|mortality|mortality
454880|NCT01203605|adverse effects|adverse effects
454881|NCT01203605|Postoperative complications|postoperative complications
454882|NCT01203605|Epidemiological Study|epidemiological study
454883|NCT01203592|Congenital myasthenic syndrome|congenital myasthenic syndrome
454884|NCT01203592|Albuterol|albuterol
454885|NCT01203592|Neuromuscular transmission|neuromuscular transmission
454886|NCT01203579|CDT-Lung,CT scan,lung cancer detection|cdt-lung,ct scan,lung cancer detection
454887|NCT01203566|Single incision laparoscopic surgery|single incision laparoscopic surgery
454888|NCT01203566|Single site access laparoscopic surgery|single site access laparoscopic surgery
454889|NCT01203566|SILS|sils
454890|NCT01203566|Single-port access|single-port access
454891|NCT01203566|Laparoendoscopic single site surgery|laparoendoscopic single site surgery
454892|NCT01203566|Appendectomy|appendectomy
454893|NCT01203553|Incisional hernias|incisional hernias
454894|NCT01203553|Prophylaxis|prophylaxis
454895|NCT01203553|Preperitoneal mesh|preperitoneal mesh
454896|NCT01203527|H1N1 influenza|h1n1 influenza
454897|NCT01203527|Swine flu|swine flu
454898|NCT01203527|Oseltamivir|oseltamivir
454899|NCT01203527|Tamiflu|tamiflu
454900|NCT01203527|Pregnancy|pregnancy
454901|NCT01203514|NICHD Neonatal Research Network|nichd neonatal research network
454902|NCT01203514|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
454903|NCT01203514|Prematurity|prematurity
454904|NCT01203514|Erythrocyte transfusions|erythrocyte transfusions
454905|NCT01203514|Erythropoietin (Epo)|erythropoietin (epo)
454906|NCT01203514|Blood loss|blood loss
454907|NCT01203514|Phlebotomy|phlebotomy
454908|NCT01203501|NICHD Neonatal Research Network|nichd neonatal research network
454909|NCT01203501|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
454910|NCT01203501|Prematurity|prematurity
454911|NCT01203501|Antenatal Magnesium sulfate|antenatal magnesium sulfate
454912|NCT01203488|NICHD Neonatal Research Network|nichd neonatal research network
454913|NCT01203488|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
454914|NCT01203488|Prematurity|prematurity
454915|NCT01203488|Vitamin A|vitamin a
454916|NCT01203488|Chronic Lung Disease|chronic lung disease
454917|NCT01203475|NICHD Neonatal Research Network|nichd neonatal research network
454918|NCT01203475|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
454919|NCT01203475|Prematurity|prematurity
454920|NCT01203475|Growth Curve|growth curve
454921|NCT01203475|Head Circumference|head circumference
454922|NCT01203475|Length|length
454923|NCT01203449|NICHD Neonatal Research Network|nichd neonatal research network
454924|NCT01203449|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
454925|NCT01203449|Prematurity|prematurity
454926|NCT01203449|Gestational Age|gestational age
454927|NCT01203436|NICHD Neonatal Research Network|nichd neonatal research network
454928|NCT01203436|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
454929|NCT01203436|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
454930|NCT01203436|Prematurity|prematurity
454931|NCT01203423|NICHD Neonatal Research Network|nichd neonatal research network
454932|NCT01203423|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
454933|NCT01203423|Prematurity|prematurity
454934|NCT01203423|Persistent Pulmonary Hypertension of Newborn (PPHN)|persistent pulmonary hypertension of newborn (pphn)
454935|NCT01203410|NICHD Neonatal Research Network|nichd neonatal research network
454936|NCT01203410|Term infant|term infant
454937|NCT01203410|Hyperbilirubinemia|hyperbilirubinemia
454938|NCT01203397|SUPERFICIAL VARICOSE VEINS|superficial varicose veins
454939|NCT01203371|naftopidil|naftopidil
454940|NCT01203371|symptoms of lower urinary tract|symptoms of lower urinary tract
454941|NCT01203371|benign prostate hyperplasia|benign prostate hyperplasia
454942|NCT01203371|LUTS|luts
454943|NCT01203358|NICHD Neonatal Research Network|nichd neonatal research network
454944|NCT01203358|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
454945|NCT01203358|Prematurity|prematurity
454946|NCT01203358|Respiratory distress syndrome|respiratory distress syndrome
454947|NCT01203358|Surfactant|surfactant
454948|NCT01203345|NICHD Neonatal Research Network|nichd neonatal research network
454949|NCT01203345|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
454950|NCT01203345|Prematurity|prematurity
454951|NCT01203345|Septicemia|septicemia
454952|NCT01203345|Meningitis|meningitis
454953|NCT01203345|Urinary tract infection|urinary tract infection
454954|NCT01203345|Immune globulin|immune globulin
454955|NCT01203332|HIV testing|hiv testing
454956|NCT01203332|Latino|latino
454957|NCT01203332|Latina|latina
454958|NCT01203332|Men who have sex with men|men who have sex with men
454959|NCT01203319|immunogenicity|immunogenicity
454960|NCT01203319|safety|safety
454961|NCT01203319|recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
454962|NCT01203319|nonresponders|nonresponders
454963|NCT01203306|bevacizumab|bevacizumab
454964|NCT01203306|somatostatin analogue|somatostatin analogue
454965|NCT01203306|metronomic capecitabine|metronomic capecitabine
454966|NCT01203306|neuroendocrine tumors|neuroendocrine tumors
454967|NCT01203280|icing|icing
454968|NCT01203280|boxer|boxer
454969|NCT01203280|balance|balance
454970|NCT01203280|neck range of motion|neck range of motion
454971|NCT01203280|neck isometric strength|neck isometric strength
454972|NCT01203280|balance performance|balance performance
454973|NCT01203267|Breast Neoplasms|breast neoplasms
454974|NCT01203267|Neoadjuvant|neoadjuvant
454975|NCT01203267|Chemotherapy|chemotherapy
454976|NCT01203267|Paclitaxel|paclitaxel
454977|NCT01203267|Carboplatin|carboplatin
454978|NCT01203267|Pathological Complete Remission|pathological complete remission
454979|NCT01203254|Colesevelam|colesevelam
454980|NCT01203254|IBD|ibd
454981|NCT01203254|Bile Acid Malabsorption|bile acid malabsorption
454982|NCT01203254|Crohns disease|crohns disease
454983|NCT01203228|Reduced Intensity conditioning|reduced intensity conditioning
454984|NCT01203228|Myeloablative conditionig|myeloablative conditionig
454985|NCT01203228|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
454986|NCT01203228|MUD|mud
454987|NCT01203215|exercise|exercise
454988|NCT01203215|physical activity|physical activity
454989|NCT01203215|women|women
454990|NCT01203215|community|community
454991|NCT01203202|PE|pe
454992|NCT01203202|IELT|ielt
454993|NCT01203202|DCIT|dcit
454994|NCT01203189|dandruff, flaky scalp|dandruff, flaky scalp
454995|NCT01203176|Endometrial polyp|endometrial polyp
454996|NCT01203176|Endometrial carcinoma|endometrial carcinoma
454997|NCT01203176|Endometrial hyperplasia|endometrial hyperplasia
454998|NCT01203176|Postmenopausal symptomatic women|postmenopausal symptomatic women
454999|NCT01203176|Postmenopausal asymptomatic women|postmenopausal asymptomatic women
455000|NCT01203163|PDT|pdt
455001|NCT01203163|porfimer sodium|porfimer sodium
455002|NCT01203163|esophageal cancer|esophageal cancer
455003|NCT01203163|NSCLC|nsclc
455004|NCT01203163|HGD in BE|hgd in be
455005|NCT01203137|tricuspid regurgitation, severe|tricuspid regurgitation, severe
455006|NCT01203124|Intranasal|intranasal
455007|NCT01203124|Biomarker|biomarker
455008|NCT01203124|Healthy|healthy
455009|NCT01203124|Effect of different doses and dosing regimens of AZD8848 on biomarkers|effect of different doses and dosing regimens of azd8848 on biomarkers
455010|NCT01203124|Effect different doses and dosing frequency of AZD8848 on biomarkers|effect different doses and dosing frequency of azd8848 on biomarkers
455011|NCT01203098|prevention|prevention
455012|NCT01203098|venous thromboembolism|venous thromboembolism
455013|NCT01203098|edoxaban|edoxaban
455014|NCT01203098|anticoagulants|anticoagulants
455015|NCT01203072|prevention|prevention
455016|NCT01203072|venous thromboembolism|venous thromboembolism
455017|NCT01203072|edoxaban|edoxaban
455018|NCT01203072|factor Xa|factor xa
455019|NCT01203046|DURATION OF THERAPY|duration of therapy
455020|NCT01203046|PENETRATING ABDOMINAL TRAUMA|penetrating abdominal trauma
455021|NCT01203033|acute myeloid leukemia|acute myeloid leukemia
455022|NCT01203033|single cell network profiling|single cell network profiling
455023|NCT01203033|AML|aml
455024|NCT01203033|SCNP|scnp
455025|NCT01203020|Hodgkin's|hodgkin's
455026|NCT01203020|non-Hodgkin's|non-hodgkin's
455027|NCT01203020|lymphomas|lymphomas
455028|NCT01203020|allogeneic hematopoietic progenitor cell transplant|allogeneic hematopoietic progenitor cell transplant
455029|NCT01203020|HPCT|hpct
455030|NCT01203020|busulfex|busulfex
455031|NCT01203020|fludarabine|fludarabine
455032|NCT01203020|reduced-toxicity conditioning|reduced-toxicity conditioning
455033|NCT01203020|reduced-intensity conditioning|reduced-intensity conditioning
455034|NCT01202994|Alzheimer's disease|alzheimer's disease
455035|NCT01202994|Mild cognitive impairment|mild cognitive impairment
455036|NCT01202994|PET|pet
455037|NCT01202994|Practice effects|practice effects
455038|NCT01202981|glistenings|glistenings
455039|NCT01202981|contrast sensitivity|contrast sensitivity
455040|NCT01202981|visual quality|visual quality
455041|NCT01202981|straylight|straylight
455042|NCT01202981|AcrySof IOL|acrysof iol
455043|NCT01202968|intubation electric stimulation deglutition disorder|intubation electric stimulation deglutition disorder
455044|NCT01202955|Smoking, Abstinence|smoking, abstinence
455045|NCT01202929|High Resolution Manometry|high resolution manometry
455046|NCT01202929|achalasia|achalasia
455047|NCT01202929|dysphagia|dysphagia
455048|NCT01202929|GERD|gerd
455049|NCT01202929|chest pain|chest pain
455050|NCT01202929|Post fundoplication|post fundoplication
455051|NCT01202916|children with congenital heart disease|children with congenital heart disease
455052|NCT01202903|omalizumab|omalizumab
455053|NCT01202903|asthma|asthma
455054|NCT01202903|immunoglobulin E|immunoglobulin e
455055|NCT01202903|IgE|ige
455056|NCT01202890|lenalidomide|lenalidomide
455057|NCT01202890|revlimid|revlimid
455058|NCT01202890|liposomal doxorubicin|liposomal doxorubicin
455059|NCT01202890|doxil|doxil
455060|NCT01202890|bevacizumab|bevacizumab
455061|NCT01202890|avastin|avastin
455062|NCT01202890|platinum resistant ovarian cancer|platinum resistant ovarian cancer
455063|NCT01202890|ovarian cancer|ovarian cancer
455064|NCT01202877|Myelodysplastic Syndrome|myelodysplastic syndrome
455065|NCT01202877|MDS|mds
455066|NCT01202877|Refractory acute leukemias|refractory acute leukemias
455067|NCT01202877|Relapsed acute leukemia|relapsed acute leukemia
455068|NCT01202877|Acute myeloid leukemia|acute myeloid leukemia
455069|NCT01202877|AML|aml
455070|NCT01202877|5-Azacytidine|5-azacytidine
455071|NCT01202877|Azacitidine|azacitidine
455072|NCT01202877|5-aza|5-aza
455073|NCT01202877|Vidaza|vidaza
455074|NCT01202877|5-AZC|5-azc
455075|NCT01202877|AZA-CR|aza-cr
455076|NCT01202877|Ladakamycin|ladakamycin
455077|NCT01202877|NSC-102816|nsc-102816
455078|NCT01202877|PKC412|pkc412
455079|NCT01202864|Intracerebral Hemorrhage|intracerebral hemorrhage
455080|NCT01202864|ICH|ich
455081|NCT01202864|Stroke|stroke
455082|NCT01202864|Cerebrovascular accident|cerebrovascular accident
455083|NCT01202851|radiotherapy|radiotherapy
455084|NCT01202851|radiation therapy|radiation therapy
455085|NCT01202851|stretching|stretching
455086|NCT01202851|relaxation|relaxation
455087|NCT01202851|quality of life|quality of life
455088|NCT01202851|QOL|qol
455089|NCT01202851|fatigue|fatigue
455090|NCT01202851|sleep disturbances|sleep disturbances
455091|NCT01202851|mental health|mental health
455092|NCT01202851|cost-effectiveness analysis|cost-effectiveness analysis
455093|NCT01202851|work productivity|work productivity
455094|NCT01202851|home productivity|home productivity
455095|NCT01202851|cortisol rhythmicity|cortisol rhythmicity
455096|NCT01202838|Cranial bone reconstruction, composite|cranial bone reconstruction, composite
455097|NCT01202825|HCV genotype 1 infected patients|hcv genotype 1 infected patients
455098|NCT01202825|TMC647055HPC1001|tmc647055hpc1001
455099|NCT01202825|TMC647055|tmc647055
455100|NCT01202825|HPC|hpc
455101|NCT01202825|Hepatitis C|hepatitis c
455102|NCT01202825|Healthy volunteers|healthy volunteers
455103|NCT01202825|TMC435|tmc435
455104|NCT01202812|Sickle Cell Anemia|sickle cell anemia
455105|NCT01202812|Sickle Cell Disease|sickle cell disease
455106|NCT01202812|Hemoglobin SS Disease|hemoglobin ss disease
455107|NCT01202812|Hemoglobin S beta-0 Thalassemia|hemoglobin s beta-0 thalassemia
455108|NCT01202812|Inflammation|inflammation
455109|NCT01202812|Quality of Life|quality of life
455110|NCT01202812|Sickle Thalassemia|sickle thalassemia
455111|NCT01202812|C-Reative Protein|c-reative protein
455112|NCT01202812|Hemolytic Anemia|hemolytic anemia
455113|NCT01202812|Hemostasis|hemostasis
455114|NCT01202812|Biomarkers|biomarkers
455115|NCT01202812|Coagulation|coagulation
455116|NCT01202812|Omega-3 Fatty Acids|omega-3 fatty acids
455117|NCT01202812|Eicosapentaenoic Acid|eicosapentaenoic acid
455118|NCT01202812|Docosahexaenoic Acid|docosahexaenoic acid
455119|NCT01202812|Fish Oils|fish oils
455120|NCT01202812|Drug: Placebo|drug: placebo
455121|NCT01202812|Drug: LOVAZA|drug: lovaza
455122|NCT01202799|Pharmacokinetics|pharmacokinetics
455123|NCT01202799|Healthy volunteers|healthy volunteers
455124|NCT01202799|PENNSAID|pennsaid
455125|NCT01202799|Topical NSAID|topical nsaid
455126|NCT01202799|Diclofenac|diclofenac
455127|NCT01202786|Cancer of Unknown Primary Site (CUP)|cancer of unknown primary site (cup)
455128|NCT01202773|Rheumatoid Arthritis|rheumatoid arthritis
455129|NCT01202760|Rheumatoid Arthritis|rheumatoid arthritis
455130|NCT01202734|CONCERTA|concerta
455131|NCT01202734|Methylphenidate HCl|methylphenidate hcl
455132|NCT01202734|Pharmacokinetic|pharmacokinetic
455133|NCT01202734|Safety|safety
455134|NCT01202734|Adult|adult
455135|NCT01202734|Men|men
455136|NCT01202734|Male|male
455137|NCT01202721|Congenital|congenital
455138|NCT01202721|Aortic Valve|aortic valve
455139|NCT01202721|Bicuspid|bicuspid
455140|NCT01202721|Aortopathy|aortopathy
455141|NCT01202721|bicuspid aortic valve aortopathy|bicuspid aortic valve aortopathy
455142|NCT01202708|chronic renal failure|chronic renal failure
455143|NCT01202708|hemodiafiltration|hemodiafiltration
455144|NCT01202682|Healthy subject exercise study|healthy subject exercise study
455145|NCT01202656|Fertility Agents, Female|fertility agents, female
455146|NCT01202656|In vitro fertilization|in vitro fertilization
455147|NCT01202643|Thin Endometrium|thin endometrium
455148|NCT01202643|Asherman's Syndrome|asherman's syndrome
455149|NCT01202643|Endometrial Scarring|endometrial scarring
455150|NCT01202630|Clostridium difficile|clostridium difficile
455151|NCT01202630|diarrhea|diarrhea
455152|NCT01202617|Seroquel XR|seroquel xr
455153|NCT01202617|schizophrenia|schizophrenia
455154|NCT01202617|relapse prevention|relapse prevention
455155|NCT01202604|Bipolar disorder I and II|bipolar disorder i and ii
455156|NCT01202604|mood event|mood event
455157|NCT01202604|manic or depressive|manic or depressive
455158|NCT01202604|Greece|greece
455159|NCT01202591|Breast Cancer|breast cancer
455160|NCT01202591|ER+|er+
455161|NCT01202591|FGFR1|fgfr1
455162|NCT01202591|Exemestane|exemestane
455163|NCT01202591|AZD4547|azd4547
455164|NCT01202591|Fulvestrant|fulvestrant
455165|NCT01202565|Post-marketing observational study (PMOS) Protocol|post-marketing observational study (pmos) protocol
455166|NCT01202565|Moderate to Severe Plaque Psoriasis|moderate to severe plaque psoriasis
455167|NCT01202565|Treatment of Scalp and Nail Affection|treatment of scalp and nail affection
455168|NCT01202565|Effectiveness of Adalimumab (HUMIRA®)|effectiveness of adalimumab (humira®)
455169|NCT01202552|influenza|influenza
455170|NCT01202552|aged|aged
455171|NCT01202552|intradermal injection|intradermal injection
455172|NCT01202526|Insulin resistance|insulin resistance
455173|NCT01202526|Gastric bypass|gastric bypass
455174|NCT01202513|Vitiligo|vitiligo
455175|NCT01202513|Repigmentation|repigmentation
455176|NCT01202487|Laceration|laceration
455177|NCT01202487|Lacerations|lacerations
455178|NCT01202487|LET|let
455179|NCT01202487|Lidocaine Epinephrine Tetracaine|lidocaine epinephrine tetracaine
455180|NCT01202487|LAT|lat
455181|NCT01202487|Lidocaine Adrenaline Tetracaine|lidocaine adrenaline tetracaine
455182|NCT01202487|Tissue Adhesive|tissue adhesive
455183|NCT01202487|Skin Glue|skin glue
455184|NCT01202487|Pre-Treatment with LET|pre-treatment with let
455185|NCT01202487|Pre-Treatment with LAT|pre-treatment with lat
455186|NCT01202487|Pre-Treatment with Lidocaine Epinephrine Tetracaine|pre-treatment with lidocaine epinephrine tetracaine
455187|NCT01202487|Pre-Treatment with Lidocaine Adrenaline Tetracaine|pre-treatment with lidocaine adrenaline tetracaine
455188|NCT01202487|Use of LET with Skin Glue|use of let with skin glue
455189|NCT01202487|Use of LET with Tissue Adhesive|use of let with tissue adhesive
455190|NCT01202487|Histoacryl|histoacryl
455191|NCT01202461|Diabetic macular edema|diabetic macular edema
455192|NCT01202461|Combination therapy for DME|combination therapy for dme
455193|NCT01202461|DME|dme
455194|NCT01202448|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
455195|NCT01202448|central nervous system|central nervous system
455196|NCT01202448|prognosis|prognosis
455197|NCT01202435|pregabalin|pregabalin
455198|NCT01202435|pharmacokinetics|pharmacokinetics
455199|NCT01202435|bioavailability|bioavailability
455200|NCT01202435|bioequivalence|bioequivalence
455201|NCT01202422|pregabalin|pregabalin
455202|NCT01202422|pharmacokinetics|pharmacokinetics
455203|NCT01202422|bioavailability|bioavailability
455204|NCT01202422|bioequivalence|bioequivalence
455205|NCT01202409|Ampulla of Vater|ampulla of vater
455206|NCT01202409|Adenocarcinoma of the small bowel|adenocarcinoma of the small bowel
455207|NCT01202409|Metastatic|metastatic
455208|NCT01202409|Kirsten rat sarcoma|kirsten rat sarcoma
455209|NCT01202409|KRAS|kras
455210|NCT01202409|Capecitabine|capecitabine
455211|NCT01202409|Xeloda|xeloda
455212|NCT01202409|Oxaliplatin|oxaliplatin
455213|NCT01202409|Eloxatin|eloxatin
455214|NCT01202409|CAPOX|capox
455215|NCT01202409|Panitumumab|panitumumab
455216|NCT01202409|Vectibix|vectibix
455217|NCT01202396|pouch|pouch
455218|NCT01202396|pouchitis|pouchitis
455219|NCT01202396|ulcerative colitis|ulcerative colitis
455220|NCT01202396|microbiota|microbiota
455221|NCT01202396|defensins|defensins
455222|NCT01202396|epithelial integrity|epithelial integrity
455223|NCT01202370|Cancer|cancer
455224|NCT01202370|Tumors|tumors
455225|NCT01202357|Psychotic Disorders|psychotic disorders
455226|NCT01202357|Psychosis|psychosis
455227|NCT01202344|Angioplasty|angioplasty
455228|NCT01202344|Stenosis|stenosis
455229|NCT01202344|Restenosis|restenosis
455230|NCT01202344|Elastic Recoil|elastic recoil
455231|NCT01202344|cheduled for percutaneous dilation of a peripheral artery|cheduled for percutaneous dilation of a peripheral artery
455232|NCT01202344|Target lesion in native artery|target lesion in native artery
455233|NCT01202344|Baseline lumen diameter greater than 4 mm|baseline lumen diameter greater than 4 mm
455234|NCT01202331|Bacterial Infections|bacterial infections
455235|NCT01202331|Chlamydia Infections|chlamydia infections
455236|NCT01202331|Eye Diseases|eye diseases
455237|NCT01202318|Cerebrovascular Accident|cerebrovascular accident
455238|NCT01202318|Stroke,Acute|stroke,acute
455239|NCT01202305|HIV|hiv
455240|NCT01202305|HIV persistence|hiv persistence
455241|NCT01202305|Lymph node fibrosis|lymph node fibrosis
455242|NCT01202292|overweight|overweight
455243|NCT01202292|obesity|obesity
455244|NCT01202292|motivational intervention|motivational intervention
455245|NCT01202279|Acute Upper Respiratory Track Infection Who Seek Treatment|acute upper respiratory track infection who seek treatment
455246|NCT01202266|Multiple Ascending Dose|multiple ascending dose
455247|NCT01202266|Phase 1|phase 1
455248|NCT01202266|Safety and Tolerability|safety and tolerability
455249|NCT01202266|PK|pk
455250|NCT01202266|Healthy Subjects|healthy subjects
455251|NCT01202253|Ecalta|ecalta
455252|NCT01202253|Eraxis|eraxis
455253|NCT01202253|Candida|candida
455254|NCT01202253|Candidemia|candidemia
455255|NCT01202253|Systemic Candidiasis|systemic candidiasis
455256|NCT01202253|ICU|icu
455257|NCT01202253|Intensive Care Unit|intensive care unit
455258|NCT01202253|Critical Care Unit|critical care unit
455259|NCT01202240|Drug-Drug Interaction|drug-drug interaction
455260|NCT01202240|Healthy Volunteers|healthy volunteers
455261|NCT01202240|Tasocitinib (CP-690|tasocitinib (cp-690
455262|NCT01202240|550)|550)
455263|NCT01202240|Ketoconazole|ketoconazole
455264|NCT01202227|Central Nervous System Diseases|central nervous system diseases
455265|NCT01202227|Therapeutic Uses|therapeutic uses
455266|NCT01202227|Wounds and Injuries|wounds and injuries
455267|NCT01202227|Trauma|trauma
455268|NCT01202227|Nervous System|nervous system
455269|NCT01202227|pregabalin|pregabalin
455270|NCT01202188|QVA149, COPD, combination bronchodilator, indacaterol, glycopyrronium bromide|qva149, copd, combination bronchodilator, indacaterol, glycopyrronium bromide
455271|NCT01202175|Genetic risk of hypertension|genetic risk of hypertension
455272|NCT01202162|Induction|induction
455273|NCT01202162|Coughing|coughing
455274|NCT01202162|Anesthesia|anesthesia
455275|NCT01202149|eczema|eczema
455276|NCT01202149|elidel|elidel
455277|NCT01202149|non-medicated device|non-medicated device
455278|NCT01202149|hylatopic plus|hylatopic plus
455279|NCT01202149|pimecrolimus|pimecrolimus
455280|NCT01202149|bilateral comparison study|bilateral comparison study
455281|NCT01202149|topical therapy|topical therapy
455282|NCT01202136|pancreatic cyst|pancreatic cyst
455283|NCT01202136|IPMN|ipmn
455284|NCT01202136|PAN INs|pan ins
455285|NCT01202136|Pancreatic cancer|pancreatic cancer
455286|NCT01202136|pancreatic neoplasia|pancreatic neoplasia
455287|NCT01202071|Rabeprazole|rabeprazole
455288|NCT01202071|proton pump inhibitor|proton pump inhibitor
455289|NCT01202071|pharmacokinetics|pharmacokinetics
455290|NCT01202071|pharmacodynamics|pharmacodynamics
455291|NCT01202071|healthy adult male Japanese subjects|healthy adult male japanese subjects
455292|NCT01202058|Coronary artery disease|coronary artery disease
455293|NCT01202058|Drug-eluting stents|drug-eluting stents
455294|NCT01202058|Reservoir technology|reservoir technology
455295|NCT01202045|Echocardiography, Stress|echocardiography, stress
455296|NCT01202045|right heart catheterization|right heart catheterization
455297|NCT01202032|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
455298|NCT01202032|Advanced solid tumors|advanced solid tumors
455299|NCT01202032|Dose escalation|dose escalation
455300|NCT01202032|Association Pazopanib-Bevacizumab|association pazopanib-bevacizumab
455301|NCT01202019|cardiovascular risk|cardiovascular risk
455302|NCT01202019|exercise|exercise
455303|NCT01202019|post-exercise diet supplementation|post-exercise diet supplementation
455304|NCT01202006|Heart failure|heart failure
455305|NCT01202006|Diagnosis|diagnosis
455306|NCT01202006|Treatment|treatment
455307|NCT01202006|Primary care|primary care
455308|NCT01201993|syncope|syncope
455309|NCT01201993|evaluation|evaluation
455310|NCT01201993|recurrence|recurrence
455311|NCT01201993|morbidity|morbidity
455312|NCT01201980|essential arterial hypertension|essential arterial hypertension
455313|NCT01201980|calcium antagonist|calcium antagonist
455314|NCT01201967|Collaborative care|collaborative care
455315|NCT01201967|Cardiovascular disease|cardiovascular disease
455316|NCT01201967|Depression|depression
455317|NCT01201967|Anxiety|anxiety
455318|NCT01201954|pain|pain
455319|NCT01201954|sucrose|sucrose
455320|NCT01201954|newborn|newborn
455321|NCT01201954|mechanical ventilation|mechanical ventilation
455322|NCT01201876|Dental Caries|dental caries
455323|NCT01201876|Assessments|assessments
455324|NCT01201876|dental materials|dental materials
455325|NCT01201863|Testosterone|testosterone
455326|NCT01201863|Traumatic Brain Injury|traumatic brain injury
455327|NCT01201863|Hypogonadism|hypogonadism
455328|NCT01201863|Endocrine Dysfunction|endocrine dysfunction
455329|NCT01201863|Low Testosterone in men with new Traumatic Brain Injury|low testosterone in men with new traumatic brain injury
455330|NCT01201850|radiation necrosis|radiation necrosis
455331|NCT01201850|Bevacizumab (Avastin®)|bevacizumab (avastin®)
455332|NCT01201850|Central Nervous System Tumors|central nervous system tumors
455333|NCT01201837|Acute coronary syndrome|acute coronary syndrome
455334|NCT01201837|HDL mimetic|hdl mimetic
455335|NCT01201837|ApoA-I|apoa-i
455336|NCT01201824|lung cancer|lung cancer
455337|NCT01201824|intracavitary ultrasound|intracavitary ultrasound
455338|NCT01201824|pulmonary nodules|pulmonary nodules
455339|NCT01201824|VATS procedures|vats procedures
455340|NCT01201811|Myelodysplastic Syndromes|myelodysplastic syndromes
455341|NCT01201811|Taiwan|taiwan
455342|NCT01201811|Azacitidine|azacitidine
455343|NCT01201811|Vidaza|vidaza
455344|NCT01201811|Celgene|celgene
455345|NCT01201811|Pathologic Processes|pathologic processes
455346|NCT01201811|Neoplasms|neoplasms
455347|NCT01201811|Bone Marrow Diseases|bone marrow diseases
455348|NCT01201811|Hematologic Diseases|hematologic diseases
455349|NCT01201811|Antineoplastic Agents|antineoplastic agents
455350|NCT01201811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic
455351|NCT01201811|Antimetabolites|antimetabolites
455352|NCT01201811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
455353|NCT01201811|Pharmacologic Actions|pharmacologic actions
455354|NCT01201811|Therapeutic Uses|therapeutic uses
455355|NCT01201811|Enzyme inhibitors|enzyme inhibitors
455356|NCT01201785|diabetes mellitus, coronary artery disease, aspirin therapy|diabetes mellitus, coronary artery disease, aspirin therapy
455357|NCT01201772|coronary artery disease|coronary artery disease
455358|NCT01201772|percutaneous coronary revascularization|percutaneous coronary revascularization
455359|NCT01201772|prasugrel therapy|prasugrel therapy
455360|NCT01201759|cardiovascular risk|cardiovascular risk
455361|NCT01201746|Non-surgical periodontal therapy|non-surgical periodontal therapy
455362|NCT01201746|Coronary heart disease (CHD)|coronary heart disease (chd)
455363|NCT01201746|periodontal Disease|periodontal disease
455364|NCT01201746|hsCRP|hscrp
455365|NCT01201746|Fibrinogen|fibrinogen
455366|NCT01201746|WBCs|wbcs
455367|NCT01201720|cirrhosis|cirrhosis
455368|NCT01201720|cirrhotic patients with acute on chronic liver failure|cirrhotic patients with acute on chronic liver failure
455369|NCT01201707|Multiple Sclerosis|multiple sclerosis
455370|NCT01201707|Angioplasty|angioplasty
455371|NCT01201707|Vein|vein
455372|NCT01201694|Advanced malignancies|advanced malignancies
455373|NCT01201694|Surface-controlled water soluble curcumin|surface-controlled water soluble curcumin
455374|NCT01201694|Turmeric|turmeric
455375|NCT01201694|Dietary supplements|dietary supplements
455376|NCT01201681|Post-operative pain|post-operative pain
455377|NCT01201681|intra-operative pain|intra-operative pain
455378|NCT01201681|root canal therapy|root canal therapy
455379|NCT01201681|feasibility|feasibility
455380|NCT01201681|post-surgical persistent pain|post-surgical persistent pain
455381|NCT01201668|post-operative pain|post-operative pain
455382|NCT01201668|root canal therapy|root canal therapy
455383|NCT01201668|feasibility|feasibility
455384|NCT01201668|post-surgical persistent pain|post-surgical persistent pain
455385|NCT01201655|Posthepatitic cirrhosis;|posthepatitic cirrhosis;
455386|NCT01201655|Hepatocarcinogenesis;|hepatocarcinogenesis;
455387|NCT01201655|Splenectomy;|splenectomy;
455388|NCT01201642|Bell's palsy|bell's palsy
455389|NCT01201642|Prednisolone|prednisolone
455390|NCT01201642|acupuncture|acupuncture
455391|NCT01201629|Ischemic Strokes|ischemic strokes
455392|NCT01201629|t DC stimulation|t dc stimulation
455393|NCT01201629|Functional recovery|functional recovery
455394|NCT01201616|Cognitive function|cognitive function
455395|NCT01201616|mood|mood
455396|NCT01201616|women|women
455397|NCT01201616|high fat diet|high fat diet
455398|NCT01201616|high carbohydrate diet|high carbohydrate diet
455399|NCT01201603|Women|women
455400|NCT01201603|Orange Juice|orange juice
455401|NCT01201603|Insulin Resistance|insulin resistance
455402|NCT01201603|Obesity|obesity
455403|NCT01201590|Insulin resistance|insulin resistance
455404|NCT01201590|obesity|obesity
455405|NCT01201590|cocoa|cocoa
455406|NCT01201590|women|women
455407|NCT01201577|Quorum sensing|quorum sensing
455408|NCT01201577|Prebiotics|prebiotics
455409|NCT01201577|Probiotics|probiotics
455410|NCT01201577|Sepsis|sepsis
455411|NCT01201564|umbilical hernia,|umbilical hernia,
455412|NCT01201564|wound complications,|wound complications,
455413|NCT01201564|mesh repair, IPOM,|mesh repair, ipom,
455414|NCT01201564|quality of life,|quality of life,
455415|NCT01201564|sublay mesh repair,|sublay mesh repair,
455416|NCT01201564|recurrence rate|recurrence rate
455417|NCT01201551|Alphagan|alphagan
455418|NCT01201551|Xalatan|xalatan
455419|NCT01201551|corneal temperature|corneal temperature
455420|NCT01201551|primary vascular dysregulation|primary vascular dysregulation
455421|NCT01201512|TMJD pain|tmjd pain
455422|NCT01201512|feasibility|feasibility
455423|NCT01201486|Ultrasound|ultrasound
455424|NCT01201486|Pregnancy|pregnancy
455425|NCT01201486|Fetal heart defects|fetal heart defects
455426|NCT01201486|Color doppler|color doppler
455427|NCT01201473|effect of participation|effect of participation
455428|NCT01201473|effect of association|effect of association
455429|NCT01201460|glucose testing|glucose testing
455430|NCT01201447|Assessment|assessment
455431|NCT01201447|Questionable Caries|questionable caries
455432|NCT01201434|cystic fibrosis|cystic fibrosis
455433|NCT01201434|probiotics|probiotics
455434|NCT01201434|pulmonary|pulmonary
455435|NCT01201434|infections|infections
455436|NCT01201421|patient satisfaction|patient satisfaction
455437|NCT01201421|assessments|assessments
455438|NCT01201421|dental caries|dental caries
455439|NCT01201421|dental materials|dental materials
455440|NCT01201408|Dental Caries|dental caries
455441|NCT01201408|Assessments|assessments
455442|NCT01201408|dental materials|dental materials
455443|NCT01201395|Dental Caries|dental caries
455444|NCT01201395|Assessment|assessment
455445|NCT01201395|dental materials|dental materials
455446|NCT01201382|Depression|depression
455447|NCT01201382|Prevention|prevention
455448|NCT01201382|Adolescents|adolescents
455449|NCT01201369|Percutaneous Coronary Intervention|percutaneous coronary intervention
455450|NCT01201369|Coronary Artery Stenosis|coronary artery stenosis
455451|NCT01201369|Acute Myocardial Infarction|acute myocardial infarction
455452|NCT01201369|Coronary Artery Stent|coronary artery stent
455453|NCT01201369|Optical Coherence Tomography|optical coherence tomography
455454|NCT01201356|Fingolimod|fingolimod
455455|NCT01201356|FTY720|fty720
455456|NCT01201356|Relapsing forms of MS|relapsing forms of ms
455457|NCT01201356|Multiple Sclerosis|multiple sclerosis
455458|NCT01201356|Efficacy|efficacy
455459|NCT01201343|Multiple sclerosis, relapsing, remitting|multiple sclerosis, relapsing, remitting
455460|NCT01201343|Interferon-beta|interferon-beta
455462|NCT01201317|Analgesic effect|analgesic effect
455463|NCT01201304|Anxiety sensitivity|anxiety sensitivity
455464|NCT01201304|Panic|panic
455465|NCT01201291|TBI|tbi
455466|NCT01201291|Normobaric hyperoxia|normobaric hyperoxia
455467|NCT01201291|Outcome|outcome
455468|NCT01201291|GOS|gos
455469|NCT01201291|GOSE|gose
455470|NCT01201278|intranasal insulin|intranasal insulin
455471|NCT01201252|children|children
455472|NCT01201252|gastroenteritis|gastroenteritis
455473|NCT01201252|Rotavirus|rotavirus
455474|NCT01201239|raltegravir|raltegravir
455475|NCT01201239|HIV-1|hiv-1
455476|NCT01201239|drug resistance|drug resistance
455477|NCT01201226|Primordial ovarian follicles|primordial ovarian follicles
455478|NCT01201226|PTEN|pten
455479|NCT01201226|PI3K activating peptide|pi3k activating peptide
455480|NCT01201226|Low ovarian reserve|low ovarian reserve
455481|NCT01201226|Gonadotrophins|gonadotrophins
455482|NCT01201213|Bupivacaine|bupivacaine
455483|NCT01201213|levobupivacaine|levobupivacaine
455484|NCT01201213|ropivacaine|ropivacaine
455485|NCT01201200|Obstructive Sleep Apnea|obstructive sleep apnea
455486|NCT01201200|Right Ventricular Function|right ventricular function
455487|NCT01201200|Pulmonary Hypertension|pulmonary hypertension
455488|NCT01201187|ADHD(Attention Deficit Hyperactivity Disorder)|adhd(attention deficit hyperactivity disorder)
455489|NCT01201174|Hemolysis in Patients with Hereditary Spherocytosis|hemolysis in patients with hereditary spherocytosis
455490|NCT01201174|with documented family history of HS.|with documented family history of hs.
455491|NCT01201174|spherocyte morphology,|spherocyte morphology,
455492|NCT01201174|splenomegaly and non-immune mediated hemolysis.|splenomegaly and non-immune mediated hemolysis.
455493|NCT01201161|Diabetic Retinopathy|diabetic retinopathy
455494|NCT01201161|Retinal detachment|retinal detachment
455495|NCT01201161|Vitreous Hemorrhage|vitreous hemorrhage
455496|NCT01201161|Preoperative Ranibizumab|preoperative ranibizumab
455497|NCT01201161|pars plana vitrectomy|pars plana vitrectomy
455498|NCT01201148|depression|depression
455499|NCT01201148|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
455500|NCT01201148|random noise stimulation|random noise stimulation
455501|NCT01201148|oscillatory tDCS|oscillatory tdcs
455502|NCT01201148|intermittent tDCS|intermittent tdcs
455503|NCT01201122|Pediatric|pediatric
455504|NCT01201122|Ulcerative colitis|ulcerative colitis
455505|NCT01201122|5-ASA|5-asa
455506|NCT01201122|Mesalamine|mesalamine
455507|NCT01201122|Dosing|dosing
455508|NCT01201109|Carpal tunnel syndrome|carpal tunnel syndrome
455509|NCT01201109|Entrapment neuropathies|entrapment neuropathies
455510|NCT01201109|Diabetes|diabetes
455511|NCT01201096|neuroendocrine tumor|neuroendocrine tumor
455512|NCT01201096|liver metastasis|liver metastasis
455513|NCT01201096|peptide receptor therapy|peptide receptor therapy
455514|NCT01201096|gastro-entero-pancreatic system|gastro-entero-pancreatic system
455515|NCT01201057|SPL7013|spl7013
455516|NCT01201057|VivaGel|vivagel
455517|NCT01201057|bacterial vaginosis|bacterial vaginosis
455518|NCT01201057|BV|bv
455519|NCT01201044|BAI|bai
455520|NCT01201044|3DCRT|3dcrt
455521|NCT01201031|for the active surveillance of VRE colinization and infection|for the active surveillance of vre colinization and infection
455522|NCT01201018|Tumor|tumor
455523|NCT01201018|cancer|cancer
455524|NCT01201018|metastasis|metastasis
455525|NCT01200992|Urinary Bladder Neoplasms|urinary bladder neoplasms
455526|NCT01200992|Neoplasms|neoplasms
455527|NCT01200992|Urologic Neoplasms|urologic neoplasms
455528|NCT01200992|Urogenital Neoplasms|urogenital neoplasms
455529|NCT01200992|Neoplasms by Site|neoplasms by site
455530|NCT01200992|Urinary Bladder Diseases|urinary bladder diseases
455531|NCT01200992|Urologic Diseases|urologic diseases
455532|NCT01200992|Mycobacterial cell wall DNA complex|mycobacterial cell wall dna complex
455533|NCT01200992|Intravesical drug administration|intravesical drug administration
455534|NCT01200979|Cytokine|cytokine
455535|NCT01200979|Lymphocyte|lymphocyte
455536|NCT01200979|Toll-Like Receptor|toll-like receptor
455537|NCT01200979|NK Cell|nk cell
455538|NCT01200979|Innate Immunity|innate immunity
455539|NCT01200979|Pregnancy|pregnancy
455540|NCT01200979|Immune Function|immune function
455541|NCT01200966|Essential Tremor|essential tremor
455542|NCT01200966|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
455543|NCT01200966|Ethanol|ethanol
455544|NCT01200966|Alcohol|alcohol
455545|NCT01200966|Alcohol Clamp|alcohol clamp
455546|NCT01200966|ET|et
455547|NCT01200953|Select Agents|select agents
455548|NCT01200953|Biosafety|biosafety
455549|NCT01200953|Bioterrorism|bioterrorism
455550|NCT01200953|SCSU (Special Clinical Studies Unit)|scsu (special clinical studies unit)
455551|NCT01200953|Infectious Disease|infectious disease
455552|NCT01200953|Bioterrorism-Related Illness|bioterrorism-related illness
455553|NCT01200940|GLP-1|glp-1
455554|NCT01200940|Glucose Tolerance|glucose tolerance
455555|NCT01200940|Gut Hormones|gut hormones
455556|NCT01200940|Gastric Bypass|gastric bypass
455557|NCT01200940|Roux-en-Y|roux-en-y
455558|NCT01200940|Bariatric Surgery|bariatric surgery
455559|NCT01200927|infant|infant
455560|NCT01200927|sitting|sitting
455561|NCT01200927|postural control|postural control
455562|NCT01200914|Hemodialysis|hemodialysis
455563|NCT01200914|Fistula|fistula
455564|NCT01200914|Angiograph|angiograph
455565|NCT01200914|Angiogram|angiogram
455566|NCT01200901|depression|depression
455567|NCT01200901|healthy|healthy
455568|NCT01200875|PRP|prp
455569|NCT01200875|platelet rich plasma|platelet rich plasma
455570|NCT01200875|platelet|platelet
455571|NCT01200875|growth hormone|growth hormone
455572|NCT01200875|tendonitis|tendonitis
455573|NCT01200875|tendinosis|tendinosis
455574|NCT01200875|tendinopathy|tendinopathy
455575|NCT01200875|enthesopathy|enthesopathy
455576|NCT01200875|muscle|muscle
455577|NCT01200875|sport|sport
455578|NCT01200875|tendon|tendon
455579|NCT01200862|Obese|obese
455580|NCT01200862|obesity|obesity
455581|NCT01200862|hypogonadism|hypogonadism
455582|NCT01200862|hypogonadotropic|hypogonadotropic
455583|NCT01200862|hyperestrogenemic|hyperestrogenemic
455584|NCT01200862|testosterone|testosterone
455585|NCT01200862|hypogonadal|hypogonadal
455586|NCT01200836|Statins|statins
455587|NCT01200836|Immune Modulation|immune modulation
455588|NCT01200836|Healthy Volunteer|healthy volunteer
455589|NCT01200823|Laboratory Research|laboratory research
455590|NCT01200823|Biologic Samples|biologic samples
455591|NCT01200823|Tissue Collection|tissue collection
455592|NCT01200823|Tissue Procurement|tissue procurement
455593|NCT01200771|FDG-PET/CT|fdg-pet/ct
455594|NCT01200771|FUO|fuo
455595|NCT01200771|Chronic Inflammatory syndrome|chronic inflammatory syndrome
455596|NCT01200771|Fever of unknown origin|fever of unknown origin
455597|NCT01200745|neck pain|neck pain
455598|NCT01200745|capsaicin|capsaicin
455599|NCT01200745|dermal patch|dermal patch
455600|NCT01200732|Tadalafil|tadalafil
455601|NCT01200732|phosphodiesterase-5 inhibitor|phosphodiesterase-5 inhibitor
455602|NCT01200732|Eisenmenger syndrome|eisenmenger syndrome
455603|NCT01200719|brain electrical stimulation|brain electrical stimulation
455604|NCT01200719|sub-acute post-stroke|sub-acute post-stroke
455605|NCT01200719|rehabilitation|rehabilitation
455606|NCT01200706|children aged under 5 years|children aged under 5 years
455607|NCT01200706|Non-severe|non-severe
455608|NCT01200693|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
455609|NCT01200693|Drug-Eluting Stents|drug-eluting stents
455610|NCT01200680|Pediatric and Adult|pediatric and adult
455611|NCT01200680|Gene Identification|gene identification
455612|NCT01200680|Rare Bone Cancer|rare bone cancer
455613|NCT01200680|All Chordoma Sites|all chordoma sites
455614|NCT01200680|Sporadic Chordoma|sporadic chordoma
455615|NCT01200680|Bone Cancer|bone cancer
455616|NCT01200654|Population pharmacokinetics|population pharmacokinetics
455617|NCT01200654|Linezolid|linezolid
455618|NCT01200654|Monolix|monolix
455619|NCT01200654|nonlinear mixed effects models|nonlinear mixed effects models
455620|NCT01200641|melatonin|melatonin
455621|NCT01200641|gabapentin|gabapentin
455622|NCT01200641|anxiety|anxiety
455623|NCT01200641|pain|pain
455624|NCT01200641|retrobulbar block|retrobulbar block
455625|NCT01200628|posttraumatic stress disorder|posttraumatic stress disorder
455626|NCT01200628|acute PTSD|acute ptsd
455627|NCT01200628|PTSD|ptsd
455628|NCT01200628|motor vehicle accident|motor vehicle accident
455629|NCT01200615|nocebo side-effects SSRI informed consent|nocebo side-effects ssri informed consent
455630|NCT01200589|Randomized trial|randomized trial
455631|NCT01200589|Ofatumumab|ofatumumab
455632|NCT01200589|Rituximab|rituximab
455633|NCT01200589|Indolent B-Cell Non Hodgkin Lymphoma|indolent b-cell non hodgkin lymphoma
455634|NCT01200576|CRF: Case Report Form|crf: case report form
455635|NCT01200576|DM: Data Management|dm: data management
455636|NCT01200576|FHI: FHI (formerly known as Family Health International)|fhi: fhi (formerly known as family health international)
455637|NCT01200576|IRB: Institutional Review Board|irb: institutional review board
455638|NCT01200576|IUD: Intra-uterine Device|iud: intra-uterine device
455639|NCT01200576|LTPM: Long-term and Permanent Contraceptive Methods|ltpm: long-term and permanent contraceptive methods
455640|NCT01200576|MSI: Marie Stopes International|msi: marie stopes international
455641|NCT01200576|MSM: Marie Stopes Madagascar|msm: marie stopes madagascar
455642|NCT01200576|PHSC: Protection of Human Subjects Committee|phsc: protection of human subjects committee
455643|NCT01200576|PI: Principal Investigator|pi: principal investigator
455644|NCT01200576|SAE: Serious Adverse Event|sae: serious adverse event
455645|NCT01200576|Sino-Implant (II)|sino-implant (ii)
455646|NCT01200576|SOP: Standard Operating Procedure|sop: standard operating procedure
455647|NCT01200576|Zarin|zarin
455648|NCT01200563|MIST Therapy|mist therapy
455649|NCT01200563|Negative Pressure Wound Therapy|negative pressure wound therapy
455650|NCT01200563|Wound care in long-term acute care hospital|wound care in long-term acute care hospital
455651|NCT01200563|Wound care in skilled nursing facility setting|wound care in skilled nursing facility setting
455652|NCT01200550|Gastroesophageal reflux disease|gastroesophageal reflux disease
455653|NCT01200550|GERD Impact Scale|gerd impact scale
455655|NCT01200537|poor responders|poor responders
455656|NCT01200537|follicle synchrony|follicle synchrony
455657|NCT01200537|IVF response|ivf response
455658|NCT01200537|estrogen|estrogen
455659|NCT01200537|estradiol (E2)|estradiol (e2)
455660|NCT01200537|oral contraceptive pill (OCP)|oral contraceptive pill (ocp)
455661|NCT01200537|birth control pill (BCP)|birth control pill (bcp)
455662|NCT01200524|Analgesic effect|analgesic effect
455663|NCT01200511|intraocular lens|intraocular lens
455664|NCT01200511|multifocal|multifocal
455665|NCT01200511|toric|toric
455666|NCT01200498|Primary Polycythemia Vera|primary polycythemia vera
455667|NCT01200498|Post Polycythemia Vera|post polycythemia vera
455668|NCT01200498|Post Essential Thrombocythemia Myelofibrosis|post essential thrombocythemia myelofibrosis
455669|NCT01200498|SB939|sb939
455670|NCT01200498|PMF|pmf
455671|NCT01200498|post-PV MF|post-pv mf
455672|NCT01200498|post-ET MF|post-et mf
455673|NCT01200485|Supportive Care|supportive care
455674|NCT01200485|Recombinant urate oxidase|recombinant urate oxidase
455675|NCT01200485|Chemotherapy|chemotherapy
455676|NCT01200485|Tumor Lysis Syndrome (TLS)|tumor lysis syndrome (tls)
455677|NCT01200485|Hematologic malignancies|hematologic malignancies
455678|NCT01200485|Acute myeloid leukemia|acute myeloid leukemia
455679|NCT01200472|EHOA|ehoa
455680|NCT01200459|Obesity|obesity
455681|NCT01200459|Weight Loss|weight loss
455682|NCT01200459|Healthy Lifestyle|healthy lifestyle
455683|NCT01200459|Social|social
455684|NCT01200459|Mobile|mobile
455685|NCT01200459|Facebook|facebook
455686|NCT01200459|Text Messages|text messages
455687|NCT01200446|Asthma|asthma
455688|NCT01200446|Exercise-Induced Bronchoconstriction|exercise-induced bronchoconstriction
455689|NCT01200446|Inflammation|inflammation
455690|NCT01200446|Airway|airway
455691|NCT01200446|Fish Oil|fish oil
455692|NCT01200446|Docosahexaenoic Acid|docosahexaenoic acid
455693|NCT01200446|DHA|dha
455694|NCT01200433|dexmedetomidine|dexmedetomidine
455695|NCT01200433|propofol|propofol
455696|NCT01200433|cerebral blood flow|cerebral blood flow
455697|NCT01200433|brain oxygenation|brain oxygenation
455698|NCT01200420|Antisense|antisense
455699|NCT01200420|miR-122 antagonist|mir-122 antagonist
455700|NCT01200420|host factor|host factor
455701|NCT01200420|CHC|chc
455702|NCT01200407|Hypertension|hypertension
455703|NCT01200407|fixed drug combination|fixed drug combination
455704|NCT01200407|Filipinos|filipinos
455705|NCT01200407|Amlodipine|amlodipine
455706|NCT01200407|Olmesartan medoxomil|olmesartan medoxomil
455707|NCT01200407|uncontrolled hypertension|uncontrolled hypertension
455708|NCT01200407|difficult to treat hypertension|difficult to treat hypertension
455709|NCT01200394|Diabetic nephropathy|diabetic nephropathy
455710|NCT01200394|chronic kidney disease|chronic kidney disease
455711|NCT01200394|PF-00489791|pf-00489791
455712|NCT01200394|phosphodiesterase|phosphodiesterase
455713|NCT01200394|PDE5|pde5
455714|NCT01200381|ICD|icd
455715|NCT01200381|CRTD|crtd
455716|NCT01200381|Remote care|remote care
455717|NCT01200381|Remote monitoring|remote monitoring
455718|NCT01200381|Heart failure|heart failure
455719|NCT01200368|vaccine|vaccine
455720|NCT01200368|pneumococcal conjugate|pneumococcal conjugate
455721|NCT01200355|MICAFUNGIN|micafungin
455722|NCT01200355|POSACONAZOLE|posaconazole
455723|NCT01200355|antifungal|antifungal
455724|NCT01200355|prolonged neutropenia|prolonged neutropenia
455725|NCT01200355|10-038|10-038
455726|NCT01200342|Uveal melanoma|uveal melanoma
455727|NCT01200342|Carboplatin|carboplatin
455728|NCT01200342|Genasense|genasense
455729|NCT01200342|Paclitaxel|paclitaxel
455730|NCT01200342|oblimersen|oblimersen
455731|NCT01200342|GCP|gcp
455732|NCT01200329|Hodgkin's disease|hodgkin's disease
455733|NCT01200329|Relapsed|relapsed
455734|NCT01200329|Refractory|refractory
455735|NCT01200329|High-dose chemotherapy|high-dose chemotherapy
455736|NCT01200329|Busulfan|busulfan
455737|NCT01200329|Gemcitabine|gemcitabine
455738|NCT01200329|Melphalan|melphalan
455739|NCT01200316|Colon Cancer|colon cancer
455740|NCT01200316|Abdominal Surgery|abdominal surgery
455741|NCT01200316|Stress|stress
455742|NCT01200316|Rocking Motion|rocking motion
455743|NCT01200316|Salivary Cortisol|salivary cortisol
455744|NCT01200316|Postoperative Ileus|postoperative ileus
455745|NCT01200303|colon cancer|colon cancer
455746|NCT01200303|adenomatous colonic polyps|adenomatous colonic polyps
455747|NCT01200303|colon screening|colon screening
455748|NCT01200303|CT Colonography (Virtual Colonoscopy)|ct colonography (virtual colonoscopy)
455749|NCT01200303|Computer Aided Detection|computer aided detection
455750|NCT01200303|Electronic Cleansing|electronic cleansing
455751|NCT01200290|end stage renal disease|end stage renal disease
455752|NCT01200290|end stage kidney disease|end stage kidney disease
455753|NCT01200290|ESRD|esrd
455754|NCT01200290|Uremia|uremia
455755|NCT01200290|Renal Dialysis|renal dialysis
455756|NCT01200277|osteoporosis|osteoporosis
455757|NCT01200277|vertebral fracture|vertebral fracture
455758|NCT01200277|vertebroplasty|vertebroplasty
455759|NCT01200277|percutaneous|percutaneous
455760|NCT01200238|STA9090|sta9090
455761|NCT01200238|STA-9090|sta-9090
455762|NCT01200238|HSP90|hsp90
455763|NCT01200212|Palliative Therapy|palliative therapy
455764|NCT01200212|bevacizimab|bevacizimab
455765|NCT01200212|Avastin|avastin
455766|NCT01200212|Xeloda|xeloda
455767|NCT01200212|metastatic breast cancer|metastatic breast cancer
455768|NCT01200212|Progression Free Survival|progression free survival
455769|NCT01200212|Time to Progression|time to progression
455770|NCT01200212|Overall survival|overall survival
455771|NCT01200173|Probiotic - Lactobacillus casei DN-114 001 - dairy|probiotic - lactobacillus casei dn-114 001 - dairy
455772|NCT01200173|product - infections - children|product - infections - children
455773|NCT01200160|Low-Density Lipoprotein Cholesterol|low-density lipoprotein cholesterol
455774|NCT01200160|Hypertriglyceridemia|hypertriglyceridemia
455775|NCT01200160|Latin America|latin america
455776|NCT01200160|Cardiovascular Diseases|cardiovascular diseases
455777|NCT01200160|Cholesterol|cholesterol
455778|NCT01200160|Sedentary Lifestyle|sedentary lifestyle
455779|NCT01200160|High-Density Lipoprotein Cholesterol|high-density lipoprotein cholesterol
455780|NCT01200134|glioma patients : anaplasic glioma (grade III) and GBM (grade IV)|glioma patients : anaplasic glioma (grade iii) and gbm (grade iv)
455781|NCT01200121|Symptomatic malignant ascites due to advanced-stage gastrointestinal cancers|symptomatic malignant ascites due to advanced-stage gastrointestinal cancers
455782|NCT01200108|Severe Asthma, requiring chronic oral steroid use|severe asthma, requiring chronic oral steroid use
455783|NCT01200082|chronic hepatitis C/B|chronic hepatitis c/b
455784|NCT01200082|alcoholic liver disease|alcoholic liver disease
455785|NCT01200082|primary biliary cirrhosis|primary biliary cirrhosis
455786|NCT01200082|primary sclerosing cholangitis|primary sclerosing cholangitis
455787|NCT01200082|progressive familial intrahepatic cholestasis|progressive familial intrahepatic cholestasis
455788|NCT01200069|depression,myalgia|depression,myalgia
455789|NCT01200056|Volumetric virtual histology intravascular ultrasound.|volumetric virtual histology intravascular ultrasound.
455790|NCT01200056|Statin-naive patient.|statin-naive patient.
455791|NCT01200056|Varying doses atorvastatin.|varying doses atorvastatin.
455792|NCT01200056|Clinical outcomes.|clinical outcomes.
455793|NCT01200043|Childhood obesity|childhood obesity
455794|NCT01200043|metabolic syndrome|metabolic syndrome
455795|NCT01200043|insulin resistance|insulin resistance
455796|NCT01200043|intrahepatic fat|intrahepatic fat
455797|NCT01200043|hypertension|hypertension
455798|NCT01200030|Sitting balance|sitting balance
455799|NCT01200030|Stroke|stroke
455800|NCT01200017|T cell depleted|t cell depleted
455801|NCT01200017|Matched unrelated donors|matched unrelated donors
455802|NCT01200017|Haplocompatible donors|haplocompatible donors
455803|NCT01200017|Graft vs Host Disease|graft vs host disease
455804|NCT01200017|Hemoglobinopathies|hemoglobinopathies
455805|NCT01200017|Leukemia|leukemia
455806|NCT01200017|Leukemia, Lymphoid|leukemia, lymphoid
455807|NCT01200017|Precursor Cell Lymphoblastic Leukemia-Lymphoma|precursor cell lymphoblastic leukemia-lymphoma
455808|NCT01200017|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
455809|NCT01200017|Leukemia, Myeloid|leukemia, myeloid
455810|NCT01200017|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
455811|NCT01200017|Lymphoma|lymphoma
455812|NCT01200017|Myelodysplastic Syndromes|myelodysplastic syndromes
455813|NCT01200017|Preleukemia|preleukemia
455814|NCT01200017|Osteopetrosis|osteopetrosis
455815|NCT01200017|Pancytopenia|pancytopenia
455816|NCT01200017|Immune System Diseases|immune system diseases
455817|NCT01200017|Hematologic Diseases|hematologic diseases
455818|NCT01200017|Genetic Diseases, Inborn|genetic diseases, inborn
455819|NCT01200017|Neoplasms by Histologic Type|neoplasms by histologic type
455820|NCT01200017|Neoplasms|neoplasms
455821|NCT01200017|Lymphoproliferative Disorders|lymphoproliferative disorders
455822|NCT01200017|Lymphatic Diseases|lymphatic diseases
455823|NCT01200017|Immunoproliferative Disorders|immunoproliferative disorders
455824|NCT01200017|Myeloproliferative Disorders|myeloproliferative disorders
455825|NCT01200017|Bone Marrow Diseases|bone marrow diseases
455826|NCT01200017|Precancerous Conditions|precancerous conditions
455827|NCT01200017|Osteosclerosis|osteosclerosis
455828|NCT01200017|Osteochondrodysplasias|osteochondrodysplasias
455829|NCT01200017|Bone Diseases, Developmental|bone diseases, developmental
455830|NCT01200017|Bone Diseases|bone diseases
455831|NCT01200017|Musculoskeletal Diseases|musculoskeletal diseases
455832|NCT01200017|Severe acquired and congenital cytopenias|severe acquired and congenital cytopenias
455833|NCT01200017|White and red blood cell abnormalities|white and red blood cell abnormalities
455834|NCT01200004|Advanced solid tumor|advanced solid tumor
455835|NCT01200004|Azacitidine|azacitidine
455836|NCT01200004|Grifola frondosa|grifola frondosa
455837|NCT01200004|Basidiomycete fungus|basidiomycete fungus
455838|NCT01200004|Lenalidomide|lenalidomide
455839|NCT01199978|radiation|radiation
455840|NCT01199978|fractionated proton radiation|fractionated proton radiation
455841|NCT01199952|contraception|contraception
455842|NCT01199939|Human Immunodeficiency Virus|human immunodeficiency virus
455843|NCT01199939|HIV|hiv
455844|NCT01199939|Etravirine|etravirine
455845|NCT01199939|Darunavir|darunavir
455846|NCT01199939|Prezista|prezista
455847|NCT01199939|Intelence|intelence
455848|NCT01199939|Ritonavir|ritonavir
455849|NCT01199939|INROADS|inroads
455850|NCT01199926|25-hydroxyvitamin D|25-hydroxyvitamin d
455851|NCT01199926|Parathyroid hormone|parathyroid hormone
455852|NCT01199926|Lean mass|lean mass
455853|NCT01199926|Muscular strength|muscular strength
455854|NCT01199926|Glucose tolerance|glucose tolerance
455855|NCT01199913|problems with thinking after surgery;|problems with thinking after surgery;
455856|NCT01199900|Healthy People|healthy people
455857|NCT01199900|Glucocorticoids|glucocorticoids
455858|NCT01199900|Prednisone|prednisone
455859|NCT01199887|safety, biologic effects, IPF, autoimmune|safety, biologic effects, ipf, autoimmune
455860|NCT01199874|Rotavirus|rotavirus
455861|NCT01199874|Rotavirus vaccine|rotavirus vaccine
455862|NCT01199874|Dosing schedule|dosing schedule
455863|NCT01199874|Immunogenicity|immunogenicity
455864|NCT01199874|Breast feeding|breast feeding
455865|NCT01199874|Pakistan|pakistan
455866|NCT01199861|Relapsing multiple sclerosis|relapsing multiple sclerosis
455867|NCT01199861|MS|ms
455868|NCT01199861|Immune response|immune response
455869|NCT01199848|nutrition|nutrition
455870|NCT01199848|polyphenolic|polyphenolic
455871|NCT01199848|strawberry|strawberry
455872|NCT01199848|insulin resistance|insulin resistance
455873|NCT01199848|metabolic syndrome|metabolic syndrome
455874|NCT01199835|obesity|obesity
455875|NCT01199835|metabolic syndrome|metabolic syndrome
455876|NCT01199835|fecal fat excretion|fecal fat excretion
455877|NCT01199835|fecal calcium|fecal calcium
455878|NCT01199835|weight loss|weight loss
455879|NCT01199835|appetite regulation|appetite regulation
455880|NCT01199835|intestinal micro flora|intestinal micro flora
455881|NCT01199835|lipid profile|lipid profile
455882|NCT01199835|energy balance|energy balance
455883|NCT01199783|Diabetic Foot,MRSA,|diabetic foot,mrsa,
455884|NCT01199783|Complicated skin and skin structure infections|complicated skin and skin structure infections
455885|NCT01199783|Antimicrobial therapy|antimicrobial therapy
455886|NCT01199783|Daptomycin|daptomycin
455887|NCT01199770|pasta|pasta
455888|NCT01199770|appetite|appetite
455889|NCT01199770|hunger|hunger
455890|NCT01199770|satiety|satiety
455891|NCT01199770|nutrition|nutrition
455892|NCT01199770|metabolic|metabolic
455893|NCT01199770|gut peptide hormones|gut peptide hormones
455894|NCT01199770|psychological phenomena and processes|psychological phenomena and processes
455895|NCT01199757|ocular symptoms|ocular symptoms
455896|NCT01199757|nasal symptoms|nasal symptoms
455897|NCT01199757|Allergic Rhinitis|allergic rhinitis
455898|NCT01199757|Symptom Free Days|symptom free days
455899|NCT01199757|Quality of Life|quality of life
455900|NCT01199744|Influenza|influenza
455901|NCT01199744|Relenza®|relenza®
455902|NCT01199744|SSMP|ssmp
455903|NCT01199731|raltegravir|raltegravir
455904|NCT01199731|NNRTI|nnrti
455905|NCT01199731|ritonavir|ritonavir
455906|NCT01199731|darunavir|darunavir
455907|NCT01199731|HIV|hiv
455908|NCT01199731|GSK2248761|gsk2248761
455909|NCT01199731|antiretroviral|antiretroviral
455910|NCT01199731|HIV Infection|hiv infection
455911|NCT01199731|HAART|haart
455912|NCT01199718|Multiple myeloma|multiple myeloma
455913|NCT01199718|Plasmacytoma|plasmacytoma
455914|NCT01199705|Immune globulin subcutaneous|immune globulin subcutaneous
455915|NCT01199705|SCIG|scig
455916|NCT01199705|Primary immunodeficiency|primary immunodeficiency
455917|NCT01199705|PID|pid
455918|NCT01199679|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
455919|NCT01199679|Heartburn|heartburn
455920|NCT01199679|Regurgitation|regurgitation
455921|NCT01199679|Dyspepsia|dyspepsia
455922|NCT01199666|Underimmunization, text message, vaccination|underimmunization, text message, vaccination
455923|NCT01199666|Underimmunization|underimmunization
455924|NCT01199653|clavicle fractures|clavicle fractures
455925|NCT01199653|midshaft|midshaft
455926|NCT01199653|dislocated|dislocated
455927|NCT01199653|operative treatment|operative treatment
455928|NCT01199653|conservative treatment|conservative treatment
455929|NCT01199653|non-operative treatment|non-operative treatment
455930|NCT01199653|randomized controlled trial|randomized controlled trial
455931|NCT01199653|bone plates|bone plates
455932|NCT01199627|total hip replacement|total hip replacement
455933|NCT01199627|tranexamic acid|tranexamic acid
455934|NCT01199614|Hypoparathyroidism|hypoparathyroidism
455935|NCT01199614|Hypopara|hypopara
455936|NCT01199614|HPTH|hpth
455937|NCT01199614|Hypocalcemia|hypocalcemia
455938|NCT01199614|Hypercalciuria|hypercalciuria
455939|NCT01199614|PTH|pth
455940|NCT01199614|PTH(1-84)|pth(1-84)
455941|NCT01199588|VLU|vlu
455942|NCT01199588|Venous Leg Ulcers|venous leg ulcers
455943|NCT01199588|Ulcers|ulcers
455944|NCT01199588|chronic wounds|chronic wounds
455945|NCT01199588|wounds|wounds
455946|NCT01199588|Nexagon|nexagon
455947|NCT01199588|CoDa|coda
455948|NCT01199575|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
455949|NCT01199575|CLL|cll
455950|NCT01199575|Relapsed or Refractory|relapsed or refractory
455951|NCT01199575|previously treated|previously treated
455952|NCT01199536|Helicobacter-positive duodenal ulcer|helicobacter-positive duodenal ulcer
455953|NCT01199523|YM178|ym178
455954|NCT01199523|Mirabegron|mirabegron
455955|NCT01199523|QT|qt
455956|NCT01199497|cough, acute rhinitis, nasal congestion, common cold, nasal symptoms, children.|cough, acute rhinitis, nasal congestion, common cold, nasal symptoms, children.
455957|NCT01199497|Nasal congestion and non-productive cough, with or without associate other nasal and extranasal symptoms.|nasal congestion and non-productive cough, with or without associate other nasal and extranasal symptoms.
455958|NCT01199484|Cow's milk allergy|cow's milk allergy
455959|NCT01199484|food allergy|food allergy
455960|NCT01199484|oral desensitization|oral desensitization
455961|NCT01199484|randomized trial|randomized trial
455962|NCT01199484|specific oral tolerance induction.|specific oral tolerance induction.
455963|NCT01199471|Sevoflurane|sevoflurane
455964|NCT01199471|Physician's Practice Patterns|physician's practice patterns
455965|NCT01199471|Economics, Pharmaceutical|economics, pharmaceutical
455966|NCT01199471|Chinese|chinese
455967|NCT01199458|Lower Esophageal Sphincter|lower esophageal sphincter
455968|NCT01199458|Barrier pressure|barrier pressure
455969|NCT01199445|vitamin A deficiency|vitamin a deficiency
455970|NCT01199432|Primary Breast Cancer|primary breast cancer
455971|NCT01199419|multivessel coronary artery disease|multivessel coronary artery disease
455972|NCT01199419|drug-eluting stent|drug-eluting stent
455973|NCT01199419|CABG|cabg
455974|NCT01199419|cost-effectiveness|cost-effectiveness
455975|NCT01199406|gallstone|gallstone
455976|NCT01199406|gallbladder|gallbladder
455977|NCT01199406|cholecystectomy|cholecystectomy
455978|NCT01199406|laparoscopic|laparoscopic
455979|NCT01199406|pain|pain
455980|NCT01199393|breast neoplasm|breast neoplasm
455981|NCT01199393|drug therapy|drug therapy
455982|NCT01199393|polymorphism|polymorphism
455983|NCT01199393|gene|gene
455984|NCT01199380|Smoking, Smoking Cessation|smoking, smoking cessation
455985|NCT01199367|advanced or metastatic breast cancer|advanced or metastatic breast cancer
455986|NCT01199354|Invasive breast carcinoma|invasive breast carcinoma
455987|NCT01199341|Phase 1|phase 1
455988|NCT01199341|Drug-Drug interaction|drug-drug interaction
455989|NCT01199341|warfarin|warfarin
455990|NCT01199341|AZD1981|azd1981
455991|NCT01199328|Nexium|nexium
455992|NCT01199328|aspirin|aspirin
455993|NCT01199328|peptic ulcers|peptic ulcers
455994|NCT01199328|pharmacodynamic (PD)|pharmacodynamic (pd)
455995|NCT01199328|Esomoeprazole|esomoeprazole
455996|NCT01199315|safety|safety
455997|NCT01199315|tolerability|tolerability
455998|NCT01199315|AZD1446|azd1446
456000|NCT01199315|ADHD|adhd
456001|NCT01199315|Japanese|japanese
456002|NCT01199302|Amgen|amgen
456003|NCT01199302|Crohn's|crohn's
456004|NCT01199302|Inflammatory Bowel Disease|inflammatory bowel disease
456005|NCT01199302|IBD|ibd
456006|NCT01199302|Irritable Bowel Syndrome|irritable bowel syndrome
456007|NCT01199302|IBS|ibs
456008|NCT01199302|Inflammation|inflammation
456009|NCT01199302|bowel|bowel
456010|NCT01199302|colon|colon
456011|NCT01199302|gastrointestinal|gastrointestinal
456012|NCT01199289|Amgen|amgen
456013|NCT01199289|chronic inflammatory disease|chronic inflammatory disease
456014|NCT01199289|wheezing|wheezing
456015|NCT01199276|Delirium|delirium
456016|NCT01199276|Hip Fracture|hip fracture
456017|NCT01199276|Elderly|elderly
456018|NCT01199237|Reflex, Pharyngeal|reflex, pharyngeal
456019|NCT01199237|Anesthetics, Inhalation|anesthetics, inhalation
456020|NCT01199224|Solid Tumors|solid tumors
456021|NCT01199224|veliparib|veliparib
456022|NCT01199224|refractory|refractory
456023|NCT01199224|relapsed|relapsed
456024|NCT01199211|hypertrophy, exercise, HDL, lipids, cholesterol|hypertrophy, exercise, hdl, lipids, cholesterol
456025|NCT01199198|Hyponatremia|hyponatremia
456026|NCT01199198|Serum sodium|serum sodium
456027|NCT01199198|Tolvaptan|tolvaptan
456028|NCT01199198|Placebo|placebo
456130|NCT01198743|Plasma|plasma
456131|NCT01198730|DM|dm
456029|NCT01199172|Student teachers with normal or mildly disordered voices|student teachers with normal or mildly disordered voices
456030|NCT01199159|misoprostol|misoprostol
456031|NCT01199159|hysterectomy|hysterectomy
456032|NCT01199159|operative blood loss|operative blood loss
456033|NCT01199159|total abdominal hysterectomy|total abdominal hysterectomy
456034|NCT01199146|Abiraterone acetate|abiraterone acetate
456035|NCT01199120|Omega-3|omega-3
456036|NCT01199120|Cognition|cognition
456037|NCT01199120|Malnourishment|malnourishment
456038|NCT01199107|PTSD|ptsd
456039|NCT01199107|Anxiety|anxiety
456040|NCT01199107|Behavior Therapy|behavior therapy
456041|NCT01199107|Prolonged Exposure|prolonged exposure
456042|NCT01199107|Exercise|exercise
456043|NCT01199107|Wellness|wellness
456044|NCT01199107|Posttraumatic|posttraumatic
456045|NCT01199107|Stress|stress
456046|NCT01199094|low density lipoprotein receptor 5|low density lipoprotein receptor 5
456047|NCT01199094|high bone mass|high bone mass
456048|NCT01199094|autosomal dominant osteopetrosis type I|autosomal dominant osteopetrosis type i
456049|NCT01199094|bone turnover markers|bone turnover markers
456050|NCT01199068|PPAR gamma agonist|ppar gamma agonist
456051|NCT01199068|Tumor|tumor
456052|NCT01199068|Cancer|cancer
456053|NCT01199068|Antineoplastic Agent|antineoplastic agent
456054|NCT01199068|Respiratory Tract Neoplasms|respiratory tract neoplasms
456055|NCT01199068|Erlotinib|erlotinib
456056|NCT01199068|Protein Kinase Inhibitors|protein kinase inhibitors
456057|NCT01199068|Neoplasms|neoplasms
456058|NCT01199055|PPAR gamma agonist|ppar gamma agonist
456059|NCT01199055|Tumor|tumor
456060|NCT01199055|Cancer|cancer
456061|NCT01199055|Antineoplastic Agent|antineoplastic agent
456062|NCT01199055|Respiratory Tract Neoplasms|respiratory tract neoplasms
456063|NCT01199055|Carboplatin|carboplatin
456064|NCT01199055|Paclitaxel|paclitaxel
456065|NCT01199055|Neoplasms|neoplasms
456066|NCT01199029|Healthy People|healthy people
456067|NCT01199029|Glucocorticoids|glucocorticoids
456068|NCT01199029|Prednisone|prednisone
456069|NCT01199016|Acute otitis media|acute otitis media
456070|NCT01199016|Prevnar 13|prevnar 13
456071|NCT01199016|Streptococcus pneumoniae|streptococcus pneumoniae
456072|NCT01199016|nasopharyngeal colonization.|nasopharyngeal colonization.
456073|NCT01198977|multiple sclerosis|multiple sclerosis
456074|NCT01198977|Fatigue|fatigue
456075|NCT01198977|exercise|exercise
456076|NCT01198977|telemedicine|telemedicine
456077|NCT01198977|motivational interviewing|motivational interviewing
456078|NCT01198977|counseling|counseling
456079|NCT01198977|depression|depression
456080|NCT01198977|physical activity|physical activity
456081|NCT01198964|ECoG|ecog
456082|NCT01198964|Epilepsy|epilepsy
456083|NCT01198964|cortical|cortical
456084|NCT01198964|stimulation|stimulation
456085|NCT01198964|Electrocorticography|electrocorticography
456086|NCT01198964|electrodes|electrodes
456087|NCT01198964|mapping|mapping
456088|NCT01198938|Cardiac surgery, delirium, melatonin|cardiac surgery, delirium, melatonin
456089|NCT01198925|Infectious disease|infectious disease
456090|NCT01198925|piperacillin|piperacillin
456091|NCT01198925|continuous infusion|continuous infusion
456092|NCT01198925|extended infusion|extended infusion
456093|NCT01198912|rhinosinusitis|rhinosinusitis
456094|NCT01198912|doxycycline|doxycycline
456095|NCT01198912|Chronic rhinosinusitis with or without nasal polyps|chronic rhinosinusitis with or without nasal polyps
456096|NCT01198899|Fabry-Anderson disease|fabry-anderson disease
456097|NCT01198899|gen mutation|gen mutation
456098|NCT01198899|left ventricular hypertrophy|left ventricular hypertrophy
456099|NCT01198886|Mobility disability|mobility disability
456100|NCT01198886|Older adults|older adults
456101|NCT01198886|Physical activity|physical activity
456102|NCT01198886|Nutritional status|nutritional status
456103|NCT01198860|HBsAg|hbsag
456104|NCT01198847|child overweight|child overweight
456105|NCT01198847|child obesity|child obesity
456106|NCT01198847|prevention|prevention
456107|NCT01198847|targeted intervention|targeted intervention
456108|NCT01198847|development of overweight|development of overweight
456109|NCT01198834|ankle sprains|ankle sprains
456110|NCT01198821|pancreas|pancreas
456111|NCT01198821|adenocarcinoma|adenocarcinoma
456112|NCT01198821|metastatic|metastatic
456113|NCT01198821|unresectable|unresectable
456114|NCT01198808|Bladder cancer|bladder cancer
456115|NCT01198808|chemotherapy|chemotherapy
456116|NCT01198808|T cells|t cells
456117|NCT01198808|Immunotherapy|immunotherapy
456118|NCT01198808|Tumor-specific immunity in bladder cancer|tumor-specific immunity in bladder cancer
456119|NCT01198795|depression|depression
456120|NCT01198795|major depressive disorder|major depressive disorder
456121|NCT01198795|escitalopram|escitalopram
456122|NCT01198795|Lexapro|lexapro
456123|NCT01198795|pediatric|pediatric
456124|NCT01198769|Human rotavirus vaccine|human rotavirus vaccine
456125|NCT01198756|Influenza|influenza
456126|NCT01198743|Genetics modifications|genetics modifications
456127|NCT01198743|colorectal cancer|colorectal cancer
456128|NCT01198743|prognosis aim|prognosis aim
456129|NCT01198743|DNA|dna
456132|NCT01198730|CAD|cad
456133|NCT01198730|Meal tolerance test|meal tolerance test
456134|NCT01198730|Acarbose|acarbose
456135|NCT01198704|Hepatocellular carcinoma|hepatocellular carcinoma
456136|NCT01198704|Cirrhosis|cirrhosis
456137|NCT01198704|Transplantation|transplantation
456138|NCT01198691|metallic staples|metallic staples
456139|NCT01198691|absorbable staples|absorbable staples
456140|NCT01198691|Cesarean Delivery|cesarean delivery
456141|NCT01198665|RAD001|rad001
456142|NCT01198665|chemotherpy|chemotherpy
456143|NCT01198665|T cell lymphoma|t cell lymphoma
456144|NCT01198626|community-acquired bacterial pneumonia|community-acquired bacterial pneumonia
456145|NCT01198626|CABP|cabp
456146|NCT01198626|CAP|cap
456147|NCT01198626|pneumonia|pneumonia
456148|NCT01198626|pneumonia, bacterial|pneumonia, bacterial
456149|NCT01198626|bacterial infections|bacterial infections
456150|NCT01198626|anti-bacterial agents|anti-bacterial agents
456151|NCT01198626|anti-infective agents|anti-infective agents
456152|NCT01198626|lung disease, interstitial|lung disease, interstitial
456153|NCT01198626|respiratory tract diseases|respiratory tract diseases
456154|NCT01198626|respiratory tract infections|respiratory tract infections
456155|NCT01198626|community-acquired infections|community-acquired infections
456156|NCT01198613|Ragweed allergy|ragweed allergy
456157|NCT01198613|Rhinoconjunctivitis|rhinoconjunctivitis
456158|NCT01198613|Exposure chamber|exposure chamber
456159|NCT01198613|Immunotherapy|immunotherapy
456160|NCT01198613|ToleroMune Ragweed|toleromune ragweed
456161|NCT01198587|Diarrhea|diarrhea
456162|NCT01198587|Gastroenteritis|gastroenteritis
456163|NCT01198587|Zinc Supplementation|zinc supplementation
456164|NCT01198574|anemia|anemia
456165|NCT01198574|iron supplementation|iron supplementation
456166|NCT01198574|sub-clinical inflammation|sub-clinical inflammation
456167|NCT01198574|adolescents|adolescents
456168|NCT01198561|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
456169|NCT01198561|Major Depressive Disorder|major depressive disorder
456170|NCT01198522|Interleukin, IL2, Gemcitabine, monoclonal, antibody, cytokine, tumour targeting, dose finding, fusion protein, Pancreatic cancer,|interleukin, il2, gemcitabine, monoclonal, antibody, cytokine, tumour targeting, dose finding, fusion protein, pancreatic cancer,
456171|NCT01198522|L19|l19
456172|NCT01198509|rheumatoid arthritis|rheumatoid arthritis
456173|NCT01198509|psoriatic arthritis|psoriatic arthritis
456174|NCT01198509|periodontitis|periodontitis
456175|NCT01198509|microbiota|microbiota
456176|NCT01198509|microbiome|microbiome
456177|NCT01198509|vancomycin|vancomycin
456178|NCT01198509|doxycycline|doxycycline
456179|NCT01198509|T cell|t cell
456180|NCT01198509|Th17|th17
456181|NCT01198496|hypertension|hypertension
456182|NCT01198496|stroke|stroke
456183|NCT01198496|blood pressure|blood pressure
456184|NCT01198483|refraction|refraction
456185|NCT01198483|refractive error|refractive error
456186|NCT01198483|combined surgery|combined surgery
456187|NCT01198483|microincision|microincision
456188|NCT01198483|smallincision|smallincision
456189|NCT01198483|cataract surgery|cataract surgery
456190|NCT01198483|vitrectomy|vitrectomy
456191|NCT01198470|Low back pain|low back pain
456192|NCT01198470|Leg pain|leg pain
456193|NCT01198470|Discogenic pain|discogenic pain
456194|NCT01198470|Degenerative Disc Disease (DDD)|degenerative disc disease (ddd)
456195|NCT01198470|Herniated disc|herniated disc
456196|NCT01198470|Radiculopathy|radiculopathy
456197|NCT01198457|Clodronate|clodronate
456198|NCT01198457|Compliance|compliance
456199|NCT01198444|Contraception|contraception
456200|NCT01198444|Compliance|compliance
456201|NCT01198431|Appetite regulation|appetite regulation
456202|NCT01198431|Physical activity|physical activity
456203|NCT01198431|Energy balance|energy balance
456204|NCT01198418|STI|sti
456205|NCT01198418|MSM|msm
456206|NCT01198418|HIV|hiv
456207|NCT01198418|Prevention|prevention
456208|NCT01198418|Men having sex with men|men having sex with men
456209|NCT01198405|coronary artery disease|coronary artery disease
456210|NCT01198405|enhanced external counterpulsation|enhanced external counterpulsation
456211|NCT01198392|gastric cancer|gastric cancer
456212|NCT01198379|aspirin|aspirin
456213|NCT01198379|aspirin resistance|aspirin resistance
456214|NCT01198379|hemodialysis|hemodialysis
456215|NCT01198379|cardiovascular|cardiovascular
456216|NCT01198379|Prevalence of aspirin resistance, cardiovascular events, and safety profile|prevalence of aspirin resistance, cardiovascular events, and safety profile
456217|NCT01198366|Tuberculosis|tuberculosis
456218|NCT01198366|Vaccine|vaccine
456219|NCT01198366|Immunogenicity|immunogenicity
456220|NCT01198366|Prevention of Tuberculosis|prevention of tuberculosis
456221|NCT01198353|Schizophrenia|schizophrenia
456222|NCT01198353|Schizoaffective Disorder|schizoaffective disorder
456223|NCT01198353|Ziprasidone|ziprasidone
456224|NCT01198353|Switch|switch
456225|NCT01198353|Metabolic syndrome|metabolic syndrome
456226|NCT01198327|RVO|rvo
456227|NCT01198327|CRVO|crvo
456228|NCT01198327|BRVO|brvo
456229|NCT01198327|Horizon|horizon
456230|NCT01198327|Bravo|bravo
456231|NCT01198327|Cruise|cruise
456232|NCT01198314|long term|long term
456233|NCT01198314|stable|stable
456234|NCT01198314|recipients|recipients
456235|NCT01198301|Metastatic Breast Neoplasms|metastatic breast neoplasms
456236|NCT01198301|Gene Expression Profiling|gene expression profiling
456237|NCT01198301|Drug Therapy|drug therapy
456238|NCT01198288|COPD|copd
456239|NCT01198288|Respiratory Physiotherapy|respiratory physiotherapy
456240|NCT01198275|PUFA atrial fibrillation|pufa atrial fibrillation
456241|NCT01198262|polymerase chain reaction|polymerase chain reaction
456242|NCT01198236|hematological malignancy|hematological malignancy
456243|NCT01198236|previous proven or probable invasive fungal infection|previous proven or probable invasive fungal infection
456244|NCT01198223|denture stomatitis|denture stomatitis
456245|NCT01198223|nystatin|nystatin
456246|NCT01198223|garlic|garlic
456247|NCT01198210|pain|pain
456248|NCT01198210|tonsillectomy|tonsillectomy
456249|NCT01198210|peritonsillar infiltration|peritonsillar infiltration
456250|NCT01198210|postoperative pain|postoperative pain
456251|NCT01198197|Nociceptin/Orphanin FQ Peptide (NOP)|nociceptin/orphanin fq peptide (nop)
456252|NCT01198197|PET Imaging|pet imaging
456253|NCT01198197|Brain Imaging|brain imaging
456254|NCT01198197|Healthy Volunteer|healthy volunteer
456255|NCT01198197|HV|hv
456256|NCT01198145|diarrhea|diarrhea
456257|NCT01198145|gastrointestinal complications|gastrointestinal complications
456258|NCT01198145|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
456259|NCT01198132|Multiple Sclerosis Relapsing-Remitting|multiple sclerosis relapsing-remitting
456260|NCT01198132|Relapsing Multiple Sclerosis (RMS)|relapsing multiple sclerosis (rms)
456261|NCT01198132|Rebif|rebif
456262|NCT01198132|Vitamin D3|vitamin d3
456263|NCT01198132|Cholecalciferol|cholecalciferol
456264|NCT01198119|oral cavity tumor|oral cavity tumor
456265|NCT01198119|narrow band imaging|narrow band imaging
456266|NCT01198119|subclinical cancer lesion|subclinical cancer lesion
456267|NCT01198106|simulator sickness|simulator sickness
456268|NCT01198106|scopolamine|scopolamine
456269|NCT01198106|cinnarizine|cinnarizine
456270|NCT01198093|Alzheimer's disease|alzheimer's disease
456271|NCT01198093|Mild Cognitive Impairment|mild cognitive impairment
456272|NCT01198093|cohort study|cohort study
456273|NCT01198080|Avascular osteonecrosis,CD133+,core decompression|avascular osteonecrosis,cd133+,core decompression
456274|NCT01198067|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
456275|NCT01198067|B-cell lymphoproliferative disorder|b-cell lymphoproliferative disorder
456276|NCT01198067|Bone marrow|bone marrow
456277|NCT01198067|Lymphoplasmacytic cells|lymphoplasmacytic cells
456278|NCT01198067|Monoclonal gammopathy|monoclonal gammopathy
456279|NCT01198067|Pomalidomide|pomalidomide
456280|NCT01198067|Actimid|actimid
456281|NCT01198067|CC-4047|cc-4047
456282|NCT01198054|AML|aml
456283|NCT01198054|Lenalidomide|lenalidomide
456284|NCT01198028|Squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
456285|NCT01198028|Cutaneous squamous cell carcinoma|cutaneous squamous cell carcinoma
456286|NCT01198028|CSCC|cscc
456287|NCT01198028|epidermal growth factor receptor|epidermal growth factor receptor
456288|NCT01198028|EGFR|egfr
456289|NCT01198028|tyrosine kinase inhibitor|tyrosine kinase inhibitor
456290|NCT01198028|recurrent|recurrent
456291|NCT01198028|Erlotinib|erlotinib
456292|NCT01198028|Erlotinib hydrochloride|erlotinib hydrochloride
456293|NCT01198028|OSI-774|osi-774
456294|NCT01198028|Tarceva|tarceva
456295|NCT01198015|Rett syndrome|rett syndrome
456296|NCT01198015|Nutritional status|nutritional status
456297|NCT01198015|Creatine metabolism|creatine metabolism
456298|NCT01198002|Rheumatoid Arthritis|rheumatoid arthritis
456299|NCT01197989|pustulosis|pustulosis
456300|NCT01197989|soles|soles
456301|NCT01197989|teflon|teflon
456302|NCT01197976|psoriasis|psoriasis
456303|NCT01197976|soles|soles
456304|NCT01197976|teflon|teflon
456305|NCT01197963|Type 2 diabetes mellitus|type 2 diabetes mellitus
456306|NCT01197950|acupuncture|acupuncture
456307|NCT01197950|labour|labour
456308|NCT01197950|pain|pain
456309|NCT01197950|pain relief|pain relief
456310|NCT01197950|complementary|complementary
456311|NCT01197924|child cancer brain|child cancer brain
456312|NCT01197898|Diabetic|diabetic
456313|NCT01197898|Foot|foot
456314|NCT01197898|Ulcers|ulcers
456315|NCT01197898|Wounds|wounds
456316|NCT01197833|varicose veins|varicose veins
456317|NCT01197833|Great saphenous vein|great saphenous vein
456318|NCT01197833|varicosities|varicosities
456319|NCT01197820|HIFU|hifu
456320|NCT01197820|mobile organs|mobile organs
456321|NCT01197820|thermometry|thermometry
456322|NCT01197820|MR|mr
456323|NCT01197820|liver|liver
456324|NCT01197820|kidney|kidney
456325|NCT01197820|cancer|cancer
456326|NCT01197820|Liver tumors, kidney carcinoma|liver tumors, kidney carcinoma
456327|NCT01197807|Suctioning|suctioning
456328|NCT01197807|Wiping|wiping
456329|NCT01197807|Neonate|neonate
456330|NCT01197807|Resuscitation|resuscitation
456331|NCT01197794|Efficacy|efficacy
456332|NCT01197794|safety|safety
456333|NCT01197794|tolerability|tolerability
456334|NCT01197794|dose finding|dose finding
456335|NCT01197794|asthma patients|asthma patients
456336|NCT01197781|Phase I|phase i
456337|NCT01197781|FosD|fosd
456338|NCT01197781|fostamatinib disodium|fostamatinib disodium
456339|NCT01197781|verapamil|verapamil
456340|NCT01197781|healthy volunteers|healthy volunteers
456341|NCT01197755|Rheumatoid Arthritis|rheumatoid arthritis
456342|NCT01197742|Diabetes|diabetes
456343|NCT01197742|STEMI|stemi
456344|NCT01197742|NSTEMI|nstemi
456345|NCT01197742|Myocardial infarction|myocardial infarction
456346|NCT01197729|Myocardial infarction|myocardial infarction
456347|NCT01197729|ST-Elevation myocardial infarction|st-elevation myocardial infarction
456348|NCT01197729|Non-ST-Elevation myocardial infarction|non-st-elevation myocardial infarction
456349|NCT01197729|Register|register
456350|NCT01197729|CARDS|cards
456351|NCT01197716|Chest Pain Unit|chest pain unit
456352|NCT01197716|Myocardial infarction|myocardial infarction
456353|NCT01197716|Register|register
456354|NCT01197716|Admission to a Chest Pain Unit for any reason|admission to a chest pain unit for any reason
456355|NCT01197703|Clinical Practice Cardiac CT|clinical practice cardiac ct
456356|NCT01197703|Clinical Implications Coronary CT Angiography|clinical implications coronary ct angiography
456480|NCT01197170|Estrogen receptor|estrogen receptor
456357|NCT01197703|Radiation Exposure of Coronary CT Angiography|radiation exposure of coronary ct angiography
456358|NCT01197703|Registry|registry
456359|NCT01197690|Bronchial asthma|bronchial asthma
456360|NCT01197690|level of control of asthma|level of control of asthma
456361|NCT01197690|fractional exhaled nitric oxide (FeNO)|fractional exhaled nitric oxide (feno)
456362|NCT01197690|asthma control test (ACT)|asthma control test (act)
456363|NCT01197677|CMR|cmr
456364|NCT01197677|Register|register
456365|NCT01197677|CAD|cad
456366|NCT01197677|myocard scarring|myocard scarring
456367|NCT01197651|Aorta|aorta
456368|NCT01197651|Aorta-Stent-Graft|aorta-stent-graft
456369|NCT01197651|Surgical operation|surgical operation
456370|NCT01197651|Aortic dissection|aortic dissection
456371|NCT01197638|Cardiac arrhythmia|cardiac arrhythmia
456372|NCT01197638|Catheter ablation|catheter ablation
456373|NCT01197638|Register|register
456374|NCT01197625|Vaccination treatment, dendritic cells|vaccination treatment, dendritic cells
456375|NCT01197599|Healthy Control|healthy control
456376|NCT01197586|surfactant protein B|surfactant protein b
456377|NCT01197586|differential diagnostics|differential diagnostics
456378|NCT01197560|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
456379|NCT01197560|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
456380|NCT01197560|relapsed|relapsed
456381|NCT01197560|refractory|refractory
456382|NCT01197560|relapsed/refractory|relapsed/refractory
456383|NCT01197560|DLBCL|dlbcl
456384|NCT01197560|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
456385|NCT01197547|Menorrhagia|menorrhagia
456386|NCT01197534|Rheumatoid Arthritis|rheumatoid arthritis
456387|NCT01197521|Rheumatoid Arthritis|rheumatoid arthritis
456388|NCT01197508|Major Depressive Disorder, MDD, Depression|major depressive disorder, mdd, depression
456389|NCT01197482|asthma|asthma
456390|NCT01197482|inhalation|inhalation
456391|NCT01197469|Secondary Pulmonary Hypertension|secondary pulmonary hypertension
456392|NCT01197456|Breast cancer|breast cancer
456393|NCT01197456|Ovarian insufficiency|ovarian insufficiency
456394|NCT01197456|Ovarian failure|ovarian failure
456395|NCT01197456|Reproduction|reproduction
456396|NCT01197443|obesity|obesity
456397|NCT01197443|overweight|overweight
456398|NCT01197443|overweight children|overweight children
456399|NCT01197443|overweight parents|overweight parents
456400|NCT01197443|families with overweight child|families with overweight child
456401|NCT01197443|body mass index|body mass index
456402|NCT01197443|BMI|bmi
456403|NCT01197443|weight|weight
456404|NCT01197443|childhood obesity|childhood obesity
456405|NCT01197443|diet|diet
456406|NCT01197443|treatment|treatment
456407|NCT01197443|parent modeling|parent modeling
456408|NCT01197443|traffic light diet|traffic light diet
456409|NCT01197443|stop light diet|stop light diet
456410|NCT01197430|volleyball|volleyball
456411|NCT01197430|neck vertical stability training|neck vertical stability training
456412|NCT01197430|eye-hand coordination|eye-hand coordination
456413|NCT01197417|Sickle Cell Disease|sickle cell disease
456414|NCT01197417|Magnesium Sulfate|magnesium sulfate
456415|NCT01197417|Pediatric|pediatric
456416|NCT01197404|HIV Prevention|hiv prevention
456417|NCT01197378|cystinosis|cystinosis
456418|NCT01197378|cysteamine|cysteamine
456419|NCT01197378|inheritable disease|inheritable disease
456420|NCT01197378|orphan disease|orphan disease
456421|NCT01197378|CTNS protein, human|ctns protein, human
456422|NCT01197378|metabolic disease|metabolic disease
456423|NCT01197378|nephropathic cystinosis|nephropathic cystinosis
456424|NCT01197365|Acidified milk|acidified milk
456425|NCT01197365|Beta-palmitate|beta-palmitate
456426|NCT01197365|Bifidobacteria|bifidobacteria
456427|NCT01197365|Infant formula|infant formula
456428|NCT01197365|Galacto-oligosaccharides|galacto-oligosaccharides
456429|NCT01197365|Growth|growth
456430|NCT01197365|Infants|infants
456431|NCT01197365|Prebiotics|prebiotics
456432|NCT01197352|Alcohol|alcohol
456433|NCT01197352|Abuse|abuse
456434|NCT01197352|Drinking|drinking
456435|NCT01197352|Behavior|behavior
456436|NCT01197352|Text|text
456437|NCT01197352|Computer|computer
456438|NCT01197339|acute phonotrauma|acute phonotrauma
456439|NCT01197339|computer modeling|computer modeling
456440|NCT01197339|resonant voice|resonant voice
456441|NCT01197339|breathy voice|breathy voice
456442|NCT01197339|voice rest|voice rest
456443|NCT01197339|relaxation|relaxation
456444|NCT01197326|patient deterioration|patient deterioration
456445|NCT01197326|unplanned ICU admissions|unplanned icu admissions
456446|NCT01197326|rapid response teams|rapid response teams
456447|NCT01197313|chronic heart failure (CHF); anxiety and depression; quality of life (QOL); exercise|chronic heart failure (chf); anxiety and depression; quality of life (qol); exercise
456448|NCT01197300|Osteoporosis, children and adolescents, zoledronic acid, chronic inflammation, Duchenne muscular dystrophy, glucocorticoids|osteoporosis, children and adolescents, zoledronic acid, chronic inflammation, duchenne muscular dystrophy, glucocorticoids
456449|NCT01197287|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
456450|NCT01197274|allergy|allergy
456451|NCT01197274|skin prick test|skin prick test
456452|NCT01197274|mite sensitivity|mite sensitivity
456453|NCT01197261|Severe pain|severe pain
456454|NCT01197261|Bladder Pain Syndrome|bladder pain syndrome
456455|NCT01197261|Interstitial Cystitis|interstitial cystitis
456456|NCT01197261|Painful Bladder Syndrome|painful bladder syndrome
456457|NCT01197261|Severe pain due to Bladder Pain Syndrome/Interstitial Cystitis/Painful Bladder Syndrome|severe pain due to bladder pain syndrome/interstitial cystitis/painful bladder syndrome
456458|NCT01197248|cystocele|cystocele
456459|NCT01197248|voiding|voiding
456460|NCT01197248|dysfunction|dysfunction
456461|NCT01197235|darbepoetin, chronic kidney disease, coronary angiography|darbepoetin, chronic kidney disease, coronary angiography
456462|NCT01197222|Laparoscopic|laparoscopic
456463|NCT01197222|EndoClear|endoclear
456464|NCT01197222|Lens Cleaning Device|lens cleaning device
456465|NCT01197209|Prostate Cancer|prostate cancer
456466|NCT01197209|Prostatectomy|prostatectomy
456467|NCT01197209|Postectomy|postectomy
456468|NCT01197209|Oncology|oncology
456469|NCT01197209|REIC|reic
456470|NCT01197209|Dikkoff|dikkoff
456471|NCT01197209|Apoptosis|apoptosis
456472|NCT01197196|Migraine|migraine
456473|NCT01197196|Obesity|obesity
456474|NCT01197196|Weight loss|weight loss
456475|NCT01197196|Lifestyle|lifestyle
456476|NCT01197196|Behavior|behavior
456477|NCT01197183|Hypothyroidism|hypothyroidism
456478|NCT01197183|Thyroid hormones|thyroid hormones
456479|NCT01197170|Hormonal therapies|hormonal therapies
456481|NCT01197170|Progesterone receptor|progesterone receptor
456482|NCT01197170|Hormone blockade|hormone blockade
456483|NCT01197170|Hormone-positive tumors|hormone-positive tumors
456484|NCT01197170|Advanced cancer|advanced cancer
456485|NCT01197170|Metastatic cancer|metastatic cancer
456486|NCT01197170|Avastin|avastin
456487|NCT01197170|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
456488|NCT01197170|rhuMAB-VEGF|rhumab-vegf
456489|NCT01197170|Afinitor|afinitor
456490|NCT01197170|RAD001|rad001
456491|NCT01197170|Nexavar|nexavar
456492|NCT01197170|BAY43-9006|bay43-9006
456493|NCT01197170|OSI-774|osi-774
456494|NCT01197170|Tarceva|tarceva
456495|NCT01197157|chronic hepatitis C|chronic hepatitis c
456496|NCT01197157|genotype 4|genotype 4
456497|NCT01197157|treatment naive patients|treatment naive patients
456498|NCT01197157|Egypt|egypt
456499|NCT01197144|TNF|tnf
456500|NCT01197144|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
456501|NCT01197144|Autonomic|autonomic
456502|NCT01197144|Vagus|vagus
456503|NCT01197144|adalimumab|adalimumab
456504|NCT01197131|autism|autism
456505|NCT01197131|autism spectrum disorder|autism spectrum disorder
456506|NCT01197131|steroids|steroids
456507|NCT01197131|steroid metabolites|steroid metabolites
456508|NCT01197131|urinary steroid metabolites|urinary steroid metabolites
456509|NCT01197131|hormone formation|hormone formation
456510|NCT01197131|androgen precursor|androgen precursor
456511|NCT01197118|gastric cancer|gastric cancer
456512|NCT01197118|sequence chemoradiotherapy|sequence chemoradiotherapy
456513|NCT01197118|OLF regimen|olf regimen
456514|NCT01197118|survival rate|survival rate
456515|NCT01197105|gingivitis|gingivitis
456516|NCT01197105|schinus terebinthifolius|schinus terebinthifolius
456517|NCT01197105|natural products|natural products
456518|NCT01197092|Diabetes|diabetes
456519|NCT01197079|HPV|hpv
456520|NCT01197079|Vaccine|vaccine
456521|NCT01197079|Vaccine utilization|vaccine utilization
456522|NCT01197079|Disease awareness|disease awareness
456523|NCT01197053|Peanut Allergy|peanut allergy
456524|NCT01197053|Food Allergy|food allergy
456525|NCT01197053|Epicutaneous Immunotherapy (EPIT)|epicutaneous immunotherapy (epit)
456526|NCT01197053|Food Challenge|food challenge
456527|NCT01197040|Minimal Change Nephrotic Syndrome|minimal change nephrotic syndrome
456528|NCT01197040|Complete remission|complete remission
456529|NCT01197040|Myfortic|myfortic
456530|NCT01197040|Minimal Change Disease|minimal change disease
456531|NCT01197014|Amlodipine, Losartan|amlodipine, losartan
456532|NCT01197001|Amlodipine, Losartan|amlodipine, losartan
456533|NCT01196988|GSK Biologicals influenza vaccine GSK2321138A|gsk biologicals influenza vaccine gsk2321138a
456534|NCT01196988|influenza infection|influenza infection
456535|NCT01196975|Influenza|influenza
456536|NCT01196962|central venous catheter|central venous catheter
456537|NCT01196962|complications|complications
456538|NCT01196962|internal jugular vein|internal jugular vein
456539|NCT01196962|randomized trial|randomized trial
456540|NCT01196962|subclavian vein|subclavian vein
456541|NCT01196949|Ankle|ankle
456542|NCT01196949|Chronic|chronic
456543|NCT01196949|Instability|instability
456544|NCT01196949|Manipulative|manipulative
456545|NCT01196949|Rehabilitative|rehabilitative
456546|NCT01196949|Manipulation|manipulation
456547|NCT01196949|Rehabilitation|rehabilitation
456548|NCT01196936|Cancer survivors|cancer survivors
456549|NCT01196936|Low Dose Tamoxifen|low dose tamoxifen
456550|NCT01196936|Breast Cancer Risk Reduction|breast cancer risk reduction
456551|NCT01196897|Atrial fibrillation|atrial fibrillation
456552|NCT01196897|Stroke|stroke
456553|NCT01196897|Warfarin|warfarin
456554|NCT01196897|Coumadin|coumadin
456555|NCT01196897|TIA|tia
456556|NCT01196897|Trans Ischemic Attack|trans ischemic attack
456557|NCT01196884|Patients with primary Immune Thrombocytopenia (ITP)|patients with primary immune thrombocytopenia (itp)
456558|NCT01196871|Fabry disease|fabry disease
456559|NCT01196871|drug drug interaction|drug drug interaction
456560|NCT01196845|adipose tissue|adipose tissue
456561|NCT01196845|obese patients|obese patients
456562|NCT01196845|inflammation|inflammation
456563|NCT01196845|oxidative stress|oxidative stress
456564|NCT01196845|sleep apnea syndrome|sleep apnea syndrome
456565|NCT01196806|Non-Invasive Blood Pressure(NIBP)|non-invasive blood pressure(nibp)
456566|NCT01196793|Feverish illness in children|feverish illness in children
456567|NCT01196767|Sternotomy|sternotomy
456568|NCT01196767|Pain|pain
456569|NCT01196767|Respiratory function|respiratory function
456570|NCT01196767|Opiates|opiates
456571|NCT01196767|Patient-controlled|patient-controlled
456572|NCT01196767|Scheduled cardiac surgery under general anaesthesia without any locoregional anaesthesia protocol other than this presently studied|scheduled cardiac surgery under general anaesthesia without any locoregional anaesthesia protocol other than this presently studied
456573|NCT01196754|Pharmacokinetics|pharmacokinetics
456574|NCT01196754|Sevoflurane|sevoflurane
456575|NCT01196754|Fluorides|fluorides
456576|NCT01196754|Sedation|sedation
456577|NCT01196754|Adult patients with a predicted sedation more than 48 h|adult patients with a predicted sedation more than 48 h
456578|NCT01196754|Stable respiratory and hemodynamic conditions for SBT|stable respiratory and hemodynamic conditions for sbt
456579|NCT01196754|Consent of patients|consent of patients
456580|NCT01196754|Arterial line|arterial line
456581|NCT01196715|Quality of Life|quality of life
456582|NCT01196715|Erythroid response|erythroid response
456583|NCT01196715|disease progression|disease progression
456584|NCT01196715|survival|survival
456585|NCT01196715|Overall erythroid response at 24 weeks|overall erythroid response at 24 weeks
456586|NCT01196715|Quality of life at 24 weeks|quality of life at 24 weeks
456587|NCT01196715|Quality of life at 12, 36 and 52 weeks|quality of life at 12, 36 and 52 weeks
456588|NCT01196715|Overall erythroid response at 12 and 52 weeks|overall erythroid response at 12 and 52 weeks
456589|NCT01196715|Incidence of disease progression|incidence of disease progression
456590|NCT01196715|Overall Survival|overall survival
456591|NCT01196702|common variable immunodeficiency|common variable immunodeficiency
456592|NCT01196702|granulomatous disease|granulomatous disease
456593|NCT01196702|crohns disease|crohns disease
456594|NCT01196702|bronchiectasis|bronchiectasis
456595|NCT01196702|immunoglobulin replacement or treatment|immunoglobulin replacement or treatment
456596|NCT01196702|B-cell immunophenotyping|b-cell immunophenotyping
456597|NCT01196689|Pharmacokinetics AZD1981|pharmacokinetics azd1981
456598|NCT01196689|Asthma|asthma
456599|NCT01196676|AZD4451|azd4451
456600|NCT01196676|Bipolar|bipolar
456601|NCT01196676|depression|depression
456602|NCT01196663|TMS|tms
456603|NCT01196637|thoracic outlet syndrome|thoracic outlet syndrome
456604|NCT01196637|brachial plexopathy|brachial plexopathy
456605|NCT01196637|ultrasonography|ultrasonography
456606|NCT01196624|PTSD|ptsd
456607|NCT01196624|FLASHBACKS|flashbacks
456608|NCT01196624|TMS|tms
456609|NCT01196624|EXPOSURE|exposure
456610|NCT01196611|Voice disorders|voice disorders
456611|NCT01196611|Voice|voice
456612|NCT01196598|pelvic floor|pelvic floor
456613|NCT01196598|pelvic organ prolapse|pelvic organ prolapse
456614|NCT01196585|Pleura|pleura
456615|NCT01196585|biopsy|biopsy
456616|NCT01196585|diagnosis|diagnosis
456617|NCT01196585|CT|ct
456618|NCT01196585|ultrasonography|ultrasonography
456619|NCT01196572|stricture|stricture
456620|NCT01196572|urethra|urethra
456621|NCT01196572|laser|laser
456622|NCT01196572|urethrotomy|urethrotomy
456623|NCT01196572|holmium|holmium
456624|NCT01196572|bladder outlet obstruction|bladder outlet obstruction
456625|NCT01196559|ovarian cancer|ovarian cancer
456626|NCT01196546|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
456627|NCT01196546|vildagliptin|vildagliptin
456628|NCT01196546|metformin|metformin
456629|NCT01196533|Non Invasive, Invasive, optical, light source, color image sensor,|non invasive, invasive, optical, light source, color image sensor,
456630|NCT01196533|, Hemodynamic, Arterial Systolic, Arterial Diastolic, MAP, PA Systolic,|, hemodynamic, arterial systolic, arterial diastolic, map, pa systolic,
456631|NCT01196533|PA Diastolic, Heart rate, Stroke volume, CBC, WBC, RBC, Hgb, HCT ,Iron.|pa diastolic, heart rate, stroke volume, cbc, wbc, rbc, hgb, hct ,iron.
456632|NCT01196533|PLT, PH, PCO2, PO2, HCO3, SaO2 , Na, K, Cl, CO2, Bun, Cr, Gluc, HGB (A1C),|plt, ph, pco2, po2, hco3, sao2 , na, k, cl, co2, bun, cr, gluc, hgb (a1c),
456633|NCT01196533|TBiLi, LDL, HDL.|tbili, ldl, hdl.
456634|NCT01196520|Burkitt Lymphoma|burkitt lymphoma
456635|NCT01196520|Epstein-Barr Virus|epstein-barr virus
456636|NCT01196520|Malaria|malaria
456637|NCT01196494|Obstructive left-sided colonic cancer|obstructive left-sided colonic cancer
456638|NCT01196494|Colorectal stent|colorectal stent
456639|NCT01196494|Intraoperative colon lavage|intraoperative colon lavage
456640|NCT01196494|Lavage|lavage
456641|NCT01196494|Stent|stent
456642|NCT01196468|HIV|hiv
456643|NCT01196468|Testing|testing
456644|NCT01196468|Targeted|targeted
456645|NCT01196468|Indicator|indicator
456646|NCT01196468|Diseases|diseases
456647|NCT01196468|Anal dysplasia|anal dysplasia
456648|NCT01196468|Cervical dysplasia|cervical dysplasia
456649|NCT01196468|STI|sti
456650|NCT01196468|Lymphoma|lymphoma
456651|NCT01196468|Seborrhoeic dermatitis|seborrhoeic dermatitis
456652|NCT01196468|Exanthema|exanthema
456653|NCT01196468|Thrombocytpaenia|thrombocytpaenia
456654|NCT01196468|Lymphopaenia|lymphopaenia
456655|NCT01196468|Hypergammaglobulinaemia|hypergammaglobulinaemia
456656|NCT01196455|Metastatic breast cancer patients|metastatic breast cancer patients
456657|NCT01196403|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
456658|NCT01196403|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
456659|NCT01196403|adenocarcinoma of the bladder|adenocarcinoma of the bladder
456660|NCT01196403|stage I bladder cancer|stage i bladder cancer
456661|NCT01196403|stage II bladder cancer|stage ii bladder cancer
456662|NCT01196403|stage III bladder cancer|stage iii bladder cancer
456663|NCT01196377|Asthma|asthma
456664|NCT01196377|Acute asthma|acute asthma
456665|NCT01196377|Pediatrics|pediatrics
456666|NCT01196364|Girls|girls
456667|NCT01196351|boys|boys
456668|NCT01196351|obesity|obesity
456669|NCT01196351|physical activity|physical activity
456670|NCT01196351|exercise|exercise
456671|NCT01196338|Ankle fracture|ankle fracture
456672|NCT01196338|Return to work|return to work
456673|NCT01196338|Return to function|return to function
456674|NCT01196338|Rehabilitation|rehabilitation
456675|NCT01196338|Weight-bearing|weight-bearing
456676|NCT01196325|Diabetes|diabetes
456677|NCT01196325|Diabetic Macular Edema|diabetic macular edema
456678|NCT01196325|Laser|laser
456679|NCT01196325|Anti-VEGF|anti-vegf
456680|NCT01196325|Morphology|morphology
456681|NCT01196325|Blood Flow|blood flow
456682|NCT01196325|Vision|vision
456683|NCT01196312|anxiety sensitivity|anxiety sensitivity
456684|NCT01196312|heroin|heroin
456685|NCT01196299|diffusion tensor imaging|diffusion tensor imaging
456686|NCT01196299|magnetic resonance spectroscopy|magnetic resonance spectroscopy
456687|NCT01196299|traumatic brain injury|traumatic brain injury
456688|NCT01196299|Metabolite changes|metabolite changes
456689|NCT01196299|Cerebral perfusion|cerebral perfusion
456690|NCT01196299|Hemorrhagic burden|hemorrhagic burden
456691|NCT01196286|First-episode psychosis|first-episode psychosis
456692|NCT01196286|cognitive remediation|cognitive remediation
456693|NCT01196286|family psychoeducation|family psychoeducation
456694|NCT01196273|Cardiac Diseases,|cardiac diseases,
456695|NCT01196273|HIV-Infection,|hiv-infection,
456696|NCT01196273|AIDS,|aids,
456697|NCT01196273|Antiretroviral Therapy,|antiretroviral therapy,
456698|NCT01196273|Cardiovascular Medication,|cardiovascular medication,
456699|NCT01196273|Risk Factors,|risk factors,
456700|NCT01196273|coronary heart disease,|coronary heart disease,
456701|NCT01196273|heart failure,|heart failure,
456702|NCT01196273|metabolic syndrome|metabolic syndrome
456703|NCT01196260|efficiency|efficiency
456704|NCT01196260|capecitabine|capecitabine
456705|NCT01196260|oxaliplatin|oxaliplatin
456706|NCT01196260|colorectal cancer|colorectal cancer
456707|NCT01196247|pancreatic cancer|pancreatic cancer
456708|NCT01196247|molecular profiling|molecular profiling
456709|NCT01196247|SU2C|su2c
456710|NCT01196247|Second line therapy|second line therapy
456711|NCT01196247|Stage 4|stage 4
456712|NCT01196208|Disease, Hodgkin|disease, hodgkin
456713|NCT01196208|Lymphoma|lymphoma
456714|NCT01196208|Monomethylauristatin E|monomethylauristatin e
456715|NCT01196208|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
456716|NCT01196208|Lymphoma, T-Cell, Cutaneous|lymphoma, t-cell, cutaneous
456717|NCT01196208|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
456718|NCT01196208|Antibodies, Monoclonal|antibodies, monoclonal
456719|NCT01196208|Antibody-Drug Conjugate|antibody-drug conjugate
456720|NCT01196208|Antigens, CD30|antigens, cd30
456721|NCT01196208|Hematologic Diseases|hematologic diseases
456722|NCT01196208|Immunotherapy|immunotherapy
456723|NCT01196195|antiretroviral therapy|antiretroviral therapy
456724|NCT01196195|child|child
456725|NCT01196195|HIV-1|hiv-1
456726|NCT01196169|daptomycin|daptomycin
456727|NCT01196169|vancomycin|vancomycin
456728|NCT01196169|perioperative|perioperative
456729|NCT01196169|prophylaxis|prophylaxis
456730|NCT01196169|arthroplasty|arthroplasty
456731|NCT01196169|prosthesis|prosthesis
456732|NCT01196169|preoperative|preoperative
456733|NCT01196156|Infant, Small for Gestational Age|infant, small for gestational age
456734|NCT01196156|Dwarfism Pituitary|dwarfism pituitary
456735|NCT01196156|Saizen|saizen
456736|NCT01196156|Somatropin; Growth Hormone|somatropin; growth hormone
456737|NCT01196156|Insulin resistance|insulin resistance
456738|NCT01196143|Ovulation induction|ovulation induction
456739|NCT01196143|Intrauterine insemination|intrauterine insemination
456740|NCT01196143|Gonal-f|gonal-f
456741|NCT01196143|Controlled ovarian stimulation|controlled ovarian stimulation
456742|NCT01196143|Female infertility|female infertility
456743|NCT01196130|Metastatic colorectal cancer|metastatic colorectal cancer
456744|NCT01196130|CRC|crc
456745|NCT01196130|Colorectal adenocarcinoma|colorectal adenocarcinoma
456746|NCT01196130|Biomarker determination|biomarker determination
456747|NCT01196130|Tumor tissue|tumor tissue
456748|NCT01196130|Treatment protocols|treatment protocols
456749|NCT01196117|automatic positive airway pressure (APAP)|automatic positive airway pressure (apap)
456750|NCT01196117|continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
456751|NCT01196117|Salivary Cortisol|salivary cortisol
456752|NCT01196117|Apnea|apnea
456753|NCT01196117|Sleep Apnea and/or any Sleep Disordered Breathing|sleep apnea and/or any sleep disordered breathing
456754|NCT01196091|Lupus|lupus
456755|NCT01196091|SLE|sle
456756|NCT01196091|Systemic Lupus Erythematosis|systemic lupus erythematosis
456757|NCT01196091|autoimmune disease|autoimmune disease
456758|NCT01196091|LY2127399|ly2127399
456759|NCT01196091|Immune system disease|immune system disease
456760|NCT01196026|Influenza|influenza
456761|NCT01196026|H1N1|h1n1
456762|NCT01196026|Fluarix|fluarix
456763|NCT01196026|Pandemrix|pandemrix
456764|NCT01195987|Hepatitis C|hepatitis c
456765|NCT01195987|Arthritis|arthritis
456766|NCT01195974|oral contraceptive, drug interaction, pharmacokinetics|oral contraceptive, drug interaction, pharmacokinetics
456767|NCT01195961|Direct Current Stimulation|direct current stimulation
456768|NCT01195961|Learning|learning
456769|NCT01195961|Cognitive Enhancement|cognitive enhancement
456770|NCT01195961|Cognitive Tasks|cognitive tasks
456771|NCT01195961|Cognitive Training|cognitive training
456772|NCT01195961|Developmental Dyscalculia|developmental dyscalculia
456773|NCT01195961|Learning Disability|learning disability
456774|NCT01195961|Cognition Disorder|cognition disorder
456775|NCT01195948|Uveitis|uveitis
456776|NCT01195948|Oral Tolerance|oral tolerance
456777|NCT01195922|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
456778|NCT01195922|Oral Cancer|oral cancer
456779|NCT01195922|mTOR Inhibitors|mtor inhibitors
456780|NCT01195922|Targeted Therapies|targeted therapies
456781|NCT01195922|Signal Transduction Inhibitors|signal transduction inhibitors
456782|NCT01195922|Head and Neck Cancer|head and neck cancer
456783|NCT01195922|Squamous Cell Carcinoma|squamous cell carcinoma
456784|NCT01195922|Tongue Cancer|tongue cancer
456785|NCT01195883|IV fluid|iv fluid
456786|NCT01195883|recovery|recovery
456787|NCT01195883|goal directed fluid replacement|goal directed fluid replacement
456788|NCT01195883|improved patient recovery|improved patient recovery
456789|NCT01195870|Multiple sclerosis|multiple sclerosis
456790|NCT01195870|Rebif|rebif
456791|NCT01195870|Interferon beta-1a|interferon beta-1a
456792|NCT01195857|Multiple sclerosis|multiple sclerosis
456793|NCT01195857|Rebif|rebif
456794|NCT01195857|Interferon beta-1a|interferon beta-1a
456795|NCT01195844|Pediatric gastroenteritis, rotavirus infection|pediatric gastroenteritis, rotavirus infection
456796|NCT01195818|Albuminuria, hyperfiltration, RAS inhibitors, ADMA|albuminuria, hyperfiltration, ras inhibitors, adma
456797|NCT01195805|Blood pressure, PWV, HRV, PWV, potassium|blood pressure, pwv, hrv, pwv, potassium
456798|NCT01195792|Opioid receptors|opioid receptors
456799|NCT01195792|Body weight|body weight
456800|NCT01195792|Over-eating behaviour|over-eating behaviour
456801|NCT01195792|Obesity|obesity
456802|NCT01195792|Fat mass|fat mass
456803|NCT01195779|immunogenicity|immunogenicity
456804|NCT01195779|safety|safety
456805|NCT01195779|Influenza|influenza
456806|NCT01195779|children|children
456807|NCT01195779|vaccine|vaccine
456808|NCT01195766|Hodgkin|hodgkin
456809|NCT01195766|Ofatumumab|ofatumumab
456810|NCT01195766|Lymphoma|lymphoma
456811|NCT01195753|Urea cycle Disorders|urea cycle disorders
456812|NCT01195740|Suicide Ideation|suicide ideation
456813|NCT01195740|Depression|depression
456814|NCT01195740|Family Conflict|family conflict
456815|NCT01195701|female sexual dysfunction|female sexual dysfunction
456816|NCT01195701|anorgasmia|anorgasmia
456817|NCT01195701|clitoral complex|clitoral complex
456818|NCT01195701|pelvic MRI|pelvic mri
456819|NCT01195701|testosterone|testosterone
456820|NCT01195662|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
456821|NCT01195662|Diabetes Mellitus|diabetes mellitus
456822|NCT01195662|Endocrine System Diseases|endocrine system diseases
456823|NCT01195662|Glucose Metabolism Disorders|glucose metabolism disorders
456824|NCT01195662|Metabolic Diseases|metabolic diseases
456825|NCT01195662|Angiotensin Receptor Inhibitors|angiotensin receptor inhibitors
456826|NCT01195662|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors
456827|NCT01195662|Antihypertensive Agents|antihypertensive agents
456828|NCT01195662|Cardiovascular Agents|cardiovascular agents
456829|NCT01195662|Pharmacological Actions|pharmacological actions
456830|NCT01195636|Pain from Shingles, PHN, Postherpetic Neuralgia|pain from shingles, phn, postherpetic neuralgia
456831|NCT01195623|varicose veins|varicose veins
456832|NCT01195623|venous insufficiency|venous insufficiency
456833|NCT01195623|surgery|surgery
456834|NCT01195623|duplex|duplex
456835|NCT01195623|recurrence|recurrence
456836|NCT01195597|electronic cigarette|electronic cigarette
456837|NCT01195597|ENDD|endd
456838|NCT01195597|nicotine|nicotine
456839|NCT01195597|smoking cessation|smoking cessation
456840|NCT01195597|smoking reduction|smoking reduction
456841|NCT01195584|complication rate in 3 cohorts (BMI < 25, > 25 and > 30)|complication rate in 3 cohorts (bmi < 25, > 25 and > 30)
456842|NCT01195558|Non-24|non-24
456843|NCT01195558|N24HSWD|n24hswd
456844|NCT01195558|Blindness|blindness
456845|NCT01195558|Sleep|sleep
456846|NCT01195558|Wake|wake
456847|NCT01195558|Circadian Rhythm|circadian rhythm
456848|NCT01195558|Nap|nap
456849|NCT01195545|Veritas® Collagen Matrix, Hiatal hernia|veritas® collagen matrix, hiatal hernia
456850|NCT01195532|hypoglycemic drug|hypoglycemic drug
456851|NCT01195519|peritoneal dialysis|peritoneal dialysis
456852|NCT01195519|hemodialysis patients|hemodialysis patients
456853|NCT01195506|We Will Collect the Bone Marrow Specimens From AML Patients|we will collect the bone marrow specimens from aml patients
456854|NCT01195493|Chronic periodontitis|chronic periodontitis
456855|NCT01195480|Immunotherapy|immunotherapy
456856|NCT01195480|Gene Therapy|gene therapy
456857|NCT01195480|Paediatric|paediatric
456858|NCT01195480|B cell Acute Lymphoblastic Leukaemia|b cell acute lymphoblastic leukaemia
456859|NCT01195441|Preeclampsia|preeclampsia
456860|NCT01195441|Doppler ultrasound|doppler ultrasound
456861|NCT01195441|First trimester|first trimester
456862|NCT01195441|Acetylsalicylic acid|acetylsalicylic acid
456863|NCT01195402|COPD|copd
456864|NCT01195402|pulmonary rehabilitation|pulmonary rehabilitation
456865|NCT01195389|dementia|dementia
456866|NCT01195389|memory loss|memory loss
456867|NCT01195389|cognitive decline|cognitive decline
456868|NCT01195376|PI3K|pi3k
456869|NCT01195376|mTOR|mtor
456870|NCT01195376|Advanced solid tumor|advanced solid tumor
456871|NCT01195363|bipolar disorder, mania, depression|bipolar disorder, mania, depression
456872|NCT01195350|Ischemic Stroke|ischemic stroke
456873|NCT01195350|Hemorrhagic Stroke|hemorrhagic stroke
456874|NCT01195350|Blood pressure|blood pressure
456875|NCT01195350|Intensive care|intensive care
456876|NCT01195337|Sedentary minority adult|sedentary minority adult
456877|NCT01195337|Psychosocial factors|psychosocial factors
456878|NCT01195337|Environmental factors|environmental factors
456879|NCT01195337|Obesity|obesity
456880|NCT01195337|Physical Activity|physical activity
456881|NCT01195337|PA|pa
456882|NCT01195337|Cancer Risk|cancer risk
456883|NCT01195337|African Americans|african americans
456884|NCT01195337|Latino|latino
456885|NCT01195324|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
456886|NCT01195324|Warfarin|warfarin
456887|NCT01195324|Pharmacokinetic|pharmacokinetic
456888|NCT01195324|Pharmacodynamic|pharmacodynamic
456889|NCT01195324|Prothrombin time (PT)|prothrombin time (pt)
456890|NCT01195324|International normalized ratio (INR)|international normalized ratio (inr)
456891|NCT01195311|Refractory, Advanced malignancies|refractory, advanced malignancies
456892|NCT01195298|metastatic breast cancer|metastatic breast cancer
456893|NCT01195298|elderly patients|elderly patients
456894|NCT01195298|chemoimmunotherapy|chemoimmunotherapy
456895|NCT01195298|Triple negative metastatic breast cancer|triple negative metastatic breast cancer
456896|NCT01195285|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
456897|NCT01195285|Quality of life|quality of life
456898|NCT01195285|Biliary Cholic|biliary cholic
456899|NCT01195285|Chronic Cholecystitis|chronic cholecystitis
456900|NCT01195285|Symptomatic Cholelithiasis|symptomatic cholelithiasis
456901|NCT01195259|rosiglitazone|rosiglitazone
456902|NCT01195259|ADOPT|adopt
456903|NCT01195259|metformin|metformin
456904|NCT01195259|malignancy|malignancy
456905|NCT01195259|RECORD|record
456906|NCT01195246|end stage renal failure|end stage renal failure
456907|NCT01195246|renal failure|renal failure
456908|NCT01195246|kidney failure|kidney failure
456909|NCT01195246|kidney failure, chronic|kidney failure, chronic
456910|NCT01195246|chronic kidney failure|chronic kidney failure
456911|NCT01195246|hepatitis B virus (HBV) vaccine|hepatitis b virus (hbv) vaccine
456912|NCT01195246|hepatitis B vaccine|hepatitis b vaccine
456913|NCT01195246|hepatitis B|hepatitis b
456914|NCT01195246|hepatitis|hepatitis
456915|NCT01195246|HBV|hbv
456916|NCT01195246|prevention and control|prevention and control
456917|NCT01195246|dialysis|dialysis
456918|NCT01195233|Xerostomia|xerostomia
456919|NCT01195233|Radiotherapy of head and neck|radiotherapy of head and neck
456920|NCT01195233|BioXtra|bioxtra
456921|NCT01195220|STI screening|sti screening
456922|NCT01195220|Emergency Department|emergency department
456923|NCT01195220|Chlamydia|chlamydia
456924|NCT01195220|Gonorrhea|gonorrhea
456925|NCT01195220|HIV|hiv
456926|NCT01195220|behavior|behavior
456927|NCT01195220|teenagers|teenagers
456928|NCT01195220|intervention|intervention
456929|NCT01195207|CNTO 3157|cnto 3157
456930|NCT01195207|healthy volunteers|healthy volunteers
456931|NCT01195207|asthma|asthma
456932|NCT01195194|T-cell lymphocyte allo-recognition|t-cell lymphocyte allo-recognition
456933|NCT01195194|CNI-free immunosuppressive regimen|cni-free immunosuppressive regimen
456934|NCT01195194|Enzyme-linked immunospot (ELISPOT)|enzyme-linked immunospot (elispot)
456935|NCT01195181|peginterferon alfa 2a and 2b type|peginterferon alfa 2a and 2b type
456936|NCT01195181|ribavirin|ribavirin
456937|NCT01195181|chronic hepatitis C|chronic hepatitis c
456938|NCT01195181|antiviral therapy cost/efficacy|antiviral therapy cost/efficacy
456939|NCT01195181|viral kinetics|viral kinetics
456940|NCT01195168|PCOS|pcos
456941|NCT01195155|PCOS|pcos
456942|NCT01195142|PCOS|pcos
456943|NCT01195129|Stent|stent
456944|NCT01195129|cerebral aneursym|cerebral aneursym
456945|NCT01195129|neurology|neurology
456946|NCT01195129|radiology|radiology
456947|NCT01195116|Post-operative pain management|post-operative pain management
456948|NCT01195116|Pain Management|pain management
456949|NCT01195116|Painful bladder syndrome|painful bladder syndrome
456950|NCT01195116|frequency and urgency|frequency and urgency
456951|NCT01195116|Dexmedetomidine|dexmedetomidine
456952|NCT01195116|hydrodistension|hydrodistension
456953|NCT01195103|Procedural sedation|procedural sedation
456954|NCT01195103|Regional Anesthesia block|regional anesthesia block
456955|NCT01195103|Orthopedic surgery|orthopedic surgery
456956|NCT01195103|Lusedra|lusedra
456957|NCT01195103|Fospropofol disodium|fospropofol disodium
456958|NCT01195103|Midazolam|midazolam
456959|NCT01195090|sitagliptin|sitagliptin
456960|NCT01195090|pioglitazone|pioglitazone
456961|NCT01195090|type 2 diabetes|type 2 diabetes
456962|NCT01195077|HIV|hiv
456963|NCT01195077|Dietary intervention|dietary intervention
456964|NCT01195077|Algae|algae
456965|NCT01195077|HIV progression|hiv progression
456966|NCT01195077|Algae specific kind|algae specific kind
456967|NCT01195064|COPD patients|copd patients
456968|NCT01195064|OSAS patients|osas patients
456969|NCT01195064|cardiovascular surgery|cardiovascular surgery
456970|NCT01195064|Endothelial function|endothelial function
456971|NCT01195051|Medication Reconciliation|medication reconciliation
456972|NCT01195051|Inpatient|inpatient
456973|NCT01195051|Electronic Medical Records|electronic medical records
456974|NCT01195038|Avian influenza, H5N1, pandemic, recombinant HA vaccine|avian influenza, h5n1, pandemic, recombinant ha vaccine
456975|NCT01195025|Blood volume|blood volume
456976|NCT01195025|blood coagulation|blood coagulation
456977|NCT01195025|volume kinetics|volume kinetics
456978|NCT01195012|child|child
456979|NCT01195012|primary care|primary care
456980|NCT01195012|treatment|treatment
456981|NCT01195012|parenting|parenting
456982|NCT01195012|lifestyle behaviors|lifestyle behaviors
456983|NCT01194999|OAB|oab
456984|NCT01194999|Urinary Bladder, Overactive|urinary bladder, overactive
456985|NCT01194999|Overactive Bladder Syndrome|overactive bladder syndrome
456986|NCT01194999|VESIcare|vesicare
456987|NCT01194999|Urgency|urgency
456988|NCT01194999|Nocturia|nocturia
456989|NCT01194999|Frequency|frequency
456990|NCT01194999|Urge Urinary Incontinence|urge urinary incontinence
456991|NCT01194999|UUI|uui
456992|NCT01194999|Pubovaginal Sling|pubovaginal sling
456993|NCT01194999|PVS|pvs
456994|NCT01194999|Incontinence|incontinence
456995|NCT01194986|Receptor binding|receptor binding
456996|NCT01194986|Histamine H3 receptor|histamine h3 receptor
456997|NCT01194986|binding|binding
456998|NCT01194986|radioligand|radioligand
456999|NCT01194973|Atypical Hemolytic-Uremic Syndrome|atypical hemolytic-uremic syndrome
457000|NCT01194960|cancer of prostate|cancer of prostate
457001|NCT01194960|cancer of the prostate|cancer of the prostate
457002|NCT01194960|neoplasms prostate|neoplasms prostate
457003|NCT01194960|neoplasms prostatic|neoplasms prostatic
457004|NCT01194960|prostate cancer|prostate cancer
457005|NCT01194960|prostate neoplasms|prostate neoplasms
457006|NCT01194960|prostatic cancer|prostatic cancer
457007|NCT01194960|prostate specific antigen|prostate specific antigen
457008|NCT01194960|prostatic hyperplasia|prostatic hyperplasia
457009|NCT01194947|banal-appearing nevi|banal-appearing nevi
457010|NCT01194947|NEVUS|nevus
457011|NCT01194934|Stem Cell Transplantation|stem cell transplantation
457012|NCT01194934|SDF-1|sdf-1
457013|NCT01194934|L-oligonucleotide Aptamer|l-oligonucleotide aptamer
457014|NCT01194934|Spiegelmer|spiegelmer
457015|NCT01194934|Hematopoietic Stem Cells|hematopoietic stem cells
457016|NCT01194908|Breast Cancer|breast cancer
457017|NCT01194908|Breast Tumors|breast tumors
457018|NCT01194908|Breast Neoplasms|breast neoplasms
457019|NCT01194895|esophagectomy|esophagectomy
457020|NCT01194895|acute lung injury|acute lung injury
457021|NCT01194895|protective ventilation|protective ventilation
457022|NCT01194869|Breast Cancer|breast cancer
457023|NCT01194856|HIV|hiv
457024|NCT01194856|Lipoatrophy|lipoatrophy
457025|NCT01194856|mitochondrial dysfunction|mitochondrial dysfunction
457026|NCT01194817|total knee arthroplasty|total knee arthroplasty
457027|NCT01194817|total knee replacement|total knee replacement
457028|NCT01194817|cementless TKA|cementless tka
457029|NCT01194817|high flexion|high flexion
457030|NCT01194817|trabecular metal|trabecular metal
457031|NCT01194804|Hemolytic Paroxysmal Nocturnal Hemoglobinuria|hemolytic paroxysmal nocturnal hemoglobinuria
457032|NCT01194804|Eculizumab|eculizumab
457033|NCT01194804|PNH|pnh
457034|NCT01194791|Amyloidosis|amyloidosis
457035|NCT01194791|Lenalidomide|lenalidomide
457036|NCT01194713|Alzheimer Disease|alzheimer disease
457037|NCT01194713|Cerebrospinal fluid|cerebrospinal fluid
457038|NCT01194713|Sleep|sleep
457039|NCT01194713|Abeta|abeta
457040|NCT01194700|lung bioavailability|lung bioavailability
457041|NCT01194700|asthma|asthma
457042|NCT01194700|seretide|seretide
457043|NCT01194700|Spacer|spacer
457044|NCT01194687|Estrogens|estrogens
457045|NCT01194687|Fecal Microbiome|fecal microbiome
457046|NCT01194687|Fecal Occult Blood|fecal occult blood
457047|NCT01194674|Microplasmin|microplasmin
457048|NCT01194674|Macular Edema|macular edema
457049|NCT01194674|Uveitis|uveitis
457050|NCT01194661|Inhibitory Control|inhibitory control
457051|NCT01194661|Executive Function|executive function
457052|NCT01194661|fMRI|fmri
457053|NCT01194661|TMS|tms
457054|NCT01194661|TBI|tbi
457055|NCT01194661|Traumatic Brain Injury|traumatic brain injury
457056|NCT01194661|Healthy Volunteer|healthy volunteer
457057|NCT01194661|HV|hv
457058|NCT01194648|urinary incontinence|urinary incontinence
457059|NCT01194648|male erectile disorder|male erectile disorder
457060|NCT01194648|therapy-related toxicity|therapy-related toxicity
457061|NCT01194648|stage I prostate cancer|stage i prostate cancer
457062|NCT01194648|stage IIB prostate cancer|stage iib prostate cancer
457063|NCT01194648|stage IIA prostate cancer|stage iia prostate cancer
457064|NCT01194635|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
457065|NCT01194635|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
457066|NCT01194635|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
457067|NCT01194635|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
457068|NCT01194635|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
457069|NCT01194635|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
457070|NCT01194635|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
457071|NCT01194609|Low dose radiation|low dose radiation
457072|NCT01194609|Adoptive immune cell therapy|adoptive immune cell therapy
457073|NCT01194609|Cervical cancer|cervical cancer
457074|NCT01194609|Pilot study|pilot study
457075|NCT01194596|smoking cessation advice|smoking cessation advice
457076|NCT01194596|spirometry|spirometry
457077|NCT01194596|primary health care|primary health care
457078|NCT01194583|electronic cigarette|electronic cigarette
457079|NCT01194583|nicotine|nicotine
457080|NCT01194583|smoking cessation|smoking cessation
457081|NCT01194583|smoking reduction|smoking reduction
457082|NCT01194557|history of fever|history of fever
457083|NCT01194557|measured fever|measured fever
457084|NCT01194557|appropriate treatment|appropriate treatment
457085|NCT01194557|appropriate referral|appropriate referral
457086|NCT01194531|Preimplantation Gentic Screening|preimplantation gentic screening
457087|NCT01194531|PGS|pgs
457088|NCT01194531|In Vitro Fertilization|in vitro fertilization
457089|NCT01194531|IVF|ivf
457090|NCT01194531|Preimplantation Genetic Diagnosis|preimplantation genetic diagnosis
457091|NCT01194531|PGD|pgd
457092|NCT01194518|Life experience|life experience
457093|NCT01194518|Life style|life style
457094|NCT01194518|Health behavior|health behavior
457095|NCT01194518|Mixed method|mixed method
457096|NCT01194505|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
457097|NCT01194505|obturator nerve block|obturator nerve block
457098|NCT01194505|sciatic nerve block|sciatic nerve block
457099|NCT01194505|femoral nerve block|femoral nerve block
457100|NCT01194505|posterior lumbar plexus block|posterior lumbar plexus block
457101|NCT01194505|ultrasound guided nerve block|ultrasound guided nerve block
457102|NCT01194492|plasma albumin|plasma albumin
457103|NCT01194492|inflammatory reaction|inflammatory reaction
457104|NCT01194492|systemic inflammatory response syndrome|systemic inflammatory response syndrome
457105|NCT01194479|type 1 diabetes|type 1 diabetes
457106|NCT01194479|hypoglycemia|hypoglycemia
457107|NCT01194479|formoterol|formoterol
457108|NCT01194466|Head and Neck Cancer|head and neck cancer
457109|NCT01194466|Oral Cancer|oral cancer
457411|NCT01193140|Temodar|temodar
457110|NCT01194466|Laryngeal Cancer|laryngeal cancer
457111|NCT01194466|Oropharyngeal Cancer|oropharyngeal cancer
457112|NCT01194466|Transcutaneous Electrical Nerve Stimulation (TENS)|transcutaneous electrical nerve stimulation (tens)
457113|NCT01194466|Oral Mucositis|oral mucositis
457114|NCT01194466|Pain|pain
457115|NCT01194466|Function|function
457116|NCT01194466|TENS|tens
457117|NCT01194466|Functional Pain|functional pain
457118|NCT01194466|Non-pharamcologic|non-pharamcologic
457119|NCT01194466|Quality of Life|quality of life
457120|NCT01194427|Preoperative|preoperative
457121|NCT01194427|Neoadjuvant|neoadjuvant
457122|NCT01194388|Patients presenting with an intracranial aneurysm|patients presenting with an intracranial aneurysm
457123|NCT01194362|aortic valve disease|aortic valve disease
457124|NCT01194362|gene expression|gene expression
457125|NCT01194349|S. pneumoniae|s. pneumoniae
457126|NCT01194349|thrombocytosis|thrombocytosis
457127|NCT01194349|pediatric patients|pediatric patients
457128|NCT01194349|The study aimed to understand the diagnostic value of thrombocytosis in children with S. pneumoniae infection|the study aimed to understand the diagnostic value of thrombocytosis in children with s. pneumoniae infection
457129|NCT01194336|Central nervous system|central nervous system
457130|NCT01194336|Cholinesterase|cholinesterase
457131|NCT01194336|Neurocognitive performance testing|neurocognitive performance testing
457132|NCT01194323|esophageal erosion|esophageal erosion
457133|NCT01194323|abnormal pH monitoring|abnormal ph monitoring
457134|NCT01194310|glaucoma|glaucoma
457135|NCT01194310|cataract|cataract
457136|NCT01194297|influenza|influenza
457137|NCT01194297|premature infant|premature infant
457138|NCT01194297|very low birth weight infant|very low birth weight infant
457139|NCT01194297|immunization|immunization
457140|NCT01194297|vaccine|vaccine
457141|NCT01194271|Hormone Ablation|hormone ablation
457142|NCT01194271|Prostate adenocarcinoma|prostate adenocarcinoma
457143|NCT01194271|Radical prostatectomy|radical prostatectomy
457144|NCT01194271|Leuprolide Acetate|leuprolide acetate
457145|NCT01194271|Lupron Depot|lupron depot
457146|NCT01194271|Ipilimumab|ipilimumab
457147|NCT01194271|BMS-734016|bms-734016
457148|NCT01194271|MDX010|mdx010
457149|NCT01194258|Type 2 diabetes|type 2 diabetes
457150|NCT01194245|Type 1 diabetes|type 1 diabetes
457151|NCT01194232|Cystic Fibrosis|cystic fibrosis
457152|NCT01194232|CF|cf
457153|NCT01194232|CMRI|cmri
457154|NCT01194232|vascularization|vascularization
457155|NCT01194232|perfusion|perfusion
457156|NCT01194219|Plaque Psoriasis|plaque psoriasis
457157|NCT01194193|Cancer|cancer
457158|NCT01194193|Advanced solid tumours|advanced solid tumours
457159|NCT01194193|lymphomas|lymphomas
457160|NCT01194193|dose escalation|dose escalation
457161|NCT01194193|preliminary anti-tumour activity|preliminary anti-tumour activity
457162|NCT01194193|Tor kinase inhibitor|tor kinase inhibitor
457163|NCT01194193|oral administration|oral administration
457164|NCT01194193|intermittent dosing|intermittent dosing
457165|NCT01194180|Mycobacterium tuberculosis|mycobacterium tuberculosis
457166|NCT01194180|BCG|bcg
457167|NCT01194180|MVA85A|mva85a
457168|NCT01194167|Platelet refractory thrombocytopenia|platelet refractory thrombocytopenia
457169|NCT01194141|Barth syndrome|barth syndrome
457170|NCT01194141|cardiomyopathy|cardiomyopathy
457171|NCT01194141|mitochondria|mitochondria
457172|NCT01194141|cardiolipin|cardiolipin
457173|NCT01194128|caregivers,|caregivers,
457174|NCT01194128|institutionalization,|institutionalization,
457175|NCT01194128|dementia patients,|dementia patients,
457176|NCT01194128|bereavement,|bereavement,
457177|NCT01194128|grief|grief
457178|NCT01194128|complicated grief|complicated grief
457179|NCT01194115|surgical site infection|surgical site infection
457180|NCT01194115|obesity|obesity
457181|NCT01194115|pregnancy|pregnancy
457182|NCT01194115|cesarean section|cesarean section
457183|NCT01194115|cesarean delivery|cesarean delivery
457184|NCT01194102|Stroke|stroke
457185|NCT01194102|Exercise|exercise
457186|NCT01194102|Physical function|physical function
457187|NCT01194102|Community program|community program
457188|NCT01194102|Patient education|patient education
457189|NCT01194102|Self-management|self-management
457190|NCT01194089|Nicotine|nicotine
457191|NCT01194089|Postoperative pain|postoperative pain
457192|NCT01194089|Bariatric surgery|bariatric surgery
457193|NCT01194076|cognitive behavior therapy|cognitive behavior therapy
457194|NCT01194076|exposure and response prevention|exposure and response prevention
457195|NCT01194076|pediatric|pediatric
457196|NCT01194076|obsessive compulsive disorder|obsessive compulsive disorder
457197|NCT01194076|child|child
457198|NCT01194076|anxiety|anxiety
457199|NCT01194076|intensive|intensive
457200|NCT01194076|OCD|ocd
457201|NCT01194076|CBT|cbt
457202|NCT01194063|short bowel syndrome|short bowel syndrome
457203|NCT01194063|parenteral nutrition associated liver disease|parenteral nutrition associated liver disease
457204|NCT01194063|pediatric|pediatric
457205|NCT01194037|Hepatitis C|hepatitis c
457206|NCT01194037|HCV|hcv
457207|NCT01194037|Interferon|interferon
457208|NCT01194037|Hanferon|hanferon
457209|NCT01194024|Inhalation Injury, Smoke|inhalation injury, smoke
457210|NCT01194024|Inhalation Injury, Acute|inhalation injury, acute
457211|NCT01194011|Health care quality, information openness, health care information website|health care quality, information openness, health care information website
457212|NCT01193972|Smoking cessation|smoking cessation
457213|NCT01193972|Smoking|smoking
457214|NCT01193972|Tobacco|tobacco
457215|NCT01193946|Protein requirement|protein requirement
457216|NCT01193946|Elderly women|elderly women
457217|NCT01193946|Indicator amino acid oxidation|indicator amino acid oxidation
457218|NCT01193933|adult ALL|adult all
457219|NCT01193933|Ph-negative|ph-negative
457220|NCT01193933|dexamethasone|dexamethasone
457221|NCT01193933|L-asparaginase|l-asparaginase
457222|NCT01193920|Group B streptococcus|group b streptococcus
457223|NCT01193920|GBS|gbs
457224|NCT01193920|Vaccine|vaccine
457225|NCT01193920|Prevention of group B streptococcus infection|prevention of group b streptococcus infection
457226|NCT01193907|Typhoid fever|typhoid fever
457227|NCT01193907|Glycoconjugate vaccine|glycoconjugate vaccine
457228|NCT01193907|Vi polysaccharide|vi polysaccharide
457229|NCT01193907|Immunogenicity|immunogenicity
457230|NCT01193894|IBD|ibd
457231|NCT01193894|UC|uc
457232|NCT01193894|Profermin|profermin
457233|NCT01193894|Fresubin|fresubin
457234|NCT01193894|Probiotics|probiotics
457235|NCT01193894|Dietetic|dietetic
457236|NCT01193855|stage IIB prostate cancer|stage iib prostate cancer
457237|NCT01193855|stage IIA prostate cancer|stage iia prostate cancer
457238|NCT01193816|restlessness during mechanical ventilation weaning|restlessness during mechanical ventilation weaning
457239|NCT01193803|Prosthetic Joint Infections|prosthetic joint infections
457240|NCT01193803|Vertebral Osteomyelitis|vertebral osteomyelitis
457241|NCT01193803|Septic arthritis|septic arthritis
457242|NCT01193803|Molecular methods|molecular methods
457243|NCT01193790|chronic tonsillitis|chronic tonsillitis
457244|NCT01193790|radio-frequency coblation|radio-frequency coblation
457245|NCT01193790|radio-frequency coblation in chronic tonsillitis treatment|radio-frequency coblation in chronic tonsillitis treatment
457246|NCT01193777|Carnitine|carnitine
457247|NCT01193777|Shock|shock
457248|NCT01193777|Sepsis|sepsis
457249|NCT01193764|acne|acne
457250|NCT01193764|cocoa|cocoa
457251|NCT01193764|chocolate|chocolate
457252|NCT01193764|gelatin|gelatin
457253|NCT01193764|pustule|pustule
457254|NCT01193764|comedones|comedones
457255|NCT01193764|papules|papules
457256|NCT01193764|pustules|pustules
457257|NCT01193751|Birth Asphyxia|birth asphyxia
457258|NCT01193751|Newborn's Resuscitation|newborn's resuscitation
457259|NCT01193751|Death|death
457260|NCT01193751|Neurodevelopmental Impairment|neurodevelopmental impairment
457261|NCT01193738|osteopathy|osteopathy
457262|NCT01193725|Combat Disorders|combat disorders
457263|NCT01193725|Exposure Therapy|exposure therapy
457264|NCT01193725|Army Personnel|army personnel
457265|NCT01193712|Electrophysiologic Techniques, Cardiac|electrophysiologic techniques, cardiac
457266|NCT01193660|umbilical cord blood|umbilical cord blood
457267|NCT01193660|stem cell|stem cell
457268|NCT01193660|cerebral palsy|cerebral palsy
457269|NCT01193634|ICD VR 9250, DR 9550 and CRT 9750 - PARADYM RF ICD|icd vr 9250, dr 9550 and crt 9750 - paradym rf icd
457270|NCT01193621|early evaluation|early evaluation
457271|NCT01193621|pharmacokinetics|pharmacokinetics
457272|NCT01193621|pharmacodynamics|pharmacodynamics
457273|NCT01193621|Biodistribution|biodistribution
457274|NCT01193621|D2-receptor occupancy|d2-receptor occupancy
457275|NCT01193608|Randomized|randomized
457276|NCT01193608|Safety Study|safety study
457277|NCT01193608|Adaptive|adaptive
457278|NCT01193608|Double Blind|double blind
457279|NCT01193582|Prevenar|prevenar
457280|NCT01193582|catch-up|catch-up
457281|NCT01193582|pneumococcal|pneumococcal
457282|NCT01193582|pneumonia|pneumonia
457283|NCT01193556|Tonsillectomy|tonsillectomy
457284|NCT01193556|PlasmaBlade|plasmablade
457285|NCT01193556|Electrosurgery|electrosurgery
457286|NCT01193556|PEAK Surgical|peak surgical
457287|NCT01193556|Medtronic Advanced Energy|medtronic advanced energy
457288|NCT01193556|Medtronic|medtronic
457289|NCT01193530|Sleep Disturbances|sleep disturbances
457290|NCT01193530|Depression|depression
457291|NCT01193530|Anxiety|anxiety
457292|NCT01193530|Fatigue|fatigue
457293|NCT01193530|Quality of life|quality of life
457294|NCT01193517|Refractory metastatic colorectal cancer|refractory metastatic colorectal cancer
457295|NCT01193517|CRC|crc
457296|NCT01193517|colorectal adenocarcinoma with metastatic disease|colorectal adenocarcinoma with metastatic disease
457297|NCT01193517|Azacitidine|azacitidine
457298|NCT01193517|5-Azacytidine|5-azacytidine
457299|NCT01193517|5-aza|5-aza
457300|NCT01193517|Vidaza|vidaza
457301|NCT01193517|5-AZC|5-azc
457302|NCT01193517|AZA-CR|aza-cr
457303|NCT01193517|Ladakamycin|ladakamycin
457304|NCT01193517|NSC-102816|nsc-102816
457305|NCT01193517|Capecitabine|capecitabine
457306|NCT01193517|Oxaliplatin|oxaliplatin
457307|NCT01193517|CAPOX|capox
457308|NCT01193517|Xeloda|xeloda
457309|NCT01193517|Eloxatin|eloxatin
457310|NCT01193517|Hypermethylation|hypermethylation
457412|NCT01193140|temozolomide|temozolomide
457311|NCT01193517|CpG island methylator phenotype|cpg island methylator phenotype
457312|NCT01193504|Prevention of Retinal Thickening and CME Following Phacoemulsification|prevention of retinal thickening and cme following phacoemulsification
457313|NCT01193504|Pseudophakia following cataract surgery|pseudophakia following cataract surgery
457314|NCT01193491|Phase 1|phase 1
457315|NCT01193491|AML|aml
457316|NCT01193491|CML|cml
457317|NCT01193491|MPD|mpd
457318|NCT01193491|Client Proteins|client proteins
457319|NCT01193491|Hsp90|hsp90
457320|NCT01193478|Hepatitis C|hepatitis c
457321|NCT01193478|HCV RNA|hcv rna
457322|NCT01193478|multiple ascending dose|multiple ascending dose
457323|NCT01193478|NS5A|ns5a
457324|NCT01193478|GS-5885|gs-5885
457325|NCT01193478|chronic genotype 1 HCV infection|chronic genotype 1 hcv infection
457326|NCT01193465|Humidity|humidity
457327|NCT01193465|Temperature|temperature
457328|NCT01193465|Low Flow Anesthesia|low flow anesthesia
457329|NCT01193452|elderly patients|elderly patients
457330|NCT01193452|advanced colorectal cancer|advanced colorectal cancer
457331|NCT01193452|chemotherapy|chemotherapy
457332|NCT01193452|S-1|s-1
457333|NCT01193452|5-fluorouracil|5-fluorouracil
457334|NCT01193452|leucovorin|leucovorin
457335|NCT01193439|thoracoscopy|thoracoscopy
457336|NCT01193439|pleural diseases|pleural diseases
457337|NCT01193439|complications|complications
457338|NCT01193439|safety|safety
457339|NCT01193426|Hepatic|hepatic
457340|NCT01193426|cirrhosis|cirrhosis
457341|NCT01193426|IL-6|il-6
457342|NCT01193426|IL-8|il-8
457343|NCT01193426|Leptine|leptine
457344|NCT01193413|acute pancreatitis|acute pancreatitis
457345|NCT01193413|Drainage|drainage
457346|NCT01193413|Pancreatic surgery|pancreatic surgery
457347|NCT01193413|Biological Markers/analysis|biological markers/analysis
457348|NCT01193413|Infection diagnosis|infection diagnosis
457349|NCT01193413|ROC Curve|roc curve
457350|NCT01193413|Sensitivity and Specificity|sensitivity and specificity
457351|NCT01193413|Endoscopic ultrasonography|endoscopic ultrasonography
457352|NCT01193400|Acute myelogenous leukemia|acute myelogenous leukemia
457353|NCT01193400|Clofarabine|clofarabine
457354|NCT01193400|Cytarabine|cytarabine
457355|NCT01193374|Childhood Obesity|childhood obesity
457356|NCT01193374|Primary Care|primary care
457357|NCT01193374|Counseling|counseling
457358|NCT01193374|Screening|screening
457359|NCT01193348|Atypical Hemolytic-Uremic Syndrome|atypical hemolytic-uremic syndrome
457360|NCT01193335|13-valent pneumococcal conjugate vaccine|13-valent pneumococcal conjugate vaccine
457361|NCT01193335|premature|premature
457362|NCT01193335|immunization|immunization
457363|NCT01193335|safety.|safety.
457364|NCT01193296|Diabetes mellitus, vildagliptin, continuous glucose monitoring|diabetes mellitus, vildagliptin, continuous glucose monitoring
457365|NCT01193283|Aplastic Anemia|aplastic anemia
457366|NCT01193283|Immunosuppression|immunosuppression
457367|NCT01193283|T-Cells|t-cells
457368|NCT01193283|Hematopoiesis|hematopoiesis
457369|NCT01193283|Autoimmunity|autoimmunity
457370|NCT01193283|Severe Aplastic Anemia|severe aplastic anemia
457371|NCT01193270|NICHD Neonatal Research Network|nichd neonatal research network
457372|NCT01193270|Intraventricular Hemorrhage (IVH)|intraventricular hemorrhage (ivh)
457373|NCT01193270|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
457374|NCT01193270|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
457375|NCT01193270|Prematurity|prematurity
457376|NCT01193231|Laser Vision Correction|laser vision correction
457377|NCT01193231|Photorefractive Keratectomy|photorefractive keratectomy
457378|NCT01193231|PRK|prk
457379|NCT01193231|Nearsighted|nearsighted
457380|NCT01193231|Myopia|myopia
457381|NCT01193205|Borderline Personality Disorder|borderline personality disorder
457382|NCT01193205|Skills Training|skills training
457383|NCT01193205|Dialectical Behavior Therapy|dialectical behavior therapy
457384|NCT01193205|Suicidal and parasuicidal behavior|suicidal and parasuicidal behavior
457385|NCT01193192|Neevo|neevo
457386|NCT01193192|Neevo DHA|neevo dha
457387|NCT01193192|L-methylfolate|l-methylfolate
457388|NCT01193192|anemia during pregnancy|anemia during pregnancy
457389|NCT01193192|folic acid|folic acid
457390|NCT01193192|vitamin B12|vitamin b12
457391|NCT01193192|prenatal vitamins|prenatal vitamins
457392|NCT01193192|hemoglobin|hemoglobin
457393|NCT01193192|iron deficiency|iron deficiency
457394|NCT01193192|Pregnancy|pregnancy
457395|NCT01193166|Schizophrenia|schizophrenia
457396|NCT01193166|Risperidone|risperidone
457397|NCT01193166|Risperdal|risperdal
457398|NCT01193166|Paliperidone palmitate|paliperidone palmitate
457399|NCT01193166|Aripiprazole|aripiprazole
457400|NCT01193166|Haloperidol|haloperidol
457401|NCT01193166|Olanzapine|olanzapine
457402|NCT01193166|Paliperidone|paliperidone
457403|NCT01193166|Perphenazine|perphenazine
457404|NCT01193166|Quetiapine|quetiapine
457405|NCT01193153|schizoaffective disorder|schizoaffective disorder
457406|NCT01193153|paliperidone palmitate|paliperidone palmitate
457407|NCT01193153|INVEGA SUSTENNA|invega sustenna
457408|NCT01193153|schizoaffective disorder relapse prevention|schizoaffective disorder relapse prevention
457409|NCT01193140|veliparib|veliparib
457410|NCT01193140|relapsed and refractory tumors|relapsed and refractory tumors
457413|NCT01193140|ABT-888|abt-888
457414|NCT01193140|Solid Tumors|solid tumors
457415|NCT01193114|substance abuse|substance abuse
457416|NCT01193114|homeless mothers|homeless mothers
457417|NCT01193101|hypertension|hypertension
457418|NCT01193101|blood pressure|blood pressure
457419|NCT01193101|LCZ696|lcz696
457420|NCT01193101|dual-acting|dual-acting
457421|NCT01193101|neprilysin|neprilysin
457422|NCT01193101|nep inhibitor|nep inhibitor
457423|NCT01193101|vasopeptidase|vasopeptidase
457424|NCT01193101|angiotensin receptor|angiotensin receptor
457425|NCT01193101|ARNi|arni
457426|NCT01193101|Essential hypertension|essential hypertension
457427|NCT01193088|CMT|cmt
457428|NCT01193088|CMT1A|cmt1a
457429|NCT01193075|Charcot Marie Tooth disease|charcot marie tooth disease
457430|NCT01193075|CMT|cmt
457431|NCT01193075|HMSN|hmsn
457432|NCT01193075|HMN|hmn
457433|NCT01193075|HSN|hsn
457434|NCT01193075|CMT1|cmt1
457435|NCT01193075|CMT2|cmt2
457436|NCT01193062|healthy volunteers|healthy volunteers
457437|NCT01193062|pharmacokinetics-pharmacodynamics|pharmacokinetics-pharmacodynamics
457438|NCT01193062|cerebrospinal fluid|cerebrospinal fluid
457439|NCT01193062|serial sampling|serial sampling
457440|NCT01193049|Nasal Allergen Challenge, Inhaled Allergen Challenge, Asthma|nasal allergen challenge, inhaled allergen challenge, asthma
457441|NCT01193036|Psychosocial|psychosocial
457442|NCT01193036|Skin Problems|skin problems
457443|NCT01193036|Supportive Care|supportive care
457444|NCT01193036|Melanoma|melanoma
457445|NCT01193036|Questionnaire|questionnaire
457446|NCT01193023|Prospective Studies|prospective studies
457447|NCT01193023|Humans, pediatric|humans, pediatric
457448|NCT01193023|Positive-Pressure Respiration/methods*|positive-pressure respiration/methods*
457449|NCT01193023|Respiration, Artificial/methods*|respiration, artificial/methods*
457450|NCT01193023|Intensive Care|intensive care
457451|NCT01193023|Intensive Care Units/statistics & numerical data*|intensive care units/statistics & numerical data*
457452|NCT01193023|Respiration, Artificial/statistics & numerical data*|respiration, artificial/statistics & numerical data*
457453|NCT01193023|Patients/statistics & numerical data*|patients/statistics & numerical data*
457454|NCT01193023|Prevalence|prevalence
457455|NCT01193023|Respiratory Muscles/innervation|respiratory muscles/innervation
457456|NCT01192997|Meningitis|meningitis
457457|NCT01192997|Meningococci|meningococci
457458|NCT01192997|Meningitis C|meningitis c
457459|NCT01192997|Meningitis A|meningitis a
457460|NCT01192997|Meningitis W135|meningitis w135
457461|NCT01192997|Meningitis Y|meningitis y
457462|NCT01192997|Antibody|antibody
457463|NCT01192971|hcc, apatinib, phase II, cancer|hcc, apatinib, phase ii, cancer
457464|NCT01192958|swine flu|swine flu
457465|NCT01192958|novel h1n1v|novel h1n1v
457466|NCT01192958|novel h1n1|novel h1n1
457467|NCT01192958|h1n1|h1n1
457468|NCT01192945|Azacitidin|azacitidin
457469|NCT01192945|Vidaza|vidaza
457470|NCT01192945|Piaza|piaza
457471|NCT01192945|myelodysplastic syndrome|myelodysplastic syndrome
457472|NCT01192945|MDS|mds
457473|NCT01192945|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
457474|NCT01192945|CMML|cmml
457475|NCT01192945|acute myeloid leukemia|acute myeloid leukemia
457476|NCT01192945|AML|aml
457477|NCT01192945|daily routine|daily routine
457478|NCT01192945|concomitant antiemetic therapy|concomitant antiemetic therapy
457479|NCT01192945|germany|germany
457480|NCT01192945|non-interventional study|non-interventional study
457481|NCT01192919|bronchial carcinoma|bronchial carcinoma
457482|NCT01192919|registry|registry
457483|NCT01192919|real life treatment|real life treatment
457484|NCT01192919|cohort study|cohort study
457485|NCT01192919|NSCLC|nsclc
457486|NCT01192919|SCLC|sclc
457487|NCT01192919|Germany|germany
457488|NCT01192854|Clevudine|clevudine
457489|NCT01192854|efficacy|efficacy
457490|NCT01192854|safety|safety
457491|NCT01192854|chronic hepatitis B|chronic hepatitis b
457492|NCT01192841|physician uniform|physician uniform
457493|NCT01192841|MRSA|mrsa
457494|NCT01192841|bacterial contamination|bacterial contamination
457495|NCT01192828|cystathionine beta-synthase (CBS)|cystathionine beta-synthase (cbs)
457496|NCT01192802|albendazole|albendazole
457497|NCT01192802|ascaris|ascaris
457498|NCT01192802|trichiurus|trichiurus
457499|NCT01192802|hookworms|hookworms
457500|NCT01192789|Severe pneumonia|severe pneumonia
457501|NCT01192789|Pneumonia|pneumonia
457502|NCT01192789|Lady health workers|lady health workers
457503|NCT01192789|Amoxicillin|amoxicillin
457504|NCT01192789|Treatment failure|treatment failure
457505|NCT01192789|Injectable Antibiotics|injectable antibiotics
457506|NCT01192789|Referral treatment|referral treatment
457507|NCT01192789|Health Facility|health facility
457508|NCT01192789|Under five children|under five children
457509|NCT01192789|home based management|home based management
457510|NCT01192789|community case management|community case management
457511|NCT01192776|NICHD Neonatal Research Network|nichd neonatal research network
457512|NCT01192776|Hypoxic-ischemic encephalopathy (HIE)|hypoxic-ischemic encephalopathy (hie)
457513|NCT01192776|Hypothermia|hypothermia
457514|NCT01192776|Neonatal depression|neonatal depression
457515|NCT01192776|Perinatal asphyxia|perinatal asphyxia
457516|NCT01192776|Fetal acidosis|fetal acidosis
457517|NCT01192750|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
457518|NCT01192750|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
457519|NCT01192750|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
457520|NCT01192750|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
457521|NCT01192750|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
457522|NCT01192750|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
457523|NCT01192750|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
457524|NCT01192750|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
457525|NCT01192750|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
457526|NCT01192750|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
457527|NCT01192750|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
457528|NCT01192750|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
457529|NCT01192750|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
457530|NCT01192750|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
457531|NCT01192750|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
457532|NCT01192750|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
457533|NCT01192750|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
457534|NCT01192750|recurrent salivary gland cancer|recurrent salivary gland cancer
457535|NCT01192750|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
457536|NCT01192737|pandemic|pandemic
457537|NCT01192737|A/H1N1|a/h1n1
457538|NCT01192737|pregnancy|pregnancy
457539|NCT01192737|cohort|cohort
457540|NCT01192737|vaccine|vaccine
457541|NCT01192737|Influenza and Pregnancy|influenza and pregnancy
457542|NCT01192724|Antiplatelet|antiplatelet
457543|NCT01192724|Coronary artery diseae|coronary artery diseae
457544|NCT01192724|Percutaneous coronary intervention|percutaneous coronary intervention
457545|NCT01192711|diabetes|diabetes
457546|NCT01192711|telemedicine|telemedicine
457547|NCT01192711|self monitoring blood glucose|self monitoring blood glucose
457548|NCT01192698|cirrhosis|cirrhosis
457549|NCT01192698|hepatitis C|hepatitis c
457550|NCT01192685|Depression|depression
457551|NCT01192685|Depressed|depressed
457552|NCT01192685|TMS|tms
457553|NCT01192685|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
457554|NCT01192646|maternal health|maternal health
457555|NCT01192646|birth preparedness|birth preparedness
457556|NCT01192646|cost effectiveness|cost effectiveness
457557|NCT01192646|male involvement|male involvement
457558|NCT01192646|delivery at hospital|delivery at hospital
457559|NCT01192646|complication readiness|complication readiness
457560|NCT01192646|Health seeking behavior in pregnancy, labour and pregnancy complication|health seeking behavior in pregnancy, labour and pregnancy complication
457561|NCT01192633|Sarcoma|sarcoma
457562|NCT01192633|gemcitabine|gemcitabine
457563|NCT01192633|vincristine|vincristine
457564|NCT01192633|cisplatin|cisplatin
457565|NCT01192633|chemotherapy|chemotherapy
457566|NCT01192620|Pediatric Appendicitis|pediatric appendicitis
457567|NCT01192620|Pathway|pathway
457568|NCT01192594|symptom management|symptom management
457569|NCT01192594|empowerment|empowerment
457570|NCT01192594|medication adherence|medication adherence
457571|NCT01192594|recovery|recovery
457572|NCT01192594|schizophrenia|schizophrenia
457573|NCT01192594|post-psychotic adjustment process|post-psychotic adjustment process
457574|NCT01192594|psychological adjustment|psychological adjustment
457575|NCT01192594|psychiatric case managers|psychiatric case managers
457576|NCT01192594|psychosis|psychosis
457577|NCT01192594|insight|insight
457578|NCT01192594|cognitive function|cognitive function
457579|NCT01192581|brain hypoperfusion|brain hypoperfusion
457580|NCT01192581|Vuloven|vuloven
457581|NCT01192581|computed tomography perfusion|computed tomography perfusion
457582|NCT01192555|Neuroblastoma|neuroblastoma
457583|NCT01192555|Chemotherapy|chemotherapy
457584|NCT01192555|Pediatrics|pediatrics
457585|NCT01192555|Cytoxan|cytoxan
457586|NCT01192555|immunotherapy|immunotherapy
457587|NCT01192555|vaccine|vaccine
457588|NCT01192529|Senile|senile
457589|NCT01192529|Dementia|dementia
457590|NCT01192529|Neurodegenerative|neurodegenerative
457591|NCT01192529|Supressi|supressi
457592|NCT01192529|Specific diet|specific diet
457593|NCT01192529|Cognitive Status|cognitive status
457594|NCT01192529|Memory|memory
457595|NCT01192529|Malnutrition|malnutrition
457596|NCT01192529|Parkinson|parkinson
457597|NCT01192529|Alzheimer|alzheimer
457598|NCT01192516|Osteoarthritis|osteoarthritis
457599|NCT01192516|Activity Pacing|activity pacing
457600|NCT01192503|Restless Legs Syndrome|restless legs syndrome
457601|NCT01192503|rasagiline|rasagiline
457602|NCT01192503|futility|futility
457603|NCT01192477|Air pollution|air pollution
457604|NCT01192477|Ozone|ozone
457605|NCT01192477|Health effects of ozone exposure|health effects of ozone exposure
457606|NCT01192464|Hodgkin's Lymphoma|hodgkin's lymphoma
457607|NCT01192464|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
457608|NCT01192438|prostate|prostate
457609|NCT01192438|cancer|cancer
457610|NCT01192438|ablation|ablation
457611|NCT01192438|laser-induced|laser-induced
457612|NCT01192438|focal therapy|focal therapy
457613|NCT01192425|PNH clone cells|pnh clone cells
457614|NCT01192425|Aplastic Anemia|aplastic anemia
457615|NCT01192425|AA|aa
457616|NCT01192425|Myelodysplastic Syndromes|myelodysplastic syndromes
457617|NCT01192425|MDS|mds
457618|NCT01192425|bone marrow failure syndromes|bone marrow failure syndromes
457619|NCT01192425|FLAER|flaer
457620|NCT01192425|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
457621|NCT01192412|hypertension|hypertension
457622|NCT01192412|pregnancy|pregnancy
457623|NCT01192412|antihypertensive therapy|antihypertensive therapy
457624|NCT01192412|perinatal outcome|perinatal outcome
457625|NCT01192412|maternal outcome|maternal outcome
457626|NCT01192412|Non-severe, non-proteinuric pre-existing or gestational hypertension in pregnancy|non-severe, non-proteinuric pre-existing or gestational hypertension in pregnancy
457627|NCT01192399|Hemolytic Paroxysmal Nocturnal Hemoglobinuria|hemolytic paroxysmal nocturnal hemoglobinuria
457628|NCT01192399|Eculizumab|eculizumab
457629|NCT01192399|PNH|pnh
457630|NCT01192399|Japan|japan
457631|NCT01192360|pediatrics|pediatrics
457632|NCT01192360|Heart Disease|heart disease
457633|NCT01192360|Cystic Fibrosis|cystic fibrosis
457634|NCT01192360|Severe Asthma|severe asthma
457635|NCT01192360|Magnetic Resonance Imaging|magnetic resonance imaging
457636|NCT01192334|knee osteoarthritis arthroplasty postural balance|knee osteoarthritis arthroplasty postural balance
457637|NCT01192321|intraocular lens|intraocular lens
457638|NCT01192321|Toric|toric
457639|NCT01192308|Breast cancer|breast cancer
457640|NCT01192308|Tamoxifen|tamoxifen
457641|NCT01192308|Pharmacokinetics|pharmacokinetics
457642|NCT01192308|Pharmacogenetics|pharmacogenetics
457643|NCT01192308|CYP2D6|cyp2d6
457644|NCT01192295|Malignant pain|malignant pain
457645|NCT01192295|Nonmalignant pain|nonmalignant pain
457646|NCT01192295|Pediatric|pediatric
457647|NCT01192295|Opioid|opioid
457648|NCT01192295|Moderate to severe malignant or nonmalignant pain|moderate to severe malignant or nonmalignant pain
457649|NCT01192282|Female Genital Warts|female genital warts
457650|NCT01192282|HPV Typing|hpv typing
457651|NCT01192282|HIV Status|hiv status
457652|NCT01192282|Treatment Modalities and Recurrence|treatment modalities and recurrence
457653|NCT01192282|Socio-economic Burdens|socio-economic burdens
457654|NCT01192269|cheek cells|cheek cells
457655|NCT01192269|phospholipids|phospholipids
457656|NCT01192269|fatty acids|fatty acids
457657|NCT01192269|docosahexaenoic acid|docosahexaenoic acid
457658|NCT01192269|Buccal Cheek cells|buccal cheek cells
457659|NCT01192269|non invasive fatty acid status marker|non invasive fatty acid status marker
457660|NCT01192256|smoking|smoking
457661|NCT01192256|cessation|cessation
457662|NCT01192256|mortality|mortality
457663|NCT01192256|quality of life|quality of life
457664|NCT01192243|Objective response rate|objective response rate
457665|NCT01192243|Time to Progression|time to progression
457666|NCT01192243|Quality of Live|quality of live
457667|NCT01192230|Objective response rate|objective response rate
457668|NCT01192230|Disease control rate|disease control rate
457669|NCT01192230|Disease free survival|disease free survival
457670|NCT01192230|Overall survival|overall survival
457671|NCT01192230|Quality of Live|quality of live
457672|NCT01192230|Nonsmall cell lung cancer|nonsmall cell lung cancer
457673|NCT01192230|toxicity|toxicity
457674|NCT01192217|video-assisted thoracic surgery|video-assisted thoracic surgery
457675|NCT01192217|axillary mini-thoracotomy|axillary mini-thoracotomy
457676|NCT01192217|bullectomy|bullectomy
457677|NCT01192204|FBR, OSCC, chemoprevention|fbr, oscc, chemoprevention
457678|NCT01192191|GW642444|gw642444
457679|NCT01192191|COPD|copd
457680|NCT01192191|Fluticasone Furoate|fluticasone furoate
457681|NCT01192178|pediatric|pediatric
457682|NCT01192178|exacerbation|exacerbation
457683|NCT01192178|viral induced exacerbation|viral induced exacerbation
457684|NCT01192178|asthma|asthma
457685|NCT01192165|Taxotere|taxotere
457686|NCT01192165|Cisplatin|cisplatin
457687|NCT01192165|Carboplatin|carboplatin
457688|NCT01192165|Trametinib|trametinib
457689|NCT01192165|GSK1120212|gsk1120212
457690|NCT01192165|Tarceva|tarceva
457691|NCT01192165|KRAS|kras
457692|NCT01192165|Pemetrexed|pemetrexed
457693|NCT01192165|MEK inhibitor|mek inhibitor
457694|NCT01192165|nab-Paclitaxel|nab-paclitaxel
457695|NCT01192165|Docetaxel|docetaxel
457696|NCT01192165|Alimta|alimta
457697|NCT01192165|Abraxane|abraxane
457698|NCT01192165|Erlotinib|erlotinib
457699|NCT01192113|Mecobalamin|mecobalamin
457700|NCT01192113|peripheral neuropathy|peripheral neuropathy
457701|NCT01192113|diabetic neuropathy|diabetic neuropathy
457702|NCT01192100|Protein-rich breakfast|protein-rich breakfast
457703|NCT01192100|Breakfast Skipping|breakfast skipping
457704|NCT01192100|Adolescents|adolescents
457705|NCT01192100|Obesity|obesity
457706|NCT01192100|Increased dietary protein|increased dietary protein
457707|NCT01192100|Breakfast|breakfast
457708|NCT01192100|fMRI|fmri
457709|NCT01192100|Ghrelin|ghrelin
457710|NCT01192100|PYY|pyy
457711|NCT01192087|adenoid cystic carcinoma|adenoid cystic carcinoma
457712|NCT01192087|carbon ion therapy|carbon ion therapy
457713|NCT01192087|IMRT (intensity-modulated therapy)|imrt (intensity-modulated therapy)
457714|NCT01192087|radioimmunotherapy|radioimmunotherapy
457715|NCT01192087|Cetuximab|cetuximab
457716|NCT01192074|Obstetric|obstetric
457717|NCT01192074|Analgesia|analgesia
457718|NCT01192074|Anesthesia|anesthesia
457719|NCT01192074|Obstetric Anesthesia|obstetric anesthesia
457720|NCT01192074|Obstetric Analgesia|obstetric analgesia
457721|NCT01192074|ultrasound|ultrasound
457722|NCT01192074|ultrasonography|ultrasonography
457723|NCT01192074|epidural analgesia|epidural analgesia
457724|NCT01192074|epidural anesthesia|epidural anesthesia
457725|NCT01192074|spinal anesthesia|spinal anesthesia
457726|NCT01192074|neuraxial anesthesia|neuraxial anesthesia
457727|NCT01192074|neuraxial analgesia|neuraxial analgesia
457728|NCT01192074|pregnancy|pregnancy
457729|NCT01192074|labor|labor
457730|NCT01192074|cesarean delivery|cesarean delivery
457731|NCT01192074|cesarean section|cesarean section
457732|NCT01192061|autonomic nervous system|autonomic nervous system
457733|NCT01192061|heart rate variability|heart rate variability
457734|NCT01192061|blood pressure variability|blood pressure variability
457735|NCT01192061|retrobulbar hemodynamics|retrobulbar hemodynamics
457736|NCT01192061|vascular dysregulation|vascular dysregulation
457737|NCT01192048|Congenital Heart Disease|congenital heart disease
457738|NCT01192048|birth defect|birth defect
457739|NCT01192048|genetics|genetics
457740|NCT01192048|gene|gene
457741|NCT01192048|DNA|dna
457742|NCT01192048|direct sequencing|direct sequencing
457743|NCT01192048|microarray|microarray
457744|NCT01192048|single nucleotide polymorphism|single nucleotide polymorphism
457745|NCT01192048|whole genome array comparative genomic hybridization|whole genome array comparative genomic hybridization
457746|NCT01192048|chromosomal copy number change|chromosomal copy number change
457747|NCT01192048|nucleotide sequence variation|nucleotide sequence variation
457748|NCT01192048|exome sequencing|exome sequencing
457749|NCT01192048|whole exome sequencing|whole exome sequencing
457750|NCT01192035|Africa, Western|africa, western
457751|NCT01192035|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
457752|NCT01192022|Liver resection|liver resection
457753|NCT01192022|Liver transplantation|liver transplantation
457754|NCT01192022|Liver surgery|liver surgery
457755|NCT01192022|Secondary hemostasis|secondary hemostasis
457756|NCT01192009|Leucine|leucine
457757|NCT01192009|Skeletal Muscle Disuse|skeletal muscle disuse
457758|NCT01192009|Atrophy|atrophy
457759|NCT01192009|Proteolysis|proteolysis
457760|NCT01191996|SPMS|spms
457761|NCT01191996|PPMS|ppms
457762|NCT01191996|MS|ms
457763|NCT01191996|Multiple Sclerosis|multiple sclerosis
457764|NCT01191970|epidural|epidural
457765|NCT01191970|beta-endorphins|beta-endorphins
457766|NCT01191970|breast-feeding|breast-feeding
457767|NCT01191970|colostrum|colostrum
457768|NCT01191970|feeding|feeding
457769|NCT01191957|Acute Myeloid Leukemia|acute myeloid leukemia
457770|NCT01191957|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
457771|NCT01191918|acetylcholinesterase inhibitor|acetylcholinesterase inhibitor
457772|NCT01191918|donepezil|donepezil
457773|NCT01191918|bipolar disorder|bipolar disorder
457774|NCT01191918|mania|mania
457775|NCT01191918|lithium|lithium
457776|NCT01191892|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
457777|NCT01191892|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
457778|NCT01191892|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
457779|NCT01191892|stage III bladder cancer|stage iii bladder cancer
457780|NCT01191892|stage IV bladder cancer|stage iv bladder cancer
457781|NCT01191892|anterior urethral cancer|anterior urethral cancer
457782|NCT01191892|posterior urethral cancer|posterior urethral cancer
457783|NCT01191892|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
457784|NCT01191892|ureter cancer|ureter cancer
457785|NCT01191866|diabetes mellitus|diabetes mellitus
457786|NCT01191866|psychosocial|psychosocial
457787|NCT01191866|metabolic control|metabolic control
457788|NCT01191866|quality of life questionnaires|quality of life questionnaires
457789|NCT01191866|children|children
457790|NCT01191866|adolescents|adolescents
457791|NCT01191853|Post Swine Flu Blood Samples|post swine flu blood samples
457792|NCT01191853|Biologic Samples|biologic samples
457793|NCT01191853|Laboratory Research Samples|laboratory research samples
457794|NCT01191853|Swine Flu|swine flu
457795|NCT01191853|Immunization|immunization
457796|NCT01191853|Healthy Volunteer|healthy volunteer
457797|NCT01191853|HV|hv
457798|NCT01191840|staphylococci|staphylococci
457799|NCT01191814|pancreatic cancer|pancreatic cancer
457800|NCT01191814|obstructive jaundice|obstructive jaundice
457801|NCT01191814|Obstructive jaundice secondary to pancreatic cancer|obstructive jaundice secondary to pancreatic cancer
457802|NCT01191801|Leukemia|leukemia
457803|NCT01191801|Acute Myeloid Leukemia|acute myeloid leukemia
457804|NCT01191801|Hematologic|hematologic
457805|NCT01191801|Hematologic diseases|hematologic diseases
457806|NCT01191801|Blood|blood
457807|NCT01191801|Cancer|cancer
457808|NCT01191801|Malignancy|malignancy
457809|NCT01191801|Vosaroxin|vosaroxin
457810|NCT01191801|Cytarabine|cytarabine
457811|NCT01191801|First Relapsed AML|first relapsed aml
457812|NCT01191801|Refractory AML|refractory aml
457813|NCT01191801|VALOR|valor
457814|NCT01191801|Sunesis|sunesis
457815|NCT01191801|Voreloxin|voreloxin
457816|NCT01191801|SNS-595|sns-595
457817|NCT01191788|Depression|depression
457818|NCT01191788|Substance Use|substance use
457819|NCT01191788|Group Cognitive Behavioral Therapy|group cognitive behavioral therapy
457820|NCT01191775|Oligonucleotide|oligonucleotide
457821|NCT01191775|DNAi|dnai
457822|NCT01191775|Oncology|oncology
457823|NCT01191775|Antineoplastic agent|antineoplastic agent
457824|NCT01191775|Lymphoma|lymphoma
457825|NCT01191775|PNT2258|pnt2258
457826|NCT01191762|secondary hyperparathyroidism|secondary hyperparathyroidism
457827|NCT01191762|phosphate|phosphate
457828|NCT01191762|calcium|calcium
457829|NCT01191762|chronic kidney disease|chronic kidney disease
457830|NCT01191749|Hematologic Disorder|hematologic disorder
457831|NCT01191749|Aplastic Anemia|aplastic anemia
457832|NCT01191749|T - Cell Large Granular Lymphocytic Leukemia|t - cell large granular lymphocytic leukemia
457833|NCT01191749|T-LGL|t-lgl
457834|NCT01191749|Myelodysplastic Syndrome|myelodysplastic syndrome
457835|NCT01191749|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
457836|NCT01191749|CLL|cll
457837|NCT01191749|Chemotherapy|chemotherapy
457838|NCT01191749|Alemtuzumab|alemtuzumab
457839|NCT01191736|hands only|hands only
457840|NCT01191736|CPR|cpr
457841|NCT01191736|resuscitation|resuscitation
457842|NCT01191736|cardiac arrest|cardiac arrest
457843|NCT01191736|Education of general public regarding resuscitation methods|education of general public regarding resuscitation methods
457844|NCT01191723|Healthy Volunteers|healthy volunteers
457845|NCT01191710|progesterone|progesterone
457846|NCT01191697|HER2 positive|her2 positive
457847|NCT01191671|Child Development|child development
457848|NCT01191671|Child|child
457849|NCT01191671|Daycare centers|daycare centers
457850|NCT01191671|Language|language
457851|NCT01191645|Lower esophageal sphincter pressure|lower esophageal sphincter pressure
457852|NCT01191645|Esophageal motility|esophageal motility
457853|NCT01191645|Remifentanil|remifentanil
457854|NCT01191645|Metoclopramide|metoclopramide
457855|NCT01191645|Naloxone|naloxone
457856|NCT01191645|High resolution solid state manometry|high resolution solid state manometry
457857|NCT01191632|T cell|t cell
457858|NCT01191632|surgery|surgery
457859|NCT01191632|radiation|radiation
457860|NCT01191619|McIvor retractor|mcivor retractor
457861|NCT01191619|Proseal laryngeal mask airway|proseal laryngeal mask airway
457862|NCT01191606|pressure controlled|pressure controlled
457863|NCT01191606|volume controlled|volume controlled
457864|NCT01191606|arterial oxygenation|arterial oxygenation
457865|NCT01191606|one lung ventilation|one lung ventilation
457866|NCT01191593|Adductor-Canal-Blockade|adductor-canal-blockade
457867|NCT01191593|postoperative pain|postoperative pain
457868|NCT01191593|US-guided nerve block|us-guided nerve block
457869|NCT01191593|revision knee arthroplasty|revision knee arthroplasty
457870|NCT01191567|acute wounds|acute wounds
457871|NCT01191567|postoperative wounds|postoperative wounds
457872|NCT01191541|ara-c|ara-c
457873|NCT01191541|As2O3|as2o3
457874|NCT01191541|pediatric|pediatric
457875|NCT01191541|acute|acute
457876|NCT01191528|Adult|adult
457877|NCT01191528|Post|post
457878|NCT01191528|operative|operative
457879|NCT01191528|oximetry|oximetry
457880|NCT01191528|capnometry|capnometry
457881|NCT01191528|Integrated|integrated
457882|NCT01191528|Pulmonary|pulmonary
457883|NCT01191528|Index|index
457884|NCT01191528|End-tidal|end-tidal
457885|NCT01191528|Monitoring Respiratory status|monitoring respiratory status
457886|NCT01191528|post-operative|post-operative
457887|NCT01191515|Previous Cataract patients|previous cataract patients
457888|NCT01191515|Monofocal IOL implant|monofocal iol implant
457889|NCT01191515|Evaluation|evaluation
457890|NCT01191502|Patients who have had binocular implantation of the Tecnis Multifocal IOL or the Crystalens™ HD Accommodating IOL.|patients who have had binocular implantation of the tecnis multifocal iol or the crystalens™ hd accommodating iol.
457891|NCT01191476|Sevoflurane|sevoflurane
457892|NCT01191476|Propofol|propofol
457893|NCT01191476|Economics|economics
457894|NCT01191476|Pharmaceutical|pharmaceutical
457895|NCT01191476|Chinese|chinese
457896|NCT01191450|chlortalidone|chlortalidone
457897|NCT01191450|amiloride|amiloride
457898|NCT01191450|arterial hypertension|arterial hypertension
457899|NCT01191424|Asthma|asthma
457900|NCT01191424|PK|pk
457901|NCT01191424|Adolescents|adolescents
457902|NCT01191424|Adults|adults
457903|NCT01191411|colorectal neoplasms|colorectal neoplasms
457904|NCT01191411|screening|screening
457905|NCT01191398|Hypersalivation|hypersalivation
457906|NCT01191398|Conscious Sedation|conscious sedation
457907|NCT01191398|Procedural Sedation|procedural sedation
457908|NCT01191398|Ketamine|ketamine
457909|NCT01191398|Atropine|atropine
457910|NCT01191398|Glycopyrrolate|glycopyrrolate
457911|NCT01191385|HCC|hcc
457912|NCT01191385|Liver cancer|liver cancer
457913|NCT01191385|Cancer of liver|cancer of liver
457914|NCT01191385|Cancer, liver|cancer, liver
457915|NCT01191385|Hepatic cancer|hepatic cancer
457916|NCT01191385|Cancer, hepatic|cancer, hepatic
457917|NCT01191385|Carcinoma, hepatocellular|carcinoma, hepatocellular
457918|NCT01191372|Hemophilia A|hemophilia a
457919|NCT01191372|Hemophilia B|hemophilia b
457920|NCT01191372|pharmacokinetics|pharmacokinetics
457921|NCT01191372|pharmacodynamics|pharmacodynamics
457922|NCT01191372|Tissue Factor Pathway Inhibitor|tissue factor pathway inhibitor
457923|NCT01191333|Mood Disorder|mood disorder
457924|NCT01191333|Depression|depression
457925|NCT01191333|stress disorder, post-traumatic|stress disorder, post-traumatic
457926|NCT01191333|Depressive Disorder|depressive disorder
457927|NCT01191333|Stress Disorders, Traumatic|stress disorders, traumatic
457928|NCT01191333|substance related disorders|substance related disorders
457929|NCT01191333|Transcranial Magnetic Stimulation, repetitive|transcranial magnetic stimulation, repetitive
457930|NCT01191333|transcranial magnetic stimulation|transcranial magnetic stimulation
457931|NCT01191333|Veterans|veterans
457932|NCT01191333|mental health|mental health
457933|NCT01191320|Adult onset hypogonadotropic hypogonadism|adult onset hypogonadotropic hypogonadism
457934|NCT01191307|Primary dystonia|primary dystonia
457935|NCT01191307|Epilepsy|epilepsy
457936|NCT01191307|Hydrocephalus|hydrocephalus
457937|NCT01191307|Bladder Control|bladder control
457938|NCT01191307|Deaf or Hearing Impaired|deaf or hearing impaired
457939|NCT01191294|Melanoma|melanoma
457940|NCT01191294|Simulation Training|simulation training
457941|NCT01191294|Medical Students|medical students
457942|NCT01191281|food habits|food habits
457943|NCT01191281|nutrition requirements|nutrition requirements
457944|NCT01191281|antiretroviral therapy|antiretroviral therapy
457945|NCT01191255|ESRD|esrd
457946|NCT01191255|end-stage renal disease|end-stage renal disease
457947|NCT01191255|dialysis|dialysis
457948|NCT01191255|hemodialysis|hemodialysis
457949|NCT01191255|peritoneal dialysis|peritoneal dialysis
457950|NCT01191255|hemodialysis (HD)|hemodialysis (hd)
457951|NCT01191255|peritoneal dialysis (PD)|peritoneal dialysis (pd)
457952|NCT01191255|chronic renal insufficiency|chronic renal insufficiency
457953|NCT01191255|phosphate binder|phosphate binder
457954|NCT01191255|kidney failure|kidney failure
457955|NCT01191255|renal failure|renal failure
457956|NCT01191242|methadone|methadone
457957|NCT01191242|genetic|genetic
457958|NCT01191203|Acceptability and Adherence to methods|acceptability and adherence to methods
457959|NCT01191190|Leukemia|leukemia
457960|NCT01191190|Chronic leukemia|chronic leukemia
457961|NCT01191190|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
457962|NCT01191190|Relapsed|relapsed
457963|NCT01191190|Refractory|refractory
457964|NCT01191177|oral fish oil|oral fish oil
457965|NCT01191177|Lovaza|lovaza
457966|NCT01191177|Omega-3-acid supplementation|omega-3-acid supplementation
457967|NCT01191164|Brachytherapy, Partial Breast Irradiation, Breast Seed Implant, Palladium Seeds|brachytherapy, partial breast irradiation, breast seed implant, palladium seeds
457968|NCT01191151|Orthopedic surgery|orthopedic surgery
457969|NCT01191151|sports medicine|sports medicine
457970|NCT01191138|Delayed Gastric emptying|delayed gastric emptying
457971|NCT01191138|Gastric emptying scintigraphy|gastric emptying scintigraphy
457972|NCT01191138|Pancreatic fistula|pancreatic fistula
457973|NCT01191138|Pancreatic Neoplasms|pancreatic neoplasms
457974|NCT01191138|Whipple Operation|whipple operation
457975|NCT01191086|Epilepsy|epilepsy
457976|NCT01191086|partial onset seizure|partial onset seizure
457977|NCT01191086|adjunctive therapy|adjunctive therapy
457978|NCT01191073|edentulous|edentulous
457979|NCT01191060|Progression free survival prolongation|progression free survival prolongation
457980|NCT01191060|Disease Progression|disease progression
457981|NCT01191060|Overall survival|overall survival
457983|NCT01191021|propofol|propofol
457984|NCT01191021|general anesthesia|general anesthesia
457985|NCT01191008|Xalacom Regulatory post marketing commitment plan safety|xalacom regulatory post marketing commitment plan safety
457986|NCT01190995|Pain|pain
457987|NCT01190995|Neonate|neonate
457988|NCT01190995|Procedure|procedure
457989|NCT01190995|Neurobehavioural outcome|neurobehavioural outcome
457990|NCT01190969|Elderly|elderly
457991|NCT01190969|malnutrition|malnutrition
457992|NCT01190969|nutritional supplement|nutritional supplement
457993|NCT01190943|localized osteosarcoma|localized osteosarcoma
457994|NCT01190943|metastatic osteosarcoma|metastatic osteosarcoma
457995|NCT01190943|recurrent osteosarcoma|recurrent osteosarcoma
457996|NCT01190917|Autism|autism
457997|NCT01190917|Autism Spectrum Disorder|autism spectrum disorder
457998|NCT01190917|Disorder|disorder
457999|NCT01190917|Autistic|autistic
458000|NCT01190917|Asperger Syndrome|asperger syndrome
458001|NCT01190917|social skills group|social skills group
458002|NCT01190917|behavioral intervention|behavioral intervention
458003|NCT01190917|Imaging, Magnetic Resonance|imaging, magnetic resonance
458004|NCT01190917|fMRI|fmri
458005|NCT01190917|Functional MRI|functional mri
458006|NCT01190917|MRI, Functional|mri, functional
458007|NCT01190917|Magnetic Resonance Imaging|magnetic resonance imaging
458008|NCT01190917|Functional|functional
458009|NCT01190904|Androgen deficiency|androgen deficiency
458010|NCT01190904|Erectile dysfunction|erectile dysfunction
458011|NCT01190904|Coronary Artery Disease|coronary artery disease
458012|NCT01190904|Coronary Revascularization|coronary revascularization
458013|NCT01190904|Diabetes mellitus|diabetes mellitus
458014|NCT01190904|MI|mi
458015|NCT01190904|Stroke|stroke
458016|NCT01190904|MACCE|macce
458017|NCT01190904|DM|dm
458018|NCT01190904|ED|ed
458019|NCT01190904|CAD|cad
458020|NCT01190904|Development of predictive cardiovascular/cerebrovascular AE|development of predictive cardiovascular/cerebrovascular ae
458021|NCT01190891|Rotator cuff tendonitis|rotator cuff tendonitis
458022|NCT01190891|Shoulder pain|shoulder pain
458023|NCT01190891|Shoulder impingement|shoulder impingement
458024|NCT01190839|Crohn's Disease|crohn's disease
458025|NCT01190839|Inflammatory Bowel Disease|inflammatory bowel disease
458026|NCT01190839|infliximab|infliximab
458027|NCT01190839|TNF-alpha|tnf-alpha
458028|NCT01190826|Stable moderate asthma|stable moderate asthma
458029|NCT01190813|amblyopia, levodopa|amblyopia, levodopa
458030|NCT01190800|Alzheimer's Disease|alzheimer's disease
458031|NCT01190800|Capacity assessment|capacity assessment
458032|NCT01190800|Decision-making assessment|decision-making assessment
458033|NCT01190800|Capacity to consent to treatment|capacity to consent to treatment
458034|NCT01190800|Capacity to vote|capacity to vote
458035|NCT01190800|Capacity to appoint a proxy|capacity to appoint a proxy
458036|NCT01190787|Multiple Myeloma|multiple myeloma
458037|NCT01190787|Elderly Patients|elderly patients
458038|NCT01190787|Diagnosis|diagnosis
458039|NCT01190787|Velcade subcutaneous|velcade subcutaneous
458040|NCT01190787|Prednisone|prednisone
458041|NCT01190787|Melphalan|melphalan
458042|NCT01190787|Cyclophosphamide|cyclophosphamide
458043|NCT01190774|dental anxiety|dental anxiety
458044|NCT01190774|state anxiety|state anxiety
458045|NCT01190774|randomised control trial|randomised control trial
458046|NCT01190774|psychological intervention|psychological intervention
458047|NCT01190761|Bioequivalence|bioequivalence
458048|NCT01190761|Galantamine|galantamine
458049|NCT01190761|Reminyl|reminyl
458050|NCT01190761|Galantamine hydrobromide|galantamine hydrobromide
458051|NCT01190761|Healthy subjects|healthy subjects
458052|NCT01190748|Bioequivalence|bioequivalence
458053|NCT01190748|Galantamine|galantamine
458054|NCT01190748|Reminyl|reminyl
458055|NCT01190748|Galantamine hydrobromide|galantamine hydrobromide
458056|NCT01190748|Healthy subjects|healthy subjects
458057|NCT01190735|Caffeine|caffeine
458058|NCT01190735|Parkinson's Disease|parkinson's disease
458059|NCT01190735|Parkinson Disease|parkinson disease
458060|NCT01190735|Parkinsonian Disorders|parkinsonian disorders
458061|NCT01190735|Basal Ganglia Diseases|basal ganglia diseases
458062|NCT01190735|Brain Diseases|brain diseases
458063|NCT01190735|Central Nervous System Diseases|central nervous system diseases
458064|NCT01190735|Nervous System Diseases|nervous system diseases
458065|NCT01190735|Movement Disorders|movement disorders
458066|NCT01190735|Neurodegenerative Diseases|neurodegenerative diseases
458067|NCT01190735|Caffeine citrate|caffeine citrate
458068|NCT01190735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
458069|NCT01190735|Pharmacologic Actions|pharmacologic actions
458070|NCT01190735|Central Nervous System Stimulants|central nervous system stimulants
458071|NCT01190735|Physiological Effects of Drugs|physiological effects of drugs
458072|NCT01190735|Central Nervous System Agents|central nervous system agents
458073|NCT01190735|Therapeutic Uses|therapeutic uses
458074|NCT01190722|Day case surgery|day case surgery
458075|NCT01190722|postoperative pain|postoperative pain
458076|NCT01190722|NSAIDs|nsaids
458077|NCT01190722|Coxibs|coxibs
458078|NCT01190709|Close Fracture|close fracture
458079|NCT01190709|Tibia|tibia
458080|NCT01190709|Unreamed Intramedullary Nailing|unreamed intramedullary nailing
458081|NCT01190709|Dynamic Compression Plate|dynamic compression plate
458082|NCT01190696|Spica Cast|spica cast
458083|NCT01190696|TEN|ten
458084|NCT01190696|Femoral Shaft Fracture|femoral shaft fracture
458085|NCT01190696|Children|children
458086|NCT01190670|ASP015K|asp015k
458087|NCT01190670|tacrolimus|tacrolimus
458088|NCT01190670|healthy volunteers|healthy volunteers
458089|NCT01190657|Teprenone|teprenone
458090|NCT01190657|safety|safety
458091|NCT01190657|efficacy|efficacy
458092|NCT01190657|acute gastric lesion|acute gastric lesion
458378|NCT01189409|Sennosides|sennosides
458093|NCT01190657|chronic gastritis|chronic gastritis
458094|NCT01190644|Red Blood Cell Mass|red blood cell mass
458095|NCT01190644|Plasma Volume|plasma volume
458096|NCT01190644|Solid Tumors|solid tumors
458097|NCT01190631|intraocular lens|intraocular lens
458098|NCT01190631|cataracts|cataracts
458099|NCT01190631|total residual spherical aberration|total residual spherical aberration
458100|NCT01190631|high order aberrations|high order aberrations
458101|NCT01190605|HIV|hiv
458102|NCT01190605|postpartum|postpartum
458103|NCT01190605|postpartum entry into HIV care|postpartum entry into hiv care
458104|NCT01190592|Resistance training|resistance training
458105|NCT01190592|Body Composition|body composition
458106|NCT01190592|Cardiovascular Risk factors|cardiovascular risk factors
458107|NCT01190592|Dairy|dairy
458108|NCT01190579|Coronary Artery Disease|coronary artery disease
458109|NCT01190579|Chest Pain|chest pain
458110|NCT01190579|Computed Tomography|computed tomography
458111|NCT01190566|Magnetic Resonance Imaging, Functional|magnetic resonance imaging, functional
458112|NCT01190566|Tomography, Positron-Emission|tomography, positron-emission
458113|NCT01190566|chemotherapy|chemotherapy
458114|NCT01190553|amantadine|amantadine
458115|NCT01190553|parkinson disease|parkinson disease
458116|NCT01190553|dyskinesia|dyskinesia
458117|NCT01190540|On site support services.|on site support services.
458118|NCT01190540|mid level health professionals.|mid level health professionals.
458119|NCT01190540|cost effectiveness.|cost effectiveness.
458120|NCT01190540|infectious disease.|infectious disease.
458121|NCT01190540|capacity building.|capacity building.
458122|NCT01190514|DVS SR|dvs sr
458123|NCT01190514|healthy|healthy
458124|NCT01190514|Bioequivalence study|bioequivalence study
458125|NCT01190501|blood pressure|blood pressure
458126|NCT01190501|antihypertensive treatments|antihypertensive treatments
458127|NCT01190488|End of life decision making|end of life decision making
458128|NCT01190488|End of life decision aid|end of life decision aid
458129|NCT01190488|Palliative care decision making|palliative care decision making
458130|NCT01190488|Palliative care decision aid|palliative care decision aid
458131|NCT01190488|Advanced care planning|advanced care planning
458132|NCT01190488|Decision Aid|decision aid
458133|NCT01190475|Endometriosis|endometriosis
458134|NCT01190475|Infertility|infertility
458135|NCT01190475|Pain|pain
458136|NCT01190475|Vaginal Diseases|vaginal diseases
458137|NCT01190475|Uterine Diseases|uterine diseases
458138|NCT01190462|recurrent colon cancer|recurrent colon cancer
458139|NCT01190462|stage III colon cancer|stage iii colon cancer
458140|NCT01190462|stage IV colon cancer|stage iv colon cancer
458141|NCT01190462|recurrent rectal cancer|recurrent rectal cancer
458142|NCT01190462|stage III rectal cancer|stage iii rectal cancer
458143|NCT01190462|stage IV rectal cancer|stage iv rectal cancer
458144|NCT01190449|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
458145|NCT01190449|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
458146|NCT01190449|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
458147|NCT01190449|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
458148|NCT01190449|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
458149|NCT01190449|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
458150|NCT01190449|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
458151|NCT01190449|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
458152|NCT01190449|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
458153|NCT01190449|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
458154|NCT01190449|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
458155|NCT01190449|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
458156|NCT01190436|Hypertension|hypertension
458157|NCT01190436|Diabetes Mellitus|diabetes mellitus
458158|NCT01190436|Bisoprolol|bisoprolol
458159|NCT01190423|AN|an
458160|NCT01190410|Certolizumab Pegol|certolizumab pegol
458161|NCT01190410|Cimzia®|cimzia®
458162|NCT01190410|Crohn's Disease|crohn's disease
458163|NCT01190410|Children and Adolescents with Crohn's Disease|children and adolescents with crohn's disease
458164|NCT01190397|Warming goggles|warming goggles
458165|NCT01190384|Metabolic Syndrome|metabolic syndrome
458166|NCT01190384|Inflammation|inflammation
458167|NCT01190384|Antioxidants|antioxidants
458168|NCT01190384|Satiety|satiety
458169|NCT01190384|Fiber|fiber
458170|NCT01190371|Artemisinin tolerance|artemisinin tolerance
458171|NCT01190345|breast cancer|breast cancer
458172|NCT01190332|common bile duct stones|common bile duct stones
458173|NCT01190319|blood pressure|blood pressure
458174|NCT01190319|strawberry|strawberry
458175|NCT01190319|fruit phenolics|fruit phenolics
458176|NCT01190319|LDL oxidation|ldl oxidation
458177|NCT01190319|Flow mediated dilation (FMD)|flow mediated dilation (fmd)
458178|NCT01190254|Asenapine|asenapine
458179|NCT01190254|adolescents|adolescents
458180|NCT01190254|schizophrenia|schizophrenia
458181|NCT01190254|phase IIIb|phase iiib
458182|NCT01190254|placebo-controlled|placebo-controlled
458183|NCT01190241|targeted therapy|targeted therapy
458184|NCT01190241|individualized medicine|individualized medicine
458185|NCT01190241|tyrosine kinase inhibitor|tyrosine kinase inhibitor
458186|NCT01190241|kinome profiling|kinome profiling
458187|NCT01190241|Metastasized|metastasized
458188|NCT01190228|Japanese Encephalitis|japanese encephalitis
458189|NCT01190228|Japanese encephalitis chimeric virus vaccine|japanese encephalitis chimeric virus vaccine
458190|NCT01190228|Varicella|varicella
458191|NCT01190228|Varicella vaccine|varicella vaccine
458192|NCT01190215|Influenza|influenza
458193|NCT01190215|Pandemrix|pandemrix
458194|NCT01190215|H1N1|h1n1
458195|NCT01190215|Fluarix|fluarix
458196|NCT01190202|Malaria|malaria
458197|NCT01190202|Plasmodium falciparum|plasmodium falciparum
458198|NCT01190189|Serious adverse events (SAEs)|serious adverse events (saes)
458199|NCT01190189|HPV vaccine|hpv vaccine
458200|NCT01190189|Medically significant conditions|medically significant conditions
458201|NCT01190189|Cervical neoplasia|cervical neoplasia
458202|NCT01190176|HPV|hpv
458203|NCT01190176|HPV vaccine|hpv vaccine
458204|NCT01190176|Cervical neoplasia|cervical neoplasia
458205|NCT01190176|Human papillomavirus|human papillomavirus
458206|NCT01190176|Papillomavirus|papillomavirus
458207|NCT01190176|Cervical cancer|cervical cancer
458208|NCT01190176|Human papillomavirus (HPV) type 16/18 infections|human papillomavirus (hpv) type 16/18 infections
458209|NCT01190163|Vaginal Birth delivery within 24 hours and C-section rate|vaginal birth delivery within 24 hours and c-section rate
458210|NCT01190150|Cyclic Heavy Menstrual Bleed|cyclic heavy menstrual bleed
458211|NCT01190150|Menorraghia|menorraghia
458212|NCT01190137|Optimal vitamin D status|optimal vitamin d status
458213|NCT01190137|25-hydroxy vitamin D|25-hydroxy vitamin d
458214|NCT01190137|Rickets and bone mineralization|rickets and bone mineralization
458215|NCT01190137|Breast fed infants|breast fed infants
458216|NCT01190137|Cholecalciferol and ergocalciferol|cholecalciferol and ergocalciferol
458217|NCT01190124|HIV infections|hiv infections
458218|NCT01190124|HIV-1|hiv-1
458219|NCT01190124|HIV-2|hiv-2
458220|NCT01190124|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
458221|NCT01190124|AIDS|aids
458222|NCT01190124|Anti-Retroviral Agents|anti-retroviral agents
458223|NCT01190124|Raltegravir|raltegravir
458224|NCT01190124|Integrase Inhibitors|integrase inhibitors
458225|NCT01190124|multiple-experienced HIV infected patients|multiple-experienced hiv infected patients
458226|NCT01190111|interleukin-7|interleukin-7
458227|NCT01190111|immune-based therapy|immune-based therapy
458228|NCT01190111|HIV|hiv
458229|NCT01190111|viral disease|viral disease
458230|NCT01190098|Partial epilepsy|partial epilepsy
458231|NCT01190098|Excessive daytime sleepiness|excessive daytime sleepiness
458232|NCT01190098|Epworth Sleepiness Scale|epworth sleepiness scale
458233|NCT01190098|Maintenance of Wakefulness Test|maintenance of wakefulness test
458234|NCT01190085|alcoholism|alcoholism
458235|NCT01190085|ghrelin|ghrelin
458236|NCT01190085|craving|craving
458237|NCT01190072|Blood lipids|blood lipids
458238|NCT01190072|percutaneous coronary intervention|percutaneous coronary intervention
458239|NCT01190072|lipid lowering treatment|lipid lowering treatment
458240|NCT01190059|Lung|lung
458241|NCT01190059|Transplantation|transplantation
458242|NCT01190059|Lung Transplantation|lung transplantation
458243|NCT01190059|Transplantation Lung|transplantation lung
458244|NCT01190046|elderly|elderly
458245|NCT01190046|muscle|muscle
458246|NCT01190046|disuse|disuse
458247|NCT01190046|osteoarthritis|osteoarthritis
458248|NCT01190046|exercise|exercise
458249|NCT01189994|Fibromyalgia|fibromyalgia
458250|NCT01189994|Acupuncture|acupuncture
458251|NCT01189994|Randomized Controlled Trial|randomized controlled trial
458252|NCT01189994|Pain|pain
458253|NCT01189994|Quality of Life|quality of life
458254|NCT01189968|Phase 1,|phase 1,
458255|NCT01189968|dose escalation,|dose escalation,
458256|NCT01189968|histologically|histologically
458257|NCT01189968|confirmed|confirmed
458258|NCT01189968|malignancy|malignancy
458259|NCT01189968|metastatic|metastatic
458260|NCT01189955|thyroidectomy|thyroidectomy
458261|NCT01189955|harmonic|harmonic
458262|NCT01189955|RLN|rln
458263|NCT01189942|Phase 1|phase 1
458264|NCT01189942|dose escalation|dose escalation
458265|NCT01189942|histologically|histologically
458266|NCT01189942|confirmed|confirmed
458267|NCT01189942|malignancy|malignancy
458268|NCT01189942|metastatic|metastatic
458269|NCT01189929|Phase 1,|phase 1,
458270|NCT01189929|dose escalation,|dose escalation,
458271|NCT01189929|histologically|histologically
458272|NCT01189929|cytologically|cytologically
458273|NCT01189929|confirmed|confirmed
458274|NCT01189929|malignancy|malignancy
458275|NCT01189929|metastatic|metastatic
458276|NCT01189890|Type 2 Diabetes Mellitus, Hemoglobin A1C, glucagon-like peptide 1 (GLP-1), gastric inhibitory polypeptide (GIP), dipeptidyl peptidase 4 inhibitor (DPP-4)|type 2 diabetes mellitus, hemoglobin a1c, glucagon-like peptide 1 (glp-1), gastric inhibitory polypeptide (gip), dipeptidyl peptidase 4 inhibitor (dpp-4)
458277|NCT01189877|Direct pO2 Measurements|direct po2 measurements
458278|NCT01189877|10-121|10-121
458279|NCT01189851|breast|breast
458280|NCT01189851|IORT|iort
459263|NCT01185678|Compliance|compliance
458281|NCT01189851|electronic brachytherapy|electronic brachytherapy
458282|NCT01189838|Cancer|cancer
458283|NCT01189838|cysteine-rich 61|cysteine-rich 61
458284|NCT01189838|prognosis|prognosis
458285|NCT01189838|transitional cell carcinoma|transitional cell carcinoma
458286|NCT01189825|Physiological|physiological
458287|NCT01189825|Antidepressive Agents|antidepressive agents
458288|NCT01189812|hopelessness|hopelessness
458289|NCT01189812|alone|alone
458290|NCT01189812|sad|sad
458291|NCT01189812|troubled|troubled
458292|NCT01189812|depression|depression
458293|NCT01189799|Co-occurring Disorders|co-occurring disorders
458294|NCT01189799|Depression|depression
458295|NCT01189799|Substance Dependence|substance dependence
458296|NCT01189799|Motivational Therapy|motivational therapy
458297|NCT01189799|Aftercare|aftercare
458298|NCT01189799|Cognitive Behavioral Therapy|cognitive behavioral therapy
458299|NCT01189786|Haploidentical Stem Cell Transplant|haploidentical stem cell transplant
458300|NCT01189786|CD34+ Selection|cd34+ selection
458301|NCT01189786|CliniMACS CD34 Reagent system|clinimacs cd34 reagent system
458302|NCT01189773|pain control|pain control
458303|NCT01189773|limb trauma|limb trauma
458304|NCT01189734|common bile duct stones|common bile duct stones
458305|NCT01189734|laparoscopic common bile duct exploration|laparoscopic common bile duct exploration
458306|NCT01189734|intraoperative ercp|intraoperative ercp
458307|NCT01189734|Preoperatively diagnosed common bile duct stones|preoperatively diagnosed common bile duct stones
458308|NCT01189721|remifentanil|remifentanil
458309|NCT01189721|hyperalgesia|hyperalgesia
458310|NCT01189708|Abdominal aortic aneurysm|abdominal aortic aneurysm
458311|NCT01189708|Abdominal hernia|abdominal hernia
458312|NCT01189695|HIV or AIDS|hiv or aids
458313|NCT01189695|Lopinavir|lopinavir
458314|NCT01189695|Ritonavir|ritonavir
458315|NCT01189695|Anti-Retroviral Agents|anti-retroviral agents
458316|NCT01189695|treatment failure|treatment failure
458317|NCT01189695|treatment experienced|treatment experienced
458318|NCT01189695|NNRTI failure|nnrti failure
458319|NCT01189695|monotherapy|monotherapy
458320|NCT01189682|catheter|catheter
458321|NCT01189682|dressing|dressing
458322|NCT01189682|chlorhexidine|chlorhexidine
458323|NCT01189682|Patient admitted in ICU with a CVC or art. catheter|patient admitted in icu with a cvc or art. catheter
458324|NCT01189669|PCOS|pcos
458325|NCT01189656|Chronic hepatitis B patients|chronic hepatitis b patients
458326|NCT01189643|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
458327|NCT01189643|IRINOTECAN (CPT-11) CAMPTOSAR|irinotecan (cpt-11) camptosar
458328|NCT01189643|TEMOZOLOMIDE|temozolomide
458329|NCT01189643|DSRCT|dsrct
458330|NCT01189643|10-091|10-091
458331|NCT01189630|"Real World Electronic Database with clinical information"|"real world electronic database with clinical information"
458332|NCT01189630|related to Implantable Cardiac devices.|related to implantable cardiac devices.
458333|NCT01189617|Personal Lubricant|personal lubricant
458334|NCT01189604|propofol endoscopy sedation|propofol endoscopy sedation
458335|NCT01189578|Recreational|recreational
458336|NCT01189578|cocaine|cocaine
458337|NCT01189578|fMRI|fmri
458338|NCT01189578|neuroimaging|neuroimaging
458339|NCT01189578|craving|craving
458340|NCT01189578|impulsivity|impulsivity
458341|NCT01189565|Total Hip Replacement/Revision|total hip replacement/revision
458342|NCT01189526|Branch retinal vein occlusion|branch retinal vein occlusion
458343|NCT01189526|macular edema|macular edema
458344|NCT01189526|intravitreal injection|intravitreal injection
458345|NCT01189526|ranibizumab|ranibizumab
458346|NCT01189513|Recurrent Glioblastoma|recurrent glioblastoma
458347|NCT01189513|Gliosarcoma|gliosarcoma
458348|NCT01189513|SCH 900105|sch 900105
458349|NCT01189500|Pharmacokinetic|pharmacokinetic
458350|NCT01189500|safety and tolerability|safety and tolerability
458351|NCT01189500|genetic testing|genetic testing
458352|NCT01189500|CYP 2D6|cyp 2d6
458353|NCT01189487|ampicillin sodium/sulbactam sodium|ampicillin sodium/sulbactam sodium
458354|NCT01189487|Unasyn-S|unasyn-s
458355|NCT01189487|community acquired pneumonia|community acquired pneumonia
458356|NCT01189487|bacterial pneumonia|bacterial pneumonia
458357|NCT01189474|Meibomian Gland Dysfunction|meibomian gland dysfunction
458358|NCT01189461|pegaptanib sodium|pegaptanib sodium
458359|NCT01189461|diabetic macular edema|diabetic macular edema
458360|NCT01189448|Congenital Toxoplasmosis,|congenital toxoplasmosis,
458361|NCT01189448|Pregnancy,|pregnancy,
458362|NCT01189448|prenatal diagnosis,|prenatal diagnosis,
458363|NCT01189448|mother-to-child transmission,|mother-to-child transmission,
458364|NCT01189448|prevention,|prevention,
458365|NCT01189448|spiramycine,|spiramycine,
458366|NCT01189448|pyrimethamine-sulfadiazine|pyrimethamine-sulfadiazine
458367|NCT01189435|OSI-774, TARCEVA (ERLOTINIB)|osi-774, tarceva (erlotinib)
458368|NCT01189435|Lung|lung
458369|NCT01189435|recurrent|recurrent
458370|NCT01189435|10-097|10-097
458371|NCT01189435|Gefitinib|gefitinib
458372|NCT01189422|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
458373|NCT01189422|T1DM|t1dm
458374|NCT01189409|Constipation|constipation
458375|NCT01189409|Opioids|opioids
458376|NCT01189409|Cancer|cancer
458377|NCT01189409|Polyethylene glycol|polyethylene glycol
458379|NCT01189409|Opioid Therapy|opioid therapy
458380|NCT01189396|asthma|asthma
458381|NCT01189396|bronchospasm|bronchospasm
458382|NCT01189396|COPD|copd
458383|NCT01189396|reversibility|reversibility
458384|NCT01189396|efficacy|efficacy
458385|NCT01189383|Melanoma|melanoma
458386|NCT01189383|Vaccine|vaccine
458387|NCT01189383|Dendritic Cell|dendritic cell
458388|NCT01189383|Immune response|immune response
458389|NCT01189383|Safety|safety
458390|NCT01189383|Efficacy|efficacy
458391|NCT01189370|carcinoma, renal cell|carcinoma, renal cell
458392|NCT01189370|kidney|kidney
458393|NCT01189370|cancer|cancer
458394|NCT01189357|meniscal transplant|meniscal transplant
458395|NCT01189344|Obesity|obesity
458396|NCT01189344|LT4|lt4
458397|NCT01189344|Absorption|absorption
458398|NCT01189344|Thyroid function|thyroid function
458399|NCT01189331|Coronary artery disease|coronary artery disease
458400|NCT01189331|CT|ct
458401|NCT01189331|Computational flow dynamics|computational flow dynamics
458402|NCT01189305|Drug Abuse|drug abuse
458403|NCT01189305|Female Patients|female patients
458404|NCT01189292|postoperative nausea and vomitus|postoperative nausea and vomitus
458405|NCT01189292|PONV|ponv
458406|NCT01189292|thyroid surgery|thyroid surgery
458407|NCT01189253|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
458408|NCT01189253|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
458409|NCT01189253|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
458410|NCT01189253|adult angiosarcoma|adult angiosarcoma
458411|NCT01189253|adult desmoplastic small round cell tumor|adult desmoplastic small round cell tumor
458412|NCT01189253|adult epithelioid sarcoma|adult epithelioid sarcoma
458413|NCT01189253|adult extraskeletal chondrosarcoma|adult extraskeletal chondrosarcoma
458414|NCT01189253|adult extraskeletal osteosarcoma|adult extraskeletal osteosarcoma
458415|NCT01189253|adult fibrosarcoma|adult fibrosarcoma
458416|NCT01189253|adult leiomyosarcoma|adult leiomyosarcoma
458417|NCT01189253|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
458418|NCT01189253|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
458419|NCT01189253|adult malignant mesenchymoma|adult malignant mesenchymoma
458420|NCT01189253|adult neurofibrosarcoma|adult neurofibrosarcoma
458421|NCT01189253|adult synovial sarcoma|adult synovial sarcoma
458422|NCT01189227|stage IV colon cancer|stage iv colon cancer
458423|NCT01189227|adenocarcinoma of the colon|adenocarcinoma of the colon
458424|NCT01189227|stage IV rectal cancer|stage iv rectal cancer
458425|NCT01189227|adenocarcinoma of the rectum|adenocarcinoma of the rectum
458426|NCT01189227|liver metastases|liver metastases
458427|NCT01189162|Primary treatment of RDS and treatment of RDS post extubation|primary treatment of rds and treatment of rds post extubation
458428|NCT01189136|Voiding dysfunction|voiding dysfunction
458429|NCT01189123|influenza|influenza
458430|NCT01189123|vaccine|vaccine
458431|NCT01189123|cell mediated immunity|cell mediated immunity
458432|NCT01189123|elderly|elderly
458433|NCT01189123|high dose influenza vaccine|high dose influenza vaccine
458434|NCT01189110|smoking cessation|smoking cessation
458435|NCT01189110|veterans|veterans
458436|NCT01189110|auriculotherapy|auriculotherapy
458437|NCT01189084|Alzheimer's disease|alzheimer's disease
458438|NCT01189084|amyloid beta|amyloid beta
458439|NCT01189084|vaccine|vaccine
458440|NCT01189071|Stents [E07.695.750]|stents [e07.695.750]
458441|NCT01189071|Darifenacin (C101207)|darifenacin (c101207)
458442|NCT01189071|Kidney calculi|kidney calculi
458443|NCT01189058|Perinatal stroke|perinatal stroke
458444|NCT01189058|Periventricular venous infarction|periventricular venous infarction
458445|NCT01189058|Presumed perinatal stroke|presumed perinatal stroke
458446|NCT01189058|Neonatal stroke|neonatal stroke
458447|NCT01189058|Arterial ischemic stroke|arterial ischemic stroke
458448|NCT01189058|Fetal stroke|fetal stroke
458449|NCT01189058|Transcranial magnetic stimulation|transcranial magnetic stimulation
458450|NCT01189058|Constraint-induced movement therapy|constraint-induced movement therapy
458451|NCT01189058|CIMT|cimt
458452|NCT01189058|Cerebral palsy|cerebral palsy
458453|NCT01189058|Congenital hemiplegia|congenital hemiplegia
458454|NCT01189058|Hemiplegic cerebral palsy|hemiplegic cerebral palsy
458455|NCT01189058|Neuroplasticity|neuroplasticity
458456|NCT01189058|Developmental plasticity|developmental plasticity
458457|NCT01189045|Stroke|stroke
458458|NCT01189045|Exercise|exercise
458459|NCT01189045|Rehabilitation|rehabilitation
458460|NCT01189045|Risk factors|risk factors
458461|NCT01189019|ranibizumab|ranibizumab
458462|NCT01189019|Wet macular degeneration|wet macular degeneration
458463|NCT01189019|macular degeneration|macular degeneration
458464|NCT01189019|PED|ped
458465|NCT01189019|Retinal Pigment Epithelial Detachment|retinal pigment epithelial detachment
458466|NCT01188967|Drugs, Investigational|drugs, investigational
458467|NCT01188967|Nicotine Dependence|nicotine dependence
458468|NCT01188967|Therapies for Relapse to Nicotine|therapies for relapse to nicotine
458469|NCT01188967|Relapse Prevention|relapse prevention
458470|NCT01188967|Smoking Cessation|smoking cessation
458471|NCT01188967|Nicotine Cessation Therapies|nicotine cessation therapies
458472|NCT01188954|Seroma|seroma
458473|NCT01188954|Doxycycline|doxycycline
458474|NCT01188954|Cardiopulmonary By-Pass|cardiopulmonary by-pass
458475|NCT01188954|Femoral Artery/Vein Cannulation|femoral artery/vein cannulation
458476|NCT01188954|Prevent Seroma Formation|prevent seroma formation
458477|NCT01188915|Hodgkin disease|hodgkin disease
458478|NCT01188915|Breast cancer|breast cancer
458479|NCT01188889|Chronic Myeloid Leukemia|chronic myeloid leukemia
458480|NCT01188876|carboplatin|carboplatin
458481|NCT01188876|recurrent|recurrent
458482|NCT01188876|platinum sensitive|platinum sensitive
458483|NCT01188876|pralatrexate|pralatrexate
458484|NCT01188850|CIN 2 or 3|cin 2 or 3
458485|NCT01188850|cervical cancer|cervical cancer
458486|NCT01188850|Human Papillomavirus (HPV)|human papillomavirus (hpv)
458487|NCT01188837|Osteoarthritis, Knee|osteoarthritis, knee
458488|NCT01188837|Manipulation Therapy|manipulation therapy
458489|NCT01188811|Multiple Sclerosis|multiple sclerosis
458490|NCT01188811|Multiple sclerosis, chronic progressive|multiple sclerosis, chronic progressive
458491|NCT01188811|Neuroprotective agents|neuroprotective agents
458492|NCT01188811|Magnetic resonance imaging|magnetic resonance imaging
458493|NCT01188811|Optical coherence tomography|optical coherence tomography
458494|NCT01188811|Gait|gait
458495|NCT01188811|Thioctic acid|thioctic acid
458496|NCT01188811|Alpha-lipoic acid|alpha-lipoic acid
458497|NCT01188798|Allogeneic Bone Marrow Transplantation|allogeneic bone marrow transplantation
458498|NCT01188798|Graft versus host disease|graft versus host disease
458499|NCT01188798|Tacrolimus|tacrolimus
458500|NCT01188798|Sirolimus|sirolimus
458501|NCT01188798|Methotrexate|methotrexate
458502|NCT01188798|Pentostatin|pentostatin
458503|NCT01188785|siRNA|sirna
458504|NCT01188785|RNA interference (RNAi)|rna interference (rnai)
458505|NCT01188785|Cancer|cancer
458506|NCT01188785|Pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
458507|NCT01188785|Pancreatic cancer|pancreatic cancer
458508|NCT01188785|Solid tumor|solid tumor
458509|NCT01188785|Operable pancreatic ductal adenocarcinoma|operable pancreatic ductal adenocarcinoma
458510|NCT01188785|Non operable pancreatic ductal adenocarcinoma|non operable pancreatic ductal adenocarcinoma
458511|NCT01188772|Hepatitis C Virus|hepatitis c virus
458512|NCT01188772|HCV|hcv
458513|NCT01188772|hepatitis|hepatitis
458514|NCT01188772|Genotype 1|genotype 1
458515|NCT01188772|Genotype 2|genotype 2
458516|NCT01188772|Genotype 3|genotype 3
458517|NCT01188759|Aspergillosis|aspergillosis
458518|NCT01188759|Combination Therapy|combination therapy
458519|NCT01188759|Voriconazole|voriconazole
458520|NCT01188759|Anidulafungin|anidulafungin
458521|NCT01188746|catheter|catheter
458522|NCT01188746|palliative|palliative
458523|NCT01188746|quality of life|quality of life
458524|NCT01188746|10-059|10-059
458525|NCT01188733|portal hypertension|portal hypertension
458526|NCT01188733|varices|varices
458527|NCT01188733|cirrhosis|cirrhosis
458528|NCT01188733|octreotide|octreotide
458529|NCT01188733|somatostatin analog|somatostatin analog
458530|NCT01188733|Child Pugh Class A,B|child pugh class a,b
458531|NCT01188707|Non small cell lung cancer|non small cell lung cancer
458532|NCT01188707|Belinostat|belinostat
458533|NCT01188707|Erlotinib|erlotinib
458534|NCT01188707|HDAC inhibitor|hdac inhibitor
458535|NCT01188707|Phase I/II|phase i/ii
458536|NCT01188681|CLL|cll
458537|NCT01188681|TRU-016|tru-016
458538|NCT01188681|chronic lymphocytic leukemia|chronic lymphocytic leukemia
458539|NCT01188681|relapsed CLL|relapsed cll
458540|NCT01188681|bendamustine|bendamustine
458541|NCT01188668|Pharmacokinetic|pharmacokinetic
458542|NCT01188668|safety and tolerability|safety and tolerability
458543|NCT01188668|genetic testing|genetic testing
458544|NCT01188668|CYP 2D6 and CYP 3A4|cyp 2d6 and cyp 3a4
458545|NCT01188655|Ankylosing Spondylitis|ankylosing spondylitis
458546|NCT01188642|childhood obesity|childhood obesity
458547|NCT01188642|adipocytokines|adipocytokines
458548|NCT01188642|physical exercise|physical exercise
458549|NCT01188642|nutrition education|nutrition education
458550|NCT01188629|Preventive Care|preventive care
458551|NCT01188629|Medication Management|medication management
458552|NCT01188629|Electronic Medical Records|electronic medical records
458553|NCT01188629|Automated Telephone System|automated telephone system
458554|NCT01188616|Childhood Obesity|childhood obesity
458555|NCT01188616|Obesity Intervention|obesity intervention
458556|NCT01188590|Post operative Respiratory insufficiency|post operative respiratory insufficiency
458557|NCT01188577|asthma|asthma
458558|NCT01188577|bronchospasm|bronchospasm
458559|NCT01188577|wheezing|wheezing
458560|NCT01188577|shortness of breath|shortness of breath
458561|NCT01188564|Hereditary Angioedema|hereditary angioedema
458562|NCT01188564|HAE|hae
458563|NCT01188564|Angioedema|angioedema
458564|NCT01188564|Recombinant C1 Inhibitor|recombinant c1 inhibitor
458565|NCT01188564|rhC1INH|rhc1inh
458566|NCT01188551|myringotomy|myringotomy
458567|NCT01188551|pressure equalization tubes|pressure equalization tubes
458568|NCT01188538|P. acnes, Acne vulgaris|p. acnes, acne vulgaris
458569|NCT01188525|pharmacokinetics|pharmacokinetics
458570|NCT01188525|enzymes|enzymes
458571|NCT01188525|metabolism prediction|metabolism prediction
458670|NCT01188044|Sub-Saharan Africa|sub-saharan africa
458572|NCT01188512|Live nasal vaccine for prevention of pertussis|live nasal vaccine for prevention of pertussis
458573|NCT01188473|Status Asthmaticus|status asthmaticus
458574|NCT01188473|Noninvasive Positive Pressure Ventilation|noninvasive positive pressure ventilation
458575|NCT01188473|Asthma in Children|asthma in children
458576|NCT01188460|Insomnia|insomnia
458577|NCT01188460|Chronic pain|chronic pain
458578|NCT01188447|cervical-spine injuries|cervical-spine injuries
458579|NCT01188447|cervical-spine fractures|cervical-spine fractures
458580|NCT01188447|spinal cord injury|spinal cord injury
458581|NCT01188447|neck injury|neck injury
458582|NCT01188447|Canadian C-Spine Rule|canadian c-spine rule
458583|NCT01188447|paramedics|paramedics
458584|NCT01188447|emergency medical services|emergency medical services
458585|NCT01188434|Methamphetamine|methamphetamine
458586|NCT01188434|Substance Abuse|substance abuse
458587|NCT01188434|Child Neglect|child neglect
458588|NCT01188434|Child Welfare|child welfare
458589|NCT01188434|Evidence Based Practice|evidence based practice
458590|NCT01188382|Intracranial pressure|intracranial pressure
458591|NCT01188382|resistance|resistance
458592|NCT01188382|CSF outflow|csf outflow
458593|NCT01188382|elderly|elderly
458594|NCT01188382|reference value|reference value
458595|NCT01188369|levosimendan|levosimendan
458596|NCT01188369|heart failure|heart failure
458597|NCT01188369|inotropics|inotropics
458598|NCT01188369|diastolic dysfunction|diastolic dysfunction
458599|NCT01188369|left ventricular hypertrophy|left ventricular hypertrophy
458600|NCT01188369|aortic valve stenosis|aortic valve stenosis
458601|NCT01188356|Reply|reply
458602|NCT01188356|Symphony|symphony
458603|NCT01188356|Atrial arrhythmias|atrial arrhythmias
458604|NCT01188356|V pacing|v pacing
458605|NCT01188356|Evaluate the incidence and evolution over-time of co-morbidities|evaluate the incidence and evolution over-time of co-morbidities
458606|NCT01188343|Japanese Encephalitis|japanese encephalitis
458607|NCT01188343|Japanese encephalitis chimeric virus vaccine|japanese encephalitis chimeric virus vaccine
458608|NCT01188343|Measles|measles
458609|NCT01188343|Mumps|mumps
458610|NCT01188343|Rubella|rubella
458611|NCT01188330|acute myeloid leukemia|acute myeloid leukemia
458612|NCT01188291|Optical Coherence Tomography|optical coherence tomography
458613|NCT01188291|Retinal Nerve Fiber Layer Thickness|retinal nerve fiber layer thickness
458614|NCT01188291|Obstructive Sleep Apnea|obstructive sleep apnea
458615|NCT01188291|Hypopnea syndrome|hypopnea syndrome
458616|NCT01188291|Glaucoma|glaucoma
458617|NCT01188252|Phase I|phase i
458618|NCT01188252|Dose escalation|dose escalation
458619|NCT01188252|Kinase inhibitor|kinase inhibitor
458620|NCT01188252|Cyclin-dependent kinases|cyclin-dependent kinases
458621|NCT01188239|electronic cigarette|electronic cigarette
458622|NCT01188239|nicotine|nicotine
458623|NCT01188239|smoking cessation|smoking cessation
458624|NCT01188239|smoking reduction|smoking reduction
458625|NCT01188187|custirsen sodium|custirsen sodium
458626|NCT01188187|prostate cancer|prostate cancer
458627|NCT01188187|overall survival|overall survival
458628|NCT01188187|Metastatic Castrate Resistant Prostate Cancer|metastatic castrate resistant prostate cancer
458629|NCT01188174|AML|aml
458630|NCT01188174|primary induction failure|primary induction failure
458631|NCT01188161|Posturography|posturography
458632|NCT01188161|Balance|balance
458633|NCT01188161|Falls|falls
458634|NCT01188161|Gyroscope|gyroscope
458635|NCT01188161|Rotational Chair|rotational chair
458636|NCT01188161|Vestibular|vestibular
458637|NCT01188161|Movement Disorders|movement disorders
458638|NCT01188135|depression|depression
458639|NCT01188135|interactive voice messaging|interactive voice messaging
458640|NCT01188135|patient persistence with antidepressant medication treatment|patient persistence with antidepressant medication treatment
458641|NCT01188122|VAP|vap
458642|NCT01188109|Pancreatic Neoplasms|pancreatic neoplasms
458643|NCT01188109|Pancreatic cancer|pancreatic cancer
458644|NCT01188096|glioma|glioma
458645|NCT01188096|pediatrics|pediatrics
458646|NCT01188096|cancer|cancer
458647|NCT01188096|brain tumor|brain tumor
458648|NCT01188096|low grade glioma|low grade glioma
458649|NCT01188083|NASH|nash
458650|NCT01188083|non-alcoholic fatty-liver disease|non-alcoholic fatty-liver disease
458651|NCT01188083|Hispanic|hispanic
458652|NCT01188083|overweight|overweight
458653|NCT01188070|Behavioral/Social|behavioral/social
458654|NCT01188070|Cardiology|cardiology
458655|NCT01188070|Clinical Laboratory Methods|clinical laboratory methods
458656|NCT01188070|Congestive Heart Failure|congestive heart failure
458657|NCT01188070|Heart Disease|heart disease
458658|NCT01188070|Knowledge Dissemination|knowledge dissemination
458659|NCT01188070|Lipids|lipids
458660|NCT01188070|Nursing|nursing
458661|NCT01188070|Health Promotion|health promotion
458662|NCT01188070|Alzheimer's Disease/Dementia|alzheimer's disease/dementia
458663|NCT01188057|Bioequivalence|bioequivalence
458664|NCT01188057|ALPRAZOLAM|alprazolam
458665|NCT01188057|Healthy subjects|healthy subjects
458666|NCT01188044|Motor activity|motor activity
458667|NCT01188044|Infant|infant
458668|NCT01188044|Validation studies|validation studies
458669|NCT01188044|Malawi|malawi
458671|NCT01188031|Bioequivalence|bioequivalence
458672|NCT01188031|ALPRAZOLAM|alprazolam
458673|NCT01188031|Healthy subjects|healthy subjects
458674|NCT01188018|Smoking|smoking
458675|NCT01188018|Smoking Cessation|smoking cessation
458676|NCT01188018|Nicotine Dependence|nicotine dependence
458677|NCT01188018|Tobacco Use Cessation|tobacco use cessation
458678|NCT01188018|Health Education|health education
458679|NCT01188018|Patient Education|patient education
458680|NCT01188005|OSAS|osas
458681|NCT01188005|Sleep Apnoea|sleep apnoea
458682|NCT01188005|IL6|il6
458683|NCT01188005|TNFα|tnfα
458684|NCT01188005|Oxidative Stress|oxidative stress
458685|NCT01188005|Antioxidants|antioxidants
458686|NCT01187992|Atorvastatin|atorvastatin
458687|NCT01187992|Acute coronary syndrome|acute coronary syndrome
458688|NCT01187992|Advanced coronary artery disease|advanced coronary artery disease
458689|NCT01187979|Cash incentive|cash incentive
458690|NCT01187979|HIV prevention|hiv prevention
458691|NCT01187979|Adolescents|adolescents
458692|NCT01187979|South Africa|south africa
458693|NCT01187979|HIV|hiv
458694|NCT01187966|Parkinson's Disease|parkinson's disease
458695|NCT01187966|PD|pd
458696|NCT01187966|Levodopa|levodopa
458697|NCT01187966|Patients with idiopathic Parkinson's disease with motor fluctuations|patients with idiopathic parkinson's disease with motor fluctuations
458698|NCT01187953|Tacrolimus|tacrolimus
458699|NCT01187953|Acute Rejection|acute rejection
458700|NCT01187953|Kidney|kidney
458701|NCT01187940|Autism Spectrum Disorder;|autism spectrum disorder;
458702|NCT01187940|Psychoeducation|psychoeducation
458703|NCT01187914|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
458704|NCT01187914|Radio-frequency Ablation|radio-frequency ablation
458705|NCT01187914|Ablation|ablation
458706|NCT01187914|Open irrigation cooled-tip|open irrigation cooled-tip
458707|NCT01187901|Familial Adenomatous Polyposis|familial adenomatous polyposis
458708|NCT01187901|Attenuated Familial Polyposis|attenuated familial polyposis
458709|NCT01187888|PSP|psp
458710|NCT01187888|Progressive Supranuclear Palsy|progressive supranuclear palsy
458711|NCT01187888|Rasagiline|rasagiline
458712|NCT01187888|Azilect|azilect
458713|NCT01187888|PROSPERA|prospera
458714|NCT01187875|satiety, dietary fiber|satiety, dietary fiber
458715|NCT01187823|Chronic heart failure|chronic heart failure
458716|NCT01187823|Central sleep apnea|central sleep apnea
458717|NCT01187823|Obstructive sleep apnea|obstructive sleep apnea
458718|NCT01187823|Adaptive servo ventilation|adaptive servo ventilation
458719|NCT01187810|leukemia,lymphoma|leukemia,lymphoma
458720|NCT01187758|antibiotic use|antibiotic use
458721|NCT01187758|antibiotic prescription|antibiotic prescription
458722|NCT01187758|antibiotic resistant S. pneumoniae|antibiotic resistant s. pneumoniae
458723|NCT01187758|MRSA|mrsa
458724|NCT01187745|renal calculi|renal calculi
458725|NCT01187732|skin damage|skin damage
458726|NCT01187732|intertrigo|intertrigo
458727|NCT01187732|dermatitis|dermatitis
458728|NCT01187732|erythema|erythema
458729|NCT01187732|aggression|aggression
458730|NCT01187732|body Wipes|body wipes
458731|NCT01187732|soaps|soaps
458732|NCT01187732|no rinse|no rinse
458733|NCT01187732|cost effectiveness|cost effectiveness
458734|NCT01187732|nursing home residents|nursing home residents
458735|NCT01187732|nurse|nurse
458736|NCT01187719|HIV|hiv
458737|NCT01187719|pregnancy|pregnancy
458738|NCT01187719|phenytoin|phenytoin
458739|NCT01187719|ARV prophylaxis|arv prophylaxis
458740|NCT01187719|nevirapine|nevirapine
458741|NCT01187706|gynecological cancer survivors|gynecological cancer survivors
458742|NCT01187706|quality of life|quality of life
458743|NCT01187680|Tissue adhesions|tissue adhesions
458744|NCT01187680|Laparoscopy|laparoscopy
458745|NCT01187667|delirium|delirium
458746|NCT01187667|prevention|prevention
458747|NCT01187667|critical care|critical care
458748|NCT01187667|haloperidol|haloperidol
458749|NCT01187654|myocardial infarction|myocardial infarction
458750|NCT01187654|bone marrow stem cell|bone marrow stem cell
458751|NCT01187654|AC133|ac133
458752|NCT01187654|mono nuclear cell|mono nuclear cell
458753|NCT01187641|cancer, colon, MRI scan|cancer, colon, mri scan
458754|NCT01187628|Long-term study in Chronic Kidney Disease|long-term study in chronic kidney disease
458755|NCT01187628|Lanthanum Carbonate|lanthanum carbonate
458756|NCT01187615|Nonsquamous Non-small cell lung cancer|nonsquamous non-small cell lung cancer
458757|NCT01187615|Phase I|phase i
458758|NCT01187576|Physical activity|physical activity
458759|NCT01187576|Hypertension|hypertension
458760|NCT01187576|Diabetes mellitus|diabetes mellitus
458761|NCT01187576|Motivational interviewing|motivational interviewing
458762|NCT01187563|Rheumatoid arthritis, tocilizumab|rheumatoid arthritis, tocilizumab
458763|NCT01187550|Dwarfism, pituitary|dwarfism, pituitary
458764|NCT01187550|Growth hormone|growth hormone
458765|NCT01187537|Knee Replacement|knee replacement
458766|NCT01187537|Analgesia|analgesia
458767|NCT01187537|Analgesics|analgesics
458768|NCT01187537|Nerve blocks|nerve blocks
458769|NCT01187537|Recovery of functions|recovery of functions
458770|NCT01187537|Post operative analgesia|post operative analgesia
459068|NCT01186406|Gliadel|gliadel
458771|NCT01187524|Patient Registry|patient registry
458772|NCT01187524|FMR1 Gene|fmr1 gene
458773|NCT01187524|Fragile X Syndrome|fragile x syndrome
458774|NCT01187524|Primary Ovarian Insufficiency|primary ovarian insufficiency
458775|NCT01187524|Premature Ovarian Failure|premature ovarian failure
458776|NCT01187524|Premature Ovarian Insufficiency|premature ovarian insufficiency
458777|NCT01187511|Addiction|addiction
458778|NCT01187511|Alcohol Dependence|alcohol dependence
458779|NCT01187511|Anxiety|anxiety
458780|NCT01187511|CRH Antagonist|crh antagonist
458781|NCT01187511|Stress Induced Craving|stress induced craving
458782|NCT01187498|Overactive bladder|overactive bladder
458783|NCT01187498|Behavioral treatment|behavioral treatment
458784|NCT01187498|Drug therapy|drug therapy
458785|NCT01187498|Lower urinary tract symptoms|lower urinary tract symptoms
458786|NCT01187498|Urinary incontinence|urinary incontinence
458787|NCT01187498|Clinical trial|clinical trial
458788|NCT01187485|Androderm®|androderm®
458789|NCT01187485|Testosterone|testosterone
458790|NCT01187485|refractory|refractory
458791|NCT01187485|prostate|prostate
458792|NCT01187485|cancer|cancer
458793|NCT01187485|"Patients with hormone refractory prostate cancer will be treated with a daily testosterone patch Androderm® applied every 24 hours to the skin"|"patients with hormone refractory prostate cancer will be treated with a daily testosterone patch androderm® applied every 24 hours to the skin"
458794|NCT01187472|Head|head
458795|NCT01187472|neck|neck
458796|NCT01187472|cancer|cancer
458797|NCT01187472|advanced|advanced
458798|NCT01187472|oral cavity|oral cavity
458799|NCT01187472|lip|lip
458800|NCT01187472|larynx|larynx
458801|NCT01187459|Vitamin D|vitamin d
458802|NCT01187459|Crohn's Disease|crohn's disease
458803|NCT01187459|Dose Response|dose response
458804|NCT01187446|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
458805|NCT01187433|Dengue|dengue
458806|NCT01187433|Dengue hemorrhagic fever|dengue hemorrhagic fever
458807|NCT01187433|CYD Dengue Vaccines|cyd dengue vaccines
458808|NCT01187420|Cerebral vasospasm|cerebral vasospasm
458809|NCT01187420|delayed cerebral ischemia (DCI)|delayed cerebral ischemia (dci)
458810|NCT01187420|subarachnoid hemorrhage (SAH) patients|subarachnoid hemorrhage (sah) patients
458811|NCT01187394|Frozen Plasma|frozen plasma
458812|NCT01187394|Fresh Frozen Plasma|fresh frozen plasma
458813|NCT01187394|Cardiac Surgery|cardiac surgery
458814|NCT01187394|Bleeding|bleeding
458815|NCT01187394|Knowledge Translation|knowledge translation
458816|NCT01187368|heart failure|heart failure
458817|NCT01187368|LVAS|lvas
458818|NCT01187368|LVAD|lvad
458819|NCT01187368|bridge-to-transplant|bridge-to-transplant
458820|NCT01187368|rotary pump|rotary pump
458821|NCT01187355|Symptomatic, Contact lens care|symptomatic, contact lens care
458822|NCT01187355|Multi-purpose solution|multi-purpose solution
458823|NCT01187342|Stroke|stroke
458824|NCT01187329|Hyperglycemia|hyperglycemia
458825|NCT01187329|open heart surgery|open heart surgery
458826|NCT01187329|bypass|bypass
458827|NCT01187316|Facial Pain|facial pain
458828|NCT01187316|Temporomandibular Joint Disorders|temporomandibular joint disorders
458829|NCT01187316|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
458830|NCT01187316|Adolescent|adolescent
458831|NCT01187290|Preoperative chemoradiotherapy|preoperative chemoradiotherapy
458832|NCT01187290|stage IIIA, N2|stage iiia, n2
458833|NCT01187277|stroke|stroke
458834|NCT01187277|rehabilitation|rehabilitation
458835|NCT01187277|gait training|gait training
458836|NCT01187277|robot-assisted therapy|robot-assisted therapy
458837|NCT01187251|tinnitus|tinnitus
458838|NCT01187251|mp3 players|mp3 players
458839|NCT01187251|noise induced hearing loss|noise induced hearing loss
458840|NCT01187251|high frequencies audiometry|high frequencies audiometry
458841|NCT01187251|acoustic otoemissions|acoustic otoemissions
458842|NCT01187238|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
458843|NCT01187238|Stage II|stage ii
458844|NCT01187238|Intensity-modulated radiotherapy|intensity-modulated radiotherapy
458845|NCT01187238|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
458846|NCT01187238|Cisplatin|cisplatin
458847|NCT01187225|Cardiac surgical procedures|cardiac surgical procedures
458848|NCT01187225|Fibrinogen|fibrinogen
458849|NCT01187225|Bleeding|bleeding
458850|NCT01187225|Cryoprecipitate|cryoprecipitate
458851|NCT01187212|First line chemotherapy in advanced gastric cancer|first line chemotherapy in advanced gastric cancer
458852|NCT01187199|Metastatic cancer|metastatic cancer
458853|NCT01187199|Chemotherapy|chemotherapy
458854|NCT01187199|Avastin|avastin
458855|NCT01187199|Carboplatin|carboplatin
458856|NCT01187199|Paclitaxel|paclitaxel
458857|NCT01187199|Sorafenib|sorafenib
458858|NCT01187199|Temsirolimus|temsirolimus
458859|NCT01187186|Liver disease|liver disease
458860|NCT01187186|ASP1941|asp1941
458861|NCT01187160|Obstructive sleep apnea|obstructive sleep apnea
458862|NCT01187147|Asthma, green tea, antioxidants|asthma, green tea, antioxidants
458863|NCT01187134|sepsis|sepsis
458864|NCT01187134|shock, septic|shock, septic
458865|NCT01187134|quality assurance, health care|quality assurance, health care
458866|NCT01187134|quality control|quality control
458867|NCT01187134|Survival Rate|survival rate
458868|NCT01187134|Follow-Up Studies|follow-up studies
458869|NCT01187134|Anti-Infective Agents/*therapeutic use|anti-infective agents/*therapeutic use
458870|NCT01187121|Graduated Sanctions|graduated sanctions
458871|NCT01187121|Probationary failure|probationary failure
458872|NCT01187121|recidivism|recidivism
458873|NCT01187121|drug relapse|drug relapse
458874|NCT01187121|criminal justice|criminal justice
458875|NCT01187108|Cobalt|cobalt
458876|NCT01187108|Excessive Erythrocytosis|excessive erythrocytosis
458877|NCT01187108|Monge's Disease|monge's disease
458878|NCT01187108|Acetazolamide|acetazolamide
458879|NCT01187108|N-acetylcysteine|n-acetylcysteine
458880|NCT01187108|Altitude Sickness|altitude sickness
458881|NCT01187108|Chronic Mountain Sickness|chronic mountain sickness
458882|NCT01187095|Involuntary childlessness|involuntary childlessness
458883|NCT01187095|Infertility|infertility
458884|NCT01187095|IVF|ivf
458885|NCT01187095|EWI|ewi
458886|NCT01187095|Couples in IVF treatment|couples in ivf treatment
458887|NCT01187095|Psychosocial intervention|psychosocial intervention
458888|NCT01187082|overactive bladder|overactive bladder
458889|NCT01187082|women|women
458890|NCT01187082|bladder training|bladder training
458891|NCT01187082|groups|groups
458892|NCT01187069|Motivation|motivation
458893|NCT01187069|patients with type 2 diabetes|patients with type 2 diabetes
458894|NCT01187069|practice nurses|practice nurses
458895|NCT01187069|general practice|general practice
458896|NCT01187069|Self-determination Theory|self-determination theory
458897|NCT01187056|Shared decision-making|shared decision-making
458898|NCT01187056|Risk information|risk information
458899|NCT01187056|Decision aids|decision aids
458900|NCT01187043|Liver Function|liver function
458901|NCT01187043|Steady State Exposure|steady state exposure
458902|NCT01187030|Frozen Plasma|frozen plasma
458903|NCT01187030|Fresh Frozen Plasma|fresh frozen plasma
458904|NCT01187030|Prothrombin Complex Concentrates|prothrombin complex concentrates
458905|NCT01187030|RAND UCLA|rand ucla
458906|NCT01187030|Modified Delphi Methodology|modified delphi methodology
458907|NCT01187030|Expert Panel|expert panel
458908|NCT01187030|Appropriateness Rating|appropriateness rating
458909|NCT01187017|Severe Aplastic Anemia|severe aplastic anemia
458910|NCT01187017|Aplastic Anemia|aplastic anemia
458911|NCT01187017|Immunosuppression|immunosuppression
458912|NCT01187017|Immunosuppressive Therapy|immunosuppressive therapy
458913|NCT01187017|T-Cells|t-cells
458914|NCT01186965|Diabetes|diabetes
458915|NCT01186965|Second Life|second life
458916|NCT01186965|virtual community|virtual community
458917|NCT01186965|diabetes education|diabetes education
458918|NCT01186965|diabetes support group|diabetes support group
458919|NCT01186952|overweight|overweight
458920|NCT01186952|obesity|obesity
458921|NCT01186952|type 2 diabetes|type 2 diabetes
458922|NCT01186952|caloric restriction|caloric restriction
458923|NCT01186952|exercise program|exercise program
458924|NCT01186952|epicardial fat|epicardial fat
458925|NCT01186939|Myelodysplastic Syndromes|myelodysplastic syndromes
458926|NCT01186939|MDS|mds
458927|NCT01186926|Obstructive sleep apnea|obstructive sleep apnea
458928|NCT01186926|OSA|osa
458929|NCT01186926|hypoglossal nerve stimulation|hypoglossal nerve stimulation
458930|NCT01186926|sleep apnea|sleep apnea
458931|NCT01186913|SCID disorders|scid disorders
458932|NCT01186913|natural history study|natural history study
458933|NCT01186900|skin abscess|skin abscess
458934|NCT01186900|needle aspiration|needle aspiration
458935|NCT01186900|incision and drainage|incision and drainage
458936|NCT01186887|primary ACL reconstruction with a hamstring graft|primary acl reconstruction with a hamstring graft
458937|NCT01186861|NSCLC|nsclc
458938|NCT01186861|Erlotinib|erlotinib
458939|NCT01186861|OSI-906|osi-906
458940|NCT01186861|Placebo|placebo
458941|NCT01186861|Platinum-based chemotherapy|platinum-based chemotherapy
458942|NCT01186848|Stretch marks|stretch marks
458943|NCT01186848|Striae distensae|striae distensae
458944|NCT01186809|hematologic malignancies (excluding Chronic Myeloid Leukemia)|hematologic malignancies (excluding chronic myeloid leukemia)
458945|NCT01186796|Women|women
458946|NCT01186796|Fulvestrant Study|fulvestrant study
458947|NCT01186796|Post Menopausal Women|post menopausal women
458948|NCT01186796|Hormones|hormones
458949|NCT01186796|Healthy Adult Women|healthy adult women
458950|NCT01186783|heart rate|heart rate
458951|NCT01186783|multiple organ dysfunction syndrome|multiple organ dysfunction syndrome
458952|NCT01186783|ivabradine|ivabradine
458953|NCT01186783|sepsis|sepsis
458954|NCT01186783|cardiogenic shock|cardiogenic shock
458955|NCT01186770|Treatment of Opioid-Induced Constipation in Subjects with Chronic, Non-Malignant Pain|treatment of opioid-induced constipation in subjects with chronic, non-malignant pain
458956|NCT01186744|OPT Retreatment|opt retreatment
458957|NCT01186744|OPT|opt
458959|NCT01186744|moderate|moderate
458960|NCT01186744|severe|severe
458961|NCT01186744|treatment|treatment
458962|NCT01186744|safety|safety
458963|NCT01186744|treatment withdrawal|treatment withdrawal
458964|NCT01186744|retreatment|retreatment
458965|NCT01186744|retreatment withdrawal|retreatment withdrawal
458966|NCT01186744|CP-690,550|cp-690,550
458967|NCT01186744|Psoriasis Vulgaris|psoriasis vulgaris
458968|NCT01186744|Plaque Psoriasis|plaque psoriasis
458969|NCT01186744|tofacitinib|tofacitinib
458970|NCT01186744|Xeljanz|xeljanz
458971|NCT01186744|nail psoriasis|nail psoriasis
458972|NCT01186744|Jak-inhibitor|jak-inhibitor
458973|NCT01186744|oral treatment|oral treatment
458974|NCT01186744|Pruritus|pruritus
458975|NCT01186744|Itch|itch
458976|NCT01186744|DLQI|dlqi
458977|NCT01186744|rebound|rebound
458978|NCT01186744|intermittent|intermittent
458979|NCT01186744|retreat|retreat
458980|NCT01186731|SPARC (secreted protein acid rich in cysteine)|sparc (secreted protein acid rich in cysteine)
458981|NCT01186731|serum Carbohydrate Antigen CA 19-9|serum carbohydrate antigen ca 19-9
458982|NCT01186718|Cervical, motions, kinematics|cervical, motions, kinematics
458983|NCT01186705|MK-2206|mk-2206
458984|NCT01186705|colon|colon
458985|NCT01186705|rectal|rectal
458986|NCT01186705|10-068|10-068
458987|NCT01186666|Atherosclerosis|atherosclerosis
458988|NCT01186666|Vulnerable plaque|vulnerable plaque
458989|NCT01186666|Intravascular ultrasound|intravascular ultrasound
458990|NCT01186666|Virtual histology|virtual histology
458991|NCT01186666|Fluorodeoxyglucose|fluorodeoxyglucose
458992|NCT01186666|Positron emission tomography|positron emission tomography
458993|NCT01186666|Multidetector computed tomography|multidetector computed tomography
458994|NCT01186640|T-PLL|t-pll
458995|NCT01186640|Polychemotherapy|polychemotherapy
458996|NCT01186640|Alemtuzumab|alemtuzumab
458997|NCT01186640|Efficacy|efficacy
458998|NCT01186627|Neurodevelopmental Impairment|neurodevelopmental impairment
458999|NCT01186627|Intraventricular hemorrhage|intraventricular hemorrhage
459000|NCT01186627|Retinopathy of prematurity|retinopathy of prematurity
459001|NCT01186627|Mortality|mortality
459002|NCT01186627|Apgar Score|apgar score
459003|NCT01186614|cardiac arrest|cardiac arrest
459004|NCT01186614|ECMO|ecmo
459005|NCT01186614|hypothermia|hypothermia
459006|NCT01186614|automated CPR|automated cpr
459007|NCT01186614|coronary intervention|coronary intervention
459008|NCT01186601|Prostatic Neoplasms|prostatic neoplasms
459009|NCT01186601|Colorectal Neoplasms|colorectal neoplasms
459010|NCT01186601|Head and Neck Neoplasms|head and neck neoplasms
459011|NCT01186601|Melanoma|melanoma
459012|NCT01186601|Neoplasm Metastasis|neoplasm metastasis
459013|NCT01186588|Canagliflozin|canagliflozin
459014|NCT01186588|JNJ-28431754|jnj-28431754
459015|NCT01186588|Liver diseases|liver diseases
459016|NCT01186588|Hepatic impairment|hepatic impairment
459017|NCT01186588|Pharmacokinetic|pharmacokinetic
459018|NCT01186588|Normal hepatic function|normal hepatic function
459019|NCT01186575|HIV Infections|hiv infections
459020|NCT01186575|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
459021|NCT01186575|Circumcision, Male|circumcision, male
459022|NCT01186575|Coitus|coitus
459023|NCT01186575|Patient Compliance|patient compliance
459024|NCT01186575|Cellular Phone|cellular phone
459025|NCT01186562|Pancreatitis|pancreatitis
459026|NCT01186562|Pancreatectomy|pancreatectomy
459027|NCT01186562|Islet autotransplant|islet autotransplant
459028|NCT01186562|Sitagliptin|sitagliptin
459029|NCT01186562|Diabetes|diabetes
459030|NCT01186549|propofol|propofol
459031|NCT01186549|ephedrine|ephedrine
459032|NCT01186549|pain|pain
459033|NCT01186536|Whey Protein|whey protein
459034|NCT01186536|Soy Protein|soy protein
459035|NCT01186536|Resistance training|resistance training
459036|NCT01186536|Weight Management|weight management
459037|NCT01186523|Obesity|obesity
459038|NCT01186523|Weight Management|weight management
459039|NCT01186523|Physical Activity|physical activity
459040|NCT01186497|Healthy|healthy
459041|NCT01186497|Rabeprazole sodium|rabeprazole sodium
459042|NCT01186497|Rabeprazole sprinkle capsule granule formulation|rabeprazole sprinkle capsule granule formulation
459043|NCT01186497|Pharmacokinetics|pharmacokinetics
459044|NCT01186497|Bioavailability|bioavailability
459045|NCT01186497|Safety|safety
459046|NCT01186497|Adult|adult
459047|NCT01186484|Castration-resistant prostate cancer|castration-resistant prostate cancer
459048|NCT01186484|Abiraterone acetate|abiraterone acetate
459049|NCT01186484|JNJ-212082|jnj-212082
459050|NCT01186471|Symptomatic treatment|symptomatic treatment
459051|NCT01186471|Cognition|cognition
459052|NCT01186471|Cognitive deficits|cognitive deficits
459053|NCT01186471|Schizophrenia|schizophrenia
459054|NCT01186445|Acute Myocardial Infarction|acute myocardial infarction
459055|NCT01186445|Cardioprotective effect|cardioprotective effect
459056|NCT01186445|Pharmacological postconditioning|pharmacological postconditioning
459057|NCT01186445|Morphine Chlorhydrate|morphine chlorhydrate
459058|NCT01186445|Cardiac MRI|cardiac mri
459059|NCT01186419|Beta-thalassemia|beta-thalassemia
459060|NCT01186419|Sickle cell anemia|sickle cell anemia
459061|NCT01186419|Transfusional iron overload|transfusional iron overload
459062|NCT01186419|Iron overload|iron overload
459063|NCT01186419|Iron chelation|iron chelation
459064|NCT01186406|glioblastoma multiforme|glioblastoma multiforme
459065|NCT01186406|gliosarcoma|gliosarcoma
459066|NCT01186406|malignant glioma|malignant glioma
459067|NCT01186406|glioma|glioma
459069|NCT01186406|carmustine wafers|carmustine wafers
459070|NCT01186406|Avastin|avastin
459071|NCT01186406|bevacizumab|bevacizumab
459072|NCT01186406|Temodar|temodar
459073|NCT01186406|temozolomide|temozolomide
459074|NCT01186406|Pro00025180|pro00025180
459075|NCT01186406|Desjardins|desjardins
459076|NCT01186406|Duke|duke
459077|NCT01186406|Preston Robert Tisch Brain Tumor Center|preston robert tisch brain tumor center
459078|NCT01186393|Weight Loss|weight loss
459079|NCT01186393|Potatoes|potatoes
459080|NCT01186393|Dietary Meetings|dietary meetings
459081|NCT01186393|Glycemic Control|glycemic control
459082|NCT01186380|TEE|tee
459083|NCT01186380|Transesophageal|transesophageal
459084|NCT01186380|Transducer|transducer
459085|NCT01186380|Esophagus|esophagus
459086|NCT01186380|Ease of passage and during transitioning into and down the esophagus to complete a normal TEE study|ease of passage and during transitioning into and down the esophagus to complete a normal tee study
459087|NCT01186367|breast cancer|breast cancer
459088|NCT01186367|Linear Versus Nonlinear Aerobic Training|linear versus nonlinear aerobic training
459089|NCT01186367|15-147|15-147
459090|NCT01186354|Type 2 diabetes|type 2 diabetes
459091|NCT01186354|health literacy|health literacy
459092|NCT01186354|genetic literacy|genetic literacy
459093|NCT01186354|genetic risk|genetic risk
459094|NCT01186341|Chronic Pain|chronic pain
459095|NCT01186328|Relapse|relapse
459096|NCT01186328|T cell|t cell
459097|NCT01186328|Lymphoblastic|lymphoblastic
459098|NCT01186328|Leukemia|leukemia
459099|NCT01186328|EZN3042|ezn3042
459100|NCT01186328|Refractory|refractory
459101|NCT01186328|Precursor B|precursor b
459102|NCT01186328|Pre B cell|pre b cell
459103|NCT01186328|Survivan|survivan
459104|NCT01186328|Acute|acute
459105|NCT01186328|Childhood|childhood
459106|NCT01186328|Pediatric|pediatric
459107|NCT01186315|Addiction|addiction
459108|NCT01186315|Posttraumatic Stress|posttraumatic stress
459109|NCT01186315|substance abuse and posttraumatic stress|substance abuse and posttraumatic stress
459110|NCT01186302|medical abortion|medical abortion
459111|NCT01186302|Nepal|nepal
459112|NCT01186302|midlevel providers|midlevel providers
459113|NCT01186289|Neurocognitive Dysfunction|neurocognitive dysfunction
459114|NCT01186263|liver metastases|liver metastases
459115|NCT01186263|MAA|maa
459116|NCT01186263|B20|b20
459117|NCT01186263|SIR spheres|sir spheres
459118|NCT01186263|SPECT|spect
459119|NCT01186263|intra-hepatic distribution|intra-hepatic distribution
459120|NCT01186250|cardiac allograft vasculopathy|cardiac allograft vasculopathy
459121|NCT01186250|pioglitazone|pioglitazone
459122|NCT01186250|insulin resistance|insulin resistance
459123|NCT01186250|heart transplant|heart transplant
459124|NCT01186237|Colon/Rectal Cancer Rectal Cancer|colon/rectal cancer rectal cancer
459125|NCT01186237|Quality of Life|quality of life
459126|NCT01186211|knee, joint|knee, joint
459127|NCT01186198|Coronary Dilatation Catheter|coronary dilatation catheter
459128|NCT01186198|Balloon Dilatation Catheter|balloon dilatation catheter
459129|NCT01186198|Predilatation Balloon|predilatation balloon
459130|NCT01186198|Angioplasty|angioplasty
459131|NCT01186198|Myocardial Ischemia|myocardial ischemia
459132|NCT01186198|Coronary Stenosis|coronary stenosis
459133|NCT01186198|PCI|pci
459134|NCT01186198|PTCA|ptca
459135|NCT01186198|CTO|cto
459136|NCT01186185|sudden|sudden
459137|NCT01186185|sensorineural|sensorineural
459138|NCT01186185|hearing loss|hearing loss
459139|NCT01186185|fludrocortisone|fludrocortisone
459140|NCT01186185|mineralocorticoid|mineralocorticoid
459141|NCT01186185|steroid|steroid
459142|NCT01186172|ethanol|ethanol
459143|NCT01186172|lock therapy|lock therapy
459144|NCT01186172|vascular access|vascular access
459145|NCT01186172|central venous catheter|central venous catheter
459146|NCT01186172|sepsis|sepsis
459147|NCT01186159|COX-2|cox-2
459148|NCT01186159|PMNL|pmnl
459149|NCT01186159|pain|pain
459150|NCT01186159|macrophages|macrophages
459151|NCT01186159|NSAIDs|nsaids
459152|NCT01186146|coronary disease|coronary disease
459153|NCT01186146|stents|stents
459154|NCT01186146|antiplatelet drugs|antiplatelet drugs
459155|NCT01186146|drug-eluting stents|drug-eluting stents
459156|NCT01186133|coronary disease|coronary disease
459157|NCT01186133|drug eluting stent|drug eluting stent
459158|NCT01186120|coronary disease|coronary disease
459159|NCT01186120|stent|stent
459160|NCT01186107|coronary disease|coronary disease
459161|NCT01186107|stent|stent
459162|NCT01186094|Coronary Artery Disease|coronary artery disease
459163|NCT01186094|Stent|stent
459164|NCT01186081|Rectal cancer|rectal cancer
459165|NCT01186081|Preoperative CCRT|preoperative ccrt
459166|NCT01186081|Postoperative CCRT|postoperative ccrt
459167|NCT01186081|Capecitabine|capecitabine
459168|NCT01186068|Rosacea, erythema|rosacea, erythema
459169|NCT01186055|Smoking Relapse|smoking relapse
459170|NCT01186055|Nicotine Abstinence|nicotine abstinence
459171|NCT01186042|HIV|hiv
459172|NCT01186042|Aging|aging
459173|NCT01186042|Neuropsychological function|neuropsychological function
459174|NCT01186042|Activity|activity
459175|NCT01186042|Sleep patterns|sleep patterns
459176|NCT01186042|Frailty|frailty
459177|NCT01186042|Emotional well-being|emotional well-being
459178|NCT01186042|Sexual health|sexual health
459179|NCT01186029|Looking at adding drug to already established treatment regimen for|looking at adding drug to already established treatment regimen for
459180|NCT01186029|Nausea and Vomiting|nausea and vomiting
459181|NCT01186016|Genetic Education|genetic education
459182|NCT01186016|Smoking Cessation|smoking cessation
459183|NCT01186016|Quitting Smoking|quitting smoking
459184|NCT01186016|Standard Smoking Cessation Program|standard smoking cessation program
459185|NCT01186016|Genetic Education for Smoking Cessation|genetic education for smoking cessation
459186|NCT01186003|Diabetes|diabetes
459187|NCT01185977|Major Depressive Disorder|major depressive disorder
459188|NCT01185977|Fluoxetine|fluoxetine
459189|NCT01185977|QEEG|qeeg
459190|NCT01185977|cordance|cordance
459191|NCT01185977|ATR|atr
459192|NCT01185964|Sarcoma, Soft Tissue|sarcoma, soft tissue
459193|NCT01185964|Advanced Soft Tissue Sarcoma|advanced soft tissue sarcoma
459194|NCT01185951|Achilles Tendon|achilles tendon
459195|NCT01185951|Patella|patella
459196|NCT01185951|Allergy|allergy
459197|NCT01185951|Necrosis|necrosis
459198|NCT01185951|Infection|infection
459199|NCT01185938|statin|statin
459200|NCT01185938|CIN|cin
459201|NCT01185938|periprocedural damage|periprocedural damage
459202|NCT01185925|PDE5-inhibition|pde5-inhibition
459203|NCT01185925|exercise ventilation|exercise ventilation
459204|NCT01185925|heart failure|heart failure
459205|NCT01185925|sildenafil|sildenafil
459206|NCT01185925|pulmonary hemodynamics|pulmonary hemodynamics
459207|NCT01185912|Cardiac MRI|cardiac mri
459208|NCT01185912|Cardiac ultrasound|cardiac ultrasound
459209|NCT01185912|Cardiac surgery|cardiac surgery
459210|NCT01185899|heart attack|heart attack
459211|NCT01185899|acute myocardial infarction|acute myocardial infarction
459212|NCT01185899|STEMI|stemi
459213|NCT01185899|NSTEMI|nstemi
459214|NCT01185899|Unstable Angina|unstable angina
459215|NCT01185899|suspected acute coronary syndrome|suspected acute coronary syndrome
459216|NCT01185899|Non-ischemic chest pain|non-ischemic chest pain
459217|NCT01185886|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
459218|NCT01185886|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
459219|NCT01185886|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
459220|NCT01185886|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
459221|NCT01185886|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
459222|NCT01185886|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
459223|NCT01185886|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
459224|NCT01185886|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
459225|NCT01185886|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
459226|NCT01185886|Philadelphia chromosome positive childhood precursor acute lymphoblastic leukemia|philadelphia chromosome positive childhood precursor acute lymphoblastic leukemia
459227|NCT01185821|BAF312|baf312
459228|NCT01185821|siponimod|siponimod
459229|NCT01185821|Multiple Sclerosis|multiple sclerosis
459230|NCT01185821|Relapsing remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
459231|NCT01185821|Demyelinating Autoimmune Diseases|demyelinating autoimmune diseases
459232|NCT01185821|MS|ms
459233|NCT01185821|RRMS|rrms
459234|NCT01185821|inflammatory disease|inflammatory disease
459235|NCT01185808|sinusitis|sinusitis
459236|NCT01185808|chronic sinusitis with polyps|chronic sinusitis with polyps
459237|NCT01185795|yogurt|yogurt
459238|NCT01185795|probiotic|probiotic
459239|NCT01185795|cholesterol|cholesterol
459240|NCT01185782|Infertility|infertility
459241|NCT01185782|Ovulation induction|ovulation induction
459242|NCT01185782|Gonalef® (Follitropin alfa)|gonalef® (follitropin alfa)
459243|NCT01185782|Purified pituitary gonadotropin (Fertinorm-P®)|purified pituitary gonadotropin (fertinorm-p®)
459244|NCT01185782|gonadotropin|gonadotropin
459245|NCT01185782|Reproductive technologies, assisted|reproductive technologies, assisted
459246|NCT01185782|Polycystic ovary syndrome|polycystic ovary syndrome
459247|NCT01185769|Vitamin E|vitamin e
459248|NCT01185769|Absorption|absorption
459249|NCT01185756|Heart failure|heart failure
459250|NCT01185756|Sudden death|sudden death
459251|NCT01185756|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
459252|NCT01185756|MIBG scintigraphy|mibg scintigraphy
459253|NCT01185743|healthy volunteers|healthy volunteers
459254|NCT01185743|antipsychotics|antipsychotics
459255|NCT01185743|gene expression|gene expression
459256|NCT01185730|Pulmonary hypertension|pulmonary hypertension
459257|NCT01185730|Prognostic factors|prognostic factors
459258|NCT01185730|Idiopathic pulmonary hypertension|idiopathic pulmonary hypertension
459259|NCT01185730|Family pulmonary hypertension|family pulmonary hypertension
459260|NCT01185730|use anorectics|use anorectics
459261|NCT01185704|Cetrorelix acetate; follitropin alfa; human chorionic-gonadotropin alfa; follicular maturation; pregnancy; ovarian stimulation|cetrorelix acetate; follitropin alfa; human chorionic-gonadotropin alfa; follicular maturation; pregnancy; ovarian stimulation
459262|NCT01185678|Contraception|contraception
459264|NCT01185665|FBSS|fbss
459265|NCT01185652|Smoking|smoking
459266|NCT01185652|airflow obstruction|airflow obstruction
459267|NCT01185652|pulmonary function tests|pulmonary function tests
459268|NCT01185639|lung cancer|lung cancer
459269|NCT01185639|metastatic|metastatic
459270|NCT01185639|SBRT|sbrt
459271|NCT01185639|Stereotactic body radiation therapy|stereotactic body radiation therapy
459272|NCT01185639|liver|liver
459273|NCT01185639|spine|spine
459274|NCT01185639|adrenal|adrenal
459275|NCT01185639|bone cancer|bone cancer
459276|NCT01185639|Spinal Column|spinal column
459277|NCT01185626|patients|patients
459278|NCT01185600|transfusion complications|transfusion complications
459279|NCT01185600|washed RBC|washed rbc
459280|NCT01185600|microparticles|microparticles
459281|NCT01185600|storage lesion|storage lesion
459282|NCT01185587|SCN5A protein|scn5a protein
459283|NCT01185587|voltage-gated Na+ channel|voltage-gated na+ channel
459284|NCT01185561|Diabetes|diabetes
459285|NCT01185561|SWEEP|sweep
459286|NCT01185561|Dysphoria|dysphoria
459287|NCT01185548|Advanced or Metastatic Solid Tumors or Lymphoma|advanced or metastatic solid tumors or lymphoma
459288|NCT01185535|topical anesthesia|topical anesthesia
459289|NCT01185535|tracheal intubation|tracheal intubation
459290|NCT01185535|difficult airway|difficult airway
459291|NCT01185509|HER2 negative|her2 negative
459292|NCT01185509|HER2 positive|her2 positive
459293|NCT01185496|diabetes mellitus|diabetes mellitus
459294|NCT01185483|Endoscopic submucosal dissection|endoscopic submucosal dissection
459295|NCT01185483|Submucosal tumor|submucosal tumor
459296|NCT01185483|Minimal invasive|minimal invasive
459297|NCT01185483|Gastroscopy|gastroscopy
459298|NCT01185470|Chronic pain|chronic pain
459299|NCT01185470|Morphine Sufate|morphine sufate
459300|NCT01185470|Intrathecal|intrathecal
459301|NCT01185470|Implantable drug delivery pumps|implantable drug delivery pumps
459302|NCT01185457|Shoulder surgery|shoulder surgery
459303|NCT01185457|Beach chair position|beach chair position
459304|NCT01185457|Interscalene block|interscalene block
459305|NCT01185457|HRV|hrv
459306|NCT01185457|Autonomic nervous system|autonomic nervous system
459307|NCT01185444|Knee Balance|knee balance
459308|NCT01185444|Hyaluronate|hyaluronate
459309|NCT01185444|Osteoarthritis|osteoarthritis
459310|NCT01185444|Viscosupplementation|viscosupplementation
459311|NCT01185431|Ficus Carica|ficus carica
459312|NCT01185431|Functional Constipation|functional constipation
459313|NCT01185431|Dietary Supplement|dietary supplement
459314|NCT01185431|Fig Paste|fig paste
459315|NCT01185405|Voriconazole|voriconazole
459316|NCT01185405|Therapeutic drug monitoring|therapeutic drug monitoring
459317|NCT01185405|Intensive care unit|intensive care unit
459318|NCT01185392|Cardiac Resynchronisation Therapy in Heart Failure|cardiac resynchronisation therapy in heart failure
459319|NCT01185379|Docosahexaenoic acid|docosahexaenoic acid
459320|NCT01185379|omega 3|omega 3
459321|NCT01185379|cerebral blood flow|cerebral blood flow
459322|NCT01185379|Near Infrared spectroscopy|near infrared spectroscopy
459323|NCT01185379|cognitive function|cognitive function
459324|NCT01185379|mood|mood
459325|NCT01185366|Advanced non-clear cell renal cell cancer (RCC)|advanced non-clear cell renal cell cancer (rcc)
459326|NCT01185366|Clear-cell renal cell carcinoma|clear-cell renal cell carcinoma
459327|NCT01185366|Collecting duct carcinoma|collecting duct carcinoma
459328|NCT01185366|Translocation carcinoma|translocation carcinoma
459329|NCT01185366|Chromophobe|chromophobe
459330|NCT01185366|Everolimus|everolimus
459331|NCT01185366|Sunitinib|sunitinib
459332|NCT01185366|Afinitor|afinitor
459333|NCT01185366|RAD001|rad001
459334|NCT01185366|Sunitinib Malate|sunitinib malate
459335|NCT01185366|SUO11248|suo11248
459336|NCT01185366|Sutent|sutent
459337|NCT01185366|ESPN|espn
459338|NCT01185353|Rheumatoid Arthritis|rheumatoid arthritis
459339|NCT01185353|RA|ra
459340|NCT01185340|Depression|depression
459341|NCT01185340|MDD|mdd
459342|NCT01185327|Regurgitation|regurgitation
459343|NCT01185327|Infants to Israeli Ethiopian-origin mothers|infants to israeli ethiopian-origin mothers
459344|NCT01185314|NSCLC, EGFR mutation|nsclc, egfr mutation
459345|NCT01185301|Arthritis|arthritis
459346|NCT01185301|Erosion|erosion
459347|NCT01185301|Humira|humira
459348|NCT01185301|Adalimumab|adalimumab
459349|NCT01185301|Injection|injection
459350|NCT01185301|Rheumatoid|rheumatoid
459351|NCT01185301|Methotrexate|methotrexate
459352|NCT01185288|Rheumatoid Arthritis|rheumatoid arthritis
459353|NCT01185262|Recurrent and refractory chronic lymphocytic leukemia|recurrent and refractory chronic lymphocytic leukemia
459354|NCT01185249|CHF|chf
459355|NCT01185249|congestive heart failure|congestive heart failure
459356|NCT01185236|Diabetes mellitus|diabetes mellitus
459357|NCT01185223|Valganciclovir|valganciclovir
459358|NCT01185223|Ganciclovir|ganciclovir
459359|NCT01185223|Antiviral Drug|antiviral drug
459360|NCT01185223|CMV disease|cmv disease
459361|NCT01185197|Minimal Change Nephrotic Syndrome|minimal change nephrotic syndrome
459362|NCT01185197|Corticosteroid|corticosteroid
459363|NCT01185197|Mycophenolate|mycophenolate
459364|NCT01185197|Remission|remission
459365|NCT01185197|Safety|safety
459366|NCT01185184|Relative bioavailability|relative bioavailability
459367|NCT01185184|controlled release|controlled release
459368|NCT01185184|Phase 1|phase 1
459369|NCT01185184|CP-690|cp-690
459370|NCT01185184|550|550
459371|NCT01185171|Larynx|larynx
459372|NCT01185171|Lip|lip
459373|NCT01185171|Oral Cavity and Pharynx|oral cavity and pharynx
459374|NCT01185158|Larynx|larynx
459375|NCT01185158|Lip|lip
459376|NCT01185158|Oral Cavity and Pharynx|oral cavity and pharynx
459377|NCT01185145|breast-conservation|breast-conservation
459378|NCT01185145|accelerated partial breast irradiation|accelerated partial breast irradiation
459379|NCT01185145|APBI|apbi
459380|NCT01185145|IMRT|imrt
459381|NCT01185145|Intensity modulated radiotherapy|intensity modulated radiotherapy
459382|NCT01185145|breast brachytherapy|breast brachytherapy
459383|NCT01185145|lumpectomy|lumpectomy
459384|NCT01185145|early stage breast cancer|early stage breast cancer
459385|NCT01185145|DCIS|dcis
459386|NCT01185145|Mammosite|mammosite
459387|NCT01185132|breast-conservation|breast-conservation
459388|NCT01185132|adjuvant radiotherapy|adjuvant radiotherapy
459389|NCT01185132|breast cancer|breast cancer
459390|NCT01185132|early-stage breast cancer|early-stage breast cancer
459391|NCT01185132|DCIS|dcis
459392|NCT01185132|lumpectomy|lumpectomy
459393|NCT01185132|accelerated partial breast irradiation|accelerated partial breast irradiation
459394|NCT01185132|APBI|apbi
459395|NCT01185132|three dimensional conformal external radiotherapy|three dimensional conformal external radiotherapy
459396|NCT01185132|intensity modulated radiotherapy|intensity modulated radiotherapy
459397|NCT01185132|3D CRT|3d crt
459398|NCT01185132|IMRT|imrt
459399|NCT01185119|glucose uptake and metabolism in brain|glucose uptake and metabolism in brain
459400|NCT01185093|Cells|cells
459401|NCT01185093|Prevention|prevention
459402|NCT01185093|Cancer education|cancer education
459403|NCT01185093|Nutrition|nutrition
459404|NCT01185093|Healthy living|healthy living
459405|NCT01185093|Physical activity|physical activity
459406|NCT01185093|Dangers of tobacco|dangers of tobacco
459407|NCT01185093|Sun protection|sun protection
459408|NCT01185080|AZD8848|azd8848
459409|NCT01185080|allergic rhinitis|allergic rhinitis
459410|NCT01185080|efficacy|efficacy
459411|NCT01185080|tolerability|tolerability
459412|NCT01185080|safety|safety
459413|NCT01185080|nasal symptoms|nasal symptoms
459414|NCT01185067|Hypertension|hypertension
459415|NCT01185067|Endothelial function|endothelial function
459416|NCT01185067|Antioxidants|antioxidants
459417|NCT01185067|Oxidative stress|oxidative stress
459418|NCT01185067|Grapes|grapes
459419|NCT01185067|Polyphenols|polyphenols
459420|NCT01185067|Resveratrol|resveratrol
459421|NCT01185067|Quercetin|quercetin
459422|NCT01185067|Anthocyanins|anthocyanins
459423|NCT01185067|Flavanols|flavanols
459424|NCT01185067|Flavonols|flavonols
459425|NCT01185067|Congestive heart failure|congestive heart failure
459426|NCT01185067|Heart failure with normal ejection fraction|heart failure with normal ejection fraction
459427|NCT01185067|Heart failure with preserved systolic function|heart failure with preserved systolic function
459428|NCT01185067|HFNEF|hfnef
459429|NCT01185067|HFPSF|hfpsf
459430|NCT01185067|HFPEF|hfpef
459431|NCT01185067|DHF|dhf
459432|NCT01185054|Pediatrics|pediatrics
459433|NCT01185054|Gastroenteritis|gastroenteritis
459434|NCT01185054|Oral Rehydration|oral rehydration
459435|NCT01185054|Electrolyte Maintenance Solution|electrolyte maintenance solution
459436|NCT01185041|Arterial Stiffness|arterial stiffness
459437|NCT01185041|Wave Reflection|wave reflection
459438|NCT01185041|Watermelon Supplementation|watermelon supplementation
459439|NCT01185041|Aortic Blood Pressure|aortic blood pressure
459440|NCT01185041|Obesity|obesity
459441|NCT01185028|Chronic HCV|chronic hcv
459442|NCT01185028|HCV Treatment Nonresponders|hcv treatment nonresponders
459443|NCT01185028|HCV Treatment Relapsers|hcv treatment relapsers
459444|NCT01185028|HIV-HCV Co-Infection|hiv-hcv co-infection
459445|NCT01185028|Nitazoxanide|nitazoxanide
459446|NCT01185028|Hepatitis C|hepatitis c
459447|NCT01185015|Angina Pectoris, Coronary disease|angina pectoris, coronary disease
459448|NCT01185002|CE|ce
459449|NCT01185002|colonoscopy|colonoscopy
459450|NCT01185002|colon|colon
459451|NCT01185002|Eligable for colon evaluation|eligable for colon evaluation
459452|NCT01184976|H5N1|h5n1
459453|NCT01184976|Avian Influenza|avian influenza
459454|NCT01184976|DNA Vaccine|dna vaccine
459455|NCT01184976|Electroporation|electroporation
459456|NCT01184976|Intramuscular (IM) Injection|intramuscular (im) injection
459457|NCT01184963|PCOS|pcos
459458|NCT01184963|High protein diet|high protein diet
459459|NCT01184924|Arthritis|arthritis
459460|NCT01184924|Tai Chi|tai chi
459461|NCT01184911|Malaria|malaria
459462|NCT01184911|Pregnancy|pregnancy
459463|NCT01184898|AML|aml
459464|NCT01184898|mTOR|mtor
459465|NCT01184898|rapamycin|rapamycin
459466|NCT01184885|hyperCVAD|hypercvad
459467|NCT01184885|rapamycin|rapamycin
459468|NCT01184885|lymphoid malignancies|lymphoid malignancies
459469|NCT01184885|lymphoblastic leukemia|lymphoblastic leukemia
459470|NCT01184885|B and T cell|b and t cell
459471|NCT01184885|philadelphia chromosome negative|philadelphia chromosome negative
459472|NCT01184885|burkitt lymphoma|burkitt lymphoma
459473|NCT01184885|burkitt-type lymphoma|burkitt-type lymphoma
459474|NCT01184885|lymphoblastic lymphoma|lymphoblastic lymphoma
459475|NCT01184885|mantle cell lymphoma|mantle cell lymphoma
459476|NCT01184885|adult t cell leukemia|adult t cell leukemia
459477|NCT01184885|adult t cell lymphoma|adult t cell lymphoma
459478|NCT01184872|Skin infection|skin infection
459479|NCT01184872|Daptomycin|daptomycin
459480|NCT01184872|Elderly|elderly
459481|NCT01184872|Gram positive|gram positive
459482|NCT01184872|Complicated skin and soft tissue infections|complicated skin and soft tissue infections
459483|NCT01184859|nocturia|nocturia
459484|NCT01184859|bladder function|bladder function
459485|NCT01184846|Chronic inflammatory demyelinating polyneuropathy|chronic inflammatory demyelinating polyneuropathy
459486|NCT01184846|CIDP|cidp
459487|NCT01184833|Multiple sclerosis|multiple sclerosis
459488|NCT01184833|Interferon beta-1b|interferon beta-1b
459489|NCT01184833|Compliance to treatment|compliance to treatment
459490|NCT01184833|Premature treatment discontinuation|premature treatment discontinuation
459491|NCT01184820|Pharmacokinetics|pharmacokinetics
459492|NCT01184820|Safety|safety
459493|NCT01184807|Advanced solid tumor|advanced solid tumor
459494|NCT01184794|Analgesia laparoscopy|analgesia laparoscopy
459495|NCT01184768|type 2 diabetes|type 2 diabetes
459496|NCT01184768|HbA1c|hba1c
459497|NCT01184768|vitamin D|vitamin d
459498|NCT01184768|diagnosis|diagnosis
459499|NCT01184755|Device-guided breathing|device-guided breathing
459500|NCT01184755|hypertension|hypertension
459501|NCT01184755|behavioral intervention|behavioral intervention
459502|NCT01184755|stress reduction|stress reduction
459503|NCT01184755|Heart Rate Variability (HRV) biofeedback|heart rate variability (hrv) biofeedback
459504|NCT01184729|aerobic capacity|aerobic capacity
459505|NCT01184716|Vitamin D status (serum 25-hydroxyvitamin D)|vitamin d status (serum 25-hydroxyvitamin d)
459506|NCT01184703|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
459507|NCT01184703|Glycemic Index Diet|glycemic index diet
459508|NCT01184703|HbA1c|hba1c
459509|NCT01184703|Lipids|lipids
459510|NCT01184690|double-balloon endoscopy|double-balloon endoscopy
459511|NCT01184690|diagnostic yield|diagnostic yield
459512|NCT01184664|Smoking cessation|smoking cessation
459513|NCT01184664|Tobacco dependence|tobacco dependence
459514|NCT01184664|Varenicline|varenicline
459515|NCT01184664|Nicotine Replacement Therapy|nicotine replacement therapy
459516|NCT01184664|Combination therapy|combination therapy
459517|NCT01184651|Congenital Adrenal Hyperplasia|congenital adrenal hyperplasia
459518|NCT01184651|CAH|cah
459519|NCT01184651|sex differences|sex differences
459520|NCT01184651|adolescence|adolescence
459521|NCT01184651|androgen|androgen
459522|NCT01184651|behavior|behavior
459523|NCT01184651|gender development|gender development
459524|NCT01184638|Cognitive Disorders|cognitive disorders
459525|NCT01184638|General anesthesia|general anesthesia
459526|NCT01184638|Sevoflurane|sevoflurane
459527|NCT01184638|Propofol|propofol
459528|NCT01184638|Memory|memory
459529|NCT01184625|Myositis|myositis
459530|NCT01184625|Physical exercise|physical exercise
459531|NCT01184625|Disability|disability
459532|NCT01184612|Inmates with heavy use of alcohol or drugs|inmates with heavy use of alcohol or drugs
459533|NCT01184599|Aliskiren|aliskiren
459534|NCT01184599|Albuminuria|albuminuria
459535|NCT01184599|Angiotensinogen|angiotensinogen
459536|NCT01184599|collagen type IV|collagen type iv
459537|NCT01184599|Transforming Growth Factor beta|transforming growth factor beta
459538|NCT01184599|aldosterone|aldosterone
459539|NCT01184599|renin|renin
459540|NCT01184599|prorenin receptor|prorenin receptor
459541|NCT01184599|des-angiotensin I renin substrate|des-angiotensin i renin substrate
459542|NCT01184599|oxidative stress|oxidative stress
459543|NCT01184599|advanced glycosylation end-product receptor|advanced glycosylation end-product receptor
459544|NCT01184599|N,N-dimethylarginine|n,n-dimethylarginine
459545|NCT01184586|function|function
459546|NCT01184586|DASH|dash
459547|NCT01184586|MHQ|mhq
459548|NCT01184586|pain|pain
459549|NCT01184586|strength|strength
459550|NCT01184573|chronic pancreatitis|chronic pancreatitis
459551|NCT01184573|breath test|breath test
459552|NCT01184573|bicarbonate|bicarbonate
459553|NCT01184560|obesity|obesity
459554|NCT01184534|Lung Biopsy|lung biopsy
459555|NCT01184534|Multimedia patient education tool|multimedia patient education tool
459556|NCT01184534|Multimedia Education Tool|multimedia education tool
459557|NCT01184534|Computed tomography guided lung biopsy|computed tomography guided lung biopsy
459558|NCT01184534|Computerized Tomography|computerized tomography
459559|NCT01184534|CT|ct
459560|NCT01184534|Questionnaire|questionnaire
459561|NCT01184534|Lung nodules|lung nodules
459562|NCT01184508|classic with aura|classic with aura
459563|NCT01184508|common without aura|common without aura
459564|NCT01184508|migraine|migraine
459565|NCT01184508|headache|headache
459566|NCT01184495|Erythropoietin|erythropoietin
459567|NCT01184495|Chronic renal failure|chronic renal failure
459568|NCT01184495|Hemodialysis|hemodialysis
459569|NCT01184495|Anemia|anemia
459570|NCT01184482|recurrent colorectal cancer|recurrent colorectal cancer
459571|NCT01184482|recurrent head and neck cancer|recurrent head and neck cancer
459572|NCT01184482|recurrent lung cancer|recurrent lung cancer
459573|NCT01184482|cetuximab|cetuximab
459574|NCT01184482|lapatinib|lapatinib
459575|NCT01184456|AIDS|aids
459576|NCT01184456|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
459577|NCT01184456|HIV|hiv
459578|NCT01184456|Human Immunodeficiency Virus|human immunodeficiency virus
459579|NCT01184443|Anorexia Nervosa|anorexia nervosa
459580|NCT01184443|Eating Disorder Not Otherwise Specified|eating disorder not otherwise specified
459581|NCT01184443|Olanzapine|olanzapine
459582|NCT01184443|Pediatric|pediatric
459583|NCT01184430|advanced hemodynamic monitoring|advanced hemodynamic monitoring
459584|NCT01184430|goal-directed therapy|goal-directed therapy
459585|NCT01184430|cardiac surgery|cardiac surgery
459586|NCT01184430|hemodynamic monitoring|hemodynamic monitoring
459587|NCT01184404|Congenital heart disease|congenital heart disease
459588|NCT01184404|Cardiac surgery|cardiac surgery
459589|NCT01184404|Bosentan|bosentan
459590|NCT01184378|infant formula|infant formula
459591|NCT01184378|dairy fat|dairy fat
459592|NCT01184378|soluble milk protein|soluble milk protein
459593|NCT01184365|fatigue|fatigue
459594|NCT01184365|energy management|energy management
459595|NCT01184365|spinal cord injury|spinal cord injury
459596|NCT01184365|self-efficacy|self-efficacy
459597|NCT01184365|environment|environment
459598|NCT01184339|Staphylococcus|staphylococcus
459599|NCT01184339|aureus|aureus
459600|NCT01184339|methicillin|methicillin
459601|NCT01184339|resistant|resistant
459602|NCT01184339|MRSA|mrsa
459603|NCT01184339|MSSA|mssa
459604|NCT01184339|Blood Culture|blood culture
459605|NCT01184339|diagnostic|diagnostic
459606|NCT01184326|RAD001|rad001
459607|NCT01184326|pazopanib|pazopanib
459608|NCT01184326|everolimus|everolimus
459609|NCT01184326|advanced cancer|advanced cancer
459610|NCT01184313|aortic valve surgery|aortic valve surgery
459611|NCT01184313|CPB|cpb
459612|NCT01184313|lung injury|lung injury
459613|NCT01184300|CYP2C19*2|cyp2c19*2
459614|NCT01184300|Pharmacogenomics|pharmacogenomics
459615|NCT01184300|Clopidogrel|clopidogrel
459616|NCT01184300|Prasugrel|prasugrel
459617|NCT01184300|Percutaneous Coronary Intervention|percutaneous coronary intervention
459618|NCT01184287|Non Small Cell Lung Cancer, NSCLC, Lung Cancer|non small cell lung cancer, nsclc, lung cancer
459619|NCT01184287|Previously untreated Non-Squamous, Non-Small Cell Lung Cancer|previously untreated non-squamous, non-small cell lung cancer
459620|NCT01184235|Circadian Disorders|circadian disorders
459621|NCT01184235|Autism Spectrum Disorders|autism spectrum disorders
459622|NCT01184235|Mood Disorders|mood disorders
459623|NCT01184235|Executive Functioning|executive functioning
459624|NCT01184235|Pediatric Mood Disorders|pediatric mood disorders
459625|NCT01184196|knee replacement|knee replacement
459626|NCT01184196|knee arthroplasty|knee arthroplasty
459627|NCT01184196|total knee replacement|total knee replacement
459628|NCT01184196|arthroplasty, knee replacement|arthroplasty, knee replacement
459629|NCT01184183|Patch for Carotid Endarterectomy|patch for carotid endarterectomy
459630|NCT01184170|obesity|obesity
459631|NCT01184170|metabolism|metabolism
459632|NCT01184170|cardiovascular metabolic syndrome|cardiovascular metabolic syndrome
459633|NCT01184144|Endometriosis|endometriosis
459634|NCT01184144|Peritoneal fluid|peritoneal fluid
459635|NCT01184144|Cytokines|cytokines
459636|NCT01184144|Peroxisome Proliferator-Activated Receptors|peroxisome proliferator-activated receptors
459637|NCT01184131|Mentor Training|mentor training
459638|NCT01184131|Randomized trial of mentoring effectiveness|randomized trial of mentoring effectiveness
459639|NCT01184131|Mentoring clinical researchers|mentoring clinical researchers
459640|NCT01184118|asthma|asthma
459641|NCT01184118|sleep apnea|sleep apnea
459642|NCT01184092|Bioequivalence|bioequivalence
459643|NCT01184092|healthy volunteer study|healthy volunteer study
459644|NCT01184092|Rheumatoid Arthritis|rheumatoid arthritis
459645|NCT01184079|human papillomavirus vaccine L1, type 6,11,16,18|human papillomavirus vaccine l1, type 6,11,16,18
459646|NCT01184079|HPV Vaccines|hpv vaccines
459647|NCT01184079|HPV L1 vaccine, quadrivalent 6,11,16,18|hpv l1 vaccine, quadrivalent 6,11,16,18
459648|NCT01184066|Chemotherapy|chemotherapy
459649|NCT01184066|Patient Adherence|patient adherence
459650|NCT01184066|African Americans|african americans
459651|NCT01184066|Cancer Survivor|cancer survivor
459652|NCT01184066|Decision Making|decision making
459653|NCT01184066|Communication|communication
459654|NCT01184066|Quality of Life|quality of life
459655|NCT01184066|Social Support|social support
459656|NCT01184066|Patient Education|patient education
459657|NCT01184053|endometrial|endometrial
459658|NCT01184053|carcinoma|carcinoma
459659|NCT01184053|recurrent|recurrent
459660|NCT01184053|metastatic|metastatic
459661|NCT01184053|Trisenox|trisenox
459662|NCT01184053|arsenic trioxide|arsenic trioxide
459663|NCT01184053|Phase II|phase ii
459664|NCT01184053|VEGF|vegf
459665|NCT01184053|gynecology|gynecology
459666|NCT01184053|Lineberger|lineberger
459667|NCT01184053|UNC|unc
459668|NCT01184053|vascular endothelial growth factor|vascular endothelial growth factor
459669|NCT01184053|University of North Carolina at Chapel Hill|university of north carolina at chapel hill
459670|NCT01184027|head and neck cancer|head and neck cancer
459671|NCT01184027|surgery|surgery
459672|NCT01184027|nutrition|nutrition
459673|NCT01184014|corticosteroid|corticosteroid
459674|NCT01184014|hyperglycemia|hyperglycemia
459675|NCT01184014|hospital|hospital
459676|NCT01184014|corticosteroid induced hyperglycemia in the hospital|corticosteroid induced hyperglycemia in the hospital
459677|NCT01184001|Healthy subjects|healthy subjects
459678|NCT01184001|Food Effect Study|food effect study
459679|NCT01183962|CAD|cad
459680|NCT01183962|Vitamin D|vitamin d
459681|NCT01183962|CVD|cvd
459682|NCT01183949|Neoplasms|neoplasms
459683|NCT01183949|Neoplasms, Plasma Cell|neoplasms, plasma cell
459684|NCT01183949|Neoplasms by Histologic Type|neoplasms by histologic type
459685|NCT01183949|Hemostatic Disorders|hemostatic disorders
459686|NCT01183949|Paraproteinemias|paraproteinemias
459687|NCT01183949|Blood Protein Disorders|blood protein disorders
459688|NCT01183949|Hematologic Diseases|hematologic diseases
459689|NCT01183949|Hemorrhagic Disorders|hemorrhagic disorders
459690|NCT01183949|Lymphoproliferative Disorders|lymphoproliferative disorders
459691|NCT01183949|Immunoproliferative Disorders|immunoproliferative disorders
459692|NCT01183949|Immune System Diseases|immune system diseases
459693|NCT01183949|Bortezomib|bortezomib
459694|NCT01183949|Antineoplastic Agents|antineoplastic agents
459695|NCT01183936|Melanoma/mortality/pathology/*surgery|melanoma/mortality/pathology/*surgery
459696|NCT01183936|Randomized Controlled Trials as Topic|randomized controlled trials as topic
459697|NCT01183936|Survival|survival
459698|NCT01183936|Disease-Free Survival|disease-free survival
459699|NCT01183923|asthma|asthma
459700|NCT01183923|dietary interventions|dietary interventions
459701|NCT01183923|mouse allergy|mouse allergy
459702|NCT01183910|PURPURA|purpura
459703|NCT01183910|SENILE PURPURA|senile purpura
459704|NCT01183910|BATEMAN'S PURPURA|bateman's purpura
459705|NCT01183897|GM-CSF|gm-csf
459706|NCT01183897|MAB 3F8|mab 3f8
459707|NCT01183897|RETINOIC ACID (CIS-9 & 13)|retinoic acid (cis-9 & 13)
459708|NCT01183897|09-161|09-161
459709|NCT01183884|GM-CSF|gm-csf
459710|NCT01183884|MAB 3F8|mab 3f8
459711|NCT01183884|RETINOIC ACID (CIS-9 & 13)|retinoic acid (cis-9 & 13)
459712|NCT01183884|09-160|09-160
459713|NCT01183871|Cerebral oxygenation|cerebral oxygenation
459714|NCT01183871|thoracotomy|thoracotomy
459715|NCT01183871|lung resection|lung resection
459716|NCT01183871|pulmonary dysfunction|pulmonary dysfunction
459717|NCT01183845|Crohn Disease|crohn disease
459718|NCT01183845|Crohn's Disease Endoscopy Index of Severity|crohn's disease endoscopy index of severity
459719|NCT01183845|Colon Capsule Endoscopy|colon capsule endoscopy
459720|NCT01183845|Crohn's Disease located in colon and/or ileum|crohn's disease located in colon and/or ileum
459721|NCT01183832|Breast cancer|breast cancer
459722|NCT01183832|radiotherapy|radiotherapy
459723|NCT01183832|hormonotherapy|hormonotherapy
459724|NCT01183819|cognitive function|cognitive function
459725|NCT01183819|fMRI|fmri
459726|NCT01183819|apoE|apoe
459727|NCT01183819|inflammatory markers|inflammatory markers
459728|NCT01183819|exercise|exercise
459729|NCT01183819|cognitive intervention|cognitive intervention
459730|NCT01183819|Space Fortress|space fortress
459731|NCT01183806|Alzheimer's disease|alzheimer's disease
459732|NCT01183806|Exercise|exercise
459733|NCT01183806|Rivastigmine|rivastigmine
459734|NCT01183806|Quality of life|quality of life
459735|NCT01183793|Gastrointestinal Tract [A03.556]|gastrointestinal tract [a03.556]
459736|NCT01183780|second line|second line
459737|NCT01183780|metastatic colorectal cancer|metastatic colorectal cancer
459738|NCT01183780|FOLFIRI|folfiri
459739|NCT01183780|ramucirumab|ramucirumab
459740|NCT01183780|CRC|crc
459741|NCT01183780|mCRC|mcrc
459742|NCT01183767|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
459743|NCT01183767|Epigallocatechin-Gallate|epigallocatechin-gallate
459744|NCT01183767|Green tea extract|green tea extract
459745|NCT01183754|coronary disease|coronary disease
459746|NCT01183754|platelet reactivity|platelet reactivity
459747|NCT01183754|drug-eluting stent|drug-eluting stent
459748|NCT01183741|Hypertension|hypertension
459749|NCT01183741|Hypotension|hypotension
459750|NCT01183741|Blood pressure|blood pressure
459751|NCT01183728|Knee degenerative disease|knee degenerative disease
459752|NCT01183728|osteoarthritis|osteoarthritis
459753|NCT01183728|gonarthrosis|gonarthrosis
459754|NCT01183728|stem cell|stem cell
459755|NCT01183728|cellular therapy|cellular therapy
459756|NCT01183728|regenerative therapy|regenerative therapy
459757|NCT01183728|Mesenchymal stem cells|mesenchymal stem cells
459758|NCT01183728|Bone marrow|bone marrow
459759|NCT01183728|musculoskeletal Diseases|musculoskeletal diseases
459760|NCT01183715|Single Ascending Dose|single ascending dose
459761|NCT01183715|Phase 1|phase 1
459762|NCT01183715|Safety and Tolerability|safety and tolerability
459763|NCT01183715|PK|pk
459764|NCT01183715|Healthy Subjects|healthy subjects
459765|NCT01183702|LASIK vs. non-LASIK|lasik vs. non-lasik
459766|NCT01183663|Lenalidomide|lenalidomide
459767|NCT01183663|Bevacizumab|bevacizumab
459768|NCT01183663|Sorafenib|sorafenib
459769|NCT01183663|Temsirolimus|temsirolimus
459770|NCT01183663|5-Fluorouracil|5-fluorouracil
459771|NCT01183663|Leucovorin|leucovorin
459772|NCT01183663|Oxaliplatin|oxaliplatin
459773|NCT01183663|Avastin|avastin
459774|NCT01183663|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
459775|NCT01183663|rhuMAB-VEGF|rhumab-vegf
459776|NCT01183663|CC-5013|cc-5013
459777|NCT01183663|Revlimid|revlimid
459778|NCT01183663|Nexavar|nexavar
459779|NCT01183663|BAY 43-90006|bay 43-90006
459780|NCT01183663|Metastatic cancer|metastatic cancer
459781|NCT01183663|Metastatic colorectal cancer|metastatic colorectal cancer
459782|NCT01183663|Advanced solid tumors|advanced solid tumors
459783|NCT01183663|Hematologic malignancies|hematologic malignancies
459784|NCT01183663|Colon cancer|colon cancer
459785|NCT01183663|Advanced colorectal cancer|advanced colorectal cancer
459786|NCT01183663|Breast cancer|breast cancer
459787|NCT01183663|Pancreatic cancer|pancreatic cancer
459788|NCT01183663|Gastric cancer|gastric cancer
459789|NCT01183663|Advanced renal cell carcinoma|advanced renal cell carcinoma
459790|NCT01183663|Prostate cancer|prostate cancer
459791|NCT01183663|Melanoma|melanoma
459792|NCT01183663|Unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
459793|NCT01183663|Renal cell carcinoma|renal cell carcinoma
459794|NCT01183663|Metastatic breast cancer|metastatic breast cancer
459795|NCT01183663|Glioblastoma|glioblastoma
459796|NCT01183663|Multiple myeloma|multiple myeloma
459797|NCT01183637|Cartilage|cartilage
459798|NCT01183637|Knee|knee
459799|NCT01183637|Osteochondral|osteochondral
459800|NCT01183624|Osteoarthritis|osteoarthritis
459801|NCT01183624|Pain|pain
459802|NCT01183624|Herbal medicine|herbal medicine
459803|NCT01183624|Topical administration|topical administration
459804|NCT01183611|safety|safety
459805|NCT01183611|immunogenicity|immunogenicity
459806|NCT01183611|HBV vaccine|hbv vaccine
459807|NCT01183611|perinatal transmission|perinatal transmission
459808|NCT01183572|multivitamins|multivitamins
459809|NCT01183572|folate|folate
459810|NCT01183572|iron|iron
459811|NCT01183572|periconception|periconception
459812|NCT01183546|rehabilitation|rehabilitation
459813|NCT01183546|spinal cord injury|spinal cord injury
459814|NCT01183546|wheelchairs|wheelchairs
459815|NCT01183533|Wake-Up Stroke|wake-up stroke
459816|NCT01183533|Ischemic stroke|ischemic stroke
459817|NCT01183533|ischemic stroke patients who wake-up with their symptoms|ischemic stroke patients who wake-up with their symptoms
459818|NCT01183481|nausea|nausea
459819|NCT01183481|vomiting|vomiting
459820|NCT01183481|antiemetics|antiemetics
459821|NCT01183481|radiotherapy|radiotherapy
459822|NCT01183481|Radiation-induced nausea and vomiting|radiation-induced nausea and vomiting
459823|NCT01183468|Diabetes Mellitus, Type 1 (new-onset)|diabetes mellitus, type 1 (new-onset)
459824|NCT01183468|Diabetes Mellitus, Insulin-Dependent (new-onset)|diabetes mellitus, insulin-dependent (new-onset)
459825|NCT01183468|new-onset T1DM|new-onset t1dm
459826|NCT01183468|new-onset T1D|new-onset t1d
459827|NCT01183468|Diabetes Mellitus, Juvenile-Onset|diabetes mellitus, juvenile-onset
459828|NCT01183468|Diabetes, Autoimmune|diabetes, autoimmune
459829|NCT01183468|Aralast NP|aralast np
459830|NCT01183468|Alpha-1 Antitrypsin|alpha-1 antitrypsin
459831|NCT01183468|AAT|aat
459832|NCT01183455|Diabetes Mellitus, Type 1 (new-onset)|diabetes mellitus, type 1 (new-onset)
459833|NCT01183455|T1DM (new-onset)|t1dm (new-onset)
459834|NCT01183455|T1D (new-onset)|t1d (new-onset)
459835|NCT01183455|Diabetes, Autoimmune|diabetes, autoimmune
459836|NCT01183455|Alpha1-Proteinase Inhibitor|alpha1-proteinase inhibitor
459837|NCT01183455|Alpha-1 Antitrypsin|alpha-1 antitrypsin
459839|NCT01183442|endothelial function|endothelial function
459840|NCT01183442|insulin sensitivity|insulin sensitivity
459841|NCT01183429|MAB 3F8|mab 3f8
459842|NCT01183429|RETINOIC ACID (CIS-9 & 13)|retinoic acid (cis-9 & 13)
459843|NCT01183429|Bone Marrow|bone marrow
459844|NCT01183429|09-159|09-159
459845|NCT01183416|GM-CSF|gm-csf
459846|NCT01183416|MAB 3F8|mab 3f8
459847|NCT01183416|RETINOIC ACID (CIS-9 & 13)|retinoic acid (cis-9 & 13)
459848|NCT01183416|09-158|09-158
459849|NCT01183403|stricture|stricture
459850|NCT01183403|anti-TNF|anti-tnf
459851|NCT01183403|ileal Crohn'Disease|ileal crohn'disease
459852|NCT01183403|patients with ileal Crohn's disease complicated by|patients with ileal crohn's disease complicated by
459853|NCT01183403|symptomatic stricture after failure of corticosteroids|symptomatic stricture after failure of corticosteroids
459854|NCT01183403|and/or immunosuppressives|and/or immunosuppressives
459855|NCT01183390|Bioequivalence|bioequivalence
459856|NCT01183390|Healthy Subjects|healthy subjects
459857|NCT01183377|Female Athlete Triad syndrom|female athlete triad syndrom
459858|NCT01183377|Eating disorder|eating disorder
459859|NCT01183377|osteoprosis|osteoprosis
459860|NCT01183364|solid tumor malignancies|solid tumor malignancies
459861|NCT01183364|tumor|tumor
459862|NCT01183364|cancer|cancer
459863|NCT01183364|STA-9090|sta-9090
459864|NCT01183364|ganetespib|ganetespib
459865|NCT01183364|HSP90 inhibitor|hsp90 inhibitor
459866|NCT01183351|Dementia|dementia
459867|NCT01183351|Agitation|agitation
459868|NCT01183351|Challenging behaviour|challenging behaviour
459869|NCT01183351|Behavioural and psychological symptoms in dementia (BPSD)|behavioural and psychological symptoms in dementia (bpsd)
459870|NCT01183338|SpO2|spo2
459871|NCT01183338|Oxygen saturation|oxygen saturation
459872|NCT01183325|Umbilical and small ventral hernias less than 3cm diameter|umbilical and small ventral hernias less than 3cm diameter
459873|NCT01183312|Hypersomnia|hypersomnia
459874|NCT01183312|Primary Hypersomnia|primary hypersomnia
459875|NCT01183312|Idiopathic Hypersomnia|idiopathic hypersomnia
459876|NCT01183312|Narcolepsy without Cataplexy|narcolepsy without cataplexy
459877|NCT01183312|Flumazenil|flumazenil
459878|NCT01183299|bone metabolism|bone metabolism
459879|NCT01183299|salt intake|salt intake
459880|NCT01183299|acid base balance|acid base balance
459881|NCT01183299|bed rest|bed rest
459882|NCT01183260|revision total hip arthroplasty|revision total hip arthroplasty
459883|NCT01183260|bone mineral density|bone mineral density
459884|NCT01183260|trabecular metal|trabecular metal
459885|NCT01183260|DEXA|dexa
459886|NCT01183247|Everolimus,|everolimus,
459887|NCT01183247|rapamycin,|rapamycin,
459888|NCT01183247|prednisone,|prednisone,
459889|NCT01183247|tacrolimus,|tacrolimus,
459890|NCT01183247|MMF,|mmf,
459891|NCT01183247|steroid-free,|steroid-free,
459892|NCT01183247|protocol biopsy|protocol biopsy
459893|NCT01183182|Lung nodule|lung nodule
459894|NCT01183182|Lung lesion|lung lesion
459895|NCT01183169|Chronic hepatitis C|chronic hepatitis c
459896|NCT01183169|Cyclophilin inhibitor|cyclophilin inhibitor
459897|NCT01183156|Colorectal Cancer|colorectal cancer
459898|NCT01183156|Screening|screening
459899|NCT01183156|Colonoscopy|colonoscopy
459900|NCT01183156|Attendance|attendance
459901|NCT01183156|Participation|participation
459902|NCT01183143|Infertility|infertility
459903|NCT01183143|Ovulation induction|ovulation induction
459904|NCT01183143|Gonal-F|gonal-f
459905|NCT01183143|Follitropin alpha|follitropin alpha
459906|NCT01183143|Controlled ovarian stimulation|controlled ovarian stimulation
459907|NCT01183130|opiate dependence|opiate dependence
459908|NCT01183130|compliance monitoring|compliance monitoring
459909|NCT01183130|substitution treatment|substitution treatment
459910|NCT01183104|Type 2 Diabetes|type 2 diabetes
459911|NCT01183104|Sitagliptin|sitagliptin
459912|NCT01183104|Glimepiride|glimepiride
459913|NCT01183104|Elderly patients|elderly patients
459914|NCT01183104|Japanese|japanese
459915|NCT01183091|Atrial fibrillation|atrial fibrillation
459916|NCT01183091|Ablation|ablation
459917|NCT01183078|efficacy|efficacy
459918|NCT01183078|drill placement|drill placement
459919|NCT01183078|nail placement|nail placement
459920|NCT01183078|radiation|radiation
459921|NCT01183078|Operative time|operative time
459922|NCT01183078|Reduction in exposure to radiation|reduction in exposure to radiation
459923|NCT01183078|Accuracy for nail placement|accuracy for nail placement
459924|NCT01183065|Pralatrexate|pralatrexate
459925|NCT01183065|Vitamin B12|vitamin b12
459926|NCT01183065|Folic Acid|folic acid
459927|NCT01183065|10-112|10-112
459928|NCT01183052|COPD|copd
459929|NCT01183052|exercise tolerance|exercise tolerance
459930|NCT01183052|oxidative stress|oxidative stress
459931|NCT01183039|Sedentary|sedentary
459932|NCT01183000|Formation of adhesions assessed at subsequent cs|formation of adhesions assessed at subsequent cs
459933|NCT01182987|Quality improvement|quality improvement
459934|NCT01182987|Quality of care|quality of care
459935|NCT01182987|Health care utilization|health care utilization
459936|NCT01182987|Behavioral change|behavioral change
459937|NCT01182974|fever in severe sepsis|fever in severe sepsis
459938|NCT01182961|Gait|gait
459939|NCT01182961|Falls|falls
459940|NCT01182961|Virtual reality|virtual reality
459941|NCT01182948|aerobic training|aerobic training
459942|NCT01182948|resistance training|resistance training
459943|NCT01182948|type 2 diabetes|type 2 diabetes
459944|NCT01182948|therapy|therapy
459945|NCT01182935|vitamin D|vitamin d
459946|NCT01182935|triglycerides|triglycerides
459947|NCT01182935|type 2 diabetes|type 2 diabetes
459948|NCT01182922|Attendance|attendance
459949|NCT01182922|Colorectal cancer|colorectal cancer
459950|NCT01182922|Screening|screening
459951|NCT01182922|Invitation letter|invitation letter
459952|NCT01182909|NPC|npc
459953|NCT01182909|Environmental and Genetic|environmental and genetic
459954|NCT01182909|evaluate putative environmental exposures and NPC|evaluate putative environmental exposures and npc
459955|NCT01182909|assess the effect of genetic factors|assess the effect of genetic factors
459956|NCT01182909|investigate gene-environment interactions|investigate gene-environment interactions
459957|NCT01182909|examine the natural history of EBV infection|examine the natural history of ebv infection
459958|NCT01182883|Maximum Tolerated Dose|maximum tolerated dose
459959|NCT01182883|Dose Escalation|dose escalation
459960|NCT01182883|Pharmacokinetics|pharmacokinetics
459961|NCT01182883|Antitumor Activity|antitumor activity
460458|NCT01180920|Periodontal|periodontal
459962|NCT01182883|Biologic Activity|biologic activity
459963|NCT01182870|vitamin D|vitamin d
459964|NCT01182870|influenza|influenza
459965|NCT01182870|prevention|prevention
459966|NCT01182857|Quality of Life|quality of life
459967|NCT01182857|Gene Therapy|gene therapy
459968|NCT01182857|ADA-SCID|ada-scid
459969|NCT01182857|SCID-ADA|scid-ada
459970|NCT01182857|Severe Combined Immunodeficiency|severe combined immunodeficiency
459971|NCT01182844|metabolic syndrome, probiotic|metabolic syndrome, probiotic
459972|NCT01182831|carcinoma pancreas|carcinoma pancreas
459973|NCT01182831|percutaneous celiac plexus neurolysis|percutaneous celiac plexus neurolysis
459974|NCT01182831|endosonography guided celiac plexus neurolysis|endosonography guided celiac plexus neurolysis
459975|NCT01182818|Cerebrovascular Accident|cerebrovascular accident
459976|NCT01182818|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
459977|NCT01182818|Fabry Disease|fabry disease
459978|NCT01182818|Fabry´s Disease|fabry´s disease
459979|NCT01182818|Anderson-Fabry Disease|anderson-fabry disease
459980|NCT01182818|CVA (Cerebrovascular Accident)|cva (cerebrovascular accident)
459981|NCT01182818|Stroke, Acute|stroke, acute
459982|NCT01182818|Cerebral Stroke|cerebral stroke
459983|NCT01182792|Endothelial Function|endothelial function
459984|NCT01182792|Chronic Hypoxia|chronic hypoxia
459985|NCT01182792|Oxidative Stress|oxidative stress
459986|NCT01182779|base of skull chordoma|base of skull chordoma
459987|NCT01182779|radiation|radiation
459988|NCT01182779|carbon ions|carbon ions
459989|NCT01182779|protons|protons
459990|NCT01182766|alcohol|alcohol
459991|NCT01182766|alcoholism|alcoholism
459992|NCT01182766|nicotine|nicotine
459993|NCT01182766|cigarette|cigarette
459994|NCT01182753|Chondrosarcoma|chondrosarcoma
459995|NCT01182753|Radiation|radiation
459996|NCT01182753|carbon ion|carbon ion
459997|NCT01182727|schizophrenia|schizophrenia
459998|NCT01182727|salsalate|salsalate
459999|NCT01182727|obesity|obesity
460000|NCT01182714|Hysterectomy|hysterectomy
460001|NCT01182714|Catheterisation|catheterisation
460002|NCT01182701|Type 2 Diabetes|type 2 diabetes
460003|NCT01182701|Asian Pacific Islanders|asian pacific islanders
460004|NCT01182701|Cognitive behavioral intervention|cognitive behavioral intervention
460005|NCT01182688|utilization of Procalcitonin in the cardiac setting|utilization of procalcitonin in the cardiac setting
460006|NCT01182675|SCID|scid
460007|NCT01182675|Transplant|transplant
460008|NCT01182675|Alemtuzumab|alemtuzumab
460009|NCT01182675|Plerixafor|plerixafor
460010|NCT01182662|Bone Marrow Disease|bone marrow disease
460011|NCT01182662|Aplastic Anemia|aplastic anemia
460012|NCT01182662|Umbilical Cord/placenta-Derived MSC|umbilical cord/placenta-derived msc
460013|NCT01182662|Transplantation|transplantation
460014|NCT01182649|Drug Eluting Stents|drug eluting stents
460015|NCT01182649|Everolimus Eluting Stent|everolimus eluting stent
460016|NCT01182649|Coronary Angioplasty|coronary angioplasty
460017|NCT01182636|Bioequivalence|bioequivalence
460018|NCT01182636|Acne Vulgaris|acne vulgaris
460019|NCT01182623|FICE|fice
460020|NCT01182623|Chromoendoscopy|chromoendoscopy
460021|NCT01182623|Colonic polyps|colonic polyps
460022|NCT01182623|Adenomas|adenomas
460023|NCT01182623|Hyperplastic polyps|hyperplastic polyps
460024|NCT01182597|Oral PPI treatment has similar benefit as proton pump inhibitor infusion in patient with bleeding ulcers after combined endoscopic hemostasis|oral ppi treatment has similar benefit as proton pump inhibitor infusion in patient with bleeding ulcers after combined endoscopic hemostasis
460025|NCT01182571|Heart Transplantation|heart transplantation
460026|NCT01182571|Symptom Distress|symptom distress
460027|NCT01182571|Fatigue|fatigue
460028|NCT01182571|Depression|depression
460029|NCT01182571|Quality Of Life.|quality of life.
460030|NCT01182558|Muscle|muscle
460031|NCT01182558|Activation|activation
460032|NCT01182558|Effect|effect
460033|NCT01182558|Compound muscle action potential|compound muscle action potential
460034|NCT01182545|Anaesthesia|anaesthesia
460035|NCT01182545|laparoscopic cholecystectomy|laparoscopic cholecystectomy
460036|NCT01182545|CO2 insufflation|co2 insufflation
460037|NCT01182545|hemodynamic|hemodynamic
460038|NCT01182545|hyperventilation|hyperventilation
460039|NCT01182532|Mild type of hand, foot and mouth disease|mild type of hand, foot and mouth disease
460040|NCT01182532|Traditional Chinese Medicine|traditional chinese medicine
460041|NCT01182532|Effectiveness|effectiveness
460042|NCT01182532|Safety|safety
460043|NCT01182519|lung inflammation|lung inflammation
460044|NCT01182519|lung metastases|lung metastases
460045|NCT01182519|10-115|10-115
460046|NCT01182506|Cogmed Working Memory Training (CWMT)|cogmed working memory training (cwmt)
460047|NCT01182506|cognitive|cognitive
460048|NCT01182506|10-105|10-105
460049|NCT01182506|Breast cancer survivor|breast cancer survivor
460050|NCT01182493|Diabetes Mellitus|diabetes mellitus
460051|NCT01182493|MDI|mdi
460052|NCT01182493|pump therapy|pump therapy
460053|NCT01182467|Inflammatory bowel disease, PET scan, Crohn's disease|inflammatory bowel disease, pet scan, crohn's disease
460054|NCT01182454|blood pressure|blood pressure
460055|NCT01182441|atrial fibrillation|atrial fibrillation
460056|NCT01182441|stroke|stroke
460057|NCT01182441|TIA|tia
460058|NCT01182441|trans ischemic attack|trans ischemic attack
460059|NCT01182441|warfarin|warfarin
460060|NCT01182441|Coumadin|coumadin
460061|NCT01182428|Stents|stents
460062|NCT01182428|Angioplasty|angioplasty
460063|NCT01182428|Total coronary occlusions|total coronary occlusions
460064|NCT01182428|Coronary restenosis|coronary restenosis
460065|NCT01182428|Stent thrombosis|stent thrombosis
460066|NCT01182428|Everolimus|everolimus
460067|NCT01182415|CNS involvement|cns involvement
460068|NCT01182402|opiate dependence|opiate dependence
460069|NCT01182402|substitution treatment|substitution treatment
460070|NCT01182402|unsupervised dosing|unsupervised dosing
460071|NCT01182402|monitoring|monitoring
460072|NCT01182389|Ventricular Tachycardia|ventricular tachycardia
460073|NCT01182389|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
460074|NCT01182389|Catheter Ablation|catheter ablation
460075|NCT01182389|Robotic|robotic
460076|NCT01182376|Multaq|multaq
460077|NCT01182376|dronedarone|dronedarone
460078|NCT01182376|Atrial Fibrillation|atrial fibrillation
460079|NCT01182363|maternal depression|maternal depression
460080|NCT01182363|prematurity|prematurity
460081|NCT01182363|early intervention|early intervention
460082|NCT01182363|developmental delay|developmental delay
460083|NCT01182350|Molecularly Determined Treatment|molecularly determined treatment
460084|NCT01182324|Expectations|expectations
460085|NCT01182324|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
460086|NCT01182324|Clinical Trial|clinical trial
460087|NCT01182324|Motivations|motivations
460088|NCT01182311|Hepatitis B Virus|hepatitis b virus
460089|NCT01182311|Hepatitis B Vaccine|hepatitis b vaccine
460090|NCT01182311|Immunity|immunity
460091|NCT01182311|B-Cell Response|b-cell response
460092|NCT01182311|T-Cell Response|t-cell response
460093|NCT01182311|Hepatitis B Immunity|hepatitis b immunity
460094|NCT01182311|Hepatitis B Virus Vaccine|hepatitis b virus vaccine
460095|NCT01182298|Latino|latino
460096|NCT01182298|HCV|hcv
460097|NCT01182298|pegIFN|pegifn
460098|NCT01182298|Viral Kinetics|viral kinetics
460099|NCT01182298|IL-28 Haplotype|il-28 haplotype
460100|NCT01182285|Depakote|depakote
460101|NCT01182285|Poorly Differentiated Thyroid Cancer|poorly differentiated thyroid cancer
460102|NCT01182285|RAI Uptake|rai uptake
460103|NCT01182285|Thyrogen|thyrogen
460104|NCT01182272|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
460105|NCT01182272|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
460106|NCT01182246|adenocarcinoma|adenocarcinoma
460107|NCT01182246|Pancreatic cancer|pancreatic cancer
460108|NCT01182233|Multiple Myeloma|multiple myeloma
460109|NCT01182233|Autologous Hematopoietic Stem Cell Transplant|autologous hematopoietic stem cell transplant
460110|NCT01182233|Total Skeletal Irradiation|total skeletal irradiation
460111|NCT01182233|High dose chemotherapy|high dose chemotherapy
460112|NCT01182220|epidural|epidural
460113|NCT01182220|labor pain|labor pain
460114|NCT01182220|ultrasound|ultrasound
460115|NCT01182207|Bioequivalence|bioequivalence
460116|NCT01182207|Healthy Subjects|healthy subjects
460117|NCT01182194|Bioequivalence|bioequivalence
460118|NCT01182194|Healthy Subjects|healthy subjects
460119|NCT01182181|Healthy Subjects|healthy subjects
460120|NCT01182181|Bioequivalence|bioequivalence
460121|NCT01182168|CISPLATIN|cisplatin
460122|NCT01182168|GEMCITABINE|gemcitabine
460123|NCT01182168|RAD001 (EVEROLIMUS)|rad001 (everolimus)
460124|NCT01182168|10-106|10-106
460125|NCT01182155|Lung Cancer Non-Small Cell Cancer (NSCLC)|lung cancer non-small cell cancer (nsclc)
460126|NCT01182155|Lung Cancer Small Cell Lung Cancer (SCLC)|lung cancer small cell lung cancer (sclc)
460127|NCT01182129|Nicotine Polacrilex chewing gum versus Swedish Snus|nicotine polacrilex chewing gum versus swedish snus
460128|NCT01182116|J pouch|j pouch
460129|NCT01182116|colorectal|colorectal
460130|NCT01182116|rectal cancer|rectal cancer
460131|NCT01182116|coloplasty|coloplasty
460132|NCT01182103|Major depression|major depression
460133|NCT01182103|BDNF|bdnf
460134|NCT01182103|DNA methylation|dna methylation
460135|NCT01182103|Histone modification|histone modification
460136|NCT01182090|pelvic organ prolapse|pelvic organ prolapse
460137|NCT01182090|colposacropexy|colposacropexy
460138|NCT01182090|surgery|surgery
460139|NCT01182077|ASP015K|asp015k
460140|NCT01182077|midazolam|midazolam
460141|NCT01182077|healthy volunteers|healthy volunteers
460142|NCT01182064|Heart injuries|heart injuries
460143|NCT01182064|Posttraumatic myocardial infarction|posttraumatic myocardial infarction
460144|NCT01182064|Echocardiography|echocardiography
460145|NCT01182064|Coronary angiography|coronary angiography
460146|NCT01182051|headache|headache
460147|NCT01182051|anxiety|anxiety
460148|NCT01182051|pediatric headache and anxiety|pediatric headache and anxiety
460149|NCT01182038|birth seat|birth seat
460150|NCT01182038|childbirth|childbirth
460151|NCT01182038|instrumental delivery|instrumental delivery
460152|NCT01182038|upright position|upright position
460153|NCT01182025|Mild type of hand, foot and mouth disease|mild type of hand, foot and mouth disease
460154|NCT01182025|Xiyanping Injection|xiyanping injection
460155|NCT01182025|Effectiveness|effectiveness
460156|NCT01182025|Safety|safety
460157|NCT01182012|Cardiovascular risk factor|cardiovascular risk factor
460158|NCT01182012|Severe mental illness|severe mental illness
460159|NCT01182012|Drug appropriateness|drug appropriateness
460160|NCT01182012|Drug compliance|drug compliance
460161|NCT01182012|Lifestyle counseling|lifestyle counseling
460162|NCT01181999|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
460163|NCT01181999|elderly patients|elderly patients
460164|NCT01181999|rituximab augmentation|rituximab augmentation
460165|NCT01181986|Type 2 diabetes mellitus, Impaired glucose tolerance|type 2 diabetes mellitus, impaired glucose tolerance
460166|NCT01181973|Relative bioavailability|relative bioavailability
460167|NCT01181973|pegvisomant|pegvisomant
460168|NCT01181960|Risperidone long acting injectable|risperidone long acting injectable
460169|NCT01181960|Risperdal Consta|risperdal consta
460170|NCT01181960|Paliperidone Palmitate|paliperidone palmitate
460171|NCT01181960|Invega Sustenna|invega sustenna
460172|NCT01181947|Stent graft|stent graft
460173|NCT01181947|thoracic aorta|thoracic aorta
460174|NCT01181947|dissection|dissection
460175|NCT01181947|aneurysm|aneurysm
460176|NCT01181947|TEVAR|tevar
460177|NCT01181947|VALIANT|valiant
460178|NCT01181947|CAPTIVIA|captivia
460179|NCT01181947|endovascular|endovascular
460180|NCT01181934|symptomatic treatment|symptomatic treatment
460181|NCT01181934|cognition|cognition
460182|NCT01181934|cognitive deficits|cognitive deficits
460183|NCT01181934|Schizophrenia|schizophrenia
460184|NCT01181921|Alzheimer Disease|alzheimer disease
460185|NCT01181921|Dementia|dementia
460186|NCT01181921|Sleep Disorders|sleep disorders
460187|NCT01181921|Galantamine|galantamine
460188|NCT01181921|Reminyl|reminyl
460189|NCT01181908|alcohol|alcohol
460190|NCT01181908|drug interaction|drug interaction
460191|NCT01181908|pharmacodynamic|pharmacodynamic
460192|NCT01181895|asthma|asthma
460193|NCT01181882|Cardiovascular Disease|cardiovascular disease
460194|NCT01181882|Aspirin Resistance|aspirin resistance
460195|NCT01181882|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
460196|NCT01181882|Platelet Function|platelet function
460197|NCT01181882|Omega-3 Fatty Acids|omega-3 fatty acids
460198|NCT01181882|Aspirin|aspirin
460199|NCT01181882|Lysophospholipids|lysophospholipids
460200|NCT01181882|Lysophosphatidic Acid|lysophosphatidic acid
460201|NCT01181882|Lysophosphatidylcholine|lysophosphatidylcholine
460202|NCT01181869|respiratory failure|respiratory failure
460203|NCT01181869|oxygen|oxygen
460204|NCT01181869|sleep apnoea|sleep apnoea
460205|NCT01181869|ventilation|ventilation
460206|NCT01181856|Vaccine|vaccine
460207|NCT01181856|MVA 85A|mva 85a
460208|NCT01181843|postoperative pain management|postoperative pain management
460209|NCT01181843|respiratory depression|respiratory depression
460210|NCT01181843|capnography|capnography
460211|NCT01181843|duramorph|duramorph
460212|NCT01181830|magnesium|magnesium
460213|NCT01181830|metabolic syndrome|metabolic syndrome
460214|NCT01181830|diabetes|diabetes
460215|NCT01181830|family history|family history
460216|NCT01181817|FBSS|fbss
460217|NCT01181817|at least one prior spinal surgery|at least one prior spinal surgery
460218|NCT01181804|boceprevir|boceprevir
460219|NCT01181804|hepatitis C|hepatitis c
460220|NCT01181804|bioequivalence|bioequivalence
460221|NCT01181804|SCH 503034|sch 503034
460222|NCT01181791|probiotics|probiotics
460223|NCT01181791|premature infants|premature infants
460224|NCT01181791|feeding tolerance|feeding tolerance
460225|NCT01181778|hormonal contraceptive methods|hormonal contraceptive methods
460226|NCT01181778|combined hormonal contraceptive methods|combined hormonal contraceptive methods
460227|NCT01181778|physician counseling|physician counseling
460228|NCT01181765|Crohn's Disease|crohn's disease
460229|NCT01181765|infliximab|infliximab
460230|NCT01181765|capsule endoscopy|capsule endoscopy
460231|NCT01181752|proficiency|proficiency
460232|NCT01181752|eye drop instillation|eye drop instillation
460233|NCT01181752|postoperative cataract surgery|postoperative cataract surgery
460234|NCT01181752|Ghana|ghana
460235|NCT01181739|Colonoscopy|colonoscopy
460236|NCT01181739|Virtual Colonoscopy|virtual colonoscopy
460237|NCT01181739|Colonography|colonography
460238|NCT01181739|Colorectal Cancer|colorectal cancer
460239|NCT01181739|Colonic Polyps|colonic polyps
460240|NCT01181739|Screening|screening
460241|NCT01181726|Bioequivalence|bioequivalence
460242|NCT01181726|Healthy Subjects|healthy subjects
460243|NCT01181687|COMFORT behavioral scale|comfort behavioral scale
460244|NCT01181687|pain assessment scale|pain assessment scale
460245|NCT01181687|child|child
460246|NCT01181687|validity|validity
460247|NCT01181687|reliability|reliability
460248|NCT01181674|Diabetes|diabetes
460249|NCT01181674|Insulin|insulin
460250|NCT01181674|Glargine|glargine
460251|NCT01181674|Metformin|metformin
460252|NCT01181674|Acarbose|acarbose
460253|NCT01181674|Diet|diet
460254|NCT01181674|Exercise|exercise
460255|NCT01181674|Lifestyle|lifestyle
460256|NCT01181661|Cigarette|cigarette
460257|NCT01181661|Smoking|smoking
460258|NCT01181661|Nicotine|nicotine
460259|NCT01181661|Contingency Management|contingency management
460260|NCT01181661|Voucher Reinforcement|voucher reinforcement
460261|NCT01181661|Smoking Abstinence|smoking abstinence
460262|NCT01181661|Internet|internet
460263|NCT01181661|Internet-based Treatment|internet-based treatment
460264|NCT01181661|Group Contingencies|group contingencies
460265|NCT01181648|Survivor|survivor
460266|NCT01181648|Human Papillomavirus (HPV)|human papillomavirus (hpv)
460267|NCT01181648|Quality of Life|quality of life
460268|NCT01181648|Surviving Oropharynx Cancer|surviving oropharynx cancer
460269|NCT01181648|10-111|10-111
460270|NCT01181596|neonates and infants, from the 23-week gestational (0.5 kg)|neonates and infants, from the 23-week gestational (0.5 kg)
460271|NCT01181596|up to a 6 month old born at term (7 kg), for whom the PIV,|up to a 6 month old born at term (7 kg), for whom the piv,
460272|NCT01181596|PAC, UAC, UVC or PICC catheter insertion is medically|pac, uac, uvc or picc catheter insertion is medically
460273|NCT01181596|indicated.|indicated.
460274|NCT01181570|psoriasis|psoriasis
460275|NCT01181570|adalimumab|adalimumab
460276|NCT01181570|obstructive sleep apnea|obstructive sleep apnea
460277|NCT01181570|obesity|obesity
460278|NCT01181557|quality of life|quality of life
460279|NCT01181544|Anticoagulation|anticoagulation
460280|NCT01181544|Heparin|heparin
460281|NCT01181544|Hemodialysis|hemodialysis
460282|NCT01181544|Dialysis|dialysis
460283|NCT01181544|Renal Dialysis|renal dialysis
460284|NCT01181531|Secondary Hyperthyroidism|secondary hyperthyroidism
460285|NCT01181531|Hemodialysis|hemodialysis
460286|NCT01181531|Parathyroid|parathyroid
460287|NCT01181531|PARADIGM|paradigm
460288|NCT01181518|Tamoxifen|tamoxifen
460289|NCT01181518|Pharmacogenomics|pharmacogenomics
460290|NCT01181518|Breast cancer|breast cancer
460291|NCT01181505|HNF4a|hnf4a
460292|NCT01181505|CYP2D6|cyp2d6
460293|NCT01181505|Toterodine|toterodine
460294|NCT01181505|Genetic polymorphism|genetic polymorphism
460295|NCT01181492|gene polymorphism|gene polymorphism
460296|NCT01181492|CYP3A4|cyp3a4
460297|NCT01181492|fentanyl|fentanyl
460298|NCT01181492|HPLC|hplc
460299|NCT01181492|Analgesics|analgesics
460300|NCT01181479|Contraceptive|contraceptive
460301|NCT01181466|PLVR|plvr
460302|NCT01181466|BLVR|blvr
460303|NCT01181466|AeriSeal|aeriseal
460304|NCT01181466|treatment|treatment
460305|NCT01181466|device|device
460306|NCT01181466|breathing|breathing
460307|NCT01181466|COPD|copd
460308|NCT01181466|emphysema|emphysema
460309|NCT01181466|polymeric lung volume reduction|polymeric lung volume reduction
460310|NCT01181466|biologic lung volume reduction|biologic lung volume reduction
460311|NCT01181466|heterogeneous|heterogeneous
460312|NCT01181466|homogeneous|homogeneous
460313|NCT01181466|Pathologic Processes|pathologic processes
460314|NCT01181466|Respiratory Tract Diseases|respiratory tract diseases
460315|NCT01181466|Lung Diseases|lung diseases
460316|NCT01181466|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
460317|NCT01181453|Diabetic foot ulcer|diabetic foot ulcer
460318|NCT01181453|Randomized trial|randomized trial
460319|NCT01181453|Clinical trial|clinical trial
460320|NCT01181453|Dermagraft|dermagraft
460321|NCT01181453|Standard care|standard care
460322|NCT01181440|Diabetic foot ulcer|diabetic foot ulcer
460323|NCT01181440|Randomized trial|randomized trial
460324|NCT01181440|Clinical trial|clinical trial
460325|NCT01181440|Dermagraft|dermagraft
460326|NCT01181440|Conventional care|conventional care
460327|NCT01181414|Permanent Atrial Fibrillation|permanent atrial fibrillation
460328|NCT01181414|Resynchronization therapy|resynchronization therapy
460329|NCT01181414|Ablation|ablation
460330|NCT01181401|induction chemotherapy|induction chemotherapy
460331|NCT01181401|radiotherapy|radiotherapy
460332|NCT01181401|locally advanced head neck tumor|locally advanced head neck tumor
460333|NCT01181401|toxicity|toxicity
460334|NCT01181401|LA SCCHN|la scchn
460335|NCT01181401|Unresectable squamous cell cancer of the head and neck,|unresectable squamous cell cancer of the head and neck,
460336|NCT01181401|Stage IV (UICC)|stage iv (uicc)
460337|NCT01181375|cervical cancer|cervical cancer
460338|NCT01181375|assay|assay
460339|NCT01181375|hypoxia|hypoxia
460340|NCT01181362|Endoscopy|endoscopy
460341|NCT01181362|Head and Neck region|head and neck region
460342|NCT01181362|Scope|scope
460343|NCT01181349|neuromuscular blockade; general anesthesia|neuromuscular blockade; general anesthesia
460344|NCT01181336|Safety|safety
460345|NCT01181336|Tolerability|tolerability
460346|NCT01181336|Immunogenicity|immunogenicity
460347|NCT01181336|Influenza|influenza
460348|NCT01181336|Virus|virus
460349|NCT01181336|Vaccine|vaccine
460350|NCT01181323|influenza, vaccine, breastfeeding, post-partum women, infant, LAIV, TIV, parent protocol|influenza, vaccine, breastfeeding, post-partum women, infant, laiv, tiv, parent protocol
460351|NCT01181310|dementia, cognitive impairment, neurodegeneration, Alzheimer's, acetylcholine, AchE|dementia, cognitive impairment, neurodegeneration, alzheimer's, acetylcholine, ache
460352|NCT01181297|Confirmed milk allergy|confirmed milk allergy
460353|NCT01181284|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
460354|NCT01181271|Lymphoma|lymphoma
460355|NCT01181271|non-hodgkins lymphoma|non-hodgkins lymphoma
460356|NCT01181271|Hodgkin's lymphoma|hodgkin's lymphoma
460357|NCT01181271|Hodgkin's disease|hodgkin's disease
460358|NCT01181271|stem cell transplant|stem cell transplant
460359|NCT01181271|High-risk diffuse large B cell|high-risk diffuse large b cell
460360|NCT01181271|Transformed low grade lymphoma|transformed low grade lymphoma
460361|NCT01181271|T-cell non-Hodgkin's lymphoma|t-cell non-hodgkin's lymphoma
460362|NCT01181271|Mantle cell lymphoma at any time in therapy|mantle cell lymphoma at any time in therapy
460363|NCT01181271|"Double-hit lymphoma"|"double-hit lymphoma"
460364|NCT01181258|related HLA-haploidentical donor|related hla-haploidentical donor
460365|NCT01181245|Pancreatic Cancer|pancreatic cancer
460366|NCT01181232|insomnia|insomnia
460367|NCT01181232|zolpidem|zolpidem
460368|NCT01181206|Surgical site infections|surgical site infections
460369|NCT01181206|Covering the abdominal wound edge in laparotomies|covering the abdominal wound edge in laparotomies
460370|NCT01181193|glioblastoma multiforme|glioblastoma multiforme
460371|NCT01181193|chemoradiotherapy|chemoradiotherapy
460372|NCT01181193|vitamin D|vitamin d
460373|NCT01181180|Ageing|ageing
460374|NCT01181180|Balance control|balance control
460375|NCT01181180|Falls|falls
460376|NCT01181180|dehydration|dehydration
460377|NCT01181167|Anticoagulants|anticoagulants
460378|NCT01181167|Venous thromboembolism|venous thromboembolism
460379|NCT01181167|Thromboembolism|thromboembolism
460380|NCT01181167|Thrombosis|thrombosis
460381|NCT01181167|enoxaparin sodium|enoxaparin sodium
460382|NCT01181167|Embolism|embolism
460383|NCT01181167|Deep vein thrombosis|deep vein thrombosis
460384|NCT01181167|DU-176b|du-176b
460385|NCT01181167|edoxaban|edoxaban
460386|NCT01181167|factor Xa|factor xa
460387|NCT01181167|total hip arthroplasty|total hip arthroplasty
460388|NCT01181154|Auto-Immune|auto-immune
460389|NCT01181154|Hemolytic|hemolytic
460390|NCT01181154|Anemia|anemia
460391|NCT01181154|AHA|aha
460392|NCT01181154|AIHA|aiha
460393|NCT01181154|Rituximab|rituximab
460394|NCT01181141|Anticoagulants|anticoagulants
460395|NCT01181141|Enoxaparin sodium|enoxaparin sodium
460396|NCT01181141|venous thromboembolism.|venous thromboembolism.
460397|NCT01181141|thromboembolism|thromboembolism
460398|NCT01181141|Thrombosis|thrombosis
460399|NCT01181141|deep vein thrombosis|deep vein thrombosis
460400|NCT01181141|DU-176b|du-176b
460401|NCT01181141|Edoxaban|edoxaban
460402|NCT01181141|factor Xa|factor xa
460403|NCT01181141|hip fracture surgery|hip fracture surgery
460404|NCT01181141|embolism|embolism
460405|NCT01181115|Chinese Patients|chinese patients
460406|NCT01181115|Relapsing MS|relapsing ms
460407|NCT01181115|Safety|safety
460408|NCT01181115|Avonex|avonex
460409|NCT01181115|Tolerability|tolerability
460410|NCT01181115|Gadolinium|gadolinium
460411|NCT01181115|Interferon Beta 1a|interferon beta 1a
460412|NCT01181102|anticoagulant|anticoagulant
460413|NCT01181102|venus thromboembolism|venus thromboembolism
460414|NCT01181102|thrombosis|thrombosis
460415|NCT01181102|thromboembolism|thromboembolism
460416|NCT01181102|embolism and thrombosis|embolism and thrombosis
460417|NCT01181102|deep vein thrombosis|deep vein thrombosis
460418|NCT01181102|DU-176b|du-176b
460419|NCT01181102|Edoxaban|edoxaban
460420|NCT01181102|factor Xa|factor xa
460421|NCT01181102|total knee arthroplasty|total knee arthroplasty
460422|NCT01181102|Enoxaparin sodium|enoxaparin sodium
460423|NCT01181076|Stem cell transplantation|stem cell transplantation
460424|NCT01181076|Individualized Nutrition|individualized nutrition
460425|NCT01181076|Quality of life|quality of life
460426|NCT01181076|Oral Mucositis|oral mucositis
460427|NCT01181076|Adult|adult
460428|NCT01181063|Asthma|asthma
460429|NCT01181063|Easyhaler|easyhaler
460430|NCT01181037|Displaced subcapital femoral fracture|displaced subcapital femoral fracture
460431|NCT01181037|Bbipolar H.A.|bbipolar h.a.
460432|NCT01181037|CRIF with Ttrochanteric Antegrade Nail|crif with ttrochanteric antegrade nail
460433|NCT01180972|Obesity, diabetes, hispanic, physical activity, nutrition|obesity, diabetes, hispanic, physical activity, nutrition
460434|NCT01180959|Advanced Liver Cancer|advanced liver cancer
460435|NCT01180959|primary neoplasm of the liver|primary neoplasm of the liver
460436|NCT01180959|Erlotinib|erlotinib
460437|NCT01180959|Bevacizumab|bevacizumab
460438|NCT01180959|Hepatocellular Carcinoma|hepatocellular carcinoma
460439|NCT01180959|HCC|hcc
460440|NCT01180959|Avastin|avastin
460441|NCT01180959|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
460442|NCT01180959|rhuMAb-VEGF|rhumab-vegf
460443|NCT01180959|OSI-774|osi-774
460444|NCT01180959|Tarceva|tarceva
460445|NCT01180946|FGF23|fgf23
460446|NCT01180946|FGF-23|fgf-23
460447|NCT01180946|vitamin D|vitamin d
460448|NCT01180946|vitamin D deficiency|vitamin d deficiency
460449|NCT01180946|insulin resistance|insulin resistance
460450|NCT01180946|Healthy volunteers|healthy volunteers
460451|NCT01180933|docosahexaenoic acid|docosahexaenoic acid
460452|NCT01180933|folate|folate
460453|NCT01180933|neurological development|neurological development
460454|NCT01180933|allergies|allergies
460455|NCT01180933|long term consequences for the offspring|long term consequences for the offspring
460456|NCT01180933|allergy risk|allergy risk
460457|NCT01180920|Dental|dental
460459|NCT01180920|Surgery|surgery
460460|NCT01180920|Gums|gums
460461|NCT01180907|18F-FAC|18f-fac
460462|NCT01180907|imaging|imaging
460463|NCT01180907|cancer|cancer
460464|NCT01180907|inflammation|inflammation
460465|NCT01180907|PET|pet
460466|NCT01180894|Trauma|trauma
460467|NCT01180894|Anemia|anemia
460468|NCT01180894|Iron|iron
460469|NCT01180894|Erythropoeisis|erythropoeisis
460470|NCT01180881|Proton Radiation|proton radiation
460471|NCT01180881|CNS tumors|cns tumors
460472|NCT01180881|Brain Tumors|brain tumors
460473|NCT01180881|Neurobehavioral functioning|neurobehavioral functioning
460474|NCT01180868|imaging probe|imaging probe
460475|NCT01180868|cancer|cancer
460476|NCT01180868|inflammatory tissue|inflammatory tissue
460477|NCT01180868|inflammatory diseases|inflammatory diseases
460478|NCT01180855|Melatonin|melatonin
460479|NCT01180855|Cognitive Behavior Therapy|cognitive behavior therapy
460480|NCT01180842|CF|cf
460481|NCT01180816|GBM|gbm
460482|NCT01180816|AA|aa
460483|NCT01180816|AO|ao
460484|NCT01180816|Brain|brain
460485|NCT01180816|Tumors|tumors
460486|NCT01180816|Malignant|malignant
460487|NCT01180816|Glioblastoma|glioblastoma
460488|NCT01180816|Multiforme|multiforme
460489|NCT01180816|Anaplastic|anaplastic
460490|NCT01180816|Astrocytoma|astrocytoma
460491|NCT01180803|COPD - long term oxygenotherapy|copd - long term oxygenotherapy
460492|NCT01180803|COPD patients with respiratory failure|copd patients with respiratory failure
460493|NCT01180790|HCV|hcv
460494|NCT01180790|Hepatitis C Genotype 1|hepatitis c genotype 1
460495|NCT01180764|hypertriglyceridemia|hypertriglyceridemia
460496|NCT01180764|omega-3 acid ethyl esters|omega-3 acid ethyl esters
460497|NCT01180764|high-density lipoproteins|high-density lipoproteins
460498|NCT01180764|fish oil|fish oil
460499|NCT01180751|Positron Emission Tomography|positron emission tomography
460500|NCT01180751|Fluorodeoxyglucose|fluorodeoxyglucose
460501|NCT01180751|FDG (18F-Fluorodeoxyglucose)|fdg (18f-fluorodeoxyglucose)
460502|NCT01180751|Oncology|oncology
460503|NCT01180751|Neurology|neurology
460504|NCT01180738|chronic stroke|chronic stroke
460505|NCT01180738|walking training|walking training
460506|NCT01180738|rehabilitation|rehabilitation
460507|NCT01180738|body weight supported treadmill training|body weight supported treadmill training
460508|NCT01180738|physical therapy|physical therapy
460509|NCT01180738|balance|balance
460510|NCT01180725|To investigate and compare the effects of dried plums and psyllium on the overall relief of constipation symptoms|to investigate and compare the effects of dried plums and psyllium on the overall relief of constipation symptoms
460511|NCT01180725|To investigate and compare the taste of dried plums and psyllium|to investigate and compare the taste of dried plums and psyllium
460512|NCT01180725|To investigate and compare the quality of life of dried plums and psyllium|to investigate and compare the quality of life of dried plums and psyllium
460513|NCT01180712|anthocyanin|anthocyanin
460514|NCT01180712|blaeberries|blaeberries
460515|NCT01180712|bilberries|bilberries
460516|NCT01180712|blueberries|blueberries
460517|NCT01180712|mirtoselect|mirtoselect
460518|NCT01180712|type 2 diabetes|type 2 diabetes
460519|NCT01180712|insulin resistance|insulin resistance
460520|NCT01180712|Adipose tissue|adipose tissue
460521|NCT01180712|inflammation|inflammation
460522|NCT01180699|adult solid organ transplant patients|adult solid organ transplant patients
460523|NCT01180686|low back pain|low back pain
460524|NCT01180686|chiropractic|chiropractic
460525|NCT01180686|manipulation|manipulation
460526|NCT01180673|Hypertension|hypertension
460527|NCT01180673|Older Adults|older adults
460528|NCT01180673|Motivational Interviewing|motivational interviewing
460529|NCT01180673|Lifestyle Counseling|lifestyle counseling
460530|NCT01180673|Senior Centers|senior centers
460531|NCT01180660|Gastric Surgery|gastric surgery
460532|NCT01180660|Pain|pain
460533|NCT01180660|Recovery|recovery
460534|NCT01180660|Laparoscopic Surgery|laparoscopic surgery
460535|NCT01180647|Extended-release naltrexone|extended-release naltrexone
460536|NCT01180647|Prisoners|prisoners
460537|NCT01180647|Opioid addiction prevention|opioid addiction prevention
460538|NCT01180647|Medication Treatment Alternatives|medication treatment alternatives
460539|NCT01180647|Prevention of Relapse to Opioid Addiction|prevention of relapse to opioid addiction
460540|NCT01180621|vaccine|vaccine
460541|NCT01180621|Seasonal Influenza Vaccine|seasonal influenza vaccine
460542|NCT01180621|Influenza Vaccine|influenza vaccine
460543|NCT01180621|Vaccine Safety|vaccine safety
460544|NCT01180621|Vaccine Immunogenicity|vaccine immunogenicity
460545|NCT01180621|Fluviral 2010-2011|fluviral 2010-2011
460546|NCT01180608|neuropathic pain|neuropathic pain
460547|NCT01180608|Diabetic Polyneuropathy|diabetic polyneuropathy
460548|NCT01180595|osteoarthritis|osteoarthritis
460549|NCT01180595|arthroplasty|arthroplasty
460550|NCT01180595|knee joint|knee joint
460551|NCT01180595|radiography|radiography
460552|NCT01180595|surgery|surgery
460553|NCT01180595|Bone Density|bone density
460554|NCT01180595|Outcome Assessment (Health Care)|outcome assessment (health care)
460555|NCT01180582|knee|knee
460556|NCT01180582|arthroplasty|arthroplasty
460557|NCT01180582|RSA|rsa
460558|NCT01180582|migration|migration
460559|NCT01180582|micromotion|micromotion
460560|NCT01180582|osteoarthritis|osteoarthritis
460561|NCT01180569|Lenalidomide|lenalidomide
460562|NCT01180569|10-022|10-022
460563|NCT01180556|childhood|childhood
460564|NCT01180556|abdominal pain|abdominal pain
460565|NCT01180556|probiotics|probiotics
460566|NCT01180517|Angioplasty Balloon|angioplasty balloon
460567|NCT01180504|ovarian cancer|ovarian cancer
460568|NCT01180504|whole-abdominal radiotherapy|whole-abdominal radiotherapy
460569|NCT01180504|consolidation treatment|consolidation treatment
460570|NCT01180504|helical tomotherapy|helical tomotherapy
460571|NCT01180491|Discoloured and deformed nails resulting from onychomycosis|discoloured and deformed nails resulting from onychomycosis
460572|NCT01180478|Bladder Cancer|bladder cancer
460573|NCT01180478|Urothelial carcinoma|urothelial carcinoma
460574|NCT01180478|Stage pTa or pT1|stage pta or pt1
460575|NCT01180478|NMIBC Ta/T1|nmibc ta/t1
460576|NCT01180478|Narrow Band Imaging|narrow band imaging
460577|NCT01180478|White Light Cystoscopy|white light cystoscopy
460578|NCT01180478|Transurethral resection|transurethral resection
460579|NCT01180478|Superficial bladder tumor|superficial bladder tumor
460580|NCT01180478|Positive urine cytology|positive urine cytology
460581|NCT01180465|Treatment of abdominal adiposity|treatment of abdominal adiposity
460582|NCT01180452|Crohn disease|crohn disease
460583|NCT01180452|dysplasia|dysplasia
460584|NCT01180452|adenocarcinoma|adenocarcinoma
460585|NCT01180452|endoscopy|endoscopy
460586|NCT01180452|jejunum|jejunum
460587|NCT01180452|ileum|ileum
460588|NCT01180439|Non-invasive ventilation|non-invasive ventilation
460589|NCT01180439|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
460590|NCT01180439|Patient-ventilator synchronisation|patient-ventilator synchronisation
460591|NCT01180439|Sleep study|sleep study
460592|NCT01180439|Polysomnography|polysomnography
460593|NCT01180426|Relapse Refractory Acute Myeloid Leukemia|relapse refractory acute myeloid leukemia
460594|NCT01180413|Inward eutrophic remodelling|inward eutrophic remodelling
460595|NCT01180400|Major Depressive Disorder|major depressive disorder
460596|NCT01180400|MDD|mdd
460597|NCT01180400|Depression|depression
460598|NCT01180400|Safety|safety
460599|NCT01180400|add-on therapy|add-on therapy
460600|NCT01180374|Cannabis|cannabis
460601|NCT01180374|Marijuana|marijuana
460602|NCT01180374|Cannabidiol|cannabidiol
460603|NCT01180374|CBD|cbd
460604|NCT01180374|THC|thc
460605|NCT01180374|Psychotic Disorders|psychotic disorders
460606|NCT01180361|rheumatoid arthritis|rheumatoid arthritis
460607|NCT01180361|systemic lupus erythematosus|systemic lupus erythematosus
460608|NCT01180361|atherosclerosis|atherosclerosis
460609|NCT01180361|adenosine|adenosine
460610|NCT01180348|Wrinkles, glabellar, facial.|wrinkles, glabellar, facial.
460611|NCT01180335|Genomic driven chemotherapy|genomic driven chemotherapy
460612|NCT01180322|azacitidine|azacitidine
460613|NCT01180322|Acute myeloid Leukemia (AML)|acute myeloid leukemia (aml)
460614|NCT01180309|Tongue frenum|tongue frenum
460615|NCT01180309|Lingual frenum|lingual frenum
460616|NCT01180309|Audio Phonology|audio phonology
460617|NCT01180309|Speech disorders|speech disorders
460618|NCT01180296|Preterm birth, prevention, progesterone, oral|preterm birth, prevention, progesterone, oral
460619|NCT01180283|Erectile dysfunction|erectile dysfunction
460620|NCT01180283|Lodenafil carbonate|lodenafil carbonate
460621|NCT01180283|Diabetes|diabetes
460622|NCT01180270|Cervical dystonia|cervical dystonia
460623|NCT01180270|torticollis spasmodicus|torticollis spasmodicus
460624|NCT01180270|botulinum toxin|botulinum toxin
460625|NCT01180270|Subjective visual vertical (SVV)|subjective visual vertical (svv)
460626|NCT01180270|SVV|svv
460627|NCT01180270|static graviceptive function|static graviceptive function
460628|NCT01180244|fibromyalgia|fibromyalgia
460629|NCT01180244|noninvasive|noninvasive
460630|NCT01180244|electrical|electrical
460631|NCT01180244|cortical|cortical
460632|NCT01180244|stimulation|stimulation
460633|NCT01180244|pain|pain
460634|NCT01180244|brain|brain
460635|NCT01180244|tender point|tender point
460636|NCT01180231|Overweight or obese young adults (18 to 30 years old) with no previous history of cardiovascular disease/psychiatric illness, and not on medications|overweight or obese young adults (18 to 30 years old) with no previous history of cardiovascular disease/psychiatric illness, and not on medications
460637|NCT01180218|myocardial revascularization|myocardial revascularization
460638|NCT01180218|myocardial infarction|myocardial infarction
460639|NCT01180205|FMD|fmd
460640|NCT01180205|hypertension|hypertension
460641|NCT01180205|Telmisartan|telmisartan
460642|NCT01180205|Amlodipine|amlodipine
460643|NCT01180192|blood loss|blood loss
460644|NCT01180192|oxygen inhalation|oxygen inhalation
460645|NCT01180179|H. pylori-negative idiopathic peptic ulcers|h. pylori-negative idiopathic peptic ulcers
460646|NCT01180179|Recurrent ulcer bleeding|recurrent ulcer bleeding
460647|NCT01180166|Gastric cancer|gastric cancer
460648|NCT01180166|concurrent chemoradiotherapy|concurrent chemoradiotherapy
460649|NCT01180166|target therapy|target therapy
460650|NCT01180153|40 S-1/L-OHP|40 s-1/l-ohp
460651|NCT01180153|biliary tract|biliary tract
460652|NCT01180153|ampullary carcinoma|ampullary carcinoma
460653|NCT01180140|Seamguard|seamguard
460654|NCT01180140|staple-line reinforcement|staple-line reinforcement
460655|NCT01180140|leak|leak
460656|NCT01180140|bleeding|bleeding
460657|NCT01180127|flavonol|flavonol
460658|NCT01180127|exercise|exercise
460659|NCT01180127|dentate gyrus|dentate gyrus
460660|NCT01180127|cerebral blood volume|cerebral blood volume
460661|NCT01180127|dentate gyrus CBV|dentate gyrus cbv
460662|NCT01180114|economic empowerment model,|economic empowerment model,
460663|NCT01180114|orphaned children and youth,|orphaned children and youth,
460664|NCT01180114|Uganda,|uganda,
460665|NCT01180114|sub-Saharan Africa|sub-saharan africa
460666|NCT01180101|Obesity|obesity
460667|NCT01180101|Chronic Kidney Disease|chronic kidney disease
460668|NCT01180088|LIVER TUMOURS|liver tumours
460669|NCT01180062|Latanoprost subconjunctival insert|latanoprost subconjunctival insert
460670|NCT01180049|Mantle Cell Lymphoma|mantle cell lymphoma
460671|NCT01180049|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
460672|NCT01180049|temsirolimus|temsirolimus
460673|NCT01180036|Membranous Nephropathy|membranous nephropathy
460674|NCT01180023|GBS|gbs
460675|NCT01180023|Membrane sweeping|membrane sweeping
460676|NCT01180010|Hodgkin's Lymphoma|hodgkin's lymphoma
460677|NCT01180010|Lung Cancer|lung cancer
460678|NCT01180010|Lung Nodule|lung nodule
460679|NCT01180010|CT scan|ct scan
460680|NCT01179971|n-3 fatty acids|n-3 fatty acids
460681|NCT01179971|n-6 fatty acids|n-6 fatty acids
460682|NCT01179971|anti-inflammatory action|anti-inflammatory action
460683|NCT01179971|clinical trial|clinical trial
460684|NCT01179971|randomized double-blinded|randomized double-blinded
460685|NCT01179971|incorporation of fatty acids|incorporation of fatty acids
460686|NCT01179958|cognitive function|cognitive function
460687|NCT01179958|fMRI|fmri
460688|NCT01179958|apoE|apoe
460689|NCT01179958|inflammatory markers|inflammatory markers
460690|NCT01179958|exercise|exercise
460691|NCT01179945|diabetes|diabetes
460692|NCT01179945|benzoic acid|benzoic acid
460693|NCT01179945|benzoate|benzoate
460694|NCT01179945|soda|soda
460695|NCT01179945|soft drink|soft drink
460696|NCT01179945|preservative|preservative
460697|NCT01179945|blood sugar|blood sugar
460698|NCT01179932|Pilot|pilot
460699|NCT01179932|Charting|charting
460700|NCT01179932|Anesthesia Record|anesthesia record
460701|NCT01179932|Cardiac surgical operating room|cardiac surgical operating room
460702|NCT01179932|Cardiac surgical intensive care unit|cardiac surgical intensive care unit
460703|NCT01179932|Electrophysiology lab|electrophysiology lab
460704|NCT01179919|Oseltamivir|oseltamivir
460705|NCT01179919|Obesity|obesity
460706|NCT01179919|Influenza|influenza
460707|NCT01179919|Pharmacokinetics in Obesity|pharmacokinetics in obesity
460708|NCT01179906|CKD|ckd
460709|NCT01179893|Myasthenia Gravis|myasthenia gravis
460710|NCT01179893|IVIG|ivig
460711|NCT01179893|PLEX|plex
460712|NCT01179880|Dermatitis|dermatitis
460713|NCT01179880|Atopic|atopic
460714|NCT01179867|Medication reconciliation|medication reconciliation
460715|NCT01179867|Adverse drug events|adverse drug events
460716|NCT01179867|Hospital readmission|hospital readmission
460717|NCT01179867|Medication management|medication management
460718|NCT01179841|Autism Spectrum Disorder|autism spectrum disorder
460719|NCT01179841|language|language
460720|NCT01179841|social|social
460721|NCT01179841|toddlers|toddlers
460722|NCT01179828|Quantitative sensory testing|quantitative sensory testing
460723|NCT01179828|Drug efficacy|drug efficacy
460724|NCT01179828|Low back pain syndrome|low back pain syndrome
460725|NCT01179828|Imipramine|imipramine
460726|NCT01179828|Oxycodone|oxycodone
460727|NCT01179828|Clobazam|clobazam
460728|NCT01179828|Tolterodine|tolterodine
460729|NCT01179815|Patients with type 1 or type 2 diabetes mellitus|patients with type 1 or type 2 diabetes mellitus
460730|NCT01179815|Monogenetic diabetes|monogenetic diabetes
460731|NCT01179815|Pancreatogenic diabetes,|pancreatogenic diabetes,
460732|NCT01179815|Drug-induced diabetes, other forms|drug-induced diabetes, other forms
460733|NCT01179815|Cohort Studies|cohort studies
460734|NCT01179789|Healthy Elderly People|healthy elderly people
460735|NCT01179776|ST-eleveation|st-eleveation
460736|NCT01179776|Myocardial infarct|myocardial infarct
460737|NCT01179776|Percutaneous coronary intervention|percutaneous coronary intervention
460738|NCT01179776|Myocardial infarct STEMI patients|myocardial infarct stemi patients
460739|NCT01179763|Amblyopia|amblyopia
460740|NCT01179763|Retinal layer thickness|retinal layer thickness
460741|NCT01179750|Ultrasonic coagulating shears in gastrectomy|ultrasonic coagulating shears in gastrectomy
460742|NCT01179737|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
460743|NCT01179737|Nilotinib|nilotinib
460744|NCT01179737|6MWD|6mwd
460745|NCT01179737|Pulmonary Hypertension|pulmonary hypertension
460746|NCT01179711|accommodative esotropia|accommodative esotropia
460747|NCT01179698|computer-assisted surgery|computer-assisted surgery
460748|NCT01179698|bone tumor|bone tumor
460749|NCT01179698|We will evaluate whether computer-assisted surgery|we will evaluate whether computer-assisted surgery
460750|NCT01179698|will be feasible and safe for bone tumor resection|will be feasible and safe for bone tumor resection
460751|NCT01179672|Diabetic Peripheral Neuropathic Pain|diabetic peripheral neuropathic pain
460752|NCT01179659|Single dose crossover BE study|single dose crossover be study
460753|NCT01179646|Bioequivalency|bioequivalency
460754|NCT01179620|Hemodialysis, Certoparin|hemodialysis, certoparin
460755|NCT01179581|Safety|safety
460756|NCT01179581|Tolerability|tolerability
460757|NCT01179581|Pharmacokinetics|pharmacokinetics
460758|NCT01179568|Grief|grief
460759|NCT01179568|Bereavement|bereavement
460760|NCT01179568|Psychotherapy|psychotherapy
460761|NCT01179568|Medication|medication
460762|NCT01179568|Treatment study|treatment study
460763|NCT01179555|Diabetic Complications|diabetic complications
460764|NCT01179555|Intervention Studies|intervention studies
460765|NCT01179555|African Americans|african americans
460766|NCT01179555|Vision Screening|vision screening
460767|NCT01179555|Vision, Low|vision, low
460768|NCT01179555|Geriatric Assessment|geriatric assessment
460769|NCT01179555|Outcomes Assessment|outcomes assessment
460770|NCT01179555|Cultural Characteristics|cultural characteristics
460771|NCT01179555|Cultural Competency|cultural competency
460772|NCT01179555|Appointment Adherence|appointment adherence
460773|NCT01179555|Cost-effectiveness|cost-effectiveness
460774|NCT01179555|Personalization of care|personalization of care
460775|NCT01179555|Follow-up Care|follow-up care
460776|NCT01179542|iugr pet eIF4E Translation Initiation Factor|iugr pet eif4e translation initiation factor
460777|NCT01179542|4E (eIF4E) in Human Placental Implantation and in the Pathological Pregnancies: Preeclampsia and IUGR|4e (eif4e) in human placental implantation and in the pathological pregnancies: preeclampsia and iugr
460778|NCT01179529|Atopic dermatitis (atopic eczema)|atopic dermatitis (atopic eczema)
460779|NCT01179516|Major Depressive Disorder|major depressive disorder
460780|NCT01179516|Depression|depression
460781|NCT01179516|Drug Therapy|drug therapy
460782|NCT01179503|vitamin D|vitamin d
460783|NCT01179503|physical performance|physical performance
460784|NCT01179490|Multiple Myeloma|multiple myeloma
460785|NCT01179477|Left heart pacing lead|left heart pacing lead
460786|NCT01179477|Cardiac resynchronization therapy (CRT)|cardiac resynchronization therapy (crt)
460787|NCT01179477|Heart failure|heart failure
460788|NCT01179425|marijuana|marijuana
460789|NCT01179425|dependence|dependence
460790|NCT01179425|cognition|cognition
460791|NCT01179425|stress|stress
460792|NCT01179386|methylphenidate|methylphenidate
460793|NCT01179386|ADHD|adhd
460794|NCT01179386|driving|driving
460795|NCT01179386|simulator|simulator
460796|NCT01179386|pressure|pressure
460797|NCT01179386|adolescent|adolescent
460798|NCT01179360|Locally advanced|locally advanced
460799|NCT01179360|HNSCC|hnscc
460800|NCT01179334|Pulmonary Hypertension|pulmonary hypertension
460801|NCT01179334|Riociguat|riociguat
460802|NCT01179334|Blood Pressure|blood pressure
460803|NCT01179308|regional analgesia|regional analgesia
460804|NCT01179308|routine general anesthesia|routine general anesthesia
460805|NCT01179308|immune system response|immune system response
460806|NCT01179308|lung cancer (stage 1-3)|lung cancer (stage 1-3)
460807|NCT01179295|MEK inhibitor|mek inhibitor
460808|NCT01179295|BAY86-9766|bay86-9766
460809|NCT01179295|RDEA 119|rdea 119
460810|NCT01179295|Solid tumor|solid tumor
460811|NCT01179282|DUST MITE ALLERGIES|dust mite allergies
460812|NCT01179269|Non-small cell lung cancer|non-small cell lung cancer
460813|NCT01179269|Pazopanib|pazopanib
460814|NCT01179269|Stage IIIB/IV non small cell lung cancer|stage iiib/iv non small cell lung cancer
460815|NCT01179256|ASTHMA|asthma
460816|NCT01179243|microcirculatory alterations|microcirculatory alterations
460817|NCT01179243|SDF imaging|sdf imaging
460818|NCT01179230|CAD|cad
460819|NCT01179230|chest pain|chest pain
460820|NCT01179230|acute coronary syndrome|acute coronary syndrome
460821|NCT01179230|Myocardial perfusion imaging|myocardial perfusion imaging
460822|NCT01179217|Sickle Cell Anemia|sickle cell anemia
460823|NCT01179217|Sickle Cell Pain Crises|sickle cell pain crises
460824|NCT01179217|Painful Crises|painful crises
460825|NCT01179217|Sickle Cell Pain|sickle cell pain
460826|NCT01179217|Vaso-occlusive Crises|vaso-occlusive crises
460827|NCT01179191|chronic pain|chronic pain
460828|NCT01179191|Embeda|embeda
460829|NCT01179191|opioid|opioid
460830|NCT01179191|moderate pain|moderate pain
460831|NCT01179191|severe pain|severe pain
460832|NCT01179191|conversion|conversion
460833|NCT01179191|converting|converting
460834|NCT01179191|switching|switching
460835|NCT01179191|morphine|morphine
460836|NCT01179191|aberrant behavior|aberrant behavior
460837|NCT01179191|Pain (DT) + Chronic Disease (DT)|pain (dt) + chronic disease (dt)
460838|NCT01179152|asthma, september epidemic, children, preventive|asthma, september epidemic, children, preventive
460839|NCT01179139|CRS|crs
460840|NCT01179126|myocardial infarction|myocardial infarction
460841|NCT01179126|primary angioplasty|primary angioplasty
460842|NCT01179126|multivessel disease|multivessel disease
460843|NCT01179126|stress echocardiography|stress echocardiography
460844|NCT01179113|Laminectomy|laminectomy
460845|NCT01179113|Esmolol Infusion|esmolol infusion
460846|NCT01179113|Quality of recovery|quality of recovery
460847|NCT01179113|beta-blockers|beta-blockers
460848|NCT01179113|Pain management|pain management
460849|NCT01179113|Postoperative pain|postoperative pain
460850|NCT01179113|Opioid requirements|opioid requirements
460851|NCT01179113|Intraoperative esmolol infusion|intraoperative esmolol infusion
460852|NCT01179113|Return to normal activities of daily living|return to normal activities of daily living
460853|NCT01179100|elderly|elderly
460854|NCT01179100|general anesthesia|general anesthesia
460855|NCT01179100|lidocaine infusion|lidocaine infusion
460856|NCT01179100|lidocaine|lidocaine
460857|NCT01179100|local anesthetic|local anesthetic
460858|NCT01179100|pain management|pain management
460859|NCT01179100|cognitive function|cognitive function
460860|NCT01179087|sleep disordered breathing|sleep disordered breathing
460861|NCT01179087|lung transplantation|lung transplantation
460862|NCT01179074|palliation inoperable oesophageal cancer|palliation inoperable oesophageal cancer
460863|NCT01179061|Apelin|apelin
460864|NCT01179061|Heart failure|heart failure
460865|NCT01179061|Pulmonary artery pressure|pulmonary artery pressure
460866|NCT01179061|Inotropic|inotropic
460867|NCT01179061|Diuretic|diuretic
460868|NCT01179035|Post-release, community health|post-release, community health
460869|NCT01179022|Bacteremia|bacteremia
460870|NCT01179022|Argon Plasma Coagulation|argon plasma coagulation
460871|NCT01179022|Endobronchial Lesions|endobronchial lesions
460872|NCT01179009|depression|depression
460873|NCT01178983|work related musculoskeletal disorders (WRMSD) among computer operators|work related musculoskeletal disorders (wrmsd) among computer operators
460874|NCT01178957|Type 1 diabetes|type 1 diabetes
460875|NCT01178957|Very-Low-Density-Lipoprotein(VLDL)|very-low-density-lipoprotein(vldl)
460876|NCT01178957|Hyperglycemia|hyperglycemia
460877|NCT01178931|IVF|ivf
460878|NCT01178931|luteal phase support|luteal phase support
460879|NCT01178931|oral progesterone|oral progesterone
460880|NCT01178931|vaginal progesterone|vaginal progesterone
460881|NCT01178931|pregnancy rate|pregnancy rate
460882|NCT01178931|safety|safety
460883|NCT01178931|tolerability|tolerability
460884|NCT01178918|Influenza H1N1|influenza h1n1
460885|NCT01178918|Vaccine|vaccine
460886|NCT01178918|Adjuvant|adjuvant
460887|NCT01178918|T Lymphocytes|t lymphocytes
460888|NCT01178918|Non-specific response|non-specific response
460889|NCT01178918|Interleukin-2|interleukin-2
460890|NCT01178918|Non-specific T cell responce|non-specific t cell responce
460891|NCT01178905|Postnatal CMV infection of preterm infants|postnatal cmv infection of preterm infants
460892|NCT01178905|breast milk|breast milk
460893|NCT01178892|Hot Flashes|hot flashes
460894|NCT01178892|Menopause|menopause
460895|NCT01178892|Vasomotor symptoms|vasomotor symptoms
460896|NCT01178892|Yoga|yoga
460897|NCT01178892|Exercise|exercise
460898|NCT01178892|Omega-3|omega-3
460899|NCT01178892|Fish oil|fish oil
460900|NCT01178879|Telehealth|telehealth
460901|NCT01178879|nurse consultation|nurse consultation
460902|NCT01178879|outpatient clinic|outpatient clinic
460903|NCT01178866|thoracic surgery|thoracic surgery
460904|NCT01178866|myocardial revascularization|myocardial revascularization
460905|NCT01178866|left ventricular dysfunction|left ventricular dysfunction
460906|NCT01178866|tissue perfusion|tissue perfusion
460907|NCT01178866|prognosis|prognosis
460908|NCT01178853|Healthy Volunteers|healthy volunteers
460909|NCT01178840|female condom|female condom
460910|NCT01178840|condom|condom
460911|NCT01178840|clinical failure|clinical failure
460912|NCT01178840|prostate-specific antigen|prostate-specific antigen
460913|NCT01178840|semen exposure|semen exposure
460914|NCT01178840|acceptability|acceptability
460915|NCT01178840|Prevention of semen exposure|prevention of semen exposure
460916|NCT01178801|liver cancer|liver cancer
460917|NCT01178801|data mining|data mining
460918|NCT01178801|knowledge discovering|knowledge discovering
460919|NCT01178801|The clinical data of the patients with liver cancer.|the clinical data of the patients with liver cancer.
460920|NCT01178788|Progestagens|progestagens
460921|NCT01178788|Tertiary Prophylaxis|tertiary prophylaxis
460922|NCT01178788|Micronized Progesterone|micronized progesterone
460923|NCT01178788|17 alpha hydroxy P|17 alpha hydroxy p
460924|NCT01178788|Preterm Delivery|preterm delivery
460925|NCT01178788|Cervical shortening|cervical shortening
460926|NCT01178775|fatigue|fatigue
460927|NCT01178775|meaning|meaning
460928|NCT01178775|education|education
460929|NCT01178775|walking program|walking program
460930|NCT01178762|Oral Azithromycin|oral azithromycin
460931|NCT01178762|Chlamydial Conjunctivitis|chlamydial conjunctivitis
460932|NCT01178749|Hepatitis C|hepatitis c
460933|NCT01178749|Interferon|interferon
460934|NCT01178749|Symptom Distress|symptom distress
460935|NCT01178749|Quality of Life|quality of life
460936|NCT01178736|neoplasms|neoplasms
460937|NCT01178723|breakfast size|breakfast size
460938|NCT01178723|blood glucose balance|blood glucose balance
460939|NCT01178723|hormonal profile|hormonal profile
460940|NCT01178723|appetite hormones|appetite hormones
460941|NCT01178723|adipokines|adipokines
460942|NCT01178723|pro-inflammatory cytokines|pro-inflammatory cytokines
460943|NCT01178684|ENFD|enfd
460944|NCT01178684|epidermal nerve fiber density|epidermal nerve fiber density
460945|NCT01178684|HIV|hiv
460946|NCT01178684|HIV-infection|hiv-infection
460947|NCT01178671|PTSD|ptsd
460948|NCT01178671|trauma|trauma
460949|NCT01178671|anxiety disorder|anxiety disorder
460950|NCT01178671|medication|medication
460951|NCT01178671|sertraline|sertraline
460952|NCT01178671|mirtazapine|mirtazapine
460953|NCT01178671|pharmacotherapy|pharmacotherapy
460954|NCT01178632|Herbal|herbal
460955|NCT01178632|Phytotherapy|phytotherapy
460956|NCT01178632|Passiflora|passiflora
460957|NCT01178632|Valeriana|valeriana
460958|NCT01178632|Anxiety|anxiety
460959|NCT01178619|IUGR fetuses|iugr fetuses
460960|NCT01178619|symmetrical IUGR|symmetrical iugr
460961|NCT01178619|asymmetrical IUGR|asymmetrical iugr
460962|NCT01178606|echogenic halo around lateral fetal ventricles|echogenic halo around lateral fetal ventricles
460963|NCT01178593|IBS|ibs
460964|NCT01178593|RCT|rct
460965|NCT01178593|psychology|psychology
460966|NCT01178593|hypnosis|hypnosis
460967|NCT01178593|psychotherapy|psychotherapy
460968|NCT01178593|group therapy|group therapy
460969|NCT01178580|fibrinolytic activity|fibrinolytic activity
460970|NCT01178580|Community acquired pneumonia (CAP)|community acquired pneumonia (cap)
460971|NCT01178580|Pleural effusion|pleural effusion
460972|NCT01178567|laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
460973|NCT01178567|Gastrectomy|gastrectomy
460974|NCT01178567|Pulmonary Complications|pulmonary complications
460975|NCT01178554|anxiety disorders|anxiety disorders
460976|NCT01178554|depression|depression
460977|NCT01178554|depressive disorders|depressive disorders
460978|NCT01178554|disruptive behavioral problems|disruptive behavioral problems
460979|NCT01178554|conduct problems|conduct problems
460980|NCT01178541|ventricles|ventricles
460981|NCT01178541|fetal|fetal
460982|NCT01178541|brain|brain
460983|NCT01178541|asymmetry|asymmetry
460984|NCT01178528|heart failure|heart failure
460985|NCT01178528|heart rate|heart rate
460986|NCT01178528|ivabradine|ivabradine
460987|NCT01178528|carvedilol|carvedilol
460988|NCT01178515|epidemiological risk|epidemiological risk
460989|NCT01178515|diet|diet
460990|NCT01178515|fat intake|fat intake
460991|NCT01178450|Renal transplant|renal transplant
460992|NCT01178450|Hypercalcemia|hypercalcemia
460993|NCT01178437|seizure disorder,|seizure disorder,
460994|NCT01178437|seizures,|seizures,
460995|NCT01178437|convulsions,|convulsions,
460996|NCT01178437|grand mal,|grand mal,
460997|NCT01178437|petit mal,|petit mal,
460998|NCT01178437|absence seizures,|absence seizures,
460999|NCT01178437|repeated seizures,|repeated seizures,
461000|NCT01178437|children's seizures,|children's seizures,
461001|NCT01178437|secondary epilepsy,|secondary epilepsy,
461002|NCT01178437|symptomatic epilepsy,|symptomatic epilepsy,
461003|NCT01178437|generalized seizures,|generalized seizures,
461004|NCT01178437|partial seizure,|partial seizure,
461005|NCT01178437|focal seizure,|focal seizure,
461006|NCT01178437|partial complex seizure,|partial complex seizure,
461007|NCT01178437|anticonvulsant medication|anticonvulsant medication
461008|NCT01178424|Unipolar depression|unipolar depression
461009|NCT01178424|Mindfulness based cognitive therapy|mindfulness based cognitive therapy
461010|NCT01178424|Cognitive behavioural Therapy|cognitive behavioural therapy
461011|NCT01178424|Functional magnetic resonance imaging|functional magnetic resonance imaging
461012|NCT01178424|Relapse|relapse
461013|NCT01178424|Depressive relapse|depressive relapse
461014|NCT01178424|Dysphoric|dysphoric
461015|NCT01178424|Cognitive reactivity|cognitive reactivity
461016|NCT01178424|Serotonin transporter gene|serotonin transporter gene
461017|NCT01178411|hepatocellular carcinoma|hepatocellular carcinoma
461018|NCT01178411|renal cell carcinoma|renal cell carcinoma
461019|NCT01178411|melanoma|melanoma
461020|NCT01178411|non-small cell lung cancer|non-small cell lung cancer
461021|NCT01178411|breast cancer|breast cancer
461022|NCT01178411|ovarian cancer|ovarian cancer
461023|NCT01178411|MiT tumors|mit tumors
461024|NCT01178398|fish|fish
461025|NCT01178398|pregnancy|pregnancy
461026|NCT01178398|nutrition|nutrition
461027|NCT01178398|mercury|mercury
461028|NCT01178398|focus group|focus group
461029|NCT01178398|omega-3 fatty acid|omega-3 fatty acid
461030|NCT01178398|docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
461031|NCT01178385|Autism|autism
461032|NCT01178385|Asperger's Syndrome|asperger's syndrome
461033|NCT01178385|Treatment|treatment
461034|NCT01178385|Cognitive-behavioral therapy|cognitive-behavioral therapy
461035|NCT01178385|Anxiety|anxiety
461036|NCT01178385|Children|children
461037|NCT01178385|Therapy|therapy
461038|NCT01178372|hepatic encephalopathy|hepatic encephalopathy
461039|NCT01178372|lactulose|lactulose
461040|NCT01178372|probiotics|probiotics
461041|NCT01178359|cardiac arrest|cardiac arrest
461042|NCT01178359|ventricular fibrillation|ventricular fibrillation
461043|NCT01178359|nitrite|nitrite
461044|NCT01178346|Pharmacoeconomic|pharmacoeconomic
461045|NCT01178346|Quality of Life|quality of life
461046|NCT01178346|Health Outcomes|health outcomes
461047|NCT01178346|Smoking|smoking
461048|NCT01178346|NicVAX|nicvax
461049|NCT01178346|Smoking vaccine|smoking vaccine
461050|NCT01178346|Smoking cessation|smoking cessation
461051|NCT01178333|Thrombocytopenia|thrombocytopenia
461052|NCT01178333|Heparin|heparin
461053|NCT01178320|Magnetic Resonance Imaging|magnetic resonance imaging
461054|NCT01178320|Atherosclerotic Plaque|atherosclerotic plaque
461055|NCT01178320|Lipid Lowering Therapy|lipid lowering therapy
461056|NCT01178307|GI cancers|gi cancers
461057|NCT01178307|GIST|gist
461058|NCT01178307|Symptom Severity|symptom severity
461059|NCT01178307|Quality of Life|quality of life
461060|NCT01178307|Questionnaire|questionnaire
461061|NCT01178307|M.D. Anderson Symptom Inventory|m.d. anderson symptom inventory
461062|NCT01178307|MDASI-GIST|mdasi-gist
461063|NCT01178307|patient-reported outcomes|patient-reported outcomes
461064|NCT01178294|hemophilia A|hemophilia a
461065|NCT01178294|haemophilia A|haemophilia a
461066|NCT01178294|blood coagulation disorders|blood coagulation disorders
461067|NCT01178294|hemorrhagic disorders|hemorrhagic disorders
461068|NCT01178294|coagulation protein disorder|coagulation protein disorder
461069|NCT01178294|hematologic diseases|hematologic diseases
461070|NCT01178294|Acquired Hemophilia A|acquired hemophilia a
461071|NCT01178281|Myelofibrosis|myelofibrosis
461072|NCT01178281|Post-polycythemia vera myelofibrosis|post-polycythemia vera myelofibrosis
461073|NCT01178281|Post-essential thrombocythemia myelofibrosis|post-essential thrombocythemia myelofibrosis
461074|NCT01178281|RBC-transfusion-dependence|rbc-transfusion-dependence
461075|NCT01178281|Primary Myelofibrosis|primary myelofibrosis
461076|NCT01178268|Drug eluting stents|drug eluting stents
461077|NCT01178268|Stents|stents
461078|NCT01178268|Angioplasty|angioplasty
461079|NCT01178255|depression|depression
461080|NCT01178255|homoeopathy|homoeopathy
461081|NCT01178242|Labial mucous membrane|labial mucous membrane
461082|NCT01178242|symblepharon|symblepharon
461083|NCT01178242|dry eye|dry eye
461084|NCT01178242|Stevens -Johnson syndrome|stevens -johnson syndrome
461085|NCT01178242|salivary gland|salivary gland
461086|NCT01178242|ocular surface disease|ocular surface disease
461087|NCT01178242|transplantation|transplantation
461088|NCT01178229|Sleep bruxism|sleep bruxism
461089|NCT01178229|Airway remodeling|airway remodeling
461090|NCT01178229|Physical therapy modalities|physical therapy modalities
461091|NCT01178229|Child preschool.|child preschool.
461092|NCT01178216|Kidney transplant|kidney transplant
461093|NCT01178216|highly sensitized|highly sensitized
461094|NCT01178203|Endodontics|endodontics
461095|NCT01178203|pain|pain
461096|NCT01178203|visual analogue scale|visual analogue scale
461097|NCT01178203|NSAIDs|nsaids
461098|NCT01178190|narrow band imaging|narrow band imaging
461099|NCT01178190|malignant lesion|malignant lesion
461100|NCT01178190|lung cancer|lung cancer
461101|NCT01178190|NBI|nbi
461102|NCT01178177|Invasive pulmonary aspergillosis|invasive pulmonary aspergillosis
461103|NCT01178177|Solid organ transplantation|solid organ transplantation
461104|NCT01178177|Hematologic disease|hematologic disease
461105|NCT01178164|chronic pains|chronic pains
461106|NCT01178164|unknown aetiology|unknown aetiology
461107|NCT01178151|Peutz-Jeghers syndrome|peutz-jeghers syndrome
461108|NCT01178151|mTOR inhibition|mtor inhibition
461109|NCT01178151|cancer|cancer
461110|NCT01178138|substance abuse|substance abuse
461111|NCT01178125|Pregnancy Prevention|pregnancy prevention
461112|NCT01178125|Oral Contraceptives|oral contraceptives
461113|NCT01178112|Metastasis|metastasis
461114|NCT01178112|Carboplatin|carboplatin
461115|NCT01178112|Trientine|trientine
461116|NCT01178112|Chemotherapy|chemotherapy
461117|NCT01178073|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
461118|NCT01178073|Ambrisentan|ambrisentan
461119|NCT01178073|Sponsor Rest of World: GSK|sponsor rest of world: gsk
461120|NCT01178073|Tadalafil|tadalafil
461121|NCT01178073|PAH|pah
461122|NCT01178073|Sponsor US: Gilead|sponsor us: gilead
461123|NCT01178060|Stroke|stroke
461124|NCT01178060|Risk|risk
461125|NCT01178060|Communication|communication
461126|NCT01178060|Cardiovascular Disease Knowledge|cardiovascular disease knowledge
461127|NCT01178060|Improve Risk Communication|improve risk communication
461128|NCT01178034|Warfarin|warfarin
461129|NCT01178034|Dose|dose
461130|NCT01178034|Pharmacogenetic|pharmacogenetic
461131|NCT01178034|INR|inr
461132|NCT01178021|malaria|malaria
461133|NCT01178021|vivax|vivax
461134|NCT01178021|relapse|relapse
461135|NCT01178008|Insomnia|insomnia
461136|NCT01178008|Post-partum Depression|post-partum depression
461137|NCT01178008|Electroacupuncture|electroacupuncture
461138|NCT01178008|Acupuncture|acupuncture
461139|NCT01178008|Randomized Clinical Trial|randomized clinical trial
461140|NCT01178008|Traditional Chinese Medicine|traditional chinese medicine
461141|NCT01177982|pregnancy, opioid, cocaine, alcohol, benzodiazepines, neonate|pregnancy, opioid, cocaine, alcohol, benzodiazepines, neonate
461142|NCT01177969|Autism|autism
461143|NCT01177969|Anxiety|anxiety
461144|NCT01177969|Asperger's Syndrome|asperger's syndrome
461145|NCT01177969|Cognitive-behavioral therapy|cognitive-behavioral therapy
461146|NCT01177969|Treatment|treatment
461147|NCT01177969|Obsessive-compulsive disorder|obsessive-compulsive disorder
461148|NCT01177969|Fears|fears
461149|NCT01177956|Recurrent and/or metastatic squamous cell carcinoma of the head and neck|recurrent and/or metastatic squamous cell carcinoma of the head and neck
461150|NCT01177956|1st-line|1st-line
461151|NCT01177956|Cetuximab|cetuximab
461152|NCT01177956|Chemotherapy|chemotherapy
461153|NCT01177956|EMR 62241 -055|emr 62241 -055
461154|NCT01177956|Merck KGaA|merck kgaa
461155|NCT01177956|Recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN)|recurrent and/or metastatic squamous cell carcinoma of the head and neck (scchn)
461156|NCT01177865|adenocarcinoma of the prostate|adenocarcinoma of the prostate
461157|NCT01177865|stage I prostate cancer|stage i prostate cancer
461158|NCT01177865|stage IIB prostate cancer|stage iib prostate cancer
461159|NCT01177865|stage IIA prostate cancer|stage iia prostate cancer
461160|NCT01177865|stage III prostate cancer|stage iii prostate cancer
461161|NCT01177852|cough, acute rhinitis, common cold, nasal symptoms, children.|cough, acute rhinitis, common cold, nasal symptoms, children.
461162|NCT01177852|Acute inflammation upper airway|acute inflammation upper airway
461163|NCT01177826|Hospitalized|hospitalized
461164|NCT01177826|Rotavirus|rotavirus
461165|NCT01177826|Children|children
461166|NCT01177826|effectiveness|effectiveness
461167|NCT01177826|Gastroenteritis|gastroenteritis
461168|NCT01177800|Psoriasis|psoriasis
461169|NCT01177800|Infliximab|infliximab
461170|NCT01177800|Remicade|remicade
461171|NCT01177787|cryolipolysis fat zeltiq thigh Korean women|cryolipolysis fat zeltiq thigh korean women
461172|NCT01177774|functional connectivity MRI|functional connectivity mri
461173|NCT01177774|brain volumetry|brain volumetry
461174|NCT01177774|negative reinforcement|negative reinforcement
461175|NCT01177774|OCD|ocd
461176|NCT01177774|ADHD|adhd
461177|NCT01177761|Osteoporosis|osteoporosis
461178|NCT01177761|exercise|exercise
461179|NCT01177761|fractures|fractures
461180|NCT01177761|Bone Mineral Density|bone mineral density
461181|NCT01177761|CHD-risk|chd-risk
461182|NCT01177748|Stroke|stroke
461183|NCT01177748|Cardiac Monitoring|cardiac monitoring
461184|NCT01177735|Pomalidomide|pomalidomide
461185|NCT01177735|multiple myeloma|multiple myeloma
461186|NCT01177735|relapsed|relapsed
461187|NCT01177722|Diphtheria|diphtheria
461188|NCT01177722|Tetanus|tetanus
461189|NCT01177722|Whooping cough|whooping cough
461190|NCT01177722|Hepatitis B|hepatitis b
461191|NCT01177722|Poliomyelitis|poliomyelitis
461192|NCT01177722|Diphtheria-Tetanus-acellular Pertussis Vaccines|diphtheria-tetanus-acellular pertussis vaccines
461193|NCT01177709|schizophrenia|schizophrenia
461194|NCT01177709|antipsychotics|antipsychotics
461195|NCT01177709|obesity|obesity
461196|NCT01177709|diabetes|diabetes
461197|NCT01177696|caregivers|caregivers
461198|NCT01177696|Family Health|family health
461199|NCT01177696|Psychotherapeutic|psychotherapeutic
461200|NCT01177696|Primary Health Care|primary health care
461201|NCT01177670|Adiana Permanent Contraception System|adiana permanent contraception system
461202|NCT01177670|women seeking permanent sterilization.|women seeking permanent sterilization.
461203|NCT01177631|Carcinoma, hepatocellular|carcinoma, hepatocellular
461204|NCT01177631|Portal vein|portal vein
461205|NCT01177631|Proteomics|proteomics
461206|NCT01177618|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
461208|NCT01177618|Emphysema|emphysema
461209|NCT01177618|Chronic Bronchitis|chronic bronchitis
461210|NCT01177618|Genetics|genetics
461211|NCT01177618|Association Studies|association studies
461212|NCT01177579|Bariatric surgery, copper deficiency, biomarkers|bariatric surgery, copper deficiency, biomarkers
461213|NCT01177566|Atopic dermatitis|atopic dermatitis
461214|NCT01177566|Elidel|elidel
461215|NCT01177566|pimecrolimus cream 1%|pimecrolimus cream 1%
461216|NCT01177566|Eletone|eletone
461217|NCT01177566|medical device cream|medical device cream
461218|NCT01177566|topical calcineurin inhibitor|topical calcineurin inhibitor
461219|NCT01177553|Intrauterine Growth Retardation in Monochorionic Twins|intrauterine growth retardation in monochorionic twins
461220|NCT01177527|Waldenstrom|waldenstrom
461221|NCT01177527|myeloma|myeloma
461222|NCT01177527|smoldering|smoldering
461223|NCT01177527|lymphoma|lymphoma
461224|NCT01177527|MGUS|mgus
461225|NCT01177527|distinct B-cell lymphoproliferative disorder|distinct b-cell lymphoproliferative disorder
461226|NCT01177514|Refractive surgery|refractive surgery
461227|NCT01177514|PRK|prk
461228|NCT01177514|PAIN|pain
461229|NCT01177514|Gabapentin|gabapentin
461230|NCT01177501|Ovarian cancer|ovarian cancer
461231|NCT01177501|Topotecan|topotecan
461232|NCT01177501|Carboplatine|carboplatine
461233|NCT01177501|Higt dose chemotherapy|higt dose chemotherapy
461234|NCT01177488|Military|military
461235|NCT01177488|Health Service Delivery|health service delivery
461236|NCT01177488|Behavioral Symptoms|behavioral symptoms
461237|NCT01177488|Telepsychology|telepsychology
461238|NCT01177488|Behavioral Activation|behavioral activation
461239|NCT01177488|Exposure Therapy|exposure therapy
461240|NCT01177488|Veterans|veterans
461241|NCT01177488|Telemedicine|telemedicine
461242|NCT01177475|kidney-transplant recipients|kidney-transplant recipients
461243|NCT01177462|coordinate system|coordinate system
461244|NCT01177462|normal|normal
461245|NCT01177449|prolotherapy|prolotherapy
461246|NCT01177436|prostate cancer|prostate cancer
461247|NCT01177436|benign prostatic hypertrophy|benign prostatic hypertrophy
461248|NCT01177423|restorative odontology|restorative odontology
461249|NCT01177423|Patients cared in restorative odontology department|patients cared in restorative odontology department
461250|NCT01177410|IBS|ibs
461251|NCT01177410|Diarrhea|diarrhea
461252|NCT01177410|IBS-D|ibs-d
461253|NCT01177410|Irritable Bowel Syndrome|irritable bowel syndrome
461254|NCT01177410|Abdominal pain|abdominal pain
461255|NCT01177410|Bloating|bloating
461256|NCT01177397|Advanced solid malignant neoplasms,Non-Hodgkin Lymphoma,|advanced solid malignant neoplasms,non-hodgkin lymphoma,
461257|NCT01177397|Multiple Myeloma|multiple myeloma
461258|NCT01177384|Type 2 diabetes mellitus|type 2 diabetes mellitus
461259|NCT01177384|T2DM|t2dm
461260|NCT01177358|Scar|scar
461261|NCT01177358|Botox|botox
461262|NCT01177332|FFA|ffa
461263|NCT01177332|Liver|liver
461264|NCT01177332|steatosis|steatosis
461265|NCT01177332|exercise|exercise
461266|NCT01177319|Parkinson's Disease|parkinson's disease
461267|NCT01177319|Glutathione|glutathione
461268|NCT01177306|ADHD, working memory|adhd, working memory
461269|NCT01177293|biological availability|biological availability
461270|NCT01177293|bioavailability|bioavailability
461271|NCT01177293|amlodipine|amlodipine
461272|NCT01177293|orally disintegrating tablet|orally disintegrating tablet
461273|NCT01177293|ODT|odt
461274|NCT01177293|tablets|tablets
461275|NCT01177280|retrospective chronic low back pain|retrospective chronic low back pain
461276|NCT01177267|retrospective database analysis in osteoarthritis patients|retrospective database analysis in osteoarthritis patients
461277|NCT01177254|retrospective chronic low back pain|retrospective chronic low back pain
461278|NCT01177241|retrospective chronic low back pain|retrospective chronic low back pain
461279|NCT01177215|Algorithm|algorithm
461280|NCT01177215|Treatment Protocol|treatment protocol
461281|NCT01177215|Thoracic Drainage Device|thoracic drainage device
461282|NCT01177202|HAC1, H1N1|hac1, h1n1
461283|NCT01177189|Oxidative Stress|oxidative stress
461284|NCT01177189|Free radicals|free radicals
461285|NCT01177189|Aging|aging
461286|NCT01177176|Cigarette smoking|cigarette smoking
461287|NCT01177176|Tobacco smoking|tobacco smoking
461288|NCT01177163|Type 2 diabetes mellitus|type 2 diabetes mellitus
461289|NCT01177163|Canagliflozin|canagliflozin
461290|NCT01177163|JNJ-28431754|jnj-28431754
461291|NCT01177163|Insulin|insulin
461292|NCT01177163|Pharmacokinetic|pharmacokinetic
461293|NCT01177163|Pharmacodynamic|pharmacodynamic
461294|NCT01177163|SGLT-1|sglt-1
461295|NCT01177150|Sodium-Glucose Transporter 2|sodium-glucose transporter 2
461296|NCT01177150|Canagliflozin|canagliflozin
461297|NCT01177150|Pharmacodynamic|pharmacodynamic
461298|NCT01177150|Pharmacokinetic|pharmacokinetic
461299|NCT01177150|Safety|safety
461300|NCT01177150|Tolerability|tolerability
461301|NCT01177137|tinnitus|tinnitus
461302|NCT01177137|tinnitus retraining therapy|tinnitus retraining therapy
461303|NCT01177137|standard of care|standard of care
461304|NCT01177137|directive counseling|directive counseling
461305|NCT01177137|sound therapy|sound therapy
461306|NCT01177137|tinnitus questionnaire|tinnitus questionnaire
461307|NCT01177137|tinnitus handicap inventory|tinnitus handicap inventory
461308|NCT01177124|Breast cancer|breast cancer
461309|NCT01177124|Survivors|survivors
461310|NCT01177124|Mindfulness-Based Stress Reduction (MBSR)|mindfulness-based stress reduction (mbsr)
461311|NCT01177124|Symptoms|symptoms
461312|NCT01177124|Immune markers|immune markers
461313|NCT01177085|obesity|obesity
461314|NCT01177085|weight|weight
461315|NCT01177085|weight-loss|weight-loss
461316|NCT01177085|mushroom|mushroom
461317|NCT01177085|oxidative|oxidative
461318|NCT01177085|stress|stress
461319|NCT01177085|immune|immune
461320|NCT01177085|function|function
461321|NCT01177085|inflammation|inflammation
461322|NCT01177072|PTSD|ptsd
461323|NCT01177059|Gene Therapy|gene therapy
461324|NCT01177059|Anti-HIV-1 Ribozyme|anti-hiv-1 ribozyme
461325|NCT01177059|OZ1|oz1
461326|NCT01177059|HIV-1 Infections|hiv-1 infections
461327|NCT01177046|Women receiving labour epidural for most recent delivery|women receiving labour epidural for most recent delivery
461328|NCT01177007|Gastrointestinal Diseases|gastrointestinal diseases
461329|NCT01177007|Colonic Diseases|colonic diseases
461330|NCT01177007|Intestinal Diseases|intestinal diseases
461331|NCT01177007|Rectal Diseases|rectal diseases
461332|NCT01177007|Neoplastic Processes|neoplastic processes
461333|NCT01177007|Pathologic Processes|pathologic processes
461334|NCT01177007|Neuroendocrine Tumors|neuroendocrine tumors
461335|NCT01177007|Neuroectodermal Tumors|neuroectodermal tumors
461336|NCT01177007|Neoplasms, Germ Cell and Embryonal|neoplasms, germ cell and embryonal
461337|NCT01177007|Adenocarcinoma|adenocarcinoma
461338|NCT01177007|Neoplasms, Nerve Tissue|neoplasms, nerve tissue
461339|NCT01177007|Liver Diseases|liver diseases
461340|NCT01177007|Neoplasms|neoplasms
461341|NCT01177007|Carcinoma|carcinoma
461342|NCT01177007|Colorectal Neoplasms|colorectal neoplasms
461343|NCT01177007|Neoplasm Metastasis|neoplasm metastasis
461344|NCT01177007|Carcinoma, Neuroendocrine|carcinoma, neuroendocrine
461345|NCT01177007|Liver Neoplasms|liver neoplasms
461346|NCT01177007|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
461347|NCT01177007|Neoplasms by Histologic Type|neoplasms by histologic type
461348|NCT01177007|Intestinal Neoplasms|intestinal neoplasms
461349|NCT01177007|Gastrointestinal Neoplasms|gastrointestinal neoplasms
461350|NCT01177007|Digestive System Neoplasms|digestive system neoplasms
461351|NCT01177007|Neoplasms by Site|neoplasms by site
461352|NCT01177007|Digestive System Diseases|digestive system diseases
461353|NCT01176994|Patients with skin lesions that are treated by dermatologists with destructive modalities without histological evaluation.|patients with skin lesions that are treated by dermatologists with destructive modalities without histological evaluation.
461354|NCT01176981|pediatrics|pediatrics
461355|NCT01176981|Osteosarcoma|osteosarcoma
461356|NCT01176981|Methotrexate|methotrexate
461357|NCT01176981|Outpatient|outpatient
461358|NCT01176968|Eplerenone|eplerenone
461359|NCT01176968|myocardial infarction|myocardial infarction
461360|NCT01176968|mortality|mortality
461361|NCT01176968|morbidity|morbidity
461362|NCT01176955|Acne|acne
461363|NCT01176955|Acne vulgaris|acne vulgaris
461364|NCT01176955|Adherence|adherence
461365|NCT01176955|Compliance|compliance
461366|NCT01176955|MEMS|mems
461367|NCT01176955|Benzoyl peroxide|benzoyl peroxide
461368|NCT01176929|Suicide, Attempted|suicide, attempted
461369|NCT01176929|prevention suicidal act|prevention suicidal act
461370|NCT01176929|telephone contact|telephone contact
461371|NCT01176929|professional coordination|professional coordination
461372|NCT01176916|breast cancer|breast cancer
461373|NCT01176916|Aromasin|aromasin
461374|NCT01176916|adjuvant chemotherapy|adjuvant chemotherapy
461375|NCT01176916|endocrine therapy|endocrine therapy
461376|NCT01176890|truncal vagotomy|truncal vagotomy
461377|NCT01176890|GLP-1|glp-1
461378|NCT01176890|gastric emptying|gastric emptying
461379|NCT01176890|appetite|appetite
461380|NCT01176890|food intake|food intake
461381|NCT01176864|Small-Bowel Disorders|small-bowel disorders
461382|NCT01176864|Double-balloon enteroscopy|double-balloon enteroscopy
461383|NCT01176864|Single-balloon enteroscopy|single-balloon enteroscopy
461384|NCT01176851|None (study in healthy volunteers)|none (study in healthy volunteers)
461385|NCT01176838|Breast Cancer Quality of Life Survey|breast cancer quality of life survey
461386|NCT01176825|bipolar disorder|bipolar disorder
461387|NCT01176825|cognitive behavior therapy|cognitive behavior therapy
461388|NCT01176825|alcohol abuse|alcohol abuse
461389|NCT01176825|drug abuse|drug abuse
461390|NCT01176825|high risk behaviors|high risk behaviors
461391|NCT01176825|medication adherence|medication adherence
461392|NCT01176825|psychosocial functioning|psychosocial functioning
461393|NCT01176812|Facialwasting|facialwasting
461394|NCT01176812|Juvederm|juvederm
461395|NCT01176812|Restylane|restylane
461396|NCT01176799|Breast cancer patients with measurable primary breast cancer tumor.|breast cancer patients with measurable primary breast cancer tumor.
461397|NCT01176786|infection|infection
461398|NCT01176786|tissue expander|tissue expander
461399|NCT01176786|breast implant|breast implant
461400|NCT01176786|breast reconstruction|breast reconstruction
461401|NCT01176786|Infections rates|infections rates
461402|NCT01176760|vagotomy|vagotomy
461403|NCT01176760|vagus|vagus
461404|NCT01176760|GLP-1|glp-1
461405|NCT01176760|Insulin secretion|insulin secretion
461406|NCT01176734|Pulsatile Tinnitus|pulsatile tinnitus
461407|NCT01176734|Ringing-Buzzing-Tinnitus|ringing-buzzing-tinnitus
461408|NCT01176734|Spontaneous Oto-Acoustic Emission Tinnitus|spontaneous oto-acoustic emission tinnitus
461409|NCT01176734|Tensor Palatini Induced Tinnitus|tensor palatini induced tinnitus
461410|NCT01176734|Tensor Tympani Induced Tinnitus|tensor tympani induced tinnitus
461411|NCT01176734|Tinnitus of Vascular Origin|tinnitus of vascular origin
461412|NCT01176734|Tinnitus, Clicking|tinnitus, clicking
461413|NCT01176734|Tinnitus, Leudet|tinnitus, leudet
461414|NCT01176734|Tinnitus, Leudet's|tinnitus, leudet's
461415|NCT01176734|Tinnitus, Noise Induced|tinnitus, noise induced
461416|NCT01176734|Tinnitus, Objective|tinnitus, objective
461417|NCT01176734|Tinnitus, Spontaneous Oto-Acoustic Emission|tinnitus, spontaneous oto-acoustic emission
461418|NCT01176734|Tinnitus, Subjective|tinnitus, subjective
461419|NCT01176734|Tinnitus, Tensor Palatini Induced|tinnitus, tensor palatini induced
461420|NCT01176734|Tinnitus, Tensor Tympani Induced|tinnitus, tensor tympani induced
461421|NCT01176734|Vascular Origin Tinnitus|vascular origin tinnitus
461422|NCT01176721|schizophrenic disorders|schizophrenic disorders
461423|NCT01176721|psychosis|psychosis
461424|NCT01176721|psychotic|psychotic
461425|NCT01176721|dementia|dementia
461426|NCT01176721|delusional|delusional
461427|NCT01176721|delusions|delusions
461428|NCT01176721|hallucinations|hallucinations
461429|NCT01176721|residual-type schizophrenia|residual-type schizophrenia
461430|NCT01176721|illusions|illusions
461431|NCT01176721|split mind|split mind
461432|NCT01176721|mental health disorder|mental health disorder
461433|NCT01176721|schizoid|schizoid
461434|NCT01176721|paranoid-type schizophrenia|paranoid-type schizophrenia
461435|NCT01176721|disorganized-type schizophrenia|disorganized-type schizophrenia
461436|NCT01176721|undifferentiated-type schizophrenia|undifferentiated-type schizophrenia
461437|NCT01176721|catatonic-type schizophrenia|catatonic-type schizophrenia
461438|NCT01176721|mental illness|mental illness
461439|NCT01176721|tardive dyskinesia|tardive dyskinesia
461440|NCT01176721|neuroleptic malignant syndrome|neuroleptic malignant syndrome
461441|NCT01176721|NMS|nms
461442|NCT01176721|antipsychotics|antipsychotics
461443|NCT01176721|atypical antipsychotics|atypical antipsychotics
461444|NCT01176721|psychosocial treatments|psychosocial treatments
461445|NCT01176721|rehabilitation|rehabilitation
461446|NCT01176708|liver transplantation|liver transplantation
461447|NCT01176708|kidney transplanted|kidney transplanted
461448|NCT01176708|glucagon-like peptide-1|glucagon-like peptide-1
461449|NCT01176708|insulin secretion|insulin secretion
461450|NCT01176708|vagotomy|vagotomy
461451|NCT01176682|NSAID-treated patients|nsaid-treated patients
461452|NCT01176682|gastrointestinal events|gastrointestinal events
461453|NCT01176682|Non-steroid anti-inflammatory drug (NSAID)|non-steroid anti-inflammatory drug (nsaid)
461454|NCT01176682|Gastrointestinal events (GI events)|gastrointestinal events (gi events)
461455|NCT01176682|Proton Pump Inhibitors (PPI)|proton pump inhibitors (ppi)
461456|NCT01176669|Apatinib|apatinib
461457|NCT01176669|Triple-Negative Breast Cancer|triple-negative breast cancer
461458|NCT01176669|Metastatic Breast Cancer|metastatic breast cancer
461459|NCT01176669|ER/PR Negative|er/pr negative
461460|NCT01176669|Her2/Neu Negative|her2/neu negative
461461|NCT01176656|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
461462|NCT01176656|Hypoglycemia|hypoglycemia
461463|NCT01176643|SLE|sle
461464|NCT01176643|Yoga|yoga
461465|NCT01176630|metabolic syndrome, ESRD patient|metabolic syndrome, esrd patient
461466|NCT01176617|Atrial Fibrillation|atrial fibrillation
461467|NCT01176617|A-Fib|a-fib
461468|NCT01176617|AF|af
461469|NCT01176617|Persistent|persistent
461470|NCT01176617|Permanent|permanent
461471|NCT01176617|Pulmonary Vein isolation|pulmonary vein isolation
461472|NCT01176617|Ablation|ablation
461473|NCT01176604|Hepatocellular carcinoma (HCC) of the liver|hepatocellular carcinoma (hcc) of the liver
461474|NCT01176604|Hepatocellular cancer|hepatocellular cancer
461475|NCT01176604|Hepatocellular carcinoma|hepatocellular carcinoma
461476|NCT01176604|Liver cancer|liver cancer
461477|NCT01176604|HCC|hcc
461478|NCT01176604|Humanitarian Device Exemption|humanitarian device exemption
461479|NCT01176604|Liver Diseases|liver diseases
461480|NCT01176604|(HDE)|(hde)
461481|NCT01176604|Radioactive|radioactive
461482|NCT01176604|TheraSphere|therasphere
461483|NCT01176591|Cocaine and alcohol dependence (CAD)|cocaine and alcohol dependence (cad)
461484|NCT01176565|Acute hypertensive response|acute hypertensive response
461485|NCT01176565|intracerebral hemorrhage|intracerebral hemorrhage
461486|NCT01176565|blood pressure|blood pressure
461487|NCT01176565|outcome|outcome
461488|NCT01176565|nicardipine|nicardipine
461489|NCT01176552|Kidney Cancer|kidney cancer
461490|NCT01176552|Renal cell carcinoma|renal cell carcinoma
461491|NCT01176552|High risk|high risk
461492|NCT01176552|Adjuvant therapy|adjuvant therapy
461493|NCT01176526|Coping|coping
461494|NCT01176526|Quality of Life|quality of life
461495|NCT01176526|Prostate Cancer|prostate cancer
461496|NCT01176513|Prostate Cancer|prostate cancer
461497|NCT01176513|MRI|mri
461498|NCT01176513|PET|pet
461499|NCT01176513|GE-148 (18F)|ge-148 (18f)
461500|NCT01176500|PET Imaging|pet imaging
461501|NCT01176500|(18F)Fluciclatide|(18f)fluciclatide
461502|NCT01176500|Anti-Angiogenic Therapies|anti-angiogenic therapies
461503|NCT01176500|Solid Tumors|solid tumors
461504|NCT01176487|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
461505|NCT01176487|recurrent small cell lung cancer|recurrent small cell lung cancer
461506|NCT01176487|extensive stage small cell lung cancer|extensive stage small cell lung cancer
461507|NCT01176487|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
461508|NCT01176487|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
461509|NCT01176487|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
461510|NCT01176474|stage IV melanoma|stage iv melanoma
461511|NCT01176474|stage IIIC melanoma|stage iiic melanoma
461512|NCT01176461|recurrent melanoma|recurrent melanoma
461513|NCT01176461|stage IIIA melanoma|stage iiia melanoma
461514|NCT01176461|stage IIIB melanoma|stage iiib melanoma
461515|NCT01176461|stage IIIC melanoma|stage iiic melanoma
461516|NCT01176461|stage IV melanoma|stage iv melanoma
461517|NCT01176448|Cicatrix|cicatrix
461518|NCT01176448|Dermabrasion|dermabrasion
461519|NCT01176448|Coagulation, Laser|coagulation, laser
461520|NCT01176435|Levodopa|levodopa
461521|NCT01176435|Albinism|albinism
461522|NCT01176435|Vision|vision
461523|NCT01176422|AML|aml
461524|NCT01176422|MDS|mds
461525|NCT01176396|Dental Caries|dental caries
461526|NCT01176396|Preventive Dentistry|preventive dentistry
461527|NCT01176396|Dental Prophylaxis|dental prophylaxis
461528|NCT01176396|Dental Care|dental care
461529|NCT01176383|Nicotine addiction|nicotine addiction
461530|NCT01176383|Behaviour|behaviour
461531|NCT01176383|Gene test|gene test
461532|NCT01176383|Lung cancer|lung cancer
461533|NCT01176383|Lifetime risk of lung cancer in smokers|lifetime risk of lung cancer in smokers
461534|NCT01176370|Heart Failure|heart failure
461535|NCT01176370|Device|device
461536|NCT01176370|Implantable|implantable
461537|NCT01176370|Active|active
461538|NCT01176370|Class III and Class IV|class iii and class iv
461539|NCT01176370|Counterpulsation|counterpulsation
461540|NCT01176357|Coronary artery disease (CAD)|coronary artery disease (cad)
461541|NCT01176357|atherosclerosis|atherosclerosis
461542|NCT01176357|mediastinal adipose tissue|mediastinal adipose tissue
461543|NCT01176357|adiponectin, inflammatory mediators|adiponectin, inflammatory mediators
461544|NCT01176344|Vitamin D supplementation|vitamin d supplementation
461545|NCT01176344|Osteoarthritis|osteoarthritis
461546|NCT01176344|Knee|knee
461547|NCT01176344|Randomised clinical trial (RCT)|randomised clinical trial (rct)
461548|NCT01176344|Cartilage|cartilage
461549|NCT01176344|MRI|mri
461550|NCT01176318|cough|cough
461551|NCT01176318|exacerbation|exacerbation
461552|NCT01176318|quality of life|quality of life
461553|NCT01176305|Thromboembolic event|thromboembolic event
461554|NCT01176292|total knee replacement|total knee replacement
461555|NCT01176292|high flexion|high flexion
461556|NCT01176292|range of motion|range of motion
461557|NCT01176292|rotating platform|rotating platform
461558|NCT01176292|TKA|tka
461559|NCT01176279|Critical illness|critical illness
461560|NCT01176279|Hyperglycemia|hyperglycemia
461561|NCT01176279|Catheters, Indwelling|catheters, indwelling
461562|NCT01176279|Intensive care unit|intensive care unit
461563|NCT01176266|Hypophosphatasia|hypophosphatasia
461564|NCT01176266|HPP|hpp
461565|NCT01176266|Bone Disease|bone disease
461566|NCT01176266|Soft Bones|soft bones
461567|NCT01176266|Low Alkaline Phosphatase|low alkaline phosphatase
461568|NCT01176266|Genetic metabolic disorder|genetic metabolic disorder
461569|NCT01176266|Alkaline phosphatase|alkaline phosphatase
461570|NCT01176266|Tissue-specific alkaline phosphatase (TNSALP)|tissue-specific alkaline phosphatase (tnsalp)
461571|NCT01176266|Rickets|rickets
461572|NCT01176266|Osteomalacia|osteomalacia
461573|NCT01176253|Type I DM|type i dm
461574|NCT01176240|lightheadedness|lightheadedness
461575|NCT01176240|unsteadiness|unsteadiness
461576|NCT01176240|dizziness|dizziness
461577|NCT01176240|weak|weak
461578|NCT01176240|fatigue|fatigue
461579|NCT01176240|concentration|concentration
461580|NCT01176240|head & neck pain|head & neck pain
461581|NCT01176240|standing/walking for a short time|standing/walking for a short time
461582|NCT01176240|standing/walking for a long time|standing/walking for a long time
461583|NCT01176240|Neurogenic Orthostatic Hypotension|neurogenic orthostatic hypotension
461584|NCT01176240|falls|falls
461585|NCT01176240|NOH|noh
461586|NCT01176240|Parkinson's disease|parkinson's disease
461587|NCT01176240|weakness|weakness
461588|NCT01176227|bloating|bloating
461589|NCT01176227|constipation|constipation
461590|NCT01176227|diarrhea|diarrhea
461591|NCT01176227|gas|gas
461592|NCT01176227|mucous|mucous
461593|NCT01176227|cramping|cramping
461594|NCT01176214|supratentorial intracerebral hemorrhage|supratentorial intracerebral hemorrhage
461595|NCT01176214|tracheostomy|tracheostomy
461596|NCT01176214|sedation|sedation
461597|NCT01176214|weaning|weaning
461598|NCT01176201|SLV337|slv337
461599|NCT01176201|Diabetes|diabetes
461600|NCT01176201|Relative bioavailability|relative bioavailability
461601|NCT01176201|ADME|adme
461602|NCT01176188|Pediatric Intensive Care Unit|pediatric intensive care unit
461603|NCT01176188|Environmental Stressors|environmental stressors
461604|NCT01176188|Sleep|sleep
461605|NCT01176188|Psychological Outcomes|psychological outcomes
461606|NCT01176188|Pediatrics|pediatrics
461607|NCT01176175|Progesterone|progesterone
461608|NCT01176175|Microspheres|microspheres
461609|NCT01176175|postmenopausal|postmenopausal
461610|NCT01176175|Luteal phase support|luteal phase support
461611|NCT01176162|Non Invasive measurement|non invasive measurement
461612|NCT01176162|Preterm infants|preterm infants
461613|NCT01176162|Aldosterone resistance|aldosterone resistance
461614|NCT01176149|Diabetes|diabetes
461615|NCT01176149|Self monitoring blood glucose|self monitoring blood glucose
461616|NCT01176136|ADHD|adhd
461617|NCT01176136|School-Based|school-based
461618|NCT01176136|Organizational Skills|organizational skills
461619|NCT01176136|Homework|homework
461620|NCT01176136|Time Management|time management
461621|NCT01176123|Cognitive behavioral therapy|cognitive behavioral therapy
461622|NCT01176123|Insomnia|insomnia
461623|NCT01176123|Traumatic Stress|traumatic stress
461624|NCT01176110|hypothermia|hypothermia
461625|NCT01176110|minimal invasive valve replacement|minimal invasive valve replacement
461626|NCT01176097|First in man study evaluating AZD5658 in Type 2 Diabetics.|first in man study evaluating azd5658 in type 2 diabetics.
461627|NCT01176097|Effect of fasting|effect of fasting
461628|NCT01176097|Safety|safety
461629|NCT01176097|Tolerability|tolerability
461630|NCT01176084|low carbohydrate diet|low carbohydrate diet
461631|NCT01176084|obesity|obesity
461632|NCT01176084|moderate exercise|moderate exercise
461633|NCT01176084|men|men
461634|NCT01176071|galactomannan|galactomannan
461635|NCT01176071|beta-D-glucan|beta-d-glucan
461636|NCT01176071|aspergillosis|aspergillosis
461637|NCT01176071|outcome|outcome
461638|NCT01176058|Phase 3b|phase 3b
461639|NCT01176058|Efficacy and Safety evaluation of Anidulafungin|efficacy and safety evaluation of anidulafungin
461640|NCT01176058|ICC|icc
461641|NCT01176045|Dry Eye Disease|dry eye disease
461642|NCT01176045|Osmolarity|osmolarity
461643|NCT01176045|Refractive Surgery|refractive surgery
461644|NCT01176045|Lasik|lasik
461645|NCT01176045|TearLab|tearlab
461646|NCT01176032|Aliskiren|aliskiren
461647|NCT01176032|hypertension|hypertension
461648|NCT01176032|concentric LVH|concentric lvh
461649|NCT01176032|LV remodeling|lv remodeling
461650|NCT01176032|LVMI|lvmi
461651|NCT01176032|biomarkers|biomarkers
461652|NCT01176032|PICP|picp
461653|NCT01176032|CT-1|ct-1
461654|NCT01176032|MMP-1|mmp-1
461655|NCT01176032|TIMP-1|timp-1
461656|NCT01176032|AnxA5|anxa5
461657|NCT01176032|Aldosterone|aldosterone
461658|NCT01176032|Essential hypertension with concentric left ventricle hypertrophy|essential hypertension with concentric left ventricle hypertrophy
461659|NCT01176019|Amniocentesis|amniocentesis
461660|NCT01176019|Chorionic Villus Sampling|chorionic villus sampling
461661|NCT01176019|First trimester screening|first trimester screening
461662|NCT01176019|Down syndrome|down syndrome
461663|NCT01176006|DOCK8|dock8
461664|NCT01176006|Molluscum|molluscum
461665|NCT01176006|Transplant|transplant
461666|NCT01176006|Immunodeficiency|immunodeficiency
461667|NCT01175993|Motor Training|motor training
461668|NCT01175993|Post-Traumatic Stress Disorder (PTSD)|post-traumatic stress disorder (ptsd)
461669|NCT01175993|Balance|balance
461670|NCT01175967|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
461671|NCT01175967|perioperative/postoperative complications|perioperative/postoperative complications
461672|NCT01175967|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
461673|NCT01175967|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
461674|NCT01175954|Partial Epilepsy|partial epilepsy
461675|NCT01175928|Diabetic polyneuropathy|diabetic polyneuropathy
461676|NCT01175928|Pneumatic Compression Device|pneumatic compression device
461677|NCT01175915|Mild type of hand, foot and mouth disease|mild type of hand, foot and mouth disease
461678|NCT01175915|Reduning Injection|reduning injection
461679|NCT01175915|Effectiveness|effectiveness
461680|NCT01175915|Safety|safety
461681|NCT01175902|Normal tension glaucoma|normal tension glaucoma
461682|NCT01175876|MMSE|mmse
461683|NCT01175876|NSE|nse
461684|NCT01175876|S100B|s100b
461685|NCT01175876|hsCRP|hscrp
461686|NCT01175876|DWI-MRI|dwi-mri
461687|NCT01175863|intravascular ultrasound|intravascular ultrasound
461688|NCT01175863|fractional flow reserve|fractional flow reserve
461689|NCT01175824|Metabolic Diseases|metabolic diseases
461690|NCT01175824|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
461691|NCT01175824|Glargine|glargine
461692|NCT01175824|Diabetes Mellitus|diabetes mellitus
461693|NCT01175824|Insulin LISPRO|insulin lispro
461694|NCT01175824|Insulin|insulin
461695|NCT01175811|Metabolic Diseases|metabolic diseases
461696|NCT01175811|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
461697|NCT01175811|Glargine|glargine
461698|NCT01175811|Diabetes Mellitus|diabetes mellitus
461699|NCT01175811|Insulin LISPRO|insulin lispro
461700|NCT01175811|Insulin|insulin
461701|NCT01175798|Vitamin D deficiency|vitamin d deficiency
461702|NCT01175798|End-stage renal disease|end-stage renal disease
461703|NCT01175798|Immunity|immunity
461704|NCT01175772|Ovary|ovary
461705|NCT01175772|Carcinoma|carcinoma
461706|NCT01175772|Maintenance|maintenance
461707|NCT01175772|Metronomic|metronomic
461708|NCT01175772|Chemotherapy|chemotherapy
461709|NCT01175772|Time to Progression|time to progression
461710|NCT01175772|overall survival|overall survival
461711|NCT01175759|Unexplained Recurrent Pregnancy Loss|unexplained recurrent pregnancy loss
461712|NCT01175759|Recurrent Abortions|recurrent abortions
461713|NCT01175759|Recurrent Miscarriages|recurrent miscarriages
461714|NCT01175759|Hormones|hormones
461715|NCT01175759|Skin tests|skin tests
461716|NCT01175759|Allergen|allergen
461717|NCT01175759|Immunotherapy|immunotherapy
461718|NCT01175759|Hypersensitivity|hypersensitivity
461719|NCT01175759|Skin reaction|skin reaction
461720|NCT01175746|healthy adult patients|healthy adult patients
461721|NCT01175746|ASA class I|asa class i
461722|NCT01175746|hypotensive anesthesia|hypotensive anesthesia
461723|NCT01175733|Panitumumab|panitumumab
461724|NCT01175733|Chemoradiation|chemoradiation
461725|NCT01175733|Pancreatic cancer|pancreatic cancer
461726|NCT01175733|Locally advanced|locally advanced
461727|NCT01175733|Inoperable|inoperable
461728|NCT01175720|gingival recession|gingival recession
461729|NCT01175720|acellular dermal matrix graft|acellular dermal matrix graft
461730|NCT01175720|root coverage|root coverage
461731|NCT01175694|Brachytherapy|brachytherapy
461732|NCT01175694|APBI|apbi
461733|NCT01175694|dose modification|dose modification
461734|NCT01175694|local recurrences|local recurrences
461735|NCT01175694|side effects|side effects
461736|NCT01175694|cosmetic result|cosmetic result
461737|NCT01175681|rheumatic heart disease|rheumatic heart disease
461738|NCT01175681|degenerated heart valve disease|degenerated heart valve disease
461739|NCT01175681|heart valve prolapse|heart valve prolapse
461740|NCT01175655|Mesenchymal stromal cells|mesenchymal stromal cells
461741|NCT01175655|Bronchiolitis obliterans|bronchiolitis obliterans
461742|NCT01175655|Lung transplant|lung transplant
461743|NCT01175642|Schizophrenia|schizophrenia
461744|NCT01175642|Psychosis|psychosis
461745|NCT01175642|Schizoaffective Disorder|schizoaffective disorder
461746|NCT01175629|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
461747|NCT01175629|Depression|depression
461748|NCT01175629|Diabetes|diabetes
461749|NCT01175629|Cardiovascular Disease|cardiovascular disease
461750|NCT01175629|Depressive Disorder|depressive disorder
461751|NCT01175629|Behavioral Symptoms|behavioral symptoms
461752|NCT01175629|Metabolic Diseases|metabolic diseases
461753|NCT01175629|Mental Disorders|mental disorders
461754|NCT01175629|Anxiety Disorders|anxiety disorders
461755|NCT01175616|Depression|depression
461756|NCT01175616|Adults|adults
461757|NCT01175603|depression, African American, home visiting, prevention|depression, african american, home visiting, prevention
461758|NCT01175577|mixed carotenes|mixed carotenes
461759|NCT01175564|TC-5214|tc-5214
461760|NCT01175564|safety|safety
461761|NCT01175564|pharmacokinetics|pharmacokinetics
461762|NCT01175564|single dose|single dose
461763|NCT01175564|repeated dose|repeated dose
461764|NCT01175564|Japanese|japanese
461765|NCT01175564|healthy subjects|healthy subjects
461766|NCT01175551|Preterm Birth|preterm birth
461767|NCT01175551|Cervix|cervix
461768|NCT01175551|Cervical Shortening|cervical shortening
461769|NCT01175551|Cervical remodeling|cervical remodeling
461771|NCT01175538|Hepatic encephalopathy|hepatic encephalopathy
461772|NCT01175538|Lactulose|lactulose
461773|NCT01175499|laryngoscopy|laryngoscopy
461774|NCT01175499|Laryngoscopic Surgery|laryngoscopic surgery
461775|NCT01175499|laryngoscopes|laryngoscopes
461776|NCT01175499|upper aerodigestive tract lesions|upper aerodigestive tract lesions
461777|NCT01175499|endoscopy|endoscopy
461778|NCT01175499|biopsy|biopsy
461779|NCT01175486|thiazolidinediones|thiazolidinediones
461780|NCT01175486|diabetes|diabetes
461781|NCT01175486|retinopathy|retinopathy
461782|NCT01175486|nephropathy|nephropathy
461783|NCT01175460|esophageal Cancer|esophageal cancer
461784|NCT01175460|radiation|radiation
461785|NCT01175460|s-1|s-1
461786|NCT01175460|nedaplatin|nedaplatin
461787|NCT01175447|S-1|s-1
461788|NCT01175447|radiation|radiation
461789|NCT01175447|esophageal Cancer|esophageal cancer
461790|NCT01175434|Asthma|asthma
461791|NCT01175421|snoring|snoring
461792|NCT01175421|sleep apnea|sleep apnea
461793|NCT01175421|sleep study|sleep study
461794|NCT01175421|cardiovascular outcomes|cardiovascular outcomes
461795|NCT01175408|Remote Blood Glucose Monitoring System,|remote blood glucose monitoring system,
461796|NCT01175408|Continuous Glucose Monitoring System,|continuous glucose monitoring system,
461797|NCT01175408|Self Monitoring Blood Glucose,|self monitoring blood glucose,
461798|NCT01175408|Strip Counting,|strip counting,
461799|NCT01175408|Type 2 Diabetes|type 2 diabetes
461800|NCT01175395|Choroidal neovascular membranes|choroidal neovascular membranes
461801|NCT01175395|CNV|cnv
461802|NCT01175395|AMD|amd
461803|NCT01175395|Age-relate Macular Degeneration|age-relate macular degeneration
461804|NCT01175395|CNVM|cnvm
461805|NCT01175395|subfoveal|subfoveal
461806|NCT01175382|Male Urogenital Diseases|male urogenital diseases
461807|NCT01175382|Urinary Bladder, overactive|urinary bladder, overactive
461808|NCT01175382|Behavioral Medicine|behavioral medicine
461809|NCT01175382|Drug Therapy|drug therapy
461810|NCT01175369|Asthma|asthma
461811|NCT01175330|Omega-3 fatty acid|omega-3 fatty acid
461812|NCT01175330|Ischemic Heart Disease|ischemic heart disease
461813|NCT01175330|Atrial Fibrillation|atrial fibrillation
461814|NCT01175330|Subcutaneous cardiac monitoring|subcutaneous cardiac monitoring
461815|NCT01175317|Hemodynamic optimization|hemodynamic optimization
461816|NCT01175317|Enhanced recovery after surgery|enhanced recovery after surgery
461817|NCT01175317|Goal-directed fluid|goal-directed fluid
461818|NCT01175304|sleep|sleep
461819|NCT01175304|sleep apnea|sleep apnea
461820|NCT01175304|work|work
461821|NCT01175304|sleep habits|sleep habits
461822|NCT01175304|sleepiness|sleepiness
461823|NCT01175291|colon|colon
461824|NCT01175291|rectum|rectum
461825|NCT01175291|colorectal|colorectal
461826|NCT01175291|metastatic|metastatic
461827|NCT01175291|adenocarcinoma|adenocarcinoma
461828|NCT01175278|vertebral|vertebral
461829|NCT01175278|compression|compression
461830|NCT01175278|fracture|fracture
461831|NCT01175278|VCF|vcf
461832|NCT01175278|kyphoplasty|kyphoplasty
461833|NCT01175278|spine|spine
461834|NCT01175265|clinically stable|clinically stable
461835|NCT01175265|COPD (GOLD-classification I-IV)|copd (gold-classification i-iv)
461836|NCT01175265|COPD|copd
461837|NCT01175265|breathing retraining|breathing retraining
461838|NCT01175265|pulmonary rehabilitation|pulmonary rehabilitation
461839|NCT01175265|cardiac autonomic function|cardiac autonomic function
461840|NCT01175265|quality of life|quality of life
461841|NCT01175265|exercise capacity|exercise capacity
461842|NCT01175265|pulmonary function|pulmonary function
461843|NCT01175252|Gastroenteritis|gastroenteritis
461844|NCT01175239|X-linked severe combined immunodeficiency, gene therapy|x-linked severe combined immunodeficiency, gene therapy
461845|NCT01175239|Patients will be enrolled following diagnosis and referral to Great Ormond Street Immunology Service.|patients will be enrolled following diagnosis and referral to great ormond street immunology service.
461846|NCT01175226|Human rhinovirus|human rhinovirus
461847|NCT01175226|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
461848|NCT01175226|Aviragen Therapeutics|aviragen therapeutics
461849|NCT01175226|Aviragen|aviragen
461850|NCT01175187|evron|evron
461851|NCT01175174|asthma|asthma
461852|NCT01175174|preschool children|preschool children
461853|NCT01175174|adenosine provocation test|adenosine provocation test
461854|NCT01175174|metacholine provocation test|metacholine provocation test
461855|NCT01175174|pediatric emergency department|pediatric emergency department
461856|NCT01175161|Postpartum Contraception|postpartum contraception
461857|NCT01175161|Intrauterine device|intrauterine device
461858|NCT01175161|feasibility|feasibility
461859|NCT01175161|IUD|iud
461860|NCT01175161|Immediate postpartum IUD|immediate postpartum iud
461861|NCT01175148|HSCT|hsct
461862|NCT01175148|HPC|hpc
461863|NCT01175148|HCT|hct
461864|NCT01175148|BMT|bmt
461865|NCT01175148|lipitor|lipitor
461866|NCT01175148|atorvastatin|atorvastatin
461867|NCT01175148|HMG-CoA Reductase Inhibitor|hmg-coa reductase inhibitor
461868|NCT01175148|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
461869|NCT01175148|allogeneic transplant|allogeneic transplant
461870|NCT01175148|GVHD|gvhd
461871|NCT01175148|graft-versus-host-disease|graft-versus-host-disease
461872|NCT01175148|Graft vs Host Disease|graft vs host disease
461873|NCT01175135|schizophrenia|schizophrenia
461874|NCT01175135|acute exacerbation|acute exacerbation
461875|NCT01175135|inpatient|inpatient
461876|NCT01175109|Chordoma|chordoma
461877|NCT01175096|neuroendocrine tumors|neuroendocrine tumors
461878|NCT01175096|carcinoid tumor|carcinoid tumor
461879|NCT01175096|RAD001 (everolimus, Afinitor®)|rad001 (everolimus, afinitor®)
461880|NCT01175083|Catch-up vaccination|catch-up vaccination
461881|NCT01175083|Pneumococcal vaccine|pneumococcal vaccine
461882|NCT01175083|Sickle cell disease|sickle cell disease
461883|NCT01175083|Booster vaccination|booster vaccination
461884|NCT01175083|Safety|safety
461885|NCT01175083|Immunogenicity|immunogenicity
461886|NCT01175083|Pneumococcal disease|pneumococcal disease
461887|NCT01175070|diabetic macular oedema|diabetic macular oedema
461888|NCT01175070|ischaemia|ischaemia
461889|NCT01175070|anti VEGF|anti vegf
461890|NCT01175070|pegaptanib|pegaptanib
461891|NCT01175070|Ischaemic diabetic macular oedema|ischaemic diabetic macular oedema
461892|NCT01175057|feasibility|feasibility
461893|NCT01175057|compliance|compliance
461894|NCT01175057|telemedical home monitoring|telemedical home monitoring
461895|NCT01175057|post stationary rehabilitation|post stationary rehabilitation
461896|NCT01175057|patients with myocardial infarction|patients with myocardial infarction
461897|NCT01175044|Revision|revision
461898|NCT01175044|Knee|knee
461899|NCT01175044|Arthroplasty|arthroplasty
461900|NCT01175044|Betadine|betadine
461901|NCT01175044|Lavage|lavage
461902|NCT01175044|Infection|infection
461903|NCT01175018|Acute myocardial infarction|acute myocardial infarction
461904|NCT01175018|Heart Failure|heart failure
461905|NCT01175018|Cardiac Remodeling|cardiac remodeling
461906|NCT01175005|Fever|fever
461907|NCT01175005|Central venous catheter|central venous catheter
461908|NCT01175005|Procalcitonin|procalcitonin
461909|NCT01175005|Fever with a central venous catheter|fever with a central venous catheter
461910|NCT01174992|Fibrin sealant|fibrin sealant
461911|NCT01174992|CSF leak|csf leak
461912|NCT01174979|Morbus Meniere|morbus meniere
461913|NCT01174979|Sudden hearing loss|sudden hearing loss
461914|NCT01174979|Blast injury|blast injury
461915|NCT01174979|Presbyacusis|presbyacusis
461916|NCT01174979|Chron. Otitis Media|chron. otitis media
461917|NCT01174966|oxygen challenge test|oxygen challenge test
461918|NCT01174966|shock|shock
461919|NCT01174966|mortality|mortality
461920|NCT01174966|Oxygen Delivery Index|oxygen delivery index
461921|NCT01174966|cardiac output index|cardiac output index
461922|NCT01174953|prostate cancer|prostate cancer
461923|NCT01174940|myelogenous leukemia|myelogenous leukemia
461924|NCT01174940|lymphocytic leukemia|lymphocytic leukemia
461925|NCT01174940|lymphoblastic leukemia|lymphoblastic leukemia
461926|NCT01174940|myelodysplastic syndrome|myelodysplastic syndrome
461927|NCT01174940|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
461928|NCT01174940|Hodgkin's disease|hodgkin's disease
461929|NCT01174927|Substance use disorder|substance use disorder
461930|NCT01174927|Stress|stress
461931|NCT01174901|cephalalgia|cephalalgia
461932|NCT01174901|copeptins|copeptins
461933|NCT01174901|biomarkers|biomarkers
461934|NCT01174901|headache|headache
461935|NCT01174901|C-terminal provasopression|c-terminal provasopression
461936|NCT01174901|physiological stress response|physiological stress response
461937|NCT01174888|Acute Myeloid Leukemia|acute myeloid leukemia
461938|NCT01174888|AML|aml
461939|NCT01174875|Epigenetics|epigenetics
461940|NCT01174875|Development|development
461941|NCT01174875|Metabolic|metabolic
461942|NCT01174875|Neurodevelopment|neurodevelopment
461943|NCT01174862|aspirin|aspirin
461944|NCT01174862|aspirin responsiveness|aspirin responsiveness
461945|NCT01174862|long-term outcome|long-term outcome
461946|NCT01174862|CABG|cabg
461947|NCT01174849|otitis media|otitis media
461948|NCT01174849|pneumococcal vaccines|pneumococcal vaccines
461949|NCT01174849|randomised controlled trial|randomised controlled trial
461950|NCT01174849|high-risk children|high-risk children
461951|NCT01174849|indigenous|indigenous
461952|NCT01174849|Australia|australia
461953|NCT01174836|CT utilization|ct utilization
461954|NCT01174836|physician attitudes|physician attitudes
461955|NCT01174810|Parkinson's Disease|parkinson's disease
461956|NCT01174810|PD|pd
461957|NCT01174810|Moderate Parkinson's Disease|moderate parkinson's disease
461958|NCT01174784|Chronic Total Occlusions|chronic total occlusions
461959|NCT01174784|Superficial Femoral Artery|superficial femoral artery
461960|NCT01174784|Popliteal Artery|popliteal artery
461961|NCT01174771|Transcranial magnetic stimulation|transcranial magnetic stimulation
461962|NCT01174771|Cortical excitability|cortical excitability
461963|NCT01174771|parkinsonism|parkinsonism
461964|NCT01174771|Progressive Supranuclear Palsy|progressive supranuclear palsy
461965|NCT01174771|Corticobasal Degeneration|corticobasal degeneration
461966|NCT01174771|PSP|psp
461967|NCT01174771|CBD|cbd
461968|NCT01174771|CBGD|cbgd
461969|NCT01174758|balance|balance
461970|NCT01174758|mobility|mobility
461971|NCT01174758|ON/OFF Levodopa|on/off levodopa
461972|NCT01174732|asthma|asthma
461973|NCT01174732|bronchospasm|bronchospasm
461974|NCT01174732|COPD|copd
461975|NCT01174732|chronic respiratory disease|chronic respiratory disease
461976|NCT01174719|Hydroxyethylstarch|hydroxyethylstarch
461977|NCT01174719|Humanalbumin|humanalbumin
461978|NCT01174719|Ringer Lactate|ringer lactate
461979|NCT01174719|patients undergoing cardiac surgery|patients undergoing cardiac surgery
461980|NCT01174706|infections|infections
461981|NCT01174706|flu|flu
461982|NCT01174706|abdominal pain|abdominal pain
461983|NCT01174706|chest pain|chest pain
461984|NCT01174706|cold|cold
461985|NCT01174706|fever|fever
461986|NCT01174706|different acute care conditions|different acute care conditions
461987|NCT01174693|prospective|prospective
461988|NCT01174693|randomized|randomized
461989|NCT01174693|open label|open label
461990|NCT01174693|multi-center|multi-center
461991|NCT01174693|double-blind for CYP2C19 genotypes|double-blind for cyp2c19 genotypes
461992|NCT01174680|cardiogoniometry|cardiogoniometry
461993|NCT01174680|stable angina pectoris patients|stable angina pectoris patients
461994|NCT01174667|Myofascial pain|myofascial pain
461995|NCT01174667|Trigger points|trigger points
461996|NCT01174641|unilateral neglect|unilateral neglect
461997|NCT01174641|TMS intervention|tms intervention
461998|NCT01174628|Exercise Tolerance|exercise tolerance
461999|NCT01174628|Venous Thrombosis|venous thrombosis
462000|NCT01174628|Pulmonary Embolism|pulmonary embolism
462001|NCT01174628|Quality of Life (QOL)|quality of life (qol)
462002|NCT01174615|Blood/bone marrow collection, hematologic diseases, leukemia|blood/bone marrow collection, hematologic diseases, leukemia
462003|NCT01174589|Lower limb strength training|lower limb strength training
462004|NCT01174589|Randomized clinical trial|randomized clinical trial
462005|NCT01174589|Patients with Hip fracture|patients with hip fracture
462006|NCT01174589|6 vs. 12 weeks physical strength training|6 vs. 12 weeks physical strength training
462007|NCT01174576|coffee|coffee
462008|NCT01174576|appetite|appetite
462009|NCT01174576|energy intake|energy intake
462010|NCT01174576|inflammation|inflammation
462011|NCT01174576|cortisol|cortisol
462012|NCT01174576|glucose|glucose
462013|NCT01174576|randomized controlled trial|randomized controlled trial
462014|NCT01174550|chest pain|chest pain
462015|NCT01174550|coronary artery disease|coronary artery disease
462016|NCT01174550|CAD|cad
462017|NCT01174537|NDV|ndv
462018|NCT01174537|Metastatic|metastatic
462019|NCT01174537|Refractory|refractory
462020|NCT01174537|Cancer|cancer
462021|NCT01174537|Progression-free|progression-free
462022|NCT01174537|survival|survival
462023|NCT01174537|recurrent|recurrent
462024|NCT01174524|Quality of life|quality of life
462025|NCT01174524|Menopause|menopause
462026|NCT01174524|Contraception|contraception
462027|NCT01174511|ATOPIC DERMATITIS|atopic dermatitis
462028|NCT01174511|A-1 COOL CREAM|a-1 cool cream
462029|NCT01174498|discomfort|discomfort
462030|NCT01174498|distress|distress
462031|NCT01174498|hurt|hurt
462032|NCT01174498|sting|sting
462033|NCT01174485|Liposuction|liposuction
462034|NCT01174485|exercise|exercise
462035|NCT01174485|metabolism|metabolism
462036|NCT01174485|adiposity|adiposity
462037|NCT01174472|Dialysis access|dialysis access
462038|NCT01174472|angioplasty|angioplasty
462039|NCT01174472|drug eluting balloon|drug eluting balloon
462040|NCT01174433|Bifurcation coronary artery disease|bifurcation coronary artery disease
462041|NCT01174433|Percutaneous coronary intervention|percutaneous coronary intervention
462042|NCT01174433|Tryton Stent|tryton stent
462043|NCT01174420|ologen|ologen
462044|NCT01174420|Mitomycin-C|mitomycin-c
462045|NCT01174420|Collagen Matrix|collagen matrix
462046|NCT01174420|trabeculectomy|trabeculectomy
462047|NCT01174420|glaucoma|glaucoma
462048|NCT01174420|filtering surgery|filtering surgery
462049|NCT01174394|Acupuncture|acupuncture
462050|NCT01174394|Post Stroke Depression|post stroke depression
462051|NCT01174394|Depressive Disorder|depressive disorder
462052|NCT01174394|Cardiovascular Accident|cardiovascular accident
462053|NCT01174394|Stroke|stroke
462054|NCT01174394|Apoplexy|apoplexy
462055|NCT01174394|CVA|cva
462056|NCT01174381|Non communicable disease|non communicable disease
462057|NCT01174381|Lifestyle Modification|lifestyle modification
462058|NCT01174381|Community Based organization|community based organization
462059|NCT01174381|community based study|community based study
462060|NCT01174342|Intraocular pressure|intraocular pressure
462061|NCT01174342|Ocular tonometry|ocular tonometry
462062|NCT01174342|Obstetric delivery|obstetric delivery
462063|NCT01174316|Acute exacerbation|acute exacerbation
462064|NCT01174316|Respiratory insufficiency|respiratory insufficiency
462065|NCT01174316|Respiratory failure|respiratory failure
462066|NCT01174316|Hypercapnia|hypercapnia
462067|NCT01174316|Hypoventilation|hypoventilation
462068|NCT01174316|Sleep|sleep
462069|NCT01174316|Hypoxia|hypoxia
462070|NCT01174316|Titration|titration
462071|NCT01174316|Non Invasive Ventilation|non invasive ventilation
462072|NCT01174290|subsyndromal delirium|subsyndromal delirium
462073|NCT01174290|delirium|delirium
462074|NCT01174290|haloperidol|haloperidol
462075|NCT01174290|antipsychotic|antipsychotic
462076|NCT01174290|randomized controlled trial|randomized controlled trial
462077|NCT01174290|placebo-controlled|placebo-controlled
462078|NCT01174290|intensive care unit|intensive care unit
462079|NCT01174290|critical care|critical care
462080|NCT01174290|subsyndromal delirium in the intensive care unit|subsyndromal delirium in the intensive care unit
462081|NCT01174277|chronic graft versus host disease|chronic graft versus host disease
462082|NCT01174277|transplant|transplant
462083|NCT01174277|stem cell|stem cell
462084|NCT01174251|general anesthesia|general anesthesia
462085|NCT01174251|electrocardiography|electrocardiography
462086|NCT01174251|long QT syndrome, acquired|long qt syndrome, acquired
462087|NCT01174238|Melanoma|melanoma
462088|NCT01174238|Axitinib|axitinib
462089|NCT01174238|Carboplatin|carboplatin
462090|NCT01174238|Paclitaxel|paclitaxel
462091|NCT01174225|Copper IUD|copper iud
462092|NCT01174225|Nova T 200|nova t 200
462093|NCT01174225|Flexi T 380|flexi t 380
462094|NCT01174225|expulsion|expulsion
462095|NCT01174225|contraception satisfaction|contraception satisfaction
462096|NCT01174225|post-abortion contraception|post-abortion contraception
462097|NCT01174212|revision|revision
462098|NCT01174212|infection|infection
462099|NCT01174212|knee|knee
462101|NCT01174212|replacement|replacement
462102|NCT01174212|antibiotics|antibiotics
462103|NCT01174173|Angina|angina
462104|NCT01174173|Right Ventricular Ischemia|right ventricular ischemia
462105|NCT01174173|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
462106|NCT01174173|Pulmonary Hypertension|pulmonary hypertension
462107|NCT01174160|Atrial Fibrillation|atrial fibrillation
462108|NCT01174121|Digestive Tract Cancers|digestive tract cancers
462109|NCT01174121|Breast Cancer|breast cancer
462110|NCT01174121|Glioblastoma|glioblastoma
462111|NCT01174121|Ovarian/Endometrial Cancer|ovarian/endometrial cancer
462112|NCT01174121|Urothelial Cancers|urothelial cancers
462113|NCT01174108|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
462114|NCT01174108|Severe Aplastic Anemia|severe aplastic anemia
462115|NCT01174108|Pure Red Cell Aplasia|pure red cell aplasia
462116|NCT01174108|Paroxysmal Nocturnal Hemoglobinuria (PNH)|paroxysmal nocturnal hemoglobinuria (pnh)
462117|NCT01174108|Miltenyi CD34 Reagent System|miltenyi cd34 reagent system
462118|NCT01174108|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
462119|NCT01174095|Diffuse Coronary Artery Disease|diffuse coronary artery disease
462120|NCT01174095|Ischemic Myocardium|ischemic myocardium
462121|NCT01174095|Ischemia|ischemia
462122|NCT01174082|Multiple Myeloma|multiple myeloma
462123|NCT01174082|Vaccine|vaccine
462124|NCT01174082|Lymphocyte Infusion|lymphocyte infusion
462125|NCT01174069|NOTES|notes
462126|NCT01174069|cholecystectomy|cholecystectomy
462127|NCT01174069|endoscopic|endoscopic
462128|NCT01174056|Lung inflammation|lung inflammation
462129|NCT01174056|positron emission tomography|positron emission tomography
462130|NCT01174056|fluorodeoxyglucose|fluorodeoxyglucose
462131|NCT01174056|rosiglitazone|rosiglitazone
462132|NCT01174056|zileuton|zileuton
462133|NCT01174056|lung anti-inflammatory therapy|lung anti-inflammatory therapy
462134|NCT01174043|Leukemia, Myelomonocytic, Acute|leukemia, myelomonocytic, acute
462135|NCT01174043|Erlotinib|erlotinib
462136|NCT01174017|prostate cancer|prostate cancer
462433|NCT01172730|acute pain|acute pain
462137|NCT01174017|Iodine 125 brachytherapy|iodine 125 brachytherapy
462138|NCT01174017|seed migration|seed migration
462139|NCT01174017|seed migration in the first month after brachytherapy|seed migration in the first month after brachytherapy
462140|NCT01173991|carbohydrate counting|carbohydrate counting
462141|NCT01173991|continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
462142|NCT01173991|type 1 diabetes mellitus|type 1 diabetes mellitus
462143|NCT01173978|Incretin hormones|incretin hormones
462144|NCT01173978|Glucagon|glucagon
462145|NCT01173978|Insulin/c-peptide|insulin/c-peptide
462146|NCT01173978|Plasma glucose|plasma glucose
462147|NCT01173978|Insulin resistance|insulin resistance
462148|NCT01173978|Deteriorated glucose homeostasis|deteriorated glucose homeostasis
462149|NCT01173978|Inactivity|inactivity
462150|NCT01173939|Hypercholesterolemia with concomitant type 2 diabetes and hypertension|hypercholesterolemia with concomitant type 2 diabetes and hypertension
462151|NCT01173913|oral docetaxel|oral docetaxel
462152|NCT01173913|ModraDoc|modradoc
462153|NCT01173913|pharmacokinetics|pharmacokinetics
462154|NCT01173913|safety|safety
462155|NCT01173913|MTD|mtd
462156|NCT01173913|DLT|dlt
462157|NCT01173900|human papillomavirus|human papillomavirus
462158|NCT01173900|vaccine|vaccine
462159|NCT01173900|school girls|school girls
462160|NCT01173900|Tanzania|tanzania
462161|NCT01173900|acceptability|acceptability
462162|NCT01173900|vaccine coverage|vaccine coverage
462163|NCT01173900|Cervical cancer prevention|cervical cancer prevention
462164|NCT01173874|Cognition|cognition
462165|NCT01173874|Function|function
462166|NCT01173874|Attention|attention
462167|NCT01173874|Vigilance|vigilance
462168|NCT01173874|Verbal Memory|verbal memory
462169|NCT01173874|Visual Memory|visual memory
462170|NCT01173874|Processing Speed|processing speed
462171|NCT01173874|Problem Solving|problem solving
462172|NCT01173874|Social Cognition|social cognition
462173|NCT01173848|CKD|ckd
462174|NCT01173848|Vitamin D|vitamin d
462175|NCT01173835|Adolescent tobacco use|adolescent tobacco use
462176|NCT01173835|Tobacco Free and Win|tobacco free and win
462177|NCT01173835|Incentive-based intervention|incentive-based intervention
462178|NCT01173835|Contingency Management|contingency management
462179|NCT01173835|Smoking Prevention|smoking prevention
462180|NCT01173835|Smoking cessation|smoking cessation
462181|NCT01173822|cardiopulmonary bypass|cardiopulmonary bypass
462182|NCT01173822|hemorrhage|hemorrhage
462183|NCT01173822|trials|trials
462184|NCT01173822|surgery|surgery
462185|NCT01173809|AF|af
462186|NCT01173809|Catheter Ablation|catheter ablation
462187|NCT01173809|Recurrence of AF|recurrence of af
462188|NCT01173809|Amiodarone|amiodarone
462189|NCT01173783|Heart failure|heart failure
462190|NCT01173783|Cardiac insufficiency|cardiac insufficiency
462191|NCT01173783|Implantable Cardioverter/Defibrillator|implantable cardioverter/defibrillator
462192|NCT01173783|Cardiac Resynchronization therapy|cardiac resynchronization therapy
462193|NCT01173783|ICD|icd
462194|NCT01173783|CRT|crt
462195|NCT01173783|Register|register
462196|NCT01173757|Healthy Volunteers|healthy volunteers
462197|NCT01173744|Intertrochanteric femoral fractures - unstable|intertrochanteric femoral fractures - unstable
462198|NCT01173731|Parkinson Disease|parkinson disease
462199|NCT01173731|L-dopa|l-dopa
462200|NCT01173731|Levodopa|levodopa
462201|NCT01173731|Dyskinesia|dyskinesia
462202|NCT01173731|involuntary movement|involuntary movement
462203|NCT01173731|motor complication|motor complication
462204|NCT01173718|Hemodialysis|hemodialysis
462205|NCT01173718|Vascular Graft|vascular graft
462206|NCT01173705|Obesity|obesity
462207|NCT01173705|Insulin Resistance|insulin resistance
462208|NCT01173705|Inflammation|inflammation
462209|NCT01173692|Oropharynx Cancer|oropharynx cancer
462210|NCT01173692|Radiation Therapy|radiation therapy
462212|NCT01173692|Radiotherapy|radiotherapy
462213|NCT01173692|Minocycline|minocycline
462214|NCT01173692|Symptoms|symptoms
462215|NCT01173692|Head and Neck|head and neck
462216|NCT01173679|CLL|cll
462217|NCT01173679|fludarabine|fludarabine
462218|NCT01173679|rituximab|rituximab
462219|NCT01173679|dasatinib|dasatinib
462220|NCT01173679|refractory|refractory
462221|NCT01173679|relapsed|relapsed
462222|NCT01173666|RAS|ras
462223|NCT01173666|LVMI|lvmi
462224|NCT01173666|Renal revascularization|renal revascularization
462225|NCT01173653|smoking|smoking
462226|NCT01173653|smoking cessation|smoking cessation
462227|NCT01173653|health behavior|health behavior
462228|NCT01173640|drug interactions|drug interactions
462229|NCT01173640|midazolam|midazolam
462230|NCT01173640|cytochrome P450|cytochrome p450
462231|NCT01173640|resveratrol|resveratrol
462232|NCT01173640|pharmacokinetics|pharmacokinetics
462233|NCT01173627|Bioequivalence|bioequivalence
462234|NCT01173627|Fentanyl|fentanyl
462235|NCT01173588|bowel function|bowel function
462236|NCT01173588|functional foods|functional foods
462237|NCT01173562|Healthy volunteers|healthy volunteers
462238|NCT01173562|Parasitic Diseases|parasitic diseases
462239|NCT01173562|Mebendazole (VERMOX)|mebendazole (vermox)
462240|NCT01173562|Anthelmintics|anthelmintics
462241|NCT01173562|Antiparasitic Agents|antiparasitic agents
462242|NCT01173562|Soil-transmitted helminth (STH) infections|soil-transmitted helminth (sth) infections
462243|NCT01173562|Pediatric|pediatric
462244|NCT01173549|Canagliflozin|canagliflozin
462245|NCT01173549|Pharmacodynamic|pharmacodynamic
462246|NCT01173549|Glucose absorption|glucose absorption
462247|NCT01173549|Glucose metabolism|glucose metabolism
462248|NCT01173523|Hsp90 Inhibitor|hsp90 inhibitor
462249|NCT01173523|relapsed|relapsed
462250|NCT01173523|refractory|refractory
462251|NCT01173510|HIV|hiv
462252|NCT01173510|AIDS|aids
462253|NCT01173510|Atripla|atripla
462254|NCT01173510|Truvada|truvada
462255|NCT01173510|Raltegravir|raltegravir
462256|NCT01173510|Human Immunodeficiency Virus|human immunodeficiency virus
462257|NCT01173510|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
462258|NCT01173497|Triple negative breast cancer|triple negative breast cancer
462259|NCT01173497|Brain metastasis|brain metastasis
462260|NCT01173497|BSI-201|bsi-201
462261|NCT01173497|iniparib|iniparib
462262|NCT01173484|Idiopathic gastroparesis|idiopathic gastroparesis
462263|NCT01173484|Vomiting|vomiting
462264|NCT01173484|Dyspepsia|dyspepsia
462265|NCT01173484|GERD|gerd
462266|NCT01173471|Raised intraocular pressure|raised intraocular pressure
462267|NCT01173458|cancer|cancer
462268|NCT01173458|lung|lung
462269|NCT01173458|small cell|small cell
462270|NCT01173445|cancer|cancer
462271|NCT01173445|kidney|kidney
462272|NCT01173445|renal cell|renal cell
462273|NCT01173445|tumor cells|tumor cells
462274|NCT01173445|circulating tumor cells|circulating tumor cells
462275|NCT01173445|circulating endothelial cells|circulating endothelial cells
462276|NCT01173432|obstructive sleep apnea|obstructive sleep apnea
462277|NCT01173432|metabolic dysfunction|metabolic dysfunction
462278|NCT01173432|metabolic syndrome|metabolic syndrome
462279|NCT01173432|adipocyte fatty acid binding protein|adipocyte fatty acid binding protein
462280|NCT01173419|Great Saphenous Vein|great saphenous vein
462281|NCT01173406|Continuous Positive Airway Pressure treatment|continuous positive airway pressure treatment
462282|NCT01173406|Adherence|adherence
462283|NCT01173406|Education|education
462284|NCT01173393|out of hospital cardiac arrest|out of hospital cardiac arrest
462285|NCT01173393|OHCA|ohca
462286|NCT01173393|EMS|ems
462287|NCT01173393|Emergency medical System|emergency medical system
462288|NCT01173393|non-VF|non-vf
462289|NCT01173393|non-ventricular fibrillation|non-ventricular fibrillation
462290|NCT01173380|Soy|soy
462291|NCT01173380|Equol|equol
462292|NCT01173380|Metabolic syndrome|metabolic syndrome
462293|NCT01173380|Endothelial function|endothelial function
462294|NCT01173367|Fever|fever
462295|NCT01173367|ICU|icu
462296|NCT01173367|Acetaminophen|acetaminophen
462297|NCT01173367|Inflammatory mediators|inflammatory mediators
462298|NCT01173367|Safety|safety
462299|NCT01173354|COPD|copd
462300|NCT01173354|Protein metabolism|protein metabolism
462301|NCT01173354|Essential amino acid intake|essential amino acid intake
462302|NCT01173328|exercise tolerance|exercise tolerance
462303|NCT01173328|dynamic hyperinflation|dynamic hyperinflation
462304|NCT01173328|respiratory mechanics|respiratory mechanics
462305|NCT01173315|Type 2 diabetes|type 2 diabetes
462306|NCT01173315|micronutrients|micronutrients
462307|NCT01173315|nephropathy|nephropathy
462308|NCT01173315|neuropathy|neuropathy
462309|NCT01173302|Rabies|rabies
462310|NCT01173302|Anti-rabies antibody|anti-rabies antibody
462311|NCT01173302|Persistence|persistence
462312|NCT01173289|Thyroid Carcinoma|thyroid carcinoma
462313|NCT01173289|External Beam Radiotherapy|external beam radiotherapy
462314|NCT01173276|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
462315|NCT01173276|Assisted Reproductive Technology|assisted reproductive technology
462316|NCT01173276|Fertility|fertility
462317|NCT01173276|HIV|hiv
462318|NCT01173276|HIV Discordant|hiv discordant
462319|NCT01173276|Infertility|infertility
462320|NCT01173276|Intrauterine Insemination|intrauterine insemination
462321|NCT01173276|Sexually Transmitted Diseases|sexually transmitted diseases
462322|NCT01173276|Sperm Washing|sperm washing
462323|NCT01173263|breathing machine|breathing machine
462324|NCT01173263|mechanical ventilator|mechanical ventilator
462325|NCT01173250|total proctocolectomy with ileal pouch anal anastomosis with and without ileostomy|total proctocolectomy with ileal pouch anal anastomosis with and without ileostomy
462326|NCT01173237|tracheal intubation|tracheal intubation
462327|NCT01173237|proseal laryngeal mask airway|proseal laryngeal mask airway
462328|NCT01173237|neonate|neonate
462329|NCT01173237|surfactant|surfactant
462330|NCT01173237|respiratory distress syndrome|respiratory distress syndrome
462331|NCT01173224|influenza, DAS181, antiviral|influenza, das181, antiviral
462332|NCT01173211|pregnant, women, influenza, vaccine|pregnant, women, influenza, vaccine
462333|NCT01173198|LOW TO MODERATE MYOPIC PATIENTS|low to moderate myopic patients
462334|NCT01173172|Boron neutron capture therapy (BNCT)|boron neutron capture therapy (bnct)
462335|NCT01173172|Head and neck cancer|head and neck cancer
462336|NCT01173172|toxicities|toxicities
462337|NCT01173172|response rate|response rate
462338|NCT01173159|Parenteral Nutrition|parenteral nutrition
462339|NCT01173159|Cholestasis|cholestasis
462340|NCT01173146|Primary prostate cancer undergoing prostatectomy|primary prostate cancer undergoing prostatectomy
462341|NCT01173133|Free Flap|free flap
462342|NCT01173133|Surgery|surgery
462343|NCT01173133|Ischemia|ischemia
462344|NCT01173133|Outcome|outcome
462345|NCT01173133|Reconstructive Plastic Surgery|reconstructive plastic surgery
462346|NCT01173133|Monitoring|monitoring
462347|NCT01173094|Critical limb ischemia|critical limb ischemia
462348|NCT01173094|Diabetes Mellitus|diabetes mellitus
462349|NCT01173094|Diabetes foot|diabetes foot
462350|NCT01173081|Jones fracture|jones fracture
462351|NCT01173081|fifth metatarsal fracture|fifth metatarsal fracture
462352|NCT01173081|teriparatide|teriparatide
462353|NCT01173081|fracture healing|fracture healing
462354|NCT01173068|Ertapenem|ertapenem
462355|NCT01173068|Clinical outcome|clinical outcome
462356|NCT01173068|Complicated Urinary Tract Infections|complicated urinary tract infections
462357|NCT01173042|Overweight|overweight
462358|NCT01173042|Obese|obese
462359|NCT01173029|Systemic arterial hypertension|systemic arterial hypertension
462360|NCT01173029|Hypertension Resistant to Conventional Therapy|hypertension resistant to conventional therapy
462361|NCT01173029|Genetic polymorphisms|genetic polymorphisms
462362|NCT01173029|Renin-angiotensin-aldosterone system genetic polymorphism|renin-angiotensin-aldosterone system genetic polymorphism
462363|NCT01173029|Risk markers|risk markers
462364|NCT01173029|Adverse events|adverse events
462365|NCT01173029|Acute myocardial infarction|acute myocardial infarction
462366|NCT01173029|Stroke|stroke
462367|NCT01173016|mucopolysaccharide IH (MPS IH)|mucopolysaccharide ih (mps ih)
462368|NCT01173003|Medical abortion|medical abortion
462369|NCT01173003|mifepristone|mifepristone
462370|NCT01173003|misoprostol|misoprostol
462371|NCT01173003|Tunisia|tunisia
462372|NCT01172990|ST Depression|st depression
462373|NCT01172977|Diabetes mellitus|diabetes mellitus
462374|NCT01172977|Stroke|stroke
462375|NCT01172964|Los Angeles|los angeles
462376|NCT01172951|Post-prandial|post-prandial
462377|NCT01172951|Nutrigenomic|nutrigenomic
462378|NCT01172951|Test meal|test meal
462379|NCT01172951|Oral glucose tolerance test|oral glucose tolerance test
462380|NCT01172951|Oral lipid tolerance test|oral lipid tolerance test
462381|NCT01172938|Psoriatic Arthritis|psoriatic arthritis
462382|NCT01172938|Psoriasis|psoriasis
462383|NCT01172938|Arthritis|arthritis
462384|NCT01172938|inflammation|inflammation
462385|NCT01172938|skin condition|skin condition
462386|NCT01172938|inflammatory cells|inflammatory cells
462387|NCT01172938|apremilast|apremilast
462388|NCT01172938|CC-10004|cc-10004
462389|NCT01172938|phosphodiesterase type 4|phosphodiesterase type 4
462390|NCT01172925|NSCLC|nsclc
462391|NCT01172925|dyspnea|dyspnea
462392|NCT01172925|phase II|phase ii
462393|NCT01172925|crossover|crossover
462394|NCT01172925|tiotropium|tiotropium
462395|NCT01172912|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
462396|NCT01172912|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
462397|NCT01172912|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
462398|NCT01172912|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
462399|NCT01172912|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
462400|NCT01172912|recurrent extragonadal seminoma|recurrent extragonadal seminoma
462401|NCT01172912|stage IV extragonadal seminoma|stage iv extragonadal seminoma
462402|NCT01172912|testicular mature teratoma|testicular mature teratoma
462403|NCT01172912|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
462404|NCT01172912|testicular immature teratoma|testicular immature teratoma
462405|NCT01172899|Bariatric Surgery|bariatric surgery
462406|NCT01172899|Adolescent|adolescent
462407|NCT01172886|Metabolic Syndrome obesity visceral adiposity breast cancer|metabolic syndrome obesity visceral adiposity breast cancer
462408|NCT01172873|OCD|ocd
462409|NCT01172873|DCS|dcs
462410|NCT01172873|D-cycloserine|d-cycloserine
462411|NCT01172873|CBT|cbt
462412|NCT01172873|E/RP|e/rp
462413|NCT01172873|exposure response prevention|exposure response prevention
462414|NCT01172860|Inoperable|inoperable
462415|NCT01172860|Colorectal|colorectal
462416|NCT01172860|Endoscopic|endoscopic
462417|NCT01172860|Electroporation|electroporation
462418|NCT01172860|Outpatient|outpatient
462419|NCT01172834|Nurses|nurses
462420|NCT01172795|Whiplash associated disorder|whiplash associated disorder
462421|NCT01172795|chronic pain|chronic pain
462422|NCT01172795|neural inhibition|neural inhibition
462423|NCT01172795|neuropsychological tests|neuropsychological tests
462424|NCT01172769|HNSCC|hnscc
462425|NCT01172756|Pulmonary Hypertension|pulmonary hypertension
462426|NCT01172756|Left ventricular dysfunction|left ventricular dysfunction
462427|NCT01172743|Diabetes Mellitus|diabetes mellitus
462428|NCT01172743|Diabetes|diabetes
462429|NCT01172743|Type-2|type-2
462430|NCT01172743|Adult Onset|adult onset
462431|NCT01172730|Post operative pain|post operative pain
462432|NCT01172730|thoracic epidural|thoracic epidural
462434|NCT01172730|Ultrasound scanning of the thoracic spine|ultrasound scanning of the thoracic spine
462435|NCT01172717|Carcinoid|carcinoid
462436|NCT01172717|Carcinoid syndrome|carcinoid syndrome
462437|NCT01172704|Motivational Interviewing|motivational interviewing
462438|NCT01172704|Serious Mental Illness|serious mental illness
462439|NCT01172704|HIV/AIDS|hiv/aids
462440|NCT01172704|HIV Testing|hiv testing
462441|NCT01172691|Liver transplant|liver transplant
462442|NCT01172665|Celiac Disease|celiac disease
462443|NCT01172652|Bipolar disorder|bipolar disorder
462444|NCT01172652|Anxiety|anxiety
462445|NCT01172652|Panic|panic
462446|NCT01172652|GAD|gad
462447|NCT01172652|Generalized Anxiety Disorder|generalized anxiety disorder
462448|NCT01172639|CoBRA|cobra
462449|NCT01172626|epilepsy|epilepsy
462450|NCT01172626|valproate sodium|valproate sodium
462451|NCT01172626|metabolic enzymes|metabolic enzymes
462452|NCT01172626|adverse effects|adverse effects
462453|NCT01172626|systemic adverse effects|systemic adverse effects
462454|NCT01172613|allergic rhinitis|allergic rhinitis
462455|NCT01172613|concentration of diagnostic reagent|concentration of diagnostic reagent
462456|NCT01172613|allergen extract, house dust mites (Dp)|allergen extract, house dust mites (dp)
462457|NCT01172613|skin prick test|skin prick test
462458|NCT01172613|nasal allergen provocation test|nasal allergen provocation test
462459|NCT01172600|radiating back pain|radiating back pain
462460|NCT01172600|epidural block|epidural block
462461|NCT01172600|steroid|steroid
462462|NCT01172600|recurrent low back pain|recurrent low back pain
462463|NCT01172600|Lumbar Epidural Steroid Block with 3 injections|lumbar epidural steroid block with 3 injections
462464|NCT01172587|Cognitive Behavioral Therapy|cognitive behavioral therapy
462465|NCT01172587|Couples Treatment|couples treatment
462466|NCT01172587|Alcohol Use|alcohol use
462467|NCT01172587|Effects on Youth|effects on youth
462468|NCT01172574|Osteoporosis|osteoporosis
462469|NCT01172574|Pain|pain
462470|NCT01172574|Kyphosis|kyphosis
462471|NCT01172574|Posture|posture
462472|NCT01172574|Exercise therapy|exercise therapy
462473|NCT01172548|Resected GIST|resected gist
462474|NCT01172548|primary GIST|primary gist
462475|NCT01172548|tumor recurrence|tumor recurrence
462476|NCT01172548|KIT receptor|kit receptor
462477|NCT01172548|KIT positive|kit positive
462478|NCT01172548|advanced GIST|advanced gist
462479|NCT01172548|minimal toxicity|minimal toxicity
462480|NCT01172548|GIST|gist
462481|NCT01172535|Lopinavir/ritonavir|lopinavir/ritonavir
462482|NCT01172535|Pediatric dosing|pediatric dosing
462483|NCT01172535|World Health Organization|world health organization
462484|NCT01172522|Under eye dark circles|under eye dark circles
462485|NCT01172522|Under eye puffiness|under eye puffiness
462486|NCT01172509|plasticity|plasticity
462487|NCT01172509|excitatory|excitatory
462488|NCT01172509|inhibitory|inhibitory
462489|NCT01172509|synaptic plasticity|synaptic plasticity
462490|NCT01172509|R-Baclofen|r-baclofen
462491|NCT01172509|TMS|tms
462492|NCT01172509|transcranial magnetic stimulation|transcranial magnetic stimulation
462493|NCT01172509|biomarker|biomarker
462494|NCT01172509|autism|autism
462495|NCT01172483|primary care|primary care
462496|NCT01172483|physical and aquatic exercises|physical and aquatic exercises
462497|NCT01172483|promotion physical activity|promotion physical activity
462498|NCT01172483|chronic disorders|chronic disorders
462499|NCT01172470|Recurrent head and neck cancer|recurrent head and neck cancer
462500|NCT01172470|larynx, lip, oral cavity and pharynx|larynx, lip, oral cavity and pharynx
462501|NCT01172457|low back pain|low back pain
462502|NCT01172457|failed back surgery syndrome (FBSS)|failed back surgery syndrome (fbss)
462503|NCT01172457|epidural fibrosis|epidural fibrosis
462504|NCT01172457|ozone therapy|ozone therapy
462505|NCT01172457|oxygen therapy|oxygen therapy
462506|NCT01172457|epiduroscopy|epiduroscopy
462507|NCT01172457|spinal endoscopy|spinal endoscopy
462508|NCT01172444|Mild to Moderate Ulcerative Proctitis|mild to moderate ulcerative proctitis
462509|NCT01172431|hypertension|hypertension
462510|NCT01172431|renal insufficiency|renal insufficiency
462511|NCT01172431|indapamide|indapamide
462512|NCT01172431|hydrochlorothiazide|hydrochlorothiazide
462513|NCT01172418|adult|adult
462514|NCT01172418|primary kidney transplant recipient|primary kidney transplant recipient
462515|NCT01172405|Headache|headache
462516|NCT01172405|Migraine|migraine
462517|NCT01172405|Ibuprofen|ibuprofen
462518|NCT01172405|Caffeine|caffeine
462519|NCT01172366|Open label, single dose, pharmacokinetic study|open label, single dose, pharmacokinetic study
462520|NCT01172353|contras-induced nephropathy|contras-induced nephropathy
462521|NCT01172340|behavioral|behavioral
462522|NCT01172340|diet|diet
462523|NCT01172340|exercise|exercise
462524|NCT01172314|NSCLC|nsclc
462525|NCT01172314|Weight loss|weight loss
462526|NCT01172314|protein metabolism|protein metabolism
462527|NCT01172314|essential amino acid intake|essential amino acid intake
462528|NCT01172301|CF|cf
462529|NCT01172301|protein metabolism|protein metabolism
462530|NCT01172301|essential amino acid intake|essential amino acid intake
462531|NCT01172288|Tic disorders,|tic disorders,
462800|NCT01171495|CD4 count|cd4 count
462532|NCT01172288|Tourette syndrome|tourette syndrome
462533|NCT01172288|Chronic Tic Disorders|chronic tic disorders
462534|NCT01172275|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
462535|NCT01172275|OCD|ocd
462536|NCT01172262|Tinnitus|tinnitus
462537|NCT01172262|MRI|mri
462538|NCT01172262|fMRI|fmri
462539|NCT01172262|task based MRI|task based mri
462540|NCT01172262|Otolaryngology|otolaryngology
462541|NCT01172249|Osteoarthritis|osteoarthritis
462542|NCT01172249|Knee|knee
462543|NCT01172249|Glucosamine|glucosamine
462544|NCT01172249|Chondroitin|chondroitin
462545|NCT01172223|HER2-positive|her2-positive
462546|NCT01172223|early breast cancer|early breast cancer
462547|NCT01172197|local anesthetic|local anesthetic
462548|NCT01172197|levobupivacaine|levobupivacaine
462549|NCT01172197|ropivacaine|ropivacaine
462550|NCT01172197|femoral perineural block|femoral perineural block
462551|NCT01172184|Left atrial distensibility|left atrial distensibility
462552|NCT01172184|Left ventricular filling pressure|left ventricular filling pressure
462553|NCT01172184|Severe mitral regurgitation|severe mitral regurgitation
462554|NCT01172184|Prognosis|prognosis
462555|NCT01172184|Post-operation (mitral valve replacement or valvuloplasty) atrial fibrillation|post-operation (mitral valve replacement or valvuloplasty) atrial fibrillation
462556|NCT01172171|Ischemia-reperfusion injury|ischemia-reperfusion injury
462557|NCT01172171|Acute Myocardial Infarction|acute myocardial infarction
462558|NCT01172171|Intracoronary melatonin|intracoronary melatonin
462559|NCT01172158|forgotten ureteral stents, SMS Reminder|forgotten ureteral stents, sms reminder
462560|NCT01172145|apathy|apathy
462561|NCT01172145|Alzheimer's disease|alzheimer's disease
462562|NCT01172145|activities of daily living performance|activities of daily living performance
462563|NCT01172145|caregiver burden|caregiver burden
462564|NCT01172132|Leukemia|leukemia
462565|NCT01172132|Lymphoma|lymphoma
462566|NCT01172132|Bone-Marrow Transplant|bone-marrow transplant
462567|NCT01172132|Neutropenia|neutropenia
462568|NCT01172132|Acute respiratory failure|acute respiratory failure
462569|NCT01172132|Mechanical ventilation|mechanical ventilation
462570|NCT01172132|Post ICU burden|post icu burden
462571|NCT01172132|ICU triage|icu triage
462572|NCT01172132|Dialysis|dialysis
462573|NCT01172132|Septic shock|septic shock
462574|NCT01172119|Coronary Disease, Coronary Stenosis, Angioplasty, Coronary restenosis, Drug Eluting Stent|coronary disease, coronary stenosis, angioplasty, coronary restenosis, drug eluting stent
462575|NCT01172106|Postpartum psychosis|postpartum psychosis
462576|NCT01172106|Perceived social support|perceived social support
462577|NCT01172106|Family psychoeducation|family psychoeducation
462578|NCT01172093|obstructive sleep apnea|obstructive sleep apnea
462579|NCT01172093|prevalence|prevalence
462580|NCT01172093|diabetes mellitus|diabetes mellitus
462581|NCT01172093|Chinese|chinese
462582|NCT01172080|colonoscopy|colonoscopy
462583|NCT01172080|adherence|adherence
462584|NCT01172080|reminders|reminders
462585|NCT01172080|quality|quality
462587|NCT01172067|heart failure|heart failure
462588|NCT01172067|optimization|optimization
462589|NCT01172067|Timing cycle optimization methods|timing cycle optimization methods
462590|NCT01172054|influenza vaccine recombinant|influenza vaccine recombinant
462591|NCT01172028|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
462592|NCT01172028|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
462593|NCT01172028|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
462594|NCT01172028|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
462595|NCT01172028|male breast cancer|male breast cancer
462596|NCT01172028|stage IIIA breast cancer|stage iiia breast cancer
462597|NCT01172028|stage IIIB breast cancer|stage iiib breast cancer
462598|NCT01172028|stage IIIC breast cancer|stage iiic breast cancer
462599|NCT01172028|stage IV breast cancer|stage iv breast cancer
462600|NCT01172028|recurrent breast cancer|recurrent breast cancer
462601|NCT01172028|stage III prostate cancer|stage iii prostate cancer
462602|NCT01172028|stage IV prostate cancer|stage iv prostate cancer
462603|NCT01172028|recurrent prostate cancer|recurrent prostate cancer
462604|NCT01172028|stage III esophageal cancer|stage iii esophageal cancer
462605|NCT01172028|stage IV esophageal cancer|stage iv esophageal cancer
462606|NCT01172028|recurrent esophageal cancer|recurrent esophageal cancer
462607|NCT01172028|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
462608|NCT01172028|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
462609|NCT01172028|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
462610|NCT01172028|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
462611|NCT01172028|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
462612|NCT01172028|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
462613|NCT01172028|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
462614|NCT01172028|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
462615|NCT01172028|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
462616|NCT01172028|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
462617|NCT01172028|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
462618|NCT01172028|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
462619|NCT01172028|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
462620|NCT01172028|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
462621|NCT01172028|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
462622|NCT01172028|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
462623|NCT01172028|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
462624|NCT01172028|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
462625|NCT01172028|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
462626|NCT01172028|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
462627|NCT01172028|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
462628|NCT01172028|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
462629|NCT01172028|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
462630|NCT01172028|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
462631|NCT01172028|recurrent salivary gland cancer|recurrent salivary gland cancer
462632|NCT01172028|stage III salivary gland cancer|stage iii salivary gland cancer
462633|NCT01172028|stage IV salivary gland cancer|stage iv salivary gland cancer
462634|NCT01172028|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
462635|NCT01172028|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
462636|NCT01172028|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
462637|NCT01172028|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
462638|NCT01172028|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
462639|NCT01172028|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
462640|NCT01172028|stage III gastric cancer|stage iii gastric cancer
462641|NCT01172028|stage IV gastric cancer|stage iv gastric cancer
462642|NCT01172028|recurrent gastric cancer|recurrent gastric cancer
462643|NCT01172028|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
462644|NCT01172028|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
462645|NCT01172028|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
462646|NCT01172028|recurrent laryngeal cancer|recurrent laryngeal cancer
462647|NCT01172028|stage III laryngeal cancer|stage iii laryngeal cancer
462648|NCT01172028|stage IV laryngeal cancer|stage iv laryngeal cancer
462649|NCT01172002|Lupus Nephritis|lupus nephritis
462650|NCT01172002|Leflunomide|leflunomide
462651|NCT01172002|Azathioprine|azathioprine
462652|NCT01171989|booster vaccination|booster vaccination
462653|NCT01171989|combined vaccine|combined vaccine
462654|NCT01171976|DME|dme
462655|NCT01171976|Diabetic macula edema|diabetic macula edema
462656|NCT01171976|RETAIN|retain
462657|NCT01171976|ranibizumab|ranibizumab
462658|NCT01171963|Liquid human retrovirus vaccine|liquid human retrovirus vaccine
462659|NCT01171950|Thoratec Corporation|thoratec corporation
462660|NCT01171937|ages 8-16|ages 8-16
462661|NCT01171937|Repetitive Behaviors|repetitive behaviors
462662|NCT01171924|Head and Neck Cancer|head and neck cancer
462663|NCT01171924|Liver Cancer|liver cancer
462664|NCT01171924|Breast Cancer|breast cancer
462665|NCT01171924|Gastric Cancer|gastric cancer
462666|NCT01171924|Non-Small Cell Lung Cancer|non-small cell lung cancer
462667|NCT01171924|EGFR|egfr
462668|NCT01171924|HDAC|hdac
462669|NCT01171924|Her2|her2
462670|NCT01171924|CUDC-101|cudc-101
462671|NCT01171911|Endothelial shear stress|endothelial shear stress
462672|NCT01171911|Calcium channel blocker|calcium channel blocker
462673|NCT01171898|Non-Metastatic|non-metastatic
462674|NCT01171898|Rising PSA|rising psa
462675|NCT01171898|Castration-Resistant|castration-resistant
462676|NCT01171898|Treatment-Naive|treatment-naive
462677|NCT01171898|Post-abiraterone|post-abiraterone
462678|NCT01171885|Superficial cervical block|superficial cervical block
462679|NCT01171885|Thyroidectomy|thyroidectomy
462680|NCT01171885|Pain|pain
462681|NCT01171872|Inflammatory Bowel Disease|inflammatory bowel disease
462682|NCT01171872|Inflammatory Bowel Disease (IBD)|inflammatory bowel disease (ibd)
462683|NCT01171872|Crohn's Disease|crohn's disease
462684|NCT01171872|Ulcerative Colitis|ulcerative colitis
462685|NCT01171872|Indeterminate Colitis|indeterminate colitis
462686|NCT01171872|IBD|ibd
462687|NCT01171872|CD|cd
462688|NCT01171872|UC|uc
462689|NCT01171872|IC|ic
462690|NCT01171859|amyloidosis|amyloidosis
462691|NCT01171859|transthyretin|transthyretin
462692|NCT01171859|doxycycline|doxycycline
462693|NCT01171859|Tauroursodeoxycholic acid|tauroursodeoxycholic acid
462694|NCT01171846|prevention|prevention
462695|NCT01171846|pelvic floor muscle training|pelvic floor muscle training
462696|NCT01171846|prolapse symptoms|prolapse symptoms
462697|NCT01171846|urinary symptoms|urinary symptoms
462698|NCT01171846|sexual function|sexual function
462699|NCT01171846|randomised controlled trial|randomised controlled trial
462700|NCT01171833|Anesthetic induction|anesthetic induction
462701|NCT01171833|Desflurane|desflurane
462702|NCT01171833|Isoflurane|isoflurane
462703|NCT01171833|Sevoflurane|sevoflurane
462704|NCT01171833|Ventilation|ventilation
462705|NCT01171820|drug eluting stents|drug eluting stents
462706|NCT01171820|stents|stents
462707|NCT01171820|Angioplasty|angioplasty
462708|NCT01171820|coronary artery disease|coronary artery disease
462709|NCT01171820|total coronary occlusion|total coronary occlusion
462710|NCT01171820|coronary artery restenosis|coronary artery restenosis
462711|NCT01171820|stent thrombosis|stent thrombosis
462712|NCT01171820|vascular disease|vascular disease
462713|NCT01171820|myocardial ischemia|myocardial ischemia
462714|NCT01171820|coronary artery stenosis|coronary artery stenosis
462715|NCT01171807|Ulcerative colitis|ulcerative colitis
462716|NCT01171807|Steroid-dependency|steroid-dependency
462717|NCT01171807|Steroid adverse events|steroid adverse events
462718|NCT01171807|Erythrocytes|erythrocytes
462719|NCT01171768|Vascular endothelial growth factor|vascular endothelial growth factor
462720|NCT01171768|angiopoietin-2|angiopoietin-2
462721|NCT01171729|Prostate cancer|prostate cancer
462722|NCT01171729|PSA|psa
462723|NCT01171729|Hormone refractory prostatic cancer|hormone refractory prostatic cancer
462724|NCT01171716|overweight, protein intake, satiety, eating, meal patterns|overweight, protein intake, satiety, eating, meal patterns
462725|NCT01171703|Critical limb ischemia|critical limb ischemia
462726|NCT01171703|Diabetes|diabetes
462727|NCT01171703|Femoropopliteal artery bypass|femoropopliteal artery bypass
462728|NCT01171703|Stent|stent
462729|NCT01171690|Hypoparathyroidism|hypoparathyroidism
462730|NCT01171677|addiction|addiction
462731|NCT01171677|exercise|exercise
462732|NCT01171677|cognitive function|cognitive function
462733|NCT01171677|mood|mood
462734|NCT01171677|self efficacy|self efficacy
462735|NCT01171664|Phase 2|phase 2
462736|NCT01171664|SAR|sar
462737|NCT01171664|STAHIST|stahist
462738|NCT01171651|Vaccinia|vaccinia
462739|NCT01171651|Vaccinia Virus|vaccinia virus
462740|NCT01171651|JX-594|jx-594
462741|NCT01171651|Jennerex|jennerex
462742|NCT01171651|Primary Hepatocellular Carcinoma|primary hepatocellular carcinoma
462743|NCT01171651|Primary Liver Cancer|primary liver cancer
462744|NCT01171651|Liver Cancer|liver cancer
462745|NCT01171651|Sorafenib|sorafenib
462746|NCT01171651|Nexavar|nexavar
462747|NCT01171651|Pexa-Vec|pexa-vec
462748|NCT01171638|near infrared spectroscopy|near infrared spectroscopy
462749|NCT01171638|compartment syndrome|compartment syndrome
462750|NCT01171638|fasciotomy|fasciotomy
462751|NCT01171638|INVOS|invos
462752|NCT01171625|PERIMOUNT, Aortic valve replacement/regurgitation|perimount, aortic valve replacement/regurgitation
462753|NCT01171612|Coronary Stent|coronary stent
462754|NCT01171612|BMS stent|bms stent
462755|NCT01171612|DES stent|des stent
462756|NCT01171612|Date of stent implantation|date of stent implantation
462757|NCT01171612|cardiac event|cardiac event
462758|NCT01171612|neurovascular event|neurovascular event
462759|NCT01171612|Bleeding|bleeding
462760|NCT01171612|transfusion|transfusion
462761|NCT01171599|Weight Loss|weight loss
462762|NCT01171599|Obesity|obesity
462763|NCT01171599|Overweight|overweight
462764|NCT01171599|Physical Activity|physical activity
462765|NCT01171599|Nutrition|nutrition
462766|NCT01171599|Youth|youth
462767|NCT01171599|Adolescent|adolescent
462768|NCT01171599|Technology|technology
462769|NCT01171586|Obesity|obesity
462770|NCT01171586|overweight|overweight
462771|NCT01171586|weight loss|weight loss
462772|NCT01171586|weight maintenance|weight maintenance
462773|NCT01171586|SMS|sms
462774|NCT01171586|technology|technology
462775|NCT01171586|cell phone|cell phone
462776|NCT01171586|physical activity|physical activity
462777|NCT01171586|nutrition|nutrition
462778|NCT01171573|Polymyositis|polymyositis
462779|NCT01171573|Dermatomyositis|dermatomyositis
462780|NCT01171573|Inclusion Body Myositis|inclusion body myositis
462781|NCT01171560|EZ Blocker|ez blocker
462782|NCT01171560|Double-lumen Tube|double-lumen tube
462783|NCT01171560|Airway|airway
462784|NCT01171560|thoracic surgery|thoracic surgery
462785|NCT01171560|time for intubation|time for intubation
462786|NCT01171560|blind insertion|blind insertion
462787|NCT01171560|conditions of surgery|conditions of surgery
462788|NCT01171560|postoperative sore throat|postoperative sore throat
462789|NCT01171560|postoperative hoarseness|postoperative hoarseness
462790|NCT01171547|pharmacokinetics|pharmacokinetics
462791|NCT01171508|Circadian Rhythm Disorders|circadian rhythm disorders
462792|NCT01171508|Breast Neoplasms Surgery|breast neoplasms surgery
462793|NCT01171508|Sleep|sleep
462794|NCT01171508|Heart Rate|heart rate
462795|NCT01171495|HIV/AIDS|hiv/aids
462796|NCT01171495|Nutrition Therapy|nutrition therapy
462797|NCT01171495|Dietary Supplement|dietary supplement
462798|NCT01171495|Antioxidant|antioxidant
462799|NCT01171495|Immunity|immunity
462801|NCT01171495|Anthropometry|anthropometry
462802|NCT01171495|Body Mass Index|body mass index
462803|NCT01171469|Brain tumor|brain tumor
462804|NCT01171469|Immunotherapy|immunotherapy
462805|NCT01171469|Glioma|glioma
462806|NCT01171456|GDM|gdm
462807|NCT01171456|Gestational Diabetes|gestational diabetes
462808|NCT01171456|Diabetes|diabetes
462809|NCT01171456|Pregnancy|pregnancy
462810|NCT01171430|multiple myeloma|multiple myeloma
462811|NCT01171430|Autologous Stem Cell Transplantation|autologous stem cell transplantation
462812|NCT01171417|Fulvestrant|fulvestrant
462813|NCT01171417|Exemestane|exemestane
462814|NCT01171417|postmenopausal patients|postmenopausal patients
462815|NCT01171417|advanced HR+ breast cancer|advanced hr+ breast cancer
462816|NCT01171417|Hormone Receptor positive|hormone receptor positive
462817|NCT01171417|advanced breast cancer|advanced breast cancer
462818|NCT01171404|Acute coronary syndrome|acute coronary syndrome
462819|NCT01171404|heart attack|heart attack
462820|NCT01171404|myocardial infarction|myocardial infarction
462821|NCT01171404|ACS long-tem follow up|acs long-tem follow up
462822|NCT01171404|antithrombotic management|antithrombotic management
462823|NCT01171404|quality of life|quality of life
462824|NCT01171404|Antithrombotic|antithrombotic
462825|NCT01171391|Nocturia|nocturia
462826|NCT01171391|Pharmacokinetics|pharmacokinetics
462827|NCT01171391|Pharmacodynamics|pharmacodynamics
462828|NCT01171391|Water-loading|water-loading
462829|NCT01171391|Females|females
462830|NCT01171378|Richter's Syndrome|richter's syndrome
462831|NCT01171378|High-grade transformation in patients with B cell chronic lymphocytic leukemia|high-grade transformation in patients with b cell chronic lymphocytic leukemia
462832|NCT01171378|Feasibility|feasibility
462833|NCT01171378|Ofatumumab Induction and maintenance|ofatumumab induction and maintenance
462834|NCT01171378|CHOP|chop
462835|NCT01171378|CHOP-0|chop-0
462836|NCT01171378|CHOP-OR|chop-or
462837|NCT01171378|Non Hodgkin's lymphoma|non hodgkin's lymphoma
462838|NCT01171365|Ciclesonide|ciclesonide
462839|NCT01171365|Asthma|asthma
462840|NCT01171365|Therapeutic Uses|therapeutic uses
462841|NCT01171365|Pulmonary Eosinophilia|pulmonary eosinophilia
462842|NCT01171365|Nitric Oxide|nitric oxide
462843|NCT01171365|Lung Diseases|lung diseases
462844|NCT01171365|Respiratory Tract Diseases|respiratory tract diseases
462845|NCT01171352|hemodialysis|hemodialysis
462846|NCT01171352|dialysis|dialysis
462847|NCT01171352|hypotension|hypotension
462848|NCT01171352|CritLine|critline
462849|NCT01171352|PiCCO|picco
462850|NCT01171352|Thermodilution|thermodilution
462851|NCT01171352|CVVHDF|cvvhdf
462852|NCT01171352|IHD|ihd
462853|NCT01171339|elderly|elderly
462854|NCT01171339|multimorbidity|multimorbidity
462855|NCT01171339|polypharmacy|polypharmacy
462856|NCT01171339|multimedication|multimedication
462857|NCT01171339|medication appropriateness|medication appropriateness
462858|NCT01171339|medication appropriateness index|medication appropriateness index
462859|NCT01171339|cluster-randomised controlled trial|cluster-randomised controlled trial
462860|NCT01171339|pragmatic trial|pragmatic trial
462861|NCT01171326|topical|topical
462862|NCT01171326|minocycline|minocycline
462863|NCT01171326|foam|foam
462864|NCT01171326|phase II|phase ii
462865|NCT01171326|impetigo|impetigo
462866|NCT01171300|staged T3-4 N0 and T1-4N1-2|staged t3-4 n0 and t1-4n1-2
462867|NCT01171300|adenocarcinoma of the rectum|adenocarcinoma of the rectum
462868|NCT01171300|rectum|rectum
462869|NCT01171287|Automobile Driving|automobile driving
462870|NCT01171287|Fracture Fixation/instrumentation|fracture fixation/instrumentation
462871|NCT01171287|Lower Extremity|lower extremity
462872|NCT01171287|Orthopedic Fixation Devices|orthopedic fixation devices
462873|NCT01171287|Orthopedic Procedures|orthopedic procedures
462874|NCT01171287|Reaction Time|reaction time
462875|NCT01171287|Task Performance and Analysis|task performance and analysis
462876|NCT01171287|Time Factors|time factors
462877|NCT01171274|neck pain|neck pain
462878|NCT01171274|yoga|yoga
462879|NCT01171274|proprioception|proprioception
462880|NCT01171274|sensory thresholds|sensory thresholds
462881|NCT01171274|randomized controlled trial|randomized controlled trial
462882|NCT01171261|Physical Activity|physical activity
462883|NCT01171261|Sedentary Behavior|sedentary behavior
462884|NCT01171261|Video Games|video games
462885|NCT01171261|Exergames|exergames
462886|NCT01171248|nocturnal blood pressure dip|nocturnal blood pressure dip
462887|NCT01171248|complications|complications
462888|NCT01171248|ambulatory blood pressure|ambulatory blood pressure
462889|NCT01171235|Laryngeal Neoplasms|laryngeal neoplasms
462890|NCT01171235|Pharyngeal Neoplasms|pharyngeal neoplasms
462891|NCT01171222|soccer|soccer
462892|NCT01171222|prevention|prevention
462893|NCT01171222|veteran athletes|veteran athletes
462894|NCT01171222|exercise|exercise
462895|NCT01171222|Cardiovascular|cardiovascular
462896|NCT01171209|MS|ms
462897|NCT01171196|Sleep Apnea|sleep apnea
462898|NCT01171196|Questionnaire|questionnaire
462899|NCT01171183|cocaine dependence|cocaine dependence
462900|NCT01171183|cocaine withdrawal|cocaine withdrawal
462901|NCT01171170|non small cell lung cancer|non small cell lung cancer
462902|NCT01171170|stage IV|stage iv
462903|NCT01171170|nitroglycerin|nitroglycerin
462904|NCT01171170|carboplatin|carboplatin
462905|NCT01171170|paclitaxel|paclitaxel
462906|NCT01171170|bevacizumab|bevacizumab
462907|NCT01171157|vaccine effectiveness|vaccine effectiveness
462908|NCT01171157|Influenza-like illness|influenza-like illness
462909|NCT01171157|elderly|elderly
462910|NCT01171157|Influenza|influenza
462911|NCT01171131|TBI|tbi
462912|NCT01171131|Brain Injury|brain injury
462913|NCT01171118|Breathing|breathing
462914|NCT01171118|Sedation|sedation
462915|NCT01171105|AZD5213 Phase 1|azd5213 phase 1
462916|NCT01171105|Safety|safety
462917|NCT01171105|tolerability|tolerability
462918|NCT01171092|stem cell|stem cell
462919|NCT01171092|transplant|transplant
462920|NCT01171092|myeloma|myeloma
462921|NCT01171092|lymphoma|lymphoma
462922|NCT01171092|BMT|bmt
462923|NCT01171092|autologous|autologous
462924|NCT01171079|postoperative adhesion after thyroidectomy|postoperative adhesion after thyroidectomy
462925|NCT01171053|Cognitive behavior therapy|cognitive behavior therapy
462926|NCT01171053|Internet|internet
462927|NCT01171053|Cost-effectiveness|cost-effectiveness
462928|NCT01171053|Irritable bowel syndrome|irritable bowel syndrome
462929|NCT01171040|left atrial distensibility|left atrial distensibility
462930|NCT01171040|mortality|mortality
462931|NCT01171040|heart failure|heart failure
462932|NCT01171040|atrial fibrillation|atrial fibrillation
462933|NCT01171040|stroke|stroke
462934|NCT01171040|prognosis|prognosis
462935|NCT01171027|Cholecystectomy|cholecystectomy
462936|NCT01171027|NOTES|notes
462937|NCT01171027|Transvaginal|transvaginal
462938|NCT01171027|Transgastric|transgastric
462939|NCT01171027|Natural orifice|natural orifice
462940|NCT01171027|Gallbladder removal|gallbladder removal
462941|NCT01170988|patients scheduled for bypass grafting|patients scheduled for bypass grafting
462942|NCT01170975|Advanced solid tumors|advanced solid tumors
462943|NCT01170949|urticaria|urticaria
462944|NCT01170936|Urticarial vasculitis|urticarial vasculitis
462945|NCT01170936|anti-IL1ß therapy|anti-il1ß therapy
462946|NCT01170923|non small cell lung cancer|non small cell lung cancer
462947|NCT01170923|FDG PET|fdg pet
462948|NCT01170910|Chronic renal failure|chronic renal failure
462949|NCT01170910|Transplantation|transplantation
462950|NCT01170910|Marginal kidney graft|marginal kidney graft
462951|NCT01170910|Pulsatile perfusion machine|pulsatile perfusion machine
462952|NCT01170897|PEGPH20|pegph20
462953|NCT01170897|PEGylated Recombinant Human Hyaluronidase|pegylated recombinant human hyaluronidase
462954|NCT01170897|Metastatic or Locally Advanced Solid Tumors|metastatic or locally advanced solid tumors
462955|NCT01170845|Esophagectomy|esophagectomy
462956|NCT01170845|Postoperative respiratory complications|postoperative respiratory complications
462957|NCT01170845|neutrophil elastase inhibitor|neutrophil elastase inhibitor
462958|NCT01170819|Cervical ripening|cervical ripening
462959|NCT01170819|Induction of labor|induction of labor
462960|NCT01170819|Prostaglandins|prostaglandins
462961|NCT01170819|Mechanical methods|mechanical methods
462962|NCT01170819|Balloon catheter|balloon catheter
462963|NCT01170806|Intestinal lipase|intestinal lipase
462964|NCT01170806|Orlistat|orlistat
462965|NCT01170806|fecal fat|fecal fat
462966|NCT01170806|obesity|obesity
462967|NCT01170793|education, quality of life|education, quality of life
462968|NCT01170780|Inguinal hernia|inguinal hernia
462969|NCT01170780|Transabdominal preperitoneal hernia repair|transabdominal preperitoneal hernia repair
462970|NCT01170780|TAPP|tapp
462971|NCT01170780|Dexamethasone|dexamethasone
462972|NCT01170780|Pain|pain
462973|NCT01170767|Age-related Macular Degeneration|age-related macular degeneration
462974|NCT01170767|Bevacizumab|bevacizumab
462975|NCT01170767|Ranibizumab|ranibizumab
462976|NCT01170754|PEG-3350, polyethylene glycol, colonoscopy|peg-3350, polyethylene glycol, colonoscopy
462977|NCT01170728|Male Sling|male sling
462978|NCT01170728|Fixation|fixation
462979|NCT01170728|Stress Urinary Incontinence|stress urinary incontinence
462980|NCT01170728|Urinary incontinence|urinary incontinence
462981|NCT01170715|Psoriasis|psoriasis
462982|NCT01170715|Co morbidities|co morbidities
462983|NCT01170715|Inflammation|inflammation
462984|NCT01170702|Cesarean Delivery|cesarean delivery
462985|NCT01170702|Ropivicaine|ropivicaine
462986|NCT01170702|TAP block|tap block
462987|NCT01170689|Schizophrenia|schizophrenia
462988|NCT01170689|inpatient|inpatient
462989|NCT01170689|obesity|obesity
462990|NCT01170689|prevalence|prevalence
462991|NCT01170676|asthma|asthma
462992|NCT01170676|smoking|smoking
462993|NCT01170676|teens|teens
462994|NCT01170663|Metastatic Adenocarcinoma|metastatic adenocarcinoma
462995|NCT01170663|Gastric Adenocarcinoma|gastric adenocarcinoma
462996|NCT01170663|Gastroesophageal Junction Adenocarcinoma|gastroesophageal junction adenocarcinoma
462997|NCT01170650|cancer|cancer
462998|NCT01170650|ovarian|ovarian
462999|NCT01170650|platinum-resistant|platinum-resistant
463000|NCT01170650|Phase III|phase iii
463001|NCT01170650|EC145|ec145
463002|NCT01170650|EC20|ec20
463003|NCT01170624|PhD|phd
463004|NCT01170624|EGM|egm
463005|NCT01170624|CRT-D|crt-d
463006|NCT01170624|The study will particularly focus on a new-based diagnostic feature, called PhD-Clinical Status (PhD)|the study will particularly focus on a new-based diagnostic feature, called phd-clinical status (phd)
463007|NCT01170598|acute myeloid leukemia|acute myeloid leukemia
463008|NCT01170598|AML|aml
463009|NCT01170598|chemotherapy|chemotherapy
463010|NCT01170598|exercise|exercise
463011|NCT01170598|quality of life|quality of life
463012|NCT01170598|cancer-related fatigue|cancer-related fatigue
463013|NCT01170598|elderly|elderly
463014|NCT01170598|physical fitness|physical fitness
463015|NCT01170598|muscular strength|muscular strength
463016|NCT01170598|Feasibility|feasibility
463017|NCT01170598|Efficacy|efficacy
463018|NCT01170598|Safety|safety
463019|NCT01170546|anterior cruciate ligament|anterior cruciate ligament
463020|NCT01170546|agility|agility
463021|NCT01170546|knee stability|knee stability
463022|NCT01170546|hamstring|hamstring
463023|NCT01170546|knee internal rotator|knee internal rotator
463024|NCT01170533|proton pump inhibitor|proton pump inhibitor
463025|NCT01170533|clopidogrel|clopidogrel
463026|NCT01170533|platelet function|platelet function
463027|NCT01170520|adolescent resistant depression|adolescent resistant depression
463028|NCT01170520|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
463029|NCT01170520|treatment of resistant adolescent depression|treatment of resistant adolescent depression
463030|NCT01170507|vitamin D3, 25 OH vitamin D3 level|vitamin d3, 25 oh vitamin d3 level
463031|NCT01170494|vitamin D2, vitamin D3, 25 Oh vitamin D2, 25 Oh vitamin D3|vitamin d2, vitamin d3, 25 oh vitamin d2, 25 oh vitamin d3
463032|NCT01170481|anterior and intermediate uveitis|anterior and intermediate uveitis
463033|NCT01170481|papilloedema|papilloedema
463034|NCT01170468|Prediabetics|prediabetics
463035|NCT01170468|DM|dm
463036|NCT01170468|vitamin D|vitamin d
463037|NCT01170455|nasal|nasal
463038|NCT01170455|intubation|intubation
463039|NCT01170455|direct laryngoscope|direct laryngoscope
463040|NCT01170455|blind|blind
463041|NCT01170455|normal airway|normal airway
463042|NCT01170429|Cough Variant Asthma|cough variant asthma
463043|NCT01170429|Procaterol Hydrochloride|procaterol hydrochloride
463044|NCT01170416|Ventricular Tachycardia|ventricular tachycardia
463045|NCT01170416|Body Surface Mapping|body surface mapping
463046|NCT01170403|coronary heart disease|coronary heart disease
463047|NCT01170403|Multidetector row cardiac computed tomography|multidetector row cardiac computed tomography
463048|NCT01170403|type 2 diabetes|type 2 diabetes
463049|NCT01170403|metabolic syndrome|metabolic syndrome
463050|NCT01170390|Obesity|obesity
463051|NCT01170390|Body weight|body weight
463052|NCT01170390|Oral contraception|oral contraception
463053|NCT01170390|Efficacy|efficacy
463054|NCT01170377|Intravenous sedation|intravenous sedation
463055|NCT01170377|Dental treatment|dental treatment
463056|NCT01170377|Mental retardation|mental retardation
463057|NCT01170377|Antiepileptic drug|antiepileptic drug
463058|NCT01170377|Valproate|valproate
463059|NCT01170377|Propofol|propofol
463060|NCT01170364|Obesity|obesity
463061|NCT01170364|sibutramine|sibutramine
463062|NCT01170364|eating behavior|eating behavior
463063|NCT01170351|autoimmune hepatitis|autoimmune hepatitis
463064|NCT01170351|corticosteroids|corticosteroids
463065|NCT01170351|cysclosporine-A|cysclosporine-a
463066|NCT01170351|treatment|treatment
463067|NCT01170351|treatment-naive|treatment-naive
463068|NCT01170351|induction of remossion|induction of remossion
463069|NCT01170351|efficacy|efficacy
463070|NCT01170351|tolerability|tolerability
463071|NCT01170338|smoking|smoking
463072|NCT01170338|tobacco abuse|tobacco abuse
463073|NCT01170325|Valproic Acid|valproic acid
463074|NCT01170325|Divalproex|divalproex
463075|NCT01170325|Autism|autism
463076|NCT01170325|EEG|eeg
463077|NCT01170325|Electroencephalogram (EEG)|electroencephalogram (eeg)
463078|NCT01170325|Depakote|depakote
463079|NCT01170312|Arthroscopic repair|arthroscopic repair
463080|NCT01170312|Rotator cuff|rotator cuff
463081|NCT01170312|Platelet rich plasma|platelet rich plasma
463082|NCT01170312|Randomized|randomized
463083|NCT01170312|Pilot|pilot
463084|NCT01170299|radiation toxicity|radiation toxicity
463085|NCT01170299|gastrointestinal complications|gastrointestinal complications
463086|NCT01170299|cervical cancer|cervical cancer
463087|NCT01170299|fallopian tube cancer|fallopian tube cancer
463088|NCT01170299|ovarian epithelial cancer|ovarian epithelial cancer
463089|NCT01170299|ovarian germ cell tumor|ovarian germ cell tumor
463090|NCT01170299|ovarian sarcoma|ovarian sarcoma
463091|NCT01170299|ovarian stromal cancer|ovarian stromal cancer
463092|NCT01170299|uterine sarcoma|uterine sarcoma
463093|NCT01170299|bladder cancer|bladder cancer
463094|NCT01170299|colon cancer|colon cancer
463095|NCT01170299|rectal cancer|rectal cancer
463096|NCT01170299|anal cancer|anal cancer
463097|NCT01170286|Food allergy|food allergy
463098|NCT01170286|Immediate hypersensitivity|immediate hypersensitivity
463099|NCT01170286|Whole peanut extract|whole peanut extract
463100|NCT01170286|Allergenic product|allergenic product
463101|NCT01170286|Specific Immunotherapy|specific immunotherapy
463296|NCT01169376|disseminated neuroblastoma|disseminated neuroblastoma
463102|NCT01170286|Epicutaneous Immunotherapy (EPIT)|epicutaneous immunotherapy (epit)
463103|NCT01170286|Safety|safety
463104|NCT01170273|aged|aged
463105|NCT01170273|vitamin d deficiency|vitamin d deficiency
463106|NCT01170247|Procedural Sedation|procedural sedation
463107|NCT01170234|Exhaled nitric oxide|exhaled nitric oxide
463108|NCT01170234|Eosinophilic esophagitis|eosinophilic esophagitis
463109|NCT01170221|ABSSSI|absssi
463110|NCT01170221|Tedizolid Phosphate|tedizolid phosphate
463111|NCT01170221|TR-701|tr-701
463112|NCT01170221|Acute Bacterial Skin and Skin Structure Infections|acute bacterial skin and skin structure infections
463113|NCT01170208|insulin|insulin
463114|NCT01170208|dosage software|dosage software
463115|NCT01170195|Postmenopausal|postmenopausal
463116|NCT01170195|licorice|licorice
463117|NCT01170195|vaginal complaints|vaginal complaints
463118|NCT01170156|deep sedation|deep sedation
463119|NCT01170156|respiratory resuscitation|respiratory resuscitation
463120|NCT01170156|Hi-Lo Evac tube|hi-lo evac tube
463121|NCT01170156|suctioning manoeuvre|suctioning manoeuvre
463122|NCT01170143|IIB-IIIB Breast Cancer|iib-iiib breast cancer
463123|NCT01170143|Her2 positive|her2 positive
463124|NCT01170130|Cataract|cataract
463125|NCT01170130|Mydriasis|mydriasis
463126|NCT01170130|Lidocaine|lidocaine
463127|NCT01170117|Eating Disorders|eating disorders
463128|NCT01170117|Anorexia Nervosa|anorexia nervosa
463129|NCT01170104|Hepatocellular Carcinoma|hepatocellular carcinoma
463130|NCT01170104|Sorafenib|sorafenib
463131|NCT01170104|TACE|tace
463132|NCT01170104|locally, advanced Hepatocellular Carcinoma|locally, advanced hepatocellular carcinoma
463133|NCT01170078|chronic renal failure requiring hemodialysis|chronic renal failure requiring hemodialysis
463134|NCT01170052|Relapsed Mantle Cell Lymphoma|relapsed mantle cell lymphoma
463135|NCT01170052|Refractory Mantle Cell Lymphoma|refractory mantle cell lymphoma
463136|NCT01170052|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
463137|NCT01170052|Temsirolimus|temsirolimus
463138|NCT01170052|Bendamustine|bendamustine
463139|NCT01170052|Phase 1/2|phase 1/2
463140|NCT01170039|Constipation|constipation
463141|NCT01170039|Diabetes|diabetes
463142|NCT01170039|Lubiprostone|lubiprostone
463143|NCT01170039|Amitiza|amitiza
463144|NCT01170039|African Americans|african americans
463145|NCT01170026|substance use|substance use
463146|NCT01170026|adolescents|adolescents
463147|NCT01170026|intervention|intervention
463148|NCT01170026|truancy|truancy
463149|NCT01170026|sexual risk behavior|sexual risk behavior
463150|NCT01170013|substance use|substance use
463151|NCT01170013|adolescents|adolescents
463152|NCT01170013|initiation|initiation
463153|NCT01169987|Multicenter study|multicenter study
463154|NCT01169974|Microcirculation|microcirculation
463155|NCT01169974|laser flowmetry|laser flowmetry
463156|NCT01169974|Skin|skin
463157|NCT01169974|Physiology|physiology
463158|NCT01169961|IRON OVERLOAD IN HEMODIALYSIS PATIENTS|iron overload in hemodialysis patients
463159|NCT01169948|Coronary disease|coronary disease
463160|NCT01169948|Coronary artery bypass|coronary artery bypass
463161|NCT01169948|Cardiac surgery|cardiac surgery
463162|NCT01169948|Computed tomography|computed tomography
463163|NCT01169948|Coronary angiography|coronary angiography
463164|NCT01169935|MRI|mri
463165|NCT01169935|SPIO|spio
463166|NCT01169935|Healthy Volunteer|healthy volunteer
463167|NCT01169909|Pterygium|pterygium
463168|NCT01169896|Impact of ventricular pacing on the incidence of VT/VF episodes for each models|impact of ventricular pacing on the incidence of vt/vf episodes for each models
463169|NCT01169883|adherence|adherence
463170|NCT01169883|asthma|asthma
463171|NCT01169883|pediatrics|pediatrics
463172|NCT01169883|behavioral intervention|behavioral intervention
463173|NCT01169883|inner city|inner city
463174|NCT01169870|metastatic|metastatic
463175|NCT01169857|Proliferative lupus nephritis|proliferative lupus nephritis
463176|NCT01169857|WHO class III/IV/V lupus nephritis|who class iii/iv/v lupus nephritis
463177|NCT01169857|Proteinuria|proteinuria
463178|NCT01169857|Hematuria|hematuria
463179|NCT01169857|Velcade|velcade
463180|NCT01169857|SLE|sle
463181|NCT01169857|Bortezomib|bortezomib
463182|NCT01169857|Proteasome inhibitor|proteasome inhibitor
463183|NCT01169844|Psoriatic arthritis|psoriatic arthritis
463184|NCT01169844|IgG1K monoclonal antibody|igg1k monoclonal antibody
463185|NCT01169844|Interleukin -17A neutralizing|interleukin -17a neutralizing
463186|NCT01169792|Tamoxifen|tamoxifen
463187|NCT01169792|Cytochrome P-450 CYP2D6|cytochrome p-450 cyp2d6
463188|NCT01169792|Polymorphism|polymorphism
463189|NCT01169792|Single nucleotide|single nucleotide
463190|NCT01169792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal
463191|NCT01169753|Chronic Myeloid Leukemia|chronic myeloid leukemia
463192|NCT01169753|CML|cml
463193|NCT01169753|Nuvigil|nuvigil
463194|NCT01169753|Armodafinil|armodafinil
463195|NCT01169753|Fatigue|fatigue
463196|NCT01169740|Hyperbilirubinemia|hyperbilirubinemia
463197|NCT01169740|Neonatal|neonatal
463198|NCT01169740|Serum bilirubin|serum bilirubin
463199|NCT01169740|Transcutaneous bilirubin|transcutaneous bilirubin
463200|NCT01169740|Skin color|skin color
463201|NCT01169727|COPD and CCQ score|copd and ccq score
463202|NCT01169727|Changes in PEF,overall CCQ score|changes in pef,overall ccq score
463203|NCT01169714|multiple dose|multiple dose
463204|NCT01169714|healthy volunteer|healthy volunteer
463205|NCT01169714|healthy elderly volunteer|healthy elderly volunteer
463206|NCT01169714|safety|safety
463207|NCT01169714|pharmacokinetic|pharmacokinetic
463208|NCT01169701|Renal transplant, everolimus, cardiovascular profile, CNI-free immunosuppression, left ventricular hypertrophy, biopsy proved acute rejection (BPAR)|renal transplant, everolimus, cardiovascular profile, cni-free immunosuppression, left ventricular hypertrophy, biopsy proved acute rejection (bpar)
463209|NCT01169688|Cataract Surgery|cataract surgery
463210|NCT01169688|Pupillary Dilation|pupillary dilation
463211|NCT01169649|MK-2206|mk-2206
463212|NCT01169649|Neuroendocrine Tumors|neuroendocrine tumors
463213|NCT01169649|10-067|10-067
463214|NCT01169636|Chemotherapy|chemotherapy
463215|NCT01169636|Panobinostat|panobinostat
463216|NCT01169636|Ifosfamide|ifosfamide
463217|NCT01169636|Mesna|mesna
463218|NCT01169636|Etoposide|etoposide
463219|NCT01169636|Carboplatin|carboplatin
463220|NCT01169636|Pegfilgrastim|pegfilgrastim
463221|NCT01169636|ICE|ice
463222|NCT01169623|Supportive leadership behaviour|supportive leadership behaviour
463223|NCT01169623|Nurse Performance|nurse performance
463224|NCT01169623|Educational Intervention|educational intervention
463225|NCT01169610|Alcohol|alcohol
463226|NCT01169610|Smoking|smoking
463227|NCT01169597|polymyalgia rheumatica|polymyalgia rheumatica
463228|NCT01169597|prednisone|prednisone
463229|NCT01169597|clinical examination|clinical examination
463230|NCT01169597|remission|remission
463231|NCT01169597|ultrasonography|ultrasonography
463232|NCT01169584|Phase I|phase i
463233|NCT01169584|advanced metastatic pediatric solid tumors|advanced metastatic pediatric solid tumors
463234|NCT01169584|pediatric|pediatric
463235|NCT01169584|vaccinia virus|vaccinia virus
463236|NCT01169584|oncolytic virus|oncolytic virus
463237|NCT01169584|neuroblastoma|neuroblastoma
463238|NCT01169584|rhabdomyosarcoma|rhabdomyosarcoma
463239|NCT01169584|lymphoma|lymphoma
463240|NCT01169584|Wilm's tumor|wilm's tumor
463241|NCT01169584|Ewing's sarcoma|ewing's sarcoma
463242|NCT01169584|osteosarcoma|osteosarcoma
463243|NCT01169584|non-rhabdomyosarcoma soft tissue sarcomas|non-rhabdomyosarcoma soft tissue sarcomas
463244|NCT01169584|malignant peripheral nerve sheath tumors|malignant peripheral nerve sheath tumors
463245|NCT01169584|Pexa-Vec|pexa-vec
463246|NCT01169571|Initially intubated|initially intubated
463247|NCT01169571|Mechanically ventilated|mechanically ventilated
463248|NCT01169571|Post-surgical|post-surgical
463249|NCT01169545|any type of cancer|any type of cancer
463250|NCT01169519|Hypoplastic left heart syndrome|hypoplastic left heart syndrome
463251|NCT01169519|Hypoplastic right heart syndrome|hypoplastic right heart syndrome
463252|NCT01169519|Superior cavopulmonary anastomosis|superior cavopulmonary anastomosis
463253|NCT01169519|Total cavopulmonary anastomosis|total cavopulmonary anastomosis
463254|NCT01169519|Children with single ventricle anatomy|children with single ventricle anatomy
463255|NCT01169506|blood gas analysis|blood gas analysis
463256|NCT01169506|ventilatory insufficiency|ventilatory insufficiency
463257|NCT01169493|Heart Failure|heart failure
463258|NCT01169493|Right Bundle-Branch Block|right bundle-branch block
463259|NCT01169493|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
463260|NCT01169480|Massage|massage
463261|NCT01169480|Therapist, Massage|therapist, massage
463262|NCT01169480|DASS|dass
463263|NCT01169480|Depression|depression
463264|NCT01169480|Anxiety, State|anxiety, state
463265|NCT01169480|Anxiety, Trait|anxiety, trait
463266|NCT01169480|Stress|stress
463267|NCT01169480|Touch|touch
463268|NCT01169480|Therapeutic Relationship|therapeutic relationship
463269|NCT01169454|Cerebral Spinal Fluid|cerebral spinal fluid
463270|NCT01169454|Ventriculostomy|ventriculostomy
463271|NCT01169454|Subarachnoid hemorrhage|subarachnoid hemorrhage
463272|NCT01169454|Vasospasm|vasospasm
463273|NCT01169454|Human Subjects|human subjects
463274|NCT01169441|ICD leads|icd leads
463275|NCT01169441|Removal|removal
463276|NCT01169441|Extraction|extraction
463277|NCT01169441|Ventricular leads|ventricular leads
463278|NCT01169441|Extract|extract
463279|NCT01169441|laser|laser
463280|NCT01169441|Observe the lead with x-ray during movement and collect information on current ways of removing an ICD lead.|observe the lead with x-ray during movement and collect information on current ways of removing an icd lead.
463281|NCT01169428|Mindfulness-Based Weight Loss Maintenance|mindfulness-based weight loss maintenance
463282|NCT01169428|prevention of weight regain|prevention of weight regain
463283|NCT01169428|Obesity|obesity
463284|NCT01169415|Randomized|randomized
463285|NCT01169415|Dexamethasone|dexamethasone
463286|NCT01169415|Abbreviated|abbreviated
463287|NCT01169415|Protracted|protracted
463288|NCT01169415|Post-operatively|post-operatively
463289|NCT01169402|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
463290|NCT01169402|ECMO|ecmo
463291|NCT01169402|extracorporeal life support|extracorporeal life support
463292|NCT01169402|fluconazole|fluconazole
463293|NCT01169402|diflucan|diflucan
463294|NCT01169402|pharmacokinetics|pharmacokinetics
463295|NCT01169402|pharmacodynamics|pharmacodynamics
463297|NCT01169376|localized resectable neuroblastoma|localized resectable neuroblastoma
463298|NCT01169376|localized unresectable neuroblastoma|localized unresectable neuroblastoma
463299|NCT01169376|regional neuroblastoma|regional neuroblastoma
463300|NCT01169376|stage 4S neuroblastoma|stage 4s neuroblastoma
463301|NCT01169363|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
463302|NCT01169363|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
463303|NCT01169363|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
463304|NCT01169363|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
463305|NCT01169363|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
463306|NCT01169363|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
463307|NCT01169363|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
463308|NCT01169363|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
463309|NCT01169363|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
463310|NCT01169363|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
463311|NCT01169363|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
463312|NCT01169363|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
463313|NCT01169363|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
463314|NCT01169363|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
463315|NCT01169363|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
463316|NCT01169363|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
463317|NCT01169324|Parkinson's disease|parkinson's disease
463318|NCT01169324|Tremor|tremor
463319|NCT01169324|Dystonia|dystonia
463320|NCT01169324|DBS|dbs
463321|NCT01169324|Sleep|sleep
463322|NCT01169311|Hemorrhoids|hemorrhoids
463323|NCT01169311|Hemorrhoid|hemorrhoid
463324|NCT01169311|grade II, III, IV|grade ii, iii, iv
463325|NCT01169298|Adult T-cell Leukemia-Lymphoma|adult t-cell leukemia-lymphoma
463326|NCT01169298|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
463327|NCT01169298|PTCL|ptcl
463328|NCT01169298|HTLV-1|htlv-1
463329|NCT01169285|Burn Department Nursing Staff|burn department nursing staff
463330|NCT01169272|ICD CRT 9770 - PARADYM RF ICD - SonR atrial lead|icd crt 9770 - paradym rf icd - sonr atrial lead
463331|NCT01169259|vitamin D3|vitamin d3
463332|NCT01169259|omega-3 fatty acids|omega-3 fatty acids
463333|NCT01169259|fish oil|fish oil
463334|NCT01169259|cardiovascular disease|cardiovascular disease
463335|NCT01169259|cancer|cancer
463336|NCT01169259|primary prevention|primary prevention
463337|NCT01169246|ATP,CRT, ICD PARADYM|atp,crt, icd paradym
463338|NCT01169233|Sleep|sleep
463339|NCT01169233|Alertness|alertness
463340|NCT01169233|fatigue|fatigue
463341|NCT01169233|performance|performance
463342|NCT01169233|spaceflight|spaceflight
463343|NCT01169233|isolation|isolation
463344|NCT01169233|light|light
463345|NCT01169233|Sleep , alertness and performance during a simulated spaceflight mission|sleep , alertness and performance during a simulated spaceflight mission
463346|NCT01169220|Colonoscopy|colonoscopy
463347|NCT01169220|Bowel preparation|bowel preparation
463348|NCT01169207|Inflammatory Bowel Disease|inflammatory bowel disease
463349|NCT01169207|Crohn's Disease|crohn's disease
463350|NCT01169207|Ulcerative Colitis|ulcerative colitis
463351|NCT01169207|Indeterminate Colitis|indeterminate colitis
463352|NCT01169207|IBD|ibd
463353|NCT01169207|CD|cd
463354|NCT01169207|UC|uc
463355|NCT01169207|IC|ic
463356|NCT01169194|Inflammatory Bowel Disease|inflammatory bowel disease
463357|NCT01169194|Crohn's Disease|crohn's disease
463358|NCT01169194|Ulcerative Colitis|ulcerative colitis
463359|NCT01169194|Indeterminate Colitis|indeterminate colitis
463360|NCT01169194|IBD|ibd
463361|NCT01169194|CD|cd
463362|NCT01169194|UC|uc
463363|NCT01169194|IC|ic
463364|NCT01169194|African American IBD|african american ibd
463365|NCT01169194|African American CD|african american cd
463366|NCT01169194|African American UC|african american uc
463367|NCT01169194|African American IC|african american ic
463368|NCT01169194|Black IBD|black ibd
463369|NCT01169194|Black CD|black cd
463370|NCT01169194|Black UC|black uc
463371|NCT01169194|Black IC|black ic
463372|NCT01169194|African American Inflammatory Bowel Disease|african american inflammatory bowel disease
463373|NCT01169194|African American Crohn's Disease|african american crohn's disease
463374|NCT01169194|African American Ulcerative Colitis|african american ulcerative colitis
463375|NCT01169194|African American Indeterminate Colitis|african american indeterminate colitis
463376|NCT01169194|Black Inflammatory Bowel Disease|black inflammatory bowel disease
463377|NCT01169194|Black Crohn's Disease|black crohn's disease
463378|NCT01169194|Black Ulcerative Colitis|black ulcerative colitis
463379|NCT01169194|Black Indeterminate Colitis|black indeterminate colitis
463380|NCT01169181|Stroke|stroke
463381|NCT01169181|Cerebrovascular Accident|cerebrovascular accident
463382|NCT01169181|Plegia|plegia
463383|NCT01169181|Upper Extremity|upper extremity
463384|NCT01169181|rTMS|rtms
463385|NCT01169181|tDCS|tdcs
463386|NCT01169168|fibrinogen|fibrinogen
463387|NCT01169168|SIRS|sirs
463388|NCT01169168|sepsis|sepsis
463389|NCT01169168|liver disease|liver disease
463390|NCT01169168|chronic liver disease|chronic liver disease
463391|NCT01169168|septic shock|septic shock
463392|NCT01169155|Smoke inhalation injury|smoke inhalation injury
463393|NCT01169155|Burns|burns
463394|NCT01169155|Injuries|injuries
463395|NCT01169142|Vitamin D|vitamin d
463396|NCT01169142|Schizophrenia|schizophrenia
463397|NCT01169142|Severely Mentally Ill|severely mentally ill
463398|NCT01169129|brain metastases|brain metastases
463399|NCT01169129|radiosurgery|radiosurgery
463400|NCT01169129|neurosurgery|neurosurgery
463401|NCT01169129|surgery|surgery
463402|NCT01169129|radiotherapy|radiotherapy
463403|NCT01169129|resectable brain metastases|resectable brain metastases
463404|NCT01169116|radiotherapy|radiotherapy
463405|NCT01169116|radiation oncology|radiation oncology
463406|NCT01169116|brain metastasis|brain metastasis
463407|NCT01169116|metastases|metastases
463408|NCT01169116|radiosurgery|radiosurgery
463409|NCT01169116|neurosurgery|neurosurgery
463410|NCT01169116|hypofractionation|hypofractionation
463411|NCT01169116|stereotaxy|stereotaxy
463412|NCT01169103|Obesity|obesity
463413|NCT01169103|Adolescent|adolescent
463414|NCT01169103|Insulin resistance|insulin resistance
463415|NCT01169103|Growth hormone|growth hormone
463416|NCT01169103|Visceral fat|visceral fat
463417|NCT01169103|Adolescent obesity|adolescent obesity
463418|NCT01169077|malaria, plasmodium falciparum, electroporation|malaria, plasmodium falciparum, electroporation
463419|NCT01169064|Wound infection prevention|wound infection prevention
463420|NCT01169064|Silver-containing surgical dressing|silver-containing surgical dressing
463421|NCT01169064|Cesarean delivery infection prevention|cesarean delivery infection prevention
463422|NCT01169051|Esophagectomy|esophagectomy
463423|NCT01169051|Pulmonary wedge resection|pulmonary wedge resection
463424|NCT01169051|Pulmonary lobectomy|pulmonary lobectomy
463425|NCT01169051|Pulmonary pneumonectomy|pulmonary pneumonectomy
463426|NCT01169051|Thoracic Surgery|thoracic surgery
463427|NCT01169051|Lung Cancer|lung cancer
463428|NCT01169051|Esophageal Cancer|esophageal cancer
463429|NCT01169038|sarcoidosis|sarcoidosis
463430|NCT01169038|mycobacteria|mycobacteria
463431|NCT01169038|lung|lung
463432|NCT01169038|pulmonary|pulmonary
463433|NCT01169038|radiographic improvement|radiographic improvement
463434|NCT01169025|Analgesia|analgesia
463435|NCT01169025|Pain|pain
463436|NCT01169012|Myelodysplastic syndrome|myelodysplastic syndrome
463437|NCT01169012|Acute Myeloid Leukemia|acute myeloid leukemia
463438|NCT01169012|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
463439|NCT01169012|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
463440|NCT01169012|Clofarabine|clofarabine
463441|NCT01169012|Clolar|clolar
463442|NCT01169012|University of North Carolina at Chapel Hill|university of north carolina at chapel hill
463443|NCT01169012|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
463444|NCT01168999|low back pain|low back pain
463445|NCT01168999|spinal manipulation|spinal manipulation
463446|NCT01168999|manual therapy|manual therapy
463447|NCT01168999|placebo|placebo
463448|NCT01168986|neck pain|neck pain
463449|NCT01168986|manual therapy|manual therapy
463450|NCT01168986|exercise|exercise
463451|NCT01168973|second line|second line
463452|NCT01168973|non small cell lung cancer|non small cell lung cancer
463453|NCT01168973|NSCLC|nsclc
463454|NCT01168973|phase 3|phase 3
463455|NCT01168973|ramucirumab|ramucirumab
463456|NCT01168973|lung cancer|lung cancer
463457|NCT01168973|docetaxel|docetaxel
463458|NCT01168973|taxotere|taxotere
463459|NCT01168947|sodium|sodium
463460|NCT01168947|hypertension|hypertension
463461|NCT01168947|fluid overload|fluid overload
463462|NCT01168947|hemodialysis|hemodialysis
463463|NCT01168947|dialysate|dialysate
463464|NCT01168947|interdialytic weight gain|interdialytic weight gain
463465|NCT01168947|intradialytic hypotension|intradialytic hypotension
463466|NCT01168934|healthy volunteers|healthy volunteers
463467|NCT01168934|crizotinib|crizotinib
463468|NCT01168934|absolute bioavailability|absolute bioavailability
463469|NCT01168934|pharmacokinetics|pharmacokinetics
463470|NCT01168921|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
463471|NCT01168921|CLL|cll
463472|NCT01168921|Thrombocytopenia|thrombocytopenia
463473|NCT01168921|Small lymphocytic lymphoma|small lymphocytic lymphoma
463474|NCT01168921|SLL|sll
463475|NCT01168921|Eltrombopag|eltrombopag
463476|NCT01168921|Promacta|promacta
463477|NCT01168921|thrombopoietin (TPO)-receptor agonist|thrombopoietin (tpo)-receptor agonist
463478|NCT01168921|platelets|platelets
463479|NCT01168908|Clinical trial|clinical trial
463480|NCT01168908|Revatio|revatio
463481|NCT01168908|Sildenafil|sildenafil
463482|NCT01168908|Muscular Dystrophy|muscular dystrophy
463483|NCT01168908|Duchenne|duchenne
463484|NCT01168908|Becker|becker
463485|NCT01168908|Adult|adult
463486|NCT01168908|Adolescent|adolescent
463487|NCT01168895|75 mg dose strength|75 mg dose strength
463488|NCT01168895|Safety|safety
463489|NCT01168895|Pharmacokinetics|pharmacokinetics
463490|NCT01168882|RGB-286638|rgb-286638
463491|NCT01168882|Hematological Malignancies|hematological malignancies
463492|NCT01168869|Manifestation|manifestation
463493|NCT01168869|Coronary Heart Disease|coronary heart disease
463494|NCT01168869|Myocardial infarction|myocardial infarction
463495|NCT01168869|Angina pectoris|angina pectoris
463496|NCT01168869|Unheralded|unheralded
463497|NCT01168869|General Practice Research Database|general practice research database
463498|NCT01168869|Myocardial Ischaemia National Audit Project|myocardial ischaemia national audit project
463499|NCT01168869|CALIBER|caliber
463500|NCT01168817|Combination Drug Therapy|combination drug therapy
463501|NCT01168817|Phosphodiesterase inhibitors|phosphodiesterase inhibitors
463502|NCT01168804|multiple myeloma|multiple myeloma
463503|NCT01168804|bendamustine|bendamustine
463504|NCT01168804|bortezomib|bortezomib
463505|NCT01168804|dexamethasone|dexamethasone
463506|NCT01168791|Metastatic|metastatic
463507|NCT01168791|Front line|front line
463508|NCT01168765|Physical Activity, Mexican-American, Obesity, Diabetes, Nutrition, Border Health|physical activity, mexican-american, obesity, diabetes, nutrition, border health
463509|NCT01168752|Cancer|cancer
463510|NCT01168752|solid tumour|solid tumour
463511|NCT01168752|lymphoma|lymphoma
463512|NCT01168752|dose-escalation|dose-escalation
463513|NCT01168752|Hsp90 inhibitor|hsp90 inhibitor
463514|NCT01168739|thermotolerance|thermotolerance
463515|NCT01168739|heat acclimation|heat acclimation
463516|NCT01168739|quercetin|quercetin
463517|NCT01168739|exertional heat illness|exertional heat illness
463518|NCT01168739|gastrointestinal barrier permeability|gastrointestinal barrier permeability
463519|NCT01168713|Adults with Community-Acquired Bacterial Pneumonia|adults with community-acquired bacterial pneumonia
463520|NCT01168700|Metabolic syndrome, Aged Garlic Extract, Insulin, inflammation, endothelium.|metabolic syndrome, aged garlic extract, insulin, inflammation, endothelium.
463521|NCT01168687|keppra|keppra
463522|NCT01168687|levetiracetam|levetiracetam
463523|NCT01168687|alcoholism|alcoholism
463524|NCT01168687|genetics|genetics
463525|NCT01168687|subjective report|subjective report
463526|NCT01168674|Major Depressive Disorder|major depressive disorder
463527|NCT01168674|MDD|mdd
463528|NCT01168674|Bipolar Disorder|bipolar disorder
463529|NCT01168674|BD|bd
463530|NCT01168674|Depression|depression
463531|NCT01168674|Major Depressive Disorder with Bipolar features|major depressive disorder with bipolar features
463532|NCT01168661|Stress|stress
463533|NCT01168661|Burnout|burnout
463534|NCT01168661|Anxiety|anxiety
463535|NCT01168661|Depression|depression
463536|NCT01168648|Yoga|yoga
463537|NCT01168648|Stress|stress
463538|NCT01168648|Stress management|stress management
463539|NCT01168648|Hypothalamus-pituitary-adrenal axis|hypothalamus-pituitary-adrenal axis
463540|NCT01168635|Asthma|asthma
463541|NCT01168635|Spirometry|spirometry
463542|NCT01168635|Pediatric|pediatric
463543|NCT01168635|Primary Health Care|primary health care
463544|NCT01168635|Education, Distance|education, distance
463545|NCT01168609|Left atrial distensibility|left atrial distensibility
463546|NCT01168609|left ventricular filling pressure|left ventricular filling pressure
463547|NCT01168609|tissue Doppler|tissue doppler
463548|NCT01168609|prognosis|prognosis
463549|NCT01168609|acute myocardial infarction|acute myocardial infarction
463550|NCT01168596|Parkinson's Disease|parkinson's disease
463551|NCT01168596|Fatigue|fatigue
463552|NCT01168570|familial Mediterranean fever|familial mediterranean fever
463553|NCT01168570|amyloidosis AA|amyloidosis aa
463554|NCT01168570|serum amyloid A|serum amyloid a
463555|NCT01168570|renal failure|renal failure
463556|NCT01168570|nephrotic syndrome|nephrotic syndrome
463557|NCT01168557|electric impedance tomography|electric impedance tomography
463558|NCT01168557|stress-echocardiography|stress-echocardiography
463559|NCT01168557|ventilation|ventilation
463560|NCT01168557|perfusion|perfusion
463561|NCT01168544|Vitamin D|vitamin d
463562|NCT01168544|Colecalciferol|colecalciferol
463563|NCT01168544|Nursing home|nursing home
463564|NCT01168544|Loading dose|loading dose
463565|NCT01168531|patients undergoing lumbar spinal surgery|patients undergoing lumbar spinal surgery
463566|NCT01168518|Evaluate the Sorin Group new passive- and active- fixation pacing leads|evaluate the sorin group new passive- and active- fixation pacing leads
463567|NCT01168492|pediatric|pediatric
463568|NCT01168492|gastroscopy|gastroscopy
463569|NCT01168492|colonoscopy|colonoscopy
463570|NCT01168492|sedation|sedation
463571|NCT01168492|ketamine|ketamine
463572|NCT01168479|prostate cancer|prostate cancer
463573|NCT01168479|external beam radiotherapy|external beam radiotherapy
463574|NCT01168479|dose escalation|dose escalation
463575|NCT01168479|dose painting|dose painting
463576|NCT01168479|95Gy in 35 fractions|95gy in 35 fractions
463577|NCT01168479|MRI|mri
463578|NCT01168479|FLAME|flame
463579|NCT01168466|Frontotemporal Lobar Degeneration|frontotemporal lobar degeneration
463580|NCT01168466|EEG Biofeedback|eeg biofeedback
463581|NCT01168466|Cerebral oxygenation biofeedback|cerebral oxygenation biofeedback
463582|NCT01168466|Frontotemporal Dementia|frontotemporal dementia
463583|NCT01168466|Peak Alpha Amplitude|peak alpha amplitude
463676|NCT01167985|bacteria|bacteria
463584|NCT01168466|Quantitative EEG Assessment|quantitative eeg assessment
463585|NCT01168453|jugular vein|jugular vein
463586|NCT01168453|anatomy|anatomy
463587|NCT01168453|ultrasonography|ultrasonography
463588|NCT01168440|von Hippel-Lindau|von hippel-lindau
463589|NCT01168440|VHL|vhl
463590|NCT01168440|sunitinib|sunitinib
463591|NCT01168401|Prevention of acute gastroenteritis due to infection with noroviruses|prevention of acute gastroenteritis due to infection with noroviruses
463592|NCT01168388|Dystonia|dystonia
463593|NCT01168388|Hemifacial spasm|hemifacial spasm
463594|NCT01168388|Cervical dystonia|cervical dystonia
463595|NCT01168388|Blepharospasm|blepharospasm
463596|NCT01168362|coronary artery disease|coronary artery disease
463597|NCT01168362|cardiovascular risk|cardiovascular risk
463598|NCT01168362|pericardial fat|pericardial fat
463599|NCT01168336|betahistine olanzapine weight sleepiness|betahistine olanzapine weight sleepiness
463600|NCT01168336|olanzapine induced weight gain and sleepiness|olanzapine induced weight gain and sleepiness
463601|NCT01168323|Medical Education|medical education
463602|NCT01168323|Educational Technology|educational technology
463603|NCT01168323|Clinical Practice Guideline|clinical practice guideline
463604|NCT01168323|Prostate specific antigen|prostate specific antigen
463605|NCT01168310|Pulmonary, Obstructive, lungs, COPD|pulmonary, obstructive, lungs, copd
463606|NCT01168297|Obesity|obesity
463607|NCT01168297|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
463608|NCT01168297|Genetics|genetics
463609|NCT01168297|Energy Expenditure|energy expenditure
463610|NCT01168297|Physical Activity|physical activity
463611|NCT01168284|Autism Spectrum Disorders|autism spectrum disorders
463612|NCT01168271|Observational|observational
463613|NCT01168271|Newborns|newborns
463614|NCT01168271|Hospitalized|hospitalized
463615|NCT01168271|Febrile|febrile
463616|NCT01168271|Resistance|resistance
463617|NCT01168258|Diabetic Retinopathy|diabetic retinopathy
463618|NCT01168258|Diabetes|diabetes
463619|NCT01168258|Single Nucleotide Polymorphism (SNP)|single nucleotide polymorphism (snp)
463620|NCT01168258|Diabetic Macular Edema|diabetic macular edema
463621|NCT01168245|Alzheimer Disease|alzheimer disease
463622|NCT01168245|Dementia|dementia
463623|NCT01168245|Brain Diseases|brain diseases
463624|NCT01168245|Central Nervous System Diseases|central nervous system diseases
463625|NCT01168245|Nervous System Disease|nervous system disease
463626|NCT01168245|Cognitive Training|cognitive training
463627|NCT01168245|Cortical Reorganization|cortical reorganization
463628|NCT01168245|Brain Plasticity|brain plasticity
463629|NCT01168193|surgery|surgery
463630|NCT01168193|post operative|post operative
463631|NCT01168193|complications|complications
463632|NCT01168193|length of stay|length of stay
463633|NCT01168180|Traditional Thai Massage|traditional thai massage
463634|NCT01168180|Scapulocostal Syndrome|scapulocostal syndrome
463635|NCT01168167|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
463636|NCT01168167|MK 0518|mk 0518
463637|NCT01168167|HIV-1 DNA species|hiv-1 dna species
463638|NCT01168167|viral slope|viral slope
463639|NCT01168167|Ribonucleic Acid|ribonucleic acid
463640|NCT01168167|DNA, Complementary|dna, complementary
463641|NCT01168154|Diverticula|diverticula
463642|NCT01168154|Diverticular disease|diverticular disease
463643|NCT01168154|Diverticulitis|diverticulitis
463644|NCT01168154|Probiotics|probiotics
463645|NCT01168141|Castrate-resistant prostate cancer with bone metastasis|castrate-resistant prostate cancer with bone metastasis
463646|NCT01168128|Enteral Nutrition|enteral nutrition
463647|NCT01168128|Parenteral Nutrition|parenteral nutrition
463648|NCT01168128|Critically ill|critically ill
463649|NCT01168128|Nutrition Therapy|nutrition therapy
463650|NCT01168128|Nutrition Support|nutrition support
463651|NCT01168128|Practice Guidelines as Topic|practice guidelines as topic
463652|NCT01168128|Guideline Adherence|guideline adherence
463653|NCT01168128|Quality Assurance, Health Care|quality assurance, health care
463654|NCT01168128|Nutrition Surveys|nutrition surveys
463655|NCT01168128|Questionnaires|questionnaires
463656|NCT01168063|Helicobacter pylori|helicobacter pylori
463657|NCT01168063|Diagnostic molecular testing|diagnostic molecular testing
463658|NCT01168063|Antibiotic resistance|antibiotic resistance
463659|NCT01168063|Treatment protocols|treatment protocols
463660|NCT01168050|Malignant Skin Melanoma T0|malignant skin melanoma t0
463661|NCT01168050|stage III unresectable melanomas,|stage iii unresectable melanomas,
463662|NCT01168050|or stage IV melanomas with c-KIT mutation|or stage iv melanomas with c-kit mutation
463663|NCT01168050|or amplification.|or amplification.
463664|NCT01168037|Aorta|aorta
463665|NCT01168037|Aneurysm|aneurysm
463666|NCT01168037|endovascular|endovascular
463667|NCT01168037|stent-graft|stent-graft
463668|NCT01168024|Acute Kidney Injury|acute kidney injury
463790|NCT01167504|saliva|saliva
463669|NCT01168024|Iodinated Contrast Agent Retrieval|iodinated contrast agent retrieval
463670|NCT01168024|Coronary Sinus Cannulation|coronary sinus cannulation
463671|NCT01167985|antibacterial polyethyleneimine nanoparticles|antibacterial polyethyleneimine nanoparticles
463672|NCT01167985|quaternary ammonium|quaternary ammonium
463673|NCT01167985|dental|dental
463674|NCT01167985|Endodotnic|endodotnic
463675|NCT01167985|pulp|pulp
463677|NCT01167985|Root canal sealer|root canal sealer
463678|NCT01167985|temporary filling|temporary filling
463679|NCT01167985|provisional restoration|provisional restoration
463680|NCT01167972|M + mutation|m + mutation
463681|NCT01167972|Non Small Cell Lung Cancer adenocarcinoma|non small cell lung cancer adenocarcinoma
463682|NCT01167972|To determine the proportion of patients with M + mutation status among patients with NSCLC adenocarcinoma|to determine the proportion of patients with m + mutation status among patients with nsclc adenocarcinoma
463683|NCT01167959|Obesity|obesity
463684|NCT01167959|Diabetes|diabetes
463685|NCT01167959|Bariatric surgery|bariatric surgery
463686|NCT01167946|Alopecia Areata|alopecia areata
463687|NCT01167946|Alopecia totalis|alopecia totalis
463688|NCT01167946|Alopecia Universalis|alopecia universalis
463689|NCT01167946|Ophiasic alopecia|ophiasic alopecia
463690|NCT01167946|Oral Pulse steroid|oral pulse steroid
463691|NCT01167946|Methylprednisolone|methylprednisolone
463692|NCT01167933|Bioequivalence|bioequivalence
463693|NCT01167933|Crossover|crossover
463694|NCT01167933|Simvastatin|simvastatin
463695|NCT01167920|High Blood Pressure|high blood pressure
463696|NCT01167920|Hypertension|hypertension
463697|NCT01167920|Home Blood Pressure Measurements|home blood pressure measurements
463698|NCT01167920|Wireless communication of measurements|wireless communication of measurements
463699|NCT01167920|Wireless communication of blood pressure measurements|wireless communication of blood pressure measurements
463700|NCT01167907|ankle|ankle
463701|NCT01167907|arthrodesis|arthrodesis
463702|NCT01167907|internal fixation|internal fixation
463703|NCT01167907|bi/tri malleolar fracture|bi/tri malleolar fracture
463704|NCT01167894|Bioequivalence|bioequivalence
463705|NCT01167894|Crossover|crossover
463706|NCT01167894|Simvastatin|simvastatin
463707|NCT01167868|fostamatinib disodium|fostamatinib disodium
463708|NCT01167868|FosD|fosd
463709|NCT01167868|Japanese|japanese
463710|NCT01167868|Healthy volunteers|healthy volunteers
463711|NCT01167868|Phase 1|phase 1
463712|NCT01167868|Single and Multiple Ascending Dose Study|single and multiple ascending dose study
463713|NCT01167868|Healthy Japanese volunteers|healthy japanese volunteers
463714|NCT01167868|Healthy White volunteers|healthy white volunteers
463715|NCT01167855|Pediatric Asthma|pediatric asthma
463716|NCT01167855|Low-income|low-income
463717|NCT01167855|Arkansas Delta Region|arkansas delta region
463718|NCT01167829|Experimental|experimental
463719|NCT01167829|Acyline plus 27 oral testosterone pills|acyline plus 27 oral testosterone pills
463720|NCT01167829|taken 3x/day|taken 3x/day
463721|NCT01167803|Bariatric surgery|bariatric surgery
463722|NCT01167803|Anesthesia|anesthesia
463723|NCT01167790|Precancerous lesions of the oral mucosa|precancerous lesions of the oral mucosa
463724|NCT01167790|Fluorescence visualization|fluorescence visualization
463725|NCT01167777|CT|ct
463726|NCT01167777|GC|gc
463727|NCT01167777|NG|ng
463728|NCT01167777|chlamydia|chlamydia
463729|NCT01167777|gonorrhoeae|gonorrhoeae
463730|NCT01167764|hemoptysis|hemoptysis
463731|NCT01167764|recurrence|recurrence
463732|NCT01167751|Myocardial infarction|myocardial infarction
463733|NCT01167751|Bone marrow stem cells|bone marrow stem cells
463734|NCT01167751|AC133|ac133
463735|NCT01167738|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
463736|NCT01167738|stage IV pancreatic cancer|stage iv pancreatic cancer
463737|NCT01167725|mucinous adenocarcinoma of the colon|mucinous adenocarcinoma of the colon
463738|NCT01167725|stage III colon cancer|stage iii colon cancer
463739|NCT01167725|stage IV colon cancer|stage iv colon cancer
463740|NCT01167699|Oxycodone/naloxone|oxycodone/naloxone
463741|NCT01167699|patient preference|patient preference
463742|NCT01167699|WHO step I/II|who step i/ii
463743|NCT01167699|Moderate to severe non-malignant pain|moderate to severe non-malignant pain
463744|NCT01167686|Respiratory infection|respiratory infection
463745|NCT01167686|Viral infection|viral infection
463746|NCT01167686|Food supplement|food supplement
463747|NCT01167686|Goldtrain Plus (GT+)|goldtrain plus (gt+)
463748|NCT01167673|irritable bowel syndrome|irritable bowel syndrome
463749|NCT01167673|selenium|selenium
463750|NCT01167673|curcumin|curcumin
463751|NCT01167673|green tea|green tea
463752|NCT01167660|Coagulation tests|coagulation tests
463753|NCT01167660|Neonates|neonates
463754|NCT01167660|Non invasive|non invasive
463755|NCT01167647|Tuberculosis, culture, bronchoscopy|tuberculosis, culture, bronchoscopy
463756|NCT01167634|Weight Loss|weight loss
463757|NCT01167634|Motivation|motivation
463758|NCT01167634|Contracts|contracts
463759|NCT01167621|Refractory Acute Respiratory Distress Syndrome|refractory acute respiratory distress syndrome
463760|NCT01167621|Indexed Extra-vascular Lung Water|indexed extra-vascular lung water
463761|NCT01167621|HFO-ventilation|hfo-ventilation
463762|NCT01167608|Parkinson's disease|parkinson's disease
463763|NCT01167608|Depression|depression
463764|NCT01167608|Anxiety|anxiety
463765|NCT01167608|Treatment|treatment
463766|NCT01167595|Critically ill|critically ill
463767|NCT01167595|Nutrition therapy|nutrition therapy
463768|NCT01167595|Enteral nutrition|enteral nutrition
463769|NCT01167582|blood transfusion|blood transfusion
463770|NCT01167582|red blood cell transfusion|red blood cell transfusion
463771|NCT01167582|myocardial infarction|myocardial infarction
463772|NCT01167582|acute coronary syndrome|acute coronary syndrome
463773|NCT01167582|anemia|anemia
463774|NCT01167569|Free Radicals|free radicals
463775|NCT01167569|Ascorbic Acid|ascorbic acid
463776|NCT01167569|Cardiac Surgery|cardiac surgery
463777|NCT01167569|Prevention of Reperfusion Injury|prevention of reperfusion injury
463778|NCT01167556|Family intervention|family intervention
463779|NCT01167556|Recent-onset schizophrenia|recent-onset schizophrenia
463780|NCT01167556|Motivational Interviewing|motivational interviewing
463781|NCT01167556|Cannabis use|cannabis use
463782|NCT01167530|Everolimus|everolimus
463783|NCT01167530|Radiotherapy|radiotherapy
463784|NCT01167530|Chemotherapy|chemotherapy
463785|NCT01167517|Breast milk|breast milk
463786|NCT01167517|Feeding|feeding
463787|NCT01167517|Prematurity|prematurity
463788|NCT01167517|Low birth weight infant|low birth weight infant
463789|NCT01167517|Low maternal breast milk feeding|low maternal breast milk feeding
463791|NCT01167504|food|food
463792|NCT01167504|sensory|sensory
463793|NCT01167504|oral health|oral health
463794|NCT01167504|film|film
463795|NCT01167504|pellicle|pellicle
463796|NCT01167491|Wegener|wegener
463797|NCT01167491|CD4+ T cells|cd4+ t cells
463798|NCT01167491|DAP12|dap12
463799|NCT01167491|NKG2D|nkg2d
463800|NCT01167478|Exercise|exercise
463801|NCT01167478|Caffeine|caffeine
463802|NCT01167478|Reserve|reserve
463803|NCT01167465|Diaper Dermatitis|diaper dermatitis
463804|NCT01167465|Diaper Rash|diaper rash
463805|NCT01167465|Erythema|erythema
463806|NCT01167452|Obesity|obesity
463807|NCT01167452|Pharmacokinetics|pharmacokinetics
463808|NCT01167452|MRSA|mrsa
463809|NCT01167452|Tuberculosis|tuberculosis
463810|NCT01167452|PCP|pcp
463811|NCT01167439|OPMD, dysphagia|opmd, dysphagia
463812|NCT01167439|Dysphagia severity|dysphagia severity
463813|NCT01167439|Nutritional state|nutritional state
463814|NCT01167439|Speech quality|speech quality
463815|NCT01167439|Upper esophageal sphincter myotomy|upper esophageal sphincter myotomy
463816|NCT01167426|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
463817|NCT01167426|RRMS|rrms
463818|NCT01167426|Clinically Isolated Syndrome|clinically isolated syndrome
463819|NCT01167426|CIS|cis
463820|NCT01167426|Copaxone|copaxone
463821|NCT01167426|glatiramer acetate|glatiramer acetate
463822|NCT01167426|Autoject 2|autoject 2
463823|NCT01167400|exercise|exercise
463824|NCT01167400|executive function|executive function
463825|NCT01167400|older adults|older adults
463826|NCT01167387|carbohydrate|carbohydrate
463827|NCT01167387|glucose metabolism|glucose metabolism
463828|NCT01167387|surgery, outcome|surgery, outcome
463829|NCT01167387|major elective surgery|major elective surgery
463830|NCT01167387|urology|urology
463831|NCT01167387|hyperglicemia|hyperglicemia
463832|NCT01167374|HCC|hcc
463833|NCT01167361|upper respiratory tract infection|upper respiratory tract infection
463834|NCT01167361|lower respiratory tract infection|lower respiratory tract infection
463835|NCT01167348|auricular acupressure|auricular acupressure
463836|NCT01167348|obesity|obesity
463837|NCT01167348|schizophrenia|schizophrenia
463838|NCT01167348|body weight|body weight
463839|NCT01167335|partial onset seizure|partial onset seizure
463840|NCT01167335|seizure frequency|seizure frequency
463841|NCT01167335|nervous system diseases|nervous system diseases
463842|NCT01167335|central nervous system diseases|central nervous system diseases
463843|NCT01167335|CNS|cns
463844|NCT01167335|brain diseases|brain diseases
463845|NCT01167335|neurologic manifestations|neurologic manifestations
463846|NCT01167335|adjunctive treatment|adjunctive treatment
463847|NCT01167335|AEDs|aeds
463848|NCT01167335|antiepileptic drug|antiepileptic drug
463849|NCT01167322|NPC-07, 5-ALA, photodynamic diagnosis, pharmacokinetics|npc-07, 5-ala, photodynamic diagnosis, pharmacokinetics
463850|NCT01167309|Safety and tolerability of LEO 27847|safety and tolerability of leo 27847
463851|NCT01167296|Intrauterine adhesion|intrauterine adhesion
463852|NCT01167296|Cook balloon uterine stent|cook balloon uterine stent
463853|NCT01167283|COPD|copd
463854|NCT01167270|Infant Diet|infant diet
463855|NCT01167270|Toddler Diet|toddler diet
463856|NCT01167270|Responsive Feeding|responsive feeding
463857|NCT01167270|Infant Temperament|infant temperament
463858|NCT01167270|Parent competency|parent competency
463859|NCT01167270|Childhood Obesity prevention|childhood obesity prevention
463860|NCT01167270|Rapid infant weight gain|rapid infant weight gain
463861|NCT01167257|Overactive bladder|overactive bladder
463862|NCT01167257|Detrusor overactivity|detrusor overactivity
463863|NCT01167257|Liposome|liposome
463864|NCT01167257|Botulinum toxin A|botulinum toxin a
463865|NCT01167231|Diabetes|diabetes
463866|NCT01167231|Acarbose|acarbose
463867|NCT01167218|verify now assay for hematological disorders|verify now assay for hematological disorders
463868|NCT01167205|Healthy adults with BMI over 25.0 kg/m2|healthy adults with bmi over 25.0 kg/m2
463869|NCT01167179|head and neck cancer|head and neck cancer
463870|NCT01167179|nurse-led care|nurse-led care
463871|NCT01167179|follow-up care|follow-up care
463872|NCT01167179|professional-patient relations|professional-patient relations
463873|NCT01167179|psychosocial adjustment|psychosocial adjustment
463874|NCT01167179|quasi-experimental|quasi-experimental
463875|NCT01167179|prospective|prospective
463876|NCT01167179|quality of life|quality of life
463877|NCT01167166|Acute Myelocytic Leukemia|acute myelocytic leukemia
463878|NCT01167166|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
463879|NCT01167166|Myeloproliferative Disease|myeloproliferative disease
463880|NCT01167166|Myelofibrosis|myelofibrosis
463881|NCT01167166|Essential thrombocythemia|essential thrombocythemia
463882|NCT01167166|Polycythemia vera|polycythemia vera
463883|NCT01167166|Chronic Myeloid Leukemia|chronic myeloid leukemia
463884|NCT01167153|Hypertension|hypertension
463885|NCT01167153|Valsartan Amlodipine single pill combination|valsartan amlodipine single pill combination
463886|NCT01167153|BP control|bp control
463887|NCT01167153|ABPM|abpm
463888|NCT01167153|Hypertensive patients not adequately controlled by mono antihypertensive drugs|hypertensive patients not adequately controlled by mono antihypertensive drugs
463889|NCT01167127|Oxycodone/naloxone|oxycodone/naloxone
463890|NCT01167127|pain relief|pain relief
463891|NCT01167127|bowel function|bowel function
463892|NCT01167127|moderate to severe non-malignant pain|moderate to severe non-malignant pain
463893|NCT01167114|STA-9090|sta-9090
463894|NCT01167101|Rebamipide|rebamipide
463895|NCT01167101|gastric ulcer|gastric ulcer
463896|NCT01167101|healing rate|healing rate
463897|NCT01167101|iatrogenic gastric ulcer after endoscopic submucosal dissection|iatrogenic gastric ulcer after endoscopic submucosal dissection
463898|NCT01167088|Double-blind|double-blind
463899|NCT01167088|Placebo-controlled|placebo-controlled
463900|NCT01167088|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
463901|NCT01167088|NAFLD|nafld
463902|NCT01167075|critically ill|critically ill
463903|NCT01167075|sepsis|sepsis
463904|NCT01167075|antioxidants|antioxidants
463905|NCT01167075|enteral nutrition|enteral nutrition
463906|NCT01167075|SIRS (APACHE score 10-30)|sirs (apache score 10-30)
463907|NCT01167075|enteral feeding within 48 h of admission|enteral feeding within 48 h of admission
463908|NCT01167049|gastric cancer with liver metastasis|gastric cancer with liver metastasis
463909|NCT01167036|Myofascial pain syndrome|myofascial pain syndrome
463910|NCT01167036|Trigger points, Myofascial|trigger points, myofascial
463911|NCT01167036|Chiropractic|chiropractic
463912|NCT01167036|Massage|massage
463913|NCT01167036|Musculoskeletal manipulation|musculoskeletal manipulation
463914|NCT01167023|Sickle Cell Disease|sickle cell disease
463915|NCT01167023|Sickle Cell Anemia|sickle cell anemia
463916|NCT01167023|Adult|adult
463917|NCT01166997|Pulmonary embolism|pulmonary embolism
463918|NCT01166997|Pulmonary thromboembolism|pulmonary thromboembolism
463919|NCT01166997|anticoagulation|anticoagulation
463920|NCT01166997|thrombolysis|thrombolysis
463921|NCT01166997|ultrasound accelerated thrombolysis|ultrasound accelerated thrombolysis
463922|NCT01166984|sepsis|sepsis
463923|NCT01166984|septic shock|septic shock
463924|NCT01166971|presbyopia|presbyopia
463925|NCT01166971|intraocular lens|intraocular lens
463926|NCT01166945|Child|child
463927|NCT01166945|Child, preschool|child, preschool
463928|NCT01166945|Sinusitis|sinusitis
463929|NCT01166945|Antimicrobial agents|antimicrobial agents
463930|NCT01166932|pneumonia|pneumonia
463931|NCT01166932|children|children
463932|NCT01166932|antibiotics|antibiotics
463933|NCT01166906|pain blocking|pain blocking
463934|NCT01166893|burn wound|burn wound
463935|NCT01166880|assessment|assessment
463936|NCT01166867|assessment|assessment
463937|NCT01166854|muscle and bone disease|muscle and bone disease
463938|NCT01166841|minimally invasive cardiac surgery|minimally invasive cardiac surgery
463939|NCT01166841|cardiac surgery|cardiac surgery
463940|NCT01166841|near infrared spectroscopy|near infrared spectroscopy
463941|NCT01166841|mitral valve repair|mitral valve repair
463942|NCT01166841|mitral valve replacement|mitral valve replacement
463943|NCT01166828|Spinal cord injury|spinal cord injury
463944|NCT01166828|telehealth|telehealth
463945|NCT01166828|pressure ulcers|pressure ulcers
463946|NCT01166828|quality of life|quality of life
463947|NCT01166815|diarrhea morbidity|diarrhea morbidity
463948|NCT01166815|malaria incidence|malaria incidence
463949|NCT01166815|zinc supplementation|zinc supplementation
463950|NCT01166802|questionnaire development|questionnaire development
463951|NCT01166802|hypervigilance|hypervigilance
463952|NCT01166802|pain sensitivity|pain sensitivity
463953|NCT01166789|IBS|ibs
463954|NCT01166789|pain threshold|pain threshold
463955|NCT01166789|constipation|constipation
463956|NCT01166776|Wharton's jelly|wharton's jelly
463957|NCT01166776|umbilical cord|umbilical cord
463958|NCT01166776|decellularization|decellularization
463959|NCT01166763|breast atypia|breast atypia
463960|NCT01166763|high risk for breast cancer|high risk for breast cancer
463961|NCT01166763|random periareolar fine needle aspiration|random periareolar fine needle aspiration
463962|NCT01166763|RPFNA|rpfna
463963|NCT01166763|breast epithelial hyperplasia|breast epithelial hyperplasia
463964|NCT01166763|ki-67|ki-67
463965|NCT01166763|chemoprevention|chemoprevention
463966|NCT01166763|vitamin D3|vitamin d3
463967|NCT01166763|Additional relevant MeSH terms:|additional relevant mesh terms:
463968|NCT01166763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
463969|NCT01166763|Physiological Effects of Drugs|physiological effects of drugs
463970|NCT01166763|Breast Neoplasms|breast neoplasms
463971|NCT01166763|Pharmacologic Actions|pharmacologic actions
463972|NCT01166763|Hyperplasia|hyperplasia
463973|NCT01166763|high risk for development of breast cancer|high risk for development of breast cancer
463974|NCT01166763|Neoplasms|neoplasms
463975|NCT01166763|Neoplasms by Site|neoplasms by site
463976|NCT01166763|Pathologic Processes|pathologic processes
463977|NCT01166763|Antirheumatic Agents|antirheumatic agents
463978|NCT01166763|Breast Diseases|breast diseases
463979|NCT01166737|Ovarian Cancer|ovarian cancer
463980|NCT01166737|Cancer of the fallopian tube|cancer of the fallopian tube
463981|NCT01166737|Primary peritoneal cancer|primary peritoneal cancer
463982|NCT01166737|Recurrent disease|recurrent disease
463983|NCT01166737|Platinum-sensitive|platinum-sensitive
463984|NCT01166737|Surgery|surgery
463985|NCT01166737|Chemotherapy|chemotherapy
463986|NCT01166737|Quality of Life|quality of life
463987|NCT01166737|First recurrence of platinum sensitive:|first recurrence of platinum sensitive:
463988|NCT01166737|Fallopian Tube Cancer|fallopian tube cancer
463989|NCT01166737|or Ovarian Cancer|or ovarian cancer
463990|NCT01166737|or Peritoneal Cavity Cancer|or peritoneal cavity cancer
463991|NCT01166724|Kidney transplant|kidney transplant
463992|NCT01166698|Safety|safety
463993|NCT01166698|tolerability|tolerability
463994|NCT01166698|healthy|healthy
463995|NCT01166698|inhalation|inhalation
463996|NCT01166685|coronary artery disease|coronary artery disease
463997|NCT01166685|drug-eluting stent|drug-eluting stent
463998|NCT01166685|anti-thrombotic therapy|anti-thrombotic therapy
463999|NCT01166685|bare-metal stent|bare-metal stent
464000|NCT01166685|long-term outcome|long-term outcome
464001|NCT01166672|obese women (BMI greater than or equal to 30), do not already have a diagnosis of lymphedema, who are done|obese women (bmi greater than or equal to 30), do not already have a diagnosis of lymphedema, who are done
464002|NCT01166672|with surgery, chemotherapy, and radiation therapy, and who were diagnosed with breast cancer within the|with surgery, chemotherapy, and radiation therapy, and who were diagnosed with breast cancer within the
464003|NCT01166672|past 2 years will be invited to participate.|past 2 years will be invited to participate.
464004|NCT01166659|Glaucoma|glaucoma
464005|NCT01166659|Glaucoma device|glaucoma device
464006|NCT01166659|Glaucoma surgery|glaucoma surgery
464007|NCT01166659|Intraocular pressure|intraocular pressure
464008|NCT01166633|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
464009|NCT01166633|hyperlipidemia|hyperlipidemia
464010|NCT01166594|Glaucoma|glaucoma
464011|NCT01166594|Elevated Intraocular Pressure (IOP)|elevated intraocular pressure (iop)
464012|NCT01166594|Optic Neuropathy|optic neuropathy
464013|NCT01166594|Bleb Failure|bleb failure
464014|NCT01166594|Avastin (Bevacizumab)|avastin (bevacizumab)
464015|NCT01166581|early stage breast cancer|early stage breast cancer
464016|NCT01166581|preoperative breast MRI|preoperative breast mri
464017|NCT01166581|mastectomy|mastectomy
464018|NCT01166568|Presbyopia|presbyopia
464019|NCT01166568|Reading Vision|reading vision
464020|NCT01166568|Near Vision|near vision
464021|NCT01166555|Safety and tolerability|safety and tolerability
464022|NCT01166555|Pharmacokinetics|pharmacokinetics
464023|NCT01166555|PF-04236921|pf-04236921
464024|NCT01166555|Rheumatoid Arthritis|rheumatoid arthritis
464025|NCT01166542|carcinoma|carcinoma
464026|NCT01166542|squamous cell|squamous cell
464027|NCT01166542|head|head
464028|NCT01166542|neck|neck
464029|NCT01166542|REOLYSIN (Reovirus Type 3 Dearing)|reolysin (reovirus type 3 dearing)
464030|NCT01166542|chemotherapy|chemotherapy
464031|NCT01166542|Carboplatin|carboplatin
464032|NCT01166542|Paclitaxel|paclitaxel
464033|NCT01166542|metastatic|metastatic
464034|NCT01166542|recurrent|recurrent
464035|NCT01166516|Prolonged air leak|prolonged air leak
464036|NCT01166516|lobectomy|lobectomy
464037|NCT01166516|segmentectomy|segmentectomy
464038|NCT01166516|lung volume reduction surgery (LVRS)|lung volume reduction surgery (lvrs)
464039|NCT01166503|pediatrics|pediatrics
464040|NCT01166503|Esotropia|esotropia
464041|NCT01166503|Surgery|surgery
464042|NCT01166490|Monomethyl auristatin E (MMAE)|monomethyl auristatin e (mmae)
464043|NCT01166490|Immunotherapy|immunotherapy
464044|NCT01166490|AGS-5 Antigen|ags-5 antigen
464045|NCT01166490|SLC44A4 Antigen|slc44a4 antigen
464046|NCT01166490|Gastric Neoplasms|gastric neoplasms
464047|NCT01166490|Pancreatic Neoplasms|pancreatic neoplasms
464048|NCT01166490|Antibody-Drug Conjugate|antibody-drug conjugate
464049|NCT01166490|Antibodies, Monoclonal|antibodies, monoclonal
464050|NCT01166490|Drug Therapy|drug therapy
464051|NCT01166464|tobacco|tobacco
464052|NCT01166464|smoking|smoking
464053|NCT01166464|text message|text message
464054|NCT01166464|therapy|therapy
464055|NCT01166451|iron deficiency anemia|iron deficiency anemia
464056|NCT01166451|cognitive development|cognitive development
464057|NCT01166451|motor development|motor development
464058|NCT01166438|incontinence|incontinence
464059|NCT01166438|overactive bladder|overactive bladder
464060|NCT01166438|botox|botox
464061|NCT01166438|anticholinergic|anticholinergic
464062|NCT01166399|Fecal Incontinence,|fecal incontinence,
464063|NCT01166399|bowel incontinence,|bowel incontinence,
464064|NCT01166399|pelvic floor disorder|pelvic floor disorder
464065|NCT01166386|rehabilitation|rehabilitation
464066|NCT01166386|brain injury|brain injury
464067|NCT01166373|prolapse|prolapse
464068|NCT01166373|urinary incontinence|urinary incontinence
464069|NCT01166373|uterosacral vaginal vault ligament suspension|uterosacral vaginal vault ligament suspension
464070|NCT01166373|sacrospinous ligament fixation|sacrospinous ligament fixation
464071|NCT01166373|behavioral therapy|behavioral therapy
464072|NCT01166373|pelvic muscle training|pelvic muscle training
464073|NCT01166360|Risk prediction|risk prediction
464074|NCT01166360|Euroscore|euroscore
464075|NCT01166360|GDF-15|gdf-15
464076|NCT01166360|hsTnT|hstnt
464077|NCT01166360|cardiac surgery|cardiac surgery
464078|NCT01166334|Smoking|smoking
464079|NCT01166334|Smoke|smoke
464080|NCT01166334|Cigarette|cigarette
464081|NCT01166334|Cessation|cessation
464082|NCT01166334|Quit|quit
464083|NCT01166334|Online|online
464084|NCT01166334|Web|web
464085|NCT01166334|Stop|stop
464086|NCT01166321|Atypical Meningioma|atypical meningioma
464087|NCT01166308|Recurrent Glioma|recurrent glioma
464088|NCT01166282|inflammatory back pain|inflammatory back pain
464089|NCT01166282|ankylosing spondylitis|ankylosing spondylitis
464090|NCT01166282|sacroiliitis|sacroiliitis
464091|NCT01166282|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
464092|NCT01166282|enthesitis|enthesitis
464093|NCT01166282|arthritis|arthritis
464094|NCT01166269|grass-pollen allergy|grass-pollen allergy
464095|NCT01166256|respiratory failure|respiratory failure
464096|NCT01166243|Hemostasis|hemostasis
464097|NCT01166217|Single Dose Study in Healthy Subjects|single dose study in healthy subjects
464098|NCT01166204|Radiotherapy|radiotherapy
464099|NCT01166204|NSCLC|nsclc
464100|NCT01166191|Radiotherapy|radiotherapy
464101|NCT01166191|SCLC|sclc
464102|NCT01166178|Multiple Sclerosis|multiple sclerosis
464103|NCT01166178|Osteoporosis|osteoporosis
464104|NCT01166178|Zoledronic Acid|zoledronic acid
464105|NCT01166165|Hypertension|hypertension
464106|NCT01166165|blood pressure|blood pressure
464107|NCT01166165|vitamin d|vitamin d
464108|NCT01166165|winter|winter
464109|NCT01166165|cholecalciferol|cholecalciferol
464110|NCT01166165|arterial stiffness|arterial stiffness
464111|NCT01166165|renin|renin
464112|NCT01166165|angiotensin|angiotensin
464113|NCT01166165|aldosterone|aldosterone
464114|NCT01166165|calcium|calcium
464115|NCT01166152|autistic spectrum disorders|autistic spectrum disorders
464116|NCT01166152|developmental disorders|developmental disorders
464117|NCT01166139|Systemic Sclerosis|systemic sclerosis
464118|NCT01166113|Pomalidomide|pomalidomide
464119|NCT01166113|Relapsed/Refractory to Lenalidomide|relapsed/refractory to lenalidomide
464120|NCT01166100|Bioequivalence|bioequivalence
464121|NCT01166100|Crossover|crossover
464122|NCT01166100|Fluoxetine Hydrochloride|fluoxetine hydrochloride
464123|NCT01166087|Bioequivalence|bioequivalence
464124|NCT01166087|Crossover|crossover
464125|NCT01166087|Fluoxetine Hydrochloride|fluoxetine hydrochloride
464126|NCT01166061|Grass Allergy|grass allergy
464127|NCT01166061|Immunotherapy|immunotherapy
464128|NCT01166061|Rhinoconjunctivitis|rhinoconjunctivitis
464129|NCT01166061|ToleroMune Grass|toleromune grass
464130|NCT01166048|Chronic Low Back Pain|chronic low back pain
464131|NCT01166048|Radicular component|radicular component
464132|NCT01166048|neuropathic pain|neuropathic pain
464133|NCT01166048|duloxetine|duloxetine
464134|NCT01166048|CLBP|clbp
464135|NCT01166035|Solid tumors|solid tumors
464136|NCT01166035|Lenalidomide|lenalidomide
464137|NCT01166035|Cetuximab|cetuximab
464138|NCT01166035|Colorectal Cancer|colorectal cancer
464139|NCT01166035|Non-Small Cell Lung Cancer|non-small cell lung cancer
464140|NCT01166035|Head and Neck Cancer|head and neck cancer
464141|NCT01166022|Spinal Muscular Atrophy|spinal muscular atrophy
464142|NCT01166022|Exercise|exercise
464143|NCT01166022|Conditioning|conditioning
464144|NCT01166022|Strengthening|strengthening
464145|NCT01166009|Data Collection|data collection
464146|NCT01166009|CIBMTR|cibmtr
464147|NCT01166009|NMDP|nmdp
464148|NCT01166009|Stem Cell Transplantation|stem cell transplantation
464149|NCT01165996|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
464150|NCT01165996|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
464151|NCT01165970|enamel|enamel
464152|NCT01165970|dentin|dentin
464153|NCT01165970|saliva substitute|saliva substitute
464154|NCT01165970|demineralization|demineralization
464155|NCT01165970|remineralization|remineralization
464156|NCT01165957|Knee replacement|knee replacement
464157|NCT01165957|Mobile and fixed bearings|mobile and fixed bearings
464158|NCT01165957|Volumetric wear|volumetric wear
464159|NCT01165957|Micro-CT analysis|micro-ct analysis
464160|NCT01165957|Articular and backside wear|articular and backside wear
464161|NCT01165944|Post transplant diabetes mellitus|post transplant diabetes mellitus
464162|NCT01165931|Coronary artery disease|coronary artery disease
464163|NCT01165905|cancer|cancer
464164|NCT01165905|solid malignancy|solid malignancy
464165|NCT01165905|tumor|tumor
464166|NCT01165905|malignant neoplasm|malignant neoplasm
464167|NCT01165905|histologically confirmed solid malignancy|histologically confirmed solid malignancy
464168|NCT01165892|Pulmonary embolism|pulmonary embolism
464169|NCT01165892|contrast agent|contrast agent
464170|NCT01165879|Pregnancy|pregnancy
464171|NCT01165879|Term|term
464172|NCT01165879|Preterm|preterm
464173|NCT01165879|Uterine Contractions|uterine contractions
464174|NCT01165866|Ondansetron|ondansetron
464175|NCT01165866|Metoclopramide|metoclopramide
464176|NCT01165866|Gastroenteritis|gastroenteritis
464177|NCT01165840|Obesity|obesity
464178|NCT01165840|Pharmacokinetics|pharmacokinetics
464179|NCT01165840|Dapsone|dapsone
464180|NCT01165840|Leprosy|leprosy
464181|NCT01165840|Tuberculosis|tuberculosis
464182|NCT01165827|Aortic Valve Insufficiency|aortic valve insufficiency
464183|NCT01165827|Aortic Valve Stenosis|aortic valve stenosis
464184|NCT01165827|Aortic Valve Valvuloplasty|aortic valve valvuloplasty
464185|NCT01165827|Aortic valve Replacement|aortic valve replacement
464186|NCT01165827|Aortic valve Intervention|aortic valve intervention
464187|NCT01165814|Pain control after cesarean section|pain control after cesarean section
464188|NCT01165801|AMD|amd
464189|NCT01165801|Cataract surgery|cataract surgery
464190|NCT01165801|Size of AMD|size of amd
464191|NCT01165801|Influence of cataract surgery on AMD Size|influence of cataract surgery on amd size
464192|NCT01165788|Blood and Marrow Transplant (BMT)|blood and marrow transplant (bmt)
464193|NCT01165736|pharmacokinetics|pharmacokinetics
464194|NCT01165736|safety|safety
464195|NCT01165736|tolerability|tolerability
464196|NCT01165736|Chronic Pain|chronic pain
464197|NCT01165723|safety|safety
464198|NCT01165723|tolerability|tolerability
464199|NCT01165723|pharmacokinetics|pharmacokinetics
464200|NCT01165723|pharmacodynamics|pharmacodynamics
464201|NCT01165723|chronic pain|chronic pain
464202|NCT01165710|Irregular heart beat|irregular heart beat
464203|NCT01165697|Fabry Disease|fabry disease
464204|NCT01165697|vascular disease|vascular disease
464205|NCT01165697|storage endotheliopathy|storage endotheliopathy
464206|NCT01165671|Primary Glioblastoma|primary glioblastoma
464207|NCT01165658|non-small cell lung cancer|non-small cell lung cancer
464208|NCT01165658|NSCLC|nsclc
464209|NCT01165658|small cell lung cancer|small cell lung cancer
464210|NCT01165658|SCLC|sclc
464211|NCT01165658|carcinoid|carcinoid
464212|NCT01165658|thymic cancer|thymic cancer
464213|NCT01165658|lung cancer|lung cancer
464214|NCT01165658|radiation therapy|radiation therapy
464215|NCT01165658|radiotherapy|radiotherapy
464216|NCT01165658|proton therapy|proton therapy
464217|NCT01165645|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
464218|NCT01165554|Amyloid|amyloid
464219|NCT01165554|PET-Positron Emission Tomography|pet-positron emission tomography
464220|NCT01165554|SUVR-Standard uptake value ratios|suvr-standard uptake value ratios
464221|NCT01165502|MAD study CM3.1-AC100|mad study cm3.1-ac100
464222|NCT01165502|Healthy men, age 18 - 50|healthy men, age 18 - 50
464223|NCT01165489|Laryngomalacia|laryngomalacia
464224|NCT01165489|Congenital Anomalies|congenital anomalies
464225|NCT01165489|Associated Health Problems|associated health problems
464226|NCT01165476|treprostinil|treprostinil
464227|NCT01165476|bioavailability|bioavailability
464228|NCT01165476|bioequivalence|bioequivalence
464229|NCT01165463|Aging|aging
464230|NCT01165463|Healthy|healthy
464231|NCT01165450|persistent epithelial defect|persistent epithelial defect
464232|NCT01165450|cornea|cornea
464233|NCT01165437|Peripheral|peripheral
464234|NCT01165437|Arterial|arterial
464235|NCT01165437|Vascular|vascular
464236|NCT01165411|Central Catheterization|central catheterization
464237|NCT01165411|Central Line|central line
464238|NCT01165411|Database|database
464239|NCT01165411|Registry|registry
464240|NCT01165411|Registries|registries
464241|NCT01165398|Education|education
464242|NCT01165398|central lines|central lines
464243|NCT01165398|infections|infections
464244|NCT01165398|complications|complications
464245|NCT01165398|Bundles|bundles
464246|NCT01165385|Relapsed or refractory solid tumors|relapsed or refractory solid tumors
464247|NCT01165385|Pazopanib|pazopanib
464248|NCT01165385|Cisplatin|cisplatin
464249|NCT01165372|Malaria|malaria
464250|NCT01165372|Drug resistance|drug resistance
464251|NCT01165346|liver cancer|liver cancer
464252|NCT01165346|hepatocellular carcinoma|hepatocellular carcinoma
464253|NCT01165333|Paediatric oncology|paediatric oncology
464254|NCT01165333|Cilengitide|cilengitide
464255|NCT01165333|Glioma|glioma
464256|NCT01165307|Menorrhagia|menorrhagia
464257|NCT01165307|Endometrial ablation|endometrial ablation
464258|NCT01165307|Heavy menstrual bleeding|heavy menstrual bleeding
464259|NCT01165294|Ketamine|ketamine
464260|NCT01165281|Pain|pain
464261|NCT01165281|R331333 (JNS024ER, CG5503), tapentadol (NUCYNTA)|r331333 (jns024er, cg5503), tapentadol (nucynta)
464262|NCT01165281|Opioid analgesic|opioid analgesic
464263|NCT01165281|Oxycodone CR (OXYCONTIN CR)|oxycodone cr (oxycontin cr)
464264|NCT01165281|Chronic malignant tumor related cancer pain|chronic malignant tumor related cancer pain
464265|NCT01165255|congenital malformation|congenital malformation
464266|NCT01165255|cardiovascular malformation|cardiovascular malformation
464267|NCT01165255|cardiovascular defect|cardiovascular defect
464268|NCT01165255|antidepressants|antidepressants
464269|NCT01165255|pregnancy|pregnancy
464270|NCT01165255|first trimester|first trimester
464271|NCT01165255|Bupropion|bupropion
464272|NCT01165255|prevalence|prevalence
464273|NCT01165242|Neisseria meningitidis|neisseria meningitidis
464274|NCT01165242|Adult|adult
464275|NCT01165242|Adolescent|adolescent
464276|NCT01165242|Safety|safety
464277|NCT01165242|Vaccines, conjugate|vaccines, conjugate
464278|NCT01165242|Meningococcal vaccines|meningococcal vaccines
464279|NCT01165242|Immunogenicity|immunogenicity
464280|NCT01165229|Immunogenicity|immunogenicity
464281|NCT01165229|Subjects 70 years and older|subjects 70 years and older
464282|NCT01165229|Efficacy|efficacy
464283|NCT01165229|Herpes Zoster|herpes zoster
464284|NCT01165229|Safety|safety
464285|NCT01165229|Adults|adults
464286|NCT01165229|Vaccine|vaccine
464287|NCT01165203|immunogenicity|immunogenicity
464288|NCT01165203|vaccine|vaccine
464289|NCT01165203|safety|safety
464290|NCT01165203|HIV|hiv
464291|NCT01165203|Herpes Zoster|herpes zoster
464292|NCT01165177|subjects 50 years and older|subjects 50 years and older
464293|NCT01165177|vaccine|vaccine
464294|NCT01165177|immunogenicity|immunogenicity
464295|NCT01165177|efficacy|efficacy
464296|NCT01165177|Herpes Zoster|herpes zoster
464297|NCT01165177|safety|safety
464298|NCT01165164|Dry eye|dry eye
464299|NCT01165164|artificial tears|artificial tears
464300|NCT01165151|obesity|obesity
464301|NCT01165151|weight loss|weight loss
464302|NCT01165151|group size|group size
464303|NCT01165138|GW642444|gw642444
464304|NCT01165138|Vilanterol|vilanterol
464305|NCT01165138|Asthma|asthma
464306|NCT01165138|Fluticasone Furoate|fluticasone furoate
464307|NCT01165125|pharmacodynamics|pharmacodynamics
464308|NCT01165125|drug interaction|drug interaction
464309|NCT01165125|ketoconazole|ketoconazole
464310|NCT01165125|pharmacokinetics|pharmacokinetics
464311|NCT01165125|Fluticasone furoate|fluticasone furoate
464312|NCT01165125|GW642444|gw642444
464313|NCT01165099|acupuncture|acupuncture
464314|NCT01165099|induced labour|induced labour
464315|NCT01165099|labour outcome|labour outcome
464316|NCT01165099|nulliparae|nulliparae
464317|NCT01165099|pain-relief|pain-relief
464318|NCT01165099|epidural during labour|epidural during labour
464319|NCT01165073|Cirrhosis|cirrhosis
464320|NCT01165073|Malnutrition|malnutrition
464321|NCT01165073|Enteral nutrition|enteral nutrition
464322|NCT01165060|X-ALD|x-ald
464323|NCT01165060|AMN|amn
464324|NCT01165060|adrenomyeloneuropathy phenotype|adrenomyeloneuropathy phenotype
464325|NCT01164995|MK-1775|mk-1775
464326|NCT01164995|Carboplatin|carboplatin
464327|NCT01164995|epithelial ovarian cancer|epithelial ovarian cancer
464328|NCT01164995|p53|p53
464329|NCT01164956|methylphenidate|methylphenidate
464330|NCT01164956|fatigue|fatigue
464331|NCT01164917|Lupus|lupus
464332|NCT01164917|Discoid Lupus|discoid lupus
464333|NCT01164917|Cutaneous Lupus|cutaneous lupus
464334|NCT01164904|Inflammatory Bowel Disease|inflammatory bowel disease
464335|NCT01164904|Amgen|amgen
464336|NCT01164878|Cholestasis|cholestasis
464337|NCT01164878|Liver damage|liver damage
464338|NCT01164878|Parenteral Nutrition|parenteral nutrition
464339|NCT01164878|Aggressive Nutrition|aggressive nutrition
464340|NCT01164878|Preterm|preterm
464341|NCT01164878|Extreme low birth weight infant|extreme low birth weight infant
464342|NCT01164878|Parenteral Nutrition Associated Cholestasis|parenteral nutrition associated cholestasis
464343|NCT01164865|Soft Contact lens|soft contact lens
464344|NCT01164865|Multi-Purpose Solution|multi-purpose solution
464345|NCT01164865|Hydrogen Peroxide|hydrogen peroxide
464346|NCT01164839|coronary artery|coronary artery
464347|NCT01164839|CT angiography|ct angiography
464348|NCT01164839|image quality|image quality
464349|NCT01164839|multicenter trial|multicenter trial
464350|NCT01164826|Bioequivalence|bioequivalence
464351|NCT01164826|Crossover|crossover
464352|NCT01164826|Nabumetone|nabumetone
464353|NCT01164813|Bioequivalence|bioequivalence
464354|NCT01164813|Crossover|crossover
464355|NCT01164813|Nabumetone|nabumetone
464356|NCT01164800|Bioequivalence|bioequivalence
464357|NCT01164800|Crossover|crossover
464358|NCT01164800|Trandolapril|trandolapril
464359|NCT01164787|Bioequivalence|bioequivalence
464360|NCT01164787|Crossover|crossover
464361|NCT01164787|Trandolapril|trandolapril
464362|NCT01164774|Bioavailability|bioavailability
464363|NCT01164774|Crossover|crossover
464364|NCT01164774|Ramipril|ramipril
464365|NCT01164761|Bioavailability|bioavailability
464366|NCT01164761|Crossover|crossover
464367|NCT01164761|Ramipril|ramipril
464368|NCT01164722|anal cancer|anal cancer
464369|NCT01164722|HIV infection|hiv infection
464720|NCT01163604|restenosis|restenosis
464370|NCT01164722|human papilloma virus infection|human papilloma virus infection
464371|NCT01164722|neoplasm of uncertain malignant potential|neoplasm of uncertain malignant potential
464372|NCT01164722|high-grade squamous intraepithelial lesion|high-grade squamous intraepithelial lesion
464373|NCT01164709|refractory multiple myeloma|refractory multiple myeloma
464374|NCT01164709|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
464375|NCT01164709|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
464376|NCT01164709|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
464377|NCT01164709|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
464378|NCT01164709|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
464379|NCT01164709|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
464380|NCT01164709|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
464381|NCT01164709|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
464382|NCT01164709|peripheral T-cell lymphoma|peripheral t-cell lymphoma
464383|NCT01164709|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
464384|NCT01164709|anaplastic large cell lymphoma|anaplastic large cell lymphoma
464385|NCT01164709|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
464386|NCT01164709|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
464387|NCT01164709|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
464388|NCT01164709|aggressive NK-cell leukemia|aggressive nk-cell leukemia
464389|NCT01164709|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
464390|NCT01164709|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
464391|NCT01164709|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
464392|NCT01164709|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
464393|NCT01164709|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
464394|NCT01164709|secondary acute myeloid leukemia|secondary acute myeloid leukemia
464395|NCT01164709|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
464396|NCT01164709|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
464397|NCT01164709|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
464398|NCT01164709|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
464399|NCT01164709|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
464400|NCT01164709|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
464401|NCT01164709|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
464402|NCT01164709|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
464403|NCT01164709|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
464404|NCT01164709|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
464405|NCT01164709|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
464406|NCT01164709|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
464641|NCT01163903|Pantoprazole|pantoprazole
464407|NCT01164709|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
464408|NCT01164709|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
464409|NCT01164709|prolymphocytic leukemia|prolymphocytic leukemia
464410|NCT01164696|Quality of Life, Health Care Costs|quality of life, health care costs
464411|NCT01164683|sleep apnea|sleep apnea
464412|NCT01164683|adherence|adherence
464413|NCT01164657|upright position|upright position
464414|NCT01164657|birth position|birth position
464415|NCT01164657|childbirth|childbirth
464416|NCT01164657|instrumental deliveries|instrumental deliveries
464417|NCT01164657|primiparous|primiparous
464418|NCT01164644|ecchymosis|ecchymosis
464419|NCT01164644|bruising|bruising
464420|NCT01164644|rhinoplasty|rhinoplasty
464421|NCT01164644|nose job|nose job
464422|NCT01164644|arnica|arnica
464423|NCT01164644|arnica montana|arnica montana
464424|NCT01164631|Sleep Apnea Syndrome|sleep apnea syndrome
464425|NCT01164631|Orthodontics|orthodontics
464426|NCT01164631|Tonsillectomy|tonsillectomy
464427|NCT01164631|Child|child
464428|NCT01164618|pediatrics|pediatrics
464429|NCT01164618|Remote ischemic preconditioning|remote ischemic preconditioning
464430|NCT01164605|NRTI-regimen|nrti-regimen
464431|NCT01164605|Raltegravir|raltegravir
464432|NCT01164605|Elvitegravir|elvitegravir
464433|NCT01164605|HIV-1 integrase inhibitor|hiv-1 integrase inhibitor
464434|NCT01164605|Fat Waste|fat waste
464435|NCT01164592|Heart failure (HF)|heart failure (hf)
464436|NCT01164592|Sleep disordered breathing (SDB)|sleep disordered breathing (sdb)
464437|NCT01164592|Cheyne Stokes Respiration (CSR)|cheyne stokes respiration (csr)
464438|NCT01164592|Adaptive Servoventilation (ASV)|adaptive servoventilation (asv)
464439|NCT01164579|Early Rheumatoid Arthritis|early rheumatoid arthritis
464440|NCT01164579|Joint Structure|joint structure
464441|NCT01164579|Magnetic Resonance Imaging|magnetic resonance imaging
464442|NCT01164579|Janus Kinase (JAK) Inhibitor|janus kinase (jak) inhibitor
464443|NCT01164579|Tasocitinib|tasocitinib
464444|NCT01164579|Tofacitinib|tofacitinib
464445|NCT01164553|influenza, pediatric, vaccine|influenza, pediatric, vaccine
464446|NCT01164540|Deep venous thrombosis|deep venous thrombosis
464447|NCT01164540|Pulmonary embolism|pulmonary embolism
464448|NCT01164540|rosuvastatin treatment|rosuvastatin treatment
464449|NCT01164514|bacterial sepsis, septicemia, vaccine|bacterial sepsis, septicemia, vaccine
464450|NCT01164449|algorithm|algorithm
464451|NCT01164449|tight glycemic control|tight glycemic control
464452|NCT01164449|glucose control|glucose control
464453|NCT01164449|intensive care|intensive care
464454|NCT01164449|insulin|insulin
464455|NCT01164449|ICU|icu
464456|NCT01164423|algorithm|algorithm
464457|NCT01164423|tight glycemic control|tight glycemic control
464458|NCT01164423|glucose control|glucose control
464459|NCT01164423|intensive care|intensive care
464460|NCT01164423|insulin|insulin
464461|NCT01164423|ICU|icu
464462|NCT01164397|Hypercholesterolemia|hypercholesterolemia
464463|NCT01164397|Statins|statins
464464|NCT01164371|coronary disease|coronary disease
464465|NCT01164371|cardiovascular disease|cardiovascular disease
464466|NCT01164371|cardiovascular risk|cardiovascular risk
464467|NCT01164371|cardiovascular risk management|cardiovascular risk management
464468|NCT01164371|primary care|primary care
464469|NCT01164371|angina|angina
464470|NCT01164371|stable angina|stable angina
464471|NCT01164371|angina pectoris|angina pectoris
464472|NCT01164371|acute coronary syndrome|acute coronary syndrome
464473|NCT01164371|coronary death|coronary death
464474|NCT01164371|unheralded acute coronary syndrome|unheralded acute coronary syndrome
464475|NCT01164371|unheralded coronary death|unheralded coronary death
464476|NCT01164371|gender differences|gender differences
464477|NCT01164371|sex differences|sex differences
464478|NCT01164371|myocardial infarction|myocardial infarction
464479|NCT01164371|ST elevation myocardial infarction|st elevation myocardial infarction
464480|NCT01164371|non ST elevation myocardial infarction|non st elevation myocardial infarction
464481|NCT01164371|STEMI|stemi
464482|NCT01164371|nSTEMI|nstemi
464483|NCT01164371|unstable angina|unstable angina
464484|NCT01164358|Presbyopia|presbyopia
464485|NCT01164358|INTRACOR|intracor
464486|NCT01164358|patient satisfaction|patient satisfaction
464487|NCT01164358|long term|long term
464488|NCT01164345|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
464489|NCT01164345|Hodgkin's lymphoma|hodgkin's lymphoma
464490|NCT01164345|stem cell mobilization|stem cell mobilization
464491|NCT01164345|autologous stem cell transplantation|autologous stem cell transplantation
464492|NCT01164319|Atrial fibrillation|atrial fibrillation
464493|NCT01164319|Percutaneous continous monitoring|percutaneous continous monitoring
464494|NCT01164319|ablation|ablation
464495|NCT01164306|LifeSkills Training|lifeskills training
464496|NCT01164306|Tobacco prevention|tobacco prevention
464497|NCT01164306|Tobacco cessation|tobacco cessation
464498|NCT01164306|Healthy lifestyles|healthy lifestyles
464499|NCT01164306|Tobacco control|tobacco control
464500|NCT01164293|Atopy patch test|atopy patch test
464501|NCT01164254|Exposure Assessment|exposure assessment
464502|NCT01164254|Web-Based Dietary Assessment|web-based dietary assessment
464503|NCT01164254|Web-Based Physical Activity Assessment|web-based physical activity assessment
464504|NCT01164241|Eczema|eczema
464505|NCT01164241|Allergy|allergy
464506|NCT01164241|Immunodeficiency|immunodeficiency
464507|NCT01164241|Netherton's Syndrome|netherton's syndrome
464508|NCT01164241|Piebaldism|piebaldism
464509|NCT01164228|recurrent renal cell cancer|recurrent renal cell cancer
464510|NCT01164228|stage IV renal cell cancer|stage iv renal cell cancer
464511|NCT01164228|clear cell renal cell carcinoma|clear cell renal cell carcinoma
464512|NCT01164228|papillary renal cell carcinoma|papillary renal cell carcinoma
464513|NCT01164228|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
464514|NCT01164215|neutropenia|neutropenia
464515|NCT01164215|diarrhea|diarrhea
464516|NCT01164215|stage I colon cancer|stage i colon cancer
464517|NCT01164215|stage II colon cancer|stage ii colon cancer
464518|NCT01164215|stage III colon cancer|stage iii colon cancer
464519|NCT01164215|stage IV colon cancer|stage iv colon cancer
464520|NCT01164215|recurrent colon cancer|recurrent colon cancer
464521|NCT01164215|stage I rectal cancer|stage i rectal cancer
464522|NCT01164215|stage II rectal cancer|stage ii rectal cancer
464523|NCT01164215|stage III rectal cancer|stage iii rectal cancer
464524|NCT01164215|stage IV rectal cancer|stage iv rectal cancer
464525|NCT01164215|recurrent rectal cancer|recurrent rectal cancer
464526|NCT01164202|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
464527|NCT01164202|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
464642|NCT01163903|Doxorubicin|doxorubicin
464528|NCT01164202|advanced adult primary liver cancer|advanced adult primary liver cancer
464529|NCT01164189|adult anaplastic astrocytoma|adult anaplastic astrocytoma
464530|NCT01164189|adult diffuse astrocytoma|adult diffuse astrocytoma
464531|NCT01164189|adult pilocytic astrocytoma|adult pilocytic astrocytoma
464532|NCT01164189|adult pineal gland astrocytoma|adult pineal gland astrocytoma
464533|NCT01164189|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
464534|NCT01164189|adult oligodendroglioma|adult oligodendroglioma
464535|NCT01164189|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
464536|NCT01164189|recurrent adult brain tumor|recurrent adult brain tumor
464537|NCT01164189|adult giant cell glioblastoma|adult giant cell glioblastoma
464538|NCT01164189|adult glioblastoma|adult glioblastoma
464539|NCT01164189|adult gliosarcoma|adult gliosarcoma
464540|NCT01164189|adult mixed glioma|adult mixed glioma
464541|NCT01164176|anaplastic thyroid cancer|anaplastic thyroid cancer
464542|NCT01164176|insular thyroid cancer|insular thyroid cancer
464543|NCT01164176|recurrent thyroid cancer|recurrent thyroid cancer
464544|NCT01164176|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
464545|NCT01164176|stage III papillary thyroid cancer|stage iii papillary thyroid cancer
464546|NCT01164176|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
464547|NCT01164176|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
464548|NCT01164176|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
464549|NCT01164163|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
464550|NCT01164163|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
464551|NCT01164163|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
464552|NCT01164163|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
464553|NCT01164163|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
464554|NCT01164163|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
464555|NCT01164163|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
464556|NCT01164163|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
464557|NCT01164163|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
464558|NCT01164163|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
464559|NCT01164163|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
464560|NCT01164163|polycythemia vera|polycythemia vera
464561|NCT01164163|essential thrombocythemia|essential thrombocythemia
464562|NCT01164163|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
464563|NCT01164163|acute myeloid leukemia/transient myeloproliferative disorder|acute myeloid leukemia/transient myeloproliferative disorder
464564|NCT01164163|primary myelofibrosis|primary myelofibrosis
464565|NCT01164150|gastrointestinal complications|gastrointestinal complications
464566|NCT01164150|urinary complications|urinary complications
464567|NCT01164150|radiation toxicity|radiation toxicity
464568|NCT01164150|recurrent endometrial carcinoma|recurrent endometrial carcinoma
464569|NCT01164150|endometrial adenocarcinoma|endometrial adenocarcinoma
464570|NCT01164150|stage IA endometrial carcinoma|stage ia endometrial carcinoma
464571|NCT01164150|stage IB endometrial carcinoma|stage ib endometrial carcinoma
464572|NCT01164150|stage II endometrial carcinoma|stage ii endometrial carcinoma
464573|NCT01164150|stage IIIA endometrial carcinoma|stage iiia endometrial carcinoma
464574|NCT01164150|stage IIIB endometrial carcinoma|stage iiib endometrial carcinoma
464575|NCT01164150|stage IIIC endometrial carcinoma|stage iiic endometrial carcinoma
464576|NCT01164137|Adverse Drug Events|adverse drug events
464577|NCT01164137|Medication Reconciliation|medication reconciliation
464578|NCT01164137|Pharmacist-led Intervention|pharmacist-led intervention
464579|NCT01164124|extremely low birth weight|extremely low birth weight
464580|NCT01164124|probiotics|probiotics
464581|NCT01164124|growth|growth
464582|NCT01164124|nutrition|nutrition
464583|NCT01164124|premature infants|premature infants
464584|NCT01164124|growth in extremely low birth weight infants|growth in extremely low birth weight infants
464585|NCT01164111|osteoarthritis|osteoarthritis
464586|NCT01164111|hip arthroplasty|hip arthroplasty
464587|NCT01164111|resistance training|resistance training
464588|NCT01164111|preoperative training|preoperative training
464589|NCT01164085|Inflammation|inflammation
464590|NCT01164085|Macular Edema|macular edema
464591|NCT01164072|electronic cigarette|electronic cigarette
464592|NCT01164072|nicotine|nicotine
464593|NCT01164072|smoking cessation|smoking cessation
464594|NCT01164072|smoking reduction|smoking reduction
464595|NCT01164059|Schizophrenia|schizophrenia
464596|NCT01164059|atypical antipsychotic drugs|atypical antipsychotic drugs
464597|NCT01164059|conventional antipsychotic drugs|conventional antipsychotic drugs
464598|NCT01164059|olanzapine|olanzapine
464599|NCT01164059|quetiapine|quetiapine
464600|NCT01164059|aripiprazole|aripiprazole
464601|NCT01164059|haloperidol|haloperidol
464602|NCT01164059|flupentixol|flupentixol
464603|NCT01164046|anticoagulants|anticoagulants
464604|NCT01164046|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight
464605|NCT01164046|4-Hydroxycoumarins|4-hydroxycoumarins
464606|NCT01164046|recurrent venous thrombosis|recurrent venous thrombosis
464607|NCT01164020|cognition|cognition
464608|NCT01164020|supplementation creatine|supplementation creatine
464609|NCT01164020|resistance training|resistance training
464610|NCT01164020|aging|aging
464611|NCT01163994|erythema migrans|erythema migrans
464612|NCT01163994|Lyme borreliosis|lyme borreliosis
464613|NCT01163994|ceftriaxone treatment|ceftriaxone treatment
464614|NCT01163994|doxycycline treatment|doxycycline treatment
464615|NCT01163994|outcome|outcome
464616|NCT01163994|subjective symptoms|subjective symptoms
464617|NCT01163981|duplex Ultrasound|duplex ultrasound
464618|NCT01163981|Haemodialysis|haemodialysis
464619|NCT01163981|Vascular Access|vascular access
464620|NCT01163968|Weight reduction|weight reduction
464621|NCT01163968|Cardiac revascularization|cardiac revascularization
464622|NCT01163968|Percutaneous Coronary Intervention|percutaneous coronary intervention
464623|NCT01163968|Cardiac Rehabilitation|cardiac rehabilitation
464624|NCT01163968|Rural|rural
464625|NCT01163955|Posture analysis|posture analysis
464626|NCT01163955|Video gaming|video gaming
464627|NCT01163955|Forward Head Position|forward head position
464628|NCT01163955|Rounded Shoulder Position|rounded shoulder position
464629|NCT01163955|Spine Posture|spine posture
464630|NCT01163929|breast cancer|breast cancer
464631|NCT01163929|HER2 positive|her2 positive
464632|NCT01163929|Phase II|phase ii
464633|NCT01163929|RAD001|rad001
464634|NCT01163929|paclitaxel|paclitaxel
464635|NCT01163929|trastuzumab|trastuzumab
464636|NCT01163929|everolimus|everolimus
464637|NCT01163916|Rheumatoid Arthritis|rheumatoid arthritis
464638|NCT01163916|Psoriatic Arthritis|psoriatic arthritis
464639|NCT01163916|Ankylosing Spondylitis|ankylosing spondylitis
464640|NCT01163903|Advanced solid tumours|advanced solid tumours
464643|NCT01163903|PANTO IV|panto iv
464644|NCT01163903|Adriamycin|adriamycin
464645|NCT01163903|no standard treatment options|no standard treatment options
464646|NCT01163903|dose-escalation schedule|dose-escalation schedule
464647|NCT01163903|Phase I|phase i
464648|NCT01163903|single-centre|single-centre
464649|NCT01163903|open label|open label
464650|NCT01163903|dose finding|dose finding
464651|NCT01163903|recommended phase II dose|recommended phase ii dose
464652|NCT01163903|proton pump inhibitor|proton pump inhibitor
464653|NCT01163903|advanced cancer|advanced cancer
464654|NCT01163903|anthracycline|anthracycline
464655|NCT01163903|gastric acid secretion|gastric acid secretion
464656|NCT01163890|Depression|depression
464657|NCT01163890|Work Performance and Productivity|work performance and productivity
464658|NCT01163890|Worksite Intervention|worksite intervention
464659|NCT01163877|iron absorption|iron absorption
464660|NCT01163877|iron utilization|iron utilization
464661|NCT01163877|malaria|malaria
464662|NCT01163877|helminth|helminth
464663|NCT01163877|Ivory Coast|ivory coast
464664|NCT01163877|Acute symptomatic uncomplicated falciparum malaria|acute symptomatic uncomplicated falciparum malaria
464665|NCT01163877|Asymptomatic falciparum malaria|asymptomatic falciparum malaria
464666|NCT01163877|Moderate to heavy hookworm infection|moderate to heavy hookworm infection
464667|NCT01163877|Heavy Schistosoma haematobium infection|heavy schistosoma haematobium infection
464668|NCT01163864|smoking|smoking
464669|NCT01163864|smoking relapse|smoking relapse
464670|NCT01163864|smoking cessation|smoking cessation
464671|NCT01163864|pregnancy|pregnancy
464672|NCT01163864|smoking cessation in pregnant women|smoking cessation in pregnant women
464673|NCT01163851|Hypercholesterolemia|hypercholesterolemia
464674|NCT01163851|Dyslipidemia|dyslipidemia
464675|NCT01163851|LDL|ldl
464676|NCT01163851|Cholesterol|cholesterol
464677|NCT01163851|High Cholesterol|high cholesterol
464678|NCT01163851|PF-04950615|pf-04950615
464679|NCT01163851|RN316|rn316
464680|NCT01163838|Hypercholesterolemia|hypercholesterolemia
464681|NCT01163838|Dyslipidemia|dyslipidemia
464682|NCT01163838|LDL|ldl
464683|NCT01163838|Cholesterol|cholesterol
464684|NCT01163838|High Cholesterol|high cholesterol
464685|NCT01163812|D2 lymph node dissection|d2 lymph node dissection
464686|NCT01163799|Kidney|kidney
464687|NCT01163799|Transplant|transplant
464688|NCT01163799|Northwestern|northwestern
464689|NCT01163799|Calcineurin Inhibitor|calcineurin inhibitor
464690|NCT01163799|Corticosteroids|corticosteroids
464691|NCT01163799|Steroid avoidance|steroid avoidance
464692|NCT01163786|Bortezomib GVHD Bronchiolitis Obliterans|bortezomib gvhd bronchiolitis obliterans
464693|NCT01163773|Cardiovascular disease|cardiovascular disease
464694|NCT01163773|Milk|milk
464695|NCT01163773|Metabolic syndrome|metabolic syndrome
464696|NCT01163773|Blood lipids|blood lipids
464697|NCT01163773|Menopausal women|menopausal women
464698|NCT01163734|Heart Failure with Preserved Ejection Fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
464699|NCT01163734|Coronary Artery Disease (CAD)|coronary artery disease (cad)
464700|NCT01163721|Type 2 diabetes mellitus|type 2 diabetes mellitus
464701|NCT01163721|T2DM|t2dm
464702|NCT01163721|Ranolazine|ranolazine
464703|NCT01163721|Ranexa|ranexa
464704|NCT01163721|HbA1c|hba1c
464705|NCT01163695|economic empowerment model, orphans, sub-Saharan Africa|economic empowerment model, orphans, sub-saharan africa
464706|NCT01163682|Taxane induced neuropathy|taxane induced neuropathy
464707|NCT01163669|hyperparathyroidism|hyperparathyroidism
464708|NCT01163656|Neonate|neonate
464709|NCT01163656|Laryngoscopes|laryngoscopes
464710|NCT01163630|open label, randomized|open label, randomized
464711|NCT01163630|single-center|single-center
464712|NCT01163630|2-way crossover|2-way crossover
464713|NCT01163630|food interaction study|food interaction study
464714|NCT01163617|Rheumatoid|rheumatoid
464715|NCT01163617|Arthritis|arthritis
464716|NCT01163604|Argatroban|argatroban
464717|NCT01163604|intracranial artery stenting|intracranial artery stenting
464718|NCT01163604|extracranial artery stenting|extracranial artery stenting
464719|NCT01163604|occlusion|occlusion
464721|NCT01163591|Diabetes|diabetes
464722|NCT01163591|Nephropathy|nephropathy
464723|NCT01163591|Screening|screening
464724|NCT01163578|Transplantation|transplantation
464725|NCT01163578|Rejection|rejection
464726|NCT01163565|Thyroidectomy|thyroidectomy
464727|NCT01163552|pleural metastases|pleural metastases
464728|NCT01163513|ethnicity|ethnicity
464729|NCT01163513|prognosis|prognosis
464730|NCT01163474|Telemedicine|telemedicine
464731|NCT01163474|Surgery, Cardiac|surgery, cardiac
464732|NCT01163448|Prostate|prostate
464733|NCT01163448|Radiation|radiation
464734|NCT01163448|Radical prostatectomy|radical prostatectomy
464735|NCT01163448|09-013|09-013
464736|NCT01163435|Helicobacter pylori|helicobacter pylori
464737|NCT01163435|antibiotic resistance|antibiotic resistance
464738|NCT01163435|high dose dual therapy|high dose dual therapy
464739|NCT01163435|sequential therapy|sequential therapy
464740|NCT01163435|clarithromycin-based triple therapy|clarithromycin-based triple therapy
464741|NCT01163435|levofloxacin-based triple therapy|levofloxacin-based triple therapy
464742|NCT01163422|Right ventricular failure|right ventricular failure
464743|NCT01163422|Pacemaker|pacemaker
464744|NCT01163422|Cardiac resynchronization therapy|cardiac resynchronization therapy
464745|NCT01163422|Pulmonary hypertension|pulmonary hypertension
464746|NCT01163409|juvenile fibromyalgia|juvenile fibromyalgia
464747|NCT01163409|acupuncture|acupuncture
464748|NCT01163409|exercise training|exercise training
464749|NCT01163383|Refractory Neuroblastoma|refractory neuroblastoma
464750|NCT01163383|Recurrent Neuroblastoma|recurrent neuroblastoma
464751|NCT01163383|Neuroblastoma|neuroblastoma
464752|NCT01163383|stage IV neuroblastoma|stage iv neuroblastoma
464753|NCT01163383|metastatic pheochromocytoma|metastatic pheochromocytoma
464754|NCT01163383|paraganglioma|paraganglioma
464755|NCT01163370|creatine supplementation|creatine supplementation
464756|NCT01163370|resistance training|resistance training
464757|NCT01163370|osteopenia|osteopenia
464758|NCT01163370|osteoporosis|osteoporosis
464759|NCT01163370|bone mineral density|bone mineral density
464760|NCT01163344|Gait, balance, Parkinson's Disease|gait, balance, parkinson's disease
464761|NCT01163331|Parkinson's Disease, voice quality, vocal strength, voice loudness|parkinson's disease, voice quality, vocal strength, voice loudness
464762|NCT01163318|Rheumatoid Arthritis|rheumatoid arthritis
464763|NCT01163305|Identifying an early indicator of drug efficacy|identifying an early indicator of drug efficacy
464764|NCT01163292|Rheumatoid Arthritis|rheumatoid arthritis
464765|NCT01163279|Age-related changes|age-related changes
464766|NCT01163266|Major Depressive Disorder|major depressive disorder
464767|NCT01163266|Depression|depression
464768|NCT01163266|Melancholia|melancholia
464769|NCT01163266|Drug Therapy|drug therapy
464770|NCT01163253|chronic|chronic
464771|NCT01163253|severe|severe
464772|NCT01163253|treatment|treatment
464773|NCT01163253|safety|safety
464774|NCT01163253|CP-690,55|cp-690,55
464775|NCT01163253|Plaque Psoriasis|plaque psoriasis
464776|NCT01163253|Psoriasis Vulgaris|psoriasis vulgaris
464777|NCT01163253|Xeljanz|xeljanz
464778|NCT01163253|Tofacitinib|tofacitinib
464779|NCT01163240|hepatitis B|hepatitis b
464780|NCT01163240|HBV|hbv
464781|NCT01163240|chronic hepatitis B|chronic hepatitis b
464782|NCT01163240|pediatric|pediatric
464783|NCT01163227|Hallucinations,|hallucinations,
464784|NCT01163227|psychotic,|psychotic,
464785|NCT01163227|delusions,|delusions,
464786|NCT01163227|cognitive deficits|cognitive deficits
464787|NCT01163188|very low birthweight/ very preterm children|very low birthweight/ very preterm children
464788|NCT01163188|Bavarian Longitudinal Study (BLS)|bavarian longitudinal study (bls)
464789|NCT01163188|Quality of life and social adjustment in adulthood|quality of life and social adjustment in adulthood
464790|NCT01163175|Cardiovascular disease|cardiovascular disease
464791|NCT01163175|Trans fatty acids|trans fatty acids
464792|NCT01163175|Ruminant|ruminant
464793|NCT01163175|Blood lipids|blood lipids
464794|NCT01163162|Chronic Kidney Disease|chronic kidney disease
464795|NCT01163162|Vitamin D|vitamin d
464796|NCT01163149|Hypophosphatasia|hypophosphatasia
464797|NCT01163149|HPP|hpp
464798|NCT01163149|Bone Disease|bone disease
464799|NCT01163149|Soft Bones|soft bones
464800|NCT01163149|Low Alkaline Phosphatase|low alkaline phosphatase
464801|NCT01163149|genetic metabolic disorder|genetic metabolic disorder
464802|NCT01163149|alkaline phosphatase|alkaline phosphatase
464803|NCT01163149|tissue-specific alkaline phosphatase (TNSALP)|tissue-specific alkaline phosphatase (tnsalp)
464804|NCT01163149|rickets|rickets
464805|NCT01163149|osteomalacia|osteomalacia
464806|NCT01163136|Parental decision making|parental decision making
464807|NCT01163136|Decision Making in Serious Pediatric Illness (DSPI)|decision making in serious pediatric illness (dspi)
464808|NCT01163136|palliative care decision making|palliative care decision making
464809|NCT01163123|Subclinical infection of Japanese encephalitis virus|subclinical infection of japanese encephalitis virus
464810|NCT01163045|neurostimulation|neurostimulation
464811|NCT01163045|intraoperative neuromonitoring|intraoperative neuromonitoring
464812|NCT01163045|recurrent laryngeal nerve|recurrent laryngeal nerve
464813|NCT01163045|palsy of recurrent laryngeal nerve|palsy of recurrent laryngeal nerve
464814|NCT01163045|RCT|rct
464815|NCT01163032|Blindness|blindness
464816|NCT01163032|Eye Diseases|eye diseases
464817|NCT01163032|Nap Disorders|nap disorders
464818|NCT01163032|Circadian Rhythm Disorders|circadian rhythm disorders
464819|NCT01163032|Sleep disorders|sleep disorders
464820|NCT01163032|Circadian Rhythm Sleep Disorders|circadian rhythm sleep disorders
464821|NCT01163032|Dyssomnias|dyssomnias
464822|NCT01163032|Nervous System Diseases|nervous system diseases
464823|NCT01163019|Chest pain|chest pain
464824|NCT01163019|acute coronary syndrome|acute coronary syndrome
464825|NCT01163019|Emergency department|emergency department
464826|NCT01163019|speckle tracking imaging|speckle tracking imaging
464827|NCT01163019|2D strain|2d strain
464828|NCT01163019|Echocardiography|echocardiography
464829|NCT01162993|Electric stimulation therapy|electric stimulation therapy
464830|NCT01162993|Diabetic Neuropathies|diabetic neuropathies
464831|NCT01162980|ACE inhibitors|ace inhibitors
464832|NCT01162980|ARBs|arbs
464833|NCT01162954|Eye drop, Dry eye|eye drop, dry eye
464834|NCT01162941|ITP|itp
464835|NCT01162928|critically ill, mechanically ventilated patients requiring enteral and parenteral nutritional support|critically ill, mechanically ventilated patients requiring enteral and parenteral nutritional support
464836|NCT01162915|Spinal Cord Injury|spinal cord injury
464837|NCT01162889|pharmacokinetics|pharmacokinetics
464838|NCT01162889|Crohn's disease|crohn's disease
464839|NCT01162876|Diabetes, Type 2|diabetes, type 2
464840|NCT01162863|IBSC|ibsc
464841|NCT01162863|irritable bowel syndrome|irritable bowel syndrome
464842|NCT01162863|constipation|constipation
464843|NCT01162850|Melasma|melasma
464844|NCT01162837|Acne|acne
464845|NCT01162824|Endothelial Dysfunction|endothelial dysfunction
464846|NCT01162824|Microvascular dysfunction|microvascular dysfunction
464847|NCT01162824|Coronary artery spasm|coronary artery spasm
464848|NCT01162824|Inflammation|inflammation
464849|NCT01162824|CD4+CD28null T cells|cd4+cd28null t cells
464850|NCT01162824|Myocardial ischemia|myocardial ischemia
464851|NCT01162824|Early atherosclerosis|early atherosclerosis
464852|NCT01162811|Visualization|visualization
464853|NCT01162811|relaxation|relaxation
464854|NCT01162811|self hypnotic relaxation|self hypnotic relaxation
464855|NCT01162811|hypnosis|hypnosis
464856|NCT01162811|invasive medical procedures|invasive medical procedures
464857|NCT01162811|atrial fibrillation|atrial fibrillation
464858|NCT01162811|ablation|ablation
464859|NCT01162811|catheter ablation|catheter ablation
464860|NCT01162811|pain|pain
464861|NCT01162811|anxiety|anxiety
464862|NCT01162798|infant formula|infant formula
464863|NCT01162798|premature infants|premature infants
464864|NCT01162798|Growth and Development|growth and development
464865|NCT01162785|BCG Refractory Superficial Bladder Cancer|bcg refractory superficial bladder cancer
464866|NCT01162785|SCH 721015|sch 721015
464867|NCT01162785|Syn3|syn3
464868|NCT01162785|novel excipient|novel excipient
464869|NCT01162785|interferon -alpha-2b|interferon -alpha-2b
464870|NCT01162785|Intravesical|intravesical
464871|NCT01162785|urine IFNa|urine ifna
464872|NCT01162785|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
464873|NCT01162785|superficial non-muscle invasive tumor|superficial non-muscle invasive tumor
464874|NCT01162759|hypertension, intervention|hypertension, intervention
464875|NCT01162733|Vancomycin|vancomycin
464876|NCT01162733|Therapeutic Levels|therapeutic levels
464877|NCT01162733|Infectious Disease|infectious disease
464878|NCT01162733|Recommendations|recommendations
464879|NCT01162720|Primary knee replacement|primary knee replacement
464880|NCT01162720|Unilateral knee replacement|unilateral knee replacement
464881|NCT01162694|Remote Blood Glucose Monitoring System,|remote blood glucose monitoring system,
464882|NCT01162694|Continuous Glucose Monitoring System,|continuous glucose monitoring system,
464883|NCT01162694|Type 2 Diabetes|type 2 diabetes
464884|NCT01162681|SLE|sle
464885|NCT01162681|Lupus|lupus
464886|NCT01162681|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
464887|NCT01162681|Autoimmune Diseases|autoimmune diseases
464888|NCT01162681|A-623|a-623
464889|NCT01162681|Blisibimod|blisibimod
464890|NCT01162668|bariatric surgery|bariatric surgery
464891|NCT01162668|obesity|obesity
464892|NCT01162668|outcomes|outcomes
464893|NCT01162655|Insomnia|insomnia
464894|NCT01162655|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
464895|NCT01162655|Internet|internet
464896|NCT01162655|Telehealth|telehealth
464897|NCT01162642|Healthy moderately heavy smokers|healthy moderately heavy smokers
464898|NCT01162629|bounded saddles|bounded saddles
464899|NCT01162629|missing teeth|missing teeth
464900|NCT01162629|dental implants|dental implants
464901|NCT01162629|Tooth, Nonvital|tooth, nonvital
464902|NCT01162616|iron absorption|iron absorption
464903|NCT01162616|polyphenols|polyphenols
464904|NCT01162616|sodium iron EDTA|sodium iron edta
464905|NCT01162616|sorghum|sorghum
464906|NCT01162590|Human Rotavirus vaccine|human rotavirus vaccine
464907|NCT01162577|Weight|weight
464908|NCT01162577|Smoking|smoking
464909|NCT01162577|Quitline|quitline
464910|NCT01162551|Leukemia|leukemia
464911|NCT01162551|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
465007|NCT01162226|balance|balance
464912|NCT01162538|Raltegravir, non B subtype, naive patients|raltegravir, non b subtype, naive patients
464913|NCT01162525|Fecal Incontinence|fecal incontinence
464914|NCT01162525|Fecal Urge Incontinence|fecal urge incontinence
464915|NCT01162525|Percutaneous tibial nerve stimulation|percutaneous tibial nerve stimulation
464916|NCT01162512|physical activity|physical activity
464917|NCT01162512|obesity|obesity
464918|NCT01162512|adolescents|adolescents
464919|NCT01162512|telephone|telephone
464920|NCT01162512|BMI|bmi
464921|NCT01162512|body mass index|body mass index
464922|NCT01162499|Post prandial hypoglycemia|post prandial hypoglycemia
464923|NCT01162499|hypoglycemia|hypoglycemia
464924|NCT01162499|Nissen fundoplication|nissen fundoplication
464925|NCT01162499|Dumping|dumping
464926|NCT01162486|Anti-infective agents|anti-infective agents
464927|NCT01162486|Anti-bacterial agents|anti-bacterial agents
464928|NCT01162486|Rifampin|rifampin
464929|NCT01162486|Rifapentine|rifapentine
464930|NCT01162486|Midazolam|midazolam
464931|NCT01162486|Molecular mechanisms of pharmacological action|molecular mechanisms of pharmacological action
464932|NCT01162486|Antitubercular agents|antitubercular agents
464933|NCT01162486|Pharmacologic actions|pharmacologic actions
464934|NCT01162473|Food hypersensitivity|food hypersensitivity
464935|NCT01162473|Milk hypersensitivity|milk hypersensitivity
464936|NCT01162473|Milk allergy|milk allergy
464937|NCT01162473|Food allergy|food allergy
464938|NCT01162447|BMP- 4 and 7, polycystic ovarian syndrome|bmp- 4 and 7, polycystic ovarian syndrome
464939|NCT01162434|Treatment resistant depression|treatment resistant depression
464940|NCT01162434|Deep brain stimulation|deep brain stimulation
464941|NCT01162434|Brain volumetric analysis|brain volumetric analysis
464942|NCT01162421|Rheumatoid Arthritis|rheumatoid arthritis
464943|NCT01162421|Anti-Inflammatory|anti-inflammatory
464944|NCT01162421|Biological Therapy|biological therapy
464945|NCT01162421|adalimumab|adalimumab
464946|NCT01162421|Disease-Modifying Antirheumatic Drugs|disease-modifying antirheumatic drugs
464947|NCT01162421|Antirheumatic Agents|antirheumatic agents
464948|NCT01162421|Agents|agents
464949|NCT01162408|ICU|icu
464950|NCT01162395|Prostate Cancer|prostate cancer
464951|NCT01162395|Tumour|tumour
464952|NCT01162395|Castration Resistant|castration resistant
464953|NCT01162395|Prostate Androgen Receptor Down Regulator|prostate androgen receptor down regulator
464954|NCT01162395|Metastatic|metastatic
464955|NCT01162382|transcranial magnetic stimulation|transcranial magnetic stimulation
464956|NCT01162382|TMS|tms
464957|NCT01162382|rTMS|rtms
464958|NCT01162382|depression|depression
464959|NCT01162382|fcMRI|fcmri
464960|NCT01162382|EEG|eeg
464961|NCT01162369|Delirium, diagnosis, elderly, hospitalization|delirium, diagnosis, elderly, hospitalization
464962|NCT01162356|Vitrectomy|vitrectomy
464963|NCT01162356|Glaucoma|glaucoma
464964|NCT01162356|Macula|macula
464965|NCT01162356|Optic nerve|optic nerve
464966|NCT01162356|Ocular Coherence Tomography|ocular coherence tomography
464967|NCT01162343|Delirium, diagnosis, elderly, hospitalization|delirium, diagnosis, elderly, hospitalization
464968|NCT01162330|Screening|screening
464969|NCT01162330|Congenital Cytomegalovirus|congenital cytomegalovirus
464970|NCT01162330|CMV|cmv
464971|NCT01162330|Hearing loss|hearing loss
464972|NCT01162317|Acupuncture|acupuncture
464973|NCT01162317|Sleep|sleep
464974|NCT01162317|Traumatic brain injury|traumatic brain injury
464975|NCT01162304|Chronic Pain|chronic pain
464976|NCT01162304|This clinical trial will compare immediate-release (IR)|this clinical trial will compare immediate-release (ir)
464977|NCT01162304|oxycodone and extended-release (ER) oxycodone in the|oxycodone and extended-release (er) oxycodone in the
464978|NCT01162304|management of chronic pain|management of chronic pain
464979|NCT01162291|intramuscular|intramuscular
464980|NCT01162291|distribution|distribution
464981|NCT01162291|NaCl|nacl
464982|NCT01162291|botulinum toxin|botulinum toxin
464983|NCT01162291|muscle|muscle
464984|NCT01162291|volume|volume
464985|NCT01162291|movement|movement
464986|NCT01162291|biceps brachii|biceps brachii
464987|NCT01162291|primary distribution of intramuscular NaCl representative for primary distribution of intramuscular botulinum toxin|primary distribution of intramuscular nacl representative for primary distribution of intramuscular botulinum toxin
464988|NCT01162291|shift from extracellular to intracellular viewed by DTI technology|shift from extracellular to intracellular viewed by dti technology
464989|NCT01162291|effect of volume|effect of volume
464990|NCT01162291|effect of muscle movement|effect of muscle movement
464991|NCT01162278|liver metastases|liver metastases
464992|NCT01162278|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
464993|NCT01162265|Tuberculosis|tuberculosis
464994|NCT01162265|IGRA|igra
464995|NCT01162265|latent|latent
464996|NCT01162252|psoriasis|psoriasis
464997|NCT01162252|mindfulness|mindfulness
464998|NCT01162252|MBSR|mbsr
464999|NCT01162252|stress|stress
465000|NCT01162252|living well|living well
465001|NCT01162239|smoking|smoking
465002|NCT01162239|tobacco|tobacco
465003|NCT01162239|nicotine|nicotine
465004|NCT01162239|smoking cessation|smoking cessation
465005|NCT01162226|gait|gait
465006|NCT01162226|movement disorders|movement disorders
465008|NCT01162226|function|function
465009|NCT01162213|Postmenopausal Women|postmenopausal women
465010|NCT01162213|Healthy Males|healthy males
465011|NCT01162213|Cardiovascular|cardiovascular
465012|NCT01162213|Flavanols|flavanols
465013|NCT01162187|secondary prevention|secondary prevention
465014|NCT01162187|aspirin|aspirin
465015|NCT01162187|beta blocker|beta blocker
465016|NCT01162187|ACE inhibitor|ace inhibitor
465017|NCT01162187|statin|statin
465018|NCT01162187|acute coronary syndrome|acute coronary syndrome
465019|NCT01162187|myocardial infarction|myocardial infarction
465020|NCT01162187|unstable angina|unstable angina
465021|NCT01162187|trends|trends
465022|NCT01162174|Flavanols|flavanols
465023|NCT01162174|cardiovascular|cardiovascular
465024|NCT01162161|sphingolipid|sphingolipid
465025|NCT01162161|ceramide|ceramide
465026|NCT01162161|sphingomyelinase|sphingomyelinase
465027|NCT01162148|inspiratory muscle training|inspiratory muscle training
465028|NCT01162148|pulmonary rehabilitation|pulmonary rehabilitation
465029|NCT01162135|Digoxin|digoxin
465030|NCT01162135|Recurrent Prostate Cancer|recurrent prostate cancer
465031|NCT01162135|Prostate Specific Antigen|prostate specific antigen
465032|NCT01162122|Elderly|elderly
465033|NCT01162122|Influenza|influenza
465034|NCT01162122|Immunogenicity|immunogenicity
465035|NCT01162122|Safety|safety
465036|NCT01162122|Adjuvant|adjuvant
465037|NCT01162122|Adjuvanted|adjuvanted
465038|NCT01162122|Adjuvants|adjuvants
465039|NCT01162122|Vaccines|vaccines
465040|NCT01162109|Zinc|zinc
465041|NCT01162109|sepsis|sepsis
465042|NCT01162109|critical illness|critical illness
465043|NCT01162109|mechanical ventilation|mechanical ventilation
465044|NCT01162109|ICU|icu
465045|NCT01162096|Reduced Intensity Haploidentical Transplant|reduced intensity haploidentical transplant
465046|NCT01162083|Exercise Physiology|exercise physiology
465047|NCT01162083|Cardiopulmonary Interaction|cardiopulmonary interaction
465048|NCT01162083|Heart Failure|heart failure
465049|NCT01162070|Uveitis|uveitis
465050|NCT01162070|etiological diagnosis|etiological diagnosis
465051|NCT01162070|standardized strategy|standardized strategy
465052|NCT01162057|Hemodialysis|hemodialysis
465053|NCT01162057|Hearing|hearing
465054|NCT01162057|Hemodialysis patients|hemodialysis patients
465055|NCT01162044|PTSD|ptsd
465056|NCT01162044|prevention|prevention
465057|NCT01162005|Primary Nephrotic syndrome|primary nephrotic syndrome
465058|NCT01161992|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
465059|NCT01161992|PSC|psc
465060|NCT01161992|Cholestatic Liver Disease|cholestatic liver disease
465061|NCT01161953|Primary Biliary Cirrhosis|primary biliary cirrhosis
465062|NCT01161953|PBC|pbc
465063|NCT01161953|Cholestatic Liver Disease|cholestatic liver disease
465064|NCT01161940|Bioavailability|bioavailability
465065|NCT01161940|Nizatidine|nizatidine
465066|NCT01161940|Crossover|crossover
465067|NCT01161927|Bioavailability|bioavailability
465068|NCT01161927|Nizatidine|nizatidine
465069|NCT01161927|Crossover|crossover
465070|NCT01161914|Type I Gaucher|type i gaucher
465071|NCT01161901|ARDS|ards
465072|NCT01161901|Plasmatic biomarkers|plasmatic biomarkers
465073|NCT01161901|Lung Morphology|lung morphology
465074|NCT01161901|Mechanical ventilation|mechanical ventilation
465075|NCT01161901|CT scan|ct scan
465076|NCT01161862|Closed-loop|closed-loop
465077|NCT01161862|Artificial pancreas|artificial pancreas
465078|NCT01161862|Bi-hormonal|bi-hormonal
465079|NCT01161862|Insulin|insulin
465080|NCT01161862|Glucagon|glucagon
465081|NCT01161862|Diabetes mellitus type 1|diabetes mellitus type 1
465082|NCT01161849|lactate|lactate
465083|NCT01161849|urgent surgery|urgent surgery
465084|NCT01161849|major surgery|major surgery
465085|NCT01161849|surgical complications|surgical complications
465086|NCT01161849|possum|possum
465087|NCT01161849|sapsII|sapsii
465088|NCT01161849|relaparotomy|relaparotomy
465089|NCT01161810|Burn|burn
465090|NCT01161810|Rehabilitation|rehabilitation
465091|NCT01161797|1,5-Anhydroglucitol|1,5-anhydroglucitol
465092|NCT01161784|Functional constipation|functional constipation
465093|NCT01161784|Probiotic|probiotic
465094|NCT01161784|Probiotic microorganism|probiotic microorganism
465095|NCT01161784|Lactobacillus casei Shirota (LcS)|lactobacillus casei shirota (lcs)
465096|NCT01161758|physical therapy|physical therapy
465097|NCT01161758|pain threshold|pain threshold
465098|NCT01161758|electromyography|electromyography
465099|NCT01161758|musculoskeletal manipulation|musculoskeletal manipulation
465100|NCT01161758|neck muscles|neck muscles
465101|NCT01161745|sepsis|sepsis
465102|NCT01161732|aortic stenosis|aortic stenosis
465103|NCT01161732|surgery, survival|surgery, survival
465104|NCT01161719|ADHD|adhd
465105|NCT01161719|Parent training|parent training
465106|NCT01161719|Videoconference|videoconference
465107|NCT01161706|vegetable juice|vegetable juice
465108|NCT01161706|cardiovascular|cardiovascular
465109|NCT01161706|blood pressure|blood pressure
465110|NCT01161693|Cesarean section|cesarean section
465111|NCT01161693|spinal anesthesia|spinal anesthesia
465112|NCT01161693|CSE|cse
465113|NCT01161693|ramped up position|ramped up position
465114|NCT01161693|TROOP pillow|troop pillow
465115|NCT01161693|elevation pillow|elevation pillow
465116|NCT01161693|maternal comfort|maternal comfort
465117|NCT01161693|Maternal Comfort after CSE during elective Cesarean Section in relation to adequate height of Anesthetic Block|maternal comfort after cse during elective cesarean section in relation to adequate height of anesthetic block
465118|NCT01161680|Cross sectional and Longitudinal Observational study|cross sectional and longitudinal observational study
465119|NCT01161641|Protein Losing Enteropathy|protein losing enteropathy
465120|NCT01161628|Chronic Graft versus Host Disease|chronic graft versus host disease
465121|NCT01161628|allogeneic stem cell transplant|allogeneic stem cell transplant
465122|NCT01161615|tendonitis and/or bursitis of the shoulder|tendonitis and/or bursitis of the shoulder
465123|NCT01161615|acute tendonitis and/or bursitis of the shoulder|acute tendonitis and/or bursitis of the shoulder
465124|NCT01161602|Symptoms of Gastroesophageal Reflux Disease (GERD)|symptoms of gastroesophageal reflux disease (gerd)
465125|NCT01161589|sensing|sensing
465126|NCT01161589|S-ICD|s-icd
465127|NCT01161589|ICD|icd
465128|NCT01161589|CRT D|crt d
465129|NCT01161576|Batten Disease|batten disease
465130|NCT01161576|Late Infantile Neuronal Lipofuscinosis|late infantile neuronal lipofuscinosis
465131|NCT01161576|gene transfer|gene transfer
465132|NCT01161563|palliative treatment|palliative treatment
465133|NCT01161563|prostate cancer|prostate cancer
465134|NCT01161511|CLL|cll
465135|NCT01161511|SLL|sll
465136|NCT01161511|CD19|cd19
465137|NCT01161498|squamous cell|squamous cell
465138|NCT01161498|OncoVEX^GM-CSF|oncovex^gm-csf
465139|NCT01161498|Oncovex|oncovex
465140|NCT01161498|chemoradiation|chemoradiation
465141|NCT01161498|Cisplatin|cisplatin
465142|NCT01161485|HIV Infections|hiv infections
465143|NCT01161485|Treatment|treatment
465144|NCT01161485|Methamphetamine|methamphetamine
465145|NCT01161459|Idiopathic Membranous Nephropathy|idiopathic membranous nephropathy
465146|NCT01161459|Treatment|treatment
465147|NCT01161459|FK506|fk506
465148|NCT01161459|Tripterygium wilfordii|tripterygium wilfordii
465149|NCT01161446|HIV|hiv
465150|NCT01161446|Home testing|home testing
465151|NCT01161446|Self-testing|self-testing
465152|NCT01161446|HIV Infections/diagnosis|hiv infections/diagnosis
465153|NCT01161446|HIV Infections/prevention and control|hiv infections/prevention and control
465154|NCT01161446|AIDS Serodiagnosis|aids serodiagnosis
465155|NCT01161446|Oral fluids|oral fluids
465156|NCT01161446|Homosexuality, Male|homosexuality, male
465157|NCT01161446|Sexually transmitted diseases|sexually transmitted diseases
465158|NCT01161446|Sexual behavior|sexual behavior
465159|NCT01161433|Asthma|asthma
465160|NCT01161433|Spirometry|spirometry
465161|NCT01161433|Pediatric|pediatric
465162|NCT01161433|Primary Health Care|primary health care
465163|NCT01161433|Education, Distance|education, distance
465164|NCT01161420|tongue|tongue
465165|NCT01161420|surgery|surgery
465166|NCT01161420|neurostimulation|neurostimulation
465167|NCT01161420|hypoglossal nerve|hypoglossal nerve
465168|NCT01161420|upper airway stimulation|upper airway stimulation
465169|NCT01161381|OSAHS|osahs
465170|NCT01161381|nonlinear analysis|nonlinear analysis
465171|NCT01161381|polysomnography|polysomnography
465172|NCT01161381|biosignal analysis|biosignal analysis
465173|NCT01161381|DFA|dfa
465174|NCT01161381|APEN|apen
465175|NCT01161381|LLE|lle
465176|NCT01161368|Metastatic Breast Cancer|metastatic breast cancer
465177|NCT01161355|Safety|safety
465178|NCT01161355|tolerability|tolerability
465179|NCT01161355|healthy|healthy
465180|NCT01161355|microdose|microdose
465181|NCT01161342|Malnutrition|malnutrition
465182|NCT01161342|Aged|aged
465183|NCT01161342|Aged 80 and over|aged 80 and over
465184|NCT01161342|Prevalence|prevalence
465185|NCT01161342|Mortality|mortality
465186|NCT01161329|stroke|stroke
465187|NCT01161329|physical activity|physical activity
465188|NCT01161329|balance|balance
465189|NCT01161329|muscle-strength|muscle-strength
465190|NCT01161316|metastatic colorectal cancer|metastatic colorectal cancer
465191|NCT01161316|wild-type KRAS tumours|wild-type kras tumours
465192|NCT01161316|cetuximab|cetuximab
465193|NCT01161316|mFOLFOX-6|mfolfox-6
465194|NCT01161303|Asthma|asthma
465195|NCT01161303|TNF alpha|tnf alpha
465196|NCT01161303|epithelial cell culture|epithelial cell culture
465197|NCT01161290|Telemedicine|telemedicine
465198|NCT01161290|Internet|internet
465199|NCT01161290|Dyspnea|dyspnea
465200|NCT01161290|Self care|self care
465201|NCT01161290|Breathing Exercises|breathing exercises
465202|NCT01161290|Real-Time Systems|real-time systems
465203|NCT01161277|Aripiprazole|aripiprazole
465204|NCT01161277|Haloperidol|haloperidol
465205|NCT01161277|Ventral striatum|ventral striatum
465206|NCT01161277|Reward|reward
465207|NCT01161277|fMRI|fmri
465208|NCT01161264|Elderly|elderly
465209|NCT01161264|Influenza|influenza
465210|NCT01161264|Immunogenicity|immunogenicity
465211|NCT01161264|Safety|safety
465212|NCT01161264|Influenza vaccine|influenza vaccine
465213|NCT01161251|Atrial Fibrillation|atrial fibrillation
465214|NCT01161251|ABI|abi
465215|NCT01161251|PAD|pad
465216|NCT01161251|Registry|registry
465217|NCT01161251|Italian|italian
465218|NCT01161225|Adolescents|adolescents
465219|NCT01161225|Peer leader program|peer leader program
465220|NCT01161225|asthma camp|asthma camp
465221|NCT01161225|asthma control|asthma control
465222|NCT01161225|quality of life|quality of life
465223|NCT01161225|self-efficacy|self-efficacy
465224|NCT01161225|knowledge|knowledge
465225|NCT01161225|attitudes|attitudes
465226|NCT01161225|barrier perceptions|barrier perceptions
465227|NCT01161212|body mass index|body mass index
465228|NCT01161212|health-related quality of life|health-related quality of life
465229|NCT01161212|physical education|physical education
465230|NCT01161212|children|children
465231|NCT01161212|cluster randomized controlled trial|cluster randomized controlled trial
465232|NCT01161212|prevention|prevention
465233|NCT01161212|Child|child
465234|NCT01161212|French|french
465235|NCT01161212|Schoolchildren|schoolchildren
465236|NCT01161199|HIV|hiv
465237|NCT01161199|latent reservoir|latent reservoir
465238|NCT01161199|functional cure|functional cure
465239|NCT01161199|leukapheresis|leukapheresis
465240|NCT01161186|pancreas|pancreas
465241|NCT01161186|cancer|cancer
465242|NCT01161186|abraxane|abraxane
465243|NCT01161186|metastatic|metastatic
465244|NCT01161186|gemcitabine|gemcitabine
465245|NCT01161186|capecitabine|capecitabine
465246|NCT01161186|adenocarcinoma|adenocarcinoma
465247|NCT01161160|H1N1|h1n1
465248|NCT01161160|Influenza|influenza
465249|NCT01161160|Pandemic|pandemic
465250|NCT01161160|GSK Bio's influenza vaccines GSK2340274A and GSK234072A|gsk bio's influenza vaccines gsk2340274a and gsk234072a
465251|NCT01161121|Fractional flow reserve|fractional flow reserve
465252|NCT01161121|adenosine|adenosine
465253|NCT01161121|regadenoson|regadenoson
465254|NCT01161108|Pediatrics|pediatrics
465255|NCT01161108|Epilepsy|epilepsy
465256|NCT01161108|Insomnia|insomnia
465257|NCT01161108|Melatonin|melatonin
465258|NCT01161095|Intrauterine Device|intrauterine device
465259|NCT01161095|Postpartum contraception|postpartum contraception
465260|NCT01161095|Long-acting reversible contraception|long-acting reversible contraception
465261|NCT01161069|phase 1|phase 1
465262|NCT01161069|healthy young adult volunteers|healthy young adult volunteers
465263|NCT01161069|healthy elderly adult volunteers|healthy elderly adult volunteers
465264|NCT01161043|diabetes|diabetes
465265|NCT01161043|glucose|glucose
465266|NCT01161043|sensor|sensor
465267|NCT01161017|migraine patients|migraine patients
465268|NCT01160991|schizophrenia|schizophrenia
465269|NCT01160991|olanzapine|olanzapine
465270|NCT01160991|atypical antipsychotic drugs|atypical antipsychotic drugs
465271|NCT01160991|amisulpride|amisulpride
465272|NCT01160991|diabetes|diabetes
465273|NCT01160991|insulin resistance|insulin resistance
465274|NCT01160991|insulin secretion|insulin secretion
465275|NCT01160991|glucose|glucose
465276|NCT01160991|euglycemic hyperinsulinemic clamp|euglycemic hyperinsulinemic clamp
465277|NCT01160991|hyperglycemic clamp|hyperglycemic clamp
465278|NCT01160978|Transplantation|transplantation
465279|NCT01160978|Simvastatin treatment|simvastatin treatment
465280|NCT01160978|Ischemia-reperfusion injury|ischemia-reperfusion injury
465281|NCT01160978|Rejection|rejection
465282|NCT01160965|epidural top-up|epidural top-up
465283|NCT01160965|emergency Caesarean section|emergency caesarean section
465284|NCT01160952|primary prophylaxis|primary prophylaxis
465285|NCT01160952|itraconazole|itraconazole
465286|NCT01160952|stem cell transplantation|stem cell transplantation
465287|NCT01160939|Exercise|exercise
465288|NCT01160939|heart failure|heart failure
465289|NCT01160939|rehabilitation|rehabilitation
465290|NCT01160926|rectal cancer|rectal cancer
465291|NCT01160926|capecitabine|capecitabine
465292|NCT01160926|radiotherapy|radiotherapy
465293|NCT01160926|AZD6244|azd6244
465294|NCT01160926|MEK inhibitor|mek inhibitor
465295|NCT01160926|AZD2171|azd2171
465296|NCT01160926|Cediranib|cediranib
465297|NCT01160926|VEGFR inhibitor|vegfr inhibitor
465298|NCT01160926|FLT-PET (fluoro-l-pyrimidine positron emission tomography)|flt-pet (fluoro-l-pyrimidine positron emission tomography)
465299|NCT01160926|DCE-MRI (dynamic contrast enhanced magnetic resonance imaging)|dce-mri (dynamic contrast enhanced magnetic resonance imaging)
465300|NCT01160900|cardiovascular diseases|cardiovascular diseases
465301|NCT01160900|heart disease|heart disease
465302|NCT01160900|hemorrhage|hemorrhage
465303|NCT01160900|coronary angioplasty|coronary angioplasty
465304|NCT01160900|drug eluting stents|drug eluting stents
465305|NCT01160874|Attention Deficit Disorder / Hyperactivity (ADHD)|attention deficit disorder / hyperactivity (adhd)
465306|NCT01160874|Cognition|cognition
465307|NCT01160874|Sleepiness|sleepiness
465308|NCT01160874|Driving|driving
465309|NCT01160848|Moderate to severe Acne Vulgaris|moderate to severe acne vulgaris
465310|NCT01160835|total knee arthroplasty|total knee arthroplasty
465311|NCT01160835|minimally invasive|minimally invasive
465312|NCT01160835|quadriceps-sparing|quadriceps-sparing
465313|NCT01160835|Quadriceps-sparing total knee arthroplasty|quadriceps-sparing total knee arthroplasty
465314|NCT01160822|Osteo arthritis|osteo arthritis
465315|NCT01160822|pain control|pain control
465316|NCT01160822|intra- articular injections|intra- articular injections
465317|NCT01160822|Knee OA|knee oa
465318|NCT01160809|Malaria|malaria
465319|NCT01160809|Mosquito repellent|mosquito repellent
465320|NCT01160809|LLINs|llins
465321|NCT01160783|Autism|autism
465322|NCT01160783|Asperger's Syndrome|asperger's syndrome
465323|NCT01160783|Asperger Syndrome|asperger syndrome
465324|NCT01160783|Autistic Disorder|autistic disorder
465325|NCT01160783|Autism Spectrum Disorder|autism spectrum disorder
465326|NCT01160783|Pervasive Developmental Disorders|pervasive developmental disorders
465327|NCT01160783|Pervasive Developmental Disorder-Not Otherwise Specified|pervasive developmental disorder-not otherwise specified
465328|NCT01160783|Child Development Disorders, Pervasive|child development disorders, pervasive
465329|NCT01160783|PDD-NOS|pdd-nos
465330|NCT01160770|Lennox-Gastaut Syndrome (LGS)|lennox-gastaut syndrome (lgs)
465331|NCT01160770|Epilepsy|epilepsy
465332|NCT01160770|Drop Seizures|drop seizures
465333|NCT01160770|Clobazam|clobazam
465334|NCT01160744|Lung neoplasms|lung neoplasms
465335|NCT01160744|Lung cancer|lung cancer
465336|NCT01160744|Non-small Cell Lung Cancer|non-small cell lung cancer
465337|NCT01160744|pemetrexed|pemetrexed
465338|NCT01160744|ALIMTA®|alimta®
465339|NCT01160744|squamous|squamous
465340|NCT01160744|nonsquamous|nonsquamous
465341|NCT01160731|extensive stage small cell lung cancer|extensive stage small cell lung cancer
465342|NCT01160718|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
465343|NCT01160718|HER2-positive breast cancer|her2-positive breast cancer
465344|NCT01160718|HER2-negative breast cancer|her2-negative breast cancer
465345|NCT01160718|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
465346|NCT01160718|recurrent breast cancer|recurrent breast cancer
465347|NCT01160718|stage IIIA breast cancer|stage iiia breast cancer
465348|NCT01160718|stage IIIB breast cancer|stage iiib breast cancer
465349|NCT01160718|stage IIIC breast cancer|stage iiic breast cancer
465350|NCT01160718|stage IV breast cancer|stage iv breast cancer
465351|NCT01160705|adenocarcinoma of the prostate|adenocarcinoma of the prostate
465352|NCT01160705|recurrent prostate cancer|recurrent prostate cancer
465353|NCT01160705|stage III prostate cancer|stage iii prostate cancer
465354|NCT01160705|stage IV prostate cancer|stage iv prostate cancer
465355|NCT01160705|bone metastases|bone metastases
465356|NCT01160705|liver metastases|liver metastases
465357|NCT01160705|lung metastases|lung metastases
465358|NCT01160705|hormone-resistant prostate cancer|hormone-resistant prostate cancer
465359|NCT01160692|Memory|memory
465360|NCT01160692|Cognitive Function|cognitive function
465361|NCT01160692|Elderly|elderly
465362|NCT01160692|Gingko|gingko
465363|NCT01160692|Age Associated Memory Impairment (AAMI)|age associated memory impairment (aami)
465364|NCT01160679|anhedonic features in patients with schizophrenia|anhedonic features in patients with schizophrenia
465365|NCT01160666|Belimumab|belimumab
465366|NCT01160666|Sjögren's syndrome|sjögren's syndrome
465367|NCT01160666|Sjögren disease|sjögren disease
465368|NCT01160653|stroke|stroke
465369|NCT01160653|Gait training|gait training
465370|NCT01160653|Cognitive Training|cognitive training
465372|NCT01160640|Pelvic Inflammatory Disease|pelvic inflammatory disease
465373|NCT01160627|CIN STEMI|cin stemi
465374|NCT01160614|Pediatric|pediatric
465375|NCT01160614|Post-operative|post-operative
465376|NCT01160614|Nonsurgical|nonsurgical
465377|NCT01160614|patients|patients
465378|NCT01160614|Opioid|opioid
465379|NCT01160601|NSCLC|nsclc
465380|NCT01160601|lung cancer|lung cancer
465381|NCT01160601|non small cell lung cancer|non small cell lung cancer
465382|NCT01160601|bavituximab|bavituximab
465383|NCT01160601|monoclonal antibody|monoclonal antibody
465384|NCT01160588|Anxiety|anxiety
465385|NCT01160588|Social Phobia|social phobia
465386|NCT01160588|Social Anxiety|social anxiety
465387|NCT01160588|Generalized Anxiety|generalized anxiety
465388|NCT01160588|Separation Anxiety|separation anxiety
465389|NCT01160575|Counseling|counseling
465390|NCT01160575|Epidemiology|epidemiology
465391|NCT01160575|HIV|hiv
465392|NCT01160575|AIDS|aids
465393|NCT01160575|Prevention|prevention
465394|NCT01160562|Prevalence|prevalence
465395|NCT01160562|Incidence|incidence
465396|NCT01160562|Children|children
465397|NCT01160562|Adults|adults
465398|NCT01160562|Global Positioning system|global positioning system
465399|NCT01160549|Pregnancy|pregnancy
465400|NCT01160549|Hormones|hormones
465401|NCT01160549|Mongolia|mongolia
465402|NCT01160549|Asian|asian
465403|NCT01160549|Breast Cancer|breast cancer
465404|NCT01160536|Hypertrophic Cardiomyopathy (HCM)|hypertrophic cardiomyopathy (hcm)
465405|NCT01160536|Genetic Testing|genetic testing
465406|NCT01160523|Podoconiosis|podoconiosis
465407|NCT01160523|Genetic Education|genetic education
465408|NCT01160523|Primary Prevention|primary prevention
465409|NCT01160523|Ethiopa|ethiopa
465410|NCT01160523|Youth|youth
465411|NCT01160510|Breast|breast
465412|NCT01160510|Mammographic Density|mammographic density
465413|NCT01160484|multiple myeloma|multiple myeloma
465414|NCT01160484|refractory|refractory
465415|NCT01160484|relapsed|relapsed
465416|NCT01160484|bortezomib|bortezomib
465417|NCT01160484|doxil|doxil
465418|NCT01160471|Heart Failure|heart failure
465419|NCT01160471|Computed Tomography|computed tomography
465420|NCT01160471|Ultrasound|ultrasound
465421|NCT01160471|Fibrosis|fibrosis
465422|NCT01160471|Biomarker|biomarker
465423|NCT01160458|Monoclonal Antibody|monoclonal antibody
465424|NCT01160458|Pleural Mesothelioma|pleural mesothelioma
465425|NCT01160458|Peritoneal Mesothelioma|peritoneal mesothelioma
465426|NCT01160445|Metastatic Melanoma|metastatic melanoma
465427|NCT01160445|Metastatic Kidney Cancer|metastatic kidney cancer
465428|NCT01160445|Clinical Performance|clinical performance
465429|NCT01160445|Tumor Regression|tumor regression
465430|NCT01160445|Toxicity|toxicity
465431|NCT01160432|opiate dependence|opiate dependence
465432|NCT01160432|methadone|methadone
465433|NCT01160432|naloxone|naloxone
465434|NCT01160432|withdrawal symptom|withdrawal symptom
465435|NCT01160432|substitution treatment|substitution treatment
465436|NCT01160406|silent paroxysmal atrial fibrillation|silent paroxysmal atrial fibrillation
465437|NCT01160406|stroke|stroke
465438|NCT01160406|tele ECG|tele ecg
465439|NCT01160393|Atrial fibrillation|atrial fibrillation
465440|NCT01160393|Cardiac surgery|cardiac surgery
465441|NCT01160393|Prevention|prevention
465442|NCT01160393|Conventional bypass system|conventional bypass system
465443|NCT01160393|Miniaturized bypass system|miniaturized bypass system
465444|NCT01160393|Arrhythmia|arrhythmia
465445|NCT01160393|The Incidence of atrial fibrillation after cardiac surgery|the incidence of atrial fibrillation after cardiac surgery
465446|NCT01160380|cancer related fatigue|cancer related fatigue
465447|NCT01160380|fatigue|fatigue
465448|NCT01160380|multiple myeloma|multiple myeloma
465449|NCT01160380|cancer|cancer
465450|NCT01160380|quality of life|quality of life
465451|NCT01160354|Leukemia|leukemia
465452|NCT01160354|AML|aml
465453|NCT01160354|Clofarabine|clofarabine
465454|NCT01160354|Plerixafor|plerixafor
465455|NCT01160354|elderly patients|elderly patients
465456|NCT01160354|previously untreated|previously untreated
465457|NCT01160354|unfavorable prognostic factors|unfavorable prognostic factors
465458|NCT01160341|Metabolic syndrome|metabolic syndrome
465459|NCT01160341|Hypogonadism|hypogonadism
465460|NCT01160341|Testosterone|testosterone
465461|NCT01160328|Regional Fat Storage|regional fat storage
465462|NCT01160328|Fat Oxidation|fat oxidation
465463|NCT01160328|Testosterone|testosterone
465464|NCT01160328|Male|male
465465|NCT01160315|ovarian failure, chemotherapy, lymphoma, GnRH agonist|ovarian failure, chemotherapy, lymphoma, gnrh agonist
465466|NCT01160302|cancer|cancer
465467|NCT01160276|renal graft|renal graft
465468|NCT01160276|colchicine|colchicine
465469|NCT01160276|drug interaction|drug interaction
465470|NCT01160276|cyclosporine|cyclosporine
465471|NCT01160276|tacrolimus|tacrolimus
465472|NCT01160276|renal transplantation|renal transplantation
465473|NCT01160276|renal transplant|renal transplant
465474|NCT01160276|ABCB1|abcb1
465475|NCT01160276|CYP3A5|cyp3a5
465476|NCT01160276|SLCO1B1|slco1b1
465477|NCT01160263|ALS|als
465478|NCT01160263|serotonin|serotonin
465479|NCT01160263|dopamine|dopamine
465480|NCT01160237|H1N1|h1n1
465481|NCT01160237|Pandemrix|pandemrix
465482|NCT01160237|Fluarix|fluarix
465483|NCT01160237|Influenza|influenza
465484|NCT01160224|Asthma|asthma
465485|NCT01160224|CCR3 receptor antagonists|ccr3 receptor antagonists
465486|NCT01160224|GW766944|gw766944
465487|NCT01160211|1st line MBC|1st line mbc
465488|NCT01160211|MBC|mbc
465489|NCT01160211|hormone receptor positive|hormone receptor positive
465490|NCT01160211|lapatinib|lapatinib
465491|NCT01160211|trastuzumab|trastuzumab
465492|NCT01160211|HER2 positive|her2 positive
465493|NCT01160211|aromatase inhibitor|aromatase inhibitor
465494|NCT01160172|vaccine|vaccine
465495|NCT01160172|young adults|young adults
465496|NCT01160172|Staphylococcus aureus|staphylococcus aureus
465497|NCT01160159|Venous thrombosis|venous thrombosis
465498|NCT01160159|Women|women
465499|NCT01160159|Vasodilatation endothelium-dependent|vasodilatation endothelium-dependent
465500|NCT01160159|IMT|imt
465501|NCT01160159|Arterial stiffness|arterial stiffness
465502|NCT01160159|Arterial compliance|arterial compliance
465503|NCT01160159|Capillary density|capillary density
465504|NCT01160146|Obestiy|obestiy
465505|NCT01160146|Over weight|over weight
465506|NCT01160146|referral patterns|referral patterns
465507|NCT01160146|Continuing Medical Education|continuing medical education
465508|NCT01160133|Systane|systane
465509|NCT01160133|Refresh Tears|refresh tears
465510|NCT01160133|Dry Eye|dry eye
465511|NCT01160133|Moderate to Severe Dry Eye|moderate to severe dry eye
465512|NCT01160120|fixed dose combinations|fixed dose combinations
465513|NCT01160120|tenofovir|tenofovir
465514|NCT01160120|lamivudine|lamivudine
465515|NCT01160120|efavirenz|efavirenz
465516|NCT01160120|therapeutic drug levels|therapeutic drug levels
465517|NCT01160120|safety and efficacy|safety and efficacy
465518|NCT01160120|HIV|hiv
465618|NCT01159626|Japanese|japanese
465644|NCT01159431|partial seizures|partial seizures
465519|NCT01160120|To evaluation new formulations of FDC of TDF/3TC/EFV|to evaluation new formulations of fdc of tdf/3tc/efv
465520|NCT01160107|Diagnosis|diagnosis
465521|NCT01160107|Elderly Patients|elderly patients
465522|NCT01160107|Imids|imids
465523|NCT01160107|Chemotherapy|chemotherapy
465524|NCT01160094|Trastuzumab|trastuzumab
465525|NCT01160094|Metastatic Breast Cancer|metastatic breast cancer
465526|NCT01160094|Breast Cancer|breast cancer
465527|NCT01160094|Observational Study|observational study
465528|NCT01160094|Lapatinib|lapatinib
465529|NCT01160003|ACTH stimulation test|acth stimulation test
465530|NCT01160003|Pharmacokinetics|pharmacokinetics
465531|NCT01160003|Nebules|nebules
465532|NCT01160003|Cortisol|cortisol
465533|NCT01159990|HIV Preventive Vaccine|hiv preventive vaccine
465534|NCT01159990|HIV Seronegativity|hiv seronegativity
465535|NCT01159964|Antigen-Specific Cancer Immunotherapeutic (ASCI)|antigen-specific cancer immunotherapeutic (asci)
465536|NCT01159964|PRAME|prame
465537|NCT01159964|PRAME-positive stage IB, II or IIIA Non-Small Cell Lung Cancer patients after complete surgical resection|prame-positive stage ib, ii or iiia non-small cell lung cancer patients after complete surgical resection
465538|NCT01159964|Non-Small Cell Lung Cancer|non-small cell lung cancer
465539|NCT01159912|fluticasone propionate|fluticasone propionate
465540|NCT01159912|Fluticasone furoate|fluticasone furoate
465541|NCT01159899|Osteoarthritis|osteoarthritis
465542|NCT01159899|knee arthritis|knee arthritis
465543|NCT01159899|Knee arthrosis|knee arthrosis
465544|NCT01159899|articular cartilage defects|articular cartilage defects
465545|NCT01159899|osteochondral defects|osteochondral defects
465546|NCT01159899|mesenchymal stem cells|mesenchymal stem cells
465547|NCT01159899|stem cells|stem cells
465548|NCT01159899|cellules souches,|cellules souches,
465549|NCT01159899|genou|genou
465550|NCT01159899|arthrose genou|arthrose genou
465551|NCT01159899|PRP platelet rich plasma|prp platelet rich plasma
465552|NCT01159899|thérapie cellulaire|thérapie cellulaire
465553|NCT01159899|implantation cellules souches mésenchymateuses|implantation cellules souches mésenchymateuses
465554|NCT01159899|régénération cartilage|régénération cartilage
465555|NCT01159899|cicatrisation ménisque|cicatrisation ménisque
465556|NCT01159899|ligament|ligament
465557|NCT01159899|plasma riche plaquettaire|plasma riche plaquettaire
465558|NCT01159899|platelet rich plasma|platelet rich plasma
465559|NCT01159899|stem cell|stem cell
465560|NCT01159899|regrowt cartilage|regrowt cartilage
465561|NCT01159899|cellules souches|cellules souches
465562|NCT01159899|PRP|prp
465563|NCT01159886|Tuberculosis|tuberculosis
465564|NCT01159886|IBD|ibd
465565|NCT01159886|endoscopy|endoscopy
465566|NCT01159860|seborrheic keratoses|seborrheic keratoses
465567|NCT01159860|cryosurgery|cryosurgery
465568|NCT01159860|curettage|curettage
465569|NCT01159847|sitagliptin|sitagliptin
465570|NCT01159847|LADA|lada
465571|NCT01159847|C-Peptide|c-peptide
465572|NCT01159847|Flow Cytometry|flow cytometry
465573|NCT01159847|ELISPOT|elispot
465574|NCT01159834|HPV infection|hpv infection
465575|NCT01159834|Cervical cancer|cervical cancer
465576|NCT01159834|HPV vaccine|hpv vaccine
465577|NCT01159821|31001074|31001074
465578|NCT01159821|Paroxetine|paroxetine
465579|NCT01159821|CYP2D6 inhibitor|cyp2d6 inhibitor
465580|NCT01159808|Safety and Pharmacokinetics|safety and pharmacokinetics
465581|NCT01159795|Respiratory Syncytial Virus|respiratory syncytial virus
465582|NCT01159795|Infant|infant
465583|NCT01159795|Interferon|interferon
465584|NCT01159769|Allergic conjunctivitis|allergic conjunctivitis
465585|NCT01159756|Travacom|travacom
465586|NCT01159756|Glaucoma|glaucoma
465587|NCT01159756|Travoprost|travoprost
465588|NCT01159756|Timolol|timolol
465589|NCT01159743|lipodystrophy|lipodystrophy
465590|NCT01159743|Lipoatrophy|lipoatrophy
465591|NCT01159743|antiretroviral treatment|antiretroviral treatment
465592|NCT01159704|HIV infection|hiv infection
465593|NCT01159704|Intervention|intervention
465594|NCT01159704|Risk-reduction|risk-reduction
465595|NCT01159704|Injection drug users|injection drug users
465596|NCT01159691|Rotigotine|rotigotine
465597|NCT01159691|Neupro®|neupro®
465598|NCT01159691|Parkinson's disease|parkinson's disease
465599|NCT01159691|Gastrointestinal|gastrointestinal
465600|NCT01159691|Switch from oral therapy to patch|switch from oral therapy to patch
465601|NCT01159652|sleep|sleep
465602|NCT01159652|memory|memory
465603|NCT01159652|hypnotics|hypnotics
465604|NCT01159652|zaleplon|zaleplon
465605|NCT01159652|zolpidem|zolpidem
465606|NCT01159652|Sonata|sonata
465607|NCT01159652|Ambien|ambien
465608|NCT01159652|Hypnotics and Sedatives|hypnotics and sedatives
465609|NCT01159652|Polysomnography|polysomnography
465610|NCT01159652|Monitoring, sleep|monitoring, sleep
465611|NCT01159639|aspirin resistance|aspirin resistance
465612|NCT01159639|coronary artery bypass grafting|coronary artery bypass grafting
465613|NCT01159639|multiple electrode aggregometry|multiple electrode aggregometry
465614|NCT01159639|multiplate|multiplate
465615|NCT01159626|Phase1|phase1
465616|NCT01159626|Pharmacokinetics|pharmacokinetics
465617|NCT01159626|Healthy Male|healthy male
465619|NCT01159626|Schizophrenia|schizophrenia
465620|NCT01159613|SVR|svr
465621|NCT01159613|Cholesterol level|cholesterol level
465622|NCT01159613|fibrosis score|fibrosis score
465623|NCT01159613|HDL|hdl
465624|NCT01159535|substance use|substance use
465625|NCT01159535|addiction|addiction
465626|NCT01159535|meditation|meditation
465627|NCT01159535|mindfulness|mindfulness
465628|NCT01159535|relapse prevention|relapse prevention
465629|NCT01159522|Advanced Solid Tumors Who Have Failed Standard Therapy|advanced solid tumors who have failed standard therapy
465630|NCT01159509|hypertrophic pyloric stenosis|hypertrophic pyloric stenosis
465631|NCT01159509|sodium intake|sodium intake
465632|NCT01159509|Healthy children with no chronic diseases|healthy children with no chronic diseases
465633|NCT01159509|Status post HPS|status post hps
465634|NCT01159483|safety|safety
465635|NCT01159483|tolerability|tolerability
465636|NCT01159483|pharmacokinetics|pharmacokinetics
465637|NCT01159470|CRP velocity|crp velocity
465638|NCT01159457|Celiac Disease|celiac disease
465639|NCT01159457|Hepatitis B vaccination|hepatitis b vaccination
465640|NCT01159444|noninvasive ventilation|noninvasive ventilation
465641|NCT01159444|ventilator software|ventilator software
465642|NCT01159444|ventilator settings|ventilator settings
465643|NCT01159444|domiciliary ventilation|domiciliary ventilation
465645|NCT01159431|poorly controlled epilepsy|poorly controlled epilepsy
465646|NCT01159431|intractable epilepsy|intractable epilepsy
465647|NCT01159431|treatment resistant epilepsy|treatment resistant epilepsy
465648|NCT01159431|Trigeminal Nerve|trigeminal nerve
465649|NCT01159431|Trigeminal Nerve Stimulation|trigeminal nerve stimulation
465650|NCT01159418|solid tumors|solid tumors
465651|NCT01159418|Panobinostat|panobinostat
465652|NCT01159418|histone deacetylase inhibitors|histone deacetylase inhibitors
465653|NCT01159392|brain injury|brain injury
465654|NCT01159392|mechanical ventilation|mechanical ventilation
465655|NCT01159392|acute lung injury|acute lung injury
465656|NCT01159392|lung recruitment|lung recruitment
465657|NCT01159379|IgE-mediated allergy|ige-mediated allergy
465658|NCT01159379|Beta-lactams|beta-lactams
465659|NCT01159379|Ertapenem|ertapenem
465660|NCT01159379|Cross-reactivity|cross-reactivity
465661|NCT01159379|Immediate-type skin tests|immediate-type skin tests
465662|NCT01159379|Intravenous tolerance tests|intravenous tolerance tests
465663|NCT01159366|myocardial infarction|myocardial infarction
465664|NCT01159366|coronary occlusion|coronary occlusion
465665|NCT01159366|myocardial revascularization|myocardial revascularization
465666|NCT01159366|collaterals|collaterals
465667|NCT01159366|prognosis|prognosis
465668|NCT01159327|Sorafenib (nexavar)|sorafenib (nexavar)
465669|NCT01159327|ED-SCLC|ed-sclc
465670|NCT01159327|Maintenance|maintenance
465671|NCT01159327|Extensive Disease Small cell lung cancer|extensive disease small cell lung cancer
465672|NCT01159314|glaucoma|glaucoma
465673|NCT01159314|Baerveldt Implants|baerveldt implants
465674|NCT01159288|Advanced unresectable non small cell lung cancer|advanced unresectable non small cell lung cancer
465675|NCT01159288|Responding or stabilized after induction chemotherapy|responding or stabilized after induction chemotherapy
465676|NCT01159275|lopinavir/ritonavir|lopinavir/ritonavir
465677|NCT01159275|pharmacokinetics|pharmacokinetics
465678|NCT01159275|HIV-1 infected adults|hiv-1 infected adults
465679|NCT01159275|aim to investigate the lower dose of boosted lopinavir in Thais and to compare the levels of lopinavir/ritonavir from Abbot and GPO|aim to investigate the lower dose of boosted lopinavir in thais and to compare the levels of lopinavir/ritonavir from abbot and gpo
465680|NCT01159262|Initially intubated and mechanically ventilated neonates|initially intubated and mechanically ventilated neonates
465681|NCT01159249|Vildagliptin, Type 2 Diabetes, HbA1c, Fasting Plasma Glucose, Long-Term Safety|vildagliptin, type 2 diabetes, hba1c, fasting plasma glucose, long-term safety
465682|NCT01159236|Gene signatures|gene signatures
465683|NCT01159236|HER-2 normal stage I-III breast cancer|her-2 normal stage i-iii breast cancer
465684|NCT01159236|Estrogen Receptor|estrogen receptor
465685|NCT01159236|ER-positive|er-positive
465686|NCT01159236|ER-negative|er-negative
465687|NCT01159236|RCB categories II-III|rcb categories ii-iii
465688|NCT01159236|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
465689|NCT01159236|adjuvant systemic therapy|adjuvant systemic therapy
465690|NCT01159236|molecular testing|molecular testing
465691|NCT01159236|Fluorouracil|fluorouracil
465692|NCT01159236|5-fluorouracil|5-fluorouracil
465693|NCT01159236|5-FU|5-fu
465694|NCT01159236|Doxorubicin|doxorubicin
465695|NCT01159236|Adriamycin|adriamycin
465696|NCT01159236|Rubex|rubex
465697|NCT01159236|Epirubicin|epirubicin
465698|NCT01159236|Ellence|ellence
465699|NCT01159236|Cyclophosphamide|cyclophosphamide
465700|NCT01159236|Cytoxan|cytoxan
465701|NCT01159236|Neosar|neosar
465702|NCT01159236|Bevacizumab|bevacizumab
465703|NCT01159236|Avastin|avastin
465704|NCT01159236|Anti-VEGF monoclonal|anti-vegf monoclonal
465705|NCT01159236|rhu-MAb-VEGF|rhu-mab-vegf
465706|NCT01159223|atazanavir / ritonavir|atazanavir / ritonavir
465707|NCT01159223|low dose|low dose
465708|NCT01159223|noninferiority|noninferiority
465709|NCT01159223|safety and efficacy|safety and efficacy
465798|NCT01158755|Meningitis, tuberculous|meningitis, tuberculous
465799|NCT01158755|Intensified Regimen|intensified regimen
465710|NCT01159223|efficacy and safety of lower dose atazanavir/ritonavir in suppressed HIV-infected adults|efficacy and safety of lower dose atazanavir/ritonavir in suppressed hiv-infected adults
465711|NCT01159197|sleep disturbance|sleep disturbance
465712|NCT01159197|cognitive behavioral therapy|cognitive behavioral therapy
465713|NCT01159197|inflammation|inflammation
465714|NCT01159197|oxidative stress|oxidative stress
465715|NCT01159197|hemodialysis|hemodialysis
465716|NCT01159184|stress|stress
465717|NCT01159184|coping methods|coping methods
465718|NCT01159184|social support|social support
465719|NCT01159184|diabetes mellitus|diabetes mellitus
465720|NCT01159145|Healthy volunteer|healthy volunteer
465721|NCT01159145|Japanese males|japanese males
465722|NCT01159145|homo-EM/hetero-EM/PM|homo-em/hetero-em/pm
465723|NCT01159132|pharmacokinetics|pharmacokinetics
465724|NCT01159132|low dose raltegravir|low dose raltegravir
465725|NCT01159132|HIV|hiv
465726|NCT01159132|To study the pharmacokinetics profile of low dose raltegravir (RAL) (400mg OD and 800mg OD) and standard dose of 400mg BID in Thai HIV-infected patients.|to study the pharmacokinetics profile of low dose raltegravir (ral) (400mg od and 800mg od) and standard dose of 400mg bid in thai hiv-infected patients.
465727|NCT01159119|Chronic Abdominal Pain|chronic abdominal pain
465728|NCT01159119|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
465729|NCT01159106|Positive Pressure Ventilation|positive pressure ventilation
465730|NCT01159106|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
465731|NCT01159106|Patient/ventilator Asynchrony|patient/ventilator asynchrony
465732|NCT01159106|Pediatric patient|pediatric patient
465733|NCT01159106|Infant|infant
465734|NCT01159093|Clinical Decision Support Systems|clinical decision support systems
465735|NCT01159080|immunosuppression control in kidney transplantation|immunosuppression control in kidney transplantation
465736|NCT01159067|hematopoietic stem cell transplant, iron overload, deferasirox, labile plasma iron|hematopoietic stem cell transplant, iron overload, deferasirox, labile plasma iron
465737|NCT01159041|Depression, children, adolescent, family|depression, children, adolescent, family
465738|NCT01159028|Liposomal Grb-2 treatment of CML, AML, CLL, MDS|liposomal grb-2 treatment of cml, aml, cll, mds
465739|NCT01159028|Liposomal Grb-2 with LDAC for AML|liposomal grb-2 with ldac for aml
465740|NCT01159002|Endoscopy, Video Capsule|endoscopy, video capsule
465741|NCT01159002|Motility, Gastrointestinal|motility, gastrointestinal
465742|NCT01158989|Critical care|critical care
465743|NCT01158989|Endoscopy, Video Capsule|endoscopy, video capsule
465744|NCT01158989|Nutrition, Enteral|nutrition, enteral
465745|NCT01158937|meropenem|meropenem
465746|NCT01158937|cystic fibrosis|cystic fibrosis
465747|NCT01158937|extended infusion|extended infusion
465748|NCT01158937|pharmacokinetic|pharmacokinetic
465749|NCT01158911|kidney disease|kidney disease
465750|NCT01158911|uric acid|uric acid
465751|NCT01158911|outcomes|outcomes
465752|NCT01158911|cardiovascular|cardiovascular
465753|NCT01158911|mortality|mortality
465754|NCT01158911|kidney failure|kidney failure
465755|NCT01158911|Uric Acid levels in patients with Chronic Kidney Disease|uric acid levels in patients with chronic kidney disease
465756|NCT01158898|Mild to moderate asthma|mild to moderate asthma
465757|NCT01158898|Allergen inhalation challenge|allergen inhalation challenge
465758|NCT01158885|relapsed|relapsed
465759|NCT01158885|relapse|relapse
465760|NCT01158885|refractory|refractory
465761|NCT01158885|Minimal Residual disease|minimal residual disease
465762|NCT01158885|MRD|mrd
465763|NCT01158885|MRD positive|mrd positive
465764|NCT01158885|MRD+|mrd+
465765|NCT01158885|ALL|all
465766|NCT01158885|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
465767|NCT01158885|AML|aml
465768|NCT01158885|Acute myelogenous leukemia|acute myelogenous leukemia
465769|NCT01158885|Relapsed AML|relapsed aml
465770|NCT01158859|Anesthesia, General|anesthesia, general
465771|NCT01158859|Propofol|propofol
465772|NCT01158859|Pregabalin|pregabalin
465773|NCT01158859|Preoperative care|preoperative care
465774|NCT01158859|Laparoscopic surgery|laparoscopic surgery
465775|NCT01158846|STEMI|stemi
465776|NCT01158846|Primary PCI|primary pci
465777|NCT01158846|anticoagulants|anticoagulants
465778|NCT01158846|antiplatelets|antiplatelets
465779|NCT01158833|Cerebral palsy|cerebral palsy
465780|NCT01158833|diplegia|diplegia
465781|NCT01158833|gait|gait
465782|NCT01158833|classification|classification
465783|NCT01158820|bronchoscopy|bronchoscopy
465784|NCT01158807|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
465785|NCT01158807|Cerebral arteriovenous malformations|cerebral arteriovenous malformations
465786|NCT01158794|Iron overload|iron overload
465787|NCT01158794|Blood Transfusion|blood transfusion
465788|NCT01158781|TBI|tbi
465789|NCT01158781|motor learning|motor learning
465790|NCT01158781|robotics|robotics
465791|NCT01158781|Functional electrical stimulation|functional electrical stimulation
465792|NCT01158768|domestic violence in childhood/adolescence|domestic violence in childhood/adolescence
465793|NCT01158768|comorbidities|comorbidities
465794|NCT01158768|climactery|climactery
465795|NCT01158768|domestic violence against women|domestic violence against women
465796|NCT01158768|trauma questionnaire|trauma questionnaire
465797|NCT01158768|Violence|violence
465972|NCT01157910|Chronic|chronic
465800|NCT01158755|PK/PD and tolerability|pk/pd and tolerability
465801|NCT01158755|Outcome|outcome
465802|NCT01158742|Glomerular Filtration Rate|glomerular filtration rate
465803|NCT01158729|Antithrombin III|antithrombin iii
465804|NCT01158729|Postoperative Hemorrhage|postoperative hemorrhage
465805|NCT01158729|Cardiopulmonary Bypass|cardiopulmonary bypass
465806|NCT01158729|Pediatrics|pediatrics
465807|NCT01158729|Blood Transfusion|blood transfusion
465808|NCT01158716|percutaneous coronary intervention|percutaneous coronary intervention
465809|NCT01158716|remote ischemic preconditioning|remote ischemic preconditioning
465810|NCT01158703|aspirin|aspirin
465811|NCT01158703|clopidogrel|clopidogrel
465812|NCT01158703|coronary artery bypass graft|coronary artery bypass graft
465813|NCT01158703|Plavix|plavix
465814|NCT01158690|Intimate partner violence|intimate partner violence
465815|NCT01158677|meniscectomy|meniscectomy
465816|NCT01158664|dental implants|dental implants
465817|NCT01158664|different tread pitch design|different tread pitch design
465818|NCT01158651|NF1|nf1
465819|NCT01158651|low-grade glioma|low-grade glioma
465820|NCT01158651|progressive|progressive
465821|NCT01158651|children|children
465822|NCT01158651|Participants studied have NF Type 1 and a low grade glioma that has either not responded to one or more standard treatments.|participants studied have nf type 1 and a low grade glioma that has either not responded to one or more standard treatments.
465823|NCT01158638|Physical Activity Enhancement|physical activity enhancement
465824|NCT01158599|Japanese Encephalitis|japanese encephalitis
465825|NCT01158599|Vaccination|vaccination
465826|NCT01158599|Ixiaro|ixiaro
465827|NCT01158599|elderly population|elderly population
465828|NCT01158586|post total knee replacement|post total knee replacement
465829|NCT01158586|patient control|patient control
465830|NCT01158586|epidural analgesia|epidural analgesia
465831|NCT01158573|Asthma|asthma
465832|NCT01158573|Obesity|obesity
465833|NCT01158560|upper respiratory tract infections|upper respiratory tract infections
465834|NCT01158560|rhinovirus infections|rhinovirus infections
465835|NCT01158560|vitamin D|vitamin d
465836|NCT01158534|recurrent renal cell cancer|recurrent renal cell cancer
465837|NCT01158508|cerebral aneurysm|cerebral aneurysm
465838|NCT01158508|cerebral vasospasm|cerebral vasospasm
465839|NCT01158508|subarachnoid hemorrhage|subarachnoid hemorrhage
465840|NCT01158508|remote ischemic preconditioning|remote ischemic preconditioning
465841|NCT01158456|smoking|smoking
465842|NCT01158456|lung cancer|lung cancer
465843|NCT01158456|ethnic racial differences|ethnic racial differences
465844|NCT01158456|tobacco specific nitrosamines|tobacco specific nitrosamines
465845|NCT01158456|metabolism of carcinogens|metabolism of carcinogens
465846|NCT01158443|HIV+|hiv+
465847|NCT01158443|fatigue|fatigue
465848|NCT01158443|return to work|return to work
465849|NCT01158430|Hypochondriasis|hypochondriasis
465850|NCT01158430|Acceptance and Commitment Therapy|acceptance and commitment therapy
465851|NCT01158430|ACT|act
465852|NCT01158417|Type 2 Diabetes|type 2 diabetes
465853|NCT01158417|Obesity|obesity
465854|NCT01158417|Insulin Resistance|insulin resistance
465855|NCT01158417|Resveratrol|resveratrol
465856|NCT01158417|Inflammation|inflammation
465857|NCT01158404|Metastatic Cancer|metastatic cancer
465858|NCT01158404|Solid Tumors|solid tumors
465859|NCT01158391|Premature Birth|premature birth
465860|NCT01158378|Adherus Dural Sealant|adherus dural sealant
465861|NCT01158378|Adherus AutoSpray Dural Sealant|adherus autospray dural sealant
465862|NCT01158352|Growth|growth
465863|NCT01158352|Low weight|low weight
465864|NCT01158352|Low height|low height
465865|NCT01158352|Nutritional Formula|nutritional formula
465866|NCT01158339|Low back pain|low back pain
465867|NCT01158339|Cognitive behavioural therapy|cognitive behavioural therapy
465868|NCT01158339|Group therapy|group therapy
465869|NCT01158339|Exposure in session|exposure in session
465870|NCT01158326|reducing symptoms|reducing symptoms
465871|NCT01158326|events|events
465872|NCT01158326|Common Cold|common cold
465873|NCT01158326|flu syndrome|flu syndrome
465874|NCT01158326|Symptomatic treatment of the Common Cold and Flu syndrome|symptomatic treatment of the common cold and flu syndrome
465875|NCT01158300|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
465876|NCT01158300|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
465877|NCT01158300|recurrent childhood brain tumor|recurrent childhood brain tumor
465878|NCT01158300|recurrent childhood central nervous system embryonal tumor|recurrent childhood central nervous system embryonal tumor
465879|NCT01158300|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
465880|NCT01158300|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
465881|NCT01158300|recurrent childhood ependymoma|recurrent childhood ependymoma
465882|NCT01158300|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
465883|NCT01158300|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
465884|NCT01158300|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
465885|NCT01158300|recurrent childhood spinal cord neoplasm|recurrent childhood spinal cord neoplasm
465886|NCT01158300|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
465887|NCT01158300|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
465888|NCT01158300|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
465889|NCT01158300|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
465890|NCT01158300|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
465891|NCT01158300|childhood central nervous system germinoma|childhood central nervous system germinoma
465892|NCT01158300|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
465893|NCT01158300|childhood central nervous system teratoma|childhood central nervous system teratoma
465894|NCT01158300|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
465895|NCT01158300|childhood astrocytoma|childhood astrocytoma
465896|NCT01158300|childhood medulloepithelioma|childhood medulloepithelioma
465897|NCT01158300|childhood meningioma|childhood meningioma
465898|NCT01158300|childhood mixed glioma|childhood mixed glioma
465899|NCT01158300|childhood oligodendroglioma|childhood oligodendroglioma
465900|NCT01158300|childhood pineal parenchymal tumor|childhood pineal parenchymal tumor
465901|NCT01158287|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
465902|NCT01158287|recurrent esophageal cancer|recurrent esophageal cancer
465903|NCT01158287|recurrent gastric cancer|recurrent gastric cancer
465904|NCT01158287|adenocarcinoma of the stomach|adenocarcinoma of the stomach
465905|NCT01158261|hemostasis|hemostasis
465906|NCT01158248|cervical adenocarcinoma|cervical adenocarcinoma
465907|NCT01158248|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
465908|NCT01158248|cervical small cell carcinoma|cervical small cell carcinoma
465909|NCT01158248|stage IB cervical cancer|stage ib cervical cancer
465910|NCT01158248|stage IIA cervical cancer|stage iia cervical cancer
465911|NCT01158248|stage IIB cervical cancer|stage iib cervical cancer
465912|NCT01158248|stage III cervical cancer|stage iii cervical cancer
465913|NCT01158248|cervical squamous cell carcinoma|cervical squamous cell carcinoma
465914|NCT01158235|MRSA|mrsa
465915|NCT01158235|nose|nose
465916|NCT01158196|laser|laser
465917|NCT01158196|keloid|keloid
465918|NCT01158196|scar|scar
465919|NCT01158183|Outcomes|outcomes
465920|NCT01158183|real world and web tool|real world and web tool
465921|NCT01158183|electronic data capture|electronic data capture
465922|NCT01158170|nonsmall cell lung cancer|nonsmall cell lung cancer
465923|NCT01158170|brain metastasis|brain metastasis
465924|NCT01158170|prophylactic cranial irradiation|prophylactic cranial irradiation
465925|NCT01158144|Non-small cell lung cancer|non-small cell lung cancer
465926|NCT01158144|Locally advanced|locally advanced
465927|NCT01158144|Radiotherapy|radiotherapy
465928|NCT01158144|Concomitant Chemotherapy|concomitant chemotherapy
465929|NCT01158144|Endostar|endostar
465930|NCT01158131|Gestational diabetes mellitus (GDM) in the most recent pregnancy|gestational diabetes mellitus (gdm) in the most recent pregnancy
465931|NCT01158118|Precursor Cell Lymphoblastic Leukemia-Lymphoma|precursor cell lymphoblastic leukemia-lymphoma
465932|NCT01158118|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
465933|NCT01158105|Steroid refractory chronic graft vs host disease (cGVHD)|steroid refractory chronic graft vs host disease (cgvhd)
465934|NCT01158105|Bortezomib|bortezomib
465935|NCT01158105|Velcade|velcade
465936|NCT01158079|Liver|liver
465937|NCT01158079|Solid Tumors|solid tumors
465938|NCT01158079|Advanced Solid Tumors with Liver Involvement|advanced solid tumors with liver involvement
465939|NCT01158066|NAFLD|nafld
465940|NCT01158066|Calcium score|calcium score
465941|NCT01158066|Liver Fat|liver fat
465942|NCT01158066|Visceral fat|visceral fat
465943|NCT01158066|excessive visceral fat|excessive visceral fat
465944|NCT01158066|excessive liver fat accumulation|excessive liver fat accumulation
465945|NCT01158066|Biomarkers of insulin resistance (HOMA), inflammation (CRP) and (MDA-Paraoxonase)|biomarkers of insulin resistance (homa), inflammation (crp) and (mda-paraoxonase)
465946|NCT01158040|Maternal intrapartum glycemic control|maternal intrapartum glycemic control
465947|NCT01158040|Pregestational diabetes|pregestational diabetes
465948|NCT01158014|pterygium|pterygium
465949|NCT01158014|conjunctival graft|conjunctival graft
465950|NCT01158014|recurrence|recurrence
465951|NCT01158014|primary pterygium|primary pterygium
465952|NCT01158001|Posttraumatic stress disorders|posttraumatic stress disorders
465953|NCT01158001|Telemedicine|telemedicine
465954|NCT01158001|Psychotherapy|psychotherapy
465955|NCT01158001|Neuropsychological test|neuropsychological test
465956|NCT01158001|Depression|depression
465957|NCT01157988|bulky diffuse large B cell lymphoma|bulky diffuse large b cell lymphoma
465958|NCT01157988|90Y-ibritumomab tiuxetan|90y-ibritumomab tiuxetan
465959|NCT01157988|clinical response|clinical response
465960|NCT01157988|Safety and toxicity|safety and toxicity
465961|NCT01157962|Sentinel Concept|sentinel concept
465962|NCT01157962|Lymphadenectomy|lymphadenectomy
465963|NCT01157962|Early Stage Cervical Cancer|early stage cervical cancer
465964|NCT01157962|Overall Survive|overall survive
465965|NCT01157962|Improvement Therapy|improvement therapy
465966|NCT01157936|hypertension|hypertension
465967|NCT01157936|hyperuricemia|hyperuricemia
465968|NCT01157936|metabolic syndrome|metabolic syndrome
465969|NCT01157923|Type 1 diabetes|type 1 diabetes
465970|NCT01157923|Insulin Pump Therapy|insulin pump therapy
465971|NCT01157910|Ear infection|ear infection
465973|NCT01157897|Malaria|malaria
465974|NCT01157897|Plasmodium Vivax|plasmodium vivax
465975|NCT01157897|Vaccine|vaccine
465976|NCT01157884|body composition|body composition
465977|NCT01157884|obesity|obesity
465978|NCT01157884|kidney transplantation|kidney transplantation
465979|NCT01157858|liver cyst|liver cyst
465980|NCT01157832|water pipe smoking acute effect|water pipe smoking acute effect
465981|NCT01157819|swimmer's ear|swimmer's ear
465982|NCT01157819|ear drops|ear drops
465983|NCT01157819|ear foam|ear foam
465984|NCT01157819|otic foam|otic foam
465985|NCT01157819|ear infection|ear infection
465986|NCT01157819|ear pain|ear pain
465987|NCT01157819|ear inflammation|ear inflammation
465988|NCT01157806|rectal cancer|rectal cancer
465989|NCT01157806|unresectable synchronous metastases|unresectable synchronous metastases
465990|NCT01157806|pelvic radiochemotherapy|pelvic radiochemotherapy
465991|NCT01157793|Dwarfism|dwarfism
465992|NCT01157793|Growth hormone deficiency|growth hormone deficiency
465993|NCT01157793|Growth hormone|growth hormone
465994|NCT01157780|Fish oil|fish oil
465995|NCT01157767|exercise|exercise
465996|NCT01157767|lymphedema|lymphedema
465997|NCT01157767|post-operative chemotherapy|post-operative chemotherapy
465998|NCT01157767|post-operative radiation|post-operative radiation
465999|NCT01157767|10-062|10-062
466000|NCT01157754|Infertility patients requiring IVF|infertility patients requiring ivf
466001|NCT01157754|good prognosis|good prognosis
466002|NCT01157741|Community based follow up, severely underweight children|community based follow up, severely underweight children
466003|NCT01157728|Multiple sclerosis|multiple sclerosis
466004|NCT01157728|Cognitive impairment|cognitive impairment
466005|NCT01157715|KH902|kh902
466006|NCT01157715|age-related macular degeneration (AMD)|age-related macular degeneration (amd)
466007|NCT01157715|choroidal neovascularization (CNV)|choroidal neovascularization (cnv)
466008|NCT01157715|intravitreal injection|intravitreal injection
466009|NCT01157715|best corrected visual acuity (BCVA)|best corrected visual acuity (bcva)
466010|NCT01157715|central retinal thickness|central retinal thickness
466011|NCT01157689|malaria|malaria
466012|NCT01157689|children|children
466013|NCT01157689|Guinea-Bissau|guinea-bissau
466014|NCT01157689|artemether|artemether
466015|NCT01157689|lumefantrine|lumefantrine
466016|NCT01157689|effectiveness|effectiveness
466017|NCT01157676|open cystectomy|open cystectomy
466018|NCT01157676|robotic assisted radical cystectomy|robotic assisted radical cystectomy
466019|NCT01157676|bladder cancer|bladder cancer
466020|NCT01157663|Functional ankle instability|functional ankle instability
466021|NCT01157650|Fistulizing Crohn's disease|fistulizing crohn's disease
466022|NCT01157650|stem cells implant|stem cells implant
466023|NCT01157624|hypoxia or hypercarbia during surgery under the drape|hypoxia or hypercarbia during surgery under the drape
466024|NCT01157611|online based mentoring program,|online based mentoring program,
466025|NCT01157611|type 1 diabetes,|type 1 diabetes,
466026|NCT01157611|blood glucose,|blood glucose,
466027|NCT01157611|satisfaction score|satisfaction score
466028|NCT01157598|gastric adenoma|gastric adenoma
466029|NCT01157598|early gastric cancer|early gastric cancer
466030|NCT01157572|Aortic valve insufficiency|aortic valve insufficiency
466031|NCT01157572|Beta-blocker|beta-blocker
466032|NCT01157533|Vancomycin|vancomycin
466033|NCT01157533|Pharmacokinetic testing|pharmacokinetic testing
466034|NCT01157533|PK|pk
466035|NCT01157507|Botulinum A toxin|botulinum a toxin
466036|NCT01157507|Painful Bladder Syndrome (PBS)|painful bladder syndrome (pbs)
466037|NCT01157507|Bladder overdistention|bladder overdistention
466038|NCT01157494|cerebral palsy|cerebral palsy
466039|NCT01157494|hemiplegia|hemiplegia
466040|NCT01157494|upper limb|upper limb
466041|NCT01157494|assessment|assessment
466042|NCT01157494|classification system|classification system
466043|NCT01157481|Diastolic Heart Failure|diastolic heart failure
466044|NCT01157481|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
466045|NCT01157481|nifedipine|nifedipine
466046|NCT01157468|Systemic Lupus Erythematosus in Martinique|systemic lupus erythematosus in martinique
466047|NCT01157468|Hydrolase and DNase activities|hydrolase and dnase activities
466048|NCT01157455|Stent|stent
466049|NCT01157455|Coronary artery diseases|coronary artery diseases
466050|NCT01157442|prevention of maternal to child transmission of HIV|prevention of maternal to child transmission of hiv
466051|NCT01157442|mhealth|mhealth
466052|NCT01157442|access to antenatal care|access to antenatal care
466053|NCT01157442|pregnancy|pregnancy
466054|NCT01157429|Cognitive Behavior Therapy|cognitive behavior therapy
466055|NCT01157429|Children|children
466056|NCT01157429|Adolescents|adolescents
466057|NCT01157429|Pharmacotherapy|pharmacotherapy
466058|NCT01157416|Cognitive Behavior Therapy|cognitive behavior therapy
466059|NCT01157416|Children|children
466060|NCT01157416|Pharmacotherapy|pharmacotherapy
466061|NCT01157403|mesenchymal stem cells|mesenchymal stem cells
466062|NCT01157390|Term-infant|term-infant
466063|NCT01157390|sn-2 palmitic acid|sn-2 palmitic acid
466064|NCT01157390|infant formula|infant formula
466065|NCT01157351|Schizophrenia|schizophrenia
466066|NCT01157351|Risperidone|risperidone
466067|NCT01157351|Risperdal|risperdal
466068|NCT01157351|Paliperidone palmitate|paliperidone palmitate
466069|NCT01157351|Aripiprazole|aripiprazole
466070|NCT01157351|Haloperidol|haloperidol
466071|NCT01157351|Olanzapine|olanzapine
466072|NCT01157351|Paliperidone|paliperidone
466073|NCT01157351|Perphenazine|perphenazine
466074|NCT01157351|Quetiapine|quetiapine
466075|NCT01157338|Catheter|catheter
466076|NCT01157338|coronary artery disease|coronary artery disease
466077|NCT01157338|embolus|embolus
466078|NCT01157338|stroke|stroke
466079|NCT01157338|retinal emboli|retinal emboli
466080|NCT01157325|Epidural analgesia|epidural analgesia
466081|NCT01157325|Latent analgesia|latent analgesia
466082|NCT01157325|Active analgesia|active analgesia
466083|NCT01157325|Cesarean section|cesarean section
466084|NCT01157312|Polycystic ovary syndrome|polycystic ovary syndrome
466085|NCT01157312|clomiphene citrate|clomiphene citrate
466086|NCT01157312|minimal stimulation|minimal stimulation
466087|NCT01157312|infertility treatment|infertility treatment
466088|NCT01157299|Hemodynamics|hemodynamics
466089|NCT01157299|Pediatric Intensive Care Unit|pediatric intensive care unit
466090|NCT01157299|Low cardiac output|low cardiac output
466091|NCT01157299|Thermodilution|thermodilution
466092|NCT01157299|Stroke volume|stroke volume
466093|NCT01157299|Global end-diastolic volume|global end-diastolic volume
466094|NCT01157299|Fluid responsiveness|fluid responsiveness
466095|NCT01157299|Passive leg raising|passive leg raising
466096|NCT01157299|Infant|infant
466097|NCT01157286|OBSTRUCTIVE SLEEP APNEA LARINGECTOMY CPAP|obstructive sleep apnea laringectomy cpap
466098|NCT01157273|Behavior|behavior
466099|NCT01157273|Anxiety|anxiety
466100|NCT01157273|Communication|communication
466101|NCT01157273|Voice|voice
466102|NCT01157260|Indoxyl sulfate|indoxyl sulfate
466103|NCT01157260|AST-120|ast-120
466104|NCT01157247|Anesthetic techniques|anesthetic techniques
466105|NCT01157247|regional, spinal|regional, spinal
466106|NCT01157247|Pain|pain
466107|NCT01157247|lumbar puncture|lumbar puncture
466108|NCT01157247|Analgesia, local|analgesia, local
466109|NCT01157247|Analgesia, intravenous|analgesia, intravenous
466110|NCT01157234|Hypertension|hypertension
466111|NCT01157234|Kidney transplantation|kidney transplantation
466112|NCT01157234|Renal function|renal function
466113|NCT01157234|Nitric Oxide|nitric oxide
466114|NCT01157234|Nebivolol|nebivolol
466115|NCT01157208|chronic pain|chronic pain
466116|NCT01157208|headache|headache
466117|NCT01157208|nutrition|nutrition
466118|NCT01157208|inflammation|inflammation
466119|NCT01157208|complementary medicine|complementary medicine
466120|NCT01157195|stroke|stroke
466121|NCT01157195|chronic|chronic
466122|NCT01157195|arm|arm
466123|NCT01157195|rehabilitation|rehabilitation
466124|NCT01157195|tele-health|tele-health
466125|NCT01157182|Healthy|healthy
466126|NCT01157182|Bioequivalence|bioequivalence
466127|NCT01157182|Post-Menopausal|post-menopausal
466128|NCT01157169|Bioequivalence|bioequivalence
466129|NCT01157169|Healthy|healthy
466130|NCT01157130|Breast Cancer|breast cancer
466131|NCT01157130|Exercise|exercise
466132|NCT01157130|CRP|crp
466133|NCT01157130|C-reactive protein|c-reactive protein
466134|NCT01157130|BMI|bmi
466135|NCT01157130|Nevada Cancer Institute|nevada cancer institute
466136|NCT01157130|Rehabilitation|rehabilitation
466137|NCT01157130|Prescriptive exercise|prescriptive exercise
466138|NCT01157130|Physical Activity|physical activity
466139|NCT01157130|DEXA|dexa
466140|NCT01157130|Obesity|obesity
466141|NCT01157130|lifestyle intervention|lifestyle intervention
466142|NCT01157130|Early Stage Breast Cancer Patients (stage 0-III)|early stage breast cancer patients (stage 0-iii)
466143|NCT01157117|food allergy|food allergy
466144|NCT01157104|HCV|hcv
466145|NCT01157104|Hepatitis C|hepatitis c
466146|NCT01157078|Major Depressive Disorder|major depressive disorder
466147|NCT01157078|MDD|mdd
466148|NCT01157078|Depression|depression
466149|NCT01157078|Safety|safety
466150|NCT01157078|add-on therapy|add-on therapy
466151|NCT01157065|Wet AMD|wet amd
466152|NCT01157065|Intravitreal Injection|intravitreal injection
466153|NCT01157065|Macular Degeneration|macular degeneration
466154|NCT01157065|VEGF treatment|vegf treatment
466155|NCT01157052|magnesium|magnesium
466156|NCT01157052|calcium|calcium
466157|NCT01157052|adverse effects|adverse effects
466158|NCT01157052|kinetics, drug|kinetics, drug
466159|NCT01157039|glutamine|glutamine
466160|NCT01157039|oxaliplatin|oxaliplatin
466161|NCT01157039|adverse effects|adverse effects
466162|NCT01157026|Breast cancer|breast cancer
466163|NCT01157026|Tocotrienol-rich fraction with tamoxifen|tocotrienol-rich fraction with tamoxifen
466164|NCT01157013|Positron Emission Tomography|positron emission tomography
466165|NCT01157013|Hepatocellular carcinoma|hepatocellular carcinoma
466166|NCT01157013|Liver Cancer|liver cancer
466167|NCT01157013|Sorafenib|sorafenib
466168|NCT01157013|Response Evaluation|response evaluation
466169|NCT01157000|Canagliflozin|canagliflozin
466170|NCT01157000|Pharmacokinetic|pharmacokinetic
466171|NCT01157000|Bioavailability|bioavailability
466172|NCT01156974|care management|care management
466173|NCT01156974|chronic disease|chronic disease
466174|NCT01156974|outpatient|outpatient
466175|NCT01156948|misoprostol|misoprostol
466176|NCT01156948|nulliparous|nulliparous
466177|NCT01156948|hysteroscopy|hysteroscopy
466178|NCT01156935|Neoplasm|neoplasm
466179|NCT01156935|Laugh-Yoga|laugh-yoga
466180|NCT01156935|Mood|mood
466181|NCT01156935|Quality of life|quality of life
466182|NCT01156922|Chronic fatigue syndrome|chronic fatigue syndrome
466183|NCT01156922|CFS|cfs
466184|NCT01156922|Myalgic encephalomyelitis|myalgic encephalomyelitis
466185|NCT01156922|Rituximab|rituximab
466186|NCT01156922|B-cell depletion|b-cell depletion
466187|NCT01156909|Chronic fatigue syndrome|chronic fatigue syndrome
466188|NCT01156909|CFS|cfs
466189|NCT01156909|Myalgic encephalomyelitis|myalgic encephalomyelitis
466190|NCT01156909|Rituximab|rituximab
466191|NCT01156909|B-cell depletion|b-cell depletion
466192|NCT01156896|Non-transferrin-bound iron|non-transferrin-bound iron
466193|NCT01156896|Iron stable isotopes|iron stable isotopes
466194|NCT01156896|Iron deficiency|iron deficiency
466195|NCT01156896|Malaria|malaria
466196|NCT01156896|Iron supplementation|iron supplementation
466197|NCT01156896|Iron fortification|iron fortification
466198|NCT01156883|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
466199|NCT01156883|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
466200|NCT01156883|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
466201|NCT01156883|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
466202|NCT01156844|Indacaterol|indacaterol
466203|NCT01156844|Asthma|asthma
466204|NCT01156844|Bronchodilation|bronchodilation
466205|NCT01156844|Beta-agonist|beta-agonist
466206|NCT01156831|Esophageal cancer|esophageal cancer
466207|NCT01156831|PET-CT planning|pet-ct planning
466208|NCT01156818|Wheeze measurements|wheeze measurements
466209|NCT01156805|Children|children
466210|NCT01156805|School-based program|school-based program
466211|NCT01156805|Obesity|obesity
466212|NCT01156792|asthma|asthma
466213|NCT01156792|GSK2190915|gsk2190915
466214|NCT01156779|SR-Exenatide|sr-exenatide
466215|NCT01156766|Fracture|fracture
466216|NCT01156766|Radius|radius
466217|NCT01156766|Osteosynthesis|osteosynthesis
466218|NCT01156766|Metaphyseal|metaphyseal
466219|NCT01156766|Pinning|pinning
466220|NCT01156766|Locking anterior plate|locking anterior plate
466221|NCT01156753|CR011-vcMMAE|cr011-vcmmae
466222|NCT01156753|locally advanced breast cancer|locally advanced breast cancer
466223|NCT01156753|metastatic breast cancer|metastatic breast cancer
466224|NCT01156753|breast cancer|breast cancer
466225|NCT01156753|CDX-011|cdx-011
466226|NCT01156753|GPNMB|gpnmb
466227|NCT01156753|Targeted treatment for breast cancer|targeted treatment for breast cancer
466228|NCT01156753|Locally advanced or metastatic breast cancer|locally advanced or metastatic breast cancer
466229|NCT01156740|streptococcal pharyngitis|streptococcal pharyngitis
466230|NCT01156740|randomized clinical trial|randomized clinical trial
466231|NCT01156740|amoxicillin|amoxicillin
466232|NCT01156740|intramuscular benzathine penicillin G.|intramuscular benzathine penicillin g.
466233|NCT01156727|OEF/OIF|oef/oif
466234|NCT01156727|Mental Health|mental health
466235|NCT01156727|Veterans|veterans
466236|NCT01156714|Parkinson's Disease|parkinson's disease
466237|NCT01156714|Treadmill Training|treadmill training
466238|NCT01156714|Exercise|exercise
466239|NCT01156714|Cognitive Training|cognitive training
466240|NCT01156714|Executive Function|executive function
466241|NCT01156714|Dual Task|dual task
466242|NCT01156701|Influenza|influenza
466243|NCT01156701|Zanamivir|zanamivir
466244|NCT01156701|Influenza prophylaxis|influenza prophylaxis
466245|NCT01156701|Relenza|relenza
466246|NCT01156688|medical abortion for pregnancy of less than 9 weeks gestation|medical abortion for pregnancy of less than 9 weeks gestation
466247|NCT01156675|Back pain|back pain
466248|NCT01156675|Pain|pain
466249|NCT01156675|Spinal Diseases|spinal diseases
466250|NCT01156675|Spinal Stenosis|spinal stenosis
466251|NCT01156675|Lumbar Vertebrae|lumbar vertebrae
466252|NCT01156675|Spinal Canal|spinal canal
466253|NCT01156662|Thrombus aspiration|thrombus aspiration
466254|NCT01156662|Percutaneous coronary intervention|percutaneous coronary intervention
466255|NCT01156649|Obstructive sleep apnea|obstructive sleep apnea
466256|NCT01156649|neurocognitive function|neurocognitive function
466257|NCT01156649|cognition|cognition
466258|NCT01156649|pediatrics|pediatrics
466259|NCT01156649|children|children
466260|NCT01156649|continuous positive airway pressure therapy|continuous positive airway pressure therapy
466261|NCT01156649|sham treatment|sham treatment
466262|NCT01156649|randomized clinical trial|randomized clinical trial
466263|NCT01156649|behavior|behavior
466264|NCT01156649|treatment|treatment
466265|NCT01156636|Diastolic Heart Failure|diastolic heart failure
466266|NCT01156636|Pulmonary Hypertension|pulmonary hypertension
466267|NCT01156623|EBUS-TBNA|ebus-tbna
466268|NCT01156623|NSCLC|nsclc
466269|NCT01156623|Mediastinal lymph node|mediastinal lymph node
466270|NCT01156623|tuberculosis|tuberculosis
466271|NCT01156610|Smoking|smoking
466272|NCT01156610|Smoking Cessation|smoking cessation
466273|NCT01156610|Electronic Health Record|electronic health record
466274|NCT01156610|Telephone|telephone
466275|NCT01156597|diabetes|diabetes
466276|NCT01156597|dyslipidemia|dyslipidemia
466277|NCT01156597|pioglitazone|pioglitazone
466278|NCT01156597|HDL-Cholesterol|hdl-cholesterol
466279|NCT01156597|Reverse cholesterol transport|reverse cholesterol transport
466280|NCT01156584|glioma|glioma
466281|NCT01156584|glioblastoma|glioblastoma
466282|NCT01156584|glioblastoma multiforme|glioblastoma multiforme
466283|NCT01156584|Grade IV astrocytoma|grade iv astrocytoma
466284|NCT01156584|brain cancer|brain cancer
466285|NCT01156584|recurrent glioblastoma|recurrent glioblastoma
466287|NCT01156584|AA|aa
466288|NCT01156584|AOD|aod
466289|NCT01156584|anaplastic astrocytoma|anaplastic astrocytoma
466290|NCT01156584|anaplastic oligodendroglioma|anaplastic oligodendroglioma
466291|NCT01156584|anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
466292|NCT01156584|malignant glioma|malignant glioma
466293|NCT01156584|high grade glioma|high grade glioma
466294|NCT01156545|BIBW 2992|bibw 2992
466295|NCT01156545|Simvastatin|simvastatin
466296|NCT01156545|NSCLC|nsclc
466297|NCT01156545|advanced stage|advanced stage
466298|NCT01156545|previously treated patients|previously treated patients
466299|NCT01156545|non-adenocarcinoma|non-adenocarcinoma
466300|NCT01156532|adalimumab therapy|adalimumab therapy
466301|NCT01156532|Psoriasis|psoriasis
466302|NCT01156532|observational study|observational study
466303|NCT01156519|Infra-clinic cortisol adenoma|infra-clinic cortisol adenoma
466304|NCT01156519|Salivary cortisol|salivary cortisol
466305|NCT01156519|Obesity|obesity
466306|NCT01156506|quality of life|quality of life
466307|NCT01156506|patient education|patient education
466308|NCT01156506|rehabilitation|rehabilitation
466309|NCT01156506|focus group interview|focus group interview
466310|NCT01156493|feeding intolerance|feeding intolerance
466311|NCT01156493|prematurity|prematurity
466312|NCT01156480|necrotizing enterocolitis|necrotizing enterocolitis
466313|NCT01156480|NEC|nec
466314|NCT01156480|premature|premature
466315|NCT01156480|hydrocortisone|hydrocortisone
466316|NCT01156480|steroids|steroids
466317|NCT01156480|anti-inflammatory|anti-inflammatory
466318|NCT01156467|Neurally adjusted ventilatory assist NAVA|neurally adjusted ventilatory assist nava
466319|NCT01156467|Premature infant|premature infant
466320|NCT01156467|Edi-signal|edi-signal
466321|NCT01156454|sentinel lymph node dissection|sentinel lymph node dissection
466322|NCT01156454|radiology|radiology
466323|NCT01156454|X-ray identification of nodes in a surgical specimen|x-ray identification of nodes in a surgical specimen
466324|NCT01156441|Myocardial Infarction|myocardial infarction
466325|NCT01156441|Mitral Regurgitation|mitral regurgitation
466326|NCT01156441|Percutaneous Coronary Intervention|percutaneous coronary intervention
466327|NCT01156428|Nephritic syndrome|nephritic syndrome
466328|NCT01156428|Nephrotic syndrome|nephrotic syndrome
466329|NCT01156428|Proteinuria|proteinuria
466330|NCT01156428|Acute kidney injury|acute kidney injury
466331|NCT01156428|Chronic kidney disease|chronic kidney disease
466332|NCT01156428|Lupus nephritis|lupus nephritis
466333|NCT01156415|agomelatine|agomelatine
466334|NCT01156415|Major Depressive Disorder|major depressive disorder
466335|NCT01156415|MDD|mdd
466336|NCT01156415|depression|depression
466337|NCT01156402|Obesity|obesity
466338|NCT01156402|Pediatric Obesity|pediatric obesity
466339|NCT01156389|malaria|malaria
466340|NCT01156389|artemisinin-based combination therapy|artemisinin-based combination therapy
466341|NCT01156350|Neuroblastoma - Haplo HSCT - Reduced Intensity Conditioning - immunotherapy NK|neuroblastoma - haplo hsct - reduced intensity conditioning - immunotherapy nk
466342|NCT01156337|Heart failure III NYHA class|heart failure iii nyha class
466343|NCT01156337|Furosemide|furosemide
466344|NCT01156337|Sodium|sodium
466345|NCT01156337|water restriction|water restriction
466346|NCT01156337|decompensated heart failure|decompensated heart failure
466347|NCT01156337|Hypertonic saline solution|hypertonic saline solution
466348|NCT01156337|Moderate sodium restriction|moderate sodium restriction
466349|NCT01156324|IVF|ivf
466350|NCT01156324|Stress management|stress management
466351|NCT01156311|BG00012|bg00012
466352|NCT01156311|MS|ms
466353|NCT01156311|RRMS|rrms
466354|NCT01156272|Isolated aortic valve replacement|isolated aortic valve replacement
466355|NCT01156272|heart valve|heart valve
466356|NCT01156259|B cell cll/lymphoma, human|b cell cll/lymphoma, human
466357|NCT01156246|Healthy volunteers|healthy volunteers
466358|NCT01156246|Dapagliflozin|dapagliflozin
466359|NCT01156246|Diabetes Type 2|diabetes type 2
466360|NCT01156246|Food interaction|food interaction
466361|NCT01156233|evaluating precision of tube tip position with two methods|evaluating precision of tube tip position with two methods
466362|NCT01156220|gender, diuretics, furosemide, aminohippuric acid|gender, diuretics, furosemide, aminohippuric acid
466363|NCT01156207|To establish the coupling between components of arterial load ( and components of LV myocardial deformations at baseline and 6 months after randomization.|to establish the coupling between components of arterial load ( and components of lv myocardial deformations at baseline and 6 months after randomization.
466421|NCT01156142|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
466364|NCT01156207|To establish the role of EPCs on modulation of the components of arterial load and LV myocardial deformations and their coupling.|to establish the role of epcs on modulation of the components of arterial load and lv myocardial deformations and their coupling.
466365|NCT01156194|third stage, labor, postpartum hemorrhage, homeopathy, arnica, bellis perennis|third stage, labor, postpartum hemorrhage, homeopathy, arnica, bellis perennis
466366|NCT01156181|Cervical mucus, Embryo transfer, ICSI cycle, Pregnancy rate|cervical mucus, embryo transfer, icsi cycle, pregnancy rate
466367|NCT01156168|male breast cancer|male breast cancer
466368|NCT01156168|stage IV breast cancer|stage iv breast cancer
466369|NCT01156168|recurrent breast cancer|recurrent breast cancer
466370|NCT01156155|rheumatoid arthritis|rheumatoid arthritis
466371|NCT01156155|osteoarthritis|osteoarthritis
466372|NCT01156155|periodontal disease|periodontal disease
466373|NCT01156142|oral complications of radiation therapy|oral complications of radiation therapy
466374|NCT01156142|mucositis|mucositis
466375|NCT01156142|pain|pain
466376|NCT01156142|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
466377|NCT01156142|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
466378|NCT01156142|squamous cell carcinoma of the hypopharynx|squamous cell carcinoma of the hypopharynx
466379|NCT01156142|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
466380|NCT01156142|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
466381|NCT01156142|squamous cell carcinoma of the larynx|squamous cell carcinoma of the larynx
466382|NCT01156142|verrucous carcinoma of the larynx|verrucous carcinoma of the larynx
466383|NCT01156142|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
466384|NCT01156142|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
466385|NCT01156142|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
466386|NCT01156142|adenoid cystic carcinoma of the oral cavity|adenoid cystic carcinoma of the oral cavity
466387|NCT01156142|mucoepidermoid carcinoma of the oral cavity|mucoepidermoid carcinoma of the oral cavity
466388|NCT01156142|verrucous carcinoma of the oral cavity|verrucous carcinoma of the oral cavity
466389|NCT01156142|squamous cell carcinoma of the lip and oral cavity|squamous cell carcinoma of the lip and oral cavity
466390|NCT01156142|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
466391|NCT01156142|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
466392|NCT01156142|basal cell carcinoma of the lip|basal cell carcinoma of the lip
466393|NCT01156142|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
466394|NCT01156142|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
466395|NCT01156142|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
466396|NCT01156142|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
466397|NCT01156142|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
466398|NCT01156142|lymphoepithelioma of the nasopharynx|lymphoepithelioma of the nasopharynx
466399|NCT01156142|squamous cell carcinoma of the nasopharynx|squamous cell carcinoma of the nasopharynx
466400|NCT01156142|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
466401|NCT01156142|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
466402|NCT01156142|lymphoepithelioma of the oropharynx|lymphoepithelioma of the oropharynx
466403|NCT01156142|squamous cell carcinoma of the oropharynx|squamous cell carcinoma of the oropharynx
466404|NCT01156142|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
466405|NCT01156142|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
466406|NCT01156142|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
466407|NCT01156142|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
466408|NCT01156142|esthesioneuroblastoma of the paranasal sinus and nasal cavity|esthesioneuroblastoma of the paranasal sinus and nasal cavity
466409|NCT01156142|inverted papilloma of the paranasal sinus and nasal cavity|inverted papilloma of the paranasal sinus and nasal cavity
466410|NCT01156142|midline lethal granuloma of the paranasal sinus and nasal cavity|midline lethal granuloma of the paranasal sinus and nasal cavity
466411|NCT01156142|squamous cell carcinoma of the paranasal sinus and nasal cavity|squamous cell carcinoma of the paranasal sinus and nasal cavity
466412|NCT01156142|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
466413|NCT01156142|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
466414|NCT01156142|recurrent salivary gland cancer|recurrent salivary gland cancer
466415|NCT01156142|salivary gland acinic cell tumor|salivary gland acinic cell tumor
466416|NCT01156142|salivary gland adenocarcinoma|salivary gland adenocarcinoma
466417|NCT01156142|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
466418|NCT01156142|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
466419|NCT01156142|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
466420|NCT01156142|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
466710|NCT01154933|obesity|obesity
466422|NCT01156142|salivary gland cancer|salivary gland cancer
466423|NCT01156142|tongue cancer|tongue cancer
466424|NCT01156129|liver transplant|liver transplant
466425|NCT01156129|liver resection|liver resection
466426|NCT01156116|CPAP|cpap
466427|NCT01156116|diabetes|diabetes
466428|NCT01156116|sleep apnea|sleep apnea
466429|NCT01156103|obesity|obesity
466430|NCT01156103|minority|minority
466431|NCT01156103|child|child
466432|NCT01156103|physical fitness|physical fitness
466433|NCT01156103|school|school
466434|NCT01156103|physical activity|physical activity
466435|NCT01156090|vectibix|vectibix
466436|NCT01156077|antibiotic|antibiotic
466437|NCT01156077|Adolescents receiving antibiotics|adolescents receiving antibiotics
466438|NCT01156064|Endoscopy|endoscopy
466439|NCT01156064|Confocal laser endomicroscopy|confocal laser endomicroscopy
466440|NCT01156064|Digestive Diseases|digestive diseases
466441|NCT01156051|ADHD|adhd
466442|NCT01156051|ADD|add
466443|NCT01156051|sleep disturbance|sleep disturbance
466444|NCT01156038|Atopy patch test|atopy patch test
466445|NCT01156025|GV550|gv550
466446|NCT01156025|Acute adenoviral keratoconjunctivitis|acute adenoviral keratoconjunctivitis
466447|NCT01155986|analgesic|analgesic
466448|NCT01155986|analgesics|analgesics
466449|NCT01155986|pain|pain
466450|NCT01155986|chronic pain|chronic pain
466451|NCT01155986|localized pain|localized pain
466452|NCT01155986|focal pain|focal pain
466453|NCT01155986|neuropathic pain|neuropathic pain
466454|NCT01155986|postoperative pain|postoperative pain
466455|NCT01155986|topical analgesia|topical analgesia
466456|NCT01155973|Hypertension.|hypertension.
466457|NCT01155973|Cardiovascular risk.|cardiovascular risk.
466458|NCT01155973|Monitoring.|monitoring.
466459|NCT01155973|Primary health care.|primary health care.
466460|NCT01155973|Randomised controlled trial.|randomised controlled trial.
466461|NCT01155973|Cluster analysis|cluster analysis
466462|NCT01155960|Bioavailability|bioavailability
466463|NCT01155960|Anastrozole|anastrozole
466464|NCT01155960|Crossover|crossover
466465|NCT01155947|Bioavailability|bioavailability
466466|NCT01155947|Anastrozole|anastrozole
466467|NCT01155947|Crossover|crossover
466468|NCT01155934|Bioavailability|bioavailability
466469|NCT01155934|Crossover|crossover
466470|NCT01155934|Risperidone|risperidone
466471|NCT01155921|Bioavailability|bioavailability
466472|NCT01155921|Crossover|crossover
466473|NCT01155921|Risperidone|risperidone
466474|NCT01155908|Bioavailability|bioavailability
466475|NCT01155908|10 mg Amlodipine besylate/20 mg benazepril hydrochloride capsules|10 mg amlodipine besylate/20 mg benazepril hydrochloride capsules
466476|NCT01155908|Crossover|crossover
466477|NCT01155895|Bioavailability|bioavailability
466478|NCT01155895|10 mg Amlopdipine besylate /20 mg Benazepril Hydrochloride|10 mg amlopdipine besylate /20 mg benazepril hydrochloride
466479|NCT01155895|Crossover|crossover
466480|NCT01155869|alcohol dependence|alcohol dependence
466481|NCT01155869|homelessness|homelessness
466482|NCT01155869|naltrexone|naltrexone
466483|NCT01155856|telemedicine|telemedicine
466484|NCT01155856|COPD|copd
466485|NCT01155830|inflammatory cytokines|inflammatory cytokines
466486|NCT01155830|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
466487|NCT01155830|ECMO|ecmo
466488|NCT01155804|preparation of the delivery|preparation of the delivery
466489|NCT01155804|lumbago|lumbago
466490|NCT01155804|anxiety|anxiety
466491|NCT01155804|urinary incontinence|urinary incontinence
466492|NCT01155778|Sanfilippo Syndrome Type A (MPS IIIA)|sanfilippo syndrome type a (mps iiia)
466493|NCT01155778|Recombinant Human Heparan N-Sulfatase (rhHNS)|recombinant human heparan n-sulfatase (rhhns)
466494|NCT01155778|Lysosomal Storage Disease (LSD)|lysosomal storage disease (lsd)
466495|NCT01155778|Intrathecal Drug Delivery Device (IDDD)|intrathecal drug delivery device (iddd)
466496|NCT01155765|Clopidogrel Resistance|clopidogrel resistance
466497|NCT01155765|prasugrel|prasugrel
466498|NCT01155765|Hemodialysis|hemodialysis
466499|NCT01155752|sinusitis|sinusitis
466500|NCT01155752|cystic fibrosis|cystic fibrosis
466501|NCT01155752|therapy|therapy
466502|NCT01155713|Neoplasms|neoplasms
466503|NCT01155713|Cancer|cancer
466504|NCT01155713|Tumors|tumors
466505|NCT01155713|Administration, oral|administration, oral
466506|NCT01155713|Capsules|capsules
466507|NCT01155713|CHIR258, CHIR-258, CHIR 258, TKI258, TKI-258, TKI 258,|chir258, chir-258, chir 258, tki258, tki-258, tki 258,
466508|NCT01155713|Bioavailability,|bioavailability,
466509|NCT01155713|Food|food
466510|NCT01155700|omalizumab|omalizumab
466511|NCT01155700|allergic asthma|allergic asthma
466512|NCT01155700|pediatric patients|pediatric patients
466513|NCT01155687|afghanistan|afghanistan
466514|NCT01155687|depression|depression
466515|NCT01155687|anxiety|anxiety
466516|NCT01155687|social stress|social stress
466517|NCT01155687|counseling|counseling
466518|NCT01155687|medication|medication
466519|NCT01155687|psychotherapy|psychotherapy
466520|NCT01155687|mental health|mental health
466521|NCT01155674|Innate immunity|innate immunity
466522|NCT01155674|Neutrophils|neutrophils
466523|NCT01155674|Band forms|band forms
466524|NCT01155648|Mechanical ventilation|mechanical ventilation
466525|NCT01155648|Chest physiotherapy|chest physiotherapy
466526|NCT01155648|Chest wall compression|chest wall compression
466527|NCT01155635|Myocardial infarction|myocardial infarction
466528|NCT01155635|Adrenergic beta-Antagonists|adrenergic beta-antagonists
466529|NCT01155635|Percutaneous coronary intervention|percutaneous coronary intervention
466530|NCT01155622|Hypothermia, induced|hypothermia, induced
466531|NCT01155622|Cardiac arrest|cardiac arrest
466532|NCT01155622|Disability evaluation|disability evaluation
466533|NCT01155622|Cardiac arrhythmia|cardiac arrhythmia
466534|NCT01155622|Ventricular function|ventricular function
466535|NCT01155622|Internal cooling|internal cooling
466536|NCT01155622|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
466537|NCT01155622|Post-cardiac arrest syndrome|post-cardiac arrest syndrome
466538|NCT01155596|Acute respiratory failure patients in medical ICUs.|acute respiratory failure patients in medical icus.
466539|NCT01155570|Psoriasis|psoriasis
466540|NCT01155557|Tension-Type Headache|tension-type headache
466541|NCT01155557|Strength Capacity|strength capacity
466542|NCT01155557|Neck and Shoulder|neck and shoulder
466543|NCT01155544|Aripiprazole|aripiprazole
466544|NCT01155544|Psychotic experiences|psychotic experiences
466545|NCT01155544|Substance abuse|substance abuse
466546|NCT01155544|Substance dependence|substance dependence
466547|NCT01155544|Craving|craving
466548|NCT01155544|Mood|mood
466549|NCT01155544|Substance use|substance use
466550|NCT01155531|Obesity|obesity
466551|NCT01155531|Overweight|overweight
466552|NCT01155531|Sertraline|sertraline
466553|NCT01155531|Telenzepine|telenzepine
466554|NCT01155531|Decrease appetite|decrease appetite
466555|NCT01155531|Reduce appetite|reduce appetite
466556|NCT01155531|Lose weight|lose weight
466557|NCT01155518|hypogonadism|hypogonadism
466558|NCT01155518|diabetes|diabetes
466559|NCT01155518|spermatogenesis|spermatogenesis
466560|NCT01155518|insulin resistance|insulin resistance
466561|NCT01155492|lipopolysaccharides|lipopolysaccharides
466562|NCT01155492|etiology|etiology
466563|NCT01155492|inflammation|inflammation
466564|NCT01155492|colonic bacteria|colonic bacteria
466565|NCT01155492|intestinal permeability|intestinal permeability
466566|NCT01155466|Idiopathic Parkinson Disease|idiopathic parkinson disease
466567|NCT01155466|Idiopathic Parkinson's Disease|idiopathic parkinson's disease
466568|NCT01155453|BKM120|bkm120
466569|NCT01155453|RAS RAF mutations,|ras raf mutations,
466570|NCT01155453|triple negative breast cancer,|triple negative breast cancer,
466571|NCT01155453|pancreatic cancer,|pancreatic cancer,
466572|NCT01155453|PI3K inhibitor,|pi3k inhibitor,
466573|NCT01155453|MEK inhibitor|mek inhibitor
466574|NCT01155440|60 patients scheduled to have a colorectal surgery|60 patients scheduled to have a colorectal surgery
466575|NCT01155440|recruit at Montreal General Hospital|recruit at montreal general hospital
466576|NCT01155401|acute upper gastrointestinal bleeding|acute upper gastrointestinal bleeding
466577|NCT01155401|patients with drug-induced upper gastrointestinal bleeding|patients with drug-induced upper gastrointestinal bleeding
466578|NCT01155401|routine management|routine management
466579|NCT01155388|Iron deficiency anemia|iron deficiency anemia
466580|NCT01155388|Feraheme|feraheme
466581|NCT01155388|ferumoxytol|ferumoxytol
466582|NCT01155388|CKD|ckd
466583|NCT01155388|pediatric|pediatric
466584|NCT01155388|nondialysis-dependent|nondialysis-dependent
466585|NCT01155375|Iron deficiency anemia|iron deficiency anemia
466586|NCT01155375|Feraheme|feraheme
466587|NCT01155375|ferumoxytol|ferumoxytol
466588|NCT01155375|CKD|ckd
466589|NCT01155375|pediatric|pediatric
466590|NCT01155375|dialysis-dependent|dialysis-dependent
466591|NCT01155375|nondialysis-dependent|nondialysis-dependent
466592|NCT01155362|Human Placenta-Derived Cells for the Treatment of Moderate-to-Severe Crohn's Disease|human placenta-derived cells for the treatment of moderate-to-severe crohn's disease
466593|NCT01155349|brain fitness|brain fitness
466594|NCT01155349|cognitive training|cognitive training
466595|NCT01155349|cognitive intervention|cognitive intervention
466596|NCT01155349|speed of processing training|speed of processing training
466597|NCT01155349|Parkinson's disease|parkinson's disease
466598|NCT01155336|Acute Coronary Syndrome|acute coronary syndrome
466599|NCT01155336|Fish Oils|fish oils
466600|NCT01155336|Platelet Function Tests|platelet function tests
466601|NCT01155336|Cardiac Electrophysiology|cardiac electrophysiology
466602|NCT01155310|Exacerbation of COPD|exacerbation of copd
466603|NCT01155310|Helium/Oxygen|helium/oxygen
466604|NCT01155310|ICU|icu
466605|NCT01155310|Non-Invasive Ventilation|non-invasive ventilation
466606|NCT01155310|Patient with known or suspected COPD|patient with known or suspected copd
466607|NCT01155310|patient Admitted in an ICU|patient admitted in an icu
466608|NCT01155310|Patient presenting current exacerbation of COPD|patient presenting current exacerbation of copd
466609|NCT01155297|Quality of Life|quality of life
466610|NCT01155297|Biological Markers|biological markers
466611|NCT01155297|Renal Insufficiency|renal insufficiency
466612|NCT01155297|Resistance Training|resistance training
466613|NCT01155297|Exercise|exercise
466614|NCT01155297|Chronic Kidney Failure|chronic kidney failure
466615|NCT01155284|diabetes|diabetes
466616|NCT01155284|HGB A1C|hgb a1c
466617|NCT01155284|Beta Cell Regeneration|beta cell regeneration
466618|NCT01155245|osteoporosis|osteoporosis
466619|NCT01155245|HR-pQCT|hr-pqct
466620|NCT01155245|PTH|pth
466621|NCT01155232|osteoporosis|osteoporosis
466622|NCT01155232|Forteo|forteo
466623|NCT01155232|Parathyroid hormone|parathyroid hormone
466624|NCT01155232|HR-pQCT|hr-pqct
466625|NCT01155219|Bilateral Glaucoma|bilateral glaucoma
466626|NCT01155219|Bilateral ocular hypertension|bilateral ocular hypertension
466627|NCT01155219|Bilateral primary open angle glaucoma|bilateral primary open angle glaucoma
466628|NCT01155219|Bilateral ocular hypertension already treated and controlled by mono-therapy of Xalatan® (1drop per day)|bilateral ocular hypertension already treated and controlled by mono-therapy of xalatan® (1drop per day)
466629|NCT01155219|With local intolerance signs in at least one eye|with local intolerance signs in at least one eye
466630|NCT01155206|glucagon,|glucagon,
466631|NCT01155206|high physiological dose and basal dose of glucagon|high physiological dose and basal dose of glucagon
466632|NCT01155206|hepatic lipoprotein production,|hepatic lipoprotein production,
466633|NCT01155206|free fatty acid|free fatty acid
466634|NCT01155206|intestinal lipoprotein production|intestinal lipoprotein production
466635|NCT01155206|particle|particle
466636|NCT01155206|glucagon affects production of fat in intestine and liver.|glucagon affects production of fat in intestine and liver.
466637|NCT01155193|Children|children
466638|NCT01155193|Pre-term infants|pre-term infants
466639|NCT01155193|Congenital heart disease|congenital heart disease
466640|NCT01155193|Infection|infection
466641|NCT01155193|Respiratory syncytial virus|respiratory syncytial virus
466642|NCT01155167|radial artery spasm|radial artery spasm
466643|NCT01155154|wounds and lacerations|wounds and lacerations
466644|NCT01155154|hand|hand
466645|NCT01155154|infection|infection
466646|NCT01155154|Antibiotics|antibiotics
466647|NCT01155154|antibacterial agents|antibacterial agents
466648|NCT01155128|physical activity|physical activity
466649|NCT01155128|exercise|exercise
466650|NCT01155128|sedentarism|sedentarism
466651|NCT01155128|chronic renal disease|chronic renal disease
466652|NCT01155128|failure renal chronic|failure renal chronic
466653|NCT01155128|proteinuria|proteinuria
466654|NCT01155128|progression|progression
466655|NCT01155128|Renal Protective Effects of Exercise|renal protective effects of exercise
466656|NCT01155128|quality of life changes with exercise in CKD|quality of life changes with exercise in ckd
466657|NCT01155128|Endothelial progenitor cells in CKD|endothelial progenitor cells in ckd
466658|NCT01155128|Chronic Kidney Disease and Ankle Brachial Index|chronic kidney disease and ankle brachial index
466659|NCT01155115|pediatrics|pediatrics
466660|NCT01155115|CF|cf
466661|NCT01155115|PCD|pcd
466662|NCT01155115|exacerbation|exacerbation
466663|NCT01155115|inflammatory markers|inflammatory markers
466664|NCT01155115|induced sputum|induced sputum
466665|NCT01155063|Exemestane|exemestane
466666|NCT01155063|Adjuvant Treatment In Postmenopausal Women|adjuvant treatment in postmenopausal women
466667|NCT01155063|Estrogen Receptor Positive Early Breast Cancer|estrogen receptor positive early breast cancer
466668|NCT01155063|Tamoxifen|tamoxifen
466669|NCT01155050|overweight|overweight
466670|NCT01155050|obese|obese
466671|NCT01155050|type II diabetes|type ii diabetes
466672|NCT01155050|hypertension|hypertension
466673|NCT01155037|HIV, influenza A H1N1, vaccine|hiv, influenza a h1n1, vaccine
466674|NCT01155024|Lower extremity amputation|lower extremity amputation
466675|NCT01155024|Prosthetic Sockets|prosthetic sockets
466676|NCT01155024|Direct Manufactured (DM)|direct manufactured (dm)
466677|NCT01155011|Older adults|older adults
466678|NCT01155011|physical activity|physical activity
466679|NCT01155011|sedentary|sedentary
466680|NCT01155011|retirement communities|retirement communities
466681|NCT01155011|advocacy|advocacy
466682|NCT01155011|built environment|built environment
466683|NCT01155011|peer mentoring|peer mentoring
466684|NCT01155011|walkability|walkability
466685|NCT01154998|non-specific interstitial pneumonia|non-specific interstitial pneumonia
466686|NCT01154985|omega-3 fatty acids|omega-3 fatty acids
466687|NCT01154985|alanine transaminase|alanine transaminase
466688|NCT01154985|triglycerides|triglycerides
466689|NCT01154985|lipids|lipids
466690|NCT01154985|EPA|epa
466691|NCT01154985|ethyl-EPA|ethyl-epa
466692|NCT01154985|ethyl icosapentate|ethyl icosapentate
466693|NCT01154985|Non Alcoholic steatohepatitis|non alcoholic steatohepatitis
466694|NCT01154985|Non Alcoholic fatty liver disease|non alcoholic fatty liver disease
466695|NCT01154985|fatty acids|fatty acids
466696|NCT01154972|breast|breast
466697|NCT01154972|cancer|cancer
466698|NCT01154972|sentinel lymph node|sentinel lymph node
466699|NCT01154959|Pulmonary TB|pulmonary tb
466700|NCT01154959|Immune response|immune response
466701|NCT01154959|ATT|att
466702|NCT01154959|Immune responses in pulmonary tuberculosis|immune responses in pulmonary tuberculosis
466703|NCT01154959|Predictors for relapse|predictors for relapse
466704|NCT01154946|detrusor after-contraction|detrusor after-contraction
466705|NCT01154946|urodynamic|urodynamic
466706|NCT01154946|LUTS|luts
466707|NCT01154946|urinary bladder, overactive|urinary bladder, overactive
466708|NCT01154946|bladder dysfunction|bladder dysfunction
466709|NCT01154933|type 2 diabetes|type 2 diabetes
466711|NCT01154920|Head and Neck Cancer|head and neck cancer
466712|NCT01154920|HNSCC|hnscc
466713|NCT01154920|Paclitaxel|paclitaxel
466714|NCT01154920|Carboplatin|carboplatin
466715|NCT01154920|Cetuximab|cetuximab
466716|NCT01154920|Docetaxel|docetaxel
466717|NCT01154920|Taxotere|taxotere
466718|NCT01154920|Cisplatin|cisplatin
466719|NCT01154920|Platinol-AQ|platinol-aq
466720|NCT01154920|Platinol|platinol
466721|NCT01154920|CDDP|cddp
466722|NCT01154920|Fluorouracil|fluorouracil
466723|NCT01154920|5-FU|5-fu
466724|NCT01154920|Adrucil|adrucil
466725|NCT01154920|Efudex|efudex
466726|NCT01154920|chemotherapy|chemotherapy
466727|NCT01154920|radiation|radiation
466728|NCT01154920|Chemoradiotherapy|chemoradiotherapy
466729|NCT01154907|Uro-genital schistosomiasis|uro-genital schistosomiasis
466730|NCT01154907|Female|female
466731|NCT01154907|South Africa|south africa
466732|NCT01154907|Rural|rural
466733|NCT01154907|Sexually transmitted diseases|sexually transmitted diseases
466734|NCT01154894|arachidonic acid|arachidonic acid
466735|NCT01154894|autism spectrum disorders|autism spectrum disorders
466736|NCT01154894|social interaction|social interaction
466737|NCT01154894|randomized controlled trial|randomized controlled trial
466738|NCT01154894|DHA|dha
466739|NCT01154855|Periodontal disease|periodontal disease
466740|NCT01154855|Gum disease|gum disease
466741|NCT01154855|Dental|dental
466742|NCT01154855|Inflammation|inflammation
466743|NCT01154855|Microorganisms|microorganisms
466744|NCT01154855|Bacteria|bacteria
466745|NCT01154842|FGF-23|fgf-23
466746|NCT01154842|Dialysis|dialysis
466747|NCT01154842|plasma FGF-23 levels|plasma fgf-23 levels
466748|NCT01154842|echocardiography|echocardiography
466749|NCT01154829|dopamine|dopamine
466750|NCT01154829|first episode|first episode
466751|NCT01154829|reward|reward
466752|NCT01154829|cognition|cognition
466753|NCT01154829|MRI|mri
466754|NCT01154829|fMRI|fmri
466755|NCT01154829|PPI|ppi
466756|NCT01154829|P300|p300
466757|NCT01154829|P50 gating|p50 gating
466758|NCT01154829|endophenotypes|endophenotypes
466759|NCT01154803|Supplementation|supplementation
466760|NCT01154803|RUTF|rutf
466761|NCT01154803|Micronutrients|micronutrients
466762|NCT01154803|Plumpynut|plumpynut
466763|NCT01154803|Mixme|mixme
466764|NCT01154803|sprinkles|sprinkles
466765|NCT01154803|convalescence|convalescence
466766|NCT01154803|weight|weight
466767|NCT01154803|morbidity|morbidity
466768|NCT01154790|healthy volunteers|healthy volunteers
466769|NCT01154777|Neurofeedback|neurofeedback
466770|NCT01154777|Braintraining|braintraining
466771|NCT01154777|Autism|autism
466772|NCT01154777|Mild|mild
466773|NCT01154777|Moderate|moderate
466774|NCT01154777|Mild to Moderate Autism|mild to moderate autism
466775|NCT01154764|healthy male volunteers|healthy male volunteers
466776|NCT01154751|Femoral artery stenosis|femoral artery stenosis
466777|NCT01154751|Peripheral vascular Disease|peripheral vascular disease
466778|NCT01154725|Patient education|patient education
466779|NCT01154725|Health-Related Quality of Life|health-related quality of life
466780|NCT01154725|patients with stomas|patients with stomas
466781|NCT01154725|stomatherapy|stomatherapy
466782|NCT01154725|health economics|health economics
466783|NCT01154712|Gambling|gambling
466784|NCT01154712|Deep TMS|deep tms
466785|NCT01154712|addiction|addiction
466786|NCT01154712|Brain stimulation|brain stimulation
466787|NCT01154699|Asthma|asthma
466788|NCT01154699|Nocturnal Asthma|nocturnal asthma
466789|NCT01154699|Lung volumes|lung volumes
466790|NCT01154699|Deep inspiration|deep inspiration
466791|NCT01154699|Obstructive sleep apnea|obstructive sleep apnea
466792|NCT01154660|any operation that required for general anesthesia|any operation that required for general anesthesia
466793|NCT01154634|Pharmacodynamic effect|pharmacodynamic effect
466794|NCT01154634|Reflux inhibition|reflux inhibition
466795|NCT01154621|Phase I|phase i
466796|NCT01154621|Double-blind|double-blind
466797|NCT01154621|Randomized|randomized
466798|NCT01154621|Placebo-controlled study|placebo-controlled study
466799|NCT01154621|Safety and tolerability of single intravenous dose of AZD9742 in healthy elderly volunteers|safety and tolerability of single intravenous dose of azd9742 in healthy elderly volunteers
466800|NCT01154608|Protein absorption in pancreatitis|protein absorption in pancreatitis
466801|NCT01154608|Protein metabolism in pancreatitis|protein metabolism in pancreatitis
466802|NCT01154595|moderate acute malnutrition, prevention, Lipid-based supplement|moderate acute malnutrition, prevention, lipid-based supplement
466803|NCT01154582|ingestive behavior|ingestive behavior
466804|NCT01154569|drug absorption|drug absorption
466805|NCT01154569|azithromycin|azithromycin
466806|NCT01154569|obesity|obesity
466807|NCT01154569|bariatric surgery|bariatric surgery
466808|NCT01154556|Antiretroviral therapy experienced|antiretroviral therapy experienced
466809|NCT01154556|failed NNRTI regime|failed nnrti regime
466810|NCT01154543|Recurrent genital Herpes Simplex Virus|recurrent genital herpes simplex virus
466811|NCT01154530|Gastroscopy|gastroscopy
466812|NCT01154530|Bacteria|bacteria
466813|NCT01154530|Chlorhexidine|chlorhexidine
466814|NCT01154530|General surgery|general surgery
466815|NCT01154504|adrenomedullin|adrenomedullin
466816|NCT01154504|heart failure|heart failure
466817|NCT01154504|ultrafiltration|ultrafiltration
466818|NCT01154504|hemofiltration|hemofiltration
466819|NCT01154491|hip fractures|hip fractures
466820|NCT01154491|blood substitutes|blood substitutes
466821|NCT01154491|blood transfusion|blood transfusion
466822|NCT01154491|intravenous infusion|intravenous infusion
466823|NCT01154491|erythropoietin, recombinant|erythropoietin, recombinant
466824|NCT01154491|frail elderly|frail elderly
466825|NCT01154478|polyphenols omega-3 postprandial lipemia adipose tissue|polyphenols omega-3 postprandial lipemia adipose tissue
466826|NCT01154465|Central venous catheterization|central venous catheterization
466827|NCT01154465|Obese|obese
466828|NCT01154465|Ultrasound guidance|ultrasound guidance
466829|NCT01154465|Jugular|jugular
466830|NCT01154465|Randomized|randomized
466831|NCT01154465|Intensive Care Unit|intensive care unit
466832|NCT01154439|secondary acute myeloid leukemia|secondary acute myeloid leukemia
466833|NCT01154439|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
466834|NCT01154439|adult acute basophilic leukemia|adult acute basophilic leukemia
466835|NCT01154439|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
466836|NCT01154439|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
466837|NCT01154439|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
466838|NCT01154439|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
466839|NCT01154439|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
466840|NCT01154439|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
466841|NCT01154439|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
466842|NCT01154439|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
466843|NCT01154439|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
466844|NCT01154439|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
466845|NCT01154439|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
466846|NCT01154439|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
466847|NCT01154439|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
466848|NCT01154439|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
466849|NCT01154400|casein protein|casein protein
466850|NCT01154400|whey protein|whey protein
466851|NCT01154400|hydrolysates|hydrolysates
466852|NCT01154400|leucine|leucine
466853|NCT01154400|protein metabolism|protein metabolism
466854|NCT01154400|COPD|copd
466855|NCT01154387|Kidney|kidney
466856|NCT01154387|Renal|renal
466857|NCT01154387|Transplant|transplant
466858|NCT01154387|Kidney Transplant|kidney transplant
466859|NCT01154387|Kidney Failure|kidney failure
466860|NCT01154387|Induction|induction
466861|NCT01154387|Monoclonal|monoclonal
466862|NCT01154387|Antibody|antibody
466863|NCT01154387|T cell|t cell
466864|NCT01154387|Anti-rejection|anti-rejection
466865|NCT01154387|Immunosuppression|immunosuppression
466866|NCT01154374|Diabetic Foot Ulcers (DFUs)|diabetic foot ulcers (dfus)
466867|NCT01154361|ACE inhibitor induced angioedema|ace inhibitor induced angioedema
466868|NCT01154361|Bradykinin|bradykinin
466869|NCT01154361|Non-itching edema|non-itching edema
466870|NCT01154361|Non-allergic angioedema|non-allergic angioedema
466871|NCT01154361|Quincke edema|quincke edema
466872|NCT01154361|Drug induced angioedema|drug induced angioedema
466873|NCT01154361|Bradykinin B2 receptor antagonist|bradykinin b2 receptor antagonist
466874|NCT01154361|Icatibant|icatibant
466875|NCT01154361|HOE 140|hoe 140
466876|NCT01154348|Metformin|metformin
466877|NCT01154335|refractory metastatic colorectal cancer|refractory metastatic colorectal cancer
466878|NCT01154309|Depression|depression
466879|NCT01154309|Substance Use|substance use
466880|NCT01154309|Group Cognitive Behavioral Therapy|group cognitive behavioral therapy
466881|NCT01154296|HIV|hiv
466882|NCT01154296|Rapid Testing|rapid testing
466883|NCT01154296|Counseling|counseling
466884|NCT01154296|STD|std
466885|NCT01154296|U.S.|u.s.
466886|NCT01154270|cancer of the salivary glands|cancer of the salivary glands
466887|NCT01154270|radiation|radiation
466888|NCT01154270|carbon ion therapy|carbon ion therapy
466889|NCT01154257|Dental plaque|dental plaque
466890|NCT01154257|Gingivitis|gingivitis
466891|NCT01154244|Insulin resistance|insulin resistance
466892|NCT01154244|Insulin deficiency|insulin deficiency
466893|NCT01154244|HOMA-IR|homa-ir
466894|NCT01154244|Drug naive|drug naive
466895|NCT01154244|Diabetes mellitus, type II|diabetes mellitus, type ii
466896|NCT01154231|BeneFIX Regulatory Post Marketing Commitment Plan|benefix regulatory post marketing commitment plan
466897|NCT01154218|bioequivalence|bioequivalence
466898|NCT01154218|food effect|food effect
466899|NCT01154218|pharmacokinetics|pharmacokinetics
466900|NCT01154218|crizotinib|crizotinib
466901|NCT01154192|PCOS|pcos
466902|NCT01154192|oligomenorrhea|oligomenorrhea
466903|NCT01154192|irregular menses|irregular menses
467764|NCT01150448|Risperidone|risperidone
466904|NCT01154192|hyperandrogenemia|hyperandrogenemia
466905|NCT01154192|elevated testosterone|elevated testosterone
466906|NCT01154192|adolescents|adolescents
466907|NCT01154192|androgens|androgens
466908|NCT01154192|ovary|ovary
466909|NCT01154192|LH|lh
466910|NCT01154179|permissive underfeeding|permissive underfeeding
466911|NCT01154179|hypocaloric feeding|hypocaloric feeding
466912|NCT01154179|artificial nutrition|artificial nutrition
466913|NCT01154140|open label|open label
466914|NCT01154140|randomized Phase 3|randomized phase 3
466915|NCT01154140|first line treatment|first line treatment
466916|NCT01154140|non squamous lung cancer|non squamous lung cancer
466917|NCT01154140|ALK translocation event positive|alk translocation event positive
466918|NCT01154127|NVA237|nva237
466919|NCT01154127|COPD|copd
466920|NCT01154127|bronchodilator|bronchodilator
466921|NCT01154127|exercise endurance|exercise endurance
466922|NCT01154114|healthy volunteer|healthy volunteer
466923|NCT01154114|hepatic impairment|hepatic impairment
466924|NCT01154114|darapladib|darapladib
466925|NCT01154114|atherosclerosis|atherosclerosis
466926|NCT01154088|Adolescent|adolescent
466927|NCT01154088|Vaccine, conjugate|vaccine, conjugate
466928|NCT01154088|Adult|adult
466929|NCT01154088|Neisseria meningitidis|neisseria meningitidis
466930|NCT01154088|Immunogenicity|immunogenicity
466931|NCT01154088|Meningococcal vaccine|meningococcal vaccine
466932|NCT01154088|Safety|safety
466933|NCT01154075|Liver transplant|liver transplant
466934|NCT01154075|Adherence|adherence
466935|NCT01154075|Compliance|compliance
466936|NCT01154075|Tacrolimus|tacrolimus
466937|NCT01154062|age-related macular degeneration|age-related macular degeneration
466938|NCT01154062|pazopanib|pazopanib
466939|NCT01154062|choroidal neovascularization|choroidal neovascularization
466940|NCT01154062|GW786034|gw786034
466941|NCT01154049|Schistosomiasis|schistosomiasis
466942|NCT01154049|Vaccine|vaccine
466943|NCT01154049|sm14|sm14
466944|NCT01154023|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
466945|NCT01154023|Behavior Therapy|behavior therapy
466946|NCT01154010|PEMF|pemf
466947|NCT01154010|iritis|iritis
466948|NCT01154010|anterior uveitis|anterior uveitis
466949|NCT01153958|Vaginosis, Bacterial|vaginosis, bacterial
466950|NCT01153958|Colposeptine|colposeptine
466951|NCT01153958|Metronidazole|metronidazole
466952|NCT01153945|Hypothyroid and non hypothyroid|hypothyroid and non hypothyroid
466953|NCT01153932|968|968
466954|NCT01153932|muscular dystrophy|muscular dystrophy
466955|NCT01153932|duchenne|duchenne
466956|NCT01153932|DMD|dmd
466957|NCT01153906|autoimmune diseases|autoimmune diseases
466958|NCT01153906|HPV vaccine|hpv vaccine
466959|NCT01153906|papillomavirus|papillomavirus
466960|NCT01153906|human papillomavirus|human papillomavirus
466961|NCT01153906|HPV|hpv
466962|NCT01153893|Pneumococcal disease|pneumococcal disease
466963|NCT01153893|Pneumococcal vaccine|pneumococcal vaccine
466964|NCT01153893|Catch-up vaccination|catch-up vaccination
466965|NCT01153893|Immunogenicity|immunogenicity
466966|NCT01153893|Booster vaccination|booster vaccination
466967|NCT01153893|Safety|safety
466968|NCT01153880|Altabax|altabax
466969|NCT01153880|United States|united states
466970|NCT01153880|topical|topical
466971|NCT01153880|Mupirocin|mupirocin
466972|NCT01153880|Retapamulin|retapamulin
466973|NCT01153880|Bactroban|bactroban
466974|NCT01153867|Schema Focused Therapy|schema focused therapy
466975|NCT01153867|Chronic Depression|chronic depression
466976|NCT01153867|Mechanisms of Change|mechanisms of change
466977|NCT01153854|acute diarrhea|acute diarrhea
466978|NCT01153854|Acute diarrhea (three or more watery or semi-watery bowel movements for at least one day lasting no more than 5 days before being admitted)|acute diarrhea (three or more watery or semi-watery bowel movements for at least one day lasting no more than 5 days before being admitted)
466979|NCT01153841|Pneumococcal vaccine|pneumococcal vaccine
466980|NCT01153828|Altargo|altargo
466981|NCT01153828|Bactroban|bactroban
466982|NCT01153828|Fucidin|fucidin
466983|NCT01153828|Fusidic acid|fusidic acid
466984|NCT01153828|Mupirocin|mupirocin
466985|NCT01153828|topical|topical
466986|NCT01153828|Retapamulin|retapamulin
466987|NCT01153828|United Kingdom|united kingdom
466988|NCT01153815|efficacy|efficacy
466989|NCT01153815|Spasticity, Post-Stroke|spasticity, post-stroke
466990|NCT01153815|safety|safety
466991|NCT01153815|Botulinum toxin type A|botulinum toxin type a
466992|NCT01153815|placebo|placebo
466993|NCT01153815|spasticity|spasticity
466994|NCT01153802|Positron Emission Tomography|positron emission tomography
466995|NCT01153802|serotonin|serotonin
466996|NCT01153802|inhibitor of the neurotransmitters|inhibitor of the neurotransmitters
466997|NCT01153802|safety of single oral doses|safety of single oral doses
466998|NCT01153802|norepinephrine|norepinephrine
466999|NCT01153802|dopamine|dopamine
467000|NCT01153789|Vergence-accommodation evaluation|vergence-accommodation evaluation
467001|NCT01153789|Vergence and postural control|vergence and postural control
467002|NCT01153789|Dynamic visual acuity|dynamic visual acuity
467003|NCT01153776|Arterial switch operation|arterial switch operation
467004|NCT01153776|Transposition of the great arteries|transposition of the great arteries
467005|NCT01153776|Congenital heart diseases|congenital heart diseases
467006|NCT01153776|CT coronary angiography|ct coronary angiography
467007|NCT01153763|Metastatic melanoma|metastatic melanoma
467008|NCT01153763|BRAF mutant|braf mutant
467009|NCT01153763|Melanoma|melanoma
467010|NCT01153763|BRAF mutant metastatic melanoma|braf mutant metastatic melanoma
467011|NCT01153750|cholangiocellular carcinoma|cholangiocellular carcinoma
467012|NCT01153750|bile duct cancer|bile duct cancer
467013|NCT01153737|Neck pain|neck pain
467014|NCT01153737|Primary Health Care|primary health care
467015|NCT01153737|Manual Therapy|manual therapy
467016|NCT01153737|TENS|tens
467017|NCT01153685|Fluviral®Influenza|fluviral®influenza
467018|NCT01153659|rabeprazole|rabeprazole
467019|NCT01153659|esomeprazole|esomeprazole
467020|NCT01153659|h. pylori-negative|h. pylori-negative
467021|NCT01153659|nocturnal acid breakthrough|nocturnal acid breakthrough
467022|NCT01153659|intragastric pH, PK/PD|intragastric ph, pk/pd
467023|NCT01153659|effect on gastric pH in healthy, H. pylori-Negative subjects|effect on gastric ph in healthy, h. pylori-negative subjects
467024|NCT01153646|HIV|hiv
467025|NCT01153646|Gene Transfer|gene transfer
467026|NCT01153646|T-Cell Immunotherapy|t-cell immunotherapy
467027|NCT01153646|HIV-1 infected patients who have failed anti-retroviral therapy|hiv-1 infected patients who have failed anti-retroviral therapy
467028|NCT01153620|Acute traumatic wounds|acute traumatic wounds
467029|NCT01153607|Alzheimer's disease|alzheimer's disease
467030|NCT01153607|Diagnostic imaging|diagnostic imaging
467031|NCT01153607|PET diagnosis|pet diagnosis
467032|NCT01153607|PET tracer|pet tracer
467033|NCT01153594|Substance Use Disorders|substance use disorders
467034|NCT01153594|Relapse|relapse
467035|NCT01153594|Recovery|recovery
467036|NCT01153594|Disease Management|disease management
467037|NCT01153594|Long term outcomes|long term outcomes
467038|NCT01153594|Addiction Treatment|addiction treatment
467039|NCT01153568|Vitamin D|vitamin d
467040|NCT01153568|osteoporosis|osteoporosis
467041|NCT01153568|african american women|african american women
467042|NCT01153529|PTSD|ptsd
467043|NCT01153516|Type 2 diabetes|type 2 diabetes
467044|NCT01153516|Bariatric surgery|bariatric surgery
467045|NCT01153516|Obesity|obesity
467046|NCT01153516|Weight loss|weight loss
467047|NCT01153503|Postoperative pain, TAP block, Hysterectomy|postoperative pain, tap block, hysterectomy
467048|NCT01153490|Quetiapine|quetiapine
467049|NCT01153490|Psychotic experiences|psychotic experiences
467050|NCT01153490|Cannabis dependence|cannabis dependence
467051|NCT01153490|Craving|craving
467052|NCT01153490|Mood|mood
467053|NCT01153490|Substance use|substance use
467054|NCT01153451|Pending tests|pending tests
467055|NCT01153451|Discharge|discharge
467056|NCT01153451|Awareness|awareness
467057|NCT01153451|Care transitions|care transitions
467058|NCT01153438|Diabetes|diabetes
467059|NCT01153438|Obesity|obesity
467060|NCT01153438|Bariatric surgery|bariatric surgery
467061|NCT01153438|Gut hormones|gut hormones
467062|NCT01153438|Glucagon like peptide 1|glucagon like peptide 1
467063|NCT01153438|Insulin|insulin
467064|NCT01153425|Osteoporosis|osteoporosis
467065|NCT01153425|Osteopenia|osteopenia
467066|NCT01153425|Fracture Risk|fracture risk
467067|NCT01153425|teriparatide or Forteo|teriparatide or forteo
467068|NCT01153425|zoledronic acid or Reclast|zoledronic acid or reclast
467069|NCT01153399|Non Small Cell Lung Cancer|non small cell lung cancer
467070|NCT01153399|EGFR mutations|egfr mutations
467071|NCT01153386|Pulmonary arterial hypertension|pulmonary arterial hypertension
467072|NCT01153386|Treprostinil|treprostinil
467073|NCT01153386|Pharmacokinetics|pharmacokinetics
467074|NCT01153373|Detection of tobacco, alcohol, and drug use.|detection of tobacco, alcohol, and drug use.
467075|NCT01153347|Major Depressive Disorder|major depressive disorder
467076|NCT01153347|MDD|mdd
467077|NCT01153347|Depression|depression
467078|NCT01153347|Safety|safety
467079|NCT01153347|add-on therapy|add-on therapy
467080|NCT01153321|Respiratory disease|respiratory disease
467081|NCT01153321|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
467082|NCT01153308|Morbid Obesity|morbid obesity
467083|NCT01153308|Obesity|obesity
467084|NCT01153308|Weight Loss|weight loss
467085|NCT01153308|Bariatric Surgery|bariatric surgery
467087|NCT01153295|Irritable bowel syndrome|irritable bowel syndrome
467088|NCT01153295|diagnosis|diagnosis
467089|NCT01153295|safety|safety
467090|NCT01153295|Health related quality of life|health related quality of life
467091|NCT01153282|Breast Cancer patients|breast cancer patients
467092|NCT01153269|Human Immunodeficiency Virus|human immunodeficiency virus
467093|NCT01153269|Co-infection with Hepatitis B or Hepatitis C|co-infection with hepatitis b or hepatitis c
467094|NCT01153269|Tolerability|tolerability
467095|NCT01153269|Effectiveness|effectiveness
467096|NCT01153243|inflammatory markers|inflammatory markers
467097|NCT01153230|PQ|pq
467098|NCT01153217|Tenofovir|tenofovir
467099|NCT01153217|HIV-infection|hiv-infection
467100|NCT01153217|BMD|bmd
467101|NCT01153217|Osteoporosis|osteoporosis
467102|NCT01153217|Osteopenia|osteopenia
467103|NCT01153204|Erectile Dysfunction|erectile dysfunction
467104|NCT01153204|Group Psychotherapy|group psychotherapy
467105|NCT01153204|Sildenafil [Substance Name]|sildenafil [substance name]
467106|NCT01153204|Patient Satisfaction|patient satisfaction
467107|NCT01153204|Efficacy|efficacy
467108|NCT01153204|Randomized Controlled Trial [Publication Type]|randomized controlled trial [publication type]
467109|NCT01153191|colorectal surgery|colorectal surgery
467110|NCT01153165|Refractory|refractory
467111|NCT01153165|Asthma|asthma
467112|NCT01153165|Depression|depression
467113|NCT01153152|wisdom teeth|wisdom teeth
467114|NCT01153152|acute pulpitis|acute pulpitis
467115|NCT01153152|extraction|extraction
467116|NCT01153152|pain|pain
467117|NCT01153152|Pain Following Removal of Wisdom Teeth with Acute Pulpitis|pain following removal of wisdom teeth with acute pulpitis
467118|NCT01153139|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
467119|NCT01153139|Depression|depression
467120|NCT01153139|Theta Burst Stimulation|theta burst stimulation
467121|NCT01153126|Diagnostic Imaging|diagnostic imaging
467122|NCT01153126|Breast Screening|breast screening
467123|NCT01153126|Breast Cancer|breast cancer
467124|NCT01153126|To be eligible for the study, subjects must:|to be eligible for the study, subjects must:
467125|NCT01153126|Be females at least 18 years of age,|be females at least 18 years of age,
467126|NCT01153126|Have had their screening mammogram performed at the UW Breast Center,|have had their screening mammogram performed at the uw breast center,
467127|NCT01153126|Be able to read and write English at the 6th grade level (as shown by their, ability to understand the informed consent),|be able to read and write english at the 6th grade level (as shown by their, ability to understand the informed consent),
467128|NCT01153126|Have access to a computer with internet capability.|have access to a computer with internet capability.
467129|NCT01153113|adenocarcinoma of the prostate|adenocarcinoma of the prostate
467130|NCT01153113|metastatic prostate adenocarcinoma, Stage (T1-4, N+, M0) or (T1-4, N0-3, M+)|metastatic prostate adenocarcinoma, stage (t1-4, n+, m0) or (t1-4, n0-3, m+)
467131|NCT01153113|rising PSA levels while maintained on LHRH analogues|rising psa levels while maintained on lhrh analogues
467132|NCT01153100|Diabetes|diabetes
467133|NCT01153074|Bronchopleural fistula|bronchopleural fistula
467134|NCT01153074|Bronchoscopy|bronchoscopy
467135|NCT01153048|Intensification of Education|intensification of education
467136|NCT01153048|learning nest methodology|learning nest methodology
467137|NCT01153048|peer educators|peer educators
467138|NCT01153048|type 2 diabetes|type 2 diabetes
467139|NCT01153048|Mali|mali
467140|NCT01153048|the focus of this study is on the intensification of education on the treatment of type 2 diabetes|the focus of this study is on the intensification of education on the treatment of type 2 diabetes
467141|NCT01153035|Breast Conservation Therapy|breast conservation therapy
467142|NCT01153035|Lumpectomy|lumpectomy
467143|NCT01153035|Radiofrequency Ablation|radiofrequency ablation
467144|NCT01153035|Radiation|radiation
467145|NCT01153022|Musculoskeletal manipulations|musculoskeletal manipulations
467146|NCT01153022|Muscle spasticity|muscle spasticity
467147|NCT01153009|Major Depressive Disorder|major depressive disorder
467148|NCT01153009|Depression|depression
467149|NCT01153009|Melancholia|melancholia
467150|NCT01153009|Drug Therapy|drug therapy
467151|NCT01152996|Depression|depression
467152|NCT01152996|Melancholia|melancholia
467153|NCT01152996|Paraphrenia|paraphrenia
467154|NCT01152996|Drug Therapy|drug therapy
467155|NCT01152983|Finger sticks|finger sticks
467156|NCT01152983|Rapid Ring|rapid ring
467157|NCT01152983|Finger sticks method of obtaining blood for diagnostic testing|finger sticks method of obtaining blood for diagnostic testing
467158|NCT01152957|diabetes|diabetes
467159|NCT01152957|cardiovascular|cardiovascular
467160|NCT01152957|chronic|chronic
467161|NCT01152957|Community Health Workers|community health workers
467162|NCT01152957|behavioral|behavioral
467163|NCT01152957|social|social
467164|NCT01152957|diet|diet
467165|NCT01152957|exercise|exercise
467166|NCT01152957|patient|patient
467167|NCT01152957|cholesterol|cholesterol
467168|NCT01152957|A1C|a1c
467169|NCT01152957|glucose|glucose
467170|NCT01152944|Symptomatic intracranial atherosclerotic disease enrolled in the medical arm of SAMMPRIS|symptomatic intracranial atherosclerotic disease enrolled in the medical arm of sammpris
467171|NCT01152931|Antioxidants|antioxidants
467172|NCT01152931|Micronutrients|micronutrients
467173|NCT01152931|Malaria|malaria
467174|NCT01152931|focus is to determine the effect of antioxidant micronutrients in malaria|focus is to determine the effect of antioxidant micronutrients in malaria
467175|NCT01152918|HIV Prevention|hiv prevention
467176|NCT01152918|HIV Treatment|hiv treatment
467177|NCT01152918|HIV Test and Treat Model of Prevention|hiv test and treat model of prevention
467178|NCT01152918|ART for Prevention|art for prevention
467179|NCT01152918|Prevention for HIV Positives|prevention for hiv positives
467180|NCT01152918|Financial Incentives|financial incentives
467181|NCT01152918|Computer-delivered risk-reduction counseling|computer-delivered risk-reduction counseling
467182|NCT01152905|Neuromuscular blockade|neuromuscular blockade
467183|NCT01152905|Neuromuscular blocking agents|neuromuscular blocking agents
467184|NCT01152905|Atracurium|atracurium
467185|NCT01152905|Nitrous oxide|nitrous oxide
467186|NCT01152892|end stage renal disease|end stage renal disease
468246|NCT01148459|EPI|epi
467187|NCT01152892|chronic kidney disease|chronic kidney disease
467188|NCT01152892|cardiovascular event|cardiovascular event
467189|NCT01152892|sudden cardiac death|sudden cardiac death
467190|NCT01152892|autonomic function|autonomic function
467191|NCT01152879|Parenteral Nutrition|parenteral nutrition
467192|NCT01152879|Quality of Life|quality of life
467193|NCT01152866|Multifollicular stimulation|multifollicular stimulation
467194|NCT01152866|Pregnancy|pregnancy
467195|NCT01152866|Reproductive Techniques, Assisted|reproductive techniques, assisted
467196|NCT01152866|Fertilization in Vitro|fertilization in vitro
467197|NCT01152866|Infertility|infertility
467198|NCT01152853|advanced gastric cancer|advanced gastric cancer
467199|NCT01152853|HER2|her2
467200|NCT01152853|PF00299804|pf00299804
467201|NCT01152840|Adenoid cystic carcinoma|adenoid cystic carcinoma
467202|NCT01152840|RAD001|rad001
467203|NCT01152827|Pheochromocytoma|pheochromocytoma
467204|NCT01152827|extra-adrenal paraganglioma|extra-adrenal paraganglioma
467205|NCT01152827|non-functioning carcinoid|non-functioning carcinoid
467206|NCT01152827|RAD001|rad001
467207|NCT01152814|Seasonal influenza|seasonal influenza
467208|NCT01152814|Vaccine|vaccine
467209|NCT01152801|mRCC,|mrcc,
467210|NCT01152801|everolimus,|everolimus,
467211|NCT01152801|mTOR,|mtor,
467212|NCT01152801|intolerant of VEGF-therapies|intolerant of vegf-therapies
467213|NCT01152775|partnered surgical decision-making|partnered surgical decision-making
467214|NCT01152775|impact of multimedia-based teaching|impact of multimedia-based teaching
467215|NCT01152775|patient education|patient education
467216|NCT01152775|understanding and retention by patients|understanding and retention by patients
467217|NCT01152762|Physiotherapy, COPD, effectiveness, primary care|physiotherapy, copd, effectiveness, primary care
467218|NCT01152749|Smoking Cessation|smoking cessation
467219|NCT01152749|Nicotine pharmacokinetics|nicotine pharmacokinetics
467220|NCT01152736|Smoking Cessation, Nicotine pharmacokinetics|smoking cessation, nicotine pharmacokinetics
467221|NCT01152723|Smoking Cessation, Nicotine pharmacokinetics|smoking cessation, nicotine pharmacokinetics
467222|NCT01152710|capecitabine|capecitabine
467223|NCT01152710|chemoradiation|chemoradiation
467224|NCT01152710|rectal cancer|rectal cancer
467225|NCT01152710|phase II study|phase ii study
467226|NCT01152697|nonadherence|nonadherence
467227|NCT01152697|noncompliance|noncompliance
467228|NCT01152697|homeless|homeless
467229|NCT01152697|schizophrenia|schizophrenia
467230|NCT01152697|schizoaffective|schizoaffective
467232|NCT01152684|HIV-Positive|hiv-positive
467233|NCT01152684|Latinos|latinos
467234|NCT01152684|US-Mexico Border region|us-mexico border region
467235|NCT01152684|San Diego-Tijuana|san diego-tijuana
467236|NCT01152684|Identify the nature and extent of complementary and alternative medicine use among HIV-positive Latinos in the US-Mexico border region|identify the nature and extent of complementary and alternative medicine use among hiv-positive latinos in the us-mexico border region
467237|NCT01152658|Partial supraspinatus tear|partial supraspinatus tear
467238|NCT01152658|partial tear ssp per echo|partial tear ssp per echo
467239|NCT01152645|Advanced/recurrent gastric cancer|advanced/recurrent gastric cancer
467240|NCT01152632|acupuncture|acupuncture
467241|NCT01152632|migraine|migraine
467242|NCT01152632|specific acupoints|specific acupoints
467243|NCT01152632|brain network|brain network
467244|NCT01152580|melatonin|melatonin
467245|NCT01152580|menopause|menopause
467246|NCT01152580|perimenopause|perimenopause
467247|NCT01152580|sleep|sleep
467248|NCT01152580|osteoporosis|osteoporosis
467249|NCT01152580|osteopenia|osteopenia
467250|NCT01152580|anxiety|anxiety
467251|NCT01152580|depression|depression
467252|NCT01152580|hypertension|hypertension
467253|NCT01152567|Hypertension|hypertension
467254|NCT01152567|ACE|ace
467255|NCT01152567|ARB|arb
467256|NCT01152567|real life data|real life data
467257|NCT01152567|CVD|cvd
467258|NCT01152567|cost effectiveness|cost effectiveness
467259|NCT01152554|Major Depressive Disorder|major depressive disorder
467260|NCT01152554|MDD|mdd
467261|NCT01152554|Depression|depression
467262|NCT01152554|Safety|safety
467263|NCT01152554|add-on therapy|add-on therapy
467264|NCT01152541|Keratoconus|keratoconus
467265|NCT01152541|Corneal Ectasia|corneal ectasia
467266|NCT01152541|Collagen Crosslinking|collagen crosslinking
467267|NCT01152541|Riboflavin|riboflavin
467268|NCT01152528|bacterial vaginosis|bacterial vaginosis
467269|NCT01152528|screening|screening
467270|NCT01152528|abortion|abortion
467271|NCT01152528|preterm delivery|preterm delivery
467272|NCT01152515|safety and efficacy of maintaining a remifentanil infusion during extubation in propofol-remifentanil sedated patients after surgery|safety and efficacy of maintaining a remifentanil infusion during extubation in propofol-remifentanil sedated patients after surgery
467273|NCT01152502|Post operative conditions, paracetamol metabolites|post operative conditions, paracetamol metabolites
467274|NCT01152489|Pain|pain
467275|NCT01152476|healthy pediatric patients undergoing tonsillectomy and adenoidectomy|healthy pediatric patients undergoing tonsillectomy and adenoidectomy
467276|NCT01152463|thoracic ultrasound (US)|thoracic ultrasound (us)
467277|NCT01152463|post-op care|post-op care
467278|NCT01152463|pneumothorax|pneumothorax
467279|NCT01152463|pleural effusion|pleural effusion
467280|NCT01152424|Acute eosinophilic pneumonia|acute eosinophilic pneumonia
467281|NCT01152424|Exhaled nitric oxide|exhaled nitric oxide
467282|NCT01152411|Renal Failure|renal failure
467283|NCT01152411|Chronic Kidney Disease|chronic kidney disease
467284|NCT01152411|Chronic Renal Failure|chronic renal failure
467285|NCT01152398|Breast cancer|breast cancer
467286|NCT01152398|Vaccine|vaccine
467287|NCT01152398|Metastatic|metastatic
467288|NCT01152398|HER-2-positive|her-2-positive
467289|NCT01152398|Phase I|phase i
467290|NCT01152398|HER-2 Positive Breast Cancer|her-2 positive breast cancer
467291|NCT01152385|Type 2 diabetes mellitus|type 2 diabetes mellitus
467292|NCT01152385|Japanese|japanese
467293|NCT01152385|phase 2|phase 2
467294|NCT01152385|AZD1656|azd1656
467295|NCT01152385|efficacy|efficacy
467296|NCT01152385|dose regimen|dose regimen
467297|NCT01152385|pharmacokinetics|pharmacokinetics
467298|NCT01152359|obesity|obesity
467299|NCT01152359|diet, low carbohydrate|diet, low carbohydrate
467300|NCT01152359|diet, fat-restricted|diet, fat-restricted
467301|NCT01152359|food preferences|food preferences
467302|NCT01152359|quality of life|quality of life
467303|NCT01152359|patient compliance|patient compliance
467304|NCT01152346|Bioequivalence|bioequivalence
467305|NCT01152346|Myelodysplastic Syndrome|myelodysplastic syndrome
467306|NCT01152346|MDS|mds
467307|NCT01152346|Azacitidine|azacitidine
467308|NCT01152320|Asthma|asthma
467309|NCT01152320|Spirometry|spirometry
467310|NCT01152320|Pediatric|pediatric
467311|NCT01152320|Primary Health Care|primary health care
467312|NCT01152320|Education, Distance|education, distance
467313|NCT01152307|Depression|depression
467314|NCT01152307|Depressive disorder|depressive disorder
467315|NCT01152307|Decision Making|decision making
467316|NCT01152307|Decision Aids|decision aids
467317|NCT01152307|Decision Quality Instrument|decision quality instrument
467318|NCT01152294|Menopause|menopause
467319|NCT01152294|Decision making|decision making
467320|NCT01152294|Decision aids|decision aids
467321|NCT01152294|Decision quality instrument|decision quality instrument
467322|NCT01152281|retention|retention
467323|NCT01152281|attrition|attrition
467324|NCT01152281|empowering|empowering
467325|NCT01152281|reactance|reactance
467326|NCT01152281|motivational|motivational
467327|NCT01152281|goals|goals
467328|NCT01152281|Basic control|basic control
467329|NCT01152281|Control with stories of people with AIDS|control with stories of people with aids
467330|NCT01152281|Instrumental|instrumental
467331|NCT01152281|Instrumental and Empowering|instrumental and empowering
467332|NCT01152268|sperm banking|sperm banking
467333|NCT01152268|Adolescent males|adolescent males
467334|NCT01152268|Infertility|infertility
467335|NCT01152268|Adolescents diagnosed with cancer|adolescents diagnosed with cancer
467336|NCT01152255|Treatment of HIV-1 Infection|treatment of hiv-1 infection
467337|NCT01152242|Insulin|insulin
467338|NCT01152203|Bendamustine|bendamustine
467339|NCT01152203|Bevacizumab|bevacizumab
467340|NCT01152177|Heading Health Plan Implementation|heading health plan implementation
467341|NCT01152177|General Practice|general practice
467342|NCT01152177|Point of care testing|point of care testing
467343|NCT01152177|education|education
467344|NCT01152164|quality of life|quality of life
467345|NCT01152164|rectal cancer|rectal cancer
467346|NCT01152151|Heading Health Plan Implementation|heading health plan implementation
467347|NCT01152151|General Practice|general practice
467348|NCT01152151|Point of care testing|point of care testing
467349|NCT01152151|education|education
467350|NCT01152138|Acute myocardial infarction|acute myocardial infarction
467351|NCT01152138|Closed cell stent|closed cell stent
467352|NCT01152138|Open cell stent|open cell stent
467353|NCT01152138|primary percutaneous coronary intervention|primary percutaneous coronary intervention
467354|NCT01152125|Osteoarthritis|osteoarthritis
467355|NCT01152125|stem cell implantation|stem cell implantation
467356|NCT01152125|bone marrow|bone marrow
467357|NCT01152125|autologous|autologous
467358|NCT01152112|morcellator|morcellator
467359|NCT01152112|hysteroscope|hysteroscope
467360|NCT01152112|myomectomy|myomectomy
467361|NCT01152112|polypectomy|polypectomy
467362|NCT01152112|uterine fibroids|uterine fibroids
467363|NCT01152112|uterine polyps|uterine polyps
467364|NCT01152112|office|office
467365|NCT01152112|cost|cost
467366|NCT01152112|local anesthetic|local anesthetic
467367|NCT01152112|cervical block|cervical block
467368|NCT01152112|pain management|pain management
467369|NCT01152099|Postmastectomy|postmastectomy
467370|NCT01152086|Physical activity|physical activity
467371|NCT01152086|mountain hiking|mountain hiking
467372|NCT01152086|exercise|exercise
467373|NCT01152086|training program|training program
467374|NCT01152086|hopelessness|hopelessness
467375|NCT01152086|chronic suicidality|chronic suicidality
467376|NCT01152086|depression|depression
467377|NCT01152086|suicide attempt|suicide attempt
467378|NCT01152086|suicide|suicide
467379|NCT01152073|Cholesterol|cholesterol
467380|NCT01152073|Statin|statin
467381|NCT01152073|Nutraceuticals|nutraceuticals
467382|NCT01152073|Niacin|niacin
467383|NCT01152073|Hyperlipidemia|hyperlipidemia
467384|NCT01152073|Liquid|liquid
467385|NCT01152060|remission of proteinuria|remission of proteinuria
467386|NCT01152060|HBVe-antigen|hbve-antigen
467387|NCT01152047|oxytocin|oxytocin
467388|NCT01152047|satiety|satiety
467389|NCT01152047|dyspepsia|dyspepsia
467390|NCT01152034|Bipolar disorder|bipolar disorder
467391|NCT01152034|psychosocial intervention|psychosocial intervention
467392|NCT01152034|group therapy|group therapy
467393|NCT01152034|relapse prevention|relapse prevention
467394|NCT01152034|parasuicide|parasuicide
467395|NCT01152034|Recurrence|recurrence
467396|NCT01152034|hospitalization|hospitalization
467397|NCT01152034|Medication adherence|medication adherence
467398|NCT01152034|Self-Injurious Behavior|self-injurious behavior
467399|NCT01152034|Quality of Life|quality of life
467400|NCT01152021|dexmedetomidine|dexmedetomidine
467401|NCT01152021|propofol|propofol
467402|NCT01152021|sedation|sedation
467403|NCT01152021|MRI|mri
467404|NCT01152021|scanning|scanning
467405|NCT01152021|pediatric|pediatric
467406|NCT01152021|children|children
467407|NCT01152021|Magnetic Resonance Imaging|magnetic resonance imaging
467408|NCT01152008|Microcirculation|microcirculation
467409|NCT01152008|laser flowmetry|laser flowmetry
467410|NCT01152008|Skin|skin
467411|NCT01152008|Physiology|physiology
467412|NCT01151995|Clinical Trial Monitoring|clinical trial monitoring
467413|NCT01151995|Effectiveness of remote monitoring|effectiveness of remote monitoring
467414|NCT01151995|Efficiency of remote monitoring|efficiency of remote monitoring
467415|NCT01151995|Costs of remote monitoring|costs of remote monitoring
467416|NCT01151982|Depression|depression
467417|NCT01151982|Primary prevention.|primary prevention.
467418|NCT01151982|Primary health care.|primary health care.
467419|NCT01151982|Randomised controlled trial.|randomised controlled trial.
467420|NCT01151969|Health Service Misuse|health service misuse
467421|NCT01151969|Overutilization of Health Services|overutilization of health services
467422|NCT01151969|Primary Health Care|primary health care
467423|NCT01151969|Cost Effectiveness|cost effectiveness
467424|NCT01151969|Quality of life|quality of life
467425|NCT01151969|Randomised Controlled Trial|randomised controlled trial
467426|NCT01151969|Multilevel analysis|multilevel analysis
467427|NCT01151956|observational study|observational study
467428|NCT01151956|actinic keratosis|actinic keratosis
467429|NCT01151956|imiquimod|imiquimod
467430|NCT01151943|cesarean section|cesarean section
467431|NCT01151943|continuous wound infiltration|continuous wound infiltration
467432|NCT01151943|transversus abdominis plane block|transversus abdominis plane block
467433|NCT01151930|Advanced solid tumor failed with standard therapy|advanced solid tumor failed with standard therapy
467434|NCT01151917|Bilio-pancreatic diversion|bilio-pancreatic diversion
467435|NCT01151917|morbid obesity|morbid obesity
467436|NCT01151917|insulin resistance|insulin resistance
467437|NCT01151917|proteomics|proteomics
467438|NCT01151891|Pedal puncture wounds|pedal puncture wounds
467439|NCT01151891|Infection in pedal puncture wounds|infection in pedal puncture wounds
467440|NCT01151891|Diabetes education and pedal puncture wounds|diabetes education and pedal puncture wounds
467441|NCT01151878|constipation|constipation
467442|NCT01151878|children|children
467443|NCT01151865|Delirium|delirium
467444|NCT01151865|Intensive Care Unit|intensive care unit
467445|NCT01151865|Dexmedetomidine|dexmedetomidine
467446|NCT01151852|Imatinib|imatinib
467447|NCT01151852|Re-challenge|re-challenge
467448|NCT01151839|Esophagus|esophagus
467449|NCT01151839|squamous cell carcinoma|squamous cell carcinoma
467450|NCT01151839|neoadjuvant chemoradiation|neoadjuvant chemoradiation
467451|NCT01151826|Lung transplantation|lung transplantation
467452|NCT01151826|Primary Graft Dysfunction|primary graft dysfunction
467453|NCT01151826|Extravascular Lung Water|extravascular lung water
467454|NCT01151826|Receptor for Advanced Glycation Endproducts (RAGE)|receptor for advanced glycation endproducts (rage)
467455|NCT01151826|Intercellular Adhesion Molecule-1 (ICAM-1)|intercellular adhesion molecule-1 (icam-1)
467456|NCT01151800|ACS|acs
467457|NCT01151800|Interactive Voice Response Technology|interactive voice response technology
467458|NCT01151800|Best Practice Guidelines|best practice guidelines
467459|NCT01151800|Health Care Utilization|health care utilization
467460|NCT01151800|Outcome Assessment|outcome assessment
467461|NCT01151787|migraine|migraine
467462|NCT01151735|Angioedema|angioedema
467463|NCT01151735|Hereditary Diseases|hereditary diseases
467464|NCT01151735|Orphan Disease|orphan disease
467465|NCT01151735|HAE|hae
467466|NCT01151709|Gout|gout
467467|NCT01151709|Chronic condition management|chronic condition management
467468|NCT01151709|Gout management|gout management
467469|NCT01151696|Pain|pain
467470|NCT01151696|morphine|morphine
467471|NCT01151696|hydroxyzine|hydroxyzine
467472|NCT01151696|acute pain|acute pain
467473|NCT01151696|traumatic pain|traumatic pain
467474|NCT01151696|anxiety|anxiety
467475|NCT01151696|post trauma stress|post trauma stress
467476|NCT01151696|post trauma anxiety|post trauma anxiety
467477|NCT01151696|post trauma disorders|post trauma disorders
467478|NCT01151683|hypertension|hypertension
468247|NCT01148459|Africa|africa
467479|NCT01151683|endothelial dysfunction|endothelial dysfunction
467480|NCT01151670|radiation therapy|radiation therapy
467481|NCT01151670|cognitive dysfunction|cognitive dysfunction
467482|NCT01151670|brain tumor|brain tumor
467483|NCT01151670|memory problems|memory problems
467484|NCT01151670|short term memory loss|short term memory loss
467485|NCT01151657|IBS|ibs
467486|NCT01151657|Irritable bowel syndrome|irritable bowel syndrome
467487|NCT01151657|Probiotics|probiotics
467488|NCT01151657|Treatment|treatment
467489|NCT01151657|Adequate relief|adequate relief
467490|NCT01151644|H1N1 VACCINE|h1n1 vaccine
467491|NCT01151644|INFLUENZA|influenza
467492|NCT01151644|RHEUMATIC DISEASES|rheumatic diseases
467493|NCT01151644|ANTI-H1N1 IMMUNIZATION|anti-h1n1 immunization
467494|NCT01151592|Iron deficiency anemia in Chronic Kidney Disease Patients|iron deficiency anemia in chronic kidney disease patients
467495|NCT01151579|Tachycardia|tachycardia
467496|NCT01151579|tachyarrhythmias|tachyarrhythmias
467497|NCT01151579|bronchodilator therapy|bronchodilator therapy
467498|NCT01151579|Critically ill patients|critically ill patients
467499|NCT01151566|Ultrasound|ultrasound
467500|NCT01151566|Contrast enhanced Ultrasound (CEUS)|contrast enhanced ultrasound (ceus)
467501|NCT01151566|Nephrotoxicity|nephrotoxicity
467502|NCT01151566|CT contrast agents|ct contrast agents
467503|NCT01151553|Cardiology|cardiology
467504|NCT01151553|Cardiomyopathy|cardiomyopathy
467505|NCT01151553|Cardiovascular Disease|cardiovascular disease
467506|NCT01151553|Cardiac Resynchronization Therapy (CRT)|cardiac resynchronization therapy (crt)
467507|NCT01151540|Epilepsy|epilepsy
467508|NCT01151540|Seizures|seizures
467509|NCT01151514|No referral|no referral
467510|NCT01151514|Late referral|late referral
467511|NCT01151514|Acute kidney injury|acute kidney injury
467512|NCT01151514|Intensive care unit|intensive care unit
467513|NCT01151514|In-hospital mortality|in-hospital mortality
467514|NCT01151514|Renal outcome|renal outcome
467515|NCT01151514|Requirement for renal replacement therapy|requirement for renal replacement therapy
467516|NCT01151514|Length of hospital stay|length of hospital stay
467517|NCT01151514|Impact|impact
467518|NCT01151514|Incidence|incidence
467519|NCT01151501|acute hypoxemic respiratory failure|acute hypoxemic respiratory failure
467520|NCT01151501|intermittent positive-pressure ventilation|intermittent positive-pressure ventilation
467521|NCT01151501|noninvasive positive pressure ventilation|noninvasive positive pressure ventilation
467522|NCT01151501|ventilator weaning|ventilator weaning
467523|NCT01151475|liver cirrhosis|liver cirrhosis
467524|NCT01151475|hepatic encephalopathy|hepatic encephalopathy
467525|NCT01151475|ammonia|ammonia
467526|NCT01151475|cerebral blood flow|cerebral blood flow
467527|NCT01151462|Postnatal HCMV infection in very preterm infants|postnatal hcmv infection in very preterm infants
467528|NCT01151462|Neurodevelopmental disabilities|neurodevelopmental disabilities
467529|NCT01151462|Hearing loss|hearing loss
467530|NCT01151462|Mental retardation|mental retardation
467531|NCT01151462|Microcephaly|microcephaly
467532|NCT01151462|Chorioretinitis|chorioretinitis
467533|NCT01151462|Growth|growth
467534|NCT01151436|Facial wrinkle correction|facial wrinkle correction
467535|NCT01151410|Pediatric hypertension|pediatric hypertension
467536|NCT01151410|primary hypertension|primary hypertension
467537|NCT01151410|secondary|secondary
467538|NCT01151410|hypertension|hypertension
467539|NCT01151397|SVR|svr
467540|NCT01151397|VITAMIN D|vitamin d
467541|NCT01151397|Hepatitis C|hepatitis c
467542|NCT01151397|Genotype 2,3|genotype 2,3
467543|NCT01151397|Naive|naive
467544|NCT01151397|RVR|rvr
467545|NCT01151384|Cancer Patients|cancer patients
467546|NCT01151358|radioimmunotherapy|radioimmunotherapy
467547|NCT01151358|follicular non-Hodgkin´s lymphoma|follicular non-hodgkin´s lymphoma
467548|NCT01151358|FDG-PET|fdg-pet
467549|NCT01151358|prognostic factors|prognostic factors
467550|NCT01151358|multicenter study|multicenter study
467551|NCT01151345|diltiazem|diltiazem
467552|NCT01151345|angiotrofin|angiotrofin
467553|NCT01151345|bioequivalence|bioequivalence
467554|NCT01151293|Type D personality|type d personality
467555|NCT01151293|diabetes|diabetes
467556|NCT01151293|medical compliance|medical compliance
467557|NCT01151293|HbA1c|hba1c
467558|NCT01151293|complication|complication
467559|NCT01151293|mortality|mortality
467560|NCT01151293|T2DM|t2dm
467561|NCT01151267|Isocapnic hyperpnoea (IH)|isocapnic hyperpnoea (ih)
467562|NCT01151267|Anesthesia|anesthesia
467563|NCT01151267|Accelerate elimination of inhalation agents|accelerate elimination of inhalation agents
467564|NCT01151267|Recovery from anesthesia|recovery from anesthesia
467565|NCT01151254|Cardiac Surgery|cardiac surgery
467566|NCT01151254|Sedation|sedation
467567|NCT01151254|Intensive care|intensive care
467568|NCT01151254|Volatile anesthesia|volatile anesthesia
467569|NCT01151254|Intravenous anesthesia|intravenous anesthesia
467570|NCT01151254|Pre and post conditioning after cardiac surgery|pre and post conditioning after cardiac surgery
467571|NCT01151241|elbow surgery|elbow surgery
467572|NCT01151241|infraclavicular nerve block|infraclavicular nerve block
467573|NCT01151241|continuous passive motion|continuous passive motion
467574|NCT01151241|ultrasound guided regional anesthesia|ultrasound guided regional anesthesia
467575|NCT01151241|early discharge|early discharge
467576|NCT01151228|gastroscopy|gastroscopy
467577|NCT01151228|ultrasound|ultrasound
467578|NCT01151228|stomach volume|stomach volume
467579|NCT01151228|patients having gastroscopy|patients having gastroscopy
467580|NCT01151215|Cancer|cancer
467581|NCT01151215|tumour|tumour
467582|NCT01151215|breast cancer|breast cancer
467583|NCT01151215|metastatic|metastatic
467584|NCT01151215|secondary|secondary
467585|NCT01151215|locally advanced|locally advanced
467586|NCT01151202|acute upper respiratory tract infection, chronic inflamatory bronchitis|acute upper respiratory tract infection, chronic inflamatory bronchitis
467587|NCT01151189|HIV|hiv
467588|NCT01151189|Tuberculosis|tuberculosis
467589|NCT01151189|Vaccine|vaccine
467590|NCT01151176|Intensive Insulin Therapy|intensive insulin therapy
467591|NCT01151176|Glucose control|glucose control
467592|NCT01151176|Acute Coronary Syndrome|acute coronary syndrome
467593|NCT01151176|Intensive Care|intensive care
467594|NCT01150916|natriuretic peptide|natriuretic peptide
467595|NCT01150916|heart failure|heart failure
467596|NCT01150916|ascites|ascites
467597|NCT01150916|liver cirrhosis|liver cirrhosis
467598|NCT01150838|intubation of children without neuromuscular blockade|intubation of children without neuromuscular blockade
467599|NCT01149226|pediatric patients|pediatric patients
467600|NCT01149226|ASA physical status I or II|asa physical status i or ii
467601|NCT01149226|aged between 1-5 yrs|aged between 1-5 yrs
467602|NCT01151163|Fibromyalgia, Peripheral arterial tonometry, sleep|fibromyalgia, peripheral arterial tonometry, sleep
467603|NCT01151111|Parkinson's disease|parkinson's disease
467604|NCT01151111|Relaxation|relaxation
467605|NCT01151111|Visual imagery|visual imagery
467606|NCT01151111|Motor fluctuations|motor fluctuations
467607|NCT01151111|Treatment|treatment
467608|NCT01151098|Chronic nonmalignant pain|chronic nonmalignant pain
467609|NCT01151098|Opioid|opioid
467610|NCT01151098|Transdermal|transdermal
467611|NCT01151098|Butrans (BTDS)|butrans (btds)
467612|NCT01151085|Systemic Mycosis|systemic mycosis
467613|NCT01151085|Aspergillus infection|aspergillus infection
467614|NCT01151085|Candidiasis|candidiasis
467615|NCT01151085|Cryptococcal infections|cryptococcal infections
467616|NCT01151085|Japanese|japanese
467617|NCT01151085|voriconazole|voriconazole
467618|NCT01151085|VFEND|vfend
467619|NCT01151085|Regulatory Post Marketing Commitment Plan.|regulatory post marketing commitment plan.
467620|NCT01151059|seasonal influenza|seasonal influenza
467621|NCT01151059|vaccine|vaccine
467622|NCT01151046|Breast Cancer|breast cancer
467623|NCT01151046|Her2 negative|her2 negative
467624|NCT01151046|Estrogen Receptor Positive|estrogen receptor positive
467625|NCT01151046|Progesterone Receptor Positive|progesterone receptor positive
467626|NCT01151046|MM-121|mm-121
467627|NCT01151046|Exemestane|exemestane
467628|NCT01151046|Postmenopausal Women|postmenopausal women
467629|NCT01151033|ProNOVA XR Polymer Free Drug Eluting Coronary Stent System|pronova xr polymer free drug eluting coronary stent system
467630|NCT01151033|DES|des
467631|NCT01151033|stent|stent
467632|NCT01151033|coronary artery lesions|coronary artery lesions
467633|NCT01151033|ProNOVA|pronova
467634|NCT01151033|stent implantation|stent implantation
467635|NCT01151020|Aortic Aneurysm|aortic aneurysm
467636|NCT01151020|Aneurysm|aneurysm
467637|NCT01151020|Vascular Prosthesis|vascular prosthesis
467638|NCT01151020|Vascular Disease|vascular disease
467639|NCT01151020|Blood Vessel Prosthesis Implantation|blood vessel prosthesis implantation
467640|NCT01151007|Kras mutation|kras mutation
467641|NCT01151007|colorectal carcinoma|colorectal carcinoma
467642|NCT01151007|Martinique|martinique
467643|NCT01150994|Suicide screening among ED patients|suicide screening among ed patients
467644|NCT01150955|Resveratrol|resveratrol
467645|NCT01150955|Diabetes|diabetes
467646|NCT01150955|SIRT1|sirt1
467647|NCT01150955|STAT5|stat5
467648|NCT01150955|IGF-I|igf-i
467649|NCT01150955|Growth hormone|growth hormone
467650|NCT01150955|NAFLD|nafld
467651|NCT01150955|Longevity|longevity
467652|NCT01150955|Substrate metabolism|substrate metabolism
467653|NCT01150955|Calorie restriction|calorie restriction
467654|NCT01150942|JEV|jev
467655|NCT01150942|vero cell|vero cell
467656|NCT01150929|Knee arthroplasty|knee arthroplasty
467657|NCT01150929|RSA|rsa
467658|NCT01150929|DXA|dxa
467659|NCT01150929|Gait analysis|gait analysis
467660|NCT01150929|Motion analysis|motion analysis
467661|NCT01150903|erectile dysfunction|erectile dysfunction
467662|NCT01150903|phosphodiesterase inhibitor|phosphodiesterase inhibitor
467663|NCT01150903|cardiovascular diseases|cardiovascular diseases
467664|NCT01150890|Ileal Crohn's Disease|ileal crohn's disease
467665|NCT01150890|Ileo-colonic Crohn's Disease|ileo-colonic crohn's disease
467666|NCT01150890|Colonic Chron's Disease|colonic chron's disease
467667|NCT01150877|Vitamin D|vitamin d
467668|NCT01150877|Vitamin D3|vitamin d3
467669|NCT01150877|colon cancer|colon cancer
467670|NCT01150877|rectal cancer|rectal cancer
467671|NCT01150877|Cholecalciferol|cholecalciferol
467672|NCT01150864|Hot water humidifier, Passive heat and moisture exchangers|hot water humidifier, passive heat and moisture exchangers
467673|NCT01150825|STEMI|stemi
467674|NCT01150825|NSTEMI|nstemi
467675|NCT01150825|acute ischemia|acute ischemia
467676|NCT01150825|non-invasive diagnosis|non-invasive diagnosis
467677|NCT01150825|elevated troponin|elevated troponin
467678|NCT01150812|First time in man|first time in man
467679|NCT01150812|healthy|healthy
467680|NCT01150812|thrombin inhibitor|thrombin inhibitor
467681|NCT01150786|inflammation|inflammation
467682|NCT01150786|oxidative stress|oxidative stress
467683|NCT01150786|selenium|selenium
467684|NCT01150786|hemodialysis|hemodialysis
467685|NCT01150760|GI recovery after bowel resection|gi recovery after bowel resection
467686|NCT01150760|morbidity after bowel resection|morbidity after bowel resection
467687|NCT01150760|mortality|mortality
467688|NCT01150760|readmission|readmission
467689|NCT01150760|length of stay|length of stay
467690|NCT01150734|differences of Muscle evoked potentials (MEP) in psychiatric illnesses|differences of muscle evoked potentials (mep) in psychiatric illnesses
467691|NCT01150734|differences in neuromodulation|differences in neuromodulation
467692|NCT01150734|normalization of neuromodulation after pharmacological treatment|normalization of neuromodulation after pharmacological treatment
467693|NCT01150721|Atypical Mycobacterium Infection|atypical mycobacterium infection
467694|NCT01150721|Microbial Tests|microbial tests
467695|NCT01150721|Molecular Tests|molecular tests
467696|NCT01150721|Inflammation|inflammation
467697|NCT01150721|Respiratory Secretions|respiratory secretions
467698|NCT01150708|Syringomyelia|syringomyelia
467699|NCT01150708|Magnetic Resonance Imaging|magnetic resonance imaging
467700|NCT01150708|Natural History Study|natural history study
467701|NCT01150708|Neurological Examination|neurological examination
467702|NCT01150695|vaccine, Francisella tularensis, Tularemia, rabbit fever, parent protocol|vaccine, francisella tularensis, tularemia, rabbit fever, parent protocol
467703|NCT01150682|endometrial adenocarcinoma|endometrial adenocarcinoma
467704|NCT01150682|stage II endometrial carcinoma|stage ii endometrial carcinoma
467705|NCT01150682|stage III endometrial carcinoma|stage iii endometrial carcinoma
467706|NCT01150682|stage IV endometrial carcinoma|stage iv endometrial carcinoma
467707|NCT01150682|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
467708|NCT01150682|endometrial clear cell carcinoma|endometrial clear cell carcinoma
467709|NCT01150682|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
467710|NCT01150656|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
467711|NCT01150643|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
467712|NCT01150643|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
467713|NCT01150643|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
467714|NCT01150643|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
467715|NCT01150630|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
467716|NCT01150630|stage I pancreatic cancer|stage i pancreatic cancer
467717|NCT01150630|stage II pancreatic cancer|stage ii pancreatic cancer
467718|NCT01150617|Type 2 diabetes mellitus|type 2 diabetes mellitus
467719|NCT01150617|Normoglycemia|normoglycemia
467720|NCT01150617|Peripheral angioplasty|peripheral angioplasty
467721|NCT01150604|Cognitive Behavioral Therapy|cognitive behavioral therapy
467722|NCT01150604|Mood Management|mood management
467723|NCT01150604|Self-help|self-help
467724|NCT01150604|Internet|internet
467725|NCT01150578|Echocardiography, 2D|echocardiography, 2d
467726|NCT01150578|speckle tracking|speckle tracking
467727|NCT01150578|Lexiscan|lexiscan
467728|NCT01150578|regadenoson|regadenoson
467729|NCT01150578|Myocardial ischemia|myocardial ischemia
467730|NCT01150578|Myocardial perfusion imaging|myocardial perfusion imaging
467731|NCT01150578|cost and cost analysis|cost and cost analysis
467732|NCT01150578|Cardiac-Gated SPECT Imaging|cardiac-gated spect imaging
467733|NCT01150578|Echocardiography|echocardiography
467734|NCT01150552|Serology|serology
467735|NCT01150552|Poultry|poultry
467736|NCT01150552|H5N1 virus|h5n1 virus
467737|NCT01150552|HPAI virus|hpai virus
467738|NCT01150526|Acute Exercise|acute exercise
467739|NCT01150526|Muscle Inflammation|muscle inflammation
467740|NCT01150526|CaHMB|cahmb
467741|NCT01150526|HMB Free Acid Gel|hmb free acid gel
467742|NCT01150526|Healthy Subjects|healthy subjects
467743|NCT01150513|TRIPLE-NEGATIVE|triple-negative
467744|NCT01150513|BREAST CANCER|breast cancer
467745|NCT01150500|Medtronic|medtronic
467746|NCT01150500|Japan|japan
467747|NCT01150500|Arterial Occlusive Diseases|arterial occlusive diseases
467748|NCT01150500|Myocardial Ischemia|myocardial ischemia
467749|NCT01150500|Cardiovascular Diseases|cardiovascular diseases
467750|NCT01150500|Coronary Artery Disease|coronary artery disease
467751|NCT01150500|Small Vessel Stent|small vessel stent
467752|NCT01150487|kidney transplant|kidney transplant
467753|NCT01150474|Belladonna|belladonna
467754|NCT01150474|Morphine|morphine
467755|NCT01150474|Suppositories|suppositories
467756|NCT01150474|Vaginal|vaginal
467757|NCT01150474|Surgery|surgery
467758|NCT01150474|Postoperative|postoperative
467759|NCT01150474|Pain|pain
467760|NCT01150461|Hypertrophic nonobstructive cardiomyopathy|hypertrophic nonobstructive cardiomyopathy
467761|NCT01150448|Paliperidone palmitate|paliperidone palmitate
467762|NCT01150448|paliperidone ER (INVEGA)|paliperidone er (invega)
467763|NCT01150448|R092670PSY1008|r092670psy1008
467765|NCT01150448|Risperdal (RISPERDAL CONSTA)|risperdal (risperdal consta)
467766|NCT01150448|Pharmacokinetics|pharmacokinetics
467767|NCT01150422|medical abortion|medical abortion
467768|NCT01150409|Sepsis|sepsis
467769|NCT01150409|hydrocortisone|hydrocortisone
467770|NCT01150396|extremely premature infant|extremely premature infant
467771|NCT01150396|outcome|outcome
467772|NCT01150396|follow-up|follow-up
467773|NCT01150383|Lung Diseases, Obstructive|lung diseases, obstructive
467774|NCT01150383|Respiratory Tract Diseases|respiratory tract diseases
467775|NCT01150383|Lung Diseases|lung diseases
467776|NCT01150383|Respiration Disorders|respiration disorders
467777|NCT01150383|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
467778|NCT01150383|COPD|copd
467779|NCT01150383|Chronic Obstructive Lung Disease|chronic obstructive lung disease
467780|NCT01150383|Chronic Obstructive Airway Disease|chronic obstructive airway disease
467781|NCT01150383|Chronic Airflow Obstruction|chronic airflow obstruction
467782|NCT01150383|oxygen|oxygen
467783|NCT01150383|oxygen supplementation|oxygen supplementation
467784|NCT01150370|male circumcision|male circumcision
467785|NCT01150370|HIV|hiv
467786|NCT01150370|Rwanda|rwanda
467787|NCT01150370|HIV Seronegativity|hiv seronegativity
467788|NCT01150357|Pediatric hypertension|pediatric hypertension
467789|NCT01150357|primary hypertension|primary hypertension
467790|NCT01150357|secondary hypertension|secondary hypertension
467791|NCT01150344|Multicentric study|multicentric study
467792|NCT01150344|Antimalarial|antimalarial
467793|NCT01150344|P. falciparum|p. falciparum
467794|NCT01150344|Efficacy|efficacy
467795|NCT01150344|Failures|failures
467796|NCT01150344|Malarone|malarone
467797|NCT01150344|RIAMET|riamet
467798|NCT01150331|status epilepticus|status epilepticus
467799|NCT01150331|generalised convulsive status epilepticus|generalised convulsive status epilepticus
467800|NCT01150331|first line treatments|first line treatments
467801|NCT01150331|double-blind randomized controlled trial|double-blind randomized controlled trial
467802|NCT01150331|prehospital treatment|prehospital treatment
467803|NCT01150318|Male|male
467804|NCT01150318|Infertility|infertility
467805|NCT01150318|Radioisotopes Therapy|radioisotopes therapy
467806|NCT01150318|Follicular thyroid cancer|follicular thyroid cancer
467930|NCT01149915|CLL|cll
467807|NCT01150305|Autosomal dominant inheritance|autosomal dominant inheritance
467808|NCT01150305|Mutation|mutation
467809|NCT01150305|Prevalence|prevalence
467810|NCT01150292|DHA supplementation|dha supplementation
467811|NCT01150292|Type 2 diabetic patient|type 2 diabetic patient
467812|NCT01150292|Platelet function|platelet function
467813|NCT01150279|medical abortion|medical abortion
467814|NCT01150279|Medical Abortion Follow Up Care|medical abortion follow up care
467815|NCT01150266|stroke|stroke
467816|NCT01150266|ischemia|ischemia
467817|NCT01150266|thrombolysis|thrombolysis
467818|NCT01150266|thrombolytics|thrombolytics
467819|NCT01150266|tPA|tpa
467820|NCT01150266|rt-PA|rt-pa
467821|NCT01150266|t-PA|t-pa
467822|NCT01150266|Activase®|activase®
467823|NCT01150266|Alteplase|alteplase
467824|NCT01150266|wake-up stroke|wake-up stroke
467825|NCT01150266|waking onset stroke|waking onset stroke
467826|NCT01150266|sleep|sleep
467827|NCT01150240|Primary Immunodeficiency Disease|primary immunodeficiency disease
467828|NCT01150214|atrial fibrillation|atrial fibrillation
467829|NCT01150214|af|af
467830|NCT01150214|magnetic resonance imaging|magnetic resonance imaging
467831|NCT01150214|mri|mri
467832|NCT01150214|left atrium|left atrium
467833|NCT01150214|fibrosis|fibrosis
467834|NCT01150214|structural remodeling|structural remodeling
467835|NCT01150201|CKD|ckd
467836|NCT01150201|proteinuria|proteinuria
467837|NCT01150201|eGFR|egfr
467838|NCT01150201|Progression of chronic kidney disease|progression of chronic kidney disease
467839|NCT01150188|aging|aging
467840|NCT01150188|lipid metabolism|lipid metabolism
467841|NCT01150188|very low density lipoproteins|very low density lipoproteins
467842|NCT01150188|amino acids|amino acids
467843|NCT01150188|dietary supplements|dietary supplements
467844|NCT01150175|END-HF|end-hf
467845|NCT01150149|Influenza|influenza
467846|NCT01150149|Humans|humans
467847|NCT01150149|Experimental|experimental
467848|NCT01150149|Challenge|challenge
467849|NCT01150136|choline|choline
467850|NCT01150136|cystic fibrosis|cystic fibrosis
467851|NCT01150136|methyl metabolism|methyl metabolism
467852|NCT01150136|oxidative stress|oxidative stress
467853|NCT01150123|Group B streptococcus|group b streptococcus
467854|NCT01150123|GBS|gbs
467855|NCT01150123|Vaccine|vaccine
467856|NCT01150123|Group B streptococcus (GBS) disease|group b streptococcus (gbs) disease
467857|NCT01150110|Temporomandibular disorders|temporomandibular disorders
467858|NCT01150110|occlusal splints|occlusal splints
467859|NCT01150110|electromyography|electromyography
467860|NCT01150110|TMD (muscle and joint dysfunction)|tmd (muscle and joint dysfunction)
467861|NCT01150110|masseteres e anterior temporalis muscles.|masseteres e anterior temporalis muscles.
467862|NCT01150097|Liver transplantation|liver transplantation
467863|NCT01150097|Everolimus|everolimus
467864|NCT01150097|Calcineurin inhibitors|calcineurin inhibitors
467865|NCT01150097|Tacrolimus|tacrolimus
467866|NCT01150097|Renal function|renal function
467867|NCT01150097|Progression of HCV related allograft fibrosis|progression of hcv related allograft fibrosis
467868|NCT01150084|increasing physical activity in sedentary employees|increasing physical activity in sedentary employees
467869|NCT01150071|extremely premature infant|extremely premature infant
467870|NCT01150071|follow-up|follow-up
467871|NCT01150071|behavior|behavior
467872|NCT01150071|growth|growth
467873|NCT01150071|mental health|mental health
467874|NCT01150071|lung function|lung function
467875|NCT01150071|spirometry|spirometry
467876|NCT01150071|muscle mass|muscle mass
467877|NCT01150071|bone density|bone density
467878|NCT01150071|magnetic Resonance imaging|magnetic resonance imaging
467879|NCT01150058|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
467880|NCT01150058|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
467881|NCT01150058|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
467882|NCT01150058|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
467883|NCT01150058|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
467884|NCT01150058|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
467885|NCT01150058|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
467886|NCT01150058|adult acute myeloid leukemia|adult acute myeloid leukemia
467887|NCT01150045|adenocarcinoma of the colon|adenocarcinoma of the colon
467888|NCT01150045|stage III colon cancer|stage iii colon cancer
467889|NCT01150032|Osteoporosis|osteoporosis
467890|NCT01150032|Fracture|fracture
467891|NCT01150032|Bone microarchitecture|bone microarchitecture
467892|NCT01150019|atherosclerosis|atherosclerosis
467893|NCT01150019|vascular inflammation|vascular inflammation
467894|NCT01150019|resistin|resistin
467895|NCT01150019|adiponectin|adiponectin
467896|NCT01150019|18FDG-PET|18fdg-pet
467897|NCT01150006|atherosclerosis|atherosclerosis
467898|NCT01150006|vascular inflammation|vascular inflammation
467899|NCT01150006|adipocyte fatty acid binding protein|adipocyte fatty acid binding protein
467900|NCT01150006|adiponectin|adiponectin
467901|NCT01150006|leptin|leptin
467902|NCT01150006|18FDG-PET|18fdg-pet
467903|NCT01149993|living donation|living donation
467904|NCT01149993|kidney transplantation|kidney transplantation
467905|NCT01149993|delayed graft function|delayed graft function
467906|NCT01149993|ischemia reperfusion injury|ischemia reperfusion injury
467907|NCT01149980|Bioequivalence|bioequivalence
467908|NCT01149980|Crossover|crossover
467909|NCT01149980|Citalopram|citalopram
467910|NCT01149967|Bioequivalence|bioequivalence
467911|NCT01149967|Citalopram|citalopram
467912|NCT01149967|Crossover|crossover
467913|NCT01149954|Bioequivalence|bioequivalence
467914|NCT01149954|Crossover|crossover
467915|NCT01149954|Ibuprofen|ibuprofen
467916|NCT01149941|Bioequivalence|bioequivalence
467917|NCT01149941|Crossover|crossover
467918|NCT01149941|Ibuprofen|ibuprofen
467919|NCT01149928|Fetal lung fluid|fetal lung fluid
467920|NCT01149928|Pulmonary adaptation|pulmonary adaptation
467921|NCT01149928|Transient tachypnea of the newborn|transient tachypnea of the newborn
467922|NCT01149928|Epinephrine|epinephrine
467923|NCT01149928|Stress hormones|stress hormones
467924|NCT01149915|Advanced Leukemias|advanced leukemias
467925|NCT01149915|Relapsed/Refractory Leukemias|relapsed/refractory leukemias
467926|NCT01149915|AML|aml
467927|NCT01149915|ALL|all
467928|NCT01149915|CML|cml
467929|NCT01149915|MDS|mds
467931|NCT01149915|MF|mf
467932|NCT01149915|Evofosfamide|evofosfamide
467933|NCT01149863|Autologous Transplantation|autologous transplantation
467934|NCT01149850|adult giant cell glioblastoma|adult giant cell glioblastoma
467935|NCT01149850|adult glioblastoma|adult glioblastoma
467936|NCT01149850|adult gliosarcoma|adult gliosarcoma
467937|NCT01149837|HTLV|htlv
467938|NCT01149837|HTLV I|htlv i
467939|NCT01149837|HTLV II|htlv ii
467940|NCT01149837|HTLV Type I and/or HTLV Type II antibody|htlv type i and/or htlv type ii antibody
467941|NCT01149824|Salvia divinorum|salvia divinorum
467942|NCT01149824|Salvinorin A|salvinorin a
467943|NCT01149811|Dyskinesia|dyskinesia
467944|NCT01149798|metastatic breast cancer|metastatic breast cancer
467945|NCT01149798|combined chemotherapy|combined chemotherapy
467946|NCT01149785|crizotinib|crizotinib
467947|NCT01149785|healthy volunteers|healthy volunteers
467948|NCT01149785|ketoconazole|ketoconazole
467949|NCT01149785|pharmacokinetics|pharmacokinetics
467950|NCT01149785|single dose|single dose
467951|NCT01149772|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
467952|NCT01149772|Heart Failure|heart failure
467953|NCT01149772|Anxiety|anxiety
467954|NCT01149772|Depression|depression
467955|NCT01149759|Atopic Dermatitis|atopic dermatitis
467956|NCT01149759|Eczema|eczema
467957|NCT01149720|Relative bioavailability|relative bioavailability
467958|NCT01149720|ARQ 197|arq 197
467959|NCT01149707|PUR 0110|pur 0110
468248|NCT01148446|DLBCL|dlbcl
467960|NCT01149707|PUR 0110 Rectal Enema|pur 0110 rectal enema
467961|NCT01149707|Distal Ulcerative Colitis|distal ulcerative colitis
467962|NCT01149707|Left-Sided Ulcerative Colitis|left-sided ulcerative colitis
467963|NCT01149707|Mild|mild
467964|NCT01149707|Moderate|moderate
467965|NCT01149694|PurGenesis Technologies Inc.|purgenesis technologies inc.
467966|NCT01149694|PUR 0110 rectal enema|pur 0110 rectal enema
467967|NCT01149694|Ulcerative colitis|ulcerative colitis
467968|NCT01149694|Distal|distal
467969|NCT01149694|Normal healthy volunteers|normal healthy volunteers
467970|NCT01149681|Aplidin|aplidin
467971|NCT01149681|Plitidepsin|plitidepsin
467972|NCT01149681|Myelofibrosis|myelofibrosis
467973|NCT01149681|Pharma Mar|pharma mar
467974|NCT01149668|PCI-24781|pci-24781
467975|NCT01149668|Lymphoma|lymphoma
467976|NCT01149668|Non-Hodgkin's|non-hodgkin's
467977|NCT01149668|Hodgkin Disease|hodgkin disease
467978|NCT01149668|Multiple Myeloma|multiple myeloma
467979|NCT01149668|Leukemia|leukemia
467980|NCT01149668|Lymphocytic|lymphocytic
467981|NCT01149668|Chronic|chronic
467982|NCT01149655|Adolescent|adolescent
467983|NCT01149655|Schizophrenia|schizophrenia
467984|NCT01149629|Droxidopa|droxidopa
467985|NCT01149629|Randomized|randomized
467986|NCT01149629|Crossover|crossover
467987|NCT01149629|Open Label|open label
467988|NCT01149629|Bioequivalence|bioequivalence
467989|NCT01149629|Fed Fast|fed fast
467990|NCT01149629|TID|tid
467991|NCT01149603|failing Fontan|failing fontan
467992|NCT01149603|single-ventricle|single-ventricle
467993|NCT01149603|destination therapy|destination therapy
467994|NCT01149603|HeartMate II|heartmate ii
467995|NCT01149603|HMII|hmii
467996|NCT01149603|cardiac congenital anomaly|cardiac congenital anomaly
467997|NCT01149603|ventricular assist device|ventricular assist device
467998|NCT01149603|VAD|vad
467999|NCT01149590|Angina|angina
468000|NCT01149590|Coronary Heart Disease|coronary heart disease
468001|NCT01149590|Computed Tomography|computed tomography
468002|NCT01149590|Angiogram|angiogram
468003|NCT01149590|Coronary Artery Calcium Score|coronary artery calcium score
468004|NCT01149590|Chest Pain|chest pain
468005|NCT01149590|Angina Pectoris due to Coronary Heart Disease|angina pectoris due to coronary heart disease
468006|NCT01149577|Olanzapine|olanzapine
468007|NCT01149577|Schizophrenia|schizophrenia
468008|NCT01149577|Polysomnography|polysomnography
468009|NCT01149577|Slow wave sleep|slow wave sleep
468010|NCT01149551|Schizophrenia|schizophrenia
468011|NCT01149551|Bipolar disorder|bipolar disorder
468012|NCT01149551|Genetic research|genetic research
468013|NCT01149538|FASD|fasd
468014|NCT01149538|FAS|fas
468015|NCT01149538|Alcohol|alcohol
468016|NCT01149538|Prenatal Alcohol|prenatal alcohol
468017|NCT01149525|Multiple Sclerosis/complications|multiple sclerosis/complications
468018|NCT01149525|Fatigue Syndrome|fatigue syndrome
468019|NCT01149525|Chronic/drug therapy|chronic/drug therapy
468020|NCT01149486|Bioequivalence|bioequivalence
468021|NCT01149486|Healthy Subjects|healthy subjects
468022|NCT01149473|Bioequivalence|bioequivalence
468023|NCT01149473|Healthy Subjects|healthy subjects
468024|NCT01149447|cryptogenic stroke|cryptogenic stroke
468025|NCT01149447|percutaneous closure of PFO|percutaneous closure of pfo
468026|NCT01149447|follow-up exams|follow-up exams
468027|NCT01149434|Low grade endocrine tumors|low grade endocrine tumors
468028|NCT01149434|ovarian cancers|ovarian cancers
468029|NCT01149434|K-RAS mutant colon cancers|k-ras mutant colon cancers
468030|NCT01149421|Type 2 Diabetes|type 2 diabetes
468031|NCT01149421|Diabetes|diabetes
468032|NCT01149421|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
468033|NCT01149421|ABPM|abpm
468034|NCT01149421|Blood Pressure|blood pressure
468035|NCT01149421|Heart Rate|heart rate
468036|NCT01149408|AML|aml
468037|NCT01149408|Decitabine|decitabine
468038|NCT01149408|Acute Myeloid Leukemia|acute myeloid leukemia
468039|NCT01149408|Elderly Patients|elderly patients
468040|NCT01149408|Cancer|cancer
468041|NCT01149395|Heartburn|heartburn
468042|NCT01149395|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
468043|NCT01149382|flu shot|flu shot
468044|NCT01149382|islet cell transplant recipients|islet cell transplant recipients
468045|NCT01149369|gastroparesis|gastroparesis
468046|NCT01149369|nausea|nausea
468047|NCT01149369|vomiting|vomiting
468048|NCT01149343|PRAME|prame
468049|NCT01149343|Cancer immunotherapeutic|cancer immunotherapeutic
468050|NCT01149343|Malignant melanoma|malignant melanoma
468051|NCT01149343|ASCI (Antigen-Specific Cancer Immunotherapeutic)|asci (antigen-specific cancer immunotherapeutic)
468052|NCT01149330|Adapalene|adapalene
468053|NCT01149330|Benzoyl Peroxide|benzoyl peroxide
468054|NCT01149330|Acne Vulgaris|acne vulgaris
468055|NCT01149317|acupuncture|acupuncture
468056|NCT01149317|health services research|health services research
468057|NCT01149317|chronic pain|chronic pain
468058|NCT01149317|health disparities|health disparities
468059|NCT01149304|brachytherapy|brachytherapy
468060|NCT01149304|liver metastases|liver metastases
468061|NCT01149304|irradiation|irradiation
468249|NCT01148446|R-CHOP|r-chop
468062|NCT01149304|radiation induced liver disease|radiation induced liver disease
468063|NCT01149304|dosimetry|dosimetry
468064|NCT01149291|high sensitivity C-reactive protein (hsCRP)|high sensitivity c-reactive protein (hscrp)
468065|NCT01149291|cardiorenal|cardiorenal
468066|NCT01149291|end stage renal disease (ESRD)|end stage renal disease (esrd)
468067|NCT01149291|Secondary hyperparathyroidism (SHPT)|secondary hyperparathyroidism (shpt)
468068|NCT01149291|dialysis|dialysis
468069|NCT01149291|paricalcitol|paricalcitol
468070|NCT01149291|osteodystrophy|osteodystrophy
468071|NCT01149291|selective Vitamin D receptor activators (sVDRA)|selective vitamin d receptor activators (svdra)
468072|NCT01149291|chronic kidney disease|chronic kidney disease
468073|NCT01149252|Psoriasis|psoriasis
468074|NCT01149213|Major depressive disorder|major depressive disorder
468075|NCT01149213|follow-up|follow-up
468076|NCT01149213|relapse|relapse
468077|NCT01149213|remission|remission
468078|NCT01149213|transcranial direct current stimulation|transcranial direct current stimulation
468079|NCT01149200|Irritable Bowel Syndrome|irritable bowel syndrome
468080|NCT01149200|IBS-C|ibs-c
468081|NCT01149174|intravesical chemotherapy|intravesical chemotherapy
468082|NCT01149174|early single instillation|early single instillation
468083|NCT01149174|mitomycin-C|mitomycin-c
468084|NCT01149174|electromotive drug administration|electromotive drug administration
468085|NCT01149161|neck dissection|neck dissection
468086|NCT01149161|sentinel lymph node|sentinel lymph node
468087|NCT01149161|Carcinoma|carcinoma
468088|NCT01149161|Papillary|papillary
468089|NCT01149161|thyroid|thyroid
468090|NCT01149161|dissection|dissection
468091|NCT01149148|Aortic Surgeries|aortic surgeries
468092|NCT01149148|Deep Hypothermic Circulatory Arrest|deep hypothermic circulatory arrest
468093|NCT01149135|Seasonal Affective Disorder|seasonal affective disorder
468094|NCT01149135|phototherapy|phototherapy
468095|NCT01149135|circadian rhythms|circadian rhythms
468096|NCT01149135|blue enriched light|blue enriched light
468097|NCT01149135|melanopsin|melanopsin
468098|NCT01149135|low intensity|low intensity
468099|NCT01149122|unresectable, metastatic biliary tract carcinoma|unresectable, metastatic biliary tract carcinoma
468100|NCT01149122|Gemcitabine/Oxaliplatin (GEMOX)|gemcitabine/oxaliplatin (gemox)
468101|NCT01149122|Erlotinib|erlotinib
468102|NCT01149109|MGMT promotor status|mgmt promotor status
468103|NCT01149109|overall survival|overall survival
468104|NCT01149070|Infertility|infertility
468105|NCT01149070|Controlled ovarian stimulation|controlled ovarian stimulation
468106|NCT01149070|Reproductive techniques, assisted|reproductive techniques, assisted
468107|NCT01149070|Sperm injections, intracytoplasmic|sperm injections, intracytoplasmic
468108|NCT01149070|Gonal-f|gonal-f
468109|NCT01149070|Ovitrelle|ovitrelle
468110|NCT01149044|Acute Coronary Syndrome|acute coronary syndrome
468111|NCT01149044|PCI|pci
468112|NCT01149044|Percutaneous Coronary Intervention|percutaneous coronary intervention
468113|NCT01149044|STEMI|stemi
468114|NCT01149044|Thrombectomy|thrombectomy
468115|NCT01149031|Provoked Vestibulodynia|provoked vestibulodynia
468116|NCT01149031|Low Level Laser Therapy|low level laser therapy
468117|NCT01149018|Fibromyalgia|fibromyalgia
468118|NCT01149018|Tetrahydrocannabinol|tetrahydrocannabinol
468119|NCT01149018|Chronic Widespread Pain|chronic widespread pain
468120|NCT01149005|Normal Glucose Tolerance Test|normal glucose tolerance test
468121|NCT01149005|Mixed Meal Tolerance Test|mixed meal tolerance test
468122|NCT01149005|Cystic Fibrosis|cystic fibrosis
468123|NCT01149005|Pulmonary Exacerbation|pulmonary exacerbation
468124|NCT01149005|Impaired Glucose Tolerance Test|impaired glucose tolerance test
468125|NCT01149005|Insulin Therapy|insulin therapy
468126|NCT01148979|Major Depressive Disorder|major depressive disorder
468127|NCT01148979|Cognitive Impairment|cognitive impairment
468128|NCT01148979|Partial Response|partial response
468129|NCT01148979|Residual Symptoms|residual symptoms
468130|NCT01148940|sickle cell trait|sickle cell trait
468131|NCT01148940|thrombosis|thrombosis
468132|NCT01148940|D-Dimer|d-dimer
468133|NCT01148914|Inflammatory biomarkers|inflammatory biomarkers
468134|NCT01148914|Atrial fibrillation|atrial fibrillation
468135|NCT01148914|Catheter ablation|catheter ablation
468136|NCT01148914|To assess if pre-ablation levels of inflammatory biomarkers serve as independent predictors of procedure outcome|to assess if pre-ablation levels of inflammatory biomarkers serve as independent predictors of procedure outcome
468137|NCT01148914|To evaluate the inflammatory activation following catheter ablation and examine its predictive role in procedure success|to evaluate the inflammatory activation following catheter ablation and examine its predictive role in procedure success
468138|NCT01148914|To determine if a change in the baseline level of biomarkers at 3-months follow-up has any correlation with long-term outcome|to determine if a change in the baseline level of biomarkers at 3-months follow-up has any correlation with long-term outcome
468139|NCT01148914|To study the association of certain biomarkers with specific types of AF (paroxysmal or persistent or long standing persistent)|to study the association of certain biomarkers with specific types of af (paroxysmal or persistent or long standing persistent)
468140|NCT01148901|Ankylosing spondylitis|ankylosing spondylitis
468141|NCT01148901|Hip arthritis|hip arthritis
468142|NCT01148901|Infliximab|infliximab
468143|NCT01148888|pediatrics|pediatrics
468144|NCT01148888|Anaesthesia|anaesthesia
468145|NCT01148888|Scoliosis|scoliosis
468146|NCT01148888|Magnesium|magnesium
468147|NCT01148875|breast cancer screening|breast cancer screening
468148|NCT01148875|mammography adherence|mammography adherence
468149|NCT01148875|non-adherent|non-adherent
468150|NCT01148862|ASPIRE (Automation to Simulate Pancreatic Insulin Response)|aspire (automation to simulate pancreatic insulin response)
468151|NCT01148862|X54|x54
468152|NCT01148862|Medtronic Diabetes|medtronic diabetes
468153|NCT01148862|Diabetes Mellitus|diabetes mellitus
468154|NCT01148862|Type 1|type 1
468155|NCT01148849|HER2 positive|her2 positive
468156|NCT01148849|breast cancer|breast cancer
468157|NCT01148849|gastric cancer|gastric cancer
468158|NCT01148836|Coenzyme Q-10|coenzyme q-10
468159|NCT01148836|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
468160|NCT01148836|Pulmonary Arterial Hypertension Class I (Venice 2003)|pulmonary arterial hypertension class i (venice 2003)
468161|NCT01148823|breast|breast
468162|NCT01148823|plastic surgery|plastic surgery
468163|NCT01148823|bandages|bandages
468164|NCT01148823|surgical site infection|surgical site infection
468165|NCT01148823|skin colonization|skin colonization
468166|NCT01148810|Inflammatory muscle disease|inflammatory muscle disease
468167|NCT01148810|Muscle weakness|muscle weakness
468168|NCT01148810|Myositis|myositis
468169|NCT01148797|FMF, Colchicine resistant|fmf, colchicine resistant
468170|NCT01148797|Colchicine intolerant|colchicine intolerant
468171|NCT01148797|Flare rate|flare rate
468172|NCT01148797|Canakinumab|canakinumab
468173|NCT01148784|anterior cruciate ligament tear|anterior cruciate ligament tear
468174|NCT01148784|ACL|acl
468175|NCT01148784|ligament|ligament
468176|NCT01148784|knee|knee
468177|NCT01148784|allograft|allograft
468178|NCT01148771|Pharmacokinetics|pharmacokinetics
468179|NCT01148771|Safety|safety
468180|NCT01148732|Endotracheal tube|endotracheal tube
468181|NCT01148732|ultrasonography|ultrasonography
468182|NCT01148719|Heart Failure|heart failure
468183|NCT01148719|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
468184|NCT01148719|Dyspnea|dyspnea
468185|NCT01148719|Elderly|elderly
468186|NCT01148719|Diagnosis|diagnosis
468187|NCT01148719|Primary health care|primary health care
468188|NCT01148706|thorax|thorax
468189|NCT01148706|abdomen|abdomen
468190|NCT01148693|Cholangitis; Cholangiopancreatography, Endoscopic Retrograde; stents; cholestasis|cholangitis; cholangiopancreatography, endoscopic retrograde; stents; cholestasis
468191|NCT01148680|Islet Cell Transplantation|islet cell transplantation
468192|NCT01148680|Metabolic Diseases|metabolic diseases
468193|NCT01148680|Endocrine System Diseases|endocrine system diseases
468194|NCT01148667|atopic dermatitis|atopic dermatitis
468195|NCT01148667|barrier function|barrier function
468196|NCT01148667|gut|gut
468197|NCT01148667|probiotics|probiotics
468198|NCT01148667|skin|skin
468199|NCT01148654|preterm birth|preterm birth
468200|NCT01148654|preterm labor|preterm labor
468201|NCT01148654|PTB|ptb
468202|NCT01148654|PTL|ptl
468203|NCT01148641|Lipid-based supplements|lipid-based supplements
468204|NCT01148641|LNS|lns
468205|NCT01148641|Acceptability|acceptability
468206|NCT01148641|Infant nutrition|infant nutrition
468207|NCT01148641|Guatemala|guatemala
468208|NCT01148641|Malnutrition|malnutrition
468209|NCT01148602|Acute stroke|acute stroke
468210|NCT01148602|Emergency departments|emergency departments
468211|NCT01148602|Quality Improvement|quality improvement
468212|NCT01148602|Improved Processes|improved processes
468213|NCT01148602|tPA|tpa
468214|NCT01148602|door-to-needle|door-to-needle
468215|NCT01148602|door-to-treatment|door-to-treatment
468216|NCT01148576|hepatic steatosis, chronic hepatitis B, entecavir|hepatic steatosis, chronic hepatitis b, entecavir
468217|NCT01148563|congestive heart failure|congestive heart failure
468218|NCT01148563|systolic|systolic
468219|NCT01148563|chronic disease|chronic disease
468220|NCT01148563|heart failure|heart failure
468221|NCT01148550|neonatal acute liver failure|neonatal acute liver failure
468222|NCT01148550|late-onset liver failure|late-onset liver failure
468223|NCT01148550|cholestasis,|cholestasis,
468224|NCT01148550|fatty liver,|fatty liver,
468225|NCT01148550|liver dysfunction,|liver dysfunction,
468226|NCT01148550|cirrhosis|cirrhosis
468227|NCT01148537|Healthy subjects|healthy subjects
468228|NCT01148537|Opioid|opioid
468229|NCT01148537|Transdermal|transdermal
468230|NCT01148524|Meningococcal disease|meningococcal disease
468231|NCT01148524|Vaccines|vaccines
468232|NCT01148524|Adolescents|adolescents
468233|NCT01148511|Macula degeneration|macula degeneration
468234|NCT01148511|Ranibizumab|ranibizumab
468235|NCT01148511|Choroidal neovascularisation|choroidal neovascularisation
468236|NCT01148511|Treat and extend|treat and extend
468237|NCT01148511|Treat and observe|treat and observe
468238|NCT01148485|- Staphylococcus aureus Carriage among Athletes|- staphylococcus aureus carriage among athletes
468239|NCT01148472|Depressive disorder, major|depressive disorder, major
468240|NCT01148472|Randomized controlled trials|randomized controlled trials
468241|NCT01148472|Antidepressive agents|antidepressive agents
468242|NCT01148459|Plasmodium falciparum|plasmodium falciparum
468243|NCT01148459|schedule|schedule
468244|NCT01148459|HIV|hiv
468245|NCT01148459|malaria vaccine|malaria vaccine
468250|NCT01148446|R-CEOP|r-ceop
468251|NCT01148446|Elderly patients|elderly patients
468252|NCT01148407|breast cancer|breast cancer
468253|NCT01148407|platelets|platelets
468254|NCT01148407|metastatic cancer|metastatic cancer
468255|NCT01148407|malignancy|malignancy
468256|NCT01148394|Colorectal surgery|colorectal surgery
468257|NCT01148394|multimodal rehabilitation|multimodal rehabilitation
468258|NCT01148394|fast track|fast track
468259|NCT01148394|early feeding|early feeding
468260|NCT01148381|Genotype|genotype
468261|NCT01148381|Phenotype|phenotype
468262|NCT01148381|Characterization|characterization
468263|NCT01148368|fimasartan|fimasartan
468264|NCT01148368|renal impairment|renal impairment
468265|NCT01148368|hypertension|hypertension
468266|NCT01148355|Craving|craving
468267|NCT01148355|Moods|moods
468268|NCT01148355|Adolescents|adolescents
468269|NCT01148355|Nicotine|nicotine
468270|NCT01148355|Reinforcement|reinforcement
468271|NCT01148342|Ecstacy|ecstacy
468272|NCT01148342|fMRI|fmri
468273|NCT01148342|Alternative Matrices|alternative matrices
468274|NCT01148342|Cognitive Training|cognitive training
468275|NCT01148342|Brain Imaging|brain imaging
468276|NCT01148329|Coronary stenting|coronary stenting
468277|NCT01148329|Drug-eluting stent|drug-eluting stent
468278|NCT01148329|Post-market surveillance study|post-market surveillance study
468279|NCT01148329|Promus Element stent|promus element stent
468280|NCT01148316|Developmental Psychiatry|developmental psychiatry
468281|NCT01148316|Sequential Randomized Clinical Trial|sequential randomized clinical trial
468282|NCT01148316|Obsessive-Compulsive Disorder D009771|obsessive-compulsive disorder d009771
468283|NCT01148303|Headache|headache
468284|NCT01148303|Fasting|fasting
468285|NCT01148303|Fasting Headache|fasting headache
468286|NCT01148303|Ramadan|ramadan
468287|NCT01148303|Ramadan Headache|ramadan headache
468288|NCT01148303|Yom Kippur|yom kippur
468289|NCT01148303|Yom Kippur Headache|yom kippur headache
468290|NCT01148290|bulking agent|bulking agent
468291|NCT01148290|emivulvectomy|emivulvectomy
468292|NCT01148290|radical vulvectomy|radical vulvectomy
468293|NCT01148290|TVT|tvt
468294|NCT01148290|urinary incontinence|urinary incontinence
468295|NCT01148290|vulvar cancer|vulvar cancer
468296|NCT01148277|Endoscopies|endoscopies
468297|NCT01148277|Liver diseases|liver diseases
468298|NCT01148277|Propofol|propofol
468299|NCT01148277|Midazolam and remifentanyl|midazolam and remifentanyl
468300|NCT01148264|break-through|break-through
468301|NCT01148264|emesis|emesis
468302|NCT01148264|break through emesis after prophylaxis with dexamethasone, 5-HT 3RA and aprepitant|break through emesis after prophylaxis with dexamethasone, 5-ht 3ra and aprepitant
468303|NCT01148238|Autoimmune diabetes|autoimmune diabetes
468304|NCT01148238|LADA|lada
468305|NCT01148238|T-reg|t-reg
468306|NCT01148238|cytokine|cytokine
468307|NCT01148225|Intermediate-Uveitis|intermediate-uveitis
468308|NCT01148225|Non-infectious Uveitis|non-infectious uveitis
468309|NCT01148225|Posterior-Uveitis|posterior-uveitis
468310|NCT01148225|Active Uveitis|active uveitis
468311|NCT01148225|Pan-uveitis|pan-uveitis
468312|NCT01148225|Uveitis|uveitis
468313|NCT01148199|biliary anastomotic stricture|biliary anastomotic stricture
468314|NCT01148199|orthotopic liver transplantation|orthotopic liver transplantation
468315|NCT01148199|ERCP|ercp
468316|NCT01148186|Polypharmacy|polypharmacy
468317|NCT01148186|Benzodiazepine use|benzodiazepine use
468318|NCT01148186|Oxybutynin use|oxybutynin use
468319|NCT01148186|cognition disorders/drug therapy|cognition disorders/drug therapy
468320|NCT01148186|incontinence|incontinence
468321|NCT01148173|CNS relapse|cns relapse
468322|NCT01148173|aggressive lymphoma|aggressive lymphoma
468323|NCT01148173|HD-ASCT|hd-asct
468324|NCT01148160|voriconazole|voriconazole
468325|NCT01148160|invasive pulmonary aspergillosis|invasive pulmonary aspergillosis
468326|NCT01148160|hematologic malignancy|hematologic malignancy
468327|NCT01148160|therapeutic drug monitoring|therapeutic drug monitoring
468328|NCT01148160|genetic polymorphism|genetic polymorphism
468329|NCT01148160|efficacy|efficacy
468330|NCT01148160|safety|safety
468331|NCT01148147|Adenosine|adenosine
468332|NCT01148147|randomized trial|randomized trial
468333|NCT01148147|periprocedural myocardial necrosis|periprocedural myocardial necrosis
468334|NCT01148147|elective coronary angioplasty|elective coronary angioplasty
468335|NCT01148108|NHL|nhl
468336|NCT01148108|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
468337|NCT01148108|Lymphoma|lymphoma
468338|NCT01148108|Mantle Cell|mantle cell
468339|NCT01148108|Diffuse Large B Cell|diffuse large b cell
468340|NCT01148108|Multiple Myeloma|multiple myeloma
468341|NCT01148108|Telcyta|telcyta
468342|NCT01148108|canfosfamide|canfosfamide
468343|NCT01148108|TLK286|tlk286
468344|NCT01148108|Prodrug|prodrug
468345|NCT01148108|Enzyme activated drug|enzyme activated drug
468346|NCT01148108|Glutathione Transferase P1-1 activated drug|glutathione transferase p1-1 activated drug
468347|NCT01148108|GSTp1-1 activated drug|gstp1-1 activated drug
468348|NCT01148108|Glutathione Transferase activated drug|glutathione transferase activated drug
468349|NCT01148108|Glutathione|glutathione
468350|NCT01148108|Glutathione analong|glutathione analong
468351|NCT01148095|AZD2516|azd2516
468352|NCT01148095|Phase 1|phase 1
468353|NCT01148095|Healthy volunteer|healthy volunteer
468354|NCT01148095|pharmacokinetics|pharmacokinetics
468355|NCT01148095|safety|safety
468356|NCT01148095|tolerability|tolerability
468357|NCT01148095|Multiple ascending doses|multiple ascending doses
468358|NCT01148082|Carcinomas (including Squamous Cell and Adenocarcinoma)|carcinomas (including squamous cell and adenocarcinoma)
468359|NCT01148069|IMRT-IGRT|imrt-igrt
468360|NCT01148069|radiotherapy toxicity|radiotherapy toxicity
468361|NCT01148069|seminal vesicles|seminal vesicles
468362|NCT01148056|IMRT|imrt
468363|NCT01148056|radiation therapy|radiation therapy
468364|NCT01148017|Meningococcal|meningococcal
468365|NCT01148017|ACWY|acwy
468366|NCT01148017|Conjugate Vaccine|conjugate vaccine
468367|NCT01148017|Meningitis|meningitis
468368|NCT01148017|Children|children
468369|NCT01148017|Persistence|persistence
468370|NCT01148017|Booster dose|booster dose
468371|NCT01148004|HIV|hiv
468372|NCT01148004|Hypertriglyceridemia|hypertriglyceridemia
468373|NCT01148004|Protease Inhibitors|protease inhibitors
468374|NCT01148004|Healthy Volunteer|healthy volunteer
468375|NCT01148004|HV|hv
468376|NCT01147991|Epstein-Barr virus infection|epstein-barr virus infection
468377|NCT01147991|stage I nasopharyngeal cancer|stage i nasopharyngeal cancer
468378|NCT01147991|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
468379|NCT01147991|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
468380|NCT01147991|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
468381|NCT01147991|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
468382|NCT01147991|stage I gastric cancer|stage i gastric cancer
468383|NCT01147991|stage II gastric cancer|stage ii gastric cancer
468384|NCT01147991|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
468385|NCT01147991|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
468386|NCT01147991|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
468387|NCT01147991|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
468388|NCT01147991|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
468389|NCT01147991|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
468390|NCT01147978|ICU|icu
468391|NCT01147978|Anxiety|anxiety
468392|NCT01147978|Depression|depression
468393|NCT01147978|PTSD|ptsd
468394|NCT01147965|Colon Cancer|colon cancer
468395|NCT01147965|Lung Cancer|lung cancer
468396|NCT01147965|Breast Cancer|breast cancer
468397|NCT01147965|CEA|cea
468398|NCT01147952|angina|angina
468399|NCT01147952|gene expression|gene expression
468400|NCT01147952|depression|depression
468401|NCT01147952|anxiety|anxiety
468402|NCT01147939|Acute Myeloid Leukaemia|acute myeloid leukaemia
468403|NCT01147939|AML|aml
468404|NCT01147939|Haematology|haematology
468405|NCT01147939|Investigator's Choice|investigator's choice
468406|NCT01147939|Elacytarabine|elacytarabine
468407|NCT01147939|Refractory or relapsed AML|refractory or relapsed aml
468408|NCT01147939|Phase III|phase iii
468409|NCT01147939|Randomized|randomized
468410|NCT01147939|CLAVELA|clavela
468411|NCT01147939|CP4055-306|cp4055-306
468412|NCT01147939|Elacyt|elacyt
468413|NCT01147926|Constipation|constipation
468414|NCT01147926|Male|male
468415|NCT01147913|Major Depression|major depression
468416|NCT01147913|Depression|depression
468417|NCT01147913|Anxiety|anxiety
468418|NCT01147913|Dysthymia|dysthymia
468419|NCT01147900|Immune persistence|immune persistence
468420|NCT01147900|Boostrix|boostrix
468421|NCT01147900|dTpa booster study|dtpa booster study
468422|NCT01147887|26489112|26489112
468423|NCT01147887|Omeprazole|omeprazole
468424|NCT01147887|Tolbutamide|tolbutamide
468425|NCT01147874|non-therapeutic|non-therapeutic
468426|NCT01147874|interventional|interventional
468427|NCT01147861|T2DM|t2dm
468428|NCT01147861|Pharmacodynamics|pharmacodynamics
468429|NCT01147861|GSK256073|gsk256073
468430|NCT01147848|Salmeterol|salmeterol
468431|NCT01147848|fluticasone furoate|fluticasone furoate
468432|NCT01147848|Vilanterol|vilanterol
468433|NCT01147848|fluticasone propionate|fluticasone propionate
468434|NCT01147848|GW642444|gw642444
468435|NCT01147835|Herbal lollipops|herbal lollipops
468436|NCT01147835|Asthma|asthma
468437|NCT01147835|Dental Caries|dental caries
468438|NCT01147835|Streptococcus mutans levels|streptococcus mutans levels
468439|NCT01147835|DMFT/dmft scores|dmft/dmft scores
468440|NCT01147822|SUTENT|sutent
468441|NCT01147822|GW76034|gw76034
468442|NCT01147822|Sunitinib|sunitinib
468443|NCT01147822|Renal cell carcinoma|renal cell carcinoma
468444|NCT01147822|Pazopanib|pazopanib
468445|NCT01147809|Solid Tumor|solid tumor
468446|NCT01147809|Eltrombopag|eltrombopag
468447|NCT01147809|chemotherapy-induced thrombocytopenia|chemotherapy-induced thrombocytopenia
468448|NCT01147809|Thrombocytopenia|thrombocytopenia
468449|NCT01147796|Thrombus|thrombus
468450|NCT01147796|computed tomography|computed tomography
468451|NCT01147796|Transoesophageal echocardiography|transoesophageal echocardiography
468452|NCT01147770|progesterone|progesterone
468453|NCT01147770|antagonist|antagonist
468454|NCT01147770|rec FSH|rec fsh
468455|NCT01147770|IVF|ivf
468456|NCT01147770|pregnancy|pregnancy
468457|NCT01147757|pediatric patients (ASA physical status I or II) aged between|pediatric patients (asa physical status i or ii) aged between
468458|NCT01147744|Efficacy|efficacy
468459|NCT01147744|Asthma|asthma
468460|NCT01147744|Safety|safety
468461|NCT01147744|Fluticasone Propionate|fluticasone propionate
468462|NCT01147744|FLAP|flap
468463|NCT01147744|Beta-agonists|beta-agonists
468464|NCT01147744|GSK2190915|gsk2190915
468465|NCT01147744|Montelukast|montelukast
468466|NCT01147744|Placebo|placebo
468467|NCT01147744|FLAIR|flair
468468|NCT01147731|pharmacokinetics|pharmacokinetics
468469|NCT01147731|albiglutide|albiglutide
468470|NCT01147731|warfarin|warfarin
468471|NCT01147731|Healthy volunteers|healthy volunteers
468472|NCT01147718|pharmacokinetics|pharmacokinetics
468473|NCT01147718|albiglutide|albiglutide
468474|NCT01147718|Healthy volunteer|healthy volunteer
468475|NCT01147718|digoxin|digoxin
468476|NCT01147705|Peripheral arterial disease|peripheral arterial disease
468477|NCT01147705|Allopurinol|allopurinol
468478|NCT01147692|albiglutide|albiglutide
468479|NCT01147692|simvastatin|simvastatin
468480|NCT01147692|healthy volunteers|healthy volunteers
468481|NCT01147692|pharmacokinetics|pharmacokinetics
468482|NCT01147679|Frontotemporal dementia|frontotemporal dementia
468483|NCT01147679|Alzheimer's disease|alzheimer's disease
468484|NCT01147679|Young-Onset|young-onset
468485|NCT01147679|Frontotemporal degeneration|frontotemporal degeneration
468486|NCT01147679|control|control
468487|NCT01147679|social|social
468488|NCT01147679|behavior|behavior
468489|NCT01147679|observation|observation
468490|NCT01147679|emotion|emotion
468491|NCT01147679|morality|morality
468492|NCT01147679|dementia|dementia
468493|NCT01147679|brain|brain
468494|NCT01147679|relationships|relationships
468495|NCT01147679|caregiver|caregiver
468496|NCT01147679|MRI|mri
468497|NCT01147679|neurology|neurology
468498|NCT01147666|Kidney|kidney
468499|NCT01147666|End Stage Renal Disease|end stage renal disease
468500|NCT01147666|ESRD|esrd
468501|NCT01147666|Chronic Kidney Disease|chronic kidney disease
468502|NCT01147666|CKD|ckd
468503|NCT01147666|Renal|renal
468504|NCT01147666|Anemia|anemia
468505|NCT01147666|Oral anemia treatment|oral anemia treatment
468506|NCT01147666|Hemoglobin levels|hemoglobin levels
468507|NCT01147666|Blood count|blood count
468508|NCT01147666|Erythropoietin|erythropoietin
468509|NCT01147666|Hemodialysis|hemodialysis
468510|NCT01147666|Normoresponder|normoresponder
468511|NCT01147666|Hyporesponder|hyporesponder
468512|NCT01147653|Cerebral Palsy|cerebral palsy
468513|NCT01147653|CP|cp
468514|NCT01147653|Spastic Cerebral Palsy|spastic cerebral palsy
468515|NCT01147653|Cord Blood|cord blood
468516|NCT01147653|Umbilical Cord Blood|umbilical cord blood
468517|NCT01147653|Autologous Cord Blood|autologous cord blood
468518|NCT01147627|diabetes mellitus, type 2|diabetes mellitus, type 2
468519|NCT01147627|newly diagnosed|newly diagnosed
468520|NCT01147627|exenatide|exenatide
468521|NCT01147627|premixed insulin analog|premixed insulin analog
468522|NCT01147627|thiazolidinedione|thiazolidinedione
468523|NCT01147627|β-cell function|β-cell function
468524|NCT01147627|glycemic control|glycemic control
468525|NCT01147614|Child|child
468526|NCT01147614|adolescent|adolescent
468527|NCT01147614|anxiety|anxiety
468528|NCT01147614|depression|depression
468529|NCT01147614|internalizing|internalizing
468530|NCT01147614|cognitive behavioral therapy|cognitive behavioral therapy
468531|NCT01147614|pediatric primary care|pediatric primary care
468532|NCT01147601|topical 0.5% Timolol|topical 0.5% timolol
468533|NCT01147601|infantile hemangioma (IH)|infantile hemangioma (ih)
468534|NCT01147588|open label|open label
468535|NCT01147588|randomized|randomized
468536|NCT01147588|4-treatment|4-treatment
468537|NCT01147588|3-period|3-period
468538|NCT01147588|crossover|crossover
468539|NCT01147588|interaction study|interaction study
468540|NCT01147588|Safety|safety
468541|NCT01147588|tolerability|tolerability
468542|NCT01147588|pharmacokinetics|pharmacokinetics
468543|NCT01147588|pharmacodynamics|pharmacodynamics
468544|NCT01147575|Rett Syndrome, Randomized, Methylation|rett syndrome, randomized, methylation
468545|NCT01147562|Lung cancer|lung cancer
468546|NCT01147562|Biopsy|biopsy
468547|NCT01147562|Biomarker|biomarker
468548|NCT01147562|Tissue Collection|tissue collection
468549|NCT01147549|ADME|adme
468550|NCT01147523|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
468551|NCT01147523|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
468552|NCT01147523|adipokines|adipokines
468553|NCT01147523|spironolactone|spironolactone
468554|NCT01147523|vitamin E|vitamin e
468555|NCT01147523|adiponectin|adiponectin
468556|NCT01147523|visfatin|visfatin
468557|NCT01147523|leptin|leptin
468558|NCT01147523|resistin|resistin
468559|NCT01147523|TNF-alpha|tnf-alpha
468560|NCT01147523|IL-6|il-6
468561|NCT01147523|IL-1|il-1
468562|NCT01147510|asthma control in elderly patients|asthma control in elderly patients
468563|NCT01147510|age 60-75|age 60-75
468564|NCT01147497|IUD insertion|iud insertion
468565|NCT01147497|nulliparous women|nulliparous women
468566|NCT01147497|contraception|contraception
468567|NCT01147497|family planning|family planning
468568|NCT01147497|IUD insertion in nulliparous women|iud insertion in nulliparous women
468569|NCT01147484|Breast Cancer|breast cancer
468570|NCT01147471|flail chest|flail chest
468571|NCT01147471|rib fixation|rib fixation
468572|NCT01147458|Cross-over|cross-over
468573|NCT01147458|safety|safety
468574|NCT01147458|efficacy|efficacy
468575|NCT01147458|tolerability|tolerability
468576|NCT01147458|osteoarthritis|osteoarthritis
468577|NCT01147458|knee|knee
468578|NCT01147458|pain|pain
468579|NCT01147445|Enterotoxigenic Escherichia coli, vaccine|enterotoxigenic escherichia coli, vaccine
468580|NCT01147432|Healthy male volunteers|healthy male volunteers
468581|NCT01147432|capsaicin challenge|capsaicin challenge
468582|NCT01147432|safety|safety
468583|NCT01147432|toleration|toleration
468584|NCT01147419|critical limb ischemia|critical limb ischemia
468585|NCT01147419|peripheral artery occlusive disease|peripheral artery occlusive disease
468586|NCT01147419|femoropopliteal artery bypass|femoropopliteal artery bypass
468587|NCT01147419|Stent|stent
468588|NCT01147367|exercise|exercise
468589|NCT01147367|breast cancer|breast cancer
468590|NCT01147367|physical activity|physical activity
468591|NCT01147367|fatigue|fatigue
468592|NCT01147367|sleep dysfunction|sleep dysfunction
468593|NCT01147367|cytokines|cytokines
468594|NCT01147367|muscle strength|muscle strength
468595|NCT01147367|inflammation|inflammation
468596|NCT01147354|Hemodialysis|hemodialysis
468597|NCT01147354|oxidative stress|oxidative stress
468598|NCT01147354|selenium|selenium
468599|NCT01147354|inflammation|inflammation
468600|NCT01147341|rheumatoid arthritis|rheumatoid arthritis
468601|NCT01147341|anti-TNF therapy|anti-tnf therapy
468602|NCT01147328|Health information technology|health information technology
468603|NCT01147328|Health information exchange|health information exchange
468604|NCT01147328|Virtual health record|virtual health record
468605|NCT01147328|Health care utilization|health care utilization
468606|NCT01147315|mandibular osteoradionecrosis|mandibular osteoradionecrosis
468607|NCT01147315|hybrid bone substitution|hybrid bone substitution
468608|NCT01147315|calcium-phosphate ceramic biomaterial|calcium-phosphate ceramic biomaterial
468609|NCT01147315|autologous bone marrow|autologous bone marrow
468610|NCT01147289|lumbar sciatic pain|lumbar sciatic pain
468611|NCT01147289|moderate to severe lumbar sciatic pain within the last three days|moderate to severe lumbar sciatic pain within the last three days
468612|NCT01147276|DPP-4|dpp-4
468613|NCT01147276|GLP-1|glp-1
468614|NCT01147276|Glucagon|glucagon
468615|NCT01147276|Catecholamines|catecholamines
468616|NCT01147276|Counterregulation|counterregulation
468617|NCT01147276|Type 1 diabetes|type 1 diabetes
468618|NCT01147263|Fibromyalgia|fibromyalgia
468619|NCT01147263|Autonomic dysfunction|autonomic dysfunction
468620|NCT01147263|Tachycardia|tachycardia
468621|NCT01147263|Palpitations|palpitations
468622|NCT01147224|Asthma|asthma
468623|NCT01147224|Allergy|allergy
468624|NCT01147224|Ciclesonide|ciclesonide
468625|NCT01147224|Alvesco|alvesco
468626|NCT01147224|Inhaled steroids|inhaled steroids
468627|NCT01147211|dose defining|dose defining
468628|NCT01147211|MK-2206|mk-2206
468629|NCT01147211|NSCLC With EGFR Mutation|nsclc with egfr mutation
468630|NCT01147211|NSCLC|nsclc
468631|NCT01147198|Moderate|moderate
468632|NCT01147198|Wasting|wasting
468633|NCT01147198|Malnutrition|malnutrition
468634|NCT01147198|Ready to Use Food|ready to use food
468635|NCT01147198|Fortified Blended Flour|fortified blended flour
468636|NCT01147185|Spinal Cord Injuries, Locomotor training, Dose-Response|spinal cord injuries, locomotor training, dose-response
468637|NCT01147172|Nasolabial Folds|nasolabial folds
468638|NCT01147172|Cosmetic|cosmetic
468639|NCT01147172|Injectable Dermal Filler|injectable dermal filler
468640|NCT01147172|Hyaluronic Acid with Lidocaine|hyaluronic acid with lidocaine
468641|NCT01147146|transurethral surgery|transurethral surgery
468642|NCT01147133|Platelet aggregation|platelet aggregation
468643|NCT01147133|Generic|generic
468644|NCT01147133|Clopidogrel|clopidogrel
468645|NCT01147133|Comparison|comparison
468646|NCT01147133|VASP-PRI|vasp-pri
468647|NCT01147107|HIV/HCV co-infection|hiv/hcv co-infection
468648|NCT01147107|Antiretroviral therapy|antiretroviral therapy
468649|NCT01147081|Influenza vaccine|influenza vaccine
468650|NCT01147081|Vaccine|vaccine
468651|NCT01147068|Influenza|influenza
468652|NCT01147055|crizotinib|crizotinib
468653|NCT01147055|healthy volunteers|healthy volunteers
468654|NCT01147055|rifampin|rifampin
468655|NCT01147055|pharmacokinetics|pharmacokinetics
468656|NCT01147055|single dose|single dose
468657|NCT01147042|NADPH Oxidase-Nicotinamide Adenine Dinucleotide Phosphate|nadph oxidase-nicotinamide adenine dinucleotide phosphate
468658|NCT01147042|Chronic Granulomatous Disease|chronic granulomatous disease
468659|NCT01147042|Gene Mutation|gene mutation
468660|NCT01147042|Superoxide by Phagocytes|superoxide by phagocytes
468661|NCT01147042|Interferon-Gamma|interferon-gamma
468662|NCT01147029|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
468663|NCT01147016|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
468664|NCT01147016|HER2-negative breast cancer|her2-negative breast cancer
468665|NCT01147016|male breast cancer|male breast cancer
468666|NCT01147016|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
468667|NCT01147016|recurrent breast cancer|recurrent breast cancer
468668|NCT01147016|stage IIA breast cancer|stage iia breast cancer
468669|NCT01147016|stage IIB breast cancer|stage iib breast cancer
468670|NCT01147016|stage IIIA breast cancer|stage iiia breast cancer
468671|NCT01147016|stage IIIB breast cancer|stage iiib breast cancer
468672|NCT01147016|triple-negative breast cancer|triple-negative breast cancer
468673|NCT01147003|Seizure frequency|seizure frequency
468674|NCT01147003|nervous system diseases|nervous system diseases
468675|NCT01147003|brain diseases|brain diseases
468676|NCT01147003|neurologic manifestations|neurologic manifestations
468677|NCT01147003|adjunctive treatment|adjunctive treatment
468678|NCT01147003|AEDs|aeds
468679|NCT01147003|antiepileptic drug|antiepileptic drug
468680|NCT01146990|17P Efficacy Trial Follow up|17p efficacy trial follow up
468681|NCT01146977|CBF(+)|cbf(+)
468682|NCT01146964|Age related cataract|age related cataract
468683|NCT01146964|Phacoemulsification|phacoemulsification
468684|NCT01146964|Manual super small incision cataract surgery|manual super small incision cataract surgery
468685|NCT01146951|Epilepsy|epilepsy
468686|NCT01146951|Seizures|seizures
468687|NCT01146938|fimasartan|fimasartan
468688|NCT01146938|hepatic impairment|hepatic impairment
468689|NCT01146925|Acute Kidney Injury|acute kidney injury
468690|NCT01146925|Contrast-Induced Nephropathy|contrast-induced nephropathy
468691|NCT01146925|Labile Iron|labile iron
468692|NCT01146925|Iron Chelation|iron chelation
468693|NCT01146925|Deferiprone|deferiprone
468694|NCT01146912|Influenza, text message, vaccination|influenza, text message, vaccination
468695|NCT01146899|influenza, vaccine, clinical decision support|influenza, vaccine, clinical decision support
468696|NCT01146860|BNO 1016, acute rhinosinusitis|bno 1016, acute rhinosinusitis
468697|NCT01146847|algorithm|algorithm
468698|NCT01146847|tight glycemic control|tight glycemic control
468699|NCT01146847|glucose control|glucose control
468700|NCT01146847|intensive care|intensive care
468701|NCT01146847|insulin|insulin
468702|NCT01146847|ICU|icu
468703|NCT01146808|Vaccination|vaccination
468704|NCT01146808|Immunocompromised Host|immunocompromised host
468705|NCT01146808|Antiviral Agents|antiviral agents
468706|NCT01146808|Drug Resistance, Viral|drug resistance, viral
468707|NCT01146808|Resource Allocation|resource allocation
468708|NCT01146769|Cancer of rectum|cancer of rectum
468709|NCT01146769|Physiotherapy|physiotherapy
468710|NCT01146756|MEK inhibitor|mek inhibitor
468711|NCT01146756|thoracic radiotherapy|thoracic radiotherapy
468712|NCT01146756|lung cancer|lung cancer
468713|NCT01146743|EUS-guided transmural cholecystostomy|eus-guided transmural cholecystostomy
468714|NCT01146730|Anxiety|anxiety
468715|NCT01146730|Depression|depression
468716|NCT01146730|Vocational Rehabilitation|vocational rehabilitation
468717|NCT01146730|Common Mental Disorders|common mental disorders
468718|NCT01146730|Mental Health Problems|mental health problems
468719|NCT01146730|Work Related Therapy|work related therapy
468720|NCT01146717|Mild Cognitive Impairment|mild cognitive impairment
468721|NCT01146717|Exercise|exercise
468722|NCT01146704|Obesity|obesity
468723|NCT01146691|Organizational models|organizational models
468724|NCT01146691|Intensive care units|intensive care units
468725|NCT01146691|Physicians|physicians
468726|NCT01146691|Staffing and scheduling|staffing and scheduling
468727|NCT01146691|Burnout, professional|burnout, professional
468728|NCT01146691|Job satisfaction|job satisfaction
468729|NCT01146691|Education, medical|education, medical
468730|NCT01146691|Patient satisfaction|patient satisfaction
468731|NCT01146665|alcohol consumption|alcohol consumption
468732|NCT01146665|personalized assessment feedback|personalized assessment feedback
468733|NCT01146665|youth|youth
468734|NCT01146665|emergency department|emergency department
468735|NCT01146639|EVAR DynaCT|evar dynact
468736|NCT01146626|Vitamin D|vitamin d
468737|NCT01146626|Hepatitis C|hepatitis c
468738|NCT01146626|Genotype2,3|genotype2,3
468739|NCT01146626|SVR|svr
468740|NCT01146626|Naive|naive
468741|NCT01146626|RVR rate|rvr rate
468742|NCT01146626|EVR rate|evr rate
468743|NCT01146626|SVR rate|svr rate
468744|NCT01146613|Alcohol|alcohol
468745|NCT01146613|Alcohol abuse|alcohol abuse
468746|NCT01146613|Alcoholism|alcoholism
468747|NCT01146613|Alcohol Dependence|alcohol dependence
468748|NCT01146613|Varenicline|varenicline
468749|NCT01146613|Drinking|drinking
468750|NCT01146600|Primary hypersomnia|primary hypersomnia
468751|NCT01146600|CNS hypersomnia|cns hypersomnia
468752|NCT01146600|hypersomnia|hypersomnia
468753|NCT01146600|idiopathic hypersomnia|idiopathic hypersomnia
468754|NCT01146600|clarithromycin|clarithromycin
468755|NCT01146600|Narcolepsy without Cataplexy|narcolepsy without cataplexy
468756|NCT01146587|Stroke|stroke
468757|NCT01146587|Robotics|robotics
468758|NCT01146587|Gait|gait
468759|NCT01146587|Rehabilitation|rehabilitation
468760|NCT01146574|End-Stage Renal Disease|end-stage renal disease
468761|NCT01146574|Anemia|anemia
468762|NCT01146574|Hemodialysis|hemodialysis
468763|NCT01146574|Renal Anemia|renal anemia
468764|NCT01146574|ESRD|esrd
468765|NCT01146548|Fluoxetine effect|fluoxetine effect
468766|NCT01146548|Multiple System Atrophy|multiple system atrophy
468767|NCT01146548|MSA|msa
468768|NCT01146535|interferon-alpha|interferon-alpha
468769|NCT01146535|oseltamivir|oseltamivir
468770|NCT01146535|drug therapy, combination|drug therapy, combination
468771|NCT01146535|influenza|influenza
468772|NCT01146535|therapies, investigational|therapies, investigational
468773|NCT01146522|Familial hyperchylomicronemia|familial hyperchylomicronemia
468774|NCT01146522|Lipoprotein lipase deficiency|lipoprotein lipase deficiency
468775|NCT01146522|Hyperlipoproteinemia|hyperlipoproteinemia
468776|NCT01146522|Triglycerides|triglycerides
468777|NCT01146522|Hypertriglyceridemia|hypertriglyceridemia
468778|NCT01146522|LCQ908|lcq908
468779|NCT01146522|Hyperlipoproteinemia associated with lipoprotein lipase deficiency|hyperlipoproteinemia associated with lipoprotein lipase deficiency
468780|NCT01146509|migraine|migraine
468781|NCT01146509|headache|headache
468782|NCT01146496|Pesticide poisoning|pesticide poisoning
468783|NCT01146496|Suicide|suicide
468784|NCT01146496|Unintentional poisoning|unintentional poisoning
468785|NCT01146496|Prevention|prevention
468786|NCT01146496|Cluster randomised controlled trial|cluster randomised controlled trial
468787|NCT01146457|Obstetric anesthesia|obstetric anesthesia
468788|NCT01146457|labor analgesia|labor analgesia
468789|NCT01146457|morphine|morphine
468790|NCT01146457|epidural analgesia|epidural analgesia
468791|NCT01146444|Sunscreening Agents|sunscreening agents
468792|NCT01146418|Reproductive Techniques, Assisted|reproductive techniques, assisted
468793|NCT01146418|Follicle Stimulating Hormone, Human|follicle stimulating hormone, human
468794|NCT01146418|Fertilization In Vitro|fertilization in vitro
468795|NCT01146405|Laparoscopic|laparoscopic
468796|NCT01146392|Epidemiological|epidemiological
468797|NCT01146392|COPD health care|copd health care
468798|NCT01146392|treatment in primary care|treatment in primary care
468799|NCT01146379|stroke|stroke
468800|NCT01146379|upper extremity|upper extremity
468801|NCT01146379|paresis|paresis
468802|NCT01146379|function|function
468803|NCT01146379|translational research|translational research
468804|NCT01146366|Early stage lung cancer|early stage lung cancer
468805|NCT01146366|Cervical mediastinoscopy|cervical mediastinoscopy
468806|NCT01146366|Observational study|observational study
468807|NCT01146366|clinical stage T2N0M0 and select T1N0M0 (suvMAX on FDG-PET of >/=10)|clinical stage t2n0m0 and select t1n0m0 (suvmax on fdg-pet of >/=10)
468808|NCT01146353|peramivir|peramivir
468809|NCT01146353|CVVH|cvvh
468810|NCT01146353|CRRT|crrt
468811|NCT01146353|CVVHD|cvvhd
468812|NCT01146353|influenza|influenza
468813|NCT01146353|sieving coefficient|sieving coefficient
468814|NCT01146353|clearance|clearance
468815|NCT01146340|Prostatic Neoplasms|prostatic neoplasms
468816|NCT01146340|Radiotherapy|radiotherapy
468817|NCT01146340|Hypofractionation|hypofractionation
468818|NCT01146340|Low and Intermediate Risk Prostate Cancer|low and intermediate risk prostate cancer
468819|NCT01146327|Multiple Dose Study in Overweight Healthy Subjects|multiple dose study in overweight healthy subjects
468820|NCT01146327|body weight|body weight
468821|NCT01146314|family-focused intervention|family-focused intervention
468822|NCT01146314|pediatric obesity|pediatric obesity
468823|NCT01146314|diabetes prevention|diabetes prevention
468824|NCT01146301|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
468825|NCT01146301|Coronary Artery Bypass Grafting|coronary artery bypass grafting
468826|NCT01146288|obesity|obesity
468827|NCT01146288|acetazolamide|acetazolamide
468828|NCT01146288|furosemide|furosemide
468829|NCT01146275|Patients who participated in pilot study (31GB0601) and performed breast augmentation with previous formulation of Macrolane|patients who participated in pilot study (31gb0601) and performed breast augmentation with previous formulation of macrolane
468830|NCT01146262|Antitumoral immune response after autologous dendritic cells vaccination|antitumoral immune response after autologous dendritic cells vaccination
468831|NCT01146249|Multisensorial integration|multisensorial integration
468832|NCT01146249|Postural control|postural control
468833|NCT01146249|Visual reliance|visual reliance
468834|NCT01146236|Surgical|surgical
468835|NCT01146236|Infection|infection
468836|NCT01146236|Post-operative|post-operative
468837|NCT01146236|Sutures|sutures
468838|NCT01146236|Staples|staples
468839|NCT01146197|Hypokalemia|hypokalemia
468840|NCT01146197|Hypomagnesemia|hypomagnesemia
468841|NCT01146197|Salt loosing nephropathy|salt loosing nephropathy
468842|NCT01146184|Cholelithiasis|cholelithiasis
468843|NCT01146184|Single Incision|single incision
468844|NCT01146184|Flexible Endoscope|flexible endoscope
468845|NCT01146184|Ethicon Manually Articulating Device|ethicon manually articulating device
468846|NCT01146184|Pain|pain
468847|NCT01146158|Axillary dissection|axillary dissection
468848|NCT01146145|postoperative|postoperative
468849|NCT01146145|pain|pain
468850|NCT01146145|analgesia|analgesia
468851|NCT01146145|morphine|morphine
468852|NCT01146145|titration|titration
468853|NCT01146145|ketamine|ketamine
468854|NCT01146132|Nutrition|nutrition
468855|NCT01146132|Physical activity|physical activity
468856|NCT01146132|Cerebrovascular disease|cerebrovascular disease
468857|NCT01146132|wine consumption|wine consumption
468858|NCT01146132|BMI|bmi
468859|NCT01146132|Pulse transit time|pulse transit time
468860|NCT01146132|transcranial Doppler sonography|transcranial doppler sonography
468861|NCT01146119|HAI|hai
468862|NCT01146119|Influenza|influenza
468863|NCT01146119|prime|prime
468864|NCT01146119|boost|boost
468865|NCT01146119|immune response|immune response
468866|NCT01146119|seroconversion|seroconversion
468867|NCT01146119|universal|universal
468868|NCT01146119|vaccine|vaccine
468869|NCT01146080|drug eluting stent|drug eluting stent
468870|NCT01146080|everolimus eluting stent|everolimus eluting stent
468871|NCT01146080|optical coherence tomography|optical coherence tomography
468872|NCT01146080|intravascular ultrasound|intravascular ultrasound
468873|NCT01146067|Bioequivalence|bioequivalence
468874|NCT01146041|Bioequivalence|bioequivalence
468875|NCT01146015|Influenza|influenza
468876|NCT01146015|Vaccine|vaccine
468877|NCT01146015|CHMP criteria|chmp criteria
468878|NCT01146002|Attention-deficit/hyperactivity disorder, primarily inattentive or combined type.|attention-deficit/hyperactivity disorder, primarily inattentive or combined type.
468879|NCT01145989|Relapsed or Refractory Multiple Myeloma|relapsed or refractory multiple myeloma
468880|NCT01145976|aplastic anemia, fludarabine, cyclophosphamide, thymoglobulin|aplastic anemia, fludarabine, cyclophosphamide, thymoglobulin
468881|NCT01145963|pasta|pasta
468882|NCT01145963|appetite|appetite
468883|NCT01145963|hunger|hunger
468884|NCT01145963|satiation|satiation
468885|NCT01145963|nutrition|nutrition
468886|NCT01145963|Psychological Phenomena and Processes|psychological phenomena and processes
468887|NCT01145950|Etanercept|etanercept
468888|NCT01145950|Enbrel|enbrel
468889|NCT01145950|healthy volunteers|healthy volunteers
468890|NCT01145937|Keratoconus|keratoconus
468891|NCT01145937|Corneal grafting|corneal grafting
468892|NCT01145937|Corneal transplantation|corneal transplantation
468893|NCT01145937|Anterior Lamellar Keratoplasty|anterior lamellar keratoplasty
468894|NCT01145924|bronchoscopy|bronchoscopy
468895|NCT01145924|endobronchial ultrasound|endobronchial ultrasound
468896|NCT01145924|transbronchial needle aspiration|transbronchial needle aspiration
468897|NCT01145924|lung cancer|lung cancer
468898|NCT01145924|staging|staging
468899|NCT01145911|Glaucoma|glaucoma
468900|NCT01145911|Blood Flow|blood flow
468901|NCT01145911|Progression|progression
468902|NCT01145898|Glaucoma|glaucoma
468903|NCT01145898|Cosopt|cosopt
468904|NCT01145898|blood flow|blood flow
468905|NCT01145898|progression|progression
468906|NCT01145872|Mindfulness|mindfulness
468907|NCT01145872|clinical trial|clinical trial
468908|NCT01145872|intervention|intervention
468909|NCT01145872|prevention|prevention
468910|NCT01145859|Venous Thrombosis|venous thrombosis
468911|NCT01145859|Pediatrics|pediatrics
468912|NCT01145833|obesity|obesity
468913|NCT01145833|guided self help treatment|guided self help treatment
468914|NCT01145833|treatment method|treatment method
468915|NCT01145833|overweight|overweight
468916|NCT01145833|overweight children and parents|overweight children and parents
468917|NCT01145833|families with overweight child|families with overweight child
468918|NCT01145833|efficacy|efficacy
468919|NCT01145833|body mass index|body mass index
468920|NCT01145833|weight|weight
468921|NCT01145820|third molar|third molar
468922|NCT01145820|trauma|trauma
468923|NCT01145820|pain|pain
468924|NCT01145820|wound healing|wound healing
468925|NCT01145820|post operative morbidity|post operative morbidity
468926|NCT01145820|acute trauma|acute trauma
468927|NCT01145820|short-term wound healing|short-term wound healing
468928|NCT01145807|Distal Subungual Toenail Onychomycosis|distal subungual toenail onychomycosis
468929|NCT01145794|SHS|shs
468930|NCT01145781|ectocervical CIN lesions|ectocervical cin lesions
468931|NCT01145768|Double-blind|double-blind
468932|NCT01145768|randomized|randomized
468933|NCT01145768|placebo-controlled|placebo-controlled
468934|NCT01145768|parallel-group study|parallel-group study
468935|NCT01145768|Safety|safety
468936|NCT01145768|pharmacokinetics|pharmacokinetics
468937|NCT01145755|Depression|depression
468938|NCT01145742|Type 2 diabetes|type 2 diabetes
468939|NCT01145742|Hypertension|hypertension
468940|NCT01145742|Health services research|health services research
468941|NCT01145742|Health disparities|health disparities
468942|NCT01145742|Behavior change|behavior change
468943|NCT01145729|Biomarker feedback|biomarker feedback
468944|NCT01145729|Smoking cessation|smoking cessation
468945|NCT01145729|Childhood secondhand smoke exposure|childhood secondhand smoke exposure
468946|NCT01145716|TFCC injuries|tfcc injuries
468947|NCT01145716|Distal radius fractures|distal radius fractures
468948|NCT01145703|Body Composition|body composition
468949|NCT01145703|Cardiovascular Risk|cardiovascular risk
468950|NCT01145703|Cognitive Function|cognitive function
468951|NCT01145690|cognitive behaviour therapy|cognitive behaviour therapy
468952|NCT01145677|Alcohol dependence|alcohol dependence
468953|NCT01145677|Alcoholism|alcoholism
468954|NCT01145677|Topiramate|topiramate
468955|NCT01145664|Chinese medicines|chinese medicines
468956|NCT01145664|Severe hand-foot-mouth diseases|severe hand-foot-mouth diseases
468957|NCT01145664|effectiveness|effectiveness
468958|NCT01145664|safety|safety
468959|NCT01145638|cancer|cancer
468960|NCT01145638|chemotherapy induced anaemia|chemotherapy induced anaemia
468961|NCT01145638|iron|iron
468962|NCT01145638|Patients with non-myeloid malignancies and Chemotherapy Induced Anaemia (CIA)|patients with non-myeloid malignancies and chemotherapy induced anaemia (cia)
468963|NCT01145638|CIA|cia
468964|NCT01145625|Female Pattern Baldness|female pattern baldness
468965|NCT01145612|Aortic dilation|aortic dilation
468966|NCT01145612|Marfan syndrome|marfan syndrome
468967|NCT01145612|Losartan|losartan
468968|NCT01145612|Atenolol|atenolol
468969|NCT01145573|calcium|calcium
468970|NCT01145573|vitamin D|vitamin d
468971|NCT01145573|bone|bone
468972|NCT01145573|pregnancy|pregnancy
468973|NCT01145560|severe sepsis|severe sepsis
468974|NCT01145560|TNF neutralisation|tnf neutralisation
468975|NCT01145560|septic shock patients|septic shock patients
468976|NCT01145547|glycemic index|glycemic index
468977|NCT01145547|Diabetes Mellitus|diabetes mellitus
468978|NCT01145547|continuous glucose monitoring|continuous glucose monitoring
468979|NCT01145534|diabetes,|diabetes,
468980|NCT01145534|medicinal plants,|medicinal plants,
468981|NCT01145534|glucose|glucose
468982|NCT01145482|Memory Disorders|memory disorders
468983|NCT01145482|Alzheimer's Disease|alzheimer's disease
468984|NCT01145469|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
468985|NCT01145469|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
468986|NCT01145469|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
468987|NCT01145469|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
468988|NCT01145469|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
468989|NCT01145443|Organizational models|organizational models
468990|NCT01145443|Intensive care units|intensive care units
468991|NCT01145443|Physicians|physicians
468992|NCT01145443|Staffing and scheduling|staffing and scheduling
468993|NCT01145443|Burnout, professional|burnout, professional
468994|NCT01145443|Job satisfaction|job satisfaction
468995|NCT01145417|peripheral neuropathic pain|peripheral neuropathic pain
468996|NCT01145417|pregabalin|pregabalin
468997|NCT01145417|safety|safety
468998|NCT01145404|Her2 Gastro Gastric Esophageal Cancer|her2 gastro gastric esophageal cancer
468999|NCT01145391|hypertension|hypertension
469000|NCT01145391|blood pressure|blood pressure
469001|NCT01145391|primary care|primary care
469002|NCT01145391|patient centered medical home|patient centered medical home
469003|NCT01145391|health information technology|health information technology
469004|NCT01145391|clinical inertia|clinical inertia
469005|NCT01145365|Crohns|crohns
469006|NCT01145365|Fistula|fistula
469007|NCT01145365|Perianal Abscess|perianal abscess
469008|NCT01145365|Perianal|perianal
469009|NCT01145352|Enbrel-JIA|enbrel-jia
469010|NCT01145326|venipuncture|venipuncture
469011|NCT01145326|phlebotomy|phlebotomy
469012|NCT01145326|pain perception|pain perception
469013|NCT01145300|COPD|copd
469014|NCT01145300|Inflammation|inflammation
469015|NCT01145300|Small airways|small airways
469016|NCT01145287|Celiac disease|celiac disease
469017|NCT01145287|Gluten-free diet|gluten-free diet
469018|NCT01145287|Screen-detected|screen-detected
469019|NCT01145287|Asymptomatic|asymptomatic
469020|NCT01145287|Quality of life|quality of life
469021|NCT01145287|Self-perceived health|self-perceived health
469022|NCT01145287|Healthcare resource utilization|healthcare resource utilization
469023|NCT01145274|allopurinol|allopurinol
469024|NCT01145274|chronic kidney diseae|chronic kidney diseae
469025|NCT01145261|Anxiety,|anxiety,
469026|NCT01145261|Emotional Regulation|emotional regulation
469027|NCT01145248|Cholangiocellular Carcinoma|cholangiocellular carcinoma
469028|NCT01145235|Breast augmentation with Macrolane|breast augmentation with macrolane
469029|NCT01145222|CNS 7056|cns 7056
469030|NCT01145222|Procedural Sedation|procedural sedation
469031|NCT01145222|Colonoscopy|colonoscopy
469032|NCT01145209|Arzerra|arzerra
469033|NCT01145209|Chemoimmunotherapy|chemoimmunotherapy
469034|NCT01145209|CLL (Chronic Lymphocytic Leukemia)|cll (chronic lymphocytic leukemia)
469035|NCT01145209|SLL|sll
469036|NCT01145209|Small Lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
469037|NCT01145196|Retinal Disease|retinal disease
469038|NCT01145196|Plaquenil-Induced|plaquenil-induced
469039|NCT01145183|Cocaine Dependence|cocaine dependence
469040|NCT01145183|Substance Related Disorders|substance related disorders
469041|NCT01145183|genotype|genotype
469042|NCT01145170|brainstem gliomas|brainstem gliomas
469043|NCT01145170|pediatric patients|pediatric patients
469044|NCT01145157|knee|knee
469045|NCT01145157|arthroplasty|arthroplasty
469046|NCT01145144|Dehydroepiandrosterone|dehydroepiandrosterone
469047|NCT01145144|DHEA|dhea
469048|NCT01145144|IVF outcome|ivf outcome
469049|NCT01145144|long protocol IVF|long protocol ivf
469050|NCT01145144|poor-responder|poor-responder
469051|NCT01145144|recombinant LH|recombinant lh
469052|NCT01145144|embryo quality|embryo quality
469053|NCT01145144|pregnancy rate|pregnancy rate
469054|NCT01145144|live birth rate|live birth rate
469055|NCT01145144|poor response to ovarian stimulation|poor response to ovarian stimulation
469056|NCT01145131|muscle|muscle
469057|NCT01145131|FSR|fsr
469058|NCT01145131|protein|protein
469059|NCT01145131|meat|meat
469060|NCT01145118|Plantar Fasciitis|plantar fasciitis
469061|NCT01145118|Physiotherapy|physiotherapy
469062|NCT01145105|Low back pain|low back pain
469063|NCT01145105|Sciatica|sciatica
469064|NCT01145105|Pain|pain
469065|NCT01145105|Physiotherapy|physiotherapy
469066|NCT01145092|type 2 diabetes|type 2 diabetes
469067|NCT01145092|exercise training|exercise training
469068|NCT01145092|ATP-synthesis|atp-synthesis
469069|NCT01145092|intramyocellular lipids|intramyocellular lipids
469070|NCT01145092|hepatocellular lipids|hepatocellular lipids
469071|NCT01145092|first degree relatives of T2DM patients|first degree relatives of t2dm patients
469072|NCT01145066|diabetes|diabetes
469073|NCT01145066|metabolic syndrome|metabolic syndrome
469074|NCT01145066|inflammation|inflammation
469075|NCT01145066|botanical oils|botanical oils
469076|NCT01145040|Overt primary hypothyroidism|overt primary hypothyroidism
469077|NCT01145040|Overt primary hyperthyroidism|overt primary hyperthyroidism
469078|NCT01145040|Thyrotropic feedback control|thyrotropic feedback control
469079|NCT01145040|Mathematical modelling|mathematical modelling
469080|NCT01145040|Nonlinear modelling|nonlinear modelling
469081|NCT01145040|Thyroid|thyroid
469082|NCT01145040|Pituitary|pituitary
469083|NCT01145040|Physiological cybernetics|physiological cybernetics
469084|NCT01145040|Full-dose levothyroxine substitution therapy|full-dose levothyroxine substitution therapy
469085|NCT01145040|Syndrome T|syndrome t
469086|NCT01145027|Capillary recruitment|capillary recruitment
469087|NCT01145027|Cephalic Phase of Insulin Secretion|cephalic phase of insulin secretion
469088|NCT01145027|Dietary Intake|dietary intake
469089|NCT01145001|smoking|smoking
469090|NCT01145001|adolescents|adolescents
469091|NCT01145001|contingency management|contingency management
469092|NCT01145001|nicotine replacement therapy|nicotine replacement therapy
469093|NCT01144988|Recurrent Malignant Glioma|recurrent malignant glioma
469094|NCT01144988|Bevacizumab / Irinotecan|bevacizumab / irinotecan
469095|NCT01144988|Functional MR Imaging|functional mr imaging
469096|NCT01144988|Metabolic Imaging (FET/FLT-PET)|metabolic imaging (fet/flt-pet)
469097|NCT01144975|Diabetes|diabetes
469098|NCT01144975|Type 2|type 2
469099|NCT01144975|Mellitus|mellitus
469100|NCT01144962|Crohn's Disease|crohn's disease
469101|NCT01144962|Fistula|fistula
469102|NCT01144962|Mesenchymal Stem Cell|mesenchymal stem cell
469103|NCT01144962|Mesenchymal Stromal Cell|mesenchymal stromal cell
469104|NCT01144962|MSC|msc
469105|NCT01144962|IBD|ibd
469106|NCT01144949|ureteral calculi|ureteral calculi
469107|NCT01144949|renal colic|renal colic
469108|NCT01144949|ureteral stones|ureteral stones
469109|NCT01144949|kidney stones|kidney stones
469110|NCT01144949|medical expulsive therapy|medical expulsive therapy
469111|NCT01144923|epidural steroid injection|epidural steroid injection
469112|NCT01144923|neck pain|neck pain
469113|NCT01144923|pharmacotherapy|pharmacotherapy
469114|NCT01144923|radiculopathy|radiculopathy
469115|NCT01144910|asthma|asthma
469116|NCT01144910|preschool child|preschool child
469117|NCT01144910|bronchial hyperresponsiveness|bronchial hyperresponsiveness
469118|NCT01144910|methacholine challenge test|methacholine challenge test
469119|NCT01144910|atopy|atopy
469120|NCT01144897|Castrate resistant|castrate resistant
469121|NCT01144897|Prostate cancer|prostate cancer
469122|NCT01144897|Docetaxel|docetaxel
469123|NCT01144897|Taxotere|taxotere
469124|NCT01144897|PET Acetate|pet acetate
469125|NCT01144884|Neck pain|neck pain
469126|NCT01144884|education|education
469127|NCT01144884|exercise|exercise
469128|NCT01144884|clinical prediction rule|clinical prediction rule
469129|NCT01144871|adolescent|adolescent
469130|NCT01144871|reproductive health|reproductive health
469131|NCT01144871|parents|parents
469132|NCT01144871|STIs|stis
469133|NCT01144871|confidentiality|confidentiality
469134|NCT01144871|Examine parental knowledge/attitudes of confidential health services/STI care for adolescents.|examine parental knowledge/attitudes of confidential health services/sti care for adolescents.
469135|NCT01144871|Examine how parental knowledge/attitudes affects parent's behavioral intentions to support adolescent's access to confidential care.|examine how parental knowledge/attitudes affects parent's behavioral intentions to support adolescent's access to confidential care.
469136|NCT01144871|Identify key mechanisms to form an intervention to parents knowledge/skills to facilitate teen's access to confidential STI services.|identify key mechanisms to form an intervention to parents knowledge/skills to facilitate teen's access to confidential sti services.
469137|NCT01144858|atrial fibrillation|atrial fibrillation
469138|NCT01144858|ablation catheter|ablation catheter
469139|NCT01144858|left atrial appendage peak emptying velocity|left atrial appendage peak emptying velocity
469140|NCT01144858|tool for predicting successful catheter ablation|tool for predicting successful catheter ablation
469141|NCT01144845|Thoracotomy|thoracotomy
469142|NCT01144845|Thoracic Surgery|thoracic surgery
469143|NCT01144845|Thoracic Surgical Procedures|thoracic surgical procedures
469144|NCT01144845|Thoracic Surgery, Video-Assisted|thoracic surgery, video-assisted
469145|NCT01144845|Lung Neoplasms|lung neoplasms
469146|NCT01144845|Thoracic Nerves|thoracic nerves
469147|NCT01144832|visceral hypersensitivity|visceral hypersensitivity
469148|NCT01144832|mast cells|mast cells
469149|NCT01144819|STEMI|stemi
469150|NCT01144819|Acute myocardial infarction|acute myocardial infarction
469151|NCT01144819|Antiplatelet therapy|antiplatelet therapy
469152|NCT01144819|aspirin|aspirin
469153|NCT01144819|clopidogrel|clopidogrel
469154|NCT01144819|VerifyNow aggregometry|verifynow aggregometry
469155|NCT01144819|Multiplate aggregometry|multiplate aggregometry
469156|NCT01144806|SAM|sam
469157|NCT01144806|RUTF|rutf
469158|NCT01144806|BIA|bia
469159|NCT01144806|D2O|d2o
469160|NCT01144806|Children with severe malnutrition|children with severe malnutrition
469161|NCT01144741|rehabilitation|rehabilitation
469162|NCT01144741|surgery|surgery
469163|NCT01144741|therapy|therapy
469164|NCT01144741|Quality Of Life|quality of life
469165|NCT01144741|Health-Related Quality Of Life|health-related quality of life
469166|NCT01144741|Health Status|health status
469167|NCT01144741|Depressive Symptoms|depressive symptoms
469168|NCT01144741|Situational Depression|situational depression
469169|NCT01144715|Stroke Rehabilitation|stroke rehabilitation
469170|NCT01144715|Home rehabilitation|home rehabilitation
469171|NCT01144715|robotic therapy|robotic therapy
469172|NCT01144702|malaria|malaria
469173|NCT01144702|Plasmodium falciparum|plasmodium falciparum
469174|NCT01144702|artesunate and mefloquine combination (ASMQ)|artesunate and mefloquine combination (asmq)
469175|NCT01144702|treatment|treatment
469176|NCT01144702|Juruá Valley|juruá valley
469177|NCT01144702|Brazil|brazil
469178|NCT01144702|multidrug resistance 1 gene of Plasmodium falciparum -Pfmdr1|multidrug resistance 1 gene of plasmodium falciparum -pfmdr1
469179|NCT01144689|mindfulness|mindfulness
469180|NCT01144689|smoking|smoking
469181|NCT01144689|stress|stress
469182|NCT01144663|Infants|infants
469183|NCT01144663|conjugate vaccine|conjugate vaccine
469184|NCT01144663|immunogenicity|immunogenicity
469185|NCT01144663|meningococcal vaccine|meningococcal vaccine
469186|NCT01144663|non-inferiority|non-inferiority
469187|NCT01144663|co-administration|co-administration
469188|NCT01144650|Dapsone|dapsone
469189|NCT01144650|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
469190|NCT01144650|Neuroprotection|neuroprotection
469191|NCT01144624|TNF neutralisation|tnf neutralisation
469192|NCT01144611|valve replacement|valve replacement
469193|NCT01144611|CABG|cabg
469194|NCT01144611|SIRTS|sirts
469195|NCT01144611|Combined aortic valve replacement and CABG surgery|combined aortic valve replacement and cabg surgery
469196|NCT01144598|Rheumatoid Arthritis|rheumatoid arthritis
469197|NCT01144598|Disease-Modifying Anti-Rheumatic Drug|disease-modifying anti-rheumatic drug
469198|NCT01144598|Work Limitation|work limitation
469199|NCT01144585|RIPC|ripc
469200|NCT01144585|lung protection|lung protection
469201|NCT01144585|ischemic reperfusion injury|ischemic reperfusion injury
469202|NCT01144585|cardiopulmonary bypass|cardiopulmonary bypass
469203|NCT01144572|Quality of Life|quality of life
469204|NCT01144572|postmenopausal HR(+)|postmenopausal hr(+)
469205|NCT01144572|Early Breast Cancer|early breast cancer
469206|NCT01144572|adjuvant AI treatment|adjuvant ai treatment
469207|NCT01144572|Quality of Life in Chinese postmenopausal HR(+) EBC patients during adjuvant Aromatase Inhibitors(AIs) treatment|quality of life in chinese postmenopausal hr(+) ebc patients during adjuvant aromatase inhibitors(ais) treatment
469208|NCT01144559|Femoral|femoral
469209|NCT01144559|Nerve Block|nerve block
469210|NCT01144559|Bolus|bolus
469211|NCT01144559|Continuous Infusion|continuous infusion
469212|NCT01144559|UCSD|ucsd
469213|NCT01144559|Perineural Catheter|perineural catheter
469214|NCT01144559|Volunteer|volunteer
469215|NCT01144559|lower extremity nerve blocks|lower extremity nerve blocks
469216|NCT01144546|Passive leg raising|passive leg raising
469217|NCT01144546|FloTrac/Vigileo|flotrac/vigileo
469218|NCT01144546|Anesthesia hypotension|anesthesia hypotension
469219|NCT01144507|Cystic Fibrosis|cystic fibrosis
469220|NCT01144507|Pancreatic insufficiency|pancreatic insufficiency
469221|NCT01144494|Aqueous Humor Dynamics|aqueous humor dynamics
469222|NCT01144494|Aqueous Humor Dynamics and Circadian Rhythms|aqueous humor dynamics and circadian rhythms
469223|NCT01144481|bone metastasis|bone metastasis
469224|NCT01144481|breast cancer|breast cancer
469225|NCT01144481|skeletal related event|skeletal related event
469226|NCT01144481|HR-pQCT|hr-pqct
469227|NCT01144481|VFA|vfa
469228|NCT01144468|breast cancer prevention|breast cancer prevention
469229|NCT01144468|osteoporosis|osteoporosis
469230|NCT01144455|Locally Advanced Unresectable Pancreatic Adenocarcinoma|locally advanced unresectable pancreatic adenocarcinoma
469231|NCT01144455|Metastatic Pancreatic Adenocarcinoma|metastatic pancreatic adenocarcinoma
470105|NCT01140958|new agents|new agents
469232|NCT01144455|Locally Advanced Unresectable or Metastatic Pancreatic Adenocarcinoma|locally advanced unresectable or metastatic pancreatic adenocarcinoma
469233|NCT01144442|recurrent ovarian cancer|recurrent ovarian cancer
469234|NCT01144442|recurrent fallopian tube cancer|recurrent fallopian tube cancer
469235|NCT01144442|recurrent peritoneal carcinoma|recurrent peritoneal carcinoma
469236|NCT01144429|Allergic Rhinitis +- intermittent asthma|allergic rhinitis +- intermittent asthma
469237|NCT01144429|Allergic Rhinoconjunctivitis +- intermittent asthma|allergic rhinoconjunctivitis +- intermittent asthma
469238|NCT01144429|Specific Immunotherapy|specific immunotherapy
469239|NCT01144416|Reproductive Techniques, Assisted|reproductive techniques, assisted
469240|NCT01144416|Follicle Stimulating Hormone, Human|follicle stimulating hormone, human
469241|NCT01144416|Fertilization In Vitro|fertilization in vitro
469242|NCT01144390|heroin dependence|heroin dependence
469243|NCT01144390|community-based|community-based
469244|NCT01144390|MMT|mmt
469245|NCT01144377|osteoporosis|osteoporosis
469246|NCT01144351|MS|ms
469247|NCT01144351|SPMS|spms
469248|NCT01144351|RRMS|rrms
469249|NCT01144351|Relapsing Forms of Secondary Progressive Multiple Sclerosis (SPMS)|relapsing forms of secondary progressive multiple sclerosis (spms)
469250|NCT01144351|or Relapsing-Remitting Multiple Sclerosis (RRMS)|or relapsing-remitting multiple sclerosis (rrms)
469251|NCT01144338|exenatide once weekly|exenatide once weekly
469252|NCT01144338|cardiovascular|cardiovascular
469253|NCT01144338|Bydureon|bydureon
469254|NCT01144338|Amylin|amylin
469255|NCT01144325|Minimally Invasive Esophagectomy|minimally invasive esophagectomy
469256|NCT01144312|LDLT|ldlt
469257|NCT01144299|Influenza|influenza
469258|NCT01144286|VVC|vvc
469259|NCT01144286|candidiasis|candidiasis
469260|NCT01144286|vaginal candidiasis|vaginal candidiasis
469261|NCT01144260|CLL|cll
469262|NCT01144260|leukemia|leukemia
469263|NCT01144260|chronic lymphocytic leukemia|chronic lymphocytic leukemia
469264|NCT01144247|Recurrent Grade III or Grade IV Gliomas|recurrent grade iii or grade iv gliomas
469265|NCT01144247|anaplastic astrocytoma|anaplastic astrocytoma
469266|NCT01144247|anaplastic oligodendroglioma|anaplastic oligodendroglioma
469267|NCT01144247|anaplastic mixed glioma|anaplastic mixed glioma
469268|NCT01144247|glioblastoma multiforme|glioblastoma multiforme
469269|NCT01144247|biotherapy|biotherapy
469270|NCT01144247|malignant meningioma|malignant meningioma
469271|NCT01144234|Prevention of mother-to-child transmission of HIV-1|prevention of mother-to-child transmission of hiv-1
469272|NCT01144221|Chronic Ischemic Heart Disease|chronic ischemic heart disease
469273|NCT01144208|Radius fracture|radius fracture
469274|NCT01144208|Adverse effects|adverse effects
469275|NCT01144208|Wrist|wrist
469276|NCT01144208|Postoperative complications|postoperative complications
469277|NCT01144208|Colles' fracture|colles' fracture
469278|NCT01144208|Intraoperative complications|intraoperative complications
469279|NCT01144208|Osteoporosis|osteoporosis
469280|NCT01144208|Dual-energy x-ray absorptiometry (DXA)|dual-energy x-ray absorptiometry (dxa)
469281|NCT01144208|Bone Density|bone density
469282|NCT01144182|heart failure|heart failure
469283|NCT01144182|quality of life|quality of life
469284|NCT01144182|readmissions|readmissions
469285|NCT01144169|Renal cell carcinoma|renal cell carcinoma
469286|NCT01144169|Hydroxychloroquine|hydroxychloroquine
469287|NCT01144169|Nephrectomy|nephrectomy
469288|NCT01144169|Autophagy|autophagy
469289|NCT01144156|Crohn's disease|crohn's disease
469290|NCT01144156|Small bowel|small bowel
469291|NCT01144156|Mucosal healing|mucosal healing
469292|NCT01144156|Capsule endoscopy|capsule endoscopy
469293|NCT01144156|Adalimumab|adalimumab
469294|NCT01144156|Small bowel Crohn's disease|small bowel crohn's disease
469295|NCT01144143|Mild to moderate osteoarthritis of the knee|mild to moderate osteoarthritis of the knee
469296|NCT01144117|Progressive Multiple Sclerosis|progressive multiple sclerosis
469297|NCT01144091|diabetes mellitus|diabetes mellitus
469298|NCT01144091|creatinin level|creatinin level
469299|NCT01144091|contrast induced nephropathy|contrast induced nephropathy
469300|NCT01144091|prevention contrast induced nephropathy in high risk patients|prevention contrast induced nephropathy in high risk patients
469301|NCT01144078|Adiposity|adiposity
469302|NCT01144078|Exercise training|exercise training
469303|NCT01144078|Older adults|older adults
469304|NCT01144065|Myocardial infarction|myocardial infarction
469305|NCT01144065|Cortisol|cortisol
469306|NCT01144065|Testosterone|testosterone
469307|NCT01144052|Natalizumab|natalizumab
469308|NCT01144052|Interferon-beta 1b|interferon-beta 1b
469309|NCT01144052|De-escalation|de-escalation
469310|NCT01144052|Ticino|ticino
469311|NCT01144026|HIV|hiv
469312|NCT01144026|vaccine|vaccine
469313|NCT01144026|lipopeptide|lipopeptide
469314|NCT01144026|Tat|tat
469315|NCT01144026|TUTI-16|tuti-16
469316|NCT01144026|THYMON|thymon
469317|NCT01144000|Prosthetic joint infection|prosthetic joint infection
469318|NCT01144000|daptomycin|daptomycin
469319|NCT01144000|staphylococcus|staphylococcus
469320|NCT01143987|hyperparathyroidism|hyperparathyroidism
469321|NCT01143987|pulse wave velocity|pulse wave velocity
469322|NCT01143987|end-stage renal disease|end-stage renal disease
469323|NCT01143987|arterial stiffness|arterial stiffness
469324|NCT01143974|progress free survival|progress free survival
469325|NCT01143974|response rate|response rate
469326|NCT01143974|safety|safety
469327|NCT01143961|Positive pressure ventilation|positive pressure ventilation
469328|NCT01143961|Electrical impedance tomography|electrical impedance tomography
469329|NCT01143948|Diabetes|diabetes
469330|NCT01143948|Cirrhosis|cirrhosis
469331|NCT01143948|Insulin|insulin
469332|NCT01143948|Inpatient|inpatient
469333|NCT01143935|Liver volume estimation|liver volume estimation
469334|NCT01143935|Indian population|indian population
469335|NCT01143922|Intraoperative ultrasound|intraoperative ultrasound
469336|NCT01143922|GI tract malignancies|gi tract malignancies
469337|NCT01143922|modality|modality
469338|NCT01143922|ultrasound|ultrasound
469339|NCT01143922|staging modality|staging modality
469340|NCT01143909|Fresh frozen plasma|fresh frozen plasma
469341|NCT01143909|Coagulopathy|coagulopathy
469342|NCT01143909|Intensive care|intensive care
469343|NCT01143909|Adverse effects|adverse effects
469344|NCT01143909|Lung injury|lung injury
469345|NCT01143896|Hepatitis C|hepatitis c
469346|NCT01143896|Depression|depression
469347|NCT01143896|Collaborative care|collaborative care
469348|NCT01143896|Antiviral treatment|antiviral treatment
469349|NCT01143883|All patients undergoing a colorectal resection|all patients undergoing a colorectal resection
469350|NCT01143883|surgical site infections|surgical site infections
469351|NCT01143844|Oncofertility|oncofertility
469352|NCT01143844|Fertility|fertility
469353|NCT01143844|Late effects|late effects
469354|NCT01143844|cancer|cancer
469355|NCT01143844|chemotherapy|chemotherapy
469356|NCT01143844|radiation therapy|radiation therapy
469357|NCT01143844|survivor|survivor
469358|NCT01143844|ovarian reserve|ovarian reserve
469359|NCT01143844|premature ovarian failure|premature ovarian failure
469360|NCT01143844|early menopause|early menopause
469361|NCT01143844|healthy volunteers|healthy volunteers
469362|NCT01143844|perimenopause|perimenopause
469363|NCT01143844|middle age|middle age
469364|NCT01143844|pediatric survivors|pediatric survivors
469365|NCT01143844|healthy women|healthy women
469366|NCT01143831|Vitamin K|vitamin k
469367|NCT01143831|Thrombosis|thrombosis
469368|NCT01143818|Male hypogonadism|male hypogonadism
469369|NCT01143805|Absolute Bioavailability|absolute bioavailability
469370|NCT01143805|Rheumatoid Arthritis|rheumatoid arthritis
469371|NCT01143792|Substance abuse|substance abuse
469372|NCT01143792|Homelessness|homelessness
469373|NCT01143792|HIV risk behavior|hiv risk behavior
469374|NCT01143779|Advanced Malignancy|advanced malignancy
469375|NCT01143779|FLT-PET Scan|flt-pet scan
469376|NCT01143779|[F-18]-fluoro-L-thymidine|[f-18]-fluoro-l-thymidine
469377|NCT01143779|FLT|flt
469378|NCT01143779|Positron emission tomography|positron emission tomography
469379|NCT01143779|PET|pet
469380|NCT01143779|Imaging Biomarker|imaging biomarker
469381|NCT01143779|Temsirolimus|temsirolimus
469382|NCT01143779|Topotecan|topotecan
469383|NCT01143779|Bortezomib|bortezomib
469384|NCT01143766|Sedation|sedation
469385|NCT01143766|Gabapentin|gabapentin
469386|NCT01143766|ERCP|ercp
469387|NCT01143766|Endoscopy|endoscopy
469388|NCT01143675|Humerus fractures|humerus fractures
469389|NCT01143675|Tomography, x-ray computed|tomography, x-ray computed
469390|NCT01143675|Bone and bones|bone and bones
469391|NCT01143675|Orthopedic fixation devices|orthopedic fixation devices
469392|NCT01143675|Surgery|surgery
469393|NCT01143675|Postoperative complications|postoperative complications
469394|NCT01143675|Osteoporosis|osteoporosis
469395|NCT01143675|Intraoperative complications|intraoperative complications
469396|NCT01143675|Bone density|bone density
469397|NCT01143675|Radiography, dual-energy scanned projection|radiography, dual-energy scanned projection
469398|NCT01143662|peginterferon|peginterferon
469399|NCT01143662|interferon|interferon
469400|NCT01143662|Pegasys|pegasys
469401|NCT01143662|HBV|hbv
469402|NCT01143662|Hepatitis B|hepatitis b
469403|NCT01143662|HBeAg positive|hbeag positive
469404|NCT01143649|Stroke|stroke
469405|NCT01143649|Transcranial direct current stimulation|transcranial direct current stimulation
469406|NCT01143649|Motor function|motor function
469407|NCT01143636|Transcranial direct current stimulation|transcranial direct current stimulation
469408|NCT01143636|Chronic Pelvic Pain|chronic pelvic pain
469409|NCT01143623|antibiotic|antibiotic
469410|NCT01143623|diarrhea|diarrhea
469411|NCT01143623|probiotic|probiotic
469412|NCT01143610|Root coverage|root coverage
469413|NCT01143610|Graft|graft
469414|NCT01143610|Soft tissue|soft tissue
469415|NCT01143610|Periodontal regeneration|periodontal regeneration
469416|NCT01143597|task-specific training|task-specific training
469417|NCT01143597|arm and hand function|arm and hand function
469418|NCT01143597|corticomotor plasticity|corticomotor plasticity
469419|NCT01143597|individuals with motor-incomplete spinal cord injury|individuals with motor-incomplete spinal cord injury
469420|NCT01143584|Prolactin|prolactin
469421|NCT01143584|Cabergoline|cabergoline
469422|NCT01143584|Macroadenomas|macroadenomas
469423|NCT01143584|escalation|escalation
469424|NCT01143571|Microbiome|microbiome
469425|NCT01143571|Samples|samples
470106|NCT01140932|Retina|retina
469426|NCT01143558|Borrelia Burgdorferi|borrelia burgdorferi
469427|NCT01143558|Xenodiagnosis|xenodiagnosis
469428|NCT01143558|Ticks|ticks
469429|NCT01143558|Skin Biopsy|skin biopsy
469430|NCT01143558|Lyme Disease|lyme disease
469431|NCT01143545|Cancer Vaccine|cancer vaccine
469432|NCT01143545|Immunotherapy|immunotherapy
469433|NCT01143545|Adjuvant Therapy|adjuvant therapy
469434|NCT01143545|Surgical Intervention|surgical intervention
469435|NCT01143545|Lung Cancer|lung cancer
469436|NCT01143545|Esophageal Cancer|esophageal cancer
469437|NCT01143545|Thymic Carcinoma|thymic carcinoma
469438|NCT01143545|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
469439|NCT01143532|African-Americans|african-americans
469440|NCT01143532|MYH9|myh9
469441|NCT01143532|Chronic Kidney Disease|chronic kidney disease
469442|NCT01143532|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
469443|NCT01143532|Proteinuria|proteinuria
469444|NCT01143532|Kidney Disease|kidney disease
469445|NCT01143532|Kidney Transplant|kidney transplant
469446|NCT01143532|African-American|african-american
469447|NCT01143519|p53|p53
469448|NCT01143519|Inflammatory Response|inflammatory response
469449|NCT01143519|Gene Association|gene association
469450|NCT01143519|Nutlin|nutlin
469451|NCT01143519|Doxorubicin|doxorubicin
469452|NCT01143519|Healthy Volunteer|healthy volunteer
469453|NCT01143519|HV|hv
469454|NCT01143506|Sense of Agency|sense of agency
469455|NCT01143506|Ulnar Nerve Block|ulnar nerve block
469456|NCT01143506|Healthy Volunteer|healthy volunteer
469457|NCT01143506|fMRI|fmri
469458|NCT01143506|EEG|eeg
469459|NCT01143493|Genetic Polymorphism|genetic polymorphism
469460|NCT01143493|Glucocorticoid|glucocorticoid
469461|NCT01143493|Health Volunteer|health volunteer
469462|NCT01143493|HV|hv
469463|NCT01143480|Endotoxin|endotoxin
469464|NCT01143480|Cytokines|cytokines
469465|NCT01143480|Gene Association|gene association
469466|NCT01143480|Inflammatory Response|inflammatory response
469467|NCT01143480|Healthy Volunteer|healthy volunteer
469468|NCT01143480|HV|hv
469469|NCT01143467|Fatigue|fatigue
469470|NCT01143467|Mitochondria|mitochondria
469471|NCT01143467|Mitochondrial Abnormality|mitochondrial abnormality
469472|NCT01143467|Oxidative Stress|oxidative stress
469473|NCT01143467|Gene Expression|gene expression
469474|NCT01143467|Prostate Cancer|prostate cancer
469475|NCT01143454|Cardiac Disease|cardiac disease
469476|NCT01143454|iPS Cells|ips cells
469477|NCT01143454|Cardiac Risk Factors|cardiac risk factors
469478|NCT01143454|Cardiac Disease Discovery|cardiac disease discovery
469479|NCT01143454|Heart Disease|heart disease
469480|NCT01143454|Heart Disease Risk|heart disease risk
469481|NCT01143441|Multiple Sclerosis|multiple sclerosis
469482|NCT01143441|Daclizumab|daclizumab
469483|NCT01143428|Motor Neuron Disease|motor neuron disease
469484|NCT01143428|Primary Lateral Sclerosis|primary lateral sclerosis
469485|NCT01143428|Oxidative Stress|oxidative stress
469486|NCT01143428|Physiology|physiology
469487|NCT01143428|PLS|pls
469488|NCT01143389|Keratoconus|keratoconus
469489|NCT01143389|Ectasia|ectasia
469490|NCT01143389|cross linking|cross linking
469491|NCT01143389|collagen cross linking|collagen cross linking
469492|NCT01143376|Obesity|obesity
469493|NCT01143376|exercise|exercise
469494|NCT01143376|body composition|body composition
469495|NCT01143376|insulin sensitivity|insulin sensitivity
469496|NCT01143376|appetite|appetite
469497|NCT01143376|food intake|food intake
469498|NCT01143363|Obesity|obesity
469499|NCT01143363|exercise|exercise
469500|NCT01143363|appetite|appetite
469501|NCT01143363|hunger|hunger
469502|NCT01143363|satiety|satiety
469503|NCT01143363|food intake|food intake
469504|NCT01143337|Rheumatoid Arthritis|rheumatoid arthritis
469505|NCT01143324|Single or double level instrumented fusion|single or double level instrumented fusion
469506|NCT01143324|Degenerative lumbar spine|degenerative lumbar spine
469507|NCT01143324|PLIF|plif
469508|NCT01143324|TLIF|tlif
469509|NCT01143324|MAST procedure|mast procedure
469510|NCT01143285|Active nutritional and dietary management|active nutritional and dietary management
469511|NCT01143285|Metastatic colorectal cancer|metastatic colorectal cancer
469512|NCT01143285|Non surgical metastatic colorectal cancer|non surgical metastatic colorectal cancer
469513|NCT01143272|antibiotic|antibiotic
469514|NCT01143272|associated|associated
469515|NCT01143272|diarrhoea|diarrhoea
469516|NCT01143272|saccharomyces boulardii|saccharomyces boulardii
469517|NCT01143272|Antibiotic-associated diarrhoea (AAD)|antibiotic-associated diarrhoea (aad)
469518|NCT01143272|Clostridium difficile-associated-diarrhoea (CDAD)|clostridium difficile-associated-diarrhoea (cdad)
469519|NCT01143259|Ileus|ileus
469520|NCT01143259|Post operative ileus|post operative ileus
469521|NCT01143246|Hepatorenal syndrome|hepatorenal syndrome
469522|NCT01143246|Renal failure|renal failure
469523|NCT01143246|Cirrhosis|cirrhosis
469524|NCT01143246|Alcoholic hepatitis|alcoholic hepatitis
469525|NCT01143246|Ascites|ascites
469526|NCT01143220|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
469527|NCT01143220|Heart Failure|heart failure
469528|NCT01143220|Pathologic Processes|pathologic processes
469529|NCT01143220|Heart Diseases|heart diseases
469530|NCT01143220|Tachycardia|tachycardia
469531|NCT01143220|Cardiovascular Diseases|cardiovascular diseases
469532|NCT01143220|Ventricular Flutter|ventricular flutter
469533|NCT01143220|Tachycardia, Ventricular|tachycardia, ventricular
469534|NCT01143220|Ventricular Fibrillation|ventricular fibrillation
469535|NCT01143220|Arrhythmias, Cardiac|arrhythmias, cardiac
469536|NCT01143220|Ease of Use|ease of use
469537|NCT01143207|AE adverse event|ae adverse event
469538|NCT01143207|DCF data collection forms|dcf data collection forms
469539|NCT01143207|DMC Data Monitoring Committee|dmc data monitoring committee
469540|NCT01143207|FDA U.S.) Food and Drug Administration|fda u.s.) food and drug administration
469541|NCT01143207|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
469542|NCT01143207|ICH International Conference of Harmonisation|ich international conference of harmonisation
469543|NCT01143207|IND Investigational New Drug Application|ind investigational new drug application
469544|NCT01143207|IRB Institutional Review Board|irb institutional review board
469545|NCT01143207|IU International units|iu international units
469546|NCT01143207|mg milligram(s)|mg milligram(s)
469547|NCT01143207|SAE serious adverse event|sae serious adverse event
469548|NCT01143207|µg microgram|µg microgram
469549|NCT01143207|ULN upper limit of the normal range|uln upper limit of the normal range
469550|NCT01143194|Attention|attention
469551|NCT01143194|Vigilance|vigilance
469552|NCT01143194|Concentration|concentration
469553|NCT01143194|Memory|memory
469554|NCT01143194|Healthy Volunteer|healthy volunteer
469555|NCT01143181|CMV, ADV, HSV, VAVC, VARV|cmv, adv, hsv, vavc, varv
469556|NCT01143181|life threatening|life threatening
469557|NCT01143168|stem cells;|stem cells;
469558|NCT01143168|diabetes mellitus;|diabetes mellitus;
469559|NCT01143168|treatment.|treatment.
469560|NCT01143155|Pneumonia|pneumonia
469561|NCT01143155|Community-acquired pneumonia|community-acquired pneumonia
469562|NCT01143155|Healthcare-associated pneumonia|healthcare-associated pneumonia
469563|NCT01143155|Failure|failure
469564|NCT01143155|Cardiovascular events|cardiovascular events
469565|NCT01143155|Outcome|outcome
469566|NCT01143142|Human papillomavirus|human papillomavirus
469567|NCT01143142|HPV|hpv
469568|NCT01143142|Prevention|prevention
469569|NCT01143142|Tailoring|tailoring
469570|NCT01143142|Persuasive communication|persuasive communication
469571|NCT01143142|Adolescent|adolescent
469572|NCT01143129|Atrial fibrillation|atrial fibrillation
469573|NCT01143129|Cardiac surgery|cardiac surgery
469574|NCT01143129|Cardiopulmonary bypass|cardiopulmonary bypass
469575|NCT01143129|New-onset|new-onset
469576|NCT01143103|Respiratory therapy in neurologic disorder|respiratory therapy in neurologic disorder
469577|NCT01143090|Schizophrenia|schizophrenia
469578|NCT01143090|Lurasidone|lurasidone
469579|NCT01143090|Latuda|latuda
469580|NCT01143077|Lurasidone|lurasidone
469581|NCT01143077|Schizophrenia|schizophrenia
469582|NCT01143077|Latuda|latuda
469583|NCT01143064|Brain Injury|brain injury
469584|NCT01143064|Trauma|trauma
469585|NCT01143051|Asthma|asthma
469586|NCT01143051|Pharmacokinetics|pharmacokinetics
469587|NCT01143051|Epinephrine|epinephrine
469588|NCT01143051|Bronchodilator|bronchodilator
469589|NCT01143051|metered dose inhaler|metered dose inhaler
469590|NCT01143038|ITP|itp
469591|NCT01143025|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
469592|NCT01143025|Nebulization|nebulization
469593|NCT01143025|Ropivacaine|ropivacaine
469594|NCT01143012|Group eczema education|group eczema education
469595|NCT01142986|Methadone|methadone
469596|NCT01142986|Syringe exchange|syringe exchange
469597|NCT01142986|Treatment retention|treatment retention
469598|NCT01142986|Voucher incentives|voucher incentives
469599|NCT01142947|Inhaled corticosteroids|inhaled corticosteroids
469600|NCT01142947|Asthma|asthma
469601|NCT01142947|Pharmacogenomics|pharmacogenomics
469602|NCT01142947|Genome wide association study|genome wide association study
469603|NCT01142947|Admixture mapping|admixture mapping
469604|NCT01142947|Continental population groups|continental population groups
469605|NCT01142934|Catheter-related bloodstream infections|catheter-related bloodstream infections
469606|NCT01142934|Chlorhexidine|chlorhexidine
469607|NCT01142934|Transparent dressings|transparent dressings
469608|NCT01142921|Stent Occlusion|stent occlusion
469609|NCT01142921|Biliary Bleeding|biliary bleeding
469610|NCT01142921|Biliary Perforation|biliary perforation
469611|NCT01142908|Cardiovascular Disease|cardiovascular disease
469612|NCT01142908|Hypertension|hypertension
469613|NCT01142908|Diabetes|diabetes
469614|NCT01142908|Hyperlipidemia|hyperlipidemia
469615|NCT01142908|Adherence|adherence
469616|NCT01142882|adolescent HIV prevention|adolescent hiv prevention
469617|NCT01142882|web-based interventions|web-based interventions
469618|NCT01142882|adolescent substance abuse treatment|adolescent substance abuse treatment
469619|NCT01142882|comparative effectiveness research|comparative effectiveness research
469620|NCT01142882|HIV prevention|hiv prevention
469621|NCT01142882|hepatitis prevention|hepatitis prevention
469622|NCT01142882|STI prevention|sti prevention
470684|NCT01138410|DNA plasmid|dna plasmid
469623|NCT01142869|Carcinoma, Squamous Cell|carcinoma, squamous cell
469624|NCT01142869|Erbitux|erbitux
469625|NCT01142869|Neoplasms, Squamous Cell|neoplasms, squamous cell
469626|NCT01142843|clinical trial|clinical trial
469627|NCT01142843|mouthwash|mouthwash
469628|NCT01142843|green propolis|green propolis
469629|NCT01142843|dental plaque|dental plaque
469630|NCT01142843|gingivitis|gingivitis
469631|NCT01142830|Craniotomy|craniotomy
469632|NCT01142830|Pain|pain
469633|NCT01142830|Children|children
469634|NCT01142817|HIV|hiv
469635|NCT01142817|Women|women
469636|NCT01142817|Menopause|menopause
469637|NCT01142817|Dyslipidemia|dyslipidemia
469638|NCT01142817|Bone Mineral Density|bone mineral density
469639|NCT01142804|Walking programs|walking programs
469640|NCT01142804|Physical Activity|physical activity
469641|NCT01142804|Behavior Modification|behavior modification
469642|NCT01142804|Social Support|social support
469643|NCT01142791|Uterine fibroids|uterine fibroids
469644|NCT01142791|MRgFUS|mrgfus
469645|NCT01142791|ExAblate|exablate
469646|NCT01142791|Focused Ultrasound|focused ultrasound
469647|NCT01142791|Symptomatic uterine fibroids|symptomatic uterine fibroids
469648|NCT01142765|Vaccine|vaccine
469649|NCT01142765|Safety|safety
469650|NCT01142765|Immunogenicity|immunogenicity
469651|NCT01142765|Protection|protection
469652|NCT01142765|Sporozoite challenge|sporozoite challenge
469653|NCT01142713|Small Bowel Radiotherapy Dose|small bowel radiotherapy dose
469654|NCT01142713|This is a prospective non-randomized open study to evaluate the impact of patient's positioning and use of belly board in rectal radiotherapy|this is a prospective non-randomized open study to evaluate the impact of patient's positioning and use of belly board in rectal radiotherapy
469655|NCT01142687|Resting energy expenditure (REE)|resting energy expenditure (ree)
469656|NCT01142687|metabolic rate|metabolic rate
469657|NCT01142674|Lymphoma, T-Cell, Peripheral|lymphoma, t-cell, peripheral
469658|NCT01142674|Prognosis|prognosis
469659|NCT01142674|Outcome|outcome
469660|NCT01142674|International Cooperation|international cooperation
469661|NCT01142674|Biological Characteristics|biological characteristics
469662|NCT01142674|Heterogeneity|heterogeneity
469663|NCT01142674|Rare Diseases|rare diseases
469664|NCT01142661|Advanced breast cancer refractory to all commercially available therapies|advanced breast cancer refractory to all commercially available therapies
469665|NCT01142648|Electroencephalogram|electroencephalogram
469666|NCT01142648|Electromyogram|electromyogram
469667|NCT01142648|Entropy Index|entropy index
469668|NCT01142648|Bispectral Index|bispectral index
469669|NCT01142648|Reversal of neuromuscular blockade|reversal of neuromuscular blockade
469670|NCT01142635|Electroencephalogram|electroencephalogram
469671|NCT01142635|Electromyogram|electromyogram
469672|NCT01142635|Entropy Index|entropy index
469673|NCT01142635|Bispectral Index|bispectral index
469674|NCT01142635|Neuromuscular blockade; rocuronium|neuromuscular blockade; rocuronium
469675|NCT01142635|Propofol|propofol
469676|NCT01142635|Intubation|intubation
469677|NCT01142622|Ovarian Cysts|ovarian cysts
469678|NCT01142622|Nebulization|nebulization
469679|NCT01142622|Ropivacaine|ropivacaine
469680|NCT01142609|Web based videoconferencing|web based videoconferencing
469681|NCT01142609|methadone|methadone
469682|NCT01142609|substance abuse counseling|substance abuse counseling
469683|NCT01142583|Multiple sclerosis|multiple sclerosis
469684|NCT01142583|Expanded Disability Status Scale|expanded disability status scale
469685|NCT01142583|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
469686|NCT01142570|Mechanical Ventilation|mechanical ventilation
469687|NCT01142557|Multiple sclerosis|multiple sclerosis
469689|NCT01142557|Interferon-beta|interferon-beta
469690|NCT01142544|acute lung injury|acute lung injury
469691|NCT01142544|incidence|incidence
469692|NCT01142544|lung damage|lung damage
469693|NCT01142544|PaO2/FiO2 ratio|pao2/fio2 ratio
469694|NCT01142518|Interferon beta-1a|interferon beta-1a
469695|NCT01142518|Multiple Sclerosis|multiple sclerosis
469696|NCT01142505|wheeze|wheeze
469697|NCT01142505|preschool|preschool
469698|NCT01142505|leukotriene|leukotriene
469699|NCT01142505|montelukast|montelukast
469700|NCT01142505|5-lipoxygenase|5-lipoxygenase
469701|NCT01142492|Interferon beta|interferon beta
469702|NCT01142492|Multiple Sclerosis|multiple sclerosis
469703|NCT01142479|Breast Cancer|breast cancer
469704|NCT01142479|Radiotherapy|radiotherapy
469705|NCT01142479|Chinese herbal medicine|chinese herbal medicine
469706|NCT01142479|TPE-1|tpe-1
469707|NCT01142479|Leukopenia|leukopenia
469708|NCT01142466|Multiple sclerosis|multiple sclerosis
469709|NCT01142466|Expanded Disability Status Scale|expanded disability status scale
469710|NCT01142466|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
469711|NCT01142466|Rebif|rebif
469712|NCT01142466|Beta-1, interferon|beta-1, interferon
469713|NCT01142453|Multiple sclerosis|multiple sclerosis
469714|NCT01142453|Rebif|rebif
469715|NCT01142453|Interferon|interferon
469716|NCT01142414|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
469717|NCT01142414|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
471073|NCT01137708|CYP3A|cyp3a
469718|NCT01142414|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
469719|NCT01142414|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
469720|NCT01142414|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
469721|NCT01142414|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
469722|NCT01142414|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
469723|NCT01142414|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
469724|NCT01142414|tongue cancer|tongue cancer
469725|NCT01142375|AML|aml
469726|NCT01142362|H5N1|h5n1
469727|NCT01142362|Avian Influenza|avian influenza
469728|NCT01142362|DNA Vaccine|dna vaccine
469729|NCT01142362|Intramuscular (IM) Injection|intramuscular (im) injection
469730|NCT01142362|Electroporation|electroporation
469731|NCT01142362|Healthy Adults|healthy adults
469732|NCT01142349|Arthritis|arthritis
469733|NCT01142349|Group Program|group program
469734|NCT01142349|Pain|pain
469735|NCT01142349|Insomnia|insomnia
469736|NCT01142349|Pain dysfunction and sleep disturbance among older adults with osteoarthritis.|pain dysfunction and sleep disturbance among older adults with osteoarthritis.
469737|NCT01142336|Alzheimer's Disease|alzheimer's disease
469738|NCT01142336|Prevention|prevention
469739|NCT01142336|Spinal Fluid|spinal fluid
469740|NCT01142336|Biomarkers|biomarkers
469741|NCT01142336|Simvastatin|simvastatin
469742|NCT01142297|dental implant|dental implant
469743|NCT01142297|implant stabilization|implant stabilization
469744|NCT01142297|type 2 diabetes|type 2 diabetes
469745|NCT01142297|glycated hemoglobin 8.0-12.0%|glycated hemoglobin 8.0-12.0%
469746|NCT01142284|Biomarker|biomarker
469747|NCT01142284|Endothelial Function|endothelial function
469748|NCT01142284|Peripheral Artery Disease|peripheral artery disease
469749|NCT01142284|Coronary Artery Disease|coronary artery disease
469750|NCT01142284|Flow Mediated Dilation|flow mediated dilation
469751|NCT01142284|Cilostazol|cilostazol
469752|NCT01142284|Probucol|probucol
469753|NCT01142271|Distal gastrectomy|distal gastrectomy
469754|NCT01142271|Reconstruction|reconstruction
469755|NCT01142271|Reflux|reflux
469756|NCT01142271|subtotal gastrectomy|subtotal gastrectomy
469757|NCT01142258|Sleep Disturbances|sleep disturbances
469758|NCT01142258|Alzheimer disease|alzheimer disease
469759|NCT01142258|Insomnia|insomnia
469760|NCT01142258|Trazodone|trazodone
469761|NCT01142258|Treatment|treatment
469762|NCT01142245|ulcer bleeding|ulcer bleeding
469763|NCT01142245|endoscopic therapy|endoscopic therapy
469764|NCT01142232|autologous stem cell transplantation|autologous stem cell transplantation
469765|NCT01142219|sickle cell disease|sickle cell disease
469766|NCT01142219|L-arginine|l-arginine
469767|NCT01142219|hemolysis|hemolysis
469768|NCT01142219|nitric oxide|nitric oxide
469769|NCT01142219|pulmonary arterial hypertension|pulmonary arterial hypertension
469770|NCT01142206|Obesity|obesity
469771|NCT01142206|Weight Loss|weight loss
469772|NCT01142206|Leisure-time activities|leisure-time activities
469773|NCT01142206|Physical Activity|physical activity
469774|NCT01142206|Television watching|television watching
469775|NCT01142206|Dietary Intake|dietary intake
469776|NCT01142206|Energy|energy
469777|NCT01142206|Behavioral|behavioral
469778|NCT01142206|Healthy Eating|healthy eating
469779|NCT01142193|Epilepsy|epilepsy
469780|NCT01142193|partial onset seizure|partial onset seizure
469781|NCT01142193|adjunctive therapy|adjunctive therapy
469782|NCT01142180|Bleeding peptic ulcer|bleeding peptic ulcer
469783|NCT01142180|Active bleeding|active bleeding
469784|NCT01142180|Trans-arterial angiographic embolization|trans-arterial angiographic embolization
469785|NCT01142167|Ultra-thin colonoscope|ultra-thin colonoscope
469786|NCT01142154|Cockayne Syndrome|cockayne syndrome
469787|NCT01142154|Ageing|ageing
469788|NCT01142154|pediatrics|pediatrics
469789|NCT01142154|Pharmacokinetics|pharmacokinetics
469790|NCT01142154|Prodarsan|prodarsan
469791|NCT01142154|Dwarfism|dwarfism
469792|NCT01142154|Genetic disease, inborn|genetic disease, inborn
469793|NCT01142154|DNA Repair-Deficiency Disorders|dna repair-deficiency disorders
469794|NCT01142154|Tolerability|tolerability
469795|NCT01142154|Safety|safety
469796|NCT01142102|Bladder|bladder
469797|NCT01142102|Radiotherapy|radiotherapy
469798|NCT01142102|Online|online
469799|NCT01142102|Adaptive|adaptive
469800|NCT01142089|traveler's|traveler's
469801|NCT01142089|diarrhea|diarrhea
469802|NCT01142089|Rifamycin SV MMX|rifamycin sv mmx
469803|NCT01142089|Rifamycin|rifamycin
469804|NCT01142089|MMX|mmx
469805|NCT01142089|Traveler's Diarrhea|traveler's diarrhea
469806|NCT01142076|adiposity|adiposity
469807|NCT01142063|Neratinib|neratinib
469808|NCT01142050|stem cells;|stem cells;
469809|NCT01142050|diabetes mellitus;|diabetes mellitus;
469810|NCT01142050|treatment.|treatment.
469811|NCT01142037|Healthy volunteer|healthy volunteer
469812|NCT01142024|contrast medium induced nephropathy|contrast medium induced nephropathy
469813|NCT01142024|polymorphism of oxidative stress genes|polymorphism of oxidative stress genes
471482|NCT01136473|aphakic|aphakic
469814|NCT01142024|antioxidant prevention|antioxidant prevention
469815|NCT01142011|Waldenstroms|waldenstroms
469816|NCT01142011|Belimumab|belimumab
469817|NCT01142011|anti Blys|anti blys
469818|NCT01142011|monoclonal antibody|monoclonal antibody
469819|NCT01141985|cataract|cataract
469820|NCT01141985|cornea|cornea
469821|NCT01141985|keratoplasty|keratoplasty
469822|NCT01141972|Vitamin D|vitamin d
469823|NCT01141972|Obesity|obesity
469824|NCT01141972|Menopause|menopause
469825|NCT01141972|Hot Flashes|hot flashes
469826|NCT01141959|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
469827|NCT01141959|cyclophosphamide|cyclophosphamide
469828|NCT01141959|fludarabine|fludarabine
469829|NCT01141959|mycophenolate mofetil|mycophenolate mofetil
469830|NCT01141959|mycophenolic acid|mycophenolic acid
469831|NCT01141959|biomarkers|biomarkers
469832|NCT01141946|lung cancer|lung cancer
469833|NCT01141946|pleural effusion|pleural effusion
469834|NCT01141946|post-op care|post-op care
469835|NCT01141946|diaphragmatic ultrasound|diaphragmatic ultrasound
469836|NCT01141933|Creating meaning|creating meaning
469837|NCT01141933|Therapy|therapy
469838|NCT01141933|Cancer|cancer
469839|NCT01141933|Oncology|oncology
469840|NCT01141933|Existential|existential
469841|NCT01141933|Spirituality|spirituality
469842|NCT01141933|Quality of life|quality of life
469843|NCT01141933|QOL|qol
469844|NCT01141933|Psycho-oncology|psycho-oncology
469845|NCT01141933|French-canadian|french-canadian
469846|NCT01141933|Cognitive therapy|cognitive therapy
469847|NCT01141933|Existentialism|existentialism
469848|NCT01141920|treatment retention|treatment retention
469849|NCT01141920|methadone maintenance|methadone maintenance
469850|NCT01141920|treatment induction|treatment induction
469851|NCT01141920|Retention in methadone maintenance treatment|retention in methadone maintenance treatment
469852|NCT01141907|heart failure|heart failure
469853|NCT01141907|self care|self care
469854|NCT01141907|decision support|decision support
469855|NCT01141907|telemonitoring|telemonitoring
469856|NCT01141907|navigator|navigator
469857|NCT01141894|Proximal Femoral Fracture|proximal femoral fracture
469858|NCT01141881|Tissue Plasminogen activator,|tissue plasminogen activator,
469859|NCT01141881|Clinically significant macular edema,|clinically significant macular edema,
469860|NCT01141881|Refractory Diabetic macular edema ,|refractory diabetic macular edema ,
469861|NCT01141881|posterior vitreous detachment|posterior vitreous detachment
469862|NCT01141868|insomnia|insomnia
469863|NCT01141868|breast cancer survivor|breast cancer survivor
469864|NCT01141868|Internet intervention|internet intervention
469865|NCT01141855|Cardiovascular Diseases|cardiovascular diseases
469866|NCT01141855|Peripheral Vascular Diseases|peripheral vascular diseases
469867|NCT01141855|Cerebrovascular Stroke|cerebrovascular stroke
469868|NCT01141855|Lung Diseases, Obstructive|lung diseases, obstructive
469869|NCT01141855|Asthma|asthma
469870|NCT01141855|Tobacco Use Disorder|tobacco use disorder
469871|NCT01141855|Smoking|smoking
469872|NCT01141855|Smoking Cessation|smoking cessation
469873|NCT01141842|lung cancer|lung cancer
469874|NCT01141842|exhalation analysis|exhalation analysis
469875|NCT01141842|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
469876|NCT01141842|cancer screening test|cancer screening test
469877|NCT01141829|NADPH oxidase|nadph oxidase
469878|NCT01141816|renal cell carcinoma|renal cell carcinoma
469879|NCT01141816|radiofrequency ablation|radiofrequency ablation
469880|NCT01141816|contrast enhanced ultrasound|contrast enhanced ultrasound
469881|NCT01141816|monitoring|monitoring
469882|NCT01141816|follow up|follow up
469883|NCT01141803|Apple|apple
469884|NCT01141803|Apple pomace|apple pomace
469885|NCT01141803|Metabolomics|metabolomics
469886|NCT01141803|Gene expression|gene expression
469887|NCT01141803|Lipid metabolism|lipid metabolism
469888|NCT01141803|Prevention|prevention
469889|NCT01141803|Antiinflammatory effect|antiinflammatory effect
469890|NCT01141790|Glasgow Coma Scale|glasgow coma scale
469891|NCT01141790|Glasgow Outcome Scale|glasgow outcome scale
469892|NCT01141790|Ethics|ethics
469893|NCT01141777|Spirulina platensis|spirulina platensis
469894|NCT01141777|Insulin resistance|insulin resistance
469895|NCT01141777|HIV/AIDS|hiv/aids
469896|NCT01141777|HAART|haart
469897|NCT01141777|Soya beans|soya beans
469898|NCT01141764|pediatrics|pediatrics
469899|NCT01141764|Epilepsy|epilepsy
469900|NCT01141764|Deep Brain Stimulation|deep brain stimulation
469901|NCT01141764|Positron Emission Tomography|positron emission tomography
469902|NCT01141751|Multiple sclerosis|multiple sclerosis
469903|NCT01141751|Expanded Disability Status Scale|expanded disability status scale
469904|NCT01141751|Multiple Sclerosis, Relapsing-Remitting; Rebif|multiple sclerosis, relapsing-remitting; rebif
469905|NCT01141751|Beta-1, interferon|beta-1, interferon
469906|NCT01141738|stroke|stroke
469907|NCT01141738|caregiver|caregiver
469908|NCT01141738|depression|depression
469909|NCT01141738|mediators|mediators
469910|NCT01141738|problem-solving|problem-solving
469911|NCT01141712|HIV|hiv
469912|NCT01141712|B-cell Lymphoma|b-cell lymphoma
469913|NCT01141712|Burkitt's Lymphoma|burkitt's lymphoma
469914|NCT01141712|Follicular Lymphoma|follicular lymphoma
469915|NCT01141712|Hodgkin's Lymphoma|hodgkin's lymphoma
469916|NCT01141699|women health behaviors|women health behaviors
469917|NCT01141686|lung cancer|lung cancer
469918|NCT01141673|FLT3-ITD|flt3-itd
469919|NCT01141673|acute myeloid leukemia|acute myeloid leukemia
469920|NCT01141673|FLT3|flt3
469921|NCT01141673|D835|d835
469922|NCT01141647|Adult|adult
469923|NCT01141647|Depression|depression
469924|NCT01141647|Supported Employment|supported employment
469925|NCT01141647|Health Service|health service
469926|NCT01141647|Humans|humans
469927|NCT01141647|Outcomes|outcomes
469928|NCT01141647|Quality of Life|quality of life
469929|NCT01141647|Veterans/rh (rehabilitation)|veterans/rh (rehabilitation)
469930|NCT01141647|Workplace|workplace
469931|NCT01141647|Spinal Cord Injuries|spinal cord injuries
469932|NCT01141634|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
469933|NCT01141634|Attention Deficit Disorder|attention deficit disorder
469934|NCT01141634|ADHD|adhd
469936|NCT01141634|Homeopathy|homeopathy
469937|NCT01141621|HS|hs
469938|NCT01141621|congenital hemolytic anemia|congenital hemolytic anemia
469939|NCT01141621|splenectomy|splenectomy
469940|NCT01141621|quality of life|quality of life
469941|NCT01141556|selenium|selenium
469942|NCT01141556|clinical outcome|clinical outcome
469943|NCT01141556|heart surgery|heart surgery
469944|NCT01141543|Plerixafor injection|plerixafor injection
469945|NCT01141530|Identify novel genes and predict putative proteins in breast cancer.|identify novel genes and predict putative proteins in breast cancer.
469946|NCT01141530|Find biomarkers that can be used for early detection, diagnosis, and prognosis.|find biomarkers that can be used for early detection, diagnosis, and prognosis.
469947|NCT01141517|adolescent quit-smoking program.|adolescent quit-smoking program.
469948|NCT01141504|Supplemental ATP|supplemental atp
469949|NCT01141504|Muscle Work Performed|muscle work performed
469950|NCT01141504|Muscle Fatigue|muscle fatigue
469951|NCT01141491|Sarcoma|sarcoma
469952|NCT01141491|Metastatic|metastatic
469953|NCT01141491|Vaccine|vaccine
469954|NCT01141491|Adjuvant|adjuvant
469955|NCT01141478|Carcinoma, Hepatocellular|carcinoma, hepatocellular
469956|NCT01141478|Proton Beam Radiotherapy|proton beam radiotherapy
469957|NCT01141478|Sorafenib|sorafenib
469958|NCT01141465|Primary care|primary care
469959|NCT01141465|Asthma management|asthma management
469960|NCT01141465|Combined therapy|combined therapy
469961|NCT01141465|Real-world|real-world
469962|NCT01141465|Effectiveness|effectiveness
469963|NCT01141465|Control|control
469964|NCT01141465|Exacerbations|exacerbations
469965|NCT01141452|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
469966|NCT01141452|inhaled corticosteroid|inhaled corticosteroid
469967|NCT01141452|increase|increase
469968|NCT01141452|initiate|initiate
469969|NCT01141452|exacerbations|exacerbations
469970|NCT01141452|treatment success|treatment success
469971|NCT01141439|Primary care|primary care
469972|NCT01141439|Asthma management|asthma management
469973|NCT01141439|Inhaled corticosteroids|inhaled corticosteroids
469974|NCT01141439|Beclomethasone dipropionate|beclomethasone dipropionate
469975|NCT01141439|Fluticasone propionate|fluticasone propionate
469976|NCT01141439|Metred dose inhaler|metred dose inhaler
469977|NCT01141439|Extra-fine hydrofluoroalkane|extra-fine hydrofluoroalkane
469978|NCT01141439|Chlorofluorocarbon|chlorofluorocarbon
469979|NCT01141426|depression|depression
469980|NCT01141426|treatment-resistance|treatment-resistance
469981|NCT01141426|psychodynamic psychotherapy|psychodynamic psychotherapy
469982|NCT01141426|Treatment refractory depression|treatment refractory depression
469983|NCT01141374|Stress|stress
469984|NCT01141361|Claudication|claudication
469985|NCT01141361|Artery|artery
469986|NCT01141361|Ambulatory technique|ambulatory technique
469987|NCT01141361|GPS|gps
469988|NCT01141335|shrinkage|shrinkage
469989|NCT01141335|postoperative pain and discomfort|postoperative pain and discomfort
469990|NCT01141322|drug-induced liver injury|drug-induced liver injury
469991|NCT01141322|hepatitis, toxic|hepatitis, toxic
469992|NCT01141322|ursodeoxycholic acid|ursodeoxycholic acid
469993|NCT01141309|Everolimus|everolimus
469994|NCT01141309|Sorafenib|sorafenib
469995|NCT01141309|Thyroid|thyroid
469996|NCT01141309|10-060|10-060
469997|NCT01141283|Osteoarthritis|osteoarthritis
469998|NCT01141283|Opioid|opioid
469999|NCT01141283|Transdermal|transdermal
470000|NCT01141270|recombinant human follicle stimulating hormone|recombinant human follicle stimulating hormone
470001|NCT01141270|pharmacokinetics|pharmacokinetics
470002|NCT01141270|bioequivalence|bioequivalence
470003|NCT01141257|Angiocal®; PRS-050-PEG40; Solid tumor; Phase I|angiocal®; prs-050-peg40; solid tumor; phase i
470004|NCT01141231|hypopharyngeal cancer|hypopharyngeal cancer
470005|NCT01141231|laryngeal cancer|laryngeal cancer
470006|NCT01141231|lip and oral cavity cancer|lip and oral cavity cancer
470007|NCT01141231|nasopharyngeal cancer|nasopharyngeal cancer
470008|NCT01141231|oropharyngeal cancer|oropharyngeal cancer
470009|NCT01141231|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
470010|NCT01141231|salivary gland cancer|salivary gland cancer
470011|NCT01141231|radiation toxicity|radiation toxicity
470012|NCT01141231|xerostomia|xerostomia
470013|NCT01141231|long-term effects of cancer treatment|long-term effects of cancer treatment
470014|NCT01141231|oral complications of radiation therapy|oral complications of radiation therapy
470015|NCT01141218|non-small cell lung cancer|non-small cell lung cancer
470016|NCT01141205|AIDS vaccines|aids vaccines
470017|NCT01141205|HIV-1 vaccine|hiv-1 vaccine
470018|NCT01141205|Therapeutic vaccine|therapeutic vaccine
470019|NCT01141205|Cellular immunity|cellular immunity
470020|NCT01141192|vitamin D status|vitamin d status
470021|NCT01141192|25-OH D|25-oh d
470022|NCT01141192|ionized calcium|ionized calcium
470023|NCT01141192|fasting glucose|fasting glucose
470024|NCT01141192|hemoglobin A1c|hemoglobin a1c
470025|NCT01141192|fasting insulin|fasting insulin
470026|NCT01141192|glucose metabolism|glucose metabolism
470027|NCT01141192|HOMA index|homa index
470028|NCT01141192|blood lipids|blood lipids
470029|NCT01141192|type 2 diabetes|type 2 diabetes
470030|NCT01141192|PTH|pth
470031|NCT01141192|adiposity|adiposity
470032|NCT01141192|body fat percentage|body fat percentage
470033|NCT01141192|dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
470034|NCT01141192|pulse wave velocity|pulse wave velocity
470035|NCT01141192|arterial stiffness|arterial stiffness
470036|NCT01141192|flow-mediated dilation|flow-mediated dilation
470037|NCT01141192|African American|african american
470038|NCT01141192|inflammatory markers|inflammatory markers
470039|NCT01141166|ELDERLY|elderly
470040|NCT01141166|NUTRITION|nutrition
470041|NCT01141153|atrial fibrillation|atrial fibrillation
470042|NCT01141153|Coronary Stent implantation|coronary stent implantation
470043|NCT01141153|Low-moderate risk of stroke|low-moderate risk of stroke
470044|NCT01141153|dual antiplatelet therapy|dual antiplatelet therapy
470045|NCT01141153|anticoagulation|anticoagulation
470046|NCT01141127|tranexamic acid in pediatric surgery|tranexamic acid in pediatric surgery
470047|NCT01141127|fibrinolysis and paediatric cardiac surgery|fibrinolysis and paediatric cardiac surgery
470048|NCT01141114|community health centers|community health centers
470049|NCT01141114|colorectal cancer screening|colorectal cancer screening
470050|NCT01141114|urban health|urban health
470051|NCT01141101|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
470052|NCT01141101|Neonatal|neonatal
470053|NCT01141101|Vertical transmission|vertical transmission
470054|NCT01141101|Horizontal transmission|horizontal transmission
470055|NCT01141101|MRSA colonization in enrolled infants|mrsa colonization in enrolled infants
470056|NCT01141101|MRSA colonization obtained from maternal source|mrsa colonization obtained from maternal source
470057|NCT01141101|MRSA colonization obtained from source other that mother|mrsa colonization obtained from source other that mother
470058|NCT01141062|Uterine Fibroids|uterine fibroids
470059|NCT01141049|Alcohol Withdrawal|alcohol withdrawal
470060|NCT01141049|Reducing Alcohol Consumption|reducing alcohol consumption
470061|NCT01141049|Promoting abstinence in alcohol-dependent patients|promoting abstinence in alcohol-dependent patients
470062|NCT01141049|Gabapentin|gabapentin
470063|NCT01141036|Propofol|propofol
470064|NCT01141036|Midazolam|midazolam
470065|NCT01141036|sedation|sedation
470066|NCT01141036|cirrhosis|cirrhosis
470067|NCT01141036|endoscopy|endoscopy
470068|NCT01141036|recovery time|recovery time
470069|NCT01141036|efficacy and safety of sedation|efficacy and safety of sedation
470070|NCT01141036|patient satisfaction|patient satisfaction
470071|NCT01141036|return to baseline function|return to baseline function
470072|NCT01141036|saturation of oxygen|saturation of oxygen
470073|NCT01141023|Parkinson|parkinson
470074|NCT01141023|Bio-markers|bio-markers
470075|NCT01141023|Neurodegenerative disorder|neurodegenerative disorder
470076|NCT01141023|Imaging|imaging
470077|NCT01141023|Prodromal|prodromal
470078|NCT01141010|Linguistic|linguistic
470079|NCT01141010|Stress response|stress response
470080|NCT01141010|Corticosteroid|corticosteroid
470081|NCT01141010|Cesarean section|cesarean section
470082|NCT01141010|Anxiety|anxiety
470083|NCT01141010|Depression|depression
470084|NCT01141010|Maternal psychosis|maternal psychosis
470085|NCT01140997|HCV|hcv
470086|NCT01140997|CHC|chc
470087|NCT01140997|Hepatitis C, Chronic|hepatitis c, chronic
470088|NCT01140997|Liver Diseases|liver diseases
470089|NCT01140997|Hepatitis, Chronic|hepatitis, chronic
470090|NCT01140997|Hepatitis, Viral, Human|hepatitis, viral, human
470091|NCT01140997|Hepadnaviridae Infections|hepadnaviridae infections
470092|NCT01140997|Antiviral Agents|antiviral agents
470093|NCT01140997|Virus Diseases|virus diseases
470094|NCT01140997|Peginterferon alfa|peginterferon alfa
470095|NCT01140984|acute graft versus host disease|acute graft versus host disease
470096|NCT01140984|intra arterial steroid infusion|intra arterial steroid infusion
470097|NCT01140984|steroid resistant acute hepatic graft versus host disease|steroid resistant acute hepatic graft versus host disease
470098|NCT01140971|Balloon dilatation,|balloon dilatation,
470099|NCT01140971|misoprostol,|misoprostol,
470100|NCT01140971|cervical ripening,|cervical ripening,
470101|NCT01140971|obstetric labor,|obstetric labor,
470102|NCT01140971|labor induced.|labor induced.
470103|NCT01140958|lung cancer|lung cancer
470104|NCT01140958|pharmacoeconomics|pharmacoeconomics
470107|NCT01140932|Electroretinography|electroretinography
470108|NCT01140932|Diabetes Mellitus|diabetes mellitus
470109|NCT01140932|Glucose Intolerance|glucose intolerance
470110|NCT01140932|Physiology|physiology
470111|NCT01140906|Major depressive disorder|major depressive disorder
470112|NCT01140906|Placebo-controlled|placebo-controlled
470113|NCT01140906|Active reference|active reference
470114|NCT01140906|Multicenter study|multicenter study
470115|NCT01140906|Randomised study|randomised study
470116|NCT01140906|Acute treatment|acute treatment
470117|NCT01140893|Type 2 diabetes|type 2 diabetes
470118|NCT01140893|CSII|csii
470119|NCT01140893|Exenatide|exenatide
470120|NCT01140893|Double Blind Placebo Controlled Study|double blind placebo controlled study
470121|NCT01140880|Methamphetamine|methamphetamine
470122|NCT01140880|Amphetamine|amphetamine
470123|NCT01140880|Cocaine|cocaine
470124|NCT01140880|HIV|hiv
470125|NCT01140880|Post-exposure prophylaxis|post-exposure prophylaxis
470126|NCT01140880|HIV seronegativity|hiv seronegativity
470127|NCT01140854|hypertension|hypertension
470128|NCT01140854|hypotension|hypotension
470129|NCT01140854|cognitive|cognitive
470130|NCT01140854|neurocognitive|neurocognitive
470131|NCT01140854|cognitive dysfunction|cognitive dysfunction
470132|NCT01140854|postoperative cognitive dysfunction (POCD)|postoperative cognitive dysfunction (pocd)
470133|NCT01140854|neuropsychometric|neuropsychometric
470134|NCT01140841|Dyskinesia|dyskinesia
470135|NCT01140828|Arthritis|arthritis
470136|NCT01140828|Bone pain|bone pain
470137|NCT01140828|dyspepsia|dyspepsia
470138|NCT01140815|Total Knee Arthroplasty|total knee arthroplasty
470139|NCT01140815|Bicompartmental Knee Arthroplasty|bicompartmental knee arthroplasty
470140|NCT01140802|First degree relatives|first degree relatives
470141|NCT01140802|Crohn's disease|crohn's disease
470142|NCT01140802|Ulcerative colitis|ulcerative colitis
470143|NCT01140802|Healthy control|healthy control
470144|NCT01140776|metastasis|metastasis
470145|NCT01140776|molecular pathology|molecular pathology
470146|NCT01140763|metastasis|metastasis
470147|NCT01140750|Heart Rate Variability|heart rate variability
470148|NCT01140750|Temperature Curve Complexity|temperature curve complexity
470149|NCT01140750|Autonomic Dysfunction|autonomic dysfunction
470150|NCT01140750|Prolonged Mechanical Ventilation|prolonged mechanical ventilation
470151|NCT01140750|Failure to Wean|failure to wean
470152|NCT01140737|advanced soft tissue sarcoma|advanced soft tissue sarcoma
470153|NCT01140724|pain|pain
470154|NCT01140724|genes|genes
470155|NCT01140724|morphine|morphine
470156|NCT01140724|respiratory depression|respiratory depression
470157|NCT01140724|tonsillectomy|tonsillectomy
470158|NCT01140724|children|children
470159|NCT01140724|Opioid adverse effects|opioid adverse effects
470160|NCT01140724|Pharmacogenetics of morphine|pharmacogenetics of morphine
470161|NCT01140724|Pharmacokinetics of morphine|pharmacokinetics of morphine
470162|NCT01140724|Personalizing analgesia|personalizing analgesia
470163|NCT01140685|mucus-stimulated (induced sputum)|mucus-stimulated (induced sputum)
470164|NCT01140685|lung disease (asthma, COPD, ILD and OLD)|lung disease (asthma, copd, ild and old)
470165|NCT01140685|HO-1 (heme oxigenase-1)|ho-1 (heme oxigenase-1)
470166|NCT01140685|oxidative stress|oxidative stress
470167|NCT01140685|CO (carbon monoxide)|co (carbon monoxide)
470168|NCT01140685|The oxidative stress in lung diseases|the oxidative stress in lung diseases
470169|NCT01140672|Healthy volunteers|healthy volunteers
470170|NCT01140672|pharmacokinetics|pharmacokinetics
470171|NCT01140672|safety|safety
470172|NCT01140672|tolerability|tolerability
470173|NCT01140672|multiple dosing|multiple dosing
470174|NCT01140672|Diabetic Nephropathies|diabetic nephropathies
470175|NCT01140659|Hyperhidrosis|hyperhidrosis
470176|NCT01140659|Thoracic sympathectomy|thoracic sympathectomy
470177|NCT01140659|Objective measurement of sweat|objective measurement of sweat
470178|NCT01140646|Hot flashes, dietary supplements, symptom management|hot flashes, dietary supplements, symptom management
470179|NCT01140633|HIV/AIDS|hiv/aids
470180|NCT01140633|pediatric|pediatric
470181|NCT01140633|wireless adherence monitoring|wireless adherence monitoring
470182|NCT01140633|HIV Infections|hiv infections
470183|NCT01140620|NMDA receptor antagonism|nmda receptor antagonism
470184|NCT01140620|cognitive processes|cognitive processes
470185|NCT01140620|healthy volunteers|healthy volunteers
470186|NCT01140620|dopamine antagonist|dopamine antagonist
470187|NCT01140620|schizophrenia|schizophrenia
470188|NCT01140568|glioma|glioma
470189|NCT01140568|PDGFR|pdgfr
470190|NCT01140568|kinase|kinase
470191|NCT01140568|inhibitor|inhibitor
470192|NCT01140568|malignant|malignant
470193|NCT01140568|nilotinib|nilotinib
470194|NCT01140542|Diabetes Mellitus Type 2|diabetes mellitus type 2
470195|NCT01140542|Roflumilast|roflumilast
470196|NCT01140529|Dexmedetomidine|dexmedetomidine
470197|NCT01140516|Antenatal|antenatal
470198|NCT01140490|Hemodialysis|hemodialysis
470199|NCT01140490|Sub-total Parathyroidectomy|sub-total parathyroidectomy
470200|NCT01140464|Adolescents|adolescents
470201|NCT01140438|Latent autoimmune diabetes|latent autoimmune diabetes
470202|NCT01140438|adults|adults
470203|NCT01140438|Beta cell rest|beta cell rest
470204|NCT01140438|Insulin secretion|insulin secretion
470205|NCT01140425|PF-00232798|pf-00232798
470206|NCT01140425|CCR5|ccr5
470207|NCT01140425|QT|qt
470208|NCT01140425|QTc|qtc
470209|NCT01140425|pharmacokinetics|pharmacokinetics
470210|NCT01140412|maraviroc|maraviroc
470211|NCT01140412|fosamprenavir|fosamprenavir
470212|NCT01140412|drug interaction|drug interaction
470213|NCT01140412|pharmacokinetics|pharmacokinetics
470214|NCT01140412|HIV|hiv
470215|NCT01140412|AIDS|aids
470216|NCT01140412|CCR5|ccr5
470217|NCT01140412|protease inhibitor|protease inhibitor
470218|NCT01140399|1 Acute Decompensated Heart Failure|1 acute decompensated heart failure
470219|NCT01140399|2 Cardiorenal Syndrome|2 cardiorenal syndrome
470220|NCT01140399|3 Ultrafiltration|3 ultrafiltration
470221|NCT01140399|4 Dopamine|4 dopamine
470222|NCT01140386|venous thromboembolism|venous thromboembolism
470223|NCT01140386|duplex ultrasound|duplex ultrasound
470224|NCT01140386|pediatric population|pediatric population
470225|NCT01140386|Vascular lab duplex ultrasound database|vascular lab duplex ultrasound database
470226|NCT01140386|Inpatient hospital admission/discharge ICD-9 database|inpatient hospital admission/discharge icd-9 database
470227|NCT01140386|PTSF pediatric trauma database|ptsf pediatric trauma database
470228|NCT01140373|Prostate|prostate
470229|NCT01140373|Autologous T Cells|autologous t cells
470230|NCT01140373|Castrate Metastatic Prostate Cancer|castrate metastatic prostate cancer
470231|NCT01140373|cyclophosphamide|cyclophosphamide
470232|NCT01140373|09-036|09-036
470233|NCT01140360|Neurofibromas|neurofibromas
470234|NCT01140347|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
470235|NCT01140347|recombinant human immunoglobulin G|recombinant human immunoglobulin g
470236|NCT01140347|subclass 1 (IgG1) monoclonal antibody (MAb)|subclass 1 (igg1) monoclonal antibody (mab)
470237|NCT01140347|Hepatocellular Carcinoma (HCC) following First-Line Therapy With Sorafenib|hepatocellular carcinoma (hcc) following first-line therapy with sorafenib
470238|NCT01140334|Psychiatric adherence|psychiatric adherence
470239|NCT01140334|Voucher incentives|voucher incentives
470240|NCT01140334|Methadone treatment|methadone treatment
470241|NCT01140321|Thalassemia|thalassemia
470242|NCT01140321|Neridronate|neridronate
470243|NCT01140321|Osteopenia|osteopenia
470244|NCT01140321|Osteoporosis|osteoporosis
470245|NCT01140308|Statin Myopathy|statin myopathy
470246|NCT01140308|CoEnzyme Q10|coenzyme q10
470247|NCT01140308|CoQ10|coq10
470248|NCT01140308|Statin Myalgia|statin myalgia
470249|NCT01140295|Preparation|preparation
470250|NCT01140295|Pediatric|pediatric
470251|NCT01140295|Colonoscopy|colonoscopy
470252|NCT01140282|cancer survivor|cancer survivor
470253|NCT01140269|Burn|burn
470254|NCT01140269|Sepsis|sepsis
470255|NCT01140269|Infection|infection
470256|NCT01140256|Zinc|zinc
470257|NCT01140256|SGA|sga
470258|NCT01140256|AGA|aga
470259|NCT01140256|stable isotope|stable isotope
470260|NCT01140243|fat formulation|fat formulation
470261|NCT01140230|rotator cuff tear|rotator cuff tear
470262|NCT01140230|rotator cuff repair|rotator cuff repair
470263|NCT01140230|age|age
470264|NCT01140230|timing to surgery|timing to surgery
470265|NCT01140217|contraception|contraception
470266|NCT01140217|pregnancy|pregnancy
470267|NCT01140204|stent|stent
470268|NCT01140204|contrast media|contrast media
470269|NCT01140204|paclitaxel|paclitaxel
470270|NCT01140204|stent implantation|stent implantation
470271|NCT01140191|leishmaniasis|leishmaniasis
470272|NCT01140191|cutaneous|cutaneous
470273|NCT01140191|WR 279,396|wr 279,396
470274|NCT01140191|paromomycin|paromomycin
470275|NCT01140191|gentamicin|gentamicin
470276|NCT01140191|pharmacokinetics|pharmacokinetics
470277|NCT01140191|safety|safety
470278|NCT01140191|efficacy|efficacy
470279|NCT01140191|military|military
470280|NCT01140178|Photodynamic Therapy|photodynamic therapy
470281|NCT01140178|Oral dysplasia|oral dysplasia
470282|NCT01140178|oral cavity carcinoma|oral cavity carcinoma
470283|NCT01140178|oropharynx carcinoma.|oropharynx carcinoma.
470284|NCT01140152|intestinal transplantation|intestinal transplantation
470285|NCT01140152|rejection|rejection
470286|NCT01140152|proteomics|proteomics
470287|NCT01140152|innate immunity|innate immunity
470288|NCT01140126|HIV-1, CD4, antibody, immunotherapy|hiv-1, cd4, antibody, immunotherapy
470289|NCT01140113|hemoconcentration|hemoconcentration
470290|NCT01140113|ultrafiltration|ultrafiltration
470291|NCT01140113|coronary artery disease|coronary artery disease
470292|NCT01140087|Face Transplant|face transplant
470293|NCT01140087|Composite Tissue Allograft|composite tissue allograft
470294|NCT01140087|Facial Allotransplantation|facial allotransplantation
470295|NCT01140074|acute diarrhoea, children|acute diarrhoea, children
470296|NCT01140048|Asthma|asthma
470297|NCT01140035|Insulin|insulin
470298|NCT01140035|Deceased donors|deceased donors
470299|NCT01140035|Renal Allograft Function|renal allograft function
470300|NCT01140035|Transplanted Allograft Outcomes|transplanted allograft outcomes
470301|NCT01140022|Chlamydia, Screening, young women, kiosk, computer module|chlamydia, screening, young women, kiosk, computer module
470302|NCT01140009|Vaccine|vaccine
470303|NCT01140009|Seasonal Influenza vaccine|seasonal influenza vaccine
470304|NCT01140009|Influenza vaccine|influenza vaccine
470305|NCT01140009|Vaccine safety|vaccine safety
470306|NCT01140009|Vaccine immunogenicity|vaccine immunogenicity
470307|NCT01140009|Fluviral 2010/11|fluviral 2010/11
470308|NCT01139983|osteosarcoma|osteosarcoma
470309|NCT01139944|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
470310|NCT01139944|stage I non-small cell lung cancer|stage i non-small cell lung cancer
470311|NCT01139944|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
470312|NCT01139944|squamous cell lung cancer|squamous cell lung cancer
470313|NCT01139931|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
470314|NCT01139918|psoriatic arthritis|psoriatic arthritis
470315|NCT01139918|psoriasis|psoriasis
470316|NCT01139918|Quality of life|quality of life
470317|NCT01139905|Lopinavir/ritonavir|lopinavir/ritonavir
470318|NCT01139905|pharmacokinetic|pharmacokinetic
470319|NCT01139905|low dose|low dose
470320|NCT01139905|HIV-infected children|hiv-infected children
470321|NCT01139905|pharmacokinetics of low-dose lopinavir/ritonavir in HIV-1 infected Thai children.|pharmacokinetics of low-dose lopinavir/ritonavir in hiv-1 infected thai children.
470322|NCT01139892|Unruptured aneurysm|unruptured aneurysm
470323|NCT01139892|endovascular treatment|endovascular treatment
470324|NCT01139892|surgical treatment|surgical treatment
470325|NCT01139892|randomized|randomized
470326|NCT01139892|intracranial aneurysm|intracranial aneurysm
470327|NCT01139879|Pressure Ulcer treatment Mattresses|pressure ulcer treatment mattresses
470328|NCT01139879|Home Care|home care
470329|NCT01139879|Extended Care|extended care
470330|NCT01139879|Wound measurements|wound measurements
470331|NCT01139866|Long-term Safety|long-term safety
470332|NCT01139866|Shoulder Surgery|shoulder surgery
470333|NCT01139866|bupivacaine|bupivacaine
470334|NCT01139853|pyloric stenosis|pyloric stenosis
470335|NCT01139853|nasogastric tube|nasogastric tube
470336|NCT01139853|pyloromyotomy|pyloromyotomy
470337|NCT01139840|vitamin D2|vitamin d2
470338|NCT01139840|vitamin D3|vitamin d3
470339|NCT01139840|ergocalciferol|ergocalciferol
470340|NCT01139840|cholecalciferol|cholecalciferol
470341|NCT01139840|vitamin D status|vitamin d status
470342|NCT01139840|To determine relative potency of vitamins D2 and D3 under conditions of continuous administration|to determine relative potency of vitamins d2 and d3 under conditions of continuous administration
470343|NCT01139840|To determine change in vitamin D content of subcutaneous fat after 12 weeks' administration|to determine change in vitamin d content of subcutaneous fat after 12 weeks' administration
470344|NCT01139827|atherosclerosis|atherosclerosis
470345|NCT01139827|inflammation|inflammation
470346|NCT01139827|hsCRP|hscrp
470347|NCT01139827|Framingham risk score|framingham risk score
470348|NCT01139827|positron emission tomography|positron emission tomography
470349|NCT01139827|inflammation in FDG-PET|inflammation in fdg-pet
470350|NCT01139814|atrial flutter|atrial flutter
470351|NCT01139814|AVNRT|avnrt
470352|NCT01139814|right sided accessory pathway|right sided accessory pathway
470353|NCT01139814|ventricular tachycardia|ventricular tachycardia
470354|NCT01139814|Patients who have one or more standard indications for a right-sided diagnostic electrophysiology procedure.|patients who have one or more standard indications for a right-sided diagnostic electrophysiology procedure.
470355|NCT01139801|Cervical Ripening|cervical ripening
470356|NCT01139801|Rate of Cesearean Section|rate of cesearean section
470357|NCT01139788|Cancer|cancer
470358|NCT01139775|solid tumors|solid tumors
470359|NCT01139775|Mesothelioma|mesothelioma
470360|NCT01139775|Carcinoma|carcinoma
470361|NCT01139762|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
470362|NCT01139762|Enlarged Prostate|enlarged prostate
470363|NCT01139749|oral isotretinoin|oral isotretinoin
470364|NCT01139749|sebaceous secretion|sebaceous secretion
470365|NCT01139749|seborrhea|seborrhea
470366|NCT01139749|seborrheic dermatitis|seborrheic dermatitis
470367|NCT01139749|quality of life|quality of life
470368|NCT01139749|Malassezia|malassezia
470369|NCT01139736|Irritable bowel syndrome|irritable bowel syndrome
470370|NCT01139736|IBS|ibs
470371|NCT01139736|probiotics|probiotics
470372|NCT01139736|rectal sensitivity|rectal sensitivity
470373|NCT01139736|gut flora|gut flora
470374|NCT01139736|gut bacteria|gut bacteria
470375|NCT01139710|SARCOIDOSIS|sarcoidosis
470376|NCT01139710|PULMONARY HYPERTENSION|pulmonary hypertension
470377|NCT01139710|outpatients clinic at Meir medical center|outpatients clinic at meir medical center
470378|NCT01139697|Heart failure|heart failure
470379|NCT01139697|Cortisol|cortisol
470380|NCT01139697|Testosterone|testosterone
470381|NCT01139684|Exercise test|exercise test
470382|NCT01139671|Remifentanil|remifentanil
470383|NCT01139671|Sufentanil|sufentanil
470384|NCT01139671|Surgical removal of three to four wisdom teeth|surgical removal of three to four wisdom teeth
470385|NCT01139671|General anaesthesia|general anaesthesia
470386|NCT01139671|Ambulatory oral surgery|ambulatory oral surgery
470387|NCT01139671|Target Controlled Infusion (TCI)|target controlled infusion (tci)
470388|NCT01139671|Opioid induced hyperalgesia|opioid induced hyperalgesia
470389|NCT01139671|Postoperative nausea and vomiting|postoperative nausea and vomiting
470390|NCT01139671|Postoperative Morphine consumption|postoperative morphine consumption
470391|NCT01139671|Under General anaesthesia|under general anaesthesia
470392|NCT01139671|In Ambulatory surgery|in ambulatory surgery
470393|NCT01139645|Calcium|calcium
470394|NCT01139645|bone|bone
470395|NCT01139645|metabolism|metabolism
470396|NCT01139645|Proton Pump Inhibitors|proton pump inhibitors
470397|NCT01139645|Rabeprazole|rabeprazole
470398|NCT01139645|Esomeprazole|esomeprazole
470399|NCT01139645|Lanzoprazole|lanzoprazole
470400|NCT01139645|Vitamin D|vitamin d
470401|NCT01139645|bone and bones|bone and bones
470402|NCT01139632|NAFLD|nafld
470403|NCT01139632|lP-pla2|lp-pla2
470404|NCT01139632|Coronary Arthery Disease|coronary arthery disease
470405|NCT01139619|Biopsy Mapping|biopsy mapping
470406|NCT01139619|Non small cell lung cancer|non small cell lung cancer
470407|NCT01139619|NSCLC|nsclc
470408|NCT01139619|Lung cancer diagnosis|lung cancer diagnosis
470409|NCT01139619|Retrospective|retrospective
470410|NCT01139619|Inoperable Non Small Cell Lung Cancer|inoperable non small cell lung cancer
470411|NCT01139593|IVF|ivf
470412|NCT01139593|ICSI|icsi
470413|NCT01139593|gonadotropin|gonadotropin
470414|NCT01139593|am dose|am dose
470415|NCT01139593|pm dose|pm dose
470416|NCT01139593|pregnancy|pregnancy
470417|NCT01139593|implantation|implantation
470418|NCT01139593|live birth|live birth
470419|NCT01139580|Plaque Psoriasis|plaque psoriasis
470420|NCT01139580|Psoriasis|psoriasis
470421|NCT01139567|Diabetic Wounds|diabetic wounds
470422|NCT01139567|Hyperbaric Oxygen|hyperbaric oxygen
470423|NCT01139567|Laser Speckle Imaging|laser speckle imaging
470424|NCT01139567|Hyperbaric Oxygenation|hyperbaric oxygenation
470425|NCT01139528|Fracture|fracture
470426|NCT01139528|5th metacarpal bone|5th metacarpal bone
470427|NCT01139528|Bouquet pinning|bouquet pinning
470428|NCT01139528|Fractures of the neck of the 5th metacarpal bone|fractures of the neck of the 5th metacarpal bone
470429|NCT01139515|pharmacokinetic|pharmacokinetic
470430|NCT01139515|eletriptan|eletriptan
470431|NCT01139515|Korean|korean
470432|NCT01139515|crossover|crossover
470433|NCT01139502|schizophrenia spectrum disorders|schizophrenia spectrum disorders
470434|NCT01139502|work rehabilitation|work rehabilitation
470435|NCT01139502|cognitive therapy|cognitive therapy
470436|NCT01139502|cognitive training|cognitive training
470437|NCT01139502|Adaptation to work|adaptation to work
470438|NCT01139502|Work as a treatment factor|work as a treatment factor
470439|NCT01139489|Procalcitonin|procalcitonin
470440|NCT01139489|antibiotic therapy|antibiotic therapy
470441|NCT01139489|antibiotics|antibiotics
470442|NCT01139489|sepsis|sepsis
470443|NCT01139489|infections|infections
470444|NCT01139489|biomarker|biomarker
470445|NCT01139476|Multiple Myeloma|multiple myeloma
470446|NCT01139476|MGUS|mgus
470447|NCT01139476|Leukemia|leukemia
470448|NCT01139476|Biorepository|biorepository
470449|NCT01139463|antipsychotics|antipsychotics
470450|NCT01139463|lactates|lactates
470451|NCT01139463|side effects|side effects
470452|NCT01139450|Atopic Dermatitis|atopic dermatitis
470453|NCT01139437|Vaccine|vaccine
470454|NCT01139437|HPIV2|hpiv2
470455|NCT01139437|Infants|infants
470456|NCT01139424|surgical leak|surgical leak
470457|NCT01139424|endoscopic suturing|endoscopic suturing
470458|NCT01139424|Anastomotic leakage|anastomotic leakage
470459|NCT01139424|esophageal or gastric resection|esophageal or gastric resection
470460|NCT01139398|Cholesterol|cholesterol
470461|NCT01139398|LDL-cholesterol|ldl-cholesterol
470462|NCT01139398|Coronary artery disease|coronary artery disease
470463|NCT01139398|Red yeast rice|red yeast rice
470464|NCT01139398|Plants extract|plants extract
470465|NCT01139398|Cholesterol excess.|cholesterol excess.
470466|NCT01139372|Dry eye, artificial tears|dry eye, artificial tears
470467|NCT01139359|Lymphoma|lymphoma
470468|NCT01139359|Darinaparsin|darinaparsin
470469|NCT01139359|CHOP|chop
470470|NCT01139359|Frontline|frontline
470471|NCT01139359|PTCL|ptcl
470472|NCT01139359|B-cell|b-cell
470473|NCT01139346|carcinoma|carcinoma
470474|NCT01139346|sarcoma|sarcoma
470475|NCT01139346|metastatic|metastatic
470476|NCT01139346|solid tumor|solid tumor
470477|NCT01139333|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
470478|NCT01139320|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
470479|NCT01139307|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
470480|NCT01139307|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
470481|NCT01139307|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
470482|NCT01139307|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
470483|NCT01139307|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
470484|NCT01139307|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
470485|NCT01139294|cardiac output|cardiac output
470486|NCT01139294|dehydration|dehydration
470487|NCT01139294|pediatrics|pediatrics
470488|NCT01139281|Ear protection|ear protection
470489|NCT01139281|Ginkgo Biloba Extract|ginkgo biloba extract
470586|NCT01138865|Obstructive sleep apnea|obstructive sleep apnea
470490|NCT01139281|Distortion-product otoacoustic emission|distortion-product otoacoustic emission
470491|NCT01139281|Ototoxicity|ototoxicity
470492|NCT01139281|Cisplatin|cisplatin
470493|NCT01139268|embryo viability|embryo viability
470494|NCT01139242|CRC screening status|crc screening status
470495|NCT01139242|physical activity level|physical activity level
470496|NCT01139242|fruit and vegetable consumption|fruit and vegetable consumption
470497|NCT01139242|Early Detection of Cancer|early detection of cancer
470498|NCT01139242|Colorectal Cancer (CRC) screening status|colorectal cancer (crc) screening status
470499|NCT01139229|Esophagogastrostomy|esophagogastrostomy
470500|NCT01139229|Circular everted anastomosis|circular everted anastomosis
470501|NCT01139229|Side-side anastomosis|side-side anastomosis
470502|NCT01139229|Randomized clinical trial|randomized clinical trial
470503|NCT01139216|Digestive system diseases|digestive system diseases
470504|NCT01139216|Gastrointestinal diseases|gastrointestinal diseases
470505|NCT01139216|Intestinal diseases|intestinal diseases
470506|NCT01139216|Colonic inertia|colonic inertia
470507|NCT01139203|HBV recurrence|hbv recurrence
470508|NCT01139203|entecavir|entecavir
470509|NCT01139190|NSAID-induced gastroduodenal ulcerations or erosion|nsaid-induced gastroduodenal ulcerations or erosion
470510|NCT01139177|Peripheral vascular disease - SFA and popliteal arteries.|peripheral vascular disease - sfa and popliteal arteries.
470511|NCT01139164|high-risk hematological malignancies|high-risk hematological malignancies
470512|NCT01139151|Advanced Hematologic Malignancies|advanced hematologic malignancies
470513|NCT01139151|4'-Thio-araC|4'-thio-arac
470514|NCT01139151|Thiarabine|thiarabine
470515|NCT01139151|4'-thio-â-D-arabinofuranosylcytosine|4'-thio-â-d-arabinofuranosylcytosine
470516|NCT01139151|deoxycytidine nucleoside analog|deoxycytidine nucleoside analog
470517|NCT01139151|poor-risk myelodysplasia|poor-risk myelodysplasia
470518|NCT01139151|MDS|mds
470519|NCT01139151|refractory anemia|refractory anemia
470520|NCT01139151|Excess blasts|excess blasts
470521|NCT01139151|RAEB-1|raeb-1
470522|NCT01139151|RAEB-2|raeb-2
470523|NCT01139151|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
470524|NCT01139151|CMML|cmml
470525|NCT01139151|Relapsed/refractory leukemia|relapsed/refractory leukemia
470526|NCT01139151|Acute non-lymphocytic leukemia|acute non-lymphocytic leukemia
470528|NCT01139151|Acute lymphocytic leukemia|acute lymphocytic leukemia
470529|NCT01139151|ALL|all
470530|NCT01139151|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
470531|NCT01139151|CLL|cll
470532|NCT01139151|Chronic myelogenous leukemia|chronic myelogenous leukemia
470533|NCT01139151|CML|cml
470534|NCT01139151|blast crisis|blast crisis
470535|NCT01139138|Colorectal Cancer|colorectal cancer
470536|NCT01139138|Colorectal Carcinoma|colorectal carcinoma
470537|NCT01139138|Colorectal Tumors|colorectal tumors
470538|NCT01139138|Neoplasms, Colorectal|neoplasms, colorectal
470539|NCT01139112|Necrotizing Fasciitis, Klebsiella Pneumoniae|necrotizing fasciitis, klebsiella pneumoniae
470540|NCT01139086|chronic heart failure|chronic heart failure
470541|NCT01139086|isokinetic test|isokinetic test
470542|NCT01139086|near-infrared spectroscopy|near-infrared spectroscopy
470543|NCT01139086|laser Doppler flowmetry|laser doppler flowmetry
470544|NCT01139086|endothelial function|endothelial function
470545|NCT01139073|Halitosis|halitosis
470546|NCT01139060|chronic or recurrent depression|chronic or recurrent depression
470547|NCT01139021|Children|children
470548|NCT01139021|Meningococcal disease|meningococcal disease
470549|NCT01139021|Prevention|prevention
470550|NCT01139021|Vaccination|vaccination
470551|NCT01138995|Poststroke/CVA hemiparesis|poststroke/cva hemiparesis
470552|NCT01138995|Drop Foot|drop foot
470553|NCT01138995|Gait Disorders, Neurological|gait disorders, neurological
470554|NCT01138995|Gait, Drop foot|gait, drop foot
470555|NCT01138982|Youth mentoring|youth mentoring
470556|NCT01138982|Effectiveness|effectiveness
470557|NCT01138982|Sweden|sweden
470558|NCT01138982|low-risk youth|low-risk youth
470559|NCT01138969|proton pump inhibitor|proton pump inhibitor
470560|NCT01138969|peptic ulcer|peptic ulcer
470561|NCT01138969|clopidogrel|clopidogrel
470562|NCT01138969|prevention|prevention
470563|NCT01138956|Visceral leishmaniasis|visceral leishmaniasis
470564|NCT01138956|N-acetylcysteine|n-acetylcysteine
470565|NCT01138956|Antimony|antimony
470566|NCT01138956|Immune response|immune response
470567|NCT01138943|Chlorhexidine mouthrinse|chlorhexidine mouthrinse
470568|NCT01138943|Plaque control|plaque control
470569|NCT01138930|Polycystic Ovary Syndrome|polycystic ovary syndrome
470570|NCT01138930|Obesity|obesity
470571|NCT01138904|gastric cancer|gastric cancer
470572|NCT01138904|oxaliplatin|oxaliplatin
470573|NCT01138904|irinotecan|irinotecan
470574|NCT01138904|sequential treatment|sequential treatment
470575|NCT01138891|Breast implants|breast implants
470576|NCT01138891|capsular contraction|capsular contraction
470577|NCT01138891|sonication|sonication
470578|NCT01138891|biofilm|biofilm
470579|NCT01138891|Complications|complications
470580|NCT01138891|surgery|surgery
470581|NCT01138878|HIV|hiv
470582|NCT01138878|testing|testing
470583|NCT01138878|non traditional settings|non traditional settings
470584|NCT01138878|acceptability|acceptability
470585|NCT01138878|feasibility|feasibility
470587|NCT01138865|Cytokine levels|cytokine levels
470588|NCT01138865|Insulin resistance|insulin resistance
470589|NCT01138865|Hypertension|hypertension
470590|NCT01138865|Dyslipidemia|dyslipidemia
470591|NCT01138865|Albumin-creatinine ratio|albumin-creatinine ratio
470592|NCT01138865|Continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
470593|NCT01138852|post-cesarean infections|post-cesarean infections
470594|NCT01138852|ampicillin-sulbactam|ampicillin-sulbactam
470595|NCT01138852|cefuroxime|cefuroxime
470596|NCT01138852|cesarean|cesarean
470597|NCT01138839|HELLP 1|hellp 1
470598|NCT01138839|Dexamethasone|dexamethasone
470599|NCT01138839|Clinical trial|clinical trial
470600|NCT01138826|biological availability|biological availability
470601|NCT01138826|bioavailability|bioavailability
470602|NCT01138826|amlodipine|amlodipine
470603|NCT01138826|orally disintegrating tablet|orally disintegrating tablet
470604|NCT01138826|ODT|odt
470605|NCT01138826|tablets|tablets
470606|NCT01138813|magnetic resonance spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
470607|NCT01138813|lactate editing|lactate editing
470608|NCT01138813|metabolite content|metabolite content
470609|NCT01138813|glioma|glioma
470610|NCT01138774|Obesity|obesity
470611|NCT01138774|Calorie restriction|calorie restriction
470612|NCT01138774|Eicosapentaenoic acid (EPA)|eicosapentaenoic acid (epa)
470613|NCT01138774|Lipoic acid|lipoic acid
470614|NCT01138774|Weight loss|weight loss
470615|NCT01138774|Insulin sensitivity|insulin sensitivity
470616|NCT01138774|Lipid metabolism|lipid metabolism
470617|NCT01138774|Adipokines|adipokines
470618|NCT01138774|Inflammation|inflammation
470619|NCT01138774|Oxidative stress|oxidative stress
470620|NCT01138774|Adipose tissue gene profile|adipose tissue gene profile
470621|NCT01138774|Metabolomic profile|metabolomic profile
470622|NCT01138761|pediatric atopic dermatitis|pediatric atopic dermatitis
470623|NCT01138761|EASI|easi
470624|NCT01138761|REALM-SF|realm-sf
470625|NCT01138761|nurse instruction|nurse instruction
470626|NCT01138761|health literacy|health literacy
470627|NCT01138748|inoperable early stage non-small cell lung cancer|inoperable early stage non-small cell lung cancer
470628|NCT01138748|radiation therapy|radiation therapy
470629|NCT01138722|early stage non-small cell lung cancer|early stage non-small cell lung cancer
470630|NCT01138722|hypofractionated radiation therapy|hypofractionated radiation therapy
470631|NCT01138696|ACL|acl
470632|NCT01138683|Acute decompensated heart failure|acute decompensated heart failure
470633|NCT01138683|ultrafiltration|ultrafiltration
470634|NCT01138683|diuretics|diuretics
470635|NCT01138683|AKI|aki
470636|NCT01138657|inflammation of uvea|inflammation of uvea
470637|NCT01138644|Atrial Fibrillation|atrial fibrillation
470638|NCT01138644|Atrial Flutter|atrial flutter
470639|NCT01138631|IVF, Infertility, embryo selection, embryoscope, time-lapse|ivf, infertility, embryo selection, embryoscope, time-lapse
470640|NCT01138618|Clozapine|clozapine
470641|NCT01138618|hematological monitoring|hematological monitoring
470642|NCT01138618|CHEMPAQ|chempaq
470643|NCT01138618|Granulocytes|granulocytes
470644|NCT01138618|WBC|wbc
470645|NCT01138605|TMC114|tmc114
470646|NCT01138605|TMC114-TiDP29-C232|tmc114-tidp29-c232
470647|NCT01138605|TMC114-C232|tmc114-c232
470648|NCT01138605|Darunavir|darunavir
470649|NCT01138605|PREZISTA|prezista
470650|NCT01138579|FBTA05|fbta05
470651|NCT01138579|CD20|cd20
470652|NCT01138579|CLL|cll
470653|NCT01138579|NHL|nhl
470654|NCT01138579|DLI|dli
470655|NCT01138579|allogeneic transplantation|allogeneic transplantation
470656|NCT01138579|CD20 positive chronic lymphocytic leukemia (CLL)|cd20 positive chronic lymphocytic leukemia (cll)
470657|NCT01138579|low and high grade non-Hodgkin´s lymphoma (NHL) after allogeneic stem cell transplantation with active disease|low and high grade non-hodgkin´s lymphoma (nhl) after allogeneic stem cell transplantation with active disease
470658|NCT01138566|community-onset urinary tract infections caused by Enterobacteriaceae|community-onset urinary tract infections caused by enterobacteriaceae
470659|NCT01138553|biomarker|biomarker
470660|NCT01138553|breast cancer|breast cancer
470661|NCT01138553|antiprogesterone|antiprogesterone
470662|NCT01138540|VAP|vap
470663|NCT01138527|multi-parametric MRI approach|multi-parametric mri approach
470664|NCT01138475|PTH|pth
470665|NCT01138475|Gastric bypass surgery|gastric bypass surgery
470666|NCT01138475|vitamin D|vitamin d
470667|NCT01138475|paricalcitol|paricalcitol
470668|NCT01138462|Methicillin-Resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
470669|NCT01138462|Decolonisation|decolonisation
470670|NCT01138462|Nursing homes|nursing homes
470671|NCT01138462|Infection Control|infection control
470672|NCT01138449|Vitamin A|vitamin a
470673|NCT01138449|Neonatal mortality|neonatal mortality
470674|NCT01138449|Infant mortality|infant mortality
470675|NCT01138436|Venous Leg Ulcers, VLU|venous leg ulcers, vlu
470676|NCT01138423|Hypertension|hypertension
470677|NCT01138423|Metabolic Syndrome X|metabolic syndrome x
470678|NCT01138423|Obesity|obesity
470679|NCT01138423|Adiposity|adiposity
470680|NCT01138423|Clinical trial|clinical trial
470681|NCT01138410|Immunotherapy|immunotherapy
470682|NCT01138410|Melanoma|melanoma
470683|NCT01138410|Gene therapy|gene therapy
470685|NCT01138410|Cancer vaccine|cancer vaccine
470686|NCT01138410|Electroporation|electroporation
470687|NCT01138410|CTL response|ctl response
470688|NCT01138397|Influenza|influenza
470689|NCT01138397|Influenza vaccine|influenza vaccine
470690|NCT01138397|Influenza virus|influenza virus
470691|NCT01138397|Intradermal|intradermal
470692|NCT01138384|Breast Cancer|breast cancer
470693|NCT01138371|LDL apheresis|ldl apheresis
470694|NCT01138371|Familial hypercholesterolemia|familial hypercholesterolemia
470695|NCT01138371|Inflammatory markers|inflammatory markers
470696|NCT01138371|Hyperlipidemia|hyperlipidemia
470697|NCT01138371|Cardiovascular disease|cardiovascular disease
470698|NCT01138358|dyspnea|dyspnea
470699|NCT01138358|lung metastases|lung metastases
470700|NCT01138358|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
470701|NCT01138358|recurrent small cell lung cancer|recurrent small cell lung cancer
470702|NCT01138358|extensive stage small cell lung cancer|extensive stage small cell lung cancer
470703|NCT01138358|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
470704|NCT01138358|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
470705|NCT01138358|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
470706|NCT01138345|cancer survivor|cancer survivor
470707|NCT01138345|stage I breast cancer|stage i breast cancer
470708|NCT01138345|stage II breast cancer|stage ii breast cancer
470709|NCT01138345|stage IIIA breast cancer|stage iiia breast cancer
470710|NCT01138345|stage IIIB breast cancer|stage iiib breast cancer
470711|NCT01138345|stage IIIC breast cancer|stage iiic breast cancer
470712|NCT01138332|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
470713|NCT01138319|adult acute myeloid leukemia|adult acute myeloid leukemia
470714|NCT01138319|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
470715|NCT01138306|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
470716|NCT01138293|differences between patients´ self-assessment and objective perception of physical activity and eating habits|differences between patients´ self-assessment and objective perception of physical activity and eating habits
470717|NCT01138280|biofilm formation|biofilm formation
470718|NCT01138280|proinflammatory cytokines|proinflammatory cytokines
470719|NCT01138280|high sensitive c reactive protein|high sensitive c reactive protein
470720|NCT01138280|cardiovascular events|cardiovascular events
470721|NCT01138280|overall mortality|overall mortality
470722|NCT01138280|hemodialysis|hemodialysis
470723|NCT01138267|pharmacogenomics|pharmacogenomics
470724|NCT01138267|ATV|atv
470725|NCT01138267|EFV|efv
470726|NCT01138267|pharmacogenomics of ATV and EFV|pharmacogenomics of atv and efv
470727|NCT01138254|flow,echocardiography,far infrared therapy,nitric oxide|flow,echocardiography,far infrared therapy,nitric oxide
470728|NCT01138241|HIV|hiv
470729|NCT01138241|Chronic kidney disease|chronic kidney disease
470730|NCT01138241|Glomerular Filtration Rate (GFR)|glomerular filtration rate (gfr)
470731|NCT01138241|Tenofovir|tenofovir
470732|NCT01138241|Serum creatinine (sCr)|serum creatinine (scr)
470733|NCT01138241|24 hr urine creatinine clearance|24 hr urine creatinine clearance
470734|NCT01138241|Serum Cystatin C[40]|serum cystatin c[40]
470735|NCT01138241|Modification of Diet in Renal Disease (MDRD)|modification of diet in renal disease (mdrd)
470736|NCT01138241|Cockcroft Gault Equation|cockcroft gault equation
470737|NCT01138241|Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI)|chronic kidney disease epidemiology collaboration (ckd-epi)
470738|NCT01138241|99mTc-diethylenetriaminepentaacetic acid (Tc-99m DTPA) scan|99mtc-diethylenetriaminepentaacetic acid (tc-99m dtpa) scan
470739|NCT01138241|Validate which renal function assessments can accurately detect GFR and assess the effect of TDF concentration on renal function|validate which renal function assessments can accurately detect gfr and assess the effect of tdf concentration on renal function
470740|NCT01138228|intravenous cannulation|intravenous cannulation
470741|NCT01138228|vein identification|vein identification
470742|NCT01138228|vascular identification|vascular identification
470743|NCT01138228|vein cannulation|vein cannulation
470744|NCT01138215|varicella-zoster virus vaccine|varicella-zoster virus vaccine
470745|NCT01138215|varicella-zoster virus antibody|varicella-zoster virus antibody
470746|NCT01138215|immunogenicity|immunogenicity
470747|NCT01138215|safety and efficacy|safety and efficacy
470748|NCT01138215|HIV-infected children|hiv-infected children
470749|NCT01138215|Assess protective VZV Antibody|assess protective vzv antibody
470750|NCT01138215|Adverse events from VZV vaccine|adverse events from vzv vaccine
470751|NCT01138202|pharmacokinetics|pharmacokinetics
470752|NCT01138202|safety|safety
470753|NCT01138202|efficacy|efficacy
470754|NCT01138202|Lopinavir/ritonavir|lopinavir/ritonavir
470755|NCT01138202|HIV/TB|hiv/tb
470756|NCT01138202|rifampicin containing anti-tuberculosis therapy|rifampicin containing anti-tuberculosis therapy
470757|NCT01138202|Pharmacokinetics and safety of Lopinavir/ritonavir with rifampicin containing anti-tuberculosis therapy|pharmacokinetics and safety of lopinavir/ritonavir with rifampicin containing anti-tuberculosis therapy
470758|NCT01138189|Wavefront-guided LASIK.|wavefront-guided lasik.
470759|NCT01138189|Wavefront-optimized LASIK.|wavefront-optimized lasik.
470760|NCT01138189|Custom LASIK|custom lasik
470761|NCT01138176|Neonatal encephalopathy|neonatal encephalopathy
470762|NCT01138176|Therapeutic hypothermia|therapeutic hypothermia
471585|NCT01135940|dermabond|dermabond
470763|NCT01138176|Phase changing material|phase changing material
470764|NCT01138176|MR imaging|mr imaging
470765|NCT01138163|NSCLC|nsclc
470766|NCT01138163|second-line|second-line
470767|NCT01138163|lung cancer|lung cancer
470768|NCT01138163|non small cell lung cancer|non small cell lung cancer
470769|NCT01138163|bavituximab|bavituximab
470770|NCT01138163|monoclonal antibody|monoclonal antibody
470771|NCT01138150|migraine, headache, sumatriptan, naproxen sodium|migraine, headache, sumatriptan, naproxen sodium
470772|NCT01138137|ovarian cancer|ovarian cancer
470773|NCT01138137|epithelial ovarian cancer|epithelial ovarian cancer
470774|NCT01138137|peritoneal cancer|peritoneal cancer
470775|NCT01138124|renal cell carcinoma|renal cell carcinoma
470776|NCT01138124|epidemiology|epidemiology
470777|NCT01138124|pancreatic cancer|pancreatic cancer
470778|NCT01138124|renal cancer|renal cancer
470779|NCT01138124|renal pelvis cancer|renal pelvis cancer
470780|NCT01138124|GPRD|gprd
470781|NCT01138124|case-control|case-control
470782|NCT01138124|Gapabentin|gapabentin
470783|NCT01138111|Florbetaben|florbetaben
470784|NCT01138111|Amyloid beta-protein|amyloid beta-protein
470786|NCT01138111|Alzheimer's disease|alzheimer's disease
470787|NCT01138098|Persistence|persistence
470788|NCT01138098|challenge dose|challenge dose
470789|NCT01138098|Engerix-B|engerix-b
470790|NCT01138098|immune response|immune response
470791|NCT01138085|Triple negative breast cancer|triple negative breast cancer
470792|NCT01138085|BRAF wild-type melanoma|braf wild-type melanoma
470793|NCT01138085|Solid tumors|solid tumors
470794|NCT01138085|Endometrial Cancer|endometrial cancer
470795|NCT01138085|Oncology|oncology
470796|NCT01138085|GSK2141795|gsk2141795
470797|NCT01138085|AKT Inhibitor|akt inhibitor
470798|NCT01138085|GSK1120212|gsk1120212
470799|NCT01138072|GSK2248761, atorvastatin, rosuvastatin, simvastatin, drug interaction, pharmacokinetics|gsk2248761, atorvastatin, rosuvastatin, simvastatin, drug interaction, pharmacokinetics
470800|NCT01138059|Acute ischemic stroke with unclear onset time|acute ischemic stroke with unclear onset time
470801|NCT01138046|advanced/metastatic breast cancer|advanced/metastatic breast cancer
470802|NCT01138046|lapatinib|lapatinib
470803|NCT01138046|ErbB2|erbb2
470804|NCT01138046|ErbB2-overexpressing|erbb2-overexpressing
470805|NCT01138046|pharmacokinetics|pharmacokinetics
470806|NCT01138046|dual kinase inhibitor|dual kinase inhibitor
470807|NCT01138046|HER-2/neu|her-2/neu
470808|NCT01138046|EGFR|egfr
470809|NCT01138046|ErbB1|erbb1
470810|NCT01138033|pharmacodynamics|pharmacodynamics
470811|NCT01138033|cancer|cancer
470812|NCT01138033|focal adhesion kinase inhibitor|focal adhesion kinase inhibitor
470813|NCT01138033|pharmacokinetics|pharmacokinetics
470814|NCT01138033|solid tumors|solid tumors
470815|NCT01138033|Phase 1|phase 1
470816|NCT01138020|Rehabilitation Outcome|rehabilitation outcome
470817|NCT01138020|Cognitive treatment|cognitive treatment
470818|NCT01138020|TBI|tbi
470819|NCT01138007|Bupropion|bupropion
470820|NCT01138007|323U66 Sustained Release (SR)|323u66 sustained release (sr)
470821|NCT01138007|MDD (Major Depressive Disorder)|mdd (major depressive disorder)
470822|NCT01138007|IVRS HAM-D|ivrs ham-d
470823|NCT01138007|IDS-SR|ids-sr
470824|NCT01138007|MADRS|madrs
470825|NCT01137994|ErbB2|erbb2
470826|NCT01137994|Trastuzumab|trastuzumab
470827|NCT01137994|p95HER2|p95her2
470828|NCT01137994|Metastatic Breast Cancer|metastatic breast cancer
470829|NCT01137994|HER2|her2
470830|NCT01137994|Lapatinib|lapatinib
470831|NCT01137981|Combivir (Zidovudine+Lamivudine)|combivir (zidovudine+lamivudine)
470832|NCT01137981|Antiretrovirals|antiretrovirals
470833|NCT01137981|ARV|arv
470834|NCT01137981|HAART|haart
470835|NCT01137981|Maraviroc|maraviroc
470836|NCT01137981|Delavirdine|delavirdine
470837|NCT01137981|Lamivudine|lamivudine
470838|NCT01137981|Antiretroviral Pregnancy Registry|antiretroviral pregnancy registry
470839|NCT01137981|Fosamprenavir|fosamprenavir
470840|NCT01137981|APR|apr
470841|NCT01137981|Zidovudine|zidovudine
470842|NCT01137981|pregnancy registry|pregnancy registry
470843|NCT01137981|Amprenavir|amprenavir
470844|NCT01137981|HIV|hiv
470845|NCT01137981|Trizivir (Abacavir+Lamivudine+Zidovudine)|trizivir (abacavir+lamivudine+zidovudine)
470846|NCT01137981|Epzicom (Abacavir+Lamivudine)|epzicom (abacavir+lamivudine)
470847|NCT01137968|imetelstat|imetelstat
470848|NCT01137968|imetelstat sodium|imetelstat sodium
470849|NCT01137968|GRN163L|grn163l
470850|NCT01137968|telomerase inhibitor|telomerase inhibitor
470851|NCT01137968|telomerase inhibition|telomerase inhibition
470852|NCT01137968|maintenance therapy|maintenance therapy
470853|NCT01137968|non-small cell lung cancer|non-small cell lung cancer
470854|NCT01137968|relapsed non-small cell lung cancer|relapsed non-small cell lung cancer
470855|NCT01137968|advanced non-small cell lung cancer|advanced non-small cell lung cancer
470856|NCT01137968|NSCLC, cancer stem cells|nsclc, cancer stem cells
470857|NCT01137968|Bevacizumab|bevacizumab
470858|NCT01137968|post induction chemotherapy|post induction chemotherapy
470859|NCT01137955|Gastrointestinal Symptom Rating Scale (GSRS)|gastrointestinal symptom rating scale (gsrs)
470860|NCT01137955|Poorly responsive|poorly responsive
470861|NCT01137955|Refractory|refractory
471586|NCT01135940|infection|infection
470862|NCT01137955|Small intestine bacterial overgrowth|small intestine bacterial overgrowth
470863|NCT01137955|Breath test|breath test
470864|NCT01137942|helicobacter pylori|helicobacter pylori
470865|NCT01137942|eradication failure|eradication failure
470866|NCT01137929|Vesicoureteral reflux|vesicoureteral reflux
470867|NCT01137929|Kidney|kidney
470868|NCT01137929|Renal Scar|renal scar
470869|NCT01137929|Urinary tract infection|urinary tract infection
470870|NCT01137903|Diabetic foot|diabetic foot
470871|NCT01137903|Osteomyelitis|osteomyelitis
470872|NCT01137903|Diabetic foot ulcers|diabetic foot ulcers
470873|NCT01137903|Foot infections|foot infections
470874|NCT01137890|cocaine|cocaine
470875|NCT01137890|addiction|addiction
470876|NCT01137890|drug dependence|drug dependence
470877|NCT01137890|anticonvulsant|anticonvulsant
470878|NCT01137890|zonisamide|zonisamide
470879|NCT01137890|drug self-administration|drug self-administration
470880|NCT01137890|nicotine withdrawal|nicotine withdrawal
470881|NCT01137890|neurocognition|neurocognition
470882|NCT01137864|Emergency wards|emergency wards
470883|NCT01137864|Hospitalization|hospitalization
470884|NCT01137864|Adults|adults
470885|NCT01137864|Antimicrobial therapy|antimicrobial therapy
470886|NCT01137825|cognitive/functional effects|cognitive/functional effects
470887|NCT01137825|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
470888|NCT01137825|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
470889|NCT01137825|acute undifferentiated leukemia|acute undifferentiated leukemia
470890|NCT01137825|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
470891|NCT01137825|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
470892|NCT01137825|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
470893|NCT01137825|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
470894|NCT01137825|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
470895|NCT01137825|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
470896|NCT01137825|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
470897|NCT01137825|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
470898|NCT01137825|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
470899|NCT01137825|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
470900|NCT01137825|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
470901|NCT01137825|mast cell leukemia|mast cell leukemia
470902|NCT01137825|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
470903|NCT01137825|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
470904|NCT01137825|prolymphocytic leukemia|prolymphocytic leukemia
470905|NCT01137825|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
470906|NCT01137825|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
470907|NCT01137825|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
470908|NCT01137825|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
470909|NCT01137825|refractory hairy cell leukemia|refractory hairy cell leukemia
470910|NCT01137825|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
470911|NCT01137825|secondary acute myeloid leukemia|secondary acute myeloid leukemia
470912|NCT01137825|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
470913|NCT01137825|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
470914|NCT01137825|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
470915|NCT01137825|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
470916|NCT01137825|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
470917|NCT01137825|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
470918|NCT01137825|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
470919|NCT01137825|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
470920|NCT01137825|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
470921|NCT01137825|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
470922|NCT01137825|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
470923|NCT01137825|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
470924|NCT01137825|untreated hairy cell leukemia|untreated hairy cell leukemia
470925|NCT01137825|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
470926|NCT01137825|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
470927|NCT01137825|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
470928|NCT01137825|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
470929|NCT01137825|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
470930|NCT01137825|anaplastic large cell lymphoma|anaplastic large cell lymphoma
470931|NCT01137825|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
470932|NCT01137825|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
470933|NCT01137825|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
470934|NCT01137825|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
471688|NCT01135459|Lupus|lupus
470935|NCT01137825|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
470936|NCT01137825|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
470937|NCT01137825|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
470938|NCT01137825|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
470939|NCT01137825|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
470940|NCT01137825|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
470941|NCT01137825|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
470942|NCT01137825|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
470943|NCT01137825|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
470944|NCT01137825|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
470945|NCT01137825|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
470946|NCT01137825|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
470947|NCT01137825|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
470948|NCT01137825|splenic marginal zone lymphoma|splenic marginal zone lymphoma
470949|NCT01137825|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
470950|NCT01137825|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
470951|NCT01137825|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
470952|NCT01137825|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
470953|NCT01137825|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
470954|NCT01137825|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
470955|NCT01137825|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
470956|NCT01137825|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
470957|NCT01137825|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
470958|NCT01137825|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
470959|NCT01137825|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
470960|NCT01137825|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
470961|NCT01137825|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
470962|NCT01137825|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
470963|NCT01137825|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
470964|NCT01137825|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
470965|NCT01137825|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
470966|NCT01137825|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
470967|NCT01137825|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
470968|NCT01137825|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
470969|NCT01137825|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
470970|NCT01137825|stage I mantle cell lymphoma|stage i mantle cell lymphoma
470971|NCT01137825|stage I marginal zone lymphoma|stage i marginal zone lymphoma
470972|NCT01137825|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
470973|NCT01137825|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
470974|NCT01137825|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
470975|NCT01137825|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
471081|NCT01137682|hormone disorder|hormone disorder
470976|NCT01137825|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
470977|NCT01137825|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
470978|NCT01137825|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
470979|NCT01137825|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
470980|NCT01137825|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
470981|NCT01137825|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
470982|NCT01137825|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
470983|NCT01137825|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
470984|NCT01137825|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
470985|NCT01137825|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
470986|NCT01137825|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
470987|NCT01137825|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
470988|NCT01137825|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
470989|NCT01137825|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
470990|NCT01137825|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
470991|NCT01137825|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
470992|NCT01137825|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
471072|NCT01137708|drug interactions|drug interactions
470993|NCT01137825|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
470994|NCT01137825|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
470995|NCT01137825|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
470996|NCT01137825|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
470997|NCT01137825|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
470998|NCT01137825|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
470999|NCT01137825|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
471000|NCT01137825|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
471001|NCT01137825|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
471002|NCT01137825|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
471003|NCT01137825|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
471004|NCT01137825|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
471005|NCT01137825|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
471006|NCT01137825|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
471007|NCT01137825|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
471008|NCT01137825|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
471009|NCT01137825|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
471010|NCT01137825|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
471011|NCT01137825|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
471012|NCT01137825|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
471013|NCT01137825|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
471014|NCT01137825|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
471015|NCT01137825|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
471016|NCT01137825|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
471017|NCT01137825|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
471018|NCT01137825|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
471019|NCT01137825|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
471020|NCT01137825|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
471021|NCT01137825|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
471022|NCT01137825|intraocular lymphoma|intraocular lymphoma
471023|NCT01137825|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
471024|NCT01137825|chronic eosinophilic leukemia|chronic eosinophilic leukemia
471025|NCT01137825|chronic neutrophilic leukemia|chronic neutrophilic leukemia
471026|NCT01137825|primary myelofibrosis|primary myelofibrosis
471027|NCT01137825|essential thrombocythemia|essential thrombocythemia
471028|NCT01137825|polycythemia vera|polycythemia vera
471029|NCT01137825|extramedullary plasmacytoma|extramedullary plasmacytoma
471030|NCT01137825|isolated plasmacytoma of bone|isolated plasmacytoma of bone
471031|NCT01137825|stage I multiple myeloma|stage i multiple myeloma
471032|NCT01137825|stage II multiple myeloma|stage ii multiple myeloma
471033|NCT01137825|stage III multiple myeloma|stage iii multiple myeloma
471034|NCT01137825|primary systemic amyloidosis|primary systemic amyloidosis
471035|NCT01137825|refractory multiple myeloma|refractory multiple myeloma
471036|NCT01137825|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
471037|NCT01137825|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
471038|NCT01137825|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
471039|NCT01137825|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
471040|NCT01137812|Canagliflozin|canagliflozin
471041|NCT01137812|Sitagliptin (Januvia)|sitagliptin (januvia)
471042|NCT01137812|Metformin|metformin
471043|NCT01137812|Sulphonylurea|sulphonylurea
471044|NCT01137812|Hemoglobin A1c|hemoglobin a1c
471045|NCT01137812|Type 2 diabetes mellitus|type 2 diabetes mellitus
471046|NCT01137799|symptomatic treatment|symptomatic treatment
471047|NCT01137799|cognition|cognition
471048|NCT01137799|cognitive deficits|cognitive deficits
471049|NCT01137799|schizophrenia|schizophrenia
471050|NCT01137799|Alzheimer's Disease|alzheimer's disease
471051|NCT01137773|SAH (Subarachnoid Hemorrhage)|sah (subarachnoid hemorrhage)
471052|NCT01137773|Brain Hemorrhage|brain hemorrhage
471053|NCT01137773|Traumatic Brain Injury|traumatic brain injury
471054|NCT01137773|SAH|sah
471055|NCT01137773|ICH|ich
471056|NCT01137760|adults|adults
471057|NCT01137760|fiber|fiber
471058|NCT01137760|cold|cold
471059|NCT01137760|flu|flu
471060|NCT01137760|stress|stress
471061|NCT01137760|microbiota|microbiota
471062|NCT01137747|carfilzomib|carfilzomib
471063|NCT01137747|acute myeloid leukemia|acute myeloid leukemia
471064|NCT01137747|acute lymphoblastic leukemia|acute lymphoblastic leukemia
471065|NCT01137747|phase I|phase i
471066|NCT01137734|Heart Diseases|heart diseases
471067|NCT01137734|Heart Valve Diseases|heart valve diseases
471068|NCT01137734|Cardiovascular Diseases|cardiovascular diseases
471069|NCT01137721|magnetic resonance imaging|magnetic resonance imaging
471070|NCT01137721|sickle cell disease|sickle cell disease
471071|NCT01137721|hydroxyurea therapy|hydroxyurea therapy
471074|NCT01137708|oral contraceptive|oral contraceptive
471075|NCT01137708|anti-rheumatic agents|anti-rheumatic agents
471076|NCT01137695|pramlintide|pramlintide
471077|NCT01137695|glucose|glucose
471078|NCT01137695|type 2 diabetes mellitus|type 2 diabetes mellitus
471079|NCT01137695|amylin|amylin
471080|NCT01137682|Acromegaly|acromegaly
471082|NCT01137682|growth hormone|growth hormone
471083|NCT01137682|insulin like growth factor-1|insulin like growth factor-1
471084|NCT01137682|pituitary tumor|pituitary tumor
471085|NCT01137682|pasireotide|pasireotide
471086|NCT01137682|SOM230|som230
471087|NCT01137669|immunocompromised,parent protocol,shingles,varicella-zoster virus,ZOSTAVAX®|immunocompromised,parent protocol,shingles,varicella-zoster virus,zostavax®
471088|NCT01137656|Blood storage|blood storage
471089|NCT01137656|Blood transfusion|blood transfusion
471090|NCT01137656|Aged blood|aged blood
471091|NCT01137656|Blood Forearm|blood forearm
471092|NCT01137656|Storage lesion in blood|storage lesion in blood
471093|NCT01137643|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
471094|NCT01137643|acute undifferentiated leukemia|acute undifferentiated leukemia
471095|NCT01137643|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
471096|NCT01137643|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
471097|NCT01137643|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
471098|NCT01137643|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
471099|NCT01137643|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
471100|NCT01137643|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
471101|NCT01137643|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
471102|NCT01137643|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
471103|NCT01137643|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
471104|NCT01137643|mast cell leukemia|mast cell leukemia
471105|NCT01137643|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
471106|NCT01137643|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
471107|NCT01137643|prolymphocytic leukemia|prolymphocytic leukemia
471108|NCT01137643|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
471109|NCT01137643|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
471110|NCT01137643|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
471111|NCT01137643|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
471112|NCT01137643|refractory hairy cell leukemia|refractory hairy cell leukemia
471113|NCT01137643|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
471114|NCT01137643|secondary acute myeloid leukemia|secondary acute myeloid leukemia
471115|NCT01137643|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
471116|NCT01137643|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
471117|NCT01137643|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
471118|NCT01137643|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
471119|NCT01137643|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
471120|NCT01137643|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
471121|NCT01137643|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
471122|NCT01137643|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
471123|NCT01137643|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
471124|NCT01137643|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
471125|NCT01137643|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
471126|NCT01137643|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
471127|NCT01137643|untreated hairy cell leukemia|untreated hairy cell leukemia
471128|NCT01137643|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
471129|NCT01137643|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
471130|NCT01137643|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
471131|NCT01137643|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
471132|NCT01137643|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
471133|NCT01137643|anaplastic large cell lymphoma|anaplastic large cell lymphoma
471134|NCT01137643|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
471135|NCT01137643|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
471136|NCT01137643|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
471137|NCT01137643|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
471138|NCT01137643|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
471139|NCT01137643|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
471140|NCT01137643|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
471141|NCT01137643|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
471142|NCT01137643|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
471143|NCT01137643|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
471144|NCT01137643|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
471145|NCT01137643|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
471146|NCT01137643|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
471147|NCT01137643|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
471148|NCT01137643|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
471149|NCT01137643|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
471150|NCT01137643|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
471151|NCT01137643|splenic marginal zone lymphoma|splenic marginal zone lymphoma
471152|NCT01137643|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
471153|NCT01137643|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
471154|NCT01137643|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
471155|NCT01137643|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
471156|NCT01137643|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
471157|NCT01137643|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
471158|NCT01137643|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
471159|NCT01137643|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
471160|NCT01137643|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
471161|NCT01137643|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
471162|NCT01137643|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
471163|NCT01137643|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
471164|NCT01137643|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
471165|NCT01137643|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
471166|NCT01137643|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
471167|NCT01137643|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
471168|NCT01137643|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
471169|NCT01137643|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
471170|NCT01137643|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
471171|NCT01137643|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
471172|NCT01137643|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
471173|NCT01137643|stage I mantle cell lymphoma|stage i mantle cell lymphoma
471174|NCT01137643|stage I marginal zone lymphoma|stage i marginal zone lymphoma
471175|NCT01137643|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
471176|NCT01137643|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
471177|NCT01137643|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
471178|NCT01137643|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
471179|NCT01137643|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
471180|NCT01137643|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
471181|NCT01137643|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
471182|NCT01137643|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
471183|NCT01137643|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
471184|NCT01137643|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
471185|NCT01137643|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
471186|NCT01137643|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
471187|NCT01137643|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
471188|NCT01137643|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
471189|NCT01137643|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
471190|NCT01137643|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
471191|NCT01137643|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
471192|NCT01137643|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
471193|NCT01137643|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
471194|NCT01137643|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
471195|NCT01137643|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
471196|NCT01137643|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
471197|NCT01137643|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
471198|NCT01137643|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
471199|NCT01137643|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
471200|NCT01137643|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
471201|NCT01137643|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
471202|NCT01137643|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
471203|NCT01137643|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
471287|NCT01137474|Diabetes Mellitus|diabetes mellitus
471204|NCT01137643|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
471205|NCT01137643|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
471206|NCT01137643|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
471207|NCT01137643|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
471208|NCT01137643|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
471209|NCT01137643|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
471210|NCT01137643|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
471211|NCT01137643|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
471212|NCT01137643|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
471213|NCT01137643|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
471214|NCT01137643|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
471215|NCT01137643|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
471216|NCT01137643|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
471217|NCT01137643|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
471218|NCT01137643|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
471219|NCT01137643|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
471220|NCT01137643|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
471221|NCT01137643|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
471222|NCT01137643|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
471223|NCT01137643|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
471224|NCT01137643|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
471225|NCT01137643|intraocular lymphoma|intraocular lymphoma
471226|NCT01137643|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
471227|NCT01137643|chronic eosinophilic leukemia|chronic eosinophilic leukemia
471228|NCT01137643|chronic neutrophilic leukemia|chronic neutrophilic leukemia
471229|NCT01137643|primary myelofibrosis|primary myelofibrosis
471230|NCT01137643|essential thrombocythemia|essential thrombocythemia
471231|NCT01137643|polycythemia vera|polycythemia vera
471232|NCT01137643|extramedullary plasmacytoma|extramedullary plasmacytoma
471233|NCT01137643|isolated plasmacytoma of bone|isolated plasmacytoma of bone
471234|NCT01137643|stage I multiple myeloma|stage i multiple myeloma
471235|NCT01137643|stage II multiple myeloma|stage ii multiple myeloma
471236|NCT01137643|stage III multiple myeloma|stage iii multiple myeloma
471237|NCT01137643|primary systemic amyloidosis|primary systemic amyloidosis
471238|NCT01137643|refractory multiple myeloma|refractory multiple myeloma
471239|NCT01137643|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
471240|NCT01137643|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
471241|NCT01137643|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
471242|NCT01137643|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
471243|NCT01137643|aplastic anemia|aplastic anemia
471244|NCT01137630|seborrhoeic dermatitis|seborrhoeic dermatitis
471245|NCT01137630|scalp|scalp
471246|NCT01137630|K40a|k40a
471247|NCT01137630|K40b|k40b
471248|NCT01137617|spinal cord stimualtor|spinal cord stimualtor
471249|NCT01137591|Acetaminophen|acetaminophen
471250|NCT01137591|Acetylcysteine|acetylcysteine
471251|NCT01137591|Antidotes|antidotes
471252|NCT01137565|Amgen|amgen
471253|NCT01137565|Adolescent|adolescent
471254|NCT01137565|Safety|safety
471255|NCT01137552|First-In-Human|first-in-human
471256|NCT01137552|Dose Escalation|dose escalation
471257|NCT01137552|Dose Expansion|dose expansion
471258|NCT01137552|Advance Solid Tumors|advance solid tumors
471259|NCT01137552|Anti-Angiopoietin|anti-angiopoietin
471260|NCT01137552|Advance Malignancy|advance malignancy
471261|NCT01137552|Cancer|cancer
471262|NCT01137552|Oncology|oncology
471263|NCT01137552|Oncology Patients|oncology patients
471264|NCT01137552|Phase 1|phase 1
471265|NCT01137552|Clinical Trial|clinical trial
471266|NCT01137552|Tumors|tumors
471267|NCT01137552|Solid Tumors|solid tumors
471268|NCT01137552|Angiogenesis Inhibitors|angiogenesis inhibitors
471269|NCT01137539|urinary incontinence|urinary incontinence
471270|NCT01137539|stress urinary incontinence|stress urinary incontinence
471271|NCT01137539|mid-urethral slings|mid-urethral slings
471272|NCT01137539|Tension-free vaginal taping|tension-free vaginal taping
471273|NCT01137539|TVT|tvt
471274|NCT01137513|Chest Pain|chest pain
471275|NCT01137513|Acute coronary syndrome|acute coronary syndrome
471276|NCT01137513|AMI|ami
471277|NCT01137487|mechanical ventilation|mechanical ventilation
471278|NCT01137487|enteral nutrition|enteral nutrition
471279|NCT01137487|Ventilation-Associated Pneumonia|ventilation-associated pneumonia
471280|NCT01137487|residual gastric volume measurement|residual gastric volume measurement
471281|NCT01137487|vomiting|vomiting
471282|NCT01137487|gastro-oesophageal reflux|gastro-oesophageal reflux
471283|NCT01137487|early enteral nutrition|early enteral nutrition
471284|NCT01137487|Intensive care unit|intensive care unit
471285|NCT01137487|Enteral Feeding|enteral feeding
471286|NCT01137474|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
471288|NCT01137474|Endocrine System Diseases|endocrine system diseases
471289|NCT01137474|Glucose Metabolism Disorders|glucose metabolism disorders
471290|NCT01137474|Metabolic Diseases|metabolic diseases
471291|NCT01137474|Angiotensin Receptor Antagonists|angiotensin receptor antagonists
471292|NCT01137474|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors
471293|NCT01137474|Hypoglycemic Agents|hypoglycemic agents
471294|NCT01137474|Pharmacologic Actions|pharmacologic actions
471295|NCT01137474|Physiological Effects of Drugs|physiological effects of drugs
471296|NCT01137461|Female infertility with indication of oocyte reception|female infertility with indication of oocyte reception
471297|NCT01137448|Psoriasis|psoriasis
471298|NCT01137448|Obesity|obesity
471299|NCT01137435|Adacel|adacel
471300|NCT01137435|Diphtheria|diphtheria
471301|NCT01137435|Tetanus|tetanus
471302|NCT01137435|Pertussis|pertussis
471303|NCT01137383|Hepatitis C|hepatitis c
471304|NCT01137331|seborrhoeic eczema|seborrhoeic eczema
471305|NCT01137331|scalp|scalp
471306|NCT01137331|dandruff|dandruff
471307|NCT01137331|K301|k301
471308|NCT01137331|K40|k40
471309|NCT01137318|ADHD|adhd
471310|NCT01137318|Impairment|impairment
471311|NCT01137318|Treatment|treatment
471312|NCT01137318|Cognitive Remediation|cognitive remediation
471313|NCT01137318|Behavioral Parent Training|behavioral parent training
471314|NCT01137305|Virtual reality|virtual reality
471315|NCT01137305|surgical training|surgical training
471316|NCT01137305|Health Care [N]|health care [n]
471317|NCT01137292|observational study|observational study
471318|NCT01137292|voriconazole|voriconazole
471319|NCT01137292|high-risk patients|high-risk patients
471320|NCT01137266|chronic pain osteo-arthritis in one or both knees, adults|chronic pain osteo-arthritis in one or both knees, adults
471321|NCT01137253|Nitric Oxide|nitric oxide
471322|NCT01137253|Autonomic Nervous System|autonomic nervous system
471323|NCT01137240|subjects suffering from mitochondrial disorders with one or more gastrointestinal symptoms would be the focus of the study|subjects suffering from mitochondrial disorders with one or more gastrointestinal symptoms would be the focus of the study
471324|NCT01137227|Physical activity|physical activity
471325|NCT01137227|Epidemiology|epidemiology
471326|NCT01137227|Questionnaire|questionnaire
471327|NCT01137227|Cross-sectional study|cross-sectional study
471328|NCT01137214|complex sleep apnea|complex sleep apnea
471329|NCT01137201|Small bowel obstruction|small bowel obstruction
471330|NCT01137201|Laparoscopic gastric bypass|laparoscopic gastric bypass
471331|NCT01137201|Internal Hernia|internal hernia
471332|NCT01137201|Mesenteric defect|mesenteric defect
471333|NCT01137201|Morbid obesity|morbid obesity
471334|NCT01137175|Rickettsioses|rickettsioses
471335|NCT01137175|Scrub Typhus|scrub typhus
471336|NCT01137175|Q fever|q fever
471337|NCT01137175|Typhus fever|typhus fever
471338|NCT01137175|Spotted fever|spotted fever
471339|NCT01137175|Rickettsioses reported cases|rickettsioses reported cases
471340|NCT01137149|Adolescent Depression|adolescent depression
471341|NCT01137149|Treatment of depression in adolescents|treatment of depression in adolescents
471342|NCT01137149|Behavioral activation treatment for depressed adolescents|behavioral activation treatment for depressed adolescents
471343|NCT01137123|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
471344|NCT01137110|Subarachnoid Hemorrhage|subarachnoid hemorrhage
471345|NCT01137110|Seizure Prophylaxis|seizure prophylaxis
471346|NCT01137110|Levetiracetam|levetiracetam
471347|NCT01137045|rabies vaccine|rabies vaccine
471348|NCT01137045|vero cells|vero cells
471349|NCT01137045|serology|serology
471350|NCT01137045|safety|safety
471351|NCT01137032|Psoriasis|psoriasis
471352|NCT01137032|Atopic Dermatitis|atopic dermatitis
471353|NCT01137019|Drug-eluting stents|drug-eluting stents
471354|NCT01137019|Tomography, Optical Coherence|tomography, optical coherence
471355|NCT01137006|Melanoma|melanoma
471356|NCT01137006|Phase I|phase i
471357|NCT01137006|antibody|antibody
471358|NCT01137006|melanin|melanin
471359|NCT01137006|tyrosinase related protein 1|tyrosinase related protein 1
471360|NCT01137006|glycoprotein|glycoprotein
471361|NCT01137006|20D7S|20d7s
471362|NCT01136993|Stroke|stroke
471363|NCT01136993|Thrombolysis|thrombolysis
471364|NCT01136993|Telestroke|telestroke
471365|NCT01136980|GERD|gerd
471366|NCT01136980|Esophagitis|esophagitis
471367|NCT01136980|Fundoplication|fundoplication
471368|NCT01136980|Anti-reflux surgery|anti-reflux surgery
471369|NCT01136980|PPI dependent|ppi dependent
471370|NCT01136928|Antiretroviral therapy|antiretroviral therapy
471371|NCT01136928|American ginseng|american ginseng
471372|NCT01136928|Efavirenz|efavirenz
471373|NCT01136928|Cytochrome P450 enzymes|cytochrome p450 enzymes
471374|NCT01136928|Complementary and Alternative Medicine|complementary and alternative medicine
471375|NCT01136928|Herbal|herbal
471376|NCT01136928|Pharmacikinetics|pharmacikinetics
471377|NCT01136928|Healthy volunteers|healthy volunteers
471378|NCT01136902|Diabetes Mellitus|diabetes mellitus
471379|NCT01136902|Retinal Vessels|retinal vessels
471380|NCT01136902|Physiology|physiology
471381|NCT01136889|PFMT|pfmt
471382|NCT01136889|Vaginal pessary|vaginal pessary
471383|NCT01136889|Pelvic Organ Prolapse|pelvic organ prolapse
471384|NCT01136863|hypertension|hypertension
471385|NCT01136863|felodipine|felodipine
471386|NCT01136863|moderate to high risk patients|moderate to high risk patients
471387|NCT01136850|Plasmodium falciparum|plasmodium falciparum
471388|NCT01136850|Plasmodium vivax|plasmodium vivax
471389|NCT01136850|azithromycin|azithromycin
471390|NCT01136850|sulphadoxine pyrimethamine|sulphadoxine pyrimethamine
471391|NCT01136850|low birth weight|low birth weight
471392|NCT01136850|haemoglobin|haemoglobin
471393|NCT01136850|Chlamydia trachomatis|chlamydia trachomatis
471394|NCT01136850|Neisseria gonorrhoeae|neisseria gonorrhoeae
471395|NCT01136850|Treponema pallidum|treponema pallidum
471396|NCT01136824|Sarcoma|sarcoma
471397|NCT01136824|questionnaire|questionnaire
471398|NCT01136824|doxorubicin plus ifosfamide (AI)|doxorubicin plus ifosfamide (ai)
471399|NCT01136798|slow wave sleep|slow wave sleep
471400|NCT01136798|exenatide and sleep|exenatide and sleep
471401|NCT01136759|Prevention|prevention
471402|NCT01136759|Microbicide|microbicide
471403|NCT01136759|Mother-to-Child-Transmission|mother-to-child-transmission
471404|NCT01136759|Pregnancy|pregnancy
471405|NCT01136746|Hyperglycemia|hyperglycemia
471406|NCT01136746|Diabetes|diabetes
471407|NCT01136746|Hospital|hospital
471408|NCT01136746|Diabetic|diabetic
471409|NCT01136733|Unresectable advanced or metastatic renal cell carcinoma|unresectable advanced or metastatic renal cell carcinoma
471410|NCT01136681|Anonymised Electronic Cohort|anonymised electronic cohort
471411|NCT01136681|Record Linkage|record linkage
471412|NCT01136681|Routine Data|routine data
471413|NCT01136681|Environment|environment
471414|NCT01136681|Childhood Obesity|childhood obesity
471415|NCT01136681|Low birth weight|low birth weight
471416|NCT01136681|Premature birth|premature birth
471417|NCT01136668|pediatrics|pediatrics
471418|NCT01136668|Transversus Abdominis Plane Block|transversus abdominis plane block
471419|NCT01136668|Ostomy Surgery|ostomy surgery
471420|NCT01136668|Anesthesia|anesthesia
471421|NCT01136668|Regional Anesthetic|regional anesthetic
471422|NCT01136655|asthmatic children|asthmatic children
471423|NCT01136655|Symbicort|symbicort
471424|NCT01136655|Foradil|foradil
471425|NCT01136642|Nicotine|nicotine
471426|NCT01136642|Nicotine Nasal Spray|nicotine nasal spray
471427|NCT01136642|Attention|attention
471428|NCT01136642|Smoking|smoking
471429|NCT01136629|Hyper-pigmented spots|hyper-pigmented spots
471430|NCT01136629|Lentigines|lentigines
471431|NCT01136629|Mealsma|mealsma
471432|NCT01136629|RNA extraction|rna extraction
471433|NCT01136629|Isolation of Keratinocytes|isolation of keratinocytes
471434|NCT01136629|Isolation of Melanocytes|isolation of melanocytes
471435|NCT01136616|Nasal fracture|nasal fracture
471436|NCT01136616|Nasal buttresses|nasal buttresses
471437|NCT01136616|Septal deviation|septal deviation
471438|NCT01136616|Nasal morphology|nasal morphology
471439|NCT01136616|CT Scan|ct scan
471440|NCT01136603|Abdominal wall defects|abdominal wall defects
471441|NCT01136603|Inflammation reactions|inflammation reactions
471442|NCT01136603|Amount of tissue ingrowth|amount of tissue ingrowth
471443|NCT01136603|Adhesion formation|adhesion formation
471444|NCT01136603|Shrinkage profiles of the implant|shrinkage profiles of the implant
471445|NCT01136590|Spinal deformity correction|spinal deformity correction
471446|NCT01136590|Surgical bleeding|surgical bleeding
471447|NCT01136590|Transfusion practice|transfusion practice
471448|NCT01136590|Spinal Fusion|spinal fusion
471449|NCT01136590|Antifibrinolytic Agents|antifibrinolytic agents
471450|NCT01136590|Hemorrhage|hemorrhage
471451|NCT01136590|Blood Transfusion|blood transfusion
471452|NCT01136577|Jaundice|jaundice
471453|NCT01136577|Hyperbilirubinemia|hyperbilirubinemia
471454|NCT01136577|Phototherapy|phototherapy
471455|NCT01136577|term newborn|term newborn
471456|NCT01136577|LED|led
471457|NCT01136577|Fluorescent lamps|fluorescent lamps
471458|NCT01136564|paricalcitol|paricalcitol
471459|NCT01136564|vitamin d|vitamin d
471460|NCT01136564|kidney disease|kidney disease
471461|NCT01136564|renin|renin
471462|NCT01136564|proteinuria|proteinuria
471463|NCT01136551|Pharmacokinetic profile of controlled release formulation of Huperzine A|pharmacokinetic profile of controlled release formulation of huperzine a
471464|NCT01136551|Bioequivalence of Huperzine A IR formulation and CR formulation|bioequivalence of huperzine a ir formulation and cr formulation
471465|NCT01136538|Bioequivalence|bioequivalence
471466|NCT01136538|Crossover|crossover
471467|NCT01136538|Valacyclovir Hydrochloride|valacyclovir hydrochloride
471468|NCT01136525|Bioequivalence|bioequivalence
471469|NCT01136525|Crossover|crossover
471470|NCT01136525|Valacyclovir Hydrochloride|valacyclovir hydrochloride
471471|NCT01136512|metformin|metformin
471472|NCT01136512|vitamin B12|vitamin b12
471473|NCT01136512|type 2 diabetes|type 2 diabetes
471474|NCT01136512|methylmalonic acid|methylmalonic acid
471475|NCT01136512|deficiency|deficiency
471476|NCT01136499|Sarcoma|sarcoma
471477|NCT01136499|Safety|safety
471478|NCT01136499|Efficacy|efficacy
471479|NCT01136499|PANOBINOSTAT|panobinostat
471480|NCT01136486|head trauma; traumatic brain injury|head trauma; traumatic brain injury
471481|NCT01136473|congenital cataract|congenital cataract
471483|NCT01136473|pseudophakic glaucoma|pseudophakic glaucoma
471484|NCT01136473|pediatric patients|pediatric patients
471485|NCT01136460|Primary congenital glaucoma|primary congenital glaucoma
471486|NCT01136460|neonatal|neonatal
471487|NCT01136460|Genotype correlation|genotype correlation
471488|NCT01136460|Phenotype correlation|phenotype correlation
471489|NCT01136447|Brachial plexus|brachial plexus
471490|NCT01136447|Ultrasound|ultrasound
471491|NCT01136421|COPD exacerbation|copd exacerbation
471492|NCT01136421|Magnesium sulfate|magnesium sulfate
471493|NCT01136421|Ipratropium bromide|ipratropium bromide
471494|NCT01136421|Emergency departement|emergency departement
471495|NCT01136395|Kidney Transplantation|kidney transplantation
471496|NCT01136395|Rituximab|rituximab
471497|NCT01136395|Living Donor|living donor
471498|NCT01136395|ABO Incompatible Transplantation|abo incompatible transplantation
471499|NCT01136395|Immunology|immunology
471500|NCT01136395|CMV|cmv
471501|NCT01136395|EBV|ebv
471502|NCT01136395|Polyomavirus|polyomavirus
471503|NCT01136382|asthma, children, budesonide pMDI|asthma, children, budesonide pmdi
471504|NCT01136369|metastasis|metastasis
471505|NCT01136369|molecular pathology|molecular pathology
471506|NCT01136356|opioid pharmacology|opioid pharmacology
471507|NCT01136356|buprenorphine|buprenorphine
471508|NCT01136356|morphine|morphine
471509|NCT01136356|withdrawal|withdrawal
471510|NCT01136356|human research|human research
471511|NCT01136343|women|women
471512|NCT01136343|middle age|middle age
471513|NCT01136343|risk factor|risk factor
471514|NCT01136330|Myotonic dystrophy|myotonic dystrophy
471515|NCT01136330|Prognosis|prognosis
471516|NCT01136330|Sudden death|sudden death
471517|NCT01136330|Respiratory failure|respiratory failure
471518|NCT01136304|Gaucher disease|gaucher disease
471519|NCT01136304|Imiglucerase|imiglucerase
471520|NCT01136304|Cerezyme|cerezyme
471521|NCT01136304|Severity score|severity score
471522|NCT01136291|pregnancy|pregnancy
471523|NCT01136291|obesity|obesity
471524|NCT01136291|physical exercise|physical exercise
471525|NCT01136291|quality of life|quality of life
471526|NCT01136278|MDMA|mdma
471527|NCT01136278|norepinephrine|norepinephrine
471528|NCT01136278|alpha2 receptor|alpha2 receptor
471529|NCT01136278|Ecstasy|ecstasy
471530|NCT01136278|stimulant|stimulant
471531|NCT01136265|dual-time PET/CT|dual-time pet/ct
471532|NCT01136265|sentinel node|sentinel node
471533|NCT01136239|COPD|copd
471534|NCT01136239|N-acetylcysteine|n-acetylcysteine
471535|NCT01136239|airtrapping|airtrapping
471536|NCT01136239|airway resistance|airway resistance
471537|NCT01136239|antioxidant|antioxidant
471538|NCT01136226|Prostate Cancer|prostate cancer
471539|NCT01136200|Surgical and medical wards|surgical and medical wards
471540|NCT01136200|Adults|adults
471541|NCT01136200|Antimicrobial therapy|antimicrobial therapy
471542|NCT01136187|Myocardial infarction|myocardial infarction
471543|NCT01136187|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
471544|NCT01136187|Radial|radial
471545|NCT01136187|Bleeding|bleeding
471546|NCT01136161|LTBI (Latent Tuberculosis Infection)|ltbi (latent tuberculosis infection)
471547|NCT01136161|TB (Tuberculosis)|tb (tuberculosis)
471548|NCT01136161|Vaccine|vaccine
471549|NCT01136148|Mental Health|mental health
471550|NCT01136148|Aged|aged
471551|NCT01136148|Hospitals, general|hospitals, general
471552|NCT01136148|Dementia|dementia
471553|NCT01136148|Delirium|delirium
471554|NCT01136148|Dementia and confusion|dementia and confusion
471555|NCT01136135|Heart transplant rejection|heart transplant rejection
471556|NCT01136135|cardiac MRI|cardiac mri
471557|NCT01136135|diagnosis|diagnosis
471558|NCT01136096|diabetes|diabetes
471559|NCT01136096|physical activity|physical activity
471560|NCT01136096|adiponectin|adiponectin
471561|NCT01136096|metabolic risks|metabolic risks
471562|NCT01136096|exercise|exercise
471563|NCT01136096|primary prevention|primary prevention
471564|NCT01136083|Tumor|tumor
471565|NCT01136083|Angiogenesis|angiogenesis
471566|NCT01136083|Exercise training|exercise training
471567|NCT01136083|VEGF|vegf
471568|NCT01136083|Myostatin|myostatin
471569|NCT01136070|Psychological Functioning in Burn Patients|psychological functioning in burn patients
471570|NCT01136044|tensor fasciae latae|tensor fasciae latae
471571|NCT01136044|septocutaneous perforators|septocutaneous perforators
471572|NCT01136031|advanced gastric cancer|advanced gastric cancer
471573|NCT01136031|1st-line failure|1st-line failure
471574|NCT01136005|receptor, epidermal growth factor|receptor, epidermal growth factor
471575|NCT01136005|skin reactions|skin reactions
471576|NCT01136005|quality of life|quality of life
471577|NCT01136005|adherence|adherence
471578|NCT01135966|COPD|copd
471579|NCT01135966|Whole Body Vibration training|whole body vibration training
471580|NCT01135966|Conventional resistance training|conventional resistance training
471581|NCT01135953|Brain excitation|brain excitation
471582|NCT01135953|transcranial Direct Stimulation|transcranial direct stimulation
471583|NCT01135953|administration pattern|administration pattern
471584|NCT01135940|neuromuscular scoliosis|neuromuscular scoliosis
471587|NCT01135940|wound closure|wound closure
471588|NCT01135914|DME|dme
471589|NCT01135914|visual impairment|visual impairment
471590|NCT01135914|diabetes|diabetes
471591|NCT01135914|macular edema|macular edema
471592|NCT01135914|diabetic macular edema|diabetic macular edema
471593|NCT01135914|ranibizumab|ranibizumab
471594|NCT01135914|laser|laser
471595|NCT01135914|photocoagulation|photocoagulation
471596|NCT01135914|retinopathy|retinopathy
471597|NCT01135914|retina|retina
471598|NCT01135901|prevention|prevention
471599|NCT01135901|public health|public health
471600|NCT01135901|community health services|community health services
471601|NCT01135901|Norway|norway
471602|NCT01135888|hypohidrotic ectodermal dysplasia|hypohidrotic ectodermal dysplasia
471603|NCT01135888|exertional hyperthermia|exertional hyperthermia
471604|NCT01135888|cooling device|cooling device
471605|NCT01135875|GBM|gbm
471606|NCT01135875|Brain Tumor|brain tumor
471607|NCT01135875|Brain Neoplasm|brain neoplasm
471608|NCT01135875|Control|control
471609|NCT01135875|Normal Control|normal control
471610|NCT01135875|Volunteer|volunteer
471611|NCT01135836|Shoulder pain|shoulder pain
471612|NCT01135836|Gynecologic laparoscopic surgery|gynecologic laparoscopic surgery
471613|NCT01135836|Nausea|nausea
471614|NCT01135836|Vomiting|vomiting
471615|NCT01135836|Abdominal fullness|abdominal fullness
471616|NCT01135810|healthy subjects|healthy subjects
471617|NCT01135771|glucose monitoring|glucose monitoring
471618|NCT01135771|diabetes|diabetes
471619|NCT01135771|glucose monitoring in patients with diabetes|glucose monitoring in patients with diabetes
471620|NCT01135758|depression, ketamine, fMRI|depression, ketamine, fmri
471621|NCT01135732|late development cholangiocarcinoma|late development cholangiocarcinoma
471622|NCT01135719|Myopia|myopia
471623|NCT01135719|Hyperopia|hyperopia
471624|NCT01135719|Astigmatism|astigmatism
471625|NCT01135719|PRK|prk
471626|NCT01135719|LASIK|lasik
471627|NCT01135706|Pulmonary Hypertension|pulmonary hypertension
471628|NCT01135706|Fractal dimension|fractal dimension
471629|NCT01135693|Section 136|section 136
471630|NCT01135693|Mental Health Act 1983|mental health act 1983
471631|NCT01135693|Police|police
471632|NCT01135693|Detention|detention
471633|NCT01135693|Failure of community care|failure of community care
471634|NCT01135667|clopidogrel|clopidogrel
471635|NCT01135667|prasugrel|prasugrel
471636|NCT01135667|low responder|low responder
471637|NCT01135667|multiplate|multiplate
471638|NCT01135667|verify now|verify now
471639|NCT01135654|alcohol dependence|alcohol dependence
471640|NCT01135654|unhealthy drinking|unhealthy drinking
471641|NCT01135654|SBIRT|sbirt
471642|NCT01135641|Adult patients (≥18 years)|adult patients (≥18 years)
471643|NCT01135641|first allogeneic stem cell transplantation|first allogeneic stem cell transplantation
471644|NCT01135641|first episode of chronic GVHD requiring systemic immunosuppressive therapy|first episode of chronic gvhd requiring systemic immunosuppressive therapy
471645|NCT01135628|Hepatic cirrhosis|hepatic cirrhosis
471646|NCT01135628|Minimal hepatic encephalopathy|minimal hepatic encephalopathy
471647|NCT01135628|Hyperproteic and fiber-rich diet|hyperproteic and fiber-rich diet
471648|NCT01135628|Lactobacillus reuteri|lactobacillus reuteri
471649|NCT01135628|Psychometric Hepatic Encephalopathy Score (PHES)|psychometric hepatic encephalopathy score (phes)
471650|NCT01135628|Critical Flicker Frequency (CFF)|critical flicker frequency (cff)
471651|NCT01135615|FGF-23, endothelial dysfunction, sevelamer|fgf-23, endothelial dysfunction, sevelamer
471652|NCT01135602|Alcohol dependence|alcohol dependence
471653|NCT01135602|Alcoholism|alcoholism
471654|NCT01135602|Topiramate|topiramate
471655|NCT01135589|pediatric|pediatric
471656|NCT01135589|adolescent|adolescent
471657|NCT01135589|micafungin|micafungin
471658|NCT01135576|Ferric pyrophosphate|ferric pyrophosphate
471659|NCT01135576|Fortification|fortification
471660|NCT01135576|Fruit juice|fruit juice
471661|NCT01135576|Functional food|functional food
471662|NCT01135576|Bioavailability|bioavailability
471663|NCT01135576|iron status|iron status
471665|NCT01135576|iron-deficiency anemia|iron-deficiency anemia
471666|NCT01135563|pediatrics|pediatrics
471667|NCT01135563|Solid Tumors|solid tumors
471668|NCT01135563|CNS Tumors|cns tumors
471669|NCT01135563|Vinblastine|vinblastine
471670|NCT01135563|Sirolimus|sirolimus
471671|NCT01135563|Recurrent|recurrent
471672|NCT01135563|Refractory|refractory
471673|NCT01135550|Pediatrics|pediatrics
471674|NCT01135550|Vomiting|vomiting
471675|NCT01135550|Headache|headache
471676|NCT01135550|Radiation Therapy|radiation therapy
471677|NCT01135537|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
471678|NCT01135537|pharmacokinetics|pharmacokinetics
471679|NCT01135537|pediatrics|pediatrics
471680|NCT01135524|Osteoarthritis|osteoarthritis
471681|NCT01135524|Opioid|opioid
471682|NCT01135524|Transdermal|transdermal
471683|NCT01135511|Dry eye|dry eye
471684|NCT01135472|NEXIUM|nexium
471685|NCT01135472|HEALTHY VOLUNTEERS|healthy volunteers
471686|NCT01135472|BLOOD DRAW|blood draw
471687|NCT01135472|to measure gastrin levels in healthy volunteers while taking nexium|to measure gastrin levels in healthy volunteers while taking nexium
471689|NCT01135433|ASP1941|asp1941
471690|NCT01135433|Diabetes mellitus|diabetes mellitus
471691|NCT01135433|Metformin|metformin
471692|NCT01135407|Parkinson's disease|parkinson's disease
471693|NCT01135407|Deep brain stimulation|deep brain stimulation
471694|NCT01135407|Subthalamic nucleus|subthalamic nucleus
471695|NCT01135407|Levodopa|levodopa
471696|NCT01135407|Selective visual attention|selective visual attention
471697|NCT01135407|Basal ganglia diseases|basal ganglia diseases
471698|NCT01135394|Pioglitazone|pioglitazone
471699|NCT01135394|Type 2 diabetes|type 2 diabetes
471700|NCT01135394|Insulin sensitivity|insulin sensitivity
471701|NCT01135394|Healthy adults|healthy adults
471702|NCT01135394|Thiazolidinediones|thiazolidinediones
471703|NCT01135394|Pharmacogenetics|pharmacogenetics
471704|NCT01135381|care transitions|care transitions
471705|NCT01135381|information technology|information technology
471706|NCT01135368|GERD|gerd
471707|NCT01135368|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
471708|NCT01135368|Drug Therapy|drug therapy
471709|NCT01135342|Insomnia|insomnia
471710|NCT01135342|Weight loss|weight loss
471711|NCT01135342|Adults|adults
471712|NCT01135329|Lymphoma|lymphoma
471713|NCT01135329|Hodgkin's lymphoma|hodgkin's lymphoma
471714|NCT01135329|Non hodgkin's lymphoma|non hodgkin's lymphoma
471715|NCT01135329|Leukemia|leukemia
471716|NCT01135329|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
471717|NCT01135329|Acute lymphoblastic leukemia(ALL)|acute lymphoblastic leukemia(all)
471718|NCT01135329|Chronic myeloid leukemia (CML)|chronic myeloid leukemia (cml)
471719|NCT01135329|Chronic Myelomonocytic (CMML)|chronic myelomonocytic (cmml)
471720|NCT01135329|Myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
471721|NCT01135329|High-risk acute leukemia in first remission|high-risk acute leukemia in first remission
471722|NCT01135329|Relapsed leukemia in remission|relapsed leukemia in remission
471723|NCT01135329|Cyclophosphamide|cyclophosphamide
471724|NCT01135329|High-dose cyclophosphamide|high-dose cyclophosphamide
471725|NCT01135329|Fludarabine|fludarabine
471726|NCT01135329|Busulfan|busulfan
471727|NCT01135329|Allogeneic|allogeneic
471728|NCT01135329|Nonmyeloablative|nonmyeloablative
471729|NCT01135329|Reduced intensity|reduced intensity
471730|NCT01135329|Haploidentical|haploidentical
471731|NCT01135329|Bone marrow transplant (BMT)|bone marrow transplant (bmt)
471732|NCT01135316|NSF, Ablavar, Kidney Disease, Magnetic Resonance Imaging (MRI),|nsf, ablavar, kidney disease, magnetic resonance imaging (mri),
471733|NCT01135303|Sleep Apnea Syndromes|sleep apnea syndromes
471734|NCT01135303|Polysomnography|polysomnography
471735|NCT01135303|Holter ECG|holter ecg
471736|NCT01135303|Thoracic impedance|thoracic impedance
471737|NCT01135303|Heart rate variability|heart rate variability
471738|NCT01135290|The management of post-treatment symptoms for subjects that had either a medium grade chemical peel or fractional resurfacing|the management of post-treatment symptoms for subjects that had either a medium grade chemical peel or fractional resurfacing
471739|NCT01135251|Neuropathic pain|neuropathic pain
471740|NCT01135251|AIDS|aids
471741|NCT01135251|Dimiracetam|dimiracetam
471742|NCT01135251|Treatment related painful neuropathy in AIDS patients|treatment related painful neuropathy in aids patients
471743|NCT01135238|adrenalectomy|adrenalectomy
471744|NCT01135238|metastasis|metastasis
471745|NCT01135238|morbidity|morbidity
471746|NCT01135238|mortality|mortality
471747|NCT01135238|survival|survival
471748|NCT01135225|Drug-eluting stent|drug-eluting stent
471749|NCT01135225|Percutaneous coronary intervention|percutaneous coronary intervention
471750|NCT01135225|Stent implantation|stent implantation
471751|NCT01135225|Evolution Stent System|evolution stent system
471752|NCT01135225|Biodegradable polymer coating|biodegradable polymer coating
471753|NCT01135225|Feasibility study|feasibility study
471754|NCT01135212|Hypertension|hypertension
471755|NCT01135212|ARB|arb
471756|NCT01135212|Fimasartan|fimasartan
471757|NCT01135173|Smoking Cessation, Waterpipe|smoking cessation, waterpipe
471758|NCT01135160|weight bearing|weight bearing
471759|NCT01135160|pain|pain
471760|NCT01135160|total hip arthroplasty|total hip arthroplasty
471761|NCT01135160|total knee arthroplasty|total knee arthroplasty
471762|NCT01135160|weight bearing after TKA or THA|weight bearing after tka or tha
471763|NCT01135108|Analgesics. Non-narcotic / therapeutic use|analgesics. non-narcotic / therapeutic use
471764|NCT01135108|Spinal Cord Injuries|spinal cord injuries
471765|NCT01135108|Pain|pain
471766|NCT01135108|Pain measurement / drug effect|pain measurement / drug effect
471767|NCT01135108|Pain postoperative / drug therapy|pain postoperative / drug therapy
471768|NCT01135095|Myocardial perfusion|myocardial perfusion
471769|NCT01135095|Low radiation dose|low radiation dose
471770|NCT01135095|Single photon emission computed tomography|single photon emission computed tomography
471771|NCT01135082|immunogenicity|immunogenicity
471772|NCT01135082|safety|safety
471773|NCT01135082|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
471774|NCT01135082|HIV infected children|hiv infected children
471775|NCT01135082|objective of this study is to assess the safety and immunogenicity of a 7 - valent PCV vaccine among HIV - infected compared with HIV - exposed children|objective of this study is to assess the safety and immunogenicity of a 7 - valent pcv vaccine among hiv - infected compared with hiv - exposed children
471878|NCT01134575|ALL|all
471776|NCT01135056|Hepatocellular Carcinoma|hepatocellular carcinoma
471777|NCT01135056|Randomized|randomized
471778|NCT01135056|Open-label|open-label
471779|NCT01135056|Multi-Centre|multi-centre
471780|NCT01135056|Phase III|phase iii
471781|NCT01135056|Sorafenib|sorafenib
471782|NCT01135056|SIR-Spheres|sir-spheres
471783|NCT01135043|acceptable sputum|acceptable sputum
471784|NCT01135043|AFB culture|afb culture
471785|NCT01135043|pulmonary tuberculosis|pulmonary tuberculosis
471786|NCT01135030|total knee arthroplasty|total knee arthroplasty
471787|NCT01135004|pneumothorax|pneumothorax
471788|NCT01135004|thoracoscopy|thoracoscopy
471789|NCT01135004|pathogenesis|pathogenesis
471790|NCT01135004|blebs|blebs
471791|NCT01135004|surgery|surgery
471792|NCT01134991|rosacea|rosacea
471793|NCT01134991|topical|topical
471794|NCT01134991|minocycline|minocycline
471795|NCT01134991|foam|foam
471796|NCT01134991|phase II|phase ii
471797|NCT01134978|repeated measures design|repeated measures design
471798|NCT01134978|random assignment to groups|random assignment to groups
471799|NCT01134952|sirolimus|sirolimus
471800|NCT01134952|everolimus|everolimus
471801|NCT01134952|mycophenolic acid|mycophenolic acid
471802|NCT01134952|hepatitis C virus|hepatitis c virus
471803|NCT01134952|tacrolimus|tacrolimus
471804|NCT01134952|viral load|viral load
471805|NCT01134926|Retained products of conception|retained products of conception
471806|NCT01134926|residua|residua
471807|NCT01134926|misoprostol|misoprostol
471808|NCT01134926|expectant management|expectant management
471810|NCT01134913|Acute Coronary Syndrome|acute coronary syndrome
471811|NCT01134913|Emergency Department|emergency department
471812|NCT01134900|Medication Errors|medication errors
471813|NCT01134900|Adverse Drug Events|adverse drug events
471814|NCT01134900|Decision Support Systems, Clinical|decision support systems, clinical
471815|NCT01134887|hypertension|hypertension
471816|NCT01134887|physician-patient relations|physician-patient relations
471817|NCT01134887|communication|communication
471818|NCT01134861|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
471819|NCT01134861|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
471820|NCT01134861|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
471821|NCT01134848|Bile ducts|bile ducts
471822|NCT01134848|Sphincter of Oddi|sphincter of oddi
471823|NCT01134848|Pancreatic ducts|pancreatic ducts
471824|NCT01134822|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
471825|NCT01134822|IPF|ipf
471826|NCT01134822|Lung Fibrosis|lung fibrosis
471827|NCT01134822|Biomarkers|biomarkers
471828|NCT01134809|Major abdominal surgery|major abdominal surgery
471829|NCT01134770|Prenatal Substance Use|prenatal substance use
471830|NCT01134770|Cocaine|cocaine
471831|NCT01134770|Cigarette Smoking|cigarette smoking
471832|NCT01134770|Mothers|mothers
471833|NCT01134770|Pregnant women|pregnant women
471834|NCT01134770|Smoking Mothers|smoking mothers
471835|NCT01134757|EAR|ear
471836|NCT01134757|LAR|lar
471837|NCT01134757|BHR|bhr
471838|NCT01134757|house dust mite|house dust mite
471839|NCT01134757|alternaria|alternaria
471840|NCT01134744|CXray|cxray
471841|NCT01134731|depression|depression
471842|NCT01134731|suicidality|suicidality
471843|NCT01134731|Major Depressive Disorder, current episode, with suicidality|major depressive disorder, current episode, with suicidality
471844|NCT01134718|TMC435-TiDP16-C119|tmc435-tidp16-c119
471845|NCT01134718|TMC435-C119|tmc435-c119
471846|NCT01134718|TMC435|tmc435
471847|NCT01134718|Protease inhibitor|protease inhibitor
471848|NCT01134718|HCV|hcv
471849|NCT01134718|Hepatitis C|hepatitis c
471850|NCT01134718|Bioavailability|bioavailability
471851|NCT01134692|Patients with cirrhosis who have large esophageal varices with No history of upper GI bleeding in the past|patients with cirrhosis who have large esophageal varices with no history of upper gi bleeding in the past
471852|NCT01134679|Drug Eluting Stent|drug eluting stent
471853|NCT01134679|Clopidogrel|clopidogrel
471854|NCT01134679|Aspirin|aspirin
471855|NCT01134666|Colorectal neoplasms|colorectal neoplasms
471856|NCT01134666|Intestinal neoplasms|intestinal neoplasms
471857|NCT01134666|Neoplasms|neoplasms
471858|NCT01134666|cetuximab|cetuximab
471859|NCT01134666|Erbitux|erbitux
471860|NCT01134653|Acute ankle sprain in children and young adults|acute ankle sprain in children and young adults
471861|NCT01134640|metastatic colorectal cancer|metastatic colorectal cancer
471862|NCT01134640|mCRC|mcrc
471863|NCT01134640|post marketing surveillance|post marketing surveillance
471864|NCT01134640|Erbitux|erbitux
471865|NCT01134640|Cetuximab|cetuximab
471866|NCT01134640|KRAS|kras
471867|NCT01134627|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
471868|NCT01134627|Interferon-β|interferon-β
471869|NCT01134627|Rebif®|rebif®
471870|NCT01134627|Minocycline|minocycline
471871|NCT01134601|Rectal Cancer|rectal cancer
471872|NCT01134601|Radiation Therapy|radiation therapy
471873|NCT01134601|Capecitabine|capecitabine
471874|NCT01134601|AZD6244|azd6244
471875|NCT01134575|Relapsed|relapsed
471876|NCT01134575|Refractory|refractory
471877|NCT01134575|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
471879|NCT01134575|Burkitt's lymphoma|burkitt's lymphoma
471880|NCT01134575|Lymphoblastic lymphoma|lymphoblastic lymphoma
471881|NCT01134575|CMC-544|cmc-544
471882|NCT01134575|Inotuzumab Ozogamycin|inotuzumab ozogamycin
471883|NCT01134575|Rituxan|rituxan
471884|NCT01134575|Rituximab|rituximab
471885|NCT01134562|Clinical Trial, Phase 1|clinical trial, phase 1
471886|NCT01134562|Renal Dialysis|renal dialysis
471887|NCT01134562|Secondary Hyperparathyroidism|secondary hyperparathyroidism
471888|NCT01134562|Parathyroid hormone|parathyroid hormone
471889|NCT01134536|Pain, Postoperative|pain, postoperative
471890|NCT01134536|Postoperative Pain|postoperative pain
471891|NCT01134536|Tapentadol|tapentadol
471892|NCT01134536|NUCYNTA|nucynta
471893|NCT01134536|CG5503|cg5503
471894|NCT01134536|R331333|r331333
471895|NCT01134536|Pharmacokinetics|pharmacokinetics
471896|NCT01134536|Postsurgical pain|postsurgical pain
471897|NCT01134536|Children|children
471898|NCT01134536|Adolescents|adolescents
471899|NCT01134523|positive lymph node|positive lymph node
471900|NCT01134510|Kidney transplantation|kidney transplantation
471901|NCT01134484|autologous stem cell transplantation|autologous stem cell transplantation
471902|NCT01134484|complete remission|complete remission
471903|NCT01134484|bortezomib|bortezomib
471904|NCT01134484|thalidomide|thalidomide
471905|NCT01134484|progression free survival|progression free survival
471906|NCT01134484|induction and consolidation therapy|induction and consolidation therapy
471907|NCT01134458|cardiovascular disease|cardiovascular disease
471908|NCT01134445|Arthroplasty|arthroplasty
471909|NCT01134445|Replacement|replacement
471910|NCT01134445|Hip|hip
471911|NCT01134445|Conservative|conservative
471912|NCT01134445|Anatomic|anatomic
471913|NCT01134445|Cementless|cementless
471914|NCT01134432|autoimmune hemolytic anemia|autoimmune hemolytic anemia
471915|NCT01134432|hemolytic anemia|hemolytic anemia
471916|NCT01134432|Rituximab|rituximab
471917|NCT01134432|Treatment of autoimmune hemolytic anemia|treatment of autoimmune hemolytic anemia
471918|NCT01134432|warm antibody dependant autoimmune hemolytic anemia|warm antibody dependant autoimmune hemolytic anemia
471919|NCT01134419|Patient Safety|patient safety
471920|NCT01134419|Medical Errors|medical errors
471921|NCT01134419|Handoff|handoff
471922|NCT01134419|Sign-out|sign-out
471923|NCT01134419|Resident|resident
471924|NCT01134419|Intern|intern
471925|NCT01134419|Graduate Medical Education|graduate medical education
471926|NCT01134406|Osteoarthritis|osteoarthritis
471927|NCT01134406|knee|knee
471928|NCT01134380|Percutaneous coronary intervention|percutaneous coronary intervention
471929|NCT01134380|Acute coronary syndrome|acute coronary syndrome
471930|NCT01134380|Dual antiplatelet therapy|dual antiplatelet therapy
471931|NCT01134380|clopidogrel/prasugrel|clopidogrel/prasugrel
471932|NCT01134380|genotyping|genotyping
471933|NCT01134380|stent|stent
471934|NCT01134380|compliance|compliance
471935|NCT01134367|gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
471936|NCT01134354|Validation study|validation study
471937|NCT01134354|Outcome Measures|outcome measures
471938|NCT01134354|Patient Outcomes Assessment|patient outcomes assessment
471939|NCT01134354|Patient expectations|patient expectations
471940|NCT01134354|Physician patient relationship|physician patient relationship
471941|NCT01134341|Relapsed|relapsed
471942|NCT01134341|Refractory|refractory
471943|NCT01134315|Evaluating incidence of hypercalcemia in pediatric patients|evaluating incidence of hypercalcemia in pediatric patients
471944|NCT01134302|Hybrid|hybrid
471945|NCT01134302|Norwood|norwood
471946|NCT01134302|congenital heart disease|congenital heart disease
471947|NCT01134302|single ventricle|single ventricle
471948|NCT01134289|complex regional pain syndrome|complex regional pain syndrome
471949|NCT01134289|lumbar sympathetic blockade|lumbar sympathetic blockade
471950|NCT01134289|photoplethysmography|photoplethysmography
471951|NCT01134289|diagnostic lumbar sympathetic blockade|diagnostic lumbar sympathetic blockade
471952|NCT01134263|Dengue Fever|dengue fever
471953|NCT01134263|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
471954|NCT01134263|CYD Dengue Vaccine|cyd dengue vaccine
471955|NCT01134263|Lot Consistency|lot consistency
471956|NCT01134250|Interleukin, IL2, F16, monoclonal, antibody, cytokine Paclitaxel, breast cancer,solid tumour|interleukin, il2, f16, monoclonal, antibody, cytokine paclitaxel, breast cancer,solid tumour
471957|NCT01134250|metastatic melanoma, non-small cell lung cancer (NSCLC)|metastatic melanoma, non-small cell lung cancer (nsclc)
471958|NCT01134237|non-surgical rate|non-surgical rate
471959|NCT01134198|Cocaine Dependence|cocaine dependence
471960|NCT01134185|Two groups of 8 hepatically impaired subjects, one group of 8 matched healthy subjects|two groups of 8 hepatically impaired subjects, one group of 8 matched healthy subjects
471961|NCT01134172|Sociodemographic|sociodemographic
471962|NCT01134172|Ethnicity|ethnicity
471963|NCT01134172|Work-related|work-related
471964|NCT01134172|Health system|health system
471965|NCT01134172|QOL|qol
471966|NCT01134172|Questionnaires|questionnaires
471967|NCT01134172|10-071|10-071
471968|NCT01134146|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
471969|NCT01134146|IMRT|imrt
471970|NCT01134146|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
471971|NCT01134146|Radical Pleurectomy|radical pleurectomy
471972|NCT01134146|Decortication|decortication
471973|NCT01134146|PD|pd
471974|NCT01134146|pleurectomy|pleurectomy
471975|NCT01134146|lung surgery|lung surgery
471976|NCT01134146|pleura|pleura
471977|NCT01134094|Undisplaced|undisplaced
471978|NCT01134094|Ankle Fracture|ankle fracture
471979|NCT01134094|Weber B|weber b
471980|NCT01134081|gum|gum
471981|NCT01134081|recession|recession
471982|NCT01134068|D-dimer|d-dimer
471983|NCT01134068|Pulmonary embolism|pulmonary embolism
471984|NCT01134068|Diagnostic strategy|diagnostic strategy
471985|NCT01134068|Safety of ruling PE with and age-adjusted DD cut-off|safety of ruling pe with and age-adjusted dd cut-off
471986|NCT01134055|ranibizumab|ranibizumab
471987|NCT01134055|wet AMD|wet amd
471988|NCT01134055|MD7110852|md7110852
471989|NCT01134055|age related macular degeneration|age related macular degeneration
471990|NCT01134055|age-related macular degeneration|age-related macular degeneration
471991|NCT01134055|macular degeneration|macular degeneration
471992|NCT01134055|pazopanib|pazopanib
471993|NCT01134042|Fluticasone propionate|fluticasone propionate
471994|NCT01134042|asthma|asthma
471995|NCT01134042|vilanterol|vilanterol
471996|NCT01134042|GW642444|gw642444
471997|NCT01134042|Fluticasone furoate|fluticasone furoate
471998|NCT01134029|obesity|obesity
471999|NCT01134029|weight management and cardiovascular risk factors|weight management and cardiovascular risk factors
472000|NCT01134016|Lung cancer|lung cancer
472001|NCT01134016|NSCLC|nsclc
472002|NCT01134003|Gynecare Prolift|gynecare prolift
472003|NCT01134003|Pelvic organ prolapse|pelvic organ prolapse
472004|NCT01134003|forming a large database of women who have recieve Gynecare prolift system|forming a large database of women who have recieve gynecare prolift system
472005|NCT01133964|Dairy proteins|dairy proteins
472006|NCT01133964|Appetite regulation|appetite regulation
472007|NCT01133964|Energy expenditure|energy expenditure
472008|NCT01133951|Helicobacter Infections|helicobacter infections
472009|NCT01133951|Helicobacter pylori|helicobacter pylori
472010|NCT01133951|Drug Therapy|drug therapy
472011|NCT01133951|Precancerous Conditions|precancerous conditions
472012|NCT01133951|Stomach Neoplasms|stomach neoplasms
472013|NCT01133951|Incidence|incidence
472014|NCT01133925|Coronary Artery Disease|coronary artery disease
472015|NCT01133925|Percutaneous Coronary Intervention|percutaneous coronary intervention
472016|NCT01133925|Drug Eluting Stent|drug eluting stent
472017|NCT01133925|Optical Coherence Tomography|optical coherence tomography
472018|NCT01133925|Thrombosi|thrombosi
472019|NCT01133925|Long lesions in native vessels requiring overlap|long lesions in native vessels requiring overlap
472020|NCT01133912|Patients with HER2 Positive Operable Breast Cancer|patients with her2 positive operable breast cancer
472021|NCT01133899|strength, anaerobic performance, recovery, ergogenic|strength, anaerobic performance, recovery, ergogenic
472022|NCT01133860|inherited thrombocytopenia|inherited thrombocytopenia
472023|NCT01133860|MYH9 mutations|myh9 mutations
472024|NCT01133860|eltrombopag|eltrombopag
472025|NCT01133834|meningococcal disease|meningococcal disease
472026|NCT01133834|cytokines|cytokines
472027|NCT01133821|Bipolar II Disorder|bipolar ii disorder
472028|NCT01133821|Bipolar II Depression|bipolar ii depression
472029|NCT01133821|Psychotherapy|psychotherapy
472030|NCT01133821|IPSRT|ipsrt
472031|NCT01133821|Seroquel|seroquel
472032|NCT01133821|Quetiapine|quetiapine
472033|NCT01133821|Placebo|placebo
472034|NCT01133821|Sugar Pill|sugar pill
472035|NCT01133808|diarrhea|diarrhea
472036|NCT01133808|childhood|childhood
472037|NCT01133808|rotavirus|rotavirus
472038|NCT01133808|vaccine|vaccine
472039|NCT01133808|Nicaragua|nicaragua
472040|NCT01133795|cirrhosis|cirrhosis
472041|NCT01133795|renal failure|renal failure
472042|NCT01133795|hepatorenal syndrome|hepatorenal syndrome
472043|NCT01133795|albumine|albumine
472044|NCT01133795|midodrine|midodrine
472045|NCT01133769|Clavicle fracture|clavicle fracture
472046|NCT01133769|fixation|fixation
472047|NCT01133769|polytrauma|polytrauma
472048|NCT01133769|Clavicle fracture patients with chest injury|clavicle fracture patients with chest injury
472049|NCT01133743|Lenalidomide|lenalidomide
472050|NCT01133743|Dexamethasone|dexamethasone
472051|NCT01133743|Immunomodulatory Drugs(IMiD™)|immunomodulatory drugs(imid™)
472052|NCT01133743|Thalidomide analogues|thalidomide analogues
472053|NCT01133730|supraclavicular nerve block|supraclavicular nerve block
472054|NCT01133730|regional anesthesia|regional anesthesia
472055|NCT01133730|transversalis fascia plane block|transversalis fascia plane block
472056|NCT01133730|ultrasound guided|ultrasound guided
472057|NCT01133730|opioid consumption|opioid consumption
472058|NCT01133730|iliac crest bone harvest|iliac crest bone harvest
472059|NCT01133730|hand surgery|hand surgery
472060|NCT01133730|wrist surgery|wrist surgery
472061|NCT01133730|Upper limb surgery combined with iliac crest bone harvest.|upper limb surgery combined with iliac crest bone harvest.
472062|NCT01133717|Sleep Apnea|sleep apnea
472063|NCT01133717|Cerebrovascular Reactivity|cerebrovascular reactivity
472064|NCT01133704|asymptomatic metastatic hormone-refractory prostate cancer|asymptomatic metastatic hormone-refractory prostate cancer
472065|NCT01133691|gastric emptying|gastric emptying
472066|NCT01133691|children|children
472067|NCT01133691|gastric fluid volume|gastric fluid volume
472068|NCT01133691|preoperative fasting|preoperative fasting
472069|NCT01133678|Squamous Cell Carcinoma|squamous cell carcinoma
472070|NCT01133665|Head and Neck, Squamous Cell|head and neck, squamous cell
472071|NCT01133665|Recurrent or metastatic squamous cell or undifferentiated carcinoma of the head and neck that is not amenable to curative therapy|recurrent or metastatic squamous cell or undifferentiated carcinoma of the head and neck that is not amenable to curative therapy
472072|NCT01133652|Venipuncture|venipuncture
472073|NCT01133652|Randomized Controlled Trial|randomized controlled trial
472074|NCT01133652|Intravenous access|intravenous access
472075|NCT01133652|Children|children
472076|NCT01133652|Pediatric Emergency Department|pediatric emergency department
472077|NCT01133652|Peripheral intravenous catheterization|peripheral intravenous catheterization
472078|NCT01133652|Catheterization, Peripheral Phlebotomy|catheterization, peripheral phlebotomy
472079|NCT01133587|Schizophrenia|schizophrenia
472080|NCT01133587|bipolar disorder|bipolar disorder
472081|NCT01133587|Long term care|long term care
472082|NCT01133587|patient admission|patient admission
472083|NCT01133574|Healthy volunteers|healthy volunteers
472084|NCT01133574|SLV354|slv354
472085|NCT01133574|Phase I|phase i
472086|NCT01133574|SRDT|srdt
472087|NCT01133561|psoriasis|psoriasis
472088|NCT01133561|insulin resistance|insulin resistance
472089|NCT01133561|metabolic syndrome|metabolic syndrome
472090|NCT01133561|pioglitazone|pioglitazone
472091|NCT01133561|randomized control trial|randomized control trial
472092|NCT01133548|testosterone, hypogonadal, males|testosterone, hypogonadal, males
472093|NCT01133522|AMG145|amg145
472094|NCT01133522|Multiple Dose|multiple dose
472095|NCT01133522|Statin|statin
472096|NCT01133522|Ascending|ascending
472097|NCT01133496|Bioequivalence|bioequivalence
472098|NCT01133496|Alendronate Sodium|alendronate sodium
472099|NCT01133496|crossover|crossover
472100|NCT01133483|Bioequivalence|bioequivalence
472101|NCT01133483|Fexofenadine Hydrochloride + Pseudoephedrine Hydrochloride|fexofenadine hydrochloride + pseudoephedrine hydrochloride
472102|NCT01133470|Bioequivalence|bioequivalence
472103|NCT01133470|Fexofenadine Hydrochloride + Pseudoephedrine Hydrochloride|fexofenadine hydrochloride + pseudoephedrine hydrochloride
472104|NCT01133457|Bioequivalence,Finasteride,Crossover|bioequivalence,finasteride,crossover
472105|NCT01133444|Bioequivalence,Finasteride,Crossover|bioequivalence,finasteride,crossover
472106|NCT01133431|CKD-501|ckd-501
472107|NCT01133431|Glimepiride|glimepiride
472108|NCT01133431|Placebo|placebo
472109|NCT01133431|Healthy male volunteer|healthy male volunteer
472110|NCT01133431|Pharmacokinetic|pharmacokinetic
472111|NCT01133431|Metabolite|metabolite
472112|NCT01133392|insulin|insulin
472113|NCT01133392|lispro|lispro
472114|NCT01133366|ISIS301012|isis301012
472115|NCT01133366|antisense|antisense
472116|NCT01133366|ApoB (Apolipoprotein B)|apob (apolipoprotein b)
472117|NCT01133366|LDL (low density lipoprotein)|ldl (low density lipoprotein)
472118|NCT01133366|mipomersen|mipomersen
472119|NCT01133340|RADIOTHERAPY|radiotherapy
472120|NCT01133340|CT simulation|ct simulation
472121|NCT01133340|MRI simulation|mri simulation
472122|NCT01133340|Endoscopic clip placement|endoscopic clip placement
472123|NCT01133340|Rectal cancer|rectal cancer
472124|NCT01133340|Accuracy of MRI Simulation for target delineation and planning|accuracy of mri simulation for target delineation and planning
472125|NCT01133327|Carotid Artery Stenting|carotid artery stenting
472126|NCT01133327|High Risk patient|high risk patient
472127|NCT01133327|Carotid artery stenosis|carotid artery stenosis
472128|NCT01133327|stroke|stroke
472129|NCT01133327|Carotid artery disease|carotid artery disease
472130|NCT01133327|ASTI study|asti study
472131|NCT01133327|Adapt Carotid Stent system|adapt carotid stent system
472132|NCT01133327|FilterWire EZ Embolic Protection System|filterwire ez embolic protection system
472133|NCT01133301|Borderline Personality Disorder|borderline personality disorder
472134|NCT01133301|Dissociation|dissociation
472135|NCT01133301|Naltrexone|naltrexone
472136|NCT01133249|total hip|total hip
472137|NCT01133236|Salt restriction|salt restriction
472138|NCT01133236|Fluid restriction|fluid restriction
472139|NCT01133236|Congestion|congestion
472140|NCT01133236|Heart Failure|heart failure
472141|NCT01133223|Stroke, mecanical thrombectomy|stroke, mecanical thrombectomy
472142|NCT01133210|hypertriglyceridemia|hypertriglyceridemia
472143|NCT01133210|triglyceride|triglyceride
472144|NCT01133210|cholesterol|cholesterol
472145|NCT01133210|Maraviroc|maraviroc
472146|NCT01133197|thumb|thumb
472147|NCT01133197|arthritis|arthritis
472148|NCT01133197|Impact of thumb arthritis on health|impact of thumb arthritis on health
472149|NCT01133184|HBV transmission PreS1/PreS2/S HBV vaccine|hbv transmission pres1/pres2/s hbv vaccine
472150|NCT01133171|Cardiovascular Disease|cardiovascular disease
472151|NCT01133171|Stroke|stroke
472152|NCT01133158|Follicular non-Hodgkin's lymphoma in relapse or refractory to standard first-line immunochemotherapy|follicular non-hodgkin's lymphoma in relapse or refractory to standard first-line immunochemotherapy
472153|NCT01133145|composite tissue allotransplantation|composite tissue allotransplantation
472154|NCT01133145|hand transplantation|hand transplantation
472155|NCT01133145|knee transplantation|knee transplantation
472481|NCT01132430|ADHERENCE|adherence
472156|NCT01133145|face transplantation|face transplantation
472157|NCT01133132|Colon cancer patients who have completed treatment|colon cancer patients who have completed treatment
472158|NCT01133119|cardiac catheterization|cardiac catheterization
472159|NCT01133119|local anesthetic|local anesthetic
472160|NCT01133119|pain experienced post-operatively|pain experienced post-operatively
472161|NCT01133119|pediatric patients|pediatric patients
472162|NCT01133106|stroke recovery|stroke recovery
472163|NCT01133106|quality of life|quality of life
472164|NCT01133093|Cardiovascular risk factors|cardiovascular risk factors
472165|NCT01133093|Nutritional assessment|nutritional assessment
472166|NCT01133093|Epidemiology|epidemiology
472167|NCT01133067|lung cancer|lung cancer
472168|NCT01133067|followup|followup
472169|NCT01133067|physical follow up|physical follow up
472170|NCT01133067|telephonic followup|telephonic followup
472171|NCT01133054|Coronary Vessel Anomalies|coronary vessel anomalies
472172|NCT01133028|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
472173|NCT01133015|FFR|ffr
472174|NCT01133015|IVUS|ivus
472175|NCT01133015|MLA|mla
472176|NCT01132989|Patients with cutaneous T cell lymphoma|patients with cutaneous t cell lymphoma
472177|NCT01132976|Personality disorders|personality disorders
472178|NCT01132976|Personal Concerns Inventory|personal concerns inventory
472179|NCT01132976|Non completion|non completion
472180|NCT01132937|Diffusion/Perfusion-MRI|diffusion/perfusion-mri
472181|NCT01132937|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
472182|NCT01132937|Traumatic Brain Injury|traumatic brain injury
472183|NCT01132937|Brain Imaging|brain imaging
472184|NCT01132937|Brain Injuries|brain injuries
472185|NCT01132937|TBI|tbi
472186|NCT01132924|Early Pregnancy|early pregnancy
472187|NCT01132924|Gestational Age|gestational age
472188|NCT01132924|Fecundability|fecundability
472189|NCT01132924|Ovulation|ovulation
472190|NCT01132924|Recall|recall
472191|NCT01132911|Solid Tumors|solid tumors
472192|NCT01132911|Maximum Tolerated Dose|maximum tolerated dose
472193|NCT01132911|Lymphoma|lymphoma
472194|NCT01132911|Dose Escalation|dose escalation
472195|NCT01132911|Pharmacokinetics|pharmacokinetics
472196|NCT01132911|Pediatric Cancer|pediatric cancer
472197|NCT01132911|Solid Tumor|solid tumor
472198|NCT01132911|Sarcoma|sarcoma
472199|NCT01132911|Wilms Tumor|wilms tumor
472200|NCT01132911|Neuroblastoma|neuroblastoma
472201|NCT01132898|Traumatic Brain Injury|traumatic brain injury
472202|NCT01132898|Biomarkers|biomarkers
472203|NCT01132898|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
472204|NCT01132898|DTI|dti
472205|NCT01132898|Functional Capacity|functional capacity
472206|NCT01132898|TBI|tbi
472207|NCT01132885|MRI|mri
472208|NCT01132885|Children|children
472209|NCT01132885|Williams Syndrome|williams syndrome
472210|NCT01132885|Phenotype|phenotype
472211|NCT01132885|Brain|brain
472212|NCT01132885|Healthy Volunteer|healthy volunteer
472213|NCT01132885|HV|hv
472214|NCT01132872|Serotonin 1A Receptor|serotonin 1a receptor
472215|NCT01132872|Positron Emission Tomograhy (PET)|positron emission tomograhy (pet)
472216|NCT01132872|Dosimetry|dosimetry
472217|NCT01132872|Healthy Volunteer|healthy volunteer
472218|NCT01132872|HV|hv
472219|NCT01132859|Specimen Collection|specimen collection
472220|NCT01132859|Mucosal Immunity|mucosal immunity
472221|NCT01132859|Immune Responses|immune responses
472222|NCT01132859|Immunity|immunity
472223|NCT01132859|Vaccines|vaccines
472224|NCT01132859|Healthy Volunteer|healthy volunteer
472225|NCT01132859|HV|hv
472226|NCT01132833|thromboembolism|thromboembolism
472227|NCT01132833|stage I multiple myeloma|stage i multiple myeloma
472228|NCT01132833|stage II multiple myeloma|stage ii multiple myeloma
472229|NCT01132833|stage III multiple myeloma|stage iii multiple myeloma
472230|NCT01132807|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
472231|NCT01132807|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
472232|NCT01132794|Pain relief and sedation condition|pain relief and sedation condition
472233|NCT01132781|rhinosinusitis|rhinosinusitis
472234|NCT01132781|asthma|asthma
472235|NCT01132781|allergic rhinitis|allergic rhinitis
472236|NCT01132781|theophylline|theophylline
472237|NCT01132755|gastric|gastric
472238|NCT01132755|pancreas|pancreas
472239|NCT01132755|laparoscopy|laparoscopy
472240|NCT01132755|peritoneal lavage|peritoneal lavage
472241|NCT01132755|10-011|10-011
472242|NCT01132755|gastric and pancreatic cancer|gastric and pancreatic cancer
472243|NCT01132742|Malnutrition|malnutrition
472244|NCT01132742|children|children
472245|NCT01132742|Hospital Stay|hospital stay
472246|NCT01132742|Screening Tools|screening tools
472247|NCT01132742|Anthropometry|anthropometry
472248|NCT01132690|gaucher disease|gaucher disease
472249|NCT01132690|pediatric|pediatric
472250|NCT01132677|OA of Knee|oa of knee
472251|NCT01132677|Osteoarthritis of Knee|osteoarthritis of knee
472252|NCT01132677|Viscosupplementation and Osteoarthritis|viscosupplementation and osteoarthritis
472253|NCT01132677|Viscosupplementation and OA|viscosupplementation and oa
472254|NCT01132677|Hyaluronic Acid|hyaluronic acid
472482|NCT01132430|ASTHMA CONTROL|asthma control
472255|NCT01132677|Corticosteroid injection versus hyaluronic acid|corticosteroid injection versus hyaluronic acid
472256|NCT01132677|Synvisc One and Knee OA|synvisc one and knee oa
472257|NCT01132677|viscosupplementation and knee pain|viscosupplementation and knee pain
472258|NCT01132677|knee Pain from OA|knee pain from oa
472259|NCT01132664|HER2|her2
472260|NCT01132664|BKM120|bkm120
472261|NCT01132664|PIK3|pik3
472262|NCT01132664|metastatic breast cancer|metastatic breast cancer
472263|NCT01132664|brain metastases|brain metastases
472264|NCT01132664|Herceptin|herceptin
472265|NCT01132664|trastuzumab|trastuzumab
472266|NCT01132664|capecitabine|capecitabine
472267|NCT01132664|open-label|open-label
472268|NCT01132664|maximum tolerated dose|maximum tolerated dose
472269|NCT01132664|Phase I/Phase ll|phase i/phase ll
472270|NCT01132651|eczema|eczema
472271|NCT01132651|itch|itch
472272|NCT01132651|pruritus|pruritus
472273|NCT01132651|head|head
472274|NCT01132651|neck|neck
472275|NCT01132638|Gastroesophageal|gastroesophageal
472276|NCT01132638|Pantoprazole|pantoprazole
472277|NCT01132638|erosive|erosive
472278|NCT01132638|Erosive GERD grades A-D, acc. to Los Angeles classification|erosive gerd grades a-d, acc. to los angeles classification
472279|NCT01132625|HSP90|hsp90
472280|NCT01132625|molecular chaperone|molecular chaperone
472281|NCT01132625|advanced solid tumors|advanced solid tumors
472282|NCT01132625|Japan|japan
472283|NCT01132612|Chronic plaque-type psoriasis|chronic plaque-type psoriasis
472284|NCT01132612|AIN457|ain457
472285|NCT01132612|dermatology|dermatology
472286|NCT01132612|Moderate to severe chronic plaque-type psoriasis|moderate to severe chronic plaque-type psoriasis
472287|NCT01132599|stage IV prostate cancer|stage iv prostate cancer
472288|NCT01132560|ductal breast carcinoma in situ|ductal breast carcinoma in situ
472289|NCT01132547|cachexia|cachexia
472290|NCT01132547|weight changes|weight changes
472291|NCT01132547|nausea and vomiting|nausea and vomiting
472292|NCT01132547|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
472293|NCT01132547|anaplastic osteosarcoma|anaplastic osteosarcoma
472294|NCT01132547|childhood alveolar soft-part sarcoma|childhood alveolar soft-part sarcoma
472295|NCT01132547|childhood angiosarcoma|childhood angiosarcoma
472296|NCT01132547|childhood epithelioid sarcoma|childhood epithelioid sarcoma
472297|NCT01132547|childhood fibrosarcoma|childhood fibrosarcoma
472298|NCT01132547|childhood gliosarcoma|childhood gliosarcoma
472299|NCT01132547|childhood leiomyosarcoma|childhood leiomyosarcoma
472300|NCT01132547|childhood liposarcoma|childhood liposarcoma
472301|NCT01132547|childhood neurofibrosarcoma|childhood neurofibrosarcoma
472302|NCT01132547|childhood synovial sarcoma|childhood synovial sarcoma
472303|NCT01132547|chondrosarcoma|chondrosarcoma
472304|NCT01132547|chondrosarcomatous osteosarcoma|chondrosarcomatous osteosarcoma
472305|NCT01132547|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
472306|NCT01132547|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
472307|NCT01132547|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
472308|NCT01132547|endometrial stromal sarcoma|endometrial stromal sarcoma
472309|NCT01132547|extraosseous Ewing sarcoma|extraosseous ewing sarcoma
472310|NCT01132547|peripheral primitive neuroectodermal tumor|peripheral primitive neuroectodermal tumor
472311|NCT01132547|fibrosarcomatous osteosarcoma|fibrosarcomatous osteosarcoma
472312|NCT01132547|localized Ewing sarcoma|localized ewing sarcoma
472313|NCT01132547|localized osteosarcoma|localized osteosarcoma
472314|NCT01132547|mast cell sarcoma|mast cell sarcoma
472315|NCT01132547|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
472316|NCT01132547|metastatic Ewing sarcoma|metastatic ewing sarcoma
472317|NCT01132547|metastatic osteosarcoma|metastatic osteosarcoma
472318|NCT01132547|mixed childhood rhabdomyosarcoma|mixed childhood rhabdomyosarcoma
472319|NCT01132547|mixed osteosarcoma|mixed osteosarcoma
472320|NCT01132547|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
472321|NCT01132547|osteoblastic osteosarcoma|osteoblastic osteosarcoma
472322|NCT01132547|ovarian carcinosarcoma|ovarian carcinosarcoma
472323|NCT01132547|ovarian sarcoma|ovarian sarcoma
472324|NCT01132547|pleomorphic childhood rhabdomyosarcoma|pleomorphic childhood rhabdomyosarcoma
472325|NCT01132547|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
472326|NCT01132547|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
472327|NCT01132547|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
472328|NCT01132547|recurrent childhood gliosarcoma|recurrent childhood gliosarcoma
472329|NCT01132547|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
472330|NCT01132547|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
472331|NCT01132547|recurrent Ewing sarcoma|recurrent ewing sarcoma
472332|NCT01132547|recurrent osteosarcoma|recurrent osteosarcoma
472333|NCT01132547|recurrent uterine sarcoma|recurrent uterine sarcoma
472334|NCT01132547|small intestine leiomyosarcoma|small intestine leiomyosarcoma
472335|NCT01132547|stage I uterine sarcoma|stage i uterine sarcoma
472336|NCT01132547|stage II uterine sarcoma|stage ii uterine sarcoma
472337|NCT01132547|stage III uterine sarcoma|stage iii uterine sarcoma
472338|NCT01132547|stage IV uterine sarcoma|stage iv uterine sarcoma
472339|NCT01132547|telangiectatic osteosarcoma|telangiectatic osteosarcoma
472340|NCT01132547|untreated childhood gliosarcoma|untreated childhood gliosarcoma
472341|NCT01132547|uterine carcinosarcoma|uterine carcinosarcoma
472342|NCT01132547|uterine leiomyosarcoma|uterine leiomyosarcoma
472343|NCT01132547|localized resectable neuroblastoma|localized resectable neuroblastoma
472344|NCT01132547|localized unresectable neuroblastoma|localized unresectable neuroblastoma
472345|NCT01132547|recurrent neuroblastoma|recurrent neuroblastoma
472346|NCT01132547|regional neuroblastoma|regional neuroblastoma
472347|NCT01132547|stage 4S neuroblastoma|stage 4s neuroblastoma
472348|NCT01132547|recurrent Wilms tumor|recurrent wilms tumor
472349|NCT01132547|childhood kidney tumors|childhood kidney tumors
472350|NCT01132547|stage III Wilms tumor|stage iii wilms tumor
472351|NCT01132547|stage IV Wilms tumor|stage iv wilms tumor
472352|NCT01132547|childhood hepatoblastoma|childhood hepatoblastoma
472353|NCT01132547|childhood extracranial germ cell tumor|childhood extracranial germ cell tumor
472354|NCT01132547|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
472355|NCT01132547|childhood gonadal germ cell tumor|childhood gonadal germ cell tumor
472356|NCT01132547|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
472357|NCT01132547|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
472358|NCT01132547|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
472359|NCT01132547|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
472360|NCT01132547|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
472361|NCT01132547|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
472362|NCT01132547|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
472363|NCT01132547|stage III extragonadal non-seminomatous germ cell tumor|stage iii extragonadal non-seminomatous germ cell tumor
472364|NCT01132547|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
472365|NCT01132547|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
472366|NCT01132547|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
472367|NCT01132547|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
472368|NCT01132547|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
472369|NCT01132547|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
472370|NCT01132547|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
472371|NCT01132547|untreated childhood medulloblastoma|untreated childhood medulloblastoma
472372|NCT01132547|childhood ependymoblastoma|childhood ependymoblastoma
472373|NCT01132547|childhood infratentorial ependymoma|childhood infratentorial ependymoma
472374|NCT01132547|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
472375|NCT01132547|recurrent childhood ependymoma|recurrent childhood ependymoma
472376|NCT01132547|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
472377|NCT01132547|untreated childhood subependymal giant cell astrocytoma|untreated childhood subependymal giant cell astrocytoma
472378|NCT01132547|peripheral primitive neuroectodermal tumor of the kidney|peripheral primitive neuroectodermal tumor of the kidney
472379|NCT01132547|childhood supratentorial primitive neuroectodermal tumor|childhood supratentorial primitive neuroectodermal tumor
472380|NCT01132547|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
472381|NCT01132547|recurrent childhood brain tumor|recurrent childhood brain tumor
472382|NCT01132547|untreated childhood brain stem glioma|untreated childhood brain stem glioma
472383|NCT01132547|recurrent childhood anaplastic astrocytoma|recurrent childhood anaplastic astrocytoma
472384|NCT01132547|recurrent childhood anaplastic oligoastrocytoma|recurrent childhood anaplastic oligoastrocytoma
472385|NCT01132547|recurrent childhood anaplastic oligodendroglioma|recurrent childhood anaplastic oligodendroglioma
472386|NCT01132547|stage I childhood anaplastic large cell lymphoma|stage i childhood anaplastic large cell lymphoma
472387|NCT01132547|stage II childhood anaplastic large cell lymphoma|stage ii childhood anaplastic large cell lymphoma
472388|NCT01132547|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
472389|NCT01132547|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
472390|NCT01132547|untreated childhood anaplastic astrocytoma|untreated childhood anaplastic astrocytoma
472391|NCT01132547|untreated childhood anaplastic oligoastrocytoma|untreated childhood anaplastic oligoastrocytoma
472392|NCT01132547|untreated childhood anaplastic oligodendroglioma|untreated childhood anaplastic oligodendroglioma
472393|NCT01132547|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
472394|NCT01132547|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
472395|NCT01132547|recurrent childhood astrocytoma|recurrent childhood astrocytoma
472396|NCT01132547|other tumor of glial origin|other tumor of glial origin
472397|NCT01132547|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
472398|NCT01132547|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
472399|NCT01132547|recurrent childhood diffuse astrocytoma|recurrent childhood diffuse astrocytoma
472400|NCT01132547|recurrent childhood fibrillary astrocytoma|recurrent childhood fibrillary astrocytoma
472401|NCT01132547|recurrent childhood gemistocytic astrocytoma|recurrent childhood gemistocytic astrocytoma
472402|NCT01132547|recurrent childhood oligoastrocytoma|recurrent childhood oligoastrocytoma
472403|NCT01132547|recurrent childhood pilocytic astrocytoma|recurrent childhood pilocytic astrocytoma
472404|NCT01132547|recurrent childhood pilomyxoid astrocytoma|recurrent childhood pilomyxoid astrocytoma
472405|NCT01132547|recurrent childhood pleomorphic xanthoastrocytoma|recurrent childhood pleomorphic xanthoastrocytoma
472406|NCT01132547|recurrent childhood protoplasmic astrocytoma|recurrent childhood protoplasmic astrocytoma
472407|NCT01132547|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
472408|NCT01132547|untreated childhood cerebral astrocytoma|untreated childhood cerebral astrocytoma
472409|NCT01132547|untreated childhood diffuse astrocytoma|untreated childhood diffuse astrocytoma
472410|NCT01132547|untreated childhood fibrillary astrocytoma|untreated childhood fibrillary astrocytoma
472411|NCT01132547|untreated childhood gemistocytic astrocytoma|untreated childhood gemistocytic astrocytoma
472412|NCT01132547|untreated childhood oligoastrocytoma|untreated childhood oligoastrocytoma
472413|NCT01132547|untreated childhood pilocytic astrocytoma|untreated childhood pilocytic astrocytoma
472414|NCT01132547|untreated childhood pilomyxoid astrocytoma|untreated childhood pilomyxoid astrocytoma
472415|NCT01132547|untreated childhood pleomorphic xanthoastrocytoma|untreated childhood pleomorphic xanthoastrocytoma
472416|NCT01132547|untreated childhood protoplasmic astrocytoma|untreated childhood protoplasmic astrocytoma
472417|NCT01132547|recurrent childhood gliomatosis cerebri|recurrent childhood gliomatosis cerebri
472418|NCT01132547|recurrent childhood oligodendroglioma|recurrent childhood oligodendroglioma
472419|NCT01132547|recurrent childhood visual pathway|recurrent childhood visual pathway
472420|NCT01132547|hypothalamic glioma|hypothalamic glioma
472421|NCT01132547|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
472422|NCT01132547|untreated childhood gliomatosis cerebri|untreated childhood gliomatosis cerebri
472423|NCT01132547|untreated childhood oligodendroglioma|untreated childhood oligodendroglioma
472424|NCT01132547|untreated childhood visual pathway|untreated childhood visual pathway
472425|NCT01132547|untreated childhood visual pathway glioma|untreated childhood visual pathway glioma
472426|NCT01132547|recurrent childhood giant cell glioblastoma|recurrent childhood giant cell glioblastoma
472427|NCT01132547|recurrent childhood glioblastoma|recurrent childhood glioblastoma
472428|NCT01132547|untreated childhood giant cell glioblastoma|untreated childhood giant cell glioblastoma
472429|NCT01132547|untreated childhood glioblastoma|untreated childhood glioblastoma
472430|NCT01132547|childhood choroid plexus tumor|childhood choroid plexus tumor
472431|NCT01132547|childhood grade I meningioma|childhood grade i meningioma
472432|NCT01132547|childhood grade II meningioma|childhood grade ii meningioma
472433|NCT01132547|childhood grade III meningioma|childhood grade iii meningioma
472434|NCT01132547|minimally differentiated myeloid leukemia (M0)|minimally differentiated myeloid leukemia (m0)
472435|NCT01132547|myeloblastic leukemia with maturation (M2)|myeloblastic leukemia with maturation (m2)
472436|NCT01132547|myeloblastic leukemia without maturation (M1)|myeloblastic leukemia without maturation (m1)
472437|NCT01132547|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
472438|NCT01132547|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
472439|NCT01132547|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
472440|NCT01132547|untreated childhood acute myeloid leukemia|untreated childhood acute myeloid leukemia
472441|NCT01132547|other myeloid malignancies|other myeloid malignancies
472442|NCT01132547|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
472443|NCT01132547|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
472444|NCT01132547|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
472445|NCT01132547|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
472446|NCT01132547|unspecified childhood solid tumor|unspecified childhood solid tumor
472447|NCT01132534|OGD|ogd
472448|NCT01132534|NBI|nbi
472449|NCT01132534|AFI|afi
472450|NCT01132534|Videoendoscopy|videoendoscopy
472451|NCT01132534|Narrow Band Imaging|narrow band imaging
472452|NCT01132534|Autofluorescence Imaging|autofluorescence imaging
472453|NCT01132521|ulinastatin|ulinastatin
472454|NCT01132521|severe acute pancreatitis|severe acute pancreatitis
472455|NCT01132508|Tibial plateau fracture|tibial plateau fracture
472456|NCT01132508|Orthopaedic Trauma Association (OTA) B2 B3 C3|orthopaedic trauma association (ota) b2 b3 c3
472457|NCT01132508|Bone Void|bone void
472458|NCT01132495|Stable angina|stable angina
472459|NCT01132495|angina pectoris|angina pectoris
472460|NCT01132495|PCI|pci
472461|NCT01132495|FAME|fame
472462|NCT01132495|FAME II|fame ii
472463|NCT01132495|FFR|ffr
472464|NCT01132495|Fractional Flow Reserve|fractional flow reserve
472465|NCT01132495|Pressure wire|pressure wire
472466|NCT01132482|Cystic fibrosis|cystic fibrosis
472467|NCT01132482|CFTR|cftr
472468|NCT01132482|Phosphodiesterase inhibitor|phosphodiesterase inhibitor
472469|NCT01132482|Nasal potential difference|nasal potential difference
472470|NCT01132482|Sweat test|sweat test
472471|NCT01132456|TARGET VESSEL REVASCULARIZATION (TVR)|target vessel revascularization (tvr)
472472|NCT01132456|MYOCARDIAL INFARCTION (MI)|myocardial infarction (mi)
472473|NCT01132456|TARGET VESSEL FAILURE (TVF)|target vessel failure (tvf)
472474|NCT01132456|TARGET LESION REVASCULARIZATION (TLR)|target lesion revascularization (tlr)
472475|NCT01132456|TARGET LESION FAILURE (TLF)|target lesion failure (tlf)
472476|NCT01132456|STENT THROMBOSIS|stent thrombosis
472477|NCT01132456|RESTENOTIC LESION|restenotic lesion
472478|NCT01132456|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
472479|NCT01132456|LONG LESION|long lesion
472480|NCT01132456|DUAL VESSEL|dual vessel
472483|NCT01132430|ASTHMA QUALITY OF LIFE|asthma quality of life
472484|NCT01132430|MOTIVATIONAL INTERVIEWING|motivational interviewing
472485|NCT01132417|Tigecycline, MDR|tigecycline, mdr
472486|NCT01132417|Patient infected with multidrug resistance bacteria|patient infected with multidrug resistance bacteria
472487|NCT01132391|anal fissure|anal fissure
472488|NCT01132391|nitroglycerin|nitroglycerin
472489|NCT01132391|medical treatment|medical treatment
472490|NCT01132378|Total knee arthroplasty|total knee arthroplasty
472491|NCT01132365|knee arthroplasty|knee arthroplasty
472492|NCT01132352|Bioavailability|bioavailability
472493|NCT01132352|Crossover|crossover
472494|NCT01132352|Levetiracetam|levetiracetam
472495|NCT01132339|Adverse reactions to Gadolinium-based contrast agents.|adverse reactions to gadolinium-based contrast agents.
472496|NCT01132339|Adverse reactions to Iodine-basedcontrast agents.|adverse reactions to iodine-basedcontrast agents.
472497|NCT01132326|Symptomatic NOH|symptomatic noh
472498|NCT01132287|Contact lens wear|contact lens wear
472499|NCT01132287|lubricant eye drops|lubricant eye drops
472500|NCT01132274|Supraventricular arrhythmia catheter ablation|supraventricular arrhythmia catheter ablation
472501|NCT01132248|schistosomiasis, schistosoma haematobium|schistosomiasis, schistosoma haematobium
472502|NCT01132222|Bioequivalence|bioequivalence
472503|NCT01132222|Crossover|crossover
472504|NCT01132222|Ibuprofen and Pseudoephedrine|ibuprofen and pseudoephedrine
472505|NCT01132209|surgery|surgery
472506|NCT01132209|incisional hernia|incisional hernia
472507|NCT01132209|woundinfection|woundinfection
472508|NCT01132209|burst abdomen|burst abdomen
472509|NCT01132209|pain|pain
472510|NCT01132196|Bioequivalence|bioequivalence
472511|NCT01132196|Crossover|crossover
472512|NCT01132196|Divalproex Sodium|divalproex sodium
472513|NCT01132170|Bioequivalence|bioequivalence
472514|NCT01132170|Crossover|crossover
472515|NCT01132170|Divalproex Sodium|divalproex sodium
472516|NCT01132157|Healthy Kidney Donors and Their Recipients with End Stage Renal Disease|healthy kidney donors and their recipients with end stage renal disease
472517|NCT01132144|Reproductive Techniques|reproductive techniques
472518|NCT01132144|Embryo Implantation|embryo implantation
472519|NCT01132144|Endometrium|endometrium
472520|NCT01132144|Ultrasonography|ultrasonography
472521|NCT01132131|Urinary tract infection|urinary tract infection
472522|NCT01132131|Cystitis|cystitis
472523|NCT01132131|Bacteruria|bacteruria
472524|NCT01132118|rheumatoid arthritis|rheumatoid arthritis
472525|NCT01132118|insulin resistance|insulin resistance
472526|NCT01132118|hydroxychloroquine|hydroxychloroquine
472527|NCT01132118|cholesterol|cholesterol
472528|NCT01132092|Evoked Potentials, Adult, Hearing Loss|evoked potentials, adult, hearing loss
472529|NCT01132079|atopic dermatitis|atopic dermatitis
472530|NCT01132079|barrier function|barrier function
472531|NCT01132079|pimecrolimus|pimecrolimus
472532|NCT01132066|swallowing|swallowing
472533|NCT01132066|stroke|stroke
472534|NCT01132053|JC Virus|jc virus
472535|NCT01132040|Bioequivalence|bioequivalence
472536|NCT01132040|Crossover|crossover
472537|NCT01132040|Primidone|primidone
472538|NCT01132027|Bioavailability, crossover, tacrolimus|bioavailability, crossover, tacrolimus
472539|NCT01132014|Subjects with recurrent ovarian, fallopian tube or primary peritoneal cancer,|subjects with recurrent ovarian, fallopian tube or primary peritoneal cancer,
472540|NCT01132014|from whom solid tumor or ascites have been harvested and are available and|from whom solid tumor or ascites have been harvested and are available and
472541|NCT01132014|sufficient for tumorlysate preparation;and whose largest tumor nodule is 4.5|sufficient for tumorlysate preparation;and whose largest tumor nodule is 4.5
472542|NCT01132014|cm. Subjects may have undergone chemotherapy or other therapy following|cm. subjects may have undergone chemotherapy or other therapy following
472543|NCT01132014|tumor harvesting and prior to enrollment.|tumor harvesting and prior to enrollment.
472544|NCT01131988|Bioavailability, crossover, tacrolimus|bioavailability, crossover, tacrolimus
472545|NCT01131975|Bioequivalence|bioequivalence
472546|NCT01131975|Crossover|crossover
472547|NCT01131975|Lamotrigine (chewable, dispersible)|lamotrigine (chewable, dispersible)
472548|NCT01131962|esophageal varices|esophageal varices
472549|NCT01131962|hematemesis|hematemesis
472550|NCT01131962|endoscopy|endoscopy
472551|NCT01131949|Bioequivalence|bioequivalence
472552|NCT01131949|Crossover|crossover
472553|NCT01131949|Lamotrigine (chewable, dispersible)|lamotrigine (chewable, dispersible)
472554|NCT01131936|Bioequivalence|bioequivalence
472555|NCT01131936|Amlodipine Besylate|amlodipine besylate
472556|NCT01131923|Bioequivalence|bioequivalence
472557|NCT01131923|Amlodipine Besylate|amlodipine besylate
472558|NCT01131910|Rheumatoid arthritis|rheumatoid arthritis
472559|NCT01131910|TBE-vaccine|tbe-vaccine
472560|NCT01131910|Immunosuppression|immunosuppression
472561|NCT01131897|Bioavailability|bioavailability
472562|NCT01131897|Crossover|crossover
472563|NCT01131897|Levetiracetam|levetiracetam
472564|NCT01131884|ASIA A or ASIA B Spinal Cord Injury|asia a or asia b spinal cord injury
472565|NCT01131871|obesity|obesity
472566|NCT01131871|overweight|overweight
472567|NCT01131832|Cholesterol, Plant sterols, Non-response, SNPs,|cholesterol, plant sterols, non-response, snps,
472568|NCT01131819|Trans-tibial Amputation|trans-tibial amputation
472569|NCT01131806|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
473145|NCT01129232|insulin|insulin
472570|NCT01131806|lung function change FEV1 FVC|lung function change fev1 fvc
472571|NCT01131806|acute exacerbation|acute exacerbation
472572|NCT01131806|life quality questionnaire|life quality questionnaire
472573|NCT01131793|Coronary Artery Chronic Total Occlusion In-Stent|coronary artery chronic total occlusion in-stent
472574|NCT01131780|Bioequivalence|bioequivalence
472575|NCT01131780|Crossover|crossover
472576|NCT01131780|Ibuprofen and Pseudoephedrine|ibuprofen and pseudoephedrine
472577|NCT01131767|Bioequivalence|bioequivalence
472578|NCT01131767|Crossover|crossover
472579|NCT01131767|Naproxen Sodium and Pseudoephedrine Hydrochloride|naproxen sodium and pseudoephedrine hydrochloride
472580|NCT01131754|Peripheral venous catheter complications|peripheral venous catheter complications
472581|NCT01131754|PVC occlusion|pvc occlusion
472582|NCT01131754|PVC phlebitis|pvc phlebitis
472583|NCT01131741|anesthesia, general|anesthesia, general
472584|NCT01131741|blood pressure|blood pressure
472585|NCT01131741|epinephrine|epinephrine
472586|NCT01131741|heart rate|heart rate
472587|NCT01131741|injections, intravenous|injections, intravenous
472588|NCT01131728|Bioequivalence|bioequivalence
472589|NCT01131728|Crossover|crossover
472590|NCT01131728|Naproxen Sodium and Pseudoephedrine Hydrochloride|naproxen sodium and pseudoephedrine hydrochloride
472591|NCT01131715|Qualitetive interview|qualitetive interview
472592|NCT01131715|Coronary heart disease (CHD)|coronary heart disease (chd)
472593|NCT01131715|Patient experience|patient experience
472594|NCT01131715|Patient perception|patient perception
472595|NCT01131702|Bioequivalence|bioequivalence
472596|NCT01131702|Crossover|crossover
472597|NCT01131702|Ranitidine|ranitidine
472598|NCT01131689|metastatic HCC|metastatic hcc
472599|NCT01131663|Infants, aerosol, acceptance, face mask, drug delivery|infants, aerosol, acceptance, face mask, drug delivery
472600|NCT01131650|Prevalence of diabetic retinopathy|prevalence of diabetic retinopathy
472601|NCT01131650|Diabetes|diabetes
472602|NCT01131650|Retinopathy|retinopathy
472603|NCT01131650|Prevalence|prevalence
472604|NCT01131650|Population|population
472605|NCT01131637|chronic heart failure|chronic heart failure
472607|NCT01131637|mortality|mortality
472608|NCT01131624|Iron deficiency|iron deficiency
472609|NCT01131611|Spinal Stenosis|spinal stenosis
472610|NCT01131611|Rehabilitation|rehabilitation
472611|NCT01131611|Physical Therapy (specialty)|physical therapy (specialty)
472612|NCT01131611|Cognitive Behavior Therapy|cognitive behavior therapy
472613|NCT01131611|Behavioral Research|behavioral research
472614|NCT01131598|ALI|ali
472615|NCT01131598|SDRA|sdra
472616|NCT01131585|Diabetic macular edema|diabetic macular edema
472617|NCT01131585|DME|dme
472618|NCT01131585|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
472619|NCT01131585|PDR|pdr
472620|NCT01131585|ranibizumab|ranibizumab
472621|NCT01131585|laser|laser
472622|NCT01131559|bipolar disorder|bipolar disorder
472623|NCT01131559|manic depression|manic depression
472624|NCT01131559|depression|depression
472625|NCT01131559|Bipolar I or II|bipolar i or ii
472626|NCT01131546|Essential Hypertension|essential hypertension
472627|NCT01131546|Levamlodipine Besylate|levamlodipine besylate
472628|NCT01131546|Amlodipine Maleate|amlodipine maleate
472629|NCT01131520|SBIRT|sbirt
472630|NCT01131520|Drug abuse|drug abuse
472631|NCT01131507|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
472632|NCT01131507|Infants with CF|infants with cf
472633|NCT01131494|Parkinson's disease|parkinson's disease
472634|NCT01131494|Dysphagia|dysphagia
472635|NCT01131494|Treatment|treatment
472636|NCT01131481|cataracts,glistenings,intraocular lenses.|cataracts,glistenings,intraocular lenses.
472637|NCT01131468|ototoxicity|ototoxicity
472638|NCT01131468|aminoglycoside|aminoglycoside
472639|NCT01131468|vancomycine|vancomycine
472640|NCT01131468|peritoneal dialysis|peritoneal dialysis
472641|NCT01131468|peritonitis|peritonitis
472642|NCT01131442|immune|immune
472643|NCT01131429|mutation analysis|mutation analysis
472644|NCT01131429|first-line|first-line
472645|NCT01131429|second-line|second-line
472646|NCT01131429|targeted therapy|targeted therapy
472647|NCT01131403|IL-1α, skin care; baby wet wipes; full-term newborn; skin barrier function|il-1α, skin care; baby wet wipes; full-term newborn; skin barrier function
472648|NCT01131377|mechanical ventilation weaning phase patients with metabolic alkalosis|mechanical ventilation weaning phase patients with metabolic alkalosis
472649|NCT01131364|Interleukin|interleukin
472650|NCT01131364|IL2|il2
472651|NCT01131364|F16|f16
472652|NCT01131364|monoclonal|monoclonal
472653|NCT01131364|antibody|antibody
472654|NCT01131364|cytokine|cytokine
472655|NCT01131364|doxorubicin|doxorubicin
472656|NCT01131364|breast cancer|breast cancer
472657|NCT01131364|solid tumour|solid tumour
472658|NCT01131364|Phase I: Advanced Solid Tumour Patients|phase i: advanced solid tumour patients
472659|NCT01131364|Phase II: Breast Cancer Patients Amenable to anthracyclin Therapy|phase ii: breast cancer patients amenable to anthracyclin therapy
472660|NCT01131351|MDR-TB|mdr-tb
472661|NCT01131351|Dose Escalation|dose escalation
472662|NCT01131351|Phase II|phase ii
472663|NCT01131351|Open Label|open label
472664|NCT01131351|Non Controlled|non controlled
472665|NCT01131351|Pulmonary Multidrug-Resistant Tuberculosis (MDR TB)|pulmonary multidrug-resistant tuberculosis (mdr tb)
472666|NCT01131325|Philadelphia chromosome positive|philadelphia chromosome positive
472667|NCT01131325|Ph+|ph+
472668|NCT01131325|chronic myelogenous leukemia chronic phase|chronic myelogenous leukemia chronic phase
472669|NCT01131325|CML-CP|cml-cp
472670|NCT01131325|low imatinib trough levels|low imatinib trough levels
472671|NCT01131312|Cervix|cervix
472672|NCT01131312|CIN|cin
472673|NCT01131312|HPV|hpv
472674|NCT01131312|Triage|triage
472675|NCT01131312|ASCUS/LSIL|ascus/lsil
472676|NCT01131312|Pap Smear|pap smear
472677|NCT01131312|HPV Test|hpv test
472678|NCT01131299|HDL|hdl
472679|NCT01131299|Cholesterol|cholesterol
472680|NCT01131299|Lipoproteins|lipoproteins
472681|NCT01131299|Serum Lipids|serum lipids
472682|NCT01131299|Alpha-Cyclodextrin|alpha-cyclodextrin
472683|NCT01131299|Atherosclerosis|atherosclerosis
472684|NCT01131299|Heart Disease|heart disease
472685|NCT01131273|buprenorphine injecting|buprenorphine injecting
472686|NCT01131273|opiate dependence|opiate dependence
472687|NCT01131273|HIV risk|hiv risk
472688|NCT01131273|treatment outcome|treatment outcome
472689|NCT01131273|opiate dependence with buprenorphine injecting|opiate dependence with buprenorphine injecting
472690|NCT01131260|STAN|stan
472691|NCT01131260|Fetal monitoring|fetal monitoring
472692|NCT01131260|Fetal acidosis|fetal acidosis
472693|NCT01131260|Fetal heart rate monitoring|fetal heart rate monitoring
472694|NCT01131260|Perinatology|perinatology
472695|NCT01131247|CLL|cll
472696|NCT01131247|bendamustine|bendamustine
472697|NCT01131247|ofatumumab|ofatumumab
472698|NCT01131247|blood cancer|blood cancer
472699|NCT01131247|leukemia|leukemia
472700|NCT01131247|lymphoma|lymphoma
472701|NCT01131247|lymphocyte|lymphocyte
472702|NCT01131247|refractory|refractory
472703|NCT01131247|Advanced|advanced
472704|NCT01131247|relapsed|relapsed
472705|NCT01131247|hematologic|hematologic
472706|NCT01131247|hematology|hematology
472707|NCT01131247|antibody|antibody
472708|NCT01131247|non-Hodgkin lymphoma|non-hodgkin lymphoma
472709|NCT01131247|small lymphocytic lymphoma|small lymphocytic lymphoma
472710|NCT01131247|nevada cancer institute|nevada cancer institute
472711|NCT01131247|cephalon|cephalon
472712|NCT01131247|Glaxosmithkline|glaxosmithkline
472713|NCT01131221|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
472714|NCT01131221|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
472715|NCT01131221|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
472716|NCT01131221|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
472717|NCT01131221|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
472718|NCT01131221|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
472719|NCT01131221|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
472720|NCT01131221|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
472721|NCT01131221|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
472722|NCT01131221|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
472723|NCT01131221|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
472724|NCT01131221|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
472725|NCT01131208|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
472726|NCT01131208|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
472727|NCT01131208|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
472728|NCT01131208|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
472729|NCT01131208|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
472730|NCT01131208|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
472731|NCT01131195|HER2-negative breast cancer|her2-negative breast cancer
472732|NCT01131195|recurrent breast cancer|recurrent breast cancer
472733|NCT01131195|stage IIIB breast cancer|stage iiib breast cancer
472734|NCT01131195|stage IIIC breast cancer|stage iiic breast cancer
472735|NCT01131195|stage IV breast cancer|stage iv breast cancer
472736|NCT01131169|Myeloma|myeloma
472737|NCT01131169|Busulfan|busulfan
472738|NCT01131169|Melphalan|melphalan
472739|NCT01131169|Fludarabine|fludarabine
472740|NCT01131169|T-Cell|t-cell
472741|NCT01131169|Stem Cell Transplantation|stem cell transplantation
472742|NCT01131169|10-051|10-051
472743|NCT01131156|postpartum|postpartum
472744|NCT01131156|smoking|smoking
472745|NCT01131156|relapse|relapse
472746|NCT01131156|breastfeeding|breastfeeding
472747|NCT01131143|Urban community centers|urban community centers
472748|NCT01131143|Obesity|obesity
472749|NCT01131143|Obesity counseling|obesity counseling
472750|NCT01131143|Low-cost intervention|low-cost intervention
472751|NCT01131130|Contact lens|contact lens
472752|NCT01131117|healthy|healthy
472753|NCT01131117|women|women
472754|NCT01131117|pregnancy|pregnancy
472755|NCT01131104|NAION|naion
472756|NCT01131065|Hepatitis B|hepatitis b
472757|NCT01131065|HBV|hbv
472758|NCT01131065|Orthotopic liver transplantation|orthotopic liver transplantation
472759|NCT01131065|Liver transplantation|liver transplantation
472760|NCT01131065|Recurrence|recurrence
472761|NCT01131065|Reinfection|reinfection
472762|NCT01131065|Protective titers|protective titers
472763|NCT01131065|HBsAb|hbsab
472764|NCT01131065|Hepatitis B virus immune globulin|hepatitis b virus immune globulin
472765|NCT01131065|Niuliva|niuliva
472766|NCT01131052|elderly populations|elderly populations
472767|NCT01131052|diabetes|diabetes
472768|NCT01131039|Ovarian Cancer|ovarian cancer
472769|NCT01131026|Helicobacter pylori|helicobacter pylori
472770|NCT01131026|levofloxacin|levofloxacin
472771|NCT01131026|amoxicillin|amoxicillin
472772|NCT01131026|lansoprazole|lansoprazole
472773|NCT01131026|efficacy|efficacy
472774|NCT01131026|safety|safety
472775|NCT01131026|triple therapy|triple therapy
472776|NCT01130987|resident|resident
472777|NCT01130987|intern|intern
472778|NCT01130987|patient safety|patient safety
472779|NCT01130987|medical error|medical error
472780|NCT01130987|time motion|time motion
472781|NCT01130987|handoff|handoff
472782|NCT01130987|sign-out|sign-out
472783|NCT01130987|Resident Workflow|resident workflow
472784|NCT01130987|Resident Communications|resident communications
472785|NCT01130961|Advanced NSCLC|advanced nsclc
472786|NCT01130961|Gefitinib|gefitinib
472787|NCT01130961|Thai patient|thai patient
472788|NCT01130948|hypoxia|hypoxia
472789|NCT01130948|altitude|altitude
472790|NCT01130948|sleep|sleep
472791|NCT01130948|sleep apnea|sleep apnea
472792|NCT01130948|periodic breathing|periodic breathing
472793|NCT01130948|vigilance|vigilance
472794|NCT01130948|psychomotor|psychomotor
472795|NCT01130948|endothelial function|endothelial function
472796|NCT01130935|GERD|gerd
472797|NCT01130935|gastric and duodenal ulcers|gastric and duodenal ulcers
472798|NCT01130935|NSAID therapy|nsaid therapy
472799|NCT01130922|Roux-and-Y gastric bypass surgery|roux-and-y gastric bypass surgery
472800|NCT01130922|stable body weight|stable body weight
472801|NCT01130909|Healthy|healthy
472802|NCT01130909|Effect of a single dose on gamma-band qEEG|effect of a single dose on gamma-band qeeg
472803|NCT01130896|MRI, pacemakers, Defibrillator|mri, pacemakers, defibrillator
472804|NCT01130883|acute tracheitis|acute tracheitis
472805|NCT01130883|acute tracheobronchitis or acute bronchitis|acute tracheobronchitis or acute bronchitis
472806|NCT01130883|acute exacerbation of chronic bronchitis|acute exacerbation of chronic bronchitis
472807|NCT01130883|mild community-acquired pneumonia|mild community-acquired pneumonia
472808|NCT01130870|Fecal incontinence|fecal incontinence
472809|NCT01130870|Sacral nerve stimulation|sacral nerve stimulation
472810|NCT01130870|Quality of life|quality of life
472811|NCT01130870|DR15.9 Incontinentia alva|dr15.9 incontinentia alva
472812|NCT01130818|Safety|safety
472813|NCT01130818|Tolerability|tolerability
472814|NCT01130818|Pharmacokinetics|pharmacokinetics
472815|NCT01130818|Bioavailability (solid vs solution, fasting vs fed)|bioavailability (solid vs solution, fasting vs fed)
472816|NCT01130818|Young healthy subjects|young healthy subjects
472817|NCT01130818|Elderly healthy subjects|elderly healthy subjects
472818|NCT01130805|gastric cancer pazopanib capecitabine, oxaliplatin|gastric cancer pazopanib capecitabine, oxaliplatin
472819|NCT01130805|Metastatic or recurrent gastric cancer|metastatic or recurrent gastric cancer
472820|NCT01130792|rotavirus|rotavirus
472821|NCT01130792|cryptosporidium|cryptosporidium
472822|NCT01130792|probiotics|probiotics
472823|NCT01130792|intestinal function|intestinal function
472824|NCT01130792|immune response|immune response
472825|NCT01130779|Non-small Cell Lung Cancer|non-small cell lung cancer
472826|NCT01130779|Erlotinib|erlotinib
472827|NCT01130779|brain metastasis|brain metastasis
472828|NCT01130766|Non-small Cell Lung Cancer|non-small cell lung cancer
472829|NCT01130766|Asymptomatic brain metastasis|asymptomatic brain metastasis
472830|NCT01130766|Stereotactic radiosurgery (SRS)|stereotactic radiosurgery (srs)
472831|NCT01130740|Osteoarthritis|osteoarthritis
472832|NCT01130740|Exercise|exercise
472833|NCT01130740|Diet|diet
472834|NCT01130740|Coping Skills|coping skills
472835|NCT01130740|Education, Medical|education, medical
472836|NCT01130727|diabetes mellitus|diabetes mellitus
472837|NCT01130727|diabetic nephropathy|diabetic nephropathy
472838|NCT01130727|hypertension|hypertension
472839|NCT01130727|green tea|green tea
472840|NCT01130727|cocoa|cocoa
472841|NCT01130727|polyphenol|polyphenol
472842|NCT01130727|nitric oxide|nitric oxide
472843|NCT01130714|inflammation|inflammation
472844|NCT01130714|chemotherapy|chemotherapy
472845|NCT01130714|lung cancer|lung cancer
472846|NCT01130701|Pancreatic Cancer|pancreatic cancer
472847|NCT01130701|Neoadjuvant|neoadjuvant
472848|NCT01130701|Panitumumab|panitumumab
472849|NCT01130701|Capecitabine|capecitabine
472850|NCT01130688|Leukemia|leukemia
472851|NCT01130688|Zileuton|zileuton
472852|NCT01130688|myeloproliferative neoplasm|myeloproliferative neoplasm
472853|NCT01130662|acute myeloid leukemia|acute myeloid leukemia
472854|NCT01130662|AML|aml
472855|NCT01130662|Relapsed AML|relapsed aml
472856|NCT01130662|Refractory AML|refractory aml
472857|NCT01130649|Epilepsy|epilepsy
472858|NCT01130649|Tracking|tracking
472859|NCT01130649|Electronic diary|electronic diary
472860|NCT01130636|oseltamivir carboxylate|oseltamivir carboxylate
472861|NCT01130636|oseltamivir phosphate|oseltamivir phosphate
472862|NCT01130636|Tamiflu pharmacokinetics in lactating women with influenza|tamiflu pharmacokinetics in lactating women with influenza
472863|NCT01130623|VEGF Inhibitor|vegf inhibitor
472864|NCT01130623|Maximum Tolerated Dose|maximum tolerated dose
472865|NCT01130623|Dose Escalation|dose escalation
472866|NCT01130623|Pharmacokinetics|pharmacokinetics
472867|NCT01130623|Antitumor Activity|antitumor activity
472868|NCT01130623|Pediatric Cancer|pediatric cancer
472869|NCT01130623|Solid Tumor|solid tumor
472870|NCT01130623|Sarcoma|sarcoma
472871|NCT01130623|Neuroblastoma|neuroblastoma
472872|NCT01130623|Wilms Tumor|wilms tumor
472873|NCT01130623|Osteosarcoma|osteosarcoma
472874|NCT01130623|Brain Tumor|brain tumor
472875|NCT01130610|preoperative period|preoperative period
472876|NCT01130610|preoperative care|preoperative care
472877|NCT01130610|anesthesia|anesthesia
472878|NCT01130610|program evaluation|program evaluation
472879|NCT01130597|HF|hf
472880|NCT01130597|Heart failure|heart failure
472881|NCT01130597|hyperkalemia|hyperkalemia
472882|NCT01130597|chronic kidney disease|chronic kidney disease
472883|NCT01130597|prevention of hyperkalemia in heart failure participants|prevention of hyperkalemia in heart failure participants
472884|NCT01130584|Cancer Patients|cancer patients
472885|NCT01130558|type 2 diabetes mellitus|type 2 diabetes mellitus
472886|NCT01130558|basal-bolus insulin|basal-bolus insulin
472887|NCT01130558|insulin ordering|insulin ordering
472888|NCT01130545|Magnetic Resonance Imaging|magnetic resonance imaging
472889|NCT01130545|Gadolinium|gadolinium
472890|NCT01130545|Healthy Volunteer|healthy volunteer
472891|NCT01130545|HV|hv
472892|NCT01130532|Erectile Dysfunction|erectile dysfunction
472893|NCT01130532|ED|ed
472894|NCT01130532|Impotence|impotence
472895|NCT01130519|Advanced HLRCC|advanced hlrcc
472896|NCT01130519|Sporadic Papillary Renal Cell Cancer|sporadic papillary renal cell cancer
472897|NCT01130519|Papillary Kidney Cancer|papillary kidney cancer
472898|NCT01130519|Bevacizumab|bevacizumab
472899|NCT01130519|Erlotinib|erlotinib
472900|NCT01130519|Kidney Cancer|kidney cancer
472901|NCT01130519|Renal Cell Cancer|renal cell cancer
472902|NCT01130519|Hereditary Leiomyomatosis and Renal Cell Cancer|hereditary leiomyomatosis and renal cell cancer
472903|NCT01130519|HLRCC|hlrcc
472904|NCT01130467|Attention Deficit Disorders with Hyperactivity|attention deficit disorders with hyperactivity
472905|NCT01130467|Attention Deficit Disorder|attention deficit disorder
472906|NCT01130467|Event related potential|event related potential
472907|NCT01130454|Unfavorable effect of environmental factors, stressors|unfavorable effect of environmental factors, stressors
472908|NCT01130441|adolescent behavior|adolescent behavior
472909|NCT01130441|harm reduction|harm reduction
472910|NCT01130428|Mechanical stimulation|mechanical stimulation
472911|NCT01130428|Vibration platform|vibration platform
472912|NCT01130428|Bone metabolism|bone metabolism
472913|NCT01130428|ATP release|atp release
472914|NCT01130415|Sacral neuromodulation|sacral neuromodulation
472915|NCT01130415|Screening|screening
472916|NCT01130415|Percutaneous nerve evaluation|percutaneous nerve evaluation
472917|NCT01130415|Tined lead|tined lead
472918|NCT01130402|age|age
472919|NCT01130402|lymphadenopathy|lymphadenopathy
472920|NCT01130402|fine needle aspiration|fine needle aspiration
472921|NCT01130402|sonography|sonography
472922|NCT01130389|ONJ|onj
472923|NCT01130376|Immune based therapy|immune based therapy
472924|NCT01130376|Therapeutic vaccination|therapeutic vaccination
472925|NCT01130376|cytokine therapy|cytokine therapy
472926|NCT01130376|HIV therapeutic vaccine|hiv therapeutic vaccine
472927|NCT01130363|Proton Pump Inhibitor|proton pump inhibitor
472928|NCT01130363|Gastric carcinoid tumors|gastric carcinoid tumors
472929|NCT01130363|Gastric cancer|gastric cancer
472930|NCT01130363|Fundic Gland Polyps|fundic gland polyps
472931|NCT01130324|VIBATIV|vibativ
472932|NCT01130324|telavancin|telavancin
472933|NCT01130324|Pregnancy|pregnancy
472934|NCT01130324|Registry|registry
472935|NCT01130298|testosterone,|testosterone,
472936|NCT01130298|Pharmacokinetics|pharmacokinetics
472937|NCT01130298|replacement,|replacement,
472938|NCT01130298|therapy|therapy
472939|NCT01130285|Lung Cancer|lung cancer
472940|NCT01130272|Irritable bowel syndrome with diarrhea|irritable bowel syndrome with diarrhea
472941|NCT01130272|Irritable bowel syndrome|irritable bowel syndrome
472942|NCT01130272|Diarrhea predominant irritable bowel syndrome|diarrhea predominant irritable bowel syndrome
472943|NCT01130272|Colonic diseases|colonic diseases
472944|NCT01130272|Colonic diseases, functional|colonic diseases, functional
472945|NCT01130272|Digestive system disease|digestive system disease
472946|NCT01130272|Gastrointestinal disease|gastrointestinal disease
472947|NCT01130272|Intestinal disease|intestinal disease
472948|NCT01130272|Colonic pseudo-obstruction|colonic pseudo-obstruction
472949|NCT01130272|Diarrhea|diarrhea
472950|NCT01130272|Signs and Symptoms, Digestive|signs and symptoms, digestive
472951|NCT01130259|mTNBC|mtnbc
472952|NCT01130259|triple negative breast cancer|triple negative breast cancer
473146|NCT01129219|Strength|strength
472953|NCT01130259|metastatic triple negative breast cancer|metastatic triple negative breast cancer
472954|NCT01130259|metastatic breast cancer that is ER-, PR-, and HER2-negative|metastatic breast cancer that is er-, pr-, and her2-negative
472955|NCT01130233|rectal cancer|rectal cancer
472956|NCT01130220|Brain Tumor|brain tumor
472957|NCT01130220|Brain Neoplasm|brain neoplasm
472958|NCT01130207|Obesity|obesity
472959|NCT01130207|Diabetes|diabetes
472960|NCT01130207|Periodontal disease|periodontal disease
472961|NCT01130194|follicular lymphoma|follicular lymphoma
472962|NCT01130194|radioimmunotherapy|radioimmunotherapy
472963|NCT01130194|rituximab|rituximab
472964|NCT01130194|C-MOPP-R|c-mopp-r
472965|NCT01130194|autologous transplant|autologous transplant
472966|NCT01130155|Antimalarials|antimalarials
472967|NCT01130155|Diagnosis|diagnosis
472968|NCT01130155|Access to treatment|access to treatment
472969|NCT01130155|Quality of care|quality of care
472970|NCT01130129|Flavonoids|flavonoids
472971|NCT01130129|Platelets|platelets
472972|NCT01130103|PTSD|ptsd
472973|NCT01130103|anxiety disorders|anxiety disorders
472974|NCT01130103|trauma|trauma
472975|NCT01130077|Pediatric glioma|pediatric glioma
472976|NCT01130077|Vaccine therapy|vaccine therapy
472977|NCT01130064|Asthma|asthma
472978|NCT01130064|QAX576|qax576
472979|NCT01130051|bioavailability|bioavailability
472980|NCT01130038|Characteristic of play|characteristic of play
472981|NCT01130038|DCD|dcd
472982|NCT01130038|children|children
472983|NCT01130038|Typical Development|typical development
472984|NCT01130038|Whether there are any differences in the issue of Characteristic of play between Children with DCD and Children with Typical Development|whether there are any differences in the issue of characteristic of play between children with dcd and children with typical development
472985|NCT01130012|Gestational diabetes mellitus|gestational diabetes mellitus
472986|NCT01130012|Lifestyle intervention|lifestyle intervention
472987|NCT01130012|Oral glucose tolerance test|oral glucose tolerance test
472988|NCT01130012|Insulin treatment|insulin treatment
472989|NCT01130012|Pregnancy outcomes|pregnancy outcomes
472990|NCT01129999|smoking cessation, CBT, hypnotherapy|smoking cessation, cbt, hypnotherapy
472991|NCT01129986|venous ulcer Dermastream|venous ulcer dermastream
472992|NCT01129973|speech and language|speech and language
472993|NCT01129973|phonoaudiology|phonoaudiology
472994|NCT01129973|marketing|marketing
472995|NCT01129960|Diabetic Neuropathic Pain|diabetic neuropathic pain
472996|NCT01129934|Low Back Pain,|low back pain,
472997|NCT01129934|Emergency medicine,|emergency medicine,
472998|NCT01129934|Promethazine,|promethazine,
472999|NCT01129934|Morphine,|morphine,
473000|NCT01129934|Pain relief|pain relief
473001|NCT01129921|Lumbar Spine Stenosis|lumbar spine stenosis
473002|NCT01129921|Decompression|decompression
473003|NCT01129908|oral health in children with celiac disease|oral health in children with celiac disease
473004|NCT01129882|Schizophrenia|schizophrenia
473005|NCT01129869|Survey|survey
473006|NCT01129869|Perception|perception
473007|NCT01129869|Perception of Clinical Research Participation|perception of clinical research participation
473008|NCT01129869|Research Participant Perception|research participant perception
473009|NCT01129856|Dry eye|dry eye
473010|NCT01129856|Keratoconjunctivitis sicca|keratoconjunctivitis sicca
473011|NCT01129856|Iontophoresis|iontophoresis
473012|NCT01129856|Ophthalmic drug delivery|ophthalmic drug delivery
473013|NCT01129856|EGP-437|egp-437
473014|NCT01129856|Dexamethasone phosphate|dexamethasone phosphate
473015|NCT01129843|anemia|anemia
473016|NCT01129843|iron deficiency|iron deficiency
473017|NCT01129843|nutritional|nutritional
473018|NCT01129843|iron supplementation|iron supplementation
473019|NCT01129843|cluster randomized control trial|cluster randomized control trial
473020|NCT01129830|ovarian reserve|ovarian reserve
473021|NCT01129830|FSH|fsh
473022|NCT01129830|anti-mullerian hormone|anti-mullerian hormone
473023|NCT01129830|estradiol|estradiol
473024|NCT01129830|oocyte|oocyte
473025|NCT01129830|IVF|ivf
473026|NCT01129830|embryo transfer|embryo transfer
473027|NCT01129817|Cognitive Functional Therapy|cognitive functional therapy
473028|NCT01129817|Manual Therapy and Exercise|manual therapy and exercise
473029|NCT01129817|Chronic Low Back Pain|chronic low back pain
473030|NCT01129817|Randomized Controlled Trial|randomized controlled trial
473031|NCT01129817|Subclassification|subclassification
473032|NCT01129804|Alcohol dependence|alcohol dependence
473033|NCT01129804|Network Support|network support
473034|NCT01129804|Cognitive-behavioral treatment|cognitive-behavioral treatment
473035|NCT01129804|Relapse prevention|relapse prevention
473036|NCT01129804|Consequences of drinking|consequences of drinking
473037|NCT01129804|Social network development|social network development
473038|NCT01129791|Lactose intolerance|lactose intolerance
473039|NCT01129791|Dairy products|dairy products
473040|NCT01129791|Raw milk|raw milk
473041|NCT01129791|Adults|adults
473042|NCT01129765|Nasal suction|nasal suction
473043|NCT01129765|Nasal aspiration|nasal aspiration
473044|NCT01129765|Nasal saline irrigation|nasal saline irrigation
473045|NCT01129765|Nasal lavage|nasal lavage
473046|NCT01129739|Bone Marrow Disease|bone marrow disease
473047|NCT01129739|MDS-RA|mds-ra
473048|NCT01129739|MDS-RARS|mds-rars
473049|NCT01129739|Umbilical Cord/placenta-Derived MSC|umbilical cord/placenta-derived msc
473050|NCT01129739|Transplant|transplant
473051|NCT01129726|Transillumination-guided|transillumination-guided
473052|NCT01129726|Fiberoptic Intubation|fiberoptic intubation
473053|NCT01129726|time|time
473054|NCT01129726|success rate|success rate
473055|NCT01129726|intubation|intubation
473056|NCT01129713|GERD|gerd
473057|NCT01129713|Acid Reflux|acid reflux
473058|NCT01129713|Heartburn|heartburn
473059|NCT01129713|Regurgitation|regurgitation
473060|NCT01129713|Indigestion|indigestion
473061|NCT01129700|rectal cancer, short-course, chemoradiotherapy|rectal cancer, short-course, chemoradiotherapy
473062|NCT01129648|Hyperuricemia, gout|hyperuricemia, gout
473063|NCT01129635|Heart failure|heart failure
473064|NCT01129635|Cardiac resynchronization therapy|cardiac resynchronization therapy
473065|NCT01129635|Regional left ventricular dyssynchrony|regional left ventricular dyssynchrony
473066|NCT01129635|CRT|crt
473067|NCT01129622|Letrozole|letrozole
473068|NCT01129622|Breast MRI|breast mri
473069|NCT01129622|Postmenopausal women|postmenopausal women
473070|NCT01129609|Post-approval observation of patients being treated according to the indications for use for the Talent Converter Stent Graft|post-approval observation of patients being treated according to the indications for use for the talent converter stent graft
473071|NCT01129583|Botulinum Toxin|botulinum toxin
473072|NCT01129583|Elbow Stiffness|elbow stiffness
473073|NCT01129544|Severe combined immunodeficiency|severe combined immunodeficiency
473074|NCT01129544|SCID|scid
473075|NCT01129544|XSCID|xscid
473076|NCT01129544|SCID-X1|scid-x1
473077|NCT01129518|meningococcal serogroup C|meningococcal serogroup c
473078|NCT01129518|vaccine|vaccine
473079|NCT01129518|conjugate|conjugate
473080|NCT01129505|pregnancy|pregnancy
473081|NCT01129505|intervention|intervention
473082|NCT01129505|exercise|exercise
473083|NCT01129505|nutrition|nutrition
473084|NCT01129505|infants|infants
473085|NCT01129492|Autoimmune Thyroiditis, Laser, Therapy, Thyroid, Ultrasound|autoimmune thyroiditis, laser, therapy, thyroid, ultrasound
473086|NCT01129479|Aphasia|aphasia
473087|NCT01129479|treatment|treatment
473088|NCT01129479|cholinesterase inhibitor|cholinesterase inhibitor
473089|NCT01129479|stroke|stroke
473090|NCT01129453|Salmonella|salmonella
473091|NCT01129453|Vaccine|vaccine
473092|NCT01129440|Children|children
473093|NCT01129440|Fluoride varnish|fluoride varnish
473094|NCT01129440|Glass ionomer sealant|glass ionomer sealant
473095|NCT01129440|Prevention|prevention
473096|NCT01129401|methamphetamine|methamphetamine
473097|NCT01129401|men who have sex with men|men who have sex with men
473098|NCT01129401|HIV/AIDS|hiv/aids
473099|NCT01129362|Pertussis|pertussis
473100|NCT01129362|Whooping Cough|whooping cough
473101|NCT01129362|Pertussis Vaccine|pertussis vaccine
473102|NCT01129349|Solid Tumors|solid tumors
473103|NCT01129336|HER2-negative|her2-negative
473104|NCT01129336|HER2|her2
473105|NCT01129336|Metastatic breast cancer|metastatic breast cancer
473106|NCT01129336|First Line breast cancer|first line breast cancer
473107|NCT01129336|Second Line breast cancer|second line breast cancer
473108|NCT01129336|Breast cancer|breast cancer
473109|NCT01129336|Metastatic|metastatic
473110|NCT01129336|Stage IV breast cancer|stage iv breast cancer
473111|NCT01129336|Progression free survival|progression free survival
473112|NCT01129336|PFS|pfs
473113|NCT01129336|Circulating Tumor Cells|circulating tumor cells
473114|NCT01129336|CTCs|ctcs
473115|NCT01129336|Zoledronic acid|zoledronic acid
473116|NCT01129336|HER2-negative metastatic breast cancer patients without bone metastasis|her2-negative metastatic breast cancer patients without bone metastasis
473117|NCT01129323|Anemia, Severe, Aplastic, Reduced-Intensity, Allogeneic, Stem, Cell, Transplantation|anemia, severe, aplastic, reduced-intensity, allogeneic, stem, cell, transplantation
473118|NCT01129310|irinotecan|irinotecan
473119|NCT01129310|capecitabine|capecitabine
473120|NCT01129310|oxaliplatin|oxaliplatin
473121|NCT01129310|health-related quality of life|health-related quality of life
473122|NCT01129310|gastroesophageal(GE) junction adenocarcinoma|gastroesophageal(ge) junction adenocarcinoma
473123|NCT01129297|Obesity|obesity
473124|NCT01129297|surgery|surgery
473125|NCT01129297|genetic expression|genetic expression
473126|NCT01129297|collection of samples|collection of samples
473127|NCT01129284|Treatment Resistance|treatment resistance
473128|NCT01129284|Nephrotic Syndrome|nephrotic syndrome
473129|NCT01129284|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
473130|NCT01129284|lipoid nephrosis|lipoid nephrosis
473131|NCT01129284|Membranous nephropathy|membranous nephropathy
473132|NCT01129284|IgA nephropathy|iga nephropathy
473133|NCT01129284|proteinuria|proteinuria
473134|NCT01129258|phase 1|phase 1
473135|NCT01129258|safety and tolerability|safety and tolerability
473136|NCT01129258|pharmacokinetics|pharmacokinetics
473137|NCT01129258|PK|pk
473138|NCT01129258|pharmacodynamics|pharmacodynamics
473139|NCT01129258|PD|pd
473140|NCT01129258|type 2 diabetes mellitus|type 2 diabetes mellitus
473141|NCT01129245|Celebrex|celebrex
473142|NCT01129245|prostoglandin inhibitor|prostoglandin inhibitor
473143|NCT01129245|ovulation|ovulation
473144|NCT01129245|emergency contraception|emergency contraception
473147|NCT01129219|Function|function
473148|NCT01129219|Mobility|mobility
473149|NCT01129206|Gastroesophageal Cancer|gastroesophageal cancer
473150|NCT01129206|Gastroesophageal Carcinoma|gastroesophageal carcinoma
473151|NCT01129206|Adenocarcinoma|adenocarcinoma
473152|NCT01129180|T-Cell Lymphoma|t-cell lymphoma
473153|NCT01129167|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
473154|NCT01129167|Local invasion by pancreatic adenocarcinoma|local invasion by pancreatic adenocarcinoma
473155|NCT01129167|Recurrence of pancreatic cancer|recurrence of pancreatic cancer
473156|NCT01129167|Surgical resection of pancreatic cancer|surgical resection of pancreatic cancer
473157|NCT01129154|Squamous cell carcinoma|squamous cell carcinoma
473158|NCT01129141|Tinnitus|tinnitus
473159|NCT01129141|Traumatic Brain Injury Counseling|traumatic brain injury counseling
473160|NCT01129141|Counseling|counseling
473161|NCT01129141|Education|education
473162|NCT01129141|Evaluation studies|evaluation studies
473163|NCT01129141|Quality of health care|quality of health care
473164|NCT01129128|Echinacea|echinacea
473165|NCT01129128|immune modulation|immune modulation
473166|NCT01129128|prevention|prevention
473167|NCT01129089|Acceptability|acceptability
473168|NCT01129089|Lipid-based nutrient supplements|lipid-based nutrient supplements
473169|NCT01129089|Micronutrient powder|micronutrient powder
473170|NCT01129089|Malnutrition|malnutrition
473171|NCT01129076|Thalassemia Major|thalassemia major
473172|NCT01129076|Stigma|stigma
473173|NCT01129076|Singapore|singapore
473174|NCT01129076|Qualitative|qualitative
473175|NCT01129050|Fish oil|fish oil
473176|NCT01129050|Omega-3 fatty acids|omega-3 fatty acids
473177|NCT01129050|Metabolic syndrome|metabolic syndrome
473178|NCT01129050|Adults|adults
473179|NCT01129037|Oncology|oncology
473180|NCT01129024|Splenectomy|splenectomy
473181|NCT01129024|Low Platelet Count|low platelet count
473182|NCT01129024|Thrombopoiesis|thrombopoiesis
473183|NCT01129024|Thrombocytopaenia|thrombocytopaenia
473184|NCT01129024|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
473185|NCT01129024|Immune Thrombocytopenia (ITP)|immune thrombocytopenia (itp)
473186|NCT01129024|Thrombotic Thrombocytopenic Purpura (ITP)|thrombotic thrombocytopenic purpura (itp)
473187|NCT01129024|Hematologic Disease|hematologic disease
473188|NCT01129024|Auto-immune Thrombocytopenic Purpura|auto-immune thrombocytopenic purpura
473189|NCT01129024|S-888711|s-888711
473190|NCT01129024|Blood Platelet Disorders|blood platelet disorders
473191|NCT01129024|Relapsed Persistent or Chronic ITP|relapsed persistent or chronic itp
473192|NCT01129024|ITP|itp
473193|NCT01129011|NSAID|nsaid
473194|NCT01129011|gastric ulcers|gastric ulcers
473195|NCT01129011|Vimovo|vimovo
473196|NCT01129011|Esomeprazole|esomeprazole
473197|NCT01129011|Naproxen|naproxen
473198|NCT01128998|Sorafenib|sorafenib
473200|NCT01128998|Advanced Solid Tumors|advanced solid tumors
473201|NCT01128998|RD|rd
473202|NCT01128998|MTD|mtd
473203|NCT01128998|DLT|dlt
473204|NCT01128998|PK|pk
473205|NCT01128998|PG|pg
473206|NCT01128998|Biomarker|biomarker
473207|NCT01128985|Canagliflozin|canagliflozin
473208|NCT01128985|Placebo|placebo
473209|NCT01128985|Type 2 diabetes mellitus|type 2 diabetes mellitus
473210|NCT01128985|Pharmacokinetic|pharmacokinetic
473211|NCT01128985|Pharmacodynamic|pharmacodynamic
473212|NCT01128972|enamel erosion|enamel erosion
473213|NCT01128972|tooth remineralization|tooth remineralization
473214|NCT01128972|tooth erosion|tooth erosion
473215|NCT01128959|Epilepsy|epilepsy
473216|NCT01128959|Intravenous Carbamazepine|intravenous carbamazepine
473217|NCT01128959|Oral Carbamazepine|oral carbamazepine
473218|NCT01128946|Enamel remineralization|enamel remineralization
473219|NCT01128946|Fluoride|fluoride
473220|NCT01128946|caries|caries
473221|NCT01128933|Fractional flow reserve|fractional flow reserve
473222|NCT01128933|Revascularization|revascularization
473223|NCT01128933|Prognosis|prognosis
473224|NCT01128933|Hemodynamics|hemodynamics
473225|NCT01128933|Hypertension|hypertension
473226|NCT01128920|bacterial infections|bacterial infections
473227|NCT01128920|skin infections|skin infections
473228|NCT01128920|HIV|hiv
473229|NCT01128920|Hepatitis C|hepatitis c
473230|NCT01128920|risk reduction intervention|risk reduction intervention
473231|NCT01128907|Invasive Aspergillosis in neutropenic patients|invasive aspergillosis in neutropenic patients
473232|NCT01128894|GSK716155|gsk716155
473233|NCT01128894|liraglutide|liraglutide
473234|NCT01128894|albiglutide|albiglutide
473235|NCT01128894|open-label|open-label
473236|NCT01128868|Reverse oblique intertrochanteric fractures|reverse oblique intertrochanteric fractures
473237|NCT01128868|Reverse oblique subtrochanteric fractures|reverse oblique subtrochanteric fractures
473238|NCT01128855|Duchenne|duchenne
473239|NCT01128855|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
473240|NCT01128855|DMD|dmd
473241|NCT01128855|968|968
473242|NCT01128842|Neratinib|neratinib
473243|NCT01128842|Capecitabine|capecitabine
473244|NCT01128842|Combination|combination
473245|NCT01128842|Solid Tumor|solid tumor
473246|NCT01128829|obesity|obesity
473247|NCT01128829|diabetes|diabetes
473248|NCT01128829|artificial sweeteners|artificial sweeteners
473249|NCT01128816|obstructive sleep apnea|obstructive sleep apnea
473250|NCT01128816|central sleep apnea|central sleep apnea
473251|NCT01128816|heart failure|heart failure
473252|NCT01128816|congestive heart failure|congestive heart failure
473253|NCT01128816|adaptive servo ventilation|adaptive servo ventilation
473254|NCT01128816|ASV|asv
473255|NCT01128803|Hepatocellular carcinoma|hepatocellular carcinoma
473256|NCT01128803|immunotherapy|immunotherapy
473257|NCT01128803|alpha foetoprotein|alpha foetoprotein
473258|NCT01128803|dendritic cells|dendritic cells
473259|NCT01128790|exercise|exercise
473260|NCT01128790|remote ischemic preconditioning|remote ischemic preconditioning
473261|NCT01128790|heart failure|heart failure
473262|NCT01128790|left ventricular dysfunction|left ventricular dysfunction
473263|NCT01128777|depression|depression
473264|NCT01128777|anxiety|anxiety
473265|NCT01128777|family conflict|family conflict
473266|NCT01128777|behavior problems|behavior problems
473267|NCT01128751|Cognition|cognition
473268|NCT01128751|Neuroprotection|neuroprotection
473269|NCT01128751|Cardiopulmonary bypass|cardiopulmonary bypass
473270|NCT01128751|Aortic valve replacement|aortic valve replacement
473271|NCT01128751|Micro-emboli|micro-emboli
473272|NCT01128738|Neuromuscular Agents|neuromuscular agents
473273|NCT01128738|Botulinum Toxin Type A|botulinum toxin type a
473274|NCT01128738|Sweating|sweating
473275|NCT01128738|Sweat Gland Disease|sweat gland disease
473276|NCT01128738|Axillary Hyperhidrosis|axillary hyperhidrosis
473277|NCT01128738|Skin Disease|skin disease
473278|NCT01128699|Ahmed valve|ahmed valve
473279|NCT01128699|Neovascular Glaucoma|neovascular glaucoma
473280|NCT01128699|Uveitic glaucoma|uveitic glaucoma
473281|NCT01128699|Failed glaucoma|failed glaucoma
473282|NCT01128699|VEGF-A|vegf-a
473283|NCT01128699|Intraocular pressure|intraocular pressure
473284|NCT01128699|Subconjunctival Avastin|subconjunctival avastin
473285|NCT01128686|retrospective|retrospective
473286|NCT01128686|naïve Chronic Hepatitis B (CHB) patients|naïve chronic hepatitis b (chb) patients
473287|NCT01128686|cohort study|cohort study
473288|NCT01128686|lamivudine|lamivudine
473289|NCT01128673|Hypoxic Ischemic encephalopathy|hypoxic ischemic encephalopathy
473290|NCT01128673|Magnet resonance imaging|magnet resonance imaging
473291|NCT01128673|Selective Head cooling|selective head cooling
473292|NCT01128673|Therapeutic hypothermia|therapeutic hypothermia
473293|NCT01128660|Prescription, General practitioner, Pharmacy|prescription, general practitioner, pharmacy
473294|NCT01128634|Verapamil|verapamil
473295|NCT01128634|Anticholinergic, β2 agonist|anticholinergic, β2 agonist
473296|NCT01128634|P-GP|p-gp
473297|NCT01128634|LABA|laba
473298|NCT01128634|Muscarinic Receptor Antagonist|muscarinic receptor antagonist
473299|NCT01128634|LAMA|lama
473300|NCT01128621|Pharmacokinetics|pharmacokinetics
473301|NCT01128621|Glucose|glucose
473302|NCT01128621|Safety|safety
473303|NCT01128621|Male|male
473304|NCT01128621|Female|female
473305|NCT01128621|Metformin|metformin
473306|NCT01128621|Pharmacodynamics|pharmacodynamics
473307|NCT01128621|Tolerability|tolerability
473308|NCT01128621|Type II Diabetes|type ii diabetes
473309|NCT01128608|GERD|gerd
473310|NCT01128608|Heartburn|heartburn
473311|NCT01128608|Acid Reflux|acid reflux
473312|NCT01128595|allergen challenge|allergen challenge
473313|NCT01128595|early asthmatic response|early asthmatic response
473314|NCT01128595|mild asthma|mild asthma
473315|NCT01128595|late asthmatic response|late asthmatic response
473316|NCT01128582|GERD|gerd
473317|NCT01128582|Insomnia|insomnia
473318|NCT01128582|Acid Reflux|acid reflux
473319|NCT01128582|Heartburn|heartburn
473320|NCT01128569|mild asthma|mild asthma
473321|NCT01128569|allergen challenge|allergen challenge
473322|NCT01128569|early asthmatic response|early asthmatic response
473323|NCT01128556|allergic conjunctivitis|allergic conjunctivitis
473324|NCT01128556|histamine skin testing|histamine skin testing
473325|NCT01128543|lapatinib|lapatinib
473326|NCT01128543|breast cancer|breast cancer
473327|NCT01128530|cSSSI|csssi
473328|NCT01128530|complicated skin and skin structure infections|complicated skin and skin structure infections
473329|NCT01128530|acute bacterial skin and skin structure infections|acute bacterial skin and skin structure infections
473330|NCT01128530|abscess|abscess
473331|NCT01128530|cellulitis|cellulitis
473332|NCT01128530|bacterial infections|bacterial infections
473333|NCT01128530|anti-bacterial agents|anti-bacterial agents
473334|NCT01128530|anti-infective agents|anti-infective agents
473335|NCT01128530|skin diseases, infectious|skin diseases, infectious
473336|NCT01128530|skin diseases|skin diseases
473337|NCT01128530|wound infection|wound infection
473338|NCT01128517|Maternal education|maternal education
473339|NCT01128517|Complementary food|complementary food
473340|NCT01128517|Infant growth|infant growth
473341|NCT01128478|Acute pancreatitis|acute pancreatitis
473342|NCT01128478|Enteral nutrition|enteral nutrition
473343|NCT01128478|Pancreas rest|pancreas rest
473344|NCT01128465|propofol|propofol
473345|NCT01128465|awake craniotomy|awake craniotomy
473346|NCT01128465|patients requiring an awake craniotomy for brain tumor/lesion resection|patients requiring an awake craniotomy for brain tumor/lesion resection
473347|NCT01128452|Treatment-Resistant Depression|treatment-resistant depression
473348|NCT01128439|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
473349|NCT01128426|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
473350|NCT01128413|Shock|shock
473351|NCT01128413|Resuscitation|resuscitation
473352|NCT01128413|Hemodynamics|hemodynamics
473353|NCT01128413|Emergencies|emergencies
473354|NCT01128413|Critical Care|critical care
473355|NCT01128413|Lactic Acid|lactic acid
473356|NCT01128413|Plasma volume|plasma volume
473357|NCT01128400|obesity|obesity
473358|NCT01128400|orlistat|orlistat
473359|NCT01128400|taste perception|taste perception
473360|NCT01128387|esophageal cancer|esophageal cancer
473361|NCT01128387|Locally advanced esophageal cancer|locally advanced esophageal cancer
473362|NCT01128374|Periodontal disease|periodontal disease
473363|NCT01128374|Nonsurgical therapy|nonsurgical therapy
473364|NCT01128374|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
473365|NCT01128374|Bacterial burden|bacterial burden
473366|NCT01128374|Gene polymorphisms|gene polymorphisms
473367|NCT01128348|asthma|asthma
473368|NCT01128348|adherence|adherence
473369|NCT01128348|quality of life|quality of life
473370|NCT01128348|health literacy|health literacy
473371|NCT01128348|health disparities|health disparities
473372|NCT01128335|Liver transplantation|liver transplantation
473373|NCT01128335|HCV-negative recipient|hcv-negative recipient
473374|NCT01128335|deceased donor|deceased donor
473375|NCT01128335|sotrastaurin|sotrastaurin
473376|NCT01128335|oran transplantation|oran transplantation
473377|NCT01128335|tacrolimus|tacrolimus
473378|NCT01128322|CKD-828|ckd-828
473379|NCT01128322|Hypertension|hypertension
473380|NCT01128322|Primary Hypertension|primary hypertension
473381|NCT01128322|S-Amlodipine|s-amlodipine
473382|NCT01128322|Telmisartan|telmisartan
473383|NCT01128322|Amlodipine|amlodipine
473384|NCT01128322|Factorial|factorial
473385|NCT01128322|Phase 2|phase 2
473386|NCT01128296|high risk stage IIb or III adenocarcinoma of the pancreas|high risk stage iib or iii adenocarcinoma of the pancreas
473387|NCT01128283|Sepsis|sepsis
473388|NCT01128283|organ failure|organ failure
473389|NCT01128283|cytokines|cytokines
473390|NCT01128283|clotting factors|clotting factors
473391|NCT01128270|Dichloroacetate|dichloroacetate
473392|NCT01128270|Chloral Hydrate|chloral hydrate
473393|NCT01128270|Metabolism|metabolism
473394|NCT01128244|oral contraceptives|oral contraceptives
473395|NCT01128244|Vitamin B6|vitamin b6
473396|NCT01128244|birth control pills|birth control pills
473397|NCT01128244|amino acids|amino acids
473398|NCT01128244|Vitamin B6 deficiency|vitamin b6 deficiency
473399|NCT01128244|Vitamin B6 deficiency in women on oral contraceptives|vitamin b6 deficiency in women on oral contraceptives
473400|NCT01128218|Brain Neoplasms|brain neoplasms
473401|NCT01128218|5-ALA|5-ala
473402|NCT01128218|Aminolevulinic acid|aminolevulinic acid
473403|NCT01128218|Fluorescence|fluorescence
473404|NCT01128218|Gliomas|gliomas
473405|NCT01128218|Glioblastoma|glioblastoma
473406|NCT01128218|Surgery|surgery
473407|NCT01128205|diabetes|diabetes
473408|NCT01128205|cardiovascular risk factors|cardiovascular risk factors
473409|NCT01128205|blood pressure|blood pressure
473410|NCT01128205|blood lipid|blood lipid
473411|NCT01128205|blood glucose|blood glucose
473412|NCT01128166|Heart Failure|heart failure
473413|NCT01128166|Decompensation|decompensation
473414|NCT01128166|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
473415|NCT01128153|Type 2 Diabetes|type 2 diabetes
473416|NCT01128153|Inadequate Glycaemic Control|inadequate glycaemic control
473417|NCT01128153|Saxagliptin|saxagliptin
473418|NCT01128153|Metformin|metformin
473419|NCT01128153|Sulfonylurea|sulfonylurea
473420|NCT01128153|Triple Oral Therapy|triple oral therapy
473421|NCT01128140|motivational enhancement therapy|motivational enhancement therapy
473422|NCT01128127|knowledge translation|knowledge translation
473423|NCT01128127|prescription|prescription
473424|NCT01128127|primary care|primary care
473425|NCT01128127|NSAID|nsaid
473426|NCT01128127|PPI|ppi
473427|NCT01128127|Gastrointestinal damage|gastrointestinal damage
473428|NCT01128127|Inappropriate prescription|inappropriate prescription
473429|NCT01128114|Acute bipolar mania|acute bipolar mania
473430|NCT01128114|Seroquel XR|seroquel xr
473431|NCT01128114|Quetiapine fumarate|quetiapine fumarate
473432|NCT01128114|Add-on therapy|add-on therapy
473433|NCT01128101|spironolactone|spironolactone
473434|NCT01128101|chronic kidney disease|chronic kidney disease
473435|NCT01128101|dialysis|dialysis
473436|NCT01128101|LHV|lhv
473437|NCT01128088|Enhanced recovery program in laparoscopic surgery|enhanced recovery program in laparoscopic surgery
473438|NCT01128075|RebiSmart|rebismart
473439|NCT01128075|Rebif|rebif
473440|NCT01128075|Adherence|adherence
473441|NCT01128075|Multidose|multidose
473442|NCT01128075|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
473443|NCT01128075|RMS|rms
473444|NCT01128062|Canthaxanthin retinopathy|canthaxanthin retinopathy
473445|NCT01128049|Aqueous deficient dry eye (ADDE)|aqueous deficient dry eye (adde)
473565|NCT01127555|Biliary Tract Cancer|biliary tract cancer
473536|NCT01127659|obesity|obesity
473446|NCT01128049|Meibomium Gland Dysfunction (MGD)|meibomium gland dysfunction (mgd)
473447|NCT01128049|Normal/Control (Non Dry Eye)|normal/control (non dry eye)
473448|NCT01128036|Congestive Heart failure|congestive heart failure
473449|NCT01128036|Cardiomyopathy|cardiomyopathy
473450|NCT01128023|myocardial perfusion imaging|myocardial perfusion imaging
473451|NCT01128023|rubidium-82|rubidium-82
473452|NCT01128023|medical isotope production|medical isotope production
473453|NCT01128023|Positron emission tomography|positron emission tomography
473454|NCT01128023|clinically useful|clinically useful
473455|NCT01127984|pacemaker|pacemaker
473456|NCT01127984|pocket haematoma|pocket haematoma
473457|NCT01127984|antiplatelet therapy|antiplatelet therapy
473458|NCT01127984|fibrin glue|fibrin glue
473459|NCT01127971|patients|patients
473460|NCT01127971|receiving|receiving
473461|NCT01127971|irradiation|irradiation
473462|NCT01127971|device|device
473463|NCT01127971|External Beam|external beam
473464|NCT01127958|In-stent restenosis|in-stent restenosis
473465|NCT01127958|Minimal lumen diameter|minimal lumen diameter
473466|NCT01127958|Drug eluting balloon|drug eluting balloon
473467|NCT01127958|Drug eluting stent|drug eluting stent
473468|NCT01127932|Cognitive Behavioral Therapy|cognitive behavioral therapy
473469|NCT01127919|Exercise|exercise
473470|NCT01127919|Activity|activity
473471|NCT01127919|Adherence|adherence
473472|NCT01127919|Genetics|genetics
473473|NCT01127906|Healthy Volunteers|healthy volunteers
473474|NCT01127906|cross-over|cross-over
473475|NCT01127906|randomized|randomized
473476|NCT01127906|placebo and active controlled|placebo and active controlled
473477|NCT01127906|heat pain|heat pain
473478|NCT01127906|UVB-Induced pain model|uvb-induced pain model
473479|NCT01127893|Musculoskeletal Diseases|musculoskeletal diseases
473480|NCT01127893|Joint Diseases|joint diseases
473481|NCT01127893|Arthritis|arthritis
473482|NCT01127893|Rheumatic Diseases|rheumatic diseases
473483|NCT01127880|Traumatic Hemopneumothorax|traumatic hemopneumothorax
473484|NCT01127880|Thoracotomy|thoracotomy
473485|NCT01127880|Antibiotics|antibiotics
473486|NCT01127854|kidney stone|kidney stone
473487|NCT01127854|urolithiasis|urolithiasis
473488|NCT01127854|calcium oxalate kidney stone|calcium oxalate kidney stone
473489|NCT01127854|calcium oxalate stone|calcium oxalate stone
473490|NCT01127854|calcium oxalate|calcium oxalate
473491|NCT01127828|IBS (Irritable Bowel Syndrome)|ibs (irritable bowel syndrome)
473492|NCT01127828|Probiotic yoghurt|probiotic yoghurt
473493|NCT01127828|Symptom severity|symptom severity
473494|NCT01127815|Peritoneal washing cytology|peritoneal washing cytology
473495|NCT01127815|pancreatic cancer|pancreatic cancer
473496|NCT01127815|peritoneal metastasis|peritoneal metastasis
473497|NCT01127815|anoikis|anoikis
473498|NCT01127815|to determine the relationship between PWC results and clinicopathologic parameters of pancreatic cancers|to determine the relationship between pwc results and clinicopathologic parameters of pancreatic cancers
473499|NCT01127815|to identify the predictive value of PWC and postoperative drainage cytology on the peritoneal recurrence or outcomes|to identify the predictive value of pwc and postoperative drainage cytology on the peritoneal recurrence or outcomes
473500|NCT01127815|to dissect the molecular mechanism of peritoneal recurrence, especially on the PWC-inducing peritoneal seeding process.|to dissect the molecular mechanism of peritoneal recurrence, especially on the pwc-inducing peritoneal seeding process.
473501|NCT01127802|CABG|cabg
473502|NCT01127802|functional status|functional status
473503|NCT01127802|symptoms distress|symptoms distress
473504|NCT01127802|quality of life|quality of life
473505|NCT01127802|the trajectory of functional status|the trajectory of functional status
473506|NCT01127802|the changes of symptoms distress|the changes of symptoms distress
473507|NCT01127802|the changes of quality of life|the changes of quality of life
473508|NCT01127776|patient after bi-trimalleolar fracture of ankle|patient after bi-trimalleolar fracture of ankle
473509|NCT01127763|metastatic|metastatic
473510|NCT01127763|breast|breast
473511|NCT01127763|cancer|cancer
473512|NCT01127750|Relapsing multiple sclerosis|relapsing multiple sclerosis
473513|NCT01127750|MS|ms
473514|NCT01127750|safety|safety
473515|NCT01127750|tolerability|tolerability
473516|NCT01127750|health outcomes|health outcomes
473517|NCT01127737|SCCs|sccs
473518|NCT01127737|Squamous Cell Carcinoma|squamous cell carcinoma
473519|NCT01127737|Skin Self Exam|skin self exam
473520|NCT01127737|SSE|sse
473521|NCT01127737|Organ Transplant|organ transplant
473522|NCT01127737|Performance of SSE with our written educational intervention|performance of sse with our written educational intervention
473523|NCT01127737|Time after organ transplantation to deliver intervention|time after organ transplantation to deliver intervention
473524|NCT01127737|Evaluate internation information|evaluate internation information
473525|NCT01127724|Vitamin B12|vitamin b12
473526|NCT01127724|Aphthous stomatitis|aphthous stomatitis
473527|NCT01127724|Cobalamin|cobalamin
473528|NCT01127724|Doses|doses
473529|NCT01127685|weight bearing|weight bearing
473530|NCT01127685|acl|acl
473531|NCT01127672|plantar fasciitis|plantar fasciitis
473532|NCT01127672|PRP|prp
473533|NCT01127672|platelet rich plasma|platelet rich plasma
473534|NCT01127659|diabetes|diabetes
473535|NCT01127659|hypogonadism|hypogonadism
473537|NCT01127659|testosterone|testosterone
473538|NCT01127659|insulin sensitivity|insulin sensitivity
473539|NCT01127659|inflammation|inflammation
473540|NCT01127620|Allergic Rhinoconjunctivitis|allergic rhinoconjunctivitis
473541|NCT01127620|Persistent allergic rhinitis|persistent allergic rhinitis
473542|NCT01127620|Hay fever|hay fever
473543|NCT01127620|Allergic Rhinitis|allergic rhinitis
473544|NCT01127620|Sneezing|sneezing
473545|NCT01127620|Nasal congestion|nasal congestion
473546|NCT01127620|Rhinorrhea|rhinorrhea
473547|NCT01127620|Nasal itching|nasal itching
473548|NCT01127620|Ocular itching|ocular itching
473549|NCT01127620|Ocular tearing|ocular tearing
473550|NCT01127620|Antihistamine|antihistamine
473551|NCT01127607|parenting|parenting
473552|NCT01127594|Melanoma|melanoma
473553|NCT01127581|Misoprostol vaginal insert|misoprostol vaginal insert
473554|NCT01127581|Dinoprostone vaginal insert|dinoprostone vaginal insert
473555|NCT01127581|Cervidil|cervidil
473556|NCT01127581|Cervical ripening|cervical ripening
473557|NCT01127581|Induction of labor|induction of labor
473558|NCT01127581|Rate of cesarean section|rate of cesarean section
473559|NCT01127568|Post-Traumatic Stress Disorders|post-traumatic stress disorders
473560|NCT01127568|Posttraumatic Stress Disorders|posttraumatic stress disorders
473561|NCT01127568|PTSD|ptsd
473562|NCT01127568|Stress Disorder, Post Traumatic|stress disorder, post traumatic
473563|NCT01127568|Stress Disorders, Posttraumatic|stress disorders, posttraumatic
473564|NCT01127568|Chronic Post Traumatic Stress Disorder|chronic post traumatic stress disorder
473566|NCT01127555|Salvage therapy|salvage therapy
473567|NCT01127555|FOLFOX|folfox
473568|NCT01127516|Susceptibility testing|susceptibility testing
473569|NCT01127516|Antimicrobial stewardship|antimicrobial stewardship
473570|NCT01127503|Patients with velocardiofacial syndrome and psychosis|patients with velocardiofacial syndrome and psychosis
473571|NCT01127477|Hypovolemia, surgical blood loss|hypovolemia, surgical blood loss
473572|NCT01127464|HIV-1|hiv-1
473573|NCT01127464|HIV preventative vaccine|hiv preventative vaccine
473574|NCT01127464|Healthy Volunteers|healthy volunteers
473575|NCT01127451|Neoplasms|neoplasms
473576|NCT01127438|Monitored anesthesia care sedation|monitored anesthesia care sedation
473577|NCT01127425|nursing hours|nursing hours
473578|NCT01127425|length of hospital stay|length of hospital stay
473579|NCT01127425|reconvalescence|reconvalescence
473580|NCT01127425|colorectal surgery|colorectal surgery
473581|NCT01127425|laparoscopic|laparoscopic
473582|NCT01127425|sigmoid neoplasms|sigmoid neoplasms
473583|NCT01127412|overweight|overweight
473584|NCT01127412|physical activity|physical activity
473585|NCT01127412|infancy|infancy
473586|NCT01127412|body composition|body composition
473587|NCT01127412|motor development|motor development
473588|NCT01127412|motor activity|motor activity
473589|NCT01127373|Breast|breast
473590|NCT01127373|Radiation|radiation
473591|NCT01127373|Multi-Beam Intensity-Modulated Radiation|multi-beam intensity-modulated radiation
473592|NCT01127373|post mastectomy|post mastectomy
473593|NCT01127373|post partial mastectomy|post partial mastectomy
473594|NCT01127373|node-positive breast cancer|node-positive breast cancer
473595|NCT01127373|10-025|10-025
473596|NCT01127360|Anti-VEGF|anti-vegf
473597|NCT01127360|Ranibizumab|ranibizumab
473598|NCT01127360|Bevacizumab|bevacizumab
473599|NCT01127360|exudative|exudative
473600|NCT01127360|macular degeneration|macular degeneration
473601|NCT01127334|Dyssynchrony|dyssynchrony
473602|NCT01127334|Cardiac resynchronization therapy|cardiac resynchronization therapy
473603|NCT01127321|Systemic lupus erythematosus|systemic lupus erythematosus
473604|NCT01127321|SLE|sle
473605|NCT01127321|MEDI-570|medi-570
473606|NCT01127308|Absorption|absorption
473607|NCT01127308|Distribution|distribution
473608|NCT01127308|Metabolism|metabolism
473609|NCT01127308|and Excretion|and excretion
473610|NCT01127308|Mass Balance|mass balance
473611|NCT01127308|Metabolic Profile|metabolic profile
473612|NCT01127308|Radiolabel Study|radiolabel study
473613|NCT01127295|Pharmacokinetics|pharmacokinetics
473614|NCT01127295|Pharmacogenetic|pharmacogenetic
473615|NCT01127295|tamoxifen|tamoxifen
473616|NCT01127295|anti-aromatases|anti-aromatases
473617|NCT01127295|breast cancer|breast cancer
473618|NCT01127295|pharmacodynamy|pharmacodynamy
473619|NCT01127295|Observance|observance
473620|NCT01127282|influenza|influenza
473621|NCT01127282|vitamin|vitamin
473622|NCT01127282|improvement of symptom|improvement of symptom
473623|NCT01127243|Hysterectomy|hysterectomy
473624|NCT01127243|laparoscopy|laparoscopy
473625|NCT01127243|day-case surgery|day-case surgery
473626|NCT01127243|quality of life|quality of life
473627|NCT01127243|Ambulatory Surgical Procedures|ambulatory surgical procedures
473628|NCT01127230|ADRC|adrc
473629|NCT01127230|adipocyte derived regenerative cells|adipocyte derived regenerative cells
473630|NCT01127230|stem cells|stem cells
473631|NCT01127230|liposuction|liposuction
473632|NCT01127230|Cytori|cytori
473633|NCT01127230|Celution|celution
473732|NCT01126827|Mania|mania
473733|NCT01126827|Hypomania|hypomania
473734|NCT01126827|Bipolar|bipolar
473735|NCT01126827|Bipolar I|bipolar i
473634|NCT01127230|Lipoaspirate is obtained from patients who have opted for liposuction and consent to donate the lipoasirate for this study, which would otherwise be discarded.|lipoaspirate is obtained from patients who have opted for liposuction and consent to donate the lipoasirate for this study, which would otherwise be discarded.
473635|NCT01127217|amlodipine|amlodipine
473636|NCT01127217|losartan|losartan
473637|NCT01127217|hypertension|hypertension
473638|NCT01127217|stage 2|stage 2
473639|NCT01127204|HIV|hiv
473640|NCT01127204|Antiretroviral therapy|antiretroviral therapy
473641|NCT01127204|Infant|infant
473642|NCT01127204|Sub Saharian Africa|sub saharian africa
473643|NCT01127191|military exercises|military exercises
473644|NCT01127191|neuromuscular fatigue|neuromuscular fatigue
473645|NCT01127191|physiological responses|physiological responses
473646|NCT01127191|biomechanical responses|biomechanical responses
473647|NCT01127191|simulated military effort|simulated military effort
473648|NCT01127191|high load carriage|high load carriage
473649|NCT01127191|Healthy voluntary|healthy voluntary
473650|NCT01127152|Noradrenalin relays|noradrenalin relays
473651|NCT01127152|Automatic relays|automatic relays
473652|NCT01127152|Manual relays|manual relays
473653|NCT01127152|Hypotension|hypotension
473654|NCT01127152|Intensive care unit|intensive care unit
473655|NCT01127139|Essential hypertension|essential hypertension
473656|NCT01127113|Myocardial infarction|myocardial infarction
473657|NCT01127113|Magnetic resonance imaging|magnetic resonance imaging
473658|NCT01127113|Nanoparticles|nanoparticles
473659|NCT01127113|Mononuclear cells|mononuclear cells
473660|NCT01127113|Cell tracking|cell tracking
473661|NCT01127100|neuropathic pain|neuropathic pain
473662|NCT01127100|gabapentin|gabapentin
473663|NCT01127100|transdermal fentanyl matrix|transdermal fentanyl matrix
473664|NCT01127100|multicenter|multicenter
473665|NCT01127100|non-inferiority trial|non-inferiority trial
473666|NCT01127087|Hyperoxaluria|hyperoxaluria
473667|NCT01127087|Oxazyme|oxazyme
473668|NCT01127087|oxalate|oxalate
473669|NCT01127087|enteric hyperoxaluria|enteric hyperoxaluria
473670|NCT01127074|metastatic breast cancer|metastatic breast cancer
473671|NCT01127074|breast cancer stage IV|breast cancer stage iv
473672|NCT01127074|vaccination|vaccination
473673|NCT01127074|CD80|cd80
473674|NCT01127074|immunotherapy|immunotherapy
473675|NCT01127061|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
473676|NCT01127061|Exercise|exercise
473677|NCT01127061|Oxygen consumption|oxygen consumption
473678|NCT01127048|bronchitis|bronchitis
473679|NCT01127048|coughing|coughing
473680|NCT01127048|children|children
473681|NCT01127048|Ivy|ivy
473682|NCT01127048|Hedera helix L.|hedera helix l.
473683|NCT01127035|allergic rhinitis|allergic rhinitis
473684|NCT01127035|alternaria alternata|alternaria alternata
473685|NCT01127035|symptom score|symptom score
473686|NCT01127022|Pregnancy|pregnancy
473687|NCT01127022|Lactation|lactation
473688|NCT01127022|Choline|choline
473689|NCT01127022|Cognition|cognition
473690|NCT01127022|Biomarkers|biomarkers
473691|NCT01126996|MenC conjugate vaccine|menc conjugate vaccine
473692|NCT01126996|Healthy children previously vaccinated against MenC|healthy children previously vaccinated against menc
473693|NCT01126970|reduced calorie diet|reduced calorie diet
473694|NCT01126970|orlistat|orlistat
473695|NCT01126970|velneperit|velneperit
473696|NCT01126944|heart failure|heart failure
473697|NCT01126944|resynchronization|resynchronization
473698|NCT01126944|left ventricular assist device|left ventricular assist device
473699|NCT01126931|Crohn disease|crohn disease
473700|NCT01126931|Involuntary weight loss in cancer|involuntary weight loss in cancer
473701|NCT01126931|IgA nephropathy|iga nephropathy
473702|NCT01126931|Depression with reduced appetite|depression with reduced appetite
473703|NCT01126918|Eating Disorders|eating disorders
473704|NCT01126918|Obesity|obesity
473705|NCT01126918|Body Dissatisfaction|body dissatisfaction
473706|NCT01126918|Female|female
473707|NCT01126905|Reticulated Haemoglobin Equivalent|reticulated haemoglobin equivalent
473708|NCT01126905|Functional Iron Deficiency|functional iron deficiency
473709|NCT01126905|Response to therapy|response to therapy
473710|NCT01126905|Iron deficiency|iron deficiency
473711|NCT01126892|Advanced Disease,|advanced disease,
473712|NCT01126892|Resistance,|resistance,
473713|NCT01126892|Intolerance|intolerance
473714|NCT01126866|advanced colorectal carcinoma|advanced colorectal carcinoma
473715|NCT01126866|CRC|crc
473716|NCT01126866|UICC Stages IV|uicc stages iv
473717|NCT01126866|liver and/or lung only metastases|liver and/or lung only metastases
473718|NCT01126853|Immunization|immunization
473719|NCT01126853|Immunity|immunity
473720|NCT01126853|Prevention|prevention
473721|NCT01126840|Lynch Syndrome|lynch syndrome
473722|NCT01126840|Families|families
473723|NCT01126840|Quality of life|quality of life
473724|NCT01126840|QOL|qol
473725|NCT01126840|First-degree relatives|first-degree relatives
473726|NCT01126840|Questionnaire|questionnaire
473727|NCT01126840|Interview|interview
473728|NCT01126827|Bipolar Disorder|bipolar disorder
473729|NCT01126827|Mood Disorders|mood disorders
473730|NCT01126827|Residual Symptoms|residual symptoms
473731|NCT01126827|Depression|depression
473736|NCT01126827|Bipolar II|bipolar ii
473737|NCT01126814|Gleevec|gleevec
473738|NCT01126814|c-kit|c-kit
473739|NCT01126814|aml|aml
473740|NCT01126775|Systematic prevention, stroke, vascular dementia, silent strokes, cerebral microangiopathy.|systematic prevention, stroke, vascular dementia, silent strokes, cerebral microangiopathy.
473741|NCT01126762|Docosahexaenoic acid|docosahexaenoic acid
473742|NCT01126762|fish|fish
473743|NCT01126762|pregnancy|pregnancy
473744|NCT01126762|methylmercury|methylmercury
473745|NCT01126762|n-3 polyunsaturated fatty acid|n-3 polyunsaturated fatty acid
473746|NCT01126749|Locally Advanced or Metastatic Bladder Cancer, including other transitional cell cancers of the urothelium (prostate, urethra, ureter, and renal pelvis)|locally advanced or metastatic bladder cancer, including other transitional cell cancers of the urothelium (prostate, urethra, ureter, and renal pelvis)
473747|NCT01126736|neoplams|neoplams
473748|NCT01126736|lung neoplasms|lung neoplasms
473749|NCT01126736|Stage IIIB|stage iiib
473750|NCT01126736|IV Nonsquamous Non Small Cell Lung Cancer|iv nonsquamous non small cell lung cancer
473751|NCT01126710|infiltration|infiltration
473752|NCT01126710|extravasation|extravasation
473753|NCT01126710|optical monitoring|optical monitoring
473754|NCT01126697|Cardiac|cardiac
473755|NCT01126697|Muscular Dystrophy|muscular dystrophy
473756|NCT01126697|Randomized|randomized
473757|NCT01126684|essential hypertension|essential hypertension
473758|NCT01126671|vitamin D|vitamin d
473759|NCT01126658|pressure-volume curve|pressure-volume curve
473760|NCT01126658|intracranial pressure|intracranial pressure
473761|NCT01126658|volume pressure response|volume pressure response
473762|NCT01126658|pressure-volume relationship|pressure-volume relationship
473763|NCT01126658|mathematical model|mathematical model
473764|NCT01126645|Liver|liver
473765|NCT01126645|HCC|hcc
473766|NCT01126632|Colonoscopy|colonoscopy
473767|NCT01126619|Psoriasis|psoriasis
473768|NCT01126567|Phase 1 Clinical Trials, Cerebrospinal Fluid, Biomarker|phase 1 clinical trials, cerebrospinal fluid, biomarker
473769|NCT01126554|Prognostic value|prognostic value
473770|NCT01126528|Vitamin D|vitamin d
473771|NCT01126528|cholecalciferol|cholecalciferol
473772|NCT01126528|Micronutrients|micronutrients
473773|NCT01126528|Developing countries|developing countries
473774|NCT01126528|Bangladesh|bangladesh
473775|NCT01126528|Infant, Newborn|infant, newborn
473776|NCT01126528|Reproductive Health|reproductive health
473777|NCT01126528|Infant, Newborn, Diseases|infant, newborn, diseases
473778|NCT01126528|Perinatology|perinatology
473779|NCT01126528|Immunology|immunology
473780|NCT01126528|cathelicidin|cathelicidin
473781|NCT01126528|Maternal Nutrition Physiology|maternal nutrition physiology
473782|NCT01126515|brain injury|brain injury
473783|NCT01126515|sequelae|sequelae
473784|NCT01126515|stroke|stroke
473785|NCT01126515|anoxia|anoxia
473786|NCT01126515|trauma|trauma
473787|NCT01126476|Adults with non-CNS recurrent tumors who have been previously irradiated|adults with non-cns recurrent tumors who have been previously irradiated
473788|NCT01126476|and have a tumor recurrence in or near prior radiation fields|and have a tumor recurrence in or near prior radiation fields
473789|NCT01126463|Hepatocellular carcinomas|hepatocellular carcinomas
473790|NCT01126463|lipiodol|lipiodol
473791|NCT01126463|rhenium|rhenium
473792|NCT01126463|Non operable Hepatocellular carcinomas|non operable hepatocellular carcinomas
473793|NCT01126450|recurrent colon cancer|recurrent colon cancer
473794|NCT01126450|recurrent rectal cancer|recurrent rectal cancer
473795|NCT01126424|Anti-muscarinics|anti-muscarinics
473796|NCT01126424|Anti-cholinergics|anti-cholinergics
473797|NCT01126424|Cognition|cognition
473798|NCT01126424|Solifenacin|solifenacin
473799|NCT01126411|pulmonary hypertension|pulmonary hypertension
473800|NCT01126411|autoantibodies|autoantibodies
473801|NCT01126411|immunoadsorption|immunoadsorption
473802|NCT01126411|immunoglobulin substitution|immunoglobulin substitution
473803|NCT01126411|right ventricular function|right ventricular function
473804|NCT01126385|Spinal Diseases|spinal diseases
473805|NCT01126385|Bone strength|bone strength
473806|NCT01126385|Transpedicular fixation|transpedicular fixation
473807|NCT01126385|Dorsal instrumentation|dorsal instrumentation
473808|NCT01126385|DensiProbe|densiprobe
473809|NCT01126372|Prostaglandin-dependent Congenital Heart Disease|prostaglandin-dependent congenital heart disease
473810|NCT01126372|Prematurity|prematurity
473811|NCT01126372|Feeding intolerances|feeding intolerances
473812|NCT01126372|Necrotizing Enterocolitis|necrotizing enterocolitis
473813|NCT01126372|Regional Oxygen Saturation|regional oxygen saturation
473814|NCT01126372|Near Infrared Spectroscopy|near infrared spectroscopy
473815|NCT01126372|Somanetics INVOS Oxyalert|somanetics invos oxyalert
473816|NCT01126359|Wound Vacuum Assisted Dressings|wound vacuum assisted dressings
473817|NCT01126359|Lidocaine|lidocaine
473818|NCT01126359|Dressing change|dressing change
473819|NCT01126359|Pain management|pain management
473820|NCT01126359|palliative care|palliative care
473821|NCT01126333|Nephrotoxicity, Kidney Transplantation, Graft Survival|nephrotoxicity, kidney transplantation, graft survival
473822|NCT01126333|Kidney transplant survival.|kidney transplant survival.
473823|NCT01126320|VAP|vap
473824|NCT01126307|refractory epilepsy- greater than 4 seizures in 2 month baseline period|refractory epilepsy- greater than 4 seizures in 2 month baseline period
473825|NCT01126294|lumbar laminectomy, melatonin, perioperative, pain, anxiety, analgesia, VAS score|lumbar laminectomy, melatonin, perioperative, pain, anxiety, analgesia, vas score
473826|NCT01126268|Eczema|eczema
473827|NCT01126268|Atopic dermatitis|atopic dermatitis
473828|NCT01126268|Infection|infection
473829|NCT01126268|Impetigo|impetigo
473830|NCT01126268|Folliculitis|folliculitis
473831|NCT01126255|vulvar lichen sclerosus|vulvar lichen sclerosus
473832|NCT01126255|progesterone|progesterone
473833|NCT01126255|clobetasol|clobetasol
473834|NCT01126255|randomized controlled trial|randomized controlled trial
473835|NCT01126242|Ankle|ankle
473836|NCT01126242|ligament injuries|ligament injuries
473837|NCT01126242|non-surgical treatment|non-surgical treatment
473838|NCT01126242|tape|tape
473839|NCT01126242|brace|brace
473840|NCT01126242|orthotic device|orthotic device
473841|NCT01126242|bandage|bandage
473842|NCT01126242|cost-effectiveness|cost-effectiveness
473843|NCT01126242|randomized trial|randomized trial
473844|NCT01126229|Resveratrol|resveratrol
473845|NCT01126229|Grape|grape
473846|NCT01126229|Aging|aging
473847|NCT01126229|functional MRI (fMRI)|functional mri (fmri)
473848|NCT01126229|Anti-Aging therapeutic|anti-aging therapeutic
473849|NCT01126229|Oxidative Stress|oxidative stress
473850|NCT01126229|Functional Performance|functional performance
473851|NCT01126216|Radiochemotherapy|radiochemotherapy
473852|NCT01126216|head and neck cancer|head and neck cancer
473853|NCT01126216|Paclitaxel|paclitaxel
473854|NCT01126216|Cisplatin|cisplatin
473855|NCT01126216|5-FU|5-fu
473856|NCT01126203|Pseudoexfoliation|pseudoexfoliation
473857|NCT01126203|Glaucoma|glaucoma
473858|NCT01126203|Ocular Hypertension|ocular hypertension
473859|NCT01126203|SLT|slt
473860|NCT01126203|Selective Laser Trabeculoplasy (SLT)|selective laser trabeculoplasy (slt)
473861|NCT01126203|Argon Laser Trabeculoplasty (ALT)|argon laser trabeculoplasty (alt)
473862|NCT01126177|asthma|asthma
473863|NCT01126164|parents|parents
473864|NCT01126164|peer|peer
473865|NCT01126164|basics|basics
473866|NCT01126164|college student drinking|college student drinking
473867|NCT01126151|drinking|drinking
473868|NCT01126151|alcohol consequences|alcohol consequences
473869|NCT01126138|unresectable|unresectable
473870|NCT01126138|locally advanced|locally advanced
473871|NCT01126138|metastatic|metastatic
473872|NCT01126138|breast cancer|breast cancer
473873|NCT01126125|iodine|iodine
473874|NCT01126125|infant|infant
473875|NCT01126125|breastfeeding|breastfeeding
473876|NCT01126125|deficiency|deficiency
473877|NCT01126112|advanced colorectal cancer; K-RAS; panitumumab|advanced colorectal cancer; k-ras; panitumumab
473878|NCT01126112|advanced Wild Type K-RAS colorectal cancer|advanced wild type k-ras colorectal cancer
473879|NCT01126099|double-blind|double-blind
473880|NCT01126099|treatment|treatment
473881|NCT01126099|prazosin|prazosin
473882|NCT01126099|Disruptive behaviors in Alzheimer's Disease|disruptive behaviors in alzheimer's disease
473883|NCT01126073|niacin/laropiprant|niacin/laropiprant
473884|NCT01126073|endothelial function|endothelial function
473885|NCT01126060|Neck dissection|neck dissection
473886|NCT01126047|Lung Diseases|lung diseases
473887|NCT01126034|Metoclopramide|metoclopramide
473888|NCT01126034|Randomized Controlled Trial|randomized controlled trial
473889|NCT01126021|Senior citizens|senior citizens
473890|NCT01126021|mental acuity|mental acuity
473891|NCT01126021|memory|memory
473892|NCT01126008|locally advanced Squamous cell carcinoma|locally advanced squamous cell carcinoma
473893|NCT01125995|limited disease|limited disease
473894|NCT01125969|diabetes|diabetes
473895|NCT01125969|glucose|glucose
473896|NCT01125969|peer mentor|peer mentor
473897|NCT01125969|incentives|incentives
473898|NCT01125969|behavioral economics|behavioral economics
473899|NCT01125969|cost-effectiveness|cost-effectiveness
473900|NCT01125956|Diabetes|diabetes
473901|NCT01125956|Diabetes mellitus|diabetes mellitus
473902|NCT01125956|HbA1c|hba1c
473903|NCT01125930|rosacea|rosacea
473904|NCT01125930|tretinoin|tretinoin
473905|NCT01125930|atralin|atralin
473906|NCT01125917|Low back pain|low back pain
473907|NCT01125917|Opioid|opioid
473908|NCT01125917|Transdermal|transdermal
473909|NCT01125904|Crizotinib|crizotinib
473910|NCT01125891|gemcitabine hydrochloride|gemcitabine hydrochloride
473911|NCT01125891|Gemzar|gemzar
473912|NCT01125891|ON 01910.Na|on 01910.na
473913|NCT01125878|satiety|satiety
473914|NCT01125878|appetite|appetite
473915|NCT01125878|fiber|fiber
473916|NCT01125878|starch|starch
473917|NCT01125878|nutrition|nutrition
473918|NCT01125865|Malignant hilar stricture|malignant hilar stricture
473919|NCT01125852|Peptic ulcer hemorrhage|peptic ulcer hemorrhage
473920|NCT01125852|Peptic ulcer bleeding|peptic ulcer bleeding
473921|NCT01125852|Angiographic embolization|angiographic embolization
473922|NCT01125852|Arterial embolization|arterial embolization
473923|NCT01125852|Angiography|angiography
473924|NCT01125839|osteomyelitis|osteomyelitis
473925|NCT01125839|16S rRNA|16s rrna
473926|NCT01125839|spine|spine
473927|NCT01125839|Magnetic resonance imaging|magnetic resonance imaging
473928|NCT01125800|Recurrent,|recurrent,
473929|NCT01125800|refractory,|refractory,
473930|NCT01125800|medulloblastoma,|medulloblastoma,
473931|NCT01125800|rhabdomyosarcoma,|rhabdomyosarcoma,
473932|NCT01125800|neuroblastoma,|neuroblastoma,
473933|NCT01125800|hepatoblastoma,|hepatoblastoma,
473934|NCT01125800|astrocytoma,|astrocytoma,
473935|NCT01125800|children,|children,
473936|NCT01125800|pediatric,|pediatric,
473937|NCT01125800|hedgehog pathway inhibitor, adult|hedgehog pathway inhibitor, adult
473938|NCT01125787|CLL|cll
473939|NCT01125787|bendamustine|bendamustine
473940|NCT01125787|ofatumumab|ofatumumab
473941|NCT01125787|blood cancer|blood cancer
473942|NCT01125787|leukemia|leukemia
473943|NCT01125787|lymphocyte|lymphocyte
473944|NCT01125787|hematology|hematology
473945|NCT01125787|non-Hodgkin lymphoma|non-hodgkin lymphoma
473946|NCT01125787|small lymphocytic lymphoma|small lymphocytic lymphoma
473947|NCT01125787|nevada cancer institute|nevada cancer institute
473948|NCT01125787|cephalon|cephalon
473949|NCT01125787|Glaxosmithkline|glaxosmithkline
473950|NCT01125774|Menstrually related migraine|menstrually related migraine
473951|NCT01125774|migraine|migraine
473952|NCT01125774|Premenstrual migraine|premenstrual migraine
473953|NCT01125761|Allergic dermatitis|allergic dermatitis
473954|NCT01125722|Urinary Incontinence|urinary incontinence
473955|NCT01125722|Overactive Bladder|overactive bladder
473956|NCT01125722|Frequency|frequency
473957|NCT01125722|Urgency|urgency
473958|NCT01125709|Neuromuscular disease|neuromuscular disease
473959|NCT01125709|Duchenne|duchenne
473960|NCT01125709|Muscular Dystrophy|muscular dystrophy
473961|NCT01125709|DMD|dmd
473962|NCT01125709|Strength assessment|strength assessment
473963|NCT01125709|CINRG Quantitative Measurement System|cinrg quantitative measurement system
473964|NCT01125709|CQMS|cqms
473965|NCT01125709|Hand Held Myometry|hand held myometry
473966|NCT01125709|HHM|hhm
473967|NCT01125696|mother-to-child transmission|mother-to-child transmission
473968|NCT01125696|HIV|hiv
473969|NCT01125696|Hepatitis B|hepatitis b
473970|NCT01125696|Pregnant women|pregnant women
473971|NCT01125696|Tenofovir|tenofovir
473972|NCT01125696|Infants|infants
473973|NCT01125683|Phase II|phase ii
473974|NCT01125683|Alzheimer's disease|alzheimer's disease
473975|NCT01125683|EEG|eeg
473976|NCT01125683|cognition|cognition
473977|NCT01125683|pharmacodynamic|pharmacodynamic
473978|NCT01125670|YM150|ym150
473979|NCT01125670|Food effect|food effect
473980|NCT01125657|YM150|ym150
473981|NCT01125657|bioequivalence study|bioequivalence study
473982|NCT01125644|necrotic pulmonary infections|necrotic pulmonary infections
473983|NCT01125631|Alzheimer's disease|alzheimer's disease
473984|NCT01125631|amyloid|amyloid
473985|NCT01125631|antibody|antibody
473986|NCT01125631|Japanese|japanese
473987|NCT01125618|child mortality|child mortality
473988|NCT01125618|intervention|intervention
473989|NCT01125618|Poverty|poverty
473990|NCT01125618|Africa|africa
473991|NCT01125618|Millennium Development Goal|millennium development goal
473992|NCT01125618|Millennium Development Goals|millennium development goals
473993|NCT01125605|PASCONAL|pasconal
473994|NCT01125605|nervousness|nervousness
473995|NCT01125605|nervosity|nervosity
473996|NCT01125605|sleep disorder|sleep disorder
473997|NCT01125592|assess the ability of the IonCleanse machine to remove heavy metals through the feet|assess the ability of the ioncleanse machine to remove heavy metals through the feet
473998|NCT01125579|nervousness|nervousness
473999|NCT01125579|restlessness|restlessness
474000|NCT01125579|depression|depression
474001|NCT01125579|affective disorder|affective disorder
474002|NCT01125540|Allergic conjunctivitis|allergic conjunctivitis
474003|NCT01125527|Haemophilus influenzae type b (Hib)|haemophilus influenzae type b (hib)
474004|NCT01125527|Vaccine|vaccine
474005|NCT01125527|Anti PRP antibody|anti prp antibody
474006|NCT01125514|Heart failure,|heart failure,
474007|NCT01125514|aliskiren,|aliskiren,
474008|NCT01125514|furosemide,|furosemide,
474009|NCT01125514|diuretic efficacy,|diuretic efficacy,
474010|NCT01125514|interaction|interaction
474011|NCT01125488|Maintenance therapy|maintenance therapy
474012|NCT01125488|LNG-IUS|lng-ius
474013|NCT01125488|recurrence,endometriosis|recurrence,endometriosis
474014|NCT01125488|Recurrence|recurrence
474015|NCT01125475|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
474016|NCT01125475|RebiSmart|rebismart
474017|NCT01125475|Rebif|rebif
474018|NCT01125475|Adherence|adherence
474019|NCT01125462|Ovulation Induction|ovulation induction
474020|NCT01125462|Infertility|infertility
474021|NCT01125462|Gonal-f|gonal-f
474022|NCT01125462|FertiQoL|fertiqol
474023|NCT01125462|Quality of Life|quality of life
474024|NCT01125449|ascorbic acid|ascorbic acid
474025|NCT01125449|vitamin C|vitamin c
474026|NCT01125449|antioxidants|antioxidants
474027|NCT01125449|vitamins|vitamins
474028|NCT01125423|Female|female
474029|NCT01125423|age 18 to 70|age 18 to 70
474030|NCT01125410|Fluomizin|fluomizin
474031|NCT01125410|Dequalinium chloride|dequalinium chloride
474032|NCT01125410|Bacterial vaginosis|bacterial vaginosis
474033|NCT01125410|vaginal therapy|vaginal therapy
474034|NCT01125397|bariatric surgery|bariatric surgery
474035|NCT01125397|behavioral weight management|behavioral weight management
474036|NCT01125397|psychosocial outcomes following bariatric surgery|psychosocial outcomes following bariatric surgery
474037|NCT01125371|Hazardous alcohol use|hazardous alcohol use
474038|NCT01125371|Binge drinking|binge drinking
474039|NCT01125371|High risk sexual behaviors|high risk sexual behaviors
474040|NCT01125371|HIV risk reduction|hiv risk reduction
474041|NCT01125345|hydrophobic acrylic|hydrophobic acrylic
474042|NCT01125345|PCO|pco
474043|NCT01125345|posterior capsule opacification|posterior capsule opacification
474044|NCT01125345|hydrophilic acrylic IO|hydrophilic acrylic io
474045|NCT01125306|Drug consumption|drug consumption
474046|NCT01125306|The Xal-Ease device|the xal-ease device
474047|NCT01125306|Patient's compliance|patient's compliance
474048|NCT01125306|Using a novel Pfizer-Pharmacia device to facilitate the Xalatan/Xalacom instillation and to avoid loss of eye drops|using a novel pfizer-pharmacia device to facilitate the xalatan/xalacom instillation and to avoid loss of eye drops
474049|NCT01125293|everolimus|everolimus
474050|NCT01125293|rituximab|rituximab
474051|NCT01125293|bortezomib|bortezomib
474052|NCT01125293|RAD001|rad001
474053|NCT01125293|Rituxan|rituxan
474054|NCT01125293|Velcade|velcade
474055|NCT01125280|Small bowel occlusion|small bowel occlusion
474056|NCT01125280|Conservative treatment for small bowel occlusion|conservative treatment for small bowel occlusion
474057|NCT01125280|Surgical treatment for small bowel occlusion|surgical treatment for small bowel occlusion
474058|NCT01125280|Small bowel resection|small bowel resection
474059|NCT01125280|Score of severity of small bowel occlusion|score of severity of small bowel occlusion
474060|NCT01125267|medication adherence|medication adherence
474061|NCT01125267|schizophrenia|schizophrenia
474062|NCT01125267|Mexican American|mexican american
474063|NCT01125267|multifamily groups|multifamily groups
474064|NCT01125254|thalassemia major|thalassemia major
474065|NCT01125254|calcium channel blockade|calcium channel blockade
474066|NCT01125254|magnetic resonance imaging|magnetic resonance imaging
474067|NCT01125241|wuling capsule|wuling capsule
474068|NCT01125241|epilepsy|epilepsy
474069|NCT01125241|depression|depression
474070|NCT01125241|superiority clinical research|superiority clinical research
474071|NCT01125228|AIDS|aids
474072|NCT01125228|Antiretroviral|antiretroviral
474073|NCT01125228|Kaposi's Sarcoma|kaposi's sarcoma
474074|NCT01125215|Painful diabetic neuropathy|painful diabetic neuropathy
474075|NCT01125215|Capsaicin|capsaicin
474076|NCT01125215|Nanoparticle|nanoparticle
474077|NCT01125215|Quantitative Sensory Testing|quantitative sensory testing
474078|NCT01125202|Intervention studies|intervention studies
474079|NCT01125202|Computers, handheld|computers, handheld
474080|NCT01125202|Randomized controlled trial|randomized controlled trial
474081|NCT01125202|Sodium, dietary|sodium, dietary
474083|NCT01125163|very low birth weight infants|very low birth weight infants
474084|NCT01125163|anemia|anemia
474085|NCT01125163|iron supplementation|iron supplementation
474086|NCT01125150|diffuse reflectance spectroscopy|diffuse reflectance spectroscopy
474087|NCT01125137|Keloid|keloid
474088|NCT01125137|MMP|mmp
474089|NCT01125137|Matrix metalloproteinase|matrix metalloproteinase
474090|NCT01125137|dermatology|dermatology
474091|NCT01125124|Pleurodesis|pleurodesis
474092|NCT01125124|Malignant pleural effusion|malignant pleural effusion
474093|NCT01125124|Silver Nitrate|silver nitrate
474094|NCT01125124|Pain|pain
474095|NCT01125098|COPD|copd
474096|NCT01125098|PRO-CT|pro-ct
474097|NCT01125098|antibiotics|antibiotics
474098|NCT01125085|I131|i131
474099|NCT01125085|L19|l19
474100|NCT01125085|antibody|antibody
474101|NCT01125085|monoclonal|monoclonal
474102|NCT01125085|multiple brain metastasis|multiple brain metastasis
474103|NCT01125085|tumor targeting|tumor targeting
474104|NCT01125085|radioimmunotherapy|radioimmunotherapy
474105|NCT01125085|Patients with brain metastases of solid tumors (>1), who are not amenable for surgical excision or stereotactic radiosurgery.|patients with brain metastases of solid tumors (>1), who are not amenable for surgical excision or stereotactic radiosurgery.
474106|NCT01125072|chest pain|chest pain
474107|NCT01125072|echocardiography|echocardiography
474108|NCT01125072|strain imaging|strain imaging
474109|NCT01125059|hydromorphone|hydromorphone
474110|NCT01125059|lumbar posterior spinal fusion|lumbar posterior spinal fusion
474111|NCT01125059|lumbosacral spondylosis|lumbosacral spondylosis
474112|NCT01125059|Spinal Fusion|spinal fusion
474113|NCT01125033|Dialysis, Restless legs syndrome, Ascorbic acid, Vitamin E|dialysis, restless legs syndrome, ascorbic acid, vitamin e
474114|NCT01125007|Dental plaque|dental plaque
474115|NCT01125007|Gingival abrasion|gingival abrasion
474116|NCT01125007|toothbrushing|toothbrushing
474117|NCT01124994|Barrett's oesophagus|barrett's oesophagus
474118|NCT01124994|High grade intraepithelial neoplasia (HGIEN)|high grade intraepithelial neoplasia (hgien)
474119|NCT01124981|Fibrinogen concentrate|fibrinogen concentrate
474120|NCT01124981|Coagulopathy|coagulopathy
474121|NCT01124968|User-Computer Interface|user-computer interface
474122|NCT01124968|Office Visits|office visits
474123|NCT01124968|Primary Health Care|primary health care
474318|NCT01124292|Disability|disability
474124|NCT01124968|Patient Satisfaction|patient satisfaction
474125|NCT01124968|Job Satisfaction|job satisfaction
474126|NCT01124968|Health Services Research|health services research
474127|NCT01124955|treatment|treatment
474128|NCT01124955|acupuncture|acupuncture
474129|NCT01124955|spine|spine
474130|NCT01124929|Intestinal tuberculosis|intestinal tuberculosis
474131|NCT01124929|Tuberculous peritonitis|tuberculous peritonitis
474132|NCT01124929|Abdominal tuberculosis|abdominal tuberculosis
474133|NCT01124916|incontinence|incontinence
474134|NCT01124916|prolapse|prolapse
474135|NCT01124916|Abdominal sacrocolpopexy|abdominal sacrocolpopexy
474136|NCT01124903|dehydration|dehydration
474137|NCT01124903|hypohydration|hypohydration
474138|NCT01124903|diagnostic accuracy|diagnostic accuracy
474139|NCT01124903|biological variation|biological variation
474140|NCT01124903|hydration assessment|hydration assessment
474141|NCT01124903|body mass|body mass
474142|NCT01124903|osmolality|osmolality
474143|NCT01124903|plasma|plasma
474144|NCT01124903|saliva|saliva
474145|NCT01124903|urine|urine
474146|NCT01124890|acute myocardial infarction|acute myocardial infarction
474147|NCT01124890|thrombolysis|thrombolysis
474148|NCT01124890|percutaneous coronary interention|percutaneous coronary interention
474149|NCT01124877|Children and Adolescents with Bipolar I Disorder (manic or mixed)|children and adolescents with bipolar i disorder (manic or mixed)
474150|NCT01124864|Non-small-cell lung cancer|non-small-cell lung cancer
474151|NCT01124864|HSP90|hsp90
474152|NCT01124864|2nd to 3rd line treatment|2nd to 3rd line treatment
474153|NCT01124851|Sleep disorder|sleep disorder
474154|NCT01124838|Uveitis|uveitis
474155|NCT01124825|Anesthesia induction and maintenance|anesthesia induction and maintenance
474156|NCT01124825|Surgery|surgery
474157|NCT01124812|I131|i131
474158|NCT01124812|L19|l19
474159|NCT01124812|antibody|antibody
474160|NCT01124812|monoclonal|monoclonal
474161|NCT01124812|NSCLC|nsclc
474162|NCT01124812|lung|lung
474163|NCT01124812|tumor targeting|tumor targeting
474164|NCT01124812|radioimmunotherapy|radioimmunotherapy
474165|NCT01124812|Patients with newly diagnosed inoperable, locally-advanced (stage III) NSCLC|patients with newly diagnosed inoperable, locally-advanced (stage iii) nsclc
474166|NCT01124799|Hepatitis C virus|hepatitis c virus
474167|NCT01124799|TMC435-TiDP16-C125|tmc435-tidp16-c125
474168|NCT01124799|TMC435-C125|tmc435-c125
474169|NCT01124799|TMC435|tmc435
474170|NCT01124799|TMC435350|tmc435350
474171|NCT01124799|protease inhibitor|protease inhibitor
474172|NCT01124799|HCV|hcv
474173|NCT01124799|Hepatitis C|hepatitis c
474174|NCT01124799|photosensitivity|photosensitivity
474175|NCT01124799|phototoxicity|phototoxicity
474176|NCT01124786|cancer|cancer
474177|NCT01124786|metastatic|metastatic
474178|NCT01124786|pancreatic|pancreatic
474179|NCT01124786|pancreas|pancreas
474180|NCT01124786|adenocarcinoma|adenocarcinoma
474181|NCT01124786|gemcitabine|gemcitabine
474182|NCT01124786|human equilibrative nucleoside transporter-1 (hENT1)|human equilibrative nucleoside transporter-1 (hent1)
474183|NCT01124786|CO-1.01|co-1.01
474184|NCT01124786|CO-101|co-101
474185|NCT01124786|CO101|co101
474186|NCT01124786|Stage 4|stage 4
474187|NCT01124786|Stage IV|stage iv
474188|NCT01124773|cognition|cognition
474189|NCT01124773|memory|memory
474190|NCT01124773|hormone therapy|hormone therapy
474191|NCT01124760|open label|open label
474192|NCT01124760|2-consecutive-group|2-consecutive-group
474193|NCT01124760|2-period|2-period
474194|NCT01124760|1-sequence crossover study|1-sequence crossover study
474195|NCT01124747|ASP1585|asp1585
474196|NCT01124747|Healthy Volunteers|healthy volunteers
474197|NCT01124734|metastatic melanoma|metastatic melanoma
474198|NCT01124721|Cognitive training|cognitive training
474199|NCT01124708|ADHD|adhd
474200|NCT01124708|Attention Deficit Hyperactive Disorder|attention deficit hyperactive disorder
474201|NCT01124695|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
474202|NCT01124695|male breast cancer|male breast cancer
474203|NCT01124695|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
474204|NCT01124695|recurrent breast cancer|recurrent breast cancer
474205|NCT01124695|stage IV breast cancer|stage iv breast cancer
474206|NCT01124682|adenocarcinoma of the bladder|adenocarcinoma of the bladder
474207|NCT01124682|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
474208|NCT01124682|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
474209|NCT01124682|recurrent bladder cancer|recurrent bladder cancer
474210|NCT01124682|stage II bladder cancer|stage ii bladder cancer
474211|NCT01124682|stage III bladder cancer|stage iii bladder cancer
474212|NCT01124682|stage IV bladder cancer|stage iv bladder cancer
474213|NCT01124669|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
474214|NCT01124669|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
474215|NCT01124669|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
474216|NCT01124656|angiotensin II receptor blocker|angiotensin ii receptor blocker
474217|NCT01124656|thiazolidinediones|thiazolidinediones
474218|NCT01124656|combination|combination
474219|NCT01124656|Actos|actos
474220|NCT01124656|HbA1c|hba1c
474221|NCT01124656|Type 2 diabetes|type 2 diabetes
474222|NCT01124656|Drug Therapy|drug therapy
474223|NCT01124656|Hypertension|hypertension
474224|NCT01124643|Replagal|replagal
474225|NCT01124643|Agalsidase alfa|agalsidase alfa
474226|NCT01124643|Alpha-Galactosidase|alpha-galactosidase
474227|NCT01124643|Enzyme Replacement Therapy|enzyme replacement therapy
474228|NCT01124617|Chronic pain|chronic pain
474229|NCT01124617|Diabetic Neuropathic Pain|diabetic neuropathic pain
474230|NCT01124617|Neuralgia, Postherpetic|neuralgia, postherpetic
474231|NCT01124617|Tapentadol hydrochloride extended-release|tapentadol hydrochloride extended-release
474232|NCT01124617|JNS024ER|jns024er
474233|NCT01124617|Placebo|placebo
474234|NCT01124604|Pain|pain
474235|NCT01124604|Low Back Pain|low back pain
474236|NCT01124604|Back Pain|back pain
474237|NCT01124604|Osteoarthritis, Knee|osteoarthritis, knee
474238|NCT01124604|Tapentadol|tapentadol
474239|NCT01124604|Tapentadol Hydrochloride Extended Release|tapentadol hydrochloride extended release
474240|NCT01124578|Ventilators, Mechanical|ventilators, mechanical
474241|NCT01124565|Lateral Canthal Lines|lateral canthal lines
474242|NCT01124565|Crow's Feet|crow's feet
474243|NCT01124565|Facial Wrinkles|facial wrinkles
474244|NCT01124552|Lateral Canthal Lines|lateral canthal lines
474245|NCT01124552|Crow's Feet Wrinkles|crow's feet wrinkles
474246|NCT01124552|Facial Wrinkles|facial wrinkles
474247|NCT01124539|Adult Patients|adult patients
474248|NCT01124539|Recurrence of Glioblastoma Multiforme|recurrence of glioblastoma multiforme
474249|NCT01124539|Recurrence of GBM|recurrence of gbm
474250|NCT01124539|Gliosarcoma|gliosarcoma
474251|NCT01124526|R F C treatment in patients with Non Hodgkin Lymphoma|r f c treatment in patients with non hodgkin lymphoma
474252|NCT01124513|Melanin Index|melanin index
474253|NCT01124513|Fitzpatrick Skin Phototype|fitzpatrick skin phototype
474254|NCT01124513|Videodermoscopy|videodermoscopy
474255|NCT01124513|Spectrophotometry|spectrophotometry
474256|NCT01124500|methylphenidate|methylphenidate
474257|NCT01124500|transdermal patch|transdermal patch
474258|NCT01124500|placebo|placebo
474259|NCT01124500|fatigue|fatigue
474260|NCT01124500|10-020|10-020
474261|NCT01124487|fat|fat
474262|NCT01124487|inflammation|inflammation
474263|NCT01124487|lipids|lipids
474264|NCT01124487|total cholesterol|total cholesterol
474265|NCT01124487|Triglycerides|triglycerides
474266|NCT01124487|insulin sensitivity|insulin sensitivity
474267|NCT01124461|Malignant Brain Tumors|malignant brain tumors
474268|NCT01124461|Cancer of the Brain|cancer of the brain
474269|NCT01124435|Carboplatin plus Celecoxib|carboplatin plus celecoxib
474270|NCT01124435|Pre-treated Recurrent Ovarian Cancer Patients|pre-treated recurrent ovarian cancer patients
474271|NCT01124435|The antitumor activity and potential adverse effects|the antitumor activity and potential adverse effects
474272|NCT01124435|tumor response rate|tumor response rate
474273|NCT01124435|toxicity|toxicity
474274|NCT01124435|progression free survival|progression free survival
474275|NCT01124435|duration of response|duration of response
474276|NCT01124435|quality of life|quality of life
474277|NCT01124422|endurance shuttle walk test|endurance shuttle walk test
474278|NCT01124422|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
474279|NCT01124422|fluticasone propionate|fluticasone propionate
474280|NCT01124422|dyspnea|dyspnea
474281|NCT01124422|exercise endurance time|exercise endurance time
474282|NCT01124422|tiotropium|tiotropium
474283|NCT01124422|salmeterol|salmeterol
474284|NCT01124422|exercise inspiratory capacity|exercise inspiratory capacity
474285|NCT01124422|quality of life|quality of life
474286|NCT01124409|IGRT|igrt
474287|NCT01124409|3DCRT|3dcrt
474288|NCT01124409|EPID|epid
474289|NCT01124409|CBCT|cbct
474290|NCT01124409|HNSCC|hnscc
474291|NCT01124383|Glycine absorption|glycine absorption
474292|NCT01124383|Operative hysteroscopy|operative hysteroscopy
474293|NCT01124383|Endometrial resection|endometrial resection
474294|NCT01124383|General anesthesia|general anesthesia
474295|NCT01124383|Local anesthesia|local anesthesia
474296|NCT01124370|Sleep Disordered Breathing|sleep disordered breathing
474297|NCT01124370|Cheyne Stokes Respiration|cheyne stokes respiration
474298|NCT01124370|Periodic Breathing|periodic breathing
474299|NCT01124370|Sleep Apnea|sleep apnea
474300|NCT01124370|Central Sleep Apnea|central sleep apnea
474301|NCT01124357|Heavy menstrual bleeding|heavy menstrual bleeding
474302|NCT01124357|menorrhagia|menorrhagia
474303|NCT01124357|ThermachoiceTM|thermachoicetm
474304|NCT01124357|NovaSureTM|novasuretm
474305|NCT01124357|Endometrail Ablation|endometrail ablation
474306|NCT01124331|prospective meta-analysis|prospective meta-analysis
474307|NCT01124331|preterm infant|preterm infant
474308|NCT01124331|pulse oximetry|pulse oximetry
474309|NCT01124331|oxygen saturation|oxygen saturation
474310|NCT01124318|Lactofiltrum|lactofiltrum
474311|NCT01124318|atopic dermatitis|atopic dermatitis
474312|NCT01124318|itching|itching
474313|NCT01124318|Dermatological Index of Life Quality|dermatological index of life quality
474314|NCT01124318|SCORAD|scorad
474315|NCT01124318|Behavioral Rating Scores|behavioral rating scores
474316|NCT01124305|Total Knee Arthroplasty|total knee arthroplasty
474317|NCT01124305|Instrumentation|instrumentation
474319|NCT01124292|Quadriplegia|quadriplegia
474320|NCT01124292|Paralysis|paralysis
474321|NCT01124292|Assistive technology|assistive technology
474322|NCT01124292|Quality of life|quality of life
474323|NCT01124292|Computer access|computer access
474324|NCT01124292|Wheeled mobility|wheeled mobility
474325|NCT01124279|Amgen|amgen
474326|NCT01124279|Healthy|healthy
474327|NCT01124279|Adult|adult
474328|NCT01124266|polyp|polyp
474329|NCT01124266|adenoma|adenoma
474330|NCT01124266|screening|screening
474331|NCT01124266|colonoscopy|colonoscopy
474332|NCT01124266|diagnosis|diagnosis
474333|NCT01124253|adjuvant therapy|adjuvant therapy
474334|NCT01124253|non-small cell lung cancer|non-small cell lung cancer
474335|NCT01124253|vinorelbine|vinorelbine
474336|NCT01124253|cisplatin|cisplatin
474337|NCT01124253|recombinant human endostatin|recombinant human endostatin
474338|NCT01124253|endostar|endostar
474339|NCT01124240|Glioblastoma Multiforme|glioblastoma multiforme
474340|NCT01124227|Congestive Heart Failure|congestive heart failure
474341|NCT01124227|Peritoneal Dialysis|peritoneal dialysis
474342|NCT01124227|Symptomatic improvement|symptomatic improvement
474343|NCT01124227|Renal function|renal function
474344|NCT01124214|Barrett's|barrett's
474345|NCT01124214|BE|be
474346|NCT01124214|esophageal cancer|esophageal cancer
474347|NCT01124214|esophageal dysplasia|esophageal dysplasia
474348|NCT01124201|low back pain|low back pain
474349|NCT01124201|clinical trial|clinical trial
474350|NCT01124201|stabilization|stabilization
474351|NCT01124201|muscle stretching exercises|muscle stretching exercises
474352|NCT01124201|exercise therapy|exercise therapy
474353|NCT01124188|Geriatric psychiatry|geriatric psychiatry
474354|NCT01124188|Aged|aged
474355|NCT01124188|Elderly|elderly
474356|NCT01124188|Venlafaxine|venlafaxine
474357|NCT01124188|Self efficacy|self efficacy
474358|NCT01124188|Pain|pain
474359|NCT01124188|Psychotherapy|psychotherapy
474360|NCT01124188|Effexor|effexor
474361|NCT01124175|Bioequivalence|bioequivalence
474362|NCT01124175|Healthy Subjects|healthy subjects
474363|NCT01124162|Bioequivalence|bioequivalence
474364|NCT01124162|Healthy Subjects|healthy subjects
474365|NCT01124136|Chronic Heart Failure|chronic heart failure
474366|NCT01124136|Neurostimulation|neurostimulation
474367|NCT01124123|Pharmacokinetics|pharmacokinetics
474368|NCT01124123|Oral bioavailability|oral bioavailability
474369|NCT01124123|absorption|absorption
474370|NCT01124123|AUC|auc
474371|NCT01124123|Bioequivalence|bioequivalence
474372|NCT01124123|Bioavailability study|bioavailability study
474373|NCT01124110|Operating Engineers|operating engineers
474374|NCT01124110|Smoking Cessation|smoking cessation
474375|NCT01124097|post herpetic neuralgia|post herpetic neuralgia
474376|NCT01124071|Korean Diet|korean diet
474377|NCT01124058|restarting warfarin|restarting warfarin
474378|NCT01124058|time to therapeutic INR|time to therapeutic inr
474379|NCT01124045|Pediatric|pediatric
474380|NCT01124045|Cataracts|cataracts
474381|NCT01124045|Inflammation|inflammation
474382|NCT01124045|Durezol|durezol
474383|NCT01124045|Pred Forte|pred forte
474384|NCT01124045|Difluprednate|difluprednate
474385|NCT01124045|Prednisolone|prednisolone
474386|NCT01124019|Women undergoing screening mammography will be chosen if they are between the ages of 40 and 65.|women undergoing screening mammography will be chosen if they are between the ages of 40 and 65.
474387|NCT01123993|Thai traditional music|thai traditional music
474388|NCT01123993|dementia|dementia
474389|NCT01123993|Cognitive function|cognitive function
474390|NCT01123993|behavioural problem|behavioural problem
474391|NCT01123993|sleep quality|sleep quality
474392|NCT01123993|psychological health|psychological health
474393|NCT01123993|quality of sleep|quality of sleep
474394|NCT01123967|nicotine replacement therapy|nicotine replacement therapy
474395|NCT01123967|smoking cessation|smoking cessation
474396|NCT01123967|tobacco dependent|tobacco dependent
474397|NCT01123954|Seasonal influenza|seasonal influenza
474398|NCT01123954|Vaccine|vaccine
474399|NCT01123941|Typhoid fever|typhoid fever
474400|NCT01123941|Glycoconjugate vaccine|glycoconjugate vaccine
474401|NCT01123941|Carrier protein|carrier protein
474402|NCT01123941|Immunogenicity|immunogenicity
474403|NCT01123928|cataract|cataract
474404|NCT01123928|counseling|counseling
474405|NCT01123928|surgical uptake|surgical uptake
474406|NCT01123928|follow-up|follow-up
474407|NCT01123915|HIV|hiv
474408|NCT01123915|Therapeutic|therapeutic
474409|NCT01123915|Immunotherapy|immunotherapy
474410|NCT01123915|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
474411|NCT01123915|Virus Diseases|virus diseases
474412|NCT01123915|Lentivirus Infections|lentivirus infections
474413|NCT01123915|Human Immunodeficiency Virus|human immunodeficiency virus
474414|NCT01123902|Breathlessness|breathlessness
474415|NCT01123902|Dyspnea|dyspnea
474416|NCT01123902|Hand-held fan|hand-held fan
474417|NCT01123902|Palliative Care|palliative care
474418|NCT01123889|subacromial impingement|subacromial impingement
474419|NCT01123889|partial thickness rotator cuff|partial thickness rotator cuff
474420|NCT01123889|PRP|prp
474421|NCT01123889|platelet rich plasma|platelet rich plasma
474422|NCT01123876|Gastric Cancer|gastric cancer
474423|NCT01123863|Neuro cognitive deficits;|neuro cognitive deficits;
474424|NCT01123863|Brigance pre-school screen;|brigance pre-school screen;
474425|NCT01123850|CopiOs|copios
474426|NCT01123850|Degenerative spondylolisthesis,|degenerative spondylolisthesis,
474427|NCT01123850|stenosis with instability, or|stenosis with instability, or
474428|NCT01123850|degenerative disc disease as diagnosed by radicular signs and/or imaging studies|degenerative disc disease as diagnosed by radicular signs and/or imaging studies
474429|NCT01123824|healthy subjects|healthy subjects
474430|NCT01123811|adenocarcinoma|adenocarcinoma
474431|NCT01123811|gastric cancer|gastric cancer
474432|NCT01123811|esophagogastric junction cancer|esophagogastric junction cancer
474433|NCT01123798|near infrared spectroscopy|near infrared spectroscopy
474434|NCT01123798|lower extremity injury|lower extremity injury
474435|NCT01123785|glaucoma|glaucoma
474436|NCT01123785|ocular hypertension|ocular hypertension
474437|NCT01123785|adenosine agonist|adenosine agonist
474438|NCT01123785|eye drop|eye drop
474439|NCT01123785|primary open angle glaucoma|primary open angle glaucoma
474440|NCT01123772|adenosine agonist|adenosine agonist
474441|NCT01123772|eye drop|eye drop
474442|NCT01123772|elderly volunteer|elderly volunteer
474443|NCT01123772|older healthy volunteer|older healthy volunteer
474444|NCT01123759|Fish|fish
474445|NCT01123759|mercury|mercury
474446|NCT01123759|omega-3 fatty acids|omega-3 fatty acids
474447|NCT01123759|infant|infant
474448|NCT01123759|brain development|brain development
474449|NCT01123759|pregnancy|pregnancy
474450|NCT01123759|nursing mother|nursing mother
474451|NCT01123759|dietary recommendations|dietary recommendations
474452|NCT01123759|Hair mercury|hair mercury
474453|NCT01123759|Blood mercury|blood mercury
474454|NCT01123759|Recommendations for pregnant or nursing women|recommendations for pregnant or nursing women
474455|NCT01123759|Infant brain health|infant brain health
474456|NCT01123746|Seizure|seizure
474457|NCT01123746|electrolyte|electrolyte
474458|NCT01123746|risk factor|risk factor
474459|NCT01123733|Baby-friendly hospitals|baby-friendly hospitals
474460|NCT01123733|Non baby-friendly hospitals|non baby-friendly hospitals
474461|NCT01123733|Breastfeeding|breastfeeding
474462|NCT01123733|Ten steps for successful breastfeeding|ten steps for successful breastfeeding
474463|NCT01123707|Major Depressive Disorder|major depressive disorder
474464|NCT01123707|MDD|mdd
474465|NCT01123707|Depression|depression
474466|NCT01123694|xeroderma pigmentosum|xeroderma pigmentosum
474467|NCT01123694|quality of life|quality of life
474468|NCT01123694|DLQI|dlqi
474469|NCT01123694|CDLQI|cdlqi
474470|NCT01123681|Respiration, Artificial|respiration, artificial
474471|NCT01123681|Pneumonia, Ventilator-Associated|pneumonia, ventilator-associated
474472|NCT01123681|Critical Illness|critical illness
474473|NCT01123668|Smoking|smoking
474474|NCT01123668|ADHD|adhd
474475|NCT01123668|Nicotine|nicotine
474476|NCT01123668|Methylphenidate|methylphenidate
474477|NCT01123668|function Magnetic Resonance Imaging|function magnetic resonance imaging
474478|NCT01123668|Neurobiological basis of abstinence-induced deficits in response inhibition|neurobiological basis of abstinence-induced deficits in response inhibition
474479|NCT01123642|post-traumatic stress disorder|post-traumatic stress disorder
474480|NCT01123642|depressive disorder|depressive disorder
474481|NCT01123642|alcoholism|alcoholism
474482|NCT01123642|Longitudinal studies|longitudinal studies
474483|NCT01123642|readjustment|readjustment
474484|NCT01123616|surgical site infection|surgical site infection
474485|NCT01123616|elective colorectal surgery|elective colorectal surgery
474486|NCT01123616|level of surgical site infection|level of surgical site infection
474487|NCT01123616|complication of surgical site infection|complication of surgical site infection
474488|NCT01123616|type of changed bandage|type of changed bandage
474489|NCT01123616|frequency of bandage changing|frequency of bandage changing
474490|NCT01123603|frequency|frequency
474491|NCT01123603|women|women
474492|NCT01123603|fibroids|fibroids
474493|NCT01123603|uterine artery embolization|uterine artery embolization
474494|NCT01123603|myomectomy|myomectomy
474495|NCT01123603|hysterectomy|hysterectomy
474496|NCT01123590|Thymoma|thymoma
474497|NCT01123590|Autoimmune diseases|autoimmune diseases
474498|NCT01123590|Immunodeficiency|immunodeficiency
474499|NCT01123577|Self Blood Pressure Monitoring|self blood pressure monitoring
474500|NCT01123577|SBPM|sbpm
474501|NCT01123577|Randomized Control Trial|randomized control trial
474502|NCT01123577|Hypertension (HTN)|hypertension (htn)
474503|NCT01123577|Cardiovascular Disease (CVD)|cardiovascular disease (cvd)
474504|NCT01123577|HTN|htn
474505|NCT01123577|CVD|cvd
474506|NCT01123564|macular edema secondary to retinal vein occlusion|macular edema secondary to retinal vein occlusion
474507|NCT01123551|Nebulized morphine|nebulized morphine
474508|NCT01123551|Intravenous morphine|intravenous morphine
474509|NCT01123551|Post traumatic|post traumatic
474510|NCT01123551|Pain|pain
474511|NCT01123551|Emergency department|emergency department
474512|NCT01123512|Vertebral Compression Fracture|vertebral compression fracture
474513|NCT01123512|Kyphoplasty|kyphoplasty
474514|NCT01123512|Spine|spine
474515|NCT01123512|Vertebral Body Compression Fracture|vertebral body compression fracture
474516|NCT01123512|Back Pain|back pain
474517|NCT01123499|G-CSF|g-csf
474518|NCT01123499|Plerixafor|plerixafor
474519|NCT01123499|Normal Volunteer|normal volunteer
474520|NCT01123499|Apheresis|apheresis
474521|NCT01123499|Healthy Volunteer|healthy volunteer
474522|NCT01123499|HV|hv
474523|NCT01123486|Intravenous opioids|intravenous opioids
474524|NCT01123486|Patient Controlled Analgesia|patient controlled analgesia
474525|NCT01123486|volunteer pharmacokinetic-pharmacodynamic study|volunteer pharmacokinetic-pharmacodynamic study
474526|NCT01123473|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
474527|NCT01123473|adenocarcinoma of the stomach|adenocarcinoma of the stomach
474528|NCT01123473|stage IIIA gastric cancer|stage iiia gastric cancer
474529|NCT01123473|stage IIIB gastric cancer|stage iiib gastric cancer
474530|NCT01123473|stage IIIC gastric cancer|stage iiic gastric cancer
474531|NCT01123473|stage IV gastric cancer|stage iv gastric cancer
474532|NCT01123460|non-small cell lung cancer|non-small cell lung cancer
474533|NCT01123434|prostate cancer|prostate cancer
474534|NCT01123434|adjuvant|adjuvant
474535|NCT01123434|hormonal|hormonal
474536|NCT01123421|osteoporosis|osteoporosis
474537|NCT01123421|fracture risk|fracture risk
474538|NCT01123421|aging|aging
474539|NCT01123421|tibia|tibia
474540|NCT01123421|sonometer|sonometer
474541|NCT01123421|ultrasound|ultrasound
474542|NCT01123421|BMD|bmd
474543|NCT01123421|bone mineral density|bone mineral density
474544|NCT01123421|DXA|dxa
474545|NCT01123421|3D-HRpQT|3d-hrpqt
474546|NCT01123421|waveform profiles|waveform profiles
474547|NCT01123408|schizophrenia|schizophrenia
474548|NCT01123408|aggression|aggression
474549|NCT01123408|clozapine|clozapine
474550|NCT01123408|olanzapine|olanzapine
474551|NCT01123395|bioavailability|bioavailability
474552|NCT01123382|Stroke|stroke
474553|NCT01123382|Shoulder pain|shoulder pain
474554|NCT01123382|Electrical stimulation|electrical stimulation
474555|NCT01123382|Neuromuscular stimulation|neuromuscular stimulation
474556|NCT01123382|Intramuscular stimulation|intramuscular stimulation
474557|NCT01123369|Sickle Cell Disease|sickle cell disease
474685|NCT01122758|Smoking|smoking
474558|NCT01123356|Relapsed chronic lymphocytic leukemia|relapsed chronic lymphocytic leukemia
474559|NCT01123343|limbal relaxing incision|limbal relaxing incision
474560|NCT01123343|LRI|lri
474561|NCT01123343|capsulorhexis|capsulorhexis
474562|NCT01123343|surgical guidance|surgical guidance
474563|NCT01123343|3d visualization|3d visualization
474564|NCT01123317|Schizophrenia|schizophrenia
474565|NCT01123317|PET|pet
474566|NCT01123317|Oxytocin|oxytocin
474567|NCT01123304|melanoma|melanoma
474568|NCT01123291|follow-up coronary angiography|follow-up coronary angiography
474569|NCT01123278|Adiponectin|adiponectin
474570|NCT01123278|Resistin|resistin
474571|NCT01123278|Adipocytes|adipocytes
474572|NCT01123278|Testosterone|testosterone
474573|NCT01123278|Aging|aging
474574|NCT01123278|HOMA-IR|homa-ir
474575|NCT01123278|Insulin|insulin
474576|NCT01123278|Hypogonadism|hypogonadism
474577|NCT01123278|Metabolic Syndrome|metabolic syndrome
474578|NCT01123278|Obesity|obesity
474579|NCT01123278|Erectile Dysfunction|erectile dysfunction
474580|NCT01123265|PsA|psa
474581|NCT01123265|methotrexate|methotrexate
474582|NCT01123265|Anti-TNF|anti-tnf
474583|NCT01123265|TNF|tnf
474584|NCT01123265|DC-Stamp|dc-stamp
474585|NCT01123252|Lactobacillus casei|lactobacillus casei
474586|NCT01123239|Healthcare Disparities|healthcare disparities
474587|NCT01123213|pelvic organ prolapse|pelvic organ prolapse
474588|NCT01123213|pessary fitting|pessary fitting
474589|NCT01123187|diabetes type 1|diabetes type 1
474590|NCT01123187|kidney transplantation|kidney transplantation
474591|NCT01123187|islet|islet
474592|NCT01123187|hypoglycemia|hypoglycemia
474593|NCT01123174|Suicide|suicide
474594|NCT01123174|case management algorithm|case management algorithm
474595|NCT01123174|suicidal behaviors|suicidal behaviors
474596|NCT01123174|prevention of suicide|prevention of suicide
474597|NCT01123161|Hypothermia|hypothermia
474598|NCT01123161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
474599|NCT01123161|Cerebral Infarction|cerebral infarction
474600|NCT01123161|Hematologic Agents|hematologic agents
474601|NCT01123161|Stroke|stroke
474602|NCT01123161|Nervous System Diseases|nervous system diseases
474603|NCT01123161|Vascular Diseases|vascular diseases
474604|NCT01123161|Tissue Plasminogen Activator|tissue plasminogen activator
474605|NCT01123161|Central Nervous System Diseases|central nervous system diseases
474606|NCT01123161|Fibrinolytic Agents|fibrinolytic agents
474607|NCT01123161|Cardiovascular Agents|cardiovascular agents
474608|NCT01123161|Body Temperature Changes|body temperature changes
474609|NCT01123161|Brain Diseases|brain diseases
474610|NCT01123161|Cerebrovascular Disorders|cerebrovascular disorders
474611|NCT01123161|Pharmacologic Actions|pharmacologic actions
474612|NCT01123161|Signs and Symptoms|signs and symptoms
474613|NCT01123161|Fibrin Modulating Agents|fibrin modulating agents
475119|NCT01120704|Smoking|smoking
474614|NCT01123161|Therapeutic Uses|therapeutic uses
474615|NCT01123161|Brain Ischemia|brain ischemia
474616|NCT01123161|Cardiovascular Diseases|cardiovascular diseases
474617|NCT01123161|Brain Infarction|brain infarction
474618|NCT01123161|Plasminogen|plasminogen
474619|NCT01123161|cooling|cooling
474620|NCT01123161|tPA|tpa
474621|NCT01123161|thrombolysis|thrombolysis
474622|NCT01123148|Brain computer interface|brain computer interface
474623|NCT01123148|wheelchair control|wheelchair control
474624|NCT01123135|urodynamic stress incontinence|urodynamic stress incontinence
474625|NCT01123135|postmenopausal women|postmenopausal women
474626|NCT01123109|nulliparous women|nulliparous women
474627|NCT01123096|Stress urinary incontinence|stress urinary incontinence
474628|NCT01123083|new onset type 1 diabetes|new onset type 1 diabetes
474629|NCT01123083|juvenile diabetes|juvenile diabetes
474630|NCT01123083|T1DM|t1dm
474631|NCT01123083|Type 1 diabetes|type 1 diabetes
474632|NCT01123057|keratoconus|keratoconus
474633|NCT01123057|collagen cross-linking|collagen cross-linking
474634|NCT01123057|LASIK ectasia|lasik ectasia
474635|NCT01123057|keratoconus,lasik ectasia|keratoconus,lasik ectasia
474636|NCT01123018|Memory Loss|memory loss
474637|NCT01122992|Limbal relaxing incision|limbal relaxing incision
474638|NCT01122992|Astigmatic correction|astigmatic correction
474639|NCT01122992|Phacoemulsification surgery|phacoemulsification surgery
474640|NCT01122992|Chinese eyes|chinese eyes
474641|NCT01122966|trabeculectomy|trabeculectomy
474642|NCT01122953|Bioequivalence|bioequivalence
474643|NCT01122953|EPAMIN|epamin
474644|NCT01122953|PHENYTOIN|phenytoin
474645|NCT01122940|Bioequivalence|bioequivalence
474646|NCT01122940|Phenytoin|phenytoin
474647|NCT01122940|Epamin|epamin
474648|NCT01122927|schizophrenia|schizophrenia
474649|NCT01122927|adolescent|adolescent
474650|NCT01122927|bipolar|bipolar
474651|NCT01122914|Kineret|kineret
474652|NCT01122914|Anakinra|anakinra
474653|NCT01122914|Atopic Dermatitis|atopic dermatitis
474654|NCT01122914|Eczema|eczema
474655|NCT01122914|Allergic Disease|allergic disease
474656|NCT01122862|tooth plaque|tooth plaque
474657|NCT01122849|trouble with sleep|trouble with sleep
474658|NCT01122849|night time nasal congestion|night time nasal congestion
474659|NCT01122836|Massage|massage
474660|NCT01122836|Chronic Neck Pain|chronic neck pain
474661|NCT01122836|Dosing Study|dosing study
474662|NCT01122823|Chronic Disease Self-Management Program (CDSMP)|chronic disease self-management program (cdsmp)
474663|NCT01122810|Diagnostic accuracy of coronary angiography|diagnostic accuracy of coronary angiography
474664|NCT01122810|Transplant heart patients|transplant heart patients
474665|NCT01122810|X-Ray and contrast agent exposure|x-ray and contrast agent exposure
474666|NCT01122810|Coronary stenosis|coronary stenosis
474667|NCT01122797|PNPLA3|pnpla3
474668|NCT01122797|fibrosis|fibrosis
474669|NCT01122797|cirrhosis|cirrhosis
474670|NCT01122797|alcoholic liver disease|alcoholic liver disease
474671|NCT01122784|Plague|plague
474672|NCT01122784|Vaccine|vaccine
474673|NCT01122771|visceral leishmaniasis|visceral leishmaniasis
474674|NCT01122771|phase III|phase iii
474675|NCT01122771|randomised ccontrolled trial|randomised ccontrolled trial
474676|NCT01122771|Bangladesh|bangladesh
474677|NCT01122771|Combination treatment|combination treatment
474678|NCT01122771|Ambisome|ambisome
474679|NCT01122771|miltefosine|miltefosine
474680|NCT01122771|paromomycin|paromomycin
474681|NCT01122758|Cohort|cohort
474682|NCT01122758|COPD|copd
474683|NCT01122758|Natural history|natural history
474684|NCT01122758|Phenotyping|phenotyping
474686|NCT01122745|continuous block|continuous block
474687|NCT01122745|single shot|single shot
474688|NCT01122745|interscalene|interscalene
474689|NCT01122745|rotator cuff surgery|rotator cuff surgery
474690|NCT01122732|nerve block|nerve block
474691|NCT01122732|continuous catheter|continuous catheter
474692|NCT01122732|shoulder surgery|shoulder surgery
474693|NCT01122732|pain control after total shoulder arthroplasty|pain control after total shoulder arthroplasty
474694|NCT01122719|Optima|optima
474695|NCT01122719|Tacrolimus|tacrolimus
474696|NCT01122719|Drug eluting stent|drug eluting stent
474697|NCT01122706|tai ji|tai ji
474698|NCT01122706|psychosocial stress|psychosocial stress
474699|NCT01122706|primary prevention|primary prevention
474700|NCT01122706|Trier Social Stress Test|trier social stress test
474701|NCT01122706|salivary cortisol|salivary cortisol
474702|NCT01122706|salivary alpha amylase|salivary alpha amylase
474703|NCT01122706|heart rate variability|heart rate variability
474704|NCT01122706|stress management|stress management
474705|NCT01122693|Regional Anesthesia|regional anesthesia
474706|NCT01122693|Pain Medicine|pain medicine
474707|NCT01122693|Ultrasound|ultrasound
474708|NCT01122693|Nerve Blocks|nerve blocks
474709|NCT01122667|Renal Insufficiency|renal insufficiency
474710|NCT01122641|Insulin resistance|insulin resistance
474711|NCT01122641|incretins|incretins
474712|NCT01122641|DPP4 inhibitors|dpp4 inhibitors
474713|NCT01122641|vildagliptin|vildagliptin
474714|NCT01122641|microcirculation|microcirculation
474715|NCT01122628|Distal Radial Fracture|distal radial fracture
474716|NCT01122628|Volar Locking Plate|volar locking plate
474717|NCT01122615|Kidney|kidney
474718|NCT01122615|metastatic renal cell carcinoma|metastatic renal cell carcinoma
474719|NCT01122615|RCC|rcc
474720|NCT01122615|Sunitinib|sunitinib
474721|NCT01122615|Sunitinib Malate|sunitinib malate
474722|NCT01122615|Sutent|sutent
474723|NCT01122615|Temsirolimus|temsirolimus
474724|NCT01122615|Torisel|torisel
474725|NCT01122602|Aspirin|aspirin
474726|NCT01122589|Smoking Abstinence|smoking abstinence
474727|NCT01122589|Smoking Cessation|smoking cessation
474728|NCT01122576|Intra Ocular Lens|intra ocular lens
474729|NCT01122576|Ocular surgery|ocular surgery
474730|NCT01122576|Phacoemulsification|phacoemulsification
474731|NCT01122563|OABSS|oabss
474732|NCT01122563|IPSS|ipss
474733|NCT01122563|PPBC|ppbc
474734|NCT01122563|3-day micturition diary|3-day micturition diary
474735|NCT01122563|Solifenacin|solifenacin
474736|NCT01122550|OABSS|oabss
474737|NCT01122550|IPSS|ipss
474738|NCT01122550|PPBC|ppbc
474739|NCT01122550|3-day micturition diary|3-day micturition diary
474740|NCT01122537|Meningitis|meningitis
474741|NCT01122537|infection|infection
474742|NCT01122537|cerebrospinal fluid|cerebrospinal fluid
474743|NCT01122537|procalcitonin|procalcitonin
474744|NCT01122537|adenosine deaminase|adenosine deaminase
474745|NCT01122524|Trisomy 21|trisomy 21
474746|NCT01122472|lenalidomide (Revlimid)|lenalidomide (revlimid)
474747|NCT01122472|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
474748|NCT01122472|phase III study|phase iii study
474749|NCT01122472|after R-CHOP|after r-chop
474750|NCT01122472|Maintenance treatment|maintenance treatment
474751|NCT01122472|Maintenance|maintenance
474752|NCT01122459|Perioperative intravenous fluids|perioperative intravenous fluids
474753|NCT01122446|Alum-GAD|alum-gad
474754|NCT01122446|Type 1 diabetes|type 1 diabetes
474755|NCT01122446|prevention|prevention
474756|NCT01122446|immune tolerance|immune tolerance
474757|NCT01122446|glucose tolerance|glucose tolerance
474758|NCT01122446|glutamate decarboxylase autoantibodies|glutamate decarboxylase autoantibodies
474759|NCT01122433|difficult airway|difficult airway
474760|NCT01122433|indirect laryngoscopy|indirect laryngoscopy
474761|NCT01122433|C-MAC video laryngoscope|c-mac video laryngoscope
474762|NCT01122420|Obesity|obesity
474763|NCT01122394|stroke|stroke
474764|NCT01122394|recurrence|recurrence
474765|NCT01122394|blood pressure|blood pressure
474766|NCT01122394|prevention|prevention
474767|NCT01122381|headache, migraine|headache, migraine
474768|NCT01122381|depression|depression
474769|NCT01122381|disability evaluation|disability evaluation
474770|NCT01122381|weight gain|weight gain
474771|NCT01122368|mycoses|mycoses
474772|NCT01122368|Micafungin|micafungin
474773|NCT01122368|intra-abdominal surgery|intra-abdominal surgery
474774|NCT01122368|invasive fungal infection|invasive fungal infection
474775|NCT01122368|intra-abdominal infection|intra-abdominal infection
474776|NCT01122342|Testosterone|testosterone
474777|NCT01122342|Vaginal administration|vaginal administration
474778|NCT01122342|Aromatase inhibitors|aromatase inhibitors
474779|NCT01122329|dementia|dementia
474780|NCT01122316|Heart Failure|heart failure
474781|NCT01122316|Diabetes|diabetes
474782|NCT01122316|Metformin|metformin
474783|NCT01122303|Autologous serum eye drops|autologous serum eye drops
474784|NCT01122303|EGF|egf
474785|NCT01122303|TGF-β1|tgf-β1
474786|NCT01122303|TGF-β2|tgf-β2
474787|NCT01122303|Fibronectin|fibronectin
474788|NCT01122303|Stevens-Johnson syndrome|stevens-johnson syndrome
474789|NCT01122303|Dry eye|dry eye
474790|NCT01122290|Emotional eating|emotional eating
474791|NCT01122290|Eating in the absence of hunger|eating in the absence of hunger
474792|NCT01122290|emotion induction|emotion induction
474793|NCT01122277|Volume therapy|volume therapy
474794|NCT01122277|Fluid therapy|fluid therapy
474795|NCT01122277|Patients in ICU|patients in icu
474796|NCT01122264|Erectile Dysfunction|erectile dysfunction
474797|NCT01122251|hypertension|hypertension
474798|NCT01122251|lercanidipine|lercanidipine
474799|NCT01122251|valsartan|valsartan
474800|NCT01122238|Smoking|smoking
474801|NCT01122238|Smoking Cessation|smoking cessation
474802|NCT01122238|Motivation|motivation
474803|NCT01122238|Nicotine Dependence|nicotine dependence
474804|NCT01122225|septic shock|septic shock
474805|NCT01122225|medical intensive care|medical intensive care
474806|NCT01122212|intracerebral hemorrhage|intracerebral hemorrhage
474807|NCT01122212|ct scans|ct scans
474808|NCT01122212|protein s100|protein s100
474809|NCT01122212|inpatient treatment|inpatient treatment
474810|NCT01122186|Medication Adherence|medication adherence
474811|NCT01122186|Methamphetamine Use|methamphetamine use
474812|NCT01122186|Sexual Risk|sexual risk
474813|NCT01122186|Poly-substance Use|poly-substance use
474814|NCT01122186|HIV|hiv
474815|NCT01122186|Treatment|treatment
474816|NCT01122186|Motivational Interviewing|motivational interviewing
474817|NCT01122186|Cognitive Behavioral Skills Training|cognitive behavioral skills training
474818|NCT01122186|Men Who Have Sex With Men|men who have sex with men
474819|NCT01122173|Atrial Fibrillation|atrial fibrillation
474820|NCT01122173|Robotic Control|robotic control
474821|NCT01122173|Remote Control|remote control
474822|NCT01122160|anthocyanin|anthocyanin
474823|NCT01122160|omeprazole|omeprazole
474824|NCT01122160|Prilosec|prilosec
474825|NCT01122160|gastric pH|gastric ph
474826|NCT01122160|proton pump inhibitor|proton pump inhibitor
474827|NCT01122160|PPI|ppi
474828|NCT01122160|nutrition|nutrition
474829|NCT01122147|Aphthous stomatitis; Herbal medicines; Matricaria Chamomilla|aphthous stomatitis; herbal medicines; matricaria chamomilla
474830|NCT01122134|severe|severe
474831|NCT01122134|malaria|malaria
474832|NCT01122134|artesunate|artesunate
474833|NCT01122134|intravenous|intravenous
474834|NCT01122121|Drug Therapy|drug therapy
474835|NCT01122121|Radiotherapy|radiotherapy
474836|NCT01122108|Bile Acid Sequestrant|bile acid sequestrant
474837|NCT01122108|Resin|resin
474838|NCT01122108|Lipids|lipids
474839|NCT01122108|Glucose|glucose
474840|NCT01122108|Cholesterol|cholesterol
474841|NCT01122108|Diabetes Mellitus|diabetes mellitus
474842|NCT01122108|Bile Acid Sequestrant Acceptability Scale|bile acid sequestrant acceptability scale
474843|NCT01122095|Psoriasis|psoriasis
474844|NCT01122095|Cardiovascular risk|cardiovascular risk
474845|NCT01122082|energy intake|energy intake
474846|NCT01122082|energy expenditure|energy expenditure
474847|NCT01122082|macronutrient selection|macronutrient selection
474848|NCT01122056|Multiple Sclerosis|multiple sclerosis
474849|NCT01122056|b1b-interferon|b1b-interferon
474850|NCT01122056|Fatigue|fatigue
474851|NCT01122056|Exercise|exercise
474852|NCT01122043|Endoglide|endoglide
474853|NCT01122043|Endothelial Keratoplasty|endothelial keratoplasty
474854|NCT01122043|Donor Insertion|donor insertion
474855|NCT01122043|DSAEK|dsaek
474856|NCT01122043|Corneal Transplant|corneal transplant
474857|NCT01122043|Patients with Bullous Keratopathy|patients with bullous keratopathy
474858|NCT01122030|Chronic pain|chronic pain
474859|NCT01122030|Opioid physical dependence|opioid physical dependence
474860|NCT01121991|Infertility|infertility
474861|NCT01121991|Ovarian Stimulation|ovarian stimulation
474862|NCT01121991|Luveris|luveris
474863|NCT01121991|Lutropin alpha|lutropin alpha
474864|NCT01121991|Controlled ovarian stimulation|controlled ovarian stimulation
474865|NCT01121991|Reproductive techniques, assisted|reproductive techniques, assisted
474866|NCT01121978|macular tractional maculopathy|macular tractional maculopathy
474867|NCT01121978|pathologic myopia|pathologic myopia
474868|NCT01121965|macular hole|macular hole
474869|NCT01121965|impending macular hole|impending macular hole
474870|NCT01121965|stage 1 macular hole|stage 1 macular hole
474871|NCT01121952|Ankle joint|ankle joint
474872|NCT01121952|Talo-crural joint|talo-crural joint
474873|NCT01121952|Vertical jump|vertical jump
474874|NCT01121952|Chiropractic manipulation (HVLA)|chiropractic manipulation (hvla)
474875|NCT01121952|ROM|rom
474876|NCT01121952|Proprioception|proprioception
474877|NCT01121952|Pain|pain
474878|NCT01121939|advanced neuroendocrine|advanced neuroendocrine
474879|NCT01121939|Gastrointestinal|gastrointestinal
474880|NCT01121939|Bevacizumab|bevacizumab
474881|NCT01121939|Avastin|avastin
474882|NCT01121939|Pertuzumab|pertuzumab
474883|NCT01121939|Omnitarg|omnitarg
474884|NCT01121939|2C4|2c4
474885|NCT01121939|Sandostatin|sandostatin
474886|NCT01121939|Octreotide|octreotide
474887|NCT01121926|Healthy subjects|healthy subjects
474888|NCT01121926|Bioavailability|bioavailability
474889|NCT01121926|Pharmacokinetics|pharmacokinetics
474890|NCT01121926|Trazodone|trazodone
474891|NCT01121926|Steady-state|steady-state
474892|NCT01121913|Healthy subjects|healthy subjects
474893|NCT01121900|Healthy subjects|healthy subjects
474894|NCT01121887|smoking cessation|smoking cessation
474895|NCT01121887|telephone counselling|telephone counselling
474896|NCT01121887|motivational interviewing|motivational interviewing
474897|NCT01121887|treatment integrity|treatment integrity
474898|NCT01121887|Tobacco Smoking|tobacco smoking
474899|NCT01121874|CMC arthritis|cmc arthritis
474900|NCT01121874|thumb carpometacarpal arthritis|thumb carpometacarpal arthritis
474901|NCT01121874|basal joint arthritis|basal joint arthritis
474902|NCT01121874|thumb CMC arthritis|thumb cmc arthritis
474903|NCT01121861|efficacy|efficacy
474904|NCT01121861|safety|safety
474905|NCT01121861|predictability|predictability
474906|NCT01121861|stability|stability
474907|NCT01121861|toric IOL|toric iol
474908|NCT01121861|refractive astigmatism|refractive astigmatism
474909|NCT01121861|phacoemulsification|phacoemulsification
474910|NCT01121822|Influenza|influenza
474911|NCT01121822|Influenza vaccine|influenza vaccine
474912|NCT01121822|Influenza virus|influenza virus
474913|NCT01121822|Intramuscular|intramuscular
474914|NCT01121809|Raltegravir|raltegravir
474915|NCT01121809|etravirine|etravirine
474916|NCT01121809|pharmacokinetics|pharmacokinetics
474917|NCT01121809|intracellular|intracellular
474918|NCT01121757|relapsed|relapsed
474919|NCT01121757|refractory|refractory
474920|NCT01121757|lymphoma|lymphoma
474921|NCT01121757|follicular|follicular
474922|NCT01121757|marginal zone|marginal zone
475722|NCT01118312|Chronic|chronic
474923|NCT01121744|Coronary Artery Disease|coronary artery disease
474924|NCT01121744|Drug Eluting Stents (DES)|drug eluting stents (des)
474925|NCT01121744|Pharmacokinetic (PK)|pharmacokinetic (pk)
474926|NCT01121731|Chronic Hepatitis C Viral Infection|chronic hepatitis c viral infection
474927|NCT01121731|Interferon alfa-5|interferon alfa-5
474928|NCT01121731|Interferon|interferon
474929|NCT01121718|lymph node|lymph node
474930|NCT01121705|genotype 3|genotype 3
474931|NCT01121705|Combination treatment|combination treatment
474932|NCT01121705|Short treatment|short treatment
474933|NCT01121692|Couples|couples
474934|NCT01121692|Alcohol use|alcohol use
474935|NCT01121692|HIV risk|hiv risk
474936|NCT01121692|Outreach|outreach
474937|NCT01121679|Older patients|older patients
474938|NCT01121679|Aged, 80 and Over|aged, 80 and over
474939|NCT01121679|Cardiology|cardiology
474940|NCT01121666|Assisted reproductive treatment|assisted reproductive treatment
474941|NCT01121666|Superovulation|superovulation
474942|NCT01121666|Follitropin alfa|follitropin alfa
474943|NCT01121666|r-hFSH|r-hfsh
474944|NCT01121666|AFOLIA|afolia
474945|NCT01121653|Neuropathic pain, magnesium|neuropathic pain, magnesium
474946|NCT01121640|Ovarian Cancer|ovarian cancer
474947|NCT01121640|Screening|screening
474948|NCT01121640|Biomarkers|biomarkers
474949|NCT01121627|Computerized Cognitive training|computerized cognitive training
474950|NCT01121627|Quality of life|quality of life
474951|NCT01121627|Gait Function|gait function
474952|NCT01121627|Executive Function|executive function
474953|NCT01121614|Harmonic scalpel|harmonic scalpel
474954|NCT01121614|ultrasonic scalpel|ultrasonic scalpel
474955|NCT01121614|LOTUS|lotus
474956|NCT01121614|LigaSure|ligasure
474957|NCT01121614|vessel sealing|vessel sealing
474958|NCT01121614|burst pressure|burst pressure
474959|NCT01121614|collateral damage|collateral damage
474960|NCT01121588|neoplasm malignant|neoplasm malignant
474961|NCT01121588|lymphoma|lymphoma
474962|NCT01121588|neuroblastoma|neuroblastoma
474963|NCT01121588|Crizotinib|crizotinib
474964|NCT01121588|anaplastic lymphoma kinase|anaplastic lymphoma kinase
474965|NCT01121588|ALK|alk
474966|NCT01121575|Phase 1 acquired resistance to erlotinib or gefitinib cMET inhibitor EGFR inhibitor panHER inhibitor combination trial Crizotinib|phase 1 acquired resistance to erlotinib or gefitinib cmet inhibitor egfr inhibitor panher inhibitor combination trial crizotinib
474967|NCT01121562|Neuroendocrine tumors|neuroendocrine tumors
474968|NCT01121549|Prospective|prospective
474969|NCT01121549|non-comparative|non-comparative
474970|NCT01121549|NIS|nis
474971|NCT01121549|600|600
474972|NCT01121549|postmenopausal|postmenopausal
474973|NCT01121549|hormone-receptor|hormone-receptor
474974|NCT01121549|positive|positive
474975|NCT01121549|EBC|ebc
474976|NCT01121549|tamoxifen|tamoxifen
474977|NCT01121549|current medical practice.|current medical practice.
474978|NCT01121536|Bipolar I Disorder|bipolar i disorder
474979|NCT01121523|Prematurity|prematurity
474980|NCT01121523|massage|massage
474981|NCT01121523|stress|stress
474982|NCT01121523|parenting|parenting
474983|NCT01121523|infancy|infancy
474984|NCT01121523|sleep|sleep
474985|NCT01121523|intervention|intervention
474986|NCT01121510|vascular closure device|vascular closure device
474987|NCT01121497|Sedation|sedation
474988|NCT01121497|Cognitive decline|cognitive decline
474989|NCT01121497|Physostigmine|physostigmine
474990|NCT01121497|Colonoscopy|colonoscopy
474991|NCT01121471|diabetes|diabetes
474992|NCT01121471|conjugated linoleic acid|conjugated linoleic acid
474993|NCT01121458|pulmonary artery|pulmonary artery
474994|NCT01121458|vascular resistance|vascular resistance
474995|NCT01121445|Sleep apnea|sleep apnea
474996|NCT01121445|CPAP|cpap
474997|NCT01121445|Saline irrigation|saline irrigation
474998|NCT01121419|Neuroblastoma|neuroblastoma
474999|NCT01121419|IMP3|imp3
475000|NCT01121419|Prognosis|prognosis
475001|NCT01121380|Healthy|healthy
475002|NCT01121380|Volunteers|volunteers
475003|NCT01121367|emphysema; pulmonary fibrosis;chemokine;sputum|emphysema; pulmonary fibrosis;chemokine;sputum
475004|NCT01121354|Cefazolin|cefazolin
475005|NCT01121354|Caphalosporin|caphalosporin
475006|NCT01121354|antibiotic|antibiotic
475007|NCT01121354|gram positive|gram positive
475008|NCT01121354|Infection control|infection control
475009|NCT01121341|Endoscopic vein harvesting|endoscopic vein harvesting
475010|NCT01121341|Saphenous vein|saphenous vein
475011|NCT01121341|Conventional vein harvesting|conventional vein harvesting
475012|NCT01121328|Preterm neonates.|preterm neonates.
475013|NCT01121328|Autologous cord blood transfusion.|autologous cord blood transfusion.
475014|NCT01121315|Epidemiological|epidemiological
475015|NCT01121315|Diabetes|diabetes
475016|NCT01121315|Glucose Lowering Drug Treatment in Primary care|glucose lowering drug treatment in primary care
475017|NCT01121315|CVD|cvd
475018|NCT01121302|AZD5213|azd5213
475019|NCT01121302|Phase 1|phase 1
475020|NCT01121302|Safety|safety
475021|NCT01121263|coronary arteriosclerosis|coronary arteriosclerosis
475022|NCT01121263|coronary heart disease|coronary heart disease
475023|NCT01121263|coronary artery bypass|coronary artery bypass
475723|NCT01118312|ACRC|acrc
475024|NCT01121263|coronary artery bypass, off-pump|coronary artery bypass, off-pump
475025|NCT01121263|coronary angiography|coronary angiography
475026|NCT01121263|drug-eluting stents|drug-eluting stents
475027|NCT01121250|Combat disorders|combat disorders
475028|NCT01121250|Spouses|spouses
475029|NCT01121250|Support|support
475030|NCT01121250|Military personnel|military personnel
475031|NCT01121237|chronic kidney disease|chronic kidney disease
475032|NCT01121237|end-stage renal disease|end-stage renal disease
475033|NCT01121237|renal anaemia|renal anaemia
475034|NCT01121237|epoetin alfa|epoetin alfa
475035|NCT01121224|Saphenous vein graft|saphenous vein graft
475036|NCT01121224|Percutaneous coronary intervention|percutaneous coronary intervention
475037|NCT01121224|Stents|stents
475038|NCT01121211|Testosterone|testosterone
475039|NCT01121211|Hormones|hormones
475040|NCT01121211|Mental Health|mental health
475041|NCT01121198|Food effect|food effect
475042|NCT01121185|Hepatitis C virus (HCV)|hepatitis c virus (hcv)
475043|NCT01121185|Liver transplantation|liver transplantation
475044|NCT01121185|Human Monoclonal Antibody|human monoclonal antibody
475045|NCT01121146|Osteolysis|osteolysis
475046|NCT01121146|Polyethylene|polyethylene
475047|NCT01121146|Crosslinked Polyethylene|crosslinked polyethylene
475048|NCT01121146|Total Hip Replacement|total hip replacement
475049|NCT01121146|CT|ct
475050|NCT01121120|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
475051|NCT01121120|Hodgkin Disease|hodgkin disease
475052|NCT01121120|Multiple myeloma|multiple myeloma
475053|NCT01121120|Peripheral Blood Stem Cell Transplant|peripheral blood stem cell transplant
475054|NCT01121120|Autologous Peripheral Blood Stem Cell Transplant|autologous peripheral blood stem cell transplant
475055|NCT01121120|Limited re-infusion of CD34+ cells|limited re-infusion of cd34+ cells
475056|NCT01121107|Heart Failure|heart failure
475057|NCT01121107|Decompensated Heart Failure|decompensated heart failure
475058|NCT01121107|Acute Decompensated Heart Failure|acute decompensated heart failure
475059|NCT01121107|Hemodynamic Monitoring|hemodynamic monitoring
475060|NCT01121107|Implantable Pressure Monitor|implantable pressure monitor
475061|NCT01121107|Left Atrial Pressure Monitoring|left atrial pressure monitoring
475062|NCT01121094|Liver, spleen , T2* , MRI, fetus|liver, spleen , t2* , mri, fetus
475063|NCT01121081|Male or female subjects|male or female subjects
475064|NCT01121081|≥18 to ≤75 years of age|≥18 to ≤75 years of age
475065|NCT01121081|who have a diagnosis of plaque or guttate psoriasis|who have a diagnosis of plaque or guttate psoriasis
475066|NCT01121068|IGRA|igra
475067|NCT01121068|variability|variability
475068|NCT01121068|Long-term variability of IGRA|long-term variability of igra
475069|NCT01121055|Fiberoptic Bronchoscopy|fiberoptic bronchoscopy
475070|NCT01121055|Patient|patient
475071|NCT01121055|Satisfaction|satisfaction
475072|NCT01121055|Lorazepam|lorazepam
475073|NCT01121016|NAEB, chronic cough, montelukast, induced sputum|naeb, chronic cough, montelukast, induced sputum
475074|NCT01121003|Fructose|fructose
475075|NCT01121003|VLDL-triglycerides|vldl-triglycerides
475076|NCT01121003|de novo lipogenesis|de novo lipogenesis
475077|NCT01121003|Human metabolism|human metabolism
475078|NCT01120990|Blood pressure measuring devices|blood pressure measuring devices
475079|NCT01120990|Essential Hypertension|essential hypertension
475080|NCT01120990|Automated blood pressure measurement|automated blood pressure measurement
475081|NCT01120951|Respiratory rate R8 Anaxsys|respiratory rate r8 anaxsys
475082|NCT01120938|AIrways, Patency, Infant death|airways, patency, infant death
475083|NCT01120925|Cirrhotic|cirrhotic
475084|NCT01120925|Stem Cells|stem cells
475085|NCT01120925|Bone marrow stem cells|bone marrow stem cells
475086|NCT01120925|Decompensate Cirrhotic Patients|decompensate cirrhotic patients
475087|NCT01120912|oral insulin|oral insulin
475088|NCT01120899|Diabetic Macular Edema|diabetic macular edema
475089|NCT01120899|Microglia|microglia
475090|NCT01120899|Minocycline|minocycline
475091|NCT01120899|Diabetes|diabetes
475092|NCT01120886|Ion channelopathy,|ion channelopathy,
475093|NCT01120886|Still birth|still birth
475094|NCT01120886|Sudden death|sudden death
475095|NCT01120873|Hyperglycemia|hyperglycemia
475096|NCT01120873|dyslipidemia|dyslipidemia
475097|NCT01120873|Hypertension|hypertension
475098|NCT01120873|Obesity|obesity
475099|NCT01120860|Cognitive Aging|cognitive aging
475100|NCT01120860|Apolipoproteins E|apolipoproteins e
475101|NCT01120860|Magnetic Resonance Imaging|magnetic resonance imaging
475102|NCT01120834|diffuse large b cell lymphoma|diffuse large b cell lymphoma
475104|NCT01120769|Myocardial Infarction|myocardial infarction
475105|NCT01120769|Percutaneous Coronary Intervention|percutaneous coronary intervention
475106|NCT01120769|Acetaminophen|acetaminophen
475107|NCT01120769|Lipid Peroxidation|lipid peroxidation
475108|NCT01120756|executive dysfunction|executive dysfunction
475109|NCT01120756|brain injury|brain injury
475110|NCT01120756|attention|attention
475111|NCT01120756|rehabilitation|rehabilitation
475112|NCT01120756|fMRI|fmri
475113|NCT01120743|liver failure|liver failure
475114|NCT01120743|cytokines|cytokines
475115|NCT01120743|hemodynamic instability|hemodynamic instability
475116|NCT01120717|QVA149|qva149
475117|NCT01120717|COPD|copd
475118|NCT01120717|combination bronchodilator|combination bronchodilator
475120|NCT01120704|Smoking Cessation|smoking cessation
475121|NCT01120704|Adherence|adherence
475122|NCT01120704|Nicotine|nicotine
475123|NCT01120704|Motivation|motivation
475124|NCT01120691|QVA149|qva149
475125|NCT01120691|NVA237|nva237
475126|NCT01120691|COPD|copd
475127|NCT01120691|exacerbation|exacerbation
475128|NCT01120691|combination bronchodilator|combination bronchodilator
475129|NCT01120678|cytokines|cytokines
475130|NCT01120678|late-onset neonatal sepsis|late-onset neonatal sepsis
475131|NCT01120678|neonatal sepsis|neonatal sepsis
475132|NCT01120678|diagnosis of sepsis|diagnosis of sepsis
475133|NCT01120678|bacteremia|bacteremia
475134|NCT01120678|blood culture|blood culture
475135|NCT01120678|clinical sepsis|clinical sepsis
475136|NCT01120665|women's health|women's health
475137|NCT01120665|hormone replacement therapy|hormone replacement therapy
475138|NCT01120665|exercise|exercise
475139|NCT01120613|Nocturnal Hypertension|nocturnal hypertension
475140|NCT01120613|Nondipping|nondipping
475141|NCT01120613|Renal Transplant|renal transplant
475142|NCT01120613|Chronotherapy|chronotherapy
475143|NCT01120587|Deglutition|deglutition
475144|NCT01120587|Fluoroscopy|fluoroscopy
475145|NCT01120574|Nocturnal hypercapnic response to oxygen|nocturnal hypercapnic response to oxygen
475146|NCT01120574|Home mechanical ventilation|home mechanical ventilation
475147|NCT01120574|COPD|copd
475148|NCT01120561|TDM-1 EAP|tdm-1 eap
475149|NCT01120561|T-DM1 EAP|t-dm1 eap
475150|NCT01120561|TDM1 EAP|tdm1 eap
475151|NCT01120561|Trastuzumab-MCC-DM1 EAP|trastuzumab-mcc-dm1 eap
475152|NCT01120561|Trastuzumab emtansine|trastuzumab emtansine
475153|NCT01120561|EAP|eap
475154|NCT01120561|T-PAS|t-pas
475155|NCT01120548|CARDIAC REHABILITATION|cardiac rehabilitation
475156|NCT01120548|Nocturnal Ventilation|nocturnal ventilation
475157|NCT01120548|Apnea hypopnea index is > 15/h|apnea hypopnea index is > 15/h
475158|NCT01120535|Vena Cava|vena cava
475159|NCT01120535|Vena Cava Filter|vena cava filter
475160|NCT01120535|Pulmonary Embolism|pulmonary embolism
475161|NCT01120535|Venous Thromboembolism|venous thromboembolism
475162|NCT01120535|Risk of Pulmonary Embolism|risk of pulmonary embolism
475163|NCT01120522|Vena Cava|vena cava
475164|NCT01120522|Vena Cava Filter|vena cava filter
475165|NCT01120522|Pulmonary Embolism|pulmonary embolism
475166|NCT01120522|Venous Thromboembolism|venous thromboembolism
475167|NCT01120522|Risk of Pulmonary Embolism|risk of pulmonary embolism
475168|NCT01120509|Vena Cava|vena cava
475169|NCT01120509|Vena Cava Filter|vena cava filter
475170|NCT01120509|Pulmonary Embolism|pulmonary embolism
475171|NCT01120509|Venous Thromboembolism|venous thromboembolism
475172|NCT01120509|Risk of Pulmonary Embolism|risk of pulmonary embolism
475173|NCT01120496|Hypertonic saline solution, bronchiolitis, RSV|hypertonic saline solution, bronchiolitis, rsv
475174|NCT01120483|mortality|mortality
475175|NCT01120483|functional status|functional status
475176|NCT01120470|Castration Resistant|castration resistant
475177|NCT01120470|Prostate Cancer|prostate cancer
475178|NCT01120470|OGX-427|ogx-427
475179|NCT01120444|Diabetes|diabetes
475180|NCT01120444|Insulin|insulin
475181|NCT01120444|Blood Glucose|blood glucose
475182|NCT01120431|dehydration|dehydration
475183|NCT01120431|fluid therapy|fluid therapy
475184|NCT01120431|hyaluronoglucosaminidase|hyaluronoglucosaminidase
475185|NCT01120431|hyaluronidase|hyaluronidase
475186|NCT01120431|hypodermoclysis|hypodermoclysis
475187|NCT01120431|clysis|clysis
475188|NCT01120431|subcutaneous hydration|subcutaneous hydration
475189|NCT01120431|subcutaneous rehydration|subcutaneous rehydration
475190|NCT01120431|hyaluronan|hyaluronan
475191|NCT01120431|rHuPH20|rhuph20
475192|NCT01120431|pediatric|pediatric
475193|NCT01120431|ORT|ort
475194|NCT01120418|Endothelial cell density|endothelial cell density
475195|NCT01120418|screening|screening
475196|NCT01120405|Xenon|xenon
475197|NCT01120405|Cardiac safety|cardiac safety
475198|NCT01120405|Cardiovascular risk|cardiovascular risk
475199|NCT01120405|Non cardiac surgery|non cardiac surgery
475200|NCT01120405|Atherosclerotic vascular surgery|atherosclerotic vascular surgery
475201|NCT01120392|Parkinson's disease|parkinson's disease
475202|NCT01120392|Physical therapy|physical therapy
475203|NCT01120392|Virtual Reality|virtual reality
475204|NCT01120392|Quality of life|quality of life
475205|NCT01120392|Motor performance|motor performance
475206|NCT01120379|drug eluting stents|drug eluting stents
475207|NCT01120379|Stents|stents
475208|NCT01120379|Angioplasty|angioplasty
475209|NCT01120379|Stent thrombosis|stent thrombosis
475210|NCT01120353|Childhood cancer|childhood cancer
475211|NCT01120353|Young Children|young children
475212|NCT01120353|Adults|adults
475213|NCT01120301|stroke|stroke
475214|NCT01120288|Anti-Angiogenesis|anti-angiogenesis
475215|NCT01120288|Targeted Therapy|targeted therapy
475216|NCT01120288|HIF|hif
475217|NCT01120288|Antisense|antisense
475218|NCT01120288|VEGF|vegf
475219|NCT01120288|Cancer|cancer
475220|NCT01120288|Solid Tumor|solid tumor
475221|NCT01120288|Liver Metastasis|liver metastasis
475222|NCT01120262|recurrent prostate cancer|recurrent prostate cancer
475223|NCT01120262|stage IV prostate cancer|stage iv prostate cancer
475224|NCT01120249|stage I renal cell cancer|stage i renal cell cancer
475225|NCT01120249|stage II renal cell cancer|stage ii renal cell cancer
475226|NCT01120249|stage III renal cell cancer|stage iii renal cell cancer
475227|NCT01120249|clear cell renal cell carcinoma|clear cell renal cell carcinoma
475228|NCT01120249|papillary renal cell carcinoma|papillary renal cell carcinoma
475229|NCT01120210|Heart Failure|heart failure
475230|NCT01120210|Cardiac Failure|cardiac failure
475231|NCT01120197|randomized controlled trial|randomized controlled trial
475232|NCT01120197|osteoporosis|osteoporosis
475233|NCT01120197|moderate-intensity circuit exercises|moderate-intensity circuit exercises
475234|NCT01120197|balance|balance
475235|NCT01120197|health-related quality of life|health-related quality of life
475236|NCT01120171|Breast cancer|breast cancer
475237|NCT01120171|Elderly|elderly
475238|NCT01120171|Chemotherapy|chemotherapy
475239|NCT01120171|Cardiotoxicity|cardiotoxicity
475240|NCT01120158|Breast cancer|breast cancer
475241|NCT01120158|Elderly|elderly
475242|NCT01120158|Chemotherapy|chemotherapy
475243|NCT01120158|Anti-angiogenesis therapy|anti-angiogenesis therapy
475244|NCT01120145|Malaria|malaria
475245|NCT01120145|Pregnancy|pregnancy
475246|NCT01120145|Sulphadoxine-pyrimethamine|sulphadoxine-pyrimethamine
475247|NCT01120106|levosimendan|levosimendan
475248|NCT01120106|pediatric cardiac surgery|pediatric cardiac surgery
475249|NCT01120106|low cardiac output syndrome|low cardiac output syndrome
475250|NCT01120106|transposition of the great arteries|transposition of the great arteries
475251|NCT01120093|COPD|copd
475252|NCT01120080|Smoking|smoking
475253|NCT01120080|Tobacco|tobacco
475254|NCT01120080|Drinking|drinking
475255|NCT01120067|Psychology|psychology
475256|NCT01120067|Pain|pain
475257|NCT01120067|Veterans|veterans
475258|NCT01120067|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
475259|NCT01120054|Traumatic Brain Injury|traumatic brain injury
475260|NCT01120054|Homelessness|homelessness
475261|NCT01120015|OA|oa
475262|NCT01120015|knee|knee
475263|NCT01120002|mild to moderate Alzheimer's Disease|mild to moderate alzheimer's disease
475264|NCT01119989|hepatic fat content|hepatic fat content
475265|NCT01119989|hepatic de novo lipogenesis|hepatic de novo lipogenesis
475266|NCT01119963|Preterm delivery|preterm delivery
475267|NCT01119950|COPD|copd
475268|NCT01119937|COPD|copd
475269|NCT01119937|NVA237|nva237
475270|NCT01119924|Mirtazapine|mirtazapine
475271|NCT01119924|Smilon|smilon
475272|NCT01119924|Depression|depression
475273|NCT01119924|Pain|pain
475274|NCT01119911|Blood sampling|blood sampling
475275|NCT01119911|Venipuncture|venipuncture
475276|NCT01119911|Peripheral venous catheter|peripheral venous catheter
475277|NCT01119911|Complete blood count|complete blood count
475278|NCT01119911|Basic chemistry|basic chemistry
475279|NCT01119911|Hemolysis|hemolysis
475280|NCT01119911|Peripheral venous catheter replaces venipuncture.|peripheral venous catheter replaces venipuncture.
475281|NCT01119911|Peripheral venous catheter blood sampling reduces pain.|peripheral venous catheter blood sampling reduces pain.
475282|NCT01119898|Osteoarthritis|osteoarthritis
475283|NCT01119898|Arthritis|arthritis
475284|NCT01119898|NSAIDs|nsaids
475285|NCT01119898|Topical NSAID|topical nsaid
475286|NCT01119898|Diclofenac|diclofenac
475287|NCT01119898|PENNSAID|pennsaid
475288|NCT01119885|chronic pain|chronic pain
475289|NCT01119885|fentanyl matrix|fentanyl matrix
475290|NCT01119885|arthritis|arthritis
475291|NCT01119885|osteoarthritis|osteoarthritis
475292|NCT01119872|Positive-Pressure Respiration|positive-pressure respiration
475293|NCT01119872|Respiration, Artificial|respiration, artificial
475294|NCT01119846|Tolerability|tolerability
475295|NCT01119846|Pharmacokinetics|pharmacokinetics
475296|NCT01119846|Safety|safety
475297|NCT01119846|Pharmacodynamics|pharmacodynamics
475298|NCT01119846|Glucose|glucose
475299|NCT01119833|Sickle Cell Disease|sickle cell disease
475300|NCT01119820|elective obstetric or gynecologic surgery|elective obstetric or gynecologic surgery
475301|NCT01119807|Intraosseous infusion|intraosseous infusion
475302|NCT01119807|Emergency Medical Services|emergency medical services
475303|NCT01119794|B-cell small lymphocytic lymphoma|b-cell small lymphocytic lymphoma
475304|NCT01119794|marginal zone lymphoma|marginal zone lymphoma
475305|NCT01119794|follicular lymphoma|follicular lymphoma
475306|NCT01119794|mantle cell lymphoma|mantle cell lymphoma
475307|NCT01119794|Waldenström macroglobulinemia.|waldenström macroglobulinemia.
475308|NCT01119794|Low Grade B cell Non-Hodgkins Lymphoma|low grade b cell non-hodgkins lymphoma
475309|NCT01119768|GI|gi
475310|NCT01119768|Nexium|nexium
475311|NCT01119768|Phase IV|phase iv
475312|NCT01119768|Co-diagnosed NERD|co-diagnosed nerd
475313|NCT01119755|TREATMENT OF HYPERTENSION|treatment of hypertension
475314|NCT01119742|Tinea Pedis|tinea pedis
475315|NCT01119742|Interdigital|interdigital
475316|NCT01119729|Cardiac Diseases • HIV-Infection • AIDS • Antiretroviral Therapy|cardiac diseases • hiv-infection • aids • antiretroviral therapy
475317|NCT01119716|Atrial Fibrillation|atrial fibrillation
475318|NCT01119716|Afib|afib
475319|NCT01119716|cardioversion|cardioversion
475320|NCT01119716|normal sinus rhythm|normal sinus rhythm
475321|NCT01119716|arrhythmia|arrhythmia
475322|NCT01119716|AF|af
475323|NCT01119703|Vaccine Hyporesponse|vaccine hyporesponse
475324|NCT01119690|Dietary|dietary
475325|NCT01119690|Cross-Over Study|cross-over study
475326|NCT01119690|Lipids|lipids
475327|NCT01119690|Rapeseed oil|rapeseed oil
475328|NCT01119690|Butter|butter
475329|NCT01119690|Milk Fat|milk fat
475330|NCT01119690|Unsaturated Fat|unsaturated fat
475331|NCT01119690|Saturated Fat|saturated fat
475332|NCT01119690|Oxidized LDL|oxidized ldl
475333|NCT01119690|Platelet Function|platelet function
475334|NCT01119690|Arterial Elasticity|arterial elasticity
475335|NCT01119664|Adult subjects with malignant pleural mesothelioma who present for first (front) line or second line chemotherapy,|adult subjects with malignant pleural mesothelioma who present for first (front) line or second line chemotherapy,
475336|NCT01119651|Healthy Volunteer Subjects|healthy volunteer subjects
475337|NCT01119638|Alzheimer's disease|alzheimer's disease
475338|NCT01119638|BPSD|bpsd
475339|NCT01119638|escitalopram|escitalopram
475340|NCT01119638|Risperidone|risperidone
475341|NCT01119638|Agitation|agitation
475342|NCT01119638|Psychosis|psychosis
475343|NCT01119638|Dementia|dementia
475344|NCT01119638|Elderly|elderly
475345|NCT01119625|safety|safety
475346|NCT01119625|Streptococcus pneumoniae|streptococcus pneumoniae
475347|NCT01119625|immunogenicity|immunogenicity
475348|NCT01119625|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
475349|NCT01119625|Haemophilus influenzae|haemophilus influenzae
475350|NCT01119612|Malaria|malaria
475351|NCT01119612|Iron|iron
475352|NCT01119612|Pregnancy|pregnancy
475353|NCT01119612|Anemia|anemia
475354|NCT01119612|Birth Weight|birth weight
475355|NCT01119586|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
475356|NCT01119586|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
475357|NCT01119586|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
475358|NCT01119586|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
475359|NCT01119573|stage I endometrial carcinoma|stage i endometrial carcinoma
475360|NCT01119573|stage III endometrial carcinoma|stage iii endometrial carcinoma
475361|NCT01119547|Musculoskeletal Diseases|musculoskeletal diseases
475362|NCT01119547|Osteoarthritis|osteoarthritis
475363|NCT01119547|Joint Diseases|joint diseases
475364|NCT01119547|Arthritis|arthritis
475365|NCT01119547|Rheumatic Diseases|rheumatic diseases
475366|NCT01119534|Cough treatment|cough treatment
475367|NCT01119521|South Africa,tuberculosis,vaccine|south africa,tuberculosis,vaccine
475368|NCT01119508|Advanced|advanced
475369|NCT01119508|Inoperable|inoperable
475370|NCT01119508|Melanoma|melanoma
475371|NCT01119508|Ipilimumab|ipilimumab
475372|NCT01119508|MDX010|mdx010
475373|NCT01119508|BMS-734016|bms-734016
475374|NCT01119508|Temozolomide|temozolomide
475375|NCT01119508|Temodar|temodar
475376|NCT01119508|TMZ|tmz
475377|NCT01119508|skin|skin
475378|NCT01119508|mucosal|mucosal
475379|NCT01119482|Serogroup A meningococcal vaccine|serogroup a meningococcal vaccine
475380|NCT01119482|meningococcal carriage|meningococcal carriage
475381|NCT01119482|incidence|incidence
475382|NCT01119482|prevalence|prevalence
475383|NCT01119469|Hypochondriasis|hypochondriasis
475384|NCT01119469|Health Anxiety|health anxiety
475385|NCT01119469|randomized controlled trial|randomized controlled trial
475386|NCT01119469|Cognitive Therapy|cognitive therapy
475387|NCT01119469|Exposure Therapy|exposure therapy
475388|NCT01119456|Tumors|tumors
475389|NCT01119456|Macrophage stimulating 1 receptor, human|macrophage stimulating 1 receptor, human
475390|NCT01119456|RON protein|ron protein
475391|NCT01119456|RON receptor protein tyrosine kinase|ron receptor protein tyrosine kinase
475392|NCT01119430|major depression|major depression
475393|NCT01119430|DU 125530|du 125530
475394|NCT01119430|Treatment depression|treatment depression
475395|NCT01119430|Latency antidepressant|latency antidepressant
475396|NCT01119417|supine Hypertension|supine hypertension
475397|NCT01119417|autonomic failure|autonomic failure
475398|NCT01119417|BQ123|bq123
475399|NCT01119417|BQ-123|bq-123
475400|NCT01119417|endothelin|endothelin
475401|NCT01119404|Metabolic Syndrome|metabolic syndrome
475402|NCT01119404|Coronary Heart Disease|coronary heart disease
475403|NCT01119404|Erectile Dysfunction|erectile dysfunction
475404|NCT01119404|Arterial Elasticity|arterial elasticity
475405|NCT01119404|Oxidized Low Density Lipoprotein|oxidized low density lipoprotein
475406|NCT01119404|Cardiovascular Diseases|cardiovascular diseases
475407|NCT01119404|Risk Assessment|risk assessment
475408|NCT01119404|Endothelial Dysfunction|endothelial dysfunction
475409|NCT01119404|Diabetes Mellitus|diabetes mellitus
475410|NCT01119404|Surrogate Markers|surrogate markers
475411|NCT01119404|Risk Factors|risk factors
475412|NCT01119391|IVF|ivf
475413|NCT01119391|Lifestyle habits|lifestyle habits
475414|NCT01119378|Post menopausal|post menopausal
475415|NCT01119378|Vitamin D sufficiency|vitamin d sufficiency
475416|NCT01119378|Calcium absorption efficiency|calcium absorption efficiency
475724|NCT01118312|STAN|stan
475417|NCT01119378|Dual isotope technique|dual isotope technique
475418|NCT01119365|Healthy controls|healthy controls
475419|NCT01119352|Safety|safety
475420|NCT01119352|tolerability|tolerability
475421|NCT01119352|PK|pk
475422|NCT01119352|healthy|healthy
475423|NCT01119352|overweight|overweight
475424|NCT01119352|obese|obese
475425|NCT01119339|psoriasis|psoriasis
475426|NCT01119339|topical|topical
475427|NCT01119339|psoriasis plaques test|psoriasis plaques test
475428|NCT01119326|scar prevention|scar prevention
475429|NCT01119326|healing|healing
475430|NCT01119326|tissue|tissue
475431|NCT01119326|AFT|aft
475432|NCT01119326|scar analysis|scar analysis
475433|NCT01119300|Venous Thromboembolism (VTE)|venous thromboembolism (vte)
475434|NCT01119300|Atrial Fibrillation (AF)|atrial fibrillation (af)
475435|NCT01119287|Conjunctivitis|conjunctivitis
475436|NCT01119287|ocular allergy|ocular allergy
475437|NCT01119261|Venous thromboembolism (VTE)|venous thromboembolism (vte)
475438|NCT01119261|Atrial fibrillation (AF)|atrial fibrillation (af)
475439|NCT01119248|Children MRI General Anesthesia|children mri general anesthesia
475440|NCT01119235|Pharmacokinetics|pharmacokinetics
475441|NCT01119235|tablet performance|tablet performance
475442|NCT01119235|healthy volunteers|healthy volunteers
475443|NCT01119235|open label|open label
475444|NCT01119222|Cold pain methodology|cold pain methodology
475445|NCT01119222|Healthy male volunteers|healthy male volunteers
475446|NCT01119222|gabapentin|gabapentin
475447|NCT01119222|Diphenhydramine|diphenhydramine
475448|NCT01119222|morphine|morphine
475449|NCT01119209|Hip fracture|hip fracture
475450|NCT01119209|intertrochanteric|intertrochanteric
475451|NCT01119196|Peritoneal Dialysis|peritoneal dialysis
475452|NCT01119196|Insulin resistance|insulin resistance
475453|NCT01119183|Patient understanding and counseling|patient understanding and counseling
475454|NCT01119170|nutrition|nutrition
475455|NCT01119170|infant formula|infant formula
475456|NCT01119170|probiotics|probiotics
475457|NCT01119157|influenza vaccine|influenza vaccine
475458|NCT01119157|cellular immune response|cellular immune response
475459|NCT01119157|humoral immune response|humoral immune response
475460|NCT01119144|Orbital|orbital
475461|NCT01119144|fractures|fractures
475462|NCT01119144|enophthalmos|enophthalmos
475463|NCT01119144|diplopia|diplopia
475465|NCT01119131|Vitamin D|vitamin d
475466|NCT01119131|Parkinson disease|parkinson disease
475467|NCT01119131|accidental falls|accidental falls
475468|NCT01119118|Metastatic|metastatic
475469|NCT01119118|castrate-resistant prostate cancer|castrate-resistant prostate cancer
475470|NCT01119118|bone metastasis|bone metastasis
475471|NCT01119105|acute bacterial skin and skin structure infection|acute bacterial skin and skin structure infection
475472|NCT01119105|bacteria|bacteria
475473|NCT01119092|Ankle Sprain|ankle sprain
475474|NCT01119092|Joint Mobilization|joint mobilization
475475|NCT01119092|Manual Therapy|manual therapy
475476|NCT01119092|Range of Motion|range of motion
475477|NCT01119079|labor pain|labor pain
475478|NCT01119079|epidural|epidural
475479|NCT01119066|Leukemia|leukemia
475480|NCT01119066|Multiple Myeloma|multiple myeloma
475481|NCT01119066|radiation|radiation
475482|NCT01119066|Thiotepa|thiotepa
475483|NCT01119066|cyclophosphamide|cyclophosphamide
475484|NCT01119066|fludarabine|fludarabine
475485|NCT01119066|Clofarabine|clofarabine
475486|NCT01119066|CliniMACS device|clinimacs device
475487|NCT01119066|GCSF|gcsf
475488|NCT01119066|10-050|10-050
475489|NCT01119053|VNS|vns
475490|NCT01119053|Depression|depression
475491|NCT01119053|Personality-Disorder|personality-disorder
475492|NCT01119053|Stimulation|stimulation
475493|NCT01119040|Dislodged PEG tube|dislodged peg tube
475494|NCT01119040|NOTES|notes
475495|NCT01119027|Laparoscopic Colectomy|laparoscopic colectomy
475496|NCT01119027|Colorectal Skills Training|colorectal skills training
475497|NCT01119014|Aripiprazole|aripiprazole
475498|NCT01119014|Quetiapine|quetiapine
475499|NCT01119014|Psychosis|psychosis
475500|NCT01119014|Child|child
475501|NCT01119014|Adolescent|adolescent
475502|NCT01118988|Peer Support|peer support
475503|NCT01118988|Social Support|social support
475504|NCT01118988|Chronic Pain|chronic pain
475505|NCT01118988|Behavioral Interventions for Pain|behavioral interventions for pain
475506|NCT01118988|Adolescents|adolescents
475507|NCT01118988|Children|children
475508|NCT01118988|Pediatric|pediatric
475509|NCT01118988|Mentorship|mentorship
475510|NCT01118988|Complementary and Alternative Medicine|complementary and alternative medicine
475511|NCT01118988|CAM|cam
475512|NCT01118988|Pain|pain
475513|NCT01118988|Pain Management|pain management
475514|NCT01118988|Behavioral|behavioral
475515|NCT01118975|lapatinib ditosylate|lapatinib ditosylate
475516|NCT01118975|Zolinza (vorinostat)|zolinza (vorinostat)
475517|NCT01118975|Cancer Stem Cells|cancer stem cells
475518|NCT01118962|Primary Generalized Tonic-Clonic (PGTC) Seizures|primary generalized tonic-clonic (pgtc) seizures
475519|NCT01118962|Absence Seizures|absence seizures
475520|NCT01118962|Myoclonic Seizures|myoclonic seizures
475521|NCT01118962|Idiopathic Generalized Epilepsy (IGE)|idiopathic generalized epilepsy (ige)
475522|NCT01118949|Primary Generalized Tonic-Clonic (PGTC) Seizures|primary generalized tonic-clonic (pgtc) seizures
475523|NCT01118949|Absence Seizures|absence seizures
475524|NCT01118949|Myoclonic Seizures|myoclonic seizures
475525|NCT01118949|Idiopathic Generalized Epilepsy (IGE)|idiopathic generalized epilepsy (ige)
475526|NCT01118936|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
475527|NCT01118936|Daily magnesium supplement|daily magnesium supplement
475528|NCT01118936|EQ-5D|eq-5d
475529|NCT01118923|Bronchial challenge test|bronchial challenge test
475530|NCT01118923|Hyperreactivity|hyperreactivity
475531|NCT01118923|PD20 for metacholine|pd20 for metacholine
475532|NCT01118923|Daily magnesium supplement|daily magnesium supplement
475533|NCT01118910|Intertrigo|intertrigo
475534|NCT01118910|Vusion|vusion
475535|NCT01118897|Gall bladder|gall bladder
475536|NCT01118897|Pancreatic cancers|pancreatic cancers
475537|NCT01118897|Tomotherapy|tomotherapy
475538|NCT01118884|Midazolam|midazolam
475539|NCT01118884|Nitrous oxide|nitrous oxide
475540|NCT01118884|Behaviour management|behaviour management
475541|NCT01118871|Treatment experienced|treatment experienced
475542|NCT01118858|CYP2D6|cyp2d6
475543|NCT01118858|CYP3A4|cyp3a4
475544|NCT01118858|cytochrome P450|cytochrome p450
475545|NCT01118858|children|children
475546|NCT01118858|pediatrics|pediatrics
475547|NCT01118858|dextromethorphan|dextromethorphan
475548|NCT01118858|phenotype|phenotype
475549|NCT01118858|genotype|genotype
475550|NCT01118845|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
475551|NCT01118845|Lymphoma, Large B-Cell|lymphoma, large b-cell
475552|NCT01118845|Diffuse, Mantle cell lymphoma, Lymphoma|diffuse, mantle cell lymphoma, lymphoma
475553|NCT01118845|Follicular, Lymphoma|follicular, lymphoma
475554|NCT01118845|Large B-Cell, Diffuse|large b-cell, diffuse
475555|NCT01118832|Thermography|thermography
475556|NCT01118819|Phase I|phase i
475557|NCT01118819|Metastatic Disease|metastatic disease
475558|NCT01118819|Solid Tumor|solid tumor
475559|NCT01118819|Malignancy|malignancy
475560|NCT01118819|Metastases|metastases
475561|NCT01118819|Clinical trial|clinical trial
475562|NCT01118819|Hypoxia|hypoxia
475563|NCT01118819|Necrosis|necrosis
475564|NCT01118780|GAD|gad
475565|NCT01118780|Generalized Anxiety Disorder|generalized anxiety disorder
475566|NCT01118780|Anxiety|anxiety
475567|NCT01118767|Adherence|adherence
475568|NCT01118767|Appointment|appointment
475569|NCT01118767|Cell Phone|cell phone
475570|NCT01118767|Cellular Phone|cellular phone
475571|NCT01118767|Clinic|clinic
475572|NCT01118767|Computers|computers
475573|NCT01118767|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
475574|NCT01118767|HIV/AIDS|hiv/aids
475575|NCT01118767|Health Informatics|health informatics
475576|NCT01118767|Health behavior|health behavior
475577|NCT01118767|Information Technology|information technology
475578|NCT01118767|Internet|internet
475579|NCT01118767|Intervention|intervention
475580|NCT01118767|Medication|medication
475581|NCT01118767|Patient Satisfaction|patient satisfaction
475582|NCT01118767|Patient Self-Report|patient self-report
475583|NCT01118767|Patients|patients
475584|NCT01118767|Peru|peru
475585|NCT01118767|Phone|phone
475586|NCT01118767|Public Health|public health
475587|NCT01118767|Public Health Informatics|public health informatics
475588|NCT01118767|Randomized|randomized
475589|NCT01118767|Randomized Controlled Clinical Trials|randomized controlled clinical trials
475590|NCT01118767|Randomized Controlled Trials|randomized controlled trials
475591|NCT01118767|Research|research
475592|NCT01118767|Secondary Prevention|secondary prevention
475593|NCT01118767|Self-Report|self-report
475594|NCT01118767|Sex Behavior|sex behavior
475595|NCT01118767|Sexual Behavior|sexual behavior
475596|NCT01118767|Sexually Transmitted Diseases|sexually transmitted diseases
475597|NCT01118767|Sexually Transmitted Infection|sexually transmitted infection
475598|NCT01118767|Survey Instrument|survey instrument
475599|NCT01118767|Surveys|surveys
475600|NCT01118767|Telephone|telephone
475601|NCT01118767|Telephone, Cellular|telephone, cellular
475602|NCT01118767|Text|text
475603|NCT01118767|Unprotected Sex|unprotected sex
475604|NCT01118767|Viral Load result|viral load result
475605|NCT01118767|Vulnerable Populations|vulnerable populations
475606|NCT01118767|WWW|www
475607|NCT01118767|anti-retroviral therapy|anti-retroviral therapy
475608|NCT01118767|consumer informatics|consumer informatics
475609|NCT01118767|evidence base|evidence base
475610|NCT01118767|follow-up|follow-up
475611|NCT01118767|medication adherence|medication adherence
475612|NCT01118767|medication compliance|medication compliance
475613|NCT01118767|randomization|randomization
475614|NCT01118767|randomized controlled study|randomized controlled study
475615|NCT01118767|randomized trial|randomized trial
475616|NCT01118767|randomly assigned|randomly assigned
475617|NCT01118767|safer sex|safer sex
475618|NCT01118767|treatment adherence|treatment adherence
475619|NCT01118767|user centered design|user centered design
475620|NCT01118767|web|web
475621|NCT01118767|world wide web|world wide web
475622|NCT01118754|Santen|santen
475623|NCT01118754|Dry|dry
475624|NCT01118754|Eye|eye
475625|NCT01118741|Rising PSA|rising psa
475626|NCT01118741|Recurrent Non Metastatic Prostate Cancer|recurrent non metastatic prostate cancer
475627|NCT01118715|distal radius fracture|distal radius fracture
475628|NCT01118715|post-traumatic carpal tunnel syndrome|post-traumatic carpal tunnel syndrome
475629|NCT01118715|complex regional pain syndrome|complex regional pain syndrome
475630|NCT01118715|compression glove|compression glove
475631|NCT01118715|edema glove|edema glove
475632|NCT01118702|Pharmacokinetic|pharmacokinetic
475633|NCT01118702|Methylphenidate|methylphenidate
475634|NCT01118702|Novo-methylphenidate ER-C|novo-methylphenidate er-c
475635|NCT01118702|Ritalin-SR|ritalin-sr
475636|NCT01118702|CONCERTA|concerta
475637|NCT01118702|Plasma profile|plasma profile
475638|NCT01118676|locally advanced non small cell lung cancer (NSCLC), locally advanced, Phase I, Cilengitide, concomitant radiochemotherapy|locally advanced non small cell lung cancer (nsclc), locally advanced, phase i, cilengitide, concomitant radiochemotherapy
475639|NCT01118663|Acetaminophen overdose; induced hepatotoxicity, liver injury|acetaminophen overdose; induced hepatotoxicity, liver injury
475640|NCT01118650|Inattention|inattention
475641|NCT01118650|Hyperactivity|hyperactivity
475642|NCT01118650|Impulsivity|impulsivity
475643|NCT01118637|trichotillomania|trichotillomania
475644|NCT01118637|self-help|self-help
475645|NCT01118637|web-based|web-based
475646|NCT01118637|habit reversal|habit reversal
475647|NCT01118637|behavior therapy|behavior therapy
475648|NCT01118624|Female|female
475649|NCT01118624|Advanced|advanced
475650|NCT01118624|Metastatic|metastatic
475651|NCT01118611|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
475652|NCT01118598|PCOS|pcos
475653|NCT01118585|GERD|gerd
475654|NCT01118585|Esophagitis|esophagitis
475655|NCT01118585|Fundoplication|fundoplication
475656|NCT01118585|Anti-reflux surgery|anti-reflux surgery
475657|NCT01118585|PPI dependent|ppi dependent
475658|NCT01118572|Celecoxib|celecoxib
475659|NCT01118572|Celecox|celecox
475660|NCT01118572|Pain|pain
475661|NCT01118572|Surgery|surgery
475662|NCT01118572|NSAIDs|nsaids
475663|NCT01118559|YM150|ym150
475664|NCT01118559|Food effect|food effect
475665|NCT01118559|Healthy volunteer|healthy volunteer
475666|NCT01118546|aspirin|aspirin
475667|NCT01118546|coronary artery disease|coronary artery disease
475668|NCT01118546|hypersensitivity|hypersensitivity
475669|NCT01118546|Platelet aggregation|platelet aggregation
475670|NCT01118533|Intubation|intubation
475671|NCT01118533|Sore throat|sore throat
475672|NCT01118533|Blades|blades
475673|NCT01118533|Laryngoscopy|laryngoscopy
475674|NCT01118533|Morbidity|morbidity
475675|NCT01118520|abdominal aortic aneurysm|abdominal aortic aneurysm
475676|NCT01118520|ACE Inhibition|ace inhibition
475677|NCT01118507|Trisomy of chromosome 21 diagnosis|trisomy of chromosome 21 diagnosis
475678|NCT01118507|first trimester of pregnancy|first trimester of pregnancy
475679|NCT01118507|maternal blood|maternal blood
475680|NCT01118507|High output shotgun sequencing|high output shotgun sequencing
475681|NCT01118494|CKD|ckd
475682|NCT01118494|RAS|ras
475683|NCT01118494|AGT|agt
475684|NCT01118481|Coronary stenosis|coronary stenosis
475685|NCT01118481|Wave intensity analysis|wave intensity analysis
475686|NCT01118481|Instantaneous Flow Reserve|instantaneous flow reserve
475687|NCT01118481|iFR|ifr
475688|NCT01118481|Fractional Flow Reserve|fractional flow reserve
475689|NCT01118468|Competitive Flow|competitive flow
475690|NCT01118468|Coronary artery bypass|coronary artery bypass
475691|NCT01118468|Wave Intensity Analysis|wave intensity analysis
475692|NCT01118442|Aortic Stenosis|aortic stenosis
475693|NCT01118442|Coronary Flow|coronary flow
475694|NCT01118442|Wave Intensity Analysis|wave intensity analysis
475695|NCT01118429|hyperhidrosis|hyperhidrosis
475696|NCT01118429|axillary|axillary
475697|NCT01118429|osmidrosis|osmidrosis
475698|NCT01118429|oxybutynin|oxybutynin
475699|NCT01118416|sexual risk|sexual risk
475700|NCT01118416|substance use|substance use
475701|NCT01118416|HIV|hiv
475702|NCT01118416|prevention|prevention
475703|NCT01118416|intervention|intervention
475704|NCT01118416|Motivational Enhancement Therapy|motivational enhancement therapy
475705|NCT01118416|young men who have sex with men|young men who have sex with men
475706|NCT01118403|Ventilator associated pneumonia|ventilator associated pneumonia
475707|NCT01118403|Coma|coma
475708|NCT01118403|Brain Injuries|brain injuries
475709|NCT01118403|Intensive care units|intensive care units
475710|NCT01118403|antibiotic prophylaxis|antibiotic prophylaxis
475711|NCT01118390|telangiectasias|telangiectasias
475712|NCT01118390|leg|leg
475713|NCT01118390|sclerotherapy|sclerotherapy
475714|NCT01118390|laser|laser
475715|NCT01118390|glycose|glycose
475716|NCT01118364|Social circumstances|social circumstances
475717|NCT01118325|Stable Coronary Artery Disease|stable coronary artery disease
475718|NCT01118325|Platelet Aggregation|platelet aggregation
475719|NCT01118312|Asthma|asthma
475720|NCT01118312|Rhinitis|rhinitis
475721|NCT01118312|Sinusitis|sinusitis
475725|NCT01118312|Nasal steroid|nasal steroid
475726|NCT01118312|Mometasone|mometasone
475727|NCT01118312|Nasal spray|nasal spray
475728|NCT01118286|Hypertension|hypertension
475729|NCT01118286|Drug therapy, combination|drug therapy, combination
475730|NCT01118273|Naproxen sodium|naproxen sodium
475731|NCT01118273|Diphenhydramine|diphenhydramine
475732|NCT01118273|Drugs, Investigational|drugs, investigational
475733|NCT01118260|prostata hyperplasia|prostata hyperplasia
475734|NCT01118260|transurethral resection|transurethral resection
475735|NCT01118260|TIVA|tiva
475736|NCT01118260|spinal anaesthesia|spinal anaesthesia
475737|NCT01118247|Uncemented THA|uncemented tha
475738|NCT01118247|alumina-on-alumina|alumina-on-alumina
475739|NCT01118247|survival|survival
475740|NCT01118247|HHS|hhs
475741|NCT01118247|Patient satisfaction|patient satisfaction
475742|NCT01118234|CLL|cll
475743|NCT01118234|Rituximab|rituximab
475744|NCT01118234|Maintenance|maintenance
475745|NCT01118221|oxidant stress|oxidant stress
475746|NCT01118221|exercise|exercise
475747|NCT01118208|Medication adherence|medication adherence
475748|NCT01118208|Accidental overdose|accidental overdose
475749|NCT01118208|Deliberate overdose|deliberate overdose
475750|NCT01118208|Suicide, attempted|suicide, attempted
475751|NCT01118182|Traumatic Brain Injury|traumatic brain injury
475752|NCT01118182|Veterans|veterans
475753|NCT01118182|Psychiatric Disorders|psychiatric disorders
475754|NCT01118182|Suicide|suicide
475755|NCT01118169|Personal values|personal values
475756|NCT01118169|Suicidal thoughts|suicidal thoughts
475757|NCT01118156|Suicide Nomenclature|suicide nomenclature
475758|NCT01118130|Genetics|genetics
475759|NCT01118130|genomics|genomics
475760|NCT01118130|Multiple Sclerosis|multiple sclerosis
475761|NCT01118130|beta-interferons|beta-interferons
475762|NCT01118117|atherosclerotic stenosis|atherosclerotic stenosis
475763|NCT01118117|occlusions|occlusions
475764|NCT01118117|Superficial Femoral Artery|superficial femoral artery
475765|NCT01118117|SFA|sfa
475766|NCT01118091|Immunotherapy|immunotherapy
475767|NCT01118091|Metastatic Melanoma|metastatic melanoma
475768|NCT01118091|Randomized|randomized
475769|NCT01118091|Cell Therapy|cell therapy
475770|NCT01118091|Skin Cancer|skin cancer
475771|NCT01118091|Melanoma|melanoma
475772|NCT01118065|anaplastic thyroid cancer|anaplastic thyroid cancer
475773|NCT01118065|recurrent thyroid cancer|recurrent thyroid cancer
475774|NCT01118065|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
475775|NCT01118065|stage III papillary thyroid cancer|stage iii papillary thyroid cancer
475776|NCT01118065|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
475777|NCT01118065|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
475778|NCT01118065|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
475779|NCT01118039|localized transitional cell cancer of the renal pelvis and ureter|localized transitional cell cancer of the renal pelvis and ureter
475780|NCT01118039|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
475781|NCT01118039|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
475782|NCT01118039|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
475783|NCT01118039|distal urethral cancer|distal urethral cancer
475784|NCT01118039|proximal urethral cancer|proximal urethral cancer
475785|NCT01118039|recurrent urethral cancer|recurrent urethral cancer
475786|NCT01118039|recurrent bladder cancer|recurrent bladder cancer
475787|NCT01118039|stage IV bladder cancer|stage iv bladder cancer
475788|NCT01118039|stage III bladder cancer|stage iii bladder cancer
475789|NCT01118039|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
475790|NCT01118039|stage III urethral cancer|stage iii urethral cancer
475791|NCT01118039|stage IV urethral cancer|stage iv urethral cancer
475792|NCT01118026|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
475793|NCT01118026|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
475794|NCT01118026|adult favorable prognosis Hodgkin lymphoma|adult favorable prognosis hodgkin lymphoma
475795|NCT01118026|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
475796|NCT01118026|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
475797|NCT01118026|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
475798|NCT01118026|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
475799|NCT01118026|adult unfavorable prognosis Hodgkin lymphoma|adult unfavorable prognosis hodgkin lymphoma
475800|NCT01118013|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
475801|NCT01118013|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
475802|NCT01118013|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
475803|NCT01118013|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
475804|NCT01118013|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
475805|NCT01118013|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
475806|NCT01118013|prolymphocytic leukemia|prolymphocytic leukemia
475807|NCT01118013|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
475808|NCT01118013|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
475809|NCT01118013|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
475810|NCT01118013|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
475811|NCT01118013|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
475812|NCT01118013|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
475813|NCT01118013|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
475814|NCT01118013|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
475815|NCT01118013|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
475816|NCT01118013|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
475817|NCT01118013|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
475818|NCT01118013|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
475819|NCT01118013|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
475820|NCT01118013|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
475821|NCT01118013|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
475822|NCT01118013|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
475823|NCT01118013|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
475824|NCT01118013|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
475825|NCT01118013|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
475826|NCT01118013|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
475827|NCT01118013|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
475828|NCT01118013|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
475829|NCT01118013|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
475830|NCT01118013|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
475831|NCT01118013|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
475832|NCT01118013|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
475833|NCT01118013|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
475834|NCT01118013|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
475835|NCT01118013|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
475836|NCT01118013|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
475837|NCT01118013|stage I multiple myeloma|stage i multiple myeloma
475838|NCT01118013|stage II multiple myeloma|stage ii multiple myeloma
475839|NCT01118013|stage III multiple myeloma|stage iii multiple myeloma
475840|NCT01118013|refractory multiple myeloma|refractory multiple myeloma
475841|NCT01118013|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
475842|NCT01118013|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
475843|NCT01118013|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
475844|NCT01118013|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
475845|NCT01118013|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
475846|NCT01118013|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
475847|NCT01118013|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
475848|NCT01118013|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
475849|NCT01118013|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
475850|NCT01118013|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
475851|NCT01118013|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
475852|NCT01118013|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
475853|NCT01118013|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
475854|NCT01118013|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
475855|NCT01118013|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
475856|NCT01118013|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
475857|NCT01118013|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
475858|NCT01118013|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
475859|NCT01118013|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
475860|NCT01118013|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
475861|NCT01118013|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
475862|NCT01118013|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
475863|NCT01118013|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
475864|NCT01118013|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
475865|NCT01118013|childhood Burkitt lymphoma|childhood burkitt lymphoma
475866|NCT01118013|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
475867|NCT01118013|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
475868|NCT01118013|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
475968|NCT01117558|CVD|cvd
475969|NCT01117545|veterans,|veterans,
475869|NCT01118013|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
475870|NCT01118013|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
475871|NCT01118013|splenic marginal zone lymphoma|splenic marginal zone lymphoma
475872|NCT01118013|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
475873|NCT01118000|ischemic preconditioning,serum proteins,human|ischemic preconditioning,serum proteins,human
475874|NCT01117987|Pulmonary arterial hypertension, imatinib, 6MWD, pulmonary hypertension|pulmonary arterial hypertension, imatinib, 6mwd, pulmonary hypertension
475875|NCT01117961|Excessive gestational weight gain|excessive gestational weight gain
475876|NCT01117935|IMRT|imrt
475877|NCT01117935|prostate cancer|prostate cancer
475878|NCT01117935|radiation therapy|radiation therapy
475879|NCT01117935|external beam|external beam
475880|NCT01117935|recurrent prostate cancer|recurrent prostate cancer
475881|NCT01117922|preterm birth|preterm birth
475882|NCT01117922|interconceptional intervention|interconceptional intervention
475883|NCT01117922|pregnancy outcomes|pregnancy outcomes
475884|NCT01117909|ankle sprain|ankle sprain
475885|NCT01117909|athletic injury|athletic injury
475886|NCT01117909|arthritis|arthritis
475887|NCT01117896|CPR|cpr
475888|NCT01117896|Rescuer fatigue|rescuer fatigue
475889|NCT01117896|Chest Compression effectiveness|chest compression effectiveness
475890|NCT01117883|Perfusion pressures|perfusion pressures
475891|NCT01117883|central venous pressure|central venous pressure
475892|NCT01117883|cardiac output|cardiac output
475893|NCT01117883|CPR|cpr
475894|NCT01117883|cardiac arrest|cardiac arrest
475895|NCT01117883|Leaning|leaning
475896|NCT01117883|incomplete release|incomplete release
475897|NCT01117870|chronic|chronic
475898|NCT01117870|pain|pain
475899|NCT01117870|lumbar|lumbar
475900|NCT01117870|Radicular|radicular
475901|NCT01117831|Diabetes mellitus|diabetes mellitus
475902|NCT01117805|Asthma|asthma
475903|NCT01117779|kidney tumors|kidney tumors
475904|NCT01117779|renal tumors|renal tumors
475905|NCT01117779|renal cell carcinoma|renal cell carcinoma
475906|NCT01117779|kidney lesions|kidney lesions
475907|NCT01117779|renal lesions|renal lesions
475908|NCT01117779|cryoablation|cryoablation
475909|NCT01117779|cryotherapy|cryotherapy
475910|NCT01117779|cryosurgery|cryosurgery
475911|NCT01117766|Methodology|methodology
475912|NCT01117766|Quantitative Sensory Testing|quantitative sensory testing
475913|NCT01117766|Neuropathies Pain|neuropathies pain
475914|NCT01117766|Pregabalin|pregabalin
475915|NCT01117740|Malignant Pleural Effusions|malignant pleural effusions
475917|NCT01117740|Lungs|lungs
475918|NCT01117740|Quality of Life|quality of life
475919|NCT01117740|M. D. Anderson Symptom Inventory|m. d. anderson symptom inventory
475920|NCT01117740|MDASI|mdasi
475921|NCT01117740|Indwelling Pleural Catheters|indwelling pleural catheters
475922|NCT01117740|Thoracoscopic Pleurodesis|thoracoscopic pleurodesis
475923|NCT01117740|Symptom burden|symptom burden
475924|NCT01117740|Pleurodesis efficacy|pleurodesis efficacy
475925|NCT01117740|Complications|complications
475926|NCT01117740|Health care resource utilization|health care resource utilization
475927|NCT01117714|Lung cancer|lung cancer
475928|NCT01117714|Lung neoplasm|lung neoplasm
475929|NCT01117714|Pulmonary cancer|pulmonary cancer
475930|NCT01117714|Pulmonary neoplasm|pulmonary neoplasm
475931|NCT01117714|Lung cancer staging|lung cancer staging
475932|NCT01117688|Ureteroscopy|ureteroscopy
475933|NCT01117675|Telemedicine|telemedicine
475934|NCT01117675|Home care|home care
475935|NCT01117675|Chronic HIV infection|chronic hiv infection
475936|NCT01117675|HIV-infected patients|hiv-infected patients
475937|NCT01117662|transplantation|transplantation
475938|NCT01117662|acute rejection|acute rejection
475939|NCT01117662|kidney|kidney
475940|NCT01117649|PVR|pvr
475941|NCT01117649|HES 130|hes 130
475942|NCT01117649|pancreatic head|pancreatic head
475943|NCT01117649|goal-directed|goal-directed
475944|NCT01117649|intraoperative PVR in elective surgery of the pancreatic head|intraoperative pvr in elective surgery of the pancreatic head
475945|NCT01117636|Aspirin|aspirin
475946|NCT01117623|Oncology patients with advanced disease|oncology patients with advanced disease
475947|NCT01117623|BAY73-4506|bay73-4506
475948|NCT01117610|pain|pain
475949|NCT01117610|preemptive|preemptive
475950|NCT01117610|postoperative|postoperative
475951|NCT01117610|epidural injection|epidural injection
475952|NCT01117610|laminectomy|laminectomy
475953|NCT01117597|Healthy subjects|healthy subjects
475954|NCT01117584|Type 2 diabetes|type 2 diabetes
475955|NCT01117584|ASP1941|asp1941
475956|NCT01117584|diabetes|diabetes
475957|NCT01117584|metformin|metformin
475958|NCT01117571|knee|knee
475959|NCT01117571|osteoarthritis|osteoarthritis
475960|NCT01117571|unicompartmental|unicompartmental
475961|NCT01117571|arthroplasty|arthroplasty
475962|NCT01117571|knee resurfacing|knee resurfacing
475963|NCT01117571|Conformis|conformis
475964|NCT01117571|patient specific|patient specific
475965|NCT01117558|PCOS,|pcos,
475966|NCT01117558|DM,|dm,
475967|NCT01117558|Hypertension,|hypertension,
475970|NCT01117545|PTSD,|ptsd,
475971|NCT01117545|EFT (Emotional Freedom Techniques),|eft (emotional freedom techniques),
475972|NCT01117545|depression,|depression,
475973|NCT01117545|anxiety|anxiety
475974|NCT01117532|students,|students,
475975|NCT01117532|depression,|depression,
475976|NCT01117532|group therapy,|group therapy,
475977|NCT01117532|EFT (Emotional Freedom Techniques),|eft (emotional freedom techniques),
475978|NCT01117532|energy psychology|energy psychology
475979|NCT01117519|fluid and volume management|fluid and volume management
475980|NCT01117519|acid-base balance|acid-base balance
475981|NCT01117519|goal-directed therapy|goal-directed therapy
475982|NCT01117519|transoesophageal doppler|transoesophageal doppler
475983|NCT01117506|Angina Pectoris|angina pectoris
475984|NCT01117506|Myocardial Ischemia|myocardial ischemia
475985|NCT01117506|Molecular Genetics|molecular genetics
475986|NCT01117506|Atherosclerosis|atherosclerosis
475987|NCT01117506|Corus CAD|corus cad
475988|NCT01117506|ASGES|asges
475989|NCT01117506|Age/Sex/Gene Expression Score|age/sex/gene expression score
475990|NCT01117506|Gene Expression|gene expression
475991|NCT01117506|GES|ges
475992|NCT01117506|CAD|cad
475993|NCT01117506|CVD|cvd
475994|NCT01117506|CHD|chd
475995|NCT01117506|Precision Medicine|precision medicine
475996|NCT01117506|Clinical Validity|clinical validity
475997|NCT01117506|Myocardial Perfusion Imaging|myocardial perfusion imaging
475998|NCT01117506|Coronary Artery Disease|coronary artery disease
475999|NCT01117506|Chest Pain|chest pain
476000|NCT01117506|Cardiovascular Disease|cardiovascular disease
476001|NCT01117506|Coronary Heart Disease|coronary heart disease
476002|NCT01117506|MPI|mpi
476003|NCT01117506|COMPASS|compass
476004|NCT01117480|Moderate Rheumatoid Arthritis|moderate rheumatoid arthritis
476005|NCT01117480|Rheumatoid Arthritis|rheumatoid arthritis
476006|NCT01117480|Severe Rheumatoid Arthritis|severe rheumatoid arthritis
476007|NCT01117480|Adalimumab|adalimumab
476008|NCT01117480|Clinical Effectiveness|clinical effectiveness
476009|NCT01117467|Simulation|simulation
476010|NCT01117467|Learning|learning
476011|NCT01117467|Medical Students|medical students
476012|NCT01117467|Empathy|empathy
476013|NCT01117467|Anxiety|anxiety
476014|NCT01117454|Catecholaminergic Polymorphic Ventricular Tachycardia|catecholaminergic polymorphic ventricular tachycardia
476015|NCT01117454|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
476016|NCT01117454|flecainide|flecainide
476017|NCT01117428|Advanced solid tumors|advanced solid tumors
476018|NCT01117428|Metastatic colorectal Cancer|metastatic colorectal cancer
476019|NCT01117415|Gall Bladder|gall bladder
476020|NCT01117415|Cholecystectomy|cholecystectomy
476021|NCT01117402|recurrent carcinoma cervix|recurrent carcinoma cervix
476022|NCT01117402|Vault carcinoma|vault carcinoma
476023|NCT01117402|Tomotherapy|tomotherapy
476024|NCT01117402|Brachytherapy|brachytherapy
476025|NCT01117389|Human Papillomavirus Vaccination|human papillomavirus vaccination
476026|NCT01117389|Childhood cancer survivors|childhood cancer survivors
476027|NCT01117389|cervical cancer|cervical cancer
476028|NCT01117389|sexually transmitted infection|sexually transmitted infection
476029|NCT01117376|Gastroparesis|gastroparesis
476030|NCT01117376|Erythromycin|erythromycin
476031|NCT01117376|Methylnaltrexone|methylnaltrexone
476032|NCT01117376|ICU|icu
476033|NCT01117363|Appetite whole grain|appetite whole grain
476034|NCT01117337|Hernia, laparoscopic, recurrence, pain, inguinal|hernia, laparoscopic, recurrence, pain, inguinal
476035|NCT01117324|Bone density|bone density
476036|NCT01117324|infant of diabetic mother|infant of diabetic mother
476037|NCT01117324|large birth weight|large birth weight
476038|NCT01117311|Vagus|vagus
476039|NCT01117311|Diabetes|diabetes
476040|NCT01117311|Obesity|obesity
476041|NCT01117298|Raynaud's phenomenon|raynaud's phenomenon
476042|NCT01117298|ischemic ulcers|ischemic ulcers
476043|NCT01117298|digital ulcers|digital ulcers
476044|NCT01117298|digital infarcts|digital infarcts
476045|NCT01117298|gangrene|gangrene
476046|NCT01117298|vasodilators|vasodilators
476047|NCT01117298|endothelial dysfunction|endothelial dysfunction
476048|NCT01117298|scleroderma|scleroderma
476049|NCT01117285|Occupational Therapy|occupational therapy
476050|NCT01117285|Evidence-Based Practice|evidence-based practice
476051|NCT01117285|Continuing Education|continuing education
476052|NCT01117285|utilization|utilization
476053|NCT01117285|Guideline|guideline
476054|NCT01117285|Dementia|dementia
476055|NCT01117285|Guideline implementation|guideline implementation
476056|NCT01117272|PCOS|pcos
476057|NCT01117272|hyperprolactinemia|hyperprolactinemia
476058|NCT01117272|obesity|obesity
476059|NCT01117272|hyperandrogenic|hyperandrogenic
476060|NCT01117246|bone metastasis|bone metastasis
476061|NCT01117246|pain palliation|pain palliation
476062|NCT01117233|Healthy volunteers|healthy volunteers
476063|NCT01117233|PK|pk
476064|NCT01117233|PD|pd
476065|NCT01117233|safety and toleration|safety and toleration
476066|NCT01117220|pediatric|pediatric
476067|NCT01117220|bipolar|bipolar
476068|NCT01117181|Alzheimer's disease|alzheimer's disease
476069|NCT01117181|Apathy|apathy
476070|NCT01117181|Methylphenidate|methylphenidate
476071|NCT01117181|Dopaminergic agents|dopaminergic agents
476072|NCT01117181|Apathy Evaluation Scale|apathy evaluation scale
476073|NCT01117181|Dementia|dementia
476074|NCT01117168|Children's Oncology Group|children's oncology group
476075|NCT01117168|Pediatric Oncology|pediatric oncology
476076|NCT01117168|Pediatric Cancer|pediatric cancer
476077|NCT01117168|Registration|registration
476078|NCT01117168|Leukemia|leukemia
476079|NCT01117168|Brain Tumor|brain tumor
476080|NCT01117168|Sarcoma|sarcoma
476081|NCT01117155|Brain Tumor|brain tumor
476082|NCT01117155|Imaging|imaging
476083|NCT01117155|FLT|flt
476084|NCT01117155|FDG|fdg
476085|NCT01117155|Spectroscopy|spectroscopy
476086|NCT01117155|Glioma|glioma
476087|NCT01117155|Glioblastoma Multiforme|glioblastoma multiforme
476088|NCT01117155|Astrocytoma|astrocytoma
476089|NCT01117142|CLL|cll
476090|NCT01117142|MBL|mbl
476091|NCT01117142|SLL|sll
476092|NCT01117142|MCL|mcl
476093|NCT01117142|Growth|growth
476094|NCT01117142|Development|development
476095|NCT01117142|Aging|aging
476096|NCT01117142|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
476097|NCT01117142|Monoclonal B-Cell Lymphocytosis|monoclonal b-cell lymphocytosis
476098|NCT01117142|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
476099|NCT01117142|Mantle Cell Lymphoma|mantle cell lymphoma
476100|NCT01117142|Healthy Volunteer|healthy volunteer
476101|NCT01117142|HV|hv
476102|NCT01117103|Type 2 diabetes|type 2 diabetes
476103|NCT01117103|Diabetes Mellitus|diabetes mellitus
476104|NCT01117103|Glucophage|glucophage
476105|NCT01117103|Metformin|metformin
476106|NCT01117090|Feasibility|feasibility
476107|NCT01117090|SynchroMed II|synchromed ii
476108|NCT01117090|Intrathecal catheter|intrathecal catheter
476109|NCT01117090|Baclofen|baclofen
476110|NCT01117077|liver transplantation|liver transplantation
476111|NCT01117077|aspergillus infection|aspergillus infection
476112|NCT01117077|interleukin-17|interleukin-17
476113|NCT01117077|Treg cell|treg cell
476114|NCT01117077|immune tolerance|immune tolerance
476115|NCT01117064|Sleep Apnea|sleep apnea
476116|NCT01117064|OSA|osa
476117|NCT01117064|CPAP|cpap
476118|NCT01117051|Opioid induced constipation/prucalopride chronic non-cancer pain|opioid induced constipation/prucalopride chronic non-cancer pain
476119|NCT01117051|Subjects with chronic non-cancer pain suffering from OIC|subjects with chronic non-cancer pain suffering from oic
476120|NCT01117038|ED|ed
476121|NCT01117038|Erectile Dysfunction|erectile dysfunction
476122|NCT01117025|Resistant hypertension|resistant hypertension
476123|NCT01117025|Atrial Fibrillation|atrial fibrillation
476124|NCT01117025|Percutaneous renal denervation|percutaneous renal denervation
476125|NCT01116986|Smoking|smoking
476126|NCT01116986|Smoking Cessation|smoking cessation
476127|NCT01116986|Nicotine|nicotine
476128|NCT01116973|CVP monitoring compared with peripheral monitoring|cvp monitoring compared with peripheral monitoring
476129|NCT01116960|P4P|p4p
476130|NCT01116947|Hypoalbuminemia|hypoalbuminemia
476131|NCT01116947|Hyperphosphatemia|hyperphosphatemia
476132|NCT01116947|Phosphorus|phosphorus
476133|NCT01116947|Protein|protein
476134|NCT01116947|CKD|ckd
476135|NCT01116947|Dialysis|dialysis
476136|NCT01116947|Meals|meals
476137|NCT01116947|Lanthanum|lanthanum
476138|NCT01116947|End-Stage Renal Disease (ESRD)|end-stage renal disease (esrd)
476139|NCT01116947|Dietary Protein Intake (DPI)|dietary protein intake (dpi)
476140|NCT01116947|Dietary Phosphorus Binding (DPB)|dietary phosphorus binding (dpb)
476141|NCT01116947|Protein-Energy Wasting (PEW)|protein-energy wasting (pew)
476142|NCT01116947|Sources of Dietary Phosphorus|sources of dietary phosphorus
476143|NCT01116934|blood culture, IL-1β, IL-6, IL-8, IP-10, interferon-gamma|blood culture, il-1β, il-6, il-8, ip-10, interferon-gamma
476144|NCT01116921|laryngeal mask airway|laryngeal mask airway
476145|NCT01116921|surfactant|surfactant
476146|NCT01116921|respiratory distress syndrome|respiratory distress syndrome
476147|NCT01116921|neonate|neonate
476148|NCT01116908|Diarrhea|diarrhea
476149|NCT01116908|Water|water
476150|NCT01116908|Household Water Treatment|household water treatment
476151|NCT01116908|HIV|hiv
476152|NCT01116908|Infant Health|infant health
476153|NCT01116895|Psoriasis Vulgaris|psoriasis vulgaris
476154|NCT01116895|Systemic|systemic
476155|NCT01116895|Anti-psoriatic|anti-psoriatic
476156|NCT01116882|PCI|pci
476157|NCT01116882|heart disease|heart disease
476158|NCT01116882|ischemic heart disease|ischemic heart disease
476159|NCT01116869|MBC|mbc
476160|NCT01116869|Healthy|healthy
476161|NCT01116869|Benign disease|benign disease
476162|NCT01116869|Confirmed metastatic breast cancer patient with at least one measurable solid tumor according to the RECIST guideline|confirmed metastatic breast cancer patient with at least one measurable solid tumor according to the recist guideline
476163|NCT01116869|Medical examinations detect no breast benign and malignant tumors|medical examinations detect no breast benign and malignant tumors
476164|NCT01116869|Benign Breast Disease|benign breast disease
476165|NCT01116869|Pathology diagnosed breast benign tumor disease|pathology diagnosed breast benign tumor disease
476166|NCT01116856|Exercise|exercise
476167|NCT01116856|Training|training
476168|NCT01116856|Obesity|obesity
476169|NCT01116856|Overweight|overweight
476170|NCT01116856|Body composition|body composition
476171|NCT01116856|Lipidic profile|lipidic profile
476172|NCT01116856|Nutrition|nutrition
476173|NCT01116856|Polymorphisms|polymorphisms
476174|NCT01116843|Oral cavity cancer|oral cavity cancer
476175|NCT01116843|No prior treatment|no prior treatment
476176|NCT01116817|Long-term Lopinavir/ritonavir monotherapy|long-term lopinavir/ritonavir monotherapy
476177|NCT01116817|neurocognitive performance|neurocognitive performance
476178|NCT01116817|ultrasensitive CSF-viraemia|ultrasensitive csf-viraemia
476179|NCT01116804|Primary liver cancer|primary liver cancer
476180|NCT01116791|cytoreductive surgery|cytoreductive surgery
476181|NCT01116791|peritoneal chemotherapy|peritoneal chemotherapy
476182|NCT01116791|cisplatin|cisplatin
476183|NCT01116791|cancer|cancer
476184|NCT01116791|gastric|gastric
476185|NCT01116791|biliary|biliary
476186|NCT01116791|pancreas|pancreas
476187|NCT01116791|peritoneal metastases|peritoneal metastases
476188|NCT01116791|liver metastases|liver metastases
476189|NCT01116791|peritoneal carcinomatosis from upper gastrointestinal cancer|peritoneal carcinomatosis from upper gastrointestinal cancer
476190|NCT01116778|perennial allergic rhinitis|perennial allergic rhinitis
476191|NCT01116778|probiotics|probiotics
476192|NCT01116778|Lactobacillus paracasei GMNL-32 (eN-Lac®)|lactobacillus paracasei gmnl-32 (en-lac®)
476193|NCT01116778|efficacy and safety|efficacy and safety
476194|NCT01116765|preterm infants born between 26 to 29 weeks of gestation age.|preterm infants born between 26 to 29 weeks of gestation age.
476195|NCT01116752|Intensive Care|intensive care
476196|NCT01116752|Critical care|critical care
476197|NCT01116752|Glycemic Control|glycemic control
476198|NCT01116752|Hypoglycemia|hypoglycemia
476199|NCT01116752|Hyperglycemia|hyperglycemia
476200|NCT01116752|Insulin treatment|insulin treatment
476201|NCT01116752|Organ Function|organ function
476202|NCT01116752|PELOD|pelod
476203|NCT01116752|Outcomes|outcomes
476204|NCT01116752|Pediatrics|pediatrics
476205|NCT01116713|Mastectomy|mastectomy
476206|NCT01116713|Breast cancer|breast cancer
476207|NCT01116713|Postoperative pain|postoperative pain
476208|NCT01116713|Postoperative nausea and vomiting|postoperative nausea and vomiting
476209|NCT01116700|Epilepsy|epilepsy
476210|NCT01116700|Dexmedetomidine|dexmedetomidine
476211|NCT01116700|Seizure|seizure
476212|NCT01116674|Intensive critical care, glycemic control, hypoglycemia, hyperglycemia , insulin treatment, intensive care outcomes, pediatrics|intensive critical care, glycemic control, hypoglycemia, hyperglycemia , insulin treatment, intensive care outcomes, pediatrics
476213|NCT01116661|glioma|glioma
476214|NCT01116661|high grade glioma, low grade glioma|high grade glioma, low grade glioma
476215|NCT01116635|chemoembolization|chemoembolization
476216|NCT01116635|drug eluting microsphere|drug eluting microsphere
476217|NCT01116635|hepato|hepato
476218|NCT01116635|embolotherapy|embolotherapy
476219|NCT01116635|downstage|downstage
476220|NCT01116622|Aerodigestive|aerodigestive
476221|NCT01116622|Targretin|targretin
476222|NCT01116622|Tarceva|tarceva
476223|NCT01116609|Phenylalanine|phenylalanine
476224|NCT01116609|Palmitate|palmitate
476225|NCT01116609|hyperinsulinemic-euglycemic-clamp|hyperinsulinemic-euglycemic-clamp
476226|NCT01116609|Effects of epinephrine in healthy volunteers|effects of epinephrine in healthy volunteers
476227|NCT01116596|Glutathione|glutathione
476228|NCT01116596|Paracetamol|paracetamol
476229|NCT01116596|elderly people|elderly people
476230|NCT01116583|Gabapentin|gabapentin
476231|NCT01116583|Thoracotomy|thoracotomy
476232|NCT01116583|Pain, Postoperative|pain, postoperative
476233|NCT01116583|Analgesia|analgesia
476234|NCT01116583|Recovery of Function|recovery of function
476235|NCT01116583|Quality of Life|quality of life
476236|NCT01116570|Muscular Dystrophy|muscular dystrophy
476237|NCT01116570|Facioscapulohumeral|facioscapulohumeral
476238|NCT01116570|Physical training|physical training
476239|NCT01116570|Exercise|exercise
476240|NCT01116557|radiofrequency|radiofrequency
476241|NCT01116557|ablation|ablation
476242|NCT01116557|atrial fibrillation|atrial fibrillation
476243|NCT01116557|CARTO|carto
476244|NCT01116557|THERMOCOOL|thermocool
476245|NCT01116557|LASSO|lasso
476246|NCT01116557|PVAC|pvac
476247|NCT01116544|AMES device|ames device
476248|NCT01116544|Cerebrovascular Accident|cerebrovascular accident
476249|NCT01116544|Chronic Stroke|chronic stroke
476250|NCT01116544|Rehabilitation|rehabilitation
476251|NCT01116544|Upper Extremity|upper extremity
476252|NCT01116544|Biofeedback|biofeedback
476253|NCT01116531|Pharmacokinetics|pharmacokinetics
476254|NCT01116531|Pharmacodynamics|pharmacodynamics
476255|NCT01116531|Interaction|interaction
476256|NCT01116531|tramadol|tramadol
476257|NCT01116531|duloxetine|duloxetine
476258|NCT01116531|pregabalin|pregabalin
476259|NCT01116505|Celiac disease|celiac disease
476260|NCT01116505|Endomysial antibodies|endomysial antibodies
476261|NCT01116505|Gluten-free diet|gluten-free diet
476262|NCT01116505|Screen-detected|screen-detected
476263|NCT01116505|Asymptomatic|asymptomatic
476264|NCT01116505|Bone mineral density|bone mineral density
476265|NCT01116492|SILS|sils
476266|NCT01116492|Inflammatory reaction|inflammatory reaction
476267|NCT01116492|a-defensins|a-defensins
476268|NCT01116492|SILS vs standard laparoscopic cholecystectomy|sils vs standard laparoscopic cholecystectomy
476269|NCT01116479|Anaemia, transfusion, cancer, chemotherapy, Quality of life|anaemia, transfusion, cancer, chemotherapy, quality of life
476270|NCT01116453|dysmenorrhea|dysmenorrhea
476271|NCT01116453|acupuncture|acupuncture
476272|NCT01116453|randomized controlled trial|randomized controlled trial
476273|NCT01116440|Menstrual pain|menstrual pain
476274|NCT01116440|Refractory endometriosis|refractory endometriosis
476275|NCT01116440|Pelvic pain|pelvic pain
476276|NCT01116427|MS|ms
476277|NCT01116427|multiple sclerosis|multiple sclerosis
476278|NCT01116427|relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
476279|NCT01116427|RRMS|rrms
476280|NCT01116401|Hot Flashes|hot flashes
476281|NCT01116401|Sleep disturbance|sleep disturbance
476282|NCT01116401|Lupron|lupron
476283|NCT01116401|Menopause|menopause
476284|NCT01116388|Autism|autism
476482|NCT01116206|Prucalopride|prucalopride
476285|NCT01116388|Gastrointestinal Disorders|gastrointestinal disorders
476286|NCT01116388|Food Allergy|food allergy
476287|NCT01116388|Gluten free, casein free diet|gluten free, casein free diet
476288|NCT01116388|Diarrhea|diarrhea
476289|NCT01116388|Constipation|constipation
476291|NCT01116388|Abdominal pain|abdominal pain
476292|NCT01116388|Pain after eating|pain after eating
476293|NCT01116388|Self injurious behavior|self injurious behavior
476294|NCT01116375|Obesity|obesity
476295|NCT01116375|OSA|osa
476296|NCT01116375|PAP therapy|pap therapy
476297|NCT01116362|ulna|ulna
476298|NCT01116362|median|median
476299|NCT01116362|repair|repair
476300|NCT01116362|primary|primary
476301|NCT01116349|humeral diaphysis fracture|humeral diaphysis fracture
476302|NCT01116349|plate and screws for humeral diaphysis fracture|plate and screws for humeral diaphysis fracture
476303|NCT01116349|nailing for humerus diaphysis fracture|nailing for humerus diaphysis fracture
476304|NCT01116349|Hanging Support System|hanging support system
476305|NCT01116336|Pre-cancerous conditions|pre-cancerous conditions
476306|NCT01116336|Head and neck tumors|head and neck tumors
476307|NCT01116336|Cancer of head and neck|cancer of head and neck
476308|NCT01116323|Adverse events|adverse events
476309|NCT01116323|Adverse effects|adverse effects
476310|NCT01116323|Emergency Service, Hospital|emergency service, hospital
476311|NCT01116323|Emergency department|emergency department
476312|NCT01116323|Crowding|crowding
476313|NCT01116310|Hot flushes|hot flushes
476314|NCT01116310|Hot flashes|hot flashes
476315|NCT01116310|menopause|menopause
476316|NCT01116310|postmenopause|postmenopause
476317|NCT01116310|Soy isoflavones|soy isoflavones
476318|NCT01116310|Red clover|red clover
476319|NCT01116310|Equol|equol
476320|NCT01116297|breast reconstruction|breast reconstruction
476321|NCT01116297|breast cancer|breast cancer
476322|NCT01116297|near infrared imaging|near infrared imaging
476323|NCT01116284|Weight Loss|weight loss
476324|NCT01116284|Obesity|obesity
476325|NCT01116284|Gastric Bypass|gastric bypass
476326|NCT01116271|colorectal|colorectal
476327|NCT01116271|second line therapy|second line therapy
476328|NCT01116271|K-ras or B-raf mutations|k-ras or b-raf mutations
476329|NCT01116271|response rate|response rate
476330|NCT01116271|Progression Free Survival|progression free survival
476331|NCT01116258|Safety|safety
476332|NCT01116245|Cervical Intraepithelial Neoplasia Stage 2/3|cervical intraepithelial neoplasia stage 2/3
476333|NCT01116232|graft versus host disease|graft versus host disease
476334|NCT01116232|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
476335|NCT01116232|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
476336|NCT01116232|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
476337|NCT01116232|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
476338|NCT01116232|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
476339|NCT01116232|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
476340|NCT01116232|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
476341|NCT01116232|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
476342|NCT01116232|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
476343|NCT01116232|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
476344|NCT01116232|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
476345|NCT01116232|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
476346|NCT01116232|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
476347|NCT01116232|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
476348|NCT01116232|prolymphocytic leukemia|prolymphocytic leukemia
476349|NCT01116232|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
476350|NCT01116232|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
476351|NCT01116232|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
476352|NCT01116232|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
476353|NCT01116232|refractory hairy cell leukemia|refractory hairy cell leukemia
476354|NCT01116232|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
476355|NCT01116232|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
476356|NCT01116232|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
476357|NCT01116232|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
476358|NCT01116232|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
476359|NCT01116232|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
476360|NCT01116232|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
476361|NCT01116232|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
476362|NCT01116232|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
476363|NCT01116232|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
476364|NCT01116232|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
476365|NCT01116232|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
476366|NCT01116232|untreated hairy cell leukemia|untreated hairy cell leukemia
476367|NCT01116232|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
476368|NCT01116232|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
476369|NCT01116232|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
476370|NCT01116232|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
476371|NCT01116232|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
476372|NCT01116232|anaplastic large cell lymphoma|anaplastic large cell lymphoma
476373|NCT01116232|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
476374|NCT01116232|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
476375|NCT01116232|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
476376|NCT01116232|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
476377|NCT01116232|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
476378|NCT01116232|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
476379|NCT01116232|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
476380|NCT01116232|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
476381|NCT01116232|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
476382|NCT01116232|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
476383|NCT01116232|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
476384|NCT01116232|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
476385|NCT01116232|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
476386|NCT01116232|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
476387|NCT01116232|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
476388|NCT01116232|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
476389|NCT01116232|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
476390|NCT01116232|splenic marginal zone lymphoma|splenic marginal zone lymphoma
476391|NCT01116232|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
476392|NCT01116232|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
476393|NCT01116232|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
476394|NCT01116232|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
476395|NCT01116232|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
476396|NCT01116232|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
476397|NCT01116232|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
476398|NCT01116232|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
476399|NCT01116232|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
476400|NCT01116232|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
476401|NCT01116232|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
476402|NCT01116232|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
476403|NCT01116232|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
476404|NCT01116232|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
476405|NCT01116232|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
476406|NCT01116232|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
476407|NCT01116232|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
476408|NCT01116232|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
476409|NCT01116232|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
476410|NCT01116232|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
476411|NCT01116232|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
476412|NCT01116232|stage I mantle cell lymphoma|stage i mantle cell lymphoma
476413|NCT01116232|stage I marginal zone lymphoma|stage i marginal zone lymphoma
476414|NCT01116232|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
476415|NCT01116232|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
476575|NCT01115712|Healthy Volunteers|healthy volunteers
476416|NCT01116232|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
476417|NCT01116232|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
476418|NCT01116232|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
476419|NCT01116232|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
476420|NCT01116232|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
476421|NCT01116232|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
476422|NCT01116232|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
476423|NCT01116232|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
476424|NCT01116232|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
476425|NCT01116232|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
476426|NCT01116232|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
476427|NCT01116232|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
476428|NCT01116232|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
476429|NCT01116232|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
476430|NCT01116232|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
476431|NCT01116232|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
476432|NCT01116232|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
476433|NCT01116232|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
476434|NCT01116232|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
476435|NCT01116232|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
476436|NCT01116232|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
476437|NCT01116232|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
476438|NCT01116232|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
476439|NCT01116232|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
476440|NCT01116232|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
476441|NCT01116232|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
476442|NCT01116232|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
476443|NCT01116232|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
476444|NCT01116232|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
476445|NCT01116232|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
476446|NCT01116232|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
476447|NCT01116232|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
476448|NCT01116232|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
476449|NCT01116232|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
476450|NCT01116232|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
476451|NCT01116232|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
476452|NCT01116232|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
476453|NCT01116232|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
476454|NCT01116232|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
476455|NCT01116232|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
476456|NCT01116232|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
476457|NCT01116232|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
476458|NCT01116232|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
476459|NCT01116232|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
476460|NCT01116232|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
476461|NCT01116232|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
476462|NCT01116232|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
476463|NCT01116232|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
476464|NCT01116232|intraocular lymphoma|intraocular lymphoma
476465|NCT01116232|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
476466|NCT01116232|chronic eosinophilic leukemia|chronic eosinophilic leukemia
476467|NCT01116232|chronic neutrophilic leukemia|chronic neutrophilic leukemia
476468|NCT01116232|primary myelofibrosis|primary myelofibrosis
476469|NCT01116232|stage I multiple myeloma|stage i multiple myeloma
476470|NCT01116232|stage II multiple myeloma|stage ii multiple myeloma
476471|NCT01116232|stage III multiple myeloma|stage iii multiple myeloma
476472|NCT01116232|refractory multiple myeloma|refractory multiple myeloma
476473|NCT01116232|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
476474|NCT01116232|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
476475|NCT01116232|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
476476|NCT01116219|adenocarcinoma of the lung|adenocarcinoma of the lung
476477|NCT01116219|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
476478|NCT01116219|large cell lung cancer|large cell lung cancer
476479|NCT01116219|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
476480|NCT01116219|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
476481|NCT01116206|Constipation|constipation
476483|NCT01116206|Resolor|resolor
476484|NCT01116193|antileukemic therapy|antileukemic therapy
476485|NCT01116193|lymphoblastic leukemia|lymphoblastic leukemia
476486|NCT01116193|lenalidomide|lenalidomide
476487|NCT01116193|dexamethasone|dexamethasone
476488|NCT01116180|Type 1 diabetes|type 1 diabetes
476489|NCT01116180|Hypoglycaemia|hypoglycaemia
476490|NCT01116180|genetic susceptibility|genetic susceptibility
476491|NCT01116180|Renin angiotensin system activity|renin angiotensin system activity
476492|NCT01116167|Polycystic Ovary Syndrome|polycystic ovary syndrome
476493|NCT01116141|rheumatoid arthritis|rheumatoid arthritis
476494|NCT01116141|MTX|mtx
476495|NCT01116141|CH-405|ch-405
476496|NCT01116141|antifolates|antifolates
476497|NCT01116128|relapsed/refractory myeloma patients|relapsed/refractory myeloma patients
476498|NCT01116128|Progression free survival|progression free survival
476499|NCT01116128|Overall survival|overall survival
476500|NCT01116128|dasatinib|dasatinib
476501|NCT01116115|Term Infants|term infants
476502|NCT01116115|Intestine flora|intestine flora
476503|NCT01116115|Stool characteristics|stool characteristics
476504|NCT01116102|dehydration|dehydration
476505|NCT01116102|fluid therapy|fluid therapy
476506|NCT01116102|hyaluronoglucosaminidase|hyaluronoglucosaminidase
476507|NCT01116102|hyaluronidase|hyaluronidase
476508|NCT01116102|hypodermoclysis|hypodermoclysis
476509|NCT01116102|clysis|clysis
476510|NCT01116102|subcutaneous hydration|subcutaneous hydration
476511|NCT01116102|subcutaneous rehydration|subcutaneous rehydration
476512|NCT01116102|hyaluronan|hyaluronan
476513|NCT01116102|rHuPH20|rhuph20
476514|NCT01116089|Cystic fibrosis, tobramycin,nebulizer, PK|cystic fibrosis, tobramycin,nebulizer, pk
476515|NCT01116063|COPD, Pulmonary hypertension|copd, pulmonary hypertension
476516|NCT01116037|Diseased Heart Valve, Replacement, Aortic, Stentless|diseased heart valve, replacement, aortic, stentless
476517|NCT01116024|Diseased Heart Valve, Replacement, Aortic|diseased heart valve, replacement, aortic
476518|NCT01116011|Phase I|phase i
476519|NCT01116011|Japanese Healthy volunteer|japanese healthy volunteer
476520|NCT01115998|cerebral palsy|cerebral palsy
476521|NCT01115998|wheelchair|wheelchair
476522|NCT01115998|disabled children|disabled children
476523|NCT01115985|ASP1585|asp1585
476524|NCT01115985|Drug-drug interaction|drug-drug interaction
476525|NCT01115985|Atorvastatin|atorvastatin
476526|NCT01115985|Healthy volunteer|healthy volunteer
476527|NCT01115972|ASP1585|asp1585
476528|NCT01115972|Drug-drug interaction|drug-drug interaction
476529|NCT01115972|valsartan|valsartan
476530|NCT01115972|Healthy volunteer|healthy volunteer
476531|NCT01115946|ASP1585|asp1585
476532|NCT01115946|Drug-drug interaction|drug-drug interaction
476533|NCT01115946|enalapril|enalapril
476534|NCT01115946|Healthy volunteer|healthy volunteer
476535|NCT01115933|drug eluting stents|drug eluting stents
476536|NCT01115933|small vessel|small vessel
476537|NCT01115933|Stents|stents
476538|NCT01115933|Everolimus|everolimus
476539|NCT01115933|Angioplasty|angioplasty
476540|NCT01115920|Drug Safety|drug safety
476541|NCT01115920|Clinical Trial, Phase I|clinical trial, phase i
476542|NCT01115920|Nontherapeutic Human Experimentation|nontherapeutic human experimentation
476543|NCT01115920|Heading Pharmacokinetics|heading pharmacokinetics
476544|NCT01115920|Phase I Safety and Tolerability|phase i safety and tolerability
476545|NCT01115907|Aortic|aortic
476546|NCT01115907|Valve replacement|valve replacement
476547|NCT01115894|problem drinking|problem drinking
476548|NCT01115894|alcohol|alcohol
476549|NCT01115881|To examine the relationship between signal strength and macular thickness measured by stratus OCT|to examine the relationship between signal strength and macular thickness measured by stratus oct
476550|NCT01115855|Double-blind|double-blind
476551|NCT01115855|eplerenone|eplerenone
476552|NCT01115855|Japanese|japanese
476553|NCT01115842|Vitamin D|vitamin d
476554|NCT01115842|Acute coronary syndrome|acute coronary syndrome
476555|NCT01115842|inflammatory cytokines|inflammatory cytokines
476556|NCT01115803|Advanced Cancer|advanced cancer
476557|NCT01115803|Metastatic Cancer|metastatic cancer
476558|NCT01115803|Non-Small Cell Lung Cancer|non-small cell lung cancer
476559|NCT01115803|Renal Cell Carcinoma|renal cell carcinoma
476560|NCT01115803|Neuroendocrine Tumors|neuroendocrine tumors
476561|NCT01115777|Pediatric patients|pediatric patients
476562|NCT01115777|treated with|treated with
476563|NCT01115777|radiation therapy|radiation therapy
476564|NCT01115777|for brain tumors|for brain tumors
476565|NCT01115777|and non-CNS malignancies|and non-cns malignancies
476566|NCT01115764|diastolic dysfunction|diastolic dysfunction
476567|NCT01115751|Advanced Cancer|advanced cancer
476568|NCT01115751|Metastatic Cancer|metastatic cancer
476569|NCT01115751|Solid Tumors|solid tumors
476570|NCT01115738|Plavix, Effient|plavix, effient
476571|NCT01115725|Follitropin alfa|follitropin alfa
476572|NCT01115725|Fertilization in vitro|fertilization in vitro
476573|NCT01115725|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
476574|NCT01115725|Reproductive techniques, assisted|reproductive techniques, assisted
476576|NCT01115699|Depression|depression
476577|NCT01115699|rTMS|rtms
476578|NCT01115660|stroke|stroke
476579|NCT01115660|patient education|patient education
476580|NCT01115660|medication adherence|medication adherence
476581|NCT01115647|Malnutrition|malnutrition
476582|NCT01115647|Nutritional intervention|nutritional intervention
476583|NCT01115647|Behavioural intervention|behavioural intervention
476584|NCT01115647|Burkina Faso|burkina faso
476585|NCT01115647|Cluster randomize trial|cluster randomize trial
476586|NCT01115634|Fibroblast|fibroblast
476587|NCT01115634|Cell transplantation|cell transplantation
476588|NCT01115634|Facial deformities|facial deformities
476589|NCT01115608|Preventive Health Services|preventive health services
476590|NCT01115595|Allergic rhinitis|allergic rhinitis
476591|NCT01115595|Allergen injection immunotherapy|allergen injection immunotherapy
476592|NCT01115595|Efficacy|efficacy
476593|NCT01115582|Inborn Errors|inborn errors
476594|NCT01115582|Bile Acid|bile acid
476595|NCT01115582|Pediatrics|pediatrics
476596|NCT01115582|Liver Disease|liver disease
476597|NCT01115569|chronic pain|chronic pain
476598|NCT01115504|Thiamine|thiamine
476599|NCT01115504|heart failure|heart failure
476600|NCT01115478|Malaria|malaria
476601|NCT01115478|Low birth weight|low birth weight
476602|NCT01115478|Anemia|anemia
476603|NCT01115478|Perinatal mortality|perinatal mortality
476604|NCT01115478|Vitamin A|vitamin a
476605|NCT01115478|Zinc|zinc
476730|NCT01114971|Anesthetic adjuvant|anesthetic adjuvant
476606|NCT01115465|Stress Urinary Incontinence|stress urinary incontinence
476607|NCT01115465|silicone elastomer|silicone elastomer
476608|NCT01115452|potassium nitrate|potassium nitrate
476609|NCT01115452|tooth sensitivity|tooth sensitivity
476610|NCT01115452|dentin sensitivity|dentin sensitivity
476611|NCT01115439|falciparum malaria|falciparum malaria
476612|NCT01115439|artemisinin combination treatments|artemisinin combination treatments
476613|NCT01115413|teenage|teenage
476614|NCT01115413|pregnancy|pregnancy
476615|NCT01115413|obstetrical risk|obstetrical risk
476616|NCT01115400|Abdominal Wall Hernia|abdominal wall hernia
476617|NCT01115400|quality of life|quality of life
476618|NCT01115387|Age-related macular degeneration|age-related macular degeneration
476619|NCT01115387|AMD|amd
476620|NCT01115387|Genetic risk|genetic risk
476621|NCT01115387|Environmental risk factors|environmental risk factors
476622|NCT01115387|Complex genetic disorder|complex genetic disorder
476623|NCT01115387|Age-related maculopathy|age-related maculopathy
476624|NCT01115387|Risk modeling|risk modeling
476625|NCT01115387|Smoking|smoking
476626|NCT01115387|Light exposure|light exposure
476627|NCT01115387|Sleep apnea|sleep apnea
476628|NCT01115387|Fundus Photography|fundus photography
476629|NCT01115387|Macula|macula
476630|NCT01115387|Drusen|drusen
476631|NCT01115387|Wet AMD|wet amd
476632|NCT01115387|Dry AMD|dry amd
476633|NCT01115387|Geographic atrophy|geographic atrophy
476634|NCT01115387|Vitamins & supplements|vitamins & supplements
476635|NCT01115361|family planning|family planning
476636|NCT01115361|postpartum|postpartum
476637|NCT01115361|immunization|immunization
476638|NCT01115361|integration|integration
476639|NCT01115361|Contraceptive behavior|contraceptive behavior
476640|NCT01115335|neonatal male circumcision|neonatal male circumcision
476641|NCT01115335|Gomco|gomco
476642|NCT01115335|Plastibell|plastibell
476643|NCT01115335|Mogen|mogen
476644|NCT01115335|Safety|safety
476645|NCT01115335|Uptake|uptake
476646|NCT01115335|Acceptability|acceptability
476647|NCT01115335|Feasibility|feasibility
476648|NCT01115335|Zambia|zambia
476649|NCT01115322|Healthy volunteer study|healthy volunteer study
476650|NCT01115322|phototoxicity|phototoxicity
476651|NCT01115309|Sinusitis|sinusitis
476652|NCT01115296|Helicobacter Pylori|helicobacter pylori
476653|NCT01115296|gastritis|gastritis
476654|NCT01115296|Probiotics|probiotics
476655|NCT01115296|Lactobacillus Reuteri|lactobacillus reuteri
476656|NCT01115283|amblyopia treatment|amblyopia treatment
476657|NCT01115283|neural plasticity|neural plasticity
476658|NCT01115283|perceptual learning|perceptual learning
476659|NCT01115283|vision therapy|vision therapy
476660|NCT01115283|spatial vision|spatial vision
476661|NCT01115283|video games|video games
476662|NCT01115283|occlusion therapy|occlusion therapy
476663|NCT01115270|Normal Pressure Hydrocephalus|normal pressure hydrocephalus
476664|NCT01115257|severe proliferative diabetic retinopathy|severe proliferative diabetic retinopathy
476665|NCT01115257|vitrectomy|vitrectomy
476666|NCT01115257|panretinalphotocoagulation|panretinalphotocoagulation
476667|NCT01115244|Dermatitis herpetiformis|dermatitis herpetiformis
476668|NCT01115244|Dapsone|dapsone
476669|NCT01115231|Age-Related Macular Degeneration|age-related macular degeneration
476670|NCT01115231|Age-Related Maculopathies|age-related maculopathies
476671|NCT01115231|Age-Related Maculopathy|age-related maculopathy
476672|NCT01115231|Macular Dystrophy|macular dystrophy
476673|NCT01115231|Maculopathies, Age-Related|maculopathies, age-related
476674|NCT01115231|Maculopathy, Age-Related|maculopathy, age-related
476675|NCT01115218|Glaucoma|glaucoma
476676|NCT01115205|Exercise, Walking, Type 2 diabetes, Therapy|exercise, walking, type 2 diabetes, therapy
476677|NCT01115179|propofol|propofol
476678|NCT01115179|inflammation|inflammation
476679|NCT01115179|perioperative|perioperative
476680|NCT01115179|lipids|lipids
476681|NCT01115179|Apolipoprotein A-I|apolipoprotein a-i
476682|NCT01115166|blood volume|blood volume
476683|NCT01115153|Acute appendicitis|acute appendicitis
476684|NCT01115153|Antibiotic prophylaxis|antibiotic prophylaxis
476685|NCT01115153|Wound infection|wound infection
476686|NCT01115153|Nosocomial infection|nosocomial infection
476687|NCT01115140|Folate|folate
476688|NCT01115140|Metformin|metformin
476689|NCT01115140|PCOS|pcos
476690|NCT01115140|Pregnancy|pregnancy
476691|NCT01115140|Trophoblastic invasion|trophoblastic invasion
476692|NCT01115140|Uterine artery velocimetry|uterine artery velocimetry
476693|NCT01115127|pre-menopause|pre-menopause
476694|NCT01115127|melatonin|melatonin
476695|NCT01115127|myo-inositol|myo-inositol
476696|NCT01115101|pain after cesarean|pain after cesarean
476697|NCT01115101|visual analog scale|visual analog scale
476698|NCT01115101|oxycodon|oxycodon
476699|NCT01115101|piritramid|piritramid
476700|NCT01115075|Leptin|leptin
476701|NCT01115075|Changes in leptin may precede the|changes in leptin may precede the
476702|NCT01115075|phasing of oscillations of dietary fat intake|phasing of oscillations of dietary fat intake
476703|NCT01115062|Pain|pain
476704|NCT01115062|Children|children
476705|NCT01115062|Local anesthetics|local anesthetics
476706|NCT01115036|glioblastoma|glioblastoma
476707|NCT01115036|recurrent|recurrent
476708|NCT01115036|surgical resection|surgical resection
476709|NCT01115023|iron deficiency anemia|iron deficiency anemia
476710|NCT01115023|dietary intervention|dietary intervention
476711|NCT01115023|To evaluate a cheap and sustainable dietary intervention to improve the iron status of the entire family of the index case of non-severe iron deficiency anemia.|to evaluate a cheap and sustainable dietary intervention to improve the iron status of the entire family of the index case of non-severe iron deficiency anemia.
476712|NCT01115010|intubation rate|intubation rate
476713|NCT01115010|intubation time|intubation time
476714|NCT01115010|stiffening device|stiffening device
476715|NCT01115010|stiffening wire|stiffening wire
476716|NCT01114997|Lidocaine Infusion|lidocaine infusion
476717|NCT01114997|Esmolol Infusion|esmolol infusion
476718|NCT01114997|Anesthetic adjuvant|anesthetic adjuvant
476719|NCT01114997|Abdominal surgery|abdominal surgery
476720|NCT01114997|Pain management|pain management
476721|NCT01114997|Hemodynamic stability|hemodynamic stability
476722|NCT01114997|Perioperative outcomes|perioperative outcomes
476723|NCT01114984|Pain management|pain management
476724|NCT01114984|Radical mastectomy|radical mastectomy
476725|NCT01114984|Breast surgery|breast surgery
476726|NCT01114984|post-operative pain|post-operative pain
476727|NCT01114971|Labetalol|labetalol
476728|NCT01114971|Esmolol|esmolol
476729|NCT01114971|Fentanyl|fentanyl
476731|NCT01114971|Ambulatory surgery|ambulatory surgery
476732|NCT01114971|Outpatient surgery|outpatient surgery
476733|NCT01114971|Pain management|pain management
476734|NCT01114971|Hemodynamic stability|hemodynamic stability
476735|NCT01114971|Perioperative outcomes|perioperative outcomes
476736|NCT01114958|Lung cancer|lung cancer
476737|NCT01114958|Non-small cell lung cancer|non-small cell lung cancer
476738|NCT01114958|Small-cell lung cancer|small-cell lung cancer
476739|NCT01114958|Lung metastases|lung metastases
476740|NCT01114958|Metastatic cancer|metastatic cancer
476741|NCT01114958|Stage IIIA|stage iiia
476742|NCT01114958|Stage IIIB|stage iiib
476743|NCT01114958|Stage III|stage iii
476744|NCT01114958|Stage 3|stage 3
476745|NCT01114945|Direct Laryngoscopy|direct laryngoscopy
476746|NCT01114945|Video-Mac|video-mac
476747|NCT01114945|GlideScope|glidescope
476748|NCT01114945|McGrath|mcgrath
476749|NCT01114945|Laryngoscopy|laryngoscopy
476750|NCT01114945|Bariatrics|bariatrics
476751|NCT01114945|Glottic view|glottic view
476752|NCT01114945|Airway intubating devices|airway intubating devices
476753|NCT01114945|Tracheal intubation|tracheal intubation
476754|NCT01114932|pre-oxygenation|pre-oxygenation
476755|NCT01114932|body mass index|body mass index
476756|NCT01114932|end-tidal O2|end-tidal o2
476757|NCT01114932|anesthesia induction|anesthesia induction
476758|NCT01114919|Problem drinking|problem drinking
476759|NCT01114919|Alcohol dependence|alcohol dependence
476760|NCT01114919|Alcohol abuse|alcohol abuse
476761|NCT01114919|Internet based intervention|internet based intervention
476762|NCT01114919|Treatment|treatment
476763|NCT01114919|Alcohol Use Disorders Identification Test|alcohol use disorders identification test
476764|NCT01114906|Asthma|asthma
476765|NCT01114906|Resource use|resource use
476766|NCT01114880|ankylosing spondylitis|ankylosing spondylitis
476767|NCT01114880|China|china
476768|NCT01114867|ultrasound|ultrasound
476769|NCT01114867|penis length|penis length
476770|NCT01114867|corpus cavernosum|corpus cavernosum
476771|NCT01114867|length of fetal penis and fetal corpus cavernosum|length of fetal penis and fetal corpus cavernosum
476772|NCT01114841|Healthy Volunteer Subjects|healthy volunteer subjects
476773|NCT01114828|Cirrhosis|cirrhosis
476774|NCT01114828|ascites|ascites
476775|NCT01114828|Tolvaptan|tolvaptan
476776|NCT01114828|OPC-41061|opc-41061
476777|NCT01114815|CADASIL|cadasil
476778|NCT01114815|cerebral|cerebral
476779|NCT01114815|autosomal dominant|autosomal dominant
476780|NCT01114815|arteriopathy|arteriopathy
476781|NCT01114815|subcortical infarcts|subcortical infarcts
476782|NCT01114815|leukoencephalopathy|leukoencephalopathy
476783|NCT01114802|Cancer survivors|cancer survivors
476784|NCT01114802|Anxiety|anxiety
476785|NCT01114802|Depression|depression
476786|NCT01114802|Technology Assisted|technology assisted
476787|NCT01114802|Internet|internet
476788|NCT01114789|chronic renal failure|chronic renal failure
476789|NCT01114789|hemodialysis|hemodialysis
476790|NCT01114789|obesity|obesity
476791|NCT01114789|proteolysis|proteolysis
476792|NCT01114763|Metabolic Syndrome|metabolic syndrome
476793|NCT01114763|Oxidized Low Density Lipoprotein|oxidized low density lipoprotein
476794|NCT01114763|Arterial Elasticity|arterial elasticity
476795|NCT01114763|Diabetes Mellitus|diabetes mellitus
476796|NCT01114763|Cardiovascular Diseases|cardiovascular diseases
476797|NCT01114750|blood glucose|blood glucose
476798|NCT01114750|blood insulin|blood insulin
476799|NCT01114750|dextran|dextran
476800|NCT01114750|diabetes|diabetes
476801|NCT01114750|hyperglycemia|hyperglycemia
476802|NCT01114750|hypoglycemia|hypoglycemia
476803|NCT01114750|oral delivery|oral delivery
476804|NCT01114750|portal delivery|portal delivery
476805|NCT01114737|Phenylketonuria|phenylketonuria
476806|NCT01114737|PKU|pku
476807|NCT01114737|Kuvan|kuvan
476808|NCT01114737|Sapropterin dihydrochloride|sapropterin dihydrochloride
476809|NCT01114737|Neuropsychiatric disorder|neuropsychiatric disorder
476810|NCT01114737|ADHD|adhd
476811|NCT01114724|Thoracic dissection|thoracic dissection
476812|NCT01114724|Endovascular aortic repair|endovascular aortic repair
476813|NCT01114711|Menstrual Migraine|menstrual migraine
476814|NCT01114711|Frova|frova
476815|NCT01114711|Imaging|imaging
476816|NCT01114711|fMRI|fmri
476817|NCT01114711|Pain|pain
476818|NCT01114698|Depression|depression
476819|NCT01114698|Major Depressive Disorder|major depressive disorder
476820|NCT01114698|Venlafaxine XR (EFFEXOR XR)|venlafaxine xr (effexor xr)
476821|NCT01114698|26489112|26489112
476822|NCT01114698|JNJ26489112|jnj26489112
476823|NCT01114672|Pruritis in hemodialysis patients|pruritis in hemodialysis patients
476824|NCT01114672|25-Vitamin D in chronic kidney disease|25-vitamin d in chronic kidney disease
476825|NCT01114646|Hemiarthroplasty|hemiarthroplasty
476826|NCT01114646|Cemented|cemented
476827|NCT01114646|Press Fit|press fit
476828|NCT01114646|Mortality|mortality
476829|NCT01114646|Morbidity|morbidity
476830|NCT01114646|Functional Status|functional status
476831|NCT01114646|Displaced femoral neck fracture|displaced femoral neck fracture
476832|NCT01114633|PCOS|pcos
476833|NCT01114633|Acne|acne
476834|NCT01114633|Hirsutism|hirsutism
476835|NCT01114620|elderly|elderly
476836|NCT01114620|post-marketing|post-marketing
476837|NCT01114620|H1N1|h1n1
476838|NCT01114620|Clinical trial|clinical trial
476839|NCT01114620|pandemic influenza|pandemic influenza
476840|NCT01114607|GSK1605786|gsk1605786
476841|NCT01114607|relative bioavailability|relative bioavailability
476842|NCT01114607|CCR9 receptor antagonist|ccr9 receptor antagonist
476843|NCT01114594|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
476844|NCT01114594|Autosomal Dominant Polycystic Kidney Disease (ADPKD)|autosomal dominant polycystic kidney disease (adpkd)
476845|NCT01114581|Acute Respiratory Infection|acute respiratory infection
476846|NCT01114581|Mucociliary|mucociliary
476847|NCT01114581|Cough Clearance|cough clearance
476848|NCT01114581|Guaifenesin|guaifenesin
476849|NCT01114568|Relative Bioavailability|relative bioavailability
476850|NCT01114568|Pharmacokinetics|pharmacokinetics
476851|NCT01114568|Pharmacodynamics|pharmacodynamics
476852|NCT01114555|Bevacizumab|bevacizumab
476853|NCT01114555|Irinotecan|irinotecan
476854|NCT01114555|Temozolomide|temozolomide
476855|NCT01114555|10-015|10-015
476856|NCT01114529|de novo renal allograft recipients|de novo renal allograft recipients
476857|NCT01114529|renal allograft function|renal allograft function
476858|NCT01114529|CNI-free regimen|cni-free regimen
476859|NCT01114516|cervical insufficiency|cervical insufficiency
476860|NCT01114503|GSK2136525|gsk2136525
476861|NCT01114503|Pharmacodynamics|pharmacodynamics
476862|NCT01114503|Safety|safety
476863|NCT01114503|Otelixizumab|otelixizumab
476864|NCT01114503|Thyroid eye disease|thyroid eye disease
476865|NCT01114503|Graves' ophthalmopathy|graves' ophthalmopathy
476866|NCT01114503|Repeat dose|repeat dose
476867|NCT01114503|Intravenous infusion|intravenous infusion
476868|NCT01114503|Tolerability|tolerability
476869|NCT01114503|EUGOGO|eugogo
476870|NCT01114490|Hepatic Insufficiency|hepatic insufficiency
476871|NCT01114477|Transcranial magnetic stimulation|transcranial magnetic stimulation
476872|NCT01114477|TMS|tms
476873|NCT01114477|Observational study|observational study
476874|NCT01114477|Major Depression|major depression
476875|NCT01114464|Breast cancer|breast cancer
476876|NCT01114464|Ovarian reserve|ovarian reserve
476877|NCT01114464|Anti-Mullerian Hormone (AMH)|anti-mullerian hormone (amh)
476878|NCT01114464|Chemotherapy|chemotherapy
476879|NCT01114451|Cesarean delivery|cesarean delivery
476880|NCT01114451|Obesity|obesity
476881|NCT01114451|Skin staples|skin staples
476882|NCT01114451|Wound complications|wound complications
476883|NCT01114425|tolerability of post exposure to HIV infection prophylaxis|tolerability of post exposure to hiv infection prophylaxis
476884|NCT01114412|focus groups|focus groups
476885|NCT01114412|overactive bladder|overactive bladder
476886|NCT01114412|bladder sensations|bladder sensations
476887|NCT01114399|Cardiovascular Disease|cardiovascular disease
476888|NCT01114399|Cardiovascular Disease risk (mild to moderate)|cardiovascular disease risk (mild to moderate)
476889|NCT01114399|Cholesterol|cholesterol
476890|NCT01114399|Ambulatory blood pressure|ambulatory blood pressure
476891|NCT01114399|Arterial Stiffness|arterial stiffness
476892|NCT01114386|Smoking|smoking
476893|NCT01114386|Dyspnea|dyspnea
476894|NCT01114386|Cough|cough
476895|NCT01114386|Exercise|exercise
476896|NCT01114373|Melatonin|melatonin
476897|NCT01114373|Hypertension|hypertension
476898|NCT01114373|Blood Pressure|blood pressure
476899|NCT01114373|Cardiovascular|cardiovascular
476900|NCT01114373|Sleep|sleep
476901|NCT01114373|Nighttime|nighttime
476902|NCT01114373|Nocturnal|nocturnal
476903|NCT01114373|Catecholamines|catecholamines
476904|NCT01114373|Sympathetic Nervous System|sympathetic nervous system
476905|NCT01114373|Endothelial Function|endothelial function
476906|NCT01114373|African American|african american
476907|NCT01114360|Melatonin|melatonin
476908|NCT01114360|Hypertension|hypertension
476909|NCT01114360|Blood Pressure|blood pressure
476910|NCT01114360|Cardiovascular|cardiovascular
476911|NCT01114360|Sleep|sleep
476912|NCT01114360|Nighttime|nighttime
476913|NCT01114360|Nocturnal|nocturnal
476914|NCT01114360|Catecholamines|catecholamines
476915|NCT01114360|Sympathetic Nervous System|sympathetic nervous system
476916|NCT01114360|Endothelial function|endothelial function
476917|NCT01114360|African American|african american
476918|NCT01114321|Idiopathic Parkinson's disease|idiopathic parkinson's disease
476919|NCT01114321|Glucose intolerance|glucose intolerance
476920|NCT01114321|Diabetes|diabetes
476921|NCT01114321|OGTT|ogtt
476922|NCT01114321|Patient with an Idiopathic Parkinson's disease|patient with an idiopathic parkinson's disease
476923|NCT01114308|opioid dependence|opioid dependence
476924|NCT01114308|opioid addiction|opioid addiction
476925|NCT01114308|buprenorphine|buprenorphine
476926|NCT01114308|implant|implant
476927|NCT01114308|methadone|methadone
476928|NCT01114308|heroin|heroin
476929|NCT01114308|suboxone|suboxone
476930|NCT01114308|opioid pain medication|opioid pain medication
476931|NCT01114308|opioid withdrawal|opioid withdrawal
476932|NCT01114295|overt|overt
476933|NCT01114295|obscure|obscure
476934|NCT01114295|gastrointestinal|gastrointestinal
476935|NCT01114295|bleeding|bleeding
476936|NCT01114295|hemorrhage|hemorrhage
476937|NCT01114269|Coronary Artery Disease|coronary artery disease
476938|NCT01114269|Sudden Cardiac Death|sudden cardiac death
476939|NCT01114269|Myocardial Infarction|myocardial infarction
476940|NCT01114269|Percutaneous Coronary Intervention|percutaneous coronary intervention
476941|NCT01114269|Implantable Cardiac Defibrillator|implantable cardiac defibrillator
476942|NCT01114230|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
476943|NCT01114230|Advanced Kidney Cancer|advanced kidney cancer
476944|NCT01114230|AGS-16M8F|ags-16m8f
476945|NCT01114217|Iron deficiency anemia|iron deficiency anemia
476946|NCT01114217|Feraheme|feraheme
476947|NCT01114217|ferumoxytol|ferumoxytol
476948|NCT01114217|AUB|aub
476949|NCT01114217|cancer|cancer
476950|NCT01114217|GI disorders|gi disorders
476951|NCT01114217|postpartum anemia|postpartum anemia
476952|NCT01114217|The treatment of iron deficiency anemia (IDA)|the treatment of iron deficiency anemia (ida)
476953|NCT01114204|Iron deficiency anemia|iron deficiency anemia
476954|NCT01114204|Feraheme|feraheme
476955|NCT01114204|ferumoxytol|ferumoxytol
476956|NCT01114204|iron sucrose|iron sucrose
476957|NCT01114204|Venofer|venofer
476958|NCT01114204|AUB|aub
476959|NCT01114204|cancer|cancer
476960|NCT01114204|GI disorders|gi disorders
476961|NCT01114204|postpartum anemia|postpartum anemia
476962|NCT01114204|The treatment of iron deficiency anemia (IDA)|the treatment of iron deficiency anemia (ida)
476963|NCT01114178|questionnaire|questionnaire
476964|NCT01114178|peripheral artery disease|peripheral artery disease
476965|NCT01114178|exercise|exercise
476966|NCT01114165|Neutropenia|neutropenia
476967|NCT01114165|Febrile Neutropenia|febrile neutropenia
476968|NCT01114165|Sepsis|sepsis
476969|NCT01114165|Polymerase Chain Reaction|polymerase chain reaction
476970|NCT01114152|AZD9742|azd9742
476971|NCT01114152|Japanese Healthy Volunteers|japanese healthy volunteers
476972|NCT01114152|Phase I|phase i
476973|NCT01114152|Single and Multiple Ascending Dose|single and multiple ascending dose
476974|NCT01114139|Iron deficiency anemia|iron deficiency anemia
476975|NCT01114139|Feraheme|feraheme
476976|NCT01114139|ferumoxytol|ferumoxytol
476977|NCT01114139|AUB|aub
476978|NCT01114139|cancer|cancer
476979|NCT01114139|GI disorders|gi disorders
476980|NCT01114139|postpartum anemia|postpartum anemia
476981|NCT01114139|The treatment of iron deficiency anemia (IDA)|the treatment of iron deficiency anemia (ida)
476982|NCT01114126|Neu-P11|neu-p11
476983|NCT01114126|Insomnia|insomnia
476984|NCT01114126|PSG|psg
476985|NCT01114126|safety|safety
476986|NCT01114113|IBS-D|ibs-d
476987|NCT01114113|Post meal Diarrhea|post meal diarrhea
476988|NCT01114113|Trigger meals|trigger meals
476989|NCT01114100|chest pain|chest pain
476990|NCT01114100|panic attacks|panic attacks
476991|NCT01114100|palpitations|palpitations
476992|NCT01114100|depression|depression
476993|NCT01114100|panic disorder|panic disorder
476994|NCT01114100|depressive disorder|depressive disorder
476995|NCT01114100|non cardiac chest pain|non cardiac chest pain
476996|NCT01114087|Spermatogenesis|spermatogenesis
476997|NCT01114087|Inhibitors of tyrosine kinase|inhibitors of tyrosine kinase
476998|NCT01114087|Fragmentation of the spermatic DNA|fragmentation of the spermatic dna
476999|NCT01114074|Thrombosis|thrombosis
477000|NCT01114074|Blood coagulation|blood coagulation
477001|NCT01114074|Perfusion flow experiments|perfusion flow experiments
477002|NCT01114074|Factor XII|factor xii
477003|NCT01114074|Factor XI|factor xi
477004|NCT01114074|Prekallikrein|prekallikrein
477005|NCT01114074|High molecular weight kininogen|high molecular weight kininogen
477006|NCT01114061|diabetes|diabetes
477007|NCT01114061|postprandial glucose level|postprandial glucose level
477008|NCT01114061|insulin pharmacodynamics|insulin pharmacodynamics
477009|NCT01114061|Insulin Pharmacokinetics|insulin pharmacokinetics
477010|NCT01114048|age under 65|age under 65
477011|NCT01114048|Previous untreated|previous untreated
477012|NCT01114035|intestinal epithelial dysplasia|intestinal epithelial dysplasia
477013|NCT01114035|characterization phenotypic|characterization phenotypic
477014|NCT01114035|genetic study|genetic study
477015|NCT01114035|"or  tufting enteropathy "|"or  tufting enteropathy "
477016|NCT01114022|Acute respiratory failure|acute respiratory failure
477017|NCT01114009|recruitment maneuvers|recruitment maneuvers
477018|NCT01114009|ARDS|ards
477019|NCT01114009|lung protective strategy|lung protective strategy
477020|NCT01114009|ARDS, Human|ards, human
477021|NCT01113996|Obesity|obesity
477022|NCT01113996|Gastric by-pass|gastric by-pass
477023|NCT01113996|Body composition|body composition
477024|NCT01113996|Nutrition|nutrition
477025|NCT01113996|Physical activity|physical activity
477026|NCT01113983|SAPIEN XT Valve, Cardiovascular Disease, Valvular Heart Disease, Aortic Stenosis, Heart Valve Therapy, Transapical, Transcatheter, Transfemoral|sapien xt valve, cardiovascular disease, valvular heart disease, aortic stenosis, heart valve therapy, transapical, transcatheter, transfemoral
477027|NCT01113970|breast cancer|breast cancer
477028|NCT01113970|Indibulin|indibulin
477029|NCT01113970|unresectable, locally advanced breast cancer|unresectable, locally advanced breast cancer
477030|NCT01113957|Ovarian Cancer|ovarian cancer
477031|NCT01113931|Chlamydia|chlamydia
477032|NCT01113918|Obesity,|obesity,
477033|NCT01113918|PCOS,|pcos,
477034|NCT01113918|HA,|ha,
477035|NCT01113918|CVD|cvd
477036|NCT01113905|Fatigue|fatigue
477037|NCT01113905|Breast Cancer|breast cancer
477038|NCT01113879|rehabilitation|rehabilitation
477039|NCT01113879|aphasia|aphasia
477040|NCT01113879|exercise|exercise
477041|NCT01113879|fMRI|fmri
477042|NCT01113879|BDNF|bdnf
477043|NCT01113853|asthma|asthma
477044|NCT01113853|exhaled nitric oxide|exhaled nitric oxide
477045|NCT01113853|lung function|lung function
477046|NCT01113840|elderly|elderly
477047|NCT01113840|heart failure|heart failure
477048|NCT01113840|exercise|exercise
477049|NCT01113840|diastolic dysfunction|diastolic dysfunction
477050|NCT01113827|Olive|olive
477051|NCT01113827|antioxidant|antioxidant
477052|NCT01113827|exercise|exercise
477053|NCT01113827|inflammation|inflammation
477054|NCT01113827|recovery|recovery
477055|NCT01113827|Healthy men|healthy men
477056|NCT01113801|Chronic Kidney Disease|chronic kidney disease
477057|NCT01113801|Diabetic Kidney Disease|diabetic kidney disease
477058|NCT01113801|End-Stage Renal Disease|end-stage renal disease
477059|NCT01113801|Transforming Growth Factor beta 1 Monoclonal Antibody|transforming growth factor beta 1 monoclonal antibody
477060|NCT01113801|Type 1 Diabetes|type 1 diabetes
477061|NCT01113801|Type 2 Diabetes|type 2 diabetes
477062|NCT01113788|atrial flutter, tricuspid isthmus, ablation|atrial flutter, tricuspid isthmus, ablation
477063|NCT01113775|pulmonary embolism|pulmonary embolism
477064|NCT01113775|computed tomography|computed tomography
477065|NCT01113762|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
477066|NCT01113762|Bone Density|bone density
477067|NCT01113762|Rehabilitation|rehabilitation
477068|NCT01113762|T-Lymphocytes|t-lymphocytes
477069|NCT01113762|Chromium Alloys|chromium alloys
477070|NCT01113749|Dementia|dementia
477071|NCT01113749|Nutrition|nutrition
477072|NCT01113749|Feeding|feeding
477073|NCT01113736|Ileostomy|ileostomy
477074|NCT01113736|Stenosis|stenosis
477075|NCT01113736|Surgical Wound Dehiscence|surgical wound dehiscence
477076|NCT01113736|Peritoneal|peritoneal
477077|NCT01113736|Colorectal Surgery|colorectal surgery
477078|NCT01113723|C-MAC|c-mac
477079|NCT01113723|Fiberoptic bronchoscope|fiberoptic bronchoscope
477080|NCT01113723|Laryngoscopy|laryngoscopy
477081|NCT01113723|Cervical spine injury|cervical spine injury
477082|NCT01113723|Glottic view|glottic view
477083|NCT01113723|Tracheal intubation|tracheal intubation
477084|NCT01113710|Rotigotine|rotigotine
477085|NCT01113710|Neupro®|neupro®
477086|NCT01113710|Restless Legs Syndrome|restless legs syndrome
477087|NCT01113697|allergen challenge|allergen challenge
477088|NCT01113697|blood draw|blood draw
477089|NCT01113697|gene expression analysis|gene expression analysis
477090|NCT01113697|protein analysis|protein analysis
477091|NCT01113697|genetics|genetics
477092|NCT01113671|Diabetes Mellitus type 2|diabetes mellitus type 2
477093|NCT01113671|Haptoglobin phenotype|haptoglobin phenotype
477094|NCT01113671|Vitamin E|vitamin e
477095|NCT01113658|negative pressure wound therapy|negative pressure wound therapy
477096|NCT01113658|NPWT|npwt
477097|NCT01113658|Spiracur|spiracur
477098|NCT01113658|SNaP Wound Care System|snap wound care system
477099|NCT01113645|Decompressive craniectomy|decompressive craniectomy
477100|NCT01113645|Cranioplasty|cranioplasty
477101|NCT01113645|Cerebral blood flow|cerebral blood flow
477102|NCT01113645|Cerebral hemodynamic|cerebral hemodynamic
477103|NCT01113645|Neurological-cognitive test GOS, FAB, MMSE,|neurological-cognitive test gos, fab, mmse,
477104|NCT01113645|Transcranial Doppler|transcranial doppler
477105|NCT01113632|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
477106|NCT01113632|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
477107|NCT01113632|Ofatumumab|ofatumumab
477108|NCT01113619|lactose maldigestion|lactose maldigestion
477109|NCT01113619|dairy intolerance|dairy intolerance
477110|NCT01113619|intolerance to milk|intolerance to milk
477111|NCT01113619|intolerance to dairy|intolerance to dairy
477112|NCT01113619|milk intolerance|milk intolerance
477113|NCT01113619|GI disorder|gi disorder
477114|NCT01113619|lactose metabolism|lactose metabolism
477115|NCT01113619|GI symptoms after dairy ingestion|gi symptoms after dairy ingestion
477116|NCT01113606|Moderate to severe facial photo damage|moderate to severe facial photo damage
477117|NCT01113606|Periocular or perioral fine wrinkles|periocular or perioral fine wrinkles
477118|NCT01113593|COPD|copd
477119|NCT01113567|Hepatic Encephalopathy|hepatic encephalopathy
477120|NCT01113567|Liver Cirrhosis|liver cirrhosis
477121|NCT01113567|Disaccharides|disaccharides
477122|NCT01113567|Lactose|lactose
477123|NCT01113567|Quality of Life|quality of life
477124|NCT01113541|Ziprasidone|ziprasidone
477125|NCT01113541|Bipolar Disorder|bipolar disorder
477126|NCT01113541|Metabolic Syndrome|metabolic syndrome
477127|NCT01113528|Bone allograft|bone allograft
477128|NCT01113528|IL-1|il-1
477129|NCT01113528|IL-10|il-10
477130|NCT01113528|periodontal regeneration|periodontal regeneration
477131|NCT01113528|omega-3|omega-3
477132|NCT01113528|aspirin|aspirin
477133|NCT01113515|Diabetic foot ulcer|diabetic foot ulcer
477134|NCT01113515|Diabetic wound|diabetic wound
477135|NCT01113515|chronic non healing ulcer|chronic non healing ulcer
477136|NCT01113476|Advanced Malignancies|advanced malignancies
477137|NCT01113476|Nab-paclitaxel|nab-paclitaxel
477138|NCT01113476|Gemcitabine|gemcitabine
477139|NCT01113476|Bevacizumab|bevacizumab
477140|NCT01113463|Brain Tumor|brain tumor
477141|NCT01113463|Central Nervous System|central nervous system
477142|NCT01113463|CNS|cns
477143|NCT01113463|Glioblastoma Multiforme|glioblastoma multiforme
477144|NCT01113463|GBM|gbm
477145|NCT01113463|TPI 287|tpi 287
477146|NCT01113463|Radiation Therapy|radiation therapy
477147|NCT01113463|Temozolomide|temozolomide
477148|NCT01113463|Chemotherapy|chemotherapy
477149|NCT01113463|taxanes|taxanes
477150|NCT01113450|hearing, newborn, screening|hearing, newborn, screening
477151|NCT01113437|Bronchial Asthma|bronchial asthma
477152|NCT01113437|Allergy|allergy
477153|NCT01113424|Smoking Cessation|smoking cessation
477154|NCT01113424|Nicotine pharmacokinetics|nicotine pharmacokinetics
477155|NCT01113411|humerus fracture|humerus fracture
477156|NCT01113411|locked plate|locked plate
477157|NCT01113398|glioblastoma multiforme|glioblastoma multiforme
477158|NCT01113398|gliosarcoma|gliosarcoma
477159|NCT01113398|malignant glioma|malignant glioma
477160|NCT01113398|glioma|glioma
477161|NCT01113398|Avastin|avastin
477162|NCT01113398|bevacizumab|bevacizumab
477163|NCT01113398|AMG 102|amg 102
477164|NCT01113398|rilotumumab|rilotumumab
477165|NCT01113398|recurrent|recurrent
477166|NCT01113398|Duke|duke
477167|NCT01113398|Pro00022491|pro00022491
477168|NCT01113385|Nephrotic syndrome|nephrotic syndrome
477169|NCT01113385|Focal Segmental glomerulosclerosis|focal segmental glomerulosclerosis
477170|NCT01113385|FSGS|fsgs
477171|NCT01113385|Minimal change|minimal change
477172|NCT01113385|Steroid resistant|steroid resistant
477173|NCT01113385|Pediatric|pediatric
477174|NCT01113385|Proteinuria|proteinuria
477175|NCT01113385|Galactose|galactose
477176|NCT01113385|FSPF|fspf
477177|NCT01113372|Coronary, Disease|coronary, disease
477178|NCT01113359|HCMV infection|hcmv infection
477179|NCT01113359|Hypertension|hypertension
477180|NCT01113359|The Potential Link Between HCMV Infection and Essential Hypertension|the potential link between hcmv infection and essential hypertension
477181|NCT01113346|enterosorbent|enterosorbent
477182|NCT01113346|sorbent|sorbent
477183|NCT01113346|gastrointestinal decontamination|gastrointestinal decontamination
477184|NCT01113346|viral diarrhea|viral diarrhea
477185|NCT01113346|rotavirus|rotavirus
477186|NCT01113346|Filtrum|filtrum
477187|NCT01113346|Filtrum-STI|filtrum-sti
477188|NCT01113346|lignin|lignin
477189|NCT01113320|Safinamide - Parkinson's disease - Levodopa induced dyskinesia|safinamide - parkinson's disease - levodopa induced dyskinesia
477190|NCT01113320|Advanced idiopathic PD patients treated with L-dopa and suffering from temporally predictable L-dopa induced peak-dose dyskinesia.|advanced idiopathic pd patients treated with l-dopa and suffering from temporally predictable l-dopa induced peak-dose dyskinesia.
477191|NCT01113307|Chronic ulcers|chronic ulcers
477192|NCT01113307|pressure ulcers|pressure ulcers
477193|NCT01113307|venous ulcers|venous ulcers
477194|NCT01113307|diabetic foot ulcers|diabetic foot ulcers
477195|NCT01113307|post operative ulcers|post operative ulcers
477196|NCT01113307|hard to heal ulcers|hard to heal ulcers
477197|NCT01113281|Tuberculosis|tuberculosis
477198|NCT01113281|Vaccine|vaccine
477199|NCT01113281|Live Vaccine|live vaccine
477200|NCT01113281|rBCG|rbcg
477201|NCT01113268|Patient collection|patient collection
477202|NCT01113268|Cardiac remodelling|cardiac remodelling
477203|NCT01113268|Echography|echography
477204|NCT01113268|Magnetic Resonance Imaging|magnetic resonance imaging
477205|NCT01113268|Gene polymorphisms|gene polymorphisms
477206|NCT01113268|Biomarkers|biomarkers
477207|NCT01113255|VENTILATORS|ventilators
477208|NCT01113255|BENCH EVALUATION|bench evaluation
477209|NCT01113255|MECHANICAL VENTILATION|mechanical ventilation
477210|NCT01113242|Parkinson Disease Dementia|parkinson disease dementia
477211|NCT01113242|Observational|observational
477212|NCT01113242|Case control|case control
477213|NCT01113242|Neuropsychological assessment|neuropsychological assessment
477214|NCT01113229|Post Partum Haemorrhage,|post partum haemorrhage,
477215|NCT01113229|oxytocin,|oxytocin,
477216|NCT01113229|misoprostol,|misoprostol,
477217|NCT01113229|prevention,|prevention,
477218|NCT01113229|delivery.|delivery.
477219|NCT01113216|CF|cf
477220|NCT01113216|CFRD|cfrd
477221|NCT01113216|Diabetes|diabetes
477222|NCT01113216|Genetic Modifiers|genetic modifiers
477223|NCT01113203|resistance training|resistance training
477224|NCT01113203|blood pressure|blood pressure
477225|NCT01113203|hemodynamics|hemodynamics
477226|NCT01113203|autonomic|autonomic
477227|NCT01113203|Elderly Subjects|elderly subjects
477228|NCT01113177|Mandibular growth temporomandibular arthritis|mandibular growth temporomandibular arthritis
477229|NCT01113164|ondansetron|ondansetron
477230|NCT01113164|sertraline|sertraline
477231|NCT01113164|lab studies|lab studies
477232|NCT01113164|alcoholism|alcoholism
477233|NCT01113164|alcohol dependence|alcohol dependence
477234|NCT01113151|Steroid-resistant|steroid-resistant
477235|NCT01113151|Severe asthmatics|severe asthmatics
477236|NCT01113151|Annual symptoms|annual symptoms
477237|NCT01113151|Daily magnesium supplement|daily magnesium supplement
477238|NCT01113151|ACT (asthma control test)|act (asthma control test)
477239|NCT01113138|Clearance|clearance
477240|NCT01113138|Half-life|half-life
477241|NCT01113138|Absorption fraction|absorption fraction
477242|NCT01113138|Pharmacokinetics|pharmacokinetics
477243|NCT01113125|hypertrophic scar|hypertrophic scar
477244|NCT01113125|keloid|keloid
477245|NCT01113125|central venous catheter|central venous catheter
477246|NCT01113125|children|children
477247|NCT01113125|cancer|cancer
477248|NCT01113112|Ovarian Neoplasms|ovarian neoplasms
477249|NCT01113086|Parkinson|parkinson
477250|NCT01113086|Transcranial direct current stimulation|transcranial direct current stimulation
477251|NCT01113086|Motor function|motor function
477252|NCT01113086|Cognitive function|cognitive function
477253|NCT01113086|Affective function|affective function
477254|NCT01113073|pulse pressure variation|pulse pressure variation
477255|NCT01113073|hemodynamic monitoring|hemodynamic monitoring
477256|NCT01113073|fluid responsiveness|fluid responsiveness
477257|NCT01113073|mechanical ventilation|mechanical ventilation
477258|NCT01113073|fluid therapy|fluid therapy
477259|NCT01113060|Coronary Artery Disease|coronary artery disease
477260|NCT01113060|Aspirin|aspirin
477261|NCT01113060|Secondary Prevention|secondary prevention
477262|NCT01113047|Hypertension|hypertension
477263|NCT01113047|Aliskiren|aliskiren
477264|NCT01113047|Amlodipine|amlodipine
477265|NCT01113034|Asthma|asthma
477266|NCT01113034|Bronchiectasis|bronchiectasis
477267|NCT01113008|Myocardial Reperfusion Injury/mortality|myocardial reperfusion injury/mortality
477268|NCT01113008|Coronary angioplasty|coronary angioplasty
477269|NCT01113008|Reperfusion|reperfusion
477270|NCT01113008|Myocardial Reperfusion Injury/prevention & control|myocardial reperfusion injury/prevention & control
477271|NCT01112995|Probiotic|probiotic
477272|NCT01112995|Lactobacillus|lactobacillus
477273|NCT01112995|Antibiotic resistance|antibiotic resistance
477274|NCT01112982|Gout|gout
477275|NCT01112982|Synovial pannus|synovial pannus
477276|NCT01112982|Magnetic resonance imaging|magnetic resonance imaging
477277|NCT01112969|Internet-based supportive coaching|internet-based supportive coaching
477278|NCT01112969|guided self-help|guided self-help
477279|NCT01112969|Caregivers|caregivers
477280|NCT01112969|Brain Injury|brain injury
477281|NCT01112969|Caregiver Burden|caregiver burden
477282|NCT01112969|Coping|coping
477283|NCT01112969|Stress|stress
477284|NCT01112969|Depression|depression
477285|NCT01112956|HSV-2|hsv-2
477286|NCT01112956|HSV-1|hsv-1
477287|NCT01112956|Sensitivity|sensitivity
477288|NCT01112956|Specificity|specificity
477289|NCT01112956|Testing algorithm|testing algorithm
477290|NCT01112956|Test evaluation|test evaluation
477291|NCT01112943|Acupuncture, Pulmonary Rehabilitation, Inflammation, COPD|acupuncture, pulmonary rehabilitation, inflammation, copd
477292|NCT01112930|essential fatty acids|essential fatty acids
477293|NCT01112930|DHA|dha
477294|NCT01112930|preschool children|preschool children
477295|NCT01112930|docosahexanoic acid (DHA)|docosahexanoic acid (dha)
477296|NCT01112904|essential fatty acids|essential fatty acids
477297|NCT01112904|DHA status|dha status
477298|NCT01112904|preschool children|preschool children
477299|NCT01112904|gestation|gestation
477300|NCT01112891|Vitamin D|vitamin d
477301|NCT01112891|Infant|infant
477302|NCT01112891|Lactation|lactation
477303|NCT01112891|Dose-Response|dose-response
477304|NCT01112878|Shoulder arthroscopy|shoulder arthroscopy
477305|NCT01112878|Knee arthroscopy|knee arthroscopy
477306|NCT01112878|Clonidine|clonidine
477307|NCT01112878|Gabapentin|gabapentin
477308|NCT01112878|Pain management|pain management
477309|NCT01112878|Ambulatory surgery|ambulatory surgery
477310|NCT01112878|Perioperative outcome|perioperative outcome
477311|NCT01112878|Analgesia|analgesia
477312|NCT01112865|Growth Hormone Deficiency|growth hormone deficiency
477313|NCT01112865|Somatropin|somatropin
477314|NCT01112865|Injection Pen|injection pen
477315|NCT01112865|Medical Device|medical device
477316|NCT01112865|Cross Over Study|cross over study
477317|NCT01112865|Preference|preference
477318|NCT01112865|Convenience|convenience
477319|NCT01112865|Children|children
477320|NCT01112865|Dyads|dyads
477321|NCT01112865|Adults|adults
477322|NCT01112852|control of bleed|control of bleed
477323|NCT01112839|Overweight|overweight
477324|NCT01112839|Obese|obese
477325|NCT01112839|Breast cancer survivors|breast cancer survivors
477326|NCT01112839|Weight loss|weight loss
477327|NCT01112839|Exercise|exercise
477328|NCT01112839|Physical activity|physical activity
477329|NCT01112826|triple-negative breast cancer|triple-negative breast cancer
477330|NCT01112826|metronomic chemotherapy|metronomic chemotherapy
477331|NCT01112826|capecitabine (xeloda)|capecitabine (xeloda)
477332|NCT01112813|Stroke|stroke
477333|NCT01112813|lithium|lithium
477334|NCT01112813|MRI|mri
477335|NCT01112813|gray matter|gray matter
477336|NCT01112800|Anthracycline|anthracycline
477337|NCT01112800|Cardiac Muscle Injury|cardiac muscle injury
477338|NCT01112800|Doxorubicin|doxorubicin
477339|NCT01112800|Doppler Imaging|doppler imaging
477340|NCT01112800|Intermediate non-rhabdomyosarcoma soft tissue sarcomas|intermediate non-rhabdomyosarcoma soft tissue sarcomas
477341|NCT01112800|High-risk non-rhabdomyosarcoma soft tissue sarcomas|high-risk non-rhabdomyosarcoma soft tissue sarcomas
477342|NCT01112787|Healthy Volunteer Subjects|healthy volunteer subjects
477343|NCT01112774|Transcranial direct current stimulation|transcranial direct current stimulation
477344|NCT01112774|Spinal cord injury|spinal cord injury
477345|NCT01112774|Chronic pain|chronic pain
477346|NCT01112774|Brain excitability|brain excitability
477347|NCT01112761|Athletes|athletes
477348|NCT01112761|Multiple Concussions|multiple concussions
477349|NCT01112761|Transcranial Stimulation|transcranial stimulation
477350|NCT01112748|Focal neuropathic pain|focal neuropathic pain
477351|NCT01112735|Abdominoplasty|abdominoplasty
477352|NCT01112735|Flap adherence in subjects undergoing abdominoplasty to eliminate dead space and reduce seroma/hematoma formation|flap adherence in subjects undergoing abdominoplasty to eliminate dead space and reduce seroma/hematoma formation
477353|NCT01112722|honeybee toxin|honeybee toxin
477354|NCT01112722|Apitox|apitox
477355|NCT01112722|pain|pain
477356|NCT01112722|inflammation|inflammation
477357|NCT01112722|osteoarthritis|osteoarthritis
477358|NCT01112722|Apitoxin|apitoxin
477359|NCT01112709|Diabetes|diabetes
477360|NCT01112709|Prediabetes|prediabetes
477361|NCT01112709|Resistance training|resistance training
477362|NCT01112709|behavior|behavior
477363|NCT01112709|behavioral change theory|behavioral change theory
477364|NCT01112696|diabetes|diabetes
477365|NCT01112696|glucose sensor|glucose sensor
477366|NCT01112696|CGM|cgm
477367|NCT01112683|Down syndrome|down syndrome
477368|NCT01112683|Trisomy 21|trisomy 21
477369|NCT01112683|Pattern Recognition Memory (PRM)|pattern recognition memory (prm)
477370|NCT01112683|Paired Associates Learning (PAL)|paired associates learning (pal)
477371|NCT01112683|California Verbal Learning Test (CVLT)|california verbal learning test (cvlt)
477372|NCT01112683|Test of Reception of Grammar (TROG-II)|test of reception of grammar (trog-ii)
477373|NCT01112683|Peabody Picture Vocabulary Test (PPVT-III)|peabody picture vocabulary test (ppvt-iii)
477374|NCT01112683|Scales of Independent Behavior revised (SIB-R)|scales of independent behavior revised (sib-r)
477375|NCT01112670|Healthy volunteers|healthy volunteers
477376|NCT01112657|Multiple Sclerosis|multiple sclerosis
477377|NCT01112657|Clinical isolated syndrome|clinical isolated syndrome
477378|NCT01112657|Demyelination|demyelination
477379|NCT01112631|NSCLC,|nsclc,
477380|NCT01112631|PORT,|port,
477381|NCT01112631|Quality of Life,|quality of life,
477382|NCT01112631|Pulmonary function after RT|pulmonary function after rt
477383|NCT01112618|Infertility|infertility
477384|NCT01112618|Reproductive technologies, Assisted|reproductive technologies, assisted
477385|NCT01112618|r-hFSH|r-hfsh
477386|NCT01112618|r-hLH|r-hlh
477387|NCT01112618|Pergoveris|pergoveris
477388|NCT01112605|achilles tendon|achilles tendon
477389|NCT01112605|sural nerve|sural nerve
477390|NCT01112605|distance|distance
477391|NCT01112605|US|us
477392|NCT01112605|ultrasound|ultrasound
477393|NCT01112605|Distance between Sural nerve and the Achilles tendon|distance between sural nerve and the achilles tendon
477394|NCT01112592|NETs|nets
477395|NCT01112592|Infections|infections
477396|NCT01112592|Neutrophil function|neutrophil function
477397|NCT01112553|Acute Migraine|acute migraine
477398|NCT01112553|Treximet|treximet
477399|NCT01112553|Imaging|imaging
477400|NCT01112553|fMRI|fmri
477401|NCT01112553|Pain|pain
477402|NCT01112553|Heat Stimulus|heat stimulus
477403|NCT01112540|to evaluate the anal. efficacy of IV morph. vs. place. for elderly presenting to the ED with UAP and determine if it has an impact on diag. accu. and phy. exam|to evaluate the anal. efficacy of iv morph. vs. place. for elderly presenting to the ed with uap and determine if it has an impact on diag. accu. and phy. exam
477404|NCT01112527|PF-00299804|pf-00299804
477405|NCT01112514|ICG|icg
477406|NCT01112514|indocyanine green|indocyanine green
477407|NCT01112501|Diagnosis|diagnosis
477408|NCT01112501|Dementia|dementia
477409|NCT01112501|Imaging|imaging
477410|NCT01112488|stroke|stroke
477411|NCT01112488|patient engagement programme|patient engagement programme
477412|NCT01112488|community rehabilitation|community rehabilitation
477413|NCT01112488|new carer|new carer
477414|NCT01112462|Nasal congestion, Headache|nasal congestion, headache
477415|NCT01112449|selenium|selenium
477416|NCT01112449|oxidative stress|oxidative stress
477417|NCT01112449|prostate cancer|prostate cancer
477418|NCT01112449|PSA|psa
477419|NCT01112449|glucose|glucose
477420|NCT01112436|Pain|pain
477421|NCT01112436|preemptive|preemptive
477422|NCT01112436|Postoperative|postoperative
477423|NCT01112436|delirium|delirium
477424|NCT01112410|Bronchiectasis|bronchiectasis
477425|NCT01112410|Hypertonic saline|hypertonic saline
477426|NCT01112397|Jak2|jak2
477427|NCT01112397|cancer|cancer
477428|NCT01112397|jak 1|jak 1
477429|NCT01112397|stat 3|stat 3
477430|NCT01112397|Phase 1|phase 1
477431|NCT01112371|scars after abdominal Caesarean section|scars after abdominal caesarean section
477432|NCT01112358|Lutropin alfa|lutropin alfa
477433|NCT01112358|Fertilization in vitro|fertilization in vitro
477434|NCT01112358|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
477435|NCT01112358|Reproductive techniques, assisted|reproductive techniques, assisted
477436|NCT01112345|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
477437|NCT01112345|Interferon-beta|interferon-beta
477438|NCT01112319|COLD HOT or Electrotherapy treatment|cold hot or electrotherapy treatment
477439|NCT01112306|Open-label|open-label
477440|NCT01112306|PAH|pah
477441|NCT01112306|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
477442|NCT01112293|Subjects who have pleural malignant mesothelioma|subjects who have pleural malignant mesothelioma
477443|NCT01112280|Colorectal neoplasm|colorectal neoplasm
477444|NCT01112280|Colonoscopy|colonoscopy
477445|NCT01112280|chromoendoscopy|chromoendoscopy
477446|NCT01112280|cap-assisted colonoscopy|cap-assisted colonoscopy
477447|NCT01112267|Chronic low back pain|chronic low back pain
477448|NCT01112267|Tramadol Hydrochloride (HCl)|tramadol hydrochloride (hcl)
477449|NCT01112267|acetaminophen|acetaminophen
477450|NCT01112254|Ductal Carcinoma In Situ (DCIS) breast cancer|ductal carcinoma in situ (dcis) breast cancer
477451|NCT01112241|Obliterative bronchiolitis|obliterative bronchiolitis
477452|NCT01112241|Bronchodilator responsiveness|bronchodilator responsiveness
477453|NCT01112241|Partial forced expiratory flow|partial forced expiratory flow
477454|NCT01112241|Lung volumes|lung volumes
477455|NCT01112215|SLE|sle
477456|NCT01112215|non-renal manifestations|non-renal manifestations
477457|NCT01112202|direct thrombin inhibitors|direct thrombin inhibitors
477458|NCT01112202|Dabigatran|dabigatran
477459|NCT01112202|Coagulation parameters|coagulation parameters
477460|NCT01112189|Lymphedema|lymphedema
477461|NCT01112189|Stem cells|stem cells
477462|NCT01112189|Mastectomy|mastectomy
477463|NCT01112189|Breast Cancer|breast cancer
477464|NCT01112176|Strain|strain
477465|NCT01112176|Ejection fraction|ejection fraction
477466|NCT01112176|Diastolic function|diastolic function
477467|NCT01112163|ischemic heart disease|ischemic heart disease
477468|NCT01112150|Edema|edema
477469|NCT01112150|Heart failure|heart failure
477470|NCT01112150|Pulmonary hypertension|pulmonary hypertension
477471|NCT01112150|Edema in legs|edema in legs
477472|NCT01112124|Typical|typical
477473|NCT01112124|Development|development
477474|NCT01112124|Microwave|microwave
477475|NCT01112124|Children|children
477476|NCT01112124|Behavior|behavior
477477|NCT01112085|Diabetic macular edema|diabetic macular edema
477478|NCT01112085|Ranibizumab|ranibizumab
477479|NCT01112072|keratoconus|keratoconus
477480|NCT01112072|corneal ectasia|corneal ectasia
477481|NCT01112072|collagen crosslinking|collagen crosslinking
477482|NCT01112072|riboflavin|riboflavin
477483|NCT01112072|cornea|cornea
477484|NCT01112072|ultraviolet|ultraviolet
477485|NCT01112059|cystic fibrosis|cystic fibrosis
477486|NCT01112046|Early colorectal neoplasms|early colorectal neoplasms
477487|NCT01112033|biliverdin reductase|biliverdin reductase
477488|NCT01112033|BLVRA|blvra
477489|NCT01112033|hepatitis C|hepatitis c
477490|NCT01112033|HCV|hcv
477491|NCT01112033|peripheral blood mononuclear cells|peripheral blood mononuclear cells
477492|NCT01112033|PBMC|pbmc
477493|NCT01112033|liver|liver
477494|NCT01112033|genetic polymorphisms|genetic polymorphisms
477495|NCT01112020|Chlorhexidine digluconate (CHG)|chlorhexidine digluconate (chg)
477496|NCT01112020|Biopatch Protective Disk|biopatch protective disk
477497|NCT01112020|Tegaderm CHG IV (intravenous) Securement Dressing|tegaderm chg iv (intravenous) securement dressing
477498|NCT01112020|parachloroaniline (PCA)|parachloroaniline (pca)
477499|NCT01112020|No condition being studied.|no condition being studied.
477500|NCT01112020|Assessing components of CHG-containing dressings after use.|assessing components of chg-containing dressings after use.
477501|NCT01112007|Insulin Resistance|insulin resistance
477502|NCT01112007|Hypertension|hypertension
477503|NCT01112007|Blood pressure|blood pressure
477504|NCT01112007|Aldosterone|aldosterone
477505|NCT01112007|Renin|renin
477506|NCT01111994|hyperpigmentation|hyperpigmentation
477507|NCT01111981|alopecia|alopecia
477508|NCT01111981|CCCA - Central Centrifugal Cicatricial Alopecia|ccca - central centrifugal cicatricial alopecia
477509|NCT01111968|vaccine|vaccine
477510|NCT01111968|pandemic influenza A|pandemic influenza a
477511|NCT01111968|adjuvant|adjuvant
477512|NCT01111968|safety|safety
477513|NCT01111942|head and neck cancer|head and neck cancer
477514|NCT01111942|chemotherapy|chemotherapy
477515|NCT01111942|radiation|radiation
477516|NCT01111929|Emergency contraception|emergency contraception
477517|NCT01111929|pregnancy during breastfeeding|pregnancy during breastfeeding
477518|NCT01111929|Lactational amenorrhea Method|lactational amenorrhea method
477519|NCT01111929|unplanned pregnancy|unplanned pregnancy
477520|NCT01111877|ear tubes|ear tubes
477521|NCT01111877|ear drainage|ear drainage
477522|NCT01111877|ear infection|ear infection
477523|NCT01111877|ear drops|ear drops
477524|NCT01111877|tympanostomy tubes|tympanostomy tubes
477525|NCT01111877|Pediatric patients|pediatric patients
477526|NCT01111851|NK1-receptor occupancy|nk1-receptor occupancy
477527|NCT01111838|STA-9090|sta-9090
477528|NCT01111838|colon|colon
477529|NCT01111838|rectal|rectal
477530|NCT01111838|10-029|10-029
477531|NCT01111825|HKI-272 (NERATINIB)|hki-272 (neratinib)
477532|NCT01111825|TEMSIROLIMUS (CCI-779)|temsirolimus (cci-779)
477533|NCT01111825|HER2-Amplified|her2-amplified
477534|NCT01111825|Triple-negative|triple-negative
477535|NCT01111825|invasive adenocarcinoma|invasive adenocarcinoma
477536|NCT01111825|10-005|10-005
477537|NCT01111825|Nerlynx|nerlynx
477538|NCT01111825|PB-272|pb-272
477539|NCT01111812|overweight|overweight
477540|NCT01111812|obese|obese
477541|NCT01111812|children|children
477542|NCT01111812|weighing|weighing
477543|NCT01111812|weight|weight
477544|NCT01111799|endometrial biopsy|endometrial biopsy
477545|NCT01111799|implantation|implantation
477546|NCT01111799|uterine receptivity|uterine receptivity
477547|NCT01111799|infertility|infertility
477548|NCT01111799|controled ovarian hyperstimulation|controled ovarian hyperstimulation
477549|NCT01111799|intra uterine insemination|intra uterine insemination
477550|NCT01111786|scleroderma|scleroderma
477551|NCT01111786|skin|skin
477552|NCT01111786|tightness|tightness
477553|NCT01111786|durometer|durometer
477554|NCT01111773|Patellar tendonitis|patellar tendonitis
477555|NCT01111760|cardiovascular disease|cardiovascular disease
477556|NCT01111760|heart CT scan|heart ct scan
477557|NCT01111760|CT scan|ct scan
477558|NCT01111760|pulmonary embolisms|pulmonary embolisms
477559|NCT01111760|aortography|aortography
477560|NCT01111747|platelet-rich plasma|platelet-rich plasma
477561|NCT01111747|patellar ligament|patellar ligament
477562|NCT01111747|regeneration|regeneration
477563|NCT01111747|growth substances|growth substances
477564|NCT01111734|self harm|self harm
477565|NCT01111734|self injury|self injury
477566|NCT01111734|self mutilation|self mutilation
477567|NCT01111734|N-Acetylcysteine|n-acetylcysteine
477568|NCT01111734|adolescents|adolescents
477569|NCT01111734|impulse control disorder|impulse control disorder
477570|NCT01111734|borderline personality disorder|borderline personality disorder
477571|NCT01111734|fMRI|fmri
477572|NCT01111721|Sexually Transmitted Diseases|sexually transmitted diseases
477573|NCT01111721|HIV Infections|hiv infections
477574|NCT01111721|Genital Diseases, Female|genital diseases, female
477575|NCT01111721|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
477576|NCT01111721|Risk Reduction Behavior|risk reduction behavior
477577|NCT01111721|HIV prevention|hiv prevention
477578|NCT01111695|wound healing|wound healing
477579|NCT01111695|granulation tissue|granulation tissue
477580|NCT01111695|Varicose Ulcer|varicose ulcer
477581|NCT01111682|traumatic brain injury|traumatic brain injury
477582|NCT01111682|hypertonic saline therapy|hypertonic saline therapy
477583|NCT01111682|intracranial pressure|intracranial pressure
477584|NCT01111669|Functional Endoscopic Sinus Surgery|functional endoscopic sinus surgery
477585|NCT01111669|Tranexamic Acid|tranexamic acid
477586|NCT01111656|Multi-center|multi-center
477587|NCT01111656|randomized|randomized
477588|NCT01111656|prospective|prospective
477589|NCT01111656|parallel-group|parallel-group
477590|NCT01111656|rater-blinded|rater-blinded
477591|NCT01111656|RR-MS|rr-ms
477592|NCT01111630|chronic renal failure|chronic renal failure
477593|NCT01111630|Anaemia|anaemia
477594|NCT01111604|Colonic Neoplasms|colonic neoplasms
477595|NCT01111604|Rectal Neoplasms|rectal neoplasms
477596|NCT01111604|Adenocarcinoma|adenocarcinoma
477597|NCT01111604|Antibodies, Monoclonal|antibodies, monoclonal
477598|NCT01111591|Cyclooxygenase-2 inhibitor (Celecoxib)|cyclooxygenase-2 inhibitor (celecoxib)
477599|NCT01111591|Extrahepatic bile duct cancer|extrahepatic bile duct cancer
477600|NCT01111591|Pancreas cancer|pancreas cancer
477601|NCT01111565|Major Depressive Disorder|major depressive disorder
477602|NCT01111565|MDD|mdd
477603|NCT01111565|Depression|depression
477604|NCT01111552|Major Depressive Disorder|major depressive disorder
477605|NCT01111552|MDD|mdd
477606|NCT01111552|Depression|depression
477607|NCT01111539|Major Depressive Disorder|major depressive disorder
477608|NCT01111539|MDD|mdd
477609|NCT01111539|Depression|depression
477610|NCT01111526|Graft versus host disease|graft versus host disease
477611|NCT01111526|GVHD|gvhd
477612|NCT01111526|allogeneic transplant|allogeneic transplant
477613|NCT01111526|acute GVHD|acute gvhd
477614|NCT01111526|chronic GVHD|chronic gvhd
477615|NCT01111513|knee surgery|knee surgery
477616|NCT01111513|total knee arthroplasty|total knee arthroplasty
477617|NCT01111513|total knee replacement|total knee replacement
477618|NCT01111513|ropivacaine|ropivacaine
477619|NCT01111513|femoral nerve block|femoral nerve block
477620|NCT01111487|COPD|copd
477621|NCT01111487|Electromyography|electromyography
477622|NCT01111487|Inspiratory muscles|inspiratory muscles
477623|NCT01111474|dentin hypersensitivity|dentin hypersensitivity
477624|NCT01111474|cyanoacrylate|cyanoacrylate
477625|NCT01111474|laser|laser
477626|NCT01111461|Advanced Endometrial Cancer|advanced endometrial cancer
477627|NCT01111448|Myelodysplastic Syndromes of all IPSS subgroups|myelodysplastic syndromes of all ipss subgroups
477628|NCT01111422|Antioxidant|antioxidant
477629|NCT01111422|Epithelial to Mesenchymal Transition|epithelial to mesenchymal transition
477630|NCT01111422|peritoneal fibrosis|peritoneal fibrosis
477631|NCT01111422|Peritoneal Dialysis, Continuous Ambulatory|peritoneal dialysis, continuous ambulatory
477632|NCT01111396|ALL|all
477633|NCT01111396|GMALL 2003|gmall 2003
477634|NCT01111396|Chemotherapy|chemotherapy
477635|NCT01111396|Hippocampus|hippocampus
477636|NCT01111383|cystic fibrosis|cystic fibrosis
477637|NCT01111383|P. aeruginosa|p. aeruginosa
477638|NCT01111383|tobramycin|tobramycin
477639|NCT01111370|diabetes mellitus requiring insulin|diabetes mellitus requiring insulin
477640|NCT01111357|Rheumatoid Arthritis|rheumatoid arthritis
477641|NCT01111357|Rheumatoid Arthritis according to ACR criteria of diagnosis|rheumatoid arthritis according to acr criteria of diagnosis
477642|NCT01111344|Dietary supplement|dietary supplement
477643|NCT01111344|Anogenital warts|anogenital warts
477644|NCT01111344|Viusid|viusid
477645|NCT01111344|Glizigen|glizigen
477646|NCT01111305|Filariasis|filariasis
477647|NCT01111305|Post-Treatment Reactions|post-treatment reactions
477648|NCT01111305|Monoclonal Antibody|monoclonal antibody
477649|NCT01111305|Loa Loa|loa loa
477650|NCT01111305|Loiasis|loiasis
477651|NCT01111266|in vivo KUF|in vivo kuf
477652|NCT01111266|ß2M|ß2m
477653|NCT01111266|leptin|leptin
477654|NCT01111253|multicenter randomized, open label, clinical trial|multicenter randomized, open label, clinical trial
477655|NCT01111253|acute uncomplicated (mild) diverticulitis|acute uncomplicated (mild) diverticulitis
477656|NCT01111253|treatment strategies|treatment strategies
477657|NCT01111253|management of diverticulitis|management of diverticulitis
477658|NCT01111253|antibiotics|antibiotics
477659|NCT01111253|observation and supportive care|observation and supportive care
477660|NCT01111253|cost analysis|cost analysis
477661|NCT01111253|economic evaluation|economic evaluation
477662|NCT01111240|Humira|humira
477663|NCT01111240|Long-term safety and effectiveness|long-term safety and effectiveness
477664|NCT01111240|Psoriatic Arthritis|psoriatic arthritis
477665|NCT01111227|cytokines|cytokines
477666|NCT01111227|propofol|propofol
477667|NCT01111227|isoflurane|isoflurane
477668|NCT01111227|flow cytometry|flow cytometry
477669|NCT01111227|Types of General Anesthesia|types of general anesthesia
477670|NCT01111214|Invasive Pneumococcal Disease (IPD)|invasive pneumococcal disease (ipd)
477671|NCT01111214|pneumococcal serotypes|pneumococcal serotypes
477672|NCT01111201|Autologous Bone Marrow Transplant|autologous bone marrow transplant
477673|NCT01111201|Breast|breast
477674|NCT01111201|Lymphoma|lymphoma
477675|NCT01111201|International travel|international travel
477676|NCT01111201|questionnaire|questionnaire
477677|NCT01111201|Hematopoietic Stem Cell Transplant (HSCT) recipients|hematopoietic stem cell transplant (hsct) recipients
477678|NCT01111175|Locally recurrent breast cancer|locally recurrent breast cancer
477679|NCT01111162|HIV|hiv
477680|NCT01111162|H1N1 vaccination|h1n1 vaccination
477681|NCT01111162|HIV infected individuals|hiv infected individuals
477682|NCT01111149|Schizophrenia|schizophrenia
477683|NCT01111149|Smoking cessation|smoking cessation
477684|NCT01111149|Varenicline|varenicline
477685|NCT01111149|Bupropion|bupropion
477686|NCT01111136|Urticaria|urticaria
477687|NCT01111136|Hives|hives
477688|NCT01111136|Stress|stress
477689|NCT01111123|plaque psoriasis|plaque psoriasis
477690|NCT01111123|lac-hydrin|lac-hydrin
477691|NCT01111123|ammonium lactate|ammonium lactate
477692|NCT01111123|Ultravate|ultravate
477693|NCT01111123|halobetasol propionate|halobetasol propionate
477694|NCT01111123|weekend only application|weekend only application
477695|NCT01111123|topical therapy|topical therapy
477696|NCT01111123|topical corticosteroid|topical corticosteroid
477697|NCT01111123|class I steroid|class i steroid
477698|NCT01111097|Brain tumors, Glioblastoma and DCA|brain tumors, glioblastoma and dca
477699|NCT01111097|Brain tumor,Glioblastoma recurrent|brain tumor,glioblastoma recurrent
477700|NCT01111084|Ovulation induction|ovulation induction
477701|NCT01111084|Ovarian Hyperstimulation Syndrome|ovarian hyperstimulation syndrome
477702|NCT01111084|Pregnancy|pregnancy
477703|NCT01111084|Fertility|fertility
477704|NCT01111071|hospital variation|hospital variation
477705|NCT01111071|30 day mortality|30 day mortality
477706|NCT01111071|in hospital mortality|in hospital mortality
477707|NCT01111071|acute coronary syndrome|acute coronary syndrome
477708|NCT01111071|myocardial infarction|myocardial infarction
477709|NCT01111071|unstable angina|unstable angina
477710|NCT01111071|hospital performance|hospital performance
477711|NCT01111071|trends|trends
477712|NCT01111058|Squamous Cell Cancer|squamous cell cancer
477713|NCT01111032|Treadmill|treadmill
477714|NCT01111032|Exercise|exercise
477715|NCT01111032|Cancer|cancer
477716|NCT01111032|Validity|validity
477717|NCT01111032|Reliability|reliability
477718|NCT01111019|Hypochondroplasia|hypochondroplasia
477719|NCT01111019|Skeletal dysplasia|skeletal dysplasia
477720|NCT01111019|Growth|growth
477721|NCT01111019|Growth Hormone|growth hormone
477722|NCT01111019|Recombinant-human Growth Hormone|recombinant-human growth hormone
477723|NCT01111006|Electronic toilet|electronic toilet
477724|NCT01111006|Bidet|bidet
477725|NCT01111006|Anorectal resting pressure|anorectal resting pressure
477726|NCT01110993|Multiple Sclerosis, Interferon-beta 1-a|multiple sclerosis, interferon-beta 1-a
477727|NCT01110980|Head and Neck neoplasms|head and neck neoplasms
477728|NCT01110980|Radiotherapy|radiotherapy
477729|NCT01110980|Diet counselling|diet counselling
477730|NCT01110980|Swallow therapy|swallow therapy
477731|NCT01110980|Food intake|food intake
477732|NCT01110941|S-1|s-1
477733|NCT01110941|leucovorin|leucovorin
477734|NCT01110941|oxaliplatin|oxaliplatin
477735|NCT01110941|colorectal cancer|colorectal cancer
477737|NCT01110941|unresectable or recurrent colorectal cancer|unresectable or recurrent colorectal cancer
477738|NCT01110902|Agomelatine|agomelatine
477739|NCT01110902|Major Depressive Disorder|major depressive disorder
477740|NCT01110902|MDD|mdd
477741|NCT01110902|depression|depression
477742|NCT01110889|Agomelatine|agomelatine
477743|NCT01110889|Major Depressive Disorder|major depressive disorder
477744|NCT01110889|MDD|mdd
477745|NCT01110889|depression|depression
477746|NCT01110876|Recurrent Glioblastoma Multiforme|recurrent glioblastoma multiforme
477747|NCT01110876|GBM|gbm
477748|NCT01110876|Brain|brain
477749|NCT01110876|Central Nervous Center|central nervous center
477750|NCT01110876|Malignant glioma|malignant glioma
477751|NCT01110876|Glioblastoma multiforme|glioblastoma multiforme
477752|NCT01110876|Gliosarcoma|gliosarcoma
477753|NCT01110876|Anaplastic astrocytoma|anaplastic astrocytoma
477754|NCT01110876|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
477755|NCT01110876|Anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
477756|NCT01110876|Vorinostat|vorinostat
477757|NCT01110876|SAHA|saha
477758|NCT01110876|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
477759|NCT01110876|MSK-390|msk-390
477760|NCT01110876|Zolinza|zolinza
477761|NCT01110876|Erlotinib|erlotinib
477762|NCT01110876|Erlotinib Hydrochloride|erlotinib hydrochloride
477763|NCT01110876|OSI-774|osi-774
477764|NCT01110876|Tarceva|tarceva
477765|NCT01110876|Temozolomide|temozolomide
477766|NCT01110876|Temodar|temodar
477767|NCT01110863|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
477768|NCT01110850|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
477769|NCT01110837|Allergic rhinitis|allergic rhinitis
477770|NCT01110837|Allergen|allergen
477771|NCT01110824|Prevention|prevention
477772|NCT01110824|ventricular dysfunction|ventricular dysfunction
477773|NCT01110824|chemotherapy|chemotherapy
477774|NCT01110824|acute myeloid leukemia|acute myeloid leukemia
477775|NCT01110824|precursor-cell lymphoblastic leukemia|precursor-cell lymphoblastic leukemia
477776|NCT01110824|multiple myeloma|multiple myeloma
477777|NCT01110824|lymphoma|lymphoma
477778|NCT01110824|ejection fraction|ejection fraction
477779|NCT01110824|Autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
477780|NCT01110811|GERD|gerd
477781|NCT01110811|Esophagitis|esophagitis
477782|NCT01110811|Fundoplication|fundoplication
477783|NCT01110811|Anti-reflux surgery|anti-reflux surgery
477784|NCT01110811|PPI dependent|ppi dependent
477785|NCT01110798|perioperative/postoperative complications|perioperative/postoperative complications
477786|NCT01110798|gastrointestinal complications|gastrointestinal complications
477787|NCT01110798|adenocarcinoma of the rectum|adenocarcinoma of the rectum
477788|NCT01110798|stage I rectal cancer|stage i rectal cancer
477789|NCT01110798|stage II rectal cancer|stage ii rectal cancer
477790|NCT01110798|stage III rectal cancer|stage iii rectal cancer
477791|NCT01110785|recurrent colon cancer|recurrent colon cancer
477792|NCT01110785|stage III colon cancer|stage iii colon cancer
477793|NCT01110785|stage IV colon cancer|stage iv colon cancer
477794|NCT01110785|recurrent rectal cancer|recurrent rectal cancer
477795|NCT01110785|stage III rectal cancer|stage iii rectal cancer
477796|NCT01110785|stage IV rectal cancer|stage iv rectal cancer
477797|NCT01110772|Surgical site infection|surgical site infection
477798|NCT01110772|Skin preparation|skin preparation
477799|NCT01110772|Cost analysis|cost analysis
477800|NCT01110759|pain management|pain management
477801|NCT01110759|ambulatory surgery|ambulatory surgery
477802|NCT01110759|opioid|opioid
477803|NCT01110759|local anesthesia|local anesthesia
477804|NCT01110759|hand surgery|hand surgery
477805|NCT01110759|postoperative pain|postoperative pain
477806|NCT01110733|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
477807|NCT01110733|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
477808|NCT01110733|Lymphoma|lymphoma
477809|NCT01110707|Reproductive technology, Assisted|reproductive technology, assisted
477810|NCT01110707|Recombinant human follicle stimulating hormone (r-hFSH)|recombinant human follicle stimulating hormone (r-hfsh)
477811|NCT01110707|Recombinant leutinizing hormone (r-hLH)|recombinant leutinizing hormone (r-hlh)
477812|NCT01110707|Ovulation induction|ovulation induction
477813|NCT01110707|Infertility|infertility
477814|NCT01110694|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
477815|NCT01110694|Interstitial lung disease|interstitial lung disease
477816|NCT01110694|Prognosis|prognosis
477817|NCT01110694|Biomarkers|biomarkers
477818|NCT01110694|Mortality|mortality
477819|NCT01110694|Acute exacerbations|acute exacerbations
477820|NCT01110668|Unresectable|unresectable
477821|NCT01110668|metastatic gastrointestinal stromal tumor|metastatic gastrointestinal stromal tumor
477822|NCT01110668|disease progression|disease progression
477823|NCT01110668|progression-free survival|progression-free survival
477824|NCT01110655|Exercise-associated hyponatremia|exercise-associated hyponatremia
477825|NCT01110655|Randomized treatment trial|randomized treatment trial
477826|NCT01110655|Endurance runners|endurance runners
477827|NCT01110629|Chronic kidney disease not on dialysis|chronic kidney disease not on dialysis
477828|NCT01110629|Lanthanum carbonate|lanthanum carbonate
477829|NCT01110616|EEG Standardization|eeg standardization
477830|NCT01110603|Cancer|cancer
477831|NCT01110603|Advanced Solid Tumors|advanced solid tumors
477832|NCT01110590|Erectile Dysfunction|erectile dysfunction
477833|NCT01110577|MRI|mri
477834|NCT01110577|Hepatic Steatosis Study|hepatic steatosis study
477835|NCT01110564|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
477836|NCT01110564|daily symptom variability|daily symptom variability
477837|NCT01110564|effects of symptom on morning activities|effects of symptom on morning activities
477838|NCT01110551|Dengue, vaccine, flavivirus|dengue, vaccine, flavivirus
477839|NCT01110525|Phase I|phase i
477840|NCT01110525|Drug-drug interaction|drug-drug interaction
477841|NCT01110525|Oral contraceptives|oral contraceptives
477842|NCT01110525|AZD 1981|azd 1981
477843|NCT01110512|Improvement of CVI parameters|improvement of cvi parameters
477844|NCT01110447|Hepatic Encephalopathy, probiotics|hepatic encephalopathy, probiotics
477845|NCT01110421|Doripenem|doripenem
477846|NCT01110421|Child, Hospitalized|child, hospitalized
477847|NCT01110421|Cefepime|cefepime
477848|NCT01110421|Infusions, Intravenous|infusions, intravenous
477849|NCT01110421|Severe community acquired pneumonia|severe community acquired pneumonia
477850|NCT01110421|Nosocomial pneumonia|nosocomial pneumonia
477851|NCT01110421|Ventilator associated pneumonia|ventilator associated pneumonia
477852|NCT01110408|Antibiotic|antibiotic
477853|NCT01110408|Child, Hospitalized|child, hospitalized
477854|NCT01110408|Complicated Urinary Tract Infection|complicated urinary tract infection
477855|NCT01110408|Pyelonephritis|pyelonephritis
477856|NCT01110408|Doripenem|doripenem
477857|NCT01110408|Cefepime|cefepime
477858|NCT01110382|Anti-Infective Agents|anti-infective agents
477859|NCT01110382|Doripenem|doripenem
477860|NCT01110382|Meropenem|meropenem
477861|NCT01110382|Child, Hospitalized|child, hospitalized
477862|NCT01110382|Complicated Intra-Abdominal Infections|complicated intra-abdominal infections
477863|NCT01110369|sarcopenia|sarcopenia
477864|NCT01110369|frail elderly|frail elderly
477865|NCT01110369|protein drink|protein drink
477866|NCT01110369|resistance exercise|resistance exercise
477867|NCT01110369|Skeletal muscle mass|skeletal muscle mass
477868|NCT01110369|muscle mass in elderly|muscle mass in elderly
477869|NCT01110343|parent stress|parent stress
477870|NCT01110343|parent coping|parent coping
477871|NCT01110343|parent anxiety|parent anxiety
477872|NCT01110343|parent health|parent health
477873|NCT01110343|parent depression|parent depression
477874|NCT01110330|Tinea Pedis|tinea pedis
477875|NCT01110330|Ketoconazole (NIZORAL)|ketoconazole (nizoral)
477876|NCT01110330|Antifungal Agents|antifungal agents
477877|NCT01110330|Miconazole (DAKTARIN)|miconazole (daktarin)
477878|NCT01110317|Paliperidone palmitate|paliperidone palmitate
477879|NCT01110317|R092670PSY1001|r092670psy1001
477880|NCT01110317|Pharmacokinetics|pharmacokinetics
477881|NCT01110317|Risperdal (CONSTA)|risperdal (consta)
477882|NCT01110317|Risperidone, Paliperidone|risperidone, paliperidone
477883|NCT01110304|acromio-clavicular joint dislocation|acromio-clavicular joint dislocation
477884|NCT01110304|type III acromio-clavicular joint dislocation|type iii acromio-clavicular joint dislocation
477885|NCT01110304|joint dislocation|joint dislocation
477886|NCT01110304|clavicle hook plate|clavicle hook plate
477887|NCT01110291|docetaxel toxicity|docetaxel toxicity
477888|NCT01110291|CYP3A activity|cyp3a activity
477889|NCT01110291|CYP3A5|cyp3a5
477890|NCT01110291|MDR1|mdr1
477891|NCT01110291|peroral midazolam|peroral midazolam
477892|NCT01110278|Urge Urinary Incontinence|urge urinary incontinence
477893|NCT01110278|Magnetic Resonance Imaging|magnetic resonance imaging
477894|NCT01110278|Diffusion Tensor Imaging|diffusion tensor imaging
477895|NCT01110278|Brain Connectivity|brain connectivity
477896|NCT01110278|Bladder Control|bladder control
477897|NCT01110278|fMRI|fmri
477898|NCT01110252|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
477899|NCT01110252|Emphysema|emphysema
477900|NCT01110252|Cell therapy|cell therapy
477901|NCT01110252|Bone marrow mononuclear cells|bone marrow mononuclear cells
477902|NCT01110252|stem cells|stem cells
477903|NCT01110239|limb preconditioning|limb preconditioning
477904|NCT01110239|remote preconditioning|remote preconditioning
477905|NCT01110239|ischemic preconditioning|ischemic preconditioning
477906|NCT01110226|non small cell lung cancer|non small cell lung cancer
477907|NCT01110226|small cell lung cancer|small cell lung cancer
477908|NCT01110226|Platinum Responsive|platinum responsive
477909|NCT01110226|solid tumor malignancies|solid tumor malignancies
477910|NCT01110213|Aging|aging
477911|NCT01110213|physical activity|physical activity
477912|NCT01110213|diet|diet
477913|NCT01110213|goal setting|goal setting
477914|NCT01110200|Hospitalization|hospitalization
477915|NCT01110200|Exacerbations of COPD|exacerbations of copd
477916|NCT01110200|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
477917|NCT01110187|Lacosamide|lacosamide
477918|NCT01110187|Fosphenytoin|fosphenytoin
477919|NCT01110187|traumatic brain injury|traumatic brain injury
477920|NCT01110187|Glasgow coma scale|glasgow coma scale
477921|NCT01110187|Disability Rating Scale|disability rating scale
477922|NCT01110187|Resource Utilization Questionnaire|resource utilization questionnaire
477923|NCT01110187|Continuous EEG|continuous eeg
477924|NCT01110187|seizures|seizures
477925|NCT01110161|Abdominal Fat|abdominal fat
477926|NCT01110161|Visceral Fat|visceral fat
477927|NCT01110161|Subcutaneous Fat|subcutaneous fat
477928|NCT01110161|Dual-energy x-ray absorptiometry|dual-energy x-ray absorptiometry
477929|NCT01110161|DXA|dxa
477930|NCT01110161|Computed Tomography|computed tomography
477931|NCT01110161|CT|ct
477932|NCT01110161|Body Mass Index|body mass index
477933|NCT01110161|Body composition|body composition
477934|NCT01110161|Percent fat|percent fat
477935|NCT01110161|Waist circumference|waist circumference
477936|NCT01110161|Hip circumference|hip circumference
477937|NCT01110148|skin biopsy|skin biopsy
477938|NCT01110148|informed consent|informed consent
477939|NCT01110148|patient education|patient education
477940|NCT01110148|video education|video education
477941|NCT01110148|patients requiring skin biopsies|patients requiring skin biopsies
477942|NCT01110122|Muscle recovery|muscle recovery
477943|NCT01110122|Intermittent exercise|intermittent exercise
477944|NCT01110122|Whey protein|whey protein
477945|NCT01110122|Soccer|soccer
477946|NCT01110109|Adult|adult
477947|NCT01110109|Surgery|surgery
477948|NCT01110109|Endotracheal Tube|endotracheal tube
477949|NCT01110109|Ventilator|ventilator
477950|NCT01110109|Pneumonia|pneumonia
477951|NCT01110109|Suctioning|suctioning
477952|NCT01110096|Obesity|obesity
477953|NCT01110096|Child|child
477954|NCT01110096|Parent|parent
477955|NCT01110096|Family|family
477956|NCT01110083|Phase 1|phase 1
477957|NCT01110083|advanced solid tumors|advanced solid tumors
477958|NCT01110083|refractory to standard therapy|refractory to standard therapy
477959|NCT01110083|Patients with solid tumors, either refractory to standard therapy or for which no effective standard therapy is available|patients with solid tumors, either refractory to standard therapy or for which no effective standard therapy is available
477960|NCT01110070|articular|articular
477961|NCT01110070|cartilage|cartilage
477962|NCT01110070|microfracture|microfracture
477963|NCT01110070|knee pain|knee pain
477964|NCT01110070|cartilage repair|cartilage repair
477965|NCT01110070|Subjects with an articular cartilage defect in the knee.|subjects with an articular cartilage defect in the knee.
477966|NCT01110057|p38 kinase inhibitor|p38 kinase inhibitor
477967|NCT01110057|male and female|male and female
477968|NCT01110057|patients|patients
477969|NCT01110044|Neonatal vaccination|neonatal vaccination
477970|NCT01110031|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
477971|NCT01110031|Cardiac Repolarization (QTc)|cardiac repolarization (qtc)
477972|NCT01110018|Tolerability|tolerability
477973|NCT01110018|COPD|copd
477974|NCT01110018|Safety|safety
477975|NCT01110018|Muscarinic receptor (mAChR) antagonist|muscarinic receptor (machr) antagonist
477976|NCT01110018|GSK573719|gsk573719
477977|NCT01110018|Healthy subjects|healthy subjects
477978|NCT01110018|Pharmacokinetics|pharmacokinetics
477979|NCT01110018|IV study|iv study
477980|NCT01110005|D5LR|d5lr
477981|NCT01110005|glucose containing IV solution|glucose containing iv solution
477982|NCT01110005|LR|lr
477983|NCT01110005|non glucose IV solution|non glucose iv solution
477984|NCT01109992|coronary artery disease|coronary artery disease
477985|NCT01109992|exercise|exercise
477986|NCT01109992|regadenoson|regadenoson
477987|NCT01109992|positron emission tomography|positron emission tomography
477988|NCT01109979|Cardiovascular, vascular|cardiovascular, vascular
477989|NCT01109966|Allergy|allergy
477990|NCT01109966|Cow's Milk|cow's milk
477991|NCT01109966|Infants|infants
477992|NCT01109966|Food Allergy|food allergy
477993|NCT01109953|Lung|lung
477994|NCT01109953|PET/CT scan|pet/ct scan
477995|NCT01109953|10-054|10-054
477996|NCT01109940|Ankylosing spondylitis|ankylosing spondylitis
477997|NCT01109940|IgG1K monoclonal antibody|igg1k monoclonal antibody
477998|NCT01109940|Interleukin -17A neutralizing|interleukin -17a neutralizing
477999|NCT01109914|Renal transplantation|renal transplantation
478000|NCT01109914|Immunosuppression|immunosuppression
478001|NCT01109914|ETEC|etec
478002|NCT01109914|Dukoral|dukoral
478003|NCT01109914|Vaccination|vaccination
478004|NCT01109914|Immunity, Humoral|immunity, humoral
478005|NCT01109901|Cubital tunnel,subcutaneous transposition,submuscular|cubital tunnel,subcutaneous transposition,submuscular
478006|NCT01109862|Femoral neck fractures|femoral neck fractures
478007|NCT01109862|Hip fractures|hip fractures
478008|NCT01109862|Elderly|elderly
478009|NCT01109862|Total hip arthroplasty|total hip arthroplasty
478010|NCT01109862|Bipolar hemiarthroplasty|bipolar hemiarthroplasty
478011|NCT01109849|ADHD|adhd
478012|NCT01109849|growth|growth
478013|NCT01109849|BMI|bmi
478014|NCT01109849|stimulant medication|stimulant medication
478015|NCT01109836|prevention|prevention
478016|NCT01109836|cognitive decline|cognitive decline
478017|NCT01109836|post-stroke dementia|post-stroke dementia
478018|NCT01109836|life-style intervention|life-style intervention
478019|NCT01109836|vascular risk factors|vascular risk factors
478020|NCT01109836|polyintervention|polyintervention
478021|NCT01109836|multifactorial treatment|multifactorial treatment
478022|NCT01109823|Patients hospitalized at Intensive Care Unit treated with levofloxacin IV|patients hospitalized at intensive care unit treated with levofloxacin iv
478023|NCT01109784|coronary angioplasty|coronary angioplasty
478024|NCT01109784|clopidogrel resistance|clopidogrel resistance
478025|NCT01109784|prasugrel|prasugrel
478026|NCT01109771|Ventral hernia|ventral hernia
478027|NCT01109758|Fenofibrate|fenofibrate
478028|NCT01109758|Gene Expression|gene expression
478029|NCT01109758|DNA methylation|dna methylation
478030|NCT01109745|Asthma|asthma
478031|NCT01109745|health-related quality of life|health-related quality of life
478032|NCT01109745|patient-centred care|patient-centred care
478033|NCT01109719|Protocol|protocol
478034|NCT01109719|Critical pathway|critical pathway
478035|NCT01109719|Intensive care units|intensive care units
478036|NCT01109706|Acute coronary syndrome|acute coronary syndrome
478037|NCT01109706|PCSK9|pcsk9
478038|NCT01109706|cardiovascular safety|cardiovascular safety
478039|NCT01109667|Thromboplastin, Prothrombin, Diagnostic Reagent Kits, International Normalized Ratio, Laboratory Tests.|thromboplastin, prothrombin, diagnostic reagent kits, international normalized ratio, laboratory tests.
478040|NCT01109654|Fertilization in Vitro|fertilization in vitro
478041|NCT01109654|Reproductive Techniques, Assisted|reproductive techniques, assisted
478042|NCT01109654|Follicle Stimulating Hormone|follicle stimulating hormone
478043|NCT01109654|Cetrotide|cetrotide
478044|NCT01109654|Gonal-f|gonal-f
478045|NCT01109628|sarcopenia|sarcopenia
478046|NCT01109628|frail elderly|frail elderly
478047|NCT01109628|protein drink|protein drink
478048|NCT01109628|skeletal muscle mass|skeletal muscle mass
478049|NCT01109628|muscle mass in elderly|muscle mass in elderly
478050|NCT01109615|Colorectal cancer|colorectal cancer
478150|NCT01109329|Vaccine|vaccine
478051|NCT01109615|Metastatic colorectal cancer|metastatic colorectal cancer
478052|NCT01109615|Treatment resistant|treatment resistant
478053|NCT01109615|Chemotherapy refractory|chemotherapy refractory
478054|NCT01109615|KRAS mutation|kras mutation
478055|NCT01109602|Stroke|stroke
478056|NCT01109602|accidental falls|accidental falls
478057|NCT01109602|Yoga|yoga
478058|NCT01109602|Blood pressure|blood pressure
478059|NCT01109602|Range of Motion|range of motion
478060|NCT01109602|Rehabilitation|rehabilitation
478061|NCT01109602|Exercise|exercise
478062|NCT01109602|balance|balance
478063|NCT01109602|quality of life|quality of life
478064|NCT01109602|mobility|mobility
478065|NCT01109589|antibiotics|antibiotics
478066|NCT01109589|prescriptions|prescriptions
478067|NCT01109589|pregnancy|pregnancy
478068|NCT01109589|children|children
478069|NCT01109576|deafness-blindness|deafness-blindness
478070|NCT01109576|pilot study|pilot study
478071|NCT01109576|self management education|self management education
478072|NCT01109576|dual sensory loss|dual sensory loss
478073|NCT01109576|rehabilitation|rehabilitation
478074|NCT01109576|peer support groups|peer support groups
478075|NCT01109576|age related|age related
478076|NCT01109563|cannabis use disorder|cannabis use disorder
478077|NCT01109563|marijuana|marijuana
478078|NCT01109563|motivational enhancement treatment|motivational enhancement treatment
478079|NCT01109563|cognitive behavioral treatment|cognitive behavioral treatment
478080|NCT01109563|continuing care|continuing care
478081|NCT01109537|Restless Legs Syndrome (RLS)|restless legs syndrome (rls)
478082|NCT01109537|GABA|gaba
478083|NCT01109537|Glutamate|glutamate
478084|NCT01109537|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
478085|NCT01109498|LPLD|lpld
478086|NCT01109498|Lipoprotein Lipase Deficiency|lipoprotein lipase deficiency
478087|NCT01109498|Chylomicronaemia|chylomicronaemia
478088|NCT01109498|Genetherapy|genetherapy
478089|NCT01109498|AAV|aav
478090|NCT01109498|Alipogene Tiparvovec|alipogene tiparvovec
478091|NCT01109498|AMT-011|amt-011
478092|NCT01109498|Lipoprotein Lipase|lipoprotein lipase
478093|NCT01109485|Allergic conjunctivitis|allergic conjunctivitis
478094|NCT01109459|preschool|preschool
478095|NCT01109459|screening|screening
478096|NCT01109459|cluster randomized|cluster randomized
478097|NCT01109459|physician practice patterns|physician practice patterns
478098|NCT01109459|behavior|behavior
478099|NCT01109459|knowledge|knowledge
478100|NCT01109459|attitudes|attitudes
478101|NCT01109459|guideline adherence|guideline adherence
478102|NCT01109446|Lateral Epicondylitis|lateral epicondylitis
478103|NCT01109446|Tennis Elbow|tennis elbow
478104|NCT01109446|Epicondylitis Lateralis|epicondylitis lateralis
478105|NCT01109433|Behcet's Disease|behcet's disease
478106|NCT01109433|Intermediate Uveitis|intermediate uveitis
478108|NCT01109433|Immunogenetics|immunogenetics
478109|NCT01109420|Hereditary Cancer|hereditary cancer
478110|NCT01109420|Susceptibility Gene(s) for Thyroid Cancer|susceptibility gene(s) for thyroid cancer
478111|NCT01109420|Screening at Risk Family Members|screening at risk family members
478112|NCT01109420|Inherited Thyroid Cancer|inherited thyroid cancer
478113|NCT01109420|Thyroid Cancer|thyroid cancer
478114|NCT01109407|Plasma Cell Neoplasm|plasma cell neoplasm
478115|NCT01109407|Natural History|natural history
478116|NCT01109407|Translational Studies|translational studies
478117|NCT01109407|Gene Expression Profiling|gene expression profiling
478118|NCT01109407|Protein Markers|protein markers
478119|NCT01109407|Smoldering Myeloma|smoldering myeloma
478120|NCT01109407|SMM|smm
478121|NCT01109407|Monoclonal Gammopathy of Undetermined Significance|monoclonal gammopathy of undetermined significance
478122|NCT01109407|MGUS|mgus
478123|NCT01109394|Genomics|genomics
478124|NCT01109394|Proteomics|proteomics
478125|NCT01109394|Tissue Repository|tissue repository
478126|NCT01109394|Omics|omics
478127|NCT01109394|Cell Lines|cell lines
478128|NCT01109394|Pediatric Cancer|pediatric cancer
478129|NCT01109394|Solid Tumor|solid tumor
478130|NCT01109394|Sarcoma|sarcoma
478131|NCT01109394|Kidney Cancer|kidney cancer
478132|NCT01109394|Neuroblastoma|neuroblastoma
478133|NCT01109381|bacterial infections|bacterial infections
478134|NCT01109381|anti-infective agents|anti-infective agents
478135|NCT01109381|gastrointestinal agents|gastrointestinal agents
478136|NCT01109381|antibacterial agents|antibacterial agents
478137|NCT01109381|omeprazole|omeprazole
478138|NCT01109381|lauric acid|lauric acid
478139|NCT01109381|n-acetylcysteine|n-acetylcysteine
478140|NCT01109381|helicobacter infections|helicobacter infections
478141|NCT01109381|helicobacter pylori|helicobacter pylori
478142|NCT01109381|non-antibiotic treatment|non-antibiotic treatment
478143|NCT01109368|Autosomal Dominant Familial Hypercholesterolemia|autosomal dominant familial hypercholesterolemia
478144|NCT01109355|PEEP|peep
478145|NCT01109355|Patients with hemorrhage stroke under mechanical ventilation|patients with hemorrhage stroke under mechanical ventilation
478146|NCT01109342|HIV Prevention|hiv prevention
478147|NCT01109342|Vaccine|vaccine
478148|NCT01109342|Recombinant Adenovirus-5|recombinant adenovirus-5
478149|NCT01109342|HIV Preventative Vaccine|hiv preventative vaccine
478151|NCT01109303|ankle fracture with syndesmotic ligament rupture|ankle fracture with syndesmotic ligament rupture
478152|NCT01109303|ankle syndesmosis rupture|ankle syndesmosis rupture
478153|NCT01109264|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
478154|NCT01109264|Bendamustine Hydrochloride|bendamustine hydrochloride
478155|NCT01109264|Chlorambucil|chlorambucil
478156|NCT01109238|Refractory Neuroblastoma|refractory neuroblastoma
478157|NCT01109238|Relapsed Neuroblastoma|relapsed neuroblastoma
478158|NCT01109225|aldosterone|aldosterone
478159|NCT01109225|myocardial infarction|myocardial infarction
478160|NCT01109225|cardiac remodeling|cardiac remodeling
478161|NCT01109212|Type 2-Diabetic Nephrophaty|type 2-diabetic nephrophaty
478162|NCT01109212|bindarit|bindarit
478163|NCT01109212|albuminuria|albuminuria
478164|NCT01109212|MCP-1|mcp-1
478165|NCT01109199|viscous|viscous
478166|NCT01109199|fibre|fibre
478167|NCT01109199|polysaccharide|polysaccharide
478168|NCT01109199|appetite|appetite
478169|NCT01109199|hunger|hunger
478170|NCT01109199|satiety|satiety
478171|NCT01109199|weight management|weight management
478172|NCT01109186|patient with a kidney transplantation since less than 30 days|patient with a kidney transplantation since less than 30 days
478173|NCT01109160|azithromycin|azithromycin
478174|NCT01109160|lymphocytic bronchitis or bronchiolitis|lymphocytic bronchitis or bronchiolitis
478175|NCT01109160|lung transplantation|lung transplantation
478176|NCT01109160|acute allograft rejection|acute allograft rejection
478177|NCT01109160|chronic allograft rejection|chronic allograft rejection
478178|NCT01109160|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
478179|NCT01109147|Schizophrenic Disorders|schizophrenic disorders
478180|NCT01109147|Schizophrenia|schizophrenia
478181|NCT01109147|Affect|affect
478182|NCT01109147|Emotional Blunting|emotional blunting
478183|NCT01109134|primary angioplasty|primary angioplasty
478184|NCT01109134|tirofiban|tirofiban
478185|NCT01109134|microcirculation|microcirculation
478186|NCT01109121|Moderate to severe gout|moderate to severe gout
478187|NCT01109121|Hyperuricemia|hyperuricemia
478188|NCT01109108|pneumococcal vaccine|pneumococcal vaccine
478189|NCT01109108|nasopharyngeal carriage|nasopharyngeal carriage
478190|NCT01109095|Glioblastoma Multiforme (GBM)|glioblastoma multiforme (gbm)
478191|NCT01109095|HER2|her2
478192|NCT01109095|CMV|cmv
478193|NCT01109095|Brain Cancer|brain cancer
478194|NCT01109095|Autologous HER2.CAR CMV-specific cytotoxic CTL|autologous her2.car cmv-specific cytotoxic ctl
478195|NCT01109095|CMV-specific cytotoxic CTL|cmv-specific cytotoxic ctl
478196|NCT01109082|Scoliosis|scoliosis
478197|NCT01109082|gait|gait
478198|NCT01109082|posture|posture
478199|NCT01109082|balance|balance
478200|NCT01109069|PCI-32765|pci-32765
478201|NCT01109069|Lymphoma, B-Cell|lymphoma, b-cell
478202|NCT01109069|Leukemia, Lymphoid|leukemia, lymphoid
478203|NCT01109069|Leukemia, B-Cell|leukemia, b-cell
478204|NCT01109069|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
478205|NCT01109043|Hypertension|hypertension
478206|NCT01109043|Bisoprolol|bisoprolol
478207|NCT01109043|Antihypertensive drugs|antihypertensive drugs
478208|NCT01109043|Blood pressure|blood pressure
478209|NCT01109043|Quality of life|quality of life
478210|NCT01109043|Diabetes|diabetes
478211|NCT01109043|Ketohexokinase|ketohexokinase
478212|NCT01109030|Major depressive disorder|major depressive disorder
478213|NCT01109030|pioglitazone|pioglitazone
478214|NCT01109030|double blind|double blind
478215|NCT01109030|placebo controlled|placebo controlled
478216|NCT01109004|Symptomatic Multiple Myeloma|symptomatic multiple myeloma
478217|NCT01109004|Lenalidomide|lenalidomide
478218|NCT01109004|Anti-Myeloma Agents|anti-myeloma agents
478219|NCT01109004|Hematologic Disorders|hematologic disorders
478220|NCT01109004|Maintenance Therapy|maintenance therapy
478221|NCT01109004|Progression|progression
478222|NCT01109004|Autologous Transplant|autologous transplant
478223|NCT01109004|RVD Consolidation|rvd consolidation
478224|NCT01108991|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
478225|NCT01108991|Randomized controlled trial|randomized controlled trial
478226|NCT01108991|Self-management support|self-management support
478227|NCT01108991|Physical activity|physical activity
478228|NCT01108978|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
478229|NCT01108978|Cardiovascular Disease|cardiovascular disease
478230|NCT01108978|hypercholesterolemia|hypercholesterolemia
478231|NCT01108965|Hydrocephalus|hydrocephalus
478232|NCT01108965|Shunt Dysfunction|shunt dysfunction
478233|NCT01108965|Shunt Flow|shunt flow
478234|NCT01108952|Chemotherapy|chemotherapy
478235|NCT01108952|Memory|memory
478236|NCT01108952|Methotrexate|methotrexate
478237|NCT01108952|Glucocorticoids|glucocorticoids
478238|NCT01108952|Trauma|trauma
478239|NCT01108952|pediatric oncology|pediatric oncology
478240|NCT01108952|traumatization|traumatization
478241|NCT01108939|Malaria, Iron absorption, Iron utilization, Benin|malaria, iron absorption, iron utilization, benin
478242|NCT01108913|COPD|copd
478243|NCT01108900|Erectile Dysfunction udenafil sildenafil treatment satisfaction|erectile dysfunction udenafil sildenafil treatment satisfaction
478244|NCT01108887|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
478245|NCT01108887|RebiSmart|rebismart
478246|NCT01108887|Rebif|rebif
478247|NCT01108887|Interferon beta-1a|interferon beta-1a
478248|NCT01108874|Cesarean section|cesarean section
478249|NCT01108874|Hypotension|hypotension
478250|NCT01108874|Metaraminol|metaraminol
478251|NCT01108874|Vasoconstrictor Agents|vasoconstrictor agents
478252|NCT01108874|Adult|adult
478253|NCT01108874|Female|female
478254|NCT01108874|Pregnancy|pregnancy
478255|NCT01108874|Anesthesia, Obstetrical/adverse effects|anesthesia, obstetrical/adverse effects
478256|NCT01108874|Anesthesia,Spinal|anesthesia,spinal
478257|NCT01108874|Blood Pressure/drug effects|blood pressure/drug effects
478258|NCT01108874|Nausea|nausea
478259|NCT01108874|Vomiting|vomiting
478260|NCT01108861|Peripheral Vascular Disease|peripheral vascular disease
478261|NCT01108861|In-stent restenosis|in-stent restenosis
478262|NCT01108861|Endoprosthesis|endoprosthesis
478263|NCT01108861|Plain old balloon angioplasty|plain old balloon angioplasty
478264|NCT01108848|C1-esterase Inhibitor|c1-esterase inhibitor
478265|NCT01108848|Hereditary angioedema|hereditary angioedema
478266|NCT01108848|Acute HAE attack|acute hae attack
478267|NCT01108835|COPD|copd
478268|NCT01108835|Comprehensive care|comprehensive care
478269|NCT01108783|Rhinitis|rhinitis
478270|NCT01108783|Allergic|allergic
478271|NCT01108783|Seasonal|seasonal
478272|NCT01108783|Hay Fever|hay fever
478273|NCT01108783|Pollen Allergy|pollen allergy
478274|NCT01108783|Pollinosis|pollinosis
478275|NCT01108783|Rhinoconjunctivitis|rhinoconjunctivitis
478276|NCT01108783|Sneezing|sneezing
478277|NCT01108783|Nasal itching|nasal itching
478278|NCT01108783|Nasal Congestion|nasal congestion
478279|NCT01108783|Rhinorrhea|rhinorrhea
478280|NCT01108783|Ocular itching|ocular itching
478281|NCT01108783|Ocular redness|ocular redness
478282|NCT01108783|Tearing|tearing
478283|NCT01108770|HED|hed
478284|NCT01108770|XLHED|xlhed
478285|NCT01108770|Hypohidrotic Ectodermal Dysplasia|hypohidrotic ectodermal dysplasia
478286|NCT01108757|catheter|catheter
478287|NCT01108757|urinary tract infection|urinary tract infection
478288|NCT01108744|clinical trial|clinical trial
478289|NCT01108744|mannitol|mannitol
478290|NCT01108744|intracranial pressure (ICP)|intracranial pressure (icp)
478291|NCT01108744|hypertonic saline|hypertonic saline
478292|NCT01108744|cerebral edema|cerebral edema
478293|NCT01108744|traumatic brain injury (TBI)|traumatic brain injury (tbi)
478294|NCT01108718|Mattress|mattress
478295|NCT01108718|Tempur-Pedic|tempur-pedic
478296|NCT01108718|Fibromyalgia|fibromyalgia
478297|NCT01108718|Sleep patterns|sleep patterns
478298|NCT01108692|atrial fibrillation|atrial fibrillation
478299|NCT01108692|supraventricular arrhythmia|supraventricular arrhythmia
478300|NCT01108692|antithrombotic treatment|antithrombotic treatment
478301|NCT01108692|antiarrhythmic drugs|antiarrhythmic drugs
478302|NCT01108692|medical reaction time|medical reaction time
478303|NCT01108692|telecardiology|telecardiology
478304|NCT01108692|early detection|early detection
478305|NCT01108692|holters memories|holters memories
478306|NCT01108692|Pacemaker|pacemaker
478307|NCT01108666|Adult subjects with a confirmed diagnosis of Stage IIIA or IIIB NSCLC, with adequate bone marrow, liver and renal function.|adult subjects with a confirmed diagnosis of stage iiia or iiib nsclc, with adequate bone marrow, liver and renal function.
478308|NCT01108653|Cardiovascular diseases|cardiovascular diseases
478309|NCT01108653|Heart diseases|heart diseases
478310|NCT01108653|Myocardial infarction|myocardial infarction
478311|NCT01108653|Rehabilitation|rehabilitation
478312|NCT01108653|Health Economy|health economy
478313|NCT01108653|Randomized controlled trials|randomized controlled trials
478314|NCT01108653|Non ST Elevation Myocardial Infarction (NSTEMI)|non st elevation myocardial infarction (nstemi)
478315|NCT01108653|Cost analysis|cost analysis
478316|NCT01108653|Sick-leave|sick-leave
478317|NCT01108653|Quality of Life|quality of life
478318|NCT01108614|Methadone maintenance treatment|methadone maintenance treatment
478319|NCT01108614|drug users|drug users
478320|NCT01108614|heroin|heroin
478321|NCT01108614|HIV|hiv
478322|NCT01108614|HCV|hcv
478323|NCT01108614|Syphilis|syphilis
478324|NCT01108614|HSV-2|hsv-2
478325|NCT01108601|Ringer's|ringer's
478326|NCT01108601|lactate|lactate
478327|NCT01108601|cisplatin|cisplatin
478328|NCT01108601|ototoxicity|ototoxicity
478329|NCT01108601|hearing loss|hearing loss
478330|NCT01108575|Mechanical ventilation|mechanical ventilation
478331|NCT01108575|mechanical ventilation weaning|mechanical ventilation weaning
478332|NCT01108575|inspiratory muscle strength training|inspiratory muscle strength training
478333|NCT01108575|Patients admitted to a surgical intensive care unit who are expected to receive mechanical ventilation for more than three days.|patients admitted to a surgical intensive care unit who are expected to receive mechanical ventilation for more than three days.
478334|NCT01108562|postoperative pain management|postoperative pain management
478335|NCT01108549|Fibromyalgia|fibromyalgia
478336|NCT01108549|Chronic Fatigue Syndrome|chronic fatigue syndrome
478337|NCT01108549|D-ribose|d-ribose
478338|NCT01108549|fatigue|fatigue
478339|NCT01108536|prosthetics|prosthetics
478340|NCT01108536|socket comfort|socket comfort
478341|NCT01108536|amputation stump|amputation stump
479791|NCT01102075|Obesity|obesity
478342|NCT01108536|amputee rehabilitation|amputee rehabilitation
478343|NCT01108523|Moisture Associated Skin Damage|moisture associated skin damage
478344|NCT01108510|Treatment Naive|treatment naive
478345|NCT01108510|HIV 1 Infected|hiv 1 infected
478346|NCT01108484|Cancer survivors, exercise, diet, emotional support|cancer survivors, exercise, diet, emotional support
478347|NCT01108471|cesarean section; hemoglobin; postpartum hemorrhage;|cesarean section; hemoglobin; postpartum hemorrhage;
478348|NCT01108445|cancer|cancer
478349|NCT01108445|kidney cancer|kidney cancer
478350|NCT01108445|sutent|sutent
478351|NCT01108445|everolimus|everolimus
478352|NCT01108445|renal cancer|renal cancer
478353|NCT01108445|papillary renal cell|papillary renal cell
478354|NCT01108445|chromophobe renal cell|chromophobe renal cell
478355|NCT01108445|papillary|papillary
478356|NCT01108445|chromophobe|chromophobe
478357|NCT01108432|Tobacco cessation counseling|tobacco cessation counseling
478358|NCT01108419|healthy adults|healthy adults
478359|NCT01108406|Hearing Loss|hearing loss
478360|NCT01108406|Unilateral Hearing Loss|unilateral hearing loss
478361|NCT01108406|Single Sided Deafness|single sided deafness
478362|NCT01108393|Obsessive Compulsive Disorder|obsessive compulsive disorder
478363|NCT01108393|Agomelatine|agomelatine
478364|NCT01108380|Liver cirrhosis|liver cirrhosis
478365|NCT01108380|liver regeneration|liver regeneration
478366|NCT01108380|liver volume|liver volume
478367|NCT01108380|liver function|liver function
478368|NCT01108380|hepatocellular carcinoma, extensive|hepatocellular carcinoma, extensive
478369|NCT01108380|hepatectomy|hepatectomy
478370|NCT01108328|viscous|viscous
478371|NCT01108328|fibre|fibre
478372|NCT01108328|polysaccharide|polysaccharide
478373|NCT01108328|blood glucose|blood glucose
478374|NCT01108328|postprandial|postprandial
478375|NCT01108328|appetite|appetite
478376|NCT01108328|hunger|hunger
478377|NCT01108328|satiety|satiety
478378|NCT01108315|Patient Reported Outcomes (PRO)|patient reported outcomes (pro)
478379|NCT01108315|Web-based|web-based
478380|NCT01108315|Phone-based|phone-based
478381|NCT01108315|Breast Cancer|breast cancer
478382|NCT01108302|uterotonic|uterotonic
478383|NCT01108302|oxytocin|oxytocin
478384|NCT01108302|randomized trial|randomized trial
478385|NCT01108302|India|india
478386|NCT01108302|community|community
478387|NCT01108302|hemorrhage|hemorrhage
478388|NCT01108289|hemorrhage|hemorrhage
478389|NCT01108289|uterotonic|uterotonic
478390|NCT01108289|oxytocin|oxytocin
478391|NCT01108289|blood loss|blood loss
478392|NCT01108289|community|community
478393|NCT01108289|Ghana|ghana
478394|NCT01108289|randomized trial|randomized trial
478395|NCT01108237|Arthroplasties, Knee Replacement|arthroplasties, knee replacement
478396|NCT01108237|Arthroplasties, Replacement, Knee|arthroplasties, replacement, knee
478397|NCT01108237|Arthroplasty, Knee Replacement|arthroplasty, knee replacement
478398|NCT01108237|Knee Replacement Arthroplasties|knee replacement arthroplasties
478399|NCT01108237|Knee Replacement Arthroplasty|knee replacement arthroplasty
478400|NCT01108237|Knee Replacement, Total|knee replacement, total
478401|NCT01108237|Replacement Arthroplasties, Knee|replacement arthroplasties, knee
478402|NCT01108237|Replacement Arthroplasty, Knee|replacement arthroplasty, knee
478403|NCT01108237|Replacement, Total Knee|replacement, total knee
478404|NCT01108237|Total Knee Replacement|total knee replacement
478405|NCT01108224|Quality of life|quality of life
478406|NCT01108224|Coping|coping
478407|NCT01108224|Social relations|social relations
478408|NCT01108224|Survival|survival
478409|NCT01108224|Psychotherapy|psychotherapy
478410|NCT01108211|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
478411|NCT01108211|AIS|ais
478412|NCT01108211|Vibration Therapy|vibration therapy
478413|NCT01108211|Low bone mass|low bone mass
478414|NCT01108211|osteopenia|osteopenia
478415|NCT01108198|phimosis,|phimosis,
478416|NCT01108198|non-retractable foreskin|non-retractable foreskin
478417|NCT01108198|topical steroids|topical steroids
478418|NCT01108198|children|children
478419|NCT01108185|treatment with Klacid®SR|treatment with klacid®sr
478420|NCT01108185|tracheitis|tracheitis
478421|NCT01108185|tracheobronchitis|tracheobronchitis
478422|NCT01108185|bronchitis|bronchitis
478423|NCT01108185|chronic bronchitis|chronic bronchitis
478424|NCT01108185|community-acquired pneumonia|community-acquired pneumonia
478425|NCT01108133|Posttraumatic Stress Disorder|posttraumatic stress disorder
478426|NCT01108133|Traumatic Memories|traumatic memories
478427|NCT01108133|fMRI|fmri
478428|NCT01108120|diabetic foot ulcer|diabetic foot ulcer
478429|NCT01108120|artery mini-pump|artery mini-pump
478430|NCT01108120|continuous infusion of urokinase|continuous infusion of urokinase
478431|NCT01108120|femoral artery|femoral artery
478432|NCT01108107|Colon cancer|colon cancer
478433|NCT01108107|Neoadjuvant treatment|neoadjuvant treatment
478434|NCT01108107|KRAS mutation|kras mutation
478435|NCT01108107|BRAF mutation|braf mutation
478436|NCT01108107|PIK3CA mutation|pik3ca mutation
478437|NCT01108107|Possibly avoid chemotherapy after operation|possibly avoid chemotherapy after operation
478438|NCT01108081|Sleep apnea|sleep apnea
478439|NCT01108081|Sleep symptoms|sleep symptoms
478440|NCT01108081|Quality of Life|quality of life
478441|NCT01108068|Osteoporosis-pseudoglioma syndrome, OPPG, LRP5 mutation|osteoporosis-pseudoglioma syndrome, oppg, lrp5 mutation
478442|NCT01108029|Parkinson's disease|parkinson's disease
478443|NCT01108029|Freezing of Gait|freezing of gait
478444|NCT01108029|Memantine|memantine
478445|NCT01108029|NMDA receptor|nmda receptor
478446|NCT01108029|glutamate|glutamate
478447|NCT01108029|No Dementia|no dementia
478448|NCT01107964|Dry Eye Syndrome|dry eye syndrome
478449|NCT01107964|Recent Diagnosis of Dry Eye Syndrome|recent diagnosis of dry eye syndrome
478450|NCT01107951|Rituximab|rituximab
478451|NCT01107951|Dexamethasone|dexamethasone
478452|NCT01107951|Low-dose|low-dose
478453|NCT01107951|ITP|itp
478454|NCT01107938|GERD|gerd
478455|NCT01107925|Platelet function|platelet function
478456|NCT01107912|Platelet function|platelet function
478457|NCT01107899|Acute Coronary Syndromes|acute coronary syndromes
478458|NCT01107899|Angina|angina
478459|NCT01107899|Platelet Function|platelet function
478460|NCT01107899|Coronary Angiography|coronary angiography
478461|NCT01107899|Clinical Symptoms of Angina|clinical symptoms of angina
478462|NCT01107899|Positive Stress Test|positive stress test
478463|NCT01107886|Risk of cardiovascular disease and death in patients with type 2 diabetes mellitus|risk of cardiovascular disease and death in patients with type 2 diabetes mellitus
478464|NCT01107873|Twenty (ASA status I) unpremedicated children, ages 1 to 5 yr old|twenty (asa status i) unpremedicated children, ages 1 to 5 yr old
478465|NCT01107847|electrical impedance tomography|electrical impedance tomography
478466|NCT01107847|EIT|eit
478467|NCT01107847|acute lung injury|acute lung injury
478468|NCT01107847|regional lung opening pressure|regional lung opening pressure
478469|NCT01107847|regional lung closing pressure|regional lung closing pressure
478471|NCT01107834|heart function|heart function
478472|NCT01107834|HAART|haart
478473|NCT01107834|in utero|in utero
478474|NCT01107834|children|children
478475|NCT01107821|Pressure sores grade III and IV|pressure sores grade iii and iv
478476|NCT01107821|Traumatic wounds with considerable soft tissue loss|traumatic wounds with considerable soft tissue loss
478477|NCT01107821|Wounds after necrotizing fasciitis|wounds after necrotizing fasciitis
478478|NCT01107821|Abdominal wounds|abdominal wounds
478479|NCT01107808|Adolescents|adolescents
478480|NCT01107808|African American|african american
478481|NCT01107808|Female|female
478482|NCT01107782|sildenafil|sildenafil
478483|NCT01107782|FGR|fgr
478484|NCT01107743|Hypertension|hypertension
478485|NCT01107743|Angina pectoris|angina pectoris
478486|NCT01107743|Hypercholesterolemia|hypercholesterolemia
478487|NCT01107743|Familial hypercholesterolemia|familial hypercholesterolemia
478488|NCT01107743|Japanese|japanese
478489|NCT01107743|caduet|caduet
478490|NCT01107743|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
478491|NCT01107730|Atrial fibrillation|atrial fibrillation
478492|NCT01107730|Cardiac valve repair|cardiac valve repair
478493|NCT01107730|Aneurysm repair|aneurysm repair
478494|NCT01107730|CABG|cabg
478495|NCT01107730|On-pump|on-pump
478496|NCT01107730|Cardiac surgery|cardiac surgery
478497|NCT01107730|Vitamin C|vitamin c
478498|NCT01107717|type 2 diabetes|type 2 diabetes
478499|NCT01107717|new onset|new onset
478500|NCT01107717|combination therapy|combination therapy
478501|NCT01107717|new onset type 2 diabetes|new onset type 2 diabetes
478502|NCT01107704|Intensive Care Units|intensive care units
478503|NCT01107704|Surrogates|surrogates
478504|NCT01107704|Family Members|family members
478505|NCT01107704|Physicians|physicians
478506|NCT01107704|Critically Ill|critically ill
478507|NCT01107704|Depression|depression
478508|NCT01107704|Anxiety|anxiety
478509|NCT01107704|Emotional|emotional
478510|NCT01107704|Support|support
478511|NCT01107704|Multi-faceted communication|multi-faceted communication
478512|NCT01107704|Grief|grief
478513|NCT01107704|Prognosis|prognosis
478514|NCT01107704|Family Support Counselor|family support counselor
478515|NCT01107691|resistance and weight loss training|resistance and weight loss training
478516|NCT01107678|YMCA; Preventative child obesity|ymca; preventative child obesity
478517|NCT01107665|pazopanib|pazopanib
478518|NCT01107665|paclitaxel|paclitaxel
478519|NCT01107665|melanoma|melanoma
478520|NCT01107639|stage IIB esophageal cancer|stage iib esophageal cancer
478521|NCT01107639|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
478522|NCT01107639|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
478523|NCT01107639|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
478524|NCT01107639|stage IIIA esophageal cancer|stage iiia esophageal cancer
478525|NCT01107639|stage IIIB esophageal cancer|stage iiib esophageal cancer
478526|NCT01107639|stage IIIC esophageal cancer|stage iiic esophageal cancer
478527|NCT01107626|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
478528|NCT01107626|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
478529|NCT01107626|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
478530|NCT01107626|adenocarcinoma of the lung|adenocarcinoma of the lung
478531|NCT01107626|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
478532|NCT01107626|large cell lung cancer|large cell lung cancer
478533|NCT01107613|opinion leader|opinion leader
478534|NCT01107613|COPD|copd
478535|NCT01107613|Emergency Department|emergency department
478536|NCT01107613|relapse|relapse
478537|NCT01107613|follow-up|follow-up
478538|NCT01107613|evidence-based guidelines|evidence-based guidelines
478539|NCT01107613|Exacerbation of COPD|exacerbation of copd
478540|NCT01107600|Dental Implants, Single-Tooth|dental implants, single-tooth
478541|NCT01107600|Bone Regeneration|bone regeneration
478542|NCT01107600|Dental Restoration|dental restoration
478543|NCT01107600|Socket preservation|socket preservation
478544|NCT01107587|Human rotavirus vaccine|human rotavirus vaccine
478545|NCT01107574|Chronic Pain, tenderpoints, insomnia, mood disorder, fatigue|chronic pain, tenderpoints, insomnia, mood disorder, fatigue
478546|NCT01107561|cricothyroidotomy|cricothyroidotomy
478547|NCT01107561|intubation|intubation
478548|NCT01107561|airway|airway
478549|NCT01107561|emergency medicine|emergency medicine
478550|NCT01107561|education|education
478551|NCT01107535|Synagis (palivizumab) immunoprophylaxis|synagis (palivizumab) immunoprophylaxis
478552|NCT01107535|Respiratory syncytial virus infection|respiratory syncytial virus infection
478553|NCT01107535|Preterm infants|preterm infants
478554|NCT01107509|Renal cell carcinoma|renal cell carcinoma
478555|NCT01107509|Metastatic|metastatic
478556|NCT01107509|everolimus|everolimus
478557|NCT01107509|neo-adjuvant|neo-adjuvant
478558|NCT01107509|biomarkers|biomarkers
478559|NCT01107509|nephrectomy|nephrectomy
478560|NCT01107509|Locally advanced clear cell renal carcinoma|locally advanced clear cell renal carcinoma
478561|NCT01107509|Metastatic clear cell renal carcinoma|metastatic clear cell renal carcinoma
478562|NCT01107509|Clear Cell Renal Carcinoma|clear cell renal carcinoma
478563|NCT01107483|endotoxaemia|endotoxaemia
478564|NCT01107470|Infertility IVF ART|infertility ivf art
478565|NCT01107457|Moderate|moderate
478566|NCT01107457|Severe|severe
478567|NCT01107457|Plaque|plaque
478568|NCT01107457|Chronic|chronic
478569|NCT01107431|glucose|glucose
478570|NCT01107431|insulin|insulin
478571|NCT01107431|L-arabinose|l-arabinose
478572|NCT01107431|Chromium|chromium
478573|NCT01107366|lupiae techinque|lupiae techinque
478574|NCT01107366|aortic aneurism|aortic aneurism
478575|NCT01107366|aortic dissection|aortic dissection
478576|NCT01107327|cancer|cancer
478577|NCT01107301|ADHD|adhd
478578|NCT01107288|Aged|aged
478579|NCT01107288|Balance|balance
478580|NCT01107288|Dual-task|dual-task
478581|NCT01107288|Exercise|exercise
478582|NCT01107288|Falls|falls
478583|NCT01107288|Gait|gait
478584|NCT01107288|Music|music
478585|NCT01107275|Rabies|rabies
478586|NCT01107275|PCECV|pcecv
478587|NCT01107275|pre-exposure immunization|pre-exposure immunization
478588|NCT01107275|intradermal|intradermal
478589|NCT01107275|children|children
478590|NCT01107262|H5N1 Subtype|h5n1 subtype
478591|NCT01107262|Avian viruses|avian viruses
478592|NCT01107262|Highly pathogenic avian influenza (HPAI)|highly pathogenic avian influenza (hpai)
478593|NCT01107249|esophageal|esophageal
478594|NCT01107249|stenting|stenting
478595|NCT01107249|perforations|perforations
478596|NCT01107249|gastric|gastric
478597|NCT01107249|esophageal stenting|esophageal stenting
478598|NCT01107236|Healthy subjects|healthy subjects
478599|NCT01107223|Antibiotic|antibiotic
478600|NCT01107223|Prescribing behaviour|prescribing behaviour
478601|NCT01107223|Guidelines|guidelines
478602|NCT01107223|Respiratory tract infections|respiratory tract infections
478603|NCT01107223|Non-antibiotic prescription|non-antibiotic prescription
478604|NCT01107210|stroke|stroke
478605|NCT01107210|physical fitness|physical fitness
478606|NCT01107210|evolution|evolution
478607|NCT01107210|determinants|determinants
478608|NCT01107197|Pressure ulcers|pressure ulcers
478609|NCT01107197|Healing|healing
478610|NCT01107197|Malnutrition|malnutrition
478611|NCT01107197|Nutritional support|nutritional support
478612|NCT01107197|Micronutrients|micronutrients
478613|NCT01107184|Remote ischemic conditioning|remote ischemic conditioning
478614|NCT01107184|CABG surgery|cabg surgery
478615|NCT01107184|Atrial fibrillation|atrial fibrillation
478616|NCT01107184|Coronary Artery Bypass|coronary artery bypass
478617|NCT01107184|Ischemic Preconditioning|ischemic preconditioning
478618|NCT01107171|Tang-min-ling pills;|tang-min-ling pills;
478619|NCT01107171|overweight type 2 diabetes mellitus;|overweight type 2 diabetes mellitus;
478620|NCT01107171|blood glucose|blood glucose
478621|NCT01107171|Traditional Chinese Medicine|traditional chinese medicine
478622|NCT01107171|Clinical Trial|clinical trial
478623|NCT01107171|Intervention Studies|intervention studies
478624|NCT01107145|Plasmodium|plasmodium
478625|NCT01107145|Vivax|vivax
478626|NCT01107145|Malaria|malaria
478627|NCT01107145|Pregnancy|pregnancy
478628|NCT01107145|Brazil|brazil
478629|NCT01107145|Treatment|treatment
478630|NCT01107119|Frail elderly|frail elderly
478631|NCT01107119|Chronic illness|chronic illness
478632|NCT01107119|Integrated care model|integrated care model
478633|NCT01107119|Clinical pathways|clinical pathways
478634|NCT01107119|Home care services|home care services
478635|NCT01107106|Contraceptive Methods|contraceptive methods
478636|NCT01107106|Female Contraception|female contraception
478637|NCT01107080|breast cancer|breast cancer
478638|NCT01107080|breast carcinoma in situ|breast carcinoma in situ
478639|NCT01107080|ductal breast carcinoma in situ|ductal breast carcinoma in situ
478640|NCT01107080|invasive carcinoma|invasive carcinoma
478641|NCT01107080|invasive ductal carcinoma|invasive ductal carcinoma
478642|NCT01107080|invasive lobular carcinoma|invasive lobular carcinoma
478643|NCT01107067|hypogonadism|hypogonadism
478644|NCT01107067|paraoxonase|paraoxonase
478645|NCT01107067|Hipogonadism|hipogonadism
478646|NCT01107054|QTC|qtc
478647|NCT01107041|Depression|depression
478648|NCT01107041|Technology Assisted|technology assisted
478649|NCT01107041|Mobile Phone|mobile phone
478650|NCT01107028|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
478651|NCT01107028|Dyspnea|dyspnea
478652|NCT01107028|Functional capacity|functional capacity
478653|NCT01107028|Quality of life|quality of life
478654|NCT01107015|Diabetes|diabetes
478655|NCT01107015|Glucose control|glucose control
478656|NCT01107015|Diabetes monitoring|diabetes monitoring
478657|NCT01107015|Care management|care management
478658|NCT01107015|Electronic communication|electronic communication
478659|NCT01107015|Mobile phone technology|mobile phone technology
478660|NCT01107015|Self care|self care
478661|NCT01107002|infertility|infertility
478662|NCT01107002|Embryo transfer|embryo transfer
478663|NCT01106976|PET|pet
478664|NCT01106976|acetylcholine|acetylcholine
478665|NCT01106963|knee|knee
478666|NCT01106963|tibial fractures|tibial fractures
478667|NCT01106963|pain|pain
478668|NCT01106963|osteosynthesis|osteosynthesis
478669|NCT01106963|intramedullary nailing|intramedullary nailing
478670|NCT01106950|acute myelogenous leukemia|acute myelogenous leukemia
478671|NCT01106950|primary acute myelogenous leukemia|primary acute myelogenous leukemia
478672|NCT01106950|secondary acute myelogenous leukemia|secondary acute myelogenous leukemia
478673|NCT01106950|relapsed acute myelogenous leukemia|relapsed acute myelogenous leukemia
478674|NCT01106924|Probiotics, Weight control, Body composition|probiotics, weight control, body composition
478675|NCT01106911|digital breast tomosynthesis|digital breast tomosynthesis
478676|NCT01106911|baseline screening mammography|baseline screening mammography
478677|NCT01106911|recall rates|recall rates
478678|NCT01106885|Diabetes|diabetes
478679|NCT01106885|Depression|depression
478680|NCT01106885|Telephone Care Management|telephone care management
478681|NCT01106885|Medication Care Management (MCM)|medication care management (mcm)
478682|NCT01106885|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
478683|NCT01106872|Sarcoma|sarcoma
478684|NCT01106872|Soft Tissue Sarcoma|soft tissue sarcoma
478685|NCT01106872|Locally Advanced Sarcoma|locally advanced sarcoma
478686|NCT01106872|Unresectable Sarcoma|unresectable sarcoma
478687|NCT01106872|Metastatic Sarcoma|metastatic sarcoma
478688|NCT01106872|Valproic Acid|valproic acid
478689|NCT01106872|Bevacizumab|bevacizumab
478690|NCT01106872|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
478691|NCT01106859|insomnia|insomnia
478692|NCT01106846|Ketamine|ketamine
478693|NCT01106846|Anesthesia|anesthesia
478694|NCT01106846|Pain|pain
478695|NCT01106846|Outpatient surgery|outpatient surgery
478696|NCT01106833|Chronic Graft-versus-Host Disease (cGVHD)|chronic graft-versus-host disease (cgvhd)
478697|NCT01106794|diffuse intrinsic pontine glioma|diffuse intrinsic pontine glioma
478698|NCT01106794|DIPG|dipg
478699|NCT01106794|childhood brainstem glioma|childhood brainstem glioma
478700|NCT01106794|pediatric brainstem glioma|pediatric brainstem glioma
478701|NCT01106794|brainstem glioma|brainstem glioma
478702|NCT01106794|BSG|bsg
478703|NCT01106781|EGFR mutation test|egfr mutation test
478704|NCT01106781|NSCLC|nsclc
478705|NCT01106781|Non-Interventional Study|non-interventional study
478706|NCT01106781|EGFR mutation status|egfr mutation status
478707|NCT01106768|oral health needs|oral health needs
478708|NCT01106768|children|children
478709|NCT01106768|attention deficit disorder with or without hyperactivity|attention deficit disorder with or without hyperactivity
478710|NCT01106755|kinematic|kinematic
478711|NCT01106755|hemiparesis|hemiparesis
478712|NCT01106755|gait|gait
478713|NCT01106755|Body weight support|body weight support
478714|NCT01106755|Functional electrical stimulation|functional electrical stimulation
478715|NCT01106742|Inflammatory|inflammatory
478716|NCT01106742|AbM|abm
478717|NCT01106742|IBD|ibd
478718|NCT01106729|Flavonoids|flavonoids
478719|NCT01106729|Anthocyanin|anthocyanin
478720|NCT01106729|Cyanidin 3 glucoside|cyanidin 3 glucoside
478721|NCT01106729|Acute feeding trial|acute feeding trial
478722|NCT01106729|Stable isotope|stable isotope
478723|NCT01106729|Metabolism|metabolism
478724|NCT01106729|Clearance|clearance
478725|NCT01106729|Bioavailability|bioavailability
478726|NCT01106729|Pharmacokinetics|pharmacokinetics
478727|NCT01106716|Lidocaine|lidocaine
478728|NCT01106716|Lignocaine|lignocaine
478729|NCT01106716|Analgesics. Non-narcotic / therapeutic use|analgesics. non-narcotic / therapeutic use
478730|NCT01106716|Neuralgia, Postherpetic|neuralgia, postherpetic
478731|NCT01106716|Pain|pain
478732|NCT01106716|Pain measurement / drug effect|pain measurement / drug effect
478733|NCT01106716|Pain postoperative / drug therapy|pain postoperative / drug therapy
478734|NCT01106716|PHN|phn
478735|NCT01106703|atopy, IgE|atopy, ige
478736|NCT01106690|Canagliflozin|canagliflozin
478737|NCT01106690|Placebo|placebo
478738|NCT01106690|Sitagliptin (Januvia)|sitagliptin (januvia)
478739|NCT01106690|Metformin|metformin
478740|NCT01106690|Pioglitazone (Actos)|pioglitazone (actos)
478741|NCT01106690|Hemoglobin A1c|hemoglobin a1c
478742|NCT01106690|Type 2 diabetes mellitus|type 2 diabetes mellitus
478743|NCT01106677|Type 2 diabetes mellitus|type 2 diabetes mellitus
478744|NCT01106677|Canagliflozin|canagliflozin
478745|NCT01106677|Placebo|placebo
478746|NCT01106677|Sitagliptin|sitagliptin
478747|NCT01106677|Januvia|januvia
478748|NCT01106677|Metformin Immediate Release (IR)|metformin immediate release (ir)
478749|NCT01106677|Hemoglobin A1c|hemoglobin a1c
478750|NCT01106664|ONO-7746|ono-7746
478751|NCT01106664|Healthy adult subjects|healthy adult subjects
478752|NCT01106651|Canagliflozin|canagliflozin
478753|NCT01106651|Placebo|placebo
478754|NCT01106651|Hemoglobin A1c|hemoglobin a1c
478755|NCT01106651|Bone|bone
478756|NCT01106651|Type 2 diabetes mellitus|type 2 diabetes mellitus
478757|NCT01106638|HIV|hiv
478758|NCT01106638|AIDS|aids
478759|NCT01106638|Smoking|smoking
478760|NCT01106638|Tobacco|tobacco
478761|NCT01106638|Cessation|cessation
478762|NCT01106638|Tobacco use in persons living with HIV/AIDS|tobacco use in persons living with hiv/aids
478763|NCT01106625|Canagliflozin|canagliflozin
478764|NCT01106625|Placebo|placebo
478765|NCT01106625|Metformin|metformin
478766|NCT01106625|Sulphonylurea|sulphonylurea
478767|NCT01106625|Hemoglobin A1c|hemoglobin a1c
478768|NCT01106625|Type 2 diabetes mellitus|type 2 diabetes mellitus
478769|NCT01106612|randomized controlled trial|randomized controlled trial
478770|NCT01106612|controlled clinical trial|controlled clinical trial
478771|NCT01106612|comparative effectiveness research|comparative effectiveness research
478772|NCT01106612|chest pain|chest pain
478773|NCT01106612|angina pectoris|angina pectoris
478774|NCT01106612|non-invasive cardiac imaging|non-invasive cardiac imaging
478775|NCT01106612|nuclear stress testing|nuclear stress testing
478776|NCT01106612|coronary CT angiography|coronary ct angiography
478777|NCT01106612|coronary catheterization|coronary catheterization
478778|NCT01106612|coronary revascularization|coronary revascularization
478779|NCT01106586|HIV 1 Infection|hiv 1 infection
478780|NCT01106586|Treatment Naive|treatment naive
478781|NCT01106573|Diabetes Mellitus|diabetes mellitus
478782|NCT01106573|Arteriosclerosis|arteriosclerosis
478783|NCT01106573|Intima media thickness|intima media thickness
478784|NCT01106573|arterial stiffness|arterial stiffness
478785|NCT01106573|pulsewave velocity|pulsewave velocity
478786|NCT01106573|fibulin-1|fibulin-1
478787|NCT01106547|abdominal hysterectomy|abdominal hysterectomy
478788|NCT01106547|glucocorticoids|glucocorticoids
478789|NCT01106547|rehabilitation|rehabilitation
478790|NCT01106547|postoperative pain|postoperative pain
478791|NCT01106547|analgetics|analgetics
478792|NCT01106534|drug eluting stents|drug eluting stents
478793|NCT01106534|Stents|stents
478794|NCT01106534|Angioplasty|angioplasty
478795|NCT01106534|Stent thrombosis|stent thrombosis
478796|NCT01106534|antiplatelet treatment|antiplatelet treatment
478797|NCT01106521|Infiltrating ductal carcinoma|infiltrating ductal carcinoma
478798|NCT01106521|Brachytherapy|brachytherapy
478799|NCT01106508|Advanced solid tumors|advanced solid tumors
478800|NCT01106508|recurrent or refractory medulloblastoma|recurrent or refractory medulloblastoma
478801|NCT01106508|locally advanced or metastatic basal cell carcinoma|locally advanced or metastatic basal cell carcinoma
478802|NCT01106508|hedgehog pathway inhibitor|hedgehog pathway inhibitor
478803|NCT01106495|Atherosclerosis|atherosclerosis
478804|NCT01106495|Vascular Endothelium|vascular endothelium
478805|NCT01106495|Counterpulsation, External|counterpulsation, external
478806|NCT01106482|TBE|tbe
478807|NCT01106482|Tick Borne Encephalitis|tick borne encephalitis
478808|NCT01106469|Healthy Volunteers|healthy volunteers
478809|NCT01106469|Healthy|healthy
478810|NCT01106469|JNJ-41443532|jnj-41443532
478811|NCT01106469|Pharmacokinetics|pharmacokinetics
478812|NCT01106443|Indeterminate thyroid nodule|indeterminate thyroid nodule
478813|NCT01106443|fine needle aspirate biopsy|fine needle aspirate biopsy
478814|NCT01106443|thyroidectomy|thyroidectomy
478815|NCT01106443|central lymph node dissection|central lymph node dissection
478816|NCT01106430|ADHD|adhd
478817|NCT01106417|Cervical Degenerative Disc Disease|cervical degenerative disc disease
478818|NCT01106417|Degenerative Spondylolisthesis|degenerative spondylolisthesis
478819|NCT01106417|Spinal Stenosis|spinal stenosis
478820|NCT01106417|Stem cells|stem cells
478821|NCT01106417|Adult Stem Cells|adult stem cells
478822|NCT01106417|Anterior cervical discectomy and Fusion (ACDF)|anterior cervical discectomy and fusion (acdf)
478823|NCT01106417|Anterior Cervical Plate Fixation|anterior cervical plate fixation
478824|NCT01106391|Abdominal aortic aneurysm|abdominal aortic aneurysm
478825|NCT01106391|AAA|aaa
478826|NCT01106391|Safety|safety
478827|NCT01106391|Performance|performance
478828|NCT01106391|Stent graft system|stent graft system
478829|NCT01106391|First in Human|first in human
478830|NCT01106391|Endovascular repair|endovascular repair
478831|NCT01106378|Coronary artery disease|coronary artery disease
478832|NCT01106378|drug-eluting stents|drug-eluting stents
478833|NCT01106378|sirolimus-eluting coronary stents|sirolimus-eluting coronary stents
478834|NCT01106365|multiple sclerosis|multiple sclerosis
478835|NCT01106365|fatigue|fatigue
478836|NCT01106365|depressivity|depressivity
478837|NCT01106365|repetitive deep transcranial magnetic stimulation|repetitive deep transcranial magnetic stimulation
478962|NCT01105780|Pharmacokinetics|pharmacokinetics
478838|NCT01106352|The target population is patients with bone metastasis from castration-resistant prostate cancer intended for treatment with docetaxel|the target population is patients with bone metastasis from castration-resistant prostate cancer intended for treatment with docetaxel
478839|NCT01106339|humans|humans
478840|NCT01106339|patients|patients
478841|NCT01106339|somatoform disorders|somatoform disorders
478842|NCT01106339|fibromyalgia|fibromyalgia
478843|NCT01106339|myofascial pain syndrome diffuse|myofascial pain syndrome diffuse
478844|NCT01106339|depression|depression
478845|NCT01106339|chronic fatigue syndrome|chronic fatigue syndrome
478846|NCT01106339|inflammation|inflammation
478847|NCT01106339|inflammatory response|inflammatory response
478848|NCT01106339|biomarkers|biomarkers
478849|NCT01106339|cytokines|cytokines
478850|NCT01106339|cell surface markers|cell surface markers
478851|NCT01106339|functional polymorphisms|functional polymorphisms
478852|NCT01106326|Asthma|asthma
478853|NCT01106248|tumor|tumor
478854|NCT01106209|premature infants|premature infants
478855|NCT01106209|polymorphonuclear leukocytes|polymorphonuclear leukocytes
478856|NCT01106209|PMNs|pmns
478857|NCT01106209|neutrophil extracellular traps|neutrophil extracellular traps
478858|NCT01106209|NET formation|net formation
478859|NCT01106209|necrotizing enterocolitis|necrotizing enterocolitis
478860|NCT01106196|Influenza, Human|influenza, human
478861|NCT01106196|Influenza, Human/complications|influenza, human/complications
478862|NCT01106196|Myocardial infarction/etiology|myocardial infarction/etiology
478863|NCT01106196|Cardiovascular Diseases/mortality|cardiovascular diseases/mortality
478864|NCT01106157|Autoimmune, Diabetes Mellitus, Glucose Metabolism|autoimmune, diabetes mellitus, glucose metabolism
478865|NCT01106079|Early psoriatic arthritis|early psoriatic arthritis
478866|NCT01106079|Tight control|tight control
478867|NCT01106079|Intensive management|intensive management
478868|NCT01106053|Binge eating disorder|binge eating disorder
478869|NCT01106053|Food craving|food craving
478870|NCT01106053|Obesity|obesity
478871|NCT01106053|Pramipexole|pramipexole
478872|NCT01106053|Mirapex|mirapex
478873|NCT01106053|Binge|binge
478874|NCT01106040|Lymphoseek|lymphoseek
478875|NCT01106040|Breast Cancer|breast cancer
478876|NCT01106040|Melanoma|melanoma
478877|NCT01106040|Experimental|experimental
478878|NCT01106014|pulmonary arterial hypertension|pulmonary arterial hypertension
478879|NCT01106014|PAH|pah
478880|NCT01106001|total hip arthroplasty|total hip arthroplasty
478881|NCT01106001|periarticular injection|periarticular injection
478882|NCT01106001|pain|pain
478883|NCT01105988|GBM|gbm
478884|NCT01105988|PET scans|pet scans
478885|NCT01105988|MRI scans|mri scans
478886|NCT01105975|Dyslipidemias|dyslipidemias
478887|NCT01105975|Mixed dyslipidemia|mixed dyslipidemia
478888|NCT01105975|Hypercholesterolemia|hypercholesterolemia
478889|NCT01105975|Atherosclerosis|atherosclerosis
478890|NCT01105975|Atorvastatin|atorvastatin
478891|NCT01105975|Simvastatin|simvastatin
478892|NCT01105975|Rosuvastatin|rosuvastatin
478893|NCT01105975|Metabolic Diseases|metabolic diseases
478894|NCT01105975|Antilipemic Agents|antilipemic agents
478895|NCT01105975|Enzyme Inhibitors|enzyme inhibitors
478896|NCT01105975|Anticholesteremic Agents|anticholesteremic agents
478897|NCT01105975|Cholesteryl Ester Transfer Protein Inhibitors|cholesteryl ester transfer protein inhibitors
478898|NCT01105975|Cholesteryl Ester|cholesteryl ester
478899|NCT01105975|Lipid Metabolism Disorders|lipid metabolism disorders
478900|NCT01105962|traumatic|traumatic
478901|NCT01105962|brain|brain
478902|NCT01105962|injury|injury
478903|NCT01105962|post-traumatic|post-traumatic
478904|NCT01105962|stress|stress
478905|NCT01105962|hyperbaric|hyperbaric
478906|NCT01105962|oxygen|oxygen
478907|NCT01105962|HBOT|hbot
478908|NCT01105962|TBI|tbi
478909|NCT01105962|PTSD|ptsd
478910|NCT01105949|nasal patency|nasal patency
478911|NCT01105949|acoustic rhinometry|acoustic rhinometry
478912|NCT01105949|nasal strip|nasal strip
478913|NCT01105936|osteoarthritis|osteoarthritis
478914|NCT01105936|pain|pain
478915|NCT01105936|paracetamol|paracetamol
478916|NCT01105936|Blood-Oxygen-Level-Dependent functional magnetic resonance imaging|blood-oxygen-level-dependent functional magnetic resonance imaging
478917|NCT01105910|Dry Eye, Post Menopausal dry eye|dry eye, post menopausal dry eye
478918|NCT01105897|endometriosis|endometriosis
478919|NCT01105897|deep endometriosis|deep endometriosis
478920|NCT01105897|surgery|surgery
478921|NCT01105897|laparoscopy|laparoscopy
478922|NCT01105897|chronic pain|chronic pain
478923|NCT01105897|quality of life|quality of life
478924|NCT01105897|sexual function|sexual function
478925|NCT01105897|complications|complications
478926|NCT01105897|recurrence|recurrence
478927|NCT01105884|Wound healing, type 2 diabetes, diabetic foot ulcers, different dressings|wound healing, type 2 diabetes, diabetic foot ulcers, different dressings
478928|NCT01105871|Pain relief|pain relief
478929|NCT01105858|Diabetes Mellitus|diabetes mellitus
478930|NCT01105858|Obesity|obesity
478931|NCT01105858|Diabetic Complications|diabetic complications
478932|NCT01105858|Genetics|genetics
478933|NCT01105858|Molecular Profiling|molecular profiling
478934|NCT01105845|Motor Learning|motor learning
478935|NCT01105845|Genetic Analysis|genetic analysis
478936|NCT01105845|BDNF|bdnf
478937|NCT01105845|Parkinson Disease|parkinson disease
478938|NCT01105845|Movement Disorders|movement disorders
478939|NCT01105845|Dystonia|dystonia
478940|NCT01105845|Healthy Volunteer|healthy volunteer
478941|NCT01105845|HV|hv
478942|NCT01105832|Teriparatide|teriparatide
478943|NCT01105832|fracture healing|fracture healing
478944|NCT01105832|proximal humeral fractures|proximal humeral fractures
478945|NCT01105819|Probiotics|probiotics
478946|NCT01105819|Lactobacillus plantarum 299|lactobacillus plantarum 299
478947|NCT01105819|Ventilator-associated pneumonia VAP|ventilator-associated pneumonia vap
478948|NCT01105819|Chlorhexidine|chlorhexidine
478949|NCT01105819|Tracheal secretions|tracheal secretions
478950|NCT01105819|Oropharyngeal secretions|oropharyngeal secretions
478951|NCT01105806|advance directive|advance directive
478952|NCT01105806|CPR Intervention|cpr intervention
478953|NCT01105806|Video|video
478954|NCT01105806|Narrative|narrative
478955|NCT01105806|10-043|10-043
478956|NCT01105793|cyclic mastalgia|cyclic mastalgia
478957|NCT01105793|cyclic breast pain|cyclic breast pain
478958|NCT01105793|fibrocystic breast disease|fibrocystic breast disease
478959|NCT01105780|Healthy Volunteers|healthy volunteers
478960|NCT01105780|Healthy|healthy
478961|NCT01105780|Japanese|japanese
478963|NCT01105780|JNJ-41443532|jnj-41443532
478964|NCT01105767|Staphylococcus aureus|staphylococcus aureus
478965|NCT01105767|MRSA Skin Infection|mrsa skin infection
478966|NCT01105767|Staphylococcal Skin Infections|staphylococcal skin infections
478967|NCT01105767|Chlorhexidine gluconate|chlorhexidine gluconate
478968|NCT01105741|Crohn's disease|crohn's disease
478969|NCT01105741|Adalimumab|adalimumab
478970|NCT01105741|Metabolome|metabolome
478971|NCT01105728|Gastric subepitelial mass|gastric subepitelial mass
478972|NCT01105728|Endoscopic full thickness resection|endoscopic full thickness resection
478973|NCT01105715|Rheumatoid Arthritis|rheumatoid arthritis
478974|NCT01105715|cLDL|cldl
478975|NCT01105715|Cardiovascular disease|cardiovascular disease
478976|NCT01105702|brain tumor|brain tumor
478977|NCT01105702|brain cancer|brain cancer
478978|NCT01105702|glioma|glioma
478979|NCT01105689|Urine Calcium to Creatinine Ratio|urine calcium to creatinine ratio
478980|NCT01105689|Hypocalciuria|hypocalciuria
478981|NCT01105689|Infants|infants
478982|NCT01105689|Toddlers|toddlers
478983|NCT01105676|vascular malformation|vascular malformation
478984|NCT01105676|vascular anomalies|vascular anomalies
478985|NCT01105676|abnormalities of growth|abnormalities of growth
478986|NCT01105676|overgrowth|overgrowth
478987|NCT01105676|subjects with vascular malformations abnormalities of growth.|subjects with vascular malformations abnormalities of growth.
478988|NCT01105663|sedated|sedated
478989|NCT01105663|intubated|intubated
478990|NCT01105663|mechanically ventilated|mechanically ventilated
478991|NCT01105663|pediatric|pediatric
478992|NCT01105663|lung injury|lung injury
478993|NCT01105650|recurrent ovarian cancer|recurrent ovarian cancer
478994|NCT01105650|recurrent fallopian tube cancer|recurrent fallopian tube cancer
478995|NCT01105650|recurrent primary peritoneal cancer|recurrent primary peritoneal cancer
478996|NCT01105650|refractory ovarian cancer|refractory ovarian cancer
478997|NCT01105650|refractory fallopian tube cancer|refractory fallopian tube cancer
478998|NCT01105650|refractory peritoneal cancer|refractory peritoneal cancer
478999|NCT01105650|metastatic breast cancer|metastatic breast cancer
479000|NCT01105637|burn injuries|burn injuries
479001|NCT01105637|exercise|exercise
479003|NCT01105611|Hepatitis C|hepatitis c
479004|NCT01105611|Co-infection|co-infection
479005|NCT01105611|Intravenous drug users|intravenous drug users
479006|NCT01105611|Treatment-naïve|treatment-naïve
479007|NCT01105611|Methadone|methadone
479008|NCT01105585|Cataracts|cataracts
479009|NCT01105585|aspheric|aspheric
479010|NCT01105585|IOL|iol
479011|NCT01105585|ocular aberrations|ocular aberrations
479012|NCT01105572|Congestive Heart Failure|congestive heart failure
479013|NCT01105559|Diphtheria|diphtheria
479014|NCT01105559|Tetanus|tetanus
479015|NCT01105559|Whooping cough|whooping cough
479016|NCT01105559|Hepatitis B|hepatitis b
479017|NCT01105559|Poliomyelitis|poliomyelitis
479018|NCT01105559|Diphtheria-Tetanus-acellular Pertussis Vaccines|diphtheria-tetanus-acellular pertussis vaccines
479019|NCT01105546|hemophilia A|hemophilia a
479020|NCT01105546|inhibitors|inhibitors
479021|NCT01105546|prophylaxis|prophylaxis
479022|NCT01105546|immune tolerance induction|immune tolerance induction
479023|NCT01105533|VGEF inhibitor|vgef inhibitor
479024|NCT01105533|Anti angiogenesis|anti angiogenesis
479025|NCT01105533|Advanced Solid Tumors|advanced solid tumors
479026|NCT01105520|Intraspinal processes (tumor or vascular malformation AVM)|intraspinal processes (tumor or vascular malformation avm)
479027|NCT01105507|Canakinumab|canakinumab
479028|NCT01105507|Cryopyrin-associated periodic syndromes|cryopyrin-associated periodic syndromes
479029|NCT01105507|Familial Cold Autoinflammatory Syndrome (FCAS)|familial cold autoinflammatory syndrome (fcas)
479030|NCT01105507|Familial Cold Urticaria (FCU)|familial cold urticaria (fcu)
479031|NCT01105507|Muckle-Wells Syndrome (MWS)|muckle-wells syndrome (mws)
479032|NCT01105507|Neonatal-Onset Multisystem Inflammatory Disease (NOMID)|neonatal-onset multisystem inflammatory disease (nomid)
479033|NCT01105507|Chronic Infantile Neurological|chronic infantile neurological
479034|NCT01105507|Cutaneous|cutaneous
479035|NCT01105507|Articular Syndrome (CINCA)|articular syndrome (cinca)
479036|NCT01105507|Treatment of patients diagnosed with CAPS (Cryopyrin associated periodic syndrome)|treatment of patients diagnosed with caps (cryopyrin associated periodic syndrome)
479037|NCT01105481|treatment-resistant schizophrenia|treatment-resistant schizophrenia
479038|NCT01105481|clozapine|clozapine
479039|NCT01105481|amisulpride|amisulpride
479040|NCT01105468|Breath gas analysis|breath gas analysis
479041|NCT01105468|Volatile components in exhaled breath|volatile components in exhaled breath
479042|NCT01105455|Randomized clinical trial|randomized clinical trial
479043|NCT01105455|Gestational diabetes|gestational diabetes
479044|NCT01105455|Carbohydrates|carbohydrates
479045|NCT01105455|Glycemic index|glycemic index
479046|NCT01105442|Post-operative pain treatment|post-operative pain treatment
479047|NCT01105442|Fast-track colonic surgery patients|fast-track colonic surgery patients
479048|NCT01105442|Surgery|surgery
479049|NCT01105416|Pediatric Emergency Department|pediatric emergency department
479050|NCT01105416|Parental monitoring|parental monitoring
479051|NCT01105416|Adolescent|adolescent
479052|NCT01105416|Parents|parents
479053|NCT01105416|Communication|communication
479054|NCT01105416|Alcohol Drinking|alcohol drinking
479055|NCT01105403|Hematopoietic stem cells|hematopoietic stem cells
479056|NCT01105403|Mobilisation|mobilisation
479057|NCT01105403|Autologous transplantation|autologous transplantation
479058|NCT01105364|recurrent renal cell cancer|recurrent renal cell cancer
479059|NCT01105364|stage IV renal cell cancer|stage iv renal cell cancer
479060|NCT01105364|liver metastases|liver metastases
479061|NCT01105351|Folate|folate
479062|NCT01105351|MTHFR|mthfr
479063|NCT01105351|Homocysteine|homocysteine
479064|NCT01105338|prostate cancer|prostate cancer
479065|NCT01105325|acute coronary syndrome|acute coronary syndrome
479066|NCT01105325|treatment compliance|treatment compliance
479067|NCT01105325|cardiac intensive care unit|cardiac intensive care unit
479068|NCT01105325|secondary prevention|secondary prevention
479069|NCT01105325|cardiac intensive care unit (CIC)|cardiac intensive care unit (cic)
479070|NCT01105325|compliance|compliance
479071|NCT01105325|intensive care|intensive care
479072|NCT01105312|male breast cancer|male breast cancer
479073|NCT01105312|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
479074|NCT01105312|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
479075|NCT01105312|HER2-negative breast cancer|her2-negative breast cancer
479076|NCT01105312|HER2-positive breast cancer|her2-positive breast cancer
479077|NCT01105312|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
479078|NCT01105312|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
479079|NCT01105312|triple-negative breast cancer|triple-negative breast cancer
479080|NCT01105312|recurrent breast cancer|recurrent breast cancer
479081|NCT01105312|stage IV breast cancer|stage iv breast cancer
479082|NCT01105299|bioequivalence|bioequivalence
479083|NCT01105299|anastrozole|anastrozole
479084|NCT01105299|Healthy subjects|healthy subjects
479085|NCT01105299|Antineoplastic Agents|antineoplastic agents
479086|NCT01105299|Therapeutic Uses|therapeutic uses
479087|NCT01105299|Enzyme Inhibitors|enzyme inhibitors
479088|NCT01105273|Aplastic anemia|aplastic anemia
479089|NCT01105273|Fludarabine|fludarabine
479090|NCT01105273|CD3±CD19 depletion|cd3±cd19 depletion
479091|NCT01105273|Haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
479092|NCT01105260|early reconditioning program|early reconditioning program
479093|NCT01105260|spinal cord injury|spinal cord injury
479094|NCT01105260|early rehabilitation|early rehabilitation
479095|NCT01105260|wheelchair|wheelchair
479096|NCT01105247|PCI-32765|pci-32765
479097|NCT01105247|Lymphoma, B-Cell|lymphoma, b-cell
479098|NCT01105247|Leukemia, Lymphoid|leukemia, lymphoid
479099|NCT01105247|Leukemia, B-Cell|leukemia, b-cell
479100|NCT01105247|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
479101|NCT01105234|Healthy volunteers|healthy volunteers
479102|NCT01105221|Acupuncture|acupuncture
479103|NCT01105221|Dry eye|dry eye
479104|NCT01105221|Artificial tear drop|artificial tear drop
479105|NCT01105221|Mixed method approach|mixed method approach
479106|NCT01105221|Qualitative study|qualitative study
479107|NCT01105221|Cost effectiveness analysis|cost effectiveness analysis
479108|NCT01105221|Tear cytokine analysis|tear cytokine analysis
479109|NCT01105195|DuraPrep|duraprep
479110|NCT01105195|ChloraPrep|chloraprep
479111|NCT01105195|Lumbar Spine|lumbar spine
479112|NCT01105182|Radiofrequency Ablation|radiofrequency ablation
479113|NCT01105169|Personalized prevention|personalized prevention
479114|NCT01105169|Colorectal cancer|colorectal cancer
479115|NCT01105169|Investigational Nutrigenetic Studies|investigational nutrigenetic studies
479116|NCT01105169|Magnesium|magnesium
479117|NCT01105169|Gene polymorphism|gene polymorphism
479118|NCT01105156|Gastric band|gastric band
479119|NCT01105156|Questionnaire|questionnaire
479120|NCT01105156|Post operative management|post operative management
479121|NCT01105156|Adjustment|adjustment
479122|NCT01105143|weight loss|weight loss
479123|NCT01105143|muscle mass|muscle mass
479124|NCT01105130|radiation toxicity|radiation toxicity
479125|NCT01105130|male erectile disorder|male erectile disorder
479126|NCT01105130|prostate cancer|prostate cancer
479127|NCT01105117|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
479129|NCT01105117|EPITOME-1|epitome-1
479130|NCT01105091|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
479131|NCT01105091|PAH|pah
479132|NCT01105091|EPITOME-1|epitome-1
479133|NCT01105078|cardiopulmonary bypass flow rate outcome tissue perfusion oxygenation l/min/m2|cardiopulmonary bypass flow rate outcome tissue perfusion oxygenation l/min/m2
479134|NCT01105065|Normal Pressure Glaucoma|normal pressure glaucoma
479135|NCT01105052|Insomnia|insomnia
479136|NCT01105052|Co-morbid|co-morbid
479137|NCT01105052|CBT|cbt
479138|NCT01105052|Self-help|self-help
479139|NCT01105052|Bibliotherapy|bibliotherapy
479140|NCT01105039|Pain pattern|pain pattern
479141|NCT01105039|overall pain|overall pain
479142|NCT01105039|incisional pain|incisional pain
479143|NCT01105039|shoulder pain|shoulder pain
479144|NCT01105039|visceral pain|visceral pain
479145|NCT01105026|alveolar ridge preservation, bioactive glass, tooth extraction, graft material|alveolar ridge preservation, bioactive glass, tooth extraction, graft material
479146|NCT01105013|fungal infections|fungal infections
479147|NCT01105013|tinea|tinea
479148|NCT01105013|tonaftato|tonaftato
479149|NCT01105000|HPV|hpv
479150|NCT01105000|HPV vaccine|hpv vaccine
479151|NCT01104987|Ankylosing spondylitis|ankylosing spondylitis
479152|NCT01104987|spondarthritis|spondarthritis
479153|NCT01104987|Osteoporosis|osteoporosis
479154|NCT01104987|Bone mineral density|bone mineral density
479155|NCT01104987|Dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
479156|NCT01104987|Quantitative computed tomography|quantitative computed tomography
479157|NCT01104974|HIV|hiv
479158|NCT01104974|HIV providers|hiv providers
479159|NCT01104974|Infectious Disease|infectious disease
479160|NCT01104974|HIV and pregnancy|hiv and pregnancy
479161|NCT01104961|Bacterial infection|bacterial infection
479162|NCT01104961|Loss of epithelial cells|loss of epithelial cells
479163|NCT01104922|Re-irradiation with Fractionated Stereotactic Radiosurgery for Head and Neck|re-irradiation with fractionated stereotactic radiosurgery for head and neck
479164|NCT01104909|Dry weight|dry weight
479165|NCT01104909|Blood Pressure|blood pressure
479166|NCT01104909|Chronic Kidney disease|chronic kidney disease
479167|NCT01104896|Cigarette|cigarette
479168|NCT01104896|tobacco|tobacco
479169|NCT01104896|mechanical ventilation|mechanical ventilation
479170|NCT01104896|nicotine|nicotine
479171|NCT01104883|Adductor-Canal-Blockade|adductor-canal-blockade
479172|NCT01104883|postoperative pain|postoperative pain
479173|NCT01104883|US-guided nerve block|us-guided nerve block
479174|NCT01104883|total knee arthroplasty|total knee arthroplasty
479175|NCT01104857|Respiratory muscle|respiratory muscle
479176|NCT01104857|Myosin|myosin
479177|NCT01104857|Mechanical ventilation|mechanical ventilation
479178|NCT01104844|dental pain|dental pain
479179|NCT01104844|Analgesia|analgesia
479180|NCT01104831|Tibial Plateau Fracture|tibial plateau fracture
479181|NCT01104831|AO/OTA 41|ao/ota 41
479182|NCT01104818|Sibling relationship quality|sibling relationship quality
479183|NCT01104818|Foster Care|foster care
479184|NCT01104818|Parent Management Training|parent management training
479185|NCT01104818|Mental health outcomes|mental health outcomes
479186|NCT01104805|Drug Abuse|drug abuse
479187|NCT01104805|Substance Abuse|substance abuse
479188|NCT01104805|Substance Use Disorder|substance use disorder
479189|NCT01104805|Addiction|addiction
479190|NCT01104805|Behavioral Treatment|behavioral treatment
479191|NCT01104792|Schizophrenia|schizophrenia
479192|NCT01104792|Acute Schizophrenia|acute schizophrenia
479193|NCT01104792|Psychotropic Drugs|psychotropic drugs
479194|NCT01104792|Antipsychotic Agents|antipsychotic agents
479195|NCT01104792|Mental Disorders|mental disorders
479196|NCT01104792|Dopamine Agents|dopamine agents
479197|NCT01104792|Central Nervous System Agents|central nervous system agents
479198|NCT01104779|Schizophrenia|schizophrenia
479199|NCT01104779|Acute Schizophrenia|acute schizophrenia
479200|NCT01104779|Psychotropic Drugs|psychotropic drugs
479201|NCT01104779|Antipsychotic Agents|antipsychotic agents
479202|NCT01104779|Mental Disorders|mental disorders
479203|NCT01104779|Dopamine Agents|dopamine agents
479204|NCT01104779|Central Nervous System Agents|central nervous system agents
479205|NCT01104766|Schizophrenia|schizophrenia
479206|NCT01104766|Acute Schizophrenia|acute schizophrenia
479207|NCT01104766|Psychotropic Drugs|psychotropic drugs
479208|NCT01104766|Aripiprazole|aripiprazole
479209|NCT01104766|Antipsychotic Agents|antipsychotic agents
479210|NCT01104766|Mental Disorders|mental disorders
479211|NCT01104766|Dopamine Agents|dopamine agents
479212|NCT01104766|Central Nervous System Agents|central nervous system agents
479213|NCT01104727|SINGLE PORT SURGERY|single port surgery
479214|NCT01104727|LAPAROSCOPY, CHOLECYSTECTOMY|laparoscopy, cholecystectomy
479215|NCT01104701|Exenatide|exenatide
479216|NCT01104701|Amylin|amylin
479217|NCT01104701|Lilly|lilly
479218|NCT01104701|Byetta|byetta
479219|NCT01104701|Exenatide Once Weekly|exenatide once weekly
479220|NCT01104688|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
479221|NCT01104688|Wall Stress|wall stress
479222|NCT01104688|Shear Stress|shear stress
479223|NCT01104688|Inflammation|inflammation
479224|NCT01104688|Magnetic Resonance Imaging|magnetic resonance imaging
479225|NCT01104675|ovarian|ovarian
479226|NCT01104675|platinum resistant ovarian cancer|platinum resistant ovarian cancer
479227|NCT01104649|Spinocerebellar ataxia|spinocerebellar ataxia
479228|NCT01104649|Friedreich ataxia|friedreich ataxia
479229|NCT01104623|ADHD|adhd
479230|NCT01104597|Healthy Asian Indians and Caucasians|healthy asian indians and caucasians
479231|NCT01104584|Breast Cancer|breast cancer
479232|NCT01104584|Gadobutrol-enhanced MRI|gadobutrol-enhanced mri
479233|NCT01104584|Mammography|mammography
479234|NCT01104584|Diagnostic Imaging|diagnostic imaging
479235|NCT01104571|HER2-positive breast cancer|her2-positive breast cancer
479236|NCT01104571|stage IA breast cancer|stage ia breast cancer
479237|NCT01104571|stage IB breast cancer|stage ib breast cancer
479238|NCT01104571|stage II breast cancer|stage ii breast cancer
479239|NCT01104571|stage IIIA breast cancer|stage iiia breast cancer
479240|NCT01104571|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
479241|NCT01104571|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
479242|NCT01104558|Bisoprolol|bisoprolol
479243|NCT01104558|Chronic Heart failure|chronic heart failure
479244|NCT01104532|ASP1941|asp1941
479245|NCT01104532|Januvia|januvia
479246|NCT01104532|sitagliptin|sitagliptin
479247|NCT01104480|Relapsing Polychondritis|relapsing polychondritis
479248|NCT01104480|Unremitting|unremitting
479249|NCT01104480|Inflammation|inflammation
479250|NCT01104480|IL6|il6
479251|NCT01104467|Acute Ischemic Stroke|acute ischemic stroke
479252|NCT01104467|Desmoteplase|desmoteplase
479253|NCT01104467|Japan|japan
479254|NCT01104467|Safety|safety
479255|NCT01104467|Stroke|stroke
479256|NCT01104467|Tolerability|tolerability
479257|NCT01104454|healthy pregnant women|healthy pregnant women
479258|NCT01104441|critical limb ischaemia|critical limb ischaemia
479259|NCT01104441|Aspirin resistance|aspirin resistance
479260|NCT01104428|Hench-schonlein purpura|hench-schonlein purpura
479261|NCT01104428|Renal damage|renal damage
479262|NCT01104428|Relapse|relapse
479263|NCT01104428|End event|end event
479264|NCT01104428|TCM syndrome|tcm syndrome
479265|NCT01104415|Carcinoid syndrome|carcinoid syndrome
479266|NCT01104402|telemedicine|telemedicine
479267|NCT01104402|spirometer|spirometer
479268|NCT01104402|CF|cf
479269|NCT01104402|pulmonary|pulmonary
479270|NCT01104402|home monitoring|home monitoring
479271|NCT01104376|Cytochrome P450|cytochrome p450
479272|NCT01104376|CYP2B6|cyp2b6
479273|NCT01104376|Voriconazole|voriconazole
479274|NCT01104376|Efavirenz|efavirenz
479275|NCT01104376|Pharmacokinetics|pharmacokinetics
479276|NCT01104376|Drug-Interactions|drug-interactions
479277|NCT01104376|Pharmacogenetics|pharmacogenetics
479278|NCT01104376|Healthy volunteers|healthy volunteers
479279|NCT01104363|Dental implants|dental implants
479280|NCT01104350|Bladder|bladder
479281|NCT01104350|Radiotherapy|radiotherapy
479282|NCT01104350|Gemcitabine|gemcitabine
479283|NCT01104350|Chemotherapy|chemotherapy
479284|NCT01104350|10-031|10-031
479285|NCT01104337|paracetamol|paracetamol
479286|NCT01104337|warfarin|warfarin
479287|NCT01104337|drug interaction|drug interaction
479288|NCT01104337|pathogenic mechanism|pathogenic mechanism
479289|NCT01104324|bone health|bone health
479290|NCT01104324|Osteonecrosis|osteonecrosis
479291|NCT01104324|acute lymphoblastic leukemia|acute lymphoblastic leukemia
479292|NCT01104311|Blood Pressure|blood pressure
479293|NCT01104311|Atherosclerosis|atherosclerosis
479294|NCT01104311|Brain Ischemia|brain ischemia
479295|NCT01104298|metastatic STS|metastatic sts
479296|NCT01104298|Trabectedin|trabectedin
479297|NCT01104298|doxorrubicin|doxorrubicin
479298|NCT01104298|soft tissue sarcoma|soft tissue sarcoma
479299|NCT01104298|non operable sarcoma|non operable sarcoma
479300|NCT01104272|Ultrasound Treatment of Subcutaneous Adipose Tissue|ultrasound treatment of subcutaneous adipose tissue
479301|NCT01104246|Hypogonadism|hypogonadism
479302|NCT01104246|Testosterone|testosterone
479303|NCT01104246|Hormone replacement therapy|hormone replacement therapy
479304|NCT01104233|Video-assisted Thoracoscopic Surgery|video-assisted thoracoscopic surgery
479305|NCT01104233|Soft spreading|soft spreading
479306|NCT01104233|LAP Protector|lap protector
479307|NCT01104220|NAFLD|nafld
479308|NCT01104220|Obesity|obesity
479309|NCT01104220|Metabolic syndrome|metabolic syndrome
479310|NCT01104207|tinnitus|tinnitus
479311|NCT01104207|TMS|tms
479312|NCT01104207|transcranial magnetic stimulation|transcranial magnetic stimulation
479313|NCT01104194|depression|depression
479314|NCT01104194|cognition|cognition
479315|NCT01104194|heart rate variability|heart rate variability
479316|NCT01104194|omega-3 fatty acids|omega-3 fatty acids
479317|NCT01104194|Depression (in remission) (vulnerability to depression)|depression (in remission) (vulnerability to depression)
479318|NCT01104181|Anal HPV|anal hpv
479319|NCT01104181|Anal Dysplasia|anal dysplasia
479320|NCT01104181|Ana Cancer|ana cancer
479321|NCT01104168|diabetes|diabetes
479322|NCT01104168|elderly|elderly
479323|NCT01104168|nursing home resident|nursing home resident
479324|NCT01104155|NSCLC|nsclc
479325|NCT01104129|Pancreatic Cancer|pancreatic cancer
479326|NCT01104129|Intraductal Papillary Mucinous Neoplasm (IPMN)|intraductal papillary mucinous neoplasm (ipmn)
479327|NCT01104129|Stool-based digital melt curve (DMC) assay|stool-based digital melt curve (dmc) assay
479328|NCT01104129|Surgical resection for pancreatic cancer|surgical resection for pancreatic cancer
479329|NCT01104129|Hereditary Pancreatic Cancer Syndrome|hereditary pancreatic cancer syndrome
479330|NCT01104129|Genetic mutations linked to pancreatic cancer|genetic mutations linked to pancreatic cancer
479331|NCT01104116|Pancreatic Cancer|pancreatic cancer
479332|NCT01104116|Intraductal Papillary Mucinous Neoplasm|intraductal papillary mucinous neoplasm
479333|NCT01104116|Pre-cancerous pancreatic lesion|pre-cancerous pancreatic lesion
479334|NCT01104116|PET Scan|pet scan
479335|NCT01104116|Pancreatic Cancer Screening|pancreatic cancer screening
479336|NCT01104103|Catheterization, Peripheral|catheterization, peripheral
479337|NCT01104103|Disposable Equipment|disposable equipment
479338|NCT01104103|Emergency Medical Technicians|emergency medical technicians
479339|NCT01104103|Emergency Nursing|emergency nursing
479340|NCT01104090|C-MAC|c-mac
479341|NCT01104090|direct laryngoscopy|direct laryngoscopy
479342|NCT01104090|indirect laryngoscopy|indirect laryngoscopy
479343|NCT01104090|to determine the safety and efficacy of the C-MAC|to determine the safety and efficacy of the c-mac
479344|NCT01104077|Pancreatic Cancer|pancreatic cancer
479345|NCT01104077|Family History|family history
479346|NCT01104077|Pre-cancerous lesion|pre-cancerous lesion
479347|NCT01104077|Intraductal Papillary Mucinous Neoplasm (IPMN)|intraductal papillary mucinous neoplasm (ipmn)
479348|NCT01104077|Intraductal Papillary Mucinous Neoplasm|intraductal papillary mucinous neoplasm
479349|NCT01104064|Stroke|stroke
479350|NCT01104038|physical activity|physical activity
479351|NCT01104038|cardiometabolic risk|cardiometabolic risk
479352|NCT01104038|children|children
479353|NCT01104025|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
479354|NCT01104025|hybrid immunotherapy|hybrid immunotherapy
479355|NCT01104025|dexamethasone|dexamethasone
479356|NCT01104025|Etoposide|etoposide
479357|NCT01104025|ATG,rabbit|atg,rabbit
479358|NCT01103999|spleen|spleen
479359|NCT01103986|health literacy|health literacy
479360|NCT01103986|consumer health information|consumer health information
479361|NCT01103986|patient education as topics/methods|patient education as topics/methods
479362|NCT01103986|patient participation|patient participation
479363|NCT01103973|IVF, Mind/Body|ivf, mind/body
479364|NCT01103947|Anesthesia induction|anesthesia induction
479365|NCT01103947|Facemask|facemask
479366|NCT01103947|surgery|surgery
479367|NCT01103921|sugar|sugar
479368|NCT01103921|fructose|fructose
479369|NCT01103921|glucose|glucose
479370|NCT01103921|HFCS|hfcs
479371|NCT01103921|metabolism|metabolism
479372|NCT01103908|cardiac output|cardiac output
479373|NCT01103908|cardiopulmonary bypass|cardiopulmonary bypass
479374|NCT01103908|ultrasound dilution|ultrasound dilution
479375|NCT01103895|cardiac output|cardiac output
479376|NCT01103895|cardiopulmonary bypass|cardiopulmonary bypass
479377|NCT01103895|ultrasound dilution|ultrasound dilution
479378|NCT01103856|HIV|hiv
479379|NCT01103856|adherence to care|adherence to care
479380|NCT01103856|retention in care|retention in care
479381|NCT01103856|patient navigation|patient navigation
479382|NCT01103843|Coronary artery disease|coronary artery disease
479383|NCT01103843|clopidogrel|clopidogrel
479384|NCT01103843|prasugrel|prasugrel
479385|NCT01103843|Verify Now|verify now
479386|NCT01103843|PRU measurements|pru measurements
479387|NCT01103843|Drug eluting stents (EDS)|drug eluting stents (eds)
479388|NCT01103843|P2Y12|p2y12
479389|NCT01103843|Platelet reactivity|platelet reactivity
479390|NCT01103830|P. falciparum Malaria, Eurartesim, ACT|p. falciparum malaria, eurartesim, act
479391|NCT01103817|Type 1 Diabetes|type 1 diabetes
479392|NCT01103817|Adolescents and Young Adults|adolescents and young adults
479393|NCT01103817|Vitamin D|vitamin d
479394|NCT01103817|Cardiovascular Disease|cardiovascular disease
479395|NCT01103804|GerdQ questionnaire|gerdq questionnaire
479396|NCT01103778|Chronic kidney disease|chronic kidney disease
479397|NCT01103778|IgA nephropathy|iga nephropathy
479398|NCT01103778|Velcade®|velcade®
479399|NCT01103778|Proteinuria|proteinuria
479400|NCT01103778|Bortezomib|bortezomib
479401|NCT01103778|Proteasome inhibitor|proteasome inhibitor
479402|NCT01103765|Post-dilatation|post-dilatation
479403|NCT01103765|noncompliant balloon|noncompliant balloon
479404|NCT01103765|optimal stent deployment of drug-eluting stent|optimal stent deployment of drug-eluting stent
479405|NCT01103765|Intravascular ultrasound (IVUS)|intravascular ultrasound (ivus)
479406|NCT01103765|Optimal stent deployment defined by intravascular ultrasound analysis|optimal stent deployment defined by intravascular ultrasound analysis
479407|NCT01103739|pharmacokinetics|pharmacokinetics
479408|NCT01103739|drug-drug interaction|drug-drug interaction
479409|NCT01103726|FDG-PET|fdg-pet
479410|NCT01103726|regional cerebral glucose metabolism|regional cerebral glucose metabolism
479411|NCT01103726|striatum|striatum
479412|NCT01103726|PDE10 inhibitor|pde10 inhibitor
479413|NCT01103713|P. falciparum malaria|p. falciparum malaria
479414|NCT01103713|asymptomatic parasitemia|asymptomatic parasitemia
479415|NCT01103713|parasitological clearance|parasitological clearance
479416|NCT01103713|Intermittent Preventive Treatment of Falciparum Malaria in Pregnant Women (IPTp)|intermittent preventive treatment of falciparum malaria in pregnant women (iptp)
479417|NCT01103700|Quality of dying and death of terminal cancer patients|quality of dying and death of terminal cancer patients
479418|NCT01103687|HIV Preventive Vaccine|hiv preventive vaccine
479419|NCT01103674|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
479420|NCT01103674|AF|af
479421|NCT01103674|Atrial Fibrillation|atrial fibrillation
479422|NCT01103674|RF ablation|rf ablation
479423|NCT01103661|Longstanding Persistent Atrial Fibrillation|longstanding persistent atrial fibrillation
479424|NCT01103661|AF|af
479425|NCT01103661|Chronic AF|chronic af
479426|NCT01103661|RF Ablation|rf ablation
479427|NCT01103661|nContact Surgical|ncontact surgical
479428|NCT01103661|Therapy Cool Path Ablation Catheter|therapy cool path ablation catheter
479429|NCT01103661|St. Jude Medical|st. jude medical
479430|NCT01103648|Prediabetes|prediabetes
479431|NCT01103648|Statin|statin
479432|NCT01103648|Ezetimibe|ezetimibe
479433|NCT01103648|Pleiotropic effects|pleiotropic effects
479434|NCT01103648|Cardiometabolic risk|cardiometabolic risk
479435|NCT01103622|Diabetes|diabetes
479436|NCT01103622|Type 2|type 2
479437|NCT01103622|Digoxin|digoxin
479438|NCT01103622|drug-drug interaction|drug-drug interaction
479439|NCT01103609|Diabetes|diabetes
479440|NCT01103609|Type 2|type 2
479441|NCT01103609|Warfarin|warfarin
479442|NCT01103609|drug-drug interaction|drug-drug interaction
479443|NCT01103596|Evaluation of the impact of Kaletra on antiretroviral resistance|evaluation of the impact of kaletra on antiretroviral resistance
479444|NCT01103570|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
479445|NCT01103570|Intra-operative cholangiography|intra-operative cholangiography
479822|NCT01101932|Rheumatoid Arthritis|rheumatoid arthritis
479446|NCT01103557|Papillary thyroid carcinoma with neck metastasis|papillary thyroid carcinoma with neck metastasis
479447|NCT01103557|neck dissection|neck dissection
479448|NCT01103544|TCCU|tccu
479449|NCT01103544|advanced TCCU|advanced tccu
479450|NCT01103544|metastatic TCCU|metastatic tccu
479451|NCT01103544|transitional cell carcinoma of the urothelium|transitional cell carcinoma of the urothelium
479452|NCT01103544|advanced transitional cell carcinoma of the urothelium|advanced transitional cell carcinoma of the urothelium
479453|NCT01103544|metastatic transitional cell carcinoma of the urothelium|metastatic transitional cell carcinoma of the urothelium
479454|NCT01103544|Cisplatinum failure|cisplatinum failure
479455|NCT01103544|Vinflunine|vinflunine
479456|NCT01103544|Javlor|javlor
479457|NCT01103544|daily routine|daily routine
479458|NCT01103544|concomitant antiemetic treatment|concomitant antiemetic treatment
479459|NCT01103544|concomitant antiobstipative treatment|concomitant antiobstipative treatment
479460|NCT01103544|concomitant antiobstipative diet|concomitant antiobstipative diet
479461|NCT01103544|patient compliance|patient compliance
479462|NCT01103544|quality of life|quality of life
479463|NCT01103544|non-interventional study|non-interventional study
479464|NCT01103544|Germany|germany
479465|NCT01103544|Advanced / metastatic TCCU after Cisplatinum-failure|advanced / metastatic tccu after cisplatinum-failure
479466|NCT01103531|Methamphetamine|methamphetamine
479467|NCT01103531|Methamphetamine Dependence|methamphetamine dependence
479468|NCT01103531|Methamphetamine Treatment|methamphetamine treatment
479469|NCT01103531|Aerobic Exercise|aerobic exercise
479470|NCT01103531|Resistance Exercise|resistance exercise
479471|NCT01103531|Brain Imaging|brain imaging
479472|NCT01103531|D2 and D3 receptor availability|d2 and d3 receptor availability
479473|NCT01103518|Menstrual irregularity|menstrual irregularity
479474|NCT01103518|Menstruation disturbances|menstruation disturbances
479475|NCT01103518|Hyperandrogenism|hyperandrogenism
479476|NCT01103505|AMD|amd
479477|NCT01103505|CNV|cnv
479478|NCT01103492|prostate cancer|prostate cancer
479479|NCT01103492|endometrial cancer|endometrial cancer
479480|NCT01103492|radiation proctitis|radiation proctitis
479481|NCT01103492|pelvic radiotherapy|pelvic radiotherapy
479482|NCT01103492|rectal bleeding|rectal bleeding
479483|NCT01103479|Early Detection of Cancer|early detection of cancer
479484|NCT01103479|Colorectal Cancer Screening|colorectal cancer screening
479485|NCT01103466|Ileostomy base plate|ileostomy base plate
479486|NCT01103453|MCI|mci
479487|NCT01103453|Executive Function|executive function
479488|NCT01103453|ADL|adl
479489|NCT01103453|Virtual Supermarket|virtual supermarket
479490|NCT01103440|Major Adverse Cardiovascular Event|major adverse cardiovascular event
479491|NCT01103440|MACE|mace
479492|NCT01103440|Death|death
479493|NCT01103440|MI|mi
479494|NCT01103440|CK MB greater 3x Normal|ck mb greater 3x normal
479495|NCT01103440|Urgent Revascularization|urgent revascularization
479496|NCT01103440|Stent Thrombosis|stent thrombosis
479497|NCT01103440|Bleeding|bleeding
479498|NCT01103427|smoking cessation|smoking cessation
479499|NCT01103427|telemedicine|telemedicine
479500|NCT01103427|smoking|smoking
479501|NCT01103427|prevention intervention|prevention intervention
479502|NCT01103427|internet-based|internet-based
479503|NCT01103427|text messages|text messages
479504|NCT01103427|behavioral|behavioral
479505|NCT01103414|Diabetes|diabetes
479506|NCT01103388|Rituximab|rituximab
479507|NCT01103388|Rituxan|rituxan
479508|NCT01103388|Lymphoma|lymphoma
479509|NCT01103388|High dose chemotherapy|high dose chemotherapy
479510|NCT01103388|Autologous transplantation|autologous transplantation
479511|NCT01103388|Autologous stem cell transplant|autologous stem cell transplant
479512|NCT01103388|ASCT|asct
479513|NCT01103336|Patients with chronic renal failure undergoing coronary angiography|patients with chronic renal failure undergoing coronary angiography
479514|NCT01103323|Metastatic Colorectal Cancer|metastatic colorectal cancer
479515|NCT01103310|Neoplasm|neoplasm
479516|NCT01103310|PET/CT diagnosis|pet/ct diagnosis
479517|NCT01103310|PET tracer|pet tracer
479518|NCT01103297|Distal radius fracture|distal radius fracture
479519|NCT01103297|Double row plate|double row plate
479520|NCT01103297|Volar approach|volar approach
479521|NCT01103297|DVR plate|dvr plate
479522|NCT01103297|Postoperative complications [MeSH]|postoperative complications [mesh]
479523|NCT01103284|beta-cells|beta-cells
479524|NCT01103284|autoimmune|autoimmune
479525|NCT01103284|Diabetes|diabetes
479526|NCT01103284|immunomodulation|immunomodulation
479527|NCT01103271|depression|depression
479528|NCT01103271|placebo effect|placebo effect
479529|NCT01103271|complementary therapies|complementary therapies
479530|NCT01103271|alternative therapies|alternative therapies
479531|NCT01103258|Incompetence of the great saphenous vein.|incompetence of the great saphenous vein.
479532|NCT01103245|Glucose|glucose
479533|NCT01103245|Insulin|insulin
479534|NCT01103232|Cross education|cross education
479535|NCT01103232|Muscle training|muscle training
479536|NCT01103219|VLBW|vlbw
479537|NCT01103219|nutrition|nutrition
479538|NCT01103219|vitamin A|vitamin a
479539|NCT01103219|long-chain unsaturated fatty acids|long-chain unsaturated fatty acids
479540|NCT01103219|growth|growth
479541|NCT01103219|cognitive functions|cognitive functions
479542|NCT01103219|Very low birth weight infants (birth weight below 1,500 grams).|very low birth weight infants (birth weight below 1,500 grams).
479543|NCT01103206|Parathyroid hormone|parathyroid hormone
479544|NCT01103206|Cinacalcet|cinacalcet
479545|NCT01103206|Primary hyperparathyroidism|primary hyperparathyroidism
479546|NCT01103206|Diagnosis|diagnosis
479547|NCT01103193|ASA class I/II patients, with surgery under general anesthesia|asa class i/ii patients, with surgery under general anesthesia
479548|NCT01103180|Selective Serotonin Reuptake Inhibitor|selective serotonin reuptake inhibitor
479549|NCT01103180|Escitalopram|escitalopram
479550|NCT01103180|Borderline Personality Disorder|borderline personality disorder
479551|NCT01103180|Major Depressive Disorder|major depressive disorder
479552|NCT01103180|Self-harm|self-harm
479553|NCT01103167|body composition|body composition
479554|NCT01103167|blood pressure|blood pressure
479555|NCT01103167|hemodialysis|hemodialysis
479556|NCT01103154|beta blocker|beta blocker
479557|NCT01103154|variceal rebleeding|variceal rebleeding
479558|NCT01103154|efficacy and safety in reducing variceal rebleeding|efficacy and safety in reducing variceal rebleeding
479559|NCT01103141|Vascular Surgical Procedures|vascular surgical procedures
479560|NCT01103141|Angioplasty|angioplasty
479561|NCT01103141|Radiology, Interventional|radiology, interventional
479562|NCT01103128|Pancreatic Cancer|pancreatic cancer
479563|NCT01103128|Pre-neoplastic lesions|pre-neoplastic lesions
479564|NCT01103128|Breast and Ovarian Cancer Syndrome|breast and ovarian cancer syndrome
479565|NCT01103128|BRCA1/2|brca1/2
479566|NCT01103128|Mouse model for pancreatic cancer|mouse model for pancreatic cancer
479567|NCT01103115|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
479568|NCT01103115|AIS|ais
479569|NCT01103115|low bone mass|low bone mass
479570|NCT01103115|osteopenia|osteopenia
479571|NCT01103115|bone health|bone health
479572|NCT01103115|bone density|bone density
479573|NCT01103102|Gingivitis|gingivitis
479574|NCT01103102|Biological Markers|biological markers
479575|NCT01103089|NSCLC|nsclc
479576|NCT01103089|EGFR|egfr
479577|NCT01103089|gefitinib|gefitinib
479578|NCT01103089|observational|observational
479579|NCT01103076|Immune dysfunction|immune dysfunction
479580|NCT01103076|Hemodialysis|hemodialysis
479581|NCT01103076|HBV|hbv
479582|NCT01103076|Vaccination|vaccination
479583|NCT01103076|Immune response|immune response
479584|NCT01103063|P. falciparum malaria|p. falciparum malaria
479585|NCT01103063|IPTp|iptp
479586|NCT01103050|Allergic inflammation|allergic inflammation
480199|NCT01100931|Survivin|survivin
479587|NCT01103050|Seasonal rhinitis|seasonal rhinitis
479588|NCT01103037|Mild|mild
479589|NCT01103037|Moderate|moderate
479590|NCT01103037|Asthma|asthma
479591|NCT01103024|Active uveitis|active uveitis
479592|NCT01103024|intermediate uveitis|intermediate uveitis
479593|NCT01103024|panuveitis|panuveitis
479594|NCT01103024|posterior uveitis|posterior uveitis
479595|NCT01103024|uveitis|uveitis
479596|NCT01102998|Sleep complaints|sleep complaints
479597|NCT01102998|Brain Tumor Survivors|brain tumor survivors
479598|NCT01102985|exercise|exercise
479599|NCT01102985|physical activity|physical activity
479600|NCT01102985|intervention|intervention
479601|NCT01102985|cancer survivor|cancer survivor
479602|NCT01102972|HIV-1|hiv-1
479603|NCT01102972|HIV|hiv
479604|NCT01102959|EDUCATION|education
479605|NCT01102959|DIABETES MELLITUS|diabetes mellitus
479606|NCT01102959|ADOLESCENT|adolescent
479607|NCT01102959|DIABETIC DIET|diabetic diet
479608|NCT01102946|proliferative diabetic retinopathy|proliferative diabetic retinopathy
479609|NCT01102946|retinal neovascularization|retinal neovascularization
479610|NCT01102946|Angiogenesis Inhibitors|angiogenesis inhibitors
479611|NCT01102946|ranibizumab|ranibizumab
479612|NCT01102946|laser|laser
479613|NCT01102920|Obstructive sleep apnea|obstructive sleep apnea
479614|NCT01102920|Obesity|obesity
479615|NCT01102920|Behavioural medicine|behavioural medicine
479616|NCT01102920|Physical therapy|physical therapy
479617|NCT01102920|Health behaviour change|health behaviour change
479618|NCT01102920|Physical activity|physical activity
479619|NCT01102920|Eating habits|eating habits
479620|NCT01102907|Appetite|appetite
479621|NCT01102907|Satiety|satiety
479622|NCT01102907|Gastric Emptying Time|gastric emptying time
479623|NCT01102907|Food Intake|food intake
479624|NCT01102907|Food Form|food form
479625|NCT01102881|Healthy adults|healthy adults
479626|NCT01102829|Knee Joint|knee joint
479627|NCT01102829|Arthroplasty|arthroplasty
479628|NCT01102829|Replacement|replacement
479629|NCT01102829|Knee|knee
479630|NCT01102816|hemodialysis|hemodialysis
479631|NCT01102816|end-stage renal disease|end-stage renal disease
479632|NCT01102816|pain|pain
479633|NCT01102816|acupuncture|acupuncture
479634|NCT01102803|Phobias|phobias
479635|NCT01102803|Anxiety Disorders|anxiety disorders
479636|NCT01102803|D-Cycloserine|d-cycloserine
479637|NCT01102803|Phobic Disorders|phobic disorders
479638|NCT01102803|Mental Disorders|mental disorders
479639|NCT01102803|Heights|heights
479640|NCT01102803|Acrophobia|acrophobia
479641|NCT01102790|HIT|hit
479642|NCT01102777|internet|internet
479643|NCT01102777|walking|walking
479644|NCT01102764|Anxiety Disorders: PTSD|anxiety disorders: ptsd
479645|NCT01102764|Prolong Exposure (PE)|prolong exposure (pe)
479646|NCT01102764|Telemedicine|telemedicine
479647|NCT01102764|cost effectiveness|cost effectiveness
479648|NCT01102764|deployment related problems|deployment related problems
479649|NCT01102764|mental health care delivery|mental health care delivery
479650|NCT01102751|fibroblast growth factor 23|fibroblast growth factor 23
479651|NCT01102751|Osteomalacia|osteomalacia
479652|NCT01102751|vitamin D|vitamin d
479653|NCT01102725|Colon Surgery|colon surgery
479654|NCT01102725|Rectal Surgery|rectal surgery
479655|NCT01102725|Colorectal Surgery|colorectal surgery
479656|NCT01102712|Emphysema|emphysema
479657|NCT01102712|COPD|copd
479658|NCT01102712|Lung Volume Reduction|lung volume reduction
479659|NCT01102712|BTVA|btva
479660|NCT01102699|Diabetes|diabetes
479661|NCT01102699|stem cells|stem cells
479662|NCT01102699|bone marrow|bone marrow
479663|NCT01102699|mobilization|mobilization
479664|NCT01102686|Late-onset GM2-gangliosidosis|late-onset gm2-gangliosidosis
479665|NCT01102686|pyrimethamine|pyrimethamine
479666|NCT01102673|phase 1|phase 1
479667|NCT01102673|safety and tolerability|safety and tolerability
479668|NCT01102673|PK|pk
479669|NCT01102673|T2DM|t2dm
479670|NCT01102673|type 2 diabetes mellitus|type 2 diabetes mellitus
479671|NCT01102660|Knee osteoarthritis|knee osteoarthritis
479672|NCT01102660|clinical trial|clinical trial
479673|NCT01102660|cross-over|cross-over
479674|NCT01102621|hearing loss|hearing loss
479675|NCT01102621|head and neck cancer|head and neck cancer
479676|NCT01102621|radiotherapy|radiotherapy
479677|NCT01102621|hearing complaint|hearing complaint
479678|NCT01102621|Hearing loss due to the exposure of radiotherapy|hearing loss due to the exposure of radiotherapy
479679|NCT01102608|sarcoma|sarcoma
479680|NCT01102608|ifosfamide|ifosfamide
479681|NCT01102595|Unresectable/inoperable glioblastomas|unresectable/inoperable glioblastomas
479682|NCT01102582|Parkinson's disease dementia, neuropsychiatric symptoms|parkinson's disease dementia, neuropsychiatric symptoms
479683|NCT01102569|Hereditary pancreatic cancer|hereditary pancreatic cancer
479684|NCT01102569|Breast and Ovarian Cancer Syndrome|breast and ovarian cancer syndrome
479685|NCT01102569|BRCA1/2|brca1/2
479686|NCT01102569|Ashkenazi Jewish patients|ashkenazi jewish patients
479687|NCT01102556|Pancreatic Cancer|pancreatic cancer
479688|NCT01102556|Pre-Neoplastic Lesions|pre-neoplastic lesions
479689|NCT01102556|Pancreatic Cancer Surgery|pancreatic cancer surgery
479690|NCT01102556|High-Risk for Pancreatic Cancer|high-risk for pancreatic cancer
479691|NCT01102556|Tissue and Blood Bank for Pancreatic Cancer|tissue and blood bank for pancreatic cancer
479692|NCT01102556|Pancreatic Cancer Questionnaire|pancreatic cancer questionnaire
479693|NCT01102543|pulmonary surfactant|pulmonary surfactant
479694|NCT01102543|Respiratory distress syndrome|respiratory distress syndrome
479695|NCT01102543|Newborn|newborn
479696|NCT01102543|prophylaxis|prophylaxis
479697|NCT01102517|NSCLC|nsclc
479698|NCT01102517|Clinical|clinical
479699|NCT01102517|Early-stage|early-stage
479700|NCT01102504|carotid atheroma|carotid atheroma
479701|NCT01102504|plaque vulnerability|plaque vulnerability
479702|NCT01102504|stroke risk|stroke risk
479703|NCT01102491|postoperative nausea and vomiting|postoperative nausea and vomiting
479704|NCT01102439|Clopidogrel|clopidogrel
479705|NCT01102439|Aspirin|aspirin
479706|NCT01102439|Interaction|interaction
479707|NCT01102426|Multiple Myeloma|multiple myeloma
479708|NCT01102426|Aplidin|aplidin
479709|NCT01102426|plitidepsin|plitidepsin
479710|NCT01102426|dexamethasone|dexamethasone
479711|NCT01102400|cancer|cancer
479712|NCT01102400|tumor|tumor
479713|NCT01102400|hepatocellular carcinoma|hepatocellular carcinoma
479714|NCT01102387|Candida infections in intertriginous areas|candida infections in intertriginous areas
479715|NCT01102374|Vitamin D Deficiency|vitamin d deficiency
479716|NCT01102374|Respiratory Infection|respiratory infection
479717|NCT01102374|Nursing Home Residents|nursing home residents
479718|NCT01102374|Geriatrics|geriatrics
479719|NCT01102374|Immunosenescence|immunosenescence
479720|NCT01102374|Prevention|prevention
479721|NCT01102348|Critically Ill|critically ill
479722|NCT01102348|Nutrition Therapy|nutrition therapy
479723|NCT01102348|Enteral Nutrition|enteral nutrition
479724|NCT01102335|hepatitis B virus|hepatitis b virus
479725|NCT01102335|Antiviral Agents|antiviral agents
479726|NCT01102335|Liver Neoplasms|liver neoplasms
479727|NCT01102335|Drug Toxicity|drug toxicity
479728|NCT01102335|Survival|survival
479729|NCT01102322|Acute respiratory distress syndrome|acute respiratory distress syndrome
479730|NCT01102309|cerebrovascular accident|cerebrovascular accident
479731|NCT01102309|hemiparesis|hemiparesis
479732|NCT01102309|recovery of function|recovery of function
479733|NCT01102309|rehabilitation|rehabilitation
479734|NCT01102309|robotics|robotics
479735|NCT01102309|subacute therapy|subacute therapy
479736|NCT01102309|training|training
479737|NCT01102296|hepatitis A vaccine|hepatitis a vaccine
479738|NCT01102296|male homosexual|male homosexual
479739|NCT01102296|HIV infection|hiv infection
479740|NCT01102296|male homosexuals who are seronegative for hepatitis A virus|male homosexuals who are seronegative for hepatitis a virus
479741|NCT01102283|Colonic obstruction|colonic obstruction
479742|NCT01102270|Obstructive sleep apnea|obstructive sleep apnea
479743|NCT01102270|Arousal threshold|arousal threshold
479744|NCT01102270|Sedative medication|sedative medication
479745|NCT01102270|upper airway|upper airway
479746|NCT01102257|Dry Eye Disease|dry eye disease
479747|NCT01102257|DED|ded
479748|NCT01102257|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
479749|NCT01102257|Omega-3|omega-3
479750|NCT01102244|blepharitis|blepharitis
479751|NCT01102244|moderate to severe chronic blepharitis|moderate to severe chronic blepharitis
479752|NCT01102218|Anemia, ESRD|anemia, esrd
479753|NCT01102192|Myasthenia gravis|myasthenia gravis
479754|NCT01102192|Thymoma|thymoma
479755|NCT01102192|T-cells|t-cells
479756|NCT01102192|Thymectomy|thymectomy
479757|NCT01102166|This study was conducted in healthy subjects|this study was conducted in healthy subjects
479758|NCT01102153|sudden cardiac arrest|sudden cardiac arrest
479759|NCT01102153|Hypothermia|hypothermia
479760|NCT01102153|Coolgard|coolgard
479761|NCT01102153|arctic sun|arctic sun
479762|NCT01102153|neurological outcome|neurological outcome
479763|NCT01102153|neuron specific enolase|neuron specific enolase
479764|NCT01102140|Cardiomyopathy|cardiomyopathy
479765|NCT01102140|Heart Failure|heart failure
479766|NCT01102127|elastography|elastography
479767|NCT01102127|thyroid nodule|thyroid nodule
479768|NCT01102127|fine-needle aspiration|fine-needle aspiration
479769|NCT01102114|Smoking Cessation|smoking cessation
479770|NCT01102114|NicVAX|nicvax
479771|NCT01102114|Smoking Vaccine|smoking vaccine
479772|NCT01102114|Smoking Abstinence|smoking abstinence
479773|NCT01102114|Smoking|smoking
479774|NCT01102114|Tobacco Cessation|tobacco cessation
479775|NCT01102101|Remifentanil|remifentanil
479776|NCT01102101|Hyperalgesia|hyperalgesia
479777|NCT01102101|Zoster|zoster
479778|NCT01102101|Postherpetic neuralgia|postherpetic neuralgia
479779|NCT01102088|Cancer|cancer
479780|NCT01102088|Gastroesophageal|gastroesophageal
479781|NCT01102088|Simultaneous Integrated Boost|simultaneous integrated boost
479782|NCT01102088|SIB|sib
479783|NCT01102088|5-Fluorouracil|5-fluorouracil
479784|NCT01102088|5-FU|5-fu
479785|NCT01102088|Adrucil|adrucil
479786|NCT01102088|Efudex|efudex
479787|NCT01102088|Docetaxel|docetaxel
479788|NCT01102088|Taxotere|taxotere
479789|NCT01102088|Radiation|radiation
479790|NCT01102088|chemoradiation|chemoradiation
479792|NCT01102075|Electroacupuncture|electroacupuncture
479793|NCT01102075|Sham electroacupuncture|sham electroacupuncture
479794|NCT01102075|Waist circumference|waist circumference
479795|NCT01102075|Thickness of subcutaneous fat|thickness of subcutaneous fat
479796|NCT01102036|Transit time|transit time
479797|NCT01102036|constipation|constipation
479798|NCT01102036|gut regularity|gut regularity
479799|NCT01102036|defecation frequency|defecation frequency
479800|NCT01102036|Colonic transit time|colonic transit time
479801|NCT01102010|Blood transfusion|blood transfusion
479802|NCT01102010|Hip fracture|hip fracture
479803|NCT01102010|Elderly|elderly
479804|NCT01102010|Geriatrics|geriatrics
479805|NCT01102010|Hospitalization|hospitalization
479806|NCT01102010|Frail elderly|frail elderly
479807|NCT01101997|Lipolysis|lipolysis
479808|NCT01101997|Cryolipolysis|cryolipolysis
479809|NCT01101997|Fat Reduction|fat reduction
479810|NCT01101971|Education, Medical|education, medical
479811|NCT01101971|Students, Medical|students, medical
479812|NCT01101971|Gynecology|gynecology
479813|NCT01101971|Physical Examination|physical examination
479814|NCT01101971|Computer-Assisted Instruction|computer-assisted instruction
479815|NCT01101945|diabetes|diabetes
479816|NCT01101945|DPP4 inhibitor|dpp4 inhibitor
479817|NCT01101945|dutogliptin|dutogliptin
479818|NCT01101945|PHX1149|phx1149
479819|NCT01101932|Safety|safety
479820|NCT01101932|Tolerability|tolerability
479821|NCT01101932|Pharmacokinetics/Pharmacodynamics|pharmacokinetics/pharmacodynamics
479823|NCT01101932|healthy volunteers|healthy volunteers
479824|NCT01101919|Rheumatoid Arthritis|rheumatoid arthritis
479826|NCT01101906|HCC|hcc
479827|NCT01101906|Hepatocellular Carcinoma|hepatocellular carcinoma
479828|NCT01101893|GSK2248761, raltegravir, drug interaction, pharmacokinetics|gsk2248761, raltegravir, drug interaction, pharmacokinetics
479829|NCT01101867|diabetes|diabetes
479830|NCT01101867|glucose|glucose
479831|NCT01101867|hospital|hospital
479832|NCT01101854|gene expression in wounds|gene expression in wounds
479833|NCT01101854|healing wounds|healing wounds
479834|NCT01101854|non-healing wounds|non-healing wounds
479835|NCT01101854|punch biopsy|punch biopsy
479836|NCT01101854|debridement|debridement
479837|NCT01101841|Vasomotor Symptoms|vasomotor symptoms
479838|NCT01101841|Menopause|menopause
479839|NCT01101841|Hot Flashes|hot flashes
479840|NCT01101841|Perimenopause|perimenopause
479841|NCT01101841|Nonhormonal therapies|nonhormonal therapies
479842|NCT01101841|Climacteric symptoms|climacteric symptoms
479843|NCT01101841|Mesafem|mesafem
479844|NCT01101841|Low-Dose Mesylate salt of Paroxetine (LDMP)|low-dose mesylate salt of paroxetine (ldmp)
479845|NCT01101815|Viral Loads|viral loads
479846|NCT01101815|Naltrexone|naltrexone
479847|NCT01101815|HIV Risk|hiv risk
479848|NCT01101815|Substance Abuse|substance abuse
479849|NCT01101802|SLE|sle
479850|NCT01101802|Atherosclerosis|atherosclerosis
479851|NCT01101802|Endothelial function|endothelial function
479852|NCT01101802|Mycophenolate mofetil|mycophenolate mofetil
479853|NCT01101789|surgical wound infection|surgical wound infection
479854|NCT01101789|triclosan-coated suture|triclosan-coated suture
479855|NCT01101776|Multiple Sclerosis, relapsing|multiple sclerosis, relapsing
479856|NCT01101776|Rebif New Formulation|rebif new formulation
479857|NCT01101776|Interferon beta-1a|interferon beta-1a
479858|NCT01101750|Gardasil|gardasil
479859|NCT01101750|HPV|hpv
479860|NCT01101750|transplant|transplant
479861|NCT01101750|adolescent|adolescent
479862|NCT01101750|prevention|prevention
479863|NCT01101750|vaccine|vaccine
479864|NCT01101750|immunogenicity|immunogenicity
479865|NCT01101750|vaccination|vaccination
479866|NCT01101737|Hypertension, clinical trial, nurse-led clinic, primary care|hypertension, clinical trial, nurse-led clinic, primary care
479867|NCT01101724|mild traumatic brain injury|mild traumatic brain injury
479868|NCT01101724|Concussion|concussion
479869|NCT01101724|postconcussive syndrome|postconcussive syndrome
479870|NCT01101698|Vitamin K|vitamin k
479871|NCT01101698|chronic kidney disease|chronic kidney disease
479872|NCT01101698|coronary artery calcification|coronary artery calcification
479873|NCT01101698|intima media thickness|intima media thickness
479874|NCT01101685|non-dysphoric|non-dysphoric
479875|NCT01101685|Dysphoric|dysphoric
479876|NCT01101672|Single port laparoscopic colectomy|single port laparoscopic colectomy
479877|NCT01101659|Activity of JNJ-40411813|activity of jnj-40411813
479878|NCT01101659|Challenge study|challenge study
479879|NCT01101646|Rabeprazole sodium|rabeprazole sodium
479880|NCT01101646|Pharmacokinetics|pharmacokinetics
479881|NCT01101646|Biological Availability|biological availability
479882|NCT01101646|Safety|safety
479883|NCT01101646|Adult|adult
479884|NCT01101633|Appetite|appetite
479885|NCT01101633|Energy intake|energy intake
479886|NCT01101633|gastric emptying|gastric emptying
479887|NCT01101633|well being|well being
479888|NCT01101633|Body weight|body weight
479889|NCT01101607|Pediatrics|pediatrics
479890|NCT01101607|Distal Forearm fractures|distal forearm fractures
479891|NCT01101607|Pediatric Emergency Medicine|pediatric emergency medicine
479892|NCT01101607|Pediatric Orthopedics|pediatric orthopedics
479893|NCT01101594|Treatment|treatment
479894|NCT01101594|Multiple Myeloma|multiple myeloma
479895|NCT01101594|Relapsed, refractory multiple myeloma|relapsed, refractory multiple myeloma
479896|NCT01101581|Diffuse Large cell NHL|diffuse large cell nhl
479897|NCT01101581|Mantle cell NHL|mantle cell nhl
479898|NCT01101581|Lymphoblastic lymphoma|lymphoblastic lymphoma
479899|NCT01101581|Diffuse mixed cell lymphoma|diffuse mixed cell lymphoma
479900|NCT01101581|Diffuse large cell lymphoma|diffuse large cell lymphoma
479901|NCT01101581|large noncleaved cell lymphoma|large noncleaved cell lymphoma
479902|NCT01101568|GSK1292263, rosuvastatin, simvastatin, pharmacokinetics, drug interaction|gsk1292263, rosuvastatin, simvastatin, pharmacokinetics, drug interaction
479903|NCT01101555|Rheumatoid arthritis|rheumatoid arthritis
479904|NCT01101555|repeat dose|repeat dose
479905|NCT01101555|pharmacodynamics|pharmacodynamics
479906|NCT01101555|pharmacokinetics|pharmacokinetics
479907|NCT01101555|subcutaneous|subcutaneous
479908|NCT01101555|safety|safety
479909|NCT01101555|Otelixizumab|otelixizumab
479910|NCT01101555|long term follow up|long term follow up
479911|NCT01101555|tolerability|tolerability
479912|NCT01101542|Post-marketing surveillance|post-marketing surveillance
479913|NCT01101542|Human papillomavirus|human papillomavirus
479914|NCT01101542|Korea|korea
479915|NCT01101542|Safety|safety
479916|NCT01101542|Prescribing Information|prescribing information
479917|NCT01101529|Chemotherapy-induced nausea and vomiting CINV|chemotherapy-induced nausea and vomiting cinv
479918|NCT01101503|Newly diagnosed type 2 diabetes|newly diagnosed type 2 diabetes
479919|NCT01101503|Endothelial dysfunction|endothelial dysfunction
479920|NCT01101503|Intensive therapy|intensive therapy
479921|NCT01101503|Metabolic Memorial Effect|metabolic memorial effect
479922|NCT01101490|To compare the change of cerebral oxygen saturation and blood flow between right and left side in lateral decubitus position during nephrectomy|to compare the change of cerebral oxygen saturation and blood flow between right and left side in lateral decubitus position during nephrectomy
479923|NCT01101477|Target-controlled infusion,|target-controlled infusion,
479924|NCT01101477|bronchoscopy,|bronchoscopy,
479925|NCT01101477|sedation,|sedation,
479926|NCT01101477|propofol|propofol
479927|NCT01101438|stage I breast cancer|stage i breast cancer
479928|NCT01101438|stage II breast cancer|stage ii breast cancer
479929|NCT01101438|stage IIIA breast cancer|stage iiia breast cancer
479930|NCT01101438|stage IIIC breast cancer|stage iiic breast cancer
479931|NCT01101438|male breast cancer|male breast cancer
479932|NCT01101438|HER2-negative breast cancer|her2-negative breast cancer
479933|NCT01101438|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
479934|NCT01101438|HER2-positive breast cancer|her2-positive breast cancer
479935|NCT01101438|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
479936|NCT01101425|male|male
479937|NCT01101425|breast cancer|breast cancer
479938|NCT01101412|infection|infection
479939|NCT01101412|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
479940|NCT01101412|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
479941|NCT01101412|acute undifferentiated leukemia|acute undifferentiated leukemia
479942|NCT01101412|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
479943|NCT01101412|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
479944|NCT01101412|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
479945|NCT01101412|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
479946|NCT01101412|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
479947|NCT01101412|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
479948|NCT01101412|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
479949|NCT01101412|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
479950|NCT01101412|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
479951|NCT01101412|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
479952|NCT01101412|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
479953|NCT01101412|mast cell leukemia|mast cell leukemia
479954|NCT01101412|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
479955|NCT01101412|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
479956|NCT01101412|prolymphocytic leukemia|prolymphocytic leukemia
479957|NCT01101412|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
479958|NCT01101412|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
479959|NCT01101412|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
479960|NCT01101412|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
479961|NCT01101412|refractory hairy cell leukemia|refractory hairy cell leukemia
479962|NCT01101412|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
479963|NCT01101412|secondary acute myeloid leukemia|secondary acute myeloid leukemia
479964|NCT01101412|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
479965|NCT01101412|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
479966|NCT01101412|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
479967|NCT01101412|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
479968|NCT01101412|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
479969|NCT01101412|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
479970|NCT01101412|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
479971|NCT01101412|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
479972|NCT01101412|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
479973|NCT01101412|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
479974|NCT01101412|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
479975|NCT01101412|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
479976|NCT01101412|untreated hairy cell leukemia|untreated hairy cell leukemia
479977|NCT01101412|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
479978|NCT01101412|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
479979|NCT01101412|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
479980|NCT01101412|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
479981|NCT01101412|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
479982|NCT01101412|anaplastic large cell lymphoma|anaplastic large cell lymphoma
479983|NCT01101412|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
479984|NCT01101412|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
479985|NCT01101412|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
479986|NCT01101412|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
479987|NCT01101412|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
479988|NCT01101412|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
479989|NCT01101412|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
479990|NCT01101412|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
479991|NCT01101412|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
479992|NCT01101412|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
479993|NCT01101412|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
479994|NCT01101412|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
479995|NCT01101412|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
479996|NCT01101412|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
479997|NCT01101412|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
479998|NCT01101412|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
479999|NCT01101412|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
480000|NCT01101412|splenic marginal zone lymphoma|splenic marginal zone lymphoma
480001|NCT01101412|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
480002|NCT01101412|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
480003|NCT01101412|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
480004|NCT01101412|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
480005|NCT01101412|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
480006|NCT01101412|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
480007|NCT01101412|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
480008|NCT01101412|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
480009|NCT01101412|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
480010|NCT01101412|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
480011|NCT01101412|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
480012|NCT01101412|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
480013|NCT01101412|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
480014|NCT01101412|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
480015|NCT01101412|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
480016|NCT01101412|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
480017|NCT01101412|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
480018|NCT01101412|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
480019|NCT01101412|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
480020|NCT01101412|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
480021|NCT01101412|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
480022|NCT01101412|stage I mantle cell lymphoma|stage i mantle cell lymphoma
480023|NCT01101412|stage I marginal zone lymphoma|stage i marginal zone lymphoma
480024|NCT01101412|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
480025|NCT01101412|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
480026|NCT01101412|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
480027|NCT01101412|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
480028|NCT01101412|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
480094|NCT01101399|Chemotherapy|chemotherapy
480029|NCT01101412|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
480030|NCT01101412|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
480385|NCT01100099|Celiac disease.|celiac disease.
480031|NCT01101412|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
480032|NCT01101412|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
480033|NCT01101412|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
480034|NCT01101412|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
480035|NCT01101412|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
480036|NCT01101412|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
480037|NCT01101412|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
480038|NCT01101412|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
480039|NCT01101412|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
480040|NCT01101412|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
480041|NCT01101412|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
480042|NCT01101412|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
480043|NCT01101412|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
480044|NCT01101412|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
480045|NCT01101412|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
480046|NCT01101412|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
480047|NCT01101412|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
480048|NCT01101412|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
480049|NCT01101412|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
480050|NCT01101412|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
480051|NCT01101412|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
480052|NCT01101412|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
480053|NCT01101412|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
480054|NCT01101412|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
480055|NCT01101412|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
480056|NCT01101412|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
480057|NCT01101412|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
480058|NCT01101412|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
480059|NCT01101412|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
480060|NCT01101412|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
480061|NCT01101412|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
480062|NCT01101412|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
480063|NCT01101412|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
480064|NCT01101412|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
480065|NCT01101412|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
480066|NCT01101412|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
480067|NCT01101412|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
480068|NCT01101412|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
480069|NCT01101412|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
480070|NCT01101412|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
480071|NCT01101412|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
480072|NCT01101412|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
480073|NCT01101412|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
480074|NCT01101412|intraocular lymphoma|intraocular lymphoma
480075|NCT01101412|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
480076|NCT01101412|chronic eosinophilic leukemia|chronic eosinophilic leukemia
480077|NCT01101412|chronic neutrophilic leukemia|chronic neutrophilic leukemia
480078|NCT01101412|primary myelofibrosis|primary myelofibrosis
480079|NCT01101412|essential thrombocythemia|essential thrombocythemia
480080|NCT01101412|polycythemia vera|polycythemia vera
480081|NCT01101412|extramedullary plasmacytoma|extramedullary plasmacytoma
480082|NCT01101412|isolated plasmacytoma of bone|isolated plasmacytoma of bone
480083|NCT01101412|stage I multiple myeloma|stage i multiple myeloma
480084|NCT01101412|stage II multiple myeloma|stage ii multiple myeloma
480085|NCT01101412|stage III multiple myeloma|stage iii multiple myeloma
480086|NCT01101412|primary systemic amyloidosis|primary systemic amyloidosis
480087|NCT01101412|refractory multiple myeloma|refractory multiple myeloma
480088|NCT01101412|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
480089|NCT01101412|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
480090|NCT01101412|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
480091|NCT01101412|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
480092|NCT01101399|Anemia|anemia
480093|NCT01101399|Lymphoproliferative Disorders|lymphoproliferative disorders
480198|NCT01100931|YM155|ym155
480095|NCT01101399|ferric carboxymaltose|ferric carboxymaltose
480096|NCT01101399|iron|iron
480097|NCT01101386|Voriconazole|voriconazole
480098|NCT01101386|SBECD|sbecd
480099|NCT01101386|pharmacokinetics|pharmacokinetics
480100|NCT01101386|Renal Failure|renal failure
480101|NCT01101373|Limbic surgery|limbic surgery
480102|NCT01101373|Stereotactic surgery|stereotactic surgery
480103|NCT01101373|Major Depressive Disorder: Treatment Refractory|major depressive disorder: treatment refractory
480104|NCT01101360|port wine stains|port wine stains
480105|NCT01101360|radiofrequency|radiofrequency
480106|NCT01101360|Pulse Dye Laser|pulse dye laser
480107|NCT01101334|NSCLC|nsclc
480108|NCT01101321|Healthy subjects|healthy subjects
480109|NCT01101321|Opioid|opioid
480110|NCT01101321|Healthy volunteers|healthy volunteers
480111|NCT01101308|Healthy subjects|healthy subjects
480112|NCT01101308|Opioid|opioid
480113|NCT01101308|Healthy volunteers|healthy volunteers
480114|NCT01101295|Immune Thrombocytopenia|immune thrombocytopenia
480115|NCT01101295|Rituximab|rituximab
480116|NCT01101295|side effects|side effects
480117|NCT01101295|tolerance|tolerance
480118|NCT01101295|safety|safety
480119|NCT01101295|splenectomy|splenectomy
480120|NCT01101295|serum sickness|serum sickness
480121|NCT01101282|PEP|pep
480122|NCT01101282|exacerbation|exacerbation
480123|NCT01101282|physiotherapy|physiotherapy
480124|NCT01101282|airway clearance|airway clearance
480125|NCT01101282|sputum|sputum
480126|NCT01101282|physical Therapy modalities|physical therapy modalities
480127|NCT01101269|Diabetic nephropathy|diabetic nephropathy
480128|NCT01101243|Vitamin D|vitamin d
480129|NCT01101243|UVB|uvb
480130|NCT01101243|Frequency|frequency
480131|NCT01101243|Body surface area|body surface area
480132|NCT01101243|Dose-Response|dose-response
480133|NCT01101230|Cardiovascular disease|cardiovascular disease
480134|NCT01101230|cholesterol|cholesterol
480135|NCT01101230|low-density|low-density
480136|NCT01101230|lipoprotein|lipoprotein
480137|NCT01101230|high-density lipoprotein|high-density lipoprotein
480138|NCT01101230|triglycerides|triglycerides
480139|NCT01101217|hemocystein zinc renal failure|hemocystein zinc renal failure
480140|NCT01101191|Healthy subjects|healthy subjects
480142|NCT01101191|Healthy volunteers|healthy volunteers
480143|NCT01101178|Healthy subjects|healthy subjects
480144|NCT01101178|Opioid|opioid
480145|NCT01101178|Healthy volunteers|healthy volunteers
480146|NCT01101165|Healthy subjects|healthy subjects
480147|NCT01101165|Opioid|opioid
480148|NCT01101165|Healthy volunteers|healthy volunteers
480149|NCT01101152|Antidepressant|antidepressant
480150|NCT01101152|healthy volunteers|healthy volunteers
480151|NCT01101152|desvenlafaxine succinate|desvenlafaxine succinate
480152|NCT01101152|norepinephrine reuptake|norepinephrine reuptake
480153|NCT01101152|serotonin reuptake|serotonin reuptake
480154|NCT01101152|tyramine test|tyramine test
480155|NCT01101126|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
480156|NCT01101126|Asthma|asthma
480157|NCT01101113|peritoneal dialysis|peritoneal dialysis
480158|NCT01101100|Psoriasis|psoriasis
480159|NCT01101087|Dialysis|dialysis
480160|NCT01101074|Swine Flu A (H1N1) vaccine|swine flu a (h1n1) vaccine
480161|NCT01101074|Adjuvanted flu egg derived|adjuvanted flu egg derived
480162|NCT01101074|Novel influenza A (H1N1): a new flu virus of swine origin|novel influenza a (h1n1): a new flu virus of swine origin
480163|NCT01101061|Amgen|amgen
480164|NCT01101061|Phase 1|phase 1
480165|NCT01101061|Postmenopausal|postmenopausal
480166|NCT01101061|Japanese|japanese
480167|NCT01101048|Amgen|amgen
480168|NCT01101048|Phase 1b|phase 1b
480169|NCT01101048|Postmenopausal|postmenopausal
480170|NCT01101048|Bone Mineral Density|bone mineral density
480171|NCT01101035|cardiovascular outcomes|cardiovascular outcomes
480172|NCT01101035|heart attack|heart attack
480173|NCT01101035|stroke|stroke
480174|NCT01101035|Drug Therapy|drug therapy
480175|NCT01101035|physiology|physiology
480176|NCT01101035|Hyperuricemia|hyperuricemia
480177|NCT01101035|Uric Acid|uric acid
480178|NCT01101009|Sevikar®|sevikar®
480179|NCT01101009|Central Arterial Blood Pressure|central arterial blood pressure
480180|NCT01100996|enteral nutrition|enteral nutrition
480181|NCT01100996|endotoxemia|endotoxemia
480182|NCT01100996|innate immunity|innate immunity
480183|NCT01100996|nutritional anti-inflammatory pathway|nutritional anti-inflammatory pathway
480184|NCT01100996|intestinal damage|intestinal damage
480185|NCT01100970|Caesarean section|caesarean section
480186|NCT01100970|cortisol|cortisol
480187|NCT01100970|stress|stress
480188|NCT01100970|unipolar electric needle|unipolar electric needle
480189|NCT01100970|bipolar electric needle|bipolar electric needle
480190|NCT01100944|Gene Expression|gene expression
480191|NCT01100944|HDAC Class I and II enzymes|hdac class i and ii enzymes
480192|NCT01100944|Thymoma|thymoma
480193|NCT01100944|Chemotherapy|chemotherapy
480194|NCT01100944|Hydroxamic Acid Deacetylase Inhibitor|hydroxamic acid deacetylase inhibitor
480195|NCT01100944|Thymic Cancer|thymic cancer
480196|NCT01100931|NSCLC|nsclc
480197|NCT01100931|Solid Tumors|solid tumors
480200|NCT01100931|Non Small-Cell Lung Cancer|non small-cell lung cancer
480201|NCT01100931|Solid Tumor|solid tumor
480202|NCT01100918|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
480203|NCT01100918|Tissue Doppler Imaging|tissue doppler imaging
480204|NCT01100918|Dyssynchrony|dyssynchrony
480205|NCT01100905|Iron|iron
480206|NCT01100905|Iron status|iron status
480207|NCT01100905|Iron deficiency|iron deficiency
480208|NCT01100905|Iron deficiency anemia|iron deficiency anemia
480209|NCT01100892|Pediatrics|pediatrics
480210|NCT01100892|Pancreas|pancreas
480211|NCT01100879|Anemia|anemia
480212|NCT01100879|Lymphoproliferative Disorders|lymphoproliferative disorders
480213|NCT01100879|Chemotherapy|chemotherapy
480214|NCT01100879|ferric carboxymaltose|ferric carboxymaltose
480215|NCT01100879|iron|iron
480216|NCT01100866|clinically localized Prostate Cancer|clinically localized prostate cancer
480217|NCT01100866|low and intermediate risk for relapse|low and intermediate risk for relapse
480218|NCT01100866|candidates for radical prostatectomy|candidates for radical prostatectomy
480219|NCT01100853|amphetamine dependence|amphetamine dependence
480220|NCT01100853|amphetamine injection|amphetamine injection
480221|NCT01100853|VIVITROL/VIVITROL placebo|vivitrol/vivitrol placebo
480222|NCT01100853|amphetamine craving|amphetamine craving
480223|NCT01100827|EGFR mutation status in patients with advanced stage adenocarcinoma NSCLC|egfr mutation status in patients with advanced stage adenocarcinoma nsclc
480224|NCT01100827|The association between EGFR mutation status and demographic data in advanced stage adenocarcinoma NSCLC patients.|the association between egfr mutation status and demographic data in advanced stage adenocarcinoma nsclc patients.
480225|NCT01100801|advanced|advanced
480226|NCT01100801|metastatic|metastatic
480227|NCT01100775|Galantamine|galantamine
480228|NCT01100775|Schizophrenia|schizophrenia
480229|NCT01100775|working memory|working memory
480230|NCT01100775|cognitive|cognitive
480231|NCT01100762|Parkinson's Disease|parkinson's disease
480232|NCT01100762|Cranial Electric Stimulation|cranial electric stimulation
480233|NCT01100762|Gait|gait
480234|NCT01100749|Hepatitis C|hepatitis c
480235|NCT01100749|Genotype 3|genotype 3
480236|NCT01100749|Demographics|demographics
480237|NCT01100749|Genetics|genetics
480238|NCT01100749|Metabolic status|metabolic status
480239|NCT01100736|Forearm Blood Flow|forearm blood flow
480240|NCT01100736|Vasodilation|vasodilation
480241|NCT01100736|Vasoconstriction|vasoconstriction
480242|NCT01100736|Endothelin System|endothelin system
480243|NCT01100736|Endothelin-1|endothelin-1
480244|NCT01100736|Endothelin-3|endothelin-3
480245|NCT01100736|Endothelin antagonists|endothelin antagonists
480246|NCT01100736|Bosentan|bosentan
480247|NCT01100736|Sitaxsentan|sitaxsentan
480248|NCT01100736|Endothelin|endothelin
480249|NCT01100736|Regional Blood Flow|regional blood flow
480250|NCT01100723|secondary hyperparathyroidism|secondary hyperparathyroidism
480251|NCT01100723|calcium|calcium
480252|NCT01100723|phosphorus|phosphorus
480253|NCT01100723|ESRD|esrd
480254|NCT01100723|CKD|ckd
480255|NCT01100723|mineral disorder|mineral disorder
480256|NCT01100710|Age Gender left ventricular mass high sensitive Troponin T|age gender left ventricular mass high sensitive troponin t
480257|NCT01100697|prenatal diagnosis|prenatal diagnosis
480258|NCT01100697|ultrasound|ultrasound
480259|NCT01100697|outcome|outcome
480260|NCT01100697|spina bifida|spina bifida
480261|NCT01100697|neural tube defect|neural tube defect
480262|NCT01100684|diarrhea predominant irritable bowel syndrome|diarrhea predominant irritable bowel syndrome
480263|NCT01100671|atherosclerosis|atherosclerosis
480264|NCT01100671|vascular inflammation|vascular inflammation
480265|NCT01100671|MDCT|mdct
480266|NCT01100671|18FDG-PET|18fdg-pet
480267|NCT01100606|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
480268|NCT01100606|Infants with CF|infants with cf
480269|NCT01100593|Ultrasound|ultrasound
480270|NCT01100593|IV catheters|iv catheters
480271|NCT01100593|Extravasation|extravasation
480272|NCT01100580|Low-salt diet|low-salt diet
480273|NCT01100580|calciuria|calciuria
480274|NCT01100580|blood pressure|blood pressure
480275|NCT01100580|nephrolithiasis|nephrolithiasis
480276|NCT01100580|hypertension|hypertension
480277|NCT01100580|BMI|bmi
480278|NCT01100580|urinary stone risk factors|urinary stone risk factors
480279|NCT01100567|skeletal health|skeletal health
480280|NCT01100567|bone turnover|bone turnover
480281|NCT01100567|bone geometry|bone geometry
480282|NCT01100567|malnutrition|malnutrition
480283|NCT01100541|Therapeutic Hyperthermia|therapeutic hyperthermia
480284|NCT01100541|Thermotherapy|thermotherapy
480285|NCT01100541|Polymers|polymers
480286|NCT01100541|Castor Oil|castor oil
480287|NCT01100515|intoxication|intoxication
480288|NCT01100515|carbon monoxide|carbon monoxide
480289|NCT01100515|adults|adults
480290|NCT01100515|domestic accident|domestic accident
480291|NCT01100515|acute domestic carbon monoxide poisoning|acute domestic carbon monoxide poisoning
480292|NCT01100502|Antigens, CD30|antigens, cd30
480293|NCT01100502|Antibody-Drug Conjugate|antibody-drug conjugate
480294|NCT01100502|Antibodies, Monoclonal|antibodies, monoclonal
480295|NCT01100502|Disease, Hodgkin|disease, hodgkin
480296|NCT01100502|Drug Therapy|drug therapy
480297|NCT01100502|Hematologic Diseases|hematologic diseases
480298|NCT01100502|Immunotherapy|immunotherapy
480299|NCT01100502|Lymphoma|lymphoma
480300|NCT01100502|Monomethylauristatin E|monomethylauristatin e
480301|NCT01100476|Closure Device|closure device
480302|NCT01100476|endovascular procedures|endovascular procedures
480303|NCT01100476|sealing femoral arterial access|sealing femoral arterial access
480304|NCT01100476|Mynx M5|mynx m5
480305|NCT01100463|HFS, Hand-Foot Syndrome, Capecitabine, Breast Cancer|hfs, hand-foot syndrome, capecitabine, breast cancer
480306|NCT01100450|bariatric surgery|bariatric surgery
480307|NCT01100450|class III obesity|class iii obesity
480308|NCT01100450|resistance training|resistance training
480309|NCT01100450|strength|strength
480310|NCT01100450|fitness|fitness
480311|NCT01100437|opioid|opioid
480312|NCT01100437|morphine|morphine
480313|NCT01100437|naltrexone|naltrexone
480314|NCT01100437|withdrawal signs|withdrawal signs
480315|NCT01100437|withdrawal symptoms|withdrawal symptoms
480316|NCT01100424|Contact lenses|contact lenses
480317|NCT01100424|Contact lens solution|contact lens solution
480318|NCT01100424|Corneal staining|corneal staining
480319|NCT01100411|Contact lenses, myopia, lens geometry|contact lenses, myopia, lens geometry
480320|NCT01100398|Fatty liver disease|fatty liver disease
480321|NCT01100385|Healthy adults|healthy adults
480322|NCT01100372|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
480323|NCT01100372|recurrent fallopian tube cancer|recurrent fallopian tube cancer
480324|NCT01100372|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
480325|NCT01100359|endometrial clear cell carcinoma|endometrial clear cell carcinoma
480326|NCT01100359|recurrent endometrial carcinoma|recurrent endometrial carcinoma
480327|NCT01100359|stage IIIA endometrial carcinoma|stage iiia endometrial carcinoma
480328|NCT01100359|stage IIIB endometrial carcinoma|stage iiib endometrial carcinoma
480329|NCT01100359|stage IIIC endometrial carcinoma|stage iiic endometrial carcinoma
480330|NCT01100359|stage IVA endometrial carcinoma|stage iva endometrial carcinoma
480331|NCT01100359|stage IVB endometrial carcinoma|stage ivb endometrial carcinoma
480332|NCT01100346|Ovulation induction|ovulation induction
480333|NCT01100346|Intrauterine insemination|intrauterine insemination
480334|NCT01100346|Gonal-f|gonal-f
480335|NCT01100346|Controlled ovarian stimulation|controlled ovarian stimulation
480336|NCT01100346|Infertility|infertility
480337|NCT01100333|Infertility|infertility
480338|NCT01100333|Reproductive technologies, Assisted|reproductive technologies, assisted
480339|NCT01100333|r-hFSH|r-hfsh
480340|NCT01100333|Gonal-f|gonal-f
480341|NCT01100320|Healthy subjects|healthy subjects
480342|NCT01100320|Opioid|opioid
480343|NCT01100307|diabetic macular edema|diabetic macular edema
480344|NCT01100307|Macugen|macugen
480345|NCT01100307|sham-controlled study|sham-controlled study
480346|NCT01100294|Influenza|influenza
480347|NCT01100294|Pandemic vaccine|pandemic vaccine
480348|NCT01100294|Seasonal vaccine|seasonal vaccine
480349|NCT01100294|Prevention|prevention
480350|NCT01100294|Influenza vaccine|influenza vaccine
480351|NCT01100294|Influenza in humans|influenza in humans
480352|NCT01100294|Pandemic influenza in humans|pandemic influenza in humans
480353|NCT01100294|Influenza vaccine for children|influenza vaccine for children
480354|NCT01100281|prefrontal cortex|prefrontal cortex
480355|NCT01100268|Hoarding|hoarding
480356|NCT01100255|OCD|ocd
480357|NCT01100242|Renal Cell Carcinoma|renal cell carcinoma
480358|NCT01100242|metastatic renal cell cancer|metastatic renal cell cancer
480359|NCT01100242|kidney cancer|kidney cancer
480360|NCT01100216|smokeless tobacco|smokeless tobacco
480361|NCT01100216|nicotine|nicotine
480362|NCT01100216|snus|snus
480363|NCT01100216|snuff|snuff
480364|NCT01100216|chewing tobacco|chewing tobacco
480365|NCT01100216|oral tobacco|oral tobacco
480366|NCT01100203|aldosterone receptor inhibition|aldosterone receptor inhibition
480367|NCT01100203|arterial stiffness|arterial stiffness
480368|NCT01100203|ambulatory arterial stiffness index|ambulatory arterial stiffness index
480369|NCT01100190|Facelift|facelift
480370|NCT01100190|Rhytidectomy|rhytidectomy
480371|NCT01100190|Ptosis|ptosis
480372|NCT01100177|Patients with non resectable Glioblastoma who have only a|patients with non resectable glioblastoma who have only a
480373|NCT01100177|biopsy as surgical treatment|biopsy as surgical treatment
480374|NCT01100164|INSOMNIA|insomnia
480375|NCT01100164|FOR THE TREATMENT OF INSOMNIA|for the treatment of insomnia
480376|NCT01100151|Opioid-induced constipation|opioid-induced constipation
480377|NCT01100151|RDC-1036|rdc-1036
480378|NCT01100151|ALKS 37|alks 37
480379|NCT01100125|Diabetes|diabetes
480380|NCT01100125|Sitagliptin|sitagliptin
480381|NCT01100125|insulin|insulin
480382|NCT01100125|C-peptide|c-peptide
480383|NCT01100112|ulcerative colitis|ulcerative colitis
480384|NCT01100112|Budesonide|budesonide
480386|NCT01100099|Food intolerance.|food intolerance.
480387|NCT01100099|Gluten intolerance without celiac disease.|gluten intolerance without celiac disease.
480388|NCT01100086|Healthy subjects|healthy subjects
480389|NCT01100086|Opioid|opioid
480390|NCT01100060|Azithromycin|azithromycin
480391|NCT01100060|chloroquine|chloroquine
480392|NCT01100060|microsphere|microsphere
480393|NCT01100060|pharmacokinetics|pharmacokinetics
480394|NCT01100060|bioavailability|bioavailability
480395|NCT01100047|Phase I|phase i
480396|NCT01100047|Japanese healthy volunteer|japanese healthy volunteer
480397|NCT01100047|AZD5069|azd5069
480398|NCT01100034|pediatric psoriasis|pediatric psoriasis
480399|NCT01100034|etanercept|etanercept
480400|NCT01100034|PASS|pass
480401|NCT01100034|safety|safety
480402|NCT01100034|effectiveness|effectiveness
480403|NCT01100008|Pulmonary arterial hypertension|pulmonary arterial hypertension
480404|NCT01100008|cardiac MRI (magnetic resonance imaging)|cardiac mri (magnetic resonance imaging)
480405|NCT01100008|severity|severity
480406|NCT01100008|prognosis|prognosis
480407|NCT01099995|domestic accident|domestic accident
480408|NCT01099995|coma|coma
480409|NCT01099995|carbon monoxide|carbon monoxide
480410|NCT01099995|intoxication|intoxication
480411|NCT01099995|acute domestic carbon monoxide poisoning|acute domestic carbon monoxide poisoning
480412|NCT01099982|Congestive Heart Failure|congestive heart failure
480413|NCT01099982|Left Ventricular Assist Device|left ventricular assist device
480414|NCT01099982|LVAD|lvad
480415|NCT01099982|Myocardium|myocardium
480416|NCT01099982|Remodeling|remodeling
480417|NCT01099982|Microvasculature|microvasculature
480418|NCT01099982|Fibrosis|fibrosis
480419|NCT01099982|Cardiac Transplant|cardiac transplant
480420|NCT01099969|Endotrol Endotracheal tube|endotrol endotracheal tube
480421|NCT01099969|Regular endotracheal tube|regular endotracheal tube
480422|NCT01099969|glide rite stylet|glide rite stylet
480423|NCT01099969|McGarth video laryngoscope|mcgarth video laryngoscope
480424|NCT01099969|Glidescope|glidescope
480425|NCT01099969|comparison of endotrol endotracheal tube to regular endotracheal tube with video laryngoscopes Glidescope and McGrath|comparison of endotrol endotracheal tube to regular endotracheal tube with video laryngoscopes glidescope and mcgrath
480426|NCT01099956|type 1 diabetes|type 1 diabetes
480427|NCT01099956|children|children
480428|NCT01099956|low grade inflammation|low grade inflammation
480429|NCT01099956|cytokine|cytokine
480430|NCT01099956|CRP|crp
480431|NCT01099930|immunoablation|immunoablation
480432|NCT01099930|stem cell transplantation|stem cell transplantation
480433|NCT01099917|MDS|mds
480434|NCT01099917|Maitake|maitake
480435|NCT01099917|mushroom|mushroom
480436|NCT01099917|09-094|09-094
480437|NCT01099878|Cycling Exercise|cycling exercise
480438|NCT01099878|Functional Electrical Stimulation|functional electrical stimulation
480439|NCT01099878|Stroke|stroke
480440|NCT01099852|dengue|dengue
480441|NCT01099852|fever|fever
480442|NCT01099852|dengue hemorrhagic fever|dengue hemorrhagic fever
480443|NCT01099852|dengue virus|dengue virus
480444|NCT01099852|Chikungunya virus|chikungunya virus
480445|NCT01099852|Zika Virus|zika virus
480446|NCT01099852|Joint pain|joint pain
480447|NCT01099839|ASP1941|asp1941
480448|NCT01099839|Miglitol|miglitol
480449|NCT01099826|colorectal cancer screening|colorectal cancer screening
480450|NCT01099826|tailored education|tailored education
480451|NCT01099826|motivational interview|motivational interview
480452|NCT01099826|patient education|patient education
480453|NCT01099813|Critical Illness|critical illness
480454|NCT01099813|Sepsis|sepsis
480455|NCT01099813|Duration|duration
480456|NCT01099813|Severity of Illness Scores|severity of illness scores
480457|NCT01099813|Trajectory|trajectory
480458|NCT01099800|asthma|asthma
480459|NCT01099800|health disparities|health disparities
480460|NCT01099800|illness representations|illness representations
480461|NCT01099800|CAM|cam
480462|NCT01099800|Latino|latino
480463|NCT01099748|Drug interaction|drug interaction
480464|NCT01099748|pharmacokinetics|pharmacokinetics
480465|NCT01099748|lersivirine|lersivirine
480466|NCT01099748|methadone|methadone
480467|NCT01099735|Bariatric Surgery|bariatric surgery
480468|NCT01099735|Sleep Apnea|sleep apnea
480469|NCT01099735|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
480470|NCT01099735|GERD|gerd
480471|NCT01099722|moderate to severe persistent reversible asthma|moderate to severe persistent reversible asthma
480472|NCT01099709|healthy subjects|healthy subjects
480473|NCT01099709|opioid|opioid
480474|NCT01099696|abdominal discomfort and bloating|abdominal discomfort and bloating
480475|NCT01099644|Peritoneum|peritoneum
480476|NCT01099644|Desmoplastic Small Round Cell Tumors|desmoplastic small round cell tumors
480477|NCT01099644|Intraperitoneal Radioimmunotherapy|intraperitoneal radioimmunotherapy
480478|NCT01099644|131 I-8H9|131 i-8h9
480479|NCT01099644|09-090|09-090
480480|NCT01099631|Salmonella typhimurium|salmonella typhimurium
480481|NCT01099631|unresectable hepatic cancer|unresectable hepatic cancer
480482|NCT01099631|attenuated Salmonella typhimurium|attenuated salmonella typhimurium
480483|NCT01099631|IL-2|il-2
480484|NCT01099605|hemorrhoidectomy|hemorrhoidectomy
480485|NCT01099605|pain management|pain management
480486|NCT01099579|HIV, Pediatric|hiv, pediatric
480487|NCT01099566|human endotoxemia|human endotoxemia
480488|NCT01099566|tissue factor induced coagulation|tissue factor induced coagulation
480489|NCT01099566|platelet activation|platelet activation
480490|NCT01099566|thienopyridines|thienopyridines
480491|NCT01099553|Educational video|educational video
480492|NCT01099553|colonoscopy|colonoscopy
480493|NCT01099553|bowel preparation|bowel preparation
480494|NCT01099553|Bowel preparation for colonoscopy|bowel preparation for colonoscopy
480495|NCT01099540|neuroendocrine tumor|neuroendocrine tumor
480496|NCT01099527|gastric cancer|gastric cancer
480497|NCT01099527|refractory|refractory
480498|NCT01099527|metastatic|metastatic
480499|NCT01099501|Mechanical Ventilation|mechanical ventilation
480500|NCT01099488|Immunological assays|immunological assays
480501|NCT01099475|liver surgery|liver surgery
480502|NCT01099475|pringle manoeuvre|pringle manoeuvre
480503|NCT01099475|hepatocellular damage|hepatocellular damage
480504|NCT01099475|surgical complications|surgical complications
480505|NCT01099475|patients requiring liver surgery|patients requiring liver surgery
480506|NCT01099462|fever|fever
480507|NCT01099462|Ibuprofen|ibuprofen
480508|NCT01099449|neurotoxicity|neurotoxicity
480509|NCT01099449|neuropathy|neuropathy
480510|NCT01099449|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
480511|NCT01099449|stage II colon cancer|stage ii colon cancer
480512|NCT01099449|stage III colon cancer|stage iii colon cancer
480513|NCT01099449|stage IV colon cancer|stage iv colon cancer
480514|NCT01099449|stage II rectal cancer|stage ii rectal cancer
480515|NCT01099449|stage III rectal cancer|stage iii rectal cancer
480516|NCT01099449|stage IV rectal cancer|stage iv rectal cancer
480517|NCT01099449|adenocarcinoma of the colon|adenocarcinoma of the colon
480518|NCT01099449|adenocarcinoma of the rectum|adenocarcinoma of the rectum
480519|NCT01099436|HER2-negative breast cancer|her2-negative breast cancer
480520|NCT01099436|stage II breast cancer|stage ii breast cancer
480521|NCT01099436|stage IIIA breast cancer|stage iiia breast cancer
480522|NCT01099436|stage IIIB breast cancer|stage iiib breast cancer
480523|NCT01099436|stage IIIC breast cancer|stage iiic breast cancer
480524|NCT01099423|clear cell renal cell carcinoma|clear cell renal cell carcinoma
480525|NCT01099423|stage IV renal cell cancer|stage iv renal cell cancer
480526|NCT01099410|macrophages, alveolar|macrophages, alveolar
480527|NCT01099410|monocytes|monocytes
480528|NCT01099410|Receptor Protein-Tyrosine Kinases|receptor protein-tyrosine kinases
480529|NCT01099410|Humans|humans
480530|NCT01099410|Phagocytosis|phagocytosis
480531|NCT01099410|Lung|lung
480532|NCT01099410|in vitro|in vitro
480533|NCT01099397|Glucose|glucose
480534|NCT01099397|Glucose Tolerance Test|glucose tolerance test
480535|NCT01099397|Insulin Resistance|insulin resistance
480536|NCT01099397|Metabolic adverse effects|metabolic adverse effects
480537|NCT01099397|Hypertension|hypertension
480538|NCT01099397|Beta-blocker|beta-blocker
480539|NCT01099397|Atenolol|atenolol
480540|NCT01099397|Diuretic|diuretic
480541|NCT01099397|Hydrochlorothiazide|hydrochlorothiazide
480542|NCT01099397|Blood pressure|blood pressure
480543|NCT01099371|Knee|knee
480544|NCT01099371|Osteoarthritis|osteoarthritis
480545|NCT01099371|Exercise|exercise
480546|NCT01099358|Cancer of Head|cancer of head
480547|NCT01099358|Cancer of Head and Neck|cancer of head and neck
480548|NCT01099358|Cancer of Neck|cancer of neck
480549|NCT01099358|Cancer of the Head|cancer of the head
480550|NCT01099358|Cancer of the Head and Neck|cancer of the head and neck
480551|NCT01099358|Cancer of the Neck|cancer of the neck
480552|NCT01099358|Head and Neck Cancer|head and neck cancer
480553|NCT01099358|Head Cancer|head cancer
480554|NCT01099358|Head Neoplasms|head neoplasms
480555|NCT01099358|Head, Neck Neoplasms|head, neck neoplasms
480556|NCT01099358|Neck Cancer|neck cancer
480557|NCT01099358|Neck Neoplasms|neck neoplasms
480558|NCT01099358|Solid Neoplasm|solid neoplasm
480559|NCT01099358|Carcinoma|carcinoma
480560|NCT01099358|Sarcoma|sarcoma
480561|NCT01099345|OAB|oab
480562|NCT01099345|Nocturia|nocturia
480563|NCT01099345|Bladder function|bladder function
480564|NCT01099345|cystometry|cystometry
480565|NCT01099345|polysomnography|polysomnography
480566|NCT01099332|Alzheimer's disease|alzheimer's disease
480567|NCT01099332|Mild Cognitive Impairment|mild cognitive impairment
480568|NCT01099332|Copper metabolism|copper metabolism
480569|NCT01099332|Zinc metabolism|zinc metabolism
480570|NCT01099332|Ceruloplasmin|ceruloplasmin
480571|NCT01099319|Dietary supplement|dietary supplement
480572|NCT01099319|Renalof|renalof
480573|NCT01099319|gallstones|gallstones
480574|NCT01099319|elderly|elderly
480575|NCT01099293|Hepatic Encephalopathy|hepatic encephalopathy
480576|NCT01099293|Psychometric Hepatic Encephalopathy Score|psychometric hepatic encephalopathy score
480577|NCT01099293|Critical Flicker Frequency|critical flicker frequency
480578|NCT01099293|Cerebrovascular Reactivity|cerebrovascular reactivity
480579|NCT01099293|Endotoxemia|endotoxemia
480580|NCT01099293|Transcranial Doppler|transcranial doppler
480581|NCT01099293|Liver Cirrhosis|liver cirrhosis
480582|NCT01099280|induction of labor in term|induction of labor in term
480583|NCT01099280|premature rupture of membranes|premature rupture of membranes
480584|NCT01099280|dinoprostone|dinoprostone
480585|NCT01099280|oxytocin|oxytocin
480586|NCT01099267|MDS|mds
480587|NCT01099254|CVP|cvp
480588|NCT01099254|US|us
480589|NCT01099254|Trendelenburg position|trendelenburg position
480590|NCT01099254|Ultrasound|ultrasound
480591|NCT01099254|Head Down Tilt|head down tilt
480592|NCT01099241|CVP|cvp
480593|NCT01099241|US|us
480594|NCT01099241|Ultrasonography|ultrasonography
480595|NCT01099228|Neuroendocrine Tumor|neuroendocrine tumor
480596|NCT01099228|Imaging|imaging
480597|NCT01099215|peripheral artery disease|peripheral artery disease
480598|NCT01099215|percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
480599|NCT01099215|stent|stent
480600|NCT01099215|balloon/stent|balloon/stent
480601|NCT01099215|superficial femoral artery|superficial femoral artery
480602|NCT01099202|Procrit|procrit
480603|NCT01099202|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
480604|NCT01099202|Lymphoblastic Lymphoma|lymphoblastic lymphoma
480605|NCT01099202|Burkitt's|burkitt's
480606|NCT01099202|Chemotherapy|chemotherapy
480607|NCT01099202|Hyper-CVAD|hyper-cvad
480608|NCT01099202|augmented BFM|augmented bfm
480609|NCT01099202|Epoetin alfa|epoetin alfa
480610|NCT01099202|Epogen|epogen
480611|NCT01099202|Erythropoietin|erythropoietin
480612|NCT01099189|Histology|histology
480613|NCT01099189|Compliance|compliance
480614|NCT01099189|Dialysis|dialysis
480615|NCT01099189|Arteriovenous access fistula|arteriovenous access fistula
480616|NCT01099189|vein|vein
480617|NCT01099176|hyperlipidemia|hyperlipidemia
480618|NCT01099176|impaired fasting glycemia|impaired fasting glycemia
480619|NCT01099176|adipokines|adipokines
480620|NCT01099176|atorvastatin|atorvastatin
480621|NCT01099176|fenofibrate|fenofibrate
480622|NCT01099163|Diabetes mellitus|diabetes mellitus
480623|NCT01099163|CLA|cla
480624|NCT01099163|Antioxidant|antioxidant
480625|NCT01099163|Glycemic control|glycemic control
480626|NCT01099150|Platelets|platelets
480627|NCT01099150|Platelet aggregation|platelet aggregation
480628|NCT01099150|Platelet activation|platelet activation
480629|NCT01099150|Platelet function|platelet function
480630|NCT01099150|Light transmission aggregometry|light transmission aggregometry
480631|NCT01099150|Platelet Function Analyzer-100 (PFA-100)|platelet function analyzer-100 (pfa-100)
480632|NCT01099150|P-selectin|p-selectin
480633|NCT01099150|Fibrinogen receptor|fibrinogen receptor
480634|NCT01099150|Glycoprotein IIb-IIIa|glycoprotein iib-iiia
480635|NCT01099150|Chocolate|chocolate
480636|NCT01099150|Cocoa|cocoa
480637|NCT01099150|Flavan-3-ols|flavan-3-ols
480638|NCT01099150|Procyanidins|procyanidins
480639|NCT01099137|Diabetes|diabetes
480640|NCT01099137|Vildagliptin|vildagliptin
480641|NCT01099137|insulin|insulin
480642|NCT01099137|C-peptide|c-peptide
480643|NCT01099124|M2ES|m2es
480644|NCT01099124|NSCLC|nsclc
480645|NCT01099124|Phase I Trial|phase i trial
480646|NCT01099124|Advanced NSCLC|advanced nsclc
480647|NCT01099124|Recurrent NSCLC|recurrent nsclc
480648|NCT01099111|IBS|ibs
480649|NCT01099111|UC|uc
480650|NCT01099111|CD|cd
480651|NCT01099111|CRAP/CRC|crap/crc
480652|NCT01099098|People who have fibrosis or nodules in their upper lobe of the lung|people who have fibrosis or nodules in their upper lobe of the lung
480653|NCT01099085|gastric cancer, unresectable/metastatic|gastric cancer, unresectable/metastatic
480654|NCT01099072|ADHD|adhd
480655|NCT01099072|carnitine|carnitine
480656|NCT01099072|methylphenidate|methylphenidate
480657|NCT01099059|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
480658|NCT01099059|Clinical Trial|clinical trial
480659|NCT01099059|Amantadine|amantadine
480660|NCT01099059|Methylphenidate|methylphenidate
480661|NCT01099046|Meniere's disease|meniere's disease
480662|NCT01099046|stress management|stress management
480663|NCT01099046|vasopressin|vasopressin
480664|NCT01099046|V2 receptor|v2 receptor
480665|NCT01099046|water intake|water intake
480666|NCT01099046|tympanic tubing|tympanic tubing
480667|NCT01099046|regular sleep under dark|regular sleep under dark
480668|NCT01099033|hiatal hernia|hiatal hernia
480669|NCT01099033|paraesophageal hernia|paraesophageal hernia
480670|NCT01099033|biologic mesh|biologic mesh
480671|NCT01099033|MMPs|mmps
480672|NCT01099033|Hiatal/Paraesophageal hernia|hiatal/paraesophageal hernia
480673|NCT01099020|Subjects receiving large volumes of Radiation|subjects receiving large volumes of radiation
480674|NCT01099007|Women|women
480675|NCT01099007|Menopause|menopause
480676|NCT01099007|Cardiovascular Disease|cardiovascular disease
480677|NCT01099007|Physical Activity|physical activity
480678|NCT01099007|Weight Loss|weight loss
480679|NCT01098994|Type 1 diabetes|type 1 diabetes
480680|NCT01098994|Haptoglobin genotype|haptoglobin genotype
480681|NCT01098994|HDL function|hdl function
480682|NCT01098994|Heart disease|heart disease
480683|NCT01098994|Feasibility of clinical trial|feasibility of clinical trial
480684|NCT01098955|Cancer|cancer
480685|NCT01098955|Smoking Cessation Treatment|smoking cessation treatment
480686|NCT01098955|Acceptance and Commitment Therapy|acceptance and commitment therapy
480687|NCT01098955|ACT Theory|act theory
480688|NCT01098955|Motivational and Behavioral Counseling|motivational and behavioral counseling
480689|NCT01098955|MBC|mbc
480690|NCT01098955|abstinence|abstinence
480691|NCT01098955|Varenicline|varenicline
480692|NCT01098955|Chantix|chantix
480693|NCT01098942|bariatric surgery|bariatric surgery
480694|NCT01098929|genes|genes
480695|NCT01098929|genetic|genetic
480696|NCT01098929|chromosome|chromosome
480697|NCT01098929|chromosome microarray|chromosome microarray
480698|NCT01098916|hospital at home|hospital at home
480699|NCT01098916|radiology at home|radiology at home
480700|NCT01098916|frail elderly|frail elderly
480701|NCT01098903|sunitinib|sunitinib
480702|NCT01098903|cancer|cancer
480703|NCT01098903|pharmacogenomics|pharmacogenomics
480704|NCT01098903|pharmacokinetics|pharmacokinetics
480705|NCT01098903|Patients who have a malignancy and are going to be treated with sunitinib|patients who have a malignancy and are going to be treated with sunitinib
480706|NCT01098903|doseindividualism|doseindividualism
480707|NCT01098877|Phase1|phase1
480708|NCT01098877|pharmacokinetics|pharmacokinetics
480709|NCT01098877|safety|safety
480710|NCT01098877|toleration|toleration
480711|NCT01098877|pharmacodynamics|pharmacodynamics
480712|NCT01098864|Behavior|behavior
480713|NCT01098864|Impulsivity|impulsivity
480714|NCT01098864|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
480715|NCT01098851|Obstructive Sleep Apnea|obstructive sleep apnea
480716|NCT01098851|Pulse Oximetry|pulse oximetry
480717|NCT01098838|Cancer|cancer
480718|NCT01098838|adults|adults
480719|NCT01098838|solid tumor|solid tumor
480720|NCT01098838|apoptosis|apoptosis
480721|NCT01098838|programmed cell death|programmed cell death
480722|NCT01098838|LCL161|lcl161
480723|NCT01098825|vaccine hesitancy|vaccine hesitancy
480724|NCT01098825|vaccine refusal|vaccine refusal
480725|NCT01098812|Cataract, Intraocular lens|cataract, intraocular lens
480726|NCT01098799|Urotensin II,Chronic renal disease|urotensin ii,chronic renal disease
480727|NCT01098786|Influenza A|influenza a
480728|NCT01098786|H1N1 subtype|h1n1 subtype
480729|NCT01098786|Vaccine|vaccine
480730|NCT01098786|Adjuvant|adjuvant
480731|NCT01098786|Cell culture|cell culture
480732|NCT01098773|Weaning from mechanical ventilation|weaning from mechanical ventilation
480733|NCT01098773|BNP|bnp
480734|NCT01098773|Lung ultrasound|lung ultrasound
480735|NCT01098773|Echocardiography|echocardiography
480736|NCT01098760|Sorafenib|sorafenib
480737|NCT01098760|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
480738|NCT01098747|Pain following third molar extraction|pain following third molar extraction
480739|NCT01098734|non-steroid|non-steroid
480740|NCT01098734|anti-inflammatory|anti-inflammatory
480741|NCT01098734|skin disease|skin disease
480742|NCT01098734|topical cream|topical cream
480743|NCT01098734|small molecule|small molecule
480744|NCT01098734|atopic dermatitis|atopic dermatitis
480745|NCT01098734|eczema|eczema
480746|NCT01098721|plaque psoriasis|plaque psoriasis
480747|NCT01098721|skin diseases|skin diseases
480748|NCT01098721|anti-inflammatory|anti-inflammatory
480749|NCT01098721|non-steroid|non-steroid
480750|NCT01098721|topical cream|topical cream
480751|NCT01098708|DMD|dmd
480752|NCT01098708|non ambulatory|non ambulatory
480753|NCT01098695|parenting interventions|parenting interventions
480754|NCT01098695|Family Check-Up|family check-up
480755|NCT01098695|Early Intervention|early intervention
480756|NCT01098695|Self-Regulation|self-regulation
480757|NCT01098669|cancer survivor|cancer survivor
480758|NCT01098669|lymphedema|lymphedema
480759|NCT01098669|head and neck cancer|head and neck cancer
480760|NCT01098656|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
480761|NCT01098656|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
481007|NCT01097564|Congenital cataract|congenital cataract
480762|NCT01098656|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
480763|NCT01098656|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
480764|NCT01098656|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
480765|NCT01098656|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
480766|NCT01098643|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
480767|NCT01098617|endoscopic sphincterotomy|endoscopic sphincterotomy
480768|NCT01098617|hemorrhage|hemorrhage
480769|NCT01098617|nonsteroidal antiinflammatory agents|nonsteroidal antiinflammatory agents
480770|NCT01098617|antiaggregants|antiaggregants
480771|NCT01098617|anticoagulants|anticoagulants
480772|NCT01098617|Endoscopic biliary sphincterotomy induced bleeding|endoscopic biliary sphincterotomy induced bleeding
480773|NCT01098591|meta-analysis|meta-analysis
480774|NCT01098591|stem cell|stem cell
480775|NCT01098591|cardiac|cardiac
480776|NCT01098591|remodeling|remodeling
480777|NCT01098591|MESS|mess
480778|NCT01098578|Posterior Epistaxis|posterior epistaxis
480779|NCT01098552|Prostate Cancer|prostate cancer
480780|NCT01098539|sitagliptin|sitagliptin
480781|NCT01098539|albiglutide|albiglutide
480782|NCT01098539|renal impairment|renal impairment
480783|NCT01098526|GSK1349572|gsk1349572
480784|NCT01098526|efavirenz|efavirenz
480785|NCT01098526|integrase|integrase
480786|NCT01098526|pharmacokinetics|pharmacokinetics
480787|NCT01098513|HIV|hiv
480788|NCT01098513|healthy|healthy
480789|NCT01098513|GSK1349572|gsk1349572
480790|NCT01098500|Liver function|liver function
480791|NCT01098500|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
480792|NCT01098487|Immune (idiopathic) thrombocytopenic purpura (ITP)|immune (idiopathic) thrombocytopenic purpura (itp)
480793|NCT01098487|bone marrow fibers|bone marrow fibers
480794|NCT01098487|eltrombopag olamine|eltrombopag olamine
480795|NCT01098487|thrombopoietin receptor agonist|thrombopoietin receptor agonist
480796|NCT01098474|Tuberculosis vaccine|tuberculosis vaccine
480797|NCT01098461|dose-ranging|dose-ranging
480798|NCT01098461|pharmacokinetics|pharmacokinetics
480799|NCT01098461|GSK716155|gsk716155
480800|NCT01098461|Japan|japan
480801|NCT01098461|albiglutide|albiglutide
480802|NCT01098448|Amoxicillin|amoxicillin
480803|NCT01098448|antibiotics|antibiotics
480804|NCT01098448|chronic periodontitis|chronic periodontitis
480805|NCT01098448|local drug delivery|local drug delivery
480806|NCT01098448|metronidazol|metronidazol
480807|NCT01098448|randomized controlled trial|randomized controlled trial
480808|NCT01098448|subgingival scaling|subgingival scaling
480809|NCT01098448|surgery|surgery
480810|NCT01098448|tetracycline|tetracycline
480811|NCT01098448|moderate to advanced chronic periodontitis|moderate to advanced chronic periodontitis
480812|NCT01098435|Binge eating disorder|binge eating disorder
480813|NCT01098435|RDC-0313|rdc-0313
480814|NCT01098422|liver|liver
480815|NCT01098422|colorectal|colorectal
480816|NCT01098422|metastasis|metastasis
480817|NCT01098422|carcinoma|carcinoma
480818|NCT01098422|Yttrium-90|yttrium-90
480819|NCT01098422|microspheres|microspheres
480820|NCT01098409|sodium nitrite|sodium nitrite
480821|NCT01098409|coronary artery bypass surgery|coronary artery bypass surgery
480822|NCT01098409|cardioprotection|cardioprotection
480823|NCT01098409|myocardial injury|myocardial injury
480824|NCT01098396|parkinson disease|parkinson disease
480825|NCT01098396|gait|gait
480826|NCT01098383|Autism|autism
480827|NCT01098357|rhPDGF, diabetic foot ulcer,|rhpdgf, diabetic foot ulcer,
480828|NCT01098344|stage III pancreatic cancer|stage iii pancreatic cancer
480829|NCT01098344|stage IV pancreatic cancer|stage iv pancreatic cancer
480830|NCT01098344|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
480831|NCT01098331|stage I prostate cancer|stage i prostate cancer
480832|NCT01098331|stage IIB prostate cancer|stage iib prostate cancer
480833|NCT01098331|stage IIA prostate cancer|stage iia prostate cancer
480834|NCT01098318|Depression|depression
480835|NCT01098318|Antidepressant Therapy|antidepressant therapy
480836|NCT01098318|Herbal Treatment|herbal treatment
480837|NCT01098318|Rhodiola rosea|rhodiola rosea
480838|NCT01098318|Alternative Therapy|alternative therapy
480839|NCT01098305|nicotine smokeless tobacco chewing tobacco varenicline|nicotine smokeless tobacco chewing tobacco varenicline
480840|NCT01098292|Fibromyalgia|fibromyalgia
480841|NCT01098292|Irritable Bowel Syndrome|irritable bowel syndrome
480842|NCT01098292|Chronic Fatigue Syndrome|chronic fatigue syndrome
480843|NCT01098292|Interstitial Cystitis|interstitial cystitis
480844|NCT01098292|Chronic Prostatitis|chronic prostatitis
480845|NCT01098292|Urological Chronic Pelvic Pain|urological chronic pelvic pain
480846|NCT01098292|Painful Bladder Syndrome|painful bladder syndrome
480847|NCT01098279|Interstitial Cystitis|interstitial cystitis
480848|NCT01098279|Chronic Prostatitis|chronic prostatitis
480849|NCT01098279|Urological Chronic Pelvic Pain|urological chronic pelvic pain
480850|NCT01098279|Painful Bladder Syndrome|painful bladder syndrome
480851|NCT01098266|MPM|mpm
480852|NCT01098266|NGR-hTNF|ngr-htnf
480853|NCT01098266|NGR-hTNF plus BIC|ngr-htnf plus bic
480854|NCT01098266|Randomized double-blind phase III study|randomized double-blind phase iii study
480855|NCT01098253|adherence|adherence
480856|NCT01098253|diabetes mellitus|diabetes mellitus
480857|NCT01098253|depression|depression
480858|NCT01098253|primary health care|primary health care
480859|NCT01098240|Antidepressant Augmentation|antidepressant augmentation
480860|NCT01098227|RSV Bronchiolitis|rsv bronchiolitis
480861|NCT01098227|Lower Respiratory Viral infection|lower respiratory viral infection
480862|NCT01098227|Exhaled Nitric Oxide|exhaled nitric oxide
480863|NCT01098214|Normal pregnancy|normal pregnancy
480864|NCT01098214|Amniotic fluid|amniotic fluid
480865|NCT01098214|Cytokines|cytokines
480866|NCT01098214|Biomarkers|biomarkers
480867|NCT01098201|Certolizumab|certolizumab
480868|NCT01098201|TNF|tnf
480869|NCT01098201|RA|ra
480870|NCT01098201|Cizmia|cizmia
480871|NCT01098175|laparotomy|laparotomy
480872|NCT01098175|thoracotomy|thoracotomy
480873|NCT01098175|peritoneal conditioning|peritoneal conditioning
480874|NCT01098175|humidification|humidification
480875|NCT01098175|temperature control|temperature control
480876|NCT01098162|Lacosamide|lacosamide
480877|NCT01098162|Vimpat®|vimpat®
480878|NCT01098162|Epilepsy|epilepsy
480879|NCT01098162|Partial-Onset Seizures|partial-onset seizures
480880|NCT01098162|Adjunctive therapy|adjunctive therapy
480881|NCT01098149|Haemodialysis treatment tolerance|haemodialysis treatment tolerance
480882|NCT01098149|acetate free biofiltration|acetate free biofiltration
480883|NCT01098149|frequency of hypotensive events during dialysis|frequency of hypotensive events during dialysis
480884|NCT01098149|nurse intervention during dialysis|nurse intervention during dialysis
480885|NCT01098136|Pelvic girdle pain|pelvic girdle pain
480886|NCT01098136|Chiropractic|chiropractic
480887|NCT01098136|Single-blinded|single-blinded
480888|NCT01098136|Outcome study|outcome study
480889|NCT01098084|Decitabine, chronic myelomonocytic leukemia|decitabine, chronic myelomonocytic leukemia
480890|NCT01098058|Adult attention deficit hyperactivity disorder|adult attention deficit hyperactivity disorder
480891|NCT01098058|cognitive-behavioural therapy|cognitive-behavioural therapy
480892|NCT01098058|randomised controlled trial|randomised controlled trial
480893|NCT01098045|HIV|hiv
480894|NCT01098045|fat redistribution|fat redistribution
480895|NCT01098045|brown adipose tissue|brown adipose tissue
480896|NCT01098045|PET|pet
480897|NCT01098032|Contrast media|contrast media
480898|NCT01098032|Kidney|kidney
480899|NCT01098032|Complication|complication
480900|NCT01098019|Notalgia paresthetica|notalgia paresthetica
480901|NCT01098019|Xeomin|xeomin
480902|NCT01098019|Botulinum Toxin A|botulinum toxin a
480903|NCT01098019|Pruritus|pruritus
480904|NCT01098019|Upper Back|upper back
480905|NCT01098019|Hyperpigmentation|hyperpigmentation
480906|NCT01098006|Immunological assays|immunological assays
480907|NCT01098006|Chronic hepatitis B|chronic hepatitis b
480908|NCT01097980|trazodone|trazodone
480909|NCT01097980|SSRI|ssri
480910|NCT01097980|sexual dysfunction|sexual dysfunction
480911|NCT01097980|5-HT2A polymorphism|5-ht2a polymorphism
480912|NCT01097967|Sleep disordered breathing|sleep disordered breathing
480913|NCT01097967|Continuous Positive Airway Pressure|continuous positive airway pressure
480914|NCT01097967|Sleep apnoea|sleep apnoea
480915|NCT01097967|Markers of atherosclerosis|markers of atherosclerosis
480916|NCT01097954|Exercise induced asthma|exercise induced asthma
480917|NCT01097954|Exercise induced bronchospasm|exercise induced bronchospasm
480918|NCT01097954|exhaled Nitric Oxide|exhaled nitric oxide
480919|NCT01097941|Influenza|influenza
480920|NCT01097941|H1N1|h1n1
480921|NCT01097915|PROP taste sensitivity|prop taste sensitivity
480922|NCT01097915|Gustin (CAVI) polymorphism|gustin (cavi) polymorphism
480923|NCT01097915|Salivary zinc|salivary zinc
480924|NCT01097915|BMI|bmi
480925|NCT01097915|Electrophysiological recording from the tongue|electrophysiological recording from the tongue
480926|NCT01097889|United Nations World Food Programme|united nations world food programme
480927|NCT01097889|blended food (CSB)|blended food (csb)
480928|NCT01097889|ready-to-use supplementary foods (RUSF)|ready-to-use supplementary foods (rusf)
480929|NCT01097889|Plumpy®|plumpy®
480930|NCT01097876|healthy volunteer|healthy volunteer
480931|NCT01097876|pharmacokinetic|pharmacokinetic
480932|NCT01097876|safety|safety
480933|NCT01097850|hand foot skin syndrome|hand foot skin syndrome
480934|NCT01097850|palmar plantar erythrodysesthesia|palmar plantar erythrodysesthesia
480935|NCT01097850|doxorubicin|doxorubicin
480936|NCT01097850|capecitabine|capecitabine
480937|NCT01097837|Epilepsy|epilepsy
480938|NCT01097837|Contraceptive|contraceptive
480939|NCT01097837|Birth Control|birth control
480940|NCT01097837|Seizure|seizure
480941|NCT01097837|This study is looking at the use of different birth control measures in women with epilepsy.|this study is looking at the use of different birth control measures in women with epilepsy.
480942|NCT01097811|Hepatic Encephalopathy|hepatic encephalopathy
480943|NCT01097811|Hypertension, Portal|hypertension, portal
480944|NCT01097811|Liver Cirrhosis|liver cirrhosis
480945|NCT01097811|Bacterial Overgrowth Syndrome|bacterial overgrowth syndrome
480946|NCT01097798|muscle injury|muscle injury
480947|NCT01097772|abdominal|abdominal
480948|NCT01097772|aortic|aortic
480949|NCT01097772|aneurysm|aneurysm
480950|NCT01097759|hemorrhoids|hemorrhoids
480951|NCT01097759|prolapsed|prolapsed
480952|NCT01097759|hemorrhoidectomy|hemorrhoidectomy
480953|NCT01097759|Hemorrhoidopexy|hemorrhoidopexy
480954|NCT01097759|LigaSure|ligasure
480955|NCT01097759|Stapled|stapled
480956|NCT01097746|Cancer|cancer
480957|NCT01097746|Fallopian Tube|fallopian tube
480958|NCT01097746|Ovary|ovary
480959|NCT01097746|Peritoneum|peritoneum
480960|NCT01097746|Epithelial ovarian|epithelial ovarian
480961|NCT01097746|Paclitaxel|paclitaxel
480962|NCT01097746|Carboplatin|carboplatin
480963|NCT01097746|Bevacizumab|bevacizumab
480964|NCT01097746|Taxol|taxol
480965|NCT01097746|Avastin|avastin
480966|NCT01097746|Paraplatin|paraplatin
480967|NCT01097746|Carcinoma|carcinoma
480968|NCT01097746|Surgery|surgery
480969|NCT01097720|Valproate|valproate
480970|NCT01097720|Lamotrigine|lamotrigine
480971|NCT01097720|Carbamazepine|carbamazepine
480972|NCT01097720|Anticonvulsant|anticonvulsant
480973|NCT01097720|Antiepileptic|antiepileptic
480974|NCT01097720|Teratogen|teratogen
480975|NCT01097720|Autism|autism
480976|NCT01097720|Developmental Delay|developmental delay
480977|NCT01097694|cKIT inhibition in Asthma|ckit inhibition in asthma
480978|NCT01097694|Efficacy of Imatinib in severe resistent asthma.|efficacy of imatinib in severe resistent asthma.
480979|NCT01097681|ASP1941|asp1941
480980|NCT01097681|Diabetes mellitus|diabetes mellitus
480981|NCT01097681|Urinary glucose excretion|urinary glucose excretion
480982|NCT01097668|Multiple sclerosis|multiple sclerosis
480983|NCT01097668|Immunomodulation|immunomodulation
480984|NCT01097668|Phase 1|phase 1
480985|NCT01097655|Tablets|tablets
480986|NCT01097655|Infection|infection
480987|NCT01097655|Non Nucleoside Reverse Transcriptase Inhibitor|non nucleoside reverse transcriptase inhibitor
480988|NCT01097655|Tolerability|tolerability
480989|NCT01097655|Viral load|viral load
480990|NCT01097655|Human immunodeficiency Virus|human immunodeficiency virus
480991|NCT01097655|Effectiveness|effectiveness
480992|NCT01097655|Treatment-naïve|treatment-naïve
480993|NCT01097603|Non-Invasive Blood Pressure|non-invasive blood pressure
480994|NCT01097590|ulcerative colitis|ulcerative colitis
480995|NCT01097590|leukapheresis treatment|leukapheresis treatment
480996|NCT01097577|photorefractive keratectomy|photorefractive keratectomy
480997|NCT01097577|excimer laser|excimer laser
480998|NCT01097577|PRK|prk
480999|NCT01097577|pain, postoperative|pain, postoperative
481000|NCT01097577|pregabalin|pregabalin
481001|NCT01097564|Genetic|genetic
481002|NCT01097564|Cerebral angiopathy|cerebral angiopathy
481003|NCT01097564|Retinal angiopathy|retinal angiopathy
481004|NCT01097564|COL4A1 gene|col4a1 gene
481005|NCT01097564|Infantile Cerebral Palsy|infantile cerebral palsy
481006|NCT01097564|Congenital porencephaly|congenital porencephaly
481008|NCT01097564|Leukoencephalopathy|leukoencephalopathy
481009|NCT01097564|COL4A1 gene related cerebra-retinal angiopathy|col4a1 gene related cerebra-retinal angiopathy
481010|NCT01097551|Type 1 diabetes mellitus|type 1 diabetes mellitus
481011|NCT01097551|Diabetic retinopathy|diabetic retinopathy
481012|NCT01097551|Pathogenesis|pathogenesis
481013|NCT01097551|Dynamic Vessel Analyser|dynamic vessel analyser
481014|NCT01097551|Endothelial dysfunction|endothelial dysfunction
481015|NCT01097538|exercise|exercise
481016|NCT01097538|rehabilitation|rehabilitation
481017|NCT01097538|progressive multiple sclerosis|progressive multiple sclerosis
481018|NCT01097538|functional ability|functional ability
481019|NCT01097538|fatigue|fatigue
481020|NCT01097538|quality of life|quality of life
481021|NCT01097512|AS703569|as703569
481022|NCT01097512|MSC1992371A|msc1992371a
481023|NCT01097512|Aurora kinase inhibitor|aurora kinase inhibitor
481024|NCT01097512|Cancer treatable with gemcitabine|cancer treatable with gemcitabine
481025|NCT01097499|Dental implant initial stability|dental implant initial stability
481026|NCT01097499|Initial bone resorption post implant placement|initial bone resorption post implant placement
481027|NCT01097499|Analgesia effect of LED intervention|analgesia effect of led intervention
481028|NCT01097486|Cervical Degenerative Disc Disease|cervical degenerative disc disease
481029|NCT01097486|Degenerative Spondylolisthesis|degenerative spondylolisthesis
481030|NCT01097486|Spinal Stenosis|spinal stenosis
481031|NCT01097486|Stem cells|stem cells
481032|NCT01097486|Adult Stem Cells|adult stem cells
481033|NCT01097486|Anterior cervical discectomy and Fusion (ACDF)|anterior cervical discectomy and fusion (acdf)
481034|NCT01097486|Cervical Allograft Spacer|cervical allograft spacer
481035|NCT01097486|Anterior Cervical Plate Fixation|anterior cervical plate fixation
481036|NCT01097460|HER2/HER3|her2/her3
481037|NCT01097460|Bispecific Antibody|bispecific antibody
481038|NCT01097460|Breast Cancer|breast cancer
481039|NCT01097460|Advanced Breast Cancer|advanced breast cancer
481040|NCT01097460|Metastatic Breast Cancer|metastatic breast cancer
481041|NCT01097460|HER2 Positive Breast Cancer|her2 positive breast cancer
481042|NCT01097460|Trastuzumab|trastuzumab
481043|NCT01097460|Herceptin|herceptin
481044|NCT01097447|Diagnosis of keratoconus, post-LASIK ectasia, FFKC, or pellucid marginal degeneration|diagnosis of keratoconus, post-lasik ectasia, ffkc, or pellucid marginal degeneration
481045|NCT01097395|ribavirin|ribavirin
481046|NCT01097395|pharmacokinetics|pharmacokinetics
481047|NCT01097395|Hepatitis C virus|hepatitis c virus
481048|NCT01097343|Clopidogrel pharmacogenomics study|clopidogrel pharmacogenomics study
481049|NCT01097343|Performing genetic study looking at clopidogrel resistance|performing genetic study looking at clopidogrel resistance
481050|NCT01097330|Defibrillators, Implantable|defibrillators, implantable
481051|NCT01097330|Tachycardia, Ventricular|tachycardia, ventricular
481052|NCT01097330|Catheter Ablation|catheter ablation
481053|NCT01097330|Amiodarone|amiodarone
481054|NCT01097317|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
481055|NCT01097317|musculoskeletal complications|musculoskeletal complications
481056|NCT01097317|fatigue|fatigue
481057|NCT01097317|stage I non-small cell lung cancer|stage i non-small cell lung cancer
481058|NCT01097317|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
481059|NCT01097317|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
481060|NCT01097317|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
481061|NCT01097317|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
481062|NCT01097317|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
481063|NCT01097278|breast cancer|breast cancer
481064|NCT01097278|ductal breast carcinoma in situ|ductal breast carcinoma in situ
481065|NCT01097278|lobular breast carcinoma in situ|lobular breast carcinoma in situ
481066|NCT01097278|BRCA1 mutation carrier|brca1 mutation carrier
481067|NCT01097278|BRCA2 mutation carrier|brca2 mutation carrier
481068|NCT01097265|stage I colon cancer|stage i colon cancer
481069|NCT01097265|stage II colon cancer|stage ii colon cancer
481070|NCT01097252|Cervical Neoplasm|cervical neoplasm
481071|NCT01097252|chemoradiation|chemoradiation
481072|NCT01097252|compliance|compliance
481073|NCT01097252|toxicity|toxicity
481074|NCT01097239|High Intensity Focused Ultrasound|high intensity focused ultrasound
481075|NCT01097239|HIFU|hifu
481076|NCT01097239|Rectal Cancer|rectal cancer
481077|NCT01097239|Sonablate 500|sonablate 500
481078|NCT01097239|Transrectal|transrectal
481079|NCT01097226|Dietary intervention|dietary intervention
481080|NCT01097226|bioavailability|bioavailability
481081|NCT01097226|Healthy volunteers|healthy volunteers
481082|NCT01097200|sacrocolpopexy|sacrocolpopexy
481083|NCT01097200|meshes|meshes
481084|NCT01097200|sacrospinous ligament|sacrospinous ligament
481085|NCT01097174|Glaucoma|glaucoma
481086|NCT01097174|Glaucoma device|glaucoma device
481087|NCT01097174|Glaucoma surgery|glaucoma surgery
481088|NCT01097174|Intraocular pressure|intraocular pressure
481089|NCT01097161|Stuttering|stuttering
481090|NCT01097161|Apraxia of speech|apraxia of speech
481091|NCT01097161|Motor control|motor control
481092|NCT01097161|Prosody|prosody
481093|NCT01097161|Pitch range|pitch range
481094|NCT01097161|Speech rate|speech rate
481095|NCT01097161|fluency disorders|fluency disorders
481096|NCT01097148|Obese|obese
481097|NCT01097148|Atracurium|atracurium
481098|NCT01097148|Cefazolin|cefazolin
481099|NCT01097148|Morfine|morfine
481100|NCT01097148|Nadroparin|nadroparin
481101|NCT01097122|bone|bone
481102|NCT01097122|motor neuron excitability|motor neuron excitability
481103|NCT01097122|forearm vibration|forearm vibration
481104|NCT01097122|mechanical loading|mechanical loading
481105|NCT01097122|muscle electrical activity|muscle electrical activity
481106|NCT01097109|Effect of Somatic Dysfunctions of Pelvis|effect of somatic dysfunctions of pelvis
481107|NCT01097109|Effect of Somatic Dysfunctions of Sacrum|effect of somatic dysfunctions of sacrum
481108|NCT01097109|Effect of Somatic Dysfunctions of Lower Lumbar Spine|effect of somatic dysfunctions of lower lumbar spine
481109|NCT01097109|Weight-Bearing|weight-bearing
481110|NCT01097096|Active immunization|active immunization
481111|NCT01097096|Alzheimer disease|alzheimer disease
481112|NCT01097096|Antibody|antibody
481113|NCT01097096|Central Nervous System Diseases|central nervous system diseases
481114|NCT01097096|Neurodegenerative diseases|neurodegenerative diseases
481115|NCT01097096|Vaccine|vaccine
481116|NCT01097083|Patients With Child-Pugh C Unresectable Hepatocellular Carcinoma|patients with child-pugh c unresectable hepatocellular carcinoma
481117|NCT01097083|Patients who are unfit for standard therapy|patients who are unfit for standard therapy
481118|NCT01097044|Erythropoietic Protoporphyria|erythropoietic protoporphyria
481119|NCT01097044|EPP|epp
481120|NCT01097044|Afamelanotide|afamelanotide
481121|NCT01097031|blood pressure|blood pressure
481122|NCT01097031|pediatric|pediatric
481123|NCT01097031|nursing|nursing
481250|NCT01096589|lymphedema|lymphedema
481124|NCT01097031|maintenance arterial catheter|maintenance arterial catheter
481125|NCT01097005|Mycobacterium Infections, Atypical|mycobacterium infections, atypical
481126|NCT01096992|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
481127|NCT01096992|CLL|cll
481128|NCT01096992|Bendamustine|bendamustine
481129|NCT01096992|Fludarabine|fludarabine
481130|NCT01096992|Fludara|fludara
481131|NCT01096992|Fludarabine Phosphate|fludarabine phosphate
481132|NCT01096992|Rituximab|rituximab
481133|NCT01096992|Rituxan|rituxan
481134|NCT01096979|Subcutaneous Adipose Tissue Reduction|subcutaneous adipose tissue reduction
481135|NCT01096966|chronic low back pain|chronic low back pain
481136|NCT01096953|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
481137|NCT01096953|ADHD|adhd
481138|NCT01096953|attention deficit|attention deficit
481139|NCT01096940|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
481140|NCT01096940|Glucose lowering|glucose lowering
481141|NCT01096927|Lower Abdominal Pain|lower abdominal pain
481142|NCT01096927|Right Iliac Fossa Pain|right iliac fossa pain
481143|NCT01096927|Acute Appendicitis|acute appendicitis
481144|NCT01096927|Antibiotic Therapy|antibiotic therapy
481145|NCT01096927|Conservative Management|conservative management
481146|NCT01096927|Appendectomy|appendectomy
481147|NCT01096927|Recurrence|recurrence
481148|NCT01096927|Length of hospital stay|length of hospital stay
481149|NCT01096927|Sick leave time|sick leave time
481150|NCT01096927|Short and Long Term Abdominal pain evaluation|short and long term abdominal pain evaluation
481151|NCT01096888|WIC|wic
481152|NCT01096888|Weight loss|weight loss
481153|NCT01096888|Overweight|overweight
481154|NCT01096888|Post Partum|post partum
481155|NCT01096888|Internet based weight loss intervention for Mothers in the WIC program.|internet based weight loss intervention for mothers in the wic program.
481156|NCT01096875|Endothelial progenitor cells|endothelial progenitor cells
481157|NCT01096875|Atorvastatin|atorvastatin
481158|NCT01096875|Coronary surgery|coronary surgery
481159|NCT01096862|Psoriasis|psoriasis
481160|NCT01096862|ASP015K|asp015k
481161|NCT01096849|urinary tract infection|urinary tract infection
481162|NCT01096849|UTI|uti
481163|NCT01096849|cUTI|cuti
481164|NCT01096849|pyelonephritis|pyelonephritis
481165|NCT01096849|AP|ap
481166|NCT01096849|ACHN-490|achn-490
481167|NCT01096836|resistance exercise|resistance exercise
481168|NCT01096836|body mass index|body mass index
481169|NCT01096836|hypertrophy|hypertrophy
481170|NCT01096836|endothelial function|endothelial function
481171|NCT01096836|blood lipids|blood lipids
481172|NCT01096823|Rheumatoid Arthritis|rheumatoid arthritis
481173|NCT01096823|Yoga|yoga
481174|NCT01096823|Adolescents|adolescents
481175|NCT01096823|Young Adults|young adults
481176|NCT01096810|Asymptomatic|asymptomatic
481177|NCT01096784|insulin-like growth factor|insulin-like growth factor
481178|NCT01096784|ROP|rop
481179|NCT01096784|IGF-I|igf-i
481180|NCT01096784|BPD|bpd
481181|NCT01096784|bronchopulmonary dysplasia|bronchopulmonary dysplasia
481182|NCT01096784|retinopathy of prematurity|retinopathy of prematurity
481183|NCT01096771|ARDS|ards
481184|NCT01096771|Parenteral|parenteral
481185|NCT01096771|Pharmaconutrition|pharmaconutrition
481186|NCT01096758|PKU|pku
481187|NCT01096758|phenylketonuria|phenylketonuria
481188|NCT01096758|adult|adult
481189|NCT01096758|patient|patient
481190|NCT01096758|development|development
481191|NCT01096758|nutritional deficiencies|nutritional deficiencies
481192|NCT01096758|neurological outcome|neurological outcome
481193|NCT01096758|psychological and neurological development|psychological and neurological development
481194|NCT01096758|comparison with healthy adults|comparison with healthy adults
481195|NCT01096758|longitudinal development|longitudinal development
481196|NCT01096758|quality of life|quality of life
481197|NCT01096745|Gemcitabine|gemcitabine
481198|NCT01096745|Cisplatin|cisplatin
481199|NCT01096745|S-1|s-1
481200|NCT01096745|bile duct cancer|bile duct cancer
481201|NCT01096732|Pancreatic|pancreatic
481202|NCT01096732|adenocarcinoma|adenocarcinoma
481203|NCT01096732|cancer|cancer
481204|NCT01096719|Weight|weight
481205|NCT01096719|Dietary intake|dietary intake
481206|NCT01096719|Energy Density|energy density
481207|NCT01096719|Behavioral|behavioral
481208|NCT01096719|Satiety|satiety
481209|NCT01096719|Deprivation|deprivation
481210|NCT01096719|Hunger|hunger
481211|NCT01096719|Fruit|fruit
481212|NCT01096719|Vegetable|vegetable
481213|NCT01096706|Urocortin 2|urocortin 2
481214|NCT01096706|Urocortin 3|urocortin 3
481215|NCT01096706|Nitric Oxide|nitric oxide
481216|NCT01096706|Plethysmography|plethysmography
481217|NCT01096706|Forearm blood flow|forearm blood flow
481218|NCT01096706|Vascular|vascular
481219|NCT01096706|Heart failure|heart failure
481220|NCT01096706|endothelium|endothelium
481221|NCT01096706|Cyclo-oxygenase pathway|cyclo-oxygenase pathway
481222|NCT01096706|EDHF|edhf
481223|NCT01096693|Urocortin 2|urocortin 2
481224|NCT01096693|Urocortin 3|urocortin 3
481225|NCT01096693|Astressin 2B|astressin 2b
481226|NCT01096693|forearm blood flow|forearm blood flow
481227|NCT01096693|plethysmography|plethysmography
481228|NCT01096693|vascular|vascular
481229|NCT01096693|heart failure|heart failure
481230|NCT01096667|type 2 diabetes|type 2 diabetes
481231|NCT01096667|hypertension|hypertension
481232|NCT01096667|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
481233|NCT01096654|endocrine hypertension|endocrine hypertension
481234|NCT01096654|primary hyperaldosteronism|primary hyperaldosteronism
481235|NCT01096654|aldosterone|aldosterone
481236|NCT01096654|aldosterone-producing adenoma|aldosterone-producing adenoma
481237|NCT01096654|bilateral adrenal hyperplasia|bilateral adrenal hyperplasia
481238|NCT01096654|computed tomography|computed tomography
481239|NCT01096654|adrenal vein sampling|adrenal vein sampling
481240|NCT01096641|Fatigued disease-free Cancer Patients|fatigued disease-free cancer patients
481241|NCT01096641|cancer treatment finished > one year and < ten years ago|cancer treatment finished > one year and < ten years ago
481242|NCT01096628|adolescent|adolescent
481243|NCT01096628|low back pain|low back pain
481244|NCT01096628|chiropractic|chiropractic
481245|NCT01096628|exercise|exercise
481246|NCT01096615|Allergic rhinitis-Probiotic Lactobacillus paracasei LP-33-|allergic rhinitis-probiotic lactobacillus paracasei lp-33-
481247|NCT01096602|Dendritic Cell/AML vaccine|dendritic cell/aml vaccine
481248|NCT01096602|CT-011|ct-011
481249|NCT01096589|lymphoedema|lymphoedema
481251|NCT01096563|Phase I|phase i
481252|NCT01096563|Japanese healthy volunteer|japanese healthy volunteer
481253|NCT01096563|AZD9164|azd9164
481254|NCT01096550|opioid dependence|opioid dependence
481255|NCT01096550|outpatient treatment|outpatient treatment
481256|NCT01096550|intensive outpatient treatment|intensive outpatient treatment
481257|NCT01096537|incidence|incidence
481258|NCT01096537|young workers|young workers
481259|NCT01096537|occupations at risk|occupations at risk
481260|NCT01096537|public health|public health
481261|NCT01096537|epidemiology|epidemiology
481262|NCT01096537|polymorphisms|polymorphisms
481263|NCT01096537|gentic|gentic
481264|NCT01096524|Kneehab|kneehab
481265|NCT01096524|NMES|nmes
481266|NCT01096524|Total Knee Arthroplasty|total knee arthroplasty
481267|NCT01096524|Total Knee Replacement|total knee replacement
481268|NCT01096524|TKA|tka
481269|NCT01096524|Disuse atrophy|disuse atrophy
481270|NCT01096524|muscle hypertrophy|muscle hypertrophy
481271|NCT01096524|TKR|tkr
481810|NCT01094717|psoriasis|psoriasis
481272|NCT01096524|Atrophy Prevention|atrophy prevention
481273|NCT01096511|Moxifloxacin,|moxifloxacin,
481274|NCT01096511|cIAI|ciai
481275|NCT01096511|non-interventional|non-interventional
481276|NCT01096472|Tinea pedis|tinea pedis
481277|NCT01096459|spina|spina
481278|NCT01096459|bifida|bifida
481279|NCT01096459|restore|restore
481280|NCT01096459|urinary|urinary
481281|NCT01096459|function|function
481282|NCT01096459|nerve|nerve
481283|NCT01096459|reroute|reroute
481284|NCT01096433|Sleep apnea|sleep apnea
481285|NCT01096433|CPAP|cpap
481286|NCT01096433|Prostaglandins|prostaglandins
481287|NCT01096433|Circadian variations|circadian variations
481288|NCT01096420|chronic migraine|chronic migraine
481289|NCT01096420|acupuncture|acupuncture
481290|NCT01096420|Topiramate|topiramate
481291|NCT01096420|Randomized trial|randomized trial
481292|NCT01096407|pain|pain
481293|NCT01096407|arthralgia|arthralgia
481294|NCT01096407|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
481295|NCT01096394|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
481296|NCT01096394|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
481297|NCT01096381|cardiovascular complications|cardiovascular complications
481298|NCT01096381|stage I breast cancer|stage i breast cancer
481299|NCT01096381|stage II breast cancer|stage ii breast cancer
481300|NCT01096381|stage IIIA breast cancer|stage iiia breast cancer
481301|NCT01096381|stage IIIB breast cancer|stage iiib breast cancer
481302|NCT01096381|stage IIIC breast cancer|stage iiic breast cancer
481303|NCT01096381|stage IV breast cancer|stage iv breast cancer
481304|NCT01096381|stage I colon cancer|stage i colon cancer
481305|NCT01096381|stage II colon cancer|stage ii colon cancer
481306|NCT01096381|stage III colon cancer|stage iii colon cancer
481307|NCT01096381|stage IV colon cancer|stage iv colon cancer
481308|NCT01096381|stage I rectal cancer|stage i rectal cancer
481309|NCT01096381|stage II rectal cancer|stage ii rectal cancer
481310|NCT01096381|stage III rectal cancer|stage iii rectal cancer
481311|NCT01096381|stage IV rectal cancer|stage iv rectal cancer
481312|NCT01096381|stage I non-small cell lung cancer|stage i non-small cell lung cancer
481313|NCT01096381|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
481314|NCT01096381|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
481315|NCT01096381|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
481316|NCT01096381|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
481317|NCT01096381|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
481318|NCT01096381|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
481319|NCT01096381|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
481320|NCT01096381|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
481321|NCT01096381|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
481322|NCT01096381|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
481323|NCT01096381|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
481324|NCT01096381|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
481325|NCT01096381|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
481326|NCT01096381|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
481327|NCT01096381|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
481328|NCT01096381|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
481329|NCT01096381|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
481330|NCT01096381|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
481331|NCT01096381|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
481332|NCT01096381|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
481333|NCT01096381|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
481334|NCT01096381|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
481335|NCT01096381|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
481336|NCT01096381|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
481337|NCT01096381|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
481338|NCT01096381|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
481339|NCT01096381|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
481340|NCT01096381|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
481341|NCT01096381|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
481342|NCT01096381|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
481343|NCT01096381|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
481344|NCT01096381|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
481345|NCT01096381|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
481346|NCT01096381|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
481347|NCT01096381|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
481348|NCT01096381|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
481349|NCT01096381|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
481350|NCT01096381|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
481351|NCT01096381|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
481352|NCT01096381|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
481353|NCT01096381|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
481354|NCT01096381|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
481355|NCT01096381|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
481356|NCT01096381|fallopian tube cancer|fallopian tube cancer
481357|NCT01096381|peritoneal cavity cancer|peritoneal cavity cancer
481358|NCT01096329|postmenopausal|postmenopausal
481359|NCT01096329|hormone replacement therapy|hormone replacement therapy
481360|NCT01096316|mood disorders|mood disorders
481361|NCT01096316|depressive disorder|depressive disorder
481363|NCT01096316|depression|depression
481364|NCT01096303|COPD|copd
481365|NCT01096303|pulmonary function|pulmonary function
481366|NCT01096303|tobacco and marihuana smoking|tobacco and marihuana smoking
481367|NCT01096290|constipation|constipation
481368|NCT01096290|lubiprostone|lubiprostone
481369|NCT01096290|healthy volunteers|healthy volunteers
481370|NCT01096264|Arterial stiffness|arterial stiffness
481371|NCT01096264|Pulse wave velocity|pulse wave velocity
481372|NCT01096264|Ultrafastecho|ultrafastecho
481373|NCT01096264|Supersonic shear imaging|supersonic shear imaging
481374|NCT01096251|Obesity|obesity
481375|NCT01096251|Binge Eating Disorder|binge eating disorder
481376|NCT01096251|Cognitive Behavioural Therapy|cognitive behavioural therapy
481377|NCT01096251|Brief Strategic Therapy|brief strategic therapy
481378|NCT01096251|Telepsychology|telepsychology
481379|NCT01096238|The immunogenicity of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in adults after half a year will be analyzed and discussed.|the immunogenicity of influenza virus vaccine, adimflu-s (a/h1n1), in adults after half a year will be analyzed and discussed.
481380|NCT01096225|the antibody response|the antibody response
481381|NCT01096225|T-cell response|t-cell response
481382|NCT01096225|S-OIV|s-oiv
481383|NCT01096225|vaccine|vaccine
481384|NCT01096225|Immunogenicity assessment|immunogenicity assessment
481385|NCT01096212|Efficacy|efficacy
481386|NCT01096212|Minimum alveolar concentration|minimum alveolar concentration
481387|NCT01096212|Safety|safety
481388|NCT01096212|Sevoflurane|sevoflurane
481389|NCT01096199|The purpose of the study is to evaluate the safety and feasibility of combining TS-1/CDDP with RAD001. Primary|the purpose of the study is to evaluate the safety and feasibility of combining ts-1/cddp with rad001. primary
481390|NCT01096199|Objectives|objectives
481391|NCT01096199|To determine the MTD/recommended phase II dose of TS-1/CDDP/RAD001 combination —To determine|to determine the mtd/recommended phase ii dose of ts-1/cddp/rad001 combination —to determine
481392|NCT01096199|the safety of TS-1/CDDP/RAD001 combination Secondary Objectives —To preliminarily describe any clinical activity in|the safety of ts-1/cddp/rad001 combination secondary objectives —to preliminarily describe any clinical activity in
481393|NCT01096199|platinum refractory disease|platinum refractory disease
481394|NCT01096199|To assess to effect of concurrent TS-1/CDDP on RAD001 pharmacokinetics —To explore|to assess to effect of concurrent ts-1/cddp on rad001 pharmacokinetics —to explore
481395|NCT01096199|the relationship of tumour biomarkers and treatment response|the relationship of tumour biomarkers and treatment response
481396|NCT01096186|motor Symptoms|motor symptoms
481397|NCT01096186|efficacy|efficacy
481398|NCT01096186|IPX066|ipx066
481399|NCT01096186|Parkinson's Disease|parkinson's disease
481400|NCT01096173|Sputum|sputum
481401|NCT01096173|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
481402|NCT01096160|Hypertension|hypertension
481403|NCT01096147|FBSS|fbss
481404|NCT01096147|chronic pain|chronic pain
481405|NCT01096147|leg pain|leg pain
481406|NCT01096147|low back pain|low back pain
481407|NCT01096147|spinal cord stimulation|spinal cord stimulation
481408|NCT01096121|Angiotensin-converting enzyme inhibitors (ACE)|angiotensin-converting enzyme inhibitors (ace)
481409|NCT01096121|Renal disease|renal disease
481410|NCT01096121|Microalbuminemia|microalbuminemia
481411|NCT01096108|Smoking cessation|smoking cessation
481412|NCT01096108|Quit smoking|quit smoking
481413|NCT01096108|Quit & Win|quit & win
481414|NCT01096095|SCA|sca
481415|NCT01096095|Spinocerebellar Ataxia|spinocerebellar ataxia
481416|NCT01096095|Sodium Phenylbutyrate|sodium phenylbutyrate
481417|NCT01096095|Machado-Joseph Disease|machado-joseph disease
481418|NCT01096095|Treatment|treatment
481419|NCT01096082|spinocerebellar ataxia|spinocerebellar ataxia
481420|NCT01096082|Treatment|treatment
481421|NCT01096082|Lithium carbonate|lithium carbonate
481422|NCT01096069|Rituximab, rheumatoid arthritis, CD55, CD59|rituximab, rheumatoid arthritis, cd55, cd59
481423|NCT01096056|Children|children
481424|NCT01096056|Influenza|influenza
481425|NCT01096056|Safety|safety
481426|NCT01096056|Immunogenicity|immunogenicity
481427|NCT01096056|Vaccine|vaccine
481428|NCT01096043|Heart Failure|heart failure
481429|NCT01096043|ADHF|adhf
481430|NCT01096030|Regorafenib|regorafenib
481431|NCT01096030|Advanced|advanced
481432|NCT01096030|Refractory solid tumors|refractory solid tumors
481433|NCT01096017|Terbutaline|terbutaline
481434|NCT01096017|Turbuhaler|turbuhaler
481435|NCT01096017|Efficacy|efficacy
481436|NCT01096017|Asthma|asthma
481437|NCT01096017|Japanese|japanese
481438|NCT01096017|salbutamol|salbutamol
481439|NCT01096017|Bricanyl|bricanyl
481440|NCT01096004|Pharmacodynamic method evaluation|pharmacodynamic method evaluation
481441|NCT01095991|Type 2 Diabetes Mellitus, Sitagliptin|type 2 diabetes mellitus, sitagliptin
481442|NCT01095978|Klacid SR|klacid sr
481443|NCT01095978|Clarithromycin|clarithromycin
481444|NCT01095978|Respiratory tract infections|respiratory tract infections
481445|NCT01095978|Bronchitis|bronchitis
481446|NCT01095978|Pneumonia|pneumonia
481447|NCT01095965|Nutrition education intervention|nutrition education intervention
481448|NCT01095965|Type 2 diabetes mellitus|type 2 diabetes mellitus
481449|NCT01095952|atrial fibrillation|atrial fibrillation
481450|NCT01095952|inappropriate shock|inappropriate shock
481451|NCT01095952|AV-node stimulation|av-node stimulation
481452|NCT01095952|ventricular arrhythmia|ventricular arrhythmia
481453|NCT01095939|Renal function consecutive to pre-eclampsia|renal function consecutive to pre-eclampsia
481454|NCT01095926|pharmacokinetic|pharmacokinetic
481455|NCT01095926|doxorubicin|doxorubicin
481456|NCT01095926|cancer|cancer
481457|NCT01095926|troponin|troponin
481458|NCT01095926|natriuretic peptide|natriuretic peptide
481459|NCT01095926|cardiotoxicity|cardiotoxicity
481460|NCT01095926|anthracyclines|anthracyclines
481461|NCT01095926|Ewing|ewing
481462|NCT01095926|ALL|all
481463|NCT01095913|Near-Infrared Imaging|near-infrared imaging
481464|NCT01095913|Fluorescent Dyes|fluorescent dyes
481465|NCT01095913|Lymph Node Mapping|lymph node mapping
481466|NCT01095913|Indocyanine green|indocyanine green
481467|NCT01095913|IC-Green|ic-green
481468|NCT01095913|nonradioactive optical imaging|nonradioactive optical imaging
481469|NCT01095913|fluorescent contrast agent|fluorescent contrast agent
481470|NCT01095913|ICG|icg
481471|NCT01095913|lymph nodes|lymph nodes
481472|NCT01095913|axillary nodal dissection|axillary nodal dissection
481473|NCT01095900|Pain after treatment|pain after treatment
481474|NCT01095900|healing of fissure after treatment|healing of fissure after treatment
481475|NCT01095900|continence scores after treatment|continence scores after treatment
481476|NCT01095887|ABO incompatibility|abo incompatibility
481477|NCT01095887|living donor kidney transplant|living donor kidney transplant
481478|NCT01095887|kidney transplant|kidney transplant
481479|NCT01095887|ABO blood type incompatible|abo blood type incompatible
481480|NCT01095874|myelodysplasia|myelodysplasia
481481|NCT01095874|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
481482|NCT01095874|Survival|survival
481483|NCT01095874|Transplantation|transplantation
481484|NCT01095861|endotracheal tube|endotracheal tube
481485|NCT01095848|vaccine|vaccine
481486|NCT01095848|cancer|cancer
481487|NCT01095848|ovarian|ovarian
481488|NCT01095848|breast|breast
481489|NCT01095848|prostate|prostate
481490|NCT01095848|tumor|tumor
481491|NCT01095848|Immunotherapy|immunotherapy
481492|NCT01095822|Diabetes|diabetes
481493|NCT01095822|Hypertension|hypertension
481494|NCT01095822|Platelets|platelets
481495|NCT01095822|Hemostasis|hemostasis
481496|NCT01095822|Aliskiren|aliskiren
481497|NCT01095822|Valsartan|valsartan
481498|NCT01095796|Treatment Naive|treatment naive
481499|NCT01095796|HIV 1 Infected|hiv 1 infected
481500|NCT01095783|low back pain|low back pain
481501|NCT01095783|physiotherapy|physiotherapy
481502|NCT01095783|hemodialysis|hemodialysis
481503|NCT01095783|end-stage renal disease|end-stage renal disease
481504|NCT01095770|Atrial Fibrillation|atrial fibrillation
481505|NCT01095770|Atrial Fibrillation Ablation|atrial fibrillation ablation
481506|NCT01095770|Atrial Fibrillation monitoring|atrial fibrillation monitoring
481507|NCT01095770|Ablation Frontiers|ablation frontiers
481508|NCT01095770|Reveal XT|reveal xt
481509|NCT01095770|LASSO|lasso
481510|NCT01095757|Myeloma|myeloma
481511|NCT01095757|Lymphoma|lymphoma
481512|NCT01095757|Stem cell transplantation|stem cell transplantation
481513|NCT01095744|PIB imaging,|pib imaging,
481514|NCT01095744|brain atrophy|brain atrophy
481515|NCT01095744|cognitive impairment|cognitive impairment
481516|NCT01095744|Pet imaging|pet imaging
481517|NCT01095744|Alzheimer's disease|alzheimer's disease
481518|NCT01095744|amyloid protein|amyloid protein
481519|NCT01095731|aneurysm|aneurysm
481520|NCT01095731|aneurysmal|aneurysmal
481521|NCT01095731|subarachnoid|subarachnoid
481522|NCT01095731|hemorrhage|hemorrhage
481523|NCT01095731|haemorrhage|haemorrhage
481524|NCT01095731|neuroprotection|neuroprotection
481525|NCT01095731|3-aminopropanal|3-aminopropanal
481526|NCT01095731|3AP|3ap
481527|NCT01095731|polyamine oxidase|polyamine oxidase
481528|NCT01095731|spermine|spermine
481529|NCT01095731|spermidine|spermidine
481530|NCT01095731|vasospasm|vasospasm
481531|NCT01095731|cerebral ischemia|cerebral ischemia
481532|NCT01095731|neurosurgery|neurosurgery
481533|NCT01095731|neurological intensive care unit|neurological intensive care unit
481534|NCT01095731|NICU|nicu
481535|NCT01095731|Tiopronin|tiopronin
481536|NCT01095731|Thiola|thiola
481537|NCT01095731|FDA|fda
481538|NCT01095731|Thiopronin|thiopronin
481539|NCT01095731|Thiosol|thiosol
481540|NCT01095731|Tioglis|tioglis
481541|NCT01095731|Acadione|acadione
481542|NCT01095731|Capen|capen
481543|NCT01095731|Captimer|captimer
481544|NCT01095731|Epatiol|epatiol
481545|NCT01095731|Vincol|vincol
481546|NCT01095731|Mucolysin|mucolysin
481547|NCT01095731|Sutilan|sutilan
481548|NCT01095731|Meprin|meprin
481549|NCT01095731|Thiolpropionamidoacetic acid|thiolpropionamidoacetic acid
481550|NCT01095731|Mercaptopropionyl glycine|mercaptopropionyl glycine
481551|NCT01095731|2 MPG|2 mpg
481552|NCT01095705|Hypnosis|hypnosis
481553|NCT01095705|Transesophageal Echocardiography|transesophageal echocardiography
481554|NCT01095705|Efficiency of Hypnosis|efficiency of hypnosis
481555|NCT01095692|Occult stress Incontinence,|occult stress incontinence,
481556|NCT01095692|Pelvic Organ Prolapse,|pelvic organ prolapse,
481557|NCT01095692|Prevention of stress urinary incontinence,|prevention of stress urinary incontinence,
481558|NCT01095692|Postoperative incontinence,|postoperative incontinence,
481559|NCT01095692|Sub-urethral tape|sub-urethral tape
481560|NCT01095679|CHEYNE Stokes respiration|cheyne stokes respiration
481561|NCT01095679|Periodic ventilation|periodic ventilation
481562|NCT01095679|baclofen|baclofen
481563|NCT01095679|hypoxia|hypoxia
481564|NCT01095679|healthy subject|healthy subject
481565|NCT01095640|acne|acne
481566|NCT01095640|adapalene|adapalene
481567|NCT01095640|Differin|differin
481568|NCT01095614|Women|women
481569|NCT01095614|Hormonal status|hormonal status
481570|NCT01095614|Exercise|exercise
481571|NCT01095614|Substrate utilization|substrate utilization
481572|NCT01095614|Women Hormonal Status (with oral contraception or without any contraception)|women hormonal status (with oral contraception or without any contraception)
481573|NCT01095601|avanafil|avanafil
481574|NCT01095601|absoprion|absoprion
481575|NCT01095601|bioavailability|bioavailability
481576|NCT01095601|food effect|food effect
481577|NCT01095601|dose-proportionality|dose-proportionality
481578|NCT01095601|TA-1790|ta-1790
481579|NCT01095601|Pharmacokinetics of avanafil|pharmacokinetics of avanafil
481580|NCT01095588|ED|ed
481581|NCT01095575|Epidural|epidural
481582|NCT01095575|Morphine|morphine
481583|NCT01095575|Preoperative|preoperative
481584|NCT01095575|Postoperative|postoperative
481585|NCT01095575|Analgesia|analgesia
481586|NCT01095575|Tolerance|tolerance
481587|NCT01095575|Preoperative, Postoperative Analgesia|preoperative, postoperative analgesia
481588|NCT01095549|ankle-brachial index (ABI)|ankle-brachial index (abi)
481589|NCT01095549|brachial-ankle pulse wave velocity (baPWV)|brachial-ankle pulse wave velocity (bapwv)
481590|NCT01095549|far infrared therapy (FIR)|far infrared therapy (fir)
481591|NCT01095549|hemodialysis (HD)|hemodialysis (hd)
481592|NCT01095549|peripheral artery disease (PAD)|peripheral artery disease (pad)
481593|NCT01095549|Peripheral artery disease in hemodialysis|peripheral artery disease in hemodialysis
481594|NCT01095536|laparoscopic cholecystectomy, elective|laparoscopic cholecystectomy, elective
481595|NCT01095536|anesthesia, general|anesthesia, general
481596|NCT01095536|shoulder pain|shoulder pain
481597|NCT01095536|nausea|nausea
481598|NCT01095536|vomiting|vomiting
481599|NCT01095536|laparoscopic cholecystectomy|laparoscopic cholecystectomy
481600|NCT01095536|general anesthesia|general anesthesia
481601|NCT01095523|Colon Cancer|colon cancer
481602|NCT01095523|Rectal Cancer|rectal cancer
481603|NCT01095523|Peritoneal Perfusion|peritoneal perfusion
481604|NCT01095523|Metastatic Cancer|metastatic cancer
481605|NCT01095523|Recurrence|recurrence
481606|NCT01095523|Colorectal Cancer|colorectal cancer
481607|NCT01095510|HAE|hae
481608|NCT01095510|CINRYZE|cinryze
481609|NCT01095510|C1 INH|c1 inh
481610|NCT01095510|C1 inhibitor|c1 inhibitor
481611|NCT01095510|Pediatric|pediatric
481612|NCT01095510|PK/PD|pk/pd
481613|NCT01095497|HAE|hae
481614|NCT01095497|C1 inhibitor (C1INH)|c1 inhibitor (c1inh)
481615|NCT01095497|Subcutaneous|subcutaneous
481616|NCT01095484|Rotigotine|rotigotine
481617|NCT01095484|Neupro®|neupro®
481618|NCT01095471|7 valent Pneumococcal conjugate vaccine|7 valent pneumococcal conjugate vaccine
481619|NCT01095471|13 valent Pneumococcal conjugate vaccine|13 valent pneumococcal conjugate vaccine
481620|NCT01095471|PCV13|pcv13
481621|NCT01095471|PCV7|pcv7
481622|NCT01095458|Obesity|obesity
481623|NCT01095458|Phone vs Clinical methods|phone vs clinical methods
481624|NCT01095445|hepatitis C|hepatitis c
481625|NCT01095445|genotype 3|genotype 3
481626|NCT01095445|end of treatment response|end of treatment response
481627|NCT01095445|relapse rate|relapse rate
481628|NCT01095445|rapid virologic response|rapid virologic response
481629|NCT01095445|complete early virologic response|complete early virologic response
481630|NCT01095432|Colonoscopy|colonoscopy
481631|NCT01095432|Flexible Sigmoidoscopy|flexible sigmoidoscopy
481632|NCT01095419|massage therapy|massage therapy
481633|NCT01095419|sleep quality|sleep quality
481634|NCT01095419|coronary artery bypass grafting surgery|coronary artery bypass grafting surgery
481635|NCT01095419|Patients after Coronary Artery Bypass Graft Surgery|patients after coronary artery bypass graft surgery
481636|NCT01095406|Weaning|weaning
481637|NCT01095406|closed loop|closed loop
481638|NCT01095406|mechanical ventilation|mechanical ventilation
481639|NCT01095406|children|children
481640|NCT01095393|Certolizumab Pegol|certolizumab pegol
481641|NCT01095393|CZP|czp
481642|NCT01095393|Cimzia®|cimzia®
481643|NCT01095393|NDB|ndb
481644|NCT01095393|registry|registry
481645|NCT01095380|task-specific training|task-specific training
481646|NCT01095380|walking|walking
481647|NCT01095380|locomotion|locomotion
481648|NCT01095380|function|function
481649|NCT01095380|body weight support|body weight support
481650|NCT01095380|Individuals with motor-incomplete spinal cord injury|individuals with motor-incomplete spinal cord injury
481651|NCT01095367|Adhesion barrier sheets|adhesion barrier sheets
481652|NCT01095367|ovarian cancer|ovarian cancer
481653|NCT01095367|Advanced stage epithelial ovarian cancer|advanced stage epithelial ovarian cancer
481654|NCT01095354|pediatric|pediatric
481655|NCT01095354|lung ventilation inhomogeneity|lung ventilation inhomogeneity
481656|NCT01095341|hyperthyroidism|hyperthyroidism
481657|NCT01095341|tertiary hyperparathyroidism|tertiary hyperparathyroidism
481658|NCT01095341|palpation thyroiditis|palpation thyroiditis
481659|NCT01095341|parathyroidectomy|parathyroidectomy
481660|NCT01095341|thyroglobulin|thyroglobulin
481661|NCT01095341|rate of postoperative hyperthyroidism|rate of postoperative hyperthyroidism
481662|NCT01095328|Q fever|q fever
481663|NCT01095328|Pregnancy|pregnancy
481664|NCT01095328|Screening|screening
481665|NCT01095328|Cost-effectiveness|cost-effectiveness
481666|NCT01095289|electromyography|electromyography
481667|NCT01095289|laryngeal neoplasms|laryngeal neoplasms
481668|NCT01095289|masticatory muscles|masticatory muscles
481669|NCT01095276|Mechanical Ventilation|mechanical ventilation
481670|NCT01095276|Extubation|extubation
481671|NCT01095276|dornase alpha|dornase alpha
481672|NCT01095276|oxygenation|oxygenation
481673|NCT01095276|chest x ray|chest x ray
481674|NCT01095250|Active uveitis|active uveitis
481675|NCT01095250|intermediate uveitis|intermediate uveitis
481676|NCT01095250|panuveitis|panuveitis
481677|NCT01095250|posterior uveitis|posterior uveitis
481678|NCT01095250|uveitis|uveitis
481679|NCT01095237|Peripheral Arterial Disease|peripheral arterial disease
481680|NCT01095237|Peripheral Vascular Disease|peripheral vascular disease
481681|NCT01095237|PAD|pad
481682|NCT01095237|vascular prosthesis|vascular prosthesis
481683|NCT01095237|revascularization|revascularization
481684|NCT01095237|patency|patency
481685|NCT01095237|blood vessel|blood vessel
481686|NCT01095237|Rutherford|rutherford
481687|NCT01095237|ABI|abi
481688|NCT01095237|Ankle Brachial Index|ankle brachial index
481689|NCT01095237|Vascular Graft|vascular graft
481690|NCT01095237|Carbothane|carbothane
481691|NCT01095237|ProEndoTecc|proendotecc
481692|NCT01095237|implantation|implantation
481693|NCT01095224|HIV Preventive Vaccine|hiv preventive vaccine
481694|NCT01095211|folic acid|folic acid
481695|NCT01095211|homocysteine|homocysteine
481696|NCT01095211|MMSE scores|mmse scores
481697|NCT01095211|methyl malonic acid|methyl malonic acid
481698|NCT01095211|betaine|betaine
481699|NCT01095198|vaginal self collection|vaginal self collection
481700|NCT01095198|human papillomavirus (hpv)|human papillomavirus (hpv)
481701|NCT01095198|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
481702|NCT01095172|Immunosuppression|immunosuppression
481703|NCT01095172|Rituximab|rituximab
481704|NCT01095172|B cell|b cell
481705|NCT01095159|TVTO|tvto
481706|NCT01095159|TVTSecur|tvtsecur
481707|NCT01095159|Mini sling|mini sling
481708|NCT01095159|stress urinary incontinence|stress urinary incontinence
481709|NCT01095146|MAS|mas
481710|NCT01095146|Hemophagocytosis|hemophagocytosis
481711|NCT01095146|Reactive HLH|reactive hlh
481712|NCT01095146|Macrophage activation syndrome|macrophage activation syndrome
481713|NCT01095146|Systemic onset juvenile idiopathic arthritis|systemic onset juvenile idiopathic arthritis
481714|NCT01095146|SoJIA|sojia
481715|NCT01095146|JIA|jia
481716|NCT01095133|Gastroesophageal reflux disease|gastroesophageal reflux disease
481717|NCT01095133|Heartburn|heartburn
481718|NCT01095107|Determining whether adjustments in the amounts of fat grams within the current inpatient protocol meal plans will lead to a change in the hospital stay duration|determining whether adjustments in the amounts of fat grams within the current inpatient protocol meal plans will lead to a change in the hospital stay duration
481719|NCT01095107|Alter their recovery by affecting vital signs|alter their recovery by affecting vital signs
481811|NCT01094717|excimer|excimer
481812|NCT01094717|acitretin|acitretin
481720|NCT01095107|Rate of weight change or need for supplemental feeds/medications|rate of weight change or need for supplemental feeds/medications
481962|NCT01094132|Nonmalignant Condition|nonmalignant condition
481721|NCT01095107|Effect gastrointestinal symptoms (bloating, gastroesophageal reflux, constipation, diarrhea, abdominal pain|effect gastrointestinal symptoms (bloating, gastroesophageal reflux, constipation, diarrhea, abdominal pain
481722|NCT01095107|And/or effect their perceived body image or cause any changes in their mood.|and/or effect their perceived body image or cause any changes in their mood.
481723|NCT01095094|adult brain tumor|adult brain tumor
481724|NCT01095094|adult anaplastic astrocytoma|adult anaplastic astrocytoma
481725|NCT01095094|adult anaplastic ependymoma|adult anaplastic ependymoma
481726|NCT01095094|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
481727|NCT01095094|adult brain stem glioma|adult brain stem glioma
481728|NCT01095094|adult giant cell glioblastoma|adult giant cell glioblastoma
481729|NCT01095094|adult glioblastoma|adult glioblastoma
481730|NCT01095094|adult gliosarcoma|adult gliosarcoma
481731|NCT01095094|adult mixed glioma|adult mixed glioma
481732|NCT01095094|recurrent adult brain tumor|recurrent adult brain tumor
481733|NCT01095042|HRV|hrv
481734|NCT01095042|emotion|emotion
481735|NCT01095042|cognition|cognition
481736|NCT01095042|stress|stress
481737|NCT01095042|cortisol|cortisol
481738|NCT01095042|Autonomic nervous system|autonomic nervous system
481739|NCT01095029|Positron emission tomography (PET)|positron emission tomography (pet)
481740|NCT01095029|Idiopathic Faecal Incontinence|idiopathic faecal incontinence
481741|NCT01095029|Bilateral Sacral Nerve Stimulation|bilateral sacral nerve stimulation
481742|NCT01095029|Sacral Nerve Stimulation|sacral nerve stimulation
481743|NCT01095029|Sacral Nervemodulation|sacral nervemodulation
481744|NCT01094990|crossover; double blinded; intrathecal chemotherapy; dexamethasone; ketamine;vomiting|crossover; double blinded; intrathecal chemotherapy; dexamethasone; ketamine;vomiting
481745|NCT01094977|Blood Loss and Transfusion|blood loss and transfusion
481746|NCT01094977|Craniosynostoses|craniosynostoses
481747|NCT01094977|Tranexamic Acid|tranexamic acid
481748|NCT01094977|Children|children
481749|NCT01094964|recurrent bladder cancer|recurrent bladder cancer
481750|NCT01094964|stage 0 bladder cancer|stage 0 bladder cancer
481751|NCT01094964|stage I bladder cancer|stage i bladder cancer
481752|NCT01094964|adenocarcinoma of the bladder|adenocarcinoma of the bladder
481753|NCT01094964|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
481754|NCT01094951|Depression|depression
481755|NCT01094938|Aortic aneurysm repair|aortic aneurysm repair
481756|NCT01094925|Cesarean section|cesarean section
481757|NCT01094925|Gabapentin|gabapentin
481758|NCT01094912|Cancer pain|cancer pain
481759|NCT01094899|diabetes|diabetes
481760|NCT01094899|osteopenia|osteopenia
481761|NCT01094899|neuropathy|neuropathy
481762|NCT01094899|foot|foot
481763|NCT01094899|AGE|age
481764|NCT01094886|Total Hip Replacement|total hip replacement
481765|NCT01094886|Total Knee Replacement|total knee replacement
481766|NCT01094886|Hip Implant|hip implant
481767|NCT01094886|Knee Implant|knee implant
481768|NCT01094886|Joint Prosthesis|joint prosthesis
481769|NCT01094886|Orthopedic Surgery|orthopedic surgery
481770|NCT01094886|Rivaroxaban|rivaroxaban
481771|NCT01094886|Xarelto|xarelto
481772|NCT01094886|Blood Clot|blood clot
481773|NCT01094873|Hepatitis C|hepatitis c
481774|NCT01094873|HCV|hcv
481775|NCT01094873|Adenovirus|adenovirus
481776|NCT01094873|Vaccine|vaccine
481777|NCT01094860|Relapsed/Refractory Lymphoid Malignancies|relapsed/refractory lymphoid malignancies
481778|NCT01094860|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
481779|NCT01094860|CLL|cll
481780|NCT01094860|Small lymphocytic lymphoma|small lymphocytic lymphoma
481781|NCT01094860|SLL|sll
481782|NCT01094860|B-prolymphocytic leukemia|b-prolymphocytic leukemia
481783|NCT01094860|Follicular lymphoma|follicular lymphoma
481784|NCT01094860|Mantle cell lymphoma|mantle cell lymphoma
481785|NCT01094860|Lymphoplasmacytoid lymphoma|lymphoplasmacytoid lymphoma
481786|NCT01094860|Marginal zone lymphoma|marginal zone lymphoma
481787|NCT01094860|T-cell prolymphocytic leukemia|t-cell prolymphocytic leukemia
481788|NCT01094860|large granular lymphocyte leukemia|large granular lymphocyte leukemia
481789|NCT01094860|mycosis fungoides|mycosis fungoides
481790|NCT01094860|Sezary syndrome|sezary syndrome
481791|NCT01094860|peripheral T-cell lymphoma|peripheral t-cell lymphoma
481792|NCT01094860|Chemotherapy|chemotherapy
481793|NCT01094860|Monoclonal antibody therapy|monoclonal antibody therapy
481794|NCT01094860|T-cell or B-cell acute lymphoblastic leukemia (ALL)|t-cell or b-cell acute lymphoblastic leukemia (all)
481795|NCT01094860|Continuous Infusion Nelarabine|continuous infusion nelarabine
481796|NCT01094860|Arranon|arranon
481797|NCT01094821|Healthy volunteers|healthy volunteers
481798|NCT01094821|ATI-7505|ati-7505
481799|NCT01094821|Scintigraphy|scintigraphy
481800|NCT01094821|Gastrointestinal transit|gastrointestinal transit
481801|NCT01094808|pregabalin|pregabalin
481802|NCT01094808|motor|motor
481803|NCT01094808|sensation|sensation
481804|NCT01094808|colon|colon
481805|NCT01094808|pain|pain
481806|NCT01094808|gas|gas
481807|NCT01094782|Pain|pain
481808|NCT01094782|Pain management|pain management
481809|NCT01094756|Obesity|obesity
481813|NCT01094717|tazarotene|tazarotene
481814|NCT01094704|cystic fibrosis|cystic fibrosis
481815|NCT01094704|mucociliary clearance|mucociliary clearance
481816|NCT01094704|hypertonic saline|hypertonic saline
481817|NCT01094678|Peripheral Aterial Disease (PAD)|peripheral aterial disease (pad)
481818|NCT01094678|Peripheral Vascular Disease|peripheral vascular disease
481819|NCT01094678|Drug-Eluting Stent|drug-eluting stent
481820|NCT01094678|Drug-Coated Stent|drug-coated stent
481821|NCT01094678|Vascular Diseases|vascular diseases
481822|NCT01094678|Cardiovascular Diseases|cardiovascular diseases
481823|NCT01094652|Adolescent|adolescent
481824|NCT01094652|Whole grain|whole grain
481825|NCT01094652|Digestive health|digestive health
481826|NCT01094652|Dietary fiber|dietary fiber
481827|NCT01094652|Grain|grain
481828|NCT01094652|Microbiota|microbiota
481829|NCT01094652|Inflammation|inflammation
481830|NCT01094652|Mucosal Immunity|mucosal immunity
481831|NCT01094626|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
481832|NCT01094626|Intraductal papillary mucinous neoplasm|intraductal papillary mucinous neoplasm
481833|NCT01094626|Imaging techniques|imaging techniques
481834|NCT01094626|Pancreatic surgical resection|pancreatic surgical resection
481835|NCT01094626|Synthetic human secretin|synthetic human secretin
481836|NCT01094613|Crohn's Disease|crohn's disease
481837|NCT01094613|Delayed Release|delayed release
481838|NCT01094613|Targeted Ileal Delivery|targeted ileal delivery
481839|NCT01094600|Pancreatic cancer|pancreatic cancer
481840|NCT01094600|Pancreatic resection|pancreatic resection
481841|NCT01094600|Synthetic human secretin|synthetic human secretin
481842|NCT01094600|Secretin-enhanced MRCP|secretin-enhanced mrcp
481843|NCT01094600|Endoscopic pancreatic function test|endoscopic pancreatic function test
481844|NCT01094600|Pancreatic exocrine insufficiency|pancreatic exocrine insufficiency
481845|NCT01094561|Family history of pancreatic cancer|family history of pancreatic cancer
481846|NCT01094561|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
481847|NCT01094561|Imaging techniques|imaging techniques
481848|NCT01094561|Synthetic human secretin|synthetic human secretin
481849|NCT01094561|Pancreatic abnormalities|pancreatic abnormalities
481850|NCT01094561|Early detection and prevention|early detection and prevention
481851|NCT01094548|L-BLP25 liposome|l-blp25 liposome
481852|NCT01094548|Multiple myeloma|multiple myeloma
481853|NCT01094535|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
481854|NCT01094535|Synthetic human secretin|synthetic human secretin
481855|NCT01094535|Secretin-enhanced MRCP|secretin-enhanced mrcp
481856|NCT01094535|Pancreatic insufficiency|pancreatic insufficiency
481857|NCT01094535|Endoscopic Pancreatic Function Test (ePFT)|endoscopic pancreatic function test (epft)
481858|NCT01094535|Endocrine pancreatic function test|endocrine pancreatic function test
481859|NCT01094535|Exocrine pancreatic function test|exocrine pancreatic function test
481860|NCT01094496|bladder cancer|bladder cancer
481861|NCT01094496|immunotherapy|immunotherapy
481862|NCT01094496|cystectomy|cystectomy
481863|NCT01094496|cancer vaccine|cancer vaccine
481864|NCT01094496|human chorionic gonadotropin|human chorionic gonadotropin
481865|NCT01094496|hCG|hcg
481866|NCT01094496|urogenital neoplasms|urogenital neoplasms
481867|NCT01094496|urinary bladder neoplasms|urinary bladder neoplasms
481868|NCT01094496|muscle invasive|muscle invasive
481869|NCT01094496|non-metastatic|non-metastatic
481870|NCT01094496|transitional cell (urothelial) bladder cancer|transitional cell (urothelial) bladder cancer
481871|NCT01094483|Thromboxane B2|thromboxane b2
481872|NCT01094470|gait|gait
481873|NCT01094470|ambulation|ambulation
481874|NCT01094470|kinematics|kinematics
481875|NCT01094457|antiplatelet therapy|antiplatelet therapy
481876|NCT01094457|clopidogrel low responsiveness|clopidogrel low responsiveness
481877|NCT01094457|acute coronary syndromes|acute coronary syndromes
481878|NCT01094457|percutaneous coronary intervention|percutaneous coronary intervention
481879|NCT01094457|cilostazol|cilostazol
481880|NCT01094444|Vitamin K3 lotion|vitamin k3 lotion
481881|NCT01094444|Cetuximab induced folliculitis|cetuximab induced folliculitis
481882|NCT01094431|Fever|fever
481883|NCT01094431|Etiology|etiology
481884|NCT01094431|Children under five years of age|children under five years of age
481885|NCT01094431|IMCI|imci
481886|NCT01094418|polyneuropathy|polyneuropathy
481887|NCT01094418|Nerve conduction study|nerve conduction study
481888|NCT01094418|Impaired glucose tolerance test|impaired glucose tolerance test
481889|NCT01094418|Diabetes mellitus|diabetes mellitus
481890|NCT01094405|NPC with persistent, recurrent or metastatic disease patients|npc with persistent, recurrent or metastatic disease patients
481891|NCT01094392|ALL|all
481892|NCT01094392|PEG-asparaginase|peg-asparaginase
481893|NCT01094392|prolonged treatment|prolonged treatment
481894|NCT01094392|Thrombosis|thrombosis
481895|NCT01094392|Central venous line|central venous line
481896|NCT01094392|Echocardiography|echocardiography
481897|NCT01094379|cholecystectomy|cholecystectomy
481898|NCT01094379|laparoscopic|laparoscopic
481899|NCT01094379|pain|pain
481900|NCT01094379|single incision|single incision
481901|NCT01094366|Paracervical Block|paracervical block
481902|NCT01094366|pain control|pain control
481903|NCT01094366|abortion|abortion
482002|NCT01093937|Nicotinic receptor|nicotinic receptor
481904|NCT01094353|Urodynamic Stress urinary incontinence|urodynamic stress urinary incontinence
481905|NCT01094353|Minisling|minisling
481906|NCT01094353|Ophira™|ophira™
481907|NCT01094353|Unitape™|unitape™
481908|NCT01094327|focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
481909|NCT01094301|electrical stimulation|electrical stimulation
481910|NCT01094301|neurostimulation|neurostimulation
481911|NCT01094301|neuromodulation|neuromodulation
481912|NCT01094301|shoulder pain|shoulder pain
481913|NCT01094301|post-stroke shoulder pain|post-stroke shoulder pain
481914|NCT01094301|hemiplegic shoulder pain|hemiplegic shoulder pain
481915|NCT01094275|drug resistance|drug resistance
481916|NCT01094275|gene polymorphism|gene polymorphism
481917|NCT01094262|Osteoarthritis pain of the knee|osteoarthritis pain of the knee
481918|NCT01094262|Osteoarthritis|osteoarthritis
481919|NCT01094262|Osteoarthritis, Knee|osteoarthritis, knee
481920|NCT01094262|Pain|pain
481921|NCT01094262|Arthralgia|arthralgia
481922|NCT01094262|Joint Pain|joint pain
481923|NCT01094262|JNJ-42160443|jnj-42160443
481924|NCT01094249|Paliperidone ER|paliperidone er
481925|NCT01094249|INVEGA|invega
481926|NCT01094249|Divalproex sodium|divalproex sodium
481927|NCT01094249|Depakote ER|depakote er
481928|NCT01094249|Valproic acid|valproic acid
481929|NCT01094249|Pharmacokinetics|pharmacokinetics
481930|NCT01094249|R076477BIM1004|r076477bim1004
481931|NCT01094236|behavior management|behavior management
481932|NCT01094236|academic performance|academic performance
481933|NCT01094236|playground supervision|playground supervision
481934|NCT01094236|harm reduction|harm reduction
481935|NCT01094236|Behavioral Research|behavioral research
481936|NCT01094223|Stimulant|stimulant
481937|NCT01094223|Addiction|addiction
481938|NCT01094223|Mindfulness|mindfulness
481939|NCT01094223|Treatment|treatment
481940|NCT01094210|Anti-erosion dental benefits|anti-erosion dental benefits
481941|NCT01094197|Transfusion-associated microchimerism|transfusion-associated microchimerism
481942|NCT01094197|Injuries|injuries
481943|NCT01094197|Leukocytes|leukocytes
481944|NCT01094171|poliomyelitis|poliomyelitis
481945|NCT01094171|diphtheria|diphtheria
481946|NCT01094171|Primary immunization|primary immunization
481947|NCT01094171|pertussis|pertussis
481948|NCT01094171|Children|children
481949|NCT01094171|tetanus|tetanus
481950|NCT01094158|NAFLD|nafld
481951|NCT01094158|NASH|nash
481952|NCT01094158|Fatty Liver|fatty liver
481953|NCT01094158|Metabolic Syndrome|metabolic syndrome
481954|NCT01094158|Endothelial Dysfunction|endothelial dysfunction
481955|NCT01094158|Insulin Resistance|insulin resistance
481956|NCT01094158|Liver Fat|liver fat
481957|NCT01094145|(light to moderate)|(light to moderate)
481958|NCT01094132|cervical cancer|cervical cancer
481959|NCT01094132|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
481960|NCT01094132|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
481961|NCT01094132|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
481963|NCT01094119|heated blanket|heated blanket
481964|NCT01094119|heated pad|heated pad
481965|NCT01094106|postoperative pain|postoperative pain
481966|NCT01094106|infiltration analgesia|infiltration analgesia
481967|NCT01094106|ropivacaine|ropivacaine
481968|NCT01094106|Caesarean Section|caesarean section
481969|NCT01094093|Amgen|amgen
481970|NCT01094093|AMG 139|amg 139
481971|NCT01094080|fully formula fed|fully formula fed
481972|NCT01094080|fully breast fed|fully breast fed
481973|NCT01094041|Gluten|gluten
481974|NCT01094041|Diarrhea or diarrhea predominant irritable bowel syndrome|diarrhea or diarrhea predominant irritable bowel syndrome
481975|NCT01094041|Colonic permeability|colonic permeability
481976|NCT01094041|Small bowel permeability|small bowel permeability
481977|NCT01094041|Colonic inflammatory response|colonic inflammatory response
481978|NCT01094041|Small bowel inflammatory response|small bowel inflammatory response
481979|NCT01094028|Blood loss in the third and fourth stage of labor and the duration of third stage of labor|blood loss in the third and fourth stage of labor and the duration of third stage of labor
481980|NCT01094015|hysteroscopy|hysteroscopy
481981|NCT01094015|local anaesthetic|local anaesthetic
481982|NCT01094015|pain relief|pain relief
481983|NCT01094015|gynecological pathology|gynecological pathology
481984|NCT01094002|OCCUPATIONAL THERAPY|occupational therapy
481985|NCT01094002|RANDOMISED CLINICAL TRIAL|randomised clinical trial
481986|NCT01094002|AGED|aged
481987|NCT01094002|PATIENT CARE|patient care
481988|NCT01093976|Skin Picking|skin picking
481989|NCT01093976|OCD|ocd
481990|NCT01093976|Trichotillomania|trichotillomania
481991|NCT01093976|Pathological Skin Picking|pathological skin picking
481992|NCT01093950|anthropometric|anthropometric
481993|NCT01093950|white light scanner|white light scanner
481994|NCT01093950|extraction profiles|extraction profiles
481995|NCT01093950|Body lipodystrophy|body lipodystrophy
481996|NCT01093937|Bipolar disorder|bipolar disorder
481997|NCT01093937|Bipolar-I|bipolar-i
481998|NCT01093937|Varenicline|varenicline
481999|NCT01093937|Champix|champix
482000|NCT01093937|Chantix|chantix
482001|NCT01093937|Nicotine|nicotine
482291|NCT01092806|tacrolimus|tacrolimus
482003|NCT01093937|Nicotinic receptor dysregulation|nicotinic receptor dysregulation
482004|NCT01093937|Dopamine|dopamine
482005|NCT01093937|Acetylcholine|acetylcholine
482006|NCT01093937|Cigarette|cigarette
482007|NCT01093937|Smoking|smoking
482008|NCT01093937|Tobacco|tobacco
482009|NCT01093937|Dependence|dependence
482010|NCT01093937|Neuropsychological function|neuropsychological function
482011|NCT01093924|Behavioral weight loss maintenance intervention|behavioral weight loss maintenance intervention
482012|NCT01093924|Weight loss|weight loss
482013|NCT01093924|Weight loss maintenance|weight loss maintenance
482014|NCT01093911|Lupus|lupus
482015|NCT01093911|SLE|sle
482016|NCT01093859|acetylcholinesterase|acetylcholinesterase
482017|NCT01093846|uveitis|uveitis
482018|NCT01093833|Diabetes|diabetes
482019|NCT01093833|Type 1 diabetes|type 1 diabetes
482020|NCT01093833|Type 2 diabetes|type 2 diabetes
482021|NCT01093833|Diabetes mellitus|diabetes mellitus
482022|NCT01093833|Blood glucose|blood glucose
482023|NCT01093833|Continuous blood glucose monitoring|continuous blood glucose monitoring
482024|NCT01093833|CGM|cgm
482025|NCT01093820|acute myocardial infarction|acute myocardial infarction
482026|NCT01093820|continuous erythropoetin receptor activator|continuous erythropoetin receptor activator
482027|NCT01093820|Mircera|mircera
482028|NCT01093820|hemoglobin kinetics|hemoglobin kinetics
482029|NCT01093807|Hypertension|hypertension
482030|NCT01093807|Lercanidipine|lercanidipine
482031|NCT01093807|Calcium antagonist|calcium antagonist
482032|NCT01093807|Enalapril|enalapril
482033|NCT01093794|Type 2 Diabetes|type 2 diabetes
482034|NCT01093781|membranous nephropathy aliskiren proteinuria, glomerulonephritis|membranous nephropathy aliskiren proteinuria, glomerulonephritis
482035|NCT01093768|Oxytocin|oxytocin
482036|NCT01093768|Vasopressin|vasopressin
482037|NCT01093768|Autism|autism
482038|NCT01093768|Amygdala|amygdala
482039|NCT01093768|Social Cognition|social cognition
482040|NCT01093768|Autism Spectrum Disorders|autism spectrum disorders
482041|NCT01093768|ASD|asd
482042|NCT01093768|Healthy Volunteer|healthy volunteer
482043|NCT01093768|HV|hv
482044|NCT01093755|Barrett's Esophagus|barrett's esophagus
482045|NCT01093755|Radiofrequency ablation|radiofrequency ablation
482046|NCT01093755|Patients post-radiofrequency ablation for Barrett's Esophagus.|patients post-radiofrequency ablation for barrett's esophagus.
482047|NCT01093742|Healthy|healthy
482048|NCT01093729|Exendin-4|exendin-4
482049|NCT01093716|Alcohol dependence|alcohol dependence
482050|NCT01093716|Craving|craving
482051|NCT01093716|rTMS|rtms
482052|NCT01093716|Dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
482053|NCT01093703|kidney transplantation|kidney transplantation
482054|NCT01093703|hypertension|hypertension
482055|NCT01093703|chronotherapy|chronotherapy
482056|NCT01093703|graft function|graft function
482057|NCT01093703|circadian pattern|circadian pattern
482058|NCT01093690|chemotherapy induced nausea and vomiting, metoclopramide|chemotherapy induced nausea and vomiting, metoclopramide
482059|NCT01093612|HER2-positive breast cancer|her2-positive breast cancer
482060|NCT01093599|Smoking|smoking
482061|NCT01093599|Smoking cessation|smoking cessation
482062|NCT01093599|Nicotine|nicotine
482063|NCT01093599|Tobacco|tobacco
482064|NCT01093599|Mindfulness|mindfulness
482065|NCT01093599|Meditation|meditation
482066|NCT01093599|MBSR|mbsr
482067|NCT01093599|Mindfulness Training|mindfulness training
482068|NCT01093599|Behavioral Intervention|behavioral intervention
482069|NCT01093599|Nicotine Patch|nicotine patch
482070|NCT01093599|Quit Line|quit line
482071|NCT01093599|Phone counseling|phone counseling
482072|NCT01093573|Untreated myelodysplastic syndromes|untreated myelodysplastic syndromes
482073|NCT01093560|metabolic syndrome|metabolic syndrome
482074|NCT01093560|premenopausal women|premenopausal women
482075|NCT01093560|fat feeding|fat feeding
482076|NCT01093534|Vesicare|vesicare
482077|NCT01093534|Solifenacin|solifenacin
482078|NCT01093534|Detrusor Overactivity|detrusor overactivity
482079|NCT01093534|Urinary Nerve Growth Factor|urinary nerve growth factor
482080|NCT01093534|Overactive Bladder|overactive bladder
482081|NCT01093534|Bladder wall thickness|bladder wall thickness
482082|NCT01093521|IV Gallium|iv gallium
482083|NCT01093521|Gallium|gallium
482084|NCT01093521|Ganite|ganite
482085|NCT01093521|Cystic Fibrosis|cystic fibrosis
482086|NCT01093521|Gallium Infusion|gallium infusion
482087|NCT01093495|Nasal Continuous positive Airway pressure|nasal continuous positive airway pressure
482088|NCT01093495|Nasal Cannula|nasal cannula
482090|NCT01093495|Premature|premature
482091|NCT01093495|RDS|rds
482092|NCT01093495|HMD|hmd
482093|NCT01093495|NICU|nicu
482094|NCT01093482|mechanical ventilation|mechanical ventilation
482095|NCT01093482|epidemiology|epidemiology
482096|NCT01093482|outcomes|outcomes
482097|NCT01093482|mortality|mortality
482098|NCT01093482|weaning|weaning
482099|NCT01093482|sedation|sedation
482100|NCT01093482|non-invasive positive pressure ventilation|non-invasive positive pressure ventilation
482101|NCT01093469|Atopic Dermatitis|atopic dermatitis
482102|NCT01093469|Wake Forest|wake forest
482103|NCT01093469|Dermatology|dermatology
482104|NCT01093469|Skin|skin
482105|NCT01093469|Over-the-counter|over-the-counter
482106|NCT01093469|Moisturizer|moisturizer
482107|NCT01093469|Children|children
482108|NCT01093456|diurnal variation|diurnal variation
482109|NCT01093456|peritoneal dialysis|peritoneal dialysis
482110|NCT01093456|uremic retention solutes|uremic retention solutes
482111|NCT01093456|phosphorous|phosphorous
482112|NCT01093456|indoxyl sulfate|indoxyl sulfate
482113|NCT01093456|p-cresol sulfate|p-cresol sulfate
482114|NCT01093443|IVF|ivf
482115|NCT01093443|ICSI|icsi
482116|NCT01093443|GnRH antagonist|gnrh antagonist
482117|NCT01093443|pretreatment|pretreatment
482118|NCT01093430|Gynecological surgery|gynecological surgery
482119|NCT01093430|laparoscopic ports|laparoscopic ports
482120|NCT01093430|neuropathy|neuropathy
482121|NCT01093417|Vitamin D|vitamin d
482122|NCT01093417|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
482123|NCT01093417|Complementary Therapies|complementary therapies
482124|NCT01093404|Heart disease|heart disease
482125|NCT01093404|Myocardial infarction|myocardial infarction
482126|NCT01093404|Angioplasty|angioplasty
482127|NCT01093404|Thrombus aspiration|thrombus aspiration
482128|NCT01093391|coronary artery|coronary artery
482129|NCT01093391|thrombosis|thrombosis
482130|NCT01093391|stent|stent
482131|NCT01093378|Infertility|infertility
482132|NCT01093378|Obesity|obesity
482133|NCT01093378|Dietary intake|dietary intake
482134|NCT01093378|Fertility|fertility
482135|NCT01093378|nutrition|nutrition
482136|NCT01093378|diet|diet
482137|NCT01093378|weight|weight
482138|NCT01093365|Schizophrenia|schizophrenia
482139|NCT01093365|Schizoaffective Disorder|schizoaffective disorder
482140|NCT01093365|Varenicline|varenicline
482141|NCT01093365|Champix|champix
482142|NCT01093365|Chantix|chantix
482143|NCT01093365|Nicotine|nicotine
482144|NCT01093365|Nicotinic receptor|nicotinic receptor
482145|NCT01093365|Dopamine|dopamine
482146|NCT01093365|Acetylcholine|acetylcholine
482147|NCT01093365|Cigarette|cigarette
482148|NCT01093365|Smoking|smoking
482149|NCT01093365|Tobacco|tobacco
482150|NCT01093365|Executive function|executive function
482151|NCT01093365|Working memory|working memory
482152|NCT01093365|Verbal memory|verbal memory
482153|NCT01093365|Cognitive function|cognitive function
482154|NCT01093365|Neuropsychological function|neuropsychological function
482155|NCT01093352|Alveolar-decortication|alveolar-decortication
482156|NCT01093352|Corticotomy assisted orthodontics|corticotomy assisted orthodontics
482157|NCT01093352|Palatally impacted canine|palatally impacted canine
482158|NCT01093352|Surgical exposure of canines|surgical exposure of canines
482159|NCT01093352|Velocity of tooth movement|velocity of tooth movement
482160|NCT01093339|GERD|gerd
482161|NCT01093339|SLEEP DEPRIVATION|sleep deprivation
482162|NCT01093339|APPETITE REGULATION|appetite regulation
482163|NCT01093339|GHRELIN|ghrelin
482164|NCT01093339|LEPTIN|leptin
482165|NCT01093274|colonoscopy|colonoscopy
482166|NCT01093274|Cathartics|cathartics
482167|NCT01093274|Sodium picosulfate|sodium picosulfate
482168|NCT01093274|Polyethylene Glycol|polyethylene glycol
482169|NCT01093261|trauma|trauma
482170|NCT01093261|trauma brain injury|trauma brain injury
482171|NCT01093261|multiple trauma|multiple trauma
482172|NCT01093261|head trauma|head trauma
482173|NCT01093261|hydrocortisone|hydrocortisone
482174|NCT01093261|fludrocortisone|fludrocortisone
482175|NCT01093261|glucocorticoid insufficiency related to ICU|glucocorticoid insufficiency related to icu
482176|NCT01093261|adrenal Insufficiency|adrenal insufficiency
482177|NCT01093261|pneumonia|pneumonia
482178|NCT01093261|intensive care unit|intensive care unit
482179|NCT01093261|shock|shock
482180|NCT01093261|neurological recovery|neurological recovery
482181|NCT01093235|cardiac toxicity|cardiac toxicity
482182|NCT01093235|perioperative/postoperative complications|perioperative/postoperative complications
482183|NCT01093235|HER2-negative breast cancer|her2-negative breast cancer
482184|NCT01093235|male breast cancer|male breast cancer
482185|NCT01093235|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
482186|NCT01093235|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
482187|NCT01093235|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
482188|NCT01093235|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
482189|NCT01093235|stage II breast cancer|stage ii breast cancer
482190|NCT01093235|stage IIIA breast cancer|stage iiia breast cancer
482191|NCT01093235|stage IIIB breast cancer|stage iiib breast cancer
482192|NCT01093235|inflammatory breast cancer|inflammatory breast cancer
482193|NCT01093209|Carpal Tunnel Syndrome|carpal tunnel syndrome
482194|NCT01093209|Interferential laser therapy|interferential laser therapy
482195|NCT01093209|Low-level laser therapy|low-level laser therapy
482196|NCT01093209|Neuropathic pain|neuropathic pain
482197|NCT01093209|Median nerve compression|median nerve compression
482198|NCT01093196|Multiple Myeloma|multiple myeloma
482199|NCT01093196|Elderly Patients|elderly patients
482200|NCT01093196|Diagnosis|diagnosis
482201|NCT01093196|Lenalidomide|lenalidomide
482202|NCT01093196|Prednisone|prednisone
482203|NCT01093196|Melphalan|melphalan
482204|NCT01093196|Dexamethasone|dexamethasone
482205|NCT01093196|Cyclophosphamide|cyclophosphamide
482206|NCT01093157|Kidney disease, Glomerulonephritis|kidney disease, glomerulonephritis
482207|NCT01093144|Delivery mode|delivery mode
482208|NCT01093144|pelvic measurement|pelvic measurement
482209|NCT01093131|Contrast induced nephropathy|contrast induced nephropathy
482210|NCT01093131|Percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
482211|NCT01093131|chronic kidney disease|chronic kidney disease
482212|NCT01093131|Prevention|prevention
482213|NCT01093131|Equivalence|equivalence
482214|NCT01093118|Distal subungual onychomycosis|distal subungual onychomycosis
482215|NCT01093105|Leukodystrophy, Globoid Cell|leukodystrophy, globoid cell
482216|NCT01093105|Classic Globoid Cell Leukodystrophy|classic globoid cell leukodystrophy
482217|NCT01093105|Early-Onset Globoid Cell Leukodystrophy|early-onset globoid cell leukodystrophy
482218|NCT01093105|Globoid Cell Leukodystrophy|globoid cell leukodystrophy
482219|NCT01093105|Globoid Cell Leukoencephalopathy|globoid cell leukoencephalopathy
482220|NCT01093105|Infantile Globoid Cell Leukodystrophy|infantile globoid cell leukodystrophy
482221|NCT01093105|Late-Onset Globoid Cell Leukodystrophy|late-onset globoid cell leukodystrophy
482222|NCT01093105|Leukodystrophy, Globoid Cell, Classic|leukodystrophy, globoid cell, classic
482223|NCT01093105|Leukodystrophy, Globoid Cell, Early-Onset|leukodystrophy, globoid cell, early-onset
482224|NCT01093105|Leukodystrophy, Globoid Cell, Infantile|leukodystrophy, globoid cell, infantile
482225|NCT01093105|Leukodystrophy, Globoid Cell, Late-Onset|leukodystrophy, globoid cell, late-onset
482226|NCT01093105|Psychosine|psychosine
482227|NCT01093105|galactosylsphingosine (psychosine) beta-galactosidase|galactosylsphingosine (psychosine) beta-galactosidase
482228|NCT01093105|Psychosine-UDP galactosyltransferase|psychosine-udp galactosyltransferase
482229|NCT01093105|Krabbe Disease|krabbe disease
482230|NCT01093105|Krabbe Leukodystrophy|krabbe leukodystrophy
482231|NCT01093105|Krabbe's Disease|krabbe's disease
482232|NCT01093105|Krabbe's Leukodystrophy|krabbe's leukodystrophy
482233|NCT01093079|Renal tumor, RCC, Partial nephrectomy, Laparoscopy|renal tumor, rcc, partial nephrectomy, laparoscopy
482234|NCT01093066|urothelial carcinoma|urothelial carcinoma
482235|NCT01093066|TURB|turb
482236|NCT01093066|chemotherapy|chemotherapy
482237|NCT01093053|Mind-Body Therapies|mind-body therapies
482238|NCT01093027|Essential Tremor|essential tremor
482239|NCT01093027|Cooling|cooling
482240|NCT01093027|Temperature|temperature
482241|NCT01093027|Patients with Essential Tremor involving the upper limbs with at least moderate tremor.|patients with essential tremor involving the upper limbs with at least moderate tremor.
482242|NCT01093014|Quadriceps Muscle|quadriceps muscle
482243|NCT01093014|RNA, Messenger|rna, messenger
482244|NCT01093014|Hypertrophy|hypertrophy
482245|NCT01093014|Electric Stimulation Therapy|electric stimulation therapy
482246|NCT01093001|Reduce Tricuspid Regurgitation|reduce tricuspid regurgitation
482247|NCT01093001|Reduce Right Ventricular pacing|reduce right ventricular pacing
482248|NCT01093001|Lead position|lead position
482249|NCT01093001|Lead size|lead size
482250|NCT01092988|Uterine Fibroids|uterine fibroids
482251|NCT01092988|Bleeding|bleeding
482252|NCT01092988|Pain|pain
482253|NCT01092988|Quality of life|quality of life
482254|NCT01092988|MR guided focused ultrasound|mr guided focused ultrasound
482255|NCT01092975|radiotherapy|radiotherapy
482256|NCT01092962|Children|children
482257|NCT01092962|Mycophenolate mofetil|mycophenolate mofetil
482258|NCT01092962|Cyclophosphamide|cyclophosphamide
482259|NCT01092962|Idiopathic nephrotic steroid sensitive syndrome|idiopathic nephrotic steroid sensitive syndrome
482260|NCT01092949|Placenta|placenta
482261|NCT01092949|perfusion|perfusion
482263|NCT01092949|spin tagging|spin tagging
482264|NCT01092949|Gadolinium|gadolinium
482265|NCT01092949|placental insufficiency|placental insufficiency
482266|NCT01092949|urinary tract, sexual organs and pregnancy conditions|urinary tract, sexual organs and pregnancy conditions
482267|NCT01092936|Comparative fit index|comparative fit index
482268|NCT01092936|Movement Disorders' Society|movement disorders' society
482269|NCT01092936|Unified Parkinson's Disease Rating Scale|unified parkinson's disease rating scale
482270|NCT01092923|Nitrous Oxide|nitrous oxide
482271|NCT01092923|washin|washin
482272|NCT01092923|washout|washout
482273|NCT01092923|second gas effect|second gas effect
482274|NCT01092923|sevoflurane|sevoflurane
482275|NCT01092923|induction|induction
482276|NCT01092923|emergence|emergence
482277|NCT01092910|Sensorineural|sensorineural
482278|NCT01092910|Hearing Loss|hearing loss
482279|NCT01092884|melasma|melasma
482280|NCT01092884|sunscreen|sunscreen
482281|NCT01092884|polypodium leucotomos|polypodium leucotomos
482282|NCT01092858|Testosterone undecanoate|testosterone undecanoate
482283|NCT01092858|Hypogonadism|hypogonadism
482284|NCT01092845|Double-Blind|double-blind
482285|NCT01092845|Randomized|randomized
482286|NCT01092845|Placebo-Controlled|placebo-controlled
482287|NCT01092845|2-Way Crossover|2-way crossover
482288|NCT01092845|Polysomnographic Endpoints|polysomnographic endpoints
482289|NCT01092832|Invasive Candidiasis Candidemia Esophageal Candidiasis|invasive candidiasis candidemia esophageal candidiasis
482290|NCT01092819|acute ischemic stroke, large vessel occlusion, natural history, functional outcome|acute ischemic stroke, large vessel occlusion, natural history, functional outcome
482292|NCT01092806|pharmacokinetics|pharmacokinetics
482293|NCT01092806|formulations|formulations
482294|NCT01092806|once daily|once daily
482295|NCT01092806|twice daily|twice daily
482296|NCT01092806|renal transplant recipients|renal transplant recipients
482297|NCT01092806|Kidney transplantation|kidney transplantation
482298|NCT01092793|Fish oil|fish oil
482299|NCT01092793|Krill|krill
482300|NCT01092793|CAD|cad
482301|NCT01092767|Thoracic Aneurysm|thoracic aneurysm
482302|NCT01092767|Thoracic Transection|thoracic transection
482303|NCT01092767|Endovascular Aortic Repair|endovascular aortic repair
482304|NCT01092754|brain, spine, liver, MRI, Pediatric|brain, spine, liver, mri, pediatric
482305|NCT01092741|Leukemia|leukemia
482306|NCT01092741|Gleevec|gleevec
482307|NCT01092741|STI571|sti571
482308|NCT01092741|CML|cml
482309|NCT01092741|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
482310|NCT01092728|Acral lentiginous melanoma|acral lentiginous melanoma
482311|NCT01092728|Mucosal melanoma|mucosal melanoma
482312|NCT01092728|Chronic sun-damaged melanoma|chronic sun-damaged melanoma
482313|NCT01092728|Surgically removed tumor|surgically removed tumor
482314|NCT01092728|biopsied|biopsied
482315|NCT01092728|Sprycel|sprycel
482316|NCT01092728|Dasatinib|dasatinib
482317|NCT01092715|Neck pain|neck pain
482318|NCT01092715|Spinal manipulation|spinal manipulation
482319|NCT01092715|Massage|massage
482320|NCT01092702|Tobacco Dependence|tobacco dependence
482321|NCT01092702|Smoking|smoking
482322|NCT01092702|Tobacco Cessation|tobacco cessation
482323|NCT01092689|heterocyclic amines|heterocyclic amines
482324|NCT01092689|PhIP|phip
482325|NCT01092689|Meat|meat
482326|NCT01092689|pancreas neoplasms|pancreas neoplasms
482327|NCT01092676|Pediatrics|pediatrics
482328|NCT01092676|Emergency|emergency
482329|NCT01092663|Colesevelam|colesevelam
482330|NCT01092663|type 2 diabetes|type 2 diabetes
482331|NCT01092663|sitagliptin|sitagliptin
482332|NCT01092663|glucose metabolism|glucose metabolism
482333|NCT01092650|Tobacco toxicants|tobacco toxicants
482334|NCT01092650|Polycyclic aromatic hydrocarbons|polycyclic aromatic hydrocarbons
482335|NCT01092650|Smoking|smoking
482336|NCT01092624|voiding dysfunction|voiding dysfunction
482337|NCT01092624|defecatory dysfunction|defecatory dysfunction
482338|NCT01092624|vaginal bulge symptoms|vaginal bulge symptoms
482339|NCT01092611|long-term follow-up study|long-term follow-up study
482340|NCT01092611|HIV-infected subjects|hiv-infected subjects
482341|NCT01092611|HIV therapeutic vaccine|hiv therapeutic vaccine
482342|NCT01092572|cystic fibrosis|cystic fibrosis
482343|NCT01092572|adult cystic fibrosis|adult cystic fibrosis
482344|NCT01092559|Diagnostic Techniques and Procedures|diagnostic techniques and procedures
482345|NCT01092546|Amyloid|amyloid
482346|NCT01092546|Normal pressure hydrocephalus (NPH)|normal pressure hydrocephalus (nph)
482347|NCT01092546|Positron Emission Tomography (PET)|positron emission tomography (pet)
482348|NCT01092546|Standard uptake value ratios (SUVR)|standard uptake value ratios (suvr)
482349|NCT01092520|Gabapentin|gabapentin
482350|NCT01092520|Burn Injuries in Children|burn injuries in children
482351|NCT01092520|pruritus|pruritus
482352|NCT01092507|Encephalitis|encephalitis
482353|NCT01092507|Japanese Encephalitis|japanese encephalitis
482354|NCT01092507|Japanese Encephalitis Vaccines|japanese encephalitis vaccines
482355|NCT01092507|Infant|infant
482356|NCT01092494|Endometrioma recurrence|endometrioma recurrence
482357|NCT01092494|oral contraceptives|oral contraceptives
482358|NCT01092494|gonadotropin-releasing hormone agonist|gonadotropin-releasing hormone agonist
482359|NCT01092481|Adjuvant FOLFOX or CAPOX Therapy|adjuvant folfox or capox therapy
482360|NCT01092481|Stage II/III Colon Cancer|stage ii/iii colon cancer
482361|NCT01092481|Adjuvant Therapy|adjuvant therapy
482362|NCT01092468|cancer|cancer
482363|NCT01092468|reconstruction|reconstruction
482364|NCT01092468|free flap|free flap
482365|NCT01092468|surgery|surgery
482366|NCT01092455|End Stage Renal Disease|end stage renal disease
482367|NCT01092455|Renal Dialysis|renal dialysis
482368|NCT01092455|Hemodialysis therapy|hemodialysis therapy
482369|NCT01092455|Heparin|heparin
482370|NCT01092455|Citrasate|citrasate
482371|NCT01092455|Anticoagulant|anticoagulant
482372|NCT01092442|Pulmonary Valve|pulmonary valve
482373|NCT01092442|Right Ventricular Outflow Tract Reconstruction|right ventricular outflow tract reconstruction
482374|NCT01092442|Ross Procedure|ross procedure
482375|NCT01092429|CAD|cad
482376|NCT01092416|CAD|cad
482377|NCT01092416|Severely calcified lesion|severely calcified lesion
482378|NCT01092390|randomized trial|randomized trial
482379|NCT01092390|omega three fatty acids|omega three fatty acids
482380|NCT01092364|Young adults|young adults
482381|NCT01092351|urinary tract infection|urinary tract infection
482382|NCT01092351|nitrofurantoin|nitrofurantoin
482383|NCT01092338|Human Immunodeficiency Virus|human immunodeficiency virus
482384|NCT01092338|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
482385|NCT01092338|Vitamin D|vitamin d
482386|NCT01092338|HIV|hiv
482387|NCT01092338|Complementary therapies|complementary therapies
482388|NCT01092325|Heart Failure|heart failure
482389|NCT01092312|knee|knee
482390|NCT01092312|arthroplasty|arthroplasty
482391|NCT01092299|Phase I|phase i
482392|NCT01092299|Relative bioavailability|relative bioavailability
482393|NCT01092299|Pharmacokinetic study|pharmacokinetic study
482394|NCT01092299|AZD1446|azd1446
482395|NCT01092299|healthy volunteers|healthy volunteers
482396|NCT01092286|Knee injury|knee injury
482397|NCT01092286|ankle sprain|ankle sprain
482398|NCT01092286|anterior cruciate ligament|anterior cruciate ligament
482399|NCT01092286|adolescent|adolescent
482400|NCT01092286|soccer|soccer
482401|NCT01092286|basketball|basketball
482402|NCT01092286|prevention|prevention
482403|NCT01092273|Glaucoma and Ocular Hypertension|glaucoma and ocular hypertension
482404|NCT01092260|Glomerular Filtration Rate|glomerular filtration rate
482405|NCT01092260|Kidney disease|kidney disease
482406|NCT01092260|Child|child
482407|NCT01092260|Iohexol|iohexol
482408|NCT01092260|Cystatin C|cystatin c
482409|NCT01092260|Measurement of kidney function in children|measurement of kidney function in children
482410|NCT01092247|Patients with malignant tumors|patients with malignant tumors
482411|NCT01092234|Observational units|observational units
482412|NCT01092234|Length of stay (LOS)|length of stay (los)
482413|NCT01092234|Readmission|readmission
482414|NCT01092221|mania, allopurinol, add-on treatment|mania, allopurinol, add-on treatment
482415|NCT01092208|Autism|autism
482416|NCT01092208|iPS Cells|ips cells
482417|NCT01092208|Fibroblasts|fibroblasts
482418|NCT01092208|Gene Networks|gene networks
482419|NCT01092208|Tuberous Sclerosis|tuberous sclerosis
482420|NCT01092208|Healthy Volunteer|healthy volunteer
482421|NCT01092208|HV|hv
482422|NCT01092195|Women's Health|women's health
482423|NCT01092195|Genital Precancer|genital precancer
482424|NCT01092195|Stem Cell Donor|stem cell donor
482425|NCT01092195|Cervical Cytology|cervical cytology
482426|NCT01092195|Healthy Volunteers|healthy volunteers
482427|NCT01092195|Stem Cell Transplant|stem cell transplant
482428|NCT01092195|Healthy Volunteer|healthy volunteer
482429|NCT01092195|HV|hv
482430|NCT01092182|Microarray|microarray
482431|NCT01092182|Toxicity|toxicity
482432|NCT01092182|Therapeutic Index|therapeutic index
482433|NCT01092182|HIV Positive|hiv positive
482434|NCT01092182|HIV Negative|hiv negative
482435|NCT01092182|Lymphoma|lymphoma
482436|NCT01092182|Burkitt Lymphoma|burkitt lymphoma
482437|NCT01092182|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
482438|NCT01092182|HIV Infections|hiv infections
482439|NCT01092156|Nipple pain during lactation|nipple pain during lactation
482440|NCT01092130|Heart failure|heart failure
482441|NCT01092130|Vitamin D|vitamin d
482442|NCT01092130|Plasma renin activity|plasma renin activity
482443|NCT01092130|Renin angiotensin system|renin angiotensin system
482444|NCT01092117|abdominal|abdominal
482445|NCT01092117|aortic|aortic
482446|NCT01092117|aneurysm|aneurysm
482447|NCT01092091|Neoplasm|neoplasm
482448|NCT01092091|Hepatocellular Carcinoma|hepatocellular carcinoma
482449|NCT01092078|hypertension|hypertension
482450|NCT01092078|colon cancer screening|colon cancer screening
482451|NCT01092078|african american|african american
482452|NCT01092078|men|men
482453|NCT01092078|motivational interviewing|motivational interviewing
482454|NCT01092078|patient navigation|patient navigation
482455|NCT01092065|Parkinson's Disease|parkinson's disease
482456|NCT01092065|Dyskinesia|dyskinesia
482457|NCT01092065|Drug-induced|drug-induced
482458|NCT01092065|Levodopa|levodopa
482459|NCT01092065|L-dopa|l-dopa
482460|NCT01092052|Phase I study|phase i study
482461|NCT01092052|Advanced/Metastatic Solid Tumors|advanced/metastatic solid tumors
482462|NCT01092052|Cdc7 kinase inhibitor|cdc7 kinase inhibitor
482463|NCT01092039|Common Cold|common cold
482464|NCT01092039|Cold Virus|cold virus
482465|NCT01092039|Feeling sick|feeling sick
482466|NCT01092039|Influenza|influenza
482467|NCT01092000|Health Promotion, Dietary Guidelines, Physical Activity Guidelines|health promotion, dietary guidelines, physical activity guidelines
482468|NCT01091987|Insomnia|insomnia
482469|NCT01091974|Insomnia|insomnia
482470|NCT01091974|Fatigue|fatigue
482471|NCT01091974|QOL|qol
482472|NCT01091974|CBT|cbt
482473|NCT01091974|Breast cancer|breast cancer
482474|NCT01091974|Survivors|survivors
482475|NCT01091974|Chemotherapy|chemotherapy
482476|NCT01091961|ACE inhibitor|ace inhibitor
482477|NCT01091961|ARB|arb
482478|NCT01091961|Non-cardiac surgery|non-cardiac surgery
482479|NCT01091961|Perioperative|perioperative
482480|NCT01091961|Preoperative|preoperative
482481|NCT01091961|Hypotension|hypotension
482482|NCT01091961|Congestive heart failure|congestive heart failure
482483|NCT01091961|Hypertension|hypertension
482484|NCT01091961|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors
482485|NCT01091961|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
482486|NCT01091961|Perioperative Care|perioperative care
482487|NCT01091948|elective general surgery|elective general surgery
482488|NCT01091948|orotracheal intubation|orotracheal intubation
482583|NCT01091571|Adenosine|adenosine
482584|NCT01091571|Endotoxin|endotoxin
482585|NCT01091571|Innate Immunity|innate immunity
482586|NCT01091571|Dipyridamole|dipyridamole
482489|NCT01091948|Patients would be eligible for inclusion if they were at least 18 years old and scheduled for elective surgery requiring orotracheal intubation.|patients would be eligible for inclusion if they were at least 18 years old and scheduled for elective surgery requiring orotracheal intubation.
482490|NCT01091935|Lidocaine,Intravenous Infusions,Neuropathic Pain,Side Effects|lidocaine,intravenous infusions,neuropathic pain,side effects
482491|NCT01091922|flavonoids|flavonoids
482492|NCT01091922|flavanols|flavanols
482493|NCT01091922|bacteria|bacteria
482494|NCT01091909|type 2 diabetes|type 2 diabetes
482495|NCT01091909|wound healing|wound healing
482496|NCT01091909|neutrophil count|neutrophil count
482497|NCT01091909|dental extraction|dental extraction
482498|NCT01091896|bevacizumab|bevacizumab
482499|NCT01091896|vitreous hemorrhage|vitreous hemorrhage
482500|NCT01091896|diabetes mellitus|diabetes mellitus
482501|NCT01091883|Bone cancer|bone cancer
482502|NCT01091883|Bone Metastases|bone metastases
482503|NCT01091883|pain palliation|pain palliation
482504|NCT01091883|metastasis|metastasis
482505|NCT01091883|breast cancer|breast cancer
482506|NCT01091883|lung cancer|lung cancer
482507|NCT01091883|prostate cancer|prostate cancer
482508|NCT01091883|cancer related pain|cancer related pain
482509|NCT01091883|tumors|tumors
482510|NCT01091870|Aneurysm|aneurysm
482511|NCT01091870|Vasospasm|vasospasm
482512|NCT01091870|sildenafil|sildenafil
482513|NCT01091870|Viagra|viagra
482514|NCT01091857|Exercise|exercise
482515|NCT01091857|Transdisciplinary|transdisciplinary
482516|NCT01091857|Physiology|physiology
482517|NCT01091857|Mood|mood
482518|NCT01091857|Motivation|motivation
482519|NCT01091844|voiding trial, urinary retention, catheterization|voiding trial, urinary retention, catheterization
482520|NCT01091844|Urinary retention after gynecologic surgery|urinary retention after gynecologic surgery
482521|NCT01091831|Multiple Myeloma|multiple myeloma
482522|NCT01091831|Lenalidomide|lenalidomide
482523|NCT01091831|High dose melphalan|high dose melphalan
482524|NCT01091831|Mobilization|mobilization
482525|NCT01091831|CD 34|cd 34
482526|NCT01091831|Newly Diagnosed patients|newly diagnosed patients
482527|NCT01091818|To see if sedation with dexmedetomidine results in faster emergence after end of intensive care treatment in children|to see if sedation with dexmedetomidine results in faster emergence after end of intensive care treatment in children
482528|NCT01091818|treatment|treatment
482529|NCT01091792|GBM|gbm
482530|NCT01091792|Grade IV|grade iv
482531|NCT01091792|glioma|glioma
482532|NCT01091779|Male patients scheduled to have spinal anaesthesia for TURP|male patients scheduled to have spinal anaesthesia for turp
482533|NCT01091766|local anaesthetics toxicity|local anaesthetics toxicity
482534|NCT01091766|heart arrhythmia|heart arrhythmia
482535|NCT01091766|heart rate|heart rate
482536|NCT01091766|heart conduction|heart conduction
482537|NCT01091766|regional anaesthesia|regional anaesthesia
482538|NCT01091766|paediatric anaesthesia|paediatric anaesthesia
482539|NCT01091766|cardio-vascular system|cardio-vascular system
482540|NCT01091766|prevention|prevention
482541|NCT01091753|Non-dipper HTN patient|non-dipper htn patient
482542|NCT01091740|Drug eluting stent|drug eluting stent
482543|NCT01091740|Tomography, optical coherence|tomography, optical coherence
482544|NCT01091727|Neurogenic|neurogenic
482545|NCT01091727|Detrusor|detrusor
482546|NCT01091727|Overactive|overactive
482547|NCT01091727|Overactivity|overactivity
482548|NCT01091727|Bladder|bladder
482549|NCT01091727|Spinal|spinal
482550|NCT01091727|Cord|cord
482551|NCT01091727|Injury|injury
482552|NCT01091701|Ischemic Cerebral Stroke|ischemic cerebral stroke
482553|NCT01091688|neonatal|neonatal
482554|NCT01091688|discharge planning|discharge planning
482555|NCT01091688|health transition|health transition
482556|NCT01091688|educational needs assessment|educational needs assessment
482557|NCT01091688|Intensive care, neonatal|intensive care, neonatal
482558|NCT01091675|ankylosing spondylitis|ankylosing spondylitis
482559|NCT01091675|biologic therapies|biologic therapies
482560|NCT01091675|ASAS|asas
482561|NCT01091675|ASASBIO|asasbio
482562|NCT01091675|etoricoxib|etoricoxib
482563|NCT01091675|NSAIDs|nsaids
482564|NCT01091675|COX-2 Inhibitor|cox-2 inhibitor
482565|NCT01091675|ARCOXIA 90 mg|arcoxia 90 mg
482566|NCT01091675|BASDAI Bath Ankylosing Spondylitis Disease Activity Index|basdai bath ankylosing spondylitis disease activity index
482567|NCT01091662|Seizures|seizures
482568|NCT01091662|Epilepsy|epilepsy
482569|NCT01091662|Anticonvulsant|anticonvulsant
482570|NCT01091662|Monotherapy|monotherapy
482571|NCT01091662|Historical control|historical control
482572|NCT01091649|Pharmacokinetics, Safety|pharmacokinetics, safety
482573|NCT01091623|improvement of exercise capacity in patients with COPD|improvement of exercise capacity in patients with copd
482574|NCT01091610|retrospective study|retrospective study
482575|NCT01091610|wounds and injuries/epidemiology|wounds and injuries/epidemiology
482576|NCT01091610|emergency medical technicians|emergency medical technicians
482577|NCT01091610|human|human
482578|NCT01091610|emergency medical services|emergency medical services
482579|NCT01091610|ambulance|ambulance
482580|NCT01091610|health personnel|health personnel
482581|NCT01091610|emergency medicine|emergency medicine
482582|NCT01091610|risk factors|risk factors
482587|NCT01091558|ulcerative colitis|ulcerative colitis
482588|NCT01091558|colon cancer|colon cancer
482589|NCT01091558|endoscopy|endoscopy
482590|NCT01091558|screening|screening
482591|NCT01091545|breast cancer|breast cancer
482592|NCT01091545|screening|screening
482593|NCT01091545|sensitivity|sensitivity
482594|NCT01091545|tomosynthesis|tomosynthesis
482595|NCT01091519|Non-interventional study fesoterodine educational materials|non-interventional study fesoterodine educational materials
482596|NCT01091506|L-methylfolate|l-methylfolate
482597|NCT01091506|Deplin|deplin
482598|NCT01091506|schizophrenia|schizophrenia
482599|NCT01091506|folate|folate
482600|NCT01091506|folic acid|folic acid
482601|NCT01091506|homocysteine|homocysteine
482602|NCT01091506|methionine|methionine
482603|NCT01091506|MTHFR genotype|mthfr genotype
482604|NCT01091506|C677T mutation|c677t mutation
482605|NCT01091506|vitamin B6|vitamin b6
482606|NCT01091506|vitamin B12|vitamin b12
482607|NCT01091506|psychotic symptoms|psychotic symptoms
482608|NCT01091506|MTHFR C677T Polymorphism|mthfr c677t polymorphism
482609|NCT01091493|COPD|copd
482610|NCT01091480|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
482611|NCT01091480|Observatory|observatory
482612|NCT01091480|LVH|lvh
482613|NCT01091467|Heart Failure|heart failure
482614|NCT01091467|Ejection Fraction|ejection fraction
482615|NCT01091467|Echocardiography|echocardiography
482616|NCT01091454|stage IV breast cancer|stage iv breast cancer
482617|NCT01091454|triple-negative breast cancer|triple-negative breast cancer
482618|NCT01091454|male breast cancer|male breast cancer
482619|NCT01091441|therapeutic education|therapeutic education
482620|NCT01091428|RECIST: Response Evaluation Criteria in Solid Tumors|recist: response evaluation criteria in solid tumors
482621|NCT01091428|OC: Ovarian Cancer|oc: ovarian cancer
482622|NCT01091428|GCIG: Gynecologic Cancer Intergroup|gcig: gynecologic cancer intergroup
482623|NCT01091428|Breast carcinoma (Phase 1)|breast carcinoma (phase 1)
482624|NCT01091402|autologous serum skin test, IL-18|autologous serum skin test, il-18
482625|NCT01091389|Atrial Fibrillation|atrial fibrillation
482626|NCT01091389|Totally Thoracoscopic PV isolation|totally thoracoscopic pv isolation
482627|NCT01091376|Non-small cell lung cancer|non-small cell lung cancer
482628|NCT01091376|EGFR-TKI|egfr-tki
482629|NCT01091376|Erlotinib|erlotinib
482630|NCT01091376|Radiotherapy|radiotherapy
482631|NCT01091363|smoking cessation|smoking cessation
482632|NCT01091363|tobacco dependence treatment|tobacco dependence treatment
482633|NCT01091363|cultural adaptation|cultural adaptation
482634|NCT01091363|Asian Americans|asian americans
482635|NCT01091324|CKD, proteinuria, dextromethorphan, silymarin|ckd, proteinuria, dextromethorphan, silymarin
482636|NCT01091324|patients with 15 ml<eGFR< 60ml and 0.5 g/day<proteinuria<3g/day|patients with 15 ml<egfr< 60ml and 0.5 g/day<proteinuria<3g/day
482637|NCT01091311|Meibomian Gland Dysfunction|meibomian gland dysfunction
482638|NCT01091298|Safety of vaccine|safety of vaccine
482639|NCT01091272|healthy volunteer|healthy volunteer
482640|NCT01091272|safety|safety
482641|NCT01091272|pharmacokinetic|pharmacokinetic
482642|NCT01091259|antibody therapy|antibody therapy
482643|NCT01091259|chemotherapy|chemotherapy
482644|NCT01091259|biologic therapy|biologic therapy
482645|NCT01091259|combination therapy|combination therapy
482646|NCT01091233|Critically ill patients|critically ill patients
482647|NCT01091233|liver cirrhosis|liver cirrhosis
482648|NCT01091233|ascites requiring Paracentesis|ascites requiring paracentesis
482649|NCT01091220|certolizumab pegol|certolizumab pegol
482650|NCT01091220|Cimzia®|cimzia®
482651|NCT01091220|healthy male volunteers|healthy male volunteers
482652|NCT01091220|sperm|sperm
482653|NCT01091207|Sorafenib|sorafenib
482654|NCT01091207|GIST|gist
482655|NCT01091207|Refractory|refractory
482656|NCT01091207|advanced GIST failed after both imatinib and sunitinib|advanced gist failed after both imatinib and sunitinib
482657|NCT01091194|Heart Transplantation|heart transplantation
482658|NCT01091194|Aerobic Exercise|aerobic exercise
482659|NCT01091194|Exercise, Physical|exercise, physical
482660|NCT01091194|Exercise Test|exercise test
482661|NCT01091194|Treadmill Test|treadmill test
482662|NCT01091194|VO2 peak|vo2 peak
482663|NCT01091194|Muscle Strength|muscle strength
482664|NCT01091194|Quality of Life|quality of life
482665|NCT01091194|Reinnervation|reinnervation
482666|NCT01091194|Heart Rate|heart rate
482667|NCT01091194|Myocardial Function|myocardial function
482668|NCT01091181|Caesarean|caesarean
482669|NCT01091155|Colon Anastomosis|colon anastomosis
482670|NCT01091155|Rectum Anastomosis|rectum anastomosis
482671|NCT01091155|Intestine|intestine
482672|NCT01091155|Colorectal Surgery|colorectal surgery
482673|NCT01091155|Colorectal Anastomosis|colorectal anastomosis
482674|NCT01091129|hyperhidrosis|hyperhidrosis
482675|NCT01091116|Injections, Intra-Articular|injections, intra-articular
482676|NCT01091090|Smoking cessation|smoking cessation
482677|NCT01091090|Nicotine dependence|nicotine dependence
482678|NCT01091090|Chronic pain|chronic pain
482679|NCT01091077|dietary supplement|dietary supplement
482680|NCT01091051|Ustekinumab, Palmo-Plantar, Pustular Psoriasis, Pustulosis|ustekinumab, palmo-plantar, pustular psoriasis, pustulosis
482681|NCT01091038|Adverse drug events|adverse drug events
482682|NCT01091038|medical errors|medical errors
482683|NCT01091038|computerized physician order entry|computerized physician order entry
482684|NCT01091038|clinical decision support|clinical decision support
482685|NCT01091025|Adults|adults
482686|NCT01091025|Cystic Fibrosis Related Diabetes|cystic fibrosis related diabetes
482687|NCT01091025|Screening|screening
482688|NCT01091025|Oral glucose tolerance test|oral glucose tolerance test
482689|NCT01091025|Royal Brompton & Harefield Foundation Trust|royal brompton & harefield foundation trust
482690|NCT01090999|COPD|copd
482691|NCT01090999|Pulmonary Rehabilitation|pulmonary rehabilitation
482692|NCT01090986|Restrictive pulmonary disease with hypercapnic chronic respiratory failure.|restrictive pulmonary disease with hypercapnic chronic respiratory failure.
482693|NCT01090986|COPD patients who need NIV hypercapnic chronic respiratory failure.|copd patients who need niv hypercapnic chronic respiratory failure.
482694|NCT01090973|relapsed|relapsed
482695|NCT01090973|refractory|refractory
482696|NCT01090973|CLL|cll
482697|NCT01090973|chronic lymphocytic leukemia|chronic lymphocytic leukemia
482698|NCT01090973|MCL|mcl
482699|NCT01090973|mantle cell lymphoma|mantle cell lymphoma
482700|NCT01090934|Diagnosis|diagnosis
482701|NCT01090934|Partial Epilepsy|partial epilepsy
482702|NCT01090921|Multiple Myeloma|multiple myeloma
482703|NCT01090921|Bortezomib|bortezomib
482704|NCT01090921|Newly diagnosed|newly diagnosed
482705|NCT01090921|Newly diagnosed Multiple Myeloma|newly diagnosed multiple myeloma
482706|NCT01090895|Percutaneous Coronary Intervention|percutaneous coronary intervention
482707|NCT01090895|Vitamin C|vitamin c
482708|NCT01090895|Biomarkers|biomarkers
482709|NCT01090895|Magnetic Risonance|magnetic risonance
482710|NCT01090882|Local anaesthetic|local anaesthetic
482711|NCT01090882|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
482712|NCT01090882|Pain scores|pain scores
482713|NCT01090882|Bupivocaine|bupivocaine
482714|NCT01090882|Day case surgery|day case surgery
482715|NCT01090856|Bifurcations|bifurcations
482716|NCT01090856|Drug eluting-stents|drug eluting-stents
482717|NCT01090856|Provisional stenting|provisional stenting
482718|NCT01090843|Obscure digestive bleeding (ODB)|obscure digestive bleeding (odb)
482719|NCT01090843|Chronic anaemia of unknown origin|chronic anaemia of unknown origin
482720|NCT01090843|Chronic diarrhoea|chronic diarrhoea
482721|NCT01090830|Non small cell lung cancer|non small cell lung cancer
482722|NCT01090830|Belinostat|belinostat
482723|NCT01090830|carboplatin|carboplatin
482724|NCT01090830|Paclitaxel|paclitaxel
482725|NCT01090830|Bevacizumab|bevacizumab
482726|NCT01090830|chemotherapy|chemotherapy
482727|NCT01090830|Maximum Tolerated Dose|maximum tolerated dose
482728|NCT01090830|Neoplasms, Pulmonary|neoplasms, pulmonary
482729|NCT01090830|Lung Cancer|lung cancer
482730|NCT01090830|Event Free Survival|event free survival
482731|NCT01090830|Disease free survival|disease free survival
482732|NCT01090830|Progression Free Survival|progression free survival
482733|NCT01090830|Histone Deacetylase Inhibitors|histone deacetylase inhibitors
482734|NCT01090830|Treatment Efficacy|treatment efficacy
482735|NCT01090817|mesenchymal stromal cells|mesenchymal stromal cells
482736|NCT01090817|ileitis|ileitis
482737|NCT01090817|colitis|colitis
482738|NCT01090804|BreatheMAX breathing device|breathemax breathing device
482739|NCT01090804|Secretion clearance|secretion clearance
482740|NCT01090804|Ventilatory dependence|ventilatory dependence
482741|NCT01090804|Intubated patients|intubated patients
482742|NCT01090791|critically ill patient|critically ill patient
482743|NCT01090778|growth hormone deficiency|growth hormone deficiency
482744|NCT01090778|circadian variation|circadian variation
482745|NCT01090765|Prostate|prostate
482746|NCT01090765|Tumor|tumor
482747|NCT01090765|Cancer|cancer
482748|NCT01090765|Hormone|hormone
482749|NCT01090765|Androgen|androgen
482750|NCT01090765|Prostate Cancer|prostate cancer
482751|NCT01090752|diabetes|diabetes
482752|NCT01090752|blood pressure|blood pressure
482753|NCT01090752|pioglitazone|pioglitazone
482754|NCT01090752|sodium|sodium
482755|NCT01090752|insulin resistance, renal function, sodium, pioglitazone|insulin resistance, renal function, sodium, pioglitazone
482756|NCT01090739|Fecal incontinence|fecal incontinence
482757|NCT01090739|Accidental bowel leakage|accidental bowel leakage
482758|NCT01090739|Failure conservative therapy|failure conservative therapy
482759|NCT01090739|Women|women
482760|NCT01090739|Class III medical device|class iii medical device
482761|NCT01090739|Surgical mesh|surgical mesh
482762|NCT01090700|TMC435-TiDP16-C112|tmc435-tidp16-c112
482763|NCT01090700|TMC435-C112|tmc435-c112
482764|NCT01090700|TMC435|tmc435
482765|NCT01090700|HCV|hcv
482766|NCT01090700|Hepatitis C|hepatitis c
482767|NCT01090687|breast cancer, CT scans, mammography|breast cancer, ct scans, mammography
482768|NCT01090674|Diaphragmatic force|diaphragmatic force
482769|NCT01090674|mobility|mobility
482770|NCT01090661|antisense|antisense
482771|NCT01090661|ApoB (Apolipoprotein B)|apob (apolipoprotein b)
482772|NCT01090661|LDL (low density lipoprotein)|ldl (low density lipoprotein)
482773|NCT01090661|thorough QT|thorough qt
482774|NCT01090648|TMC125HIV1083|tmc125hiv1083
482775|NCT01090648|TMC125|tmc125
482776|NCT01090648|HIV|hiv
482777|NCT01090648|Etravirine|etravirine
482778|NCT01090648|ETR|etr
482779|NCT01090648|Intelence|intelence
482780|NCT01090648|HIV Infections|hiv infections
482781|NCT01090635|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
482782|NCT01090609|Coronary Stent|coronary stent
482783|NCT01090609|Cobalt-Chromium coronary stent|cobalt-chromium coronary stent
482784|NCT01090583|Cytokines|cytokines
482785|NCT01090583|Pregnancy|pregnancy
482786|NCT01090583|Cesarean|cesarean
482787|NCT01090544|COPD|copd
482788|NCT01090544|TNI|tni
482789|NCT01090544|PaCO2|paco2
482790|NCT01090492|Raynaud's phenomenon|raynaud's phenomenon
482791|NCT01090492|vasospasm|vasospasm
482792|NCT01090492|scleroderma|scleroderma
482793|NCT01090492|systemic sclerosis|systemic sclerosis
482794|NCT01090492|CREST|crest
482795|NCT01090492|phosphodiesterase inhibitor|phosphodiesterase inhibitor
482796|NCT01090479|Surgical site infections|surgical site infections
482797|NCT01090479|Chlorhexidine|chlorhexidine
482798|NCT01090479|Shoulder surgery|shoulder surgery
482799|NCT01090466|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
482800|NCT01090466|recurrent bladder cancer|recurrent bladder cancer
482801|NCT01090466|recurrent urethral cancer|recurrent urethral cancer
482802|NCT01090466|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
482803|NCT01090466|stage IV bladder cancer|stage iv bladder cancer
482804|NCT01090466|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
482805|NCT01090466|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
482806|NCT01090466|distal urethral cancer|distal urethral cancer
482807|NCT01090466|proximal urethral cancer|proximal urethral cancer
482808|NCT01090466|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
482809|NCT01090466|stage IV urethral cancer|stage iv urethral cancer
482810|NCT01090440|schizophrenia|schizophrenia
482811|NCT01090440|GSK1144814|gsk1144814
482812|NCT01090440|effect of food|effect of food
482813|NCT01090440|healthy subjects|healthy subjects
482814|NCT01090440|depressive disorder|depressive disorder
482815|NCT01090440|pharmacokinetics|pharmacokinetics
482816|NCT01090427|Ustekinumab|ustekinumab
482817|NCT01090427|Injection|injection
482818|NCT01090427|CNTO 1275|cnto 1275
482819|NCT01090427|Stelara|stelara
482820|NCT01090427|Pediatric psoriasis|pediatric psoriasis
482821|NCT01090427|Adolescents|adolescents
482822|NCT01090414|Idelalisib|idelalisib
482823|NCT01090414|Chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
482824|NCT01090414|Non-Hodgkin lymphoma (NHL)|non-hodgkin lymphoma (nhl)
482825|NCT01090414|Phosphatidylinositol 3-kinase (PI3K)|phosphatidylinositol 3-kinase (pi3k)
482826|NCT01090388|Cross-sectional survey|cross-sectional survey
482827|NCT01090388|Health-related quality of life|health-related quality of life
482828|NCT01090388|Symptom management|symptom management
482829|NCT01090375|osteoarthritis|osteoarthritis
482830|NCT01090375|biochemical markers|biochemical markers
482831|NCT01090375|cartilage|cartilage
482832|NCT01090375|inflammation|inflammation
482833|NCT01090375|microdialysis|microdialysis
482834|NCT01090362|Atrial fibrillation|atrial fibrillation
482835|NCT01090362|Anticoagulation|anticoagulation
482836|NCT01090362|Stroke|stroke
482837|NCT01090362|Stroke prevention|stroke prevention
482838|NCT01090362|Health Economics|health economics
482839|NCT01090349|ICD, CRTD, Remote Care|icd, crtd, remote care
482840|NCT01090336|platelet aggregation inhibition|platelet aggregation inhibition
482841|NCT01090336|prasugrel|prasugrel
482842|NCT01090336|clopidogrel|clopidogrel
482843|NCT01090336|ACS|acs
482844|NCT01090323|Deferasirox|deferasirox
482845|NCT01090323|ICL670A|icl670a
482846|NCT01090323|Iron chelators|iron chelators
482847|NCT01090323|Sickle Cell Disease|sickle cell disease
482848|NCT01090323|Transfusional Hemosiderosis|transfusional hemosiderosis
482849|NCT01090310|Quiescent uveitis|quiescent uveitis
482850|NCT01090310|intermediate uveitis|intermediate uveitis
482851|NCT01090310|panuveitis|panuveitis
482852|NCT01090310|posterior uveitis|posterior uveitis
482853|NCT01090310|uveitis|uveitis
482854|NCT01090310|NVS Definition: Words or phrases that best describe the protocol. Keywords help users find studies in the database.|nvs definition: words or phrases that best describe the protocol. keywords help users find studies in the database.
482855|NCT01090310|Avoid acronyms, abbreviations and trade names.|avoid acronyms, abbreviations and trade names.
482856|NCT01090310|Examples: Heart failure, aliskiren, heart attack, cardiovascular diseases|examples: heart failure, aliskiren, heart attack, cardiovascular diseases
482857|NCT01090310|Psoriasis, inflammatory skin disease, scaly patches|psoriasis, inflammatory skin disease, scaly patches
482858|NCT01090297|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
482859|NCT01090297|Blood pressure|blood pressure
482860|NCT01090297|Continuous Positive Airway Pressure|continuous positive airway pressure
482861|NCT01090284|Inguinal hernia|inguinal hernia
482862|NCT01090284|Immune system|immune system
482863|NCT01090284|Cytokines|cytokines
482864|NCT01090284|Prosthetic repair|prosthetic repair
482865|NCT01090284|Oxidative Stress|oxidative stress
482866|NCT01090271|Subacromial impingement syndrome|subacromial impingement syndrome
483064|NCT01089400|lymphocytes|lymphocytes
482867|NCT01090271|Muscle Strength|muscle strength
482868|NCT01090271|Resistance Training|resistance training
482869|NCT01090258|cardiac surgery|cardiac surgery
482870|NCT01090258|mechanical ventilation|mechanical ventilation
482871|NCT01090258|automation|automation
482872|NCT01090258|weaning|weaning
482873|NCT01090245|contingency management|contingency management
482874|NCT01090245|substance abuse treatment|substance abuse treatment
482875|NCT01090245|criminal justice populations|criminal justice populations
482876|NCT01090245|substance abuse treatment retention|substance abuse treatment retention
482877|NCT01090245|HIV prevention in criminal justice settings|hiv prevention in criminal justice settings
482878|NCT01090245|voucher based reinforcement therapy|voucher based reinforcement therapy
482879|NCT01090245|Parole treatment admission for substance abusing parolees|parole treatment admission for substance abusing parolees
482880|NCT01090245|Parole treatment retention for substance abusing parolees|parole treatment retention for substance abusing parolees
482881|NCT01090245|HIV testing and counseling for substance abusing parolees|hiv testing and counseling for substance abusing parolees
482882|NCT01090219|Inguinal Hernia|inguinal hernia
482883|NCT01090219|contraction of two different meshes in the repair of inguinal hernias in men|contraction of two different meshes in the repair of inguinal hernias in men
482884|NCT01090206|Hemophilia|hemophilia
482885|NCT01090206|Vitamin D|vitamin d
482886|NCT01090193|Obstructive jaundice|obstructive jaundice
482887|NCT01090193|kidney histopathology|kidney histopathology
482888|NCT01090193|lactulose|lactulose
482889|NCT01090180|PTSD|ptsd
482890|NCT01090180|combat|combat
482891|NCT01090180|stress disorders|stress disorders
482892|NCT01090180|veteran|veteran
482893|NCT01090154|Ulcerative colitis|ulcerative colitis
482894|NCT01090154|UC|uc
482895|NCT01090154|Inflammatory Bowel Disease|inflammatory bowel disease
482896|NCT01090141|Micafungin|micafungin
482897|NCT01090141|Body Weight|body weight
482898|NCT01090141|Anti-Infective Agents|anti-infective agents
482899|NCT01090141|Signs and Symptoms|signs and symptoms
482900|NCT01090141|Mycoses|mycoses
482901|NCT01090141|Therapeutic Uses|therapeutic uses
482902|NCT01090141|Antifungal Agents|antifungal agents
482903|NCT01090141|Overnutrition|overnutrition
482904|NCT01090141|Pharmacologic Actions|pharmacologic actions
482905|NCT01090076|Pressure Ulcer Wound|pressure ulcer wound
482906|NCT01090076|Specialized Amino Acid Mixture|specialized amino acid mixture
482907|NCT01090063|Palmar Plantar Psoriasis|palmar plantar psoriasis
482908|NCT01090050|Chronic Migraine|chronic migraine
482909|NCT01090050|Migraine|migraine
482910|NCT01090050|Treximet|treximet
482911|NCT01090050|naproxen|naproxen
482912|NCT01090050|sumatriptan|sumatriptan
482913|NCT01090037|ESRD|esrd
482914|NCT01090037|Chronic Renal Failure|chronic renal failure
482915|NCT01090037|Prostaglandin|prostaglandin
482916|NCT01090037|Prostacyclin|prostacyclin
482917|NCT01090037|Asian Multinational Study|asian multinational study
482918|NCT01089998|Neoplasm|neoplasm
482919|NCT01089998|PET/CT diagnosis|pet/ct diagnosis
482920|NCT01089998|PET tracer|pet tracer
482921|NCT01089998|Inflammation|inflammation
482922|NCT01089972|radial artery|radial artery
482923|NCT01089972|ulnar artery|ulnar artery
482924|NCT01089972|catheterization|catheterization
482925|NCT01089972|regional blood flow|regional blood flow
482926|NCT01089959|Acid re-flux,GERD|acid re-flux,gerd
482927|NCT01089959|sleep related arousals due to GERD|sleep related arousals due to gerd
482928|NCT01089959|Treatment of acid reflux during sleep in patients with GERD.|treatment of acid reflux during sleep in patients with gerd.
482929|NCT01089946|Mobilization|mobilization
482930|NCT01089946|Hip arthroplasty|hip arthroplasty
482931|NCT01089946|cardiovascular|cardiovascular
482932|NCT01089933|Anesthesia|anesthesia
482933|NCT01089933|Local Anesthetics|local anesthetics
482934|NCT01089933|Analgesia|analgesia
482935|NCT01089933|Quality of life|quality of life
482936|NCT01089933|Paravertebral blocks|paravertebral blocks
482937|NCT01089933|Arm morbidity|arm morbidity
482938|NCT01089907|genomic|genomic
482939|NCT01089907|childhood|childhood
482940|NCT01089907|acute lymphoblastic leukemia|acute lymphoblastic leukemia
482941|NCT01089894|18F-FLT|18f-flt
482942|NCT01089894|PET|pet
482943|NCT01089894|non-small cell lung cancer|non-small cell lung cancer
482944|NCT01089894|cell proliferation|cell proliferation
482945|NCT01089894|therapeutic response|therapeutic response
482946|NCT01089894|18F-3'-fluoro-3'-deoxy-L-thymidine (18F-FLT)|18f-3'-fluoro-3'-deoxy-l-thymidine (18f-flt)
482947|NCT01089881|prostate cancer|prostate cancer
482948|NCT01089881|18F-fluorocholine|18f-fluorocholine
482949|NCT01089881|PET|pet
482950|NCT01089881|recurrence|recurrence
482951|NCT01089881|metastases|metastases
482952|NCT01089868|Glioblastoma multiforme|glioblastoma multiforme
482953|NCT01089868|Microsurgery|microsurgery
482954|NCT01089868|Stereotactic biopsy|stereotactic biopsy
482955|NCT01089868|Radiochemotherapy|radiochemotherapy
482956|NCT01089868|Temodar|temodar
482957|NCT01089868|FET PET|fet pet
482958|NCT01089868|Molecular imaging|molecular imaging
482959|NCT01089855|Neuropathic Pain|neuropathic pain
482960|NCT01089855|Brief Pain Inventory|brief pain inventory
482961|NCT01089855|DN4 questionnaire|dn4 questionnaire
482962|NCT01089855|ElectroCardioGram|electrocardiogram
482963|NCT01089842|Secondary Prevention|secondary prevention
482964|NCT01089842|Health Promotion|health promotion
482965|NCT01089842|Behavioral Medicine|behavioral medicine
482966|NCT01089842|Exercise Therapy|exercise therapy
482967|NCT01089829|CKD|ckd
482968|NCT01089829|Foot Ulceration|foot ulceration
482969|NCT01089829|Diabetes|diabetes
482970|NCT01089816|Influenza infections|influenza infections
482971|NCT01089816|Orthomyxoviridae infections|orthomyxoviridae infections
482972|NCT01089816|Influenza Human|influenza human
482973|NCT01089803|laryngectomy|laryngectomy
482974|NCT01089803|larynx|larynx
482975|NCT01089803|hypopharynx|hypopharynx
482976|NCT01089764|breast neoplasm|breast neoplasm
482977|NCT01089764|breast cancer|breast cancer
482978|NCT01089764|behavioral intervention|behavioral intervention
482979|NCT01089764|online support|online support
482980|NCT01089764|relationship distress|relationship distress
482981|NCT01089764|dyadic coping|dyadic coping
482982|NCT01089738|mulitple dose|mulitple dose
482983|NCT01089738|pharmacokinetics|pharmacokinetics
482984|NCT01089738|safety|safety
482985|NCT01089738|healthy elderly volunteers|healthy elderly volunteers
482986|NCT01089725|safety|safety
482987|NCT01089725|efficacy|efficacy
482988|NCT01089725|parallel group|parallel group
482989|NCT01089725|double-blind|double-blind
482990|NCT01089725|multicenter|multicenter
482991|NCT01089725|injection|injection
482992|NCT01089725|infusion|infusion
482993|NCT01089725|osteoarthritis|osteoarthritis
482994|NCT01089725|bridging|bridging
482995|NCT01089725|subcutaneous|subcutaneous
482996|NCT01089725|intravenous|intravenous
482997|NCT01089725|tanezumab|tanezumab
482998|NCT01089712|Infection|infection
482999|NCT01089712|Cardiac Surgery|cardiac surgery
483000|NCT01089712|Post Operative Cardiac Surgery Infection|post operative cardiac surgery infection
483001|NCT01089712|Management Practices|management practices
483002|NCT01089699|breast cancer|breast cancer
483003|NCT01089699|support groups|support groups
483004|NCT01089699|Primary diagnosis of breast cancer within the past three years.|primary diagnosis of breast cancer within the past three years.
483005|NCT01089686|Chronic Cerebrospinal Venous Insufficiency|chronic cerebrospinal venous insufficiency
483006|NCT01089673|retrospective data collection|retrospective data collection
483007|NCT01089660|Influenza|influenza
483008|NCT01089660|Pandemic Flu|pandemic flu
483009|NCT01089660|Swine-origin Influenza|swine-origin influenza
483010|NCT01089660|Inactivated split-virion vaccine|inactivated split-virion vaccine
483011|NCT01089647|OSA|osa
483012|NCT01089647|Medical treatment|medical treatment
483013|NCT01089634|LV measurement|lv measurement
483014|NCT01089634|CRT|crt
483015|NCT01089634|Concerto|concerto
483016|NCT01089634|LVCM|lvcm
483017|NCT01089634|LV threshold|lv threshold
483018|NCT01089634|new CRT|new crt
483019|NCT01089608|Azyter in patients affected by chronic blepharitis.|azyter in patients affected by chronic blepharitis.
483020|NCT01089595|Imatinib Resistance|imatinib resistance
483021|NCT01089595|GIST|gist
483022|NCT01089595|Advanced Disease|advanced disease
483023|NCT01089595|Nilotinib|nilotinib
483024|NCT01089582|non-interventional|non-interventional
483025|NCT01089582|mild to moderate Alzheimer's|mild to moderate alzheimer's
483026|NCT01089582|ARICEPT.|aricept.
483027|NCT01089569|diabetes|diabetes
483028|NCT01089569|continuous glucose monitoring|continuous glucose monitoring
483029|NCT01089569|exenatide|exenatide
483030|NCT01089569|insulin glargine|insulin glargine
483031|NCT01089543|dyspepsia|dyspepsia
483032|NCT01089543|rabeprazole|rabeprazole
483033|NCT01089543|Japan|japan
483034|NCT01089530|Fibrinogen|fibrinogen
483035|NCT01089530|Cholesterol|cholesterol
483036|NCT01089530|Cardiovascular risk factors|cardiovascular risk factors
483037|NCT01089530|Primary prevention|primary prevention
483038|NCT01089530|High levels fibrinogen|high levels fibrinogen
483039|NCT01089530|High plasma fibrinogen|high plasma fibrinogen
483040|NCT01089504|phenobarbital|phenobarbital
483041|NCT01089504|neonate|neonate
483042|NCT01089504|antiepileptic drugs|antiepileptic drugs
483043|NCT01089504|neurodevelopmental outcome|neurodevelopmental outcome
483044|NCT01089504|seizure|seizure
483045|NCT01089491|Low back pain|low back pain
483046|NCT01089491|Epiduroscopy|epiduroscopy
483047|NCT01089491|Cytology|cytology
483048|NCT01089491|Electrical stimulation|electrical stimulation
483049|NCT01089478|Back pain|back pain
483050|NCT01089478|Low back pain|low back pain
483051|NCT01089478|Cytology|cytology
483052|NCT01089478|Epiduroscopy|epiduroscopy
483053|NCT01089478|Pain|pain
483054|NCT01089478|Radiculopathy|radiculopathy
483055|NCT01089465|Bed bugs|bed bugs
483056|NCT01089465|Cimex|cimex
483057|NCT01089465|insects|insects
483058|NCT01089465|bites|bites
483059|NCT01089452|Mild to moderate hypertension|mild to moderate hypertension
483060|NCT01089439|Nitric oxide|nitric oxide
483061|NCT01089426|Pediatric patients with Parenteral Nutrition (PN) induced Liver Injury|pediatric patients with parenteral nutrition (pn) induced liver injury
483062|NCT01089400|influenza|influenza
483063|NCT01089400|H1N1|h1n1
483065|NCT01089400|T cell|t cell
483066|NCT01089400|CD4|cd4
483067|NCT01089400|CD8|cd8
483068|NCT01089400|cytokine|cytokine
483069|NCT01089400|serology|serology
483070|NCT01089400|broncho-alveolar lavage|broncho-alveolar lavage
483071|NCT01089400|acute respiratory distress syndrome|acute respiratory distress syndrome
483072|NCT01089400|ventilation|ventilation
483073|NCT01089400|intensive care unit|intensive care unit
483074|NCT01089387|radical prostatectomy|radical prostatectomy
483075|NCT01089374|Phyllodes|phyllodes
483076|NCT01089361|systemic inflammatory syndrome|systemic inflammatory syndrome
483077|NCT01089361|sepsis syndrome|sepsis syndrome
483078|NCT01089361|septic shock|septic shock
483079|NCT01089361|Cytokine|cytokine
483080|NCT01089361|Ketamine|ketamine
483081|NCT01089348|Vaginosis, Bacterial|vaginosis, bacterial
483082|NCT01089348|Prebiotics|prebiotics
483083|NCT01089348|Lactofiltrum|lactofiltrum
483084|NCT01089348|Therapy|therapy
483085|NCT01089335|Sentinel node|sentinel node
483086|NCT01089335|Thyroid cancer|thyroid cancer
483087|NCT01089335|Thyroid neoplasia|thyroid neoplasia
483088|NCT01089335|Follicular neoplasia|follicular neoplasia
483089|NCT01089322|SEVERE ASTHMA|severe asthma
483090|NCT01089322|RISK FACTORS|risk factors
483091|NCT01089322|CHARACTERIZATION|characterization
483092|NCT01089322|CLINICAL CONTROL|clinical control
483093|NCT01089322|INFLAMMATORY MARKERS|inflammatory markers
483094|NCT01089322|SEVERE|severe
483095|NCT01089322|CONTROL|control
483096|NCT01089309|Aldosterone Blockade|aldosterone blockade
483097|NCT01089309|Arterial elasticity|arterial elasticity
483098|NCT01089309|Glycemic control|glycemic control
483099|NCT01089296|Infants born preterm|infants born preterm
483100|NCT01089296|Early physiotherapy intervention|early physiotherapy intervention
483101|NCT01089296|Motor development|motor development
483102|NCT01089296|Parental participation|parental participation
483103|NCT01089296|Parental competency|parental competency
483104|NCT01089283|parkinson|parkinson
483105|NCT01089283|fdg pet-ct|fdg pet-ct
483106|NCT01089283|i123 dat scan|i123 dat scan
483107|NCT01089283|LRRK2|lrrk2
483108|NCT01089283|GBA|gba
483109|NCT01089283|parkinson patients with known genetic characteristic|parkinson patients with known genetic characteristic
483110|NCT01089270|Parkinson|parkinson
483111|NCT01089270|fdg pet-ct|fdg pet-ct
483112|NCT01089270|i123 dat scan|i123 dat scan
483113|NCT01089270|first degree relatives of diagnosed Parkinson patients|first degree relatives of diagnosed parkinson patients
483114|NCT01089270|with no clinical evidence of movement disorders|with no clinical evidence of movement disorders
483115|NCT01089257|Cardiovascular risks|cardiovascular risks
483116|NCT01089257|Oxidative stress|oxidative stress
483117|NCT01089257|Systemic inflammation|systemic inflammation
483118|NCT01089257|Endothelial function|endothelial function
483119|NCT01089257|Peripheral Arterial Tone|peripheral arterial tone
483120|NCT01089257|Positive Airway Pressure|positive airway pressure
483121|NCT01089244|Low grade glioma|low grade glioma
483122|NCT01089244|Astrocytoma|astrocytoma
483123|NCT01089244|Molecular imaging|molecular imaging
483124|NCT01089244|FET PET|fet pet
483125|NCT01089244|Therapy monitoring|therapy monitoring
483126|NCT01089244|Temodar|temodar
483127|NCT01089231|Hyperlipidemia|hyperlipidemia
483128|NCT01089231|coronary heart disease|coronary heart disease
483129|NCT01089231|gene expression|gene expression
483130|NCT01089231|fish oil|fish oil
483131|NCT01089231|DHA, EPA|dha, epa
483132|NCT01089218|bronchoscopy|bronchoscopy
483133|NCT01089218|post-bronchoscopy fever|post-bronchoscopy fever
483134|NCT01089218|pneumonia|pneumonia
483135|NCT01089218|cytokines|cytokines
483136|NCT01089218|amoxicillin/clavulanate|amoxicillin/clavulanate
483137|NCT01089218|prophylaxis|prophylaxis
483138|NCT01089153|human blood, urine and fecal samples|human blood, urine and fecal samples
483139|NCT01089140|pediatrics|pediatrics
483140|NCT01089140|scoliosis|scoliosis
483141|NCT01089140|tranexamic acid|tranexamic acid
483142|NCT01089140|Investigating non-idiopathic scoliosis|investigating non-idiopathic scoliosis
483143|NCT01089127|Indacaterol|indacaterol
483144|NCT01089127|COPD|copd
483145|NCT01089127|salmeterol|salmeterol
483146|NCT01089114|Cardiac Imaging|cardiac imaging
483147|NCT01089114|MR Spectroscopy|mr spectroscopy
483148|NCT01089114|HIV|hiv
483149|NCT01089114|Lipid Metabolism|lipid metabolism
483150|NCT01089114|HIV Infection|hiv infection
483151|NCT01089114|Cardiovascular Disease|cardiovascular disease
483152|NCT01089114|HIV Infections|hiv infections
483153|NCT01089088|recurrent urethral cancer|recurrent urethral cancer
483154|NCT01089088|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
483155|NCT01089088|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
483156|NCT01089088|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
483157|NCT01089088|posterior urethral cancer|posterior urethral cancer
483158|NCT01089088|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
483159|NCT01089088|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
483160|NCT01089088|stage IV bladder cancer|stage iv bladder cancer
483161|NCT01089088|recurrent bladder cancer|recurrent bladder cancer
483162|NCT01089088|anterior urethral cancer|anterior urethral cancer
483163|NCT01089075|neuropsychological effects of hydrocortisone replacement|neuropsychological effects of hydrocortisone replacement
483164|NCT01089062|Healthy volunteers|healthy volunteers
483165|NCT01089049|Urinary Estrogen Metabolites|urinary estrogen metabolites
483166|NCT01089049|2-OH Estrone|2-oh estrone
483167|NCT01089049|16-alpha-OH Estrone|16-alpha-oh estrone
483168|NCT01089049|Urinary 2/16a Estrogen Metabolite Ratio|urinary 2/16a estrogen metabolite ratio
483169|NCT01089036|ECMO|ecmo
483170|NCT01089036|cardiogenic shock|cardiogenic shock
483171|NCT01089036|ROS|ros
483172|NCT01089036|GPx|gpx
483173|NCT01089036|cytokines|cytokines
483174|NCT01088997|Persistent pulmonary hypertension of newborn|persistent pulmonary hypertension of newborn
483175|NCT01088997|PPHN|pphn
483176|NCT01088997|Persistent pulmonary hypertension|persistent pulmonary hypertension
483177|NCT01088997|Pulmonary hypertension|pulmonary hypertension
483178|NCT01088997|Pulmonary hypertension of newborn|pulmonary hypertension of newborn
483179|NCT01088958|Kenya|kenya
483180|NCT01088958|Child Nutrition Disorders|child nutrition disorders
483181|NCT01088958|Social marketing|social marketing
483182|NCT01088945|Infant, Premature, Diseases|infant, premature, diseases
483183|NCT01088932|Safety in Healthy Volunteers|safety in healthy volunteers
483184|NCT01088919|ASP1941|asp1941
483185|NCT01088919|Actos|actos
483186|NCT01088919|pioglitazone hydrochloride|pioglitazone hydrochloride
483187|NCT01088906|Phalcis|phalcis
483188|NCT01088906|BRCA1|brca1
483189|NCT01088906|RAP80|rap80
483190|NCT01088906|TS|ts
483191|NCT01088906|First line|first line
483192|NCT01088906|Non-squamous|non-squamous
483193|NCT01088893|everolimus|everolimus
483194|NCT01088893|neoadjuvant|neoadjuvant
483195|NCT01088893|m-TOR inhibitor|m-tor inhibitor
483196|NCT01088880|Familial Mediterranean Fever|familial mediterranean fever
483197|NCT01088880|canakinumab|canakinumab
483198|NCT01088880|colchicine resistance|colchicine resistance
483199|NCT01088867|Pain|pain
483200|NCT01088867|Acupuncture|acupuncture
483201|NCT01088867|DNIC|dnic
483202|NCT01088867|Electroacupuncture|electroacupuncture
483203|NCT01088828|MRI, clubfoot, CTEV, Congenital Talipes Equinovarus|mri, clubfoot, ctev, congenital talipes equinovarus
483204|NCT01088815|Adenocarcinoma|adenocarcinoma
483205|NCT01088815|Hedgehog|hedgehog
483206|NCT01088815|Neoplasms|neoplasms
483207|NCT01088815|Digestive System Diseases|digestive system diseases
483208|NCT01088815|Neoplasms by Site|neoplasms by site
483209|NCT01088815|Digestive System Neoplasms|digestive system neoplasms
483210|NCT01088815|Neoplasms by Histologic Type|neoplasms by histologic type
483211|NCT01088815|Pancreatic Neoplasms|pancreatic neoplasms
483212|NCT01088815|Pancreatic Diseases|pancreatic diseases
483213|NCT01088815|Carcinoma|carcinoma
483214|NCT01088802|Squamous Cell Carcinoma|squamous cell carcinoma
483215|NCT01088802|Oropharynx|oropharynx
483216|NCT01088789|Adenocarcinoma|adenocarcinoma
483217|NCT01088789|Cyclophosphamide|cyclophosphamide
483218|NCT01088789|Immunotherapy|immunotherapy
483219|NCT01088789|Neo-Adjuvant|neo-adjuvant
483220|NCT01088789|Pancreatic tumor vaccine|pancreatic tumor vaccine
483221|NCT01088789|GM-CSF|gm-csf
483222|NCT01088789|Randomize|randomize
483223|NCT01088776|CKD|ckd
483224|NCT01088776|hypertriglyceridemia|hypertriglyceridemia
483225|NCT01088776|Fatty Acid Supplementation|fatty acid supplementation
483226|NCT01088776|Children|children
483227|NCT01088776|Omega-3|omega-3
483228|NCT01088750|childhood nodular lymphocyte predominant Hodgkin lymphoma|childhood nodular lymphocyte predominant hodgkin lymphoma
483229|NCT01088750|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
483230|NCT01088750|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
483231|NCT01088737|Lentigo maligna|lentigo maligna
483232|NCT01088737|melanoma|melanoma
483233|NCT01088737|imiquimod|imiquimod
483234|NCT01088737|prevention|prevention
483235|NCT01088711|Type 2 diabetes (T2D)|type 2 diabetes (t2d)
483236|NCT01088698|psoriasis|psoriasis
483237|NCT01088698|golimumab|golimumab
483238|NCT01088698|TNF-alpha inhibition|tnf-alpha inhibition
483239|NCT01088698|phototherapy|phototherapy
483240|NCT01088698|311-nm|311-nm
483241|NCT01088672|Stroke|stroke
483242|NCT01088672|Ischemic|ischemic
483243|NCT01088672|Thrombus|thrombus
483244|NCT01088672|Embolectomy|embolectomy
483245|NCT01088672|Thrombectomy|thrombectomy
483246|NCT01088672|Concentric|concentric
483247|NCT01088672|Embolus|embolus
483248|NCT01088672|Mechanical|mechanical
483249|NCT01088672|Trevo|trevo
483250|NCT01088646|capsule endoscopy|capsule endoscopy
483251|NCT01088646|small bowel disease|small bowel disease
483252|NCT01088646|inflammatory bowel disease|inflammatory bowel disease
483253|NCT01088646|Subjects indicated for EGD endoscopy|subjects indicated for egd endoscopy
483254|NCT01088633|COPD|copd
483255|NCT01088620|NSCLC|nsclc
483256|NCT01088620|Stage IIIb or IV|stage iiib or iv
483257|NCT01088620|Nonsquamous|nonsquamous
483258|NCT01088620|KRAS-Wildtype|kras-wildtype
483259|NCT01088607|Primary sclerosing cholangitis|primary sclerosing cholangitis
483260|NCT01088607|Autoimmune hepatitis|autoimmune hepatitis
483261|NCT01088607|Cholestatic liver disease|cholestatic liver disease
483262|NCT01088607|Cirrhosis|cirrhosis
483263|NCT01088607|Children|children
483264|NCT01088607|Primary Sclerosing Cholangitis/Autoimmune Hepatitis Overlap|primary sclerosing cholangitis/autoimmune hepatitis overlap
483265|NCT01088594|urinary sodium excretion|urinary sodium excretion
483266|NCT01088594|Pioglitazone|pioglitazone
483267|NCT01088594|Rosiglitazone|rosiglitazone
483268|NCT01088594|Methodological study|methodological study
483269|NCT01088581|hepatocellular carcinoma|hepatocellular carcinoma
483270|NCT01088581|hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
483271|NCT01088581|5-fluorouracil|5-fluorouracil
483272|NCT01088581|cisplatin|cisplatin
483273|NCT01088581|adjuvant chemotherapy|adjuvant chemotherapy
483274|NCT01088581|hepatectomy|hepatectomy
483275|NCT01088568|Keratomileusis, laser in situ|keratomileusis, laser in situ
483276|NCT01088568|Phakic Intraocular Lenses|phakic intraocular lenses
483277|NCT01088568|myopia|myopia
483278|NCT01088568|astigmatism|astigmatism
483279|NCT01088568|Implantable Collamer Lens, Toric|implantable collamer lens, toric
483280|NCT01088555|nephrolithiasis|nephrolithiasis
483281|NCT01088555|calcium stones|calcium stones
483282|NCT01088555|kidney stones|kidney stones
483283|NCT01088555|hypercalciuria|hypercalciuria
483284|NCT01088555|sodium thiosulfate|sodium thiosulfate
483285|NCT01088555|Calcium containing kidney stones|calcium containing kidney stones
483286|NCT01088542|substance use|substance use
483287|NCT01088542|delinquency|delinquency
483288|NCT01088542|risky sexual behavior|risky sexual behavior
483289|NCT01088542|risk factors|risk factors
483290|NCT01088542|protective factors|protective factors
483291|NCT01088542|prevention|prevention
483292|NCT01088542|community coalitions|community coalitions
483293|NCT01088542|systems transformation|systems transformation
483294|NCT01088542|violence|violence
483295|NCT01088529|Neoadjuvant Prostate Cancer|neoadjuvant prostate cancer
483296|NCT01088529|Abiraterone Acetate|abiraterone acetate
483297|NCT01088529|LHRHa|lhrha
483298|NCT01088529|high risk prostate cancer|high risk prostate cancer
483299|NCT01088529|Radical prostatectomy|radical prostatectomy
483300|NCT01088529|Prednisone|prednisone
483301|NCT01088529|Luteinizing Hormone-Releasing Hormone|luteinizing hormone-releasing hormone
483302|NCT01088529|LHRH analogue|lhrh analogue
483303|NCT01088516|Human Immunodeficiency Virus|human immunodeficiency virus
483304|NCT01088516|Vertical Transmission|vertical transmission
483305|NCT01088516|Pregnancy|pregnancy
483306|NCT01088516|Breastfeeding|breastfeeding
483307|NCT01088516|Prevention of mother to child transmission|prevention of mother to child transmission
483308|NCT01088516|HAART|haart
483309|NCT01088516|Aluvia|aluvia
483310|NCT01088516|Lopinavir|lopinavir
483311|NCT01088516|Africa|africa
483312|NCT01088516|Infectious Disease Transmission, Vertical|infectious disease transmission, vertical
483313|NCT01088490|Hydrogen sulfide|hydrogen sulfide
483314|NCT01088490|critically ill|critically ill
483315|NCT01088490|mortality|mortality
483316|NCT01088477|Acquired anti-hormonal resistant breast cancer|acquired anti-hormonal resistant breast cancer
483317|NCT01088464|Human Immunoglobulin Gamma-1 (IgG1)|human immunoglobulin gamma-1 (igg1)
483318|NCT01088464|Monoclonal Antibody (MAb)|monoclonal antibody (mab)
483319|NCT01088464|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
483320|NCT01088464|Advanced Solid Tumors|advanced solid tumors
483321|NCT01088451|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
483322|NCT01088451|Prandial Glycemia|prandial glycemia
483323|NCT01088451|Rapid Acting Insulin Analogue|rapid acting insulin analogue
483324|NCT01088451|Human Insulin|human insulin
483325|NCT01088438|medical education|medical education
483326|NCT01088438|decision making|decision making
483327|NCT01088438|diagnostic error|diagnostic error
483328|NCT01088438|contextualization|contextualization
483329|NCT01088425|vitrification|vitrification
483330|NCT01088425|2PN oocyte|2pn oocyte
483331|NCT01088425|maternal and infant health|maternal and infant health
483332|NCT01088425|embryo survival, clinical pregnancy rate|embryo survival, clinical pregnancy rate
483333|NCT01088425|mode of delivery|mode of delivery
483334|NCT01088425|injury during delivery|injury during delivery
483335|NCT01088425|infant development|infant development
483336|NCT01088425|infant morbidity|infant morbidity
483337|NCT01088425|slow- rate freezing|slow- rate freezing
483338|NCT01088347|TRAIL|trail
483339|NCT01088347|TRM1|trm1
483340|NCT01088347|advanced cervical cancer|advanced cervical cancer
483341|NCT01088347|mapatumumab|mapatumumab
483342|NCT01088347|Uterine cervical neoplasm|uterine cervical neoplasm
483343|NCT01088347|Radiotherapy|radiotherapy
483344|NCT01088347|Cisplatin|cisplatin
483345|NCT01088334|Idiopathic venous thromboembolism|idiopathic venous thromboembolism
483346|NCT01088334|Malignancy|malignancy
483347|NCT01088334|screening|screening
483348|NCT01088295|Metabolic|metabolic
483349|NCT01088295|HIV|hiv
483350|NCT01088295|Fat accumulation|fat accumulation
483351|NCT01088295|AIDS|aids
483447|NCT01087931|Local anesthetic|local anesthetic
483352|NCT01088295|Metabolic abnormalities in HIV infection|metabolic abnormalities in hiv infection
483353|NCT01088295|HIV Infections|hiv infections
483354|NCT01088282|Diffractive multifocal IOL|diffractive multifocal iol
483355|NCT01088269|Blood Pressure Measurement|blood pressure measurement
483356|NCT01088269|Atrial Fibrillation|atrial fibrillation
483357|NCT01088269|Blood pressure measurement in atrial fibrillation|blood pressure measurement in atrial fibrillation
483358|NCT01088269|Atrial Fibrillation diagnosis|atrial fibrillation diagnosis
483359|NCT01088256|CRPS|crps
483360|NCT01088256|Morbus Sudeck|morbus sudeck
483361|NCT01088256|Causalgia|causalgia
483362|NCT01088256|Etoricoxib|etoricoxib
483363|NCT01088256|Polyneuropathy|polyneuropathy
483364|NCT01088256|post herpetic neuralgia|post herpetic neuralgia
483365|NCT01088256|peripheral nerve injury|peripheral nerve injury
483366|NCT01088256|radiculopathy|radiculopathy
483367|NCT01088256|Nervenverletzung|nervenverletzung
483368|NCT01088256|postherpetische Neuralgie|postherpetische neuralgie
483369|NCT01088256|COX-2-Inhibitor|cox-2-inhibitor
483370|NCT01088243|Berylliosis|berylliosis
483371|NCT01088243|Beryllium Disease|beryllium disease
483372|NCT01088230|hemiparesis|hemiparesis
483373|NCT01088230|robotics|robotics
483374|NCT01088230|stroke|stroke
483375|NCT01088230|Botox®|botox®
483376|NCT01088230|rehabilitation|rehabilitation
483377|NCT01088230|wrist spasticity|wrist spasticity
483378|NCT01088217|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
483379|NCT01088217|Familial Pulmonary Fibrosis|familial pulmonary fibrosis
483380|NCT01088217|Idiopathic Interstitial Pneumonia|idiopathic interstitial pneumonia
483381|NCT01088217|Familial Interstitial Pneumonia|familial interstitial pneumonia
483382|NCT01088217|Pulmonary Fibrosis|pulmonary fibrosis
483383|NCT01088191|Acute Anterior Cruciate Ligament Injury|acute anterior cruciate ligament injury
483384|NCT01088191|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
483385|NCT01088191|Adult Stem Cells|adult stem cells
483386|NCT01088191|Mesenchymal precursor cells|mesenchymal precursor cells
483387|NCT01088178|Long-Acting Reversible Contraception|long-acting reversible contraception
483388|NCT01088178|Contraceptive Agents|contraceptive agents
483389|NCT01088178|Therapeutic Uses|therapeutic uses
483390|NCT01088178|Contraceptive Agents, Female|contraceptive agents, female
483391|NCT01088178|Reproductive Control Agents|reproductive control agents
483392|NCT01088178|Pharmacologic Actions|pharmacologic actions
483393|NCT01088178|Levonorgestrel|levonorgestrel
483394|NCT01088165|Psoriasis|psoriasis
483395|NCT01088165|Cardiovascular Diseases|cardiovascular diseases
483396|NCT01088165|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
483397|NCT01088165|Adalimumab|adalimumab
483398|NCT01088165|Fumaric acid esters|fumaric acid esters
483399|NCT01088152|Celiac disease|celiac disease
483400|NCT01088152|Education|education
483401|NCT01088152|Sweden|sweden
483402|NCT01088152|Gluten-free diet|gluten-free diet
483403|NCT01088139|Nutritional support|nutritional support
483404|NCT01088139|Rehabilitation outcomes|rehabilitation outcomes
483405|NCT01088113|Tai Chi|tai chi
483406|NCT01088113|Qigong|qigong
483407|NCT01088113|Heart rate variability|heart rate variability
483408|NCT01088113|Near Infrared Spectroscopy|near infrared spectroscopy
483409|NCT01088113|blood pressure|blood pressure
483410|NCT01088100|POCD|pocd
483411|NCT01088100|clock-gene genotypes|clock-gene genotypes
483412|NCT01088100|HPER3|hper3
483413|NCT01088074|Total Knee Replacement|total knee replacement
483414|NCT01088074|Closure Methods|closure methods
483415|NCT01088048|CLL|cll
483416|NCT01088048|non-Hodgkin lymphoma (NHL)|non-hodgkin lymphoma (nhl)
483417|NCT01088048|mantle cell lymphoma (MCL)|mantle cell lymphoma (mcl)
483418|NCT01088048|phosphatidylinositol 3-kinase|phosphatidylinositol 3-kinase
483419|NCT01088048|bendamustine|bendamustine
483420|NCT01088048|CD20 mAb|cd20 mab
483421|NCT01088048|rituximab|rituximab
483422|NCT01088048|CAL-101|cal-101
483423|NCT01088048|Ofatumumab|ofatumumab
483424|NCT01088048|indolent non-Hodgkin lymphoma (iNHL)|indolent non-hodgkin lymphoma (inhl)
483425|NCT01088048|fludarabine|fludarabine
483426|NCT01088048|everolimus|everolimus
483427|NCT01088048|bortezomib|bortezomib
483428|NCT01088048|chlorambucil|chlorambucil
483429|NCT01088048|lenalidomide|lenalidomide
483430|NCT01088035|Childhood ependymoma|childhood ependymoma
483431|NCT01088035|Ependymoma|ependymoma
483432|NCT01088035|Survivin|survivin
483433|NCT01088022|the complete response (CR) rate defined as the number of patients with no emetic episodes and no rescue medication in the first 120 hours post-chemotherapy|the complete response (cr) rate defined as the number of patients with no emetic episodes and no rescue medication in the first 120 hours post-chemotherapy
483434|NCT01088009|chronic hepatitis B|chronic hepatitis b
483435|NCT01087996|Chronic Ischemic Left Ventricular|chronic ischemic left ventricular
483436|NCT01087983|Metastatic cancer|metastatic cancer
483437|NCT01087983|Lapatinib|lapatinib
483438|NCT01087983|Tykerb|tykerb
483439|NCT01087983|Metformin|metformin
483440|NCT01087983|Glucophage|glucophage
483441|NCT01087983|Sirolimus|sirolimus
483442|NCT01087983|Rapamune|rapamune
483443|NCT01087970|Pharynx|pharynx
483444|NCT01087970|Larynx|larynx
483445|NCT01087970|Nose|nose
483446|NCT01087970|Parathyroid|parathyroid
483448|NCT01087931|Iliac crest bone harvest|iliac crest bone harvest
483449|NCT01087931|Patients undergoing spine surgery that require use of iliac crest bone autograft|patients undergoing spine surgery that require use of iliac crest bone autograft
483450|NCT01087918|ASIA C and D|asia c and d
483451|NCT01087905|Smoking|smoking
483452|NCT01087905|Smoking cessation|smoking cessation
483453|NCT01087905|Medication adherence|medication adherence
483454|NCT01087879|oral glucose tolerance test|oral glucose tolerance test
483455|NCT01087879|hormonal contraception|hormonal contraception
483456|NCT01087879|androgens|androgens
483457|NCT01087879|crp|crp
483458|NCT01087866|Gestational diabetes mellitus|gestational diabetes mellitus
483459|NCT01087866|treatment|treatment
483460|NCT01087866|metformin|metformin
483461|NCT01087853|Fluid Therapy|fluid therapy
483462|NCT01087853|Water Electrolyte Imbalance|water electrolyte imbalance
483463|NCT01087853|Acid Base Imbalance|acid base imbalance
483464|NCT01087853|Renal Circulation|renal circulation
483465|NCT01087853|Magnetic Resonance Imaging|magnetic resonance imaging
483466|NCT01087840|HIV|hiv
483467|NCT01087840|nonoccupational|nonoccupational
483468|NCT01087840|postexposure|postexposure
483469|NCT01087840|prophylaxis|prophylaxis
483470|NCT01087840|HIV Seronegativity|hiv seronegativity
483471|NCT01087827|oscillometric blood pressure|oscillometric blood pressure
483472|NCT01087827|cuff site|cuff site
483473|NCT01087827|forearm blood pressure|forearm blood pressure
483474|NCT01087827|upper arm blood pressure|upper arm blood pressure
483475|NCT01087827|anthropometric measurements|anthropometric measurements
483476|NCT01087827|tonometry|tonometry
483477|NCT01087827|site of blood pressure measurement|site of blood pressure measurement
483478|NCT01087827|measurement accuracy|measurement accuracy
483479|NCT01087814|efavirenz|efavirenz
483480|NCT01087814|Sustiva|sustiva
483481|NCT01087814|pharmacokinetics|pharmacokinetics
483482|NCT01087801|Genetic End Marker|genetic end marker
483483|NCT01087788|Certolizumab Pegol|certolizumab pegol
483484|NCT01087788|Cimzia|cimzia
483485|NCT01087762|Certolizumab Pegol|certolizumab pegol
483486|NCT01087762|Cimzia|cimzia
483487|NCT01087736|PTSD|ptsd
483488|NCT01087736|Alcohol abuse|alcohol abuse
483489|NCT01087736|Alcoholism|alcoholism
483490|NCT01087736|Topiramate|topiramate
483491|NCT01087736|Stress Disorder, Post Traumatic|stress disorder, post traumatic
483492|NCT01087736|Chronic Post-Traumatic Stress Disorder|chronic post-traumatic stress disorder
483493|NCT01087723|EUROMAX|euromax
483494|NCT01087723|STEMI|stemi
483495|NCT01087723|STE-ACS|ste-acs
483496|NCT01087723|UFH|ufh
483497|NCT01087723|bivalirudin|bivalirudin
483498|NCT01087723|PCI|pci
483499|NCT01087723|ambulance study|ambulance study
483500|NCT01087723|STE-MI participants|ste-mi participants
483501|NCT01087697|bladder cancer|bladder cancer
483502|NCT01087697|radical cystectomy|radical cystectomy
483503|NCT01087697|incontinent urinary diversion|incontinent urinary diversion
483504|NCT01087684|Glaucoma|glaucoma
483505|NCT01087684|laser trabeculoplasty|laser trabeculoplasty
483506|NCT01087684|intraocular pressure|intraocular pressure
483507|NCT01087632|Metabolic Syndrome Insulin-resistance Endothelial Function|metabolic syndrome insulin-resistance endothelial function
483508|NCT01087619|Hyperparathyroidism, primary|hyperparathyroidism, primary
483509|NCT01087619|Aged 66 years or older|aged 66 years or older
483510|NCT01087619|Mild hypercalcaemia|mild hypercalcaemia
483511|NCT01087619|Surgical Procedures, Elective|surgical procedures, elective
483512|NCT01087619|Indication|indication
483513|NCT01087619|Osteoporosis|osteoporosis
483514|NCT01087619|Cognitive function|cognitive function
483515|NCT01087619|Atherosclerosis|atherosclerosis
483516|NCT01087619|Follow-up|follow-up
483517|NCT01087619|Randomized trial|randomized trial
483518|NCT01087593|estrogen|estrogen
483519|NCT01087593|substitution|substitution
483520|NCT01087593|pain|pain
483521|NCT01087593|hormonal levels|hormonal levels
483522|NCT01087593|quantitative sensory testing|quantitative sensory testing
483523|NCT01087580|Prostate Cancer|prostate cancer
483524|NCT01087580|non metastatic prostate cancer|non metastatic prostate cancer
483525|NCT01087580|oligometastatic prostate cancer|oligometastatic prostate cancer
483526|NCT01087567|diabetes|diabetes
483527|NCT01087567|insulin|insulin
483528|NCT01087567|rescue therapy|rescue therapy
483529|NCT01087554|Advanced Cancer|advanced cancer
483530|NCT01087554|Sirolimus|sirolimus
483531|NCT01087554|Rapamune|rapamune
483532|NCT01087554|mTOR Inhibitor|mtor inhibitor
483533|NCT01087554|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
483534|NCT01087554|Vorinostat|vorinostat
483535|NCT01087554|SAHA|saha
483536|NCT01087554|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
483537|NCT01087554|MSK-390|msk-390
483538|NCT01087554|Zolinza|zolinza
483539|NCT01087554|Everolimus|everolimus
483540|NCT01087554|Afinitor|afinitor
483541|NCT01087554|Zortress|zortress
483542|NCT01087554|RAD001|rad001
483543|NCT01087554|Temsirolimus|temsirolimus
483544|NCT01087554|CCI-779|cci-779
483545|NCT01087554|Torisel|torisel
483546|NCT01087541|Patient's Safety|patient's safety
483547|NCT01087541|Diabetes mellitus|diabetes mellitus
483548|NCT01087541|Public Health for professionals|public health for professionals
483549|NCT01087541|Safety|safety
483550|NCT01087541|Public health|public health
483551|NCT01087528|Colonic Diseases|colonic diseases
483552|NCT01087528|bowel diseases|bowel diseases
483553|NCT01087528|large bowel diseases|large bowel diseases
483554|NCT01087489|pain|pain
483555|NCT01087489|discomfort|discomfort
483556|NCT01087489|anesthetic drugs|anesthetic drugs
483557|NCT01087489|topical drug administration|topical drug administration
483558|NCT01087489|injections, intraocular|injections, intraocular
483559|NCT01087489|lidocaine|lidocaine
483560|NCT01087489|intraocular pressure|intraocular pressure
483561|NCT01087489|keratopathy|keratopathy
483562|NCT01087476|oral mucositis|oral mucositis
483563|NCT01087476|chemotherapy|chemotherapy
483564|NCT01087476|acute leukemia|acute leukemia
483565|NCT01087476|salivary flow.|salivary flow.
483566|NCT01087450|Erythropoietin|erythropoietin
483567|NCT01087450|Sepsis|sepsis
483568|NCT01087450|Septic shock|septic shock
483569|NCT01087450|Orthogonal Polarization Spectroscopy|orthogonal polarization spectroscopy
483570|NCT01087450|Severe sepsis or Septic shock|severe sepsis or septic shock
483571|NCT01087437|Distraction osteogenesis|distraction osteogenesis
483572|NCT01087424|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
483573|NCT01087411|accelerometry|accelerometry
483574|NCT01087411|physical activity|physical activity
483575|NCT01087411|obesity|obesity
483576|NCT01087411|children|children
483577|NCT01087411|cardiovascular risk markers|cardiovascular risk markers
483578|NCT01087411|metabolic risk markers|metabolic risk markers
483580|NCT01087411|obesity prevention|obesity prevention
483581|NCT01087411|omega 3|omega 3
483582|NCT01087411|fish liver oil|fish liver oil
483583|NCT01087411|motivational interviewing|motivational interviewing
483584|NCT01087398|Osteopetrosis|osteopetrosis
483585|NCT01087398|HSCT|hsct
483586|NCT01087385|peripheral arterial occlusive disease|peripheral arterial occlusive disease
483587|NCT01087385|mortality|mortality
483588|NCT01087385|cardiovascular events|cardiovascular events
483589|NCT01087385|amputation|amputation
483590|NCT01087385|peripheral arterial revascularization|peripheral arterial revascularization
483591|NCT01087372|Stress hyperglycemia|stress hyperglycemia
483592|NCT01087372|Incretins|incretins
483593|NCT01087372|GLP-1|glp-1
483594|NCT01087372|GIP|gip
483595|NCT01087372|glucoregulatory hormones|glucoregulatory hormones
483596|NCT01087346|Parents|parents
483597|NCT01087346|Family History|family history
483598|NCT01087346|Healthy Volunteer|healthy volunteer
483599|NCT01087346|HV|hv
483600|NCT01087333|Cytotoxicity Assay|cytotoxicity assay
483601|NCT01087333|Neutralizing Antibodies|neutralizing antibodies
483602|NCT01087333|Apheresis|apheresis
483603|NCT01087333|Flow Cytometry|flow cytometry
483604|NCT01087333|Hemolytic Uremic Syndrome (HUS)|hemolytic uremic syndrome (hus)
483605|NCT01087333|Leukemia|leukemia
483606|NCT01087333|Lymphoma|lymphoma
483607|NCT01087333|Hairy Cell Leukemia|hairy cell leukemia
483608|NCT01087333|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
483609|NCT01087333|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
483610|NCT01087333|Cutaneous T Cell Lymphoma|cutaneous t cell lymphoma
483611|NCT01087333|Adult T Cell Lymphoma|adult t cell lymphoma
483612|NCT01087320|Genetic Counseling|genetic counseling
483613|NCT01087320|Genetic Disorders|genetic disorders
483614|NCT01087320|Genetic Testing|genetic testing
483615|NCT01087320|Genetic/Genomic Researchers|genetic/genomic researchers
483616|NCT01087320|Human Genetic Variation|human genetic variation
483617|NCT01087320|Congenital Disorders|congenital disorders
483618|NCT01087320|Inherited Diseases|inherited diseases
483619|NCT01087307|Biospecimen|biospecimen
483620|NCT01087307|Registry|registry
483621|NCT01087307|Assay Development|assay development
483622|NCT01087307|Assay Validation|assay validation
483623|NCT01087307|Specimen Collection|specimen collection
483624|NCT01087294|CD19|cd19
483625|NCT01087294|Chimeric-Antigen-Receptor|chimeric-antigen-receptor
483626|NCT01087294|Gene Therapy|gene therapy
483627|NCT01087294|Adoptive T Cell Therapy|adoptive t cell therapy
483628|NCT01087294|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
483629|NCT01087294|B Cell Cancer|b cell cancer
483630|NCT01087294|Allogenic Stem Cell Transplant|allogenic stem cell transplant
483631|NCT01087281|Visual Attention|visual attention
483632|NCT01087281|Visual Cortex|visual cortex
483633|NCT01087281|Focal Lesions|focal lesions
483634|NCT01087281|Neurological Disorder|neurological disorder
483635|NCT01087281|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
483636|NCT01087281|Focal Brain Lesion|focal brain lesion
483637|NCT01087281|Healthy Volunteer|healthy volunteer
483638|NCT01087281|HV|hv
483639|NCT01087268|gastrointestinal complications|gastrointestinal complications
483640|NCT01087268|radiation toxicity|radiation toxicity
483641|NCT01087268|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
483642|NCT01087268|stage I rectal cancer|stage i rectal cancer
483643|NCT01087268|stage II rectal cancer|stage ii rectal cancer
483644|NCT01087268|stage III rectal cancer|stage iii rectal cancer
483645|NCT01087268|stage I prostate cancer|stage i prostate cancer
483646|NCT01087268|stage IIB prostate cancer|stage iib prostate cancer
483647|NCT01087268|stage IIA prostate cancer|stage iia prostate cancer
483648|NCT01087268|stage III prostate cancer|stage iii prostate cancer
483649|NCT01087268|stage IV prostate cancer|stage iv prostate cancer
483650|NCT01087268|stage I bladder cancer|stage i bladder cancer
483651|NCT01087268|stage II bladder cancer|stage ii bladder cancer
483652|NCT01087268|stage III bladder cancer|stage iii bladder cancer
483653|NCT01087268|stage IV bladder cancer|stage iv bladder cancer
483654|NCT01087268|stage IA cervical cancer|stage ia cervical cancer
483655|NCT01087268|stage IB cervical cancer|stage ib cervical cancer
483656|NCT01087268|stage IIA cervical cancer|stage iia cervical cancer
483657|NCT01087268|stage IIB cervical cancer|stage iib cervical cancer
483658|NCT01087268|stage III cervical cancer|stage iii cervical cancer
483659|NCT01087268|stage I vaginal cancer|stage i vaginal cancer
483660|NCT01087268|stage II vaginal cancer|stage ii vaginal cancer
483661|NCT01087268|stage III vaginal cancer|stage iii vaginal cancer
483662|NCT01087268|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
483663|NCT01087268|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
483664|NCT01087268|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
483665|NCT01087268|stage I endometrial carcinoma|stage i endometrial carcinoma
483666|NCT01087268|stage II endometrial carcinoma|stage ii endometrial carcinoma
483667|NCT01087268|stage III endometrial carcinoma|stage iii endometrial carcinoma
483668|NCT01087268|stage I uterine sarcoma|stage i uterine sarcoma
483669|NCT01087268|stage II uterine sarcoma|stage ii uterine sarcoma
483670|NCT01087268|stage III uterine sarcoma|stage iii uterine sarcoma
483671|NCT01087268|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
483672|NCT01087268|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
483673|NCT01087268|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
483674|NCT01087268|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
483675|NCT01087268|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
483676|NCT01087268|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
483677|NCT01087268|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
483678|NCT01087268|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
483679|NCT01087268|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
483680|NCT01087268|stage IA ovarian germ cell tumor|stage ia ovarian germ cell tumor
483681|NCT01087268|stage IB ovarian germ cell tumor|stage ib ovarian germ cell tumor
483682|NCT01087268|stage IC ovarian germ cell tumor|stage ic ovarian germ cell tumor
483683|NCT01087268|stage IIA ovarian germ cell tumor|stage iia ovarian germ cell tumor
483684|NCT01087268|stage IIB ovarian germ cell tumor|stage iib ovarian germ cell tumor
483685|NCT01087268|stage IIC ovarian germ cell tumor|stage iic ovarian germ cell tumor
483686|NCT01087268|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
483687|NCT01087268|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
483688|NCT01087268|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
483689|NCT01087255|Caregiver-based interventions|caregiver-based interventions
483690|NCT01087255|Chronic Kidney Disease|chronic kidney disease
483691|NCT01087255|Medication Adherence|medication adherence
483692|NCT01087242|Tang-min Lin pills|tang-min lin pills
483693|NCT01087242|type 2 diabetes|type 2 diabetes
483694|NCT01087242|liver and stomach heat retention|liver and stomach heat retention
483695|NCT01087242|Evaluate the safety and efficacy of Tang-min Lin pills|evaluate the safety and efficacy of tang-min lin pills
483696|NCT01087203|diabetic peripheral neuropathy|diabetic peripheral neuropathy
483697|NCT01087203|tanezumab|tanezumab
483698|NCT01087203|diabetic neuropathies|diabetic neuropathies
483699|NCT01087203|diabetic polyneuropathy|diabetic polyneuropathy
483700|NCT01087203|diabetic neuropathy painful|diabetic neuropathy painful
483701|NCT01087190|kidney|kidney
483702|NCT01087190|transplantation|transplantation
483703|NCT01087190|tuberculosis|tuberculosis
483704|NCT01087190|ELISPOT|elispot
483705|NCT01087190|isoniazid|isoniazid
483706|NCT01087177|Smoking|smoking
483707|NCT01087177|Tobacco|tobacco
483708|NCT01087177|Pediatrics|pediatrics
483709|NCT01087164|Vaccine acceptance|vaccine acceptance
483710|NCT01087164|human papillomavirus|human papillomavirus
483711|NCT01087164|brief messages|brief messages
483712|NCT01087164|social compliance|social compliance
483713|NCT01087164|Message sidedness|message sidedness
483714|NCT01087151|Rituxan|rituxan
483715|NCT01087151|Apoptosis|apoptosis
483716|NCT01087151|BCl-2|bcl-2
483717|NCT01087138|bone health|bone health
483718|NCT01087138|bone density|bone density
483719|NCT01087138|bone mass|bone mass
483720|NCT01087112|MIP|mip
483721|NCT01087112|RCT|rct
483722|NCT01087112|postnatal depression|postnatal depression
483723|NCT01087112|Mother-child relationship|mother-child relationship
483724|NCT01087086|Metabolic syndrome|metabolic syndrome
483725|NCT01087086|Oxidative stress|oxidative stress
483726|NCT01087086|Proinflammatory state|proinflammatory state
483727|NCT01087086|Insulin resistance|insulin resistance
483728|NCT01087086|Hypertension|hypertension
483729|NCT01087086|Dyslipidemia|dyslipidemia
483730|NCT01087086|Mediterranean diet|mediterranean diet
483731|NCT01087086|Glycemic index|glycemic index
483732|NCT01087086|Hypocaloric diet|hypocaloric diet
483733|NCT01087086|Hyperproteic diet|hyperproteic diet
483734|NCT01087086|Macronutrient distribution|macronutrient distribution
483735|NCT01087086|Antioxidant capacity of the diet|antioxidant capacity of the diet
483736|NCT01087086|Crononutrition|crononutrition
483737|NCT01087086|Dietary and psychological support|dietary and psychological support
483738|NCT01087086|Waist circumference|waist circumference
483739|NCT01087073|Healthcare Disparities|healthcare disparities
483740|NCT01087073|Health Care Quality Improvement|health care quality improvement
483741|NCT01087073|Shared Decision-Making|shared decision-making
483742|NCT01087073|Patient Education|patient education
483743|NCT01087073|Patient Activation|patient activation
483744|NCT01087073|Community Outreach|community outreach
483745|NCT01087073|Provider Training|provider training
483746|NCT01087047|Pregnancy|pregnancy
483747|NCT01087047|Upper airways|upper airways
483748|NCT01087047|Acoustic reflection method|acoustic reflection method
483749|NCT01087034|Infantile scoliosis|infantile scoliosis
483750|NCT01087034|bracing|bracing
483751|NCT01087034|acoustic reflection method|acoustic reflection method
483752|NCT01087034|EOS™|eos™
483753|NCT01087034|noninvasive|noninvasive
483754|NCT01087034|upper airways|upper airways
483755|NCT01087034|thoracic penetration index|thoracic penetration index
483756|NCT01087034|Idiopathic juvenile evolutive thoracic scoliosis|idiopathic juvenile evolutive thoracic scoliosis
483757|NCT01087008|Multiple Myeloma|multiple myeloma
483758|NCT01087008|Zoledronic acid|zoledronic acid
483759|NCT01086995|extubation|extubation
483760|NCT01086995|weaning|weaning
483761|NCT01086995|mechanical ventilation|mechanical ventilation
483762|NCT01086969|Meningococcal Infection|meningococcal infection
483763|NCT01086969|Meningitis, Bacterial|meningitis, bacterial
483764|NCT01086969|Menactra®|menactra®
483765|NCT01086956|patients of prostatic cancer aged more than 65 years|patients of prostatic cancer aged more than 65 years
483766|NCT01086917|Malaria Challenge|malaria challenge
483767|NCT01086917|Plasmodium falciparum|plasmodium falciparum
483768|NCT01086917|Controlled human malaria infection|controlled human malaria infection
483769|NCT01086917|PfSPZ Challenge|pfspz challenge
483770|NCT01086904|renal transplantation|renal transplantation
483771|NCT01086904|immunosuppression|immunosuppression
483772|NCT01086904|inflenza A (H1N1)|inflenza a (h1n1)
483773|NCT01086904|vaccine|vaccine
483774|NCT01086878|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
483775|NCT01086878|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
483776|NCT01086878|anemia|anemia
483777|NCT01086878|neutropenia|neutropenia
483778|NCT01086878|safety|safety
483779|NCT01086878|hematologic toxicity|hematologic toxicity
483780|NCT01086865|inappetence|inappetence
483781|NCT01086865|apetiviton BC|apetiviton bc
483782|NCT01086852|Factor X deficiency|factor x deficiency
483783|NCT01086852|surgery|surgery
483784|NCT01086852|Factor X deficiency subjects requiring surgery|factor x deficiency subjects requiring surgery
483785|NCT01086839|Cystic Fibrosis|cystic fibrosis
483786|NCT01086839|chronic rhinosinusitis|chronic rhinosinusitis
483787|NCT01086813|Safety|safety
483788|NCT01086813|Tolerability|tolerability
483789|NCT01086813|Pharmacokinetics|pharmacokinetics
483790|NCT01086813|Sedation|sedation
483791|NCT01086787|Heart failure|heart failure
483792|NCT01086787|Bone marrow|bone marrow
483793|NCT01086787|Bone marrow mononuclear cells|bone marrow mononuclear cells
483794|NCT01086787|Surgery|surgery
483795|NCT01086787|Orthopedic surgery|orthopedic surgery
483796|NCT01086787|Cardiac surgery|cardiac surgery
483797|NCT01086774|Dry eye|dry eye
483798|NCT01086774|Tear Film Stability|tear film stability
483799|NCT01086735|hematological malignancy|hematological malignancy
483800|NCT01086735|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
483801|NCT01086735|donor lymphocyte infusion|donor lymphocyte infusion
483802|NCT01086735|antitumor immunotherapy|antitumor immunotherapy
483803|NCT01086735|graft-versus-tumor effect|graft-versus-tumor effect
483804|NCT01086735|gene therapy|gene therapy
483805|NCT01086735|relapse|relapse
483806|NCT01086735|adult|adult
483807|NCT01086709|Human Papillomavirus|human papillomavirus
483808|NCT01086709|Vaccine|vaccine
483809|NCT01086709|Crossover|crossover
483810|NCT01086709|Hepatitis A|hepatitis a
483811|NCT01086709|Hepatitis B|hepatitis b
483812|NCT01086696|PET Imaging|pet imaging
483813|NCT01086696|F-18 Paclitaxel (FPAC)|f-18 paclitaxel (fpac)
483814|NCT01086696|Breast Cancer|breast cancer
483815|NCT01086696|Lung Cancer|lung cancer
483816|NCT01086696|Renal and Adrenal Cancers|renal and adrenal cancers
483817|NCT01086696|Kidney Cancer|kidney cancer
483818|NCT01086696|Adrenal Cancer|adrenal cancer
483819|NCT01086683|neoplasms|neoplasms
483820|NCT01086683|rehabilitation|rehabilitation
483821|NCT01086683|intervention|intervention
483822|NCT01086683|quality of life|quality of life
483823|NCT01086683|lifestyle|lifestyle
483824|NCT01086670|Coordination|coordination
483825|NCT01086670|Neuroimaging|neuroimaging
483826|NCT01086670|Motion Analysis|motion analysis
483827|NCT01086670|Locomotor|locomotor
483828|NCT01086670|Cerebral Palsy|cerebral palsy
483829|NCT01086670|Pediatrics|pediatrics
483830|NCT01086657|Bird Flu|bird flu
483831|NCT01086657|Avian Influenza|avian influenza
483832|NCT01086657|Healthy|healthy
483833|NCT01086657|Immunity|immunity
483834|NCT01086657|Prevention|prevention
483835|NCT01086657|Healthy Volunteer|healthy volunteer
483836|NCT01086657|HV|hv
483837|NCT01086631|Autoimmune Retinopathy|autoimmune retinopathy
483838|NCT01086631|RITUXAN|rituxan
483839|NCT01086631|Rituximab|rituximab
483840|NCT01086631|Immunosuppression|immunosuppression
483841|NCT01086618|stage IV colon cancer|stage iv colon cancer
483842|NCT01086618|stage IV rectal cancer|stage iv rectal cancer
483843|NCT01086605|HER2-negative breast cancer|her2-negative breast cancer
483844|NCT01086605|male breast cancer|male breast cancer
483845|NCT01086605|recurrent breast cancer|recurrent breast cancer
483846|NCT01086605|stage IV breast cancer|stage iv breast cancer
483847|NCT01086605|stage IIIC breast cancer|stage iiic breast cancer
483848|NCT01086592|Aged|aged
483849|NCT01086592|Strength|strength
483850|NCT01086592|Balance|balance
483851|NCT01086592|Electrotherapy|electrotherapy
483852|NCT01086592|Quality of life|quality of life
483853|NCT01086579|paclitaxel PTCA drug-eluting balloon|paclitaxel ptca drug-eluting balloon
483854|NCT01086579|provisional spot stenting|provisional spot stenting
483855|NCT01086579|coronary artery disease|coronary artery disease
483856|NCT01086579|Late Lumen Loss|late lumen loss
483857|NCT01086579|Minimal lumen diameter|minimal lumen diameter
483858|NCT01086579|coronary artery disease in a small vessel|coronary artery disease in a small vessel
483859|NCT01086566|Influenza, H5N1, avian influenza, parent protocol|influenza, h5n1, avian influenza, parent protocol
483860|NCT01086553|Crohn´s disease|crohn´s disease
483861|NCT01086553|budesonide|budesonide
483862|NCT01086553|induction of remission|induction of remission
483863|NCT01086540|Systemic Sclerosis-Associated Pulmonary Arterial Hypertension|systemic sclerosis-associated pulmonary arterial hypertension
483864|NCT01086540|Autoimmune Disease|autoimmune disease
483865|NCT01086540|Systemic Scleroderma|systemic scleroderma
483866|NCT01086540|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
483867|NCT01086527|Pharmacogenetics|pharmacogenetics
483868|NCT01086527|Singulair|singulair
483869|NCT01086527|montelukast|montelukast
483870|NCT01086527|Leukotriene Antagonists|leukotriene antagonists
483871|NCT01086527|Anti-Asthmatic Agents|anti-asthmatic agents
483872|NCT01086527|Intestinal Absorption|intestinal absorption
483873|NCT01086527|pharmacokinetics|pharmacokinetics
483874|NCT01086527|absorption|absorption
483875|NCT01086527|biochemical transport|biochemical transport
483876|NCT01086527|Membrane Transport Proteins|membrane transport proteins
483877|NCT01086514|Breast|breast
483878|NCT01086514|mammography|mammography
483879|NCT01086514|MRI|mri
483880|NCT01086514|Digital Mammography|digital mammography
483881|NCT01086514|10-024|10-024
483882|NCT01086501|open, non-interventional|open, non-interventional
483883|NCT01086488|recurrent or persistent Nasopharyngeal Carcinoma|recurrent or persistent nasopharyngeal carcinoma
483884|NCT01086488|treatment of patients with squamous cell carcinoma of the head and neck|treatment of patients with squamous cell carcinoma of the head and neck
483885|NCT01086488|Foscan-PDT|foscan-pdt
483886|NCT01086488|Brachytherapy|brachytherapy
483887|NCT01086475|Autism Spectrum Disorder|autism spectrum disorder
483888|NCT01086475|D-cycloserine|d-cycloserine
483889|NCT01086475|Social Skills Training|social skills training
483890|NCT01086462|GSK2239633|gsk2239633
483891|NCT01086462|RADIOLABEL|radiolabel
483892|NCT01086462|PHARMACOKINETICS|pharmacokinetics
483893|NCT01086462|INTRAVENOUS|intravenous
483894|NCT01086462|MICRODOSE|microdose
483895|NCT01086449|safety|safety
483896|NCT01086449|Japanese|japanese
483897|NCT01086449|Herpes Zoster|herpes zoster
483898|NCT01086449|immunogenicity|immunogenicity
483899|NCT01086449|Herpes Zoster in healthy ethnic Japanese adults|herpes zoster in healthy ethnic japanese adults
483900|NCT01086449|Vaccine|vaccine
483901|NCT01086436|Human Rotavirus vaccine|human rotavirus vaccine
483902|NCT01086423|Infanrix-IPV+Hib|infanrix-ipv+hib
483903|NCT01086410|HPA axis|hpa axis
483904|NCT01086397|pneumococcal pneumonia|pneumococcal pneumonia
483905|NCT01086397|community-acquired pneumonia|community-acquired pneumonia
483906|NCT01086371|Multiple Sclerosis|multiple sclerosis
483907|NCT01086371|gait|gait
483908|NCT01086358|Productivity|productivity
483909|NCT01086358|Migraine|migraine
483910|NCT01086358|Treximet|treximet
483911|NCT01086358|Triptan|triptan
483912|NCT01086345|adult giant cell glioblastoma|adult giant cell glioblastoma
483913|NCT01086345|adult gliosarcoma|adult gliosarcoma
483914|NCT01086345|recurrent adult brain tumor|recurrent adult brain tumor
483915|NCT01086332|radiotherapy|radiotherapy
483916|NCT01086332|gemcitabine|gemcitabine
483917|NCT01086332|nelfinavir|nelfinavir
483918|NCT01086332|neoplasms|neoplasms
483919|NCT01086241|Tomography|tomography
483920|NCT01086241|Mammography|mammography
483921|NCT01086241|Breast Neoplasms|breast neoplasms
483922|NCT01086241|Prevention and Control|prevention and control
483923|NCT01086228|Drug eluting stents|drug eluting stents
483924|NCT01086228|Stents|stents
483925|NCT01086228|Angioplasty|angioplasty
483926|NCT01086202|irreparable rotator cuff tears|irreparable rotator cuff tears
483927|NCT01086163|Omacor|omacor
483928|NCT01086163|Simvastatin|simvastatin
483929|NCT01086163|Aspirin|aspirin
483930|NCT01086163|Platelet activity|platelet activity
483931|NCT01086163|Coronary artery disease|coronary artery disease
483932|NCT01086137|salivary biomarker|salivary biomarker
483933|NCT01086137|metabolic syndrome|metabolic syndrome
483934|NCT01086137|prediabetes|prediabetes
483935|NCT01086137|diabetes hypertension|diabetes hypertension
483936|NCT01086124|echocardiography|echocardiography
483937|NCT01086124|ST elevation myocardial infarction|st elevation myocardial infarction
483938|NCT01086124|Heart failure|heart failure
483939|NCT01086124|Coronary artery disease|coronary artery disease
483940|NCT01086124|Cardiovascular diseases|cardiovascular diseases
483941|NCT01086111|type 2 diabetes|type 2 diabetes
483942|NCT01086111|gastric bypass|gastric bypass
483943|NCT01086111|sleeve gastrectomy|sleeve gastrectomy
483944|NCT01086111|clamp study|clamp study
483945|NCT01086111|weight loss surgery|weight loss surgery
483946|NCT01086098|Pacemakers|pacemakers
483947|NCT01086098|Survival|survival
483948|NCT01086059|Autoimmune diseases|autoimmune diseases
483949|NCT01086059|adalimumab|adalimumab
483950|NCT01086059|pregnancy|pregnancy
483951|NCT01086059|birth defects|birth defects
483952|NCT01086059|TNF|tnf
483953|NCT01086059|Tumor necrosis factor|tumor necrosis factor
483954|NCT01086046|platelet|platelet
483955|NCT01086046|thrombozyme|thrombozyme
483956|NCT01086046|ASD|asd
483957|NCT01086046|Heparin|heparin
483958|NCT01086046|Enoxaparin|enoxaparin
483959|NCT01086033|Evaluation of safety and efficacy|evaluation of safety and efficacy
483960|NCT01086033|Adalimumab treatment|adalimumab treatment
483961|NCT01086033|Rheumatoid Arthritis|rheumatoid arthritis
483962|NCT01086020|IVUS|ivus
483963|NCT01086020|coronary plaque|coronary plaque
483964|NCT01086020|regression|regression
483965|NCT01086007|Groin hernia|groin hernia
483966|NCT01086007|chronic pain|chronic pain
483967|NCT01086007|Persistent postoperative pain|persistent postoperative pain
483968|NCT01086007|Laparoscopic inguinal herniotomy|laparoscopic inguinal herniotomy
483969|NCT01086007|Sexual dysfunction|sexual dysfunction
483970|NCT01085994|antibiotics|antibiotics
483971|NCT01085994|resistance|resistance
483972|NCT01085994|bio-marker|bio-marker
483973|NCT01085994|procalcitonin|procalcitonin
483974|NCT01085994|algorithm|algorithm
483975|NCT01085994|critically ill|critically ill
483976|NCT01085981|quantitative assessment of the effects of a topically|quantitative assessment of the effects of a topically
483977|NCT01085981|applied vasodilating cream to the clitoris using doppler|applied vasodilating cream to the clitoris using doppler
483978|NCT01085981|flow plethysmography|flow plethysmography
483979|NCT01085968|Parkinson's disease|parkinson's disease
483980|NCT01085968|Cognitive deficits|cognitive deficits
483981|NCT01085968|fMRI|fmri
483982|NCT01085968|neuro rehabilitation|neuro rehabilitation
483983|NCT01085968|Age Matched Controls|age matched controls
483984|NCT01085955|peripartum|peripartum
483985|NCT01085955|cardiomyopathy|cardiomyopathy
483986|NCT01085955|post pregnancy|post pregnancy
483987|NCT01085955|myocardial recovery|myocardial recovery
483988|NCT01085955|pregnant women with peripartum cardiomyopathy|pregnant women with peripartum cardiomyopathy
483989|NCT01085942|rotator cuff tear|rotator cuff tear
483990|NCT01085942|asymptomatic|asymptomatic
483991|NCT01085942|natural course|natural course
483992|NCT01085942|tear characteristics|tear characteristics
483993|NCT01085942|Asymptomatic rotator cuff tears|asymptomatic rotator cuff tears
483994|NCT01085942|Natural course of rotator cuff tears|natural course of rotator cuff tears
483995|NCT01085929|abscess|abscess
483996|NCT01085929|infection|infection
483997|NCT01085929|ultrasound guidance|ultrasound guidance
483998|NCT01085929|incision and drainage|incision and drainage
483999|NCT01085929|needle aspiration|needle aspiration
484000|NCT01085929|skin|skin
484001|NCT01085929|ultrasound|ultrasound
484002|NCT01085916|prevalence of asthma and Rhinitis symptoms among secondary school students in Saudi Arabia|prevalence of asthma and rhinitis symptoms among secondary school students in saudi arabia
484003|NCT01085903|Spatial Neglect|spatial neglect
484004|NCT01085903|Dysphagia|dysphagia
484005|NCT01085903|Arousal|arousal
484006|NCT01085903|Modafinil|modafinil
484007|NCT01085903|Stroke|stroke
484008|NCT01085890|Blood Pressure|blood pressure
484009|NCT01085890|Life Style|life style
484010|NCT01085890|Body Mass Index|body mass index
484011|NCT01085890|Obesity, Abdominal|obesity, abdominal
484012|NCT01085890|Blood Chemical Analysis|blood chemical analysis
484013|NCT01085864|Lung Nodules|lung nodules
484014|NCT01085864|A need exists for non-invasive testing to aid in clinical decision-making for CT scan detected lung nodules of indeterminate etiology.|a need exists for non-invasive testing to aid in clinical decision-making for ct scan detected lung nodules of indeterminate etiology.
484015|NCT01085851|Sunburn|sunburn
484016|NCT01085851|Dexchlorpheniramine|dexchlorpheniramine
484017|NCT01085851|Lotion|lotion
484018|NCT01085851|Cream|cream
484019|NCT01085838|Erlotinib|erlotinib
484296|NCT01084668|monoclonals|monoclonals
484020|NCT01085838|myelodysplastic syndrome|myelodysplastic syndrome
484021|NCT01085825|induced abortion|induced abortion
484022|NCT01085825|termination of pregnancy|termination of pregnancy
484023|NCT01085825|manual vacuum aspiration|manual vacuum aspiration
484024|NCT01085825|electric vacuum aspiration|electric vacuum aspiration
484025|NCT01085799|Educational activities|educational activities
484026|NCT01085799|Cluster-randomized controlled trial|cluster-randomized controlled trial
484027|NCT01085799|Albendazole|albendazole
484028|NCT01085799|Deworming|deworming
484029|NCT01085799|School-age children|school-age children
484030|NCT01085799|Peru|peru
484031|NCT01085799|Ascaris lumbricoides|ascaris lumbricoides
484032|NCT01085799|Trichuris trichiura|trichuris trichiura
484033|NCT01085799|Hookworm|hookworm
484034|NCT01085799|STH infections|sth infections
484035|NCT01085799|Intestinal helminth infections|intestinal helminth infections
484036|NCT01085786|Helicobacter pylori infection|helicobacter pylori infection
484037|NCT01085773|HbA1c|hba1c
484038|NCT01085773|Type 2 Diabetes|type 2 diabetes
484039|NCT01085773|Lifestyle changes|lifestyle changes
484040|NCT01085773|Exercise|exercise
484041|NCT01085747|Chronic pancreatitis|chronic pancreatitis
484042|NCT01085747|Biliary stricture|biliary stricture
484043|NCT01085747|Endoscopic treatment|endoscopic treatment
484044|NCT01085747|SEMS|sems
484045|NCT01085721|allergic rhinitis|allergic rhinitis
484046|NCT01085721|viral infections of the upper respiratory tract|viral infections of the upper respiratory tract
484047|NCT01085721|dexchlorpheniramine|dexchlorpheniramine
484048|NCT01085721|pseudoephedrine|pseudoephedrine
484049|NCT01085721|guaifenesin|guaifenesin
484050|NCT01085708|Rabeprazole|rabeprazole
484051|NCT01085708|Japan|japan
484052|NCT01085708|healthy Japanese male|healthy japanese male
484053|NCT01085695|Rabeprazole|rabeprazole
484054|NCT01085695|Japan|japan
484055|NCT01085695|healthy Japanese male|healthy japanese male
484056|NCT01085682|Diabetes prevention|diabetes prevention
484057|NCT01085682|Lifestyle modification|lifestyle modification
484058|NCT01085682|Obesity|obesity
484059|NCT01085682|Impaired glucose tolerance|impaired glucose tolerance
484060|NCT01085682|Diet|diet
484061|NCT01085682|Physical activity|physical activity
484062|NCT01085669|Infection rate of VEPTR-Implants|infection rate of veptr-implants
484063|NCT01085669|VEPTR. Vertical Expandable|veptr. vertical expandable
484064|NCT01085669|Prosthetic Titanium Rib|prosthetic titanium rib
484065|NCT01085643|IBS|ibs
484066|NCT01085643|Lubiprostone|lubiprostone
484067|NCT01085643|Small Bowel|small bowel
484068|NCT01085643|High Resolution Manometry|high resolution manometry
484069|NCT01085643|Delayed Intestinal Transit|delayed intestinal transit
484070|NCT01085630|epithelial mesothelioma|epithelial mesothelioma
484071|NCT01085630|sarcomatous mesothelioma|sarcomatous mesothelioma
484072|NCT01085630|stage II malignant mesothelioma|stage ii malignant mesothelioma
484073|NCT01085630|stage III malignant mesothelioma|stage iii malignant mesothelioma
484074|NCT01085630|stage IV malignant mesothelioma|stage iv malignant mesothelioma
484075|NCT01085617|oral complications|oral complications
484076|NCT01085617|mucositis|mucositis
484077|NCT01085617|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
484078|NCT01085617|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
484079|NCT01085617|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
484080|NCT01085617|Philadelphia chromosome positive adult precursor acute lymphoblastic leukemia|philadelphia chromosome positive adult precursor acute lymphoblastic leukemia
484081|NCT01085604|low back pain|low back pain
484082|NCT01085604|clinical instability|clinical instability
484083|NCT01085604|neuromuscular control|neuromuscular control
484084|NCT01085604|core stabilization|core stabilization
484085|NCT01085604|physical therapy|physical therapy
484086|NCT01085591|CDI|cdi
484087|NCT01085591|Clostridium difficile Infection|clostridium difficile infection
484088|NCT01085591|Diarrhea|diarrhea
484089|NCT01085578|healthy male volunteers|healthy male volunteers
484090|NCT01085578|fasted and fed state|fasted and fed state
484091|NCT01085565|Bone cancer|bone cancer
484092|NCT01085565|Bone Metastases|bone metastases
484093|NCT01085565|pain palliation|pain palliation
484094|NCT01085565|metastasis|metastasis
484095|NCT01085565|breast cancer|breast cancer
484096|NCT01085565|lung cancer|lung cancer
484097|NCT01085565|prostate cancer|prostate cancer
484098|NCT01085565|cancer related pain|cancer related pain
484099|NCT01085565|tumors|tumors
484100|NCT01085552|NeoRecormon®|neorecormon®
484101|NCT01085552|Caucasian|caucasian
484102|NCT01085552|Japanese|japanese
484103|NCT01085552|Bioequivalence|bioequivalence
484104|NCT01085552|Ethnic|ethnic
484105|NCT01085539|neonatal intensive care|neonatal intensive care
484106|NCT01085539|infant pulse oximetry|infant pulse oximetry
484107|NCT01085526|basophil activity|basophil activity
484108|NCT01085526|plasma cells|plasma cells
484109|NCT01085526|IgE|ige
484110|NCT01085526|IgG1|igg1
484111|NCT01085526|IgG4|igg4
484112|NCT01085526|mast cells|mast cells
484113|NCT01085526|IgE receptor|ige receptor
484114|NCT01085526|allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
484297|NCT01084642|Survey|survey
484115|NCT01085526|grass pollen allergy|grass pollen allergy
484116|NCT01085513|intestinal abnormalities|intestinal abnormalities
484117|NCT01085500|laparoscopic|laparoscopic
484118|NCT01085500|totally extraperitoneal inguinal hernia repair|totally extraperitoneal inguinal hernia repair
484119|NCT01085487|Menorrhagia|menorrhagia
484120|NCT01085474|Asthma|asthma
484121|NCT01085474|Pharmaceutical intervention|pharmaceutical intervention
484122|NCT01085474|Effect of a pharmaceutical intervention on the level of control of the asthmatic patient|effect of a pharmaceutical intervention on the level of control of the asthmatic patient
484123|NCT01085448|low back pain|low back pain
484124|NCT01085448|core stabilization|core stabilization
484125|NCT01085448|physical therapy|physical therapy
484126|NCT01085435|ICD|icd
484127|NCT01085435|defibrillator|defibrillator
484128|NCT01085422|Prostate Cancer|prostate cancer
484129|NCT01085409|experienced utility|experienced utility
484130|NCT01085409|decision utility|decision utility
484131|NCT01085409|subjective well-being|subjective well-being
484132|NCT01085409|experience sampling method|experience sampling method
484133|NCT01085409|day reconstruction method|day reconstruction method
484134|NCT01085409|Quality of life|quality of life
484135|NCT01085396|Fiber Optic|fiber optic
484136|NCT01085396|Melanoma|melanoma
484137|NCT01085396|UV Exposure|uv exposure
484138|NCT01085383|Antipsychotic|antipsychotic
484139|NCT01085383|hyperprolactinemia|hyperprolactinemia
484140|NCT01085383|hypogonadism|hypogonadism
484141|NCT01085383|aripiprazole|aripiprazole
484142|NCT01085370|posttraumatic stress|posttraumatic stress
484143|NCT01085370|prevention|prevention
484144|NCT01085370|children|children
484145|NCT01085370|acute stress disorder due to burn injury or injuries associated with road traffic accidents|acute stress disorder due to burn injury or injuries associated with road traffic accidents
484146|NCT01085357|Glaucoma|glaucoma
484147|NCT01085357|Glaucoma device|glaucoma device
484148|NCT01085357|Glaucoma surgery|glaucoma surgery
484149|NCT01085357|Intraocular pressure|intraocular pressure
484150|NCT01085344|hemophilia, prophylaxis, cost effectiveness|hemophilia, prophylaxis, cost effectiveness
484151|NCT01085331|Mek Inhibitor|mek inhibitor
484152|NCT01085331|Metastatic Colorectal Cancer|metastatic colorectal cancer
484153|NCT01085331|K-Ras Mutation|k-ras mutation
484154|NCT01085331|Phase II|phase ii
484155|NCT01085331|Second line K-Ras mutated metastatic colorectal cancer|second line k-ras mutated metastatic colorectal cancer
484156|NCT01085305|Behavior problems|behavior problems
484157|NCT01085305|Parent-Child Interaction|parent-child interaction
484158|NCT01085305|Locus of control|locus of control
484159|NCT01085305|Psychiatric symptoms|psychiatric symptoms
484160|NCT01085305|Depressive symptoms|depressive symptoms
484161|NCT01085305|Attachment|attachment
484162|NCT01085279|fractional laser|fractional laser
484163|NCT01085279|melasma|melasma
484164|NCT01085279|topical bleaching|topical bleaching
484165|NCT01085253|Parkinson's|parkinson's
484166|NCT01085253|supranuclear palsy|supranuclear palsy
484167|NCT01085253|substantia nigra|substantia nigra
484168|NCT01085253|sub thalamic nucleus|sub thalamic nucleus
484169|NCT01085253|MRI|mri
484170|NCT01085227|Parkinson's disease|parkinson's disease
484171|NCT01085227|LRRK2|lrrk2
484172|NCT01085227|asymptomatic carriers|asymptomatic carriers
484173|NCT01085201|lexiscan|lexiscan
484174|NCT01085175|Heart Failure,|heart failure,
484175|NCT01085175|PET Imaging,|pet imaging,
484176|NCT01085175|Implantable Cardioverter-Defibrillator,|implantable cardioverter-defibrillator,
484177|NCT01085175|Sudden Cardiac Death|sudden cardiac death
484178|NCT01085162|Coronary Artery Disease|coronary artery disease
484179|NCT01085162|PET imaging|pet imaging
484180|NCT01085162|SPECT imaging|spect imaging
484181|NCT01085149|simvastatin|simvastatin
484182|NCT01085149|alveolar bone|alveolar bone
484183|NCT01085149|tooth extraction|tooth extraction
484184|NCT01085149|remodeling|remodeling
484185|NCT01085149|alveolar bone remodeling|alveolar bone remodeling
484186|NCT01085123|Migraine|migraine
484187|NCT01085123|ZOMIG® Rapimelt|zomig® rapimelt
484188|NCT01085110|Groin hernia|groin hernia
484189|NCT01085110|Chronic pain|chronic pain
484190|NCT01085110|QST|qst
484191|NCT01085110|Quantitative sensory testing|quantitative sensory testing
484192|NCT01085110|Persistent postoperative pain|persistent postoperative pain
484193|NCT01085110|Laparoscopic inguinal herniotomy|laparoscopic inguinal herniotomy
484194|NCT01085110|Postherniotomy Pain after laparoscopic inguinal herniotomy|postherniotomy pain after laparoscopic inguinal herniotomy
484195|NCT01085110|laparoscopic inguinal hernia repair|laparoscopic inguinal hernia repair
484196|NCT01085097|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
484197|NCT01085097|Lupus Nephritis|lupus nephritis
484198|NCT01085097|Laquinimod|laquinimod
484199|NCT01085084|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
484200|NCT01085084|Lupus Arthritis|lupus arthritis
484201|NCT01085084|Laquinimod|laquinimod
484202|NCT01085071|intensive care unit|intensive care unit
484203|NCT01085071|potassium|potassium
484204|NCT01085071|atrial fibrillation|atrial fibrillation
484205|NCT01085071|cardiac surgery|cardiac surgery
484206|NCT01085071|Critically ill patients post CABG and/or valvular surgery|critically ill patients post cabg and/or valvular surgery
484207|NCT01085071|Critically ill patients not post CABG and/or valvular surgery|critically ill patients not post cabg and/or valvular surgery
484208|NCT01085071|coronary artery bypass graft|coronary artery bypass graft
484209|NCT01085058|Lymphoproliferative diseases (Hodgkin's disease, non-Hodgkin's lymphomas, multiple myelomas) and high-dose therapy|lymphoproliferative diseases (hodgkin's disease, non-hodgkin's lymphomas, multiple myelomas) and high-dose therapy
484210|NCT01085045|COPD|copd
484211|NCT01085032|Smoking Cessation|smoking cessation
484212|NCT01085032|Substance Withdrawal Syndrome|substance withdrawal syndrome
484213|NCT01085032|Depression|depression
484214|NCT01085019|Endothelial function|endothelial function
484215|NCT01085019|Cardiovascular risk factors|cardiovascular risk factors
484216|NCT01085019|Spices|spices
484217|NCT01085019|Herbs|herbs
484218|NCT01085019|Antioxidant|antioxidant
484219|NCT01085006|cesarean delivery|cesarean delivery
484220|NCT01085006|Tranexamic acid|tranexamic acid
484221|NCT01085006|hemorrhage|hemorrhage
484222|NCT01085006|Spinal analgesia|spinal analgesia
484223|NCT01085006|1-the amount of hemorrhage during cesarean delivery|1-the amount of hemorrhage during cesarean delivery
484224|NCT01085006|2-the amount of hemorrhage in the first 2 hours of cesarean delivery|2-the amount of hemorrhage in the first 2 hours of cesarean delivery
484225|NCT01085006|3-the amount of hemorrhage in the first 24 hour after cesarean delivery|3-the amount of hemorrhage in the first 24 hour after cesarean delivery
484226|NCT01084993|Coronary artery stenting, transradial, intracoronary|coronary artery stenting, transradial, intracoronary
484227|NCT01084980|minimal change disease|minimal change disease
484228|NCT01084980|tacrolimus|tacrolimus
484229|NCT01084980|corticosteroid|corticosteroid
484230|NCT01084967|obesity|obesity
484231|NCT01084967|metabolic syndrome|metabolic syndrome
484232|NCT01084967|genetic risk markers|genetic risk markers
484233|NCT01084967|copy number variation|copy number variation
484234|NCT01084954|HIV validation helicase-dependent amplification|hiv validation helicase-dependent amplification
484235|NCT01084941|pregnancy|pregnancy
484236|NCT01084941|weight gain|weight gain
484237|NCT01084941|obesity|obesity
484238|NCT01084941|pregnancy and weight gain|pregnancy and weight gain
484239|NCT01084928|diabetes|diabetes
484240|NCT01084928|obesity|obesity
484241|NCT01084928|pre-diabetes|pre-diabetes
484242|NCT01084928|South Asian|south asian
484243|NCT01084915|Weight loss after SAGB VC band placement|weight loss after sagb vc band placement
484244|NCT01084902|POAG|poag
484245|NCT01084902|OH|oh
484246|NCT01084902|Xalatan|xalatan
484247|NCT01084902|Azopt|azopt
484248|NCT01084902|Primary Open Angle Study|primary open angle study
484249|NCT01084889|polypropylene mesh|polypropylene mesh
484250|NCT01084889|Prolapse|prolapse
484251|NCT01084889|Cystocele|cystocele
484252|NCT01084889|Surgical Mesh|surgical mesh
484253|NCT01084876|Herceptin|herceptin
484254|NCT01084876|metastatic breast cancer|metastatic breast cancer
484255|NCT01084876|CT-P6|ct-p6
484256|NCT01084863|Herceptin|herceptin
484257|NCT01084863|Her 2-positive|her 2-positive
484258|NCT01084863|metastatic breast cancer|metastatic breast cancer
484259|NCT01084863|CT-P6|ct-p6
484260|NCT01084850|Corneal endothelium|corneal endothelium
484261|NCT01084850|diabetes mellitus|diabetes mellitus
484262|NCT01084850|corneal thickness|corneal thickness
484263|NCT01084837|Multiple myeloma|multiple myeloma
484264|NCT01084837|Renal failure|renal failure
484265|NCT01084824|Warts|warts
484266|NCT01084824|Verruca vulgaris|verruca vulgaris
484267|NCT01084824|Liquid Nitrogen|liquid nitrogen
484268|NCT01084824|Cantharidin|cantharidin
484269|NCT01084824|combination treatment|combination treatment
484270|NCT01084798|Multiple sclerosis|multiple sclerosis
484271|NCT01084798|Expanded Disability Status Scale|expanded disability status scale
484272|NCT01084798|Sclerosis|sclerosis
484273|NCT01084785|Cancer|cancer
484274|NCT01084785|genomics|genomics
484275|NCT01084785|proteomics|proteomics
484276|NCT01084746|Colorectal Cancer Screening|colorectal cancer screening
484277|NCT01084746|Computer Interactive Intervention|computer interactive intervention
484278|NCT01084746|Predictors|predictors
484279|NCT01084746|Cost Effective Analysis|cost effective analysis
484280|NCT01084746|Transtheoretical Model|transtheoretical model
484281|NCT01084707|Smoking Cessation, Nicotine pharmacokinetics|smoking cessation, nicotine pharmacokinetics
484283|NCT01084694|Caregiver|caregiver
484284|NCT01084694|Caregiver Burden|caregiver burden
484285|NCT01084694|Allogeneic Transplant|allogeneic transplant
484286|NCT01084694|Autologous Transplant|autologous transplant
484287|NCT01084694|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
484288|NCT01084681|SILK flow diverter, intracranial stents, intracranial aneurysms|silk flow diverter, intracranial stents, intracranial aneurysms
484289|NCT01084668|moderate to severe chronic plaque psoriasis|moderate to severe chronic plaque psoriasis
484290|NCT01084668|adalimumab|adalimumab
484291|NCT01084668|Psoriasis Area and Severity Index (PASI)|psoriasis area and severity index (pasi)
484292|NCT01084668|Disease Life Quality Index (DLQI)|disease life quality index (dlqi)
484293|NCT01084668|Nail Psoriasis Severity Index (NAPSI)|nail psoriasis severity index (napsi)
484294|NCT01084668|biologic disease modifying anti-rheumatic drug (BDMARD)|biologic disease modifying anti-rheumatic drug (bdmard)
484295|NCT01084668|antibodies|antibodies
484298|NCT01084642|Sexual Health Issues|sexual health issues
484299|NCT01084642|10-034|10-034
484300|NCT01084629|Barrett's Esophagus|barrett's esophagus
484301|NCT01084629|Surveillance|surveillance
484302|NCT01084603|Smoking Cessation|smoking cessation
484303|NCT01084603|Nicotine pharmacokinetics|nicotine pharmacokinetics
484304|NCT01084590|Prevention|prevention
484305|NCT01084590|Obesity|obesity
484306|NCT01084590|Safety|safety
484307|NCT01084590|Unhealthy weight gain|unhealthy weight gain
484308|NCT01084590|Injury prevention|injury prevention
484309|NCT01084564|Cost-effectiveness analysis|cost-effectiveness analysis
484310|NCT01084564|Colombia|colombia
484311|NCT01084538|paricalcitol iv|paricalcitol iv
484312|NCT01084538|vitamin D|vitamin d
484313|NCT01084538|secondary hyperparathyroidism|secondary hyperparathyroidism
484314|NCT01084538|hemodialysis|hemodialysis
484315|NCT01084525|Meniere's Disease|meniere's disease
484316|NCT01084525|Vertigo|vertigo
484317|NCT01084525|Definitive vertigo|definitive vertigo
484318|NCT01084525|Vertigo episodes|vertigo episodes
484319|NCT01084525|Vertigo frequency|vertigo frequency
484320|NCT01084525|Tinnitus|tinnitus
484321|NCT01084525|Hearing loss|hearing loss
484322|NCT01084525|Aural Fullness|aural fullness
484323|NCT01084512|kinematic analysis,|kinematic analysis,
484324|NCT01084512|three-compartment model,|three-compartment model,
484325|NCT01084512|chest wall motion,|chest wall motion,
484326|NCT01084512|spinal cord injury.|spinal cord injury.
484327|NCT01084499|Healthy Subjects|healthy subjects
484328|NCT01084486|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
484329|NCT01084486|Pulse wave velocity|pulse wave velocity
484330|NCT01084486|augmentation index|augmentation index
484331|NCT01084486|metformin|metformin
484332|NCT01084473|Dexmedetomidine|dexmedetomidine
484333|NCT01084473|gastric emptying|gastric emptying
484334|NCT01084473|oro-cecal transit time|oro-cecal transit time
484335|NCT01084473|Sedation in intensive care|sedation in intensive care
484336|NCT01084473|Gastrointestinal effects of sedation|gastrointestinal effects of sedation
484337|NCT01084460|Gastrointestinal stromal tumor,endoscopic ultrasound,submucosal tumor|gastrointestinal stromal tumor,endoscopic ultrasound,submucosal tumor
484338|NCT01084447|obesity|obesity
484339|NCT01084447|gastroplasty|gastroplasty
484340|NCT01084447|respiratory muscle training|respiratory muscle training
484341|NCT01084447|muscle strength|muscle strength
484342|NCT01084447|physical therapy|physical therapy
484343|NCT01084421|Adolescents|adolescents
484344|NCT01084421|Parents|parents
484345|NCT01084421|Computer Based|computer based
484346|NCT01084421|Latino|latino
484347|NCT01084421|Sexual Communication|sexual communication
484348|NCT01084408|de-novo|de-novo
484349|NCT01084408|coronary stenoses|coronary stenoses
484350|NCT01084408|PEPCAD|pepcad
484351|NCT01084408|DEBonly|debonly
484352|NCT01084408|Paclitaxel|paclitaxel
484353|NCT01084395|Parent|parent
484354|NCT01084395|Adolescent|adolescent
484355|NCT01084395|Mexico|mexico
484356|NCT01084395|Safer Sex Communication|safer sex communication
484357|NCT01084395|Randomized Controlled Trial|randomized controlled trial
484358|NCT01084395|HIV/AIDS|hiv/aids
484359|NCT01084395|STD|std
484360|NCT01084395|Sexual Behavior|sexual behavior
484361|NCT01084382|Arthrospira platensis|arthrospira platensis
484362|NCT01084382|female HIV patient|female hiv patient
484363|NCT01084382|Yaounde|yaounde
484364|NCT01084382|Redox potential|redox potential
484365|NCT01084382|Life quality|life quality
484366|NCT01084382|female patient infected by HIV in Yaounde: Cameroon|female patient infected by hiv in yaounde: cameroon
484367|NCT01084369|Type 2 diabetes|type 2 diabetes
484368|NCT01084369|Hypogonadism|hypogonadism
484369|NCT01084369|Testosterone|testosterone
484370|NCT01084369|Endothelial dysfunction|endothelial dysfunction
484371|NCT01084356|CZT|czt
484372|NCT01084356|sentinel node|sentinel node
484373|NCT01084356|osseous processes|osseous processes
484374|NCT01084343|vaccination|vaccination
484375|NCT01084343|prophylaxis|prophylaxis
484376|NCT01084330|gastric cancer|gastric cancer
484377|NCT01084330|metastatic gastric cancer|metastatic gastric cancer
484378|NCT01084330|advanced gastric cancer|advanced gastric cancer
484379|NCT01084317|asthma|asthma
484380|NCT01084317|children|children
484381|NCT01084317|delay in asthma diagnosis|delay in asthma diagnosis
484382|NCT01084304|Pregnancy|pregnancy
484383|NCT01084304|Ovulation tests|ovulation tests
484384|NCT01084304|stress|stress
484385|NCT01084304|Wishing to become pregnant|wishing to become pregnant
484386|NCT01084291|Vaccine|vaccine
484387|NCT01084291|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
484388|NCT01084265|Hypogonadism|hypogonadism
484389|NCT01084265|Recombinant human follicle stimulating hormone (r-hFSH)|recombinant human follicle stimulating hormone (r-hfsh)
484390|NCT01084265|Recombinant leutinizing hormone (r-hLH)|recombinant leutinizing hormone (r-hlh)
484391|NCT01084239|acute chest pain|acute chest pain
484392|NCT01084239|emergency department|emergency department
484393|NCT01084239|cardiac computed tomography|cardiac computed tomography
484394|NCT01084226|Rye fiber|rye fiber
484395|NCT01084226|Alkylresorcinols|alkylresorcinols
484396|NCT01084226|Plant sterols|plant sterols
484397|NCT01084226|Cholesterol|cholesterol
484398|NCT01084226|Antioxidant|antioxidant
484399|NCT01084226|Effects of plant sterols in rye bread on serum lipids|effects of plant sterols in rye bread on serum lipids
484400|NCT01084226|Effects of alkylresorcinols in rye fiber on LDL particles|effects of alkylresorcinols in rye fiber on ldl particles
484401|NCT01084213|Low birth weight|low birth weight
484402|NCT01084213|Placenta malaria|placenta malaria
484403|NCT01084213|Anaemia|anaemia
484404|NCT01084213|Intermittent preventive treatment|intermittent preventive treatment
484405|NCT01084213|Intermittent screening and treatment|intermittent screening and treatment
484406|NCT01084213|Rapid diagnostic test|rapid diagnostic test
484407|NCT01084200|Postoperative pain|postoperative pain
484408|NCT01084200|Sevoflurane|sevoflurane
484409|NCT01084200|Propofol|propofol
484410|NCT01084200|Female|female
484411|NCT01084200|Elective gynaecological surgery|elective gynaecological surgery
484412|NCT01084200|Laparoscopic and hysteroscopic surgery|laparoscopic and hysteroscopic surgery
484413|NCT01084200|Female patients|female patients
484414|NCT01084200|Undergoing elective laparoscopic and hysteroscopic surgery|undergoing elective laparoscopic and hysteroscopic surgery
484415|NCT01084187|erectile dysfunction|erectile dysfunction
484416|NCT01084187|arterial hypertension|arterial hypertension
484417|NCT01084187|flow mediated vasodilation|flow mediated vasodilation
484418|NCT01084187|endothelial dysfunction|endothelial dysfunction
484419|NCT01084187|carotid intima media thickness|carotid intima media thickness
484420|NCT01084187|vardenafil|vardenafil
484421|NCT01084174|Peanut Allergy|peanut allergy
484422|NCT01084135|Clinical trial|clinical trial
484423|NCT01084135|Down syndrome|down syndrome
484424|NCT01084135|adolescents|adolescents
484425|NCT01084135|cognitive|cognitive
484426|NCT01084135|rivastigmine|rivastigmine
484427|NCT01084122|Intravenous iron sucrose|intravenous iron sucrose
484428|NCT01084122|Anemia|anemia
484429|NCT01084122|Transfusion|transfusion
484430|NCT01084109|Complementary feeding|complementary feeding
484431|NCT01084109|Infant growth|infant growth
484432|NCT01084109|Developing countries|developing countries
484433|NCT01084096|Antenatal Corticosteroids, Preterm Birth, Diffusion|antenatal corticosteroids, preterm birth, diffusion
484434|NCT01084083|human papilloma virus infection|human papilloma virus infection
484435|NCT01084083|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
484436|NCT01084083|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
484437|NCT01084083|tongue cancer|tongue cancer
484438|NCT01084070|early feeding|early feeding
484439|NCT01084070|postoperative care|postoperative care
484440|NCT01084070|emergency surgery|emergency surgery
484441|NCT01084018|acute postoperative pain|acute postoperative pain
484442|NCT01084018|nursing intervention|nursing intervention
484443|NCT01083992|NAFLD|nafld
484444|NCT01083992|Galvus|galvus
484445|NCT01083992|vitamin D|vitamin d
484446|NCT01083966|Vestibular|vestibular
484447|NCT01083966|Schwannoma|schwannoma
484448|NCT01083966|earing-loss|earing-loss
484449|NCT01083966|brain-tumor|brain-tumor
484450|NCT01083966|Acoustic|acoustic
484451|NCT01083966|Neuroma|neuroma
484452|NCT01083953|end tidal concentration|end tidal concentration
484453|NCT01083927|Pterygium|pterygium
484454|NCT01083914|extracorporeal circulation, off-pump CABG|extracorporeal circulation, off-pump cabg
484455|NCT01083888|Pharmacokinetics|pharmacokinetics
484456|NCT01083888|Safety and tolerability|safety and tolerability
484457|NCT01083888|Plasma concentration|plasma concentration
484458|NCT01083888|ASP1517|asp1517
484459|NCT01083888|FG-4592|fg-4592
484460|NCT01083875|Radiation|radiation
484461|NCT01083875|mucositis|mucositis
484462|NCT01083875|head and neck carcinoma|head and neck carcinoma
484463|NCT01083875|oral rinse|oral rinse
484464|NCT01083875|amlexanox|amlexanox
484465|NCT01083875|MuGard|mugard
484466|NCT01083862|Health literacy|health literacy
484467|NCT01083862|patient education|patient education
484468|NCT01083862|health behaviors|health behaviors
484469|NCT01083862|chronic disease management|chronic disease management
484470|NCT01083862|shared decision-making|shared decision-making
484471|NCT01083862|patient-centered decision making|patient-centered decision making
484472|NCT01083849|Observational study|observational study
484473|NCT01083849|Paricalcitol|paricalcitol
484474|NCT01083849|Treatment of Hyperparathyroidism|treatment of hyperparathyroidism
484475|NCT01083849|Chronic kidney disease stage 3, 4 and 5 (CKD stage 3, 4 and 5)|chronic kidney disease stage 3, 4 and 5 (ckd stage 3, 4 and 5)
484476|NCT01083849|Chronic Kidney Disease|chronic kidney disease
484477|NCT01083849|Zemplar|zemplar
484478|NCT01083849|sHPT|shpt
484479|NCT01083849|Secondary|secondary
484480|NCT01083823|Mental health telemetry|mental health telemetry
484481|NCT01083823|Mood telemetry|mood telemetry
484482|NCT01083823|Mood|mood
484483|NCT01083823|Bipolar disorder|bipolar disorder
484484|NCT01083823|Affective instability|affective instability
484485|NCT01083823|Cyclothymia|cyclothymia
484486|NCT01083823|Electronic diaries|electronic diaries
484487|NCT01083823|Mood diaries|mood diaries
484488|NCT01083823|Mood swings|mood swings
484489|NCT01083810|Human Immunodeficiency Virus|human immunodeficiency virus
484490|NCT01083810|Infection|infection
484491|NCT01083810|Kaletra|kaletra
484492|NCT01083810|Resistance|resistance
484493|NCT01083810|Mutations|mutations
484494|NCT01083810|alternative Therapy regimen|alternative therapy regimen
484495|NCT01083797|Sedation|sedation
484496|NCT01083797|Electroencephalography|electroencephalography
484497|NCT01083797|Dexmedetomidine|dexmedetomidine
484498|NCT01083797|Chloral hydrate|chloral hydrate
484499|NCT01083784|Cardiac arrest|cardiac arrest
484500|NCT01083784|Prophylactic anticonvulsant|prophylactic anticonvulsant
484501|NCT01083719|Glioblastoma|glioblastoma
484502|NCT01083719|FDG-PET|fdg-pet
484503|NCT01083719|MRI|mri
484504|NCT01083693|Monoclonals|monoclonals
484505|NCT01083693|Antibodies|antibodies
484506|NCT01083693|Ankylosing Spondylitis|ankylosing spondylitis
484507|NCT01083693|Antirheumatic Agents|antirheumatic agents
484508|NCT01083693|Quality of Life|quality of life
484509|NCT01083693|Adalimumab|adalimumab
484510|NCT01083693|rheumatoid arthritis|rheumatoid arthritis
484511|NCT01083693|psoriatic arthritis|psoriatic arthritis
484512|NCT01083680|Routine clinical setting|routine clinical setting
484513|NCT01083680|Long-term efficacy and safety|long-term efficacy and safety
484514|NCT01083680|Crohn's Disease|crohn's disease
484515|NCT01083680|Humira®|humira®
484516|NCT01083680|Adalimumab|adalimumab
484517|NCT01083667|ALS|als
484518|NCT01083667|Familial ALS|familial als
484519|NCT01083667|SOD1 Gene Mutation|sod1 gene mutation
484520|NCT01083654|Smoking|smoking
484521|NCT01083654|Smoking cessation|smoking cessation
484522|NCT01083641|Breast Cancer|breast cancer
484523|NCT01083615|CRPC patients with cancer related pain|crpc patients with cancer related pain
484524|NCT01083615|CRPC|crpc
484525|NCT01083615|HRPC|hrpc
484526|NCT01083602|Multiple Myeloma|multiple myeloma
484527|NCT01083602|Relapsed Multiple Myeloma|relapsed multiple myeloma
484528|NCT01083602|Refractory Multiple Myeloma|refractory multiple myeloma
484529|NCT01083589|Lung Cancer|lung cancer
484530|NCT01083589|Metastatic NSCLC|metastatic nsclc
484531|NCT01083589|Tumor|tumor
484532|NCT01083589|Imatinib Mesylate|imatinib mesylate
484533|NCT01083589|Gleevec|gleevec
484534|NCT01083589|Docetaxel|docetaxel
484535|NCT01083589|Taxotere|taxotere
484536|NCT01083576|leishmaniasis|leishmaniasis
484537|NCT01083576|cutaneous|cutaneous
484538|NCT01083576|WR 279,396|wr 279,396
484539|NCT01083576|paromomycin|paromomycin
484540|NCT01083576|gentamicin|gentamicin
484541|NCT01083576|pharmacokinetics|pharmacokinetics
484542|NCT01083576|safety|safety
484543|NCT01083576|efficacy|efficacy
484544|NCT01083563|TNF|tnf
484545|NCT01083563|CD20|cd20
484546|NCT01083563|RA|ra
484547|NCT01083550|thyroid carcinoma|thyroid carcinoma
484548|NCT01083550|thyroid cancer|thyroid cancer
484549|NCT01083550|therapeutic radioisotopes|therapeutic radioisotopes
484550|NCT01083550|radioactive iodine|radioactive iodine
484551|NCT01083537|malignant bowel obstruction|malignant bowel obstruction
484552|NCT01083537|ovarian cancer|ovarian cancer
484553|NCT01083537|Peritoneal cancer|peritoneal cancer
484554|NCT01083537|Fallopian Tube cancer|fallopian tube cancer
484555|NCT01083524|Pulmonary arterial hypertension|pulmonary arterial hypertension
484556|NCT01083524|Pulmonary hypertension|pulmonary hypertension
484557|NCT01083524|Dichloroacetate|dichloroacetate
484558|NCT01083524|Dichloroacetate Sodium|dichloroacetate sodium
484559|NCT01083524|DCA|dca
484560|NCT01083511|Influenza|influenza
484561|NCT01083511|Influenza A|influenza a
484562|NCT01083511|Influenza B|influenza b
484563|NCT01083511|Swine Influenza A/H1N1|swine influenza a/h1n1
484564|NCT01083511|Respiratory Virus|respiratory virus
484565|NCT01083498|Becker's nevus|becker's nevus
484566|NCT01083498|ablative fractional laser therapy|ablative fractional laser therapy
484567|NCT01083498|randomized controlled trial|randomized controlled trial
484568|NCT01083498|split-lesion design|split-lesion design
484569|NCT01083485|Oxycodone|oxycodone
484570|NCT01083485|Naloxone|naloxone
484571|NCT01083485|Postoperative pain|postoperative pain
484572|NCT01083485|Arthroplasty|arthroplasty
484573|NCT01083485|Efficacy|efficacy
484574|NCT01083472|dehiscence|dehiscence
484575|NCT01083472|laparotomy|laparotomy
484576|NCT01083472|Hernia repair|hernia repair
484577|NCT01083472|surgical wound|surgical wound
484578|NCT01083472|surgical mesh|surgical mesh
484579|NCT01083446|Encephalopathy|encephalopathy
484580|NCT01083446|Cirrhotics|cirrhotics
484581|NCT01083433|Continuous Glucose Monitor|continuous glucose monitor
484582|NCT01083433|Adherence|adherence
484583|NCT01083433|Adolescents|adolescents
484584|NCT01083433|Diabetes Education|diabetes education
484585|NCT01083420|Oral lichen planus|oral lichen planus
484586|NCT01083420|Minocycline|minocycline
484587|NCT01083420|Dexamethasone|dexamethasone
484588|NCT01083407|Oral care.|oral care.
484589|NCT01083407|Chlorhexidine.|chlorhexidine.
484590|NCT01083407|Pediatric Nursing|pediatric nursing
484591|NCT01083407|Intensive Care|intensive care
484592|NCT01083407|Nosocomial infection|nosocomial infection
484593|NCT01083407|Pneumonia|pneumonia
484594|NCT01083407|Oropharyngeal colonization|oropharyngeal colonization
484595|NCT01083407|Tracheal colonization|tracheal colonization
484596|NCT01083394|PTA|pta
484597|NCT01083394|paclitaxel|paclitaxel
484598|NCT01083394|restenosis|restenosis
484599|NCT01083381|Schizophrenia treatment MS14 randomized clinical trial|schizophrenia treatment ms14 randomized clinical trial
484600|NCT01083368|adenocarcinoma of the prostate|adenocarcinoma of the prostate
484601|NCT01083368|hormone-resistant prostate cancer|hormone-resistant prostate cancer
484602|NCT01083368|recurrent prostate cancer|recurrent prostate cancer
484603|NCT01083368|stage IV prostate cancer|stage iv prostate cancer
484604|NCT01083355|Variable ventilation|variable ventilation
484605|NCT01083355|Pressure regulated volume control ventilation|pressure regulated volume control ventilation
484606|NCT01083355|Airway pressure release ventilation|airway pressure release ventilation
484607|NCT01083342|primary CNS lymphoma|primary cns lymphoma
484608|NCT01083342|MTX: Methotrexate,Leucovorin|mtx: methotrexate,leucovorin
484609|NCT01083342|MVD: Methotrexate,Vincristine,Dexamethasone|mvd: methotrexate,vincristine,dexamethasone
484610|NCT01083342|VIA: VP-16 (Etoposide),Ifosfamide,Mesna, Cytarabine (ara-C)|via: vp-16 (etoposide),ifosfamide,mesna, cytarabine (ara-c)
484611|NCT01083342|Newly diagnosed primary CNS lymphoma patients|newly diagnosed primary cns lymphoma patients
484612|NCT01083329|nicotinic acid|nicotinic acid
484613|NCT01083329|lipolysis|lipolysis
484614|NCT01083329|training program|training program
484615|NCT01083329|adipose tissue inflammation|adipose tissue inflammation
484616|NCT01083329|obese|obese
484617|NCT01083316|Amyloid|amyloid
484618|NCT01083316|Amyloidosis|amyloidosis
484619|NCT01083316|AL Amyloidosis|al amyloidosis
484620|NCT01083316|Primary Amyloidosis|primary amyloidosis
484621|NCT01083316|Stem Cell Transplant|stem cell transplant
484622|NCT01083303|energy expenditure|energy expenditure
484623|NCT01083303|hypothermia|hypothermia
484624|NCT01083303|body temperature|body temperature
484625|NCT01083303|weaning|weaning
484626|NCT01083303|preterm infants|preterm infants
484627|NCT01083290|spironolactone|spironolactone
484628|NCT01083290|linearity of pharmacokinetics|linearity of pharmacokinetics
484629|NCT01083290|Healthy volunteers|healthy volunteers
484630|NCT01083277|oxygenation|oxygenation
484631|NCT01083277|ventilation|ventilation
484632|NCT01083277|tidal volume|tidal volume
484633|NCT01083277|patterns of breathing|patterns of breathing
484634|NCT01083277|variable ventilation|variable ventilation
484635|NCT01083277|mechanical ventilation|mechanical ventilation
484636|NCT01083264|Pharmacokinetics|pharmacokinetics
484637|NCT01083251|HBV|hbv
484638|NCT01083251|VITAMIN D|vitamin d
484639|NCT01083251|PEGITERFERON|pegiterferon
484640|NCT01083251|Telbivudine|telbivudine
484641|NCT01083238|pharmacokinetics|pharmacokinetics
484642|NCT01083238|fasting or after a high fat meal|fasting or after a high fat meal
484643|NCT01083238|adult|adult
484644|NCT01083238|elderly adult|elderly adult
484645|NCT01083238|COPD|copd
484646|NCT01083212|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
484647|NCT01083212|Gemfibrozil|gemfibrozil
484648|NCT01083199|Prostate Cancer|prostate cancer
484649|NCT01083199|Radical Prostatectomy|radical prostatectomy
484650|NCT01083199|Vesico-Urethral Anastomosis|vesico-urethral anastomosis
484651|NCT01083186|Secondary Hyperparathyroidism|secondary hyperparathyroidism
484652|NCT01083186|Chronic Kidney Failure|chronic kidney failure
484653|NCT01083173|Postmarketing Drug Surveillance|postmarketing drug surveillance
484654|NCT01083173|HIV-1 infection|hiv-1 infection
484655|NCT01083173|Kaletra|kaletra
484656|NCT01083160|Rheumatoid Arthritis|rheumatoid arthritis
484657|NCT01083160|Anti-TNF|anti-tnf
484658|NCT01083160|Adalimumab|adalimumab
484659|NCT01083160|Infliximab|infliximab
484660|NCT01083160|Etanercept|etanercept
484661|NCT01083147|Intermediate AMD|intermediate amd
484662|NCT01083134|CAD|cad
484663|NCT01083121|Postmarketing Drug Surveillance|postmarketing drug surveillance
484664|NCT01083108|Behavioral Weight Loss Treatment|behavioral weight loss treatment
484665|NCT01083108|Bariatric Surgery|bariatric surgery
484666|NCT01083108|Diabetes Type II|diabetes type ii
484667|NCT01083108|Obesity|obesity
484668|NCT01083108|Adult|adult
484669|NCT01083108|Type 2 Diabetes|type 2 diabetes
484670|NCT01083095|Malaria|malaria
484671|NCT01083095|Sporozoite|sporozoite
484672|NCT01083095|Challenge Model|challenge model
484673|NCT01083095|Plasmodium vivax|plasmodium vivax
484674|NCT01083095|Human Volunteers|human volunteers
484675|NCT01083082|lifestyles|lifestyles
484676|NCT01083082|diet|diet
484677|NCT01083082|exercise|exercise
484678|NCT01083082|central blood pressure|central blood pressure
484679|NCT01083082|arterial stiffness|arterial stiffness
484680|NCT01083082|endothelial dysfunction|endothelial dysfunction
484681|NCT01083082|Healthy people|healthy people
484682|NCT01083069|Sudden cardiac arrest|sudden cardiac arrest
484683|NCT01083069|hypothermia|hypothermia
484684|NCT01083069|neurological outcome|neurological outcome
484685|NCT01083056|retina|retina
484686|NCT01083056|gliosis|gliosis
484687|NCT01083056|macula|macula
484688|NCT01083056|membrane|membrane
484689|NCT01083056|ILM|ilm
484690|NCT01083043|Glycemic Variability|glycemic variability
484691|NCT01083043|Endothelial Dysfunction|endothelial dysfunction
484692|NCT01083030|pAVK|pavk
484693|NCT01083030|PTA|pta
484694|NCT01083030|drug coated balloon|drug coated balloon
484695|NCT01083004|dye|dye
484696|NCT01083004|internal limiting membrane|internal limiting membrane
484697|NCT01083004|macular hole|macular hole
484698|NCT01083004|macular pucker|macular pucker
484699|NCT01082978|Quality of Life|quality of life
484700|NCT01082978|Health Care Quality and Safety|health care quality and safety
484701|NCT01082978|Randomized controlled trial|randomized controlled trial
484702|NCT01082965|ASL MRI|asl mri
484703|NCT01082965|perfusion|perfusion
484704|NCT01082965|cognition|cognition
484705|NCT01082965|donepezil|donepezil
484706|NCT01082965|alzheimer's disease|alzheimer's disease
484707|NCT01082965|translational medicine|translational medicine
484708|NCT01082939|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
484709|NCT01082939|Refractory CLL|refractory cll
484710|NCT01082939|CFAR|cfar
484711|NCT01082939|Alemtuzumab|alemtuzumab
484712|NCT01082939|Campath-1H|campath-1h
484713|NCT01082939|Campath|campath
484714|NCT01082939|Cyclophosphamide|cyclophosphamide
484715|NCT01082939|Cytoxan|cytoxan
484716|NCT01082939|Neosar|neosar
484717|NCT01082939|Fludarabine|fludarabine
484718|NCT01082939|Fludara|fludara
484719|NCT01082939|Fludarabine Phosphate|fludarabine phosphate
484720|NCT01082939|Rituximab|rituximab
484721|NCT01082939|Rituxan|rituxan
484722|NCT01082939|CLL|cll
484723|NCT01082926|adult anaplastic astrocytoma|adult anaplastic astrocytoma
484724|NCT01082926|adult anaplastic ependymoma|adult anaplastic ependymoma
484725|NCT01082926|adult anaplastic meningioma|adult anaplastic meningioma
484726|NCT01082926|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
484727|NCT01082926|adult brain stem glioma|adult brain stem glioma
484728|NCT01082926|adult ependymoblastoma|adult ependymoblastoma
484729|NCT01082926|adult giant cell glioblastoma|adult giant cell glioblastoma
484730|NCT01082926|adult glioblastoma|adult glioblastoma
484731|NCT01082926|adult gliosarcoma|adult gliosarcoma
484732|NCT01082926|adult grade III meningioma|adult grade iii meningioma
484733|NCT01082926|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
484734|NCT01082926|adult mixed glioma|adult mixed glioma
484735|NCT01082926|adult pineal gland astrocytoma|adult pineal gland astrocytoma
484736|NCT01082926|recurrent adult brain tumor|recurrent adult brain tumor
484737|NCT01082926|Los Angeles|los angeles
484738|NCT01082900|Transient Tachypnea of the Newborn|transient tachypnea of the newborn
484739|NCT01082900|Elective Cesarean section|elective cesarean section
484740|NCT01082900|Late preterm|late preterm
484741|NCT01082900|CPAP|cpap
484742|NCT01082900|Delivery Room|delivery room
484743|NCT01082887|Immunotherapy TIL (Tumor Infiltrating Lymphocytes)|immunotherapy til (tumor infiltrating lymphocytes)
484744|NCT01082887|Intra-tumoral injection|intra-tumoral injection
484745|NCT01082887|Interferon gamma-adenovirus(Ad-IFNg)|interferon gamma-adenovirus(ad-ifng)
484746|NCT01082887|Metastatic melanoma|metastatic melanoma
484747|NCT01082887|A stage IIIc/IV metastatic melanoma with nodal relapse|a stage iiic/iv metastatic melanoma with nodal relapse
484748|NCT01082887|in transit metastasis|in transit metastasis
484749|NCT01082887|cutaneous unresectable metastases|cutaneous unresectable metastases
484750|NCT01082887|visceral metastases|visceral metastases
484751|NCT01082874|Randomized Controlled Trial|randomized controlled trial
484752|NCT01082874|Blinded|blinded
484753|NCT01082874|Clonidine|clonidine
484754|NCT01082874|acetyl-salicylic acid (ASA)|acetyl-salicylic acid (asa)
484755|NCT01082874|Perioperative vascular complications|perioperative vascular complications
484756|NCT01082874|Noncardiac surgery|noncardiac surgery
484757|NCT01082861|1998 female birth cohort eligible for HPV vaccination in 2011 within the Dutch NIP|1998 female birth cohort eligible for hpv vaccination in 2011 within the dutch nip
484758|NCT01082835|Chinese herbs|chinese herbs
484759|NCT01082822|cell sheet PDLSC periodontitis|cell sheet pdlsc periodontitis
484760|NCT01082809|advanced biliary tract carcinoma|advanced biliary tract carcinoma
484761|NCT01082809|Sunitinib|sunitinib
484762|NCT01082783|stroke-induced immunodepression|stroke-induced immunodepression
484763|NCT01082783|acute media infarct|acute media infarct
484764|NCT01082783|acute intracerebral bleeding|acute intracerebral bleeding
484765|NCT01082783|leucocytes|leucocytes
484766|NCT01082783|autoaggressive T-cells|autoaggressive t-cells
484767|NCT01082783|acute media infarct or acute intracerebral bleeding|acute media infarct or acute intracerebral bleeding
484768|NCT01082757|Colorectal neoplasms|colorectal neoplasms
484769|NCT01082757|metastasis|metastasis
484770|NCT01082757|colorectal cancer|colorectal cancer
484771|NCT01082744|Paravertebral Block|paravertebral block
484772|NCT01082744|Regional Anesthesia|regional anesthesia
484773|NCT01082744|Anesthetics Local|anesthetics local
484774|NCT01082744|Ropivacaine|ropivacaine
484775|NCT01082744|Sufentanil|sufentanil
484776|NCT01082744|Pain Postoperative|pain postoperative
484777|NCT01082744|Chronic Pain|chronic pain
484778|NCT01082744|Thoracic Surgery Video-Assisted.|thoracic surgery video-assisted.
484779|NCT01082731|Malaria|malaria
484780|NCT01082731|Plasmodium falciparum|plasmodium falciparum
484781|NCT01082731|Treatment|treatment
484782|NCT01082731|Brazil|brazil
484783|NCT01082718|Malaria|malaria
484784|NCT01082718|Pregnancy|pregnancy
484785|NCT01082718|Pharmacokinetics|pharmacokinetics
484786|NCT01082718|Brazil|brazil
484787|NCT01082705|malaria|malaria
484788|NCT01082705|treatment|treatment
484789|NCT01082705|artemisinin combination therapy|artemisinin combination therapy
484790|NCT01082705|Tanzania|tanzania
484791|NCT01082705|P. falciparum malaria in children age 6-59 months|p. falciparum malaria in children age 6-59 months
484792|NCT01082692|HIV Infection|hiv infection
484793|NCT01082692|DNA vaccine|dna vaccine
484794|NCT01082692|Electroporation|electroporation
484795|NCT01082692|HIV therapeutic vaccine|hiv therapeutic vaccine
484796|NCT01082679|opioid dependent|opioid dependent
484797|NCT01082679|methadone|methadone
484798|NCT01082679|Suboxone|suboxone
484799|NCT01082679|buprenorphine|buprenorphine
484800|NCT01082666|Cuff pressure|cuff pressure
484801|NCT01082666|microaspiration|microaspiration
484802|NCT01082666|pepsin|pepsin
484803|NCT01082666|VAP|vap
484804|NCT01082666|Mechanical ventilation|mechanical ventilation
484805|NCT01082653|ALS|als
484806|NCT01082653|Lou Gehrig's Disease|lou gehrig's disease
484807|NCT01082640|Gout|gout
484808|NCT01082640|physiology|physiology
484809|NCT01082640|Hyperuricemia|hyperuricemia
484810|NCT01082640|Uric Acid|uric acid
484811|NCT01082640|Drug Therapy|drug therapy
484812|NCT01082627|Somatostatin small bowel obstruction|somatostatin small bowel obstruction
484813|NCT01082601|Catheter Ablation|catheter ablation
484814|NCT01082601|Atrial Fibrillation|atrial fibrillation
484815|NCT01082601|Congestive heart failure|congestive heart failure
484816|NCT01082588|schizophrenia|schizophrenia
484817|NCT01082588|pravastatin|pravastatin
484818|NCT01082588|inflammation|inflammation
484819|NCT01082588|cognition|cognition
484820|NCT01082588|antipsychotics|antipsychotics
484821|NCT01082588|cholesterol|cholesterol
484822|NCT01082575|Post Op Patients|post op patients
484823|NCT01082575|Continuous Pulse Oximetry Monitoring|continuous pulse oximetry monitoring
484824|NCT01082575|Major Surgery|major surgery
484825|NCT01082549|Patients with Previously Untreated Advanced Squamous Cell Lung Cancer|patients with previously untreated advanced squamous cell lung cancer
484826|NCT01082536|Pediatrics|pediatrics
484827|NCT01082536|Congenital heart disease|congenital heart disease
484828|NCT01082536|NIRS|nirs
484829|NCT01082536|Brain oxygenation|brain oxygenation
484830|NCT01082510|UFT|uft
484831|NCT01082510|BCG|bcg
484832|NCT01082497|Mindfulness|mindfulness
484833|NCT01082497|Stress|stress
484834|NCT01082497|Burnout|burnout
484835|NCT01082497|Ward atmosphere|ward atmosphere
484836|NCT01082497|Stress and burnout among staff, psychosocial atmosphere at the ward|stress and burnout among staff, psychosocial atmosphere at the ward
484837|NCT01082484|Healthy volunteers|healthy volunteers
484838|NCT01082484|iontophoresis|iontophoresis
484839|NCT01082471|Morphine 6-glucuronide|morphine 6-glucuronide
484840|NCT01082471|Morphine|morphine
484841|NCT01082471|Patient Controlled Analgesia|patient controlled analgesia
484842|NCT01082471|Post Operative Nausea and Vomiting|post operative nausea and vomiting
484843|NCT01082458|Patients scheduled to undergo thyroidectomy|patients scheduled to undergo thyroidectomy
484844|NCT01082445|stage C|stage c
484845|NCT01082445|grade 0 (Texas University)|grade 0 (texas university)
484846|NCT01082432|thumb|thumb
484847|NCT01082432|Ulnar collateral ligament|ulnar collateral ligament
484848|NCT01082432|superimposed electrical stimulation|superimposed electrical stimulation
484849|NCT01082432|stiffness|stiffness
484850|NCT01082432|adhesions|adhesions
484851|NCT01082419|Liver stiffness measurement|liver stiffness measurement
484852|NCT01082419|ARFI|arfi
484853|NCT01082419|fibrosis|fibrosis
484854|NCT01082419|hepatopathy|hepatopathy
484855|NCT01082393|vitiligo|vitiligo
484856|NCT01082380|radiolabeled|radiolabeled
484857|NCT01082380|healthy volunteers|healthy volunteers
484858|NCT01082367|Tobramycin Inhalation solution|tobramycin inhalation solution
484859|NCT01082367|Cystic fibrosis|cystic fibrosis
484860|NCT01082367|Lung disease|lung disease
484861|NCT01082367|anti-bacterial agents|anti-bacterial agents
484862|NCT01082354|Infant, Low birth weight|infant, low birth weight
484863|NCT01082354|Infant, Low birth height|infant, low birth height
484864|NCT01082354|Infant, Small for Gestational Age|infant, small for gestational age
484865|NCT01082341|GCP Good Clinical Practice|gcp good clinical practice
484866|NCT01082341|IFAT Indirect Immunofluorescence antibody test|ifat indirect immunofluorescence antibody test
484867|NCT01082341|MFA Membrane Feeding Assay|mfa membrane feeding assay
484868|NCT01082341|N Number (typically refers to subjects)|n number (typically refers to subjects)
484869|NCT01082341|RBC Red Blood Cells|rbc red blood cells
484870|NCT01082341|SOP Standard Operating Procedure|sop standard operating procedure
484871|NCT01082341|TBS Thick blood smear|tbs thick blood smear
484872|NCT01082341|P. Vivax|p. vivax
484873|NCT01082341|irradiated sporozoite vaccination.|irradiated sporozoite vaccination.
484874|NCT01082328|Phenylketonuria (PKU)|phenylketonuria (pku)
484875|NCT01082328|Hyperphenylalaninemia (HPA)|hyperphenylalaninemia (hpa)
484876|NCT01082328|Kuvan®|kuvan®
484877|NCT01082328|Sapropterin dihydrochloride|sapropterin dihydrochloride
484878|NCT01082328|Kuvan responder|kuvan responder
484879|NCT01082328|Tetrahydrobiopterin (BH4)|tetrahydrobiopterin (bh4)
484880|NCT01082315|Colorectal cancer|colorectal cancer
484881|NCT01082315|Neoplasm metastasis|neoplasm metastasis
484882|NCT01082315|Cetuximab|cetuximab
484883|NCT01082315|Erbitux|erbitux
484884|NCT01082315|EGFR|egfr
484885|NCT01082302|green tea extract|green tea extract
484886|NCT01082302|Polyphenon E|polyphenon e
484887|NCT01082302|Pharmacokinetics|pharmacokinetics
484888|NCT01082289|Lurasidone|lurasidone
484889|NCT01082289|Schizophrenia|schizophrenia
484890|NCT01082289|Latuda|latuda
484891|NCT01082276|Rifampin DDI with Lurasidone HCl|rifampin ddi with lurasidone hcl
484892|NCT01082263|DDI study between Midazolam and Lurasidone HCl|ddi study between midazolam and lurasidone hcl
484893|NCT01082263|Male and Female|male and female
484894|NCT01082250|Bioequivalence|bioequivalence
484895|NCT01082250|Male/Female Patient|male/female patient
484896|NCT01082250|Reference/Test Formulation|reference/test formulation
484897|NCT01082250|Schizophrenia Patients|schizophrenia patients
484898|NCT01082237|Major Depressive Disorder|major depressive disorder
484899|NCT01082237|EEG|eeg
484900|NCT01082237|SSRI|ssri
484901|NCT01082224|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
484902|NCT01082224|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
484903|NCT01082224|recurrent adult primary liver cancer|recurrent adult primary liver cancer
484904|NCT01082211|invasive ductal breast carcinoma|invasive ductal breast carcinoma
484905|NCT01082211|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
484906|NCT01082211|invasive lobular breast carcinoma|invasive lobular breast carcinoma
484907|NCT01082211|tubular ductal breast carcinoma|tubular ductal breast carcinoma
484908|NCT01082211|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
484909|NCT01082211|ductal breast carcinoma in situ|ductal breast carcinoma in situ
484910|NCT01082211|lobular breast carcinoma in situ|lobular breast carcinoma in situ
484911|NCT01082211|recurrent breast cancer|recurrent breast cancer
484912|NCT01082198|stage III melanoma|stage iii melanoma
484913|NCT01082185|abdominal|abdominal
484914|NCT01082185|aortic|aortic
484915|NCT01082185|aneurysm|aneurysm
484916|NCT01082185|AAA|aaa
484917|NCT01082172|thoracic|thoracic
484918|NCT01082172|aortic|aortic
484919|NCT01082172|aneurysm|aneurysm
484920|NCT01082172|TAA|taa
484921|NCT01082159|Spinal Stenosis|spinal stenosis
484922|NCT01082159|Lumbar Spinal Stenosis|lumbar spinal stenosis
484923|NCT01082146|pharmacokinetics, lurasidone|pharmacokinetics, lurasidone
484924|NCT01082133|Fanconi Anemia|fanconi anemia
484925|NCT01082120|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
484926|NCT01082120|Pioglitazone|pioglitazone
484927|NCT01082094|Ischemic heart failure|ischemic heart failure
484928|NCT01082094|Congestive heart failure|congestive heart failure
484929|NCT01082094|Stromal cell-derived factor 1|stromal cell-derived factor 1
484930|NCT01082094|SDF-1|sdf-1
484931|NCT01082094|Gene therapy|gene therapy
484932|NCT01082081|paracetamol|paracetamol
484933|NCT01082081|dental pain|dental pain
484934|NCT01082081|Post-surgical dental pain|post-surgical dental pain
484935|NCT01082068|HER2 negative|her2 negative
484936|NCT01082068|Hormone Receptor Positive|hormone receptor positive
484937|NCT01082068|Breast Neoplasms|breast neoplasms
484938|NCT01082055|Cardiac|cardiac
484939|NCT01082055|Dysrhythmia|dysrhythmia
484940|NCT01082055|Safety|safety
484941|NCT01082042|Balance, postural|balance, postural
484942|NCT01082042|Aged, over 70|aged, over 70
484943|NCT01082042|Exercise|exercise
484944|NCT01082042|Accidental falls|accidental falls
484945|NCT01082016|Sleep|sleep
484946|NCT01082016|Critical Illness|critical illness
484947|NCT01082016|Sleep promotion during recovery form illness|sleep promotion during recovery form illness
484948|NCT01082003|Capsular contractures in breast cancer patients|capsular contractures in breast cancer patients
484949|NCT01081977|Delayed cord clamping|delayed cord clamping
484950|NCT01081977|Ferritin|ferritin
484951|NCT01081977|Hemoglobin|hemoglobin
484952|NCT01081977|Neonatal anemia|neonatal anemia
484953|NCT01081977|Postpartum haemorrhage|postpartum haemorrhage
484954|NCT01081977|Neonatal jaundice|neonatal jaundice
484955|NCT01081964|pneumonia|pneumonia
484956|NCT01081964|Community acquired pneumonia of moderate severity|community acquired pneumonia of moderate severity
484957|NCT01081951|Poly(ADP ribose)|poly(adp ribose)
484958|NCT01081951|polymerisation (PARP)|polymerisation (parp)
484959|NCT01081951|Platinum sensitive|platinum sensitive
484960|NCT01081951|Advanced Serous Ovarian cancer|advanced serous ovarian cancer
484961|NCT01081951|olaparib|olaparib
484962|NCT01081951|PARP inhibitors|parp inhibitors
484963|NCT01081951|Platinum Sensitive Advanced Serous Ovarian Cancer|platinum sensitive advanced serous ovarian cancer
484964|NCT01081925|Congestive Heart Failure|congestive heart failure
484965|NCT01081925|Cardiac Failure|cardiac failure
484966|NCT01081912|chronic pain|chronic pain
484967|NCT01081912|back pain|back pain
484968|NCT01081899|dying patients|dying patients
484969|NCT01081899|cancer|cancer
484970|NCT01081899|hospital|hospital
484971|NCT01081899|Liverpool Care Pathways|liverpool care pathways
484972|NCT01081886|Total knee arthroplasty|total knee arthroplasty
484973|NCT01081886|PlasmaBlade|plasmablade
484974|NCT01081886|Electrosurgery|electrosurgery
484975|NCT01081886|PEAK Surgical|peak surgical
484976|NCT01081886|Medtronic Advanced Energy|medtronic advanced energy
484977|NCT01081886|Medtronic|medtronic
484978|NCT01081873|Multicenter study|multicenter study
484979|NCT01081860|Carpal tunnel syndrome|carpal tunnel syndrome
484980|NCT01081860|CTS|cts
484981|NCT01081860|Skinstiffness|skinstiffness
484982|NCT01081860|Jointstiffness|jointstiffness
484983|NCT01081847|Malaria|malaria
484984|NCT01081847|Synthetic peptides|synthetic peptides
484985|NCT01081847|Plasmodium vivax|plasmodium vivax
484986|NCT01081847|Human volunteers|human volunteers
484987|NCT01081834|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
484988|NCT01081834|Canagliflozin|canagliflozin
484989|NCT01081834|Placebo|placebo
484990|NCT01081834|Hemoglobin A1c|hemoglobin a1c
484991|NCT01081834|Type 2 diabetes mellitus|type 2 diabetes mellitus
484992|NCT01081821|JNJ 39758979|jnj 39758979
484993|NCT01081821|Japanese descent|japanese descent
484994|NCT01081808|PhaseI|phasei
484995|NCT01081808|Solid Tumor|solid tumor
484996|NCT01081808|biomarkers|biomarkers
484997|NCT01081808|T cell|t cell
484998|NCT01081808|Cetuximab|cetuximab
484999|NCT01081808|Epidermal Growth Factor Receptor|epidermal growth factor receptor
485000|NCT01081808|Aldesleukin|aldesleukin
485001|NCT01081808|Lymphocytes|lymphocytes
485002|NCT01081808|Autologous|autologous
485003|NCT01081808|Recurrent|recurrent
485004|NCT01081808|Refractory|refractory
485005|NCT01081808|Metastatic|metastatic
485006|NCT01081808|Immunotherapy|immunotherapy
485007|NCT01081808|Antibodies|antibodies
485008|NCT01081808|Neoplasms by Site|neoplasms by site
485009|NCT01081808|Anti-Retroviral Agents|anti-retroviral agents
485010|NCT01081808|Therapeutic Uses|therapeutic uses
485011|NCT01081808|Anti-Infective Agents|anti-infective agents
485012|NCT01081808|Neoplasms by Histologic Type|neoplasms by histologic type
485013|NCT01081808|Antineoplastic Agents|antineoplastic agents
485014|NCT01081808|Antiviral Agents|antiviral agents
485015|NCT01081808|Pharmacologic Actions|pharmacologic actions
485016|NCT01081808|Carcinoma|carcinoma
485017|NCT01081808|Neoplasms|neoplasms
485018|NCT01081795|Topiramate|topiramate
485019|NCT01081795|Migraine|migraine
485020|NCT01081782|Multiple Sclerosis|multiple sclerosis
485021|NCT01081782|ONO-4641|ono-4641
485022|NCT01081769|Schizophrenia|schizophrenia
485023|NCT01081769|paliperidone palmitate|paliperidone palmitate
485024|NCT01081769|Invega|invega
485025|NCT01081769|Intramuscular injection|intramuscular injection
485026|NCT01081769|Oral antipsychotics|oral antipsychotics
485027|NCT01081769|Relapse|relapse
485028|NCT01081756|Reproductive technology; Assisted|reproductive technology; assisted
485029|NCT01081756|recombinant human chorionic hormone (r-hCG)|recombinant human chorionic hormone (r-hcg)
485030|NCT01081743|Alzheimer|alzheimer
485031|NCT01081743|Dementia|dementia
485032|NCT01081743|Mild to moderately severe|mild to moderately severe
485033|NCT01081743|New diagnosis|new diagnosis
485034|NCT01081743|Prevention of behavioural problems|prevention of behavioural problems
485035|NCT01081730|psoriasis|psoriasis
485036|NCT01081730|ustekinumab|ustekinumab
485037|NCT01081730|anti-TNF biologics|anti-tnf biologics
485038|NCT01081730|non-anti-TNF biologics|non-anti-tnf biologics
485039|NCT01081730|systemic non-biological treatments|systemic non-biological treatments
485040|NCT01081717|Rheumatoid arthritis|rheumatoid arthritis
485041|NCT01081717|psoriatic arthritis|psoriatic arthritis
485042|NCT01081717|ankylosing spondylitis|ankylosing spondylitis
485043|NCT01081717|golimumab|golimumab
485044|NCT01081717|anti-TNF biologics|anti-tnf biologics
485045|NCT01081717|non-anti-TNF biologics|non-anti-tnf biologics
485046|NCT01081717|non-biological treatments|non-biological treatments
485047|NCT01081704|Healthy volunteer|healthy volunteer
485048|NCT01081704|Chinese male|chinese male
485049|NCT01081704|Stelara|stelara
485050|NCT01081691|CNTO 5825|cnto 5825
485051|NCT01081691|Safety|safety
485052|NCT01081691|Phase I|phase i
485053|NCT01081691|Healthy adults|healthy adults
485054|NCT01081691|Healthy Atopic adults|healthy atopic adults
485055|NCT01081678|AMG 785|amg 785
485056|NCT01081678|Proximal Femur|proximal femur
485057|NCT01081678|Fracture Healing|fracture healing
485058|NCT01081678|Hip Fracture|hip fracture
485059|NCT01081665|Chronic Kidney Failure|chronic kidney failure
485060|NCT01081665|Secondary Hyperparathyroidism|secondary hyperparathyroidism
485061|NCT01081665|Paricalcitol IV treatment|paricalcitol iv treatment
485062|NCT01081665|Safety and efficacy assessment|safety and efficacy assessment
485063|NCT01081652|Fertilisation, In vitro|fertilisation, in vitro
485064|NCT01081652|Embryo transfer|embryo transfer
485065|NCT01081652|progesterone|progesterone
485066|NCT01081652|Reproductive technologies, Assisted|reproductive technologies, assisted
485067|NCT01081639|Follitropin alfa|follitropin alfa
485068|NCT01081639|Follitropin beta|follitropin beta
485069|NCT01081639|Fertilization, in vitro|fertilization, in vitro
485070|NCT01081639|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
485071|NCT01081639|Assisted reproductive techniques|assisted reproductive techniques
485072|NCT01081639|Polycystic ovary syndrome|polycystic ovary syndrome
485073|NCT01081626|Infertility|infertility
485074|NCT01081626|Ovulation induction|ovulation induction
485075|NCT01081626|Gonal-f|gonal-f
485076|NCT01081626|Follitropin alpha|follitropin alpha
485077|NCT01081626|Polycystic ovarian syndrome|polycystic ovarian syndrome
485078|NCT01081626|Anovulatory infertility|anovulatory infertility
485079|NCT01081613|heat shock protein|heat shock protein
485080|NCT01081613|breast cancer|breast cancer
485081|NCT01081613|PET imaging|pet imaging
485082|NCT01081613|bevacizumab|bevacizumab
485083|NCT01081600|Heat shock protein|heat shock protein
485084|NCT01081600|breast cancer|breast cancer
485085|NCT01081600|PET imaging|pet imaging
485086|NCT01081600|trastuzumab|trastuzumab
485087|NCT01081587|Non MeSH terms:|non mesh terms:
485088|NCT01081587|Children|children
485089|NCT01081587|Malnutrition|malnutrition
485090|NCT01081587|Computer Clinical Decision Support System|computer clinical decision support system
485091|NCT01081587|Cluster randomized trial|cluster randomized trial
485092|NCT01081587|Healthcare workers|healthcare workers
485093|NCT01081587|Guideline adherence|guideline adherence
485094|NCT01081587|Patient safety|patient safety
485095|NCT01081587|MeSH terms:|mesh terms:
485096|NCT01081587|Nutrition Surveys|nutrition surveys
485097|NCT01081587|Secondary Prevention|secondary prevention
485098|NCT01081587|Pediatrics|pediatrics
485099|NCT01081587|Child Care|child care
485100|NCT01081587|Health Personnel|health personnel
485101|NCT01081587|Reminder Systems|reminder systems
485102|NCT01081587|Intervention Studies|intervention studies
485103|NCT01081587|Quality of Health Care|quality of health care
485104|NCT01081574|Allergic Rhinitis|allergic rhinitis
485105|NCT01081574|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
485106|NCT01081574|Perennial Allergic Rhinitis|perennial allergic rhinitis
485107|NCT01081574|Urticaria|urticaria
485108|NCT01081574|Chronic Idiopathic Urticaria|chronic idiopathic urticaria
485109|NCT01081574|Allergy|allergy
485110|NCT01081574|Sneezing|sneezing
485111|NCT01081574|Nasal Itching|nasal itching
485112|NCT01081574|Rhinorrhea|rhinorrhea
485113|NCT01081574|Nasal Congestion|nasal congestion
485114|NCT01081574|Wheals|wheals
485115|NCT01081574|Hives|hives
485116|NCT01081574|Skin itching|skin itching
485117|NCT01081574|Flare|flare
485118|NCT01081574|Erythema|erythema
485119|NCT01081535|Pediatric patients (6 months-5 years) scheduled elective ureteroneocystostomy|pediatric patients (6 months-5 years) scheduled elective ureteroneocystostomy
485120|NCT01081509|adherence|adherence
485121|NCT01081509|early breast cancer|early breast cancer
485122|NCT01081509|Arimidex|arimidex
485123|NCT01081509|Therapy adherence|therapy adherence
485124|NCT01081496|EGFR mutation, Non-small cell lung carcinoma, Spain|egfr mutation, non-small cell lung carcinoma, spain
485125|NCT01081496|Evaluate the prevalence of EGFR mutation status in patients with newly diagnosed locally advanced or metastatic NSCLC|evaluate the prevalence of egfr mutation status in patients with newly diagnosed locally advanced or metastatic nsclc
485126|NCT01081483|Healthy Volunteers|healthy volunteers
485127|NCT01081483|HCV Infections|hcv infections
485128|NCT01081457|Parkinson's disease|parkinson's disease
485129|NCT01081457|deep brain stimulation|deep brain stimulation
485130|NCT01081457|GI motility|gi motility
485131|NCT01081444|repetitive transcranial stimulation|repetitive transcranial stimulation
485132|NCT01081431|Myelodysplastic Syndromes|myelodysplastic syndromes
485133|NCT01081431|MDS|mds
485134|NCT01081431|deletion 5q|deletion 5q
485135|NCT01081431|del 5q|del 5q
485136|NCT01081431|IPSS|ipss
485137|NCT01081431|low risk|low risk
485138|NCT01081431|intermediate-1 risk|intermediate-1 risk
485139|NCT01081431|GMIHO|gmiho
485140|NCT01081431|ClinAssess|clinassess
485141|NCT01081431|Germing|germing
485142|NCT01081431|Düsseldorf|düsseldorf
485143|NCT01081431|MDS-LE-MON-5|mds-le-mon-5
485144|NCT01081431|Lenalidomide|lenalidomide
485145|NCT01081431|Revlimid|revlimid
485146|NCT01081418|Schizophrenia, assertive community treatment, quetiapine|schizophrenia, assertive community treatment, quetiapine
485147|NCT01081405|ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION|allogeneic hematopoietic cell transplantation
485148|NCT01081405|TOTAL LYMPHOID IRRADIATION|total lymphoid irradiation
485149|NCT01081405|ANTI-THYMOCYTE GLOBULIN|anti-thymocyte globulin
485150|NCT01081392|LPS|lps
485151|NCT01081392|endotoxin|endotoxin
485152|NCT01081392|inflammatory markers|inflammatory markers
485153|NCT01081392|healthy volunteers|healthy volunteers
485154|NCT01081392|neutrophils in sputum|neutrophils in sputum
485155|NCT01081379|Cytomegalovirus Infections|cytomegalovirus infections
485156|NCT01081379|Pregnancy|pregnancy
485157|NCT01081379|T-Lymphocytes|t-lymphocytes
485158|NCT01081379|Transmission|transmission
485159|NCT01081353|Aspirin|aspirin
485160|NCT01081353|Acetylsalicylic Acid|acetylsalicylic acid
485161|NCT01081340|gestational weight gain|gestational weight gain
485162|NCT01081340|postpartum weight loss|postpartum weight loss
485163|NCT01081340|breastfeeding|breastfeeding
485164|NCT01081340|overfeeding|overfeeding
485165|NCT01081327|Atrial Fibrillation|atrial fibrillation
485166|NCT01081327|Warfarin|warfarin
485167|NCT01081327|Safety|safety
485168|NCT01081301|hope|hope
485169|NCT01081301|quality of life|quality of life
485170|NCT01081301|caregivers|caregivers
485171|NCT01081288|Breast cancer|breast cancer
485370|NCT01080430|vertigo|vertigo
485172|NCT01081288|Breast screening|breast screening
485173|NCT01081288|Mammography|mammography
485174|NCT01081288|Routine screening programme|routine screening programme
485175|NCT01081275|Multiple Sclerosis|multiple sclerosis
485176|NCT01081275|MS|ms
485177|NCT01081275|CI Therapy|ci therapy
485178|NCT01081275|CIMT|cimt
485179|NCT01081275|Constraint-Induced Movement Therapy|constraint-induced movement therapy
485180|NCT01081275|Complementary and Alternative Medicine|complementary and alternative medicine
485181|NCT01081275|CAM|cam
485182|NCT01081275|Physical Therapy|physical therapy
485183|NCT01081275|Occupational Therapy|occupational therapy
485184|NCT01081275|Relaxation|relaxation
485185|NCT01081275|Exercise|exercise
485186|NCT01081275|Massage|massage
485187|NCT01081275|Yoga|yoga
485188|NCT01081275|Pool Therapy|pool therapy
485189|NCT01081275|Aquatherapy|aquatherapy
485190|NCT01081275|Aquatic Therapy|aquatic therapy
485191|NCT01081249|psychotherapy|psychotherapy
485192|NCT01081236|liver cirrhosis|liver cirrhosis
485193|NCT01081236|intestinal permeability|intestinal permeability
485194|NCT01081236|microbiota|microbiota
485195|NCT01081236|complications|complications
485196|NCT01081223|Brain Neoplasms|brain neoplasms
485197|NCT01081223|Central Nervous System Neoplasms|central nervous system neoplasms
485198|NCT01081223|Brain Diseases|brain diseases
485199|NCT01081223|Neoplasms|neoplasms
485200|NCT01081223|Nervous System Neoplasms|nervous system neoplasms
485201|NCT01081223|Glioblastoma|glioblastoma
485202|NCT01081223|Astrocytoma|astrocytoma
485203|NCT01081223|Nervous System Diseases|nervous system diseases
485204|NCT01081223|Central Nervous System Diseases|central nervous system diseases
485205|NCT01081223|Glioma|glioma
485206|NCT01081223|Recurrent astrocytoma|recurrent astrocytoma
485207|NCT01081223|Recurrent glioma|recurrent glioma
485208|NCT01081223|Cancer vaccine|cancer vaccine
485209|NCT01081223|Immunotherapy|immunotherapy
485210|NCT01081223|Killer T cells|killer t cells
485211|NCT01081223|Activated T cells|activated t cells
485212|NCT01081223|GM-CSF|gm-csf
485213|NCT01081223|Low dose IL-2|low dose il-2
485214|NCT01081223|Activated lymphocytes|activated lymphocytes
485215|NCT01081210|Echocardiography|echocardiography
485216|NCT01081210|Heart failure|heart failure
485217|NCT01081210|Kidney|kidney
485218|NCT01081210|Lung|lung
485219|NCT01081210|Aorta|aorta
485220|NCT01081197|heart failure|heart failure
485221|NCT01081197|liver|liver
485222|NCT01081197|depression|depression
485223|NCT01081197|neuropathy|neuropathy
485224|NCT01081184|primary Sjögren syndrome|primary sjögren syndrome
485225|NCT01081184|neurotrophins|neurotrophins
485226|NCT01081184|B cell|b cell
485227|NCT01081184|sicca syndrome|sicca syndrome
485228|NCT01081184|T cell|t cell
485229|NCT01081119|adolescent|adolescent
485230|NCT01081119|middle school|middle school
485231|NCT01081119|prevention|prevention
485232|NCT01081119|alcohol|alcohol
485233|NCT01081119|cigarettes|cigarettes
485234|NCT01081119|marijuana|marijuana
485235|NCT01081106|Breast Cancer|breast cancer
485236|NCT01081093|Hypertrophic Cardiomyopathy Diastolic Ventricular Interaction|hypertrophic cardiomyopathy diastolic ventricular interaction
485237|NCT01081093|Biventricular Pacemaker cardiac surgery aortic valve replacement|biventricular pacemaker cardiac surgery aortic valve replacement
485238|NCT01081080|cardiac|cardiac
485239|NCT01081080|muscle|muscle
485240|NCT01081080|pediatric|pediatric
485241|NCT01081080|dystrophy|dystrophy
485242|NCT01081054|Diverticulitis|diverticulitis
485243|NCT01081054|Not complicated diverticulitis|not complicated diverticulitis
485244|NCT01081028|Multiple Myeloma|multiple myeloma
485245|NCT01081028|MM|mm
485246|NCT01081028|disease registry|disease registry
485247|NCT01081028|Connect®|connect®
485248|NCT01081015|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
485249|NCT01081015|CLL|cll
485250|NCT01081015|disease registry|disease registry
485251|NCT01081015|Connect™|connect™
485252|NCT01081002|Propofol|propofol
485253|NCT01081002|Conscious sedation|conscious sedation
485254|NCT01081002|Topical pharyngeal anesthesia|topical pharyngeal anesthesia
485255|NCT01081002|Anesthetics, Local|anesthetics, local
485256|NCT01081002|Gastrointestinal Endoscopy|gastrointestinal endoscopy
485257|NCT01080989|solomon islands|solomon islands
485258|NCT01080989|malaria|malaria
485259|NCT01080989|flavivirus|flavivirus
485260|NCT01080989|alphavirus|alphavirus
485261|NCT01080989|parasite|parasite
485262|NCT01080989|leptospirosis|leptospirosis
485263|NCT01080963|Prophylaxis|prophylaxis
485264|NCT01080963|Antibiotic|antibiotic
485265|NCT01080963|Sternotomy|sternotomy
485266|NCT01080963|Heart-Lung Machine|heart-lung machine
485267|NCT01080950|zinc|zinc
485268|NCT01080950|sepsis|sepsis
485269|NCT01080950|fever|fever
485270|NCT01080950|vitamin d|vitamin d
485271|NCT01080937|acute heart failure|acute heart failure
485272|NCT01080911|Spinal morphine|spinal morphine
485273|NCT01080911|Vaginal hysterectomy|vaginal hysterectomy
485274|NCT01080898|Age - Related Macular Degeneration|age - related macular degeneration
485275|NCT01080898|Optical Coherence Tomography|optical coherence tomography
485276|NCT01080898|Choroidal neovascularization|choroidal neovascularization
485277|NCT01080898|FLORESCEIN Angiography|florescein angiography
485278|NCT01080898|Fundus photographs|fundus photographs
485279|NCT01080885|Prevention|prevention
485280|NCT01080885|Prevention of unhealthy weight gain|prevention of unhealthy weight gain
485281|NCT01080872|acute coronary syndrome|acute coronary syndrome
485282|NCT01080872|coronary flow reserve|coronary flow reserve
485283|NCT01080872|OCT|oct
485284|NCT01080872|healing|healing
485285|NCT01080872|drug eluting stent|drug eluting stent
485286|NCT01080859|titanium|titanium
485287|NCT01080859|everolimus|everolimus
485288|NCT01080859|oct|oct
485289|NCT01080859|acute coronary syndrome|acute coronary syndrome
485290|NCT01080859|stent|stent
485291|NCT01080859|pci|pci
485292|NCT01080859|stenting|stenting
485293|NCT01080846|Primary postpartum hemorrhage|primary postpartum hemorrhage
485294|NCT01080846|PPH|pph
485295|NCT01080846|uterine atony|uterine atony
485296|NCT01080846|high fever|high fever
485297|NCT01080846|hyperpyrexia|hyperpyrexia
485298|NCT01080833|EMS|ems
485299|NCT01080833|ERCP|ercp
485300|NCT01080833|Training|training
485301|NCT01080833|Trainees|trainees
485302|NCT01080820|Healthy adult volunteers|healthy adult volunteers
485303|NCT01080820|Pharmacokinetics|pharmacokinetics
485304|NCT01080794|Parkinson's Disease|parkinson's disease
485305|NCT01080794|Depression|depression
485306|NCT01080794|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
485307|NCT01080781|Cardiomyopathy|cardiomyopathy
485308|NCT01080781|Ephrin-B1 expression|ephrin-b1 expression
485309|NCT01080781|cell-cell junctions|cell-cell junctions
485310|NCT01080781|heart rate variability|heart rate variability
485311|NCT01080781|right appendage|right appendage
485312|NCT01080768|Pedal edema|pedal edema
485313|NCT01080768|hypertension|hypertension
485314|NCT01080768|aliskiren|aliskiren
485315|NCT01080768|amlodipine|amlodipine
485316|NCT01080755|Adult Growth Hormone Deficiency|adult growth hormone deficiency
485317|NCT01080755|Pituitary|pituitary
485318|NCT01080755|Saizen|saizen
485319|NCT01080755|Somatropin|somatropin
485320|NCT01080755|Growth Hormone|growth hormone
485321|NCT01080742|Hypertension|hypertension
485322|NCT01080742|Lodoz|lodoz
485323|NCT01080742|Bisoprolol|bisoprolol
485324|NCT01080742|Hydrochlorothiazide|hydrochlorothiazide
485325|NCT01080729|Ovulation induction|ovulation induction
485326|NCT01080729|Ovarian Hyperstimulation Syndrome|ovarian hyperstimulation syndrome
485327|NCT01080729|Multifollicular stimulation|multifollicular stimulation
485328|NCT01080729|Pregnancy|pregnancy
485329|NCT01080729|Sperm injections, intracytoplasmic|sperm injections, intracytoplasmic
485330|NCT01080729|Fertility|fertility
485331|NCT01080703|Lung Transplant|lung transplant
485332|NCT01080703|Quadriceps Strength|quadriceps strength
485333|NCT01080703|Quality of Life|quality of life
485334|NCT01080703|Patients with pulmonary disease awaiting lung transplant.|patients with pulmonary disease awaiting lung transplant.
485335|NCT01080690|endosonography, right side abdominal pain|endosonography, right side abdominal pain
485336|NCT01080690|Endosonography (diagnostic value in right side abdominal pain)|endosonography (diagnostic value in right side abdominal pain)
485337|NCT01080664|AS703569|as703569
485338|NCT01080664|Aurora Kinase Inhibitor|aurora kinase inhibitor
485339|NCT01080664|Haematological malignancies|haematological malignancies
485340|NCT01080638|abciximab|abciximab
485341|NCT01080638|Myocardial Infarction|myocardial infarction
485342|NCT01080638|angioplasty|angioplasty
485343|NCT01080638|Platelet|platelet
485344|NCT01080625|postreperfusion syndrome|postreperfusion syndrome
485345|NCT01080625|phenylephrine|phenylephrine
485346|NCT01080625|epinephrine|epinephrine
485347|NCT01080625|liver transplantation|liver transplantation
485348|NCT01080612|pregabalin|pregabalin
485349|NCT01080612|pharmacokinetics|pharmacokinetics
485350|NCT01080612|bioavailability|bioavailability
485351|NCT01080599|obturator nerve block in TURB|obturator nerve block in turb
485352|NCT01080586|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
485353|NCT01080573|Multiple sclerosis|multiple sclerosis
485354|NCT01080573|Rebif|rebif
485355|NCT01080573|Interferon beta-1a|interferon beta-1a
485356|NCT01080560|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
485357|NCT01080534|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
485358|NCT01080508|pressure pattern|pressure pattern
485359|NCT01080508|esophageal and tracheal ventilation.|esophageal and tracheal ventilation.
485360|NCT01080508|esophageal intubation.|esophageal intubation.
485361|NCT01080495|left ventricular function|left ventricular function
485362|NCT01080495|radial strain|radial strain
485363|NCT01080495|fractional shortening|fractional shortening
485364|NCT01080495|fractional area change|fractional area change
485365|NCT01080482|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
485366|NCT01080469|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
485367|NCT01080456|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
485368|NCT01080443|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
485369|NCT01080430|vestibular|vestibular
485371|NCT01080430|rehabilitation|rehabilitation
485372|NCT01080430|rotation|rotation
485373|NCT01080430|balance|balance
485374|NCT01080417|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
485375|NCT01080404|Obstructive sleep apnea|obstructive sleep apnea
485376|NCT01080404|Obesity|obesity
485377|NCT01080404|Metabolism|metabolism
485378|NCT01080404|Bariatric surgery|bariatric surgery
485379|NCT01080404|CPAP|cpap
485380|NCT01080391|Multiple Myeloma|multiple myeloma
485381|NCT01080352|Prostate cancer|prostate cancer
485382|NCT01080352|palliative care|palliative care
485383|NCT01080352|antioxidants|antioxidants
485384|NCT01080352|ascorbic acid|ascorbic acid
485385|NCT01080352|rna expression|rna expression
485386|NCT01080339|insulin resistance|insulin resistance
485387|NCT01080339|cardiovascular risk|cardiovascular risk
485388|NCT01080339|physical activity|physical activity
485389|NCT01080339|child|child
485390|NCT01080326|ulcer repair surgery|ulcer repair surgery
485391|NCT01080326|transluminal omental patch|transluminal omental patch
485392|NCT01080300|Hot Flushes|hot flushes
485393|NCT01080300|Vasomotor Symptoms|vasomotor symptoms
485394|NCT01080300|Menopausal Hot Flashes|menopausal hot flashes
485395|NCT01080287|autonomic|autonomic
485396|NCT01080287|orthostatic|orthostatic
485397|NCT01080287|syncope|syncope
485398|NCT01080287|biopsy|biopsy
485399|NCT01080287|prevalence of autonomic dysfunction in migraineurs with orthostatic intolerance|prevalence of autonomic dysfunction in migraineurs with orthostatic intolerance
485400|NCT01080287|characterize autonomic findings utilizing neurocardiac testing, neurophysiological testing and skin biopsies to analyze autonomic fibers in the dermis|characterize autonomic findings utilizing neurocardiac testing, neurophysiological testing and skin biopsies to analyze autonomic fibers in the dermis
485401|NCT01080274|ergometry|ergometry
485402|NCT01080274|vitamin d|vitamin d
485403|NCT01080274|zinc|zinc
485404|NCT01080261|Atherosclerosis|atherosclerosis
485405|NCT01080261|Coronary Artery Disease|coronary artery disease
485406|NCT01080248|Pancreas|pancreas
485407|NCT01080235|quality improvement|quality improvement
485408|NCT01080235|geriatric care|geriatric care
485409|NCT01080235|residency training|residency training
485410|NCT01080222|VX-950|vx-950
485411|NCT01080196|Falling risk|falling risk
485412|NCT01080196|muscle conditioning|muscle conditioning
485413|NCT01080196|muscle size|muscle size
485414|NCT01080196|isometric strength|isometric strength
485415|NCT01080196|Incidence in falls|incidence in falls
485416|NCT01080183|Health-related quality of life|health-related quality of life
485417|NCT01080183|physical activity|physical activity
485418|NCT01080170|Aromatase Inhibitor|aromatase inhibitor
485419|NCT01080170|Anastrazole|anastrazole
485420|NCT01080170|Arimidex|arimidex
485421|NCT01080170|Heart disease|heart disease
485422|NCT01080170|Lipids|lipids
485423|NCT01080170|Body composition|body composition
485424|NCT01080170|Breast cancer.|breast cancer.
485425|NCT01080157|Diabetes|diabetes
485426|NCT01080157|Diabetes Screening|diabetes screening
485427|NCT01080157|Experimental Medical Device|experimental medical device
485428|NCT01080144|Cirrhosis|cirrhosis
485429|NCT01080144|TIPS (Transjugular intrahepatic portosystemic shunt)|tips (transjugular intrahepatic portosystemic shunt)
485430|NCT01080144|Encephalopathy|encephalopathy
485431|NCT01080131|Frequent flares|frequent flares
485432|NCT01080131|Gout|gout
485433|NCT01080131|Anti-interleukin-1β monoclonal antibody|anti-interleukin-1β monoclonal antibody
485434|NCT01080118|Teaching|teaching
485435|NCT01080118|Video Scope|video scope
485436|NCT01080118|Intubation|intubation
485437|NCT01080105|Depression Prevention|depression prevention
485438|NCT01080105|Prevention|prevention
485439|NCT01080105|Major Depressive Disorder|major depressive disorder
485440|NCT01080105|Internet|internet
485441|NCT01080105|Technology Assisted|technology assisted
485442|NCT01080092|smokers|smokers
485443|NCT01080079|Onychomycosis|onychomycosis
485444|NCT01080066|Carcinoma|carcinoma
485445|NCT01080066|Squamous cell|squamous cell
485446|NCT01080066|Erbitux|erbitux
485447|NCT01080066|cetuximab|cetuximab
485448|NCT01080066|Head|head
485449|NCT01080066|Neck|neck
485450|NCT01080053|Multiple Sclerosis, Relapsing Remitting|multiple sclerosis, relapsing remitting
485451|NCT01080053|Sexual dysfunction|sexual dysfunction
485452|NCT01080040|Multiple Sclerosis, Relapsing Remitting|multiple sclerosis, relapsing remitting
485453|NCT01080040|Quality of life|quality of life
485454|NCT01080027|Multiple sclerosis|multiple sclerosis
485455|NCT01080027|Relapsing remitting|relapsing remitting
485456|NCT01080027|Rebif|rebif
485457|NCT01080014|Relapsing-remitting multiple sclerosis (RRMS)|relapsing-remitting multiple sclerosis (rrms)
485458|NCT01080014|primary progressive multiple sclerosis (PPMS)|primary progressive multiple sclerosis (ppms)
485459|NCT01080014|secondary progressive multiple sclerosis (SPMS)|secondary progressive multiple sclerosis (spms)
485460|NCT01080014|Multiple Sclerosis Functional Composite (MSFC)|multiple sclerosis functional composite (msfc)
485461|NCT01080014|Expanded Disability Status Scale (EDSS)|expanded disability status scale (edss)
485462|NCT01080001|Multiple sclerosis|multiple sclerosis
485463|NCT01080001|Multiple sclerosis, Relapsing-remitting|multiple sclerosis, relapsing-remitting
485561|NCT01079598|IPV|ipv
485464|NCT01080001|Expanded Disability Status Scale|expanded disability status scale
485465|NCT01080001|Fatigue|fatigue
485466|NCT01080001|Hamilton Depression Inventory|hamilton depression inventory
485467|NCT01080001|Depression|depression
485468|NCT01079988|Psoriasis|psoriasis
485469|NCT01079988|Discontinuation of efalizumab|discontinuation of efalizumab
485470|NCT01079988|Managing inflammatory recurrence|managing inflammatory recurrence
485471|NCT01079975|Multiple sclerosis|multiple sclerosis
485472|NCT01079975|Depression|depression
485473|NCT01079962|Bisoprolol|bisoprolol
485474|NCT01079962|Atenolol|atenolol
485475|NCT01079962|Hypertension|hypertension
485476|NCT01079962|Blood pressure|blood pressure
485477|NCT01079949|Infertility|infertility
485478|NCT01079949|Ovulation induction|ovulation induction
485479|NCT01079949|Luveris|luveris
485480|NCT01079949|Lutropin alfa|lutropin alfa
485481|NCT01079949|Controlled ovarian stimulation|controlled ovarian stimulation
485482|NCT01079949|Reproductive technologies, Assisted|reproductive technologies, assisted
485483|NCT01079936|Multiple Myeloma|multiple myeloma
485484|NCT01079936|Lenalidomide|lenalidomide
485485|NCT01079936|Revlimid|revlimid
485486|NCT01079936|Melphalan|melphalan
485487|NCT01079936|Alkeran|alkeran
485488|NCT01079936|Autologous stem cell transplantation|autologous stem cell transplantation
485489|NCT01079936|High-dose chemotherapy|high-dose chemotherapy
485490|NCT01079923|healthy volunteers|healthy volunteers
485491|NCT01079923|healthy subjects|healthy subjects
485492|NCT01079923|vitamin D|vitamin d
485493|NCT01079923|cholecalciferol|cholecalciferol
485494|NCT01079923|vitamin D3|vitamin d3
485495|NCT01079923|total vitamin D|total vitamin d
485496|NCT01079910|Plaque|plaque
485497|NCT01079910|Toothpaste|toothpaste
485498|NCT01079910|Gingivitis|gingivitis
485499|NCT01079897|Atopic dermatitis|atopic dermatitis
485500|NCT01079897|Ectoine|ectoine
485501|NCT01079897|Treatment|treatment
485502|NCT01079897|Atopiclair|atopiclair
485503|NCT01079897|Medical device|medical device
485504|NCT01079871|Sjogren's Syndrome|sjogren's syndrome
485505|NCT01079871|Dry Eye|dry eye
485506|NCT01079858|Meibomian Gland Dysfunction|meibomian gland dysfunction
485507|NCT01079858|Dry Eye|dry eye
485508|NCT01079845|Diet|diet
485509|NCT01079845|Nutrition|nutrition
485510|NCT01079845|Adolescent|adolescent
485511|NCT01079845|Young Adult|young adult
485512|NCT01079845|Overweight|overweight
485513|NCT01079845|Obesity|obesity
485514|NCT01079793|adenocarcinoma of the prostate|adenocarcinoma of the prostate
485515|NCT01079793|stage III prostate cancer|stage iii prostate cancer
485516|NCT01079780|mucinous adenocarcinoma of the colon|mucinous adenocarcinoma of the colon
485517|NCT01079780|recurrent colon cancer|recurrent colon cancer
485518|NCT01079780|signet ring adenocarcinoma of the colon|signet ring adenocarcinoma of the colon
485519|NCT01079780|stage III colon cancer|stage iii colon cancer
485520|NCT01079780|stage IV colon cancer|stage iv colon cancer
485521|NCT01079780|mucinous adenocarcinoma of the rectum|mucinous adenocarcinoma of the rectum
485522|NCT01079780|recurrent rectal cancer|recurrent rectal cancer
485523|NCT01079780|signet ring adenocarcinoma of the rectum|signet ring adenocarcinoma of the rectum
485524|NCT01079780|stage III rectal cancer|stage iii rectal cancer
485525|NCT01079780|stage IV rectal cancer|stage iv rectal cancer
485526|NCT01079767|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
485527|NCT01079767|advanced adult primary liver cancer|advanced adult primary liver cancer
485528|NCT01079767|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
485529|NCT01079767|recurrent adult primary liver cancer|recurrent adult primary liver cancer
485530|NCT01079754|Spinal morphine 0.05 mg|spinal morphine 0.05 mg
485531|NCT01079754|Spinal morphine|spinal morphine
485532|NCT01079741|Melanoma|melanoma
485533|NCT01079741|Skin Cancer|skin cancer
485534|NCT01079741|Adjuvant Therapy|adjuvant therapy
485535|NCT01079741|Oncogenesis|oncogenesis
485536|NCT01079741|LAGE|lage
485537|NCT01079741|Cancer Immunity|cancer immunity
485538|NCT01079741|Neoplasms|neoplasms
485539|NCT01079741|Immunogenicity|immunogenicity
485540|NCT01079741|Vaccine|vaccine
485541|NCT01079741|Immunotherapy|immunotherapy
485542|NCT01079728|ischemic stroke|ischemic stroke
485543|NCT01079728|stroke-associated pneumonia|stroke-associated pneumonia
485544|NCT01079728|prediction|prediction
485545|NCT01079728|immune and infection parameters|immune and infection parameters
485546|NCT01079715|Newborn|newborn
485547|NCT01079715|Retinal Diseases|retinal diseases
485548|NCT01079715|Angiogenesis Modulating Agents|angiogenesis modulating agents
485549|NCT01079715|Adrenergic beta-Antagonists|adrenergic beta-antagonists
485550|NCT01079689|basic science|basic science
485551|NCT01079689|healthy volunteers|healthy volunteers
485552|NCT01079650|children|children
485553|NCT01079637|Sella and Barrete Stage 0 1 or 2|sella and barrete stage 0 1 or 2
485554|NCT01079624|Incretin hormones|incretin hormones
485555|NCT01079624|Glucose-insulinotropic peptide|glucose-insulinotropic peptide
485556|NCT01079624|Glucagon-like peptide-1|glucagon-like peptide-1
485557|NCT01079624|Gastric emptying|gastric emptying
485558|NCT01079624|Appetite|appetite
485559|NCT01079624|Glucose disposal|glucose disposal
485560|NCT01079624|Gut hormones|gut hormones
485562|NCT01079598|RadioFrequency|radiofrequency
485563|NCT01079598|QOL|qol
485564|NCT01079572|osteoarthritis|osteoarthritis
485565|NCT01079572|arthroplasty|arthroplasty
485566|NCT01079572|web-based|web-based
485567|NCT01079572|electronic follow-up|electronic follow-up
485568|NCT01079559|total knee arthroplasty|total knee arthroplasty
485569|NCT01079559|infection|infection
485570|NCT01079559|antibiotic bone cement|antibiotic bone cement
485571|NCT01079546|HPV, Israel, Squamous cell carcinoma of head and neck|hpv, israel, squamous cell carcinoma of head and neck
485572|NCT01079533|Colorectal Neoplasms|colorectal neoplasms
485573|NCT01079533|Mass Screening|mass screening
485574|NCT01079533|Patient Compliance|patient compliance
485575|NCT01079533|Intervention Studies|intervention studies
485576|NCT01079533|Clinical Trial|clinical trial
485577|NCT01079520|Cancer|cancer
485578|NCT01079520|Lung Cancer|lung cancer
485579|NCT01079520|Ultrasound|ultrasound
485580|NCT01079520|Surgery|surgery
485581|NCT01079507|single nucleotide polymorphism|single nucleotide polymorphism
485582|NCT01079507|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
485583|NCT01079494|Uncontrolled blood pressure|uncontrolled blood pressure
485584|NCT01079481|Relapsed or Refractory Small Cell Lung Cancer|relapsed or refractory small cell lung cancer
485585|NCT01079481|Paclitaxel|paclitaxel
485586|NCT01079481|Everolimus|everolimus
485587|NCT01079468|Transient cognitive decline following orthopaedic surgery|transient cognitive decline following orthopaedic surgery
485588|NCT01079455|Coxarthrosis|coxarthrosis
485589|NCT01079455|Hip|hip
485590|NCT01079455|Infiltration|infiltration
485591|NCT01079455|Hyaluronic Acid|hyaluronic acid
485592|NCT01079455|Corticosterone|corticosterone
485593|NCT01079442|postoperative ileus after colonic resections|postoperative ileus after colonic resections
485594|NCT01079429|Monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
485595|NCT01079429|MGUS|mgus
485596|NCT01079429|Smoldering myeloma|smoldering myeloma
485597|NCT01079429|SMM|smm
485598|NCT01079429|Multiple myeloma|multiple myeloma
485599|NCT01079416|Esophageal Capsule Endoscopy, Screening|esophageal capsule endoscopy, screening
485600|NCT01079390|acupuncture|acupuncture
485601|NCT01079390|osteoarthritis|osteoarthritis
485602|NCT01079390|fMRI|fmri
485603|NCT01079377|Adolescents|adolescents
485604|NCT01079377|Bariatric Surgery|bariatric surgery
485605|NCT01079377|Psychological Symptoms|psychological symptoms
485606|NCT01079377|Cognitive Behavioral Therapy|cognitive behavioral therapy
485607|NCT01079377|Telemedicine|telemedicine
485608|NCT01079377|Longitudinal|longitudinal
485609|NCT01079351|Epilepsy|epilepsy
485610|NCT01079351|Intravenous Carbamazepine|intravenous carbamazepine
485611|NCT01079351|Oral Carbamazepine|oral carbamazepine
485612|NCT01079338|sensitivity to caffeine|sensitivity to caffeine
485613|NCT01079325|Diabetic neuropathy|diabetic neuropathy
485614|NCT01079325|Diabetes Type 1 or 2|diabetes type 1 or 2
485615|NCT01079325|Moderately severe sensorimotor diabetic polyneuropathy|moderately severe sensorimotor diabetic polyneuropathy
485616|NCT01079312|ERCP|ercp
485617|NCT01079312|patient-controlled sedation|patient-controlled sedation
485618|NCT01079312|propofol|propofol
485619|NCT01079312|remifentanil|remifentanil
485620|NCT01079312|sedation level|sedation level
485621|NCT01079299|venous ulcer|venous ulcer
485622|NCT01079299|secondary lymphedema|secondary lymphedema
485623|NCT01079299|chronic lower leg ulceration|chronic lower leg ulceration
485624|NCT01079286|mTOR inhibition|mtor inhibition
485625|NCT01079286|advanced malignancies|advanced malignancies
485626|NCT01079286|pharmacokinetics|pharmacokinetics
485627|NCT01079286|Akt inhibition|akt inhibition
485628|NCT01079286|Advanced malignancies, including metastatic renal cell cancer|advanced malignancies, including metastatic renal cell cancer
485629|NCT01079273|Influenza|influenza
485630|NCT01079273|Vaccines|vaccines
485631|NCT01079273|A/H1N1|a/h1n1
485632|NCT01079273|Influenza Vaccines|influenza vaccines
485633|NCT01079260|Malnourished|malnourished
485634|NCT01079260|Elderly|elderly
485635|NCT01079260|Nutrition support|nutrition support
485636|NCT01079247|Burn|burn
485637|NCT01079247|Transfusion|transfusion
485638|NCT01079247|blood|blood
485639|NCT01079247|hemoglobin|hemoglobin
485640|NCT01079221|exercise|exercise
485641|NCT01079221|Knee extensor|knee extensor
485642|NCT01079208|infant formula, synbiotics, probiotics, nutrition|infant formula, synbiotics, probiotics, nutrition
485643|NCT01079195|Effectiveness and tolerability of Tarka|effectiveness and tolerability of tarka
485644|NCT01079195|Hypertensive patients|hypertensive patients
485645|NCT01079195|Diabetes mellitus|diabetes mellitus
485646|NCT01079195|Observational study|observational study
485647|NCT01079182|Daily practice|daily practice
485648|NCT01079182|Humira|humira
485649|NCT01079182|Efficacy|efficacy
485650|NCT01079182|Safety|safety
485651|NCT01079182|Ankylosing spondylitis|ankylosing spondylitis
485652|NCT01079169|urinary tract infection|urinary tract infection
485653|NCT01079169|prevention|prevention
485654|NCT01079169|rehabilitation|rehabilitation
485655|NCT01079169|spinal cord injury|spinal cord injury
485656|NCT01079143|De Novo renal transplantation|de novo renal transplantation
485657|NCT01079130|Indacaterol|indacaterol
485658|NCT01079130|asthma|asthma
485659|NCT01079130|salmeterol|salmeterol
485660|NCT01079117|Opiate|opiate
485661|NCT01079117|Methadone|methadone
485662|NCT01079117|Slow Release Oral Morphine (SORM)|slow release oral morphine (sorm)
485663|NCT01079117|Sevre-Long™|sevre-long™
485664|NCT01079104|Liver failure|liver failure
485665|NCT01079104|Hepatic insufficiency|hepatic insufficiency
485666|NCT01079104|Artificial liver|artificial liver
485667|NCT01079104|Albumin dialysis|albumin dialysis
485668|NCT01079091|Liver failure|liver failure
485669|NCT01079091|Hepatic insufficiency|hepatic insufficiency
485670|NCT01079091|Liver Cirrhosis|liver cirrhosis
485671|NCT01079091|Artificial liver|artificial liver
485672|NCT01079091|Albumin dialysis|albumin dialysis
485673|NCT01079078|Acetaminophen fed study|acetaminophen fed study
485674|NCT01079065|Famotidine tablets fasting study|famotidine tablets fasting study
485675|NCT01079052|Famotidine tablets fed study|famotidine tablets fed study
485676|NCT01079026|biomarker|biomarker
485677|NCT01079026|epidural steroid|epidural steroid
485678|NCT01079026|radiculopathy|radiculopathy
485679|NCT01079026|hnp|hnp
485680|NCT01079000|asthma|asthma
485681|NCT01079000|exacerbation|exacerbation
485682|NCT01079000|emergency department|emergency department
485683|NCT01079000|relapse|relapse
485684|NCT01078987|Nephrogenic Fibrosing Dermopathy (NFD)|nephrogenic fibrosing dermopathy (nfd)
485685|NCT01078987|Nephrogenic Systemic Fibrosis (NSF)|nephrogenic systemic fibrosis (nsf)
485686|NCT01078974|WM|wm
485687|NCT01078974|pomalidomide|pomalidomide
485688|NCT01078974|dexamethasone|dexamethasone
485689|NCT01078974|rituximab|rituximab
485690|NCT01078961|bortezomib|bortezomib
485691|NCT01078961|sorafenib|sorafenib
485692|NCT01078961|advanced melanoma|advanced melanoma
485693|NCT01078948|tDCS|tdcs
485694|NCT01078948|transcranial direct current stimulation|transcranial direct current stimulation
485695|NCT01078948|major depression|major depression
485696|NCT01078948|double-blind|double-blind
485697|NCT01078948|randomized|randomized
485698|NCT01078948|placebo-controlled|placebo-controlled
485699|NCT01078948|treatment|treatment
485700|NCT01078935|Crohn's disease activity index|crohn's disease activity index
485701|NCT01078935|CDAI|cdai
485702|NCT01078922|ofatumumab diffuse B cell non hodgkins lymphoma DLBCL|ofatumumab diffuse b cell non hodgkins lymphoma dlbcl
485703|NCT01078922|refractory DLBCL|refractory dlbcl
485704|NCT01078922|relapsed DLBCL|relapsed dlbcl
485705|NCT01078909|Cardiovascular disease|cardiovascular disease
485706|NCT01078909|Inflammation|inflammation
485707|NCT01078909|Fish Oil|fish oil
485708|NCT01078909|Omega-3 Fatty Acids|omega-3 fatty acids
485709|NCT01078909|LPS|lps
485710|NCT01078909|Endotoxin|endotoxin
485711|NCT01078883|Lung cancer|lung cancer
485712|NCT01078883|Respiratory muscle strength|respiratory muscle strength
485713|NCT01078883|Dyspnea|dyspnea
485714|NCT01078883|Functional capacity|functional capacity
485715|NCT01078870|Negative symptom|negative symptom
485716|NCT01078857|Chronic kidney disease|chronic kidney disease
485717|NCT01078857|Small-fiber neuropathy|small-fiber neuropathy
485718|NCT01078857|Skin biopsy|skin biopsy
485719|NCT01078857|Contact heat evoked potential|contact heat evoked potential
485720|NCT01078857|Autonomic neuropathy|autonomic neuropathy
485721|NCT01078857|Neuropathy in late stage chronic kidney disease|neuropathy in late stage chronic kidney disease
485722|NCT01078844|Autism|autism
485723|NCT01078844|Asperger's Disorder|asperger's disorder
485724|NCT01078844|Pervasive Developmental Disorder NOS|pervasive developmental disorder nos
485725|NCT01078844|Adult|adult
485726|NCT01078844|Memantine|memantine
485727|NCT01078818|Cardiac surgery|cardiac surgery
485728|NCT01078818|Extracorporeal circulation|extracorporeal circulation
485729|NCT01078818|Anaemia|anaemia
485730|NCT01078818|Intravenous iron|intravenous iron
485731|NCT01078818|Oral Iron|oral iron
485732|NCT01078779|Influenza|influenza
485733|NCT01078779|Prevention|prevention
485734|NCT01078779|Chloroquine|chloroquine
485735|NCT01078779|Randomised controlled trial|randomised controlled trial
485736|NCT01078779|Respiratory virus infection|respiratory virus infection
485737|NCT01078766|cerebral palsy|cerebral palsy
485738|NCT01078740|cystic fibrosis|cystic fibrosis
485739|NCT01078740|cystic fibrosis transmembrane conductance regulator|cystic fibrosis transmembrane conductance regulator
485740|NCT01078740|biomarkers|biomarkers
485741|NCT01078740|Intestinal Current Measurement|intestinal current measurement
485742|NCT01078727|Thermal Stimulation|thermal stimulation
485743|NCT01078727|Upper Extremity|upper extremity
485744|NCT01078727|Motor Recovery|motor recovery
485745|NCT01078727|Stroke|stroke
485746|NCT01078714|Autism|autism
485747|NCT01078714|Bumetanide|bumetanide
485748|NCT01078714|GABA|gaba
485749|NCT01078714|NKCC1|nkcc1
485750|NCT01078701|live attenuated flu vaccines|live attenuated flu vaccines
485751|NCT01078701|Influenza A (H1N1)|influenza a (h1n1)
485752|NCT01078701|intranasal application|intranasal application
485753|NCT01078701|replication-deficient influenza virus|replication-deficient influenza virus
485754|NCT01078688|Limitations of activities|limitations of activities
485755|NCT01078688|persistent asthma|persistent asthma
485944|NCT01077921|propranolol|propranolol
485756|NCT01078688|general practitioner|general practitioner
485757|NCT01078688|frequency of limitations of activities|frequency of limitations of activities
485758|NCT01078688|depending on gender and age-group|depending on gender and age-group
485759|NCT01078675|Familial Hypercholesterolaemia|familial hypercholesterolaemia
485760|NCT01078675|pediatric|pediatric
485761|NCT01078662|olaparib|olaparib
485762|NCT01078662|PARP inhibitors|parp inhibitors
485763|NCT01078662|genetic BRCA1 mutation|genetic brca1 mutation
485764|NCT01078662|BRCA2 mutation|brca2 mutation
485765|NCT01078662|solid tumour refractory|solid tumour refractory
485766|NCT01078649|cancer|cancer
485767|NCT01078649|solid tumors|solid tumors
485768|NCT01078649|lymphoma|lymphoma
485769|NCT01078649|smac mimetic|smac mimetic
485770|NCT01078649|IAP inhibitor|iap inhibitor
485771|NCT01078649|Phase I|phase i
485772|NCT01078649|Dose escalation|dose escalation
485773|NCT01078636|amyloid|amyloid
485774|NCT01078636|plaques|plaques
485775|NCT01078636|imaging|imaging
485776|NCT01078636|early detection|early detection
485777|NCT01078636|Amnestic MCI|amnestic mci
485778|NCT01078636|pre-dementia|pre-dementia
485779|NCT01078623|Bronchitis|bronchitis
485780|NCT01078623|Chronic|chronic
485781|NCT01078623|Emphysema|emphysema
485782|NCT01078610|Psoriatic Arthritis|psoriatic arthritis
485783|NCT01078610|Long-term Observation|long-term observation
485784|NCT01078610|Humira|humira
485785|NCT01078610|Safety|safety
485786|NCT01078610|Effectiveness|effectiveness
485787|NCT01078610|Quality of Life|quality of life
485788|NCT01078610|Work Productivity|work productivity
485789|NCT01078597|anti-MCV|anti-mcv
485790|NCT01078597|anti-CCP|anti-ccp
485791|NCT01078597|Biomarkers|biomarkers
485792|NCT01078597|Rheumatoid Arthritis|rheumatoid arthritis
485793|NCT01078584|Uncontrolled hypertension|uncontrolled hypertension
485794|NCT01078584|trandolapril|trandolapril
485795|NCT01078571|Rheumatoid Arthritis|rheumatoid arthritis
485796|NCT01078571|Biologic|biologic
485797|NCT01078571|Tumor Necrosis Factors blockers agents Monoclonal antibody|tumor necrosis factors blockers agents monoclonal antibody
485798|NCT01078558|Multicenter study|multicenter study
485799|NCT01078545|Prostate cancer|prostate cancer
485800|NCT01078545|Lower urinary tract symptoms|lower urinary tract symptoms
485801|NCT01078545|Hormonotherapy|hormonotherapy
485802|NCT01078545|LHRH analogue|lhrh analogue
485803|NCT01078545|Androgen deprivation therapy (ADT)|androgen deprivation therapy (adt)
485804|NCT01078532|medically complex diseases that increase cardiovascular risk|medically complex diseases that increase cardiovascular risk
485805|NCT01078519|Fever|fever
485806|NCT01078519|anesthesia|anesthesia
485807|NCT01078519|Labor|labor
485808|NCT01078506|Chinese|chinese
485809|NCT01078506|intracranial aneurysm|intracranial aneurysm
485810|NCT01078506|magnetic resonance imaging|magnetic resonance imaging
485811|NCT01078493|Platelet rich plasma|platelet rich plasma
485812|NCT01078493|PRP|prp
485813|NCT01078493|wrinkles|wrinkles
485814|NCT01078493|MyCells®|mycells®
485815|NCT01078493|CREATE|create
485816|NCT01078493|Life Source Medical Centre|life source medical centre
485817|NCT01078493|Dr Tan Kok leong|dr tan kok leong
485818|NCT01078480|Fracture|fracture
485819|NCT01078480|Collar bone|collar bone
485820|NCT01078467|Wound Healing|wound healing
485821|NCT01078467|Oral Wounds|oral wounds
485822|NCT01078467|Cutaneous Wounds|cutaneous wounds
485823|NCT01078467|Gene Array Analysis|gene array analysis
485824|NCT01078467|Proteomic Analysis|proteomic analysis
485825|NCT01078467|Healthy Volunteer|healthy volunteer
485826|NCT01078467|HV|hv
485827|NCT01078454|Melphalan|melphalan
485828|NCT01078454|Dexamethasone|dexamethasone
485829|NCT01078454|Bortezomib|bortezomib
485830|NCT01078454|Systemic Light-chain (AL) Amyloidosis|systemic light-chain (al) amyloidosis
485831|NCT01078441|Bortezomib|bortezomib
485832|NCT01078441|Liposomal Doxorubicin|liposomal doxorubicin
485833|NCT01078441|Dexamethasone|dexamethasone
485834|NCT01078441|Cyclophosphamide|cyclophosphamide
485835|NCT01078441|refractory multiple myeloma|refractory multiple myeloma
485836|NCT01078428|Hypertrophic scars|hypertrophic scars
485837|NCT01078428|Topical silicone gel|topical silicone gel
485838|NCT01078428|Scar thickness|scar thickness
485839|NCT01078428|Scar Color|scar color
485840|NCT01078428|Scar pliability|scar pliability
485841|NCT01078428|Scar appearance|scar appearance
485842|NCT01078415|HCC|hcc
485843|NCT01078415|Hepatocellular Carcinoma|hepatocellular carcinoma
485844|NCT01078415|Early Stage|early stage
485845|NCT01078415|Prospective|prospective
485846|NCT01078415|Multicenter|multicenter
485847|NCT01078415|Irreversible Electroporation (IRE)|irreversible electroporation (ire)
485848|NCT01078415|Electroporation|electroporation
485849|NCT01078415|Low Energy Direct Current|low energy direct current
485850|NCT01078415|LEDC|ledc
485851|NCT01078415|Nonthermal ablation|nonthermal ablation
485852|NCT01078415|NTIRE (nonthermal IRE)|ntire (nonthermal ire)
485853|NCT01078415|Ablation|ablation
485854|NCT01078415|Soft Tissue|soft tissue
485855|NCT01078402|Treatment compliance and tolerability of Humira in patients|treatment compliance and tolerability of humira in patients
486384|NCT01076283|alcoholism|alcoholism
485856|NCT01078402|Eastern European countries|eastern european countries
485857|NCT01078402|Rheumatoid Arthritis|rheumatoid arthritis
485858|NCT01078402|Psoriatic Arthritis|psoriatic arthritis
485859|NCT01078402|Adalimumab|adalimumab
485860|NCT01078402|Ankylosing Spondylitis|ankylosing spondylitis
485861|NCT01078402|Evaluation of clinical outcome|evaluation of clinical outcome
485862|NCT01078389|Gout|gout
485863|NCT01078389|Hyperuricemia|hyperuricemia
485864|NCT01078389|Uric Acid|uric acid
485865|NCT01078389|Drug Therapy|drug therapy
485866|NCT01078376|Pediatrics|pediatrics
485867|NCT01078376|Blood Pressure, High|blood pressure, high
485868|NCT01078376|Drug Therapy|drug therapy
485869|NCT01078363|Heart Transplantation|heart transplantation
485870|NCT01078350|Lymphoma|lymphoma
485871|NCT01078350|Hodgkin Disease|hodgkin disease
485872|NCT01078311|Patients with advanced hepatocellular cancer|patients with advanced hepatocellular cancer
485873|NCT01078298|smoking|smoking
485874|NCT01078298|smoking cessation|smoking cessation
485875|NCT01078298|smoking cessation in depressed subjects|smoking cessation in depressed subjects
485876|NCT01078285|Integrated program on adherence using counseling|integrated program on adherence using counseling
485877|NCT01078285|support services including cost-sharing where appropriate and educational materials mailed monthly.|support services including cost-sharing where appropriate and educational materials mailed monthly.
485878|NCT01078272|Coronary Atherosclerosis|coronary atherosclerosis
485879|NCT01078272|Percutaneous Coronary Intervention|percutaneous coronary intervention
485880|NCT01078272|Coronary Stenting|coronary stenting
485881|NCT01078272|Coronary Stenosis|coronary stenosis
485882|NCT01078272|Remote Ischemic Preconditioning|remote ischemic preconditioning
485883|NCT01078246|HIV|hiv
485884|NCT01078233|HIV|hiv
485885|NCT01078233|antiretroviral treatment|antiretroviral treatment
485886|NCT01078233|HIV Cohort|hiv cohort
485887|NCT01078233|Treatment|treatment
485888|NCT01078220|Human Papillomavirus (HPV)|human papillomavirus (hpv)
485889|NCT01078194|Weight regain|weight regain
485890|NCT01078194|Weight loss failure|weight loss failure
485891|NCT01078194|Gastric bypass|gastric bypass
485892|NCT01078181|gastric bypass|gastric bypass
485893|NCT01078181|banded gastric bypass|banded gastric bypass
485894|NCT01078181|weight loss|weight loss
485895|NCT01078181|weight regain|weight regain
485896|NCT01078181|bariatric surgery|bariatric surgery
485897|NCT01078168|Alzheimer`s Disease|alzheimer`s disease
485898|NCT01078155|Bone mineral density|bone mineral density
485899|NCT01078155|Bone turnover markers|bone turnover markers
485900|NCT01078155|Rheumatoid arthritis|rheumatoid arthritis
485901|NCT01078155|Osteoporosis|osteoporosis
485902|NCT01078142|temsirolimus|temsirolimus
485903|NCT01078142|bendamustine|bendamustine
485904|NCT01078142|rituximab|rituximab
485905|NCT01078142|mantle cell lymphoma|mantle cell lymphoma
485906|NCT01078142|follicular lymphoma|follicular lymphoma
485907|NCT01078129|cognitive deficits|cognitive deficits
485908|NCT01078116|Rheumatoid Arthritis|rheumatoid arthritis
485909|NCT01078116|Adalimumab treatment|adalimumab treatment
485910|NCT01078116|Evaluation of the patients' Health Related Quality of Life|evaluation of the patients' health related quality of life
485911|NCT01078116|Cost of the disease management|cost of the disease management
485912|NCT01078103|Diabetes Mellitus|diabetes mellitus
485913|NCT01078103|cornea endothelium|cornea endothelium
485914|NCT01078103|cell loss|cell loss
485915|NCT01078103|cataract surgery|cataract surgery
485916|NCT01078090|Safety|safety
485917|NCT01078090|Rheumatoid Arthritis|rheumatoid arthritis
485918|NCT01078090|Effectiveness|effectiveness
485919|NCT01078077|healthy females ages twentyfive through sixty|healthy females ages twentyfive through sixty
485920|NCT01078064|Gastroesophageal reflux disease, gastric motility|gastroesophageal reflux disease, gastric motility
485921|NCT01078051|chronic total occlusion|chronic total occlusion
485922|NCT01078051|stent|stent
485923|NCT01078051|medical therapy|medical therapy
485924|NCT01078038|Coronary Artery Disease|coronary artery disease
485925|NCT01078038|Stent|stent
485926|NCT01078025|transvaginal access for cholecystectomy|transvaginal access for cholecystectomy
485927|NCT01077999|chemoradiation|chemoradiation
485928|NCT01077999|panitumumab|panitumumab
485929|NCT01077999|esophageal cancer|esophageal cancer
485930|NCT01077999|Resectable squamous cell carcinoma, adenocarcinoma or undifferentiated carcinoma of the intrathoracic esophagus or gastro esophageal junction|resectable squamous cell carcinoma, adenocarcinoma or undifferentiated carcinoma of the intrathoracic esophagus or gastro esophageal junction
485931|NCT01077986|mTOR inhibition|mtor inhibition
485932|NCT01077986|EGFR inhibition|egfr inhibition
485933|NCT01077986|pancreatic cancer|pancreatic cancer
485934|NCT01077986|pharmacodynamics|pharmacodynamics
485935|NCT01077973|Headache|headache
485936|NCT01077960|Serostim|serostim
485937|NCT01077960|HARS|hars
485938|NCT01077947|low back pain|low back pain
485939|NCT01077947|spinal fusion|spinal fusion
485940|NCT01077947|Primarily axial low back pain|primarily axial low back pain
485941|NCT01077934|All Patients admitted to Grady Memorial Hospital with Unilateral Lower leg injury at risk for compartment syndrome|all patients admitted to grady memorial hospital with unilateral lower leg injury at risk for compartment syndrome
485942|NCT01077921|sickle|sickle
485943|NCT01077921|adhesion|adhesion
485945|NCT01077908|Adoptive cellular therapy|adoptive cellular therapy
485946|NCT01077908|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
485947|NCT01077895|Critically ill patients with positive fluid balance, IAH and AKI requiring RRT|critically ill patients with positive fluid balance, iah and aki requiring rrt
485948|NCT01077882|Moderate and severe psoriasis and atopic dermatitis|moderate and severe psoriasis and atopic dermatitis
485949|NCT01077869|oropharynx and lymph node metastases from an unknown primary tumor|oropharynx and lymph node metastases from an unknown primary tumor
485950|NCT01077856|congenital anomaly|congenital anomaly
485951|NCT01077856|pregnancy|pregnancy
485952|NCT01077856|GARDASIL®|gardasil®
485953|NCT01077856|Nordic|nordic
485954|NCT01077856|population-based|population-based
485955|NCT01077843|Ankylosing Spondylitis|ankylosing spondylitis
485956|NCT01077830|New Incidence of Cancer|new incidence of cancer
485957|NCT01077791|Schizophrenia|schizophrenia
485958|NCT01077791|social cognition|social cognition
485959|NCT01077791|theory of mind|theory of mind
485960|NCT01077791|cognitive therapy|cognitive therapy
485961|NCT01077791|therapeutic trial|therapeutic trial
485962|NCT01077791|magnetoencephalography (MEG)|magnetoencephalography (meg)
485963|NCT01077778|Magnetic Resonance Imaging/methods|magnetic resonance imaging/methods
485964|NCT01077778|Magnetic Resonance Angiography|magnetic resonance angiography
485965|NCT01077778|Perfusion Imaging|perfusion imaging
485966|NCT01077778|Pulmonary Embolism/diagnosis|pulmonary embolism/diagnosis
485967|NCT01077765|HIV-associated Lipodystrophy|hiv-associated lipodystrophy
485968|NCT01077765|Polyacrylamide hydrogel|polyacrylamide hydrogel
485969|NCT01077752|Pain, postoperative|pain, postoperative
485970|NCT01077752|Local infiltration|local infiltration
485971|NCT01077752|Hyperalgesia, postoperative|hyperalgesia, postoperative
485972|NCT01077752|Local anesthetic, ropivacaine, lidocaine|local anesthetic, ropivacaine, lidocaine
485973|NCT01077752|Colorectal laparoscopic surgery|colorectal laparoscopic surgery
485974|NCT01077752|Pain management after colorectal laparoscopic surgery|pain management after colorectal laparoscopic surgery
485975|NCT01077687|schizophrenia|schizophrenia
485976|NCT01077687|genome-wide association study (GWAS)|genome-wide association study (gwas)
485977|NCT01077687|single-nucleotide polymorphisms (SNPs)|single-nucleotide polymorphisms (snps)
485978|NCT01077687|Han Chinese population|han chinese population
485979|NCT01077687|trio families|trio families
485980|NCT01077687|Schizophrenia with trio families|schizophrenia with trio families
485981|NCT01077674|Electroencephalogram|electroencephalogram
485982|NCT01077674|Entropy|entropy
485983|NCT01077674|BIS|bis
485984|NCT01077674|Sevoflurane|sevoflurane
485985|NCT01077661|Nebivolol|nebivolol
485986|NCT01077661|PMS (post-marketing surveillance)|pms (post-marketing surveillance)
485987|NCT01077648|Breast Cancer|breast cancer
485988|NCT01077648|Treatment|treatment
485989|NCT01077648|Brain metastases|brain metastases
485990|NCT01077648|ErbB2 expression|erbb2 expression
485991|NCT01077635|HIV|hiv
485992|NCT01077635|Antiretroviral therapy|antiretroviral therapy
485993|NCT01077635|protease inbitor|protease inbitor
485994|NCT01077635|fosamprenavir|fosamprenavir
485995|NCT01077635|paediatrics|paediatrics
485996|NCT01077609|Intranasal steroids|intranasal steroids
485997|NCT01077609|beclometasone diproprionate|beclometasone diproprionate
485998|NCT01077609|steroid-related outcomes|steroid-related outcomes
485999|NCT01077596|Carcinogenicity|carcinogenicity
486000|NCT01077596|Case control|case control
486001|NCT01077596|Bupropion|bupropion
486002|NCT01077583|Pregnancy test|pregnancy test
486003|NCT01077583|Wishing to become pregnant|wishing to become pregnant
486004|NCT01077557|Combivir (Zidovudine+Lamivudine)|combivir (zidovudine+lamivudine)
486005|NCT01077557|Trizivir (Abacavir+Lamivudine+Zidovudine)|trizivir (abacavir+lamivudine+zidovudine)
486006|NCT01077557|Zidovudine|zidovudine
486007|NCT01077557|Epzicom (Abacavir+Lamivudine)|epzicom (abacavir+lamivudine)
486008|NCT01077557|Fracture|fracture
486009|NCT01077557|Amprenavir|amprenavir
486010|NCT01077557|human immunodeficiency virus (HIV) infection|human immunodeficiency virus (hiv) infection
486011|NCT01077557|antiretroviral (ARV) therapy|antiretroviral (arv) therapy
486012|NCT01077557|Lamivudine|lamivudine
486013|NCT01077557|incidence|incidence
486014|NCT01077557|Abacavir|abacavir
486015|NCT01077557|risk|risk
486016|NCT01077557|Fosamprenavir|fosamprenavir
486017|NCT01077544|Chronic Myeloid Leukemia|chronic myeloid leukemia
486018|NCT01077544|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
486019|NCT01077544|Ph+ CML|ph+ cml
486020|NCT01077544|Ph+ ALL|ph+ all
486021|NCT01077544|pediatric|pediatric
486022|NCT01077544|nilotinib|nilotinib
486023|NCT01077544|imatinib|imatinib
486024|NCT01077544|chronic phase|chronic phase
486025|NCT01077544|accelerated phase|accelerated phase
486026|NCT01077544|newly diagnosed Ph+ CML|newly diagnosed ph+ cml
486027|NCT01077544|dasatinib|dasatinib
486028|NCT01077531|Rheumatoid arthritis|rheumatoid arthritis
486029|NCT01077531|intravenous infusion|intravenous infusion
486030|NCT01077531|long-term followup|long-term followup
486031|NCT01077518|Refractory|refractory
486032|NCT01077518|Safety|safety
486033|NCT01077518|Efficacy|efficacy
486034|NCT01077518|Rituximab refractory|rituximab refractory
486035|NCT01077518|Oncology|oncology
486036|NCT01077505|pharmacokinetics|pharmacokinetics
486037|NCT01077505|GSK716155|gsk716155
486038|NCT01077505|Brevicon|brevicon
486039|NCT01077505|albiglutide|albiglutide
486040|NCT01077505|healthy female volunteers|healthy female volunteers
486041|NCT01077505|oral contraceptive|oral contraceptive
486042|NCT01077492|lung cancer|lung cancer
486043|NCT01077492|mediastinal lymph nodes|mediastinal lymph nodes
486044|NCT01077492|TBNA|tbna
486045|NCT01077492|staging lung cancer|staging lung cancer
486046|NCT01077479|body fat mass gain|body fat mass gain
486047|NCT01077479|Insulin resistance|insulin resistance
486048|NCT01077466|Primary Progressive Multiple Sclerosis|primary progressive multiple sclerosis
486049|NCT01077466|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
486050|NCT01077466|Natalizumab|natalizumab
486051|NCT01077466|Treatment|treatment
486052|NCT01077466|Safety|safety
486053|NCT01077466|Efficacy|efficacy
486054|NCT01077466|Cerebrospinal fluid|cerebrospinal fluid
486055|NCT01077466|Osteopontin|osteopontin
486056|NCT01077440|cancer survivor|cancer survivor
486057|NCT01077440|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
486058|NCT01077440|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
486059|NCT01077440|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
486060|NCT01077440|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
486061|NCT01077440|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
486062|NCT01077440|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
486063|NCT01077440|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
486064|NCT01077440|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
486065|NCT01077440|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
486066|NCT01077440|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
486067|NCT01077440|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
486068|NCT01077440|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
486069|NCT01077440|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
486070|NCT01077440|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
486071|NCT01077440|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
486072|NCT01077440|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
486073|NCT01077440|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
486074|NCT01077440|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
486075|NCT01077440|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
486076|NCT01077440|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
486077|NCT01077440|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
486078|NCT01077440|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
486079|NCT01077440|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
486080|NCT01077440|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
486081|NCT01077440|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
486082|NCT01077440|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
486083|NCT01077440|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
486084|NCT01077440|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
486085|NCT01077440|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
486086|NCT01077440|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
486087|NCT01077440|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
486088|NCT01077440|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
486089|NCT01077440|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
486090|NCT01077440|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
486091|NCT01077440|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
486092|NCT01077440|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
486093|NCT01077440|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
486094|NCT01077440|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
486095|NCT01077440|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
486096|NCT01077440|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
486097|NCT01077440|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
486098|NCT01077440|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
486099|NCT01077440|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
486100|NCT01077440|splenic marginal zone lymphoma|splenic marginal zone lymphoma
486101|NCT01077440|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
486102|NCT01077440|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
486103|NCT01077440|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
486104|NCT01077440|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
486105|NCT01077440|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
486385|NCT01076283|urge|urge
486106|NCT01077440|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
486107|NCT01077440|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
486108|NCT01077440|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
486109|NCT01077440|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
486110|NCT01077440|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
486111|NCT01077440|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
486112|NCT01077440|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
486113|NCT01077440|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
486114|NCT01077440|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
486115|NCT01077440|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
486116|NCT01077440|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
486117|NCT01077440|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
486118|NCT01077440|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
486119|NCT01077440|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
486120|NCT01077440|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
486121|NCT01077440|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
486122|NCT01077440|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
486123|NCT01077440|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
486124|NCT01077440|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
486125|NCT01077440|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
486126|NCT01077440|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
486127|NCT01077440|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
486128|NCT01077440|refractory hairy cell leukemia|refractory hairy cell leukemia
486129|NCT01077440|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
486130|NCT01077440|secondary acute myeloid leukemia|secondary acute myeloid leukemia
486131|NCT01077440|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
486132|NCT01077440|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
486133|NCT01077440|chronic eosinophilic leukemia|chronic eosinophilic leukemia
486134|NCT01077440|primary myelofibrosis|primary myelofibrosis
486135|NCT01077440|chronic neutrophilic leukemia|chronic neutrophilic leukemia
486136|NCT01077440|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
486137|NCT01077440|disseminated neuroblastoma|disseminated neuroblastoma
486138|NCT01077440|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
486139|NCT01077440|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
486140|NCT01077440|recurrent neuroblastoma|recurrent neuroblastoma
486141|NCT01077440|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
486142|NCT01077440|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
486143|NCT01077440|stage I multiple myeloma|stage i multiple myeloma
486144|NCT01077440|stage II multiple myeloma|stage ii multiple myeloma
486145|NCT01077440|stage III multiple myeloma|stage iii multiple myeloma
486146|NCT01077440|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
486147|NCT01077440|refractory multiple myeloma|refractory multiple myeloma
486148|NCT01077427|pancreatic cancer|pancreatic cancer
486149|NCT01077427|adjuvant treatment|adjuvant treatment
486150|NCT01077427|hyperthermia|hyperthermia
486151|NCT01077414|Psychosocial Functioning|psychosocial functioning
486152|NCT01077414|Psychosocial Stress|psychosocial stress
486153|NCT01077414|Palliative Care|palliative care
486154|NCT01077414|Spirituality|spirituality
486155|NCT01077414|Cancer|cancer
486156|NCT01077401|Diabetic|diabetic
486157|NCT01077401|edema|edema
486158|NCT01077401|DME|dme
486159|NCT01077388|CVD|cvd
486160|NCT01077388|uncontrolled HTN|uncontrolled htn
486161|NCT01077375|Milnacipran|milnacipran
486162|NCT01077375|Duloxetine|duloxetine
486163|NCT01077375|Switch|switch
486164|NCT01077375|Forest Research Institute|forest research institute
486165|NCT01077362|Ustekinumab|ustekinumab
486166|NCT01077362|CNTO 1275|cnto 1275
486167|NCT01077362|Stelara|stelara
486168|NCT01077362|Psoriatic Arthritis|psoriatic arthritis
486169|NCT01077362|Psoriasis|psoriasis
486170|NCT01077362|TNF alpha|tnf alpha
486171|NCT01077349|Cardiac surgery|cardiac surgery
486172|NCT01077349|Shock|shock
486173|NCT01077349|Continuous Veno-Venous Haemofiltration|continuous veno-venous haemofiltration
486174|NCT01077349|Continuous Renal Replacement Therapy|continuous renal replacement therapy
486175|NCT01077349|Renal Insufficiency|renal insufficiency
486176|NCT01077349|Acute|acute
486177|NCT01077336|susceptibility testing|susceptibility testing
486178|NCT01077323|pancreatitis|pancreatitis
486179|NCT01077323|exenatide|exenatide
486180|NCT01077323|Byetta|byetta
486181|NCT01077323|Amylin|amylin
486182|NCT01077323|Lilly|lilly
486183|NCT01077310|HIV|hiv
486382|NCT01076309|endothelium cell|endothelium cell
486184|NCT01077310|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
486185|NCT01077310|Alcohol dependence|alcohol dependence
486186|NCT01077310|CD4|cd4
486187|NCT01077310|HIV-1 RNA|hiv-1 rna
486188|NCT01077310|Alcohol treatment outcomes|alcohol treatment outcomes
486189|NCT01077284|Kidney Calculi|kidney calculi
486190|NCT01077284|Kidney Stones|kidney stones
486191|NCT01077284|Nephrolithiasis|nephrolithiasis
486192|NCT01077284|Drug Therapy|drug therapy
486193|NCT01077284|Uric Acid|uric acid
486194|NCT01077271|Premature infants|premature infants
486195|NCT01077271|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
486196|NCT01077271|Compliance|compliance
486197|NCT01077271|Palivizumab|palivizumab
486198|NCT01077258|Safety|safety
486199|NCT01077258|Long-term observation|long-term observation
486200|NCT01077258|Routine Clinical Setting|routine clinical setting
486201|NCT01077258|Rheumatoid Arthritis|rheumatoid arthritis
486202|NCT01077258|Effectiveness|effectiveness
486203|NCT01077245|Clostridium difficile|clostridium difficile
486204|NCT01077245|Clostridium Infections|clostridium infections
486205|NCT01077245|Gram-Positive Bacterial Infections|gram-positive bacterial infections
486206|NCT01077245|Bacterial Infections|bacterial infections
486207|NCT01077245|Anti-Infective Agents|anti-infective agents
486208|NCT01077245|Clostridium butyricum|clostridium butyricum
486209|NCT01077245|Metronidazole|metronidazole
486210|NCT01077245|Vancomycin|vancomycin
486211|NCT01077245|Gastrointestinal Diseases|gastrointestinal diseases
486212|NCT01077245|Physiological Effects of Drugs|physiological effects of drugs
486213|NCT01077245|Colonic Diseases|colonic diseases
486214|NCT01077245|Enterocolitis, Pseudomembranous|enterocolitis, pseudomembranous
486215|NCT01077245|Intestinal Diseases|intestinal diseases
486216|NCT01077245|Enterocolitis|enterocolitis
486217|NCT01077245|Pharmacologic Actions|pharmacologic actions
486218|NCT01077245|Digestive System Diseases|digestive system diseases
486219|NCT01077245|Therapeutic Uses|therapeutic uses
486220|NCT01077245|Gastroenteritis|gastroenteritis
486221|NCT01077245|Colitis|colitis
486222|NCT01077245|Diarrhea|diarrhea
486223|NCT01077245|Probiotics|probiotics
486224|NCT01077245|Gastrointestinal Agents|gastrointestinal agents
486225|NCT01077232|Moderate to Severe Plaque Psoriasis|moderate to severe plaque psoriasis
486226|NCT01077232|Humira|humira
486227|NCT01077232|Safety|safety
486228|NCT01077232|Efficacy|efficacy
486229|NCT01077232|Work Productivity|work productivity
486230|NCT01077219|healthy female|healthy female
486231|NCT01077206|Aneurysm|aneurysm
486232|NCT01077206|statin|statin
486233|NCT01077206|subarachnoid hemorrhage|subarachnoid hemorrhage
486234|NCT01077193|Bariatric|bariatric
486235|NCT01077193|Obesity|obesity
486236|NCT01077167|Omecamtiv mecarbil|omecamtiv mecarbil
486237|NCT01077167|pharmacokinetics|pharmacokinetics
486238|NCT01077154|Early Stage Breast Cancer|early stage breast cancer
486239|NCT01077154|Bone Metastasis|bone metastasis
486240|NCT01077154|Adjuvant treatment|adjuvant treatment
486241|NCT01077154|Neoadjuvant treatment|neoadjuvant treatment
486242|NCT01077154|Denosumab|denosumab
486243|NCT01077154|Stage II breast cancer|stage ii breast cancer
486244|NCT01077154|Stage III breast cancer|stage iii breast cancer
486245|NCT01077154|Stage IIA breast cancer|stage iia breast cancer
486246|NCT01077154|Stage IIB breast cancer|stage iib breast cancer
486247|NCT01077154|Stage IIIA breast cancer|stage iiia breast cancer
486248|NCT01077154|Stage IIIB breast cancer|stage iiib breast cancer
486249|NCT01077154|Stage IIIC breast cancer|stage iiic breast cancer
486250|NCT01077154|Early breast cancer|early breast cancer
486251|NCT01077154|Breast Tumors|breast tumors
486252|NCT01077154|Breast Neoplasms|breast neoplasms
486253|NCT01077128|Psoriasis|psoriasis
486254|NCT01077128|Quality of life|quality of life
486255|NCT01077115|Cholecystectomy|cholecystectomy
486256|NCT01077115|Cholecystitis|cholecystitis
486257|NCT01077115|Laparoscopy|laparoscopy
486258|NCT01077115|Cholelithiasis|cholelithiasis
486259|NCT01077115|Operative trauma|operative trauma
486260|NCT01077102|COPD|copd
486261|NCT01077102|eccentric exercise training|eccentric exercise training
486262|NCT01077102|cycle ergometer|cycle ergometer
486263|NCT01077102|muscle function|muscle function
486264|NCT01077089|traumatic brain injury|traumatic brain injury
486265|NCT01077089|In-hospital transport|in-hospital transport
486266|NCT01077076|Gastric Acid|gastric acid
486267|NCT01077076|Human Experimentation|human experimentation
486268|NCT01077063|Pleurx catheter|pleurx catheter
486269|NCT01077063|malignant ascites|malignant ascites
486270|NCT01077024|Stimulant treatment|stimulant treatment
486271|NCT01077024|Smoking Cessation|smoking cessation
486272|NCT01077011|Dry eye|dry eye
486273|NCT01077011|artificial tears|artificial tears
486274|NCT01076998|Dry eye|dry eye
486275|NCT01076998|artificial tears|artificial tears
486276|NCT01076985|Human Immunodeficiency Virus|human immunodeficiency virus
486277|NCT01076972|Human Immunodeficiency Virus|human immunodeficiency virus
486278|NCT01076959|Rheumatoid Arthritis|rheumatoid arthritis
486279|NCT01076946|ballooning|ballooning
486280|NCT01076946|TLVBS|tlvbs
486281|NCT01076933|Borderline Personality Disorder|borderline personality disorder
486282|NCT01076933|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
486283|NCT01076933|Neuropsychological Test|neuropsychological test
486284|NCT01076933|Randomised Control Trial|randomised control trial
486285|NCT01076907|colonoscopy|colonoscopy
486286|NCT01076907|polyps|polyps
486287|NCT01076894|pain|pain
486288|NCT01076894|thoracotomy|thoracotomy
486289|NCT01076894|pulmonary function|pulmonary function
486290|NCT01076894|epidural anesthesia|epidural anesthesia
486291|NCT01076894|intercostal nerve block|intercostal nerve block
486292|NCT01076868|vivax|vivax
486293|NCT01076868|malaria|malaria
486294|NCT01076868|relapse|relapse
486295|NCT01076842|Diabetes|diabetes
486296|NCT01076829|MDA|mda
486297|NCT01076829|Spice|spice
486298|NCT01076816|Patients with single-organ failure in need of mechanical ventilation|patients with single-organ failure in need of mechanical ventilation
486299|NCT01076803|Malignant intestinal obstruction in inoperable patients|malignant intestinal obstruction in inoperable patients
486300|NCT01076790|Nociception|nociception
486301|NCT01076790|Dexmedetomidine|dexmedetomidine
486302|NCT01076790|Electroencephalogram|electroencephalogram
486303|NCT01076790|Electromyogram|electromyogram
486304|NCT01076790|Entropy Index|entropy index
486305|NCT01076790|Bispectral Index|bispectral index
486306|NCT01076790|Electrocardiogram|electrocardiogram
486307|NCT01076790|Plethysmogram|plethysmogram
486308|NCT01076790|Heart|heart
486309|NCT01076790|Heart rate|heart rate
486310|NCT01076790|Heart rate variability|heart rate variability
486311|NCT01076790|Surgery|surgery
486312|NCT01076777|Panic disorder|panic disorder
486313|NCT01076777|Physical exercise|physical exercise
486314|NCT01076777|Cognitive-behavioral therapy|cognitive-behavioral therapy
486315|NCT01076777|Manualized|manualized
486316|NCT01076725|ProSeal LMA|proseal lma
486317|NCT01076725|standard insertion|standard insertion
486318|NCT01076725|rotational insertion|rotational insertion
486319|NCT01076699|abdominal pain|abdominal pain
486320|NCT01076699|bloating|bloating
486321|NCT01076699|diarrhea|diarrhea
486322|NCT01076699|irritable bowel|irritable bowel
486323|NCT01076686|Augmentation mammoplasty|augmentation mammoplasty
486324|NCT01076686|Breast augmentation|breast augmentation
486325|NCT01076686|Postoperative pain|postoperative pain
486326|NCT01076686|Analgesia|analgesia
486327|NCT01076660|Ischemic cardiomyopathy|ischemic cardiomyopathy
486328|NCT01076660|Nonischemic cardiomyopathy|nonischemic cardiomyopathy
486329|NCT01076660|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
486330|NCT01076660|Sudden Cardiac Death|sudden cardiac death
486331|NCT01076660|Ventricular tachycardia|ventricular tachycardia
486332|NCT01076660|Ventricular fibrillation|ventricular fibrillation
486333|NCT01076608|primary care patients|primary care patients
486334|NCT01076595|Multiple sclerosis|multiple sclerosis
486335|NCT01076595|BetaPlus program|betaplus program
486336|NCT01076595|Recurrent/remittent multiple sclerosis patients|recurrent/remittent multiple sclerosis patients
486337|NCT01076595|Adherence to treatment regimen|adherence to treatment regimen
486338|NCT01076582|hormone withdrawal associated symptoms|hormone withdrawal associated symptoms
486339|NCT01076504|SCLC|sclc
486340|NCT01076504|Amrubicin|amrubicin
486341|NCT01076504|Carboplatin|carboplatin
486342|NCT01076504|Pegfilgrastim|pegfilgrastim
486343|NCT01076504|Neulasta|neulasta
486344|NCT01076478|Symmetric Diabetic Polyneuropathy|symmetric diabetic polyneuropathy
486345|NCT01076465|Heart failure|heart failure
486346|NCT01076465|Elderly|elderly
486347|NCT01076465|Disease management|disease management
486348|NCT01076452|Parkinson's Disease|parkinson's disease
486349|NCT01076452|levo-dopa|levo-dopa
486350|NCT01076452|tremor|tremor
486351|NCT01076452|dyskinesia|dyskinesia
486352|NCT01076452|subthalamic nucleus|subthalamic nucleus
486353|NCT01076452|globus pallidus|globus pallidus
486354|NCT01076426|probiotic|probiotic
486355|NCT01076426|peritoneal dialysis|peritoneal dialysis
486356|NCT01076426|peritonitis|peritonitis
486357|NCT01076426|nutrition status|nutrition status
486358|NCT01076413|gait|gait
486359|NCT01076413|exercise|exercise
486360|NCT01076413|skill-based|skill-based
486361|NCT01076413|aerobic|aerobic
486362|NCT01076387|Bladder|bladder
486363|NCT01076387|Cystectomy|cystectomy
486364|NCT01076387|Robotic|robotic
486365|NCT01076387|Open Radical|open radical
486366|NCT01076387|10-016|10-016
486367|NCT01076374|pacemaker|pacemaker
486368|NCT01076361|Epicardial|epicardial
486369|NCT01076361|Pacing Lead|pacing lead
486370|NCT01076348|Epicardial|epicardial
486371|NCT01076348|Pacing Lead|pacing lead
486372|NCT01076335|Neoadjuvant Hormonal Therapy|neoadjuvant hormonal therapy
486373|NCT01076335|Docetaxel|docetaxel
486374|NCT01076335|Taxotere|taxotere
486375|NCT01076335|Chemotherapy|chemotherapy
486376|NCT01076335|Radical Prostatectomy|radical prostatectomy
486377|NCT01076335|Node-positive Prostate Cancer|node-positive prostate cancer
486378|NCT01076335|Androgen-dependent prostate cancer|androgen-dependent prostate cancer
486379|NCT01076335|Lymph node metastases|lymph node metastases
486380|NCT01076309|cataract surgery|cataract surgery
486381|NCT01076309|tamsulosin|tamsulosin
486383|NCT01076283|baclofen|baclofen
486386|NCT01076283|craving|craving
486387|NCT01076283|alcohol drinking|alcohol drinking
486388|NCT01076283|biobehavioral mechanisms of baclofen in alcoholism|biobehavioral mechanisms of baclofen in alcoholism
486389|NCT01076257|brain damage|brain damage
486390|NCT01076257|constraint induced movement therapy|constraint induced movement therapy
486391|NCT01076257|kinematic|kinematic
486392|NCT01076257|function|function
486393|NCT01076257|outcome|outcome
486394|NCT01076257|Quality of life|quality of life
486395|NCT01076218|Continuous Glucose Monitoring|continuous glucose monitoring
486396|NCT01076218|Accuracy|accuracy
486397|NCT01076218|Continuous Glucose Error-Grid Analysis|continuous glucose error-grid analysis
486398|NCT01076205|Work Productivity|work productivity
486399|NCT01076205|Long-term Observation|long-term observation
486400|NCT01076205|Humira|humira
486401|NCT01076205|Quality of Life|quality of life
486402|NCT01076205|Rheumatoid Arthritis|rheumatoid arthritis
486403|NCT01076192|Moderate Psoriasis|moderate psoriasis
486404|NCT01076192|Psoriasis|psoriasis
486405|NCT01076192|Severe Psoriasis|severe psoriasis
486406|NCT01076192|Adalimumab|adalimumab
486407|NCT01076192|Effectiveness|effectiveness
486408|NCT01076192|Safety|safety
486409|NCT01076192|Clinical practice|clinical practice
486410|NCT01076179|Infection|infection
486411|NCT01076179|Rilpivirine|rilpivirine
486412|NCT01076179|CCR5 antagonists|ccr5 antagonists
486413|NCT01076179|Etravirine|etravirine
486414|NCT01076179|Human Immunodeficiency Virus|human immunodeficiency virus
486415|NCT01076179|Maraviroc|maraviroc
486416|NCT01076179|Safety and efficacy|safety and efficacy
486417|NCT01076179|Non nucleoside reverse transcriptase inhibitors (NNRTIs)|non nucleoside reverse transcriptase inhibitors (nnrtis)
486418|NCT01076179|Integrase inhibitors|integrase inhibitors
486419|NCT01076179|Raltegravir|raltegravir
486420|NCT01076179|Kaletra|kaletra
486421|NCT01076166|Post-marketing observational study|post-marketing observational study
486422|NCT01076166|Lower respiratory tract infections|lower respiratory tract infections
486423|NCT01076166|Klacid Granules for Oral Suspension|klacid granules for oral suspension
486424|NCT01076153|Post-marketing observational study|post-marketing observational study
486425|NCT01076153|Upper or lower respiratory tract infection|upper or lower respiratory tract infection
486426|NCT01076153|Klacid MR|klacid mr
486427|NCT01076140|Hypertension as a result of bevacizumab therapy|hypertension as a result of bevacizumab therapy
486428|NCT01076101|SLE|sle
486429|NCT01076101|sister|sister
486430|NCT01076101|autoimmune disease|autoimmune disease
486431|NCT01076075|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
486432|NCT01076062|Pregnancy Maintenance|pregnancy maintenance
486433|NCT01076062|Labor, Induced|labor, induced
486434|NCT01076062|spontaneous labor|spontaneous labor
486435|NCT01076062|cesarean delivery|cesarean delivery
486436|NCT01076036|ischemia|ischemia
486437|NCT01076036|stent|stent
486438|NCT01076023|Diabetes|diabetes
486439|NCT01076023|Cardiovascular disease|cardiovascular disease
486440|NCT01076023|Observational study|observational study
486441|NCT01076023|China|china
486442|NCT01075997|Diabetes Mellitus|diabetes mellitus
486443|NCT01075984|Antifungal Agents pharmacokinetics|antifungal agents pharmacokinetics
486444|NCT01075984|Mycoses prevention and control|mycoses prevention and control
486445|NCT01075971|Buprenorphine tablet|buprenorphine tablet
486446|NCT01075971|Fast dissolving tablet|fast dissolving tablet
486447|NCT01075971|Opioid dependant patients|opioid dependant patients
486448|NCT01075958|n-3 PUFAs|n-3 pufas
486449|NCT01075958|Fish oil|fish oil
486450|NCT01075958|Cognitive function|cognitive function
486451|NCT01075958|Healthy young adults|healthy young adults
486452|NCT01075945|antimalarials|antimalarials
486453|NCT01075945|ACTs|acts
486454|NCT01075945|Piperaquine|piperaquine
486455|NCT01075945|uncomplicated|uncomplicated
486456|NCT01075932|cerebral blood flow|cerebral blood flow
486457|NCT01075932|NIRS|nirs
486458|NCT01075932|n-3 PUFAs|n-3 pufas
486459|NCT01075932|fish oil|fish oil
486460|NCT01075932|cognitive function|cognitive function
486461|NCT01075919|n-3 PUFAs|n-3 pufas
486462|NCT01075919|Cognitive function|cognitive function
486463|NCT01075919|Healthy young adults|healthy young adults
486464|NCT01075919|Fish oil|fish oil
486465|NCT01075919|Mood|mood
486466|NCT01075906|pharmacokinetics|pharmacokinetics
486467|NCT01075893|Colorectal cancer|colorectal cancer
486468|NCT01075893|Stem cells|stem cells
486469|NCT01075893|Ulcerative colitis|ulcerative colitis
486470|NCT01075893|Polyps|polyps
486471|NCT01075880|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
486472|NCT01075880|Rebif|rebif
486473|NCT01075880|Interferon beta-1a|interferon beta-1a
486474|NCT01075854|Gonal-F|gonal-f
486475|NCT01075854|Multifollicular stimulation|multifollicular stimulation
486476|NCT01075854|Pregnancy|pregnancy
486477|NCT01075854|Ovarian hyperstimulation|ovarian hyperstimulation
486478|NCT01075854|In vitro fertilization|in vitro fertilization
486479|NCT01075854|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
486480|NCT01075854|Infertility|infertility
486481|NCT01075841|Head and neck neoplasms|head and neck neoplasms
486482|NCT01075841|Carcinoma, squamous cell|carcinoma, squamous cell
486483|NCT01075841|Cetuximab|cetuximab
486484|NCT01075828|Head and Neck Neoplasms|head and neck neoplasms
486485|NCT01075828|Neoplasms, Squamous Cell|neoplasms, squamous cell
486486|NCT01075828|Cetuximab|cetuximab
486487|NCT01075815|Infertility|infertility
486488|NCT01075815|Ovulation induction|ovulation induction
486489|NCT01075815|Luveris|luveris
486490|NCT01075815|Controlled ovarian stimulation|controlled ovarian stimulation
486491|NCT01075815|Reproductive technologies, assisted|reproductive technologies, assisted
486492|NCT01075802|Breast cancer|breast cancer
486493|NCT01075802|Tamoxifen|tamoxifen
486494|NCT01075802|Endoxifen|endoxifen
486495|NCT01075802|polymorphism of CYP2D6|polymorphism of cyp2d6
486496|NCT01075789|Pain|pain
486497|NCT01075789|Discomfort|discomfort
486498|NCT01075789|Insertion|insertion
486499|NCT01075789|Nasogastric tube|nasogastric tube
486500|NCT01075763|Alzheimer's|alzheimer's
486501|NCT01075763|Dementia|dementia
486502|NCT01075763|Interferon beta-1a|interferon beta-1a
486503|NCT01075763|Rebif|rebif
486504|NCT01075750|hyperkalaemia|hyperkalaemia
486505|NCT01075750|metabolic acidosis|metabolic acidosis
486506|NCT01075750|renal transplantation|renal transplantation
486507|NCT01075750|normal saline|normal saline
486508|NCT01075750|elomel isoton|elomel isoton
486509|NCT01075750|fluid management in renal transplantation|fluid management in renal transplantation
486510|NCT01075737|Multiple sclerosis|multiple sclerosis
486511|NCT01075737|Sclerosis|sclerosis
486512|NCT01075737|Quality of life|quality of life
486513|NCT01075724|Perioperative Hypothermia Prevention|perioperative hypothermia prevention
486514|NCT01075724|Accidental Perioperative Hypothermia|accidental perioperative hypothermia
486515|NCT01075711|Arthritis, Rheumatoid|arthritis, rheumatoid
486516|NCT01075711|Prednisone|prednisone
486517|NCT01075698|Type 2 Diabetes|type 2 diabetes
486518|NCT01075698|Cerebrovascular disease|cerebrovascular disease
486519|NCT01075698|Coronary Artery Disease|coronary artery disease
486520|NCT01075698|Chronic Kidney Disease|chronic kidney disease
486521|NCT01075698|Peripheral Artery Disease|peripheral artery disease
486522|NCT01075672|OCD|ocd
486523|NCT01075672|BDD|bdd
486524|NCT01075672|Tourette syndrome|tourette syndrome
486525|NCT01075672|trichotillomania|trichotillomania
486526|NCT01075672|Compulsive Skin Picking|compulsive skin picking
486527|NCT01075672|panic disorder|panic disorder
486528|NCT01075672|social phobia|social phobia
486529|NCT01075672|generalized anxiety disorder|generalized anxiety disorder
486530|NCT01075672|depression|depression
486531|NCT01075672|PTSD|ptsd
486532|NCT01075672|ADHD|adhd
486533|NCT01075672|eating disorder|eating disorder
486534|NCT01075672|Specific Phobia|specific phobia
486535|NCT01075659|Smoking Cessation|smoking cessation
486536|NCT01075659|VAS|vas
486537|NCT01075659|Urges to smoke|urges to smoke
486538|NCT01075646|postoperative pain|postoperative pain
486539|NCT01075646|wound infusion|wound infusion
486540|NCT01075646|local anesthesia|local anesthesia
486541|NCT01075633|FOBT|fobt
486542|NCT01075633|colonoscopy|colonoscopy
486543|NCT01075633|familiar risk|familiar risk
486544|NCT01075633|colorectal cancer|colorectal cancer
486545|NCT01075633|advanced adenoma|advanced adenoma
486546|NCT01075620|rotating platform|rotating platform
486547|NCT01075620|posterior stabilized|posterior stabilized
486548|NCT01075620|non-posterior stabilized|non-posterior stabilized
486549|NCT01075607|Lymph fluid collection|lymph fluid collection
486550|NCT01075594|Dyslipidemia|dyslipidemia
486551|NCT01075594|Target cholesterol|target cholesterol
486552|NCT01075594|Undertreatment|undertreatment
486553|NCT01075581|Hemodynamic instability|hemodynamic instability
486554|NCT01075581|Hemostasis|hemostasis
486555|NCT01075555|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
486556|NCT01075555|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
486557|NCT01075555|advanced adult primary liver cancer|advanced adult primary liver cancer
486558|NCT01075555|recurrent adult primary liver cancer|recurrent adult primary liver cancer
486559|NCT01075542|Corneal astigmatism|corneal astigmatism
486560|NCT01075542|Intraocular lens|intraocular lens
486561|NCT01075529|major depressive disorder, fluoxetine, Hamilton Rating Scale for Depression (HAM-D-17)|major depressive disorder, fluoxetine, hamilton rating scale for depression (ham-d-17)
486562|NCT01075516|Remote Monitoring|remote monitoring
486563|NCT01075516|ICD patients|icd patients
486564|NCT01075516|EQ-5D questionnaire|eq-5d questionnaire
486565|NCT01075516|remote follow up|remote follow up
486566|NCT01075503|Supraclavicular|supraclavicular
486567|NCT01075503|Interscalene|interscalene
486568|NCT01075503|Infraclavicular|infraclavicular
486569|NCT01075503|Brachial plexus block|brachial plexus block
486570|NCT01075503|Ropivacaine|ropivacaine
486571|NCT01075490|spinal anesthesia|spinal anesthesia
486572|NCT01075490|neonates|neonates
486573|NCT01075490|clonidine|clonidine
486574|NCT01075490|post operative apnea|post operative apnea
486575|NCT01075464|Solid Tumor|solid tumor
486576|NCT01075451|Staphylococcus aureus|staphylococcus aureus
486577|NCT01075451|Antimicrobial Stewardship|antimicrobial stewardship
486578|NCT01075451|Antibacterial resistance|antibacterial resistance
486579|NCT01075451|Vancomycin|vancomycin
486580|NCT01075438|ataxia telangiectasia|ataxia telangiectasia
486581|NCT01075438|Pneumococcal Vaccines|pneumococcal vaccines
486582|NCT01075425|leukemia|leukemia
486583|NCT01075425|acute leukemia|acute leukemia
486584|NCT01075425|chronic myelogenous leukemia|chronic myelogenous leukemia
486585|NCT01075425|myelodysplastic syndrome|myelodysplastic syndrome
486586|NCT01075425|relapsed acute leukemia|relapsed acute leukemia
486587|NCT01075425|refractory acute leukemia|refractory acute leukemia
486588|NCT01075425|belinostat|belinostat
486589|NCT01075425|bortezomib|bortezomib
486590|NCT01075425|Velcade|velcade
486591|NCT01075425|PXD-101|pxd-101
486592|NCT01075412|Positron-Emission Tomography|positron-emission tomography
486593|NCT01075412|Radiotherapy, Intensity-Modulated|radiotherapy, intensity-modulated
486594|NCT01075399|[F 18]HX4|[f 18]hx4
486595|NCT01075399|HX4|hx4
486596|NCT01075399|Hypoxia|hypoxia
486597|NCT01075399|Head/Neck Cancer|head/neck cancer
486598|NCT01075399|Lung Cancer|lung cancer
486599|NCT01075399|Liver Cancer|liver cancer
486600|NCT01075399|Rectal Cancer|rectal cancer
486601|NCT01075399|Cervical Cancer|cervical cancer
486602|NCT01075399|HIF1 alpha|hif1 alpha
486603|NCT01075399|CAIX|caix
486604|NCT01075386|Hysterectomy|hysterectomy
486605|NCT01075386|Endometrial cancer|endometrial cancer
486606|NCT01075386|Benign|benign
486607|NCT01075386|Endocrine system|endocrine system
486608|NCT01075386|Tissue collection|tissue collection
486609|NCT01075373|early stage schizophrenia|early stage schizophrenia
486610|NCT01075373|drug naïve schizophrenia|drug naïve schizophrenia
486611|NCT01075373|treatment response|treatment response
486612|NCT01075373|Aripiprazole|aripiprazole
486613|NCT01075373|pharmacogenetics|pharmacogenetics
486614|NCT01075373|Disrupted-in-Schizophrenia 1 gene (DISC1)|disrupted-in-schizophrenia 1 gene (disc1)
486615|NCT01075373|Neuregulin 1 gene (NRG1)|neuregulin 1 gene (nrg1)
486616|NCT01075373|Dopamine receptor type 2 gene (DRD2)|dopamine receptor type 2 gene (drd2)
486617|NCT01075373|Catechol-O-Methyltransferase gene (COMT)|catechol-o-methyltransferase gene (comt)
486618|NCT01075373|neurocognitive function|neurocognitive function
486619|NCT01075373|event-related evoked potential (ERP)|event-related evoked potential (erp)
486620|NCT01075373|Niacin skin test|niacin skin test
486621|NCT01075373|plasma neurotransmitter level|plasma neurotransmitter level
486622|NCT01075373|plasma cytokine level|plasma cytokine level
486623|NCT01075373|plasma signaling protein level|plasma signaling protein level
486624|NCT01075373|AKT1 protein level in the peripheral lymphocytes|akt1 protein level in the peripheral lymphocytes
486625|NCT01075373|16-45 y/o|16-45 y/o
486626|NCT01075373|without mental retardation or epilepsy|without mental retardation or epilepsy
486627|NCT01075360|Neuroblastoma, MYCN, AHR|neuroblastoma, mycn, ahr
486628|NCT01075347|autoserum|autoserum
486629|NCT01075347|ocular surgery|ocular surgery
486630|NCT01075347|corneal epithelium healing|corneal epithelium healing
486631|NCT01075334|sperm|sperm
486632|NCT01075334|male infertility|male infertility
486633|NCT01075334|Carnitine|carnitine
486634|NCT01075334|food supplementation|food supplementation
486635|NCT01075334|insemination|insemination
486636|NCT01075308|hormone-resistant prostate cancer|hormone-resistant prostate cancer
486637|NCT01075308|recurrent prostate cancer|recurrent prostate cancer
486638|NCT01075308|stage IV prostate cancer|stage iv prostate cancer
486639|NCT01075308|stage III prostate cancer|stage iii prostate cancer
486640|NCT01075308|adenocarcinoma of the prostate|adenocarcinoma of the prostate
486641|NCT01075295|Schizophreniform Disorder|schizophreniform disorder
486642|NCT01075295|Schizophrenia, Schizoaffective disorder|schizophrenia, schizoaffective disorder
486643|NCT01075295|Bipolar I Disorder|bipolar i disorder
486644|NCT01075295|Bipolar II Disorder|bipolar ii disorder
486645|NCT01075295|Major Depressive Disorder with Psychotic Features,|major depressive disorder with psychotic features,
486646|NCT01075295|Substance-Induced Psychoses|substance-induced psychoses
486647|NCT01075295|Psychosis Not Otherwise Specified|psychosis not otherwise specified
486648|NCT01075295|antipsychotic|antipsychotic
486649|NCT01075295|weight gain|weight gain
486650|NCT01075295|body mass index|body mass index
486651|NCT01075295|BMI|bmi
486652|NCT01075295|waist circumference|waist circumference
486653|NCT01075295|WC|wc
486654|NCT01075295|coronary heart disease|coronary heart disease
486655|NCT01075295|CHD|chd
486656|NCT01075269|robotic thyroidectomy, comparative study, cosmetic result, postoperative neck discomfort, swallowing symptom|robotic thyroidectomy, comparative study, cosmetic result, postoperative neck discomfort, swallowing symptom
486657|NCT01075269|Robotic thyroidectomy, cosmetic effect, postoperative distress, surgical outcome|robotic thyroidectomy, cosmetic effect, postoperative distress, surgical outcome
486658|NCT01075256|sensitivity|sensitivity
486659|NCT01075256|occlusion|occlusion
486660|NCT01075243|dental pain|dental pain
486661|NCT01075243|paracetamol|paracetamol
486662|NCT01075243|Post-surgical dental pain|post-surgical dental pain
486663|NCT01075230|PRP, TKA, pain scale, hemoglobin, hematocrit, narcotics|prp, tka, pain scale, hemoglobin, hematocrit, narcotics
486664|NCT01075217|Peripheral arterial occlusive disease (PAOD)|peripheral arterial occlusive disease (paod)
486665|NCT01075204|Respiratory Tract Infection|respiratory tract infection
486666|NCT01075204|Clarithromycin|clarithromycin
486667|NCT01075204|Recovery|recovery
486668|NCT01075191|Viral load|viral load
486669|NCT01075191|Resistance|resistance
486670|NCT01075191|Double protease inhibitors|double protease inhibitors
486671|NCT01075191|Mutations|mutations
486672|NCT01075191|Immune system|immune system
486673|NCT01075191|Infection|infection
486674|NCT01075191|Nucleoside Reverse Transcriptase Inhibitors-free|nucleoside reverse transcriptase inhibitors-free
486675|NCT01075191|Human Immunodeficiency Virus|human immunodeficiency virus
486676|NCT01075178|Infection|infection
486677|NCT01075178|Arrhythmia|arrhythmia
486678|NCT01075178|Death|death
486679|NCT01075178|Palivizumab|palivizumab
486680|NCT01075178|Safety|safety
486681|NCT01075178|Hemodynamically Significant Congenital Heart Disease|hemodynamically significant congenital heart disease
486682|NCT01075178|Pediatric|pediatric
486683|NCT01075178|Observational|observational
486684|NCT01075165|silicone|silicone
486685|NCT01075165|burn scar|burn scar
486686|NCT01075165|hypertrophic scar|hypertrophic scar
486687|NCT01075165|keloid|keloid
486688|NCT01075165|scar assessment|scar assessment
486689|NCT01075165|abnormal scarring|abnormal scarring
486690|NCT01075165|Burn patients|burn patients
486691|NCT01075152|cryptococcal meningitis|cryptococcal meningitis
486692|NCT01075152|cryptococcus|cryptococcus
486693|NCT01075152|cryptococcosis|cryptococcosis
486694|NCT01075152|HIV|hiv
486695|NCT01075152|AIDS|aids
486696|NCT01075152|strategy|strategy
486697|NCT01075139|Motivational interviewing|motivational interviewing
486698|NCT01075139|Physical activity|physical activity
486699|NCT01075139|Diet|diet
486700|NCT01075126|bipolar affective disorder|bipolar affective disorder
486701|NCT01075126|African American|african american
486702|NCT01075126|antimanic|antimanic
486703|NCT01075126|lithium|lithium
486704|NCT01075126|depakote|depakote
486705|NCT01075113|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
486706|NCT01075113|advanced adult primary liver cancer|advanced adult primary liver cancer
486707|NCT01075113|recurrent adult primary liver cancer|recurrent adult primary liver cancer
486708|NCT01075100|metastatic|metastatic
486709|NCT01075100|breast|breast
486710|NCT01075100|cancer|cancer
486711|NCT01075087|TAP Block|tap block
486712|NCT01075087|Pain|pain
486713|NCT01075087|Obesity|obesity
486714|NCT01075087|Surgery|surgery
486715|NCT01075087|Laparoscopic Banding|laparoscopic banding
486716|NCT01075074|Pain|pain
486717|NCT01075074|TAP block|tap block
486718|NCT01075074|Laparoscopic|laparoscopic
486719|NCT01075074|Gynecologic|gynecologic
486720|NCT01075061|Congenital mirror movement, physiopathology, imaging, transcranial magnetic stimulation, candidate gene|congenital mirror movement, physiopathology, imaging, transcranial magnetic stimulation, candidate gene
486721|NCT01075048|Colorectal cancer|colorectal cancer
486722|NCT01075048|wild-type KRAS|wild-type kras
486723|NCT01075048|irinotecan|irinotecan
486724|NCT01075048|cetuximab|cetuximab
486725|NCT01075048|second-line therapy|second-line therapy
486726|NCT01075035|Traumatic Brain Injury|traumatic brain injury
486727|NCT01075035|TBI|tbi
486728|NCT01075035|Military|military
486729|NCT01075035|Imaging|imaging
486730|NCT01075035|MEG|meg
486731|NCT01075035|PET/CT|pet/ct
486732|NCT01075035|MRI|mri
486733|NCT01075035|fMRI|fmri
486734|NCT01075035|DTI|dti
486735|NCT01075035|SANIC|sanic
486736|NCT01075035|veteran|veteran
486737|NCT01075009|Antibiotics|antibiotics
486738|NCT01075009|Resistance|resistance
486739|NCT01075009|Epidemiology|epidemiology
486740|NCT01075009|Gram-negative bacteria|gram-negative bacteria
486741|NCT01075009|Epidemiology of antibiotic use|epidemiology of antibiotic use
486742|NCT01074996|Pancreatic cancer|pancreatic cancer
486743|NCT01074996|S-1|s-1
486744|NCT01074996|S-1 plus Leucovorin|s-1 plus leucovorin
486745|NCT01074996|second-line therapy|second-line therapy
486746|NCT01074983|Prehospital, Oxygen, Trauma, Hypoxemia|prehospital, oxygen, trauma, hypoxemia
486747|NCT01074970|PARP inhibition + breast cancer|parp inhibition + breast cancer
486748|NCT01074970|breast cancer|breast cancer
486749|NCT01074970|PARP inhibitor|parp inhibitor
486750|NCT01074970|Triple negative|triple negative
486751|NCT01074944|Gaucher disease|gaucher disease
486752|NCT01074944|Genz-112638|genz-112638
486753|NCT01074944|beta-glucosidase|beta-glucosidase
486754|NCT01074944|acid β-glucosidase|acid β-glucosidase
486755|NCT01074944|glucocerebrosidase|glucocerebrosidase
486756|NCT01074944|glucosylceramide|glucosylceramide
486757|NCT01074944|D-glucosyl-N-acylsphingosine glucohydrolase|d-glucosyl-n-acylsphingosine glucohydrolase
486758|NCT01074944|substrate reduction therapy|substrate reduction therapy
486759|NCT01074931|Lopinavir/ritonavir|lopinavir/ritonavir
486760|NCT01074918|Pre-hypertension|pre-hypertension
486761|NCT01074918|Hypertension|hypertension
486762|NCT01074905|vivax malaria|vivax malaria
486763|NCT01074905|artesunate|artesunate
486764|NCT01074905|chloroquine|chloroquine
486765|NCT01074905|primaquine|primaquine
486766|NCT01074905|relapse|relapse
486767|NCT01074892|endometrial hyperplasia treatment MPA per os LNG-IUD|endometrial hyperplasia treatment mpa per os lng-iud
486768|NCT01074879|Elderly|elderly
486769|NCT01074879|protein consumption|protein consumption
486770|NCT01074879|resistance exercise|resistance exercise
486771|NCT01074879|muscle mass|muscle mass
486772|NCT01074866|Mechanical ventilation|mechanical ventilation
486773|NCT01074866|Non invasive Ventilation|non invasive ventilation
486774|NCT01074866|Patient-ventilator interaction|patient-ventilator interaction
486775|NCT01074866|Pressure support|pressure support
486776|NCT01074866|Neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
486777|NCT01074840|Food Hypersensitivity|food hypersensitivity
486778|NCT01074840|Hypersensitivity|hypersensitivity
486779|NCT01074840|Immune System Diseases|immune system diseases
486780|NCT01074840|Hypersensitivity, Immediate|hypersensitivity, immediate
486781|NCT01074840|Peanut Hypersensitivity|peanut hypersensitivity
486782|NCT01074840|Food Allergy|food allergy
486783|NCT01074827|Multiple Sclerosis|multiple sclerosis
486784|NCT01074827|Walking ability|walking ability
486785|NCT01074827|Strength|strength
486786|NCT01074827|Balance|balance
486787|NCT01074827|Treadmill walking|treadmill walking
486788|NCT01074814|Metastatic Breast Cancer|metastatic breast cancer
486789|NCT01074814|Molecular profiling|molecular profiling
486790|NCT01074801|Closed-loop systems|closed-loop systems
486791|NCT01074801|day-and-night glucose control|day-and-night glucose control
486792|NCT01074788|rehabilitation|rehabilitation
486793|NCT01074788|mind body therapy|mind body therapy
486794|NCT01074788|integrative medicine|integrative medicine
486795|NCT01074775|innate immunity|innate immunity
486796|NCT01074775|mycobacterium bovis|mycobacterium bovis
486797|NCT01074775|mucosal immunity|mucosal immunity
486798|NCT01074775|adaptive immunity|adaptive immunity
486799|NCT01074775|genomics|genomics
486800|NCT01074762|Diabetes mellitus|diabetes mellitus
486801|NCT01074762|Quality of health care|quality of health care
486802|NCT01074762|Health services research|health services research
486803|NCT01074749|AF|af
486804|NCT01074749|Automatic Mode Switch|automatic mode switch
486805|NCT01074749|FFRW|ffrw
486806|NCT01074749|paroxysmal AF|paroxysmal af
486807|NCT01074736|influenza A/H5N1|influenza a/h5n1
486808|NCT01074736|host genetic susceptibility|host genetic susceptibility
486809|NCT01074736|genotyping|genotyping
486810|NCT01074723|b-cryptoxanthin|b-cryptoxanthin
486811|NCT01074723|cholesterol|cholesterol
486812|NCT01074723|bone markers|bone markers
486813|NCT01074723|Osteoporosis|osteoporosis
486814|NCT01074723|cardiovascular risk|cardiovascular risk
486815|NCT01074723|post-menopausal women|post-menopausal women
486816|NCT01074697|Randomized Controlled Trial|randomized controlled trial
486817|NCT01074697|Serotonin Agonists|serotonin agonists
486818|NCT01074697|Dexamethasone|dexamethasone
486819|NCT01074697|Receptors, Neurokinin-1|receptors, neurokinin-1
486820|NCT01074697|Radiotherapy|radiotherapy
486821|NCT01074697|Cisplatin|cisplatin
486822|NCT01074697|Prevention & control|prevention & control
486823|NCT01074684|diagnosis|diagnosis
486824|NCT01074684|nodules|nodules
486825|NCT01074684|fine needle aspiration|fine needle aspiration
486826|NCT01074658|Advance|advance
486827|NCT01074658|Medtronic CoreValve System|medtronic corevalve system
486828|NCT01074658|International|international
486829|NCT01074658|Interventional|interventional
486830|NCT01074658|Post Market Study|post market study
486831|NCT01074645|Acute-on -chronic liver failure|acute-on -chronic liver failure
486832|NCT01074645|Reactivation of hepatitis B|reactivation of hepatitis b
486833|NCT01074645|Spontaneous reactivation of chronic hepatitis B presenting as to acute-on-chronic liver failure|spontaneous reactivation of chronic hepatitis b presenting as to acute-on-chronic liver failure
486834|NCT01074606|Cataract|cataract
486835|NCT01074593|PHARMACOKINETICS AND PHARMACODYNAMICS OF DRUG INTERFERON BETA-1A|pharmacokinetics and pharmacodynamics of drug interferon beta-1a
486836|NCT01074580|Crohn's disease|crohn's disease
486837|NCT01074580|sonography|sonography
486838|NCT01074580|contrast enhanced ultrasound|contrast enhanced ultrasound
486839|NCT01074554|sarcoidosis|sarcoidosis
486840|NCT01074554|mycobacteria|mycobacteria
486841|NCT01074554|cutaneous lesions|cutaneous lesions
486842|NCT01074541|Vitamin D|vitamin d
486843|NCT01074541|UVB|uvb
486844|NCT01074541|Dose-Response|dose-response
486845|NCT01074541|UV intensity|uv intensity
486846|NCT01074541|Skin cancer|skin cancer
486847|NCT01074528|cancer patients|cancer patients
486848|NCT01074528|relatives or partners of cancer patients|relatives or partners of cancer patients
486849|NCT01074515|COPD|copd
486850|NCT01074515|Depression|depression
486851|NCT01074515|Inflammation|inflammation
486852|NCT01074515|Genetics|genetics
486853|NCT01074515|Functioning|functioning
486854|NCT01074515|Dyspnea|dyspnea
486855|NCT01074515|Physical activity|physical activity
486856|NCT01074502|acne|acne
486857|NCT01074489|GDM|gdm
486858|NCT01074489|Gestational Diabetes|gestational diabetes
486859|NCT01074489|GTT|gtt
486860|NCT01074489|CGMS|cgms
486861|NCT01074476|Knee osteoarthritis|knee osteoarthritis
486862|NCT01074476|glucosamine|glucosamine
486863|NCT01074476|synovial fluid|synovial fluid
486864|NCT01074476|viscosity|viscosity
486865|NCT01074476|viscoelasticity|viscoelasticity
486866|NCT01074476|WOMAC|womac
486867|NCT01074463|Bioequivalence|bioequivalence
486868|NCT01074463|Healthy Subjects|healthy subjects
486869|NCT01074450|Bioequivalence|bioequivalence
486870|NCT01074450|Healthy Subjects|healthy subjects
486871|NCT01074424|stage IIB cervical cancer|stage iib cervical cancer
486872|NCT01074424|stage III cervical cancer|stage iii cervical cancer
486873|NCT01074424|stage IVA cervical cancer|stage iva cervical cancer
486874|NCT01074424|cervical adenocarcinoma|cervical adenocarcinoma
486875|NCT01074424|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
486876|NCT01074424|cervical squamous cell carcinoma|cervical squamous cell carcinoma
486877|NCT01074398|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
486878|NCT01074398|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
486879|NCT01074398|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
486880|NCT01074398|fallopian tube cancer|fallopian tube cancer
486881|NCT01074398|peritoneal cavity cancer|peritoneal cavity cancer
486882|NCT01074385|Stage IV Colorectal Cancer|stage iv colorectal cancer
486883|NCT01074359|A3243G Mitochondrial DNA Point Mutation|a3243g mitochondrial dna point mutation
486884|NCT01074346|Multiple sclerosis|multiple sclerosis
486885|NCT01074346|Interferon-beta 1-a|interferon-beta 1-a
486886|NCT01074333|Colorectal cancer|colorectal cancer
486887|NCT01074333|Metastasis|metastasis
486888|NCT01074333|Cetuximab|cetuximab
486889|NCT01074333|Erbitux|erbitux
486890|NCT01074333|Epidermal growth factor receptor|epidermal growth factor receptor
486891|NCT01074320|breast cancer|breast cancer
486892|NCT01074320|aromatase inhibitors|aromatase inhibitors
486893|NCT01074320|musculoskeletal symptoms|musculoskeletal symptoms
486894|NCT01074307|Systolic heart failure|systolic heart failure
486895|NCT01074307|Bisoprolol|bisoprolol
486896|NCT01074307|Concor|concor
486897|NCT01074307|Echocardiogram|echocardiogram
486898|NCT01074294|Inattention|inattention
486899|NCT01074294|Hyperactivity|hyperactivity
486900|NCT01074294|Impulsivity|impulsivity
486901|NCT01074294|Distractibility|distractibility
486902|NCT01074294|Procrastination|procrastination
486903|NCT01074294|Disorganized|disorganized
486904|NCT01074294|ADHD|adhd
486905|NCT01074281|Hypertension|hypertension
486906|NCT01074281|Isolated systolic hypertonia|isolated systolic hypertonia
486907|NCT01074281|Eneas|eneas
486908|NCT01074255|Nausea|nausea
486909|NCT01074255|Vomiting|vomiting
486910|NCT01074255|Chemotherapy|chemotherapy
486911|NCT01074255|Post-chemotherapy|post-chemotherapy
486912|NCT01074242|Gastroenteritis rotavirus|gastroenteritis rotavirus
486913|NCT01074229|Pain|pain
486914|NCT01074229|Post Operative|post operative
486915|NCT01074229|Opioids|opioids
486916|NCT01074229|Laparoscopic|laparoscopic
486917|NCT01074229|Surgery|surgery
486918|NCT01074229|Hysterectomy|hysterectomy
486919|NCT01074216|Vitamin D|vitamin d
486920|NCT01074216|Vitamin D3|vitamin d3
486921|NCT01074216|colon cancer|colon cancer
486922|NCT01074216|rectum cancer|rectum cancer
486923|NCT01074216|Cholecalciferol|cholecalciferol
486924|NCT01074216|09-143|09-143
486925|NCT01074203|nitazoxanide|nitazoxanide
486926|NCT01074203|liver transplantation|liver transplantation
486927|NCT01074203|HCV recurrence|hcv recurrence
486928|NCT01074190|Epidural Labor Analgesia|epidural labor analgesia
486929|NCT01074190|Pain|pain
486930|NCT01074190|Infant|infant
486931|NCT01074190|Breastfeeding|breastfeeding
486932|NCT01074177|BIBW 2992|bibw 2992
486933|NCT01074177|NSCLC|nsclc
486934|NCT01074164|eczema|eczema
486935|NCT01074164|atopic dermatitis|atopic dermatitis
486936|NCT01074164|itch|itch
486937|NCT01074164|pruritus|pruritus
486938|NCT01074164|acupressure|acupressure
486939|NCT01074164|acupuncture|acupuncture
486940|NCT01074151|Pregnancy|pregnancy
486941|NCT01074151|pregnant|pregnant
486942|NCT01074151|Cymbalta|cymbalta
486943|NCT01074151|Pregnancy Outcomes|pregnancy outcomes
486944|NCT01074138|CPRC|cprc
486945|NCT01074125|Hyperphosphatemia|hyperphosphatemia
486946|NCT01074125|ESRD|esrd
486947|NCT01074125|Dialysis|dialysis
486948|NCT01074125|End Stage Renal Disease|end stage renal disease
486949|NCT01074125|Phosphorus|phosphorus
486950|NCT01074125|Renal|renal
486951|NCT01074125|Kidney|kidney
486952|NCT01074112|Ultrasound|ultrasound
486953|NCT01074112|Prehospital|prehospital
486954|NCT01074112|Trauma|trauma
486955|NCT01074112|EMS|ems
486956|NCT01074112|Paramedics|paramedics
486957|NCT01074112|Sonography|sonography
486958|NCT01074112|Ultrasonography|ultrasonography
486959|NCT01074112|Ambulance|ambulance
486960|NCT01074112|FAST|fast
486961|NCT01074112|EFAST|efast
486962|NCT01074086|RAD 001 in relapsed AML|rad 001 in relapsed aml
486963|NCT01074073|Lithium DDI with Lurasidone HCl|lithium ddi with lurasidone hcl
486964|NCT01074073|Male/Female, Schizophrenia Patients|male/female, schizophrenia patients
486965|NCT01074047|Acute Myeloid Leukemia|acute myeloid leukemia
486966|NCT01074047|Cytarabine|cytarabine
486967|NCT01074047|Vidaza|vidaza
486968|NCT01074047|azacitidine|azacitidine
486969|NCT01074047|Intensive Chemotherapy|intensive chemotherapy
486970|NCT01074047|Low Dose Cytarabine|low dose cytarabine
486971|NCT01074047|Celgene|celgene
486972|NCT01074021|Nimotuzumab|nimotuzumab
486973|NCT01074021|Nasopharyngeal cancer|nasopharyngeal cancer
486974|NCT01074021|chemoradiation|chemoradiation
486975|NCT01073995|Radiculopathy|radiculopathy
486976|NCT01073995|Sciatica|sciatica
486977|NCT01073995|Lumbar Disc Herniation|lumbar disc herniation
486978|NCT01073995|Surgical Alternative|surgical alternative
486979|NCT01073982|pain|pain
486980|NCT01073982|inflammation|inflammation
486981|NCT01073982|osteoarthritis|osteoarthritis
486982|NCT01073969|prebiotic study|prebiotic study
486983|NCT01073969|modulating colonic bacteria|modulating colonic bacteria
486984|NCT01073956|Subacromial Impingement Syndrome|subacromial impingement syndrome
486985|NCT01073956|Shoulder Pain|shoulder pain
486986|NCT01073956|Physical therapy|physical therapy
486987|NCT01073956|Electrotherapy|electrotherapy
486988|NCT01073956|Ultrasonic therapy|ultrasonic therapy
486989|NCT01073956|Medium-wave 448 kHz therapy|medium-wave 448 khz therapy
486990|NCT01073943|Bowel Preparation|bowel preparation
486991|NCT01073943|Colonoscopy|colonoscopy
486992|NCT01073930|Bowel Preparation|bowel preparation
486993|NCT01073930|Colonoscopy|colonoscopy
486994|NCT01073917|Ventilation|ventilation
486995|NCT01073917|General Anesthesia|general anesthesia
486996|NCT01073917|electrical impedance tomography|electrical impedance tomography
486997|NCT01073917|pressure support|pressure support
486998|NCT01073917|spontaneous breathing|spontaneous breathing
486999|NCT01073917|laryngeal mask|laryngeal mask
487000|NCT01073917|Patients who are scheduled for elective knee or ankle surgery|patients who are scheduled for elective knee or ankle surgery
487001|NCT01073891|Pharmacokinetics|pharmacokinetics
487002|NCT01073891|Bioavailability|bioavailability
487003|NCT01073891|Food effect|food effect
487004|NCT01073891|Oral liquid formulation|oral liquid formulation
487005|NCT01073878|Urinary Urge Incontinence|urinary urge incontinence
487006|NCT01073878|Urinary Stress Incontinence|urinary stress incontinence
487007|NCT01073878|Urinary Mixed Incontinence|urinary mixed incontinence
487008|NCT01073865|ZOLADEX|zoladex
487009|NCT01073865|Pre-menopausal|pre-menopausal
487010|NCT01073865|Oestrogen Receptor|oestrogen receptor
487011|NCT01073865|Advanced Breast Cancer|advanced breast cancer
487012|NCT01073865|Progression Free Survival|progression free survival
487013|NCT01073852|Chronic Urticaria|chronic urticaria
487014|NCT01073852|Hives|hives
487015|NCT01073852|Hydroxychloroquine|hydroxychloroquine
487016|NCT01073813|Minocycline|minocycline
487017|NCT01073813|Retinal nerve fibre layer thickness|retinal nerve fibre layer thickness
487018|NCT01073813|Macular volume|macular volume
487019|NCT01073813|Visual outcomes|visual outcomes
487020|NCT01073800|atorvastatin|atorvastatin
487021|NCT01073800|vascular occlusion|vascular occlusion
487022|NCT01073800|myocardial infarction|myocardial infarction
487023|NCT01073800|stroke|stroke
487024|NCT01073800|renal failure|renal failure
487025|NCT01073800|critically ill|critically ill
487026|NCT01073800|Vascular occlusive events among the critically ill|vascular occlusive events among the critically ill
487027|NCT01073787|migraine|migraine
487028|NCT01073787|headache|headache
487029|NCT01073787|pediatric|pediatric
487030|NCT01073787|children|children
487031|NCT01073787|Emergency Department|emergency department
487032|NCT01073774|breast cancer couples coping|breast cancer couples coping
487033|NCT01073748|Asthma|asthma
487034|NCT01073748|Acetaminophen|acetaminophen
487035|NCT01073748|paracetamol|paracetamol
487036|NCT01073748|FeNO|feno
487037|NCT01073748|Spirometry|spirometry
487038|NCT01073748|Lung function|lung function
487039|NCT01073735|Needs assessment|needs assessment
487040|NCT01073735|Health-related needs|health-related needs
487041|NCT01073735|Childhood cancer survivors|childhood cancer survivors
487042|NCT01073722|thoracic surgery|thoracic surgery
487043|NCT01073722|one-lung ventilation|one-lung ventilation
487044|NCT01073722|double lumen tube|double lumen tube
487045|NCT01073722|endobronchial blocker|endobronchial blocker
487046|NCT01073709|Acetaminophen fasting study|acetaminophen fasting study
487047|NCT01073696|Sancuso|sancuso
487048|NCT01073696|granisetron|granisetron
487049|NCT01073696|Pharmacokinetics|pharmacokinetics
487050|NCT01073683|TPF|tpf
487051|NCT01073683|INDUCTION CHEMOTHERAPY|induction chemotherapy
487052|NCT01073683|LARYNX PRESERVATION|larynx preservation
487053|NCT01073683|SUPACRICOID LARYNGECTOMY|supacricoid laryngectomy
487054|NCT01073683|Stage 3 and 4 larynx cancer|stage 3 and 4 larynx cancer
487055|NCT01073670|NSAIDs|nsaids
487056|NCT01073670|bleeding|bleeding
487057|NCT01073670|thromboelastography|thromboelastography
487058|NCT01073670|cardiac surgery|cardiac surgery
487059|NCT01073670|Indomethacin|indomethacin
487060|NCT01073670|acetaminophen|acetaminophen
487061|NCT01073657|Rehabilitation|rehabilitation
487062|NCT01073644|imatinib resistant or intolerant|imatinib resistant or intolerant
487063|NCT01073631|voriconazole|voriconazole
487064|NCT01073631|Korea|korea
487065|NCT01073631|invasive fungal infection|invasive fungal infection
487066|NCT01073618|voriconazole|voriconazole
487067|NCT01073618|Korea|korea
487068|NCT01073618|invasive fungal infection|invasive fungal infection
487069|NCT01073605|Short height|short height
487070|NCT01073605|intra-uterine growth retardation|intra-uterine growth retardation
487071|NCT01073605|Genotonorm|genotonorm
487072|NCT01073605|continuous treatment|continuous treatment
487073|NCT01073605|intermittent treatment|intermittent treatment
487074|NCT01073592|HMP|hmp
487075|NCT01073592|CNV|cnv
487076|NCT01073592|AMD|amd
487077|NCT01073592|PHP|php
487078|NCT01073592|HPHP|hphp
487079|NCT01073592|FORESEE HOME|foresee home
487080|NCT01073579|Cryptogenic Infantile Spasms|cryptogenic infantile spasms
487081|NCT01073579|Cryptogenic West Syndrome|cryptogenic west syndrome
487082|NCT01073579|Hypsarrhythmia|hypsarrhythmia
487083|NCT01073579|Infantile Spasms|infantile spasms
487084|NCT01073579|Symptomatic Infantile Spasms|symptomatic infantile spasms
487085|NCT01073579|Symptomatic West Syndrome|symptomatic west syndrome
487086|NCT01073579|West Syndrome|west syndrome
487087|NCT01073579|Refractory Complex Partial Seizures|refractory complex partial seizures
487323|NCT01072526|Dry Eye Syndromes|dry eye syndromes
487088|NCT01073579|Complex Partial Epilepsy|complex partial epilepsy
487089|NCT01073579|Complex Partial Seizure Disorder|complex partial seizure disorder
487090|NCT01073579|Cryptogenic Partial Complex Epilepsy|cryptogenic partial complex epilepsy
487091|NCT01073579|Disorder, Complex Partial Seizures|disorder, complex partial seizures
487092|NCT01073579|Epilepsy, Cryptogenic, Partial Complex|epilepsy, cryptogenic, partial complex
487093|NCT01073579|Epilepsy, Psychic Equivalent|epilepsy, psychic equivalent
487094|NCT01073579|Epilepsy, Psychomotor|epilepsy, psychomotor
487095|NCT01073579|Epilepsy, Symptomatic, Partial Complex|epilepsy, symptomatic, partial complex
487096|NCT01073579|Partial Complex Epilepsy, Cryptogenic|partial complex epilepsy, cryptogenic
487097|NCT01073579|Partial Complex Epilepsy, Symptomatic|partial complex epilepsy, symptomatic
487098|NCT01073579|Seizure Disorder, Complex Partial|seizure disorder, complex partial
487099|NCT01073579|Symptomatic Partial Complex Epilepsy|symptomatic partial complex epilepsy
487100|NCT01073566|Autoimmune Diseases|autoimmune diseases
487101|NCT01073566|Diabetes Mellitus|diabetes mellitus
487102|NCT01073566|Endocrine System Diseases|endocrine system diseases
487103|NCT01073566|Glucose Metabolism Disorders|glucose metabolism disorders
487104|NCT01073566|Immune System Diseases|immune system diseases
487105|NCT01073566|Insulin|insulin
487106|NCT01073566|Metabolic Diseases|metabolic diseases
487107|NCT01073527|Child, preschool|child, preschool
487108|NCT01073527|Pediatric emergency department|pediatric emergency department
487109|NCT01073514|Malignant biliary obstruction (MBO)|malignant biliary obstruction (mbo)
487110|NCT01073501|UREMIC PRURITUS|uremic pruritus
487111|NCT01073501|PREGABALIN|pregabalin
487112|NCT01073501|UP|up
487113|NCT01073488|Pregnancy|pregnancy
487114|NCT01073488|Maternal child health|maternal child health
487115|NCT01073488|Developing countries|developing countries
487116|NCT01073488|Stillbirth|stillbirth
487117|NCT01073488|Neonatal mortality|neonatal mortality
487118|NCT01073488|Maternal mortality|maternal mortality
487119|NCT01073488|Community intervention|community intervention
487120|NCT01073488|Community mobilization|community mobilization
487121|NCT01073488|Home-based Life Saving Skills|home-based life saving skills
487122|NCT01073475|Pregnancy|pregnancy
487123|NCT01073475|Maternal mortality|maternal mortality
487124|NCT01073475|Neonatal mortality|neonatal mortality
487125|NCT01073475|Stillbirth|stillbirth
487126|NCT01073475|Maternal Near Miss|maternal near miss
487127|NCT01073475|Maternal Cause of Death|maternal cause of death
487128|NCT01073475|Neonatal Cause of Death|neonatal cause of death
487129|NCT01073462|Secondary Hyperparathyroidism (sHPT)|secondary hyperparathyroidism (shpt)
487130|NCT01073462|Paricalcitol|paricalcitol
487131|NCT01073462|Chronic kidney disease stage 5 (CKD stage 5)|chronic kidney disease stage 5 (ckd stage 5)
487132|NCT01073449|Cardiac devices|cardiac devices
487133|NCT01073449|In-Hospital Follow-up|in-hospital follow-up
487134|NCT01073449|Analytical|analytical
487135|NCT01073436|diagnosis of Ph+) CML in chronic phase.|diagnosis of ph+) cml in chronic phase.
487136|NCT01073436|prior therapy with interferon-alpha for at least 2 years, and achieved at least a partial cytogenetic response|prior therapy with interferon-alpha for at least 2 years, and achieved at least a partial cytogenetic response
487137|NCT01073436|receiving a TKI (imatinib mesylate, dasatinib, nilotinib)|receiving a tki (imatinib mesylate, dasatinib, nilotinib)
487138|NCT01073436|WBC ≤ 10 x 109/L.|wbc ≤ 10 x 109/l.
487139|NCT01073436|Platelet count < 450,000 x 109/L.|platelet count < 450,000 x 109/l.
487140|NCT01073436|No blasts or promyelocytes in peripheral blood.|no blasts or promyelocytes in peripheral blood.
487141|NCT01073436|No evidence of disease-related symptoms and extramedullary disease|no evidence of disease-related symptoms and extramedullary disease
487142|NCT01073436|complete cytogenetic response (CCyR) on a TKI for a minimum of 1 yr|complete cytogenetic response (ccyr) on a tki for a minimum of 1 yr
487143|NCT01073436|major molecular remission on a TKI for a minimum of 1 yr|major molecular remission on a tki for a minimum of 1 yr
487144|NCT01073436|18 years of age or older|18 years of age or older
487145|NCT01073436|ECOG performance status of 0-2 (Appendix 13.1)|ecog performance status of 0-2 (appendix 13.1)
487146|NCT01073436|Informed Consent|informed consent
487147|NCT01073423|HIV|hiv
487148|NCT01073423|sleep|sleep
487149|NCT01073423|insomnia|insomnia
487150|NCT01073423|yoga|yoga
487151|NCT01073423|music|music
487152|NCT01073397|Menopause|menopause
487153|NCT01073397|Hot Flashes|hot flashes
487154|NCT01073397|Vasomotor symptoms|vasomotor symptoms
487155|NCT01073397|Yoga|yoga
487156|NCT01073371|Liposome|liposome
487157|NCT01073371|Prilocaine|prilocaine
487158|NCT01073371|Dental anesthesia|dental anesthesia
487159|NCT01073358|resectable hepatic metastases of colorectal cancer|resectable hepatic metastases of colorectal cancer
487160|NCT01073345|Patients undergoing elective hepatic resection|patients undergoing elective hepatic resection
487161|NCT01073319|Methamphetamine|methamphetamine
487162|NCT01073319|Rivastigmine|rivastigmine
487163|NCT01073306|Vaccine|vaccine
487164|NCT01073306|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
487165|NCT01073280|Cerebral and subarachnoid biopsy|cerebral and subarachnoid biopsy
487166|NCT01073280|flexible endoscopy|flexible endoscopy
487167|NCT01073280|Patients with neurological findings without diagnosis.|patients with neurological findings without diagnosis.
487168|NCT01073267|Stage IB-IIIA Mycosis fungoides|stage ib-iiia mycosis fungoides
487169|NCT01073267|Total Skin Electron Beam Therapy|total skin electron beam therapy
487170|NCT01073267|TSEBT|tsebt
487171|NCT01073241|benign prostatic hyperplasia|benign prostatic hyperplasia
487172|NCT01073241|Transurethral Resection of Prostate|transurethral resection of prostate
487173|NCT01073241|transurethral enucleation of prostate|transurethral enucleation of prostate
487174|NCT01073228|Alzheimer's disease|alzheimer's disease
487175|NCT01073228|Central Nervous System diseases|central nervous system diseases
487176|NCT01073228|Cognition|cognition
487177|NCT01073215|Adolescents|adolescents
487178|NCT01073215|Obesity|obesity
487179|NCT01073215|Weight Management|weight management
487180|NCT01073215|Family-based Lifestyle Modification|family-based lifestyle modification
487181|NCT01073189|Acute kidney injury|acute kidney injury
487182|NCT01073189|Fenoldopam mesylate|fenoldopam mesylate
487183|NCT01073189|Benephit catheter|benephit catheter
487184|NCT01073176|ADHD|adhd
487185|NCT01073176|Executive function|executive function
487186|NCT01073176|Preschool children|preschool children
487187|NCT01073176|Treatment|treatment
487188|NCT01073176|Memory|memory
487189|NCT01073176|Attention|attention
487190|NCT01073176|Training|training
487191|NCT01073176|Cognitive enhancement|cognitive enhancement
487192|NCT01073150|Tea Tree Oil|tea tree oil
487193|NCT01073150|Chronic Blepharitis|chronic blepharitis
487194|NCT01073137|diabetes|diabetes
487195|NCT01073072|bovine pericardium bioprosthesis|bovine pericardium bioprosthesis
487196|NCT01073072|contamination|contamination
487197|NCT01073072|hernia repair|hernia repair
487198|NCT01073072|abdominal wall reconstruction|abdominal wall reconstruction
487199|NCT01073072|Tutomesh|tutomesh
487200|NCT01073072|Tutopatch|tutopatch
487576|NCT01071538|Late-Life Depression|late-life depression
487201|NCT01073072|Potentially Contaminated Hernia Repair|potentially contaminated hernia repair
487202|NCT01073072|Potentially Contaminated Abdominal Wall Reconstruction|potentially contaminated abdominal wall reconstruction
487203|NCT01073059|valproic acid|valproic acid
487204|NCT01073059|ertapenem|ertapenem
487205|NCT01073046|Naso-Gastric/Jejunal Tube|naso-gastric/jejunal tube
487206|NCT01073046|Sub-total Gastrectomy|sub-total gastrectomy
487207|NCT01073046|Gastric Cancer|gastric cancer
487208|NCT01073046|Decompression|decompression
487209|NCT01073046|Discomfort|discomfort
487210|NCT01073046|Complications|complications
487211|NCT01073033|pregnancy|pregnancy
487212|NCT01073033|lactation|lactation
487213|NCT01073033|oral supplement|oral supplement
487214|NCT01073033|probiotics|probiotics
487215|NCT01073033|early infections|early infections
487216|NCT01073020|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
487217|NCT01073020|Obesity|obesity
487218|NCT01073020|Lifestyle|lifestyle
487219|NCT01073020|Bariatric Surgery|bariatric surgery
487220|NCT01073020|Laparoscopic Adjustable Gastric Band|laparoscopic adjustable gastric band
487221|NCT01073020|Laparoscopic Roux-en-Y Gastric Bypass|laparoscopic roux-en-y gastric bypass
487222|NCT01073007|Acute Stroke|acute stroke
487223|NCT01073007|tissue plasminogen activator|tissue plasminogen activator
487224|NCT01073007|simvastatin|simvastatin
487225|NCT01072994|Myocardium|myocardium
487226|NCT01072994|Phospholipid|phospholipid
487227|NCT01072994|Fish oil|fish oil
487228|NCT01072994|Cardiolipin|cardiolipin
487229|NCT01072994|Transplantation|transplantation
487230|NCT01072981|Pancreatic Cancer|pancreatic cancer
487231|NCT01072981|Vaccine Therapy|vaccine therapy
487232|NCT01072968|Multicenter|multicenter
487233|NCT01072968|Randomized|randomized
487234|NCT01072968|Double-blind|double-blind
487235|NCT01072968|Efficacy and safety study|efficacy and safety study
487236|NCT01072968|BF2.649 versus placebo|bf2.649 versus placebo
487237|NCT01072968|Patients suffering from Obstructive Sleep Apnea|patients suffering from obstructive sleep apnea
487238|NCT01072968|Complaining from Excessive Daytime Sleepiness|complaining from excessive daytime sleepiness
487239|NCT01072968|Refusing nasal Continuous Positive Airway Pressure|refusing nasal continuous positive airway pressure
487240|NCT01072942|Chronic Obstructive|chronic obstructive
487241|NCT01072942|Phase I|phase i
487242|NCT01072942|Pharmacokinetics|pharmacokinetics
487243|NCT01072942|Microbiology|microbiology
487244|NCT01072929|Bipolar I Disorder|bipolar i disorder
487846|NCT01070186|T1b|t1b
487245|NCT01072916|Colon, Irritable|colon, irritable
487246|NCT01072916|Microbiota|microbiota
487247|NCT01072903|inflammation|inflammation
487248|NCT01072903|colon, irritable|colon, irritable
487249|NCT01072903|Colonic Diseases, Functional|colonic diseases, functional
487250|NCT01072903|Irritable Bowel Syndrome|irritable bowel syndrome
487251|NCT01072890|Temsirolimus, Pazopanib|temsirolimus, pazopanib
487252|NCT01072877|Varicose Veins|varicose veins
487253|NCT01072864|Postmenopausal|postmenopausal
487254|NCT01072851|colorectal cancer screening|colorectal cancer screening
487255|NCT01072851|multimedia education|multimedia education
487256|NCT01072851|print education|print education
487257|NCT01072851|culturally competent|culturally competent
487258|NCT01072838|breast cancer|breast cancer
487259|NCT01072838|APBI|apbi
487260|NCT01072838|brachytherapy|brachytherapy
487261|NCT01072838|Contura|contura
487262|NCT01072812|Alzheimer's|alzheimer's
487263|NCT01072812|Amnestic Mild Cognitive Impairment|amnestic mild cognitive impairment
487264|NCT01072812|Pharmacokinetics|pharmacokinetics
487265|NCT01072812|Pharmacodynamics|pharmacodynamics
487266|NCT01072812|Biomarkers|biomarkers
487267|NCT01072799|A (H1N1)|a (h1n1)
487268|NCT01072786|Dengue Virus|dengue virus
487269|NCT01072786|Dengue Fever|dengue fever
487270|NCT01072786|Dengue Vaccine|dengue vaccine
487271|NCT01072786|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
487272|NCT01072786|Dengue Shock Syndrome|dengue shock syndrome
487273|NCT01072760|Mallet finger|mallet finger
487274|NCT01072760|extensor tendon|extensor tendon
487275|NCT01072760|Kirschner wire|kirschner wire
487276|NCT01072760|Fracture Fixation|fracture fixation
487277|NCT01072734|Lupus|lupus
487278|NCT01072734|CXCR4 on leucocytes of patients with SLE|cxcr4 on leucocytes of patients with sle
487279|NCT01072734|Influenza vaccine|influenza vaccine
487280|NCT01072721|Liver|liver
487281|NCT01072721|Fibrosis|fibrosis
487282|NCT01072721|Elastometry|elastometry
487283|NCT01072721|FIBROSCANN|fibroscann
487284|NCT01072721|Children|children
487285|NCT01072708|Cystic fibrosis -diabetes - glucose tolerance - reversibility - oral glucose tolerance test - predictive factors|cystic fibrosis -diabetes - glucose tolerance - reversibility - oral glucose tolerance test - predictive factors
487286|NCT01072695|Hepatitis C|hepatitis c
487287|NCT01072695|HCV|hcv
487288|NCT01072695|GS-9256|gs-9256
487289|NCT01072695|GS-9190|gs-9190
487290|NCT01072695|Genotype 1|genotype 1
487291|NCT01072682|Acute Renal Failure|acute renal failure
487292|NCT01072682|Acute tubular necrosis|acute tubular necrosis
487293|NCT01072682|Continuous Renal Replacement Therapy|continuous renal replacement therapy
487294|NCT01072682|Selective cytopheretic device|selective cytopheretic device
487295|NCT01072669|Ambrisentan increases digital micro-vascular flow (measured by LDPI) in patients with Raynaud's phenomenon (RP) and digital ischemia secondary to SSc.|ambrisentan increases digital micro-vascular flow (measured by ldpi) in patients with raynaud's phenomenon (rp) and digital ischemia secondary to ssc.
487296|NCT01072643|Sedation|sedation
487297|NCT01072643|Pulmonary Hypertension|pulmonary hypertension
487298|NCT01072643|Pediatric|pediatric
487299|NCT01072643|Cardiac Catheterization|cardiac catheterization
487300|NCT01072643|Pulmonary Vascular Resistance|pulmonary vascular resistance
487301|NCT01072630|Bipolar I Disorder|bipolar i disorder
487302|NCT01072604|Aspirin|aspirin
487303|NCT01072604|Acetylsalicylic Acid|acetylsalicylic acid
487304|NCT01072591|anti-NGF|anti-ngf
487305|NCT01072591|OA|oa
487306|NCT01072591|pain|pain
487307|NCT01072578|Healthy volunteers|healthy volunteers
487308|NCT01072578|Inhibition of glucose re-absorption|inhibition of glucose re-absorption
487309|NCT01072578|diabetes|diabetes
487310|NCT01072578|dapagliflozin|dapagliflozin
487311|NCT01072565|Type 2 Diabetes|type 2 diabetes
487312|NCT01072565|A1c|a1c
487313|NCT01072565|Continuous Glucose Monitoring|continuous glucose monitoring
487314|NCT01072565|Blood Glucose|blood glucose
487315|NCT01072552|recurrent wheezing|recurrent wheezing
487316|NCT01072552|asthma|asthma
487317|NCT01072552|preterm infants|preterm infants
487318|NCT01072552|palivizumab|palivizumab
487319|NCT01072552|atopic diseases|atopic diseases
487320|NCT01072539|infection|infection
487321|NCT01072539|Tygacil|tygacil
487322|NCT01072539|PMS|pms
487324|NCT01072526|Lacrimal Apparatus Diseases|lacrimal apparatus diseases
487325|NCT01072513|Semen Analysis, Prostate Cancer, Proton Radiation|semen analysis, prostate cancer, proton radiation
487326|NCT01072500|Aging|aging
487327|NCT01072500|Physical Activity|physical activity
487328|NCT01072500|Exercise|exercise
487329|NCT01072500|Sedentary Lifestyle|sedentary lifestyle
487330|NCT01072500|Mobility|mobility
487331|NCT01072500|Disability|disability
487332|NCT01072500|Falls|falls
487333|NCT01072500|Cost effectiveness|cost effectiveness
487334|NCT01072500|Behavioral counseling|behavioral counseling
487335|NCT01072487|Safety|safety
487336|NCT01072487|Sedation|sedation
487337|NCT01072487|Gastrointestinal endoscopy|gastrointestinal endoscopy
487338|NCT01072487|Colonoscopy|colonoscopy
487339|NCT01072474|Safety|safety
487340|NCT01072474|Sedation|sedation
487341|NCT01072474|Gastrointestinal endoscopy|gastrointestinal endoscopy
487342|NCT01072474|Colonoscopy|colonoscopy
487343|NCT01072461|Cerebrovascular Accident|cerebrovascular accident
487344|NCT01072461|Robotics|robotics
487345|NCT01072461|Virtual Reality|virtual reality
487346|NCT01072461|Rehabilitation|rehabilitation
487347|NCT01072461|Neuroplasticity|neuroplasticity
487348|NCT01072448|COPD|copd
487349|NCT01072448|indacaterol|indacaterol
487350|NCT01072435|ERCP|ercp
487351|NCT01072435|patient-controlled sedation|patient-controlled sedation
487352|NCT01072435|target-controlled infusion|target-controlled infusion
487353|NCT01072435|propofol|propofol
487354|NCT01072435|Sedation with propofol for ERCP|sedation with propofol for ercp
487355|NCT01072435|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
487356|NCT01072422|Smoking|smoking
487357|NCT01072422|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
487358|NCT01072422|Questionnaires|questionnaires
487359|NCT01072422|Nurses|nurses
487360|NCT01072422|Primary Health Care|primary health care
487361|NCT01072409|Speech perception ability in the CI alone condition|speech perception ability in the ci alone condition
487362|NCT01072383|chronic plaque psoriasis|chronic plaque psoriasis
487363|NCT01072383|psoriasis vulgaris|psoriasis vulgaris
487364|NCT01072383|autoimmune disease|autoimmune disease
487365|NCT01072370|Umbilical Cord Blood|umbilical cord blood
487366|NCT01072370|Stem Cells|stem cells
487367|NCT01072370|Autologous Blood Transfusion|autologous blood transfusion
487368|NCT01072370|Cerebral Palsy|cerebral palsy
487369|NCT01072357|High-Risk Corneal Transplantation|high-risk corneal transplantation
487370|NCT01072357|Penetrating Keratoplasty|penetrating keratoplasty
487371|NCT01072357|Neovascularization|neovascularization
487372|NCT01072357|Corneal Blood Vessels|corneal blood vessels
487373|NCT01072357|Avastin|avastin
487374|NCT01072357|Bevacizumab|bevacizumab
487375|NCT01072357|Corneal Graft|corneal graft
487376|NCT01072344|Anxiety|anxiety
487377|NCT01072344|Chamomile|chamomile
487378|NCT01072344|Herbal Remedy|herbal remedy
487379|NCT01072344|Complementary and Alternative Medicine|complementary and alternative medicine
487380|NCT01072331|insulin resistance|insulin resistance
487381|NCT01072318|Breast cancer|breast cancer
487382|NCT01072318|extended adjuvant hormonal therapy|extended adjuvant hormonal therapy
487383|NCT01072318|letrozole|letrozole
487384|NCT01072318|Toremifene|toremifene
487385|NCT01072305|fluid restriction|fluid restriction
487386|NCT01072305|fluid therapy|fluid therapy
487387|NCT01072305|intraoperative care|intraoperative care
487388|NCT01072279|Malnutrition;|malnutrition;
487389|NCT01072279|Infant nutrition;|infant nutrition;
487390|NCT01072279|Fortified food|fortified food
487391|NCT01072279|Linear growth|linear growth
487392|NCT01072279|Cluster randomized controlled trials|cluster randomized controlled trials
487393|NCT01072279|Effectiveness|effectiveness
487394|NCT01072279|Impact evaluation studies|impact evaluation studies
487395|NCT01072279|Burundi|burundi
487396|NCT01072279|Guatemala|guatemala
487397|NCT01072266|Refractory, Advanced malignancies|refractory, advanced malignancies
487398|NCT01072227|Non-typeable Haemophilus Influenzae|non-typeable haemophilus influenzae
487399|NCT01072227|Acute Otitis Media|acute otitis media
487400|NCT01072227|Streptococcus Pneumoniae|streptococcus pneumoniae
487401|NCT01072227|Etiology|etiology
487402|NCT01072214|Pazopanib|pazopanib
487403|NCT01072214|Tolerability|tolerability
487404|NCT01072214|Pharmacokinetics|pharmacokinetics
487405|NCT01072214|GW786034|gw786034
487406|NCT01072214|Safety|safety
487407|NCT01072175|drug-drug interaction|drug-drug interaction
487408|NCT01072175|BRAF inhibitor|braf inhibitor
487409|NCT01072175|expansion cohorts|expansion cohorts
487410|NCT01072175|melanoma|melanoma
487411|NCT01072175|dose escalation|dose escalation
487412|NCT01072175|MEK inhibitor|mek inhibitor
487413|NCT01072162|healthy|healthy
487414|NCT01072162|powder for suspension|powder for suspension
487415|NCT01072162|tablets|tablets
487416|NCT01072162|bioavailibility|bioavailibility
487417|NCT01072162|eltrombopag|eltrombopag
487418|NCT01072149|COPD|copd
487419|NCT01072149|Safety|safety
487420|NCT01072149|FEV1|fev1
487421|NCT01072149|Efficacy|efficacy
487422|NCT01072136|mucopurulent cervicitis, chlamydia, gonorrhea, women|mucopurulent cervicitis, chlamydia, gonorrhea, women
487423|NCT01072110|Patients with diarrhea|patients with diarrhea
487424|NCT01072097|PCOS|pcos
487425|NCT01072097|Atorvastatin|atorvastatin
487426|NCT01072097|Androgens|androgens
487427|NCT01072097|Glucose metabolism|glucose metabolism
487428|NCT01072097|Inflammatory markers|inflammatory markers
487429|NCT01072084|food allergy|food allergy
487430|NCT01072084|confocal laser endoscope|confocal laser endoscope
487431|NCT01072084|diagnosis|diagnosis
487432|NCT01072084|Diagnosis of food allergy|diagnosis of food allergy
487433|NCT01072071|abdominal compartment syndrome|abdominal compartment syndrome
487434|NCT01072071|intra-abdominal pressure|intra-abdominal pressure
487435|NCT01072071|furosemide|furosemide
487436|NCT01072071|fluid balance|fluid balance
487437|NCT01072058|Infliximab|infliximab
487438|NCT01072058|Adalimumab|adalimumab
487439|NCT01072058|Etanercept|etanercept
487440|NCT01072058|Heart failure|heart failure
487441|NCT01072058|Diastolic disfunction|diastolic disfunction
487442|NCT01072058|TNF blocker|tnf blocker
487443|NCT01072058|Anti-TNF|anti-tnf
487444|NCT01072058|Echocardiography|echocardiography
487445|NCT01072058|Tissue doppler imaging|tissue doppler imaging
487446|NCT01072058|Brain Natriuretic Peptide|brain natriuretic peptide
487447|NCT01072058|NT-proBNP|nt-probnp
487448|NCT01072045|Hemangioma|hemangioma
487449|NCT01072045|Proliferative hemangioma|proliferative hemangioma
487450|NCT01072045|Treatment|treatment
487451|NCT01072045|Propranolol|propranolol
487452|NCT01072045|Corticosteroid|corticosteroid
487454|NCT01072032|Robotics (ankle)|robotics (ankle)
487455|NCT01072032|Motor-learning|motor-learning
487456|NCT01072032|Brain Plasticity|brain plasticity
487457|NCT01072006|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
487458|NCT01072006|PTSD|ptsd
487459|NCT01072006|fMRI|fmri
487460|NCT01072006|attention|attention
487461|NCT01071993|prevention|prevention
487462|NCT01071993|nephropathy|nephropathy
487463|NCT01071967|Community Health Nursing|community health nursing
487464|NCT01071967|Nursing Care Management|nursing care management
487465|NCT01071967|Aged|aged
487466|NCT01071967|Aged, 80 and over|aged, 80 and over
487467|NCT01071967|Health Services for the Aged|health services for the aged
487468|NCT01071967|Geriatric Nursing|geriatric nursing
487469|NCT01071967|Geriatric Assessment|geriatric assessment
487470|NCT01071967|Longevity|longevity
487471|NCT01071967|Mortality|mortality
487472|NCT01071954|Immune thrombocytopenic Purpura|immune thrombocytopenic purpura
487473|NCT01071954|Pediatric|pediatric
487474|NCT01071954|Thrombocytopenia|thrombocytopenia
487475|NCT01071941|rRp450|rrp450
487476|NCT01071941|Herpes virus|herpes virus
487477|NCT01071941|Gene therapy|gene therapy
487478|NCT01071928|Advanced Urothelial Carcinoma|advanced urothelial carcinoma
487479|NCT01071902|ear tubes|ear tubes
487480|NCT01071902|ear drainage|ear drainage
487481|NCT01071902|ear infection|ear infection
487482|NCT01071902|ear drops|ear drops
487483|NCT01071902|acute otitis media|acute otitis media
487484|NCT01071889|Healthy Volunteers|healthy volunteers
487485|NCT01071876|Sleep disorder|sleep disorder
487486|NCT01071876|obstructive sleep apnea|obstructive sleep apnea
487487|NCT01071876|excessive daytime sleepiness|excessive daytime sleepiness
487488|NCT01071876|patients with OSA treated by CPAP presenting EDS|patients with osa treated by cpap presenting eds
487489|NCT01071850|ASP1941|asp1941
487490|NCT01071850|Metformin|metformin
487491|NCT01071850|Type 2 diabetes|type 2 diabetes
487492|NCT01071850|diabetes|diabetes
487493|NCT01071837|Glioblastoma Multiforme|glioblastoma multiforme
487494|NCT01071824|size|size
487495|NCT01071824|limb|limb
487496|NCT01071824|transverse coloplasty pouch|transverse coloplasty pouch
487497|NCT01071824|rectal resection|rectal resection
487498|NCT01071824|mesorectal excision|mesorectal excision
487499|NCT01071824|treatment outcome|treatment outcome
487500|NCT01071811|Randomized controlled trial|randomized controlled trial
487501|NCT01071811|Pedometer|pedometer
487502|NCT01071811|Physical activity|physical activity
487503|NCT01071811|Health measurement|health measurement
487504|NCT01071811|Self-rated health|self-rated health
487505|NCT01071811|Stress|stress
487506|NCT01071811|Sleep quality|sleep quality
487507|NCT01071785|Metabolic Syndrome|metabolic syndrome
487508|NCT01071785|diet|diet
487509|NCT01071785|fiber|fiber
487510|NCT01071785|Serum lipids|serum lipids
487511|NCT01071785|Albuminuria|albuminuria
487512|NCT01071759|Pregnancy|pregnancy
487513|NCT01071759|anemia|anemia
487514|NCT01071759|Helicobacter pylori|helicobacter pylori
487515|NCT01071759|Hemoglobin|hemoglobin
487516|NCT01071759|Iron|iron
487517|NCT01071759|Ferritin|ferritin
487518|NCT01071720|Healthy subjects|healthy subjects
487519|NCT01071707|IPF|ipf
487520|NCT01071707|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
487521|NCT01071694|Multiple Sclerosis,|multiple sclerosis,
487522|NCT01071694|Relapsing-Remitting,|relapsing-remitting,
487523|NCT01071694|Interferon beta-1b,|interferon beta-1b,
487524|NCT01071694|Quality of life|quality of life
487525|NCT01071681|Arterial hypertension|arterial hypertension
487526|NCT01071668|onset of labor|onset of labor
487527|NCT01071668|metabolomics|metabolomics
487528|NCT01071668|vaginal secretions|vaginal secretions
487529|NCT01071668|urine|urine
487530|NCT01071668|blood|blood
487531|NCT01071655|colorectal cancer|colorectal cancer
487532|NCT01071655|Bevacizumab|bevacizumab
487533|NCT01071655|Oxaliplatin|oxaliplatin
487534|NCT01071655|Irinotecan|irinotecan
487535|NCT01071655|5FU|5fu
487536|NCT01071655|capecitabine|capecitabine
487537|NCT01071642|Change in eGFR from baseline to 72 hours following the exposure to the contrast.|change in egfr from baseline to 72 hours following the exposure to the contrast.
487538|NCT01071642|Rate of eGFR decrease>25% from the baseline|rate of egfr decrease>25% from the baseline
487539|NCT01071642|Length of hospitalization.|length of hospitalization.
487540|NCT01071642|Requirement of unplanned therapy for elevated blood pressure|requirement of unplanned therapy for elevated blood pressure
487541|NCT01071629|interval training|interval training
487542|NCT01071629|strength training|strength training
487543|NCT01071629|exercise capacity|exercise capacity
487544|NCT01071629|chronic heart failure|chronic heart failure
487545|NCT01071629|Cardiac rehabilitation|cardiac rehabilitation
487546|NCT01071616|Cannabinoids|cannabinoids
487547|NCT01071616|Oral Fluid|oral fluid
487548|NCT01071616|Pharmacokinetics|pharmacokinetics
487549|NCT01071616|Stability|stability
487550|NCT01071616|Smoked Cannabis|smoked cannabis
487551|NCT01071603|Biomarkers|biomarkers
487552|NCT01071603|Extrapulmonary TB|extrapulmonary tb
487553|NCT01071603|NTM|ntm
487554|NCT01071603|HRCT|hrct
487555|NCT01071603|MDRTB|mdrtb
487556|NCT01071603|Tuberculosis|tuberculosis
487557|NCT01071590|Parkinson's Disease|parkinson's disease
487558|NCT01071590|Sensory Input|sensory input
487559|NCT01071590|Gait|gait
487560|NCT01071590|Imagery|imagery
487561|NCT01071590|Parkinson Disease|parkinson disease
487562|NCT01071590|PD|pd
487563|NCT01071577|Bone Marrow Stromal Cells|bone marrow stromal cells
487564|NCT01071577|Mesenchymal Stem Cells|mesenchymal stem cells
487565|NCT01071577|Immune Modulation|immune modulation
487566|NCT01071577|Tissue Regeneration|tissue regeneration
487567|NCT01071577|Bone Marrow|bone marrow
487568|NCT01071577|Healthy Volunteer|healthy volunteer
487569|NCT01071577|HV|hv
487570|NCT01071551|Children|children
487571|NCT01071551|Obesity|obesity
487572|NCT01071551|Lifestyle|lifestyle
487573|NCT01071551|LSES|lses
487574|NCT01071551|Caries|caries
487575|NCT01071538|Depressive Disorder, Major|depressive disorder, major
487577|NCT01071538|Geriatrics|geriatrics
487578|NCT01071538|Buprenorphine|buprenorphine
487579|NCT01071512|MRI|mri
487580|NCT01071512|OCT|oct
487581|NCT01071512|Tysabri|tysabri
487582|NCT01071512|Multiple Sclerosis|multiple sclerosis
487583|NCT01071512|cognition|cognition
487584|NCT01071499|pharmacokinetics|pharmacokinetics
487585|NCT01071499|pharmacogenetics|pharmacogenetics
487586|NCT01071499|morphine|morphine
487587|NCT01071499|children|children
487588|NCT01071486|Busulfan|busulfan
487589|NCT01071486|Glutathione S-transferase|glutathione s-transferase
487590|NCT01071486|Genetic polymorphism|genetic polymorphism
487591|NCT01071486|HVOD|hvod
487592|NCT01071486|GVHD|gvhd
487593|NCT01071473|Childhood cancer|childhood cancer
487594|NCT01071473|Anthracyclines|anthracyclines
487595|NCT01071473|Cardiomyopathy|cardiomyopathy
487596|NCT01071460|PAD|pad
487597|NCT01071447|Rheumatic diseases|rheumatic diseases
487598|NCT01071447|Biologic treatment|biologic treatment
487599|NCT01071447|Nurse-led|nurse-led
487600|NCT01071421|Sleep apnea syndrome|sleep apnea syndrome
487601|NCT01071421|community acquired pneumonia|community acquired pneumonia
487602|NCT01071421|prevalence|prevalence
487603|NCT01071408|chronic care model|chronic care model
487604|NCT01071408|stroke prevention|stroke prevention
487605|NCT01071408|health services research|health services research
487606|NCT01071395|Parkinson's disease|parkinson's disease
487607|NCT01071395|Dyskinesia|dyskinesia
487608|NCT01071395|Dyskinesia Rating Scales|dyskinesia rating scales
487609|NCT01071395|Amantadine|amantadine
487610|NCT01071395|Placebo|placebo
487611|NCT01071382|Aeromedical Evacuation|aeromedical evacuation
487612|NCT01071382|Repatriation|repatriation
487613|NCT01071356|methamphetamine|methamphetamine
487614|NCT01071356|motivational interviewing|motivational interviewing
487615|NCT01071343|muscular atrophy|muscular atrophy
487616|NCT01071343|recovery of function|recovery of function
487617|NCT01071343|rehabilitation|rehabilitation
487618|NCT01071343|Intensive care unit|intensive care unit
487619|NCT01071304|Relapsed or refractory advanced cancer, metastatic cancer, locally advanced cancer|relapsed or refractory advanced cancer, metastatic cancer, locally advanced cancer
487620|NCT01071278|Lipid metabolism disorder|lipid metabolism disorder
487621|NCT01071252|Moderate to severe chronic plaque-type psoriasis|moderate to severe chronic plaque-type psoriasis
487622|NCT01071252|AIN457|ain457
487623|NCT01071252|dermatology|dermatology
487624|NCT01071239|Fanconi Anemia|fanconi anemia
487625|NCT01071239|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
487626|NCT01071226|Malignant and non-malignant diseases|malignant and non-malignant diseases
487627|NCT01071226|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
487628|NCT01071226|Peripheral blood progenitor cell transplant|peripheral blood progenitor cell transplant
487629|NCT01071226|CliniMACS device|clinimacs device
487630|NCT01071226|T cell depletion|t cell depletion
487631|NCT01071200|Reproductive Techniques, Assisted|reproductive techniques, assisted
487632|NCT01071200|Recombinant human follicle stimulating hormone (r-hFSH)|recombinant human follicle stimulating hormone (r-hfsh)
487633|NCT01071200|Recombinant leutinizing hormone (r-hLH)|recombinant leutinizing hormone (r-hlh)
487634|NCT01071187|alcohol dependence|alcohol dependence
487635|NCT01071187|addiction|addiction
487636|NCT01071187|alcohol|alcohol
487637|NCT01071187|relapse prevention|relapse prevention
487638|NCT01071174|HIV infections|hiv infections
487639|NCT01071174|Anti-HIV agents|anti-hiv agents
487640|NCT01071174|HIV-1|hiv-1
487641|NCT01071161|chronic cough|chronic cough
487642|NCT01071161|COPD|copd
487643|NCT01071161|Azithromycin|azithromycin
487644|NCT01071161|Zithromax|zithromax
487645|NCT01071161|LCQ|lcq
487646|NCT01071148|Infertility|infertility
487647|NCT01071148|Gonal-f|gonal-f
487648|NCT01071148|Pergoveris|pergoveris
487649|NCT01071148|Luveris|luveris
487650|NCT01071122|Central blood pressure|central blood pressure
487651|NCT01071122|Nifedipine|nifedipine
487652|NCT01071122|Valsartan|valsartan
487653|NCT01071109|Therapeutic massage|therapeutic massage
487654|NCT01071109|massage|massage
487655|NCT01071109|inflammation|inflammation
487656|NCT01071109|fatigue|fatigue
487657|NCT01071109|insomnia|insomnia
487658|NCT01071109|radiation therapy|radiation therapy
487659|NCT01071109|breast cancer|breast cancer
487660|NCT01071109|Breast Cancer patients receiving radiation therapy|breast cancer patients receiving radiation therapy
487661|NCT01071096|Botox|botox
487662|NCT01071096|OnabotulinumtoxinA|onabotulinumtoxina
487663|NCT01071096|Chronic Migraine|chronic migraine
487664|NCT01071096|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide
487665|NCT01071096|Saliva|saliva
487666|NCT01071083|MS|ms
487667|NCT01071070|Chronic Kidney Disease|chronic kidney disease
487668|NCT01071070|Secondary hyperparathyroidism|secondary hyperparathyroidism
487669|NCT01071057|opioid-induced pruritus|opioid-induced pruritus
487670|NCT01071057|naloxone|naloxone
487671|NCT01071044|Chronic Fatigue Syndrome|chronic fatigue syndrome
487672|NCT01071031|Safety|safety
487673|NCT01071031|Tolerability|tolerability
487674|NCT01071031|Immunogenicity|immunogenicity
487675|NCT01071031|Human Immunodeficiency Virus|human immunodeficiency virus
487676|NCT01071031|HIV-1|hiv-1
487677|NCT01071031|Vaccine|vaccine
487678|NCT01071031|CD4|cd4
487679|NCT01071031|Viral Load|viral load
487680|NCT01071031|HIV|hiv
487681|NCT01071018|locally advanced or metastatic solid tumors|locally advanced or metastatic solid tumors
487682|NCT01071005|Decrease serum levels of luteinizing hormone, FSH and Testosterone|decrease serum levels of luteinizing hormone, fsh and testosterone
487683|NCT01070966|Atherosclerosis|atherosclerosis
487684|NCT01070953|Hypercholesterolemia|hypercholesterolemia
487685|NCT01070940|L-NMMA|l-nmma
487686|NCT01070940|blood pressure|blood pressure
487687|NCT01070940|arterial stiffness|arterial stiffness
487688|NCT01070940|pulse wave velocity|pulse wave velocity
487689|NCT01070940|augmentation index|augmentation index
487690|NCT01070940|dose-response|dose-response
487691|NCT01070940|healthy subjects|healthy subjects
487692|NCT01070940|GFR|gfr
487693|NCT01070914|Cilia|cilia
487694|NCT01070914|Phenotyping|phenotyping
487695|NCT01070914|Diagnosis|diagnosis
487696|NCT01070914|Nitric Oxide|nitric oxide
487697|NCT01070914|Bronchiectasis|bronchiectasis
487698|NCT01070888|Asthma|asthma
487699|NCT01070888|Exercise Induced Asthma|exercise induced asthma
487700|NCT01070875|Antithrombotic prophylaxis|antithrombotic prophylaxis
487701|NCT01070862|multiple myeloma, treatment, first line|multiple myeloma, treatment, first line
487702|NCT01070849|exercise|exercise
487703|NCT01070849|physical activity|physical activity
487704|NCT01070836|JCV|jcv
487705|NCT01070836|Sample Collection|sample collection
487706|NCT01070836|PML|pml
487707|NCT01070836|Antibody|antibody
487708|NCT01070823|Sample Collection|sample collection
487709|NCT01070823|JCV|jcv
487710|NCT01070823|PML|pml
487711|NCT01070810|Septic Shock|septic shock
487712|NCT01070810|Sepsis|sepsis
487713|NCT01070797|Epstein-Barr virus|epstein-barr virus
487714|NCT01070797|CTL|ctl
487715|NCT01070797|cytotoxic T Lymphocytes|cytotoxic t lymphocytes
487716|NCT01070797|CMV|cmv
487717|NCT01070797|Adenovirus Infection|adenovirus infection
487718|NCT01070797|viral infection|viral infection
487719|NCT01070797|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
487720|NCT01070784|Symbicort|symbicort
487721|NCT01070784|Safety|safety
487722|NCT01070784|Efficacy|efficacy
487723|NCT01070784|COPD|copd
487724|NCT01070784|Japanese|japanese
487725|NCT01070771|Pressure wire|pressure wire
487726|NCT01070771|Fractional flow reserve|fractional flow reserve
487727|NCT01070758|Congenital hyperinsulinism|congenital hyperinsulinism
487728|NCT01070758|Somatostatin analog|somatostatin analog
487729|NCT01070758|Lanreotide autogel|lanreotide autogel
487730|NCT01070758|Hypoglycemia|hypoglycemia
487731|NCT01070745|PDA|pda
487732|NCT01070745|Indomethacin|indomethacin
487733|NCT01070745|Ibuprofen|ibuprofen
487734|NCT01070732|Fever|fever
487735|NCT01070732|Infectious diseases|infectious diseases
487736|NCT01070732|Neoplasia|neoplasia
487737|NCT01070732|Pain|pain
487738|NCT01070732|cholecystectomy|cholecystectomy
487739|NCT01070732|Colectomy|colectomy
487740|NCT01070719|Multiple Sclerosis, relapsing forms|multiple sclerosis, relapsing forms
487741|NCT01070706|Patients with HER2- stage II/III breast cancer|patients with her2- stage ii/iii breast cancer
487742|NCT01070693|Inguinal hernia|inguinal hernia
487743|NCT01070693|Open mesh repair|open mesh repair
487744|NCT01070693|Long term outcome|long term outcome
487745|NCT01070693|Recurrence|recurrence
487746|NCT01070693|Discomfort|discomfort
487747|NCT01070680|ERCP|ercp
487748|NCT01070680|dexmedetomidine|dexmedetomidine
487749|NCT01070680|propofol|propofol
487750|NCT01070680|patient-controlled sedation|patient-controlled sedation
487751|NCT01070680|Chronic Alcoholic pancreatitis|chronic alcoholic pancreatitis
487752|NCT01070667|PAF|paf
487753|NCT01070667|AF|af
487754|NCT01070667|Dronedarone|dronedarone
487755|NCT01070667|AF Burden|af burden
487756|NCT01070667|AFB|afb
487757|NCT01070667|PPM|ppm
487758|NCT01070667|Permanent Pacemaker|permanent pacemaker
487759|NCT01070667|Atrial Fibrillation Burden in Paroxysmal Atrial Fibrillation|atrial fibrillation burden in paroxysmal atrial fibrillation
487760|NCT01070654|ARDS|ards
487761|NCT01070654|Recruitment Manoeuvres|recruitment manoeuvres
487762|NCT01070654|PEEP|peep
487763|NCT01070654|Cytokines|cytokines
487764|NCT01070654|Respiratory Insufficiency|respiratory insufficiency
487765|NCT01070641|CARVEDILOL|carvedilol
487766|NCT01070641|VARICEAL BAND LIGATION|variceal band ligation
487767|NCT01070641|PRIMARY PROPHYLAXIS|primary prophylaxis
487768|NCT01070628|Pharmacokinetic|pharmacokinetic
487769|NCT01070602|IFIS|ifis
487770|NCT01070589|Obesity|obesity
487771|NCT01070589|Growth hormone secretion|growth hormone secretion
487772|NCT01070589|Anaerobic exercise|anaerobic exercise
487773|NCT01070576|non union|non union
487774|NCT01070576|fracture|fracture
487775|NCT01070576|healing|healing
487776|NCT01070576|arginine|arginine
487777|NCT01070576|NO|no
487778|NCT01070563|Brain death|brain death
487779|NCT01070563|CT angiography|ct angiography
487780|NCT01070563|Ultrasonography, doppler, transcranial|ultrasonography, doppler, transcranial
487781|NCT01070537|Otolaryngology|otolaryngology
487782|NCT01070537|Equipment and Supplies|equipment and supplies
487783|NCT01070537|Intubation|intubation
487784|NCT01070511|Muscular Dystrophy|muscular dystrophy
487785|NCT01070511|Tadalafil|tadalafil
487786|NCT01070498|peanut hypersensitivity|peanut hypersensitivity
487787|NCT01070498|tree nut hypersensitivity|tree nut hypersensitivity
487788|NCT01070498|allergy|allergy
487789|NCT01070498|Trichuris suis|trichuris suis
487790|NCT01070498|hygiene hypothesis|hygiene hypothesis
487791|NCT01070498|treatment|treatment
487792|NCT01070498|clinical trial|clinical trial
487793|NCT01070498|food/adverse effect|food/adverse effect
487794|NCT01070498|peanut allergy (mild to moderate)|peanut allergy (mild to moderate)
487795|NCT01070498|tree nut allergy (mild to moderate)|tree nut allergy (mild to moderate)
487796|NCT01070472|labor induction at term using a titrated oral misoprostol solution|labor induction at term using a titrated oral misoprostol solution
487797|NCT01070459|Stroke aerobic exercise daily functioning rehabilitation|stroke aerobic exercise daily functioning rehabilitation
487798|NCT01070446|choline|choline
487799|NCT01070446|cystic fibrosis|cystic fibrosis
487800|NCT01070446|methyl metabolism|methyl metabolism
487801|NCT01070446|fatty acids|fatty acids
487802|NCT01070446|oxidative stress|oxidative stress
487803|NCT01070446|pulmonary function|pulmonary function
487804|NCT01070433|Diabetic Foot Ulcers (DFUs)|diabetic foot ulcers (dfus)
487805|NCT01070420|Adenosine|adenosine
487806|NCT01070420|Fractional flow reserve, Hyperemia|fractional flow reserve, hyperemia
487807|NCT01070420|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
487808|NCT01070407|Hepatitis C virus|hepatitis c virus
487809|NCT01070407|HCV|hcv
487810|NCT01070407|Adenovirus|adenovirus
487811|NCT01070407|Vaccine|vaccine
487812|NCT01070394|ADHD|adhd
487813|NCT01070394|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate
487814|NCT01070394|Amphetamine|amphetamine
487815|NCT01070368|skin test|skin test
487816|NCT01070368|open wheat challenge|open wheat challenge
487817|NCT01070355|Colorectal Neoplasms|colorectal neoplasms
487818|NCT01070355|Fish Oils|fish oils
487819|NCT01070355|Fatty Acids, Omega-3|fatty acids, omega-3
487820|NCT01070355|Eicosapentaenoic Acid|eicosapentaenoic acid
487821|NCT01070355|Liver Metastases|liver metastases
487822|NCT01070355|Randomised Controlled Trial|randomised controlled trial
487823|NCT01070316|Epilepsy|epilepsy
487824|NCT01070316|Tuberous Sclerosis Complex|tuberous sclerosis complex
487825|NCT01070316|Everolimus|everolimus
487826|NCT01070316|RAD001|rad001
487827|NCT01070316|Mammalian Target of Rapamycin (MTOR)|mammalian target of rapamycin (mtor)
487828|NCT01070303|HUMIRA|humira
487829|NCT01070303|adalimumab|adalimumab
487830|NCT01070303|Inflammatory Bowel Disease|inflammatory bowel disease
487831|NCT01070290|gastric carcinoma|gastric carcinoma
487832|NCT01070290|Locally Advanced or Metastatic Gastric Cancer|locally advanced or metastatic gastric cancer
487833|NCT01070277|chronic diarrhea|chronic diarrhea
487834|NCT01070277|travelers|travelers
487835|NCT01070277|Parasites|parasites
487836|NCT01070277|albendazole|albendazole
487837|NCT01070277|tinidazole|tinidazole
487838|NCT01070264|Osteoarthritis|osteoarthritis
487839|NCT01070238|Isomaltulose|isomaltulose
487840|NCT01070238|Slow Released Carbohydrates|slow released carbohydrates
487841|NCT01070238|Postprandial Glucose Metabolism|postprandial glucose metabolism
487842|NCT01070238|Type 2 diabetes|type 2 diabetes
487843|NCT01070212|human, chewing, appetite,|human, chewing, appetite,
487844|NCT01070199|obese, liquid, solid, fitness, humans, appetite|obese, liquid, solid, fitness, humans, appetite
487845|NCT01070186|nephrectomy|nephrectomy
487847|NCT01070186|T2|t2
487848|NCT01070186|T3|t3
487849|NCT01070186|T4|t4
487850|NCT01070186|N1|n1
487851|NCT01070186|Kidney Cancer|kidney cancer
487852|NCT01070173|Ghrelin|ghrelin
487853|NCT01070173|short stature|short stature
487854|NCT01070173|failure to thrive|failure to thrive
487855|NCT01070160|Polycystic Ovarian Syndrome (PCOS)|polycystic ovarian syndrome (pcos)
487856|NCT01070160|Metformin|metformin
487857|NCT01070160|Endometrin|endometrin
487858|NCT01070147|asthma|asthma
487859|NCT01070147|emergency medicine|emergency medicine
487860|NCT01070147|medical informatics|medical informatics
487861|NCT01070147|computerized reminder systems|computerized reminder systems
487862|NCT01070121|Rheumatoid Arthritis|rheumatoid arthritis
487863|NCT01070121|RA|ra
487864|NCT01070121|Autoimmune Disease|autoimmune disease
487865|NCT01070121|Muscular Skeletal Disease|muscular skeletal disease
487866|NCT01070108|Preemption, ketamine, escalating, dose, pain, analgesia|preemption, ketamine, escalating, dose, pain, analgesia
487867|NCT01070082|adult ICU patients|adult icu patients
487868|NCT01070082|procedural pain|procedural pain
487869|NCT01070082|pain intensity|pain intensity
487870|NCT01070082|pain distress|pain distress
487871|NCT01070082|pain behaviors|pain behaviors
487872|NCT01070082|pain|pain
487873|NCT01070082|ICU procedures|icu procedures
487874|NCT01070069|Percutaneous|percutaneous
487875|NCT01070069|Preclose|preclose
487876|NCT01070069|Endologix|endologix
487877|NCT01070069|Abbott Vascular|abbott vascular
487878|NCT01070069|Endovascular|endovascular
487879|NCT01070069|PEVAR|pevar
487880|NCT01070069|Stent graft|stent graft
487881|NCT01070069|Suture mediated closure devices|suture mediated closure devices
487882|NCT01070056|Blood Pressure|blood pressure
487883|NCT01070056|Lifestyle Changes|lifestyle changes
487884|NCT01070056|African American|african american
487885|NCT01070043|Hypertension|hypertension
487886|NCT01070043|valsartan|valsartan
487887|NCT01070043|amlodipine|amlodipine
487888|NCT01070043|high blood pressure|high blood pressure
487889|NCT01070030|Stage II Hypertension, Aliskiren, Amlodipine, Hydrochlorothiazide|stage ii hypertension, aliskiren, amlodipine, hydrochlorothiazide
487890|NCT01070017|Peru|peru
487891|NCT01070017|DOT|dot
487892|NCT01070017|HIV|hiv
487893|NCT01070017|AIDS|aids
487894|NCT01070017|Community based|community based
487895|NCT01070017|social capital|social capital
487896|NCT01070004|sleepiness|sleepiness
487897|NCT01070004|driving|driving
487898|NCT01070004|countermeasures|countermeasures
487899|NCT01070004|coffee|coffee
487900|NCT01070004|blue light exposure|blue light exposure
487901|NCT01070004|physical activity|physical activity
487902|NCT01069991|Asthma|asthma
487903|NCT01069991|Adolescents|adolescents
487904|NCT01069991|Patient Education|patient education
487905|NCT01069991|Schools|schools
487906|NCT01069965|Type 2|type 2
487907|NCT01069952|Deep Brain Stimulation|deep brain stimulation
487908|NCT01069952|Treatment Refractory|treatment refractory
487909|NCT01069952|Neurosurgery|neurosurgery
487910|NCT01069952|Implantable Neurostimulator (INS)|implantable neurostimulator (ins)
487911|NCT01069952|Internal Capsule|internal capsule
487912|NCT01069939|Gastric ulcer|gastric ulcer
487913|NCT01069939|Duodenal ulcer|duodenal ulcer
487914|NCT01069939|Low-dose aspirin|low-dose aspirin
487915|NCT01069926|Diabetes|diabetes
487916|NCT01069913|Healthy Volunteer|healthy volunteer
487917|NCT01069900|Intra-abdominal infection|intra-abdominal infection
487918|NCT01069900|Pediatric infection|pediatric infection
487919|NCT01069887|febrile events|febrile events
487920|NCT01069887|invasive fungal infections|invasive fungal infections
487921|NCT01069887|hematological patients|hematological patients
487922|NCT01069874|Bone Density Conservation Agents|bone density conservation agents
487923|NCT01069874|Cholecalciferol|cholecalciferol
487924|NCT01069874|Communicable Diseases|communicable diseases
487925|NCT01069874|Growth Substances|growth substances
487926|NCT01069874|Housing for the Elderly|housing for the elderly
487927|NCT01069874|Infection|infection
487928|NCT01069874|Micronutrients|micronutrients
487929|NCT01069874|Pharmacologic Actions|pharmacologic actions
487930|NCT01069874|Physiological Effects of Drugs|physiological effects of drugs
487931|NCT01069874|Respiratory Tract Diseases|respiratory tract diseases
487932|NCT01069874|Vitamins|vitamins
487933|NCT01069874|Respiratory Tract Infections/prevention & control*|respiratory tract infections/prevention & control*
487934|NCT01069874|Vitamin D|vitamin d
487935|NCT01069861|PPHN|pphn
487936|NCT01069861|neonates|neonates
487937|NCT01069861|sildanefil IV|sildanefil iv
487938|NCT01069835|Non small cell lung cancer|non small cell lung cancer
487939|NCT01069835|EGFR mutation|egfr mutation
487940|NCT01069835|NSCLC|nsclc
487941|NCT01069822|Midazolam|midazolam
487942|NCT01069822|Pharmacokinetics|pharmacokinetics
487943|NCT01069796|triple negative|triple negative
487944|NCT01069796|metastatic|metastatic
487945|NCT01069796|breast cancer|breast cancer
487946|NCT01069796|First line chemotherapy|first line chemotherapy
487947|NCT01069783|dyslipidemia|dyslipidemia
487948|NCT01069783|cholesterol|cholesterol
487949|NCT01069783|LDL|ldl
487950|NCT01069770|Neoadjuvant Therapy|neoadjuvant therapy
487951|NCT01069770|Sunitinib|sunitinib
487952|NCT01069770|Clear Cell Renal Cell Carcinoma|clear cell renal cell carcinoma
487953|NCT01069770|Metastasis|metastasis
487954|NCT01069757|Advanced/recurrent non-small-cell lung cancer|advanced/recurrent non-small-cell lung cancer
487955|NCT01069705|Tobramycin Inhalation Powder|tobramycin inhalation powder
487956|NCT01069705|Cystic fibrosis|cystic fibrosis
487957|NCT01069705|Lung diseases|lung diseases
487958|NCT01069705|Anti-Bacterial Agents|anti-bacterial agents
487959|NCT01069705|Treatment of pulmonary infections with P. aeruginosa in cystic fibrosis patients|treatment of pulmonary infections with p. aeruginosa in cystic fibrosis patients
487960|NCT01069692|Chronic Kidney Disease|chronic kidney disease
487961|NCT01069692|Hemodialysis|hemodialysis
487962|NCT01069692|Hyperphosphatemia|hyperphosphatemia
487963|NCT01069692|Hyperphosphatemia patients with chronic kidney disease on 3x/week hemodialysis|hyperphosphatemia patients with chronic kidney disease on 3x/week hemodialysis
487964|NCT01069666|atopic dermatitis|atopic dermatitis
487965|NCT01069666|Thai pediatricians|thai pediatricians
487967|NCT01069653|KIF20A|kif20a
487968|NCT01069653|lung cancer|lung cancer
487969|NCT01069653|vaccine|vaccine
487970|NCT01069653|HLA-A*2402|hla-a*2402
487971|NCT01069640|URLC10|urlc10
487972|NCT01069640|lung cancer|lung cancer
487973|NCT01069640|vaccine|vaccine
487974|NCT01069640|HLA-A*0201|hla-a*0201
487975|NCT01069640|HLA-A*0206|hla-a*0206
487976|NCT01069614|Equipment and supplies|equipment and supplies
487977|NCT01069601|solid organ transplantation|solid organ transplantation
487978|NCT01069601|bone marrow transplantation|bone marrow transplantation
487979|NCT01069601|adults|adults
487980|NCT01069601|adults with solid organ transplantation|adults with solid organ transplantation
487981|NCT01069601|adults with bone marrow transplantation|adults with bone marrow transplantation
487982|NCT01069588|bioabsorbable screw|bioabsorbable screw
487983|NCT01069588|acl reconstruction|acl reconstruction
487984|NCT01069575|URLC10|urlc10
487985|NCT01069575|CDCA1|cdca1
487986|NCT01069575|KIF20A|kif20a
487987|NCT01069575|lung cancer|lung cancer
487988|NCT01069575|vaccine|vaccine
487989|NCT01069575|HLA-A*2402|hla-a*2402
487990|NCT01069562|closed loop control of anesthesia|closed loop control of anesthesia
487991|NCT01069562|isoflurane|isoflurane
487992|NCT01069562|open heart surgery|open heart surgery
487993|NCT01069549|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
487994|NCT01069549|Diabetic Nephropathy|diabetic nephropathy
487995|NCT01069549|Angiotensin II type 1 receptor gene polymorphism|angiotensin ii type 1 receptor gene polymorphism
487996|NCT01069549|Acetyl coA carboxylase beta gene polymorphism.|acetyl coa carboxylase beta gene polymorphism.
487997|NCT01069536|metoclopramide|metoclopramide
487998|NCT01069536|akathisia|akathisia
487999|NCT01069536|nausea|nausea
488000|NCT01069536|vomiting|vomiting
488001|NCT01069536|antiemetic|antiemetic
488002|NCT01069536|improvement of nausea|improvement of nausea
488003|NCT01069523|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
488004|NCT01069523|Guanfacine|guanfacine
488005|NCT01069523|Event Related Potentials|event related potentials
488006|NCT01069497|Infection control|infection control
488007|NCT01069497|Urinary Tract Infections|urinary tract infections
488008|NCT01069497|Respiratory Tract Infections|respiratory tract infections
488009|NCT01069484|Randomized controlled trial|randomized controlled trial
488010|NCT01069484|Post partum pelvic floor muscle training|post partum pelvic floor muscle training
488011|NCT01069484|Urinary incontinence|urinary incontinence
488012|NCT01069484|Pelvic floor dysfunction|pelvic floor dysfunction
488013|NCT01069484|Pelvic floor muscle injury|pelvic floor muscle injury
488014|NCT01069484|Pelvic floor muscle strength|pelvic floor muscle strength
488015|NCT01069484|Pelvic floor muscle morphology|pelvic floor muscle morphology
488016|NCT01069471|S.dysenteriae|s.dysenteriae
488017|NCT01069471|Healthy volunteers|healthy volunteers
488018|NCT01069471|Conjugate vaccine|conjugate vaccine
488019|NCT01069471|Safety|safety
488020|NCT01069471|Immunogenicity|immunogenicity
488021|NCT01069471|Dose scaling|dose scaling
488022|NCT01069458|Dietary intervention|dietary intervention
488023|NCT01069458|Smoking cessation|smoking cessation
488024|NCT01069458|Body weight|body weight
488025|NCT01069445|diet|diet
488026|NCT01069445|probiotics|probiotics
488027|NCT01069445|inflammaging|inflammaging
488028|NCT01069445|oxidative stress|oxidative stress
488029|NCT01069445|gut microbiota|gut microbiota
488030|NCT01069445|food complements|food complements
488031|NCT01069432|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
488032|NCT01069432|CLL|cll
488033|NCT01069432|Normal Volunteers|normal volunteers
488034|NCT01069419|Certolizumab Pegol|certolizumab pegol
488035|NCT01069419|Cimzia|cimzia
488036|NCT01069406|notch|notch
488037|NCT01069406|uterine|uterine
488038|NCT01069406|first|first
488039|NCT01069406|bleeding|bleeding
488040|NCT01069380|resting metabolic rate|resting metabolic rate
488041|NCT01069380|bed ridden, vegetative|bed ridden, vegetative
488042|NCT01069380|low conscious|low conscious
488043|NCT01069380|minimal conscious state|minimal conscious state
488044|NCT01069380|immobilized|immobilized
488045|NCT01069380|resting energy expenditure|resting energy expenditure
488046|NCT01069367|Influenza A|influenza a
488047|NCT01069367|H1N1 subtype|h1n1 subtype
488048|NCT01069367|Children/adolescent|children/adolescent
488049|NCT01069367|Vaccine|vaccine
488050|NCT01069367|Adjuvant|adjuvant
488051|NCT01069367|Cell culture|cell culture
488052|NCT01069354|Moderate to severe wrinkles and folds such as nasolabial folds|moderate to severe wrinkles and folds such as nasolabial folds
488053|NCT01069341|Rubeosis|rubeosis
488054|NCT01069341|Neovascularization of iris|neovascularization of iris
488055|NCT01069341|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
488056|NCT01069341|PDR|pdr
488057|NCT01069341|Cataract|cataract
488058|NCT01069328|Lung|lung
488059|NCT01069328|cancer|cancer
488060|NCT01069328|NSCLC|nsclc
488061|NCT01069315|open wound|open wound
488062|NCT01069315|solution|solution
488063|NCT01069315|pressure|pressure
488064|NCT01069315|randomized|randomized
488065|NCT01069302|Coronary artery disease|coronary artery disease
488066|NCT01069289|Symbicort|symbicort
488067|NCT01069289|Oxis|oxis
488068|NCT01069289|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
488069|NCT01069289|COPD|copd
488070|NCT01069289|Efficacy|efficacy
488071|NCT01069276|Stroke|stroke
488072|NCT01069276|prehospital ultrasound|prehospital ultrasound
488073|NCT01069263|Interstitial cystitis|interstitial cystitis
488074|NCT01069263|Painful bladder syndrome|painful bladder syndrome
488075|NCT01069263|Chronic pelvic pain|chronic pelvic pain
488076|NCT01069263|DMSO|dmso
488077|NCT01069263|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
488078|NCT01069250|dynamic cerebrovascular autoregulation|dynamic cerebrovascular autoregulation
488079|NCT01069250|static cerebrovascular autoregulation|static cerebrovascular autoregulation
488080|NCT01069250|acute brain injury|acute brain injury
488081|NCT01069250|transcranial Doppler ultrasound|transcranial doppler ultrasound
488082|NCT01069250|critical care|critical care
488083|NCT01069237|contact lens wear|contact lens wear
488084|NCT01069237|multi-purpose solution|multi-purpose solution
488085|NCT01069237|corneal staining|corneal staining
488086|NCT01069224|rotator cuff|rotator cuff
488087|NCT01069224|synovial fluid|synovial fluid
488088|NCT01069224|proinflammatory cytokines|proinflammatory cytokines
488089|NCT01069211|Breast cancer, Letrozole|breast cancer, letrozole
488090|NCT01069211|postmenopause|postmenopause
488091|NCT01069211|hormone receptor positive breast cancer|hormone receptor positive breast cancer
488092|NCT01069198|Visceral leishmaniasis|visceral leishmaniasis
488093|NCT01069198|Kala-azar|kala-azar
488094|NCT01069198|Bangladesh|bangladesh
488095|NCT01069198|Malnutrition|malnutrition
488096|NCT01069198|Asymptomatic|asymptomatic
488097|NCT01069198|Albendazole|albendazole
488098|NCT01069198|Iron|iron
488099|NCT01069198|Zinc|zinc
488100|NCT01069198|Vitamin A|vitamin a
488101|NCT01069185|Unplanned extubation|unplanned extubation
488102|NCT01069185|Length of stay in PICU|length of stay in picu
488103|NCT01069185|Length of mechanical ventilation|length of mechanical ventilation
488104|NCT01069172|Cataract|cataract
488105|NCT01069172|Surgery, cataract extraction|surgery, cataract extraction
488106|NCT01069172|Optical devices, laser|optical devices, laser
488107|NCT01069159|Traumatic memory|traumatic memory
488108|NCT01069159|Traumatic memories|traumatic memories
488109|NCT01069159|Traumatic memories and associated symptoms|traumatic memories and associated symptoms
488110|NCT01069159|Posttraumatic Stress Disorder|posttraumatic stress disorder
488111|NCT01069159|PTSD|ptsd
488112|NCT01069146|sepsis,|sepsis,
488113|NCT01069146|septic shock,|septic shock,
488114|NCT01069146|therapeutic hypothermia|therapeutic hypothermia
488115|NCT01069133|minimal hepatic encephalopathy|minimal hepatic encephalopathy
488116|NCT01069133|cirrhosis|cirrhosis
488117|NCT01069133|complications|complications
488118|NCT01069120|Uterine Fibroids|uterine fibroids
488119|NCT01069107|community hospital|community hospital
488120|NCT01069107|alternative acute admissions|alternative acute admissions
488121|NCT01069094|Uterine fibroids|uterine fibroids
488122|NCT01069081|Metastasis Breast Cancer|metastasis breast cancer
488123|NCT01069081|Proton Pump Inhibitor|proton pump inhibitor
488124|NCT01069081|Chemotherapy|chemotherapy
488125|NCT01069081|Phase II study|phase ii study
488127|NCT01069068|To evaluate the effect of advancing Jaw on airway dimension|to evaluate the effect of advancing jaw on airway dimension
488128|NCT01069055|inguinal hernia|inguinal hernia
488129|NCT01069055|surgery|surgery
488130|NCT01069055|general anesthesia|general anesthesia
488131|NCT01069055|analgesia|analgesia
488132|NCT01069055|pre-emptive|pre-emptive
488133|NCT01069055|SF36|sf36
488134|NCT01069042|Rho kinase activity|rho kinase activity
488135|NCT01069042|Heart failure|heart failure
488136|NCT01069042|ACE inhibitor|ace inhibitor
488137|NCT01069042|LVEF change|lvef change
488138|NCT01069042|Rho kinase activity change|rho kinase activity change
488139|NCT01069029|Macular Hole|macular hole
488140|NCT01069029|Cataract surgery|cataract surgery
488141|NCT01069029|Vitreoretinal surgery|vitreoretinal surgery
488142|NCT01069029|Combined surgery|combined surgery
488143|NCT01069029|Idiopathic|idiopathic
488144|NCT01069016|Fecal Incontinence|fecal incontinence
488145|NCT01069016|Colorectal surgery|colorectal surgery
488146|NCT01069016|Sacral nerve stimulation|sacral nerve stimulation
488147|NCT01069016|Pudendal nerve stimulation|pudendal nerve stimulation
488148|NCT01069003|Heart Disease|heart disease
488149|NCT01069003|Cardiovascular Disease|cardiovascular disease
488150|NCT01069003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
488151|NCT01069003|Dual Antiplatelet Therapy|dual antiplatelet therapy
488152|NCT01069003|Clopidogrel|clopidogrel
488153|NCT01069003|Prasugrel|prasugrel
488154|NCT01069003|Vascular Disease|vascular disease
488155|NCT01069003|Myocardial Ischemia|myocardial ischemia
488156|NCT01068990|pneumonia|pneumonia
488157|NCT01068951|type 1 diabetes|type 1 diabetes
488158|NCT01068951|mesenchymal stem cells|mesenchymal stem cells
488159|NCT01068951|intervention|intervention
488160|NCT01068938|visual field|visual field
488161|NCT01068938|perimetry|perimetry
488162|NCT01068938|glaucoma progression|glaucoma progression
488163|NCT01068938|grid|grid
488164|NCT01068938|POAG and glaucoma suspects with prostaglandin monotherapy|poag and glaucoma suspects with prostaglandin monotherapy
488165|NCT01068925|healthy volunteer|healthy volunteer
488166|NCT01068925|pharmacokinetics|pharmacokinetics
488167|NCT01068925|HIV, GSK1349572, tipranavir, ritonavir, drug interaction|hiv, gsk1349572, tipranavir, ritonavir, drug interaction
488168|NCT01068912|Influenza|influenza
488169|NCT01068899|healthy adults|healthy adults
488170|NCT01068899|healthy children|healthy children
488171|NCT01068886|Pancreaticoduodenectomy|pancreaticoduodenectomy
488172|NCT01068873|HIV|hiv
488173|NCT01068873|Protease Inhibitor|protease inhibitor
488174|NCT01068873|CCR5 Co-receptor Antagonist|ccr5 co-receptor antagonist
488175|NCT01068873|treatment naive|treatment naive
488176|NCT01068860|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
488177|NCT01068860|canakinumab|canakinumab
488178|NCT01068860|Pre diabetic|pre diabetic
488179|NCT01068860|glucose intolerant|glucose intolerant
488180|NCT01068860|oral anti diabetic medication|oral anti diabetic medication
488181|NCT01068860|insulin treatment|insulin treatment
488182|NCT01068860|metabolic syndrome|metabolic syndrome
488183|NCT01068847|Opioid dependence|opioid dependence
488184|NCT01068847|methadone|methadone
488185|NCT01068847|opioid|opioid
488186|NCT01068834|Adherence|adherence
488187|NCT01068834|Statins|statins
488188|NCT01068834|Kinesin-like protein 6|kinesin-like protein 6
488189|NCT01068821|Slide|slide
488190|NCT01068821|Trendelenburg's position|trendelenburg's position
488191|NCT01068821|Postoperative|postoperative
488192|NCT01068821|neurologic complaints|neurologic complaints
488193|NCT01068808|Nonallergic rhinitis|nonallergic rhinitis
488194|NCT01068808|Allergic rhinitis|allergic rhinitis
488195|NCT01068808|Development|development
488196|NCT01068795|placental syndrome|placental syndrome
488197|NCT01068795|maternal thromboembolic event|maternal thromboembolic event
488198|NCT01068795|enoxaparin|enoxaparin
488199|NCT01068795|anti-factor Xa|anti-factor xa
488200|NCT01068782|Glioblastoma|glioblastoma
488201|NCT01068782|Glioma|glioma
488202|NCT01068782|Brain Cancer|brain cancer
488203|NCT01068782|Brain Tumor|brain tumor
488204|NCT01068782|Astrocytoma|astrocytoma
488205|NCT01068769|regorafenib|regorafenib
488206|NCT01068769|GIST|gist
488207|NCT01068691|aortic dissection|aortic dissection
488208|NCT01068691|ambulatory blood pressure|ambulatory blood pressure
488209|NCT01068691|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
488210|NCT01068691|patients undergoing surgery for a dissection of the thoracic aorta|patients undergoing surgery for a dissection of the thoracic aorta
488211|NCT01068613|COPD|copd
488212|NCT01068613|Long acting muscarinic antagonist|long acting muscarinic antagonist
488213|NCT01068600|COPD|copd
488214|NCT01068600|Indacaterol|indacaterol
488215|NCT01068587|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
488216|NCT01068587|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
488217|NCT01068587|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
488218|NCT01068587|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
488219|NCT01068574|Acute illnesses in children under five|acute illnesses in children under five
488220|NCT01068561|Retinitis pigmentosa|retinitis pigmentosa
488221|NCT01068561|stem cell|stem cell
488222|NCT01068561|bone marrow|bone marrow
488223|NCT01068535|metabolic syndrome|metabolic syndrome
488224|NCT01068535|MetS|mets
488225|NCT01068535|premenopausal women|premenopausal women
488226|NCT01068535|vascular risk|vascular risk
488227|NCT01068535|atherosclerosis detection|atherosclerosis detection
488228|NCT01068522|Intracranial pressure|intracranial pressure
488229|NCT01068522|Intracranial pressure monitoring|intracranial pressure monitoring
488230|NCT01068522|Head injury|head injury
488231|NCT01068509|Cvac|cvac
488232|NCT01068483|Advanced solid tumors|advanced solid tumors
488233|NCT01068483|Breast Cancer|breast cancer
488234|NCT01068483|Colon Cancer|colon cancer
488235|NCT01068483|Ovarian Cancer|ovarian cancer
488236|NCT01068483|Endometrium cancer|endometrium cancer
488237|NCT01068470|Interleukin-2|interleukin-2
488238|NCT01068470|Melanoma|melanoma
488239|NCT01068470|Kidney Cancer|kidney cancer
488240|NCT01068470|Lymphokine Activated Killer cells|lymphokine activated killer cells
488241|NCT01068457|persistent pain|persistent pain
488242|NCT01068457|neuropathic pain|neuropathic pain
488243|NCT01068457|Thoracic Surgery, Video Assisted|thoracic surgery, video assisted
488244|NCT01068457|Chronic Pain|chronic pain
488245|NCT01068444|NASH|nash
488246|NCT01068444|Pioglitazone|pioglitazone
488247|NCT01068444|Treatment|treatment
488248|NCT01068431|lymphedema|lymphedema
488249|NCT01068431|conservative treatment|conservative treatment
488250|NCT01068431|compression therapy|compression therapy
488251|NCT01068431|interface pressure|interface pressure
488252|NCT01068418|Obesity|obesity
488253|NCT01068418|Renin Angiotensin System|renin angiotensin system
488254|NCT01068418|Vitamin D deficiency|vitamin d deficiency
488255|NCT01068418|Hypertension|hypertension
488256|NCT01068392|relapsed|relapsed
488257|NCT01068392|marginal zone B-cell lymphoma|marginal zone b-cell lymphoma
488258|NCT01068392|oxaliplatin|oxaliplatin
488259|NCT01068392|prednisolone|prednisolone
488260|NCT01068379|rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
488261|NCT01068379|cryopexy|cryopexy
488262|NCT01068379|photocoagulation|photocoagulation
488263|NCT01068366|Nickel Allergic Syndrome|nickel allergic syndrome
488264|NCT01068366|Septal Closure Devices|septal closure devices
488265|NCT01068353|Alzheimer's disease|alzheimer's disease
488266|NCT01068353|Dementia|dementia
488267|NCT01068353|TNF-alpha|tnf-alpha
488268|NCT01068353|Etanercept|etanercept
488269|NCT01068340|Adhesions|adhesions
488270|NCT01068340|Small Bowel Obstruction|small bowel obstruction
488271|NCT01068340|Ileus|ileus
488272|NCT01068314|Endothelium|endothelium
488273|NCT01068314|Vasodilatation|vasodilatation
488274|NCT01068314|Vein|vein
488275|NCT01068314|Compliance|compliance
488276|NCT01068314|Arteriovenous shunt, surgical|arteriovenous shunt, surgical
488277|NCT01068301|Allogeneic Stem Cell transplantation|allogeneic stem cell transplantation
488278|NCT01068301|Plerixafor|plerixafor
488279|NCT01068301|Acute Lymphoblastic leukemia|acute lymphoblastic leukemia
488280|NCT01068301|Acute Myeloid leukemia|acute myeloid leukemia
488281|NCT01068301|Chronic Myeloid leukemia|chronic myeloid leukemia
488282|NCT01068301|Myelodysplastic Syndrome|myelodysplastic syndrome
488283|NCT01068301|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
488284|NCT01068301|Other Leukemia|other leukemia
488285|NCT01068288|laparoscopic appendectomy|laparoscopic appendectomy
488286|NCT01068288|open appendectomy|open appendectomy
488287|NCT01068288|expectant management|expectant management
488288|NCT01068288|paediatric|paediatric
488289|NCT01068275|anterior cruciate ligament|anterior cruciate ligament
488290|NCT01068275|pain, postoperative|pain, postoperative
488291|NCT01068275|peripheral nerve catheter|peripheral nerve catheter
488292|NCT01068275|nerve block|nerve block
488293|NCT01068275|Children undergoing anterior cruciate ligament repair|children undergoing anterior cruciate ligament repair
488294|NCT01068249|Advanced|advanced
488295|NCT01068249|Recurrent|recurrent
488296|NCT01068249|Progressive|progressive
488297|NCT01068249|Endometrial Cancer|endometrial cancer
488298|NCT01068249|Letrozole|letrozole
488299|NCT01068249|RAD001|rad001
488300|NCT01068249|Afinitor|afinitor
488301|NCT01068249|Everolimus|everolimus
488302|NCT01068249|Femara|femara
488303|NCT01068236|Teen girls|teen girls
488304|NCT01068236|weightloss|weightloss
488305|NCT01068236|healthy lifestyle|healthy lifestyle
488306|NCT01068236|yoga|yoga
488307|NCT01068236|Weight loss and healthy lifestyle|weight loss and healthy lifestyle
488308|NCT01068223|Cetirizine, CR016609|cetirizine, cr016609
488309|NCT01068210|Exercise Intervention|exercise intervention
488310|NCT01068210|Lung Cancer|lung cancer
488311|NCT01068210|15-215|15-215
488312|NCT01068197|Low Glycemic Load diet|low glycemic load diet
488313|NCT01068197|Low Glycemic Index diet|low glycemic index diet
488314|NCT01068197|Low Fat diet|low fat diet
488315|NCT01068197|Obese Hispanic American children and adolescents|obese hispanic american children and adolescents
488316|NCT01068197|At risk for type 2 diabetes mellitus|at risk for type 2 diabetes mellitus
488317|NCT01068184|AZD6553|azd6553
488318|NCT01068184|Chronic|chronic
488319|NCT01068184|obstructive|obstructive
488320|NCT01068184|pulmonary|pulmonary
488321|NCT01068184|lung|lung
488322|NCT01068184|respiratory disease|respiratory disease
488323|NCT01068184|placebo-controlled|placebo-controlled
488324|NCT01068184|COPD|copd
488325|NCT01068184|Healthy Volunteers|healthy volunteers
488326|NCT01068184|COPD Patients|copd patients
488327|NCT01068171|diabetes|diabetes
488328|NCT01068171|foot ulcers|foot ulcers
488329|NCT01068171|off-loading|off-loading
488330|NCT01068171|collagen|collagen
488331|NCT01068171|Wagner 1|wagner 1
488332|NCT01068158|Head lice infestation|head lice infestation
488333|NCT01068158|Pediculus humanus capitis|pediculus humanus capitis
488334|NCT01068145|COPD|copd
488335|NCT01068132|Colorectal Neoplasms|colorectal neoplasms
488336|NCT01068132|KRAS|kras
488337|NCT01068132|PTEN|pten
488338|NCT01068119|Acute coronary syndrome|acute coronary syndrome
488339|NCT01068119|percutaneous coronary angioplasty|percutaneous coronary angioplasty
488340|NCT01068119|Troponin negative|troponin negative
488341|NCT01068119|cardiac|cardiac
488342|NCT01068080|fatty acid metabolism|fatty acid metabolism
488343|NCT01068080|insulin resistance|insulin resistance
488344|NCT01068080|cardiac death|cardiac death
488345|NCT01068080|hemodialysis|hemodialysis
488346|NCT01068080|normal coronary arteries|normal coronary arteries
488347|NCT01068080|Predictive values of impaired myocardial fatty acid metabolism or insulin resistance for cardiac death of hemodialysis patients with normal coronary arteries|predictive values of impaired myocardial fatty acid metabolism or insulin resistance for cardiac death of hemodialysis patients with normal coronary arteries
488348|NCT01068054|vernal keratoconjunctivitis|vernal keratoconjunctivitis
488349|NCT01068054|FK-506|fk-506
488350|NCT01068054|tacrolimus|tacrolimus
488351|NCT01068054|cyclosporine|cyclosporine
488352|NCT01068054|children|children
488353|NCT01068028|Healthy volunteer study|healthy volunteer study
488354|NCT01068015|MSM|msm
488355|NCT01068015|Intervention|intervention
488356|NCT01068015|Popular Opinion Leader|popular opinion leader
488357|NCT01068015|Male Circumcision|male circumcision
488358|NCT01068015|HIV|hiv
488359|NCT01068015|Syphilis|syphilis
488360|NCT01068015|HSV-2|hsv-2
488361|NCT01068002|Hypertension Pregnancy|hypertension pregnancy
488362|NCT01067989|metronomic chemotherapy|metronomic chemotherapy
488363|NCT01067989|anti-angiogenic effect|anti-angiogenic effect
488364|NCT01067989|Breast cancer|breast cancer
488365|NCT01067976|Breast Cancer|breast cancer
488366|NCT01067976|Gadobutrol-enhanced MRI|gadobutrol-enhanced mri
488367|NCT01067976|Mammography|mammography
488368|NCT01067963|self-care|self-care
488369|NCT01067963|self-management|self-management
488370|NCT01067963|health behavior change|health behavior change
488371|NCT01067963|motivational interviewing|motivational interviewing
488372|NCT01067963|computer assisted learning|computer assisted learning
488373|NCT01067950|isolated pancreas transplant|isolated pancreas transplant
488374|NCT01067950|intensive insulin therapy|intensive insulin therapy
488375|NCT01067937|Appendicitis|appendicitis
488376|NCT01067937|children|children
488377|NCT01067924|Type 2 diabetes, motivational interviewing, physical activity maintenance, physical activity adherence|type 2 diabetes, motivational interviewing, physical activity maintenance, physical activity adherence
488378|NCT01067911|Postprandial lipids|postprandial lipids
488379|NCT01067911|test meal|test meal
488380|NCT01067911|fatty acids|fatty acids
488381|NCT01067898|vitamin D supplementation|vitamin d supplementation
488382|NCT01067898|cholecalciferol|cholecalciferol
488383|NCT01067898|PTH|pth
488384|NCT01067898|bone turnover markers|bone turnover markers
488385|NCT01067898|elderly women|elderly women
488386|NCT01067885|Nitinol Stent|nitinol stent
488387|NCT01067885|Superficial femoral artery|superficial femoral artery
488388|NCT01067885|SFA|sfa
488389|NCT01067885|Angioplasty|angioplasty
488390|NCT01067885|peripheral artery disease|peripheral artery disease
488391|NCT01067885|peripheral artery obstructive disease|peripheral artery obstructive disease
488392|NCT01067885|PAOD|paod
488393|NCT01067885|PAD|pad
488394|NCT01067885|Peripheral Vascular Disease|peripheral vascular disease
488395|NCT01067859|Heart Failure|heart failure
488396|NCT01067846|cocaine dependence|cocaine dependence
488397|NCT01067846|relapse prevention|relapse prevention
488398|NCT01067846|computerized cognitive behavioral therapy (CBT)|computerized cognitive behavioral therapy (cbt)
488399|NCT01067846|D-cycloserine (DCS)|d-cycloserine (dcs)
488400|NCT01067833|atrial fibrillation|atrial fibrillation
488401|NCT01067833|AF|af
488402|NCT01067820|ApolipoproteinA1|apolipoproteina1
488403|NCT01067820|HDL-C|hdl-c
488404|NCT01067820|Atherosclerosis|atherosclerosis
488405|NCT01067807|Pharmacokinetics|pharmacokinetics
488406|NCT01067794|Metastatic|metastatic
488407|NCT01067794|Advanced|advanced
488408|NCT01067794|Stage IIIB-IV|stage iiib-iv
488409|NCT01067794|daily|daily
488410|NCT01067794|hospital|hospital
488411|NCT01067794|practice|practice
488412|NCT01067794|setting|setting
488413|NCT01067781|Prevention of Travelers' Diarrhea|prevention of travelers' diarrhea
488414|NCT01067768|Urinary Tract Infections|urinary tract infections
488415|NCT01067768|Catheter-associated urinary tract infections|catheter-associated urinary tract infections
488416|NCT01067768|Prevention and control|prevention and control
488417|NCT01067768|Controlled clinical trial|controlled clinical trial
488418|NCT01067755|navigation|navigation
488419|NCT01067755|bronchoscopy|bronchoscopy
488420|NCT01067755|lymphadenopathy|lymphadenopathy
488421|NCT01067742|Mucolipidosis, retinal dystrophy, mucolipin-1,|mucolipidosis, retinal dystrophy, mucolipin-1,
488422|NCT01067742|lysosomal storage disease, gastrin, mental retardation,|lysosomal storage disease, gastrin, mental retardation,
488423|NCT01067742|dysmyelination, dysplastic corpus callosum,corneal clouding|dysmyelination, dysplastic corpus callosum,corneal clouding
488424|NCT01067729|Burn|burn
488425|NCT01067729|Superficial burns|superficial burns
488426|NCT01067729|Partial thickness burns|partial thickness burns
488427|NCT01067729|Rate of healing|rate of healing
488428|NCT01067729|Infection rate|infection rate
488429|NCT01067729|Pain perception|pain perception
488430|NCT01067729|Non adherence|non adherence
488431|NCT01067729|Scarring|scarring
488432|NCT01067703|remote ischaemic preconditioning, cardiac surgery|remote ischaemic preconditioning, cardiac surgery
488433|NCT01067690|classical Kaposi's sarcoma|classical kaposi's sarcoma
488434|NCT01067690|chemotherapy|chemotherapy
488435|NCT01067690|indinavir|indinavir
488436|NCT01067690|HIV protease inhibitor|hiv protease inhibitor
488437|NCT01067690|Advanced classical (non HIV-associated) Kaposi's sarcoma|advanced classical (non hiv-associated) kaposi's sarcoma
488438|NCT01067677|PONV|ponv
488439|NCT01067677|Post operative nausea and vomiting|post operative nausea and vomiting
488440|NCT01067677|rescue emetic therapy|rescue emetic therapy
488441|NCT01067599|Biomarkers of tobacco exposure|biomarkers of tobacco exposure
488442|NCT01067599|Smokeless Tobacco|smokeless tobacco
488443|NCT01067586|Smokeless Tobacco|smokeless tobacco
488444|NCT01067586|Biomarkers of tobacco exposure|biomarkers of tobacco exposure
488445|NCT01067573|MS|ms
488446|NCT01067573|Serum Leptin Levels during relapse|serum leptin levels during relapse
488447|NCT01067573|Multiple sclerosis|multiple sclerosis
488448|NCT01067573|relapse|relapse
488449|NCT01067560|Glucose|glucose
488450|NCT01067560|CSF|csf
488451|NCT01067560|Cesarean section, spinal anesthesia|cesarean section, spinal anesthesia
488452|NCT01067560|Nova Stat Strip|nova stat strip
488453|NCT01067560|Abbott Precision Xtra|abbott precision xtra
488454|NCT01067560|Roche Accucheck Inform 2|roche accucheck inform 2
488455|NCT01067547|Iron deficiency|iron deficiency
488456|NCT01067547|Inflammatory Bowel Disease|inflammatory bowel disease
488457|NCT01067547|Crohn's Disease|crohn's disease
488458|NCT01067547|Ulcerative colitis|ulcerative colitis
488459|NCT01067521|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
488460|NCT01067521|Glatiramer Acetate|glatiramer acetate
488461|NCT01067495|stroke|stroke
488462|NCT01067495|rehabilitation|rehabilitation
488463|NCT01067495|exercise|exercise
488464|NCT01067495|walking|walking
488465|NCT01067495|risk factors|risk factors
488466|NCT01067482|OCT|oct
488467|NCT01067482|spectral domain cirrus|spectral domain cirrus
488468|NCT01067482|glaucoma|glaucoma
488469|NCT01067482|glaucoma suspect|glaucoma suspect
488470|NCT01067482|normal population|normal population
488471|NCT01067469|CNS|cns
488472|NCT01067469|Central Nervous System|central nervous system
488473|NCT01067469|malignant brain tumor|malignant brain tumor
488474|NCT01067469|Recurrent Glioblastoma Multiforme|recurrent glioblastoma multiforme
488475|NCT01067469|GBM|gbm
488476|NCT01067469|Bevacizumab|bevacizumab
488477|NCT01067469|Lomustine|lomustine
488478|NCT01067469|CCNU|ccnu
488479|NCT01067443|Phase II|phase ii
488480|NCT01067443|Randomised clinical trial|randomised clinical trial
488481|NCT01067443|Visceral Leishmaniasis|visceral leishmaniasis
488482|NCT01067430|Rheumatoid Arthritis|rheumatoid arthritis
488483|NCT01067430|Etoricoxib|etoricoxib
488484|NCT01067430|Diclofenac|diclofenac
488485|NCT01067430|Pain|pain
488486|NCT01067430|Stiffness|stiffness
488487|NCT01067417|Hydroxychloroquine|hydroxychloroquine
488488|NCT01067417|Chloroquine|chloroquine
488489|NCT01067417|HIV Infection|hiv infection
488490|NCT01067417|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
488491|NCT01067417|Immune Activation|immune activation
488492|NCT01067417|inflammation|inflammation
488493|NCT01067417|treatment naive|treatment naive
488494|NCT01067417|disease progression|disease progression
488495|NCT01067404|Influenza vaccines|influenza vaccines
488496|NCT01067404|Infant|infant
488497|NCT01067404|Dose-Response relationship, immunologic|dose-response relationship, immunologic
488498|NCT01067391|Hypotension in SCI males|hypotension in sci males
488499|NCT01067391|Erectile Dysfunction|erectile dysfunction
488500|NCT01067378|Interdisciplinary Health Team|interdisciplinary health team
488501|NCT01067378|Training|training
488502|NCT01067365|Secondary Hypogonadism|secondary hypogonadism
488503|NCT01067352|Infant, small for gestational age|infant, small for gestational age
488504|NCT01067352|Growth hormone|growth hormone
488505|NCT01067352|Saizen|saizen
488506|NCT01067339|coronary endothelial dysfunction|coronary endothelial dysfunction
488507|NCT01067339|coronary vasospasm|coronary vasospasm
488508|NCT01067326|Endothelial Dysfunction|endothelial dysfunction
488509|NCT01067326|Endothelial Function|endothelial function
488510|NCT01067326|Tekturna|tekturna
488511|NCT01067326|Endothelial Peripheral Arterial Tomography (EndoPAT)|endothelial peripheral arterial tomography (endopat)
488512|NCT01067326|Progenitor Cells|progenitor cells
488513|NCT01067326|renin inhibition|renin inhibition
488514|NCT01067326|endothelial progenitor cells|endothelial progenitor cells
488515|NCT01067326|early atherosclerosis|early atherosclerosis
488516|NCT01067313|Intensive Care Unit|intensive care unit
488517|NCT01067313|continuous hemodialysis|continuous hemodialysis
488518|NCT01067313|continuous hemofiltration|continuous hemofiltration
488519|NCT01067313|High Cut-off membrane|high cut-off membrane
488520|NCT01067313|"Enhanced middle molecule clearance membrane"|"enhanced middle molecule clearance membrane"
488521|NCT01067313|Septic shock|septic shock
488522|NCT01067313|Acute kidney injury|acute kidney injury
488523|NCT01067313|Blood purification|blood purification
488524|NCT01067313|Renal replacement therapy|renal replacement therapy
488525|NCT01067300|young|young
488526|NCT01067300|acute leukemia in remission|acute leukemia in remission
488527|NCT01067300|Children or young adults (< 35 years) with acute leukemia in remission|children or young adults (< 35 years) with acute leukemia in remission
488528|NCT01067287|dendritic cell fusion vaccine|dendritic cell fusion vaccine
488529|NCT01067287|CT-011|ct-011
488530|NCT01067287|autologous stem cell transplant|autologous stem cell transplant
488531|NCT01067274|Acute Myeloid Leukemia|acute myeloid leukemia
488532|NCT01067274|Aged of 65 to 79 years|aged of 65 to 79 years
488533|NCT01067274|Older Patients with Acute Myeloblastic Leukemia|older patients with acute myeloblastic leukemia
488534|NCT01067261|Nerve stimulation|nerve stimulation
488535|NCT01067261|TMNS|tmns
488536|NCT01067261|Prostatectomy|prostatectomy
488537|NCT01067261|Prevention|prevention
488538|NCT01067261|Restoration|restoration
488539|NCT01067261|Treatment|treatment
488540|NCT01067261|Vibration|vibration
488541|NCT01067261|Non-invasive|non-invasive
488542|NCT01067248|COPD|copd
488543|NCT01067248|Osteoporosis|osteoporosis
488544|NCT01067248|Pathophysiology|pathophysiology
488545|NCT01067248|Mechanism|mechanism
488546|NCT01067248|Bone markers|bone markers
488547|NCT01067248|Bone turnover|bone turnover
488548|NCT01067248|Protein turnover|protein turnover
488549|NCT01067248|Ageing|ageing
488550|NCT01067248|Endocrinology|endocrinology
488551|NCT01067248|Vitamin D|vitamin d
488552|NCT01067235|Narcolespy|narcolespy
488553|NCT01067235|Cataplexy|cataplexy
488554|NCT01067235|Excesssive daytime Sleepiness|excesssive daytime sleepiness
488555|NCT01067235|Sleep Disorders|sleep disorders
488556|NCT01067235|Sleep attacks|sleep attacks
488557|NCT01067235|Orphan Drug|orphan drug
488558|NCT01067235|Pitolisant|pitolisant
488559|NCT01067222|Narcolepsy|narcolepsy
488560|NCT01067222|Excessive daytime Sleepiness|excessive daytime sleepiness
488561|NCT01067222|Cataplexy|cataplexy
488562|NCT01067222|Sleep Disorders|sleep disorders
488563|NCT01067222|Sleep attacks|sleep attacks
488564|NCT01067222|Orphan Drug|orphan drug
488565|NCT01067222|Pitolisant|pitolisant
488692|NCT01066624|Multiple myeloma|multiple myeloma
488566|NCT01067209|Reversal of Obesity-related and Diabetic Cardiomyopathy|reversal of obesity-related and diabetic cardiomyopathy
488567|NCT01067196|Proton Radiation|proton radiation
488568|NCT01067196|Central Nervous System Tumors|central nervous system tumors
488569|NCT01067196|Brain|brain
488570|NCT01067196|Spine|spine
488571|NCT01067196|Cancer|cancer
488572|NCT01067183|stress reduction|stress reduction
488573|NCT01067183|physician wellness|physician wellness
488574|NCT01067170|Hemodialysis|hemodialysis
488575|NCT01067170|Intradialytic hypotension|intradialytic hypotension
488576|NCT01067157|Obesity|obesity
488577|NCT01067157|overweight|overweight
488578|NCT01067157|childhood|childhood
488579|NCT01067157|adolescence|adolescence
488580|NCT01067157|inpatient therapy|inpatient therapy
488581|NCT01067157|lifestyle intervention|lifestyle intervention
488582|NCT01067157|cardiovascular risk|cardiovascular risk
488583|NCT01067157|gene-lifestyle-interaction|gene-lifestyle-interaction
488584|NCT01067157|Obesity and associated cardiovascular risk in childhood and adolescence,|obesity and associated cardiovascular risk in childhood and adolescence,
488585|NCT01067157|health behaviour|health behaviour
488586|NCT01067131|Candida albicans|candida albicans
488587|NCT01067131|Fungal vaginal infection|fungal vaginal infection
488588|NCT01067131|Vulvovaginal candidiasis|vulvovaginal candidiasis
488589|NCT01067131|Candidose|candidose
488590|NCT01067131|Vaccine|vaccine
488591|NCT01067131|Virosome|virosome
488592|NCT01067105|Perennial allergic rhinitis|perennial allergic rhinitis
488593|NCT01067105|allergic rhinitis|allergic rhinitis
488594|NCT01067105|ciclesonide|ciclesonide
488595|NCT01067079|Rabies vaccine|rabies vaccine
488596|NCT01067079|Long-term Immunogenicity|long-term immunogenicity
488597|NCT01067066|TPI 287|tpi 287
488598|NCT01067066|microtubule inhibitor|microtubule inhibitor
488599|NCT01067066|Temozolomide|temozolomide
488600|NCT01067066|Temodar|temodar
488601|NCT01067066|cytotoxic agent|cytotoxic agent
488602|NCT01067066|unresectable Stage III|unresectable stage iii
488603|NCT01067066|Stage IV|stage iv
488604|NCT01067066|Metastatic Melanoma|metastatic melanoma
488605|NCT01067053|Bevacizumab|bevacizumab
488606|NCT01067053|Capecitabine|capecitabine
488607|NCT01067053|Oxaliplatin|oxaliplatin
488608|NCT01067053|Metastatic colorectal cancer|metastatic colorectal cancer
488609|NCT01067027|Colic|colic
488610|NCT01067027|Colic in Breast-fed Infants|colic in breast-fed infants
488611|NCT01067014|Lumbar spinal stenosis|lumbar spinal stenosis
488612|NCT01067014|Decompression|decompression
488613|NCT01067014|Lumbar spinal decompression|lumbar spinal decompression
488614|NCT01067014|Lumbar spinal decompressive surgery|lumbar spinal decompressive surgery
488615|NCT01066988|lipid layer thickness|lipid layer thickness
488616|NCT01066975|loaded backpack|loaded backpack
488617|NCT01066975|unloaded backpack|unloaded backpack
488618|NCT01066962|HIV-infected antiretroviral naïve subjects|hiv-infected antiretroviral naïve subjects
488619|NCT01066949|hemodialysis|hemodialysis
488726|NCT01066494|sAML|saml
488620|NCT01066949|behavior change|behavior change
488621|NCT01066949|patient adherence|patient adherence
488622|NCT01066949|self management|self management
488623|NCT01066923|firefighter|firefighter
488624|NCT01066923|heat stress|heat stress
488625|NCT01066923|platelet activation|platelet activation
488626|NCT01066923|aspirin|aspirin
488627|NCT01066910|Obesity|obesity
488628|NCT01066910|Childhood Obesity|childhood obesity
488629|NCT01066910|Exercise|exercise
488630|NCT01066910|Nutrition|nutrition
488631|NCT01066871|Knee cartilage injury|knee cartilage injury
488632|NCT01066871|fibroblast growth factor 18|fibroblast growth factor 18
488633|NCT01066871|FGF18|fgf18
488634|NCT01066858|tenofovir|tenofovir
488635|NCT01066858|renal and bone toxicity|renal and bone toxicity
488636|NCT01066858|pregnancy|pregnancy
488637|NCT01066858|breastfeeding|breastfeeding
488638|NCT01066858|mother to child transmission|mother to child transmission
488639|NCT01066832|Drug-eluting balloon|drug-eluting balloon
488640|NCT01066832|Paclitaxel|paclitaxel
488641|NCT01066832|DIOR|dior
488642|NCT01066832|short term registry|short term registry
488643|NCT01066832|Valentines Trial|valentines trial
488644|NCT01066832|Drug-eluting balloon treatment of in-stent restenosis|drug-eluting balloon treatment of in-stent restenosis
488645|NCT01066780|cochlear implant|cochlear implant
488646|NCT01066780|adults|adults
488647|NCT01066780|HiResolution|hiresolution
488648|NCT01066780|Fidelity 120|fidelity 120
488649|NCT01066780|listening benefits|listening benefits
488650|NCT01066780|noise|noise
488651|NCT01066780|cochlear implant benefit|cochlear implant benefit
488652|NCT01066741|Epidermoid carcinoma|epidermoid carcinoma
488653|NCT01066741|Hypopharynx|hypopharynx
488654|NCT01066741|Oropharynx|oropharynx
488655|NCT01066741|Oral cavity|oral cavity
488656|NCT01066741|Oral mucosa|oral mucosa
488657|NCT01066741|Cavum|cavum
488658|NCT01066741|Severe Oral mucositis|severe oral mucositis
488659|NCT01066741|Radiotherapy|radiotherapy
488660|NCT01066741|Phytotherapy|phytotherapy
488661|NCT01066728|apnea|apnea
488662|NCT01066728|premature|premature
488663|NCT01066728|infant|infant
488664|NCT01066728|prematurity|prematurity
488665|NCT01066715|Diabetes|diabetes
488666|NCT01066715|Type 2|type 2
488667|NCT01066715|Mellitus|mellitus
488668|NCT01066689|kidney transplantation, acute humoral rejection, rituximab|kidney transplantation, acute humoral rejection, rituximab
488669|NCT01066663|CLL|cll
488670|NCT01066663|SLL|sll
488671|NCT01066663|relapsed|relapsed
488672|NCT01066663|pyrimethamine|pyrimethamine
488673|NCT01066650|TWENTE|twente
488674|NCT01066650|randomized study|randomized study
488675|NCT01066650|stent|stent
488676|NCT01066650|coronary stent|coronary stent
488677|NCT01066650|drug-eluting stent|drug-eluting stent
488678|NCT01066650|Zotarolimus|zotarolimus
488679|NCT01066650|Everolimus|everolimus
488680|NCT01066650|Xience V|xience v
488681|NCT01066650|Endeavor Resolute|endeavor resolute
488682|NCT01066650|head to head comparison|head to head comparison
488683|NCT01066650|real world patients|real world patients
488684|NCT01066650|target vessel failure|target vessel failure
488685|NCT01066650|investigator initiated study|investigator initiated study
488686|NCT01066650|coronary artery disease|coronary artery disease
488687|NCT01066650|coronary arteries|coronary arteries
488688|NCT01066650|atherosclerosis|atherosclerosis
488689|NCT01066650|non inferiority|non inferiority
488690|NCT01066637|Heart transplant patients|heart transplant patients
488691|NCT01066624|Mucositis|mucositis
488693|NCT01066624|Autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
488694|NCT01066611|Allergic Rhinitis|allergic rhinitis
488695|NCT01066611|Allergy|allergy
488696|NCT01066611|Phosphatidylinositol 3-kinase|phosphatidylinositol 3-kinase
488697|NCT01066598|graft versus host disease|graft versus host disease
488698|NCT01066598|chronic graft versus host disease|chronic graft versus host disease
488699|NCT01066598|cGVHD|cgvhd
488700|NCT01066585|Head lice|head lice
488701|NCT01066585|Pediculus humanus capitis|pediculus humanus capitis
488702|NCT01066546|Delirium|delirium
488703|NCT01066546|Dementia|dementia
488704|NCT01066546|Amnestic|amnestic
488705|NCT01066546|Cognitive Disorders|cognitive disorders
488706|NCT01066546|Mental Disorders|mental disorders
488707|NCT01066546|Nervous System Diseases|nervous system diseases
488708|NCT01066546|Central Nervous System Diseases|central nervous system diseases
488710|NCT01066533|NEC|nec
488711|NCT01066533|Immunohistochemistry|immunohistochemistry
488712|NCT01066533|fibronectin|fibronectin
488713|NCT01066533|tenascin|tenascin
488714|NCT01066520|ankle sprain|ankle sprain
488715|NCT01066520|traumeel|traumeel
488716|NCT01066520|diclofenac|diclofenac
488717|NCT01066520|antiinflammatory|antiinflammatory
488718|NCT01066520|time to normal function|time to normal function
488719|NCT01066507|Her2|her2
488720|NCT01066507|FISH|fish
488721|NCT01066507|Breast cancer|breast cancer
488722|NCT01066507|Amplification|amplification
488723|NCT01066494|AML|aml
488724|NCT01066494|Pgp|pgp
488725|NCT01066494|MDR|mdr
488727|NCT01066494|AS1413|as1413
488728|NCT01066494|Amonafide|amonafide
488729|NCT01066481|Alzheimer's disease|alzheimer's disease
488730|NCT01066481|clinical trial|clinical trial
488731|NCT01066481|memory loss|memory loss
488732|NCT01066481|investigational drug|investigational drug
488733|NCT01066481|neurodegenerative disease|neurodegenerative disease
488734|NCT01066481|dementia|dementia
488735|NCT01066468|Chronic myeloid leukemia|chronic myeloid leukemia
488736|NCT01066468|CML|cml
488737|NCT01066468|Philadelphia chromosome positive|philadelphia chromosome positive
488738|NCT01066468|acute lymphoblastic leukemia|acute lymphoblastic leukemia
488739|NCT01066468|PhGlivec,|phglivec,
488740|NCT01066468|Gleevec,|gleevec,
488741|NCT01066468|hypereosinophilic syndrome,|hypereosinophilic syndrome,
488742|NCT01066468|HES,|hes,
488743|NCT01066468|chronic eosinophilic leukemia,|chronic eosinophilic leukemia,
488744|NCT01066468|CEL,|cel,
488745|NCT01066468|myelodysplastic syndrome,|myelodysplastic syndrome,
488746|NCT01066468|MDS,|mds,
488747|NCT01066468|myeloproliferative disease,|myeloproliferative disease,
488748|NCT01066468|MPD+ ALL|mpd+ all
488749|NCT01066455|Cardiac|cardiac
488750|NCT01066455|Muscular Dystrophy|muscular dystrophy
488751|NCT01066455|Prospective|prospective
488752|NCT01066455|Pediatric|pediatric
488753|NCT01066455|Echocardiogram|echocardiogram
488754|NCT01066442|Excessive Daytime Sleepiness (EDS)|excessive daytime sleepiness (eds)
488755|NCT01066442|Parkinson's Disease|parkinson's disease
488756|NCT01066429|poor-prognosis diffuse large B-cell lymphoma|poor-prognosis diffuse large b-cell lymphoma
488757|NCT01066429|dose-adjusted|dose-adjusted
488758|NCT01066429|R-EDOCH-14|r-edoch-14
488759|NCT01066429|rituximab|rituximab
488760|NCT01066429|age-adjusted IPI|age-adjusted ipi
488761|NCT01066429|toxicity|toxicity
488762|NCT01066403|schizophrenia|schizophrenia
488763|NCT01066403|cognitive deficits|cognitive deficits
488764|NCT01066403|dopamine|dopamine
488765|NCT01066403|dopamine agonists|dopamine agonists
488766|NCT01066403|prefrontal cortex|prefrontal cortex
488767|NCT01066403|D1 specific modulation|d1 specific modulation
488768|NCT01066403|pergolide|pergolide
488769|NCT01066403|executive control|executive control
488770|NCT01066403|working memory|working memory
488771|NCT01066403|Influence of pergolide on cognition in Schizophrenia|influence of pergolide on cognition in schizophrenia
488772|NCT01066403|D1-specific modulation of prefrontal functions|d1-specific modulation of prefrontal functions
488773|NCT01066403|Influence of pergolide on psychopathology and depression|influence of pergolide on psychopathology and depression
488774|NCT01066403|Influence of pergolide on extrapyramidal symptoms|influence of pergolide on extrapyramidal symptoms
488775|NCT01066390|stage IIIC/IV melanoma|stage iiic/iv melanoma
488776|NCT01066377|prebiotic|prebiotic
488777|NCT01066377|probiotic|probiotic
488778|NCT01066377|influenza|influenza
488779|NCT01066377|vaccination|vaccination
488780|NCT01066377|ageing|ageing
488781|NCT01066377|immunosenescence|immunosenescence
488782|NCT01066364|NASH|nash
488783|NCT01066364|NAFLD|nafld
488784|NCT01066364|Steatohepatitis|steatohepatitis
488785|NCT01066364|Nonalcoholic|nonalcoholic
488786|NCT01066364|Fatty Liver Disease|fatty liver disease
488787|NCT01066351|acute kidney injury|acute kidney injury
488788|NCT01066351|erythropoietin|erythropoietin
488789|NCT01066351|cardiac surgery|cardiac surgery
488790|NCT01066338|SNP array|snp array
488791|NCT01066338|prognosis|prognosis
488792|NCT01066338|acute myeloid leukemia|acute myeloid leukemia
488793|NCT01066338|normal karyotype|normal karyotype
488794|NCT01066338|acute myeloid leukemia with normal karyotype|acute myeloid leukemia with normal karyotype
488795|NCT01066325|Sit-n-Reach Test|sit-n-reach test
488796|NCT01066325|Flexibility|flexibility
488797|NCT01066325|Hamstring|hamstring
488798|NCT01066325|Mindbody|mindbody
488799|NCT01066325|Complementary and Alternative Medicine|complementary and alternative medicine
488800|NCT01066325|Neuro Emotional Technique (NET)|neuro emotional technique (net)
488801|NCT01066312|Muscle testing|muscle testing
488802|NCT01066312|Kinesiology|kinesiology
488803|NCT01066312|Muscles|muscles
488804|NCT01066312|Complementary and Alternative Medicine|complementary and alternative medicine
488805|NCT01066312|Practitioner Experience|practitioner experience
488806|NCT01066312|This study is actually not a randomised controlled trial,|this study is actually not a randomised controlled trial,
488807|NCT01066312|but an assessment of diagnostic test accuracy. We will be|but an assessment of diagnostic test accuracy. we will be
488808|NCT01066312|looking at the accuracy of MMT to distinguish congruent from|looking at the accuracy of mmt to distinguish congruent from
488809|NCT01066312|incongruent statements under varying levels of blinding.|incongruent statements under varying levels of blinding.
488810|NCT01066299|oxytocin|oxytocin
488811|NCT01066299|psychophysiology|psychophysiology
488812|NCT01066299|startle|startle
488813|NCT01066299|anxiety|anxiety
488814|NCT01066299|emotion|emotion
488815|NCT01066299|physiology|physiology
488816|NCT01066286|genome wide SNP-array|genome wide snp-array
488817|NCT01066286|micro-cytogenetic lesion|micro-cytogenetic lesion
488818|NCT01066286|KIT mutation|kit mutation
488819|NCT01066286|core binding factor|core binding factor
488820|NCT01066286|acute myeloid leukemia|acute myeloid leukemia
488821|NCT01066286|The Approval status was changed from Pending to Approved.|the approval status was changed from pending to approved.
488822|NCT01066260|Probiotics|probiotics
488823|NCT01066260|Energy balance|energy balance
488824|NCT01066247|spinal anesthesia|spinal anesthesia
488825|NCT01066247|heart rate variability|heart rate variability
488826|NCT01066247|premedication|premedication
488827|NCT01066247|heart rate|heart rate
488828|NCT01066247|blood pressure|blood pressure
488829|NCT01066234|Microscopic N2 Non-small Cell Lung Cancer|microscopic n2 non-small cell lung cancer
488830|NCT01066234|Paclitaxel|paclitaxel
488831|NCT01066234|Carboplatin|carboplatin
488832|NCT01066234|Cisplatin|cisplatin
488833|NCT01066221|clostridium difficile|clostridium difficile
488834|NCT01066208|Classification criteria|classification criteria
488835|NCT01066208|Diagnostic criteria|diagnostic criteria
488836|NCT01066195|Non-Small Cell Lung Cancer|non-small cell lung cancer
488837|NCT01066195|Never-Smoker and Adenocarcinoma patients|never-smoker and adenocarcinoma patients
488838|NCT01066195|Pemetrexed (ALIMTA)|pemetrexed (alimta)
488839|NCT01066195|Gefitinib (IRESSA®)|gefitinib (iressa®)
488840|NCT01066182|DHA|dha
488841|NCT01066182|Learning|learning
488842|NCT01066182|Reading|reading
488843|NCT01066182|Memory|memory
488844|NCT01066182|Children|children
488845|NCT01066182|Omega 3|omega 3
488846|NCT01066182|Education|education
488847|NCT01066182|Learning and behaviour in children|learning and behaviour in children
488848|NCT01066169|Pandemic Influenza A/H1N1|pandemic influenza a/h1n1
488849|NCT01066169|HIV|hiv
488850|NCT01066169|Antibodies|antibodies
488851|NCT01066169|Replicaton|replicaton
488852|NCT01066156|Post-traumatic Stress Disorder|post-traumatic stress disorder
488853|NCT01066156|PTSD|ptsd
488854|NCT01066156|Seroquel|seroquel
488855|NCT01066156|fMRI|fmri
488856|NCT01066143|Seroquel|seroquel
488857|NCT01066143|Generalized Anxiety Disorder|generalized anxiety disorder
488858|NCT01066143|fMRI|fmri
488859|NCT01066130|Diabetes Mellitus|diabetes mellitus
488860|NCT01066130|Arthritis, Rheumatoid|arthritis, rheumatoid
488861|NCT01066130|psychosocial aspects|psychosocial aspects
488862|NCT01066130|Patient Adherence|patient adherence
488863|NCT01066130|Social Work|social work
488864|NCT01066130|Coping Behavior|coping behavior
488865|NCT01066130|Coping Skills|coping skills
488866|NCT01066130|Adaptation, Psychological|adaptation, psychological
488867|NCT01066117|urinary incontinent|urinary incontinent
488868|NCT01066091|Inflammatory response|inflammatory response
488869|NCT01066091|High-fat meal|high-fat meal
488870|NCT01066091|cytokines|cytokines
488871|NCT01066091|Body composition|body composition
488872|NCT01066078|heart failure - congestive|heart failure - congestive
488873|NCT01066078|Cardiovascular imaging agents/Techniques]|cardiovascular imaging agents/techniques]
488874|NCT01066078|Echocardiography|echocardiography
488875|NCT01066078|Other diagnostic testing|other diagnostic testing
488876|NCT01066078|Other Treatment|other treatment
488877|NCT01066078|Recipients of cardiac resynchronization therapy systems|recipients of cardiac resynchronization therapy systems
488878|NCT01066065|cardiovascular disease|cardiovascular disease
488879|NCT01066065|HIV|hiv
488880|NCT01066065|metabolic disorder|metabolic disorder
488881|NCT01066065|HIV naive patients initiating HAART with Raltegravir or boosted Darunavir|hiv naive patients initiating haart with raltegravir or boosted darunavir
488882|NCT01066052|Growth hormone|growth hormone
488883|NCT01066052|Turner syndrome|turner syndrome
488884|NCT01066052|r-hGH|r-hgh
488885|NCT01066052|early treatment|early treatment
488886|NCT01066039|Bisoprolol|bisoprolol
488887|NCT01066039|Hypertension|hypertension
488888|NCT01066039|Diabetes mellitus, Type II|diabetes mellitus, type ii
488889|NCT01066039|Blood pressure|blood pressure
488890|NCT01066039|Glycemic level|glycemic level
488891|NCT01066026|metallic cannula|metallic cannula
488892|NCT01066026|Hyaluronic acid|hyaluronic acid
488893|NCT01066013|Antimicrobial De escalation|antimicrobial de escalation
488894|NCT01066013|Meropenem|meropenem
488895|NCT01066013|Piperacillin tazobactam|piperacillin tazobactam
488896|NCT01066013|Medical patients|medical patients
488897|NCT01066013|Appropriate use|appropriate use
488898|NCT01066013|Cost savings|cost savings
488899|NCT01066013|Antimicrobial De-escalation strategy|antimicrobial de-escalation strategy
488900|NCT01065974|Nutritional Intake|nutritional intake
488901|NCT01065974|Psychosocial Outcome|psychosocial outcome
488902|NCT01065961|anterior|anterior
488903|NCT01065961|cervical|cervical
488904|NCT01065961|fusion|fusion
488905|NCT01065961|swallowing|swallowing
488906|NCT01065961|Swallowing after anterior cervical discectomy and fusion|swallowing after anterior cervical discectomy and fusion
488907|NCT01065961|Bony fusion rates post anterior cervical discectomy and fusion|bony fusion rates post anterior cervical discectomy and fusion
488908|NCT01065948|subcutaneous glucose monitoring|subcutaneous glucose monitoring
488909|NCT01065948|diabetes|diabetes
488910|NCT01065948|fluorescence|fluorescence
488911|NCT01065948|affinity|affinity
488912|NCT01065948|biosensor|biosensor
488913|NCT01065948|type I Diabetes|type i diabetes
488914|NCT01065948|type II diabetes|type ii diabetes
488915|NCT01065935|ALN-RSV01|aln-rsv01
488916|NCT01065935|RSV|rsv
488917|NCT01065935|Respiratory Syncytial Virus|respiratory syncytial virus
488918|NCT01065896|spinal cord injury|spinal cord injury
488919|NCT01065896|coronary artery disease|coronary artery disease
488920|NCT01065857|Colonoscopy, Preparation, Evacuating, Bowel Cleansing.|colonoscopy, preparation, evacuating, bowel cleansing.
488921|NCT01065844|Nelfinavir|nelfinavir
488922|NCT01065831|motivational interviewing, lay health advisers|motivational interviewing, lay health advisers
488923|NCT01065818|Esophageal cancer|esophageal cancer
488924|NCT01065818|Non-small cell lung cancer|non-small cell lung cancer
488925|NCT01065818|FLT-PET|flt-pet
488926|NCT01065818|Chemoradiotherapy|chemoradiotherapy
488927|NCT01065805|18F-FLT|18f-flt
488928|NCT01065805|Positive Emission Tomography|positive emission tomography
488929|NCT01065805|Cancer|cancer
488930|NCT01065792|HIV Infection|hiv infection
488931|NCT01065766|Diabetes Mellitus|diabetes mellitus
488932|NCT01065766|Non-Insulin-Dependent|non-insulin-dependent
488933|NCT01065753|Rho kinase|rho kinase
488934|NCT01065753|Brain-derived neurotrophic factor|brain-derived neurotrophic factor
488935|NCT01065740|Peripheral arterial disease|peripheral arterial disease
488936|NCT01065740|Patient education|patient education
488937|NCT01065740|Physical activity coaching|physical activity coaching
488938|NCT01065740|Lifestyle modifications|lifestyle modifications
488939|NCT01065740|Walking capacity|walking capacity
488940|NCT01065740|6 minutes walking test|6 minutes walking test
488941|NCT01065727|Reemitting aggressive multiple sclerosis|reemitting aggressive multiple sclerosis
488942|NCT01065714|Transepidermal water loss|transepidermal water loss
488943|NCT01065714|Epidermal barrier|epidermal barrier
488944|NCT01065714|Skin hydration|skin hydration
488945|NCT01065688|distal gastrectomy|distal gastrectomy
488946|NCT01065688|Billroth-I reconstruction|billroth-i reconstruction
488947|NCT01065688|gastric cancer|gastric cancer
488948|NCT01065688|QOL|qol
488949|NCT01065675|Medication Reconciliation|medication reconciliation
488950|NCT01065675|Emergency Department|emergency department
488951|NCT01065675|Nurse|nurse
488952|NCT01065675|Pharmacist|pharmacist
488953|NCT01065675|Certified Pharmacy Technician|certified pharmacy technician
488954|NCT01065675|Medication reconciliation: inpatients admitted from the ED|medication reconciliation: inpatients admitted from the ed
488955|NCT01065662|AZD2171|azd2171
488956|NCT01065662|temsirolimus|temsirolimus
488957|NCT01065662|advanced gynecological malignancies|advanced gynecological malignancies
488958|NCT01065649|reflux disease|reflux disease
488959|NCT01065649|heartburn|heartburn
488960|NCT01065623|Phase I|phase i
488961|NCT01065623|Dose escalation|dose escalation
488962|NCT01065623|Immunoconjugate|immunoconjugate
488963|NCT01065597|electroconvulsive therapy|electroconvulsive therapy
488964|NCT01065597|seizure|seizure
488965|NCT01065597|nonconvulsive|nonconvulsive
488966|NCT01065597|subconvulsive|subconvulsive
488967|NCT01065597|major depression|major depression
488968|NCT01065597|bipolar disorder|bipolar disorder
488969|NCT01065584|liver transplantation|liver transplantation
488970|NCT01065584|Patients undergoing liver transplantation|patients undergoing liver transplantation
488971|NCT01065571|relapse|relapse
488972|NCT01065571|carrageenan|carrageenan
488973|NCT01065571|inflammation|inflammation
488974|NCT01065558|Ecopipam|ecopipam
488975|NCT01065558|Lesch-Nyhan Disease|lesch-nyhan disease
488976|NCT01065558|Safety|safety
488977|NCT01065558|Self-Injurious Behavior|self-injurious behavior
488978|NCT01065545|leukemia|leukemia
488979|NCT01065532|Restenosis|restenosis
488980|NCT01065532|PCI|pci
488981|NCT01065532|Drug-eluting stent|drug-eluting stent
488982|NCT01065532|Drug-eluting balloon|drug-eluting balloon
488983|NCT01065532|Optical Coherence Tomography|optical coherence tomography
488984|NCT01065519|Coronary stent|coronary stent
488985|NCT01065519|Optical coherence tomography|optical coherence tomography
488986|NCT01065519|Intravascular ultrasound|intravascular ultrasound
488987|NCT01065480|Training|training
488988|NCT01065480|Substance Abuse|substance abuse
488989|NCT01065480|Counseling|counseling
488990|NCT01065480|Motivational Interviewing|motivational interviewing
488991|NCT01065467|LBH589|lbh589
488992|NCT01065467|panobinostat|panobinostat
488993|NCT01065454|Pulmonary Hypertension|pulmonary hypertension
488994|NCT01065454|Left ventricular dysfunction|left ventricular dysfunction
488995|NCT01065441|breast cancer|breast cancer
488996|NCT01065441|colorectal cancer|colorectal cancer
488997|NCT01065441|prostate cancer|prostate cancer
488998|NCT01065441|melanoma|melanoma
488999|NCT01065441|ovarian cancer|ovarian cancer
489000|NCT01065441|GI cancer|gi cancer
489001|NCT01065441|Sarcoma|sarcoma
489002|NCT01065441|Renal Cell Carcinoma|renal cell carcinoma
489003|NCT01065428|neuromechanical efficiency|neuromechanical efficiency
489004|NCT01065428|neuroventilatory efficiency|neuroventilatory efficiency
489005|NCT01065428|weaning|weaning
489006|NCT01065428|Respiration, Artificial|respiration, artificial
489007|NCT01065415|Magnetic Resonance Imaging/Positron Emission Tomography|magnetic resonance imaging/positron emission tomography
489008|NCT01065415|Whole body imaging|whole body imaging
489009|NCT01065415|Non-small cell lung cancer|non-small cell lung cancer
489010|NCT01065415|staging|staging
489011|NCT01065415|Diagnostic accuracy|diagnostic accuracy
489012|NCT01065402|Diabetes mellitus|diabetes mellitus
489013|NCT01065402|continuous glucose monitoring system (CGMS)|continuous glucose monitoring system (cgms)
489014|NCT01065389|Intradialysis|intradialysis
489015|NCT01065389|Resistance training|resistance training
489016|NCT01065389|Protein Catabolic Rate|protein catabolic rate
489017|NCT01065389|Urea kinetics|urea kinetics
489018|NCT01065389|Quality of life|quality of life
489019|NCT01065389|VO2 max|vo2 max
489020|NCT01065376|IVF|ivf
489021|NCT01065376|OHSS|ohss
489022|NCT01065376|cabergoline|cabergoline
489023|NCT01065363|Hepatitis B virus DNA|hepatitis b virus dna
489024|NCT01065363|Metabolic factor|metabolic factor
489025|NCT01065363|Body mass index|body mass index
489026|NCT01065363|Obesity|obesity
489027|NCT01065363|Insulin resistance|insulin resistance
489028|NCT01065363|Lifestyle factor|lifestyle factor
489029|NCT01065363|Preventive Medicine|preventive medicine
489030|NCT01065363|Health Promotion|health promotion
489031|NCT01065350|ketofol|ketofol
489032|NCT01065350|hemodynamics|hemodynamics
489033|NCT01065350|propofol|propofol
489034|NCT01065350|anesthesia|anesthesia
489035|NCT01065337|peripheral arterial occlusion disease (PAD)|peripheral arterial occlusion disease (pad)
489036|NCT01065337|diabetic foot|diabetic foot
489037|NCT01065337|critical limb ischemia (CLI)|critical limb ischemia (cli)
489038|NCT01065337|stem cell therapy|stem cell therapy
489039|NCT01065324|balloon|balloon
489040|NCT01065324|enteroscopy|enteroscopy
489041|NCT01065324|bacteremia|bacteremia
489042|NCT01065311|Depressive Disorder|depressive disorder
489043|NCT01065311|Psychotherapy|psychotherapy
489044|NCT01065285|Influenza|influenza
489045|NCT01065285|autoimmune diseases|autoimmune diseases
489046|NCT01065285|vaccination|vaccination
489047|NCT01065285|H1N1|h1n1
489048|NCT01065272|Dexamethasone|dexamethasone
489049|NCT01065272|Bronchiolitis|bronchiolitis
489050|NCT01065259|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
489051|NCT01065259|executive function|executive function
489052|NCT01065259|OROS MPH|oros mph
489053|NCT01065259|atomoxetine|atomoxetine
489054|NCT01065246|malignant ascites|malignant ascites
489055|NCT01065246|second cycle|second cycle
489056|NCT01065246|trifunctional|trifunctional
489057|NCT01065220|Serotonin Transporter|serotonin transporter
489058|NCT01065220|Hormone therapy|hormone therapy
489059|NCT01065220|Gender Dysphoria|gender dysphoria
489060|NCT01065220|Transsexualism|transsexualism
489061|NCT01065181|shoulder|shoulder
489062|NCT01065181|posterior inferior glenohumeral ligament|posterior inferior glenohumeral ligament
489063|NCT01065181|posterior capsule|posterior capsule
489064|NCT01065181|capsular contracture|capsular contracture
489065|NCT01065181|baseball|baseball
489066|NCT01065181|throwing injury|throwing injury
489067|NCT01065168|endometriosis|endometriosis
489068|NCT01065168|endometrioma|endometrioma
489069|NCT01065168|antimullerian hormone|antimullerian hormone
489070|NCT01065168|cystectomy|cystectomy
489071|NCT01065142|Heart Failure|heart failure
489072|NCT01065142|Patient Education as Topic|patient education as topic
489073|NCT01065142|Primary Health Care|primary health care
489074|NCT01065142|Quality of Life|quality of life
489075|NCT01065116|Malaria|malaria
489076|NCT01065103|STEMI|stemi
489077|NCT01065103|Primary angioplasty|primary angioplasty
489078|NCT01065103|Non-culprit vessel at STEMI|non-culprit vessel at stemi
489079|NCT01065103|Fractional Flow Reserve|fractional flow reserve
489080|NCT01065103|ST-elevation myocardial infarction|st-elevation myocardial infarction
489081|NCT01065103|Fractional Flow Reserve in non-culprit vessel at STEMI|fractional flow reserve in non-culprit vessel at stemi
489082|NCT01065090|Capacity for Work Questionnaire|capacity for work questionnaire
489083|NCT01065090|exercise|exercise
489084|NCT01065090|AVONEX|avonex
489085|NCT01065090|SDMT: Symbol Digit Modalities Test|sdmt: symbol digit modalities test
489086|NCT01065090|FSMC: Fatigue Scale for Motor and Cognitive functions|fsmc: fatigue scale for motor and cognitive functions
489087|NCT01065090|effects of exercise|effects of exercise
489088|NCT01065090|EDSS: Expanded Disability Status Scale|edss: expanded disability status scale
489089|NCT01065077|Heart Failure|heart failure
489090|NCT01065064|Multifocal IOL|multifocal iol
489091|NCT01065064|ReSTOR IOL|restor iol
489092|NCT01065051|Pulmonary Hypertension|pulmonary hypertension
489093|NCT01065051|Left ventricular dysfunction|left ventricular dysfunction
489094|NCT01065025|4SC-205|4sc-205
489095|NCT01065025|Solid tumors|solid tumors
489096|NCT01065025|Lymphomas|lymphomas
489097|NCT01065025|Phase I|phase i
489098|NCT01064999|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
489099|NCT01064999|locally advanced rectal cancer|locally advanced rectal cancer
489100|NCT01064999|intensity-modulated radiation therapy|intensity-modulated radiation therapy
489101|NCT01064999|pathological complete response|pathological complete response
489102|NCT01064986|Immune System|immune system
489103|NCT01064973|autism|autism
489104|NCT01064960|Neoplasms, Connective and Soft Tissue|neoplasms, connective and soft tissue
489105|NCT01064960|Neoplasms, Muscle Tissue|neoplasms, muscle tissue
489106|NCT01064960|Neoplasms|neoplasms
489107|NCT01064960|Myofibroma|myofibroma
489108|NCT01064960|Neoplasms by Histologic Type|neoplasms by histologic type
489109|NCT01064960|Connective Tissue Diseases|connective tissue diseases
489110|NCT01064960|Neoplasms, Connective Tissue|neoplasms, connective tissue
489111|NCT01064960|Leiomyoma|leiomyoma
489112|NCT01064934|coronary heart disease|coronary heart disease
489113|NCT01064934|cerebrovascular disease|cerebrovascular disease
489114|NCT01064934|peripheral arterial disease|peripheral arterial disease
489115|NCT01064934|atherosclerosis|atherosclerosis
489116|NCT01064934|hyperlipoproteinemia|hyperlipoproteinemia
489117|NCT01064921|oropharyngeal cancer|oropharyngeal cancer
489118|NCT01064921|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
489119|NCT01064908|Endarterectomy, Carotid|endarterectomy, carotid
489120|NCT01064908|Carotid stenosis|carotid stenosis
489121|NCT01064908|Oxygen mask|oxygen mask
489122|NCT01064895|Benephit|benephit
489123|NCT01064895|Acute Kidney Injury|acute kidney injury
489124|NCT01064895|Acute Renal Failure|acute renal failure
489125|NCT01064895|Contrast Induced Nephropathy|contrast induced nephropathy
489126|NCT01064895|Chronic Kidney Disease|chronic kidney disease
489127|NCT01064869|Adherence|adherence
489128|NCT01064869|Asthma|asthma
489129|NCT01064869|medication|medication
489130|NCT01064856|peripheral spondyloarthritis|peripheral spondyloarthritis
489131|NCT01064856|adalimumab|adalimumab
489132|NCT01064856|humira|humira
489133|NCT01064843|Edentulous|edentulous
489134|NCT01064843|Edentulism|edentulism
489135|NCT01064843|Lower denture|lower denture
489136|NCT01064843|Mini dental implant|mini dental implant
489137|NCT01064843|Imtec MDI|imtec mdi
489138|NCT01064843|Denture stabilization|denture stabilization
489139|NCT01064843|Case success rate of overdentures stabilized by MDI|case success rate of overdentures stabilized by mdi
489140|NCT01064843|General satisfaction of patients with this treatment|general satisfaction of patients with this treatment
489141|NCT01064843|Oral health-related quality of life of these patients|oral health-related quality of life of these patients
489142|NCT01064843|Cost estimates|cost estimates
489143|NCT01064830|brittle nail|brittle nail
489144|NCT01064817|glaucoma, trabeculectomy|glaucoma, trabeculectomy
489145|NCT01064791|Renal transplantation|renal transplantation
489146|NCT01064778|Glycemic Index|glycemic index
489147|NCT01064778|Brain|brain
489148|NCT01064778|Intake Regulation|intake regulation
489149|NCT01064778|Weight Loss|weight loss
489150|NCT01064778|Hunger|hunger
489151|NCT01064778|Diet|diet
489152|NCT01064765|Heart failure|heart failure
489153|NCT01064765|Self management|self management
489154|NCT01064765|cognitive dysfunction|cognitive dysfunction
489155|NCT01064765|Self management of heart failure|self management of heart failure
489156|NCT01064752|Minocycline|minocycline
489157|NCT01064752|HIV-1|hiv-1
489158|NCT01064752|Immune activation|immune activation
489159|NCT01064752|Cerebrospinal fluid|cerebrospinal fluid
489160|NCT01064752|Observational|observational
489161|NCT01064739|Healthy Volunteers|healthy volunteers
489162|NCT01064739|Fava bean consumption|fava bean consumption
489163|NCT01064739|L-Dopa content in Fava Beans|l-dopa content in fava beans
489164|NCT01064739|Sodium|sodium
489165|NCT01064739|Potassium|potassium
489166|NCT01064739|Electrolyte Balance|electrolyte balance
489167|NCT01064739|Natriuresis|natriuresis
489168|NCT01064726|Allergic Rhinitis Nasal Allergen Challenge Inflammatory Markers|allergic rhinitis nasal allergen challenge inflammatory markers
489169|NCT01064713|Tesetaxel|tesetaxel
489170|NCT01064713|Second-line therapy|second-line therapy
489171|NCT01064713|Metastatic melanoma|metastatic melanoma
489172|NCT01064713|Normal serum LDH|normal serum ldh
489173|NCT01064700|Anxiety|anxiety
489174|NCT01064700|Phototherapy|phototherapy
489175|NCT01064700|Psychic Anxiety|psychic anxiety
489176|NCT01064674|renal transplantation|renal transplantation
489177|NCT01064674|cardiovascular morbidity|cardiovascular morbidity
489178|NCT01064674|evaluation before renal transplantation|evaluation before renal transplantation
489179|NCT01064661|Probiotics|probiotics
489180|NCT01064661|abdominal pain|abdominal pain
489181|NCT01064661|abdominal discomfort|abdominal discomfort
489182|NCT01064661|bloating|bloating
489183|NCT01064661|Functional Bowel Disorders|functional bowel disorders
489184|NCT01064635|stage IA breast cancer|stage ia breast cancer
489185|NCT01064635|stage IB breast cancer|stage ib breast cancer
489186|NCT01064635|stage II breast cancer|stage ii breast cancer
489187|NCT01064635|stage IIIA breast cancer|stage iiia breast cancer
489188|NCT01064635|stage IIIB breast cancer|stage iiib breast cancer
489189|NCT01064635|stage IIIC breast cancer|stage iiic breast cancer
489190|NCT01064596|obesity|obesity
489191|NCT01064596|fondaparinux|fondaparinux
489192|NCT01064596|surgery|surgery
489193|NCT01064596|anti-Xa activity|anti-xa activity
489194|NCT01064570|Acute Promyelocytic Leukemia|acute promyelocytic leukemia
489195|NCT01064570|APL|apl
489196|NCT01064557|Acute promyelocytic Leukemia|acute promyelocytic leukemia
489197|NCT01064544|Sleep problems|sleep problems
489198|NCT01064544|melatonin|melatonin
489199|NCT01064544|mood|mood
489200|NCT01064544|Hemodialysis|hemodialysis
489201|NCT01064518|Lateral Canthal Lines|lateral canthal lines
489202|NCT01064518|Crow's Feet Wrinkles|crow's feet wrinkles
489203|NCT01064518|Facial Wrinkles|facial wrinkles
489204|NCT01064505|Ocular Neuroprotection|ocular neuroprotection
489205|NCT01064505|ocular neuroprotectant|ocular neuroprotectant
489206|NCT01064505|NAION|naion
489207|NCT01064505|NAAION|naaion
489208|NCT01064505|Non-arteritic ischemic optic neuropathy|non-arteritic ischemic optic neuropathy
489209|NCT01064505|Non-arteritic anterior ischemic optic neuropathy|non-arteritic anterior ischemic optic neuropathy
489210|NCT01064505|chronic optic nerve atrophy|chronic optic nerve atrophy
489211|NCT01064505|optic nerve atrophy|optic nerve atrophy
489212|NCT01064505|retinal degeneration|retinal degeneration
489213|NCT01064505|optic neuritis|optic neuritis
489214|NCT01064505|end stage glaucoma|end stage glaucoma
489215|NCT01064505|Leber's hereditary optic neuropathy|leber's hereditary optic neuropathy
489216|NCT01064479|SCCHN|scchn
489217|NCT01064479|Oral cavity|oral cavity
489218|NCT01064479|Oropharynx|oropharynx
489219|NCT01064479|Hypopharynx|hypopharynx
489220|NCT01064479|Larynx|larynx
489221|NCT01064479|Tarceva|tarceva
489222|NCT01064479|Erlotinib|erlotinib
489223|NCT01064479|OSI-774|osi-774
489224|NCT01064479|Docetaxel|docetaxel
489225|NCT01064479|Taxotere|taxotere
489226|NCT01064479|Cisplatin|cisplatin
489227|NCT01064479|Platinol|platinol
489228|NCT01064479|CDDP|cddp
489229|NCT01064479|Placebo|placebo
489230|NCT01064479|Chemotherapy|chemotherapy
489231|NCT01064466|SCLC|sclc
489232|NCT01064466|Etoposide|etoposide
489233|NCT01064466|SNP|snp
489234|NCT01064466|Topo|topo
489235|NCT01064466|CYP|cyp
489236|NCT01064466|Genotype|genotype
489237|NCT01064466|Oncology|oncology
489238|NCT01064466|Genetics|genetics
489239|NCT01064466|Lung|lung
489240|NCT01064466|Cancer|cancer
489241|NCT01064453|Menopause|menopause
489242|NCT01064453|Menopausal symptoms|menopausal symptoms
489243|NCT01064453|Prevention of osteoporosis in menopausal women|prevention of osteoporosis in menopausal women
489244|NCT01064453|Estrogen deficiency symptoms|estrogen deficiency symptoms
489245|NCT01064453|Hormone replacement therapy|hormone replacement therapy
489246|NCT01064440|Painful legs|painful legs
489247|NCT01064440|Ischemic legs|ischemic legs
489248|NCT01064440|Treatment for Claudication|treatment for claudication
489249|NCT01064440|Gene therapy|gene therapy
489250|NCT01064427|breast cancer|breast cancer
489251|NCT01064427|fatigue|fatigue
489252|NCT01064427|adjuvant chemotherapy|adjuvant chemotherapy
489253|NCT01064427|quality of life|quality of life
489254|NCT01064414|Canagliflozin|canagliflozin
489255|NCT01064414|JNJ 28431754|jnj 28431754
489256|NCT01064414|Placebo|placebo
489257|NCT01064414|Sodium-Glucose Transporter 2|sodium-glucose transporter 2
489258|NCT01064414|hemoglobin A1c protein, Blood Glucose|hemoglobin a1c protein, blood glucose
489259|NCT01064414|reduced kidney function, Type 2 diabetes mellitus|reduced kidney function, type 2 diabetes mellitus
489260|NCT01064388|Safety|safety
489261|NCT01064375|DNA vaccine|dna vaccine
489262|NCT01064375|Electroporation|electroporation
489263|NCT01064362|Haemorrhage|haemorrhage
489264|NCT01064362|Thromboprophylaxis|thromboprophylaxis
489265|NCT01064349|brain metastases|brain metastases
489266|NCT01064349|ErbB2 treatment|erbb2 treatment
489267|NCT01064349|ErbB2+ breast cancer|erbb2+ breast cancer
489268|NCT01064336|Thrombocytopenia|thrombocytopenia
489269|NCT01064336|Pregnancy|pregnancy
489270|NCT01064323|intermittent pneumatic leg compression|intermittent pneumatic leg compression
489271|NCT01064323|nitric oxide|nitric oxide
489272|NCT01064323|vascular endothelial cells|vascular endothelial cells
489273|NCT01064323|IPC|ipc
489274|NCT01064323|EECP|eecp
489275|NCT01064323|atherosclerosis|atherosclerosis
489276|NCT01064310|renal cell carcinoma|renal cell carcinoma
489277|NCT01064310|Votrient|votrient
489278|NCT01064310|cancer|cancer
489279|NCT01064310|pazopanib|pazopanib
489280|NCT01064310|patient preference|patient preference
489281|NCT01064310|quality of life|quality of life
489282|NCT01064297|Pregnancy registry|pregnancy registry
489283|NCT01064297|Major congenital malformations|major congenital malformations
489284|NCT01064297|Pregnancy outcomes|pregnancy outcomes
489285|NCT01064297|Pregnancy|pregnancy
489286|NCT01064297|First trimester|first trimester
489287|NCT01064297|Lamotrigine|lamotrigine
489288|NCT01064284|Hemophilia A|hemophilia a
489289|NCT01064284|Factor VIII inhibitors|factor viii inhibitors
489290|NCT01064284|vWF/FVIII|vwf/fviii
489291|NCT01064284|rFVIII|rfviii
489292|NCT01064258|treatment|treatment
489293|NCT01064258|CPAP|cpap
489294|NCT01064258|sleep apnea|sleep apnea
489295|NCT01064245|Asthma|asthma
489296|NCT01064245|Cough Variant Asthma|cough variant asthma
489297|NCT01064245|Mannitol|mannitol
489298|NCT01064245|Methacholine|methacholine
489299|NCT01064245|Cough|cough
489300|NCT01064245|Hypersensitivity|hypersensitivity
489301|NCT01064219|hCG|hcg
489302|NCT01064219|Treg cells|treg cells
489303|NCT01064219|implantation|implantation
489304|NCT01064219|pinopodes|pinopodes
489305|NCT01064219|endometrium|endometrium
489306|NCT01064206|thrombangiitis obliterans|thrombangiitis obliterans
489307|NCT01064206|Buerger's disease|buerger's disease
489598|NCT01062867|Anaesthetic|anaesthetic
489308|NCT01064206|atheromatous arteritis|atheromatous arteritis
489309|NCT01064206|psychiatric disorders|psychiatric disorders
489310|NCT01064206|personality disorders|personality disorders
489311|NCT01064206|addictive profile|addictive profile
489312|NCT01064206|addiction|addiction
489313|NCT01064206|tobacco|tobacco
489314|NCT01064206|cannabis|cannabis
489315|NCT01064193|In Vitro Fertilization|in vitro fertilization
489316|NCT01064193|biopsy|biopsy
489317|NCT01064193|pregnancy|pregnancy
489318|NCT01064193|Implantation|implantation
489319|NCT01064193|Embryo|embryo
489320|NCT01064193|first or second IVF tentative|first or second ivf tentative
489321|NCT01064167|Tranexamic Acid|tranexamic acid
489322|NCT01064167|off-pump coronary Artery Bypass|off-pump coronary artery bypass
489323|NCT01064141|Dengue Fever|dengue fever
489324|NCT01064141|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
489325|NCT01064141|CYD Dengue Vaccine|cyd dengue vaccine
489326|NCT01064141|Toddlers|toddlers
489327|NCT01064128|Single-port|single-port
489328|NCT01064128|Laparoscopy|laparoscopy
489329|NCT01064128|Hysterectomy|hysterectomy
489330|NCT01064128|Pain|pain
489331|NCT01064128|Cosmesis|cosmesis
489332|NCT01064128|Analgesics|analgesics
489333|NCT01064089|HSP990|hsp990
489334|NCT01064089|HSP90|hsp90
489335|NCT01064089|Japan/Korea|japan/korea
489336|NCT01064089|Phase I|phase i
489337|NCT01064089|advanced solid tumors|advanced solid tumors
489338|NCT01064089|dose escalation|dose escalation
489339|NCT01064089|maximum tolerated dose|maximum tolerated dose
489340|NCT01064089|MTD|mtd
489341|NCT01064089|Japanese paatients|japanese paatients
489342|NCT01064089|Korean patients|korean patients
489343|NCT01064076|ICD, defibrillator|icd, defibrillator
489344|NCT01064050|tumoral obstruction of the main stem bronchus|tumoral obstruction of the main stem bronchus
489345|NCT01064050|bronchoscopy|bronchoscopy
489346|NCT01064050|silicone stent|silicone stent
489347|NCT01064037|Heart Failure|heart failure
489348|NCT01064024|uUTI|uuti
489349|NCT01064024|Pain or burning associated with Uncomplicated Urinary Tract Infections|pain or burning associated with uncomplicated urinary tract infections
489350|NCT01063998|Renal cell|renal cell
489351|NCT01063998|Carcinoma|carcinoma
489352|NCT01063998|Biomarkers|biomarkers
489353|NCT01063985|Skin testing for mouse allergies|skin testing for mouse allergies
489354|NCT01063959|Laparoscopic Sleeve Gastrectomy|laparoscopic sleeve gastrectomy
489355|NCT01063959|Laparoscopic Gastric Bypass|laparoscopic gastric bypass
489356|NCT01063933|influenza, Peramivir, children, pharmacokinetic, pharmacodynamic|influenza, peramivir, children, pharmacokinetic, pharmacodynamic
489357|NCT01063920|LT-NS001|lt-ns001
489358|NCT01063920|Gastric Ulcers|gastric ulcers
489359|NCT01063920|NSAID|nsaid
489360|NCT01063920|Osteoarthritis|osteoarthritis
489361|NCT01063920|Naproxen|naproxen
489362|NCT01063907|Leukemia|leukemia
489363|NCT01063907|Immunoproliferative Disorder|immunoproliferative disorder
489364|NCT01063907|Neoplasma by Histologic Type|neoplasma by histologic type
489365|NCT01063907|Immune System Diseases|immune system diseases
489366|NCT01063907|Hematologic Diseases|hematologic diseases
489367|NCT01063907|Blood Protein Disorders|blood protein disorders
489368|NCT01063907|Paraproteinemias|paraproteinemias
489369|NCT01063907|Multiple Myeloma|multiple myeloma
489370|NCT01063907|Hematologic Disorders|hematologic disorders
489371|NCT01063907|Leukemia, Chronic, B-cell|leukemia, chronic, b-cell
489372|NCT01063907|Leukemia, B-cell|leukemia, b-cell
489373|NCT01063907|Leukemia, Chronic|leukemia, chronic
489374|NCT01063907|Neoplasms, Plasma Cell|neoplasms, plasma cell
489375|NCT01063907|Monoclonal Gammopathy of unknown significance (MGUS)|monoclonal gammopathy of unknown significance (mgus)
489376|NCT01063881|Sexual Dysfunction, physiological|sexual dysfunction, physiological
489377|NCT01063881|R096769|r096769
489378|NCT01063881|Dapoxetine|dapoxetine
489379|NCT01063881|Phase 3b|phase 3b
489380|NCT01063881|Premature Ejaculation|premature ejaculation
489381|NCT01063868|Diabetic neuropathy|diabetic neuropathy
489382|NCT01063868|Painful|painful
489383|NCT01063868|Polyneuropathy|polyneuropathy
489384|NCT01063868|Peripheral neuropathy|peripheral neuropathy
489385|NCT01063855|Erectile Dysfunction|erectile dysfunction
489386|NCT01063855|Sexual Dysfunction|sexual dysfunction
489387|NCT01063855|Dapoxetine hydrochloride|dapoxetine hydrochloride
489388|NCT01063855|PRILIGY|priligy
489389|NCT01063855|Premature ejaculation|premature ejaculation
489390|NCT01063855|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
489391|NCT01063855|Sildenafil (Viagra)|sildenafil (viagra)
489392|NCT01063855|Vardenafil (Levitra)|vardenafil (levitra)
489393|NCT01063855|Tadalafil (Cialis)|tadalafil (cialis)
489394|NCT01063842|Drop-out rate|drop-out rate
489395|NCT01063842|Osteoarthritis|osteoarthritis
489396|NCT01063842|Tolerability|tolerability
489397|NCT01063842|Tramadol|tramadol
489398|NCT01063842|Acetaminophen|acetaminophen
489399|NCT01063829|HCMV|hcmv
489400|NCT01063816|PARP Inhibitors|parp inhibitors
489401|NCT01063803|Open-label|open-label
489402|NCT01063803|Long-term safety study of ATN-103 in RA|long-term safety study of atn-103 in ra
489403|NCT01063790|Post-operative pain|post-operative pain
489404|NCT01063790|inguinal hernia repair surgery|inguinal hernia repair surgery
489405|NCT01063790|Patient education|patient education
489406|NCT01063777|Hip Osteoarthritis, Exercise therapy, Patient Education|hip osteoarthritis, exercise therapy, patient education
489407|NCT01063764|Keppra|keppra
489408|NCT01063764|Levetiracetam|levetiracetam
489409|NCT01063764|Children|children
489410|NCT01063764|Epilepsy|epilepsy
489411|NCT01063764|Partial Seizures|partial seizures
489412|NCT01063751|Osteoarthritis|osteoarthritis
489413|NCT01063751|Traumatic arthritis|traumatic arthritis
489414|NCT01063751|Avascular Necrosis|avascular necrosis
489415|NCT01063738|Rehabilitation|rehabilitation
489416|NCT01063738|Intensive Care|intensive care
489417|NCT01063738|Critical illness|critical illness
489418|NCT01063738|Physiotherapy|physiotherapy
489419|NCT01063738|Nutritional supplementation|nutritional supplementation
489420|NCT01063725|menopause|menopause
489421|NCT01063725|hot flashes|hot flashes
489422|NCT01063725|vasomotor symptoms|vasomotor symptoms
489423|NCT01063725|femarelle|femarelle
489424|NCT01063725|soy extract|soy extract
489425|NCT01063725|SERM|serm
489426|NCT01063712|Ductus|ductus
489427|NCT01063712|Patent ductus Arterious|patent ductus arterious
489428|NCT01063712|"Nit-Occlud® PDA-R"|"nit-occlud® pda-r"
489429|NCT01063712|Interventional closure of PDA|interventional closure of pda
489430|NCT01063712|Percutaneous closure|percutaneous closure
489431|NCT01063699|biliary atresia - laparoscopy - kasai - portoenterostomy|biliary atresia - laparoscopy - kasai - portoenterostomy
489432|NCT01063686|Pregnancy|pregnancy
489433|NCT01063673|Running, overuse injury, limits humans|running, overuse injury, limits humans
489434|NCT01063660|Treosulfan|treosulfan
489435|NCT01063660|Fludarabine|fludarabine
489436|NCT01063660|ATG|atg
489437|NCT01063660|AML|aml
489438|NCT01063647|Treosulfan|treosulfan
489439|NCT01063647|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
489440|NCT01063647|Conditioning therapy|conditioning therapy
489441|NCT01063634|malignant biliary obstruction|malignant biliary obstruction
489442|NCT01063634|viaduct|viaduct
489443|NCT01063634|self-expandable metal stents|self-expandable metal stents
489444|NCT01063595|Octaplas LG|octaplas lg
489445|NCT01063595|Octaplas SD|octaplas sd
489446|NCT01063582|echocardiogram|echocardiogram
489447|NCT01063582|electrocardiographic|electrocardiographic
489448|NCT01063582|risk factors|risk factors
489449|NCT01063582|noise|noise
489450|NCT01063569|Addison's disease|addison's disease
489451|NCT01063569|Glucocorticoid treatment|glucocorticoid treatment
489452|NCT01063569|Continuous subcutaneous hydrocortisone infusion|continuous subcutaneous hydrocortisone infusion
489453|NCT01063569|CSHI|cshi
489454|NCT01063569|Quality of Life|quality of life
489455|NCT01063569|Sleep|sleep
489456|NCT01063556|end-stage renal disease hemodialysis donepezil hydrochloride pharmacokinetics Cross-Over Study|end-stage renal disease hemodialysis donepezil hydrochloride pharmacokinetics cross-over study
489457|NCT01063543|fondaparinux|fondaparinux
489458|NCT01063543|orthopedic surgery|orthopedic surgery
489459|NCT01063543|patients with major orthopedic surgery|patients with major orthopedic surgery
489460|NCT01063530|FLuoride|fluoride
489461|NCT01063530|Dental Sensitivity|dental sensitivity
489462|NCT01063530|Abfraction|abfraction
489463|NCT01063530|Cervical lesions|cervical lesions
489464|NCT01063517|Poly(ADP ribose)|poly(adp ribose)
489465|NCT01063517|polymerase (PARP)|polymerase (parp)
489466|NCT01063517|Gastric cancer|gastric cancer
489467|NCT01063517|olaparib|olaparib
489468|NCT01063517|PARP inhibitor|parp inhibitor
489469|NCT01063517|ATM AZD2281|atm azd2281
489470|NCT01063517|Ku0059436|ku0059436
489471|NCT01063517|Homologous Recombination deficiency (HRD)|homologous recombination deficiency (hrd)
489472|NCT01063517|Recurrent gastric cancer|recurrent gastric cancer
489473|NCT01063517|metastatic gastric cancer|metastatic gastric cancer
489474|NCT01063491|coronary artery bypass graft surgery|coronary artery bypass graft surgery
489475|NCT01063491|bypass grafts|bypass grafts
489476|NCT01063491|angiography|angiography
489477|NCT01063491|percutaneous coronary intervention|percutaneous coronary intervention
489478|NCT01063491|coronary imaging|coronary imaging
489479|NCT01063491|coronary artery bypass graft surgery, bypass graft patency|coronary artery bypass graft surgery, bypass graft patency
489480|NCT01063478|Non-Small Cell|non-small cell
489481|NCT01063478|Lung Cancer|lung cancer
489482|NCT01063478|Unresectable advanced NSCLC|unresectable advanced nsclc
489483|NCT01063465|Achilles|achilles
489484|NCT01063465|Tendon|tendon
489485|NCT01063465|weightbearing|weightbearing
489486|NCT01063452|Urinary Catheterization|urinary catheterization
489487|NCT01063452|Urinary Tract Infections|urinary tract infections
489488|NCT01063439|DLBCL|dlbcl
489489|NCT01063439|NHL|nhl
489490|NCT01063426|Statin|statin
489491|NCT01063426|Vein|vein
489492|NCT01063413|Behavioral Research|behavioral research
489493|NCT01063413|Community-Based Participatory Research|community-based participatory research
489494|NCT01063387|cervical cancer,semaphorin 4C (Sema4C),|cervical cancer,semaphorin 4c (sema4c),
489495|NCT01063387|Prophylactic Irradiation|prophylactic irradiation
489496|NCT01063348|N-Acetyl Cysteine|n-acetyl cysteine
489497|NCT01063348|Picking|picking
489498|NCT01063348|Impulse Control Disorder|impulse control disorder
489700|NCT01062516|clopidogrel|clopidogrel
489499|NCT01063348|Obsessive Compulsive Disorder|obsessive compulsive disorder
489500|NCT01063335|CB1 Receptor|cb1 receptor
489501|NCT01063335|Schizophrenia|schizophrenia
489502|NCT01063335|Positron Emission Tomography (PET)|positron emission tomography (pet)
489503|NCT01063335|Healthy Volunteers|healthy volunteers
489504|NCT01063335|HV|hv
489505|NCT01063322|Mitral Regurgitation|mitral regurgitation
489506|NCT01063322|Echocardiography|echocardiography
489507|NCT01063322|Cardiac Magnetic Resonance|cardiac magnetic resonance
489508|NCT01063322|Regurgitant Volume|regurgitant volume
489509|NCT01063322|Mitral Valve Regurgitation|mitral valve regurgitation
489510|NCT01063309|Chronic Granulomatous Disease (CGD)|chronic granulomatous disease (cgd)
489511|NCT01063309|Atherosclerosis|atherosclerosis
489512|NCT01063309|Inflammatory Bowel Disease|inflammatory bowel disease
489513|NCT01063309|Immune Deficiencies|immune deficiencies
489514|NCT01063309|Immune System Deficiences|immune system deficiences
489515|NCT01063309|Chronic Granulomatous Disease|chronic granulomatous disease
489516|NCT01063309|CGD|cgd
489517|NCT01063296|cervical cancer|cervical cancer
489518|NCT01063283|Non-squamous Non-Small Cell Lung Cancer|non-squamous non-small cell lung cancer
489519|NCT01063283|Bevacizumab|bevacizumab
489520|NCT01063283|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
489521|NCT01063270|Hidradenitis Suppurativa|hidradenitis suppurativa
489522|NCT01063270|Antibiotics|antibiotics
489523|NCT01063270|Laser|laser
489524|NCT01063257|Myelodysplastic Syndrome|myelodysplastic syndrome
489525|NCT01063244|pregnancy|pregnancy
489526|NCT01063244|induction of Labor|induction of labor
489527|NCT01063244|Cervical ripening|cervical ripening
489528|NCT01063244|Foley balloon|foley balloon
489529|NCT01063231|Colonic Diseases|colonic diseases
489530|NCT01063231|bowel diseases|bowel diseases
489531|NCT01063218|Dermatitis, Atopic|dermatitis, atopic
489532|NCT01063218|Corticoids, topic|corticoids, topic
489533|NCT01063218|Corticosteroids|corticosteroids
489534|NCT01063205|Methamphetamine|methamphetamine
489535|NCT01063205|NAC|nac
489536|NCT01063205|N-acetylcysteine|n-acetylcysteine
489537|NCT01063192|Locally Advanced Pancreatic Cancer|locally advanced pancreatic cancer
489538|NCT01063179|Elderly patients|elderly patients
489539|NCT01063179|Bortezomib|bortezomib
489540|NCT01063179|Thalidomide|thalidomide
489541|NCT01063153|ADHD|adhd
489542|NCT01063153|Adults|adults
489543|NCT01063153|Electroencephalography (EEG)|electroencephalography (eeg)
489544|NCT01063153|Concerta|concerta
489545|NCT01063140|Rabies Immune Globulin|rabies immune globulin
489546|NCT01063140|Source Plasma Donors|source plasma donors
489547|NCT01063140|Booster Immunization|booster immunization
489548|NCT01063127|Morbid obesity|morbid obesity
489549|NCT01063127|Insulin resistance|insulin resistance
489550|NCT01063127|Euglycemic clamp|euglycemic clamp
489551|NCT01063114|proton beam radiation|proton beam radiation
489552|NCT01063088|Prophylaxis of seasonal influenza in adults|prophylaxis of seasonal influenza in adults
489553|NCT01063075|Cancer of Head|cancer of head
489554|NCT01063075|Cancer of Head and Neck|cancer of head and neck
489555|NCT01063075|Cancer of Neck|cancer of neck
489556|NCT01063075|Head and Neck Cancer|head and neck cancer
489557|NCT01063075|Head Cancer|head cancer
489558|NCT01063075|Head Neoplasms|head neoplasms
489559|NCT01063075|Head, Neck Neoplasms|head, neck neoplasms
489560|NCT01063075|Neck Cancer|neck cancer
489561|NCT01063075|Neck Neoplasms|neck neoplasms
489562|NCT01063075|Solid Neoplasm|solid neoplasm
489563|NCT01063075|Carcinoma|carcinoma
489564|NCT01063075|Sarcoma|sarcoma
489565|NCT01063010|sepsis|sepsis
489566|NCT01063010|septic shock|septic shock
489567|NCT01063010|Bevacizumab|bevacizumab
489568|NCT01063010|Avastin|avastin
489569|NCT01062984|Renal Replacement Therapy|renal replacement therapy
489570|NCT01062971|Open-angle glaucoma|open-angle glaucoma
489571|NCT01062971|Ocular hypertension|ocular hypertension
489572|NCT01062971|POAG|poag
489573|NCT01062971|Treatment|treatment
489574|NCT01062958|Neevo|neevo
489575|NCT01062958|Neevo DHA|neevo dha
489576|NCT01062958|L-methylfolate|l-methylfolate
489577|NCT01062958|anemia during pregnancy|anemia during pregnancy
489578|NCT01062958|folic acid|folic acid
489579|NCT01062958|vitamin B12|vitamin b12
489580|NCT01062958|prenatal vitamins|prenatal vitamins
489581|NCT01062958|hemoglobin|hemoglobin
489582|NCT01062958|iron deficiency|iron deficiency
489583|NCT01062958|Pregnancy|pregnancy
489584|NCT01062945|Cocaine|cocaine
489585|NCT01062945|Doxazosin|doxazosin
489586|NCT01062932|Cycloserine|cycloserine
489587|NCT01062932|Nicotine|nicotine
489588|NCT01062932|Smoking|smoking
489589|NCT01062906|intravenous lidocaine|intravenous lidocaine
489590|NCT01062906|postoperative pain|postoperative pain
489591|NCT01062906|laparoscopic surgery|laparoscopic surgery
489592|NCT01062906|opioids|opioids
489593|NCT01062906|opioids side-effects|opioids side-effects
489594|NCT01062893|labor pain treatment|labor pain treatment
489595|NCT01062893|duration analgesia|duration analgesia
489596|NCT01062893|Analgesic duration with normal saline injection.|analgesic duration with normal saline injection.
489597|NCT01062893|Analgesic duration without normal saline injection|analgesic duration without normal saline injection
489599|NCT01062854|snoring, sleep disordered breathing, polysomnography, sleep fragmentation|snoring, sleep disordered breathing, polysomnography, sleep fragmentation
489600|NCT01062841|Long-Term Care|long-term care
489601|NCT01062841|Nursing Homes|nursing homes
489602|NCT01062841|Infection Control|infection control
489603|NCT01062841|Multi-drug resistant pathogens|multi-drug resistant pathogens
489604|NCT01062841|Long-term care residents with in-dwelling devices|long-term care residents with in-dwelling devices
489605|NCT01062828|Prematurity|prematurity
489606|NCT01062828|Necrotizing Enterocolitis|necrotizing enterocolitis
489607|NCT01062828|Feeding Intolerance|feeding intolerance
489608|NCT01062815|PNALD|pnald
489609|NCT01062815|PNAC|pnac
489610|NCT01062815|Parenteral Nutrition-Associated Cholestasis|parenteral nutrition-associated cholestasis
489611|NCT01062815|Congenital Anomalies of Gastrointestinal Tract|congenital anomalies of gastrointestinal tract
489612|NCT01062789|lung biopsy|lung biopsy
489613|NCT01062789|computed tomograph|computed tomograph
489614|NCT01062789|respiratory motion|respiratory motion
489615|NCT01062789|Controlling respiratory motion in CT guided lung biopsies|controlling respiratory motion in ct guided lung biopsies
489616|NCT01062789|biopsy|biopsy
489617|NCT01062776|dehydration|dehydration
489618|NCT01062776|fluid therapy|fluid therapy
489619|NCT01062776|pharmacokinetics|pharmacokinetics
489620|NCT01062776|hemoglobin|hemoglobin
489621|NCT01062763|hypertension|hypertension
489622|NCT01062763|spironolactone|spironolactone
489623|NCT01062763|antihypertensive treatment|antihypertensive treatment
489624|NCT01062763|Type-2 diabetes|type-2 diabetes
489625|NCT01062750|Liver Cirrhosis|liver cirrhosis
489626|NCT01062724|Cholestasis|cholestasis
489627|NCT01062724|TPN|tpn
489628|NCT01062724|Neonates|neonates
489629|NCT01062724|Primene|primene
489630|NCT01062724|Trophamine|trophamine
489631|NCT01062724|Methionine|methionine
489632|NCT01062724|Cysteine|cysteine
489633|NCT01062724|Taurine|taurine
489634|NCT01062724|Total Parenteral Nutrition|total parenteral nutrition
489635|NCT01062711|sarcopenia|sarcopenia
489636|NCT01062711|muscle|muscle
489637|NCT01062711|protein|protein
489638|NCT01062711|muscle protein synthesis|muscle protein synthesis
489639|NCT01062711|muscle protein breakdown|muscle protein breakdown
489640|NCT01062711|whey|whey
489641|NCT01062711|soy|soy
489642|NCT01062711|casein|casein
489643|NCT01062711|dose response|dose response
489644|NCT01062711|resistance exercise|resistance exercise
489645|NCT01062711|unilateral|unilateral
489646|NCT01062711|knee extension|knee extension
489647|NCT01062711|whole body protein|whole body protein
489648|NCT01062698|mechanical Thrombectomy|mechanical thrombectomy
489649|NCT01062698|CVA (Cerebrovascular Accident)|cva (cerebrovascular accident)
489650|NCT01062698|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
489651|NCT01062685|septic shock|septic shock
489652|NCT01062685|sepsis|sepsis
489653|NCT01062685|St02|st02
489654|NCT01062685|Near Infrared Spectroscopy|near infrared spectroscopy
489655|NCT01062685|NIRS|nirs
489656|NCT01062672|plasticity|plasticity
489657|NCT01062672|reorganization|reorganization
489658|NCT01062672|cortical|cortical
489659|NCT01062672|fMRI|fmri
489660|NCT01062672|rehabilitation|rehabilitation
489661|NCT01062659|HCV|hcv
489662|NCT01062659|hepatitis C virus|hepatitis c virus
489663|NCT01062659|CHC|chc
489664|NCT01062659|chronic hepatitis c|chronic hepatitis c
489665|NCT01062659|interferon|interferon
489666|NCT01062659|ribavirin|ribavirin
489667|NCT01062659|Hepatitis, Viral, Human|hepatitis, viral, human
489668|NCT01062659|Anti-Infective Agents|anti-infective agents
489669|NCT01062659|peginterferon alfa-2a|peginterferon alfa-2a
489670|NCT01062659|peginterferon alfa-2b|peginterferon alfa-2b
489671|NCT01062646|music therapy|music therapy
489672|NCT01062646|multimodal psychotherapy|multimodal psychotherapy
489673|NCT01062646|children|children
489674|NCT01062646|anxiety disorders|anxiety disorders
489675|NCT01062646|pediatric anxiety|pediatric anxiety
489676|NCT01062633|dental caries|dental caries
489677|NCT01062633|prevention|prevention
489678|NCT01062633|dietary supplements|dietary supplements
489679|NCT01062607|bipolar disorders|bipolar disorders
489680|NCT01062607|everyday setting|everyday setting
489681|NCT01062607|treatment adherence|treatment adherence
489682|NCT01062607|global|global
489683|NCT01062581|Recipient|recipient
489684|NCT01062581|Donor|donor
489685|NCT01062581|Organ Transplant|organ transplant
489686|NCT01062581|Registry|registry
489687|NCT01062581|University of Minnesota|university of minnesota
489688|NCT01062568|adolescents|adolescents
489689|NCT01062568|puberty|puberty
489690|NCT01062568|androgens|androgens
489691|NCT01062568|hyperandrogenemia|hyperandrogenemia
489692|NCT01062529|GH signalling|gh signalling
489693|NCT01062529|insulin resistance|insulin resistance
489694|NCT01062529|somatostatin|somatostatin
489695|NCT01062529|acromegaly|acromegaly
489696|NCT01062516|acute coronary syndrome|acute coronary syndrome
489697|NCT01062516|acute myocardial infarction|acute myocardial infarction
489698|NCT01062516|percutaneous coronary intervention|percutaneous coronary intervention
489699|NCT01062516|aspirin|aspirin
489701|NCT01062516|esomeprazole|esomeprazole
489702|NCT01062516|famotidine|famotidine
489703|NCT01062516|platelet function|platelet function
489704|NCT01062503|Cancer|cancer
489705|NCT01062503|Prostate|prostate
489706|NCT01062503|metastatic|metastatic
489707|NCT01062490|Treosulfan|treosulfan
489708|NCT01062490|MDS|mds
489709|NCT01062490|allogeneic stem cell transplantation|allogeneic stem cell transplantation
489710|NCT01062490|leukemia|leukemia
489711|NCT01062490|Conditioning|conditioning
489712|NCT01062477|Diphtheria Tetanus Pertussis Haemophilus Influenzae Type B|diphtheria tetanus pertussis haemophilus influenzae type b
489713|NCT01062451|Methamphetamine|methamphetamine
489714|NCT01062451|Perindopril|perindopril
489715|NCT01062451|Candesartan|candesartan
489716|NCT01062451|Angiotensin receptor blocker|angiotensin receptor blocker
489717|NCT01062451|ACE Inhibitor|ace inhibitor
489718|NCT01062438|localized osteosarcoma|localized osteosarcoma
489719|NCT01062438|metastatic osteosarcoma|metastatic osteosarcoma
489720|NCT01062399|adult glioblastoma|adult glioblastoma
489721|NCT01062399|adult giant cell glioblastoma|adult giant cell glioblastoma
489722|NCT01062399|adult gliosarcoma|adult gliosarcoma
489723|NCT01062386|prevalence|prevalence
489724|NCT01062386|transmission|transmission
489725|NCT01062386|knowledge|knowledge
489726|NCT01062386|attitude|attitude
489727|NCT01062386|practice|practice
489728|NCT01062373|Premature Newborns|premature newborns
489729|NCT01062373|Human Milk|human milk
489730|NCT01062373|DHA|dha
489731|NCT01062373|Mother-child|mother-child
489732|NCT01062360|Sore Throat|sore throat
489733|NCT01062360|Upper Respiratory Tract Infections|upper respiratory tract infections
489734|NCT01062360|Nasal Congestion|nasal congestion
489735|NCT01062347|To identify a new bio-marker for zinc status|to identify a new bio-marker for zinc status
489736|NCT01062334|Anastomotic leakage after LAR|anastomotic leakage after lar
489737|NCT01062321|Hepatitis E Virus|hepatitis e virus
489738|NCT01062321|Cytokines|cytokines
489739|NCT01062321|Pregnancy|pregnancy
489740|NCT01062308|Stroke|stroke
489741|NCT01062308|Taping|taping
489742|NCT01062308|Pain|pain
489743|NCT01062308|Shoulder Injury|shoulder injury
489744|NCT01062295|passenger,|passenger,
489745|NCT01062295|sleep,|sleep,
489746|NCT01062295|rest,|rest,
489747|NCT01062282|Pulmonary Hypertension|pulmonary hypertension
489748|NCT01062269|Bile acid sequestrant|bile acid sequestrant
489749|NCT01062269|Resin|resin
489750|NCT01062269|Cholesterol|cholesterol
489751|NCT01062269|Diabetes mellitus|diabetes mellitus
489752|NCT01062269|Lipids|lipids
489753|NCT01062269|Glucose|glucose
489754|NCT01062269|Bile Acid Sequestrant Acceptability Scale (BASA)validation study|bile acid sequestrant acceptability scale (basa)validation study
489755|NCT01062256|Cough assessment in upper respiratory infection|cough assessment in upper respiratory infection
489756|NCT01062256|guaifenesin|guaifenesin
489757|NCT01062256|honey|honey
489758|NCT01062243|brain injury|brain injury
489759|NCT01062243|family treatment|family treatment
489760|NCT01062230|Cancer|cancer
489761|NCT01062230|Hematologic malignancy|hematologic malignancy
489762|NCT01062204|Skin Graft donor sites|skin graft donor sites
489763|NCT01062191|hydrogel|hydrogel
489764|NCT01062191|dressing|dressing
489765|NCT01062191|burn|burn
489766|NCT01062191|joint|joint
489767|NCT01062178|Small renal Mass|small renal mass
489768|NCT01062178|Contrast Enhanced Ultrasound|contrast enhanced ultrasound
489769|NCT01062178|Renal Cell Carcinoma|renal cell carcinoma
489770|NCT01062178|noninvasive diagnosis of RCC|noninvasive diagnosis of rcc
489771|NCT01062165|Echinocandin|echinocandin
489772|NCT01062165|Obesity|obesity
489773|NCT01062165|Pharmacokinetics|pharmacokinetics
489774|NCT01062165|Pharmacodynamics|pharmacodynamics
489775|NCT01062165|Fungal infection|fungal infection
489776|NCT01062152|Hematology|hematology
489777|NCT01062152|MDS|mds
489778|NCT01062152|Myelodysplastic Syndrome|myelodysplastic syndrome
489779|NCT01062152|Low risk MDS|low risk mds
489780|NCT01062152|Patients with non-deletion(5q)|patients with non-deletion(5q)
489781|NCT01062152|Non-deletion 5q|non-deletion 5q
489782|NCT01062152|Non del(5q)|non del(5q)
489783|NCT01062152|Revlimid|revlimid
489784|NCT01062152|lenalidomide|lenalidomide
489785|NCT01062152|Telintra|telintra
489786|NCT01062152|ezatiostat hydrochloride|ezatiostat hydrochloride
489787|NCT01062152|ezatiostat|ezatiostat
489788|NCT01062152|TLK199|tlk199
489789|NCT01062152|Glutathione|glutathione
489790|NCT01062152|Glutathione analog|glutathione analog
489791|NCT01062152|Glutathione Transferase|glutathione transferase
489792|NCT01062152|Glutathione Transferase inhibitor|glutathione transferase inhibitor
489793|NCT01062152|Glutathione Transferase P1-1 inhibitor|glutathione transferase p1-1 inhibitor
489794|NCT01062152|GSTp1-1 inhibitor|gstp1-1 inhibitor
489795|NCT01062152|Apoptosis|apoptosis
489796|NCT01062152|Differentiation|differentiation
489797|NCT01062152|Enzyme inhibitor|enzyme inhibitor
489798|NCT01062126|Pacemaker|pacemaker
489799|NCT01062126|Advanced Features|advanced features
489800|NCT01062126|Clinical Outcomes|clinical outcomes
490094|NCT01060839|counseling|counseling
489801|NCT01062113|Acute pain after oral surgery lateral mandibular Impacted third molar tooth extraction|acute pain after oral surgery lateral mandibular impacted third molar tooth extraction
489802|NCT01062100|breast cancer|breast cancer
489803|NCT01062100|molecular breast imaging|molecular breast imaging
489804|NCT01062100|MRI|mri
489805|NCT01062100|gamma camera|gamma camera
489806|NCT01062087|postoperative pain|postoperative pain
489807|NCT01062087|tubal ligation|tubal ligation
489808|NCT01062087|local anesthetic|local anesthetic
489809|NCT01062061|Varicella|varicella
489810|NCT01062035|Advanced colon polyp|advanced colon polyp
489811|NCT01062035|Adenomatous colon polyp|adenomatous colon polyp
489812|NCT01062035|Adenoma, villous colon polyp|adenoma, villous colon polyp
489813|NCT01062035|Advanced colorectal adenomas|advanced colorectal adenomas
489814|NCT01062035|Colonic neoplasms|colonic neoplasms
489815|NCT01062035|High grade dysplasia|high grade dysplasia
489816|NCT01062035|Telomere blood testing|telomere blood testing
489817|NCT01062022|intervention|intervention
489818|NCT01062022|combat wounded|combat wounded
489820|NCT01062022|Focus-CI|focus-ci
489821|NCT01061996|Ulcerative Colitis|ulcerative colitis
489822|NCT01061983|Deep brain stimulation|deep brain stimulation
489823|NCT01061983|Treatment refractory|treatment refractory
489824|NCT01061983|Ventral internal capsule/ventral striatum|ventral internal capsule/ventral striatum
489825|NCT01061983|Neurosurgery|neurosurgery
489826|NCT01061983|Neuroimaging|neuroimaging
489827|NCT01061970|Hypogonadism|hypogonadism
489828|NCT01061970|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
489829|NCT01061970|COPD|copd
489830|NCT01061957|Treatment outcome|treatment outcome
489831|NCT01061957|HIV treatment|hiv treatment
489832|NCT01061944|biopsy|biopsy
489833|NCT01061944|tumor biopsy|tumor biopsy
489834|NCT01061944|genetic studies|genetic studies
489835|NCT01061931|MRI|mri
489836|NCT01061931|left-sided atrial catheter ablation|left-sided atrial catheter ablation
489837|NCT01061931|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
489838|NCT01061931|cryoballoon technique|cryoballoon technique
489839|NCT01061931|mesh ablator catheter|mesh ablator catheter
489840|NCT01061931|stroke|stroke
489841|NCT01061931|silent stroke|silent stroke
489842|NCT01061931|major complications|major complications
489843|NCT01061918|Compare the visual outcomes with bilateral implantation of Tecnis MF and ReSTOR IOLs 6 months post cataract surgery.|compare the visual outcomes with bilateral implantation of tecnis mf and restor iols 6 months post cataract surgery.
489844|NCT01061905|health behavior|health behavior
489845|NCT01061905|behavioral economics|behavioral economics
489846|NCT01061905|calorie labeling|calorie labeling
489847|NCT01061905|exercise|exercise
489848|NCT01061879|umbilical cord|umbilical cord
489849|NCT01061879|umbilical cord blood collection|umbilical cord blood collection
489850|NCT01061879|pregnancy|pregnancy
489851|NCT01061866|Thalidomide|thalidomide
489852|NCT01061866|Antiepileptic drugs|antiepileptic drugs
489853|NCT01061866|Refractory epilepsy|refractory epilepsy
489854|NCT01061866|Sedative drugs|sedative drugs
489855|NCT01061853|Oral lichen planus|oral lichen planus
489856|NCT01061853|chronic inflammatory|chronic inflammatory
489857|NCT01061853|mucous membranes|mucous membranes
489858|NCT01061853|erosive lesions|erosive lesions
489859|NCT01061840|Ewings Sarcoma|ewings sarcoma
489860|NCT01061840|Non Small Cell Lung Cancer|non small cell lung cancer
489861|NCT01061840|Liver Cancer|liver cancer
489862|NCT01061827|GMS-package;dementia;depression|gms-package;dementia;depression
489863|NCT01061814|ApoB (Apolipoprotein B)|apob (apolipoprotein b)
489864|NCT01061814|LDL (low density lipoprotein)|ldl (low density lipoprotein)
489865|NCT01061814|mipomersen|mipomersen
489866|NCT01061814|ISIS301012|isis301012
489867|NCT01061814|antisense|antisense
489868|NCT01061801|caregivers|caregivers
489869|NCT01061801|cancer|cancer
489870|NCT01061801|emotion|emotion
489871|NCT01061801|protective buffering|protective buffering
489872|NCT01061788|Phase I|phase i
489873|NCT01061788|Solid Tumor|solid tumor
489874|NCT01061788|AMG 479|amg 479
489875|NCT01061788|Panitumumab|panitumumab
489876|NCT01061788|Everolimus|everolimus
489877|NCT01061788|RAD001|rad001
489878|NCT01061788|Duke|duke
489879|NCT01061788|Subjects with refractory advanced solid tumors|subjects with refractory advanced solid tumors
489880|NCT01061788|non-small cell lung cancer|non-small cell lung cancer
489881|NCT01061775|Hypothalamic Obesity|hypothalamic obesity
489882|NCT01061775|Exenatide|exenatide
489883|NCT01061775|Byetta|byetta
489884|NCT01061775|Craniopharyngioma|craniopharyngioma
489885|NCT01061762|Treatment adherence|treatment adherence
489886|NCT01061762|Low literacy skills|low literacy skills
489887|NCT01061762|HIV treatment|hiv treatment
489888|NCT01061710|Smoking|smoking
489889|NCT01061710|smoking cessation|smoking cessation
489890|NCT01061710|Japanese|japanese
489891|NCT01061710|varenicline|varenicline
489892|NCT01061710|retreatment|retreatment
489893|NCT01061710|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
489894|NCT01061684|fatty liver disease|fatty liver disease
489895|NCT01061684|NASH|nash
489896|NCT01061684|NAFLD|nafld
489897|NCT01061684|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
489898|NCT01061671|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
489899|NCT01061671|COPD|copd
489900|NCT01061671|Exacerbation|exacerbation
489901|NCT01061671|Lung function|lung function
489902|NCT01061671|Cardiovascular|cardiovascular
489903|NCT01061671|Smoking|smoking
489904|NCT01061671|Statins|statins
489905|NCT01061671|Simvastatin|simvastatin
489906|NCT01061645|MDT and DLT|mdt and dlt
489907|NCT01061632|deadlift|deadlift
489908|NCT01061632|motor control|motor control
489909|NCT01061632|exercises|exercises
489910|NCT01061632|pain|pain
489911|NCT01061632|function|function
489912|NCT01061632|functional capacity|functional capacity
489913|NCT01061619|prediagnostic symptoms|prediagnostic symptoms
489914|NCT01061619|sentinel events|sentinel events
489915|NCT01061619|pathway to diagnosis|pathway to diagnosis
489916|NCT01061593|TB|tb
489917|NCT01061593|MDR-TB|mdr-tb
489918|NCT01061593|XDR-TB|xdr-tb
489919|NCT01061593|TB/HIV|tb/hiv
489920|NCT01061580|Bone Marrow Concentrate|bone marrow concentrate
489921|NCT01061580|CABG|cabg
489922|NCT01061580|Cardiac|cardiac
489923|NCT01061580|Stem Cell|stem cell
489924|NCT01061554|Bioavailability|bioavailability
489925|NCT01061554|Eicosapentaenoic acid|eicosapentaenoic acid
489926|NCT01061554|Docosahexaenoic acid|docosahexaenoic acid
489927|NCT01061554|Soft gel capsules|soft gel capsules
489928|NCT01061554|Gastric stable emulsion|gastric stable emulsion
489929|NCT01061554|Omega-3|omega-3
489930|NCT01061554|Tri-glycerides|tri-glycerides
489931|NCT01061554|Marine phospholipids|marine phospholipids
489932|NCT01061541|Pertussis|pertussis
489933|NCT01061541|Tetanus|tetanus
489934|NCT01061541|Hiberix™|hiberix™
489935|NCT01061541|Hepatitis B|hepatitis b
489936|NCT01061541|DTPw-HBV vaccine|dtpw-hbv vaccine
489937|NCT01061541|Tritanrix™-HepB|tritanrix™-hepb
489938|NCT01061541|Haemophilus influenzae type b|haemophilus influenzae type b
489939|NCT01061541|Diphtheria|diphtheria
489940|NCT01061541|Hib vaccine|hib vaccine
489941|NCT01061528|cigarette smoking|cigarette smoking
489942|NCT01061528|smoking cessation|smoking cessation
489943|NCT01061528|nicotine dependence|nicotine dependence
489944|NCT01061502|Burns|burns
489945|NCT01061502|Wounds and Injuries|wounds and injuries
489946|NCT01061502|Skin Grafts, Bioelectric|skin grafts, bioelectric
489947|NCT01061502|Grafting, skin|grafting, skin
489948|NCT01061489|neuroplasticity|neuroplasticity
489949|NCT01061489|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
489950|NCT01061489|Alzheimer|alzheimer
489951|NCT01061489|sensory-cognitive training|sensory-cognitive training
489952|NCT01061489|physical fitness|physical fitness
489953|NCT01061476|sleep apnea|sleep apnea
489954|NCT01061476|treatment|treatment
489955|NCT01061476|collapsibility|collapsibility
489956|NCT01061476|expiratory nasal resistance|expiratory nasal resistance
489957|NCT01061463|Radiation cataracts|radiation cataracts
489958|NCT01061463|Lens opacities|lens opacities
489959|NCT01061463|X-rays|x-rays
489960|NCT01061463|Interventional Cardiologists|interventional cardiologists
489961|NCT01061463|Electrophysiologists|electrophysiologists
489962|NCT01061450|Diastolic dysfunction|diastolic dysfunction
489963|NCT01061450|hypertension|hypertension
489964|NCT01061450|Statins|statins
489965|NCT01061450|ACE inhibitor|ace inhibitor
489966|NCT01061450|Echocardiography|echocardiography
489967|NCT01061437|H. pylori|h. pylori
489968|NCT01061424|pediatric asthma|pediatric asthma
489969|NCT01061398|cardiac ct|cardiac ct
489970|NCT01061398|stress testing|stress testing
489971|NCT01061398|coronary artery disease|coronary artery disease
489972|NCT01061372|RLS|rls
489973|NCT01061359|Breast Cancer|breast cancer
489974|NCT01061359|Neoadjuvant Treatment|neoadjuvant treatment
489975|NCT01061359|Chemotherapy|chemotherapy
489976|NCT01061359|Adjuvant|adjuvant
489977|NCT01061359|Epirubicin|epirubicin
489978|NCT01061346|Fructose|fructose
489979|NCT01061346|Glucose|glucose
489980|NCT01061320|Alpha-Tocopherol (Vitamin E)|alpha-tocopherol (vitamin e)
489981|NCT01061320|Contrast induced nephropathy|contrast induced nephropathy
489982|NCT01061320|Chronic kidney disease|chronic kidney disease
489983|NCT01061320|Coronary procedures|coronary procedures
489984|NCT01061307|Fe deficiency, Zn deficiency, vitamin A deficiency|fe deficiency, zn deficiency, vitamin a deficiency
489985|NCT01061294|Assess the efficacy, predictability and safety of the Advanced CustomVue™ iLASIK procedure.|assess the efficacy, predictability and safety of the advanced customvue™ ilasik procedure.
489986|NCT01061281|Aphakia following refractive lensectomy to treat presbyopia|aphakia following refractive lensectomy to treat presbyopia
489987|NCT01061268|Relief of dry eye symptoms following implantation of TMF IOL|relief of dry eye symptoms following implantation of tmf iol
489988|NCT01061255|Stress|stress
489989|NCT01061255|Cortisol|cortisol
489990|NCT01061255|Clinical reasoning|clinical reasoning
489991|NCT01061255|Ambulatory setting|ambulatory setting
489992|NCT01061255|Medical students|medical students
489993|NCT01061255|Year 6 medical students|year 6 medical students
489994|NCT01061242|Neurocognitive function|neurocognitive function
489995|NCT01061242|Sleep quality|sleep quality
489996|NCT01061242|Critical care|critical care
489997|NCT01061242|Quality Assurance, health care|quality assurance, health care
489998|NCT01061216|Diabetes|diabetes
489999|NCT01061216|Insulin Therapy|insulin therapy
490000|NCT01061216|Blood Glucose|blood glucose
490001|NCT01061216|Basal insulin|basal insulin
490002|NCT01061216|Diabetics|diabetics
490003|NCT01061203|Rhinitis|rhinitis
490004|NCT01061203|allergic|allergic
490005|NCT01061203|Seasonal|seasonal
490006|NCT01061203|grass|grass
490007|NCT01061203|Asthma|asthma
490008|NCT01061190|Stroke|stroke
490009|NCT01061177|Leukemia|leukemia
490010|NCT01061177|myeloid|myeloid
490011|NCT01061177|myelogenous|myelogenous
490012|NCT01061177|chronic BCR-ABL positive|chronic bcr-abl positive
490013|NCT01061177|Nilotinib|nilotinib
490014|NCT01061177|Philadelphia chromosome|philadelphia chromosome
490015|NCT01061177|CML in chronic phase|cml in chronic phase
490016|NCT01061151|Mother to Child Transmission|mother to child transmission
490017|NCT01061151|HIV Infection|hiv infection
490018|NCT01061151|HAART|haart
490019|NCT01061151|Maternal Health|maternal health
490020|NCT01061151|Breastfeeding|breastfeeding
490021|NCT01061151|Perinatal transmission|perinatal transmission
490022|NCT01061138|breast cancer|breast cancer
490023|NCT01061138|screening mammograms|screening mammograms
490024|NCT01061138|breast biopsy|breast biopsy
490025|NCT01061125|atrial fibrillation|atrial fibrillation
490026|NCT01061125|implantable loop recorder|implantable loop recorder
490027|NCT01061125|TTM|ttm
490028|NCT01061112|drug interactions|drug interactions
490029|NCT01061112|genetics|genetics
490030|NCT01061112|healthy volunteers|healthy volunteers
490031|NCT01061112|normal controls|normal controls
490032|NCT01061112|CYP2C9|cyp2c9
490033|NCT01061099|Type II or Type III Osteogenesis imperfecta|type ii or type iii osteogenesis imperfecta
490034|NCT01061099|OI|oi
490035|NCT01061099|Mesenchymal Stromal Cells|mesenchymal stromal cells
490036|NCT01061099|MSC|msc
490037|NCT01061086|Acute Coronary Syndromes|acute coronary syndromes
490038|NCT01061086|Epidemiology|epidemiology
490039|NCT01061086|Management of disease|management of disease
490040|NCT01061086|Outcomes|outcomes
490041|NCT01061086|Greece|greece
490042|NCT01061060|Prostaglandin I2|prostaglandin i2
490043|NCT01061060|Beraprost Na|beraprost na
490044|NCT01061060|Endothelial cell function|endothelial cell function
490045|NCT01061047|patients infected with a bacteria sensible to ertapeneme|patients infected with a bacteria sensible to ertapeneme
490046|NCT01061034|pharmacokinetics|pharmacokinetics
490047|NCT01061034|aspirin|aspirin
490048|NCT01061034|proton pump inhiditor|proton pump inhiditor
490049|NCT01061021|HIV prevention|hiv prevention
490050|NCT01061021|Treatment adherence|treatment adherence
490051|NCT01061021|Treatment for Prevention|treatment for prevention
490052|NCT01061008|Exercise; arteriovenous fistula; chronic kidney disease|exercise; arteriovenous fistula; chronic kidney disease
490053|NCT01060995|Informed Consent|informed consent
490054|NCT01060995|Oral Health|oral health
490055|NCT01060995|Patient Decision-making|patient decision-making
490056|NCT01060982|Primary hyperparathyroidism|primary hyperparathyroidism
490057|NCT01060982|High Intensity Focused Ultrasound|high intensity focused ultrasound
490058|NCT01060982|Parathyroid tumor|parathyroid tumor
490059|NCT01060982|Parathyroid hormone|parathyroid hormone
490061|NCT01060969|Acute Mountain Sickness|acute mountain sickness
490062|NCT01060969|travellers|travellers
490063|NCT01060969|Acetazolamide|acetazolamide
490064|NCT01060969|Tadalafil|tadalafil
490065|NCT01060969|Acute Mountain Sickness assessed by Lake Louise score|acute mountain sickness assessed by lake louise score
490066|NCT01060969|High altitude pulmonary edema|high altitude pulmonary edema
490067|NCT01060969|High altitude cerebral edema|high altitude cerebral edema
490068|NCT01060956|Urinary tract infection with two bacteria in culture|urinary tract infection with two bacteria in culture
490069|NCT01060943|injectable collagen filler|injectable collagen filler
490070|NCT01060943|correction of wrinkles and folds|correction of wrinkles and folds
490071|NCT01060943|enrolled : 73|enrolled : 73
490072|NCT01060943|withdrawal : 4|withdrawal : 4
490073|NCT01060943|ongoing : 0|ongoing : 0
490074|NCT01060943|completed : 69|completed : 69
490075|NCT01060930|Nitric oxide|nitric oxide
490076|NCT01060930|Diesel exhaust|diesel exhaust
490077|NCT01060930|Air pollution|air pollution
490078|NCT01060930|Cardiac output|cardiac output
490079|NCT01060930|Healthy volunteers|healthy volunteers
490080|NCT01060917|diabetes|diabetes
490081|NCT01060904|Antibodies, Monoclonal|antibodies, monoclonal
490082|NCT01060904|Antibody-Drug Conjugate|antibody-drug conjugate
490083|NCT01060904|Antigens, CD30|antigens, cd30
490084|NCT01060904|Disease, Hodgkin|disease, hodgkin
490085|NCT01060904|Hematologic Diseases|hematologic diseases
490086|NCT01060904|Immunotherapy|immunotherapy
490087|NCT01060904|Lymphoma|lymphoma
490088|NCT01060904|monomethyl auristatin E|monomethyl auristatin e
490089|NCT01060891|patients infected with with multiresistant gram-negative bacteria|patients infected with with multiresistant gram-negative bacteria
490090|NCT01060878|Early-stage|early-stage
490091|NCT01060865|hypertension|hypertension
490092|NCT01060865|aliskiren|aliskiren
490093|NCT01060865|Blood Pressure Monitoring, Ambulatory|blood pressure monitoring, ambulatory
490095|NCT01060826|acute pancreatits|acute pancreatits
490096|NCT01060813|cirrhosis|cirrhosis
490097|NCT01060813|exercise|exercise
490098|NCT01060813|leucin|leucin
490099|NCT01060813|glutamine synthetase|glutamine synthetase
490100|NCT01060800|Chiari|chiari
490101|NCT01060800|Chiari Type I|chiari type i
490102|NCT01060800|Chiari Type I Malformation|chiari type i malformation
490103|NCT01060800|Familial Chiari|familial chiari
490104|NCT01060774|Bupivacaine|bupivacaine
490105|NCT01060774|Inflammation|inflammation
490106|NCT01060774|Pain|pain
490107|NCT01060774|Local Anesthetic|local anesthetic
490108|NCT01060774|peripheral sensitization|peripheral sensitization
490109|NCT01060761|cancer|cancer
490110|NCT01060761|Rehabilitation program (patient and a relative together)|rehabilitation program (patient and a relative together)
490111|NCT01060761|counselling|counselling
490112|NCT01060761|retreat weekend|retreat weekend
490113|NCT01060748|Vaccination|vaccination
490114|NCT01060748|Challenge|challenge
490115|NCT01060748|Diarrhea|diarrhea
490116|NCT01060748|ETEC illness|etec illness
490117|NCT01060748|Travelers diarrhea|travelers diarrhea
490118|NCT01060748|ETEC|etec
490119|NCT01060748|Enterotoxigenic E.coli|enterotoxigenic e.coli
490120|NCT01060735|Vitamin D|vitamin d
490121|NCT01060735|pregnancy|pregnancy
490122|NCT01060735|children|children
490123|NCT01060735|bone|bone
490124|NCT01060735|quantitative ultrasound|quantitative ultrasound
490125|NCT01060735|Healthy pregnant women|healthy pregnant women
490126|NCT01060722|Healthy Male Volunteers|healthy male volunteers
490127|NCT01060709|Carbon dioxide|carbon dioxide
490128|NCT01060709|TcC02|tcc02
490129|NCT01060709|Hypoventilation|hypoventilation
490130|NCT01060709|endoscopic|endoscopic
490131|NCT01060709|elective colonoscopy and requiring sedation|elective colonoscopy and requiring sedation
490132|NCT01060696|Infertility|infertility
490133|NCT01060696|Saline infusion sonohysterography|saline infusion sonohysterography
490134|NCT01060696|Pain|pain
490135|NCT01060696|Hyoscine|hyoscine
490136|NCT01060696|Mefenamic acid|mefenamic acid
490137|NCT01060696|women|women
490138|NCT01060683|hemoglobin|hemoglobin
490139|NCT01060683|Coagulation variables|coagulation variables
490140|NCT01060683|blood chemistry|blood chemistry
490141|NCT01060683|Blood gas analysis|blood gas analysis
490142|NCT01060670|Foot Ulcer|foot ulcer
490143|NCT01060670|Diabetic|diabetic
490144|NCT01060670|Wound Healing|wound healing
490145|NCT01060670|Integra Dermal Regeneration Template|integra dermal regeneration template
490146|NCT01060670|Full Thickness|full thickness
490147|NCT01060670|Neuropathic|neuropathic
490148|NCT01060670|Omnigraft|omnigraft
490149|NCT01060657|X-ray Computed Tomography|x-ray computed tomography
490150|NCT01060657|Coronary vessels|coronary vessels
490151|NCT01060657|Radiation dosage|radiation dosage
490152|NCT01060644|Maxillary Sinus|maxillary sinus
490153|NCT01060644|Bone Augmentation|bone augmentation
490154|NCT01060644|Dental Implant|dental implant
490155|NCT01060644|Sinus Membrane|sinus membrane
490156|NCT01060631|bispectral index|bispectral index
490157|NCT01060631|lesions|lesions
490158|NCT01060631|consciousness|consciousness
490159|NCT01060605|islet transplantation|islet transplantation
490160|NCT01060605|insulin independence|insulin independence
490161|NCT01060605|C-peptide secretion|c-peptide secretion
490162|NCT01060592|Gastric Band|gastric band
490163|NCT01060592|LapBand|lapband
490164|NCT01060592|Bariatric Surgery|bariatric surgery
490165|NCT01060579|Glaucoma|glaucoma
490166|NCT01060553|Post-traumatic stress disorders|post-traumatic stress disorders
490167|NCT01060553|Acupuncture|acupuncture
490168|NCT01060553|Quality of life|quality of life
490169|NCT01060553|sleep disorder|sleep disorder
490170|NCT01060540|genetic screening|genetic screening
490171|NCT01060527|irritable bowel syndrome,protease activity,China|irritable bowel syndrome,protease activity,china
490172|NCT01060514|Lung cancer|lung cancer
490173|NCT01060514|Breast cancer|breast cancer
490174|NCT01060501|rectal cancer|rectal cancer
490175|NCT01060501|adjuvant chemoradiotherapy|adjuvant chemoradiotherapy
490176|NCT01060501|5-FU, interferon-alpha|5-fu, interferon-alpha
490177|NCT01060501|Locally advanced resectable rectal cancer (UICC stage II and III)|locally advanced resectable rectal cancer (uicc stage ii and iii)
490178|NCT01060488|GH secretion tests|gh secretion tests
490179|NCT01060488|adverse effects|adverse effects
490180|NCT01060488|adult growth hormone deficiency|adult growth hormone deficiency
490181|NCT01060488|growth-hormone releasing hormone and arginine test|growth-hormone releasing hormone and arginine test
490182|NCT01060488|insulin tolerance test|insulin tolerance test
490183|NCT01060488|GHRH + Arginine test|ghrh + arginine test
490184|NCT01060475|Transplant|transplant
490185|NCT01060462|Defervescence rate|defervescence rate
490186|NCT01060462|Defervescence timing|defervescence timing
490187|NCT01060462|Itraconazole|itraconazole
490188|NCT01060449|cardiac resynchronization therapy|cardiac resynchronization therapy
490189|NCT01060449|congestive heart failure|congestive heart failure
490190|NCT01060436|sleep apnea|sleep apnea
490191|NCT01060436|sleep disordered breathing|sleep disordered breathing
490192|NCT01060436|CPAP|cpap
490193|NCT01060436|BiPAP|bipap
490194|NCT01060436|treatment outcomes|treatment outcomes
490195|NCT01060423|colorectal|colorectal
490196|NCT01060423|liver metastasis|liver metastasis
490197|NCT01060423|KRAS wildtype|kras wildtype
490198|NCT01060423|chemoembolization|chemoembolization
490199|NCT01060423|irinotecan eluting beads|irinotecan eluting beads
490200|NCT01060410|Myelosuppression|myelosuppression
490201|NCT01060410|Infection|infection
490202|NCT01060410|Nausea|nausea
490203|NCT01060397|Alcohol|alcohol
490204|NCT01060397|nurse|nurse
490205|NCT01060397|alcohol dependence|alcohol dependence
490206|NCT01060397|acute hospital|acute hospital
490207|NCT01060397|brief interventions|brief interventions
490208|NCT01060371|Spinocerebellar Ataxia|spinocerebellar ataxia
490209|NCT01060371|Natural History|natural history
490210|NCT01060371|Genetic Modifiers|genetic modifiers
490211|NCT01060371|DNA testing|dna testing
490212|NCT01060358|lumbar spine|lumbar spine
490213|NCT01060358|low back pain|low back pain
490214|NCT01060345|DCIS|dcis
490215|NCT01060293|Heart Failure|heart failure
490216|NCT01060293|Dopamine|dopamine
490217|NCT01060293|Furosemide|furosemide
490218|NCT01060293|Worsening Renal Function|worsening renal function
490219|NCT01060293|Hypokalemia|hypokalemia
490220|NCT01060293|Outcomes|outcomes
490221|NCT01060293|Prognosis|prognosis
490222|NCT01060280|low back pain|low back pain
490223|NCT01060280|physiotherapy|physiotherapy
490224|NCT01060280|exercise|exercise
490225|NCT01060280|active management|active management
490226|NCT01060254|Interstitial cystitis (IC) and/or painful bladder syndrome (PBS)-related pain|interstitial cystitis (ic) and/or painful bladder syndrome (pbs)-related pain
490227|NCT01060254|Moderate to severe chronic bladder pain|moderate to severe chronic bladder pain
490228|NCT01060254|JNJ-42160443|jnj-42160443
490229|NCT01060241|Remote Blood Glucose Monitoring System, Type 2 Diabetes|remote blood glucose monitoring system, type 2 diabetes
490230|NCT01060228|Paliperidone ER|paliperidone er
490231|NCT01060228|INVEGA|invega
490232|NCT01060228|Divalproex sodium|divalproex sodium
490233|NCT01060228|Depakote ER|depakote er
490234|NCT01060228|Pharmacokinetics|pharmacokinetics
490235|NCT01060228|Valproic Acid|valproic acid
490236|NCT01060228|Human Experimentation|human experimentation
490237|NCT01060215|effusion|effusion
490238|NCT01060215|osteoarthritis|osteoarthritis
490239|NCT01060215|knee|knee
490240|NCT01060202|Multiple Myeloma|multiple myeloma
490241|NCT01060202|Bortezomib|bortezomib
490242|NCT01060202|Velcade|velcade
490243|NCT01060202|QoL|qol
490244|NCT01060202|Proteasome inhibitor|proteasome inhibitor
490245|NCT01060202|EORTC QLQ C30|eortc qlq c30
490246|NCT01060202|EQ 5D|eq 5d
490247|NCT01060189|ulinastatin|ulinastatin
490248|NCT01060189|tranexamic acid|tranexamic acid
490249|NCT01060189|cardiac surgery procedures|cardiac surgery procedures
490250|NCT01060189|hemostasis|hemostasis
490251|NCT01060189|anti-inflammation|anti-inflammation
490252|NCT01060176|tranexamic acid|tranexamic acid
490253|NCT01060176|cardiac surgery procedures|cardiac surgery procedures
490254|NCT01060176|hemostasis|hemostasis
490255|NCT01060176|anti-inflammation|anti-inflammation
490256|NCT01060163|Clopidogrel|clopidogrel
490257|NCT01060163|Tranexamic Acid|tranexamic acid
490258|NCT01060163|Cardiac Surgical Procedures|cardiac surgical procedures
490259|NCT01060163|Hemostasis|hemostasis
490260|NCT01060150|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
490261|NCT01060150|Methylphenidate hydrochloride|methylphenidate hydrochloride
490262|NCT01060150|Methylphenidate|methylphenidate
490263|NCT01060150|CONCERTA|concerta
490264|NCT01060137|fentanyl matrix|fentanyl matrix
490265|NCT01060124|Pain; Cancer|pain; cancer
490266|NCT01060124|TTS-Fentanyl D-trans|tts-fentanyl d-trans
490267|NCT01060124|Durogesic D-trans|durogesic d-trans
490268|NCT01060111|Migraine|migraine
490269|NCT01060111|Topiramate|topiramate
490270|NCT01060111|Propranolol|propranolol
490271|NCT01060085|Breast Cancer|breast cancer
490272|NCT01060059|diabetes; exenatide; Byetta; basal insulin; Amylin; Lilly|diabetes; exenatide; byetta; basal insulin; amylin; lilly
490273|NCT01060046|biologic mesh|biologic mesh
490274|NCT01060046|ventral hernia repair|ventral hernia repair
490275|NCT01060046|breast reconstruction|breast reconstruction
490276|NCT01060046|MMPs|mmps
490277|NCT01060033|Squamous cell cervical cancer|squamous cell cervical cancer
490278|NCT01060020|Aortic valve stenosis|aortic valve stenosis
490279|NCT01060020|Sildenafil|sildenafil
490280|NCT01060020|Phosphodiesterase inhibitors|phosphodiesterase inhibitors
490281|NCT01060020|Hypertension, Pulmonary|hypertension, pulmonary
490282|NCT01059994|fatigue|fatigue
490283|NCT01059994|aging|aging
490284|NCT01059968|bone density|bone density
490285|NCT01059968|energy availability|energy availability
490286|NCT01059968|menstrual status|menstrual status
490287|NCT01059968|female|female
490288|NCT01059968|adolescent|adolescent
490289|NCT01059955|scleritis|scleritis
490290|NCT01059955|anterior scleritis|anterior scleritis
490291|NCT01059955|nodular anterior scleritis|nodular anterior scleritis
490292|NCT01059955|diffuse anterior scleritis|diffuse anterior scleritis
490293|NCT01059942|communication barriers|communication barriers
490294|NCT01059942|clinical competence|clinical competence
490295|NCT01059942|medical education|medical education
490296|NCT01059942|internship and residency|internship and residency
490297|NCT01059942|hospitalist|hospitalist
490298|NCT01059942|Quality Assurance, Healthcare|quality assurance, healthcare
490299|NCT01059942|Patient Care|patient care
490300|NCT01059942|Internal Medicine|internal medicine
490301|NCT01059929|Hypnotics and Sedatives|hypnotics and sedatives
490302|NCT01059929|Respiration, Artificial|respiration, artificial
490303|NCT01059929|Ventilators, Mechanical|ventilators, mechanical
490304|NCT01059929|Critical care|critical care
490305|NCT01059929|Intensive care|intensive care
490306|NCT01059929|Physical therapy|physical therapy
490307|NCT01059929|Occupational therapy|occupational therapy
490308|NCT01059929|Sedative medications|sedative medications
490309|NCT01059903|Rotigotine|rotigotine
490310|NCT01059903|Neupro®|neupro®
490311|NCT01059903|Transdermal Patch|transdermal patch
490312|NCT01059877|dementia alzheimers frontotemporal lyme,|dementia alzheimers frontotemporal lyme,
490313|NCT01059877|lewy body cognitive impairment|lewy body cognitive impairment
490314|NCT01059864|cholesterol|cholesterol
490315|NCT01059864|lipids|lipids
490316|NCT01059864|rheumatoid arthritis|rheumatoid arthritis
490317|NCT01059864|CP-690|cp-690
490318|NCT01059864|550|550
490319|NCT01059838|pediatrics|pediatrics
490320|NCT01059838|cochlear implant|cochlear implant
490321|NCT01059825|Phase 2|phase 2
490322|NCT01059825|safety and efficacy study with ertugliflozin (PF-04971729, MK-8835)|safety and efficacy study with ertugliflozin (pf-04971729, mk-8835)
490323|NCT01059825|Type 2 diabetes mellitus|type 2 diabetes mellitus
490324|NCT01059786|Monoclonal Antibody|monoclonal antibody
490325|NCT01059786|Purine Analog|purine analog
490326|NCT01059786|Soluble CD25|soluble cd25
490327|NCT01059786|Minimal Residual Disease MRD|minimal residual disease mrd
490328|NCT01059786|CD20|cd20
490329|NCT01059786|Hairy Cell Leukemia|hairy cell leukemia
490330|NCT01059773|Psoriasis|psoriasis
490331|NCT01059773|Ustekinumab|ustekinumab
490332|NCT01059773|Stelara|stelara
490333|NCT01059773|Methotrexate|methotrexate
490334|NCT01059773|Biologic|biologic
490335|NCT01059760|Fasting|fasting
490336|NCT01059760|Short-term starvation|short-term starvation
490337|NCT01059760|Diet|diet
490338|NCT01059760|Coronary artery disease|coronary artery disease
490339|NCT01059734|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
490340|NCT01059734|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
490341|NCT01059734|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
490342|NCT01059734|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
490343|NCT01059734|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
490344|NCT01059734|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
490345|NCT01059734|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
490346|NCT01059734|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
490347|NCT01059734|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
490348|NCT01059734|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
490349|NCT01059734|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
490350|NCT01059734|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
490351|NCT01059734|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
490352|NCT01059734|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
490353|NCT01059734|secondary acute myeloid leukemia|secondary acute myeloid leukemia
490354|NCT01059734|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
490355|NCT01059734|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
490356|NCT01059721|Centralisation|centralisation
490357|NCT01059721|Patella dislocation|patella dislocation
490358|NCT01059721|Open epiphyses|open epiphyses
490359|NCT01059721|Malalignment syndrome|malalignment syndrome
490360|NCT01059721|Relapse rate|relapse rate
490361|NCT01059708|outcomes carbon monoxide poisoning children pediatric|outcomes carbon monoxide poisoning children pediatric
490362|NCT01059695|cervical cancer|cervical cancer
490363|NCT01059695|retrospective|retrospective
490364|NCT01059695|quality of life|quality of life
490365|NCT01059695|treatment|treatment
490366|NCT01059669|Chronic pancreatitis|chronic pancreatitis
490367|NCT01059669|Pain|pain
490368|NCT01059669|Exocrine insufficiency|exocrine insufficiency
490369|NCT01059669|Diabetes|diabetes
490370|NCT01059669|Nutrition|nutrition
490371|NCT01059669|Ultrasound|ultrasound
490372|NCT01059656|Dermatofibrosarcoma|dermatofibrosarcoma
490373|NCT01059656|Pazopanib¨|pazopanib¨
490374|NCT01059656|Phase II|phase ii
490375|NCT01059630|follicular|follicular
490376|NCT01059630|follicular lymphoma|follicular lymphoma
490377|NCT01059617|Pandemic|pandemic
490378|NCT01059617|GSK Bio's influenza vaccine GSK2340274A|gsk bio's influenza vaccine gsk2340274a
490379|NCT01059617|H1N1|h1n1
490380|NCT01059617|Influenza|influenza
490381|NCT01059604|pregnancy outcomes|pregnancy outcomes
490382|NCT01059604|pregnancy|pregnancy
490383|NCT01059604|first trimester|first trimester
490384|NCT01059604|Sumatriptan|sumatriptan
490385|NCT01059604|major congenital malformations|major congenital malformations
490386|NCT01059604|naratriptan|naratriptan
490387|NCT01059604|sumatriptan-naproxen combination|sumatriptan-naproxen combination
490388|NCT01059604|pregnancy registry|pregnancy registry
490389|NCT01059591|NK1 antagonist and SSRI|nk1 antagonist and ssri
490390|NCT01059591|Healthy subjects|healthy subjects
490391|NCT01059591|Safety|safety
490392|NCT01059591|First time in Human|first time in human
490393|NCT01059578|Nk1 Antagonist and SSRI|nk1 antagonist and ssri
490394|NCT01059578|Safety|safety
490395|NCT01059578|First Time in Humans|first time in humans
490396|NCT01059578|Healthy Subjects|healthy subjects
490397|NCT01059565|Cystic Fibrosis|cystic fibrosis
490398|NCT01059565|Aztreonam Lysine|aztreonam lysine
490399|NCT01059565|lung infection|lung infection
490400|NCT01059565|Burkholderia|burkholderia
490401|NCT01059565|CFQ-R|cfq-r
490402|NCT01059565|inhaled antibiotic|inhaled antibiotic
490403|NCT01059552|lung cancer|lung cancer
490404|NCT01059552|locally advanced lung cancer|locally advanced lung cancer
490405|NCT01059539|mania|mania
490406|NCT01059539|acute mania|acute mania
490407|NCT01059539|bipolar I disorder|bipolar i disorder
490408|NCT01059526|HAE|hae
490409|NCT01059513|T1c|t1c
490410|NCT01059513|T2a|t2a
490411|NCT01059513|T2b|t2b
490412|NCT01059500|Computer-derived, quantitative pretest probability (PTP)|computer-derived, quantitative pretest probability (ptp)
490413|NCT01059500|Overtesting|overtesting
490414|NCT01059500|Radiation|radiation
490415|NCT01059500|Intravenous Contrast|intravenous contrast
490416|NCT01059500|Anticoagulation|anticoagulation
490417|NCT01059487|Traditional Chinese Medicine|traditional chinese medicine
490418|NCT01059487|Acupuncture|acupuncture
490419|NCT01059474|DMPS|dmps
490420|NCT01059474|mercury|mercury
490421|NCT01059461|Hypoxic Ischemic Encephalopathy (HIE)|hypoxic ischemic encephalopathy (hie)
490422|NCT01059461|Perinatal Asphyxia|perinatal asphyxia
490423|NCT01059461|Nerve growth factor|nerve growth factor
490424|NCT01059461|Cerebrolysin|cerebrolysin
490425|NCT01059461|Cerebral palsy|cerebral palsy
490426|NCT01059448|Amgen|amgen
490428|NCT01059448|AMG 827|amg 827
490429|NCT01059448|20090061|20090061
490430|NCT01059435|Amgen|amgen
490431|NCT01059435|First in Human|first in human
490432|NCT01059435|Postmenopausal|postmenopausal
490433|NCT01059435|Phase 1|phase 1
490434|NCT01059409|Meniscal Allografts|meniscal allografts
490435|NCT01059409|Osteoarthritis|osteoarthritis
490436|NCT01059383|Gastroesophageal Reflux|gastroesophageal reflux
490437|NCT01059383|GERD|gerd
490438|NCT01059383|Nocturnal GERD|nocturnal gerd
490439|NCT01059383|Heartburn|heartburn
490440|NCT01059383|Nighttime Heartburn|nighttime heartburn
490441|NCT01059370|Autonomic dysfunction|autonomic dysfunction
490442|NCT01059370|Spinal cord injured|spinal cord injured
490443|NCT01059370|Neurogenic bowel|neurogenic bowel
490444|NCT01059370|Neurogenic bladder|neurogenic bladder
490445|NCT01059344|Mesalamine|mesalamine
490446|NCT01059344|Asacol|asacol
490447|NCT01059344|Ulcerative colitis|ulcerative colitis
490448|NCT01059344|induction therapy|induction therapy
490449|NCT01059344|acute disease|acute disease
490450|NCT01059344|mild to moderate|mild to moderate
490451|NCT01059344|Active Ulcerative Colitis (mild to moderate)|active ulcerative colitis (mild to moderate)
490452|NCT01059331|Kidney|kidney
490453|NCT01059318|Lymphangioleiomyomatosis,|lymphangioleiomyomatosis,
490454|NCT01059318|High Resolution CT scan,|high resolution ct scan,
490455|NCT01059318|chest x-ray,|chest x-ray,
490456|NCT01059318|6 minute walk test,|6 minute walk test,
490457|NCT01059318|pulse oximetry,|pulse oximetry,
490458|NCT01059318|renal MRI,|renal mri,
490459|NCT01059318|Pikometer|pikometer
490460|NCT01059305|Erlotinib|erlotinib
490461|NCT01059305|Erlotinib Hydrochloride|erlotinib hydrochloride
490462|NCT01059305|OSI-774|osi-774
490463|NCT01059305|Tarceva|tarceva
490464|NCT01059305|Squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
490465|NCT01059305|Aggressive cutaneous squamous cell carcinoma|aggressive cutaneous squamous cell carcinoma
490466|NCT01059305|CSCC|cscc
490467|NCT01059305|Local surgery|local surgery
490468|NCT01059305|Radiation therapy|radiation therapy
490469|NCT01059305|Epidermal growth factor receptor|epidermal growth factor receptor
490470|NCT01059305|EGFR|egfr
490471|NCT01059305|Small Molecule Tyrosine Kinase Inhibitor|small molecule tyrosine kinase inhibitor
490472|NCT01059292|we have complieted party research|we have complieted party research
490473|NCT01059279|Familial Mediterranean fever|familial mediterranean fever
490474|NCT01059279|Cytokines|cytokines
490475|NCT01059279|Inflammatory proteins|inflammatory proteins
490476|NCT01059279|MEFV|mefv
490477|NCT01059279|mutations|mutations
490478|NCT01059279|Heat Intolerance|heat intolerance
490479|NCT01059279|Heat Tolerance Test|heat tolerance test
490480|NCT01059266|immunotherapy|immunotherapy
490481|NCT01059266|grass pollen|grass pollen
490482|NCT01059266|seasonal allergy|seasonal allergy
490483|NCT01059266|dose tolerability|dose tolerability
490484|NCT01059253|Falls|falls
490485|NCT01059253|Balance|balance
490486|NCT01059253|Elderly|elderly
490487|NCT01059253|Aged|aged
490488|NCT01059240|Survival Motor Neuron 1 (SMN1)|survival motor neuron 1 (smn1)
490489|NCT01059240|Survival Motor Neuron 2 (SMN2)|survival motor neuron 2 (smn2)
490490|NCT01059240|Spinal Muscular Atrophy (SMA)|spinal muscular atrophy (sma)
490491|NCT01059240|SMN Copy Number in Mali|smn copy number in mali
490492|NCT01059240|Spinal Muscular Antrophy|spinal muscular antrophy
490493|NCT01059240|SMA|sma
490494|NCT01059227|Treatment|treatment
490495|NCT01059227|Anxiety|anxiety
490496|NCT01059227|Fear|fear
490497|NCT01059227|Fear Potentiated Startle|fear potentiated startle
490498|NCT01059227|Healthy Volunteer|healthy volunteer
490499|NCT01059227|HV|hv
490500|NCT01059214|Acute Myocardial Infarction|acute myocardial infarction
490501|NCT01059214|Reperfusion|reperfusion
490502|NCT01059214|MRI|mri
490503|NCT01059214|Heart Attack|heart attack
490504|NCT01059201|Autism Spectrum Disorder|autism spectrum disorder
490505|NCT01059201|Cholesterol|cholesterol
490506|NCT01059201|Exome Sequencing|exome sequencing
490507|NCT01059201|Autistic Spectrum Disorder|autistic spectrum disorder
490508|NCT01059201|ASD|asd
490509|NCT01059188|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
490510|NCT01059188|adenocarcinoma of the lung|adenocarcinoma of the lung
490511|NCT01059188|adenosquamous cell lung cancer|adenosquamous cell lung cancer
490512|NCT01059188|large cell lung cancer|large cell lung cancer
490513|NCT01059188|squamous cell lung cancer|squamous cell lung cancer
490514|NCT01059175|Heart failure|heart failure
490515|NCT01059175|Cardiac resynchronization therapy|cardiac resynchronization therapy
490516|NCT01059175|Biventricular stimulation|biventricular stimulation
490517|NCT01059175|Multisite stimulation|multisite stimulation
490518|NCT01059175|Non responders|non responders
490519|NCT01059162|Glaucoma Surgery|glaucoma surgery
490520|NCT01059162|Filtering Surgery|filtering surgery
490521|NCT01059162|Non Penetrating glaucoma surgery|non penetrating glaucoma surgery
490522|NCT01059149|Rehabilitation|rehabilitation
490523|NCT01059149|Transcranial magnetic stimulation|transcranial magnetic stimulation
490524|NCT01059149|Brain magnetic stimulation|brain magnetic stimulation
490525|NCT01059149|Repetitive|repetitive
490526|NCT01059149|Stroke|stroke
490527|NCT01059149|Subacute|subacute
490528|NCT01059136|Myocardial infarction|myocardial infarction
490529|NCT01059136|Outcome|outcome
490530|NCT01059136|Aldosterone|aldosterone
490531|NCT01059136|Spironolactone|spironolactone
490532|NCT01059123|Amoxicillin|amoxicillin
490533|NCT01059123|Erysipelas|erysipelas
490534|NCT01059123|Short course|short course
490535|NCT01059110|Occlusive dressings|occlusive dressings
490536|NCT01059110|Salicylate ointment|salicylate ointment
490537|NCT01059110|Cryotherapy|cryotherapy
490538|NCT01059110|Topical 5-fluoro-uracil|topical 5-fluoro-uracil
490539|NCT01059110|Imiquimod|imiquimod
490540|NCT01059110|Randomized clinical trial|randomized clinical trial
490541|NCT01059110|Plantar warts|plantar warts
490542|NCT01059084|HIV|hiv
490543|NCT01059084|Valacyclovir|valacyclovir
490544|NCT01059084|Valtrex®|valtrex®
490545|NCT01059071|Refractory Neuroblastoma|refractory neuroblastoma
490546|NCT01059071|Relapsed neuroblastoma|relapsed neuroblastoma
490547|NCT01059058|MI Paste Plus|mi paste plus
490548|NCT01059058|Fluoride Varnish|fluoride varnish
490549|NCT01059058|CPP-ACP|cpp-acp
490550|NCT01059058|White Spot Lesions|white spot lesions
490551|NCT01059058|Remineralization|remineralization
490552|NCT01059058|Orthodontic Treatment|orthodontic treatment
490553|NCT01059019|Refractive Surgery|refractive surgery
490554|NCT01059019|PRK|prk
490555|NCT01059019|Photorefractive Keratectomy|photorefractive keratectomy
490556|NCT01059019|Omega 3 Fatty Acids|omega 3 fatty acids
490557|NCT01059019|Cornea|cornea
490558|NCT01059006|Reflective Surgery|reflective surgery
490559|NCT01059006|Presbyopia|presbyopia
490560|NCT01059006|PresbyLASIK|presbylasik
490561|NCT01058993|neutropenia|neutropenia
490562|NCT01058993|myelokathexis|myelokathexis
490563|NCT01058993|WHIM syndrome|whim syndrome
490564|NCT01058993|AMD 3100|amd 3100
490565|NCT01058993|plerixafor|plerixafor
490566|NCT01058993|Myelokathexis syndrome|myelokathexis syndrome
490567|NCT01058993|Neutropenia due to mutations of CXCR-4|neutropenia due to mutations of cxcr-4
490568|NCT01058980|catheter ablation|catheter ablation
490569|NCT01058980|atrial fibrillation|atrial fibrillation
490570|NCT01058980|adenosine|adenosine
490571|NCT01058967|Code III trauma (highest acuity)|code iii trauma (highest acuity)
490572|NCT01058967|Life Flight aeromedical ambulance service|life flight aeromedical ambulance service
490573|NCT01058941|Alzheimer's disease|alzheimer's disease
490574|NCT01058941|fish oil|fish oil
490575|NCT01058941|lipoic acid|lipoic acid
490576|NCT01058928|Tracheal tube|tracheal tube
490577|NCT01058928|Size|size
490578|NCT01058915|ST-Segment Elevation Myocardial Infarction|st-segment elevation myocardial infarction
490579|NCT01058902|Non small cell lung cancer|non small cell lung cancer
490580|NCT01058902|survival|survival
490581|NCT01058902|aspirin|aspirin
490582|NCT01058889|Diabetes mellitus Type 2|diabetes mellitus type 2
490583|NCT01058889|Telemedicine|telemedicine
490584|NCT01058889|Insulin|insulin
490585|NCT01058876|Smoking|smoking
490586|NCT01058876|nicotine|nicotine
490587|NCT01058837|Sudden Cardiac Death|sudden cardiac death
490588|NCT01058837|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
490589|NCT01058837|Ventricular Fibrillation|ventricular fibrillation
490590|NCT01058824|Bioequivalence|bioequivalence
490591|NCT01058824|Lincomycin Hydrocloride|lincomycin hydrocloride
490592|NCT01058811|lung cancer|lung cancer
490593|NCT01058798|Neuroblastoma|neuroblastoma
490594|NCT01058798|B4GALNT3|b4galnt3
490595|NCT01058798|Prognosis|prognosis
490596|NCT01058785|Gene therapy|gene therapy
490597|NCT01058785|Flow cytometry|flow cytometry
490598|NCT01058785|Immunoenzyme technique|immunoenzyme technique
490599|NCT01058785|Laboratory biomarker analysis|laboratory biomarker analysis
490600|NCT01058785|Tumor cell-derivative vaccine therapy|tumor cell-derivative vaccine therapy
490601|NCT01058772|Induced Labour|induced labour
490602|NCT01058772|Expectant Management|expectant management
490603|NCT01058772|C-section rate|c-section rate
490604|NCT01058772|Maternal Outcomes|maternal outcomes
490605|NCT01058772|Neonatal Outcomes|neonatal outcomes
490606|NCT01058759|non-small cell lung cancer|non-small cell lung cancer
490607|NCT01058759|NSCLC|nsclc
490608|NCT01058759|Enoxaparin|enoxaparin
490609|NCT01058759|Locally Advanced or Metastatic Non-small Cell Lung Cancer stadium IIIb/IV|locally advanced or metastatic non-small cell lung cancer stadium iiib/iv
490610|NCT01058746|pancreas|pancreas
490611|NCT01058746|surgery|surgery
490612|NCT01058746|Pancreaticoduodenectomy|pancreaticoduodenectomy
490613|NCT01058746|Central Pancreatectomy|central pancreatectomy
490614|NCT01058746|Distal Pancreatectomy|distal pancreatectomy
490615|NCT01058746|resection|resection
490616|NCT01058746|IV fluids|iv fluids
490617|NCT01058746|09-185|09-185
490618|NCT01058733|semi-automatic response system (SARS)|semi-automatic response system (sars)
490619|NCT01058733|Diabetes Mellitus|diabetes mellitus
490620|NCT01058733|Internet|internet
490621|NCT01058733|ubiquitous health care system|ubiquitous health care system
490622|NCT01058720|Vitamin D|vitamin d
490623|NCT01058720|Supplementation|supplementation
490624|NCT01058720|Adolescence|adolescence
490625|NCT01058707|Solid tumors, MLN0128, TORC1/2 inhibitors|solid tumors, mln0128, torc1/2 inhibitors
490626|NCT01058694|Mobile phones,|mobile phones,
490627|NCT01058694|Medication Adherence|medication adherence
490628|NCT01058694|Micro-Electrical-Mechanical Systems|micro-electrical-mechanical systems
490629|NCT01058694|HIV Infections|hiv infections
490630|NCT01058681|LH pulsatility|lh pulsatility
490631|NCT01058681|GnRH regulation|gnrh regulation
490632|NCT01058681|isocaloric nutrition|isocaloric nutrition
490633|NCT01058681|hypercaloric nutrition|hypercaloric nutrition
490634|NCT01058681|euglycemic clamps|euglycemic clamps
490635|NCT01058681|hyperinsulinemic clamps|hyperinsulinemic clamps
490636|NCT01058681|testosterone|testosterone
490637|NCT01058681|LH|lh
490638|NCT01058681|leptine|leptine
490639|NCT01058681|ghrelin|ghrelin
490640|NCT01058681|PYY|pyy
490641|NCT01058681|CCK|cck
490642|NCT01058681|GLP-1|glp-1
490643|NCT01058681|GIP|gip
490644|NCT01058681|cortisol|cortisol
490645|NCT01058668|Acute Mania|acute mania
490646|NCT01058668|Bipolar I Disorder|bipolar i disorder
490647|NCT01058655|Colorectal Cancer|colorectal cancer
490648|NCT01058642|pain|pain
490649|NCT01058642|delta opioid receptor agonist|delta opioid receptor agonist
490650|NCT01058629|Hybrid|hybrid
490651|NCT01058629|contact lens|contact lens
490652|NCT01058629|myopia|myopia
490653|NCT01058629|hyperopia|hyperopia
490654|NCT01058629|near sighted|near sighted
490655|NCT01058629|astigmatism|astigmatism
490656|NCT01058629|far sighted|far sighted
490657|NCT01058603|Infertility|infertility
490658|NCT01058603|Cell Culture|cell culture
490659|NCT01058603|AECC|aecc
490660|NCT01058603|Endocell|endocell
490661|NCT01058603|IVF|ivf
490662|NCT01058590|Inflammation|inflammation
490663|NCT01058590|Adenotonsillectomy|adenotonsillectomy
490664|NCT01058577|diabetes|diabetes
490665|NCT01058564|GERD|gerd
490666|NCT01058551|Sleep Apnea|sleep apnea
490667|NCT01058551|Atrial Fibrillation|atrial fibrillation
490668|NCT01058538|Interleukin, IL2, monoclonal, antibody, cytokine, tumour targeting, solid tumours, dose finding, renal cell carcinoma, fusion protein, RCC,|interleukin, il2, monoclonal, antibody, cytokine, tumour targeting, solid tumours, dose finding, renal cell carcinoma, fusion protein, rcc,
490669|NCT01058538|L19|l19
490670|NCT01058512|hepatitis C|hepatitis c
490671|NCT01058512|chronic HCV|chronic hcv
490672|NCT01058512|viral HCV|viral hcv
490673|NCT01058512|genotype 1|genotype 1
490674|NCT01058512|failed treatment with pegylated interferon plus ribavirin|failed treatment with pegylated interferon plus ribavirin
490675|NCT01058499|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
490676|NCT01058499|COPD|copd
490677|NCT01058486|Chronic Disease Management|chronic disease management
490678|NCT01058486|Physical Activity|physical activity
490679|NCT01058486|Self-efficacy|self-efficacy
490680|NCT01058486|Self management|self management
490681|NCT01058473|Sickle Cell Disease|sickle cell disease
490682|NCT01058473|Pain|pain
490683|NCT01058473|Assessment|assessment
490684|NCT01058460|Cervical Intraepithelial Neoplasia, Grade III|cervical intraepithelial neoplasia, grade iii
490685|NCT01058460|Cervical Intraepithelial Neoplasia, Grade II|cervical intraepithelial neoplasia, grade ii
490686|NCT01058447|ADME|adme
490687|NCT01058447|Healthy volunteers|healthy volunteers
490688|NCT01058434|Multiple myeloma|multiple myeloma
490689|NCT01058434|relapsed|relapsed
490690|NCT01058434|refractory|refractory
490691|NCT01058434|t(4;14)|t(4;14)
490692|NCT01058434|FGFR3|fgfr3
490693|NCT01058421|mechanical ventilation|mechanical ventilation
490694|NCT01058421|acute respiratory failure|acute respiratory failure
490695|NCT01058421|physical therapy|physical therapy
490696|NCT01058421|critical illness neuropathy|critical illness neuropathy
490697|NCT01058421|critical illness myopathy|critical illness myopathy
490698|NCT01058408|advanced head and neck cancer|advanced head and neck cancer
490699|NCT01058408|cisplatin|cisplatin
490700|NCT01058408|RAD001|rad001
490701|NCT01058408|radiation|radiation
490702|NCT01058408|HNSCC|hnscc
490703|NCT01058395|Traumatic Brain Injury|traumatic brain injury
490704|NCT01058395|Minocycline|minocycline
490705|NCT01058395|Outcome|outcome
490706|NCT01058382|FET|fet
490707|NCT01058382|Progesterone Support|progesterone support
490708|NCT01058382|Frozen Embryo Transfer|frozen embryo transfer
490709|NCT01058356|antibiotics associated colitis|antibiotics associated colitis
490710|NCT01058356|lactobacilli|lactobacilli
490711|NCT01058356|probiotics|probiotics
490712|NCT01058356|prevention|prevention
490713|NCT01058356|pulmonary infection|pulmonary infection
490714|NCT01058356|Prevention of antibiotics associated colitis|prevention of antibiotics associated colitis
490715|NCT01058356|the role of probiotics for prevention of antibiotics associated colitis|the role of probiotics for prevention of antibiotics associated colitis
490716|NCT01058356|the lactobacilli effect for antibiotics associated colitis|the lactobacilli effect for antibiotics associated colitis
490717|NCT01058356|antibiotic associated colitis on pulmonary infectious disease|antibiotic associated colitis on pulmonary infectious disease
490718|NCT01058343|SLE|sle
490719|NCT01058330|Neurofibromatosis type 1|neurofibromatosis type 1
490720|NCT01058330|NF1|nf1
490721|NCT01058317|respiratory, papilloma, pediatric, juvenile|respiratory, papilloma, pediatric, juvenile
490722|NCT01058304|osteoarthritis|osteoarthritis
490723|NCT01058304|knee|knee
490724|NCT01058304|physical therapy (specialty)|physical therapy (specialty)
490725|NCT01058304|veterans|veterans
490726|NCT01058278|Glaucoma|glaucoma
490727|NCT01058278|Ocular Hypertension|ocular hypertension
490728|NCT01058278|Intraocular Pressure|intraocular pressure
490729|NCT01058278|Trabeculectomy|trabeculectomy
490730|NCT01058239|bortezomib|bortezomib
490731|NCT01058239|rituximab|rituximab
490732|NCT01058239|PTLD|ptld
490733|NCT01058239|EBV|ebv
490734|NCT01058239|transplantation|transplantation
490735|NCT01058226|Experimental malaria challenge|experimental malaria challenge
490736|NCT01058213|COPD|copd
490737|NCT01058213|Pulmonary rehabilitation|pulmonary rehabilitation
490738|NCT01058213|Resistance Training|resistance training
490739|NCT01058213|Aerobic Training|aerobic training
490740|NCT01058213|Dyspnea|dyspnea
490741|NCT01058174|Prophylaxis|prophylaxis
490742|NCT01058174|Liver transplantation|liver transplantation
490743|NCT01058174|Invasive Fungal Infection|invasive fungal infection
490744|NCT01058174|Micafungin|micafungin
490745|NCT01058174|Prevention|prevention
490746|NCT01058174|Mycoses|mycoses
490747|NCT01058161|wrist and hand cartilage abnormalities in inflammatory and chronic rheumatisms|wrist and hand cartilage abnormalities in inflammatory and chronic rheumatisms
490748|NCT01058148|Cervical Cancer Screening|cervical cancer screening
490749|NCT01058148|Cervical Precancer|cervical precancer
490750|NCT01058148|Self-Collection|self-collection
490751|NCT01058148|Cytology|cytology
490752|NCT01058148|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
490753|NCT01058135|insulin resistance|insulin resistance
490754|NCT01058135|dietary fiber|dietary fiber
490755|NCT01058135|resistant starch|resistant starch
490756|NCT01058122|Adverse drug reactions in patients on the oncology ward|adverse drug reactions in patients on the oncology ward
490757|NCT01058109|bone health, bone density, bone mass|bone health, bone density, bone mass
490758|NCT01058096|Acute Mania|acute mania
490759|NCT01058096|Bipolar I Disorder|bipolar i disorder
490760|NCT01058070|GERD|gerd
490761|NCT01058057|atorvastatin|atorvastatin
490762|NCT01058057|percutaneous coronary intervention|percutaneous coronary intervention
490763|NCT01058057|periprocedural myocardial infarction|periprocedural myocardial infarction
490764|NCT01058057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
490765|NCT01058044|Cancer, Sunitinib, capecitabine, anastrozole, letrozole|cancer, sunitinib, capecitabine, anastrozole, letrozole
490766|NCT01058044|adherence, anticancer treatment|adherence, anticancer treatment
490767|NCT01058018|Cholesterol|cholesterol
490768|NCT01058018|High density lipoprotein|high density lipoprotein
490769|NCT01058018|Atherosclerosis|atherosclerosis
490770|NCT01058018|ApolipoproteinA1|apolipoproteina1
490771|NCT01058018|Stable angina artery disease|stable angina artery disease
490772|NCT01058005|MS|ms
490773|NCT01057979|exercise|exercise
490774|NCT01057979|college students|college students
490775|NCT01057979|Sedentary college students|sedentary college students
490776|NCT01057966|Bioavailability|bioavailability
490777|NCT01057966|Ocular Vitamins|ocular vitamins
490778|NCT01057953|Colo-Rectal Cancer|colo-rectal cancer
490779|NCT01057914|Randomized controlled trial|randomized controlled trial
490780|NCT01057914|Malnutrition|malnutrition
490781|NCT01057914|Aged|aged
490782|NCT01057914|Aged 80 and over|aged 80 and over
490783|NCT01057914|Nutrition therapy|nutrition therapy
490784|NCT01057888|Immunization status for:|immunization status for:
490785|NCT01057888|Tdap|tdap
490786|NCT01057888|Menactra|menactra
490787|NCT01057888|HPV (if female)|hpv (if female)
490788|NCT01057888|Well child care visit|well child care visit
490789|NCT01057862|Naltrexone|naltrexone
490790|NCT01057862|Pathological Gambling|pathological gambling
490791|NCT01057862|Opioid Antagonist|opioid antagonist
490792|NCT01057849|schizophrenia|schizophrenia
490793|NCT01057849|first episode|first episode
490794|NCT01057849|atypical antipsychotics|atypical antipsychotics
490795|NCT01057849|psychosocial intervention|psychosocial intervention
490796|NCT01057849|outcome|outcome
490797|NCT01057849|effectiveness|effectiveness
490798|NCT01057823|aged|aged
490799|NCT01057823|sleep deprivation|sleep deprivation
490800|NCT01057823|actigraphy|actigraphy
490801|NCT01057823|ambulatory monitoring|ambulatory monitoring
490802|NCT01057797|COPD|copd
490803|NCT01057797|Pulmonary rehabilitation|pulmonary rehabilitation
490804|NCT01057797|Self-efficacy|self-efficacy
490805|NCT01057797|Muscle strength|muscle strength
490806|NCT01057797|Dyspnea|dyspnea
490807|NCT01057797|Exercise adherence|exercise adherence
490808|NCT01057784|obesity|obesity
490809|NCT01057784|bariatric|bariatric
490810|NCT01057784|surgery|surgery
490811|NCT01057784|sleeve|sleeve
490812|NCT01057784|gastric bypass|gastric bypass
490813|NCT01057784|vitamin D|vitamin d
490814|NCT01057784|quality of life|quality of life
490815|NCT01057784|body composition|body composition
490816|NCT01057784|bone density|bone density
490817|NCT01057784|adolescent|adolescent
490818|NCT01057784|child|child
490819|NCT01057784|teenager|teenager
490820|NCT01057784|fertility|fertility
490821|NCT01057784|offspring|offspring
490822|NCT01057784|biomarker|biomarker
490823|NCT01057784|epigenome|epigenome
490824|NCT01057784|gene expression|gene expression
490825|NCT01057771|meditation|meditation
490826|NCT01057771|exercise|exercise
490827|NCT01057771|immunity|immunity
490828|NCT01057771|respiratory infection|respiratory infection
490829|NCT01057771|influenza|influenza
490830|NCT01057771|flu shot|flu shot
490831|NCT01057771|immunomodulation|immunomodulation
490832|NCT01057758|Suspicion of ventilator-associated pneumonia|suspicion of ventilator-associated pneumonia
490833|NCT01057745|woman|woman
490834|NCT01057745|chemotherapy|chemotherapy
490835|NCT01057745|radiation|radiation
490836|NCT01057745|fertility preservation|fertility preservation
490837|NCT01057745|cryobank|cryobank
490838|NCT01057719|cross-over design|cross-over design
490839|NCT01057719|mixed model|mixed model
490840|NCT01057719|multiple sclerosis|multiple sclerosis
490841|NCT01057719|physical performance measures|physical performance measures
490842|NCT01057719|physical therapy|physical therapy
490843|NCT01057719|the Bobath concept|the bobath concept
490844|NCT01057719|warm climate|warm climate
490845|NCT01057719|6-minute walk test|6-minute walk test
490846|NCT01057706|chiropractic|chiropractic
490847|NCT01057706|exercise|exercise
490848|NCT01057706|seniors|seniors
490849|NCT01057693|Diabetic peripheral neuropathy|diabetic peripheral neuropathy
490850|NCT01057693|Lyrica|lyrica
490851|NCT01057693|pregabalin|pregabalin
490852|NCT01057693|pain|pain
490853|NCT01057680|Bone|bone
490854|NCT01057680|Muscle|muscle
490855|NCT01057680|Strength|strength
490856|NCT01057680|Kidney|kidney
490857|NCT01057680|Liver|liver
490858|NCT01057680|Creatine|creatine
490859|NCT01057654|Cholesterol|cholesterol
490860|NCT01057641|PIDLSS, Spacer|pidlss, spacer
490861|NCT01057628|ASP1941|asp1941
490862|NCT01057628|Diabetes mellitus|diabetes mellitus
490863|NCT01057628|Blood glucose|blood glucose
490864|NCT01057615|Asthma|asthma
490865|NCT01057615|Exercise-Induced Bronchoconstriction|exercise-induced bronchoconstriction
490866|NCT01057615|Inflammation|inflammation
490867|NCT01057615|Airway|airway
490868|NCT01057615|Fish Oil|fish oil
490869|NCT01057615|Ascorbic Acid|ascorbic acid
490870|NCT01057602|Dementia|dementia
490871|NCT01057602|Screening Tests|screening tests
490872|NCT01057602|Cognition|cognition
490873|NCT01057602|Memory|memory
490874|NCT01057602|MOST|most
490875|NCT01057589|Pharynx|pharynx
490876|NCT01057589|Larynx|larynx
490877|NCT01057589|Cervical esophagus|cervical esophagus
490878|NCT01057589|Nose|nose
490879|NCT01057589|Thyroid Gland|thyroid gland
490880|NCT01057589|Parathyroid Gland|parathyroid gland
490881|NCT01057576|bioactives|bioactives
490882|NCT01057576|insulin|insulin
490883|NCT01057576|botanicals|botanicals
490884|NCT01057563|Coronary artery disease|coronary artery disease
490885|NCT01057563|Neointimal hyperplasia|neointimal hyperplasia
490886|NCT01057563|Drug-eluting balloon|drug-eluting balloon
490887|NCT01057563|Optical coherence tomography|optical coherence tomography
490888|NCT01057550|Stress urinary Incontinence|stress urinary incontinence
490889|NCT01057550|autologous slings|autologous slings
490890|NCT01057550|slings|slings
490891|NCT01057550|tvt|tvt
490892|NCT01057550|grafts|grafts
490893|NCT01057550|surgery|surgery
490894|NCT01057537|Polypill|polypill
490895|NCT01057537|Red Heart Pill|red heart pill
490896|NCT01057537|Cardiovascular disease|cardiovascular disease
490897|NCT01057537|Adherence|adherence
490898|NCT01057537|Secondary prevention|secondary prevention
490899|NCT01057524|Airway clearance|airway clearance
490900|NCT01057524|Cystic fibrosis|cystic fibrosis
490901|NCT01057524|High frequency chest wall oscillation|high frequency chest wall oscillation
490902|NCT01057511|Crinone|crinone
490903|NCT01057511|progesterone|progesterone
490904|NCT01057511|endometrial progesterone concentration|endometrial progesterone concentration
490905|NCT01057485|Atrial Fibrillation|atrial fibrillation
490906|NCT01057485|Ablation|ablation
490907|NCT01057472|Repeatability of measurements|repeatability of measurements
490908|NCT01057459|Stage II Grade 1 Contiguous Follicular Lymphoma|stage ii grade 1 contiguous follicular lymphoma
490909|NCT01057459|Stage II Grade 1 Non-Contiguous Follicular Lymphoma|stage ii grade 1 non-contiguous follicular lymphoma
490910|NCT01057459|Stage II Grade 2 Contiguous Follicular Lymphoma|stage ii grade 2 contiguous follicular lymphoma
490911|NCT01057459|Stage II Grade 2 Non-Contiguous Follicular Lymphoma|stage ii grade 2 non-contiguous follicular lymphoma
490912|NCT01057459|Stage II Grade 3 Contiguous Follicular Lymphoma|stage ii grade 3 contiguous follicular lymphoma
490913|NCT01057459|Stage II Grade 3 Non-Contiguous Follicular Lymphoma|stage ii grade 3 non-contiguous follicular lymphoma
490914|NCT01057459|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
490915|NCT01057459|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
490916|NCT01057459|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
490917|NCT01057459|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
490918|NCT01057459|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
490919|NCT01057459|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
490920|NCT01057446|Colonoscopy preparation|colonoscopy preparation
490921|NCT01057446|sennoside|sennoside
490922|NCT01057446|sodium phosphate|sodium phosphate
490923|NCT01057446|the aim is to assess the bowel cleansing effects of two different agents|the aim is to assess the bowel cleansing effects of two different agents
490924|NCT01057433|Healthy Volunteers|healthy volunteers
490925|NCT01057407|Hyperphosphatemia|hyperphosphatemia
490926|NCT01057407|hemodialysis|hemodialysis
490928|NCT01057407|ASP1585|asp1585
490929|NCT01057394|Atrial Fibrillation|atrial fibrillation
490930|NCT01057381|Adenotonsillectomy|adenotonsillectomy
490931|NCT01057381|Postoperative analgesia|postoperative analgesia
490932|NCT01057381|Pediatrics|pediatrics
490933|NCT01057355|Intraductal papillary mucinous neoplasm|intraductal papillary mucinous neoplasm
490934|NCT01057355|Mucinous cystic neoplasm|mucinous cystic neoplasm
490935|NCT01057355|Endoscopic ultrasound|endoscopic ultrasound
490936|NCT01057355|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
490937|NCT01057355|Pancreatic cyst|pancreatic cyst
490938|NCT01057355|Pancreas cyst|pancreas cyst
490939|NCT01057355|Alcohol|alcohol
490940|NCT01057342|extensive stage small cell lung cancer|extensive stage small cell lung cancer
490941|NCT01057329|TDM|tdm
490942|NCT01057329|Drug|drug
490943|NCT01057329|Psychopharmacology|psychopharmacology
490944|NCT01057329|children|children
490945|NCT01057329|adolescents|adolescents
490946|NCT01057303|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
490947|NCT01057290|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
490948|NCT01057277|Head and Neck Cancer|head and neck cancer
490949|NCT01057277|Advanced Inoperable Head & Neck Cancer|advanced inoperable head & neck cancer
490950|NCT01057264|Liver|liver
490951|NCT01057264|Cancer|cancer
490952|NCT01057264|Hepatic arterial infusion|hepatic arterial infusion
490953|NCT01057264|HAI|hai
490954|NCT01057264|Abraxane|abraxane
490955|NCT01057264|Nab-Paclitaxel|nab-paclitaxel
490956|NCT01057264|Paclitaxel|paclitaxel
490957|NCT01057264|ABI-007|abi-007
490958|NCT01057264|Gemcitabine|gemcitabine
490959|NCT01057264|Gemcitabine Hydrochloride|gemcitabine hydrochloride
490960|NCT01057264|Gemzar|gemzar
490961|NCT01057264|Bevacizumab|bevacizumab
490962|NCT01057264|Avastin|avastin
490963|NCT01057264|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
490964|NCT01057264|rhuMAb-VEGF|rhumab-vegf
490965|NCT01057264|Filgrastim|filgrastim
490966|NCT01057264|G-CSF|g-csf
490967|NCT01057264|Neupogen|neupogen
490968|NCT01057251|Nebivolol|nebivolol
490969|NCT01057251|Bystolic TM|bystolic tm
490970|NCT01057251|Hypertension|hypertension
490971|NCT01057251|Stage 2 Hypertension|stage 2 hypertension
490972|NCT01057238|mechanical ventilation|mechanical ventilation
490973|NCT01057238|critical care|critical care
490974|NCT01057212|advanced or metastatic non-squamous non-small cell lung cancer (NSCLC)|advanced or metastatic non-squamous non-small cell lung cancer (nsclc)
490975|NCT01057199|adult acute myeloid leukemia|adult acute myeloid leukemia
490976|NCT01057199|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
490977|NCT01057173|Heart Valve Disease|heart valve disease
490978|NCT01057173|Heart Valve Prosthesis|heart valve prosthesis
490979|NCT01057173|Heart Valve Prosthesis Implantation|heart valve prosthesis implantation
490980|NCT01057173|Randomized Controlled Trial|randomized controlled trial
490981|NCT01057121|HIV Infections|hiv infections
490982|NCT01057108|Hyperphosphatemia|hyperphosphatemia
490983|NCT01057108|chronic kidney disease|chronic kidney disease
490984|NCT01057108|salivary phosphorus|salivary phosphorus
490985|NCT01057095|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
490986|NCT01057095|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
490987|NCT01057095|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
490988|NCT01057095|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
490989|NCT01057095|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
490990|NCT01057095|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
490991|NCT01057095|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
490992|NCT01057095|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
490993|NCT01057095|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
490994|NCT01057095|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
490995|NCT01057082|Sarcopenia|sarcopenia
490996|NCT01057082|Aging|aging
490997|NCT01057082|Muscle|muscle
490998|NCT01057082|Dietary Supplement|dietary supplement
490999|NCT01057082|HMB|hmb
491000|NCT01057082|Arginine|arginine
491001|NCT01057082|Glutamine|glutamine
491002|NCT01057069|Neo adjuvant|neo adjuvant
491003|NCT01057069|Triple negative|triple negative
491004|NCT01057069|primary tumor over 2 cm and/or positive lymphnodes|primary tumor over 2 cm and/or positive lymphnodes
491005|NCT01057056|patients in a sub-acute geriatric rehabilitation department|patients in a sub-acute geriatric rehabilitation department
491006|NCT01057043|Osteoarthritis|osteoarthritis
491007|NCT01057017|colorectal cancer|colorectal cancer
491008|NCT01057004|heart failure|heart failure
491009|NCT01056978|palliative care unit|palliative care unit
491010|NCT01056978|bleeding|bleeding
491011|NCT01056978|thromboembolic|thromboembolic
491012|NCT01056978|hemorrhagic risk|hemorrhagic risk
491013|NCT01056978|antithrombotic prophylaxis|antithrombotic prophylaxis
491014|NCT01056965|Frontotemporal Dementia|frontotemporal dementia
491015|NCT01056965|Corticobasal Degeneration|corticobasal degeneration
491016|NCT01056965|Progressive Nonfluent Aphasia|progressive nonfluent aphasia
491017|NCT01056965|Progressive Supranuclear Palsy|progressive supranuclear palsy
491018|NCT01056965|FTLD|ftld
491019|NCT01056965|FTD|ftd
491020|NCT01056965|PNFA|pnfa
491021|NCT01056965|CBD|cbd
491022|NCT01056965|PSP|psp
491023|NCT01056965|Predicted tauopathies, including:|predicted tauopathies, including:
491024|NCT01056965|Progressive Supranuclear Palsy (PSP)|progressive supranuclear palsy (psp)
491025|NCT01056965|(CBS)|(cbs)
491026|NCT01056965|Progressive Nonfluent Aphasia (PNFA)|progressive nonfluent aphasia (pnfa)
491027|NCT01056939|Ventilatory care, children, intensive care, NAVA|ventilatory care, children, intensive care, nava
491028|NCT01056939|Children needing ventilatory care|children needing ventilatory care
491029|NCT01056926|smoking|smoking
491030|NCT01056926|nicotine|nicotine
491031|NCT01056926|Effects of nicotine and non-nicotine factors on continuous working memory.|effects of nicotine and non-nicotine factors on continuous working memory.
491032|NCT01056926|Effects of nicotine and non-nicotine factors on cue reactivity.|effects of nicotine and non-nicotine factors on cue reactivity.
491033|NCT01056926|Use of nicotine patches, placebo patches, and denicotinized cigarettes.|use of nicotine patches, placebo patches, and denicotinized cigarettes.
491034|NCT01056926|memory|memory
491035|NCT01056913|anastomotic leakage|anastomotic leakage
491036|NCT01056913|bleeding from the anastomotic region|bleeding from the anastomotic region
491037|NCT01056913|anastomotic stenosis|anastomotic stenosis
491038|NCT01056900|articular cartilage defects|articular cartilage defects
491039|NCT01056900|ACI|aci
491040|NCT01056900|Autologous Chondrocyte Implantation|autologous chondrocyte implantation
491041|NCT01056900|Knee joint|knee joint
491042|NCT01056900|chondron|chondron
491043|NCT01056887|diabetes insipidus|diabetes insipidus
491044|NCT01056887|primary polydipsia|primary polydipsia
491045|NCT01056887|copeptin|copeptin
491046|NCT01056887|Utility of plasma copeptin in differential diagnosis of polyuria/ polydipsia while performing a traditional deprivation test|utility of plasma copeptin in differential diagnosis of polyuria/ polydipsia while performing a traditional deprivation test
491047|NCT01056874|Maraviroc|maraviroc
491048|NCT01056874|Digoxin|digoxin
491049|NCT01056874|P-glycoprotein|p-glycoprotein
491050|NCT01056874|Pharmacokinetics|pharmacokinetics
491051|NCT01056874|Drug Interaction|drug interaction
491052|NCT01056874|HIV|hiv
491053|NCT01056861|cervical dystonia|cervical dystonia
491054|NCT01056861|torticollis|torticollis
491055|NCT01056861|Botulinum toxin|botulinum toxin
491056|NCT01056861|magnetoencephalography|magnetoencephalography
491057|NCT01056861|MEG|meg
491058|NCT01056861|cortical organizational changes detected by MEG after botulinum toxin in patients with torticollis, correlating with improvement in the symptoms|cortical organizational changes detected by meg after botulinum toxin in patients with torticollis, correlating with improvement in the symptoms
491059|NCT01056848|Euvolemic Hyponatremia|euvolemic hyponatremia
491060|NCT01056848|Hypervolemic Hyponatremia|hypervolemic hyponatremia
491061|NCT01056848|SIADH|siadh
491062|NCT01056848|Serum Sodium|serum sodium
491063|NCT01056809|Colorectal cancer|colorectal cancer
491064|NCT01056809|Metastases|metastases
491065|NCT01056809|Treatment strategies|treatment strategies
491066|NCT01056809|Colorectal cancer with synchronous metastases|colorectal cancer with synchronous metastases
491067|NCT01056796|compression anastomosis|compression anastomosis
491068|NCT01056796|Colorectal cancer|colorectal cancer
491069|NCT01056796|Low anterior resection|low anterior resection
491070|NCT01056796|Radiated to the pelvic area|radiated to the pelvic area
491071|NCT01056796|Radiotherapy|radiotherapy
491072|NCT01056783|EoE|eoe
491073|NCT01056770|Smallpox vaccine efficacy|smallpox vaccine efficacy
491074|NCT01056757|metastatic breast cancer|metastatic breast cancer
491075|NCT01056757|ribavirin|ribavirin
491076|NCT01056757|eIF4E|eif4e
491077|NCT01056744|coronary stent|coronary stent
491078|NCT01056744|optical coherence tomography|optical coherence tomography
491079|NCT01056744|drug-eluting|drug-eluting
491080|NCT01056744|neointimal proliferation|neointimal proliferation
491081|NCT01056731|high blood pressure|high blood pressure
491082|NCT01056731|aliskiren|aliskiren
491083|NCT01056731|hydrochlorothiazide|hydrochlorothiazide
491084|NCT01056731|control rate|control rate
491085|NCT01056718|Diastolic Function|diastolic function
491086|NCT01056718|Nebivolol|nebivolol
491087|NCT01056705|Inactivated Poliomyelitis Vaccine|inactivated poliomyelitis vaccine
491088|NCT01056705|Sabin Strains|sabin strains
491089|NCT01056705|poliomyelitis|poliomyelitis
491090|NCT01056692|Asthma|asthma
491091|NCT01056692|bronchial allergen challenge|bronchial allergen challenge
491092|NCT01056692|sputum eosinophiilia|sputum eosinophiilia
491093|NCT01056653|father-child relations|father-child relations
491094|NCT01056653|paternal behaviour|paternal behaviour
491095|NCT01056653|early intervention|early intervention
491096|NCT01056653|child-rearing|child-rearing
491097|NCT01056640|telemonitoring|telemonitoring
491098|NCT01056640|usual care|usual care
491099|NCT01056640|elderly|elderly
491100|NCT01056640|hospitalization|hospitalization
491101|NCT01056640|Emergency room visits|emergency room visits
491102|NCT01056601|insulinoma|insulinoma
491103|NCT01056601|cancer of pancreas|cancer of pancreas
491104|NCT01056601|neoplasms, pancreas|neoplasms, pancreas
491105|NCT01056601|alpha-cell tumor|alpha-cell tumor
491106|NCT01056601|glucagonoma|glucagonoma
491107|NCT01056601|beta-cell tumor|beta-cell tumor
491108|NCT01056601|somatostatinoma|somatostatinoma
491109|NCT01056588|adolescent smoking|adolescent smoking
491110|NCT01056588|Contingency management|contingency management
491111|NCT01056588|Quit smoking|quit smoking
491112|NCT01056562|Prostate|prostate
491113|NCT01056562|GU|gu
491114|NCT01056562|Urological Oncology|urological oncology
491115|NCT01056549|Intestinal lipoprotein|intestinal lipoprotein
491116|NCT01056549|Apo B48 and apoB100|apo b48 and apob100
491117|NCT01056549|Pancreatic clamp|pancreatic clamp
491118|NCT01056549|GLP-1 agonist|glp-1 agonist
491119|NCT01056536|Travel|travel
491120|NCT01056536|casual sexual relationships|casual sexual relationships
491121|NCT01056536|condoms|condoms
491122|NCT01056536|Structured intervention|structured intervention
491123|NCT01056523|AML|aml
491124|NCT01056497|diabetes|diabetes
491125|NCT01056497|alpha lipoic acid|alpha lipoic acid
491126|NCT01056497|endoplasmic reticulum (ER) stress|endoplasmic reticulum (er) stress
491127|NCT01056497|insulin secretion|insulin secretion
491128|NCT01056497|insulin sensitivity|insulin sensitivity
491129|NCT01056484|Alcohol Dependence|alcohol dependence
491130|NCT01056484|Alcoholism|alcoholism
491131|NCT01056484|Substance Use Disorders|substance use disorders
491132|NCT01056484|Substance Abuse|substance abuse
491133|NCT01056471|Multiple Sclerosis|multiple sclerosis
491134|NCT01056471|Mesenchymal Stem Cells|mesenchymal stem cells
491135|NCT01056471|Autologous|autologous
491136|NCT01056458|acupressure|acupressure
491137|NCT01056458|perimenopause|perimenopause
491138|NCT01056458|menopause|menopause
491139|NCT01056458|anxiety|anxiety
491140|NCT01056458|life quality|life quality
491141|NCT01056458|insomnia|insomnia
491142|NCT01056445|Carotid artery stenting|carotid artery stenting
491143|NCT01056445|Hemodynamic Instability|hemodynamic instability
491144|NCT01056445|Valsalva Ratio|valsalva ratio
491145|NCT01056432|osteoporosis, bone fracture risk, bone ultrasonometry|osteoporosis, bone fracture risk, bone ultrasonometry
491146|NCT01056419|Graves' ophthalmopathy|graves' ophthalmopathy
491147|NCT01056419|Total thyroidectomy|total thyroidectomy
491148|NCT01056419|Anti-thyroid drug treatment|anti-thyroid drug treatment
491149|NCT01056419|Clinical activity score|clinical activity score
491150|NCT01056406|Pregnancy|pregnancy
491151|NCT01056406|Overweight|overweight
491152|NCT01056406|Obese|obese
491153|NCT01056406|Nutrition intervention|nutrition intervention
491154|NCT01056393|HIV|hiv
491155|NCT01056380|influenza|influenza
491156|NCT01056380|influenza like illness|influenza like illness
491157|NCT01056367|Resistant hypertension|resistant hypertension
491158|NCT01056367|Type-II-Diabetes Mellitus|type-ii-diabetes mellitus
491159|NCT01056367|Arterial stiffness|arterial stiffness
491160|NCT01056367|Ventricular function|ventricular function
491161|NCT01056354|Influenza|influenza
491162|NCT01056354|respiratory virus|respiratory virus
491163|NCT01056354|pandemic|pandemic
491164|NCT01056354|swine flu|swine flu
491165|NCT01056354|infection|infection
491166|NCT01056354|MERS-CoV|mers-cov
491167|NCT01056354|SARS-CoV|sars-cov
491168|NCT01056341|Infantile Hemangioma|infantile hemangioma
491169|NCT01056341|Propranolol|propranolol
491170|NCT01056315|Analgesia|analgesia
491171|NCT01056315|Diabetic Neuropathy|diabetic neuropathy
491172|NCT01056315|Neuropathic pain|neuropathic pain
491173|NCT01056315|Painful|painful
491174|NCT01056315|Chronic pain|chronic pain
491175|NCT01056302|Reconstructive surgical procedures|reconstructive surgical procedures
491176|NCT01056302|visuohaptic|visuohaptic
491177|NCT01056276|Multiple Myeloma|multiple myeloma
491178|NCT01056276|Bendamustine|bendamustine
491179|NCT01056276|Bortezomib|bortezomib
491180|NCT01056276|Dexamethasone|dexamethasone
491181|NCT01056263|retrospective trial|retrospective trial
491182|NCT01056263|5-year survival|5-year survival
491183|NCT01056263|metastatic renal cancer cell|metastatic renal cancer cell
491184|NCT01056250|cholelithiasis|cholelithiasis
491185|NCT01056224|skull pin insertion|skull pin insertion
491186|NCT01056224|remifentanil|remifentanil
491187|NCT01056224|short acting opioid|short acting opioid
491188|NCT01056224|craniotomy|craniotomy
491189|NCT01056224|cervical spine surgery|cervical spine surgery
491190|NCT01056224|hemodynamic changes|hemodynamic changes
491191|NCT01056224|dose requirement|dose requirement
491192|NCT01056224|age related|age related
491193|NCT01056198|Diabetic Foot Ulcers|diabetic foot ulcers
491194|NCT01056198|Diabetic Foot Wounds|diabetic foot wounds
491195|NCT01056185|influenza|influenza
491196|NCT01056185|flu|flu
491197|NCT01056185|swine flu|swine flu
491198|NCT01056185|respiratory virus|respiratory virus
491199|NCT01056185|hospitalization|hospitalization
491200|NCT01056185|MERS-CoV|mers-cov
491201|NCT01056185|SARS-CoV|sars-cov
491202|NCT01056172|Chronic hepatitis C|chronic hepatitis c
491203|NCT01056172|Genotype 2|genotype 2
491204|NCT01056172|Rapid virologic response|rapid virologic response
491205|NCT01056172|Sustained virologic response|sustained virologic response
491206|NCT01056172|Peginterferon alfa-2a|peginterferon alfa-2a
491207|NCT01056172|Ribavirin|ribavirin
491208|NCT01056159|asthma|asthma
491209|NCT01056159|dry powder inhaler|dry powder inhaler
491210|NCT01056159|short-acting beta2-agonist|short-acting beta2-agonist
491211|NCT01056159|SABA|saba
491212|NCT01056159|bronchoconstriction|bronchoconstriction
491213|NCT01056159|bronchodilation|bronchodilation
491214|NCT01056159|bronchodilator|bronchodilator
491215|NCT01056159|metered dose inhaler|metered dose inhaler
491216|NCT01056146|TBI|tbi
491217|NCT01056146|intracranial edema|intracranial edema
491218|NCT01056146|brain edema|brain edema
491219|NCT01056146|craniocerebral trauma|craniocerebral trauma
491220|NCT01056146|head injury|head injury
491221|NCT01056146|brain hemorrhage, traumatic|brain hemorrhage, traumatic
491222|NCT01056146|subdural hematoma|subdural hematoma
491223|NCT01056146|brain concussion|brain concussion
491224|NCT01056146|head injuries, closed|head injuries, closed
491225|NCT01056146|epidural hematoma|epidural hematoma
491226|NCT01056146|extra-axial hemorrhage|extra-axial hemorrhage
491227|NCT01056146|cortical contusion|cortical contusion
491228|NCT01056146|Additional relevant MeSH terms:|additional relevant mesh terms:
491229|NCT01056146|Nervous System Diseases|nervous system diseases
491230|NCT01056146|Wounds and Injuries|wounds and injuries
491231|NCT01056146|Disorders of Environmental Origin|disorders of environmental origin
491232|NCT01056146|Central Nervous System Diseases|central nervous system diseases
491233|NCT01056146|Trauma, Nervous System|trauma, nervous system
491234|NCT01056146|Brain Diseases|brain diseases
491235|NCT01056146|Brain Injuries|brain injuries
491236|NCT01056133|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
491237|NCT01056133|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
491238|NCT01056107|Constipation, Irritable Bowel Syndrome (IBS), Glucagon Like Peptide analogue|constipation, irritable bowel syndrome (ibs), glucagon like peptide analogue
491239|NCT01056081|COPD|copd
491240|NCT01056081|inspiratory muscles|inspiratory muscles
491241|NCT01056081|diaphragm|diaphragm
491242|NCT01056055|Ankle|ankle
491243|NCT01056055|Chronic lateral instability|chronic lateral instability
491244|NCT01056055|Modified Brostrom procedure|modified brostrom procedure
491245|NCT01056055|Suture anchor|suture anchor
491246|NCT01056055|Bone tunnel|bone tunnel
491247|NCT01056042|pelvic pain|pelvic pain
491248|NCT01056042|postoperative|postoperative
491249|NCT01056042|medical therapy|medical therapy
491250|NCT01056029|Solid Tumors|solid tumors
491251|NCT01056016|ADHD|adhd
491252|NCT01056003|gastric inlet patch|gastric inlet patch
491253|NCT01056003|prevalence|prevalence
491254|NCT01056003|globus sensations|globus sensations
491255|NCT01055990|pandemic influenza A (H1N1) 2009|pandemic influenza a (h1n1) 2009
491256|NCT01055990|blood fix treatment|blood fix treatment
491257|NCT01055990|influenza A (H1N1) 2009 monovalent vaccine|influenza a (h1n1) 2009 monovalent vaccine
491258|NCT01055990|effectiveness|effectiveness
491259|NCT01055990|immunogenicity|immunogenicity
491260|NCT01055990|safety|safety
491261|NCT01055977|statin therapy|statin therapy
491262|NCT01055977|treatment goal|treatment goal
491263|NCT01055977|dyslipidaemia|dyslipidaemia
491264|NCT01055951|Insulin pumps|insulin pumps
491265|NCT01055951|Diabetes|diabetes
491266|NCT01055912|Congestive Heart Failure|congestive heart failure
491267|NCT01055912|Volume Overload|volume overload
491268|NCT01055899|RA|ra
491269|NCT01055886|PTSD|ptsd
491270|NCT01055886|smoking cessation|smoking cessation
491271|NCT01055886|nicotine patch|nicotine patch
491272|NCT01055873|immune status|immune status
491273|NCT01055873|adolescents or young adults infected|adolescents or young adults infected
491274|NCT01055873|impact of viral replication|impact of viral replication
491275|NCT01055860|uterine Prolapse|uterine prolapse
491276|NCT01055860|vaginal prolapse|vaginal prolapse
491277|NCT01055860|mesh erosion|mesh erosion
491278|NCT01055860|urinary incontinence|urinary incontinence
491279|NCT01055860|bowel symptoms|bowel symptoms
491280|NCT01055847|cystic fibrosis|cystic fibrosis
491281|NCT01055847|CF|cf
491282|NCT01055847|aztreonam|aztreonam
491283|NCT01055847|lung infection|lung infection
491284|NCT01055847|Pseudomonas aeruginosa|pseudomonas aeruginosa
491285|NCT01055834|Insomnia|insomnia
491286|NCT01055834|primary insomnia|primary insomnia
491287|NCT01055834|insomnia associated with psychiatric or physical disorder(s)|insomnia associated with psychiatric or physical disorder(s)
491288|NCT01055821|Hepatitis C|hepatitis c
491289|NCT01055821|Vaccine|vaccine
491290|NCT01055821|HCVac|hcvac
491291|NCT01055821|MVA-HCV|mva-hcv
491292|NCT01055808|Insulin|insulin
491293|NCT01055808|ITR-QOL|itr-qol
491294|NCT01055808|DTSQ|dtsq
491295|NCT01055808|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
491296|NCT01055782|Colonoscopy|colonoscopy
491297|NCT01055782|Endoguide|endoguide
491298|NCT01055782|Pain perception|pain perception
491299|NCT01055782|Colonoscopy to the coecum (success rate)|colonoscopy to the coecum (success rate)
491300|NCT01055782|Patient's perception of pain|patient's perception of pain
491301|NCT01055782|Duration of successful colonoscopies|duration of successful colonoscopies
491302|NCT01055769|Bio-equivalence|bio-equivalence
491303|NCT01055769|Linezolid OS|linezolid os
491304|NCT01055769|Linezolid tablet|linezolid tablet
491305|NCT01055756|Reduction of signs and symptoms and enhanced nasal flow|reduction of signs and symptoms and enhanced nasal flow
491306|NCT01055756|Nasal Flow|nasal flow
491307|NCT01055743|Fluorouracil Implants|fluorouracil implants
491308|NCT01055743|Hepatocellular carcinoma|hepatocellular carcinoma
491309|NCT01055743|Radical resection|radical resection
491310|NCT01055730|Pulmonary rehabilitation|pulmonary rehabilitation
491311|NCT01055730|Exercise therapy|exercise therapy
491312|NCT01055730|Interstitial lung disease|interstitial lung disease
491313|NCT01055730|Pulmonary fibrosis|pulmonary fibrosis
491314|NCT01055730|Mobility limitation|mobility limitation
491315|NCT01055730|Dyspnea|dyspnea
491316|NCT01055730|Mental health|mental health
491317|NCT01055717|avenanthramide|avenanthramide
491318|NCT01055717|enriched|enriched
491319|NCT01055717|oat|oat
491320|NCT01055717|phytochemical|phytochemical
491321|NCT01055717|bioavailability|bioavailability
491322|NCT01055704|Methylnaltrexone|methylnaltrexone
491323|NCT01055704|Codeine|codeine
491324|NCT01055704|Gastrointestinal motility|gastrointestinal motility
491325|NCT01055704|Colonic transit|colonic transit
491326|NCT01055691|healthy volunteers|healthy volunteers
491327|NCT01055691|bioequivalence|bioequivalence
491328|NCT01055691|dapagliflozin|dapagliflozin
491329|NCT01055691|metformin|metformin
491330|NCT01055678|breast cancer|breast cancer
491331|NCT01055678|ductal breast carcinoma in situ|ductal breast carcinoma in situ
491332|NCT01055678|breast cancer in situ|breast cancer in situ
491333|NCT01055678|invasive carcinoma|invasive carcinoma
491334|NCT01055678|invasive ductal carcinoma|invasive ductal carcinoma
491335|NCT01055678|invasive lobular carcinoma|invasive lobular carcinoma
491336|NCT01055652|Type 2 diabetes mellitus|type 2 diabetes mellitus
491337|NCT01055652|Japanese|japanese
491338|NCT01055652|phase 1|phase 1
491339|NCT01055652|safety|safety
491340|NCT01055652|dapagliflozin|dapagliflozin
491341|NCT01055652|Pharmacokinetics|pharmacokinetics
491342|NCT01055652|Drug-drug Interaction|drug-drug interaction
491343|NCT01055652|voglibose|voglibose
491344|NCT01055639|Chronic Pain|chronic pain
491345|NCT01055639|Acceptance and Commitment Therapy (ACT)|acceptance and commitment therapy (act)
491346|NCT01055626|Body mass index|body mass index
491347|NCT01055626|Body fat|body fat
491348|NCT01055626|Obesity|obesity
491349|NCT01055626|Overweight|overweight
491350|NCT01055626|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
491351|NCT01055626|Air displacement plethysmography|air displacement plethysmography
491352|NCT01055600|eltrombopag|eltrombopag
491353|NCT01055600|pharmacokinetics|pharmacokinetics
491354|NCT01055600|PROMACTA|promacta
491355|NCT01055600|lactation|lactation
491356|NCT01055600|milk-only study|milk-only study
491357|NCT01055587|major abdominal surgery|major abdominal surgery
491358|NCT01055587|severe burn injury|severe burn injury
491359|NCT01055587|infection|infection
491360|NCT01055587|diagnostic|diagnostic
491361|NCT01055574|lumbar disc arthroplasty|lumbar disc arthroplasty
491362|NCT01055574|total disc replacement|total disc replacement
491363|NCT01055574|ProDisc L|prodisc l
491364|NCT01055574|anterior lumbar interbody fusion|anterior lumbar interbody fusion
491365|NCT01055574|lumbar spine surgery outcomes|lumbar spine surgery outcomes
491366|NCT01055561|Acupuncture|acupuncture
491367|NCT01055561|Behavioral and Psychological Symptoms of Dementia|behavioral and psychological symptoms of dementia
491368|NCT01055561|BPSD|bpsd
491369|NCT01055561|MMSE|mmse
491370|NCT01055561|BEHAVE-AD|behave-ad
491371|NCT01055561|The Questionnaire of Acupuncture Events|the questionnaire of acupuncture events
491372|NCT01055561|healthy volunteers|healthy volunteers
491373|NCT01055548|Preterm|preterm
491374|NCT01055548|Perinatal|perinatal
491375|NCT01055548|Ultrasound|ultrasound
491376|NCT01055548|Cerebral palsy|cerebral palsy
491377|NCT01055548|Anxiety|anxiety
491378|NCT01055548|Parents|parents
491379|NCT01055522|Interleukin, IL2, monoclonal, antibody, cytokine, Dacarbazine, metastatic, melanoma, tumor targeting, Dose definition|interleukin, il2, monoclonal, antibody, cytokine, dacarbazine, metastatic, melanoma, tumor targeting, dose definition
491380|NCT01055522|, L19|, l19
491381|NCT01055509|Social Adjustment|social adjustment
491382|NCT01055509|Quality of life|quality of life
491383|NCT01055509|Recurrence|recurrence
491384|NCT01055509|Hospitalization|hospitalization
491385|NCT01055496|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
491386|NCT01055483|Acute myeloid leukemia|acute myeloid leukemia
491387|NCT01055483|AML|aml
491388|NCT01055483|relapsed acute myeloid leukemia|relapsed acute myeloid leukemia
491389|NCT01055483|refractory acute myeloid leukemia|refractory acute myeloid leukemia
491390|NCT01055431|iron|iron
491391|NCT01055431|bioavailability|bioavailability
491392|NCT01055431|status|status
491393|NCT01055431|deficiency|deficiency
491394|NCT01055431|anaemia|anaemia
491395|NCT01055431|functional foods|functional foods
491396|NCT01055431|child bearing|child bearing
491397|NCT01055418|Vitamin C|vitamin c
491398|NCT01055418|Cognitive performance|cognitive performance
491399|NCT01055418|Cerebral blood flow|cerebral blood flow
491400|NCT01055418|Trans cranial doppler|trans cranial doppler
491401|NCT01055418|Near infrared spectroscopy|near infrared spectroscopy
491402|NCT01055405|Exercise tolerance|exercise tolerance
491403|NCT01055405|COPD|copd
491404|NCT01055405|Pulmonary hypertension|pulmonary hypertension
491405|NCT01055405|Sildenafil|sildenafil
491406|NCT01055392|mild cognitive impairment|mild cognitive impairment
491407|NCT01055392|Alzheimer's disease|alzheimer's disease
491408|NCT01055392|Lithium|lithium
491409|NCT01055392|disease-modification|disease-modification
491410|NCT01055392|cognition|cognition
491411|NCT01055392|early Alzheimer`s disease|early alzheimer`s disease
491412|NCT01055379|Rasagiline|rasagiline
491413|NCT01055379|Depressive Symptoms|depressive symptoms
491414|NCT01055379|Cognition|cognition
491415|NCT01055366|Open angle glaucoma|open angle glaucoma
491416|NCT01055366|OAG|oag
491417|NCT01055366|Elazop|elazop
491418|NCT01055366|Azarga|azarga
491419|NCT01055366|Brinzolamide/Timolol combination|brinzolamide/timolol combination
491420|NCT01055353|Target organs damage|target organs damage
491421|NCT01055353|hypertensive patients|hypertensive patients
491422|NCT01055340|Ketogenesis|ketogenesis
491423|NCT01055340|Glucose-Dependent Insulin Secretion|glucose-dependent insulin secretion
491424|NCT01055340|Graded Glucose Infusion|graded glucose infusion
491425|NCT01055340|Oxyntomodulin|oxyntomodulin
491426|NCT01055327|Isolated oral clefts|isolated oral clefts
491427|NCT01055327|lamotrigine|lamotrigine
491428|NCT01055327|EUROCAT|eurocat
491429|NCT01055327|congenital malformations|congenital malformations
491430|NCT01055327|anti-epileptic drugs|anti-epileptic drugs
491431|NCT01055301|stage I multiple myeloma|stage i multiple myeloma
491432|NCT01055301|stage II multiple myeloma|stage ii multiple myeloma
491433|NCT01055301|stage III multiple myeloma|stage iii multiple myeloma
491434|NCT01055275|iliac aneurysm|iliac aneurysm
491435|NCT01055275|aortic aneurysm|aortic aneurysm
491436|NCT01055275|endovascular grafts|endovascular grafts
491437|NCT01055262|Safety|safety
491438|NCT01055262|tolerability|tolerability
491439|NCT01055262|heatwrap|heatwrap
491440|NCT01055262|lower back|lower back
491441|NCT01055262|healthy subjects|healthy subjects
491442|NCT01055249|UVB|uvb
491443|NCT01055249|pain|pain
491444|NCT01055249|inflammation|inflammation
491445|NCT01055249|model|model
491446|NCT01055249|healthy volunteers|healthy volunteers
491546|NCT01054664|liver enzymes|liver enzymes
491447|NCT01055249|Ultraviolet radiation (UVR) induced pain and inflammation in healthy volunteers|ultraviolet radiation (uvr) induced pain and inflammation in healthy volunteers
491448|NCT01055236|sedation|sedation
491449|NCT01055223|thiazolidinediones|thiazolidinediones
491450|NCT01055223|rosiglitazone|rosiglitazone
491451|NCT01055223|amiloride|amiloride
491452|NCT01055223|pioglitazone|pioglitazone
491453|NCT01055223|fracture|fracture
491454|NCT01055223|Spironolactone|spironolactone
491455|NCT01055210|Heart Failure|heart failure
491456|NCT01055210|Pacemakers|pacemakers
491457|NCT01055197|extensive stage small cell lung cancer|extensive stage small cell lung cancer
491458|NCT01055184|Influenza|influenza
491459|NCT01055184|H1N1|h1n1
491460|NCT01055171|alcohol dependence|alcohol dependence
491461|NCT01055171|PTSD|ptsd
491462|NCT01055171|propanolol|propanolol
491463|NCT01055171|craving|craving
491464|NCT01055171|beta-block|beta-block
491465|NCT01055171|cue exposure|cue exposure
491466|NCT01055171|addiction|addiction
491467|NCT01055171|memory|memory
491468|NCT01055171|trauma|trauma
491469|NCT01055171|addictive behavior|addictive behavior
491470|NCT01055158|HIV|hiv
491471|NCT01055145|Multidrug-resistant TB, sensitive to levofloxacin and moxifloxacin|multidrug-resistant tb, sensitive to levofloxacin and moxifloxacin
491472|NCT01055106|bacterial vaginosis|bacterial vaginosis
491473|NCT01055106|vaginal infection|vaginal infection
491474|NCT01055106|vaginal discharge|vaginal discharge
491475|NCT01055106|vaginal disease|vaginal disease
491476|NCT01055093|diabetes mellitus|diabetes mellitus
491477|NCT01055093|prospective observational study|prospective observational study
491478|NCT01055093|diabetic complications|diabetic complications
491479|NCT01055080|type 1 diabetes|type 1 diabetes
491480|NCT01055080|beta-cell autoantibodies|beta-cell autoantibodies
491481|NCT01055080|cow's milk formula|cow's milk formula
491482|NCT01055080|bovine insulin|bovine insulin
491483|NCT01055054|bariatrics|bariatrics
491484|NCT01055015|total knee arthroplasty|total knee arthroplasty
491485|NCT01055002|Health male volunteers|health male volunteers
491486|NCT01055002|Male volunteers aged 18-45 years|male volunteers aged 18-45 years
491487|NCT01055002|Non-smokers and in good health|non-smokers and in good health
491488|NCT01054989|Healthy adults|healthy adults
491489|NCT01054989|Insulin sensitivity|insulin sensitivity
491490|NCT01054976|Alzheimer's disease|alzheimer's disease
491491|NCT01054976|Galantamine|galantamine
491492|NCT01054976|Dementia|dementia
491493|NCT01054963|early inflammatory arthritis|early inflammatory arthritis
491494|NCT01054963|chronic disease|chronic disease
491495|NCT01054963|peer support|peer support
491496|NCT01054963|peer mentor|peer mentor
491497|NCT01054963|peer counselling|peer counselling
491498|NCT01054937|4SC-203|4sc-203
491499|NCT01054937|Phase I|phase i
491500|NCT01054937|single dose|single dose
491501|NCT01054937|healthy volunteers|healthy volunteers
491502|NCT01054911|GIST|gist
491503|NCT01054911|gastrointestinal stromal tumor|gastrointestinal stromal tumor
491504|NCT01054911|gastrointestinal stomach tumor|gastrointestinal stomach tumor
491505|NCT01054911|Sunitinib|sunitinib
491506|NCT01054898|depression|depression
491507|NCT01054898|spouse abuse|spouse abuse
491508|NCT01054898|intervention studies|intervention studies
491509|NCT01054885|COPD|copd
491510|NCT01054885|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
491511|NCT01054885|Efficacy|efficacy
491512|NCT01054885|FEV1|fev1
491513|NCT01054885|Safety|safety
491514|NCT01054872|HIV Seronegativity|hiv seronegativity
491515|NCT01054872|HIV Preventive Vaccine|hiv preventive vaccine
491516|NCT01054846|Bicycle helmet|bicycle helmet
491517|NCT01054820|FLECTORÂ® Patch|flectorâ® patch
491518|NCT01054820|acute back strain|acute back strain
491519|NCT01054794|Gastroparesis|gastroparesis
491520|NCT01054794|Gastric Electrical Stimulation|gastric electrical stimulation
491521|NCT01054781|Diffuse Large B-Cell Lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
491522|NCT01054781|rituximab|rituximab
491523|NCT01054781|CHOP|chop
491524|NCT01054768|Antioxidant|antioxidant
491525|NCT01054768|Inflammation|inflammation
491526|NCT01054768|Sickle Cell Disease|sickle cell disease
491527|NCT01054768|Oxidative Stress|oxidative stress
491528|NCT01054768|Cytokines|cytokines
491529|NCT01054768|anti-inflammatory|anti-inflammatory
491530|NCT01054768|Acetylcarnitine|acetylcarnitine
491531|NCT01054729|Chronic Hepatitis C infection Genotype 1|chronic hepatitis c infection genotype 1
491532|NCT01054729|HCV|hcv
491533|NCT01054729|GT1|gt1
491534|NCT01054729|GT 1|gt 1
491535|NCT01054716|RhD negative|rhd negative
491536|NCT01054716|RhD disease|rhd disease
491537|NCT01054716|fetal nucleic acid|fetal nucleic acid
491538|NCT01054716|fetal DNA|fetal dna
491539|NCT01054716|cell free fetal DNA|cell free fetal dna
491540|NCT01054716|Fetal RHD genotype|fetal rhd genotype
491541|NCT01054690|Catheterization|catheterization
491542|NCT01054690|Urinary Tract Infection|urinary tract infection
491543|NCT01054690|Elective Surgery|elective surgery
491544|NCT01054677|Infections in nursing homes|infections in nursing homes
491545|NCT01054677|especially urinary tract infections|especially urinary tract infections
492131|NCT01052480|Antiviral|antiviral
491547|NCT01054664|peripheral mononuclear blood cells|peripheral mononuclear blood cells
491548|NCT01054664|hemodialysis|hemodialysis
491549|NCT01054664|hepatitis C|hepatitis c
491551|NCT01054651|Schistosoma mansoni|schistosoma mansoni
491552|NCT01054651|Praziquantel|praziquantel
491553|NCT01054651|Artesunate + Sulfamethoxypyrazine/pyrimethamine|artesunate + sulfamethoxypyrazine/pyrimethamine
491554|NCT01054651|Randomized open-label controlled clinical trial|randomized open-label controlled clinical trial
491555|NCT01054638|amprenavir|amprenavir
491556|NCT01054638|fosamprenavir|fosamprenavir
491557|NCT01054638|HIV|hiv
491558|NCT01054638|HAART treatment|haart treatment
491559|NCT01054638|Epzicom|epzicom
491560|NCT01054638|Trizivir|trizivir
491561|NCT01054638|Combivir|combivir
491562|NCT01054638|zidovudine|zidovudine
491563|NCT01054638|lamivudine|lamivudine
491564|NCT01054638|cardiovascular disease|cardiovascular disease
491565|NCT01054638|HIV Infections|hiv infections
491566|NCT01054625|Squamous Cell Carcinoma of the Head and Neck|squamous cell carcinoma of the head and neck
491567|NCT01054625|Head and Neck Cancer|head and neck cancer
491568|NCT01054625|Head and Neck Neoplasms|head and neck neoplasms
491569|NCT01054625|anti-EGFr monoclonal antibody|anti-egfr monoclonal antibody
491570|NCT01054625|Zalutumumab|zalutumumab
491571|NCT01054612|Histology|histology
491572|NCT01054612|Immunohistochemical|immunohistochemical
491573|NCT01054612|Gene Expression|gene expression
491574|NCT01054612|Tissue Sectioning|tissue sectioning
491575|NCT01054599|epilepsy|epilepsy
491576|NCT01054599|memory|memory
491577|NCT01054599|memantine|memantine
491578|NCT01054599|localization related epilepsy|localization related epilepsy
491579|NCT01054599|focal epilepsy|focal epilepsy
491580|NCT01054586|antiretroviral therapy|antiretroviral therapy
491581|NCT01054586|hepatic impairment|hepatic impairment
491582|NCT01054586|HIV|hiv
491583|NCT01054573|Hepatitis C, Chronic|hepatitis c, chronic
491584|NCT01054573|Telaprevir|telaprevir
491585|NCT01054573|Roll-over study|roll-over study
491586|NCT01054560|Ischemic Stroke|ischemic stroke
491587|NCT01054560|SOLITAIRE™ Device|solitaire™ device
491588|NCT01054560|SOLITAIRE™|solitaire™
491589|NCT01054560|MERCI® Device|merci® device
491590|NCT01054560|MERCI®|merci®
491591|NCT01054560|Stroke|stroke
491592|NCT01054560|Ischemic|ischemic
491593|NCT01054560|Mechanical Thrombectomy|mechanical thrombectomy
491594|NCT01054560|Brain|brain
491595|NCT01054560|Brain Clot|brain clot
491596|NCT01054560|Brain Artery Revascularization|brain artery revascularization
491597|NCT01054560|Recanalization|recanalization
491598|NCT01054560|Brain Stroke|brain stroke
491599|NCT01054560|Clot Retriever|clot retriever
491600|NCT01054560|Device|device
491601|NCT01054560|Neurosurgery|neurosurgery
491602|NCT01054560|Neurovascular Intervention|neurovascular intervention
491603|NCT01054560|Interventional Neuroradiology|interventional neuroradiology
491604|NCT01054560|Brain study|brain study
491605|NCT01054560|neurovascular clinical trial|neurovascular clinical trial
491606|NCT01054547|topical anesthetic|topical anesthetic
491607|NCT01054547|liposomal ropivacaine|liposomal ropivacaine
491608|NCT01054547|dentistry|dentistry
491609|NCT01054534|urinary incontinence|urinary incontinence
491610|NCT01054521|radiofrequency turbinate reduction|radiofrequency turbinate reduction
491611|NCT01054521|nasal obstruction|nasal obstruction
491612|NCT01054521|Temperature-controlled radiofrequency|temperature-controlled radiofrequency
491613|NCT01054521|Bipolar radiofrequency|bipolar radiofrequency
491614|NCT01054521|chronic rhinitis.|chronic rhinitis.
491615|NCT01054495|Acupuncture|acupuncture
491616|NCT01054495|Sham acupuncture|sham acupuncture
491617|NCT01054495|Laser|laser
491618|NCT01054495|Methodology|methodology
491619|NCT01054495|Control intervention|control intervention
491620|NCT01054495|Pilot|pilot
491621|NCT01054495|Nausea and vomiting in early pregnancy|nausea and vomiting in early pregnancy
491622|NCT01054495|Patient's experience of different acu-stimulation|patient's experience of different acu-stimulation
491623|NCT01054495|Blinding in acupuncture research|blinding in acupuncture research
491624|NCT01054482|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
491625|NCT01054482|neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
491626|NCT01054469|nephrectomy|nephrectomy
491627|NCT01054456|LEC|lec
491628|NCT01054456|Low Emetogenic Chemotherapy|low emetogenic chemotherapy
491629|NCT01054456|Nausea and Vomiting|nausea and vomiting
491630|NCT01054456|Nausea|nausea
491631|NCT01054456|Vomiting|vomiting
491632|NCT01054456|Anti- emetic|anti- emetic
491633|NCT01054443|Blood Platelet Disorders|blood platelet disorders
491634|NCT01054443|Immune Thrombocytopenia (ITP)|immune thrombocytopenia (itp)
491635|NCT01054443|Low Platelet Count|low platelet count
491636|NCT01054443|Thrombocytopaenia|thrombocytopaenia
491637|NCT01054443|S-888711|s-888711
491638|NCT01054443|Splenectomy|splenectomy
491639|NCT01054443|Thrombopoiesis|thrombopoiesis
491640|NCT01054443|Hematologic Disease|hematologic disease
491641|NCT01054443|Auto-immune thrombocytopenic Purpura|auto-immune thrombocytopenic purpura
491642|NCT01054443|Relapsed Persistent or Chronic ITP|relapsed persistent or chronic itp
491643|NCT01054443|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
491644|NCT01054443|Thrombotic Thrombocytopenic Purpura (TTP)|thrombotic thrombocytopenic purpura (ttp)
491645|NCT01054430|Avanafil|avanafil
491646|NCT01054430|Hepatic|hepatic
491647|NCT01054430|Erectile Dysfunction|erectile dysfunction
491648|NCT01054430|Impairment|impairment
491649|NCT01054417|Appendicitis|appendicitis
491650|NCT01054417|Laparoscopy|laparoscopy
491651|NCT01054417|Appendectomy|appendectomy
491652|NCT01054404|Brain Swelling|brain swelling
491653|NCT01054404|Brain Edema|brain edema
491654|NCT01054404|Dehydration|dehydration
491655|NCT01054352|Seasonal allergies|seasonal allergies
491656|NCT01054352|Allergic rhinitis|allergic rhinitis
491657|NCT01054339|Alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
491658|NCT01054339|Adeno-associated virus vector|adeno-associated virus vector
491659|NCT01054339|AAV|aav
491660|NCT01054339|Gene therapy|gene therapy
491661|NCT01054339|Human gene transfer|human gene transfer
491662|NCT01054326|arthroscopic subacromial decompression|arthroscopic subacromial decompression
491663|NCT01054326|exercise|exercise
491664|NCT01054326|physical therapy|physical therapy
491665|NCT01054326|rotator cuff|rotator cuff
491666|NCT01054326|shoulder impingement syndrome|shoulder impingement syndrome
491667|NCT01054326|Subacromial impingement after arthroscopic subacromial decompression|subacromial impingement after arthroscopic subacromial decompression
491668|NCT01054313|Advanced Malignancies|advanced malignancies
491669|NCT01054313|Taxotere|taxotere
491670|NCT01054313|Docetaxel|docetaxel
491671|NCT01054313|Rapamycin|rapamycin
491672|NCT01054313|Sirolimus|sirolimus
491673|NCT01054313|Rapamune|rapamune
491674|NCT01054313|Prednisone|prednisone
491675|NCT01054313|Resistant to standard therapy|resistant to standard therapy
491676|NCT01054274|esophageal cancer|esophageal cancer
491677|NCT01054274|dysphagia|dysphagia
491678|NCT01054274|stent|stent
491679|NCT01054274|brachytherapy|brachytherapy
491680|NCT01054261|avanafil, renal, impairment, TA-1790|avanafil, renal, impairment, ta-1790
491681|NCT01054248|pregnancy, malaria, artemisinin, vivax, falciparum|pregnancy, malaria, artemisinin, vivax, falciparum
491682|NCT01054235|prenatal care|prenatal care
491683|NCT01054235|community-based randomized controlled trial|community-based randomized controlled trial
491684|NCT01054235|perinatal mortality|perinatal mortality
491685|NCT01054235|China|china
491686|NCT01054222|overactive bladder idiopathic|overactive bladder idiopathic
491687|NCT01054222|elderly fesoterodine SOFIA Portugal extension study|elderly fesoterodine sofia portugal extension study
491688|NCT01054209|Inadvertent Peri-operative Hypothermia|inadvertent peri-operative hypothermia
491689|NCT01054209|Shivering|shivering
491690|NCT01054209|Caesarean Section|caesarean section
491691|NCT01054209|Elective|elective
491692|NCT01054209|Warming Mattress|warming mattress
491693|NCT01054209|Regional Anaesthesia|regional anaesthesia
491694|NCT01054183|respiratory failure, intubation, GlideScope, pediatric|respiratory failure, intubation, glidescope, pediatric
491695|NCT01054170|Chronic|chronic
491696|NCT01054170|obstructive|obstructive
491697|NCT01054170|pulmonary|pulmonary
491698|NCT01054170|lung|lung
491699|NCT01054170|respiratory disease|respiratory disease
491700|NCT01054170|efficacy|efficacy
491701|NCT01054170|placebo-controlled|placebo-controlled
491702|NCT01054170|COPD|copd
491703|NCT01054170|FEV1|fev1
491704|NCT01054170|St Georges Respiratory Questionnaire|st georges respiratory questionnaire
491705|NCT01054170|Computed Tomography|computed tomography
491706|NCT01054170|MSCT|msct
491707|NCT01054144|Newly Diagnosed Standard Risk Multiple Myeloma|newly diagnosed standard risk multiple myeloma
491708|NCT01054144|Senior Adults|senior adults
491709|NCT01054131|peer support|peer support
491710|NCT01054131|peer mentor|peer mentor
491711|NCT01054131|self-management|self-management
491712|NCT01054131|early inflammatory arthritis|early inflammatory arthritis
491713|NCT01054131|chronic disease|chronic disease
491714|NCT01054118|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
491715|NCT01054105|Pulmonary hypertension|pulmonary hypertension
491716|NCT01054105|genes|genes
491717|NCT01054105|mutation|mutation
491718|NCT01054105|drug therapy|drug therapy
491719|NCT01054092|ASP1941|asp1941
491720|NCT01054092|Diabetes mellitus|diabetes mellitus
491721|NCT01054092|Blood glucose|blood glucose
491722|NCT01054092|Food effect|food effect
491723|NCT01054066|Chronic Kidney Disease|chronic kidney disease
491724|NCT01054066|Cardiovascular Disease|cardiovascular disease
491725|NCT01054066|Hypertension|hypertension
491726|NCT01054066|Anemia|anemia
491727|NCT01054053|Neisseria meningitidis B:14, P1-7, 16|neisseria meningitidis b:14, p1-7, 16
491728|NCT01054053|Serum bactericidal activity|serum bactericidal activity
491729|NCT01054053|Menbvac|menbvac
491730|NCT01054040|cardiovascular disease, portion plate|cardiovascular disease, portion plate
491731|NCT01054027|Retinopathy of Prematurity (ROP)|retinopathy of prematurity (rop)
491732|NCT01054027|Eye exams|eye exams
491733|NCT01054027|Premature infants|premature infants
491734|NCT01054027|cyclomydril|cyclomydril
491735|NCT01054014|CR016795|cr016795
491736|NCT01054001|prostate cancer|prostate cancer
491737|NCT01054001|prostatectomy|prostatectomy
491738|NCT01054001|erectile dysfunction|erectile dysfunction
491739|NCT01053988|Safety|safety
491740|NCT01053988|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
491741|NCT01053988|Efficacy|efficacy
491742|NCT01053988|FEV1|fev1
491743|NCT01053988|COPD|copd
491744|NCT01053975|RSR|rsr
491745|NCT01053975|SECG|secg
491746|NCT01053975|SPECT|spect
491747|NCT01053975|QCA|qca
491748|NCT01053975|SCAD|scad
491749|NCT01053962|Chronic Idiopathic Constipation|chronic idiopathic constipation
491750|NCT01053962|Constipation|constipation
491751|NCT01053962|Irritable Bowel Syndrome|irritable bowel syndrome
491752|NCT01053949|Multiple myeloma|multiple myeloma
491753|NCT01053949|dexamethasone|dexamethasone
491754|NCT01053949|pomalidomide|pomalidomide
491755|NCT01053949|response|response
491756|NCT01053949|safety|safety
491757|NCT01053936|Chronic Kidney Disease|chronic kidney disease
491758|NCT01053936|Type 2 diabetes|type 2 diabetes
491759|NCT01053936|Diabetic Nephropathy|diabetic nephropathy
491760|NCT01053923|Perianal Cancer|perianal cancer
491761|NCT01053923|Anal Cancer|anal cancer
491762|NCT01053923|MRI scan|mri scan
491763|NCT01053897|GBT009|gbt009
491764|NCT01053897|incisional scar|incisional scar
491765|NCT01053897|breast reconstruction|breast reconstruction
491766|NCT01053884|Invasive Candidiasis|invasive candidiasis
491767|NCT01053884|invasive fungal disease|invasive fungal disease
491768|NCT01053884|Anidulafungin|anidulafungin
491769|NCT01053871|normal|normal
491770|NCT01053858|bevacizumab,triamcinolone, intravitreal injection|bevacizumab,triamcinolone, intravitreal injection
491771|NCT01053845|Neuropathic pain|neuropathic pain
491772|NCT01053832|ventricular pace suppression|ventricular pace suppression
491773|NCT01053832|pacemaker|pacemaker
491774|NCT01053832|efficacy|efficacy
491775|NCT01053832|safety|safety
491776|NCT01053832|support of intrinsic heart rhythm|support of intrinsic heart rhythm
491777|NCT01053819|psoriasis|psoriasis
491778|NCT01053819|melanoma|melanoma
491779|NCT01053819|non-melanoma skin cancer|non-melanoma skin cancer
491780|NCT01053819|etanercept|etanercept
491781|NCT01053819|Enbrel|enbrel
491782|NCT01053806|MDS|mds
491783|NCT01053806|Lenalidomide|lenalidomide
491784|NCT01053806|5-Azacytidine.|5-azacytidine.
491785|NCT01053806|ORR|orr
491786|NCT01053806|PFS|pfs
491787|NCT01053806|myelodysplastic syndrome.High risk.|myelodysplastic syndrome.high risk.
491788|NCT01053793|Glycemic index|glycemic index
491789|NCT01053793|Anthocyanin|anthocyanin
491790|NCT01053793|Potato|potato
491791|NCT01053793|Polyphenol|polyphenol
491792|NCT01053780|Intercessory Prayer, pregnants|intercessory prayer, pregnants
491793|NCT01053767|Group B streptococcus|group b streptococcus
491794|NCT01053767|GBS|gbs
491795|NCT01053767|Vaccine|vaccine
491796|NCT01053754|adrenocortical insufficiency|adrenocortical insufficiency
491797|NCT01053754|prolonged corticotherapy|prolonged corticotherapy
491798|NCT01053715|Hemophilia|hemophilia
491799|NCT01053715|Quality of Life|quality of life
491800|NCT01053689|Bioequivalence, Glimepiride, Crossover|bioequivalence, glimepiride, crossover
491801|NCT01053676|Hyperphosphatemia|hyperphosphatemia
491802|NCT01053676|BE|be
491803|NCT01053676|Granule|granule
491804|NCT01053676|Healthy volunteers|healthy volunteers
491805|NCT01053650|Healthy volunteers|healthy volunteers
491806|NCT01053650|Open / hidden|open / hidden
491807|NCT01053650|Placebo effect|placebo effect
491808|NCT01053637|lacerations|lacerations
491809|NCT01053637|sutures|sutures
491810|NCT01053637|pediatrics|pediatrics
491811|NCT01053637|child|child
491812|NCT01053637|pain|pain
491813|NCT01053637|Anxiety|anxiety
491814|NCT01053624|Tracheostomy and thoracic surgery|tracheostomy and thoracic surgery
491815|NCT01053624|postoperative complications|postoperative complications
491816|NCT01053624|pulmonary surgical procedures|pulmonary surgical procedures
491817|NCT01053624|respiratory failure|respiratory failure
491818|NCT01053611|composite variability index|composite variability index
491819|NCT01053611|bispectral index|bispectral index
491820|NCT01053611|pain|pain
491821|NCT01053598|Mycobacterium tuberculosis|mycobacterium tuberculosis
491822|NCT01053598|Nitrate Reductase Assay|nitrate reductase assay
491823|NCT01053598|NRA|nra
491824|NCT01053598|REMA|rema
491825|NCT01053598|RETA|reta
491826|NCT01053598|Rezazurine|rezazurine
491827|NCT01053585|Gastro-esophageal junction, reflux, insertion angle, magnetic resonance imaging, manometry|gastro-esophageal junction, reflux, insertion angle, magnetic resonance imaging, manometry
491828|NCT01053572|Chronic low back pain|chronic low back pain
491829|NCT01053572|Post lumbar laminectomy syndrome|post lumbar laminectomy syndrome
491830|NCT01053572|Lower extremity pain|lower extremity pain
491831|NCT01053572|Local anesthetic|local anesthetic
491832|NCT01053572|Steroid|steroid
491833|NCT01053572|Percutaneous lumbar adhesiolysis|percutaneous lumbar adhesiolysis
491834|NCT01053559|Crohn's|crohn's
491835|NCT01053559|Inflammatory Bowel Disease|inflammatory bowel disease
491836|NCT01053533|Chinese herbal medicines|chinese herbal medicines
491837|NCT01053533|pandemic H1N1 influenza|pandemic h1n1 influenza
491838|NCT01053533|effectiveness|effectiveness
491839|NCT01053533|safety|safety
491840|NCT01053507|Headache|headache
492335|NCT01051700|GW786034|gw786034
491841|NCT01053507|Post-traumatic headache|post-traumatic headache
491842|NCT01053507|Brain injury|brain injury
491843|NCT01053507|Cognitive impairment|cognitive impairment
491844|NCT01053468|breast cancer|breast cancer
491845|NCT01053468|physical activity|physical activity
491846|NCT01053468|quality of life|quality of life
491847|NCT01053468|theory of planned behavior|theory of planned behavior
491848|NCT01053468|behavior change|behavior change
491849|NCT01053468|health promotion|health promotion
491850|NCT01053455|Non-invasive ventilation|non-invasive ventilation
491851|NCT01053455|SiPAP|sipap
491852|NCT01053455|CPAP|cpap
491853|NCT01053455|low birth weight infants|low birth weight infants
491854|NCT01053455|respiratory distress syndrome|respiratory distress syndrome
491855|NCT01053442|iron absorption|iron absorption
491856|NCT01053442|stable isotopes|stable isotopes
491857|NCT01053442|NaFeEDTA|nafeedta
491858|NCT01053442|Non-transferrin-bound iron (NTBI)|non-transferrin-bound iron (ntbi)
491859|NCT01053442|Hepcidin|hepcidin
491860|NCT01053429|Regulatory Post-Marketing Surveillance|regulatory post-marketing surveillance
491861|NCT01053429|Regulatory Pharmacovigilance|regulatory pharmacovigilance
491862|NCT01053429|ziprasidone|ziprasidone
491863|NCT01053416|glaucoma|glaucoma
491864|NCT01053416|pigmentary glaucoma|pigmentary glaucoma
491865|NCT01053416|laser iridotomy|laser iridotomy
491866|NCT01053403|MDMA|mdma
491867|NCT01053403|Ecstasy|ecstasy
491868|NCT01053403|MDMA effect on sleep|mdma effect on sleep
491869|NCT01053403|MDMA effect on water homeostasis|mdma effect on water homeostasis
491870|NCT01053403|MDMA effect on neurocognitive function|mdma effect on neurocognitive function
491871|NCT01053403|Recreational Drug Use|recreational drug use
491872|NCT01053403|Drug Abuse|drug abuse
491873|NCT01053390|gallbladder neoplasmas|gallbladder neoplasmas
491874|NCT01053390|Gallbladder Neoplasms,Advanced Stage,Chemotherapy,Somatostatin|gallbladder neoplasms,advanced stage,chemotherapy,somatostatin
491875|NCT01053377|Influenza|influenza
491876|NCT01053377|Tamiflu|tamiflu
491877|NCT01053377|Osteltamivir|osteltamivir
491878|NCT01053377|Transmission|transmission
491879|NCT01053377|Prevention|prevention
491880|NCT01053377|Resistance|resistance
491881|NCT01053377|Post-Exposure Profylaxe|post-exposure profylaxe
491882|NCT01053338|Bioequivalence,Ibuprofen Diphenhydramine Citrate,Crossover|bioequivalence,ibuprofen diphenhydramine citrate,crossover
491883|NCT01053325|Malaria|malaria
491884|NCT01053325|Pregnancy|pregnancy
491885|NCT01053325|Prevention|prevention
491886|NCT01053325|HIV|hiv
491887|NCT01053325|Sub-Sahara Africa|sub-sahara africa
491888|NCT01053312|Amyloid|amyloid
491889|NCT01053312|NPH Normal pressure hydrocephalus|nph normal pressure hydrocephalus
491890|NCT01053312|PET Positron Emission Tomography|pet positron emission tomography
491891|NCT01053312|SUVR Standard uptake value ratios|suvr standard uptake value ratios
491892|NCT01053299|Developmental dysplasia of the hip (DDH)|developmental dysplasia of the hip (ddh)
491893|NCT01053299|newborn|newborn
491894|NCT01053299|universal screening|universal screening
491895|NCT01053299|Universal ultrasound-screening for DDH in newborns|universal ultrasound-screening for ddh in newborns
491896|NCT01053299|The accuracy of ultrasound-recording of the hip in newborns|the accuracy of ultrasound-recording of the hip in newborns
491897|NCT01053286|Dysphagia|dysphagia
491898|NCT01053286|Globus|globus
491899|NCT01053286|Gastroesophageal reflux|gastroesophageal reflux
491900|NCT01053273|Low back pain|low back pain
491901|NCT01053273|Post lumbar laminectomy syndrome|post lumbar laminectomy syndrome
491902|NCT01053273|Lumbar spinal stenosis|lumbar spinal stenosis
491903|NCT01053273|Local anesthetic steroid|local anesthetic steroid
491904|NCT01053273|Lumbar transforaminal epidural injection|lumbar transforaminal epidural injection
491905|NCT01053273|Percutaneous epidural adhesiolysis|percutaneous epidural adhesiolysis
491906|NCT01053273|Caudal epidural injection|caudal epidural injection
491907|NCT01053260|Contingency Management|contingency management
491908|NCT01053260|Weight Loss|weight loss
491909|NCT01053247|Atopic Dermatitis|atopic dermatitis
491910|NCT01053234|Hyperglycaemia|hyperglycaemia
491911|NCT01053234|Postprandial|postprandial
491912|NCT01053234|Type 2 diabetes|type 2 diabetes
491913|NCT01053234|Cardiovascular risk markers|cardiovascular risk markers
491914|NCT01053221|mycophenolate|mycophenolate
491915|NCT01053221|living donor|living donor
491916|NCT01053208|Bioequivalence,Ibuprofen Diphenhydramine Citrate,Crossover|bioequivalence,ibuprofen diphenhydramine citrate,crossover
491917|NCT01053195|Diabetes|diabetes
491918|NCT01053195|prevention|prevention
491919|NCT01053195|intervention|intervention
491920|NCT01053182|esophageal cancer|esophageal cancer
491921|NCT01053182|postoperative complications|postoperative complications
491922|NCT01053182|diaphragm|diaphragm
491923|NCT01053182|pulmonary function|pulmonary function
491924|NCT01053169|Coagulopathy|coagulopathy
491925|NCT01053169|Perioperative bleeding|perioperative bleeding
491926|NCT01053169|Prothrombin complex|prothrombin complex
491927|NCT01053169|Liver disease|liver disease
491928|NCT01053156|Fragile X syndrome|fragile x syndrome
491929|NCT01053156|minocycline|minocycline
491930|NCT01053156|targeted treatment|targeted treatment
491931|NCT01053143|Influenza|influenza
491932|NCT01053143|Pandemic Influenza|pandemic influenza
492626|NCT01050556|nutrition|nutrition
491933|NCT01053143|Swine-Origin Influenza A/H1N1 Non-adjuvanted Vaccine|swine-origin influenza a/h1n1 non-adjuvanted vaccine
491934|NCT01053143|Influenza A Virus, H1N1 subtype|influenza a virus, h1n1 subtype
491935|NCT01053143|Adults|adults
491936|NCT01053130|obesity|obesity
491937|NCT01053130|bariatric surgery|bariatric surgery
491938|NCT01053130|chronic kidney disease|chronic kidney disease
491939|NCT01053130|weight loss|weight loss
491940|NCT01053130|exercise|exercise
491941|NCT01053117|central venous catheter|central venous catheter
491942|NCT01053117|arteriovenous fistula|arteriovenous fistula
491943|NCT01053117|hemodialysis|hemodialysis
491944|NCT01053117|vascular access|vascular access
491945|NCT01053117|dialysis|dialysis
491946|NCT01053104|Colorectal cancer|colorectal cancer
491947|NCT01053104|Breast cancer|breast cancer
491948|NCT01053104|Capecitabine|capecitabine
491949|NCT01053104|Docetaxel|docetaxel
491950|NCT01053104|Mobile phone|mobile phone
491951|NCT01053104|Toxicity|toxicity
491952|NCT01053104|Metastatic|metastatic
491953|NCT01053091|exercise-base rehabilitation|exercise-base rehabilitation
491954|NCT01053091|diastolic heart failure|diastolic heart failure
491955|NCT01053091|cardiovascular function|cardiovascular function
491956|NCT01053091|aerobic fitness|aerobic fitness
491957|NCT01053078|Type 1 diabetes|type 1 diabetes
491958|NCT01053078|Hypoglycemia unawareness|hypoglycemia unawareness
491959|NCT01053078|low blood sugar|low blood sugar
491960|NCT01053065|Atherosclerosis|atherosclerosis
491961|NCT01053065|Macrophages|macrophages
491962|NCT01053065|Carotid arteries|carotid arteries
491963|NCT01053065|Statin|statin
491964|NCT01053052|Patency Tests, Fallopian Tubes|patency tests, fallopian tubes
491965|NCT01053052|Hysterosalpingography|hysterosalpingography
491966|NCT01053052|Sonography, Medical|sonography, medical
491967|NCT01053026|Angiotensin receptor II antagonist|angiotensin receptor ii antagonist
491968|NCT01053013|macrobead|macrobead
491969|NCT01053013|biological|biological
491970|NCT01053013|mouse cells|mouse cells
491971|NCT01053000|ACTINIC KERATOSES|actinic keratoses
491972|NCT01053000|HAND|hand
491973|NCT01053000|FOREARM|forearm
491974|NCT01052987|Gout|gout
491975|NCT01052987|Hyperuricemia|hyperuricemia
491976|NCT01052974|femoral neck fracture|femoral neck fracture
491977|NCT01052974|analgesia|analgesia
491978|NCT01052961|severe influenza|severe influenza
491979|NCT01052961|hospitalized adults|hospitalized adults
491980|NCT01052961|oseltamivir treatment|oseltamivir treatment
491981|NCT01052948|dopamine agonists|dopamine agonists
491982|NCT01052948|cabergoline|cabergoline
491983|NCT01052948|Parkinson's disease|parkinson's disease
491984|NCT01052948|hyperprolactinemia|hyperprolactinemia
491985|NCT01052948|epidemiology|epidemiology
491986|NCT01052948|cardiac valvulopathy|cardiac valvulopathy
491987|NCT01052935|Group B streptococcus|group b streptococcus
491988|NCT01052935|GBS|gbs
491989|NCT01052935|Vaccine|vaccine
491990|NCT01052922|Colorectal Neoplasms|colorectal neoplasms
491991|NCT01052922|Mass Screening|mass screening
491992|NCT01052922|Population Surveillance|population surveillance
491993|NCT01052922|Randomized controlled trial|randomized controlled trial
491994|NCT01052922|Occult Blood|occult blood
491995|NCT01052922|Colonoscopy|colonoscopy
491996|NCT01052922|Sigmoidoscopy|sigmoidoscopy
491997|NCT01052922|Health Behavior|health behavior
491998|NCT01052909|Bioequivalence, Glimepiride, Crossover|bioequivalence, glimepiride, crossover
491999|NCT01052896|Dyspepsia|dyspepsia
492000|NCT01052896|Functional|functional
492001|NCT01052883|TMC114-TiDP3-C182|tmc114-tidp3-c182
492002|NCT01052883|TMC114-C182|tmc114-c182
492003|NCT01052883|TMC114|tmc114
492004|NCT01052883|HIV|hiv
492005|NCT01052883|HIV Infections|hiv infections
492006|NCT01052870|pharmacogenomics, androgen receptor gene, androgen sensitivity, CAG repeats, androgenetic alopecia|pharmacogenomics, androgen receptor gene, androgen sensitivity, cag repeats, androgenetic alopecia
492007|NCT01052870|Pharmacogenomics in treatment for androgenetic alopecia in women|pharmacogenomics in treatment for androgenetic alopecia in women
492008|NCT01052857|to evaluate acupuncture as possible alternative treatment for induction of labor|to evaluate acupuncture as possible alternative treatment for induction of labor
492009|NCT01052857|Induction|induction
492010|NCT01052857|treatment|treatment
492011|NCT01052857|posterm|posterm
492012|NCT01052844|Vomiting|vomiting
492013|NCT01052844|Antiemetics|antiemetics
492014|NCT01052844|Dexamethasone|dexamethasone
492015|NCT01052844|Cisplatin|cisplatin
492016|NCT01052844|Antineoplastic combined chemotherapy protocols|antineoplastic combined chemotherapy protocols
492017|NCT01052831|Compulsive Gambling|compulsive gambling
492018|NCT01052831|Compulsive Buying|compulsive buying
492019|NCT01052831|Compulsive Shopping|compulsive shopping
492020|NCT01052831|Compulsive Eating|compulsive eating
492021|NCT01052831|Hypersexuality|hypersexuality
492022|NCT01052831|Dopamine Agonists|dopamine agonists
492023|NCT01052831|Mirapex|mirapex
492024|NCT01052831|Pramipexole|pramipexole
492025|NCT01052831|Requip|requip
492026|NCT01052831|Ropinirole|ropinirole
492027|NCT01052831|Impulse Control Disorders|impulse control disorders
492028|NCT01052818|Non small-cell lung cancer|non small-cell lung cancer
492029|NCT01052818|Circulating tumor cells|circulating tumor cells
492030|NCT01052818|Carcinoembryonic antigen|carcinoembryonic antigen
492031|NCT01052818|Cytokeratin|cytokeratin
492032|NCT01052805|nerve|nerve
492033|NCT01052805|myelinated nerve|myelinated nerve
492034|NCT01052805|unmyelinated nerve|unmyelinated nerve
492035|NCT01052792|Bioequivalence|bioequivalence
492036|NCT01052792|Naproxen|naproxen
492037|NCT01052792|crossover|crossover
492038|NCT01052779|Iron deficiency anemia|iron deficiency anemia
492039|NCT01052779|Chronic kidney disease|chronic kidney disease
492040|NCT01052779|Feraheme|feraheme
492041|NCT01052779|Ferumoxytol|ferumoxytol
492042|NCT01052779|Iron sucrose|iron sucrose
492043|NCT01052779|IDA|ida
492044|NCT01052779|CKD|ckd
492045|NCT01052779|Venofer|venofer
492046|NCT01052766|lung cancer|lung cancer
492047|NCT01052766|PET Scan|pet scan
492048|NCT01052766|CT Scan|ct scan
492049|NCT01052766|BH-PET scan|bh-pet scan
492050|NCT01052766|09-134|09-134
492051|NCT01052753|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
492052|NCT01052753|executive function|executive function
492053|NCT01052753|endophenotype|endophenotype
492054|NCT01052753|dopaminergic system|dopaminergic system
492055|NCT01052753|noradrenergic system|noradrenergic system
492056|NCT01052753|candidate gene|candidate gene
492057|NCT01052753|Family-based association study|family-based association study
492058|NCT01052740|Breast Cancer|breast cancer
492059|NCT01052740|Mammography|mammography
492060|NCT01052740|Screening|screening
492061|NCT01052727|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
492062|NCT01052727|quality of life|quality of life
492063|NCT01052714|Antipsychotic|antipsychotic
492064|NCT01052714|Bipolar|bipolar
492065|NCT01052714|Diabetes|diabetes
492066|NCT01052714|Mental Illness|mental illness
492067|NCT01052714|Nutrition|nutrition
492068|NCT01052714|Obesity|obesity
492069|NCT01052714|Schizoaffective|schizoaffective
492070|NCT01052714|Schizophrenia|schizophrenia
492071|NCT01052714|Weight Gain|weight gain
492072|NCT01052714|Weight Loss|weight loss
492073|NCT01052688|Down syndrome, aneuploidy, amniocentesis, chorionic villus sampling, Trisomy|down syndrome, aneuploidy, amniocentesis, chorionic villus sampling, trisomy
492074|NCT01052675|Drug and substance problematic use, abuse or dependence|drug and substance problematic use, abuse or dependence
492075|NCT01052662|Drug Abuse|drug abuse
492076|NCT01052649|MNC subpopulations|mnc subpopulations
492077|NCT01052649|Gene Expression|gene expression
492078|NCT01052649|Metabolomics|metabolomics
492079|NCT01052649|Immunological Status|immunological status
492080|NCT01052636|Hip fracture|hip fracture
492081|NCT01052636|Intervention program|intervention program
492082|NCT01052636|Elderly|elderly
492083|NCT01052623|GH/IGF-1|gh/igf-1
492084|NCT01052623|Ataxia telangiectasia (AT)|ataxia telangiectasia (at)
492085|NCT01052623|IGF-1 Generation Test|igf-1 generation test
492086|NCT01052623|Growth hormone|growth hormone
492087|NCT01052610|SLIT|slit
492088|NCT01052610|bronchial asthma|bronchial asthma
492089|NCT01052610|allergic rhinitis|allergic rhinitis
492090|NCT01052597|Type 2 diabetes|type 2 diabetes
492091|NCT01052597|Metabolic syndrome|metabolic syndrome
492092|NCT01052597|cardiovascular risk|cardiovascular risk
492093|NCT01052584|malaria|malaria
492094|NCT01052584|therapeutic efficacy|therapeutic efficacy
492095|NCT01052584|in vivo|in vivo
492096|NCT01052584|artemether lumefantrine|artemether lumefantrine
492097|NCT01052584|coartem|coartem
492098|NCT01052584|chloroquine|chloroquine
492099|NCT01052584|Plasmodium falciparum|plasmodium falciparum
492100|NCT01052584|Plasmodium vivax|plasmodium vivax
492101|NCT01052571|Chronic low back pain|chronic low back pain
492102|NCT01052571|Lumbar disc herniation|lumbar disc herniation
492103|NCT01052571|Lower extremity pain|lower extremity pain
492104|NCT01052571|Lumbar radiculitis|lumbar radiculitis
492105|NCT01052571|Local anesthetic|local anesthetic
492106|NCT01052571|Steroid|steroid
492107|NCT01052571|Lumbar transforaminal epidural injection|lumbar transforaminal epidural injection
492108|NCT01052558|Open angle|open angle
492109|NCT01052558|Glaucoma|glaucoma
492110|NCT01052558|Cataract|cataract
492111|NCT01052558|Surgery|surgery
492112|NCT01052558|Intraocular Pressure|intraocular pressure
492113|NCT01052545|urinary tract infection|urinary tract infection
492114|NCT01052545|urinary catheter|urinary catheter
492115|NCT01052545|bacteriuria|bacteriuria
492116|NCT01052545|clinical guidelines|clinical guidelines
492117|NCT01052545|audit-feedback|audit-feedback
492118|NCT01052545|guidelines implementation|guidelines implementation
492119|NCT01052532|Mitral Regurgitation|mitral regurgitation
492120|NCT01052532|LV remodeling|lv remodeling
492121|NCT01052532|Reactive nitrogen species|reactive nitrogen species
492122|NCT01052532|Cardiac MRI|cardiac mri
492123|NCT01052532|Adrenergic overdrive|adrenergic overdrive
492124|NCT01052519|Obesity|obesity
492125|NCT01052519|Esophageal Doppler monitoring|esophageal doppler monitoring
492126|NCT01052519|tissue oxygen tension|tissue oxygen tension
492127|NCT01052506|Human volunteers|human volunteers
492128|NCT01052493|obesity|obesity
492129|NCT01052493|pancreatic polypeptide|pancreatic polypeptide
492130|NCT01052493|gut hormones|gut hormones
492132|NCT01052480|Anti-Influenza Immune Plasma|anti-influenza immune plasma
492133|NCT01052480|Emerging Infectious Disease|emerging infectious disease
492134|NCT01052480|Swine Flu|swine flu
492135|NCT01052454|hot flashes|hot flashes
492136|NCT01052454|mindfulness|mindfulness
492137|NCT01052454|stress|stress
492138|NCT01052441|CCTA|ccta
492139|NCT01052441|Coronary Artery Stenosis|coronary artery stenosis
492140|NCT01052441|Iodinated Contrast|iodinated contrast
492141|NCT01052441|Invasive Coronary Angiography|invasive coronary angiography
492142|NCT01052428|Chronic MR|chronic mr
492143|NCT01052428|Volume Overload|volume overload
492144|NCT01052428|Beta-1 receptor blocker|beta-1 receptor blocker
492145|NCT01052428|LV remodelling, LV dimensions|lv remodelling, lv dimensions
492146|NCT01052428|LV systolic function|lv systolic function
492147|NCT01052428|LV diastolic dysfunction|lv diastolic dysfunction
492148|NCT01052428|Cardiac MRI|cardiac mri
492149|NCT01052415|HIV|hiv
492150|NCT01052415|Stigma|stigma
492151|NCT01052415|POL|pol
492152|NCT01052415|Service providers|service providers
492153|NCT01052415|China|china
492154|NCT01052415|Universal precaution|universal precaution
492155|NCT01052389|Schizophrenia|schizophrenia
492156|NCT01052389|Pragmatic RCT|pragmatic rct
492157|NCT01052389|Aripiprazole|aripiprazole
492158|NCT01052389|Olanzapine|olanzapine
492159|NCT01052389|Haloperidol|haloperidol
492160|NCT01052389|Metabolic syndrome|metabolic syndrome
492161|NCT01052389|Drug discontinuation|drug discontinuation
492162|NCT01052376|nflammatory bowel diseases (IBD)|nflammatory bowel diseases (ibd)
492163|NCT01052376|Familial adenomatous polyposis (FAP)|familial adenomatous polyposis (fap)
492164|NCT01052363|CNS tumors|cns tumors
492165|NCT01052350|Parkinson disease|parkinson disease
492166|NCT01052350|PET imaging|pet imaging
492168|NCT01052350|dementia|dementia
492169|NCT01052311|Coronary artery disease|coronary artery disease
492170|NCT01052311|Endothelial function|endothelial function
492171|NCT01052311|Platelet function|platelet function
492172|NCT01052311|Statins|statins
492173|NCT01052311|Niacin|niacin
492174|NCT01052298|Ciprofloxacin|ciprofloxacin
492175|NCT01052298|Inhalation|inhalation
492176|NCT01052298|Pharmacokinetics|pharmacokinetics
492177|NCT01052298|Safety|safety
492178|NCT01052298|Tolerability|tolerability
492179|NCT01052298|COPD|copd
492180|NCT01052285|Transversus abdominis plane block|transversus abdominis plane block
492181|NCT01052272|Diabetes|diabetes
492182|NCT01052272|Acute MI|acute mi
492183|NCT01052272|Ang II type-1 receptor blockade (AT1RB)|ang ii type-1 receptor blockade (at1rb)
492184|NCT01052272|LV remodeling|lv remodeling
492185|NCT01052272|ACE inhibitor therapy|ace inhibitor therapy
492186|NCT01052272|XO inhibitor, Allopurinol|xo inhibitor, allopurinol
492187|NCT01052272|Systolic dysfunction|systolic dysfunction
492188|NCT01052272|Diastolic dysfunction|diastolic dysfunction
492189|NCT01052272|LV dimensions|lv dimensions
492190|NCT01052272|Cardiac MRI|cardiac mri
492191|NCT01052259|Chronic rejection|chronic rejection
492192|NCT01052259|Kidney|kidney
492193|NCT01052259|Transplantation|transplantation
492194|NCT01052259|Immunosuppressive|immunosuppressive
492195|NCT01052246|acne vulgaris|acne vulgaris
492196|NCT01052246|laser surgery|laser surgery
492197|NCT01052246|pulsed dye lasers|pulsed dye lasers
492198|NCT01052246|benzoyl peroxidase|benzoyl peroxidase
492199|NCT01052246|clindamycin|clindamycin
492200|NCT01052246|randomized controlled trial|randomized controlled trial
492201|NCT01052233|Sham-surgery|sham-surgery
492202|NCT01052233|Development of osteoarthritis|development of osteoarthritis
492203|NCT01052233|Randomized, double-blinded, placebo-controlled|randomized, double-blinded, placebo-controlled
492204|NCT01052220|Hypertension|hypertension
492205|NCT01052220|Blood Pressure|blood pressure
492206|NCT01052220|End Stage Renal Disease|end stage renal disease
492207|NCT01052220|Hemodialysis|hemodialysis
492208|NCT01052220|Interdialytic Weight Gain|interdialytic weight gain
492209|NCT01052220|Self-Regulation|self-regulation
492210|NCT01052207|Biological Response Modifiers|biological response modifiers
492211|NCT01052207|Endocrinology|endocrinology
492212|NCT01052207|Hormone Dysfunction|hormone dysfunction
492213|NCT01052207|Hormones|hormones
492214|NCT01052207|Neuroendocrinology|neuroendocrinology
492215|NCT01052194|Rheumatoid Arthritis|rheumatoid arthritis
492216|NCT01052181|Vitamin D|vitamin d
492217|NCT01052181|Insulin sensitivity|insulin sensitivity
492218|NCT01052181|Centrally obese|centrally obese
492219|NCT01052168|simulation|simulation
492220|NCT01052168|simulators|simulators
492221|NCT01052168|motion metrics|motion metrics
492222|NCT01052168|performance metrics|performance metrics
492223|NCT01052168|skills training|skills training
492224|NCT01052168|proficiency|proficiency
492225|NCT01052168|laparoscopic|laparoscopic
492226|NCT01052155|Controlled substances|controlled substances
492227|NCT01052155|Opioids|opioids
492228|NCT01052155|Benzodiazepines|benzodiazepines
492229|NCT01052155|Illicit drugs|illicit drugs
492230|NCT01052155|Immunoassay drug testing|immunoassay drug testing
492231|NCT01052155|Point of care (POC) testing|point of care (poc) testing
492336|NCT01051700|tolerability|tolerability
492232|NCT01052155|Liquid Chromatography Tandem Mass Spectometry|liquid chromatography tandem mass spectometry
492233|NCT01052142|Melanoma|melanoma
492234|NCT01052142|Cancer vaccines|cancer vaccines
492235|NCT01052129|Bioequivalence|bioequivalence
492236|NCT01052129|Naproxen|naproxen
492237|NCT01052129|crossover|crossover
492238|NCT01052116|Asthma|asthma
492239|NCT01052116|Soy|soy
492240|NCT01052116|Supplement|supplement
492241|NCT01052116|ACRC|acrc
492242|NCT01052116|SOYA|soya
492243|NCT01052090|HCV|hcv
492244|NCT01052077|OPC-34712|opc-34712
492245|NCT01052077|Major Depressive Disorder|major depressive disorder
492246|NCT01052077|Adjunctive Treatment|adjunctive treatment
492247|NCT01052064|Children|children
492248|NCT01052064|ADHD|adhd
492249|NCT01052064|rTMS|rtms
492250|NCT01052064|Safety|safety
492251|NCT01052038|Sore throat|sore throat
492252|NCT01052038|Dexamethasone|dexamethasone
492253|NCT01052038|Pain|pain
492254|NCT01052012|Postoperative pain|postoperative pain
492255|NCT01052012|Post-operative pain|post-operative pain
492256|NCT01052012|Opioid|opioid
492257|NCT01052012|Laparoscopic surgery|laparoscopic surgery
492258|NCT01052012|Bupivacaine|bupivacaine
492259|NCT01052012|Local anesthetic|local anesthetic
492260|NCT01051999|Glutamine|glutamine
492261|NCT01051986|coronary artery bypass|coronary artery bypass
492262|NCT01051986|off-pump surgery|off-pump surgery
492263|NCT01051986|composite graft|composite graft
492264|NCT01051986|saphenous vein|saphenous vein
492265|NCT01051986|internal thoracic artery|internal thoracic artery
492266|NCT01051973|Cognitive behavior therapy|cognitive behavior therapy
492267|NCT01051973|exposure|exposure
492268|NCT01051973|stress management|stress management
492269|NCT01051960|Systemic Sclerosis|systemic sclerosis
492270|NCT01051960|connective tissue disease|connective tissue disease
492271|NCT01051960|Shortness of breath|shortness of breath
492272|NCT01051960|Pulmonary Hypertension|pulmonary hypertension
492273|NCT01051947|Nebivolol|nebivolol
492274|NCT01051947|Metoprolol|metoprolol
492275|NCT01051947|central aortic pressure|central aortic pressure
492276|NCT01051947|hypertension|hypertension
492277|NCT01051934|Recombinant Immunotoxin|recombinant immunotoxin
492278|NCT01051934|Monoclonal Antibody|monoclonal antibody
492279|NCT01051934|Pseudomonas Exotoxin|pseudomonas exotoxin
492280|NCT01051934|Targeted Therapy|targeted therapy
492281|NCT01051934|Lung Cancer|lung cancer
492282|NCT01051934|Non-Small Cell Lung Cancer|non-small cell lung cancer
492283|NCT01051921|HCV|hcv
492284|NCT01051921|Null Responder|null responder
492285|NCT01051895|Cervical intra-epithelial neoplasia|cervical intra-epithelial neoplasia
492286|NCT01051895|Colposcopy|colposcopy
492287|NCT01051895|HPV DNA testing|hpv dna testing
492288|NCT01051895|treatment failure|treatment failure
492289|NCT01051882|Mesenchymal Stromal Cells (MSC)|mesenchymal stromal cells (msc)
492290|NCT01051882|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
492291|NCT01051882|Neuroprotection|neuroprotection
492292|NCT01051882|Neurodegeneration|neurodegeneration
492293|NCT01051882|Stem cells|stem cells
492294|NCT01051882|ALS|als
492295|NCT01051869|distal humerus|distal humerus
492296|NCT01051869|fractures|fractures
492297|NCT01051869|ulnar nerve|ulnar nerve
492298|NCT01051869|simple decompression|simple decompression
492299|NCT01051869|anterior transposition|anterior transposition
492300|NCT01051843|Maternal Breastfeeding|maternal breastfeeding
492301|NCT01051843|Orofacial Difficulties|orofacial difficulties
492302|NCT01051843|Rooming-in|rooming-in
492303|NCT01051843|Speech and Language Therapy|speech and language therapy
492304|NCT01051817|relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
492305|NCT01051817|RRMS|rrms
492306|NCT01051804|Dry eye|dry eye
492307|NCT01051804|Visual Performance|visual performance
492308|NCT01051791|RAD001|rad001
492309|NCT01051791|Everolimus|everolimus
492310|NCT01051778|Recurrent abortion|recurrent abortion
492311|NCT01051778|Antiphospholipid syndrome|antiphospholipid syndrome
492312|NCT01051778|unfractionated heparin|unfractionated heparin
492313|NCT01051778|Low Molecular Weight Heparin|low molecular weight heparin
492314|NCT01051752|Nontuberculous mycobacterial diseases|nontuberculous mycobacterial diseases
492315|NCT01051752|pharmacokinetics|pharmacokinetics
492316|NCT01051752|pharmacodynamics|pharmacodynamics
492317|NCT01051739|vision testing|vision testing
492318|NCT01051739|perimetry|perimetry
492319|NCT01051739|glaucoma|glaucoma
492320|NCT01051739|test variability|test variability
492321|NCT01051726|aromatherapy|aromatherapy
492322|NCT01051726|childbirth|childbirth
492323|NCT01051726|Obstetrics|obstetrics
492324|NCT01051726|Labour|labour
492325|NCT01051726|Complementary Medicine|complementary medicine
492326|NCT01051726|delivery, obstetric|delivery, obstetric
492327|NCT01051713|obesity|obesity
492328|NCT01051713|behavioraladherence|behavioraladherence
492329|NCT01051713|weight loss|weight loss
492330|NCT01051713|smartphone|smartphone
492331|NCT01051700|repeat-dose|repeat-dose
492332|NCT01051700|pharmacokinetics|pharmacokinetics
492333|NCT01051700|choroidal neovascularization|choroidal neovascularization
492334|NCT01051700|safety|safety
492337|NCT01051700|age-related macular degeneration|age-related macular degeneration
492338|NCT01051700|stem cell growth factor|stem cell growth factor
492339|NCT01051700|pazopanib|pazopanib
492340|NCT01051700|platelet derived growth factor|platelet derived growth factor
492341|NCT01051700|vascular endothelial growth factor|vascular endothelial growth factor
492342|NCT01051687|vitiligo|vitiligo
492343|NCT01051674|Obesity|obesity
492344|NCT01051674|Type 2 diabetes|type 2 diabetes
492345|NCT01051674|Fiber|fiber
492346|NCT01051674|Dietary fiber|dietary fiber
492347|NCT01051674|Low-carbohydrate diet|low-carbohydrate diet
492348|NCT01051674|High protein diet|high protein diet
492349|NCT01051661|Influenza|influenza
492350|NCT01051661|H1N1|h1n1
492351|NCT01051661|Pandemic|pandemic
492352|NCT01051648|Triamcinolone acetenoide|triamcinolone acetenoide
492353|NCT01051648|anterior vitrectomy|anterior vitrectomy
492354|NCT01051648|presence of vitreous in the anterior chamber.|presence of vitreous in the anterior chamber.
492355|NCT01051648|effect of triamcinolone injection on IOP,intraocular infection|effect of triamcinolone injection on iop,intraocular infection
492356|NCT01051635|DNA Repair|dna repair
492357|NCT01051635|DNA Damage|dna damage
492358|NCT01051635|Advanced Cancer|advanced cancer
492359|NCT01051635|Advanced Malignancies|advanced malignancies
492360|NCT01051635|Topoisomerase Inhibitor|topoisomerase inhibitor
492361|NCT01051622|PBMC (Peripheral Blood Mononuclear Cells)|pbmc (peripheral blood mononuclear cells)
492362|NCT01051622|Crohn's Disease|crohn's disease
492363|NCT01051622|SPECT (Single Photon Emission Computerized Tomography)|spect (single photon emission computerized tomography)
492364|NCT01051609|Post Menopausal|post menopausal
492365|NCT01051609|Breast Cancer|breast cancer
492366|NCT01051596|metastatic|metastatic
492367|NCT01051596|colorectal cancer|colorectal cancer
492368|NCT01051583|Neovascular glaucoma|neovascular glaucoma
492369|NCT01051583|diode laser|diode laser
492370|NCT01051583|cyclophotocoagulation|cyclophotocoagulation
492371|NCT01051583|Avastin|avastin
492372|NCT01051570|hormone-resistant prostate cancer|hormone-resistant prostate cancer
492373|NCT01051570|recurrent prostate cancer|recurrent prostate cancer
492374|NCT01051570|stage IV prostate cancer|stage iv prostate cancer
492375|NCT01051570|adenocarcinoma of the prostate|adenocarcinoma of the prostate
492376|NCT01051544|ITI|iti
492377|NCT01051544|HAEMOPHILIA A|haemophilia a
492378|NCT01051544|INHIBITORS|inhibitors
492379|NCT01051544|VWF/FVIII Concentrates|vwf/fviii concentrates
492380|NCT01051531|Schizophrenia|schizophrenia
492381|NCT01051531|R092670|r092670
492382|NCT01051531|Paliperidone palmitate|paliperidone palmitate
492383|NCT01051531|Diagnostic and Statistical Manual of Mental Disorders, 4th Edition|diagnostic and statistical manual of mental disorders, 4th edition
492384|NCT01051531|Intramuscular injection|intramuscular injection
492385|NCT01051505|Phase I|phase i
492386|NCT01051505|multiple ascending dose|multiple ascending dose
492387|NCT01051505|Safety|safety
492388|NCT01051505|Tolerability|tolerability
492389|NCT01051505|Healthy Volunteer|healthy volunteer
492390|NCT01051479|PET Positron emission tomography|pet positron emission tomography
492391|NCT01051479|CT X-ray computed tomography|ct x-ray computed tomography
492392|NCT01051479|Patients with Locally Advanced Esophageal Cancer|patients with locally advanced esophageal cancer
492393|NCT01051440|lisdexamfetamine|lisdexamfetamine
492394|NCT01051440|vyvanse|vyvanse
492395|NCT01051440|bipolar disorder|bipolar disorder
492396|NCT01051440|depression|depression
492397|NCT01051440|stimulant|stimulant
492398|NCT01051440|magnetic resonance spectroscopy|magnetic resonance spectroscopy
492399|NCT01051440|functional magnetic resonance imaging|functional magnetic resonance imaging
492400|NCT01051440|neuropsychological testing|neuropsychological testing
492401|NCT01051427|Nasal packing|nasal packing
492402|NCT01051427|Haemostatic matrix|haemostatic matrix
492403|NCT01051427|Epistaxis control|epistaxis control
492404|NCT01051388|The efficacy of PPI|the efficacy of ppi
492405|NCT01051388|Patients receiving low-dose aspirin for vascular protection|patients receiving low-dose aspirin for vascular protection
492406|NCT01051375|anorexia nervosa|anorexia nervosa
492407|NCT01051375|bulimia nervosa|bulimia nervosa
492408|NCT01051375|EDNOS|ednos
492409|NCT01051362|Advanced Non-small Cell Lung Cancer|advanced non-small cell lung cancer
492410|NCT01051362|Pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
492411|NCT01051362|Carboplatin|carboplatin
492412|NCT01051362|Chemotherapy|chemotherapy
492413|NCT01051349|MS|ms
492414|NCT01051349|Multiple Sclerosis|multiple sclerosis
492415|NCT01051336|TARIS Placebo|taris placebo
492416|NCT01051336|Bladder|bladder
492417|NCT01051336|Interstitial Cystitis|interstitial cystitis
492418|NCT01051336|Normal Healthy Volunteers|normal healthy volunteers
492419|NCT01051297|Obstructive sleep apnea|obstructive sleep apnea
492420|NCT01051297|venous thrombosis|venous thrombosis
492421|NCT01051297|pulmonary embolism|pulmonary embolism
492422|NCT01051297|venous thromboembolism|venous thromboembolism
492423|NCT01051284|Pancreas|pancreas
492424|NCT01051284|Newly diagnosed|newly diagnosed
492425|NCT01051284|Cyberknife|cyberknife
492426|NCT01051284|Gemcitabine|gemcitabine
492427|NCT01051271|metoclopramide|metoclopramide
492428|NCT01051271|akathisia|akathisia
492429|NCT01051271|midazolam|midazolam
492430|NCT01051271|diphenhydramine|diphenhydramine
492431|NCT01051271|metoclopramide induced akathisia|metoclopramide induced akathisia
492432|NCT01051258|Polymeric Lung Volume Reduction (PLVR)|polymeric lung volume reduction (plvr)
492433|NCT01051258|Biologic Lung Volume Reduction (BLVR)|biologic lung volume reduction (blvr)
492434|NCT01051258|AeriSeal|aeriseal
492435|NCT01051258|treatment|treatment
492436|NCT01051258|device|device
492437|NCT01051258|breathing|breathing
492438|NCT01051258|COPD|copd
492439|NCT01051258|emphysema|emphysema
492440|NCT01051258|heterogeneous|heterogeneous
492441|NCT01051258|homogeneous|homogeneous
492442|NCT01051258|Pathologic Processes|pathologic processes
492443|NCT01051258|Respiratory Tract Diseases|respiratory tract diseases
492444|NCT01051258|Lung Diseases|lung diseases
492445|NCT01051258|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
492446|NCT01051245|Diabetes Mellitus, Type 2 [C18.452.394.750.149]|diabetes mellitus, type 2 [c18.452.394.750.149]
492447|NCT01051245|Case Management [N04.590.233.624.250]|case management [n04.590.233.624.250]
492448|NCT01051245|Disease Management [N04.590.607]|disease management [n04.590.607]
492449|NCT01051245|Diabetes Complications [C19.246.099]|diabetes complications [c19.246.099]
492450|NCT01051232|filibuvir|filibuvir
492451|NCT01051232|pharmacokinetics|pharmacokinetics
492452|NCT01051232|Japanese|japanese
492453|NCT01051232|Asian|asian
492454|NCT01051219|Losartan|losartan
492455|NCT01051219|Liver fibrosis|liver fibrosis
492456|NCT01051219|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
492457|NCT01051193|Seizures|seizures
492458|NCT01051193|oxcarbazepine|oxcarbazepine
492459|NCT01051193|child|child
492460|NCT01051180|HEMORRHOIDS|hemorrhoids
492461|NCT01051180|TREATMENT|treatment
492462|NCT01051180|PILES|piles
492463|NCT01051180|BLEEDING|bleeding
492464|NCT01051180|HALO|halo
492465|NCT01051154|Docosahexaenoic acid|docosahexaenoic acid
492466|NCT01051154|Nutritional status|nutritional status
492467|NCT01051154|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
492468|NCT01051154|Long chain polyunsaturated fatty acids|long chain polyunsaturated fatty acids
492469|NCT01051154|n-3 fatty acids|n-3 fatty acids
492470|NCT01051154|Remission-induction phase|remission-induction phase
492471|NCT01051141|alcohol use|alcohol use
492472|NCT01051141|brief intervention|brief intervention
492473|NCT01051141|risk behaviors|risk behaviors
492474|NCT01051128|neurological disorders|neurological disorders
492475|NCT01051128|multiple sclerosis|multiple sclerosis
492476|NCT01051128|stroke|stroke
492477|NCT01051128|cerebral palsy|cerebral palsy
492478|NCT01051128|spinal cord|spinal cord
492479|NCT01051128|brain injuries|brain injuries
492480|NCT01051128|neurodegenerative diseases|neurodegenerative diseases
492481|NCT01051115|CLL|cll
492482|NCT01051115|refractory|refractory
492483|NCT01051115|dasatinib|dasatinib
492484|NCT01051115|fludarabine|fludarabine
492485|NCT01051089|type 2 diabetes mellitus|type 2 diabetes mellitus
492486|NCT01051089|lifestyle modification|lifestyle modification
492487|NCT01051076|ITI|iti
492488|NCT01051076|Haemophilia A|haemophilia a
492489|NCT01051076|Inhibitors|inhibitors
492490|NCT01051076|Failed ITI|failed iti
492491|NCT01051076|VWF/FVIII concentrates|vwf/fviii concentrates
492492|NCT01051063|adult|adult
492493|NCT01051063|WT1|wt1
492494|NCT01051063|ASCI|asci
492495|NCT01051063|complete remission with incomplete blood count recovery|complete remission with incomplete blood count recovery
492496|NCT01051063|partial remission|partial remission
492497|NCT01051063|post-induction therapy|post-induction therapy
492498|NCT01051063|tumor antigen|tumor antigen
492499|NCT01051063|Acute Myeloid Leukemia|acute myeloid leukemia
492500|NCT01051063|Immunotherapy|immunotherapy
492501|NCT01051050|Evidence based medicine|evidence based medicine
492502|NCT01051050|Improving surgical residents skills and application of EBM in surgical practice|improving surgical residents skills and application of ebm in surgical practice
492503|NCT01051037|lung tumors|lung tumors
492504|NCT01051037|central airways|central airways
492505|NCT01051024|Dietary supplement|dietary supplement
492506|NCT01051024|Diamel|diamel
492507|NCT01051024|Polycystic Ovary Syndrome|polycystic ovary syndrome
492508|NCT01051024|Female Infertility|female infertility
492509|NCT01050998|Rheumatoid Arthritis|rheumatoid arthritis
492510|NCT01050998|Mavrilimumab|mavrilimumab
492511|NCT01050998|CAM-3001|cam-3001
492512|NCT01050985|advanced cancer|advanced cancer
492513|NCT01050985|temsirolimus|temsirolimus
492514|NCT01050985|capecitabine|capecitabine
492515|NCT01050972|Headache|headache
492516|NCT01050972|Cervical Pain|cervical pain
492517|NCT01050972|Cognitive treatment|cognitive treatment
492518|NCT01050972|Relaxation|relaxation
492519|NCT01050972|Exercise|exercise
492520|NCT01050946|Unrelated Umbilical Cord Blood Transplant(UCB)|unrelated umbilical cord blood transplant(ucb)
492521|NCT01050946|CD34+ Selected mismatched related donor|cd34+ selected mismatched related donor
492522|NCT01050946|Haploidentical donor|haploidentical donor
492523|NCT01050946|hematopoietic stem cell transplantation(HSCT)|hematopoietic stem cell transplantation(hsct)
492524|NCT01050946|ALL|all
492525|NCT01050946|Leukemia, Lymphocytic, Acute|leukemia, lymphocytic, acute
492526|NCT01050946|AML|aml
492527|NCT01050946|Leukemia, Myelocytic, Acute|leukemia, myelocytic, acute
492528|NCT01050946|CML|cml
492529|NCT01050946|Leukemia, Myeloid, Chronic|leukemia, myeloid, chronic
492530|NCT01050946|NHL|nhl
492531|NCT01050946|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
492532|NCT01050946|HL|hl
492533|NCT01050946|Lymphoma, Hodgkins|lymphoma, hodgkins
492534|NCT01050933|Healthy volunteer|healthy volunteer
492535|NCT01050907|leishmaniasis|leishmaniasis
492536|NCT01050907|cutaneous disease|cutaneous disease
492537|NCT01050907|mucosal disease|mucosal disease
492538|NCT01050907|miltefosine|miltefosine
492539|NCT01050894|osteoarthritis|osteoarthritis
492540|NCT01050881|blood donor notification|blood donor notification
492541|NCT01050881|emotional response|emotional response
492542|NCT01050881|variant Creutzfeldt-Jacob Disease|variant creutzfeldt-jacob disease
492543|NCT01050855|Non-malignant diseases|non-malignant diseases
492544|NCT01050855|Immune deficiencies|immune deficiencies
492545|NCT01050855|Hemoglobinopathies|hemoglobinopathies
492546|NCT01050855|Reduced Intensity Conditioning(RIC)|reduced intensity conditioning(ric)
492547|NCT01050829|Magnetic resonance imaging|magnetic resonance imaging
492548|NCT01050829|Tumor|tumor
492549|NCT01050829|Contrast media|contrast media
492550|NCT01050829|Gadobutrol|gadobutrol
492551|NCT01050816|articular cartilage defects|articular cartilage defects
492552|NCT01050816|ACI|aci
492553|NCT01050816|ankle joint|ankle joint
492554|NCT01050816|chondron|chondron
492555|NCT01050803|Diabetes Mellitus|diabetes mellitus
492556|NCT01050803|Intervention studies|intervention studies
492557|NCT01050803|Program effectiveness|program effectiveness
492558|NCT01050790|stage I multiple myeloma|stage i multiple myeloma
492559|NCT01050790|stage II multiple myeloma|stage ii multiple myeloma
492560|NCT01050790|stage III multiple myeloma|stage iii multiple myeloma
492561|NCT01050777|Cutaneous Leishmaniasis caused by l. tropica|cutaneous leishmaniasis caused by l. tropica
492562|NCT01050751|Bioavailability|bioavailability
492563|NCT01050751|Bioequivalence|bioequivalence
492564|NCT01050751|Lersivirine|lersivirine
492565|NCT01050751|UK-453|uk-453
492566|NCT01050751|061|061
492567|NCT01050751|Pharmacokinetics|pharmacokinetics
492568|NCT01050725|proteome|proteome
492569|NCT01050725|biomarkers|biomarkers
492570|NCT01050725|radiotherapy|radiotherapy
492571|NCT01050725|cancer|cancer
492572|NCT01050699|critical illness|critical illness
492573|NCT01050699|sleep|sleep
492574|NCT01050699|polysomnography|polysomnography
492575|NCT01050699|inflammatory cytokines|inflammatory cytokines
492576|NCT01050699|dexmedetomidine|dexmedetomidine
492577|NCT01050699|acute lung injury|acute lung injury
492578|NCT01050699|acute respiratory distress syndrome|acute respiratory distress syndrome
492579|NCT01050699|midazolam|midazolam
492580|NCT01050699|fentanyl|fentanyl
492581|NCT01050699|cytokines|cytokines
492582|NCT01050686|ileostomy reversal|ileostomy reversal
492583|NCT01050686|subcutaneous drain|subcutaneous drain
492584|NCT01050686|hospital stay|hospital stay
492585|NCT01050686|postoperative wound infection|postoperative wound infection
492586|NCT01050686|patients with elective ileostomy reversal|patients with elective ileostomy reversal
492587|NCT01050673|VERSAJET hydro-surgical debridement|versajet hydro-surgical debridement
492588|NCT01050673|traumatic wound|traumatic wound
492589|NCT01050660|Parenteral nutrition associated liver disease|parenteral nutrition associated liver disease
492590|NCT01050660|Direct bilirubin|direct bilirubin
492591|NCT01050660|Intravenous fat emulsion|intravenous fat emulsion
492592|NCT01050660|Very low birth weight infants|very low birth weight infants
492593|NCT01050660|PNAC|pnac
492594|NCT01050634|Aromatase inhibitor|aromatase inhibitor
492595|NCT01050634|Switch after Tamoxifen|switch after tamoxifen
492596|NCT01050634|Quality of Life|quality of life
492597|NCT01050634|Safety|safety
492598|NCT01050621|ascorbic acid|ascorbic acid
492599|NCT01050621|vitamin C|vitamin c
492600|NCT01050621|antioxidants|antioxidants
492601|NCT01050621|redox therapy|redox therapy
492602|NCT01050621|cytotoxic chemotherapy|cytotoxic chemotherapy
492603|NCT01050608|Alcohol Rub|alcohol rub
492604|NCT01050608|Hand Hygiene|hand hygiene
492605|NCT01050608|Provider Feedback|provider feedback
492606|NCT01050608|Health Care Associated Infections|health care associated infections
492607|NCT01050595|Intensive Care Unit|intensive care unit
492608|NCT01050595|Constipation|constipation
492609|NCT01050595|Bowel Management|bowel management
492610|NCT01050582|Schizophrenia|schizophrenia
492611|NCT01050582|Bipolar Disorder|bipolar disorder
492612|NCT01050582|Autistic Disorder|autistic disorder
492613|NCT01050582|Conduct and Other Disruptive Behavior Disorders|conduct and other disruptive behavior disorders
492614|NCT01050582|Risperidone|risperidone
492615|NCT01050582|RISPERDAL|risperdal
492616|NCT01050582|Antipsychotic Agents|antipsychotic agents
492617|NCT01050582|Prolactin|prolactin
492618|NCT01050582|Pediatrics|pediatrics
492619|NCT01050569|Smoking Cessation|smoking cessation
492620|NCT01050569|Nicotine Free Cigarettes|nicotine free cigarettes
492621|NCT01050556|arsenic|arsenic
492622|NCT01050556|folate|folate
492623|NCT01050556|folic acid|folic acid
492624|NCT01050556|creatine|creatine
492625|NCT01050556|arsenicosis|arsenicosis
492627|NCT01050530|Cirrhosis|cirrhosis
492628|NCT01050530|ascites|ascites
492629|NCT01050530|Tolvaptan|tolvaptan
492630|NCT01050530|OPC-41061|opc-41061
492631|NCT01050491|asthma|asthma
492632|NCT01050491|airway remodeling|airway remodeling
492633|NCT01050491|airway obstruction|airway obstruction
492634|NCT01050478|acute agitation|acute agitation
492635|NCT01050478|aggression|aggression
492636|NCT01050478|psychosis|psychosis
492637|NCT01050478|paliperidone extended release|paliperidone extended release
492638|NCT01050465|HIV|hiv
492639|NCT01050465|Knee pain|knee pain
492640|NCT01050465|Colonoscopy|colonoscopy
492641|NCT01050465|Mammography|mammography
492642|NCT01050465|Vaccination|vaccination
492643|NCT01050439|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
492644|NCT01050439|Unrelated donor|unrelated donor
492645|NCT01050439|Cord blood donor|cord blood donor
492646|NCT01050413|Thymidine Kinase 1 activity|thymidine kinase 1 activity
492647|NCT01050413|diagnosis|diagnosis
492648|NCT01050413|prognosis|prognosis
492649|NCT01050413|follow-up|follow-up
492650|NCT01050400|CYP2D6|cyp2d6
492651|NCT01050400|Genetic Polymorphism|genetic polymorphism
492652|NCT01050400|codeine|codeine
492653|NCT01050400|breastfeeding|breastfeeding
492654|NCT01050387|Vitamin D Deficiency|vitamin d deficiency
492655|NCT01050387|VDD|vdd
492656|NCT01050387|Vitamin D Supplementation|vitamin d supplementation
492657|NCT01050387|Vitamin D Binding Protein|vitamin d binding protein
492658|NCT01050387|DBP|dbp
492659|NCT01050387|Nutritional rickets|nutritional rickets
492660|NCT01050387|rickets|rickets
492661|NCT01050387|25hydroxyvitamin D|25hydroxyvitamin d
492662|NCT01050387|25OHD|25ohd
492663|NCT01050387|1,25OH2D|1,25oh2d
492664|NCT01050387|vitamin D metabolites|vitamin d metabolites
492665|NCT01050387|PTH|pth
492666|NCT01050387|vitamin D homeostasis|vitamin d homeostasis
492667|NCT01050361|To reduce perioperative morbidity and mortality associated with congestive heart failure for non-cardiac surgeries|to reduce perioperative morbidity and mortality associated with congestive heart failure for non-cardiac surgeries
492668|NCT01050322|receptor HER two positive|receptor her two positive
492669|NCT01050322|lapatinib|lapatinib
492670|NCT01050322|metastatic breast cancer|metastatic breast cancer
492671|NCT01050296|Neuroblastoma|neuroblastoma
492672|NCT01050296|Retinoblastoma|retinoblastoma
492673|NCT01050296|Osteosarcoma|osteosarcoma
492674|NCT01050296|Rhabdomyosarcoma|rhabdomyosarcoma
492675|NCT01050296|Ewing sarcoma|ewing sarcoma
492676|NCT01050296|Non-rhabdomyosarcoma soft tissue sarcoma|non-rhabdomyosarcoma soft tissue sarcoma
492677|NCT01050296|Adrenocortical tumors|adrenocortical tumors
492678|NCT01050296|Liver malignancies|liver malignancies
492679|NCT01050283|Advanced pancreatic adenocarcinoma|advanced pancreatic adenocarcinoma
492680|NCT01050244|Soy protein|soy protein
492681|NCT01050244|Milk protein|milk protein
492682|NCT01050244|Neuropathic pain|neuropathic pain
492683|NCT01050231|stroke|stroke
492684|NCT01050231|cerebrovascular accident|cerebrovascular accident
492685|NCT01050231|robot|robot
492686|NCT01050218|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
492687|NCT01050205|Diabetes Prevention|diabetes prevention
492688|NCT01050205|Cardiovascular Risk Reduction|cardiovascular risk reduction
492689|NCT01050205|Lifestyle Intervention|lifestyle intervention
492690|NCT01050205|Group Lifestyle Balance|group lifestyle balance
492691|NCT01050192|Prematurity|prematurity
492692|NCT01050192|Nutrition|nutrition
492693|NCT01050192|Breast Feeding|breast feeding
492694|NCT01050179|chemosensitivity|chemosensitivity
492695|NCT01050166|islet transplantation|islet transplantation
492696|NCT01050166|magnetic resonance|magnetic resonance
492697|NCT01050166|Type 1 DM|type 1 dm
492698|NCT01050153|Prevention of venous thromboembolism|prevention of venous thromboembolism
492699|NCT01050140|fructose|fructose
492700|NCT01050140|fatty liver disease|fatty liver disease
492701|NCT01050140|diet|diet
492702|NCT01050127|Pharmacokinetics|pharmacokinetics
492703|NCT01050127|Pharmacodynamics|pharmacodynamics
492704|NCT01050127|Drug Safety|drug safety
492705|NCT01050127|Phase 1 Clinical Trial|phase 1 clinical trial
492706|NCT01050114|Botulinum Toxin|botulinum toxin
492707|NCT01050114|Oxybutynin|oxybutynin
492708|NCT01050114|Overactive Bladder|overactive bladder
492709|NCT01050114|Spinal Cord Injury|spinal cord injury
492710|NCT01050114|Urinary Incontinence|urinary incontinence
492711|NCT01050114|Nerve Growth Factor|nerve growth factor
492712|NCT01050114|Urine Biomarkers|urine biomarkers
492713|NCT01050101|Satiety|satiety
492714|NCT01050101|Fiber|fiber
492715|NCT01050101|Nutrition|nutrition
492716|NCT01050101|Pre- and post-menopausal women|pre- and post-menopausal women
492717|NCT01050101|overweight|overweight
492718|NCT01050088|clubfoot|clubfoot
492719|NCT01050088|casting|casting
492720|NCT01050088|ponseti|ponseti
492721|NCT01050088|discomfort|discomfort
492722|NCT01050075|male breast cancer|male breast cancer
492723|NCT01050075|neurotoxicity|neurotoxicity
492724|NCT01050075|recurrent breast cancer|recurrent breast cancer
492725|NCT01050036|Leukemia, Myeloid|leukemia, myeloid
492726|NCT01050036|Primary complete remission|primary complete remission
492727|NCT01050036|Favorable karyotype|favorable karyotype
492728|NCT01050036|Autologous hematopoietic cell transplantation|autologous hematopoietic cell transplantation
492729|NCT01050036|Hematopoietic cell transplantation|hematopoietic cell transplantation
492730|NCT01050023|venous stasis ulcer|venous stasis ulcer
492731|NCT01050023|wound healing|wound healing
492732|NCT01050023|Provant Wound Closure System|provant wound closure system
492733|NCT01050023|radiofrequency|radiofrequency
492734|NCT01050023|Provant|provant
492735|NCT01050023|pain relief|pain relief
492736|NCT01050010|rheumatoid arthritis|rheumatoid arthritis
492737|NCT01050010|clinical remission|clinical remission
492738|NCT01050010|synovitis|synovitis
492739|NCT01050010|dedicated extremity MRI|dedicated extremity mri
492740|NCT01049997|Non ST Elevation Myocardial Infarction (NSTEMI)|non st elevation myocardial infarction (nstemi)
492741|NCT01049997|Elderly|elderly
492742|NCT01049997|Frailty|frailty
492743|NCT01049984|Parkinson's Disease|parkinson's disease
492744|NCT01049984|UPDRS|updrs
492745|NCT01049984|Clinical Global Evaluation Illness Severity score|clinical global evaluation illness severity score
492746|NCT01049984|Clinical Global Evaluation Improvement|clinical global evaluation improvement
492747|NCT01049984|B-SIT|b-sit
492748|NCT01049984|SCOPA - Sleep Daytime Sleepiness|scopa - sleep daytime sleepiness
492749|NCT01049984|PDQ -39|pdq -39
492750|NCT01049984|SCOPA - Cognition|scopa - cognition
492751|NCT01049984|Levodopa|levodopa
492752|NCT01049984|rasagiline|rasagiline
492753|NCT01049984|Dopamine Agonist Therapy|dopamine agonist therapy
492754|NCT01049984|monoamine oxidase type B inhibitor|monoamine oxidase type b inhibitor
492755|NCT01049971|colorectal surgery|colorectal surgery
492756|NCT01049971|wound infection|wound infection
492757|NCT01049971|wound protector|wound protector
492758|NCT01049971|laparoscopy|laparoscopy
492759|NCT01049971|surgical site infection after laparoscopic colorectal surgery with minilaparotomy|surgical site infection after laparoscopic colorectal surgery with minilaparotomy
492760|NCT01049958|asynchrony|asynchrony
492761|NCT01049958|mechanical ventilation|mechanical ventilation
492762|NCT01049958|blunt trauma|blunt trauma
492763|NCT01049932|HIV|hiv
492764|NCT01049932|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
492765|NCT01049932|HIV Seronegativity|hiv seronegativity
492766|NCT01049919|Critical Limb Ischemia|critical limb ischemia
492767|NCT01049919|Peripheral Arterial Disease|peripheral arterial disease
492768|NCT01049919|Peripheral Vascular Disease|peripheral vascular disease
492769|NCT01049919|CLI|cli
492770|NCT01049919|PAD|pad
492771|NCT01049919|PVD|pvd
492772|NCT01049919|Angiogenesis|angiogenesis
492773|NCT01049919|Stem Cells|stem cells
492774|NCT01049919|Cell Therapy|cell therapy
492775|NCT01049919|Limb Salvage|limb salvage
492776|NCT01049919|Amputation|amputation
492777|NCT01049919|Leg Pain|leg pain
492778|NCT01049906|foot surgery|foot surgery
492779|NCT01049906|ankle surgery|ankle surgery
492780|NCT01049906|Patients scheduled for foot and ankle surgery|patients scheduled for foot and ankle surgery
492781|NCT01049880|Ascorbic Acid|ascorbic acid
492782|NCT01049880|Gemcitabine|gemcitabine
492783|NCT01049854|unrelated donor transplant|unrelated donor transplant
492784|NCT01049854|CD34 selection|cd34 selection
492785|NCT01049841|pediatric|pediatric
492786|NCT01049841|children|children
492787|NCT01049841|perifosine|perifosine
492788|NCT01049841|temsirolimus|temsirolimus
492789|NCT01049841|recurrent|recurrent
492790|NCT01049841|progressive|progressive
492791|NCT01049841|09-124|09-124
492792|NCT01049828|Tinnitus|tinnitus
492793|NCT01049828|fcMRI|fcmri
492794|NCT01049828|Neural Connectivity|neural connectivity
492795|NCT01049828|Bother|bother
492796|NCT01049815|hemodialysis|hemodialysis
492797|NCT01049815|intimal media thickness|intimal media thickness
492798|NCT01049802|stroke|stroke
492799|NCT01049802|hemiplegia|hemiplegia
492800|NCT01049802|TMS|tms
492801|NCT01049789|youth|youth
492802|NCT01049789|HIV|hiv
492803|NCT01049789|Depression|depression
492804|NCT01049789|Cognitive Behavioral Therapy|cognitive behavioral therapy
492805|NCT01049789|Medication management|medication management
492806|NCT01049776|Lung Cancer Non Small Cell|lung cancer non small cell
492807|NCT01049763|obese adult|obese adult
492808|NCT01049763|non obese healthy volunteers|non obese healthy volunteers
492809|NCT01049763|oseltamivir carboxylate|oseltamivir carboxylate
492810|NCT01049763|pharmacokinetics|pharmacokinetics
492811|NCT01049763|healthy volunteers|healthy volunteers
492812|NCT01049750|type 2 diabetes mellitus|type 2 diabetes mellitus
492813|NCT01049750|male|male
492814|NCT01049750|erectile dysfunction|erectile dysfunction
492815|NCT01049724|Myopia|myopia
492816|NCT01049724|refractive surgery|refractive surgery
492817|NCT01049724|LASIK|lasik
492818|NCT01049724|PRK|prk
492819|NCT01049724|Lacritin|lacritin
492820|NCT01049724|Heparanase|heparanase
492821|NCT01049711|erythropoietin|erythropoietin
492822|NCT01049711|hemodialysis|hemodialysis
492823|NCT01049711|cost utility|cost utility
492824|NCT01049711|incremental cost-effectiveness ratio|incremental cost-effectiveness ratio
492825|NCT01049711|Quality adjusted life year|quality adjusted life year
492922|NCT01049373|diathesism|diathesism
492826|NCT01049711|quality of life|quality of life
492827|NCT01049698|Obesity|obesity
492828|NCT01049698|Overweight|overweight
492829|NCT01049698|Older adults|older adults
492830|NCT01049698|resistance training|resistance training
492831|NCT01049698|exercise|exercise
492832|NCT01049685|HIV|hiv
492833|NCT01049685|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
492834|NCT01049685|Efavirenz|efavirenz
492835|NCT01049685|Lopinavir|lopinavir
492836|NCT01049685|Comparative Effectiveness Research|comparative effectiveness research
492837|NCT01049685|Treatment Naive|treatment naive
492838|NCT01049659|pregnancy|pregnancy
492839|NCT01049659|iodine deficiency|iodine deficiency
492840|NCT01049659|neuropsychological development|neuropsychological development
492841|NCT01049646|renin-angiotensin system|renin-angiotensin system
492842|NCT01049646|apelin|apelin
492843|NCT01049646|systemic haemodynamics|systemic haemodynamics
492844|NCT01049633|Insulin dependence|insulin dependence
492845|NCT01049633|Hypoglycemia|hypoglycemia
492846|NCT01049633|Hypoglycemia unawareness|hypoglycemia unawareness
492847|NCT01049633|Islet transplantation|islet transplantation
492848|NCT01049620|XELOX|xelox
492849|NCT01049620|RAD001|rad001
492850|NCT01049620|phase 1|phase 1
492851|NCT01049607|Patients undergoing hepatic resection|patients undergoing hepatic resection
492852|NCT01049581|Gross motor function performance|gross motor function performance
492853|NCT01049581|pediatric aquatic therapy|pediatric aquatic therapy
492854|NCT01049581|spastic cerebral palsy|spastic cerebral palsy
492855|NCT01049568|HIV|hiv
492856|NCT01049568|Cell phone|cell phone
492857|NCT01049568|HAART|haart
492858|NCT01049555|alzheimer|alzheimer
492859|NCT01049555|apathy|apathy
492860|NCT01049555|actigraphy|actigraphy
492861|NCT01049542|Astressin 2B|astressin 2b
492862|NCT01049542|Forearm blood flow|forearm blood flow
492863|NCT01049542|vascular|vascular
492864|NCT01049542|plethysmography|plethysmography
492865|NCT01049542|heart failure|heart failure
492866|NCT01049529|Docosahexaenoic acid|docosahexaenoic acid
492867|NCT01049529|n-3 Long Chain Polyunsaturated Fatty Acids|n-3 long chain polyunsaturated fatty acids
492868|NCT01049529|omega 3 fatty acids|omega 3 fatty acids
492869|NCT01049529|neonates|neonates
492870|NCT01049529|clinical outcomes|clinical outcomes
492871|NCT01049529|critically ill patients|critically ill patients
492872|NCT01049529|Inflammatory and antiinflammatory cytokines|inflammatory and antiinflammatory cytokines
492873|NCT01049529|Length of intensive care stay|length of intensive care stay
492874|NCT01049516|Military|military
492875|NCT01049516|Combat|combat
492876|NCT01049516|Psychological Treatment|psychological treatment
492877|NCT01049516|Psychotherapy|psychotherapy
492878|NCT01049516|Trauma|trauma
492879|NCT01049516|Posttraumatic Stress|posttraumatic stress
492880|NCT01049516|Posttraumatic Stress Disorder|posttraumatic stress disorder
492881|NCT01049516|PTSD|ptsd
492882|NCT01049516|Prolonged Exposure|prolonged exposure
492883|NCT01049516|Exposure therapy|exposure therapy
492884|NCT01049516|Behavior Therapy|behavior therapy
492885|NCT01049516|Cognitive Behavior Therapy|cognitive behavior therapy
492886|NCT01049516|Post-Traumatic Stress Disorders|post-traumatic stress disorders
492887|NCT01049516|Stress Disorders, Post-traumatic|stress disorders, post-traumatic
492888|NCT01049503|Dentifrices|dentifrices
492889|NCT01049503|Fluoride|fluoride
492890|NCT01049503|Nails|nails
492891|NCT01049503|Plaque|plaque
492892|NCT01049490|Intradermal vaccination, H1N1, microneedle|intradermal vaccination, h1n1, microneedle
492893|NCT01049477|Pregnancy|pregnancy
492894|NCT01049477|Cesarean Section|cesarean section
492895|NCT01049464|Atrial fibrillation|atrial fibrillation
492896|NCT01049464|Hemodynamically unstable patients|hemodynamically unstable patients
492897|NCT01049464|Magnesium sulfate|magnesium sulfate
492898|NCT01049464|Septic shock|septic shock
492899|NCT01049464|Medical intensive care unit|medical intensive care unit
492900|NCT01049464|New onset atrial fibrillation|new onset atrial fibrillation
492901|NCT01049464|Critically ill patients|critically ill patients
492902|NCT01049451|Multiple Sclerosis|multiple sclerosis
492903|NCT01049451|ACTH|acth
492904|NCT01049451|Steroids|steroids
492905|NCT01049438|MRSA|mrsa
492906|NCT01049438|Methicillin Resistant Staphylococcus aureus|methicillin resistant staphylococcus aureus
492907|NCT01049438|Staphylococcus aureus|staphylococcus aureus
492908|NCT01049438|Skin Infections|skin infections
492909|NCT01049438|Body Decolonization|body decolonization
492910|NCT01049425|anthracycline-free|anthracycline-free
492911|NCT01049425|OncotypDX|oncotypdx
492912|NCT01049425|taxane|taxane
492913|NCT01049425|Her2 negative breast cancer|her2 negative breast cancer
492914|NCT01049386|intestinal permeability|intestinal permeability
492915|NCT01049386|health|health
492916|NCT01049386|sugar absorption|sugar absorption
492917|NCT01049386|intestinal permeability examined in different men (lean vs obese) and different conditions (no breakfast and high-fat breakfast)|intestinal permeability examined in different men (lean vs obese) and different conditions (no breakfast and high-fat breakfast)
492918|NCT01049373|low-back|low-back
492919|NCT01049373|pain|pain
492920|NCT01049373|chronic|chronic
492921|NCT01049373|constitution|constitution
492923|NCT01049373|homoeopathy|homoeopathy
492924|NCT01049373|fixed combination|fixed combination
492925|NCT01049373|herbal preparation|herbal preparation
492926|NCT01049373|chronic low back pain lasting more than 6 months|chronic low back pain lasting more than 6 months
492927|NCT01049360|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
492928|NCT01049360|COPD|copd
492929|NCT01049360|Chronic Bronchitis|chronic bronchitis
492930|NCT01049360|Emphysema|emphysema
492931|NCT01049360|Airflow Obstruction, Chronic|airflow obstruction, chronic
492932|NCT01049360|Chronic Airflow Obstruction|chronic airflow obstruction
492933|NCT01049360|Chronic Obstructive Airway Disease|chronic obstructive airway disease
492934|NCT01049360|Chronic Obstructive Lung Disease|chronic obstructive lung disease
492935|NCT01049347|depression|depression
492936|NCT01049321|Dietary Approach to Stop Hypertension|dietary approach to stop hypertension
492937|NCT01049321|weight|weight
492938|NCT01049321|coagulation|coagulation
492939|NCT01049321|DASH eating pattern.|dash eating pattern.
492940|NCT01049308|heart failure|heart failure
492941|NCT01049308|cognitive disorders|cognitive disorders
492942|NCT01049308|medication adherence|medication adherence
492943|NCT01049308|patient readmissions|patient readmissions
492944|NCT01049295|taxanes|taxanes
492945|NCT01049295|breast cancer|breast cancer
492946|NCT01049295|n3 fatty acids|n3 fatty acids
492947|NCT01049295|inflammation|inflammation
492948|NCT01049282|safety|safety
492949|NCT01049282|immunogenicity|immunogenicity
492950|NCT01049282|adjuvanted TB subunit vaccine|adjuvanted tb subunit vaccine
492951|NCT01049269|Body Scanning|body scanning
492952|NCT01049269|Body Fat|body fat
492953|NCT01049269|Body Volume|body volume
492954|NCT01049269|Obesity|obesity
492955|NCT01049269|No Conditions|no conditions
492956|NCT01049256|Periodic breathing|periodic breathing
492957|NCT01049256|Heart Failure|heart failure
492958|NCT01049256|Chemoreflex|chemoreflex
492959|NCT01049256|Chemosensitivity|chemosensitivity
492960|NCT01049243|Atopic Dermatitis|atopic dermatitis
492961|NCT01049243|Open-Label|open-label
492962|NCT01049243|Topical|topical
492963|NCT01049243|Cream|cream
492964|NCT01049243|Eczema|eczema
492965|NCT01049243|Vanos|vanos
492966|NCT01049230|proton beam radiation|proton beam radiation
492967|NCT01049230|CNS germ cell tumor|cns germ cell tumor
492968|NCT01049217|neuropathy|neuropathy
492969|NCT01049217|pain|pain
492970|NCT01049217|HIV-1|hiv-1
492971|NCT01049217|HIV Infections|hiv infections
492972|NCT01049204|HIV|hiv
492973|NCT01049204|HIV-1 Infections|hiv-1 infections
492974|NCT01049191|Osteoporosis|osteoporosis
492975|NCT01049191|Fracture|fracture
492976|NCT01049191|microMRI|micromri
492977|NCT01049191|Bone architecture|bone architecture
492978|NCT01049191|Bone matrix|bone matrix
492979|NCT01049191|Bone and Bones|bone and bones
492980|NCT01049191|Magnetic Resonance Imaging|magnetic resonance imaging
492981|NCT01049178|antioxidant enzymes|antioxidant enzymes
492982|NCT01049178|asthma|asthma
492983|NCT01049178|silymarin|silymarin
492984|NCT01049178|RCT|rct
492985|NCT01049152|Diabetes mellitus|diabetes mellitus
492986|NCT01049152|ESRD|esrd
492987|NCT01049152|CGM|cgm
492988|NCT01049152|Inflammation markers|inflammation markers
492989|NCT01049152|Hemodialysis|hemodialysis
492990|NCT01049152|Diabetic patients|diabetic patients
492991|NCT01049152|Nondiabetic patients|nondiabetic patients
492992|NCT01049152|All with ESRD|all with esrd
492993|NCT01049152|All undergone hemodialysis|all undergone hemodialysis
492994|NCT01049139|vaccination|vaccination
492995|NCT01049139|HIV prevention|hiv prevention
492996|NCT01049139|YMSM|ymsm
492997|NCT01049139|youth|youth
492998|NCT01049139|HIV Preventative Vaccine|hiv preventative vaccine
492999|NCT01049126|Late Stage|late stage
493000|NCT01049113|Lymphoma|lymphoma
493001|NCT01049113|B-cell Acute Lymphocytic Leukemia|b-cell acute lymphocytic leukemia
493002|NCT01049113|ALL|all
493003|NCT01049100|Surgical Staging|surgical staging
493004|NCT01049100|Cervical Cancer|cervical cancer
493005|NCT01049100|Chemoradiation|chemoradiation
493006|NCT01049100|Outcome|outcome
493007|NCT01049100|Toxicity|toxicity
493008|NCT01049087|plasma volume|plasma volume
493009|NCT01049087|technetium-labeled albumin|technetium-labeled albumin
493010|NCT01049087|radioiodine-labeled albumin|radioiodine-labeled albumin
493011|NCT01049087|Healthy volunteers|healthy volunteers
493012|NCT01049074|Low Back Pain|low back pain
493013|NCT01049074|Acupuncture|acupuncture
493014|NCT01049074|RCT|rct
493015|NCT01049061|Cancer|cancer
493016|NCT01049061|FRα|frα
493017|NCT01049048|Endothelial Function|endothelial function
493018|NCT01049048|Arterial stiffness|arterial stiffness
493019|NCT01049048|Vitamin D|vitamin d
493020|NCT01049035|Meningitis|meningitis
493021|NCT01049035|Meningococcal Infection|meningococcal infection
493022|NCT01049035|Neisseria meningitidis|neisseria meningitidis
493023|NCT01049035|Tetravalent Meningococcal Vaccine|tetravalent meningococcal vaccine
493024|NCT01049022|Pharmacokinetics|pharmacokinetics
493025|NCT01049009|Nitric Oxide|nitric oxide
493722|NCT01047553|OT|ot
493026|NCT01049009|Adrenergic beta-Antagonists|adrenergic beta-antagonists
493027|NCT01049009|Antihypertensive Agents|antihypertensive agents
493028|NCT01049009|Vasodilator Agents|vasodilator agents
493029|NCT01049009|Anti-Arrhythmia Agents|anti-arrhythmia agents
493030|NCT01049009|Sympatholytics|sympatholytics
493031|NCT01049009|Vascular Resistance|vascular resistance
493032|NCT01049009|Neurotransmitter Agents|neurotransmitter agents
493033|NCT01049009|Cardiovascular Diseases|cardiovascular diseases
493034|NCT01049009|Metoprolol succinate|metoprolol succinate
493035|NCT01049009|Therapeutic Uses|therapeutic uses
493036|NCT01049009|Metoprolol|metoprolol
493037|NCT01049009|Vascular Diseases|vascular diseases
493038|NCT01049009|Nebivolol|nebivolol
493039|NCT01049009|Cardiovascular Agents|cardiovascular agents
493040|NCT01049009|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors
493041|NCT01048996|Acute Lung Injury|acute lung injury
493042|NCT01048996|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
493043|NCT01048996|Genetic Variability|genetic variability
493044|NCT01048996|Plasma Biomarkers|plasma biomarkers
493045|NCT01048996|Pediatrics|pediatrics
493046|NCT01048983|Lung Cancer|lung cancer
493047|NCT01048983|NSCLC|nsclc
493048|NCT01048983|Concurrent Chemoradiation Therapy|concurrent chemoradiation therapy
493049|NCT01048983|Side Effects|side effects
493050|NCT01048983|Armodafinil|armodafinil
493051|NCT01048983|Nuvigil|nuvigil
493052|NCT01048983|Bupropion|bupropion
493053|NCT01048983|Wellbutrin|wellbutrin
493054|NCT01048983|Wellbutrin SR|wellbutrin sr
493055|NCT01048983|Zyban|zyban
493056|NCT01048983|Curcumin|curcumin
493057|NCT01048983|Minocycline|minocycline
493058|NCT01048983|Dynacin|dynacin
493059|NCT01048983|Minocin|minocin
493060|NCT01048983|Minocin PAC|minocin pac
493061|NCT01048983|Myrac|myrac
493062|NCT01048983|Solodyn|solodyn
493063|NCT01048970|Lung cancer|lung cancer
493064|NCT01048970|Eicosapentaenoic acid oral supplementation|eicosapentaenoic acid oral supplementation
493065|NCT01048970|Weight loss|weight loss
493066|NCT01048970|Toxicity|toxicity
493067|NCT01048970|Body composition|body composition
493068|NCT01048970|Inflammatory response|inflammatory response
493069|NCT01048957|Nicotine|nicotine
493070|NCT01048957|Craving|craving
493071|NCT01048957|fMRI|fmri
493072|NCT01048957|EEG|eeg
493073|NCT01048957|Real Time fMRI Feedback|real time fmri feedback
493074|NCT01048944|Electroencephalography|electroencephalography
493075|NCT01048944|nicotine|nicotine
493076|NCT01048944|bupropion|bupropion
493077|NCT01048944|attention|attention
493078|NCT01048944|drug withdrawal symptoms|drug withdrawal symptoms
493079|NCT01048931|Single-port, laparoscopic-assisted, vaginal hysterectomy|single-port, laparoscopic-assisted, vaginal hysterectomy
493080|NCT01048918|Circulating tumor cells in breast cancer|circulating tumor cells in breast cancer
493081|NCT01048905|Pulmonary Hypertension|pulmonary hypertension
493082|NCT01048905|Sickle Cell Disease|sickle cell disease
493083|NCT01048905|Thalassemia|thalassemia
493084|NCT01048892|recurrent neuroblastoma|recurrent neuroblastoma
493085|NCT01048892|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
493086|NCT01048892|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
493087|NCT01048892|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
493088|NCT01048892|recurrent retinoblastoma|recurrent retinoblastoma
493089|NCT01048892|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
493090|NCT01048892|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
493091|NCT01048879|oseltamivir|oseltamivir
493092|NCT01048879|influenza|influenza
493093|NCT01048879|continuous renal replacement therapy|continuous renal replacement therapy
493094|NCT01048879|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
493095|NCT01048879|pharmacokinetics|pharmacokinetics
493096|NCT01048866|pharyngitis|pharyngitis
493097|NCT01048866|swollen throat|swollen throat
493098|NCT01048866|difficulty swallowing|difficulty swallowing
493099|NCT01048853|Cervix|cervix
493100|NCT01048853|Stage IA2 or IB1 Carcinoma|stage ia2 or ib1 carcinoma
493101|NCT01048853|Conservative Surgery|conservative surgery
493102|NCT01048853|Cervix Cancer recurrence|cervix cancer recurrence
493103|NCT01048853|Quality of Life Factors|quality of life factors
493104|NCT01048853|Pelvic lymph nodes|pelvic lymph nodes
493105|NCT01048853|Pelvic Lymphadenectomy|pelvic lymphadenectomy
493106|NCT01048853|parametrium|parametrium
493107|NCT01048853|Cervical cone biopsy|cervical cone biopsy
493108|NCT01048853|Endocervical curettage|endocervical curettage
493109|NCT01048853|ECC|ecc
493110|NCT01048840|Gastroesophageal Reflux|gastroesophageal reflux
493111|NCT01048827|AML|aml
493112|NCT01048827|autologous transplant|autologous transplant
493113|NCT01048801|History of fever|history of fever
493114|NCT01048801|measured fever|measured fever
493115|NCT01048788|Cirrhosis|cirrhosis
493116|NCT01048788|ascites|ascites
493117|NCT01048788|Tolvaptan|tolvaptan
493118|NCT01048788|OPC-41061|opc-41061
493119|NCT01048775|bispectral index|bispectral index
493120|NCT01048775|cardiac surgery|cardiac surgery
493121|NCT01048775|asymmetry|asymmetry
493122|NCT01048762|pulmonary cancer|pulmonary cancer
493123|NCT01048762|radically operated|radically operated
493124|NCT01048762|exercise training|exercise training
493125|NCT01048762|dyspnea counseling|dyspnea counseling
493126|NCT01048762|quality of life|quality of life
493127|NCT01048762|physical therapy|physical therapy
493128|NCT01048749|Low back pain|low back pain
493129|NCT01048749|nerve root compression|nerve root compression
493130|NCT01048749|spinal height|spinal height
493131|NCT01048736|obesity|obesity
493132|NCT01048736|exercise|exercise
493133|NCT01048736|intensity|intensity
493134|NCT01048736|weight loss|weight loss
493135|NCT01048736|diet|diet
493136|NCT01048723|Soft Tissue|soft tissue
493137|NCT01048723|Retroperitoneal|retroperitoneal
493138|NCT01048723|resectable|resectable
493139|NCT01048710|Knee osteoarthritis|knee osteoarthritis
493140|NCT01048710|knee osteonecrosis|knee osteonecrosis
493141|NCT01048710|osteotomy|osteotomy
493142|NCT01048697|Obesity|obesity
493143|NCT01048697|Pharmacokinetics|pharmacokinetics
493144|NCT01048697|Pharmacodynamics|pharmacodynamics
493145|NCT01048697|Dose individualization|dose individualization
493146|NCT01048697|Tuberculosis|tuberculosis
493147|NCT01048684|Brain tumor|brain tumor
493148|NCT01048684|Intracranial pressure|intracranial pressure
493149|NCT01048671|HIV|hiv
493150|NCT01048658|Sevoflurane|sevoflurane
493151|NCT01048658|anesthesia|anesthesia
493152|NCT01048658|abortion|abortion
493153|NCT01048658|blood loss|blood loss
493154|NCT01048645|All-trans retinoic acid|all-trans retinoic acid
493155|NCT01048645|non-small cell lung cancer|non-small cell lung cancer
493156|NCT01048645|retinoic acid receptor beta|retinoic acid receptor beta
493157|NCT01048645|chemotherapy|chemotherapy
493158|NCT01048632|Neonates with HLHS or variant with plan to undergo Norwood Procedure|neonates with hlhs or variant with plan to undergo norwood procedure
493159|NCT01048619|Myelodysplastic Syndrome|myelodysplastic syndrome
493161|NCT01048606|Postmenopause|postmenopause
493162|NCT01048606|Overweight|overweight
493163|NCT01048606|Women|women
493164|NCT01048606|Phytoestrogens|phytoestrogens
493165|NCT01048606|Exercise|exercise
493166|NCT01048606|Cardiovascular Diseases|cardiovascular diseases
493167|NCT01048606|Risk Factors|risk factors
493168|NCT01048606|Aging|aging
493169|NCT01048593|ocular inflammation cataract surgery|ocular inflammation cataract surgery
493170|NCT01048593|post cataract surgery inflammation|post cataract surgery inflammation
493171|NCT01048580|Perifosine|perifosine
493172|NCT01048580|Capecitabine|capecitabine
493173|NCT01048580|Colon Cancer|colon cancer
493174|NCT01048567|Antibiotics|antibiotics
493175|NCT01048567|Diarrhea|diarrhea
493176|NCT01048567|Clostridium difficile|clostridium difficile
493177|NCT01048567|Probiotics|probiotics
493178|NCT01048567|Prevention & control|prevention & control
493179|NCT01048554|Melanoma|melanoma
493180|NCT01048554|Brain mets|brain mets
493181|NCT01048554|Bevacizumab|bevacizumab
493182|NCT01048554|Temozolomide|temozolomide
493183|NCT01048554|Avastin|avastin
493184|NCT01048554|Temodar|temodar
493185|NCT01048554|Melanoma with brain mets|melanoma with brain mets
493186|NCT01048528|immune response to vaccines|immune response to vaccines
493187|NCT01048528|stress management|stress management
493188|NCT01048528|perceived risk for breast cancer|perceived risk for breast cancer
493189|NCT01048515|Caffeine|caffeine
493190|NCT01048515|Physiological Effects of Drugs|physiological effects of drugs
493191|NCT01048515|Central Nervous System Agents|central nervous system agents
493192|NCT01048502|healthy volunteer|healthy volunteer
493193|NCT01048476|AMD|amd
493194|NCT01048463|gastric cancer|gastric cancer
493195|NCT01048463|colorectal cancer|colorectal cancer
493196|NCT01048463|chemotherapy|chemotherapy
493197|NCT01048463|eicosapentaenoic acid|eicosapentaenoic acid
493198|NCT01048463|enteral nutrition|enteral nutrition
493199|NCT01048450|arthritis|arthritis
493200|NCT01048450|degeneration|degeneration
493201|NCT01048424|Urinary incontinence|urinary incontinence
493202|NCT01048424|Paced respiration|paced respiration
493203|NCT01048411|stroke rehabilitation|stroke rehabilitation
493204|NCT01048411|outcome|outcome
493205|NCT01048411|barthel-index|barthel-index
493206|NCT01048411|geriatrics|geriatrics
493207|NCT01048411|elderly|elderly
493208|NCT01048398|ceophalic version|ceophalic version
493209|NCT01048398|breech presentation|breech presentation
493210|NCT01048398|pregnancy|pregnancy
493211|NCT01048398|remifentanil|remifentanil
493212|NCT01048398|paracetamol|paracetamol
493213|NCT01048385|Mitochondrial dysfunction|mitochondrial dysfunction
493214|NCT01048385|Mitochondrial nutrients|mitochondrial nutrients
493215|NCT01048385|Aneuploidy|aneuploidy
493216|NCT01048385|Meiotic Spindle|meiotic spindle
493217|NCT01048385|Coenzyme Q10|coenzyme q10
493218|NCT01048385|Electron transfer chain|electron transfer chain
493219|NCT01048372|HIV|hiv
493220|NCT01048372|monoclonal antibody|monoclonal antibody
493221|NCT01048372|immune therapy|immune therapy
493222|NCT01048372|pathogenesis|pathogenesis
493223|NCT01048372|cytotoxic T lymphocyte|cytotoxic t lymphocyte
493224|NCT01048372|anti-CD4|anti-cd4
493225|NCT01048372|anti-self|anti-self
493723|NCT01047553|Oxis|oxis
493226|NCT01048372|viral replication|viral replication
493227|NCT01048372|Acute Infection|acute infection
493228|NCT01048359|Drug abuse, injury, trauma, screening, brief intervention.|drug abuse, injury, trauma, screening, brief intervention.
493229|NCT01048346|employment, disabilities|employment, disabilities
493230|NCT01048333|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
493231|NCT01048333|Onset of effect|onset of effect
493232|NCT01048333|COPD|copd
493233|NCT01048333|Oxis Turbuhaler|oxis turbuhaler
493234|NCT01048320|pancreatic cancer|pancreatic cancer
493235|NCT01048320|toxicity|toxicity
493236|NCT01048320|chemotherapy|chemotherapy
493237|NCT01048320|dose finding|dose finding
493238|NCT01048307|prontosan|prontosan
493239|NCT01048307|wound cleansing|wound cleansing
493240|NCT01048307|wound irrigation|wound irrigation
493241|NCT01048307|phmb|phmb
493242|NCT01048307|polihexanide|polihexanide
493243|NCT01048307|betaine|betaine
493244|NCT01048294|Seasonal affective disorder|seasonal affective disorder
493245|NCT01048294|phototherapy|phototherapy
493246|NCT01048294|circadian rhythms|circadian rhythms
493247|NCT01048294|blue enriched light|blue enriched light
493248|NCT01048294|melanopsin|melanopsin
493249|NCT01048294|Primary disease: Seasonal Affective Disorder, winter type|primary disease: seasonal affective disorder, winter type
493250|NCT01048268|T1DM|t1dm
493251|NCT01048268|T2DM|t2dm
493252|NCT01048268|GIP|gip
493253|NCT01048268|Glucose-dependent insulinotropic polypeptide|glucose-dependent insulinotropic polypeptide
493254|NCT01048268|Incretin|incretin
493255|NCT01048216|colorectal liver cancer|colorectal liver cancer
493256|NCT01048216|metastatic|metastatic
493257|NCT01048216|radiation therapy|radiation therapy
493258|NCT01048203|14C ABR 215050 Metabolism and Mass Balance Study|14c abr 215050 metabolism and mass balance study
493259|NCT01048203|tasquinimod|tasquinimod
493260|NCT01048203|Metabolic pattern of 14C ABR-215050|metabolic pattern of 14c abr-215050
493261|NCT01048190|Inactivated Poliomyelitis Vaccine|inactivated poliomyelitis vaccine
493262|NCT01048190|Sabin Strains|sabin strains
493263|NCT01048190|poliomyelitis|poliomyelitis
493264|NCT01048177|vulvodynia|vulvodynia
493265|NCT01048177|interstitial cystitis|interstitial cystitis
493266|NCT01048177|pelvic pain|pelvic pain
493267|NCT01048164|Massage|massage
493268|NCT01048164|Relaxation|relaxation
493269|NCT01048151|Prostate|prostate
493270|NCT01048151|TNFerade Biologic|tnferade biologic
493271|NCT01048138|Biperiden|biperiden
493272|NCT01048138|Post-traumatic Epilepsy|post-traumatic epilepsy
493273|NCT01048138|Traumatic Brain Injury|traumatic brain injury
493274|NCT01048125|Stress-induced cardiomyopathy|stress-induced cardiomyopathy
493275|NCT01048125|Takotsubo cardiomyopathy|takotsubo cardiomyopathy
493276|NCT01048112|campylobacter|campylobacter
493277|NCT01048112|gastroenteritis|gastroenteritis
493278|NCT01048112|challenge models|challenge models
493279|NCT01048099|Breast Cancer|breast cancer
493280|NCT01048099|Metastatic|metastatic
493281|NCT01048099|PRO Onc Assay|pro onc assay
493282|NCT01048099|FISH Testing|fish testing
493283|NCT01048099|HER Negative|her negative
493284|NCT01048099|HER Overexpression|her overexpression
493285|NCT01048099|HER Activation|her activation
493286|NCT01048086|neuroblastoma|neuroblastoma
493287|NCT01048086|neuroendocrine tumor|neuroendocrine tumor
493288|NCT01048086|NET|net
493289|NCT01048086|retinoic acid|retinoic acid
493290|NCT01048073|lower respiratory tract infection|lower respiratory tract infection
493291|NCT01048073|non influenza|non influenza
493292|NCT01048073|PCR assay|pcr assay
493293|NCT01048047|aliskiren|aliskiren
493294|NCT01048047|amlodipine|amlodipine
493295|NCT01048047|hypertension|hypertension
493296|NCT01048047|ankle-foot volume|ankle-foot volume
493297|NCT01048047|mild and moderate hypertension|mild and moderate hypertension
493298|NCT01048034|Myelodysplastic syndrome|myelodysplastic syndrome
493299|NCT01048034|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
493300|NCT01048034|Transfusion therapy|transfusion therapy
493301|NCT01048034|Transfusion dependency|transfusion dependency
493302|NCT01048034|Hypomethylating therapy|hypomethylating therapy
493303|NCT01048034|Azacitidine|azacitidine
493304|NCT01048034|DNA-methylation|dna-methylation
493305|NCT01048034|Epigenetic modifications|epigenetic modifications
493306|NCT01048021|Measurement of lung mechanics (FEV1, FVC and PEF)|measurement of lung mechanics (fev1, fvc and pef)
493307|NCT01048008|Glioblastoma multiforme|glioblastoma multiforme
493308|NCT01048008|Advanced cancers|advanced cancers
493309|NCT01048008|Brain Neoplasms, Malignant, Primary|brain neoplasms, malignant, primary
493310|NCT01048008|Brain Tumor, Recurrent|brain tumor, recurrent
493311|NCT01048008|Advanced cancer|advanced cancer
493312|NCT01047982|gestational diabetes|gestational diabetes
493313|NCT01047982|macrosomia|macrosomia
493314|NCT01047982|hypertension in pregnancy|hypertension in pregnancy
493315|NCT01047982|HOMA-IR|homa-ir
493316|NCT01047982|obesity|obesity
493317|NCT01047969|locally invasive high-risk rectal adenocarcinoma|locally invasive high-risk rectal adenocarcinoma
493318|NCT01047956|Methadone|methadone
493319|NCT01047956|NAC|nac
493320|NCT01047956|opioids|opioids
493321|NCT01047930|Insomnia|insomnia
493322|NCT01047930|Smoking|smoking
493323|NCT01047930|Cue reactivity|cue reactivity
493324|NCT01047930|Exercise timing|exercise timing
493325|NCT01047930|Acute nicotine withdrawal|acute nicotine withdrawal
493326|NCT01047930|Mood disturbances|mood disturbances
493327|NCT01047930|Smoking abstinence|smoking abstinence
493328|NCT01047930|Exercise intensity|exercise intensity
493329|NCT01047930|Altered sleep|altered sleep
493330|NCT01047930|Exercise duration|exercise duration
493331|NCT01047930|Nonpharmacologic behavioral treatment|nonpharmacologic behavioral treatment
493332|NCT01047930|Smoking cessation|smoking cessation
493333|NCT01047930|Exercise Test|exercise test
493334|NCT01047930|Polysomnography|polysomnography
493335|NCT01047917|Meditation|meditation
493336|NCT01047917|Relaxation Therapy|relaxation therapy
493337|NCT01047917|Quality of Life|quality of life
493338|NCT01047865|Type 1 Diabetes (T1D)|type 1 diabetes (t1d)
493339|NCT01047865|Autoimmunity|autoimmunity
493340|NCT01047852|chronic respiratory disorders|chronic respiratory disorders
493341|NCT01047852|hypercapnic respiratory failure|hypercapnic respiratory failure
493342|NCT01047852|noninvasive ventilation|noninvasive ventilation
493343|NCT01047839|Pediatric|pediatric
493344|NCT01047839|Japanese Encephalitis Vaccine|japanese encephalitis vaccine
493345|NCT01047839|non-endemic countries|non-endemic countries
493346|NCT01047839|to assess immunogenicity of purified inactivated Japanese Encephalitis (JE) vaccine IC51|to assess immunogenicity of purified inactivated japanese encephalitis (je) vaccine ic51
493347|NCT01047826|Fractured Tibia|fractured tibia
493348|NCT01047826|Expert Tibial Nail|expert tibial nail
493349|NCT01047826|Minimally Invasive Plate Osteosynthesis (M.I.P.O)|minimally invasive plate osteosynthesis (m.i.p.o)
493350|NCT01047826|Intramedullary Nailing|intramedullary nailing
493351|NCT01047826|Locked Plate|locked plate
493352|NCT01047826|distal third|distal third
493353|NCT01047826|43-A|43-a
493354|NCT01047813|Cognitive performance|cognitive performance
493355|NCT01047813|Type 2 diabetes|type 2 diabetes
493356|NCT01047813|Blood glucose|blood glucose
493357|NCT01047800|Functional gastrointestinal disorder|functional gastrointestinal disorder
493358|NCT01047800|GERD|gerd
493359|NCT01047800|reflux|reflux
493360|NCT01047800|irritable bowel syndrome|irritable bowel syndrome
493361|NCT01047800|Functional dyspepsia|functional dyspepsia
493362|NCT01047800|postprandial fullness|postprandial fullness
493363|NCT01047800|counseling|counseling
493364|NCT01047800|service|service
493365|NCT01047787|Sleep apnea|sleep apnea
493366|NCT01047787|Cheyne-Stokes Respiration|cheyne-stokes respiration
493367|NCT01047787|Congestive Heart Failure|congestive heart failure
493368|NCT01047774|soy protein|soy protein
493369|NCT01047774|diet|diet
493370|NCT01047761|Myasthenia Gravis|myasthenia gravis
493371|NCT01047761|Exercise|exercise
493372|NCT01047761|Fitness|fitness
493373|NCT01047761|Body Composition|body composition
493374|NCT01047761|Physical Activity|physical activity
493375|NCT01047761|Pulmonary Function|pulmonary function
493376|NCT01047761|Balance|balance
493377|NCT01047748|abortion|abortion
493378|NCT01047735|21+ years old|21+ years old
493379|NCT01047735|Address|address
493380|NCT01047735|Adult|adult
493381|NCT01047735|Amputation|amputation
493382|NCT01047735|Area|area
493383|NCT01047735|Arm|arm
493384|NCT01047735|Atheroscleroses|atheroscleroses
493385|NCT01047735|Atherosclerosis|atherosclerosis
493386|NCT01047735|Atherosclerotic|atherosclerotic
493387|NCT01047735|Cardiovascular Disease|cardiovascular disease
493388|NCT01047735|Bariatrics|bariatrics
493389|NCT01047735|Behavior Conditioning Therapy|behavior conditioning therapy
493390|NCT01047735|Behavior Modification|behavior modification
493391|NCT01047735|Behavior Therapy|behavior therapy
493392|NCT01047735|Behavior Treatment|behavior treatment
493393|NCT01047735|Behavior or Life Style Modifications|behavior or life style modifications
493394|NCT01047735|Behavioral|behavioral
493395|NCT01047735|Behavioral Conditioning Therapy|behavioral conditioning therapy
493396|NCT01047735|Behavioral Modification|behavioral modification
493397|NCT01047735|Behavioral Therapy|behavioral therapy
493398|NCT01047735|Behavioral Treatment|behavioral treatment
493399|NCT01047735|Beta Cell|beta cell
493400|NCT01047735|Blindness|blindness
493401|NCT01047735|Blood Pressure, High|blood pressure, high
493402|NCT01047735|Blood Vessels|blood vessels
493403|NCT01047735|Body Composition|body composition
493404|NCT01047735|Body Weight decreased|body weight decreased
493405|NCT01047735|Cancers|cancers
493406|NCT01047735|Cardiac infarction|cardiac infarction
493407|NCT01047735|Cardiovascular Diseases|cardiovascular diseases
493408|NCT01047735|Care, Health|care, health
493409|NCT01047735|Cause of Death|cause of death
493410|NCT01047735|Cell Function|cell function
493411|NCT01047735|Cell Process|cell process
493412|NCT01047735|Cell physiology|cell physiology
493413|NCT01047735|Cellular Function|cellular function
493414|NCT01047735|Cellular Physiology|cellular physiology
493415|NCT01047735|Cellular Process|cellular process
493416|NCT01047735|Cessation of life|cessation of life
493417|NCT01047735|Clinical|clinical
493418|NCT01047735|Clinical Trials Design|clinical trials design
493419|NCT01047735|Communities|communities
493827|NCT01047176|Statins|statins
493420|NCT01047735|Conditioning Therapy|conditioning therapy
493421|NCT01047735|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
493422|NCT01047735|Controlled Study|controlled study
493423|NCT01047735|Country|country
493424|NCT01047735|D-Glucose|d-glucose
493425|NCT01047735|Death|death
493426|NCT01047735|Decision Making|decision making
493427|NCT01047735|Dextrose|dextrose
493428|NCT01047735|Diabetes Mellitus|diabetes mellitus
493429|NCT01047735|Diabetes Mellitus, Adult-Onset|diabetes mellitus, adult-onset
493430|NCT01047735|Diabetes Mellitus, Ketosis-Resistant|diabetes mellitus, ketosis-resistant
493431|NCT01047735|Diabetes Mellitus, Non-Insulin-Dependent|diabetes mellitus, non-insulin-dependent
493432|NCT01047735|Diabetes Mellitus, Noninsulin Dependent|diabetes mellitus, noninsulin dependent
493433|NCT01047735|Diabetes Mellitus, Slow-Onset|diabetes mellitus, slow-onset
493434|NCT01047735|Diabetes Mellitus, Stable|diabetes mellitus, stable
493435|NCT01047735|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
493436|NCT01047735|Diabetes Mellitus, Type II|diabetes mellitus, type ii
493437|NCT01047735|Diet|diet
493438|NCT01047735|Disease|disease
493439|NCT01047735|Disease remission|disease remission
493440|NCT01047735|Disorder|disorder
493441|NCT01047735|Drugs|drugs
493442|NCT01047735|Dysfunction|dysfunction
493443|NCT01047735|Effectiveness|effectiveness
493444|NCT01047735|Epidemic|epidemic
493445|NCT01047735|Functional disorder|functional disorder
493446|NCT01047735|Future|future
493447|NCT01047735|Gastric Bypass|gastric bypass
493448|NCT01047735|Glucose|glucose
493449|NCT01047735|Health|health
493450|NCT01047735|Healthcare|healthcare
493451|NCT01047735|Hepatic Disorder|hepatic disorder
493452|NCT01047735|Human, Adult|human, adult
493453|NCT01047735|Hypertension|hypertension
493454|NCT01047735|INFLM|inflm
493455|NCT01047735|Incidence|incidence
493456|NCT01047735|Inflammation|inflammation
493457|NCT01047735|Insulin Cell|insulin cell
493458|NCT01047735|Insulin Resistance|insulin resistance
493459|NCT01047735|Insulin Secreting Cell|insulin secreting cell
493460|NCT01047735|Intestinal|intestinal
493461|NCT01047735|Intestines|intestines
493462|NCT01047735|Intravenous Glucose Tolerance|intravenous glucose tolerance
493463|NCT01047735|Intravenous Glucose Tolerance Test|intravenous glucose tolerance test
493464|NCT01047735|Kidney Failure|kidney failure
493465|NCT01047735|Kidney Insufficiency|kidney insufficiency
493466|NCT01047735|Learning|learning
493467|NCT01047735|Life Style|life style
493468|NCT01047735|Life Style Modification|life style modification
493469|NCT01047735|Lifestyle|lifestyle
493470|NCT01047735|Link|link
493471|NCT01047735|Liver diseases|liver diseases
493472|NCT01047735|Longitudinal Studies|longitudinal studies
493473|NCT01047735|MODY|mody
493474|NCT01047735|Malignant Neoplasms|malignant neoplasms
493475|NCT01047735|Malignant Tumor|malignant tumor
493476|NCT01047735|Maturity-Onset Diabetes Mellitus|maturity-onset diabetes mellitus
493477|NCT01047735|Measures|measures
493478|NCT01047735|Medical|medical
493479|NCT01047735|Medication|medication
493480|NCT01047735|Metabolic|metabolic
493481|NCT01047735|Methods|methods
493482|NCT01047735|Modification|modification
493483|NCT01047735|Morbid Obesity|morbid obesity
493484|NCT01047735|Morbidity|morbidity
493485|NCT01047735|Morbidity - disease rate|morbidity - disease rate
493486|NCT01047735|Mortality|mortality
493487|NCT01047735|Mortality Vital Statistics|mortality vital statistics
493488|NCT01047735|Myocardial Infarct|myocardial infarct
493489|NCT01047735|Myocardial Infarction|myocardial infarction
493490|NCT01047735|NAFLD|nafld
493491|NCT01047735|NASH|nash
493492|NCT01047735|NIDDM|niddm
493493|NCT01047735|Non-Insulin Dependent Diabetes|non-insulin dependent diabetes
493494|NCT01047735|Non-Insulin-Dependent Diabetes Mellitus|non-insulin-dependent diabetes mellitus
493495|NCT01047735|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
493496|NCT01047735|Obesity|obesity
493497|NCT01047735|Obesity, Morbid|obesity, morbid
493498|NCT01047735|Operation|operation
493499|NCT01047735|Operative Procedures|operative procedures
493500|NCT01047735|Operative Surgical Procedures|operative surgical procedures
493501|NCT01047735|Outcome|outcome
493502|NCT01047735|Outcome Measure|outcome measure
493503|NCT01047735|PROV|prov
493504|NCT01047735|Participant|participant
493505|NCT01047735|Patients|patients
493506|NCT01047735|Pharmaceutic Preparations|pharmaceutic preparations
493507|NCT01047735|Pharmaceutical Preparations|pharmaceutical preparations
493508|NCT01047735|Physical activity|physical activity
493509|NCT01047735|Physiopathology|physiopathology
493510|NCT01047735|Pilot Projects|pilot projects
493511|NCT01047735|Population|population
493512|NCT01047735|Procedures|procedures
493513|NCT01047735|Programs (PT)|programs (pt)
493514|NCT01047735|Programs [Publication Type]|programs [publication type]
493515|NCT01047735|Provider|provider
493516|NCT01047735|Psychosocial Factor|psychosocial factor
493517|NCT01047735|Public Health|public health
493518|NCT01047735|RMSN|rmsn
493519|NCT01047735|Randomized|randomized
493520|NCT01047735|Randomized Controlled Clinical Trials|randomized controlled clinical trials
493521|NCT01047735|Randomized Controlled Trials|randomized controlled trials
493522|NCT01047735|Remission|remission
493523|NCT01047735|Renal Failure|renal failure
493524|NCT01047735|Renal Insufficiency|renal insufficiency
493525|NCT01047735|Reporting|reporting
493526|NCT01047735|Resolution|resolution
493527|NCT01047735|Science|science
493528|NCT01047735|Severe obesity|severe obesity
493529|NCT01047735|Structure|structure
493530|NCT01047735|Subcellular Process|subcellular process
493531|NCT01047735|Surgical|surgical
493532|NCT01047735|Surgical Interventions|surgical interventions
493533|NCT01047735|Surgical Procedure|surgical procedure
493534|NCT01047735|T2D|t2d
493535|NCT01047735|T2DM|t2dm
493536|NCT01047735|Testing|testing
493537|NCT01047735|Type 2 diabetes|type 2 diabetes
493538|NCT01047735|Type II diabetes|type ii diabetes
493539|NCT01047735|United States|united states
493540|NCT01047735|Upper arm|upper arm
493541|NCT01047735|Vascular Hypertensive Disease|vascular hypertensive disease
493542|NCT01047735|Vascular Hypertensive Disorder|vascular hypertensive disorder
493543|NCT01047735|Weight|weight
493544|NCT01047735|Weight Loss|weight loss
493545|NCT01047735|Weight Reduction|weight reduction
493546|NCT01047735|Work|work
493547|NCT01047735|adiposity|adiposity
493548|NCT01047735|adult human (21+)|adult human (21+)
493549|NCT01047735|adult onset diabetes|adult onset diabetes
493550|NCT01047735|atheromatosis|atheromatosis
493551|NCT01047735|atherosclerotic vascular disease|atherosclerotic vascular disease
493552|NCT01047735|bariatric surgery|bariatric surgery
493553|NCT01047735|behavior intervention|behavior intervention
493554|NCT01047735|behavioral intervention|behavioral intervention
493555|NCT01047735|blood glucose regulation|blood glucose regulation
493556|NCT01047735|body weight loss|body weight loss
493557|NCT01047735|bowel|bowel
493558|NCT01047735|cardiac infarct|cardiac infarct
493559|NCT01047735|cardiovascular disorder|cardiovascular disorder
493560|NCT01047735|cardiovascular risk|cardiovascular risk
493561|NCT01047735|cardiovascular risk factor|cardiovascular risk factor
493562|NCT01047735|clinical practice|clinical practice
493563|NCT01047735|comparative effectiveness|comparative effectiveness
493564|NCT01047735|coronary attack|coronary attack
493565|NCT01047735|coronary infarct|coronary infarct
493566|NCT01047735|coronary infarction|coronary infarction
493567|NCT01047735|corpulence|corpulence
493568|NCT01047735|corpulency|corpulency
493569|NCT01047735|corpulentia|corpulentia
493570|NCT01047735|design|design
493571|NCT01047735|designing|designing
493572|NCT01047735|diabetes|diabetes
493573|NCT01047735|diabetic patient|diabetic patient
493574|NCT01047735|disease/disorder|disease/disorder
493575|NCT01047735|drug/agent|drug/agent
493576|NCT01047735|effective therapy|effective therapy
493577|NCT01047735|effectiveness research|effectiveness research
493578|NCT01047735|fitness|fitness
493579|NCT01047735|gastric banding|gastric banding
493580|NCT01047735|gastric bypass surgery|gastric bypass surgery
493581|NCT01047735|glucose control|glucose control
493582|NCT01047735|glucose homeostasis|glucose homeostasis
493583|NCT01047735|glucose metabolism|glucose metabolism
493584|NCT01047735|glucose regulation|glucose regulation
493585|NCT01047735|heart attack|heart attack
493586|NCT01047735|heart infarct|heart infarct
493587|NCT01047735|heart infarction|heart infarction
493588|NCT01047735|hepatopathy|hepatopathy
493589|NCT01047735|hyperpiesia|hyperpiesia
493590|NCT01047735|hyperpiesis|hyperpiesis
493591|NCT01047735|hypertensive disease|hypertensive disease
493592|NCT01047735|implantable gastric stimulation banding|implantable gastric stimulation banding
493593|NCT01047735|insulin resistant|insulin resistant
493594|NCT01047735|interest|interest
493595|NCT01047735|ketosis resistant diabetes|ketosis resistant diabetes
493596|NCT01047735|life style intervention|life style intervention
493597|NCT01047735|lifestyle intervention|lifestyle intervention
493598|NCT01047735|liver disorder|liver disorder
493599|NCT01047735|long-term study|long-term study
493600|NCT01047735|malignancy|malignancy
493601|NCT01047735|maturity onset diabetes|maturity onset diabetes
493602|NCT01047735|moderate obesity|moderate obesity
493603|NCT01047735|neoplasm/cancer|neoplasm/cancer
493604|NCT01047735|non-alcohol fatty liver|non-alcohol fatty liver
493605|NCT01047735|non-alcohol induced steatohepatitis|non-alcohol induced steatohepatitis
493606|NCT01047735|non-alcoholic fatty liver|non-alcoholic fatty liver
493607|NCT01047735|non-alcoholic steato-hepatitis|non-alcoholic steato-hepatitis
493608|NCT01047735|nonalcohol fatty liver|nonalcohol fatty liver
493609|NCT01047735|nonalcoholic fatty liver|nonalcoholic fatty liver
493610|NCT01047735|nonalcoholic steato-hepatitis|nonalcoholic steato-hepatitis
493611|NCT01047735|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
493612|NCT01047735|obese|obese
493613|NCT01047735|obese people|obese people
493614|NCT01047735|obese person|obese person
493615|NCT01047735|obese population|obese population
493616|NCT01047735|obesity surgery|obesity surgery
493617|NCT01047735|obesity, extreme|obesity, extreme
493618|NCT01047735|pathophysiology|pathophysiology
493619|NCT01047735|pilot study|pilot study
493620|NCT01047735|programs|programs
493621|NCT01047735|psychosocial|psychosocial
493622|NCT01047735|psychosocial variables|psychosocial variables
493623|NCT01047735|public health medicine (field)|public health medicine (field)
493624|NCT01047735|public health relevance|public health relevance
493625|NCT01047735|randomisation|randomisation
493626|NCT01047735|randomization|randomization
493627|NCT01047735|randomized controlled study|randomized controlled study
493628|NCT01047735|randomized trial|randomized trial
493629|NCT01047735|randomly assigned|randomly assigned
493630|NCT01047735|respiratory|respiratory
493631|NCT01047735|response|response
493632|NCT01047735|stomach bypass|stomach bypass
493633|NCT01047735|stomach stapling|stomach stapling
493634|NCT01047735|surgery|surgery
493635|NCT01047735|trial comparing|trial comparing
493636|NCT01047735|vascular|vascular
493637|NCT01047735|weight loss intervention|weight loss intervention
493638|NCT01047735|weight loss surgery|weight loss surgery
493639|NCT01047735|wt-loss|wt-loss
493640|NCT01047722|platelet function test|platelet function test
493641|NCT01047722|platelets|platelets
493642|NCT01047722|in vivo test|in vivo test
493643|NCT01047722|aspirin|aspirin
493644|NCT01047722|aspirin resistance|aspirin resistance
493645|NCT01047722|aspirin non-responsiveness|aspirin non-responsiveness
493646|NCT01047722|in-vivo|in-vivo
493647|NCT01047722|To assess the specificity and sensitivity of a novel in-vivo diagnostic test of platelet function|to assess the specificity and sensitivity of a novel in-vivo diagnostic test of platelet function
493648|NCT01047722|"To use this test to define and assess aspirin resistance"|"to use this test to define and assess aspirin resistance"
493649|NCT01047683|hypertriglyceridemia|hypertriglyceridemia
493650|NCT01047683|omega-3 fatty acids|omega-3 fatty acids
493651|NCT01047683|statin|statin
493652|NCT01047683|triglycerides|triglycerides
493653|NCT01047683|lipids|lipids
493655|NCT01047683|docosahexaenoic acid|docosahexaenoic acid
493656|NCT01047683|fish|fish
493657|NCT01047683|fatty acids|fatty acids
493658|NCT01047683|fibrates|fibrates
493659|NCT01047683|niacin|niacin
493660|NCT01047683|lipid|lipid
493661|NCT01047683|atorvastatin|atorvastatin
493662|NCT01047683|Lovaza|lovaza
493663|NCT01047683|simvastatin|simvastatin
493664|NCT01047683|lovastatin|lovastatin
493665|NCT01047683|pravastatin|pravastatin
493666|NCT01047683|fluvastatin|fluvastatin
493667|NCT01047683|rosuvastatin|rosuvastatin
493668|NCT01047683|Trilipix|trilipix
493669|NCT01047683|Vytorin|vytorin
493670|NCT01047683|Simcor|simcor
493671|NCT01047683|Niaspan|niaspan
493672|NCT01047683|ezetimibe|ezetimibe
493673|NCT01047683|Zetia|zetia
493674|NCT01047683|ethyl-EPA|ethyl-epa
493675|NCT01047683|ethyl icosapentate|ethyl icosapentate
493676|NCT01047683|Crestor|crestor
493677|NCT01047683|Zocor|zocor
493678|NCT01047683|Lipitor|lipitor
493679|NCT01047683|LDL|ldl
493680|NCT01047683|HDL|hdl
493681|NCT01047683|cholesterol|cholesterol
493682|NCT01047683|dyslipidemia|dyslipidemia
493683|NCT01047683|VASCEPA|vascepa
493684|NCT01047683|icosapent ethyl|icosapent ethyl
493685|NCT01047670|sepsis, shock, adrenal insufficiency, hydrocortisone, children, paediatric intensive care.|sepsis, shock, adrenal insufficiency, hydrocortisone, children, paediatric intensive care.
493686|NCT01047670|number of days free of vasoactive support in 7 days|number of days free of vasoactive support in 7 days
493687|NCT01047670|days free of mechanical ventilation|days free of mechanical ventilation
493688|NCT01047670|PICU mortality|picu mortality
493689|NCT01047670|mortality among patient with inappropriate response to the ACTH test|mortality among patient with inappropriate response to the acth test
493690|NCT01047670|baseline cortisol/ PIM2 correlation|baseline cortisol/ pim2 correlation
493691|NCT01047657|Asthma|asthma
493692|NCT01047657|Obesity|obesity
493693|NCT01047657|weight loss|weight loss
493694|NCT01047644|port|port
493695|NCT01047644|catheter|catheter
493696|NCT01047644|infusion|infusion
493697|NCT01047644|flush|flush
493698|NCT01047644|cleanse|cleanse
493699|NCT01047644|chemotherapy|chemotherapy
493700|NCT01047618|venous thromboembolism|venous thromboembolism
493701|NCT01047605|qEEG|qeeg
493702|NCT01047605|herbal medicine|herbal medicine
493703|NCT01047605|cognitive function|cognitive function
493704|NCT01047605|Neurapas balance|neurapas balance
493705|NCT01047605|Pascoflair|pascoflair
493706|NCT01047605|hypericum|hypericum
493707|NCT01047605|passionflower|passionflower
493708|NCT01047605|valerian|valerian
493709|NCT01047605|Healthy volunteers|healthy volunteers
493710|NCT01047605|Influence on quantitative electro-encephalogram (qEEG).|influence on quantitative electro-encephalogram (qeeg).
493711|NCT01047592|Schizophrenia|schizophrenia
493712|NCT01047592|cognitive function|cognitive function
493713|NCT01047592|N-methyl-D-aspartate receptor|n-methyl-d-aspartate receptor
493714|NCT01047579|Alzheimer's Disease|alzheimer's disease
493715|NCT01047579|Rivastigmine transdermal|rivastigmine transdermal
493716|NCT01047579|caregiver preference|caregiver preference
493717|NCT01047553|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
493718|NCT01047553|COPD|copd
493719|NCT01047553|Japanese|japanese
493720|NCT01047553|Phase 3|phase 3
493721|NCT01047553|Safety|safety
493724|NCT01047527|nicotine replacement therapy, smoking cessation, transdermal nicotine|nicotine replacement therapy, smoking cessation, transdermal nicotine
493725|NCT01047501|hypertriglyceridemia|hypertriglyceridemia
493726|NCT01047501|omega-3 fatty acids|omega-3 fatty acids
493727|NCT01047501|statin|statin
493728|NCT01047501|triglycerides|triglycerides
493729|NCT01047501|lipids|lipids
493730|NCT01047501|EPA|epa
493731|NCT01047501|docosahexaenoic acid|docosahexaenoic acid
493732|NCT01047501|fish|fish
493733|NCT01047501|fatty acids|fatty acids
493734|NCT01047501|fibrates|fibrates
493735|NCT01047501|niacin|niacin
493736|NCT01047501|lipid|lipid
493737|NCT01047501|atorvastatin|atorvastatin
493738|NCT01047501|Lovaza|lovaza
493739|NCT01047501|simvastatin|simvastatin
493740|NCT01047501|lovastatin|lovastatin
493741|NCT01047501|pravastatin|pravastatin
493742|NCT01047501|fluvastatin|fluvastatin
493743|NCT01047501|rosuvastatin|rosuvastatin
493744|NCT01047501|Trilipix|trilipix
493745|NCT01047501|Vytorin|vytorin
493746|NCT01047501|Simcor|simcor
493747|NCT01047501|Niaspan|niaspan
493748|NCT01047501|ezetimibe|ezetimibe
493749|NCT01047501|Zetia|zetia
493750|NCT01047501|ethyl-EPA|ethyl-epa
493751|NCT01047501|ethyl icosapentate|ethyl icosapentate
493752|NCT01047501|Crestor|crestor
493753|NCT01047501|Zocor|zocor
493754|NCT01047501|Lipitor|lipitor
493755|NCT01047501|LDL|ldl
493756|NCT01047501|HDL|hdl
493757|NCT01047501|cholesterol|cholesterol
493758|NCT01047501|dyslipidemia|dyslipidemia
493759|NCT01047501|VASCEPA|vascepa
493760|NCT01047501|icosapent ethyl|icosapent ethyl
493761|NCT01047488|polyneuropathy|polyneuropathy
493762|NCT01047488|neuropathic pain|neuropathic pain
493763|NCT01047488|treatment|treatment
493764|NCT01047475|MB-6|mb-6
493765|NCT01047475|FOLFOX4|folfox4
493766|NCT01047475|Metastatic Colorectal Cancer|metastatic colorectal cancer
493767|NCT01047449|saphenous vein graft patency|saphenous vein graft patency
493768|NCT01047449|fish oil supplementation|fish oil supplementation
493769|NCT01047449|coronary artery bypass surgery|coronary artery bypass surgery
493770|NCT01047449|coronary artery disease|coronary artery disease
493771|NCT01047436|Plasmodium infections|plasmodium infections
493772|NCT01047436|Remittent fever|remittent fever
493773|NCT01047436|Artemether|artemether
493774|NCT01047436|Artemisinins|artemisinins
493775|NCT01047436|quinine|quinine
493776|NCT01047436|Malaria|malaria
493777|NCT01047436|Protozoan Infections|protozoan infections
493778|NCT01047436|Anti-Infective Agents|anti-infective agents
493779|NCT01047436|Antiprotozoal Agents|antiprotozoal agents
493780|NCT01047436|Schistosomicides|schistosomicides
493781|NCT01047436|Pharmacologic Actions|pharmacologic actions
493782|NCT01047436|Malaria, Falciparum|malaria, falciparum
493783|NCT01047436|Antimalarials|antimalarials
493784|NCT01047436|Antiparasitic Agents|antiparasitic agents
493785|NCT01047436|Parasitic Diseases|parasitic diseases
493786|NCT01047436|sublingual|sublingual
493787|NCT01047423|Hypertension endothelial dysfunction statin prevention|hypertension endothelial dysfunction statin prevention
493788|NCT01047410|physical exercise training|physical exercise training
493789|NCT01047410|quality of life|quality of life
493790|NCT01047410|exercise capacity|exercise capacity
493791|NCT01047410|skeletal muscle strength|skeletal muscle strength
493792|NCT01047410|physical activity level|physical activity level
493793|NCT01047410|costeffectiveness|costeffectiveness
493794|NCT01047410|renal transplantation|renal transplantation
493795|NCT01047410|hemodialysis|hemodialysis
493796|NCT01047410|peritoneal dialysis|peritoneal dialysis
493797|NCT01047410|diet|diet
493798|NCT01047397|hemodialysis|hemodialysis
493799|NCT01047397|tolerability|tolerability
493800|NCT01047397|pharmacokinetics|pharmacokinetics
493801|NCT01047397|safety|safety
493802|NCT01047397|anemia|anemia
493803|NCT01047397|renal impairment|renal impairment
493804|NCT01047397|repeat dose|repeat dose
493805|NCT01047345|Cervical cancer|cervical cancer
493806|NCT01047345|Genital warts|genital warts
493807|NCT01047345|Human papillomavirus vaccine|human papillomavirus vaccine
493808|NCT01047345|GARDASIL™|gardasil™
493809|NCT01047319|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
493810|NCT01047293|colorectal cancer|colorectal cancer
493811|NCT01047280|Conjugated linoleic acid|conjugated linoleic acid
493812|NCT01047280|Body weight|body weight
493813|NCT01047280|Body composition|body composition
493814|NCT01047280|Blood lipid profile|blood lipid profile
493815|NCT01047280|Body inflammatory and oxidative status|body inflammatory and oxidative status
493816|NCT01047267|candidiasis|candidiasis
493817|NCT01047267|invasive fungal disease|invasive fungal disease
493818|NCT01047267|critically ill|critically ill
493819|NCT01047267|anidulafungin|anidulafungin
493820|NCT01047267|pharmacokinetics|pharmacokinetics
493821|NCT01047241|Painful medical procedures|painful medical procedures
493822|NCT01047215|schizophrenia|schizophrenia
493823|NCT01047215|bipolar|bipolar
493824|NCT01047215|aripiprazole|aripiprazole
493825|NCT01047215|quetiapine|quetiapine
493826|NCT01047189|Mild to moderate acne vulgaris|mild to moderate acne vulgaris
493828|NCT01047176|Coronary Heart Disease|coronary heart disease
493829|NCT01047176|Percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
493830|NCT01047163|Muscle soreness|muscle soreness
493831|NCT01047163|Simvastatin|simvastatin
493832|NCT01047163|Men|men
493833|NCT01047163|Muscle Atrophy|muscle atrophy
493834|NCT01047150|Myocardial Perfusion Imaging|myocardial perfusion imaging
493835|NCT01047150|Repeat studies|repeat studies
493836|NCT01047150|Tetrofosmin|tetrofosmin
493837|NCT01047150|Sestamibi|sestamibi
493838|NCT01047137|Urticaria|urticaria
493839|NCT01047137|Hives|hives
493840|NCT01047137|Stress|stress
493841|NCT01047137|Immune dysregulation|immune dysregulation
493842|NCT01047124|Depression|depression
493843|NCT01047124|Collaborative Care|collaborative care
493844|NCT01047124|Cognitive Behaviour Therapy|cognitive behaviour therapy
493845|NCT01047124|Mental Health Services|mental health services
493846|NCT01047124|Antidepressants|antidepressants
493847|NCT01047111|Esophageal Neoplasms|esophageal neoplasms
493848|NCT01047111|Esophagectomy|esophagectomy
493849|NCT01047098|Lactation|lactation
493850|NCT01047098|Breastfeeding|breastfeeding
493851|NCT01047098|Iron|iron
493852|NCT01047098|Oxidative stress|oxidative stress
493853|NCT01047098|Iron status and oxidative stress during lactation|iron status and oxidative stress during lactation
493854|NCT01047085|cholecystolithiasis|cholecystolithiasis
493855|NCT01047085|cholecystectomy|cholecystectomy
493856|NCT01047085|gastroesophageal reflux|gastroesophageal reflux
493857|NCT01047085|impedance pH|impedance ph
493858|NCT01047085|The relationship between cholecystolithiasis, cholecystectomy and gastroesophageal reflux by impedance pH-method.|the relationship between cholecystolithiasis, cholecystectomy and gastroesophageal reflux by impedance ph-method.
493859|NCT01047072|Scleroderma, systemic sclerosis, allogeneic hematopoietic stem cell transplantation|scleroderma, systemic sclerosis, allogeneic hematopoietic stem cell transplantation
493860|NCT01047059|NSCLC|nsclc
493861|NCT01047059|Lung Cancer|lung cancer
493862|NCT01047046|SNM device|snm device
493863|NCT01047046|Chart review of patients with surgical placed SNM device|chart review of patients with surgical placed snm device
493864|NCT01047033|Poverty|poverty
493865|NCT01047033|Global health|global health
493866|NCT01047033|International health|international health
493867|NCT01047033|Latin America|latin america
493868|NCT01047033|Peru|peru
493869|NCT01047033|Child health|child health
493870|NCT01047033|Microcredit|microcredit
493871|NCT01047033|Microenterprise|microenterprise
493872|NCT01047033|Microfinance|microfinance
493873|NCT01047020|Impairments of musculoskeletal Health;|impairments of musculoskeletal health;
493874|NCT01047020|Physical activity;|physical activity;
493875|NCT01047020|Motor Proficiency;|motor proficiency;
493876|NCT01047007|Head and Neck Cancer|head and neck cancer
493877|NCT01047007|Esophageal Cancer|esophageal cancer
493878|NCT01047007|Gastric Cancer|gastric cancer
493879|NCT01046981|Surgical site infections|surgical site infections
493880|NCT01046981|Prevention|prevention
493881|NCT01046981|Prophylaxis|prophylaxis
493882|NCT01046981|Tumescent|tumescent
493883|NCT01046981|Intravenous|intravenous
493884|NCT01046981|Antibiotic|antibiotic
493885|NCT01046981|Absorption|absorption
493886|NCT01046981|Pharmacokinetics|pharmacokinetics
493887|NCT01046981|Bioavailability|bioavailability
493888|NCT01046968|Obesity|obesity
493889|NCT01046968|metabolic syndrome|metabolic syndrome
493890|NCT01046968|C-reactive protein|c-reactive protein
493891|NCT01046968|Leptin|leptin
493892|NCT01046955|ESRD|esrd
493893|NCT01046942|Saphenous vein|saphenous vein
493894|NCT01046942|Antiplatelet therapy|antiplatelet therapy
493895|NCT01046942|Hypercoagulable|hypercoagulable
493896|NCT01046942|Clopidogrel resistance|clopidogrel resistance
493897|NCT01046942|Aspirin resistance|aspirin resistance
493898|NCT01046942|Clopidogrel|clopidogrel
493899|NCT01046942|Aspirin|aspirin
493900|NCT01046942|Saphenous vein graft disease|saphenous vein graft disease
493901|NCT01046942|TEG|teg
493902|NCT01046942|Thrombelastography|thrombelastography
493903|NCT01046942|Multiplate aggregometry|multiplate aggregometry
493904|NCT01046942|Multislice CT|multislice ct
493905|NCT01046942|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
493906|NCT01046942|coagulation status|coagulation status
493907|NCT01046942|graft patency|graft patency
493908|NCT01046942|CABG|cabg
493909|NCT01046929|limonene|limonene
493910|NCT01046929|breast cancer|breast cancer
493911|NCT01046929|cancer prevention|cancer prevention
493912|NCT01046903|observational prolonged thromboprophylaxis|observational prolonged thromboprophylaxis
493913|NCT01046890|Darunavir|darunavir
493914|NCT01046890|Echinacea purpurea|echinacea purpurea
493915|NCT01046890|Interaction|interaction
493916|NCT01046890|Complementary Therapies|complementary therapies
493917|NCT01046864|Gastro-Intestinal Cancer, NOS|gastro-intestinal cancer, nos
493918|NCT01046838|Diastolic Heart Failure|diastolic heart failure
493919|NCT01046825|Lymphoma|lymphoma
493920|NCT01046825|Leukemia|leukemia
493921|NCT01046825|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
493922|NCT01046812|questionnaire|questionnaire
493923|NCT01046812|halitosis|halitosis
493924|NCT01046812|caphosol|caphosol
493925|NCT01046812|Quality of life questionnaire assessing halitosis|quality of life questionnaire assessing halitosis
493926|NCT01046799|hepatitis B|hepatitis b
493927|NCT01046799|liver transplantation|liver transplantation
493928|NCT01046799|shortterm HBIg|shortterm hbig
493929|NCT01046799|lamivudine resistance|lamivudine resistance
493930|NCT01046786|spinal cord injury|spinal cord injury
493931|NCT01046786|cord blood mononuclear cell|cord blood mononuclear cell
493932|NCT01046786|Methylprednisolone|methylprednisolone
493933|NCT01046786|Lithium Carbonate|lithium carbonate
493934|NCT01046773|Children|children
493935|NCT01046773|Crohn's disease|crohn's disease
493936|NCT01046773|Vitamin D|vitamin d
493937|NCT01046760|epilepsy|epilepsy
493938|NCT01046760|language|language
493939|NCT01046760|childhood|childhood
493940|NCT01046760|praxis|praxis
493941|NCT01046747|external fixation|external fixation
493942|NCT01046747|pin tract infection|pin tract infection
493943|NCT01046747|self drilling|self drilling
493944|NCT01046734|Influenza|influenza
493945|NCT01046734|virus shedding|virus shedding
493946|NCT01046734|infection control|infection control
493947|NCT01046734|swine flu|swine flu
493948|NCT01046721|blood pressure|blood pressure
493949|NCT01046721|superior mesenteric artery blood flow|superior mesenteric artery blood flow
493950|NCT01046721|cardiovascular effects|cardiovascular effects
493951|NCT01046721|Exenatide|exenatide
493952|NCT01046708|IUI|iui
493953|NCT01046708|clomiphene citrate|clomiphene citrate
493954|NCT01046708|utrogestan|utrogestan
493955|NCT01046695|VATS|vats
493956|NCT01046695|Video-Assisted Thoracotomy|video-assisted thoracotomy
493957|NCT01046695|Thoracic Surgery, Video-Assisted|thoracic surgery, video-assisted
493958|NCT01046682|HIV|hiv
493959|NCT01046682|Endothelial dysfunction|endothelial dysfunction
493960|NCT01046682|Inflammation|inflammation
493961|NCT01046682|Insulin resistance|insulin resistance
493962|NCT01046656|nosocomial infection|nosocomial infection
493963|NCT01046656|diarrhea|diarrhea
493964|NCT01046656|Lactobacillus reuteri|lactobacillus reuteri
493965|NCT01046656|gastroenteritis|gastroenteritis
493966|NCT01046656|rotavirus|rotavirus
493967|NCT01046643|Women|women
493968|NCT01046643|Healthy|healthy
493969|NCT01046643|Menopausal|menopausal
493970|NCT01046643|Hormone treatment|hormone treatment
493971|NCT01046630|Phase I|phase i
493972|NCT01046630|BOLD signal|bold signal
493973|NCT01046630|fMRI|fmri
493974|NCT01046630|AZD6765|azd6765
493975|NCT01046630|BOLD signal measured by fMRI|bold signal measured by fmri
493976|NCT01046617|infantile colic|infantile colic
493977|NCT01046617|Lactobacillus reuteri|lactobacillus reuteri
493978|NCT01046617|duration of crying|duration of crying
493979|NCT01046604|mitral valve regurgitation|mitral valve regurgitation
493980|NCT01046604|omega 3 fatty acids|omega 3 fatty acids
493981|NCT01046604|fish oil|fish oil
493982|NCT01046604|cardiac|cardiac
493983|NCT01046604|mitochondria|mitochondria
493984|NCT01046604|apoptosis|apoptosis
493985|NCT01046604|human heart|human heart
493986|NCT01046591|Cleft Palate|cleft palate
493987|NCT01046591|Cleft Lip|cleft lip
493988|NCT01046591|Obstructive Sleep Apnea|obstructive sleep apnea
493989|NCT01046591|Sleep-Disordered Breathing|sleep-disordered breathing
493990|NCT01046591|Behavior|behavior
493991|NCT01046591|Learning|learning
493992|NCT01046578|Folliculogenesis|folliculogenesis
493993|NCT01046578|Letrozole|letrozole
493994|NCT01046578|Aromatase Inhibitor|aromatase inhibitor
493995|NCT01046578|Estrogen|estrogen
493996|NCT01046552|Choledocholithias|choledocholithias
493997|NCT01046552|Common bile duct stones|common bile duct stones
493998|NCT01046552|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
493999|NCT01046552|endoscopic sphincterotomy|endoscopic sphincterotomy
494000|NCT01046552|Preoperative|preoperative
494001|NCT01046552|intraoperative|intraoperative
494002|NCT01046552|Laparoscopic common bile duct exploration|laparoscopic common bile duct exploration
494003|NCT01046526|Psychopathology|psychopathology
494004|NCT01046526|Nicotine Patch|nicotine patch
494005|NCT01046526|Eye Tracking|eye tracking
494006|NCT01046526|Attention|attention
494007|NCT01046526|Schizophrenic Participants|schizophrenic participants
494008|NCT01046513|Nicotinic Acetylcholine Receptors|nicotinic acetylcholine receptors
494009|NCT01046513|Neuroimaging|neuroimaging
494010|NCT01046513|Positron Emission Tomography (PET)|positron emission tomography (pet)
494011|NCT01046513|Alpha4beta2|alpha4beta2
494012|NCT01046513|Nicotine|nicotine
494013|NCT01046513|Receptor Upregulation|receptor upregulation
494014|NCT01046500|insulin resistance|insulin resistance
494015|NCT01046500|body mass index|body mass index
494016|NCT01046500|myo-inositol|myo-inositol
494017|NCT01046500|serum triglycerides and cholesterol|serum triglycerides and cholesterol
494018|NCT01046500|blood pressure|blood pressure
494019|NCT01046500|metformin|metformin
494020|NCT01046487|dermatofibrosarcoma|dermatofibrosarcoma
494021|NCT01046487|cylindroma|cylindroma
494022|NCT01046487|choroid melanoma|choroid melanoma
494023|NCT01046487|gastrointestinal stroma tumor|gastrointestinal stroma tumor
494024|NCT01046487|chordoma|chordoma
494025|NCT01046487|ocular melanoma|ocular melanoma
494026|NCT01046487|conjunctival melanoma|conjunctival melanoma
494027|NCT01046487|malignant melanoma of the anus|malignant melanoma of the anus
494028|NCT01046487|gastric melanoma|gastric melanoma
494029|NCT01046487|desmoid tumor|desmoid tumor
494030|NCT01046474|school children|school children
494031|NCT01046474|body mass index|body mass index
494032|NCT01046474|sugar intake|sugar intake
494033|NCT01046474|beverage intake|beverage intake
494034|NCT01046461|Ramosetron|ramosetron
494035|NCT01046461|aprepitant|aprepitant
494036|NCT01046461|dexamethasone|dexamethasone
494037|NCT01046461|cancer|cancer
494038|NCT01046461|chemotherapy|chemotherapy
494039|NCT01046461|antiemetics|antiemetics
494040|NCT01046461|cisplatin|cisplatin
494041|NCT01046461|nausea|nausea
494042|NCT01046461|vomiting|vomiting
494043|NCT01046461|high dose cisplatin|high dose cisplatin
494044|NCT01046448|Children|children
494045|NCT01046448|chronic renal failure|chronic renal failure
494046|NCT01046448|chronic kidney disease|chronic kidney disease
494047|NCT01046448|cardiovascular disease|cardiovascular disease
494048|NCT01046448|cardiovascular morbidity|cardiovascular morbidity
494049|NCT01046448|left ventricular hypertrophy|left ventricular hypertrophy
494050|NCT01046448|carotid intima media thickness|carotid intima media thickness
494051|NCT01046448|arterial stiffness|arterial stiffness
494052|NCT01046448|pulse wave velocity|pulse wave velocity
494053|NCT01046448|augmentation index|augmentation index
494054|NCT01046448|left ventricular cardiac function|left ventricular cardiac function
494055|NCT01046448|progression|progression
494056|NCT01046448|genetic risk factors|genetic risk factors
494057|NCT01046448|vasculopathy|vasculopathy
494058|NCT01046448|cardiopathy|cardiopathy
494059|NCT01046448|whole genome analysis|whole genome analysis
494060|NCT01046448|haplotype analysis|haplotype analysis
494061|NCT01046448|SNP-screening|snp-screening
494062|NCT01046435|periodontitis|periodontitis
494063|NCT01046435|cardiovascular disease|cardiovascular disease
494064|NCT01046435|diabetes|diabetes
494065|NCT01046409|Coronary artery disease|coronary artery disease
494066|NCT01046409|Bifurcation|bifurcation
494067|NCT01046409|Myocardial infarction|myocardial infarction
494068|NCT01046409|Myocardial ischemia|myocardial ischemia
494069|NCT01046409|Collateral|collateral
494070|NCT01046383|NON-SMALL CELL LUNG CANCER PATIENTS|non-small cell lung cancer patients
494071|NCT01046383|WEIGHT LOSS|weight loss
494072|NCT01046383|QUALITY OF LIFE|quality of life
494073|NCT01046383|SURVIVAL|survival
494074|NCT01046383|CHEMOTHERAPY|chemotherapy
494075|NCT01046383|RADIOTHERAPY|radiotherapy
494076|NCT01046383|SURGERY|surgery
494077|NCT01046383|CYSTEINE-RICH WHEY PROTEIN ISOLATE|cysteine-rich whey protein isolate
494078|NCT01046383|IMN1207|imn1207
494079|NCT01046383|CANCER-RELATED WASTING (CACHEXIA)|cancer-related wasting (cachexia)
494080|NCT01046383|BODY WEIGHT|body weight
494081|NCT01046383|NUTRITIONAL PROTEIN SUPPLEMENT|nutritional protein supplement
494082|NCT01046357|First in human|first in human
494083|NCT01046357|Safety|safety
494084|NCT01046305|Chronic Myeloid Leukemia|chronic myeloid leukemia
494085|NCT01046305|CML|cml
494086|NCT01046305|Symptom Burden|symptom burden
494087|NCT01046305|M. D. Anderson Symptom Inventory|m. d. anderson symptom inventory
494088|NCT01046305|MDASI-CML|mdasi-cml
494089|NCT01046305|Severity|severity
494090|NCT01046305|Interference|interference
494091|NCT01046305|Questionnaire|questionnaire
494092|NCT01046305|Interview|interview
494093|NCT01046292|Gait, Ginkgo biloba, mild cognitive impairment|gait, ginkgo biloba, mild cognitive impairment
494094|NCT01046253|Bioequivalence|bioequivalence
494095|NCT01046253|Healthy Subjects|healthy subjects
494096|NCT01046240|chemotherapy|chemotherapy
494097|NCT01046240|emesis|emesis
494098|NCT01046240|palonosetron|palonosetron
494099|NCT01046227|Serology|serology
494100|NCT01046227|Monovalent inactivated H1N1 vaccine|monovalent inactivated h1n1 vaccine
494101|NCT01046227|Pediatric haemato-oncology patients|pediatric haemato-oncology patients
494102|NCT01046188|Education|education
494103|NCT01046188|Internet|internet
494104|NCT01046188|In vitro fertilization|in vitro fertilization
494105|NCT01046175|Respiratory complications|respiratory complications
494106|NCT01046175|respiratory insufficiency|respiratory insufficiency
494107|NCT01046175|respiratory therapy|respiratory therapy
494108|NCT01046162|Alprazolam|alprazolam
494109|NCT01046162|Tafil|tafil
494110|NCT01046162|Xanax|xanax
494111|NCT01046162|Bioequivalence|bioequivalence
494112|NCT01046162|Drug Kinetics|drug kinetics
494113|NCT01046149|Depression|depression
494114|NCT01046149|Depressive Symptoms|depressive symptoms
494115|NCT01046149|postmenopause|postmenopause
494116|NCT01046149|RSA biofeedback|rsa biofeedback
494117|NCT01046136|common cold|common cold
494118|NCT01046097|Pneumococcal vaccine|pneumococcal vaccine
494119|NCT01046084|Bioequivalence|bioequivalence
494120|NCT01046084|Healthy Subjects|healthy subjects
494121|NCT01046071|Transversus abdominis plane block, postoperative pain.|transversus abdominis plane block, postoperative pain.
494122|NCT01046058|TMC435-TiDP16-C113|tmc435-tidp16-c113
494123|NCT01046058|TMC435-C113|tmc435-c113
494124|NCT01046058|TMC435|tmc435
494125|NCT01046058|HCV|hcv
494126|NCT01046058|Protease Inhibitor|protease inhibitor
494127|NCT01046058|Hepatitis C|hepatitis c
494128|NCT01046045|mammalian target-of-rapamycin inhibitors|mammalian target-of-rapamycin inhibitors
494129|NCT01046045|chronic allograft dysfunction|chronic allograft dysfunction
494130|NCT01046045|everolimus|everolimus
494131|NCT01046045|calcineurin inhibitors|calcineurin inhibitors
494132|NCT01046032|Polycystic ovaries|polycystic ovaries
494133|NCT01046032|Ovarian stimulation|ovarian stimulation
494134|NCT01046032|IVF|ivf
494135|NCT01046032|Ovarian hyperstimulation|ovarian hyperstimulation
494136|NCT01046032|Metformin|metformin
494137|NCT01046019|DXA|dxa
494138|NCT01046019|Hip|hip
494139|NCT01046019|Arthroplasty|arthroplasty
494140|NCT01046006|lymphoma|lymphoma
494141|NCT01046006|Bortezomib|bortezomib
494142|NCT01046006|Rituximab|rituximab
494143|NCT01045993|Pilot Study to Assess Methodologies|pilot study to assess methodologies
494144|NCT01045980|Peritoneal dialysis|peritoneal dialysis
494145|NCT01045980|Impedance, bioelectric|impedance, bioelectric
494146|NCT01045980|Hypertrophy, left ventricular|hypertrophy, left ventricular
494147|NCT01045980|Fluid status|fluid status
494148|NCT01045980|Volume overload|volume overload
494149|NCT01045980|Congestive heart failure|congestive heart failure
494150|NCT01045980|Cardiovascular outcomes|cardiovascular outcomes
494151|NCT01045980|Randomized controlled trial|randomized controlled trial
494152|NCT01045967|Bioequivalence|bioequivalence
494153|NCT01045967|Healthy Subjects|healthy subjects
494154|NCT01045954|diabetes mellitus type 1|diabetes mellitus type 1
494155|NCT01045954|continuous glucose monitoring|continuous glucose monitoring
494156|NCT01045941|Distal Pancreas|distal pancreas
494157|NCT01045941|Adenocarcinoma|adenocarcinoma
494158|NCT01045941|Laparoscopic|laparoscopic
494159|NCT01045941|Gemcitabine|gemcitabine
494160|NCT01045915|Stage IIIB, stage IIIC or stage IV melanoma|stage iiib, stage iiic or stage iv melanoma
494161|NCT01045915|Progressive melanoma not responding to previous treatments|progressive melanoma not responding to previous treatments
494162|NCT01045902|Pulmonary Abscess|pulmonary abscess
494163|NCT01045902|Aspiration Pneumonia|aspiration pneumonia
494164|NCT01045889|HIV|hiv
494165|NCT01045889|non hodgkin lymphoma|non hodgkin lymphoma
494166|NCT01045889|peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
494167|NCT01045876|Randomized controlled trial|randomized controlled trial
494168|NCT01045876|Dexamethasone|dexamethasone
494169|NCT01045876|Single dose|single dose
494170|NCT01045876|Preoperative|preoperative
494171|NCT01045876|Plasma Cortisol level|plasma cortisol level
494172|NCT01045863|volunteer|volunteer
494173|NCT01045850|coronary stents|coronary stents
494174|NCT01045850|non cardiac surgery|non cardiac surgery
494175|NCT01045850|cardiovascular complications|cardiovascular complications
494176|NCT01045850|hemorrhagic complications|hemorrhagic complications
494177|NCT01045850|antiplatelet agents|antiplatelet agents
494178|NCT01045850|bare metal stent|bare metal stent
494179|NCT01045850|drug eluting stent|drug eluting stent
494180|NCT01045850|surgery|surgery
494181|NCT01045837|Celiac disease, steroids, immunohistochemistry|celiac disease, steroids, immunohistochemistry
494182|NCT01045824|Schizophrenia|schizophrenia
494183|NCT01045824|DNA|dna
494184|NCT01045824|MRI|mri
494185|NCT01045811|Depression|depression
494186|NCT01045811|Depressive Symptoms|depressive symptoms
494187|NCT01045811|postmenopause|postmenopause
494188|NCT01045811|RSA biofeedback|rsa biofeedback
494189|NCT01045798|Candidiasis|candidiasis
494190|NCT01045798|Invasive Candidiasis|invasive candidiasis
494191|NCT01045798|Fungal Infection|fungal infection
494192|NCT01045798|Empirical Therapy|empirical therapy
494193|NCT01045785|aspirin resistance, platelet function assay, dialysis, end stage renal disease|aspirin resistance, platelet function assay, dialysis, end stage renal disease
494194|NCT01045772|Schnitler syndrome, Muckle-Wells syndrome, anti-IL-1|schnitler syndrome, muckle-wells syndrome, anti-il-1
494195|NCT01045759|VENOUS THROMBOSIS|venous thrombosis
494196|NCT01045759|ultrasonography|ultrasonography
494197|NCT01045759|intensive care unit|intensive care unit
494198|NCT01045746|whole-body vibration|whole-body vibration
494199|NCT01045746|stochastic resonance Therapy|stochastic resonance therapy
494200|NCT01045746|static balance|static balance
494201|NCT01045746|balance, mobility|balance, mobility
494202|NCT01045746|elderly, reaction time|elderly, reaction time
494203|NCT01045746|The focus of the study is effect of SRT on postural balance|the focus of the study is effect of srt on postural balance
494204|NCT01045733|Cataract|cataract
494205|NCT01045733|Toric|toric
494206|NCT01045733|IOL|iol
494207|NCT01045733|AcrySof|acrysof
494208|NCT01045733|LRI|lri
494209|NCT01045733|Astigmatism|astigmatism
494210|NCT01045720|Schizophrenia|schizophrenia
494211|NCT01045720|clozapine|clozapine
494212|NCT01045720|hypersalivation|hypersalivation
494213|NCT01045720|Suo Quan Wan|suo quan wan
494214|NCT01045720|Wu Lin San|wu lin san
494215|NCT01045694|Carpometacarpal Joints|carpometacarpal joints
494216|NCT01045694|Osteoarthritis|osteoarthritis
494217|NCT01045694|Basal thumb joint arthritis|basal thumb joint arthritis
494218|NCT01045694|Trapeziometacarpal arthritis|trapeziometacarpal arthritis
494219|NCT01045681|Multiple Myeloma|multiple myeloma
494220|NCT01045681|Elderly patients|elderly patients
494221|NCT01045681|first relapse|first relapse
494222|NCT01045681|refractory to first line therapy|refractory to first line therapy
494223|NCT01045681|Bendamustine Velcade Dexamethasone Association|bendamustine velcade dexamethasone association
494224|NCT01045655|Depression|depression
494225|NCT01045655|Perinatal care|perinatal care
494226|NCT01045655|Postpartum period|postpartum period
494227|NCT01045655|Pregnancy|pregnancy
494228|NCT01045655|Female|female
494229|NCT01045655|Low-income population|low-income population
494230|NCT01045642|Bioequivalence|bioequivalence
494231|NCT01045642|Omeprazole|omeprazole
494232|NCT01045642|Crossover|crossover
494233|NCT01045629|schizophrenia|schizophrenia
494234|NCT01045629|PANSS|panss
494235|NCT01045603|Instanyl|instanyl
494236|NCT01045603|non-interventional|non-interventional
494237|NCT01045603|breakthrough cancer pain|breakthrough cancer pain
494238|NCT01045603|BTP|btp
494239|NCT01045603|BTCP|btcp
494240|NCT01045603|Intranasal fentanyl spray|intranasal fentanyl spray
494241|NCT01045577|Severe Psoriasis|severe psoriasis
494242|NCT01045577|Kinase Inhibitor|kinase inhibitor
494243|NCT01045577|Masitinib|masitinib
494244|NCT01045564|Immunogenicity|immunogenicity
494245|NCT01045564|Vaccines|vaccines
494246|NCT01045564|H5N1|h5n1
494247|NCT01045564|Influenza|influenza
494248|NCT01045564|Pandemic|pandemic
494249|NCT01045564|Human|human
494250|NCT01045564|Avian|avian
494251|NCT01045564|Safety|safety
494252|NCT01045551|Inflammatory rosacea|inflammatory rosacea
494253|NCT01045551|Papules and pustules|papules and pustules
494254|NCT01045551|Moderate to severe erythema|moderate to severe erythema
494255|NCT01045551|Telangiectasia|telangiectasia
494256|NCT01045538|gastric cancer|gastric cancer
494257|NCT01045538|histone deacetylase inhibitor|histone deacetylase inhibitor
494258|NCT01045538|1st line chemotherapy|1st line chemotherapy
494259|NCT01045525|Phlebotomy|phlebotomy
494260|NCT01045525|Dysmetabolic liversiderosis|dysmetabolic liversiderosis
494261|NCT01045525|Hepatic Iron overload|hepatic iron overload
494262|NCT01045512|immunosenescence|immunosenescence
494263|NCT01045512|heart rate variability|heart rate variability
494264|NCT01045512|autonomic nervous system|autonomic nervous system
494265|NCT01045512|ageing|ageing
494266|NCT01045512|inflammatory/pathogen burden|inflammatory/pathogen burden
494267|NCT01045512|physical activity|physical activity
494268|NCT01045499|adolescent obesity surgery|adolescent obesity surgery
494269|NCT01045499|bariatric surgery|bariatric surgery
494270|NCT01045499|adjustable gastric banding|adjustable gastric banding
494271|NCT01045486|Atopic dermatitis|atopic dermatitis
494272|NCT01045486|Food allergy|food allergy
494273|NCT01045486|Probiotics|probiotics
494274|NCT01045473|MIS|mis
494275|NCT01045473|Minimally Invasive Spine Surgery|minimally invasive spine surgery
494276|NCT01045473|Fusion|fusion
494277|NCT01045473|Spine|spine
494278|NCT01045473|SMISS|smiss
494279|NCT01045460|Patients with active myeloma (Stage II/III) that have completed induction therapy and are eligible for an autologous stem cell transplant|patients with active myeloma (stage ii/iii) that have completed induction therapy and are eligible for an autologous stem cell transplant
494280|NCT01045434|Bioequivalence|bioequivalence
494281|NCT01045434|omeprazole|omeprazole
494282|NCT01045434|crossover|crossover
494283|NCT01045421|NSCLC|nsclc
494284|NCT01045421|SCLC|sclc
494285|NCT01045421|HNSCC|hnscc
494286|NCT01045408|Helicobacter pylori|helicobacter pylori
494287|NCT01045408|Berry extract|berry extract
494288|NCT01045408|Triple therapy|triple therapy
494289|NCT01045395|Algae|algae
494290|NCT01045395|Psoriasis|psoriasis
494291|NCT01045395|Lipid metabolism|lipid metabolism
494292|NCT01045395|Inflammation|inflammation
494293|NCT01045395|Oxidative stress|oxidative stress
494294|NCT01045382|HSC transplantation|hsc transplantation
494295|NCT01045382|HLA-mismatched|hla-mismatched
494296|NCT01045382|Mesenchymal stem cells|mesenchymal stem cells
494297|NCT01045382|GVHD|gvhd
494298|NCT01045382|co-infusion|co-infusion
494300|NCT01045369|Treatment Naive|treatment naive
494301|NCT01045343|heart failure|heart failure
494302|NCT01045343|home monitoring|home monitoring
494303|NCT01045343|integrated diagnostics|integrated diagnostics
494304|NCT01045343|Cardiac Resynchronization Therapy with Defibrillator (CRT D)|cardiac resynchronization therapy with defibrillator (crt d)
494305|NCT01045317|micro-dose|micro-dose
494306|NCT01045317|pharmacokinetics|pharmacokinetics
494307|NCT01045317|open label|open label
494308|NCT01045317|PF-04776548|pf-04776548
494309|NCT01045278|Hepatitis C patients|hepatitis c patients
494310|NCT01045278|Hepacivirus|hepacivirus
494311|NCT01045252|hemodynamics|hemodynamics
494312|NCT01045252|neonatal|neonatal
494313|NCT01045239|Diabetic macular edema|diabetic macular edema
494314|NCT01045239|Diabetic macular oedema|diabetic macular oedema
494315|NCT01045239|micropulse laser|micropulse laser
494316|NCT01045239|laser treatment|laser treatment
494317|NCT01045239|macular thickness|macular thickness
494318|NCT01045213|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
494319|NCT01045213|COPD|copd
494320|NCT01045200|rectal cancer|rectal cancer
494321|NCT01045200|follow-up|follow-up
494322|NCT01045200|specialist nurse|specialist nurse
494323|NCT01045187|endometrial cancer|endometrial cancer
494324|NCT01045187|Uterine cancer|uterine cancer
494325|NCT01045187|electronic brachytherapy|electronic brachytherapy
494326|NCT01045187|Xoft|xoft
494327|NCT01045174|Asthma|asthma
494328|NCT01045174|Pediatric|pediatric
494329|NCT01045174|Emergency department|emergency department
494330|NCT01045174|Nebulizer|nebulizer
494331|NCT01045161|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
494332|NCT01045161|COPD|copd
494333|NCT01045161|Chronic Bronchitis|chronic bronchitis
494334|NCT01045161|Emphysema|emphysema
494335|NCT01045161|Airflow Obstruction, Chronic|airflow obstruction, chronic
494336|NCT01045161|Chronic Airflow Obstruction|chronic airflow obstruction
494337|NCT01045161|Chronic Obstructive Airway Disease|chronic obstructive airway disease
494338|NCT01045161|Chronic Obstructive Lung Disease|chronic obstructive lung disease
494339|NCT01045148|Prostatic Cancer|prostatic cancer
494340|NCT01045148|Prostatic Neoplasms|prostatic neoplasms
494341|NCT01045148|Prostate Neoplasms|prostate neoplasms
494342|NCT01045148|Cancer of the Prostate|cancer of the prostate
494343|NCT01045135|Pelvic organ prolapse|pelvic organ prolapse
494344|NCT01045135|Levator hiatus|levator hiatus
494345|NCT01045135|3 and 4 dimensional ultrasound|3 and 4 dimensional ultrasound
494346|NCT01045122|Obstructive Sleep Apnea|obstructive sleep apnea
494347|NCT01045109|prostate|prostate
494348|NCT01045109|cancer|cancer
494349|NCT01045109|vitamin D3|vitamin d3
494350|NCT01045109|early stage|early stage
494351|NCT01045109|active surveillance|active surveillance
494352|NCT01045096|Gastroesophageal Reflux|gastroesophageal reflux
494353|NCT01045096|Erosive Esophagitis|erosive esophagitis
494354|NCT01045096|Pharmacokinetics|pharmacokinetics
494355|NCT01045096|Pediatrics|pediatrics
494356|NCT01045096|Drug Therapy|drug therapy
494357|NCT01045070|periodontitis and coronary heart disease|periodontitis and coronary heart disease
494358|NCT01045057|voice prosthesis, larynx cancer, laryngectomy|voice prosthesis, larynx cancer, laryngectomy
494359|NCT01045044|Breast cancer|breast cancer
494360|NCT01045044|Magnetic Resonance Imaging|magnetic resonance imaging
494361|NCT01045044|Anthracycline based systemic chemotherapy|anthracycline based systemic chemotherapy
494362|NCT01045044|Tumor response|tumor response
494363|NCT01045044|Cognitive Impairment|cognitive impairment
494364|NCT01045044|Chemo Brain|chemo brain
494365|NCT01045031|cognitive function, aging, brain-derived neurotrophic factor|cognitive function, aging, brain-derived neurotrophic factor
494366|NCT01045018|colitis|colitis
494367|NCT01045018|ulcerative|ulcerative
494368|NCT01045018|ulcerative colitis|ulcerative colitis
494369|NCT01045005|Type 1 diabetes|type 1 diabetes
494370|NCT01045005|Endothelial dysfunction|endothelial dysfunction
494371|NCT01045005|Doppler Ultrasound Velocity Waveforms|doppler ultrasound velocity waveforms
494372|NCT01044992|Multi systemic atrophy|multi systemic atrophy
494373|NCT01044992|Parkinson Disease|parkinson disease
494374|NCT01044992|PET investigation|pet investigation
494375|NCT01044992|Motor control|motor control
494376|NCT01044992|levodopa|levodopa
494377|NCT01044992|MSA|msa
494378|NCT01044992|Comparison with Parkinson disease and dopaminergic challenge.|comparison with parkinson disease and dopaminergic challenge.
494379|NCT01044979|Colloid osmotic pressure in interstitial fluid|colloid osmotic pressure in interstitial fluid
494380|NCT01044979|Colloid osmotic pressure in plasma|colloid osmotic pressure in plasma
494381|NCT01044979|Protein fractions in interstitial fluid|protein fractions in interstitial fluid
494382|NCT01044966|Glioblastoma|glioblastoma
494383|NCT01044966|Subventricular|subventricular
494384|NCT01044966|gliomagenesis|gliomagenesis
494385|NCT01044966|temozolomide|temozolomide
494386|NCT01044966|depocyt|depocyt
494387|NCT01044953|injury incidence|injury incidence
494388|NCT01044953|male professional soccer|male professional soccer
494389|NCT01044953|Change of injury incidence in professional soccer|change of injury incidence in professional soccer
494390|NCT01044940|Colloid Osmotic pressure in interstitial fluid|colloid osmotic pressure in interstitial fluid
494391|NCT01044940|Colloid Osmotic pressure in plasma|colloid osmotic pressure in plasma
494392|NCT01044940|Protein fractions in interstitial fluid|protein fractions in interstitial fluid
494393|NCT01044927|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
494394|NCT01044927|telemedicine|telemedicine
494395|NCT01044927|COPD|copd
494396|NCT01044901|Sickle Cell Disease|sickle cell disease
494397|NCT01044901|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
494398|NCT01044901|Coronary Disease|coronary disease
494399|NCT01044901|Pulmonary Hypertension|pulmonary hypertension
494400|NCT01044888|Heparin responsiveness|heparin responsiveness
494401|NCT01044888|Off-pump coronary artery bypass graft surgery|off-pump coronary artery bypass graft surgery
494402|NCT01044888|Risk factors|risk factors
494403|NCT01044888|Myocardial infarction|myocardial infarction
494404|NCT01044875|Diabetic retinopathy|diabetic retinopathy
494405|NCT01044875|Laser treatment|laser treatment
494406|NCT01044875|Complications|complications
494407|NCT01044875|Laser wavelength|laser wavelength
494408|NCT01044862|Pregnancy|pregnancy
494409|NCT01044862|Infertility|infertility
494410|NCT01044862|Ovarian stimulation|ovarian stimulation
494411|NCT01044862|Aromatase inhibitors|aromatase inhibitors
494412|NCT01044862|Follicle Stimulating Hormone|follicle stimulating hormone
494413|NCT01044849|Blood Pressure|blood pressure
494414|NCT01044836|Healthy volunteer|healthy volunteer
494415|NCT01044823|RA|ra
494416|NCT01044823|JRA|jra
494417|NCT01044810|HIV|hiv
494418|NCT01044810|efavirenz|efavirenz
494419|NCT01044810|nevirapine|nevirapine
494420|NCT01044810|allergy|allergy
494421|NCT01044810|rash|rash
494422|NCT01044810|Cohort Studies, Historical|cohort studies, historical
494423|NCT01044810|Retrospective Study|retrospective study
494424|NCT01044810|exanthem|exanthem
494425|NCT01044810|Antiretroviral Agents|antiretroviral agents
494426|NCT01044810|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
494427|NCT01044810|HAART|haart
494428|NCT01044810|treatment failure|treatment failure
494429|NCT01044797|Healthy Volunteer|healthy volunteer
494430|NCT01044797|Given Capsule Manipulation|given capsule manipulation
494431|NCT01044784|CRT|crt
494432|NCT01044771|HIV|hiv
494433|NCT01044771|Human immunodeficiency virus|human immunodeficiency virus
494434|NCT01044771|tenofovir|tenofovir
494435|NCT01044771|viread|viread
494436|NCT01044771|truvada|truvada
494437|NCT01044771|proteinuria|proteinuria
494438|NCT01044758|Mild Cognitive Impairment|mild cognitive impairment
494439|NCT01044758|Amnestic Mild Cognitive Impairment|amnestic mild cognitive impairment
494440|NCT01044758|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
494441|NCT01044758|Levetiracetam|levetiracetam
494442|NCT01044758|Keppra|keppra
494443|NCT01044758|Medial Temporal Lobe|medial temporal lobe
494444|NCT01044758|Memory Impairment|memory impairment
494445|NCT01044758|Alzheimer's Disease|alzheimer's disease
494446|NCT01044758|AD|ad
494447|NCT01044732|Colorectal|colorectal
494448|NCT01044732|Neoplasms|neoplasms
494449|NCT01044732|Adenomas|adenomas
494450|NCT01044732|Polyps|polyps
494451|NCT01044732|Miss rates|miss rates
494452|NCT01044732|Detection rates|detection rates
494453|NCT01044732|Colonoscope|colonoscope
494454|NCT01044732|Third Eye Retroscope|third eye retroscope
494455|NCT01044706|Bioequivalency|bioequivalency
494456|NCT01044693|supine Hypertension|supine hypertension
494457|NCT01044693|autonomic failure|autonomic failure
494458|NCT01044693|nitric oxide|nitric oxide
494459|NCT01044693|nebivolol|nebivolol
494460|NCT01044680|fiber|fiber
494461|NCT01044680|metabolic syndrome|metabolic syndrome
494462|NCT01044680|overweight|overweight
494463|NCT01044680|satiety|satiety
494464|NCT01044654|HIV|hiv
494465|NCT01044654|Treatment Experienced|treatment experienced
494466|NCT01044641|Colloid Osmotic pressure in interstitial fluid|colloid osmotic pressure in interstitial fluid
494467|NCT01044641|Colloid Osmotic pressure in plasma|colloid osmotic pressure in plasma
494468|NCT01044641|Protein fractions in interstitial fluid|protein fractions in interstitial fluid
494469|NCT01044628|COPD|copd
494470|NCT01044628|Oxygen therapy|oxygen therapy
494471|NCT01044628|Nocturnal|nocturnal
494472|NCT01044628|Desaturation|desaturation
494473|NCT01044628|INOX|inox
494474|NCT01044615|Mild Traumatic Brain Injury|mild traumatic brain injury
494475|NCT01044615|Concussion|concussion
494476|NCT01044615|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
494477|NCT01044615|Positron Emission Tomography(PET)|positron emission tomography(pet)
494478|NCT01044615|Computed Tomography (CT)|computed tomography (ct)
494479|NCT01044602|Obesity|obesity
494480|NCT01044602|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
494481|NCT01044602|Roux-en-Y Gastric Bypass Surgery|roux-en-y gastric bypass surgery
494482|NCT01044576|Multiple Sclerosis|multiple sclerosis
494483|NCT01044563|Depression|depression
494484|NCT01044563|Depressive Symptoms|depressive symptoms
494485|NCT01044563|postmenopause|postmenopause
494486|NCT01044563|RSA biofeedback|rsa biofeedback
494487|NCT01044550|Diaphragm injury|diaphragm injury
494488|NCT01044550|Herniation|herniation
494489|NCT01044537|phase 1|phase 1
494490|NCT01044537|safety and tolerability|safety and tolerability
494491|NCT01044537|PK|pk
494492|NCT01044537|PD|pd
494493|NCT01044537|type 2 diabetes mellitus|type 2 diabetes mellitus
494494|NCT01044537|T2DM|t2dm
494495|NCT01044524|14C labeled ADME (Aborption Distribution Metabolism and Elimination) study|14c labeled adme (aborption distribution metabolism and elimination) study
494496|NCT01044524|Phase I|phase i
494497|NCT01044511|Esophageal cancer|esophageal cancer
494498|NCT01044511|Cardia cancer|cardia cancer
494499|NCT01044511|Health Related quality of Life|health related quality of life
494500|NCT01044511|SEMS|sems
494501|NCT01044511|Home visits|home visits
494502|NCT01044485|HER-2 positive advanced or metastatic breast cancer|her-2 positive advanced or metastatic breast cancer
494503|NCT01044485|dose escalation study|dose escalation study
494504|NCT01044485|lapatinib|lapatinib
494505|NCT01044485|docetaxel|docetaxel
494506|NCT01044472|CRT-D|crt-d
494507|NCT01044459|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
494508|NCT01044459|COPD|copd
494509|NCT01044459|Chronic Bronchitis|chronic bronchitis
494510|NCT01044459|Emphysema|emphysema
494511|NCT01044459|Airflow Obstruction, Chronic|airflow obstruction, chronic
494512|NCT01044459|Chronic Airflow Obstruction|chronic airflow obstruction
494513|NCT01044459|Chronic Obstructive Airway Disease|chronic obstructive airway disease
494514|NCT01044459|Chronic Obstructive Lung Disease|chronic obstructive lung disease
494515|NCT01044446|peritoneal dialysis|peritoneal dialysis
494516|NCT01044446|peritonitis|peritonitis
494517|NCT01044446|CAPD|capd
494518|NCT01044446|end-stage renal disease|end-stage renal disease
494519|NCT01044446|peritonitis outcome and ultrafiltration|peritonitis outcome and ultrafiltration
494520|NCT01044407|respiration|respiration
494521|NCT01044407|sleep apnea|sleep apnea
494522|NCT01044407|pacemaker|pacemaker
494523|NCT01044394|colonoscopy|colonoscopy
494524|NCT01044394|bowel preparation|bowel preparation
494525|NCT01044394|polyethylene glycol|polyethylene glycol
494526|NCT01044394|Quality in endoscopy|quality in endoscopy
494527|NCT01044394|Bowel Preparation for colonoscopy|bowel preparation for colonoscopy
494528|NCT01044381|Toenail|toenail
494529|NCT01044381|Fungal Infections|fungal infections
494530|NCT01044381|DSO|dso
494531|NCT01044368|Remote Blood Glucose Monitoring System, Type 2 Diabetes|remote blood glucose monitoring system, type 2 diabetes
494532|NCT01044355|Resistant Hypertension|resistant hypertension
494533|NCT01044355|Obstructive Sleep Apnea|obstructive sleep apnea
494534|NCT01044355|24 Hour Blood Pressure|24 hour blood pressure
494535|NCT01044355|Arterial Stiffness|arterial stiffness
494536|NCT01044355|Insulin Resistance|insulin resistance
494537|NCT01044355|CPAP|cpap
494538|NCT01044355|APAP|apap
494539|NCT01044342|Healthy Volunteers|healthy volunteers
494540|NCT01044342|EEG|eeg
494541|NCT01044316|Haemophilus influenzae type b (Hib)|haemophilus influenzae type b (hib)
494542|NCT01044316|Vaccine|vaccine
494543|NCT01044316|Booster|booster
494544|NCT01044303|Kidney Transplantation|kidney transplantation
494545|NCT01044303|Mycophenolic Acid|mycophenolic acid
494546|NCT01044303|Donor-Specific Antibodies|donor-specific antibodies
494547|NCT01044303|Kidney Rejection|kidney rejection
494548|NCT01044290|quality of life|quality of life
494549|NCT01044290|end of life|end of life
494550|NCT01044290|self-disclosure|self-disclosure
494551|NCT01044290|palliative care|palliative care
494552|NCT01044277|glutathione|glutathione
494553|NCT01044277|gluthathione peroxidases|gluthathione peroxidases
494554|NCT01044277|GSH|gsh
494555|NCT01044264|Acne Vulgaris|acne vulgaris
494556|NCT01044264|bioequivalency|bioequivalency
494557|NCT01044264|clindamycin|clindamycin
494558|NCT01044264|benzoyl peroxide|benzoyl peroxide
494559|NCT01044251|Medication overuse headache|medication overuse headache
494560|NCT01044251|Rebound headache|rebound headache
494561|NCT01044251|Analgesic overuse headache|analgesic overuse headache
494562|NCT01044251|Transitional therapy|transitional therapy
494563|NCT01044251|Frovatriptan|frovatriptan
494564|NCT01044251|Migraine|migraine
494565|NCT01044238|methamphetamine|methamphetamine
494566|NCT01044238|methylphenidate|methylphenidate
494567|NCT01044238|clinical trial|clinical trial
494568|NCT01044238|random assignment|random assignment
494569|NCT01044238|double blind|double blind
494570|NCT01044238|abstinence|abstinence
494571|NCT01044238|reduction in methamphetamine use|reduction in methamphetamine use
494572|NCT01044225|newly diagnosed glioblastoma|newly diagnosed glioblastoma
494573|NCT01044212|Urogynecology|urogynecology
494574|NCT01044199|rabies|rabies
494575|NCT01044199|rabies vaccine|rabies vaccine
494576|NCT01044199|purified cultured embryo chicken rabies vaccine|purified cultured embryo chicken rabies vaccine
494577|NCT01044186|Deferasirox|deferasirox
494578|NCT01044186|ICL670A|icl670a
494579|NCT01044186|Iron chelators|iron chelators
494580|NCT01044186|Deferiprone|deferiprone
494581|NCT01044186|Transfusional hemosiderosis|transfusional hemosiderosis
494582|NCT01044186|Congenital aplastic anemia (Diamond Blackfan anemia)|congenital aplastic anemia (diamond blackfan anemia)
494583|NCT01044186|Red cell aplasia|red cell aplasia
494584|NCT01044186|Thalassemia|thalassemia
494585|NCT01044186|β thalassemia|β thalassemia
494586|NCT01044173|acute abdomen|acute abdomen
494587|NCT01044173|CT|ct
494588|NCT01044173|MRI|mri
494589|NCT01044173|fast imaging|fast imaging
494590|NCT01044160|cancer as trauma in children|cancer as trauma in children
494591|NCT01044160|PTG/PTSS/ PTSD in children with cancer vs healthy children|ptg/ptss/ ptsd in children with cancer vs healthy children
494592|NCT01044147|Obesity|obesity
494593|NCT01044147|Internet|internet
494594|NCT01044121|mattress|mattress
494595|NCT01044121|pain|pain
494596|NCT01044121|sleep|sleep
494597|NCT01044121|low back pain|low back pain
494598|NCT01044121|back|back
494599|NCT01044121|neck|neck
494600|NCT01044121|arousal|arousal
494601|NCT01044121|pillow|pillow
494602|NCT01044121|kingsdown|kingsdown
494603|NCT01044121|sleep to live|sleep to live
494604|NCT01044121|duke university|duke university
494605|NCT01044121|sleep to live institute|sleep to live institute
494606|NCT01044121|missouri|missouri
494607|NCT01044121|springfield|springfield
494608|NCT01044121|joplin|joplin
494609|NCT01044121|body diagnostic|body diagnostic
494610|NCT01044121|dormo diagnostic|dormo diagnostic
494611|NCT01044121|morning pain|morning pain
494612|NCT01044095|seasonal influenza vaccine|seasonal influenza vaccine
494613|NCT01044095|avian influenza H5N1|avian influenza h5n1
494614|NCT01044095|cross reactivity|cross reactivity
494615|NCT01044095|prime boost|prime boost
494616|NCT01044082|Postpartum haemorrhage|postpartum haemorrhage
494617|NCT01044082|Third stage of labour|third stage of labour
494618|NCT01044082|Controlled cord traction|controlled cord traction
494619|NCT01044082|Randomized controlled trial|randomized controlled trial
494620|NCT01044082|Prevention|prevention
494621|NCT01044069|Cyclophosphamide|cyclophosphamide
494622|NCT01044069|T cell|t cell
494623|NCT01044069|leukapheresis|leukapheresis
494624|NCT01044069|stem cell transplant|stem cell transplant
494625|NCT01044069|bone marrow transplant|bone marrow transplant
494626|NCT01044069|09-114|09-114
494627|NCT01044030|otitis media|otitis media
494628|NCT01044030|ear infection|ear infection
494629|NCT01043991|STEMI|stemi
494630|NCT01043991|AMI,|ami,
494631|NCT01043991|acute myocardial infarct|acute myocardial infarct
494632|NCT01043991|Epo|epo
494633|NCT01043991|Erythropoietin|erythropoietin
494634|NCT01043991|ischemia-reperfusion|ischemia-reperfusion
494635|NCT01043991|apoptosis|apoptosis
494636|NCT01043965|Diabetes Mellitus|diabetes mellitus
494637|NCT01043965|Myocardial perfusion imaging|myocardial perfusion imaging
494638|NCT01043965|Heart diseases|heart diseases
494639|NCT01043965|Echocardiography|echocardiography
494640|NCT01043965|Endothelium|endothelium
494641|NCT01043952|Propofol|propofol
494642|NCT01043952|Remifentanil|remifentanil
494643|NCT01043952|Bispectral Index Monitor|bispectral index monitor
494644|NCT01043939|childhood cancers|childhood cancers
494645|NCT01043939|cardiovascular disease|cardiovascular disease
494646|NCT01043939|childhood cancer survivor|childhood cancer survivor
494647|NCT01043926|Hepatic Insufficiency|hepatic insufficiency
494648|NCT01043913|Fatigue|fatigue
494649|NCT01043913|Breast Neoplasms|breast neoplasms
494650|NCT01043913|Quality of Life|quality of life
494651|NCT01043913|Paullinia|paullinia
494652|NCT01043900|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
494653|NCT01043900|rTMS|rtms
494654|NCT01043900|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
494655|NCT01043900|treatment|treatment
494656|NCT01043900|randomized controlled trials|randomized controlled trials
494657|NCT01043887|Healthy Volunteers|healthy volunteers
494658|NCT01043887|Hepatic Insufficiency|hepatic insufficiency
494659|NCT01043874|Chronic phase|chronic phase
494660|NCT01043874|Chronic myelogenous leukemia|chronic myelogenous leukemia
494661|NCT01043874|CML|cml
494662|NCT01043874|Philadelphia chromosome positive|philadelphia chromosome positive
494663|NCT01043874|Ph+|ph+
494664|NCT01043874|Nilotinib|nilotinib
494665|NCT01043874|CML-CP|cml-cp
494666|NCT01043874|Suboptimal molecular response|suboptimal molecular response
494667|NCT01043848|neurogenic detrusor overactivity|neurogenic detrusor overactivity
494668|NCT01043848|neuromodulation|neuromodulation
494669|NCT01043848|spinal cord injury|spinal cord injury
494670|NCT01043848|pudendal nerve stimulation|pudendal nerve stimulation
494671|NCT01043848|videocystometry|videocystometry
494672|NCT01043848|neurophysiology|neurophysiology
494673|NCT01043848|neuroplasticity|neuroplasticity
494674|NCT01043835|Stomach Neoplasm|stomach neoplasm
494675|NCT01043835|Laparoscopy|laparoscopy
494676|NCT01043835|gastrectomy|gastrectomy
494677|NCT01043822|Autism|autism
494678|NCT01043822|mental retardation|mental retardation
494679|NCT01043822|pain|pain
494680|NCT01043822|emotion|emotion
494681|NCT01043822|sensory profile|sensory profile
494682|NCT01043822|children|children
494683|NCT01043809|schools|schools
494684|NCT01043809|handwashing|handwashing
494685|NCT01043809|prevention and control|prevention and control
494686|NCT01043809|communicable diseases|communicable diseases
494687|NCT01043809|absenteeism|absenteeism
494688|NCT01043796|Insecticide treated wall liners|insecticide treated wall liners
494689|NCT01043796|Insecticide treated nets|insecticide treated nets
494690|NCT01043796|Incidence cohort|incidence cohort
494691|NCT01043783|Obesity|obesity
494692|NCT01043770|Metabolic syndrome|metabolic syndrome
494693|NCT01043770|Primary prevention|primary prevention
494694|NCT01043770|Diabetes|diabetes
494695|NCT01043770|Cardiovascular disease|cardiovascular disease
494696|NCT01043770|Patient education|patient education
494697|NCT01043757|Sedentary lifestyle|sedentary lifestyle
494698|NCT01043757|physical exercise|physical exercise
494699|NCT01043757|behavioral economics|behavioral economics
494700|NCT01043757|financial incentives|financial incentives
494701|NCT01043757|obesity|obesity
494702|NCT01043744|malaria|malaria
494703|NCT01043744|presumptive treatment|presumptive treatment
494704|NCT01043744|Integrated Management of Childhood Illness|integrated management of childhood illness
494705|NCT01043744|fever|fever
494706|NCT01043718|Obesity|obesity
494707|NCT01043718|Internet|internet
494708|NCT01043705|Pacemaker infection|pacemaker infection
494709|NCT01043705|Defibrillator infection|defibrillator infection
494710|NCT01043705|ICD infection|icd infection
494711|NCT01043705|CRT infection|crt infection
494712|NCT01043705|Cardiovascular implantable electronic device infection|cardiovascular implantable electronic device infection
494713|NCT01043705|Infection|infection
494714|NCT01043705|Pacemaker, Artificial|pacemaker, artificial
494715|NCT01043705|Defibrillators|defibrillators
494716|NCT01043692|Chronic Pain > 3 months|chronic pain > 3 months
494717|NCT01043692|Acupuncture|acupuncture
494718|NCT01043692|Acceptability|acceptability
494719|NCT01043692|Geriatrics|geriatrics
494720|NCT01043679|Bipolar, Mania|bipolar, mania
494721|NCT01043679|Utapine|utapine
494722|NCT01043679|Seroquel|seroquel
494723|NCT01043666|Micturition|micturition
494724|NCT01043666|YM178|ym178
494725|NCT01043666|Urinary incontinence|urinary incontinence
494726|NCT01043666|Frequency|frequency
494727|NCT01043666|Overactive Bladder|overactive bladder
494728|NCT01043666|Urgency|urgency
494729|NCT01043666|Urinary urge incontinence|urinary urge incontinence
494730|NCT01043653|recovery|recovery
494731|NCT01043653|serious mental illness|serious mental illness
494732|NCT01043640|inherited metabolic disorders|inherited metabolic disorders
494733|NCT01043614|Obesity|obesity
494734|NCT01043614|Obesity Prevention|obesity prevention
494735|NCT01043614|Freshman women|freshman women
494736|NCT01043614|Freshman 15 weight gain|freshman 15 weight gain
494737|NCT01043614|Self efficacy|self efficacy
494738|NCT01043614|Activity and nutrition intervention|activity and nutrition intervention
494739|NCT01043614|Peer education|peer education
494740|NCT01043588|Surgery|surgery
494741|NCT01043588|Prostate|prostate
494742|NCT01043588|Laser 532 nm|laser 532 nm
494743|NCT01043588|Photo selective Vaporization of the Prostate (PVP)|photo selective vaporization of the prostate (pvp)
494744|NCT01043588|TransUrethral Resection of the Prostate (TURP)|transurethral resection of the prostate (turp)
494745|NCT01043588|Men health|men health
494746|NCT01043575|rifapentine, pharmacokinetics, pharmacodynamics, tuberculosis|rifapentine, pharmacokinetics, pharmacodynamics, tuberculosis
494747|NCT01043549|Gilles de la Tourette syndrome|gilles de la tourette syndrome
494748|NCT01043549|Tics|tics
494749|NCT01043549|Transcranial magnetic stimulation|transcranial magnetic stimulation
494750|NCT01043536|IMRT|imrt
494751|NCT01043536|Radiotherapy escalation dose|radiotherapy escalation dose
494752|NCT01043536|glioblastoma|glioblastoma
494753|NCT01043536|escalation radiotherapy dose|escalation radiotherapy dose
494754|NCT01043523|Liver neoplasms|liver neoplasms
494755|NCT01043523|Adenoma|adenoma
494756|NCT01043523|Liver cell carcinoma|liver cell carcinoma
494757|NCT01043523|Hepatocellular|hepatocellular
494758|NCT01043523|Liver abscess|liver abscess
494759|NCT01043484|Resectable rectal cancer|resectable rectal cancer
494760|NCT01043484|Radiotherapy|radiotherapy
494761|NCT01043484|Bevacizumab|bevacizumab
494762|NCT01043484|Capecitabine|capecitabine
494763|NCT01043471|Obesity|obesity
494764|NCT01043458|Pharmacokinetics|pharmacokinetics
494765|NCT01043445|GPR 119|gpr 119
494766|NCT01043445|GLP-1 secretion|glp-1 secretion
494767|NCT01043445|2-oleoyl-glycerol|2-oleoyl-glycerol
494768|NCT01043445|Dietary supplementation|dietary supplementation
494769|NCT01043432|Traumatic Brain Injury|traumatic brain injury
494770|NCT01043432|Suicide|suicide
494771|NCT01043432|Executive Function|executive function
494772|NCT01043419|Xenon Anesthesia|xenon anesthesia
494773|NCT01043419|LENOXe™ (xénon 100 % v/v) anesthesia|lenoxe™ (xénon 100 % v/v) anesthesia
494774|NCT01043419|Muscle Sympathetic Activity|muscle sympathetic activity
494775|NCT01043419|Baroreflex reagibility|baroreflex reagibility
494776|NCT01043406|Epilepsy|epilepsy
494777|NCT01043406|Seizures|seizures
494778|NCT01043406|Advisory|advisory
494779|NCT01043406|Prediction|prediction
494780|NCT01043393|Plaque psoriasis|plaque psoriasis
494781|NCT01043380|Heart Diseases|heart diseases
494782|NCT01043380|Hyperlipidemia|hyperlipidemia
494783|NCT01043380|Atorvastatin|atorvastatin
494784|NCT01043380|Ezetimibe|ezetimibe
494785|NCT01043380|Cardiovascular Diseases|cardiovascular diseases
494786|NCT01043380|Hypercholesterolemia|hypercholesterolemia
494787|NCT01043380|Coronary Artery Disease|coronary artery disease
494788|NCT01043380|Dyslipidemias|dyslipidemias
494789|NCT01043380|Intravascular Ultrasound|intravascular ultrasound
494790|NCT01043367|Depression|depression
494791|NCT01043367|Dietary supplement|dietary supplement
494792|NCT01043367|Deprexil|deprexil
494793|NCT01043354|cholesterol|cholesterol
494794|NCT01043354|diabetes|diabetes
494795|NCT01043354|adherence|adherence
494797|NCT01043341|vaccines|vaccines
494798|NCT01043341|knowledge|knowledge
494799|NCT01043341|attitude|attitude
494800|NCT01043328|human papillomavirus|human papillomavirus
494801|NCT01043328|nested PCR|nested pcr
494802|NCT01043328|saliva|saliva
494803|NCT01043328|serum|serum
494804|NCT01043328|oral tissues|oral tissues
494805|NCT01043315|Cognitive Function|cognitive function
494806|NCT01043315|Cognitive Impairment|cognitive impairment
494807|NCT01043315|Hospitalization|hospitalization
494808|NCT01043315|Cardiac Disease|cardiac disease
494809|NCT01043302|lymphoma, intestine, outcome, quality of life|lymphoma, intestine, outcome, quality of life
494810|NCT01043289|light therapy|light therapy
494811|NCT01043289|antepartum depression|antepartum depression
494812|NCT01043289|controlled trial|controlled trial
494813|NCT01043276|Healthy|healthy
494814|NCT01043250|schizophrenia|schizophrenia
494815|NCT01043250|atypical antipsychotics|atypical antipsychotics
494816|NCT01043250|appetite|appetite
494817|NCT01043250|eating behavior|eating behavior
494818|NCT01043237|acoustic|acoustic
494819|NCT01043237|digital|digital
494820|NCT01043237|sound|sound
494821|NCT01043237|vibration|vibration
494822|NCT01043237|coronary|coronary
494823|NCT01043237|auscultation|auscultation
494824|NCT01043237|artery|artery
494825|NCT01043237|diagnosis|diagnosis
494826|NCT01043211|Back Pain|back pain
494827|NCT01043211|Lidocaine|lidocaine
494828|NCT01043198|CGH array technology|cgh array technology
494829|NCT01043198|mental retardation|mental retardation
494830|NCT01043198|chromosomal abnormalities|chromosomal abnormalities
494831|NCT01043198|syndromic obesity|syndromic obesity
494832|NCT01043198|obesity|obesity
494833|NCT01043185|GERD|gerd
494834|NCT01043185|lesogaberan|lesogaberan
494835|NCT01043185|impedance|impedance
494836|NCT01043185|pH|ph
494837|NCT01043185|pharmacokinetics|pharmacokinetics
494838|NCT01043185|safety|safety
494839|NCT01043185|tolerability|tolerability
494840|NCT01043146|anti-beta1 adrenergic receptor|anti-beta1 adrenergic receptor
494841|NCT01043146|autoantibody|autoantibody
494842|NCT01043146|cyclic peptide|cyclic peptide
494843|NCT01043146|heart failure|heart failure
494844|NCT01043133|electronic medical records|electronic medical records
494845|NCT01043133|documentation templates|documentation templates
494846|NCT01043133|clinical encounter notes|clinical encounter notes
494847|NCT01043081|African American women who have sex with women|african american women who have sex with women
494848|NCT01043081|Sexually transmitted infections|sexually transmitted infections
494849|NCT01043081|Homosexuality|homosexuality
494850|NCT01043081|Human papillomavirus|human papillomavirus
494851|NCT01043081|Cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
494852|NCT01043081|Herpes simplex virus types 1 and 2|herpes simplex virus types 1 and 2
494853|NCT01043081|Chlamydia|chlamydia
494854|NCT01043081|Gonorrhea|gonorrhea
494855|NCT01043081|Trichomoniasis|trichomoniasis
494856|NCT01043081|Bacterial vaginosis|bacterial vaginosis
494857|NCT01043081|Syphilis|syphilis
494858|NCT01043081|Human immunodeficiency virus|human immunodeficiency virus
494859|NCT01043068|cancer pain|cancer pain
494860|NCT01043068|opioid|opioid
494861|NCT01043068|guideline|guideline
494862|NCT01043055|Breast Cancer Screening|breast cancer screening
494863|NCT01043042|hypoglycemia among inpatients|hypoglycemia among inpatients
494864|NCT01043042|hyperglycemia among inpatients|hyperglycemia among inpatients
494865|NCT01043016|skin cancer|skin cancer
494866|NCT01043016|esophageal cancer|esophageal cancer
494867|NCT01043016|photodynamic therapy|photodynamic therapy
494868|NCT01042990|Stroke|stroke
494869|NCT01042990|Exercise|exercise
494870|NCT01042990|Balance|balance
494871|NCT01042990|Dynamic Gait|dynamic gait
494872|NCT01042990|Cardiovascular Fitness|cardiovascular fitness
494873|NCT01042977|dapagliflozin|dapagliflozin
494874|NCT01042977|diabetes|diabetes
494875|NCT01042977|cardiovascular disease|cardiovascular disease
494876|NCT01042964|platelet adhesion and aggregation|platelet adhesion and aggregation
494877|NCT01042964|acute coronary syndrome|acute coronary syndrome
494878|NCT01042964|myocardial infarction|myocardial infarction
494879|NCT01042964|stroke|stroke
494880|NCT01042964|inhibition of platelet adhesion to plaques|inhibition of platelet adhesion to plaques
494881|NCT01042964|collagen-induced platelet aggregation|collagen-induced platelet aggregation
494882|NCT01042951|safety|safety
494883|NCT01042951|immunogenicity|immunogenicity
494884|NCT01042951|Healthy Participants|healthy participants
494885|NCT01042938|Radiation dermatitis in breast cancer patients|radiation dermatitis in breast cancer patients
494886|NCT01042925|HER2 positive breast cancer|her2 positive breast cancer
494887|NCT01042925|breast cancer|breast cancer
494888|NCT01042925|breast tumors|breast tumors
494889|NCT01042925|human mammary carcinoma|human mammary carcinoma
494890|NCT01042912|diagnosis|diagnosis
494891|NCT01042912|carotid|carotid
494892|NCT01042912|artery|artery
494893|NCT01042912|disease|disease
494894|NCT01042912|auscultation|auscultation
494895|NCT01042912|sound|sound
494896|NCT01042899|TBI|tbi
494897|NCT01042899|intracranial edema|intracranial edema
494898|NCT01042899|brain edema|brain edema
494899|NCT01042899|craniocerebral trauma|craniocerebral trauma
494900|NCT01042899|head injury|head injury
494901|NCT01042899|brain hemorrhage, traumatic|brain hemorrhage, traumatic
494902|NCT01042899|subdural hematoma|subdural hematoma
494903|NCT01042899|brain concussion|brain concussion
494904|NCT01042899|head injuries, closed|head injuries, closed
494905|NCT01042899|epidural hematoma|epidural hematoma
494906|NCT01042899|extra-axial hemorrhage|extra-axial hemorrhage
494907|NCT01042899|cortical contusion|cortical contusion
494908|NCT01042899|wounds and injuries|wounds and injuries
494909|NCT01042899|disorders of environmental origin|disorders of environmental origin
495200|NCT01041755|Cirrhosis|cirrhosis
494910|NCT01042899|trauma, nervous system|trauma, nervous system
494911|NCT01042899|brain injuries|brain injuries
494912|NCT01042886|Non-blind, randomized controlled trial|non-blind, randomized controlled trial
494913|NCT01042886|Pilot study|pilot study
494914|NCT01042873|Desensitization|desensitization
494915|NCT01042873|beta adrenergic receptors|beta adrenergic receptors
494916|NCT01042873|Healthy subjects|healthy subjects
494917|NCT01042860|macular pigment|macular pigment
494918|NCT01042860|lutein|lutein
494919|NCT01042860|age-related macular degeneration|age-related macular degeneration
494920|NCT01042860|AMD|amd
494921|NCT01042847|ovarian|ovarian
494922|NCT01042834|air pollution|air pollution
494923|NCT01042834|autonomic nervous system|autonomic nervous system
494924|NCT01042834|sleep apnea|sleep apnea
494925|NCT01042834|Heart rate variability|heart rate variability
494926|NCT01042834|Healthy volunteers|healthy volunteers
494927|NCT01042821|anal fistula|anal fistula
494928|NCT01042821|advancement flap|advancement flap
494929|NCT01042821|incontinence|incontinence
494930|NCT01042795|sunitinib|sunitinib
494931|NCT01042795|bladder neoplasm|bladder neoplasm
494932|NCT01042795|adjuvant treatment|adjuvant treatment
494933|NCT01042795|disease free survival|disease free survival
494934|NCT01042795|cystectomy|cystectomy
494935|NCT01042782|gastric cancer|gastric cancer
494936|NCT01042782|RAD001|rad001
494937|NCT01042782|Mitomycin C|mitomycin c
494938|NCT01042782|MTD|mtd
494939|NCT01042743|colon cancer|colon cancer
494940|NCT01042743|robot|robot
494941|NCT01042743|laparoscopy|laparoscopy
494942|NCT01042743|primary, right-side colon cancer|primary, right-side colon cancer
494943|NCT01042743|robot-assisted surgery|robot-assisted surgery
494944|NCT01042730|Pitavastatin|pitavastatin
494945|NCT01042730|Coronary Artery Disease|coronary artery disease
494946|NCT01042730|Cardiovascular Disease|cardiovascular disease
494947|NCT01042717|plerixafor|plerixafor
494948|NCT01042717|autologous transplantation|autologous transplantation
494949|NCT01042717|hematopoietic stem cell mobilization|hematopoietic stem cell mobilization
494950|NCT01042717|multiple myeloma|multiple myeloma
494951|NCT01042717|non-Hodgkins lymphoma|non-hodgkins lymphoma
494952|NCT01042704|Relapsed Myeloma|relapsed myeloma
494953|NCT01042704|Refractory Myeloma|refractory myeloma
494954|NCT01042665|Glaucoma|glaucoma
494955|NCT01042665|intraocular pressure|intraocular pressure
494956|NCT01042665|latanoprost|latanoprost
494957|NCT01042665|retinal ganglion cell|retinal ganglion cell
494958|NCT01042665|pattern electroretinogram|pattern electroretinogram
494959|NCT01042652|Methadone|methadone
494960|NCT01042652|HIV|hiv
494961|NCT01042652|Raltegravir|raltegravir
494962|NCT01042652|Antiretroviral|antiretroviral
494963|NCT01042652|Intravenous Drug User|intravenous drug user
494964|NCT01042652|Methadone Maintenance|methadone maintenance
494965|NCT01042652|Treatment Naive|treatment naive
494966|NCT01042639|osteopenia|osteopenia
494967|NCT01042639|very low birthweight infants|very low birthweight infants
494968|NCT01042639|bone speed of sound|bone speed of sound
494969|NCT01042639|quantitative ultrasound|quantitative ultrasound
494970|NCT01042626|Receptors, Calcium sensing|receptors, calcium sensing
494971|NCT01042626|Parathyroid Hormone|parathyroid hormone
494972|NCT01042613|AccuVein AV300 device;|accuvein av300 device;
494973|NCT01042613|Intravenous cannulation|intravenous cannulation
494974|NCT01042600|Respiratory distress syndrome|respiratory distress syndrome
494975|NCT01042600|Surfactant|surfactant
494976|NCT01042600|Tracheal intubation|tracheal intubation
494977|NCT01042600|Laryngeal mask airway|laryngeal mask airway
494978|NCT01042600|Newborn|newborn
494979|NCT01042587|bright light therapy|bright light therapy
494980|NCT01042587|circadian rhythm,|circadian rhythm,
494981|NCT01042587|entrainment|entrainment
494982|NCT01042574|intracranial hemorrhage (ICH)|intracranial hemorrhage (ich)
494983|NCT01042574|subarachnoid hemorrhage (SAH)|subarachnoid hemorrhage (sah)
494984|NCT01042574|intracranial monitoring|intracranial monitoring
494985|NCT01042574|external ventricular drain (ventriculostomy)|external ventricular drain (ventriculostomy)
494986|NCT01042574|hypertension|hypertension
494987|NCT01042561|vitamin d|vitamin d
494988|NCT01042561|prematurity|prematurity
494989|NCT01042561|25(OH)D|25(oh)d
494990|NCT01042561|infant|infant
494991|NCT01042561|CRP|crp
494992|NCT01042561|PTH|pth
494993|NCT01042548|Proteomics|proteomics
494994|NCT01042548|Breast Cancer Markers|breast cancer markers
494995|NCT01042548|Tissue Interstitial Fluid|tissue interstitial fluid
494996|NCT01042509|Chronic Graft vs Host Disease|chronic graft vs host disease
494997|NCT01042509|Alemtuzumab|alemtuzumab
494998|NCT01042509|Rituximab|rituximab
494999|NCT01042509|Low-dose|low-dose
495000|NCT01042509|Alemtuzumab and rituximab combination|alemtuzumab and rituximab combination
495001|NCT01042496|Bipolar|bipolar
495002|NCT01042496|depression|depression
495003|NCT01042483|active stage|active stage
495004|NCT01042483|labor|labor
495005|NCT01042483|progression|progression
495006|NCT01042483|pregnant women during active phases of labor|pregnant women during active phases of labor
495007|NCT01042470|pelvic organ prolapse|pelvic organ prolapse
495008|NCT01042470|pelvic floor dysfunction|pelvic floor dysfunction
495009|NCT01042470|biomechanics|biomechanics
495010|NCT01042470|aspiration device|aspiration device
495011|NCT01042470|connective tissue|connective tissue
495012|NCT01042457|trough level|trough level
495013|NCT01042457|therapeutic drug monitoring|therapeutic drug monitoring
495014|NCT01042457|Mycophenolate mofetil|mycophenolate mofetil
495015|NCT01042457|Mycophenolic acid|mycophenolic acid
495016|NCT01042457|lupus nephritis|lupus nephritis
495017|NCT01042444|Heart disease|heart disease
495018|NCT01042444|Embolic Protection Device|embolic protection device
495019|NCT01042444|PCI|pci
495020|NCT01042444|SVG|svg
495021|NCT01042431|Nutritional status of ward patients and hospitalization outcome|nutritional status of ward patients and hospitalization outcome
495022|NCT01042418|satiety|satiety
495023|NCT01042418|grain structure|grain structure
495024|NCT01042418|rye|rye
495025|NCT01042392|Moderate systolic hypertension - adults - aliskiren -ramipril|moderate systolic hypertension - adults - aliskiren -ramipril
495026|NCT01042379|I-SPY 2|i-spy 2
495027|NCT01042379|Neoadjuvant|neoadjuvant
495028|NCT01042379|Breast|breast
495029|NCT01042379|Cancer|cancer
495030|NCT01042379|Neoplasm|neoplasm
495031|NCT01042379|Adaptive|adaptive
495032|NCT01042379|pCR|pcr
495033|NCT01042379|Pathologic Complete Response|pathologic complete response
495034|NCT01042379|Biomarkers signature|biomarkers signature
495035|NCT01042379|MRI Volume|mri volume
495036|NCT01042366|Melanoma|melanoma
495037|NCT01042340|nutrition|nutrition
495038|NCT01042340|geriatric|geriatric
495039|NCT01042340|supplement|supplement
495040|NCT01042340|energy|energy
495041|NCT01042327|solute clearances|solute clearances
495042|NCT01042288|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
495043|NCT01042288|NSCLC|nsclc
495044|NCT01042288|Panitumumab|panitumumab
495045|NCT01042288|Vectibix|vectibix
495046|NCT01042288|Pemetrexed|pemetrexed
495047|NCT01042288|Alimta|alimta
495048|NCT01042288|Carboplatin|carboplatin
495049|NCT01042275|stress urinary incontinence|stress urinary incontinence
495050|NCT01042275|retropubic sling|retropubic sling
495051|NCT01042275|transobturator sling|transobturator sling
495052|NCT01042275|tension-free vaginal tape|tension-free vaginal tape
495053|NCT01042275|transobturator tape|transobturator tape
495054|NCT01042275|TVT|tvt
495055|NCT01042275|TVT-O|tvt-o
495056|NCT01042275|TOT|tot
495057|NCT01042275|REMEEX|remeex
495058|NCT01042275|IVS|ivs
495059|NCT01042262|Superoxide dismutase|superoxide dismutase
495060|NCT01042262|Oxygen|oxygen
495061|NCT01042262|Oxygen free radicals|oxygen free radicals
495062|NCT01042262|Labor and delivery|labor and delivery
495063|NCT01042249|PFMT|pfmt
495064|NCT01042249|Stroke|stroke
495065|NCT01042249|LUTS|luts
495066|NCT01042249|Men|men
495067|NCT01042236|Phase 2 stress urinary incontinence Fesoterodine|phase 2 stress urinary incontinence fesoterodine
495068|NCT01042223|Factors Predisposing or Causing|factors predisposing or causing
495069|NCT01042210|preeclampsia|preeclampsia
495070|NCT01042210|agouti-related peptide|agouti-related peptide
495071|NCT01042210|intrauterine growth|intrauterine growth
495072|NCT01042210|birth weight|birth weight
495073|NCT01042210|Intrauterine growth restriction due to preeclampsia|intrauterine growth restriction due to preeclampsia
495074|NCT01042197|Vitamin D|vitamin d
495075|NCT01042197|UVB|uvb
495076|NCT01042197|Dose-Response|dose-response
495077|NCT01042197|Body surface area|body surface area
495078|NCT01042184|H. pylori infected patients without prior eradication therapy|h. pylori infected patients without prior eradication therapy
495079|NCT01042158|Tadalafil|tadalafil
495080|NCT01042158|Ambrisentan|ambrisentan
495081|NCT01042158|Quality of Life|quality of life
495082|NCT01042145|Primary Care|primary care
495083|NCT01042145|Treatment|treatment
495084|NCT01042145|Croup|croup
495085|NCT01042145|Corticosteroids|corticosteroids
495086|NCT01042145|Prednisone|prednisone
495087|NCT01042145|Dexamethasone|dexamethasone
495088|NCT01042145|Randomized trial|randomized trial
495089|NCT01042132|intramedullary reaming|intramedullary reaming
495090|NCT01042132|inflammatory response|inflammatory response
495091|NCT01042132|human|human
495092|NCT01042132|femoral shaft fracture|femoral shaft fracture
495093|NCT01042132|Reamer-irrigator-aspirator|reamer-irrigator-aspirator
495094|NCT01042119|botulinum neurotoxin type A|botulinum neurotoxin type a
495095|NCT01042119|BoNT/A|bont/a
495096|NCT01042119|Botox|botox
495097|NCT01042119|overactive bladder syndrome|overactive bladder syndrome
495098|NCT01042106|diabetes|diabetes
495099|NCT01042093|Analgesia|analgesia
495100|NCT01042093|postoperative pain|postoperative pain
495101|NCT01042093|periarticular|periarticular
495102|NCT01042093|arthroplasty|arthroplasty
495103|NCT01042093|pain management|pain management
495104|NCT01042080|Mechanical ventilation|mechanical ventilation
495105|NCT01042080|Neurally adjusted ventilatory assist (NAVA)|neurally adjusted ventilatory assist (nava)
495106|NCT01042080|Acute respiratory failure|acute respiratory failure
495107|NCT01042080|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
495108|NCT01042080|Weaning|weaning
495109|NCT01042080|Invasive mechanical ventilation|invasive mechanical ventilation
495110|NCT01042080|Positive Pressure support Ventilation|positive pressure support ventilation
495111|NCT01042067|warfarin|warfarin
495112|NCT01042067|genotyping|genotyping
495113|NCT01042067|vitamin K|vitamin k
495114|NCT01042067|dosing|dosing
495115|NCT01042067|adverse events|adverse events
495116|NCT01042067|initial phase of treatment|initial phase of treatment
495117|NCT01042067|algorithm|algorithm
495118|NCT01042054|Postoperative Care|postoperative care
495119|NCT01042054|Enhanced|enhanced
495120|NCT01042054|Recovery|recovery
495121|NCT01042054|Hepatectomy|hepatectomy
495122|NCT01042054|Analgesia|analgesia
495123|NCT01042028|Pancreas cancer|pancreas cancer
495124|NCT01042028|Everolimus|everolimus
495125|NCT01042028|Irinotecan|irinotecan
495126|NCT01042028|Cetuximab|cetuximab
495127|NCT01042028|Capecitabine|capecitabine
495128|NCT01042028|Oxaliplatin|oxaliplatin
495129|NCT01042028|Gemcitabine resistant pancreascancer|gemcitabine resistant pancreascancer
495130|NCT01042015|trauma|trauma
495131|NCT01042015|cardiac arrest|cardiac arrest
495132|NCT01042015|hemorrhagic shock|hemorrhagic shock
495133|NCT01042002|High intensity exercise|high intensity exercise
495134|NCT01042002|morbid obesity|morbid obesity
495135|NCT01042002|gastric bypass|gastric bypass
495136|NCT01041989|dementia|dementia
495137|NCT01041989|cognitive impairment|cognitive impairment
495138|NCT01041989|disability|disability
495139|NCT01041989|intervention|intervention
495140|NCT01041989|elderly|elderly
495141|NCT01041989|lifestyle counseling|lifestyle counseling
495142|NCT01041976|Veterans|veterans
495143|NCT01041976|Vocational Rehabilitation|vocational rehabilitation
495144|NCT01041963|ACEI|acei
495145|NCT01041963|ARB|arb
495146|NCT01041963|CAPD|capd
495147|NCT01041963|Peritoneal membrane transport|peritoneal membrane transport
495148|NCT01041950|intracerebral hemorrhage|intracerebral hemorrhage
495149|NCT01041950|intraventricular hemorrhage|intraventricular hemorrhage
495150|NCT01041950|hydrocephalus|hydrocephalus
495151|NCT01041950|Intracerebral hemorrhage with severe ventricular involvement and obstructive hydrocephalus|intracerebral hemorrhage with severe ventricular involvement and obstructive hydrocephalus
495152|NCT01041924|Sleep apnea|sleep apnea
495153|NCT01041924|Periodic breathing|periodic breathing
495154|NCT01041924|Heart Failure|heart failure
495155|NCT01041911|Hemorrhoids|hemorrhoids
495156|NCT01041898|osteocalcin|osteocalcin
495157|NCT01041898|insulin|insulin
495158|NCT01041898|body composition|body composition
495159|NCT01041898|bone mineral density|bone mineral density
495160|NCT01041898|Evaluate the effect of osteocalcin on bone mineral density|evaluate the effect of osteocalcin on bone mineral density
495161|NCT01041898|Evaluate the effect of osteocalcin on body fat distribution|evaluate the effect of osteocalcin on body fat distribution
495162|NCT01041898|Evaluate the effect of osteocalcin on insulin homeostasis|evaluate the effect of osteocalcin on insulin homeostasis
495163|NCT01041885|knee cartilage defect repair|knee cartilage defect repair
495164|NCT01041885|cartilage lesion|cartilage lesion
495165|NCT01041885|autologous chondrocyte|autologous chondrocyte
495166|NCT01041885|scaffold|scaffold
495167|NCT01041885|INSTRUCT|instruct
495168|NCT01041859|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
495170|NCT01041859|Polyneuropathy|polyneuropathy
495171|NCT01041859|Peripheral neuropathy|peripheral neuropathy
495172|NCT01041846|Myelodysplastic Syndrome|myelodysplastic syndrome
495173|NCT01041846|Dacogen|dacogen
495174|NCT01041846|Decitabine|decitabine
495175|NCT01041846|Epigenetic therapy|epigenetic therapy
495176|NCT01041846|Hypomethylating agent|hypomethylating agent
495177|NCT01041833|All-trans retinoic acid|all-trans retinoic acid
495178|NCT01041833|non-small cell lung cancer|non-small cell lung cancer
495179|NCT01041833|retinoic acid receptor beta|retinoic acid receptor beta
495180|NCT01041820|exercise|exercise
495181|NCT01041820|bone marrow adipose tissue|bone marrow adipose tissue
495182|NCT01041820|bone mineral density|bone mineral density
495183|NCT01041820|Children in the intervention condition will complete a supervised physical activity program 3 days/wk for 10 weeks|children in the intervention condition will complete a supervised physical activity program 3 days/wk for 10 weeks
495184|NCT01041820|Control treatment will be provided no intervention|control treatment will be provided no intervention
495185|NCT01041820|All participants will be instructed not to change their current dietary habits during the study period.|all participants will be instructed not to change their current dietary habits during the study period.
495186|NCT01041807|Hypertension|hypertension
495187|NCT01041794|body composition|body composition
495188|NCT01041794|fat distribution|fat distribution
495189|NCT01041794|exercise|exercise
495190|NCT01041794|diet|diet
495191|NCT01041781|adenocarcinoma of the lung|adenocarcinoma of the lung
495192|NCT01041781|adenosquamous cell lung cancer|adenosquamous cell lung cancer
495193|NCT01041781|large cell lung cancer|large cell lung cancer
495194|NCT01041781|squamous cell lung cancer|squamous cell lung cancer
495195|NCT01041781|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
495196|NCT01041781|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
495197|NCT01041781|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
495198|NCT01041768|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
495199|NCT01041755|Encephalopathy|encephalopathy
495201|NCT01041716|Carbapenem|carbapenem
495202|NCT01041716|Klebsiella pneumoniae carbapenemase|klebsiella pneumoniae carbapenemase
495203|NCT01041716|Acinetobacter baumannii|acinetobacter baumannii
495204|NCT01041716|Pseudomonas aeruginosa|pseudomonas aeruginosa
495205|NCT01041690|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
495206|NCT01041690|Vitrectomy|vitrectomy
495207|NCT01041690|Bevacizumab|bevacizumab
495208|NCT01041677|Obesity|obesity
495209|NCT01041677|Overweight|overweight
495210|NCT01041677|Body Weight|body weight
495211|NCT01041677|Body Size|body size
495212|NCT01041677|Nutritional and Metabolic Diseases|nutritional and metabolic diseases
495213|NCT01041664|nutrigenomics|nutrigenomics
495214|NCT01041664|admixture|admixture
495215|NCT01041664|Hispanic American|hispanic american
495216|NCT01041664|body composition|body composition
495217|NCT01041664|Association of diet and body composition|association of diet and body composition
495218|NCT01041664|Association between genes and body composition|association between genes and body composition
495219|NCT01041664|Association between gen by diet interaction and body composition|association between gen by diet interaction and body composition
495220|NCT01041625|Lichen Planus|lichen planus
495221|NCT01041612|CBD|cbd
495222|NCT01041612|HBD|hbd
495223|NCT01041612|cancer of bile duct|cancer of bile duct
495224|NCT01041612|pancreatic cancer|pancreatic cancer
495225|NCT01041599|Diabetes Mellitus|diabetes mellitus
495226|NCT01041599|Hypertension|hypertension
495227|NCT01041599|Albuminuria|albuminuria
495228|NCT01041599|vascular stiffness|vascular stiffness
495229|NCT01041586|Emphysema|emphysema
495230|NCT01041586|COPD|copd
495231|NCT01041586|Lung Volume Reduction|lung volume reduction
495232|NCT01041586|BTVA|btva
495233|NCT01041573|Pediatric|pediatric
495234|NCT01041573|Japanese Encephalitis Vaccine|japanese encephalitis vaccine
495235|NCT01041573|endemic countries|endemic countries
495236|NCT01041573|to assess the systemic and local safety profile of purified inactivated Japanese Encephalitis Virus (JEV) vaccine IC51|to assess the systemic and local safety profile of purified inactivated japanese encephalitis virus (jev) vaccine ic51
495237|NCT01041560|Stroke|stroke
495238|NCT01041560|Tone|tone
495239|NCT01041560|Strength|strength
495240|NCT01041547|Insulin sensitivity|insulin sensitivity
495241|NCT01041547|Vascular function|vascular function
495242|NCT01041547|Flow-mediated dilation|flow-mediated dilation
495243|NCT01041547|Arterial stiffness|arterial stiffness
495244|NCT01041547|Glucose tolerance|glucose tolerance
495245|NCT01041547|Hypertension|hypertension
495246|NCT01041534|Adjustable gastric band, morbid obesity, bariatric surgery|adjustable gastric band, morbid obesity, bariatric surgery
495247|NCT01041521|HIV infection|hiv infection
495248|NCT01041521|Dyslipidemia|dyslipidemia
495249|NCT01041521|Elevated Triglyceride level|elevated triglyceride level
495250|NCT01041521|vascular function (BART)|vascular function (bart)
495251|NCT01041521|arterial stiffness|arterial stiffness
495252|NCT01041521|omega three fatty acids|omega three fatty acids
495253|NCT01041521|complementary therapies|complementary therapies
495254|NCT01041508|ALL|all
495255|NCT01041508|AML|aml
495256|NCT01041508|Recurrence|recurrence
495257|NCT01041508|Relapsed|relapsed
495258|NCT01041508|Stem Cell Transplant|stem cell transplant
495259|NCT01041508|Non-myeloablastive|non-myeloablastive
495260|NCT01041495|fibromyalgia|fibromyalgia
495261|NCT01041495|Pain|pain
495262|NCT01041495|Sleep|sleep
495263|NCT01041495|Fatigue|fatigue
495264|NCT01041482|sorafenib|sorafenib
495265|NCT01041482|renal cell carcinoma|renal cell carcinoma
495266|NCT01041482|disease free survival|disease free survival
495267|NCT01041482|Hand food skin reaction|hand food skin reaction
495268|NCT01041469|Down syndrome, Humans,Clinical study,Immunity, Autoimmunity,|down syndrome, humans,clinical study,immunity, autoimmunity,
495269|NCT01041456|complicated biliopancreatic diversion|complicated biliopancreatic diversion
495270|NCT01041456|failed biliopancreatic diversion|failed biliopancreatic diversion
495271|NCT01041456|revision gastric bypass|revision gastric bypass
495272|NCT01041456|conversion bariatric surgery|conversion bariatric surgery
495273|NCT01041456|revision bariatric surgery|revision bariatric surgery
495274|NCT01041456|re-operative bariatric surgery|re-operative bariatric surgery
495275|NCT01041456|malabsorptive syndrome|malabsorptive syndrome
495276|NCT01041456|protein malnutrition|protein malnutrition
495277|NCT01041456|metabolic bone disease|metabolic bone disease
495278|NCT01041430|Ambulatory Surgery|ambulatory surgery
495279|NCT01041430|Aged|aged
495280|NCT01041417|claudication|claudication
495281|NCT01041391|Surgical intervention vs Non-Surgical intervention|surgical intervention vs non-surgical intervention
495282|NCT01041378|Pediatric patients (6 months-5 years) scheduled elective day-case orchiopexy|pediatric patients (6 months-5 years) scheduled elective day-case orchiopexy
495283|NCT01041365|insulin sensitivity|insulin sensitivity
495284|NCT01041365|vascular function|vascular function
495285|NCT01041365|flow-mediated dilation|flow-mediated dilation
495286|NCT01041365|arterial stiffness|arterial stiffness
495287|NCT01041365|ethnicity|ethnicity
495288|NCT01041365|adolescents|adolescents
495289|NCT01041365|females|females
495290|NCT01041365|glucose tolerance|glucose tolerance
495291|NCT01041365|diabetes|diabetes
495581|NCT01040338|Dependence|dependence
495292|NCT01041365|hypertension|hypertension
495293|NCT01041365|cardiovascular|cardiovascular
495294|NCT01041352|anaesthesia|anaesthesia
495295|NCT01041352|laryngeal mask|laryngeal mask
495296|NCT01041352|prone position|prone position
495297|NCT01041339|LpPLA2|lppla2
495298|NCT01041339|ST elevation|st elevation
495299|NCT01041339|acute pericarditis|acute pericarditis
495300|NCT01041326|prostatectomy|prostatectomy
495301|NCT01041326|radiation|radiation
495302|NCT01041326|neoadjuvant|neoadjuvant
495303|NCT01041313|Adjuvants, pharmaceuticals|adjuvants, pharmaceuticals
495304|NCT01041313|Receptors, N-Methyl-D-Aspartate|receptors, n-methyl-d-aspartate
495305|NCT01041313|Drug tolerance|drug tolerance
495306|NCT01041313|Pain Measurement|pain measurement
495307|NCT01041300|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
495308|NCT01041300|TMS|tms
495309|NCT01041300|Motor Threashold|motor threashold
495310|NCT01041300|Multiway|multiway
495311|NCT01041300|Magstim Rapid 2|magstim rapid 2
495312|NCT01041300|Abductor policis brevis|abductor policis brevis
495313|NCT01041300|Figure 8 coil|figure 8 coil
495314|NCT01041300|Double cone coil|double cone coil
495315|NCT01041300|Circular coil|circular coil
495316|NCT01041300|Brainsway|brainsway
495317|NCT01041300|Healthy participants.|healthy participants.
495318|NCT01041274|Schizophrenia|schizophrenia
495319|NCT01041274|Citalopram|citalopram
495320|NCT01041274|First episode|first episode
495321|NCT01041274|fMRI|fmri
495322|NCT01041274|Cognitive behavioral therapy|cognitive behavioral therapy
495323|NCT01041274|Psychoeducation|psychoeducation
495324|NCT01041261|Laparoscopic gastric bypass surgery|laparoscopic gastric bypass surgery
495325|NCT01041261|Medical food|medical food
495326|NCT01041261|Body composition|body composition
495327|NCT01041261|Dietary intervention|dietary intervention
495328|NCT01041248|Relapsing Polychondritis|relapsing polychondritis
495329|NCT01041248|Single Patient Study|single patient study
495330|NCT01041248|Tocilizumab|tocilizumab
495331|NCT01041235|Solid Neoplasms|solid neoplasms
495332|NCT01041235|Carcinoma|carcinoma
495333|NCT01041235|Breast|breast
495334|NCT01041235|Ovarian|ovarian
495335|NCT01041235|Ovary|ovary
495336|NCT01041235|Pancreas|pancreas
495337|NCT01041235|Pancreatic|pancreatic
495338|NCT01041235|Lung|lung
495339|NCT01041235|NSCLC|nsclc
495340|NCT01041235|Non Small Cell Lung|non small cell lung
495341|NCT01041235|Prostate|prostate
495342|NCT01041235|Gastric|gastric
495343|NCT01041235|Head and Neck|head and neck
495344|NCT01041222|Familial ALS|familial als
495345|NCT01041222|ALS|als
495346|NCT01041222|SOD1 Protein|sod1 protein
495347|NCT01041222|ISIS 333611|isis 333611
495348|NCT01041222|SOD1Rx|sod1rx
495349|NCT01041209|Pneumonia|pneumonia
495350|NCT01041209|Children|children
495351|NCT01041196|obesity|obesity
495352|NCT01041196|ulcer disease|ulcer disease
495353|NCT01041196|marginal ulcer|marginal ulcer
495354|NCT01041196|perforation|perforation
495355|NCT01041196|abdominal pain|abdominal pain
495356|NCT01041196|bariatric surgery|bariatric surgery
495357|NCT01041196|weight loss surgery|weight loss surgery
495358|NCT01041183|Oral plus IV ramosetron may be more effective than|oral plus iv ramosetron may be more effective than
495359|NCT01041183|IV ramosetron and oral ramosetron for the prophylaxis of|iv ramosetron and oral ramosetron for the prophylaxis of
495360|NCT01041183|PONV after laparoscopic cholecystectomy|ponv after laparoscopic cholecystectomy
495361|NCT01041170|Rimonabant|rimonabant
495362|NCT01041170|fMRI|fmri
495363|NCT01041170|Alternative Matrices|alternative matrices
495364|NCT01041170|Brain Imaging|brain imaging
495365|NCT01041170|THC|thc
495366|NCT01041157|Torticollis|torticollis
495367|NCT01041157|Botulinum Toxins|botulinum toxins
495368|NCT01041144|Diabetes|diabetes
495369|NCT01041144|PDA|pda
495370|NCT01041144|Internet|internet
495371|NCT01041144|HbA1c|hba1c
495372|NCT01041131|Obesity|obesity
495373|NCT01041131|Obesity recidivism|obesity recidivism
495374|NCT01041131|Inadequate Initial Weight Loss|inadequate initial weight loss
495375|NCT01041131|Technical bariatric complications|technical bariatric complications
495376|NCT01041131|Complicated gastroplasty|complicated gastroplasty
495377|NCT01041131|Failed gastroplasty|failed gastroplasty
495378|NCT01041131|Gastroesophageal reflux disease|gastroesophageal reflux disease
495379|NCT01041131|Revisional gastric bypass|revisional gastric bypass
495380|NCT01041131|Conversion bariatric surgery|conversion bariatric surgery
495381|NCT01041131|Re-operative bariatric surgery|re-operative bariatric surgery
495382|NCT01041131|Technical complications of vertical gastroplasty|technical complications of vertical gastroplasty
495383|NCT01041131|Complicated vertical gastroplasty|complicated vertical gastroplasty
495384|NCT01041105|Obesity|obesity
495385|NCT01041105|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
495386|NCT01041105|Nissen funduplication|nissen funduplication
495387|NCT01041105|Antireflux surgery|antireflux surgery
495388|NCT01041105|Revisional Gastric Bypass|revisional gastric bypass
495389|NCT01041105|Re-operative bariatric surgery|re-operative bariatric surgery
495390|NCT01041105|Bariatric surgery|bariatric surgery
495391|NCT01041105|Nissen|nissen
495392|NCT01041105|Conversion of Nissen to Gastric Bypass|conversion of nissen to gastric bypass
495393|NCT01041079|ulcer disease|ulcer disease
495394|NCT01041079|marginal ulcer|marginal ulcer
495395|NCT01041079|morbidity of gastric bypass|morbidity of gastric bypass
495396|NCT01041079|late morbidity of gastric bypass|late morbidity of gastric bypass
495397|NCT01041079|chronic abdominal pain|chronic abdominal pain
495398|NCT01041079|GI hemorrhage|gi hemorrhage
495399|NCT01041079|Perforation|perforation
495400|NCT01041079|Penetration|penetration
495401|NCT01041079|Obstruction|obstruction
495402|NCT01041066|patients who are intubated for general anesthesia|patients who are intubated for general anesthesia
495403|NCT01041040|Acute Myeloblastic Leukemia|acute myeloblastic leukemia
495404|NCT01041014|Limited English proficiency|limited english proficiency
495405|NCT01041014|Cost-effectiveness|cost-effectiveness
495406|NCT01041014|Emergency Departments|emergency departments
495407|NCT01041014|Language Discordance|language discordance
495408|NCT01041014|Satisfaction|satisfaction
495409|NCT01041014|Limited English proficient patients|limited english proficient patients
495410|NCT01041014|Spanish-speaking patients|spanish-speaking patients
495411|NCT01041001|Umbilical Cord Blood|umbilical cord blood
495412|NCT01041001|Mesenchymal Stem Cells|mesenchymal stem cells
495413|NCT01041001|cartilage injury|cartilage injury
495414|NCT01041001|osteoarthritis|osteoarthritis
495415|NCT01040988|Pacemaker|pacemaker
495416|NCT01040988|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
495417|NCT01040962|neuropathy|neuropathy
495418|NCT01040962|diabetes|diabetes
495419|NCT01040949|smoking cessation|smoking cessation
495420|NCT01040949|pregnant Latinas|pregnant latinas
495421|NCT01040949|couples communication|couples communication
495422|NCT01040949|Latino community|latino community
495423|NCT01040949|couples communication in Latino couples|couples communication in latino couples
495424|NCT01040936|acute coronary syndrome|acute coronary syndrome
495425|NCT01040936|intervention|intervention
495426|NCT01040936|outcome|outcome
495427|NCT01040936|patients diagnosed ad Non-ST elevation ACS|patients diagnosed ad non-st elevation acs
495428|NCT01040936|patients received PCI therapy|patients received pci therapy
495429|NCT01040923|CAD|cad
495430|NCT01040923|Diagnostic|diagnostic
495431|NCT01040910|cannabis|cannabis
495432|NCT01040910|Crohn's disease|crohn's disease
495433|NCT01040910|Ulcerative colitis|ulcerative colitis
495434|NCT01040910|IBD|ibd
495435|NCT01040897|Obesity prevention|obesity prevention
495436|NCT01040897|Health Literacy|health literacy
495437|NCT01040897|Health Communication|health communication
495438|NCT01040858|cognitive strategy intervention|cognitive strategy intervention
495439|NCT01040858|cognitive disorders|cognitive disorders
495440|NCT01040845|healthy|healthy
495441|NCT01040845|pharmacokinetics|pharmacokinetics
495442|NCT01040845|drug-interaction|drug-interaction
495443|NCT01040832|Head and Neck Cancer|head and neck cancer
495444|NCT01040832|Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Cancer|recurrent or metastatic squamous cell carcinoma of the head and neck cancer
495445|NCT01040832|Cetuximab|cetuximab
495446|NCT01040832|EMD 1201081|emd 1201081
495447|NCT01040819|Diabetes Mellitus|diabetes mellitus
495448|NCT01040819|6-Ketoprostaglandin F1 alpha|6-ketoprostaglandin f1 alpha
495449|NCT01040819|15-epi-lipoxin A4|15-epi-lipoxin a4
495450|NCT01040819|Thiazolidinediones|thiazolidinediones
495451|NCT01040819|Pioglitazone|pioglitazone
495452|NCT01040806|Diabetes|diabetes
495453|NCT01040780|Efficacy|efficacy
495454|NCT01040780|Safety|safety
495455|NCT01040780|EGFR-TKI|egfr-tki
495456|NCT01040780|phase III|phase iii
495457|NCT01040780|NSCLC|nsclc
495458|NCT01040767|Ultrasound education|ultrasound education
495459|NCT01040767|Blended learning|blended learning
495460|NCT01040767|Distance education|distance education
495461|NCT01040767|Trauma ultrasound|trauma ultrasound
495462|NCT01040767|FAST|fast
495463|NCT01040741|Pandemic influenza A (H1N1) vaccine|pandemic influenza a (h1n1) vaccine
495464|NCT01040741|Adjuvanted|adjuvanted
495465|NCT01040715|Rheumatoid arthritis|rheumatoid arthritis
495466|NCT01040715|anti-drug antibodies|anti-drug antibodies
495467|NCT01040715|Rheumatoid arthritis with secondary loss of efficacy to anti-TNFa antagonists and anti-drug antibodies|rheumatoid arthritis with secondary loss of efficacy to anti-tnfa antagonists and anti-drug antibodies
495468|NCT01040676|Diabetes Mellitus|diabetes mellitus
495469|NCT01040676|Telephone|telephone
495470|NCT01040676|Nutrition Support|nutrition support
495471|NCT01040676|Automated|automated
495472|NCT01040676|Low English Proficiency|low english proficiency
495473|NCT01040676|Hispanic|hispanic
495474|NCT01040676|Latino|latino
495475|NCT01040637|Healthy subjects|healthy subjects
495476|NCT01040624|Prostate Cancer, Proton Radiation|prostate cancer, proton radiation
495477|NCT01040611|music therapy|music therapy
495478|NCT01040611|Tuberculosis|tuberculosis
495479|NCT01040611|anxiety|anxiety
495480|NCT01040611|physiological response|physiological response
495481|NCT01040598|Eosinophilic Esophagitis|eosinophilic esophagitis
495482|NCT01040598|Xolair|xolair
495483|NCT01040598|Omalizumab|omalizumab
495484|NCT01040598|Esophagitis|esophagitis
495485|NCT01040598|Eosinophils|eosinophils
495486|NCT01040598|monoclonal antibody|monoclonal antibody
495487|NCT01040585|cost effectiveness|cost effectiveness
495488|NCT01040585|linezolid|linezolid
495489|NCT01040585|ventilator acquired pneumonia|ventilator acquired pneumonia
495490|NCT01040585|central america|central america
495491|NCT01040572|Obesity recidivism|obesity recidivism
495492|NCT01040572|Weight Regain|weight regain
495493|NCT01040572|Weight recidivism|weight recidivism
495494|NCT01040572|Morbidity|morbidity
495495|NCT01040572|Complication|complication
495496|NCT01040572|Late complications|late complications
495497|NCT01040572|Revisional gastric bypass|revisional gastric bypass
495498|NCT01040572|Re-operative gastric bypass|re-operative gastric bypass
495499|NCT01040572|Revisional bariatric surgery|revisional bariatric surgery
495500|NCT01040572|Re-operative bariatric surgery|re-operative bariatric surgery
495501|NCT01040546|Obesity|obesity
495502|NCT01040546|Metabolic syndrome|metabolic syndrome
495503|NCT01040546|Weight control educational intervention|weight control educational intervention
495504|NCT01040546|Food intake|food intake
495505|NCT01040533|Failed jejunoileal bypass|failed jejunoileal bypass
495506|NCT01040533|Complicated jejunoileal bypass|complicated jejunoileal bypass
495507|NCT01040533|Revision gastric bypass|revision gastric bypass
495508|NCT01040533|Revisional surgery|revisional surgery
495509|NCT01040533|Reoperations|reoperations
495510|NCT01040533|Metabolic and nutritional complications|metabolic and nutritional complications
495511|NCT01040520|CT-based autopsy|ct-based autopsy
495512|NCT01040520|virtual autopsy|virtual autopsy
495513|NCT01040520|medical autopsy|medical autopsy
495514|NCT01040520|quality control|quality control
495515|NCT01040507|severe obesity|severe obesity
495516|NCT01040507|morbid obesity|morbid obesity
495517|NCT01040507|gastric bypass|gastric bypass
495518|NCT01040507|efficacy of gastric bypass|efficacy of gastric bypass
495519|NCT01040494|Aliskiren|aliskiren
495520|NCT01040494|Congestive heart failure|congestive heart failure
495521|NCT01040494|Central hemodynamics|central hemodynamics
495522|NCT01040481|Failed gastric bypass|failed gastric bypass
495523|NCT01040481|Malabsorptive distal gastric bypass|malabsorptive distal gastric bypass
495524|NCT01040481|Distal gastric bypass|distal gastric bypass
495525|NCT01040481|Malabsorptive gastric bypass|malabsorptive gastric bypass
495526|NCT01040481|Adding malabsorption|adding malabsorption
495527|NCT01040481|Increasing malabsorption|increasing malabsorption
495528|NCT01040481|Re-operative bariatric surgery|re-operative bariatric surgery
495529|NCT01040481|Revisional bariatric surgery|revisional bariatric surgery
495530|NCT01040481|Revisional gastric bypass|revisional gastric bypass
495531|NCT01040481|Reoperations|reoperations
495532|NCT01040481|Conversions|conversions
495533|NCT01040468|Type 2 Diabetes|type 2 diabetes
495534|NCT01040468|Bariatric Surgery|bariatric surgery
495535|NCT01040468|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
495536|NCT01040468|Gastric Banding|gastric banding
495537|NCT01040468|Obesity|obesity
495538|NCT01040468|Weight loss|weight loss
495539|NCT01040468|Insulin sensitivity|insulin sensitivity
495540|NCT01040468|GLP-1|glp-1
495541|NCT01040468|Meal Challenge|meal challenge
495542|NCT01040468|Euglycemic Clamp|euglycemic clamp
495543|NCT01040455|functional dyspepsia|functional dyspepsia
495544|NCT01040455|lansoprazole|lansoprazole
495545|NCT01040455|placebo effect|placebo effect
495546|NCT01040442|Postural Balance|postural balance
495547|NCT01040442|Aging|aging
495548|NCT01040442|Accidental Falls|accidental falls
495549|NCT01040442|Vibration|vibration
495550|NCT01040429|Adolescent|adolescent
495551|NCT01040429|Clonidine|clonidine
495552|NCT01040429|Autonomic nervous system|autonomic nervous system
495553|NCT01040429|Stress|stress
495554|NCT01040416|complicated marginal ulcer|complicated marginal ulcer
495555|NCT01040416|complex marginal ulcer|complex marginal ulcer
495556|NCT01040416|complication after gastric bypass|complication after gastric bypass
495557|NCT01040416|gastrointestinal hemorrhage|gastrointestinal hemorrhage
495558|NCT01040390|Acne Vulgaris|acne vulgaris
495559|NCT01040390|Homoeopathy|homoeopathy
495560|NCT01040390|Lappa Arctium|lappa arctium
495561|NCT01040377|Inadequate Initial Weight Loss|inadequate initial weight loss
495562|NCT01040377|Inadequate weight loss|inadequate weight loss
495563|NCT01040377|Poor weight loss|poor weight loss
495564|NCT01040377|Failed gastric bypass|failed gastric bypass
495565|NCT01040377|Revision gastric bypass|revision gastric bypass
495566|NCT01040364|Internal hernia|internal hernia
495567|NCT01040364|Mesocolic hernia|mesocolic hernia
495568|NCT01040364|Petersen´s hernia|petersen´s hernia
495569|NCT01040364|Jejunojejunostomy hernia|jejunojejunostomy hernia
495570|NCT01040364|Bowel obstruction|bowel obstruction
495571|NCT01040364|Ischemic bowel|ischemic bowel
495572|NCT01040364|Complication after gastric bypass|complication after gastric bypass
495573|NCT01040364|Re-operative bariatric surgery|re-operative bariatric surgery
495574|NCT01040364|Chronic pain after gastric bypass|chronic pain after gastric bypass
495575|NCT01040351|Infertility|infertility
495576|NCT01040351|Hydrosalpinx|hydrosalpinx
495577|NCT01040351|IVF-ET|ivf-et
495578|NCT01040338|Smoking|smoking
495579|NCT01040338|Tobacco|tobacco
495580|NCT01040338|Nicotine|nicotine
495582|NCT01040338|Genetics|genetics
495583|NCT01040312|UGT1A1, irinotecan|ugt1a1, irinotecan
495584|NCT01040299|GangTrainer|gangtrainer
495585|NCT01040299|Gait Rehabilitation|gait rehabilitation
495586|NCT01040299|Cerebrovascular Disorders|cerebrovascular disorders
495587|NCT01040299|Robot assisted|robot assisted
495588|NCT01040299|Transcranial direct current stimulation|transcranial direct current stimulation
495589|NCT01040286|Subjects, age>21, with Chronic periodontal disease on natural teeth characterized by the presence of at least 2 teeth with periodontal|subjects, age>21, with chronic periodontal disease on natural teeth characterized by the presence of at least 2 teeth with periodontal
495590|NCT01040286|pockets of 5-9 mm in depth demonstrating bleeding on probing without involving the|pockets of 5-9 mm in depth demonstrating bleeding on probing without involving the
495591|NCT01040286|apex of the tooth and confirmed by dental X-ray.|apex of the tooth and confirmed by dental x-ray.
495592|NCT01040260|tobacco use disorder|tobacco use disorder
495593|NCT01040247|Infertility|infertility
495594|NCT01040247|Low Responder|low responder
495595|NCT01040247|IVF|ivf
495596|NCT01040247|Embryo Transfer|embryo transfer
495597|NCT01040234|postoperative pain|postoperative pain
495598|NCT01040234|abdominal surgery|abdominal surgery
495599|NCT01040234|bilateral dual TAP block|bilateral dual tap block
495600|NCT01040221|Autism, Autism Spectrum Disorder|autism, autism spectrum disorder
495601|NCT01040221|ASD|asd
495602|NCT01040221|Trichuris Suis Ova|trichuris suis ova
495603|NCT01040221|TSO|tso
495604|NCT01040221|Treatment|treatment
495605|NCT01040221|Clinical Trial|clinical trial
495606|NCT01040195|ankylosing spondylitis|ankylosing spondylitis
495607|NCT01040195|undifferentiated spondyloarthropathy|undifferentiated spondyloarthropathy
495608|NCT01040195|spondyloarthropathy|spondyloarthropathy
495609|NCT01040195|inflammatory back pain|inflammatory back pain
495610|NCT01040195|methotrexate|methotrexate
495611|NCT01040195|sulfasalazine|sulfasalazine
495612|NCT01040195|hydroxychloroquine|hydroxychloroquine
495613|NCT01040182|ischemic stroke patients|ischemic stroke patients
495614|NCT01040143|Pneumococci|pneumococci
495615|NCT01040143|Streptococcus pneumoniae|streptococcus pneumoniae
495616|NCT01040117|Equilibrium|equilibrium
495617|NCT01040117|Rehabilitation|rehabilitation
495618|NCT01040117|Randomized Controlled Trial|randomized controlled trial
495619|NCT01040117|Postural instability|postural instability
495620|NCT01040117|Sensory-motor integration|sensory-motor integration
495621|NCT01040104|wound healing|wound healing
495622|NCT01040104|hypertrophic scar|hypertrophic scar
495623|NCT01040104|skin transplantation|skin transplantation
495624|NCT01040104|diabetes mellitus|diabetes mellitus
495625|NCT01040091|HIV Seronegativity|hiv seronegativity
495626|NCT01040091|Treatment Experienced|treatment experienced
495627|NCT01040065|Acromioclavicular joint arthritis|acromioclavicular joint arthritis
495628|NCT01040065|distal clavicle resection|distal clavicle resection
495629|NCT01040065|Mumford procedure|mumford procedure
495630|NCT01040052|Diphtheria|diphtheria
495631|NCT01040052|Tetanus|tetanus
495632|NCT01040052|Pertussis|pertussis
495633|NCT01040052|Adacel®|adacel®
495634|NCT01040039|HCV|hcv
495635|NCT01040039|HIV|hiv
495636|NCT01040013|LAPAROSCOPY,|laparoscopy,
495637|NCT01040013|LAPAROTOMY,|laparotomy,
495638|NCT01040013|OXYGENATION,|oxygenation,
495639|NCT01040013|ISCHEMIA-REPERFUSION INJURY|ischemia-reperfusion injury
495640|NCT01040000|NPC-1C|npc-1c
495641|NCT01040000|Monoclonal antibody|monoclonal antibody
495642|NCT01040000|Pancreatic Cancer|pancreatic cancer
495643|NCT01040000|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
495644|NCT01040000|Ductal carcinoma of the pancreas|ductal carcinoma of the pancreas
495645|NCT01040000|Duct cell carcinomas, pancreas|duct cell carcinomas, pancreas
495646|NCT01040000|Carcinomas, pancreas duct cell|carcinomas, pancreas duct cell
495647|NCT01040000|Pancreas duct cell carcinoma|pancreas duct cell carcinoma
495648|NCT01040000|Pancreatic duct cell carcinoma|pancreatic duct cell carcinoma
495649|NCT01040000|Adenocarcinoma of the colon|adenocarcinoma of the colon
495650|NCT01040000|Adenocarcinoma of the rectum|adenocarcinoma of the rectum
495651|NCT01040000|Colorectal cancer|colorectal cancer
495652|NCT01040000|Colorectal tumor|colorectal tumor
495653|NCT01040000|Colorectal neoplasm|colorectal neoplasm
495654|NCT01039987|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
495655|NCT01039987|ADPKD|adpkd
495656|NCT01039987|kidney|kidney
495657|NCT01039987|Biomarker|biomarker
495658|NCT01039987|MRI|mri
495659|NCT01039974|ketoconazole|ketoconazole
495660|NCT01039974|GSK962040|gsk962040
495661|NCT01039974|Drug-Drug Interaction|drug-drug interaction
495662|NCT01039974|Phase I|phase i
495663|NCT01039961|healthy volunteers|healthy volunteers
495664|NCT01039961|IV formulation study|iv formulation study
495665|NCT01039948|Neoplasms|neoplasms
495666|NCT01039948|Carcinoma|carcinoma
495667|NCT01039948|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
495668|NCT01039948|Lung Neoplasms|lung neoplasms
495669|NCT01039948|Respiratory Tract Neoplasms|respiratory tract neoplasms
495670|NCT01039948|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
495671|NCT01039948|Neoplasms by Histological Type|neoplasms by histological type
495672|NCT01039948|Thoracic Neoplasms|thoracic neoplasms
495673|NCT01039948|Neoplasms by Site|neoplasms by site
495674|NCT01039948|Lung Diseases|lung diseases
495675|NCT01039948|Respiratory Tract Diseases|respiratory tract diseases
495676|NCT01039948|Gefitinib|gefitinib
495677|NCT01039948|Antineoplastic Agents|antineoplastic agents
495678|NCT01039948|Therapeutic Uses|therapeutic uses
495679|NCT01039948|Pharmacologic Actions|pharmacologic actions
495680|NCT01039948|Protein Kinase Inhibitors|protein kinase inhibitors
495681|NCT01039948|Enzyme Inhibitors|enzyme inhibitors
495682|NCT01039948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
495683|NCT01039935|Odor Discrimination|odor discrimination
495684|NCT01039922|Neuroendocrine Tumors|neuroendocrine tumors
495685|NCT01039922|Registries|registries
495686|NCT01039883|Healthy Volunteers|healthy volunteers
495687|NCT01039870|postthoracotomy pain|postthoracotomy pain
495688|NCT01039857|Psychotherapy|psychotherapy
495689|NCT01039857|Depression|depression
495690|NCT01039857|Adjustment Disorders|adjustment disorders
495691|NCT01039857|Neuropsychology|neuropsychology
495692|NCT01039857|Rehabilitation|rehabilitation
495693|NCT01039857|Coping Skills|coping skills
495694|NCT01039857|Stroke|stroke
495695|NCT01039857|Caregivers|caregivers
495696|NCT01039844|LOC-paclitaxel Injection|loc-paclitaxel injection
495697|NCT01039844|metastatic Melanoma|metastatic melanoma
495698|NCT01039831|PIGD|pigd
495699|NCT01039831|tremor|tremor
495700|NCT01039831|falls|falls
495701|NCT01039831|white matter|white matter
495702|NCT01039818|Graves Disease|graves disease
495703|NCT01039818|Hyperthyroidism|hyperthyroidism
495704|NCT01039818|Radioiodine|radioiodine
495705|NCT01039818|Clinical trial|clinical trial
495706|NCT01039805|GSK962040|gsk962040
495707|NCT01039805|13C octanoic acid breath test|13c octanoic acid breath test
495708|NCT01039805|pharmacokinetics|pharmacokinetics
495709|NCT01039805|critically ill patients|critically ill patients
495710|NCT01039805|gut motility|gut motility
495711|NCT01039805|pharmacodynamics|pharmacodynamics
495712|NCT01039805|tolerability|tolerability
495713|NCT01039805|single dose|single dose
495714|NCT01039805|gastric emtpying|gastric emtpying
495715|NCT01039792|Autism|autism
495716|NCT01039792|Pervasive Developmental Disorders|pervasive developmental disorders
495717|NCT01039779|older fallers|older fallers
495718|NCT01039779|tai chi|tai chi
495719|NCT01039766|post traumatic stress disorder|post traumatic stress disorder
495720|NCT01039766|prevention|prevention
495721|NCT01039766|oxytocin|oxytocin
495722|NCT01039753|acute kidney injury|acute kidney injury
495723|NCT01039753|renal replacement therapy|renal replacement therapy
495724|NCT01039753|biomarkers|biomarkers
495725|NCT01039740|Pharmacogenomics|pharmacogenomics
495726|NCT01039740|Prediction of Mirtazapine response|prediction of mirtazapine response
495727|NCT01039740|Depressed patients|depressed patients
495728|NCT01039740|Mirtazapine response|mirtazapine response
495729|NCT01039740|Adverse event|adverse event
495730|NCT01039727|Pain [C10.597.617]|pain [c10.597.617]
495731|NCT01039714|Hypocalcemia|hypocalcemia
495732|NCT01039714|Hypoparathyroidism|hypoparathyroidism
495733|NCT01039714|Vitamin D deficiency|vitamin d deficiency
495734|NCT01039714|Total thyroidectomy|total thyroidectomy
495735|NCT01039714|calcium|calcium
495736|NCT01039714|PTH|pth
495737|NCT01039701|safety|safety
495738|NCT01039701|tolerability|tolerability
495739|NCT01039701|mild to moderate Alzheimer's disease|mild to moderate alzheimer's disease
495740|NCT01039701|To determine the safety and tolerability of AZD1446 vs Placebo given as an add-on treatment to Donepezil in patients with mild to moderate Alzheimer's disease|to determine the safety and tolerability of azd1446 vs placebo given as an add-on treatment to donepezil in patients with mild to moderate alzheimer's disease
495741|NCT01039688|oral JAK inhibitor|oral jak inhibitor
495742|NCT01039688|MTX|mtx
495743|NCT01039688|DMARD|dmard
495744|NCT01039688|clinical trial|clinical trial
495745|NCT01039688|joint diseases|joint diseases
495746|NCT01039688|autoimmune diseases|autoimmune diseases
495747|NCT01039688|anti-Inflammatory agents|anti-inflammatory agents
495748|NCT01039688|rheumatic diseases|rheumatic diseases
495749|NCT01039675|long-acting beta2-receptor agonist|long-acting beta2-receptor agonist
495750|NCT01039675|Safety and tolerability|safety and tolerability
495751|NCT01039675|pharmacodynamics|pharmacodynamics
495752|NCT01039675|pharmacokinetics|pharmacokinetics
495753|NCT01039675|long-acting muscarinic receptor antagonist|long-acting muscarinic receptor antagonist
495754|NCT01039675|COPD|copd
495755|NCT01039649|radiation|radiation
495756|NCT01039649|Tomography, Spiral Computed|tomography, spiral computed
495757|NCT01039649|Four-Dimensional Computed Tomography|four-dimensional computed tomography
495758|NCT01039649|Respiratory Function Tests|respiratory function tests
495759|NCT01039636|Beta-thalassemia|beta-thalassemia
495760|NCT01039636|Sickle cell anemia|sickle cell anemia
495761|NCT01039636|Transfusional iron overload|transfusional iron overload
495762|NCT01039636|Iron overload|iron overload
495763|NCT01039636|Iron chelation|iron chelation
495764|NCT01039623|Healthy volunteers|healthy volunteers
495765|NCT01039610|single dose|single dose
495766|NCT01039610|pharmacokinetics|pharmacokinetics
495767|NCT01039610|GSK945237|gsk945237
495768|NCT01039610|tolerability|tolerability
495769|NCT01039610|safety|safety
495770|NCT01039610|antibiotics|antibiotics
495771|NCT01039610|linezolid|linezolid
495772|NCT01039610|QTc|qtc
495773|NCT01039610|bacterial type II topoisomerase Inhibitors (BTI)|bacterial type ii topoisomerase inhibitors (bti)
495774|NCT01039610|moxifloxacin|moxifloxacin
495775|NCT01039610|repeat dose|repeat dose
495776|NCT01039597|IBD|ibd
495777|NCT01039597|Ulcerative colitis|ulcerative colitis
495778|NCT01039584|bioequivalence|bioequivalence
495779|NCT01039584|butoconazole|butoconazole
495780|NCT01039584|vulvovaginal|vulvovaginal
495781|NCT01039584|candidiasis|candidiasis
495782|NCT01039571|rotator cuff tear|rotator cuff tear
495783|NCT01039571|arthroscopic repair|arthroscopic repair
495784|NCT01039571|single row repair|single row repair
495785|NCT01039571|double row repair|double row repair
495786|NCT01039571|retear rate|retear rate
495787|NCT01039558|gastroesophageal reflux disease|gastroesophageal reflux disease
495788|NCT01039558|lansoprazole|lansoprazole
495789|NCT01039558|ecabet sodium|ecabet sodium
495790|NCT01039545|Urinary tract infections|urinary tract infections
495791|NCT01039545|Anti-bacterial agents|anti-bacterial agents
495792|NCT01039532|Type 2 diabetes mellitus|type 2 diabetes mellitus
495793|NCT01039532|Biphasic human insulin thrice a day|biphasic human insulin thrice a day
495794|NCT01039532|Basal bolus insulin|basal bolus insulin
495795|NCT01039519|G.I. Stromal Tumor|g.i. stromal tumor
495796|NCT01039519|GIST|gist
495797|NCT01039506|UGT1A1, irinotecan|ugt1a1, irinotecan
495798|NCT01039480|pharmacological biomarker|pharmacological biomarker
495799|NCT01039480|compliance monitoring|compliance monitoring
495800|NCT01039480|platelet aggregometry|platelet aggregometry
495801|NCT01039480|resistance|resistance
495802|NCT01039480|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
495803|NCT01039480|Medication Non-Compliance|medication non-compliance
495804|NCT01039467|Managed Ventricular Pacing|managed ventricular pacing
495805|NCT01039454|Food Reward|food reward
495806|NCT01039454|fMRI|fmri
495807|NCT01039454|Obese|obese
495808|NCT01039454|Cognition|cognition
495809|NCT01039454|Food Addiction|food addiction
495810|NCT01039454|Behaviour|behaviour
495811|NCT01039454|Overweight|overweight
495812|NCT01039454|Food Reinforcement|food reinforcement
495813|NCT01039454|Metabolic endpoints|metabolic endpoints
495814|NCT01039428|hyperphosphatemia|hyperphosphatemia
495815|NCT01039428|hemodialysis|hemodialysis
495816|NCT01039428|chitosan|chitosan
495817|NCT01039415|marijuana|marijuana
495818|NCT01039415|marijuana abuse|marijuana abuse
495819|NCT01039415|marijuana dependence|marijuana dependence
495820|NCT01039415|cannabis|cannabis
495821|NCT01039415|substance-related disorder|substance-related disorder
495822|NCT01039415|abstinence|abstinence
495823|NCT01039402|cardiovascular risk|cardiovascular risk
495824|NCT01039402|France|france
495825|NCT01039402|Observational, descriptive study|observational, descriptive study
495826|NCT01039389|Coronary Artery Disease|coronary artery disease
495827|NCT01039389|Stable|stable
495828|NCT01039389|Coronary Collaterals|coronary collaterals
495829|NCT01039389|Therapeutic Collateral Promotion|therapeutic collateral promotion
495830|NCT01039389|Arteriogenesis|arteriogenesis
495831|NCT01039389|Bradycardia|bradycardia
495832|NCT01039376|maintenance therapy|maintenance therapy
495833|NCT01039376|anti-CD20 monoclonal antibody|anti-cd20 monoclonal antibody
495834|NCT01039376|ofatumumab|ofatumumab
495835|NCT01039363|Relapse or refractory acute myeloid leukemia|relapse or refractory acute myeloid leukemia
495836|NCT01039350|Myelodysplastic syndrome|myelodysplastic syndrome
495837|NCT01039337|osteoarthritis|osteoarthritis
495838|NCT01039337|manual therapy|manual therapy
495839|NCT01039337|manipulation|manipulation
495840|NCT01039337|hip school|hip school
495841|NCT01039337|chiropractic|chiropractic
495842|NCT01039337|patient education|patient education
495843|NCT01039324|Complex patients|complex patients
495844|NCT01039324|Care transitions|care transitions
495845|NCT01039324|Patient safety|patient safety
495846|NCT01039324|Patient care|patient care
495847|NCT01039324|Health Information Technology|health information technology
495848|NCT01039324|Health Information Exchange|health information exchange
495849|NCT01039324|Clinical Decision Support|clinical decision support
495850|NCT01039324|Care coordination|care coordination
495851|NCT01039324|Data sharing|data sharing
495852|NCT01039311|Lung|lung
495853|NCT01039311|cancer|cancer
495854|NCT01039311|bronchoscopy|bronchoscopy
495855|NCT01039311|optical|optical
495856|NCT01039311|coherence|coherence
495857|NCT01039311|tomography|tomography
495858|NCT01039298|Oral cancer|oral cancer
495859|NCT01039298|fluorescence visualization|fluorescence visualization
495860|NCT01039298|surgical margin|surgical margin
495861|NCT01039298|recurrence|recurrence
495862|NCT01039285|Very premature infant|very premature infant
495863|NCT01039285|Surfactant|surfactant
495864|NCT01039285|Respiratory Distress|respiratory distress
495865|NCT01039285|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
495866|NCT01039272|oral cancer|oral cancer
495867|NCT01039272|EBV|ebv
495868|NCT01039272|PCR|pcr
495869|NCT01039259|adolescent|adolescent
495870|NCT01039259|body piercing/adverse effects|body piercing/adverse effects
495871|NCT01039259|tongue piercing|tongue piercing
495872|NCT01039259|tongue/microbiology|tongue/microbiology
495873|NCT01039181|Vitamin D|vitamin d
495874|NCT01039181|Calcitriol|calcitriol
495875|NCT01039181|cholangiocarcinoma|cholangiocarcinoma
495876|NCT01039181|Clinical trial|clinical trial
495877|NCT01039168|Burnout|burnout
495878|NCT01039168|Sick leave|sick leave
495879|NCT01039168|Intervention study|intervention study
495880|NCT01039168|Prospective study|prospective study
495881|NCT01039168|Work|work
495882|NCT01039142|Psoriasis|psoriasis
495883|NCT01039129|Gallstones|gallstones
495884|NCT01039129|Appendicitis|appendicitis
495885|NCT01039129|Pelvic pain|pelvic pain
495886|NCT01039129|Peritoneal mass|peritoneal mass
495887|NCT01039116|obesity|obesity
495888|NCT01039116|nutrition|nutrition
495889|NCT01039116|type 2 diabetes|type 2 diabetes
495890|NCT01039116|community-based.|community-based.
495891|NCT01039103|PEG-liposomal prednisolone sodium phosphate|peg-liposomal prednisolone sodium phosphate
495892|NCT01039090|Not eligible for deep brain stimulation|not eligible for deep brain stimulation
495893|NCT01039090|Parkinsons's patients|parkinsons's patients
495894|NCT01039038|prostate|prostate
495895|NCT01039038|curietherapy|curietherapy
495896|NCT01039038|radiotherapy|radiotherapy
495897|NCT01039038|intermediate risk|intermediate risk
495898|NCT01039025|Myeloma|myeloma
495899|NCT01039025|Topotecan|topotecan
495900|NCT01039025|Hycamtin|hycamtin
495901|NCT01039025|Melphalan|melphalan
495902|NCT01039025|Alkeran|alkeran
495903|NCT01039025|Cyclophosphamide|cyclophosphamide
495904|NCT01039025|Cytoxan|cytoxan
495905|NCT01039025|Neosar|neosar
495906|NCT01039025|Stem Cell Harvest|stem cell harvest
495907|NCT01039025|Peripheral Blood Stem Cells|peripheral blood stem cells
495908|NCT01039012|bone mineral density|bone mineral density
495909|NCT01039012|osteoporosis|osteoporosis
495910|NCT01039012|exercise|exercise
495911|NCT01039012|bone remodeling|bone remodeling
495912|NCT01039012|biomotion analysis|biomotion analysis
495913|NCT01038999|Complementary Therapies|complementary therapies
495914|NCT01038986|chronic wound|chronic wound
495915|NCT01038986|refractory wound|refractory wound
495916|NCT01038986|CureXcell|curexcell
495917|NCT01038986|activated cell suspension|activated cell suspension
495918|NCT01038960|ICD, training|icd, training
495919|NCT01038934|Buccal Mucosa|buccal mucosa
495920|NCT01038934|DNA|dna
495921|NCT01038934|Polymerase Chain Reaction|polymerase chain reaction
495922|NCT01038921|Blood Pressure|blood pressure
495923|NCT01038921|Glucose levels|glucose levels
495924|NCT01038921|HDL levels|hdl levels
495925|NCT01038921|Triglyceride levels|triglyceride levels
495926|NCT01038921|Waist Circumference|waist circumference
495927|NCT01038908|sentinel lymph node biopsy (SLNB)|sentinel lymph node biopsy (slnb)
495928|NCT01038908|axillary lymph node dissection (ALND)|axillary lymph node dissection (alnd)
495929|NCT01038908|lymphatics|lymphatics
495930|NCT01038908|blue dye|blue dye
495931|NCT01038895|Hypertension|hypertension
495932|NCT01038895|type 2 diabetes|type 2 diabetes
495933|NCT01038895|aliskiren|aliskiren
495934|NCT01038895|ramipril|ramipril
495935|NCT01038895|microalbuminuria|microalbuminuria
495936|NCT01038895|blood pressure> 130/80 <180/105 mmHg at the end of the wash−out|blood pressure> 130/80 <180/105 mmhg at the end of the wash−out
495937|NCT01038895|type 2 diabetes mellitus well controlled by medication and / or|type 2 diabetes mellitus well controlled by medication and / or
495938|NCT01038895|compliance with diet (HbA1c <7%)|compliance with diet (hba1c <7%)
495939|NCT01038895|Microalbuminuria in the upper range of normal (> 200 <300 mg/24 h)|microalbuminuria in the upper range of normal (> 200 <300 mg/24 h)
495940|NCT01038882|sedation|sedation
495941|NCT01038882|midazolam|midazolam
495942|NCT01038882|flexible bronchoscopy|flexible bronchoscopy
495943|NCT01038882|tolerance|tolerance
495944|NCT01038843|VA106483|va106483
495945|NCT01038843|Nocturia|nocturia
495946|NCT01038843|males|males
495947|NCT01038843|nocturnal voids|nocturnal voids
495948|NCT01038843|anti-diuretic|anti-diuretic
495949|NCT01038843|hyponatraemia|hyponatraemia
495950|NCT01038817|tooth-decay|tooth-decay
495951|NCT01038817|prevention|prevention
495952|NCT01038817|fluoride-varnish|fluoride-varnish
495953|NCT01038817|institutionalised elderly people|institutionalised elderly people
495954|NCT01038804|Breast Cancer|breast cancer
495955|NCT01038804|Metastatic|metastatic
495956|NCT01038804|HER2 Negative|her2 negative
495957|NCT01038804|YM155|ym155
495958|NCT01038791|chronic hypercapnic respiratory failure|chronic hypercapnic respiratory failure
495959|NCT01038791|COPD|copd
495960|NCT01038791|RTD|rtd
495961|NCT01038791|sleep architecture|sleep architecture
495962|NCT01038791|humidification|humidification
495963|NCT01038765|Recurrent Major Depressive Disorder|recurrent major depressive disorder
495964|NCT01038765|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
495965|NCT01038765|Randomized Controlled Trial|randomized controlled trial
495966|NCT01038752|NSCLC|nsclc
495967|NCT01038752|suramin|suramin
495968|NCT01038752|lung cancer|lung cancer
495969|NCT01038752|chemotherapy|chemotherapy
495970|NCT01038726|Healthy Aging|healthy aging
495971|NCT01038700|Circulating endothelial compartment|circulating endothelial compartment
495972|NCT01038700|microparticles|microparticles
495973|NCT01038700|endothelial progenitors cells|endothelial progenitors cells
495974|NCT01038700|circulating endothelial cells|circulating endothelial cells
495975|NCT01038700|transcriptome|transcriptome
495976|NCT01038700|aging|aging
495977|NCT01038700|Healthy volunteers|healthy volunteers
495978|NCT01038687|functional constipation|functional constipation
495979|NCT01038687|bile acid|bile acid
495980|NCT01038648|Sitagliptin|sitagliptin
495981|NCT01038648|Type 2 diabetes|type 2 diabetes
495982|NCT01038648|Prevention of type 2 diabetes|prevention of type 2 diabetes
495983|NCT01038635|5-Azacytidine|5-azacytidine
495984|NCT01038635|5-Aza|5-aza
495985|NCT01038635|Lenalidomide|lenalidomide
495986|NCT01038635|Revlimid|revlimid
495987|NCT01038635|CC-5103|cc-5103
495988|NCT01038635|Myelodysplastic Syndrome|myelodysplastic syndrome
495989|NCT01038635|MDS|mds
495990|NCT01038635|Acute Myelogenous Leukemia|acute myelogenous leukemia
495991|NCT01038635|AML|aml
495992|NCT01038622|L-arginine|l-arginine
495993|NCT01038622|Nasal NO|nasal no
495994|NCT01038622|Nosocomial infection|nosocomial infection
495995|NCT01038622|Immune function|immune function
495996|NCT01038622|HLA-DR expression|hla-dr expression
495997|NCT01038622|Critically ill|critically ill
495998|NCT01038622|Medical ICU patients|medical icu patients
495999|NCT01038609|Postoperative Pain|postoperative pain
496000|NCT01038596|osteoarthritis, mesenchymal stromal cells, proliferation|osteoarthritis, mesenchymal stromal cells, proliferation
496001|NCT01038583|Aspirin|aspirin
496002|NCT01038583|Prevention|prevention
496003|NCT01038583|Healthy|healthy
496004|NCT01038583|Over 65 years old|over 65 years old
496005|NCT01038583|ASPREE|aspree
496006|NCT01038583|Aspirin in Reducing Events in the Elderly|aspirin in reducing events in the elderly
496007|NCT01038583|Australia|australia
496008|NCT01038583|Functional disability|functional disability
496009|NCT01038583|Dementia|dementia
496010|NCT01038583|Heart Disease/ Stroke|heart disease/ stroke
496011|NCT01038583|Cancer|cancer
496012|NCT01038583|Bleeding|bleeding
496013|NCT01038570|Prader Willi syndrome|prader willi syndrome
496014|NCT01038570|adults|adults
496015|NCT01038570|social behaviour|social behaviour
496016|NCT01038570|stress|stress
496017|NCT01038570|anxiety|anxiety
496018|NCT01038570|psychological tests|psychological tests
496019|NCT01038557|frozen|frozen
496020|NCT01038557|red blood cells|red blood cells
496021|NCT01038557|transfusion|transfusion
496022|NCT01038557|trauma|trauma
496023|NCT01038544|Esophageal Cancer|esophageal cancer
496024|NCT01038544|Mediastinal lymph nodes|mediastinal lymph nodes
496025|NCT01038544|Staging|staging
496026|NCT01038544|EBUS|ebus
496027|NCT01038544|EUS|eus
496028|NCT01038544|Endobronchial Ultrasound|endobronchial ultrasound
496029|NCT01038544|Endoscopic Ultrasound|endoscopic ultrasound
496030|NCT01038531|Acute lung injury (ALI)|acute lung injury (ali)
496031|NCT01038531|Adult respiratory distress syndrome (ARDS)|adult respiratory distress syndrome (ards)
496032|NCT01038531|Low-tidal-volume strategy|low-tidal-volume strategy
496033|NCT01038531|ARDS Net|ards net
496034|NCT01038531|airway pressure release ventilation (APRV)|airway pressure release ventilation (aprv)
496035|NCT01038531|biomarkers of lung injury|biomarkers of lung injury
496036|NCT01038518|epidemiology|epidemiology
496037|NCT01038518|risk factors|risk factors
496038|NCT01038518|micronutrients|micronutrients
496039|NCT01038479|Xylitol|xylitol
496040|NCT01038479|Mutans streptococci|mutans streptococci
496041|NCT01038479|Maternal consumption|maternal consumption
496042|NCT01038479|Early childhood tooth decay|early childhood tooth decay
496043|NCT01038479|Early childhood caries|early childhood caries
496044|NCT01038479|Childsmile|childsmile
496045|NCT01038466|CHAT|chat
496046|NCT01038466|breast cancer|breast cancer
496047|NCT01038466|non interventional observational study|non interventional observational study
496048|NCT01038440|Omega 3 fatty acids|omega 3 fatty acids
496049|NCT01038440|Omega 3 Index|omega 3 index
496050|NCT01038440|Stearidonic acid (SDA)|stearidonic acid (sda)
496051|NCT01038440|Eicosapentaenoic acid (EPA)|eicosapentaenoic acid (epa)
496052|NCT01038440|Red blood cells|red blood cells
496053|NCT01038440|Lipids|lipids
496054|NCT01038440|Inflammation markers|inflammation markers
496055|NCT01038427|Rhinitis|rhinitis
496056|NCT01038427|Allergic|allergic
496057|NCT01038427|Seasonal|seasonal
496058|NCT01038427|Mometasone Furoate|mometasone furoate
496059|NCT01038427|Equivalence|equivalence
496060|NCT01038401|HIV infection|hiv infection
496061|NCT01038401|HAART|haart
496062|NCT01038401|Viral DNA test positive-10063306|viral dna test positive-10063306
496063|NCT01038401|Blood HIV RNA 10049826|blood hiv rna 10049826
496064|NCT01038401|Treatment Experienced|treatment experienced
496065|NCT01038388|Multiple Myeloma|multiple myeloma
496066|NCT01038375|hypertension|hypertension
496067|NCT01038375|stroke|stroke
496068|NCT01038375|adherence|adherence
496069|NCT01038362|endothelium|endothelium
496070|NCT01038362|almonds|almonds
496071|NCT01038362|dietary interventions|dietary interventions
496072|NCT01038362|coronary artery disease|coronary artery disease
496073|NCT01038336|Hearing Loss - Noise-Induced|hearing loss - noise-induced
496074|NCT01038336|Prevention|prevention
496075|NCT01038336|Computer-assisted instruction|computer-assisted instruction
496076|NCT01038323|Fibromyalgia|fibromyalgia
496077|NCT01038323|FMS|fms
496078|NCT01038310|Parkinson´s disease|parkinson´s disease
496079|NCT01038310|FP-CIT-SPECT|fp-cit-spect
496080|NCT01038297|Scarring|scarring
496081|NCT01038284|Patient Education|patient education
496082|NCT01038284|Drug Toxicity|drug toxicity
496083|NCT01038271|palliative care|palliative care
496084|NCT01038258|neoadjuvant chemotherapy|neoadjuvant chemotherapy
496085|NCT01038245|Receptor Up-Regulation|receptor up-regulation
496086|NCT01038245|Smoking|smoking
496087|NCT01038245|Nicotine|nicotine
496088|NCT01038245|Neuroimaging|neuroimaging
496089|NCT01038232|Distress Tolerance|distress tolerance
496090|NCT01038232|Cocaine Dependence|cocaine dependence
496091|NCT01038232|Relapse|relapse
496092|NCT01038232|Limbic System|limbic system
496093|NCT01038232|Prefrontal Cortex|prefrontal cortex
496094|NCT01038232|Healthy Volunteer|healthy volunteer
496095|NCT01038232|HV|hv
496096|NCT01038219|fever|fever
496097|NCT01038219|children|children
496098|NCT01038219|SUBJECTIVE ASSESSMENT|subjective assessment
496099|NCT01038206|prevention|prevention
496100|NCT01038206|HIV|hiv
496101|NCT01038206|drugs|drugs
496102|NCT01038206|smoking|smoking
496103|NCT01038206|Hispanic|hispanic
496104|NCT01038206|Adolescent|adolescent
496105|NCT01038206|Familias Unidas|familias unidas
496106|NCT01038206|Parent-Preadolescent Training|parent-preadolescent training
496107|NCT01038206|parent-centered|parent-centered
496108|NCT01038206|unsafe sexual behavior|unsafe sexual behavior
496109|NCT01038206|efficacy|efficacy
496110|NCT01038206|intervention|intervention
496111|NCT01038193|Cognition, subarachnoid hemorrhage.|cognition, subarachnoid hemorrhage.
496112|NCT01038180|pacemaker|pacemaker
496113|NCT01038180|adverse effects|adverse effects
496114|NCT01038167|VX-950|vx-950
496115|NCT01038154|advanced esophageal cancer and stomach cancer|advanced esophageal cancer and stomach cancer
496116|NCT01038154|Pravastatin|pravastatin
496117|NCT01038154|Survival|survival
496118|NCT01038154|adverse effects|adverse effects
496119|NCT01038128|Bulimia nervosa|bulimia nervosa
496120|NCT01038128|Bulimia|bulimia
496121|NCT01038128|Body dysmorphic disorder|body dysmorphic disorder
496122|NCT01038128|Eating disorders|eating disorders
496123|NCT01038128|Body image|body image
496124|NCT01038128|Binge eating|binge eating
496125|NCT01038128|purging|purging
496126|NCT01038115|Catheter Ablation|catheter ablation
496127|NCT01038102|Obesity|obesity
496128|NCT01038102|Diabetes|diabetes
496129|NCT01038102|Insulin resistance|insulin resistance
496130|NCT01038102|Fatty liver|fatty liver
496131|NCT01038102|NAFLD|nafld
496132|NCT01038102|Steatosis|steatosis
496133|NCT01038102|Dietary fatty acids|dietary fatty acids
496134|NCT01038089|endothelium|endothelium
496135|NCT01038089|resveratrol|resveratrol
496136|NCT01038089|diabetes mellitus|diabetes mellitus
496137|NCT01038076|HIV|hiv
496138|NCT01038076|AIDS|aids
496139|NCT01038076|adherence|adherence
496140|NCT01038076|antiretroviral|antiretroviral
496141|NCT01038076|aCASI|acasi
496142|NCT01038076|HAART|haart
496143|NCT01038076|Complementary Therapies|complementary therapies
496144|NCT01038076|Adherence Care Manager|adherence care manager
496145|NCT01038050|Endothelial progenitor cell|endothelial progenitor cell
496146|NCT01038050|endothelial function(FMD)|endothelial function(fmd)
496147|NCT01038050|Gingko Biloba Extract|gingko biloba extract
496148|NCT01038050|Type 2 Diabetes mellitus|type 2 diabetes mellitus
496149|NCT01038050|Stable coronary artery disease|stable coronary artery disease
496150|NCT01038050|Endothelial progenitor cells Numbers|endothelial progenitor cells numbers
496151|NCT01038037|Lung Cancer|lung cancer
496152|NCT01038037|Non small cell lung cancer|non small cell lung cancer
496153|NCT01038037|Triple mutational status|triple mutational status
496154|NCT01038037|KRAS|kras
496155|NCT01038037|BRAF|braf
496156|NCT01038037|PI3K|pi3k
496157|NCT01038024|antioxidant supplement|antioxidant supplement
496158|NCT01037998|adenocarcinoma|adenocarcinoma
496159|NCT01037998|non-small-cell lung cancer|non-small-cell lung cancer
496160|NCT01037998|gefitinib|gefitinib
496161|NCT01037998|UFUR|ufur
496162|NCT01037985|Scarring|scarring
496163|NCT01037972|Galileo|galileo
496164|NCT01037972|Whole body vibration|whole body vibration
496165|NCT01037972|Osteoarthritis|osteoarthritis
496166|NCT01037972|Knee|knee
496167|NCT01037972|Physiotherapy|physiotherapy
496168|NCT01037959|severe cirrhosis|severe cirrhosis
496169|NCT01037959|Patients with severe cirrhosis|patients with severe cirrhosis
496170|NCT01037946|HIV|hiv
496171|NCT01037946|Family interventions|family interventions
496172|NCT01037946|Thailand|thailand
496173|NCT01037933|Cancer|cancer
496174|NCT01037933|Humor|humor
496175|NCT01037933|Distraction|distraction
496176|NCT01037933|Comedy|comedy
496177|NCT01037933|Chemotherapy|chemotherapy
496178|NCT01037907|Oral treatment for MS|oral treatment for ms
496179|NCT01037907|Oral drug for multiple sclerosis|oral drug for multiple sclerosis
496180|NCT01037907|Oral RRMS|oral rrms
496181|NCT01037907|Oral relapsing remitting multiple sclerosis|oral relapsing remitting multiple sclerosis
496182|NCT01037907|Gamma Linolenic Acid|gamma linolenic acid
496183|NCT01037907|GLA|gla
496184|NCT01037907|Fatty acid|fatty acid
496185|NCT01037907|Triglyceride|triglyceride
496186|NCT01037907|Structured lipid|structured lipid
496187|NCT01037907|MRI|mri
496188|NCT01037907|Magnetic resonance imaging|magnetic resonance imaging
496189|NCT01037907|gadolinium enhancing lesions|gadolinium enhancing lesions
496190|NCT01037907|expanded disability status scale|expanded disability status scale
496191|NCT01037907|EDSS|edss
496192|NCT01037907|Demyelination|demyelination
496193|NCT01037907|Remyelination|remyelination
496194|NCT01037907|TGFB1|tgfb1
496195|NCT01037907|Transforming growth factor beta 1|transforming growth factor beta 1
496196|NCT01037907|cytokines|cytokines
496197|NCT01037907|disease modifying therapy|disease modifying therapy
496198|NCT01037907|immunomodulator|immunomodulator
496199|NCT01037907|Anti inflammatory|anti inflammatory
496200|NCT01037907|Pro inflammatory|pro inflammatory
496201|NCT01037907|TNF alpha|tnf alpha
496202|NCT01037907|interleukin 1 beta|interleukin 1 beta
496203|NCT01037907|interferon gamma|interferon gamma
496204|NCT01037907|Fayaz Master|fayaz master
496205|NCT01037907|Omega 6|omega 6
496206|NCT01037907|Polyunsaturated fatty acid|polyunsaturated fatty acid
496207|NCT01037907|Cytokine balance|cytokine balance
496208|NCT01037907|Pleneva TM|pleneva tm
496209|NCT01037907|BGC20-0134|bgc20-0134
496210|NCT01037907|RRMS|rrms
496211|NCT01037894|Acupuncture,Intracerebral hemorrhage, Stroke|acupuncture,intracerebral hemorrhage, stroke
496212|NCT01037868|depression|depression
496213|NCT01037868|alcohol dependency syndrome|alcohol dependency syndrome
496214|NCT01037868|dual diagnosis|dual diagnosis
496215|NCT01037868|SMS text messages|sms text messages
496216|NCT01037855|Swine Flu H1N1 vaccine|swine flu h1n1 vaccine
496217|NCT01037855|Adjuvanted flu cell culture derived|adjuvanted flu cell culture derived
496218|NCT01037816|Ankle Sprain|ankle sprain
496219|NCT01037803|perioperative sublingual microcirculation SDF|perioperative sublingual microcirculation sdf
496220|NCT01037777|individuals at risk for SCA1, SCA2, SCA3, SCA6 and SCA7|individuals at risk for sca1, sca2, sca3, sca6 and sca7
496221|NCT01037764|acute lymphoid leukemia|acute lymphoid leukemia
496222|NCT01037764|primary complete remission|primary complete remission
496223|NCT01037764|secondary complete remission|secondary complete remission
496224|NCT01037764|postremission therapy|postremission therapy
496225|NCT01037764|allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
496226|NCT01037751|Cancer|cancer
496227|NCT01037751|Symptom burden|symptom burden
496228|NCT01037751|M. D. Anderson Symptom Inventory|m. d. anderson symptom inventory
496229|NCT01037751|MDASI-Ovarian Cancer|mdasi-ovarian cancer
496230|NCT01037751|Symptoms|symptoms
496231|NCT01037751|Daily functioning|daily functioning
496232|NCT01037751|Symptom severity|symptom severity
496233|NCT01037751|Questionnaire|questionnaire
496234|NCT01037751|Interview|interview
496235|NCT01037738|ACL reconstruction|acl reconstruction
496236|NCT01037738|autologous conditioned serum|autologous conditioned serum
496237|NCT01037738|Orthokine|orthokine
496238|NCT01037738|osteoarthritis|osteoarthritis
496239|NCT01037738|interleukin receptor antagonist|interleukin receptor antagonist
496240|NCT01037738|growth factors|growth factors
496241|NCT01037738|WOMAC|womac
496242|NCT01037738|IKDC|ikdc
496243|NCT01037725|Healthy volunteer|healthy volunteer
496244|NCT01037725|first time in human|first time in human
496245|NCT01037725|food effect|food effect
496246|NCT01037712|Foetuses infection with CMV|foetuses infection with cmv
496247|NCT01037712|neurological handicap of infectious origin.|neurological handicap of infectious origin.
496248|NCT01037699|Ovarian stimulation|ovarian stimulation
496249|NCT01037699|In Vitro Fertilization|in vitro fertilization
496250|NCT01037699|Luteinizing Hormone|luteinizing hormone
496251|NCT01037699|GnRH antagonist|gnrh antagonist
496252|NCT01037699|Implantation rate in infertile patients undergoing In vitro fertilization and embryo transfer.|implantation rate in infertile patients undergoing in vitro fertilization and embryo transfer.
496253|NCT01037686|PD|pd
496254|NCT01037686|DBS|dbs
496255|NCT01037660|endothelium|endothelium
496256|NCT01037660|cardiovascular disease|cardiovascular disease
496257|NCT01037660|dietary fat|dietary fat
496258|NCT01037660|insulin resistance|insulin resistance
496259|NCT01037647|Type 2 diabetes|type 2 diabetes
496260|NCT01037647|Diabetic dyslipidemia|diabetic dyslipidemia
496261|NCT01037647|VLDL-TG kinetics|vldl-tg kinetics
496262|NCT01037647|VLDL-TG metabolism|vldl-tg metabolism
496263|NCT01037634|Avian Influenza|avian influenza
496264|NCT01037634|H1N1 Influenza|h1n1 influenza
496265|NCT01037634|Seasonal Influenza|seasonal influenza
496266|NCT01037621|Herpes simplex type 2|herpes simplex type 2
496267|NCT01037621|Hepatitis C virus|hepatitis c virus
496268|NCT01037621|Valacyclovir|valacyclovir
496269|NCT01037621|Herpes Simplex virus type 2 infection|herpes simplex virus type 2 infection
496270|NCT01037608|Sativex|sativex
496271|NCT01037608|fMRI|fmri
496272|NCT01037608|Alternative Matrices|alternative matrices
496273|NCT01037608|Brain Imaging|brain imaging
496274|NCT01037608|THC|thc
496275|NCT01037595|hemodialysis|hemodialysis
496276|NCT01037595|turmeric|turmeric
496277|NCT01037595|pruritus|pruritus
496278|NCT01037569|Toxicological Screening|toxicological screening
496279|NCT01037569|Drugs|drugs
496280|NCT01037569|Alternative Matrices|alternative matrices
496281|NCT01037569|Urine|urine
496282|NCT01037569|Children|children
496283|NCT01037556|AML|aml
496284|NCT01037556|Acute Myeloid Leukemia|acute myeloid leukemia
496285|NCT01037556|Acute Myelogenous Leukemia|acute myelogenous leukemia
496286|NCT01037556|Refractory AML|refractory aml
496287|NCT01037556|Relapsed AML|relapsed aml
496288|NCT01037556|Refractory Acute Myeloid Leukemia|refractory acute myeloid leukemia
496289|NCT01037556|Relapsed Acute Myeloid Leukemia|relapsed acute myeloid leukemia
496290|NCT01037556|Refractory Acute Myelogenous Leukemia|refractory acute myelogenous leukemia
496291|NCT01037556|Relapsed Acute Myelogenous Leukemia|relapsed acute myelogenous leukemia
496292|NCT01037556|ALL|all
496293|NCT01037556|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
496294|NCT01037556|Relapsed Acute Lymphocytic Leukemia|relapsed acute lymphocytic leukemia
496295|NCT01037556|Refractory Acute Lymphocytic Leukemia|refractory acute lymphocytic leukemia
496296|NCT01037556|Relapsed ALL|relapsed all
496297|NCT01037556|Refractory ALL|refractory all
496298|NCT01037530|ACE inhibitors|ace inhibitors
496299|NCT01037530|Intermittent claudication|intermittent claudication
496300|NCT01037530|Ramipril|ramipril
496301|NCT01037517|Myeloma|myeloma
496302|NCT01037517|Multiple Myeloma or Lymphoma Patients undergoing|multiple myeloma or lymphoma patients undergoing
496303|NCT01037517|mobilization for the purpose of autologous stem cell collection|mobilization for the purpose of autologous stem cell collection
496304|NCT01037504|safety|safety
496305|NCT01037504|tolerability|tolerability
496306|NCT01037504|healthy|healthy
496307|NCT01037504|inhalation|inhalation
496308|NCT01037504|Healthy volunteers|healthy volunteers
496309|NCT01037491|aspirin, clopidogrel, peptic ulcer, proton pump inhibitor, rabeprazole, ulcer bleeding|aspirin, clopidogrel, peptic ulcer, proton pump inhibitor, rabeprazole, ulcer bleeding
496310|NCT01037478|Hodgkin's Lymphoma|hodgkin's lymphoma
496311|NCT01037478|HDAC|hdac
496312|NCT01037478|4SC-201|4sc-201
496313|NCT01037478|Resminostat|resminostat
496314|NCT01037478|Phase II|phase ii
496315|NCT01037465|endothelium|endothelium
496316|NCT01037465|cell signaling|cell signaling
496317|NCT01037465|N-acetylcysteine|n-acetylcysteine
496318|NCT01037465|reactive oxygen species|reactive oxygen species
496319|NCT01037452|Heartburn|heartburn
496320|NCT01037452|antacid|antacid
496321|NCT01037452|PPI|ppi
496322|NCT01037452|Lansoprazole|lansoprazole
496323|NCT01037452|calcium carbonate|calcium carbonate
496324|NCT01037452|magnesium hydroxide|magnesium hydroxide
496325|NCT01037452|Relief of heartburn following ingestion of a heartburn-inducing meal|relief of heartburn following ingestion of a heartburn-inducing meal
496326|NCT01037426|SND Sinus Node Disease|snd sinus node disease
496327|NCT01037426|Falls|falls
496328|NCT01037426|Fractures|fractures
496329|NCT01037413|Scarring|scarring
496330|NCT01037400|Knee Replacement|knee replacement
496331|NCT01037400|Arthroplasty|arthroplasty
496332|NCT01037374|risk|risk
496333|NCT01037374|assessment|assessment
496334|NCT01037374|difficult|difficult
496335|NCT01037374|endotracheal|endotracheal
496336|NCT01037374|intubation|intubation
496337|NCT01037361|Children and Adolescents|children and adolescents
496338|NCT01037361|Motor Control|motor control
496339|NCT01037361|Movement-Related Potential|movement-related potential
496340|NCT01037361|Stereotypic Movement Disorder|stereotypic movement disorder
496341|NCT01037361|Electroencephalogram (EEG)|electroencephalogram (eeg)
496342|NCT01037348|Choroidal Neovascularisation|choroidal neovascularisation
496343|NCT01037348|Pathological Myopia|pathological myopia
496344|NCT01037335|bone graft|bone graft
496345|NCT01037335|pain|pain
496346|NCT01037335|chronic|chronic
496347|NCT01037322|crohn's disease|crohn's disease
496348|NCT01037322|ulcerative colitis|ulcerative colitis
496349|NCT01037322|cannabis|cannabis
496350|NCT01037322|cannabidiol|cannabidiol
496351|NCT01037296|catheter ablation|catheter ablation
496352|NCT01037296|robotic navigation|robotic navigation
496353|NCT01037283|Bipolar|bipolar
496354|NCT01037283|Depressed|depressed
496355|NCT01037270|Patients with conditions (PE, Afib, DVT) requiring ongoing INR measurements.|patients with conditions (pe, afib, dvt) requiring ongoing inr measurements.
496356|NCT01037231|hyperoxaluria|hyperoxaluria
496357|NCT01037231|oxalate|oxalate
496358|NCT01037231|PH|ph
496359|NCT01037192|outpatient|outpatient
496360|NCT01037192|skin and soft tissue infections|skin and soft tissue infections
496361|NCT01037192|vancomycin intravenous|vancomycin intravenous
496362|NCT01037153|Intravenous|intravenous
496363|NCT01037153|Rate of Delivery|rate of delivery
496364|NCT01037153|Dose Responses|dose responses
496365|NCT01037153|Variable Intervals|variable intervals
496366|NCT01037153|Multiple Rapid Injections|multiple rapid injections
496367|NCT01037127|GSK1120212|gsk1120212
496368|NCT01037127|BRAF Inhibitor|braf inhibitor
496369|NCT01037127|melanoma|melanoma
496370|NCT01037127|MEK Inhibitor|mek inhibitor
496371|NCT01037114|Hepatitis A and hepatitis B|hepatitis a and hepatitis b
496372|NCT01037101|acrophobia|acrophobia
496373|NCT01037101|virtual reality|virtual reality
496374|NCT01037101|exposure therapy|exposure therapy
496375|NCT01037101|In Vivo Exposure Therapy plus D-Cycloserine|in vivo exposure therapy plus d-cycloserine
496376|NCT01037101|In Vivo Exposure Therapy plus Placebo|in vivo exposure therapy plus placebo
496377|NCT01037101|Virtual Reality Exposure Therapy plus D-Cycloserine|virtual reality exposure therapy plus d-cycloserine
496378|NCT01037101|Virtual Reality Exposure Therapy plus Placebo|virtual reality exposure therapy plus placebo
496379|NCT01037101|Wait-List|wait-list
496380|NCT01037088|cannabis|cannabis
496381|NCT01037088|marijuana|marijuana
496382|NCT01037088|neuropathy|neuropathy
496383|NCT01037088|antinociception|antinociception
496384|NCT01037088|mood|mood
496385|NCT01037088|cognition|cognition
496386|NCT01037088|neuropathic pain|neuropathic pain
496387|NCT01037075|Schizophrenia|schizophrenia
496388|NCT01037075|Dual Diagnosis|dual diagnosis
496389|NCT01037075|Nicotine Nasal Spray|nicotine nasal spray
496390|NCT01037075|Drug Abuse/Dependence|drug abuse/dependence
496391|NCT01037075|Cognitive Processes|cognitive processes
496392|NCT01037049|Rectal Cancer|rectal cancer
496393|NCT01037049|6vs12|6vs12
496394|NCT01037049|6 vs 12|6 vs 12
496395|NCT01037049|Cancer|cancer
496396|NCT01037049|CRM|crm
496397|NCT01037049|Circumferential Resection Margin|circumferential resection margin
496398|NCT01037049|Quality of Life|quality of life
496399|NCT01037049|MRI|mri
496400|NCT01037049|Radiology|radiology
496401|NCT01037049|Abdominoperineal Excision|abdominoperineal excision
496402|NCT01037049|Anterior Resection|anterior resection
496403|NCT01037049|Surgery|surgery
496404|NCT01037049|Pathology|pathology
496405|NCT01037049|Radiotherapy|radiotherapy
496406|NCT01037036|Ocular Hypertension|ocular hypertension
496407|NCT01037036|Open-Angle Glaucoma|open-angle glaucoma
496408|NCT01037036|Xalatan|xalatan
496409|NCT01037036|IOP|iop
496410|NCT01037023|PMS (post-marketing surveillance)|pms (post-marketing surveillance)
496411|NCT01037023|Topotecan|topotecan
496412|NCT01036971|Physical Examination|physical examination
496413|NCT01036971|Medical Information|medical information
496414|NCT01036971|Assessment|assessment
496415|NCT01036971|Blood Work|blood work
496416|NCT01036971|Screening|screening
496417|NCT01036958|Pediatric cGVHD|pediatric cgvhd
496418|NCT01036958|Response Criteria|response criteria
496419|NCT01036958|Symptoms|symptoms
496420|NCT01036958|Quality of Life|quality of life
496421|NCT01036958|Graft-Versus-Host Disease|graft-versus-host disease
496422|NCT01036958|GVHD|gvhd
496423|NCT01036958|Pediatric GVHD|pediatric gvhd
496424|NCT01036854|Ondansetron, EUR-1025|ondansetron, eur-1025
496425|NCT01036841|MNE with nocturnal polyuria|mne with nocturnal polyuria
496426|NCT01036841|monosymptomatic nocturnal enuresis with nocturnal polyuria|monosymptomatic nocturnal enuresis with nocturnal polyuria
496427|NCT01036802|sickle cell disease|sickle cell disease
496428|NCT01036802|pulmonary hypertension|pulmonary hypertension
496429|NCT01036802|coagulation activation|coagulation activation
496430|NCT01036802|platelet activation|platelet activation
496431|NCT01036802|endothelial activation|endothelial activation
496432|NCT01036711|Attention|attention
496433|NCT01036711|Working Memory|working memory
496434|NCT01036711|Central Executive Processes|central executive processes
496435|NCT01036711|Response Preparation|response preparation
496436|NCT01036711|Cigarettes|cigarettes
496437|NCT01036685|Children|children
496438|NCT01036685|fMRI|fmri
496439|NCT01036685|Task Development|task development
496440|NCT01036685|Cognition|cognition
496441|NCT01036659|acute angiotensin converting enzyme inhibitor angioedema|acute angiotensin converting enzyme inhibitor angioedema
496442|NCT01036646|Patients on stable OAT therapy for at least 3 months.|patients on stable oat therapy for at least 3 months.
496443|NCT01036633|mucositis|mucositis
496444|NCT01036594|Ketoconazole|ketoconazole
496445|NCT01036594|Dexamethasone|dexamethasone
496446|NCT01036581|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
496447|NCT01036581|Functional Brain Imaging|functional brain imaging
496448|NCT01036581|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
496449|NCT01036581|Diffusion Tensor Imaging|diffusion tensor imaging
496450|NCT01036581|Drug Abuse|drug abuse
496451|NCT01036568|Psychosis|psychosis
496452|NCT01036568|Smooth Pursuit|smooth pursuit
496453|NCT01036568|Motion Perception|motion perception
496454|NCT01036568|Neurophysiology|neurophysiology
496455|NCT01036568|fMRI|fmri
496456|NCT01036529|Spinal Cord Stimulation|spinal cord stimulation
496457|NCT01036529|Decompression|decompression
496458|NCT01036529|Fusion with or without instrumentation|fusion with or without instrumentation
496459|NCT01036529|Discectomy|discectomy
496460|NCT01036529|Laminectomy|laminectomy
496461|NCT01036529|Laminotomy|laminotomy
496462|NCT01036529|Foraminotomy|foraminotomy
496463|NCT01036516|Drug Cues|drug cues
496464|NCT01036516|Dopamine Release|dopamine release
496465|NCT01036516|Psychomotor Stimulants|psychomotor stimulants
496466|NCT01036516|D2 Dopamine Receptor Subtype|d2 dopamine receptor subtype
496467|NCT01036516|Neuroimaging|neuroimaging
496468|NCT01036412|Chlorhexidine|chlorhexidine
496469|NCT01036412|Chlorhexidine Gel Therapy|chlorhexidine gel therapy
496470|NCT01036412|1% chlorhexidine gluconate gel|1% chlorhexidine gluconate gel
496471|NCT01036412|Cariogenic Oral Microflora|cariogenic oral microflora
496472|NCT01036412|Irradiated Head and Neck Cancer Patients|irradiated head and neck cancer patients
496473|NCT01036412|caries-forming organisms|caries-forming organisms
496474|NCT01036412|Radiation treatment|radiation treatment
496475|NCT01036412|Mouth Cancer|mouth cancer
496476|NCT01036412|Throat Cancer|throat cancer
496477|NCT01036412|Tooth decay|tooth decay
496478|NCT01036399|PTCL|ptcl
496479|NCT01036360|Obesity|obesity
496480|NCT01036360|Acute exercise|acute exercise
496481|NCT01036360|Intensity of exercise|intensity of exercise
496482|NCT01036360|Energy balance regulation|energy balance regulation
496483|NCT01036360|Appetite|appetite
496484|NCT01036308|dietary fibre|dietary fibre
496485|NCT01036308|legumes|legumes
496486|NCT01036308|lupin kernel fibre|lupin kernel fibre
496487|NCT01036308|soy fibre|soy fibre
496488|NCT01036308|bile acids|bile acids
496489|NCT01036308|short-chain fatty acids|short-chain fatty acids
496490|NCT01036308|cholesterol metabolism|cholesterol metabolism
496491|NCT01036308|Subjects|subjects
496492|NCT01036243|digestive tolerance|digestive tolerance
496493|NCT01036243|night sleep|night sleep
496494|NCT01036243|crying|crying
496495|NCT01036243|growth|growth
496496|NCT01036230|fMRI|fmri
496497|NCT01036230|Methylphenidate|methylphenidate
496498|NCT01036230|Taste|taste
496499|NCT01036230|Olfaction|olfaction
496500|NCT01036230|Addiction|addiction
496501|NCT01036217|Recruitment|recruitment
496502|NCT01036217|Adult|adult
496503|NCT01036217|Telephone|telephone
496504|NCT01036217|Selection|selection
496505|NCT01036217|Testing|testing
496506|NCT01036139|EDS in Parkinson's Disease|eds in parkinson's disease
496507|NCT01036126|Nicotine|nicotine
496508|NCT01036126|Cocaine|cocaine
496509|NCT01036126|N-Back|n-back
496510|NCT01036126|Craving|craving
496511|NCT01036126|Dependence|dependence
496512|NCT01036113|EZN-2208 (PEG-SN38)|ezn-2208 (peg-sn38)
496513|NCT01036087|Inflammatory Breast Cancer|inflammatory breast cancer
496514|NCT01036087|IBC|ibc
496515|NCT01036087|Primary breast carcinoma|primary breast carcinoma
496516|NCT01036087|HER2 negative overexpression|her2 negative overexpression
496517|NCT01036087|Panitumumab|panitumumab
496518|NCT01036087|Vectibix|vectibix
496519|NCT01036087|Nab-paclitaxel|nab-paclitaxel
496520|NCT01036087|Paclitaxel|paclitaxel
496521|NCT01036087|Abraxane|abraxane
496522|NCT01036087|Carboplatin|carboplatin
496523|NCT01036087|Paraplatin|paraplatin
496524|NCT01036087|PNC|pnc
496525|NCT01036087|5-fluorouracil|5-fluorouracil
496526|NCT01036087|5-FU|5-fu
496527|NCT01036087|Adrucil|adrucil
496528|NCT01036087|Efudex|efudex
496529|NCT01036087|Epirubicin|epirubicin
496530|NCT01036087|Ellence|ellence
496531|NCT01036087|Cyclophosphamide|cyclophosphamide
496532|NCT01036087|Cytoxan|cytoxan
496533|NCT01036087|Neosar|neosar
496534|NCT01036087|FEC|fec
496535|NCT01036074|Drug Abuse|drug abuse
496536|NCT01036074|Cocaine|cocaine
496537|NCT01036074|Cocaine Dependence|cocaine dependence
496538|NCT01036074|Functional MRI|functional mri
496539|NCT01036074|Pharmalogical MRI|pharmalogical mri
496540|NCT01036074|Conditioning|conditioning
496541|NCT01036061|compulsive discorders|compulsive discorders
496542|NCT01036061|addiction|addiction
496543|NCT01036048|saphenous vein graft|saphenous vein graft
496544|NCT01036048|stent|stent
496545|NCT01036035|Tolterodine|tolterodine
496546|NCT01036035|Over active Bladder (OAB)|over active bladder (oab)
496547|NCT01036035|Incontinence|incontinence
496548|NCT01036022|mesalazine|mesalazine
496549|NCT01036022|ulcerative colitis|ulcerative colitis
496550|NCT01036022|pharmacokinetics/dynamics|pharmacokinetics/dynamics
496551|NCT01036022|GSK1399686|gsk1399686
496552|NCT01036009|Hematologic|hematologic
496553|NCT01036009|Malignancy|malignancy
496554|NCT01036009|Leukemia|leukemia
496555|NCT01036009|Pre-leukemic|pre-leukemic
496556|NCT01036009|Allogeneic|allogeneic
496557|NCT01036009|Transplant|transplant
496558|NCT01036009|Pediatric|pediatric
496559|NCT01035996|Classical Conditioning|classical conditioning
496560|NCT01035996|fMRI|fmri
496561|NCT01035996|Schizophrenia|schizophrenia
496562|NCT01035996|TD Model|td model
496563|NCT01035996|Incentive Salience|incentive salience
496564|NCT01035983|menstrually associated migraine (MAM), Migraines,Menstrual Migraines, menstrually related migraines|menstrually associated migraine (mam), migraines,menstrual migraines, menstrually related migraines
496565|NCT01035944|Chronic wounds|chronic wounds
496566|NCT01035944|Chronic wound debridement|chronic wound debridement
496567|NCT01035944|Debridement|debridement
496568|NCT01035944|Bedside debridement|bedside debridement
496569|NCT01035944|Surgical debridement|surgical debridement
496570|NCT01035944|Wound debridement|wound debridement
496571|NCT01035944|Minimize bacterial re-colonization of wounds|minimize bacterial re-colonization of wounds
496572|NCT01035944|HemCon ChitoGauze Dressings|hemcon chitogauze dressings
496573|NCT01035944|HemCon Dressings|hemcon dressings
496574|NCT01035944|Chitosan-based dressings|chitosan-based dressings
496575|NCT01035788|PTSD|ptsd
496576|NCT01035788|mindfulness meditation|mindfulness meditation
496577|NCT01035788|cognitive behavior therapy|cognitive behavior therapy
496578|NCT01035788|relationship function|relationship function
496579|NCT01035788|couple therapy|couple therapy
496580|NCT01035775|Colonoscopy|colonoscopy
496581|NCT01035775|Adenoma detection|adenoma detection
496582|NCT01035775|Colorectal polyps|colorectal polyps
496583|NCT01035749|pandemic influenza|pandemic influenza
496584|NCT01035749|Clinical trial|clinical trial
496585|NCT01035749|H1N1|h1n1
496586|NCT01035749|children|children
496587|NCT01035723|Prefrontal Cortex|prefrontal cortex
496588|NCT01035723|Hippocampus|hippocampus
496589|NCT01035723|Amygdala|amygdala
496590|NCT01035723|MRI|mri
496591|NCT01035723|Cognitive Tasks|cognitive tasks
496592|NCT01035697|NICHD Neonatal Research Network|nichd neonatal research network
496593|NCT01035697|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
496594|NCT01035697|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
496595|NCT01035697|Prematurity|prematurity
496596|NCT01035697|Pro-inflammatory cytokines|pro-inflammatory cytokines
496597|NCT01035697|Anti-inflammatory cytokines|anti-inflammatory cytokines
496598|NCT01035697|Interleukin-1 (IL-1β)|interleukin-1 (il-1β)
496599|NCT01035697|Interleukin-2 (IL-2)|interleukin-2 (il-2)
496600|NCT01035697|Interleukin-3 (IL-3)|interleukin-3 (il-3)
496601|NCT01035697|Interleukin-8 (IL-8)|interleukin-8 (il-8)
496602|NCT01035697|Interleukin-9 (IL-9)|interleukin-9 (il-9)
496603|NCT01035697|Tumor necrosis factor-α (TNF-α)|tumor necrosis factor-α (tnf-α)
496604|NCT01035697|Regulated upon Activation, Normal T-cell Expressed and Secreted (RANTES)|regulated upon activation, normal t-cell expressed and secreted (rantes)
496605|NCT01035658|Pazopanib|pazopanib
496606|NCT01035658|Doxil|doxil
496607|NCT01035658|Liposomal doxorubicin|liposomal doxorubicin
496608|NCT01035658|Advanced relapsed|advanced relapsed
496609|NCT01035658|platinum-sensitive|platinum-sensitive
496610|NCT01035658|platinum-resistant|platinum-resistant
496611|NCT01035645|First time in human|first time in human
496612|NCT01035645|Interleukin-18|interleukin-18
496613|NCT01035645|Healthy male subjects|healthy male subjects
496614|NCT01035645|Obese male subjects|obese male subjects
496615|NCT01035645|Monoclonal antibody|monoclonal antibody
496616|NCT01035645|Pharmacokinetics|pharmacokinetics
496617|NCT01035645|Tolerability|tolerability
496618|NCT01035645|Safety|safety
496619|NCT01035645|Pharmacodynamics|pharmacodynamics
496620|NCT01035632|Craving|craving
496621|NCT01035632|Incubation|incubation
496622|NCT01035632|Relapse|relapse
496623|NCT01035632|Smoking Cues|smoking cues
496624|NCT01035632|Cortisol|cortisol
496625|NCT01035619|onchocerciasis; river blindness; moxidectin; pediatric|onchocerciasis; river blindness; moxidectin; pediatric
496626|NCT01035606|attention|attention
496627|NCT01035606|rehabilitation|rehabilitation
496628|NCT01035606|training|training
496629|NCT01035606|functional MRI|functional mri
496630|NCT01035606|executive function|executive function
496631|NCT01035606|brain injury|brain injury
496632|NCT01035580|chemoprevention|chemoprevention
496633|NCT01035580|curcumin|curcumin
496634|NCT01035580|pharmacokinetics|pharmacokinetics
496635|NCT01035580|safety|safety
496636|NCT01035567|Multivessel coronary artery disease|multivessel coronary artery disease
496637|NCT01035567|Hybrid revascularization|hybrid revascularization
496638|NCT01035567|Coronary Artery Bypass Grafting|coronary artery bypass grafting
496639|NCT01035567|Percutaneous Coronary Interventions|percutaneous coronary interventions
496640|NCT01035567|Drug eluting stents|drug eluting stents
496641|NCT01035554|high blood pressure|high blood pressure
496642|NCT01035541|Major non-cardiac surgery,|major non-cardiac surgery,
496643|NCT01035541|hemodynamic management,|hemodynamic management,
496644|NCT01035541|PiCCO,|picco,
496645|NCT01035541|acute kidney injury,|acute kidney injury,
496646|NCT01035541|renal outcome|renal outcome
496647|NCT01035528|diastolic function, postmeal glucose, insulin glargine|diastolic function, postmeal glucose, insulin glargine
496648|NCT01035515|Healthy subjects|healthy subjects
496649|NCT01035502|Cancer|cancer
496650|NCT01035502|CP-4055|cp-4055
496651|NCT01035502|elacytarabine|elacytarabine
496652|NCT01035502|combination|combination
496653|NCT01035502|idarubicin|idarubicin
496654|NCT01035502|Acute myeloid leukaemia (AML)|acute myeloid leukaemia (aml)
496655|NCT01035489|Pacemaker treatment in heart failure|pacemaker treatment in heart failure
496656|NCT01035489|Cardiac resynchronization therapy|cardiac resynchronization therapy
496657|NCT01035489|DDD pacemakers|ddd pacemakers
496658|NCT01035476|ALS|als
496659|NCT01035476|nasal ventilation|nasal ventilation
496660|NCT01035476|data card recording|data card recording
496661|NCT01035450|Coronary stent|coronary stent
496662|NCT01035437|obstructing|obstructing
496663|NCT01035424|Batten Disease|batten disease
496760|NCT01034956|Patient satisfaction|patient satisfaction
496664|NCT01035424|Late Infantile Neuronal Lipofuscinosis|late infantile neuronal lipofuscinosis
496665|NCT01035424|LINCL|lincl
496666|NCT01035411|COPD|copd
496667|NCT01035398|stage 0 esophageal cancer|stage 0 esophageal cancer
496668|NCT01035398|stage I esophageal cancer|stage i esophageal cancer
496669|NCT01035398|stage II esophageal cancer|stage ii esophageal cancer
496670|NCT01035398|stage III esophageal cancer|stage iii esophageal cancer
496671|NCT01035398|stage IV esophageal cancer|stage iv esophageal cancer
496672|NCT01035385|FOFLOX4|foflox4
496673|NCT01035385|resectable liver metastasis from colorectal cancer|resectable liver metastasis from colorectal cancer
496674|NCT01035372|healthy older people|healthy older people
496675|NCT01035359|radius|radius
496676|NCT01035359|fracture|fracture
496677|NCT01035359|wrist|wrist
496678|NCT01035359|external|external
496679|NCT01035359|fixation|fixation
496680|NCT01035359|volar|volar
496681|NCT01035359|plate|plate
496682|NCT01035359|DASH|dash
496683|NCT01035359|PRWE|prwe
496684|NCT01035346|Fever|fever
496685|NCT01035346|antipyretic|antipyretic
496686|NCT01035346|uncomplicated acute viral infection|uncomplicated acute viral infection
496687|NCT01035346|uncomplicated acute bacterial infections|uncomplicated acute bacterial infections
496688|NCT01035333|gastric bypass surgery|gastric bypass surgery
496689|NCT01035307|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
496690|NCT01035307|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
496691|NCT01035281|Diabetic Neuropathies|diabetic neuropathies
496692|NCT01035281|Neuropathic Pain|neuropathic pain
496693|NCT01035281|Cannabinoids|cannabinoids
496694|NCT01035281|Tree Number C10.668.829.300|tree number c10.668.829.300
496695|NCT01035268|breast cancer treated by conservative surgery|breast cancer treated by conservative surgery
496696|NCT01035255|chronic heart failure|chronic heart failure
496697|NCT01035255|cardiovascular death|cardiovascular death
496698|NCT01035255|hospitalization|hospitalization
496699|NCT01035255|outcome study|outcome study
496700|NCT01035255|BNP|bnp
496701|NCT01035255|KCCQ|kccq
496702|NCT01035255|eGFR|egfr
496703|NCT01035242|OCD|ocd
496704|NCT01035242|obsessions|obsessions
496705|NCT01035242|cognitive|cognitive
496706|NCT01035229|Hepatocellular carcinoma|hepatocellular carcinoma
496707|NCT01035229|randomized trial|randomized trial
496708|NCT01035229|medical treatment|medical treatment
496709|NCT01035229|RAD001|rad001
496710|NCT01035229|placebo|placebo
496711|NCT01035229|Advanced Hepatocellular Carcinoma (HCC)|advanced hepatocellular carcinoma (hcc)
496712|NCT01035216|Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)|relapsed or refractory b-cell chronic lymphocytic leukemia (b-cll)
496713|NCT01035190|Preterm Infants|preterm infants
496714|NCT01035190|Inhaled Corticosteroids|inhaled corticosteroids
496715|NCT01035190|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
496716|NCT01035177|Bone Mineral Density (BMD);|bone mineral density (bmd);
496717|NCT01035177|Cortical bone;|cortical bone;
496718|NCT01035177|Hip fracture;|hip fracture;
496719|NCT01035177|Osteoporosis;|osteoporosis;
496720|NCT01035177|Quantitative Computed Tomography (QCT).|quantitative computed tomography (qct).
496721|NCT01035164|Alzheimer's Disease|alzheimer's disease
496722|NCT01035164|Diagnostic Imaging|diagnostic imaging
496723|NCT01035164|Neuroinflammation|neuroinflammation
496724|NCT01035164|PET Diagnosis|pet diagnosis
496725|NCT01035164|PET Tracer|pet tracer
496726|NCT01035151|randomized cluster design|randomized cluster design
496727|NCT01035151|tobacco cessation|tobacco cessation
496728|NCT01035151|smoking cessation|smoking cessation
496729|NCT01035151|African American|african american
496730|NCT01035125|Self-management|self-management
496731|NCT01035125|Self-efficacy|self-efficacy
496732|NCT01035125|Coping|coping
496733|NCT01035125|Health consumer|health consumer
496734|NCT01035125|Patient education|patient education
496735|NCT01035125|Health related quality of life|health related quality of life
496736|NCT01035099|Letrozole|letrozole
496737|NCT01035099|IVF (in vitro fertilization)|ivf (in vitro fertilization)
496738|NCT01035099|Cryopreservation|cryopreservation
496739|NCT01035099|Fertility Preservation|fertility preservation
496740|NCT01035099|Breast Cancer|breast cancer
496741|NCT01035086|dietary fibre|dietary fibre
496742|NCT01035086|lupin kernel fibre|lupin kernel fibre
496743|NCT01035086|bile acids|bile acids
496744|NCT01035086|cholesterol metabolism|cholesterol metabolism
496745|NCT01035086|blood lipids|blood lipids
496746|NCT01035086|hypercholesterolemia|hypercholesterolemia
496747|NCT01035086|fibre-enriched food|fibre-enriched food
496748|NCT01035086|moderate hypercholesterolemia|moderate hypercholesterolemia
496749|NCT01035047|Acute Coronary Syndrome|acute coronary syndrome
496750|NCT01035047|Chest pain|chest pain
496751|NCT01035047|Cardiac MRI|cardiac mri
496752|NCT01035047|Risk Stratification|risk stratification
496753|NCT01035047|Emergency Department|emergency department
496754|NCT01035008|pancreatic cysts|pancreatic cysts
496755|NCT01034982|COPD|copd
496756|NCT01034969|Hereditary angioedema|hereditary angioedema
496757|NCT01034956|Soft tissue filler|soft tissue filler
496758|NCT01034956|Dermal filler|dermal filler
496759|NCT01034956|Complications|complications
496761|NCT01034943|radius|radius
496762|NCT01034943|fracture|fracture
496763|NCT01034943|wrist|wrist
496764|NCT01034943|external|external
496765|NCT01034943|fixation|fixation
496766|NCT01034943|volar|volar
496767|NCT01034943|plate|plate
496768|NCT01034943|DASH|dash
496769|NCT01034943|PRWE|prwe
496770|NCT01034930|MANDIBLE|mandible
496771|NCT01034930|IMPLANTS|implants
496772|NCT01034930|OVERDENTURE|overdenture
496773|NCT01034917|Active Comparator|active comparator
496774|NCT01034917|Placebo Comparator|placebo comparator
496775|NCT01034917|Sham Comparator|sham comparator
496776|NCT01034917|No intervention|no intervention
496777|NCT01034917|Other|other
496778|NCT01034917|Treatment Experienced|treatment experienced
496779|NCT01034904|Quality of Life|quality of life
496780|NCT01034904|HRQoL|hrqol
496781|NCT01034904|Hemophilia A|hemophilia a
496782|NCT01034904|Helixate FS|helixate fs
496783|NCT01034891|BRCA mutation|brca mutation
496784|NCT01034891|benign breast disease|benign breast disease
496785|NCT01034891|family history of breast cancer|family history of breast cancer
496786|NCT01034891|strong family history of breast cancer|strong family history of breast cancer
496787|NCT01034891|atypical ductal hyperplasia|atypical ductal hyperplasia
496788|NCT01034891|atypical lobular hyperplasia|atypical lobular hyperplasia
496789|NCT01034891|high risk for breast cancer|high risk for breast cancer
496790|NCT01034852|Atrial Fibrillation|atrial fibrillation
496791|NCT01034852|Maze|maze
496792|NCT01034852|Ablation|ablation
496793|NCT01034839|acute myeloid leukemia|acute myeloid leukemia
496794|NCT01034839|prognosis|prognosis
496795|NCT01034839|cytarabine|cytarabine
496796|NCT01034826|NGT, IGT, diabetes|ngt, igt, diabetes
496797|NCT01034813|contractures, range of motion, scar formation|contractures, range of motion, scar formation
496798|NCT01034800|HIV Positive|hiv positive
496799|NCT01034787|CP-675,206|cp-675,206
496800|NCT01034787|Immunotherapy|immunotherapy
496801|NCT01034787|AntiCTLA4|antictla4
496802|NCT01034787|Clinical Trial|clinical trial
496803|NCT01034787|Unresectable or Metastatic|unresectable or metastatic
496804|NCT01034774|Human volunteers|human volunteers
496805|NCT01034761|Electronic prescribing|electronic prescribing
496806|NCT01034761|Inappropriate medications|inappropriate medications
496807|NCT01034761|Patient safety|patient safety
496808|NCT01034761|Elderly patients in the hospital|elderly patients in the hospital
496809|NCT01034748|Radiolabelled|radiolabelled
496810|NCT01034748|Mass Balance|mass balance
496811|NCT01034748|Healthy Volunteers|healthy volunteers
496812|NCT01034748|Pharmacokinetics|pharmacokinetics
496813|NCT01034735|Saizen®|saizen®
496814|NCT01034735|bioequivalence|bioequivalence
496815|NCT01034735|recombinant human|recombinant human
496816|NCT01034735|Growth Hormone|growth hormone
496817|NCT01034735|treatment of growth failure in children|treatment of growth failure in children
496818|NCT01034735|growth hormone deficiency in adults|growth hormone deficiency in adults
496819|NCT01034722|Breast Milk|breast milk
496820|NCT01034722|Fat Globules|fat globules
496821|NCT01034709|Cytomegalovirus|cytomegalovirus
496822|NCT01034709|CMV|cmv
496823|NCT01034657|MDS|mds
496824|NCT01034657|bone marrow|bone marrow
496825|NCT01034657|anemia|anemia
496826|NCT01034657|cytopenia|cytopenia
496827|NCT01034657|transfusion dependance|transfusion dependance
496828|NCT01034657|EPO|epo
496829|NCT01034657|ESA|esa
496830|NCT01034657|erythropoietin|erythropoietin
496831|NCT01034657|LBH589|lbh589
496832|NCT01034657|Myelodysplastic Syndromes|myelodysplastic syndromes
496833|NCT01034657|hematopoietic improvement|hematopoietic improvement
496834|NCT01034657|IPSS Low|ipss low
496835|NCT01034657|IPSS Int-1|ipss int-1
496836|NCT01034657|HI-E|hi-e
496837|NCT01034657|HDAC Inhibitor|hdac inhibitor
496838|NCT01034657|HDAC-I|hdac-i
496839|NCT01034657|DAC-I|dac-i
496840|NCT01034657|Deacetylase-Inhibitor|deacetylase-inhibitor
496841|NCT01034657|Histone Deacetylase-Inhibitor|histone deacetylase-inhibitor
496842|NCT01034657|red blood cell transfusions|red blood cell transfusions
496843|NCT01034644|Biomarkers|biomarkers
496844|NCT01034644|Genetic markers|genetic markers
496845|NCT01034631|Metastatic Kidney Cancer|metastatic kidney cancer
496846|NCT01034631|BNC105P|bnc105p
496847|NCT01034618|Diabetes|diabetes
496848|NCT01034618|protein|protein
496849|NCT01034618|protein hydrolysate|protein hydrolysate
496850|NCT01034579|Biomarkers|biomarkers
496851|NCT01034579|Genetic markers|genetic markers
496852|NCT01034527|Anterior Cruciate Ligament|anterior cruciate ligament
496853|NCT01034527|Female Athlete|female athlete
496854|NCT01034527|Sports Injuries|sports injuries
496855|NCT01034527|Injury Prevention|injury prevention
496856|NCT01034501|periodontitis|periodontitis
496857|NCT01034501|photodynamic therapy|photodynamic therapy
496858|NCT01034475|acute myeloid leukemia|acute myeloid leukemia
496859|NCT01034475|acute lymphoblastic leukemia|acute lymphoblastic leukemia
496860|NCT01034475|multiple myeloma|multiple myeloma
496861|NCT01034475|chronic myeloid\ leukemia in blast phase|chronic myeloid\ leukemia in blast phase
496862|NCT01034462|Depression|depression
497349|NCT01032382|cutaneous|cutaneous
496863|NCT01034462|Major Depressive Disorder|major depressive disorder
496864|NCT01034449|allo graft|allo graft
496865|NCT01034449|cord blood|cord blood
496866|NCT01034449|expansion|expansion
496867|NCT01034449|reduced-intensity conditioning|reduced-intensity conditioning
496868|NCT01034423|Focus: health effects from omega-3 fatty acids, from fish oil with different quality|focus: health effects from omega-3 fatty acids, from fish oil with different quality
496869|NCT01034410|AS1411|as1411
496870|NCT01034410|AML|aml
496871|NCT01034410|relapsed|relapsed
496872|NCT01034410|refractory|refractory
496873|NCT01034410|aptamer|aptamer
496874|NCT01034410|nucleolin|nucleolin
496875|NCT01034384|fMRI|fmri
496876|NCT01034384|Smoking Withdrawal|smoking withdrawal
496877|NCT01034384|Imaging|imaging
496878|NCT01034384|Memory|memory
496879|NCT01034384|Mood|mood
496880|NCT01034371|Coronary Artery Disease; Hybrid Revascularization;|coronary artery disease; hybrid revascularization;
496881|NCT01034371|Percutaneous Coronary Intervention; Coronary Artery Bypass|percutaneous coronary intervention; coronary artery bypass
496882|NCT01034358|inflammatory bowel disease|inflammatory bowel disease
496883|NCT01034358|Crohn disease|crohn disease
496884|NCT01034358|ulcerative colitis|ulcerative colitis
496885|NCT01034358|Papillomavirus vaccines|papillomavirus vaccines
496886|NCT01034345|Sirolimus|sirolimus
496887|NCT01034345|Liver Transplantation|liver transplantation
496888|NCT01034345|Tolerance|tolerance
496889|NCT01034345|Immune responses|immune responses
496890|NCT01034345|Allograft tolerance|allograft tolerance
496891|NCT01034332|Esophageal cancer|esophageal cancer
496892|NCT01034332|Esophagectomy|esophagectomy
496893|NCT01034332|Paclitaxel|paclitaxel
496894|NCT01034332|Induction chemotherapy|induction chemotherapy
496895|NCT01034319|type 2 diabetes|type 2 diabetes
496896|NCT01034319|genetics|genetics
496897|NCT01034319|genetic counseling|genetic counseling
496898|NCT01034319|diabetes prevention|diabetes prevention
496899|NCT01034293|feeding frequency|feeding frequency
496900|NCT01034293|insulin metabolism|insulin metabolism
496901|NCT01034293|glucose metabolism|glucose metabolism
496902|NCT01034293|substrate partitioning|substrate partitioning
496903|NCT01034280|Down Syndrome|down syndrome
496904|NCT01034280|phenotype|phenotype
496905|NCT01034280|genotype|genotype
496906|NCT01034280|patient family|patient family
496907|NCT01034267|Depression|depression
496908|NCT01034267|Major Depressive Disorder|major depressive disorder
496909|NCT01034254|influenza|influenza
496910|NCT01034254|immunization|immunization
496911|NCT01034254|pregnancy|pregnancy
496912|NCT01034254|efficacy|efficacy
496913|NCT01034254|pertussis|pertussis
496914|NCT01034254|hepatitis E|hepatitis e
496915|NCT01034241|milk protein|milk protein
496916|NCT01034241|overweight|overweight
496917|NCT01034241|insulin metabolism|insulin metabolism
496918|NCT01034241|substrate partitioning|substrate partitioning
496919|NCT01034228|Diarrhoea|diarrhoea
496920|NCT01034228|L-isoleucine|l-isoleucine
496921|NCT01034228|children|children
496922|NCT01034228|ORS|ors
496923|NCT01034228|Antibacterial peptide|antibacterial peptide
496924|NCT01034215|Behavioral|behavioral
496925|NCT01034215|Quality of Life|quality of life
496926|NCT01034215|Breast Cancer|breast cancer
496927|NCT01034189|Esophageal cancer|esophageal cancer
496928|NCT01034189|Chemoradiotherapy|chemoradiotherapy
496929|NCT01034189|Paclitaxel|paclitaxel
496930|NCT01034189|Cetuximab|cetuximab
496931|NCT01034176|BK viremia|bk viremia
496932|NCT01034176|kidney transplantation|kidney transplantation
496933|NCT01034176|BK viremia in kidney transplant recipients|bk viremia in kidney transplant recipients
496934|NCT01034163|Phase III randomized|phase iii randomized
496935|NCT01034163|double blind|double blind
496936|NCT01034163|placebo controlled multi-center study|placebo controlled multi-center study
496937|NCT01034163|panobinostat|panobinostat
496938|NCT01034163|Hodgkin's lymphoma|hodgkin's lymphoma
496939|NCT01034163|at risk for relapse|at risk for relapse
496940|NCT01034163|autologous stem cell transplant|autologous stem cell transplant
496941|NCT01034137|Treat-to-target, tight control, strategy study, TCZ, MTX|treat-to-target, tight control, strategy study, tcz, mtx
496942|NCT01034124|warfarin|warfarin
496943|NCT01034124|midazolam|midazolam
496944|NCT01034124|cranberry juice|cranberry juice
496945|NCT01034124|pharmacokinetics|pharmacokinetics
496946|NCT01034098|Obesity|obesity
496947|NCT01034098|Postmenopausal women|postmenopausal women
496948|NCT01034098|Mechanical ventilatory constraints|mechanical ventilatory constraints
496949|NCT01034098|Dynamic lung volume|dynamic lung volume
496950|NCT01034098|Expiratory flow limitation|expiratory flow limitation
496951|NCT01034085|Nicotine|nicotine
496952|NCT01034085|Schizophrenia|schizophrenia
496953|NCT01034085|Cognition|cognition
496954|NCT01034085|Genes|genes
496955|NCT01034085|Smoking|smoking
496956|NCT01034085|Cigarette Smoking|cigarette smoking
496957|NCT01034046|Obesity|obesity
496958|NCT01034033|quality of life|quality of life
496959|NCT01034020|Nasal Spray|nasal spray
496960|NCT01034020|Attention Network Test|attention network test
496961|NCT01034020|Continuous Performance Test|continuous performance test
497350|NCT01032382|WR 279,396|wr 279,396
496962|NCT01034020|Attentional Blink Test|attentional blink test
496963|NCT01034007|tissue engineered vascular graft|tissue engineered vascular graft
496964|NCT01033994|Knee osteoarthritis|knee osteoarthritis
496965|NCT01033994|Fibroblast growth factor 18|fibroblast growth factor 18
496966|NCT01033994|Sprifermin|sprifermin
496967|NCT01033981|cost effectiveness|cost effectiveness
496968|NCT01033981|Sunitinib Central America and Caribbean Metastatic Renal Cell Carcinoma|sunitinib central america and caribbean metastatic renal cell carcinoma
496969|NCT01033968|lasers|lasers
496970|NCT01033968|pain measurement|pain measurement
496971|NCT01033968|photocoagulation|photocoagulation
496972|NCT01033968|retina|retina
496973|NCT01033955|critical care|critical care
496974|NCT01033955|H1N1/influenza infection|h1n1/influenza infection
496975|NCT01033955|respiration|respiration
496976|NCT01033955|ventilation, artificial|ventilation, artificial
496977|NCT01033955|critically ill patients|critically ill patients
496978|NCT01033955|invasive mechanical ventilation|invasive mechanical ventilation
496979|NCT01033955|H1N1/influenza infection (suspected, probable or confirmed)|h1n1/influenza infection (suspected, probable or confirmed)
496980|NCT01033942|Pre-exposure prophylaxis|pre-exposure prophylaxis
496981|NCT01033942|HIV Prevention|hiv prevention
496982|NCT01033942|Truvada|truvada
496983|NCT01033942|Many Men, Many Voices|many men, many voices
496984|NCT01033942|Emtricitabine|emtricitabine
496985|NCT01033942|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
496986|NCT01033942|Young men who have sex with men|young men who have sex with men
496987|NCT01033942|HIV Seronegativity|hiv seronegativity
496988|NCT01033929|tuberculosis|tuberculosis
496989|NCT01033929|ESAT-6|esat-6
496990|NCT01033929|CFP-10|cfp-10
496991|NCT01033929|skin test|skin test
496992|NCT01033929|diagnostic test|diagnostic test
496993|NCT01033916|Blood Glucose|blood glucose
496994|NCT01033916|Insulin/Administration and Dosage|insulin/administration and dosage
496995|NCT01033916|Coronary Artery Bypass|coronary artery bypass
496996|NCT01033903|Abortion, Spontaneous|abortion, spontaneous
496997|NCT01033903|Randomized Controlled Trial|randomized controlled trial
496998|NCT01033890|local anesthesia|local anesthesia
496999|NCT01033890|cochlear implant|cochlear implant
497000|NCT01033890|sedation|sedation
497001|NCT01033890|3 patients submitted to cochlear implant surgery with local anesthesia with sedation|3 patients submitted to cochlear implant surgery with local anesthesia with sedation
497002|NCT01033877|Immunisation, active|immunisation, active
497003|NCT01033812|Networks|networks
497004|NCT01033812|Index recruiter|index recruiter
497005|NCT01033799|Probiotic - Lactobacillus casei DN114-001|probiotic - lactobacillus casei dn114-001
497006|NCT01033799|dairy product - infections - shiftworkers|dairy product - infections - shiftworkers
497007|NCT01033799|Common infectious diseases,|common infectious diseases,
497008|NCT01033799|occuring in healthy subjects,|occuring in healthy subjects,
497009|NCT01033799|including upper respiratory tract infections (defined as rhinopharyngitis, sore throat, sinusitis and otitis),|including upper respiratory tract infections (defined as rhinopharyngitis, sore throat, sinusitis and otitis),
497010|NCT01033799|lower respiratory tract infections (defined as bronchitis,|lower respiratory tract infections (defined as bronchitis,
497011|NCT01033799|pneumopathy and flu and flu-like syndromes), and|pneumopathy and flu and flu-like syndromes), and
497012|NCT01033799|gastrointestinal tract infection defined as gastroenteritis.|gastrointestinal tract infection defined as gastroenteritis.
497013|NCT01033773|Type 2 diabetes mellitus|type 2 diabetes mellitus
497014|NCT01033773|Uncontrolled hyperglycemia|uncontrolled hyperglycemia
497015|NCT01033773|Emergency Department|emergency department
497016|NCT01033760|Primary HIV-1 infection|primary hiv-1 infection
497017|NCT01033760|antiretroviral treatment|antiretroviral treatment
497018|NCT01033760|HIV reservoirs|hiv reservoirs
497019|NCT01033760|HIV-DNA levels|hiv-dna levels
497020|NCT01033760|randomized|randomized
497021|NCT01033760|Treatment Naive|treatment naive
497022|NCT01033747|iron overload|iron overload
497023|NCT01033747|iron chelation therapy|iron chelation therapy
497024|NCT01033747|B-thalassemia|b-thalassemia
497025|NCT01033708|Psychotherapy|psychotherapy
497026|NCT01033708|PTSD|ptsd
497027|NCT01033708|Borderline personality disorders|borderline personality disorders
497028|NCT01033695|Endoscopy|endoscopy
497029|NCT01033695|Endoscopic Ultrasound|endoscopic ultrasound
497030|NCT01033695|Endoscopic Sonoelastography|endoscopic sonoelastography
497031|NCT01033695|Cancer|cancer
497032|NCT01033695|Interobserver agreement|interobserver agreement
497033|NCT01033669|Inhalation profiles|inhalation profiles
497034|NCT01033669|asthma|asthma
497035|NCT01033669|COPD|copd
497036|NCT01033656|adult-onset Still's disease|adult-onset still's disease
497037|NCT01033656|anakinra|anakinra
497038|NCT01033656|prednisolone|prednisolone
497039|NCT01033656|disease-modifying antirheumatic drug|disease-modifying antirheumatic drug
497040|NCT01033656|methotrexate|methotrexate
497041|NCT01033656|efficacy|efficacy
497042|NCT01033656|patients|patients
497043|NCT01033617|Stem cells|stem cells
497044|NCT01033617|Cellular therapy|cellular therapy
497045|NCT01033617|Myocardial repair|myocardial repair
497046|NCT01033591|Primary Health Care|primary health care
497047|NCT01033591|Family PractiCe|family practice
497048|NCT01033591|Hearth Failure|hearth failure
497049|NCT01033591|Exercise|exercise
497050|NCT01033591|Randomized Controlled Trials|randomized controlled trials
497051|NCT01033591|Multicenter Study|multicenter study
497052|NCT01033591|Quality of life|quality of life
497053|NCT01033565|Impaired sleep maintenance|impaired sleep maintenance
497054|NCT01033565|Autism Spectrum Disorders|autism spectrum disorders
497055|NCT01033565|Pediatric|pediatric
497056|NCT01033539|Survive|survive
497057|NCT01033539|safety|safety
497058|NCT01033539|lactobacillus Reuteri|lactobacillus reuteri
497059|NCT01033526|Symptomatic treatment of Common Cold symptoms|symptomatic treatment of common cold symptoms
497060|NCT01033487|Safety|safety
497061|NCT01033487|Pharmacokinetics|pharmacokinetics
497062|NCT01033487|Pharmacodynamics|pharmacodynamics
497063|NCT01033487|PF-03635659|pf-03635659
497064|NCT01033487|COPD|copd
497065|NCT01033474|Infertile Patients|infertile patients
497066|NCT01033461|probiotic|probiotic
497067|NCT01033461|lactobacillus paracasei|lactobacillus paracasei
497068|NCT01033461|calcium|calcium
497069|NCT01033461|faecal microbiota|faecal microbiota
497070|NCT01033461|cholesterol metabolism|cholesterol metabolism
497071|NCT01033435|Inflammation|inflammation
497072|NCT01033435|Oxidative stress|oxidative stress
497073|NCT01033435|HbA1c|hba1c
497074|NCT01033435|Hemodialysis|hemodialysis
497075|NCT01033422|Glaucoma|glaucoma
497076|NCT01033422|Ocular hypertension|ocular hypertension
497077|NCT01033422|Intraocular hypertension|intraocular hypertension
497078|NCT01033409|Salmonella Typhi|salmonella typhi
497079|NCT01033409|pneumonia|pneumonia
497080|NCT01033409|oral|oral
497081|NCT01033409|vaccine|vaccine
497082|NCT01033396|Allergic rhinitis Environmental exposure unit|allergic rhinitis environmental exposure unit
497083|NCT01033370|acute|acute
497084|NCT01033370|aortic|aortic
497085|NCT01033370|emergencies|emergencies
497086|NCT01033370|Aortic dissection|aortic dissection
497087|NCT01033357|dialysis|dialysis
497088|NCT01033357|hemodialysis|hemodialysis
497089|NCT01033357|neointimal hyperplasia|neointimal hyperplasia
497090|NCT01033344|Cat allergy|cat allergy
497091|NCT01033344|Rhinoconjunctivitis|rhinoconjunctivitis
497092|NCT01033344|Exposure chamber|exposure chamber
497093|NCT01033344|Immunotherapy|immunotherapy
497094|NCT01033344|Cat-PAD|cat-pad
497095|NCT01033331|Spinal Muscular atrophy|spinal muscular atrophy
497096|NCT01033331|Valproic acid|valproic acid
497097|NCT01033331|HMAS|hmas
497098|NCT01033331|MRC scale|mrc scale
497099|NCT01033318|Hypertension|hypertension
497100|NCT01033305|UC|uc
497101|NCT01033292|ovarian|ovarian
497102|NCT01033292|cancer|cancer
497103|NCT01033292|sensitive|sensitive
497104|NCT01033292|PARP|parp
497105|NCT01033292|recurrent|recurrent
497106|NCT01033292|platinum-resistant recurrent ovarian cancer|platinum-resistant recurrent ovarian cancer
497107|NCT01033279|Coaguchek|coaguchek
497108|NCT01033279|Portable coagulometer|portable coagulometer
497109|NCT01033279|Self-monitoring|self-monitoring
497110|NCT01033279|Coumadin|coumadin
497111|NCT01033279|Warfarin|warfarin
497112|NCT01033279|Quality of life|quality of life
497113|NCT01033279|Pharmacist|pharmacist
497114|NCT01033227|sickle cell disease|sickle cell disease
497115|NCT01033227|sickle cell anemia|sickle cell anemia
497116|NCT01033227|pain crisis|pain crisis
497117|NCT01033227|nitric oxide|nitric oxide
497118|NCT01033227|nitrite|nitrite
497119|NCT01033227|vaso occlusive crisis|vaso occlusive crisis
497120|NCT01033227|pain medication|pain medication
497121|NCT01033227|sickled cells|sickled cells
497122|NCT01033227|blood flow|blood flow
497123|NCT01033227|microcirculation|microcirculation
497124|NCT01033214|TAA|taa
497125|NCT01033214|Thoracic|thoracic
497126|NCT01033214|Descending Thoracic Aorta|descending thoracic aorta
497127|NCT01033214|TAArget|taarget
497128|NCT01033201|Lung rejection|lung rejection
497129|NCT01033188|double bundle|double bundle
497130|NCT01033188|hamstring graft|hamstring graft
497131|NCT01033188|ACL reconstruction|acl reconstruction
497132|NCT01033188|single bundle|single bundle
497133|NCT01033175|COPD|copd
497134|NCT01033175|anemia|anemia
497135|NCT01033175|exercise|exercise
497136|NCT01033175|cytokines|cytokines
497137|NCT01033175|erythropoietin|erythropoietin
497138|NCT01033123|ovarian|ovarian
497139|NCT01033123|cancer|cancer
497140|NCT01033123|sensitive|sensitive
497141|NCT01033123|PARP|parp
497142|NCT01033123|recurrent|recurrent
497143|NCT01033123|platinum-sensitive recurrent ovarian cancer|platinum-sensitive recurrent ovarian cancer
497144|NCT01033110|inactive|inactive
497145|NCT01033110|>45 years|>45 years
497146|NCT01033110|female|female
497147|NCT01033097|Dermatitis|dermatitis
497148|NCT01033097|inflammatory skin disease|inflammatory skin disease
497149|NCT01033097|itch|itch
497150|NCT01033097|eczema|eczema
497151|NCT01033084|Depressive Disorder, Major|depressive disorder, major
497152|NCT01033071|Hypertensive|hypertensive
497153|NCT01033071|Blood Pressure, High|blood pressure, high
497154|NCT01033071|Cardiovascular disease|cardiovascular disease
497155|NCT01033071|Vascular Disease|vascular disease
497351|NCT01032382|paromomycin|paromomycin
497156|NCT01033071|Drug Therapy|drug therapy
497157|NCT01033058|STEMI|stemi
497158|NCT01033058|atorvastatin|atorvastatin
497159|NCT01033058|PCI|pci
497160|NCT01033045|Hepatitis C|hepatitis c
497161|NCT01033045|Viral|viral
497162|NCT01033045|Non-A|non-a
497163|NCT01033045|Non-B|non-b
497164|NCT01033045|Parenterally-Transmitted|parenterally-transmitted
497165|NCT01033032|Metastatic Breast Cancer|metastatic breast cancer
497166|NCT01033032|Amrubicin|amrubicin
497167|NCT01033019|Basal cell carcinomas,|basal cell carcinomas,
497168|NCT01033019|sporadic,|sporadic,
497169|NCT01033019|superficial and nodular,|superficial and nodular,
497170|NCT01033019|skin|skin
497171|NCT01033006|Peripheral Nerves|peripheral nerves
497172|NCT01033006|Axillary Block|axillary block
497173|NCT01033006|MRI|mri
497174|NCT01032993|CoQ10|coq10
497175|NCT01032993|Statins|statins
497176|NCT01032993|Myalgia|myalgia
497177|NCT01032993|Muscle Pain|muscle pain
497178|NCT01032993|Muscle Weakness|muscle weakness
497179|NCT01032980|HUMENZA|humenza
497180|NCT01032980|PANENZA|panenza
497181|NCT01032980|Influenza|influenza
497182|NCT01032980|Swine-Origin Influenza A H1N1 Virus|swine-origin influenza a h1n1 virus
497183|NCT01032980|Influenza virus vaccines|influenza virus vaccines
497184|NCT01032967|squamous cell carcinoma|squamous cell carcinoma
497185|NCT01032967|esophagectomy|esophagectomy
497186|NCT01032967|chemoradiotherapy|chemoradiotherapy
497187|NCT01032967|chemoradiation|chemoradiation
497188|NCT01032967|Squamous cell carcinomas of the esophagus|squamous cell carcinomas of the esophagus
497189|NCT01032954|Botulinum Toxin|botulinum toxin
497190|NCT01032954|Rejuvenation|rejuvenation
497191|NCT01032954|Facial dynamic wrinkles|facial dynamic wrinkles
497192|NCT01032941|Portal Hypertension|portal hypertension
497193|NCT01032941|Portal Pressure Measurement|portal pressure measurement
497194|NCT01032941|VSL3|vsl3
497195|NCT01032941|Cirrhosis|cirrhosis
497196|NCT01032941|End Stage Liver Disease|end stage liver disease
497197|NCT01032941|Probiotics|probiotics
497198|NCT01032928|Swallowing|swallowing
497199|NCT01032928|Dysphagia|dysphagia
497200|NCT01032928|Breathing and swallowing|breathing and swallowing
497201|NCT01032928|Oropharyngeal cancer|oropharyngeal cancer
497202|NCT01032915|Quiescent uveitis|quiescent uveitis
497203|NCT01032915|intermediate uveitis|intermediate uveitis
497204|NCT01032915|panuveitis|panuveitis
497205|NCT01032915|posterior uveitis|posterior uveitis
497206|NCT01032915|uveitis|uveitis
497207|NCT01032902|Human immunodeficiency virus|human immunodeficiency virus
497208|NCT01032902|Rapid Test|rapid test
497209|NCT01032902|HIV|hiv
497210|NCT01032902|HIV Seronegativity|hiv seronegativity
497211|NCT01032876|Congenital Heart disease|congenital heart disease
497212|NCT01032876|Cardiopulmonary bypass|cardiopulmonary bypass
497213|NCT01032876|Neonatal brain injury|neonatal brain injury
497214|NCT01032876|Deep Hypothermic Circulatory Arrest|deep hypothermic circulatory arrest
497215|NCT01032876|Antegrade Cerebral Perfusion|antegrade cerebral perfusion
497216|NCT01032863|Chronic musculoskeletal pain|chronic musculoskeletal pain
497217|NCT01032863|Benign joint hypermobility syndrome|benign joint hypermobility syndrome
497218|NCT01032863|Fibromyalgia|fibromyalgia
497219|NCT01032850|INST 0820|inst 0820
497220|NCT01032850|sorafenib|sorafenib
497221|NCT01032850|capecitabine|capecitabine
497222|NCT01032850|hepatocellular carcinoma|hepatocellular carcinoma
497223|NCT01032850|lung|lung
497224|NCT01032850|nexavar|nexavar
497225|NCT01032850|xeloda|xeloda
497226|NCT01032850|liver cancer|liver cancer
497227|NCT01032824|Complementary Therapies|complementary therapies
497228|NCT01032811|ADHD, childhood cancer|adhd, childhood cancer
497229|NCT01032811|ADHD/Secondary ADHD Among Survivors of Childhood Cancer|adhd/secondary adhd among survivors of childhood cancer
497230|NCT01032785|Patent Foramen Ovale|patent foramen ovale
497231|NCT01032785|Patent Ductus Arteriosus|patent ductus arteriosus
497232|NCT01032785|PFO|pfo
497233|NCT01032785|PDA|pda
497234|NCT01032772|alcohol-exposed pregnancy|alcohol-exposed pregnancy
497235|NCT01032772|tobacco-exposed pregnancy|tobacco-exposed pregnancy
497236|NCT01032772|alcohol|alcohol
497237|NCT01032772|contraception|contraception
497238|NCT01032772|smoking|smoking
497239|NCT01032772|pregnancy|pregnancy
497240|NCT01032746|colon cancer|colon cancer
497241|NCT01032746|rectal cancer|rectal cancer
497242|NCT01032733|Weight Loss|weight loss
497243|NCT01032733|Physical Function|physical function
497244|NCT01032733|Oxidative Stress|oxidative stress
497245|NCT01032733|Inflammation|inflammation
497246|NCT01032720|ultrasound|ultrasound
497247|NCT01032720|osteoarthritis|osteoarthritis
497248|NCT01032720|knee|knee
497249|NCT01032720|corticosteroids|corticosteroids
497250|NCT01032720|intra-articular|intra-articular
497251|NCT01032720|injections|injections
497252|NCT01032694|Community-Acquired Pneumonia|community-acquired pneumonia
497253|NCT01032694|Azithromycin SR|azithromycin sr
497254|NCT01032694|Amoxiclav|amoxiclav
497255|NCT01032681|Solid tumor|solid tumor
497256|NCT01032681|B-Cell Non-Hodgkin Lymphoma|b-cell non-hodgkin lymphoma
497257|NCT01032681|Immunocytokine|immunocytokine
497258|NCT01032681|interleukin-2|interleukin-2
497259|NCT01032681|immunotherapy|immunotherapy
497260|NCT01032681|Metastatic or Locally Advanced Solid Tumors or B-Cell Non-Hodgkin Lymphoma|metastatic or locally advanced solid tumors or b-cell non-hodgkin lymphoma
497382|NCT01032291|Cetuximab|cetuximab
497261|NCT01032668|percutaneous coronary intervention, clopidogrel resistance, ASA resistance|percutaneous coronary intervention, clopidogrel resistance, asa resistance
497262|NCT01032655|Helicobacter pylori|helicobacter pylori
497263|NCT01032655|sequential therapy|sequential therapy
497264|NCT01032655|susceptibility-driven|susceptibility-driven
497265|NCT01032655|rescue|rescue
497266|NCT01032655|levofloxacin|levofloxacin
497267|NCT01032655|clarithromycin|clarithromycin
497268|NCT01032655|salvage|salvage
497269|NCT01032655|treatment failure|treatment failure
497270|NCT01032655|those who fail from two standard eradication therapies|those who fail from two standard eradication therapies
497271|NCT01032642|infertility fallopian tubes|infertility fallopian tubes
497272|NCT01032629|Diabetes|diabetes
497273|NCT01032629|Type 2 diabetes mellitus|type 2 diabetes mellitus
497274|NCT01032629|Cardiovascular risk|cardiovascular risk
497275|NCT01032629|Cardiovascular outcomes|cardiovascular outcomes
497276|NCT01032629|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
497277|NCT01032629|Placebo|placebo
497278|NCT01032616|splanchnic bed|splanchnic bed
497279|NCT01032616|theronine and lysine metabolism uptake|theronine and lysine metabolism uptake
497280|NCT01032616|isotopes|isotopes
497281|NCT01032616|metabolism of two indispensable amino acids, threonine and lysine, by the splanchnic bed by Healthy Males|metabolism of two indispensable amino acids, threonine and lysine, by the splanchnic bed by healthy males
497282|NCT01032603|IXT|ixt
497283|NCT01032603|Exotropia|exotropia
497284|NCT01032603|Strabismus|strabismus
497285|NCT01032603|Intermittent exotropia|intermittent exotropia
497286|NCT01032590|weight changes|weight changes
497287|NCT01032590|cancer survivor|cancer survivor
497288|NCT01032590|stage I colon cancer|stage i colon cancer
497289|NCT01032590|stage II colon cancer|stage ii colon cancer
497290|NCT01032590|stage III colon cancer|stage iii colon cancer
497291|NCT01032590|stage I rectal cancer|stage i rectal cancer
497292|NCT01032590|stage II rectal cancer|stage ii rectal cancer
497293|NCT01032590|stage III rectal cancer|stage iii rectal cancer
497294|NCT01032577|ischemic cardiomyopathy|ischemic cardiomyopathy
497295|NCT01032577|nonischemic cardiomyopathy|nonischemic cardiomyopathy
497296|NCT01032577|implant|implant
497297|NCT01032577|bipolar sensing|bipolar sensing
497298|NCT01032577|extended bipolar sensing|extended bipolar sensing
497299|NCT01032564|estimate the interest of the measure of cervix elasticity degree by elastography in prediction of premature birth within a population of pregnant women|estimate the interest of the measure of cervix elasticity degree by elastography in prediction of premature birth within a population of pregnant women
497300|NCT01032551|Coronary Angiogram|coronary angiogram
497301|NCT01032551|Decision Aid|decision aid
497302|NCT01032551|Vascular Access|vascular access
497303|NCT01032551|Radial|radial
497304|NCT01032551|Femoral|femoral
497305|NCT01032538|Unicondylar Knee Replacement|unicondylar knee replacement
497306|NCT01032525|Crohn's Disease|crohn's disease
497307|NCT01032525|Ulcerative Colitis|ulcerative colitis
497308|NCT01032525|IBD|ibd
497309|NCT01032525|Inflammatory Bowel Disease in Monroe County, NY|inflammatory bowel disease in monroe county, ny
497310|NCT01032512|IMMUNE-ENHANCING|immune-enhancing
497311|NCT01032512|GLUTAMINE|glutamine
497312|NCT01032512|ARGININE|arginine
497313|NCT01032512|OMEGA 3 FATTY ACIDS|omega 3 fatty acids
497314|NCT01032512|ONCOLOGIC SURGERY|oncologic surgery
497315|NCT01032512|PREOPERATIVE NUTRITION|preoperative nutrition
497316|NCT01032499|Acne Vulgaris|acne vulgaris
497317|NCT01032499|Boil|boil
497318|NCT01032499|Taro Elixir|taro elixir
497319|NCT01032486|Rasagiline|rasagiline
497320|NCT01032486|Sleep|sleep
497321|NCT01032486|Sleepiness|sleepiness
497322|NCT01032486|Parkinson's Disease Sleep Scale|parkinson's disease sleep scale
497323|NCT01032486|Epworth Sleepiness Scale|epworth sleepiness scale
497324|NCT01032460|airway|airway
497325|NCT01032460|airway device|airway device
497326|NCT01032460|cervical spine immobilisation|cervical spine immobilisation
497327|NCT01032434|sertraline|sertraline
497328|NCT01032434|Polysomnograph|polysomnograph
497329|NCT01032421|women admitted to the In Vitro Fertilization unit|women admitted to the in vitro fertilization unit
497330|NCT01032408|Influenza A Virus|influenza a virus
497331|NCT01032408|Virus Diseases|virus diseases
497332|NCT01032408|Influenza, Human|influenza, human
497333|NCT01032408|HIV-1|hiv-1
497334|NCT01032408|Immunodeficiency Virus|immunodeficiency virus
497335|NCT01032408|H1N1|h1n1
497336|NCT01032408|HIV Infection|hiv infection
497337|NCT01032408|Immunogenicity|immunogenicity
497338|NCT01032408|safety|safety
497339|NCT01032408|tolerability|tolerability
497340|NCT01032395|H1N1|h1n1
497341|NCT01032395|Pulmonary Disease|pulmonary disease
497342|NCT01032395|Heart Disease|heart disease
497343|NCT01032395|Diabetes|diabetes
497344|NCT01032395|Influenza|influenza
497345|NCT01032395|immunogenicity|immunogenicity
497346|NCT01032395|safety|safety
497347|NCT01032395|tolerability|tolerability
497348|NCT01032382|leishmaniasis|leishmaniasis
497352|NCT01032382|gentamicin|gentamicin
497353|NCT01032382|pharmacokinetics|pharmacokinetics
497354|NCT01032382|safety|safety
497355|NCT01032382|efficacy|efficacy
497356|NCT01032369|"Over-weight or obese subjects with learning disability who have completed Nitzan Onim two-year training program and live in housing within the community"|"over-weight or obese subjects with learning disability who have completed nitzan onim two-year training program and live in housing within the community"
497357|NCT01032356|Distal Radius fracture|distal radius fracture
497358|NCT01032343|Immunosuppression|immunosuppression
497359|NCT01032343|Ultraviolet radiation|ultraviolet radiation
497360|NCT01032343|Nickel|nickel
497361|NCT01032343|Contact hypersensitivity|contact hypersensitivity
497362|NCT01032330|intermittent exotropia|intermittent exotropia
497363|NCT01032330|IXT|ixt
497364|NCT01032330|natural history|natural history
497365|NCT01032330|occlusion therapy|occlusion therapy
497366|NCT01032330|occlusion|occlusion
497367|NCT01032330|patching|patching
497368|NCT01032330|strabismus|strabismus
497369|NCT01032330|strabismus treatment|strabismus treatment
497370|NCT01032330|stereoacuity|stereoacuity
497371|NCT01032330|motor alignment|motor alignment
497372|NCT01032317|Arrhythmia|arrhythmia
497373|NCT01032317|Electrophysiology|electrophysiology
497374|NCT01032317|Fibrillation|fibrillation
497375|NCT01032317|Tachycardia|tachycardia
497376|NCT01032317|Ablation|ablation
497377|NCT01032317|Atrial Fibrillation (AF)|atrial fibrillation (af)
497378|NCT01032317|Ischemic Ventricular Tachycardia (VT)|ischemic ventricular tachycardia (vt)
497379|NCT01032291|Colorectal cancer|colorectal cancer
497380|NCT01032291|Revlimid|revlimid
497381|NCT01032291|Lenalidomide|lenalidomide
497383|NCT01032291|Erbitux|erbitux
497384|NCT01032291|KRAS|kras
497385|NCT01032278|cardiac toxicity|cardiac toxicity
497386|NCT01032278|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
497387|NCT01032265|female|female
497388|NCT01032265|stress urinary incontinence|stress urinary incontinence
497389|NCT01032265|treatment|treatment
497390|NCT01032265|pelvic floor muscle training|pelvic floor muscle training
497391|NCT01032265|cognitive behavioral therapy|cognitive behavioral therapy
497392|NCT01032265|internet|internet
497393|NCT01032265|life style|life style
497394|NCT01032265|pamphlet|pamphlet
497395|NCT01032265|eHealth|ehealth
497396|NCT01032252|fall prevention|fall prevention
497397|NCT01032252|general practitioners setting|general practitioners setting
497398|NCT01032252|implementation|implementation
497399|NCT01032252|network|network
497400|NCT01032252|community dwelling older adults|community dwelling older adults
497401|NCT01032252|exercise intervention|exercise intervention
497402|NCT01032239|Severe spasticity in post-stroke patients|severe spasticity in post-stroke patients
497403|NCT01032200|fatigue|fatigue
497404|NCT01032200|cognitive/functional effects|cognitive/functional effects
497405|NCT01032200|adult giant cell glioblastoma|adult giant cell glioblastoma
497406|NCT01032200|adult glioblastoma|adult glioblastoma
497407|NCT01032200|adult gliosarcoma|adult gliosarcoma
497408|NCT01032200|adult anaplastic astrocytoma|adult anaplastic astrocytoma
497409|NCT01032200|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
497410|NCT01032200|adult mixed glioma|adult mixed glioma
497411|NCT01032200|adult diffuse astrocytoma|adult diffuse astrocytoma
497412|NCT01032200|adult pilocytic astrocytoma|adult pilocytic astrocytoma
497413|NCT01032200|adult pineal gland astrocytoma|adult pineal gland astrocytoma
497414|NCT01032200|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
497415|NCT01032200|adult oligodendroglioma|adult oligodendroglioma
497416|NCT01032200|adult anaplastic ependymoma|adult anaplastic ependymoma
497417|NCT01032200|adult ependymoma|adult ependymoma
497418|NCT01032200|adult myxopapillary ependymoma|adult myxopapillary ependymoma
497419|NCT01032200|adult subependymoma|adult subependymoma
497420|NCT01032200|adult anaplastic meningioma|adult anaplastic meningioma
497421|NCT01032200|adult grade I meningioma|adult grade i meningioma
497422|NCT01032200|adult grade II meningioma|adult grade ii meningioma
497423|NCT01032200|adult grade III meningioma|adult grade iii meningioma
497424|NCT01032200|adult papillary meningioma|adult papillary meningioma
497425|NCT01032200|adult brain stem glioma|adult brain stem glioma
497426|NCT01032187|Visceral leishmaniasis|visceral leishmaniasis
497427|NCT01032187|Amphotericin B deoxycholate|amphotericin b deoxycholate
497428|NCT01032187|Meglumine antimoniate|meglumine antimoniate
497429|NCT01032187|Children|children
497430|NCT01032187|Brazil|brazil
497431|NCT01032174|Azithromycin SR Amoxiclav 1000 mg Maxillary Sinusitis|azithromycin sr amoxiclav 1000 mg maxillary sinusitis
497432|NCT01032161|Delirium|delirium
497433|NCT01032161|Postoperative|postoperative
497434|NCT01032161|Non-cardiovascular surgery|non-cardiovascular surgery
497435|NCT01032161|Post-anaesthesia care unit|post-anaesthesia care unit
497436|NCT01032161|patients between 3 to 12 years old|patients between 3 to 12 years old
497437|NCT01032161|undergoing selective non-cardiac surgery|undergoing selective non-cardiac surgery
497438|NCT01032161|under general anesthesia|under general anesthesia
497439|NCT01032161|surgery|surgery
497440|NCT01032161|general anesthesia|general anesthesia
497441|NCT01032148|Recurrent|recurrent
497442|NCT01032148|Refractory|refractory
497443|NCT01032122|melanoma|melanoma
497444|NCT01032122|rituximab|rituximab
497445|NCT01032122|metastatic|metastatic
497446|NCT01032122|stage IIIc/IV|stage iiic/iv
497447|NCT01032122|stem cell|stem cell
497448|NCT01032122|overall survival|overall survival
497449|NCT01032122|disease free interval|disease free interval
497450|NCT01032122|anti-CD20 therapy|anti-cd20 therapy
497451|NCT01032083|SSRI antidepressant|ssri antidepressant
497452|NCT01032083|Negative symptoms|negative symptoms
497453|NCT01032083|Schizophrenia|schizophrenia
497454|NCT01032070|phase 2|phase 2
497455|NCT01032070|erlotinib|erlotinib
497456|NCT01032070|pediatric|pediatric
497457|NCT01032070|etoposide|etoposide
497458|NCT01032070|ependymoma|ependymoma
497459|NCT01032057|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
497460|NCT01032057|stage II pancreatic cancer|stage ii pancreatic cancer
497461|NCT01032057|stage III pancreatic cancer|stage iii pancreatic cancer
497462|NCT01032044|Barrett's esophagus|barrett's esophagus
497463|NCT01032044|EsoGastroDuodenoscopy|esogastroduodenoscopy
497464|NCT01032044|Barrett's carcinoma|barrett's carcinoma
497465|NCT01032044|adenocarcinoma|adenocarcinoma
497466|NCT01032044|Cellvizio|cellvizio
497467|NCT01032044|endomicroscopy|endomicroscopy
497468|NCT01032044|probe-based Confocal Laser Endomicroscopy|probe-based confocal laser endomicroscopy
497469|NCT01032044|pCLE|pcle
497470|NCT01032044|Radio-frequency ablation|radio-frequency ablation
497471|NCT01032044|Endoscopic mucosal resection|endoscopic mucosal resection
497472|NCT01032044|Photodynamic therapy|photodynamic therapy
497473|NCT01032031|Green tea|green tea
497474|NCT01032031|Vitamin C|vitamin c
497475|NCT01032031|Ultraviolet radiation|ultraviolet radiation
497476|NCT01032031|Inflammation|inflammation
497477|NCT01032031|Photoageing|photoageing
497478|NCT01032018|Acute coronary syndrome|acute coronary syndrome
497479|NCT01032018|Depression|depression
497480|NCT01032018|Satisfaction with care|satisfaction with care
497481|NCT01031992|Hereditary hemorrhagic telangiectasia|hereditary hemorrhagic telangiectasia
497482|NCT01031992|Rendu-Osler-Weber syndrome|rendu-osler-weber syndrome
497483|NCT01031992|Epistaxis|epistaxis
497484|NCT01031992|Nosebleeds|nosebleeds
497485|NCT01031992|Anemia|anemia
497486|NCT01031992|Tranexamic acid|tranexamic acid
497487|NCT01031992|Antifibrinolytics|antifibrinolytics
497488|NCT01031979|PTSD|ptsd
497489|NCT01031979|Prolonged Exposure|prolonged exposure
497490|NCT01031979|extinction|extinction
497491|NCT01031979|habituation|habituation
497492|NCT01031979|psychophysiology|psychophysiology
497493|NCT01031966|ESRD|esrd
497494|NCT01031953|nausea and vomiting|nausea and vomiting
497495|NCT01031953|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
497496|NCT01031927|obsessive compulsive disorder|obsessive compulsive disorder
497497|NCT01031927|sarcosine|sarcosine
497498|NCT01031927|glycine transporter I|glycine transporter i
497499|NCT01031927|NMDA receptor|nmda receptor
497500|NCT01031914|Paced Breathing|paced breathing
497502|NCT01031914|sleep/wake detection|sleep/wake detection
497503|NCT01031901|Tuberous Sclerosis|tuberous sclerosis
497504|NCT01031901|Neurofibromatoses|neurofibromatoses
497505|NCT01031901|Angiofibroma|angiofibroma
497506|NCT01031901|Neurofibroma|neurofibroma
497507|NCT01031901|Sirolimus|sirolimus
497508|NCT01031888|Corneal re-epithelialization|corneal re-epithelialization
497509|NCT01031888|Topical insulin application|topical insulin application
497510|NCT01031888|pars planar vitrectomy|pars planar vitrectomy
497511|NCT01031888|diabetic retinopathy|diabetic retinopathy
497512|NCT01031888|penetrating keratoplasty|penetrating keratoplasty
497513|NCT01031875|recurrent bladder cancer|recurrent bladder cancer
497514|NCT01031875|stage IV bladder cancer|stage iv bladder cancer
497515|NCT01031875|recurrent urethral cancer|recurrent urethral cancer
497516|NCT01031875|distal urethral cancer|distal urethral cancer
497517|NCT01031875|proximal urethral cancer|proximal urethral cancer
497518|NCT01031875|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
497519|NCT01031875|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
497520|NCT01031875|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
497521|NCT01031875|stage IV urethral cancer|stage iv urethral cancer
497522|NCT01031862|healthy volunteer|healthy volunteer
497523|NCT01031862|reverse cholesterol transport|reverse cholesterol transport
497524|NCT01031862|RCT|rct
497525|NCT01031862|3H|3h
497526|NCT01031849|HIV 1 patients|hiv 1 patients
497527|NCT01031836|Systemic Lupus Erythematosus|systemic lupus erythematosus
497528|NCT01031836|Japanese|japanese
497529|NCT01031836|phase 2|phase 2
497530|NCT01031836|safety|safety
497531|NCT01031836|tolerability|tolerability
497532|NCT01031836|MEDI-545|medi-545
497533|NCT01031836|Autoimmune Disease|autoimmune disease
497534|NCT01031836|Immune System Diseases|immune system diseases
497535|NCT01031823|Autism Spectrum Disorder|autism spectrum disorder
497536|NCT01031810|Treatment Resistant depression|treatment resistant depression
497537|NCT01031810|Major Depression|major depression
497538|NCT01031810|MDD|mdd
497539|NCT01031810|Depression|depression
497540|NCT01031797|SLE|sle
497541|NCT01031797|Disease activity score|disease activity score
497542|NCT01031797|QT dispersion|qt dispersion
497543|NCT01031784|liver metastasis|liver metastasis
497544|NCT01031784|Liver tumors|liver tumors
497545|NCT01031784|microspheres|microspheres
497546|NCT01031784|holmium|holmium
497547|NCT01031784|toxicity|toxicity
497548|NCT01031771|Cerebral Palsy|cerebral palsy
497549|NCT01031771|Deglutition|deglutition
497550|NCT01031771|Deglutition disorders|deglutition disorders
497551|NCT01031771|Endoscopy|endoscopy
497552|NCT01031758|Low HDL|low hdl
497553|NCT01031758|High HDL|high hdl
497554|NCT01031758|HDL|hdl
497555|NCT01031758|Reverse Cholesterol Transport|reverse cholesterol transport
497556|NCT01031758|RCT|rct
497557|NCT01031758|healthy volunteer|healthy volunteer
497558|NCT01031758|3H|3h
497559|NCT01031758|Average HDL|average hdl
497560|NCT01031745|Complementary Therapies|complementary therapies
497561|NCT01031745|Drug Users|drug users
497562|NCT01031732|Minimally invasive|minimally invasive
497563|NCT01031732|Total hip arthroplasty|total hip arthroplasty
497564|NCT01031732|Functional outcome|functional outcome
497565|NCT01031732|To compare the surgical results of 4 MIS THA techniques|to compare the surgical results of 4 mis tha techniques
497566|NCT01031732|To investigate the functional outcomes of 4 MIS THA techniques|to investigate the functional outcomes of 4 mis tha techniques
497567|NCT01031732|To study the biochemical parameters after the MIS surgeries.|to study the biochemical parameters after the mis surgeries.
497568|NCT01031719|Influenza A Virus|influenza a virus
497569|NCT01031719|Virus Diseases|virus diseases
497570|NCT01031719|Influenza, Human|influenza, human
497571|NCT01031719|H1N1|h1n1
497572|NCT01031719|Immunogenicity|immunogenicity
497573|NCT01031719|safety|safety
497574|NCT01031719|tolerability|tolerability
497575|NCT01031719|tumors|tumors
497576|NCT01031719|oncology|oncology
497577|NCT01031706|Hypertonic Saline|hypertonic saline
497578|NCT01031706|Pediatrics|pediatrics
497579|NCT01031706|Cystic Fibrosis|cystic fibrosis
497580|NCT01031706|Mucociliary Clearance|mucociliary clearance
497581|NCT01031706|Lung Clearance Index|lung clearance index
497582|NCT01031693|Nicotine|nicotine
497583|NCT01031693|Cigarettes|cigarettes
497584|NCT01031693|Tobacco|tobacco
497585|NCT01031693|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
497586|NCT01031693|Cue-Induced Craving|cue-induced craving
497587|NCT01031693|Smoking|smoking
497588|NCT01031680|dapagliflozin|dapagliflozin
497589|NCT01031680|diabetes|diabetes
497590|NCT01031680|cardiovascular disease|cardiovascular disease
497591|NCT01031680|hypertension|hypertension
497592|NCT01031667|Patients treated with PCI with stent|patients treated with pci with stent
497593|NCT01031641|Patient-Reported Outcomes|patient-reported outcomes
497594|NCT01031641|Symptoms|symptoms
497595|NCT01031641|Instrument Development|instrument development
497596|NCT01031641|Adverse Events|adverse events
497597|NCT01031641|Questionnaire|questionnaire
497598|NCT01031641|Patient Reported Outcomes|patient reported outcomes
497599|NCT01031628|GIST|gist
497600|NCT01031628|Gastrointestinal stromal tumors|gastrointestinal stromal tumors
497601|NCT01031628|Exon 9|exon 9
497602|NCT01031628|Gleevec|gleevec
497603|NCT01031628|Imatinib blood levels|imatinib blood levels
497604|NCT01031615|School age children and adolescents exposed to a potentially traumatic event|school age children and adolescents exposed to a potentially traumatic event
497605|NCT01031602|Cancer|cancer
497606|NCT01031602|Gynecology|gynecology
497607|NCT01031602|Sexual Dysfunction|sexual dysfunction
497608|NCT01031602|Depression|depression
497609|NCT01031602|Anxiety|anxiety
497610|NCT01031602|Underserved|underserved
497611|NCT01031602|Minority|minority
497612|NCT01031602|Psychological distress|psychological distress
497613|NCT01031589|TMC278-TiDP15-C158|tmc278-tidp15-c158
497614|NCT01031589|TMC278-C158|tmc278-c158
497615|NCT01031589|TMC278|tmc278
497616|NCT01031589|HIV|hiv
497617|NCT01031589|Non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
497618|NCT01031589|HIV Seronegativity|hiv seronegativity
497619|NCT01031576|Osteoarthritis, posture, knee|osteoarthritis, posture, knee
497620|NCT01031563|Risk Taking|risk taking
497621|NCT01031563|Schizophrenia|schizophrenia
497622|NCT01031563|Drug Abuse/Dependence|drug abuse/dependence
497623|NCT01031563|Comorbidity|comorbidity
497624|NCT01031563|Impulsivity|impulsivity
497625|NCT01031563|Drug Abuse|drug abuse
497626|NCT01031550|liver resection for liver disease|liver resection for liver disease
497627|NCT01031537|FSME-Immun|fsme-immun
497628|NCT01031537|TBEV|tbev
497629|NCT01031537|TBE Researcher|tbe researcher
497630|NCT01031537|Plavivirus|plavivirus
497631|NCT01031537|Anti-TBEV Levels|anti-tbev levels
497632|NCT01031537|Tic-Borne Encephalitis|tic-borne encephalitis
497633|NCT01031524|Plasmodium falciparum malaria|plasmodium falciparum malaria
497634|NCT01031511|High-Functioning Autistic Spectrum Disorder|high-functioning autistic spectrum disorder
497635|NCT01031511|Anxiety|anxiety
497636|NCT01031511|Cognitive Behavioural Therapy|cognitive behavioural therapy
497637|NCT01031511|Social Recreational|social recreational
497638|NCT01031511|Parent Stress|parent stress
497639|NCT01031498|Nausea|nausea
497640|NCT01031498|Vomiting|vomiting
497641|NCT01031498|CINV|cinv
497642|NCT01031498|Leukemia|leukemia
497643|NCT01031498|High-risk Myelodysplastic syndrome|high-risk myelodysplastic syndrome
497644|NCT01031498|AML|aml
497645|NCT01031498|Hematologic malignancies|hematologic malignancies
497646|NCT01031498|Hematologic Disorder|hematologic disorder
497647|NCT01031498|Continuous multi-day chemotherapy|continuous multi-day chemotherapy
497648|NCT01031498|High-dose cytarabine|high-dose cytarabine
497649|NCT01031498|Palonosetron|palonosetron
497650|NCT01031498|Aloxi|aloxi
497651|NCT01031498|Ondansetron|ondansetron
497652|NCT01031498|Zofran|zofran
497653|NCT01031485|hypertension|hypertension
497654|NCT01031485|blood pressure|blood pressure
497655|NCT01031485|milk peptides|milk peptides
497656|NCT01031485|bioactive peptides|bioactive peptides
497657|NCT01031485|randomized controlled trial|randomized controlled trial
497658|NCT01031472|HIV, relative bioavailability, food effect, GSK2248761, healthy subjects|hiv, relative bioavailability, food effect, gsk2248761, healthy subjects
497659|NCT01031472|HIV Seronegativity|hiv seronegativity
497660|NCT01031446|stage IV breast cancer|stage iv breast cancer
497661|NCT01031446|Human epidermal growth factor (HER2)-negative breast cancer|human epidermal growth factor (her2)-negative breast cancer
497662|NCT01031446|triple-negative breast cancer|triple-negative breast cancer
497663|NCT01031446|hormone-resistant breast cancer|hormone-resistant breast cancer
497664|NCT01031433|Tobacco Craving|tobacco craving
497665|NCT01031433|Virtual Reality|virtual reality
497666|NCT01031433|Schizophrenia|schizophrenia
497667|NCT01031433|Smoking|smoking
497668|NCT01031420|bladder|bladder
497669|NCT01031420|cancer|cancer
497670|NCT01031420|invasive|invasive
497671|NCT01031407|Adolescents and Adults|adolescents and adults
497672|NCT01031407|Autism|autism
497673|NCT01031407|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
497674|NCT01031407|MEG|meg
497675|NCT01031407|Structural MRI|structural mri
497676|NCT01031407|HV|hv
497677|NCT01031407|Autism Spectrum Disorder|autism spectrum disorder
497678|NCT01031407|ASD|asd
497679|NCT01031407|Autistic Disorder|autistic disorder
497680|NCT01031407|Asperger Syndrome|asperger syndrome
497681|NCT01031407|Mental Retardation|mental retardation
497682|NCT01031407|Healthy Volunteer|healthy volunteer
497683|NCT01031394|exercise|exercise
497684|NCT01031394|resistance training|resistance training
497685|NCT01031381|Recurrent|recurrent
497686|NCT01031381|ovarian|ovarian
497687|NCT01031381|fallopian tube|fallopian tube
497688|NCT01031381|primary peritoneal|primary peritoneal
497689|NCT01031381|cancer|cancer
497690|NCT01031381|Recurrent ovarian, fallopian tube, primary peritoneal cancer|recurrent ovarian, fallopian tube, primary peritoneal cancer
497691|NCT01031355|Female Contraception|female contraception
497692|NCT01031355|Contraceptives, Oral|contraceptives, oral
497693|NCT01031342|Colonoscopy|colonoscopy
497694|NCT01031342|Gastrointestinal bleeding|gastrointestinal bleeding
497695|NCT01031316|Echocardiography|echocardiography
497696|NCT01031316|Infant, Premature|infant, premature
497697|NCT01031316|Infant, Very Low Birth Weight|infant, very low birth weight
497698|NCT01031303|Diphtheria|diphtheria
497699|NCT01031303|Tetanus|tetanus
497700|NCT01031303|Pertussis|pertussis
497701|NCT01031303|Poliomyelitis|poliomyelitis
497702|NCT01031303|PENTAXIM™|pentaxim™
497703|NCT01031303|TETRAXIM™|tetraxim™
497704|NCT01031290|Cue-Induced Craving|cue-induced craving
497705|NCT01031290|Cannabis|cannabis
497706|NCT01031290|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
497707|NCT01031290|Repetitive TMS (rTMS)|repetitive tms (rtms)
497708|NCT01031290|Cannabis Craving|cannabis craving
497709|NCT01031277|Hypercholesterolemia|hypercholesterolemia
497710|NCT01031277|Update NCEP ATP111|update ncep atp111
497711|NCT01031277|Survey|survey
497712|NCT01031264|social drinkers|social drinkers
497713|NCT01031238|PEM Uptake Value|pem uptake value
497714|NCT01031238|PUV|puv
497715|NCT01031238|Standardized Uptake Value|standardized uptake value
497716|NCT01031238|SUV|suv
497717|NCT01031238|Malignancies of the Breast|malignancies of the breast
497718|NCT01031238|[18F]-FDG-PET/CT scanning|[18f]-fdg-pet/ct scanning
497719|NCT01031238|Tumor|tumor
497720|NCT01031238|positron emission tomography/computed tomography|positron emission tomography/computed tomography
497721|NCT01031238|PET/CT scan|pet/ct scan
497722|NCT01031225|Synta|synta
497723|NCT01031225|STA 9090|sta 9090
497724|NCT01031225|ganetespib)|ganetespib)
497725|NCT01031225|Lung Cancer|lung cancer
497726|NCT01031225|Non Small Cell Lung Cancer|non small cell lung cancer
497727|NCT01031225|NSCLC|nsclc
497728|NCT01031212|cancer|cancer
497729|NCT01031212|neoplasms|neoplasms
497730|NCT01031212|adult solid tumor|adult solid tumor
497731|NCT01031212|antineoplastic agents|antineoplastic agents
497732|NCT01031199|Multiple sclerosis|multiple sclerosis
497733|NCT01031199|Diagnostic imaging|diagnostic imaging
497734|NCT01031199|Neuroinflammation|neuroinflammation
497735|NCT01031199|PET diagnosis|pet diagnosis
497736|NCT01031199|PET tracer|pet tracer
497737|NCT01031186|healthy male volunteers|healthy male volunteers
497738|NCT01031186|GSK356278|gsk356278
497739|NCT01031186|first time in man|first time in man
497740|NCT01031186|major depressive disorder|major depressive disorder
497741|NCT01031173|α galactosidase A|α galactosidase a
497742|NCT01031173|glycosphingolipid storage disorder|glycosphingolipid storage disorder
497743|NCT01031173|agalsidase alfa|agalsidase alfa
497744|NCT01031173|enzyme replacement therapy|enzyme replacement therapy
497745|NCT01031173|Replagal|replagal
497746|NCT01031173|agalsidase beta|agalsidase beta
497747|NCT01031173|Fabrazyme|fabrazyme
497748|NCT01031160|Adolescence|adolescence
497749|NCT01031160|Obesity|obesity
497750|NCT01031160|Substance Abuse|substance abuse
497751|NCT01031160|Etiology|etiology
497752|NCT01031160|Social and Environmental Contexts|social and environmental contexts
497753|NCT01031160|Health Behaviors|health behaviors
497754|NCT01031147|Magnetic resonance angiography|magnetic resonance angiography
497755|NCT01031147|Intracranial aneurysm|intracranial aneurysm
497756|NCT01031147|Digital subtraction angiography|digital subtraction angiography
497757|NCT01031147|Volume rendering|volume rendering
497758|NCT01031121|Cigarette Smoking|cigarette smoking
497759|NCT01031121|Biomarkers|biomarkers
497760|NCT01031121|Nicotine|nicotine
497761|NCT01031121|Cotinine|cotinine
497762|NCT01031121|Metabolites|metabolites
497763|NCT01031095|percutaneous coronary intervention|percutaneous coronary intervention
497764|NCT01031095|low dose intracoronary heparin|low dose intracoronary heparin
497765|NCT01031069|Cervarix|cervarix
497766|NCT01031069|Gardasil|gardasil
497767|NCT01031069|Immunogenicity|immunogenicity
497768|NCT01031069|Cervical cancer|cervical cancer
497769|NCT01031069|Safety|safety
497770|NCT01031069|HPV vaccine|hpv vaccine
497771|NCT01031043|IEM|iem
497772|NCT01031030|stage I breast cancer|stage i breast cancer
497773|NCT01031030|stage II breast cancer|stage ii breast cancer
497774|NCT01031030|stage IIIA breast cancer|stage iiia breast cancer
497775|NCT01031030|stage IIIB breast cancer|stage iiib breast cancer
497776|NCT01031030|stage IIIC breast cancer|stage iiic breast cancer
497777|NCT01031017|twin pregnancies|twin pregnancies
497778|NCT01031017|preterm delivery|preterm delivery
497779|NCT01031017|progesterone|progesterone
497780|NCT01030991|Heart failure|heart failure
497781|NCT01030991|Ejection fraction|ejection fraction
497782|NCT01030991|Diastolic heart failure|diastolic heart failure
497783|NCT01030991|Diastolic dysfunction|diastolic dysfunction
497784|NCT01030991|Ventricular-arterial coupling|ventricular-arterial coupling
497785|NCT01030991|Exercise testing|exercise testing
497786|NCT01030991|Echocardiography|echocardiography
497787|NCT01030991|Tissue Doppler imaging|tissue doppler imaging
497788|NCT01030991|Arterial tonometry|arterial tonometry
497789|NCT01030991|Genetics|genetics
497790|NCT01030991|Epidemiology|epidemiology
497791|NCT01030978|Impaired Glucose Tolerance|impaired glucose tolerance
497792|NCT01030978|PreDiabetes|prediabetes
497793|NCT01030978|Diabetes Prevention|diabetes prevention
497794|NCT01030965|Chronic Bronchitis|chronic bronchitis
497795|NCT01030965|Anticholinergic|anticholinergic
497796|NCT01030965|Emphysema|emphysema
497797|NCT01030965|Long-acting muscarinic antagonist|long-acting muscarinic antagonist
497798|NCT01030965|COPD|copd
497799|NCT01030952|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
497800|NCT01030952|Nateglinide|nateglinide
497801|NCT01030952|Acarbose|acarbose
497802|NCT01030952|glucose fluctuation|glucose fluctuation
497803|NCT01030939|Healthy volunteers|healthy volunteers
497804|NCT01030939|Men and women|men and women
497805|NCT01030939|adults and elderly|adults and elderly
497806|NCT01030939|repeat dose|repeat dose
497807|NCT01030913|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
497808|NCT01030900|Immunosuppression|immunosuppression
497809|NCT01030900|Microenvironment|microenvironment
497810|NCT01030900|Hodgkin Lymphoma|hodgkin lymphoma
497811|NCT01030900|B-Cell Lymphoma|b-cell lymphoma
497812|NCT01030900|Microarray|microarray
497813|NCT01030900|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
497814|NCT01030887|Cancer|cancer
497815|NCT01030887|Exercise|exercise
497816|NCT01030887|Physical Activity|physical activity
497817|NCT01030887|Randomized controlled trial|randomized controlled trial
497818|NCT01030874|hypotension, orthostatic|hypotension, orthostatic
497819|NCT01030874|falls|falls
497820|NCT01030874|rehabilitation|rehabilitation
497821|NCT01030874|blood pressure|blood pressure
497822|NCT01030874|aging|aging
497823|NCT01030861|type 1 diabetes|type 1 diabetes
497824|NCT01030861|pre-diabetic|pre-diabetic
497825|NCT01030861|autoantibody positive|autoantibody positive
497826|NCT01030861|at risk for type 1 diabetes|at risk for type 1 diabetes
497827|NCT01030861|glucose intolerance|glucose intolerance
497828|NCT01030861|relatives of people with type 1 diabetes|relatives of people with type 1 diabetes
497829|NCT01030835|Screening Protocol|screening protocol
497830|NCT01030835|Comorbidity|comorbidity
497831|NCT01030835|Normal Controls|normal controls
497832|NCT01030835|Substance Use Disorders|substance use disorders
497833|NCT01030835|Substance Abuse Disorders|substance abuse disorders
497834|NCT01030822|Catch-up vaccination|catch-up vaccination
497835|NCT01030822|Safety|safety
497836|NCT01030822|Pneumococcal vaccine|pneumococcal vaccine
497837|NCT01030822|Pneumococcal disease|pneumococcal disease
497838|NCT01030822|Booster vaccination|booster vaccination
497839|NCT01030822|Immunogenicity|immunogenicity
497840|NCT01030809|Crohn's disease|crohn's disease
497841|NCT01030809|community based gastroenterology practices Canada and Belgium|community based gastroenterology practices canada and belgium
497842|NCT01030809|Cluster randomization controlled trial|cluster randomization controlled trial
497843|NCT01030809|Remission|remission
497844|NCT01030809|Corticosteroids|corticosteroids
497845|NCT01030809|Documented diagnosis of Crohn's disease|documented diagnosis of crohn's disease
497846|NCT01030770|Diabetes|diabetes
497847|NCT01030770|Vitreous Haemorrhages|vitreous haemorrhages
497848|NCT01030757|Liver Cancer|liver cancer
497849|NCT01030757|Metastatic Liver Cancer|metastatic liver cancer
497850|NCT01030757|Tomotherapy|tomotherapy
497851|NCT01030757|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
497852|NCT01030744|Gestational Diabetes|gestational diabetes
497853|NCT01030744|Self-Monitoring of Blood Glucose|self-monitoring of blood glucose
497854|NCT01030731|Renal Dialysis, Ceftobiprole|renal dialysis, ceftobiprole
497855|NCT01030731|Skin and soft tissue Infections|skin and soft tissue infections
497856|NCT01030731|Staphylococcal Skin Infections|staphylococcal skin infections
497857|NCT01030731|Streptococcal Infection|streptococcal infection
497858|NCT01030705|Bradycardia|bradycardia
497859|NCT01030705|pacemaker|pacemaker
497860|NCT01030692|Cocaine|cocaine
497861|NCT01030692|Rivastigmine|rivastigmine
497862|NCT01030692|Huperzine A|huperzine a
497863|NCT01030679|Diabetes Mellitus, type 2|diabetes mellitus, type 2
497864|NCT01030679|Glitazone|glitazone
497865|NCT01030666|periodontal regeneration|periodontal regeneration
497866|NCT01030666|radiographic bone fill|radiographic bone fill
497867|NCT01030666|infrabony defects|infrabony defects
497868|NCT01030666|randomized placebo-controlled clinical trial|randomized placebo-controlled clinical trial
497869|NCT01030666|guided tissue regeneration, periodontal|guided tissue regeneration, periodontal
497870|NCT01030653|Voriconazole|voriconazole
497871|NCT01030653|Pharmacokinetics|pharmacokinetics
497872|NCT01030653|Obese|obese
497873|NCT01030653|Healthy Volunteer|healthy volunteer
497874|NCT01030640|intraepidermal nerve fiber density|intraepidermal nerve fiber density
497875|NCT01030640|IENF|ienf
497876|NCT01030640|tanezumab|tanezumab
497877|NCT01030640|subcutaneous|subcutaneous
497878|NCT01030640|healthy volunteers|healthy volunteers
497879|NCT01030627|Eclampsia|eclampsia
497880|NCT01030627|Preeclampsia|preeclampsia
497881|NCT01030627|Magnesium sulfate|magnesium sulfate
497882|NCT01030614|Laparoscopic cholecystectomy,postoperative symptoms|laparoscopic cholecystectomy,postoperative symptoms
497883|NCT01030601|Diabetic|diabetic
497884|NCT01030601|Macular Edema|macular edema
497885|NCT01030601|Pseudophakic|pseudophakic
497886|NCT01030601|Dexamethasone|dexamethasone
497887|NCT01030601|Intravitreal|intravitreal
497888|NCT01030601|Cataract surgery|cataract surgery
497889|NCT01030575|NICHD Neonatal Research Network|nichd neonatal research network
497890|NCT01030575|Pharmacokinetics|pharmacokinetics
497891|NCT01030575|Inositol|inositol
497892|NCT01030575|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
497893|NCT01030575|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
497894|NCT01030575|Prematurity|prematurity
497895|NCT01030562|adolescent, vaccine, human papillomavirus, HPV|adolescent, vaccine, human papillomavirus, hpv
497896|NCT01030549|cardiovascular magnetic resonance|cardiovascular magnetic resonance
497897|NCT01030549|ventricular volumes|ventricular volumes
497898|NCT01030549|ventricular function|ventricular function
497899|NCT01030549|Healthy normal individuals from 20 to 80 years of age|healthy normal individuals from 20 to 80 years of age
497901|NCT01030536|CLL|cll
497902|NCT01030497|Cancer|cancer
497903|NCT01030497|Cervical Lymph Node Metastases|cervical lymph node metastases
497904|NCT01030497|High-Resolution PET Imaging System|high-resolution pet imaging system
497905|NCT01030497|Upper Aerodigestive Tract|upper aerodigestive tract
497906|NCT01030497|Head|head
497907|NCT01030497|Neck|neck
497908|NCT01030497|HR PET Imaging System|hr pet imaging system
497909|NCT01030497|High-Resolution PET|high-resolution pet
497910|NCT01030497|PET/CT|pet/ct
497911|NCT01030497|PEMFlex Solo II|pemflex solo ii
497912|NCT01030497|positron emission tomography/computed tomography (PET/CT)|positron emission tomography/computed tomography (pet/ct)
497913|NCT01030484|NAFLD|nafld
497914|NCT01030484|NASH|nash
497915|NCT01030484|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
497916|NCT01030484|fatty liver disease|fatty liver disease
497917|NCT01030471|adolescents|adolescents
497918|NCT01030471|depression|depression
497919|NCT01030471|adherence|adherence
497920|NCT01030471|family functioning|family functioning
497921|NCT01030471|intervention|intervention
497922|NCT01030458|Blood pressure|blood pressure
497923|NCT01030458|Hypertension|hypertension
497924|NCT01030458|Blacks|blacks
497925|NCT01030458|Africa|africa
497926|NCT01030458|Blood pressure control|blood pressure control
497927|NCT01030458|Side-effects|side-effects
498034|NCT01030003|Fetal Growth Retardation|fetal growth retardation
497928|NCT01030445|non-invasive cardiac output monitor|non-invasive cardiac output monitor
497929|NCT01030445|electrical velocimetry|electrical velocimetry
497930|NCT01030445|Aesculon|aesculon
497931|NCT01030445|Icon|icon
497932|NCT01030445|pediatrics|pediatrics
497933|NCT01030445|normal reference|normal reference
497934|NCT01030419|Aging|aging
497935|NCT01030419|Quality of Life|quality of life
497936|NCT01030419|Functional fitness|functional fitness
497937|NCT01030406|Abuse Liability|abuse liability
497938|NCT01030406|Abuse Prevention|abuse prevention
497939|NCT01030406|Abuse Resistance|abuse resistance
497940|NCT01030406|Abuse Deterrence|abuse deterrence
497941|NCT01030393|hCG|hcg
497942|NCT01030393|pregnancy|pregnancy
497943|NCT01030393|implantation|implantation
497944|NCT01030393|ICSI|icsi
497945|NCT01030393|IVF|ivf
497946|NCT01030380|Facial toning|facial toning
497947|NCT01030380|Facial lift|facial lift
497948|NCT01030380|Improve facial complexion|improve facial complexion
497949|NCT01030380|Improve facial tone|improve facial tone
497950|NCT01030380|Improve radiance of the face|improve radiance of the face
497951|NCT01030380|Reduce signs of facial aging|reduce signs of facial aging
497952|NCT01030380|firming, lift, tone face|firming, lift, tone face
497953|NCT01030367|Coronary artery disease|coronary artery disease
497954|NCT01030354|Satiety|satiety
497955|NCT01030354|Meal Replacements|meal replacements
497956|NCT01030354|High Protein|high protein
497957|NCT01030354|Standard Protein|standard protein
497958|NCT01030341|Diabetes|diabetes
497959|NCT01030341|Gastroparesis|gastroparesis
497960|NCT01030315|Erythropoietin|erythropoietin
497961|NCT01030315|Long-acting|long-acting
497962|NCT01030315|EPO|epo
497963|NCT01030302|Bortezomib retreatment|bortezomib retreatment
497964|NCT01030302|Velcade|velcade
497965|NCT01030302|Proteasome inhibitor|proteasome inhibitor
497966|NCT01030302|Bortezomib|bortezomib
497967|NCT01030289|food cravings|food cravings
497968|NCT01030250|Breast Cancer|breast cancer
497969|NCT01030250|Adjuvant Chemotherapy|adjuvant chemotherapy
497970|NCT01030237|Dry eye|dry eye
497971|NCT01030237|artificial tears|artificial tears
497972|NCT01030224|Healthy volunteer|healthy volunteer
497973|NCT01030224|First time in human|first time in human
497974|NCT01030211|Dengue|dengue
497975|NCT01030211|Platelet transfusion|platelet transfusion
497976|NCT01030211|Bleeding|bleeding
497977|NCT01030211|Prevention|prevention
497978|NCT01030185|ascites|ascites
497979|NCT01030185|liver cirrhosis|liver cirrhosis
497980|NCT01030159|Cancer Anemia Survey|cancer anemia survey
497981|NCT01030159|Thai National Cancer Institute|thai national cancer institute
497982|NCT01030133|pain|pain
497983|NCT01030120|chronic idiopathic urticaria|chronic idiopathic urticaria
497984|NCT01030120|etanercept|etanercept
497985|NCT01030107|sleep|sleep
497986|NCT01030107|obesity|obesity
497987|NCT01030107|children|children
497988|NCT01030107|eating behaviors|eating behaviors
497989|NCT01030107|activity|activity
497990|NCT01030107|leptin|leptin
497991|NCT01030107|ghrelin|ghrelin
497992|NCT01030094|Topiramate|topiramate
497993|NCT01030094|Carbamazepine|carbamazepine
497994|NCT01030094|Valproic acid|valproic acid
497995|NCT01030094|Epilepsy|epilepsy
497996|NCT01030094|Bone mineral density|bone mineral density
497997|NCT01030094|Monotherapy|monotherapy
497998|NCT01030081|24 hour blood pressure|24 hour blood pressure
497999|NCT01030081|morning blood pressure surge|morning blood pressure surge
498000|NCT01030081|amlodipine|amlodipine
498001|NCT01030081|nifedipine GITS|nifedipine gits
498002|NCT01030068|Smoking Cessation|smoking cessation
498003|NCT01030068|Yoga|yoga
498004|NCT01030068|Wellness|wellness
498005|NCT01030068|Feasibility|feasibility
498006|NCT01030068|Smoking Cessation Therapy|smoking cessation therapy
498007|NCT01030055|Neoplasms|neoplasms
498008|NCT01030055|Cancer|cancer
498009|NCT01030055|Tumors|tumors
498010|NCT01030055|Administration, oral|administration, oral
498011|NCT01030055|Capsules|capsules
498012|NCT01030055|CHIR258|chir258
498013|NCT01030055|CHIR-258|chir-258
498014|NCT01030055|CHIR 258|chir 258
498015|NCT01030055|TKI258|tki258
498016|NCT01030055|TKI-258|tki-258
498017|NCT01030055|TKI 258|tki 258
498018|NCT01030055|Bioavailability|bioavailability
498019|NCT01030055|Food|food
498020|NCT01030042|metastatic|metastatic
498021|NCT01030042|colorectal cancer|colorectal cancer
498022|NCT01030042|two sequences therapy|two sequences therapy
498023|NCT01030029|auricular acupuncture|auricular acupuncture
498024|NCT01030029|postoperative pain|postoperative pain
498025|NCT01030029|opioid consumption|opioid consumption
498026|NCT01030029|laparoscopic surgery|laparoscopic surgery
498027|NCT01030029|ACUPUNCTURE THERAPY (IM) + EAR, EXTERNAL (IM)|acupuncture therapy (im) + ear, external (im)
498028|NCT01030016|resistance exercise|resistance exercise
498029|NCT01030016|beta-blockers|beta-blockers
498030|NCT01030016|blood pressure|blood pressure
498031|NCT01030003|Sleep-Disordered Breathing|sleep-disordered breathing
498032|NCT01030003|Snoring|snoring
498033|NCT01030003|Pregnancy|pregnancy
498035|NCT01030003|Pre-Eclampsia|pre-eclampsia
498036|NCT01029990|participation|participation
498037|NCT01029990|mass screening|mass screening
498038|NCT01029990|cervical neoplasia|cervical neoplasia
498039|NCT01029990|health economics|health economics
498040|NCT01029990|cost-benefit|cost-benefit
498041|NCT01029964|Childhood obesity|childhood obesity
498042|NCT01029964|Age-dependent|age-dependent
498043|NCT01029964|Long-term treatment|long-term treatment
498044|NCT01029964|BMI SDS|bmi sds
498045|NCT01029964|Dropouts|dropouts
498046|NCT01029951|Chiropractic; osteopathic physicians; manipulation; neck pain; adverse effects; randomized clinical trial|chiropractic; osteopathic physicians; manipulation; neck pain; adverse effects; randomized clinical trial
498047|NCT01029951|Subacute non-specific neck pain|subacute non-specific neck pain
498048|NCT01029938|Intracranial aneurysms;|intracranial aneurysms;
498049|NCT01029938|Covered stent;|covered stent;
498050|NCT01029938|Coil embolization|coil embolization
498051|NCT01029925|metastatic breast cancer|metastatic breast cancer
498052|NCT01029925|lung cancer|lung cancer
498053|NCT01029925|Previously treated metastatic breast cancer|previously treated metastatic breast cancer
498054|NCT01029925|stage IIIb lung cancer|stage iiib lung cancer
498055|NCT01029925|stage IV lung cancer|stage iv lung cancer
498056|NCT01029912|Stroke|stroke
498057|NCT01029912|Hemiplegia|hemiplegia
498058|NCT01029912|Footdrop|footdrop
498059|NCT01029912|Electrical Stimulation|electrical stimulation
498060|NCT01029912|Motor Relearning|motor relearning
498061|NCT01029912|Neuroplasticity|neuroplasticity
498062|NCT01029899|Colonoscopy|colonoscopy
498063|NCT01029899|Force|force
498064|NCT01029899|Monitor|monitor
498065|NCT01029899|Endoscopist|endoscopist
498066|NCT01029899|Trainee|trainee
498067|NCT01029886|diabetes|diabetes
498068|NCT01029886|exenatide once weekly|exenatide once weekly
498069|NCT01029886|Byetta|byetta
498070|NCT01029886|liraglutide|liraglutide
498071|NCT01029886|Victoza|victoza
498072|NCT01029886|Amylin|amylin
498073|NCT01029886|Lilly|lilly
498074|NCT01029873|cancer|cancer
498075|NCT01029873|immunotherapy|immunotherapy
498076|NCT01029873|targeted|targeted
498077|NCT01029873|metastatic|metastatic
498078|NCT01029873|interleukin-2|interleukin-2
498079|NCT01029873|IL-2|il-2
498080|NCT01029873|Cisplatin|cisplatin
498081|NCT01029873|antitumor|antitumor
498082|NCT01029873|melanoma|melanoma
498083|NCT01029873|TCR|tcr
498084|NCT01029873|T-cell receptor|t-cell receptor
498085|NCT01029873|p53|p53
498086|NCT01029873|p53 gene|p53 gene
498087|NCT01029873|p53 tumor suppressor protein|p53 tumor suppressor protein
498088|NCT01029860|Hypertension|hypertension
498089|NCT01029860|Ambulatory measurement|ambulatory measurement
498090|NCT01029847|Patients with axial spondyloarthritis|patients with axial spondyloarthritis
498091|NCT01029834|BMI >85%for age and gender|bmi >85%for age and gender
498092|NCT01029821|Low-Molecular-Weight-Heparin|low-molecular-weight-heparin
498093|NCT01029821|Open Reduction and Internal Fixation|open reduction and internal fixation
498094|NCT01029821|Thromboprophylaxis|thromboprophylaxis
498095|NCT01029808|carriers of hemophilia|carriers of hemophilia
498096|NCT01029782|Cellulitis|cellulitis
498097|NCT01029782|Emergency Department|emergency department
498098|NCT01029782|Cefazolin|cefazolin
498099|NCT01029782|Probenecid|probenecid
498100|NCT01029782|Cephalexin|cephalexin
498101|NCT01029756|Pentax Airway Scope AWS S100|pentax airway scope aws s100
498102|NCT01029756|Pentax AWS|pentax aws
498103|NCT01029756|Macintosh|macintosh
498104|NCT01029756|Laryngoscope|laryngoscope
498105|NCT01029756|Video Laryngoscope|video laryngoscope
498106|NCT01029743|TKR (Total Knee Replacement)|tkr (total knee replacement)
498107|NCT01029743|THR (Total Hip Replacement)|thr (total hip replacement)
498108|NCT01029743|VTE (Venous Thromboembolism)|vte (venous thromboembolism)
498109|NCT01029743|LMWH (Low Molecular Weight Heparin)|lmwh (low molecular weight heparin)
498110|NCT01029743|VKA (Vitamin K antagonist)|vka (vitamin k antagonist)
498111|NCT01029730|Low grade lymphoma|low grade lymphoma
498112|NCT01029730|Previously untreated lymphoma|previously untreated lymphoma
498113|NCT01029730|Lymphoma first line|lymphoma first line
498114|NCT01029730|bendamustine|bendamustine
498115|NCT01029730|Treanda|treanda
498116|NCT01029730|bortezomib|bortezomib
498117|NCT01029730|Velcade|velcade
498118|NCT01029730|rituximab|rituximab
498119|NCT01029730|Rituxan|rituxan
498120|NCT01029717|Central Venous Catheters|central venous catheters
498121|NCT01029717|blood stream infection|blood stream infection
498122|NCT01029717|children, intensive care|children, intensive care
498123|NCT01029717|Heparin bonded|heparin bonded
498124|NCT01029717|antibiotic coated|antibiotic coated
498125|NCT01029717|Children in Paediatric Intensive Care Unit|children in paediatric intensive care unit
498126|NCT01029704|Diabetes Mellitus Type 2|diabetes mellitus type 2
498127|NCT01029691|Sleep disordered breathing|sleep disordered breathing
498128|NCT01029691|Preeclampsia|preeclampsia
498129|NCT01029691|Positive Airway Pressure|positive airway pressure
498130|NCT01029678|Locally advanced lung cancer|locally advanced lung cancer
498131|NCT01029678|Elderly patients|elderly patients
498132|NCT01029678|NSCLC|nsclc
498133|NCT01029665|Hernia, Diaphragmatic|hernia, diaphragmatic
498134|NCT01029665|Asthma|asthma
498135|NCT01029665|Feeding and Eating Disorders of Childhood|feeding and eating disorders of childhood
498136|NCT01029665|Growth & Development|growth & development
498137|NCT01029652|frequent flares|frequent flares
498138|NCT01029652|gout|gout
498139|NCT01029652|anti-interleukin-1β monoclonal antibody|anti-interleukin-1β monoclonal antibody
498140|NCT01029639|Pulsatile intravenous insulin|pulsatile intravenous insulin
498141|NCT01029639|Oral carbohydrate loading|oral carbohydrate loading
498142|NCT01029639|Respiratory Quotients|respiratory quotients
498143|NCT01029639|Hypoglycemia|hypoglycemia
498144|NCT01029639|Diabetes Mellitus, with complications|diabetes mellitus, with complications
498145|NCT01029600|Randomized study capsulotomy vs distention with steroid|randomized study capsulotomy vs distention with steroid
498146|NCT01029587|CAPS|caps
498147|NCT01029587|Kidney transplant|kidney transplant
498148|NCT01029587|Renal transplant|renal transplant
498149|NCT01029587|Catastrophic Antiphospholipid Antibody Syndrome|catastrophic antiphospholipid antibody syndrome
498150|NCT01029574|Rotator cuff lesions|rotator cuff lesions
498151|NCT01029574|Platelet rich plasma|platelet rich plasma
498152|NCT01029574|Arthroscopic repair|arthroscopic repair
498153|NCT01029561|Metabolic syndrome|metabolic syndrome
498154|NCT01029561|Insulin Resistance|insulin resistance
498155|NCT01029561|Adipokines|adipokines
498156|NCT01029561|Proinflammatory markers|proinflammatory markers
498157|NCT01029561|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
498158|NCT01029561|Continuous Positive Airway Pressure|continuous positive airway pressure
498159|NCT01029561|Obesity|obesity
498160|NCT01029561|Bariatric surgery|bariatric surgery
498161|NCT01029548|HIV|hiv
498162|NCT01029548|Therapeutic Vaccine|therapeutic vaccine
498163|NCT01029522|Dyslipidemia|dyslipidemia
498164|NCT01029509|Advanced Leukemia|advanced leukemia
498165|NCT01029509|Acute myeloid leukemia|acute myeloid leukemia
498166|NCT01029509|ALL|all
498167|NCT01029509|Chronic myeloid leukemia blast crisis|chronic myeloid leukemia blast crisis
498168|NCT01029509|CMS|cms
498169|NCT01029509|Acute lymphocytic leukemia|acute lymphocytic leukemia
498170|NCT01029509|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
498171|NCT01029509|Myelodysplastic syndromes|myelodysplastic syndromes
498172|NCT01029509|MDS|mds
498173|NCT01029509|OPB 31121|opb 31121
498174|NCT01029496|umbilical CORD CLAMPING|umbilical cord clamping
498175|NCT01029496|Neonatal anemia|neonatal anemia
498176|NCT01029496|Omphalitis|omphalitis
498177|NCT01029483|Obesity|obesity
498178|NCT01029483|Weight loss|weight loss
498179|NCT01029483|low carbohydrate diets|low carbohydrate diets
498180|NCT01029483|high complex carbohydrate diets|high complex carbohydrate diets
498181|NCT01029483|Healthy adults|healthy adults
498182|NCT01029483|Body composition|body composition
498183|NCT01029483|Energy Expenditure|energy expenditure
498184|NCT01029470|Luveris|luveris
498185|NCT01029470|hyporesponse|hyporesponse
498186|NCT01029470|pituitary downregulation|pituitary downregulation
498187|NCT01029470|IVF|ivf
498188|NCT01029470|Infertility women|infertility women
498189|NCT01029444|Diabetes|diabetes
498190|NCT01029444|Pulsatile intravenous insulin|pulsatile intravenous insulin
498191|NCT01029444|Oral carbohydrate loading|oral carbohydrate loading
498192|NCT01029444|Respiratory Quotients|respiratory quotients
498193|NCT01029444|Hypoglycemia|hypoglycemia
498194|NCT01029444|Hyperglycemia|hyperglycemia
498195|NCT01029444|Diabetes Mellitus, with complications|diabetes mellitus, with complications
498196|NCT01029431|intubating laryngeal airway|intubating laryngeal airway
498197|NCT01029431|pediatric|pediatric
498198|NCT01029418|HCC|hcc
498199|NCT01029418|hepatocellular carcinoma|hepatocellular carcinoma
498200|NCT01029418|liver cancer|liver cancer
498201|NCT01029405|Topical|topical
498202|NCT01029405|Plaque type psoriasis|plaque type psoriasis
498203|NCT01029392|Diabetes|diabetes
498204|NCT01029392|Type I|type i
498205|NCT01029392|Newly Diagnosis Type I Diabetes Mellitus|newly diagnosis type i diabetes mellitus
498206|NCT01029379|propofol|propofol
498207|NCT01029379|depth of anesthesia|depth of anesthesia
498208|NCT01029379|pharmacogenetics|pharmacogenetics
498209|NCT01029379|Depth of anesthesia in correlation to plasma concentrations of propofol|depth of anesthesia in correlation to plasma concentrations of propofol
498210|NCT01029353|NICHD Neonatal Research Network|nichd neonatal research network
498211|NCT01029353|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
498212|NCT01029353|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
498213|NCT01029353|Prematurity|prematurity
498214|NCT01029353|Laparotomy|laparotomy
498215|NCT01029353|Drainage|drainage
498216|NCT01029353|Isolated intestinal perforation|isolated intestinal perforation
498217|NCT01029353|Focal intestinal perforation|focal intestinal perforation
498218|NCT01029340|Hemophilia A|hemophilia a
498219|NCT01029340|Factor VIII|factor viii
498220|NCT01029340|Prophylaxis|prophylaxis
498221|NCT01029314|Thermometry|thermometry
498222|NCT01029301|Skin aging|skin aging
498223|NCT01029301|Skin Wrinkling|skin wrinkling
498224|NCT01029288|Diabetes|diabetes
498225|NCT01029288|Decision aid|decision aid
498226|NCT01029288|Cardiovascular risk|cardiovascular risk
498227|NCT01029288|Patient education|patient education
498228|NCT01029275|Acromegaly|acromegaly
498229|NCT01029275|pituitary adenoma|pituitary adenoma
498230|NCT01029275|octreotide|octreotide
498231|NCT01029275|transsphenoïdal surgery|transsphenoïdal surgery
498232|NCT01029275|GH|gh
498233|NCT01029275|IGF-1|igf-1
498234|NCT01029262|Myelodysplastic Syndromes|myelodysplastic syndromes
498235|NCT01029262|MDS|mds
498236|NCT01029262|transfusion dependent anemia|transfusion dependent anemia
498237|NCT01029262|Erythropoiesis stimulating agents|erythropoiesis stimulating agents
498238|NCT01029262|non-del 5q|non-del 5q
498239|NCT01029236|obesity|obesity
498240|NCT01029236|metabolism|metabolism
498241|NCT01029236|weight loss|weight loss
498242|NCT01029236|energy expenditure|energy expenditure
498243|NCT01029236|thermogenesis|thermogenesis
498244|NCT01029236|Metabolism-Boosting Beverages effect on REE|metabolism-boosting beverages effect on ree
498369|NCT01028677|paranoia|paranoia
498245|NCT01029236|Metabolism-Boosting Beverages effect on appetite|metabolism-boosting beverages effect on appetite
498246|NCT01029210|osteoporosis|osteoporosis
498247|NCT01029210|temporomandibular disorders|temporomandibular disorders
498248|NCT01029210|resonance magnetic|resonance magnetic
498249|NCT01029184|weaning|weaning
498250|NCT01029184|cereals|cereals
498251|NCT01029184|allergy|allergy
498252|NCT01029184|atopy|atopy
498253|NCT01029184|open allergenic test|open allergenic test
498254|NCT01029171|falls|falls
498255|NCT01029171|balance training|balance training
498256|NCT01029171|strength training|strength training
498257|NCT01029158|Healthy volunteers|healthy volunteers
498258|NCT01029158|Comparison of two formulations|comparison of two formulations
498259|NCT01029158|Improvement of scar appearance|improvement of scar appearance
498260|NCT01029145|Bipolar disorder|bipolar disorder
498261|NCT01029145|New occured episode: manic depressive or mixed|new occured episode: manic depressive or mixed
498262|NCT01029132|Alzheimer's disease|alzheimer's disease
498263|NCT01029132|Galantamine|galantamine
498264|NCT01029132|Treatment response|treatment response
498265|NCT01029132|Efficacy|efficacy
498266|NCT01029132|Adverse Event|adverse event
498267|NCT01029119|blood pressure|blood pressure
498268|NCT01029106|SUI|sui
498269|NCT01029106|Stress Urinary Incontinence|stress urinary incontinence
498270|NCT01029106|Patients with Stress Urinary Incontinence|patients with stress urinary incontinence
498271|NCT01029093|extremity with immobilisation|extremity with immobilisation
498272|NCT01029093|brain platicity|brain platicity
498273|NCT01029093|deprivation|deprivation
498274|NCT01029093|MRI|mri
498275|NCT01029080|Brain, blood flow|brain, blood flow
498276|NCT01029080|Measurement techniques, flow velocity waveform analysis|measurement techniques, flow velocity waveform analysis
498277|NCT01029080|Monitoring, intensive care|monitoring, intensive care
498278|NCT01029080|Sepsis|sepsis
498279|NCT01029080|transcranial doppler ultrasound (TCD)|transcranial doppler ultrasound (tcd)
498280|NCT01029080|Cerebrovascular autoregulation|cerebrovascular autoregulation
498281|NCT01029080|sepsis-associated delir|sepsis-associated delir
498282|NCT01029067|schizophrenia|schizophrenia
498283|NCT01029067|delusion|delusion
498284|NCT01029067|paranoia|paranoia
498285|NCT01029067|psychosis|psychosis
498286|NCT01029054|Multiple Myeloma|multiple myeloma
498287|NCT01029041|fibromyalgia, exercise, strength, stretch|fibromyalgia, exercise, strength, stretch
498288|NCT01029015|OAB|oab
498289|NCT01029015|Insomnia|insomnia
498290|NCT01029015|Bladder function|bladder function
498291|NCT01029015|cystometry|cystometry
498292|NCT01029015|polysomnography|polysomnography
498293|NCT01029002|Vitamin D|vitamin d
498294|NCT01029002|CKD|ckd
498295|NCT01029002|proteinuria|proteinuria
498296|NCT01028989|Polycystic Ovary Syndrome|polycystic ovary syndrome
498297|NCT01028989|Insulin|insulin
498298|NCT01028989|Diet|diet
498299|NCT01028989|Glycemic Load|glycemic load
498300|NCT01028976|randomized controlled trial|randomized controlled trial
498301|NCT01028976|primary prevention|primary prevention
498302|NCT01028976|Vitamin C|vitamin c
498303|NCT01028976|Antioxidants|antioxidants
498304|NCT01028976|C-reactive protein|c-reactive protein
498305|NCT01028976|inflammation|inflammation
498306|NCT01028976|anti-inflammatory agents|anti-inflammatory agents
498307|NCT01028976|obesity|obesity
498308|NCT01028950|YM150|ym150
498309|NCT01028950|Bleeding|bleeding
498310|NCT01028950|VTE|vte
498311|NCT01028950|FXa inhibitor|fxa inhibitor
498312|NCT01028950|Deep Vein Thrombosis|deep vein thrombosis
498313|NCT01028950|Venous thromboembolism|venous thromboembolism
498314|NCT01028937|Hyperopia correction|hyperopia correction
498315|NCT01028937|Laser vision correction|laser vision correction
498316|NCT01028937|Optimal keratoplasty|optimal keratoplasty
498317|NCT01028924|Thorough QTc-Study|thorough qtc-study
498318|NCT01028924|Short Bowel Syndrome|short bowel syndrome
498319|NCT01028924|Cardiac safety|cardiac safety
498320|NCT01028911|Phase 1 Alzheimer's disease Safety Tolerability Pharmacokinetics|phase 1 alzheimer's disease safety tolerability pharmacokinetics
498321|NCT01028898|IBS|ibs
498322|NCT01028898|proteomics|proteomics
498323|NCT01028898|fluorescent quantitation polymerase chain reaction|fluorescent quantitation polymerase chain reaction
498324|NCT01028898|Western blot|western blot
498325|NCT01028898|immunohistochemistry staining (IHC)|immunohistochemistry staining (ihc)
498326|NCT01028898|ATP content|atp content
498327|NCT01028898|micRNA|micrna
498328|NCT01028872|higher-order aberrations, contrast sensitivity|higher-order aberrations, contrast sensitivity
498329|NCT01028859|Tubulin polymerization inhibitor|tubulin polymerization inhibitor
498330|NCT01028859|CKD-516|ckd-516
498331|NCT01028859|Phase I|phase i
498332|NCT01028859|Vascular disrupting agent|vascular disrupting agent
498333|NCT01028859|DCE MRI|dce mri
498334|NCT01028846|Type 2 Diabetes|type 2 diabetes
498335|NCT01028833|power wheelchairs|power wheelchairs
498336|NCT01028833|power mobility|power mobility
498337|NCT01028833|young children|young children
498338|NCT01028820|autism|autism
498339|NCT01028820|asperger's|asperger's
498340|NCT01028820|repetitive|repetitive
498341|NCT01028820|restricted|restricted
498342|NCT01028820|compulsions|compulsions
498343|NCT01028807|Early feeding|early feeding
498344|NCT01028807|Bowel anastomosis|bowel anastomosis
498345|NCT01028807|Children|children
498346|NCT01028794|stroke|stroke
498347|NCT01028794|bone marrow|bone marrow
498348|NCT01028794|mononuclear cell|mononuclear cell
498349|NCT01028794|angiogenesis|angiogenesis
498350|NCT01028794|neurogenesis|neurogenesis
498351|NCT01028768|Renal impairment|renal impairment
498352|NCT01028768|Renal impairment study|renal impairment study
498353|NCT01028755|Maximum Tolerated Dose|maximum tolerated dose
498354|NCT01028742|Traumatic brain injury|traumatic brain injury
498355|NCT01028742|Hypopituitarism|hypopituitarism
498356|NCT01028742|Incidence|incidence
498357|NCT01028703|Chronic kidney disease|chronic kidney disease
498358|NCT01028703|left ventricular dysfunction|left ventricular dysfunction
498359|NCT01028703|diastolic dysfunction|diastolic dysfunction
498360|NCT01028703|hypertension|hypertension
498361|NCT01028690|Helicobacter pylori|helicobacter pylori
498362|NCT01028690|Eradication therapy|eradication therapy
498363|NCT01028690|Lactobacillus reuteri|lactobacillus reuteri
498364|NCT01028690|Dyspeptic symptoms|dyspeptic symptoms
498365|NCT01028677|oxytocin|oxytocin
498366|NCT01028677|social cognition|social cognition
498367|NCT01028677|social skill|social skill
498368|NCT01028677|social functioning|social functioning
498370|NCT01028677|psychotic symptoms|psychotic symptoms
498371|NCT01028677|schizophrenia|schizophrenia
498372|NCT01028677|social deficits|social deficits
498373|NCT01028677|intranasal administration|intranasal administration
498374|NCT01028664|Glaucoma and ocular hypertension patients|glaucoma and ocular hypertension patients
498376|NCT01028651|Pulmonary Hypertension|pulmonary hypertension
498377|NCT01028651|Remodulin|remodulin
498378|NCT01028651|Treprostinil|treprostinil
498379|NCT01028651|Quality of Life|quality of life
498380|NCT01028638|VEGF imaging|vegf imaging
498381|NCT01028638|everolimus|everolimus
498382|NCT01028638|renal cell carcinoma|renal cell carcinoma
498383|NCT01028638|PET|pet
498384|NCT01028638|bevacizumab|bevacizumab
498385|NCT01028625|Heart failure|heart failure
498386|NCT01028625|Depression|depression
498387|NCT01028625|Self Care|self care
498388|NCT01028625|Cognitive behavior therapy|cognitive behavior therapy
498389|NCT01028599|Heart transplantation|heart transplantation
498390|NCT01028599|Exercise capacity|exercise capacity
498391|NCT01028599|Endothelial function|endothelial function
498392|NCT01028573|bowel preparation|bowel preparation
498393|NCT01028573|colonoscopy|colonoscopy
498394|NCT01028560|Wheezing|wheezing
498395|NCT01028560|Asthma|asthma
498396|NCT01028560|Allergy|allergy
498397|NCT01028560|Immunotherapy|immunotherapy
498398|NCT01028547|PONV|ponv
498399|NCT01028534|Continuous positive pressure ventilation|continuous positive pressure ventilation
498400|NCT01028534|Blood pressure|blood pressure
498401|NCT01028534|Oxygen desaturation index|oxygen desaturation index
498402|NCT01028534|Endothelial dysfunction|endothelial dysfunction
498403|NCT01028534|Patient reported measurement|patient reported measurement
498404|NCT01028521|First time in man, safety study, Cm3.1-AC100|first time in man, safety study, cm3.1-ac100
498405|NCT01028521|Male volunteer aged 18 to 50 years at Screening|male volunteer aged 18 to 50 years at screening
498406|NCT01028508|Depression|depression
498407|NCT01028508|ECT|ect
498408|NCT01028508|electroconvulsive therapy|electroconvulsive therapy
498409|NCT01028508|mood disorders|mood disorders
498410|NCT01028508|continuation ECT|continuation ect
498411|NCT01028508|continuation pharmacotherapy|continuation pharmacotherapy
498412|NCT01028508|geriatric|geriatric
498413|NCT01028508|elderly|elderly
498414|NCT01028508|lithium|lithium
498415|NCT01028508|venlafaxine|venlafaxine
498416|NCT01028482|severity of depression measured by MADRS and CGI|severity of depression measured by madrs and cgi
498417|NCT01028456|Seizures|seizures
498418|NCT01028456|Light Therapy|light therapy
498419|NCT01028430|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
498420|NCT01028417|subcentimetre nodules|subcentimetre nodules
498421|NCT01028365|Fertility|fertility
498422|NCT01028365|Trying to Conceive|trying to conceive
498423|NCT01028365|Trying to Get Pregnant|trying to get pregnant
498424|NCT01028365|Pregnancy|pregnancy
498425|NCT01028339|traumatic brain injury|traumatic brain injury
498426|NCT01028339|PtiO2|ptio2
498427|NCT01028339|Cerebral microdialysis|cerebral microdialysis
498428|NCT01028339|Osmotherapy|osmotherapy
498429|NCT01028339|hypertonic saline|hypertonic saline
498430|NCT01028339|mannitol|mannitol
498431|NCT01028326|Pneumococcal pneumonia vaccine|pneumococcal pneumonia vaccine
498432|NCT01028313|Chronic Graft-Versus-Host Disease|chronic graft-versus-host disease
498433|NCT01028313|GVHD|gvhd
498434|NCT01028313|LBH589|lbh589
498435|NCT01028313|Panobinostat|panobinostat
498436|NCT01028300|DDD|ddd
498437|NCT01028287|Diabetic Nephropathy|diabetic nephropathy
498438|NCT01028287|Nephrotic syndrome|nephrotic syndrome
498439|NCT01028274|Hypercholesterolemia|hypercholesterolemia
498440|NCT01028274|Hypertriglyceridemia|hypertriglyceridemia
498441|NCT01028274|Fish Oil|fish oil
498442|NCT01028274|Red Yeast Rice|red yeast rice
498443|NCT01028261|Obese|obese
498444|NCT01028261|Obesity|obesity
498445|NCT01028261|Overweight|overweight
498446|NCT01028248|Central Retinal Vein Occlusion|central retinal vein occlusion
498447|NCT01028248|Retinal Vein Occlusive disease|retinal vein occlusive disease
498448|NCT01028235|Eosinophilic Esophagitis|eosinophilic esophagitis
498449|NCT01028222|Melanoma|melanoma
498450|NCT01028222|AMN107|amn107
498451|NCT01028222|c-Kit|c-kit
498452|NCT01028222|c-Kit mutated metastatic and/or inoperable melanoma|c-kit mutated metastatic and/or inoperable melanoma
498453|NCT01028196|schizophrenia|schizophrenia
498454|NCT01028196|schizoaffective disorder|schizoaffective disorder
498455|NCT01028196|recurrent depression|recurrent depression
498456|NCT01028196|Bipolar disorders|bipolar disorders
498457|NCT01028183|therapeutics|therapeutics
498458|NCT01028183|safety|safety
498459|NCT01028183|maternal|maternal
498460|NCT01028183|neonatal|neonatal
498461|NCT01028170|Congestive Heart Failure|congestive heart failure
498462|NCT01028170|Renal Insufficiency|renal insufficiency
498463|NCT01028170|Cardio-renal Syndrome|cardio-renal syndrome
498464|NCT01028157|HIV|hiv
498465|NCT01028157|risk reduction|risk reduction
498466|NCT01028157|behavioral intervention|behavioral intervention
498467|NCT01028144|Exercise|exercise
498468|NCT01028144|Physical Activity|physical activity
498469|NCT01028144|Adolescent|adolescent
498470|NCT01028144|Minority Health|minority health
498471|NCT01028131|cigarette smoking|cigarette smoking
498472|NCT01028131|pregnancy|pregnancy
498473|NCT01028131|intervention|intervention
498474|NCT01028131|efficacy|efficacy
498475|NCT01028131|Motivational Interviewing|motivational interviewing
498476|NCT01028131|Contingency Management|contingency management
498477|NCT01028118|domestic and sexual violence|domestic and sexual violence
498478|NCT01028118|menopause|menopause
498479|NCT01028118|professional improvement|professional improvement
498480|NCT01028118|social support network|social support network
498481|NCT01028105|Preoperative screening|preoperative screening
498482|NCT01028105|MRSA|mrsa
498483|NCT01028105|Incidence|incidence
498484|NCT01028105|Postoperative infection|postoperative infection
498485|NCT01028105|Preoperative MRSA Screening Incidence|preoperative mrsa screening incidence
498486|NCT01028105|Postoperative MRSA Infection Rate|postoperative mrsa infection rate
498487|NCT01028079|Back Pain|back pain
498488|NCT01028079|Acute low back pain|acute low back pain
498489|NCT01028066|nutritional intervention|nutritional intervention
498490|NCT01028066|nutritional counseling|nutritional counseling
498491|NCT01028066|feeding behavior|feeding behavior
498492|NCT01028066|food consumption|food consumption
498493|NCT01028066|angioplasty|angioplasty
498494|NCT01028053|Mild Cognitive Impairment|mild cognitive impairment
498495|NCT01028053|Positron Emission Tomography|positron emission tomography
498496|NCT01028053|National Institute of Neurological and Communicative Disorders and Stroke|national institute of neurological and communicative disorders and stroke
498497|NCT01028053|Alzheimer's Disease and Related Disorders Association|alzheimer's disease and related disorders association
498498|NCT01028053|Assess Prognostic Usefulness of Flutemetamol Injection for Identifying Subjects who will Convert to Clinically Probable Alzheimer's Disease|assess prognostic usefulness of flutemetamol injection for identifying subjects who will convert to clinically probable alzheimer's disease
498499|NCT01028040|Phase I|phase i
498500|NCT01028040|AZD3043|azd3043
498501|NCT01028040|Japanese healthy volunteer|japanese healthy volunteer
498502|NCT01028027|Blepharokeratoconjunctivitis|blepharokeratoconjunctivitis
498503|NCT01027988|Retinal Microvascularisation|retinal microvascularisation
498504|NCT01027988|Fundus|fundus
498505|NCT01027988|mfERGs|mfergs
498507|NCT01027988|Cardiovascular Disease|cardiovascular disease
498508|NCT01027988|Coronarography|coronarography
498509|NCT01027988|Macrovascularisation|macrovascularisation
498510|NCT01027988|The objectives are to assess if if any retinal vascular disorder in arterioles and venules can be predictive for cardiovascular morbidity and mortality|the objectives are to assess if if any retinal vascular disorder in arterioles and venules can be predictive for cardiovascular morbidity and mortality
498511|NCT01027975|laparoscopy|laparoscopy
498512|NCT01027975|fundoplication|fundoplication
498513|NCT01027975|Nissen|nissen
498514|NCT01027975|Thal|thal
498515|NCT01027975|children|children
499187|NCT01025115|Diamel|diamel
498516|NCT01027975|operative treatment of gastro-oesophageal reflux disease in children|operative treatment of gastro-oesophageal reflux disease in children
498517|NCT01027962|Early Onset Psychosis|early onset psychosis
498518|NCT01027962|Laptop Computer|laptop computer
498519|NCT01027962|Brain Training|brain training
498520|NCT01027936|Healthy Volunteers|healthy volunteers
498521|NCT01027910|PCI-24781|pci-24781
498522|NCT01027910|doxorubicin|doxorubicin
498523|NCT01027897|Pharmacokinetics|pharmacokinetics
498524|NCT01027897|Pharmacodynamics|pharmacodynamics
498525|NCT01027897|Doripenem|doripenem
498526|NCT01027897|Trauma|trauma
498527|NCT01027897|sepsis|sepsis
498528|NCT01027897|Trauma patients with sepsis|trauma patients with sepsis
498529|NCT01027884|Idebenone|idebenone
498530|NCT01027884|Duchenne Muscular Dystrophy (DMD)|duchenne muscular dystrophy (dmd)
498531|NCT01027884|Respiratory function|respiratory function
498532|NCT01027884|Ambulatory and non-ambulatory patients|ambulatory and non-ambulatory patients
498533|NCT01027884|Subjects not using glucocorticoids|subjects not using glucocorticoids
498534|NCT01027858|exercise|exercise
498535|NCT01027858|aerobic exercise training|aerobic exercise training
498536|NCT01027858|vascular cognitive impairment|vascular cognitive impairment
498537|NCT01027858|Mild Sub-cortical Ischaemic Vascular Cognitive Impairment (SIVCI)|mild sub-cortical ischaemic vascular cognitive impairment (sivci)
498538|NCT01027845|Pneumococcal disease|pneumococcal disease
498539|NCT01027845|Immunogenicity|immunogenicity
498540|NCT01027845|Booster vaccination|booster vaccination
498541|NCT01027845|Pneumococcal vaccine|pneumococcal vaccine
498542|NCT01027845|Primary vaccination|primary vaccination
498543|NCT01027845|Safety|safety
498544|NCT01027832|tracheobronchitis|tracheobronchitis
498545|NCT01027819|Total knee arthroplasty|total knee arthroplasty
498546|NCT01027819|Mobile bearing|mobile bearing
498547|NCT01027819|Fixed bearing|fixed bearing
498548|NCT01027819|Range of motion|range of motion
498549|NCT01027819|Knee Society Score|knee society score
498550|NCT01027806|Children|children
498551|NCT01027806|Sleep|sleep
498552|NCT01027806|Obstructive Sleep Apnea|obstructive sleep apnea
498553|NCT01027793|Stretch marks|stretch marks
498554|NCT01027793|Striae|striae
498555|NCT01027793|Tretinoin|tretinoin
498556|NCT01027793|Superficial dermabrasion|superficial dermabrasion
498557|NCT01027780|Mindfulness-Based Stress Reduction|mindfulness-based stress reduction
498558|NCT01027780|MBSR|mbsr
498559|NCT01027780|Seniors|seniors
498560|NCT01027780|immune system|immune system
498561|NCT01027780|keyhole limpet hemocyanin (KLH)|keyhole limpet hemocyanin (klh)
498562|NCT01027767|Breast|breast
498563|NCT01027767|MBI|mbi
498564|NCT01027767|Molecular|molecular
498565|NCT01027767|Molecular Breast Imaging|molecular breast imaging
498566|NCT01027767|Dense breast tissue|dense breast tissue
498567|NCT01027767|Surgery|surgery
498568|NCT01027767|Radiation|radiation
498569|NCT01027767|BCT|bct
498570|NCT01027754|methadone maintenance|methadone maintenance
498571|NCT01027715|Neonatal Seizures|neonatal seizures
498572|NCT01027715|Neonatal encephalopathy|neonatal encephalopathy
498573|NCT01027702|Donor Lymphocyte Infusion|donor lymphocyte infusion
498574|NCT01027702|Immune Recovery|immune recovery
498575|NCT01027702|T cell depleted transplant|t cell depleted transplant
498576|NCT01027702|Mismatched related donor transplants|mismatched related donor transplants
498577|NCT01027702|Unrelated donor transplants|unrelated donor transplants
498578|NCT01027689|alprazolam|alprazolam
498579|NCT01027689|bioequivalence|bioequivalence
498580|NCT01027689|sublingual|sublingual
498581|NCT01027676|Gefitinib|gefitinib
498582|NCT01027676|Vorinostat|vorinostat
498583|NCT01027663|anemia|anemia
498584|NCT01027663|malaria|malaria
498585|NCT01027637|breast reconstruction|breast reconstruction
498586|NCT01027637|tissue expander|tissue expander
498587|NCT01027637|Alloderm|alloderm
498588|NCT01027637|tissue matrix|tissue matrix
498589|NCT01027624|Pan South African Survey on the Undertreatment of Hypercholesterolaemia|pan south african survey on the undertreatment of hypercholesterolaemia
498590|NCT01027611|Effectiveness of topical pain medicine for control of pain associated with intravitreal injections|effectiveness of topical pain medicine for control of pain associated with intravitreal injections
498591|NCT01027611|Eye discomfort|eye discomfort
498592|NCT01027598|Lung Cancer|lung cancer
498593|NCT01027598|Previously Treated Advanced Non Small Cell Lung Cancer|previously treated advanced non small cell lung cancer
498594|NCT01027598|Erlotinib|erlotinib
498595|NCT01027598|Pazopanib|pazopanib
498596|NCT01027572|Vegetative state|vegetative state
498597|NCT01027572|Minimally conscious state|minimally conscious state
498598|NCT01027572|Thalamic stimulation|thalamic stimulation
498599|NCT01027559|Major Depression|major depression
498600|NCT01027559|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
498601|NCT01027559|Emotional Circuitry|emotional circuitry
498602|NCT01027559|Cognitive Behavioral Therapy|cognitive behavioral therapy
498603|NCT01027546|perioperative blood loss, spinal surgery|perioperative blood loss, spinal surgery
498604|NCT01027533|multifocal intraocular lens|multifocal intraocular lens
498605|NCT01027533|visual acuity|visual acuity
498606|NCT01027533|presbiopia|presbiopia
498607|NCT01027520|Hand burn|hand burn
498608|NCT01027520|skin graft|skin graft
498609|NCT01027520|coban dressing|coban dressing
498610|NCT01027520|range of motion|range of motion
498611|NCT01027494|ear tubes|ear tubes
498612|NCT01027494|ear drainage|ear drainage
498613|NCT01027494|ear infection|ear infection
498614|NCT01027494|ear drops|ear drops
498615|NCT01027494|tympanostomy tubes|tympanostomy tubes
498616|NCT01027481|lucentis, macular edema, branch retinal vein occlusion|lucentis, macular edema, branch retinal vein occlusion
498617|NCT01027468|bevacizumab, choroidal neovascularization|bevacizumab, choroidal neovascularization
498618|NCT01027442|Stereolithography|stereolithography
498619|NCT01027442|Dental implants,|dental implants,
498620|NCT01027442|Prosthetics|prosthetics
498621|NCT01027442|positioning-errors|positioning-errors
498622|NCT01027442|logistic regression analysis|logistic regression analysis
498623|NCT01027429|infant|infant
498624|NCT01027429|newborn|newborn
498625|NCT01027429|sepsis|sepsis
498626|NCT01027429|infection|infection
498627|NCT01027429|community|community
498628|NCT01027416|ER positive|er positive
498629|NCT01027416|Tamoxifen|tamoxifen
498630|NCT01027403|Heart failure|heart failure
498631|NCT01027403|Adult stem cells|adult stem cells
498632|NCT01027403|Circulating stem cells|circulating stem cells
498633|NCT01027403|Acute decompensated heart failure|acute decompensated heart failure
498634|NCT01027390|neck/shoulder|neck/shoulder
498635|NCT01027351|Children|children
498636|NCT01027351|Pre-school|pre-school
498637|NCT01027351|Meningococcal disease|meningococcal disease
498638|NCT01027351|Prevention|prevention
498639|NCT01027351|Vaccination|vaccination
498640|NCT01027325|Resistant Starch|resistant starch
498641|NCT01027325|Amylose|amylose
498642|NCT01027325|Amylopectin|amylopectin
498643|NCT01027325|LDL subclasses|ldl subclasses
498644|NCT01027325|Dietary carbohydrate|dietary carbohydrate
498645|NCT01027325|Postprandial insulinemia|postprandial insulinemia
498646|NCT01027312|Glaucoma|glaucoma
498647|NCT01027312|quality of life|quality of life
498648|NCT01027312|daily living activities|daily living activities
498649|NCT01027312|visual fields|visual fields
498650|NCT01027312|contrast sensitivity|contrast sensitivity
498651|NCT01027299|cardiac failure|cardiac failure
498652|NCT01027299|thoracic surgery|thoracic surgery
498653|NCT01027299|cardiac pacing, artificial|cardiac pacing, artificial
498654|NCT01027273|Stroke|stroke
498655|NCT01027273|Ischemic Stroke|ischemic stroke
498656|NCT01027273|Transient Ischemic Attack|transient ischemic attack
498657|NCT01027273|Stroke Recurrence Prevention|stroke recurrence prevention
498658|NCT01027273|Cerebrovascular Disorders|cerebrovascular disorders
498659|NCT01027273|Brain Ischemia|brain ischemia
498660|NCT01027273|Brain Infraction|brain infraction
498661|NCT01027273|Brain Diseases|brain diseases
498662|NCT01027273|Cerebral Infraction|cerebral infraction
498663|NCT01027273|Self-management|self-management
498664|NCT01027273|Peer-led|peer-led
498665|NCT01027273|Community Based|community based
498666|NCT01027247|Primary Glaucoma|primary glaucoma
498667|NCT01027234|Healthy volunteers|healthy volunteers
498668|NCT01027221|Low Dose Radiation|low dose radiation
498669|NCT01027221|pancreatic cancer|pancreatic cancer
498670|NCT01027221|Immunostimulation|immunostimulation
498671|NCT01027182|HIV|hiv
498672|NCT01027169|Hepatic impairment|hepatic impairment
498673|NCT01027169|Liver diseases|liver diseases
498674|NCT01027169|Pharmacokinetics|pharmacokinetics
498675|NCT01027169|To Investigate Pharmacokinetics of Safinamide in Subjects With Mild and Moderate Hepatic Impairment as Compared to Healthy Subjects With Normal Hepatic Function|to investigate pharmacokinetics of safinamide in subjects with mild and moderate hepatic impairment as compared to healthy subjects with normal hepatic function
498676|NCT01027156|Public Health|public health
498677|NCT01027156|Biochemistry|biochemistry
498678|NCT01027156|Ecological|ecological
498679|NCT01027143|Asthma|asthma
498680|NCT01027143|Obesity|obesity
498681|NCT01027143|Pharmacogenetics|pharmacogenetics
498682|NCT01027143|Nutrigenetics|nutrigenetics
498683|NCT01027117|Bioavailability|bioavailability
498684|NCT01027117|Revatio|revatio
498685|NCT01027117|Healthy Volunteers|healthy volunteers
498686|NCT01027104|injury prevention|injury prevention
498687|NCT01027104|firearms|firearms
498688|NCT01027104|training|training
498689|NCT01027104|counseling|counseling
498690|NCT01027104|medical education|medical education
498691|NCT01027104|safety|safety
498692|NCT01027104|anticipatory guidance|anticipatory guidance
498693|NCT01027104|Firearm injury prevention anticipatory guidance|firearm injury prevention anticipatory guidance
498694|NCT01027091|hypocalcemia|hypocalcemia
498695|NCT01027091|total thyroidectomy|total thyroidectomy
498696|NCT01027065|interleukin-7|interleukin-7
498697|NCT01027065|immune-based therapies|immune-based therapies
498698|NCT01027065|hepatitis B|hepatitis b
498699|NCT01027065|HBe negative|hbe negative
498700|NCT01027065|HBV vaccination|hbv vaccination
498701|NCT01027065|entecavir|entecavir
498702|NCT01027065|tenofovir|tenofovir
498703|NCT01027065|chronic hepatitis|chronic hepatitis
498704|NCT01027065|immune specific responses to HBV|immune specific responses to hbv
498705|NCT01027065|phase 1/2a|phase 1/2a
498706|NCT01027065|viral disease|viral disease
498707|NCT01027065|liver disease|liver disease
498708|NCT01027052|MDA|mda
498709|NCT01027052|Spice|spice
498710|NCT01027039|primary open angle glaucoma|primary open angle glaucoma
498711|NCT01027039|pigmentary glaucoma|pigmentary glaucoma
498712|NCT01027039|exfoliative glaucoma|exfoliative glaucoma
498713|NCT01027039|angle closure glaucoma|angle closure glaucoma
498714|NCT01027039|low tension glaucoma|low tension glaucoma
498715|NCT01027026|Cost analysis|cost analysis
498716|NCT01027026|Safety|safety
498717|NCT01027026|Length of stay|length of stay
498718|NCT01027026|Randomized controlled trials|randomized controlled trials
498719|NCT01027026|Early discharge|early discharge
498720|NCT01027000|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
498721|NCT01027000|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
498722|NCT01027000|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
498723|NCT01027000|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
498724|NCT01027000|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
498725|NCT01027000|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
498726|NCT01027000|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
498727|NCT01027000|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
498728|NCT01027000|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
498729|NCT01027000|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
498730|NCT01027000|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
498731|NCT01027000|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
498732|NCT01026974|Children|children
498733|NCT01026974|Pre-school|pre-school
498734|NCT01026974|Meningococcal disease|meningococcal disease
498735|NCT01026974|Prevention|prevention
498736|NCT01026974|Vaccination|vaccination
498737|NCT01026961|Safety|safety
498738|NCT01026961|heart rate|heart rate
498739|NCT01026961|systolic and diastolic blood pressure|systolic and diastolic blood pressure
498740|NCT01026961|arrhythmias|arrhythmias
498741|NCT01026948|Induction of labour|induction of labour
498742|NCT01026948|Intraprtum fetal monitoring|intraprtum fetal monitoring
498743|NCT01026935|open mesh repair|open mesh repair
498744|NCT01026935|sutured|sutured
498745|NCT01026935|non-sutured|non-sutured
498746|NCT01026935|pro-grip|pro-grip
498747|NCT01026935|postoperative pain|postoperative pain
498748|NCT01026922|antroduodenal manometry|antroduodenal manometry
498749|NCT01026922|gastric dysmotility|gastric dysmotility
498750|NCT01026922|intestinal dysmotility|intestinal dysmotility
498751|NCT01026896|Mental practice|mental practice
498752|NCT01026896|motor imagery|motor imagery
498753|NCT01026896|stroke|stroke
498754|NCT01026896|hemiplegia|hemiplegia
498755|NCT01026896|motor recovery|motor recovery
498756|NCT01026896|neuroplasticity|neuroplasticity
498757|NCT01026883|hematocrit|hematocrit
498758|NCT01026883|layered resonant piezoelectric sensors|layered resonant piezoelectric sensors
498759|NCT01026844|erlotinib|erlotinib
498760|NCT01026844|tarceva|tarceva
498761|NCT01026844|hydroxychloroquine|hydroxychloroquine
498762|NCT01026844|NSCLC|nsclc
498763|NCT01026818|Erectile Dysfunction|erectile dysfunction
498764|NCT01026818|Radical Prostatectomy|radical prostatectomy
498765|NCT01026805|morcellator|morcellator
498766|NCT01026805|hysteroscope|hysteroscope
498767|NCT01026805|myomectomy|myomectomy
498768|NCT01026805|polypectomy|polypectomy
498769|NCT01026805|uterine fibroids|uterine fibroids
498770|NCT01026779|rotavirus|rotavirus
498771|NCT01026779|gastroenteritis|gastroenteritis
498772|NCT01026779|vaccine|vaccine
498773|NCT01026779|case-control study|case-control study
498774|NCT01026779|serotype|serotype
498775|NCT01026766|Hypothermia|hypothermia
498776|NCT01026766|Obesity|obesity
498777|NCT01026766|Heat and moisture exchanger|heat and moisture exchanger
498778|NCT01026766|Warming blanket|warming blanket
498779|NCT01026766|Warming fluids|warming fluids
498780|NCT01026766|Gynecological surgery|gynecological surgery
498781|NCT01026766|Intravenous anesthesia|intravenous anesthesia
498782|NCT01026766|Obese patients|obese patients
498783|NCT01026766|Non obese patients|non obese patients
498784|NCT01026753|colorectal cancer|colorectal cancer
498785|NCT01026753|screening|screening
498786|NCT01026753|fecal occult blood test|fecal occult blood test
498787|NCT01026753|randomized control trial|randomized control trial
498788|NCT01026753|primary care oncology|primary care oncology
498789|NCT01026753|web site|web site
498790|NCT01026753|provincial health contact center|provincial health contact center
498791|NCT01026740|Staphylococcal Skin Infections|staphylococcal skin infections
498792|NCT01026740|Streptococcal Infections|streptococcal infections
498793|NCT01026727|HIV Infections|hiv infections
498794|NCT01026727|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
498795|NCT01026727|Virus Diseases|virus diseases
498796|NCT01026727|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
498797|NCT01026727|RNA Virus Infections|rna virus infections
498798|NCT01026727|Slow Virus Diseases|slow virus diseases
498799|NCT01026727|Immune System Diseases|immune system diseases
498800|NCT01026727|Sexually Transmitted Diseases|sexually transmitted diseases
498801|NCT01026727|Lentivirus Infections|lentivirus infections
498802|NCT01026727|Infection|infection
498803|NCT01026727|Retroviridae Infections|retroviridae infections
498804|NCT01026727|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
498805|NCT01026727|HIV|hiv
498806|NCT01026727|treatment experienced|treatment experienced
498807|NCT01026727|bevirimat|bevirimat
498808|NCT01026701|Osteoblst effect|osteoblst effect
498809|NCT01026701|Velcade|velcade
498810|NCT01026701|Proteasome inhibitor|proteasome inhibitor
498811|NCT01026701|Bortezomib|bortezomib
498812|NCT01026701|Multjple Myeloma|multjple myeloma
498813|NCT01026688|Pragmatic randomized controlled trial|pragmatic randomized controlled trial
498814|NCT01026688|Cardiovascular risk reduction|cardiovascular risk reduction
498815|NCT01026688|Knowledge translation|knowledge translation
498816|NCT01026688|Clinical practice guidelines|clinical practice guidelines
498817|NCT01026662|Aesthetic dermatology|aesthetic dermatology
498818|NCT01026649|hematoma formation|hematoma formation
498819|NCT01026649|success rate|success rate
498820|NCT01026636|Staphylococcal Skin Infections|staphylococcal skin infections
498821|NCT01026636|Skin Infections|skin infections
498822|NCT01026636|Streptococcal Infections|streptococcal infections
498823|NCT01026610|Chronic hepatitis B|chronic hepatitis b
498824|NCT01026610|LB80380|lb80380
498825|NCT01026610|treatment-naive|treatment-naive
498826|NCT01026610|entecavir|entecavir
498827|NCT01026571|Bicuspid aortic valve|bicuspid aortic valve
498828|NCT01026558|Obesity, Ceftobiprole|obesity, ceftobiprole
498829|NCT01026558|Skin Infections|skin infections
498830|NCT01026558|Staphylococcal Skin Infections|staphylococcal skin infections
498831|NCT01026558|Bacterial Skin Infections|bacterial skin infections
498832|NCT01026558|Streptococcal Infection|streptococcal infection
498833|NCT01026545|safety|safety
498834|NCT01026545|tolerability|tolerability
498835|NCT01026545|pharmacokinetics|pharmacokinetics
498836|NCT01026545|multiple-dose|multiple-dose
498837|NCT01026545|macrolide|macrolide
498838|NCT01026506|c9,t11-CLA|c9,t11-cla
498839|NCT01026506|allergic bronchial asthma|allergic bronchial asthma
498840|NCT01026506|children and adolescents|children and adolescents
498841|NCT01026493|adult giant cell glioblastoma|adult giant cell glioblastoma
498842|NCT01026493|adult glioblastoma|adult glioblastoma
498843|NCT01026493|adult gliosarcoma|adult gliosarcoma
498844|NCT01026493|recurrent adult brain tumor|recurrent adult brain tumor
498845|NCT01026493|adult anaplastic astrocytoma|adult anaplastic astrocytoma
498846|NCT01026493|adult anaplastic ependymoma|adult anaplastic ependymoma
498847|NCT01026493|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
498848|NCT01026493|adult brain stem glioma|adult brain stem glioma
498849|NCT01026493|adult mixed glioma|adult mixed glioma
498850|NCT01026493|adult pineal gland astrocytoma|adult pineal gland astrocytoma
498851|NCT01026480|Ileal Pouch Anal Anastomosis|ileal pouch anal anastomosis
498852|NCT01026480|IPAA|ipaa
498853|NCT01026480|Pull through|pull through
498855|NCT01026480|Ulcerative colitis|ulcerative colitis
498856|NCT01026480|Familial adenomatous polyposis|familial adenomatous polyposis
498857|NCT01026480|FAP|fap
498858|NCT01026480|Hereditary nonpolyposis colorectal cancer|hereditary nonpolyposis colorectal cancer
498859|NCT01026480|HNPCC|hnpcc
498860|NCT01026454|HSV|hsv
498861|NCT01026454|HIV|hiv
498862|NCT01026441|Aesthetic|aesthetic
498863|NCT01026428|safinamide|safinamide
498864|NCT01026428|levodopa|levodopa
498865|NCT01026428|drug -drug interaction|drug -drug interaction
498866|NCT01026428|pharmacokinetics|pharmacokinetics
498867|NCT01026428|Patients diagnosed with idiopathic Parkinson's disease, levodopa-responsive, treated with a stable dose of levodopa/carbidopa|patients diagnosed with idiopathic parkinson's disease, levodopa-responsive, treated with a stable dose of levodopa/carbidopa
498868|NCT01026415|Antibody-Drug Conjugate|antibody-drug conjugate
498869|NCT01026415|Antigens, CD30|antigens, cd30
498870|NCT01026415|Disease, Hodgkin|disease, hodgkin
498871|NCT01026415|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
498872|NCT01026415|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
498873|NCT01026415|monomethyl auristatin E|monomethyl auristatin e
498874|NCT01026415|Drug Therapy|drug therapy
498875|NCT01026415|Immunotherapy|immunotherapy
498876|NCT01026415|Hematologic Diseases|hematologic diseases
498877|NCT01026415|Lymphoma|lymphoma
498878|NCT01026415|Antibodies, Monoclonal|antibodies, monoclonal
498879|NCT01026402|Phase I|phase i
498880|NCT01026402|cancer|cancer
498881|NCT01026402|advanced solid malignancies|advanced solid malignancies
498882|NCT01026402|dose escalation|dose escalation
498883|NCT01026402|AZD2014|azd2014
498884|NCT01026402|mTor kinase inhibitor|mtor kinase inhibitor
498885|NCT01026402|safety|safety
498886|NCT01026402|pharmacokinetics|pharmacokinetics
498887|NCT01026389|MRA-Contrast agent comparison in peripheral disease|mra-contrast agent comparison in peripheral disease
498888|NCT01026376|Myelodysplastic Syndromes|myelodysplastic syndromes
498889|NCT01026376|Decitabine|decitabine
498890|NCT01026363|Vitamin D|vitamin d
498891|NCT01026363|Chronic Kidney Disease|chronic kidney disease
498892|NCT01026350|modulating immune response to flu antigen|modulating immune response to flu antigen
498893|NCT01026337|recurrent renal cell cancer|recurrent renal cell cancer
498894|NCT01026311|Coenzyme q10|coenzyme q10
498895|NCT01026311|statins|statins
498896|NCT01026311|myalgias|myalgias
498897|NCT01026311|anaerobic threshold|anaerobic threshold
498898|NCT01026311|athletic performance|athletic performance
498899|NCT01026298|asthma|asthma
498900|NCT01026298|obstructive sleep apnea|obstructive sleep apnea
498901|NCT01026298|severe asthma|severe asthma
498902|NCT01026298|OSA|osa
498903|NCT01026285|Risperdal Consta|risperdal consta
498904|NCT01026272|Endocannabinoid|endocannabinoid
498905|NCT01026272|Fish Oil|fish oil
498906|NCT01026272|Multiple Sclerosis|multiple sclerosis
498907|NCT01026272|Monocyte Migration|monocyte migration
498908|NCT01026259|Surgical site infection|surgical site infection
498909|NCT01026259|wound healing|wound healing
498910|NCT01026259|tissue oxygen|tissue oxygen
498911|NCT01026259|angiogenesis|angiogenesis
498912|NCT01026259|flow cytometry|flow cytometry
498913|NCT01026259|immunohistochemistry|immunohistochemistry
498914|NCT01026246|Ghana, malaria, vaccine, Plasmodium falciparum|ghana, malaria, vaccine, plasmodium falciparum
498915|NCT01026233|Antibodies, Monoclonal|antibodies, monoclonal
498916|NCT01026233|Antibody-Drug Conjugate|antibody-drug conjugate
498917|NCT01026233|Antigens, CD30|antigens, cd30
498918|NCT01026233|Disease, Hodgkin|disease, hodgkin
498919|NCT01026233|Drug Therapy|drug therapy
498920|NCT01026233|Hematologic Diseases|hematologic diseases
498921|NCT01026233|Immunotherapy|immunotherapy
498922|NCT01026233|Lymphoma|lymphoma
498923|NCT01026233|monomethylauristatin E|monomethylauristatin e
498924|NCT01026233|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
498925|NCT01026207|Diagnostic test|diagnostic test
498926|NCT01026207|polysomnography|polysomnography
498927|NCT01026207|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
498928|NCT01026207|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
498929|NCT01026194|insulin resistance|insulin resistance
498930|NCT01026155|Obese patients (BMI > 30 kg / m²)|obese patients (bmi > 30 kg / m²)
498931|NCT01026103|gastric bypass|gastric bypass
498932|NCT01026103|Gastric bypass surgery|gastric bypass surgery
498933|NCT01026077|Savella pregnant|savella pregnant
498934|NCT01026077|savella pregnancy|savella pregnancy
498935|NCT01026077|fibromyalgia pregnant|fibromyalgia pregnant
498936|NCT01026077|fibromyalgia pregnancy|fibromyalgia pregnancy
498937|NCT01026077|pregnancy registry savella|pregnancy registry savella
498938|NCT01026064|Macrolides|macrolides
498939|NCT01026064|Inflammation|inflammation
498940|NCT01026064|Azithromycin|azithromycin
498941|NCT01026064|Cantharidin induced skin blister model|cantharidin induced skin blister model
498942|NCT01026051|Cancer Vaccine, Immunotherapy, Melanoma|cancer vaccine, immunotherapy, melanoma
498943|NCT01026038|Pneumococcal vaccine 13-valent|pneumococcal vaccine 13-valent
498944|NCT01026025|lobectomy|lobectomy
498945|NCT01026025|segmentectomy|segmentectomy
498946|NCT01026025|pulmonary resection|pulmonary resection
498947|NCT01026012|Regadenoson|regadenoson
498948|NCT01026012|85% predicted heart rate|85% predicted heart rate
498949|NCT01026012|Myocardial perfusion stress testing|myocardial perfusion stress testing
498950|NCT01025999|RYGB|rygb
498951|NCT01025999|Gastrostomy tube|gastrostomy tube
498952|NCT01025999|DM|dm
498953|NCT01025999|Gastric Bypass|gastric bypass
498954|NCT01025960|colonoscopy|colonoscopy
498955|NCT01025960|adenoma detection|adenoma detection
498956|NCT01025960|polyps|polyps
498957|NCT01025947|Atrial fibrillation|atrial fibrillation
498958|NCT01025947|Cryptogenic stroke|cryptogenic stroke
498959|NCT01025947|Implantable loop recorder|implantable loop recorder
498960|NCT01025921|Tracheobronchitis|tracheobronchitis
498961|NCT01025921|pneumonia|pneumonia
498962|NCT01025921|inhaled antibiotics|inhaled antibiotics
498963|NCT01025921|colistin|colistin
498964|NCT01025921|Ventilator associated tracheobronchitis|ventilator associated tracheobronchitis
498965|NCT01025921|Ventilator associated pneumonia|ventilator associated pneumonia
498966|NCT01025908|psychotherapy|psychotherapy
498967|NCT01025908|panic disorder|panic disorder
498968|NCT01025908|anxiety|anxiety
498969|NCT01025908|behavior|behavior
498970|NCT01025908|cognition|cognition
498971|NCT01025895|arthroscopic surgical procedure|arthroscopic surgical procedure
498972|NCT01025882|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
498973|NCT01025882|stage I pancreatic cancer|stage i pancreatic cancer
498974|NCT01025882|stage II pancreatic cancer|stage ii pancreatic cancer
498975|NCT01025882|stage III pancreatic cancer|stage iii pancreatic cancer
498976|NCT01025856|liver fat|liver fat
498977|NCT01025856|postprandial lipids metabolism|postprandial lipids metabolism
498978|NCT01025856|diet|diet
498979|NCT01025856|exercise|exercise
498980|NCT01025856|type 2 diabetes|type 2 diabetes
498981|NCT01025830|HIV;Bioequivalence;Triomune|hiv;bioequivalence;triomune
498982|NCT01025817|Kidney transplant|kidney transplant
498983|NCT01025817|renal transplant|renal transplant
498984|NCT01025817|immunosuppression|immunosuppression
498985|NCT01025817|mycophenolate mofetil|mycophenolate mofetil
498986|NCT01025817|tacrolimus|tacrolimus
498987|NCT01025817|everolimus|everolimus
498988|NCT01025804|Interfant-06|interfant-06
498989|NCT01025804|Infant ALL|infant all
498990|NCT01025804|Asparaginase|asparaginase
498991|NCT01025804|Pharmacokinetics of asparaginase|pharmacokinetics of asparaginase
498992|NCT01025804|Antibody formation|antibody formation
498993|NCT01025778|Haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
498994|NCT01025778|Graft versus host disease|graft versus host disease
498995|NCT01025778|Donor lymphocyte infusion|donor lymphocyte infusion
498996|NCT01025778|Graft versus leukemia effect|graft versus leukemia effect
498997|NCT01025778|Immunological recovery|immunological recovery
498998|NCT01025778|Bridge to transplant approach|bridge to transplant approach
498999|NCT01025778|Therapy resistant leukemia|therapy resistant leukemia
499000|NCT01025778|Hematological malignancy|hematological malignancy
499001|NCT01025752|chronic pain|chronic pain
499002|NCT01025752|cognitive behavior therapy|cognitive behavior therapy
499003|NCT01025752|low back pain|low back pain
499004|NCT01025739|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
499005|NCT01025739|EsophyX|esophyx
499006|NCT01025713|Cystic Fibrosis|cystic fibrosis
499007|NCT01025713|CF|cf
499008|NCT01025713|Mucociliary Clearance|mucociliary clearance
499009|NCT01025713|Epithelial Sodium Channel Inhibitor|epithelial sodium channel inhibitor
499010|NCT01025713|ENaC Inhibitor|enac inhibitor
499011|NCT01025713|Airway Hydration|airway hydration
499012|NCT01025713|Amiloride|amiloride
499013|NCT01025700|Efficacy|efficacy
499014|NCT01025700|Marijuana|marijuana
499015|NCT01025700|Reduction|reduction
499016|NCT01025700|Craving|craving
499017|NCT01025687|girls|girls
499018|NCT01025687|obesity|obesity
499019|NCT01025687|television viewing|television viewing
499020|NCT01025687|puberty|puberty
499021|NCT01025674|School health program|school health program
499022|NCT01025674|Positive health behavior|positive health behavior
499023|NCT01025674|School-wide climate|school-wide climate
499024|NCT01025674|Mental health|mental health
499025|NCT01025674|Self-esteem|self-esteem
499026|NCT01025674|Social support|social support
499027|NCT01025674|Exercise|exercise
499028|NCT01025674|Nutrition|nutrition
499029|NCT01025674|Parent involvement|parent involvement
499030|NCT01025674|Community involvement|community involvement
499031|NCT01025661|chiropractic|chiropractic
499032|NCT01025661|hip osteoarthritis|hip osteoarthritis
499033|NCT01025661|hip arthroplasty|hip arthroplasty
499034|NCT01025661|pain|pain
499035|NCT01025661|activities of daily living.|activities of daily living.
499036|NCT01025648|Mild to Moderate Asthma|mild to moderate asthma
499037|NCT01025648|Dyspnea|dyspnea
499038|NCT01025648|Wheezing|wheezing
499039|NCT01025648|Status Asthmaticus|status asthmaticus
499040|NCT01025635|rosacea|rosacea
499041|NCT01025635|papulopustular|papulopustular
499042|NCT01025635|azelaic acid|azelaic acid
499043|NCT01025635|foam|foam
499044|NCT01025622|Stem Cells|stem cells
499045|NCT01025622|Liver Cirrhosis|liver cirrhosis
499046|NCT01025622|Cell Therapy|cell therapy
499047|NCT01025609|spinal cord injury|spinal cord injury
499048|NCT01025609|cardiovascular disease|cardiovascular disease
499049|NCT01025609|dietary patterns|dietary patterns
499050|NCT01025596|interleukin-7|interleukin-7
499051|NCT01025596|immune-based therapies|immune-based therapies
499052|NCT01025596|hepatitis C|hepatitis c
499053|NCT01025596|chronic hepatitis|chronic hepatitis
499054|NCT01025596|resistance to Peg-interferon and ribavirin bi-therapy|resistance to peg-interferon and ribavirin bi-therapy
499055|NCT01025596|immune specific responses to HCV|immune specific responses to hcv
499056|NCT01025596|phase 1|phase 1
499057|NCT01025596|viral disease|viral disease
499058|NCT01025596|liver disease|liver disease
499059|NCT01025583|acute gastroenteritis|acute gastroenteritis
499060|NCT01025583|intestinal infection|intestinal infection
499061|NCT01025583|intestinal fluid secretion|intestinal fluid secretion
499062|NCT01025583|intestinal microflora|intestinal microflora
499063|NCT01025583|treatment of childhood acute diarrhea|treatment of childhood acute diarrhea
499064|NCT01025570|pancreas|pancreas
499065|NCT01025570|pancreatic|pancreatic
499066|NCT01025570|bosutinib|bosutinib
499067|NCT01025570|SKI-606|ski-606
499068|NCT01025570|gemcitabine|gemcitabine
499069|NCT01025570|gemzar|gemzar
499070|NCT01025570|Patients with resected pancreatic cancer|patients with resected pancreatic cancer
499071|NCT01025557|Food intake|food intake
499072|NCT01025557|Blood glucose|blood glucose
499073|NCT01025557|Milk|milk
499074|NCT01025544|Haemophilus influenzae type b (Hib)|haemophilus influenzae type b (hib)
499075|NCT01025544|Vaccine|vaccine
499076|NCT01025544|Booster|booster
499077|NCT01025531|Hepatitis C|hepatitis c
499078|NCT01025518|Head and Neck Neoplasms|head and neck neoplasms
499079|NCT01025518|Resistance training|resistance training
499080|NCT01025518|Muscle mass|muscle mass
499081|NCT01025518|Functional capacity|functional capacity
499082|NCT01025505|Untreated Ph+ ALL unfit for intense therapy and allo SCT|untreated ph+ all unfit for intense therapy and allo sct
499083|NCT01025492|high density lipoprotein|high density lipoprotein
499084|NCT01025492|arterial compliance|arterial compliance
499085|NCT01025492|brachial artery flow-mediated dilatation|brachial artery flow-mediated dilatation
499086|NCT01025479|Osteoporosis|osteoporosis
499087|NCT01025479|Prostate cancer|prostate cancer
499088|NCT01025479|LHRH agonist and/or anti-androgen agent|lhrh agonist and/or anti-androgen agent
499089|NCT01025479|Korean prostate cancer|korean prostate cancer
499090|NCT01025453|thyroid|thyroid
499091|NCT01025453|follicular cell|follicular cell
499092|NCT01025453|papillary cell|papillary cell
499093|NCT01025453|Hurthle cell|hurthle cell
499094|NCT01025453|BAY 43-9006|bay 43-9006
499095|NCT01025453|Temsirolimus|temsirolimus
499096|NCT01025453|Sorafenib|sorafenib
499097|NCT01025453|09-148|09-148
499098|NCT01025427|HIV|hiv
499099|NCT01025427|HIV persistence|hiv persistence
499100|NCT01025427|HIV reservoirs|hiv reservoirs
499101|NCT01025414|pancreatic fistula|pancreatic fistula
499102|NCT01025401|epilepsy|epilepsy
499103|NCT01025401|seizures|seizures
499104|NCT01025401|movement|movement
499105|NCT01025388|Hypercholesterolemia|hypercholesterolemia
499106|NCT01025388|The study is focusing on the undertreatment of hypercholesterolemia|the study is focusing on the undertreatment of hypercholesterolemia
499107|NCT01025375|overweight|overweight
499108|NCT01025349|bevacizumab|bevacizumab
499109|NCT01025349|metastatic breast cancer|metastatic breast cancer
499110|NCT01025349|docetaxel|docetaxel
499111|NCT01025336|Antibody persistence|antibody persistence
499112|NCT01025323|Pre hypertension|pre hypertension
499113|NCT01025323|Lifestyle modification|lifestyle modification
499114|NCT01025323|DASH diet|dash diet
499115|NCT01025310|eye movements|eye movements
499116|NCT01025310|saccades|saccades
499117|NCT01025310|visual|visual
499118|NCT01025310|stress|stress
499119|NCT01025310|search coil|search coil
499120|NCT01025310|environment|environment
499121|NCT01025310|Saccadic eye movements|saccadic eye movements
499122|NCT01025310|Urban environment|urban environment
499123|NCT01025297|interleukin-7|interleukin-7
499124|NCT01025297|immune-based therapies|immune-based therapies
499125|NCT01025297|hepatitis C|hepatitis c
499126|NCT01025297|chronic hepatitis|chronic hepatitis
499127|NCT01025297|resistance to Peg-interferon and ribavirin bi-therapy|resistance to peg-interferon and ribavirin bi-therapy
499128|NCT01025297|immune specific responses to HCV|immune specific responses to hcv
499129|NCT01025297|phase 1/2a|phase 1/2a
499130|NCT01025297|viral disease|viral disease
499131|NCT01025297|liver disease|liver disease
499132|NCT01025271|meningitis|meningitis
499133|NCT01025258|Cystic Fibrosis|cystic fibrosis
499134|NCT01025258|Medication Adherence|medication adherence
499135|NCT01025258|Multidisciplinary Team|multidisciplinary team
499136|NCT01025258|Clinical Outcomes|clinical outcomes
499137|NCT01025245|Remifentanil induced postoperative hyperalgesia|remifentanil induced postoperative hyperalgesia
499138|NCT01025232|Antibodies, Monoclonal|antibodies, monoclonal
499139|NCT01025232|Immunologic Factors|immunologic factors
499140|NCT01025232|Eye Diseases|eye diseases
499141|NCT01025232|Retinal Degeneration|retinal degeneration
499142|NCT01025232|Macular Degeneration|macular degeneration
499143|NCT01025232|Pharmacologic Actions|pharmacologic actions
499144|NCT01025232|Retinal Diseases|retinal diseases
499145|NCT01025219|Diagnosis of dependence on cocaine according to DSM-IV-TR criteria|diagnosis of dependence on cocaine according to dsm-iv-tr criteria
499146|NCT01025206|Multiple Myeloma|multiple myeloma
499147|NCT01025206|monoclonal antibody|monoclonal antibody
499148|NCT01025206|safety|safety
499149|NCT01025206|pharmacokinetic|pharmacokinetic
499150|NCT01025193|belimumab|belimumab
499151|NCT01025193|Benlysta|benlysta
499152|NCT01025193|LymphoStat B|lymphostat b
499153|NCT01025193|BLyS specific inhibitors|blys specific inhibitors
499154|NCT01025180|safety|safety
499155|NCT01025180|Procalcitonin|procalcitonin
499156|NCT01025180|PCT|pct
499157|NCT01025180|SOFA|sofa
499158|NCT01025180|Sepsis|sepsis
499159|NCT01025180|Antibiotic|antibiotic
499160|NCT01025180|Strategy|strategy
499161|NCT01025180|SIRS|sirs
499162|NCT01025180|severe sepsis without obvious infection|severe sepsis without obvious infection
499163|NCT01025167|cancer|cancer
499164|NCT01025167|enteral nutrition|enteral nutrition
499165|NCT01025167|omega-3-fatty acids|omega-3-fatty acids
499166|NCT01025154|Leukemia|leukemia
499167|NCT01025154|AML|aml
499168|NCT01025154|chemotherapy-naïve|chemotherapy-naïve
499169|NCT01025154|Clofarabine|clofarabine
499170|NCT01025154|Clofarex|clofarex
499171|NCT01025154|Clolar|clolar
499172|NCT01025154|Idarubicin|idarubicin
499173|NCT01025154|Idamycin|idamycin
499174|NCT01025154|Cytarabine|cytarabine
499175|NCT01025154|Ara-C|ara-c
499176|NCT01025154|Cytosar|cytosar
499177|NCT01025154|DepoCyt|depocyt
499178|NCT01025154|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
499179|NCT01025141|MINISCREW|miniscrew
499180|NCT01025141|space extraction closure|space extraction closure
499181|NCT01025141|anchorage|anchorage
499182|NCT01025141|Orthodontic Treatment|orthodontic treatment
499183|NCT01025141|Extraction of 2 Maxillary Premolar|extraction of 2 maxillary premolar
499184|NCT01025141|closing of extraction space|closing of extraction space
499185|NCT01025141|patient aged from 12 to 50 years old|patient aged from 12 to 50 years old
499186|NCT01025115|Dietary supplement|dietary supplement
499188|NCT01025115|Metabolic Syndrome|metabolic syndrome
499189|NCT01025089|Cetuximab|cetuximab
499190|NCT01025089|Cisplatin|cisplatin
499191|NCT01025089|Cyclophosphamide|cyclophosphamide
499192|NCT01025089|09-038|09-038
499193|NCT01025076|Enlarged gastric pouch and stoma|enlarged gastric pouch and stoma
499194|NCT01025076|Post bariatric surgery|post bariatric surgery
499195|NCT01025063|Spectral OCT|spectral oct
499196|NCT01025063|Choroidal Neovascularization|choroidal neovascularization
499197|NCT01025063|Lucentis|lucentis
499198|NCT01025063|Visudyne|visudyne
499199|NCT01025063|PDT|pdt
499200|NCT01025063|anti-VEGF|anti-vegf
499201|NCT01025050|Presbyopia|presbyopia
499202|NCT01025050|Intrastromal|intrastromal
499203|NCT01025050|Femtosecond Laser|femtosecond laser
499204|NCT01025050|minimal-invasive|minimal-invasive
499205|NCT01025050|INTRACOR|intracor
499206|NCT01025050|Enhance Near Visual Acuity|enhance near visual acuity
499207|NCT01025037|Rotator Cuff Tear, Large, Massive, Rotator, Cuff. Tear|rotator cuff tear, large, massive, rotator, cuff. tear
499208|NCT01025024|SNP|snp
499209|NCT01025024|single-nucleotide polymorphism|single-nucleotide polymorphism
499210|NCT01025024|glaucoma|glaucoma
499211|NCT01025024|primary open angle glaucoma|primary open angle glaucoma
499212|NCT01025011|retinal hemoglobin concentration|retinal hemoglobin concentration
499213|NCT01025011|non-invasive hemoglobin measurement|non-invasive hemoglobin measurement
499214|NCT01024998|Age-Related Macular Degeneration|age-related macular degeneration
499215|NCT01024998|AMD|amd
499216|NCT01024998|Wet AMD|wet amd
499217|NCT01024998|Neovascular AMD|neovascular amd
499218|NCT01024998|Ocular|ocular
499219|NCT01024998|Ocular gene therapy|ocular gene therapy
499220|NCT01024998|Subretinal neovascularization|subretinal neovascularization
499221|NCT01024985|optic neuritis|optic neuritis
499222|NCT01024985|longitudinally extensive transverse myelitis|longitudinally extensive transverse myelitis
499223|NCT01024985|retinal nerve fiber layer|retinal nerve fiber layer
499224|NCT01024985|macular thickness|macular thickness
499225|NCT01024959|Prostate Cancer|prostate cancer
499226|NCT01024959|Prostate Biopsy|prostate biopsy
499227|NCT01024959|PCA3|pca3
499228|NCT01024946|mesothelioma|mesothelioma
499229|NCT01024946|pleural|pleural
499230|NCT01024946|RAD001|rad001
499231|NCT01024946|Everolimus|everolimus
499232|NCT01024946|09-142|09-142
499233|NCT01024946|thoracic|thoracic
499234|NCT01024946|lung|lung
499235|NCT01024946|epithelioid|epithelioid
499236|NCT01024946|sarcomatoid|sarcomatoid
499237|NCT01024933|Hypertension|hypertension
499238|NCT01024933|High Blood Pressure|high blood pressure
499239|NCT01024894|interleukin-7|interleukin-7
499240|NCT01024894|immune-based therapies|immune-based therapies
499241|NCT01024894|hepatitis C|hepatitis c
499242|NCT01024894|chronic hepatitis|chronic hepatitis
499243|NCT01024894|resistance to Peg-interferon and ribavirin bitherapy|resistance to peg-interferon and ribavirin bitherapy
499244|NCT01024894|immune specific responses to HCV|immune specific responses to hcv
499245|NCT01024894|taiwan|taiwan
499246|NCT01024894|phase 1/2a|phase 1/2a
499247|NCT01024894|viral disease|viral disease
499248|NCT01024894|liver disease|liver disease
499249|NCT01024881|catheterization success rate|catheterization success rate
499250|NCT01024868|Transversus Abdominis Plane Block|transversus abdominis plane block
499251|NCT01024829|Non small cell lung cancer|non small cell lung cancer
499252|NCT01024829|Inoperable|inoperable
499254|NCT01024816|Metabolic Syndrome|metabolic syndrome
499255|NCT01024816|Restorative Yoga|restorative yoga
499256|NCT01024816|Stretching|stretching
499257|NCT01024816|Visceral adiposity|visceral adiposity
499258|NCT01024816|Randomized controlled trial|randomized controlled trial
499259|NCT01024803|Retina implant, Subretinal|retina implant, subretinal
499260|NCT01024803|Legal blindness|legal blindness
499261|NCT01024803|Genetic Diseases, Inborn|genetic diseases, inborn
499262|NCT01024803|Eye Diseases|eye diseases
499263|NCT01024803|Retinitis Pigmentosa|retinitis pigmentosa
499264|NCT01024803|Retinitis|retinitis
499265|NCT01024803|Retinal Degeneration|retinal degeneration
499266|NCT01024803|Eye Diseases, Hereditary|eye diseases, hereditary
499267|NCT01024803|Retinal Diseases|retinal diseases
499268|NCT01024777|cholecalciferol|cholecalciferol
499269|NCT01024777|multiple sclerosis|multiple sclerosis
499270|NCT01024777|vitamin D|vitamin d
499271|NCT01024777|D3|d3
499272|NCT01024764|HIV|hiv
499273|NCT01024764|Tat protein|tat protein
499274|NCT01024764|Preventive vaccine|preventive vaccine
499275|NCT01024725|A(H1N1)v influenza|a(h1n1)v influenza
499276|NCT01024725|vaccination|vaccination
499277|NCT01024725|pandemic|pandemic
499278|NCT01024712|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
499279|NCT01024712|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
499280|NCT01024712|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
499281|NCT01024712|adenocarcinoma of the lung|adenocarcinoma of the lung
499282|NCT01024712|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
499283|NCT01024712|large cell lung cancer|large cell lung cancer
499284|NCT01024673|H1N1|h1n1
499380|NCT01024166|Patient-Reported Outcomes Computer System|patient-reported outcomes computer system
499285|NCT01024660|Patients with Mild to Moderate Alzheimer's Disease|patients with mild to moderate alzheimer's disease
499286|NCT01024634|Arterial stiffness|arterial stiffness
499287|NCT01024634|Endothelial function|endothelial function
499288|NCT01024634|Autonomic function|autonomic function
499289|NCT01024634|Inflammation|inflammation
499290|NCT01024621|gastric intestinal metaplasia|gastric intestinal metaplasia
499291|NCT01024621|Confocal laser endomicroscopy|confocal laser endomicroscopy
499292|NCT01024595|HIV|hiv
499293|NCT01024595|Tat protein|tat protein
499294|NCT01024582|breast cancer|breast cancer
499295|NCT01024582|invasive breast cancer|invasive breast cancer
499296|NCT01024582|adenocarcinoma of the breast|adenocarcinoma of the breast
499297|NCT01024569|Severe Mental Illness|severe mental illness
499298|NCT01024569|Recovery|recovery
499299|NCT01024569|Psychiatric Disability|psychiatric disability
499300|NCT01024569|Wellness|wellness
499301|NCT01024569|Peer Service|peer service
499302|NCT01024569|WRAP|wrap
499303|NCT01024556|HIV, HAART|hiv, haart
499304|NCT01024543|Angiotensin II|angiotensin ii
499305|NCT01024530|hepatocellular carcinoma|hepatocellular carcinoma
499306|NCT01024530|HCC|hcc
499307|NCT01024530|NK|nk
499308|NCT01024530|immune killer cells|immune killer cells
499309|NCT01024517|Safety|safety
499310|NCT01024517|Tolerability|tolerability
499311|NCT01024517|Pharmacokinetics|pharmacokinetics
499312|NCT01024504|Cancer|cancer
499313|NCT01024504|Colorectal cancer|colorectal cancer
499314|NCT01024504|Elderly|elderly
499315|NCT01024504|Chemotherapy|chemotherapy
499316|NCT01024504|Capecitabine|capecitabine
499317|NCT01024504|Oxaliplatin|oxaliplatin
499318|NCT01024504|Bevacizumab|bevacizumab
499319|NCT01024491|premature ejaculation|premature ejaculation
499320|NCT01024491|paroxetine|paroxetine
499321|NCT01024491|daily treatment|daily treatment
499322|NCT01024478|Coronary Artery|coronary artery
499323|NCT01024478|Magnetic Resonance Angiography|magnetic resonance angiography
499324|NCT01024478|Coronary Artery disease|coronary artery disease
499325|NCT01024478|Multicenter Trial|multicenter trial
499326|NCT01024478|Cardiac MRI|cardiac mri
499327|NCT01024465|obesity|obesity
499328|NCT01024465|intragastric balloon|intragastric balloon
499329|NCT01024452|anticoagulation|anticoagulation
499330|NCT01024452|warfarin|warfarin
499331|NCT01024452|computer systems|computer systems
499332|NCT01024452|international normalized ratio|international normalized ratio
499333|NCT01024452|nomograms|nomograms
499334|NCT01024426|Uganda|uganda
499335|NCT01024426|malaria|malaria
499336|NCT01024426|enhanced health facility-based care|enhanced health facility-based care
499337|NCT01024426|febrile illnesses|febrile illnesses
499338|NCT01024426|health services|health services
499339|NCT01024413|Thoracic Neoplasms|thoracic neoplasms
499340|NCT01024413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
499341|NCT01024413|Protein Kinase Inhibitors|protein kinase inhibitors
499342|NCT01024413|Respiratory Tract Diseases|respiratory tract diseases
499343|NCT01024413|Lung Neoplasms|lung neoplasms
499344|NCT01024413|Erlotinib|erlotinib
499345|NCT01024413|Gefitinib|gefitinib
499346|NCT01024413|Epidermal growth factor receptor genes|epidermal growth factor receptor genes
499347|NCT01024400|Influenza|influenza
499348|NCT01024400|Vaccine|vaccine
499349|NCT01024400|Pregnancy|pregnancy
499350|NCT01024387|AMG 479|amg 479
499351|NCT01024361|Preterm infants|preterm infants
499352|NCT01024361|Nasal CPAP|nasal cpap
499353|NCT01024361|Delivery room|delivery room
499354|NCT01024361|Newborn|newborn
499355|NCT01024348|Surgery, knee arthroscopy|surgery, knee arthroscopy
499356|NCT01024348|Pain, postoperative|pain, postoperative
499357|NCT01024348|tramadol, extended release|tramadol, extended release
499358|NCT01024335|opioid dependence|opioid dependence
499359|NCT01024335|naltrexone|naltrexone
499360|NCT01024335|vivitrol|vivitrol
499361|NCT01024335|dronabinol|dronabinol
499362|NCT01024335|marinol|marinol
499363|NCT01024322|Diagnosis of keratoconus, post-LASIK ectasia, FFKC, or pellucid marginal degeneration|diagnosis of keratoconus, post-lasik ectasia, ffkc, or pellucid marginal degeneration
499364|NCT01024309|total hip arthroplasty|total hip arthroplasty
499365|NCT01024283|Heat Shock Protein 90 Inhibitor (HSP90)|heat shock protein 90 inhibitor (hsp90)
499366|NCT01024283|Pharmacodynamic|pharmacodynamic
499367|NCT01024283|Blood|blood
499368|NCT01024283|Biopsy|biopsy
499369|NCT01024283|Solid malignancies|solid malignancies
499370|NCT01024270|endometrial pathology of uterus|endometrial pathology of uterus
499371|NCT01024270|operative hysteroscopy|operative hysteroscopy
499372|NCT01024270|efficacy of misoprostol per different routes|efficacy of misoprostol per different routes
499373|NCT01024257|beta-irradiation;conjunctival autograft;pterygium;recurrence; clinical trial|beta-irradiation;conjunctival autograft;pterygium;recurrence; clinical trial
499374|NCT01024205|clear cell renal cell carcinoma|clear cell renal cell carcinoma
499375|NCT01024205|stage IV renal cell cancer|stage iv renal cell cancer
499376|NCT01024179|Optical Coherence Tomography|optical coherence tomography
499377|NCT01024179|Coronary artery disease|coronary artery disease
499378|NCT01024179|Chronic total occlusion|chronic total occlusion
499379|NCT01024166|Cancer|cancer
499381|NCT01024166|PRO|pro
499382|NCT01024166|Palliative Care|palliative care
499383|NCT01024166|Symptoms|symptoms
499384|NCT01024166|Questionnaire|questionnaire
499385|NCT01024166|Patients|patients
499386|NCT01024166|Caregivers|caregivers
499387|NCT01024166|Palliative Care Physicians|palliative care physicians
499388|NCT01024166|Palliative Care Nurses|palliative care nurses
499389|NCT01024153|active video games|active video games
499390|NCT01024153|children|children
499391|NCT01024153|physical activity|physical activity
499392|NCT01024140|Posttraumatic Stress Disorder|posttraumatic stress disorder
499393|NCT01024140|Escitalopram|escitalopram
499394|NCT01024140|Efficacy|efficacy
499395|NCT01024114|MBI|mbi
499396|NCT01024114|Molecular Breast Imaging|molecular breast imaging
499397|NCT01024114|Breast Cancer|breast cancer
499398|NCT01024114|Positive Molecular Breast Imaging scan.|positive molecular breast imaging scan.
499399|NCT01024088|Guillain Barré syndrome|guillain barré syndrome
499400|NCT01024088|Swallowing disorders|swallowing disorders
499401|NCT01024088|Respiratory failure|respiratory failure
499402|NCT01024075|Chronic Rhinosinusitis|chronic rhinosinusitis
499403|NCT01024075|Endoscopic sinus surgery|endoscopic sinus surgery
499404|NCT01024075|Sinufoam|sinufoam
499405|NCT01024075|Dexamethasone|dexamethasone
499406|NCT01024075|For patients with Chronic Rhinosinusitis without nasal polyps|for patients with chronic rhinosinusitis without nasal polyps
499407|NCT01024075|Focus: Define the postoperative sinonasal mucosal healing status of 2 Sinufoam mixtures|focus: define the postoperative sinonasal mucosal healing status of 2 sinufoam mixtures
499408|NCT01024049|heart failure blood left ventricular dysfunction|heart failure blood left ventricular dysfunction
499409|NCT01024036|Multicentric Castleman's Disease|multicentric castleman's disease
499410|NCT01024036|MCD|mcd
499411|NCT01024036|CNTO 328|cnto 328
499412|NCT01024036|Best Supportive Care|best supportive care
499413|NCT01024036|Tumor|tumor
499414|NCT01024036|Symptomatic response|symptomatic response
499415|NCT01024036|Pharmacokinetics|pharmacokinetics
499416|NCT01024036|Interleukin-6|interleukin-6
499417|NCT01024036|IL6|il6
499418|NCT01024023|Early Walking Aid|early walking aid
499419|NCT01024023|Amputee|amputee
499420|NCT01024023|Trans-tibial|trans-tibial
499421|NCT01024023|Quality of life|quality of life
499422|NCT01023997|corneal thickness|corneal thickness
499423|NCT01023997|exfoliation|exfoliation
499424|NCT01023984|RECTAL NEOPLASMS|rectal neoplasms
499425|NCT01023945|ASP1941|asp1941
499426|NCT01023945|Diabetes mellitus|diabetes mellitus
499427|NCT01023945|Blood glucose|blood glucose
499428|NCT01023919|Optical coherence tomography|optical coherence tomography
499429|NCT01023919|Drug eluting stent|drug eluting stent
499430|NCT01023919|Coronary Artery Disease|coronary artery disease
499431|NCT01023919|Diabetes Mellitus|diabetes mellitus
499432|NCT01023906|Taste|taste
499433|NCT01023906|general Labeled Magnitude Scale|general labeled magnitude scale
499434|NCT01023906|Aging|aging
499435|NCT01023906|Chronic Disease Risk|chronic disease risk
499436|NCT01023906|Smell|smell
499437|NCT01023867|Alzheimer's disease|alzheimer's disease
499438|NCT01023867|Mixed Dementia|mixed dementia
499439|NCT01023867|Donepezil|donepezil
499440|NCT01023867|Efficacy|efficacy
499441|NCT01023867|Adverse Event|adverse event
499442|NCT01023854|Paravertebral block|paravertebral block
499443|NCT01023854|loco regional anesthesia|loco regional anesthesia
499444|NCT01023854|renal surgery|renal surgery
499445|NCT01023854|PCA morphine|pca morphine
499446|NCT01023828|K-RAS ONCOGENE MUTATION|k-ras oncogene mutation
499447|NCT01023828|NON-SMALL CELL LUNG CANCER|non-small cell lung cancer
499448|NCT01023828|WOOD SMOKE|wood smoke
499449|NCT01023815|Immunosuppression|immunosuppression
499450|NCT01023815|renal transplantation|renal transplantation
499451|NCT01023815|once-a-day regimen|once-a-day regimen
499452|NCT01023815|steroid withdrawal|steroid withdrawal
499453|NCT01023815|drug minimization|drug minimization
499454|NCT01023815|immunosuppression for prevention of acute rejections|immunosuppression for prevention of acute rejections
499455|NCT01023802|neoadjuvant therapy|neoadjuvant therapy
499456|NCT01023802|chemotherapy|chemotherapy
499457|NCT01023802|hormone therapy|hormone therapy
499458|NCT01023802|breast cancer|breast cancer
499459|NCT01023802|MBI|mbi
499460|NCT01023802|Molecular Breast Imaging|molecular breast imaging
499461|NCT01023789|Drug eluting stent|drug eluting stent
499462|NCT01023789|Stents|stents
499463|NCT01023789|Angioplasty|angioplasty
499464|NCT01023789|Bioabsorbable|bioabsorbable
499465|NCT01023789|Bioresorbable|bioresorbable
499466|NCT01023789|Scaffold|scaffold
499467|NCT01023776|Swine Flu|swine flu
499468|NCT01023776|H1N1|h1n1
499469|NCT01023763|Nursing homes|nursing homes
499470|NCT01023763|Intravenous|intravenous
499471|NCT01023763|Treatment|treatment
499472|NCT01023763|Patient trajectory|patient trajectory
499473|NCT01023763|Hospital admissions|hospital admissions
499474|NCT01023750|hypertriglyceridemia|hypertriglyceridemia
499475|NCT01023750|Triglycerides|triglycerides
499476|NCT01023750|HDL|hdl
499477|NCT01023750|Insulin resistance|insulin resistance
499478|NCT01023737|Malignant Solid Tumor|malignant solid tumor
499479|NCT01023737|Solid Tumor|solid tumor
499480|NCT01023737|Hydroxychloroquine|hydroxychloroquine
499481|NCT01023737|Vorinostat|vorinostat
499482|NCT01023711|Influenza|influenza
499483|NCT01023698|Diabetic retinopathy|diabetic retinopathy
499484|NCT01023698|Diabetic macular edema|diabetic macular edema
499485|NCT01023698|Panretinal photocoagulation|panretinal photocoagulation
499486|NCT01023685|Active immunization|active immunization
499487|NCT01023685|Alzheimer disease|alzheimer disease
499488|NCT01023685|Antibody|antibody
499489|NCT01023685|Central Nervous System diseases|central nervous system diseases
499490|NCT01023685|Neurodegenerative diseases|neurodegenerative diseases
499491|NCT01023685|Vaccine|vaccine
499492|NCT01023672|Dementia with Lewy Bodies|dementia with lewy bodies
499493|NCT01023672|hypersomnolence|hypersomnolence
499494|NCT01023672|cognition|cognition
499495|NCT01023672|neuropsychiatric morbidity|neuropsychiatric morbidity
499496|NCT01023672|quality of life|quality of life
499497|NCT01023659|Smoking cessation|smoking cessation
499498|NCT01023659|Bupropion|bupropion
499499|NCT01023659|Varenicline|varenicline
499500|NCT01023659|Population-level|population-level
499501|NCT01023659|Mass distribution|mass distribution
499502|NCT01023659|Drug Therapy|drug therapy
499503|NCT01023646|Glycemic Index|glycemic index
499504|NCT01023646|Glycemic Load|glycemic load
499505|NCT01023646|Glucose|glucose
499506|NCT01023646|Insulin|insulin
499507|NCT01023646|Lipoproteins|lipoproteins
499508|NCT01023646|Free fatty acids|free fatty acids
499509|NCT01023633|to investigate the efficacy and feasibility of this novel treatment strategy in Chinese mCRC patients|to investigate the efficacy and feasibility of this novel treatment strategy in chinese mcrc patients
499510|NCT01023633|Primary Endpoint:DDC|primary endpoint:ddc
499511|NCT01023633|Secondary Endpoint:OS, RR,DCR, PFS,safety|secondary endpoint:os, rr,dcr, pfs,safety
499512|NCT01023620|HIV|hiv
499513|NCT01023620|Lipodystrophy|lipodystrophy
499514|NCT01023620|Lipoatrophy|lipoatrophy
499515|NCT01023620|Lipohypertrophy|lipohypertrophy
499516|NCT01023620|Human Immunodeficiency Virus|human immunodeficiency virus
499517|NCT01023607|optical coherence tomography|optical coherence tomography
499518|NCT01023607|intravascular ultrasound|intravascular ultrasound
499519|NCT01023607|Coronary artery disease|coronary artery disease
499520|NCT01023607|Hyperlipidemia|hyperlipidemia
499521|NCT01023594|Pancreatic fistula|pancreatic fistula
499522|NCT01023594|Pancreatic leakage|pancreatic leakage
499523|NCT01023594|Pancreatoduodenectomy|pancreatoduodenectomy
499524|NCT01023594|Pancreatic stent|pancreatic stent
499525|NCT01023581|Type 2 Diabetes mellitus|type 2 diabetes mellitus
499526|NCT01023581|Non-insulin dependent diabetes mellitus|non-insulin dependent diabetes mellitus
499527|NCT01023581|Drug Therapy|drug therapy
499528|NCT01023581|Hypoglycemia,|hypoglycemia,
499529|NCT01023581|Hyperglycemia|hyperglycemia
499530|NCT01023568|intubation|intubation
499531|NCT01023568|pediatric|pediatric
499532|NCT01023568|videolaryngoscope devices|videolaryngoscope devices
499533|NCT01023555|Bacteremia|bacteremia
499534|NCT01023555|Blood Cultures|blood cultures
499535|NCT01023555|Sepsis|sepsis
499536|NCT01023542|renal impairment|renal impairment
499537|NCT01023542|MELD>25|meld>25
499538|NCT01023542|Liver transplantation|liver transplantation
499539|NCT01023542|CNI-free|cni-free
499540|NCT01023542|Bottom-Up|bottom-up
499541|NCT01023542|Everolimus|everolimus
499542|NCT01023529|Prostatic Neoplasms|prostatic neoplasms
499543|NCT01023529|Rectal Neoplasms|rectal neoplasms
499544|NCT01023529|Palliative treatment|palliative treatment
499545|NCT01023529|Radiotherapy|radiotherapy
499546|NCT01023529|Quality of life|quality of life
499547|NCT01023516|Chronic|chronic
499548|NCT01023516|obstructive|obstructive
499549|NCT01023516|pulmonary|pulmonary
499550|NCT01023516|lung|lung
499551|NCT01023516|respiratory disease|respiratory disease
499552|NCT01023516|efficacy|efficacy
499553|NCT01023516|placebo-controlled|placebo-controlled
499554|NCT01023516|COPD|copd
499555|NCT01023516|FEV1|fev1
499556|NCT01023516|St Georges Respiratory Questionnaire|st georges respiratory questionnaire
499557|NCT01023503|Statins|statins
499558|NCT01023503|Dyslipidemia|dyslipidemia
499559|NCT01023503|Spain|spain
499560|NCT01023503|Rosuvastatin|rosuvastatin
499561|NCT01023503|Naive|naive
499562|NCT01023503|Switching|switching
499563|NCT01023503|New statins prescriptions in Spain (naive patients and switching)|new statins prescriptions in spain (naive patients and switching)
499564|NCT01023490|back pain|back pain
499565|NCT01023490|hypovitaminosis D|hypovitaminosis d
499566|NCT01023477|Carcinoma, Intraductal, Noninfiltrating|carcinoma, intraductal, noninfiltrating
499567|NCT01023477|Ductal Carcinoma In Situ|ductal carcinoma in situ
499568|NCT01023477|DCIS|dcis
499569|NCT01023477|Carcinoma, Intraductal|carcinoma, intraductal
499570|NCT01023477|Breast Cancer|breast cancer
499571|NCT01023477|Breast Tumors|breast tumors
499572|NCT01023477|chloroquine|chloroquine
499573|NCT01023477|autophagy|autophagy
499574|NCT01023477|Autophagic Cell Death|autophagic cell death
499575|NCT01023477|Autophagocytosis|autophagocytosis
499576|NCT01023477|Programmed Cell Death, Type II|programmed cell death, type ii
499577|NCT01023477|Autophagy, Cellular|autophagy, cellular
499578|NCT01023477|Autophagic Programmed Cell Death|autophagic programmed cell death
499579|NCT01023464|tear film break-up time|tear film break-up time
499580|NCT01023451|Pulmonary hypertension|pulmonary hypertension
499581|NCT01023451|Sickle cell disease|sickle cell disease
499582|NCT01023451|Pediatric patients|pediatric patients
499583|NCT01023451|Brain Natriuretic Peptide levels|brain natriuretic peptide levels
499584|NCT01023425|naive group|naive group
499585|NCT01023425|switching group|switching group
499586|NCT01023425|treatment response|treatment response
499587|NCT01023425|Efficacy|efficacy
499588|NCT01023425|Adverse event|adverse event
499589|NCT01023412|Immunonutrition|immunonutrition
499590|NCT01023412|cancer|cancer
499591|NCT01023412|GI cancer surgery|gi cancer surgery
499592|NCT01023386|YM155|ym155
499593|NCT01023386|Mass-balance|mass-balance
499594|NCT01023386|Phase I|phase i
499595|NCT01023386|Pharmacokinetics|pharmacokinetics
499596|NCT01023373|Angioplasty|angioplasty
499597|NCT01023373|Atherosclerotic reno vascular disease (ARVD)|atherosclerotic reno vascular disease (arvd)
499598|NCT01023373|Cardio- and cerebro- vascular comorbidity|cardio- and cerebro- vascular comorbidity
499599|NCT01023373|End stage renal disease (ERSD)|end stage renal disease (ersd)
499600|NCT01023373|kidney diseases|kidney diseases
499601|NCT01023373|High blood pressure|high blood pressure
499602|NCT01023373|Hypertension|hypertension
499603|NCT01023373|Ischemic nephropathy|ischemic nephropathy
499604|NCT01023373|Percutaneous transluminal renal artery stenting (PTRS)|percutaneous transluminal renal artery stenting (ptrs)
499605|NCT01023373|Randomized controlled trials|randomized controlled trials
499606|NCT01023373|Renal artery stenosis (RAS)|renal artery stenosis (ras)
499607|NCT01023373|Renal insufficiency|renal insufficiency
499608|NCT01023373|Vascular diseases|vascular diseases
499609|NCT01023347|NSCLC|nsclc
499610|NCT01023334|Topical analgesia|topical analgesia
499611|NCT01023334|FlACC Pain Scale|flacc pain scale
499612|NCT01023334|intracameral lignocaine|intracameral lignocaine
499613|NCT01023334|Anesthetics|anesthetics
499614|NCT01023334|Physiological Effects of Drugs|physiological effects of drugs
499615|NCT01023334|Lidocaine|lidocaine
499616|NCT01023321|Safety|safety
499617|NCT01023321|Tolerability|tolerability
499618|NCT01023321|Pharmacokinetics|pharmacokinetics
499619|NCT01023308|Myeloma|myeloma
499620|NCT01023308|DACi|daci
499621|NCT01023308|Bortezomib|bortezomib
499622|NCT01023308|Combination|combination
499623|NCT01023308|Panobinostat|panobinostat
499624|NCT01023308|LBH589D|lbh589d
499625|NCT01023308|relapsed|relapsed
499626|NCT01023308|Velcade®|velcade®
499627|NCT01023295|Polypoidal Choroidal Vasculopathy|polypoidal choroidal vasculopathy
499628|NCT01023295|PCV|pcv
499629|NCT01023295|Polypoid|polypoid
499630|NCT01023295|oxigene|oxigene
499631|NCT01023295|VDA|vda
499632|NCT01023295|vascular disrupting agent|vascular disrupting agent
499633|NCT01023295|combretastatin|combretastatin
499634|NCT01023295|fosbretabulin|fosbretabulin
499635|NCT01023282|Parkinson's disease|parkinson's disease
499636|NCT01023282|Levodopa|levodopa
499637|NCT01023282|Dyskinesia|dyskinesia
499638|NCT01023282|ACR325|acr325
499639|NCT01023269|Neurogenic overactive bladder|neurogenic overactive bladder
499640|NCT01023269|Urinary incontinence due to incomplete spinal cord injury|urinary incontinence due to incomplete spinal cord injury
499641|NCT01023269|Neuromodulation|neuromodulation
499642|NCT01023269|Neuromodulation for treatment of neurogenic overactive bladder|neuromodulation for treatment of neurogenic overactive bladder
499643|NCT01023269|Patients with Urge urinary incontinence and detrusor overactivity|patients with urge urinary incontinence and detrusor overactivity
499644|NCT01023256|Rheumatoid arthritis|rheumatoid arthritis
499645|NCT01023256|GM-CSF|gm-csf
499646|NCT01023256|MOR103|mor103
499647|NCT01023243|foot exam|foot exam
499648|NCT01023243|health services|health services
499649|NCT01023243|practice improvement|practice improvement
499650|NCT01023243|quality|quality
499651|NCT01023243|preventive services|preventive services
499652|NCT01023243|Natural Language Processing|natural language processing
499653|NCT01023230|DV-601|dv-601
499654|NCT01023230|hepatitis B|hepatitis b
499655|NCT01023230|entecavir|entecavir
499656|NCT01023230|therapeutic vaccine|therapeutic vaccine
499657|NCT01023217|Chronic hepatitis B|chronic hepatitis b
499658|NCT01023217|lamivudine|lamivudine
499659|NCT01023217|adefovir|adefovir
499660|NCT01023217|entecavir|entecavir
499661|NCT01023191|Dialysis|dialysis
499662|NCT01023191|Peritoneal|peritoneal
499663|NCT01023191|Catheter|catheter
499664|NCT01023191|Surgery|surgery
499665|NCT01023165|Diabetes Mellitus|diabetes mellitus
499666|NCT01023165|Metabolic Integrity|metabolic integrity
499667|NCT01023165|Intravenous Bolus Insulin|intravenous bolus insulin
499668|NCT01023139|Adolescent|adolescent
499669|NCT01023139|Obesity|obesity
499670|NCT01023139|Pharmacotherapy|pharmacotherapy
499671|NCT01023139|Sibutramine|sibutramine
499672|NCT01023126|Obesity|obesity
499673|NCT01023126|Exercise|exercise
499674|NCT01023126|Psychotherapy|psychotherapy
499675|NCT01023113|Diabetic retinopathy|diabetic retinopathy
499676|NCT01023113|laser|laser
499677|NCT01023113|field loss|field loss
499678|NCT01023113|macular edema|macular edema
499679|NCT01023113|Visual field loss|visual field loss
499680|NCT01023100|taste study open label investigational drug oral therapy|taste study open label investigational drug oral therapy
499681|NCT01023074|MS|ms
499682|NCT01023074|CAP|cap
499683|NCT01023048|preimplantation diagnosis|preimplantation diagnosis
499684|NCT01023022|CareLink|carelink
499685|NCT01023022|Remote Monitoring|remote monitoring
499686|NCT01023022|Cardiac Pacemaker, Artificial|cardiac pacemaker, artificial
499687|NCT01023022|Implantable Cardioverter-Defibrillators|implantable cardioverter-defibrillators
499688|NCT01023009|Occlusion|occlusion
499689|NCT01023009|vitrectomy|vitrectomy
499690|NCT01023009|small gauge vitrectomy|small gauge vitrectomy
499691|NCT01023009|Postoperative occlusion|postoperative occlusion
499692|NCT01022996|Hodgkin's Lymphoma|hodgkin's lymphoma
499693|NCT01022996|Hodgkin Lymphoma|hodgkin lymphoma
499694|NCT01022996|Hodgkin's Disease|hodgkin's disease
499695|NCT01022996|Hodgkin Disease|hodgkin disease
499696|NCT01022996|Lymphoma|lymphoma
499697|NCT01022996|Lymphoproliferative Disorders|lymphoproliferative disorders
499698|NCT01022996|Neoplasms by Histological type|neoplasms by histological type
499699|NCT01022996|Lymphatic Diseases|lymphatic diseases
499700|NCT01022996|Hemic and Lymphatic Diseases|hemic and lymphatic diseases
499701|NCT01022996|Recurrent Lymphoma|recurrent lymphoma
499702|NCT01022996|Refractory Lymphoma|refractory lymphoma
499703|NCT01022996|Relapsed Lymphoma|relapsed lymphoma
499704|NCT01022996|Classical Hodgkin Lymphoma|classical hodgkin lymphoma
499705|NCT01022996|Classical Hodgkin's Disease|classical hodgkin's disease
499706|NCT01022996|Nodular sclerosing Hodgkin Lymphoma|nodular sclerosing hodgkin lymphoma
499707|NCT01022996|Mixed-cellularity Hodgkin Lymphoma|mixed-cellularity hodgkin lymphoma
499708|NCT01022996|Lymphocyte-rich Hodgkin Lymphoma|lymphocyte-rich hodgkin lymphoma
499709|NCT01022996|Lymphocyte depleted Hodgkin Lymphoma|lymphocyte depleted hodgkin lymphoma
499710|NCT01022970|Esophagitis|esophagitis
499711|NCT01022970|Digestive System Diseases|digestive system diseases
499712|NCT01022970|Esophageal disorder|esophageal disorder
499713|NCT01022970|Eosinophilic esophagitis|eosinophilic esophagitis
499714|NCT01022957|extra renal damages|extra renal damages
499715|NCT01022944|Serous otitis media|serous otitis media
499716|NCT01022944|Biofilm|biofilm
499717|NCT01022944|Adenoidectomy|adenoidectomy
499718|NCT01022944|Chronic otitis media|chronic otitis media
499719|NCT01022931|Influenza A H1N1|influenza a h1n1
499720|NCT01022931|Children|children
499721|NCT01022931|Epidemiology|epidemiology
499722|NCT01022931|Treatment|treatment
499723|NCT01022931|Oseltamivir|oseltamivir
499724|NCT01022931|Genetics|genetics
499725|NCT01022918|unresectable glioblastoma|unresectable glioblastoma
499726|NCT01022905|HIV infection|hiv infection
499727|NCT01022905|transplant|transplant
499728|NCT01022905|rheumatic disease|rheumatic disease
499729|NCT01022905|cancer|cancer
499730|NCT01022905|children|children
499731|NCT01022892|Endovascular|endovascular
499732|NCT01022892|Abdominal|abdominal
499733|NCT01022892|Aortic|aortic
499734|NCT01022892|Aneurysm|aneurysm
499735|NCT01022892|Repair|repair
499736|NCT01022892|Surveillance|surveillance
499737|NCT01022892|EVAR|evar
499738|NCT01022892|CT|ct
499739|NCT01022892|Scan|scan
499740|NCT01022892|Endoleaks|endoleaks
499741|NCT01022892|Contrast|contrast
499742|NCT01022892|Enhanced|enhanced
499743|NCT01022892|Ultrasound|ultrasound
499744|NCT01022892|Definity|definity
499745|NCT01022892|AAA|aaa
499746|NCT01022892|imaging|imaging
499747|NCT01022892|No Endoleaks|no endoleaks
499748|NCT01022879|Pain scale of pain|pain scale of pain
499749|NCT01022866|falls|falls
499750|NCT01022866|older adults|older adults
499751|NCT01022827|stiff shoulder|stiff shoulder
499752|NCT01022827|massage|massage
499753|NCT01022827|muscle stiffness|muscle stiffness
499754|NCT01022775|Degenerative rotator cuff disease|degenerative rotator cuff disease
499755|NCT01022775|Impingement syndrome|impingement syndrome
499756|NCT01022775|Dynamic humeral centering|dynamic humeral centering
499757|NCT01022775|Randomized clinical trial|randomized clinical trial
499758|NCT01022749|inflammatory bowel disease (IBD)|inflammatory bowel disease (ibd)
499759|NCT01022749|immunosuppressed or non-immunosuppressed|immunosuppressed or non-immunosuppressed
499760|NCT01022749|influenza vaccine|influenza vaccine
499761|NCT01022749|antibody titers|antibody titers
499762|NCT01022749|seroprotective titers|seroprotective titers
499763|NCT01022749|vaccine-associated adverse events|vaccine-associated adverse events
499764|NCT01022736|gabapentin|gabapentin
499765|NCT01022736|pharmacokinetics|pharmacokinetics
499766|NCT01022736|visual analogue pain scale|visual analogue pain scale
499767|NCT01022736|cardiopulmonary bypass|cardiopulmonary bypass
499768|NCT01022723|Circulating tumor cells|circulating tumor cells
499769|NCT01022723|metastasis|metastasis
499770|NCT01022723|cancer|cancer
499771|NCT01022723|cell isolation|cell isolation
499772|NCT01022723|mircofludics|mircofludics
499773|NCT01022723|cell detection|cell detection
499774|NCT01022710|hearing loss|hearing loss
499775|NCT01022710|otoacoustic emissions|otoacoustic emissions
499776|NCT01022684|atherosclerosis|atherosclerosis
499777|NCT01022684|vascular inflammation|vascular inflammation
499778|NCT01022684|LpPLA2|lppla2
499779|NCT01022684|hsCRP|hscrp
499780|NCT01022684|MCP-1|mcp-1
499781|NCT01022684|18FDG-PET|18fdg-pet
499782|NCT01022671|Belotecan|belotecan
499783|NCT01022671|Camtobell inj|camtobell inj
499784|NCT01022671|NSCLC|nsclc
499785|NCT01022658|Insulin Therapy|insulin therapy
499786|NCT01022658|Vago-sympathetic activity|vago-sympathetic activity
499787|NCT01022658|arterial stiffness|arterial stiffness
499788|NCT01022658|endothelial function|endothelial function
499789|NCT01022645|Intrauterine device|intrauterine device
499790|NCT01022645|Gestational diabetes|gestational diabetes
499791|NCT01022645|Postpartum contraception|postpartum contraception
499792|NCT01022645|Postpartum birth control|postpartum birth control
499793|NCT01022632|Depression|depression
499794|NCT01022619|Sleep apnea|sleep apnea
499795|NCT01022619|high risk pregnancy|high risk pregnancy
499796|NCT01022619|fetal outcome|fetal outcome
499797|NCT01022619|cord blood|cord blood
499798|NCT01022580|nitric oxide|nitric oxide
499799|NCT01022580|surfactant|surfactant
499800|NCT01022580|bronchopulmonary dysplasia|bronchopulmonary dysplasia
499801|NCT01022580|BPD|bpd
499802|NCT01022580|prematurity|prematurity
499803|NCT01022580|neonates|neonates
499804|NCT01022580|iNO|ino
499805|NCT01022580|pulmonary outcome|pulmonary outcome
499806|NCT01022580|neurodevelopmental outcome|neurodevelopmental outcome
499807|NCT01022580|Infasurf|infasurf
499808|NCT01022580|lung function|lung function
499809|NCT01022580|Surfactant Dysfunction|surfactant dysfunction
499810|NCT01022528|Elective total abdominal hysterectomy (with or without salpingo-oophorectomy or minor bladder repair) or myomectomy|elective total abdominal hysterectomy (with or without salpingo-oophorectomy or minor bladder repair) or myomectomy
499811|NCT01022528|through a lower transverse or low midline incision under general anesthesia|through a lower transverse or low midline incision under general anesthesia
499812|NCT01022515|pheochromocytoma|pheochromocytoma
499813|NCT01022515|paraganglioma|paraganglioma
499814|NCT01022515|hypertension|hypertension
499815|NCT01022502|psoriasis, indigo naturalis|psoriasis, indigo naturalis
499816|NCT01022489|Schizophrenia, auditory hallucinations, TMS|schizophrenia, auditory hallucinations, tms
499817|NCT01022476|Pharmacokinetics|pharmacokinetics
499818|NCT01022476|Raltegravir|raltegravir
499819|NCT01022476|Immunosuppressive Agents|immunosuppressive agents
499820|NCT01022476|Severe hepatic insufficiency|severe hepatic insufficiency
499821|NCT01022476|Liver Transplantation|liver transplantation
499822|NCT01022476|Additional Keywords|additional keywords
499823|NCT01022476|HIV Infection|hiv infection
499824|NCT01022476|Hepatocarcinoma|hepatocarcinoma
499825|NCT01022476|Hepatitis C|hepatitis c
499826|NCT01022476|Hepatitis B|hepatitis b
499827|NCT01022450|rhabdomyolysis|rhabdomyolysis
499828|NCT01022450|myopathy|myopathy
499829|NCT01022450|acute renal failure|acute renal failure
499830|NCT01022450|neuroleptic malignant syndrome|neuroleptic malignant syndrome
499831|NCT01022450|Pharmaceutical Preparations|pharmaceutical preparations
499832|NCT01022450|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
499833|NCT01022450|fibrates|fibrates
499834|NCT01022450|creatine kinase|creatine kinase
499835|NCT01022424|ADPKD|adpkd
499836|NCT01022424|Tolvaptan|tolvaptan
499837|NCT01022424|OPC-41061|opc-41061
499838|NCT01022411|brown rice|brown rice
499839|NCT01022411|white rice|white rice
499840|NCT01022411|diabetes risk|diabetes risk
499841|NCT01022398|Vitamin D3|vitamin d3
499842|NCT01022398|HMG-CoA reductase inhibitors (statin)-related myalgias|hmg-coa reductase inhibitors (statin)-related myalgias
499843|NCT01022359|haemodialysis|haemodialysis
499844|NCT01022359|vascular access|vascular access
499845|NCT01022359|central venous catheter|central venous catheter
499846|NCT01022346|Cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
499847|NCT01022346|RO5217790|ro5217790
499848|NCT01022333|BRCA1|brca1
499849|NCT01022333|breast cancer|breast cancer
499850|NCT01022333|3,3'-di-indolylmethane|3,3'-di-indolylmethane
499851|NCT01022333|dietary intervention|dietary intervention
499852|NCT01022333|estrogen metabolites|estrogen metabolites
499853|NCT01022333|mRNA expression|mrna expression
499854|NCT01022333|BRCA1 protein|brca1 protein
499855|NCT01022333|Estrogen|estrogen
499856|NCT01022320|OSA|osa
499857|NCT01022320|Blood pressure|blood pressure
499858|NCT01022320|Lateral Pharyngoplasty|lateral pharyngoplasty
499859|NCT01022307|behavioral data acquisition|behavioral data acquisition
499860|NCT01022307|MRI|mri
499861|NCT01022294|children|children
499862|NCT01022294|analgesia|analgesia
499863|NCT01022294|dental treatment|dental treatment
499864|NCT01022294|inhalation|inhalation
499865|NCT01022281|Exfoliation|exfoliation
499866|NCT01022281|Scanning Laser Polarimetry|scanning laser polarimetry
499867|NCT01022281|Corneal Thickness|corneal thickness
499868|NCT01022255|autologous vaccine|autologous vaccine
499869|NCT01022255|follicular lymphoma|follicular lymphoma
499870|NCT01022255|magnICON|magnicon
499871|NCT01022255|plant-made vaccines|plant-made vaccines
499872|NCT01022255|immune response|immune response
500071|NCT01021423|Revlimid|revlimid
499873|NCT01022242|Surgical Adhesions|surgical adhesions
499874|NCT01022242|Post-surgical adhesions|post-surgical adhesions
499875|NCT01022242|Flexor tendon|flexor tendon
499876|NCT01022229|Attention Deficit Disorder|attention deficit disorder
499877|NCT01022229|Pediatrics|pediatrics
499878|NCT01022229|Attention|attention
499879|NCT01022229|Impulsivity|impulsivity
499880|NCT01022229|Complementary Therapies|complementary therapies
499881|NCT01022216|Wound|wound
499882|NCT01022216|Skin lesion|skin lesion
499883|NCT01022216|Antimicrobial|antimicrobial
499884|NCT01022216|Bioelectric|bioelectric
499885|NCT01022216|Diabetic foot|diabetic foot
499886|NCT01022216|Pressure Ulcer|pressure ulcer
499887|NCT01022203|Couples Therapy|couples therapy
499888|NCT01022203|PTSD|ptsd
499889|NCT01022190|Arthroplasty|arthroplasty
499890|NCT01022190|Hip|hip
499891|NCT01022190|Cemented|cemented
499892|NCT01022190|Heterotopic ossification|heterotopic ossification
499893|NCT01022190|Selective Cyclooxygenase-2 Inhibitors|selective cyclooxygenase-2 inhibitors
499894|NCT01022190|Arthroplasty, Replacement|arthroplasty, replacement
499895|NCT01022190|Hip Prosthesis|hip prosthesis
499896|NCT01022190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors
499897|NCT01022164|fibrin glue|fibrin glue
499898|NCT01022164|vitrectomy|vitrectomy
499899|NCT01022164|safety and efficacy of fibrin glue|safety and efficacy of fibrin glue
499900|NCT01022151|Aminophylline|aminophylline
499901|NCT01022151|sevoflurane|sevoflurane
499902|NCT01022151|anaesthesia|anaesthesia
499903|NCT01022151|recovery|recovery
499904|NCT01022151|cognitive function|cognitive function
499905|NCT01022151|entropy|entropy
499906|NCT01022138|HER2-negative breast cancer|her2-negative breast cancer
499907|NCT01022138|stage IV breast cancer|stage iv breast cancer
499908|NCT01022138|recurrent breast cancer|recurrent breast cancer
499909|NCT01022125|TMC435-TiDP16-C121|tmc435-tidp16-c121
499910|NCT01022125|TMC435-C121|tmc435-c121
499911|NCT01022125|TMC435|tmc435
499912|NCT01022125|TMC435350|tmc435350
499913|NCT01022125|Protease inhibitor|protease inhibitor
499914|NCT01022125|HCV|hcv
499915|NCT01022125|Hepatitis C|hepatitis c
499916|NCT01022112|TA-7284|ta-7284
499917|NCT01022112|JNJ-28431754|jnj-28431754
499918|NCT01022112|Canagliflozin|canagliflozin
499919|NCT01022112|Type 2 diabetes mellitus|type 2 diabetes mellitus
499920|NCT01022112|Sodium Glucose Co-transporter (SGLT2 inhibitor)|sodium glucose co-transporter (sglt2 inhibitor)
499921|NCT01022099|Total Knee Arthroplasty|total knee arthroplasty
499922|NCT01022099|Navigation|navigation
499923|NCT01022086|Breast Cancer|breast cancer
499924|NCT01022086|Cardiotoxicity|cardiotoxicity
499925|NCT01022086|Trastuzumab|trastuzumab
499926|NCT01022086|Cardiac MRI|cardiac mri
499927|NCT01022073|Deep Brain Stimulation|deep brain stimulation
499928|NCT01022073|Subthalamic Nucleus|subthalamic nucleus
499929|NCT01022073|Globus Pallidus|globus pallidus
499930|NCT01022073|Parkinson Disease|parkinson disease
499931|NCT01022060|Dietary supplement|dietary supplement
499932|NCT01022060|Renalof|renalof
499933|NCT01022060|Recurrent calcic urolithiasis|recurrent calcic urolithiasis
499934|NCT01022060|Renal calculi|renal calculi
499935|NCT01022034|Rectal prolapse|rectal prolapse
499936|NCT01022034|mesh|mesh
499937|NCT01022034|recurrence|recurrence
499938|NCT01022021|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
499939|NCT01022021|autologous stem cell transplant|autologous stem cell transplant
499940|NCT01022008|Exorbitism|exorbitism
499941|NCT01022008|Upper respiratory airways|upper respiratory airways
499942|NCT01022008|Osteodistraction|osteodistraction
499943|NCT01022008|Polysomnography|polysomnography
499944|NCT01021995|Safety of Echinacea in comparison to placebo|safety of echinacea in comparison to placebo
499945|NCT01021982|Pupillometer|pupillometer
499946|NCT01021982|Retinitis Pigmentosa|retinitis pigmentosa
499947|NCT01021982|Glaucoma|glaucoma
499948|NCT01021982|Objective perimetry|objective perimetry
499949|NCT01021956|Macular Degeneration|macular degeneration
499950|NCT01021956|Age Related Macular Degeneration|age related macular degeneration
499951|NCT01021956|Choroidal Neovascularization|choroidal neovascularization
499952|NCT01021956|AMD|amd
499953|NCT01021956|CNV|cnv
499954|NCT01021956|WST11|wst11
499955|NCT01021956|Stakel|stakel
499956|NCT01021956|Photodynamic therapy|photodynamic therapy
499957|NCT01021956|Vascular Targeted Photodynamic therapy|vascular targeted photodynamic therapy
499958|NCT01021956|VTP|vtp
499959|NCT01021943|calcineurin inhibitors|calcineurin inhibitors
499960|NCT01021943|fibrosis|fibrosis
499961|NCT01021943|spironolactone|spironolactone
499962|NCT01021943|Focus of the study is to assess if aldosterone blockade has an effect on interstitial fibrosis amongst kidney transplant recipients|focus of the study is to assess if aldosterone blockade has an effect on interstitial fibrosis amongst kidney transplant recipients
499963|NCT01021930|Optical coherence tomography|optical coherence tomography
499964|NCT01021930|Drug eluting stent|drug eluting stent
499965|NCT01021930|Coronary heart disease|coronary heart disease
499966|NCT01021930|Diabetes mellitus|diabetes mellitus
499967|NCT01021917|Obesity|obesity
499968|NCT01021917|Weight Loss|weight loss
499969|NCT01021917|Meal Replacements|meal replacements
499970|NCT01021904|Primary prevention|primary prevention
499971|NCT01021904|HPV Vaccination|hpv vaccination
499972|NCT01021904|HPV Infection|hpv infection
499973|NCT01021904|Cervical Cancer|cervical cancer
499974|NCT01021904|HPV Related Diseases|hpv related diseases
499975|NCT01021891|Technosphere® Insulin Inhalation Powder|technosphere® insulin inhalation powder
499976|NCT01021878|Peritoneal dialysis|peritoneal dialysis
499977|NCT01021878|Renal replacement therapy|renal replacement therapy
499978|NCT01021878|Dialysis solutions|dialysis solutions
499979|NCT01021878|Icodextrin|icodextrin
499980|NCT01021865|GLP-1|glp-1
499981|NCT01021865|Myocardial contrast echocardiography|myocardial contrast echocardiography
499982|NCT01021865|Myocardial perfusion|myocardial perfusion
499983|NCT01021839|renal dialysis|renal dialysis
499984|NCT01021839|bioprosthesis|bioprosthesis
499985|NCT01021839|arteriovenous shunt|arteriovenous shunt
499986|NCT01021839|surgical|surgical
499987|NCT01021826|knee replacement|knee replacement
499988|NCT01021826|hip replacement|hip replacement
499989|NCT01021826|hyperglycemia|hyperglycemia
499990|NCT01021826|diabetes|diabetes
499991|NCT01021826|osteoarthritis|osteoarthritis
499992|NCT01021800|Pancreatic tubular adenocarcinoma adjuvant setting|pancreatic tubular adenocarcinoma adjuvant setting
499993|NCT01021787|Sun Protection|sun protection
499994|NCT01021735|Rheumatoid|rheumatoid
499995|NCT01021735|Outcome|outcome
499996|NCT01021735|Cost effectiveness|cost effectiveness
499997|NCT01021735|Safety|safety
499998|NCT01021722|sphincter|sphincter
499999|NCT01021722|obstetric tears|obstetric tears
500000|NCT01021722|long-term follow-up|long-term follow-up
500001|NCT01021709|depression|depression
500002|NCT01021709|direct current stimulation|direct current stimulation
500003|NCT01021709|extracephalic electrode|extracephalic electrode
500004|NCT01021696|Dementia|dementia
500005|NCT01021696|Nursing home|nursing home
500006|NCT01021696|Pain treatment|pain treatment
500007|NCT01021696|Pain assessment|pain assessment
500008|NCT01021696|Agitation|agitation
500009|NCT01021683|Hematological neoplasms|hematological neoplasms
500010|NCT01021683|Neutropenia|neutropenia
500011|NCT01021683|Fever|fever
500012|NCT01021683|Itraconazole|itraconazole
500013|NCT01021683|Sporanox|sporanox
500014|NCT01021683|Antifungal prophylaxis|antifungal prophylaxis
500015|NCT01021683|Defeverscence|defeverscence
500016|NCT01021670|Dapoxetine hydrochloride|dapoxetine hydrochloride
500017|NCT01021670|Priligy|priligy
500018|NCT01021670|Premature ejaculation|premature ejaculation
500019|NCT01021670|Non-dapoxetine hydrochloride treatment(s)|non-dapoxetine hydrochloride treatment(s)
500020|NCT01021657|Glaucoma|glaucoma
500021|NCT01021657|Tenon's Capsule|tenon's capsule
500022|NCT01021657|Lipid profile|lipid profile
500023|NCT01021657|Assessment of lipid profile in Tenon's capsule in patients with Glaucoma|assessment of lipid profile in tenon's capsule in patients with glaucoma
500024|NCT01021644|APOE|apoe
500025|NCT01021644|Apolipoprotein E|apolipoprotein e
500026|NCT01021644|Cognition Disorders|cognition disorders
500027|NCT01021644|Neurocognition|neurocognition
500028|NCT01021631|Cardiac surgery|cardiac surgery
500029|NCT01021631|Strategies of transfusion|strategies of transfusion
500030|NCT01021631|Red blood cells|red blood cells
500031|NCT01021631|Liberal|liberal
500032|NCT01021631|Restrictive|restrictive
500033|NCT01021631|Anemia|anemia
500034|NCT01021592|Velcade|velcade
500035|NCT01021592|QoL|qol
500036|NCT01021592|Proteasome inhibitor|proteasome inhibitor
500037|NCT01021592|Bortezomib|bortezomib
500038|NCT01021592|EORTC QLQ C30|eortc qlq c30
500039|NCT01021592|EQ 5D|eq 5d
500040|NCT01021579|Polycystic ovary syndrome|polycystic ovary syndrome
500041|NCT01021579|Metformin|metformin
500042|NCT01021579|Simvastatin|simvastatin
500043|NCT01021566|Opiate addiction|opiate addiction
500044|NCT01021566|Withdrawal symptoms|withdrawal symptoms
500045|NCT01021566|hemoperfusion|hemoperfusion
500046|NCT01021566|hemodialysis|hemodialysis
500047|NCT01021566|methadone|methadone
500048|NCT01021553|Proof of Concept|proof of concept
500049|NCT01021553|Double Blind|double blind
500050|NCT01021540|Nephritis,Nephropathy|nephritis,nephropathy
500051|NCT01021514|sRAGE|srage
500052|NCT01021514|SUV|suv
500053|NCT01021514|TBR|tbr
500054|NCT01021514|FDG PET CT|fdg pet ct
500055|NCT01021514|Type 2 DM|type 2 dm
500056|NCT01021501|nifedipine controlled release tablets|nifedipine controlled release tablets
500057|NCT01021501|hypertensive|hypertensive
500058|NCT01021501|chronic maintenance hemodialysis|chronic maintenance hemodialysis
500059|NCT01021501|Pharmacokinetics|pharmacokinetics
500060|NCT01021488|Thrombosis|thrombosis
500061|NCT01021488|Vein|vein
500062|NCT01021488|Statin|statin
500063|NCT01021488|Prevention|prevention
500064|NCT01021475|Functional Dyspepsia, Visceral Manipulation|functional dyspepsia, visceral manipulation
500065|NCT01021449|schizophrenia, BDNF, DNA methylation, histone modification|schizophrenia, bdnf, dna methylation, histone modification
500066|NCT01021436|Pneumonia|pneumonia
500067|NCT01021436|Gram-negative bacteria|gram-negative bacteria
500068|NCT01021423|Mantle Cell Lymphoma|mantle cell lymphoma
500069|NCT01021423|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
500070|NCT01021423|CC-5013|cc-5013
500072|NCT01021423|Lenalidomide|lenalidomide
500073|NCT01021410|acetaminophen|acetaminophen
500074|NCT01021410|paracetamol|paracetamol
500075|NCT01021410|protein adduct|protein adduct
500076|NCT01021410|healthy volunteer|healthy volunteer
500077|NCT01021410|acetaminophen-protein adduct formation|acetaminophen-protein adduct formation
500078|NCT01021397|Respiratory Tract Infection|respiratory tract infection
500079|NCT01021384|Depression,|depression,
500080|NCT01021384|Early Intervention,|early intervention,
500081|NCT01021384|Behavior Disorder,|behavior disorder,
500082|NCT01021384|Parenting Skills,|parenting skills,
500083|NCT01021384|Children with Special Health Care Needs,|children with special health care needs,
500084|NCT01021384|Developmental Disabilities,|developmental disabilities,
500085|NCT01021384|Family Support Programs|family support programs
500086|NCT01021371|HRQOL|hrqol
500087|NCT01021371|Rehabilitation|rehabilitation
500088|NCT01021371|Cancer Patients|cancer patients
500089|NCT01021371|General Practice|general practice
500090|NCT01021332|Vesomni|vesomni
500091|NCT01021332|Solifenacin succinate|solifenacin succinate
500092|NCT01021332|EC905|ec905
500093|NCT01021332|Tamsulosin hydrochloride OCAS|tamsulosin hydrochloride ocas
500094|NCT01021332|Treatment|treatment
500095|NCT01021332|Lower Urinary Tract Symptoms|lower urinary tract symptoms
500096|NCT01021332|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
500097|NCT01021319|ischemic stroke|ischemic stroke
500098|NCT01021319|thrombolysis|thrombolysis
500099|NCT01021319|magnetic resonance imaging|magnetic resonance imaging
500100|NCT01021319|diffusion weighted imaging|diffusion weighted imaging
500101|NCT01021319|fluid attenuated inversion recovery|fluid attenuated inversion recovery
500102|NCT01021319|time window|time window
500103|NCT01021293|Poliorix|poliorix
500104|NCT01021293|IPV|ipv
500105|NCT01021280|Bartter syndrome,|bartter syndrome,
500106|NCT01021280|parathyroid hormone,|parathyroid hormone,
500107|NCT01021280|calcium sensing receptor,|calcium sensing receptor,
500108|NCT01021280|ROMK channel|romk channel
500109|NCT01021280|Barttin gene|barttin gene
500110|NCT01021280|PTH response to hypo- and hypercalcemia|pth response to hypo- and hypercalcemia
500111|NCT01021267|sexual dysfunctions|sexual dysfunctions
500112|NCT01021267|benign prostatic hyperplasia|benign prostatic hyperplasia
500113|NCT01021267|saw palmetto|saw palmetto
500114|NCT01021228|Liver resection|liver resection
500115|NCT01021228|Continuous volatile anesthesia|continuous volatile anesthesia
500116|NCT01021228|Continuous intravenous anesthesia|continuous intravenous anesthesia
500117|NCT01021228|Preconditioning volatile anesthesia|preconditioning volatile anesthesia
500118|NCT01021228|Comparing three groups of anesthesia during the liver surgery according to their benefit on liver and outcome.|comparing three groups of anesthesia during the liver surgery according to their benefit on liver and outcome.
500119|NCT01021215|Cancer Prevention|cancer prevention
500120|NCT01021215|Smoking-related lung disease|smoking-related lung disease
500121|NCT01021215|Smoking|smoking
500122|NCT01021215|Celecoxib|celecoxib
500123|NCT01021215|Celebrex|celebrex
500124|NCT01021215|Zileuton|zileuton
500125|NCT01021215|Zyflo CR|zyflo cr
500126|NCT01021215|Prevention|prevention
500127|NCT01021202|tracheostomy|tracheostomy
500128|NCT01021202|tracheotomy|tracheotomy
500129|NCT01021202|dilational|dilational
500130|NCT01021202|dilatative|dilatative
500131|NCT01021202|critical care|critical care
500132|NCT01021202|intensive care|intensive care
500133|NCT01021202|COPD|copd
500134|NCT01021202|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
500135|NCT01021202|lung disease|lung disease
500136|NCT01021202|pneumonia|pneumonia
500137|NCT01021202|prospective study|prospective study
500138|NCT01021202|questionnaire|questionnaire
500139|NCT01021202|quality of life|quality of life
500140|NCT01021202|outcome|outcome
500141|NCT01021202|mortality|mortality
500142|NCT01021189|safety|safety
500143|NCT01021189|tolerability|tolerability
500144|NCT01021189|AZD1446|azd1446
500145|NCT01021189|AD|ad
500146|NCT01021189|Japanese|japanese
500147|NCT01021176|Food Intake|food intake
500148|NCT01021176|Hunger|hunger
500149|NCT01021176|Lidocaine|lidocaine
500150|NCT01021176|Nose|nose
500151|NCT01021176|smell|smell
500152|NCT01021137|vestibular function tests|vestibular function tests
500153|NCT01021137|postural balance|postural balance
500154|NCT01021137|neuroimaging|neuroimaging
500155|NCT01021124|tuberculosis|tuberculosis
500156|NCT01021124|bone marrow transplant|bone marrow transplant
500157|NCT01021124|diagnosis|diagnosis
500158|NCT01021098|influenza|influenza
500159|NCT01021098|illness|illness
500160|NCT01021098|active-duty|active-duty
500161|NCT01021098|virus|virus
500162|NCT01021098|flu|flu
500163|NCT01021098|military|military
500164|NCT01021098|Influenza-like-illnesses|influenza-like-illnesses
500165|NCT01021085|Assisted Reproductive Technology|assisted reproductive technology
500166|NCT01021085|circulating cell free fetal DNA|circulating cell free fetal dna
500167|NCT01021085|First trimester|first trimester
500168|NCT01021059|Biological Effects of rhIL-15|biological effects of rhil-15
500169|NCT01021059|Estimate Antitumor Activity|estimate antitumor activity
500170|NCT01021059|rhIL-15 Pharmacokinetics|rhil-15 pharmacokinetics
500171|NCT01021059|Dose and Safety Determination of IL-15|dose and safety determination of il-15
500172|NCT01021059|Kidney Cancer|kidney cancer
500173|NCT01021059|Melanoma|melanoma
500174|NCT01021059|Renal Cell Cancer|renal cell cancer
500175|NCT01021046|deep anterior lamellar keratoplasty|deep anterior lamellar keratoplasty
500176|NCT01021046|rejection|rejection
500177|NCT01021046|high risk patients|high risk patients
500178|NCT01021046|acellular corneal tissue|acellular corneal tissue
500179|NCT01021033|Ischemia|ischemia
500180|NCT01021033|Hemorrhage|hemorrhage
500181|NCT01021033|Rehabilitation|rehabilitation
500182|NCT01021033|Stroke|stroke
500183|NCT01021020|bioequivalence|bioequivalence
500184|NCT01021020|fasting|fasting
500185|NCT01021020|fed|fed
500186|NCT01021020|healthy|healthy
500187|NCT01020994|Superficial infected eczema|superficial infected eczema
500188|NCT01020994|Superinfected eczema|superinfected eczema
500189|NCT01020981|OEF/OIF|oef/oif
500190|NCT01020981|Peer Group|peer group
500191|NCT01020981|Veterans|veterans
500192|NCT01020968|Ischemic Dilated Cardiomyopathy|ischemic dilated cardiomyopathy
500193|NCT01020968|Non-Ischemic Dilated Cardiomyopathy|non-ischemic dilated cardiomyopathy
500194|NCT01020968|ixmyelocel-T|ixmyelocel-t
500195|NCT01020955|GH and IGF-I|gh and igf-i
500196|NCT01020955|growth hormone deficiency and IGT or diabetes|growth hormone deficiency and igt or diabetes
500197|NCT01020942|ischemia|ischemia
500198|NCT01020942|myocardial infarction|myocardial infarction
500199|NCT01020942|prognosis|prognosis
500200|NCT01020942|pretreatment|pretreatment
500201|NCT01020942|electroacupuncture|electroacupuncture
500202|NCT01020942|stents|stents
500203|NCT01020942|troponin|troponin
500204|NCT01020942|percutaneous coronary intervention|percutaneous coronary intervention
500205|NCT01020916|Induced hypothermia|induced hypothermia
500206|NCT01020916|Mild induced hypothermia|mild induced hypothermia
500207|NCT01020916|Therapeutic hypothermia|therapeutic hypothermia
500208|NCT01020916|Cardiac arrest|cardiac arrest
500209|NCT01020916|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
500210|NCT01020916|Mortality|mortality
500211|NCT01020916|Neurological function|neurological function
500212|NCT01020916|Randomised clinical trial|randomised clinical trial
500213|NCT01020890|GERD diagnosis|gerd diagnosis
500214|NCT01020890|GERD-Q|gerd-q
500215|NCT01020890|GERD patients' characteristics|gerd patients' characteristics
500216|NCT01020890|GERD|gerd
500217|NCT01020877|Bioequivalence|bioequivalence
500218|NCT01020877|Healthy Subjects|healthy subjects
500219|NCT01020877|Healthy, Normal Subjects|healthy, normal subjects
500220|NCT01020864|Platinum-resistent head and neck cancer|platinum-resistent head and neck cancer
500221|NCT01020864|Cetuximab|cetuximab
500222|NCT01020864|Carboplatin|carboplatin
500223|NCT01020864|Navelbine|navelbine
500224|NCT01020864|Phase II trial|phase ii trial
500225|NCT01020864|Combination chemotherapy|combination chemotherapy
500226|NCT01020851|hypertension|hypertension
500227|NCT01020851|stroke|stroke
500228|NCT01020851|cholesterol|cholesterol
500229|NCT01020851|adherence|adherence
500230|NCT01020838|Florbetaben|florbetaben
500231|NCT01020838|Amyloid beta-protein|amyloid beta-protein
500232|NCT01020838|Alzheimer's disease|alzheimer's disease
500233|NCT01020825|Complex perianal fistula|complex perianal fistula
500234|NCT01020825|Adipose-derived adult stem cells|adipose-derived adult stem cells
500235|NCT01020825|Fibrin glue|fibrin glue
500236|NCT01020799|Depression|depression
500237|NCT01020786|Non-squamous|non-squamous
500238|NCT01020773|extubation,Respiration, Artificial|extubation,respiration, artificial
500239|NCT01020760|Macular hole|macular hole
500240|NCT01020760|Vitrectomy|vitrectomy
500241|NCT01020760|Prone posturing|prone posturing
500242|NCT01020734|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
500243|NCT01020734|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
500244|NCT01020734|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
500245|NCT01020734|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
500246|NCT01020734|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
500247|NCT01020734|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
500248|NCT01020734|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
500249|NCT01020734|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
500250|NCT01020734|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
500251|NCT01020734|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
500252|NCT01020734|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
500253|NCT01020734|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
500254|NCT01020734|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
500255|NCT01020734|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
500342|NCT01020357|methylxanthines|methylxanthines
500256|NCT01020734|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
500257|NCT01020734|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
500258|NCT01020734|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
500259|NCT01020734|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
500260|NCT01020734|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
500261|NCT01020734|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
500262|NCT01020734|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
500263|NCT01020734|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
500264|NCT01020734|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
500265|NCT01020734|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
500266|NCT01020721|CYP1B1 gene|cyp1b1 gene
500267|NCT01020695|PTSD|ptsd
500268|NCT01020695|EEG|eeg
500269|NCT01020695|QEEG|qeeg
500270|NCT01020695|LORETA|loreta
500271|NCT01020682|apathy|apathy
500272|NCT01020682|parkinson|parkinson
500273|NCT01020682|agonist dopaminergic|agonist dopaminergic
500274|NCT01020669|fMRI|fmri
500275|NCT01020669|Prenatal Drug Exposure|prenatal drug exposure
500276|NCT01020669|Decision Making|decision making
500277|NCT01020669|Working Memory|working memory
500278|NCT01020669|Vulnerability|vulnerability
500279|NCT01020656|anticoagulant agents|anticoagulant agents
500280|NCT01020656|antiplatelet agents|antiplatelet agents
500281|NCT01020656|vitreoretinal surgery|vitreoretinal surgery
500282|NCT01020656|Patients suffered from retinal detachment|patients suffered from retinal detachment
500283|NCT01020630|adenocarcinoma of stomach|adenocarcinoma of stomach
500284|NCT01020630|adenocarcinoma of lower oesophagus|adenocarcinoma of lower oesophagus
500285|NCT01020630|sunitinib|sunitinib
500286|NCT01020630|FOLFIRI|folfiri
500287|NCT01020604|BMI|bmi
500288|NCT01020604|Prostate cancer|prostate cancer
500289|NCT01020604|Recurrence|recurrence
500290|NCT01020591|knee osteoarthritis|knee osteoarthritis
500291|NCT01020591|manual therapy|manual therapy
500292|NCT01020591|osteopathy|osteopathy
500293|NCT01020552|APHIA II|aphia ii
500294|NCT01020552|AIDS, Population, and Health Integrated Assistance project|aids, population, and health integrated assistance project
500295|NCT01020552|DCF|dcf
500296|NCT01020552|data collection forms|data collection forms
500297|NCT01020552|FDA|fda
500298|NCT01020552|Federal Drug Administration|federal drug administration
500299|NCT01020552|FP|fp
500300|NCT01020552|family planning|family planning
500301|NCT01020552|IRB|irb
500302|NCT01020552|Institutional Review Board|institutional review board
500303|NCT01020552|PAC|pac
500304|NCT01020552|postabortion care|postabortion care
500305|NCT01020552|To document the ESD PAC svc pkg including the provision of services, client satisfaction with those services and provider attitudes towards PAC services|to document the esd pac svc pkg including the provision of services, client satisfaction with those services and provider attitudes towards pac services
500306|NCT01020552|To examine any differences in implementation of the ESD PAC services package for youth and adult clients|to examine any differences in implementation of the esd pac services package for youth and adult clients
500307|NCT01020552|To assess the usefulness of five Youth-Friendly PAC Job Aids developed by ESD|to assess the usefulness of five youth-friendly pac job aids developed by esd
500308|NCT01020539|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
500309|NCT01020539|Targeted Immune Therapy|targeted immune therapy
500310|NCT01020539|Acute Myelogenous Leukemia|acute myelogenous leukemia
500311|NCT01020539|Myelodysplastic Syndrome|myelodysplastic syndrome
500312|NCT01020539|Juvenile Myelomonocytic Leukemia|juvenile myelomonocytic leukemia
500313|NCT01020539|AML|aml
500314|NCT01020539|MDS|mds
500315|NCT01020539|JMML|jmml
500316|NCT01020474|juvenile primary fibromyalgia syndrome|juvenile primary fibromyalgia syndrome
500317|NCT01020474|pediatric fibromyalgia|pediatric fibromyalgia
500318|NCT01020474|pregabalin|pregabalin
500319|NCT01020474|and Lyrica|and lyrica
500320|NCT01020448|Locally advanced or metastatic Prostate Cancer|locally advanced or metastatic prostate cancer
500321|NCT01020435|Hypertension|hypertension
500322|NCT01020422|breast hypertrophy|breast hypertrophy
500323|NCT01020422|mammaplasty|mammaplasty
500324|NCT01020422|sexuality|sexuality
500325|NCT01020422|depression|depression
500326|NCT01020409|cardiac surgery|cardiac surgery
500327|NCT01020409|cardiopulmonary bypass|cardiopulmonary bypass
500328|NCT01020409|acute lung injury|acute lung injury
500329|NCT01020409|acute respiratory distress syndrome|acute respiratory distress syndrome
500330|NCT01020409|acute kidney injury|acute kidney injury
500331|NCT01020409|atrial fibrillation|atrial fibrillation
500332|NCT01020409|postoperative psychosis|postoperative psychosis
500333|NCT01020409|myocardial infarct|myocardial infarct
500334|NCT01020409|sepsis|sepsis
500335|NCT01020396|Bioequivalence|bioequivalence
500336|NCT01020396|Metronidazole|metronidazole
500337|NCT01020396|Vaginosis|vaginosis
500338|NCT01020370|Patients with RRMS who are participating in the CARE MS I and CARE MS II|patients with rrms who are participating in the care ms i and care ms ii
500339|NCT01020357|preterm infants|preterm infants
500340|NCT01020357|very low birthweight|very low birthweight
500341|NCT01020357|apnea of prematurity|apnea of prematurity
500445|NCT01019915|pgc1alpha|pgc1alpha
500343|NCT01020357|sleep disturbance|sleep disturbance
500344|NCT01020357|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
500345|NCT01020357|polysomnography|polysomnography
500346|NCT01020357|sleep disruption|sleep disruption
500347|NCT01020331|ALS|als
500348|NCT01020318|Traumatic Brain Injury|traumatic brain injury
500349|NCT01020318|TBI|tbi
500350|NCT01020318|Brain Injuries|brain injuries
500351|NCT01020279|muscle pain|muscle pain
500352|NCT01020279|model|model
500353|NCT01020266|brain protection|brain protection
500354|NCT01020266|cardiac surgery|cardiac surgery
500355|NCT01020266|heart valve replacement|heart valve replacement
500356|NCT01020266|electroacupuncture|electroacupuncture
500357|NCT01020266|pretreatment|pretreatment
500358|NCT01020266|preconditioning|preconditioning
500359|NCT01020266|Thoracic Surgery|thoracic surgery
500360|NCT01020253|bisphosphonate, vitamin D3|bisphosphonate, vitamin d3
500361|NCT01020253|Total Hip arthroplasty|total hip arthroplasty
500362|NCT01020240|Immediate puerperium|immediate puerperium
500363|NCT01020240|physiotherapy in postpartum|physiotherapy in postpartum
500364|NCT01020240|cesarean complications|cesarean complications
500365|NCT01020227|Postoperative Care|postoperative care
500366|NCT01020227|Quality of Life|quality of life
500367|NCT01020227|Integrative Medicine|integrative medicine
500368|NCT01020227|Coronary Artery Bypass Graft Surgery|coronary artery bypass graft surgery
500369|NCT01020201|Anesthesia, General|anesthesia, general
500370|NCT01020201|Elective Gynecological Operation|elective gynecological operation
500371|NCT01020201|Chinese female patient|chinese female patient
500372|NCT01020201|Adult|adult
500373|NCT01020175|allogeneic transplantation|allogeneic transplantation
500374|NCT01020175|Leukemia|leukemia
500375|NCT01020175|GvHD|gvhd
500376|NCT01020175|MDS|mds
500377|NCT01020162|Chronic pelvic pain|chronic pelvic pain
500378|NCT01020162|ilioinguinal nerve entrapment|ilioinguinal nerve entrapment
500379|NCT01020162|randomized study|randomized study
500380|NCT01020162|Chronic pelvic pain in women|chronic pelvic pain in women
500381|NCT01020149|Nerve transsection|nerve transsection
500382|NCT01020136|Bioequivalence Pharmacokinetics|bioequivalence pharmacokinetics
500383|NCT01020123|Type II Diabetes Mellitus|type ii diabetes mellitus
500384|NCT01020123|metformin|metformin
500385|NCT01020123|glipizide|glipizide
500386|NCT01020110|perfusion chamber|perfusion chamber
500387|NCT01020110|thrombus D-Dimer|thrombus d-dimer
500388|NCT01020110|HUVEC|huvec
500389|NCT01020084|Saliva|saliva
500390|NCT01020084|Mastication|mastication
500391|NCT01020084|Communication|communication
500392|NCT01020071|iridotomy|iridotomy
500393|NCT01020071|iridoplasty|iridoplasty
500394|NCT01020071|angle closure glaucoma|angle closure glaucoma
500395|NCT01020045|HIV|hiv
500396|NCT01020045|Osteopenia|osteopenia
500397|NCT01020045|Osteoporosis|osteoporosis
500398|NCT01020032|Music therapy|music therapy
500399|NCT01020032|Pain|pain
500400|NCT01020032|Anxiety|anxiety
500401|NCT01020032|Depression|depression
500402|NCT01020032|Controlled randomized trial|controlled randomized trial
500403|NCT01020019|Cannabis Dependence|cannabis dependence
500404|NCT01020019|Marijuana Dependence|marijuana dependence
500405|NCT01020019|Marinol|marinol
500406|NCT01020019|Lofexidine|lofexidine
500407|NCT01020006|PCI-27483|pci-27483
500408|NCT01020006|Factor VIIa|factor viia
500409|NCT01020006|Gemcitabine|gemcitabine
500410|NCT01020006|4 months life expectancy|4 months life expectancy
500411|NCT01020006|Pharmacyclics|pharmacyclics
500412|NCT01020006|Locally Advanced|locally advanced
500413|NCT01020006|Metastatic disease|metastatic disease
500414|NCT01019993|Thoracotomy|thoracotomy
500415|NCT01019993|one lung ventilation|one lung ventilation
500416|NCT01019993|HFPPV|hfppv
500417|NCT01019993|right ventricular function.|right ventricular function.
500418|NCT01019980|Antipyretics|antipyretics
500419|NCT01019980|fever|fever
500420|NCT01019980|diclofenac|diclofenac
500421|NCT01019980|acetaminophen|acetaminophen
500422|NCT01019980|children|children
500423|NCT01019980|acute upper respiratory tract infections|acute upper respiratory tract infections
500424|NCT01019967|Children and Adolescents|children and adolescents
500425|NCT01019967|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
500426|NCT01019967|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
500427|NCT01019967|Autism|autism
500428|NCT01019967|OCD|ocd
500429|NCT01019967|Obsessive Compulsive Disorder|obsessive compulsive disorder
500430|NCT01019941|Docetaxel|docetaxel
500431|NCT01019941|CKD-810|ckd-810
500432|NCT01019941|Taxotere inj.|taxotere inj.
500433|NCT01019941|Advanced Solid cancer|advanced solid cancer
500434|NCT01019941|Pharmacokinetic evaluation|pharmacokinetic evaluation
500435|NCT01019928|GERD|gerd
500436|NCT01019928|patient|patient
500437|NCT01019928|esophagus|esophagus
500438|NCT01019928|pain|pain
500439|NCT01019915|CRT|crt
500440|NCT01019915|heart failure|heart failure
500441|NCT01019915|left bundle branch block|left bundle branch block
500442|NCT01019915|skeletal muscle|skeletal muscle
500443|NCT01019915|cytokines|cytokines
500444|NCT01019915|VO2|vo2
500446|NCT01019902|iron|iron
500447|NCT01019902|pregnancy|pregnancy
500448|NCT01019902|adolescents|adolescents
500449|NCT01019902|auditory brainstem responses|auditory brainstem responses
500450|NCT01019902|anemia|anemia
500451|NCT01019902|neonate|neonate
500452|NCT01019889|upper respiratory tract infections|upper respiratory tract infections
500453|NCT01019889|herbal medicine|herbal medicine
500454|NCT01019876|Bone marrow Failure|bone marrow failure
500455|NCT01019876|Fanconi|fanconi
500456|NCT01019876|SCID|scid
500457|NCT01019850|disseminated neuroblastoma|disseminated neuroblastoma
500458|NCT01019850|localized unresectable neuroblastoma|localized unresectable neuroblastoma
500459|NCT01019850|recurrent neuroblastoma|recurrent neuroblastoma
500460|NCT01019850|regional neuroblastoma|regional neuroblastoma
500461|NCT01019837|Vaccine|vaccine
500462|NCT01019824|nerve compression|nerve compression
500463|NCT01019824|compression radiculopathy|compression radiculopathy
500464|NCT01019824|post-traumatic/post-surgical lumbar radiculopathy|post-traumatic/post-surgical lumbar radiculopathy
500465|NCT01019811|Cross-finger flap|cross-finger flap
500466|NCT01019811|finger injuries|finger injuries
500467|NCT01019811|fingertip reconstruction|fingertip reconstruction
500468|NCT01019811|proper digital artery|proper digital artery
500469|NCT01019811|proper digital nerve.|proper digital nerve.
500470|NCT01019798|non small cell lung cancer|non small cell lung cancer
500471|NCT01019798|sunitinib|sunitinib
500472|NCT01019798|docetaxel|docetaxel
500473|NCT01019785|Pregnancy rate (pos test, live fetus at 12 weeks, baby home)|pregnancy rate (pos test, live fetus at 12 weeks, baby home)
500474|NCT01019785|Pregnancy complication (Pregnancy hypertension, SGA, diab)|pregnancy complication (pregnancy hypertension, sga, diab)
500475|NCT01019785|Thrombin generation|thrombin generation
500476|NCT01019759|Atrial fibrillation|atrial fibrillation
500477|NCT01019759|cardiac surgery|cardiac surgery
500478|NCT01019759|ablation|ablation
500479|NCT01019759|pulmonary veins|pulmonary veins
500480|NCT01019746|Hypnosis with propofol|hypnosis with propofol
500481|NCT01019733|Hypoxia|hypoxia
500482|NCT01019733|Ischemia|ischemia
500483|NCT01019733|Brain|brain
500484|NCT01019733|Children|children
500485|NCT01019733|Cerebral Palsy|cerebral palsy
500486|NCT01019707|crystal meth|crystal meth
500487|NCT01019707|methamphetamine|methamphetamine
500488|NCT01019707|substance abuse|substance abuse
500489|NCT01019681|Cord blood injection in peripheral vascular disease|cord blood injection in peripheral vascular disease
500490|NCT01019668|chorioretinopathy|chorioretinopathy
500491|NCT01019668|photodynamic therapy|photodynamic therapy
500492|NCT01019668|reduced fluence|reduced fluence
500493|NCT01019668|reduced dose|reduced dose
500494|NCT01019655|thrombophilia|thrombophilia
500495|NCT01019655|pregnancy|pregnancy
500496|NCT01019655|heparin|heparin
500497|NCT01019642|vitamin D|vitamin d
500498|NCT01019642|diabetes|diabetes
500499|NCT01019642|C-reactive protein|c-reactive protein
500500|NCT01019642|insulin resistance|insulin resistance
500501|NCT01019629|Fabry, Fabry Disease, Alpha-galactosidase A deficiency, GLA gene, mutations|fabry, fabry disease, alpha-galactosidase a deficiency, gla gene, mutations
500502|NCT01019603|Acne|acne
500503|NCT01019551|Controlled viremia|controlled viremia
500504|NCT01019551|Viral reservoirs|viral reservoirs
500505|NCT01019551|Virus eradication|virus eradication
500506|NCT01019551|Therapeutic intensification|therapeutic intensification
500507|NCT01019551|Immunointervention|immunointervention
500508|NCT01019538|Oxygen|oxygen
500509|NCT01019538|Hypoxemia|hypoxemia
500510|NCT01019538|Air travel|air travel
500511|NCT01019525|respiration|respiration
500512|NCT01019525|respiratory disorders|respiratory disorders
500513|NCT01019525|Otolaryngology|otolaryngology
500514|NCT01019525|Otorhinolaryngology|otorhinolaryngology
500515|NCT01019525|Posture|posture
500516|NCT01019499|human|human
500517|NCT01019499|intervention|intervention
500518|NCT01019499|blood pressure|blood pressure
500519|NCT01019499|cardiovascular risk factors|cardiovascular risk factors
500520|NCT01019499|polyphenols|polyphenols
500521|NCT01019499|bioavailability|bioavailability
500522|NCT01019486|Myocardial blood flow|myocardial blood flow
500523|NCT01019486|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
500524|NCT01019486|Myocardial perfusion imaging|myocardial perfusion imaging
500525|NCT01019486|Coronary artery flow reserve|coronary artery flow reserve
500526|NCT01019486|Regadenoson|regadenoson
500527|NCT01019473|Huntington's disease|huntington's disease
500528|NCT01019473|Chorea|chorea
500529|NCT01019473|Dyskinesia|dyskinesia
500530|NCT01019460|Small intestine|small intestine
500531|NCT01019460|Magnetic resonance imaging|magnetic resonance imaging
500532|NCT01019460|Computed tomography scanning|computed tomography scanning
500533|NCT01019460|Capsule endoscopy|capsule endoscopy
500534|NCT01019447|Surgical site infection|surgical site infection
500535|NCT01019447|Antimicrobial triclosan-coated polyglactin 910 suture|antimicrobial triclosan-coated polyglactin 910 suture
500536|NCT01019447|Length of hospital stay|length of hospital stay
500537|NCT01019447|SSI|ssi
500538|NCT01019434|adult glioblastoma|adult glioblastoma
500539|NCT01019421|Cognition|cognition
500540|NCT01019408|Clinical Trial|clinical trial
500541|NCT01019408|Chloroquine|chloroquine
500542|NCT01019408|Refugees|refugees
500543|NCT01019408|Afghanistan|afghanistan
500544|NCT01019408|Pakistan|pakistan
500545|NCT01019395|Gram Positive Infection|gram positive infection
500546|NCT01019395|Concurrent Antibiotic Treatment|concurrent antibiotic treatment
500547|NCT01019382|pancreatic|pancreatic
500548|NCT01019382|carcinoma|carcinoma
500549|NCT01019382|cancer|cancer
500550|NCT01019382|fish|fish
500551|NCT01019382|alternative|alternative
500552|NCT01019369|Contraception|contraception
500553|NCT01019369|Medroxyprogesterone 17-acetate|medroxyprogesterone 17-acetate
500554|NCT01019369|Self administration|self administration
500555|NCT01019356|PCOS|pcos
500556|NCT01019343|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
500557|NCT01019343|Magnetoencephalogram|magnetoencephalogram
500558|NCT01019343|Electroencephalogram (EEG)|electroencephalogram (eeg)
500559|NCT01019343|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
500560|NCT01019343|Motor Deficit|motor deficit
500561|NCT01019343|Dystonia|dystonia
500562|NCT01019343|Movement Disorder|movement disorder
500563|NCT01019343|Parkinson Disease|parkinson disease
500564|NCT01019343|PD|pd
500565|NCT01019343|Tourette Syndrome|tourette syndrome
500566|NCT01019343|TS|ts
500567|NCT01019343|Tic Disorder|tic disorder
500568|NCT01019330|radial vs femoral|radial vs femoral
500569|NCT01019330|radial artery cardiac catheterization|radial artery cardiac catheterization
500570|NCT01019317|Acute Myelogenous Leukemia|acute myelogenous leukemia
500571|NCT01019317|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
500572|NCT01019317|Chronic myeloid leukemia|chronic myeloid leukemia
500573|NCT01019317|CML|cml
500574|NCT01019317|Blast crisis|blast crisis
500575|NCT01019317|Cytarabine|cytarabine
500576|NCT01019317|Ara-C|ara-c
500577|NCT01019317|Cytosar|cytosar
500578|NCT01019317|DepoCyt|depocyt
500579|NCT01019317|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
500580|NCT01019317|Arabinosine Hydrochloride|arabinosine hydrochloride
500581|NCT01019317|Fludarabine|fludarabine
500582|NCT01019317|Fludarabine Phosphate|fludarabine phosphate
500584|NCT01019317|Gemtuzumab Ozogamicin|gemtuzumab ozogamicin
500585|NCT01019317|Mylotarg|mylotarg
500586|NCT01019291|Indoor pollutants|indoor pollutants
500587|NCT01019265|Norspan patch|norspan patch
500588|NCT01019265|Buprenorphine transdermal patch (BTDS)|buprenorphine transdermal patch (btds)
500589|NCT01019265|efficacy|efficacy
500590|NCT01019265|buprenorphine|buprenorphine
500591|NCT01019252|Adolescent|adolescent
500592|NCT01019252|ADHD|adhd
500593|NCT01019239|Non-faeculant|non-faeculant
500594|NCT01019239|Perforated|perforated
500595|NCT01019239|Diverticulitis|diverticulitis
500596|NCT01019226|myocardium|myocardium
500597|NCT01019226|Magnetic resonance imaging|magnetic resonance imaging
500598|NCT01019213|His-pacing|his-pacing
500599|NCT01019200|psoriasis|psoriasis
500600|NCT01019200|heart disease|heart disease
500601|NCT01019200|cardiovascular disease|cardiovascular disease
500602|NCT01019200|hyperlipidemia|hyperlipidemia
500603|NCT01019161|Acute Myeloid Leukaemia (AML)|acute myeloid leukaemia (aml)
500604|NCT01019161|AML|aml
500605|NCT01019161|AZD1152|azd1152
500606|NCT01019161|Pharmacokinetics|pharmacokinetics
500607|NCT01019135|Women|women
500608|NCT01019135|Cardiac Care Facilities|cardiac care facilities
500609|NCT01019135|Patient satisfaction|patient satisfaction
500610|NCT01019135|Patient participation|patient participation
500611|NCT01019135|Patient compliance|patient compliance
500612|NCT01019135|Randomized Control Trial|randomized control trial
500613|NCT01019135|Coronary artery bypass|coronary artery bypass
500614|NCT01019135|Angioplasty, transluminal, percutaneous coronary|angioplasty, transluminal, percutaneous coronary
500615|NCT01019109|scoliosis|scoliosis
500616|NCT01019096|iron|iron
500617|NCT01019096|pregnancy|pregnancy
500618|NCT01019096|heme iron|heme iron
500619|NCT01019096|non-heme iron|non-heme iron
500620|NCT01019096|stable isotopes|stable isotopes
500621|NCT01019096|women/adolescents|women/adolescents
500622|NCT01019083|Cholera|cholera
500623|NCT01019083|Typhoid|typhoid
500624|NCT01019083|Oral Vaccine|oral vaccine
500625|NCT01019083|Immune response|immune response
500626|NCT01019083|Vaccine Evaluation|vaccine evaluation
500627|NCT01019083|Nutrition|nutrition
500628|NCT01019083|Child Health|child health
500629|NCT01019057|DDD|ddd
500630|NCT01019057|decompression|decompression
500631|NCT01019057|spinous process plate|spinous process plate
500632|NCT01019044|HIV|hiv
500633|NCT01019044|Viral reservoirs|viral reservoirs
500634|NCT01019044|Viral load|viral load
500635|NCT01019018|subtenon block|subtenon block
500636|NCT01019005|post-operative analgesia|post-operative analgesia
500637|NCT01019005|opioid|opioid
500638|NCT01019005|catheter|catheter
500639|NCT01019005|tibial nerve block|tibial nerve block
500640|NCT01018992|PTSD|ptsd
500641|NCT01018992|Anxiety Disorder|anxiety disorder
500642|NCT01018992|Corticotropin releasing factor|corticotropin releasing factor
500643|NCT01018992|Women|women
500644|NCT01018927|Cardiac MR (CMR)|cardiac mr (cmr)
500925|NCT01017653|Gliosarcoma|gliosarcoma
500645|NCT01018927|Early Myocardial Infiltration|early myocardial infiltration
500646|NCT01018927|Amyloid|amyloid
500647|NCT01018927|Light Chain Deposition Disease|light chain deposition disease
500648|NCT01018927|Multiple Myeloma|multiple myeloma
500649|NCT01018914|Prograf|prograf
500650|NCT01018914|Advagraf|advagraf
500651|NCT01018914|Myfortic|myfortic
500652|NCT01018888|Cornea|cornea
500653|NCT01018888|Transplantation, Cornea|transplantation, cornea
500654|NCT01018888|Keratoplasty|keratoplasty
500655|NCT01018888|Grafting, Corneal|grafting, corneal
500656|NCT01018849|Vitamin D|vitamin d
500657|NCT01018849|Cardiac Catheterization|cardiac catheterization
500658|NCT01018849|Cardiovascular event|cardiovascular event
500659|NCT01018849|Cardiovascular Disease|cardiovascular disease
500660|NCT01018836|tumors metastatic to brain|tumors metastatic to brain
500661|NCT01018836|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
500662|NCT01018810|Psoriasis|psoriasis
500663|NCT01018797|INTRASTROMAL CORNEAL RING|intrastromal corneal ring
500664|NCT01018797|ASTIGMATISM|astigmatism
500665|NCT01018797|POSTKERATOPLASTY|postkeratoplasty
500666|NCT01018797|EYES|eyes
500667|NCT01018797|To evaluate the clinical outcomes of ICRS implantation to correct high-degree astigmatism on eyes with prior penetrating keratoplasty (PK)|to evaluate the clinical outcomes of icrs implantation to correct high-degree astigmatism on eyes with prior penetrating keratoplasty (pk)
500668|NCT01018784|Cancer|cancer
500669|NCT01018784|Mesothelin-positive|mesothelin-positive
500670|NCT01018771|actifuse|actifuse
500671|NCT01018771|INFUSE|infuse
500672|NCT01018771|InductOs|inductos
500673|NCT01018771|DDD|ddd
500674|NCT01018771|Degenerative disc disease|degenerative disc disease
500675|NCT01018771|PLF|plf
500676|NCT01018771|posterolateral lumbar fusion|posterolateral lumbar fusion
500677|NCT01018771|bone substitute|bone substitute
500678|NCT01018771|bone graft|bone graft
500679|NCT01018771|synthetic bone substitute|synthetic bone substitute
500680|NCT01018771|spinal surgery|spinal surgery
500681|NCT01018758|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
500682|NCT01018758|Quality of life|quality of life
500683|NCT01018758|Chemotherapy toxicity|chemotherapy toxicity
500684|NCT01018758|aggressive Non Hodgkin's Lymphomas treated with moderately emetogenic chemotherapy|aggressive non hodgkin's lymphomas treated with moderately emetogenic chemotherapy
500685|NCT01018732|Meningococcal|meningococcal
500686|NCT01018732|ACWY|acwy
500687|NCT01018732|Conjugate Vaccine|conjugate vaccine
500688|NCT01018732|Meningitis|meningitis
500689|NCT01018732|Adolescents|adolescents
500690|NCT01018732|Persistence|persistence
500691|NCT01018719|breast cancer radiotherapy cardiotoxicity multidetector CT|breast cancer radiotherapy cardiotoxicity multidetector ct
500692|NCT01018719|Radiotherapy|radiotherapy
500693|NCT01018706|Primary pci|primary pci
500694|NCT01018706|Stent|stent
500695|NCT01018706|Medical Hystory|medical hystory
500696|NCT01018706|Antiplatelet therapy|antiplatelet therapy
500697|NCT01018706|Compliance|compliance
500698|NCT01018693|Seasonal allergic rhinitis,|seasonal allergic rhinitis,
500699|NCT01018693|late phase response,|late phase response,
500700|NCT01018693|alutard avanz,|alutard avanz,
500701|NCT01018693|immunotherapy,|immunotherapy,
500702|NCT01018693|visual analogue scale,|visual analogue scale,
500703|NCT01018693|mini rhinitis quality of life,|mini rhinitis quality of life,
500704|NCT01018693|immune modulation|immune modulation
500705|NCT01018667|Heart Failure|heart failure
500706|NCT01018667|clinical trial|clinical trial
500707|NCT01018667|biventricular pacing|biventricular pacing
500708|NCT01018667|cardiac device|cardiac device
500709|NCT01018654|Substance Abuse|substance abuse
500710|NCT01018654|Substance Addiction|substance addiction
500711|NCT01020708|colitis|colitis
500712|NCT01020708|inflammatory bowel disease|inflammatory bowel disease
500713|NCT01020708|ulcerative colitis|ulcerative colitis
500714|NCT01020708|rectal administration|rectal administration
500715|NCT01020708|enema|enema
500716|NCT01020708|mesalamine|mesalamine
500717|NCT01020487|Reduction of parathyroid hormone levels in pediatric patients with Chronic Kidney Disease Stage 3 and 4|reduction of parathyroid hormone levels in pediatric patients with chronic kidney disease stage 3 and 4
500718|NCT01020292|Adult subjects with a diagnosis of Grade IV Glioma|adult subjects with a diagnosis of grade iv glioma
500719|NCT01020097|Stage 1 squamous cell carcinoma of the larynx|stage 1 squamous cell carcinoma of the larynx
500720|NCT01019954|Adults with premalignant head and neck tumors and adults who have Carcinoma in situ of the head and neck in whom standard therapy is not indicated|adults with premalignant head and neck tumors and adults who have carcinoma in situ of the head and neck in whom standard therapy is not indicated
500721|NCT01019122|cerebral palsy|cerebral palsy
500722|NCT01019122|DEXA scan|dexa scan
500723|NCT01019122|bone density|bone density
500724|NCT01018641|Staphylococcus aureus|staphylococcus aureus
500725|NCT01018641|Vaccine|vaccine
500726|NCT01018615|chronic hepatitis C|chronic hepatitis c
500727|NCT01018615|silymarin|silymarin
500728|NCT01018615|green tea catechins|green tea catechins
500729|NCT01018615|green tea extract|green tea extract
500730|NCT01018615|pharmacokinetics|pharmacokinetics
500731|NCT01018615|antioxidant activity|antioxidant activity
500732|NCT01018589|Post surgical scars|post surgical scars
500733|NCT01018589|Epidermic burn|epidermic burn
500734|NCT01018589|Cicatrix cream|cicatrix cream
500735|NCT01018576|delayed cord clamping|delayed cord clamping
500736|NCT01018576|premature infants|premature infants
500737|NCT01018576|hypothermia|hypothermia
500738|NCT01018576|anemia|anemia
500739|NCT01018576|intraventricular hemorrhage|intraventricular hemorrhage
500740|NCT01018576|Anemia in premature infants|anemia in premature infants
500741|NCT01018563|Extension study|extension study
500742|NCT01018563|Epithelial ovarian cancer|epithelial ovarian cancer
500743|NCT01018537|Multiple Sclerosis|multiple sclerosis
500744|NCT01018537|NARCOMS|narcoms
500745|NCT01018537|Global Patient Registry|global patient registry
500746|NCT01018524|position of the mesh|position of the mesh
500747|NCT01018524|recurrence rate|recurrence rate
500748|NCT01018524|surgical procedure|surgical procedure
500749|NCT01018524|long time outcome|long time outcome
500750|NCT01018511|EC905|ec905
500751|NCT01018511|Solifenacin succinate|solifenacin succinate
500752|NCT01018511|Tamsulosin hydrochloride OCAS|tamsulosin hydrochloride ocas
500753|NCT01018511|Treatment|treatment
500754|NCT01018511|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
500755|NCT01018511|Vesomni|vesomni
500756|NCT01018511|Lower Urinary Tract Symptoms|lower urinary tract symptoms
500757|NCT01018498|Irritable Bowel Syndrome|irritable bowel syndrome
500758|NCT01018498|Children|children
500759|NCT01018472|cyanotic heart disease|cyanotic heart disease
500760|NCT01018472|congenital heart disease|congenital heart disease
500761|NCT01018472|intestinal microbiota|intestinal microbiota
500762|NCT01018472|probiotics|probiotics
500763|NCT01018459|malaria, vaccine, Burkina Faso|malaria, vaccine, burkina faso
500764|NCT01018446|Hematopoietic stem cell transplantation with busulfan based conditioning|hematopoietic stem cell transplantation with busulfan based conditioning
500765|NCT01018433|self-injury|self-injury
500766|NCT01018433|non-suicidal self-injury|non-suicidal self-injury
500767|NCT01018433|deliberate self-harm|deliberate self-harm
500768|NCT01018433|self-mutilation|self-mutilation
500769|NCT01018420|healthy|healthy
500770|NCT01018394|tobacco dependence|tobacco dependence
500771|NCT01018394|tobacco reduction|tobacco reduction
500772|NCT01018394|chewing tobacco|chewing tobacco
500773|NCT01018394|snuff|snuff
500774|NCT01018394|moist snuff|moist snuff
500775|NCT01018381|HCC|hcc
500776|NCT01018381|HBV|hbv
500777|NCT01018381|MGN-3|mgn-3
500778|NCT01018381|BioBran|biobran
500779|NCT01018381|Alternative Therapy|alternative therapy
500780|NCT01018355|Patent foramen ovale|patent foramen ovale
500781|NCT01018355|PFO|pfo
500782|NCT01018355|Stroke|stroke
500783|NCT01018355|TIA|tia
500784|NCT01018355|Percutaneus closure|percutaneus closure
500785|NCT01018355|Intervention|intervention
500786|NCT01018329|Adult Brain Tumor|adult brain tumor
500787|NCT01018316|preoxygenation|preoxygenation
500788|NCT01018316|UMOX|umox
500789|NCT01018303|cystic fibrosis|cystic fibrosis
500790|NCT01018303|vitamins|vitamins
500791|NCT01018303|antioxidants|antioxidants
500792|NCT01018303|anthropometric measurements|anthropometric measurements
500793|NCT01018303|pulmonary function|pulmonary function
500794|NCT01018264|Overactive bladder|overactive bladder
500795|NCT01018264|Urinary incontinence|urinary incontinence
500796|NCT01018264|Urinary frequency|urinary frequency
500797|NCT01018264|Parkinson's disease|parkinson's disease
500798|NCT01018212|Cutaneous Groves|cutaneous groves
500799|NCT01018199|C-reactive protein|c-reactive protein
500800|NCT01018199|procalcitonin|procalcitonin
500801|NCT01018199|community-acquired pneumonia|community-acquired pneumonia
500802|NCT01018199|antibiotic therapy|antibiotic therapy
500803|NCT01018160|Rabeprazole sodium|rabeprazole sodium
500804|NCT01018160|Gastroesophageal Reflux|gastroesophageal reflux
500805|NCT01018160|GERD|gerd
500806|NCT01018160|Observational|observational
500807|NCT01018147|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
500808|NCT01018147|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
500809|NCT01018147|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
500810|NCT01018147|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
500811|NCT01018147|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
500812|NCT01018147|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
500813|NCT01018134|Psoriasis|psoriasis
500814|NCT01018134|Topical corticosteroids|topical corticosteroids
500815|NCT01018134|Plaque psoriasis|plaque psoriasis
500816|NCT01018121|Behavioral Treatment|behavioral treatment
500817|NCT01018121|Preschool Children|preschool children
500818|NCT01018121|Obesity Treatment|obesity treatment
500819|NCT01018069|Acute|acute
500820|NCT01018069|myeloid|myeloid
500821|NCT01018069|leukemia|leukemia
500822|NCT01018069|antisense|antisense
500823|NCT01018069|chemotherapy|chemotherapy
500824|NCT01018069|idarubicin|idarubicin
500825|NCT01018069|cytarabine|cytarabine
500826|NCT01018069|Patients with AML, except those with APL (acute promyelocytic leukemia), failing a single standard dose cytarabine based frontline induction regimen.|patients with aml, except those with apl (acute promyelocytic leukemia), failing a single standard dose cytarabine based frontline induction regimen.
500827|NCT01018056|Tourette syndrome|tourette syndrome
500828|NCT01018056|glutamatergic therapy|glutamatergic therapy
500829|NCT01018056|D-serine|d-serine
500830|NCT01018056|riluzole|riluzole
500831|NCT01018056|glutamate|glutamate
500832|NCT01018056|glutamate agonist|glutamate agonist
500833|NCT01018056|glutamate antagonist|glutamate antagonist
500834|NCT01018056|Tourette syndrome treatment study|tourette syndrome treatment study
500835|NCT01018056|OCD|ocd
500836|NCT01018056|tics|tics
500837|NCT01018043|Cancer Anemia Survey|cancer anemia survey
500838|NCT01018043|Chulalongkorn hospital|chulalongkorn hospital
500839|NCT01018030|uncomplicated acute rhinosinusitis|uncomplicated acute rhinosinusitis
500840|NCT01018030|fluticasone furoate|fluticasone furoate
500841|NCT01018030|sinusitis|sinusitis
500842|NCT01018004|stage IB melanoma|stage ib melanoma
500843|NCT01018004|stage II melanoma|stage ii melanoma
500844|NCT01017991|infants|infants
500845|NCT01017991|formula|formula
500846|NCT01017991|probiotic|probiotic
500847|NCT01017991|crying|crying
500848|NCT01017965|Type 1 diabetes|type 1 diabetes
500849|NCT01017952|Safety|safety
500850|NCT01017952|COPD|copd
500851|NCT01017952|FEV1|fev1
500852|NCT01017952|Efficacy|efficacy
500853|NCT01017939|Prostate neoplasms|prostate neoplasms
500854|NCT01017939|Metastatic castration resistant prostate cancer|metastatic castration resistant prostate cancer
500855|NCT01017939|Metastatic castration refractory prostate cancer|metastatic castration refractory prostate cancer
500856|NCT01017939|Prostate cancer|prostate cancer
500857|NCT01017939|Abiraterone acetate|abiraterone acetate
500858|NCT01017939|CB7630|cb7630
500859|NCT01017926|Triazolam bioequivalence|triazolam bioequivalence
500860|NCT01017913|rehabilitation|rehabilitation
500861|NCT01017913|electrotherapy|electrotherapy
500862|NCT01017913|back pain|back pain
500863|NCT01017900|surgery|surgery
500864|NCT01017900|manual rupture|manual rupture
500865|NCT01017900|dorsal carpal ganglion|dorsal carpal ganglion
500866|NCT01017887|laparoscopy|laparoscopy
500867|NCT01017887|airseal|airseal
500868|NCT01017887|carbon dioxide|carbon dioxide
500869|NCT01017887|insufflation|insufflation
500870|NCT01017887|pneumoperitoneum|pneumoperitoneum
500871|NCT01017861|Temporal summation|temporal summation
500872|NCT01017861|Venipuncture pain|venipuncture pain
500873|NCT01017848|diabetes|diabetes
500874|NCT01017848|urine pH|urine ph
500875|NCT01017848|insulin resistance|insulin resistance
500876|NCT01017848|metabolic syndrome|metabolic syndrome
500877|NCT01017848|development of diabetes|development of diabetes
500878|NCT01017835|statins|statins
500879|NCT01017835|isolated hypertension|isolated hypertension
500880|NCT01017835|atherosclerosis|atherosclerosis
500881|NCT01017835|lipid profile|lipid profile
500882|NCT01017822|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
500883|NCT01017822|stage III pancreatic cancer|stage iii pancreatic cancer
500884|NCT01017809|ovarian|ovarian
500885|NCT01017809|chemotherapy|chemotherapy
500886|NCT01017809|nausea|nausea
500887|NCT01017796|Contrast induced nephropathy|contrast induced nephropathy
500888|NCT01017770|Uncomplicated malaria|uncomplicated malaria
500889|NCT01017757|Interstitial lung disease|interstitial lung disease
500890|NCT01017757|Immunosuppressive therapy|immunosuppressive therapy
500891|NCT01017757|Renal transplant|renal transplant
500892|NCT01017744|Anesthetic Conserving Device|anesthetic conserving device
500893|NCT01017744|Anaconda®|anaconda®
500894|NCT01017744|Sevoflurane|sevoflurane
500895|NCT01017744|Remifentanil|remifentanil
500896|NCT01017744|Sedation|sedation
500897|NCT01017744|Pressure support ventilation|pressure support ventilation
500898|NCT01017744|Work of breathing|work of breathing
500899|NCT01017744|Intrinsic positive end expiratory pressure|intrinsic positive end expiratory pressure
500900|NCT01017744|Ventilatory dead space|ventilatory dead space
500901|NCT01017744|Intensive care|intensive care
500902|NCT01017744|Weaning of mechanical ventilation|weaning of mechanical ventilation
500903|NCT01017744|Ventilated ICU patients in PSV|ventilated icu patients in psv
500904|NCT01017744|No more in acute state|no more in acute state
500905|NCT01017744|No respiratory distress|no respiratory distress
500906|NCT01017744|Sedated by intravenous remifentanil|sedated by intravenous remifentanil
500907|NCT01017744|In light sedation as define by a Richmond Agitation Sedation Scale (RASS) of - 1 to - 2.|in light sedation as define by a richmond agitation sedation scale (rass) of - 1 to - 2.
500908|NCT01017731|Advanced Solid tumor|advanced solid tumor
500909|NCT01017731|Antibodies, Monoclonal|antibodies, monoclonal
500910|NCT01017731|QTc|qtc
500911|NCT01017731|Metastatic|metastatic
500912|NCT01017731|Malignant|malignant
500913|NCT01017718|Diabetes mellitus type I|diabetes mellitus type i
500914|NCT01017718|nerve conduction velocity|nerve conduction velocity
500915|NCT01017718|Young score|young score
500916|NCT01017718|long term vascular complications|long term vascular complications
500917|NCT01017666|Healthy Volunteer|healthy volunteer
500918|NCT01017653|Panitumumab|panitumumab
500919|NCT01017653|Vectibix|vectibix
500920|NCT01017653|Irinotecan|irinotecan
500921|NCT01017653|CPT-11|cpt-11
500922|NCT01017653|Camptosar|camptosar
500923|NCT01017653|Malignant glioma|malignant glioma
500924|NCT01017653|Glioblastoma multiforme|glioblastoma multiforme
500926|NCT01017653|Duke|duke
500927|NCT01017653|Vredenburgh|vredenburgh
500928|NCT01017653|Pro00015447|pro00015447
500929|NCT01017627|ESRD|esrd
500930|NCT01017627|Anemia|anemia
500931|NCT01017627|Hospitalizations|hospitalizations
500932|NCT01017627|Mortality|mortality
500933|NCT01017614|Inflammatory Bowel Disease|inflammatory bowel disease
500934|NCT01017614|Iron deficiency|iron deficiency
500935|NCT01017614|Iron deficiency anaemia|iron deficiency anaemia
500936|NCT01017614|Anaemia|anaemia
500937|NCT01017601|extensive stage small cell lung cancer|extensive stage small cell lung cancer
500938|NCT01017588|lumbar support|lumbar support
500939|NCT01017588|rubber tapper|rubber tapper
500940|NCT01017562|To clarify the 18F-fluoride uptake patterns associated with aseptic or septic loosening|to clarify the 18f-fluoride uptake patterns associated with aseptic or septic loosening
500941|NCT01017549|Stage I|stage i
500942|NCT01017549|Stage II|stage ii
500943|NCT01017549|Breast|breast
500944|NCT01017549|Cancer|cancer
500945|NCT01017536|HIV|hiv
500946|NCT01017536|Tuberculosis|tuberculosis
500947|NCT01017536|Vaccine|vaccine
500948|NCT01017523|diabetes|diabetes
500949|NCT01017523|relationship|relationship
500950|NCT01017523|social support|social support
500951|NCT01017523|telemedicine|telemedicine
500952|NCT01017497|Brain Metastases|brain metastases
500953|NCT01017484|blood pressure|blood pressure
500954|NCT01017484|DASH diet|dash diet
500955|NCT01017484|hypertension|hypertension
500956|NCT01017471|carpal tunnel syndrome|carpal tunnel syndrome
500957|NCT01017471|surgery|surgery
500958|NCT01017471|PSU retractor|psu retractor
500959|NCT01017471|carpal tunnel syndrome who failed to conservative treatment|carpal tunnel syndrome who failed to conservative treatment
500960|NCT01017458|Healthy Adults|healthy adults
500961|NCT01017445|osteoarthritis, exercise|osteoarthritis, exercise
500962|NCT01017419|hearing aids|hearing aids
500963|NCT01017419|counseling|counseling
500964|NCT01017406|plantar fasciitis|plantar fasciitis
500965|NCT01017406|heel cushion|heel cushion
500966|NCT01017406|treatment|treatment
500967|NCT01017393|preemptive epidural ketamine|preemptive epidural ketamine
500968|NCT01017393|prevention of chronic post-thoracotomy pain|prevention of chronic post-thoracotomy pain
500969|NCT01017380|preemptive analgesia|preemptive analgesia
500970|NCT01017380|cruciate ligament|cruciate ligament
500971|NCT01017367|RA|ra
500972|NCT01017367|inflammatory joint disease|inflammatory joint disease
500973|NCT01017354|vitamin D|vitamin d
500974|NCT01017354|function|function
500975|NCT01017354|falls|falls
500976|NCT01017354|25-hydroxyvitamin D|25-hydroxyvitamin d
500977|NCT01017354|disability|disability
500978|NCT01017341|hip fracture|hip fracture
500979|NCT01017341|back support|back support
500980|NCT01017328|infants and children undergoing surgery with general anesthesia|infants and children undergoing surgery with general anesthesia
500981|NCT01017315|baby talcum|baby talcum
500982|NCT01017315|pruritus|pruritus
500983|NCT01017315|cast|cast
500984|NCT01017276|Hyperphosphatemia|hyperphosphatemia
500985|NCT01017276|Peritoneal dialysis|peritoneal dialysis
500986|NCT01017276|CKD|ckd
500987|NCT01017276|ASP1585|asp1585
500988|NCT01017263|ADHD|adhd
500989|NCT01017263|Glucose Intolerance|glucose intolerance
500990|NCT01017263|Obesity|obesity
500991|NCT01017263|Vyvanse|vyvanse
500992|NCT01017250|Recurrent|recurrent
500993|NCT01017237|Dexmedetomidine sedation|dexmedetomidine sedation
500994|NCT01017237|Oral surgery sedation|oral surgery sedation
500995|NCT01017237|Dexmedetomidine amnesia|dexmedetomidine amnesia
500996|NCT01017211|Pain|pain
500997|NCT01017211|Electromyography|electromyography
500998|NCT01017211|Acupuncture|acupuncture
500999|NCT01017211|Randomized controlled trial|randomized controlled trial
501000|NCT01017211|Rehabilitation|rehabilitation
501001|NCT01017159|Polyradiculoneuropathy, Chronic Inflammatory Demyelinating|polyradiculoneuropathy, chronic inflammatory demyelinating
501002|NCT01017159|Subcutaneous immunoglobulin|subcutaneous immunoglobulin
501003|NCT01017146|Ance|ance
501004|NCT01017120|Acne|acne
501005|NCT01017107|acute pancreatitis|acute pancreatitis
501006|NCT01017107|treatment|treatment
501007|NCT01017107|organ failure|organ failure
501008|NCT01017107|activated protein c|activated protein c
501009|NCT01017094|Pin-site infection|pin-site infection
501010|NCT01017094|silversulfadiazine|silversulfadiazine
501011|NCT01017094|open fracture|open fracture
501012|NCT01017094|open tibial fracture underwent external fixator|open tibial fracture underwent external fixator
501013|NCT01017081|physiotherapy|physiotherapy
501014|NCT01017081|children|children
501015|NCT01017081|clinical trial|clinical trial
501016|NCT01017068|GLAUCOMA|glaucoma
501017|NCT01017042|healthy|healthy
501018|NCT01017042|blood levels|blood levels
501019|NCT01017003|healthy|healthy
501020|NCT01017003|pharmacokinetics|pharmacokinetics
501021|NCT01016990|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
501022|NCT01016990|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
501023|NCT01016990|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
501024|NCT01016990|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
501025|NCT01016990|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
501026|NCT01016990|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
501027|NCT01016990|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
501028|NCT01016990|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
501029|NCT01016990|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
501030|NCT01016990|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
501031|NCT01016990|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
501032|NCT01016990|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
501033|NCT01016990|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
501034|NCT01016990|peripheral T-cell lymphoma|peripheral t-cell lymphoma
501035|NCT01016990|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
501036|NCT01016990|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
501037|NCT01016990|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
501038|NCT01016990|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
501039|NCT01016990|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
501040|NCT01016990|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
501041|NCT01016990|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
501042|NCT01016990|Waldenström macroglobulinemia|waldenström macroglobulinemia
501043|NCT01016964|Androgenetic Alopecia|androgenetic alopecia
501044|NCT01016964|Hair Loss|hair loss
501045|NCT01016964|Female Pattern Baldness|female pattern baldness
501046|NCT01016951|Phase I|phase i
501047|NCT01016951|Safety study|safety study
501048|NCT01016951|AZD9164|azd9164
501049|NCT01016925|femoral perineural catheter|femoral perineural catheter
501050|NCT01016925|tunnelization|tunnelization
501051|NCT01016925|complication|complication
501052|NCT01016925|colonization|colonization
501053|NCT01016925|infection|infection
501054|NCT01016899|Electronic|electronic
501055|NCT01016899|Brachytherapy|brachytherapy
501056|NCT01016899|Nonmelanoma|nonmelanoma
501057|NCT01016899|cancer|cancer
501058|NCT01016886|trastuzumab|trastuzumab
501059|NCT01016886|cardiac MRI|cardiac mri
501060|NCT01016886|beta-blocker|beta-blocker
501061|NCT01016886|biomarkers|biomarkers
501062|NCT01016886|angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
501063|NCT01016886|cardiotoxicity|cardiotoxicity
501064|NCT01016886|HER2 positive|her2 positive
501065|NCT01016873|Oraya|oraya
501066|NCT01016873|Oraya Therapeutics, Inc.|oraya therapeutics, inc.
501067|NCT01016873|low voltage stereotactic radiotherapy|low voltage stereotactic radiotherapy
501068|NCT01016873|radiotherapy|radiotherapy
501069|NCT01016873|IRay|iray
501070|NCT01016873|Ranibizumab|ranibizumab
501071|NCT01016873|Lucentis|lucentis
501072|NCT01016873|AMD|amd
501073|NCT01016873|Macular Degeneration|macular degeneration
501074|NCT01016873|xray|xray
501075|NCT01016873|radiation|radiation
501076|NCT01016873|x ray|x ray
501077|NCT01016873|external beam radiation|external beam radiation
501078|NCT01016873|radiosurgery|radiosurgery
501079|NCT01016860|OSI-906, irinotecan, colorectal cancer|osi-906, irinotecan, colorectal cancer
501080|NCT01016834|migraine|migraine
501081|NCT01016834|treatment satisfaction|treatment satisfaction
501082|NCT01016821|Oxycodone|oxycodone
501083|NCT01016821|Labour pain|labour pain
501084|NCT01016821|Pregnancy|pregnancy
501085|NCT01016821|Pregnant women|pregnant women
501086|NCT01016808|Bunionectomy|bunionectomy
501087|NCT01016808|Opioids|opioids
501088|NCT01016795|SCF|scf
501089|NCT01016795|Priming|priming
501090|NCT01016795|Mobilization|mobilization
501091|NCT01016795|Lymphoma|lymphoma
501092|NCT01016795|Clinical Trial|clinical trial
501093|NCT01016782|Inflammatory Rosacea|inflammatory rosacea
501094|NCT01016782|Rosacea|rosacea
501095|NCT01016769|Paclitaxel|paclitaxel
501096|NCT01016769|Carboplatin|carboplatin
501097|NCT01016769|Temsirolimus|temsirolimus
501098|NCT01016769|Head and Neck|head and neck
501099|NCT01016769|recurrent and/or metastatic|recurrent and/or metastatic
501100|NCT01016769|09-131|09-131
501101|NCT01016756|PHACE syndrome|phace syndrome
501102|NCT01016756|Hemangioma|hemangioma
501103|NCT01016756|Coarctation of aorta|coarctation of aorta
501104|NCT01016756|Dandy Walker|dandy walker
501105|NCT01016756|Brain malformation|brain malformation
501106|NCT01016756|Eye anomaly|eye anomaly
501107|NCT01016756|Sternal malformation|sternal malformation
501108|NCT01016756|Genetic analysis|genetic analysis
501109|NCT01016756|Cerebral artery anomaly|cerebral artery anomaly
501110|NCT01016743|parkinson|parkinson
501111|NCT01016743|rTMS|rtms
501112|NCT01016717|clopidogrel|clopidogrel
501113|NCT01016717|platelet function|platelet function
501114|NCT01016717|omeprazole|omeprazole
501115|NCT01016717|pantoprazole|pantoprazole
501116|NCT01016717|coronary disease|coronary disease
501117|NCT01016665|Breast cancer|breast cancer
501118|NCT01016665|Short Term|short term
501119|NCT01016665|Homontherapy|homontherapy
501120|NCT01016665|aromatase inhibitor|aromatase inhibitor
501121|NCT01016665|Short term hormonetherapy in breast cancer|short term hormonetherapy in breast cancer
501122|NCT01016639|Stomach cancer|stomach cancer
501123|NCT01016639|Gall bladder cancer|gall bladder cancer
501124|NCT01016639|Bile ductus cancer|bile ductus cancer
501125|NCT01016639|Pancreas cancer|pancreas cancer
501126|NCT01016639|Colorectal cancer|colorectal cancer
501127|NCT01016639|Chemo radiotherapy|chemo radiotherapy
501128|NCT01016639|Phase I-II|phase i-ii
501129|NCT01016639|Oxaliplatin|oxaliplatin
501130|NCT01016639|Capecitabine|capecitabine
501131|NCT01016639|Response|response
501132|NCT01016626|Pharmacokinetics|pharmacokinetics
501133|NCT01016626|Healthy volunteers|healthy volunteers
501134|NCT01016626|Mycophenolate Mofetil|mycophenolate mofetil
501135|NCT01016613|chronic kidney disease|chronic kidney disease
501136|NCT01016613|glomerulonephritis|glomerulonephritis
501137|NCT01016613|proteinuria|proteinuria
501138|NCT01016613|nephrotic syndrome|nephrotic syndrome
501139|NCT01016613|nephropathy|nephropathy
501140|NCT01016613|biobank|biobank
501141|NCT01016587|symptoms|symptoms
501142|NCT01016587|dyspnea|dyspnea
501143|NCT01016587|pain|pain
501144|NCT01016587|fatigue|fatigue
501145|NCT01016587|anxiety|anxiety
501146|NCT01016587|depression|depression
501147|NCT01016587|sleeplessness|sleeplessness
501148|NCT01016587|genetic markers|genetic markers
501149|NCT01016587|immune markers|immune markers
501150|NCT01016587|COPD|copd
501151|NCT01016587|Quality of Life|quality of life
501152|NCT01016548|Lymphoma|lymphoma
501153|NCT01016548|Multiple myeloma|multiple myeloma
501154|NCT01016548|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
501155|NCT01016548|Influenza A Virus, H1N1 Subtype|influenza a virus, h1n1 subtype
501156|NCT01016548|Influenza Vaccines|influenza vaccines
501157|NCT01016548|Bone Marrow Transplantation|bone marrow transplantation
501158|NCT01016535|Family Health Program|family health program
501159|NCT01016535|Hygiene|hygiene
501160|NCT01016535|Child Health|child health
501161|NCT01016522|ALS|als
501162|NCT01016522|Ketogenic Diet|ketogenic diet
501163|NCT01016509|restenosis|restenosis
501164|NCT01016509|insulin|insulin
501165|NCT01016509|hyperglycemia|hyperglycemia
501166|NCT01016496|Cerebral Palsy|cerebral palsy
501167|NCT01016496|Mirror neurons|mirror neurons
501168|NCT01016496|hemiplegia|hemiplegia
501169|NCT01016496|action observation therapy|action observation therapy
501170|NCT01016496|children affected by hemiplegia as a consequence of Cerebral Palsy|children affected by hemiplegia as a consequence of cerebral palsy
501171|NCT01016483|MEK inhibitor|mek inhibitor
501172|NCT01016483|cancer|cancer
501173|NCT01016483|pancreatic Adenocarcinoma|pancreatic adenocarcinoma
501174|NCT01016483|metastatic|metastatic
501175|NCT01016483|chemo-naive|chemo-naive
501176|NCT01016483|phase II|phase ii
501177|NCT01016457|Diabetes Mellitus|diabetes mellitus
501178|NCT01016444|asthma|asthma
501179|NCT01016444|albuterol|albuterol
501180|NCT01016444|B2AR receptors|b2ar receptors
501181|NCT01016444|Acute asthma responsive and unresponsive to albuterol|acute asthma responsive and unresponsive to albuterol
501182|NCT01016431|cardiac pacing|cardiac pacing
501183|NCT01016431|heart failure|heart failure
501184|NCT01016431|oxygen consumption|oxygen consumption
501185|NCT01016431|ventricular dysfunction|ventricular dysfunction
501186|NCT01016431|left, exercise tolerance|left, exercise tolerance
501187|NCT01016431|chronotropic incompetence|chronotropic incompetence
501188|NCT01016431|pacemaker programming|pacemaker programming
501189|NCT01016418|NASH|nash
501190|NCT01016418|fatty liver disease|fatty liver disease
501191|NCT01016418|colostrum|colostrum
501192|NCT01016405|Dry eye|dry eye
501193|NCT01016405|incidence and severity|incidence and severity
501194|NCT01016405|cataract surgery|cataract surgery
501195|NCT01016392|Observational post-authorization safety study on Kuvan®.|observational post-authorization safety study on kuvan®.
501196|NCT01016379|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
501197|NCT01016379|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
501198|NCT01016366|Friedreich's Ataxia|friedreich's ataxia
501199|NCT01016366|FRDA|frda
501200|NCT01016366|Neurodegenerative|neurodegenerative
501201|NCT01016366|Erythropoietin|erythropoietin
501202|NCT01016366|Carbamylated|carbamylated
501203|NCT01016366|Neuroprotection|neuroprotection
501204|NCT01016366|Frataxin|frataxin
501205|NCT01016353|ABThera|abthera
501206|NCT01016353|Barker's Vacuum Packing Technique|barker's vacuum packing technique
501207|NCT01016340|Male Oligoasthenospermia|male oligoasthenospermia
501208|NCT01016340|MCS|mcs
501209|NCT01016327|Phase I study|phase i study
501210|NCT01016327|Advanced Solid Tumors|advanced solid tumors
501211|NCT01016327|Cdc7 kinase inhibitor|cdc7 kinase inhibitor
501212|NCT01016288|EUS-FNA|eus-fna
501213|NCT01016288|22 Gauge Needle|22 gauge needle
501214|NCT01016288|25 Gauge Needle|25 gauge needle
501215|NCT01016275|To obtain the first iliac long-term results for a patient cohort treated with nitinol stents only|to obtain the first iliac long-term results for a patient cohort treated with nitinol stents only
501216|NCT01016262|Ulcerative proctitis|ulcerative proctitis
501217|NCT01016262|Proctocolitis|proctocolitis
501218|NCT01016262|Inflammatory Bowel Disease|inflammatory bowel disease
501219|NCT01016262|Gastrointestinal Diseases|gastrointestinal diseases
501220|NCT01016262|Colonic Diseases|colonic diseases
501221|NCT01016262|Mesalamine|mesalamine
501222|NCT01016262|5-ASA|5-asa
501223|NCT01016249|Bronchiolitis, Viral|bronchiolitis, viral
501224|NCT01016249|An acute inflammation of the upper RESPIRATORY TRACT|an acute inflammation of the upper respiratory tract
501225|NCT01016223|Eosinophilic esophagitis|eosinophilic esophagitis
501226|NCT01016223|Beclomethasone|beclomethasone
501227|NCT01016223|Ultrasensitive CRP|ultrasensitive crp
501228|NCT01016210|pregnancy|pregnancy
501229|NCT01016210|IVF|ivf
501230|NCT01016197|Soft tissue mallet finger|soft tissue mallet finger
501231|NCT01016184|Quality of life|quality of life
501232|NCT01016158|Umbilical cord serum|umbilical cord serum
501233|NCT01016158|Recurrent corneal erosion|recurrent corneal erosion
501234|NCT01016145|Schizophrenia|schizophrenia
501235|NCT01016145|predictors of response|predictors of response
501236|NCT01016145|antipsychotics|antipsychotics
501237|NCT01016145|18-45 years old|18-45 years old
501238|NCT01016145|non-refractory|non-refractory
501239|NCT01016106|eczema|eczema
501240|NCT01016106|atopic dermatitis|atopic dermatitis
501241|NCT01016106|dry skin|dry skin
501242|NCT01016106|ichthyosis vulgaris|ichthyosis vulgaris
501243|NCT01016093|Thalassemia|thalassemia
501244|NCT01016093|BMT|bmt
501245|NCT01016093|HSCT|hsct
501246|NCT01016080|glutathione|glutathione
501247|NCT01016080|melanin|melanin
501248|NCT01016080|whitening|whitening
501249|NCT01016080|UV spots|uv spots
501250|NCT01016080|skin pigment|skin pigment
501251|NCT01016067|Tibia|tibia
501252|NCT01016067|Tibial|tibial
501253|NCT01016067|Fracture|fracture
501254|NCT01016067|Nonunion|nonunion
501255|NCT01016067|delayed|delayed
501256|NCT01016067|healing|healing
501257|NCT01016067|iliac|iliac
501258|NCT01016067|crest|crest
501259|NCT01016067|autograft|autograft
501260|NCT01016067|INFUSE|infuse
501261|NCT01016067|MASTERGRAFT|mastergraft
501262|NCT01016067|Fixation|fixation
501263|NCT01016067|Internal|internal
501264|NCT01016054|Clinical Trial, Phase1|clinical trial, phase1
501265|NCT01016054|Combination Drug Therapy|combination drug therapy
501266|NCT01016054|pharmacokinetics|pharmacokinetics
501267|NCT01016054|safety|safety
501268|NCT01016054|Ovarian|ovarian
501269|NCT01016041|drug-eluting stent|drug-eluting stent
501270|NCT01016041|stable angina|stable angina
501271|NCT01016041|ACS|acs
501272|NCT01016041|MACE|mace
501273|NCT01016041|safety|safety
501274|NCT01016041|stent thrombosis|stent thrombosis
501275|NCT01016028|Cancer|cancer
501276|NCT01016028|Colorectum Cancer|colorectum cancer
501277|NCT01016028|Colorectal disease|colorectal disease
501278|NCT01016028|neuropathic symptom tool|neuropathic symptom tool
501279|NCT01016028|chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
501280|NCT01016028|CIPN|cipn
501281|NCT01016028|Pain|pain
501282|NCT01016028|Quantitative Sensory Testing|quantitative sensory testing
501283|NCT01016028|QST|qst
501284|NCT01016028|symptom measurement tools|symptom measurement tools
501285|NCT01016028|platinum agents|platinum agents
501286|NCT01016028|cisplatin|cisplatin
501287|NCT01016028|oxaliplatin|oxaliplatin
501288|NCT01016028|taxanes|taxanes
501289|NCT01016028|bortezomib|bortezomib
501290|NCT01015989|HIV treatment|hiv treatment
501291|NCT01015989|ART adherence|art adherence
501292|NCT01015989|Using new technology to improve adherence|using new technology to improve adherence
501293|NCT01015989|CARE+|care+
501294|NCT01015989|HIV-1 viral loads|hiv-1 viral loads
501295|NCT01015976|Gastric Bypass|gastric bypass
501296|NCT01015976|Sertraline|sertraline
501297|NCT01015976|Pharmacokinetics|pharmacokinetics
501298|NCT01015963|recurrent breast cancer|recurrent breast cancer
501299|NCT01015963|stage IIIA breast cancer|stage iiia breast cancer
501300|NCT01015963|stage IIIB breast cancer|stage iiib breast cancer
501301|NCT01015963|stage IIIC breast cancer|stage iiic breast cancer
501302|NCT01015963|stage IV breast cancer|stage iv breast cancer
501303|NCT01015963|extensive stage small cell lung cancer|extensive stage small cell lung cancer
501304|NCT01015963|recurrent small cell lung cancer|recurrent small cell lung cancer
501305|NCT01015963|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
501306|NCT01015963|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
501307|NCT01015963|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
501308|NCT01015963|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
501309|NCT01015963|stage IV bladder cancer|stage iv bladder cancer
501310|NCT01015963|recurrent bladder cancer|recurrent bladder cancer
501311|NCT01015963|stage III bladder cancer|stage iii bladder cancer
501312|NCT01015963|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
501313|NCT01015963|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
501314|NCT01015963|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
501369|NCT01015937|turmeric|turmeric
501315|NCT01015963|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
501316|NCT01015963|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
501317|NCT01015963|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
501318|NCT01015963|pulmonary carcinoid tumor|pulmonary carcinoid tumor
501319|NCT01015963|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
501320|NCT01015963|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
501321|NCT01015963|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
501322|NCT01015963|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
501323|NCT01015963|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
501324|NCT01015963|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
501325|NCT01015963|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
501326|NCT01015963|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
501327|NCT01015963|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
501328|NCT01015963|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
501329|NCT01015963|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
501330|NCT01015963|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
501331|NCT01015963|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
501332|NCT01015963|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
501333|NCT01015963|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
501334|NCT01015963|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
501335|NCT01015963|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
501336|NCT01015963|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
501337|NCT01015963|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
501338|NCT01015963|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
501339|NCT01015963|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
501340|NCT01015963|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
501341|NCT01015963|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
501342|NCT01015963|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
501343|NCT01015963|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
501344|NCT01015963|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
501345|NCT01015963|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
501346|NCT01015963|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
501347|NCT01015963|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
501348|NCT01015963|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
501349|NCT01015963|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
501350|NCT01015963|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
501351|NCT01015963|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
501352|NCT01015963|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
501353|NCT01015963|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
501354|NCT01015963|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
501355|NCT01015963|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
501356|NCT01015963|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
501357|NCT01015963|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
501358|NCT01015963|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
501359|NCT01015963|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
501360|NCT01015963|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
501361|NCT01015963|recurrent salivary gland cancer|recurrent salivary gland cancer
501362|NCT01015963|stage III salivary gland cancer|stage iii salivary gland cancer
501363|NCT01015963|stage IV salivary gland cancer|stage iv salivary gland cancer
501364|NCT01015963|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
501365|NCT01015963|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
501366|NCT01015963|tongue cancer|tongue cancer
501367|NCT01015937|diabetes|diabetes
501368|NCT01015937|nephropathy|nephropathy
501370|NCT01015937|serum IL8|serum il8
501371|NCT01015937|serum TGFb|serum tgfb
501372|NCT01015937|serumINF|seruminf
501373|NCT01015937|urinary IL8|urinary il8
501374|NCT01015937|urine TGFb|urine tgfb
501375|NCT01015924|clavicle|clavicle
501376|NCT01015924|TEN|ten
501377|NCT01015924|Plate osteosynthesis|plate osteosynthesis
501378|NCT01015924|displaced|displaced
501379|NCT01015924|ESIN|esin
501380|NCT01015924|displaced midshaft clavicular fractures|displaced midshaft clavicular fractures
501381|NCT01015911|Antibodies, Monoclonal|antibodies, monoclonal
501382|NCT01015911|Antibody-Drug Conjugate|antibody-drug conjugate
501383|NCT01015911|Antigens, CD70|antigens, cd70
501384|NCT01015911|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
501385|NCT01015911|Carcinoma, Renal Cell|carcinoma, renal cell
501386|NCT01015911|Immunotherapy|immunotherapy
501387|NCT01015911|Drug Therapy|drug therapy
501388|NCT01015911|monomethylauristatin F|monomethylauristatin f
501389|NCT01015898|basal cell carcinoma|basal cell carcinoma
501390|NCT01015898|photodynamic therapy|photodynamic therapy
501391|NCT01015898|photo chemotherapy|photo chemotherapy
501392|NCT01015898|basal cell epithelioma|basal cell epithelioma
501393|NCT01015872|sleep apnea syndrome|sleep apnea syndrome
501394|NCT01015872|CPAP|cpap
501395|NCT01015872|prostanoids|prostanoids
501396|NCT01015859|AV conduction|av conduction
501397|NCT01015859|Atrial fibrillation|atrial fibrillation
501398|NCT01015846|Core|core
501399|NCT01015846|Redcord|redcord
501400|NCT01015846|RUSI|rusi
501401|NCT01015846|low back|low back
501402|NCT01015820|Pancreatic Cancer|pancreatic cancer
501403|NCT01015820|Duodenum|duodenum
501404|NCT01015820|Spectroscopy|spectroscopy
501405|NCT01015820|Fiberoptic probe|fiberoptic probe
501406|NCT01015820|4D-ELF|4d-elf
501407|NCT01015807|postoperative|postoperative
501408|NCT01015807|hyperalgesia|hyperalgesia
501409|NCT01015807|pain|pain
501410|NCT01015807|transversus abdominis plane block|transversus abdominis plane block
501411|NCT01015807|TAP block|tap block
501412|NCT01015807|cesarean section|cesarean section
501413|NCT01015781|Tinnitus|tinnitus
501414|NCT01015781|Counseling|counseling
501415|NCT01015781|Education|education
501416|NCT01015781|Rehabilitation of hearing impaired|rehabilitation of hearing impaired
501418|NCT01015781|Evaluation studies|evaluation studies
501419|NCT01015781|Quality of health care|quality of health care
501420|NCT01015768|corneal staining|corneal staining
501421|NCT01015768|barrier function|barrier function
501422|NCT01015768|contact lenses|contact lenses
501423|NCT01015768|contact lens care solutions|contact lens care solutions
501424|NCT01015768|contact lens material and care solution bioincompatibility|contact lens material and care solution bioincompatibility
501425|NCT01015755|thirst palliation and intensive care unit|thirst palliation and intensive care unit
501426|NCT01015755|thirst intensity and distress|thirst intensity and distress
501427|NCT01015755|predictors of thirst|predictors of thirst
501428|NCT01015742|AML|aml
501429|NCT01015742|ALL|all
501430|NCT01015742|CML|cml
501431|NCT01015729|Bioequivalence|bioequivalence
501432|NCT01015729|ASA|asa
501433|NCT01015729|Esomeprazole|esomeprazole
501434|NCT01015729|peptic ulcer disease|peptic ulcer disease
501435|NCT01015729|pH measurements|ph measurements
501436|NCT01015716|Weight loss|weight loss
501437|NCT01015716|Physical activity|physical activity
501438|NCT01015716|Cognitive Behavioral Training|cognitive behavioral training
501439|NCT01015703|Vaccine, hypertension|vaccine, hypertension
501440|NCT01015690|unexplained infertility|unexplained infertility
501441|NCT01015690|hCG|hcg
501442|NCT01015690|early pregnancy loss|early pregnancy loss
501443|NCT01015651|nociception, intraoperative, baroreflex|nociception, intraoperative, baroreflex
501444|NCT01015638|Healthy volunteers|healthy volunteers
501445|NCT01015625|breast cancer|breast cancer
501446|NCT01015625|ABCSG|abcsg
501447|NCT01015625|POSYTIVE|posytive
501448|NCT01015625|growth factor|growth factor
501449|NCT01015625|median survival|median survival
501450|NCT01015625|surgery on demand|surgery on demand
501451|NCT01015625|surgical therapy|surgical therapy
501452|NCT01015625|blood specimen|blood specimen
501453|NCT01015625|tissue specimen|tissue specimen
501454|NCT01015625|VEGF|vegf
501455|NCT01015625|TGF|tgf
501456|NCT01015625|circulating tumor cells|circulating tumor cells
501457|NCT01015625|stem cells|stem cells
501458|NCT01015612|Aortic Valve Stenosis|aortic valve stenosis
501459|NCT01015612|Aortic Valve Insufficiency|aortic valve insufficiency
501460|NCT01015599|Obesity prevention|obesity prevention
501461|NCT01015599|after-school|after-school
501462|NCT01015599|physical activity|physical activity
501463|NCT01015599|fruit|fruit
501464|NCT01015599|vegetable|vegetable
501465|NCT01015599|children|children
501466|NCT01015586|Alcohol|alcohol
501467|NCT01015586|Bipolar Disorder|bipolar disorder
501468|NCT01015586|Manic depression|manic depression
501469|NCT01015586|Addiction|addiction
501470|NCT01015586|Alcoholism|alcoholism
501471|NCT01015586|Cognitive impairment|cognitive impairment
501472|NCT01015586|Executive function|executive function
501473|NCT01015586|Anxiety|anxiety
501474|NCT01015586|Depression|depression
501475|NCT01015586|Mania|mania
501476|NCT01015586|Affective disorder|affective disorder
501477|NCT01015586|Psychosis|psychosis
501478|NCT01015586|Carbohydrate deficient transferrin|carbohydrate deficient transferrin
501479|NCT01015586|Gammaglutamyltransferase|gammaglutamyltransferase
501480|NCT01015586|California Verbal Learning Test|california verbal learning test
501481|NCT01015586|Wisconsin Card Sort Test|wisconsin card sort test
501482|NCT01015586|Stroop Color and Word Test|stroop color and word test
501483|NCT01015586|Alcohol Stroop Test|alcohol stroop test
501484|NCT01015586|Emotion Stroop Test|emotion stroop test
501485|NCT01015586|Point Scoring Reaction Time Test|point scoring reaction time test
501486|NCT01015586|Rey Osterrieth Complex Figure Test|rey osterrieth complex figure test
501487|NCT01015586|Trail Making Test|trail making test
501488|NCT01015586|Montgomery Asberg Depression Rating Scale|montgomery asberg depression rating scale
501489|NCT01015586|Young Mania Rating Scale|young mania rating scale
501490|NCT01015586|Timeline Follow Back|timeline follow back
501491|NCT01015560|bone metastases|bone metastases
501492|NCT01015560|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
501493|NCT01015547|juvenile idiopathic arthritis|juvenile idiopathic arthritis
501494|NCT01015547|polyarthritis|polyarthritis
501495|NCT01015547|combination therapy|combination therapy
501496|NCT01015547|biologic agents|biologic agents
501497|NCT01015547|TNF antagonists|tnf antagonists
501498|NCT01015547|infliximab|infliximab
501499|NCT01015534|Brain metastases|brain metastases
501500|NCT01015534|Temozolomide|temozolomide
501501|NCT01015534|Whole-brain radiotherapy|whole-brain radiotherapy
501502|NCT01015534|Phase II trial|phase ii trial
501503|NCT01015521|breast cancer|breast cancer
501504|NCT01015508|Weight loss and maintenance|weight loss and maintenance
501505|NCT01015508|body composition|body composition
501506|NCT01015508|energy expenditure|energy expenditure
501507|NCT01015508|adipogenic capacity|adipogenic capacity
501508|NCT01015508|physical activity|physical activity
501509|NCT01015495|angioid streaks|angioid streaks
501510|NCT01015495|CNV|cnv
501511|NCT01015495|intra vitreal ranibizumab|intra vitreal ranibizumab
501512|NCT01015482|Sunburn|sunburn
501513|NCT01015482|Remifentanil|remifentanil
501514|NCT01015482|Hyperalgesia|hyperalgesia
501515|NCT01015469|bariatric|bariatric
501516|NCT01015469|surgery|surgery
501517|NCT01015469|obesity|obesity
501518|NCT01015469|Roux-en-Y|roux-en-y
501519|NCT01015469|gastric|gastric
501520|NCT01015469|medical device|medical device
501521|NCT01015469|bypass|bypass
501522|NCT01015469|adiposity|adiposity
501523|NCT01015469|GaBP-Ring|gabp-ring
501524|NCT01015469|BMI|bmi
501525|NCT01015469|banded|banded
501526|NCT01015469|laparoscopic|laparoscopic
501527|NCT01015456|lupus nephritis|lupus nephritis
501528|NCT01015456|mycophenolate sodium|mycophenolate sodium
501529|NCT01015456|cyclophosphamide|cyclophosphamide
501530|NCT01015443|Non-Small Cell Lung Carcinoma|non-small cell lung carcinoma
501531|NCT01015443|Tecemotide|tecemotide
501532|NCT01015443|L-BLP25|l-blp25
501533|NCT01015443|Cyclophosphamide|cyclophosphamide
501534|NCT01015443|placebo controlled|placebo controlled
501535|NCT01015443|Non-Small Cell Lung Cancer|non-small cell lung cancer
501536|NCT01015417|Acute lithiasic cholecystitis|acute lithiasic cholecystitis
501537|NCT01015417|Cholecystectomy|cholecystectomy
501538|NCT01015417|Postoperative antibiotherapy|postoperative antibiotherapy
501539|NCT01015417|Surgical site infection|surgical site infection
501540|NCT01015417|Remote surgical site infection|remote surgical site infection
501541|NCT01015404|Trafermin|trafermin
501542|NCT01015404|Periodontitis|periodontitis
501543|NCT01015391|T2|t2
501544|NCT01015391|AZA|aza
501545|NCT01015391|remission|remission
501546|NCT01015391|Crohn's disease|crohn's disease
501547|NCT01015378|Recurrent sigmoid diverticulitis|recurrent sigmoid diverticulitis
501548|NCT01015378|diverticulitis|diverticulitis
501549|NCT01015378|Colon|colon
501550|NCT01015378|sigmoid|sigmoid
501551|NCT01015378|recurrence|recurrence
501552|NCT01015365|Chronic infected hip arthroplasty|chronic infected hip arthroplasty
501553|NCT01015365|Fast-track|fast-track
501554|NCT01015365|One-stage cementless revision|one-stage cementless revision
501555|NCT01015352|Myelodysplastic Syndromes|myelodysplastic syndromes
501556|NCT01015326|EGFRI|egfri
501557|NCT01015326|HRQL|hrql
501558|NCT01015326|Quality of Life|quality of life
501559|NCT01015326|Development of a standardized HRQL instrument for anti-EGFR therapy induced|development of a standardized hrql instrument for anti-egfr therapy induced
501560|NCT01015313|sodium, hypertension, volume overload|sodium, hypertension, volume overload
501561|NCT01015300|Hemangioblastoma|hemangioblastoma
501562|NCT01015300|Von Hippel Lindau|von hippel lindau
501563|NCT01015300|VHL|vhl
501564|NCT01015300|lesion|lesion
501565|NCT01015300|EGFR|egfr
501566|NCT01015287|Acute Coronary Syndromes|acute coronary syndromes
501567|NCT01015287|Heart Disease|heart disease
501568|NCT01015287|Percutaneous Coronary Intervention|percutaneous coronary intervention
501569|NCT01015287|P2Y12|p2y12
501570|NCT01015287|NSTEMI|nstemi
501571|NCT01015261|ALL|all
501572|NCT01015261|BMT|bmt
501573|NCT01015261|Chemotherapy|chemotherapy
501574|NCT01015261|Allogenic|allogenic
501575|NCT01015248|CD 20 positive|cd 20 positive
501576|NCT01015235|Ketorolac / therapeutic use|ketorolac / therapeutic use
501577|NCT01015235|Analgesics. Non-narcotic / therapeutic use|analgesics. non-narcotic / therapeutic use
501578|NCT01015235|Arthroplasty, replacement hip|arthroplasty, replacement hip
501579|NCT01015235|Arthroplasty, replacement knee|arthroplasty, replacement knee
501580|NCT01015235|Pain measurement / drug effect|pain measurement / drug effect
501581|NCT01015235|Pain postoperative / drug therapy|pain postoperative / drug therapy
501582|NCT01015222|Advanced Malignancies|advanced malignancies
501583|NCT01015222|Metastatic cancer|metastatic cancer
501584|NCT01015222|Bevacizumab|bevacizumab
501585|NCT01015222|Avastin|avastin
501586|NCT01015222|Dasatinib|dasatinib
501587|NCT01015222|Sprycel|sprycel
501588|NCT01015222|Paclitaxel|paclitaxel
501589|NCT01015222|Taxol|taxol
501590|NCT01015209|Dry eye syndromes|dry eye syndromes
501591|NCT01015196|acute myeloid leukemia in first complete remission|acute myeloid leukemia in first complete remission
501592|NCT01015183|Mucositis|mucositis
501593|NCT01015183|Bone Marrow Transplantation|bone marrow transplantation
501594|NCT01015183|BMT|bmt
501595|NCT01015183|HSCT|hsct
501596|NCT01015170|smoking cessation|smoking cessation
501597|NCT01015170|nicotine addiction|nicotine addiction
501598|NCT01015170|Zyban|zyban
501599|NCT01015170|bupropion hydrochloride|bupropion hydrochloride
501600|NCT01015157|Gastric bypass|gastric bypass
501601|NCT01015157|staple line reinforcement|staple line reinforcement
501602|NCT01015157|outcomes|outcomes
501603|NCT01015157|per and postoperative blood loss|per and postoperative blood loss
501604|NCT01015144|atorvastatin|atorvastatin
501605|NCT01015144|dilated cardiomyopathy|dilated cardiomyopathy
501606|NCT01015144|heart failure|heart failure
501607|NCT01015144|inflammation|inflammation
501608|NCT01015105|patients with hip fracture|patients with hip fracture
501609|NCT01015092|HIV|hiv
501610|NCT01015092|Cardiovascular|cardiovascular
501611|NCT01015092|Coronary hear disease|coronary hear disease
501612|NCT01015092|HAART|haart
501613|NCT01015092|antiretroviral|antiretroviral
501614|NCT01015079|Pap smear screening|pap smear screening
501615|NCT01015066|drug dependence|drug dependence
501616|NCT01015066|substance abuse|substance abuse
501617|NCT01015066|substance use disorders|substance use disorders
501618|NCT01015066|buprenorphine|buprenorphine
501619|NCT01015066|naltrexone|naltrexone
501620|NCT01015066|adolescents|adolescents
501621|NCT01015053|postoperative pain|postoperative pain
501622|NCT01015053|pediatric|pediatric
501623|NCT01015053|umbilical hernia|umbilical hernia
501624|NCT01015053|ropivacaine|ropivacaine
501625|NCT01015053|rectus sheath block|rectus sheath block
501626|NCT01015053|regional block|regional block
501627|NCT01015053|ultrasound-guided regional block|ultrasound-guided regional block
501628|NCT01015053|local infiltration|local infiltration
501629|NCT01015053|ambulatory surgery|ambulatory surgery
501630|NCT01015040|solifenacin succinate|solifenacin succinate
501631|NCT01015040|VESIcare|vesicare
501632|NCT01015040|Healthy Volunteers|healthy volunteers
501633|NCT01015014|Gram negative|gram negative
501634|NCT01015014|bacteria|bacteria
501635|NCT01015014|infection|infection
501636|NCT01015001|refractory schizophrenia|refractory schizophrenia
501637|NCT01015001|rTMS|rtms
501638|NCT01015001|auditory hallucinations|auditory hallucinations
501639|NCT01014988|pandemic|pandemic
501640|NCT01014988|seasonal influenza|seasonal influenza
501641|NCT01014988|Influenza B virus|influenza b virus
501642|NCT01014988|H1N1|h1n1
501643|NCT01014988|zanamivir|zanamivir
501644|NCT01014988|Influenza A virus, H1N1 Subtype|influenza a virus, h1n1 subtype
501645|NCT01014988|Relenza|relenza
501646|NCT01014988|influenza|influenza
501647|NCT01014988|neuraminidase inhibitor|neuraminidase inhibitor
501648|NCT01014975|stroke|stroke
501649|NCT01014975|plasmin|plasmin
501650|NCT01014975|thrombus|thrombus
501651|NCT01014975|ischemic|ischemic
501652|NCT01014975|middle cerebral artery|middle cerebral artery
501653|NCT01014975|thrombolysis|thrombolysis
501654|NCT01014975|intra-arterial|intra-arterial
501655|NCT01014975|fibrin|fibrin
501656|NCT01014962|Pharmacokinetic|pharmacokinetic
501657|NCT01014962|tolerability|tolerability
501658|NCT01014962|multiple escalating doses|multiple escalating doses
501659|NCT01014936|Phase 1|phase 1
501660|NCT01014936|advanced solid tumors|advanced solid tumors
501661|NCT01014936|refractory to standard therapy|refractory to standard therapy
501662|NCT01014923|motor vehicle|motor vehicle
501663|NCT01014923|accidents, traffic|accidents, traffic
501664|NCT01014923|prevention and control|prevention and control
501665|NCT01014910|Bronchiolitis|bronchiolitis
501666|NCT01014910|Hypoxia|hypoxia
501667|NCT01014910|Pulse|pulse
501668|NCT01014910|Oximetry|oximetry
501669|NCT01014910|Hospitalized|hospitalized
501670|NCT01014897|stroke|stroke
501671|NCT01014897|recovery|recovery
501672|NCT01014897|tDCS|tdcs
501673|NCT01014897|direct current|direct current
501674|NCT01014897|electric stimulation|electric stimulation
501675|NCT01014871|Forehead Wrinkles Toxin|forehead wrinkles toxin
501676|NCT01014858|Parkinson's disease|parkinson's disease
501677|NCT01014858|mild dementia|mild dementia
501678|NCT01014858|donepezil|donepezil
501679|NCT01014858|NIHR HTA|nihr hta
501680|NCT01014845|hepatitis E|hepatitis e
501681|NCT01014845|vaccine|vaccine
501682|NCT01014845|efficacy|efficacy
501683|NCT01014832|Diabetes, insulin.|diabetes, insulin.
501684|NCT01014819|Dermacorder|dermacorder
501685|NCT01014819|Electric field|electric field
501686|NCT01014819|basal cell carcinoma|basal cell carcinoma
501687|NCT01014819|Gorlin Syndrome|gorlin syndrome
501688|NCT01014793|Acromegaly resistant|acromegaly resistant
501689|NCT01014793|combined-treatment|combined-treatment
501690|NCT01014793|dopamine agonist|dopamine agonist
501691|NCT01014780|dry eye|dry eye
501692|NCT01014780|tear film|tear film
501693|NCT01014780|thickness|thickness
501694|NCT01014780|artificial tears|artificial tears
501695|NCT01014767|Choroid Plexus Tumors|choroid plexus tumors
501696|NCT01014767|Brain Tumor|brain tumor
501697|NCT01014767|Chemotherapy|chemotherapy
501698|NCT01014767|Etoposide|etoposide
501699|NCT01014767|Carboplatin|carboplatin
501700|NCT01014767|Vincristine|vincristine
501701|NCT01014767|Cyclophosphamide|cyclophosphamide
501702|NCT01014767|Methotrexate|methotrexate
501703|NCT01014767|Doxorubicin|doxorubicin
501704|NCT01014767|Cisplatin|cisplatin
501705|NCT01014767|Dactinomycin|dactinomycin
501706|NCT01014767|temozolomide|temozolomide
501707|NCT01014767|irinotecan|irinotecan
501708|NCT01014767|Pediatrics|pediatrics
501709|NCT01014741|Atrial Fibrillation|atrial fibrillation
501710|NCT01014741|Catheter Ablation|catheter ablation
501711|NCT01014741|Complex Fractionate Electrograms|complex fractionate electrograms
501712|NCT01014715|Breast Cancer|breast cancer
501713|NCT01014702|Cataract|cataract
501714|NCT01014702|Capsulotomy|capsulotomy
501715|NCT01014702|Capsulorrhexis|capsulorrhexis
501716|NCT01014702|lens fragmentation|lens fragmentation
501717|NCT01014702|phacoemulsification|phacoemulsification
501718|NCT01014689|acne vulgaris|acne vulgaris
501719|NCT01014676|Costs and Cost Analysis|costs and cost analysis
501720|NCT01014663|Parkinson's disease|parkinson's disease
501721|NCT01014663|exercise|exercise
501722|NCT01014663|training program|training program
501723|NCT01014663|rehabilitation|rehabilitation
501724|NCT01014663|boxing|boxing
501725|NCT01014650|glycine site partial agonist|glycine site partial agonist
501726|NCT01014650|normal volunteers|normal volunteers
501727|NCT01014650|safety in normal volunteers|safety in normal volunteers
501728|NCT01014637|Dermatomycoses|dermatomycoses
501729|NCT01014637|Infection|infection
501730|NCT01014637|Mycoses|mycoses
501731|NCT01014637|Nail diseases|nail diseases
501732|NCT01014637|Ski diseases|ski diseases
501733|NCT01014637|Skin diseases/infectious|skin diseases/infectious
501734|NCT01014624|thienopyridine|thienopyridine
501735|NCT01014624|pharmacologic action|pharmacologic action
501736|NCT01014624|prasugrel|prasugrel
501737|NCT01014624|clopidogrel|clopidogrel
501738|NCT01014611|Heart failure|heart failure
501739|NCT01014611|Skeletal muscle|skeletal muscle
501740|NCT01014611|Calcium|calcium
501741|NCT01014611|Ryanodine receptor|ryanodine receptor
501742|NCT01014611|Mitochondria|mitochondria
501743|NCT01014611|Exercise training|exercise training
501744|NCT01014611|Muscle biopsy|muscle biopsy
501745|NCT01014611|Healthy volunteers|healthy volunteers
501746|NCT01014585|Milnacipran|milnacipran
501747|NCT01014585|Pain|pain
501748|NCT01014585|Durability of Effect|durability of effect
501749|NCT01014585|Loss of Therapeutic Response|loss of therapeutic response
501750|NCT01014585|Fatigue|fatigue
501751|NCT01014585|Forest Research Institute|forest research institute
501752|NCT01014585|Savella ®|savella ®
501753|NCT01014572|Clinical Trials, Phase II|clinical trials, phase ii
501754|NCT01014572|Exercise|exercise
501755|NCT01014572|Exercise Tolerance|exercise tolerance
501756|NCT01014572|Aging|aging
501757|NCT01014559|Constipation|constipation
501758|NCT01014559|Oxycodone|oxycodone
501759|NCT01014559|Oxycodone hydrochloride|oxycodone hydrochloride
501760|NCT01014559|Naloxone hydrochloride|naloxone hydrochloride
501761|NCT01014559|Naloxone|naloxone
501762|NCT01014533|Alcoholism|alcoholism
501763|NCT01014533|Alcohol dependence|alcohol dependence
501764|NCT01014533|Insomnia|insomnia
501765|NCT01014533|Dim light melatonin onset|dim light melatonin onset
501766|NCT01014533|Gabapentin|gabapentin
501767|NCT01014520|Lumbar|lumbar
501768|NCT01014520|Diskectomy|diskectomy
501769|NCT01014520|Laminectomy|laminectomy
501771|NCT01014481|tuberculosis|tuberculosis
501772|NCT01014481|antiretroviral treatment|antiretroviral treatment
501773|NCT01014481|timing|timing
501774|NCT01014468|ranibizumab|ranibizumab
501775|NCT01014468|bevacizumab|bevacizumab
501776|NCT01014468|AMD|amd
501777|NCT01014468|Complications|complications
501778|NCT01014468|Visual acuity|visual acuity
501779|NCT01014468|OCt|oct
501780|NCT01014468|Age Macular Degeneration|age macular degeneration
501781|NCT01014455|surgery|surgery
501782|NCT01014429|Phase I dose escalation study|phase i dose escalation study
501783|NCT01014429|Advanced or metastatic solid tumors|advanced or metastatic solid tumors
501784|NCT01014429|PLK 1 inhibitor|plk 1 inhibitor
501785|NCT01014429|Adult patients|adult patients
501786|NCT01014416|Healthy Korean male|healthy korean male
501787|NCT01014403|venous thromboembolism|venous thromboembolism
501788|NCT01014403|enoxaparin|enoxaparin
501789|NCT01014403|traumatic brain injury|traumatic brain injury
501790|NCT01014403|Venous thromboembolism prophylaxis after traumatic brain injury|venous thromboembolism prophylaxis after traumatic brain injury
501791|NCT01014390|benign biliary strictures secondary to chronic pancreatitis/post abdominal surgery/post liver transplant|benign biliary strictures secondary to chronic pancreatitis/post abdominal surgery/post liver transplant
501792|NCT01014364|Acute lung injury|acute lung injury
501793|NCT01014364|Acute respiratory distress syndrome|acute respiratory distress syndrome
501794|NCT01014364|corticosteroids|corticosteroids
501795|NCT01014364|inflammation|inflammation
501796|NCT01014351|Metastatic Melanoma|metastatic melanoma
501797|NCT01014351|Everolimus|everolimus
501798|NCT01014351|Paclitaxel|paclitaxel
501799|NCT01014351|Carboplatin|carboplatin
501800|NCT01014312|Depression|depression
501801|NCT01014299|Intubation|intubation
501802|NCT01014299|Hypoxemia|hypoxemia
501803|NCT01014299|Mechanical ventilation|mechanical ventilation
501804|NCT01014299|Recruitment maneuver|recruitment maneuver
501805|NCT01014299|Acute lung injury|acute lung injury
501806|NCT01014299|Bacterial translocation|bacterial translocation
501807|NCT01014299|Hypoxemic ICU patients requiring invasive mechanical ventilation|hypoxemic icu patients requiring invasive mechanical ventilation
501808|NCT01014273|Acute Coronary Syndrome|acute coronary syndrome
501810|NCT01014273|Percutaneous Coronary Intervention|percutaneous coronary intervention
501811|NCT01014273|Radial Access|radial access
501812|NCT01014260|Inflammatory markers of cardiovascular disease|inflammatory markers of cardiovascular disease
501813|NCT01014247|Moxifloxacin|moxifloxacin
501814|NCT01014234|Immunosuppressive Agents|immunosuppressive agents
501815|NCT01014234|Immune system regulation|immune system regulation
501816|NCT01014234|Regulatory T cells|regulatory t cells
501817|NCT01014234|Rapamycin|rapamycin
501818|NCT01014234|Tolerance|tolerance
501819|NCT01014221|acupuncture|acupuncture
501820|NCT01014221|carpal tunnel syndrome|carpal tunnel syndrome
501821|NCT01014221|CTS|cts
501822|NCT01014221|steroid|steroid
501823|NCT01014221|global symptom score (GSS)|global symptom score (gss)
501824|NCT01014208|The All Ireland Cooperative Oncology Research Group|the all ireland cooperative oncology research group
501825|NCT01014208|GELTAMO|geltamo
501826|NCT01014208|National Cancer Research Institute Lymphoma Clinical Studies Group|national cancer research institute lymphoma clinical studies group
501827|NCT01014208|Genmab|genmab
501828|NCT01014208|ofatumumab|ofatumumab
501829|NCT01014208|Japan Clinical Oncology Group|japan clinical oncology group
501830|NCT01014208|Oncology|oncology
501831|NCT01014208|Polish Lymphoma Research Group|polish lymphoma research group
501832|NCT01014208|Salvage chemotherapy|salvage chemotherapy
501833|NCT01014208|refractory|refractory
501834|NCT01014208|HOVON|hovon
501835|NCT01014208|DVD|dvd
501836|NCT01014208|relapsed|relapsed
501837|NCT01014208|safety|safety
501838|NCT01014208|efficacy|efficacy
501839|NCT01014208|DHAP|dhap
501840|NCT01014208|rituximab|rituximab
501841|NCT01014208|Autologous Stem Cell Transplant|autologous stem cell transplant
501842|NCT01014208|Dutch-Belgian Cooperative Trial Group for Hematology-Oncology|dutch-belgian cooperative trial group for hematology-oncology
501843|NCT01014208|Grupo Espanol de Linfomas|grupo espanol de linfomas
501844|NCT01014208|Nordic Lymphoma Group|nordic lymphoma group
501845|NCT01014195|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
501846|NCT01014195|Neurocognitive function|neurocognitive function
501847|NCT01014195|ADHD|adhd
501848|NCT01014195|brain imaging|brain imaging
501849|NCT01014195|genetic polymorphisms|genetic polymorphisms
501850|NCT01014195|Psychopathology and neurocognitive Impairment in Leukemia Survivors|psychopathology and neurocognitive impairment in leukemia survivors
501851|NCT01014182|Early PCI|early pci
501852|NCT01014182|Myocardial Infarction|myocardial infarction
501853|NCT01014182|Thrombolysis|thrombolysis
501854|NCT01014182|Optimal revascularization therapy in STEMI patients|optimal revascularization therapy in stemi patients
501855|NCT01014169|Health education|health education
501856|NCT01014169|Sudden Infant Death|sudden infant death
501857|NCT01014169|Breast Feeding|breast feeding
501858|NCT01014169|Infant Equipment|infant equipment
501859|NCT01014156|pulmonary embolism|pulmonary embolism
501860|NCT01014156|vasoconstriction|vasoconstriction
501861|NCT01014156|right ventricular dysfunction|right ventricular dysfunction
501862|NCT01014156|epoprostenol|epoprostenol
501863|NCT01014156|acute pulmonary embolism with right ventricular dysfunction|acute pulmonary embolism with right ventricular dysfunction
501864|NCT01014130|Non Small Cell Lung Cancer|non small cell lung cancer
501865|NCT01014130|Hypofractionated|hypofractionated
501866|NCT01014130|Stereotactic Radiotherapy|stereotactic radiotherapy
501867|NCT01014104|Ovarian hyper stimulation syndrome|ovarian hyper stimulation syndrome
501868|NCT01014104|Methylprednisolone|methylprednisolone
501869|NCT01014104|IVF|ivf
501870|NCT01014091|influenza infection|influenza infection
501871|NCT01014091|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
501872|NCT01014065|sunitinib|sunitinib
501873|NCT01014065|cardiac MRI|cardiac mri
501874|NCT01014065|maximal exercise testing|maximal exercise testing
501875|NCT01014065|biomarkers|biomarkers
501876|NCT01014065|pharmacokinetics|pharmacokinetics
501877|NCT01014026|Mass Screening|mass screening
501878|NCT01014026|Polymerase Chain Reaction|polymerase chain reaction
501879|NCT01014026|Vaginal Smears|vaginal smears
501880|NCT01013987|HIV-1|hiv-1
501881|NCT01013987|triple class failure|triple class failure
501882|NCT01013987|Maraviroc|maraviroc
501883|NCT01013987|Raltegravir|raltegravir
501884|NCT01013987|Darunavir/ritonavir|darunavir/ritonavir
501885|NCT01013987|Maraviroc with raltegravir and darunavir/ritonavir|maraviroc with raltegravir and darunavir/ritonavir
501886|NCT01013961|chronic lymphocytic leukemia|chronic lymphocytic leukemia
501887|NCT01013961|small lymphocytic lymphoma|small lymphocytic lymphoma
501888|NCT01013961|CLL|cll
501889|NCT01013961|elderly|elderly
501890|NCT01013961|low dose rituximab|low dose rituximab
501891|NCT01013961|alemtuzumab|alemtuzumab
501892|NCT01013961|monoclonal antibodies|monoclonal antibodies
501893|NCT01013948|Spirometry|spirometry
501894|NCT01013948|Bronchitis|bronchitis
501895|NCT01013948|COPD|copd
501896|NCT01013948|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
501897|NCT01013948|Emphysema|emphysema
501898|NCT01013948|Chronic Bronchitis|chronic bronchitis
501899|NCT01013935|HIV treatment|hiv treatment
501900|NCT01013935|ART adherence|art adherence
501901|NCT01013935|Using new technology to improve adherence|using new technology to improve adherence
501902|NCT01013935|CARE+|care+
501903|NCT01013935|HIV-1 viral loads|hiv-1 viral loads
501904|NCT01013922|COPD|copd
501905|NCT01013922|COPD-6|copd-6
501906|NCT01013922|Spirometry|spirometry
501907|NCT01013922|VC|vc
501908|NCT01013922|FEV|fev
501909|NCT01013922|FEV1|fev1
501910|NCT01013909|Bifonazole|bifonazole
501911|NCT01013909|Terbinafine|terbinafine
501912|NCT01013909|Reduced treatment duration|reduced treatment duration
501913|NCT01013909|Efficacy|efficacy
501914|NCT01013909|Safety|safety
501915|NCT01013909|Athlete's foot|athlete's foot
501916|NCT01013909|Moderate severity|moderate severity
501917|NCT01013883|systolic dysfunction|systolic dysfunction
501918|NCT01013883|diastolic dysfunction|diastolic dysfunction
501919|NCT01013883|mortality|mortality
501920|NCT01013883|treatment|treatment
501921|NCT01013883|heart rate|heart rate
501922|NCT01013870|mild traumatic brain injury|mild traumatic brain injury
501923|NCT01013870|post-concussion syndrome|post-concussion syndrome
501924|NCT01013870|acute stress disorder|acute stress disorder
501925|NCT01013870|post-traumatic stress disorder|post-traumatic stress disorder
501926|NCT01013870|atorvastatin|atorvastatin
501927|NCT01013844|skin self-examination|skin self-examination
501929|NCT01013844|melanoma|melanoma
501930|NCT01013805|Rectal Cancer|rectal cancer
501931|NCT01013805|Chemotherapy|chemotherapy
501932|NCT01013805|Radiotherapy|radiotherapy
501933|NCT01013792|Diabetic|diabetic
501934|NCT01013792|Foot|foot
501935|NCT01013792|Ulcer|ulcer
501936|NCT01013792|Neuropathic|neuropathic
501937|NCT01013792|Tegaderm Matrix Dressing|tegaderm matrix dressing
501938|NCT01013792|DFU|dfu
501939|NCT01013792|Wound Care|wound care
501940|NCT01013792|PHI|phi
501941|NCT01013779|Merkel Cell Cancer|merkel cell cancer
501942|NCT01013779|PET scanning|pet scanning
501943|NCT01013766|GSK1362885|gsk1362885
501944|NCT01013766|Pharmacodynamics|pharmacodynamics
501945|NCT01013766|Safety|safety
501946|NCT01013766|Pharmacokinetics|pharmacokinetics
501947|NCT01013766|T2DM|t2dm
501948|NCT01013766|Tolerability|tolerability
501949|NCT01013740|Neoplasms, Breast|neoplasms, breast
501950|NCT01013727|Volunteers|volunteers
501951|NCT01013727|healthy subjects|healthy subjects
501952|NCT01013714|Sudden cardiac death|sudden cardiac death
501953|NCT01013714|Ventricular tachycardia|ventricular tachycardia
501954|NCT01013714|Ventricular fibrillation|ventricular fibrillation
501955|NCT01013714|Cardiomyopathy|cardiomyopathy
501956|NCT01013714|Internal cardiac defibrillator shocks|internal cardiac defibrillator shocks
501957|NCT01013714|Internal cardiac defibrillator therapies|internal cardiac defibrillator therapies
501958|NCT01013701|nasal polyps|nasal polyps
501959|NCT01013701|nasal steroid|nasal steroid
501960|NCT01013701|fluticasone furoate|fluticasone furoate
501961|NCT01013688|Radiofrequency ablation|radiofrequency ablation
501962|NCT01013688|Maze|maze
501963|NCT01013688|Atrial fibrillation|atrial fibrillation
501964|NCT01013675|influenza|influenza
501965|NCT01013675|active-controlled|active-controlled
501966|NCT01013675|Phase 2|phase 2
501967|NCT01013662|septic shock|septic shock
501968|NCT01013662|glycemic control|glycemic control
501969|NCT01013662|icu|icu
501970|NCT01013662|lipid metabolism|lipid metabolism
501971|NCT01013662|septic patients|septic patients
501972|NCT01013623|melanoma|melanoma
501973|NCT01013623|stage IV|stage iv
501974|NCT01013623|resectable|resectable
501975|NCT01013623|surgery|surgery
501976|NCT01013623|medical therapy|medical therapy
501977|NCT01013610|Healthy Elderly Volunteers|healthy elderly volunteers
501978|NCT01013597|thyroid|thyroid
501979|NCT01013597|medullary|medullary
501980|NCT01013597|differentiated|differentiated
501981|NCT01013597|radioiodine-resistant|radioiodine-resistant
501982|NCT01013597|LBH589|lbh589
501983|NCT01013597|panobinostat|panobinostat
501984|NCT01013584|vitamin D|vitamin d
501985|NCT01013558|fetal pain|fetal pain
501986|NCT01013558|intrauterine|intrauterine
501987|NCT01013558|needling|needling
501988|NCT01013545|joint engagement|joint engagement
501989|NCT01013545|augmentative communication (AAC)|augmentative communication (aac)
501990|NCT01013545|enhanced milieu training|enhanced milieu training
501991|NCT01013545|autism spectrum disorder|autism spectrum disorder
501992|NCT01013545|language|language
501993|NCT01013532|Ischemic Stroke|ischemic stroke
501994|NCT01013532|Intracranial Hemorrhage|intracranial hemorrhage
501995|NCT01013532|Cilostazol|cilostazol
501996|NCT01013532|Probucol|probucol
501997|NCT01013506|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
501998|NCT01013506|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
501999|NCT01013506|stage IV breast cancer|stage iv breast cancer
502000|NCT01013506|recurrent breast cancer|recurrent breast cancer
502001|NCT01013493|breastfeeding|breastfeeding
502002|NCT01013493|myopia|myopia
502003|NCT01013493|nearsightedness|nearsightedness
502004|NCT01013493|children|children
502005|NCT01013480|Fragile X Syndrome|fragile x syndrome
502006|NCT01013467|blood pressure|blood pressure
502007|NCT01013467|control|control
502008|NCT01013467|adherence|adherence
502009|NCT01013467|behaviour|behaviour
502010|NCT01013454|varenicline percutaneous transcutaneous topical transdermal transdermal delivery system patch|varenicline percutaneous transcutaneous topical transdermal transdermal delivery system patch
502011|NCT01013441|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
502012|NCT01013428|Traumatic Rupture of Tendon|traumatic rupture of tendon
502013|NCT01013415|HIV-1|hiv-1
502014|NCT01013402|Hypoglycemia|hypoglycemia
502015|NCT01013402|Home Blood Glucose Monitoring|home blood glucose monitoring
502016|NCT01013402|Subjects are being investigated for the integrity of|subjects are being investigated for the integrity of
502017|NCT01013402|pituitary-adrenal functions by insulin hypoglycemia test.|pituitary-adrenal functions by insulin hypoglycemia test.
502018|NCT01013389|actifuse|actifuse
502019|NCT01013389|INFUSE|infuse
502020|NCT01013389|InductOs|inductos
502021|NCT01013389|DDD|ddd
502022|NCT01013389|degenerative disk disease|degenerative disk disease
502023|NCT01013389|PLIF|plif
502024|NCT01013389|PITF|pitf
502025|NCT01013389|PLF|plf
502026|NCT01013389|poterolateral lumber fusion|poterolateral lumber fusion
502027|NCT01013389|Bone substitute|bone substitute
502028|NCT01013389|bone graft|bone graft
502029|NCT01013389|synthetic bone substitute|synthetic bone substitute
502030|NCT01013363|abortion|abortion
502031|NCT01013363|first trimester|first trimester
502032|NCT01013363|suction aspiration|suction aspiration
502033|NCT01013363|vacuum aspiration|vacuum aspiration
502034|NCT01013363|music|music
502035|NCT01013363|anesthesia|anesthesia
502036|NCT01013363|analgesia|analgesia
502037|NCT01013363|anxiolytic|anxiolytic
502038|NCT01013363|pain|pain
502039|NCT01013363|anxiety|anxiety
502040|NCT01013363|blood pressure|blood pressure
502041|NCT01013363|heart rate|heart rate
502042|NCT01013363|satisfaction|satisfaction
502043|NCT01013350|Multiple Sclerosis|multiple sclerosis
502044|NCT01013350|Cladribine|cladribine
502045|NCT01013350|PREMIERE|premiere
502046|NCT01013350|Observational study|observational study
502047|NCT01013324|endometrial cancer|endometrial cancer
502048|NCT01013324|endometrial carcinoma|endometrial carcinoma
502049|NCT01013324|carcinoma of the endometrium|carcinoma of the endometrium
502050|NCT01013324|cancer of the endometrium|cancer of the endometrium
502051|NCT01013311|Implantable Cardioverter-Defibrillator (ICD)- pre-existing|implantable cardioverter-defibrillator (icd)- pre-existing
502052|NCT01013298|percutaneous tracheostomy|percutaneous tracheostomy
502053|NCT01013298|paratracheal insertion|paratracheal insertion
502054|NCT01013298|tracheal injury|tracheal injury
502055|NCT01013298|transtracheal needle|transtracheal needle
502056|NCT01013298|ventilatory parameters|ventilatory parameters
502057|NCT01013285|adult giant cell glioblastoma|adult giant cell glioblastoma
502058|NCT01013285|adult gliosarcoma|adult gliosarcoma
502059|NCT01013285|adult glioblastoma|adult glioblastoma
502060|NCT01013272|entecavir|entecavir
502061|NCT01013272|lamivudine|lamivudine
502062|NCT01013272|sequential therapy|sequential therapy
502063|NCT01013259|E.coli|e.coli
502064|NCT01013259|Mutaflor|mutaflor
502065|NCT01013259|grass pollen|grass pollen
502066|NCT01013259|rhinoconjunctivitis|rhinoconjunctivitis
502067|NCT01013259|rhinoconjunctivitis caused by grass pollen|rhinoconjunctivitis caused by grass pollen
502068|NCT01013246|Video games|video games
502069|NCT01013246|Energy balance|energy balance
502070|NCT01013246|Metabolism|metabolism
502171|NCT01012739|QAB149|qab149
502071|NCT01013246|Appetite control|appetite control
502072|NCT01013233|cognitive dysfunction chemotherapy|cognitive dysfunction chemotherapy
502073|NCT01013220|depression|depression
502074|NCT01013220|depression care management|depression care management
502075|NCT01013220|financing|financing
502076|NCT01013220|absenteeism|absenteeism
502077|NCT01013220|presenteeism|presenteeism
502078|NCT01013220|employer decisions to purchase health care benefits|employer decisions to purchase health care benefits
502079|NCT01013207|CPAP compliance|cpap compliance
502080|NCT01013194|Liver cirrhosis|liver cirrhosis
502081|NCT01013194|Fetal stem cells|fetal stem cells
502082|NCT01013194|Stem cell transplantation|stem cell transplantation
502083|NCT01013194|Liver transplant candidate|liver transplant candidate
502084|NCT01013181|Immune Thrombopenia|immune thrombopenia
502085|NCT01013181|Thrombocytopenia|thrombocytopenia
502086|NCT01013181|romiplostim|romiplostim
502087|NCT01013181|compassionate program|compassionate program
502088|NCT01013168|OncoSorb|oncosorb
502089|NCT01013168|immune apheresis|immune apheresis
502090|NCT01013168|sTNF-R1|stnf-r1
502091|NCT01013168|sTNF-R2|stnf-r2
502092|NCT01013168|sIL-2R|sil-2r
502093|NCT01013168|TNF|tnf
502094|NCT01013142|COPD|copd
502095|NCT01013129|hereditary prostate cancer|hereditary prostate cancer
502096|NCT01013129|prostate cancer|prostate cancer
502097|NCT01013090|Epidural anesthesia|epidural anesthesia
502098|NCT01013090|Spinal anesthesia|spinal anesthesia
502099|NCT01013090|Combined spinal-epidural anesthesia|combined spinal-epidural anesthesia
502100|NCT01013090|Fluid therapy|fluid therapy
502101|NCT01013090|Crystalloid|crystalloid
502102|NCT01013090|Colloid|colloid
502103|NCT01013077|functional vision|functional vision
502104|NCT01013077|contrast sensitivity|contrast sensitivity
502105|NCT01013077|aberrometry|aberrometry
502106|NCT01013077|reading ability|reading ability
502107|NCT01013064|Erythropoietin|erythropoietin
502108|NCT01013064|Long acting|long acting
502109|NCT01013064|EPO|epo
502110|NCT01013051|obesity|obesity
502111|NCT01013051|gastric bypass|gastric bypass
502112|NCT01013051|metformin|metformin
502113|NCT01013051|pharmacokinetics|pharmacokinetics
502114|NCT01013051|absorption|absorption
502115|NCT01013038|myocardial infarction|myocardial infarction
502116|NCT01013038|percutaneous coronary intervention|percutaneous coronary intervention
502117|NCT01013038|thrombus aspiration|thrombus aspiration
502118|NCT01013025|prostate cancer|prostate cancer
502119|NCT01013025|implant retrieval|implant retrieval
502120|NCT01013012|highly susceptible patients following spine surgery|highly susceptible patients following spine surgery
502121|NCT01012999|acute pain, intranasal, sufentanil,|acute pain, intranasal, sufentanil,
502122|NCT01012999|Acute pain control with an intranasal opiate|acute pain control with an intranasal opiate
502123|NCT01012973|Macular Edema|macular edema
502124|NCT01012973|Central Retinal Vein Occlusion|central retinal vein occlusion
502125|NCT01012973|CRVO|crvo
502126|NCT01012973|VEGF Trap-Eye|vegf trap-eye
502127|NCT01012973|best-corrected visual acuity|best-corrected visual acuity
502128|NCT01012960|methylnaltrexone|methylnaltrexone
502129|NCT01012960|upper esophageal sphincter|upper esophageal sphincter
502130|NCT01012960|lower esophageal sphincter|lower esophageal sphincter
502131|NCT01012960|high resolution solid state manometry|high resolution solid state manometry
502132|NCT01012960|opioid induced pharyngeal and esophageal dysfunction|opioid induced pharyngeal and esophageal dysfunction
502133|NCT01012947|MMSE|mmse
502134|NCT01012947|activity|activity
502135|NCT01012921|GBR|gbr
502136|NCT01012921|GTR|gtr
502137|NCT01012921|Dental Implant surgery|dental implant surgery
502138|NCT01012869|Coronary chronic total occlusions|coronary chronic total occlusions
502139|NCT01012856|depressive episode|depressive episode
502140|NCT01012856|psychotherapy|psychotherapy
502141|NCT01012856|cognitive therapy|cognitive therapy
502142|NCT01012856|emotional processing|emotional processing
502143|NCT01012856|RCT|rct
502144|NCT01012856|exposure|exposure
502145|NCT01012856|dual process model|dual process model
502146|NCT01012856|Implicit Association Test|implicit association test
502147|NCT01012856|mechanism of change|mechanism of change
502148|NCT01012843|Perianal|perianal
502149|NCT01012843|Abscess|abscess
502150|NCT01012843|Fistulae in ano|fistulae in ano
502151|NCT01012843|Antibiotic|antibiotic
502152|NCT01012843|Anorectal|anorectal
502153|NCT01012830|Schizophrenia|schizophrenia
502154|NCT01012830|Cognitive Disorders|cognitive disorders
502155|NCT01012830|Dementia|dementia
502156|NCT01012830|Huperzine A|huperzine a
502157|NCT01012830|HupA|hupa
502158|NCT01012804|stage IV colon cancer|stage iv colon cancer
502159|NCT01012804|recurrent colon cancer|recurrent colon cancer
502160|NCT01012791|Zumba exercise|zumba exercise
502161|NCT01012791|ApoE|apoe
502162|NCT01012778|Performance impairment|performance impairment
502163|NCT01012778|Yoga|yoga
502164|NCT01012778|Meditation|meditation
502165|NCT01012778|Peer mediated|peer mediated
502166|NCT01012765|COPD|copd
502167|NCT01012765|indacaterol|indacaterol
502168|NCT01012765|QAB149|qab149
502169|NCT01012765|inspiratory capacity|inspiratory capacity
502170|NCT01012739|asthma|asthma
502172|NCT01012739|indacaterol|indacaterol
502173|NCT01012739|pulmonary function|pulmonary function
502174|NCT01012713|Psoriasis|psoriasis
502175|NCT01012713|Excimer|excimer
502176|NCT01012713|Laser|laser
502177|NCT01012713|Clobex|clobex
502178|NCT01012713|Vectical|vectical
502179|NCT01012713|clobetasol spray|clobetasol spray
502180|NCT01012713|calcitriol|calcitriol
502181|NCT01012713|Generalized plaque type psoriasis|generalized plaque type psoriasis
502182|NCT01012674|carotid or vertebral artery disease|carotid or vertebral artery disease
502183|NCT01012674|Contrast agent|contrast agent
502184|NCT01012674|MRA|mra
502185|NCT01012661|Moderate to severe wrinkles and folds such as nasolabial folds|moderate to severe wrinkles and folds such as nasolabial folds
502186|NCT01012635|spinal cord injury|spinal cord injury
502187|NCT01012635|chronic pain|chronic pain
502188|NCT01012622|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
502189|NCT01012622|Methylphenidate Hydrochloride|methylphenidate hydrochloride
502190|NCT01012609|high-grade astrocytomas|high-grade astrocytomas
502191|NCT01012609|newly diagnosed diffuse pontine tumors|newly diagnosed diffuse pontine tumors
502192|NCT01012609|External beam radiation therapy|external beam radiation therapy
502193|NCT01012609|cetuximab|cetuximab
502194|NCT01012609|irinotecan|irinotecan
502195|NCT01012609|POETIC|poetic
502196|NCT01012596|Natural Family Planning Methods|natural family planning methods
502197|NCT01012596|Ovulation Detection|ovulation detection
502198|NCT01012596|Cervix Mucus|cervix mucus
502199|NCT01012596|Intention|intention
502200|NCT01012596|Behavior|behavior
502201|NCT01012596|Birth Control|birth control
502202|NCT01012596|Contraception|contraception
502203|NCT01012596|Pregnancy|pregnancy
502204|NCT01012596|Fertility|fertility
502205|NCT01012583|Optical coherence tomography|optical coherence tomography
502206|NCT01012583|Drug eluting stent|drug eluting stent
502207|NCT01012583|Biodegradable polymer|biodegradable polymer
502208|NCT01012583|Intimal|intimal
502209|NCT01012583|Coverage|coverage
502210|NCT01012583|assess intimal hyperplasia of drug eluting stent with biodegradable polymer|assess intimal hyperplasia of drug eluting stent with biodegradable polymer
502211|NCT01012557|H1N1v|h1n1v
502212|NCT01012557|vaccine|vaccine
502213|NCT01012557|pregnant|pregnant
502214|NCT01012557|women|women
502215|NCT01012557|Assess whether the adjuvanted vaccine offers a meaningful benefit in pregnant women in terms of immune response over the non-adjuvanted vaccine.|assess whether the adjuvanted vaccine offers a meaningful benefit in pregnant women in terms of immune response over the non-adjuvanted vaccine.
502216|NCT01012557|Assess the persistence of immune response over a 15 month time period after one single vaccination of the pregnant mother.|assess the persistence of immune response over a 15 month time period after one single vaccination of the pregnant mother.
502217|NCT01012557|Assess whether the immune response to H1N1 in pregnant women is different from that of non-pregnant women of similar age.|assess whether the immune response to h1n1 in pregnant women is different from that of non-pregnant women of similar age.
502218|NCT01012557|Gain insight on safety of the Novartis egg-based MF59 adjuvanted H1N1 vaccine Focetria in pregnant women and their babies.|gain insight on safety of the novartis egg-based mf59 adjuvanted h1n1 vaccine focetria in pregnant women and their babies.
502219|NCT01012557|Assess the maternally transferred specific antibodies against H1N1v in the newborn|assess the maternally transferred specific antibodies against h1n1v in the newborn
502220|NCT01012557|Passive immunity transferred to the infant.|passive immunity transferred to the infant.
502221|NCT01012544|clopidogrel|clopidogrel
502222|NCT01012544|pharmacokinetics|pharmacokinetics
502223|NCT01012544|platelet function tests|platelet function tests
502224|NCT01012544|platelet reactivity|platelet reactivity
502225|NCT01012518|percutaneous tracheostomy|percutaneous tracheostomy
502226|NCT01012518|paratracheal insertion|paratracheal insertion
502227|NCT01012518|tracheal injury|tracheal injury
502228|NCT01012518|transtracheal needle|transtracheal needle
502229|NCT01012518|ventilatory parameters|ventilatory parameters
502230|NCT01012492|cancer|cancer
502231|NCT01012492|leukemia|leukemia
502232|NCT01012492|transplant|transplant
502233|NCT01012492|bone marrow|bone marrow
502234|NCT01012479|Blood Pressure|blood pressure
502235|NCT01012479|Blood Pressure, High|blood pressure, high
502236|NCT01012479|Drug Therapy|drug therapy
502237|NCT01012466|pregnancy|pregnancy
502238|NCT01012466|birth|birth
502239|NCT01012466|labor|labor
502240|NCT01012466|labor pain|labor pain
502241|NCT01012466|catastrophizing|catastrophizing
502242|NCT01012453|Hand eczema|hand eczema
502243|NCT01012453|Hand dermatitis|hand dermatitis
502244|NCT01012453|Occupational skin disease|occupational skin disease
502245|NCT01012453|skindisease in health care workers|skindisease in health care workers
502246|NCT01012453|occupational hand dermatitis|occupational hand dermatitis
502247|NCT01012453|occupational hand eczema|occupational hand eczema
502248|NCT01012427|Kidney|kidney
502249|NCT01012427|Cryoablation|cryoablation
502250|NCT01012427|09-108|09-108
502251|NCT01012414|Vitamin D|vitamin d
502252|NCT01012414|Coronary Artery Disease (CAD)|coronary artery disease (cad)
502253|NCT01012414|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
502254|NCT01012401|Lung cancer|lung cancer
502255|NCT01012401|Quality of life|quality of life
502256|NCT01012401|Communication with physician|communication with physician
502356|NCT01011881|empyema|empyema
502257|NCT01012388|Moderate to severe wrinkles and folds such as nasolabial folds|moderate to severe wrinkles and folds such as nasolabial folds
502258|NCT01012375|Adult ADHD|adult adhd
502259|NCT01012362|Solid tumor malignancy|solid tumor malignancy
502260|NCT01012362|breast cancer|breast cancer
502261|NCT01012362|lung cancer|lung cancer
502262|NCT01012362|colon cancer|colon cancer
502263|NCT01012362|pancreatic cancer|pancreatic cancer
502264|NCT01012362|head and neck cancer|head and neck cancer
502265|NCT01012362|kidney cancer|kidney cancer
502266|NCT01012362|sarcoma|sarcoma
502267|NCT01012362|hepatocellular cancer|hepatocellular cancer
502268|NCT01012336|efficacy and safety of Aprepitant/Ramosetron/Dexamethasone in ovary cancer patients with taxol and carboplatin|efficacy and safety of aprepitant/ramosetron/dexamethasone in ovary cancer patients with taxol and carboplatin
502269|NCT01012323|PID|pid
502270|NCT01012310|pharmacokinetics safety tolerability multiple dosing|pharmacokinetics safety tolerability multiple dosing
502271|NCT01012284|Moderate Hepatic Impairment|moderate hepatic impairment
502272|NCT01012284|Tuberculosis|tuberculosis
502273|NCT01012284|TMC207|tmc207
502274|NCT01012284|Mycobacterial adenosine triphosphate (ATP)-synthase|mycobacterial adenosine triphosphate (atp)-synthase
502275|NCT01012271|Wrist abnormalities|wrist abnormalities
502276|NCT01012258|antitumor activity|antitumor activity
502277|NCT01012258|safety|safety
502278|NCT01012258|cetuximab in combination with radiotherapy|cetuximab in combination with radiotherapy
502410|NCT01011621|Betamethasone valerate|betamethasone valerate
502279|NCT01012258|locally advanced squamous cell head & neck carcinoma|locally advanced squamous cell head & neck carcinoma
502280|NCT01012245|Xchange|xchange
502281|NCT01012245|Xalatan|xalatan
502282|NCT01012245|Xalacom|xalacom
502283|NCT01012245|Betablocker|betablocker
502284|NCT01012245|observational|observational
502285|NCT01012245|longterm|longterm
502286|NCT01012232|total knee arthroplasty|total knee arthroplasty
502287|NCT01012232|postoperative pain|postoperative pain
502288|NCT01012206|Children|children
502289|NCT01012206|Overweight|overweight
502290|NCT01012206|Obesity|obesity
502291|NCT01012206|Food habits|food habits
502292|NCT01012206|Dietary assessment|dietary assessment
502293|NCT01012206|Physical activity|physical activity
502294|NCT01012193|adjunctive cilostazol|adjunctive cilostazol
502295|NCT01012193|high-MD clopidogrel|high-md clopidogrel
502296|NCT01012193|CYP 2C19 polymorphism|cyp 2c19 polymorphism
502297|NCT01012193|high risk patients|high risk patients
502298|NCT01012180|Bipolar Disorder|bipolar disorder
502299|NCT01012180|Adaptation|adaptation
502300|NCT01012180|Parents|parents
502301|NCT01012180|Risk|risk
502302|NCT01012180|Coping|coping
502303|NCT01012180|Survey|survey
502304|NCT01012167|Schizophrenia, oxytocin, galantamine|schizophrenia, oxytocin, galantamine
502305|NCT01012128|Temporal Artery Thermometer|temporal artery thermometer
502306|NCT01012128|Temperature|temperature
502307|NCT01012128|Preterm Infants|preterm infants
502308|NCT01012115|Histones|histones
502309|NCT01012115|organ failure|organ failure
502310|NCT01012115|sepsis|sepsis
502311|NCT01012102|EMD 640744|emd 640744
502312|NCT01012102|Montanide|montanide
502313|NCT01012102|Advanced solid tumours|advanced solid tumours
502314|NCT01012089|Hemodialysis|hemodialysis
502315|NCT01012089|Peritoneal dialysis|peritoneal dialysis
502316|NCT01012089|Daptomycin|daptomycin
502317|NCT01012089|Pharmacokinetics|pharmacokinetics
502318|NCT01012076|maternal synchrony|maternal synchrony
502319|NCT01012076|parent-child|parent-child
502320|NCT01012076|parent child play|parent child play
502321|NCT01012076|social communication|social communication
502322|NCT01012063|iron|iron
502323|NCT01012063|erythropoietin|erythropoietin
502324|NCT01012063|hemoglobin|hemoglobin
502325|NCT01012063|Total knee replacement arthroplasty|total knee replacement arthroplasty
502326|NCT01012050|Asthma|asthma
502327|NCT01012050|status asthmatics|status asthmatics
502328|NCT01012011|Carcinoma, Hepatocellular|carcinoma, hepatocellular
502329|NCT01012011|Carcinoma, Renal Cell|carcinoma, renal cell
502330|NCT01011998|CML|cml
502331|NCT01011998|Chronic Myelogenous leukemia|chronic myelogenous leukemia
502332|NCT01011998|INST 0901|inst 0901
502333|NCT01011998|imatinib|imatinib
502334|NCT01011998|valproic acid|valproic acid
502335|NCT01011998|Gleevec|gleevec
502336|NCT01011985|end stage renal disease|end stage renal disease
502337|NCT01011985|inflammation|inflammation
502338|NCT01011985|vascular access|vascular access
502339|NCT01011985|hemodialysis|hemodialysis
502340|NCT01011972|Dose escalation|dose escalation
502341|NCT01011972|XMT-1107|xmt-1107
502342|NCT01011972|1107|1107
502343|NCT01011972|Tumor|tumor
502344|NCT01011972|Phase 1|phase 1
502345|NCT01011972|Fumagillol|fumagillol
502346|NCT01011972|PHF|phf
502347|NCT01011972|Fleximer|fleximer
502348|NCT01011972|cancer|cancer
502349|NCT01011972|maximum tolerated dose|maximum tolerated dose
502350|NCT01011972|MTD|mtd
502351|NCT01011920|newly diagnosed primary central nervous system lymphoma|newly diagnosed primary central nervous system lymphoma
502352|NCT01011894|Lenalidomide|lenalidomide
502353|NCT01011894|CLL|cll
502354|NCT01011894|09-045|09-045
502355|NCT01011881|pleuritis|pleuritis
502357|NCT01011881|procalcitonin|procalcitonin
502358|NCT01011829|methamphetamine|methamphetamine
502359|NCT01011829|crystal meth|crystal meth
502360|NCT01011829|addiction|addiction
502361|NCT01011829|los angeles|los angeles
502362|NCT01011829|medication|medication
502363|NCT01011829|meth|meth
502364|NCT01011816|intervertebral disk|intervertebral disk
502365|NCT01011803|Deglutition|deglutition
502366|NCT01011803|Phonation|phonation
502367|NCT01011790|Healing Rhythms™|healing rhythms™
502368|NCT01011790|Meditation|meditation
502369|NCT01011790|Biofeedback|biofeedback
502370|NCT01011790|Stress|stress
502371|NCT01011777|bladder exstrophy epispadias complex|bladder exstrophy epispadias complex
502372|NCT01011777|urinary incontinence|urinary incontinence
502373|NCT01011777|muscle derive cell therapy|muscle derive cell therapy
502374|NCT01011777|stem cells|stem cells
502375|NCT01011764|social networks|social networks
502376|NCT01011764|friendships|friendships
502377|NCT01011764|autism spectrum disorder|autism spectrum disorder
502378|NCT01011751|Drug Therapy|drug therapy
502379|NCT01011712|Genetics|genetics
502380|NCT01011712|Virus|virus
502381|NCT01011712|Defense|defense
502382|NCT01011712|Immune Defects|immune defects
502383|NCT01011712|Respiratory Viruses|respiratory viruses
502384|NCT01011712|Herpesvirus|herpesvirus
502385|NCT01011712|Cytomegalovirus|cytomegalovirus
502386|NCT01011712|Human Papillomavirus|human papillomavirus
502387|NCT01011712|Adenovirus|adenovirus
502388|NCT01011699|nicotinamide|nicotinamide
502389|NCT01011699|sevelamer hydrochloride|sevelamer hydrochloride
502390|NCT01011699|phosphatemia|phosphatemia
502391|NCT01011699|cinacalcet|cinacalcet
502392|NCT01011699|dyslipidemia|dyslipidemia
502393|NCT01011699|vascular calcification|vascular calcification
502394|NCT01011699|bone mass loss|bone mass loss
502395|NCT01011673|headache|headache
502396|NCT01011673|tension-type headache|tension-type headache
502397|NCT01011660|hypertension|hypertension
502398|NCT01011660|cardiovascular risk factors|cardiovascular risk factors
502399|NCT01011660|drugs intervention|drugs intervention
502400|NCT01011660|lipid-lowering therapy|lipid-lowering therapy
502401|NCT01011660|50-79 years of age|50-79 years of age
502402|NCT01011660|sign|sign
502403|NCT01011660|the informed|the informed
502404|NCT01011660|consent|consent
502405|NCT01011660|forms|forms
502406|NCT01011634|abortion|abortion
502407|NCT01011634|uterine aspiration|uterine aspiration
502408|NCT01011634|pain control|pain control
502409|NCT01011621|Prednisolone acetate|prednisolone acetate
502411|NCT01011595|lung cancer|lung cancer
502412|NCT01011595|mediastinoscopy|mediastinoscopy
502413|NCT01011595|mediastinal lymph nodes|mediastinal lymph nodes
502414|NCT01011595|staging|staging
502415|NCT01011595|EBUS|ebus
502416|NCT01011595|EUS|eus
502417|NCT01011595|Endobronchial Ultrasound|endobronchial ultrasound
502418|NCT01011595|Endoscopic Ultrasound|endoscopic ultrasound
502419|NCT01011582|To evaluate biomarkers that cause critical illness in patients with novel H1N1 influenza and with seasonal influenza.|to evaluate biomarkers that cause critical illness in patients with novel h1n1 influenza and with seasonal influenza.
502420|NCT01011569|difference|difference
502421|NCT01011556|Age Related Osteoporosis|age related osteoporosis
502422|NCT01011556|Senile Osteoporosis|senile osteoporosis
502423|NCT01011543|pulmonary tuberculosis|pulmonary tuberculosis
502424|NCT01011543|negative sputum exam|negative sputum exam
502425|NCT01011543|induced sputum|induced sputum
502426|NCT01011543|endoscopy|endoscopy
502427|NCT01011530|Melanoma|melanoma
502428|NCT01011517|muscadine grapes|muscadine grapes
502429|NCT01011517|endothelial function|endothelial function
502430|NCT01011491|Obesity|obesity
502431|NCT01011491|Weight loss|weight loss
502432|NCT01011491|meal replacements|meal replacements
502433|NCT01011491|inflammation|inflammation
502434|NCT01011491|oxidative stress|oxidative stress
502435|NCT01011491|visceral fat|visceral fat
502436|NCT01011478|adenomatous polyp|adenomatous polyp
502437|NCT01011478|stage I colon cancer|stage i colon cancer
502438|NCT01011478|stage II colon cancer|stage ii colon cancer
502439|NCT01011478|adenocarcinoma of the colon|adenocarcinoma of the colon
502440|NCT01011465|Stress|stress
502441|NCT01011465|Oxytocin|oxytocin
502442|NCT01011465|Social Support|social support
502443|NCT01011465|Resilience|resilience
502444|NCT01011452|Acute Asthma Exacerbation|acute asthma exacerbation
502445|NCT01011452|Montelukast|montelukast
502446|NCT01011452|Management of acute asthma exacerbation|management of acute asthma exacerbation
502447|NCT01011439|B3 and C malignant thymoma|b3 and c malignant thymoma
502448|NCT01011426|laxative|laxative
502449|NCT01011426|postoperative care|postoperative care
502450|NCT01011426|ob-Gyn population|ob-gyn population
502451|NCT01011426|post-operative patients|post-operative patients
502452|NCT01011426|obstetrical and gynecological surgery|obstetrical and gynecological surgery
502453|NCT01011413|HIV|hiv
502454|NCT01011413|ART|art
502455|NCT01011413|Efavirenz|efavirenz
502456|NCT01011413|Dose reduction|dose reduction
502457|NCT01011400|clitoris|clitoris
502458|NCT01011387|Diabetic foot ulcers|diabetic foot ulcers
502459|NCT01011374|Retinal vein occlusion|retinal vein occlusion
502460|NCT01011374|Ranibizumab|ranibizumab
502461|NCT01011374|Lucentis|lucentis
502462|NCT01011374|Depression|depression
502463|NCT01011348|Gulf War Illness|gulf war illness
502464|NCT01011348|Coenzyme Q10|coenzyme q10
502465|NCT01011348|Quality of Life|quality of life
502466|NCT01011348|Fatigue|fatigue
502467|NCT01011348|oxidative stress|oxidative stress
502468|NCT01011335|Staphylococcus aureus|staphylococcus aureus
502469|NCT01011335|Skin and soft tissue infection|skin and soft tissue infection
502470|NCT01011335|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
502471|NCT01011335|Recombinant alpha-toxoid (rAT)|recombinant alpha-toxoid (rat)
502472|NCT01011335|Recombinant LukS subunit of Panton-Valentine Leukocidin (rLukS-PV)|recombinant luks subunit of panton-valentine leukocidin (rluks-pv)
502473|NCT01011309|Leishmaniasis|leishmaniasis
502474|NCT01011309|vaccine|vaccine
502475|NCT01011309|immunotherapy|immunotherapy
502476|NCT01011283|MDS|mds
502477|NCT01011283|Myelodysplastic Syndromes|myelodysplastic syndromes
502478|NCT01011270|Back pain|back pain
502479|NCT01011270|postural balance|postural balance
502480|NCT01011270|RDM|rdm
502481|NCT01011270|industrial operators|industrial operators
502482|NCT01011257|CAD|cad
502483|NCT01011231|Gamma Knife radiosurgery|gamma knife radiosurgery
502484|NCT01011231|recurrent glioma|recurrent glioma
502485|NCT01011231|MRI|mri
502486|NCT01011231|Spectroscopy|spectroscopy
502487|NCT01011231|Recurrent grade IV glioma (glioblastoma), with two additional exploratory arms for patients with recurrent grade II and grade III gliomas|recurrent grade iv glioma (glioblastoma), with two additional exploratory arms for patients with recurrent grade ii and grade iii gliomas
502488|NCT01011218|quality of life|quality of life
502489|NCT01011205|Immunosuppression|immunosuppression
502490|NCT01011205|Liver|liver
502491|NCT01011205|Transplant|transplant
502492|NCT01011205|Advagraf|advagraf
502493|NCT01011192|Intravenous anesthesia|intravenous anesthesia
502494|NCT01011192|propofol|propofol
502495|NCT01011192|pharmacokinetic model|pharmacokinetic model
502496|NCT01011192|Monitoring|monitoring
502497|NCT01011192|bispectral index.|bispectral index.
502498|NCT01011179|Teens Taking Charge|teens taking charge
502499|NCT01011179|Managing Arthritis Online|managing arthritis online
502500|NCT01011179|juvenile idiopathic arthritis|juvenile idiopathic arthritis
502501|NCT01011179|internet|internet
502502|NCT01011179|self-management|self-management
502503|NCT01011166|Chronic Hepatitis C|chronic hepatitis c
502504|NCT01011166|HepC|hepc
502505|NCT01011166|Hep C|hep c
502506|NCT01011140|Parenteral Hydration|parenteral hydration
502507|NCT01011140|Latin American Association for Palliative Care|latin american association for palliative care
502508|NCT01011140|ALCP|alcp
502509|NCT01011140|Spanish Society for Palliative Care|spanish society for palliative care
502510|NCT01011140|SECPAL|secpal
502511|NCT01011140|Online survey|online survey
502512|NCT01011140|Palliative care|palliative care
502513|NCT01011140|Physicians' attitudes|physicians' attitudes
502514|NCT01011140|End of life|end of life
502515|NCT01011140|Latin America|latin america
502516|NCT01011140|Spain|spain
502517|NCT01011127|Statins|statins
502518|NCT01011127|Insulin resistance|insulin resistance
502519|NCT01011114|hypophosphatemia|hypophosphatemia
502520|NCT01011114|hyperparathyroidism|hyperparathyroidism
502521|NCT01011114|renal transplant|renal transplant
502522|NCT01011101|Saccadic Eye Movements|saccadic eye movements
502523|NCT01011101|Schizophrenia|schizophrenia
502524|NCT01011101|Healthy Volunteer|healthy volunteer
502525|NCT01011101|HV|hv
502526|NCT01011088|Paternity|paternity
502527|NCT01011088|Psychology|psychology
502528|NCT01011088|Risk factor|risk factor
502529|NCT01011075|Lung cancer,|lung cancer,
502530|NCT01011075|Non-small cell lung cancer|non-small cell lung cancer
502531|NCT01011075|NSCLC|nsclc
502532|NCT01011075|Metastatic|metastatic
502533|NCT01011075|Gleevec|gleevec
502534|NCT01011075|elderly|elderly
502535|NCT01011062|Adipose tissue|adipose tissue
502536|NCT01011062|Adipokines|adipokines
502537|NCT01011049|Influenza|influenza
502538|NCT01011049|Fluzone Vaccine|fluzone vaccine
502539|NCT01011049|Intradermal Injections|intradermal injections
502540|NCT01011049|Adults|adults
502541|NCT01011036|healthy study subjects, no disease|healthy study subjects, no disease
502542|NCT01011023|Bowel anastomosis|bowel anastomosis
502543|NCT01011023|nasogastric tube|nasogastric tube
502544|NCT01011023|children|children
502545|NCT01011010|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
502546|NCT01011010|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
502547|NCT01011010|recurrent adult primary liver cancer|recurrent adult primary liver cancer
502548|NCT01010997|AMD, CNV|amd, cnv
502549|NCT01010984|metastatic melanoma|metastatic melanoma
502550|NCT01010984|stage IV melanoma|stage iv melanoma
502551|NCT01010984|metastatic melanoma to the liver|metastatic melanoma to the liver
502552|NCT01010971|Mountain Cedar|mountain cedar
502553|NCT01010945|Advanced Pancreatic Cancer|advanced pancreatic cancer
502554|NCT01010945|erlotinib|erlotinib
502555|NCT01010945|gemcitabine|gemcitabine
502556|NCT01010945|nab-paclitaxel|nab-paclitaxel
502557|NCT01010945|Adenocarcinoma|adenocarcinoma
502558|NCT01010945|Phase 1b|phase 1b
502559|NCT01010932|carotid or vertebral artery disease|carotid or vertebral artery disease
502560|NCT01010932|Contrast agent|contrast agent
502561|NCT01010932|MRA|mra
502562|NCT01010893|pandemic|pandemic
502563|NCT01010893|prevention|prevention
502564|NCT01010893|influenza|influenza
502565|NCT01010893|infection|infection
502566|NCT01010893|influenza vaccine|influenza vaccine
502567|NCT01010893|vaccine|vaccine
502568|NCT01010893|influenza in humans|influenza in humans
502569|NCT01010880|Multiple Myeloma|multiple myeloma
502570|NCT01010880|CXCR4|cxcr4
502571|NCT01010880|Stem Cells|stem cells
502572|NCT01010880|Mobilization|mobilization
502573|NCT01010880|Transplantation|transplantation
502574|NCT01010880|Chemotherapy|chemotherapy
502575|NCT01010867|Probiotics|probiotics
502576|NCT01010867|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
502577|NCT01010867|Pediatrics|pediatrics
502578|NCT01010854|breast cancer|breast cancer
502579|NCT01010854|advanced|advanced
502580|NCT01010854|local|local
502581|NCT01010841|Metabolic syndrome|metabolic syndrome
502582|NCT01010841|Serum lipid|serum lipid
502583|NCT01010841|Dietary intervention|dietary intervention
502584|NCT01010841|Lifestyle modification|lifestyle modification
502585|NCT01010841|Glycemic load|glycemic load
502586|NCT01010841|Phytochemical|phytochemical
502587|NCT01010841|Hops|hops
502588|NCT01010841|Acacia|acacia
502589|NCT01010841|Mediterranean diet|mediterranean diet
502590|NCT01010841|Kinase modulator|kinase modulator
502591|NCT01010815|ulcerative colitis|ulcerative colitis
502592|NCT01010815|gut microbiome|gut microbiome
502593|NCT01010815|metagenomics|metagenomics
502594|NCT01010802|Neuroprotection|neuroprotection
502595|NCT01010802|Parkinson Disease|parkinson disease
502596|NCT01010802|Erythropoietin|erythropoietin
502597|NCT01010776|Schizophrenia|schizophrenia
502598|NCT01010776|Paliperidone|paliperidone
502599|NCT01010750|ADHD|adhd
502600|NCT01010737|Multimeric|multimeric
502601|NCT01010737|Vaccine|vaccine
502602|NCT01010737|Influenza|influenza
502603|NCT01010737|elderly|elderly
502604|NCT01010737|phase 1/2|phase 1/2
502605|NCT01010737|safety|safety
502606|NCT01010737|efficacy|efficacy
502607|NCT01010737|tolerability|tolerability
502608|NCT01010737|reactogenicity|reactogenicity
502609|NCT01010737|Montanide|montanide
502610|NCT01010737|hemagglutinin inhibition|hemagglutinin inhibition
502611|NCT01010737|HAI|hai
502612|NCT01010737|TIV|tiv
502613|NCT01010711|migraine|migraine
502614|NCT01010711|children|children
502615|NCT01010711|dietary supplement|dietary supplement
502616|NCT01010711|q10|q10
502617|NCT01010711|prevention|prevention
502618|NCT01010698|cimetidine|cimetidine
502619|NCT01010698|acyclovir|acyclovir
502620|NCT01010698|pharmacokinetics|pharmacokinetics
502621|NCT01010698|excipient|excipient
502622|NCT01010698|formulation|formulation
502623|NCT01010685|Natural Orifice Transluminal Endoscopic Surgery (NOTES)|natural orifice transluminal endoscopic surgery (notes)
502624|NCT01010685|Transgastric surgery|transgastric surgery
502625|NCT01010685|Surgical Procedures, Minimally Invasive|surgical procedures, minimally invasive
502626|NCT01010659|Dacryocystorhinostomy|dacryocystorhinostomy
502627|NCT01010646|hepatitis C|hepatitis c
502628|NCT01010646|viral kinetics|viral kinetics
502629|NCT01010646|antiviral response|antiviral response
502630|NCT01010646|Genotype 1 or 4|genotype 1 or 4
502631|NCT01010620|screening|screening
502632|NCT01010620|research participation|research participation
502633|NCT01010620|substance abuse|substance abuse
502634|NCT01010620|Schizophrenia|schizophrenia
502635|NCT01010620|nicotine|nicotine
502636|NCT01010620|Healthy|healthy
502637|NCT01010620|cigarettes|cigarettes
502638|NCT01010620|smoking|smoking
502639|NCT01010620|marijuana|marijuana
502640|NCT01010620|cocaine|cocaine
502641|NCT01010581|Rheumatoid Arthritis|rheumatoid arthritis
502642|NCT01010581|SC12267|sc12267
502643|NCT01010581|4SC-101|4sc-101
502644|NCT01010581|Methotrexate|methotrexate
502645|NCT01010581|Phase II|phase ii
502646|NCT01010568|CLL|cll
502647|NCT01010568|SLL|sll
502648|NCT01010568|Bendamustine|bendamustine
502649|NCT01010568|Ofatumumab|ofatumumab
502650|NCT01010542|Single dose psoriasis study|single dose psoriasis study
502651|NCT01010529|Occupational Therapy|occupational therapy
502652|NCT01010529|Parkinson's Disease|parkinson's disease
502653|NCT01010529|Feasibility|feasibility
502654|NCT01010529|Effectiveness|effectiveness
502655|NCT01010529|RCT|rct
502656|NCT01010529|Activities of daily living|activities of daily living
502657|NCT01010529|Participation|participation
502658|NCT01010529|Caregiver's Burden|caregiver's burden
502659|NCT01010490|PACHYMETRY|pachymetry
502660|NCT01010490|CELL LOSS|cell loss
502661|NCT01010490|SAFETY|safety
502662|NCT01010490|EFFICACY|efficacy
502663|NCT01010490|PHACOEMULSIFICATION|phacoemulsification
502664|NCT01010490|Intraoperative complications|intraoperative complications
502665|NCT01010490|CLOCK TIME|clock time
502666|NCT01010490|FLUID USED|fluid used
502667|NCT01010490|CORNEAL THICKNESS|corneal thickness
502668|NCT01010490|ENDOTHELIUM CELL LOSS|endothelium cell loss
502669|NCT01010477|smoking cessation|smoking cessation
502670|NCT01010477|schizophrenia|schizophrenia
502671|NCT01010477|nicotine nasal spray|nicotine nasal spray
502672|NCT01010477|behavioral counseling|behavioral counseling
502673|NCT01010464|Adhesions|adhesions
502674|NCT01010464|Open abdomen|open abdomen
502675|NCT01010464|Laparotomy|laparotomy
502676|NCT01010451|pulpotomy|pulpotomy
502677|NCT01010451|pulpectomy|pulpectomy
502678|NCT01010451|primary teeth|primary teeth
502679|NCT01010451|dental care for children|dental care for children
502680|NCT01010438|sleep studies|sleep studies
502681|NCT01010438|sleep apnea|sleep apnea
502682|NCT01010438|OSA|osa
502683|NCT01010438|Referred for sleep studies by a medical professional|referred for sleep studies by a medical professional
502684|NCT01010412|Ultrasound|ultrasound
502685|NCT01010412|Nerve blocks|nerve blocks
502686|NCT01010412|Upper extremity|upper extremity
502687|NCT01010399|HIV|hiv
502688|NCT01010399|triglycerides|triglycerides
502689|NCT01010399|fosamprenavir|fosamprenavir
502690|NCT01010386|Pregnancy|pregnancy
502691|NCT01010386|Infertility|infertility
502692|NCT01010386|Physiologic Oxygen Tension|physiologic oxygen tension
502693|NCT01010386|Atmospheric Oxygen Tension|atmospheric oxygen tension
502694|NCT01010373|Primary Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) induced AML.|primary acute myeloid leukemia (aml) and myelodysplastic syndrome (mds) induced aml.
502695|NCT01010360|celiac ganglia|celiac ganglia
502696|NCT01010347|fractures|fractures
502697|NCT01010347|casting|casting
502698|NCT01010347|splinting|splinting
502699|NCT01010347|pediatrics|pediatrics
502700|NCT01010334|INST 0813|inst 0813
502701|NCT01010334|Standard of Care|standard of care
502702|NCT01010321|skin lesion suspect as BCC or SCC or others|skin lesion suspect as bcc or scc or others
502703|NCT01010308|infantile hemangioma|infantile hemangioma
502704|NCT01010308|nadolol|nadolol
502705|NCT01010295|NHL of the ocular adnexae|nhl of the ocular adnexae
502706|NCT01010256|To evaluate the phosphate and tension homolog deleted on chromosome ten (PTEN) protein level in leukemia cells from patients with CMML.|to evaluate the phosphate and tension homolog deleted on chromosome ten (pten) protein level in leukemia cells from patients with cmml.
502707|NCT01010256|To identify the PTEN genetic defect in patients with deficient PTEN protein levels.|to identify the pten genetic defect in patients with deficient pten protein levels.
502708|NCT01010256|To evaluate the role of PTEN deregulation in CMML pathogenesis.|to evaluate the role of pten deregulation in cmml pathogenesis.
502709|NCT01010243|multiple myeloma|multiple myeloma
502710|NCT01010243|anti-inflammatory|anti-inflammatory
502711|NCT01010243|relapsed|relapsed
502712|NCT01010243|refractory|refractory
502713|NCT01010243|progressive|progressive
502714|NCT01010230|Childhood cancer survivors|childhood cancer survivors
502715|NCT01010217|Hematologic Neoplasms|hematologic neoplasms
502716|NCT01010217|Blood Disorders|blood disorders
502717|NCT01010217|Blood Cancer|blood cancer
502718|NCT01010217|Transplantation, Blood And Marrow|transplantation, blood and marrow
502719|NCT01010217|Acute myelogenous leukemia|acute myelogenous leukemia
502720|NCT01010217|Myelodysplastic syndrome|myelodysplastic syndrome
502721|NCT01010217|Acute lymphocytic leukemia|acute lymphocytic leukemia
502722|NCT01010217|Aplastic anemia|aplastic anemia
502723|NCT01010217|Chronic myelogenous leukemia|chronic myelogenous leukemia
502724|NCT01010217|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
502725|NCT01010217|Myeloproliferative disease|myeloproliferative disease
502726|NCT01010217|Hodgkin's disease|hodgkin's disease
502727|NCT01010217|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
502728|NCT01010217|Multiple myeloma|multiple myeloma
502729|NCT01010217|Cyclophosphamide|cyclophosphamide
502730|NCT01010217|Fludarabine|fludarabine
502731|NCT01010217|Melphalan|melphalan
502732|NCT01010217|Mesna|mesna
502733|NCT01010217|Rituximab|rituximab
502734|NCT01010217|Tacrolimus|tacrolimus
502735|NCT01010217|Prograf|prograf
502736|NCT01010217|Mycofenolate mofetil|mycofenolate mofetil
502737|NCT01010217|MMF|mmf
502738|NCT01010217|CellCept|cellcept
502739|NCT01010217|G-CSF|g-csf
502740|NCT01010217|Filgrastim|filgrastim
502741|NCT01010217|Neupogen|neupogen
502742|NCT01010204|Varenicline|varenicline
502743|NCT01010204|Chantix|chantix
502744|NCT01010204|Smoking|smoking
502745|NCT01010204|Bipolar Disorder|bipolar disorder
502746|NCT01010191|irritable bowel syndrome|irritable bowel syndrome
502747|NCT01010191|no organic digestive disease|no organic digestive disease
502748|NCT01010178|COPD|copd
502749|NCT01010178|Macrolid|macrolid
502750|NCT01010178|reversibility|reversibility
502751|NCT01010178|Theophylline|theophylline
502752|NCT01010178|Corticosteroids|corticosteroids
502753|NCT01010178|symptoms PFT|symptoms pft
502754|NCT01010165|acute arthritis|acute arthritis
502755|NCT01010165|bacteria|bacteria
502756|NCT01010165|crystal arthritis|crystal arthritis
502757|NCT01010165|proteomic|proteomic
502758|NCT01010165|SELDI-TOF|seldi-tof
502759|NCT01010113|infants|infants
502760|NCT01010113|prebiotics|prebiotics
502761|NCT01010113|probiotics|probiotics
502762|NCT01010113|safety|safety
502763|NCT01010100|Metabolic Disease|metabolic disease
502764|NCT01010100|IGT Impaired Glucose Tolerance|igt impaired glucose tolerance
502765|NCT01010087|patients admitted to ICU|patients admitted to icu
502766|NCT01010074|retina, Parkinson's disease, ganglion cell, pupillary|retina, parkinson's disease, ganglion cell, pupillary
502767|NCT01010048|ESWL|eswl
502768|NCT01010048|urinary calculus|urinary calculus
502769|NCT01010048|drugs treat|drugs treat
502770|NCT01010035|type 2 diabetes mellitus|type 2 diabetes mellitus
502771|NCT01010035|dyslipidemia|dyslipidemia
502772|NCT01010035|kinetics|kinetics
502773|NCT01010022|hypovolemia|hypovolemia
502774|NCT01010022|surgical blood loss|surgical blood loss
502775|NCT01010022|orthopedic procedures|orthopedic procedures
502776|NCT01010022|Treatment of reduced circulating blood volume (hypovolemia) including massive hemorrhage|treatment of reduced circulating blood volume (hypovolemia) including massive hemorrhage
502777|NCT01010009|resveratrol|resveratrol
502778|NCT01010009|cerebral blood flow|cerebral blood flow
502779|NCT01010009|NIRS|nirs
502780|NCT01010009|cognitive performance|cognitive performance
502781|NCT01009996|Coronary bifurcation lesions|coronary bifurcation lesions
502782|NCT01009983|triple-negative breast cancer|triple-negative breast cancer
502783|NCT01009970|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
502784|NCT01009957|ADPKD|adpkd
502785|NCT01009957|CKD|ckd
502786|NCT01009957|Renal disease progression|renal disease progression
502787|NCT01009957|Everolimus|everolimus
502788|NCT01009944|High blood pressure|high blood pressure
502789|NCT01009931|Acute Myelogenous Leukemia|acute myelogenous leukemia
502790|NCT01009931|Relapsed AML|relapsed aml
502791|NCT01009931|Refractory AML|refractory aml
502792|NCT01009918|cardiac toxicity|cardiac toxicity
502793|NCT01009918|HER2-positive breast cancer|her2-positive breast cancer
502794|NCT01009918|recurrent breast cancer|recurrent breast cancer
502795|NCT01009918|stage IA breast cancer|stage ia breast cancer
502796|NCT01009918|stage IB breast cancer|stage ib breast cancer
502797|NCT01009918|stage II breast cancer|stage ii breast cancer
502798|NCT01009918|stage IIIA breast cancer|stage iiia breast cancer
502799|NCT01009918|stage IIIB breast cancer|stage iiib breast cancer
502800|NCT01009918|stage IIIC breast cancer|stage iiic breast cancer
502801|NCT01009918|male breast cancer|male breast cancer
502802|NCT01009879|rheumatoid arthritis|rheumatoid arthritis
502803|NCT01009879|B lymphocytes|b lymphocytes
502804|NCT01009866|Malignant brain tumor|malignant brain tumor
502805|NCT01009866|GBM|gbm
502806|NCT01009866|recurrent brain tumor|recurrent brain tumor
502807|NCT01009866|Supratentorial malignant brain tumor|supratentorial malignant brain tumor
502808|NCT01009866|astrocytomas|astrocytomas
502809|NCT01009866|ependymomas|ependymomas
502810|NCT01009866|Residual, progressive, or recurrent supratentorial malignant brain tumor based on imaging studies with measurable|residual, progressive, or recurrent supratentorial malignant brain tumor based on imaging studies with measurable
502811|NCT01009866|disease (>0.5cm).|disease (>0.5cm).
502812|NCT01009840|Multiple Myeloma|multiple myeloma
502813|NCT01009840|Bone marrow transplant|bone marrow transplant
502814|NCT01009840|Stem cell transplant|stem cell transplant
502815|NCT01009840|Busulfan|busulfan
502816|NCT01009840|Bortezomib|bortezomib
502817|NCT01009827|Medication adherence|medication adherence
502818|NCT01009827|Substance use|substance use
502819|NCT01009827|Sexual risk behaviors|sexual risk behaviors
502820|NCT01009814|HIV, HIV attachment inhibitor, attachment inhibitor|hiv, hiv attachment inhibitor, attachment inhibitor
502821|NCT01009801|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
502822|NCT01009801|recurrent adult primary liver cancer|recurrent adult primary liver cancer
502823|NCT01009801|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
502824|NCT01009788|ABT-888|abt-888
502825|NCT01009788|temozolomide|temozolomide
502826|NCT01009788|TMZ|tmz
502827|NCT01009775|Melanoma, Stage III|melanoma, stage iii
502828|NCT01009775|Melanoma, Stage IV|melanoma, stage iv
502829|NCT01009775|YM 155|ym 155
502830|NCT01009775|Metastatic Melanoma|metastatic melanoma
502831|NCT01009762|VACCINE|vaccine
502832|NCT01009762|THERAPY|therapy
502833|NCT01009762|CELLULAR IMMUNITY|cellular immunity
502834|NCT01009762|IMMUNITY|immunity
502835|NCT01009749|HAART|haart
502836|NCT01009749|HIV|hiv
502837|NCT01009749|Adherence|adherence
502838|NCT01009736|stage I prostate cancer|stage i prostate cancer
502839|NCT01009736|stage IIB prostate cancer|stage iib prostate cancer
502840|NCT01009736|stage IIA prostate cancer|stage iia prostate cancer
502841|NCT01009736|stage III prostate cancer|stage iii prostate cancer
502842|NCT01009736|stage IV prostate cancer|stage iv prostate cancer
502843|NCT01009723|Preterm delivery|preterm delivery
502844|NCT01009723|preterm labor|preterm labor
502845|NCT01009723|maternal-fetal care|maternal-fetal care
502846|NCT01009723|maternal serum screening biomarkers|maternal serum screening biomarkers
502847|NCT01009723|alphafetoprotein|alphafetoprotein
502848|NCT01009723|AFP|afp
502849|NCT01009723|human chorionic gonadotropin|human chorionic gonadotropin
502850|NCT01009723|hCG|hcg
502851|NCT01009723|unconjugated estriol|unconjugated estriol
502852|NCT01009723|Inhibin A|inhibin a
502853|NCT01009723|pregnancy associated plasma protein|pregnancy associated plasma protein
502854|NCT01009723|PAPP-A|papp-a
502855|NCT01009723|maternal screening|maternal screening
502856|NCT01009684|Contraception|contraception
502857|NCT01009684|Estradiol valerate|estradiol valerate
502858|NCT01009671|knee osteoarthritis|knee osteoarthritis
502859|NCT01009658|Gastrointestinal motility|gastrointestinal motility
502860|NCT01009658|Gastroesophageal reflux|gastroesophageal reflux
502861|NCT01009658|Gastric emptying|gastric emptying
502862|NCT01009658|Sodium glutamate|sodium glutamate
502863|NCT01009658|Lower esophageal sphincter|lower esophageal sphincter
502864|NCT01009645|education|education
502865|NCT01009645|vaccination|vaccination
502866|NCT01009645|preventive service|preventive service
502867|NCT01009645|Prevention & Control|prevention & control
502868|NCT01009619|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
502869|NCT01009619|Acute allograft Rejection|acute allograft rejection
502870|NCT01009619|Lymphocytic bronchiolitis|lymphocytic bronchiolitis
502871|NCT01009619|Respiratory infection|respiratory infection
502872|NCT01009619|Survival|survival
502873|NCT01009619|Mortality|mortality
502874|NCT01009619|Pulmonary function|pulmonary function
502875|NCT01009619|FEV1|fev1
502876|NCT01009619|Broncho-alveolar lavage|broncho-alveolar lavage
502877|NCT01009619|Neutrophils|neutrophils
502878|NCT01009619|Interleukin|interleukin
502879|NCT01009619|Culture|culture
502880|NCT01009619|Azithromycin|azithromycin
502881|NCT01009606|Out-of-hospital|out-of-hospital
502882|NCT01009606|Emergency|emergency
502883|NCT01009606|Cardiac arrest|cardiac arrest
502884|NCT01009606|Post-traumatic stress disorder|post-traumatic stress disorder
502885|NCT01009593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
502886|NCT01009593|Antineoplastic Agents|antineoplastic agents
502887|NCT01009593|Growth Substances|growth substances
502888|NCT01009593|Physiological Effects of Drugs|physiological effects of drugs
502889|NCT01009593|Enzyme Inhibitors|enzyme inhibitors
502890|NCT01009593|Angiogenesis Inhibitors|angiogenesis inhibitors
502891|NCT01009593|Inhibitors, Angiogenesis|inhibitors, angiogenesis
502892|NCT01009593|Protein Kinase Inhibitors|protein kinase inhibitors
502893|NCT01009593|Pharmacologic Actions|pharmacologic actions
502894|NCT01009593|Growth Inhibitors|growth inhibitors
502895|NCT01009593|Angiogenesis Modulating Agents|angiogenesis modulating agents
502896|NCT01009593|Sorafenib|sorafenib
502897|NCT01009567|OHSS|ohss
502898|NCT01009554|Mouthwashes|mouthwashes
502899|NCT01009541|pregabalin pharmacokinetics bioavailability bioequivalence|pregabalin pharmacokinetics bioavailability bioequivalence
502900|NCT01009528|Quality of care|quality of care
502901|NCT01009528|General Practice|general practice
502902|NCT01009528|Electronic Feedback System|electronic feedback system
502903|NCT01009515|metastatic|metastatic
502904|NCT01009515|melanoma|melanoma
502905|NCT01009515|skin cancer|skin cancer
502906|NCT01009515|paclitaxel|paclitaxel
502907|NCT01009515|carboplatin|carboplatin
502908|NCT01009515|temozolomide|temozolomide
502909|NCT01009476|Dementia|dementia
502910|NCT01009476|Galantamine|galantamine
502911|NCT01009476|Cholinesterase inhibitors|cholinesterase inhibitors
502912|NCT01009476|Nootropic agents|nootropic agents
502913|NCT01009476|Alzheimer|alzheimer
502914|NCT01009476|Vascular dementia|vascular dementia
502915|NCT01009476|Cognitive symptoms|cognitive symptoms
502916|NCT01009476|Behavioural symptoms|behavioural symptoms
502917|NCT01009476|Care giving times|care giving times
502918|NCT01009463|COPD|copd
502919|NCT01009463|Safety|safety
502920|NCT01009463|FEV1|fev1
502921|NCT01009463|Efficacy|efficacy
502922|NCT01009450|cirrhotic liver, gall bladder stone|cirrhotic liver, gall bladder stone
502923|NCT01009437|HER2-negative breast cancer|her2-negative breast cancer
502924|NCT01009437|HER2-positive breast cancer|her2-positive breast cancer
502925|NCT01009437|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
502926|NCT01009437|triple-negative breast cancer|triple-negative breast cancer
502927|NCT01009437|stage I breast cancer|stage i breast cancer
502928|NCT01009437|stage II breast cancer|stage ii breast cancer
502929|NCT01009437|stage IIIA breast cancer|stage iiia breast cancer
502930|NCT01009437|stage IIIB breast cancer|stage iiib breast cancer
502931|NCT01009437|stage IIIC breast cancer|stage iiic breast cancer
502932|NCT01009437|stage IV breast cancer|stage iv breast cancer
502933|NCT01009437|ductal breast carcinoma in situ|ductal breast carcinoma in situ
502934|NCT01009398|Anesthesia and Analgesia|anesthesia and analgesia
502935|NCT01009398|Regional anesthesia|regional anesthesia
502936|NCT01009398|Thoracic Paravertebral block|thoracic paravertebral block
502937|NCT01009398|Catheter location|catheter location
502938|NCT01009385|cervical|cervical
502939|NCT01009385|epidural|epidural
502940|NCT01009385|epidural pressure|epidural pressure
502941|NCT01009385|monitoring|monitoring
502942|NCT01009372|surgeon's physiology|surgeon's physiology
502943|NCT01009372|stress response|stress response
502944|NCT01009372|break scheme|break scheme
502945|NCT01009359|Alzheimers disease|alzheimers disease
502946|NCT01009359|Diagnostic imaging|diagnostic imaging
502947|NCT01009359|PET/CT diagnosis|pet/ct diagnosis
502948|NCT01009359|PET tracer|pet tracer
502949|NCT01009333|urgency frequency|urgency frequency
502950|NCT01009333|urinary urge incontinence|urinary urge incontinence
502951|NCT01009333|InterStim Therapy|interstim therapy
502952|NCT01009320|Pacemaker|pacemaker
502953|NCT01009320|Magnets|magnets
502954|NCT01009320|Drape|drape
502955|NCT01009320|Ferrite|ferrite
502956|NCT01009320|Magnetic field|magnetic field
502957|NCT01009320|Pacemaker interference|pacemaker interference
502958|NCT01009307|adult anaplastic astrocytoma|adult anaplastic astrocytoma
502959|NCT01009307|adult diffuse astrocytoma|adult diffuse astrocytoma
502960|NCT01009307|adult pilocytic astrocytoma|adult pilocytic astrocytoma
502961|NCT01009307|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
502962|NCT01009307|adult anaplastic ependymoma|adult anaplastic ependymoma
502963|NCT01009307|adult ependymoma|adult ependymoma
502964|NCT01009307|adult myxopapillary ependymoma|adult myxopapillary ependymoma
502965|NCT01009307|adult subependymoma|adult subependymoma
502966|NCT01009307|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
502967|NCT01009307|adult oligodendroglioma|adult oligodendroglioma
502968|NCT01009307|adult brain stem glioma|adult brain stem glioma
502969|NCT01009307|adult giant cell glioblastoma|adult giant cell glioblastoma
502970|NCT01009307|adult glioblastoma|adult glioblastoma
502971|NCT01009307|recurrent adult brain tumor|recurrent adult brain tumor
502972|NCT01009307|adult gliosarcoma|adult gliosarcoma
502973|NCT01009307|adult mixed glioma|adult mixed glioma
502974|NCT01009307|adult pineal gland astrocytoma|adult pineal gland astrocytoma
502975|NCT01009307|adult ependymoblastoma|adult ependymoblastoma
502976|NCT01009307|adult medulloblastoma|adult medulloblastoma
502977|NCT01009307|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
502978|NCT01009307|adult pineoblastoma|adult pineoblastoma
502979|NCT01009307|adult pineocytoma|adult pineocytoma
502980|NCT01009294|Duchenne muscular dystrophy|duchenne muscular dystrophy
502981|NCT01009294|Becker muscular dystrophy|becker muscular dystrophy
502982|NCT01009294|Nonsense mutation|nonsense mutation
502983|NCT01009294|Premature stop codon|premature stop codon
502984|NCT01009294|DMD|dmd
502985|NCT01009294|BMD|bmd
502986|NCT01009294|Ataluren|ataluren
502987|NCT01009294|PTC124|ptc124
502988|NCT01009281|Crohn's Disease|crohn's disease
502989|NCT01009281|Crohns|crohns
502990|NCT01009281|Bowel disease|bowel disease
502991|NCT01009281|digestive disorders|digestive disorders
502992|NCT01009281|auto immune|auto immune
502993|NCT01009281|diarrhea|diarrhea
502994|NCT01009281|Inflammatory Bowel Disease (IBD)|inflammatory bowel disease (ibd)
502995|NCT01009281|gastrointestinal diseases|gastrointestinal diseases
502996|NCT01009281|digestive system diseases|digestive system diseases
502997|NCT01009281|Antibody|antibody
502998|NCT01009281|IL 17|il 17
502999|NCT01009281|anti IL-17|anti il-17
503000|NCT01009281|monoclonal antibody|monoclonal antibody
503001|NCT01009281|Crohn's Disease (Chron's, CD)|crohn's disease (chron's, cd)
503002|NCT01009255|Alzheimer's disease|alzheimer's disease
503003|NCT01009255|placebo controlled|placebo controlled
503004|NCT01009255|randomised|randomised
503005|NCT01009255|Histamine|histamine
503006|NCT01009255|H3 Antagonist|h3 antagonist
503007|NCT01009255|double blind|double blind
503008|NCT01009255|Cognition|cognition
503009|NCT01009242|CDP6038|cdp6038
503010|NCT01009216|Pharmacokinetics|pharmacokinetics
503011|NCT01009216|Pharmacology|pharmacology
503012|NCT01009216|Drug Safety|drug safety
503013|NCT01009216|Phase 1 Clinical Trials|phase 1 clinical trials
503014|NCT01009203|squamous cell carcinoma|squamous cell carcinoma
503015|NCT01009203|head|head
503016|NCT01009203|neck|neck
503017|NCT01009203|aerodigestive|aerodigestive
503018|NCT01009190|Dose finding PARPi Chemotherapy|dose finding parpi chemotherapy
503019|NCT01009177|Melanoma|melanoma
503020|NCT01009177|Metastatic|metastatic
503021|NCT01009177|DTIC|dtic
503022|NCT01009177|Bosentan|bosentan
503023|NCT01009151|telemonitoring|telemonitoring
503024|NCT01009151|internet|internet
503025|NCT01009151|home monitoring system|home monitoring system
503026|NCT01009151|heart failure|heart failure
503027|NCT01009151|self management plan|self management plan
503028|NCT01009151|web portal|web portal
503029|NCT01009138|Subthreshold Depression|subthreshold depression
503030|NCT01009138|Diabetes-related Distress|diabetes-related distress
503031|NCT01009138|Minor Depression|minor depression
503032|NCT01009138|Light affective Disorder|light affective disorder
503033|NCT01009138|Subclinical depressive Symptoms|subclinical depressive symptoms
503034|NCT01009138|Diabetes mellitus|diabetes mellitus
503035|NCT01009138|Late Complications|late complications
503036|NCT01009138|Markers of Inflammation|markers of inflammation
503037|NCT01009125|questionnaires|questionnaires
503038|NCT01009125|health care surveys/methods|health care surveys/methods
503039|NCT01009125|motivation|motivation
503040|NCT01009125|living donors|living donors
503041|NCT01009125|living kidney donation|living kidney donation
503042|NCT01009112|Sleep|sleep
503043|NCT01009112|Sleep Disorder|sleep disorder
503044|NCT01009112|Veterans|veterans
503045|NCT01009112|Active Duty|active duty
503046|NCT01009112|OEF|oef
503047|NCT01009112|OIF|oif
503048|NCT01009112|PTSD|ptsd
503049|NCT01009099|pulmonary disease|pulmonary disease
503050|NCT01009099|COPD|copd
503051|NCT01009086|Arthritis, Psoriatic|arthritis, psoriatic
503052|NCT01009086|Ustekinumab|ustekinumab
503053|NCT01009086|CNTO 1275|cnto 1275
503054|NCT01009086|Stelara|stelara
503055|NCT01009086|Psoriasis|psoriasis
503056|NCT01009060|H3 Antagonist|h3 antagonist
503057|NCT01009060|Schizophrenia|schizophrenia
503058|NCT01009060|double blind|double blind
503059|NCT01009060|Histamine|histamine
503060|NCT01009060|randomised|randomised
503061|NCT01009060|placebo controlled|placebo controlled
503062|NCT01009060|Cognition|cognition
503063|NCT01009047|Schizophrenia|schizophrenia
503064|NCT01009047|Paliperidone|paliperidone
503065|NCT01009047|Aripiprazole|aripiprazole
503066|NCT01009021|pain|pain
503067|NCT01009021|retinal photocoagulation|retinal photocoagulation
503068|NCT01009021|potassium diclofenac|potassium diclofenac
503069|NCT01009008|cancer|cancer
503070|NCT01009008|breast cancer|breast cancer
503071|NCT01009008|mastectomy|mastectomy
503072|NCT01009008|breast reconstruction|breast reconstruction
503073|NCT01009008|reconstruction|reconstruction
503074|NCT01009008|tissue expansion|tissue expansion
503075|NCT01009008|two-stage breast reconstruction|two-stage breast reconstruction
503076|NCT01009008|tissue expander|tissue expander
503077|NCT01009008|AeroForm|aeroform
503078|NCT01009008|AirXpander|airxpander
503079|NCT01008995|psoriasis|psoriasis
503080|NCT01008995|asian patients|asian patients
503081|NCT01008995|Chinese|chinese
503082|NCT01008995|ustekinumab|ustekinumab
503083|NCT01008995|CNTO 1275|cnto 1275
503084|NCT01008995|Stelara|stelara
503085|NCT01008982|Belimumab,Sjögren's Syndrome.|belimumab,sjögren's syndrome.
503086|NCT01008982|Have a diagnosis of primary SS according to the updated American European Consensus Group Criteria|have a diagnosis of primary ss according to the updated american european consensus group criteria
503087|NCT01008969|Prostate|prostate
503088|NCT01008969|SPECT/CT|spect/ct
503089|NCT01008956|Influenza|influenza
503090|NCT01008956|H1N1|h1n1
503091|NCT01008956|Pandemic|pandemic
503092|NCT01008956|GSK Bio's influenza vaccine GSK2340274A|gsk bio's influenza vaccine gsk2340274a
503093|NCT01008930|Peripheral Tumors|peripheral tumors
503094|NCT01008930|Arm|arm
503095|NCT01008930|Leg|leg
503096|NCT01008930|Head|head
503097|NCT01008930|Neck|neck
503098|NCT01008930|HR PET Imaging System|hr pet imaging system
503099|NCT01008930|High-Resolution PET|high-resolution pet
503100|NCT01008930|PET/CT|pet/ct
503101|NCT01008930|PEMFlex Solo II|pemflex solo ii
503102|NCT01008930|positron emission tomography/computed tomography (PET/CT)|positron emission tomography/computed tomography (pet/ct)
503103|NCT01008917|Hepatocellular carcinoma|hepatocellular carcinoma
503104|NCT01008917|HCC|hcc
503105|NCT01008917|Liver cancer|liver cancer
503106|NCT01008917|Hepatoma|hepatoma
503107|NCT01008904|cancer survivor|cancer survivor
503108|NCT01008904|hot flashes|hot flashes
503109|NCT01008904|breast cancer|breast cancer
503110|NCT01008904|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
503111|NCT01008891|arthritis|arthritis
503112|NCT01008891|ankle pain|ankle pain
503113|NCT01008891|foot pain|foot pain
503114|NCT01008891|hindfoot fracture|hindfoot fracture
503115|NCT01008891|ankle fracture|ankle fracture
503116|NCT01008891|rheumatoid arthritis|rheumatoid arthritis
503117|NCT01008891|arthrosis|arthrosis
503118|NCT01008891|Foot/Hindfoot Fusion|foot/hindfoot fusion
503119|NCT01008852|rheumatoid arthritis|rheumatoid arthritis
503120|NCT01008852|seropositive|seropositive
503121|NCT01008852|methotrexate|methotrexate
503122|NCT01008839|study sarcopenia, which muscle becomes weaker with age|study sarcopenia, which muscle becomes weaker with age
503123|NCT01008826|sulforaphane|sulforaphane
503124|NCT01008826|pharmacokinetics|pharmacokinetics
503125|NCT01008813|HIV infection|hiv infection
503126|NCT01008813|adjuvanted and non-adjuvanted A(H1N1)v influenza vaccine|adjuvanted and non-adjuvanted a(h1n1)v influenza vaccine
503127|NCT01008813|immunogenicity|immunogenicity
503128|NCT01008813|safety|safety
503129|NCT01008800|Autism Spectrum Disorder|autism spectrum disorder
503130|NCT01008800|language|language
503131|NCT01008800|social|social
503132|NCT01008800|toddlers|toddlers
503133|NCT01008787|Cancer Prevention|cancer prevention
503134|NCT01008787|Focus Group|focus group
503135|NCT01008787|Interview|interview
503136|NCT01008787|Physical Activity|physical activity
503137|NCT01008787|African American women|african american women
503138|NCT01008787|Exercise|exercise
503139|NCT01008787|Exercise habits|exercise habits
503140|NCT01008787|Health behavior|health behavior
503141|NCT01008761|Pre-school child|pre-school child
503142|NCT01008761|Wheezy episode|wheezy episode
503143|NCT01008748|Smoking|smoking
503144|NCT01008748|Latinos|latinos
503145|NCT01008748|Mexican American|mexican american
503146|NCT01008748|Spanish-speaking smokers|spanish-speaking smokers
503147|NCT01008748|Ecological momentary assessment|ecological momentary assessment
503148|NCT01008748|Nicotine patch|nicotine patch
503149|NCT01008748|Smoking cessation counseling|smoking cessation counseling
503150|NCT01008748|Questionnaire|questionnaire
503151|NCT01008748|EMA|ema
503152|NCT01008722|Atrial Fibrillation|atrial fibrillation
503153|NCT01008722|Ablation|ablation
503154|NCT01008696|Reflux esophagitis|reflux esophagitis
503155|NCT01008696|Rabeprazole|rabeprazole
503156|NCT01008696|Lansoprazole|lansoprazole
503157|NCT01008683|Stem cell and and heart transplant patients who will receive pandemic H1N1 influenza vaccinations|stem cell and and heart transplant patients who will receive pandemic h1n1 influenza vaccinations
503158|NCT01008670|Cardiac resynchronization therapy|cardiac resynchronization therapy
503159|NCT01008657|Radiofrequency-Extranodular-Multipolar ablation|radiofrequency-extranodular-multipolar ablation
503160|NCT01008657|Recurrence|recurrence
503161|NCT01008644|carbon dioxide|carbon dioxide
503162|NCT01008644|ventilation|ventilation
503163|NCT01008644|gender|gender
503164|NCT01008644|osmolality|osmolality
503165|NCT01008644|menstruation cycle|menstruation cycle
503166|NCT01008631|renal failure|renal failure
503167|NCT01008631|sodium Thiosulfate|sodium thiosulfate
503168|NCT01008631|pharmakokinetic|pharmakokinetic
503169|NCT01008618|Chronic pain|chronic pain
503170|NCT01008618|Osteoarthritis|osteoarthritis
503171|NCT01008618|Low back pain|low back pain
503172|NCT01008618|Fentanyl|fentanyl
503173|NCT01008618|JNS020QD|jns020qd
503174|NCT01008618|Patch, transdermal|patch, transdermal
503175|NCT01008618|Opioid analgesics|opioid analgesics
503176|NCT01008605|Erectile Dysfunction|erectile dysfunction
503177|NCT01008592|dermatographism, levocetirizine (Xyzal)|dermatographism, levocetirizine (xyzal)
503178|NCT01008592|chronic idiopathic urticaria, dermatographism|chronic idiopathic urticaria, dermatographism
503179|NCT01008579|Patient Reported Outcome Measures|patient reported outcome measures
503180|NCT01008579|falls|falls
503181|NCT01008579|older adults|older adults
503182|NCT01008553|Postherpetic Neuralgia|postherpetic neuralgia
503183|NCT01008553|Complex Regional Pain Syndromes (CRPS)|complex regional pain syndromes (crps)
503184|NCT01008553|Postoperative Pain|postoperative pain
503185|NCT01008553|Fentanyl|fentanyl
503186|NCT01008553|Patch, transdermal|patch, transdermal
503187|NCT01008553|Opioid analgesics|opioid analgesics
503188|NCT01008540|cytomegalovirus|cytomegalovirus
503189|NCT01008540|resistance|resistance
503190|NCT01008540|transplantation|transplantation
503191|NCT01008540|Patient coming to an French transplantation center for solid organ or bone marrow transplant, with information and signed consent|patient coming to an french transplantation center for solid organ or bone marrow transplant, with information and signed consent
503192|NCT01008527|skin|skin
503193|NCT01008527|cutaneous|cutaneous
503194|NCT01008527|immunotherapy|immunotherapy
503195|NCT01008527|immunology|immunology
503196|NCT01008527|dose escalation|dose escalation
503197|NCT01008514|ductal breast carcinoma in situ|ductal breast carcinoma in situ
503198|NCT01008514|stage IA breast cancer|stage ia breast cancer
503199|NCT01008514|stage IB breast cancer|stage ib breast cancer
503200|NCT01008514|stage II breast cancer|stage ii breast cancer
503201|NCT01008501|hydatidiform moles|hydatidiform moles
503202|NCT01008501|complete hydatidiform moles|complete hydatidiform moles
503203|NCT01008501|partial hydatidiform moles|partial hydatidiform moles
503204|NCT01008501|Molar pregnancy|molar pregnancy
503205|NCT01008501|NLRP7|nlrp7
503206|NCT01008501|pregnancy wastage|pregnancy wastage
503207|NCT01008501|imprinting|imprinting
503208|NCT01008501|sporadic hydatidiform moles|sporadic hydatidiform moles
503209|NCT01008501|recurrent hydatidiform moles|recurrent hydatidiform moles
503210|NCT01008488|colonic diverticulitis|colonic diverticulitis
503211|NCT01008488|diverticular disease|diverticular disease
503212|NCT01008488|antibiotic therapy|antibiotic therapy
503213|NCT01008475|EMD 525797|emd 525797
503214|NCT01008475|Cetuximab|cetuximab
503215|NCT01008475|Irinotecan|irinotecan
503216|NCT01008475|metastatic colorectal cancer|metastatic colorectal cancer
503217|NCT01008449|Staples|staples
503218|NCT01008449|Sutures|sutures
503219|NCT01008449|Cesarean Delivery|cesarean delivery
503220|NCT01008449|Wound|wound
503221|NCT01008449|Skin Closure|skin closure
503222|NCT01008449|Wound infection|wound infection
503223|NCT01008449|Wound disruption|wound disruption
503224|NCT01008436|Ability of topical drug to reduce acute and overall bleeding as well as blood transfusions|ability of topical drug to reduce acute and overall bleeding as well as blood transfusions
503225|NCT01008423|Proctitis|proctitis
503226|NCT01008423|Proctosigmoiditis|proctosigmoiditis
503227|NCT01008423|Ulcerative|ulcerative
503228|NCT01008423|Salix|salix
503229|NCT01008423|Budesonide foam|budesonide foam
503230|NCT01008423|Budesonide|budesonide
503231|NCT01008423|Rectal|rectal
503232|NCT01008423|Gastrointestinal|gastrointestinal
503233|NCT01008423|Colitis|colitis
503234|NCT01008423|UC|uc
503235|NCT01008423|UP|up
503236|NCT01008423|UPS|ups
503237|NCT01008423|Additional relevant MeSH terms:|additional relevant mesh terms:
503238|NCT01008423|Proctocolitis|proctocolitis
503239|NCT01008423|Ulcer|ulcer
503240|NCT01008423|Colitis, Ulcerative|colitis, ulcerative
503241|NCT01008423|Gastroenteritis|gastroenteritis
503242|NCT01008423|Gastrointestinal Diseases|gastrointestinal diseases
503243|NCT01008423|Digestive System Diseases|digestive system diseases
503244|NCT01008423|Rectal Diseases|rectal diseases
503245|NCT01008423|Intestinal Diseases|intestinal diseases
503246|NCT01008423|Colonic Diseases|colonic diseases
503247|NCT01008423|Sigmoid Diseases|sigmoid diseases
503248|NCT01008423|Pathologic Processes|pathologic processes
503249|NCT01008423|Inflammatory Bowel Diseases|inflammatory bowel diseases
503250|NCT01008423|Bronchodilator Agents|bronchodilator agents
503251|NCT01008423|Autonomic Agents|autonomic agents
503252|NCT01008423|Peripheral Nervous System Agents|peripheral nervous system agents
503253|NCT01008423|Physiological Effects of Drugs|physiological effects of drugs
503254|NCT01008423|Pharmacologic Actions|pharmacologic actions
503255|NCT01008423|Anti-Asthmatic Agents|anti-asthmatic agents
503256|NCT01008423|Respiratory System Agents|respiratory system agents
503257|NCT01008423|Therapeutic Uses|therapeutic uses
503258|NCT01008423|Glucocorticoids|glucocorticoids
503259|NCT01008423|Hormones|hormones
503260|NCT01008423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
503261|NCT01008423|Anti-Inflammatory Agents|anti-inflammatory agents
503262|NCT01008410|Proctitis|proctitis
503263|NCT01008410|Proctosigmoiditis|proctosigmoiditis
503264|NCT01008410|Ulcerative|ulcerative
503265|NCT01008410|Salix|salix
503266|NCT01008410|Budesonide foam|budesonide foam
503267|NCT01008410|Budesonide|budesonide
503268|NCT01008410|Rectal|rectal
503269|NCT01008410|Gastrointestinal|gastrointestinal
503270|NCT01008410|Colitis|colitis
503271|NCT01008410|UC|uc
503272|NCT01008410|UP|up
503273|NCT01008410|UPS|ups
503274|NCT01008410|Additional relevant MeSH terms:|additional relevant mesh terms:
503275|NCT01008410|Proctocolitis|proctocolitis
503276|NCT01008410|Ulcer|ulcer
503277|NCT01008410|Colitis, Ulcerative|colitis, ulcerative
503278|NCT01008410|Gastroenteritis|gastroenteritis
503279|NCT01008410|Gastrointestinal Diseases|gastrointestinal diseases
503280|NCT01008410|Digestive System Diseases|digestive system diseases
503281|NCT01008410|Rectal Diseases|rectal diseases
503282|NCT01008410|Intestinal Diseases|intestinal diseases
503283|NCT01008410|Colonic Diseases|colonic diseases
503284|NCT01008410|Sigmoid Diseases|sigmoid diseases
503285|NCT01008410|Pathologic Processes|pathologic processes
503286|NCT01008410|Inflammatory Bowel Diseases|inflammatory bowel diseases
503287|NCT01008410|Bronchodilator Agents|bronchodilator agents
503288|NCT01008410|Autonomic Agents|autonomic agents
503289|NCT01008410|Peripheral Nervous System Agents|peripheral nervous system agents
503290|NCT01008410|Physiological Effects of Drugs|physiological effects of drugs
503291|NCT01008410|Pharmacologic Actions|pharmacologic actions
503292|NCT01008410|Anti-Asthmatic Agents|anti-asthmatic agents
503293|NCT01008410|Respiratory System Agents|respiratory system agents
503294|NCT01008410|Therapeutic Uses|therapeutic uses
503295|NCT01008410|Glucocorticoids|glucocorticoids
503296|NCT01008410|Hormones|hormones
503297|NCT01008410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
503298|NCT01008410|Anti-Inflammatory Agents|anti-inflammatory agents
503299|NCT01008397|Rhinitis, Allergic, Seasonal|rhinitis, allergic, seasonal
503300|NCT01008371|Obesity|obesity
503301|NCT01008371|Cholecystokinin|cholecystokinin
503302|NCT01008371|Oxytocin|oxytocin
503303|NCT01008371|Satiety|satiety
503304|NCT01008371|Gastric emptying|gastric emptying
503305|NCT01008371|Anxiety|anxiety
503306|NCT01008371|Depression|depression
503307|NCT01008371|Panic Disorder|panic disorder
503308|NCT01008332|House Dust Mite Allergy|house dust mite allergy
503309|NCT01008332|Immunotherapy|immunotherapy
503310|NCT01008332|Rhinoconjunctivitis|rhinoconjunctivitis
503311|NCT01008332|Toleromune HDM|toleromune hdm
503312|NCT01008319|Anovulation|anovulation
503313|NCT01008319|Ovulation induction|ovulation induction
503314|NCT01008306|Cardiorespiratory fitness|cardiorespiratory fitness
503315|NCT01008306|physical activity|physical activity
503316|NCT01008306|hypertension|hypertension
503317|NCT01008306|overweight and obesity|overweight and obesity
503318|NCT01008306|metabolic syndrome|metabolic syndrome
503319|NCT01008306|Body composition|body composition
503320|NCT01008241|Hospice|hospice
503321|NCT01008241|End of Life|end of life
503322|NCT01008241|Knowledge|knowledge
503323|NCT01008241|Attitudes|attitudes
503324|NCT01008241|Opinions|opinions
503325|NCT01008241|Advanced Care Planning|advanced care planning
503326|NCT01008241|Death and Dying|death and dying
503327|NCT01008241|Communication|communication
503328|NCT01008241|Knowledge and Attitudes of South Florida Residents on Hospice Care|knowledge and attitudes of south florida residents on hospice care
503329|NCT01008228|spontaneous|spontaneous
503330|NCT01008228|primary|primary
503331|NCT01008228|first episode|first episode
503332|NCT01008215|INR Control|inr control
503333|NCT01008215|Warfarin dosing|warfarin dosing
503334|NCT01008215|Family physicians|family physicians
503335|NCT01008215|Cluster randomization|cluster randomization
503336|NCT01008176|Hypertension|hypertension
503337|NCT01008176|Sleep|sleep
503338|NCT01008176|Blood Pressure|blood pressure
503339|NCT01008176|Inflammatory Markers|inflammatory markers
503340|NCT01008150|breast cancer|breast cancer
503341|NCT01008150|neoadjuvant|neoadjuvant
503342|NCT01008150|neratinib|neratinib
503343|NCT01008150|paclitaxel|paclitaxel
503344|NCT01008150|trastuzumab|trastuzumab
503345|NCT01008150|doxorubicin|doxorubicin
503346|NCT01008150|cyclophosphamide|cyclophosphamide
503347|NCT01008124|Benign Paroxysmal Positional Vertigo|benign paroxysmal positional vertigo
503348|NCT01008124|BPPV|bppv
503349|NCT01008124|PC|pc
503350|NCT01008124|BPPN|bppn
503351|NCT01008124|Vertigo|vertigo
503352|NCT01008111|regeneration|regeneration
503353|NCT01008111|tissue survival|tissue survival
503354|NCT01008111|biological processes|biological processes
503355|NCT01008111|connective tissue|connective tissue
503356|NCT01008111|tissue|tissue
503357|NCT01008098|Posttraumatic Stress Disorder|posttraumatic stress disorder
503358|NCT01008098|Escitalopram|escitalopram
503359|NCT01008098|Magnetic Resonance Imaging|magnetic resonance imaging
503360|NCT01008098|BDNF|bdnf
503361|NCT01008085|STEMI|stemi
503362|NCT01008085|self-expandable|self-expandable
503363|NCT01008085|balloon-expandable|balloon-expandable
503364|NCT01008046|Polycystic ovary syndrome|polycystic ovary syndrome
503365|NCT01008046|clomiphene resistance|clomiphene resistance
503366|NCT01008046|metformin|metformin
503367|NCT01008046|N-acetyl cysteine|n-acetyl cysteine
503368|NCT01008020|tea catechin extracts|tea catechin extracts
503369|NCT01008020|influenza infection|influenza infection
503370|NCT01008020|prophylaxis|prophylaxis
503371|NCT01008020|supplements|supplements
503372|NCT01008020|adults over 20 years old|adults over 20 years old
503373|NCT01008020|both men and women|both men and women
503374|NCT01008007|Viusid|viusid
503375|NCT01008007|Dietary supplements|dietary supplements
503376|NCT01008007|Acute fever|acute fever
503377|NCT01008007|Viral etiology|viral etiology
503378|NCT01007994|Nocturnal hypertension|nocturnal hypertension
503379|NCT01007994|Pediatric|pediatric
503380|NCT01007994|Renal Transplant|renal transplant
503381|NCT01007994|Pulse Wave Velocity|pulse wave velocity
503382|NCT01007994|Echocardiogram|echocardiogram
503383|NCT01007994|Pediatric Renal Transplant Recipient|pediatric renal transplant recipient
503384|NCT01007968|solid tumors|solid tumors
503385|NCT01007968|hepatic function|hepatic function
503386|NCT01007968|advanced|advanced
503387|NCT01007968|panobinostat|panobinostat
503388|NCT01007929|ADME|adme
503389|NCT01007929|safety|safety
503390|NCT01007929|oral solution|oral solution
503391|NCT01007890|ChemoFX|chemofx
503392|NCT01007890|Operable|operable
503393|NCT01007890|Breast|breast
503394|NCT01007890|Cancer|cancer
503395|NCT01007890|Measurable|measurable
503396|NCT01007890|Disease|disease
503397|NCT01008163|diabetes|diabetes
503398|NCT01007942|Metastatic breast cancer|metastatic breast cancer
503399|NCT01007942|locally advanced breast cancer|locally advanced breast cancer
503400|NCT01007942|HER2/neu positive breast cancer|her2/neu positive breast cancer
503401|NCT01007942|HER2/neu over-expressing|her2/neu over-expressing
503402|NCT01007942|progressive-free survival (PFS)|progressive-free survival (pfs)
503403|NCT01007942|over survival (OS)|over survival (os)
503404|NCT01007942|bolero|bolero
503405|NCT01007942|bolero 3|bolero 3
503406|NCT01007942|Breast cancer|breast cancer
503407|NCT01007942|everolimus|everolimus
503408|NCT01007942|HER+|her+
503409|NCT01007942|vinorelbine|vinorelbine
503410|NCT01007942|herceptin|herceptin
503411|NCT01007942|trastuzumab|trastuzumab
503412|NCT01007942|RAD001|rad001
503413|NCT01007877|sleepiness|sleepiness
503414|NCT01007877|driving|driving
503415|NCT01007864|Parkinson|parkinson
503416|NCT01007864|piribedil|piribedil
503417|NCT01007864|vigilance|vigilance
503418|NCT01007864|dopamine agonist|dopamine agonist
503419|NCT01007864|cognition|cognition
503420|NCT01007851|GnRH agonist|gnrh agonist
503421|NCT01007851|GnRH antagonist|gnrh antagonist
503422|NCT01007851|IVF|ivf
503423|NCT01007851|ICSI|icsi
503424|NCT01007851|assisted reproduction|assisted reproduction
503425|NCT01007851|luteal phase|luteal phase
503426|NCT01007838|Progressive Resistance Training/Exercise|progressive resistance training/exercise
503427|NCT01007838|Muscle wasting|muscle wasting
503428|NCT01007838|Chronic Kidney Disease|chronic kidney disease
503429|NCT01007786|Pediatric Hydrocephalus|pediatric hydrocephalus
503430|NCT01007786|Ultrasound Guided Surgery|ultrasound guided surgery
503431|NCT01007773|Dexmedetomidine|dexmedetomidine
503432|NCT01007773|Intracranial Pressure|intracranial pressure
503433|NCT01007773|Traumatic Brain Injury|traumatic brain injury
503434|NCT01007760|Tobacco smoke|tobacco smoke
503435|NCT01007760|Oxidative stress|oxidative stress
503436|NCT01007760|Endothelial Function|endothelial function
503437|NCT01007760|Atherosclerosis|atherosclerosis
503438|NCT01007760|Arterial Stiffness|arterial stiffness
503439|NCT01007760|Microvascular Function|microvascular function
503440|NCT01007747|Geranium oil|geranium oil
503441|NCT01007747|Neuropathy|neuropathy
503824|NCT01006096|efficacy|efficacy
503442|NCT01007734|Quality of life|quality of life
503443|NCT01007734|COPD patients|copd patients
503444|NCT01007734|Evaluation According to Gender the Determining Independent Factors of Quality of Life Related to Respiratory Status of Patient With Moderate to Severe COPD|evaluation according to gender the determining independent factors of quality of life related to respiratory status of patient with moderate to severe copd
503445|NCT01007695|breast cancer|breast cancer
503446|NCT01007682|intrusive memories|intrusive memories
503447|NCT01007669|Physical activity|physical activity
503448|NCT01007656|healthy adult subjects|healthy adult subjects
503449|NCT01007656|safety evaluation|safety evaluation
503450|NCT01007656|GD Antrodia camphorata|gd antrodia camphorata
503451|NCT01007643|anterior knee pain|anterior knee pain
503452|NCT01007643|adolescents|adolescents
503453|NCT01007643|female|female
503454|NCT01007643|interactive video games|interactive video games
503455|NCT01007643|patellofemoral syndrome|patellofemoral syndrome
503456|NCT01007643|treatment|treatment
503457|NCT01007643|compliance|compliance
503458|NCT01007643|home exercises|home exercises
503459|NCT01007630|Parkinson's|parkinson's
503460|NCT01007630|Parkinsons|parkinsons
503461|NCT01007630|Parkinson|parkinson
503462|NCT01007630|Parkinson's Disease|parkinson's disease
503463|NCT01007630|PD|pd
503464|NCT01007630|Rasagiline|rasagiline
503465|NCT01007630|Azilect|azilect
503466|NCT01007630|Olfactory|olfactory
503467|NCT01007630|Sense of Smell|sense of smell
503468|NCT01007630|UPSIT|upsit
503469|NCT01007617|Children|children
503470|NCT01007617|Cancer|cancer
503471|NCT01007617|Mucositis|mucositis
503472|NCT01007617|Laser|laser
503473|NCT01007617|Prevention|prevention
503474|NCT01007617|Chemotherapy|chemotherapy
503475|NCT01007617|Children with malignancies receiving chemotherapy and/or radiotherapy inducing severe mucositis|children with malignancies receiving chemotherapy and/or radiotherapy inducing severe mucositis
503476|NCT01007604|claudication|claudication
503477|NCT01007604|pneumatic compression device|pneumatic compression device
503478|NCT01007578|Paclitaxel|paclitaxel
503479|NCT01007578|Paclitaxel-coated balloon catheters|paclitaxel-coated balloon catheters
503480|NCT01007578|Peripheral arterial occlusive disease (PAOD)|peripheral arterial occlusive disease (paod)
503481|NCT01007578|Plasma levels|plasma levels
503482|NCT01007578|Femoral artery|femoral artery
503483|NCT01007578|Popliteal artery|popliteal artery
503484|NCT01007578|Peripheral arterial disease (PAD) including stenotic or occluded femoro-popliteal arteries due to atherosclerosis|peripheral arterial disease (pad) including stenotic or occluded femoro-popliteal arteries due to atherosclerosis
503485|NCT01007565|periarticular injection|periarticular injection
503486|NCT01007552|Biliary Duct Cancer|biliary duct cancer
503487|NCT01007552|Cancer of the Gallbladder|cancer of the gallbladder
503488|NCT01007552|Adenocarcinoma of the Gall Bladder|adenocarcinoma of the gall bladder
503489|NCT01007552|Adenocarcinoma of the Biliary Ducts|adenocarcinoma of the biliary ducts
503490|NCT01007552|Cholangiocarcinoma|cholangiocarcinoma
503491|NCT01007552|Extrahepatic cholangiocarcinoma|extrahepatic cholangiocarcinoma
503492|NCT01007526|Extranodal Lymphoma|extranodal lymphoma
503493|NCT01007526|Natural killer cell|natural killer cell
503494|NCT01007526|T cell|t cell
503495|NCT01007526|Radiotherapy|radiotherapy
503496|NCT01007526|Chemotherapy|chemotherapy
503497|NCT01007513|Prematurity|prematurity
503498|NCT01007513|Inflammation|inflammation
503499|NCT01007513|Transvaginal ultrasound|transvaginal ultrasound
503500|NCT01007513|Vaginal secretion|vaginal secretion
503501|NCT01007513|Inflammatory process|inflammatory process
503502|NCT01007513|Neonatal morbidity|neonatal morbidity
503503|NCT01007500|Postoperative nausea and vomiting after video-assisted thoracoscopic surgery|postoperative nausea and vomiting after video-assisted thoracoscopic surgery
503504|NCT01007487|Plastic wound protector|plastic wound protector
503505|NCT01007487|Plastic wound retractor|plastic wound retractor
503506|NCT01007487|Bacterial translocation|bacterial translocation
503507|NCT01007487|Surgical site infection|surgical site infection
503508|NCT01007487|Abdominal surgery|abdominal surgery
503509|NCT01007487|Wound infection|wound infection
503510|NCT01007461|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
503511|NCT01007461|STEMI|stemi
503512|NCT01007461|Acute ST-Segment Elevation Myocardial Infraction (STEMI)|acute st-segment elevation myocardial infraction (stemi)
503513|NCT01007448|CTCL|ctcl
503514|NCT01007448|bexarotene|bexarotene
503515|NCT01007448|Targretin|targretin
503516|NCT01007448|Refractory Cutaneous T-cell Lymphoma|refractory cutaneous t-cell lymphoma
503517|NCT01007448|cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
503518|NCT01007448|MF|mf
503519|NCT01007448|Mycoses fungoides|mycoses fungoides
503520|NCT01007422|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
503521|NCT01007422|pain|pain
503522|NCT01007409|To assess food effect on the pharmacokinetics of fimasartan in healthy male volunteers|to assess food effect on the pharmacokinetics of fimasartan in healthy male volunteers
503651|NCT01006837|ISS ≥9|iss ≥9
503523|NCT01007396|Interferon-gamma release assay|interferon-gamma release assay
503524|NCT01007383|Safety and tolerability of LEO 27847|safety and tolerability of leo 27847
503525|NCT01007370|tracheal intubation|tracheal intubation
503526|NCT01007370|supraglottic airway devices|supraglottic airway devices
503527|NCT01007344|flaxseed|flaxseed
503528|NCT01007344|hypercholesterolemia|hypercholesterolemia
503529|NCT01007344|children|children
503530|NCT01007331|Infants|infants
503531|NCT01007331|Atopic Dermatitis|atopic dermatitis
503532|NCT01007331|SCORAD|scorad
503533|NCT01007331|IgE|ige
503534|NCT01007331|Eosinophil Cation Protein|eosinophil cation protein
503535|NCT01007331|Calprotectin|calprotectin
503536|NCT01007331|Intestinal microflora|intestinal microflora
503537|NCT01007292|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
503538|NCT01007292|relapsed|relapsed
503539|NCT01007292|CD20-Positive|cd20-positive
503540|NCT01007292|YM155|ym155
503541|NCT01007279|Percutaneous angioplasty|percutaneous angioplasty
503542|NCT01007279|Myocardial Infarction|myocardial infarction
503543|NCT01007266|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
503544|NCT01007266|Adolescents|adolescents
503545|NCT01007266|Pediatric|pediatric
503546|NCT01007266|Patient Partner|patient partner
503547|NCT01007266|Buddy|buddy
503548|NCT01007266|Obesity|obesity
503549|NCT01007266|Type 2 Diabetes|type 2 diabetes
503550|NCT01007240|head and neck carcinoma|head and neck carcinoma
503551|NCT01007240|obturators|obturators
503552|NCT01007240|maxillectomy|maxillectomy
503553|NCT01007240|soft liner|soft liner
503554|NCT01007240|nano particles|nano particles
503555|NCT01007240|antibacterial properties|antibacterial properties
503556|NCT01007240|patients post maxillectomy|patients post maxillectomy
503557|NCT01007214|Prostate cancer|prostate cancer
503558|NCT01007214|Prostatectomy|prostatectomy
503559|NCT01007201|Influenza|influenza
503560|NCT01007201|H1N1|h1n1
503561|NCT01007201|vaccine|vaccine
503562|NCT01007201|Immunogenicity|immunogenicity
503563|NCT01007188|almond|almond
503564|NCT01007188|nuts|nuts
503565|NCT01007188|energy value|energy value
503566|NCT01007188|cardiovascular disease|cardiovascular disease
503567|NCT01007188|phytonutrient|phytonutrient
503568|NCT01007188|gene expression|gene expression
503569|NCT01007188|energy value of almonds|energy value of almonds
503570|NCT01007188|energy|energy
503571|NCT01007175|TNF inhibitor|tnf inhibitor
503572|NCT01007175|Multiple ascending dose study|multiple ascending dose study
503573|NCT01007149|Severe asthma,|severe asthma,
503574|NCT01007149|non-atopic,|non-atopic,
503575|NCT01007149|omalizumab|omalizumab
503576|NCT01007136|tDCS|tdcs
503577|NCT01007136|stroke|stroke
503578|NCT01007136|functional MRI|functional mri
503579|NCT01007136|TMS|tms
503580|NCT01007123|Chronic idiopathic constipation|chronic idiopathic constipation
503581|NCT01007123|A3309|a3309
503582|NCT01007110|DHA|dha
503583|NCT01007097|Diabetes Mellitus, Non Insulin Dependent|diabetes mellitus, non insulin dependent
503584|NCT01007097|Diabetes Mellitus, Type II|diabetes mellitus, type ii
503585|NCT01007097|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
503586|NCT01007097|Drug Therapy|drug therapy
503587|NCT01007084|pain|pain
503588|NCT01007084|trauma|trauma
503589|NCT01007084|propranolol|propranolol
503590|NCT01007058|Urinary Bladder|urinary bladder
503591|NCT01007058|Non-muscle-invasive transitional cell carcinoma|non-muscle-invasive transitional cell carcinoma
503592|NCT01007058|Intact bladder|intact bladder
503593|NCT01007058|Intravesical Bladder Cancer Therapy|intravesical bladder cancer therapy
503594|NCT01007058|Tumor Recurrence|tumor recurrence
503595|NCT01007058|Surrogate markers of response|surrogate markers of response
503596|NCT01007058|BCG|bcg
503597|NCT01007058|Bacillus Calmette Guérin|bacillus calmette guérin
503598|NCT01007058|Interferon-alfa-2b|interferon-alfa-2b
503599|NCT01007058|IFN-alfa-2b|ifn-alfa-2b
503600|NCT01007058|Interferon|interferon
503601|NCT01007058|Fluorescence in situ hybridization|fluorescence in situ hybridization
503602|NCT01007058|FISH|fish
503603|NCT01007045|deep vein thrombosis|deep vein thrombosis
503604|NCT01007045|venous thromboembolic disorders|venous thromboembolic disorders
503605|NCT01007045|diagnostic ultrasound|diagnostic ultrasound
503606|NCT01007032|anti-IGF-IR|anti-igf-ir
503607|NCT01007032|monoclonal|monoclonal
503608|NCT01007032|solid tumor|solid tumor
503609|NCT01007032|insulin-like growth factor|insulin-like growth factor
503610|NCT01007019|Safety, tolerability and PK/PD|safety, tolerability and pk/pd
503611|NCT01007006|Telepharmacy Robotic Medicine Delivery Unit|telepharmacy robotic medicine delivery unit
503612|NCT01007006|Brain Injuries|brain injuries
503613|NCT01007006|Stress Disorders|stress disorders
503614|NCT01007006|Combat disorders|combat disorders
503615|NCT01007006|Polytrauma|polytrauma
503616|NCT01007006|Adherence|adherence
503617|NCT01006967|balance|balance
503618|NCT01006967|gait|gait
503619|NCT01006967|physical therapy|physical therapy
503620|NCT01006967|ActiveStep|activestep
503621|NCT01006954|Poor responder|poor responder
503622|NCT01006954|Flare up|flare up
503623|NCT01006954|Micro dose GnRH agonist flare up|micro dose gnrh agonist flare up
503624|NCT01006954|IVF/ICSI|ivf/icsi
503625|NCT01006941|Multiple sclerosis|multiple sclerosis
503626|NCT01006941|safety|safety
503627|NCT01006941|MRI|mri
503628|NCT01006941|immunological|immunological
503629|NCT01006941|Helminths|helminths
503630|NCT01006941|Trichuris suis|trichuris suis
503631|NCT01006928|Subjective health feeling|subjective health feeling
503632|NCT01006928|NICU|nicu
503633|NCT01006928|team support|team support
503634|NCT01006915|Diabetic sensorimotor polyneuropathy|diabetic sensorimotor polyneuropathy
503635|NCT01006902|Elderly|elderly
503636|NCT01006902|Function|function
503637|NCT01006902|Oncologic therapy|oncologic therapy
503638|NCT01006902|Functional change with chemotherapy|functional change with chemotherapy
503639|NCT01006876|coumadin|coumadin
503640|NCT01006876|peri-procedural thromboembolism|peri-procedural thromboembolism
503641|NCT01006876|RFCA|rfca
503642|NCT01006876|high risk atrial fibrillation|high risk atrial fibrillation
503643|NCT01006863|Ephedrine|ephedrine
503644|NCT01006863|phenylephrine|phenylephrine
503645|NCT01006863|hypotension|hypotension
503646|NCT01006863|propofol|propofol
503647|NCT01006863|anesthesia|anesthesia
503648|NCT01006863|cardiac valve surgery|cardiac valve surgery
503649|NCT01006837|trauma patients|trauma patients
503650|NCT01006837|severe injury|severe injury
503652|NCT01006824|Capsule endoscopy|capsule endoscopy
503653|NCT01006824|gastrointestinal hemorrhage|gastrointestinal hemorrhage
503654|NCT01006811|West syndrome|west syndrome
503655|NCT01006811|Hypsarrhythmia|hypsarrhythmia
503656|NCT01006798|Virus Diseases|virus diseases
503657|NCT01006798|Respiratory Tract Diseases|respiratory tract diseases
503658|NCT01006798|Vaccine|vaccine
503659|NCT01006785|Breast Cancer|breast cancer
503660|NCT01006785|DLBS 1425|dlbs 1425
503661|NCT01006785|Cancer|cancer
503662|NCT01006785|Advanced/Metastatic (Stage IIIB/IV) Breast Cancer|advanced/metastatic (stage iiib/iv) breast cancer
503663|NCT01006772|Stroke|stroke
503664|NCT01006772|Ankle Foot Orthosis|ankle foot orthosis
503665|NCT01006772|Walking Speed|walking speed
503666|NCT01006772|Gait|gait
503667|NCT01006772|Rehabilitation|rehabilitation
503668|NCT01006772|Hemiplegia|hemiplegia
503669|NCT01006759|Leprosy|leprosy
503670|NCT01006759|Disability Evaluation|disability evaluation
503671|NCT01006759|Quality of Life|quality of life
503672|NCT01006759|Sensation|sensation
503673|NCT01006746|Remote monitoring|remote monitoring
503674|NCT01006746|Defibrillators|defibrillators
503675|NCT01006746|Survey|survey
503676|NCT01006746|Indication for ICD (primary and secondary prevention)|indication for icd (primary and secondary prevention)
503677|NCT01006733|pharmacogenetics|pharmacogenetics
503678|NCT01006733|arthroplasty|arthroplasty
503679|NCT01006733|VKORC1|vkorc1
503680|NCT01006733|thromboembolism|thromboembolism
503681|NCT01006733|warfarin|warfarin
503682|NCT01006720|Residual neuromuscular block|residual neuromuscular block
503683|NCT01006720|post-operative residual curarization|post-operative residual curarization
503684|NCT01006720|PORC|porc
503685|NCT01006720|sugammadex|sugammadex
503686|NCT01006720|neostigmine|neostigmine
503687|NCT01006694|depression|depression
503688|NCT01006694|collaborative care|collaborative care
503689|NCT01006694|Vietnam|vietnam
503690|NCT01006694|behavioral activation|behavioral activation
503691|NCT01006681|rheumatoid|rheumatoid
503692|NCT01006681|SLE|sle
503693|NCT01006681|Psoriatic arthritis|psoriatic arthritis
503694|NCT01006681|Ankylosing|ankylosing
503695|NCT01006681|Influenza H1N1|influenza h1n1
503696|NCT01006681|Vaccine|vaccine
503697|NCT01006681|Vaccination against H1N1 in rheumatic diseases|vaccination against h1n1 in rheumatic diseases
503698|NCT01006668|Neonates|neonates
503699|NCT01006668|Intensive care|intensive care
503700|NCT01006668|Endotracheal intubation|endotracheal intubation
503701|NCT01006668|Neonates in intensive care|neonates in intensive care
503702|NCT01006655|asthma|asthma
503703|NCT01006655|preschool children|preschool children
503704|NCT01006655|bronchial hyperresponsiveness|bronchial hyperresponsiveness
503705|NCT01006655|beclometasone dipropionate - HFA|beclometasone dipropionate - hfa
503706|NCT01006655|Qvar|qvar
503707|NCT01006655|Adenosine Challenge test|adenosine challenge test
503708|NCT01006629|Efficacy of palivizumab|efficacy of palivizumab
503709|NCT01006629|Respiratory syncytial virus (RSV) infection|respiratory syncytial virus (rsv) infection
503710|NCT01006629|Prevention of severe RSV infection|prevention of severe rsv infection
503711|NCT01006629|Preterm infants|preterm infants
503712|NCT01006629|Infants with bronchopulmonary dysplasia|infants with bronchopulmonary dysplasia
503713|NCT01006629|Infants with hemodynamically significant congenital heart disease|infants with hemodynamically significant congenital heart disease
503714|NCT01006603|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
503715|NCT01006603|elderly patients|elderly patients
503716|NCT01006603|saxagliptin|saxagliptin
503717|NCT01006603|randomised|randomised
503718|NCT01006603|double-blind|double-blind
503719|NCT01006590|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
503720|NCT01006590|Saxagliptin|saxagliptin
503721|NCT01006590|Randomised|randomised
503722|NCT01006590|Double-blind|double-blind
503723|NCT01006577|rectal cancer|rectal cancer
503724|NCT01006577|side-to-end anastomosis|side-to-end anastomosis
503725|NCT01006577|colon J pouch|colon j pouch
503726|NCT01006577|fecal incontinence|fecal incontinence
503727|NCT01006577|anorectal function|anorectal function
503822|NCT01006096|placebo-controlled|placebo-controlled
503823|NCT01006096|erlotinib|erlotinib
503728|NCT01006577|Are there differences between side-to-end anastomosis and colon J pouch in|are there differences between side-to-end anastomosis and colon j pouch in
503729|NCT01006577|bowel function (fecal incontinence, frequency of bowel movements, rectal urgency, incomplete evacuation)|bowel function (fecal incontinence, frequency of bowel movements, rectal urgency, incomplete evacuation)
503730|NCT01006577|quality of life|quality of life
503731|NCT01006577|postoperative complications|postoperative complications
503732|NCT01006577|operation time/ institutional costs|operation time/ institutional costs
503733|NCT01006564|Magnetic Resonance Imaging|magnetic resonance imaging
503734|NCT01006564|Prostate Cancer|prostate cancer
503735|NCT01006564|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
503736|NCT01006564|Radiotherapy planning|radiotherapy planning
503737|NCT01006551|Schizophrenia Spectrum Disorders|schizophrenia spectrum disorders
503738|NCT01006538|Wet Age-related Macular Degeneration|wet age-related macular degeneration
503739|NCT01006538|Predominantly classic|predominantly classic
503740|NCT01006538|Minimally classic|minimally classic
503741|NCT01006538|Occult with no classic|occult with no classic
503742|NCT01006538|Retinal Angiomatous Proliferation (RAP) lesions|retinal angiomatous proliferation (rap) lesions
503743|NCT01006499|neonatal sepsis|neonatal sepsis
503744|NCT01006499|pentoxyfilline|pentoxyfilline
503745|NCT01006499|pentaglobin|pentaglobin
503746|NCT01006499|biomarker|biomarker
503747|NCT01006499|To reduce mortality in neonatal sepsis|to reduce mortality in neonatal sepsis
503748|NCT01006486|Oral anticoagulants|oral anticoagulants
503749|NCT01006486|Warfarin|warfarin
503750|NCT01006486|Anticoagulation clinic|anticoagulation clinic
503751|NCT01006486|Thrombosis|thrombosis
503752|NCT01006486|Hemorrhage|hemorrhage
503753|NCT01006473|Chagas Disease|chagas disease
503754|NCT01006473|Chagas Cardiomyopathy|chagas cardiomyopathy
503755|NCT01006473|Exercise Movement Techniques|exercise movement techniques
503756|NCT01006460|Quality of life and subjective well-being in middle aged women|quality of life and subjective well-being in middle aged women
503757|NCT01006447|tai chi|tai chi
503758|NCT01006447|exercise|exercise
503759|NCT01006447|older adults|older adults
503760|NCT01006447|exercise persistence|exercise persistence
503761|NCT01006434|Stroke|stroke
503762|NCT01006434|Thrombolysis|thrombolysis
503763|NCT01006421|phototherapy|phototherapy
503764|NCT01006421|Gingko biloba|gingko biloba
503765|NCT01006421|repigmentation|repigmentation
503766|NCT01006408|Neuropathy|neuropathy
503767|NCT01006395|Prostate Cancer|prostate cancer
503768|NCT01006395|Androgen deprivation|androgen deprivation
503769|NCT01006395|Bone Health|bone health
503770|NCT01006395|Insulin resistance|insulin resistance
503771|NCT01006395|Men with nonmetastatic prostate cancer receiving androgen deprivation|men with nonmetastatic prostate cancer receiving androgen deprivation
503772|NCT01006369|stage IV colon cancer|stage iv colon cancer
503773|NCT01006369|stage IV rectal cancer|stage iv rectal cancer
503774|NCT01006369|recurrent colon cancer|recurrent colon cancer
503775|NCT01006369|recurrent rectal cancer|recurrent rectal cancer
503776|NCT01006356|Hydromorphone hydrochloride Oral Osmotic System|hydromorphone hydrochloride oral osmotic system
503777|NCT01006356|Jurnista|jurnista
503778|NCT01006317|Maternal health services|maternal health services
503779|NCT01006317|utilization|utilization
503780|NCT01006317|education|education
503781|NCT01006317|randomized controlled trial|randomized controlled trial
503782|NCT01006317|cost|cost
503783|NCT01006317|clinical skills|clinical skills
503784|NCT01006317|rural China|rural china
503785|NCT01006304|JNJ-39439335|jnj-39439335
503786|NCT01006304|Placebo|placebo
503787|NCT01006304|Pain|pain
503788|NCT01006304|Pain Measurements|pain measurements
503789|NCT01006304|Adults|adults
503790|NCT01006304|Men|men
503791|NCT01006278|biomarker|biomarker
503792|NCT01006278|knee arthroscopy|knee arthroscopy
503793|NCT01006278|pain|pain
503794|NCT01006252|metastatic|metastatic
503795|NCT01006252|second-line|second-line
503796|NCT01006239|Cancer|cancer
503797|NCT01006213|Motivational Intervention|motivational intervention
503798|NCT01006200|granulation tissue|granulation tissue
503799|NCT01006200|benign|benign
503800|NCT01006200|tracheal stenosis|tracheal stenosis
503801|NCT01006200|ultraflex|ultraflex
503802|NCT01006200|COPD|copd
503803|NCT01006187|Analgesics|analgesics
503804|NCT01006187|Influenza|influenza
503805|NCT01006187|Vapocoolant|vapocoolant
503806|NCT01006187|vaccination|vaccination
503807|NCT01006187|pain|pain
503808|NCT01006148|Metopic Craniosynostosis|metopic craniosynostosis
503809|NCT01006122|Randomized|randomized
503810|NCT01006122|double-blind|double-blind
503811|NCT01006122|placebo-controlled|placebo-controlled
503812|NCT01006122|crossover study of PF-03654746 in Excessive Daytime Sleepiness associated with Narcolepsy|crossover study of pf-03654746 in excessive daytime sleepiness associated with narcolepsy
503813|NCT01006109|MEG|meg
503814|NCT01006109|Repetitive TMS (rTMS)|repetitive tms (rtms)
503815|NCT01006109|Decision-Making|decision-making
503816|NCT01006109|Healthy Volunteers|healthy volunteers
503817|NCT01006109|HV|hv
503818|NCT01006109|Healthy Volunteer|healthy volunteer
503819|NCT01006096|Psoriasis|psoriasis
503820|NCT01006096|double-blind|double-blind
503821|NCT01006096|randomized|randomized
503825|NCT01006083|Aspirin|aspirin
503826|NCT01006083|Plavix|plavix
503827|NCT01006083|antiplatelet therapy|antiplatelet therapy
503828|NCT01006083|Hemorrhage|hemorrhage
503829|NCT01006083|ischemic events|ischemic events
503830|NCT01006070|multiple myeloma|multiple myeloma
503831|NCT01006070|spinal disease|spinal disease
503832|NCT01006044|Glioblastoma multiforme, vaccine, dendritic cells, glioma|glioblastoma multiforme, vaccine, dendritic cells, glioma
503833|NCT01006031|Liver cirrhosis|liver cirrhosis
503834|NCT01006031|Hepatitis C virus|hepatitis c virus
503835|NCT01006031|HIV infection|hiv infection
503836|NCT01006031|Pegylated interferon alfa-2a|pegylated interferon alfa-2a
503837|NCT01006031|Ribavirin|ribavirin
503838|NCT01006031|Treatment experienced|treatment experienced
503839|NCT01006018|Prediabetic State|prediabetic state
503840|NCT01006005|HIV|hiv
503841|NCT01006005|Treatment experienced|treatment experienced
503842|NCT01005992|Scars secondary to injuries to tissues caused by contact with physical (heat, electricity) o chemical agent.|scars secondary to injuries to tissues caused by contact with physical (heat, electricity) o chemical agent.
503843|NCT01005979|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
503844|NCT01005979|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
503845|NCT01005979|Lymphoma, Small Lymphocytic|lymphoma, small lymphocytic
503846|NCT01005979|Lymphoma|lymphoma
503847|NCT01005979|Leukemia|leukemia
503848|NCT01005966|remineralization|remineralization
503849|NCT01005966|enamel|enamel
503850|NCT01005966|in situ|in situ
503851|NCT01005966|fluoride|fluoride
503852|NCT01005966|caries|caries
503853|NCT01005953|Autism|autism
503854|NCT01005953|Behavioral Observations|behavioral observations
503855|NCT01005953|Electronic diaries|electronic diaries
503856|NCT01005953|Professionals treating children 3-10 with lower functioning autism|professionals treating children 3-10 with lower functioning autism
503857|NCT01005940|Sleep Apnea Syndromes|sleep apnea syndromes
503858|NCT01005940|Insulin Resistance|insulin resistance
503859|NCT01005940|Mandibular advancement device|mandibular advancement device
503860|NCT01005927|Calcium|calcium
503861|NCT01005927|Bone and Bones|bone and bones
503862|NCT01005927|Girls|girls
503863|NCT01005927|Bone Mineralization|bone mineralization
503864|NCT01005927|Fiber|fiber
503865|NCT01005927|Fructooligosaccharide|fructooligosaccharide
503866|NCT01005927|Female|female
503867|NCT01005927|Healthy|healthy
503868|NCT01005927|Adolescents|adolescents
503869|NCT01005914|adults|adults
503870|NCT01005914|Philadelphia chromosome precursor ALL,|philadelphia chromosome precursor all,
503871|NCT01005914|T-cell ALL|t-cell all
503872|NCT01005914|untreated ALL|untreated all
503873|NCT01005901|COPD|copd
503874|NCT01005901|NVA|nva
503875|NCT01005901|FEV1|fev1
503876|NCT01005888|Hereditary angioedema|hereditary angioedema
503877|NCT01005888|HAE|hae
503878|NCT01005888|C1 esterase inhibitor (human)|c1 esterase inhibitor (human)
503879|NCT01005888|C1INH-nf|c1inh-nf
503880|NCT01005875|Hepatocellular carcinoma|hepatocellular carcinoma
503881|NCT01005875|HCC|hcc
503882|NCT01005875|Liver Cancer|liver cancer
503883|NCT01005875|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
503884|NCT01005862|Alzheimer's disease antibody leucine ABeta|alzheimer's disease antibody leucine abeta
503885|NCT01005849|Probiotics|probiotics
503886|NCT01005849|Traveler's diarrhea|traveler's diarrhea
503887|NCT01005849|Prevention|prevention
503888|NCT01005836|Cognitive behavioral therapy|cognitive behavioral therapy
503889|NCT01005836|Anxiety treatment|anxiety treatment
503890|NCT01005836|Depression treatment|depression treatment
503891|NCT01005836|Child treatment|child treatment
503892|NCT01005836|Usual care|usual care
503893|NCT01005797|Renal Cancer|renal cancer
503894|NCT01005797|Non Small Cell Lung Cancer (NSCLC)|non small cell lung cancer (nsclc)
503895|NCT01005797|Solid Tumor|solid tumor
503896|NCT01005797|Soft tissue sarcoma|soft tissue sarcoma
503897|NCT01005797|Sorafenib|sorafenib
503898|NCT01005797|Panobinostat|panobinostat
503899|NCT01005784|GnRH antagonists|gnrh antagonists
503900|NCT01005771|Secondarily infected traumatic lesions|secondarily infected traumatic lesions
503901|NCT01005758|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
503902|NCT01005758|Philadelphia chromosome positive adult precursor acute lymphoblastic leukemia|philadelphia chromosome positive adult precursor acute lymphoblastic leukemia
503903|NCT01005758|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
503904|NCT01005758|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
503905|NCT01005758|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
503907|NCT01005745|adoptive cell therapy|adoptive cell therapy
503908|NCT01005745|tumor-infiltrating lymphocytes (TIL)|tumor-infiltrating lymphocytes (til)
503909|NCT01005745|lymphodepletion|lymphodepletion
503910|NCT01005732|hypertrophic|hypertrophic
503911|NCT01005732|scar|scar
503912|NCT01005732|burn|burn
503913|NCT01005732|cicatrix|cicatrix
503914|NCT01005732|pressure|pressure
503915|NCT01005732|garment|garment
503916|NCT01005693|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
503917|NCT01005667|Nulliparous women in spontaneous labor|nulliparous women in spontaneous labor
503918|NCT01005654|Gene Expression|gene expression
503919|NCT01005654|Epigenetic (methylation)|epigenetic (methylation)
503920|NCT01005654|Tissues Histological Evaluations|tissues histological evaluations
503921|NCT01005654|Establishment of Tumor Cell Lines|establishment of tumor cell lines
503922|NCT01005654|Metabolite and Protein Expression|metabolite and protein expression
503923|NCT01005654|Adrenal Cancer|adrenal cancer
503924|NCT01005654|Endocrine Tumor|endocrine tumor
503925|NCT01005654|Thyroid Cancer|thyroid cancer
503926|NCT01005641|advanced breast cancer|advanced breast cancer
503927|NCT01005641|hormone-responsive|hormone-responsive
503928|NCT01005641|metastatic breast cancer|metastatic breast cancer
503929|NCT01005628|Bortezomib postmarketing surveillance|bortezomib postmarketing surveillance
503930|NCT01005628|Korea bortezomib PMS|korea bortezomib pms
503931|NCT01005602|Digoxin|digoxin
503932|NCT01005602|Pharmacokinetics|pharmacokinetics
503933|NCT01005602|Dosing|dosing
503934|NCT01005602|Heart Failure|heart failure
503935|NCT01005589|Neonatal sepsis|neonatal sepsis
503936|NCT01005589|Necrotizing enterocolitis|necrotizing enterocolitis
503937|NCT01005589|CD64 antigen|cd64 antigen
503938|NCT01005589|Receptors, IgG|receptors, igg
503939|NCT01005576|Thalassemia|thalassemia
503940|NCT01005576|Alemtuzumab|alemtuzumab
503941|NCT01005576|Hematopoietic cell transplant|hematopoietic cell transplant
503942|NCT01005576|non-myeloablative|non-myeloablative
503943|NCT01005550|Unilateral spinal anaesthesia|unilateral spinal anaesthesia
503944|NCT01005550|Hypobaric anaesthesia|hypobaric anaesthesia
503945|NCT01005550|Ropivacaine|ropivacaine
503946|NCT01005550|Traumatic hip surgery|traumatic hip surgery
503947|NCT01005537|stage IV melanoma|stage iv melanoma
503948|NCT01005524|brain computer interface|brain computer interface
503949|NCT01005524|P3Speller|p3speller
503950|NCT01005524|P300|p300
503951|NCT01005524|Event Related potential|event related potential
503952|NCT01005524|tetraplegia|tetraplegia
503953|NCT01005524|Guillain barre syndrome|guillain barre syndrome
503954|NCT01005524|Feasibility|feasibility
503955|NCT01005524|Speed of spelling|speed of spelling
503956|NCT01005524|Accuracy|accuracy
503957|NCT01005511|Bruxism|bruxism
503958|NCT01005498|Low carbohydrate diet. Dietary treatment of diabetes mellitus.|low carbohydrate diet. dietary treatment of diabetes mellitus.
503959|NCT01005498|Diabetes mellitus type 2 and dietary treatment.|diabetes mellitus type 2 and dietary treatment.
503960|NCT01005485|Myocardial Infarction (MI)|myocardial infarction (mi)
503961|NCT01005485|Circulating Endothelial Cells (CEC)|circulating endothelial cells (cec)
503962|NCT01005485|Control Group A: (Vascular Surgery)|control group a: (vascular surgery)
503963|NCT01005485|Control Group B: (Healthy controls)|control group b: (healthy controls)
503964|NCT01005472|stage III melanoma|stage iii melanoma
503965|NCT01005472|stage IV melanoma|stage iv melanoma
503966|NCT01005472|recurrent melanoma|recurrent melanoma
503967|NCT01005472|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
503968|NCT01005472|extraocular extension melanoma|extraocular extension melanoma
503969|NCT01005472|iris melanoma|iris melanoma
503970|NCT01005472|metastatic intraocular melanoma|metastatic intraocular melanoma
503971|NCT01005472|recurrent intraocular melanoma|recurrent intraocular melanoma
503972|NCT01005459|labor pain|labor pain
503973|NCT01005459|combined spinal epidural labor analgesia|combined spinal epidural labor analgesia
503974|NCT01005459|CSE analgesia|cse analgesia
503975|NCT01005459|labor analgesia|labor analgesia
503976|NCT01005433|dexmedetomidine|dexmedetomidine
503977|NCT01005433|stress response|stress response
503978|NCT01005433|cesarean delivery|cesarean delivery
503979|NCT01005420|Insulin Sensitivity|insulin sensitivity
503980|NCT01005420|Pre-diabetes|pre-diabetes
503981|NCT01005420|Diabetes|diabetes
503982|NCT01005420|Blueberries|blueberries
503983|NCT01005420|Anthocyanins|anthocyanins
503984|NCT01005407|HBV vaccine|hbv vaccine
503985|NCT01005407|Hepatitis B vaccine|hepatitis b vaccine
503986|NCT01005407|Hepatitis B|hepatitis b
503987|NCT01005407|Hepatitis|hepatitis
503988|NCT01005407|HBV|hbv
503989|NCT01005407|Prevention & Control|prevention & control
503990|NCT01005407|Healthy|healthy
503991|NCT01005407|Healthy volunteers|healthy volunteers
503992|NCT01005381|Calcium|calcium
503993|NCT01005381|Vitamin D|vitamin d
503994|NCT01005381|Particle Size|particle size
503995|NCT01005381|Adolescents|adolescents
503996|NCT01005381|Bone|bone
503997|NCT01005381|Osteoporosis|osteoporosis
503998|NCT01005368|chronic lymphocytic leukemia|chronic lymphocytic leukemia
503999|NCT01005355|Solid tumor|solid tumor
504000|NCT01005355|recombinant human IgG1|recombinant human igg1
504001|NCT01005355|MAB|mab
504002|NCT01005355|monoclonal antibody|monoclonal antibody
504003|NCT01005355|VEGFR 2|vegfr 2
504004|NCT01005355|human vascular endothelial growth factor receptor 2|human vascular endothelial growth factor receptor 2
504005|NCT01005342|gene expression|gene expression
504006|NCT01005342|oats|oats
504007|NCT01005342|rye|rye
504008|NCT01005342|sugar beet fiber|sugar beet fiber
504009|NCT01005342|glucose|glucose
504010|NCT01005342|insulin|insulin
504011|NCT01005342|triglyceride|triglyceride
504012|NCT01005342|decreased postprandial glucose|decreased postprandial glucose
504288|NCT01004224|FGFR|fgfr
504013|NCT01005342|decreased postprandial insulin|decreased postprandial insulin
504014|NCT01005342|glycemic index|glycemic index
504015|NCT01005316|cohort study|cohort study
504016|NCT01005316|allo-antibodies|allo-antibodies
504017|NCT01005316|allosensitization|allosensitization
504018|NCT01005303|Heart Failure|heart failure
504019|NCT01005303|Micronutrients|micronutrients
504020|NCT01005303|Vitamin D|vitamin d
504021|NCT01005303|Inflammation|inflammation
504022|NCT01005303|Oxidative Stress|oxidative stress
504023|NCT01005303|Quality of Life|quality of life
504024|NCT01005303|Physical Functioning|physical functioning
504025|NCT01005290|cardiovascular|cardiovascular
504026|NCT01005290|fixed|fixed
504027|NCT01005290|dose|dose
504028|NCT01005290|combination|combination
504029|NCT01005290|pill|pill
504030|NCT01005290|hypertension|hypertension
504031|NCT01005277|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
504032|NCT01005277|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
504033|NCT01005277|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
504034|NCT01005277|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
504035|NCT01005277|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
504036|NCT01005277|secondary acute myeloid leukemia|secondary acute myeloid leukemia
504037|NCT01005277|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
504038|NCT01005277|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
504039|NCT01005277|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
504040|NCT01005264|diabetic foot|diabetic foot
504041|NCT01005264|neuropathic plantar ulcer|neuropathic plantar ulcer
504042|NCT01005264|ulcer healing|ulcer healing
504043|NCT01005264|non-removable total contact cast|non-removable total contact cast
504044|NCT01005264|removable cast walker|removable cast walker
504045|NCT01005251|GERD treatment|gerd treatment
504046|NCT01005251|Acid and non-acid Reflux|acid and non-acid reflux
504047|NCT01005251|Heartburn|heartburn
504048|NCT01005251|Regurgitation|regurgitation
504049|NCT01005251|Add-on treatment to PPI|add-on treatment to ppi
504050|NCT01005225|Solid tumor|solid tumor
504051|NCT01005225|prostate cancer|prostate cancer
504052|NCT01005225|colon cancer|colon cancer
504053|NCT01005212|EVAR|evar
504054|NCT01005212|Ultrasounds|ultrasounds
504055|NCT01005212|AAA|aaa
504056|NCT01005212|endoleaks after endovascular repair of AAA|endoleaks after endovascular repair of aaa
504057|NCT01005199|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
504058|NCT01005199|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
504059|NCT01005173|Acetaminophen|acetaminophen
504060|NCT01005173|APAP|apap
504061|NCT01005160|Mellitus, type 2|mellitus, type 2
504062|NCT01005160|pharmacokinetic evaluation|pharmacokinetic evaluation
504063|NCT01005160|drug interaction between CKD-501 and metformin|drug interaction between ckd-501 and metformin
504064|NCT01005147|tranexamic acid|tranexamic acid
504065|NCT01005147|upper GI bleeding|upper gi bleeding
504066|NCT01005147|blood transfusion|blood transfusion
504067|NCT01005147|GI bleeding|gi bleeding
504068|NCT01005108|Hot Flashes for Breast Cancer Patients|hot flashes for breast cancer patients
504069|NCT01005082|Low salt diet, idiopathic hypercalciuria, calcium stone formers|low salt diet, idiopathic hypercalciuria, calcium stone formers
504070|NCT01005082|Calcium stone formers with idiopathic hypercalciuria|calcium stone formers with idiopathic hypercalciuria
504071|NCT01005069|diabetes mellitus|diabetes mellitus
504072|NCT01005069|DLBS-32|dlbs-32
504073|NCT01005069|fasting plasma glucose|fasting plasma glucose
504074|NCT01005069|insulin resistance|insulin resistance
504075|NCT01005043|non-resectable osteosarcoma|non-resectable osteosarcoma
504076|NCT01005043|heavy ion radiotherapy|heavy ion radiotherapy
504077|NCT01005043|particle therapy|particle therapy
504078|NCT01005043|safety|safety
504079|NCT01005043|toxicity|toxicity
504080|NCT01005043|survival|survival
504081|NCT01005043|radiotherapy|radiotherapy
504082|NCT01005030|Parkinson Disease|parkinson disease
504083|NCT01005030|blood|blood
504084|NCT01005030|plasma|plasma
504085|NCT01005030|metabolomics|metabolomics
504086|NCT01005030|spectroscopy|spectroscopy
504087|NCT01005030|oxidative stress.|oxidative stress.
504088|NCT01005017|Radiofrequent ablation|radiofrequent ablation
504089|NCT01005017|Percutaneous radiofrequent therapy|percutaneous radiofrequent therapy
504090|NCT01005004|PMD|pmd
504091|NCT01005004|stem cells|stem cells
504092|NCT01005004|Pelizaeus-Merzbacher Disease|pelizaeus-merzbacher disease
504093|NCT01005004|human stem cells|human stem cells
504094|NCT01005004|central nervous system stem cells|central nervous system stem cells
504095|NCT01004965|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
504096|NCT01004965|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
504097|NCT01004965|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
504098|NCT01004965|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
506169|NCT00996814|Bioethics|bioethics
504099|NCT01004965|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
504100|NCT01004965|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
504101|NCT01004965|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
504102|NCT01004952|Skin|skin
504103|NCT01004952|Sunscreen|sunscreen
504104|NCT01004952|UVR Protection|uvr protection
504105|NCT01004952|09-137|09-137
504106|NCT01004939|prophylaxis|prophylaxis
504107|NCT01004939|venous thromboembolism|venous thromboembolism
504108|NCT01004939|postpartum|postpartum
504109|NCT01004939|fondaparinux|fondaparinux
504110|NCT01004939|pregnancy|pregnancy
504111|NCT01004926|Unilateral trans-tibial amputees|unilateral trans-tibial amputees
504112|NCT01004913|Benign paroxysmal positional vertigo|benign paroxysmal positional vertigo
504113|NCT01004913|Vestibular evoked myogenic potentials|vestibular evoked myogenic potentials
504114|NCT01004913|Sacculo-colic reflex|sacculo-colic reflex
504115|NCT01004900|Glaucoma, Angle Closure|glaucoma, angle closure
504116|NCT01004900|Selective laser trabeculoplasty|selective laser trabeculoplasty
504117|NCT01004900|Primary Angle Closure Disease|primary angle closure disease
504118|NCT01004887|adult anaplastic astrocytoma|adult anaplastic astrocytoma
504119|NCT01004887|adult giant cell glioblastoma|adult giant cell glioblastoma
504120|NCT01004887|adult gliosarcoma|adult gliosarcoma
504121|NCT01004887|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
504122|NCT01004887|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
504123|NCT01004874|malignant glioma|malignant glioma
504124|NCT01004874|glioblastoma|glioblastoma
504125|NCT01004874|gliosarcoma|gliosarcoma
504126|NCT01004874|Avastin|avastin
504127|NCT01004874|bevacizumab|bevacizumab
504128|NCT01004874|Topotecan|topotecan
504129|NCT01004874|Hycamtin|hycamtin
504130|NCT01004874|Temozolomide|temozolomide
504131|NCT01004874|Temodar|temodar
504132|NCT01004874|Pro00019960|pro00019960
504133|NCT01004874|Vredenburgh|vredenburgh
504134|NCT01004874|Duke|duke
504135|NCT01004874|Desjardins|desjardins
504136|NCT01004861|PVNS|pvns
504137|NCT01004848|Pre-diabetes|pre-diabetes
504138|NCT01004848|pre-diabetic state|pre-diabetic state
504139|NCT01004848|community-based participatory research|community-based participatory research
504140|NCT01004848|overweight|overweight
504141|NCT01004848|weight loss intervention, peer-led lifestyle education|weight loss intervention, peer-led lifestyle education
504142|NCT01004835|migraine|migraine
504143|NCT01004822|Treatment Non-Randomized Single Group Assignment Safety Study Neoplasms Carcinoma Cancer Malignancy|treatment non-randomized single group assignment safety study neoplasms carcinoma cancer malignancy
504144|NCT01004809|Dutasteride|dutasteride
504145|NCT01004796|breast cancer|breast cancer
504146|NCT01004783|stage I Wilms tumor|stage i wilms tumor
504147|NCT01004783|stage II Wilms tumor|stage ii wilms tumor
504148|NCT01004783|epithelial predominant Wilms tumor|epithelial predominant wilms tumor
504149|NCT01004770|CECT - Contrast-enhanced computed tomography|cect - contrast-enhanced computed tomography
504150|NCT01004770|HCG - Human Chorionic Gonadotropin|hcg - human chorionic gonadotropin
504151|NCT01004770|HU - Hounsfield Units|hu - hounsfield units
504152|NCT01004770|Patient Safety|patient safety
504153|NCT01004770|Tolerance|tolerance
504154|NCT01004770|Pharmacokinetic|pharmacokinetic
504155|NCT01004757|diastolic function|diastolic function
504156|NCT01004757|postmeal glucose|postmeal glucose
504157|NCT01004757|insulin resistance|insulin resistance
504158|NCT01004757|low carb diet|low carb diet
504159|NCT01004757|type 2 diabetes|type 2 diabetes
504160|NCT01004744|Postmenopausal women|postmenopausal women
504161|NCT01004744|ER+|er+
504162|NCT01004744|Estrogen positive|estrogen positive
504163|NCT01004744|PR+|pr+
504164|NCT01004744|Progesterone positive|progesterone positive
504165|NCT01004731|EGFr|egfr
504166|NCT01004731|cetuximab|cetuximab
504167|NCT01004731|gemcitabine|gemcitabine
504168|NCT01004731|carboplatin|carboplatin
504169|NCT01004731|NSCLC|nsclc
504170|NCT01004705|cardiovascular|cardiovascular
504171|NCT01004705|fixed|fixed
504172|NCT01004705|dose|dose
504173|NCT01004705|combination|combination
504174|NCT01004705|pill|pill
504175|NCT01004705|LDL|ldl
504176|NCT01004705|cholesterol|cholesterol
504177|NCT01004666|Breast cancer|breast cancer
504178|NCT01004666|Scintimammography|scintimammography
504179|NCT01004666|CZT|czt
504180|NCT01004666|High-risk|high-risk
504181|NCT01004640|chronic myelogenous leukemia|chronic myelogenous leukemia
504182|NCT01004627|fistula|fistula
504183|NCT01004627|ultrasound|ultrasound
504184|NCT01004627|angioaccess|angioaccess
504185|NCT01004627|preoperative vein mapping|preoperative vein mapping
504186|NCT01004627|Haemodialysis|haemodialysis
504187|NCT01004627|Angioaccess surgery|angioaccess surgery
504188|NCT01004601|pretreated failure advanced stage IIIb/IV NSCLC|pretreated failure advanced stage iiib/iv nsclc
504189|NCT01004588|elderly|elderly
504190|NCT01004588|sarcopenia|sarcopenia
504191|NCT01004588|protein drink|protein drink
504192|NCT01004588|resistance training|resistance training
504193|NCT01004575|stents|stents
504194|NCT01004575|bare metal stents|bare metal stents
504195|NCT01004562|breast cancer|breast cancer
504196|NCT01004549|Patients who have previously undergone bilateral intraocular lens implantation|patients who have previously undergone bilateral intraocular lens implantation
504197|NCT01004523|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
504198|NCT01004523|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
504199|NCT01004523|childhood mixed glioma|childhood mixed glioma
504200|NCT01004523|adult mixed glioma|adult mixed glioma
504201|NCT01004523|adult diffuse astrocytoma|adult diffuse astrocytoma
504202|NCT01004523|childhood oligodendroglioma|childhood oligodendroglioma
504203|NCT01004523|adult oligodendroglioma|adult oligodendroglioma
504204|NCT01004510|malignant pleural effusion|malignant pleural effusion
504205|NCT01004510|non small cell lung cancer|non small cell lung cancer
504206|NCT01004497|Acute lymphoblastic leukemia, adult, dasatinib|acute lymphoblastic leukemia, adult, dasatinib
504207|NCT01004484|non-patients|non-patients
504208|NCT01004484|non-diarrhea functional bowel symptoms|non-diarrhea functional bowel symptoms
504209|NCT01004471|Nasal dilator strip|nasal dilator strip
504210|NCT01004471|Sleep disordered breathing|sleep disordered breathing
504211|NCT01004458|fibromyalgia|fibromyalgia
504212|NCT01004458|cognitive behavioral therapy|cognitive behavioral therapy
504213|NCT01004458|women|women
504214|NCT01004458|pain|pain
504215|NCT01004458|stress|stress
504216|NCT01004458|type A behavior|type a behavior
504217|NCT01004445|Pneumonia|pneumonia
504218|NCT01004445|Adjunctive treatment|adjunctive treatment
504219|NCT01004445|Gram-negative bacteria|gram-negative bacteria
504220|NCT01004432|humira, remicade|humira, remicade
504221|NCT01004432|rheumatoid arthritis|rheumatoid arthritis
504222|NCT01004432|enbrel failure|enbrel failure
504223|NCT01004432|humira failure|humira failure
504224|NCT01004432|arthritis|arthritis
504225|NCT01004432|enbrel|enbrel
504226|NCT01004419|non small cell lung cancer|non small cell lung cancer
504227|NCT01004419|vandetanib|vandetanib
504228|NCT01004419|ZD6474|zd6474
504229|NCT01004419|fulvestrant|fulvestrant
504230|NCT01004419|faslodex|faslodex
504231|NCT01004419|phase 1|phase 1
504232|NCT01004406|plaque|plaque
504233|NCT01004406|LDL|ldl
504234|NCT01004406|statin|statin
504235|NCT01004406|endothelial|endothelial
504236|NCT01004406|apheresis|apheresis
504237|NCT01004406|acute coronary syndrome|acute coronary syndrome
504238|NCT01004393|Methylnaltrexone|methylnaltrexone
504239|NCT01004393|Constipation|constipation
504240|NCT01004393|Narcotic Antagonists|narcotic antagonists
504241|NCT01004393|Analgesics, Opioid|analgesics, opioid
504242|NCT01004393|Neoplasms|neoplasms
504243|NCT01004380|Epithelial Ovarian Cancer|epithelial ovarian cancer
504244|NCT01004380|Ovarian Cancer|ovarian cancer
504245|NCT01004367|Promoting healthy lifestyles in adolescents in Ecuador to prevent overweight|promoting healthy lifestyles in adolescents in ecuador to prevent overweight
504246|NCT01004354|Psychiatric illnesses|psychiatric illnesses
504247|NCT01004354|Vitamin D deficiency|vitamin d deficiency
504248|NCT01004354|Obesity|obesity
504249|NCT01004341|pediatric obesity|pediatric obesity
504250|NCT01004341|parenting style|parenting style
504251|NCT01004341|feeding style|feeding style
504252|NCT01004341|behavioral skills|behavioral skills
504253|NCT01004341|parenting skills|parenting skills
504254|NCT01004341|family meals|family meals
504255|NCT01004328|patient safety|patient safety
504256|NCT01004328|care transitions|care transitions
504257|NCT01004328|therapeutic monitoring|therapeutic monitoring
504258|NCT01004328|skilled nursing facilities|skilled nursing facilities
504259|NCT01004328|Adverse outcomes after discharge from a SNF to home|adverse outcomes after discharge from a snf to home
504260|NCT01004315|Overactive bladder|overactive bladder
504261|NCT01004315|Frequency|frequency
504262|NCT01004315|Micturition|micturition
504263|NCT01004315|Urgency|urgency
504264|NCT01004315|Urge urinary incontinence|urge urinary incontinence
504265|NCT01004315|OAB|oab
504266|NCT01004302|Obsessive-compulsive disorder|obsessive-compulsive disorder
504267|NCT01004302|Radiosurgery|radiosurgery
504268|NCT01004302|Psychosurgery|psychosurgery
504269|NCT01004302|Treatment outcome|treatment outcome
504270|NCT01004302|Randomized Controlled Trials|randomized controlled trials
504271|NCT01004289|Acute myocardial infarction|acute myocardial infarction
504272|NCT01004289|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
504273|NCT01004289|Postconditioning|postconditioning
504274|NCT01004276|primary health care|primary health care
504275|NCT01004276|delivery of health care|delivery of health care
504276|NCT01004276|smoking cessation|smoking cessation
504277|NCT01004276|chronic disease|chronic disease
504278|NCT01004276|disease management|disease management
504279|NCT01004276|pilot projects|pilot projects
504280|NCT01004263|acute migraine with or without aura in adolescents|acute migraine with or without aura in adolescents
504281|NCT01004237|insulin resistance|insulin resistance
504282|NCT01004237|hypertensive|hypertensive
504283|NCT01004237|hypercholesterolemic patients|hypercholesterolemic patients
504284|NCT01004224|advanced solid tumors|advanced solid tumors
504285|NCT01004224|lung cancer|lung cancer
504286|NCT01004224|bladder cancer|bladder cancer
504287|NCT01004224|BGJ398|bgj398
504289|NCT01004224|kinase inhibitor|kinase inhibitor
504290|NCT01004224|advanced solid malignancies|advanced solid malignancies
504291|NCT01004211|bladder cancer|bladder cancer
504292|NCT01004211|recurrence|recurrence
504293|NCT01004198|Trauma|trauma
504294|NCT01004198|Hemorrhage|hemorrhage
504295|NCT01004198|Hemorrhagic shock|hemorrhagic shock
504296|NCT01004198|Lactic acidosis|lactic acidosis
504297|NCT01004198|Oxygen carriers|oxygen carriers
504298|NCT01004198|Oxygen therapeutics|oxygen therapeutics
504299|NCT01004198|Hemoglobin solutions|hemoglobin solutions
504300|NCT01004198|Hemoglobin substitutes|hemoglobin substitutes
504301|NCT01004198|Red cell substitutes|red cell substitutes
504302|NCT01004198|PEG-hemoglobin|peg-hemoglobin
504303|NCT01004172|carboplatin|carboplatin
504304|NCT01004172|bevacizumab|bevacizumab
504305|NCT01004159|Colorectal cancer|colorectal cancer
504306|NCT01004159|KRAS wild type tumors|kras wild type tumors
504307|NCT01004146|incentive spirometry|incentive spirometry
504308|NCT01004146|bariatric surgery|bariatric surgery
504309|NCT01004146|obesity|obesity
504310|NCT01004133|Age 80 or older|age 80 or older
504311|NCT01004133|No chronic disease|no chronic disease
504312|NCT01004094|children|children
504313|NCT01004094|video games|video games
504314|NCT01004094|internet|internet
504315|NCT01004094|parents|parents
504316|NCT01004094|fruit|fruit
504317|NCT01004094|vegetable|vegetable
504318|NCT01004094|implementation intention|implementation intention
504319|NCT01004094|goal setting|goal setting
504320|NCT01004094|fruit and vegetable consumption|fruit and vegetable consumption
504321|NCT01004094|obesity prevention|obesity prevention
504322|NCT01004094|cancer prevention|cancer prevention
504323|NCT01004081|Cancer of Breast|cancer of breast
504324|NCT01004081|Cancer of the Breast|cancer of the breast
504325|NCT01004068|Clomiphene|clomiphene
504326|NCT01004068|Diet|diet
504327|NCT01004068|Exercise|exercise
504328|NCT01004068|Infertility|infertility
504329|NCT01004068|PCOS|pcos
504330|NCT01004068|Physical activity|physical activity
504331|NCT01004068|Treatment|treatment
504332|NCT01004055|Wound|wound
504333|NCT01004055|Skin lesion|skin lesion
504334|NCT01004055|Antimicrobial|antimicrobial
504335|NCT01004055|Bioelectric|bioelectric
504336|NCT01004042|Depression|depression
504337|NCT01004042|Botulinum toxin|botulinum toxin
504338|NCT01004042|Glabella|glabella
504339|NCT01004042|Quality of life|quality of life
504340|NCT01004042|Self-steem|self-steem
504341|NCT01004029|17P|17p
504342|NCT01004029|hydroxyprogesterone caproate|hydroxyprogesterone caproate
504343|NCT01004029|preterm birth|preterm birth
504344|NCT01004029|progesterone|progesterone
504345|NCT01004029|women with a singleton pregnancy aged 18 years or older with a history of a previous singleton spontaneous preterm delivery|women with a singleton pregnancy aged 18 years or older with a history of a previous singleton spontaneous preterm delivery
504346|NCT01004016|Spinocerebellar degeneration|spinocerebellar degeneration
504347|NCT01004016|Thyrotropin-Releasing Hormone (TRH)|thyrotropin-releasing hormone (trh)
504348|NCT01004016|SCD|scd
504349|NCT01003990|Treatment experienced|treatment experienced
504350|NCT01003964|NON-SMALL CELL LUNG CANCER|non-small cell lung cancer
504351|NCT01003964|excision repair cross-complementing 1|excision repair cross-complementing 1
504352|NCT01003964|Gemcitabine and cisplatin|gemcitabine and cisplatin
504353|NCT01003964|Irinotecan and cisplatin|irinotecan and cisplatin
504354|NCT01003964|Pemetrexed|pemetrexed
504355|NCT01003964|Docetaxel|docetaxel
504356|NCT01003964|advanced NSCLC|advanced nsclc
504357|NCT01003951|Lymphedema|lymphedema
504358|NCT01003951|Acupuncture|acupuncture
504359|NCT01003951|09-136|09-136
504360|NCT01003938|chemotherapy|chemotherapy
504361|NCT01003938|combination therapy|combination therapy
504362|NCT01003938|targeted therapy|targeted therapy
504363|NCT01003938|second-line|second-line
504364|NCT01003925|Knee pain, osteoarthritis, non-surgical treatment, age 65+|knee pain, osteoarthritis, non-surgical treatment, age 65+
504365|NCT01003912|Lysosomal Storage Diseases|lysosomal storage diseases
504366|NCT01003912|Inborn Errors of Metabolism|inborn errors of metabolism
504367|NCT01003912|Krabbe|krabbe
504368|NCT01003912|Infantile metachromatic leukodystrophy disease|infantile metachromatic leukodystrophy disease
504369|NCT01003912|MLD|mld
504370|NCT01003912|Tay Sachs|tay sachs
504371|NCT01003912|Sandhoff|sandhoff
504372|NCT01003912|GM2 gangliosidoses|gm2 gangliosidoses
504373|NCT01003912|Pelizaeus-Merzbacher disease|pelizaeus-merzbacher disease
504374|NCT01003912|PMD|pmd
504375|NCT01003886|post marketing surveillance Filipino benign prostatic hyperplasia BPH Doxazosin GITS|post marketing surveillance filipino benign prostatic hyperplasia bph doxazosin gits
504376|NCT01003873|morbid obesity|morbid obesity
504377|NCT01003873|bariatric surgery|bariatric surgery
504378|NCT01003873|lifestyle intervention|lifestyle intervention
504379|NCT01003873|endocannabinoids system|endocannabinoids system
504380|NCT01003860|postoperative analgesia|postoperative analgesia
504381|NCT01003847|Insulin resistance|insulin resistance
504382|NCT01003834|substance use|substance use
504383|NCT01003834|drug use|drug use
504384|NCT01003834|drug abuse|drug abuse
504385|NCT01003782|cholangitis|cholangitis
504386|NCT01003782|antibiotic|antibiotic
504387|NCT01003782|bacteriobilia|bacteriobilia
504389|NCT01003782|ERCP|ercp
504390|NCT01003756|Preoperative|preoperative
504391|NCT01003756|Exercise|exercise
504392|NCT01003756|Joint Replacement|joint replacement
504393|NCT01003756|Hip|hip
504394|NCT01003756|Knee|knee
504395|NCT01003730|Intraoperative protective ventilation strategies|intraoperative protective ventilation strategies
504396|NCT01003691|Phase 1b Advanced Dry Age-Related Macular Degeneration RN6G|phase 1b advanced dry age-related macular degeneration rn6g
504397|NCT01003678|Myelodysplastic syndrome|myelodysplastic syndrome
504398|NCT01003678|Clofarabine|clofarabine
504399|NCT01003678|low-dose oral clofarabine|low-dose oral clofarabine
504400|NCT01003678|intermediate risk Myelodysplastic syndrome|intermediate risk myelodysplastic syndrome
504401|NCT01003678|high risk Myelodysplastic syndrome|high risk myelodysplastic syndrome
504402|NCT01003652|goiter|goiter
504403|NCT01003639|papilledema|papilledema
504404|NCT01003639|vision loss|vision loss
504405|NCT01003639|headache|headache
504406|NCT01003639|obesity|obesity
504407|NCT01003639|women|women
504408|NCT01003639|diplopia|diplopia
504409|NCT01003639|tinnitus|tinnitus
504410|NCT01003626|Advanced cutaneous melanoma|advanced cutaneous melanoma
504411|NCT01003626|Tumor Pressure|tumor pressure
504412|NCT01003626|Tumor IFP|tumor ifp
504413|NCT01003626|Interstitial Fluid Pressure|interstitial fluid pressure
504414|NCT01003626|IFP|ifp
504415|NCT01003626|Transducer-tipped catheter Mikro-Tip SPC-320|transducer-tipped catheter mikro-tip spc-320
504416|NCT01003626|Transducer Millar|transducer millar
504417|NCT01003626|Power Lab 8/30 amplifier|power lab 8/30 amplifier
504418|NCT01003613|Tranilast|tranilast
504419|NCT01003613|fibrin glue|fibrin glue
504420|NCT01003613|primary pterygium|primary pterygium
504421|NCT01003613|conjunctival autograft|conjunctival autograft
504422|NCT01003600|Survivorship|survivorship
504423|NCT01003600|Quality of Life|quality of life
504424|NCT01003600|Questionnaire|questionnaire
504425|NCT01003600|09-133|09-133
504426|NCT01003587|India|india
504427|NCT01003587|evidence-based policy|evidence-based policy
504428|NCT01003587|knowledge translation|knowledge translation
504429|NCT01003587|disease control priorities|disease control priorities
504430|NCT01003587|decision-makers|decision-makers
504431|NCT01003587|health spending|health spending
504432|NCT01003587|health services delivery|health services delivery
504433|NCT01003587|maternal and child health|maternal and child health
504434|NCT01003587|policy making|policy making
504435|NCT01003587|delivery of health care|delivery of health care
504436|NCT01003574|cardiovascular health outcomes in cancer survivors|cardiovascular health outcomes in cancer survivors
504437|NCT01003561|ultrasonographic exam on upper and lower extremities|ultrasonographic exam on upper and lower extremities
504438|NCT01003548|Embryo culture|embryo culture
504439|NCT01003548|IVF|ivf
504440|NCT01003548|Microfluidics|microfluidics
504441|NCT01003548|infertility|infertility
504442|NCT01003535|Parkinson´s disease|parkinson´s disease
504443|NCT01003535|Acetylcholine receptors|acetylcholine receptors
504444|NCT01003522|Bronchial stents|bronchial stents
504445|NCT01003522|Airway obstruction|airway obstruction
504446|NCT01003522|Non-small cell lung cancer|non-small cell lung cancer
504447|NCT01003509|inguinal|inguinal
504448|NCT01003509|hernia|hernia
504449|NCT01003509|new|new
504450|NCT01003509|repair|repair
504451|NCT01003509|modified shouldice|modified shouldice
504452|NCT01003509|double|double
504453|NCT01003496|Cocaine|cocaine
504454|NCT01003496|crack|crack
504455|NCT01003496|heroin|heroin
504456|NCT01003496|non-prescribed opioids|non-prescribed opioids
504457|NCT01003496|contingency management|contingency management
504458|NCT01003496|community reinforcement approach|community reinforcement approach
504459|NCT01003496|facilitated therapeutic alliance|facilitated therapeutic alliance
504460|NCT01003496|chronic disease treatment models|chronic disease treatment models
504461|NCT01003483|metformin|metformin
504462|NCT01003483|orlistat|orlistat
504463|NCT01003483|pcos|pcos
504464|NCT01003483|obese|obese
504465|NCT01003470|cerebral infarction|cerebral infarction
504466|NCT01003470|Paralysis|paralysis
504467|NCT01003470|acupuncture|acupuncture
504468|NCT01003470|rehabilitation|rehabilitation
504469|NCT01003470|trial|trial
504470|NCT01003444|Muscle biopsy Malonyl CoA Biomarker assay|muscle biopsy malonyl coa biomarker assay
504471|NCT01003418|GSK2340272A|gsk2340272a
504472|NCT01003418|H1N1 pandemic influenza|h1n1 pandemic influenza
504473|NCT01003405|Overactive bladder|overactive bladder
504474|NCT01003405|Frequency|frequency
504475|NCT01003405|Micturition|micturition
504476|NCT01003405|Urgency|urgency
504477|NCT01003405|Urge urinary incontinence|urge urinary incontinence
504478|NCT01003405|OAB|oab
504479|NCT01003392|Coronary artery disease|coronary artery disease
504480|NCT01003392|Coffee|coffee
504481|NCT01003392|Heart system|heart system
504482|NCT01003379|cognitive dysfunction|cognitive dysfunction
504483|NCT01003379|schizophrenia|schizophrenia
504484|NCT01003379|Phase 2|phase 2
504485|NCT01003366|safety during central venous catheterization|safety during central venous catheterization
504486|NCT01003353|Stroke|stroke
504487|NCT01003353|Strength training|strength training
504488|NCT01003353|exercise therapy|exercise therapy
504489|NCT01003340|asthma|asthma
504490|NCT01003340|children|children
504491|NCT01003340|community health workers|community health workers
504492|NCT01003340|home intervention|home intervention
504493|NCT01003327|laryngeal mask, leak pressure|laryngeal mask, leak pressure
504494|NCT01003327|leak pressure|leak pressure
504495|NCT01003314|Vaccine|vaccine
504496|NCT01003314|Safety|safety
504497|NCT01003314|Immunogenicity|immunogenicity
504498|NCT01003314|Protection|protection
504499|NCT01003314|Sporozoite challenge|sporozoite challenge
504500|NCT01003301|cat allergy|cat allergy
504501|NCT01003288|H1N1 pandemic vaccine immunogenicity safety|h1n1 pandemic vaccine immunogenicity safety
504502|NCT01003288|Health employees|health employees
504503|NCT01003275|Chronic kidney disease|chronic kidney disease
504504|NCT01003275|Vitamin D|vitamin d
504505|NCT01003275|Paricalcitol|paricalcitol
504506|NCT01003275|Placebo|placebo
504507|NCT01003275|Kidney|kidney
504508|NCT01003275|Renal|renal
504509|NCT01003275|Oxidative Stress|oxidative stress
504510|NCT01003275|Immune cell function|immune cell function
504511|NCT01003275|Glucose|glucose
504512|NCT01003275|Glucose tolerance|glucose tolerance
504513|NCT01003262|Observation Unit|observation unit
504514|NCT01003262|Emergency Department|emergency department
504515|NCT01003249|over distention of bladder|over distention of bladder
504516|NCT01003249|Dysfunctional voiding|dysfunctional voiding
504517|NCT01003249|dysfunctional elimination syndrome|dysfunctional elimination syndrome
504518|NCT01003236|Diabetic nephropathy|diabetic nephropathy
504519|NCT01003236|Type II Diabetes|type ii diabetes
504520|NCT01003236|Milk Thistle extract|milk thistle extract
504521|NCT01003236|Silymarin|silymarin
504522|NCT01003223|phosphorus|phosphorus
504523|NCT01003223|dialysis|dialysis
504524|NCT01003223|PhosLo|phoslo
504525|NCT01003223|CKD stage V|ckd stage v
504526|NCT01003210|otitis media|otitis media
504527|NCT01003210|children|children
504528|NCT01003210|homeopathy|homeopathy
504529|NCT01003197|Development|development
504530|NCT01003197|Validation|validation
504531|NCT01003197|Prediction Score|prediction score
504532|NCT01003197|Complication|complication
504533|NCT01003197|Liver resection|liver resection
504534|NCT01003197|develop and validate a score to predict serious complications following liver resection using pre-operative risk factors.|develop and validate a score to predict serious complications following liver resection using pre-operative risk factors.
504535|NCT01003184|diabetes|diabetes
504536|NCT01003184|exenatide once weekly|exenatide once weekly
504537|NCT01003184|Byetta|byetta
504538|NCT01003184|insulin detemir|insulin detemir
504539|NCT01003184|Levemir|levemir
504540|NCT01003184|Amylin|amylin
504541|NCT01003184|Lilly|lilly
504542|NCT01003171|Pharmacokinetics|pharmacokinetics
504543|NCT01003171|PK|pk
504544|NCT01003171|MCS|mcs
504545|NCT01003171|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
504546|NCT01003171|Multi-Carotenoids|multi-carotenoids
504547|NCT01003171|Healthy subjects|healthy subjects
504548|NCT01003158|Cancer|cancer
504549|NCT01003158|tumour|tumour
504550|NCT01003158|metastatic|metastatic
504551|NCT01003158|breast cancer|breast cancer
504552|NCT01003145|Influenza|influenza
504553|NCT01003145|vaccine|vaccine
504554|NCT01003145|Immunogenicity|immunogenicity
504555|NCT01003132|Psychosis|psychosis
504556|NCT01003132|Distress|distress
504557|NCT01003132|Mindfulness|mindfulness
504558|NCT01003132|Acceptance|acceptance
504559|NCT01003132|Values|values
504560|NCT01003119|Alcohol addiction|alcohol addiction
504561|NCT01003119|Alcohol treatment|alcohol treatment
504562|NCT01003119|Alcohol recovery|alcohol recovery
504563|NCT01003119|Post residential treatment DSM-IV diagnosis of alcohol dependence|post residential treatment dsm-iv diagnosis of alcohol dependence
504564|NCT01003106|RVO|rvo
504565|NCT01003106|BRVO|brvo
504566|NCT01003106|CRVO|crvo
504567|NCT01003106|Vein occlusion|vein occlusion
504568|NCT01003093|Tuberculosis|tuberculosis
504569|NCT01003093|Vaccine|vaccine
504570|NCT01003093|Ag85B|ag85b
504571|NCT01003093|ESAT-6|esat-6
504572|NCT01003093|IC31|ic31
504573|NCT01003080|The evaluation of hemostasis during total knee arthroplasty using the aquamantys device.|the evaluation of hemostasis during total knee arthroplasty using the aquamantys device.
504574|NCT01003054|Leukemia|leukemia
504575|NCT01003054|CML|cml
504576|NCT01003054|Busulfan|busulfan
504577|NCT01003054|Busulfex|busulfex
504578|NCT01003054|Myleran|myleran
504579|NCT01003054|Cyclophosphamide|cyclophosphamide
504580|NCT01003054|Cytoxan|cytoxan
504581|NCT01003054|Neosar|neosar
504582|NCT01003054|Imatinib Mesylate|imatinib mesylate
504583|NCT01003054|Gleevec|gleevec
504584|NCT01003054|Autologous Stem Cell Transplantation|autologous stem cell transplantation
504585|NCT01003054|Stem Cell Transplant|stem cell transplant
504586|NCT01003041|healthy normal infants|healthy normal infants
504587|NCT01003028|Total intravenous anesthesia|total intravenous anesthesia
504787|NCT01002248|Multiple Myeloma|multiple myeloma
504588|NCT01003028|Maximum plasma concentration of remifentanil|maximum plasma concentration of remifentanil
504589|NCT01003015|HCC|hcc
504590|NCT01003015|Safety|safety
504591|NCT01003015|BAY73-4506|bay73-4506
504592|NCT01003002|Parkinson's disease|parkinson's disease
504593|NCT01003002|Dyskinesia|dyskinesia
504594|NCT01003002|Movement Disorders|movement disorders
504595|NCT01002989|ankle brachial index|ankle brachial index
504596|NCT01002989|WatchBP Office|watchbp office
504597|NCT01002989|oscillometric measurement|oscillometric measurement
504598|NCT01002937|Biomarkers|biomarkers
504599|NCT01002937|Prognosis response to treatment|prognosis response to treatment
504600|NCT01002937|Renal cancer|renal cancer
504601|NCT01002924|Cancer|cancer
504602|NCT01002924|Adenocarcinoma|adenocarcinoma
504603|NCT01002924|Phase II|phase ii
504604|NCT01002924|Lung|lung
504605|NCT01002924|Non-small cell lung cancer|non-small cell lung cancer
504606|NCT01002924|NSCLC|nsclc
504607|NCT01002924|extension|extension
504608|NCT01002924|EC145|ec145
504609|NCT01002924|Prior exposure to EC145|prior exposure to ec145
504610|NCT01002911|Device procedure|device procedure
504611|NCT01002911|pacemaker|pacemaker
504612|NCT01002911|ICD|icd
504613|NCT01002911|antibiotics|antibiotics
504614|NCT01002898|HIV-1 RNA|hiv-1 rna
504615|NCT01002898|Treatment experienced|treatment experienced
504616|NCT01002885|Infertility|infertility
504617|NCT01002885|FSH Receptor Polymorphisms|fsh receptor polymorphisms
504618|NCT01002872|FGF23|fgf23
504619|NCT01002872|CKD|ckd
504620|NCT01002872|Fosrenol|fosrenol
504621|NCT01002872|Hyperphosphatemia|hyperphosphatemia
504622|NCT01002859|Coronary artery bypass graft surgery (CABG)|coronary artery bypass graft surgery (cabg)
504623|NCT01002859|Cardiopulmonary Bypass (CPB)|cardiopulmonary bypass (cpb)
504624|NCT01002859|Cyclosporine|cyclosporine
504625|NCT01002859|ischaemia reperfusion|ischaemia reperfusion
504626|NCT01002846|Efficacy|efficacy
504627|NCT01002846|Acupuncture|acupuncture
504628|NCT01002846|Hypertension|hypertension
504629|NCT01002833|Plasmodium falciparum|plasmodium falciparum
504630|NCT01002833|Malaria|malaria
504631|NCT01002820|Epileptic Seizures|epileptic seizures
504632|NCT01002820|Seizure Disorder|seizure disorder
504633|NCT01002820|Seizures|seizures
504634|NCT01002820|Convulsions|convulsions
504635|NCT01002820|Anticonvulsant|anticonvulsant
504636|NCT01002820|Anticonvulsive|anticonvulsive
504637|NCT01002820|Antiepileptic|antiepileptic
504638|NCT01002820|Ganaxolone|ganaxolone
504639|NCT01002794|Degenerative meniscal tear|degenerative meniscal tear
504640|NCT01002794|Arthroscopy|arthroscopy
504641|NCT01002794|Exercise therapy|exercise therapy
504642|NCT01002781|Tocilizumab Still|tocilizumab still
504643|NCT01002755|Leukemia|leukemia
504644|NCT01002755|CLL|cll
504645|NCT01002755|SLL|sll
504646|NCT01002755|Lenalidomide|lenalidomide
504647|NCT01002755|Ofatumumab|ofatumumab
504648|NCT01002742|GVHD|gvhd
504649|NCT01002729|Oseltamivir Pharmacokinetics Obesity|oseltamivir pharmacokinetics obesity
504650|NCT01002729|Oseltamivir Pharmacokinetics in Obesity|oseltamivir pharmacokinetics in obesity
504651|NCT01002716|rheumatoid influenza vaccine cell immunity|rheumatoid influenza vaccine cell immunity
504652|NCT01002703|Lenalidomide|lenalidomide
504653|NCT01002703|Bendamustine|bendamustine
504654|NCT01002703|Multiple Myeloma|multiple myeloma
504655|NCT01002703|Myeloma|myeloma
504656|NCT01002703|Revlimid|revlimid
504657|NCT01002703|Phase I/II|phase i/ii
504658|NCT01002703|refractory Myeloma|refractory myeloma
504659|NCT01002703|relapsed Myeloma|relapsed myeloma
504660|NCT01002690|Asthma|asthma
504661|NCT01002690|Allergen challenge|allergen challenge
504662|NCT01002690|Airway responsiveness|airway responsiveness
504663|NCT01002690|Prostaglandins|prostaglandins
504664|NCT01002690|Eicosanoids|eicosanoids
504665|NCT01002677|brain injury|brain injury
504666|NCT01002677|traumatic brain injury|traumatic brain injury
504667|NCT01002677|training|training
504668|NCT01002677|teaching|teaching
504669|NCT01002677|curriculum|curriculum
504670|NCT01002664|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
504671|NCT01002664|Multi-carotenoids|multi-carotenoids
504672|NCT01002664|MCS-2|mcs-2
504673|NCT01002664|Lower Urinary Tract Symptoms|lower urinary tract symptoms
504674|NCT01002664|International prostate symptom scores|international prostate symptom scores
504675|NCT01002651|gastrointestinal health|gastrointestinal health
504676|NCT01002651|healthy subjects|healthy subjects
504677|NCT01002625|Double-Blind Randomized Placebo-Controlled 2-Way Crossover Polysomnographic Endpoints|double-blind randomized placebo-controlled 2-way crossover polysomnographic endpoints
504678|NCT01002612|Nutritional status|nutritional status
504679|NCT01002612|Thai HIV-infected children|thai hiv-infected children
504680|NCT01002599|bariatric surgery|bariatric surgery
504681|NCT01002599|morbidly obese|morbidly obese
504682|NCT01002599|BMI >35|bmi >35
504683|NCT01002599|CPAP|cpap
504684|NCT01002599|Venturi|venturi
504685|NCT01002599|Boussignac|boussignac
504686|NCT01002599|Ventilation|ventilation
504687|NCT01002599|Pulmonary function|pulmonary function
504788|NCT01002248|Relapsed multiple myeloma|relapsed multiple myeloma
504688|NCT01002599|Morbidly Obese Patients undergoing bariatric surgery|morbidly obese patients undergoing bariatric surgery
504689|NCT01002586|Alzheimer's dementia|alzheimer's dementia
504690|NCT01002586|Wii-Fit|wii-fit
504691|NCT01002586|Walking|walking
504692|NCT01002586|Falls|falls
504693|NCT01002573|Pediatric|pediatric
504694|NCT01002573|Fever|fever
504695|NCT01002560|Melanoma|melanoma
504696|NCT01002560|Novel Prognostic Markers|novel prognostic markers
504697|NCT01002547|steatohepatitis|steatohepatitis
504698|NCT01002547|type 2 diabetes|type 2 diabetes
504699|NCT01002547|fatty liver|fatty liver
504700|NCT01002534|Cystic Fibrosis|cystic fibrosis
504701|NCT01002534|Vardenafil|vardenafil
504702|NCT01002534|Nasal instillation|nasal instillation
504703|NCT01002534|Nasal Potential difference|nasal potential difference
504704|NCT01002521|Diabetes|diabetes
504705|NCT01002521|vascular|vascular
504706|NCT01002521|haptoglobin|haptoglobin
504707|NCT01002521|tumor|tumor
504708|NCT01002521|necrosis|necrosis
504709|NCT01002521|factor|factor
504710|NCT01002521|alpha|alpha
504711|NCT01002521|traps|traps
504712|NCT01002521|impaired|impaired
504713|NCT01002521|wound|wound
504714|NCT01002521|healing|healing
504715|NCT01002521|Impaired wound healing in patients with diabetes mellitus|impaired wound healing in patients with diabetes mellitus
504716|NCT01002508|influenza vaccine scleroderma immunogenicity safety|influenza vaccine scleroderma immunogenicity safety
504717|NCT01002495|myocardial|myocardial
504718|NCT01002495|ischemia|ischemia
504719|NCT01002495|coronary disease|coronary disease
504720|NCT01002495|angina|angina
504721|NCT01002482|Hyperglycemia|hyperglycemia
504722|NCT01002482|Hypoglycemia|hypoglycemia
504723|NCT01002482|Intensive Care Unit|intensive care unit
504724|NCT01002482|Glucose Control|glucose control
504725|NCT01002482|Insulin|insulin
504726|NCT01002482|Computer Protocol|computer protocol
504727|NCT01002482|Metabolic Disorders|metabolic disorders
504728|NCT01002469|isotope ratio measurement|isotope ratio measurement
504729|NCT01002469|urea cycle|urea cycle
504730|NCT01002469|13C acetate|13c acetate
504731|NCT01002469|Healthy adults|healthy adults
504732|NCT01002456|Adrenergic beta-Antagonists|adrenergic beta-antagonists
504733|NCT01002456|Guideline Adherence|guideline adherence
504734|NCT01002456|Drug Prescriptions|drug prescriptions
504735|NCT01002456|target dose|target dose
504736|NCT01002443|Helicobacter pylori|helicobacter pylori
504737|NCT01002443|glandular atrophy|glandular atrophy
504738|NCT01002443|intestinal metaplasia|intestinal metaplasia
504739|NCT01002443|subtotal gastrectomy|subtotal gastrectomy
504740|NCT01002443|gastric cancer|gastric cancer
504741|NCT01002443|Precancerous lesion of gastric cancer|precancerous lesion of gastric cancer
504742|NCT01002430|Myocardial ischemia|myocardial ischemia
504743|NCT01002430|Refractory angina pectoris|refractory angina pectoris
504744|NCT01002430|Vascular endothelial growth factor|vascular endothelial growth factor
504745|NCT01002430|Gene therapy|gene therapy
504746|NCT01002430|Perfusion|perfusion
504747|NCT01002417|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
504748|NCT01002417|Multi-carotenoids|multi-carotenoids
504749|NCT01002417|MCS-2|mcs-2
504750|NCT01002417|Lower Urinary Tract Symptoms|lower urinary tract symptoms
504751|NCT01002417|International prostate symptom scores|international prostate symptom scores
504752|NCT01002404|ERCP|ercp
504753|NCT01002404|deep biliary cannulation|deep biliary cannulation
504754|NCT01002404|guide wire cannulation|guide wire cannulation
504755|NCT01002404|post-ERCP pancreatitis|post-ercp pancreatitis
504756|NCT01002404|Success of deep biliary cannulation|success of deep biliary cannulation
504757|NCT01002404|Rate of post-ERCP pancreatitis|rate of post-ercp pancreatitis
504758|NCT01002404|Time used to deep biliary cannulation|time used to deep biliary cannulation
504759|NCT01002391|breast hypertrophy|breast hypertrophy
504760|NCT01002391|mammaplasty|mammaplasty
504761|NCT01002391|bandages|bandages
504762|NCT01002391|surgical site infection|surgical site infection
504763|NCT01002391|skin colonization|skin colonization
504764|NCT01002352|obesity|obesity
504765|NCT01002352|bariatric|bariatric
504766|NCT01002352|BOLD|bold
504767|NCT01002352|weightloss|weightloss
504768|NCT01002352|database|database
504769|NCT01002352|data registry|data registry
504770|NCT01002326|Pediatric|pediatric
504771|NCT01002326|Body Dysmorphic Disorder|body dysmorphic disorder
504772|NCT01002326|BDD|bdd
504773|NCT01002326|CBT|cbt
504774|NCT01002326|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
504775|NCT01002300|Social Cognition|social cognition
504776|NCT01002300|Oxytocin|oxytocin
504777|NCT01002274|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
504778|NCT01002274|BPH|bph
504779|NCT01002274|MCS-2|mcs-2
504780|NCT01002274|Multi-Carotenoids|multi-carotenoids
504781|NCT01002274|Lower Urinary Tract Symptoms|lower urinary tract symptoms
504782|NCT01002274|International prostate symptom score|international prostate symptom score
504783|NCT01002261|Galactose|galactose
504784|NCT01002261|PET/CT|pet/ct
504785|NCT01002261|Liver physiology|liver physiology
504786|NCT01002261|Liver pathophysiology|liver pathophysiology
505569|NCT00999154|HV|hv
504789|NCT01002248|Refractory multiple myeloma|refractory multiple myeloma
504790|NCT01002248|Relapsed refractory multiple myeloma|relapsed refractory multiple myeloma
504791|NCT01002235|Diabetic|diabetic
504792|NCT01002235|Neuropathy|neuropathy
504793|NCT01002235|peripheral|peripheral
504794|NCT01002235|diabetes|diabetes
504795|NCT01002222|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
504796|NCT01002222|MCS-2|mcs-2
504797|NCT01002222|Multi-Carotenoids|multi-carotenoids
504798|NCT01002222|Lower Urinary Tract Symptoms|lower urinary tract symptoms
504799|NCT01002222|International prostate symptom score|international prostate symptom score
504800|NCT01002209|Diabetes|diabetes
504801|NCT01002209|Vascular Surgery|vascular surgery
504802|NCT01002209|Hyperbaric oxygen|hyperbaric oxygen
504803|NCT01002209|Surgical complications|surgical complications
504804|NCT01002209|Wound complication|wound complication
504805|NCT01002209|Randomized|randomized
504806|NCT01002209|Controlled|controlled
504807|NCT01002196|Selective Mutism|selective mutism
504808|NCT01002196|Intervention|intervention
504809|NCT01002183|Malaria|malaria
504810|NCT01002183|Plasmodium falciparum|plasmodium falciparum
504811|NCT01002183|acute uncomplicated|acute uncomplicated
504812|NCT01002170|Tuberculosis|tuberculosis
504813|NCT01002170|Cycloserine|cycloserine
504814|NCT01002170|Pharmacokinetics|pharmacokinetics
504815|NCT01002157|Coronary Artery Calcification|coronary artery calcification
504816|NCT01002157|Vitamin K|vitamin k
504817|NCT01002157|Trial|trial
504818|NCT01002157|Treatment|treatment
504819|NCT01002131|Digital Volume Tomography|digital volume tomography
504820|NCT01002131|Cone Beam CT|cone beam ct
504821|NCT01002131|impacted and supernumerary teeth|impacted and supernumerary teeth
504822|NCT01002131|dental and maxillofacial radiology|dental and maxillofacial radiology
504823|NCT01002118|heart rate variability|heart rate variability
504824|NCT01002118|Dialysis|dialysis
504825|NCT01002105|Baclofen|baclofen
504826|NCT01002105|Alcohol|alcohol
504827|NCT01002105|Baclofen as add-on to standard treatment of alcohol|baclofen as add-on to standard treatment of alcohol
504828|NCT01002092|Osteosarcoma|osteosarcoma
504829|NCT01002092|Endostar|endostar
504830|NCT01002092|Chemotherapy|chemotherapy
504831|NCT01002066|Fever|fever
504832|NCT01002066|Malaria|malaria
504833|NCT01002066|RDT|rdt
504834|NCT01002066|IMCI|imci
504835|NCT01002066|Children<5 years of age|children<5 years of age
504836|NCT01002066|ACT|act
504837|NCT01002053|diabetes|diabetes
504838|NCT01002053|neuropathy|neuropathy
504839|NCT01002053|ankle block|ankle block
504840|NCT01002053|regional anesthesia|regional anesthesia
504841|NCT01002053|ultrasound|ultrasound
504842|NCT01002053|nerve localization|nerve localization
504843|NCT01002053|Nerve localization in patients undergoing foot surgery and having ankle block|nerve localization in patients undergoing foot surgery and having ankle block
504844|NCT01002040|HIV|hiv
504845|NCT01002040|vaccine,|vaccine,
504846|NCT01002040|H1N1|h1n1
504847|NCT01002040|influenza|influenza
504848|NCT01002040|H1N1 Influenza vaccine|h1n1 influenza vaccine
504849|NCT01002040|Arepanrix|arepanrix
504850|NCT01002040|Pandemic|pandemic
504851|NCT01002040|H1N1 2009 Influenza|h1n1 2009 influenza
504852|NCT01002040|HIV preventive vaccine|hiv preventive vaccine
504853|NCT01002027|Postnatal Depression|postnatal depression
504854|NCT01002027|CBT-Counselling|cbt-counselling
504855|NCT01002027|Primary care|primary care
504856|NCT01002014|Breast Cancer|breast cancer
504857|NCT01002014|Skin Sparing Mastectomy|skin sparing mastectomy
504858|NCT01002014|Breast Cancer Prophylaxis|breast cancer prophylaxis
504859|NCT01002014|Nipple Sparing Mastectomy|nipple sparing mastectomy
504860|NCT01002014|Nipple Areolar Complex|nipple areolar complex
504861|NCT01002014|Mastectomy|mastectomy
504862|NCT01002014|Breast Reconstruction|breast reconstruction
504863|NCT01002014|Local recurrence following nipple sparing mastectomy|local recurrence following nipple sparing mastectomy
504864|NCT01002014|Cosmetic outcomes following nipple sparing mastectomy|cosmetic outcomes following nipple sparing mastectomy
504865|NCT01002014|Complications following nipple sparing mastectomy|complications following nipple sparing mastectomy
504866|NCT01001988|Encephalitis|encephalitis
504867|NCT01001988|Japanese Encephalitis|japanese encephalitis
504868|NCT01001988|Japanese Encephalitis Chimeric Virus Vaccine|japanese encephalitis chimeric virus vaccine
504869|NCT01001988|Toddlers|toddlers
504870|NCT01001975|Sunscreens|sunscreens
504871|NCT01001962|Hypertension in type II diabetes|hypertension in type ii diabetes
504872|NCT01001962|Cardiovascular morbidity and mortality|cardiovascular morbidity and mortality
504873|NCT01001936|PHASE 1 SKI-606 Solid tumor|phase 1 ski-606 solid tumor
504874|NCT01001897|IUD insertion|iud insertion
504875|NCT01001897|nulliparous women|nulliparous women
504876|NCT01001897|contraception|contraception
504877|NCT01001884|caregiver, psychoeducational, colon|caregiver, psychoeducational, colon
504878|NCT01001871|Iron deficiency anemia|iron deficiency anemia
504879|NCT01001871|Sprinkles®|sprinkles®
504880|NCT01001871|micronutrients|micronutrients
504881|NCT01001871|malaria incidence|malaria incidence
504882|NCT01001871|iron supplement|iron supplement
504883|NCT01001858|OSA|osa
506505|NCT00995852|COPD|copd
504884|NCT01001858|CPAP compliance|cpap compliance
504885|NCT01001858|nurse domiciliary led|nurse domiciliary led
504886|NCT01001858|sleep disease|sleep disease
504887|NCT01001845|hemodialysis|hemodialysis
504888|NCT01001845|oxidative stress|oxidative stress
504889|NCT01001845|plasma malondialdehyde|plasma malondialdehyde
504890|NCT01001845|Glutathion peroxidase|glutathion peroxidase
504891|NCT01001780|Graft versus Host Disease|graft versus host disease
504892|NCT01001780|Allogeneic Hematopoietic Stem Cell Transplant|allogeneic hematopoietic stem cell transplant
504893|NCT01001767|Omega-3 Fatty Acids|omega-3 fatty acids
504894|NCT01001767|HIV|hiv
504895|NCT01001767|Heart Disease|heart disease
504896|NCT01001767|Treatment experienced|treatment experienced
504897|NCT01001754|Hepatitis C|hepatitis c
504898|NCT01001754|Hepatitis C, Chronic|hepatitis c, chronic
504899|NCT01001754|PEGylated recombinant interleukin 29|pegylated recombinant interleukin 29
504900|NCT01001754|PEG-interferon lambda|peg-interferon lambda
504901|NCT01001754|Interleukin 29|interleukin 29
504902|NCT01001754|Virus|virus
504903|NCT01001754|Infection|infection
504904|NCT01001754|Liver Diseases|liver diseases
504905|NCT01001741|HIV|hiv
504906|NCT01001741|Antiretrovirals|antiretrovirals
504907|NCT01001741|Adherence|adherence
504908|NCT01001741|Text messaging|text messaging
504909|NCT01001741|Antiretroviral adherence|antiretroviral adherence
504910|NCT01001741|Treatment experienced|treatment experienced
504911|NCT01001728|Breast Cancer|breast cancer
504912|NCT01001728|Radiotherapy|radiotherapy
504913|NCT01001728|Prone position|prone position
504914|NCT01001702|Open Label|open label
504915|NCT01001702|Aripiprazole|aripiprazole
504916|NCT01001689|Pregnancy|pregnancy
504917|NCT01001689|Preventive health care|preventive health care
504918|NCT01001689|Fitness|fitness
504919|NCT01001689|Nutrition|nutrition
504920|NCT01001689|Obesity|obesity
504921|NCT01001689|Diabetes|diabetes
504922|NCT01001689|Weight gain|weight gain
504923|NCT01001676|renal failure|renal failure
504924|NCT01001676|Restenosis|restenosis
504925|NCT01001676|Dialysis access|dialysis access
504926|NCT01001676|Paclitaxel|paclitaxel
504927|NCT01001676|Angioplasty|angioplasty
504928|NCT01001676|Intimal hyperplasia|intimal hyperplasia
504929|NCT01001663|CAG|cag
504930|NCT01001650|Malaria Vaccine|malaria vaccine
504931|NCT01001650|Plasmodium falciparum|plasmodium falciparum
504932|NCT01001637|curcumin|curcumin
504933|NCT01001637|alzheimer's|alzheimer's
504934|NCT01001637|longVida|longvida
504935|NCT01001637|dementia|dementia
504936|NCT01001624|Cosmetic|cosmetic
504937|NCT01001624|Facial cream|facial cream
504938|NCT01001624|Melasma|melasma
504939|NCT01001624|Melanil|melanil
504940|NCT01001611|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
504941|NCT01001611|glitazone|glitazone
504942|NCT01001611|Type II Diabetes|type ii diabetes
504943|NCT01001611|Hypolipidemic|hypolipidemic
504944|NCT01001611|oral hypoglycemic agent|oral hypoglycemic agent
504945|NCT01001585|mitochondrial disease|mitochondrial disease
504946|NCT01001585|sevoflurane|sevoflurane
504947|NCT01001585|mitochondrial disease and sevoflurane sensitivity|mitochondrial disease and sevoflurane sensitivity
504948|NCT01001572|Blood pressure|blood pressure
504949|NCT01001572|hypertension|hypertension
504950|NCT01001572|Exforge|exforge
504951|NCT01001572|valsartan/amlodipine|valsartan/amlodipine
504952|NCT01001559|Depression|depression
504953|NCT01001559|Combination therapy|combination therapy
504954|NCT01001559|antidepressant|antidepressant
504955|NCT01001559|Deplin|deplin
504956|NCT01001559|folate|folate
504957|NCT01001559|methylfolate|methylfolate
504958|NCT01001546|Veterans|veterans
504959|NCT01001546|Smoking cessation|smoking cessation
504960|NCT01001546|Operation Enduring Freedom|operation enduring freedom
504961|NCT01001546|Operation Iraqi Freedom|operation iraqi freedom
504962|NCT01001533|Electrical Cardiometry|electrical cardiometry
504963|NCT01001533|Dexmedetomidine|dexmedetomidine
504964|NCT01001533|ICON|icon
504965|NCT01001533|bio-impedance|bio-impedance
504966|NCT01001533|cardiac monitor|cardiac monitor
504967|NCT01001520|Genetics|genetics
504968|NCT01001520|Nicotine|nicotine
504969|NCT01001520|Cognition|cognition
504970|NCT01001520|fMRI|fmri
504971|NCT01001507|Family planning|family planning
504972|NCT01001507|HIV|hiv
504973|NCT01001507|Integrated services|integrated services
504974|NCT01001507|Unintended pregnancy|unintended pregnancy
504975|NCT01001507|Kenya|kenya
504976|NCT01001494|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
504977|NCT01001494|antimuscarinic|antimuscarinic
504978|NCT01001494|COPD|copd
504979|NCT01001481|Treatment review|treatment review
504980|NCT01001481|Schizophrenia|schizophrenia
504981|NCT01001481|Observational|observational
504982|NCT01001481|Prospective studies|prospective studies
504983|NCT01001481|Australia|australia
504984|NCT01001468|Psoriasis|psoriasis
504985|NCT01001455|BP|bp
504986|NCT01001442|Multiple myeloma|multiple myeloma
504987|NCT01001442|Relapsed|relapsed
504988|NCT01001442|Refractory|refractory
507219|NCT00993551|paediatric|paediatric
504989|NCT01001429|sedation for vitreoretinal surgery|sedation for vitreoretinal surgery
504990|NCT01001390|Acute Lymphoblastic leukemia|acute lymphoblastic leukemia
504991|NCT01001377|Panitumumab|panitumumab
504992|NCT01001377|Vectibix|vectibix
504993|NCT01001377|Colon Cancer|colon cancer
504994|NCT01001377|Colorectal Cancer|colorectal cancer
504995|NCT01001377|Rectal Cancer|rectal cancer
504996|NCT01001377|Cetuximab|cetuximab
504997|NCT01001377|Erbitux|erbitux
504998|NCT01001377|Metastatic|metastatic
504999|NCT01001351|Chronic Kidney Disease|chronic kidney disease
505000|NCT01001351|Arteriovenous Grafts (AVG)|arteriovenous grafts (avg)
505001|NCT01001351|Hemodialysis|hemodialysis
505002|NCT01001351|Vascular Access|vascular access
505003|NCT01001351|Dialysis|dialysis
505004|NCT01001351|Graft|graft
505005|NCT01001351|Access|access
505006|NCT01001351|vonapanitase|vonapanitase
505007|NCT01001351|kidney|kidney
505008|NCT01001351|renal|renal
505009|NCT01001325|influenza|influenza
505010|NCT01001325|vaccine|vaccine
505011|NCT01001325|observer blind|observer blind
505012|NCT01001312|Heart Failure|heart failure
505013|NCT01001312|Therapeutics|therapeutics
505014|NCT01001312|Blood volume|blood volume
505015|NCT01001286|dropout youth in low income communities in Amman, Jordan|dropout youth in low income communities in amman, jordan
505016|NCT01001273|Pancreas Transplantation|pancreas transplantation
505017|NCT01001273|Kidney Transplantation|kidney transplantation
505018|NCT01001273|Organ Transplantation|organ transplantation
505019|NCT01001273|Pancreas and Simultaneous Pancreas/Kidney Transplant Recipients|pancreas and simultaneous pancreas/kidney transplant recipients
505020|NCT01001260|Prostaglandins|prostaglandins
505021|NCT01001260|vascular injury|vascular injury
505022|NCT01001247|TMC278-TiDP6-C154|tmc278-tidp6-c154
505023|NCT01001247|TMC278-C154|tmc278-c154
505024|NCT01001247|TMC278|tmc278
505025|NCT01001247|Healthy volunteers|healthy volunteers
505026|NCT01001247|omeprazole|omeprazole
505027|NCT01001247|proton pump inhibitor|proton pump inhibitor
505028|NCT01001247|HIV|hiv
505029|NCT01001208|Etanercept|etanercept
505030|NCT01001208|Methotrexate|methotrexate
505031|NCT01001208|Psoriasis|psoriasis
505032|NCT01001182|observational|observational
505033|NCT01001182|non-interventional|non-interventional
505034|NCT01001182|prospective|prospective
505035|NCT01001169|GSK Bio's influenza vaccine GSK2340274A|gsk bio's influenza vaccine gsk2340274a
505036|NCT01001169|influenza infection|influenza infection
505037|NCT01001156|Aged|aged
505038|NCT01001156|Breathing Muscles|breathing muscles
505039|NCT01001156|Strength Muscles|strength muscles
505040|NCT01001156|Institution of long Permanence for elderly|institution of long permanence for elderly
505041|NCT01001130|avamys|avamys
505042|NCT01001130|Allergic Rhinitis|allergic rhinitis
505043|NCT01001130|post marketing surveillance|post marketing surveillance
505044|NCT01001130|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
505045|NCT01001130|Perennial Allergic Rhinitis (PAR)|perennial allergic rhinitis (par)
505046|NCT01001117|Cataract|cataract
505047|NCT01001117|Capsulotomy|capsulotomy
505048|NCT01001117|Capsulorrhexis|capsulorrhexis
505049|NCT01001117|Phacoemulsification|phacoemulsification
505050|NCT01001104|Metabolic Diseases|metabolic diseases
505051|NCT01001104|Glucose Metabolism Disorders|glucose metabolism disorders
505052|NCT01001104|Diabetes|diabetes
505053|NCT01001104|GLP-1|glp-1
505054|NCT01001104|Lilly|lilly
505055|NCT01001091|Conjunctivitis|conjunctivitis
505056|NCT01001091|conjunctival inflammation|conjunctival inflammation
505057|NCT01001091|ocular allergies|ocular allergies
505058|NCT01001078|supraglottic airway devices|supraglottic airway devices
505059|NCT01001078|I-Gel|i-gel
505060|NCT01001078|Supreme Laryngeal mask airway|supreme laryngeal mask airway
505061|NCT01001078|Airway leak pressure|airway leak pressure
505062|NCT01001078|peak airway pressure|peak airway pressure
505063|NCT01001052|Healthy|healthy
505064|NCT01001052|bioavailability|bioavailability
505065|NCT01001039|chronic sinusitis|chronic sinusitis
505066|NCT01001039|facial pain|facial pain
505067|NCT01001026|vaccine|vaccine
505068|NCT01001026|H1N1|h1n1
505069|NCT01001026|influenza|influenza
505070|NCT01001026|H1N1 influenza vaccine|h1n1 influenza vaccine
505071|NCT01001026|pandemic|pandemic
505072|NCT01000987|alcohol|alcohol
505073|NCT01000987|reactivity|reactivity
505074|NCT01000987|smoking cessation medications|smoking cessation medications
505075|NCT01000974|primary vaccination course|primary vaccination course
505076|NCT01000974|Haemophilus influenzae type b|haemophilus influenzae type b
505077|NCT01000974|infants, children|infants, children
505078|NCT01000974|booster vaccination|booster vaccination
505079|NCT01000974|immunogenicity|immunogenicity
505080|NCT01000974|safety|safety
505081|NCT01000974|Gram-negative bacterial infections|gram-negative bacterial infections
505082|NCT01000974|vaccines, conjugate|vaccines, conjugate
505083|NCT01000961|cystinosis|cystinosis
505084|NCT01000961|cysteamine|cysteamine
505085|NCT01000961|inheritable disease|inheritable disease
505086|NCT01000961|orphan disease|orphan disease
505087|NCT01000961|CTNS protein, human|ctns protein, human
505088|NCT01000961|metabolic disease|metabolic disease
505089|NCT01000961|nephropathic cystinosis|nephropathic cystinosis
505090|NCT01000948|Prostate cancer|prostate cancer
505091|NCT01000948|Castration resistant|castration resistant
505092|NCT01000948|Chemotherapy resistant|chemotherapy resistant
505093|NCT01000948|Endothelial receptor A inhibitor|endothelial receptor a inhibitor
505094|NCT01000948|ZD4054|zd4054
505095|NCT01000935|Rotator Cuff Decompression Repair|rotator cuff decompression repair
505096|NCT01000922|Mealtime Insulin|mealtime insulin
505097|NCT01000922|Rapid acting insulin|rapid acting insulin
505098|NCT01000922|Ultra fast VIAject|ultra fast viaject
505099|NCT01000922|prandial insulin|prandial insulin
505100|NCT01000896|Phase I|phase i
505101|NCT01000896|cancer|cancer
505102|NCT01000896|solid tumors|solid tumors
505103|NCT01000896|advanced solid malignancies|advanced solid malignancies
505104|NCT01000896|NSCLC|nsclc
505105|NCT01000896|epithelial ovarian cancer|epithelial ovarian cancer
505106|NCT01000896|dose escalation|dose escalation
505107|NCT01000896|combination treatment|combination treatment
505108|NCT01000896|src inhibitor|src inhibitor
505109|NCT01000896|Japanese|japanese
505110|NCT01000883|stage IIIA breast cancer|stage iiia breast cancer
505111|NCT01000883|stage IIIB breast cancer|stage iiib breast cancer
505112|NCT01000883|stage IIIC breast cancer|stage iiic breast cancer
505113|NCT01000883|stage IV breast cancer|stage iv breast cancer
505114|NCT01000883|recurrent breast cancer|recurrent breast cancer
505115|NCT01000857|controlled-release tablet|controlled-release tablet
505116|NCT01000857|repeat dose|repeat dose
505117|NCT01000857|immediate-release tablet|immediate-release tablet
505118|NCT01000857|paroxetine|paroxetine
505119|NCT01000857|safety|safety
505120|NCT01000857|crossover|crossover
505121|NCT01000857|pharmacokinetics|pharmacokinetics
505122|NCT01000857|steady-state|steady-state
505123|NCT01000857|Japanese healthy male volunteers|japanese healthy male volunteers
505124|NCT01000857|tolerance|tolerance
505125|NCT01000844|Hemophilia|hemophilia
505126|NCT01000844|Joint|joint
505127|NCT01000844|Cartilage|cartilage
505128|NCT01000844|Damage|damage
505129|NCT01000844|Prophylaxis|prophylaxis
505130|NCT01000844|Factor VIII|factor viii
505131|NCT01000844|FVIII|fviii
505132|NCT01000844|Disease|disease
505133|NCT01000844|Arthropathy|arthropathy
505134|NCT01000831|vaccine|vaccine
505135|NCT01000831|influenza|influenza
505136|NCT01000831|H1N1 influenza vaccine|h1n1 influenza vaccine
505137|NCT01000831|influenza vaccine|influenza vaccine
505138|NCT01000831|Arepanrix|arepanrix
505139|NCT01000818|Treatment experienced|treatment experienced
505140|NCT01000779|Non Cirrhotic Portal Hypertension, secondary prophylaxis|non cirrhotic portal hypertension, secondary prophylaxis
505141|NCT01000753|adult diffuse small cleaved cell lymphoma|adult diffuse small cleaved cell lymphoma
505142|NCT01000753|adult diffuse mixed cell lymphoma|adult diffuse mixed cell lymphoma
505143|NCT01000753|grade 1 follicular lymphoma|grade 1 follicular lymphoma
505144|NCT01000753|grade 2 follicular lymphoma|grade 2 follicular lymphoma
505145|NCT01000753|grade 3 follicular lymphoma|grade 3 follicular lymphoma
505146|NCT01000753|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
505147|NCT01000753|adult immunoblastic large cell lymphoma|adult immunoblastic large cell lymphoma
505148|NCT01000753|mantle cell lymphoma|mantle cell lymphoma
505149|NCT01000753|marginal zone lymphoma|marginal zone lymphoma
505150|NCT01000753|small lymphocytic lymphoma|small lymphocytic lymphoma
505151|NCT01000753|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
505152|NCT01000753|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
505153|NCT01000753|cutaneous T-cell non-Hodgkin lymphoma|cutaneous t-cell non-hodgkin lymphoma
505154|NCT01000753|lymphoproliferative disorder|lymphoproliferative disorder
505155|NCT01000740|EAP|eap
505156|NCT01000740|Long term survival (3 years)|long term survival (3 years)
505157|NCT01000740|Gefitinib|gefitinib
505158|NCT01000740|efficacy|efficacy
505159|NCT01000727|Atherosclerosis|atherosclerosis
505160|NCT01000727|Heart disease|heart disease
505161|NCT01000727|Cardiovascular disease|cardiovascular disease
505162|NCT01000727|Lp-PLA2 inhibitor|lp-pla2 inhibitor
505163|NCT01000727|The TIMI Study Group|the timi study group
505164|NCT01000727|Coronary Heart Disease (CHD)|coronary heart disease (chd)
505165|NCT01000727|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
505166|NCT01000701|Inflammation|inflammation
505167|NCT01000701|ACS|acs
505168|NCT01000701|Prevention|prevention
505169|NCT01000701|Education|education
505170|NCT01000701|Clinical management|clinical management
505171|NCT01000675|aneurysm|aneurysm
505172|NCT01000675|coils|coils
505173|NCT01000662|whole breast radiotherapy|whole breast radiotherapy
505174|NCT01000662|tumor bed boost|tumor bed boost
505175|NCT01000649|V1a agonist|v1a agonist
505176|NCT01000636|Renal transplant patients|renal transplant patients
505177|NCT01000636|Actinic Keratoses|actinic keratoses
505178|NCT01000636|Metvix PDT|metvix pdt
505179|NCT01000636|Field cancerisation|field cancerisation
505180|NCT01000636|Gene expression|gene expression
505181|NCT01000597|pharmacokinetics|pharmacokinetics
505182|NCT01000597|serum cortisol|serum cortisol
505183|NCT01000597|pharmacodynamics|pharmacodynamics
505184|NCT01000597|fluticasone furoate|fluticasone furoate
505185|NCT01000597|healthy Caucasian, Japanese, Korean and Chinese subjects|healthy caucasian, japanese, korean and chinese subjects
505186|NCT01000584|vaccine|vaccine
505187|NCT01000584|H1N1|h1n1
505188|NCT01000584|influenza|influenza
505189|NCT01000584|H1N1 influenza vaccine|h1n1 influenza vaccine
505190|NCT01000584|influenza vaccine|influenza vaccine
505191|NCT01000584|seasonal Influenza|seasonal influenza
505192|NCT01000571|H1N1 pandemic flu|h1n1 pandemic flu
505193|NCT01000558|non-Hodgkin lymphoma|non-hodgkin lymphoma
505194|NCT01000545|Diabetes Mellitus|diabetes mellitus
505195|NCT01000545|Chronic Kidney Disease|chronic kidney disease
505196|NCT01000545|Glycosaminoglycans|glycosaminoglycans
505197|NCT01000545|Sulodexide|sulodexide
505198|NCT01000545|Macroalbuminuria|macroalbuminuria
505199|NCT01000545|Safety and Efficacy|safety and efficacy
505200|NCT01000532|steroid, leads, threshold, pacemaker|steroid, leads, threshold, pacemaker
505201|NCT01000519|Diabetes mellitus|diabetes mellitus
505202|NCT01000519|Randomized control trial|randomized control trial
505203|NCT01000519|Exercise|exercise
505204|NCT01000519|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
505205|NCT01000506|Dose-ranging|dose-ranging
505206|NCT01000506|Safety|safety
505207|NCT01000506|Pharmacodynamics|pharmacodynamics
505208|NCT01000506|eosinophils|eosinophils
505209|NCT01000506|SB-240563|sb-240563
505210|NCT01000506|Efficacy|efficacy
505211|NCT01000506|Severe refractory asthma|severe refractory asthma
505212|NCT01000506|mepolizumab|mepolizumab
505213|NCT01000506|Placebo|placebo
505214|NCT01000493|efficacy|efficacy
505215|NCT01000493|double-blind|double-blind
505216|NCT01000493|Clinician Administered PTSD Scale|clinician administered ptsd scale
505217|NCT01000493|placebo|placebo
505218|NCT01000493|Sleep|sleep
505219|NCT01000493|safety|safety
505220|NCT01000493|CAPS|caps
505221|NCT01000493|neurokinin-1 antagonist|neurokinin-1 antagonist
505222|NCT01000493|orvepitant|orvepitant
505223|NCT01000493|PTSD|ptsd
505224|NCT01000493|randomized|randomized
505225|NCT01000493|Post traumatic stress disorder|post traumatic stress disorder
505226|NCT01000493|Phase II|phase ii
505227|NCT01000467|PK assessment for healthy male volunteer|pk assessment for healthy male volunteer
505228|NCT01000467|Healthy male subjects aged 20 to 40 years|healthy male subjects aged 20 to 40 years
505229|NCT01000441|Rheumatoid arthritis with inadequate response to 1 anti-TNF|rheumatoid arthritis with inadequate response to 1 anti-tnf
505230|NCT01000428|NSCLC|nsclc
505231|NCT01000428|Tarceva|tarceva
505232|NCT01000428|Positron emission technology|positron emission technology
505233|NCT01000428|FLT|flt
505234|NCT01000428|FDG|fdg
505235|NCT01000415|Stage Ib2-early IIb of cervical cancer|stage ib2-early iib of cervical cancer
505236|NCT01000415|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
505237|NCT01000415|Cisplatin plus gemcitabine|cisplatin plus gemcitabine
505238|NCT01000415|Radical hysterectomy with pelvic lymphadenectomy|radical hysterectomy with pelvic lymphadenectomy
505239|NCT01000415|Quality of life|quality of life
505240|NCT01000415|Stage Ib2-IIb of cervical cancer patients|stage ib2-iib of cervical cancer patients
505241|NCT01000402|Bipolar Disorder|bipolar disorder
505242|NCT01000402|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
505243|NCT01000402|Genetics|genetics
505244|NCT01000402|Environmental Factors|environmental factors
505245|NCT01000402|Family Factors|family factors
505246|NCT01000376|Cancer|cancer
505247|NCT01000376|solid tumors|solid tumors
505248|NCT01000350|orthostatic intolerance|orthostatic intolerance
505249|NCT01000350|exercise capacity|exercise capacity
505250|NCT01000350|tachycardia|tachycardia
505251|NCT01000350|POTS|pots
505252|NCT01000337|Liver Apoptosis|liver apoptosis
505253|NCT01000324|Hepatitis A|hepatitis a
505254|NCT01000324|Hepatitis B|hepatitis b
505255|NCT01000311|MenACWY conjugate vaccine in infants|menacwy conjugate vaccine in infants
505256|NCT01000311|Meningococcal vaccine in infants|meningococcal vaccine in infants
505257|NCT01000311|MenACWY|menacwy
505258|NCT01000246|mammacarcinoma|mammacarcinoma
505259|NCT01000246|breastcancer|breastcancer
505260|NCT01000246|chemotherapy|chemotherapy
505261|NCT01000246|heart failure|heart failure
505262|NCT01000246|influenza virus vaccine|influenza virus vaccine
505263|NCT01000233|PATOLOGIC CALCIFICATION|patologic calcification
505264|NCT01000233|AORTIC VALVE STENOSIS|aortic valve stenosis
505265|NCT01000233|INOSITOL HEXAPHOSPHATE|inositol hexaphosphate
505266|NCT01000207|Influenza A|influenza a
505267|NCT01000207|H1N1 subtype|h1n1 subtype
505268|NCT01000207|Children/adolescent|children/adolescent
505269|NCT01000207|Vaccine|vaccine
505270|NCT01000207|Adjuvant|adjuvant
505271|NCT01000194|postprandial|postprandial
505272|NCT01000194|gene expression profiles|gene expression profiles
505273|NCT01000194|microarray|microarray
505274|NCT01000168|Brain Injury|brain injury
505275|NCT01000168|Rehabilitation|rehabilitation
505276|NCT01000168|Treadmill therapy|treadmill therapy
505277|NCT01000155|fetal hemoglobin|fetal hemoglobin
505278|NCT01000155|vorinostat|vorinostat
505279|NCT01000155|HDAC inhibitor|hdac inhibitor
505280|NCT01000155|SAHA|saha
505281|NCT01000142|Osteopathic|osteopathic
505282|NCT01000142|Manipulation|manipulation
505283|NCT01000142|Preventative|preventative
505284|NCT01000142|Elderly|elderly
505285|NCT01000142|Nursing Home|nursing home
505286|NCT01000142|Prevention: General Health Status|prevention: general health status
505287|NCT01000129|Radiotherapy|radiotherapy
505288|NCT01000129|Bladder cancer|bladder cancer
505289|NCT01000129|Adaptive planning|adaptive planning
505290|NCT01000116|Tapp|tapp
505291|NCT01000116|Early pain|early pain
505292|NCT01000116|well-being|well-being
505293|NCT01000116|Seroma|seroma
505294|NCT01000116|Haematoma|haematoma
505295|NCT01000116|Fibrin glue|fibrin glue
505296|NCT01000116|tacks|tacks
505297|NCT01000103|Stroke|stroke
505298|NCT01000103|Visuospatial neglect|visuospatial neglect
505299|NCT01000103|Visuospatial extinction|visuospatial extinction
505300|NCT01000103|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
505301|NCT01000103|Non-invasive brain stimulation|non-invasive brain stimulation
505302|NCT01000103|Neuromodulation|neuromodulation
505303|NCT01000103|Brain parietal cortex|brain parietal cortex
505304|NCT01000103|Neurological sequels|neurological sequels
505305|NCT01000103|Cognitive rehabilitation|cognitive rehabilitation
505306|NCT01000090|Acromegaly|acromegaly
505307|NCT01000090|Somatostatin analogues|somatostatin analogues
505308|NCT01000090|Treatment|treatment
505309|NCT01000077|Regenerative Medicine|regenerative medicine
505310|NCT01000077|Tissue Collection|tissue collection
505311|NCT01000077|Cell Culture Systems|cell culture systems
505312|NCT01000077|Routine Surgery|routine surgery
505313|NCT01000064|Traumatic Brain Injury|traumatic brain injury
505314|NCT01000064|Attention Deficit|attention deficit
505315|NCT01000064|TBI|tbi
505316|NCT01000051|Transplant Thrombocytopenia|transplant thrombocytopenia
505317|NCT01000051|Hematopoietic cell transplantation|hematopoietic cell transplantation
505318|NCT01000051|HCT|hct
505319|NCT01000051|Low platelet count|low platelet count
505320|NCT01000051|Bleeding|bleeding
505321|NCT01000051|Blood clot|blood clot
505322|NCT01000051|Stem Cell Transplant|stem cell transplant
505323|NCT01000051|Blood And Marrow Transplantation|blood and marrow transplantation
505324|NCT01000051|Eltrombopag|eltrombopag
505325|NCT01000051|Promacta|promacta
505326|NCT01000038|Wii-Fit|wii-fit
505327|NCT01000038|Assisted living|assisted living
505328|NCT01000038|Alzheimer's dementia|alzheimer's dementia
505329|NCT01000025|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
505330|NCT01000025|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
505331|NCT01000025|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
505332|NCT00999999|Craniotomy outcome|craniotomy outcome
505333|NCT00999999|CSF leakage|csf leakage
505334|NCT00999999|Dural sealant|dural sealant
505335|NCT00999960|Laparoscopy|laparoscopy
505336|NCT00999960|Prostate|prostate
505337|NCT00999960|Cancer|cancer
505338|NCT00999960|Learning|learning
505339|NCT00999960|Simulation|simulation
505340|NCT00999960|Simulator|simulator
505341|NCT00999947|genetics|genetics
505342|NCT00999947|mutation screening|mutation screening
505343|NCT00999947|phenotype-genotype analysis|phenotype-genotype analysis
505344|NCT00999947|desmosomal genes|desmosomal genes
505345|NCT00999921|Fibrocystic Breast Disease|fibrocystic breast disease
505346|NCT00999921|Fibroadenoma|fibroadenoma
505347|NCT00999921|Mastalgia|mastalgia
505348|NCT00999908|COPD|copd
505349|NCT00999908|indacaterol|indacaterol
505350|NCT00999908|tiotropium|tiotropium
505351|NCT00999895|Schizophrenia|schizophrenia
505352|NCT00999895|Switch of antipsychotic treatment|switch of antipsychotic treatment
505353|NCT00999895|Outcome evaluation|outcome evaluation
505354|NCT00999895|monotherapy|monotherapy
505355|NCT00999895|Greece|greece
505356|NCT00999882|mTor Kinase Inhibitor|mtor kinase inhibitor
505357|NCT00999882|Phase I/II|phase i/ii
505358|NCT00999882|Dose escalation|dose escalation
505359|NCT00999882|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
505360|NCT00999882|Asia|asia
505361|NCT00999882|HCC|hcc
505362|NCT00999882|Safety and pharmacokinetics|safety and pharmacokinetics
505363|NCT00999869|Newly diagnosed|newly diagnosed
505364|NCT00999869|Alopecia areata|alopecia areata
505365|NCT00999869|Botulinum toxin A|botulinum toxin a
505366|NCT00999869|Corticosteroid|corticosteroid
505367|NCT00999869|Intralesional injection|intralesional injection
505368|NCT00999856|medical device,|medical device,
505369|NCT00999856|sub-conjunctival insert|sub-conjunctival insert
505370|NCT00999856|photometer|photometer
505371|NCT00999856|fluorescence|fluorescence
505372|NCT00999856|subconjunctival interstitial fluid glucose|subconjunctival interstitial fluid glucose
505373|NCT00999856|non-invasive measurement|non-invasive measurement
505374|NCT00999843|Sorafenib|sorafenib
505375|NCT00999843|Three-dimensional conformal radiation therapy|three-dimensional conformal radiation therapy
505376|NCT00999843|Intensity-modulated radiation therapy|intensity-modulated radiation therapy
505377|NCT00999843|Transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
505378|NCT00999817|Drug-Drug interaction Study CYP2D6 inhibition Healthy Subjects|drug-drug interaction study cyp2d6 inhibition healthy subjects
507220|NCT00993551|pediatric|pediatric
505379|NCT00999804|Locally Advanced Breast Cancer Neoadjuvant Endocrine|locally advanced breast cancer neoadjuvant endocrine
505380|NCT00999778|Autism|autism
505381|NCT00999778|Social and Communication Deficits in Autism|social and communication deficits in autism
505382|NCT00999778|Parent and Caregiver interventions with children with Autism|parent and caregiver interventions with children with autism
505383|NCT00999778|Autism Spectrum Disorder|autism spectrum disorder
505384|NCT00999778|ASD|asd
505385|NCT00999765|Bipolar Disorder|bipolar disorder
505386|NCT00999765|Bipolar Depression|bipolar depression
505387|NCT00999765|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
505388|NCT00999765|MBCT|mbct
505389|NCT00999765|Maintenance|maintenance
505390|NCT00999765|Euthymic|euthymic
505391|NCT00999765|Efficacy|efficacy
505392|NCT00999765|Feasibility|feasibility
505393|NCT00999752|Hypertension|hypertension
505394|NCT00999752|African Americans|african americans
505395|NCT00999752|Arterial Stiffness|arterial stiffness
505396|NCT00999752|Vascular Resistance|vascular resistance
505397|NCT00999739|pneumococcal vaccines|pneumococcal vaccines
505398|NCT00999739|HIV|hiv
505399|NCT00999739|antibody response|antibody response
505400|NCT00999739|antibody affinity|antibody affinity
505401|NCT00999739|Antibody formation|antibody formation
505402|NCT00999739|Phagocytosis|phagocytosis
505403|NCT00999713|Acute Lung Injury|acute lung injury
505404|NCT00999713|Cancer|cancer
505405|NCT00999713|Pediatrics|pediatrics
505406|NCT00999700|Locally advanced HNSCC|locally advanced hnscc
505407|NCT00999700|Chemo-radiation|chemo-radiation
505408|NCT00999700|Induction chemotherapy|induction chemotherapy
505409|NCT00999700|Stage III/IV|stage iii/iv
505410|NCT00999700|Unresectable disease|unresectable disease
505411|NCT00999687|Nail psoriasis|nail psoriasis
505412|NCT00999687|Indigo naturalis|indigo naturalis
505413|NCT00999674|Exercise|exercise
505414|NCT00999648|Tinnitus|tinnitus
505415|NCT00999648|Myofascial Trigger Points|myofascial trigger points
505416|NCT00999648|Myofascial Pain Syndrome|myofascial pain syndrome
505417|NCT00999648|Controlled Clinical Trial|controlled clinical trial
505418|NCT00999635|Insoles|insoles
505419|NCT00999635|Prevention of Ulceration|prevention of ulceration
505420|NCT00999635|Diabetic Foot|diabetic foot
505421|NCT00999635|Neuropathic|neuropathic
505422|NCT00999622|infection|infection
505423|NCT00999622|adult anaplastic astrocytoma|adult anaplastic astrocytoma
505424|NCT00999622|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
505425|NCT00999622|adult giant cell glioblastoma|adult giant cell glioblastoma
505426|NCT00999622|adult gliosarcoma|adult gliosarcoma
505427|NCT00999622|adult oligodendroglioma|adult oligodendroglioma
505428|NCT00999622|adult glioblastoma|adult glioblastoma
505429|NCT00999622|adult diffuse astrocytoma|adult diffuse astrocytoma
505430|NCT00999622|adult pilocytic astrocytoma|adult pilocytic astrocytoma
505431|NCT00999622|adult pineal gland astrocytoma|adult pineal gland astrocytoma
505432|NCT00999622|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
505433|NCT00999609|Adeno-associated virus|adeno-associated virus
505434|NCT00999609|AAV|aav
505435|NCT00999609|Leber congenital amaurosis|leber congenital amaurosis
505436|NCT00999609|RPE65|rpe65
505437|NCT00999609|Gene therapy|gene therapy
505438|NCT00999609|Gene transfer|gene transfer
505439|NCT00999609|voretigene neparvovec-rzyl|voretigene neparvovec-rzyl
505440|NCT00999609|Retinitis pigmentosa|retinitis pigmentosa
505441|NCT00999596|Breast Cancer|breast cancer
505442|NCT00999596|Digital Mammography|digital mammography
505443|NCT00999583|Cardiac arrest|cardiac arrest
505444|NCT00999583|erythropoietin|erythropoietin
505445|NCT00999583|post-anoxic encephalopathy|post-anoxic encephalopathy
505446|NCT00999583|neuroprotective drugs|neuroprotective drugs
505447|NCT00999570|outcome|outcome
505448|NCT00999570|quality of life|quality of life
505449|NCT00999570|total knee arthroplasty|total knee arthroplasty
505450|NCT00999570|clinical outcome scores post total knee arthroplasty|clinical outcome scores post total knee arthroplasty
505451|NCT00999570|quality of life scores post total knee arthroplasty|quality of life scores post total knee arthroplasty
505452|NCT00999557|breast cancer|breast cancer
505453|NCT00999557|male breast cancer|male breast cancer
505454|NCT00999557|alopecia|alopecia
505455|NCT00999544|opioid|opioid
505456|NCT00999544|oxycodone|oxycodone
505457|NCT00999544|NK1 antagonist|nk1 antagonist
505458|NCT00999544|aprepitant|aprepitant
505459|NCT00999544|intranasal|intranasal
505460|NCT00999544|abuse|abuse
505461|NCT00999531|Cystic Fibrosis|cystic fibrosis
505462|NCT00999531|CF|cf
505463|NCT00999531|Mucociliary Clearance|mucociliary clearance
505464|NCT00999531|Epithelial Sodium Channel Inhibitor|epithelial sodium channel inhibitor
505465|NCT00999531|ENaC Inhibitor|enac inhibitor
505466|NCT00999531|Airway Hydration|airway hydration
505467|NCT00999531|Amiloride|amiloride
505468|NCT00999518|Randomized double blind placebo-controlled parallel-group dose-range finding interstitial cystitis efficacy pain urinary symptoms safety|randomized double blind placebo-controlled parallel-group dose-range finding interstitial cystitis efficacy pain urinary symptoms safety
505469|NCT00999505|Schizophrenia|schizophrenia
505470|NCT00999505|Amantadine|amantadine
505471|NCT00999505|Residual symptoms|residual symptoms
505472|NCT00999492|Tecnis Multifocal|tecnis multifocal
505473|NCT00999492|Patients scheduled for cataract or lens replacement surgery with implantation of multifocal intraocular lenses|patients scheduled for cataract or lens replacement surgery with implantation of multifocal intraocular lenses
505474|NCT00999453|LDL-cholesterol|ldl-cholesterol
505475|NCT00999453|Prevalent peritoneal dialysis patients with hypercholesterolemia|prevalent peritoneal dialysis patients with hypercholesterolemia
505476|NCT00999440|Chronic Pain|chronic pain
505477|NCT00999440|Methadone|methadone
505478|NCT00999440|Perceived Sleep|perceived sleep
505479|NCT00999440|QTc|qtc
505480|NCT00999427|Povidone-iodine|povidone-iodine
505481|NCT00999427|prostate cancer|prostate cancer
505482|NCT00999427|biopsy|biopsy
505483|NCT00999427|transrectal ultrasound|transrectal ultrasound
505484|NCT00999427|urinary tract infection|urinary tract infection
505485|NCT00999427|fever|fever
505486|NCT00999427|sepsis|sepsis
505487|NCT00999427|antisepsis|antisepsis
505488|NCT00999427|prevention|prevention
505489|NCT00999427|complications|complications
505490|NCT00999414|MM|mm
505491|NCT00999388|Lifestyle|lifestyle
505492|NCT00999388|Environment|environment
505493|NCT00999388|Neurodegenerative Diseases|neurodegenerative diseases
505494|NCT00999388|Elderly|elderly
505495|NCT00999388|Public Health|public health
505496|NCT00999388|PD|pd
505497|NCT00999388|Parkinson Disease|parkinson disease
505498|NCT00999375|Type 1 Diabetes|type 1 diabetes
505499|NCT00999375|Diet|diet
505500|NCT00999375|Behavioral Intervention|behavioral intervention
505501|NCT00999375|Children|children
505502|NCT00999375|Adolescents|adolescents
505503|NCT00999362|calcineurin activity|calcineurin activity
505504|NCT00999362|real-time PCR|real-time pcr
505505|NCT00999362|Gene expression of calcineurin|gene expression of calcineurin
505506|NCT00999362|T-lymphocytes|t-lymphocytes
505507|NCT00999362|interferon-gamma|interferon-gamma
505508|NCT00999362|Pharmacodynamics|pharmacodynamics
505509|NCT00999362|Pharmacokinetics|pharmacokinetics
505510|NCT00999362|tacrolimus|tacrolimus
505511|NCT00999362|western blot|western blot
505512|NCT00999362|Hoechst|hoechst
505513|NCT00999349|iron overload condition|iron overload condition
505514|NCT00999349|regular desferrioxamine administration|regular desferrioxamine administration
505515|NCT00999349|receiving continuous blood transfusions|receiving continuous blood transfusions
505516|NCT00999336|Betrixaban|betrixaban
505517|NCT00999336|Renal impairment|renal impairment
505518|NCT00999336|Healthy|healthy
505519|NCT00999336|Kidney dysfunction|kidney dysfunction
505520|NCT00999310|Klinefelter syndrome|klinefelter syndrome
505521|NCT00999310|Neuropsychology|neuropsychology
505522|NCT00999310|Neuroradiology|neuroradiology
505523|NCT00999310|Genetics|genetics
505524|NCT00999297|thermogenesis|thermogenesis
505525|NCT00999297|respiratory quotient|respiratory quotient
505526|NCT00999297|fat oxidation|fat oxidation
505527|NCT00999284|ZK200775 is tested for its effects on vision on healthy probands.|zk200775 is tested for its effects on vision on healthy probands.
505528|NCT00999271|Glucose-dependent insulinotropic polypeptide|glucose-dependent insulinotropic polypeptide
505529|NCT00999271|gastric emptying|gastric emptying
505530|NCT00999271|appetite|appetite
505531|NCT00999271|energy intake|energy intake
505532|NCT00999271|lipid metabolism|lipid metabolism
505533|NCT00999258|glomerular filtration rate|glomerular filtration rate
505534|NCT00999258|chronic allograft nephropathy|chronic allograft nephropathy
505535|NCT00999258|Kidney transplantation|kidney transplantation
505536|NCT00999258|African American|african american
505537|NCT00999232|erythromycin|erythromycin
505538|NCT00999232|prokinetics|prokinetics
505539|NCT00999232|nasojejunal tubes|nasojejunal tubes
505540|NCT00999232|Bengmark feeding tube|bengmark feeding tube
505541|NCT00999232|post-pyloric feeding|post-pyloric feeding
505542|NCT00999232|pancreatitis|pancreatitis
505543|NCT00999232|Non-critically ill patients having pancreatitis who require jejunal enteral nutrition|non-critically ill patients having pancreatitis who require jejunal enteral nutrition
505544|NCT00999219|FK199B|fk199b
505545|NCT00999219|Zolpidem|zolpidem
505546|NCT00999206|Influenza|influenza
505547|NCT00999206|Vaccine|vaccine
505548|NCT00999206|CHMP criteria|chmp criteria
505549|NCT00999193|Shoulder|shoulder
505550|NCT00999193|Fracture|fracture
505551|NCT00999193|Locking Plate|locking plate
505552|NCT00999193|Hemiarthroplasty|hemiarthroplasty
505553|NCT00999193|Conservative|conservative
505554|NCT00999193|Comminuted Proximal Humerus Fracture|comminuted proximal humerus fracture
505555|NCT00999180|Botulinum Toxin|botulinum toxin
505556|NCT00999180|Rehabilitation|rehabilitation
505557|NCT00999180|Stroke|stroke
505558|NCT00999167|Cirrhosis|cirrhosis
505559|NCT00999167|Episodic Hepatic Encephalopathy|episodic hepatic encephalopathy
505560|NCT00999167|HE|he
505561|NCT00999167|HPN-100|hpn-100
505562|NCT00999167|GT4P|gt4p
505563|NCT00999167|glycerol phenylbutyrate|glycerol phenylbutyrate
505564|NCT00999154|Energy Expenditure|energy expenditure
505565|NCT00999154|Dietary Intake|dietary intake
505566|NCT00999154|Physical Activity|physical activity
505567|NCT00999154|Body Weight Regulation|body weight regulation
505568|NCT00999154|Sedentary|sedentary
505570|NCT00999154|Healthy Volunteer|healthy volunteer
505571|NCT00999128|PI3K inhibitor|pi3k inhibitor
505572|NCT00999128|PI3 kinase|pi3 kinase
505573|NCT00999128|PI3 kinase inhibitor|pi3 kinase inhibitor
505574|NCT00999115|Rectovaginal Fistula|rectovaginal fistula
505575|NCT00999115|Crohn Disease|crohn disease
505576|NCT00999115|Allogenic|allogenic
505577|NCT00999115|Adipose-Derived Stem Cells|adipose-derived stem cells
505578|NCT00999102|hypertension|hypertension
505579|NCT00999102|beta blockers|beta blockers
505580|NCT00999102|Metoprolol|metoprolol
505581|NCT00999102|blood pressure, high|blood pressure, high
505582|NCT00999102|antihypertensive agents|antihypertensive agents
505583|NCT00999102|vascular resistance|vascular resistance
505584|NCT00999102|adrenergic beta-receptor blockaders|adrenergic beta-receptor blockaders
505585|NCT00999102|beta-Adrenergic blockers|beta-adrenergic blockers
505586|NCT00999102|beta-Adrenergic Blocking Agents|beta-adrenergic blocking agents
505587|NCT00999102|beta-Adrenergic Receptor Blockaders|beta-adrenergic receptor blockaders
505588|NCT00999102|beta-Blockers, Adrenergic|beta-blockers, adrenergic
505589|NCT00999102|Bystolic|bystolic
505590|NCT00999102|Nebivolol|nebivolol
505591|NCT00999102|Nebivololum|nebivololum
505592|NCT00999102|Nebivololum [Latin]|nebivololum [latin]
505593|NCT00999102|R65,824|r65,824
505594|NCT00999102|Beloc- Zok|beloc- zok
505595|NCT00999102|H 93/26 succinate|h 93/26 succinate
505596|NCT00999102|Metoprolol succinate|metoprolol succinate
505597|NCT00999102|Seloken ZOC|seloken zoc
505598|NCT00999102|Selozok|selozok
505599|NCT00999102|Spesicor Dos|spesicor dos
505600|NCT00999102|Toprol XL|toprol xl
505601|NCT00999102|Toprol-XL|toprol-xl
505602|NCT00999102|UNII-TH25PD4CCB|unii-th25pd4ccb
505603|NCT00999089|Coronary disease|coronary disease
505604|NCT00999089|Coronary artery bypass grafting|coronary artery bypass grafting
505605|NCT00999089|Cardiopulmonary bypass|cardiopulmonary bypass
505606|NCT00999089|Extracorporeal circulation|extracorporeal circulation
505607|NCT00999089|Cardioplegia|cardioplegia
505608|NCT00999089|Off pump|off pump
505609|NCT00999063|GerdQ|gerdq
505610|NCT00999050|type two diabetes|type two diabetes
505611|NCT00999050|gastric bypass surgery|gastric bypass surgery
505612|NCT00999050|overweight or moderately obese|overweight or moderately obese
505613|NCT00999011|critical care|critical care
505614|NCT00999011|inflammatory biomarkers|inflammatory biomarkers
505615|NCT00999011|cytokines|cytokines
505616|NCT00999011|mechanical ventilation|mechanical ventilation
505617|NCT00999011|activity|activity
505618|NCT00999011|mobility therapy|mobility therapy
505619|NCT00999011|More than 48 hours of mechanical ventilation|more than 48 hours of mechanical ventilation
505620|NCT00998998|iron deficiency anemia|iron deficiency anemia
505621|NCT00998998|infant behavior|infant behavior
505622|NCT00998998|infant development|infant development
505623|NCT00998972|kidney graft,|kidney graft,
505624|NCT00998972|delayed graft function|delayed graft function
505625|NCT00998972|N-acetylcysteine|n-acetylcysteine
505626|NCT00998959|Depression|depression
505627|NCT00998959|Major Depression|major depression
505628|NCT00998946|Relapsed|relapsed
505629|NCT00998946|Refractory|refractory
505630|NCT00998946|Non-Hodgkin's|non-hodgkin's
505631|NCT00998933|Testosterone replacement therapy|testosterone replacement therapy
505632|NCT00998920|Healthy volunteers|healthy volunteers
505633|NCT00998907|Open Abdominal Surgery|open abdominal surgery
505634|NCT00998907|Fascial Closure|fascial closure
505635|NCT00998894|BIS|bis
505636|NCT00998894|MAC|mac
505637|NCT00998894|MAP|map
505638|NCT00998881|insulin resistance|insulin resistance
505639|NCT00998868|Rotator Cuff|rotator cuff
505640|NCT00998868|Tendinopathy|tendinopathy
505641|NCT00998868|ultrasonography|ultrasonography
505642|NCT00998855|Exercise in obesity|exercise in obesity
505643|NCT00998842|ECG|ecg
505644|NCT00998842|EKG|ekg
505645|NCT00998842|healthy subjects|healthy subjects
505646|NCT00998842|electrocardiography, ambulatory|electrocardiography, ambulatory
505647|NCT00998829|psoriasis|psoriasis
505648|NCT00998829|psoriatic arthritis|psoriatic arthritis
505649|NCT00998829|epidemiology|epidemiology
505650|NCT00998829|prevalence|prevalence
505651|NCT00998816|thoracotomy|thoracotomy
505652|NCT00998816|chronic|chronic
505653|NCT00998816|pain|pain
505654|NCT00998816|pregabalin|pregabalin
505655|NCT00998816|Lyrica|lyrica
505656|NCT00998803|Influenza virus|influenza virus
505657|NCT00998790|Urinary Incontinence, Stress|urinary incontinence, stress
505658|NCT00998790|Intrinsic sphincter deficiency|intrinsic sphincter deficiency
505659|NCT00998790|Secondary|secondary
505660|NCT00998790|TUR|tur
505661|NCT00998790|TURP|turp
505662|NCT00998790|Radical prostatectomy|radical prostatectomy
505663|NCT00998790|Open prostatectomy|open prostatectomy
505664|NCT00998790|Post-suprapubic prostatectomy|post-suprapubic prostatectomy
505665|NCT00998777|tubing program|tubing program
505666|NCT00998777|shoulder strengthening|shoulder strengthening
505667|NCT00998777|injury prevention|injury prevention
505668|NCT00998764|antibody|antibody
505669|NCT00998764|immunotherapy|immunotherapy
505670|NCT00998751|cKIT inhibitor|ckit inhibitor
505671|NCT00998751|GIST|gist
505672|NCT00998712|gestational diabetes mellitus|gestational diabetes mellitus
505673|NCT00998712|pregnancy|pregnancy
505674|NCT00998712|cardiovascular disease risk|cardiovascular disease risk
505675|NCT00998699|Diabetes|diabetes
505676|NCT00998699|Type 1|type 1
505677|NCT00998686|diabetes|diabetes
505678|NCT00998686|DPP4 inhibitor|dpp4 inhibitor
505679|NCT00998686|dutogliptin|dutogliptin
505680|NCT00998673|Silica gel fiber|silica gel fiber
505681|NCT00998673|Chronic venous leg ulcers|chronic venous leg ulcers
505682|NCT00998673|Venous ulcer|venous ulcer
505683|NCT00998673|Stasis ulcer|stasis ulcer
505684|NCT00998673|Varicose ulcer|varicose ulcer
505685|NCT00998660|Parkinson's disease|parkinson's disease
505686|NCT00998660|Essential Tremor|essential tremor
505687|NCT00998660|Dystonia (where indication is approved)|dystonia (where indication is approved)
505688|NCT00998660|Deep brain stimulation|deep brain stimulation
505689|NCT00998660|Activa RC|activa rc
505690|NCT00998647|modified ultrafiltration|modified ultrafiltration
505691|NCT00998647|cardiac surgery|cardiac surgery
505692|NCT00998647|ROTEM|rotem
505693|NCT00998647|Multiple Electrode Aggregometry|multiple electrode aggregometry
505694|NCT00998634|SCA2|sca2
505695|NCT00998634|Lithium|lithium
505696|NCT00998621|Hepatitis C, Chronic|hepatitis c, chronic
505697|NCT00998621|HIV Infection|hiv infection
505698|NCT00998621|Medication Adherence|medication adherence
505699|NCT00998621|Questionnaire Design|questionnaire design
505700|NCT00998621|Treatment experienced|treatment experienced
505701|NCT00998595|Diabetes, Gestational|diabetes, gestational
505702|NCT00998595|Postpartum Period|postpartum period
505703|NCT00998595|Reproductive Health Services|reproductive health services
505704|NCT00998595|Health Promotion|health promotion
505705|NCT00998595|Health Personnel|health personnel
505706|NCT00998582|Cardiovascular Disease|cardiovascular disease
505707|NCT00998582|HIV Infection|hiv infection
505708|NCT00998582|Abacavir|abacavir
505709|NCT00998582|Artery Elasticity|artery elasticity
505710|NCT00998582|Treatment experienced|treatment experienced
505711|NCT00998556|Peripartum cardiomyopathy|peripartum cardiomyopathy
505712|NCT00998556|Bromocriptine|bromocriptine
505713|NCT00998543|Smallpox Vaccinia Virus Smallpox Vaccine Variola Virus|smallpox vaccinia virus smallpox vaccine variola virus
505714|NCT00998530|Trichomonas vaginalis|trichomonas vaginalis
505715|NCT00998530|trichomoniasis|trichomoniasis
505716|NCT00998530|MLST|mlst
505717|NCT00998530|Multilocus sequence typing|multilocus sequence typing
505718|NCT00998517|Malnutrition|malnutrition
505719|NCT00998517|Supplemental Food|supplemental food
505720|NCT00998517|CSB++|csb++
505721|NCT00998517|Supplementary Plumpy|supplementary plumpy
505722|NCT00998504|impaired fat oxidation|impaired fat oxidation
505723|NCT00998504|fat accumulation|fat accumulation
505724|NCT00998504|mitochondrial dysfunction|mitochondrial dysfunction
505725|NCT00998504|mitochondrial biogenesis|mitochondrial biogenesis
505726|NCT00998465|Obesity|obesity
505727|NCT00998465|Hypertension|hypertension
505728|NCT00998465|Salt sensitivity|salt sensitivity
505729|NCT00998465|Laparoscopic gastric bypass|laparoscopic gastric bypass
505730|NCT00998465|Bariatric surgery|bariatric surgery
505731|NCT00998452|Weight|weight
505732|NCT00998452|Diet|diet
505733|NCT00998452|Physical Activity|physical activity
505734|NCT00998452|Veterans|veterans
505735|NCT00998452|MOVE! Program|move! program
505736|NCT00998439|in stent restenosis|in stent restenosis
505737|NCT00998439|paclitaxel coated balloon catheter|paclitaxel coated balloon catheter
505738|NCT00998439|pepcad|pepcad
505739|NCT00998439|drug eluting balloon|drug eluting balloon
505740|NCT00998426|hepatitis B immune globulin|hepatitis b immune globulin
505741|NCT00998426|HBIG|hbig
505742|NCT00998426|HepaGam B|hepagam b
505743|NCT00998426|orthotopic liver transplant|orthotopic liver transplant
505744|NCT00998413|asthma|asthma
505745|NCT00998413|overweight|overweight
505746|NCT00998413|obesity|obesity
505747|NCT00998413|children|children
505748|NCT00998400|Cognitive-behavioral treatment|cognitive-behavioral treatment
505749|NCT00998400|Well-being therapy|well-being therapy
505750|NCT00998400|Depression|depression
505751|NCT00998400|Demoralization|demoralization
505752|NCT00998400|Acute coronary syndrome|acute coronary syndrome
505754|NCT00998361|allogeneic|allogeneic
505755|NCT00998361|Hemopoietic stem cell transplant|hemopoietic stem cell transplant
505756|NCT00998348|parenting|parenting
505757|NCT00998348|diet|diet
505758|NCT00998348|physical activity|physical activity
505759|NCT00998348|family|family
505760|NCT00998348|home|home
505761|NCT00998348|child|child
505762|NCT00998335|Type 2 diabetes mellitus|type 2 diabetes mellitus
505763|NCT00998335|Insulin therapy|insulin therapy
505764|NCT00998335|Detemir (Levemir)|detemir (levemir)
505765|NCT00998335|Aspart (Novolog)|aspart (novolog)
505766|NCT00998335|Hepatic steatosis|hepatic steatosis
505767|NCT00998322|metastatic|metastatic
505768|NCT00998322|pancreatic|pancreatic
505769|NCT00998322|adenocarcinoma|adenocarcinoma
505770|NCT00998322|REOLYSIN|reolysin
505771|NCT00998322|chemotherapy|chemotherapy
505772|NCT00998322|gemcitabine|gemcitabine
505773|NCT00998309|skin infection|skin infection
505774|NCT00998309|soft tissue infection|soft tissue infection
505775|NCT00998309|sexually-transmitted infection|sexually-transmitted infection
505776|NCT00998309|infection oral|infection oral
505777|NCT00998309|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
505778|NCT00998270|MM|mm
505779|NCT00998257|Contraception|contraception
505780|NCT00998257|Premenstrual Dysphoric Disorder|premenstrual dysphoric disorder
505781|NCT00998257|PMDD|pmdd
505782|NCT00998257|Acne|acne
505783|NCT00998244|low carbohydrate|low carbohydrate
505784|NCT00998244|low fat|low fat
505785|NCT00998244|diet|diet
505786|NCT00998244|overweight|overweight
505787|NCT00998244|GERD|gerd
505788|NCT00998244|gastroesophageal reflux disease|gastroesophageal reflux disease
505789|NCT00998244|acid reflux|acid reflux
505790|NCT00998244|heartburn|heartburn
505791|NCT00998218|Sudden Cardiac Death|sudden cardiac death
505792|NCT00998218|Arrythmias|arrythmias
505793|NCT00998218|Triggered activity|triggered activity
505794|NCT00998218|left ventricular dysfunction|left ventricular dysfunction
505795|NCT00998192|carcinoma|carcinoma
505796|NCT00998192|squamous cell|squamous cell
505797|NCT00998192|lung|lung
505798|NCT00998192|REOLYSIN|reolysin
505799|NCT00998192|chemotherapy|chemotherapy
505800|NCT00998192|carboplatin|carboplatin
505801|NCT00998192|paclitaxel|paclitaxel
505802|NCT00998192|Carcinoma, Squamous Cell of the Lung|carcinoma, squamous cell of the lung
505803|NCT00998179|TENS|tens
505804|NCT00998179|acupuncture|acupuncture
505805|NCT00998179|FEV1|fev1
505806|NCT00998179|Normal Healthy subjects|normal healthy subjects
505807|NCT00998166|NSCLC|nsclc
505808|NCT00998153|substance use|substance use
505809|NCT00998153|PTSD|ptsd
505810|NCT00998153|risky behaviors|risky behaviors
505811|NCT00998153|revictimization|revictimization
505812|NCT00998140|resuscitation|resuscitation
505813|NCT00998140|sudden death|sudden death
505814|NCT00998140|cardiopulmonary resuscitation|cardiopulmonary resuscitation
505815|NCT00998140|emergency medical services|emergency medical services
505816|NCT00998140|termination of resuscitation|termination of resuscitation
505817|NCT00998140|ventricular fibrillation|ventricular fibrillation
505818|NCT00998140|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
505819|NCT00998140|asystole|asystole
505820|NCT00998140|medical futility|medical futility
505821|NCT00998140|withdrawing treatment|withdrawing treatment
505822|NCT00998140|transportation of patients|transportation of patients
505823|NCT00998140|health expenditures|health expenditures
505824|NCT00998140|healthcare costs|healthcare costs
505825|NCT00998127|Dual Anti-Platelet Therapy|dual anti-platelet therapy
505826|NCT00998127|Non-adherence|non-adherence
505827|NCT00998127|MACE|mace
505828|NCT00998127|NACE|nace
505829|NCT00998114|Early Cardiac Diastolic Dysfunction|early cardiac diastolic dysfunction
505830|NCT00998114|Aerobic Exercise|aerobic exercise
505831|NCT00998114|Weight Reduction|weight reduction
505832|NCT00998101|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
505833|NCT00998101|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
505834|NCT00998101|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
505835|NCT00998088|Blood management|blood management
505836|NCT00998088|Orthopedic surgery|orthopedic surgery
505837|NCT00998088|elective|elective
505838|NCT00998088|randomized study|randomized study
505839|NCT00998088|adults|adults
505840|NCT00998088|hip replacement|hip replacement
505841|NCT00998088|knee replacement|knee replacement
505842|NCT00998075|Bioequivalence|bioequivalence
505843|NCT00998075|ASA|asa
505844|NCT00998075|Esomeprazole|esomeprazole
505845|NCT00998075|peptic ulcer disease|peptic ulcer disease
505846|NCT00998075|primary cardiovascular protection|primary cardiovascular protection
505847|NCT00998075|healthy volunteers|healthy volunteers
505848|NCT00998062|Dyslipaemia|dyslipaemia
505849|NCT00998062|atherosclerosis risk|atherosclerosis risk
505850|NCT00998062|increased hsCRP|increased hscrp
505851|NCT00998062|inflammatory and oxidative status in the Spanish population|inflammatory and oxidative status in the spanish population
505852|NCT00998036|TNBC|tnbc
505853|NCT00998036|Temsirolimus|temsirolimus
505854|NCT00998036|Erlotinib|erlotinib
505855|NCT00998036|Cisplatin|cisplatin
505856|NCT00998036|Breast Cancer|breast cancer
505857|NCT00998023|Angiogram|angiogram
505858|NCT00998023|Catheter Angiogram|catheter angiogram
505859|NCT00998010|adult giant cell glioblastoma|adult giant cell glioblastoma
505860|NCT00998010|adult glioblastoma|adult glioblastoma
505861|NCT00998010|adult gliosarcoma|adult gliosarcoma
505862|NCT00997997|Skin Diseases, Bacterial|skin diseases, bacterial
505863|NCT00997997|Product Surveillance|product surveillance
505864|NCT00997997|Postmarketing|postmarketing
505865|NCT00997984|ADHD|adhd
505866|NCT00997971|Hydrolysed rice protein formula|hydrolysed rice protein formula
505867|NCT00997971|Cow's milk protein allergy|cow's milk protein allergy
505868|NCT00997971|Infant formula|infant formula
505869|NCT00997971|Gastrointestinal tolerance|gastrointestinal tolerance
505968|NCT00997646|hospitalization|hospitalization
505870|NCT00997945|Phase I, advanced solid malignancies, advance solid tumour|phase i, advanced solid malignancies, advance solid tumour
505871|NCT00997945|advanced cancer|advanced cancer
505872|NCT00997945|ZD4054 (Zibotentan)|zd4054 (zibotentan)
505873|NCT00997945|china|china
505874|NCT00997945|PK|pk
505875|NCT00997945|pharmacokinetics|pharmacokinetics
505876|NCT00997932|levonorgestrel releasing intrauterine device|levonorgestrel releasing intrauterine device
505877|NCT00997932|levonorgestrel releasing intrauterine contraception|levonorgestrel releasing intrauterine contraception
505878|NCT00997932|unintended pregnancy prevention|unintended pregnancy prevention
505879|NCT00997932|postpartum contraception|postpartum contraception
505880|NCT00997906|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
505881|NCT00997906|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
505882|NCT00997906|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
505883|NCT00997906|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
505884|NCT00997893|menopause|menopause
505885|NCT00997893|hot flashes|hot flashes
505886|NCT00997893|soy|soy
505887|NCT00997893|estrogen|estrogen
505888|NCT00997893|anxiety|anxiety
505889|NCT00997880|rosuvastatin|rosuvastatin
505890|NCT00997867|Pain|pain
505891|NCT00997867|Surgery|surgery
505892|NCT00997867|Catheter|catheter
505893|NCT00997867|Nerve Block|nerve block
505894|NCT00997867|Popliteal|popliteal
505895|NCT00997867|Sciatic|sciatic
505896|NCT00997867|Femoral|femoral
505897|NCT00997867|Interscalene|interscalene
505898|NCT00997867|UCSD|ucsd
505899|NCT00997867|Moderate-to-severe pain|moderate-to-severe pain
505900|NCT00997867|Perineural Catheter|perineural catheter
505901|NCT00997867|Orthopedic Surgery|orthopedic surgery
505902|NCT00997854|Feeding|feeding
505903|NCT00997854|Intolerance|intolerance
505904|NCT00997854|Preterm|preterm
505905|NCT00997854|Bolus|bolus
505906|NCT00997841|POC|poc
505907|NCT00997841|ROTEM|rotem
505908|NCT00997841|Multiplate|multiplate
505909|NCT00997841|bleeding tendency|bleeding tendency
505910|NCT00997841|coagulation management|coagulation management
505911|NCT00997841|amount of transfused red blood cell concentrates,|amount of transfused red blood cell concentrates,
505912|NCT00997841|FFP|ffp
505913|NCT00997841|platelet concentrates|platelet concentrates
505914|NCT00997841|rate of rethoracotomy|rate of rethoracotomy
505915|NCT00997841|ventilation time|ventilation time
505916|NCT00997828|Coronary Artery Disease|coronary artery disease
505917|NCT00997828|stent|stent
505918|NCT00997828|coronary artery bypass graft surgery|coronary artery bypass graft surgery
505919|NCT00997828|multivessel coronary artery disease|multivessel coronary artery disease
505920|NCT00997815|Recalcitrant|recalcitrant
505921|NCT00997815|Alopecia totalis|alopecia totalis
505922|NCT00997815|Alopecia universalis|alopecia universalis
505923|NCT00997815|Botulinum toxin A|botulinum toxin a
505924|NCT00997802|Computed Tomographic Colonography|computed tomographic colonography
505925|NCT00997802|Colonic Polyps|colonic polyps
505926|NCT00997802|Colonic Neoplasms|colonic neoplasms
505927|NCT00997802|Computer Aided Diagnosis|computer aided diagnosis
505928|NCT00997789|Rebamipide|rebamipide
505929|NCT00997789|Bioequivalence|bioequivalence
505930|NCT00997789|ABCB1 genetic polymorphisms|abcb1 genetic polymorphisms
505931|NCT00997776|Hip Fracture|hip fracture
505932|NCT00997776|Exercise|exercise
505933|NCT00997776|Rehabilitation|rehabilitation
505934|NCT00997776|Functional Performance|functional performance
505935|NCT00997763|stenting, XIENCE V, CYPHER|stenting, xience v, cypher
505936|NCT00997750|ACS|acs
505937|NCT00997750|Acute Coronary Syndrome|acute coronary syndrome
505938|NCT00997750|NSAID|nsaid
505939|NCT00997750|Lornoxicam|lornoxicam
505940|NCT00997750|Xefocam|xefocam
505941|NCT00997737|incentive spirometry|incentive spirometry
505942|NCT00997737|diaphragm mobility|diaphragm mobility
505943|NCT00997737|ultrasound|ultrasound
505944|NCT00997737|diaphragmatic breathing|diaphragmatic breathing
505945|NCT00997724|assisted-VATS (video-assisted thoracoscopic surgery)|assisted-vats (video-assisted thoracoscopic surgery)
505946|NCT00997724|sleeve lobectomy|sleeve lobectomy
505947|NCT00997724|bronchoplasty|bronchoplasty
505948|NCT00997711|Diabetes|diabetes
505949|NCT00997711|death|death
505950|NCT00997711|MI|mi
505951|NCT00997711|TVR|tvr
505952|NCT00997698|Intracranial aneurysm|intracranial aneurysm
505953|NCT00997698|Magnetic resonance angiography|magnetic resonance angiography
505954|NCT00997698|Epidemiology|epidemiology
505955|NCT00997685|XELOX|xelox
505956|NCT00997685|potentially resectable liver metastasis from CRC|potentially resectable liver metastasis from crc
505957|NCT00997672|MSA|msa
505958|NCT00997672|Lithium|lithium
505959|NCT00997672|Lithium carbonate|lithium carbonate
505960|NCT00997672|MSA-P|msa-p
505961|NCT00997672|MSA-C|msa-c
505962|NCT00997659|chromium picolinate|chromium picolinate
505963|NCT00997659|insulin resistance|insulin resistance
505964|NCT00997659|obesity|obesity
505965|NCT00997646|Performance|performance
505966|NCT00997646|hospitalist|hospitalist
505967|NCT00997646|ward|ward
505969|NCT00997633|Intraperitoneal volume|intraperitoneal volume
505970|NCT00997633|peritoneal carcinomatosis|peritoneal carcinomatosis
505971|NCT00997633|cytoreductive surgery|cytoreductive surgery
505972|NCT00997633|SPECT|spect
505973|NCT00997633|intraperitoneal chemotherapy|intraperitoneal chemotherapy
505974|NCT00997620|Hay Fever|hay fever
505975|NCT00997620|Daytime somnolence|daytime somnolence
505976|NCT00997620|Cognition|cognition
505977|NCT00997607|Vaccine|vaccine
505978|NCT00997594|adrenal gland|adrenal gland
505979|NCT00997581|Gout|gout
505980|NCT00997568|transesophageal|transesophageal
505981|NCT00997568|transducer|transducer
505982|NCT00997568|TEE|tee
505983|NCT00997555|inhalation|inhalation
505984|NCT00997555|bronchoscopy|bronchoscopy
505985|NCT00997555|burn|burn
505986|NCT00997555|pneumonia|pneumonia
505987|NCT00997529|Stem cell transplant|stem cell transplant
505988|NCT00997529|Non-myeloablative|non-myeloablative
505989|NCT00997529|Metastatic Solid Tumor|metastatic solid tumor
505990|NCT00997529|Donor Leukocyte Infusion|donor leukocyte infusion
505991|NCT00997516|Laparoscopy|laparoscopy
505992|NCT00997516|Appendicitis|appendicitis
505993|NCT00997516|Single-incision laparoscopic surgery|single-incision laparoscopic surgery
505994|NCT00997516|SILS|sils
505995|NCT00997490|depression|depression
505996|NCT00997490|HAMD 21|hamd 21
505997|NCT00997490|anxiety|anxiety
505998|NCT00997490|HAMA|hama
505999|NCT00997490|Hypericum|hypericum
506000|NCT00997490|Valerian|valerian
506001|NCT00997490|Passionflower|passionflower
506002|NCT00997490|F32.0|f32.0
506003|NCT00997490|F33.0|f33.0
506004|NCT00997477|aerolizer|aerolizer
506005|NCT00997477|formoterol|formoterol
506006|NCT00997477|budesonide|budesonide
506007|NCT00997477|asthma|asthma
506008|NCT00997451|Medically unexplained chronic fatigue|medically unexplained chronic fatigue
506009|NCT00997451|Chronic fatigue syndrome|chronic fatigue syndrome
506010|NCT00997451|Cognitive-behavior therapy|cognitive-behavior therapy
506011|NCT00997451|Self-management|self-management
506012|NCT00997451|Primary care|primary care
506013|NCT00997451|Nurses|nurses
506014|NCT00997451|Economic analysis|economic analysis
506015|NCT00997451|Cost effectiveness|cost effectiveness
506016|NCT00997451|One year follow-up|one year follow-up
506017|NCT00997425|wandering|wandering
506018|NCT00997425|subjective exit barriers|subjective exit barriers
506019|NCT00997399|Ph I|ph i
506020|NCT00997399|panobinostat (DACi)|panobinostat (daci)
506021|NCT00997399|PK & safety|pk & safety
506022|NCT00997399|solid tumors|solid tumors
506023|NCT00997399|varying renal function|varying renal function
506024|NCT00997399|advanced|advanced
506025|NCT00997386|Hematologic malignancies|hematologic malignancies
506026|NCT00997386|lymphoma, leukemia, MDS (myelodysplastic syndrome)|lymphoma, leukemia, mds (myelodysplastic syndrome)
506027|NCT00997386|reduced-intensity preparative regimen|reduced-intensity preparative regimen
506028|NCT00997386|allogeneic peripheral blood stem cell transplant|allogeneic peripheral blood stem cell transplant
506029|NCT00997386|myelofibrosis or other myeloproliferative syndromes|myelofibrosis or other myeloproliferative syndromes
506030|NCT00997373|Endometrial Cancer|endometrial cancer
506031|NCT00997373|Endometrial Carcinoma|endometrial carcinoma
506032|NCT00997373|Aromatase Inhibitor|aromatase inhibitor
506033|NCT00997373|Letrozole|letrozole
506034|NCT00997373|Femara|femara
506035|NCT00997360|Phase 1|phase 1
506036|NCT00997360|Maximum tolerated dose|maximum tolerated dose
506037|NCT00997360|Solid tumors|solid tumors
506038|NCT00997334|erlotinib|erlotinib
506039|NCT00997334|EGFR mutation|egfr mutation
506040|NCT00997334|NSCLC|nsclc
506041|NCT00997321|ketamine|ketamine
506042|NCT00997321|propofol|propofol
506043|NCT00997321|procedural sedation|procedural sedation
506044|NCT00997321|moderate procedural sedation in the ED|moderate procedural sedation in the ed
506045|NCT00997308|AZD1446|azd1446
506046|NCT00997308|to investigate safety and tolerability in Healthy subjects during 4 weeks of administration|to investigate safety and tolerability in healthy subjects during 4 weeks of administration
506047|NCT00997295|low flow gas|low flow gas
506048|NCT00997295|Heat and moisture exchanger|heat and moisture exchanger
506049|NCT00997295|Humidity|humidity
506050|NCT00997295|Temperature|temperature
506051|NCT00997295|Core temperature|core temperature
506052|NCT00997295|Women|women
506053|NCT00997269|CoQ-10|coq-10
506054|NCT00997269|statin|statin
506055|NCT00997269|muscle pain|muscle pain
506056|NCT00997269|cardiovascular|cardiovascular
506057|NCT00997256|sleep-EEG|sleep-eeg
506058|NCT00997256|sleep architecture|sleep architecture
506059|NCT00997256|sleep duration|sleep duration
506060|NCT00997256|sleep continuity|sleep continuity
506061|NCT00997256|REM-sleep|rem-sleep
506062|NCT00997256|vigilance|vigilance
506063|NCT00997256|well-being|well-being
506064|NCT00997256|Healthy volunteers|healthy volunteers
506065|NCT00997243|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
506066|NCT00997243|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
506067|NCT00997243|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
506168|NCT00996827|Cytokine|cytokine
506068|NCT00997243|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
506069|NCT00997243|refractory anemia with excess blasts|refractory anemia with excess blasts
506070|NCT00997243|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
506071|NCT00997243|refractory anemia|refractory anemia
506072|NCT00997243|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
506073|NCT00997230|EGFR mutation ,newly diagnosed NSCLC, locally advanced or metastatic NSCLC|egfr mutation ,newly diagnosed nsclc, locally advanced or metastatic nsclc
506074|NCT00997217|RIPC|ripc
506075|NCT00997217|cardiac surgery|cardiac surgery
506076|NCT00997217|ischemic preconditioning|ischemic preconditioning
506077|NCT00997217|cardiac surgical procedures|cardiac surgical procedures
506078|NCT00997204|HAE|hae
506079|NCT00997204|Type I HAE|type i hae
506080|NCT00997204|Type II HAE|type ii hae
506081|NCT00997191|Bevacizumab|bevacizumab
506082|NCT00997191|Diabetes|diabetes
506083|NCT00997191|Intravitreal|intravitreal
506084|NCT00997191|Macular edema|macular edema
506085|NCT00997191|triamcinolone|triamcinolone
506086|NCT00997191|VEGF|vegf
506087|NCT00997178|Diabetes|diabetes
506088|NCT00997178|Diabetes Mellitus|diabetes mellitus
506089|NCT00997178|Periodontal Disease|periodontal disease
506090|NCT00997178|Periodontitis|periodontitis
506091|NCT00997178|Glycosylated Hemoglobin|glycosylated hemoglobin
506092|NCT00997178|HbA1c|hba1c
506093|NCT00997165|fatty liver|fatty liver
506094|NCT00997165|adipose tissue|adipose tissue
506095|NCT00997152|Diabetes|diabetes
506096|NCT00997139|healthcare|healthcare
506097|NCT00997139|staphylococcus aureus|staphylococcus aureus
506098|NCT00997139|nasal|nasal
506099|NCT00997126|propofol|propofol
506100|NCT00997126|alfentanil|alfentanil
506101|NCT00997126|nitrous oxide|nitrous oxide
506102|NCT00997126|moderate procedural sedation|moderate procedural sedation
506103|NCT00997126|Moderate Procedural Sedation in the Emergency Department|moderate procedural sedation in the emergency department
506104|NCT00997113|propofol|propofol
506105|NCT00997113|alfentanil|alfentanil
506106|NCT00997113|procedural sedation|procedural sedation
506107|NCT00997113|stress biomarkers|stress biomarkers
506108|NCT00997113|Deep procedural sedation in the ED|deep procedural sedation in the ed
506109|NCT00997100|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
506110|NCT00997100|ABR-215757|abr-215757
506111|NCT00997100|Change in Biomarkers|change in biomarkers
506112|NCT00997087|OCD|ocd
506113|NCT00997074|pain after abortion|pain after abortion
506114|NCT00997074|abortion|abortion
506115|NCT00997035|Fungal Infections|fungal infections
506116|NCT00997035|Eye Disease|eye disease
506117|NCT00997035|Fungal Keratitis|fungal keratitis
506118|NCT00997035|Visual Acuity|visual acuity
506119|NCT00997022|HCC|hcc
506120|NCT00997022|High-risk Hepatocellular Cancer|high-risk hepatocellular cancer
506121|NCT00997009|EGFR|egfr
506122|NCT00997009|chemotherapy|chemotherapy
506123|NCT00996996|Radioimmunotherapy|radioimmunotherapy
506248|NCT00996398|Cryotherapy|cryotherapy
506124|NCT00996996|Anti-B1 Antibody and Iodine-131 Anti-B1 Antibody|anti-b1 antibody and iodine-131 anti-b1 antibody
506125|NCT00996996|Tositumomab and Iodine I 131 Tositumomab|tositumomab and iodine i 131 tositumomab
506126|NCT00996996|non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
506127|NCT00996996|Bexxar|bexxar
506128|NCT00996970|HIV|hiv
506129|NCT00996970|H1N1|h1n1
506130|NCT00996970|Influenza|influenza
506131|NCT00996970|Vaccination|vaccination
506132|NCT00996970|Seroresponse|seroresponse
506133|NCT00996970|Immunogenicity|immunogenicity
506134|NCT00996970|Vaccine|vaccine
506135|NCT00996944|ropinirole|ropinirole
506136|NCT00996944|haemodialysis|haemodialysis
506137|NCT00996944|restless legs syndrome|restless legs syndrome
506138|NCT00996931|autistic spectrum disorder|autistic spectrum disorder
506139|NCT00996931|lenalidomide|lenalidomide
506140|NCT00996918|antibody|antibody
506141|NCT00996905|Epidural Analgesia|epidural analgesia
506142|NCT00996905|Ultrasound|ultrasound
506143|NCT00996905|Training, Inservice|training, inservice
506144|NCT00996892|GDC0941|gdc0941
506145|NCT00996892|GDC0973|gdc0973
506146|NCT00996892|MEK|mek
506147|NCT00996892|MEK Inhibitor|mek inhibitor
506148|NCT00996892|PI3K|pi3k
506149|NCT00996892|PI3K Inhibitor|pi3k inhibitor
506150|NCT00996892|PI3 Kinase|pi3 kinase
506151|NCT00996892|PI3 Kinase Inhibitor|pi3 kinase inhibitor
506152|NCT00996879|Human Volunteers|human volunteers
506153|NCT00996853|safety|safety
506154|NCT00996853|Influenza|influenza
506155|NCT00996853|vaccine|vaccine
506156|NCT00996853|reactogenicity|reactogenicity
506157|NCT00996853|swine flu|swine flu
506158|NCT00996840|dilmapimod|dilmapimod
506159|NCT00996840|p38|p38
506160|NCT00996840|SB-681323|sb-681323
506161|NCT00996840|Acute Lung Injury (ALI)|acute lung injury (ali)
506162|NCT00996840|Acute Respiratory Distress Syndrome (ARDS)|acute respiratory distress syndrome (ards)
506163|NCT00996827|Melanoma|melanoma
506164|NCT00996827|Skin cancer|skin cancer
506165|NCT00996827|Vitamin D|vitamin d
506166|NCT00996827|Vitamin D receptor|vitamin d receptor
506167|NCT00996827|Sunlight|sunlight
506170|NCT00996788|Patients suffering of dyspepsia due to chronic gastritis|patients suffering of dyspepsia due to chronic gastritis
506171|NCT00996775|Alcohol Consumption|alcohol consumption
506172|NCT00996762|bioequivalence, lapatinib, GW572016|bioequivalence, lapatinib, gw572016
506173|NCT00996736|Fungal Infections|fungal infections
506174|NCT00996736|Eye Disease|eye disease
506175|NCT00996736|Fungal Keratitis|fungal keratitis
506176|NCT00996736|Visual Acuity|visual acuity
506177|NCT00996710|Genome-wide|genome-wide
506178|NCT00996710|09-068|09-068
506179|NCT00996697|COPD (chronic obstructive pulmonary disease)|copd (chronic obstructive pulmonary disease)
506180|NCT00996684|Wet age related macular degeneration (AMD)|wet age related macular degeneration (amd)
506181|NCT00996684|Wet AMD|wet amd
506182|NCT00996684|Vitreomacular adhesion (VMA)|vitreomacular adhesion (vma)
506183|NCT00996684|Vitreomacular traction (VMT)|vitreomacular traction (vmt)
506184|NCT00996684|Neovascular age related macular degeneration|neovascular age related macular degeneration
506185|NCT00996671|focal adhesion kinase inhibitor|focal adhesion kinase inhibitor
506186|NCT00996671|healthy volunteers|healthy volunteers
506187|NCT00996671|first time in human|first time in human
506188|NCT00996645|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
506189|NCT00996645|Coronary Artery Disease|coronary artery disease
506190|NCT00996645|Primary Health Care|primary health care
506191|NCT00996645|Feedback, Psychological|feedback, psychological
506192|NCT00996645|Quality Assurance, Health Care|quality assurance, health care
506193|NCT00996632|breast cancer|breast cancer
506194|NCT00996632|ultrasonic knife|ultrasonic knife
506195|NCT00996632|volume drainage|volume drainage
506196|NCT00996593|Tositumomab|tositumomab
506197|NCT00996593|radioimmunotherapy|radioimmunotherapy
506198|NCT00996593|rituximab|rituximab
506199|NCT00996593|anti-B1|anti-b1
506200|NCT00996593|I 131|i 131
506201|NCT00996593|Bexxar|bexxar
506202|NCT00996593|iodine|iodine
506203|NCT00996593|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
506204|NCT00996580|Contraception|contraception
506205|NCT00996580|Oral contraceptives|oral contraceptives
506206|NCT00996567|Malignant mesothelioma|malignant mesothelioma
506207|NCT00996554|Hand-sutured colo-colonic and ileo-colonic anastomoses in elective surgery|hand-sutured colo-colonic and ileo-colonic anastomoses in elective surgery
506208|NCT00996541|Runaway youth|runaway youth
506209|NCT00996541|Homeless youth|homeless youth
506210|NCT00996541|Family intervention|family intervention
506211|NCT00996541|Family functioning|family functioning
506212|NCT00996541|HIV risk behavior|hiv risk behavior
506213|NCT00996541|HIV Seronegativity|hiv seronegativity
506214|NCT00996528|fetal alcohol syndrome|fetal alcohol syndrome
506215|NCT00996528|alcohol abuse|alcohol abuse
506216|NCT00996528|HIV|hiv
506217|NCT00996528|malnutrition|malnutrition
506218|NCT00996528|children|children
506219|NCT00996528|mentor mother|mentor mother
506220|NCT00996528|behavioral intervention|behavioral intervention
506221|NCT00996528|South Africa|south africa
506222|NCT00996528|Maternal alcohol use|maternal alcohol use
506223|NCT00996528|HIV-related transmission behaviors|hiv-related transmission behaviors
506224|NCT00996528|low birth weight babies and low-weight children|low birth weight babies and low-weight children
506225|NCT00996528|HIV Seronegativity|hiv seronegativity
506226|NCT00996515|Advanced Solid Tumor Malignancies|advanced solid tumor malignancies
506227|NCT00996515|Erlotinib|erlotinib
506228|NCT00996515|Vidaza|vidaza
506229|NCT00996515|Tarceva|tarceva
506230|NCT00996515|5-azacytidine|5-azacytidine
506231|NCT00996476|Hepatitis C|hepatitis c
506232|NCT00996476|Hepatitis C virus|hepatitis c virus
506233|NCT00996476|Interferon Alfa-2a|interferon alfa-2a
506234|NCT00996476|Ribavirin|ribavirin
506235|NCT00996476|Viral RNA|viral rna
506236|NCT00996450|brain tumour|brain tumour
506237|NCT00996437|vitreous|vitreous
506238|NCT00996437|hemorrhage|hemorrhage
506239|NCT00996437|proliferative|proliferative
506240|NCT00996437|diabetic|diabetic
506241|NCT00996437|retinopathy|retinopathy
506242|NCT00996437|intravitreal|intravitreal
506243|NCT00996437|ranibizumab|ranibizumab
506244|NCT00996437|Lucentis|lucentis
506245|NCT00996437|saline|saline
506246|NCT00996437|vitrectomy|vitrectomy
506247|NCT00996411|Healthy volunteers are being studied to evaluate the subject-rated, behavioral, and abuse liability effects of salvinorin A|healthy volunteers are being studied to evaluate the subject-rated, behavioral, and abuse liability effects of salvinorin a
506249|NCT00996398|Joint Position Sense|joint position sense
506250|NCT00996398|Proprioception|proprioception
506251|NCT00996398|Pre Cooling|pre cooling
506252|NCT00996398|Knee Injury|knee injury
506253|NCT00996398|Physical Therapy Modalities|physical therapy modalities
506254|NCT00996398|Physical Therapy Techniques|physical therapy techniques
506255|NCT00996398|Weightbearing|weightbearing
506256|NCT00996398|NonWeightbearing|nonweightbearing
506257|NCT00996398|Randomised Control Trial|randomised control trial
506258|NCT00996385|Pleural Mesothelioma|pleural mesothelioma
506259|NCT00996385|Peritoneal Mesothelioma|peritoneal mesothelioma
506260|NCT00996359|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
506261|NCT00996359|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
507221|NCT00993551|surgery|surgery
506262|NCT00996359|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
506263|NCT00996359|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
506264|NCT00996359|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
506265|NCT00996359|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
506266|NCT00996359|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
506267|NCT00996359|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
506268|NCT00996359|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
506269|NCT00996359|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
506270|NCT00996359|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
506271|NCT00996359|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
506272|NCT00996359|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
506273|NCT00996359|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
506274|NCT00996359|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
506275|NCT00996359|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
506276|NCT00996359|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
506277|NCT00996359|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
506278|NCT00996359|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
506279|NCT00996359|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
506280|NCT00996359|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
506281|NCT00996359|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
506282|NCT00996359|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
506283|NCT00996359|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
506284|NCT00996359|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
506285|NCT00996359|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
506286|NCT00996359|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
506287|NCT00996359|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
506288|NCT00996359|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
506289|NCT00996359|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
506290|NCT00996359|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
506291|NCT00996359|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
506292|NCT00996359|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
506293|NCT00996359|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
506294|NCT00996359|peripheral T-cell lymphoma|peripheral t-cell lymphoma
506295|NCT00996359|hepatosplenic T-cell lymphoma|hepatosplenic t-cell lymphoma
506296|NCT00996359|anaplastic large cell lymphoma|anaplastic large cell lymphoma
506297|NCT00996359|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
506298|NCT00996359|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
506299|NCT00996359|splenic marginal zone lymphoma|splenic marginal zone lymphoma
506300|NCT00996359|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
506301|NCT00996359|refractory multiple myeloma|refractory multiple myeloma
506302|NCT00996359|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
506303|NCT00996359|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
506304|NCT00996359|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
506305|NCT00996359|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
506306|NCT00996359|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
506307|NCT00996359|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
506308|NCT00996359|Burkitt lymphoma|burkitt lymphoma
506309|NCT00996359|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
506310|NCT00996359|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
506311|NCT00996359|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
506312|NCT00996359|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
506313|NCT00996359|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
506314|NCT00996359|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
506315|NCT00996359|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
506316|NCT00996346|INST 0909|inst 0909
506317|NCT00996346|Irinotecan|irinotecan
506318|NCT00996346|Temsirolimus|temsirolimus
506319|NCT00996346|refractory sarcomas|refractory sarcomas
506320|NCT00996346|3066K1|3066k1
506321|NCT00996346|3066K1-1208|3066k1-1208
506322|NCT00996346|20091334|20091334
506323|NCT00996333|Stage IVB|stage ivb
506324|NCT00996320|Internship and Residency|internship and residency
506325|NCT00996320|Medical Errors|medical errors
506326|NCT00996320|Burnout, Professional|burnout, professional
506327|NCT00996320|Burnout|burnout
506328|NCT00996320|Depression|depression
506329|NCT00996320|Actigraphy|actigraphy
506330|NCT00996320|Personnel Staffing and Scheduling|personnel staffing and scheduling
506331|NCT00996320|Sleep Deprivation|sleep deprivation
506332|NCT00996320|Workload|workload
506333|NCT00996320|Humans|humans
506334|NCT00996320|Adult|adult
506335|NCT00996320|Male|male
506336|NCT00996320|Female|female
506337|NCT00996320|Intensive Care Units|intensive care units
506338|NCT00996320|Prospective Studies|prospective studies
506339|NCT00996320|Crossover Studies|crossover studies
506340|NCT00996320|Work Schedule Tolerance|work schedule tolerance
506341|NCT00996320|Disorders of Excessive Somnolence|disorders of excessive somnolence
506342|NCT00996320|Guideline Adherence|guideline adherence
506343|NCT00996320|Internal Medicine Education|internal medicine education
506344|NCT00996307|Swine Flu|swine flu
506345|NCT00996307|Flu|flu
506346|NCT00996307|Vaccine|vaccine
506347|NCT00996307|Children|children
506348|NCT00996307|Adjuvant|adjuvant
506349|NCT00996307|A/H1N1 2009 Influenza|a/h1n1 2009 influenza
506350|NCT00996281|Hypertensive|hypertensive
506351|NCT00996281|Blood Pressure, High|blood pressure, high
506352|NCT00996281|Cardiovascular disease|cardiovascular disease
506353|NCT00996281|Vascular Disease|vascular disease
506354|NCT00996281|Drug Therapy|drug therapy
506355|NCT00996268|hypertriglyceridemia|hypertriglyceridemia
506356|NCT00996268|GSK2212836|gsk2212836
506357|NCT00996268|relative bioavailability|relative bioavailability
506358|NCT00996242|Schizophrenia|schizophrenia
506359|NCT00996242|L-lysine|l-lysine
506360|NCT00996242|PANSS|panss
506361|NCT00996229|Diet|diet
506362|NCT00996229|elderly|elderly
506363|NCT00996229|cognition|cognition
506364|NCT00996229|prevention|prevention
506365|NCT00996229|cognitive decline|cognitive decline
506366|NCT00996229|Lifestyle|lifestyle
506367|NCT00996216|Peginterferon|peginterferon
506368|NCT00996216|Platelets|platelets
506369|NCT00996216|Ribavirin|ribavirin
506370|NCT00996216|Hepatitis C-related thrombocytopenia|hepatitis c-related thrombocytopenia
506371|NCT00996216|Thrombocytopenia|thrombocytopenia
506372|NCT00996216|Hepatitis C|hepatitis c
506373|NCT00996216|Thrombopoietin|thrombopoietin
506374|NCT00996190|transthoracic bioreactance|transthoracic bioreactance
506375|NCT00996190|noninvasive monitoring|noninvasive monitoring
506376|NCT00996190|vasopressor|vasopressor
506377|NCT00996190|blood pressure|blood pressure
506378|NCT00996177|Pain|pain
506379|NCT00996177|Patient-controlled analgesia|patient-controlled analgesia
506380|NCT00996177|Postoperative pain|postoperative pain
506381|NCT00996177|Transdermal fentanyl|transdermal fentanyl
506382|NCT00996177|Surgical pain|surgical pain
506383|NCT00996177|Opioid analgesics|opioid analgesics
506384|NCT00996151|Hypergonadism|hypergonadism
506385|NCT00996151|Testosterone Transfer|testosterone transfer
506386|NCT00996138|Influenza A|influenza a
506387|NCT00996138|H1N1 subtype|h1n1 subtype
506388|NCT00996138|Adult|adult
506389|NCT00996138|Vaccine|vaccine
506390|NCT00996138|Adjuvant|adjuvant
506391|NCT00996138|Swine-Origin Influenza A H1N1 Virus|swine-origin influenza a h1n1 virus
506392|NCT00996125|Immunogenicity|immunogenicity
506393|NCT00996125|Safety|safety
506394|NCT00996125|Human papillomavirus|human papillomavirus
506395|NCT00996125|China|china
506396|NCT00996125|HPV vaccine|hpv vaccine
506397|NCT00996112|primary health care|primary health care
506398|NCT00996099|continuous glucose monitoring|continuous glucose monitoring
506399|NCT00996099|intensive insulin therapy|intensive insulin therapy
506400|NCT00996099|critically ill|critically ill
506401|NCT00996099|cardiac surgery|cardiac surgery
506402|NCT00996099|hyperglycemia of critically ill|hyperglycemia of critically ill
506403|NCT00996073|Degenerative disc disease|degenerative disc disease
506404|NCT00996073|Spondylolisthesis|spondylolisthesis
506405|NCT00996073|Spinal stenosis|spinal stenosis
506406|NCT00996073|Stem cells|stem cells
506407|NCT00996073|Adult Stem Cells|adult stem cells
506408|NCT00996073|Spinal Fusion|spinal fusion
506409|NCT00996073|Lumbar Spinal Fusion|lumbar spinal fusion
506410|NCT00996073|TLIF|tlif
506411|NCT00996073|PLIF|plif
506412|NCT00996073|Mesoblast|mesoblast
506413|NCT00996060|Lung Cancer|lung cancer
506414|NCT00996060|Advanced Lung Cancer|advanced lung cancer
506415|NCT00996060|Unresectable Lung cancer|unresectable lung cancer
506416|NCT00996060|Previously treated lung cancer|previously treated lung cancer
506417|NCT00996047|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
506418|NCT00996047|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
506419|NCT00996047|acute undifferentiated leukemia|acute undifferentiated leukemia
506420|NCT00996047|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
506421|NCT00996047|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
506422|NCT00996047|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
506423|NCT00996047|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
506424|NCT00996047|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
506425|NCT00996047|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
507222|NCT00993551|speech|speech
506426|NCT00996047|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
506427|NCT00996047|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
506428|NCT00996047|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
506429|NCT00996047|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
506430|NCT00996047|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
506431|NCT00996047|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
506432|NCT00996047|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
506433|NCT00996047|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
506434|NCT00996047|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
506435|NCT00996047|mast cell leukemia|mast cell leukemia
506436|NCT00996047|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
506437|NCT00996047|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
506438|NCT00996047|prolymphocytic leukemia|prolymphocytic leukemia
506439|NCT00996047|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
506440|NCT00996047|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
506441|NCT00996047|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
506442|NCT00996047|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
506443|NCT00996047|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
506444|NCT00996047|refractory hairy cell leukemia|refractory hairy cell leukemia
506445|NCT00996047|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
506446|NCT00996047|secondary acute myeloid leukemia|secondary acute myeloid leukemia
506447|NCT00996047|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
506448|NCT00996047|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
506449|NCT00996047|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
506450|NCT00996047|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
506451|NCT00996047|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
506452|NCT00996047|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
506453|NCT00996047|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
506454|NCT00996047|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
506455|NCT00996047|untreated hairy cell leukemia|untreated hairy cell leukemia
506456|NCT00996047|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
506457|NCT00996047|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
506458|NCT00996047|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
506459|NCT00996047|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
506460|NCT00996047|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
506461|NCT00996047|myelodysplastic/myeloproliferative neoplasms|myelodysplastic/myeloproliferative neoplasms
506462|NCT00996034|Nicotine, SPECT, vaccine, receptor|nicotine, spect, vaccine, receptor
506463|NCT00996021|GSK1349572|gsk1349572
506464|NCT00996021|moxifloxacin|moxifloxacin
506465|NCT00996021|Avelox|avelox
506466|NCT00996021|QTc|qtc
506467|NCT00995982|Influenza|influenza
506468|NCT00995982|Healthy|healthy
506469|NCT00995982|Immunity|immunity
506470|NCT00995982|Preventive|preventive
506471|NCT00995982|Flu|flu
506472|NCT00995982|HV|hv
506473|NCT00995982|Healthy Volunteer|healthy volunteer
506474|NCT00995969|Mild to moderate psoriasis vulgaris|mild to moderate psoriasis vulgaris
506475|NCT00995956|Albumin|albumin
506476|NCT00995956|Mycophenolic acid|mycophenolic acid
506477|NCT00995956|IMPDH|impdh
506478|NCT00995956|Free fraction|free fraction
506479|NCT00995930|Atherosclerosis,|atherosclerosis,
506480|NCT00995930|Type 2 Diabetes Mellitus, T2DM,|type 2 diabetes mellitus, t2dm,
506481|NCT00995930|Cardiovascular Diseases, ACZ885, impaired glucose tolerance, IGT, Canakinumab|cardiovascular diseases, acz885, impaired glucose tolerance, igt, canakinumab
506482|NCT00995917|acupuncture|acupuncture
506483|NCT00995917|menstrual pain|menstrual pain
506484|NCT00995917|dysmenorrhea|dysmenorrhea
506485|NCT00995917|menstrual cramps|menstrual cramps
506486|NCT00995917|vitamin K1|vitamin k1
506487|NCT00995904|asthmatic children|asthmatic children
506488|NCT00995891|Laboratory Research Specimens|laboratory research specimens
506489|NCT00995891|Biologic Samples|biologic samples
506490|NCT00995891|Sample Collection|sample collection
506491|NCT00995891|Tissue Procurement|tissue procurement
506492|NCT00995891|HV|hv
506493|NCT00995891|Healthy Volunteer|healthy volunteer
506494|NCT00995878|Uterine fibroids|uterine fibroids
506495|NCT00995878|Fibroids|fibroids
506496|NCT00995878|Uterine leiomyomas|uterine leiomyomas
506497|NCT00995878|UAE|uae
506498|NCT00995878|UFE|ufe
506499|NCT00995878|Magnetic resonance guided focused ultrasound|magnetic resonance guided focused ultrasound
506500|NCT00995878|MRgFUS|mrgfus
506501|NCT00995878|Pelvic pain|pelvic pain
506502|NCT00995865|Prevention of yellow fever virus infection|prevention of yellow fever virus infection
506503|NCT00995852|Endoscopic lung volume reduction|endoscopic lung volume reduction
506504|NCT00995852|emphysema|emphysema
506506|NCT00995852|Patients with bilateral heterogeneous pulmonary emphysema|patients with bilateral heterogeneous pulmonary emphysema
506507|NCT00995839|terlipressin|terlipressin
506508|NCT00995839|vasopressin|vasopressin
506509|NCT00995839|sepsis|sepsis
506510|NCT00995839|septic shock|septic shock
506511|NCT00995839|norepinephrine|norepinephrine
506512|NCT00995813|Intestinal failure|intestinal failure
506513|NCT00995813|Rotavirus vaccine|rotavirus vaccine
506514|NCT00995813|Infants|infants
506515|NCT00995800|Asthma|asthma
506516|NCT00995787|Type II diabetes mellitus|type ii diabetes mellitus
506517|NCT00995787|metformin|metformin
506518|NCT00995787|sulfonylurea|sulfonylurea
506519|NCT00995774|stroke|stroke
506520|NCT00995774|function|function
506521|NCT00995774|arm|arm
506522|NCT00995774|hand|hand
506523|NCT00995774|robotic|robotic
506524|NCT00995774|therapy|therapy
506525|NCT00995774|motor|motor
506526|NCT00995774|movement|movement
506527|NCT00995774|treatment|treatment
506528|NCT00995761|biweekly|biweekly
506529|NCT00995761|docetaxel|docetaxel
506530|NCT00995761|cisplatin|cisplatin
506531|NCT00995761|non-small cell lung cancer|non-small cell lung cancer
506532|NCT00995735|NOTES|notes
506533|NCT00995735|Natural Orifice Translumenal Endoscopic surgery|natural orifice translumenal endoscopic surgery
506534|NCT00995735|Cholecystectomy|cholecystectomy
506535|NCT00995735|Appendectomy|appendectomy
506536|NCT00995735|Endoscopy|endoscopy
506537|NCT00995735|Laparoscopy|laparoscopy
506538|NCT00995735|Minimally invasive surgery|minimally invasive surgery
506539|NCT00995735|clinical trials|clinical trials
506540|NCT00995722|Ocular myasthenia gravis|ocular myasthenia gravis
506541|NCT00995722|Prednisone|prednisone
506542|NCT00995722|Steroids|steroids
506543|NCT00995709|Behçet's disease,|behçet's disease,
506544|NCT00995709|intermediate uveitis|intermediate uveitis
506545|NCT00995709|panuveitis|panuveitis
506546|NCT00995709|posterior uveitis|posterior uveitis
506547|NCT00995709|uveitis|uveitis
506548|NCT00995696|Interactive Voice Response (IVR)|interactive voice response (ivr)
506549|NCT00995696|Antidepressant|antidepressant
506550|NCT00995683|intracranial hypertension|intracranial hypertension
506551|NCT00995683|neurological outcome|neurological outcome
506552|NCT00995683|osmotherapy|osmotherapy
506553|NCT00995670|hyperglycemia|hyperglycemia
506554|NCT00995670|statin|statin
506555|NCT00995670|blood vessels|blood vessels
506556|NCT00995670|ischemic preconditioning|ischemic preconditioning
506557|NCT00995670|Anesthesia, inhalational|anesthesia, inhalational
506558|NCT00995670|endothelium|endothelium
506559|NCT00995670|5% dextrose|5% dextrose
506560|NCT00995644|smoking|smoking
506561|NCT00995644|smoking cessation|smoking cessation
506562|NCT00995644|tobacco use cessation|tobacco use cessation
506563|NCT00995644|tobacco use disorder|tobacco use disorder
506564|NCT00995631|liposuction|liposuction
506565|NCT00995631|adipose tissue|adipose tissue
506566|NCT00995631|dietary fatty acids|dietary fatty acids
506567|NCT00995631|triglyceride storage|triglyceride storage
506568|NCT00995631|Normal healthy aging|normal healthy aging
506569|NCT00995618|Gout|gout
506570|NCT00995618|Hyperuricemia|hyperuricemia
506571|NCT00995592|nutrition|nutrition
506572|NCT00995592|child weight|child weight
506573|NCT00995592|undernourishment|undernourishment
506574|NCT00995592|mentor mother|mentor mother
506575|NCT00995592|South Africa|south africa
506576|NCT00995579|Physical Activity|physical activity
506577|NCT00995579|Energy Expenditure|energy expenditure
506578|NCT00995540|T1DM|t1dm
506579|NCT00995540|Regeneration|regeneration
506580|NCT00995540|Islet|islet
506581|NCT00995540|Beta cell|beta cell
506582|NCT00995540|INGAP Peptide|ingap peptide
506583|NCT00995527|Post Swine Flu Blood Samples|post swine flu blood samples
506584|NCT00995527|Biologic Sample Collection|biologic sample collection
506585|NCT00995527|Laboratory Research Samples|laboratory research samples
506586|NCT00995527|H1N1 Vaccine Samples|h1n1 vaccine samples
506587|NCT00995527|HV|hv
506588|NCT00995527|Healthy Volunteer|healthy volunteer
506589|NCT00995514|acute coronary syndrome|acute coronary syndrome
506590|NCT00995514|cardiovascular death|cardiovascular death
506591|NCT00995514|non-fatal MI|non-fatal mi
506592|NCT00995514|non-fatal stroke|non-fatal stroke
506593|NCT00995514|genetic testing|genetic testing
506594|NCT00995514|CYP2C19|cyp2c19
506595|NCT00995514|clopidogrel|clopidogrel
506596|NCT00995514|prasugrel|prasugrel
506597|NCT00995514|antiplatelet therapy|antiplatelet therapy
506598|NCT00995514|genotyping|genotyping
506599|NCT00995514|bleeding|bleeding
506600|NCT00995501|steroid administration|steroid administration
506601|NCT00995501|tight glucose control|tight glucose control
506602|NCT00995501|light anesthesiReducing inflammatory response to surgical stress|light anesthesireducing inflammatory response to surgical stress
506603|NCT00995501|a|a
506604|NCT00995488|Urothelial Cancer|urothelial cancer
506605|NCT00995488|ABI-007|abi-007
506606|NCT00995488|Bladder Cancer|bladder cancer
506607|NCT00995488|front-line|front-line
506608|NCT00995449|Rheumatoid Arthritis|rheumatoid arthritis
506609|NCT00995449|Biologics-Inadequate|biologics-inadequate
506610|NCT00995449|KB003|kb003
506611|NCT00995449|GM-CSF|gm-csf
506612|NCT00995436|Extractions|extractions
506613|NCT00995436|Anchorage supplementation|anchorage supplementation
506614|NCT00995423|Coronary Artery Disease|coronary artery disease
506615|NCT00995423|stent|stent
506616|NCT00995410|Subjects Who are at Risk for Developing Aspirin-ASA|subjects who are at risk for developing aspirin-asa
506617|NCT00995410|Subject must have a pre-existing condition for which aspirin is already indicated|subject must have a pre-existing condition for which aspirin is already indicated
506618|NCT00995410|Gastric Ulcers|gastric ulcers
506619|NCT00995397|Insect bites|insect bites
506620|NCT00995397|Dexchlorpheniramine|dexchlorpheniramine
506621|NCT00995397|Lotion|lotion
506622|NCT00995397|Cream|cream
506623|NCT00995371|Spinal Stenosis|spinal stenosis
506624|NCT00995371|Lumbar Spinal Stenosis|lumbar spinal stenosis
506625|NCT00995371|Laminotomy|laminotomy
506626|NCT00995371|Laminectomy|laminectomy
506627|NCT00995371|Spine Surgery|spine surgery
506628|NCT00995358|Epitope peptide|epitope peptide
506629|NCT00995358|CTL|ctl
506630|NCT00995358|Esophageal cancer|esophageal cancer
506631|NCT00995358|Vaccination|vaccination
506632|NCT00995345|Type 2 Diabetes|type 2 diabetes
506633|NCT00995345|Metformin|metformin
506634|NCT00995332|Acute myelogenous leukemia|acute myelogenous leukemia
506635|NCT00995332|all-trans retinoic acid|all-trans retinoic acid
506636|NCT00995332|valproic acid|valproic acid
506637|NCT00995332|cytarabine|cytarabine
506638|NCT00995332|Disease stabilization|disease stabilization
506639|NCT00995332|survival|survival
506640|NCT00995332|toxicity|toxicity
506641|NCT00995319|mouth|mouth
506642|NCT00995319|Mucositis|mucositis
506643|NCT00995319|Dysphagia|dysphagia
506644|NCT00995319|malnutrition|malnutrition
506645|NCT00995319|Xerostomia|xerostomia
506646|NCT00995319|saliva|saliva
506647|NCT00995319|tooth injuries|tooth injuries
506648|NCT00995306|Active comparator|active comparator
506649|NCT00995306|Active civamide cream, 0.075%|active civamide cream, 0.075%
506650|NCT00995306|Active civamide cream, 0.01%|active civamide cream, 0.01%
506651|NCT00995280|follicle flushing|follicle flushing
506652|NCT00995280|oocyte retrieval|oocyte retrieval
506653|NCT00995280|needle|needle
506654|NCT00995267|childhood obesity|childhood obesity
506655|NCT00995267|nutrition|nutrition
506656|NCT00995267|exercise|exercise
506657|NCT00995267|Alfred Adler|alfred adler
506658|NCT00995267|schoolchildren|schoolchildren
506659|NCT00995267|intervention study|intervention study
506660|NCT00995267|community-based trial|community-based trial
506661|NCT00995267|parent-child interaction|parent-child interaction
506662|NCT00995267|nutritional behaviors|nutritional behaviors
506663|NCT00995254|secondhand smoke|secondhand smoke
506664|NCT00995254|children|children
506665|NCT00995254|Chinese|chinese
506666|NCT00995254|respiratory symptoms|respiratory symptoms
506667|NCT00995254|household smoking policy|household smoking policy
506668|NCT00995254|Respiratory illnesses among children|respiratory illnesses among children
506669|NCT00995241|Raltegravir|raltegravir
506670|NCT00995241|intracellular concentration|intracellular concentration
506671|NCT00995241|plasmatic concentration|plasmatic concentration
506672|NCT00995241|HIV|hiv
506673|NCT00995241|Treatment experienced|treatment experienced
506674|NCT00995228|overhydration|overhydration
506675|NCT00995228|fluid restriction|fluid restriction
506676|NCT00995228|post-anesthesia care unit|post-anesthesia care unit
506677|NCT00995215|spinal cord injury|spinal cord injury
506678|NCT00995215|SCI|sci
506679|NCT00995215|paralysis|paralysis
506680|NCT00995215|cough|cough
506681|NCT00995215|cervical spinal cord injury|cervical spinal cord injury
506682|NCT00995215|thoracic spinal cord injury|thoracic spinal cord injury
506683|NCT00995202|stage II colon cancer|stage ii colon cancer
506684|NCT00995202|stage II rectal cancer|stage ii rectal cancer
506685|NCT00995202|stage III colon cancer|stage iii colon cancer
506686|NCT00995202|stage III rectal cancer|stage iii rectal cancer
506687|NCT00995202|adenocarcinoma of the colon|adenocarcinoma of the colon
506688|NCT00995202|adenocarcinoma of the rectum|adenocarcinoma of the rectum
506689|NCT00995189|contact lens wear|contact lens wear
506690|NCT00995189|multi-purpose solution|multi-purpose solution
506691|NCT00995189|corneal staining|corneal staining
506692|NCT00995176|Prevention|prevention
506693|NCT00995176|HIV|hiv
506694|NCT00995176|HIV seronegativity|hiv seronegativity
506695|NCT00995163|outcomes study|outcomes study
506696|NCT00995163|hemodialysis|hemodialysis
506697|NCT00995163|CKD-MBD|ckd-mbd
506698|NCT00995150|contraception|contraception
506699|NCT00995150|intrauterine|intrauterine
506700|NCT00995150|long-term|long-term
506701|NCT00995150|reversible|reversible
506702|NCT00995137|Relapsed or refractory B-Lineage ALL|relapsed or refractory b-lineage all
506703|NCT00995124|ovicide|ovicide
506704|NCT00995124|head lice infestation|head lice infestation
506705|NCT00995098|Acute severe pancreatitis|acute severe pancreatitis
506706|NCT00995098|nutritional support|nutritional support
506707|NCT00995098|enteral nutrition|enteral nutrition
507324|NCT00993031|HIV|hiv
506708|NCT00995098|parenteral nutrition|parenteral nutrition
506709|NCT00995085|ADHD|adhd
506710|NCT00995085|ADD|add
506711|NCT00995085|TOVA|tova
506712|NCT00995085|METADOXINE|metadoxine
506713|NCT00995072|sexual dysfunction|sexual dysfunction
506714|NCT00995072|female|female
506715|NCT00995072|hypertension|hypertension
506716|NCT00995072|high blood pressure|high blood pressure
506717|NCT00995072|beta blockers|beta blockers
506718|NCT00995072|metoprolol|metoprolol
506719|NCT00995072|nebivolol|nebivolol
506720|NCT00995072|Bystolic|bystolic
506721|NCT00995072|Toprol XL|toprol xl
506722|NCT00995059|stage I multiple myeloma|stage i multiple myeloma
506723|NCT00995059|stage II multiple myeloma|stage ii multiple myeloma
506724|NCT00995059|stage III multiple myeloma|stage iii multiple myeloma
506725|NCT00995046|Hemophilia A|hemophilia a
506726|NCT00995046|prophylaxis|prophylaxis
506727|NCT00995046|thrombin generation test (TGT)|thrombin generation test (tgt)
506728|NCT00995033|Smoking cessation|smoking cessation
506729|NCT00995033|Smoking lapse behavior|smoking lapse behavior
506730|NCT00995033|Smoking Relapse behavior|smoking relapse behavior
506731|NCT00995033|Varenicline|varenicline
506732|NCT00995033|Nicotine conjugate vaccine|nicotine conjugate vaccine
506733|NCT00995033|Medication effect on smoking lapse behavior|medication effect on smoking lapse behavior
506734|NCT00995020|Cone biopsy|cone biopsy
506735|NCT00995020|Conization|conization
506736|NCT00995020|Loop electrosurgical excisional procedures|loop electrosurgical excisional procedures
506737|NCT00995020|Large Loop Excision of Transformation Zone|large loop excision of transformation zone
506738|NCT00995020|Needle Excision of Transformation Zone|needle excision of transformation zone
506739|NCT00995020|Straight Wire Excision of Transformation Zone|straight wire excision of transformation zone
506740|NCT00995020|Electrosurgery|electrosurgery
506741|NCT00995007|Brain Tumor|brain tumor
506742|NCT00995007|Chemotherapy|chemotherapy
506743|NCT00995007|Antiangiogenesis|antiangiogenesis
506744|NCT00995007|Radiation|radiation
506745|NCT00995007|Progression|progression
506746|NCT00995007|Glioma|glioma
506747|NCT00995007|Glioblastoma Multiforme|glioblastoma multiforme
506748|NCT00994994|pediatric cardiac surgery|pediatric cardiac surgery
506749|NCT00994994|bleeding|bleeding
506750|NCT00994994|tranexamic acid|tranexamic acid
506751|NCT00994994|fibrinolysis|fibrinolysis
506752|NCT00994994|blood loss in pediatric cardiac surgery|blood loss in pediatric cardiac surgery
506753|NCT00994981|magnesium and reperfusion injury|magnesium and reperfusion injury
506754|NCT00994968|stage II breast cancer|stage ii breast cancer
506755|NCT00994968|stage III breast cancer|stage iii breast cancer
506756|NCT00994955|SRT|srt
506757|NCT00994955|laser|laser
506758|NCT00994955|diabetic macular edema|diabetic macular edema
506759|NCT00994955|diabetes|diabetes
506760|NCT00994955|Clinically significant diabetic macular edema|clinically significant diabetic macular edema
506761|NCT00994929|biologic effects|biologic effects
506762|NCT00994929|von Willebrand disease|von willebrand disease
506763|NCT00994929|hemophilia|hemophilia
506764|NCT00994929|interleukin-11|interleukin-11
506765|NCT00994929|DDAVp|ddavp
506766|NCT00994916|Lambert-Eaton myasthenic syndrome|lambert-eaton myasthenic syndrome
506767|NCT00994916|3,4 diaminopyridine|3,4 diaminopyridine
506768|NCT00994903|Statin|statin
506769|NCT00994903|Colon|colon
506770|NCT00994903|Colorectal|colorectal
506771|NCT00994903|Intestinal Neoplasms|intestinal neoplasms
506772|NCT00994903|ERAS|eras
506773|NCT00994903|Perioperative Care|perioperative care
506774|NCT00994890|Double-blind safety|double-blind safety
506775|NCT00994825|levosimendan|levosimendan
506776|NCT00994825|cardiac surgery|cardiac surgery
506777|NCT00994825|cardiac anesthesia|cardiac anesthesia
506778|NCT00994825|mortality|mortality
506779|NCT00994825|survival|survival
506780|NCT00994825|inotropic drugs|inotropic drugs
506781|NCT00994812|Polycystic ovary syndrome|polycystic ovary syndrome
506782|NCT00994812|PCOS|pcos
506783|NCT00994812|Metformin|metformin
506784|NCT00994812|Miscarriage|miscarriage
506785|NCT00994812|Infertility|infertility
506786|NCT00994812|Complications of pregnancy|complications of pregnancy
506787|NCT00994786|treatment-resistant|treatment-resistant
506788|NCT00994786|refractory|refractory
506789|NCT00994786|obsessive compulsive disorder|obsessive compulsive disorder
506790|NCT00994786|Lyrica|lyrica
506791|NCT00994786|pregabalin|pregabalin
506792|NCT00994786|Serotonin Reuptake Inhibitor-Refractory Obsessive-Compulsive Disorder|serotonin reuptake inhibitor-refractory obsessive-compulsive disorder
506793|NCT00994773|Hepatitis B|hepatitis b
506794|NCT00994773|simvastatin|simvastatin
506795|NCT00994773|HBV DNA|hbv dna
506796|NCT00994760|intranasal fentanyl spray|intranasal fentanyl spray
506797|NCT00994747|infancy|infancy
506798|NCT00994747|nutrition|nutrition
506799|NCT00994747|protein hydrolysate formula|protein hydrolysate formula
506800|NCT00994747|flavor preferences|flavor preferences
506801|NCT00994747|food preferences|food preferences
506802|NCT00994747|growth|growth
506803|NCT00994747|emotional development|emotional development
506804|NCT00994747|mother-infant interaction|mother-infant interaction
506805|NCT00994747|infant temperament|infant temperament
506806|NCT00994747|feeding patterning|feeding patterning
506807|NCT00994747|taste receptor and obesity genotype|taste receptor and obesity genotype
506808|NCT00994747|sensitive period|sensitive period
506809|NCT00994721|Pancreatic Cancer|pancreatic cancer
506810|NCT00994695|Trivalent meningococcal polysaccharide vaccine|trivalent meningococcal polysaccharide vaccine
506811|NCT00994695|Children|children
506812|NCT00994695|Safety|safety
506813|NCT00994695|Immunogenicity|immunogenicity
506814|NCT00994695|To assess Safety of trivalent meningococcal polysaccharide vaccine in children|to assess safety of trivalent meningococcal polysaccharide vaccine in children
506815|NCT00994695|To assess the immunogenicity of the trivalent polysaccharide vaccine in children|to assess the immunogenicity of the trivalent polysaccharide vaccine in children
506816|NCT00994682|Additional relevant MeSH terms:|additional relevant mesh terms:
506817|NCT00994682|Hypoglycemic Agents|hypoglycemic agents
506818|NCT00994682|Physiological Effects of Drugs|physiological effects of drugs
506819|NCT00994682|Pharmacologic Actions|pharmacologic actions
506820|NCT00994682|Pioglitazone|pioglitazone
506821|NCT00994656|invasive procedures|invasive procedures
506822|NCT00994656|hypovolemia|hypovolemia
506823|NCT00994643|NHL|nhl
506824|NCT00994643|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
506825|NCT00994643|Lymphoma|lymphoma
506826|NCT00994591|Nicotine|nicotine
506827|NCT00994591|Cotinine|cotinine
506828|NCT00994591|CYP2A6|cyp2a6
506829|NCT00994578|Advanced cancer|advanced cancer
506830|NCT00994565|Physical activity|physical activity
506831|NCT00994565|health behaviour|health behaviour
506832|NCT00994565|lifestyle|lifestyle
506833|NCT00994565|productivity|productivity
506834|NCT00994565|outcomes|outcomes
506835|NCT00994526|Colorectal cancer|colorectal cancer
506836|NCT00994526|Processed meat|processed meat
506837|NCT00994526|Calcium|calcium
506838|NCT00994526|Vitamin E|vitamin e
506839|NCT00994526|Preventive strategies|preventive strategies
506840|NCT00994513|Antioxidant|antioxidant
506841|NCT00994513|Obesity|obesity
506842|NCT00994487|Childhood Obesity|childhood obesity
506843|NCT00994487|Breastfeeding|breastfeeding
506844|NCT00994487|Bottle Feeding|bottle feeding
506845|NCT00994487|Dietary Intake|dietary intake
506846|NCT00994487|Preload|preload
506847|NCT00994487|Compensation|compensation
506848|NCT00994487|Parental Feeding Style|parental feeding style
506849|NCT00994474|Laser surgery|laser surgery
506850|NCT00994474|Profilometry|profilometry
506851|NCT00994474|Fitzpatrick wrinkle score|fitzpatrick wrinkle score
506852|NCT00994474|Patient Benefit Index|patient benefit index
506853|NCT00994474|Patient satisfaction|patient satisfaction
506854|NCT00994461|Endoscopy|endoscopy
506855|NCT00994448|Adolescents|adolescents
506856|NCT00994448|Methamphetamine abuse|methamphetamine abuse
506857|NCT00994448|Bupropion|bupropion
506858|NCT00994448|Addiction|addiction
506859|NCT00994448|Pharmacotherapy|pharmacotherapy
506860|NCT00994448|Cognitive Behavioral Therapy|cognitive behavioral therapy
506861|NCT00994448|Contingency Management|contingency management
506862|NCT00994448|Teens|teens
506863|NCT00994435|obesity|obesity
506864|NCT00994422|PEDICULUS HUMANUS CAPITIS|pediculus humanus capitis
506865|NCT00994422|Head Lice|head lice
506866|NCT00994409|Stroke|stroke
506867|NCT00994370|Pro-angiogenic markers|pro-angiogenic markers
506868|NCT00994370|SIRT|sirt
506869|NCT00994370|hepatic metastases|hepatic metastases
506870|NCT00994357|Real-time Continuous Glucose Monitoring|real-time continuous glucose monitoring
506871|NCT00994357|Macrosomia|macrosomia
506872|NCT00994344|Darunavir|darunavir
506873|NCT00994344|Lopinavir|lopinavir
506874|NCT00994344|Monotherapy|monotherapy
506875|NCT00994344|Antiretroviral simplification strategy|antiretroviral simplification strategy
506876|NCT00994344|HIV|hiv
506877|NCT00994344|Treatment experienced|treatment experienced
506878|NCT00994331|Percutaneous Coronary Intervention|percutaneous coronary intervention
506879|NCT00994331|Magnetic Navigation|magnetic navigation
506880|NCT00994331|Computed Tomography|computed tomography
506881|NCT00994318|Ferinject Iron Deficiency Anaemia Chronic Kidney Disease|ferinject iron deficiency anaemia chronic kidney disease
506882|NCT00994305|kidney transplantation|kidney transplantation
506883|NCT00994305|oxidative stress|oxidative stress
506884|NCT00994305|acetylcysteine|acetylcysteine
506885|NCT00994305|graft rejection|graft rejection
506886|NCT00994292|Factor Xa|factor xa
506887|NCT00994292|Anticoagulant|anticoagulant
506888|NCT00994292|YM150|ym150
506889|NCT00994292|Acute Coronary Syndrome|acute coronary syndrome
506890|NCT00994279|fatigue|fatigue
506891|NCT00994279|depression|depression
506892|NCT00994279|sleep disorders|sleep disorders
506893|NCT00994279|stage IA breast cancer|stage ia breast cancer
506894|NCT00994279|stage IB breast cancer|stage ib breast cancer
506895|NCT00994279|stage II breast cancer|stage ii breast cancer
506896|NCT00994279|stage IIIA breast cancer|stage iiia breast cancer
506897|NCT00994279|stage IIIB breast cancer|stage iiib breast cancer
506898|NCT00994279|stage IIIC breast cancer|stage iiic breast cancer
506899|NCT00994279|recurrent breast cancer|recurrent breast cancer
506900|NCT00994266|Type 2 diabetes|type 2 diabetes
506901|NCT00994266|Diamel|diamel
506902|NCT00994266|Dietary supplement|dietary supplement
506903|NCT00994227|electron microscopy|electron microscopy
506904|NCT00994227|internal limiting membrane|internal limiting membrane
506905|NCT00994227|macular disease|macular disease
506906|NCT00994227|optical coherence tomography|optical coherence tomography
506907|NCT00994188|Renal tumor|renal tumor
506908|NCT00994188|Ureteral tumor|ureteral tumor
506909|NCT00994188|Ureteral stricture|ureteral stricture
506910|NCT00994188|Restored kidney|restored kidney
506911|NCT00994188|Renal transplantation|renal transplantation
506912|NCT00994188|Family members|family members
506913|NCT00994175|Pioglitazone|pioglitazone
506914|NCT00994175|Severe, Refractory Asthma|severe, refractory asthma
506915|NCT00994175|Peroxisome Proliferator-Activated Receptor Gamma|peroxisome proliferator-activated receptor gamma
506916|NCT00994175|Airflow Obstruction|airflow obstruction
506917|NCT00994175|Airway Inflammation|airway inflammation
506918|NCT00994175|Asthma|asthma
506919|NCT00994162|NPWT|npwt
506920|NCT00994162|Gauze-based filler|gauze-based filler
506921|NCT00994162|Acute or Chronic Wounds|acute or chronic wounds
506922|NCT00994162|Efficacy|efficacy
506923|NCT00994149|Infants of Diabetic Mothers|infants of diabetic mothers
506924|NCT00994149|Hypoglycemia|hypoglycemia
506925|NCT00994149|Diazoxide|diazoxide
506926|NCT00994149|Large for Gestation Infants|large for gestation infants
506927|NCT00994136|Catheters, indwelling|catheters, indwelling
506928|NCT00994136|Catheterization, Central Venous|catheterization, central venous
506929|NCT00994136|Withdrawal occlusion|withdrawal occlusion
506930|NCT00994136|Heparin lock|heparin lock
506931|NCT00994123|Non-Small Cell Lung Cancer|non-small cell lung cancer
506932|NCT00994123|NSCLC|nsclc
506933|NCT00994123|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
506934|NCT00994123|Metastatic Non-Small Cell Lung Cancer|metastatic non-small cell lung cancer
506935|NCT00994123|Lung Cancer|lung cancer
506936|NCT00994123|Erlotinib|erlotinib
506937|NCT00994123|Tarceva|tarceva
506938|NCT00994123|MM-121|mm-121
506939|NCT00994123|ErbB3|erbb3
506940|NCT00994123|Her3|her3
506941|NCT00994123|Epidermal Growth Factor Receptor|epidermal growth factor receptor
506942|NCT00994123|anti-ErbB3 human monoclonal antibody|anti-erbb3 human monoclonal antibody
506943|NCT00994123|ErbB3 antagonist|erbb3 antagonist
506944|NCT00994110|PANCREAS|pancreas
506945|NCT00994110|Pasireotide|pasireotide
506946|NCT00994110|SOM230|som230
506947|NCT00994110|saline placebo|saline placebo
506948|NCT00994110|09-039|09-039
506949|NCT00994097|NGR-hTNF|ngr-htnf
506950|NCT00994097|Randomized controlled trial|randomized controlled trial
506951|NCT00994097|Gemcitabine|gemcitabine
506952|NCT00994097|Cisplatin|cisplatin
506953|NCT00994097|Pemetrexed|pemetrexed
506954|NCT00994097|Carcinoma, non-small cell lung|carcinoma, non-small cell lung
506955|NCT00994084|Obesity|obesity
506956|NCT00994084|Minority children|minority children
506957|NCT00994084|Community intervention program|community intervention program
506958|NCT00994084|Lifestyle changes|lifestyle changes
506959|NCT00994084|Physical activities|physical activities
506960|NCT00994084|Nutrition lessons|nutrition lessons
506961|NCT00994084|Behavior modification|behavior modification
506962|NCT00994071|Brain Tumor|brain tumor
506963|NCT00994071|CNC Tumor|cnc tumor
506964|NCT00994071|Pediatric|pediatric
506965|NCT00994071|PARP Inhibitor|parp inhibitor
506966|NCT00994071|Oral Chemotherapy|oral chemotherapy
506967|NCT00994058|Preterm Labor|preterm labor
506968|NCT00994058|Uterine Inhibitor|uterine inhibitor
506969|NCT00994058|Electro-Inhibition|electro-inhibition
506970|NCT00994045|Thoraco-Abdominal Aneurysm (TAAA)|thoraco-abdominal aneurysm (taaa)
506971|NCT00994045|Coagulopathy|coagulopathy
506972|NCT00994045|Fresh Frozen Plasma|fresh frozen plasma
506973|NCT00994045|Fibrinogen Concentrate|fibrinogen concentrate
506974|NCT00994032|vertebroplasty|vertebroplasty
506975|NCT00994032|disability evaluation|disability evaluation
506976|NCT00994032|outcome assessment|outcome assessment
506977|NCT00994032|pain measurement|pain measurement
506978|NCT00994019|HPV|hpv
506979|NCT00994019|oral cancer|oral cancer
506980|NCT00994019|young adults|young adults
506981|NCT00994006|Magnesium|magnesium
506982|NCT00994006|nutrition|nutrition
506983|NCT00994006|platelets|platelets
506984|NCT00994006|aggregation|aggregation
506985|NCT00993993|cleft palate|cleft palate
506986|NCT00993980|qigong|qigong
506987|NCT00993980|traditional chinese medicine|traditional chinese medicine
506988|NCT00993980|exercise therapy|exercise therapy
506989|NCT00993980|low back pain|low back pain
506990|NCT00993967|FRDA|frda
506991|NCT00993967|idebenone|idebenone
506992|NCT00993967|FRDA disease|frda disease
506993|NCT00993954|Nurse Treatment|nurse treatment
506994|NCT00993954|Pulled Elbow|pulled elbow
506995|NCT00993941|BMSC|bmsc
506996|NCT00993941|Stem cells|stem cells
506997|NCT00993941|Liver cirrhosis|liver cirrhosis
506998|NCT00993941|Transplantation|transplantation
506999|NCT00993928|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
507000|NCT00993928|fatigue|fatigue
507001|NCT00993928|sleep disorders|sleep disorders
507002|NCT00993928|cancer survivor|cancer survivor
507419|NCT00992758|tositumomab|tositumomab
507003|NCT00993915|Coronary Artery Disease|coronary artery disease
507004|NCT00993915|Hyperlipidemia|hyperlipidemia
507005|NCT00993915|Atorvastatin|atorvastatin
507006|NCT00993902|Double IUI|double iui
507007|NCT00993902|Intrauterine insemination|intrauterine insemination
507008|NCT00993902|Unexplained infertility|unexplained infertility
507009|NCT00993889|Virtual Reality Peds|virtual reality peds
507010|NCT00993876|Depression|depression
507011|NCT00993876|CREB|creb
507012|NCT00993876|cognitive performance|cognitive performance
507013|NCT00993876|psychotherapy|psychotherapy
507014|NCT00993876|SSRI|ssri
507015|NCT00993876|SNRI|snri
507016|NCT00993863|delta opioid agonist|delta opioid agonist
507017|NCT00993863|dental pain|dental pain
507018|NCT00993850|Bipolar disorder|bipolar disorder
507019|NCT00993850|Insomnia|insomnia
507020|NCT00993850|Sleep disturbance|sleep disturbance
507021|NCT00993850|Cognitive behavioral therapy|cognitive behavioral therapy
507022|NCT00993837|endoscopic thyroidectomy|endoscopic thyroidectomy
507023|NCT00993837|thyroid carcinoma|thyroid carcinoma
507024|NCT00993811|male circumcision|male circumcision
507025|NCT00993811|HIV|hiv
507026|NCT00993811|Africa|africa
507027|NCT00993811|HIV Seronegativity|hiv seronegativity
507028|NCT00993798|Post operative pain|post operative pain
507029|NCT00993798|Local anaesthesia|local anaesthesia
507030|NCT00993798|Postoperative pain after arthroscopic shoulder surgery|postoperative pain after arthroscopic shoulder surgery
507031|NCT00993759|common cold|common cold
507032|NCT00993759|rhinovirus|rhinovirus
507033|NCT00993759|prevention|prevention
507034|NCT00993746|Ultrasound guided infraclavicular brachial plexus block|ultrasound guided infraclavicular brachial plexus block
507035|NCT00993746|Bupivacaine|bupivacaine
507036|NCT00993746|Bupivacaine plus lidocaine|bupivacaine plus lidocaine
507037|NCT00993746|End stage renal disease|end stage renal disease
507038|NCT00993746|Arteriovenous fistula|arteriovenous fistula
507039|NCT00993733|hemodiafiltration|hemodiafiltration
507040|NCT00993733|cost|cost
507041|NCT00993733|dialysis solution|dialysis solution
507042|NCT00993733|acute renal failure|acute renal failure
507043|NCT00993733|intensive care unit|intensive care unit
507044|NCT00993720|patients with type 1 diabetes mellitus|patients with type 1 diabetes mellitus
507045|NCT00993707|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
507046|NCT00993694|methemoglobinemia|methemoglobinemia
507047|NCT00993694|aplastic anemia|aplastic anemia
507048|NCT00993694|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
507049|NCT00993694|acute undifferentiated leukemia|acute undifferentiated leukemia
507050|NCT00993694|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
507051|NCT00993694|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
507052|NCT00993694|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
507053|NCT00993694|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
507054|NCT00993694|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
507055|NCT00993694|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
507056|NCT00993694|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
507057|NCT00993694|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
507058|NCT00993694|mast cell leukemia|mast cell leukemia
507059|NCT00993694|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
507060|NCT00993694|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
507061|NCT00993694|prolymphocytic leukemia|prolymphocytic leukemia
507062|NCT00993694|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
507063|NCT00993694|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
507064|NCT00993694|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
507065|NCT00993694|refractory hairy cell leukemia|refractory hairy cell leukemia
507066|NCT00993694|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
507067|NCT00993694|secondary acute myeloid leukemia|secondary acute myeloid leukemia
507068|NCT00993694|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
507069|NCT00993694|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
507070|NCT00993694|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
507071|NCT00993694|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
507072|NCT00993694|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
507073|NCT00993694|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
507074|NCT00993694|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
507075|NCT00993694|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
507076|NCT00993694|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
507077|NCT00993694|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
507078|NCT00993694|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
507079|NCT00993694|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
507080|NCT00993694|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
507081|NCT00993694|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
507082|NCT00993694|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
507083|NCT00993694|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
507084|NCT00993694|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
507085|NCT00993694|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
507086|NCT00993694|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
507087|NCT00993694|anaplastic large cell lymphoma|anaplastic large cell lymphoma
507088|NCT00993694|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
507089|NCT00993694|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
507090|NCT00993694|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
507091|NCT00993694|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
507092|NCT00993694|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
507093|NCT00993694|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
507094|NCT00993694|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
507095|NCT00993694|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
507096|NCT00993694|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
507097|NCT00993694|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
507098|NCT00993694|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
507099|NCT00993694|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
507100|NCT00993694|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
507101|NCT00993694|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
507102|NCT00993694|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
507103|NCT00993694|splenic marginal zone lymphoma|splenic marginal zone lymphoma
507104|NCT00993694|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
507105|NCT00993694|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
507106|NCT00993694|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
507107|NCT00993694|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
507108|NCT00993694|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
507109|NCT00993694|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
507110|NCT00993694|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
507111|NCT00993694|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
507112|NCT00993694|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
507113|NCT00993694|stage I mantle cell lymphoma|stage i mantle cell lymphoma
507114|NCT00993694|stage I marginal zone lymphoma|stage i marginal zone lymphoma
507115|NCT00993694|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
507116|NCT00993694|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
507117|NCT00993694|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
507118|NCT00993694|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
507119|NCT00993694|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
507120|NCT00993694|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
507121|NCT00993694|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
507122|NCT00993694|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
507123|NCT00993694|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
507124|NCT00993694|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
507125|NCT00993694|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
507126|NCT00993694|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
507127|NCT00993694|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
507128|NCT00993694|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
507129|NCT00993694|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
507130|NCT00993694|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
507131|NCT00993694|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
507132|NCT00993694|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
507133|NCT00993694|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
507134|NCT00993694|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
507135|NCT00993694|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
507136|NCT00993694|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
507137|NCT00993694|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
507138|NCT00993694|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
507139|NCT00993694|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
507140|NCT00993694|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
507141|NCT00993694|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
507142|NCT00993694|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
507143|NCT00993694|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
507144|NCT00993694|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
507145|NCT00993694|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
507146|NCT00993694|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
507147|NCT00993694|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
507148|NCT00993694|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
507149|NCT00993694|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
507150|NCT00993694|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
507151|NCT00993694|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
507152|NCT00993694|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
507153|NCT00993694|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
507154|NCT00993694|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
507155|NCT00993694|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
507156|NCT00993694|Burkitt lymphoma|burkitt lymphoma
507157|NCT00993694|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
507158|NCT00993694|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
507159|NCT00993694|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
507160|NCT00993694|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
507161|NCT00993694|intraocular lymphoma|intraocular lymphoma
507162|NCT00993694|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
507163|NCT00993694|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
507164|NCT00993694|chronic eosinophilic leukemia|chronic eosinophilic leukemia
507165|NCT00993694|chronic neutrophilic leukemia|chronic neutrophilic leukemia
507166|NCT00993694|primary myelofibrosis|primary myelofibrosis
507167|NCT00993694|essential thrombocythemia|essential thrombocythemia
507168|NCT00993694|polycythemia vera|polycythemia vera
507169|NCT00993694|extramedullary plasmacytoma|extramedullary plasmacytoma
507170|NCT00993694|isolated plasmacytoma of bone|isolated plasmacytoma of bone
507171|NCT00993694|stage I multiple myeloma|stage i multiple myeloma
507172|NCT00993694|stage II multiple myeloma|stage ii multiple myeloma
507173|NCT00993694|stage III multiple myeloma|stage iii multiple myeloma
507174|NCT00993694|primary systemic amyloidosis|primary systemic amyloidosis
507175|NCT00993694|refractory multiple myeloma|refractory multiple myeloma
507176|NCT00993694|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
507177|NCT00993694|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
507178|NCT00993694|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
507179|NCT00993694|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
507180|NCT00993694|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
507181|NCT00993694|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
507182|NCT00993694|stage I childhood anaplastic large cell lymphoma|stage i childhood anaplastic large cell lymphoma
507183|NCT00993694|stage II childhood anaplastic large cell lymphoma|stage ii childhood anaplastic large cell lymphoma
507184|NCT00993694|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
507185|NCT00993694|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
507186|NCT00993694|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
507187|NCT00993681|Prevention of Travelers' Diarrhea|prevention of travelers' diarrhea
507188|NCT00993668|influenza|influenza
507189|NCT00993668|vaccine|vaccine
507190|NCT00993668|pneumococcal vaccine|pneumococcal vaccine
507191|NCT00993668|certolizumab pegol|certolizumab pegol
507192|NCT00993668|Cimzia|cimzia
507193|NCT00993655|peritoneal cavity cancer|peritoneal cavity cancer
507194|NCT00993655|fallopian tube cancer|fallopian tube cancer
507195|NCT00993655|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
507196|NCT00993655|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
507197|NCT00993655|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
507198|NCT00993655|malignant pleural effusion|malignant pleural effusion
507199|NCT00993655|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
507200|NCT00993655|ovarian clear cell tumor with proliferating activity|ovarian clear cell tumor with proliferating activity
507201|NCT00993642|estrogen receptor positive tamoxifen resistant breast cancer|estrogen receptor positive tamoxifen resistant breast cancer
507202|NCT00993629|PTSD|ptsd
507203|NCT00993629|Depression|depression
507204|NCT00993629|Neurosteroids|neurosteroids
507205|NCT00993603|Lifestyle|lifestyle
507206|NCT00993603|Diabetes Mellitus|diabetes mellitus
507207|NCT00993603|prevention/onset delay.|prevention/onset delay.
507208|NCT00993590|Persistent asthma|persistent asthma
507209|NCT00993590|Asthma related emergency room visits|asthma related emergency room visits
507210|NCT00993590|Asthma control, adolescents|asthma control, adolescents
507211|NCT00993590|Adherence, asthma control medications|adherence, asthma control medications
507212|NCT00993577|Stretching|stretching
507213|NCT00993577|Pain|pain
507214|NCT00993564|Therapeutic hypothermia|therapeutic hypothermia
507215|NCT00993564|Head cooling|head cooling
507216|NCT00993564|Hypoxic ischemic encephalopathy|hypoxic ischemic encephalopathy
507217|NCT00993564|Newborn|newborn
507218|NCT00993551|cleft palate|cleft palate
507223|NCT00993551|velopharyngeal|velopharyngeal
507224|NCT00993538|Leukaemia|leukaemia
507225|NCT00993538|Blood and marrow cells culture|blood and marrow cells culture
507226|NCT00993538|Cell growth|cell growth
507227|NCT00993538|Cell differentiation|cell differentiation
507228|NCT00993525|diabetic retinopathy|diabetic retinopathy
507229|NCT00993525|ranibizumab|ranibizumab
507230|NCT00993525|new vessels|new vessels
507231|NCT00993525|intravitreal injection|intravitreal injection
507232|NCT00993525|Persistent retina new vessels|persistent retina new vessels
507233|NCT00993512|photochemical internalisation|photochemical internalisation
507234|NCT00993512|photosensitiser|photosensitiser
507235|NCT00993512|cutaneous tumour|cutaneous tumour
507236|NCT00993512|sub-cutaneous tumour|sub-cutaneous tumour
507237|NCT00993512|dose escalation|dose escalation
507238|NCT00993486|Haploidentical stem cell transplantation|haploidentical stem cell transplantation
507239|NCT00993486|Graft-versus-host disease|graft-versus-host disease
507240|NCT00993486|Immune reconstitution|immune reconstitution
507241|NCT00993486|Alloreactive T-cells|alloreactive t-cells
507242|NCT00993486|Photodepletion|photodepletion
507243|NCT00993486|TH9402|th9402
507244|NCT00993486|Transplant related mortality|transplant related mortality
507245|NCT00993486|Hematologic malignancy|hematologic malignancy
507246|NCT00993460|Obesity|obesity
507247|NCT00993460|Insulin sensitivity|insulin sensitivity
507248|NCT00993460|Inflammation|inflammation
507249|NCT00993447|Dengue|dengue
507250|NCT00993447|Dengue hemorrhagic fever|dengue hemorrhagic fever
507251|NCT00993447|Dengue virus|dengue virus
507252|NCT00993447|Dengue fever|dengue fever
507253|NCT00993447|Sanofi pasteur's CYD Dengue vaccine|sanofi pasteur's cyd dengue vaccine
507254|NCT00993434|Child|child
507255|NCT00993395|addiction|addiction
507256|NCT00993395|peer mentor|peer mentor
507257|NCT00993395|adherence|adherence
507258|NCT00993369|Prediction of neuro developmental delay|prediction of neuro developmental delay
507259|NCT00993356|Acromegaly|acromegaly
507260|NCT00993356|Macroadenomas|macroadenomas
507261|NCT00993356|Lanreotide|lanreotide
507262|NCT00993356|Transsphenoidal neurosurgery|transsphenoidal neurosurgery
507263|NCT00993356|Preoperative|preoperative
507264|NCT00993343|GVHD|gvhd
507265|NCT00993343|tacrolimus|tacrolimus
507266|NCT00993343|sirolimus|sirolimus
507267|NCT00993343|cyclosporine|cyclosporine
507268|NCT00993343|allogeneic|allogeneic
507269|NCT00993343|stem cell transplantation|stem cell transplantation
507270|NCT00993343|Relapse-free survival|relapse-free survival
507271|NCT00993330|macular pigment|macular pigment
507272|NCT00993330|to measure macular pigment in the retina|to measure macular pigment in the retina
507273|NCT00993317|CDP870|cdp870
507274|NCT00993317|Korea|korea
507275|NCT00993317|CIMZIA|cimzia
507276|NCT00993291|Parkinson's Disease|parkinson's disease
507277|NCT00993291|DBS|dbs
507278|NCT00993291|Frequency|frequency
507279|NCT00993291|Deep brain stimulation|deep brain stimulation
507280|NCT00993265|Trichotillomania|trichotillomania
507281|NCT00993265|Hair pulling|hair pulling
507282|NCT00993265|glutamate|glutamate
507283|NCT00993265|N-Acetylcysteine|n-acetylcysteine
507284|NCT00993265|Children|children
507285|NCT00993252|head injury|head injury
507286|NCT00993252|radiography|radiography
507287|NCT00993252|clinical impact|clinical impact
507288|NCT00993252|dissemination|dissemination
507289|NCT00993226|Postoperative pain|postoperative pain
507290|NCT00993226|Local anaesthesia|local anaesthesia
507291|NCT00993226|Postoperative pain after open abdominal hysterectomy surgery|postoperative pain after open abdominal hysterectomy surgery
507292|NCT00993213|fat mass|fat mass
507293|NCT00993213|body composition|body composition
507294|NCT00993200|Warfarin|warfarin
507295|NCT00993200|Pharmacogenetic|pharmacogenetic
507296|NCT00993161|Neuromuscular disorders|neuromuscular disorders
507297|NCT00993161|Evaluation|evaluation
507298|NCT00993161|Strength|strength
507299|NCT00993161|Upper limb|upper limb
507300|NCT00993148|Treatment naive|treatment naive
507301|NCT00993135|renal toxicity|renal toxicity
507302|NCT00993135|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
507303|NCT00993135|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
507304|NCT00993122|pre treatment|pre treatment
507305|NCT00993122|therapy compliance|therapy compliance
507307|NCT00993122|sustained virological response|sustained virological response
507308|NCT00993122|TH1 TH2 ratio|th1 th2 ratio
507309|NCT00993109|Nifedipine GITS/OROS (Adalat®)|nifedipine gits/oros (adalat®)
507310|NCT00993109|Valsartan (Diovan®)|valsartan (diovan®)
507311|NCT00993109|Hypertension|hypertension
507312|NCT00993083|Influenza|influenza
507313|NCT00993083|Vaccine|vaccine
507314|NCT00993070|capsaicin|capsaicin
507315|NCT00993070|placebo|placebo
507316|NCT00993070|trial|trial
507317|NCT00993070|diabetic polyneuropathy|diabetic polyneuropathy
507318|NCT00993070|neuropathic pain|neuropathic pain
507319|NCT00993057|Euglycemia|euglycemia
507320|NCT00993057|craniotomy|craniotomy
507321|NCT00993057|neurosurgery|neurosurgery
507322|NCT00993057|hypoglycemia|hypoglycemia
507323|NCT00993057|insulin|insulin
507325|NCT00993031|Placental Malaria|placental malaria
507326|NCT00993031|Pregnancy|pregnancy
507327|NCT00993031|Uganda|uganda
507328|NCT00993031|Protease inhibitors|protease inhibitors
507329|NCT00993031|Trimethoprim-sulfamethoxazole|trimethoprim-sulfamethoxazole
507330|NCT00993031|Treatment experienced|treatment experienced
507331|NCT00993018|Diabetic Neuropathy|diabetic neuropathy
507332|NCT00993018|Diabetic painful neuropathy|diabetic painful neuropathy
507333|NCT00993018|JNJ-42160443|jnj-42160443
507334|NCT00993018|Neuropathic pain|neuropathic pain
507335|NCT00993018|Pain|pain
507336|NCT00993018|Pharmacokinetics|pharmacokinetics
507337|NCT00993005|Hypertrophic scars|hypertrophic scars
507338|NCT00993005|Keloids|keloids
507339|NCT00993005|Asian Gotu Kola|asian gotu kola
507340|NCT00993005|Asian Pennywort|asian pennywort
507341|NCT00992992|Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP)|cyclophosphamide, doxorubicin, vincristine, and prednisone (chop)
507342|NCT00992992|Tositumomab|tositumomab
507343|NCT00992992|Tositumomab and Iodine I-131 tostumomab|tositumomab and iodine i-131 tostumomab
507344|NCT00992992|Bexxar|bexxar
507345|NCT00992992|Iodine-131 Anti-B1 Antibody|iodine-131 anti-b1 antibody
507346|NCT00992992|Mantle Cell|mantle cell
507347|NCT00992992|radioimmunotherapy|radioimmunotherapy
507348|NCT00992979|Addiction|addiction
507349|NCT00992979|Anxiety|anxiety
507350|NCT00992979|Withdrawal|withdrawal
507351|NCT00992979|Psychoactive Drugs|psychoactive drugs
507352|NCT00992979|Therapeutic Massage|therapeutic massage
507353|NCT00992966|to acquire database of pneumonia cases in children|to acquire database of pneumonia cases in children
507354|NCT00992953|Virtual Reality|virtual reality
507355|NCT00992953|Post Traumatic Stress Disorder|post traumatic stress disorder
507356|NCT00992953|Combat|combat
507357|NCT00992953|Military|military
507358|NCT00992953|Major Depressive Disorder|major depressive disorder
507359|NCT00992953|Anxiety|anxiety
507360|NCT00992953|Virtual Reality Exposure with Stimulus Control|virtual reality exposure with stimulus control
507361|NCT00992953|Treatment as Usual|treatment as usual
507362|NCT00992940|awake craniotomy|awake craniotomy
507363|NCT00992940|patient-controlled sedation analgesia|patient-controlled sedation analgesia
507364|NCT00992940|anesthetist-controlled sedation analgesia|anesthetist-controlled sedation analgesia
507365|NCT00992940|remifentanil-propofol|remifentanil-propofol
507366|NCT00992940|tumour surgery|tumour surgery
507367|NCT00992927|Injections, Intra-Articular|injections, intra-articular
507368|NCT00992927|Range of Motion, Articular|range of motion, articular
507369|NCT00992927|Pain|pain
507370|NCT00992914|Hot flushes (vasomotor symptoms)|hot flushes (vasomotor symptoms)
507371|NCT00992901|gastric bypass surgery|gastric bypass surgery
507372|NCT00992901|glucose tolerance|glucose tolerance
507373|NCT00992901|Insulin response to meal ingestion|insulin response to meal ingestion
507374|NCT00992901|Gut hormone and neural response to meal ingestion|gut hormone and neural response to meal ingestion
507375|NCT00992888|Alcoholic Hepatitis|alcoholic hepatitis
507376|NCT00992888|Alcohol|alcohol
507377|NCT00992888|Endotoxin|endotoxin
507378|NCT00992888|LPS|lps
507379|NCT00992888|Liver dialysis|liver dialysis
507380|NCT00992888|Innate immunity|innate immunity
507381|NCT00992888|Toll Like receptors|toll like receptors
507382|NCT00992875|Healthy but stressed individuals|healthy but stressed individuals
507383|NCT00992849|Corneal neovascularization|corneal neovascularization
507384|NCT00992849|bevacizumab|bevacizumab
507385|NCT00992836|Influenza A Virus, H1N1 Subtype|influenza a virus, h1n1 subtype
507386|NCT00992836|Vaccine|vaccine
507387|NCT00992836|Children|children
507388|NCT00992836|Adolescents|adolescents
507389|NCT00992836|HIV-Infected|hiv-infected
507390|NCT00992836|Perinatal HIV Infection|perinatal hiv infection
507391|NCT00992836|Treatment experienced|treatment experienced
507392|NCT00992823|Iron|iron
507393|NCT00992823|anemia|anemia
507394|NCT00992823|supplementation|supplementation
507395|NCT00992823|preschoolers|preschoolers
507396|NCT00992823|prevalence|prevalence
507397|NCT00992823|preschoolers children from public day care centers|preschoolers children from public day care centers
507398|NCT00992810|upper limb|upper limb
507399|NCT00992810|hand|hand
507400|NCT00992810|arm|arm
507401|NCT00992810|surgery|surgery
507402|NCT00992810|supraclavicular nerve block|supraclavicular nerve block
507403|NCT00992810|brachial plexus nerve block|brachial plexus nerve block
507404|NCT00992810|ultrasound-guided regional anesthesia|ultrasound-guided regional anesthesia
507405|NCT00992797|Insulin resistance|insulin resistance
507406|NCT00992797|Insulin secretory dysfunction|insulin secretory dysfunction
507407|NCT00992797|Inflammation|inflammation
507408|NCT00992797|Vascular stiffness|vascular stiffness
507409|NCT00992784|Influenza Vaccines|influenza vaccines
507410|NCT00992784|GSK Bio's influenza vaccine GSK2186877A|gsk bio's influenza vaccine gsk2186877a
507411|NCT00992784|influenza infection|influenza infection
507412|NCT00992758|bone marrow|bone marrow
507413|NCT00992758|Radioimmunotherapy|radioimmunotherapy
507414|NCT00992758|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
507415|NCT00992758|Bexxar|bexxar
507416|NCT00992758|anti-B1 antibody|anti-b1 antibody
507417|NCT00992758|tositumomab and iodine I-131 tositumomab|tositumomab and iodine i-131 tositumomab
507418|NCT00992758|NHL|nhl
507420|NCT00992745|prostate cancer|prostate cancer
507421|NCT00992745|imaging|imaging
507422|NCT00992745|metastases|metastases
507423|NCT00992745|PSMA|psma
507424|NCT00992745|ProstaScint®|prostascint®
507425|NCT00992719|H1N1, influenza A viruses, vaccine, pregnant women|h1n1, influenza a viruses, vaccine, pregnant women
507426|NCT00992706|palmar-plantar erythrodysesthesia|palmar-plantar erythrodysesthesia
507427|NCT00992706|stage IV breast cancer|stage iv breast cancer
507428|NCT00992706|male breast cancer|male breast cancer
507429|NCT00992693|Crimean-Congo Hemorrhagic Fever|crimean-congo hemorrhagic fever
507430|NCT00992693|Lassa Fever|lassa fever
507431|NCT00992693|CCHF|cchf
507432|NCT00992693|LF|lf
507433|NCT00992693|Viral Hemorrhagic Fever|viral hemorrhagic fever
507434|NCT00992693|VHF|vhf
507435|NCT00992693|Ribavirin|ribavirin
507436|NCT00992680|Lung Disease|lung disease
507437|NCT00992680|Chronic Airflow Obstruction|chronic airflow obstruction
507438|NCT00992680|Chronic Bronchitis|chronic bronchitis
507439|NCT00992680|Pulmonary Emphysema|pulmonary emphysema
507440|NCT00992680|Walk|walk
507441|NCT00992667|apocynin|apocynin
507442|NCT00992667|asthma|asthma
507443|NCT00992654|Open Label Access Program|open label access program
507444|NCT00992654|Treatment experienced|treatment experienced
507445|NCT00992641|Systems biology|systems biology
507446|NCT00992641|Nutrition|nutrition
507447|NCT00992641|Nordic diet|nordic diet
507448|NCT00992641|Dietary recommendations|dietary recommendations
507449|NCT00992641|Metabolic syndrome|metabolic syndrome
507450|NCT00992641|Features of metabolic syndrome|features of metabolic syndrome
507451|NCT00992628|GlideScope Video Laryngoscope|glidescope video laryngoscope
507452|NCT00992628|Macintosh Direct Laryngoscope|macintosh direct laryngoscope
507453|NCT00992628|Intubation|intubation
507454|NCT00992628|Applied Forces|applied forces
507455|NCT00992628|Elective surgery where endotracheal intubation required|elective surgery where endotracheal intubation required
507456|NCT00992589|Gastroesophageal Reflux|gastroesophageal reflux
507457|NCT00992589|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
507458|NCT00992589|GERD|gerd
507459|NCT00992589|Proton Pump Inhibitor|proton pump inhibitor
507460|NCT00992589|PPI|ppi
507461|NCT00992589|Regurgitation|regurgitation
507462|NCT00992589|Infants|infants
507463|NCT00992589|AcipHex, PARIET|aciphex, pariet
507464|NCT00992589|ALFENCE|alfence
507465|NCT00992576|Confirmatory|confirmatory
507466|NCT00992576|Constipation|constipation
507467|NCT00992576|Pain|pain
507468|NCT00992576|Hydromorphone|hydromorphone
507469|NCT00992576|Naloxone|naloxone
507470|NCT00992563|wet age-related macular degeneration, exudative|wet age-related macular degeneration, exudative
507471|NCT00992550|hookah|hookah
507472|NCT00992550|cigarette|cigarette
507473|NCT00992550|smoking|smoking
507474|NCT00992524|Misoprostol|misoprostol
507475|NCT00992524|Labor, Obstetric|labor, obstetric
507476|NCT00992524|Labor, Induced|labor, induced
507477|NCT00992511|influenza infection|influenza infection
507478|NCT00992511|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
507479|NCT00992498|COPD (Chronic Obstructive Pulmonary Disease)|copd (chronic obstructive pulmonary disease)
507480|NCT00992498|outpatients|outpatients
507481|NCT00992498|rehabilitation|rehabilitation
507482|NCT00992498|comorbidities|comorbidities
507483|NCT00992498|patient-centered outcome|patient-centered outcome
507484|NCT00992459|Urea Cycle Disorder (UCD)|urea cycle disorder (ucd)
507485|NCT00992459|UCD|ucd
507486|NCT00992459|hyperammonemia|hyperammonemia
507487|NCT00992459|Buphenyl (NaPBA)|buphenyl (napba)
507488|NCT00992459|glycerol phenylbutyrate (GPB)|glycerol phenylbutyrate (gpb)
507489|NCT00992459|Sodium Phenylbutyrate (NaPBA)|sodium phenylbutyrate (napba)
507490|NCT00992446|Autologous stem cell transplant|autologous stem cell transplant
507491|NCT00992446|NHL|nhl
507492|NCT00992446|maintenance therapy|maintenance therapy
507493|NCT00992433|influenza, H1N1, vaccine, human immunodeficiency virus|influenza, h1n1, vaccine, human immunodeficiency virus
507494|NCT00992420|thienopyridine|thienopyridine
507495|NCT00992420|platelets|platelets
507496|NCT00992420|CYP2C19|cyp2c19
507497|NCT00992420|clopidogrel|clopidogrel
507498|NCT00992420|platelet function tests|platelet function tests
507499|NCT00992420|platelet|platelet
507500|NCT00992420|genes|genes
507501|NCT00992420|cytochrome P450|cytochrome p450
507502|NCT00992420|single nucleotide polymorphisms|single nucleotide polymorphisms
507503|NCT00992420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
507504|NCT00992407|Schizophrenia|schizophrenia
507505|NCT00992407|Risperidone|risperidone
507506|NCT00992407|Risperdal|risperdal
507507|NCT00992394|Plaque psoriasis - etanercept - response maintenance|plaque psoriasis - etanercept - response maintenance
507508|NCT00992381|GI Pain|gi pain
507509|NCT00992381|healthy participants|healthy participants
507510|NCT00992381|Safety|safety
507511|NCT00992381|bioavailability|bioavailability
507512|NCT00992368|Quality-Adjusted Life Years:A measurement index|quality-adjusted life years:a measurement index
507513|NCT00992368|Cost-Benefit Analysis:A method of comparing costs|cost-benefit analysis:a method of comparing costs
507514|NCT00992368|Mammaplasty|mammaplasty
507515|NCT00992368|QALY|qaly
507516|NCT00992368|Health-related quality of life|health-related quality of life
507517|NCT00992368|Cost-effectiveness|cost-effectiveness
507518|NCT00992368|Breast|breast
507519|NCT00992355|Cataract|cataract
507520|NCT00992355|Phacoemulsification|phacoemulsification
507521|NCT00992355|Treatment duration|treatment duration
507522|NCT00992329|ciprofloxacin|ciprofloxacin
507523|NCT00992329|pharmacokinetics|pharmacokinetics
507524|NCT00992329|formulation|formulation
507525|NCT00992316|Inflammatory pain|inflammatory pain
507526|NCT00992303|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
507527|NCT00992290|cirrhosis|cirrhosis
507528|NCT00992290|hepatic encephalopathy|hepatic encephalopathy
507529|NCT00992290|complications|complications
507530|NCT00992290|probiotic|probiotic
507531|NCT00992290|lactobacillus GG|lactobacillus gg
507532|NCT00992264|Cigarette Smoking|cigarette smoking
507533|NCT00992264|Health Behavior|health behavior
507534|NCT00992264|Intervention Studies|intervention studies
507535|NCT00992264|Personal Communication|personal communication
507536|NCT00992251|prostate cancer|prostate cancer
507537|NCT00992225|Metastatic|metastatic
507538|NCT00992212|Pandemic influenza|pandemic influenza
507539|NCT00992212|vaccine|vaccine
507540|NCT00992199|intraperitoneal chemotherapy|intraperitoneal chemotherapy
507541|NCT00992199|cisplatin|cisplatin
507542|NCT00992199|fluorouracil|fluorouracil
507543|NCT00992199|advanced gastric cancer|advanced gastric cancer
507544|NCT00992186|Prostate cancer|prostate cancer
507545|NCT00992186|Infusion|infusion
507546|NCT00992186|Carlumab|carlumab
507547|NCT00992186|CNTO 888|cnto 888
507548|NCT00992173|Neuroblastoma|neuroblastoma
507549|NCT00992173|MIBG|mibg
507550|NCT00992173|Iobenguane|iobenguane
507551|NCT00992160|Polysomnography (PSG)|polysomnography (psg)
507552|NCT00992160|Adults|adults
507553|NCT00992160|Primary Insomnia|primary insomnia
507554|NCT00992134|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
507555|NCT00992134|Bendamustine|bendamustine
507556|NCT00992134|Cytarabine|cytarabine
507557|NCT00992134|Rituximab|rituximab
507558|NCT00992134|Treatment|treatment
507559|NCT00992134|Combination chemotherapy|combination chemotherapy
507560|NCT00992121|pazopanib|pazopanib
507561|NCT00992121|Renal Cell Carcinoma|renal cell carcinoma
507562|NCT00992121|Kidney|kidney
507563|NCT00992121|cancer|cancer
507564|NCT00992121|bevacizumab|bevacizumab
507565|NCT00992108|Bruxism|bruxism
507566|NCT00992108|Myofascial pain|myofascial pain
507567|NCT00992108|EMG|emg
507568|NCT00992108|Ultrasound|ultrasound
507569|NCT00992108|Masticatory myofascial face pain from bruxism and clenching|masticatory myofascial face pain from bruxism and clenching
507570|NCT00992082|Postoperative pain|postoperative pain
507571|NCT00992082|Local Infiltration Analgesia|local infiltration analgesia
507572|NCT00992082|Knee arthroplasty|knee arthroplasty
507573|NCT00992069|ARV|arv
507574|NCT00992069|Pharmacokinetics|pharmacokinetics
507575|NCT00992069|TMC207|tmc207
507576|NCT00992069|Efavirenz|efavirenz
507577|NCT00992043|creatine supplementation|creatine supplementation
507578|NCT00992043|exercise training|exercise training
507579|NCT00992017|Vaccine|vaccine
507580|NCT00992017|Pregnant|pregnant
507581|NCT00992017|Perinatal|perinatal
507582|NCT00992004|Osteoarthritis, Knee|osteoarthritis, knee
507583|NCT00992004|Osteoarthritis|osteoarthritis
507584|NCT00992004|Joint Diseases|joint diseases
507585|NCT00992004|Arthritis|arthritis
507586|NCT00992004|Rheumatic Diseases|rheumatic diseases
507587|NCT00991991|stage I melanoma|stage i melanoma
507588|NCT00991991|stage II melanoma|stage ii melanoma
507589|NCT00991991|stage III melanoma|stage iii melanoma
507590|NCT00991978|breast cancer|breast cancer
507591|NCT00991978|VEGF|vegf
507592|NCT00991978|Screening|screening
507593|NCT00991965|Alveolar Ridge Augmentation|alveolar ridge augmentation
507594|NCT00991965|Dental Implantation, Endosseous|dental implantation, endosseous
507595|NCT00991965|Osseointegration|osseointegration
507596|NCT00991965|Bone Morphogenetic Proteins|bone morphogenetic proteins
507597|NCT00991939|Immune thrombocytopenic purpura|immune thrombocytopenic purpura
507598|NCT00991939|ITP|itp
507599|NCT00991939|Dexamethasone|dexamethasone
507600|NCT00991939|Prednisone|prednisone
507601|NCT00991926|obesity|obesity
507602|NCT00991926|GH/IGF-1 axis|gh/igf-1 axis
507603|NCT00991926|postprandial NEFA|postprandial nefa
507604|NCT00991913|Delirium|delirium
507605|NCT00991913|Postoperative|postoperative
507606|NCT00991913|Non-cardiovascular surgery|non-cardiovascular surgery
507607|NCT00991913|Post-anaesthesia care unit|post-anaesthesia care unit
507608|NCT00991887|Heterotopic Ossification|heterotopic ossification
507609|NCT00991887|Distal humerus Fracture-dislocations of the elbow|distal humerus fracture-dislocations of the elbow
507610|NCT00991887|Radiation Therapy|radiation therapy
507611|NCT00991874|Nitric oxide|nitric oxide
507612|NCT00991874|Asthma|asthma
507613|NCT00991874|Longitudinal studies|longitudinal studies
507614|NCT00991874|Child|child
507615|NCT00991861|Actinic Keratosis|actinic keratosis
507616|NCT00991861|AK|ak
507617|NCT00991861|NMSC|nmsc
507618|NCT00991848|Lidocaine;|lidocaine;
507619|NCT00991848|Fibromyalgia|fibromyalgia
507620|NCT00991848|signs|signs
507621|NCT00991848|symptoms|symptoms
507622|NCT00991822|open angle glaucoma|open angle glaucoma
507623|NCT00991822|timolol|timolol
507624|NCT00991822|dorzolamide|dorzolamide
507625|NCT00991809|opioid induced hyperalgesia|opioid induced hyperalgesia
507626|NCT00991783|Fimasartan|fimasartan
507627|NCT00991783|Drug interaction|drug interaction
507628|NCT00991770|Discomfort|discomfort
507629|NCT00991770|Port-a-Catheters|port-a-catheters
507630|NCT00991770|Complementary and Alternative Medicine|complementary and alternative medicine
507631|NCT00991770|Massage|massage
507632|NCT00991757|RWJ-333369|rwj-333369
507633|NCT00991757|Anticonvulsants|anticonvulsants
507634|NCT00991757|Antiepileptic drugs|antiepileptic drugs
507635|NCT00991757|Epilepsy, Focal|epilepsy, focal
507636|NCT00991757|Seizure Disorder|seizure disorder
507637|NCT00991744|Leukemia|leukemia
507638|NCT00991744|Central nervous system|central nervous system
507639|NCT00991744|Neurotoxicity|neurotoxicity
507640|NCT00991744|Liposomal cytarabine|liposomal cytarabine
507641|NCT00991744|Children|children
507642|NCT00991744|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
507643|NCT00991744|Childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
507644|NCT00991744|Intrathecal|intrathecal
507645|NCT00991744|Efficacy|efficacy
507646|NCT00991744|Safety|safety
507647|NCT00991731|Physical Activity|physical activity
507648|NCT00991731|Faith based|faith based
507649|NCT00991731|Non faith based|non faith based
507650|NCT00991731|African American|african american
507651|NCT00991731|Female|female
507652|NCT00991731|Pedometers|pedometers
507653|NCT00991718|GDC0449|gdc0449
507654|NCT00991705|Fimasartan, Atorvastatin|fimasartan, atorvastatin
507655|NCT00991692|Pediatric CI Therapy|pediatric ci therapy
507656|NCT00991692|ACQUIREc Therapy|acquirec therapy
507657|NCT00991692|Dosage|dosage
507658|NCT00991692|Occupational Therapy|occupational therapy
507659|NCT00991692|Physical Therapy|physical therapy
507660|NCT00991692|Cerebral Palsy|cerebral palsy
507661|NCT00991692|Hemiparesis|hemiparesis
507662|NCT00991679|Dry eye syndrome|dry eye syndrome
507663|NCT00991679|CXCL9 chemokine|cxcl9 chemokine
507664|NCT00991679|CXCL10 chemokine|cxcl10 chemokine
507665|NCT00991679|CXCL11 chemokine|cxcl11 chemokine
507666|NCT00991679|CXCR3 receptor|cxcr3 receptor
507667|NCT00991666|AMD|amd
507668|NCT00991666|rigidity|rigidity
507669|NCT00991666|pulsatile ocular blood flow|pulsatile ocular blood flow
507670|NCT00991666|Physiology of the eye|physiology of the eye
507671|NCT00991653|Weight|weight
507672|NCT00991653|Breast|breast
507673|NCT00991653|Cancer|cancer
507674|NCT00991627|Ephedrine|ephedrine
507675|NCT00991627|Adrenergic Agents|adrenergic agents
507676|NCT00991627|Central Nervous System Stimulants|central nervous system stimulants
507677|NCT00991627|Sympathomimetics|sympathomimetics
507678|NCT00991627|Vasoconstrictor Agents|vasoconstrictor agents
507679|NCT00991627|Bupivacaine|bupivacaine
507680|NCT00991627|Anesthetics, Local|anesthetics, local
507681|NCT00991627|Atropine|atropine
507682|NCT00991627|Adjuvants, Anesthesia|adjuvants, anesthesia
507683|NCT00991627|Anti-Arrhythmia Agents|anti-arrhythmia agents
507684|NCT00991627|Bronchodilator Agents|bronchodilator agents
507685|NCT00991627|Muscarinic Antagonists|muscarinic antagonists
507686|NCT00991627|Mydriatics|mydriatics
507687|NCT00991627|Parasympatholytics|parasympatholytics
507688|NCT00991627|Morphine|morphine
507689|NCT00991627|Analgesics, Opioid|analgesics, opioid
507690|NCT00991627|Narcotics|narcotics
507691|NCT00991627|Ringer's Lactate|ringer's lactate
507692|NCT00991627|Isotonic Solutions|isotonic solutions
507693|NCT00991627|Hypotension|hypotension
507694|NCT00991627|Blood pressure|blood pressure
507695|NCT00991627|Signs and Symptoms|signs and symptoms
507696|NCT00991627|Pregnancy|pregnancy
507697|NCT00991627|Anesthesia, Obstetrical|anesthesia, obstetrical
507698|NCT00991627|Inferior Vena Cava|inferior vena cava
507699|NCT00991601|liver|liver
507700|NCT00991601|pancreas|pancreas
507701|NCT00991601|cancer|cancer
507702|NCT00991601|tumor|tumor
507703|NCT00991601|FNAC|fnac
507704|NCT00991588|PCL|pcl
507705|NCT00991588|Posterolateral|posterolateral
507706|NCT00991575|Diabetes mellitus, type1|diabetes mellitus, type1
507707|NCT00991575|cardiovascular disease|cardiovascular disease
507708|NCT00991575|diabetes complications|diabetes complications
507709|NCT00991575|Glycation end products, advanced|glycation end products, advanced
507710|NCT00991562|relapsed or relapsed/refractory multiple myeloma|relapsed or relapsed/refractory multiple myeloma
507711|NCT00991549|overweight|overweight
507712|NCT00991549|obesity|obesity
507713|NCT00991549|glucose intolerance|glucose intolerance
507714|NCT00991549|pre-diabetes|pre-diabetes
507715|NCT00991523|resistance|resistance
507716|NCT00991523|exercise|exercise
507717|NCT00991523|protein|protein
507718|NCT00991523|recovery|recovery
507719|NCT00991510|renal transplantation|renal transplantation
507720|NCT00991510|mycophenolate mofetil|mycophenolate mofetil
507721|NCT00991510|pharmacokinetics|pharmacokinetics
507722|NCT00991510|immunosuppression|immunosuppression
507723|NCT00991497|varicose veins|varicose veins
507724|NCT00991497|foam sclerotherapy|foam sclerotherapy
507725|NCT00991497|compression bandaging|compression bandaging
507726|NCT00991497|duration|duration
507727|NCT00991484|ventral|ventral
507728|NCT00991484|inguinal|inguinal
507729|NCT00991484|hernia|hernia
507730|NCT00991484|inheritance|inheritance
507731|NCT00991484|genetics|genetics
507732|NCT00991471|Emergency Department Wait Times|emergency department wait times
507733|NCT00991471|Physician Nurse at Triage|physician nurse at triage
507734|NCT00991471|Overcrowding|overcrowding
507735|NCT00991471|CostEffectiveness|costeffectiveness
507736|NCT00991445|Unicompartmental knee arthroplasty|unicompartmental knee arthroplasty
507737|NCT00991445|Surgical exposure|surgical exposure
507738|NCT00991445|Minimal invasive surgery|minimal invasive surgery
507739|NCT00991445|Local Infiltration Analgesia|local infiltration analgesia
507740|NCT00991445|Knee Arthroplasty|knee arthroplasty
507741|NCT00991432|Alveolar Ridge Augmentation|alveolar ridge augmentation
507742|NCT00991432|Dental Implantation, Endosseous|dental implantation, endosseous
507743|NCT00991432|Osseointegration|osseointegration
507744|NCT00991432|Space Maintenance|space maintenance
507745|NCT00991432|Bone Morphogenetic Proteins|bone morphogenetic proteins
507746|NCT00991419|PET|pet
507747|NCT00991419|Alzheimer's disease|alzheimer's disease
507748|NCT00991419|diagnostic|diagnostic
507749|NCT00991406|Electric Stimulation|electric stimulation
507750|NCT00991406|Hemiplegia|hemiplegia
507751|NCT00991406|walking|walking
507752|NCT00991393|Maxillary Sinus Augmentation|maxillary sinus augmentation
507753|NCT00991393|Dental Implantation|dental implantation
507754|NCT00991393|Osseointegration|osseointegration
507755|NCT00991393|Bone Morphogenetic Proteins|bone morphogenetic proteins
507756|NCT00991367|Post-surgical scars|post-surgical scars
507757|NCT00991367|Asian Gotu Kola|asian gotu kola
507758|NCT00991367|Asian Pennywort|asian pennywort
507759|NCT00991354|HIV Seronegativity|hiv seronegativity
507760|NCT00991354|HIV Preventive Vaccine|hiv preventive vaccine
507761|NCT00991341|Cardiac surgery|cardiac surgery
507762|NCT00991341|Red blood cell|red blood cell
507763|NCT00991341|Transfusion|transfusion
507764|NCT00991328|PD|pd
507765|NCT00991328|POCD|pocd
507766|NCT00991328|Post-op Delirium (PD)|post-op delirium (pd)
507767|NCT00991328|Post-op Cognitive Dysfunction (POCD)|post-op cognitive dysfunction (pocd)
507768|NCT00991315|prostate cancer|prostate cancer
507769|NCT00991302|Adherence|adherence
507770|NCT00991302|Behavioral Intervention|behavioral intervention
507771|NCT00991302|Antiretroviral Therapy|antiretroviral therapy
507772|NCT00991302|ART|art
507773|NCT00991302|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
507774|NCT00991302|HAART|haart
507775|NCT00991302|Treatment experienced|treatment experienced
507776|NCT00991289|Hepatitis C genotype 1|hepatitis c genotype 1
507777|NCT00991289|HCV treatment naive|hcv treatment naive
507778|NCT00991289|HCV/HIV coinfection|hcv/hiv coinfection
507779|NCT00991289|Antiretroviral|antiretroviral
507780|NCT00991289|Ribavirin|ribavirin
507781|NCT00991289|Pegylated Interferon alfa|pegylated interferon alfa
507782|NCT00991289|Nitazoxanide|nitazoxanide
507783|NCT00991276|restless legs syndrome RLS polysomnography PSG sleep disturbance patient reported outcome|restless legs syndrome rls polysomnography psg sleep disturbance patient reported outcome
507784|NCT00991263|stage II breast cancer|stage ii breast cancer
507785|NCT00991263|stage IIIA breast cancer|stage iiia breast cancer
507786|NCT00991250|Malignant melanoma|malignant melanoma
507787|NCT00991237|NRS|nrs
507788|NCT00991237|GPE|gpe
507789|NCT00991237|pain reduction|pain reduction
507790|NCT00991237|quality of life|quality of life
507791|NCT00991224|HIV|hiv
507792|NCT00991224|HIV therapeutic vaccine|hiv therapeutic vaccine
507793|NCT00991211|Comparison|comparison
507794|NCT00991211|Bendamustine + Rituximab|bendamustine + rituximab
507795|NCT00991211|CHOP + Rituximab|chop + rituximab
507796|NCT00991211|Progression free survival|progression free survival
507797|NCT00991211|Overall survival|overall survival
507798|NCT00991211|Toxicity|toxicity
507799|NCT00991211|Safety|safety
507800|NCT00991198|Topically dissolved oxygen|topically dissolved oxygen
507801|NCT00991198|inflammatory cutaneous disease|inflammatory cutaneous disease
507802|NCT00991198|rosacea|rosacea
507803|NCT00991198|acne vulgaris|acne vulgaris
507804|NCT00991198|atopic dermatitis|atopic dermatitis
507805|NCT00991198|seborrheic dermatitis|seborrheic dermatitis
507806|NCT00991198|photodamage|photodamage
507807|NCT00991185|Infections in Children|infections in children
507808|NCT00991172|sciatica|sciatica
507809|NCT00991172|sciatic pain|sciatic pain
507810|NCT00991172|pain|pain
507811|NCT00991172|back pain|back pain
507812|NCT00991159|Endocrinology; Hypercholesterolemia; Hyperlipidemia; Lipid Metabolism Disorders RN316 PF-04950615|endocrinology; hypercholesterolemia; hyperlipidemia; lipid metabolism disorders rn316 pf-04950615
507813|NCT00991146|CAPS|caps
507814|NCT00991146|FCAS|fcas
507815|NCT00991146|MWS|mws
507816|NCT00991146|NOMID|nomid
507817|NCT00991146|cryopyrin-associated periodic syndromes|cryopyrin-associated periodic syndromes
507818|NCT00991146|Familial Cold Autoinflammatory Syndrome|familial cold autoinflammatory syndrome
507819|NCT00991146|Muckle-Wells Syndrome|muckle-wells syndrome
507820|NCT00991146|Neonatal Onset Multisystem Inflammatory Disease|neonatal onset multisystem inflammatory disease
507821|NCT00991146|canakinumab|canakinumab
507822|NCT00991146|ACZ885|acz885
507823|NCT00991146|children|children
507824|NCT00991146|systemic autoinflammatory disease|systemic autoinflammatory disease
507825|NCT00991146|NALP-3|nalp-3
507826|NCT00991146|human monoclonal anti-human interleukin-1beta (IL-1beta)antibody|human monoclonal anti-human interleukin-1beta (il-1beta)antibody
507827|NCT00991146|autosomal dominant|autosomal dominant
507828|NCT00991146|familial autoinflammatory syndrome|familial autoinflammatory syndrome
507829|NCT00991107|phase I|phase i
507830|NCT00991107|safety|safety
507831|NCT00991107|tolerance|tolerance
507832|NCT00991107|insulin resistance|insulin resistance
507833|NCT00991107|obese|obese
507834|NCT00991094|Proton Therapy|proton therapy
507835|NCT00991094|Proton Therapy Treatment Plan|proton therapy treatment plan
507836|NCT00991094|Proton Dose Distributions|proton dose distributions
507837|NCT00991094|Side Effects|side effects
507838|NCT00991094|Symptoms|symptoms
507839|NCT00991094|Normal Tissue Toxicity|normal tissue toxicity
507840|NCT00991094|Dose Response Relationship|dose response relationship
507841|NCT00991081|pharmacogenetics|pharmacogenetics
507842|NCT00991081|genetic counseling|genetic counseling
507843|NCT00991081|genetic feedback|genetic feedback
507844|NCT00991081|nicotine replacement|nicotine replacement
507845|NCT00991081|bupropion|bupropion
507846|NCT00991081|smoking cessation|smoking cessation
507847|NCT00991081|primary care|primary care
507848|NCT00991081|telehealth|telehealth
507849|NCT00991081|motivational interviewing|motivational interviewing
507850|NCT00991068|Pain|pain
507851|NCT00991068|Mild to moderate Carpal Tunnel Syndrome|mild to moderate carpal tunnel syndrome
507852|NCT00991042|Cytokines|cytokines
507853|NCT00991042|Low back pain|low back pain
507854|NCT00991042|Intervertebral disk displacement|intervertebral disk displacement
507855|NCT00991042|Interleukins|interleukins
507856|NCT00991042|Tumor necrosis factor-alpha|tumor necrosis factor-alpha
507857|NCT00991029|Transient Ischemic Attack|transient ischemic attack
507858|NCT00991029|TIA|tia
507859|NCT00991029|minor stroke|minor stroke
507860|NCT00991003|Colon Capsule Endoscopy|colon capsule endoscopy
507861|NCT00991003|Colorectal Cancer|colorectal cancer
507862|NCT00991003|Colonoscopy|colonoscopy
507863|NCT00990990|Safety tolerability pharmacokinetics (PK) pharmacodynamics whole blood activity (WBA) PNU-100480 linezolid pyrazinamide multiple dose|safety tolerability pharmacokinetics (pk) pharmacodynamics whole blood activity (wba) pnu-100480 linezolid pyrazinamide multiple dose
507864|NCT00990977|breast cancer|breast cancer
507865|NCT00990977|supportive care|supportive care
507866|NCT00990977|post-treatment|post-treatment
507867|NCT00990977|intervention|intervention
507868|NCT00990977|MBSR|mbsr
507869|NCT00990977|mindfulness|mindfulness
507870|NCT00990977|anxiety|anxiety
507871|NCT00990977|depression|depression
507872|NCT00990977|lifestyle|lifestyle
507873|NCT00990977|diet|diet
507874|NCT00990977|alcohol consumption|alcohol consumption
507875|NCT00990977|smoking|smoking
507876|NCT00990977|exercise|exercise
507877|NCT00990977|spirituality|spirituality
507878|NCT00990977|existential well-being|existential well-being
507879|NCT00990977|physical symptoms|physical symptoms
507880|NCT00990977|women|women
507881|NCT00990925|Obesity|obesity
507882|NCT00990925|Schizophrenia|schizophrenia
507883|NCT00990925|Schizoaffective disorder|schizoaffective disorder
507884|NCT00990925|weight loss|weight loss
507885|NCT00990899|hypertension|hypertension
507886|NCT00990899|obstructive sleep apnea|obstructive sleep apnea
507887|NCT00990899|pediatrics|pediatrics
507888|NCT00990886|Oxybutynin|oxybutynin
507889|NCT00990886|Ditropan|ditropan
507890|NCT00990886|Menopause Treatment|menopause treatment
507891|NCT00990886|Vasomotor symptoms|vasomotor symptoms
507892|NCT00990886|Hot Flashes|hot flashes
507893|NCT00990886|Non-hormonal therapy for Vasomotor symptoms|non-hormonal therapy for vasomotor symptoms
507894|NCT00990873|stage I non-small cell lung cancer|stage i non-small cell lung cancer
507895|NCT00990860|Combination of TACE With Sorafenib|combination of tace with sorafenib
507896|NCT00990834|Statin|statin
507897|NCT00990834|Myopathy|myopathy
507898|NCT00990834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
507899|NCT00990834|Atrogin-1|atrogin-1
507900|NCT00990795|open heart surgery|open heart surgery
507901|NCT00990795|cyclosporine|cyclosporine
507902|NCT00990795|myocardial protection|myocardial protection
507903|NCT00990769|Emergence delirium|emergence delirium
507904|NCT00990769|Bispectral Index|bispectral index
507905|NCT00990769|Depth of anesthesia|depth of anesthesia
507906|NCT00990743|Ocular hypertension|ocular hypertension
507907|NCT00990743|Glaucoma|glaucoma
507908|NCT00990743|Beta-blocker|beta-blocker
507909|NCT00990730|rheumatoid arthritis|rheumatoid arthritis
507910|NCT00990730|endothelial dysfunction|endothelial dysfunction
507911|NCT00990730|lipoproteins|lipoproteins
507912|NCT00990730|inflammation|inflammation
507913|NCT00990730|oxidative stress|oxidative stress
507914|NCT00990730|arterial stiffness|arterial stiffness
507915|NCT00990717|natural killer cells|natural killer cells
507916|NCT00990717|leukemia|leukemia
507917|NCT00990717|lymphoma|lymphoma
507918|NCT00990717|myeloma|myeloma
507919|NCT00990717|Hodgkin's disease|hodgkin's disease
507920|NCT00990717|cell therapy|cell therapy
507921|NCT00990704|Secondary hyperparathyroidism|secondary hyperparathyroidism
507922|NCT00990704|Hemodialysis|hemodialysis
507923|NCT00990704|paricalcitol|paricalcitol
507924|NCT00990704|maxacalcitol|maxacalcitol
507925|NCT00990691|Rett syndrome|rett syndrome
507926|NCT00990678|HIV-1|hiv-1
507927|NCT00990678|humans|humans
507928|NCT00990678|vitamin D|vitamin d
507929|NCT00990678|1-hydroxy-vitamin D|1-hydroxy-vitamin d
507930|NCT00990678|Rocaltrol|rocaltrol
507931|NCT00990678|calcium|calcium
507932|NCT00990678|complementary therapies|complementary therapies
507934|NCT00990665|Heart Failure|heart failure
507935|NCT00990665|LV Leads|lv leads
507936|NCT00990652|brain tumor|brain tumor
507937|NCT00990639|hepatic fibrosis|hepatic fibrosis
507938|NCT00990639|angiotensin II blocking agents|angiotensin ii blocking agents
507939|NCT00990639|alcoholic liver disease|alcoholic liver disease
507940|NCT00990626|Seroquel XR|seroquel xr
507941|NCT00990626|schizophrenia relapse prevention|schizophrenia relapse prevention
507942|NCT00990613|percutaneous transcutaneous dimebon transdermal pharmacokinetics|percutaneous transcutaneous dimebon transdermal pharmacokinetics
507943|NCT00990600|adherence|adherence
507944|NCT00990600|Qol|qol
507945|NCT00990600|virologic efficacy|virologic efficacy
507946|NCT00990600|immunologic efficacy|immunologic efficacy
507947|NCT00990600|patients' preference|patients' preference
507948|NCT00990600|once-daily|once-daily
507949|NCT00990600|HAART|haart
507950|NCT00990600|treatment experienced|treatment experienced
507951|NCT00990587|relapsed and refractory hematologic malignancy|relapsed and refractory hematologic malignancy
507952|NCT00990587|ALL (acute lymphoid leukemia)|all (acute lymphoid leukemia)
507953|NCT00990587|CLL (chronic lymphoid leukemia)|cll (chronic lymphoid leukemia)
507954|NCT00990587|High risk myelodysplasia (MDS) with an IPSS (International Prognostic Scoring System) score >2.5|high risk myelodysplasia (mds) with an ipss (international prognostic scoring system) score >2.5
507955|NCT00990587|CML (chronic myelogenous leukemia) blast crisis|cml (chronic myelogenous leukemia) blast crisis
507956|NCT00990587|Relapsed or refractory acute myeloid leukemia (AML)|relapsed or refractory acute myeloid leukemia (aml)
507957|NCT00990548|Cardiac Caregivers|cardiac caregivers
507958|NCT00990548|Cardiac Patient Clinical Outcomes|cardiac patient clinical outcomes
507959|NCT00990548|Prevention of CVD|prevention of cvd
507960|NCT00990535|neuroendocrine tumors|neuroendocrine tumors
507961|NCT00990535|octreotide|octreotide
507962|NCT00990535|somatostatin analogues|somatostatin analogues
507963|NCT00990522|sharp debridment|sharp debridment
507964|NCT00990522|patients with full thickness wounds of greater than 30 days duration|patients with full thickness wounds of greater than 30 days duration
507965|NCT00990509|Primary ICH|primary ich
507966|NCT00990509|Albumin|albumin
507967|NCT00990509|MRI|mri
507968|NCT00990509|Neuroimaging outcome|neuroimaging outcome
507969|NCT00990509|Placebo-controlled|placebo-controlled
507970|NCT00990509|Phase II|phase ii
507971|NCT00990509|Blinded|blinded
507972|NCT00990509|Safety|safety
507973|NCT00990509|Acute ICH|acute ich
507974|NCT00990509|ICH|ich
507975|NCT00990509|Primary acute (< 48 hours) supratentorial ICH|primary acute (< 48 hours) supratentorial ich
507976|NCT00990496|Glioblastoma multiforme|glioblastoma multiforme
507977|NCT00990496|GBM|gbm
507978|NCT00990496|Cytomegalovirus|cytomegalovirus
507979|NCT00990496|CMV|cmv
507980|NCT00990496|Cytotoxic T lymphocyte|cytotoxic t lymphocyte
507981|NCT00990496|CTL|ctl
507982|NCT00990470|Transplantation|transplantation
507983|NCT00990470|Liver|liver
507984|NCT00990470|Endoscopy|endoscopy
507985|NCT00990470|Colonoscopy|colonoscopy
507986|NCT00990470|Gastroscopy|gastroscopy
507987|NCT00990457|Exercise|exercise
507988|NCT00990457|Weight loss diet|weight loss diet
507989|NCT00990457|Obesity|obesity
507990|NCT00990457|Overweight|overweight
507991|NCT00990457|Abdominal obesity|abdominal obesity
507992|NCT00990457|Cardiovascular function|cardiovascular function
507993|NCT00990457|Body composition|body composition
507994|NCT00990444|blood glucose|blood glucose
507995|NCT00990444|blood insulin|blood insulin
507996|NCT00990444|dextran|dextran
507997|NCT00990444|diabetes|diabetes
507998|NCT00990444|hyperglycemia|hyperglycemia
507999|NCT00990444|hypoglycemia|hypoglycemia
508000|NCT00990444|oral delivery|oral delivery
508001|NCT00990444|portal delivery|portal delivery
508002|NCT00990431|skin aging|skin aging
508003|NCT00990431|laser surgery|laser surgery
508004|NCT00990431|fractional photothermolysis|fractional photothermolysis
508005|NCT00990431|comparative study|comparative study
508006|NCT00990431|Ablative fractional treatment of peri-orbital rhytides|ablative fractional treatment of peri-orbital rhytides
508007|NCT00990418|Postoperative pain|postoperative pain
508008|NCT00990418|E-TRANS System, fentanyl HCl System|e-trans system, fentanyl hcl system
508009|NCT00990418|E-TRANSS (fentanyl HCl) System|e-transs (fentanyl hcl) system
508010|NCT00990418|Acute postoperative pain|acute postoperative pain
508106|NCT00990067|stimulant|stimulant
508011|NCT00990405|Rome III criteria|rome iii criteria
508012|NCT00990392|Blood stream infections|blood stream infections
508013|NCT00990392|Catheter related infections|catheter related infections
508014|NCT00990392|Central venous catheter related infections|central venous catheter related infections
508015|NCT00990392|Line sepsis|line sepsis
508016|NCT00990392|Topical antibiotics|topical antibiotics
508017|NCT00990392|Bacitracin|bacitracin
508018|NCT00990392|Polymixin|polymixin
508019|NCT00990392|Gramicidin|gramicidin
508020|NCT00990392|Polysporin Triple Therapy|polysporin triple therapy
508021|NCT00990392|Intensive care unit|intensive care unit
508022|NCT00990379|HIV|hiv
508023|NCT00990379|brain diseases|brain diseases
508024|NCT00990379|spinal fluid|spinal fluid
508025|NCT00990379|HIV positive|hiv positive
508026|NCT00990366|antireflux valve|antireflux valve
508027|NCT00990366|biliary obstruction|biliary obstruction
508028|NCT00990366|cholangitis|cholangitis
508029|NCT00990366|biliary stent|biliary stent
508030|NCT00990353|Spatial neglect|spatial neglect
508031|NCT00990353|hemineglect|hemineglect
508032|NCT00990353|stroke|stroke
508033|NCT00990353|cognition|cognition
508034|NCT00990353|prism adaptation|prism adaptation
508035|NCT00990353|Hierarchical linear modeling|hierarchical linear modeling
508036|NCT00990353|growth curve modeling|growth curve modeling
508037|NCT00990327|Coronary artery disease|coronary artery disease
508038|NCT00990327|Myocardial Perfusion Imaging|myocardial perfusion imaging
508039|NCT00990301|Healthy Subjects|healthy subjects
508040|NCT00990301|Bioequivalence|bioequivalence
508041|NCT00990288|To decrease blood loss during knee surgery|to decrease blood loss during knee surgery
508042|NCT00990262|acute chest pain|acute chest pain
508043|NCT00990262|emergency department|emergency department
508044|NCT00990262|cardiac computed tomography|cardiac computed tomography
508045|NCT00990249|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
508046|NCT00990249|ALL|all
508047|NCT00990249|Acute lymphoblastic lymphoma|acute lymphoblastic lymphoma
508048|NCT00990249|acute biphenotypic leukemia|acute biphenotypic leukemia
508049|NCT00990249|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
508050|NCT00990249|HCT|hct
508051|NCT00990249|Stem Cell Transplant|stem cell transplant
508052|NCT00990249|Treatment-related mortality|treatment-related mortality
508053|NCT00990249|Tyrosine kinase inhibitors|tyrosine kinase inhibitors
508054|NCT00990249|TKI|tki
508055|NCT00990249|Busulfan|busulfan
508056|NCT00990249|Busulfex|busulfex
508057|NCT00990249|Myleran|myleran
508058|NCT00990249|Clofarabine|clofarabine
508059|NCT00990249|Clolar|clolar
508060|NCT00990249|Clofarex|clofarex
508061|NCT00990249|Gleevec|gleevec
508062|NCT00990249|Imatinib Mesylate|imatinib mesylate
508063|NCT00990236|deep vein thrombosis|deep vein thrombosis
508064|NCT00990236|superficial venous thrombosis|superficial venous thrombosis
508065|NCT00990236|pulmonary embolus|pulmonary embolus
508066|NCT00990223|Eplerenone Aldosterone and Plasma Renin Activity responses Pharmacodynamics|eplerenone aldosterone and plasma renin activity responses pharmacodynamics
508067|NCT00990197|Pilot study|pilot study
508068|NCT00990197|Randomized clinical trial|randomized clinical trial
508069|NCT00990197|Smoking cessation|smoking cessation
508070|NCT00990197|Acute coronary syndrome|acute coronary syndrome
508071|NCT00990197|Transdermal nicotine patch|transdermal nicotine patch
508072|NCT00990184|Impaired Fasting Glucose|impaired fasting glucose
508073|NCT00990184|PreDiabetes|prediabetes
508074|NCT00990171|peritoneal Dialysis|peritoneal dialysis
508075|NCT00990171|wasting and malnutrition|wasting and malnutrition
508076|NCT00990171|nutrition status|nutrition status
508077|NCT00990171|bioelectrical impedance analysis|bioelectrical impedance analysis
508078|NCT00990171|body composition|body composition
508079|NCT00990158|Vitamin K1 (phytonadione)|vitamin k1 (phytonadione)
508080|NCT00990158|Randomized controlled trial|randomized controlled trial
508081|NCT00990158|Warfarin|warfarin
508082|NCT00990158|Coagulopathy|coagulopathy
508083|NCT00990158|Time in therapeutic range|time in therapeutic range
508084|NCT00990158|Bleeding|bleeding
508085|NCT00990158|Thrombosis|thrombosis
508086|NCT00990158|VKORC1 and CYP2C9 genotypes|vkorc1 and cyp2c9 genotypes
508087|NCT00990158|Time INR in therapeutic range|time inr in therapeutic range
508088|NCT00990132|COPD|copd
508089|NCT00990132|Respiratory failure|respiratory failure
508090|NCT00990132|Non-invasive ventilation|non-invasive ventilation
508091|NCT00990132|Home mechanical ventilation|home mechanical ventilation
508092|NCT00990119|high flow therapy|high flow therapy
508093|NCT00990119|high flow nasal cannula|high flow nasal cannula
508094|NCT00990119|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
508095|NCT00990119|respiratory insufficiency|respiratory insufficiency
508096|NCT00990106|posttraumatic stress disorder|posttraumatic stress disorder
508097|NCT00990106|PTSD|ptsd
508098|NCT00990106|nightmares|nightmares
508099|NCT00990106|prazosin|prazosin
508100|NCT00990106|sleep disturbance|sleep disturbance
508101|NCT00990106|combat trauma|combat trauma
508102|NCT00990067|MDMA|mdma
508103|NCT00990067|serotonin|serotonin
508104|NCT00990067|norepinephrine|norepinephrine
508105|NCT00990067|Ecstasy|ecstasy
508107|NCT00990054|Cytarabine,|cytarabine,
508108|NCT00990054|Daunorubicin,|daunorubicin,
508109|NCT00990054|De Novo,|de novo,
508110|NCT00990054|Acute Myeloid Leukemia,|acute myeloid leukemia,
508111|NCT00990054|AML|aml
508112|NCT00990041|periodontitis|periodontitis
508113|NCT00990041|find cytokines in blood of periodontal patients|find cytokines in blood of periodontal patients
508114|NCT00990028|moderate head injury|moderate head injury
508115|NCT00990028|rosuvastatin|rosuvastatin
508116|NCT00990028|statin|statin
508117|NCT00990028|amnesia|amnesia
508118|NCT00990028|orientation|orientation
508119|NCT00990015|Safety; tolerability; pharmacokinetics/pharmacodynamics|safety; tolerability; pharmacokinetics/pharmacodynamics
508120|NCT00989989|DME|dme
508121|NCT00989989|Diabetic|diabetic
508122|NCT00989989|macula|macula
508123|NCT00989989|edema|edema
508124|NCT00989989|ranibizumab|ranibizumab
508125|NCT00989989|REVEAL|reveal
508126|NCT00989976|Sleep|sleep
508127|NCT00989976|Diabetes Risk|diabetes risk
508128|NCT00989963|PAH|pah
508129|NCT00989950|daytrana|daytrana
508130|NCT00989950|sleep latency|sleep latency
508131|NCT00989950|adhd rating scales|adhd rating scales
508132|NCT00989950|ADHD|adhd
508133|NCT00989937|oxytocin|oxytocin
508134|NCT00989924|Diabetes mellitus|diabetes mellitus
508135|NCT00989924|Coronary heart disease|coronary heart disease
508136|NCT00989924|Magnetocardiography|magnetocardiography
508137|NCT00989911|Single ventricle congenital heart disease|single ventricle congenital heart disease
508138|NCT00989898|T1D, closed-loop systems, overnight hypoglycaemia|t1d, closed-loop systems, overnight hypoglycaemia
508139|NCT00989885|Evaluation|evaluation
508140|NCT00989885|Obstructive sleep apnea|obstructive sleep apnea
508141|NCT00989885|Polysomnography|polysomnography
508142|NCT00989872|Macrolides|macrolides
508143|NCT00989872|Antibiotics|antibiotics
508144|NCT00989872|Safety|safety
508145|NCT00989872|Tolerability|tolerability
508146|NCT00989872|Pharmacokinetics|pharmacokinetics
508147|NCT00989872|Phase I|phase i
508148|NCT00989872|MRSA/SSTI|mrsa/ssti
508149|NCT00989859|monitoring|monitoring
508150|NCT00989846|biomarker|biomarker
508151|NCT00989846|lung disease|lung disease
508152|NCT00989833|Exercise induced asthma|exercise induced asthma
508153|NCT00989833|Mild intermittent asthma|mild intermittent asthma
508154|NCT00989833|Exercise induced bronchoconstriction|exercise induced bronchoconstriction
508155|NCT00989820|osteoradionecrosis|osteoradionecrosis
508156|NCT00989820|mandible|mandible
508157|NCT00989820|radiotherapy|radiotherapy
508158|NCT00989820|hyperbaric oxygen therapy|hyperbaric oxygen therapy
508159|NCT00989807|CF|cf
508160|NCT00989807|Cystic fibrosis|cystic fibrosis
508161|NCT00989807|Pseudomonas aeruginosa|pseudomonas aeruginosa
508162|NCT00989807|EAP|eap
508163|NCT00989807|Expanded access|expanded access
508164|NCT00989807|AZLI|azli
508165|NCT00989807|Aztreonam lysine|aztreonam lysine
508166|NCT00989794|cartilage|cartilage
508167|NCT00989794|implantation|implantation
508168|NCT00989794|chondrocyte|chondrocyte
508169|NCT00989794|condyle|condyle
508170|NCT00989781|PCOS, Androgens, ovary, polycystic|pcos, androgens, ovary, polycystic
508171|NCT00989768|Botulinum toxin type A|botulinum toxin type a
508172|NCT00989768|field effects|field effects
508173|NCT00989768|dose-equivalence|dose-equivalence
508174|NCT00989768|anhydrotic action halos|anhydrotic action halos
508175|NCT00989755|Tobacco dependence treatment in primary health care setting|tobacco dependence treatment in primary health care setting
508176|NCT00989755|Fax to Quit|fax to quit
508177|NCT00989755|Fax to Quit plus Enhanced Academic Detailing|fax to quit plus enhanced academic detailing
508178|NCT00989755|Fax referral|fax referral
508179|NCT00989755|Quitline|quitline
508180|NCT00989742|lymphangioleiomatosis|lymphangioleiomatosis
508181|NCT00989742|LAM|lam
508182|NCT00989742|tuberous sclerosis|tuberous sclerosis
508183|NCT00989742|doxycycline|doxycycline
508184|NCT00989742|matrix metalloproteinases|matrix metalloproteinases
508185|NCT00989742|MMP|mmp
508186|NCT00989729|Endovascular Aortic Repair|endovascular aortic repair
508187|NCT00989729|Methylprednisolone|methylprednisolone
508188|NCT00989729|Systemic inflammatory response syndrome|systemic inflammatory response syndrome
508189|NCT00989703|Safety|safety
508190|NCT00989703|Tolerability|tolerability
508191|NCT00989703|Pharmacokinetics|pharmacokinetics
508192|NCT00989690|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
508193|NCT00989690|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
508194|NCT00989690|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
508195|NCT00989664|non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
508196|NCT00989664|radioimmunotherapy|radioimmunotherapy
508197|NCT00989664|NHL|nhl
508198|NCT00989664|Bexxar|bexxar
508199|NCT00989664|lymphoma|lymphoma
508200|NCT00989664|Tositumomab|tositumomab
508201|NCT00989625|migraine|migraine
508202|NCT00989625|single dose|single dose
508203|NCT00989625|healthy volunteer|healthy volunteer
508204|NCT00989625|adolescence|adolescence
508205|NCT00989625|pharmacokinetics|pharmacokinetics
508206|NCT00989612|influenza infection|influenza infection
508304|NCT00989261|FLT3|flt3
508207|NCT00989612|GSK Biologicals' influenza vaccine GSK2340272A|gsk biologicals' influenza vaccine gsk2340272a
508208|NCT00989599|phlebitis|phlebitis
508209|NCT00989599|Chamomilla recutita|chamomilla recutita
508210|NCT00989599|Catheterization peripheral|catheterization peripheral
508211|NCT00989586|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
508212|NCT00989586|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
508213|NCT00989586|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
508214|NCT00989586|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
508215|NCT00989586|MALT lymphoma|malt lymphoma
508216|NCT00989586|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
508217|NCT00989586|splenic marginal zone lymphoma|splenic marginal zone lymphoma
508218|NCT00989586|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
508219|NCT00989586|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
508220|NCT00989534|shift work|shift work
508221|NCT00989534|diabetes|diabetes
508222|NCT00989534|Affects of shift work and sleep loss on health|affects of shift work and sleep loss on health
508223|NCT00989521|Asthma|asthma
508224|NCT00989521|bronchial diseases|bronchial diseases
508225|NCT00989521|lung diseases|lung diseases
508226|NCT00989521|bronchitis|bronchitis
508227|NCT00989521|respiratory tract diseases|respiratory tract diseases
508228|NCT00989508|Perhexiline|perhexiline
508229|NCT00989508|Aortic Valve Stenosis|aortic valve stenosis
508230|NCT00989508|Hypertrophy, Left Ventricular|hypertrophy, left ventricular
508231|NCT00989508|Myocardial Reperfusion Injury|myocardial reperfusion injury
508232|NCT00989508|Cardiac Output, Low|cardiac output, low
508233|NCT00989508|Troponin|troponin
508234|NCT00989495|AIS|ais
508235|NCT00989456|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
508236|NCT00989456|Heart failure|heart failure
508237|NCT00989456|Stroke|stroke
508238|NCT00989456|quality of life|quality of life
508239|NCT00989456|self management education|self management education
508240|NCT00989456|physical exercise|physical exercise
508241|NCT00989456|primary health care|primary health care
508242|NCT00989443|Cervix Intraepithelial Neoplasia grades 2 and 3|cervix intraepithelial neoplasia grades 2 and 3
508243|NCT00989430|stroke|stroke
508244|NCT00989430|CVA|cva
508245|NCT00989430|cerebrovascular accident|cerebrovascular accident
508246|NCT00989430|rehabilitation|rehabilitation
508247|NCT00989417|Remote monitoring|remote monitoring
508248|NCT00989417|Defibrillators, Implantable|defibrillators, implantable
508249|NCT00989417|Home monitoring|home monitoring
508250|NCT00989417|Shock|shock
508251|NCT00989417|Implantable cardioverter-defibrillator Therapy|implantable cardioverter-defibrillator therapy
508252|NCT00989404|pk|pk
508253|NCT00989404|healthy subjects|healthy subjects
508254|NCT00989404|influenza virus|influenza virus
508255|NCT00989404|Safety|safety
508256|NCT00989404|pandemic|pandemic
508257|NCT00989391|Phase 1 multiple dose safety toleration pharmacokinetic|phase 1 multiple dose safety toleration pharmacokinetic
508258|NCT00989378|sleep|sleep
508259|NCT00989378|insulin|insulin
508260|NCT00989378|diabetes|diabetes
508261|NCT00989378|determine association between sleep characteristics and diabetes risk|determine association between sleep characteristics and diabetes risk
508262|NCT00989365|Aerobic Exercise|aerobic exercise
508263|NCT00989365|Exercise|exercise
508264|NCT00989352|PCNSL|pcnsl
508265|NCT00989352|Lymphoma|lymphoma
508266|NCT00989352|Methotrexate|methotrexate
508267|NCT00989352|Lomustine|lomustine
508268|NCT00989352|Procarbazine|procarbazine
508269|NCT00989352|Rituximab|rituximab
508270|NCT00989352|Elderly|elderly
508271|NCT00989352|Chemotherapy|chemotherapy
508272|NCT00989339|lipid emulsion|lipid emulsion
508273|NCT00989339|endothelial function|endothelial function
508274|NCT00989339|inflammatory markers|inflammatory markers
508275|NCT00989339|oxidative stress|oxidative stress
508276|NCT00989339|insulin sensitivity|insulin sensitivity
508277|NCT00989339|carbohydrate metabolism|carbohydrate metabolism
508278|NCT00989326|Remote monitoring|remote monitoring
508279|NCT00989326|Pacemaker|pacemaker
508280|NCT00989326|Follow up|follow up
508281|NCT00989326|Follow-up studies|follow-up studies
508282|NCT00989313|Peplin|peplin
508283|NCT00989313|Actinic keratosis|actinic keratosis
508284|NCT00989313|PEP005|pep005
508285|NCT00989300|Drug-Drug interaction|drug-drug interaction
508286|NCT00989300|Clopidogrel|clopidogrel
508287|NCT00989300|Rabeprazol|rabeprazol
508288|NCT00989300|Omeprazol|omeprazol
508289|NCT00989300|Pharmacodynamic Study|pharmacodynamic study
508290|NCT00989287|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
508291|NCT00989287|influenza infection|influenza infection
508292|NCT00989274|Influenza|influenza
508293|NCT00989274|Vaccination|vaccination
508294|NCT00989274|Immunology|immunology
508295|NCT00989274|Immunogenicity|immunogenicity
508296|NCT00989274|Reactogenicity|reactogenicity
508297|NCT00989274|Safety|safety
508298|NCT00989274|Influenza vaccine|influenza vaccine
508299|NCT00989274|Immune response|immune response
508300|NCT00989274|Adverse effects|adverse effects
508301|NCT00989261|AML|aml
508302|NCT00989261|AC220|ac220
508303|NCT00989261|acute|acute
508305|NCT00989261|inhibitor|inhibitor
508306|NCT00989261|kinase|kinase
508307|NCT00989261|leukemia|leukemia
508308|NCT00989261|leukaemia|leukaemia
508309|NCT00989261|myeloid|myeloid
508310|NCT00989261|relapsed|relapsed
508311|NCT00989261|refractory|refractory
508312|NCT00989248|Ergospirometry|ergospirometry
508313|NCT00989248|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
508314|NCT00989248|Exercises|exercises
508315|NCT00989248|Immersion|immersion
508316|NCT00989235|NOS|nos
508317|NCT00989222|Distal radius fractures|distal radius fractures
508318|NCT00989222|Fractures of the distal radius|fractures of the distal radius
508319|NCT00989222|Volar plate|volar plate
508320|NCT00989222|External fixation|external fixation
508321|NCT00989209|facial paralysis|facial paralysis
508322|NCT00989209|asymmetry|asymmetry
508323|NCT00989209|myofunctional therapy|myofunctional therapy
508324|NCT00989209|botulinum toxin|botulinum toxin
508325|NCT00989209|facial evaluation|facial evaluation
508326|NCT00989183|Ovaries|ovaries
508327|NCT00989183|Reproductive Age|reproductive age
508328|NCT00989183|Oophorectomy|oophorectomy
508329|NCT00989157|Gastric Bypass|gastric bypass
508330|NCT00989157|Duloxetine|duloxetine
508331|NCT00989157|Cymbalta|cymbalta
508332|NCT00989157|Pharmacokinetics|pharmacokinetics
508333|NCT00989144|HIV seronegative|hiv seronegative
508334|NCT00989144|acute infection|acute infection
508335|NCT00989131|Ovarian Cancer|ovarian cancer
508336|NCT00989105|stage I prostate cancer|stage i prostate cancer
508337|NCT00989105|stage IIB prostate cancer|stage iib prostate cancer
508338|NCT00989105|stage IIA prostate cancer|stage iia prostate cancer
508339|NCT00989105|stage III prostate cancer|stage iii prostate cancer
508340|NCT00989105|stage IV prostate cancer|stage iv prostate cancer
508341|NCT00989105|recurrent prostate cancer|recurrent prostate cancer
508342|NCT00989092|anemia of cancer|anemia of cancer
508343|NCT00989092|darbepoetin alfa|darbepoetin alfa
508344|NCT00989092|Aranesp|aranesp
508345|NCT00989079|Single Ascending Dose Study in healthy subjects|single ascending dose study in healthy subjects
508346|NCT00989066|Xience V|xience v
508347|NCT00989066|stent|stent
508348|NCT00989066|coronary disease|coronary disease
508349|NCT00989053|depression|depression
508350|NCT00989053|anxiety|anxiety
508351|NCT00989053|stress|stress
508352|NCT00989053|antidepressant therapy|antidepressant therapy
508353|NCT00989053|SSRI|ssri
508354|NCT00989053|infertility|infertility
508355|NCT00989053|in vitro fertilization (IVF)|in vitro fertilization (ivf)
508356|NCT00989053|immunological factors|immunological factors
508357|NCT00989053|depressive and anxiety symptoms in women undergoing IVF treatment|depressive and anxiety symptoms in women undergoing ivf treatment
508358|NCT00989040|NPZ|npz
508359|NCT00989040|Pain|pain
508360|NCT00989027|Uterine contraction|uterine contraction
508361|NCT00989027|Dose-response|dose-response
508362|NCT00989027|Oxytocin pre-treatment|oxytocin pre-treatment
508363|NCT00989014|Erythematotelangiectatic|erythematotelangiectatic
508364|NCT00989014|Rosacea|rosacea
508365|NCT00989001|Atrial Fibrillation|atrial fibrillation
508366|NCT00989001|RSD1235|rsd1235
508367|NCT00989001|Vernakalant|vernakalant
508368|NCT00989001|conversion|conversion
508369|NCT00988988|Multiple Sclerosis|multiple sclerosis
508370|NCT00988988|AGEE|agee
508371|NCT00988988|histamine response|histamine response
508372|NCT00988962|pain|pain
508373|NCT00988962|opioids|opioids
508374|NCT00988949|Proof of mechanism study|proof of mechanism study
508375|NCT00988936|[F-18]RGD-K5|[f-18]rgd-k5
508376|NCT00988936|RGD-K5|rgd-k5
508377|NCT00988936|K5-101|k5-101
508378|NCT00988936|Avastin|avastin
508379|NCT00988936|angiogenesis|angiogenesis
508380|NCT00988936|anti-angiogenesis|anti-angiogenesis
508381|NCT00988936|chemotherapy|chemotherapy
508382|NCT00988936|breast cancer|breast cancer
508383|NCT00988936|colon cancer|colon cancer
508384|NCT00988936|rectal cancer|rectal cancer
508385|NCT00988936|lung cancer|lung cancer
508386|NCT00988936|non-squamous|non-squamous
508387|NCT00988936|non small cell|non small cell
508388|NCT00988910|Combined Oral Contraceptives|combined oral contraceptives
508389|NCT00988910|COC|coc
508390|NCT00988871|PICC (peripherally inserted central venous catheter)|picc (peripherally inserted central venous catheter)
508391|NCT00988871|CICC (centrally inserted central venous catheter|cicc (centrally inserted central venous catheter
508392|NCT00988871|CVP (central venous pressure)|cvp (central venous pressure)
508393|NCT00988871|LT (liver transplantation)|lt (liver transplantation)
508394|NCT00988871|agreement|agreement
508395|NCT00988845|dietary supplement|dietary supplement
508396|NCT00988845|indole 3 carbinol|indole 3 carbinol
508397|NCT00988845|estrogen|estrogen
508398|NCT00988806|Advanced heart failure|advanced heart failure
508399|NCT00988806|Levosimendan|levosimendan
508400|NCT00988806|Intermittent long-term infusions|intermittent long-term infusions
508401|NCT00988780|Immune reconstitution inflammatory syndrome|immune reconstitution inflammatory syndrome
508402|NCT00988780|CCR5 antagonist|ccr5 antagonist
508403|NCT00988780|Maraviroc|maraviroc
508404|NCT00988780|HIV|hiv
508405|NCT00988780|treatment naive|treatment naive
508406|NCT00988767|Hepatitis B|hepatitis b
508407|NCT00988767|DNA vaccine|dna vaccine
508408|NCT00988767|immunotherapy|immunotherapy
508409|NCT00988754|Obesity|obesity
508410|NCT00988754|childhood and adolescence|childhood and adolescence
508411|NCT00988754|school and family-based lifestyle intervention|school and family-based lifestyle intervention
508412|NCT00988754|cardiovascular risk|cardiovascular risk
508413|NCT00988754|Obesity and associated cardiovascular risk in childhood and adolescence,|obesity and associated cardiovascular risk in childhood and adolescence,
508414|NCT00988754|health behaviour|health behaviour
508415|NCT00988741|Unresectable|unresectable
508416|NCT00988741|Hepatocellular|hepatocellular
508417|NCT00988741|Carcinoma|carcinoma
508418|NCT00988702|Dan Tian Breathing|dan tian breathing
508419|NCT00988702|Physiological measurement|physiological measurement
508420|NCT00988702|progressive muscle relaxation|progressive muscle relaxation
508421|NCT00988702|Monitoring, Physiologic|monitoring, physiologic
508422|NCT00988689|starch|starch
508423|NCT00988689|carbohydrates|carbohydrates
508424|NCT00988689|blood glucose|blood glucose
508425|NCT00988689|food intake|food intake
508426|NCT00988689|satiety|satiety
508427|NCT00988689|appetite|appetite
508428|NCT00988663|electroconvulsive therapy|electroconvulsive therapy
508429|NCT00988663|memantine|memantine
508430|NCT00988663|cognitive function|cognitive function
508431|NCT00988663|memory|memory
508432|NCT00988650|Metabolic syndrome|metabolic syndrome
508433|NCT00988650|Mediterranean diet|mediterranean diet
508434|NCT00988650|Blood lipids|blood lipids
508435|NCT00988650|Coronary heart disease|coronary heart disease
508436|NCT00988650|Apolipoprotein|apolipoprotein
508437|NCT00988624|bioavailability pharmacokinetics Alzheimer's Disease Huntington Disease|bioavailability pharmacokinetics alzheimer's disease huntington disease
508438|NCT00988611|Reproductive aging|reproductive aging
508439|NCT00988598|phase 1 Alzheimer's disease donepezil|phase 1 alzheimer's disease donepezil
508440|NCT00988585|Heart Disease Risk Reduction|heart disease risk reduction
508441|NCT00988572|Wrist fractures|wrist fractures
508442|NCT00988572|Vestibular asymmetry|vestibular asymmetry
508443|NCT00988572|Vestibular rehabilitation|vestibular rehabilitation
508444|NCT00988572|Fall-related wrist fractures|fall-related wrist fractures
508445|NCT00988572|Patients 50 years or older|patients 50 years or older
508446|NCT00988559|high grade cervical dysplasia|high grade cervical dysplasia
508447|NCT00988559|treatment vaccine|treatment vaccine
508448|NCT00988559|therapeutic|therapeutic
508449|NCT00988559|HPV|hpv
508450|NCT00988559|DNA vaccine|dna vaccine
508451|NCT00988559|gene therapy|gene therapy
508452|NCT00988559|gene gun|gene gun
508453|NCT00988559|pre-cancerous|pre-cancerous
508454|NCT00988546|Disability Evaluation|disability evaluation
508455|NCT00988546|Joint Diseases|joint diseases
508456|NCT00988546|Joint Disability|joint disability
508457|NCT00988533|Head Lice|head lice
508458|NCT00988533|Pediculus|pediculus
508459|NCT00988520|Neuromuscular Blocking Agents|neuromuscular blocking agents
508460|NCT00988481|Bulimia Nervosa|bulimia nervosa
508461|NCT00988481|Topiramate|topiramate
508462|NCT00988481|Augmentation|augmentation
508463|NCT00988468|Knee Osteoarthritis|knee osteoarthritis
508464|NCT00988468|Manual Therapy|manual therapy
508465|NCT00988468|Therapeutic Exercise|therapeutic exercise
508466|NCT00988468|Ultrasound|ultrasound
508467|NCT00988468|Effusion|effusion
508468|NCT00988455|basal cell carcinoma|basal cell carcinoma
508469|NCT00988455|photodynamic therapy|photodynamic therapy
508470|NCT00988455|photo chemotherapy|photo chemotherapy
508471|NCT00988455|basal cell epithelioma|basal cell epithelioma
508472|NCT00988442|Adherence|adherence
508473|NCT00988442|Treatment|treatment
508474|NCT00988442|Adherence Intervention|adherence intervention
508475|NCT00988442|Telephone Intervention|telephone intervention
508476|NCT00988442|treatment experienced|treatment experienced
508477|NCT00988429|Refractory|refractory
508478|NCT00988429|partial|partial
508479|NCT00988429|epilepsy|epilepsy
508480|NCT00988429|efficacy|efficacy
508481|NCT00988429|eslicarbazepine|eslicarbazepine
508482|NCT00988429|safety|safety
508483|NCT00988416|IPMN|ipmn
508484|NCT00988390|mothers living with HIV|mothers living with hiv
508485|NCT00988390|family intervention|family intervention
508486|NCT00988390|family functioning|family functioning
508487|NCT00988390|conflict|conflict
508488|NCT00988390|Mental health|mental health
508489|NCT00988390|and physical health|and physical health
508490|NCT00988390|Family relationships (functioning and conflict)|family relationships (functioning and conflict)
508491|NCT00988377|whey protein|whey protein
508492|NCT00988377|subjective appetite|subjective appetite
508493|NCT00988377|shor-term food intake|shor-term food intake
508494|NCT00988377|blood glucose|blood glucose
508495|NCT00988364|Metabolic Syndrome|metabolic syndrome
508496|NCT00988364|LDL subfraction L5|ldl subfraction l5
508497|NCT00988364|The reduction of LDL Chol in patients with Metabolic Syndrome|the reduction of ldl chol in patients with metabolic syndrome
508498|NCT00988364|The prevalence of L5 in patients with Metabolic Syndrome|the prevalence of l5 in patients with metabolic syndrome
508499|NCT00988364|The reduction of L5 subfraction in patients with Metabolic Syndrome|the reduction of l5 subfraction in patients with metabolic syndrome
508500|NCT00988351|sleep apnea|sleep apnea
508501|NCT00988351|positive airway pressure|positive airway pressure
508502|NCT00988351|portable monitoring|portable monitoring
508503|NCT00988351|auto positive airway pressure|auto positive airway pressure
508504|NCT00988338|Trinity Evolution|trinity evolution
508505|NCT00988338|Arthrodesis|arthrodesis
508506|NCT00988338|Foot Fusion|foot fusion
508507|NCT00988338|Ankle Fusion|ankle fusion
508508|NCT00988338|Allograft|allograft
508509|NCT00988312|dendritic cells (DC)|dendritic cells (dc)
508510|NCT00988312|idiotype (Id)|idiotype (id)
508511|NCT00988312|immunotherapy|immunotherapy
508512|NCT00988299|older|older
508513|NCT00988299|NEAT|neat
508514|NCT00988299|exercise|exercise
508515|NCT00988299|RMR|rmr
508516|NCT00988299|energy expenditure|energy expenditure
508517|NCT00988273|Crohn's disease|crohn's disease
508518|NCT00988273|Ulcerative colitis|ulcerative colitis
508519|NCT00988273|dysplasia|dysplasia
508520|NCT00988247|Rhinitis, Allergic, Perennial|rhinitis, allergic, perennial
508521|NCT00988247|BDP-HFA|bdp-hfa
508522|NCT00988247|Hay fever|hay fever
508523|NCT00988247|Allergic rhinitis|allergic rhinitis
508524|NCT00988234|Lumbar plexus block|lumbar plexus block
508525|NCT00988234|sciatic nerve block|sciatic nerve block
508526|NCT00988234|position|position
508527|NCT00988234|ultrasound guidance|ultrasound guidance
508528|NCT00988234|elective lower limb surgery|elective lower limb surgery
508529|NCT00988208|Castrate-Resistant Prostate Cancer|castrate-resistant prostate cancer
508530|NCT00988208|Revlimid|revlimid
508531|NCT00988208|Lenalidomide|lenalidomide
508532|NCT00988195|Neoplasm|neoplasm
508533|NCT00988195|Hepatocellular Carcinoma|hepatocellular carcinoma
508534|NCT00988182|Whey protein|whey protein
508535|NCT00988182|Hydrolysate whey protein|hydrolysate whey protein
508536|NCT00988182|Blood glucose|blood glucose
508537|NCT00988182|Insulin|insulin
508538|NCT00988169|AT-101|at-101
508539|NCT00988169|erlotinib|erlotinib
508540|NCT00988169|Unresectable Stage IIIB|unresectable stage iiib
508541|NCT00988169|09-026|09-026
508542|NCT00988156|Epilepsy|epilepsy
508543|NCT00988156|Partial|partial
508544|NCT00988156|Refractory|refractory
508545|NCT00988156|Children|children
508546|NCT00988156|Adolescents|adolescents
508547|NCT00988156|Adjunctive|adjunctive
508548|NCT00988156|Randomised|randomised
508549|NCT00988156|Double-blind|double-blind
508550|NCT00988156|Placebo-controlled|placebo-controlled
508551|NCT00988156|Parallel-group|parallel-group
508552|NCT00988143|Influenza|influenza
508553|NCT00988143|Trivalent Influenza Virus Vaccine|trivalent influenza virus vaccine
508554|NCT00988143|Quadrivalent Influenza Virus Vaccine|quadrivalent influenza virus vaccine
508555|NCT00988130|sexual dysfunction|sexual dysfunction
508556|NCT00988130|stage I prostate cancer|stage i prostate cancer
508557|NCT00988130|stage IIB prostate cancer|stage iib prostate cancer
508558|NCT00988130|stage IIA prostate cancer|stage iia prostate cancer
508559|NCT00988130|stage III prostate cancer|stage iii prostate cancer
508560|NCT00988117|PDD|pdd
508561|NCT00988117|Parkinson's Disease with Dementia|parkinson's disease with dementia
508562|NCT00988117|rivastigmine|rivastigmine
508563|NCT00988117|rivastigmine patch|rivastigmine patch
508564|NCT00988117|open label|open label
508565|NCT00988117|Parkinson's Disease|parkinson's disease
508566|NCT00988117|Parkinsons Disease|parkinsons disease
508567|NCT00988117|memory|memory
508568|NCT00988117|Exelon|exelon
508569|NCT00988117|Exelon Patch|exelon patch
508570|NCT00988104|Behavior Therapy|behavior therapy
508571|NCT00988104|Randomized Controlled Trial|randomized controlled trial
508572|NCT00988078|metformin|metformin
508573|NCT00988078|Hyperandrogenism|hyperandrogenism
508574|NCT00988078|Metabolic Syndrome X|metabolic syndrome x
508575|NCT00988078|adolescents|adolescents
508576|NCT00988078|melatonin|melatonin
508577|NCT00988078|Polycystic Ovary Syndrome|polycystic ovary syndrome
508578|NCT00988078|Insulin Resistance|insulin resistance
508579|NCT00988078|Menstrual Cycle|menstrual cycle
508580|NCT00988052|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
508581|NCT00988039|Human Immunodeficiency virus|human immunodeficiency virus
508582|NCT00988039|second line therapy|second line therapy
508583|NCT00988039|raltegravir|raltegravir
508584|NCT00988039|aluvia|aluvia
508585|NCT00988039|monotherapy|monotherapy
508586|NCT00988039|integrase inhibitor|integrase inhibitor
508587|NCT00988039|protease inhibitor|protease inhibitor
508588|NCT00988039|Randomized Controlled Trial|randomized controlled trial
508589|NCT00988013|total marrow irradiation|total marrow irradiation
508590|NCT00988013|intensity modulated radiation|intensity modulated radiation
508591|NCT00988013|leukemia|leukemia
508592|NCT00988013|hematologic diseases|hematologic diseases
508593|NCT00988000|outpatients|outpatients
508594|NCT00987987|hematological malignancy|hematological malignancy
508595|NCT00987987|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
508596|NCT00987987|donor lymphocyte infusion|donor lymphocyte infusion
508597|NCT00987987|antitumor immunotherapy|antitumor immunotherapy
508598|NCT00987987|graft-versus-tumor effect|graft-versus-tumor effect
508699|NCT00987636|soft tissue|soft tissue
508599|NCT00987987|regulatory T cells|regulatory t cells
508600|NCT00987987|adult|adult
508601|NCT00987974|ischemia reperfusion injury|ischemia reperfusion injury
508602|NCT00987974|endothelial dysfunction|endothelial dysfunction
508603|NCT00987974|statins|statins
508604|NCT00987974|rosuvastatin|rosuvastatin
508605|NCT00987974|atorvastatin|atorvastatin
508606|NCT00987974|placebo|placebo
508607|NCT00987974|ecto-5'-nucleotidase|ecto-5'-nucleotidase
508608|NCT00987974|flow mediated dilation|flow mediated dilation
508609|NCT00987961|opioid dependence|opioid dependence
508610|NCT00987961|suboxone|suboxone
508611|NCT00987961|HIV risk behavior|hiv risk behavior
508612|NCT00987948|HIV|hiv
508613|NCT00987948|dementia|dementia
508614|NCT00987948|High HIV DNA within CD14+ PBMCs|high hiv dna within cd14+ pbmcs
508615|NCT00987948|treatment experienced|treatment experienced
508616|NCT00987922|Stroke|stroke
508617|NCT00987922|Acute|acute
508618|NCT00987922|Infarction|infarction
508619|NCT00987922|Ischemic|ischemic
508620|NCT00987922|Thrombolysis|thrombolysis
508621|NCT00987922|Mild|mild
508622|NCT00987922|Hypothermia|hypothermia
508623|NCT00987909|Cat|cat
508624|NCT00987909|Allergy|allergy
508625|NCT00987909|Immunotherapy|immunotherapy
508626|NCT00987909|Sublingual|sublingual
508627|NCT00987909|Exposure chamber|exposure chamber
508628|NCT00987909|Safety|safety
508629|NCT00987909|Rhinoconjunctivitis|rhinoconjunctivitis
508630|NCT00987896|colonoscopy|colonoscopy
508631|NCT00987896|polypectomy|polypectomy
508632|NCT00987896|NOTES|notes
508633|NCT00987883|Nutritional Support|nutritional support
508634|NCT00987870|Stable plaque Psoriasis|stable plaque psoriasis
508635|NCT00987870|inflammatory skin|inflammatory skin
508636|NCT00987870|with or without arthritis|with or without arthritis
508637|NCT00987857|esophageal cancer|esophageal cancer
508638|NCT00987857|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
508639|NCT00987857|Barrett esophagus|barrett esophagus
508640|NCT00987831|SLE|sle
508641|NCT00987831|lupus|lupus
508642|NCT00987831|biomarkers|biomarkers
508643|NCT00987831|depomedrol|depomedrol
508644|NCT00987831|flare|flare
508645|NCT00987831|disease activity|disease activity
508646|NCT00987818|Biomarkers|biomarkers
508647|NCT00987818|Antibiotic therapy|antibiotic therapy
508648|NCT00987805|Functional dyspepsia|functional dyspepsia
508649|NCT00987805|Banhasasim-tang|banhasasim-tang
508650|NCT00987805|Gastrointestinal Symptom score|gastrointestinal symptom score
508651|NCT00987805|Visual Analogue Scale|visual analogue scale
508652|NCT00987805|Functional Dyspepsia-related Quality of Life|functional dyspepsia-related quality of life
508653|NCT00987805|Electrogastrography|electrogastrography
508654|NCT00987792|Community Acquired Pneumonia|community acquired pneumonia
508655|NCT00987779|Bioequivalence study|bioequivalence study
508656|NCT00987779|Food effect study|food effect study
508657|NCT00987779|Pharmacokinetics|pharmacokinetics
508658|NCT00987779|Gabapentin|gabapentin
508659|NCT00987766|advanced adult primary liver cancer|advanced adult primary liver cancer
508660|NCT00987766|stage III pancreatic cancer|stage iii pancreatic cancer
508661|NCT00987766|stage IV pancreatic cancer|stage iv pancreatic cancer
508662|NCT00987766|periampullary adenocarcinoma|periampullary adenocarcinoma
508663|NCT00987766|small intestine adenocarcinoma|small intestine adenocarcinoma
508664|NCT00987766|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
508665|NCT00987766|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
508666|NCT00987766|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
508667|NCT00987766|unresectable gallbladder cancer|unresectable gallbladder cancer
508668|NCT00987753|L-377202, prostate cancer, PSA|l-377202, prostate cancer, psa
508669|NCT00987740|hypercapnic respiratory failure, COPD|hypercapnic respiratory failure, copd
508670|NCT00987714|Organ Donors|organ donors
508671|NCT00987714|Recipients|recipients
508672|NCT00987701|Neurobehavior|neurobehavior
508673|NCT00987701|Development|development
508674|NCT00987701|Fluid management|fluid management
508675|NCT00987701|Neuraxial anesthesia|neuraxial anesthesia
508676|NCT00987688|trauma|trauma
508677|NCT00987688|Brain injury|brain injury
508678|NCT00987688|Pre-hospital|pre-hospital
508679|NCT00987688|cooling|cooling
508680|NCT00987675|stage I prostate cancer|stage i prostate cancer
508681|NCT00987675|stage IIB prostate cancer|stage iib prostate cancer
508682|NCT00987675|stage IIA prostate cancer|stage iia prostate cancer
508683|NCT00987675|stage III prostate cancer|stage iii prostate cancer
508684|NCT00987662|irbesartan|irbesartan
508685|NCT00987662|amlodipine|amlodipine
508686|NCT00987662|obesity|obesity
508687|NCT00987662|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
508688|NCT00987662|new onset diabetes|new onset diabetes
508689|NCT00987649|pelvic mass|pelvic mass
508690|NCT00987649|ovarian cancer|ovarian cancer
508691|NCT00987649|adnexal mass|adnexal mass
508692|NCT00987649|CA125|ca125
508693|NCT00987649|HE4|he4
508694|NCT00987636|Ewing Sarcoma|ewing sarcoma
508695|NCT00987636|localized|localized
508696|NCT00987636|disseminated|disseminated
508697|NCT00987636|metastases|metastases
508698|NCT00987636|bone|bone
508700|NCT00987610|Percutaneous coronary intervention|percutaneous coronary intervention
508701|NCT00987610|chronic total occlusion|chronic total occlusion
508702|NCT00987610|guidewire|guidewire
508703|NCT00987610|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
508704|NCT00987610|Angioplasty|angioplasty
508705|NCT00987610|Percutaneous Coronary|percutaneous coronary
508706|NCT00987597|Smoking|smoking
508707|NCT00987597|nicotine replacement|nicotine replacement
508708|NCT00987597|psychological behaviour|psychological behaviour
508709|NCT00987597|Smoking > 5 cigarettes per day|smoking > 5 cigarettes per day
508710|NCT00987597|Hospitalisation for acute coronary syndrome|hospitalisation for acute coronary syndrome
508711|NCT00987571|carpal tunnel syndrome|carpal tunnel syndrome
508712|NCT00987571|median nerve|median nerve
508713|NCT00987571|ultrasound|ultrasound
508714|NCT00987571|electrodiagnosis|electrodiagnosis
508715|NCT00987571|Normal subjects|normal subjects
508716|NCT00987558|Eslicarbazepine acetate|eslicarbazepine acetate
508717|NCT00987558|simvastatin|simvastatin
508718|NCT00987545|Keloids|keloids
508719|NCT00987545|recurrence|recurrence
508720|NCT00987532|preschool|preschool
508721|NCT00987532|participatory intervention|participatory intervention
508722|NCT00987532|cluster-randomization|cluster-randomization
508723|NCT00987532|children|children
508724|NCT00987532|obesity prevention|obesity prevention
508725|NCT00987519|acute bronchiolitis|acute bronchiolitis
508726|NCT00987519|acute gastroenteritis|acute gastroenteritis
508727|NCT00987519|febrile convulsion|febrile convulsion
508728|NCT00987519|viral agents|viral agents
508729|NCT00987519|molecular methods|molecular methods
508730|NCT00987506|drug eluting stents|drug eluting stents
508731|NCT00987506|Stents|stents
508732|NCT00987506|Angioplasty|angioplasty
508733|NCT00987506|Chronic coronary occlusion|chronic coronary occlusion
508734|NCT00987506|Stent thrombosis|stent thrombosis
508735|NCT00987506|Vascular disease|vascular disease
508736|NCT00987506|Myocardial ischemia|myocardial ischemia
508737|NCT00987506|Coronary artery stenosis|coronary artery stenosis
508738|NCT00987506|Coronary Disease|coronary disease
508739|NCT00987506|Coronary Artery Disease|coronary artery disease
508740|NCT00987506|Coronary Restenosis|coronary restenosis
508741|NCT00987493|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
508742|NCT00987493|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
508743|NCT00987480|Stem Cell Transplantation|stem cell transplantation
508744|NCT00987480|Anemia|anemia
508745|NCT00987480|Busulfan|busulfan
508746|NCT00987480|Cyclophosphamide|cyclophosphamide
508747|NCT00987480|Fludarabine|fludarabine
508748|NCT00987480|08-031|08-031
508749|NCT00987467|Atopic|atopic
508750|NCT00987467|Keratoconjunctivitis|keratoconjunctivitis
508751|NCT00987467|Restasis|restasis
508752|NCT00987467|Cyclosporine|cyclosporine
508753|NCT00987441|Neurobehavior|neurobehavior
508754|NCT00987441|Epidural analgesia|epidural analgesia
508755|NCT00987441|Local anesthetic|local anesthetic
508756|NCT00987441|Opioid|opioid
508757|NCT00987428|ERCP|ercp
508758|NCT00987428|EUS|eus
508759|NCT00987428|Pancreatitis biliary|pancreatitis biliary
508760|NCT00987428|Severe|severe
508761|NCT00987428|Interventional endoscopy|interventional endoscopy
508762|NCT00987428|Choledocolithiasis|choledocolithiasis
508763|NCT00987402|Surgery|surgery
508764|NCT00987402|hand scrubbing|hand scrubbing
508765|NCT00987402|post-operative infection|post-operative infection
508766|NCT00987402|surgical site infection|surgical site infection
508767|NCT00987402|surgical hand preparation|surgical hand preparation
508768|NCT00987402|plain soap and water|plain soap and water
508769|NCT00987402|alcohol-based hand rub|alcohol-based hand rub
508770|NCT00987402|Cost of surgical hand preparation agent|cost of surgical hand preparation agent
508771|NCT00987402|Side effects of use of hand preparation agent|side effects of use of hand preparation agent
508772|NCT00987389|Vasculitis|vasculitis
508773|NCT00987389|Granulomatosis with Polyangiitis|granulomatosis with polyangiitis
508774|NCT00987389|Microscopic Polyangiitis|microscopic polyangiitis
508775|NCT00987389|Wegener's|wegener's
508776|NCT00987389|ANCA-Associated Vasculitis|anca-associated vasculitis
508777|NCT00987389|GPA|gpa
508778|NCT00987389|MPA|mpa
508779|NCT00987389|Treatment|treatment
508780|NCT00987389|Plasma exchange|plasma exchange
508781|NCT00987389|Glucocorticoids|glucocorticoids
508782|NCT00987389|ANCA-Positive|anca-positive
508783|NCT00987363|critical limb ischemia (CLI)|critical limb ischemia (cli)
508784|NCT00987363|diabetic foot|diabetic foot
508785|NCT00987363|bone marrow derived mononuclear cells|bone marrow derived mononuclear cells
508786|NCT00987363|cell therapy|cell therapy
508787|NCT00987350|Jet Injector|jet injector
508788|NCT00987350|Vaccine|vaccine
508789|NCT00987350|Influenza|influenza
508790|NCT00987337|Hepatitis C Polymerase Inhibitor PF-00868554 Filibuvir|hepatitis c polymerase inhibitor pf-00868554 filibuvir
508791|NCT00987311|Probiotics|probiotics
508792|NCT00987311|intestinal immune system|intestinal immune system
508793|NCT00987311|human|human
508794|NCT00987311|healthy subjects|healthy subjects
508795|NCT00987311|dairy drink|dairy drink
508796|NCT00987311|Healthy adults|healthy adults
508797|NCT00987298|Abdominal Fat|abdominal fat
508798|NCT00987298|Visceral Fat|visceral fat
508799|NCT00987298|Subcutaneous Fat|subcutaneous fat
508800|NCT00987298|Dual-energy x-ray absorptiometry|dual-energy x-ray absorptiometry
508801|NCT00987298|DXA|dxa
508802|NCT00987298|Computed Tomography|computed tomography
508803|NCT00987298|CT|ct
508804|NCT00987298|Body Mass Index|body mass index
508805|NCT00987298|Body composition|body composition
508806|NCT00987298|Percent fat|percent fat
508807|NCT00987298|Waist circumference|waist circumference
508808|NCT00987298|Hip circumference|hip circumference
508809|NCT00987285|RE AIM model|re aim model
508810|NCT00987285|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
508811|NCT00987285|Interactive voice recognition|interactive voice recognition
508812|NCT00987285|Computer Assisted Self Management|computer assisted self management
508813|NCT00987272|Allergies|allergies
508814|NCT00987272|Ocular|ocular
508815|NCT00987259|Myocardial infarction|myocardial infarction
508816|NCT00987259|Myocardial oedema|myocardial oedema
508817|NCT00987259|Magnetic resonance|magnetic resonance
508818|NCT00987246|Actinic Keratosis|actinic keratosis
508819|NCT00987246|AK|ak
508820|NCT00987246|NMSC|nmsc
508821|NCT00987246|Combination|combination
508822|NCT00987220|CSF Biomarkers Acetylcholine|csf biomarkers acetylcholine
508823|NCT00987207|Postconditioning|postconditioning
508824|NCT00987207|cyclosporine A|cyclosporine a
508825|NCT00987207|myocardial ischemia|myocardial ischemia
508826|NCT00987207|cardiac surgery|cardiac surgery
508827|NCT00987207|aortic valvulopathy|aortic valvulopathy
508828|NCT00987194|HIV|hiv
508829|NCT00987194|rapid testing|rapid testing
508830|NCT00987194|HIV seronegativity|hiv seronegativity
508831|NCT00987181|Pulse wave velocity|pulse wave velocity
508832|NCT00987181|Non contact|non contact
508833|NCT00987181|Non-invasive|non-invasive
508834|NCT00987181|Photoplethysmography|photoplethysmography
508835|NCT00987181|Doppler flow velocimetry|doppler flow velocimetry
508836|NCT00987168|Congenital Hyperinsulinism|congenital hyperinsulinism
508837|NCT00987168|Hypoglycemia,|hypoglycemia,
508838|NCT00987168|Sandostatine subcutaneous in 3 daily injections|sandostatine subcutaneous in 3 daily injections
508839|NCT00987168|Intramuscular injection of Sandostatine® LP per month|intramuscular injection of sandostatine® lp per month
508840|NCT00987155|Functional electrical stimulation cycling|functional electrical stimulation cycling
508841|NCT00987155|arm crank|arm crank
508842|NCT00987155|wheelchair|wheelchair
508843|NCT00987155|ergometry|ergometry
508844|NCT00987155|paraplegia|paraplegia
508845|NCT00987155|spinal cord injury|spinal cord injury
508846|NCT00987155|exercise testing|exercise testing
508847|NCT00987129|DHA|dha
508848|NCT00987129|EPA|epa
508849|NCT00987129|AMD|amd
508850|NCT00987129|drusen|drusen
508851|NCT00987129|omega-3 fatty acids|omega-3 fatty acids
508852|NCT00987129|omega6:omega3 ratio|omega6:omega3 ratio
508853|NCT00987116|Myasthenia gravis|myasthenia gravis
508854|NCT00987116|Steroids side effects|steroids side effects
508855|NCT00987116|Comparison of strategies for tapering steroids|comparison of strategies for tapering steroids
508856|NCT00987116|Generalized MG corresponding to grade III, IV or V of MGFA|generalized mg corresponding to grade iii, iv or v of mgfa
508857|NCT00987103|renal transplantation|renal transplantation
508858|NCT00987103|tacrolimus|tacrolimus
508859|NCT00987103|pharmacokinetics|pharmacokinetics
508860|NCT00987103|rectal|rectal
508861|NCT00987103|sublingual|sublingual
508862|NCT00987103|rectal administration|rectal administration
508863|NCT00987103|sublingual administration|sublingual administration
508864|NCT00987090|subjects developing symptoms of Alzheimer Disease|subjects developing symptoms of alzheimer disease
508865|NCT00987077|CSC|csc
508866|NCT00987077|SRT|srt
508867|NCT00987064|Protexo|protexo
508868|NCT00987064|Asthma|asthma
508869|NCT00987064|Temperature controlled Laminar Airflow|temperature controlled laminar airflow
508870|NCT00987064|Perennial allergy|perennial allergy
508871|NCT00987064|Quality of life|quality of life
508872|NCT00987064|MiniAQLQ|miniaqlq
508873|NCT00987064|FeNO|feno
508874|NCT00987064|FEV1|fev1
508875|NCT00987064|PEF|pef
508876|NCT00987051|sentinel node procedure|sentinel node procedure
508877|NCT00987051|radiocolloid|radiocolloid
508878|NCT00987051|patent blue|patent blue
508879|NCT00987038|drug interaction CYP3A4 glucocorticoids midazolam|drug interaction cyp3a4 glucocorticoids midazolam
508880|NCT00987025|hypertension|hypertension
508881|NCT00987025|telehealth|telehealth
508882|NCT00987025|nurse monitor|nurse monitor
508883|NCT00987025|nutrition center|nutrition center
508884|NCT00986999|HIV infected|hiv infected
508885|NCT00986999|treatment experienced|treatment experienced
508886|NCT00986986|Human immunodeficiency virus|human immunodeficiency virus
508887|NCT00986986|Low high density lipoprotein|low high density lipoprotein
508888|NCT00986986|Endothelial function|endothelial function
508889|NCT00986986|Flow-mediated vasodilation|flow-mediated vasodilation
508890|NCT00986973|PKU|pku
508891|NCT00986973|BH4|bh4
508892|NCT00986973|KUVAN|kuvan
508893|NCT00986973|PET scan|pet scan
508894|NCT00986973|Neurodevelopment|neurodevelopment
508895|NCT00986960|multiple sclerosis|multiple sclerosis
508896|NCT00986960|relapsing remitting|relapsing remitting
508897|NCT00986960|RRMS|rrms
508898|NCT00986921|Length of time for procedure to be completed|length of time for procedure to be completed
508899|NCT00986921|Need for additional dilation|need for additional dilation
508900|NCT00986921|Subject satisfaction with procedure|subject satisfaction with procedure
508901|NCT00986895|HPN-100|hpn-100
508902|NCT00986895|GT4P|gt4p
508903|NCT00986895|Glyceryl tri-(4-phenylbutyrate)|glyceryl tri-(4-phenylbutyrate)
508904|NCT00986882|Postoperative pain|postoperative pain
508905|NCT00986869|Safety|safety
508906|NCT00986869|Bronchoscopy|bronchoscopy
508907|NCT00986869|Pulmonary|pulmonary
508908|NCT00986869|Hypertension|hypertension
508909|NCT00986843|HM30181A|hm30181a
508910|NCT00986843|Irinotecan|irinotecan
508911|NCT00986843|MTD|mtd
508912|NCT00986843|DLT|dlt
508913|NCT00986830|Rhinosinusitis|rhinosinusitis
508914|NCT00986830|Balloon catheters|balloon catheters
508915|NCT00986830|Office treatment|office treatment
508916|NCT00986830|Otorhinolaryngologic Diseases|otorhinolaryngologic diseases
508917|NCT00986830|Respiratory Tract Infections|respiratory tract infections
508918|NCT00986830|Respiratory Tract Diseases|respiratory tract diseases
508919|NCT00986830|FinESS Sinus Treatment|finess sinus treatment
508920|NCT00986830|endoscopic sinus surgery|endoscopic sinus surgery
508921|NCT00986817|Refractory ascites|refractory ascites
508922|NCT00986817|Cirrhosis Terlipressin|cirrhosis terlipressin
508923|NCT00986817|Paracentesis|paracentesis
508924|NCT00986791|risk reduction|risk reduction
508925|NCT00986765|Fetal growth restriction|fetal growth restriction
508926|NCT00986765|Abruptio placentae|abruptio placentae
508927|NCT00986765|Perinatal death|perinatal death
508928|NCT00986752|stent|stent
508929|NCT00986752|atherectomy|atherectomy
508930|NCT00986752|paclitaxel-eluting balloon|paclitaxel-eluting balloon
508931|NCT00986739|Chronic pathologies|chronic pathologies
508932|NCT00986739|elderly|elderly
508933|NCT00986739|atmospheric pollution|atmospheric pollution
508934|NCT00986739|unplanned hospitalization|unplanned hospitalization
508935|NCT00986739|case-crossover|case-crossover
508936|NCT00986687|Oocyte cryopreservation|oocyte cryopreservation
508937|NCT00986687|vitrification|vitrification
508938|NCT00986674|Advanced Non-small Cell Lung Cancer|advanced non-small cell lung cancer
508939|NCT00986674|Carboplatin|carboplatin
508940|NCT00986674|Paclitaxel|paclitaxel
508941|NCT00986674|Cetuximab|cetuximab
508942|NCT00986674|IMC-A12|imc-a12
508943|NCT00986661|melanoma|melanoma
508944|NCT00986661|uveal|uveal
508945|NCT00986661|ocular|ocular
508946|NCT00986661|mUM|mum
508947|NCT00986661|mOM|mom
508948|NCT00986661|OM|om
508949|NCT00986661|UM|um
508950|NCT00986661|pancreatic|pancreatic
508951|NCT00986661|colon|colon
508952|NCT00986661|colorectal|colorectal
508953|NCT00986661|lung|lung
508954|NCT00986661|metastatic|metastatic
508955|NCT00986661|carcinoid|carcinoid
508956|NCT00986661|neuroendocrine|neuroendocrine
508957|NCT00986648|acute liver failure|acute liver failure
508958|NCT00986648|hepatic encephalopathy|hepatic encephalopathy
508959|NCT00986648|acetaminophen toxicity|acetaminophen toxicity
508960|NCT00986635|Activated partial thromboplastin time|activated partial thromboplastin time
508961|NCT00986635|Thrombin clotting Time|thrombin clotting time
508962|NCT00986635|Anti-Xa-activity|anti-xa-activity
508963|NCT00986635|Factor X-activity|factor x-activity
508964|NCT00986635|Factor XIII-activity|factor xiii-activity
508965|NCT00986635|Antithrombin (based on factor II)|antithrombin (based on factor ii)
508966|NCT00986635|Antithrombin (based on factor X<9|antithrombin (based on factor x<9
508967|NCT00986596|vitamin D|vitamin d
508968|NCT00986596|skeletal muscle|skeletal muscle
508969|NCT00986596|vitamin D receptor|vitamin d receptor
508970|NCT00986583|Succinylcholine|succinylcholine
508971|NCT00986583|Statins|statins
508972|NCT00986583|myalgias|myalgias
508973|NCT00986583|statins with succinylcholine and pain|statins with succinylcholine and pain
508974|NCT00986570|Botulinum Toxin A|botulinum toxin a
508975|NCT00986570|Wrinkles|wrinkles
508976|NCT00986557|cytomegalovirus infection|cytomegalovirus infection
508977|NCT00986557|graft versus host disease|graft versus host disease
508978|NCT00986544|Laparoscopy|laparoscopy
508979|NCT00986544|cholecystectomy|cholecystectomy
508980|NCT00986544|drainage|drainage
508981|NCT00986531|schizophrenia|schizophrenia
508982|NCT00986531|early phase trials|early phase trials
508983|NCT00986518|Advanced Colorectal Cancer|advanced colorectal cancer
508984|NCT00986518|Hepatic and/or lung metastasis|hepatic and/or lung metastasis
508985|NCT00986518|Adaptive autologous cell immunotherapy|adaptive autologous cell immunotherapy
508986|NCT00986518|T- regulatory lymphocyte depletion|t- regulatory lymphocyte depletion
508987|NCT00986518|Neo-adjuvant reduced intensity chemotherapeutic conditioning|neo-adjuvant reduced intensity chemotherapeutic conditioning
508988|NCT00986505|lidocaine|lidocaine
508989|NCT00986505|fibromyalgia|fibromyalgia
508990|NCT00986505|intravenous lidocaine|intravenous lidocaine
508991|NCT00986505|manifestations|manifestations
508992|NCT00986492|Sleep deprivation|sleep deprivation
508993|NCT00986492|Food intake|food intake
508994|NCT00986492|Motor activity|motor activity
508995|NCT00986492|Normal, healthy subjects|normal, healthy subjects
508996|NCT00986479|Patients|patients
508997|NCT00986466|exercise|exercise
508998|NCT00986466|falls|falls
508999|NCT00986466|physical functioning|physical functioning
509000|NCT00986466|vitamin D|vitamin d
509001|NCT00986466|mobility function|mobility function
509002|NCT00986466|neuromuscular functioning¨|neuromuscular functioning¨
509003|NCT00986466|quality of life|quality of life
509004|NCT00986466|number of fallers|number of fallers
509005|NCT00986466|fall-related injuries including bone fractures|fall-related injuries including bone fractures
509006|NCT00986466|bone mass|bone mass
509007|NCT00986453|Breast Reduction|breast reduction
509008|NCT00986453|PlasmaBlade|plasmablade
509009|NCT00986453|Electrosurgery|electrosurgery
509010|NCT00986453|PEAK Surgical|peak surgical
509011|NCT00986453|Medtronic Advanced Energy|medtronic advanced energy
509012|NCT00986453|Medtronic|medtronic
509013|NCT00986414|Parkinson Disease|parkinson disease
509014|NCT00986414|L-dopa|l-dopa
509015|NCT00986414|Levodopa|levodopa
509016|NCT00986414|dyskinesia|dyskinesia
509017|NCT00986401|Adults|adults
509018|NCT00986375|Randomized Controlled Trial|randomized controlled trial
509019|NCT00986375|evidence- and theory-based behavioral intervention|evidence- and theory-based behavioral intervention
509020|NCT00986375|expert system|expert system
509021|NCT00986375|stages of change|stages of change
509022|NCT00986375|motivational interviewing|motivational interviewing
509023|NCT00986375|tailoring|tailoring
509024|NCT00986375|Self Care|self care
509025|NCT00986375|Rehabilitation|rehabilitation
509026|NCT00986375|Expert Systems|expert systems
509027|NCT00986375|Behavior|behavior
509028|NCT00986375|Motivation|motivation
509029|NCT00986362|Safety in pediatrics|safety in pediatrics
509030|NCT00986349|Diabetes|diabetes
509031|NCT00986349|Weight Loss|weight loss
509032|NCT00986349|GI Dynamics|gi dynamics
509033|NCT00986349|EndoBarrier|endobarrier
509034|NCT00986336|topiramate|topiramate
509035|NCT00986336|risperidone, bipolar disorder|risperidone, bipolar disorder
509036|NCT00986323|Asthma|asthma
509037|NCT00986323|Temperature controlled Laminar Airflow|temperature controlled laminar airflow
509038|NCT00986323|TLA|tla
509039|NCT00986323|Perennial allergy|perennial allergy
509040|NCT00986323|Quality of life|quality of life
509041|NCT00986323|Environmental control|environmental control
509042|NCT00986310|fluoxetine|fluoxetine
509043|NCT00986310|epilepsy|epilepsy
509044|NCT00986310|Prozac|prozac
509045|NCT00986297|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
509046|NCT00986297|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
509047|NCT00986297|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
509048|NCT00986297|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
509049|NCT00986297|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
509050|NCT00986297|adenocarcinoma of the lung|adenocarcinoma of the lung
509051|NCT00986297|adenosquamous cell lung cancer|adenosquamous cell lung cancer
509052|NCT00986297|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
509053|NCT00986297|large cell lung cancer|large cell lung cancer
509054|NCT00986297|squamous cell lung cancer|squamous cell lung cancer
509055|NCT00986284|Non Small Cell Lung Cancer|non small cell lung cancer
509056|NCT00986284|Gefitinib|gefitinib
509057|NCT00986284|Neoadjuvant Therapy|neoadjuvant therapy
509058|NCT00986271|severe sepsis, intensive care units|severe sepsis, intensive care units
509059|NCT00986258|pain assessment|pain assessment
509060|NCT00986258|tapentadol|tapentadol
509061|NCT00986258|centrally acting analgesic|centrally acting analgesic
509062|NCT00986245|Parkinson disease|parkinson disease
509063|NCT00986245|Ropinirole|ropinirole
509064|NCT00986219|Asthma|asthma
509065|NCT00986219|Language|language
509066|NCT00986219|Symptoms,|symptoms,
509067|NCT00986219|Limitation of Daily activities|limitation of daily activities
509068|NCT00986219|Patients|patients
509069|NCT00986219|Physicians|physicians
509070|NCT00986219|Greece|greece
509071|NCT00986206|ovarian epithelial cancer|ovarian epithelial cancer
509072|NCT00986206|BRCA1 mutation carrier|brca1 mutation carrier
509073|NCT00986206|BRCA2 mutation carrier|brca2 mutation carrier
509074|NCT00986206|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
509075|NCT00986206|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
509076|NCT00986206|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
509077|NCT00986206|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
509078|NCT00986206|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
509079|NCT00986206|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
509080|NCT00986206|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
509081|NCT00986206|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
509082|NCT00986206|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
509083|NCT00986206|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
509084|NCT00986193|Aortic Valve Stenosis|aortic valve stenosis
509085|NCT00986193|Stent Valve|stent valve
509285|NCT00985426|hepatitis B vaccine|hepatitis b vaccine
509086|NCT00986193|Biological Aortic Valve Prosthesis|biological aortic valve prosthesis
509087|NCT00986180|Acute Low Back Pain|acute low back pain
509088|NCT00986180|Low Back Pain With Leg Pain Below The Knee|low back pain with leg pain below the knee
509089|NCT00986180|Radiculopathy, Oxycodone|radiculopathy, oxycodone
509090|NCT00986180|Tapentadol|tapentadol
509091|NCT00986180|NUCYNTA|nucynta
509092|NCT00986167|Psychosis|psychosis
509093|NCT00986167|Aggression|aggression
509094|NCT00986167|Acute|acute
509095|NCT00986167|Quetiapine XR|quetiapine xr
509096|NCT00986154|Recurrent Thrombosis|recurrent thrombosis
509097|NCT00986154|Recurrent Pulmonary Embolism|recurrent pulmonary embolism
509098|NCT00986154|Symptomatic Deep Vein Thrombosis|symptomatic deep vein thrombosis
509099|NCT00986154|Symptomatic Pulmonary Embolism|symptomatic pulmonary embolism
509100|NCT00986154|Venous Thromboembolism (VTE)|venous thromboembolism (vte)
509101|NCT00986128|Topiramate|topiramate
509102|NCT00986128|Lithium|lithium
509103|NCT00986128|Bipolar disorder|bipolar disorder
509104|NCT00986115|epilepsy|epilepsy
509105|NCT00986115|memory|memory
509106|NCT00986115|cognition|cognition
509107|NCT00986115|memantine|memantine
509108|NCT00986102|Carbapenem|carbapenem
509109|NCT00986102|Doripenem|doripenem
509110|NCT00986102|Doribax|doribax
509111|NCT00986102|Nosocomial pneumonia, Intra-abdominal infections|nosocomial pneumonia, intra-abdominal infections
509112|NCT00986102|Urinary tract infection|urinary tract infection
509113|NCT00986089|post-placental|post-placental
509114|NCT00986089|IUD|iud
509115|NCT00986089|Copper IUD|copper iud
509116|NCT00986089|cesarean section|cesarean section
509117|NCT00986089|immediate post-partum|immediate post-partum
509118|NCT00986089|continuation|continuation
509119|NCT00986076|Pediatric Cataract Surgery|pediatric cataract surgery
509120|NCT00986076|Low-Molecular weight Heparin|low-molecular weight heparin
509121|NCT00986076|Intraocular infusion|intraocular infusion
509122|NCT00986076|Anti-inflammatory effect|anti-inflammatory effect
509123|NCT00986063|Nevirapine induced rash|nevirapine induced rash
509124|NCT00986063|Hepatitis|hepatitis
509125|NCT00986063|Pharmacogenomics|pharmacogenomics
509126|NCT00986063|AIDS|aids
509127|NCT00986063|HIV|hiv
509128|NCT00986063|treatment naive|treatment naive
509129|NCT00986050|STEMI|stemi
509130|NCT00986050|DES|des
509131|NCT00986050|BMS|bms
509132|NCT00986050|abciximab|abciximab
509133|NCT00986037|Adverse events|adverse events
509134|NCT00986037|Pharmacokinetics|pharmacokinetics
509135|NCT00986024|Exercise therapy|exercise therapy
509136|NCT00986011|obesity|obesity
509137|NCT00986011|weight changes|weight changes
509138|NCT00986011|healthy, no evidence of disease|healthy, no evidence of disease
509139|NCT00985998|nimotuzumab|nimotuzumab
509140|NCT00985998|non-small cell lung cancer|non-small cell lung cancer
509141|NCT00985998|chemotherapy|chemotherapy
509142|NCT00985985|smoking cessation|smoking cessation
509143|NCT00985985|nicotine lozenge|nicotine lozenge
509144|NCT00985985|nicotine replacement therapy|nicotine replacement therapy
509145|NCT00985972|PHYSICAL ACTIVITY|physical activity
509146|NCT00985972|SCHOOL|school
509147|NCT00985972|NUTRITION|nutrition
509148|NCT00985972|EDUCATION|education
509149|NCT00985972|OVERWEIGHT|overweight
509150|NCT00985959|Multiple myeloma|multiple myeloma
509151|NCT00985959|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
509152|NCT00985959|HSCT|hsct
509153|NCT00985959|Melphalan|melphalan
509154|NCT00985959|Prednisolone|prednisolone
509155|NCT00985959|Bortezomib|bortezomib
509156|NCT00985959|JNJ-26866138|jnj-26866138
509157|NCT00985933|Healthy normal volunteers|healthy normal volunteers
509158|NCT00985920|blood loss|blood loss
509159|NCT00985920|postoperative|postoperative
509160|NCT00985907|myeloma|myeloma
509161|NCT00985907|DMV|dmv
509162|NCT00985894|Teledermatology|teledermatology
509163|NCT00985894|Telemedicine|telemedicine
509164|NCT00985894|Atopic Dermatitis|atopic dermatitis
509165|NCT00985881|Artificial limbs|artificial limbs
509166|NCT00985881|Gait|gait
509167|NCT00985881|Posture|posture
509168|NCT00985881|Prosthesis|prosthesis
509169|NCT00985881|Vibration|vibration
509170|NCT00985868|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
509171|NCT00985842|Artificial limbs|artificial limbs
509172|NCT00985842|Gait|gait
509173|NCT00985842|Oximetry|oximetry
509174|NCT00985842|Prosthesis|prosthesis
509175|NCT00985842|Rehabilitation|rehabilitation
509176|NCT00985829|basal cell carcinoma|basal cell carcinoma
509177|NCT00985829|photodynamic therapy|photodynamic therapy
509178|NCT00985829|photo chemotherapy|photo chemotherapy
509179|NCT00985829|basal cell epithelioma|basal cell epithelioma
509180|NCT00985816|Preterm|preterm
509181|NCT00985816|newborns|newborns
509182|NCT00985816|Gastric|gastric
509183|NCT00985816|Motility|motility
509184|NCT00985816|Mucosal|mucosal
509185|NCT00985816|immunity|immunity
509186|NCT00985803|Systemic Lupus Erythematosus|systemic lupus erythematosus
509187|NCT00985803|Activity Physical|activity physical
509286|NCT00985426|hepatitis B|hepatitis b
509188|NCT00985803|Activity Disease,trials randomized|activity disease,trials randomized
509189|NCT00985790|vaccine|vaccine
509190|NCT00985790|Influenza|influenza
509191|NCT00985777|pancreas|pancreas
509192|NCT00985777|resectable|resectable
509193|NCT00985777|pancreatic tumor|pancreatic tumor
509194|NCT00985777|pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
509195|NCT00985777|intraductal papillary mucinous neoplasm of the pancreas|intraductal papillary mucinous neoplasm of the pancreas
509196|NCT00985777|mucinous cystic neoplasm|mucinous cystic neoplasm
509197|NCT00985777|pancreatic exocrine neoplasia|pancreatic exocrine neoplasia
509198|NCT00985751|immunogenicity|immunogenicity
509199|NCT00985751|toddlers|toddlers
509200|NCT00985751|Pneumococcal vaccine|pneumococcal vaccine
509201|NCT00985751|Haemophilus influenzae|haemophilus influenzae
509202|NCT00985751|safety|safety
509203|NCT00985751|Streptococcus pneumoniae|streptococcus pneumoniae
509204|NCT00985751|Streptococcus Pneumoniae Vaccines|streptococcus pneumoniae vaccines
509205|NCT00985738|Prostate Cancer|prostate cancer
509206|NCT00985738|Early Stage Prostate Cancer|early stage prostate cancer
509207|NCT00985725|Major Depressive Disorder|major depressive disorder
509208|NCT00985699|non-Hodgkin lymphoma|non-hodgkin lymphoma
509209|NCT00985699|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
509210|NCT00985699|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
509211|NCT00985699|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
509212|NCT00985686|e-mental health|e-mental health
509213|NCT00985686|Adolescent mental health|adolescent mental health
509214|NCT00985686|Spirituality|spirituality
509215|NCT00985673|GSK Bio's influenza vaccine GSK2340274A|gsk bio's influenza vaccine gsk2340274a
509216|NCT00985673|influenza infection|influenza infection
509217|NCT00985673|GSK Bio's influenza vaccine GSK2340273A|gsk bio's influenza vaccine gsk2340273a
509218|NCT00985647|HIV|hiv
509219|NCT00985647|HAART|haart
509220|NCT00985647|ART|art
509221|NCT00985647|Pharmacokinetic|pharmacokinetic
509222|NCT00985647|Healthy volunteers|healthy volunteers
509223|NCT00985647|3TC|3tc
509224|NCT00985647|Lamivudine|lamivudine
509225|NCT00985634|off pump bypass OPCAB|off pump bypass opcab
509226|NCT00985634|OPCAB|opcab
509227|NCT00985621|monoclonal antibody|monoclonal antibody
509228|NCT00985621|RN624|rn624
509229|NCT00985621|PF-04383119|pf-04383119
509230|NCT00985621|nerve growth factor|nerve growth factor
509231|NCT00985621|OA|oa
509232|NCT00985621|pain|pain
509233|NCT00985621|arthritis|arthritis
509234|NCT00985608|H pylori|h pylori
509235|NCT00985608|eradication therapy|eradication therapy
509236|NCT00985595|Adolescent|adolescent
509237|NCT00985595|substance abuse|substance abuse
509238|NCT00985582|Influenza A Virus (H1N1)|influenza a virus (h1n1)
509239|NCT00985569|Constipation|constipation
509240|NCT00985569|Nursing Home|nursing home
509241|NCT00985569|Quality Indicator|quality indicator
509242|NCT00985556|recurrent gastric cancer|recurrent gastric cancer
509243|NCT00985556|adenocarcinoma of the stomach|adenocarcinoma of the stomach
509244|NCT00985556|stage IIIA gastric cancer|stage iiia gastric cancer
509245|NCT00985556|stage IIIB gastric cancer|stage iiib gastric cancer
509246|NCT00985556|stage IIIC gastric cancer|stage iiic gastric cancer
509247|NCT00985556|stage IV gastric cancer|stage iv gastric cancer
509248|NCT00985543|HIV|hiv
509249|NCT00985543|ART|art
509250|NCT00985543|HAART|haart
509251|NCT00985543|Pharmacokinetics|pharmacokinetics
509252|NCT00985543|Lopinavir/ritonavir|lopinavir/ritonavir
509253|NCT00985543|Lower dose selection|lower dose selection
509254|NCT00985517|Parkinson's disease|parkinson's disease
509255|NCT00985517|Movement Disorders|movement disorders
509256|NCT00985517|Gene Therapy|gene therapy
509257|NCT00985517|Neurotrophic Factors|neurotrophic factors
509258|NCT00985517|GDNF|gdnf
509259|NCT00985517|Neurturin|neurturin
509260|NCT00985517|DBS|dbs
509261|NCT00985517|Dopamine|dopamine
509262|NCT00985504|Major Depressive Disorder|major depressive disorder
509263|NCT00985504|Apathy|apathy
509264|NCT00985504|Duloxetine Hydrochloride|duloxetine hydrochloride
509265|NCT00985504|SSRI|ssri
509266|NCT00985504|Escitalopram|escitalopram
509267|NCT00985491|obesity|obesity
509268|NCT00985478|First in Man|first in man
509269|NCT00985478|SLV342|slv342
509270|NCT00985478|Atherosclerosis|atherosclerosis
509271|NCT00985465|Booster vaccination|booster vaccination
509272|NCT00985465|Pneumococcal vaccine|pneumococcal vaccine
509273|NCT00985465|Catch-up vaccination|catch-up vaccination
509274|NCT00985465|Pneumococcal disease|pneumococcal disease
509275|NCT00985465|Safety|safety
509276|NCT00985465|Immunogenicity|immunogenicity
509277|NCT00985452|Medication|medication
509278|NCT00985452|Adherence|adherence
509279|NCT00985452|Hypertension|hypertension
509280|NCT00985426|chronic kidney disease|chronic kidney disease
509281|NCT00985426|kidney failure|kidney failure
509282|NCT00985426|kidney failure,chronic|kidney failure,chronic
509283|NCT00985426|chronic kidney failure|chronic kidney failure
509284|NCT00985426|hepatitis B virus (HBV) vaccine|hepatitis b virus (hbv) vaccine
509287|NCT00985426|hepatitis|hepatitis
509288|NCT00985426|HBV|hbv
509289|NCT00985426|prevention and control|prevention and control
509290|NCT00985426|dialysis|dialysis
509291|NCT00985413|Cockayne Syndrome|cockayne syndrome
509292|NCT00985413|pediatrics|pediatrics
509293|NCT00985413|growth|growth
509294|NCT00985413|hearing|hearing
509295|NCT00985413|Ageing|ageing
509296|NCT00985400|recurrent colon cancer|recurrent colon cancer
509297|NCT00985400|stage IV colon cancer|stage iv colon cancer
509298|NCT00985400|Gastrointestinal|gastrointestinal
509299|NCT00985400|Exercise|exercise
509300|NCT00985400|Relaxation|relaxation
509301|NCT00985400|Meditation|meditation
509302|NCT00985387|Solifenacin|solifenacin
509303|NCT00985387|Overactive bladder|overactive bladder
509304|NCT00985387|persistency of the treatment|persistency of the treatment
509305|NCT00985387|Vesicare|vesicare
509306|NCT00985348|Levetiracetam|levetiracetam
509307|NCT00985348|Healthy volunteers|healthy volunteers
509308|NCT00985348|Healthy Subjects|healthy subjects
509309|NCT00985322|Hemodialysis|hemodialysis
509310|NCT00985309|unsatisfactory|unsatisfactory
509311|NCT00985309|Pap smear|pap smear
509312|NCT00985296|Allergic rhinitis|allergic rhinitis
509313|NCT00985296|Allergic conjunctivitis|allergic conjunctivitis
509314|NCT00985283|prevention|prevention
509315|NCT00985283|older adults|older adults
509316|NCT00985283|function|function
509317|NCT00985283|participation|participation
509318|NCT00985283|life satisfaction|life satisfaction
509319|NCT00985283|self-rated health|self-rated health
509320|NCT00985244|COPD|copd
509321|NCT00985244|COPD exacerbation|copd exacerbation
509322|NCT00985244|macrolide|macrolide
509323|NCT00985244|diseae progression|diseae progression
509324|NCT00985244|bacterial colonisation|bacterial colonisation
509325|NCT00985218|infertility|infertility
509326|NCT00985218|embryo development|embryo development
509327|NCT00985205|Randomized Clinical Trial|randomized clinical trial
509328|NCT00985205|Glutamine|glutamine
509329|NCT00985205|Themal Burn Injuries|themal burn injuries
509330|NCT00985205|Nutrition|nutrition
509331|NCT00985205|Outcome Assessment|outcome assessment
509332|NCT00985205|Critical Care|critical care
509333|NCT00985205|Total Body Surface Area|total body surface area
509334|NCT00985192|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
509335|NCT00985192|adenocarcinoma of the stomach|adenocarcinoma of the stomach
509336|NCT00985192|recurrent esophageal cancer|recurrent esophageal cancer
509337|NCT00985192|stage III esophageal cancer|stage iii esophageal cancer
509338|NCT00985192|stage IV esophageal cancer|stage iv esophageal cancer
509339|NCT00985192|recurrent gastric cancer|recurrent gastric cancer
509340|NCT00985192|stage III gastric cancer|stage iii gastric cancer
509341|NCT00985192|stage IV gastric cancer|stage iv gastric cancer
509342|NCT00985179|Randomized Controlled Trial|randomized controlled trial
509343|NCT00985179|evidence- and theory-based behavioral intervention|evidence- and theory-based behavioral intervention
509344|NCT00985179|expert system|expert system
509345|NCT00985179|stages of change|stages of change
509346|NCT00985179|motivational interviewing|motivational interviewing
509347|NCT00985179|tailoring|tailoring
509348|NCT00985179|Self Care|self care
509349|NCT00985179|Expert Systems|expert systems
509350|NCT00985127|Hyperuricemia|hyperuricemia
509351|NCT00985127|Gout|gout
509352|NCT00985114|Type II Diabetes|type ii diabetes
509353|NCT00985114|Obesity|obesity
509354|NCT00985088|GSK Bio's influenza vaccine GSK2340274A|gsk bio's influenza vaccine gsk2340274a
509355|NCT00985088|influenza infection|influenza infection
509356|NCT00985088|GSK Bio's influenza vaccine GSK2340273A|gsk bio's influenza vaccine gsk2340273a
509357|NCT00985075|Allergic rhinitis|allergic rhinitis
509358|NCT00985075|Allergic conjunctivitis|allergic conjunctivitis
509359|NCT00985062|Folic Acid|folic acid
509360|NCT00985062|Homocysteine|homocysteine
509361|NCT00985062|Ovarian response|ovarian response
509362|NCT00985062|In Vitro Fertilization|in vitro fertilization
509363|NCT00985036|glioma|glioma
509364|NCT00985036|meningioma|meningioma
509365|NCT00985036|VEGF|vegf
509366|NCT00985023|Unstable|unstable
509367|NCT00985023|Lisfranc|lisfranc
509368|NCT00985023|fracture|fracture
509369|NCT00985023|dislocation|dislocation
509370|NCT00985023|midfoot|midfoot
509371|NCT00985010|hepatic encephalopathy|hepatic encephalopathy
509372|NCT00985010|hepatitis C|hepatitis c
509373|NCT00985010|manganese|manganese
509374|NCT00985010|mortality|mortality
509375|NCT00985010|prognosis.|prognosis.
509376|NCT00984997|Superior Sulcus Tumor|superior sulcus tumor
509377|NCT00984997|Lung Cancer|lung cancer
509378|NCT00984997|Non-Small Cell|non-small cell
509379|NCT00984997|Multimodality Treatment|multimodality treatment
509380|NCT00984997|Surgery|surgery
509381|NCT00984997|Segmentectomy|segmentectomy
509382|NCT00984997|Lobectomy|lobectomy
509383|NCT00984997|Cisplatin|cisplatin
509384|NCT00984997|CDDP|cddp
509385|NCT00984997|Etoposide|etoposide
509386|NCT00984997|VP-16|vp-16
509387|NCT00984997|VePesid|vepesid
509388|NCT00984997|Radiation Therapy|radiation therapy
509389|NCT00984997|Radiotherapy|radiotherapy
509491|NCT00984529|symptoms|symptoms
509390|NCT00984997|Chest Irradiation|chest irradiation
509391|NCT00984997|Prophylactic Cranial Irradiation|prophylactic cranial irradiation
509392|NCT00984997|PCI|pci
509393|NCT00984971|Microbicides|microbicides
509394|NCT00984971|Tenofovir|tenofovir
509395|NCT00984971|HIV seronegativity|hiv seronegativity
509396|NCT00984945|pandemic vaccine|pandemic vaccine
509397|NCT00984945|influenza|influenza
509398|NCT00984945|H5N1|h5n1
509399|NCT00984945|Virus Like Particle (VLP)|virus like particle (vlp)
509400|NCT00984932|systemic sclerosis|systemic sclerosis
509401|NCT00984932|pulmonary hypertension|pulmonary hypertension
509402|NCT00984932|rosuvastatin|rosuvastatin
509403|NCT00984919|recurrent prostate cancer|recurrent prostate cancer
509404|NCT00984919|stage I prostate cancer|stage i prostate cancer
509405|NCT00984919|stage II prostate cancer|stage ii prostate cancer
509406|NCT00984919|stage III prostate cancer|stage iii prostate cancer
509407|NCT00984919|stage IV prostate cancer|stage iv prostate cancer
509408|NCT00984893|Osteoporosis|osteoporosis
509409|NCT00984893|Bone Mineral density|bone mineral density
509410|NCT00984893|fragility fractures|fragility fractures
509411|NCT00984893|zoledronic acid.|zoledronic acid.
509412|NCT00984893|Treatment|treatment
509413|NCT00984880|Sedation|sedation
509414|NCT00984880|anaesthesia|anaesthesia
509415|NCT00984880|Safety|safety
509416|NCT00984880|Tolerability|tolerability
509417|NCT00984880|Pharmacokinetics|pharmacokinetics
509418|NCT00984880|Pharmacodynamics|pharmacodynamics
509419|NCT00984867|Dapagliflozin DPP IV inhibitor add on study|dapagliflozin dpp iv inhibitor add on study
509420|NCT00984867|Inadequate control|inadequate control
509421|NCT00984854|Cicatrix|cicatrix
509422|NCT00984854|Scar|scar
509423|NCT00984854|Wound-healing|wound-healing
509424|NCT00984854|Re-epithelialisation|re-epithelialisation
509425|NCT00984854|RN1004|rn1004
509426|NCT00984854|Mannose-6-phosphate|mannose-6-phosphate
509427|NCT00984854|M6P|m6p
509428|NCT00984854|Juvidex|juvidex
509429|NCT00984841|Diabetes Mellitus targeted mailing|diabetes mellitus targeted mailing
509430|NCT00984828|multiple myeloma|multiple myeloma
509431|NCT00984828|autologous stem cell transplantation|autologous stem cell transplantation
509432|NCT00984828|velcade|velcade
509433|NCT00984815|NSAID|nsaid
509434|NCT00984815|Chronic Pain|chronic pain
509435|NCT00984815|Osteoarthritis|osteoarthritis
509436|NCT00984815|Rheumatoid Arthritis|rheumatoid arthritis
509437|NCT00984789|Transdermal Patch|transdermal patch
509438|NCT00984789|Bleeding|bleeding
509439|NCT00984789|Pregnancy|pregnancy
509440|NCT00984776|coronary artery|coronary artery
509441|NCT00984776|MRI|mri
509442|NCT00984776|vessel wall imaging|vessel wall imaging
509443|NCT00984763|Malaria|malaria
509444|NCT00984763|Vaccine|vaccine
509445|NCT00984724|Smoking|smoking
509446|NCT00984724|Motivation and Problem Solving|motivation and problem solving
509447|NCT00984724|MAPS|maps
509448|NCT00984724|Low Income Smokers|low income smokers
509449|NCT00984724|HCHD community clinics|hchd community clinics
509450|NCT00984724|Telephone-based counseling|telephone-based counseling
509451|NCT00984698|Posttraumatic Stress Disorder|posttraumatic stress disorder
509452|NCT00984698|Depression|depression
509453|NCT00984698|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
509454|NCT00984698|Insomnia|insomnia
509455|NCT00984698|Psychotherapy, Group|psychotherapy, group
509456|NCT00984698|Cognitive Behavioral Therapy|cognitive behavioral therapy
509457|NCT00984698|Randomized Controlled Trial|randomized controlled trial
509458|NCT00984698|Veterans|veterans
509459|NCT00984698|Social Rhythms|social rhythms
509460|NCT00984672|Lumbar Degenerative Disease|lumbar degenerative disease
509461|NCT00984672|Bone Morphogenetic Protein|bone morphogenetic protein
509462|NCT00984672|TLIF|tlif
509463|NCT00984659|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
509464|NCT00984659|Dyspnea|dyspnea
509465|NCT00984646|Cicatrix|cicatrix
509466|NCT00984646|Scar|scar
509467|NCT00984646|Wound-healing|wound-healing
509468|NCT00984646|Prevascar|prevascar
509469|NCT00984646|Interleukin-10 (IL-10)|interleukin-10 (il-10)
509470|NCT00984646|Ilodecakin|ilodecakin
509471|NCT00984646|RN1003|rn1003
509472|NCT00984633|Neuromuscular Blocking Agents|neuromuscular blocking agents
509473|NCT00984607|Laparoscopic Gastric Band|laparoscopic gastric band
509474|NCT00984607|LAP BAND system|lap band system
509475|NCT00984594|allograft|allograft
509476|NCT00984594|knee injury|knee injury
509477|NCT00984594|cartilage injury|cartilage injury
509478|NCT00984581|Cicatrix|cicatrix
509479|NCT00984581|Scar|scar
509480|NCT00984581|Wound healing|wound healing
509481|NCT00984581|Avotermin|avotermin
509482|NCT00984581|TGF beta 3|tgf beta 3
509483|NCT00984581|Juvista|juvista
509484|NCT00984581|RN1001|rn1001
509485|NCT00984555|Biomarkers|biomarkers
509486|NCT00984555|Semen Exposure|semen exposure
509487|NCT00984542|recurrent small cell lung cancer|recurrent small cell lung cancer
509488|NCT00984529|Chronic heart failure|chronic heart failure
509489|NCT00984529|candesartan cilexetil|candesartan cilexetil
509490|NCT00984529|clinical signs|clinical signs
509492|NCT00984516|Cicatrix|cicatrix
509493|NCT00984516|Scar|scar
509494|NCT00984516|Wound-healing|wound-healing
509495|NCT00984516|Juvidex|juvidex
509496|NCT00984516|Mannose-6-phosphate|mannose-6-phosphate
509497|NCT00984516|M6P|m6p
509498|NCT00984516|RN1004|rn1004
509499|NCT00984503|Cicatrix|cicatrix
509500|NCT00984503|Scar|scar
509501|NCT00984503|Wound healing|wound healing
509502|NCT00984503|Avotermin|avotermin
509503|NCT00984503|TGF beta 3|tgf beta 3
509504|NCT00984503|Juvista|juvista
509505|NCT00984503|RN1001|rn1001
509506|NCT00984490|stage I breast cancer|stage i breast cancer
509507|NCT00984490|stage II breast cancer|stage ii breast cancer
509508|NCT00984477|Healthy volunteer|healthy volunteer
509509|NCT00984477|healthy subjects|healthy subjects
509510|NCT00984477|AZD5122|azd5122
509511|NCT00984477|single oral dose|single oral dose
509512|NCT00984477|phase 1|phase 1
509513|NCT00984477|Healthy volunteer phase 1 study|healthy volunteer phase 1 study
509514|NCT00984464|metastatic|metastatic
509515|NCT00984464|melanoma|melanoma
509516|NCT00984464|REOLYSIN|reolysin
509517|NCT00984464|chemotherapy|chemotherapy
509518|NCT00984464|carboplatin|carboplatin
509519|NCT00984464|paclitaxel|paclitaxel
509520|NCT00984451|Antibody Treatment|antibody treatment
509521|NCT00984451|Immune Therapy|immune therapy
509522|NCT00984451|Infectious Diseases|infectious diseases
509523|NCT00984451|IVIG|ivig
509524|NCT00984451|Plasma Apheresis|plasma apheresis
509525|NCT00984451|Influenza A|influenza a
509526|NCT00984451|Swine Flu|swine flu
509527|NCT00984399|vaginitis|vaginitis
509528|NCT00984399|Postmenopausal|postmenopausal
509529|NCT00984399|17-β estradiol|17-β estradiol
509530|NCT00984399|09-110|09-110
509531|NCT00984386|Cicatrix|cicatrix
509532|NCT00984386|Scar|scar
509533|NCT00984386|Wound-healing|wound-healing
509534|NCT00984386|Zesteem|zesteem
509535|NCT00984386|17β-Estradiol|17β-estradiol
509536|NCT00984386|RN1002|rn1002
509537|NCT00984373|Schizophrenia epidemiology|schizophrenia epidemiology
509538|NCT00984373|Schizophrenic patients' social and health characteristics|schizophrenic patients' social and health characteristics
509539|NCT00984360|Meth|meth
509540|NCT00984360|Methamphetamine Addiction|methamphetamine addiction
509541|NCT00984360|Methamphetamine Treatment|methamphetamine treatment
509542|NCT00984360|Naltrexone|naltrexone
509543|NCT00984360|Vivitrol|vivitrol
509544|NCT00984360|A118G|a118g
509545|NCT00984360|OPRM1|oprm1
509546|NCT00984347|nipple stimulation|nipple stimulation
509547|NCT00984347|Oxytocin|oxytocin
509548|NCT00984347|induction of labor|induction of labor
509549|NCT00984347|term pregnancies|term pregnancies
509550|NCT00984347|grandmultipara|grandmultipara
509551|NCT00984347|VBAC|vbac
509552|NCT00984347|PROM|prom
509553|NCT00984347|comparison of two methods for induction of labor|comparison of two methods for induction of labor
509554|NCT00984334|pain|pain
509555|NCT00984334|opioid|opioid
509556|NCT00984334|constipation|constipation
509557|NCT00984334|Subjects taking opioids for chronic non-cancer pain, who|subjects taking opioids for chronic non-cancer pain, who
509558|NCT00984334|experience symptoms of opioid induced constipation|experience symptoms of opioid induced constipation
509559|NCT00984321|Geriatric|geriatric
509560|NCT00984321|Elderly|elderly
509561|NCT00984321|Counseling|counseling
509562|NCT00984321|Depression|depression
509563|NCT00984321|Anxiety|anxiety
509564|NCT00984321|Intervention|intervention
509565|NCT00984321|Psychoeducational|psychoeducational
509566|NCT00984321|09-116|09-116
509567|NCT00984308|sleep apnea|sleep apnea
509568|NCT00984308|hypertension|hypertension
509569|NCT00984308|brain ischemia|brain ischemia
509570|NCT00984282|RAI-Refractory|rai-refractory
509571|NCT00984282|Differentiated|differentiated
509572|NCT00984282|Follicular|follicular
509573|NCT00984282|Papillary|papillary
509574|NCT00984282|Hurthle|hurthle
509575|NCT00984256|Malaria|malaria
509576|NCT00984256|Prophylaxis|prophylaxis
509577|NCT00984256|Atovaquone|atovaquone
509578|NCT00984256|Malarone|malarone
509579|NCT00984256|Challenge|challenge
509580|NCT00984243|lung cancer|lung cancer
509581|NCT00984230|Infant Formula|infant formula
509582|NCT00984230|Gut|gut
509583|NCT00984217|panitumumab|panitumumab
509584|NCT00984217|salivary gland malignancies|salivary gland malignancies
509585|NCT00984217|radiotherapy|radiotherapy
509586|NCT00984204|cavo-tricuspid dependent|cavo-tricuspid dependent
509587|NCT00984191|Papillary thyroid cancer|papillary thyroid cancer
509588|NCT00984191|99mTechnetium MIBI SPECT CT|99mtechnetium mibi spect ct
509589|NCT00984191|preoperative|preoperative
509590|NCT00984191|cervical lymphadenopathy|cervical lymphadenopathy
509591|NCT00984191|cervical metastasis|cervical metastasis
509592|NCT00984178|Reperfusion|reperfusion
509593|NCT00984178|acute myocardial infarction|acute myocardial infarction
509594|NCT00984178|stem cell therapy|stem cell therapy
509595|NCT00984178|GCSF|gcsf
509596|NCT00984178|bone marrow mononuclear cells|bone marrow mononuclear cells
509597|NCT00984178|magnetic resonance|magnetic resonance
509598|NCT00984165|Allotransplant|allotransplant
509599|NCT00984165|Relapse|relapse
509600|NCT00984165|Radiation|radiation
509601|NCT00984165|Donor Lymphocyte Infusion|donor lymphocyte infusion
509602|NCT00984165|Hematologic Malignancies|hematologic malignancies
509603|NCT00984165|Multiple Myeloma|multiple myeloma
509604|NCT00984165|Hodgkin Lymphoma|hodgkin lymphoma
509605|NCT00984165|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
509606|NCT00984165|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
509607|NCT00984152|HIV|hiv
509608|NCT00984152|Raltegravir|raltegravir
509609|NCT00984152|Women|women
509610|NCT00984152|Viral Suppression|viral suppression
509611|NCT00984152|Viral Reservoir|viral reservoir
509612|NCT00984152|Immune Parameters|immune parameters
509613|NCT00984152|Gut|gut
509614|NCT00984152|Genital Tract|genital tract
509615|NCT00984139|persistence|persistence
509616|NCT00984139|HBV|hbv
509617|NCT00984139|Long-term|long-term
509618|NCT00984139|Engerix™-B Kinder|engerix™-b kinder
509619|NCT00984139|Hepatitis B|hepatitis b
509620|NCT00984139|adolescent|adolescent
509621|NCT00984113|Elinogrel|elinogrel
509622|NCT00984113|Renal impairment|renal impairment
509623|NCT00984113|Healthy|healthy
509624|NCT00984113|Kidney dysfunction|kidney dysfunction
509625|NCT00984100|Cholelithiasis|cholelithiasis
509626|NCT00984100|Biliary dyskinesia|biliary dyskinesia
509627|NCT00984087|depression|depression
509628|NCT00984087|TMS|tms
509629|NCT00984087|adolescent|adolescent
509630|NCT00984087|transcranial magnetic stimulation|transcranial magnetic stimulation
509631|NCT00984087|MDD|mdd
509632|NCT00984087|Major depression|major depression
509633|NCT00984087|mood disorders|mood disorders
509634|NCT00984074|stage III salivary gland cancer|stage iii salivary gland cancer
509635|NCT00984074|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
509636|NCT00984074|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
509637|NCT00984074|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
509638|NCT00984074|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
509639|NCT00984074|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
509640|NCT00984074|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
509641|NCT00984074|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
509642|NCT00984074|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
509643|NCT00984074|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
509644|NCT00984074|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
509645|NCT00984074|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
509646|NCT00984074|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
509647|NCT00984074|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
509648|NCT00984074|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
509649|NCT00984074|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
509742|NCT00983983|Lipid|lipid
509650|NCT00984074|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
509651|NCT00984074|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
509652|NCT00984074|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
509653|NCT00984074|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
509654|NCT00984074|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
509655|NCT00984074|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
509656|NCT00984074|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
509657|NCT00984074|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
509658|NCT00984074|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
509659|NCT00984074|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
509660|NCT00984074|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
509661|NCT00984074|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
509662|NCT00984074|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
509663|NCT00984074|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
509664|NCT00984074|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
509665|NCT00984074|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
509666|NCT00984074|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
509667|NCT00984074|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
509668|NCT00984074|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
509669|NCT00984074|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
509732|NCT00984009|healthy|healthy
509670|NCT00984074|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
509671|NCT00984074|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
509672|NCT00984074|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
509673|NCT00984074|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
509674|NCT00984074|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
509675|NCT00984074|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
509676|NCT00984074|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
509677|NCT00984074|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
509678|NCT00984074|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
509679|NCT00984074|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
509680|NCT00984074|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
509681|NCT00984074|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
509682|NCT00984074|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
509683|NCT00984074|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
509684|NCT00984074|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
509685|NCT00984074|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
509686|NCT00984074|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
509687|NCT00984074|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
509688|NCT00984074|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
509689|NCT00984074|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
509690|NCT00984074|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
509691|NCT00984074|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
509692|NCT00984074|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
509693|NCT00984074|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
509694|NCT00984074|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
509695|NCT00984074|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
509696|NCT00984074|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
509697|NCT00984074|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
509698|NCT00984074|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
509699|NCT00984074|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
509700|NCT00984074|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
509701|NCT00984074|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
509702|NCT00984074|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
509703|NCT00984074|recurrent salivary gland cancer|recurrent salivary gland cancer
509704|NCT00984074|salivary gland acinic cell tumor|salivary gland acinic cell tumor
509705|NCT00984074|salivary gland adenocarcinoma|salivary gland adenocarcinoma
509706|NCT00984074|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
509707|NCT00984074|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
509708|NCT00984074|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
509709|NCT00984074|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
509710|NCT00984074|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
509711|NCT00984074|stage I salivary gland cancer|stage i salivary gland cancer
509712|NCT00984074|stage II salivary gland cancer|stage ii salivary gland cancer
509713|NCT00984074|tongue cancer|tongue cancer
509714|NCT00984061|healthy|healthy
509715|NCT00984061|pharmacokinetics|pharmacokinetics
509716|NCT00984061|drug-drug interaction|drug-drug interaction
509717|NCT00984048|Colorectal cancer|colorectal cancer
509718|NCT00984048|FOLFOX|folfox
509719|NCT00984048|FOLFIRI|folfiri
509720|NCT00984048|Avastin|avastin
509721|NCT00984048|Metastases|metastases
509722|NCT00984048|Liver|liver
509723|NCT00984048|Colon cancer|colon cancer
509724|NCT00984048|Biomarkers|biomarkers
509725|NCT00984048|Resistance|resistance
509726|NCT00984048|Biobanking|biobanking
509727|NCT00984048|Colorectal cancer with unresectable metastases to the liver|colorectal cancer with unresectable metastases to the liver
509728|NCT00984022|abscess|abscess
509729|NCT00984022|MRSA|mrsa
509730|NCT00984022|Aquacel dressing|aquacel dressing
509731|NCT00984022|Iodoform dressing|iodoform dressing
509733|NCT00984009|pharmacokinetics|pharmacokinetics
509734|NCT00984009|grapefruit juice|grapefruit juice
509735|NCT00984009|furanocoumarins|furanocoumarins
509736|NCT00984009|cytochrome p450 3A4|cytochrome p450 3a4
509737|NCT00983983|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
509738|NCT00983983|ALS|als
509739|NCT00983983|Motor Neuron Disease|motor neuron disease
509740|NCT00983983|MND|mnd
509741|NCT00983983|Fat|fat
509743|NCT00983983|Cholesterol|cholesterol
509744|NCT00983983|Omega-3 fatty acid|omega-3 fatty acid
509745|NCT00983983|Diet|diet
509746|NCT00983983|Tube feed|tube feed
509747|NCT00983983|Gastrostomy|gastrostomy
509748|NCT00983983|PEG|peg
509749|NCT00983983|Adults with Amyotrophic Lateral Sclerosis (ALS)|adults with amyotrophic lateral sclerosis (als)
509750|NCT00983970|Adolescents|adolescents
509751|NCT00983970|Obesity|obesity
509752|NCT00983970|Exercise|exercise
509753|NCT00983970|Music|music
509754|NCT00983970|Virtual Reality|virtual reality
509755|NCT00983944|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
509756|NCT00983944|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
509757|NCT00983944|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
509758|NCT00983944|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
509759|NCT00983944|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
509760|NCT00983944|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
509761|NCT00983944|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
509762|NCT00983944|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
509763|NCT00983944|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
509764|NCT00983944|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
509765|NCT00983931|healthy|healthy
509766|NCT00983931|adult|adult
509767|NCT00983931|colchicine|colchicine
509768|NCT00983931|cyclosporine|cyclosporine
509769|NCT00983931|blood levels over time|blood levels over time
509770|NCT00983905|healthy;|healthy;
509771|NCT00983905|adult;|adult;
509772|NCT00983905|blood levels over time|blood levels over time
509773|NCT00983892|Cancer|cancer
509774|NCT00983892|caregiver|caregiver
509775|NCT00983892|pain|pain
509776|NCT00983892|symptom|symptom
509777|NCT00983892|information technology|information technology
509778|NCT00983892|palliative care|palliative care
509779|NCT00983879|Infantile globoid cell leukodystrophy|infantile globoid cell leukodystrophy
509780|NCT00983879|GLD|gld
509781|NCT00983879|Krabbe disease|krabbe disease
509782|NCT00983879|Natural History Study|natural history study
509783|NCT00983853|VX-950|vx-950
509784|NCT00983853|INCIVEK|incivek
509785|NCT00983853|INCIVO|incivo
509786|NCT00983840|diet|diet
509787|NCT00983840|African-American families|african-american families
509788|NCT00983840|web-based|web-based
509789|NCT00983814|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
509790|NCT00983814|ADHD|adhd
509791|NCT00983814|Adult ADHD|adult adhd
509792|NCT00983814|Adult Attention Deficit Hyperactivity Disorder|adult attention deficit hyperactivity disorder
509793|NCT00983788|CPT II|cpt ii
509794|NCT00983788|VLCAD|vlcad
509795|NCT00983775|Pharmacokinetic profile|pharmacokinetic profile
509796|NCT00983775|Pharmacodynamic profile|pharmacodynamic profile
509797|NCT00983775|insulin|insulin
509798|NCT00983775|jet injector|jet injector
509799|NCT00983762|Knee osteoarthritis|knee osteoarthritis
509800|NCT00983762|Leg strength|leg strength
509801|NCT00983762|Functional outcomes|functional outcomes
509802|NCT00983762|Minimally Invasive Surgery Mini-Incision (MIS) TKA|minimally invasive surgery mini-incision (mis) tka
509803|NCT00983762|Unicompartmental knee arthroplasty|unicompartmental knee arthroplasty
509804|NCT00983762|Standard Para-patellar surgery TKA|standard para-patellar surgery tka
509805|NCT00983762|gait|gait
509806|NCT00983762|knee arthroplasty|knee arthroplasty
509807|NCT00983749|External Counterpulsation|external counterpulsation
509808|NCT00983749|Counterpulsation, Diastolic|counterpulsation, diastolic
509809|NCT00983749|Ultrasonography, Doppler, Transcranial|ultrasonography, doppler, transcranial
509810|NCT00983749|Blood Flow Velocity|blood flow velocity
509811|NCT00983749|Neurologic Deficit|neurologic deficit
509812|NCT00983723|Patient Foramen Ovale|patient foramen ovale
509813|NCT00983723|PFO|pfo
509814|NCT00983723|Stroke|stroke
509815|NCT00983723|Ischemic Brain Injury|ischemic brain injury
509816|NCT00983723|Neurovascular Disease|neurovascular disease
509817|NCT00983710|prostate neoplasms|prostate neoplasms
509818|NCT00983697|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
509819|NCT00983697|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
509820|NCT00983697|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
509821|NCT00983697|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
509822|NCT00983697|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
509823|NCT00983697|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
509824|NCT00983697|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
509825|NCT00983697|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
509826|NCT00983697|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
509827|NCT00983697|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
509828|NCT00983697|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
509829|NCT00983697|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
509830|NCT00983697|tongue cancer|tongue cancer
509831|NCT00983684|Neoplasms by Site|neoplasms by site
509832|NCT00983684|Breast Neoplasms|breast neoplasms
509833|NCT00983684|Breast Diseases|breast diseases
509834|NCT00983684|Breast Cancer|breast cancer
509835|NCT00983684|Cancer of Breast|cancer of breast
509836|NCT00983684|Cancer of the Breast|cancer of the breast
509837|NCT00983684|Carcinoma|carcinoma
509838|NCT00983671|Asthma|asthma
509839|NCT00983671|cystic fibrosis|cystic fibrosis
509840|NCT00983671|chronic lung disease|chronic lung disease
509841|NCT00983671|bronchopulmonary dysplasia|bronchopulmonary dysplasia
509842|NCT00983671|pneumonia|pneumonia
509843|NCT00983658|Anti-OX40L|anti-ox40l
509844|NCT00983658|Mild Allergic Asthma|mild allergic asthma
509845|NCT00983658|Allergies|allergies
509846|NCT00983658|Allergic Asthma|allergic asthma
509847|NCT00983658|Adult Asthma|adult asthma
509848|NCT00983645|Kidney Transplantation|kidney transplantation
509849|NCT00983645|Immunosuppression|immunosuppression
509850|NCT00983632|vagus nerve stimulation|vagus nerve stimulation
509851|NCT00983632|heart rate|heart rate
509852|NCT00983632|systolic arterial pressure|systolic arterial pressure
509853|NCT00983619|Cancer|cancer
509854|NCT00983593|Mind Body Bridging|mind body bridging
509855|NCT00983593|Domestic Violence Offender Treatment|domestic violence offender treatment
509856|NCT00983593|Batterer Treatment|batterer treatment
509857|NCT00983554|testosterone|testosterone
509858|NCT00983554|insulin|insulin
509859|NCT00983554|obesity|obesity
509860|NCT00983554|aromatase|aromatase
509861|NCT00983554|5 alpha reductase|5 alpha reductase
509862|NCT00983541|intra or extrahepatic cholangiocarcinoma|intra or extrahepatic cholangiocarcinoma
509863|NCT00983541|liver cancer|liver cancer
509864|NCT00983541|liver|liver
509865|NCT00983541|HCC|hcc
509866|NCT00983541|EHCC|ehcc
509867|NCT00983528|cancer|cancer
509868|NCT00983528|lymphoblastic|lymphoblastic
509869|NCT00983528|leukemia|leukemia
509870|NCT00983502|Idiopathic Chronic Fatigue|idiopathic chronic fatigue
509871|NCT00983502|Chronic Fatigue Syndrome|chronic fatigue syndrome
509872|NCT00983502|Myalgic encephalomyelitis|myalgic encephalomyelitis
509873|NCT00983489|breast feeding|breast feeding
509874|NCT00983489|counselling|counselling
509875|NCT00983489|video demonstration|video demonstration
509876|NCT00983476|Randomized controlled trial|randomized controlled trial
509877|NCT00983476|Obesity|obesity
509878|NCT00983476|Comparative Effectiveness|comparative effectiveness
509879|NCT00983476|Clinical practice guidelines|clinical practice guidelines
509880|NCT00983476|Medical Informatics Computing|medical informatics computing
509881|NCT00983476|Services, Mental Health|services, mental health
509882|NCT00983476|Self-care|self-care
509883|NCT00983476|Psychotic disorders|psychotic disorders
509884|NCT00983476|Mental Health Care|mental health care
509885|NCT00983476|Veterans|veterans
509886|NCT00983463|Nonalcoholic fatty liver disease (NAFLD)|nonalcoholic fatty liver disease (nafld)
509887|NCT00983463|Nonalcoholic steatohepatitis (NASH)|nonalcoholic steatohepatitis (nash)
509888|NCT00983463|Obesity|obesity
509889|NCT00983463|Lipidomics|lipidomics
509890|NCT00983463|Proteomics|proteomics
509891|NCT00983424|Breast Cancer|breast cancer
509892|NCT00983411|non-invasive intermittent positive-pressure ventilation|non-invasive intermittent positive-pressure ventilation
509893|NCT00983411|work of breathing|work of breathing
509894|NCT00983411|Pulse transit time|pulse transit time
509895|NCT00983385|low back pain|low back pain
509896|NCT00983385|pain|pain
509897|NCT00983385|assessment|assessment
509898|NCT00983385|tapentadol|tapentadol
509899|NCT00983385|centrally acting analgesic|centrally acting analgesic
509900|NCT00983372|healthy; adult; volunteer; colchicine; diltiazem; blood levels over time|healthy; adult; volunteer; colchicine; diltiazem; blood levels over time
509901|NCT00983359|tumors metastatic to brain|tumors metastatic to brain
509902|NCT00983359|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
509903|NCT00983346|cancer|cancer
509904|NCT00983346|myeloma|myeloma
509905|NCT00983346|multiple myeloma|multiple myeloma
509906|NCT00983346|smoldering myeloma|smoldering myeloma
509907|NCT00983333|Health communication|health communication
509908|NCT00983333|Health literacy|health literacy
509909|NCT00983333|Patient|patient
509910|NCT00983333|Health Care Professional|health care professional
509911|NCT00983333|Satisfaction|satisfaction
509912|NCT00983320|Fibromyalgia|fibromyalgia
509913|NCT00983320|pain|pain
509914|NCT00983320|quetiapine|quetiapine
509915|NCT00983320|randomized placebo controlled trial|randomized placebo controlled trial
509916|NCT00983307|Radiation|radiation
509917|NCT00983307|Erlotinib|erlotinib
509918|NCT00983307|Tarceva|tarceva
509919|NCT00983294|blood levels over time;|blood levels over time;
509920|NCT00983294|colchicine;|colchicine;
509921|NCT00983294|azithromycin;|azithromycin;
509922|NCT00983294|healthy|healthy
509923|NCT00983281|Combat casualty care|combat casualty care
509924|NCT00983281|Hextend|hextend
509925|NCT00983281|Colloid|colloid
509926|NCT00983268|periampullary adenocarcinoma|periampullary adenocarcinoma
509927|NCT00983268|stage I pancreatic cancer|stage i pancreatic cancer
509928|NCT00983268|stage II pancreatic cancer|stage ii pancreatic cancer
509929|NCT00983268|stage III pancreatic cancer|stage iii pancreatic cancer
509930|NCT00983229|difficult airway|difficult airway
509931|NCT00983229|fibreoptic intubation|fibreoptic intubation
509932|NCT00983229|supraglottic airways|supraglottic airways
509933|NCT00983229|laryngeal mask airway|laryngeal mask airway
509934|NCT00983216|blood levels over time;|blood levels over time;
509935|NCT00983216|pharmacokinetics;|pharmacokinetics;
509936|NCT00983216|healthy adult;|healthy adult;
509937|NCT00983216|cytochrome p450|cytochrome p450
509938|NCT00983203|Dry eye|dry eye
509939|NCT00983203|artificial tears|artificial tears
509940|NCT00983190|HeartMate II|heartmate ii
509941|NCT00983190|BeneMACS|benemacs
509942|NCT00983190|LVAD|lvad
509943|NCT00983190|Thoratec Corporation|thoratec corporation
509944|NCT00983164|antiviral therapy|antiviral therapy
509945|NCT00983164|antioxidant therapy|antioxidant therapy
509946|NCT00983164|hepatitis C virus|hepatitis c virus
509947|NCT00983164|oxidative stress|oxidative stress
509948|NCT00983164|vitamin E|vitamin e
509949|NCT00983125|Labour|labour
509950|NCT00983125|Epidural analgesia|epidural analgesia
509951|NCT00983125|Clonidine|clonidine
509952|NCT00983125|Levobupivacaine|levobupivacaine
509953|NCT00983125|Opiates|opiates
509954|NCT00983125|Patient-controlled|patient-controlled
509955|NCT00983125|Active spontaneous labour requiring epidural analgesia|active spontaneous labour requiring epidural analgesia
509956|NCT00983112|Gonarthrosis|gonarthrosis
509957|NCT00983112|Knee prosthesis insertion|knee prosthesis insertion
509958|NCT00983112|Bleeding|bleeding
509959|NCT00983112|Undergoing a total knee prothesis surgery|undergoing a total knee prothesis surgery
509960|NCT00983112|knee prothesis surgery|knee prothesis surgery
509961|NCT00983112|Knee arthrosis|knee arthrosis
509962|NCT00983112|Thrombosis|thrombosis
509963|NCT00983086|Flavanones and vascular function|flavanones and vascular function
509964|NCT00983073|Osteoarthritis|osteoarthritis
509965|NCT00983073|Pain|pain
509966|NCT00983073|Assessment|assessment
509967|NCT00983073|Tapentadol|tapentadol
509968|NCT00983073|Centrally acting analgesic|centrally acting analgesic
509969|NCT00983073|Chronic pain due to osteoarthritis|chronic pain due to osteoarthritis
509970|NCT00983060|NIM811|nim811
509971|NCT00983060|chronic hepatitis|chronic hepatitis
509972|NCT00983060|chronic hepatitis C|chronic hepatitis c
509973|NCT00983060|chronic hepatitis C genotype-1|chronic hepatitis c genotype-1
509974|NCT00983060|HCV|hcv
509975|NCT00983060|HCV-1|hcv-1
509976|NCT00983060|relapser|relapser
509977|NCT00983047|Nimotuzumab|nimotuzumab
509978|NCT00983047|NSCLC|nsclc
509979|NCT00983047|Docetaxel|docetaxel
509980|NCT00983034|nephrotic syndrome|nephrotic syndrome
509981|NCT00983034|Helicobacter pylori infection|helicobacter pylori infection
509982|NCT00983034|proteinuria|proteinuria
509983|NCT00983034|membranous nephropathy|membranous nephropathy
509984|NCT00983008|Signs and Symptoms|signs and symptoms
509985|NCT00983008|Fatigue|fatigue
509986|NCT00983008|Sleep Deprivation|sleep deprivation
509987|NCT00983008|Internship and Residency|internship and residency
509988|NCT00983008|Depression|depression
509989|NCT00983008|Medical Errors|medical errors
509990|NCT00983008|Burnout, Professional|burnout, professional
509991|NCT00983008|Burnout|burnout
509992|NCT00983008|Actigraphy|actigraphy
509993|NCT00983008|Personnel Staffing and Scheduling|personnel staffing and scheduling
509994|NCT00983008|Workload|workload
509995|NCT00983008|Humans|humans
509996|NCT00983008|Adult|adult
509997|NCT00983008|Male|male
509998|NCT00983008|Female|female
509999|NCT00983008|Intensive Care Units|intensive care units
510000|NCT00983008|Prospective Studies|prospective studies
510001|NCT00983008|Work Schedule Tolerance|work schedule tolerance
510002|NCT00983008|Disorders of Excessive Somnolence|disorders of excessive somnolence
510003|NCT00983008|Guideline Adherence|guideline adherence
510004|NCT00983008|Internal Medicine Education|internal medicine education
510005|NCT00982982|Schizophrenia|schizophrenia
510006|NCT00982982|Mental Disorders|mental disorders
510007|NCT00982982|Psychotic Disorders|psychotic disorders
510008|NCT00982982|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
510009|NCT00982982|Cannabis|cannabis
510010|NCT00982969|tuberculosis|tuberculosis
510011|NCT00982969|pneumonia|pneumonia
510012|NCT00982969|QuantiFERON-TB Gold in-tube|quantiferon-tb gold in-tube
510013|NCT00982969|Tuberculin skin test|tuberculin skin test
510014|NCT00982930|Tobramycin Inhalation Powder|tobramycin inhalation powder
510015|NCT00982930|Cystic fibrosis|cystic fibrosis
510016|NCT00982930|Lung diseases|lung diseases
510017|NCT00982930|Anti-Bacterial Agents|anti-bacterial agents
510018|NCT00982917|playground|playground
510019|NCT00982917|injury prevention|injury prevention
510020|NCT00982904|neglected disease|neglected disease
510021|NCT00982904|africa|africa
510022|NCT00982904|new drug|new drug
510023|NCT00982904|oral drug|oral drug
510024|NCT00982904|parasite|parasite
510025|NCT00982891|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
510026|NCT00982891|palliation|palliation
510027|NCT00982891|opioids|opioids
510028|NCT00982878|treatment experienced|treatment experienced
510029|NCT00982865|MEK inhibitor|mek inhibitor
510030|NCT00982865|Cancer|cancer
510031|NCT00982865|Solid tumors|solid tumors
510032|NCT00982852|Angioplasty|angioplasty
510033|NCT00982852|Coronary Vessels|coronary vessels
510034|NCT00982852|Heart Disease|heart disease
510035|NCT00982852|Cardiology|cardiology
510036|NCT00982852|Atherosclerosis|atherosclerosis
510037|NCT00982852|Catheterization|catheterization
510038|NCT00982826|Phase 1|phase 1
510039|NCT00982826|Single and Multiple Ascending Dose|single and multiple ascending dose
510040|NCT00982826|Food Effect|food effect
510041|NCT00982813|Periodontal disease|periodontal disease
510042|NCT00982813|Per-term delivery|per-term delivery
510043|NCT00982813|Sulcular bleeding index|sulcular bleeding index
510044|NCT00982813|Bacteriological gingival presence|bacteriological gingival presence
510045|NCT00982813|Cytokines|cytokines
510046|NCT00982813|Active periodontal disease with sulcular bleeding index|active periodontal disease with sulcular bleeding index
510047|NCT00982813|Bacteriological sampling in periodontal pocketing|bacteriological sampling in periodontal pocketing
510048|NCT00982813|Cytokines in the periodontal pocketing|cytokines in the periodontal pocketing
510049|NCT00982800|gabapentin|gabapentin
510050|NCT00982800|opioid consumption|opioid consumption
510051|NCT00982800|analgesic|analgesic
510052|NCT00982800|anxiety|anxiety
510053|NCT00982800|quality of life|quality of life
510054|NCT00982787|Epilepsy|epilepsy
510055|NCT00982787|Seizures|seizures
510056|NCT00982787|Passiflora|passiflora
510057|NCT00982774|PKDL|pkdl
510058|NCT00982761|occupational drivers|occupational drivers
510059|NCT00982761|health status|health status
510060|NCT00982748|Fatigue|fatigue
510061|NCT00982748|Chemotherapy|chemotherapy
510062|NCT00982748|Yoga|yoga
510063|NCT00982748|Breathing|breathing
510064|NCT00982748|Cancer|cancer
510065|NCT00982748|Anxiety|anxiety
510066|NCT00982748|Pranayama|pranayama
510067|NCT00982748|Stress|stress
510068|NCT00982748|Fatigue-associated symptoms in chemotherapy patients|fatigue-associated symptoms in chemotherapy patients
510069|NCT00982748|Quality of life in chemotherapy patients|quality of life in chemotherapy patients
510070|NCT00982722|primary hyperparathyroidism|primary hyperparathyroidism
510071|NCT00982722|postoperative vitamin D supplementation|postoperative vitamin d supplementation
510072|NCT00982696|head and neck cancer|head and neck cancer
510073|NCT00982696|opioid growth factor|opioid growth factor
510074|NCT00982683|Surgery|surgery
510075|NCT00982683|Moon phases|moon phases
510076|NCT00982683|hemorrhage|hemorrhage
510077|NCT00982670|Metabolic syndrome|metabolic syndrome
510078|NCT00982670|Systemic lupus erythematosus|systemic lupus erythematosus
510079|NCT00982657|Phase Ib Phase II Advanced solid tumor Clear cell renal cancer Sunitinib plus / minus CVX-060|phase ib phase ii advanced solid tumor clear cell renal cancer sunitinib plus / minus cvx-060
510080|NCT00982631|temsirolimus (Torisel®)|temsirolimus (torisel®)
510081|NCT00982631|pegylated liposomal doxorubicin (PLD, Doxil®/ Caelyx®)|pegylated liposomal doxorubicin (pld, doxil®/ caelyx®)
510082|NCT00982579|HIV preventive vaccine|hiv preventive vaccine
510083|NCT00982553|Healthy Volunteers|healthy volunteers
510084|NCT00982540|empiric antifungal therapy|empiric antifungal therapy
510085|NCT00982540|preemptive antifungal therapy|preemptive antifungal therapy
510086|NCT00982540|febrile neutropenia|febrile neutropenia
510087|NCT00982540|risk stratification|risk stratification
510088|NCT00982540|invasive fungal infection|invasive fungal infection
510089|NCT00982527|cardiopulmonary bypass|cardiopulmonary bypass
510090|NCT00982527|pediatric cardiac surgery|pediatric cardiac surgery
510091|NCT00982527|acute renal failure|acute renal failure
510092|NCT00982527|renal biomarkers|renal biomarkers
510093|NCT00982527|fenoldopam|fenoldopam
510094|NCT00982527|Focus on optimization of perfusion during pediatric CPB|focus on optimization of perfusion during pediatric cpb
510095|NCT00982514|Asparaginase|asparaginase
510096|NCT00982514|thrombosis|thrombosis
510097|NCT00982514|ALL|all
510098|NCT00982514|central line|central line
510099|NCT00982501|(BMI 25-29,9 kg/m2)|(bmi 25-29,9 kg/m2)
510100|NCT00982475|pulmonary vein isolation|pulmonary vein isolation
510101|NCT00982475|robotic navigation|robotic navigation
510102|NCT00982475|atrial fibrillation|atrial fibrillation
510103|NCT00982462|cognition|cognition
510104|NCT00982462|vision|vision
510105|NCT00982462|immunology|immunology
510106|NCT00982462|DHA|dha
510107|NCT00982462|ARA|ara
510108|NCT00982462|infant|infant
510109|NCT00982462|nutrition|nutrition
510110|NCT00982449|EBV+ malignancies|ebv+ malignancies
510111|NCT00982449|KSHV+ malignancies|kshv+ malignancies
510112|NCT00982449|HIV-associated lymphomas|hiv-associated lymphomas
510113|NCT00982449|Hodgkin Lymphoma|hodgkin lymphoma
510114|NCT00982449|nonHodgkin Lymphoma or|nonhodgkin lymphoma or
510115|NCT00982449|nonHodgkins Lymphoproliferative Disease|nonhodgkins lymphoproliferative disease
510116|NCT00982449|Primary Effusion Lymphoma|primary effusion lymphoma
510117|NCT00982449|Kaposi's Sarcoma|kaposi's sarcoma
510118|NCT00982449|Gastric Cancer|gastric cancer
510119|NCT00982449|Nasopharyngeal Cancer|nasopharyngeal cancer
510120|NCT00982436|Combined Modality Therapy|combined modality therapy
510121|NCT00982436|Neoadjuvant Therapy|neoadjuvant therapy
510122|NCT00982436|Head and neck neoplasms|head and neck neoplasms
510123|NCT00982423|heart failure|heart failure
510124|NCT00982423|heart failure with and without kidney dysfunction|heart failure with and without kidney dysfunction
510125|NCT00982410|pain|pain
510126|NCT00982410|alcohol|alcohol
510127|NCT00982410|illicit drugs|illicit drugs
510128|NCT00982410|pain management|pain management
510129|NCT00982384|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
510130|NCT00982384|Disease management|disease management
510131|NCT00982384|Pulmonary rehabilitation|pulmonary rehabilitation
510132|NCT00982384|Quality of life|quality of life
510133|NCT00982371|type 2 diabetes mellitus|type 2 diabetes mellitus
510134|NCT00982371|osteoporosis|osteoporosis
510135|NCT00982371|bone quality|bone quality
510136|NCT00982371|magnetic resonance imaging|magnetic resonance imaging
510137|NCT00982371|fracture|fracture
510138|NCT00982371|postmenopausal women >65 years old|postmenopausal women >65 years old
510139|NCT00982345|Depression|depression
510140|NCT00982345|Anxiety|anxiety
510141|NCT00982345|Seroquel|seroquel
510142|NCT00982345|Quetiapine|quetiapine
510143|NCT00982345|fMRI|fmri
510144|NCT00982345|pictures|pictures
510145|NCT00982332|polymyalgia rheumatica|polymyalgia rheumatica
510146|NCT00982319|Broccoli Sprout Extract|broccoli sprout extract
510147|NCT00982319|Breast Cancer|breast cancer
510148|NCT00982306|alcohol|alcohol
510149|NCT00982306|brief interventions|brief interventions
510150|NCT00982306|counseling|counseling
510151|NCT00982306|harmful/hazardous alcohol drinkers|harmful/hazardous alcohol drinkers
510152|NCT00982280|Osteoarthritis|osteoarthritis
510153|NCT00982280|pain assessment|pain assessment
510154|NCT00982280|tapentadol|tapentadol
510155|NCT00982280|centrally acting analgesic|centrally acting analgesic
510156|NCT00982267|cancer|cancer
510157|NCT00982254|Type 2 Diabetes|type 2 diabetes
510158|NCT00982254|Oral Insulin|oral insulin
510159|NCT00982254|Pharmacokinetics|pharmacokinetics
510160|NCT00982254|Pharmacodynamics|pharmacodynamics
510161|NCT00982241|OAB|oab
510162|NCT00982241|urine|urine
510163|NCT00982241|osmolality|osmolality
510164|NCT00982241|urge|urge
510165|NCT00982241|fluid intake|fluid intake
510166|NCT00982241|PPIUS|ppius
510167|NCT00982241|urge score|urge score
510168|NCT00982241|bladder|bladder
510169|NCT00982215|Paracetamol|paracetamol
510170|NCT00982215|per-oral mucosa PMB|per-oral mucosa pmb
510171|NCT00982215|No disease, healthy volunteers|no disease, healthy volunteers
510172|NCT00982202|PPAR-gamma|ppar-gamma
510173|NCT00982202|inflammation|inflammation
510174|NCT00982189|treatment experienced|treatment experienced
510175|NCT00982176|Anatomo-functional determinants|anatomo-functional determinants
510176|NCT00982176|cognitive impairment|cognitive impairment
510177|NCT00982176|coronary syndrome|coronary syndrome
510178|NCT00982176|brain MRI|brain mri
510179|NCT00982176|cerebral perfusion scintigraphy|cerebral perfusion scintigraphy
510180|NCT00982150|Talampanel|talampanel
510181|NCT00982150|Open-Label Study|open-label study
510182|NCT00982150|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
510183|NCT00982137|Japanese Encephalitis|japanese encephalitis
510184|NCT00982137|Yellow Fever|yellow fever
510185|NCT00982137|ChimeriVax™-JE|chimerivax™-je
510186|NCT00982137|STAMARIL®|stamaril®
510187|NCT00982137|Adult|adult
510188|NCT00982124|Osteogenesis Imperfecta|osteogenesis imperfecta
510189|NCT00982124|Infants with moderate to severe Osteogenesis Imperfecta|infants with moderate to severe osteogenesis imperfecta
510190|NCT00982111|Nonsquamous|nonsquamous
510191|NCT00982111|Non Small Cell Lung Cancer|non small cell lung cancer
510192|NCT00982111|First line treatment|first line treatment
510193|NCT00982111|Monoclonal|monoclonal
510194|NCT00982111|Antibodies|antibodies
510195|NCT00982111|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
510196|NCT00982098|Prostatectomy|prostatectomy
510197|NCT00982098|Prostatic cancer|prostatic cancer
510198|NCT00982098|Urinary incontinence|urinary incontinence
510199|NCT00982098|Exercise|exercise
510200|NCT00982098|Electric stimulation therapy|electric stimulation therapy
510201|NCT00982098|Counseling|counseling
510202|NCT00982085|Asthma|asthma
510203|NCT00982085|Allergic rhinitis|allergic rhinitis
510204|NCT00982085|Military|military
510205|NCT00982072|nephrotic minimal change tacrolimus prednisolone|nephrotic minimal change tacrolimus prednisolone
510206|NCT00982059|Colorectal cancer screening|colorectal cancer screening
510207|NCT00982059|Cancer survivor|cancer survivor
510208|NCT00982059|Radiation therapy|radiation therapy
510209|NCT00982046|contact lenses|contact lenses
510210|NCT00982046|disinfection solutions|disinfection solutions
510211|NCT00982046|contact lens care|contact lens care
510212|NCT00982033|Heart failure with normal ejection fraction|heart failure with normal ejection fraction
510213|NCT00982033|Elderly|elderly
510214|NCT00982020|safety|safety
510215|NCT00982020|schizophrenia|schizophrenia
510216|NCT00982020|bipolar I (manic or mixed)|bipolar i (manic or mixed)
510217|NCT00982020|adolescents|adolescents
510218|NCT00982020|weight management|weight management
510219|NCT00982007|IDA|ida
510220|NCT00981994|respiratory infection|respiratory infection
510221|NCT00981994|antimicrobial drugs|antimicrobial drugs
510222|NCT00981994|decision support|decision support
510223|NCT00981994|Adult patients|adult patients
510224|NCT00981981|humans|humans
510225|NCT00981981|randomized clinical trial|randomized clinical trial
510226|NCT00981981|dietary fiber|dietary fiber
510227|NCT00981981|nutrition|nutrition
510228|NCT00981981|beta-glucan|beta-glucan
510229|NCT00981981|oats|oats
510230|NCT00981981|LDL cholesterol|ldl cholesterol
510231|NCT00981981|coronary heart disease|coronary heart disease
510232|NCT00981955|Caffeine|caffeine
510233|NCT00981955|Ltheanine|ltheanine
510234|NCT00981955|Near Infrared Spectroscopy|near infrared spectroscopy
510235|NCT00981955|Cerebral Blood Flow|cerebral blood flow
510236|NCT00981955|Cognitive Function|cognitive function
510237|NCT00981955|Mood|mood
510238|NCT00981942|Nephrogenic systemic fibrosis|nephrogenic systemic fibrosis
510239|NCT00981942|Imatinib mesylate|imatinib mesylate
510240|NCT00981942|Glivec|glivec
510241|NCT00981942|Gleevec|gleevec
510242|NCT00981929|CYP2D6|cyp2d6
510243|NCT00981929|CYP2C9|cyp2c9
510244|NCT00981929|CYP2C19|cyp2c19
510245|NCT00981929|CYP1A2|cyp1a2
510246|NCT00981916|determination of depth to epidural space using ultrasound|determination of depth to epidural space using ultrasound
510247|NCT00981903|VTE in cancer patients|vte in cancer patients
510248|NCT00981890|Brain Metastases|brain metastases
510249|NCT00981890|Stereotactic radiosurgery|stereotactic radiosurgery
510250|NCT00981890|Sunitinib|sunitinib
510251|NCT00981890|Patients with Brain Metastases|patients with brain metastases
510252|NCT00981877|acute diarrhea|acute diarrhea
510253|NCT00981877|rotavirus|rotavirus
510254|NCT00981877|probiotic|probiotic
510255|NCT00981877|children|children
510256|NCT00981864|radiation therapy in breast cancer|radiation therapy in breast cancer
510257|NCT00981864|concurrent radiation|concurrent radiation
510258|NCT00981864|Breast cancer patients|breast cancer patients
510259|NCT00981851|intervention study|intervention study
510260|NCT00981851|interaction|interaction
510261|NCT00981851|COPD|copd
510262|NCT00981812|PET|pet
510263|NCT00981812|PEM|pem
510264|NCT00981812|Positron Emission Mammography|positron emission mammography
510265|NCT00981812|Breast Biopsy|breast biopsy
510266|NCT00981799|Relapse|relapse
510267|NCT00981799|T cell|t cell
510268|NCT00981799|Lymphoblastic|lymphoblastic
510269|NCT00981799|Leukemia|leukemia
510270|NCT00981799|Lymphoma|lymphoma
510271|NCT00981799|Nelarabine|nelarabine
510272|NCT00981799|TACL|tacl
510273|NCT00981799|NECTAR|nectar
510274|NCT00981786|24-hour IOP control|24-hour iop control
510275|NCT00981786|brinzolamide/timolol|brinzolamide/timolol
510276|NCT00981786|brimonidine/timolol|brimonidine/timolol
510277|NCT00981786|travoprost|travoprost
510278|NCT00981773|HIV switch|hiv switch
510279|NCT00981773|HIV|hiv
510280|NCT00981773|treatment experienced|treatment experienced
510281|NCT00981734|Aging|aging
510282|NCT00981734|functionality|functionality
510283|NCT00981734|life style|life style
510284|NCT00981734|To have more than sixty years|to have more than sixty years
510285|NCT00981721|Phase I|phase i
510286|NCT00981721|Advanced solid malignancies|advanced solid malignancies
510287|NCT00981721|Advanced solid tumour|advanced solid tumour
510288|NCT00981721|Advanced cancer|advanced cancer
510289|NCT00981721|Cediranib (RECENTIN™, AZD2171)|cediranib (recentin™, azd2171)
510290|NCT00981721|China|china
510291|NCT00981721|PK|pk
510292|NCT00981721|pharmacokinetics|pharmacokinetics
510293|NCT00981708|Amyloidosis|amyloidosis
510294|NCT00981708|lenalidomide|lenalidomide
510295|NCT00981708|newly diagnosed|newly diagnosed
510296|NCT00981708|relapsed|relapsed
510297|NCT00981708|primary systemic AL amyloidosis|primary systemic al amyloidosis
510298|NCT00981695|HIV|hiv
510299|NCT00981695|Vaccine|vaccine
510300|NCT00981695|MVA|mva
510301|NCT00981695|PMTCT|pmtct
510302|NCT00981695|HIV preventive vaccine|hiv preventive vaccine
510303|NCT00981695|HIV seronegativity|hiv seronegativity
510304|NCT00981682|decrease in the number of nocturic episodes for patients with nocturia|decrease in the number of nocturic episodes for patients with nocturia
510305|NCT00981669|brazilian pentavalent rotavirus vaccine|brazilian pentavalent rotavirus vaccine
510306|NCT00981669|safety|safety
510307|NCT00981669|tolerability|tolerability
510308|NCT00981669|immunogenicity|immunogenicity
510309|NCT00981656|stage I bladder cancer|stage i bladder cancer
510310|NCT00981656|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
510311|NCT00981643|Meditation|meditation
510312|NCT00981643|Multiple Sclerosis|multiple sclerosis
510313|NCT00981643|Peripheral Neuropathy|peripheral neuropathy
510314|NCT00981630|Japanese Encephalitis|japanese encephalitis
510315|NCT00981630|ChimeriVax™-JE Vaccine|chimerivax™-je vaccine
510316|NCT00981630|Adult|adult
510317|NCT00981604|SILS|sils
510318|NCT00981604|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
510319|NCT00981604|Children|children
510320|NCT00981591|Iloprost|iloprost
510321|NCT00981591|Nitric oxide|nitric oxide
510322|NCT00981591|Mechanical ventilator|mechanical ventilator
510323|NCT00981578|bone cancer|bone cancer
510324|NCT00981578|pain palliation|pain palliation
510325|NCT00981578|metastasis|metastasis
510326|NCT00981578|breast cancer|breast cancer
510327|NCT00981578|lung cancer|lung cancer
510328|NCT00981578|prostate cancer|prostate cancer
510329|NCT00981578|cancer related pain|cancer related pain
510330|NCT00981578|tumors|tumors
510331|NCT00981565|Carpal tunnel syndrome|carpal tunnel syndrome
510332|NCT00981565|CTS|cts
510333|NCT00981565|medianus impingement|medianus impingement
510334|NCT00981552|Cervix Cancer|cervix cancer
510335|NCT00981552|IMRT|imrt
510336|NCT00981552|Organ Motion|organ motion
510337|NCT00981552|Target Definition|target definition
510338|NCT00981539|The focus of this study is to determine whether it is beneficial to administer enemas before surgery|the focus of this study is to determine whether it is beneficial to administer enemas before surgery
510339|NCT00981526|Schizophrenia|schizophrenia
510340|NCT00981526|Cognition|cognition
510341|NCT00981526|Metabolism|metabolism
510342|NCT00981526|Antipsychotics|antipsychotics
510343|NCT00981526|Psychopathology|psychopathology
510344|NCT00981500|obesity|obesity
510345|NCT00981500|gastric bypass|gastric bypass
510346|NCT00981500|gastric banding|gastric banding
510347|NCT00981500|weight loss|weight loss
510348|NCT00981500|insulin sensitivity|insulin sensitivity
510349|NCT00981500|sleeve gastrectomy|sleeve gastrectomy
510350|NCT00981500|fibroblast growth factor 21|fibroblast growth factor 21
510351|NCT00981500|fibroblast growth factor 19|fibroblast growth factor 19
510352|NCT00981474|cardiac surgery; brain injury; cerebral autoregulation|cardiac surgery; brain injury; cerebral autoregulation
510353|NCT00981461|Andregenetic Alopecia|andregenetic alopecia
510354|NCT00981461|Hair Loss|hair loss
510355|NCT00981461|Female Pattern Baldness|female pattern baldness
510356|NCT00981448|zinc|zinc
510357|NCT00981448|diabetes|diabetes
510358|NCT00981448|genetics|genetics
510359|NCT00981435|Glaucoma|glaucoma
510360|NCT00981435|Trabeculoplasty|trabeculoplasty
510361|NCT00981435|Selective laser trabeculoplasty|selective laser trabeculoplasty
510362|NCT00981435|Intraocular pressure|intraocular pressure
510363|NCT00981422|glaucoma|glaucoma
510364|NCT00981422|immunology|immunology
510365|NCT00981422|immunophenotype|immunophenotype
510366|NCT00981409|Fondaparinux sodium|fondaparinux sodium
510367|NCT00981409|contrast-enhanced MDCT|contrast-enhanced mdct
510368|NCT00981409|Deep Vein Thrombosis|deep vein thrombosis
510369|NCT00981409|Pulmonary thromboembolism|pulmonary thromboembolism
510370|NCT00981396|smoking|smoking
510371|NCT00981396|EFT (Emotional Freedom Techniques)|eft (emotional freedom techniques)
510372|NCT00981396|CBT (cognitive behavior therapy)|cbt (cognitive behavior therapy)
510373|NCT00981396|cravings|cravings
510374|NCT00981396|trauma|trauma
510375|NCT00981383|Fatty Acids, Omega-3|fatty acids, omega-3
510376|NCT00981370|Sickle Cell Disease|sickle cell disease
510377|NCT00981370|Sickle Cell Anemia|sickle cell anemia
510378|NCT00981370|Iron Overload|iron overload
510379|NCT00981370|Chelation Therapy|chelation therapy
510380|NCT00981370|Iron overload from blood transfusions|iron overload from blood transfusions
510381|NCT00981370|Heart rate variability|heart rate variability
510382|NCT00981370|Autonomic dysfunction|autonomic dysfunction
510383|NCT00981357|Cross-over evaluate the efficacy of PF-04457845 in relieving pain due to osteoarthritis OA knee osteoarthritis of knee pain due to osteoarthritis|cross-over evaluate the efficacy of pf-04457845 in relieving pain due to osteoarthritis oa knee osteoarthritis of knee pain due to osteoarthritis
510384|NCT00981344|wheelchair|wheelchair
510385|NCT00981344|mobility disability|mobility disability
510386|NCT00981344|evidence based practice|evidence based practice
510387|NCT00981344|self help devices|self help devices
510388|NCT00981344|Veterans prescribed mobility aids|veterans prescribed mobility aids
510389|NCT00981331|Subtalar joint|subtalar joint
510390|NCT00981331|Musculoskeletal Manipulations|musculoskeletal manipulations
510391|NCT00981331|Manipulation, Chiropractic|manipulation, chiropractic
510392|NCT00981331|Ankle sprain|ankle sprain
510393|NCT00981331|Inversion sprain|inversion sprain
510394|NCT00981331|Range of motion, Articular|range of motion, articular
510395|NCT00981331|Quaternion|quaternion
510396|NCT00981331|Eigen analysis|eigen analysis
510397|NCT00981318|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
510398|NCT00981318|HIV|hiv
510399|NCT00981318|AIDS|aids
510400|NCT00981318|treatment experienced|treatment experienced
510401|NCT00981305|dyspareunia|dyspareunia
510402|NCT00981305|breast cancer|breast cancer
510403|NCT00981305|sexual dysfunction|sexual dysfunction
510404|NCT00981305|vaginal lubricant|vaginal lubricant
510405|NCT00981292|Epigallocatechin Gallate|epigallocatechin gallate
510406|NCT00981292|cerebral blood flow|cerebral blood flow
510407|NCT00981292|Near Infrared spectroscopy|near infrared spectroscopy
510408|NCT00981292|Electroencephalography|electroencephalography
510409|NCT00981292|cognitive function|cognitive function
510410|NCT00981292|mood|mood
510411|NCT00981292|cerebro-electrical activity|cerebro-electrical activity
510412|NCT00981279|Health Profile|health profile
510413|NCT00981279|AIDS|aids
510414|NCT00981279|Health Promotion|health promotion
510415|NCT00981279|HIV|hiv
510416|NCT00981279|treatment experienced|treatment experienced
510417|NCT00981266|Augmentation|augmentation
510418|NCT00981266|Augmentation Revision|augmentation revision
510419|NCT00981253|Stress Management Training|stress management training
510420|NCT00981253|Cardiac Rehabilitation|cardiac rehabilitation
510421|NCT00981253|Stress|stress
510422|NCT00981253|Depression|depression
510423|NCT00981227|pain herpetic neuralgia|pain herpetic neuralgia
510424|NCT00981214|Cystic fibrosis|cystic fibrosis
510425|NCT00981214|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
510426|NCT00981214|Zenpep-1009|zenpep-1009
510427|NCT00981201|Smoking|smoking
510428|NCT00981201|Cancer Prevention|cancer prevention
510429|NCT00981201|Celecoxib|celecoxib
510430|NCT00981201|Celebrex|celebrex
510431|NCT00981201|Placebo|placebo
510432|NCT00981175|Japanese Encephalitis|japanese encephalitis
510433|NCT00981175|Japanese Encephalitis Vaccines|japanese encephalitis vaccines
510434|NCT00981175|Adult|adult
510435|NCT00981136|Appendicitis|appendicitis
510436|NCT00981136|Appendectomy|appendectomy
510437|NCT00981136|Children|children
510438|NCT00981136|Laparoscopic|laparoscopic
510439|NCT00981136|SILS|sils
510440|NCT00981110|Surgical site infections (SSI)|surgical site infections (ssi)
510441|NCT00981110|Advanced antimicrobial dressing and clean surgery|advanced antimicrobial dressing and clean surgery
510442|NCT00981110|Hydrofibre dressing|hydrofibre dressing
510443|NCT00981097|HIV infection|hiv infection
510444|NCT00981097|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
510445|NCT00981097|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
510446|NCT00981097|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
510447|NCT00981097|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
510448|NCT00981097|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
510449|NCT00981097|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
510450|NCT00981097|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
510451|NCT00981097|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
510452|NCT00981097|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
510453|NCT00981097|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
510454|NCT00981097|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
510455|NCT00981097|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
510456|NCT00981097|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
510457|NCT00981097|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
510458|NCT00981097|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
510459|NCT00981097|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
510460|NCT00981097|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
510461|NCT00981097|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
510462|NCT00981097|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
510463|NCT00981097|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
510464|NCT00981071|Tuberculosis|tuberculosis
510465|NCT00981071|QuantiFERON|quantiferon
510466|NCT00981071|Outbreak|outbreak
510467|NCT00981071|Conversion|conversion
510468|NCT00981058|Squamous|squamous
510469|NCT00981058|Non Small Cell Lung Cancer|non small cell lung cancer
510470|NCT00981058|First line treatment|first line treatment
510471|NCT00981058|Monoclonal|monoclonal
510472|NCT00981058|Antibodies|antibodies
510473|NCT00981058|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
510474|NCT00981045|IDA|ida
510475|NCT00981032|Aspirin|aspirin
510476|NCT00981032|Behavior|behavior
510477|NCT00981032|Cardiovascular Disease|cardiovascular disease
510478|NCT00981019|survival rates|survival rates
510479|NCT00981019|risk communication|risk communication
510480|NCT00981019|screening counselling|screening counselling
510481|NCT00981019|screening recommendation|screening recommendation
510482|NCT00981019|understanding of medical risk|understanding of medical risk
510483|NCT00981006|ischemic cardiomyopathy (ICM)|ischemic cardiomyopathy (icm)
510484|NCT00980993|Prostate|prostate
510485|NCT00980993|Motion|motion
510486|NCT00980993|Respiration|respiration
510487|NCT00980980|MRSA infection|mrsa infection
510488|NCT00980967|Lung transplantation|lung transplantation
510489|NCT00980967|Chronic lung rejection|chronic lung rejection
510490|NCT00980967|Obliterative bronchiolitis|obliterative bronchiolitis
510491|NCT00980967|Predictive factors|predictive factors
510492|NCT00980954|cervical adenocarcinoma|cervical adenocarcinoma
510493|NCT00980954|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
510494|NCT00980954|cervical squamous cell carcinoma|cervical squamous cell carcinoma
510495|NCT00980954|stage IA cervical cancer|stage ia cervical cancer
510496|NCT00980954|stage IB cervical cancer|stage ib cervical cancer
510497|NCT00980954|stage IIA cervical cancer|stage iia cervical cancer
510498|NCT00980941|starch|starch
510499|NCT00980941|carbohydrates|carbohydrates
510500|NCT00980941|blood glucose|blood glucose
510501|NCT00980941|food intake|food intake
510502|NCT00980941|satiety|satiety
510503|NCT00980941|appetite|appetite
510504|NCT00980915|Acute Lung Injury|acute lung injury
510505|NCT00980915|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
510506|NCT00980915|Respiratory Distress|respiratory distress
510507|NCT00980915|pneumonia|pneumonia
510508|NCT00980915|sepsis|sepsis
510509|NCT00980915|aspiration|aspiration
510510|NCT00980915|pancreatitis|pancreatitis
510511|NCT00980889|bile duct obstruction|bile duct obstruction
510512|NCT00980889|jaundice|jaundice
510513|NCT00980889|metal stent|metal stent
510514|NCT00980850|Flu vaccine|flu vaccine
510515|NCT00980850|H1N1 swine flu virus|h1n1 swine flu virus
510516|NCT00980850|Immunogenicity|immunogenicity
510517|NCT00980850|Reactogenicity|reactogenicity
510518|NCT00980824|cognitive behaviour therapy|cognitive behaviour therapy
510519|NCT00980824|self harm|self harm
510520|NCT00980824|personality disorder|personality disorder
510521|NCT00980824|complex comorbidity|complex comorbidity
510522|NCT00980824|mental health|mental health
510523|NCT00980798|Osteoarthritis|osteoarthritis
510524|NCT00980798|Strong pain killer|strong pain killer
510525|NCT00980798|Strong opioid|strong opioid
510526|NCT00980798|Low starting dose|low starting dose
510527|NCT00980798|Fewer side effects|fewer side effects
510528|NCT00980798|Physical functioning|physical functioning
510529|NCT00980798|Pain control|pain control
510530|NCT00980798|Quality of life|quality of life
510531|NCT00980798|Sleep quality|sleep quality
510532|NCT00980785|Alzheimer's Disease|alzheimer's disease
510533|NCT00980785|Hypertension|hypertension
510534|NCT00980759|Extended-field Irradiation (EFI)|extended-field irradiation (efi)
510535|NCT00980759|Cervical cancer|cervical cancer
510536|NCT00980759|Hypoxia|hypoxia
510537|NCT00980759|Carbonic anhydrase 9 (CA9)|carbonic anhydrase 9 (ca9)
510538|NCT00980759|locally advanced uterine cervical cancer|locally advanced uterine cervical cancer
510539|NCT00980746|pain diabetes neuropathy|pain diabetes neuropathy
510540|NCT00980733|Micronutrients|micronutrients
510541|NCT00980733|zinc|zinc
510542|NCT00980733|iron|iron
510543|NCT00980733|iodine|iodine
510544|NCT00980733|fortification|fortification
510545|NCT00980733|school children|school children
510546|NCT00980707|versican|versican
510547|NCT00980707|hyaluronan|hyaluronan
510548|NCT00980707|sputum|sputum
510549|NCT00980694|ubiquinol|ubiquinol
510550|NCT00980694|coenzyme Q10|coenzyme q10
510551|NCT00980694|Huntington disease|huntington disease
510552|NCT00980681|Renal disease|renal disease
510553|NCT00980681|Contrast agent|contrast agent
510554|NCT00980681|MRA|mra
510555|NCT00980642|surgery|surgery
510556|NCT00980642|thermometer|thermometer
510557|NCT00980642|non-invasive|non-invasive
510558|NCT00980642|interoperative core temperature|interoperative core temperature
510559|NCT00980642|anesthesia|anesthesia
510560|NCT00980616|Arthroplasty, hip|arthroplasty, hip
510561|NCT00980616|blood losses|blood losses
510562|NCT00980616|pain|pain
510563|NCT00980616|local analgesia|local analgesia
510564|NCT00980616|epinephrine|epinephrine
510565|NCT00980616|Primary total hip arthroplasty|primary total hip arthroplasty
510566|NCT00980603|gastric cancer|gastric cancer
510567|NCT00980603|metastatic|metastatic
510568|NCT00980603|docetaxel|docetaxel
510569|NCT00980603|cisplatin|cisplatin
510570|NCT00980603|S-1|s-1
510571|NCT00980590|supine emergency intubations|supine emergency intubations
510572|NCT00980590|emergency intubations|emergency intubations
510573|NCT00980538|TMC125-TiDP35-C239|tmc125-tidp35-c239
510574|NCT00980538|TMC125-C239|tmc125-c239
510575|NCT00980538|TMC125|tmc125
510576|NCT00980538|HIV|hiv
510577|NCT00980538|Etravirine|etravirine
510578|NCT00980538|Intelence|intelence
510579|NCT00980538|IntelenceTM|intelencetm
510580|NCT00980525|healthy|healthy
510581|NCT00980512|behavior problems|behavior problems
510582|NCT00980512|parent training|parent training
510583|NCT00980512|foster care|foster care
510584|NCT00980486|Antibiotic Concentration|antibiotic concentration
510585|NCT00980486|Tissue|tissue
510586|NCT00980486|Obesity|obesity
510587|NCT00980486|Cesarean|cesarean
510588|NCT00980473|Primary Angle Closure Disease|primary angle closure disease
510589|NCT00980447|H5N1|h5n1
510590|NCT00980447|Vaccine|vaccine
510591|NCT00980447|Influenza H5N1|influenza h5n1
510592|NCT00980447|Avian influenza H5N1|avian influenza h5n1
510593|NCT00980447|Pandemic|pandemic
510594|NCT00980434|vertebral fracture|vertebral fracture
510595|NCT00980434|spinal cord injury|spinal cord injury
510596|NCT00980421|iron|iron
510689|NCT00980200|efficacy|efficacy
510597|NCT00980421|iron toxicity markers|iron toxicity markers
510598|NCT00980421|oxidative stress markers|oxidative stress markers
510599|NCT00980421|iron supplementation|iron supplementation
510600|NCT00980421|NTBI|ntbi
510601|NCT00980421|iron over load|iron over load
510602|NCT00980421|interleukin levels|interleukin levels
510603|NCT00980421|iron status|iron status
510604|NCT00980421|acut phase reactants|acut phase reactants
510605|NCT00980421|preschool children|preschool children
510606|NCT00980395|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
510607|NCT00980395|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
510608|NCT00980395|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
510609|NCT00980395|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
510610|NCT00980395|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
510611|NCT00980395|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
510612|NCT00980395|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
510613|NCT00980395|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
510614|NCT00980395|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
510615|NCT00980395|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
510616|NCT00980395|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
510617|NCT00980395|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
510618|NCT00980395|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
510619|NCT00980395|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
510620|NCT00980395|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
510621|NCT00980395|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
510622|NCT00980395|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
510623|NCT00980395|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
510624|NCT00980395|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
510625|NCT00980395|extranodal marginal zone BCL mucosa assoc lymphoid tissue|extranodal marginal zone bcl mucosa assoc lymphoid tissue
510626|NCT00980395|nodal marginal zone B Cell lymphoma|nodal marginal zone b cell lymphoma
510627|NCT00980395|splenic marginal zone lymphoma|splenic marginal zone lymphoma
510628|NCT00980382|Stomach Neoplasms|stomach neoplasms
510629|NCT00980382|phase I/II|phase i/ii
510630|NCT00980382|Combination chemotherapy|combination chemotherapy
510631|NCT00980382|S-1|s-1
510632|NCT00980382|Docetaxel|docetaxel
510633|NCT00980369|Lateral internal sphincterotomy|lateral internal sphincterotomy
510634|NCT00980369|Anal fissure|anal fissure
510635|NCT00980369|Surgical technique|surgical technique
510636|NCT00980369|Incision|incision
510637|NCT00980369|Wound healing|wound healing
510638|NCT00980356|Diabetes Kidney transplantation|diabetes kidney transplantation
510639|NCT00980356|New onset diabetes mellitus after transplantation|new onset diabetes mellitus after transplantation
510640|NCT00980330|Hepatitis C|hepatitis c
510641|NCT00980330|Peginterferon alpha-2a|peginterferon alpha-2a
510642|NCT00980330|PegIFNalpha-2a|pegifnalpha-2a
510643|NCT00980330|RBV|rbv
510644|NCT00980330|Ribavirin|ribavirin
510645|NCT00980330|Placebo|placebo
510646|NCT00980330|TMC435-TIDP16-C206|tmc435-tidp16-c206
510647|NCT00980330|TMC435-C206|tmc435-c206
510648|NCT00980330|TMC435|tmc435
510649|NCT00980330|HCV|hcv
510650|NCT00980317|Renal tumor|renal tumor
510651|NCT00980317|Restored kidney|restored kidney
510652|NCT00980317|Renal transplantation|renal transplantation
510653|NCT00980317|Third party|third party
510654|NCT00980304|Diffuse large B cell lymphomas|diffuse large b cell lymphomas
510655|NCT00980278|sinus lift|sinus lift
510656|NCT00980278|tooth extraction|tooth extraction
510657|NCT00980278|dental implant|dental implant
510658|NCT00980252|Schizophrenia|schizophrenia
510659|NCT00980252|Cognitive Behavioral Therapy|cognitive behavioral therapy
510660|NCT00980252|Compliance|compliance
510661|NCT00980252|Medication Adherence|medication adherence
510662|NCT00980252|Psychotic Disorders|psychotic disorders
510663|NCT00980252|Mental Disorders|mental disorders
510664|NCT00980252|Outcomes|outcomes
510665|NCT00980252|Psychoeducation|psychoeducation
510666|NCT00980252|Adherence Attitudes|adherence attitudes
510667|NCT00980252|Intervention|intervention
510668|NCT00980252|Nonadherence|nonadherence
510669|NCT00980252|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
510670|NCT00980239|Solid Tumors|solid tumors
510671|NCT00980239|Liver|liver
510672|NCT00980239|hepatic arterial infusion|hepatic arterial infusion
510673|NCT00980239|HAI|hai
510674|NCT00980239|Bevacizumab|bevacizumab
510675|NCT00980239|Avastin|avastin
510676|NCT00980239|Cetuximab|cetuximab
510677|NCT00980239|Erbitux|erbitux
510678|NCT00980239|Irinotecan|irinotecan
510679|NCT00980239|Camptosar|camptosar
510680|NCT00980239|Oxaliplatin|oxaliplatin
510681|NCT00980239|Eloxatin|eloxatin
510682|NCT00980213|renal cell cancer|renal cell cancer
510683|NCT00980213|sunitinib|sunitinib
510684|NCT00980213|costs|costs
510685|NCT00980213|quality of life|quality of life
510686|NCT00980200|GW642444|gw642444
510687|NCT00980200|once daily dosing|once daily dosing
510688|NCT00980200|asthma|asthma
510690|NCT00980200|safety|safety
510691|NCT00980200|FEV1|fev1
510692|NCT00980187|blood tests|blood tests
510693|NCT00980187|cardiac function|cardiac function
510694|NCT00980187|endothelial function|endothelial function
510695|NCT00980187|arterial function|arterial function
510696|NCT00980174|men|men
510697|NCT00980174|male|male
510698|NCT00980174|denosumab|denosumab
510699|NCT00980174|BMD|bmd
510700|NCT00980174|lumbar spine|lumbar spine
510701|NCT00980174|ADAMO|adamo
510702|NCT00980174|The ADAMO Trial|the adamo trial
510703|NCT00980174|male osteoporosis|male osteoporosis
510704|NCT00980174|osteoporosis in men|osteoporosis in men
510705|NCT00980174|males with low bone mineral density|males with low bone mineral density
510706|NCT00980161|Hepatitis C|hepatitis c
510707|NCT00980161|Peginterferon|peginterferon
510708|NCT00980161|Ribavirin|ribavirin
510709|NCT00980161|MicroRNA|microrna
510710|NCT00980148|Chlamydia trachomatis, Chlamydia, Doxycycline, Azithromycin|chlamydia trachomatis, chlamydia, doxycycline, azithromycin
510711|NCT00980135|Sinecort|sinecort
510712|NCT00980135|Hydrocortison|hydrocortison
510713|NCT00980135|Mild atopic dermatitis|mild atopic dermatitis
510714|NCT00980135|Efficacy, safety|efficacy, safety
510715|NCT00980122|Advanced cancer patients dying in hospital receive aggressive cancer-specific therapy and supportive measures.|advanced cancer patients dying in hospital receive aggressive cancer-specific therapy and supportive measures.
510716|NCT00980109|Influenza Prophylaxis|influenza prophylaxis
510717|NCT00980109|Long Term|long term
510718|NCT00980109|Oral Oseltamivir|oral oseltamivir
510719|NCT00980109|Inhaled Zanamivir|inhaled zanamivir
510720|NCT00980083|GLP-1|glp-1
510721|NCT00980083|exendin(9-39)|exendin(9-39)
510722|NCT00980083|gastric emptying|gastric emptying
510723|NCT00980083|incretin|incretin
510724|NCT00980083|human|human
510725|NCT00980070|lumbar puncture positioning device|lumbar puncture positioning device
510726|NCT00980031|Aldosterone Blockade|aldosterone blockade
510727|NCT00980031|Aldosterone Receptor Blockers|aldosterone receptor blockers
510728|NCT00980031|cardiac chamber size|cardiac chamber size
510729|NCT00980031|wall thickness|wall thickness
510730|NCT00980031|left ventricular ejection fraction|left ventricular ejection fraction
510731|NCT00980031|left atrial volumes|left atrial volumes
510732|NCT00980031|diastolic function|diastolic function
510733|NCT00980018|CML|cml
510734|NCT00980018|Leukemia|leukemia
510735|NCT00980018|Tasigna|tasigna
510736|NCT00980018|nilotinib|nilotinib
510737|NCT00980018|AMN107|amn107
510738|NCT00980018|CML-CP|cml-cp
510739|NCT00980018|Chronic Phase|chronic phase
510740|NCT00980005|GSK Biologicals influenza vaccine GSK1557482A|gsk biologicals influenza vaccine gsk1557482a
510741|NCT00980005|influenza infection|influenza infection
510742|NCT00979979|Hepatitis C|hepatitis c
510743|NCT00979979|Genotype|genotype
510744|NCT00979979|Realtime PCR|realtime pcr
510745|NCT00979966|Locally advanced or metastatic non-clear cell renal cell cancer (ncc-RCC)|locally advanced or metastatic non-clear cell renal cell cancer (ncc-rcc)
510746|NCT00979953|delta opioid receptor agonist|delta opioid receptor agonist
510747|NCT00979953|osteoarthritis|osteoarthritis
510748|NCT00979953|pain|pain
510749|NCT00979940|atorvastatin|atorvastatin
510750|NCT00979940|clopidogrel|clopidogrel
510751|NCT00979940|percutaneous intervention|percutaneous intervention
510752|NCT00979940|periprocedural myonecrosis|periprocedural myonecrosis
510753|NCT00979927|Antisense|antisense
510754|NCT00979927|miR-122 antagonist|mir-122 antagonist
510755|NCT00979927|safety in healthy Volunteers|safety in healthy volunteers
510756|NCT00979927|Hepatitis C|hepatitis c
510757|NCT00979914|osteoarthritis|osteoarthritis
510758|NCT00979914|patient education|patient education
510759|NCT00979914|function|function
510760|NCT00979914|physio therapy|physio therapy
510761|NCT00979888|dyspnea|dyspnea
510762|NCT00979888|depression|depression
510763|NCT00979888|fatigue|fatigue
510764|NCT00979888|anxiety disorder|anxiety disorder
510765|NCT00979888|small cell lung cancer|small cell lung cancer
510766|NCT00979888|non-small cell lung cancer|non-small cell lung cancer
510767|NCT00979875|insulin|insulin
510768|NCT00979875|recombinant human hyaluronidase|recombinant human hyaluronidase
510769|NCT00979875|Healthy volunteers|healthy volunteers
510770|NCT00979849|safety|safety
510771|NCT00979849|tolerability|tolerability
510772|NCT00979849|healthy|healthy
510773|NCT00979849|inhalation|inhalation
510774|NCT00979836|venous|venous
510775|NCT00979836|ulcer|ulcer
510776|NCT00979836|phlebotonic|phlebotonic
510777|NCT00979836|calcium dobesilate|calcium dobesilate
510778|NCT00979836|clinical trial|clinical trial
510779|NCT00979810|PET scan|pet scan
510780|NCT00979810|CT scan|ct scan
510781|NCT00979810|09-060|09-060
510782|NCT00979810|CNS|cns
510783|NCT00979797|Community IMCI|community imci
510784|NCT00979797|C-IMCI|c-imci
510785|NCT00979797|CHW|chw
510786|NCT00979797|Children|children
510787|NCT00979797|Evaluation|evaluation
510788|NCT00979797|Behaviour|behaviour
510789|NCT00979797|Counselling|counselling
510790|NCT00979797|Under 5 mortality|under 5 mortality
510791|NCT00979797|Under 5 Nutrition|under 5 nutrition
510792|NCT00979784|obesity|obesity
510793|NCT00979784|primary care|primary care
510794|NCT00979771|GSK706769|gsk706769
510795|NCT00979771|Enbrel|enbrel
510796|NCT00979771|Rheumatoid Arthritis|rheumatoid arthritis
510797|NCT00979745|Erythropoietic Protoporphyria|erythropoietic protoporphyria
510798|NCT00979745|EPP|epp
510799|NCT00979745|Afamelanotide|afamelanotide
510800|NCT00979732|high blood pressure|high blood pressure
510801|NCT00979732|dietary supplements|dietary supplements
510802|NCT00979732|nutrition|nutrition
510803|NCT00979719|Randomized Controlled Trial|randomized controlled trial
510804|NCT00979719|evidence- and theory-based behavioral intervention|evidence- and theory-based behavioral intervention
510805|NCT00979719|expert system|expert system
510806|NCT00979719|stages of change|stages of change
510807|NCT00979719|motivational interviewing|motivational interviewing
510808|NCT00979719|tailoring|tailoring
510809|NCT00979719|Self Care|self care
510810|NCT00979719|Rehabilitation|rehabilitation
510811|NCT00979719|Expert Systems|expert systems
510812|NCT00979693|anxiety|anxiety
510813|NCT00979693|stage IV melanoma|stage iv melanoma
510814|NCT00979693|depression|depression
510815|NCT00979693|spirituality|spirituality
510816|NCT00979693|pain|pain
510817|NCT00979680|sphincter preservation|sphincter preservation
510818|NCT00979680|neoadjuvant therapy|neoadjuvant therapy
510819|NCT00979667|Upper respiratory tract infection|upper respiratory tract infection
510820|NCT00979667|Influenza A|influenza a
510821|NCT00979667|Human Swine Influenza|human swine influenza
510822|NCT00979654|Sifalimumab|sifalimumab
510823|NCT00979654|MEDI-545|medi-545
510824|NCT00979641|breast cancer|breast cancer
510825|NCT00979641|metastatic|metastatic
510826|NCT00979641|chemotherapy|chemotherapy
510827|NCT00979641|bevacizumab|bevacizumab
510828|NCT00979641|docetaxel|docetaxel
510829|NCT00979641|Phase II|phase ii
510830|NCT00979641|first line chemotherapy|first line chemotherapy
510831|NCT00979641|metastatic breast cancer patients|metastatic breast cancer patients
510832|NCT00979628|Type 2 Diabetes|type 2 diabetes
510833|NCT00979628|Inpatient Hyperglycemia|inpatient hyperglycemia
510834|NCT00979615|vasomotor rhinitis|vasomotor rhinitis
510835|NCT00979615|chronic non-allergic rhinitis|chronic non-allergic rhinitis
510836|NCT00979615|VMR|vmr
510837|NCT00979602|GSK Bio's influenza vaccine GSK2340274A|gsk bio's influenza vaccine gsk2340274a
510838|NCT00979602|Influenza Vaccines|influenza vaccines
510839|NCT00979602|GSK Bio's influenza vaccine GSK2340273A|gsk bio's influenza vaccine gsk2340273a
510840|NCT00979602|influenza infection|influenza infection
510841|NCT00979589|stroke|stroke
510842|NCT00979589|transient ischemic attack|transient ischemic attack
510843|NCT00979589|acute treatment|acute treatment
510844|NCT00979589|acute non-disabling cerebrovascular event|acute non-disabling cerebrovascular event
510845|NCT00979589|clopidogrel|clopidogrel
510846|NCT00979589|clopidogrel combined with ASA|clopidogrel combined with asa
510847|NCT00979589|recurrence of stroke and other vascular events|recurrence of stroke and other vascular events
510848|NCT00979563|HM30181AK|hm30181ak
510849|NCT00979563|Irinotecan tablet|irinotecan tablet
510850|NCT00979563|MTD|mtd
510851|NCT00979563|DLT|dlt
510852|NCT00979550|laser|laser
510853|NCT00979550|pediatric|pediatric
510854|NCT00979550|skin pigmentation|skin pigmentation
510855|NCT00979524|Depressive symptoms|depressive symptoms
510856|NCT00979524|Mental health services|mental health services
510857|NCT00979524|Adolescents|adolescents
510858|NCT00979524|Young adults|young adults
510859|NCT00979524|African-American|african-american
510860|NCT00979511|osteoporosis|osteoporosis
510861|NCT00979511|calcium|calcium
510862|NCT00979511|weight-bearing exercise|weight-bearing exercise
510863|NCT00979511|bone mass|bone mass
510864|NCT00979511|prepubertal girls|prepubertal girls
510865|NCT00979485|Pediatric IBD|pediatric ibd
510866|NCT00979485|Microparticles|microparticles
510867|NCT00979472|Solifenacin|solifenacin
510868|NCT00979472|Overactive bladder|overactive bladder
510869|NCT00979472|Micturition|micturition
510870|NCT00979472|Urinary urgency|urinary urgency
510871|NCT00979472|Vesicare|vesicare
510872|NCT00979446|Interactive phone-based intervention with written materials|interactive phone-based intervention with written materials
510873|NCT00979446|Older adults|older adults
510874|NCT00979446|Physical activity|physical activity
510875|NCT00979446|Cognitive stimulation|cognitive stimulation
510876|NCT00979446|Social engagement|social engagement
510877|NCT00979433|Extubation failure|extubation failure
510878|NCT00979433|Continuous positive airway pressure|continuous positive airway pressure
510879|NCT00979433|Bubble CPAP|bubble cpap
510880|NCT00979420|treatment experienced|treatment experienced
510881|NCT00979407|influenza infection|influenza infection
510882|NCT00979407|GSK Biologicals' influenza vaccine GSK2340272A and GSK2340274A|gsk biologicals' influenza vaccine gsk2340272a and gsk2340274a
510883|NCT00979394|Diabetes Care at GPs in Austria|diabetes care at gps in austria
510884|NCT00979394|Characteristic of diabetes patients at GPs in Austria|characteristic of diabetes patients at gps in austria
510885|NCT00979381|sunitinib|sunitinib
510886|NCT00979381|sorafenib|sorafenib
510887|NCT00979381|immune response|immune response
510888|NCT00979355|Whole body|whole body
510889|NCT00979355|SPECT|spect
510890|NCT00979342|morcellator|morcellator
510891|NCT00979342|hysteroscope|hysteroscope
510892|NCT00979342|myomectomy|myomectomy
510893|NCT00979342|polypectomy|polypectomy
510894|NCT00979342|uterine fibroids|uterine fibroids
510895|NCT00979342|uterine polyps|uterine polyps
510896|NCT00979342|local anesthetic|local anesthetic
510897|NCT00979342|cervical block|cervical block
510898|NCT00979342|pain management|pain management
510899|NCT00979329|sunitinib|sunitinib
510900|NCT00979329|sorafenib|sorafenib
510901|NCT00979329|fatigue|fatigue
510902|NCT00979329|depression|depression
510903|NCT00979329|quality of life|quality of life
510904|NCT00979329|metastatic RCC|metastatic rcc
510905|NCT00979329|colorectal cancer|colorectal cancer
510906|NCT00979329|GIST|gist
510907|NCT00979303|Pediatric|pediatric
510908|NCT00979303|Electrophysiology|electrophysiology
510909|NCT00979303|Ablation|ablation
510910|NCT00979303|Radiation|radiation
510911|NCT00979303|Devices|devices
510912|NCT00979303|SVT|svt
510913|NCT00979290|Fix-dose combination anti-TB drug|fix-dose combination anti-tb drug
510914|NCT00979290|adverse effect|adverse effect
510915|NCT00979290|efficiency|efficiency
510916|NCT00979264|Quality Improvement|quality improvement
510917|NCT00979251|Influenza|influenza
510918|NCT00979251|Immunocompromised|immunocompromised
510919|NCT00979251|HIV|hiv
510920|NCT00979251|History of transplant|history of transplant
510921|NCT00979238|Hemophilia B|hemophilia b
510922|NCT00979238|Factor IX Gene|factor ix gene
510923|NCT00979238|Factor IX Protein|factor ix protein
510924|NCT00979238|Vector|vector
510925|NCT00979225|health information technology|health information technology
510926|NCT00979225|clinical decision support|clinical decision support
510927|NCT00979225|medication management|medication management
510928|NCT00979225|medication adherence|medication adherence
510929|NCT00979212|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
510930|NCT00979212|adenocarcinoma of the lung|adenocarcinoma of the lung
510931|NCT00979212|adenosquamous cell lung cancer|adenosquamous cell lung cancer
510932|NCT00979212|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
510933|NCT00979212|large cell lung cancer|large cell lung cancer
510934|NCT00979212|squamous cell lung cancer|squamous cell lung cancer
510935|NCT00979199|IHD|ihd
510936|NCT00979199|CAD|cad
510937|NCT00979199|Non invasive imaging|non invasive imaging
510938|NCT00979199|SPECT|spect
510939|NCT00979199|PET|pet
510940|NCT00979199|CMR|cmr
510941|NCT00979199|Echocardiography|echocardiography
510942|NCT00979186|transgastric cholecystectomy|transgastric cholecystectomy
510943|NCT00979173|malignant glioma|malignant glioma
510944|NCT00979173|glioblastoma multiforme|glioblastoma multiforme
510945|NCT00979173|gliosarcoma|gliosarcoma
510946|NCT00979173|anaplastic astrocytoma|anaplastic astrocytoma
510947|NCT00979173|anaplastic oligodendroglioma|anaplastic oligodendroglioma
510948|NCT00979173|anaplastic mixed glioma|anaplastic mixed glioma
510949|NCT00979173|Pro00018751|pro00018751
510950|NCT00979173|Duke|duke
510951|NCT00979173|Ambit|ambit
510952|NCT00979173|AC480|ac480
510953|NCT00979147|knee arthritis|knee arthritis
510954|NCT00979147|total knee arthroplasty|total knee arthroplasty
510955|NCT00979147|total knee replacement|total knee replacement
510956|NCT00979147|metal backed tibial component|metal backed tibial component
510957|NCT00979147|all-polyethylene tibia|all-polyethylene tibia
510958|NCT00979147|modular polished tibial baseplate|modular polished tibial baseplate
510959|NCT00979134|Cancer|cancer
510960|NCT00979134|Tumour|tumour
510961|NCT00979134|Advanced Solid Malignancies|advanced solid malignancies
510962|NCT00979134|FGFR|fgfr
510963|NCT00979134|Squamous NSCLC|squamous nsclc
510964|NCT00979134|Gastric adenocarcinoma|gastric adenocarcinoma
510965|NCT00979121|ALI|ali
510966|NCT00979121|Sepsis|sepsis
510967|NCT00979121|statin|statin
510968|NCT00979108|Radiculopathy|radiculopathy
510969|NCT00979108|Neck pain|neck pain
510970|NCT00979108|Physical therapy modalities|physical therapy modalities
510971|NCT00979108|Rehabilitation|rehabilitation
510972|NCT00979095|multiple hernia|multiple hernia
510973|NCT00979056|Traveller's diarrhoea|traveller's diarrhoea
510974|NCT00979056|Prevention|prevention
510975|NCT00979043|knee osteoarthritis|knee osteoarthritis
510976|NCT00979043|weight-loss|weight-loss
510977|NCT00979043|exercise|exercise
510978|NCT00979043|obesity|obesity
510979|NCT00979043|physical function|physical function
510980|NCT00979043|total mortality|total mortality
510981|NCT00979017|malignant glioma|malignant glioma
510982|NCT00979017|glioblastoma multiforme|glioblastoma multiforme
510983|NCT00979017|gliosarcoma|gliosarcoma
510984|NCT00979017|Avastin|avastin
510985|NCT00979017|bevacizumab|bevacizumab
510986|NCT00979017|Temodar|temodar
510987|NCT00979017|temozolomide|temozolomide
510988|NCT00979017|Irinotecan|irinotecan
510989|NCT00979017|CPT-11|cpt-11
510990|NCT00979017|Pro00019065|pro00019065
510991|NCT00979017|Vredenburgh|vredenburgh
510992|NCT00979017|Duke|duke
510993|NCT00979004|Photosensitivity|photosensitivity
510994|NCT00979004|Epilepsy|epilepsy
510995|NCT00979004|Seizures|seizures
510996|NCT00978991|Benign prostate hyperplasia|benign prostate hyperplasia
510997|NCT00978991|Erectile dysfunction|erectile dysfunction
510998|NCT00978965|kidney transplantation|kidney transplantation
510999|NCT00978965|immunosuppression|immunosuppression
511000|NCT00978965|single nucleotide polymorphism|single nucleotide polymorphism
511001|NCT00978965|IMPDH|impdh
511002|NCT00978926|Anti-Vascular Endothelial growth factor|anti-vascular endothelial growth factor
511003|NCT00978913|dendritic cell|dendritic cell
511004|NCT00978913|cancervaccine|cancervaccine
511005|NCT00978913|breast cancer|breast cancer
511006|NCT00978913|malignant melanoma|malignant melanoma
511007|NCT00978913|Cyclophosphamide|cyclophosphamide
511008|NCT00978900|satiety peptides|satiety peptides
511009|NCT00978900|GLP-1|glp-1
511010|NCT00978900|PYY|pyy
511011|NCT00978900|ghrelin|ghrelin
511012|NCT00978900|appetite profile|appetite profile
511013|NCT00978900|Sweetening Agents|sweetening agents
511014|NCT00978887|Facial cream|facial cream
511015|NCT00978887|natural product|natural product
511016|NCT00978887|facial wrinkles|facial wrinkles
511017|NCT00978874|recurrent cervical cancer|recurrent cervical cancer
511018|NCT00978874|stage IB cervical cancer|stage ib cervical cancer
511019|NCT00978874|stage IIA cervical cancer|stage iia cervical cancer
511020|NCT00978874|stage IIB cervical cancer|stage iib cervical cancer
511021|NCT00978874|stage III cervical cancer|stage iii cervical cancer
511022|NCT00978874|stage IVA cervical cancer|stage iva cervical cancer
511023|NCT00978874|stage IVB cervical cancer|stage ivb cervical cancer
511024|NCT00978848|trichomonas|trichomonas
511025|NCT00978848|chlamydia|chlamydia
511026|NCT00978848|gonorrhea|gonorrhea
511027|NCT00978848|emergency contraception|emergency contraception
511028|NCT00978848|emergency contraception use|emergency contraception use
511029|NCT00978835|Diabetes|diabetes
511030|NCT00978835|Hypertension|hypertension
511031|NCT00978835|Physical Activity|physical activity
511032|NCT00978835|Diet|diet
511033|NCT00978835|Medication Adherence|medication adherence
511034|NCT00978822|Subarachnoid hemorrhage|subarachnoid hemorrhage
511035|NCT00978822|Hypertension|hypertension
511036|NCT00978822|brain Aneurysm|brain aneurysm
511037|NCT00978822|intracerebral hemorrhage|intracerebral hemorrhage
511038|NCT00978822|antihypertensive|antihypertensive
511039|NCT00978822|calcium channel blockers|calcium channel blockers
511040|NCT00978822|infusion|infusion
511041|NCT00978822|neurocritical care|neurocritical care
511042|NCT00978809|BPPV|bppv
511043|NCT00978809|postural stability|postural stability
511044|NCT00978809|Epley|epley
511045|NCT00978809|Semont|semont
511046|NCT00978796|Diabetes Mellitus|diabetes mellitus
511047|NCT00978796|Type 1 diabetes|type 1 diabetes
511048|NCT00978796|glucose variability|glucose variability
511049|NCT00978783|Phonation|phonation
511050|NCT00978783|Tracheostomy|tracheostomy
511051|NCT00978783|phonation valve|phonation valve
511052|NCT00978783|positive end expiratory pressure|positive end expiratory pressure
511053|NCT00978770|stage II breast cancer|stage ii breast cancer
511054|NCT00978770|stage IIIA breast cancer|stage iiia breast cancer
511055|NCT00978770|stage IIIB breast cancer|stage iiib breast cancer
511056|NCT00978770|stage IIIC breast cancer|stage iiic breast cancer
511057|NCT00978757|hepatectomy|hepatectomy
511058|NCT00978757|IL 6|il 6
511059|NCT00978757|organ failure|organ failure
511060|NCT00978757|ketamine|ketamine
511061|NCT00978757|Pringle|pringle
511062|NCT00978744|Clinical Health Record|clinical health record
511063|NCT00978744|Computerized Decision Support|computerized decision support
511064|NCT00978744|Patient Safety|patient safety
511065|NCT00978744|Resource Utilization|resource utilization
511066|NCT00978718|prostate cancer|prostate cancer
511067|NCT00978705|Keratinocyte Cell|keratinocyte cell
511068|NCT00978705|severe burn wound|severe burn wound
511069|NCT00978692|Myopia|myopia
511070|NCT00978692|Astigmatism|astigmatism
511071|NCT00978692|Orthokeratology|orthokeratology
511072|NCT00978692|Corneal thickness|corneal thickness
511073|NCT00978692|Corneal curvatures|corneal curvatures
511074|NCT00978692|Corneal biomechanics|corneal biomechanics
511075|NCT00978679|Children|children
511076|NCT00978679|Peripheral refraction|peripheral refraction
511077|NCT00978679|Aberration|aberration
511078|NCT00978679|Eyeball length|eyeball length
511079|NCT00978679|Myopic control|myopic control
511080|NCT00978679|Myopia|myopia
511081|NCT00978679|Corneal reshaping|corneal reshaping
511082|NCT00978679|Orthokeratology|orthokeratology
511083|NCT00978653|allopurinol|allopurinol
511084|NCT00978653|chronic kidney disease|chronic kidney disease
511085|NCT00978653|endothelial dysfunction|endothelial dysfunction
511086|NCT00978653|hyperuricemia|hyperuricemia
511087|NCT00978653|uric acid|uric acid
511088|NCT00978653|vascular endothelium|vascular endothelium
511089|NCT00978653|xanthine oxidase inhibitor|xanthine oxidase inhibitor
511090|NCT00978640|Sirt1 activity|sirt1 activity
511091|NCT00978601|post-operative analgesia|post-operative analgesia
511092|NCT00978601|early discharge,|early discharge,
511093|NCT00978601|fast recovery,|fast recovery,
511094|NCT00978601|minimally invasive myomectomy,|minimally invasive myomectomy,
511095|NCT00978601|laparoscopy,|laparoscopy,
511096|NCT00978601|laparoscopically assisted myomectomy|laparoscopically assisted myomectomy
511097|NCT00978601|patient discharge|patient discharge
511098|NCT00978601|Anesthesia Recovery Period|anesthesia recovery period
511099|NCT00978575|Iron treatment|iron treatment
511100|NCT00978575|Upper gastrointestinal bleeding|upper gastrointestinal bleeding
511101|NCT00978549|pain|pain
511102|NCT00978549|nausea and vomiting|nausea and vomiting
511103|NCT00978549|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
511104|NCT00978549|adenocarcinoma of the stomach|adenocarcinoma of the stomach
511105|NCT00978549|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
511106|NCT00978549|recurrent gastric cancer|recurrent gastric cancer
511107|NCT00978549|stage IIIA gastric cancer|stage iiia gastric cancer
511108|NCT00978549|stage IIIB gastric cancer|stage iiib gastric cancer
511109|NCT00978549|stage IIIC gastric cancer|stage iiic gastric cancer
511110|NCT00978549|stage IV gastric cancer|stage iv gastric cancer
511111|NCT00978549|recurrent esophageal cancer|recurrent esophageal cancer
511112|NCT00978549|stage IIIA esophageal cancer|stage iiia esophageal cancer
511113|NCT00978549|stage IIIB esophageal cancer|stage iiib esophageal cancer
511114|NCT00978549|stage IIIC esophageal cancer|stage iiic esophageal cancer
511115|NCT00978549|stage IV esophageal cancer|stage iv esophageal cancer
511116|NCT00978536|Multiple sclerosis|multiple sclerosis
511117|NCT00978536|cognitive deterioration|cognitive deterioration
511118|NCT00978536|biomarkers|biomarkers
511119|NCT00978536|cerebrospinal fluid|cerebrospinal fluid
511120|NCT00978536|Alzheimer disease|alzheimer disease
511121|NCT00978510|Tuberculosis|tuberculosis
511122|NCT00978510|Disease transmission|disease transmission
511123|NCT00978510|Exposure to biological agents|exposure to biological agents
511124|NCT00978510|Health personnel|health personnel
511125|NCT00978484|PTSD|ptsd
511126|NCT00978484|Depression|depression
511127|NCT00978484|Anxiety|anxiety
511128|NCT00978484|Virtual Reality|virtual reality
511129|NCT00978484|Computer Therapy|computer therapy
511130|NCT00978484|Exposure Therapy|exposure therapy
511131|NCT00978484|Prolonged Exposure|prolonged exposure
511132|NCT00978484|Military Medicine|military medicine
511133|NCT00978484|Combat|combat
511134|NCT00978484|Iraq|iraq
511135|NCT00978484|Afghanistan|afghanistan
511136|NCT00978484|Air Force Personnel|air force personnel
511137|NCT00978484|Armed Forces Personnel|armed forces personnel
511138|NCT00978484|Army Personnel|army personnel
511139|NCT00978484|Coast Guard|coast guard
511140|NCT00978484|psychology|psychology
511141|NCT00978484|military psychiatry|military psychiatry
511142|NCT00978484|combat disorders|combat disorders
511143|NCT00978484|combat neurosis|combat neurosis
511144|NCT00978484|Marines|marines
511145|NCT00978484|Military|military
511146|NCT00978484|Navy Personnel|navy personnel
511147|NCT00978484|Sailors|sailors
511148|NCT00978484|Soldiers|soldiers
511149|NCT00978471|Conventional chemotherapy|conventional chemotherapy
511150|NCT00978471|cytapheresis|cytapheresis
511151|NCT00978471|Peripheral stem cell autograft|peripheral stem cell autograft
511152|NCT00978471|Surgical resection|surgical resection
511153|NCT00978471|Thiotepa|thiotepa
511154|NCT00978458|neurotoxicity|neurotoxicity
511155|NCT00978458|adult diffuse astrocytoma|adult diffuse astrocytoma
511156|NCT00978458|adult oligodendroglioma|adult oligodendroglioma
511157|NCT00978458|recurrent adult brain tumor|recurrent adult brain tumor
511158|NCT00978458|adult mixed glioma|adult mixed glioma
511159|NCT00978445|Systemic embolic events|systemic embolic events
511160|NCT00978445|Thromboembolic Complications with Atrial Fibrillation|thromboembolic complications with atrial fibrillation
511161|NCT00978445|Prophylaxis with Atrial Fibrillation|prophylaxis with atrial fibrillation
511162|NCT00978445|Mechanical Cardiac Valve Replacement|mechanical cardiac valve replacement
511164|NCT00978432|DLBCL|dlbcl
511165|NCT00978432|recurrent|recurrent
511166|NCT00978432|refractory|refractory
511167|NCT00978432|de novo|de novo
511168|NCT00978419|Statins|statins
511169|NCT00978419|Burns|burns
511170|NCT00978419|Sedatives|sedatives
511171|NCT00978419|Neurocognitive|neurocognitive
511172|NCT00978419|Septic|septic
511173|NCT00978419|Mortality|mortality
511174|NCT00978419|C Reactive Protein|c reactive protein
511175|NCT00978419|Septic shock|septic shock
511176|NCT00978419|Sedation|sedation
511177|NCT00978419|Neurocognitive function|neurocognitive function
511178|NCT00978406|Dietary Assessment Methods|dietary assessment methods
511179|NCT00978406|Measurement of Diet|measurement of diet
511180|NCT00978406|24-Hour Diet Recall|24-hour diet recall
511181|NCT00978406|Validation|validation
511182|NCT00978406|Feeding Study|feeding study
511183|NCT00978367|Cicatrix|cicatrix
511184|NCT00978367|Scar|scar
511185|NCT00978367|Avotermin|avotermin
511186|NCT00978367|Juvista|juvista
511187|NCT00978367|RN1001|rn1001
511188|NCT00978367|TGF beta 3|tgf beta 3
511189|NCT00978354|acute kidney injury|acute kidney injury
511190|NCT00978354|acute renal failure|acute renal failure
511191|NCT00978354|loop diuretic|loop diuretic
511192|NCT00978354|critical illness|critical illness
511193|NCT00978354|sepsis|sepsis
511194|NCT00978354|renal replacement therapy|renal replacement therapy
511195|NCT00978354|dialysis|dialysis
511196|NCT00978354|renal recovery|renal recovery
511197|NCT00978354|survival|survival
511198|NCT00978341|Clinical Trial Methodology study Neuropathic pain in Spinal cord injury patients Pain endpoints Crossover design|clinical trial methodology study neuropathic pain in spinal cord injury patients pain endpoints crossover design
511199|NCT00978328|Pain conditions|pain conditions
511200|NCT00978328|Oxycodone immediate release|oxycodone immediate release
511201|NCT00978328|Percocet®, Tylox®|percocet®, tylox®
511202|NCT00978328|Roxicodone®|roxicodone®
511203|NCT00978328|Registry|registry
511204|NCT00978328|Side effects|side effects
511205|NCT00978328|Observational|observational
511206|NCT00978328|Pain management|pain management
511207|NCT00978302|Cicatrix|cicatrix
511208|NCT00978302|Scar|scar
511209|NCT00978302|Wound healing|wound healing
511210|NCT00978302|Avotermin|avotermin
511211|NCT00978302|TGF beta 3|tgf beta 3
511212|NCT00978302|Juvista|juvista
511213|NCT00978302|RN1001|rn1001
511214|NCT00978289|obesity|obesity
511215|NCT00978289|gastric bypass surgery|gastric bypass surgery
511216|NCT00978276|Receptors|receptors
511217|NCT00978276|Immunohistochemistry|immunohistochemistry
511218|NCT00978276|Breast|breast
511219|NCT00978276|Over expression of Hormone receptors in carcinoma of the breast sues|over expression of hormone receptors in carcinoma of the breast sues
511220|NCT00978250|DNA Methylation|dna methylation
511221|NCT00978250|Advanced Cancer|advanced cancer
511222|NCT00978250|Methyltransferase Inhibitor|methyltransferase inhibitor
511223|NCT00978250|Epigenetics|epigenetics
511224|NCT00978250|Gene Re-Expression|gene re-expression
511225|NCT00978250|Breast Cancer|breast cancer
511226|NCT00978250|Head and Neck Cancer|head and neck cancer
511227|NCT00978250|Lung Cancer|lung cancer
511228|NCT00978250|Non-Small Cell Lung Cancer|non-small cell lung cancer
511229|NCT00978250|Bladder Cancer|bladder cancer
511230|NCT00978237|HIV - Lipoatrophy|hiv - lipoatrophy
511231|NCT00978237|treatment experienced|treatment experienced
511232|NCT00978224|dietary supplement|dietary supplement
511233|NCT00978224|hemodialysis|hemodialysis
511234|NCT00978224|Chronic Inflammatory Syndrome|chronic inflammatory syndrome
511235|NCT00978224|Viusid|viusid
511236|NCT00978211|DOTATOC|dotatoc
511237|NCT00978211|somatostatin|somatostatin
511238|NCT00978211|radiopeptide|radiopeptide
511239|NCT00978211|Yttrium|yttrium
511240|NCT00978211|Lutetium|lutetium
511241|NCT00978211|neuroendocrine|neuroendocrine
511242|NCT00978211|cancer|cancer
511243|NCT00978198|Pharmacokinetics|pharmacokinetics
511244|NCT00978198|Safety and tolerability|safety and tolerability
511245|NCT00978198|Plasma concentration|plasma concentration
511246|NCT00978198|ASP1517|asp1517
511247|NCT00978198|FG-4592|fg-4592
511248|NCT00978185|nausea and vomiting|nausea and vomiting
511249|NCT00978185|anxiety disorder|anxiety disorder
511250|NCT00978185|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
511251|NCT00978159|esomeprazole|esomeprazole
511252|NCT00978159|famotidine|famotidine
511253|NCT00978159|aspirin|aspirin
511254|NCT00978159|dyspepsia|dyspepsia
511255|NCT00978133|Colectomy|colectomy
511256|NCT00978133|Closure|closure
511257|NCT00978133|Wound|wound
511258|NCT00978133|Dermabond|dermabond
511259|NCT00978133|Propen|propen
511260|NCT00978120|Influenza A Virus, H1N1 Subtype|influenza a virus, h1n1 subtype
511261|NCT00978120|Vaccine|vaccine
511262|NCT00978107|Hepatic tumors|hepatic tumors
511263|NCT00978107|Metastatic colorectal cancer|metastatic colorectal cancer
511264|NCT00978081|precancerous condition|precancerous condition
511265|NCT00978081|stage 0 hypopharyngeal cancer|stage 0 hypopharyngeal cancer
511266|NCT00978081|stage 0 laryngeal cancer|stage 0 laryngeal cancer
511267|NCT00978081|stage 0 lip and oral cavity cancer|stage 0 lip and oral cavity cancer
511268|NCT00978081|stage 0 nasopharyngeal cancer|stage 0 nasopharyngeal cancer
511269|NCT00978081|stage 0 oropharyngeal cancer|stage 0 oropharyngeal cancer
511270|NCT00978081|stage 0 paranasal sinus and nasal cavity cancer|stage 0 paranasal sinus and nasal cavity cancer
511271|NCT00978068|Pediatric HIV|pediatric hiv
511272|NCT00978068|Malaria|malaria
511273|NCT00978068|Uganda|uganda
511274|NCT00978068|Nevirapine|nevirapine
511275|NCT00978068|Zidovudine|zidovudine
511276|NCT00978068|Lamivudine|lamivudine
511277|NCT00978068|Lopinavir/ritonavir|lopinavir/ritonavir
511278|NCT00978068|Stavudine|stavudine
511279|NCT00978068|Efavirenz|efavirenz
511280|NCT00978068|HIV|hiv
511281|NCT00978029|immunotherapy|immunotherapy
511282|NCT00978016|GERD|gerd
511283|NCT00978003|Vasti Medialis|vasti medialis
511284|NCT00978003|Knee|knee
511285|NCT00978003|MR Imaging|mr imaging
511286|NCT00978003|Vasti Lateralis|vasti lateralis
511287|NCT00978003|HV|hv
511288|NCT00978003|Healthy Volunteer|healthy volunteer
511289|NCT00977990|Skin Swab|skin swab
511290|NCT00977990|Self-Sample|self-sample
511291|NCT00977977|Nephrotic Syndrome|nephrotic syndrome
511292|NCT00977977|Renal Disease|renal disease
511293|NCT00977977|Autoimmune Diseases|autoimmune diseases
511294|NCT00977977|Clinical Trial|clinical trial
511295|NCT00977977|Proteinuria|proteinuria
511296|NCT00977964|Infant|infant
511297|NCT00977951|Cicatrix|cicatrix
511298|NCT00977951|Scar|scar
511299|NCT00977951|Avotermin|avotermin
511300|NCT00977951|Juvista|juvista
511301|NCT00977951|RN1001|rn1001
511302|NCT00977951|TGF beta 3|tgf beta 3
511303|NCT00977938|Acute Coronary Syndrome|acute coronary syndrome
511304|NCT00977938|Adverse event|adverse event
511305|NCT00977938|Antiplatelet therapy|antiplatelet therapy
511306|NCT00977938|Sirolimus|sirolimus
511307|NCT00977938|Everolimus|everolimus
511308|NCT00977938|Paclitaxel|paclitaxel
511309|NCT00977938|Zotarolimus|zotarolimus
511310|NCT00977938|Bare Metal Stent|bare metal stent
511311|NCT00977938|Drug Eluting Stent|drug eluting stent
511312|NCT00977938|Clinical Events Committee|clinical events committee
511313|NCT00977938|Dual antiplatelet therapy|dual antiplatelet therapy
511314|NCT00977938|Harvard Clinical Research Institute|harvard clinical research institute
511315|NCT00977938|Major Adverse Cardiac and Cerebral Event|major adverse cardiac and cerebral event
511316|NCT00977938|Major Bleeding|major bleeding
511317|NCT00977938|Myocardial infarction|myocardial infarction
511318|NCT00977938|Myocardial ischemia|myocardial ischemia
511319|NCT00977938|Percutaneous coronary intervention|percutaneous coronary intervention
511320|NCT00977938|Stent placement|stent placement
511321|NCT00977938|Stent Thrombosis|stent thrombosis
511322|NCT00977938|Thienopyridine|thienopyridine
511323|NCT00977938|Clopidogrel|clopidogrel
511324|NCT00977938|Prasugrel|prasugrel
511325|NCT00977925|Hemostasis|hemostasis
511326|NCT00977912|B. lactis|b. lactis
511327|NCT00977912|Preterm|preterm
511328|NCT00977912|Necrotizing Enterocolitis (NEC)|necrotizing enterocolitis (nec)
511329|NCT00977899|Plasmodium Falciparum|plasmodium falciparum
511330|NCT00977899|Alum Adsorbed|alum adsorbed
511331|NCT00977899|Ookinete Surface Protein|ookinete surface protein
511332|NCT00977899|Malaria Vaccine|malaria vaccine
511333|NCT00977899|Healthy Volunteer|healthy volunteer
511334|NCT00977899|HV|hv
511335|NCT00977860|Prostate|prostate
511336|NCT00977860|Stereotactic|stereotactic
511337|NCT00977860|Radiosurgery|radiosurgery
511338|NCT00977847|Family History|family history
511339|NCT00977847|Electronic Health Record|electronic health record
511340|NCT00977834|Geriatric Assessment|geriatric assessment
511341|NCT00977808|Artificial pancreas|artificial pancreas
511342|NCT00977808|Closed-Loop control|closed-loop control
511343|NCT00977795|Brain Neoplasms|brain neoplasms
511344|NCT00977795|5-ALA|5-ala
511345|NCT00977795|Aminolevulinic acid|aminolevulinic acid
511346|NCT00977795|Fluorescence|fluorescence
511347|NCT00977795|Gliomas|gliomas
511348|NCT00977795|Glioblastoma|glioblastoma
511349|NCT00977795|Surgery|surgery
511350|NCT00977769|cesarean delivery|cesarean delivery
511351|NCT00977769|blood pressure|blood pressure
511352|NCT00977769|cardiac output|cardiac output
511353|NCT00977756|Treatment|treatment
511354|NCT00977756|Children|children
511355|NCT00977756|Integrase Inhibitors|integrase inhibitors
511356|NCT00977756|Entry Inhibitors|entry inhibitors
511357|NCT00977756|Treatment Experienced|treatment experienced
511358|NCT00977730|Hepatitis|hepatitis
511359|NCT00977730|Fatty Liver|fatty liver
511360|NCT00977730|Non Alcoholic Steatohepatitis|non alcoholic steatohepatitis
511361|NCT00977730|Protandim|protandim
511362|NCT00977717|oxaliplatin|oxaliplatin
511363|NCT00977717|neuropathy|neuropathy
511364|NCT00977717|SNPs|snps
511365|NCT00977704|Correction of peri-oral wrinkles|correction of peri-oral wrinkles
511366|NCT00977691|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
511367|NCT00977691|Anemia, Sickle Cell|anemia, sickle cell
511368|NCT00977691|Graft-Versus-Host Disease|graft-versus-host disease
511369|NCT00977691|Sirolimus (Rapamune )|sirolimus (rapamune )
511370|NCT00977691|Alemtuzumab (Campath )|alemtuzumab (campath )
511371|NCT00977691|Thalassemia|thalassemia
511372|NCT00977691|Sickle Cell Disease|sickle cell disease
511373|NCT00977678|open access gastroscopy|open access gastroscopy
511374|NCT00977652|fecal incontinence|fecal incontinence
511375|NCT00977626|Safety|safety
511376|NCT00977626|Tolerability|tolerability
511377|NCT00977626|Healthy|healthy
511378|NCT00977626|Pharmacokinetics|pharmacokinetics
511379|NCT00977626|Healthy volunteers|healthy volunteers
511380|NCT00977613|Treated Stage 2 and Stage 3 colorectal cancer|treated stage 2 and stage 3 colorectal cancer
511381|NCT00977600|Ammonul|ammonul
511382|NCT00977600|Sodium phenylacetate|sodium phenylacetate
511383|NCT00977600|sodium benzoate|sodium benzoate
511384|NCT00977600|Buphenyl|buphenyl
511385|NCT00977600|sodium phenylbutyrate|sodium phenylbutyrate
511386|NCT00977600|HPN-100|hpn-100
511387|NCT00977600|GT4P|gt4p
511388|NCT00977600|Glyceryl tri-(4-phenylbutyrate)|glyceryl tri-(4-phenylbutyrate)
511389|NCT00977600|Healthy Volunteers|healthy volunteers
511390|NCT00977587|irritable bowel syndrome|irritable bowel syndrome
511391|NCT00977587|faecal serine proteases|faecal serine proteases
511392|NCT00977561|Small Cell Lung Cancer|small cell lung cancer
511393|NCT00977561|Extensive stage disease|extensive stage disease
511394|NCT00977561|SCLC|sclc
511395|NCT00977561|IGF-1R inhibitor|igf-1r inhibitor
511396|NCT00977548|MDS|mds
511397|NCT00977548|blood diseases|blood diseases
511398|NCT00977548|bone marrow|bone marrow
511399|NCT00977548|hematopoietic|hematopoietic
511400|NCT00977548|leukemia|leukemia
511401|NCT00977522|schizophrenia negative symptoms adjunctive|schizophrenia negative symptoms adjunctive
511402|NCT00977509|genes|genes
511403|NCT00977509|mutation|mutation
511404|NCT00977509|non-small cell lung cancer|non-small cell lung cancer
511405|NCT00977509|cancer cells|cancer cells
511406|NCT00977496|hemodialysis|hemodialysis
511407|NCT00977496|microbiota|microbiota
511408|NCT00977496|Staphylococcus aureus|staphylococcus aureus
511409|NCT00977470|NSCLC|nsclc
511410|NCT00977470|HCQ|hcq
511411|NCT00977470|erlotinib|erlotinib
511412|NCT00977470|Tarceva|tarceva
511413|NCT00977457|stage I prostate cancer|stage i prostate cancer
511414|NCT00977457|stage II prostate cancer|stage ii prostate cancer
511415|NCT00977457|stage III prostate cancer|stage iii prostate cancer
511416|NCT00977457|stage IV prostate cancer|stage iv prostate cancer
511417|NCT00977444|knee|knee
511418|NCT00977444|osteoarthritis|osteoarthritis
511419|NCT00977418|Healthy Aging|healthy aging
511420|NCT00977418|Exercise|exercise
511421|NCT00977418|Cognition|cognition
511422|NCT00977418|Cognitive Training|cognitive training
511423|NCT00977418|Keeping healthy seniors as mentally efficient as possible|keeping healthy seniors as mentally efficient as possible
511424|NCT00977405|Wound infection|wound infection
511425|NCT00977405|Gentamicin|gentamicin
511426|NCT00977405|Contaminated wounds|contaminated wounds
511427|NCT00977392|human papilloma virus infection|human papilloma virus infection
511428|NCT00977392|health status unknown|health status unknown
511429|NCT00977353|Major depressive disorder|major depressive disorder
511430|NCT00977353|Depression|depression
511431|NCT00977353|Sarcosine|sarcosine
511432|NCT00977353|N-methylglycine|n-methylglycine
511433|NCT00977353|NMDA|nmda
511434|NCT00977340|Chronic nightmare sufferers|chronic nightmare sufferers
511435|NCT00977340|nightmares|nightmares
511436|NCT00977340|Imagery Rehearsal Therapy IRT|imagery rehearsal therapy irt
511437|NCT00977340|sleep disturbance|sleep disturbance
511438|NCT00977340|treatment of nightmares|treatment of nightmares
511439|NCT00977340|confrontation|confrontation
511440|NCT00977340|People who suffer of chronic nightmares|people who suffer of chronic nightmares
511441|NCT00977327|Glioma|glioma
511442|NCT00977327|Intraoperative MR|intraoperative mr
511443|NCT00977327|Intraoperative Ultrasound|intraoperative ultrasound
511444|NCT00977327|resection|resection
511445|NCT00977327|Intraoperative navigation|intraoperative navigation
511446|NCT00977327|Extent of resection|extent of resection
511447|NCT00977314|Unilateral Hearing Loss|unilateral hearing loss
511448|NCT00977301|HIV infection|hiv infection
511449|NCT00977301|interaction|interaction
511450|NCT00977301|pharmacokinetics|pharmacokinetics
511451|NCT00977275|early stage invasive breast cancer|early stage invasive breast cancer
511452|NCT00977275|Partial breast irradiation|partial breast irradiation
511453|NCT00977275|interstitial implant|interstitial implant
511454|NCT00977262|fatty acids|fatty acids
511455|NCT00977262|peripheral blood mononuclear cells|peripheral blood mononuclear cells
511456|NCT00977262|inflammation|inflammation
511457|NCT00977262|nutrigenomics|nutrigenomics
511458|NCT00977249|long term nicotine gum use|long term nicotine gum use
511459|NCT00977249|varenicline|varenicline
511460|NCT00977249|adverse effects|adverse effects
511461|NCT00977236|children|children
511462|NCT00977236|corneal reshaping|corneal reshaping
511463|NCT00977236|myopia|myopia
511464|NCT00977236|myopia control|myopia control
511465|NCT00977236|orthokeratology|orthokeratology
511466|NCT00977223|Aldosterone|aldosterone
511467|NCT00977223|Substance P|substance p
511468|NCT00977223|Cortisol|cortisol
511469|NCT00977223|Aprepitant|aprepitant
511470|NCT00977223|Adrenal glands|adrenal glands
511471|NCT00977210|Phase 1|phase 1
511472|NCT00977210|oxi4503|oxi4503
511473|NCT00977210|oxigene|oxigene
511474|NCT00977210|cruk|cruk
511475|NCT00977210|solid tumors|solid tumors
511476|NCT00977210|VDA|vda
511477|NCT00977210|vascular disrupting agent|vascular disrupting agent
511478|NCT00977184|Parkinson's Disease|parkinson's disease
511971|NCT00975247|Scope Withdrawal time|scope withdrawal time
511479|NCT00977184|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
511480|NCT00977184|Treatment Study|treatment study
511481|NCT00977184|PD|pd
511482|NCT00977184|Parkinson Disease|parkinson disease
511483|NCT00977171|chronic fatigue syndrome|chronic fatigue syndrome
511484|NCT00977171|CFS|cfs
511485|NCT00977171|neurally mediated hypotension|neurally mediated hypotension
511486|NCT00977171|NMH|nmh
511487|NCT00977171|neurogenic orthostatic hypotension|neurogenic orthostatic hypotension
511488|NCT00977171|NOH|noh
511489|NCT00977171|orthostatic hypotension|orthostatic hypotension
511490|NCT00977171|droxidopa|droxidopa
511491|NCT00977158|Cystic Fibrosis|cystic fibrosis
511492|NCT00977158|Microbiota|microbiota
511493|NCT00977158|upper respiratory tract|upper respiratory tract
511494|NCT00977158|16S rRNA sequence analysis|16s rrna sequence analysis
511495|NCT00977158|Staphylococcus aureus|staphylococcus aureus
511496|NCT00977158|Pseudomonas aeruginosa|pseudomonas aeruginosa
511497|NCT00977158|Burkholderia cepacia|burkholderia cepacia
511498|NCT00977158|Haemophilus influenzae|haemophilus influenzae
511499|NCT00977158|Streptococcus pneumoniae|streptococcus pneumoniae
511500|NCT00977145|melanoma|melanoma
511501|NCT00977145|peptide vaccine|peptide vaccine
511502|NCT00977145|interferon gamma|interferon gamma
511503|NCT00977145|immunotherapy|immunotherapy
511504|NCT00977132|Myelodysplastic Syndromes|myelodysplastic syndromes
511505|NCT00977132|Valproic acid|valproic acid
511506|NCT00977132|Lenalidomide|lenalidomide
511507|NCT00977119|breast cancer|breast cancer
511508|NCT00977119|capecitabine|capecitabine
511509|NCT00977093|Coronary artery disease|coronary artery disease
511510|NCT00977093|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
511511|NCT00977093|single photon emission computed tomography|single photon emission computed tomography
511512|NCT00977093|invasive coronary angiography|invasive coronary angiography
511513|NCT00977080|Zemplar|zemplar
511514|NCT00977080|paricalcitol|paricalcitol
511515|NCT00977080|IMPACT SHPT|impact shpt
511516|NCT00977080|Hemodialysis|hemodialysis
511517|NCT00977080|Chronic Kidney Disease Stage 5|chronic kidney disease stage 5
511518|NCT00977067|GDC0152|gdc0152
511519|NCT00977067|IAP|iap
511520|NCT00977067|IAP Antagonist|iap antagonist
511521|NCT00977054|Hepatitis C|hepatitis c
511522|NCT00977054|Peginterferon alfa-2a|peginterferon alfa-2a
511523|NCT00977054|Ribavirin|ribavirin
511524|NCT00977054|Plasmapheresis|plasmapheresis
511525|NCT00977054|Genotype 1|genotype 1
511526|NCT00977041|Neurofeedback|neurofeedback
511527|NCT00977028|Tumescent|tumescent
511528|NCT00977028|Local Anesthesia|local anesthesia
511529|NCT00977028|Lidocaine|lidocaine
511530|NCT00977028|Dosage Maximum|dosage maximum
511531|NCT00977028|Subcutaneous infiltration|subcutaneous infiltration
511532|NCT00977028|maximum Safe mg per kg dosage of lidocaine|maximum safe mg per kg dosage of lidocaine
511533|NCT00977028|Tumescent Local Anesthesia|tumescent local anesthesia
511534|NCT00977002|noninvasive ventilation|noninvasive ventilation
511535|NCT00977002|extubation|extubation
511536|NCT00977002|Respiratory failure|respiratory failure
511537|NCT00977002|reintubation|reintubation
511538|NCT00976976|Resected advanced gastric cancer stage IIIB and IV|resected advanced gastric cancer stage iiib and iv
511539|NCT00976963|UTI|uti
511540|NCT00976924|blood glucose|blood glucose
511541|NCT00976898|proton beam radiation|proton beam radiation
511542|NCT00976872|omega 3|omega 3
511543|NCT00976872|inflammation|inflammation
511544|NCT00976872|augmentation index|augmentation index
511545|NCT00976872|endothelial function|endothelial function
511546|NCT00976859|childhood sexual abuse|childhood sexual abuse
511547|NCT00976859|CSA|csa
511548|NCT00976859|posttraumatic stress disorder|posttraumatic stress disorder
511549|NCT00976859|PTSD, feeling of being polluted|ptsd, feeling of being polluted
511550|NCT00976859|mental pollution, mental contamination|mental pollution, mental contamination
511551|NCT00976859|feeling of being contaminated|feeling of being contaminated
511552|NCT00976859|sexual assault|sexual assault
511553|NCT00976859|disgust, shame|disgust, shame
511554|NCT00976846|hemodialysis|hemodialysis
511555|NCT00976846|on line|on line
511556|NCT00976846|postdilution|postdilution
511557|NCT00976846|high-flux dialyzer|high-flux dialyzer
511558|NCT00976846|hemodiafiltration|hemodiafiltration
511559|NCT00976833|Acute Respiratory Failure|acute respiratory failure
511560|NCT00976833|Early ICU Mobility|early icu mobility
511561|NCT00976833|Early Physical Therapy|early physical therapy
511562|NCT00976833|Critical Care|critical care
511563|NCT00976833|Intensive Care|intensive care
511564|NCT00976833|ICU|icu
511565|NCT00976820|influenza infection|influenza infection
511566|NCT00976820|Influenza Vaccines|influenza vaccines
511567|NCT00976820|GSK Bio's influenza vaccine GSK2340273A|gsk bio's influenza vaccine gsk2340273a
511568|NCT00976820|GSK Bio's influenza vaccine GSK2340274A|gsk bio's influenza vaccine gsk2340274a
511569|NCT00976807|critical care|critical care
511570|NCT00976807|intensive care|intensive care
511571|NCT00976807|weakness|weakness
511572|NCT00976807|myopathy|myopathy
511573|NCT00976807|paresis|paresis
511574|NCT00976807|rehabilitation|rehabilitation
511575|NCT00976794|BD I|bd i
511576|NCT00976768|Advanced gastric cancer|advanced gastric cancer
511577|NCT00976768|FOLFIRI|folfiri
511578|NCT00976755|adenocarcinoma of the prostate|adenocarcinoma of the prostate
511579|NCT00976755|hormone-resistant prostate cancer|hormone-resistant prostate cancer
511580|NCT00976755|stage III prostate cancer|stage iii prostate cancer
511581|NCT00976755|stage IV prostate cancer|stage iv prostate cancer
511582|NCT00976742|plasma lipoprotein lipids|plasma lipoprotein lipids
511583|NCT00976742|body composition|body composition
511584|NCT00976742|glucose tolerance|glucose tolerance
511585|NCT00976742|inflammation markers|inflammation markers
511586|NCT00976742|insulin sensitivity|insulin sensitivity
511587|NCT00976742|coagulation markers|coagulation markers
511588|NCT00976729|monocyte chemoattractant protein-1 (MCP-1)|monocyte chemoattractant protein-1 (mcp-1)
511589|NCT00976729|L-oligonucleotide aptamer|l-oligonucleotide aptamer
511590|NCT00976729|Spiegelmer|spiegelmer
511591|NCT00976716|posttraumatic pain|posttraumatic pain
511592|NCT00976703|cervical foley catheter|cervical foley catheter
511593|NCT00976690|Crohn's Disease|crohn's disease
511594|NCT00976690|Ileocolic resection|ileocolic resection
511595|NCT00976690|Endoscopic recurrence|endoscopic recurrence
511596|NCT00976690|Ileocolic or colon resection (>50cm)|ileocolic or colon resection (>50cm)
511597|NCT00976651|infertility|infertility
511598|NCT00976651|ICSI|icsi
511599|NCT00976651|hCG|hcg
511600|NCT00976651|infertility treatment|infertility treatment
511601|NCT00976638|Antimicrobial Resistant Bacteria|antimicrobial resistant bacteria
511602|NCT00976638|Hospital acquired infections|hospital acquired infections
511603|NCT00976638|Colonization|colonization
511604|NCT00976638|Bacteremia|bacteremia
511605|NCT00976638|MRSA|mrsa
511606|NCT00976638|VRE|vre
511607|NCT00976638|ESBL|esbl
511608|NCT00976638|Intensive Care|intensive care
511609|NCT00976638|ICU|icu
511610|NCT00976625|diastolic function|diastolic function
511611|NCT00976625|aortic regurgitation|aortic regurgitation
511612|NCT00976625|aortic valve replacement|aortic valve replacement
511613|NCT00976625|left ventricular hypertrophy|left ventricular hypertrophy
511614|NCT00976625|myocardial structure|myocardial structure
511615|NCT00976625|LV remodeling|lv remodeling
511616|NCT00976625|Muscular regression|muscular regression
511617|NCT00976625|LV fibrous tissue|lv fibrous tissue
511618|NCT00976612|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
511619|NCT00976612|pharmacokinetics|pharmacokinetics
511620|NCT00976612|nilotinib|nilotinib
511621|NCT00976586|Incontinentia pigmenti|incontinentia pigmenti
511622|NCT00976586|recombination|recombination
511623|NCT00976586|IKBKG|ikbkg
511624|NCT00976586|IKBKGP|ikbkgp
511625|NCT00976573|Stage IV Skin Melanoma|stage iv skin melanoma
511626|NCT00976573|recurrent melanoma|recurrent melanoma
511627|NCT00976560|Lack of interest and energy|lack of interest and energy
511628|NCT00976560|Psychomotor retardation|psychomotor retardation
511629|NCT00976560|Cytokines|cytokines
511630|NCT00976560|Major Depressive disorder|major depressive disorder
511631|NCT00976547|tinnitus|tinnitus
511632|NCT00976547|depression|depression
511633|NCT00976547|audiometry|audiometry
511634|NCT00976547|measurement|measurement
511635|NCT00976534|Analgesic effect|analgesic effect
511636|NCT00976534|Peripheral Neuropathic pain|peripheral neuropathic pain
511637|NCT00976534|Posttraumatic Neuralgia (PTN)|posttraumatic neuralgia (ptn)
511638|NCT00976534|Postherpetic Neuralgia (PHN)|postherpetic neuralgia (phn)
511639|NCT00976508|advanced solid tumors cancer refractory cancer figitumumab pegvisomant|advanced solid tumors cancer refractory cancer figitumumab pegvisomant
511640|NCT00976482|Cardiovascular|cardiovascular
511641|NCT00976482|Pacemaker|pacemaker
511642|NCT00976482|Mortality|mortality
511643|NCT00976482|Physiologic pacing|physiologic pacing
511644|NCT00976456|lung cancer|lung cancer
511645|NCT00976456|NSCLC|nsclc
511646|NCT00976456|elderly|elderly
511647|NCT00976456|non-squamous|non-squamous
511648|NCT00976456|Elderly patients at least 65 years old|elderly patients at least 65 years old
511649|NCT00976456|first line therapy|first line therapy
511650|NCT00976456|non-squamous non-small cell lung cancer stage IIIb or IV|non-squamous non-small cell lung cancer stage iiib or iv
511651|NCT00976443|Obesity|obesity
511652|NCT00976443|Gastric Emptying|gastric emptying
511653|NCT00976443|Satiation|satiation
511654|NCT00976443|Endosonography|endosonography
511655|NCT00976443|Endoscopy|endoscopy
511656|NCT00976443|Feeding Behavior|feeding behavior
511657|NCT00976430|Autologous Stem Cells.|autologous stem cells.
511658|NCT00976404|HIV-1 infection|hiv-1 infection
511659|NCT00976404|Treatment intensification|treatment intensification
511660|NCT00976404|Immunomodulation|immunomodulation
511661|NCT00976404|HIV-rAd5 vaccine|hiv-rad5 vaccine
511662|NCT00976391|open-label|open-label
511663|NCT00976391|albiglutide|albiglutide
511664|NCT00976391|insulin glargine|insulin glargine
511665|NCT00976391|preprandial insulin|preprandial insulin
511666|NCT00976378|stromal cell-derived factor-1 (SDF-1)|stromal cell-derived factor-1 (sdf-1)
511667|NCT00976378|L-oligonucleotide aptamer|l-oligonucleotide aptamer
511668|NCT00976378|Spiegelmer|spiegelmer
511669|NCT00976365|Breast Cancer|breast cancer
511670|NCT00976352|Gene Therapy|gene therapy
511671|NCT00976352|Pompe Disease|pompe disease
511672|NCT00976352|Glycogen Storage Disease|glycogen storage disease
511673|NCT00976339|Breast cancer|breast cancer
511674|NCT00976339|Vitamin D|vitamin d
511675|NCT00976339|Premenopausal|premenopausal
511676|NCT00976313|thoracic epidural analgesia|thoracic epidural analgesia
511677|NCT00976313|urinary micturition|urinary micturition
511678|NCT00976313|thoracotomy|thoracotomy
511679|NCT00976300|SLE|sle
511680|NCT00976300|lupus nephritis|lupus nephritis
511681|NCT00976300|cyclosporine A|cyclosporine a
511682|NCT00976300|cyclophosphamide|cyclophosphamide
511683|NCT00976300|active proliferative lupus nephritis (class III or IV according to WHO)|active proliferative lupus nephritis (class iii or iv according to who)
511684|NCT00976287|Stem cells|stem cells
511685|NCT00976287|Liver cirrhosis|liver cirrhosis
511686|NCT00976287|Radiology|radiology
511687|NCT00976287|Interventional|interventional
511688|NCT00976287|Transplantation|transplantation
511689|NCT00976274|Korean red ginseng|korean red ginseng
511690|NCT00976274|metabolic syndrome|metabolic syndrome
511691|NCT00976274|blood pressure|blood pressure
511692|NCT00976274|arterial stiffness|arterial stiffness
511693|NCT00976274|inflammation|inflammation
511694|NCT00976274|oxidative stress|oxidative stress
511695|NCT00976261|type 2 diabetes|type 2 diabetes
511696|NCT00976261|single dose|single dose
511697|NCT00976261|3-O-methylglucose|3-o-methylglucose
511698|NCT00976261|healthy volunteer|healthy volunteer
511699|NCT00976261|repeat dose|repeat dose
511700|NCT00976248|everolimus|everolimus
511701|NCT00976248|RAD001|rad001
511702|NCT00976248|WM|wm
511703|NCT00976235|Macular Degeneration|macular degeneration
511704|NCT00976235|Visual Impairment|visual impairment
511705|NCT00976235|Quality of Life|quality of life
511706|NCT00976235|Telescope Prosthesis|telescope prosthesis
511707|NCT00976196|Aspirin|aspirin
511708|NCT00976196|Blood platelets|blood platelets
511709|NCT00976196|proteomics|proteomics
511710|NCT00976196|Platelet reactivity|platelet reactivity
511711|NCT00976183|ovarian cancer|ovarian cancer
511712|NCT00976183|gynecologic oncology|gynecologic oncology
511713|NCT00976183|vorinostat|vorinostat
511714|NCT00976183|treatment|treatment
511715|NCT00976170|Advanced or metastatic HCC|advanced or metastatic hcc
511716|NCT00976157|STREM-1|strem-1
511717|NCT00976157|BAL|bal
511718|NCT00976157|VAP|vap
511719|NCT00976144|safety|safety
511720|NCT00976144|LAMA|lama
511721|NCT00976144|pharmacodynamics|pharmacodynamics
511722|NCT00976144|tolerability|tolerability
511723|NCT00976144|Muscarinic receptor antagonist,|muscarinic receptor antagonist,
511724|NCT00976144|anticholinergic,|anticholinergic,
511725|NCT00976144|beta-2 agonist|beta-2 agonist
511726|NCT00976144|healthy Japanese subjects|healthy japanese subjects
511727|NCT00976144|LABA|laba
511728|NCT00976144|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
511729|NCT00976144|pharmacokinetics|pharmacokinetics
511730|NCT00976131|Breast Cancer|breast cancer
511731|NCT00976131|Early Stage Breast Cancer|early stage breast cancer
511732|NCT00976131|Complementary and Alternative Medicine|complementary and alternative medicine
511733|NCT00976131|CAM|cam
511734|NCT00976118|Dementia of Alzheimer's type|dementia of alzheimer's type
511735|NCT00976118|mild to moderate Alzheimer's Disease|mild to moderate alzheimer's disease
511736|NCT00976105|Pharmacokinetics|pharmacokinetics
511737|NCT00976105|Pharmacodynamics|pharmacodynamics
511738|NCT00976105|Safety and tolerability|safety and tolerability
511739|NCT00976105|Repeat dose|repeat dose
511740|NCT00976105|Personality traits|personality traits
511741|NCT00976105|Fat mass|fat mass
511742|NCT00976105|Healthy volunteers|healthy volunteers
511743|NCT00976092|myocardial infarction|myocardial infarction
511744|NCT00976092|clopidogrel|clopidogrel
511745|NCT00976092|prasugrel|prasugrel
511746|NCT00976092|bivalirudin|bivalirudin
511747|NCT00976092|primary PCI|primary pci
511748|NCT00976079|Tibial femoral knee osteoarthritis|tibial femoral knee osteoarthritis
511749|NCT00976079|Osteoarthritis|osteoarthritis
511750|NCT00976066|Obesity|obesity
511751|NCT00976066|Naltrexone|naltrexone
511752|NCT00976066|Carfentanil|carfentanil
511753|NCT00976066|Receptor Occupancy|receptor occupancy
511754|NCT00976066|mu-opioid Receptor|mu-opioid receptor
511755|NCT00976066|PET (Positron Emission Tomography)|pet (positron emission tomography)
511756|NCT00976066|BOLD-fMRI|bold-fmri
511757|NCT00976053|Myocardial perfusion imaging|myocardial perfusion imaging
511758|NCT00976053|Single photon emission computed tomography|single photon emission computed tomography
511759|NCT00976053|Positron emission tomography|positron emission tomography
511760|NCT00976040|HIV-1|hiv-1
511761|NCT00976040|Africa|africa
511762|NCT00976040|Botswana|botswana
511763|NCT00976040|Highly active antiretroviral therapy|highly active antiretroviral therapy
511764|NCT00976040|treatment naive|treatment naive
511765|NCT00976027|Influenza|influenza
511766|NCT00976027|Respiratory Tract Infections|respiratory tract infections
511767|NCT00976027|Influenza-like illness|influenza-like illness
511768|NCT00976027|Elderly|elderly
511769|NCT00976027|Fluzone®|fluzone®
511770|NCT00976027|Efficacy|efficacy
511771|NCT00976001|Follow-up after stroke|follow-up after stroke
511772|NCT00975988|PMS (post-marketing surveillance)|pms (post-marketing surveillance)
511773|NCT00975988|TYKERB® tablets|tykerb® tablets
511774|NCT00975975|Paroxysmal nocturnal hemoglobinuria|paroxysmal nocturnal hemoglobinuria
511775|NCT00975975|severe aplastic anemia|severe aplastic anemia
511776|NCT00975975|Mantle cell|mantle cell
511777|NCT00975962|Stroke|stroke
511778|NCT00975962|Neuroprotection|neuroprotection
511779|NCT00975962|remote preconditioning|remote preconditioning
511780|NCT00975962|Salvage index (%): Difference in infarct growth (PWI-DWI)|salvage index (%): difference in infarct growth (pwi-dwi)
511781|NCT00975949|fluconazole prophylaxis|fluconazole prophylaxis
511782|NCT00975949|fungal colonization|fungal colonization
511783|NCT00975949|fungal infection|fungal infection
511784|NCT00975949|preterm infants|preterm infants
511785|NCT00975949|long term outcomes|long term outcomes
511786|NCT00975949|quality of life|quality of life
511787|NCT00975936|Microdose|microdose
511788|NCT00975936|Drug-Drug Interaction|drug-drug interaction
511789|NCT00975936|Ketoconazole|ketoconazole
511790|NCT00975936|Phase 0|phase 0
511791|NCT00975923|Quality Improvement|quality improvement
511792|NCT00975923|Critical Care|critical care
511793|NCT00975923|Collaboratives|collaboratives
511794|NCT00975923|Patient Safety|patient safety
511795|NCT00975923|Tool Kit|tool kit
511796|NCT00975910|Supratentorial Craniotomy|supratentorial craniotomy
511797|NCT00975897|adenocarcinoma of the colon|adenocarcinoma of the colon
511798|NCT00975897|recurrent colon cancer|recurrent colon cancer
511799|NCT00975897|stage III colon cancer|stage iii colon cancer
511800|NCT00975897|stage IV colon cancer|stage iv colon cancer
511801|NCT00975897|adenocarcinoma of the rectum|adenocarcinoma of the rectum
511802|NCT00975897|recurrent rectal cancer|recurrent rectal cancer
511803|NCT00975897|stage III rectal cancer|stage iii rectal cancer
511804|NCT00975897|stage IV rectal cancer|stage iv rectal cancer
511805|NCT00975884|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
511806|NCT00975884|influenza infection|influenza infection
511807|NCT00975884|Influenza vaccine|influenza vaccine
511808|NCT00975871|Livedo vasculitis|livedo vasculitis
511809|NCT00975871|Genetic pleomorphism|genetic pleomorphism
511810|NCT00975858|Symptomatic Coronary Artery Disease Patients|symptomatic coronary artery disease patients
511811|NCT00975845|ACL|acl
511812|NCT00975845|Anterior Cruciate Ligament|anterior cruciate ligament
511813|NCT00975845|Torn tendon|torn tendon
511814|NCT00975845|ACL Repair|acl repair
511815|NCT00975845|ACL reconstruction|acl reconstruction
511816|NCT00975832|The independent effect of PCOS and obesity on adipose expression and plasma levels of adipocytokines|the independent effect of pcos and obesity on adipose expression and plasma levels of adipocytokines
511817|NCT00975793|Sepsis|sepsis
511818|NCT00975793|Severe sepsis|severe sepsis
511819|NCT00975793|Septic shock|septic shock
511820|NCT00975780|Pneumonia|pneumonia
511821|NCT00975780|Lower respiratory tract infection|lower respiratory tract infection
511822|NCT00975780|Lower respiratory tract infection other than pneumonia|lower respiratory tract infection other than pneumonia
511823|NCT00975754|Inhalation|inhalation
511824|NCT00975754|lung deposition|lung deposition
511825|NCT00975741|Asthma|asthma
511826|NCT00975741|Mometasone furoate|mometasone furoate
511827|NCT00975741|Inhalation devices|inhalation devices
511828|NCT00975741|Forced expiratory volume|forced expiratory volume
511829|NCT00975728|Anti-oxidant|anti-oxidant
511830|NCT00975728|Açai|açai
511831|NCT00975728|Food supplement|food supplement
511832|NCT00975728|Sun protection|sun protection
511833|NCT00975728|Skin erythema prevention|skin erythema prevention
511834|NCT00975728|Anti-oxidant efficacy|anti-oxidant efficacy
511835|NCT00975728|Anti-age efficacy|anti-age efficacy
511836|NCT00975728|Skin photo-induced damage protection|skin photo-induced damage protection
511837|NCT00975715|Seizures|seizures
511838|NCT00975715|oxcarbazepine|oxcarbazepine
511839|NCT00975715|child|child
511840|NCT00975702|Remote ischemic preconditioning|remote ischemic preconditioning
511841|NCT00975702|deceased organ donors|deceased organ donors
511842|NCT00975702|ischemia reperfusion injury|ischemia reperfusion injury
511843|NCT00975702|Delayed graft function|delayed graft function
511844|NCT00975702|Clinical outcomes in kidney transplant recipients|clinical outcomes in kidney transplant recipients
511845|NCT00975702|Clinical outcomes in liver transplant recipients|clinical outcomes in liver transplant recipients
512096|NCT00974649|drop-out|drop-out
511846|NCT00975702|Clinical outcomes in pancreas transplant recipients|clinical outcomes in pancreas transplant recipients
511847|NCT00975689|Niemann-Pick Disease, Type C|niemann-pick disease, type c
511848|NCT00975689|Biomarkers|biomarkers
511849|NCT00975689|N-Acetyl Cysteine|n-acetyl cysteine
511850|NCT00975689|Oxidized Cholesterol|oxidized cholesterol
511851|NCT00975689|Neurodegeneration|neurodegeneration
511852|NCT00975689|NPC|npc
511853|NCT00975676|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
511854|NCT00975676|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
511855|NCT00975676|stage IA breast cancer|stage ia breast cancer
511856|NCT00975676|stage IB breast cancer|stage ib breast cancer
511857|NCT00975676|stage II breast cancer|stage ii breast cancer
511858|NCT00975676|stage IIIA breast cancer|stage iiia breast cancer
511859|NCT00975663|Lung transplantation|lung transplantation
511860|NCT00975663|heart-lung transplantation|heart-lung transplantation
511861|NCT00975663|therapeutic drug monitoring|therapeutic drug monitoring
511862|NCT00975663|tacrolimus|tacrolimus
511863|NCT00975663|mycophenolate|mycophenolate
511864|NCT00975663|immunosuppressant|immunosuppressant
511865|NCT00975663|pharmacokinetics|pharmacokinetics
511866|NCT00975650|Primary Hypogonadism|primary hypogonadism
511867|NCT00975650|Secondary Hypogonadism|secondary hypogonadism
511868|NCT00975611|schizophrenia|schizophrenia
511869|NCT00975611|schizoaffective disorder|schizoaffective disorder
511870|NCT00975611|paliperidone ER|paliperidone er
511871|NCT00975611|risperidone Consta|risperidone consta
511872|NCT00975611|prolactin|prolactin
511873|NCT00975611|hyperprolactinemia|hyperprolactinemia
511874|NCT00975572|Flu|flu
511875|NCT00975572|adjuvanted H1N1 vaccine|adjuvanted h1n1 vaccine
511876|NCT00975572|non-adjuvanted H1N1 vaccine|non-adjuvanted h1n1 vaccine
511877|NCT00975572|Immunogenictiy|immunogenictiy
511878|NCT00975572|Safety|safety
511879|NCT00975546|fertility|fertility
511880|NCT00975546|HIV discordant|hiv discordant
511881|NCT00975546|HIV|hiv
511882|NCT00975546|Infertility in HIV-discordant couples|infertility in hiv-discordant couples
511883|NCT00975546|HIV seronegativity|hiv seronegativity
511884|NCT00975533|type 2 diabetes mellitus|type 2 diabetes mellitus
511885|NCT00975533|obesity|obesity
511886|NCT00975520|Neurotropic|neurotropic
511887|NCT00975520|Melanoma|melanoma
511888|NCT00975520|Observation|observation
511889|NCT00975520|Radiation Therapy|radiation therapy
511890|NCT00975520|Relapse|relapse
511891|NCT00975494|pde5-inhibition|pde5-inhibition
511892|NCT00975494|sildenafil|sildenafil
511893|NCT00975494|LV diastolic function|lv diastolic function
511894|NCT00975494|heart failure patients|heart failure patients
511895|NCT00975481|oral single-dose 6-way crossover recreational drug users abuse potential pharmacodynamics safety|oral single-dose 6-way crossover recreational drug users abuse potential pharmacodynamics safety
511896|NCT00975468|pressure-controlled|pressure-controlled
511897|NCT00975468|volume-controlled|volume-controlled
511898|NCT00975468|one lung|one lung
511899|NCT00975468|ventilation|ventilation
511900|NCT00975468|lung injury|lung injury
511901|NCT00975468|thoracotomy|thoracotomy
511902|NCT00975442|Elbow|elbow
511903|NCT00975442|Tendinitis|tendinitis
511904|NCT00975442|Sports Medicine|sports medicine
511905|NCT00975442|Athletic injuries|athletic injuries
511906|NCT00975429|Prostatic Disease|prostatic disease
511907|NCT00975429|Genital neoplasm, male|genital neoplasm, male
511908|NCT00975429|Urogenital neoplasm|urogenital neoplasm
511909|NCT00975429|Genital disease,male|genital disease,male
511910|NCT00975429|Male urogenital disease|male urogenital disease
511911|NCT00975429|Neoplasms|neoplasms
511912|NCT00975429|Neoplasm by site|neoplasm by site
511913|NCT00975429|Prostatic neoplasm|prostatic neoplasm
511914|NCT00975429|Carcinoma|carcinoma
511915|NCT00975416|Drug Dependence|drug dependence
511916|NCT00975416|Cognitive Behavior|cognitive behavior
511917|NCT00975416|Oxytocin|oxytocin
511918|NCT00975416|Cocaine|cocaine
511919|NCT00975416|Heroin|heroin
511920|NCT00975416|fMRI|fmri
511921|NCT00975403|mild COPD|mild copd
511922|NCT00975403|dyspnea|dyspnea
511923|NCT00975403|exercise|exercise
511924|NCT00975403|respiratory mechanics|respiratory mechanics
511925|NCT00975403|COPD|copd
511926|NCT00975390|Glycogen|glycogen
511927|NCT00975390|Carbohydrate|carbohydrate
511928|NCT00975390|Protein|protein
511929|NCT00975390|Caffeine|caffeine
511930|NCT00975390|Post exercise muscle glycogen synthesis|post exercise muscle glycogen synthesis
511931|NCT00975390|Sports nutrition|sports nutrition
511932|NCT00975377|hair removal|hair removal
511933|NCT00975377|hair clipping|hair clipping
511934|NCT00975377|surgical site infection|surgical site infection
511935|NCT00975377|incisional infection|incisional infection
511936|NCT00975377|wound infection|wound infection
511937|NCT00975364|Folate|folate
511938|NCT00975364|Methylenetetrahydrofolate reductase|methylenetetrahydrofolate reductase
511939|NCT00975364|Speciation|speciation
511940|NCT00975364|Nutrient status|nutrient status
511941|NCT00975364|Bioavailability|bioavailability
511942|NCT00975364|Polymorphism, single nucleotide|polymorphism, single nucleotide
511943|NCT00975351|folates|folates
511944|NCT00975351|5-methyltetrahydrofolic acid|5-methyltetrahydrofolic acid
511945|NCT00975351|pharmacokinetics|pharmacokinetics
511946|NCT00975351|bioavailability|bioavailability
511947|NCT00975351|biotransformation|biotransformation
511948|NCT00975338|health care transition, young adults, rehabilitation|health care transition, young adults, rehabilitation
511949|NCT00975325|Bioequivalency|bioequivalency
511950|NCT00975312|lentigo|lentigo
511951|NCT00975312|hydroquinone|hydroquinone
511952|NCT00975312|tretinoin|tretinoin
511953|NCT00975312|fluocinolone acetonide|fluocinolone acetonide
511954|NCT00975299|Neoplasm|neoplasm
511955|NCT00975299|PET/CT diagnosis|pet/ct diagnosis
511956|NCT00975299|PET tracer|pet tracer
511957|NCT00975273|Asthma|asthma
511958|NCT00975273|Dyspnea|dyspnea
511959|NCT00975273|Paroxysmal|paroxysmal
511960|NCT00975273|Pulmonary|pulmonary
511961|NCT00975273|Respiratory hypersensitivity|respiratory hypersensitivity
511962|NCT00975273|Airway inflammation|airway inflammation
511963|NCT00975273|Airway obstruction|airway obstruction
511964|NCT00975273|Wheezing|wheezing
511965|NCT00975247|Quality Improvement|quality improvement
511966|NCT00975247|Colonoscopy|colonoscopy
511967|NCT00975247|Screening|screening
511968|NCT00975247|Colon Cancer|colon cancer
511969|NCT00975247|Polyp detection rates|polyp detection rates
511970|NCT00975247|Colonoscopy completion rates|colonoscopy completion rates
511972|NCT00975247|Reduce costs through improving bowel prep quality|reduce costs through improving bowel prep quality
511973|NCT00975234|Intra-lesion injection of autologous myoblasts|intra-lesion injection of autologous myoblasts
511974|NCT00975221|Primary hyperparathyroidism|primary hyperparathyroidism
511975|NCT00975221|Parathyroidectomy|parathyroidectomy
511976|NCT00975221|Hypercalcemia|hypercalcemia
511977|NCT00975208|Osteogenesis [G07.700.320.500.325.377.625.100.729]|osteogenesis [g07.700.320.500.325.377.625.100.729]
511978|NCT00975208|Tooth Eruption [G10.549.235.726]|tooth eruption [g10.549.235.726]
511979|NCT00975182|PI3K|pi3k
511980|NCT00975182|NSCLC|nsclc
511981|NCT00975182|Tarceva|tarceva
511982|NCT00975143|isotretinoin|isotretinoin
511983|NCT00975143|dermatology|dermatology
511984|NCT00975143|skin|skin
511985|NCT00975117|Dietary supplement|dietary supplement
511986|NCT00975117|male infertility|male infertility
511987|NCT00975117|spermatogenesis|spermatogenesis
511988|NCT00975104|Aging|aging
511989|NCT00975104|Frailty|frailty
511990|NCT00975104|Sedentary|sedentary
511991|NCT00975104|Immobilization|immobilization
511992|NCT00975104|Atrophy|atrophy
511993|NCT00975104|Muscle Wasting|muscle wasting
511994|NCT00975104|Physical Activity|physical activity
511995|NCT00975078|dexamethasone-suppression-test|dexamethasone-suppression-test
511996|NCT00975078|high dose glucocorticoid treatment|high dose glucocorticoid treatment
511997|NCT00975078|Population at Risk|population at risk
511998|NCT00975065|Galvus|galvus
511999|NCT00975039|Inoperable|inoperable
512000|NCT00975039|Inoperable Cholangiocarcinoma|inoperable cholangiocarcinoma
512001|NCT00975039|Non-resectable|non-resectable
512002|NCT00975039|Non-resectable Cholangiocarcinoma|non-resectable cholangiocarcinoma
512003|NCT00975039|Carcinoma|carcinoma
512004|NCT00975026|Massage|massage
512005|NCT00975026|Chair Massage|chair massage
512006|NCT00975026|Pain|pain
512007|NCT00975026|Discomfort|discomfort
512008|NCT00975026|Stretching|stretching
512009|NCT00975026|Stretching Exercises|stretching exercises
512010|NCT00975026|Sonographer|sonographer
512011|NCT00975026|Cardiac Sonographer|cardiac sonographer
512012|NCT00975013|Laparoscopic Gastric Bypass|laparoscopic gastric bypass
512013|NCT00975013|Morbid Obesity|morbid obesity
512014|NCT00975013|Bone Mineral Density|bone mineral density
512015|NCT00975000|Intervention|intervention
512016|NCT00975000|Cinacalcet|cinacalcet
512017|NCT00975000|Sensipar|sensipar
512018|NCT00975000|Mimpara|mimpara
512019|NCT00975000|hyperparathyroidism|hyperparathyroidism
512020|NCT00975000|calcium|calcium
512021|NCT00975000|osteodystrophy|osteodystrophy
512022|NCT00975000|hypercalcemia|hypercalcemia
512023|NCT00975000|renal|renal
512024|NCT00975000|transplant|transplant
512025|NCT00975000|acute rejection|acute rejection
512026|NCT00975000|kidney transplant failure|kidney transplant failure
512027|NCT00975000|hypophosphatemia|hypophosphatemia
512028|NCT00974987|adult giant cell glioblastoma|adult giant cell glioblastoma
512029|NCT00974987|adult glioblastoma|adult glioblastoma
512030|NCT00974987|adult gliosarcoma|adult gliosarcoma
512031|NCT00974974|Parkinson's Disease|parkinson's disease
512032|NCT00974961|Levobupivacaine|levobupivacaine
512034|NCT00974961|Spinal Anesthesia|spinal anesthesia
512035|NCT00974961|Responses of ANS to these two drugs|responses of ans to these two drugs
512036|NCT00974948|Pancreatic cancer|pancreatic cancer
512037|NCT00974948|Therapy|therapy
512038|NCT00974948|Neurolysis|neurolysis
512039|NCT00974935|Staphylococcal enterotoxin B, vaccine, Staphylococcus aureus, toxic shock syndrome|staphylococcal enterotoxin b, vaccine, staphylococcus aureus, toxic shock syndrome
512040|NCT00974922|Vitamin D|vitamin d
512041|NCT00974922|Hypertension|hypertension
512042|NCT00974909|Fecal incontinence|fecal incontinence
512043|NCT00974896|Advanced Solid Tumors|advanced solid tumors
512044|NCT00974896|AMG 479|amg 479
512045|NCT00974896|Amgen|amgen
512046|NCT00974896|Oncology|oncology
512047|NCT00974896|Phase 1b|phase 1b
512048|NCT00974883|ultrasound|ultrasound
512049|NCT00974883|GCA|gca
512050|NCT00974883|temporal arteritis|temporal arteritis
512051|NCT00974883|biopsy|biopsy
512052|NCT00974857|Hemodialysis|hemodialysis
512053|NCT00974857|Left Ventricular Hypertrophy|left ventricular hypertrophy
512054|NCT00974857|Body Composition Monitor|body composition monitor
512055|NCT00974844|posterior assisted levitation|posterior assisted levitation
512056|NCT00974844|Pars Plana|pars plana
512057|NCT00974844|Dropped nucleus|dropped nucleus
512058|NCT00974844|cataract|cataract
512059|NCT00974844|complication of|complication of
512060|NCT00974844|surgery|surgery
512061|NCT00974818|Bladder|bladder
512062|NCT00974818|Mitomycin C|mitomycin c
512063|NCT00974818|MMC|mmc
512064|NCT00974818|TheracysR Bacillus Calmette-Guerin|theracysr bacillus calmette-guerin
512065|NCT00974818|BCG|bcg
512066|NCT00974818|intravesical|intravesical
512067|NCT00974818|09-118|09-118
512068|NCT00974805|COPD|copd
512069|NCT00974805|Emphysema|emphysema
512070|NCT00974805|Bronchitis|bronchitis
512071|NCT00974792|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
512072|NCT00974792|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
512073|NCT00974779|kidney failure chronic|kidney failure chronic
512074|NCT00974779|renal dialysis|renal dialysis
512075|NCT00974779|inflammation|inflammation
512076|NCT00974779|monocytes|monocytes
512175|NCT00974402|Coping|coping
512176|NCT00974402|Counseling|counseling
512077|NCT00974779|end stage renal disease on regular thrice weekly hemodialysis|end stage renal disease on regular thrice weekly hemodialysis
512078|NCT00974766|bronchial asthma|bronchial asthma
512079|NCT00974766|allergic bronchopulmonary aspergillosis|allergic bronchopulmonary aspergillosis
512080|NCT00974753|epiretinal membrane|epiretinal membrane
512081|NCT00974740|type 1 diabetes|type 1 diabetes
512082|NCT00974727|Childhood overweight|childhood overweight
512083|NCT00974727|Gardening|gardening
512084|NCT00974727|Summer weight gain|summer weight gain
512085|NCT00974714|chronic hypertension in pregnancy|chronic hypertension in pregnancy
512086|NCT00974701|symptoms of acute overt upper gastrointestinal hemorrhage|symptoms of acute overt upper gastrointestinal hemorrhage
512087|NCT00974688|Congenital|congenital
512088|NCT00974688|physical activity participation|physical activity participation
512089|NCT00974688|Moderate-to-vigorous physical activity|moderate-to-vigorous physical activity
512090|NCT00974675|Asthma|asthma
512091|NCT00974675|CAT-354|cat-354
512092|NCT00974675|Tralokinumab|tralokinumab
512093|NCT00974662|Non-Small Cell Lung Cancer|non-small cell lung cancer
512094|NCT00974662|Lung Cancer|lung cancer
512095|NCT00974662|NSCLC|nsclc
512097|NCT00974649|predictors of treatment continuation/discontinuation|predictors of treatment continuation/discontinuation
512098|NCT00974649|IVF/ICSI|ivf/icsi
512099|NCT00974649|infertility|infertility
512100|NCT00974649|counseling|counseling
512101|NCT00974649|psychology|psychology
512102|NCT00974649|Assisted Reproduction|assisted reproduction
512103|NCT00974649|Counselling|counselling
512104|NCT00974636|Kidney Disease|kidney disease
512105|NCT00974636|Albuminuria|albuminuria
512106|NCT00974636|Glomerular filtration rate|glomerular filtration rate
512107|NCT00974636|Volume status|volume status
512108|NCT00974636|Bioimpedance analysis|bioimpedance analysis
512109|NCT00974623|Bone growth substitute|bone growth substitute
512110|NCT00974623|Autograft|autograft
512111|NCT00974623|Allograft|allograft
512112|NCT00974623|Spine fusion|spine fusion
512113|NCT00974610|stage IV melanoma|stage iv melanoma
512114|NCT00974610|recurrent melanoma|recurrent melanoma
512115|NCT00974610|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
512116|NCT00974610|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
512117|NCT00974610|extensive stage small cell lung cancer|extensive stage small cell lung cancer
512118|NCT00974610|recurrent small cell lung cancer|recurrent small cell lung cancer
512119|NCT00974610|stage IV breast cancer|stage iv breast cancer
512120|NCT00974610|recurrent breast cancer|recurrent breast cancer
512121|NCT00974610|male breast cancer|male breast cancer
512122|NCT00974610|stage III pancreatic cancer|stage iii pancreatic cancer
512123|NCT00974610|stage IV pancreatic cancer|stage iv pancreatic cancer
512124|NCT00974610|recurrent pancreatic cancer|recurrent pancreatic cancer
512125|NCT00974610|stage IV colon cancer|stage iv colon cancer
512126|NCT00974610|recurrent colon cancer|recurrent colon cancer
512127|NCT00974610|stage IV rectal cancer|stage iv rectal cancer
512128|NCT00974610|recurrent rectal cancer|recurrent rectal cancer
512129|NCT00974597|burn|burn
512130|NCT00974597|donor site|donor site
512131|NCT00974597|treatment of burns|treatment of burns
512132|NCT00974597|Treatment of Donor Sites|treatment of donor sites
512133|NCT00974584|NSCLC|nsclc
512134|NCT00974584|PI3K|pi3k
512135|NCT00974584|Avastin|avastin
512136|NCT00974558|dyspnea|dyspnea
512137|NCT00974558|fan|fan
512138|NCT00974532|balance|balance
512139|NCT00974532|chronic kidney disease|chronic kidney disease
512140|NCT00974532|calcium|calcium
512141|NCT00974532|phosphorus|phosphorus
512142|NCT00974519|ADIS|adis
512143|NCT00974519|complementary therapies|complementary therapies
512144|NCT00974506|geriatric patients living in residential community (shared flats), multiple disease-conditions|geriatric patients living in residential community (shared flats), multiple disease-conditions
512145|NCT00974493|oral|oral
512146|NCT00974493|intravenous|intravenous
512147|NCT00974493|antibiotics|antibiotics
512148|NCT00974493|bone|bone
512149|NCT00974493|joint|joint
512150|NCT00974493|infection|infection
512151|NCT00974480|Skin|skin
512152|NCT00974480|Aging|aging
512153|NCT00974480|Rejuva-a|rejuva-a
512154|NCT00974480|Redermic|redermic
512155|NCT00974454|AIDS|aids
512156|NCT00974454|complementary therapies|complementary therapies
512157|NCT00974454|treatment experienced|treatment experienced
512158|NCT00974441|Bioequivalence|bioequivalence
512159|NCT00974428|Osteoarthritis|osteoarthritis
512160|NCT00974428|Disease of joints|disease of joints
512161|NCT00974428|Wobenzym® N|wobenzym® n
512162|NCT00974428|WOMAC pain score|womac pain score
512163|NCT00974428|Subject reported pain (VAS)|subject reported pain (vas)
512164|NCT00974415|BMI classification-overweight|bmi classification-overweight
512165|NCT00974402|Active duty|active duty
512166|NCT00974402|Afghanistan|afghanistan
512167|NCT00974402|Anger|anger
512168|NCT00974402|Anxiety|anxiety
512169|NCT00974402|Avoidance|avoidance
512170|NCT00974402|BAMC|bamc
512171|NCT00974402|Brooke Army Medical Center|brooke army medical center
512172|NCT00974402|Cognitive Behavioral Therapy|cognitive behavioral therapy
512173|NCT00974402|Combat|combat
512174|NCT00974402|Combat Disorder|combat disorder
512177|NCT00974402|Counselor|counselor
512178|NCT00974402|Deployment|deployment
512179|NCT00974402|Depression|depression
512180|NCT00974402|Exposure|exposure
512181|NCT00974402|Fear|fear
512182|NCT00974402|Feeling alone|feeling alone
512183|NCT00974402|Flashbacks|flashbacks
512184|NCT00974402|Guard|guard
512185|NCT00974402|Guilt|guilt
512186|NCT00974402|Hospitalization|hospitalization
512187|NCT00974402|Iraq|iraq
512188|NCT00974402|Mental Health|mental health
512189|NCT00974402|Military|military
512190|NCT00974402|Military member|military member
512191|NCT00974402|Military personnel|military personnel
512192|NCT00974402|Neuroses|neuroses
512193|NCT00974402|Nightmares|nightmares
512194|NCT00974402|OEF|oef
512195|NCT00974402|OIF|oif
512196|NCT00974402|Prolonged Exposure Therapy|prolonged exposure therapy
512197|NCT00974402|Psychiatric|psychiatric
512198|NCT00974402|Psychiatric medication|psychiatric medication
512199|NCT00974402|Psychological distress|psychological distress
512200|NCT00974402|Psychotherapy|psychotherapy
512201|NCT00974402|Reserve|reserve
512202|NCT00974402|Retired|retired
512203|NCT00974402|Sadness|sadness
512204|NCT00974402|Separated|separated
512205|NCT00974402|Sleeplessness|sleeplessness
512206|NCT00974402|Soldier|soldier
512207|NCT00974402|Stress|stress
512208|NCT00974402|Stress disorder|stress disorder
512209|NCT00974402|Stress management|stress management
512210|NCT00974402|STRONG STAR|strong star
512211|NCT00974402|Suicidal|suicidal
512212|NCT00974402|Suicide|suicide
512213|NCT00974402|Therapy|therapy
512214|NCT00974402|Trauma|trauma
512215|NCT00974402|Traumatic Event|traumatic event
512216|NCT00974402|Trouble Sleeping|trouble sleeping
512217|NCT00974402|Veteran|veteran
512218|NCT00974402|Veterans|veterans
512219|NCT00974402|War|war
512220|NCT00974402|WHMC|whmc
512221|NCT00974402|Wilford Hall Medical Center|wilford hall medical center
512222|NCT00974402|PTSD|ptsd
512223|NCT00974402|Posttraumatic Stress Disorders|posttraumatic stress disorders
512224|NCT00974389|stage III colon cancer|stage iii colon cancer
512225|NCT00974389|stage III rectal cancer|stage iii rectal cancer
512226|NCT00974389|stage IV colon cancer|stage iv colon cancer
512227|NCT00974389|stage IV rectal cancer|stage iv rectal cancer
512228|NCT00974389|recurrent colon cancer|recurrent colon cancer
512229|NCT00974389|recurrent rectal cancer|recurrent rectal cancer
512230|NCT00974376|Cannabis Treatment|cannabis treatment
512231|NCT00974376|Cannabis Use|cannabis use
512232|NCT00974376|Cannabis Dependence|cannabis dependence
512233|NCT00974376|Executive Functioning|executive functioning
512234|NCT00974376|Cognitive Deficits|cognitive deficits
512235|NCT00974363|meningococcal vaccine GSK 134612|meningococcal vaccine gsk 134612
512236|NCT00974350|Post-operative pain|post-operative pain
512237|NCT00974350|hernia surgery|hernia surgery
512238|NCT00974350|opioid|opioid
512239|NCT00974337|Adrenal insufficiency|adrenal insufficiency
512240|NCT00974337|cortisol|cortisol
512241|NCT00974337|preterm|preterm
512242|NCT00974337|shock|shock
512243|NCT00974337|neonate|neonate
512244|NCT00974324|peripheral T cell lymphoma|peripheral t cell lymphoma
512245|NCT00974324|chemotherapy|chemotherapy
512246|NCT00974324|anti-angiogeneses|anti-angiogeneses
512247|NCT00974311|Prostate Cancer|prostate cancer
512248|NCT00974311|Castration-resistant|castration-resistant
512249|NCT00974285|AIDS|aids
512250|NCT00974285|complementary therapies|complementary therapies
512251|NCT00974259|Hypoxia|hypoxia
512252|NCT00974259|Ischemia|ischemia
512253|NCT00974259|Intracranial hypertension|intracranial hypertension
512254|NCT00974259|Neurocritical care|neurocritical care
512255|NCT00974246|COPD|copd
512256|NCT00974246|Depression|depression
512257|NCT00974246|Nursing Home|nursing home
512258|NCT00974233|CLL|cll
512259|NCT00974233|SLL|sll
512260|NCT00974220|inhaled fentanyl|inhaled fentanyl
512261|NCT00974220|dyspnea|dyspnea
512262|NCT00974220|exercise|exercise
512263|NCT00974220|COPD|copd
512264|NCT00974194|Cholecystolithiasis|cholecystolithiasis
512265|NCT00974194|Cholecystectomy|cholecystectomy
512266|NCT00974194|Laparoscopic surgery|laparoscopic surgery
512267|NCT00974194|Single port|single port
512268|NCT00974168|pain|pain
512269|NCT00974168|radiation toxicity|radiation toxicity
512270|NCT00974168|spinal cord compression|spinal cord compression
512271|NCT00974168|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
512272|NCT00974155|Major|major
512273|NCT00974155|Depression|depression
512274|NCT00974155|Disorder|disorder
512275|NCT00974142|COPD|copd
512276|NCT00974142|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
512277|NCT00974142|Cyclosporine|cyclosporine
512278|NCT00974142|Oral Immunotherapy|oral immunotherapy
512279|NCT00974142|Advanced stage|advanced stage
512280|NCT00974103|low back pain|low back pain
512281|NCT00974103|pelvic pain|pelvic pain
512282|NCT00974103|pelvic girdle pain|pelvic girdle pain
512283|NCT00974103|post partum|post partum
512284|NCT00974090|insulin resistance|insulin resistance
512285|NCT00974077|recurrent depression,|recurrent depression,
512286|NCT00974077|mindfulness training|mindfulness training
512287|NCT00974077|attention|attention
512288|NCT00974077|Evoked EEG potentials|evoked eeg potentials
512289|NCT00974077|Relapse prevention in recurrent depression|relapse prevention in recurrent depression
512290|NCT00974064|COPD|copd
512291|NCT00974064|Lung disease|lung disease
512292|NCT00974064|Chronic bronchitis|chronic bronchitis
512293|NCT00974064|Emphysema|emphysema
512294|NCT00974064|Smoking|smoking
512295|NCT00974064|Smoking cessation|smoking cessation
512296|NCT00974064|Quit smoking|quit smoking
512297|NCT00974064|Healthy smoker|healthy smoker
512298|NCT00974064|Smoker|smoker
512299|NCT00974064|Non-smoker|non-smoker
512300|NCT00974051|Children|children
512301|NCT00974051|Exercise|exercise
512302|NCT00974051|Hypoglycemia|hypoglycemia
512303|NCT00974038|Bulimia Nervosa, EDNOS, Adolescents|bulimia nervosa, ednos, adolescents
512304|NCT00974012|Bioequivalence|bioequivalence
512305|NCT00973999|Botulinum Toxin|botulinum toxin
512306|NCT00973999|Saliva|saliva
512307|NCT00973999|Tracheostomy tube|tracheostomy tube
512308|NCT00973986|atorvastatin|atorvastatin
512309|NCT00973986|genetic polymorphisms|genetic polymorphisms
512310|NCT00973986|coronary heart disease|coronary heart disease
512311|NCT00973986|pharmacokinetics|pharmacokinetics
512312|NCT00973986|CYP3A|cyp3a
512313|NCT00973973|Pelvic Pain|pelvic pain
512314|NCT00973973|NBI-56418|nbi-56418
512315|NCT00973973|Endometriosis|endometriosis
512316|NCT00973947|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
512317|NCT00973947|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
512318|NCT00973947|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
512319|NCT00973947|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
512320|NCT00973947|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
512321|NCT00973947|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
512322|NCT00973947|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
512323|NCT00973947|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
512324|NCT00973947|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
512325|NCT00973947|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
512326|NCT00973947|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
512327|NCT00973947|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
512328|NCT00973947|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
512329|NCT00973947|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
512330|NCT00973947|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
512331|NCT00973947|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
512332|NCT00973947|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
512333|NCT00973947|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
512334|NCT00973947|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
512335|NCT00973947|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
512336|NCT00973947|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
512337|NCT00973947|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
512338|NCT00973947|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
512339|NCT00973947|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
512340|NCT00973947|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
512341|NCT00973947|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
512342|NCT00973947|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
512343|NCT00973947|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
512344|NCT00973947|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
512345|NCT00973947|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
512346|NCT00973947|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
512347|NCT00973947|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
512348|NCT00973947|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
512349|NCT00973947|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
512350|NCT00973947|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
512351|NCT00973947|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
512352|NCT00973947|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
512353|NCT00973947|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
512406|NCT00973921|StentOp|stentop
512354|NCT00973947|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
512355|NCT00973947|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
512356|NCT00973947|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
512357|NCT00973947|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
512358|NCT00973947|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
512359|NCT00973947|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
512360|NCT00973947|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
512361|NCT00973947|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
512362|NCT00973947|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
512363|NCT00973947|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
512364|NCT00973947|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
512365|NCT00973947|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
512366|NCT00973947|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
512367|NCT00973947|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
512368|NCT00973947|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
512369|NCT00973947|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
512370|NCT00973947|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
512371|NCT00973947|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
512372|NCT00973947|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
512373|NCT00973947|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
512374|NCT00973947|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
512375|NCT00973947|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
512376|NCT00973947|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
512377|NCT00973947|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
512378|NCT00973947|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
512379|NCT00973947|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
512380|NCT00973947|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
512381|NCT00973947|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
512382|NCT00973947|stage I salivary gland cancer|stage i salivary gland cancer
512383|NCT00973947|stage II salivary gland cancer|stage ii salivary gland cancer
512384|NCT00973947|stage III salivary gland cancer|stage iii salivary gland cancer
512385|NCT00973947|stage IV salivary gland cancer|stage iv salivary gland cancer
512386|NCT00973947|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
512387|NCT00973947|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
512388|NCT00973947|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
512389|NCT00973947|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
512390|NCT00973947|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
512391|NCT00973947|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
512392|NCT00973947|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
512393|NCT00973947|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
512394|NCT00973947|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
512395|NCT00973947|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
512396|NCT00973947|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
512397|NCT00973947|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
512398|NCT00973947|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
512399|NCT00973947|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
512400|NCT00973947|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
512401|NCT00973947|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
512402|NCT00973947|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
512403|NCT00973947|recurrent salivary gland cancer|recurrent salivary gland cancer
512404|NCT00973921|Stent|stent
512405|NCT00973921|under-expansion|under-expansion
512407|NCT00973921|StentOptimizer|stentoptimizer
512408|NCT00973921|IVUS|ivus
512409|NCT00973921|IC-PRO|ic-pro
512410|NCT00973921|image enhancement|image enhancement
512411|NCT00973908|Clostridium difficile associated diarrhoea|clostridium difficile associated diarrhoea
512412|NCT00973908|antibiotic associated diarrhoea|antibiotic associated diarrhoea
512413|NCT00973895|Influenza|influenza
512414|NCT00973895|Healthy|healthy
512415|NCT00973895|Immunity|immunity
512416|NCT00973895|Preventive|preventive
512417|NCT00973895|Pandemic|pandemic
512418|NCT00973882|Hormone resistant prostate cancer|hormone resistant prostate cancer
512419|NCT00973882|Neuro-endocrine marker|neuro-endocrine marker
512420|NCT00973882|Carboplatin-Etoposide combination|carboplatin-etoposide combination
512421|NCT00973882|Neuro-endocrine differentiation|neuro-endocrine differentiation
512422|NCT00973869|colon cancer|colon cancer
512423|NCT00973869|rectal cancer|rectal cancer
512424|NCT00973830|Changes in HbA1c|changes in hba1c
512425|NCT00973817|Hepatitis|hepatitis
512426|NCT00973817|AOCH|aoch
512427|NCT00973804|Reduced Intensity Conditioning|reduced intensity conditioning
512428|NCT00973804|Umbilical Cord Blood Transplant|umbilical cord blood transplant
512429|NCT00973804|Targeted Immune Depletion|targeted immune depletion
512430|NCT00973804|Leukemia|leukemia
512431|NCT00973804|Lymphoma|lymphoma
512432|NCT00973804|Multiple Myeloma|multiple myeloma
512433|NCT00973804|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
512434|NCT00973804|Hodgkins Lymphoma|hodgkins lymphoma
512435|NCT00973791|Spinal anesthesia|spinal anesthesia
512436|NCT00973791|Fluid therapy|fluid therapy
512437|NCT00973778|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
512438|NCT00973778|Capecitabine|capecitabine
512439|NCT00973778|Resectable Rectal Carcinoma|resectable rectal carcinoma
512440|NCT00973765|abcess|abcess
512441|NCT00973765|MRSA|mrsa
512442|NCT00973765|cellulitis|cellulitis
512443|NCT00973765|antibiotics|antibiotics
512444|NCT00973765|uncomplicated abscesses|uncomplicated abscesses
512445|NCT00973752|ALL|all
512446|NCT00973739|NF-2|nf-2
512447|NCT00973739|NF-2 related tumors|nf-2 related tumors
512448|NCT00973739|Schwannoma, Acoustic, Bilateral|schwannoma, acoustic, bilateral
512449|NCT00973739|schwannomas|schwannomas
512450|NCT00973739|Neurilemmoma of other cranial and peripheral nerves|neurilemmoma of other cranial and peripheral nerves
512451|NCT00973739|NF2 related benign intracranial tumors including|nf2 related benign intracranial tumors including
512452|NCT00973739|NF2 related meningiomas|nf2 related meningiomas
512453|NCT00973739|NF2 related ependymomas|nf2 related ependymomas
512454|NCT00973739|NF2 related spinal neurofibromas|nf2 related spinal neurofibromas
512455|NCT00973739|NF2 related gliomas|nf2 related gliomas
512456|NCT00973713|Advanced cholangiocarcinoma|advanced cholangiocarcinoma
512457|NCT00973700|Swine Flu|swine flu
512458|NCT00973700|Flu|flu
512459|NCT00973700|Vaccine|vaccine
512460|NCT00973700|Adjuvant|adjuvant
512461|NCT00973687|pediatric|pediatric
512462|NCT00973687|dexamethasone|dexamethasone
512463|NCT00973687|management|management
512464|NCT00973687|corticosteroids|corticosteroids
512465|NCT00973687|asthma|asthma
512466|NCT00973661|Overweight|overweight
512467|NCT00973661|Diagnosis|diagnosis
512468|NCT00973661|Counseling|counseling
512469|NCT00973661|Medical Records Systems, Computerized|medical records systems, computerized
512470|NCT00973648|Tinnitus|tinnitus
512471|NCT00973648|Ringing in ears|ringing in ears
512472|NCT00973648|Functional connectivity MRI|functional connectivity mri
512473|NCT00973648|Voluntary control of tinnitus|voluntary control of tinnitus
512474|NCT00973635|education|education
512475|NCT00973635|web-based intervention|web-based intervention
512476|NCT00973635|patient care|patient care
512477|NCT00973622|Tobacco cessation|tobacco cessation
512478|NCT00973622|Tobacco dependence|tobacco dependence
512479|NCT00973622|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
512480|NCT00973622|Nicotine Dependence|nicotine dependence
512481|NCT00973622|Delayed Discounting|delayed discounting
512482|NCT00973609|metastatic colorectal cancer|metastatic colorectal cancer
512483|NCT00973609|Bevacizumab|bevacizumab
512484|NCT00973609|Avastin®|avastin®
512485|NCT00973609|phase 3|phase 3
512486|NCT00973609|maintenance treatment|maintenance treatment
512487|NCT00973609|treatment pause|treatment pause
512488|NCT00973609|drug holiday|drug holiday
512489|NCT00973609|stage IV|stage iv
512490|NCT00973583|vitamin D|vitamin d
512491|NCT00973583|infection|infection
512492|NCT00973583|Vitamin D for the prevention of respiratory tract infections|vitamin d for the prevention of respiratory tract infections
512493|NCT00973570|tobacco cessation|tobacco cessation
512494|NCT00973570|evaluation|evaluation
512495|NCT00973570|epidémiology|epidémiology
512496|NCT00973570|adolescent|adolescent
512497|NCT00973570|apprentices|apprentices
512498|NCT00973557|bevacizumab|bevacizumab
512499|NCT00973544|breast reconstruction complications|breast reconstruction complications
512500|NCT00973544|drains|drains
512501|NCT00973544|silicone implant|silicone implant
512502|NCT00973531|Sleep Disordered Breathing|sleep disordered breathing
512503|NCT00973531|Sleep Apnea|sleep apnea
512504|NCT00973531|Hypertension|hypertension
512505|NCT00973531|Continuous Positive Airway Pressure|continuous positive airway pressure
512506|NCT00973518|Alzheimer's Disease|alzheimer's disease
512507|NCT00973518|AD|ad
512508|NCT00973518|Healthy Control|healthy control
512509|NCT00973505|Breast neoplasms|breast neoplasms
512510|NCT00973505|Aromatase inhibitors|aromatase inhibitors
512511|NCT00973505|Genetic polymorphisms|genetic polymorphisms
512512|NCT00973505|Arthralgia|arthralgia
512513|NCT00973505|Arthritis|arthritis
512514|NCT00973492|type 1 diabetes|type 1 diabetes
512515|NCT00973492|functional insulinotherapy|functional insulinotherapy
512516|NCT00973479|Arthritis, Rheumatoid|arthritis, rheumatoid
512517|NCT00973479|Active rheumatoid arthritis|active rheumatoid arthritis
512518|NCT00973479|Golimumab|golimumab
512519|NCT00973479|CNTO148|cnto148
512520|NCT00973479|Anti-TNFalpha monoclonal antibody|anti-tnfalpha monoclonal antibody
512521|NCT00973479|Methotrexate|methotrexate
512522|NCT00973479|Intravenous|intravenous
512523|NCT00973466|HIV-infection|hiv-infection
512524|NCT00973466|Neisseria gonorrhea|neisseria gonorrhea
512525|NCT00973466|Chlamydia trachomatis|chlamydia trachomatis
512526|NCT00973466|Herpes simplex virus|herpes simplex virus
512527|NCT00973466|prevalence|prevalence
512528|NCT00973453|non-seasonal allergy|non-seasonal allergy
512529|NCT00973453|house dust mite|house dust mite
512530|NCT00973453|immunotherapy|immunotherapy
512531|NCT00973453|dose tolerability|dose tolerability
512532|NCT00973440|geriatric assessment|geriatric assessment
512533|NCT00973427|NSCLC|nsclc
512534|NCT00973414|Combined epidural spinal anesthesia|combined epidural spinal anesthesia
512535|NCT00973414|Fluid therapy|fluid therapy
512536|NCT00973388|VX-950-TiDP24-C136|vx-950-tidp24-c136
512537|NCT00973388|VX-950-C136|vx-950-c136
512538|NCT00973388|VX-950|vx-950
512539|NCT00973388|HEPATITIS|hepatitis
512540|NCT00973388|Telaprevir|telaprevir
512541|NCT00973388|Moxifloxacin|moxifloxacin
512542|NCT00973388|ECG|ecg
512543|NCT00973388|QT|qt
512544|NCT00973388|QTc|qtc
512545|NCT00973375|Drug-eluting stent|drug-eluting stent
512546|NCT00973375|coronary restenosis|coronary restenosis
512547|NCT00973375|coronary thrombosis|coronary thrombosis
512548|NCT00973362|Cervix Cancer|cervix cancer
512549|NCT00973362|Cervical Intraepithelial Neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
512550|NCT00973362|Human Papillomavirus Virus (HPV)|human papillomavirus virus (hpv)
512551|NCT00973362|APTIMA HPV Assay|aptima hpv assay
512552|NCT00973362|FDA-Approved HPV DNA Test|fda-approved hpv dna test
512553|NCT00973362|TIGRIS DTS (direct tube sampling) System|tigris dts (direct tube sampling) system
512554|NCT00973362|Clinical Sensitivity (%)|clinical sensitivity (%)
512555|NCT00973362|Clinical Specificity (%)|clinical specificity (%)
512556|NCT00973362|Positive Predictive Value [PPV] (%)|positive predictive value [ppv] (%)
512557|NCT00973362|Negative Predictive Value [NPV] (%)|negative predictive value [npv] (%)
512558|NCT00973362|Atypical Squamous Cells Undetermined Significance (ASC-US)|atypical squamous cells undetermined significance (asc-us)
512559|NCT00973362|Relative Risk|relative risk
512560|NCT00973349|Swine Flu|swine flu
512561|NCT00973349|Flu|flu
512562|NCT00973349|Vaccine|vaccine
512563|NCT00973349|Adults|adults
512564|NCT00973349|Elderly|elderly
512565|NCT00973349|Non-Elderly|non-elderly
512566|NCT00973349|Adjuvant|adjuvant
512567|NCT00973336|postoperative follow-up|postoperative follow-up
512568|NCT00973323|BAY59-7939|bay59-7939
512569|NCT00973323|Rivaroxaban|rivaroxaban
512570|NCT00973323|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
512571|NCT00973323|Japanese Patients|japanese patients
512572|NCT00973323|Phase II|phase ii
512573|NCT00973310|Non-small-cell lung cancer|non-small-cell lung cancer
512574|NCT00973310|Radiation therapy|radiation therapy
512575|NCT00973310|Epidermal growth factor receptor|epidermal growth factor receptor
512576|NCT00973310|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
512577|NCT00973297|Falls|falls
512578|NCT00973284|Prevention of acute gastroenteritis due to infection with and experimental Norwalk Virus|prevention of acute gastroenteritis due to infection with and experimental norwalk virus
512579|NCT00973271|hypertriglyceridemia|hypertriglyceridemia
512580|NCT00973245|BAY59-7939|bay59-7939
512581|NCT00973245|Rivaroxaban|rivaroxaban
512582|NCT00973245|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
512583|NCT00973245|Japanese Patients|japanese patients
512584|NCT00973245|Phase II|phase ii
512585|NCT00973232|Tramadol|tramadol
512586|NCT00973232|Acetaminophen|acetaminophen
512587|NCT00973232|combination|combination
512588|NCT00973232|pharmacokinetics|pharmacokinetics
512589|NCT00973232|bioavailability|bioavailability
512590|NCT00973232|Zaldiar|zaldiar
512591|NCT00973232|Ultracet|ultracet
512592|NCT00973232|fed|fed
512593|NCT00973232|fasted|fasted
512594|NCT00973232|single-dose|single-dose
512595|NCT00973232|multiple-dose|multiple-dose
512596|NCT00973232|healthy|healthy
512597|NCT00973232|volunteers|volunteers
512598|NCT00973232|Healthy volunteers|healthy volunteers
512599|NCT00973219|HBsAg loss|hbsag loss
512600|NCT00973219|HBsAg seroconversion|hbsag seroconversion
512601|NCT00973219|chronic hepatitis B|chronic hepatitis b
512602|NCT00973219|low viral load|low viral load
512603|NCT00973219|inactive carrier hepatitis B|inactive carrier hepatitis b
512604|NCT00973206|cardiovascular morbidity|cardiovascular morbidity
512605|NCT00973206|mortality community study|mortality community study
512606|NCT00973193|rectum|rectum
512607|NCT00973193|colorectal|colorectal
512608|NCT00973193|cancer|cancer
512609|NCT00973193|adenocarcinoma|adenocarcinoma
512610|NCT00973193|anti-EGFR|anti-egfr
512611|NCT00973193|monoclonal antibodies|monoclonal antibodies
512612|NCT00973193|neoadjuvant therapy|neoadjuvant therapy
512613|NCT00973193|preoperative radiotherapy|preoperative radiotherapy
512614|NCT00973180|Prescription medication understanding among diabetic and hypertension patients.|prescription medication understanding among diabetic and hypertension patients.
512615|NCT00973180|Prescription medication use among diabetic and hypertension patients.|prescription medication use among diabetic and hypertension patients.
512616|NCT00973180|Hemoglobin A1c changes among diabetic patients.|hemoglobin a1c changes among diabetic patients.
512617|NCT00973180|Blood pressure changes among hypertension patients.|blood pressure changes among hypertension patients.
512618|NCT00973167|Fracture rate|fracture rate
512619|NCT00973167|Fracture risks|fracture risks
512620|NCT00973154|Pneumonia|pneumonia
512621|NCT00973154|Corticosteroids|corticosteroids
512622|NCT00973154|clinical stability|clinical stability
512623|NCT00973141|Moderate to severe, osteoarthritis-related pain|moderate to severe, osteoarthritis-related pain
512624|NCT00973141|Osteoarthritis-related pain|osteoarthritis-related pain
512625|NCT00973141|Moderate to severe chronic pain|moderate to severe chronic pain
512626|NCT00973141|JNJ-42160443|jnj-42160443
512627|NCT00973089|Primary tooth|primary tooth
512628|NCT00973089|Caries, Dental|caries, dental
512629|NCT00973089|Alternative treatment|alternative treatment
512630|NCT00973076|Phase I, cancer|phase i, cancer
512631|NCT00973076|solid tumors|solid tumors
512632|NCT00973076|advanced solid malignancies|advanced solid malignancies
512633|NCT00973076|dose escalation|dose escalation
512634|NCT00973076|mTOR Kinase Inhibitor|mtor kinase inhibitor
512635|NCT00973076|Japanese|japanese
512636|NCT00973063|bacteremia|bacteremia
512637|NCT00973063|blood culture|blood culture
512638|NCT00973063|contamination|contamination
512639|NCT00973050|Bioequivalence|bioequivalence
512640|NCT00973037|Breast neoplasms|breast neoplasms
512641|NCT00973037|Tamoxifen|tamoxifen
512642|NCT00973037|Genotype|genotype
512643|NCT00973037|CYP2D6|cyp2d6
512644|NCT00973024|JNJ-42160443|jnj-42160443
512645|NCT00973024|Low back pain-related pain|low back pain-related pain
512646|NCT00973024|moderate to severe, chronic pain|moderate to severe, chronic pain
512647|NCT00973011|GA|ga
512648|NCT00972998|anal sphincter pressure|anal sphincter pressure
512649|NCT00972998|phenyephrine|phenyephrine
512650|NCT00972985|Healthy Control subjects|healthy control subjects
512651|NCT00972972|fruit polyphenols|fruit polyphenols
512652|NCT00972972|phytochemicals|phytochemicals
512653|NCT00972972|neurocognition|neurocognition
512654|NCT00972972|neuropsychology|neuropsychology
512655|NCT00972972|psychopharmacology|psychopharmacology
512656|NCT00972972|gene expression|gene expression
512657|NCT00972972|biochemistry|biochemistry
512658|NCT00972959|multiple myeloma|multiple myeloma
512659|NCT00972959|1-3 Prior Lines of Therapy|1-3 prior lines of therapy
512660|NCT00972959|bortezomib (Velcade)|bortezomib (velcade)
512661|NCT00972959|zoledronic acid (Zometa)|zoledronic acid (zometa)
512662|NCT00972959|Dexamethasone|dexamethasone
512663|NCT00972959|bone mineral density|bone mineral density
512664|NCT00972959|bone pain|bone pain
512665|NCT00972959|bone metabolism|bone metabolism
512666|NCT00972959|osteolytic lesions|osteolytic lesions
512667|NCT00972959|DEXA-scans|dexa-scans
512668|NCT00972959|X-ray radiography|x-ray radiography
512669|NCT00972946|MRI|mri
512670|NCT00972946|SPIO|spio
512671|NCT00972933|Immunogenicity Analysis|immunogenicity analysis
512672|NCT00972933|Biomarker Analysis|biomarker analysis
512673|NCT00972933|experimental|experimental
512674|NCT00972920|Transversus abdominis plane|transversus abdominis plane
512675|NCT00972920|Acute pain service|acute pain service
512676|NCT00972920|Ultrasound|ultrasound
512677|NCT00972907|anal fissure|anal fissure
512678|NCT00972907|pain|pain
512679|NCT00972907|nifedipine|nifedipine
512680|NCT00972894|Group B streptococcus|group b streptococcus
512681|NCT00972894|Polymerase chain reaction|polymerase chain reaction
512682|NCT00972894|PCR|pcr
512683|NCT00972894|Intrapartum screening|intrapartum screening
512684|NCT00972894|Risk factors|risk factors
512685|NCT00972894|arly onset Group B streptococcus infection|arly onset group b streptococcus infection
512686|NCT00972881|adenocarcinoma of the rectum|adenocarcinoma of the rectum
512687|NCT00972881|Locally advanced rectal cancer|locally advanced rectal cancer
512688|NCT00972868|Unidirectional mask|unidirectional mask
512689|NCT00972868|NPPV|nppv
512690|NCT00972868|COPD|copd
512691|NCT00972868|respiratory physiology|respiratory physiology
512692|NCT00972855|Bioequivalence|bioequivalence
512693|NCT00972842|PTCL|ptcl
512694|NCT00972842|Peripheral T-Cell Non-Hodgkin's Lymphoma|peripheral t-cell non-hodgkin's lymphoma
512695|NCT00972842|Vorinostat|vorinostat
512696|NCT00972842|Lenalidomid|lenalidomid
512697|NCT00972829|Hypercholesterolemia|hypercholesterolemia
512698|NCT00972816|Swine Flu|swine flu
512699|NCT00972816|Flu|flu
512700|NCT00972816|Vaccine|vaccine
512701|NCT00972816|Children|children
512702|NCT00972816|Adjuvant|adjuvant
512703|NCT00972803|gingivitis|gingivitis
512704|NCT00972803|dental plaque|dental plaque
512705|NCT00972803|mouthrinse|mouthrinse
512706|NCT00972790|brain tumor|brain tumor
512707|NCT00972790|un-ruptured aneurysm|un-ruptured aneurysm
512708|NCT00972790|arteriovenous malformation|arteriovenous malformation
512709|NCT00972790|epileptic focus|epileptic focus
512710|NCT00972790|supratentorial|supratentorial
512711|NCT00972764|Laryngomalacia|laryngomalacia
512712|NCT00972764|Factors Associated or Predisposing|factors associated or predisposing
512713|NCT00972751|stage II rectal cancer|stage ii rectal cancer
512714|NCT00972751|stage III rectal cancer|stage iii rectal cancer
512715|NCT00972751|adenocarcinoma of the rectum|adenocarcinoma of the rectum
512716|NCT00972725|Chloroquine|chloroquine
512717|NCT00972725|Human Immunodeficiency Virus|human immunodeficiency virus
512718|NCT00972712|Multiple Myeloma|multiple myeloma
512719|NCT00972699|Human Immunodeficiency Virus|human immunodeficiency virus
512720|NCT00972699|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
512721|NCT00972699|Tuberculosis|tuberculosis
512722|NCT00972699|Women|women
512723|NCT00972699|Pregnancy|pregnancy
512724|NCT00972699|Vertical Transmission of Human Immunodeficiency Virus|vertical transmission of human immunodeficiency virus
512725|NCT00972699|South Africa|south africa
512726|NCT00972699|Low Birth Weight|low birth weight
512727|NCT00972686|solid tumors|solid tumors
512728|NCT00972686|lymphoma|lymphoma
512729|NCT00972686|Phosphoinositide 3-kinase inhibitor|phosphoinositide 3-kinase inhibitor
512730|NCT00972660|Mesenchymal stem cell|mesenchymal stem cell
512731|NCT00972660|Efficacy|efficacy
512732|NCT00972660|Safety|safety
512733|NCT00972647|fracture|fracture
512734|NCT00972647|fixation|fixation
512735|NCT00972647|fluoroscopy|fluoroscopy
512736|NCT00972647|laser|laser
512737|NCT00972647|radiation|radiation
512738|NCT00972634|depression|depression
512739|NCT00972634|cachexia|cachexia
512740|NCT00972634|pain|pain
512741|NCT00972634|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
512742|NCT00972608|congenital heart disease|congenital heart disease
512743|NCT00972608|surgical planning|surgical planning
512744|NCT00972582|leucine intake|leucine intake
512745|NCT00972582|tolerable upper limit|tolerable upper limit
512746|NCT00972582|adults|adults
512747|NCT00972582|amino acid supplements|amino acid supplements
512748|NCT00972582|Excessive Leucine Intake|excessive leucine intake
512749|NCT00972569|BNP with or without PDE-V in heart failure|bnp with or without pde-v in heart failure
512750|NCT00972556|Mineral Trioxide Aggregate|mineral trioxide aggregate
512751|NCT00972556|Formocresol|formocresol
512752|NCT00972556|pulpotomy|pulpotomy
512753|NCT00972556|primary molar|primary molar
512754|NCT00972556|treatment outcome|treatment outcome
512755|NCT00972543|Moderate to severe chronic plaque psoriasis|moderate to severe chronic plaque psoriasis
512756|NCT00972543|palms and/or soles|palms and/or soles
512757|NCT00972543|with or without pustules|with or without pustules
512758|NCT00972530|rheumatoid arthritis|rheumatoid arthritis
512759|NCT00972530|treatment|treatment
512760|NCT00972517|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
512761|NCT00972517|influenza infection|influenza infection
512762|NCT00972504|Proof of concept|proof of concept
512763|NCT00972465|nimotuzumab colorectal cancer chemotherapy|nimotuzumab colorectal cancer chemotherapy
512764|NCT00972452|Type II Diabetes|type ii diabetes
512765|NCT00972452|Insulin Resistance|insulin resistance
512766|NCT00972452|Exercise|exercise
512767|NCT00972452|Continuous Glucose Monitoring|continuous glucose monitoring
512768|NCT00972439|Oral Contraceptives|oral contraceptives
512769|NCT00972439|Breast Tissue|breast tissue
512770|NCT00972413|breast cancer|breast cancer
512771|NCT00972413|cone beam computed tomography|cone beam computed tomography
512772|NCT00972400|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
512773|NCT00972400|fatigue|fatigue
512774|NCT00972400|cancer survivor|cancer survivor
512775|NCT00972400|breast cancer|breast cancer
512776|NCT00972387|carbohydrate-protein|carbohydrate-protein
512777|NCT00972387|endurance exercise|endurance exercise
512778|NCT00972387|supplement|supplement
512779|NCT00972361|Adenoidectomy|adenoidectomy
512780|NCT00972361|Tonsillectomy|tonsillectomy
512781|NCT00972361|Ventilation Tubes|ventilation tubes
512782|NCT00972361|Preoperational screening|preoperational screening
512783|NCT00972361|Coagulation Profile|coagulation profile
512784|NCT00972361|Lupus anticoagulant|lupus anticoagulant
512785|NCT00972348|HIV|hiv
512786|NCT00972348|Personal Health Record|personal health record
512787|NCT00972348|Laboratory values: CD4 cells and HIV Viral load|laboratory values: cd4 cells and hiv viral load
512788|NCT00972348|Medication Reconciliation|medication reconciliation
512789|NCT00972335|Avastin|avastin
512790|NCT00972335|RAD001|rad001
512791|NCT00972335|Meningioma|meningioma
512792|NCT00972335|Bevacizumab|bevacizumab
512793|NCT00972335|Everolimus|everolimus
512794|NCT00972335|Brain|brain
512795|NCT00972309|Epotope-Enhanced TARP Peptide|epotope-enhanced tarp peptide
512796|NCT00972309|Prostate Cancer|prostate cancer
512797|NCT00972309|TARP Peptide-Pulsed Dendritic Cells|tarp peptide-pulsed dendritic cells
512798|NCT00972309|PSADT|psadt
512799|NCT00972309|HLA-A*0201|hla-a*0201
512800|NCT00972270|Arterial Occlusive Disease|arterial occlusive disease
512801|NCT00972270|Heart Diseases|heart diseases
512802|NCT00972270|Myocardial Ischemia|myocardial ischemia
512803|NCT00972270|Vascular Disease|vascular disease
512804|NCT00972270|Arteriosclerosis|arteriosclerosis
512805|NCT00972270|Ischemia|ischemia
512806|NCT00972257|24-hour IOP control|24-hour iop control
512807|NCT00972257|primary open-angle glaucoma|primary open-angle glaucoma
512808|NCT00972257|brimonidine/timolol|brimonidine/timolol
512809|NCT00972257|dorzolamide/timolol|dorzolamide/timolol
512810|NCT00972244|Type 2 diabetes mellitus|type 2 diabetes mellitus
512811|NCT00972244|Japanese|japanese
512812|NCT00972244|phase 2|phase 2
512813|NCT00972244|efficacy|efficacy
512814|NCT00972244|safety|safety
512815|NCT00972244|dapagliflozin|dapagliflozin
512816|NCT00972231|Thalassemia Major|thalassemia major
512817|NCT00972231|Thalassemia Intermedia|thalassemia intermedia
512818|NCT00972231|Sickle Cell Anemia|sickle cell anemia
512819|NCT00972231|Sickle Cell Thalassemia|sickle cell thalassemia
512820|NCT00972231|Iron Overload|iron overload
512821|NCT00972231|Growth Velocity|growth velocity
512822|NCT00972218|Spondyloarthritis|spondyloarthritis
512823|NCT00972218|Ankylosing Spondylitis|ankylosing spondylitis
512824|NCT00972218|Crohn's disease|crohn's disease
512825|NCT00972218|adalimumab|adalimumab
512826|NCT00972218|treatment|treatment
512827|NCT00972205|Pgp|pgp
512828|NCT00972205|Solid Tumors|solid tumors
512829|NCT00972205|Drug Resistance|drug resistance
512830|NCT00972205|Sestamibi|sestamibi
512831|NCT00972205|Cancer|cancer
512832|NCT00972205|Solid Tumor|solid tumor
512833|NCT00972192|HIV testing|hiv testing
512834|NCT00972192|HIV risk behavior|hiv risk behavior
512835|NCT00972192|access to care|access to care
512836|NCT00972179|healthy volunteers|healthy volunteers
512837|NCT00972153|Decrease in CFU density at surgery site|decrease in cfu density at surgery site
512838|NCT00972153|Decrease in airborne particulate at surgery site|decrease in airborne particulate at surgery site
512839|NCT00972140|Patients with stable COPD|patients with stable copd
512840|NCT00972101|Blood And Marrow Transplantation|blood and marrow transplantation
512841|NCT00972101|Leukemia|leukemia
512842|NCT00972101|Lymphoma|lymphoma
512843|NCT00972101|Pediatrics|pediatrics
512844|NCT00972101|Etoposide|etoposide
512845|NCT00972101|Expanded Cord Blood T Cells|expanded cord blood t cells
512846|NCT00972101|Filgrastim|filgrastim
512847|NCT00972101|Fludarabine|fludarabine
512848|NCT00972101|Melphalan|melphalan
512849|NCT00972101|Mycophenolate Mofetil|mycophenolate mofetil
512850|NCT00972101|Rituximab|rituximab
512851|NCT00972101|Tacrolimus|tacrolimus
512852|NCT00972101|Thiotepa|thiotepa
512853|NCT00972101|Thymoglobulin|thymoglobulin
512854|NCT00972101|Total Body Irradiation|total body irradiation
512855|NCT00972088|inflammation of the small bowel|inflammation of the small bowel
512856|NCT00972075|totally blind subjects|totally blind subjects
512857|NCT00972062|Subcutaneous injections|subcutaneous injections
512858|NCT00972062|Skin abnormalities|skin abnormalities
512859|NCT00972049|safety|safety
512860|NCT00972049|tolerability|tolerability
512861|NCT00972049|AZD2516|azd2516
512862|NCT00972049|pain|pain
512863|NCT00972049|Japanese|japanese
512864|NCT00972036|COLON|colon
512865|NCT00972036|LIVER|liver
512866|NCT00972036|RECTUM|rectum
512867|NCT00972036|SIR-Spheres|sir-spheres
512868|NCT00972036|09-030|09-030
512869|NCT00972023|triple-negative breast cancer|triple-negative breast cancer
512870|NCT00972023|stage I breast cancer|stage i breast cancer
512871|NCT00972023|stage II breast cancer|stage ii breast cancer
512872|NCT00972023|stage IIIA breast cancer|stage iiia breast cancer
512873|NCT00972023|stage IIIB breast cancer|stage iiib breast cancer
512874|NCT00972023|stage IIIC breast cancer|stage iiic breast cancer
512875|NCT00972010|Breast|breast
512876|NCT00972010|Cancer|cancer
512877|NCT00972010|Lumpectomies|lumpectomies
512878|NCT00972010|PlasmaBlade|plasmablade
512879|NCT00972010|Breast conservation therapy|breast conservation therapy
512880|NCT00971971|Hypotension|hypotension
512881|NCT00971971|Acute renal failure|acute renal failure
512882|NCT00971971|acute kidney injury|acute kidney injury
512883|NCT00971971|dialysis|dialysis
512884|NCT00971971|ICU|icu
512885|NCT00971958|HIV prevention|hiv prevention
512886|NCT00971958|infant, neonatal, male circumcision|infant, neonatal, male circumcision
512887|NCT00971932|Recurrent and/or metastatic|recurrent and/or metastatic
512888|NCT00971932|SCCHN|scchn
512889|NCT00971919|pain|pain
512890|NCT00971919|perioperative/postoperative complications|perioperative/postoperative complications
512891|NCT00971919|breast cancer in situ|breast cancer in situ
512892|NCT00971919|stage IA breast cancer|stage ia breast cancer
512893|NCT00971919|stage IB breast cancer|stage ib breast cancer
512894|NCT00971919|stage II breast cancer|stage ii breast cancer
512895|NCT00971919|stage IIIA breast cancer|stage iiia breast cancer
512896|NCT00971919|stage IIIB breast cancer|stage iiib breast cancer
512897|NCT00971919|stage IIIC breast cancer|stage iiic breast cancer
512898|NCT00971906|Pandemic influenza|pandemic influenza
512899|NCT00971906|Vaccine|vaccine
512900|NCT00971893|Acute Exacerbation of Bronchial Asthma Acute Asthma|acute exacerbation of bronchial asthma acute asthma
512901|NCT00971880|Blood transfusions|blood transfusions
512902|NCT00971880|Adverse events|adverse events
512903|NCT00971880|Hepatitis C|hepatitis c
512904|NCT00971880|HIV|hiv
512905|NCT00971854|Dystonia|dystonia
512906|NCT00971828|Myositis|myositis
512907|NCT00971828|polymyositis|polymyositis
512908|NCT00971828|dermatomyositis|dermatomyositis
512909|NCT00971815|HPA-axis|hpa-axis
512910|NCT00971815|fetal programming|fetal programming
512911|NCT00971789|Sirolimus|sirolimus
512912|NCT00971789|Cowden Syndrome|cowden syndrome
512913|NCT00971789|PTEN Mutation|pten mutation
512914|NCT00971789|Hamartoma Syndrome|hamartoma syndrome
512915|NCT00971776|Patient receiving AB5000 ventricle potentially recoverable|patient receiving ab5000 ventricle potentially recoverable
512916|NCT00971763|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
512917|NCT00971763|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
512918|NCT00971763|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
512919|NCT00971763|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
512920|NCT00971763|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
512921|NCT00971750|ultrasonography|ultrasonography
512922|NCT00971750|gallbladder|gallbladder
512923|NCT00971750|cholelithiasis|cholelithiasis
512924|NCT00971750|laparoscopic|laparoscopic
512925|NCT00971750|gastric bypass|gastric bypass
512926|NCT00971750|obesity|obesity
512927|NCT00971750|bariatric surgery|bariatric surgery
512928|NCT00971737|stage IV breast cancer|stage iv breast cancer
512929|NCT00971737|male breast cancer|male breast cancer
512930|NCT00971724|Prednisolone|prednisolone
512931|NCT00971724|Glucocorticoids|glucocorticoids
512932|NCT00971711|IBS|ibs
512933|NCT00971711|irritable bowel syndrome|irritable bowel syndrome
512934|NCT00971711|abdominal pain|abdominal pain
512935|NCT00971711|urgency|urgency
512936|NCT00971711|bloating|bloating
512937|NCT00971711|diarrhea|diarrhea
512938|NCT00971698|Splenectomy|splenectomy
512939|NCT00971698|Thrombocytosis|thrombocytosis
512940|NCT00971698|Infections|infections
512941|NCT00971698|Spleen|spleen
512942|NCT00971698|Sickle Cell Thalassemia|sickle cell thalassemia
512943|NCT00971672|Infants|infants
512944|NCT00971672|Iron Deficiency|iron deficiency
512945|NCT00971672|Anemia|anemia
512946|NCT00971672|Healthy infants that attend the pediatric community clinics|healthy infants that attend the pediatric community clinics
512947|NCT00971659|type 2 diabetes|type 2 diabetes
512948|NCT00971646|overactive bladder|overactive bladder
512949|NCT00971646|self-consciousness|self-consciousness
512950|NCT00971646|perceptual urge sensation|perceptual urge sensation
512951|NCT00971620|Cutaneous Leiomyomas|cutaneous leiomyomas
512952|NCT00971620|Skin Pain|skin pain
512953|NCT00971620|Botox Therapy|botox therapy
512954|NCT00971620|Hereditary Leiomyomatosis|hereditary leiomyomatosis
512955|NCT00971620|Renal Cell Cancer|renal cell cancer
512956|NCT00971620|Cutaneous Leiomyoma|cutaneous leiomyoma
512957|NCT00971607|Acute myocardial infarction|acute myocardial infarction
512958|NCT00971607|Postconditioning|postconditioning
512959|NCT00971607|Sevoflurane|sevoflurane
512960|NCT00971594|weight loss|weight loss
512961|NCT00971594|glucose metabolism|glucose metabolism
512962|NCT00971568|Interstitial cystitis|interstitial cystitis
512963|NCT00971568|Painful bladder syndrome|painful bladder syndrome
512964|NCT00971555|Transient Hypothyroxinemia|transient hypothyroxinemia
512965|NCT00971555|Late Preterm Infants|late preterm infants
512966|NCT00971555|Total T4|total t4
512967|NCT00971555|TSH|tsh
512968|NCT00971555|Illness severity|illness severity
512969|NCT00971555|NICU|nicu
512970|NCT00971542|Pandemic influenza|pandemic influenza
512971|NCT00971542|Vaccine|vaccine
512972|NCT00971529|Smoking cessation|smoking cessation
512973|NCT00971529|tea filter|tea filter
512974|NCT00971516|diabetes|diabetes
512975|NCT00971516|implants|implants
512976|NCT00971516|cytokines|cytokines
512977|NCT00971503|Diabetes type 1|diabetes type 1
512978|NCT00971503|Adult Stem cells|adult stem cells
512979|NCT00971503|Local injection|local injection
512980|NCT00971503|Catheter delivery|catheter delivery
512981|NCT00971503|Bone marrow|bone marrow
512982|NCT00971490|COPD|copd
512983|NCT00971490|FEV1|fev1
512984|NCT00971490|beta endorphin|beta endorphin
512985|NCT00971490|SGRQ|sgrq
512986|NCT00971490|Acu-TENS|acu-tens
512987|NCT00971477|Teledermatology|teledermatology
512988|NCT00971477|Telemedicine|telemedicine
512989|NCT00971477|Psoriasis|psoriasis
512990|NCT00971464|AMD|amd
512991|NCT00971464|EV|ev
512992|NCT00971464|CCTV|cctv
512993|NCT00971464|Reading|reading
512994|NCT00971464|vision|vision
512995|NCT00971451|Anterior cruciate ligament|anterior cruciate ligament
512996|NCT00971451|ACL|acl
512997|NCT00971438|appendicitis|appendicitis
512998|NCT00971438|diagnosis|diagnosis
512999|NCT00971438|diagnostic imaging|diagnostic imaging
513000|NCT00971438|clinical scoring system|clinical scoring system
513001|NCT00971425|influenza infection|influenza infection
513002|NCT00971425|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
513003|NCT00971386|Heart Failure|heart failure
513004|NCT00971373|antimicrobial|antimicrobial
513005|NCT00971373|epidemiology|epidemiology
513006|NCT00971373|bacteriology|bacteriology
513007|NCT00971373|CFU|cfu
513008|NCT00971360|conversion|conversion
513009|NCT00971360|cytokine|cytokine
513010|NCT00971360|inflammation|inflammation
513011|NCT00971347|obesity|obesity
513012|NCT00971347|overweight|overweight
513013|NCT00971347|weight loss|weight loss
513014|NCT00971347|randomized controlled trial|randomized controlled trial
513015|NCT00971347|chewing gum|chewing gum
513016|NCT00971334|Down Syndrome|down syndrome
513017|NCT00971334|Aneuploidy|aneuploidy
513018|NCT00971334|Amniocentesis|amniocentesis
513019|NCT00971334|CVS|cvs
513020|NCT00971321|influenza infection|influenza infection
513021|NCT00971321|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
513022|NCT00971295|eslicarbazepine acetate|eslicarbazepine acetate
513023|NCT00971295|zebinix|zebinix
513024|NCT00971295|metformin|metformin
513025|NCT00971256|Bladder|bladder
513026|NCT00971256|Cancer|cancer
513027|NCT00971256|Cytology|cytology
513028|NCT00971243|Insulin resistance|insulin resistance
513029|NCT00971230|HIV|hiv
513030|NCT00971230|Human Immunodeficiency Virus|human immunodeficiency virus
513031|NCT00971217|Internet based Cognitive-Behavioural Intervention|internet based cognitive-behavioural intervention
513032|NCT00971217|Exercise Intervention|exercise intervention
513033|NCT00971217|Depression|depression
513034|NCT00971217|Perceived Social Support|perceived social support
513035|NCT00971217|Physical Self-Concept|physical self-concept
513036|NCT00971204|atrial fibrillation|atrial fibrillation
513037|NCT00971204|PAF|paf
513038|NCT00971191|Stage I - III surgical resection molecular change brief pre-operative exposure|stage i - iii surgical resection molecular change brief pre-operative exposure
513039|NCT00971178|Analgesia|analgesia
513040|NCT00971178|Dental pain|dental pain
513041|NCT00971178|Dexmedetomidine|dexmedetomidine
513042|NCT00971178|Pain|pain
513043|NCT00971178|Peripheral effects|peripheral effects
513044|NCT00971165|Hypertension|hypertension
513045|NCT00971165|Chlorthalidone|chlorthalidone
513046|NCT00971165|Amiloride|amiloride
513047|NCT00971165|Losartan|losartan
513048|NCT00971165|treatment|treatment
513049|NCT00971152|IVF|ivf
513050|NCT00971152|dose comparison of gonadotrophins|dose comparison of gonadotrophins
513051|NCT00971152|poor responder to ovarian stimulation|poor responder to ovarian stimulation
513052|NCT00971139|Online patient-provider communication|online patient-provider communication
513053|NCT00971139|Organizational change|organizational change
513054|NCT00971139|Symptom management|symptom management
513055|NCT00971126|hepatocellular carcinoma|hepatocellular carcinoma
513056|NCT00971100|Pandemic influenza|pandemic influenza
513057|NCT00971100|Vaccine|vaccine
513058|NCT00971087|Breast cancer|breast cancer
513059|NCT00971087|breast cancer screening|breast cancer screening
513060|NCT00971074|Arthralgia|arthralgia
513061|NCT00971074|Viscosupplementation|viscosupplementation
513062|NCT00971074|Knee|knee
513063|NCT00971074|Menisci, Tibial|menisci, tibial
513064|NCT00971074|Surgery, Outpatient|surgery, outpatient
513065|NCT00971061|Ahmed valve|ahmed valve
513066|NCT00971061|single-plate Molteno implant|single-plate molteno implant
513067|NCT00971061|refractory glaucoma|refractory glaucoma
513068|NCT00971061|surgical treatment|surgical treatment
513069|NCT00971048|pressure ulcers|pressure ulcers
513070|NCT00971048|PU|pu
513071|NCT00971048|diabetic foot ulcers|diabetic foot ulcers
513072|NCT00971048|DFU|dfu
513073|NCT00971048|Bates-Jensen Wound Assessment|bates-jensen wound assessment
513074|NCT00971035|MILR1444A|milr1444a
513075|NCT00971022|Low-income populations|low-income populations
513076|NCT00971022|Chronic health condition|chronic health condition
513077|NCT00971022|Prescription medication|prescription medication
513078|NCT00971022|Prescription drugs|prescription drugs
513079|NCT00971022|Discount generic prescription programs|discount generic prescription programs
513080|NCT00971022|Survey|survey
513081|NCT00971022|Awareness|awareness
513082|NCT00971022|Focus Group|focus group
513083|NCT00971022|Houston|houston
513084|NCT00971009|Symptom management|symptom management
513085|NCT00971009|Interactive Health Communication Application|interactive health communication application
513086|NCT00971009|Patient-provider communication|patient-provider communication
513087|NCT00971009|Health care costs|health care costs
513088|NCT00970996|Melanoma|melanoma
513089|NCT00970996|Abraxane|abraxane
513090|NCT00970996|Nab-paclitaxel|nab-paclitaxel
513091|NCT00970996|Paclitaxel (protein-bound)|paclitaxel (protein-bound)
513092|NCT00970996|ABI-007|abi-007
513093|NCT00970996|Cisplatin|cisplatin
513094|NCT00970996|Platinol-AQ|platinol-aq
513095|NCT00970996|Platinol|platinol
513096|NCT00970996|CDDP|cddp
513097|NCT00970996|Interleukin 2|interleukin 2
513098|NCT00970996|IL-2|il-2
513099|NCT00970996|Proleukin|proleukin
513100|NCT00970996|Intron A|intron a
513101|NCT00970996|Interferon alpha 2b|interferon alpha 2b
513102|NCT00970996|Interferon alfa-2b|interferon alfa-2b
513103|NCT00970996|Temodar|temodar
513104|NCT00970996|Temozolomide|temozolomide
513105|NCT00970970|Vascular endothelial growth factor|vascular endothelial growth factor
513106|NCT00970970|von Hippel Lindau disease|von hippel lindau disease
513107|NCT00970970|molecular imaging|molecular imaging
513108|NCT00970970|biomarker|biomarker
513109|NCT00970957|Macular edema|macular edema
513110|NCT00970957|Retinal Vein Occlusion|retinal vein occlusion
513111|NCT00970957|Bevacizumab|bevacizumab
513112|NCT00970944|Traumatic Brain Injury|traumatic brain injury
513113|NCT00970944|Rehabilitation|rehabilitation
513114|NCT00970944|Disorders of Consciousness|disorders of consciousness
513115|NCT00970944|Functional Outcome|functional outcome
513116|NCT00970944|Amantadine Hydrochloride|amantadine hydrochloride
513117|NCT00970931|hypertension|hypertension
513118|NCT00970931|diuretics|diuretics
513119|NCT00970918|Cardiovascular disease|cardiovascular disease
513120|NCT00970918|Carotid Intima Media Thickness|carotid intima media thickness
513121|NCT00970905|Radiation|radiation
513122|NCT00970905|Nausea|nausea
513123|NCT00970905|Vomiting|vomiting
513124|NCT00970905|Ondansetron|ondansetron
513125|NCT00970905|Aprepitant|aprepitant
513126|NCT00970892|Anticoagulation|anticoagulation
513127|NCT00970892|warfarin|warfarin
513128|NCT00970892|VKORC1|vkorc1
513129|NCT00970892|CYP2C9|cyp2c9
513130|NCT00970892|thromboembolism|thromboembolism
513131|NCT00970892|pharmacogenetics|pharmacogenetics
513132|NCT00970879|malaria|malaria
513133|NCT00970879|pregnancy|pregnancy
513134|NCT00970879|HIV|hiv
513135|NCT00970879|prevention|prevention
513136|NCT00970879|cotrimoxazole|cotrimoxazole
513137|NCT00970879|mefloquine|mefloquine
513138|NCT00970866|multiple micronutrients|multiple micronutrients
513139|NCT00970866|home fortification|home fortification
513140|NCT00970866|complementary foods|complementary foods
513141|NCT00970866|infant feeding|infant feeding
513142|NCT00970866|lipid-based nutrient supplements|lipid-based nutrient supplements
513143|NCT00970853|Evaluate developmental outcomes|evaluate developmental outcomes
513144|NCT00970853|Evaluate child cognitive, academic, and behavioral outcomes|evaluate child cognitive, academic, and behavioral outcomes
513145|NCT00970840|Acceptability|acceptability
513146|NCT00970840|Supplements|supplements
513147|NCT00970840|Home-fortification|home-fortification
513148|NCT00970827|Coronary artery disease|coronary artery disease
513149|NCT00970827|PCI|pci
513150|NCT00970827|Postconditioning|postconditioning
513151|NCT00970827|Elective or urgent PCI|elective or urgent pci
513152|NCT00970814|Alcoholism|alcoholism
513153|NCT00970814|Alcohol Drinking|alcohol drinking
513154|NCT00970814|Alcoholic Intoxication|alcoholic intoxication
513155|NCT00970814|Alcohol Abuse|alcohol abuse
513156|NCT00970801|Atypical mycobacteria|atypical mycobacteria
513157|NCT00970775|Phase I|phase i
513158|NCT00970775|Japanese healthy volunteer|japanese healthy volunteer
513159|NCT00970775|AZD2423|azd2423
513160|NCT00970749|chlamydia|chlamydia
513161|NCT00970749|healthy women|healthy women
513162|NCT00970749|history of endocervical chlamydia|history of endocervical chlamydia
513163|NCT00970749|no history of endocervical chlamydia|no history of endocervical chlamydia
513164|NCT00970736|Motor cortex|motor cortex
513165|NCT00970736|Motor control|motor control
513166|NCT00970736|Neuroplasticity|neuroplasticity
513167|NCT00970736|Aging|aging
513168|NCT00970736|Swallowing|swallowing
513169|NCT00970723|Diabetic retinopathy|diabetic retinopathy
513170|NCT00970723|Macula edema|macula edema
513171|NCT00970723|Sleep apnea|sleep apnea
513172|NCT00970723|High blood pressure|high blood pressure
513173|NCT00970697|MARTORELL'S ULCER|martorell's ulcer
513174|NCT00970697|hydrogel|hydrogel
513175|NCT00970697|Hypertensive leg ulcer|hypertensive leg ulcer
513176|NCT00970684|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
513177|NCT00970684|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
513178|NCT00970684|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
513179|NCT00970684|adenocarcinoma of the lung|adenocarcinoma of the lung
513180|NCT00970684|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
513181|NCT00970684|large cell lung cancer|large cell lung cancer
513182|NCT00970671|scar|scar
513183|NCT00970671|laser therapy|laser therapy
513184|NCT00970671|lasers, pulsed dye|lasers, pulsed dye
513185|NCT00970658|Plaster|plaster
513186|NCT00970658|injuries|injuries
513187|NCT00970658|regions miofasciais articulated|regions miofasciais articulated
513188|NCT00970658|Reducing signs, symptoms|reducing signs, symptoms
513189|NCT00970645|Non small cell lung cancer|non small cell lung cancer
513190|NCT00970645|mediastinum|mediastinum
513191|NCT00970645|endobronchial ultrasound fine needle aspiration|endobronchial ultrasound fine needle aspiration
513192|NCT00970645|endoscopic ultrasound|endoscopic ultrasound
513193|NCT00970645|mediastinoscopy|mediastinoscopy
513194|NCT00970645|surgical or minimally invasive evaluation of mediastinum|surgical or minimally invasive evaluation of mediastinum
513195|NCT00970645|NSCLC|nsclc
513196|NCT00970606|ARDS|ards
513197|NCT00970606|H1N1|h1n1
513198|NCT00970606|Influenza|influenza
513199|NCT00970606|Statin|statin
513200|NCT00970580|BIIB022|biib022
513201|NCT00970580|Stage IV|stage iv
513202|NCT00970580|Taxol|taxol
513203|NCT00970580|Stage IIIB|stage iiib
513204|NCT00970580|Carboplatin|carboplatin
513205|NCT00970580|Paclitaxel|paclitaxel
513206|NCT00970580|Non Small Cell Lung Cancer|non small cell lung cancer
513207|NCT00970580|Treatment Naive|treatment naive
513208|NCT00970580|Anti IGF1R|anti igf1r
513209|NCT00970580|NSCLC|nsclc
513210|NCT00970580|Open Label|open label
513211|NCT00970580|IGF1R|igf1r
513212|NCT00970580|Paraplatin|paraplatin
513213|NCT00970580|Cytotoxic|cytotoxic
513214|NCT00970580|Mitotic Inhibitor|mitotic inhibitor
513215|NCT00970580|Taxane|taxane
513216|NCT00970580|Alkylating agent|alkylating agent
513217|NCT00970567|therapy after positive ketone bodies in the blood|therapy after positive ketone bodies in the blood
513218|NCT00970567|timepoint of diagnosis|timepoint of diagnosis
513219|NCT00970567|timepoint of metabolic normalisation|timepoint of metabolic normalisation
513220|NCT00970554|Amblyopia|amblyopia
513221|NCT00970554|Telescopic magnification|telescopic magnification
513222|NCT00970554|Patching|patching
513223|NCT00970541|Cinnamon|cinnamon
513224|NCT00970541|PCOS|pcos
513225|NCT00970541|low blood sugar|low blood sugar
513226|NCT00970541|Insulin|insulin
513227|NCT00970541|Glucose|glucose
513228|NCT00970528|Oral Hypoglycemic Agent|oral hypoglycemic agent
513229|NCT00970515|Laparoscopy|laparoscopy
513230|NCT00970515|Incisional hernia|incisional hernia
513231|NCT00970515|Umbilical hernia|umbilical hernia
513232|NCT00970515|Mesh repair|mesh repair
513233|NCT00970515|Postoperative complications|postoperative complications
513234|NCT00970502|celecoxib|celecoxib
513235|NCT00970502|erlotinib|erlotinib
513236|NCT00970502|epidermal growth factor receptor|epidermal growth factor receptor
513237|NCT00970502|intensity-modulated radiotherapy|intensity-modulated radiotherapy
513238|NCT00970502|cyclooxygenase-2|cyclooxygenase-2
513239|NCT00970502|reirradiation|reirradiation
513240|NCT00970489|atrial fibrillation|atrial fibrillation
513241|NCT00970489|fish oil|fish oil
513242|NCT00970463|The GH-system and cardiac function|the gh-system and cardiac function
513243|NCT00970450|Paracetamol|paracetamol
513244|NCT00970450|Tropisetron|tropisetron
513245|NCT00970450|Central analgesic effect|central analgesic effect
513246|NCT00970450|Area of allodynia|area of allodynia
513247|NCT00970450|Secondary hyperalgesia|secondary hyperalgesia
513248|NCT00970398|Infant formula|infant formula
513249|NCT00970398|Bovine milk Osteopontin|bovine milk osteopontin
513250|NCT00970398|growth|growth
513251|NCT00970398|health|health
513252|NCT00970398|immune functions|immune functions
513253|NCT00970372|Coercion|coercion
513254|NCT00970359|thyroid|thyroid
513255|NCT00970359|metastases|metastases
513256|NCT00970359|AZD6244|azd6244
513257|NCT00970359|09-048|09-048
513258|NCT00970346|Digestive System Diseases|digestive system diseases
513259|NCT00970346|Genetic Diseases|genetic diseases
513260|NCT00970346|Inborn|inborn
513261|NCT00970346|Respiratory Tract Diseases|respiratory tract diseases
513262|NCT00970346|Cystic Fibrosis|cystic fibrosis
513263|NCT00970346|Lung Disease|lung disease
513264|NCT00970346|Pancreatic Diseases|pancreatic diseases
513265|NCT00970333|Alzheimer disease|alzheimer disease
513266|NCT00970333|Parkinson disease|parkinson disease
513267|NCT00970333|Multiple Sclerosis|multiple sclerosis
513268|NCT00970320|Anal Incontinence|anal incontinence
513269|NCT00970320|urinary incontinence|urinary incontinence
513270|NCT00970320|primiparas|primiparas
513271|NCT00970320|prevalence|prevalence
513272|NCT00970320|pelvic floor exercise treatment|pelvic floor exercise treatment
513273|NCT00970320|Quality of Life (QoL)|quality of life (qol)
513274|NCT00970294|diabetes|diabetes
513275|NCT00970268|COPD|copd
513276|NCT00970268|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
513277|NCT00970268|Chronic Bronchitis|chronic bronchitis
513278|NCT00970268|Emphysema|emphysema
513279|NCT00970268|Airflow Obstruction, Chronic|airflow obstruction, chronic
513280|NCT00970268|Chronic Airflow Obstruction|chronic airflow obstruction
513281|NCT00970268|Chronic Obstructive Airway Disease|chronic obstructive airway disease
513282|NCT00970268|Chronic Obstructive Lung Disease|chronic obstructive lung disease
513283|NCT00970255|Breastfeeding difficulties|breastfeeding difficulties
513284|NCT00970255|lingual frenulum|lingual frenulum
513285|NCT00970255|labial frenulum|labial frenulum
513286|NCT00970255|frenotomy|frenotomy
513287|NCT00970216|HBV DNA non-detectability|hbv dna non-detectability
513288|NCT00970203|Vaccine|vaccine
513289|NCT00970203|Androgen Ablation|androgen ablation
513290|NCT00970203|PSA Progression|psa progression
513291|NCT00970190|sinusitis|sinusitis
513292|NCT00970177|Pandemic influenza vaccine|pandemic influenza vaccine
513293|NCT00970151|Fetal Inflammation|fetal inflammation
513294|NCT00970151|Birth Outcome|birth outcome
513295|NCT00970151|Pregnancy|pregnancy
513296|NCT00970138|Progress free survival|progress free survival
513297|NCT00970138|Toxicity|toxicity
513298|NCT00970138|Response rate|response rate
513299|NCT00970138|Overall survival|overall survival
513300|NCT00970138|Quality of live|quality of live
513301|NCT00970125|advance care planning|advance care planning
513302|NCT00970125|cancer|cancer
513303|NCT00970112|pain|pain
513304|NCT00970112|pain assessment|pain assessment
513305|NCT00970086|measure of postoperative pain|measure of postoperative pain
513306|NCT00970086|children undergoing groin surgery|children undergoing groin surgery
513307|NCT00970073|calcineurin inhibitor delay|calcineurin inhibitor delay
513308|NCT00970073|Kidney|kidney
513309|NCT00970060|neuropathy|neuropathy
513310|NCT00970060|diabetes|diabetes
513311|NCT00970047|pregnant|pregnant
513312|NCT00970047|fetal sex determination|fetal sex determination
513313|NCT00970047|gender determination|gender determination
513314|NCT00970047|noninvasive test|noninvasive test
513315|NCT00970047|fetal DNA|fetal dna
513316|NCT00970034|Atrial fibrillation, apoptosis, oligonucleotide microarray|atrial fibrillation, apoptosis, oligonucleotide microarray
513317|NCT00970008|Osteoarthritis|osteoarthritis
513318|NCT00970008|Knee|knee
513319|NCT00969995|inflammation|inflammation
513320|NCT00969995|migraine|migraine
513321|NCT00969995|headache|headache
513322|NCT00969982|Pregnancy termination|pregnancy termination
513323|NCT00969982|abortion|abortion
513324|NCT00969982|medical abortion|medical abortion
513325|NCT00969982|2nd trimester|2nd trimester
513326|NCT00969982|mifepristone|mifepristone
513327|NCT00969982|misoprostol|misoprostol
513328|NCT00969969|First MTP Joint|first mtp joint
513329|NCT00969969|Hallux Rigidus|hallux rigidus
513330|NCT00969969|Hallux Limitus|hallux limitus
513331|NCT00969969|Cartilage Replacement|cartilage replacement
513332|NCT00969969|Osteoarthritis|osteoarthritis
513333|NCT00969969|First MTP Joint Osteoarthritis|first mtp joint osteoarthritis
513334|NCT00969969|Big Toe Pain|big toe pain
513335|NCT00969956|Diabetes, Complication, Cardio-vascular disease|diabetes, complication, cardio-vascular disease
513336|NCT00969943|HPA axis|hpa axis
513337|NCT00969930|COMT|comt
513338|NCT00969930|ApoE|apoe
513339|NCT00969930|BDNF|bdnf
513340|NCT00969930|executive function|executive function
513341|NCT00969930|bipolar|bipolar
513342|NCT00969930|cognition|cognition
513343|NCT00969930|Cognitive deficits and Bipolar disease type I|cognitive deficits and bipolar disease type i
513344|NCT00969878|Cocaine Vaccine, TA-CD 09|cocaine vaccine, ta-cd 09
513345|NCT00969865|Atherosclerosis|atherosclerosis
513346|NCT00969852|Sertraline|sertraline
513347|NCT00969852|PET|pet
513348|NCT00969852|Serotonin receptor occupancy|serotonin receptor occupancy
513349|NCT00969852|PK-PD Model|pk-pd model
513350|NCT00969839|Fracture|fracture
513351|NCT00969839|Humerus|humerus
513352|NCT00969839|Intramedullary|intramedullary
513353|NCT00969839|Fixation|fixation
513354|NCT00969826|GCPGC|gcpgc
513355|NCT00969826|Pharmacokinetics|pharmacokinetics
513356|NCT00969826|Pharmacodynamics|pharmacodynamics
513357|NCT00969813|Hepatic impairment|hepatic impairment
513358|NCT00969800|Common cold|common cold
513359|NCT00969800|Influenza|influenza
513360|NCT00969800|Pneumonia|pneumonia
513361|NCT00969774|Face|face
513362|NCT00969774|Cephalometry|cephalometry
513363|NCT00969774|Anthropometry|anthropometry
513364|NCT00969774|Photography|photography
513365|NCT00969774|Diagnosis|diagnosis
513366|NCT00969774|Adult|adult
513367|NCT00969774|Morphology|morphology
513368|NCT00969774|Comparative Study|comparative study
513369|NCT00969735|Atrial fibrillation|atrial fibrillation
513370|NCT00969735|Catheter ablation|catheter ablation
513371|NCT00969735|Cryoenergy|cryoenergy
513372|NCT00969735|Implantable loop recorder|implantable loop recorder
513373|NCT00969735|Pulmonary vein|pulmonary vein
513374|NCT00969722|Neuroblastoma|neuroblastoma
513375|NCT00969722|3F8|3f8
513376|NCT00969722|Primary refractory|primary refractory
513377|NCT00969709|Depression|depression
513378|NCT00969709|Major Depressive Disorder|major depressive disorder
513379|NCT00969696|ability to learn, working memory|ability to learn, working memory
513380|NCT00969657|rectal cancer stage I-III|rectal cancer stage i-iii
513381|NCT00969657|concurrent chemoradiotherapie|concurrent chemoradiotherapie
513382|NCT00969657|response prediction|response prediction
513383|NCT00969631|Polycystic ovary syndrome|polycystic ovary syndrome
513384|NCT00969631|clomiphene resistance|clomiphene resistance
513385|NCT00969631|metformin|metformin
513386|NCT00969631|laparoscopic ovarian diathermy|laparoscopic ovarian diathermy
513387|NCT00969618|ADHD|adhd
513388|NCT00969605|weaning|weaning
513389|NCT00969605|adaptive support ventilation|adaptive support ventilation
513390|NCT00969605|COPD|copd
513391|NCT00969592|diabetes|diabetes
513392|NCT00969579|Cancer|cancer
513393|NCT00969579|Psychosocial Stress|psychosocial stress
513394|NCT00969579|Parenting|parenting
513395|NCT00969566|Diabetes|diabetes
513396|NCT00969566|Sitagliptin|sitagliptin
513397|NCT00969566|C-peptide|c-peptide
513398|NCT00969566|Glucagon|glucagon
513399|NCT00969540|Back Pain|back pain
513400|NCT00969540|Sleep|sleep
513401|NCT00969527|Oncoxin|oncoxin
513402|NCT00969527|Viusid|viusid
513403|NCT00969527|dietary supplements|dietary supplements
513404|NCT00969527|rheumatoid arthritis|rheumatoid arthritis
513405|NCT00969514|Robotic cystectomy|robotic cystectomy
513406|NCT00969514|Bladder|bladder
513407|NCT00969488|matern diet|matern diet
513408|NCT00969488|obese|obese
513409|NCT00969488|postpartum|postpartum
513410|NCT00969488|body weight change|body weight change
513411|NCT00969488|Women with overweight|women with overweight
513412|NCT00969475|scar revision|scar revision
513413|NCT00969475|intraoperative|intraoperative
513414|NCT00969475|fractional carbon dioxide laser|fractional carbon dioxide laser
513415|NCT00969462|Doxorubicin|doxorubicin
513416|NCT00969462|pharmacokinetics|pharmacokinetics
513417|NCT00969462|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
513418|NCT00969462|response|response
513419|NCT00969462|association between response to chemotherapy|association between response to chemotherapy
513420|NCT00969462|myelosuppression degree|myelosuppression degree
513421|NCT00969462|doxorubicin pharmacokinetics|doxorubicin pharmacokinetics
513422|NCT00969449|Naproxen Sodium|naproxen sodium
513423|NCT00969436|Mumps|mumps
513424|NCT00969436|Immunogenicity|immunogenicity
513425|NCT00969436|Vaccines|vaccines
513426|NCT00969436|Safety|safety
513427|NCT00969436|Rubella|rubella
513428|NCT00969436|Combined Vaccine|combined vaccine
513429|NCT00969436|Varicella Vaccine|varicella vaccine
513430|NCT00969436|Children|children
513431|NCT00969436|Measles|measles
513432|NCT00969436|Humans|humans
513433|NCT00969423|persistent pain|persistent pain
513434|NCT00969423|neuropathic pain|neuropathic pain
513435|NCT00969423|Chronic Pain|chronic pain
513436|NCT00969423|VATS|vats
513437|NCT00969423|Primary spontaneous pneumothorax patients|primary spontaneous pneumothorax patients
513438|NCT00969410|Neoplasms|neoplasms
513439|NCT00969410|Neoplasm metastasis|neoplasm metastasis
513440|NCT00969410|Liver neoplasms|liver neoplasms
513441|NCT00969410|Neoplastic processes|neoplastic processes
513442|NCT00969410|Pathologic processes|pathologic processes
513443|NCT00969410|Digestive system neoplasms|digestive system neoplasms
513444|NCT00969410|Neoplasms by site|neoplasms by site
513445|NCT00969410|Digestive system diseases|digestive system diseases
513446|NCT00969410|Liver diseases|liver diseases
513447|NCT00969397|Birthmark|birthmark
513448|NCT00969397|PWS|pws
513449|NCT00969384|Physical health|physical health
513450|NCT00969384|Mental illness|mental illness
513451|NCT00969384|prevention|prevention
513452|NCT00969384|Waist circumference|waist circumference
513453|NCT00969371|posterior chamber intraocular lens|posterior chamber intraocular lens
513454|NCT00969371|PCIOL|pciol
513455|NCT00969371|IOL|iol
513456|NCT00969345|Healthy Elderly Subjects|healthy elderly subjects
513457|NCT00969345|Respiratory Yoga Exercises|respiratory yoga exercises
513458|NCT00969345|Heart Rate Variability|heart rate variability
513459|NCT00969345|Baroreflex|baroreflex
513460|NCT00969345|Quality of Life|quality of life
513461|NCT00969332|liver|liver
513462|NCT00969332|Parenteral Nutrition|parenteral nutrition
513463|NCT00969332|fish oil|fish oil
513464|NCT00969332|Omegaven|omegaven
513465|NCT00969332|children|children
513466|NCT00969319|Octocog alfa|octocog alfa
513467|NCT00969319|Hemophilia A|hemophilia a
513468|NCT00969293|Macular Edema|macular edema
513469|NCT00969293|Occlusive retinal vascular disease|occlusive retinal vascular disease
513470|NCT00969293|Central Retinal Vein Occlusion|central retinal vein occlusion
513471|NCT00969293|CRVO|crvo
513472|NCT00969280|Acupuncture|acupuncture
513473|NCT00969280|Dry eye syndrome|dry eye syndrome
513474|NCT00969280|Ocular Surface Disease Index|ocular surface disease index
513475|NCT00969280|Schirmer test|schirmer test
513476|NCT00969280|Tear film Break-up time|tear film break-up time
513477|NCT00969267|ear acupuncture|ear acupuncture
513478|NCT00969267|obese|obese
513479|NCT00969267|obese women|obese women
513480|NCT00969267|women|women
513481|NCT00969254|Pílulas de Lussen|pílulas de lussen
513482|NCT00969254|Efficacy|efficacy
513483|NCT00969254|Safety|safety
513484|NCT00969254|Dysuria|dysuria
513485|NCT00969254|Symptomatic control|symptomatic control
513486|NCT00969241|saliva|saliva
513487|NCT00969241|free-radicals|free-radicals
513488|NCT00969241|periodontitis|periodontitis
513489|NCT00969228|Gastroenteritis|gastroenteritis
513490|NCT00969215|burn scar|burn scar
513491|NCT00969215|fractional carbon dioxide laser|fractional carbon dioxide laser
513492|NCT00969215|scar revision|scar revision
513493|NCT00969202|Prostate Cancer|prostate cancer
513494|NCT00969202|Cancer of the Prostate|cancer of the prostate
513495|NCT00969202|Prostate Tumor|prostate tumor
513496|NCT00969202|Novalis Tx|novalis tx
513497|NCT00969202|Novalis|novalis
513498|NCT00969202|Stereotactic Radiosurgery|stereotactic radiosurgery
513499|NCT00969202|Radiosurgery|radiosurgery
513500|NCT00969202|Radiation|radiation
513501|NCT00969189|anesthesia|anesthesia
513502|NCT00969189|child|child
513503|NCT00969189|infant|infant
513504|NCT00969189|laryngeal mask|laryngeal mask
513505|NCT00969176|pain|pain
513506|NCT00969176|fever|fever
513507|NCT00969176|neonate|neonate
513508|NCT00969176|preterm|preterm
513509|NCT00969176|term|term
513510|NCT00969176|newborn|newborn
513511|NCT00969163|Biomarkers of Skin Androgenization|biomarkers of skin androgenization
513512|NCT00969150|Major Depressive Disorder|major depressive disorder
513513|NCT00969150|Depression|depression
513514|NCT00969137|smoking, nicotine, cigarettes|smoking, nicotine, cigarettes
513515|NCT00969124|colonoscopy|colonoscopy
513516|NCT00969124|polyps|polyps
513517|NCT00969124|adenomas|adenomas
513518|NCT00969124|miss rates|miss rates
513519|NCT00969111|Proton Radiation, Prostate Cancer|proton radiation, prostate cancer
513520|NCT00969098|Histologically proven of Malignant pleural mesothelioma;|histologically proven of malignant pleural mesothelioma;
513521|NCT00969098|Patients not candidate to radical surgery;|patients not candidate to radical surgery;
513522|NCT00969098|Candidate to first-line pemetrexed-based chemotherapy;|candidate to first-line pemetrexed-based chemotherapy;
513523|NCT00969085|Cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
513524|NCT00969085|Skin|skin
513525|NCT00969085|Mycosis fungoides|mycosis fungoides
513526|NCT00969085|MF|mf
513527|NCT00969085|Sézary syndrome|sézary syndrome
513528|NCT00969085|SS|ss
513529|NCT00969085|Curcumin|curcumin
513530|NCT00969085|Turmeric|turmeric
513531|NCT00969072|GI198745|gi198745
513532|NCT00969072|Long term extension study|long term extension study
513533|NCT00969072|BPH|bph
513534|NCT00969059|peripheral nerve injury|peripheral nerve injury
513535|NCT00969059|p38 kinase inhibitor|p38 kinase inhibitor
513536|NCT00969059|neuropathic pain|neuropathic pain
513537|NCT00969046|Colon cancer|colon cancer
513538|NCT00969046|MTD|mtd
513539|NCT00969046|DLT|dlt
513540|NCT00969046|EPO906|epo906
513541|NCT00969046|patupilone|patupilone
513542|NCT00969020|Length of stay|length of stay
513543|NCT00969020|Timed up and go|timed up and go
513544|NCT00968994|Wound Healing|wound healing
513545|NCT00968994|Wound Infection|wound infection
513546|NCT00968981|Hedgehog|hedgehog
513547|NCT00968981|BCC|bcc
513548|NCT00968981|basal cell carcinoma|basal cell carcinoma
513549|NCT00968955|Postoperative acute pain|postoperative acute pain
513550|NCT00968955|Total hip arthroplasty|total hip arthroplasty
513551|NCT00968955|Local infiltration analgesia|local infiltration analgesia
513552|NCT00968942|Lateral Canthal Lines|lateral canthal lines
513553|NCT00968942|Crow's Feet|crow's feet
513554|NCT00968942|Facial Wrinkles|facial wrinkles
513555|NCT00968929|pulmonary embolism|pulmonary embolism
513556|NCT00968929|thrombolysis|thrombolysis
513557|NCT00968929|massive|massive
513558|NCT00968929|submassive|submassive
513559|NCT00968929|recombinant streptokinase|recombinant streptokinase
513560|NCT00968929|urokinase|urokinase
513561|NCT00968903|Hip arthroplasty|hip arthroplasty
513562|NCT00968903|Methylprednisolone|methylprednisolone
513563|NCT00968903|Post-operative pain|post-operative pain
513564|NCT00968890|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
513565|NCT00968890|Influenza infection|influenza infection
513566|NCT00968877|Renal Insufficiency|renal insufficiency
513567|NCT00968877|Cholecalciferol|cholecalciferol
513568|NCT00968877|Kidney Disease|kidney disease
513569|NCT00968877|Kidney Failure|kidney failure
513570|NCT00968877|Vitamin D|vitamin d
513571|NCT00968877|Vitamin D Deficiency|vitamin d deficiency
513572|NCT00968877|Vitamin D3|vitamin d3
513573|NCT00968864|T cell depleted|t cell depleted
513574|NCT00968864|Matched unrelated donors|matched unrelated donors
513575|NCT00968864|Haplocompatible donors|haplocompatible donors
513576|NCT00968851|Schizophrenia|schizophrenia
513577|NCT00968851|Central nervous System Diseases|central nervous system diseases
513578|NCT00968851|Cognition|cognition
513579|NCT00968838|White Blood Cell Transfusion|white blood cell transfusion
513580|NCT00968838|Radiated Cells|radiated cells
513581|NCT00968838|Unradiated Cells|unradiated cells
513582|NCT00968838|Leukocyte Transfusions|leukocyte transfusions
513583|NCT00968838|Life-threatening Infections|life-threatening infections
513584|NCT00968825|Lateral Canthal Lines|lateral canthal lines
513585|NCT00968825|Crow's Feet|crow's feet
513586|NCT00968825|Facial Wrinkles|facial wrinkles
513587|NCT00968812|Diabetes|diabetes
513588|NCT00968812|Metformin|metformin
513589|NCT00968812|Glimepiride|glimepiride
513590|NCT00968812|Hemoglobin A1c|hemoglobin a1c
513591|NCT00968812|Type 2 diabetes mellitus|type 2 diabetes mellitus
513592|NCT00968812|Canagliflozin|canagliflozin
513593|NCT00968799|Ovarian Neoplasms|ovarian neoplasms
513594|NCT00968799|Recurrence|recurrence
513595|NCT00968799|Hyperthermia, Induced|hyperthermia, induced
513596|NCT00968799|Peritoneal Neoplasms|peritoneal neoplasms
513597|NCT00968799|recurrent epithelial ovarian cancer|recurrent epithelial ovarian cancer
513598|NCT00968799|recurrent fallopian tube carcinoma|recurrent fallopian tube carcinoma
513599|NCT00968786|hypertension|hypertension
513600|NCT00968786|type 2 diabetes|type 2 diabetes
513601|NCT00968786|home monitoring|home monitoring
513602|NCT00968773|inguinal hernia|inguinal hernia
513603|NCT00968773|mesh|mesh
513604|NCT00968773|hernia repair device|hernia repair device
513605|NCT00968760|CD19+ lymphoid malignancies|cd19+ lymphoid malignancies
513606|NCT00968760|non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
513607|NCT00968760|NHL|nhl
513608|NCT00968760|small lymphocytic lymphoma|small lymphocytic lymphoma
513609|NCT00968760|SLL|sll
513610|NCT00968760|follicular lymphoma|follicular lymphoma
513611|NCT00968760|mantle cell lymphoma|mantle cell lymphoma
513612|NCT00968760|gene cell transfer|gene cell transfer
513613|NCT00968760|CD19-specific T cells|cd19-specific t cells
513614|NCT00968760|Stem Cell Transplant|stem cell transplant
513615|NCT00968760|T Cell Infusion|t cell infusion
513616|NCT00968760|Chemotherapy|chemotherapy
513617|NCT00968760|Leukapheresis|leukapheresis
513618|NCT00968760|BCNU|bcnu
513619|NCT00968760|carmustine|carmustine
513620|NCT00968760|Cytarabine|cytarabine
513621|NCT00968760|Etoposide|etoposide
513622|NCT00968760|Interleukin-2|interleukin-2
513623|NCT00968760|Proleukin|proleukin
513624|NCT00968760|Melphalan|melphalan
513625|NCT00968760|Rituximab|rituximab
513626|NCT00968760|T cell therapy|t cell therapy
513627|NCT00968747|Fasting|fasting
513628|NCT00968747|Fast|fast
513629|NCT00968747|healthy|healthy
513630|NCT00968747|diet|diet
513631|NCT00968747|study|study
513632|NCT00968747|manipulation|manipulation
513633|NCT00968747|dietary|dietary
513634|NCT00968747|FGF21|fgf21
513635|NCT00968747|Fibroblast growth factor|fibroblast growth factor
513636|NCT00968747|PTRF|ptrf
513637|NCT00968747|Polymerase 1 and transcript release factor|polymerase 1 and transcript release factor
513638|NCT00968747|adipose|adipose
513639|NCT00968747|fat|fat
513640|NCT00968747|blood|blood
513641|NCT00968747|inpatient|inpatient
513642|NCT00968747|outpatient|outpatient
513643|NCT00968747|NAFLD|nafld
513644|NCT00968747|metabolism|metabolism
513645|NCT00968734|Vitamin D|vitamin d
513646|NCT00968734|colecalciferol|colecalciferol
513647|NCT00968734|absorption by Vitamin D|absorption by vitamin d
513648|NCT00968721|Inflammatory bowel disease|inflammatory bowel disease
513649|NCT00968721|Crohn's disease|crohn's disease
513650|NCT00968721|Ulcerative colitis|ulcerative colitis
513651|NCT00968721|medication adherence|medication adherence
513652|NCT00968721|Decisional influences|decisional influences
513653|NCT00968708|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
513654|NCT00968708|Diabetes Mellitus|diabetes mellitus
513655|NCT00968708|cardiovascular outcomes|cardiovascular outcomes
513656|NCT00968708|heart attack|heart attack
513657|NCT00968708|stroke|stroke
513658|NCT00968708|dipeptidyl-peptidase IV inhibitors|dipeptidyl-peptidase iv inhibitors
513659|NCT00968708|metabolic disorders|metabolic disorders
513660|NCT00968708|metabolic diseases|metabolic diseases
513661|NCT00968708|glucose metabolism disorders|glucose metabolism disorders
513662|NCT00968682|cardiac toxicity|cardiac toxicity
513663|NCT00968682|HER2-positive breast cancer|her2-positive breast cancer
513664|NCT00968682|stage IA breast cancer|stage ia breast cancer
513665|NCT00968682|stage IB breast cancer|stage ib breast cancer
513666|NCT00968682|stage II breast cancer|stage ii breast cancer
513667|NCT00968682|stage IIIA breast cancer|stage iiia breast cancer
513668|NCT00968682|stage IIIB breast cancer|stage iiib breast cancer
513669|NCT00968682|stage IIIC breast cancer|stage iiic breast cancer
513670|NCT00968656|Breast cancer|breast cancer
513671|NCT00968656|Head and Neck Cancer|head and neck cancer
513672|NCT00968656|Diffuse Large B-cell lymphoma|diffuse large b-cell lymphoma
513673|NCT00968656|Cellular proliferation|cellular proliferation
513674|NCT00968643|spinal cord compression|spinal cord compression
513675|NCT00968643|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
513676|NCT00968617|Anemia|anemia
513677|NCT00968604|Pancreatic Cancer|pancreatic cancer
513678|NCT00968604|Pancreas|pancreas
513679|NCT00968604|Liver|liver
513680|NCT00968604|Liver Tumor Biopsy|liver tumor biopsy
513681|NCT00968604|BikDD Nanoparticle|bikdd nanoparticle
513682|NCT00968604|C-VISA BikDD|c-visa bikdd
513683|NCT00968591|Hepatic insufficiency|hepatic insufficiency
513684|NCT00968591|liver disease|liver disease
513685|NCT00968591|cirrhosis|cirrhosis
513686|NCT00968591|pharmacokinetics|pharmacokinetics
513687|NCT00968578|Knee arthroplasty|knee arthroplasty
513688|NCT00968578|Methylprednisolone|methylprednisolone
513689|NCT00968578|Post-operative pain|post-operative pain
513690|NCT00968565|Heart Defects, Congenital|heart defects, congenital
513691|NCT00968565|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
513692|NCT00968565|Citric Acid|citric acid
513693|NCT00968565|Heparin|heparin
513694|NCT00968565|Respiratory Insufficiency|respiratory insufficiency
513695|NCT00968552|Any Gastrointestinal problem that would require an endoscopically placed stent|any gastrointestinal problem that would require an endoscopically placed stent
513696|NCT00968539|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
513697|NCT00968539|influenza infection|influenza infection
513698|NCT00968526|influenza infection|influenza infection
513699|NCT00968526|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
513798|NCT00968253|Prednisone|prednisone
513700|NCT00968513|Smoking Cessation, Inpatient Psychiatry, Stages of Change|smoking cessation, inpatient psychiatry, stages of change
513701|NCT00968500|Grief|grief
513702|NCT00968500|bereavement|bereavement
513703|NCT00968500|questionnaires|questionnaires
513704|NCT00968500|09-107|09-107
513705|NCT00968487|Lyophilized Plasma|lyophilized plasma
513706|NCT00968487|Fresh Frozen Plasma|fresh frozen plasma
513707|NCT00968487|Hemorrhage|hemorrhage
513708|NCT00968487|Coagulopathy|coagulopathy
513709|NCT00968487|Autologous|autologous
513710|NCT00968487|HemCon|hemcon
513711|NCT00968487|Plasmapheresis|plasmapheresis
513712|NCT00968487|Freeze Drying|freeze drying
513713|NCT00968487|Transfusion|transfusion
513714|NCT00968487|Resuscitation|resuscitation
513715|NCT00968487|Safety of Lyophilized Plasma in Normal, Healthy Volunteers|safety of lyophilized plasma in normal, healthy volunteers
513716|NCT00968461|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
513718|NCT00968461|PEITC|peitc
513719|NCT00968461|Phenethyl Isothiocyanate|phenethyl isothiocyanate
513720|NCT00968461|Fludarabine|fludarabine
513721|NCT00968448|respiratory muscle|respiratory muscle
513722|NCT00968448|breathing pattern|breathing pattern
513723|NCT00968448|exercise performance|exercise performance
513724|NCT00968435|bevacizumab|bevacizumab
513725|NCT00968435|cisplatin|cisplatin
513726|NCT00968435|cetuximab|cetuximab
513727|NCT00968435|radiation therapy|radiation therapy
513728|NCT00968435|Phase II|phase ii
513729|NCT00968435|09-083|09-083
513730|NCT00968422|Pharmacology|pharmacology
513731|NCT00968422|Drug Safety|drug safety
513732|NCT00968422|Phase 1 Clinical Trials|phase 1 clinical trials
513733|NCT00968422|Pharmacokinetics|pharmacokinetics
513734|NCT00968409|Breast Cancer|breast cancer
513735|NCT00968409|Hormone Receptor|hormone receptor
513736|NCT00968396|Myeloma|myeloma
513737|NCT00968396|Ex-Vivo Depletion of Myeloma Cells|ex-vivo depletion of myeloma cells
513738|NCT00968396|Peripheral Blood Progenitor Cell Grafts|peripheral blood progenitor cell grafts
513739|NCT00968396|PBPC|pbpc
513740|NCT00968396|Stem Cell Transplant|stem cell transplant
513741|NCT00968396|Bone marrow stem cells|bone marrow stem cells
513742|NCT00968396|Melphalan|melphalan
513743|NCT00968396|Alkeran|alkeran
513744|NCT00968396|Apheresis|apheresis
513745|NCT00968383|Acute Coronary Syndrome|acute coronary syndrome
513746|NCT00968383|Myocardial infarction|myocardial infarction
513747|NCT00968383|Infarct Related Artery|infarct related artery
513748|NCT00968383|Percutaneous Coronary Intervention|percutaneous coronary intervention
513749|NCT00968383|Medical treatment|medical treatment
513750|NCT00968383|Tissue Viability|tissue viability
513751|NCT00968383|Magnetic Resonance|magnetic resonance
513752|NCT00968370|Severe and very severe pneumonia|severe and very severe pneumonia
513753|NCT00968370|severe malnutrition|severe malnutrition
513754|NCT00968370|children|children
513755|NCT00968370|day-care management|day-care management
513756|NCT00968370|hospital management|hospital management
513757|NCT00968357|SCV-07|scv-07
513758|NCT00968357|relapsers|relapsers
513759|NCT00968357|Hepatitis C|hepatitis c
513760|NCT00968331|relapsed and refractory DLBCL|relapsed and refractory dlbcl
513761|NCT00968318|Tissue expander|tissue expander
513762|NCT00968318|seroma|seroma
513763|NCT00968318|extrusion|extrusion
513764|NCT00968318|lymphatics|lymphatics
513765|NCT00968318|deep fascia|deep fascia
513766|NCT00968318|Rate of seroma formation after excision of strip of deep fascia|rate of seroma formation after excision of strip of deep fascia
513767|NCT00968305|African American children with stable asthma|african american children with stable asthma
513768|NCT00968305|Asthma severity|asthma severity
513769|NCT00968305|Interleukin 13 from PHA stimulated PBMC|interleukin 13 from pha stimulated pbmc
513770|NCT00968305|Lung function (FEV1%)|lung function (fev1%)
513771|NCT00968305|Total serum IgE|total serum ige
513772|NCT00968305|Pediatrics|pediatrics
513773|NCT00968292|K3 Promoter prosthetic foot Tensegrity Prosthetics Jerome Rifkin|k3 promoter prosthetic foot tensegrity prosthetics jerome rifkin
513774|NCT00968279|Patients with atrial fibrillation|patients with atrial fibrillation
513775|NCT00968266|Adherence|adherence
513776|NCT00968266|Compliance|compliance
513777|NCT00968266|Rheumatoid Arthritis|rheumatoid arthritis
513778|NCT00968266|Intervention|intervention
513779|NCT00968266|Beliefs about medication|beliefs about medication
513780|NCT00968266|Motivational Interviewing|motivational interviewing
513781|NCT00968266|Medication adherence|medication adherence
513782|NCT00968266|Patient compliance|patient compliance
513783|NCT00968266|Intervention studies|intervention studies
513784|NCT00968253|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
513785|NCT00968253|ALL|all
513786|NCT00968253|Hyper-CVAD|hyper-cvad
513787|NCT00968253|Everolimus|everolimus
513788|NCT00968253|6-mercaptopurine|6-mercaptopurine
513789|NCT00968253|Citrovorum|citrovorum
513790|NCT00968253|Cyclophosphamide|cyclophosphamide
513791|NCT00968253|Cytarabine|cytarabine
513792|NCT00968253|Dexamethasone|dexamethasone
513793|NCT00968253|Doxorubicin|doxorubicin
513794|NCT00968253|G-CSF|g-csf
513795|NCT00968253|Methotrexate|methotrexate
513796|NCT00968253|MESNA|mesna
513797|NCT00968253|Pegfilgrastim|pegfilgrastim
513799|NCT00968253|RAD001|rad001
513800|NCT00968253|Solumedrol|solumedrol
513801|NCT00968253|Vincristine Sulfate|vincristine sulfate
513802|NCT00968240|GBM|gbm
513803|NCT00968240|AA|aa
513804|NCT00968240|AO|ao
513805|NCT00968240|Brain|brain
513806|NCT00968240|Tumors|tumors
513807|NCT00968240|Malignant|malignant
513808|NCT00968240|Glioblastoma|glioblastoma
513809|NCT00968240|Multiforme|multiforme
513810|NCT00968240|Anaplastic|anaplastic
513811|NCT00968240|Astrocytoma|astrocytoma
513812|NCT00968227|subarachnoid hemorrhage|subarachnoid hemorrhage
513813|NCT00968227|vasospasm|vasospasm
513814|NCT00968227|transfusion|transfusion
513815|NCT00968227|cerebral oxygen delivery|cerebral oxygen delivery
513816|NCT00968227|hemoglobin|hemoglobin
513817|NCT00968214|stage IA breast cancer|stage ia breast cancer
513818|NCT00968214|stage IB breast cancer|stage ib breast cancer
513819|NCT00968214|stage II breast cancer|stage ii breast cancer
513820|NCT00968214|stage IIIA breast cancer|stage iiia breast cancer
513821|NCT00968214|stage IIIB breast cancer|stage iiib breast cancer
513822|NCT00968214|stage IIIC breast cancer|stage iiic breast cancer
513823|NCT00968214|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
513824|NCT00968214|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
513825|NCT00968188|HIV Risk|hiv risk
513826|NCT00968188|Internet Intervention|internet intervention
513827|NCT00968188|Homosexuality, Male|homosexuality, male
513828|NCT00968188|HIV Seronegativity|hiv seronegativity
513829|NCT00968175|Ultrasound guided celiac plexus neurolysis|ultrasound guided celiac plexus neurolysis
513830|NCT00968175|CPN|cpn
513831|NCT00968175|Pancreatic Cancer|pancreatic cancer
513832|NCT00968175|Pain Management|pain management
513833|NCT00968162|Bone Marrow Transplant|bone marrow transplant
513834|NCT00968162|Sickle Cell Disease|sickle cell disease
513835|NCT00968136|refractory infantile spasms|refractory infantile spasms
513836|NCT00968110|Milk Allergy|milk allergy
513837|NCT00968097|Alzheimer' disease|alzheimer' disease
513838|NCT00968097|SPECT imaging|spect imaging
513839|NCT00968084|Diagnostic Work Up|diagnostic work up
513840|NCT00968084|Normal Volunteers|normal volunteers
513841|NCT00968084|HV|hv
513842|NCT00968084|Inflammatory Disease|inflammatory disease
513843|NCT00968084|Autoimmune Disease|autoimmune disease
513844|NCT00968084|Immunologic Disease|immunologic disease
513845|NCT00968084|Healthy Volunteer|healthy volunteer
513846|NCT00968071|Leukemia|leukemia
513847|NCT00968071|AML|aml
513848|NCT00968071|MDS|mds
513849|NCT00968071|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
513850|NCT00968071|Decitabine|decitabine
513851|NCT00968071|5-aza-2 deoxycytidine|5-aza-2 deoxycytidine
513852|NCT00968071|Dacogen|dacogen
513853|NCT00968071|Gemtuzumab Ozogamicin|gemtuzumab ozogamicin
513854|NCT00968071|Mylotarg|mylotarg
513855|NCT00968058|Leak Pressure|leak pressure
513856|NCT00968058|Intubation, Endotracheal|intubation, endotracheal
513857|NCT00968058|Pediatric|pediatric
513858|NCT00968058|Temporal Variation|temporal variation
513859|NCT00968045|Fibrinogen|fibrinogen
513860|NCT00968045|Postoperative bleeding|postoperative bleeding
513861|NCT00968045|Transfusions|transfusions
513862|NCT00968045|CABG|cabg
513863|NCT00968032|PFO|pfo
513864|NCT00968032|Patent Foramen Ovale|patent foramen ovale
513865|NCT00968006|diabetes|diabetes
513866|NCT00968006|endothelium|endothelium
513867|NCT00968006|stem cells|stem cells
513868|NCT00967993|hyperphosphatemia|hyperphosphatemia
513869|NCT00967993|end-stage renal disease|end-stage renal disease
513870|NCT00967993|ESRD|esrd
513871|NCT00967993|hemodialysis|hemodialysis
513872|NCT00967993|diabetes|diabetes
513873|NCT00967993|dialysis|dialysis
513874|NCT00967980|pain|pain
513875|NCT00967980|Hip Resurfacing|hip resurfacing
513876|NCT00967980|catheter|catheter
513877|NCT00967980|nerve block|nerve block
513878|NCT00967980|UCSD|ucsd
513879|NCT00967980|hip surgery|hip surgery
513880|NCT00967980|psoas|psoas
513881|NCT00967980|femoral|femoral
513882|NCT00967980|ambulation|ambulation
513883|NCT00967980|hip flexion|hip flexion
513884|NCT00967980|infusion|infusion
513885|NCT00967967|control|control
513886|NCT00967967|symptoms|symptoms
513887|NCT00967954|stage IIB prostate cancer|stage iib prostate cancer
513888|NCT00967954|stage IIA prostate cancer|stage iia prostate cancer
513889|NCT00967954|stage III prostate cancer|stage iii prostate cancer
513890|NCT00967954|stage IV prostate cancer|stage iv prostate cancer
513891|NCT00967941|Vascular Surgery|vascular surgery
513892|NCT00967928|Stage IV or Recurrent Cervical cancer|stage iv or recurrent cervical cancer
513893|NCT00967915|Ankyloglossia|ankyloglossia
513894|NCT00967915|Tongue tie|tongue tie
513895|NCT00967915|Frenotomy|frenotomy
513896|NCT00967915|Frenulectomy|frenulectomy
513897|NCT00967915|Breast feeding|breast feeding
513898|NCT00967915|HATLFF|hatlff
513899|NCT00967915|IBFAT|ibfat
513900|NCT00967902|intracoronary stent|intracoronary stent
513901|NCT00967902|drug eluting stent|drug eluting stent
513902|NCT00967902|sirolimus|sirolimus
514002|NCT00967434|surgery|surgery
513903|NCT00967902|endothelial progenitor cells|endothelial progenitor cells
513904|NCT00967889|stage III prostate cancer|stage iii prostate cancer
513905|NCT00967889|stage IV prostate cancer|stage iv prostate cancer
513906|NCT00967889|recurrent prostate cancer|recurrent prostate cancer
513907|NCT00967876|Men or women of any ethnic group scheduled to undergo conventional coronary angiography for suspected coronary artery stent stenosis|men or women of any ethnic group scheduled to undergo conventional coronary angiography for suspected coronary artery stent stenosis
513908|NCT00967863|adenocarcinoma of the prostate|adenocarcinoma of the prostate
513909|NCT00967863|stage III prostate cancer|stage iii prostate cancer
513910|NCT00967863|stage IV prostate cancer|stage iv prostate cancer
513911|NCT00967850|High Myopia|high myopia
513912|NCT00967850|Bevacizumab|bevacizumab
513913|NCT00967850|Photodynamic therapy|photodynamic therapy
513914|NCT00967837|Diabetes with complications|diabetes with complications
513915|NCT00967837|Wound healing|wound healing
513916|NCT00967824|breast cancer|breast cancer
513917|NCT00967798|cystic fibrosis|cystic fibrosis
513918|NCT00967798|diabetes|diabetes
513919|NCT00967798|inflammation|inflammation
513920|NCT00967798|oxidative stress|oxidative stress
513921|NCT00967798|redox balance|redox balance
513922|NCT00967798|lung disease|lung disease
513923|NCT00967785|WHIM|whim
513924|NCT00967785|Mozobil (TM)|mozobil (tm)
513925|NCT00967785|Neutrophil Disorder|neutrophil disorder
513926|NCT00967785|Plerixafor|plerixafor
513927|NCT00967772|Pharmacokinetics|pharmacokinetics
513928|NCT00967772|Safety|safety
513929|NCT00967772|tolerability|tolerability
513930|NCT00967759|common cold|common cold
513931|NCT00967759|treatment|treatment
513932|NCT00967759|inflammatory symptoms of superior air passages affection|inflammatory symptoms of superior air passages affection
513933|NCT00967694|Glaucoma|glaucoma
513934|NCT00967694|Nitrous oxide|nitrous oxide
513935|NCT00967668|Counseling|counseling
513936|NCT00967668|Veterans|veterans
513937|NCT00967668|Weight loss|weight loss
513938|NCT00967668|Physical activity|physical activity
513939|NCT00967668|Diet|diet
513940|NCT00967655|adenocarcinoma of the rectum|adenocarcinoma of the rectum
513941|NCT00967655|stage I rectal cancer|stage i rectal cancer
513942|NCT00967655|stage II rectal cancer|stage ii rectal cancer
513943|NCT00967655|stage III rectal cancer|stage iii rectal cancer
513944|NCT00967642|Patients with Diabetes Mellitus Submitted to Percutaneous Coronary Intervention with Stent|patients with diabetes mellitus submitted to percutaneous coronary intervention with stent
513945|NCT00967629|Diabetic nephropathy|diabetic nephropathy
513946|NCT00967629|CKD progression|ckd progression
513947|NCT00967629|AGEs|ages
513948|NCT00967629|oxidative stress|oxidative stress
513949|NCT00967629|dietary AGEs|dietary ages
513950|NCT00967616|metastatic|metastatic
513951|NCT00967616|colon|colon
513952|NCT00967616|rectum|rectum
513953|NCT00967616|combination|combination
513954|NCT00967616|chemotherapy|chemotherapy
513955|NCT00967603|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
513956|NCT00967603|stage IV pancreatic cancer|stage iv pancreatic cancer
513957|NCT00967564|Myelodysplastic Syndrome|myelodysplastic syndrome
513958|NCT00967564|Quality of Life|quality of life
513959|NCT00967564|Anemia|anemia
513960|NCT00967564|Epoetin alfa|epoetin alfa
513961|NCT00967564|Eprex|eprex
513962|NCT00967551|Diarrhea|diarrhea
513963|NCT00967551|Pneumonia|pneumonia
513964|NCT00967551|Upper respiratory infections|upper respiratory infections
513965|NCT00967551|Acute gastroenteritis|acute gastroenteritis
513966|NCT00967538|psoriasis|psoriasis
513967|NCT00967538|etanercept|etanercept
513968|NCT00967538|efficacy|efficacy
513969|NCT00967538|response|response
513970|NCT00967538|anti-TNF alpha|anti-tnf alpha
513971|NCT00967538|treatment efficacy|treatment efficacy
513972|NCT00967525|AML|aml
513973|NCT00967525|ALL|all
513974|NCT00967525|leukemia|leukemia
513975|NCT00967525|CML|cml
513976|NCT00967525|Myelodysplastic Syndrome|myelodysplastic syndrome
513977|NCT00967525|malignancies|malignancies
513978|NCT00967525|Undifferentiated leukemia|undifferentiated leukemia
513979|NCT00967525|High risk malignancies|high risk malignancies
513980|NCT00967512|Oligonucleotides, Antisense|oligonucleotides, antisense
513981|NCT00967512|Tumor Suppressor Protein p53|tumor suppressor protein p53
513982|NCT00967512|idarubicin|idarubicin
513983|NCT00967512|cytarabine|cytarabine
513984|NCT00967499|PONV|ponv
513985|NCT00967499|rescue|rescue
513986|NCT00967473|Astigmatism|astigmatism
513987|NCT00967473|cataract|cataract
513988|NCT00967473|corneal astigmatism|corneal astigmatism
513989|NCT00967473|IOL|iol
513990|NCT00967473|AcrySof|acrysof
513991|NCT00967460|Childhood obesity|childhood obesity
513992|NCT00967460|Children|children
513993|NCT00967460|Inactivity|inactivity
513994|NCT00967460|Physical activity|physical activity
513995|NCT00967460|Motor skills|motor skills
513996|NCT00967460|Motor fitness|motor fitness
513997|NCT00967460|Quality of life|quality of life
513998|NCT00967460|Nutrition|nutrition
513999|NCT00967460|Family|family
514000|NCT00967434|infarction|infarction
514001|NCT00967434|ischemia|ischemia
514003|NCT00967434|perioperative|perioperative
514004|NCT00967434|statins|statins
514005|NCT00967421|Driving|driving
514006|NCT00967421|DUI|dui
514007|NCT00967421|Driving simulation|driving simulation
514008|NCT00967421|Drugs|drugs
514009|NCT00967421|Ethanol|ethanol
514010|NCT00967408|Stroke|stroke
514011|NCT00967408|Antidepressive Agents,Second-Generation|antidepressive agents,second-generation
514012|NCT00967408|Treatment Outcome|treatment outcome
514013|NCT00967408|Rehabilitation|rehabilitation
514014|NCT00967382|Pregnancy|pregnancy
514015|NCT00967382|Thrombophilia|thrombophilia
514016|NCT00967382|High-risk pregnancy|high-risk pregnancy
514017|NCT00967382|LMWH prophylaxis|lmwh prophylaxis
514018|NCT00967382|Placenta mediated pregnancy complications|placenta mediated pregnancy complications
514019|NCT00967369|Lymphoma|lymphoma
514020|NCT00967369|Classical Hodgkin Lymphoma|classical hodgkin lymphoma
514021|NCT00967369|Cancer|cancer
514022|NCT00967369|Bortezomib|bortezomib
514023|NCT00967369|Velcade|velcade
514024|NCT00967369|Chemotherapy|chemotherapy
514025|NCT00967369|ICE|ice
514026|NCT00967369|Ifosfamide|ifosfamide
514027|NCT00967369|Ifex|ifex
514028|NCT00967369|Mesna|mesna
514029|NCT00967369|Mesnex|mesnex
514030|NCT00967369|Carboplatin|carboplatin
514031|NCT00967369|Paraplatin|paraplatin
514032|NCT00967369|Etoposide|etoposide
514033|NCT00967369|VePesid|vepesid
514034|NCT00967369|BICE|bice
514035|NCT00967369|Pegfilgrastim|pegfilgrastim
514036|NCT00967369|Neulasta|neulasta
514037|NCT00967356|Healthy volunteers|healthy volunteers
514038|NCT00967343|Haploidentical stem cell transplantation|haploidentical stem cell transplantation
514039|NCT00967343|Graft-versus-host disease|graft-versus-host disease
514040|NCT00967343|Immune reconstitution|immune reconstitution
514041|NCT00967343|Alloreactive T-cells|alloreactive t-cells
514042|NCT00967343|Photodepletion|photodepletion
514043|NCT00967343|TH9402|th9402
514044|NCT00967343|Transplant related mortality|transplant related mortality
514045|NCT00967343|Hematologic malignancy|hematologic malignancy
514046|NCT00967317|Auris-Sedina|auris-sedina
514047|NCT00967317|Otitis|otitis
514048|NCT00967317|Efficacy|efficacy
514049|NCT00967317|Tolerability|tolerability
514050|NCT00967304|Unprovoked Venous thromboembolism|unprovoked venous thromboembolism
514051|NCT00967304|Clinical decision rule|clinical decision rule
514052|NCT00967304|Anticoagulants|anticoagulants
514053|NCT00967304|Recurrence|recurrence
514054|NCT00967304|Prognostic|prognostic
514055|NCT00967304|Risk stratification|risk stratification
514056|NCT00967291|acinar cell adenocarcinoma of the pancreas|acinar cell adenocarcinoma of the pancreas
514057|NCT00967291|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
514058|NCT00967291|stage IV pancreatic cancer|stage iv pancreatic cancer
514059|NCT00967291|recurrent pancreatic cancer|recurrent pancreatic cancer
514060|NCT00967278|OPCAB|opcab
514061|NCT00967278|pulmonary artery catheter|pulmonary artery catheter
514062|NCT00967278|esophageal doppler|esophageal doppler
514063|NCT00967278|hemodynamics|hemodynamics
514064|NCT00967265|Introduction seminar|introduction seminar
514065|NCT00967265|Psychoeducation|psychoeducation
514066|NCT00967265|Waiting list|waiting list
514067|NCT00967265|Patient participation|patient participation
514068|NCT00967265|Mental disorders|mental disorders
514069|NCT00967252|surgery|surgery
514070|NCT00967252|inflammation|inflammation
514071|NCT00967252|infection|infection
514072|NCT00967252|statins|statins
514073|NCT00967239|ductal breast carcinoma in situ|ductal breast carcinoma in situ
514074|NCT00967239|invasive ductal breast carcinoma|invasive ductal breast carcinoma
514075|NCT00967239|invasive lobular breast carcinoma|invasive lobular breast carcinoma
514076|NCT00967239|invasive lobular breast carcinoma with predominant in situ component|invasive lobular breast carcinoma with predominant in situ component
514077|NCT00967226|hemangioma|hemangioma
514078|NCT00967200|adult anaplastic astrocytoma|adult anaplastic astrocytoma
514079|NCT00967200|adult diffuse astrocytoma|adult diffuse astrocytoma
514080|NCT00967200|adult glioblastoma|adult glioblastoma
514081|NCT00967200|adult giant cell glioblastoma|adult giant cell glioblastoma
514082|NCT00967200|adult gliosarcoma|adult gliosarcoma
514083|NCT00967200|adult pilocytic astrocytoma|adult pilocytic astrocytoma
514084|NCT00967200|adult pineal gland astrocytoma|adult pineal gland astrocytoma
514085|NCT00967200|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
514086|NCT00967200|adult brain stem glioma|adult brain stem glioma
514087|NCT00967200|adult choroid plexus tumor|adult choroid plexus tumor
514088|NCT00967200|adult craniopharyngioma|adult craniopharyngioma
514089|NCT00967200|adult ependymoblastoma|adult ependymoblastoma
514090|NCT00967200|adult medulloblastoma|adult medulloblastoma
514091|NCT00967200|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
514092|NCT00967200|adult anaplastic ependymoma|adult anaplastic ependymoma
514093|NCT00967200|adult ependymoma|adult ependymoma
514094|NCT00967200|adult myxopapillary ependymoma|adult myxopapillary ependymoma
514095|NCT00967200|adult subependymoma|adult subependymoma
514096|NCT00967200|meningeal melanocytoma|meningeal melanocytoma
514097|NCT00967200|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
514098|NCT00967200|adult grade I meningioma|adult grade i meningioma
514099|NCT00967200|adult grade II meningioma|adult grade ii meningioma
514100|NCT00967200|adult anaplastic meningioma|adult anaplastic meningioma
514101|NCT00967200|adult papillary meningioma|adult papillary meningioma
514102|NCT00967200|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
514103|NCT00967200|adult oligodendroglioma|adult oligodendroglioma
514104|NCT00967200|adult pineoblastoma|adult pineoblastoma
514105|NCT00967200|adult pineocytoma|adult pineocytoma
514106|NCT00967200|adult mixed glioma|adult mixed glioma
514107|NCT00967200|recurrent adult brain tumor|recurrent adult brain tumor
514108|NCT00967161|knee replacement motion analysis|knee replacement motion analysis
514109|NCT00967135|Thoracotomy|thoracotomy
514110|NCT00967135|Neuropathic pain|neuropathic pain
514111|NCT00967122|adjustment, hunger|adjustment, hunger
514112|NCT00967122|Hunger/satiety changes before and after gastric band adjustment|hunger/satiety changes before and after gastric band adjustment
514113|NCT00967109|Anemia|anemia
514114|NCT00967109|Tissue oxygenation|tissue oxygenation
514115|NCT00967109|Spine surgery|spine surgery
514116|NCT00967096|rifaximin|rifaximin
514117|NCT00967096|acute graft versus host disease|acute graft versus host disease
514118|NCT00967096|bone marrow transplant|bone marrow transplant
514119|NCT00967096|non-malignancy requiring BMT|non-malignancy requiring bmt
514120|NCT00967083|Quality of Life|quality of life
514121|NCT00967083|Questionnaires|questionnaires
514122|NCT00967083|Interviews|interviews
514123|NCT00967083|family members|family members
514124|NCT00967083|care givers|care givers
514125|NCT00967083|09-104|09-104
514126|NCT00967057|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
514127|NCT00967057|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
514128|NCT00967044|Relapsed or Refractory Lymphoma|relapsed or refractory lymphoma
514129|NCT00967044|Hodgkin's lymphoma|hodgkin's lymphoma
514130|NCT00967044|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
514132|NCT00967044|LBH589|lbh589
514133|NCT00967044|Panobinostat|panobinostat
514134|NCT00967044|RAD001|rad001
514135|NCT00967044|Everolimus|everolimus
514136|NCT00967031|HER2-positive breast cancer|her2-positive breast cancer
514137|NCT00967031|male breast cancer|male breast cancer
514138|NCT00967031|stage IV breast cancer|stage iv breast cancer
514139|NCT00967031|tumors metastatic to brain|tumors metastatic to brain
514140|NCT00967018|Safety parameters|safety parameters
514141|NCT00967018|ECG, blood and urine samples|ecg, blood and urine samples
514142|NCT00967018|general health state|general health state
514143|NCT00967005|N acetyl cysteine|n acetyl cysteine
514144|NCT00967005|Pathological gambling|pathological gambling
514145|NCT00967005|Nicotine dependence|nicotine dependence
514146|NCT00966992|Uterine Cervical Cancer|uterine cervical cancer
514147|NCT00966992|Cancer of Cervix|cancer of cervix
514148|NCT00966992|Cervix Cancer|cervix cancer
514149|NCT00966979|Osteoarthritis, Post-traumatic arthritis|osteoarthritis, post-traumatic arthritis
514150|NCT00966966|Alzheimer Disease|alzheimer disease
514151|NCT00966940|Glaucoma|glaucoma
514152|NCT00966940|IOP|iop
514153|NCT00966940|Travoprost|travoprost
514154|NCT00966927|quality of life|quality of life
514155|NCT00966927|functional independence|functional independence
514156|NCT00966927|spina bifid|spina bifid
514157|NCT00966888|stage II breast cancer|stage ii breast cancer
514158|NCT00966875|rheumatoid arthritis|rheumatoid arthritis
514159|NCT00966875|RA|ra
514160|NCT00966849|Randomized Controlled Trial|randomized controlled trial
514161|NCT00966849|Financial Support|financial support
514162|NCT00966849|Poverty|poverty
514163|NCT00966849|Child, Orphaned|child, orphaned
514164|NCT00966849|HIV|hiv
514165|NCT00966836|Heart Transplantation|heart transplantation
514166|NCT00966836|Cardiac Allograft Vasculopathy|cardiac allograft vasculopathy
514167|NCT00966836|Cytomegalovirus Infection|cytomegalovirus infection
514168|NCT00966836|Everolimus|everolimus
514169|NCT00966836|Valganciclovir|valganciclovir
514170|NCT00966836|Mycophenolate|mycophenolate
514171|NCT00966823|Diaphragm|diaphragm
514172|NCT00966823|Trachea|trachea
514173|NCT00966823|Lung development|lung development
514174|NCT00966823|Lung growth|lung growth
514175|NCT00966823|Tracheal occlusion|tracheal occlusion
514176|NCT00966823|ECMO|ecmo
514177|NCT00966823|Neonatal death|neonatal death
514178|NCT00966810|chronic myelocytic leukemia|chronic myelocytic leukemia
514179|NCT00966810|allogeneic stem cell transplantation|allogeneic stem cell transplantation
514180|NCT00966810|T cell depletion|t cell depletion
514181|NCT00966810|donor lymphocyte infusion|donor lymphocyte infusion
514182|NCT00966810|GvHD|gvhd
514183|NCT00966810|transplant related mortality|transplant related mortality
514184|NCT00966771|contraception|contraception
514185|NCT00966771|emergency contraception|emergency contraception
514186|NCT00966771|pregnancy prevention after unprotected intercourse|pregnancy prevention after unprotected intercourse
514187|NCT00966745|surgical field condition|surgical field condition
514188|NCT00966719|Jaundice|jaundice
514189|NCT00966719|Breastfeeding|breastfeeding
514190|NCT00966719|Infants|infants
514191|NCT00966706|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
514820|NCT00964353|Warfarin|warfarin
514192|NCT00966706|stage III pancreatic cancer|stage iii pancreatic cancer
514193|NCT00966706|stage IV pancreatic cancer|stage iv pancreatic cancer
514194|NCT00966693|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
514195|NCT00966693|RRMM|rrmm
514196|NCT00966693|Lenalidomide|lenalidomide
514197|NCT00966693|Revlimid|revlimid
514198|NCT00966693|CC-5013|cc-5013
514199|NCT00966693|Thalidomide|thalidomide
514200|NCT00966693|Thalomid|thalomid
514201|NCT00966693|Dexamethasone|dexamethasone
514202|NCT00966693|Decadron|decadron
514203|NCT00966680|general anesthesia|general anesthesia
514204|NCT00966680|spinal anesthesia|spinal anesthesia
514205|NCT00966680|emergency cesarean delivery|emergency cesarean delivery
514206|NCT00966667|cancer survivor|cancer survivor
514207|NCT00966667|stage I colon cancer|stage i colon cancer
514208|NCT00966667|stage II colon cancer|stage ii colon cancer
514209|NCT00966667|stage III colon cancer|stage iii colon cancer
514210|NCT00966667|stage I rectal cancer|stage i rectal cancer
514211|NCT00966667|stage II rectal cancer|stage ii rectal cancer
514212|NCT00966667|stage III rectal cancer|stage iii rectal cancer
514213|NCT00966654|CABG|cabg
514214|NCT00966654|Cardiac Surgical Patient|cardiac surgical patient
514215|NCT00966628|pediatric|pediatric
514216|NCT00966628|dengue|dengue
514217|NCT00966628|hypertonic sodium lactate|hypertonic sodium lactate
514218|NCT00966628|fluid resuscitation|fluid resuscitation
514219|NCT00966628|Ringer's lactate|ringer's lactate
514220|NCT00966615|malnutrition|malnutrition
514221|NCT00966615|fluid status|fluid status
514222|NCT00966615|survival|survival
514223|NCT00966589|groin pain|groin pain
514224|NCT00966589|sportsman hernia|sportsman hernia
514225|NCT00966589|osteitis pubis|osteitis pubis
514226|NCT00966589|laparoscopic surgery|laparoscopic surgery
514227|NCT00966576|Glaucoma|glaucoma
514228|NCT00966576|IOP|iop
514229|NCT00966576|AZARGA|azarga
514230|NCT00966563|Mangafodipir|mangafodipir
514231|NCT00966563|Primary Percutaneous Coronary Intervention|primary percutaneous coronary intervention
514232|NCT00966563|Myocardial infarction|myocardial infarction
514233|NCT00966563|Troponin|troponin
514234|NCT00966563|CK-MB|ck-mb
514235|NCT00966563|Magnetic Resonance Imaging|magnetic resonance imaging
514236|NCT00966550|Tomato|tomato
514237|NCT00966550|Nutrition|nutrition
514238|NCT00966537|to study the clinical application of 3D/4D ultrasound for fetal scanning|to study the clinical application of 3d/4d ultrasound for fetal scanning
514239|NCT00966537|to study the clinical application of 3D/4D ultrasound for pelvic scanning;|to study the clinical application of 3d/4d ultrasound for pelvic scanning;
514240|NCT00966537|to demonstrate how to optimally display the different organs.|to demonstrate how to optimally display the different organs.
514241|NCT00966537|to correlate our findings with other diagnostic tools like MRI, CT;|to correlate our findings with other diagnostic tools like mri, ct;
514242|NCT00966537|to correlate our findings with clinical outcome.|to correlate our findings with clinical outcome.
514243|NCT00966524|Endotracheal intubation|endotracheal intubation
514244|NCT00966511|lung cancer|lung cancer
514245|NCT00966511|lung resection|lung resection
514246|NCT00966511|lobectomy|lobectomy
514247|NCT00966511|pneumonectomy|pneumonectomy
514248|NCT00966511|lung function|lung function
514249|NCT00966511|perfusion|perfusion
514250|NCT00966498|malignancy|malignancy
514251|NCT00966498|solid tumor|solid tumor
514252|NCT00966498|recurrent|recurrent
514253|NCT00966498|high risk|high risk
514254|NCT00966485|ASA resistance|asa resistance
514255|NCT00966485|coronary stenting|coronary stenting
514256|NCT00966485|platelet function|platelet function
514257|NCT00966485|laboratory ASA resistance|laboratory asa resistance
514258|NCT00966485|MACE|mace
514259|NCT00966485|Positive SPECT|positive spect
514260|NCT00966472|Rosuvastatin|rosuvastatin
514261|NCT00966472|Erlotinib|erlotinib
514262|NCT00966472|Squamous Cell Carcinoma|squamous cell carcinoma
514263|NCT00966472|Nom-Small Cell Lung Cancer|nom-small cell lung cancer
514264|NCT00966459|COPD|copd
514265|NCT00966446|MRSA; household; infection; colonization|mrsa; household; infection; colonization
514266|NCT00966433|Proseal™ LMA|proseal™ lma
514267|NCT00966433|children|children
514268|NCT00966433|ventilation|ventilation
514269|NCT00966433|general anesthesia|general anesthesia
514270|NCT00966433|Children under general anesthesia for outpatient surgery|children under general anesthesia for outpatient surgery
514271|NCT00966407|Metabolic Syndrome|metabolic syndrome
514272|NCT00966407|Obesity|obesity
514273|NCT00966407|Genetic risk markers|genetic risk markers
514274|NCT00966407|Single Nucleotide Polymorphisms|single nucleotide polymorphisms
514275|NCT00966407|Young adults|young adults
514276|NCT00966407|Fitness testing|fitness testing
514277|NCT00966394|ADHD, saliva, caries|adhd, saliva, caries
514278|NCT00966381|breastfeeding|breastfeeding
514279|NCT00966381|bone mineral density|bone mineral density
514280|NCT00966381|exercise|exercise
514281|NCT00966381|diet|diet
514282|NCT00966355|Cirrhosis, Esophagus Disorders, Varicose Veins|cirrhosis, esophagus disorders, varicose veins
514283|NCT00966342|vaccine|vaccine
514284|NCT00966342|influenza|influenza
514285|NCT00966342|influenza vaccine|influenza vaccine
514821|NCT00964327|TMC114-C201|tmc114-c201
514286|NCT00966342|pandemic preparedness|pandemic preparedness
514287|NCT00966329|Switching|switching
514288|NCT00966329|Maraviroc|maraviroc
514289|NCT00966329|Virological efficacy|virological efficacy
514290|NCT00966329|Lipid profile|lipid profile
514291|NCT00966329|Tropism|tropism
514292|NCT00966316|Acute Ischemic Stroke；clinical pathway;TCM；|acute ischemic stroke；clinical pathway;tcm；
514293|NCT00966303|rehabilitation|rehabilitation
514294|NCT00966303|dyspnea|dyspnea
514295|NCT00966303|strength|strength
514296|NCT00966290|anticoagulants|anticoagulants
514297|NCT00966290|management|management
514298|NCT00966290|anticoagulation clinics|anticoagulation clinics
514299|NCT00966290|randomized comparison|randomized comparison
514300|NCT00966277|Pancreas|pancreas
514301|NCT00966277|Primary venous thromboembolism|primary venous thromboembolism
514302|NCT00966277|VTE|vte
514303|NCT00966277|Chemotherapy|chemotherapy
514304|NCT00966277|Deep venous thrombosis|deep venous thrombosis
514305|NCT00966277|Pulmonary embolism|pulmonary embolism
514306|NCT00966277|Dalteparin|dalteparin
514307|NCT00966277|Fragmin|fragmin
514308|NCT00966277|Thromboprophylaxis|thromboprophylaxis
514309|NCT00966264|randomized controlled trial|randomized controlled trial
514310|NCT00966264|menorrhagia|menorrhagia
514311|NCT00966264|LNG-IUS|lng-ius
514312|NCT00966264|hysterectomy|hysterectomy
514313|NCT00966251|Primary Hepatocellular Carcinoma|primary hepatocellular carcinoma
514314|NCT00966238|influenza|influenza
514315|NCT00966238|vaccine|vaccine
514316|NCT00966199|blood pressure|blood pressure
514317|NCT00966199|aging|aging
514318|NCT00966199|cerebrovascular circulation|cerebrovascular circulation
514319|NCT00966199|hypertension|hypertension
514320|NCT00966186|ProSeal Laryngeal Mask Airway|proseal laryngeal mask airway
514321|NCT00966186|Rotational technique|rotational technique
514322|NCT00966186|Success rate|success rate
514323|NCT00966186|Postoperative complications|postoperative complications
514324|NCT00966160|treatment naive|treatment naive
514325|NCT00966134|mountain medicine|mountain medicine
514326|NCT00966134|ghrelin|ghrelin
514327|NCT00966134|growth hormone|growth hormone
514328|NCT00966134|hypoxia|hypoxia
514329|NCT00966134|physiology of hormonal adaptation to high altitude|physiology of hormonal adaptation to high altitude
514330|NCT00966121|Cirrhosis|cirrhosis
514331|NCT00966121|Esophagus Disorders|esophagus disorders
514332|NCT00966121|Varicose Veins|varicose veins
514333|NCT00966095|prostate cancer|prostate cancer
514334|NCT00966082|Cirrhosis|cirrhosis
514335|NCT00966082|Esophagus Disorders|esophagus disorders
514336|NCT00966082|Varicose Veins|varicose veins
514337|NCT00966069|Respiratory tract infections|respiratory tract infections
514338|NCT00966069|Viral infections|viral infections
514339|NCT00966069|Pediatrics|pediatrics
514340|NCT00966069|Specimen collection|specimen collection
514341|NCT00966056|Nasal adhesions|nasal adhesions
514342|NCT00966056|Nasal synechiae|nasal synechiae
514343|NCT00966056|Mitomycin|mitomycin
514344|NCT00966056|Mitomycin c|mitomycin c
514345|NCT00966056|Teflon|teflon
514346|NCT00966056|Splints|splints
514347|NCT00966056|Septal splints|septal splints
514348|NCT00966017|PET Scan|pet scan
514349|NCT00966004|Urge incontinence|urge incontinence
514350|NCT00966004|YM178|ym178
514351|NCT00966004|Overactive Bladder|overactive bladder
514352|NCT00966004|Urgency|urgency
514353|NCT00966004|Urinary incontinence|urinary incontinence
514354|NCT00966004|mirabegron|mirabegron
514355|NCT00966004|Micturition|micturition
514356|NCT00965991|Gestational diabetes|gestational diabetes
514357|NCT00965991|Metformin|metformin
514358|NCT00965991|Glyburide|glyburide
514359|NCT00965991|oral agents|oral agents
514360|NCT00965978|ONO-5920|ono-5920
514361|NCT00965978|YM529|ym529
514362|NCT00965978|Minodronic Acid|minodronic acid
514363|NCT00965978|Food Effect|food effect
514364|NCT00965965|health behavior|health behavior
514365|NCT00965965|randomized controlled trials|randomized controlled trials
514366|NCT00965965|self-efficacy|self-efficacy
514367|NCT00965965|patient education|patient education
514368|NCT00965965|comprehension|comprehension
514369|NCT00965965|mass screening|mass screening
514370|NCT00965965|prevention and control|prevention and control
514371|NCT00965926|Overactive Bladder|overactive bladder
514372|NCT00965926|Urinary incontinence|urinary incontinence
514373|NCT00965926|YM178|ym178
514374|NCT00965926|mirabegron|mirabegron
514375|NCT00965900|Cirrhosis|cirrhosis
514376|NCT00965900|Esophagus Disorders|esophagus disorders
514377|NCT00965900|Varicose Veins|varicose veins
514378|NCT00965874|Rapid Atrial Fibrillation|rapid atrial fibrillation
514379|NCT00965874|Magnesium Sulfate|magnesium sulfate
514380|NCT00965874|Cardiac arrhythmia|cardiac arrhythmia
514381|NCT00965861|Tissue Registry|tissue registry
514382|NCT00965861|Tissue Collection|tissue collection
514383|NCT00965861|Unknown Primary|unknown primary
514384|NCT00965861|Breast|breast
514385|NCT00965861|Lung|lung
514386|NCT00965861|Gastrointestinal|gastrointestinal
514387|NCT00965861|Bone Marrow Transplant|bone marrow transplant
514388|NCT00965861|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
514822|NCT00964327|TMC114|tmc114
514389|NCT00965861|Central Nervous System|central nervous system
514390|NCT00965861|Head and Neck|head and neck
514391|NCT00965861|Melanoma|melanoma
514392|NCT00965861|Myelodysplastic syndrome|myelodysplastic syndrome
514393|NCT00965861|Multiple Myeloma|multiple myeloma
514394|NCT00965861|Lymphoma|lymphoma
514395|NCT00965861|Gynecologic|gynecologic
514396|NCT00965861|Genitourinary|genitourinary
514397|NCT00965861|Refractory Malignancy|refractory malignancy
514398|NCT00965848|Pneumonia, Ventilator-Associated|pneumonia, ventilator-associated
514399|NCT00965848|Intra-abdominal Infections|intra-abdominal infections
514400|NCT00965848|Urinary tract Infections|urinary tract infections
514401|NCT00965848|Doripenem|doripenem
514402|NCT00965848|Doribax|doribax
514403|NCT00965835|PET Scan|pet scan
514404|NCT00965822|URTI|urti
514405|NCT00965822|Natural Health Products|natural health products
514406|NCT00965796|Intravenous lidocaine|intravenous lidocaine
514407|NCT00965796|postoperative analgesia|postoperative analgesia
514408|NCT00965783|Sleep, Apnea, OSA, obese, middle-aged|sleep, apnea, osa, obese, middle-aged
514409|NCT00965770|abortion|abortion
514410|NCT00965770|intrauterine device|intrauterine device
514411|NCT00965770|cost-effectiveness|cost-effectiveness
514412|NCT00965744|Ligasure vessel sealing system|ligasure vessel sealing system
514413|NCT00965744|Azygoportal Disconnection|azygoportal disconnection
514414|NCT00965744|Splenectomy|splenectomy
514415|NCT00965744|Portal hypertension|portal hypertension
514416|NCT00965731|Lung Neoplasms|lung neoplasms
514417|NCT00965731|Crizotinib|crizotinib
514418|NCT00965718|advanced pancreatic cancer|advanced pancreatic cancer
514419|NCT00965705|Binge Eating Disorder|binge eating disorder
514420|NCT00965705|overeating|overeating
514421|NCT00965705|binge eating|binge eating
514422|NCT00965705|women|women
514423|NCT00965705|overweight|overweight
514424|NCT00965705|compulsive overeating|compulsive overeating
514425|NCT00965679|Cardiac CT|cardiac ct
514426|NCT00965679|Iodinated Radiocontrast|iodinated radiocontrast
514427|NCT00965679|Ionizing Radiation|ionizing radiation
514428|NCT00965679|Aortic Valve Stenosis|aortic valve stenosis
514429|NCT00965679|Percutaneous Aortic Valve Replacement|percutaneous aortic valve replacement
514430|NCT00965679|Heart Valve|heart valve
514431|NCT00965666|Fanconi Anemia|fanconi anemia
514432|NCT00965666|Hemic and Lymphatic Diseases|hemic and lymphatic diseases
514433|NCT00965666|Anti-Rheumatic Agents|anti-rheumatic agents
514434|NCT00965666|Anemia, Hypoplastic, Congenital|anemia, hypoplastic, congenital
514435|NCT00965666|DNA Repair-Deficiency Disorders|dna repair-deficiency disorders
514436|NCT00965666|Congenital, Hereditary, and|congenital, hereditary, and
514437|NCT00965666|Neonatal Diseases and Abnormalities|neonatal diseases and abnormalities
514438|NCT00965640|male pattern baldness|male pattern baldness
514439|NCT00965640|androgenetic alopecia|androgenetic alopecia
514440|NCT00965640|hair loss|hair loss
514441|NCT00965614|diagnose cardiac arrhythmia and CAD.|diagnose cardiac arrhythmia and cad.
514442|NCT00965614|we'll try to establish the specific model to detect and diagnose cardiac arrhythmia and CAD.|we'll try to establish the specific model to detect and diagnose cardiac arrhythmia and cad.
514443|NCT00965601|Fibromyalgia|fibromyalgia
514444|NCT00965588|Alzheimer's disease|alzheimer's disease
514445|NCT00965588|amyloid beta|amyloid beta
514446|NCT00965588|vaccine|vaccine
514447|NCT00965575|epilepsy|epilepsy
514448|NCT00965575|sleep|sleep
514449|NCT00965575|seizures|seizures
514450|NCT00965575|cognition|cognition
514451|NCT00965562|Premenstrual syndrome|premenstrual syndrome
514452|NCT00965562|PMS|pms
514453|NCT00965562|calcium|calcium
514454|NCT00965536|Schizophrenia|schizophrenia
514455|NCT00965536|Bipolar Disorder|bipolar disorder
514456|NCT00965536|Manic Disorder|manic disorder
514457|NCT00965536|Register study|register study
514458|NCT00965536|Quetiapine|quetiapine
514459|NCT00965536|Quetiapine Prolong|quetiapine prolong
514460|NCT00965536|Seroquel|seroquel
514461|NCT00965536|Seroquel Prolong|seroquel prolong
514462|NCT00965536|Seroquel XR|seroquel xr
514463|NCT00965536|In-patient|in-patient
514464|NCT00965523|Cancer|cancer
514465|NCT00965523|breast cancer|breast cancer
514466|NCT00965523|neoplasm|neoplasm
514467|NCT00965523|E7389|e7389
514468|NCT00965523|Eribulin|eribulin
514469|NCT00965510|diabetes|diabetes
514470|NCT00965497|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
514471|NCT00965497|ALS|als
514472|NCT00965497|Multiple Sclerosis|multiple sclerosis
514473|NCT00965497|MS|ms
514474|NCT00965497|Major Depression|major depression
514475|NCT00965497|Depression|depression
514476|NCT00965497|Major Depressive Disorder|major depressive disorder
514477|NCT00965497|antidepressants|antidepressants
514478|NCT00965497|Escitalopram|escitalopram
514479|NCT00965497|Lexapro|lexapro
514480|NCT00965484|Genotropin Medical device Patient reported outcome|genotropin medical device patient reported outcome
514481|NCT00965471|percutaneous coronary artery intervention|percutaneous coronary artery intervention
514482|NCT00965471|coronary artery bypass graft|coronary artery bypass graft
514483|NCT00965471|acute coronary syndrome|acute coronary syndrome
514484|NCT00965458|New-onset Type 1 Diabetes Mellitus|new-onset type 1 diabetes mellitus
514485|NCT00965458|New-onset T1DM|new-onset t1dm
514486|NCT00965458|New-onset T1D|new-onset t1d
514487|NCT00965458|Alefacept|alefacept
514488|NCT00965458|Amevive®|amevive®
514489|NCT00965445|isoprostanes|isoprostanes
514490|NCT00965445|mass spectrometry|mass spectrometry
514491|NCT00965406|acute coronary syndrome|acute coronary syndrome
514492|NCT00965406|glucose insulin potassium|glucose insulin potassium
514493|NCT00965393|Ischaemia reperfusion|ischaemia reperfusion
514494|NCT00965393|Platelet activation|platelet activation
514495|NCT00965393|Endothelial function|endothelial function
514496|NCT00965393|Remote ischaemic preconditioning|remote ischaemic preconditioning
514497|NCT00965393|Bradykinin|bradykinin
514498|NCT00965380|Trinity Evolution|trinity evolution
514499|NCT00965380|Symptomatic lumbar degenerative disc disease|symptomatic lumbar degenerative disc disease
514500|NCT00965380|Posterior lumbar interbody fusion|posterior lumbar interbody fusion
514501|NCT00965380|Transforaminal lumbar interbody fusion|transforaminal lumbar interbody fusion
514502|NCT00965367|POV tonsillectomy adenoidectomy acupuncture acupressure child|pov tonsillectomy adenoidectomy acupuncture acupressure child
514503|NCT00965367|Effectiveness of acupuncture on|effectiveness of acupuncture on
514504|NCT00965354|severe|severe
514505|NCT00965354|acute|acute
514506|NCT00965354|influenza|influenza
514507|NCT00965354|consortium|consortium
514508|NCT00965354|swine|swine
514509|NCT00965354|flu|flu
514510|NCT00965354|influenza A|influenza a
514511|NCT00965354|H1N1|h1n1
514512|NCT00965354|hospital|hospital
514513|NCT00965354|admission|admission
514514|NCT00965341|Cancer|cancer
514515|NCT00965341|Fatigue|fatigue
514516|NCT00965341|Testosterone Replacement Therapy|testosterone replacement therapy
514517|NCT00965341|Depo-Testosterone|depo-testosterone
514518|NCT00965341|Testosterone cypionate|testosterone cypionate
514519|NCT00965341|Testosterone enanthate|testosterone enanthate
514520|NCT00965341|Hypogonadic|hypogonadic
514521|NCT00965341|Functional Assessment of Cancer Therapy-Fatigue subscale|functional assessment of cancer therapy-fatigue subscale
514522|NCT00965341|FACIT-F|facit-f
514523|NCT00965328|anticoagulation|anticoagulation
514524|NCT00965328|hemofiltration|hemofiltration
514525|NCT00965328|acute kidney injury|acute kidney injury
514526|NCT00965328|heparin|heparin
514527|NCT00965328|hemostasis|hemostasis
514528|NCT00965328|nadroparin|nadroparin
514529|NCT00965328|anti-Xa|anti-xa
514530|NCT00965328|endogenous thrombin potential|endogenous thrombin potential
514531|NCT00965315|CV (cardiovascular)|cv (cardiovascular)
514532|NCT00965315|MI (myocardial infarction)|mi (myocardial infarction)
514533|NCT00965315|fenofibrate|fenofibrate
514534|NCT00965315|rosuvastatin|rosuvastatin
514535|NCT00965315|this trial is to test the hypothesis that the addition of fenofibrate on rosuvastatin would provide a further reduction in the time|this trial is to test the hypothesis that the addition of fenofibrate on rosuvastatin would provide a further reduction in the time
514536|NCT00965302|Obesity|obesity
514537|NCT00965302|Diabetes mellitus, Type 2|diabetes mellitus, type 2
514538|NCT00965302|Sleeve gastrectomy|sleeve gastrectomy
514539|NCT00965302|Metabolic surgery|metabolic surgery
514540|NCT00965289|Aggressive large B-cell lymphoma (DLBCL)|aggressive large b-cell lymphoma (dlbcl)
514541|NCT00965289|Intensive chemotherapy|intensive chemotherapy
514542|NCT00965289|Rituximab|rituximab
514543|NCT00965289|ASCT|asct
514544|NCT00965276|Adjuvant Therapy|adjuvant therapy
514545|NCT00965276|Paclitaxel|paclitaxel
514546|NCT00965276|Chemoresistance|chemoresistance
514547|NCT00965276|Serine/Threonine Kinase|serine/threonine kinase
514548|NCT00965276|Cell Survival|cell survival
514549|NCT00965276|Breast Cancer|breast cancer
514550|NCT00965263|Cocaine|cocaine
514551|NCT00965263|immunotherapy|immunotherapy
514552|NCT00965263|vaccination|vaccination
514553|NCT00965263|antibody|antibody
514554|NCT00965263|addiction|addiction
514555|NCT00965263|dependence|dependence
514556|NCT00965250|Thymic Malignancies|thymic malignancies
514557|NCT00965250|IMC-A12|imc-a12
514558|NCT00965250|Insulin-Like Growth Factor|insulin-like growth factor
514559|NCT00965224|AML (acute myeloid leukemia)|aml (acute myeloid leukemia)
514560|NCT00965224|CML (chronic myeloid leukemia)|cml (chronic myeloid leukemia)
514561|NCT00965224|MM (multiple myeloma)|mm (multiple myeloma)
514562|NCT00965211|Tourette's, OCD, dTMS, YGTSS, YBOCS, supplementary motor cortex|tourette's, ocd, dtms, ygtss, ybocs, supplementary motor cortex
514563|NCT00965211|Tourette's syndrome and Obsessive compulsive disorder|tourette's syndrome and obsessive compulsive disorder
514564|NCT00965198|Catheters, Indwelling|catheters, indwelling
514565|NCT00965198|Biofilms|biofilms
514566|NCT00965185|Cardiovascular Disease|cardiovascular disease
514567|NCT00965185|HIV|hiv
514568|NCT00965185|Atherosclerosis|atherosclerosis
514569|NCT00965185|Inflammation|inflammation
514570|NCT00965185|Statins|statins
514571|NCT00965185|treatment experienced|treatment experienced
514572|NCT00965172|Cancer|cancer
514573|NCT00965172|Mucositis|mucositis
514574|NCT00965172|Chemotherapy|chemotherapy
514575|NCT00965172|Caphosol|caphosol
514576|NCT00965172|Calcium phosphate|calcium phosphate
514577|NCT00965172|Sodium Bicarbonate|sodium bicarbonate
514578|NCT00965172|Baking Soda Solution|baking soda solution
514823|NCT00964327|HIV|hiv
514579|NCT00965172|Multi-cycle chemotherapy|multi-cycle chemotherapy
514580|NCT00965146|Osteoarthritis, traumatic arthritis, avascular necrosis|osteoarthritis, traumatic arthritis, avascular necrosis
514581|NCT00965120|Ischaemia reperfusion|ischaemia reperfusion
514582|NCT00965120|Bradykinin|bradykinin
514583|NCT00965120|Platelet activation|platelet activation
514584|NCT00965120|Endothelial function|endothelial function
514585|NCT00965068|Autism|autism
514586|NCT00965068|Autism Spectrum Disorder|autism spectrum disorder
514587|NCT00965068|Cholesterol|cholesterol
514588|NCT00965068|Smith-Lemli-Opitz Syndrome|smith-lemli-opitz syndrome
514589|NCT00965068|ASD|asd
514590|NCT00965068|Pervasive Developmental Disorder|pervasive developmental disorder
514591|NCT00965068|PPD-NOS|ppd-nos
514592|NCT00965042|Ceftobiprole|ceftobiprole
514593|NCT00965042|ZEVTERA|zevtera
514594|NCT00965042|ZEFTERA|zeftera
514595|NCT00965042|Intestinal Microflora|intestinal microflora
514596|NCT00965029|COPD|copd
514597|NCT00965029|Spirometry|spirometry
514598|NCT00965029|Weaning|weaning
514599|NCT00965016|Extracorporeal membrane oxygenation，induced hypothermia|extracorporeal membrane oxygenation，induced hypothermia
514600|NCT00964990|Moderate to severe chronic peripheral neuropathic pain|moderate to severe chronic peripheral neuropathic pain
514601|NCT00964990|Postherpetic neuralgia|postherpetic neuralgia
514602|NCT00964990|Post-traumatic neuralgia|post-traumatic neuralgia
514603|NCT00964990|Moderate to severe chronic pain|moderate to severe chronic pain
514604|NCT00964990|JNJ-42160443|jnj-42160443
514605|NCT00964977|pN1|pn1
514606|NCT00964977|head and neck cancer|head and neck cancer
514607|NCT00964977|radiation|radiation
514608|NCT00964977|prognosis|prognosis
514609|NCT00964977|comprehensive cohort design|comprehensive cohort design
514610|NCT00964951|H1N1, influenza A viruses, vaccine, elderly|h1n1, influenza a viruses, vaccine, elderly
514611|NCT00964938|Hemodynamic response|hemodynamic response
514612|NCT00964938|Cardiac resynchronization therapy|cardiac resynchronization therapy
514613|NCT00964886|chronic pain|chronic pain
514614|NCT00964886|back pain|back pain
514615|NCT00964886|antidepressants|antidepressants
514616|NCT00964873|Synta|synta
514617|NCT00964873|STA-9090|sta-9090
514618|NCT00964873|ganetespib|ganetespib
514619|NCT00964873|Hematologic Cancers|hematologic cancers
514620|NCT00964873|Acute Myeloid Leukemia|acute myeloid leukemia
514621|NCT00964873|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
514622|NCT00964873|Blast-phase Chronic Myelogenous Leukemia|blast-phase chronic myelogenous leukemia
514623|NCT00964873|AML|aml
514624|NCT00964873|ALL|all
514625|NCT00964873|CML|cml
514626|NCT00964873|HSP90 Inhibitor|hsp90 inhibitor
514627|NCT00964847|hypertension|hypertension
514628|NCT00964847|cardiovascular disease|cardiovascular disease
514629|NCT00964847|yoga|yoga
514630|NCT00964821|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
514631|NCT00964821|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
514632|NCT00964821|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
514633|NCT00964821|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
514634|NCT00964821|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
514635|NCT00964821|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
514636|NCT00964821|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
514637|NCT00964821|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
514638|NCT00964821|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
514639|NCT00964821|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
514640|NCT00964821|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
514641|NCT00964821|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
514642|NCT00964821|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
514643|NCT00964821|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
514644|NCT00964821|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
514645|NCT00964821|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
514646|NCT00964821|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
514647|NCT00964821|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
514648|NCT00964821|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
514649|NCT00964821|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
514650|NCT00964821|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
514651|NCT00964821|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
514652|NCT00964821|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
514653|NCT00964821|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
514654|NCT00964821|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
514655|NCT00964821|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
514656|NCT00964821|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
514657|NCT00964821|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
514658|NCT00964821|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
514659|NCT00964821|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
514824|NCT00964327|darunavir|darunavir
514660|NCT00964821|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
514661|NCT00964821|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
514662|NCT00964821|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
514663|NCT00964821|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
514664|NCT00964821|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
514665|NCT00964821|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
514666|NCT00964821|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
514667|NCT00964821|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
514668|NCT00964821|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
514669|NCT00964821|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
514670|NCT00964821|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
514671|NCT00964821|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
514672|NCT00964821|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
514673|NCT00964821|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
514674|NCT00964821|splenic marginal zone lymphoma|splenic marginal zone lymphoma
514675|NCT00964821|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
514676|NCT00964821|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
514677|NCT00964821|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
514678|NCT00964821|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
514679|NCT00964821|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
514680|NCT00964821|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
514681|NCT00964821|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
514682|NCT00964821|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
514683|NCT00964821|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
514684|NCT00964821|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
514685|NCT00964821|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
514686|NCT00964821|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
514687|NCT00964821|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
514688|NCT00964821|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
514689|NCT00964821|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
514690|NCT00964821|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
514691|NCT00964821|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
514692|NCT00964821|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
514693|NCT00964821|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
514694|NCT00964821|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
514695|NCT00964821|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
514696|NCT00964821|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
514697|NCT00964821|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
514698|NCT00964821|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
514699|NCT00964821|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
514700|NCT00964821|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
514701|NCT00964821|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
514702|NCT00964821|refractory hairy cell leukemia|refractory hairy cell leukemia
514703|NCT00964821|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
514704|NCT00964821|secondary acute myeloid leukemia|secondary acute myeloid leukemia
514705|NCT00964821|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
514706|NCT00964821|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
514707|NCT00964821|chronic eosinophilic leukemia|chronic eosinophilic leukemia
514708|NCT00964821|primary myelofibrosis|primary myelofibrosis
514709|NCT00964821|chronic neutrophilic leukemia|chronic neutrophilic leukemia
514710|NCT00964821|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
514711|NCT00964821|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
514712|NCT00964821|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
514713|NCT00964821|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
514714|NCT00964821|stage I multiple myeloma|stage i multiple myeloma
514715|NCT00964821|stage II multiple myeloma|stage ii multiple myeloma
514716|NCT00964821|stage III multiple myeloma|stage iii multiple myeloma
514717|NCT00964821|refractory multiple myeloma|refractory multiple myeloma
514718|NCT00964821|aplastic anemia|aplastic anemia
514719|NCT00964808|Hip fractures|hip fractures
514720|NCT00964808|Treatment Outcome|treatment outcome
514721|NCT00964808|Painkiller|painkiller
514722|NCT00964795|Eyes|eyes
514723|NCT00964795|Neovascular|neovascular
514724|NCT00964795|Macular Degeneration|macular degeneration
514725|NCT00964795|Retina|retina
514727|NCT00964795|VEGF Trap-Eye|vegf trap-eye
514728|NCT00964795|Best Corrected Visual Acuity|best corrected visual acuity
514729|NCT00964782|Fontan|fontan
514730|NCT00964782|sildenafil|sildenafil
514731|NCT00964782|exercise capacity|exercise capacity
514732|NCT00964782|Patients with Fontan Circulation|patients with fontan circulation
514733|NCT00964769|Pneumococcal Vaccine|pneumococcal vaccine
514734|NCT00964769|Aged|aged
514735|NCT00964756|ovarian cancer|ovarian cancer
514736|NCT00964756|Recurrent ovarian cancer and other gynecologic cancers|recurrent ovarian cancer and other gynecologic cancers
514737|NCT00964743|Neurologic Oncology|neurologic oncology
514738|NCT00964743|Neoplastic Meningitis from solid tumors|neoplastic meningitis from solid tumors
514739|NCT00964743|Brain and Nervous System|brain and nervous system
514740|NCT00964743|Breast Cancer|breast cancer
514741|NCT00964730|Thorough QT Study|thorough qt study
514742|NCT00964730|Talampanel|talampanel
514743|NCT00964730|Cardiac Repolarizatiom|cardiac repolarizatiom
514744|NCT00964730|Healthy Volunteers|healthy volunteers
514745|NCT00964717|back pain|back pain
514746|NCT00964717|neck pain|neck pain
514747|NCT00964717|anxiety|anxiety
514748|NCT00964717|range of motion|range of motion
514749|NCT00964691|malaria|malaria
514750|NCT00964691|IPTp|iptp
514751|NCT00964691|Fansidar|fansidar
514752|NCT00964691|Intermittent Preventive Treatment in pregnancy|intermittent preventive treatment in pregnancy
514753|NCT00964691|pregnancy|pregnancy
514754|NCT00964691|prophylaxis|prophylaxis
514755|NCT00964691|Chloroquine|chloroquine
514756|NCT00964691|Anemia|anemia
514757|NCT00964691|Prevention|prevention
514758|NCT00964691|Placental malaria|placental malaria
514759|NCT00964691|Solomon Islands|solomon islands
514760|NCT00964691|Low birth weight|low birth weight
514761|NCT00964665|Hepatitis B,|hepatitis b,
514762|NCT00964665|Chronic,|chronic,
514763|NCT00964665|Hepatitis B e Antigens positive|hepatitis b e antigens positive
514764|NCT00964652|treadmill|treadmill
514765|NCT00964652|body load|body load
514766|NCT00964652|Parkinson's disease|parkinson's disease
514767|NCT00964652|gait|gait
514768|NCT00964639|Pain|pain
514769|NCT00964639|Postoperative|postoperative
514770|NCT00964639|Local infiltration analgesia|local infiltration analgesia
514771|NCT00964639|Cerebral palsy|cerebral palsy
514772|NCT00964639|r-FLACC|r-flacc
514773|NCT00964626|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
514774|NCT00964626|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
514775|NCT00964626|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
514776|NCT00964626|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
514777|NCT00964626|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
514778|NCT00964626|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
514779|NCT00964626|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
514780|NCT00964626|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
514781|NCT00964626|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
514782|NCT00964626|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
514783|NCT00964613|Pars Plana|pars plana
514784|NCT00964613|Surgical Capsulotomy|surgical capsulotomy
514785|NCT00964613|Posterior capsule opacification|posterior capsule opacification
514786|NCT00964613|visual outcome|visual outcome
514787|NCT00964613|Complications|complications
514788|NCT00964600|transversus abdominis block|transversus abdominis block
514789|NCT00964600|postoperative pain|postoperative pain
514790|NCT00964600|cesarean|cesarean
514791|NCT00964587|diabetes self management education|diabetes self management education
514792|NCT00964587|problem-solving training|problem-solving training
514793|NCT00964587|health behavior change|health behavior change
514794|NCT00964587|health literacy|health literacy
514795|NCT00964548|vasospasm|vasospasm
514796|NCT00964548|subarachnoid hemorrhage|subarachnoid hemorrhage
514797|NCT00964548|neurocritical care|neurocritical care
514798|NCT00964548|dantrolene|dantrolene
514799|NCT00964548|vasorelaxation|vasorelaxation
514800|NCT00964522|Quality of life|quality of life
514801|NCT00964522|Breast Cancer|breast cancer
514802|NCT00964522|Nursing Care|nursing care
514803|NCT00964522|Education|education
514804|NCT00964522|Chemotherapy|chemotherapy
514805|NCT00964496|vascular malformation|vascular malformation
514806|NCT00964496|gastrointestinal bleeding|gastrointestinal bleeding
514807|NCT00964496|thalidomide|thalidomide
514808|NCT00964483|Hypertension|hypertension
514809|NCT00964470|Burn, donor site, skin graft, dressing, AWBAT™-D, XEROFORM™, GLUCAN II™|burn, donor site, skin graft, dressing, awbat™-d, xeroform™, glucan ii™
514810|NCT00964457|cetuximab|cetuximab
514811|NCT00964457|rectum cancer|rectum cancer
514812|NCT00964457|radiation|radiation
514813|NCT00964457|MRI|mri
514814|NCT00964444|Labor and delivery|labor and delivery
514815|NCT00964444|Vaginal delivery|vaginal delivery
514816|NCT00964379|Intra versus extraperitoneal colostomy|intra versus extraperitoneal colostomy
514817|NCT00964353|coumadine|coumadine
514818|NCT00964353|genotype|genotype
514819|NCT00964353|genes|genes
514825|NCT00964314|advanced cancer|advanced cancer
514826|NCT00964314|TCM five elements music therapy|tcm five elements music therapy
514827|NCT00964314|quality of life (QOL)|quality of life (qol)
514828|NCT00964301|Asthma|asthma
514829|NCT00964301|Low-income|low-income
514830|NCT00964301|Quality of life|quality of life
514831|NCT00964301|Children|children
514832|NCT00964288|electrical hyperalgesia|electrical hyperalgesia
514833|NCT00964288|threshold tracking|threshold tracking
514834|NCT00964288|pain|pain
514835|NCT00964275|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
514836|NCT00964275|thromboembolism|thromboembolism
514837|NCT00964262|diabetes|diabetes
514838|NCT00964262|exenatide|exenatide
514839|NCT00964262|SR exenatide|sr exenatide
514840|NCT00964262|Peptron|peptron
514841|NCT00964236|sapropterin|sapropterin
514842|NCT00964236|Kuvan|kuvan
514843|NCT00964236|cognition|cognition
514844|NCT00964236|brain|brain
514845|NCT00964223|Acne vulgaris|acne vulgaris
514846|NCT00964210|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
514847|NCT00964210|Inflammatory Bowel Disease|inflammatory bowel disease
514848|NCT00964210|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
514849|NCT00964210|Chronic Renal Disease|chronic renal disease
514850|NCT00964210|Solid Organ Transplant|solid organ transplant
514851|NCT00964197|FemmeJock|femmejock
514852|NCT00964197|Pelvic Organ Prolapse|pelvic organ prolapse
514853|NCT00964184|Maturity onset diabetes of the young 3 protein, human|maturity onset diabetes of the young 3 protein, human
514854|NCT00964171|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
514855|NCT00964171|recurrent pancreatic cancer|recurrent pancreatic cancer
514856|NCT00964171|stage IV pancreatic cancer|stage iv pancreatic cancer
514857|NCT00964158|influenza infection|influenza infection
514858|NCT00964158|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
514859|NCT00964145|Nulliparous women|nulliparous women
514860|NCT00964145|ultrasound|ultrasound
514861|NCT00964132|Non-Small Cell Lung Cancer|non-small cell lung cancer
514862|NCT00964132|NSCLC|nsclc
514863|NCT00964132|Rexinoid|rexinoid
514864|NCT00964132|NRX194204|nrx194204
514865|NCT00964132|Lung Cancer|lung cancer
514866|NCT00964132|RXR|rxr
514867|NCT00964106|inducer|inducer
514868|NCT00964106|midazolam|midazolam
514869|NCT00964106|inhibitor|inhibitor
514870|NCT00964106|rosiglitazone|rosiglitazone
514871|NCT00964106|dextromethorphan|dextromethorphan
514872|NCT00964106|caffeine|caffeine
514873|NCT00964106|cocktail|cocktail
514874|NCT00964106|pioglitazone|pioglitazone
514875|NCT00964106|omeprazole|omeprazole
514876|NCT00964106|CYP|cyp
514877|NCT00964106|rosuvastatin|rosuvastatin
514878|NCT00964106|probe drug|probe drug
514879|NCT00964106|drug interaction|drug interaction
514880|NCT00964106|flurbiprofen|flurbiprofen
514881|NCT00964093|premature|premature
514882|NCT00964093|infection|infection
514883|NCT00964093|central line|central line
514884|NCT00964093|very low birth weight|very low birth weight
514885|NCT00964093|silver alginate|silver alginate
514886|NCT00964093|Algidex|algidex
514887|NCT00964093|neonatal|neonatal
514888|NCT00964093|NICU|nicu
514889|NCT00964067|rehabilitation outcome|rehabilitation outcome
514890|NCT00964067|cardiac patients|cardiac patients
514891|NCT00964067|exercise intensity|exercise intensity
514892|NCT00964054|adolescents|adolescents
514893|NCT00964054|exercise|exercise
514894|NCT00964054|depression|depression
514895|NCT00964054|dose response|dose response
514896|NCT00964054|pilot study|pilot study
514897|NCT00964041|Cognitive Impairment|cognitive impairment
514898|NCT00964041|Neuroplasticity|neuroplasticity
514899|NCT00964041|D-cycloserine|d-cycloserine
514900|NCT00964041|N-methyl-D-aspartate (NMDA)|n-methyl-d-aspartate (nmda)
514901|NCT00964041|Anti-Bacterial Agents|anti-bacterial agents
514902|NCT00964041|Mental Disorders|mental disorders
514903|NCT00964041|Psychotic Disorders|psychotic disorders
514904|NCT00964041|Antitubercular Agents|antitubercular agents
514905|NCT00964041|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
514906|NCT00964041|Schizoaffective Disorder|schizoaffective disorder
514907|NCT00964028|Combined vaccine|combined vaccine
514908|NCT00964015|colloid fluid|colloid fluid
514909|NCT00964015|crystalloid fluid|crystalloid fluid
514910|NCT00964015|surgery|surgery
514911|NCT00964015|coronary artery bypass grafting|coronary artery bypass grafting
514912|NCT00964015|renal function|renal function
514913|NCT00964015|Patients undergoing coronary artery bypass surgery|patients undergoing coronary artery bypass surgery
514914|NCT00964002|recurrent prostate cancer|recurrent prostate cancer
514915|NCT00964002|stage IV prostate cancer|stage iv prostate cancer
514916|NCT00963989|Acute stroke|acute stroke
514917|NCT00963989|Large cerebral vessel occlusion|large cerebral vessel occlusion
514918|NCT00963989|Core infarct volume|core infarct volume
514919|NCT00963989|Penumbra System|penumbra system
514920|NCT00963989|Revascularization|revascularization
514921|NCT00963989|Intracerebral hemorrhage|intracerebral hemorrhage
514922|NCT00963989|mRS|mrs
514923|NCT00963989|NIHSS|nihss
515844|NCT00960596|children|children
514924|NCT00963989|Procedural serious adverse events|procedural serious adverse events
514925|NCT00963989|All cause mortality|all cause mortality
514926|NCT00963976|Stroke|stroke
514927|NCT00963976|Hypertension|hypertension
514928|NCT00963976|Cerebral Blood Flow|cerebral blood flow
514929|NCT00963976|CT Perfusion|ct perfusion
514930|NCT00963963|sexual health|sexual health
514931|NCT00963963|adolescent health|adolescent health
514932|NCT00963963|parent education|parent education
514933|NCT00963963|HIV Seronegativity|hiv seronegativity
514934|NCT00963963|treatment experienced|treatment experienced
514935|NCT00963950|cholecystectomy|cholecystectomy
514936|NCT00963937|adolescent|adolescent
514937|NCT00963937|sumatriptan|sumatriptan
514938|NCT00963937|children|children
514939|NCT00963937|migraine|migraine
514940|NCT00963924|Cognitive Impairment|cognitive impairment
514941|NCT00963924|Neuroplasticity|neuroplasticity
514942|NCT00963924|D-cycloserine|d-cycloserine
514943|NCT00963924|NMDA|nmda
514944|NCT00963924|Anti-Bacterial Agents|anti-bacterial agents
514945|NCT00963924|Mental Disorders|mental disorders
514946|NCT00963924|Psychotic Disorders|psychotic disorders
514947|NCT00963924|Antitubercular Agents|antitubercular agents
514948|NCT00963924|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
514949|NCT00963924|Schizoaffective Disorder|schizoaffective disorder
514950|NCT00963911|colon cancer|colon cancer
514951|NCT00963911|rectal cancer|rectal cancer
514952|NCT00963911|non-small cell lung cancer|non-small cell lung cancer
514953|NCT00963911|small cell lung cancer|small cell lung cancer
514954|NCT00963911|hypopharyngeal squamous cell carcinoma|hypopharyngeal squamous cell carcinoma
514955|NCT00963911|laryngeal squamous cell carcinoma|laryngeal squamous cell carcinoma
514956|NCT00963911|laryngeal verrucous carcinoma|laryngeal verrucous carcinoma
514957|NCT00963911|lip and oral cavity squamous cell carcinoma|lip and oral cavity squamous cell carcinoma
514958|NCT00963911|oral cavity verrucous carcinoma|oral cavity verrucous carcinoma
514959|NCT00963911|nasopharyngeal squamous cell carcinoma|nasopharyngeal squamous cell carcinoma
514960|NCT00963911|oropharyngeal squamous cell carcinoma|oropharyngeal squamous cell carcinoma
514961|NCT00963911|paranasal sinus and nasal cavity squamous cell carcinoma|paranasal sinus and nasal cavity squamous cell carcinoma
514962|NCT00963911|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
514963|NCT00963911|prostate cancer|prostate cancer
514964|NCT00963911|breast cancer|breast cancer
514965|NCT00963911|adult non-Hodgkin lymphoma|adult non-hodgkin lymphoma
514966|NCT00963898|Intravenous sedation|intravenous sedation
514967|NCT00963898|Target controlled infusion|target controlled infusion
514968|NCT00963898|Bispectral index|bispectral index
514969|NCT00963898|Dental treatment|dental treatment
514970|NCT00963898|Mental Retardation|mental retardation
514971|NCT00963898|Deep sedation|deep sedation
514972|NCT00963859|Robotic-assisted laparoscopic surgery|robotic-assisted laparoscopic surgery
514973|NCT00963859|Extended pelvic lymph node dissection|extended pelvic lymph node dissection
514974|NCT00963859|RA-PLND|ra-plnd
514975|NCT00963859|Second-look open lymph node dissection|second-look open lymph node dissection
514976|NCT00963859|O-PLND|o-plnd
514977|NCT00963859|Radical Cystectomy|radical cystectomy
514978|NCT00963859|Urinary diversion|urinary diversion
514979|NCT00963859|Bladder|bladder
514980|NCT00963846|schizophrenia|schizophrenia
514981|NCT00963846|cognition|cognition
514982|NCT00963846|functioning|functioning
514983|NCT00963833|Multiple Sclerosis|multiple sclerosis
514984|NCT00963833|MS|ms
514985|NCT00963833|Non-interventional|non-interventional
514986|NCT00963820|Relapsed multiple myeloma|relapsed multiple myeloma
514987|NCT00963820|Refractory multiple myeloma|refractory multiple myeloma
514988|NCT00963820|Drug therapy|drug therapy
514989|NCT00963794|Rectal cancer|rectal cancer
514990|NCT00963794|Population screening|population screening
514991|NCT00963794|Early detection|early detection
514992|NCT00963781|Coronary Artery Disease|coronary artery disease
514993|NCT00963781|Drug-Eluting Stents|drug-eluting stents
514994|NCT00963781|Coronary Thrombosis|coronary thrombosis
514995|NCT00963781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
514996|NCT00963781|Coronary Restenosis|coronary restenosis
514997|NCT00963768|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
514998|NCT00963768|JNJ-28431754|jnj-28431754
514999|NCT00963768|Canagliflozin|canagliflozin
515000|NCT00963768|Sodium Glucose Co-transporter (SGLT2 inhibitor)|sodium glucose co-transporter (sglt2 inhibitor)
515001|NCT00963768|Pharmacokinetics|pharmacokinetics
515002|NCT00963768|Pharmacodynamics|pharmacodynamics
515003|NCT00963755|Imaging|imaging
515004|NCT00963755|Positron emission tomography|positron emission tomography
515005|NCT00963755|F-18-FCH|f-18-fch
515006|NCT00963755|Magnetic resonance imaging|magnetic resonance imaging
515007|NCT00963755|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
515008|NCT00963742|cataract surgery|cataract surgery
515009|NCT00963742|IOL|iol
515010|NCT00963742|Intraocular lens|intraocular lens
515011|NCT00963729|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
515012|NCT00963729|recurrent breast cancer|recurrent breast cancer
515013|NCT00963729|stage II breast cancer|stage ii breast cancer
515940|NCT00960167|Toxicity|toxicity
515014|NCT00963729|stage IIIA breast cancer|stage iiia breast cancer
515015|NCT00963729|stage IIIB breast cancer|stage iiib breast cancer
515016|NCT00963729|stage IIIC breast cancer|stage iiic breast cancer
515017|NCT00963716|endobronchial biopsy|endobronchial biopsy
515018|NCT00963716|bronchoscopy|bronchoscopy
515019|NCT00963716|interventional pulmonology|interventional pulmonology
515020|NCT00963677|Shikani optical stylet(SOS)|shikani optical stylet(sos)
515021|NCT00963677|difficult airways|difficult airways
515022|NCT00963677|intubation|intubation
515023|NCT00963664|melanoma|melanoma
515024|NCT00963664|malignant melanoma|malignant melanoma
515025|NCT00963664|interferon|interferon
515026|NCT00963664|interferon alfa-2b|interferon alfa-2b
515027|NCT00963664|Intron-A|intron-a
515028|NCT00963664|Intron A|intron a
515030|NCT00963664|lovastatin|lovastatin
515031|NCT00963664|mevinolin|mevinolin
515032|NCT00963664|Mevacor|mevacor
515033|NCT00963664|statin|statin
515034|NCT00963664|HRI|hri
515035|NCT00963651|Pulmonary nodule, solitary|pulmonary nodule, solitary
515036|NCT00963651|Multiple pulmonary nodules|multiple pulmonary nodules
515037|NCT00963625|Blastocyst transfer|blastocyst transfer
515038|NCT00963625|endometrial receptivity|endometrial receptivity
515039|NCT00963625|IVF|ivf
515040|NCT00963625|in vitro fertilization|in vitro fertilization
515041|NCT00963625|embryo cryopreservation|embryo cryopreservation
515042|NCT00963612|Microvascular Invasion|microvascular invasion
515043|NCT00963612|Blood-Oxygen-Level Dependent Magnetic Resonance Imaging (BOLD MRI)|blood-oxygen-level dependent magnetic resonance imaging (bold mri)
515044|NCT00963560|ReSTOR +3|restor +3
515045|NCT00963547|Documented to be HER2+|documented to be her2+
515046|NCT00963534|Mantle cell lymphoma|mantle cell lymphoma
515047|NCT00963534|Lenalidomide|lenalidomide
515048|NCT00963534|Bendamustine|bendamustine
515049|NCT00963534|Rituximab|rituximab
515050|NCT00963534|Nordic Lymphoma Group|nordic lymphoma group
515051|NCT00963534|MTD for lenalidomide|mtd for lenalidomide
515052|NCT00963534|Untreated patients|untreated patients
515053|NCT00963534|Patients with mantle cell lymphoma, age over 65 years|patients with mantle cell lymphoma, age over 65 years
515054|NCT00963521|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
515055|NCT00963521|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
515056|NCT00963521|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
515057|NCT00963521|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
515058|NCT00963521|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
515059|NCT00963521|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
515060|NCT00963521|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
515061|NCT00963508|Head Lice|head lice
515062|NCT00963495|clioquinol|clioquinol
515063|NCT00963495|relapsed and refractory hematologic malignancy|relapsed and refractory hematologic malignancy
515064|NCT00963495|ALL|all
515065|NCT00963495|HD|hd
515066|NCT00963495|CLL|cll
515067|NCT00963495|High risk myelodysplasia (MDS) with an IPSS score >2.5|high risk myelodysplasia (mds) with an ipss score >2.5
515068|NCT00963495|CML blast crisis|cml blast crisis
515069|NCT00963495|Relapsed or refractory acute myeloid leukemia (AML)|relapsed or refractory acute myeloid leukemia (aml)
515070|NCT00963482|Smoking|smoking
515071|NCT00963482|Alcohol|alcohol
515072|NCT00963482|Outcome|outcome
515073|NCT00963482|Harm reduction|harm reduction
515074|NCT00963482|Alcohol drinking|alcohol drinking
515075|NCT00963482|Treatment outcome|treatment outcome
515076|NCT00963482|Treatment effectiveness|treatment effectiveness
515077|NCT00963443|Aspirin Complex|aspirin complex
515078|NCT00963443|Acetylsalicylic Acid|acetylsalicylic acid
515079|NCT00963443|Pseudoephedrine|pseudoephedrine
515080|NCT00963443|Common Cold|common cold
515081|NCT00963430|H1N1, influenza A viruses, pregnant women|h1n1, influenza a viruses, pregnant women
515082|NCT00963417|osteoporosis|osteoporosis
515083|NCT00963417|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
515084|NCT00963417|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
515085|NCT00963417|stage IA breast cancer|stage ia breast cancer
515086|NCT00963417|stage IB breast cancer|stage ib breast cancer
515087|NCT00963417|stage II breast cancer|stage ii breast cancer
515088|NCT00963417|stage IIIA breast cancer|stage iiia breast cancer
515089|NCT00963404|Image-guided Radiotherapy|image-guided radiotherapy
515090|NCT00963404|Fiducial marker|fiducial marker
515091|NCT00963404|Adverse effects|adverse effects
515092|NCT00963391|Health Production|health production
515093|NCT00963391|Government Policy; Regulation; Public Health|government policy; regulation; public health
515094|NCT00963391|Government Policy; Provision and Effects of Welfare Programs|government policy; provision and effects of welfare programs
515095|NCT00963391|Gastrointestinal diseases|gastrointestinal diseases
515096|NCT00963391|Respiratory Tract Infections|respiratory tract infections
515097|NCT00963391|Diarrhea|diarrhea
515098|NCT00963391|Ethanol|ethanol
515099|NCT00963391|Child, Preschool|child, preschool
515100|NCT00963391|Handwashing|handwashing
515101|NCT00963365|Phase 1|phase 1
515102|NCT00963365|Healthy volunteers|healthy volunteers
515103|NCT00963352|Colon cancer|colon cancer
515104|NCT00963352|Open surgery resection|open surgery resection
515105|NCT00963352|Laparoscopic surgery resection|laparoscopic surgery resection
515106|NCT00963352|Morbidity|morbidity
515107|NCT00963352|Mortality|mortality
515108|NCT00963352|Metastases|metastases
515109|NCT00963352|Oncology|oncology
515110|NCT00963352|Freedom of malignant disease recurrence|freedom of malignant disease recurrence
515111|NCT00963352|Safety of intervention open and laparoscopic|safety of intervention open and laparoscopic
515112|NCT00963352|Examination of adverse markers|examination of adverse markers
515113|NCT00963352|Development of metastases in lungs and other organs|development of metastases in lungs and other organs
515114|NCT00963339|AMD|amd
515115|NCT00963326|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
515116|NCT00963326|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
515117|NCT00963326|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
515118|NCT00963326|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
515119|NCT00963326|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
515120|NCT00963326|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
515121|NCT00963326|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
515122|NCT00963326|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
515123|NCT00963326|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
515124|NCT00963326|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
515125|NCT00963326|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
515126|NCT00963326|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
515127|NCT00963326|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
515128|NCT00963326|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
515129|NCT00963326|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
515130|NCT00963326|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
515131|NCT00963326|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
515132|NCT00963326|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
515133|NCT00963326|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
515134|NCT00963326|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
515135|NCT00963326|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
515136|NCT00963326|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
515137|NCT00963326|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
515138|NCT00963326|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
515139|NCT00963326|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
515140|NCT00963326|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
515141|NCT00963326|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
515142|NCT00963326|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
515143|NCT00963326|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
515144|NCT00963326|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
515145|NCT00963326|tongue cancer|tongue cancer
515146|NCT00963313|Axial psoriatic arthritis|axial psoriatic arthritis
515147|NCT00963313|Adalimumab|adalimumab
515148|NCT00963313|Humira|humira
515149|NCT00963313|anti-TNF|anti-tnf
515150|NCT00963300|adenocarcinoma of the prostate|adenocarcinoma of the prostate
515151|NCT00963300|stage I prostate cancer|stage i prostate cancer
515152|NCT00963300|stage IIB prostate cancer|stage iib prostate cancer
515153|NCT00963300|stage IIA prostate cancer|stage iia prostate cancer
515154|NCT00963300|stage III prostate cancer|stage iii prostate cancer
515155|NCT00963300|stage IV prostate cancer|stage iv prostate cancer
515156|NCT00963287|alternative medicine|alternative medicine
515157|NCT00963287|traditional Chinese medicine|traditional chinese medicine
515158|NCT00963274|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
515159|NCT00963274|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
515160|NCT00963274|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
515161|NCT00963274|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
515162|NCT00963274|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
515163|NCT00963274|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
515164|NCT00963274|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
515165|NCT00963274|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
515166|NCT00963274|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
515167|NCT00963274|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
515168|NCT00963274|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
515169|NCT00963274|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
515170|NCT00963274|anaplastic large cell lymphoma|anaplastic large cell lymphoma
515171|NCT00963274|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
515172|NCT00963274|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
515173|NCT00963274|hepatosplenic T-cell lymphoma|hepatosplenic t-cell lymphoma
515174|NCT00963274|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
515175|NCT00963274|peripheral T-cell lymphoma|peripheral t-cell lymphoma
515176|NCT00963261|melanoma|melanoma
515177|NCT00963261|interferon-a|interferon-a
515178|NCT00963261|quality of life|quality of life
515179|NCT00963261|psychological distress|psychological distress
515180|NCT00963261|depressive symptoms|depressive symptoms
515181|NCT00963261|side effects|side effects
515183|NCT00963248|PTLD|ptld
515184|NCT00963248|RTx|rtx
515185|NCT00963248|pediatric|pediatric
515186|NCT00963235|vaccine|vaccine
515187|NCT00963235|13-valent pneumococcal conjugate vaccine|13-valent pneumococcal conjugate vaccine
515188|NCT00963235|human immunodeficiency virus|human immunodeficiency virus
515189|NCT00963222|Atherosclerosis|atherosclerosis
515190|NCT00963222|Coronary Artery Disease|coronary artery disease
515191|NCT00963222|Vitamin A|vitamin a
515192|NCT00963222|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
515193|NCT00963222|Th1 Cells|th1 cells
515194|NCT00963222|Th2 Cells|th2 cells
515195|NCT00963209|endocrine sensitive|endocrine sensitive
515196|NCT00963209|breast cancer|breast cancer
515197|NCT00963209|tamoxifen|tamoxifen
515198|NCT00963209|genotyping|genotyping
515199|NCT00963209|phenotyping|phenotyping
515200|NCT00963209|Pharmacokinetics|pharmacokinetics
515201|NCT00963209|Endoxifen|endoxifen
515202|NCT00963183|Safety|safety
515203|NCT00963183|Tolerability|tolerability
515204|NCT00963183|Healthy|healthy
515205|NCT00963183|Inhalation|inhalation
515206|NCT00963157|H1N1, influenza A viruses, vaccine, elderly|h1n1, influenza a viruses, vaccine, elderly
515207|NCT00963144|Gerd Questionnaire|gerd questionnaire
515208|NCT00963131|Central serous chorioretinopathy,antioxidants|central serous chorioretinopathy,antioxidants
515209|NCT00963118|Angelica keiskei|angelica keiskei
515210|NCT00963118|Glycine max|glycine max
515211|NCT00963118|metabolic syndrome|metabolic syndrome
515212|NCT00963092|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
515213|NCT00963092|recurrent gastric cancer|recurrent gastric cancer
515214|NCT00963092|stage IV gastric cancer|stage iv gastric cancer
515215|NCT00963092|adenocarcinoma of the stomach|adenocarcinoma of the stomach
515216|NCT00963092|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
515217|NCT00963092|recurrent esophageal cancer|recurrent esophageal cancer
515218|NCT00963092|stage I esophageal cancer|stage i esophageal cancer
515219|NCT00963092|stage II esophageal cancer|stage ii esophageal cancer
515220|NCT00963092|stage III esophageal cancer|stage iii esophageal cancer
515221|NCT00963092|stage IV esophageal cancer|stage iv esophageal cancer
515222|NCT00963092|stage IA gastric cancer|stage ia gastric cancer
515223|NCT00963092|stage IB gastric cancer|stage ib gastric cancer
515224|NCT00963092|stage IIA gastric cancer|stage iia gastric cancer
515225|NCT00963092|stage IIB gastric cancer|stage iib gastric cancer
515226|NCT00963092|stage IIIA gastric cancer|stage iiia gastric cancer
515227|NCT00963092|stage IIIB gastric cancer|stage iiib gastric cancer
515228|NCT00963092|stage IIIC gastric cancer|stage iiic gastric cancer
515229|NCT00963079|IVF|ivf
515230|NCT00963079|in vitro fertilization|in vitro fertilization
515231|NCT00963079|blastocyst transfer|blastocyst transfer
515232|NCT00963079|endometrial receptivity|endometrial receptivity
515233|NCT00963079|embryo cryopreservation|embryo cryopreservation
515234|NCT00963066|NAVA|nava
515235|NCT00963066|Acute Lung Injury|acute lung injury
515236|NCT00963066|Pressure Support Ventilation|pressure support ventilation
515237|NCT00963066|Intubation|intubation
515238|NCT00963066|Tracheostomy|tracheostomy
515239|NCT00963066|Mechanical ventilation|mechanical ventilation
515240|NCT00963053|dysmenorrhoea|dysmenorrhoea
515241|NCT00963053|dysmenorrhea|dysmenorrhea
515242|NCT00963053|pain|pain
515243|NCT00963053|pre-emptive|pre-emptive
515244|NCT00963040|intranasal oxytocin|intranasal oxytocin
515245|NCT00963040|acute headache treatment|acute headache treatment
515246|NCT00963040|chronic daily headache|chronic daily headache
515247|NCT00963027|Hypertension, Pulmonary|hypertension, pulmonary
515248|NCT00963027|Treprostinil|treprostinil
515249|NCT00963027|Pharmacokinetics|pharmacokinetics
515250|NCT00963027|Treprostinil Diethanolamine|treprostinil diethanolamine
515251|NCT00963027|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
515252|NCT00963027|Esomeprazole|esomeprazole
515253|NCT00963001|Hypertension, Pulmonary|hypertension, pulmonary
515254|NCT00963001|Treprostinil|treprostinil
515255|NCT00963001|Pharmacokinetics|pharmacokinetics
515256|NCT00963001|Treprostinil Diethanolamine|treprostinil diethanolamine
515257|NCT00963001|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
515258|NCT00962988|Cerebrovascular disease|cerebrovascular disease
515259|NCT00962988|stroke|stroke
515260|NCT00962988|Transient Ischemic Attack|transient ischemic attack
515261|NCT00962988|smoking cessation|smoking cessation
515262|NCT00962988|Pharmacotherapy|pharmacotherapy
515263|NCT00962962|Abnormal fasting glucose|abnormal fasting glucose
515264|NCT00962949|POTS|pots
515265|NCT00962949|Orthostatic intolerance|orthostatic intolerance
515266|NCT00962936|Chronic Hepatitis C|chronic hepatitis c
515267|NCT00962936|HCV Genotype I infection|hcv genotype i infection
515268|NCT00962936|Liver disease|liver disease
515269|NCT00962923|Systemic sclerosis|systemic sclerosis
515270|NCT00962923|Mesenchymal Stem Cells|mesenchymal stem cells
515271|NCT00962923|Transplantation|transplantation
515272|NCT00962910|Femoral Fractures|femoral fractures
515273|NCT00962910|Critical Pathway|critical pathway
515274|NCT00962910|Cluster Randomized Controlled Trial|cluster randomized controlled trial
515275|NCT00962910|Safety|safety
515276|NCT00962910|Efficiency|efficiency
515277|NCT00962897|atherosclerosis|atherosclerosis
515278|NCT00962897|covered stent|covered stent
515279|NCT00962897|percutaneous intervention|percutaneous intervention
515280|NCT00962897|stent|stent
515281|NCT00962897|angioplasty|angioplasty
515282|NCT00962884|Orthostatic hypotension|orthostatic hypotension
515283|NCT00962884|Breathing|breathing
515284|NCT00962884|Blood pressure|blood pressure
515285|NCT00962884|standing|standing
515286|NCT00962845|stage III melanoma|stage iii melanoma
515287|NCT00962845|stage IV melanoma|stage iv melanoma
515288|NCT00962832|rhuMAb IFNalpha|rhumab ifnalpha
515289|NCT00962832|SLE|sle
515290|NCT00962819|Mumps|mumps
515291|NCT00962819|Immunity|immunity
515292|NCT00962819|Vaccine|vaccine
515293|NCT00962819|Mumps antibodies|mumps antibodies
515294|NCT00962819|Mumps immunity|mumps immunity
515295|NCT00962806|Pediatric obesity|pediatric obesity
515296|NCT00962806|Insulin resistance|insulin resistance
515297|NCT00962806|Diabetes|diabetes
515298|NCT00962806|Mitochondria|mitochondria
515299|NCT00962793|latent tuberculosis prevalence of health care workers|latent tuberculosis prevalence of health care workers
515300|NCT00962780|vaccine|vaccine
515301|NCT00962780|13-valent pneumococcal conjugate vaccine|13-valent pneumococcal conjugate vaccine
515302|NCT00962780|23-valent pneumococcal polysaccharide vaccine|23-valent pneumococcal polysaccharide vaccine
515303|NCT00962780|human immunodeficiency virus|human immunodeficiency virus
515304|NCT00962767|Oncology comparison study|oncology comparison study
515305|NCT00962754|recording fluid balance|recording fluid balance
515306|NCT00962754|reliability|reliability
515307|NCT00962754|utility|utility
515308|NCT00962754|sick neonate|sick neonate
515309|NCT00962754|fluid balance|fluid balance
515310|NCT00962754|inpatient|inpatient
515311|NCT00962754|sick|sick
515312|NCT00962728|heart rate|heart rate
515313|NCT00962728|tachycardia|tachycardia
515314|NCT00962728|orthostatic intolerance|orthostatic intolerance
515315|NCT00962715|Leukemia|leukemia
515316|NCT00962715|CLL|cll
515317|NCT00962715|Influenza Vaccine Trivalent Inactivated|influenza vaccine trivalent inactivated
515318|NCT00962715|TIV|tiv
515319|NCT00962715|Flu|flu
515320|NCT00962715|Pegasys|pegasys
515321|NCT00962715|Pegylated interferon|pegylated interferon
515322|NCT00962715|Roferon|roferon
515323|NCT00962715|Interferon|interferon
515324|NCT00962702|Exclusion|exclusion
515325|NCT00962702|Left Atrial Appendage|left atrial appendage
515326|NCT00962702|Surgical|surgical
515327|NCT00962702|Open chest|open chest
515328|NCT00962689|chronic rhinosinusitis|chronic rhinosinusitis
515329|NCT00962689|biofilm|biofilm
515330|NCT00962689|sinus tissue|sinus tissue
515331|NCT00962689|nasal secretions|nasal secretions
515332|NCT00962689|proteomics|proteomics
515333|NCT00962689|diagnosis|diagnosis
515334|NCT00962689|decreased antibiotics|decreased antibiotics
515335|NCT00962689|Develop a test to identify patients with sinusitis subtypes|develop a test to identify patients with sinusitis subtypes
515336|NCT00962676|suspicious of tuberculosis|suspicious of tuberculosis
515337|NCT00962676|immunocompromised patients|immunocompromised patients
515338|NCT00962650|abdominal adhesions|abdominal adhesions
515339|NCT00962650|diagnostic peritoneoscopy|diagnostic peritoneoscopy
515340|NCT00962650|Natural Orifice Transluminal Endoscopic Surgery|natural orifice transluminal endoscopic surgery
515341|NCT00962650|NOTES|notes
515342|NCT00962637|Secondary Hypogonadism|secondary hypogonadism
515343|NCT00962624|Meningococcal|meningococcal
515344|NCT00962624|Vaccine|vaccine
515345|NCT00962624|Meningitis|meningitis
515346|NCT00962611|Solid tumors|solid tumors
515347|NCT00962611|Advanced cancer|advanced cancer
515348|NCT00962598|Adolescents|adolescents
515349|NCT00962598|Major Depressive Disorder|major depressive disorder
515350|NCT00962598|Proton Magnetic Resonance Spectroscopy|proton magnetic resonance spectroscopy
515351|NCT00962598|Immune System Activation|immune system activation
515352|NCT00962598|Omega-3 Fatty Acids|omega-3 fatty acids
515353|NCT00962572|Outcomes|outcomes
515354|NCT00962572|Cancer|cancer
515355|NCT00962572|Radiotherapy|radiotherapy
515356|NCT00962572|Socio-economic|socio-economic
515357|NCT00962546|cerebral aneurysm|cerebral aneurysm
515358|NCT00962546|subarachnoid hemorrhage|subarachnoid hemorrhage
515359|NCT00962546|cerebral vasospasm|cerebral vasospasm
515360|NCT00962546|computed tomographic perfusion|computed tomographic perfusion
515361|NCT00962546|computed tomographic angiography|computed tomographic angiography
515362|NCT00962533|Chronic Hepatitis B|chronic hepatitis b
515363|NCT00962520|pancreatic cancer|pancreatic cancer
515364|NCT00962520|resectable|resectable
515365|NCT00962520|Tarceva|tarceva
515366|NCT00962507|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
515367|NCT00962507|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
515368|NCT00962507|anaplastic large cell lymphoma|anaplastic large cell lymphoma
515369|NCT00962507|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
515370|NCT00962507|splenic marginal zone lymphoma|splenic marginal zone lymphoma
515371|NCT00962507|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
515372|NCT00962507|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
515373|NCT00962507|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
515374|NCT00962507|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
515375|NCT00962507|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
515376|NCT00962507|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
515377|NCT00962507|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
515378|NCT00962507|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
515379|NCT00962507|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
515380|NCT00962507|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
515381|NCT00962507|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
515382|NCT00962507|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
515383|NCT00962507|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
515384|NCT00962507|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
515385|NCT00962507|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
515386|NCT00962507|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
515387|NCT00962507|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
515388|NCT00962507|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
515389|NCT00962507|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
515390|NCT00962507|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
515391|NCT00962507|refractory multiple myeloma|refractory multiple myeloma
515392|NCT00962468|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
515393|NCT00962468|Critical Pathway|critical pathway
515394|NCT00962468|Cluster Randomized Controlled Trial|cluster randomized controlled trial
515395|NCT00962468|Safety|safety
515396|NCT00962468|Efficiency|efficiency
515397|NCT00962455|Spirometry|spirometry
515398|NCT00962455|Family Practice|family practice
515399|NCT00962455|Randomized Controlled Trial|randomized controlled trial
515400|NCT00962455|Feedback|feedback
515401|NCT00962455|Intervention Studies|intervention studies
515402|NCT00962442|alcoholic hepatitis|alcoholic hepatitis
515403|NCT00962442|N-Acetylcysteine|n-acetylcysteine
515404|NCT00962442|enteral nutrition|enteral nutrition
515405|NCT00962442|oxidative stress|oxidative stress
515406|NCT00962442|severe acute alcoholic hepatitis|severe acute alcoholic hepatitis
515407|NCT00962429|neuropathy, lipoic acid|neuropathy, lipoic acid
515408|NCT00962416|Drug eluting stent|drug eluting stent
515409|NCT00962416|Biolimus|biolimus
515410|NCT00962416|Biodegradable stent|biodegradable stent
515411|NCT00962416|ST-elevation myocardial infarction|st-elevation myocardial infarction
515412|NCT00962416|Coronary artery disease|coronary artery disease
515413|NCT00962403|post traumatic stress disorder|post traumatic stress disorder
515414|NCT00962403|yoga|yoga
515415|NCT00962403|meditation|meditation
515416|NCT00962403|military|military
515417|NCT00962403|veteran|veteran
515418|NCT00962403|trauma|trauma
515419|NCT00962403|stress|stress
515420|NCT00962403|depression|depression
515421|NCT00962403|anxiety|anxiety
515422|NCT00962403|insomnia|insomnia
515423|NCT00962403|autonomic|autonomic
515424|NCT00962377|molecular expression testing|molecular expression testing
515425|NCT00962377|right ventricular endomyocardial biopsy|right ventricular endomyocardial biopsy
515426|NCT00962351|total hip replacement|total hip replacement
515427|NCT00962351|primary cementless total hip arthroplasty|primary cementless total hip arthroplasty
515428|NCT00962351|metal ion|metal ion
515429|NCT00962351|metal-on-metal|metal-on-metal
515430|NCT00962338|convalescence|convalescence
515431|NCT00962338|pain|pain
515432|NCT00962338|nausea|nausea
515433|NCT00962338|vomiting|vomiting
515434|NCT00962338|sexual dysfunction|sexual dysfunction
515435|NCT00962325|Physical activity|physical activity
515436|NCT00962325|Obesity|obesity
515437|NCT00962325|Bariatric surgery|bariatric surgery
515438|NCT00962325|Weight Loss|weight loss
515439|NCT00962312|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
515440|NCT00962312|recurrent pancreatic cancer|recurrent pancreatic cancer
515441|NCT00962312|stage IV pancreatic cancer|stage iv pancreatic cancer
515442|NCT00962299|Child|child
515443|NCT00962299|Wheezing|wheezing
515444|NCT00962299|Dyspnea|dyspnea
515445|NCT00962299|Inhaled corticosteroids|inhaled corticosteroids
515446|NCT00962286|Furosemide|furosemide
515447|NCT00962286|obesity|obesity
515448|NCT00962273|health personnel|health personnel
515449|NCT00962273|communicable diseases|communicable diseases
515450|NCT00962273|stress, psychological|stress, psychological
515451|NCT00962273|resilience, psychological|resilience, psychological
515452|NCT00962273|disaster planning|disaster planning
515453|NCT00962273|education|education
515454|NCT00962273|online|online
515455|NCT00962260|glucocerebrosidase|glucocerebrosidase
515456|NCT00962260|enzyme replacement therapy|enzyme replacement therapy
515457|NCT00962260|Gaucher disease|gaucher disease
515458|NCT00962260|plant cell culture|plant cell culture
515459|NCT00962260|splenomegaly|splenomegaly
515460|NCT00962260|hepatomegaly|hepatomegaly
515461|NCT00962260|anemia|anemia
515462|NCT00962260|thrombocytopenia|thrombocytopenia
515463|NCT00962247|physical activity|physical activity
515464|NCT00962247|relative reinforcing value|relative reinforcing value
515465|NCT00962247|sedentary behavior|sedentary behavior
515466|NCT00962247|obesity|obesity
515467|NCT00962234|Lipogenesis|lipogenesis
515468|NCT00962234|Lipolysis|lipolysis
515469|NCT00962234|Phospholipids|phospholipids
515470|NCT00962234|Body Composition|body composition
515471|NCT00962234|Nutritional Status|nutritional status
515472|NCT00962234|Lipid Metabolism|lipid metabolism
515473|NCT00962221|LDL lipoprotein subclasses in subclinical hypothyroidism|ldl lipoprotein subclasses in subclinical hypothyroidism
515474|NCT00962208|children|children
515475|NCT00962208|corneal reshaping|corneal reshaping
515476|NCT00962208|myopia|myopia
515477|NCT00962208|myopia control|myopia control
515478|NCT00962208|orthokeratology|orthokeratology
515479|NCT00962195|health|health
515480|NCT00962195|blood pressure|blood pressure
515481|NCT00962195|liver enzymes|liver enzymes
515482|NCT00962195|insulin resistance|insulin resistance
515483|NCT00962182|celiac disease|celiac disease
515484|NCT00962182|transglutaminase antibody|transglutaminase antibody
515485|NCT00962169|Guideline adherence|guideline adherence
515486|NCT00962169|Implementation|implementation
515487|NCT00962169|Physical therapy|physical therapy
515488|NCT00962169|Low back pain|low back pain
515489|NCT00962169|Health plan implementation|health plan implementation
515490|NCT00962156|Sepsis|sepsis
515491|NCT00962156|Shock|shock
515492|NCT00962156|Fluid therapy|fluid therapy
515493|NCT00962156|Plasma expanders|plasma expanders
515494|NCT00962143|Acute Achilles Tendon Tear|acute achilles tendon tear
515495|NCT00962143|Acute Achilles Tendon Repair|acute achilles tendon repair
515496|NCT00962130|tissue perfusion|tissue perfusion
515497|NCT00962130|reconstructive surgery|reconstructive surgery
515498|NCT00962130|continuous glucose monitoring|continuous glucose monitoring
515499|NCT00962117|Food Reinforcement|food reinforcement
515500|NCT00962117|Energy Intake|energy intake
515501|NCT00962117|Obesity|obesity
515502|NCT00962117|Dopamine|dopamine
515503|NCT00962104|ADHD|adhd
515504|NCT00962091|Area under the plasma concentration versus time curve (AUC)|area under the plasma concentration versus time curve (auc)
515505|NCT00962091|Maximum plasma concentration (Cmax)|maximum plasma concentration (cmax)
515506|NCT00962091|Area under the plasma concentration versus time curve zero to the time of the last quantifiable concentration (AUC0-tlast)|area under the plasma concentration versus time curve zero to the time of the last quantifiable concentration (auc0-tlast)
515507|NCT00962091|Confidence intervals (CI)|confidence intervals (ci)
515508|NCT00962091|Time of first observed maximum plasma concentration (Tmax)|time of first observed maximum plasma concentration (tmax)
515509|NCT00962078|COPD|copd
515510|NCT00962078|Pre-Lung-Transplantation|pre-lung-transplantation
515511|NCT00962078|Intervall versus continuous training|intervall versus continuous training
515512|NCT00962078|6 MWD|6 mwd
515513|NCT00962039|Abdominal Pain|abdominal pain
515514|NCT00962039|Anxiety|anxiety
515515|NCT00962026|Interleukin 1|interleukin 1
515516|NCT00962026|Type 1 diabetes mellitus|type 1 diabetes mellitus
515517|NCT00962026|Rilonacept|rilonacept
515518|NCT00962026|Arcalyst|arcalyst
515519|NCT00962000|Hemodialysis|hemodialysis
515520|NCT00962000|Dialysis, Renal|dialysis, renal
515521|NCT00961987|Maternity care|maternity care
515522|NCT00961987|Interprofessional collaboration|interprofessional collaboration
515523|NCT00961987|Continuity of Care|continuity of care
515524|NCT00961987|Integration|integration
515525|NCT00961974|type 1 diabetes|type 1 diabetes
515526|NCT00961974|hemoglobin A1c|hemoglobin a1c
515527|NCT00961974|family|family
515528|NCT00961974|involvement|involvement
515529|NCT00961974|responsibility|responsibility
515530|NCT00961974|conflict|conflict
515531|NCT00961974|quality of life|quality of life
515532|NCT00961974|children|children
515533|NCT00961961|Bipolar Disorder|bipolar disorder
515534|NCT00961961|Manic Depression|manic depression
515535|NCT00961961|Major Depressive Episode|major depressive episode
515536|NCT00961961|Mania|mania
515537|NCT00961961|Hypomania|hypomania
515538|NCT00961961|Long Term Treatment|long term treatment
515539|NCT00961948|Indigo carmine dye spraying|indigo carmine dye spraying
515540|NCT00961948|Narrow band imaging (NBI)|narrow band imaging (nbi)
515541|NCT00961948|Confocal Microscopy|confocal microscopy
515542|NCT00961935|bipolar disorder|bipolar disorder
516044|NCT00959751|migraine|migraine
515543|NCT00961935|child bipolar disorder|child bipolar disorder
515544|NCT00961935|adolescent bipolar disorder|adolescent bipolar disorder
515545|NCT00961935|pediatric bipolar disorder|pediatric bipolar disorder
515546|NCT00961935|fMRI|fmri
515547|NCT00961935|MRI|mri
515548|NCT00961935|EEG|eeg
515549|NCT00961935|neurocognitive tasks|neurocognitive tasks
515550|NCT00961922|childhood brain tumour survivors|childhood brain tumour survivors
515551|NCT00961896|Basal Cell Carcinoma|basal cell carcinoma
515552|NCT00961896|Gorlin Syndrome,|gorlin syndrome,
515553|NCT00961896|Gorlin-Goltz Syndrome,|gorlin-goltz syndrome,
515554|NCT00961896|Basal Cell Nevus Syndrome,|basal cell nevus syndrome,
515555|NCT00961896|Nevoid Basal Cell Carcinoma Syndrome,|nevoid basal cell carcinoma syndrome,
515556|NCT00961896|Basal Cell Carcinoma Nevus Syndrome|basal cell carcinoma nevus syndrome
515557|NCT00961883|HIV|hiv
515558|NCT00961883|Vaccine|vaccine
515559|NCT00961883|HIV Seronegativity|hiv seronegativity
515560|NCT00961883|Preventive Vaccine|preventive vaccine
515561|NCT00961870|bone|bone
515562|NCT00961870|motor neuron excitability|motor neuron excitability
515563|NCT00961870|forearm vibration|forearm vibration
515564|NCT00961870|Mechanical Loading|mechanical loading
515565|NCT00961831|Neoplasm|neoplasm
515566|NCT00961831|PET/CT diagnosis|pet/ct diagnosis
515567|NCT00961831|PET tracer|pet tracer
515568|NCT00961818|Voice|voice
515569|NCT00961818|Voice Quality|voice quality
515570|NCT00961818|Voice Training|voice training
515571|NCT00961818|Evaluation|evaluation
515572|NCT00961805|Fibromyalgia|fibromyalgia
515573|NCT00961805|Treatment|treatment
515574|NCT00961805|Dance|dance
515575|NCT00961805|Randomized controlled study|randomized controlled study
515576|NCT00961805|Exercise|exercise
515577|NCT00961753|PDA|pda
515578|NCT00961753|Ibuprofen|ibuprofen
515579|NCT00961753|Preterm|preterm
515580|NCT00961753|Neonate|neonate
515581|NCT00961740|Childhood Obesity|childhood obesity
515582|NCT00961740|CBT|cbt
515583|NCT00961740|Family|family
515584|NCT00961740|Lifestyle change|lifestyle change
515585|NCT00961727|Bedside Pews|bedside pews
515586|NCT00961727|Credit Valley Hospital|credit valley hospital
515587|NCT00961727|The Bedside Paediatric Early Warning System|the bedside paediatric early warning system
515588|NCT00961727|clinically deteriorating|clinically deteriorating
515589|NCT00961714|VCF|vcf
515590|NCT00961688|PCOS|pcos
515591|NCT00961688|polycystic ovary syndrome|polycystic ovary syndrome
515592|NCT00961688|Polycystic ovarian syndrome|polycystic ovarian syndrome
515593|NCT00961688|infertility|infertility
515594|NCT00961688|ovulation|ovulation
515595|NCT00961675|otitis|otitis
515596|NCT00961675|acute|acute
515597|NCT00961675|externa|externa
515598|NCT00961675|ear|ear
515599|NCT00961649|Open-Angle Glaucoma|open-angle glaucoma
515600|NCT00961649|Ocular Hypertension|ocular hypertension
515601|NCT00961649|Brinzolamide|brinzolamide
515602|NCT00961649|Brimonidine|brimonidine
515603|NCT00961649|Intraocular Pressure|intraocular pressure
515604|NCT00961610|internet support|internet support
515605|NCT00961610|cancer|cancer
515606|NCT00961610|rehabilitation|rehabilitation
515607|NCT00961597|Meniscus|meniscus
515608|NCT00961597|Avascular region|avascular region
515609|NCT00961597|Platelet rich plasma|platelet rich plasma
515610|NCT00961571|colorectal cancer|colorectal cancer
515611|NCT00961571|sunitinib|sunitinib
515612|NCT00961571|capecitabine|capecitabine
515613|NCT00961558|varicocelectomy|varicocelectomy
515614|NCT00961558|male infertility|male infertility
515615|NCT00961558|clinical varicoceles|clinical varicoceles
515616|NCT00961558|randomized control trial|randomized control trial
515617|NCT00961532|intracerebral hemorrhage|intracerebral hemorrhage
515618|NCT00961532|platelets|platelets
515619|NCT00961506|cholecystectomy|cholecystectomy
515620|NCT00961506|gallbladder|gallbladder
515621|NCT00961506|laparoscopy|laparoscopy
515622|NCT00961506|laparoendoscopic|laparoendoscopic
515623|NCT00961467|Relapsed/ refractory Multiple Myeloma|relapsed/ refractory multiple myeloma
515624|NCT00961454|Major depressive disorder, anxiety disorders, treatments, photobiomodulation, near infra-red phototherapy, cerebral blood flow|major depressive disorder, anxiety disorders, treatments, photobiomodulation, near infra-red phototherapy, cerebral blood flow
515625|NCT00961441|Levetiracetam|levetiracetam
515626|NCT00961441|Epilepsy|epilepsy
515627|NCT00961441|Children|children
515628|NCT00961441|Adults|adults
515629|NCT00961428|Anorexia Nervosa|anorexia nervosa
515630|NCT00961428|Eating Disorders|eating disorders
515631|NCT00961428|Exercise|exercise
515632|NCT00961428|Physical Activity|physical activity
515633|NCT00961402|Exercise|exercise
515634|NCT00961402|PostParum Depression|postparum depression
515635|NCT00961389|delirium|delirium
515636|NCT00961389|critical care|critical care
515637|NCT00961389|risk factors|risk factors
515638|NCT00961389|prediction|prediction
515639|NCT00961389|inflammation|inflammation
515640|NCT00961376|melanoma|melanoma
515641|NCT00961376|unresectable stage III or IV melanoma|unresectable stage iii or iv melanoma
515742|NCT00960999|adenocarcinoma of the lung|adenocarcinoma of the lung
516142|NCT00959335|treatment|treatment
515642|NCT00961350|PA32540 is proposed for the secondary prevention of cardio- and cerebrovascular events in patients at risk for developing aspirin-associated gastric ulcers.|pa32540 is proposed for the secondary prevention of cardio- and cerebrovascular events in patients at risk for developing aspirin-associated gastric ulcers.
515643|NCT00961337|school children|school children
515644|NCT00961337|influenza vaccination|influenza vaccination
515645|NCT00961337|vaccine effectiveness|vaccine effectiveness
515646|NCT00961337|influenza attack rate|influenza attack rate
515647|NCT00961337|absenteeism|absenteeism
515648|NCT00961337|Influenza vaccine|influenza vaccine
515649|NCT00961311|Balloon|balloon
515650|NCT00961311|Angioplasty|angioplasty
515651|NCT00961311|Coronary Artery|coronary artery
515652|NCT00961311|PCI|pci
515653|NCT00961311|PTCA|ptca
515654|NCT00961311|Heart Disease|heart disease
515655|NCT00961311|Myocardial Ischemia|myocardial ischemia
515656|NCT00961298|IBS|ibs
515657|NCT00961298|Irritable Bowel Syndrome|irritable bowel syndrome
515658|NCT00961298|GAD|gad
515659|NCT00961298|Generalized Anxiety Disorder|generalized anxiety disorder
515660|NCT00961285|pharmacogenomics|pharmacogenomics
515661|NCT00961285|genotyping|genotyping
515662|NCT00961272|Pre-menopausal|pre-menopausal
515663|NCT00961272|Pharmacokinetics|pharmacokinetics
515664|NCT00961272|Raltegravir|raltegravir
515665|NCT00961272|Women|women
515666|NCT00961272|HIV-infected|hiv-infected
515667|NCT00961259|healthy|healthy
515668|NCT00961259|pharmacokinetics|pharmacokinetics
515669|NCT00961259|therapeutic equivalency|therapeutic equivalency
515670|NCT00961259|fenofibric acid|fenofibric acid
515671|NCT00961246|web based intervention|web based intervention
515672|NCT00961246|individually-tailored|individually-tailored
515673|NCT00961246|Chinese-American children|chinese-american children
515674|NCT00961246|compared the changes in physical activity level|compared the changes in physical activity level
515675|NCT00961246|changes in dietary intake|changes in dietary intake
515676|NCT00961246|changes in coping strategy used|changes in coping strategy used
515677|NCT00961246|changes in BMI|changes in bmi
515678|NCT00961233|eosinophilic esophagitis|eosinophilic esophagitis
515679|NCT00961194|Ketamine|ketamine
515680|NCT00961194|pain|pain
515681|NCT00961194|neuropathic pain|neuropathic pain
515682|NCT00961194|chronic|chronic
515683|NCT00961181|paclitaxel|paclitaxel
515684|NCT00961181|in-stent restenosis|in-stent restenosis
515685|NCT00961181|BMS-ISR|bms-isr
515686|NCT00961181|DES-ISR|des-isr
515687|NCT00961181|drug eluting balloon|drug eluting balloon
515688|NCT00961168|Mechanical Ventilation|mechanical ventilation
515689|NCT00961155|asthma|asthma
515690|NCT00961155|children|children
515691|NCT00961155|EBC|ebc
515692|NCT00961155|exposure to tabacco|exposure to tabacco
515693|NCT00961155|antiasthma treatment|antiasthma treatment
515694|NCT00961142|Haploidentical Transplantation|haploidentical transplantation
515695|NCT00961142|CD3/CD19 Depletion|cd3/cd19 depletion
515696|NCT00961142|AML|aml
515697|NCT00961142|ALL|all
515698|NCT00961142|Reduced Intensity Conditioning|reduced intensity conditioning
515699|NCT00961129|colorectal cancer|colorectal cancer
515700|NCT00961129|needs|needs
515701|NCT00961129|survivors|survivors
515702|NCT00961129|any stage|any stage
515703|NCT00961116|healthy|healthy
515704|NCT00961116|pharmacokinetics|pharmacokinetics
515705|NCT00961116|therapeutic equivalency|therapeutic equivalency
515706|NCT00961116|fasting|fasting
515707|NCT00961116|procetofen|procetofen
515708|NCT00961116|fenofibric acid|fenofibric acid
515709|NCT00961103|spinal muscular atrophy|spinal muscular atrophy
515710|NCT00961103|motor development|motor development
515711|NCT00961103|orthoses|orthoses
515712|NCT00961090|Brain tumor|brain tumor
515713|NCT00961090|glioma|glioma
515714|NCT00961090|surgical resection|surgical resection
515715|NCT00961090|ALA|ala
515716|NCT00961090|ultraviolet light|ultraviolet light
515717|NCT00961077|elderly|elderly
515718|NCT00961077|S-1|s-1
515719|NCT00961077|Oxaliplatin|oxaliplatin
515720|NCT00961077|relapsed or metastatic gastric cancer|relapsed or metastatic gastric cancer
515721|NCT00961064|Promacta|promacta
515722|NCT00961064|Thrombocytopenia|thrombocytopenia
515723|NCT00961064|Myelodysplastic Syndrome|myelodysplastic syndrome
515724|NCT00961064|MDS|mds
515725|NCT00961051|adapted contact lens wearers|adapted contact lens wearers
515726|NCT00961038|Ciprofloxacin|ciprofloxacin
515727|NCT00961038|Inhalation|inhalation
515728|NCT00961038|Pharmacokinetics|pharmacokinetics
515729|NCT00961038|Safety|safety
515730|NCT00961038|Tolerability|tolerability
515731|NCT00961038|COPD|copd
515732|NCT00961012|Randomized control trial|randomized control trial
515733|NCT00961012|pressure mapping|pressure mapping
515734|NCT00961012|High Fowler's position|high fowler's position
515735|NCT00961012|bed|bed
515736|NCT00961012|ventilation|ventilation
515737|NCT00961012|slow vital capacity|slow vital capacity
515738|NCT00961012|older adult population|older adult population
515739|NCT00961012|65 years and older|65 years and older
515740|NCT00960999|stage I non-small cell lung cancer|stage i non-small cell lung cancer
515741|NCT00960999|squamous cell lung cancer|squamous cell lung cancer
515743|NCT00960999|large cell lung cancer|large cell lung cancer
515744|NCT00960973|vitamin K|vitamin k
515745|NCT00960973|beta cell|beta cell
515746|NCT00960973|glucose metabolism|glucose metabolism
515747|NCT00960973|insulin resistance|insulin resistance
515748|NCT00960960|MBC|mbc
515749|NCT00960960|PI3K|pi3k
515750|NCT00960960|Avastin|avastin
515751|NCT00960960|Herceptin|herceptin
515752|NCT00960934|Osteoporosis|osteoporosis
515753|NCT00960934|Postmenopausal|postmenopausal
515754|NCT00960934|MK-5442|mk-5442
515755|NCT00960921|Pulmonary artery pressure|pulmonary artery pressure
515756|NCT00960921|Hypoxia|hypoxia
515757|NCT00960921|Iron|iron
515758|NCT00960921|Hypoxia-inducible factor|hypoxia-inducible factor
515759|NCT00960921|High altitude|high altitude
515760|NCT00960908|Zotarolimus|zotarolimus
515761|NCT00960908|Drug eluting stent|drug eluting stent
515762|NCT00960908|Endeavor Resolute|endeavor resolute
515763|NCT00960895|Lymphangioleiomyomatosis|lymphangioleiomyomatosis
515764|NCT00960895|Pulmonary hypertension|pulmonary hypertension
515765|NCT00960882|Pharmacokinetics|pharmacokinetics
515766|NCT00960882|Diabetes|diabetes
515767|NCT00960882|gastric tolerability|gastric tolerability
515768|NCT00960869|PA32540 is proposed for the secondary prevention of cardio- and cerebrovascular events in patients at risk for developing aspirin-associated gastric ulcers.|pa32540 is proposed for the secondary prevention of cardio- and cerebrovascular events in patients at risk for developing aspirin-associated gastric ulcers.
515769|NCT00960856|pharmacokinetics|pharmacokinetics
515770|NCT00960843|Morbid Obesity|morbid obesity
515771|NCT00960843|Gastric Banding|gastric banding
515772|NCT00960843|Bariatric Banding|bariatric banding
515773|NCT00960843|Swedish Adjustable Gastric Band|swedish adjustable gastric band
515774|NCT00960817|Normal coronary artery with slow blood flow|normal coronary artery with slow blood flow
515775|NCT00960804|OA|oa
515776|NCT00960791|Type II diabetes mellitus|type ii diabetes mellitus
515777|NCT00960791|absorption|absorption
515778|NCT00960791|distribution|distribution
515779|NCT00960791|metabolism|metabolism
515780|NCT00960791|excretion|excretion
515781|NCT00960791|14C-labelled|14c-labelled
515782|NCT00960778|gender|gender
515783|NCT00960778|nicotine dependence|nicotine dependence
515784|NCT00960778|nicotine replacement therapy|nicotine replacement therapy
515785|NCT00960778|extinction|extinction
515786|NCT00960778|denicotinized cigarettes|denicotinized cigarettes
515787|NCT00960765|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
515788|NCT00960765|Gastric Bypass|gastric bypass
515789|NCT00960765|Gastric Banding|gastric banding
515790|NCT00960765|Endotoxin|endotoxin
515791|NCT00960752|gp100 peptide|gp100 peptide
515792|NCT00960752|MAGE-3 peptide|mage-3 peptide
515793|NCT00960752|R848|r848
515794|NCT00960752|Resiquimod|resiquimod
515795|NCT00960752|Toll Like Receptor|toll like receptor
515796|NCT00960752|TLR|tlr
515797|NCT00960752|T-cells|t-cells
515798|NCT00960752|Tumor|tumor
515799|NCT00960752|Metastatic|metastatic
515800|NCT00960752|Lesions|lesions
515801|NCT00960752|Injection Site|injection site
515802|NCT00960739|disseminated neuroblastoma|disseminated neuroblastoma
515803|NCT00960739|localized unresectable neuroblastoma|localized unresectable neuroblastoma
515804|NCT00960739|recurrent neuroblastoma|recurrent neuroblastoma
515805|NCT00960739|stage 4S neuroblastoma|stage 4s neuroblastoma
515806|NCT00960726|Leukemia|leukemia
515807|NCT00960726|NOV-002|nov-002
515808|NCT00960726|Myelodysplastic Syndrome|myelodysplastic syndrome
515809|NCT00960726|MDS|mds
515810|NCT00960713|observational cohort|observational cohort
515811|NCT00960713|rituximab|rituximab
515812|NCT00960713|off-label use|off-label use
515813|NCT00960713|auto-immunity|auto-immunity
515814|NCT00960713|cytopenia|cytopenia
515815|NCT00960700|MFlex|mflex
515816|NCT00960700|Multifocal|multifocal
515817|NCT00960700|630F|630f
515818|NCT00960687|healthy|healthy
515819|NCT00960687|pharmacokinetics|pharmacokinetics
515820|NCT00960687|therapeutic equivalency|therapeutic equivalency
515821|NCT00960661|diabetes|diabetes
515822|NCT00960661|exenatide|exenatide
515823|NCT00960661|Byetta|byetta
515824|NCT00960661|insulin lispro|insulin lispro
515825|NCT00960661|Humalog|humalog
515826|NCT00960661|insulin glargine|insulin glargine
515827|NCT00960661|Lantus|lantus
515828|NCT00960661|Amylin|amylin
515829|NCT00960661|Lilly|lilly
515830|NCT00960648|Everolimus|everolimus
515831|NCT00960648|Sirolimus|sirolimus
515832|NCT00960648|Drug eluting stent|drug eluting stent
515833|NCT00960635|new-onset|new-onset
515834|NCT00960622|treatment experienced|treatment experienced
515835|NCT00960609|Communicating veins|communicating veins
515836|NCT00960609|hepatic venous anastomosis|hepatic venous anastomosis
515837|NCT00960609|intra-operative ultrasonography|intra-operative ultrasonography
515838|NCT00960609|hepatic resection|hepatic resection
515839|NCT00960609|hepatic neoplasm|hepatic neoplasm
515840|NCT00960609|Primary and metastatic liver tumors|primary and metastatic liver tumors
515841|NCT00960596|educational intervention|educational intervention
515842|NCT00960596|asthma|asthma
515843|NCT00960596|Environmental Tobacco Smoke(ETS)|environmental tobacco smoke(ets)
515845|NCT00960583|Chronic low back pain|chronic low back pain
515846|NCT00960583|Multidisciplinary rehabilitation|multidisciplinary rehabilitation
515847|NCT00960583|Exercise|exercise
515848|NCT00960583|Cost-effectiveness|cost-effectiveness
515849|NCT00960570|healthy|healthy
515850|NCT00960570|adult|adult
515851|NCT00960570|efavirenz|efavirenz
515852|NCT00960570|fenofibric acid|fenofibric acid
515853|NCT00960570|blood levels|blood levels
515854|NCT00960557|hepatic tumor burden|hepatic tumor burden
515855|NCT00960557|liver cancer|liver cancer
515856|NCT00960557|liver carcinoma|liver carcinoma
515857|NCT00960557|carcinoma|carcinoma
515858|NCT00960557|hepatic cancer|hepatic cancer
515859|NCT00960557|hepatic carcinoma|hepatic carcinoma
515860|NCT00960557|VDA|vda
515861|NCT00960557|Vascular Disrupting Agent|vascular disrupting agent
515862|NCT00960544|Capecitabine|capecitabine
515863|NCT00960544|Xeloda|xeloda
515864|NCT00960544|Gene expression|gene expression
515865|NCT00960544|Pharmacokinetic testing|pharmacokinetic testing
515866|NCT00960544|PK sampling|pk sampling
515867|NCT00960544|DNA analysis|dna analysis
515868|NCT00960518|HBV-related unresectable HCC|hbv-related unresectable hcc
515869|NCT00960518|TACE|tace
515870|NCT00960518|adefovir|adefovir
515871|NCT00960518|recurrence rate|recurrence rate
515872|NCT00960505|Diet|diet
515873|NCT00960505|Coronary heart disease|coronary heart disease
515874|NCT00960505|Obesity|obesity
515875|NCT00960505|Weight loss|weight loss
515876|NCT00960505|Weight maintenance|weight maintenance
515877|NCT00960492|Astrocytic tumor|astrocytic tumor
515878|NCT00960492|Glioblastoma with oligodendroglial components|glioblastoma with oligodendroglial components
515879|NCT00960466|Stress, Psychological|stress, psychological
515880|NCT00960466|Neoplasms/psychology|neoplasms/psychology
515881|NCT00960466|Psychology|psychology
515882|NCT00960440|randomized double-blind placebo-controlled investigational drug oral therapy safety and efficacy|randomized double-blind placebo-controlled investigational drug oral therapy safety and efficacy
515883|NCT00960427|adenocarcinoma of the rectum|adenocarcinoma of the rectum
515884|NCT00960427|stage II rectal cancer|stage ii rectal cancer
515885|NCT00960427|stage III rectal cancer|stage iii rectal cancer
515886|NCT00960414|obesity|obesity
515887|NCT00960414|randomized controlled trial|randomized controlled trial
515888|NCT00960414|weight loss|weight loss
515889|NCT00960414|metabolic syndrome|metabolic syndrome
515890|NCT00960401|coronary calcium scoring|coronary calcium scoring
515891|NCT00960401|breast cancer patients|breast cancer patients
515892|NCT00960401|radiation treatment|radiation treatment
515893|NCT00960375|smoking cessation|smoking cessation
515894|NCT00960375|serious mental illness|serious mental illness
515895|NCT00960349|Gastric cancer|gastric cancer
515896|NCT00960349|Japanese|japanese
515897|NCT00960349|PhI|phi
515898|NCT00960349|Safety and tolerability|safety and tolerability
515899|NCT00960349|Cediranib in combination with cisplatin plus a fluoropyrimidine|cediranib in combination with cisplatin plus a fluoropyrimidine
515900|NCT00960349|Cediranib|cediranib
515901|NCT00960349|Capecitabine|capecitabine
515902|NCT00960349|S-1|s-1
515903|NCT00960349|Cisplatin|cisplatin
515904|NCT00960349|Untreated locally advanced or metastatic unresectable gastric cancer (GC)|untreated locally advanced or metastatic unresectable gastric cancer (gc)
515905|NCT00960336|HER2-negative breast cancer|her2-negative breast cancer
515906|NCT00960336|recurrent breast cancer|recurrent breast cancer
515907|NCT00960336|stage IV breast cancer|stage iv breast cancer
515908|NCT00960336|invasive ductal breast carcinoma|invasive ductal breast carcinoma
515909|NCT00960336|invasive lobular breast carcinoma|invasive lobular breast carcinoma
515910|NCT00960323|pharmacokinetics|pharmacokinetics
515911|NCT00960310|Treatment|treatment
515912|NCT00960297|Non-Small Cell Lung Cancer|non-small cell lung cancer
515913|NCT00960297|NSCLC|nsclc
515914|NCT00960297|Preoperative chemotherapy|preoperative chemotherapy
515915|NCT00960297|Bevacizumab|bevacizumab
515916|NCT00960297|Avastin|avastin
515917|NCT00960284|stage IB pancreatic cancer|stage ib pancreatic cancer
515918|NCT00960284|stage II pancreatic cancer|stage ii pancreatic cancer
515919|NCT00960284|stage III pancreatic cancer|stage iii pancreatic cancer
515920|NCT00960284|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
515921|NCT00960271|Non-small cell lung cancer|non-small cell lung cancer
515922|NCT00960271|mediastinal lymph node|mediastinal lymph node
515923|NCT00960271|resectable|resectable
515924|NCT00960271|EBUS|ebus
515925|NCT00960271|stage IIIA|stage iiia
515926|NCT00960271|significant mediastinal lymph node at thoracic CT Scan|significant mediastinal lymph node at thoracic ct scan
515927|NCT00960258|Solid Tumors|solid tumors
515928|NCT00960232|vitamin D|vitamin d
515929|NCT00960232|blood pressure|blood pressure
515930|NCT00960232|lipids|lipids
515931|NCT00960232|infection|infection
515932|NCT00960232|depression|depression
515933|NCT00960193|blood levels over time|blood levels over time
515934|NCT00960193|colchicine|colchicine
515935|NCT00960193|seville orange juice|seville orange juice
515936|NCT00960193|pharmacokinetics|pharmacokinetics
515937|NCT00960167|HCC|hcc
515938|NCT00960167|radiotherapy|radiotherapy
515939|NCT00960167|dose escalation|dose escalation
515941|NCT00960167|Local control|local control
515942|NCT00960154|Lumpectomy|lumpectomy
515943|NCT00960154|PlasmaBlade|plasmablade
515944|NCT00960154|Electrosurgery|electrosurgery
515945|NCT00960154|PEAK Surgical|peak surgical
515946|NCT00960154|Medtronic Advanced Energy|medtronic advanced energy
515947|NCT00960154|Medtronic|medtronic
515948|NCT00960115|NSCLC|nsclc
515949|NCT00960115|Stage III|stage iii
515950|NCT00960115|EMD531444|emd531444
515951|NCT00960115|L-BLP25|l-blp25
515952|NCT00960115|Cyclophosphamide|cyclophosphamide
515953|NCT00960115|Immunotherapy|immunotherapy
515954|NCT00960115|Tecemotide|tecemotide
515955|NCT00960102|cochlear implantation|cochlear implantation
515956|NCT00960089|Toenail|toenail
515957|NCT00960089|Fungus|fungus
515958|NCT00960089|Onychomycosis|onychomycosis
515959|NCT00960089|Dermatophyte|dermatophyte
515960|NCT00960076|T2DM|t2dm
515961|NCT00960076|Metformin|metformin
515962|NCT00960076|A1c|a1c
515963|NCT00960037|Vitamin D3|vitamin d3
515964|NCT00960037|obesity|obesity
515965|NCT00960037|cholecalciferol|cholecalciferol
515966|NCT00960024|Vocational rehabilitation|vocational rehabilitation
515967|NCT00960024|Severe mental illness|severe mental illness
515968|NCT00960024|Psychosis|psychosis
515969|NCT00960024|Mental Health|mental health
515970|NCT00960011|Inguinal hernia|inguinal hernia
515971|NCT00960011|mesh|mesh
515972|NCT00960011|progrip|progrip
515973|NCT00959998|Persistent Cancer-Related Fatigue|persistent cancer-related fatigue
515974|NCT00959985|compression sleeve|compression sleeve
515975|NCT00959985|compression bandage|compression bandage
515976|NCT00959972|Varenicline|varenicline
515977|NCT00959972|transdermal nicotine patch|transdermal nicotine patch
515978|NCT00959972|cardiovascular disease|cardiovascular disease
515979|NCT00959972|prevention|prevention
515980|NCT00959972|coronary heart disease|coronary heart disease
515981|NCT00959972|Smoking cessation|smoking cessation
515982|NCT00959959|CRPC|crpc
515983|NCT00959959|HRPC|hrpc
515984|NCT00959959|TOK-001|tok-001
515985|NCT00959959|ARMOR|armor
515986|NCT00959959|ARMOR1|armor1
515987|NCT00959946|Phase 1/2|phase 1/2
515988|NCT00959946|2-part study|2-part study
515989|NCT00959946|bosutinib and capecitabine|bosutinib and capecitabine
515990|NCT00959920|Indwelling bladder catheter|indwelling bladder catheter
515991|NCT00959920|Intermittent straight catheterization|intermittent straight catheterization
515992|NCT00959920|Labor and Delivery|labor and delivery
515993|NCT00959920|Time to delivery during labor|time to delivery during labor
515994|NCT00959907|Muscular activity|muscular activity
515995|NCT00959907|wrinkles in frontal area|wrinkles in frontal area
515996|NCT00959907|action halos|action halos
515997|NCT00959894|HIV|hiv
515998|NCT00959894|Infection|infection
515999|NCT00959894|Treatment Naive|treatment naive
516000|NCT00959894|Adults|adults
516001|NCT00959894|Once|once
516002|NCT00959894|Daily|daily
516003|NCT00959894|Etravirine|etravirine
516004|NCT00959894|HIV-1 Infection|hiv-1 infection
516005|NCT00959881|Alzheimer Disease|alzheimer disease
516006|NCT00959868|Bladder cancer|bladder cancer
516007|NCT00959868|Superficial bladder cancer (Ta or T1)|superficial bladder cancer (ta or t1)
516008|NCT00959868|Muscle invasive bladder cancer (T2)|muscle invasive bladder cancer (t2)
516009|NCT00959868|Transurethral resection|transurethral resection
516010|NCT00959868|Radical cystectomy|radical cystectomy
516011|NCT00959868|OGX-427|ogx-427
516012|NCT00959868|Antisense oligonucleotide|antisense oligonucleotide
516013|NCT00959868|Heat shock protein 27|heat shock protein 27
516014|NCT00959868|superficial bladder tumour (Ta or T1) or CIS prior to a transurethral resection|superficial bladder tumour (ta or t1) or cis prior to a transurethral resection
516015|NCT00959868|Muscle invasive (T2) bladder cancer prior to radical cystectomy|muscle invasive (t2) bladder cancer prior to radical cystectomy
516016|NCT00959855|COPD|copd
516017|NCT00959855|Pulmonary Rehabilitation|pulmonary rehabilitation
516018|NCT00959855|Inflammation|inflammation
516019|NCT00959855|Oxidative Stress|oxidative stress
516020|NCT00959855|Steps|steps
516021|NCT00959855|Free Living Activities|free living activities
516022|NCT00959855|Exacerbation|exacerbation
516023|NCT00959842|hypertriglyceridemia|hypertriglyceridemia
516024|NCT00959842|Omega-3 Fatty Acids|omega-3 fatty acids
516025|NCT00959842|Lipoprotein|lipoprotein
516026|NCT00959842|Statin|statin
516027|NCT00959842|Lovaza|lovaza
516028|NCT00959829|Communication|communication
516029|NCT00959829|Complementary Therapies|complementary therapies
516030|NCT00959829|Intensive Care|intensive care
516031|NCT00959829|Ethics|ethics
516032|NCT00959816|Volunteers|volunteers
516033|NCT00959803|Phase 1|phase 1
516034|NCT00959803|Pharmacokinetics|pharmacokinetics
516035|NCT00959803|Healthy Young Adult|healthy young adult
516036|NCT00959803|Japanese|japanese
516037|NCT00959803|Healthy Elderly|healthy elderly
516038|NCT00959803|Alzheimer disease|alzheimer disease
516039|NCT00959790|Health|health
516040|NCT00959790|Obesity|obesity
516041|NCT00959790|Oxidative stress|oxidative stress
516042|NCT00959790|Challenge concept|challenge concept
516043|NCT00959790|Vegetables|vegetables
516045|NCT00959738|loop ileostomy|loop ileostomy
516046|NCT00959738|quality of life|quality of life
516047|NCT00959738|morbidity|morbidity
516048|NCT00959738|Rectal Neoplasms|rectal neoplasms
516049|NCT00959725|Infliximab|infliximab
516050|NCT00959725|Diabetes|diabetes
516051|NCT00959725|Macular Edema|macular edema
516052|NCT00959699|coinfection|coinfection
516053|NCT00959699|protease inhibitor|protease inhibitor
516054|NCT00959699|HIV|hiv
516055|NCT00959686|Bendamustine refractory or relapsed T-cell lymphoma.|bendamustine refractory or relapsed t-cell lymphoma.
516056|NCT00959660|Diastolic heart failure|diastolic heart failure
516057|NCT00959660|Heart Failure|heart failure
516058|NCT00959660|Elderly|elderly
516059|NCT00959660|Obesity|obesity
516060|NCT00959647|Hedgehog pathway inhibitor|hedgehog pathway inhibitor
516061|NCT00959621|Habitual abortion|habitual abortion
516062|NCT00959621|recurrent abortion|recurrent abortion
516063|NCT00959621|hereditary and acquired|hereditary and acquired
516064|NCT00959621|thrombophilia|thrombophilia
516065|NCT00959621|preeclampsia|preeclampsia
516066|NCT00959621|premature birth|premature birth
516067|NCT00959621|miscarriage|miscarriage
516068|NCT00959621|stillbirth|stillbirth
516069|NCT00959621|LMWH (low molecular weigh heparin)|lmwh (low molecular weigh heparin)
516070|NCT00959621|ASA|asa
516071|NCT00959621|aspirin|aspirin
516072|NCT00959608|Weight Management in adults|weight management in adults
516073|NCT00959608|Reducing Health Disparities|reducing health disparities
516074|NCT00959595|Diabetes mellitus|diabetes mellitus
516075|NCT00959595|neuropathy|neuropathy
516076|NCT00959595|foot|foot
516077|NCT00959595|sensibility|sensibility
516078|NCT00959595|brain plasticity|brain plasticity
516079|NCT00959582|Relapsed ovarian cancer|relapsed ovarian cancer
516080|NCT00959569|esmolol|esmolol
516081|NCT00959569|cardiac surgery|cardiac surgery
516082|NCT00959569|cardiac anesthesia|cardiac anesthesia
516083|NCT00959569|mortality|mortality
516084|NCT00959569|beta blockers|beta blockers
516085|NCT00959569|beta-blockers|beta-blockers
516086|NCT00959569|cardiac protection|cardiac protection
516087|NCT00959556|recurrent breast cancer|recurrent breast cancer
516088|NCT00959556|stage IA breast cancer|stage ia breast cancer
516089|NCT00959556|stage IB breast cancer|stage ib breast cancer
516090|NCT00959556|stage II breast cancer|stage ii breast cancer
516091|NCT00959556|stage IIIA breast cancer|stage iiia breast cancer
516092|NCT00959556|stage IIIB breast cancer|stage iiib breast cancer
516093|NCT00959556|stage IIIC breast cancer|stage iiic breast cancer
516094|NCT00959556|stage IV breast cancer|stage iv breast cancer
516095|NCT00959530|complete dentures|complete dentures
516096|NCT00959530|patient satisfaction|patient satisfaction
516097|NCT00959530|treatment cost|treatment cost
516098|NCT00959517|Placebo controlled|placebo controlled
516099|NCT00959517|Efficacy|efficacy
516100|NCT00959517|Artemisinin-based combination therapy|artemisinin-based combination therapy
516101|NCT00959517|Primaquine|primaquine
516102|NCT00959517|Gametocytes|gametocytes
516103|NCT00959491|Colonoscopy|colonoscopy
516104|NCT00959491|Occult Blood|occult blood
516105|NCT00959491|Fecal|fecal
516106|NCT00959478|Carbon Monoxide (CO)|carbon monoxide (co)
516107|NCT00959478|Carbon Monoxide Poisoning|carbon monoxide poisoning
516108|NCT00959478|Carbon Monoxide Alarm/Detector|carbon monoxide alarm/detector
516109|NCT00959478|Precaution Adoption Process Model (PAPM)|precaution adoption process model (papm)
516110|NCT00959478|Injury Prevention|injury prevention
516111|NCT00959478|Emergency Department|emergency department
516112|NCT00959452|Hypochondria|hypochondria
516113|NCT00959452|Cognitive behavioural therapy|cognitive behavioural therapy
516114|NCT00959452|Long term follow-up|long term follow-up
516115|NCT00959452|Psychosomatics|psychosomatics
516116|NCT00959452|Psychotherapy|psychotherapy
516117|NCT00959426|- Mutliple Ascending Dose Study in Overweight Subjects - Body Weight - Signs and Symptoms|- mutliple ascending dose study in overweight subjects - body weight - signs and symptoms
516118|NCT00959400|Fentanyl Transdermal|fentanyl transdermal
516119|NCT00959400|Pain|pain
516120|NCT00959400|Cancer|cancer
516121|NCT00959387|head and neck cancer|head and neck cancer
516122|NCT00959387|induction chemotherapy|induction chemotherapy
516123|NCT00959374|Abdominoplasty|abdominoplasty
516124|NCT00959374|Reduction Mammaplasty|reduction mammaplasty
516125|NCT00959374|Mastopexy|mastopexy
516126|NCT00959361|patient compliance|patient compliance
516127|NCT00959361|guidelines adherence|guidelines adherence
516128|NCT00959361|advance directive adherence|advance directive adherence
516129|NCT00959361|treatment refusal|treatment refusal
516130|NCT00959361|directly observed therapy|directly observed therapy
516131|NCT00959361|anti-retroviral agents|anti-retroviral agents
516132|NCT00959361|HIV seropositivity|hiv seropositivity
516133|NCT00959361|HIV infections|hiv infections
516134|NCT00959361|HIV|hiv
516135|NCT00959361|pharmaceutical services|pharmaceutical services
516136|NCT00959361|HIV-positives patients|hiv-positives patients
516137|NCT00959361|treatment experienced|treatment experienced
516138|NCT00959348|Asthma|asthma
516139|NCT00959348|Diabetes|diabetes
516140|NCT00959348|Impaired glucose tolerance|impaired glucose tolerance
516141|NCT00959348|Insulin resistance|insulin resistance
516143|NCT00959322|Capsulotomy|capsulotomy
516144|NCT00959309|pediatrics|pediatrics
516145|NCT00959309|media|media
516146|NCT00959309|MUPS|mups
516147|NCT00959296|Registry|registry
516148|NCT00959296|Pain|pain
516149|NCT00959296|Chronic Pain|chronic pain
516150|NCT00959296|Back Pain|back pain
516151|NCT00959296|Intractable Spasticity|intractable spasticity
516152|NCT00959296|Parkinson's Disease|parkinson's disease
516153|NCT00959296|Essential Tremor|essential tremor
516154|NCT00959296|Dystonia|dystonia
516155|NCT00959296|Implantable Pumps|implantable pumps
516156|NCT00959296|Incontinence|incontinence
516157|NCT00959283|acute myeloid leukemia/transient myeloproliferative disorder|acute myeloid leukemia/transient myeloproliferative disorder
516158|NCT00959257|Asthma|asthma
516159|NCT00959257|Inhaled corticosteroids|inhaled corticosteroids
516160|NCT00959257|Cardiovascular morbidities|cardiovascular morbidities
516161|NCT00959257|Systemic inflammation|systemic inflammation
516162|NCT00959244|ductal breast carcinoma in situ|ductal breast carcinoma in situ
516163|NCT00959244|stage I breast cancer|stage i breast cancer
516164|NCT00959244|stage II breast cancer|stage ii breast cancer
516165|NCT00959244|stage IIIA breast cancer|stage iiia breast cancer
516166|NCT00959244|stage IIIB breast cancer|stage iiib breast cancer
516167|NCT00959244|stage IIIC breast cancer|stage iiic breast cancer
516168|NCT00959244|stage IV breast cancer|stage iv breast cancer
516169|NCT00959231|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
516170|NCT00959218|Dronabinol|dronabinol
516171|NCT00959218|(-)trans-delta9-tetrahydrocannabinol|(-)trans-delta9-tetrahydrocannabinol
516172|NCT00959218|central neuropathic pain|central neuropathic pain
516173|NCT00959218|multiple sclerosis|multiple sclerosis
516174|NCT00959218|analgesic|analgesic
516175|NCT00959218|Central neuropathic pain related to multiple sclerosis|central neuropathic pain related to multiple sclerosis
516176|NCT00959179|CHF|chf
516177|NCT00959166|Acute hepatitis C|acute hepatitis c
516178|NCT00959166|HIV|hiv
516179|NCT00959166|Neurocognitive function|neurocognitive function
516180|NCT00959166|Neuroinflammation|neuroinflammation
516181|NCT00959153|Fragmenting of kidney stones|fragmenting of kidney stones
516182|NCT00959153|extracorporeal shockwave lithotripsy|extracorporeal shockwave lithotripsy
516183|NCT00959140|Allo PBSC|allo pbsc
516184|NCT00959140|HSCT|hsct
516185|NCT00959140|Bone Marrow Transplant|bone marrow transplant
516186|NCT00959140|Allogeneic Bone Marrow Transplant|allogeneic bone marrow transplant
516187|NCT00959140|Matched Related Donor Transplant|matched related donor transplant
516188|NCT00959140|MRD HSCT|mrd hsct
516189|NCT00959127|Colorectal Adenocarcinoma|colorectal adenocarcinoma
516190|NCT00959127|Colon Cancer|colon cancer
516191|NCT00959127|Rectal Cancer|rectal cancer
516192|NCT00959114|Celiac Disease|celiac disease
516193|NCT00959114|Coeliac Disease|coeliac disease
516194|NCT00959114|Celiac Sprue|celiac sprue
516195|NCT00959114|Keliakia|keliakia
516196|NCT00959075|Thiamin supplementation|thiamin supplementation
516197|NCT00959075|Thiamin deficiency|thiamin deficiency
516198|NCT00959075|Heart failure|heart failure
516199|NCT00959075|Improve heart function|improve heart function
516200|NCT00959075|Vitamin B1 supplementation|vitamin b1 supplementation
516201|NCT00959062|Pilot Study|pilot study
516202|NCT00959062|Randomized Controlled Trial|randomized controlled trial
516203|NCT00959062|Critically Ill|critically ill
516204|NCT00959062|Child|child
516205|NCT00959062|Pediatric|pediatric
516206|NCT00959062|Clonidine|clonidine
516207|NCT00959062|Sedation|sedation
516208|NCT00959023|stage I prostate cancer|stage i prostate cancer
516209|NCT00959023|stage IIB prostate cancer|stage iib prostate cancer
516210|NCT00959023|stage IIA prostate cancer|stage iia prostate cancer
516211|NCT00959023|stage III prostate cancer|stage iii prostate cancer
516212|NCT00959023|stage IV prostate cancer|stage iv prostate cancer
516213|NCT00959023|recurrent prostate cancer|recurrent prostate cancer
516214|NCT00959010|Omega 3|omega 3
516215|NCT00959010|Cystic Fibrosis|cystic fibrosis
516216|NCT00959010|Inflammatory markers|inflammatory markers
516217|NCT00958997|diabetes|diabetes
516218|NCT00958997|islet|islet
516219|NCT00958997|pancreas|pancreas
516220|NCT00958997|beta cell mass|beta cell mass
516221|NCT00958997|PET imaging|pet imaging
516222|NCT00958997|FPDTBZ|fpdtbz
516223|NCT00958997|arginine stimulus test|arginine stimulus test
516224|NCT00958984|pediatric|pediatric
516225|NCT00958984|solid organ transplant|solid organ transplant
516226|NCT00958984|hemoglobin|hemoglobin
516227|NCT00958971|Breast cancer|breast cancer
516228|NCT00958971|HER2 negative|her2 negative
516229|NCT00958971|FGFR1|fgfr1
516230|NCT00958958|Acute Coronary Syndrome|acute coronary syndrome
516231|NCT00958958|randomized cluster trial|randomized cluster trial
516232|NCT00958958|quality improvement|quality improvement
516233|NCT00958945|Postoperative Hematocrit|postoperative hematocrit
516234|NCT00958945|Postoperative Hemoglobin|postoperative hemoglobin
516235|NCT00958919|breathlessness intensity|breathlessness intensity
516236|NCT00958919|breathlessness unpleasantness|breathlessness unpleasantness
516237|NCT00958919|endorphins|endorphins
516238|NCT00958919|resistive breathing loads|resistive breathing loads
516239|NCT00958906|Infliximab|infliximab
516240|NCT00958906|Uveitis|uveitis
516241|NCT00958906|Macular Edema|macular edema
516242|NCT00958906|Intraocular Inflammation|intraocular inflammation
516243|NCT00958893|Uterine fibroids|uterine fibroids
516244|NCT00958867|Resistance exercise training|resistance exercise training
516245|NCT00958867|aerobic exercise training|aerobic exercise training
516246|NCT00958854|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
516247|NCT00958841|Rare tumors of neuroendocrine origin|rare tumors of neuroendocrine origin
516248|NCT00958841|NETs of the pancreatic|nets of the pancreatic
516249|NCT00958841|Pituitary NETs|pituitary nets
516250|NCT00958841|EAS Tumors|eas tumors
516251|NCT00958841|Nelson's Syndrome|nelson's syndrome
516252|NCT00958841|Pancreatic neoplasm|pancreatic neoplasm
516253|NCT00958841|pituitary neoplasm|pituitary neoplasm
516254|NCT00958841|Nelson Syndrome|nelson syndrome
516255|NCT00958841|ectopic ACTH syndrome|ectopic acth syndrome
516256|NCT00958841|pasireotide LAR|pasireotide lar
516257|NCT00958841|PNETs|pnets
516258|NCT00958841|PiNETS|pinets
516259|NCT00958815|vascular imaging|vascular imaging
516260|NCT00958815|diabetes|diabetes
516261|NCT00958815|rupture prone plaques|rupture prone plaques
516262|NCT00958815|HIV|hiv
516263|NCT00958815|treatment experienced|treatment experienced
516264|NCT00958802|tissue engineering|tissue engineering
516265|NCT00958776|Influenza|influenza
516266|NCT00958776|Hospitalized|hospitalized
516267|NCT00958776|Antiviral|antiviral
516268|NCT00958776|Flu|flu
516269|NCT00958763|HCV|hcv
516270|NCT00958763|Alcohol|alcohol
516271|NCT00958763|Methadone Maintained|methadone maintained
516272|NCT00958750|Androgenetic alopecia|androgenetic alopecia
516273|NCT00958750|female pattern hair loss|female pattern hair loss
516274|NCT00958737|stage III colon cancer|stage iii colon cancer
516275|NCT00958737|adenocarcinoma of the colon|adenocarcinoma of the colon
516276|NCT00958724|HKI-272|hki-272
516277|NCT00958724|Vinorelbine|vinorelbine
516278|NCT00958724|Combination|combination
516279|NCT00958724|Solid Tumor|solid tumor
516280|NCT00958724|Neratinib|neratinib
516281|NCT00958724|Nerlynx|nerlynx
516282|NCT00958724|PB-272|pb-272
516283|NCT00958685|ginger extract|ginger extract
516284|NCT00958685|ARDS|ards
516285|NCT00958685|enteral feeding|enteral feeding
516286|NCT00958685|mechanical ventilation|mechanical ventilation
516287|NCT00958685|ICU|icu
516288|NCT00958646|OMT|omt
516289|NCT00958646|biomarker|biomarker
516290|NCT00958646|Manipulation, osteopathic|manipulation, osteopathic
516291|NCT00958633|Bipolar I disorder|bipolar i disorder
516292|NCT00958633|Depression|depression
516293|NCT00958633|Antidepressant|antidepressant
516294|NCT00958620|Chronic Achilles Tendinopathy|chronic achilles tendinopathy
516295|NCT00958607|Caregivers|caregivers
516296|NCT00958607|Stroke|stroke
516297|NCT00958607|Social support|social support
516298|NCT00958607|Phase specific care|phase specific care
516299|NCT00958581|antifibrinolytics|antifibrinolytics
516300|NCT00958542|cerebral palsy|cerebral palsy
516301|NCT00958542|scoliosis|scoliosis
516302|NCT00958542|children|children
516303|NCT00958529|fiber|fiber
516304|NCT00958529|inulin|inulin
516305|NCT00958529|gastrointestinal tolerance|gastrointestinal tolerance
516306|NCT00958516|volunteers|volunteers
516307|NCT00958503|safety|safety
516308|NCT00958503|biomarker|biomarker
516309|NCT00958503|thiamphenicol|thiamphenicol
516310|NCT00958503|EAAT2|eaat2
516311|NCT00958477|Safety|safety
516312|NCT00958477|tolerability|tolerability
516313|NCT00958477|pharmacokinetics|pharmacokinetics
516314|NCT00958477|pharmacodynamics of EMD 525797|pharmacodynamics of emd 525797
516315|NCT00958477|prostate cancer patients|prostate cancer patients
516316|NCT00958464|MRI|mri
516317|NCT00958464|Perthes'disease|perthes'disease
516318|NCT00958464|hip|hip
516319|NCT00958464|cartilage|cartilage
516320|NCT00958451|Calcium|calcium
516321|NCT00958451|Vitamin D deficiency|vitamin d deficiency
516322|NCT00958451|Chronic Kidney disease|chronic kidney disease
516323|NCT00958438|Intercritical Gout|intercritical gout
516324|NCT00958438|Metabolism, Inborn Errors|metabolism, inborn errors
516325|NCT00958438|Allopurinol|allopurinol
516326|NCT00958438|Metabolic Diseases|metabolic diseases
516327|NCT00958438|Genetic Diseases, Inborn|genetic diseases, inborn
516328|NCT00958438|Musculoskeletal Diseases|musculoskeletal diseases
516329|NCT00958438|Joint Diseases|joint diseases
516330|NCT00958438|Arthritis|arthritis
516331|NCT00958438|Rheumatic Diseases|rheumatic diseases
516332|NCT00958438|Metabolic disorder|metabolic disorder
516333|NCT00958438|Purine-Pyrimidine Metabolism, Inborn Errors|purine-pyrimidine metabolism, inborn errors
516334|NCT00958438|Gout|gout
516335|NCT00958412|Endometriosis|endometriosis
516336|NCT00958412|Pelvic pain|pelvic pain
516337|NCT00958412|Oral progesterone blocker|oral progesterone blocker
516338|NCT00958399|satiety|satiety
516339|NCT00958399|fiber|fiber
516340|NCT00958399|food intake|food intake
516341|NCT00958399|gut hormones|gut hormones
516342|NCT00958399|visual analog scales|visual analog scales
516343|NCT00958399|microflora|microflora
516344|NCT00958386|colorectal cancer|colorectal cancer
516345|NCT00958386|Panitumumab|panitumumab
516346|NCT00958386|irinotecan|irinotecan
516347|NCT00958373|Scoliosis|scoliosis
516348|NCT00958373|adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
516349|NCT00958373|spine curve|spine curve
516350|NCT00958373|pediatric|pediatric
516351|NCT00958373|mental health|mental health
516352|NCT00958373|screening|screening
516353|NCT00958360|vision, low|vision, low
516354|NCT00958334|Uterine fibroids|uterine fibroids
516355|NCT00958321|adenocarcinoma of the lung|adenocarcinoma of the lung
516356|NCT00958321|large cell lung cancer|large cell lung cancer
516357|NCT00958321|squamous cell lung cancer|squamous cell lung cancer
516358|NCT00958321|malignant pleural effusion|malignant pleural effusion
516359|NCT00958321|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
516360|NCT00958321|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
516361|NCT00958321|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
516362|NCT00958321|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
516363|NCT00958321|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
516364|NCT00958321|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
516365|NCT00958308|Probiotic|probiotic
516366|NCT00958308|Antibiotic-Associated Diarrhea (AAD) Prevention|antibiotic-associated diarrhea (aad) prevention
516367|NCT00958308|Clostridium Difficile-Associated Diarrhea (CDAD)Prevention|clostridium difficile-associated diarrhea (cdad)prevention
516368|NCT00958295|urinary tract infection|urinary tract infection
516369|NCT00958295|cystitis|cystitis
516370|NCT00958282|cocaine|cocaine
516371|NCT00958282|treatment|treatment
516372|NCT00958282|lisdexamfetamine|lisdexamfetamine
516373|NCT00958282|dependence|dependence
516374|NCT00958282|addiction|addiction
516375|NCT00958282|crack|crack
516376|NCT00958269|diabetes|diabetes
516377|NCT00958269|DPP4 inhibitor|dpp4 inhibitor
516378|NCT00958269|dutogliptin|dutogliptin
516379|NCT00958269|PHX1149|phx1149
516380|NCT00958256|Mantle Cell Lymphoma|mantle cell lymphoma
516381|NCT00958256|Lymphoma|lymphoma
516382|NCT00958256|Bortezomib|bortezomib
516383|NCT00958256|Velcade|velcade
516384|NCT00958256|Rituximab|rituximab
516385|NCT00958256|Rituxan|rituxan
516386|NCT00958256|Cyclophosphamide|cyclophosphamide
516387|NCT00958256|Cytoxan|cytoxan
516388|NCT00958256|Neosar|neosar
516389|NCT00958256|Mesna|mesna
516390|NCT00958256|Mesnex|mesnex
516391|NCT00958256|G-CSF|g-csf
516392|NCT00958256|Filgrastim|filgrastim
516393|NCT00958256|Neupogen|neupogen
516394|NCT00958230|endarterectomy|endarterectomy
516395|NCT00958230|dCell|dcell
516396|NCT00958230|Tissue Regenix Ltd|tissue regenix ltd
516397|NCT00958230|TRL|trl
516398|NCT00958230|Vascular Patch|vascular patch
516399|NCT00958230|Treatment|treatment
516400|NCT00958217|Depressive symptoms|depressive symptoms
516401|NCT00958217|Substance-related disorders|substance-related disorders
516402|NCT00958217|Posttraumatic stress disorders|posttraumatic stress disorders
516403|NCT00958217|Psychotherapy|psychotherapy
516404|NCT00958204|Depression|depression
516405|NCT00958204|rating scales|rating scales
516406|NCT00958204|RCT|rct
516407|NCT00958204|combination treatment|combination treatment
516408|NCT00958204|light therapy|light therapy
516409|NCT00958204|negative ion therapy|negative ion therapy
516410|NCT00958204|fluoxetine|fluoxetine
516411|NCT00958204|antidepressants|antidepressants
516412|NCT00958165|Treatment of PAF using EAS-AC|treatment of paf using eas-ac
516413|NCT00958152|VX-950|vx-950
516414|NCT00958152|VX-222|vx-222
516415|NCT00958152|STAT-C|stat-c
516416|NCT00958139|Lyme disease|lyme disease
516417|NCT00958139|tick|tick
516418|NCT00958100|raltegravir switch toxicity|raltegravir switch toxicity
516419|NCT00958100|treatment experienced|treatment experienced
516420|NCT00958061|CVD|cvd
516421|NCT00958048|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
516422|NCT00958048|hypoventilation|hypoventilation
516423|NCT00957996|influenza|influenza
516424|NCT00957996|hospitalized|hospitalized
516425|NCT00957996|flu|flu
516426|NCT00957996|antiviral|antiviral
516427|NCT00957970|Stress shielding|stress shielding
516428|NCT00957970|Bone mineral density|bone mineral density
516429|NCT00957970|stemless femoral component|stemless femoral component
516430|NCT00957944|Rotigotine|rotigotine
516431|NCT00957944|Neupro®|neupro®
516432|NCT00957918|levodopa-induced dyskinesia|levodopa-induced dyskinesia
516433|NCT00957918|Parkinson's disease|parkinson's disease
516434|NCT00957918|parkinsonian|parkinsonian
516435|NCT00957918|levodopa-induced dyskinesias in Parkinson's disease|levodopa-induced dyskinesias in parkinson's disease
516436|NCT00957892|Healthy Infants|healthy infants
516437|NCT00957892|Satiation|satiation
516438|NCT00957892|Satiety|satiety
516439|NCT00957892|Intake Regulation|intake regulation
516440|NCT00957892|Infant Feeding|infant feeding
516441|NCT00957892|Infant Formula Feeding|infant formula feeding
516442|NCT00957879|Vitamin D|vitamin d
516443|NCT00957879|FGF23|fgf23
516444|NCT00957879|FGF-23|fgf-23
516445|NCT00957879|Phosphate|phosphate
516446|NCT00957866|The number of cases in the database thus far (4,477) is clearly sufficient to achieve meaningful results|the number of cases in the database thus far (4,477) is clearly sufficient to achieve meaningful results
516447|NCT00957853|Head and Neck Cancer|head and neck cancer
516448|NCT00957853|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
516449|NCT00957853|HNSCC|hnscc
516450|NCT00957853|Cetuximab|cetuximab
516451|NCT00957853|IMC-A12|imc-a12
516452|NCT00957853|Tumor|tumor
516453|NCT00957853|Biomarkers|biomarkers
516454|NCT00957853|Phospho-AKT|phospho-akt
516455|NCT00957853|Surgical resection|surgical resection
516456|NCT00957840|Omaya reservoirs|omaya reservoirs
516457|NCT00957840|cerebral oxygenation|cerebral oxygenation
516458|NCT00957840|VP shunt|vp shunt
516459|NCT00957840|IVH|ivh
516460|NCT00957840|post hemorrhagic ventricular dilation (PVHD)|post hemorrhagic ventricular dilation (pvhd)
516461|NCT00957814|nutritional education|nutritional education
516462|NCT00957814|diet adherence|diet adherence
516463|NCT00957814|nutritional knowledge|nutritional knowledge
516464|NCT00957814|life quality|life quality
516465|NCT00957814|nutritional status|nutritional status
516466|NCT00957814|impact of nutritional orientations by a systematic education program applied to outpatients with HF, in comparison to patients in a conventional treatment.|impact of nutritional orientations by a systematic education program applied to outpatients with hf, in comparison to patients in a conventional treatment.
516467|NCT00957801|Sarcopenia|sarcopenia
516468|NCT00957801|Aging muscle|aging muscle
516469|NCT00957801|Androgen|androgen
516470|NCT00957801|Cytokines|cytokines
516471|NCT00957801|Muscle metabolism|muscle metabolism
516472|NCT00957788|tinnitus|tinnitus
516473|NCT00957788|acouphenes|acouphenes
516474|NCT00957788|ear|ear
516475|NCT00957788|ringing|ringing
516476|NCT00957788|buzzing|buzzing
516477|NCT00957788|roaring|roaring
516478|NCT00957788|hissing|hissing
516479|NCT00957788|clicking|clicking
516480|NCT00957775|Substance Abuse Treatment|substance abuse treatment
516481|NCT00957775|Adolescents|adolescents
516482|NCT00957775|Substance-Related Disorders|substance-related disorders
516483|NCT00957775|Alcohol-Related Disorders|alcohol-related disorders
516484|NCT00957775|Marijuana Abuse|marijuana abuse
516485|NCT00957762|Body Composition|body composition
516486|NCT00957762|Glucose Tolerance|glucose tolerance
516487|NCT00957762|Insulin Sensitivity|insulin sensitivity
516488|NCT00957762|Metabolic Syndrome|metabolic syndrome
516489|NCT00957736|graft versus host disease|graft versus host disease
516490|NCT00957736|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
516491|NCT00957736|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
516492|NCT00957736|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
516493|NCT00957736|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
516494|NCT00957736|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
516495|NCT00957736|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
516496|NCT00957736|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
516497|NCT00957736|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
516498|NCT00957736|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
516499|NCT00957736|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
516500|NCT00957736|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
516501|NCT00957736|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
516502|NCT00957736|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
516503|NCT00957736|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
516504|NCT00957736|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
516505|NCT00957736|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
516506|NCT00957736|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
516507|NCT00957736|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
516508|NCT00957736|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
516509|NCT00957736|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
516510|NCT00957736|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
516511|NCT00957736|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
516512|NCT00957736|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
516513|NCT00957736|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
516514|NCT00957736|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
516515|NCT00957736|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
516516|NCT00957736|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
516517|NCT00957736|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
516518|NCT00957736|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
516519|NCT00957736|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
516520|NCT00957736|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
516521|NCT00957736|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
516522|NCT00957736|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
516769|NCT00956943|high dose|high dose
516523|NCT00957736|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
516524|NCT00957736|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
516525|NCT00957736|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
516526|NCT00957736|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
516527|NCT00957736|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
516528|NCT00957736|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
516529|NCT00957736|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
516530|NCT00957736|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
516531|NCT00957736|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
516532|NCT00957736|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
516533|NCT00957736|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
516534|NCT00957736|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
516535|NCT00957736|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
516536|NCT00957736|splenic marginal zone lymphoma|splenic marginal zone lymphoma
516537|NCT00957736|noncontiguous (NC) stage II adult Burkitt lymphoma|noncontiguous (nc) stage ii adult burkitt lymphoma
516538|NCT00957736|NC stage II adult diffuse large cell lymphoma|nc stage ii adult diffuse large cell lymphoma
516539|NCT00957736|NC stage II adult diffuse mixed cell lymphoma|nc stage ii adult diffuse mixed cell lymphoma
516540|NCT00957736|NC stage II adult diffuse small cleaved cell lymphoma|nc stage ii adult diffuse small cleaved cell lymphoma
516541|NCT00957736|NC stage II adult immunoblastic large cell lymphoma|nc stage ii adult immunoblastic large cell lymphoma
516542|NCT00957736|NC stage II adult lymphoblastic lymphoma|nc stage ii adult lymphoblastic lymphoma
516543|NCT00957736|NC stage II grade 1 follicular lymphoma|nc stage ii grade 1 follicular lymphoma
516544|NCT00957736|NC stage II grade 2 follicular lymphoma|nc stage ii grade 2 follicular lymphoma
516545|NCT00957736|NC stage II grade 3 follicular lymphoma|nc stage ii grade 3 follicular lymphoma
516546|NCT00957736|NC stage II mantle cell lymphoma|nc stage ii mantle cell lymphoma
516547|NCT00957736|NC stage II marginal zone lymphoma|nc stage ii marginal zone lymphoma
516548|NCT00957736|NC stage II small lymphocytic lymphoma|nc stage ii small lymphocytic lymphoma
516549|NCT00957736|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
516550|NCT00957736|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
516551|NCT00957736|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
516552|NCT00957736|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
516553|NCT00957736|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
516554|NCT00957736|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
516555|NCT00957736|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
516556|NCT00957736|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
516557|NCT00957736|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
516558|NCT00957736|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
516559|NCT00957736|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
516560|NCT00957736|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
516561|NCT00957736|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
516562|NCT00957736|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
516563|NCT00957736|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
516564|NCT00957736|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
516565|NCT00957736|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
516566|NCT00957736|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
516567|NCT00957736|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
516801|NCT00956774|HSG|hsg
516568|NCT00957736|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
516569|NCT00957736|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
516570|NCT00957736|refractory hairy cell leukemia|refractory hairy cell leukemia
516571|NCT00957736|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
516572|NCT00957736|secondary acute myeloid leukemia|secondary acute myeloid leukemia
516573|NCT00957736|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
516574|NCT00957736|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
516575|NCT00957736|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
516576|NCT00957736|chronic eosinophilic leukemia|chronic eosinophilic leukemia
516577|NCT00957736|primary myelofibrosis|primary myelofibrosis
516578|NCT00957736|chronic neutrophilic leukemia|chronic neutrophilic leukemia
516579|NCT00957736|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
516580|NCT00957736|disseminated neuroblastoma|disseminated neuroblastoma
516581|NCT00957736|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
516582|NCT00957736|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
516583|NCT00957736|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
516584|NCT00957736|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
516585|NCT00957736|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
516586|NCT00957736|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
516587|NCT00957736|recurrent neuroblastoma|recurrent neuroblastoma
516588|NCT00957736|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
516589|NCT00957736|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
516590|NCT00957736|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
516591|NCT00957736|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
516592|NCT00957736|stage I multiple myeloma|stage i multiple myeloma
516593|NCT00957736|stage II multiple myeloma|stage ii multiple myeloma
516594|NCT00957736|stage III multiple myeloma|stage iii multiple myeloma
516595|NCT00957736|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
516596|NCT00957736|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
516597|NCT00957736|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
516598|NCT00957736|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
516599|NCT00957736|stage IIIA breast cancer|stage iiia breast cancer
516600|NCT00957736|stage IIIB breast cancer|stage iiib breast cancer
516601|NCT00957736|stage IIIC breast cancer|stage iiic breast cancer
516602|NCT00957736|stage IV breast cancer|stage iv breast cancer
516603|NCT00957736|refractory multiple myeloma|refractory multiple myeloma
516604|NCT00957710|progressive aphasia|progressive aphasia
516605|NCT00957710|semantic dementia|semantic dementia
516606|NCT00957710|neuroimaging|neuroimaging
516607|NCT00957710|treatment|treatment
516608|NCT00957710|errorless learning|errorless learning
516609|NCT00957697|Central Neuropathic Pain|central neuropathic pain
516610|NCT00957697|Central Post-Stroke Pain|central post-stroke pain
516612|NCT00957697|Pain|pain
516613|NCT00957684|refractory|refractory
516614|NCT00957684|partial|partial
516615|NCT00957684|epilepsy|epilepsy
516616|NCT00957671|TBI|tbi
516617|NCT00957671|Traumatic Brain injury|traumatic brain injury
516618|NCT00957671|Growth hormone deficiency|growth hormone deficiency
516619|NCT00957671|Anterior pituitary hormone|anterior pituitary hormone
516620|NCT00957671|Recombinant human growth Hormone|recombinant human growth hormone
516621|NCT00957671|Genotropin|genotropin
516622|NCT00957658|Osteoarthritis|osteoarthritis
516623|NCT00957645|Central post-stroke pain|central post-stroke pain
516624|NCT00957645|post-stroke pain|post-stroke pain
516625|NCT00957645|shoulder pain|shoulder pain
516626|NCT00957619|pentoxyfilline|pentoxyfilline
516627|NCT00957619|liver regeneration|liver regeneration
516628|NCT00957619|major liver resection|major liver resection
516629|NCT00957619|reduction of the I/R injury|reduction of the i/r injury
516630|NCT00957606|Prostate cancer|prostate cancer
516631|NCT00957606|androgen deprivation therapy|androgen deprivation therapy
516632|NCT00957606|osteoporosis|osteoporosis
516633|NCT00957593|Induction of labor in term pregnancies|induction of labor in term pregnancies
516634|NCT00957593|Term pregnancy|term pregnancy
516635|NCT00957593|Cesarean delivery|cesarean delivery
516636|NCT00957580|MEK Inhibitor|mek inhibitor
516637|NCT00957580|Pimasertib|pimasertib
516638|NCT00957580|Acute Myeloid Leukemia|acute myeloid leukemia
516639|NCT00957580|Hematological Malignancies|hematological malignancies
516640|NCT00957580|Elderly Patients|elderly patients
516641|NCT00957580|Phase II|phase ii
516642|NCT00957541|NYHA Class III or IV|nyha class iii or iv
516643|NCT00957541|Implantable Cardiac Defibrillator|implantable cardiac defibrillator
516644|NCT00957541|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
516645|NCT00957528|Low Normal Testosterone|low normal testosterone
516646|NCT00957528|Male|male
516647|NCT00957528|Aging|aging
516648|NCT00957489|Orthodontic treatment of Class II division 1 malocclusion|orthodontic treatment of class ii division 1 malocclusion
516649|NCT00957476|Pregnancy|pregnancy
516650|NCT00957476|Metabolic Diseases|metabolic diseases
516651|NCT00957476|Obesity|obesity
516652|NCT00957476|Fetal adiposity|fetal adiposity
516653|NCT00957476|Omega-3|omega-3
516654|NCT00957476|Inflammation|inflammation
516655|NCT00957476|Insulin Resistance|insulin resistance
516656|NCT00957463|endothelial function|endothelial function
516657|NCT00957450|cervix cancer|cervix cancer
516658|NCT00957450|intra-pelvic organ motion|intra-pelvic organ motion
516659|NCT00957450|cervical cancer and CBCT|cervical cancer and cbct
516660|NCT00957437|Phase 1|phase 1
516661|NCT00957437|healthy volunteer|healthy volunteer
516662|NCT00957437|male|male
516663|NCT00957437|pharmacokinetics|pharmacokinetics
516664|NCT00957437|AZD1305|azd1305
516665|NCT00957424|tobacco use disorder|tobacco use disorder
516666|NCT00957424|bladder cancer|bladder cancer
516667|NCT00957424|cervical cancer|cervical cancer
516668|NCT00957424|esophageal cancer|esophageal cancer
516669|NCT00957424|gastric cancer|gastric cancer
516670|NCT00957424|renal cell carcinoma|renal cell carcinoma
516671|NCT00957424|adult primary liver cancer|adult primary liver cancer
516672|NCT00957424|non-small cell lung cancer|non-small cell lung cancer
516673|NCT00957424|small cell lung cancer|small cell lung cancer
516674|NCT00957424|pancreatic cancer|pancreatic cancer
516675|NCT00957424|hypopharyngeal cancer|hypopharyngeal cancer
516676|NCT00957424|laryngeal cancer|laryngeal cancer
516677|NCT00957424|lip and oral cavity cancer|lip and oral cavity cancer
516678|NCT00957424|nasopharyngeal cancer|nasopharyngeal cancer
516679|NCT00957424|oropharyngeal cancer|oropharyngeal cancer
516680|NCT00957424|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
516681|NCT00957424|adult acute myeloid leukemia|adult acute myeloid leukemia
516682|NCT00957411|stage IB cervical cancer|stage ib cervical cancer
516683|NCT00957411|stage IIA cervical cancer|stage iia cervical cancer
516684|NCT00957411|stage IIB cervical cancer|stage iib cervical cancer
516685|NCT00957411|stage III cervical cancer|stage iii cervical cancer
516686|NCT00957411|cervical adenocarcinoma|cervical adenocarcinoma
516687|NCT00957411|cervical squamous cell carcinoma|cervical squamous cell carcinoma
516688|NCT00957398|Irritable Bowel Syndrome|irritable bowel syndrome
516689|NCT00957398|Irritable Bowel Syndrome subgroups|irritable bowel syndrome subgroups
516690|NCT00957398|Motility|motility
516691|NCT00957385|Leukemia|leukemia
516692|NCT00957385|Remission|remission
516693|NCT00957372|epilepsy|epilepsy
516694|NCT00957359|Cancer|cancer
516695|NCT00957359|Anxiety|anxiety
516696|NCT00957359|Depression|depression
516697|NCT00957359|Hallucinogens|hallucinogens
516698|NCT00957346|Pregnancy termination|pregnancy termination
516699|NCT00957346|abortion|abortion
516700|NCT00957346|medical abortion|medical abortion
516701|NCT00957346|2nd trimester|2nd trimester
516702|NCT00957346|mifepristone|mifepristone
516703|NCT00957346|misoprostol|misoprostol
516704|NCT00957333|ketamine|ketamine
516705|NCT00957333|bladder dysfunction|bladder dysfunction
516706|NCT00957333|bladder mucosa|bladder mucosa
516707|NCT00957333|mechanisms|mechanisms
516708|NCT00957320|leukemia|leukemia
516709|NCT00957320|cancer|cancer
516710|NCT00957320|oncology|oncology
516711|NCT00957320|sirolimus|sirolimus
516712|NCT00957320|ALL|all
516713|NCT00957281|Asthma|asthma
516714|NCT00957281|Systemic inflammation|systemic inflammation
516715|NCT00957281|Oxidative stress|oxidative stress
516716|NCT00957281|Cardiovascular morbidity|cardiovascular morbidity
516717|NCT00957281|Airway inflammation|airway inflammation
516718|NCT00957268|Type 2 diabetes mellitus|type 2 diabetes mellitus
516719|NCT00957268|Non-insulin dependent diabetes mellitus|non-insulin dependent diabetes mellitus
516720|NCT00957268|Drug therapy|drug therapy
516721|NCT00957268|Pediatrics|pediatrics
516722|NCT00957255|rotator cuff tear|rotator cuff tear
516723|NCT00957255|rotator cuff repair|rotator cuff repair
516724|NCT00957242|IPF|ipf
516725|NCT00957242|Warfarin|warfarin
516726|NCT00957216|adult onset ataxia|adult onset ataxia
516727|NCT00957203|Parkinson's disease|parkinson's disease
516728|NCT00957203|levodopa|levodopa
516729|NCT00957203|end of dose wearing off|end of dose wearing off
516730|NCT00957203|OFF time|off time
516731|NCT00957190|Ocular Hypertension|ocular hypertension
516732|NCT00957190|Open Angle Glaucoma|open angle glaucoma
516733|NCT00957164|Chronic pain|chronic pain
516734|NCT00957164|PTSD|ptsd
516735|NCT00957151|chronic pancreatitis|chronic pancreatitis
516736|NCT00957151|exocrine pancreatic insufficiency|exocrine pancreatic insufficiency
516737|NCT00957151|enzyme therapy|enzyme therapy
516738|NCT00957151|patients with chronic pancreatitis and exocrine pancreatic insufficiency|patients with chronic pancreatitis and exocrine pancreatic insufficiency
516739|NCT00957151|taking enzyme replacement therapy|taking enzyme replacement therapy
516740|NCT00957125|Localized primary breast cancer|localized primary breast cancer
516741|NCT00957125|Inflammatory breast cancer|inflammatory breast cancer
516742|NCT00957112|anxiety disorder|anxiety disorder
516743|NCT00957112|depression|depression
516744|NCT00957112|fatigue|fatigue
516745|NCT00957112|stage IA breast cancer|stage ia breast cancer
516746|NCT00957112|stage IB breast cancer|stage ib breast cancer
516747|NCT00957112|stage II breast cancer|stage ii breast cancer
516748|NCT00957112|stage IIIA breast cancer|stage iiia breast cancer
516749|NCT00957086|Phase III Adjuvant Concurrent Chemo-RT +/- nimotuzumab|phase iii adjuvant concurrent chemo-rt +/- nimotuzumab
516750|NCT00957073|Heart Failure|heart failure
516751|NCT00957073|Diastolic dysfunction|diastolic dysfunction
516752|NCT00957047|refractory|refractory
516753|NCT00957047|partial|partial
516754|NCT00957047|epilepsy|epilepsy
516755|NCT00957021|Knee|knee
516756|NCT00956982|Hepatitis C Virus Pegylated Interferon Ribavirin Older|hepatitis c virus pegylated interferon ribavirin older
516757|NCT00956969|headaches|headaches
516758|NCT00956969|stress management|stress management
516759|NCT00956969|assertiveness training|assertiveness training
516760|NCT00956969|relaxation training|relaxation training
516761|NCT00956969|emotional expression|emotional expression
516762|NCT00956956|An investigator and subject blinded (sponsor open)|an investigator and subject blinded (sponsor open)
516763|NCT00956956|multiple dose|multiple dose
516764|NCT00956956|dose escalation design with PF 04455242 and matching placebo.|dose escalation design with pf 04455242 and matching placebo.
516765|NCT00956943|nicotine dependence|nicotine dependence
516766|NCT00956943|nicotine replacement therapy|nicotine replacement therapy
516767|NCT00956943|transdermal nicotine|transdermal nicotine
516768|NCT00956943|nicotine metabolism|nicotine metabolism
516770|NCT00956930|advanced adult primary liver cancer|advanced adult primary liver cancer
516771|NCT00956930|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
516772|NCT00956930|recurrent adult primary liver cancer|recurrent adult primary liver cancer
516773|NCT00956930|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
516774|NCT00956904|Prostate Cancer|prostate cancer
516775|NCT00956904|Prostatectomy|prostatectomy
516776|NCT00956904|Transrectal Ultrasound|transrectal ultrasound
516777|NCT00956904|Tandem RALP|tandem ralp
516778|NCT00956891|short-term effects|short-term effects
516779|NCT00956891|long-term follow-up|long-term follow-up
516780|NCT00956891|liver failure patients|liver failure patients
516781|NCT00956891|autologous MSCs transplantation|autologous mscs transplantation
516782|NCT00956878|Cancer|cancer
516783|NCT00956878|Pain|pain
516784|NCT00956878|SNP|snp
516785|NCT00956865|Glaucoma|glaucoma
516786|NCT00956865|Intervention|intervention
516787|NCT00956865|Follow up|follow up
516788|NCT00956839|Tropical calcific pancreatitis|tropical calcific pancreatitis
516789|NCT00956839|Tropical chronic pancreatitis|tropical chronic pancreatitis
516790|NCT00956839|Chronic pancreatitis|chronic pancreatitis
516791|NCT00956839|Vitamin D|vitamin d
516792|NCT00956839|Vitamin D deficiency|vitamin d deficiency
516793|NCT00956839|Cholecalciferol|cholecalciferol
516794|NCT00956839|Intramuscular vitamin D3|intramuscular vitamin d3
516795|NCT00956826|electrode vacuum delivery|electrode vacuum delivery
516796|NCT00956813|menopausal symptoms|menopausal symptoms
516797|NCT00956813|hot flashes|hot flashes
516798|NCT00956813|breast cancer|breast cancer
516799|NCT00956813|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
516800|NCT00956787|Myelodysplastic Syndrome|myelodysplastic syndrome
516802|NCT00956774|Cannula|cannula
516803|NCT00956774|HSG procedure|hsg procedure
516804|NCT00956774|infertility evaluation|infertility evaluation
516805|NCT00956761|Influenza vaccine|influenza vaccine
516806|NCT00956748|chronic suppurative otitis media with persistent otorrhea|chronic suppurative otitis media with persistent otorrhea
516807|NCT00956735|Cardiovascular Disease|cardiovascular disease
516808|NCT00956735|Type II Diabetes|type ii diabetes
516809|NCT00956735|Nutrition|nutrition
516810|NCT00956735|Pistachios|pistachios
516811|NCT00956735|Cardiovascular disease risk factors in adults with Type II diabetes|cardiovascular disease risk factors in adults with type ii diabetes
516812|NCT00956696|Epilepsy|epilepsy
516813|NCT00956696|mental retardation|mental retardation
516814|NCT00956683|infraclavicular nerve block ultrasound dual endpoint stimulation|infraclavicular nerve block ultrasound dual endpoint stimulation
516815|NCT00956657|Randomised Controlled Trial|randomised controlled trial
516816|NCT00956657|Adherence|adherence
516817|NCT00956657|Patient Participation|patient participation
516818|NCT00956631|Spinal Stenosis|spinal stenosis
516819|NCT00956631|Lumbar Spinal Stenosis|lumbar spinal stenosis
516820|NCT00956605|EEG-biofeedback|eeg-biofeedback
516821|NCT00956605|neurofeedback|neurofeedback
516822|NCT00956605|computer attention training systems|computer attention training systems
516823|NCT00956605|ADHD|adhd
516825|NCT00956605|child|child
516826|NCT00956605|children|children
516827|NCT00956592|Video laryngoscopy|video laryngoscopy
516828|NCT00956592|Intubation success|intubation success
516829|NCT00956592|Difficult airway|difficult airway
516830|NCT00956592|CMAC laryngoscope|cmac laryngoscope
516831|NCT00956579|autism|autism
516832|NCT00956579|autistic|autistic
516833|NCT00956579|sensory|sensory
516834|NCT00956579|MEG|meg
516835|NCT00956579|connectivity|connectivity
516836|NCT00956579|brain|brain
516837|NCT00956579|MRI|mri
516838|NCT00956579|language|language
516839|NCT00956579|developmental|developmental
516840|NCT00956579|neurodevelopmental|neurodevelopmental
516841|NCT00956579|aspergers|aspergers
516842|NCT00956579|asperger's|asperger's
516843|NCT00956579|dyslexia|dyslexia
516844|NCT00956579|coherence|coherence
516845|NCT00956553|HPV|hpv
516846|NCT00956553|Human Papilloma Virus|human papilloma virus
516847|NCT00956553|Cervical cancer vaccine|cervical cancer vaccine
516848|NCT00956540|Tracheostomy|tracheostomy
516849|NCT00956540|decannulation|decannulation
516850|NCT00956540|weaning|weaning
516851|NCT00956540|Tracheostomy Weaning|tracheostomy weaning
516852|NCT00956527|Adolescent|adolescent
516853|NCT00956527|Substance Use|substance use
516854|NCT00956527|Early Intervention|early intervention
516855|NCT00956527|Martial Arts|martial arts
516856|NCT00956527|Karate|karate
516857|NCT00956514|depression|depression
516858|NCT00956514|major depressive disorder|major depressive disorder
516859|NCT00956514|transcranial magnetic stimulation|transcranial magnetic stimulation
516860|NCT00956514|TMS|tms
516861|NCT00956514|EEG|eeg
516862|NCT00956514|electroencephalography|electroencephalography
516863|NCT00956514|Major Depression,|major depression,
516864|NCT00956501|fall|fall
516865|NCT00956501|balance|balance
516866|NCT00956488|Exercise for Amyotrophic lateral sclerosis|exercise for amyotrophic lateral sclerosis
516867|NCT00956475|anxiety disorder|anxiety disorder
517082|NCT00956202|Influenza|influenza
516868|NCT00956475|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
516869|NCT00956475|fatigue|fatigue
516870|NCT00956475|pain|pain
516871|NCT00956475|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
516872|NCT00956475|cancer survivor|cancer survivor
516873|NCT00956475|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
516874|NCT00956475|acute undifferentiated leukemia|acute undifferentiated leukemia
516875|NCT00956475|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
516876|NCT00956475|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
516877|NCT00956475|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
516878|NCT00956475|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
516879|NCT00956475|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
516880|NCT00956475|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
516881|NCT00956475|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
516882|NCT00956475|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
516883|NCT00956475|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
516884|NCT00956475|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
516885|NCT00956475|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
516886|NCT00956475|mast cell leukemia|mast cell leukemia
516887|NCT00956475|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
516888|NCT00956475|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
516889|NCT00956475|prolymphocytic leukemia|prolymphocytic leukemia
516890|NCT00956475|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
516891|NCT00956475|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
516892|NCT00956475|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
516893|NCT00956475|refractory hairy cell leukemia|refractory hairy cell leukemia
516894|NCT00956475|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
516895|NCT00956475|secondary acute myeloid leukemia|secondary acute myeloid leukemia
516896|NCT00956475|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
516897|NCT00956475|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
516898|NCT00956475|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
516899|NCT00956475|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
516900|NCT00956475|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
516901|NCT00956475|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
516902|NCT00956475|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
516903|NCT00956475|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
516904|NCT00956475|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
516905|NCT00956475|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
516906|NCT00956475|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
516907|NCT00956475|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
516908|NCT00956475|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
516909|NCT00956475|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
516910|NCT00956475|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
516911|NCT00956475|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
516912|NCT00956475|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
516913|NCT00956475|stage I mantle cell lymphoma|stage i mantle cell lymphoma
516914|NCT00956475|stage I marginal zone lymphoma|stage i marginal zone lymphoma
516915|NCT00956475|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
516916|NCT00956475|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
516917|NCT00956475|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
516918|NCT00956475|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
516919|NCT00956475|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
516920|NCT00956475|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
516921|NCT00956475|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
516922|NCT00956475|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
516923|NCT00956475|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
516924|NCT00956475|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
516925|NCT00956475|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
516926|NCT00956475|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
516927|NCT00956475|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
516928|NCT00956475|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
516929|NCT00956475|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
516930|NCT00956475|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
516931|NCT00956475|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
516932|NCT00956475|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
517083|NCT00956202|Pandemic Flu|pandemic flu
516933|NCT00956475|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
516934|NCT00956475|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
516935|NCT00956475|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
516936|NCT00956475|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
516937|NCT00956475|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
516938|NCT00956475|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
516939|NCT00956475|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
516940|NCT00956475|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
516941|NCT00956475|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
516942|NCT00956475|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
516943|NCT00956475|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
516944|NCT00956475|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
516945|NCT00956475|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
516946|NCT00956475|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
516947|NCT00956475|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
516948|NCT00956475|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
516949|NCT00956475|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
516950|NCT00956475|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
516951|NCT00956475|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
516952|NCT00956475|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
516953|NCT00956475|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
516954|NCT00956475|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
516955|NCT00956475|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
516956|NCT00956475|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
516957|NCT00956475|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
516958|NCT00956475|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
516959|NCT00956475|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
516960|NCT00956475|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
516961|NCT00956475|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
516962|NCT00956475|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
516963|NCT00956475|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
516964|NCT00956475|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
516965|NCT00956475|anaplastic large cell lymphoma|anaplastic large cell lymphoma
516966|NCT00956475|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
516967|NCT00956475|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
516968|NCT00956475|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
516969|NCT00956475|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
516970|NCT00956475|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
516971|NCT00956475|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
516972|NCT00956475|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
516973|NCT00956475|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
516974|NCT00956475|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
516975|NCT00956475|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
516976|NCT00956475|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
516977|NCT00956475|splenic marginal zone lymphoma|splenic marginal zone lymphoma
516978|NCT00956475|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
516979|NCT00956475|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
516980|NCT00956475|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
516981|NCT00956475|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
516982|NCT00956475|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
516983|NCT00956475|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
516984|NCT00956475|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
516985|NCT00956475|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
516986|NCT00956475|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
516987|NCT00956475|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
516988|NCT00956475|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
516989|NCT00956475|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
516990|NCT00956475|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
516991|NCT00956475|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
516992|NCT00956475|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
516993|NCT00956475|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
516994|NCT00956475|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
516995|NCT00956475|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
516996|NCT00956475|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
516997|NCT00956475|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
516998|NCT00956475|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
516999|NCT00956475|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
517000|NCT00956475|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
517001|NCT00956475|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
517002|NCT00956475|intraocular lymphoma|intraocular lymphoma
517003|NCT00956475|primary central nervous system lymphoma|primary central nervous system lymphoma
517004|NCT00956475|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
517005|NCT00956475|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
517006|NCT00956475|small intestine lymphoma|small intestine lymphoma
517007|NCT00956462|intraocular pressure|intraocular pressure
517008|NCT00956462|Ahmed valve|ahmed valve
517010|NCT00956462|steroids|steroids
517011|NCT00956449|flu|flu
517012|NCT00956449|influenza|influenza
517013|NCT00956449|seasonal influenza|seasonal influenza
517014|NCT00956449|influenza vaccine antigen|influenza vaccine antigen
517015|NCT00956449|immunogenicity|immunogenicity
517016|NCT00956449|safety|safety
517017|NCT00956449|tolerability|tolerability
517018|NCT00956449|antibody response|antibody response
517019|NCT00956449|intra muscular|intra muscular
517020|NCT00956449|elderly|elderly
517021|NCT00956449|non-elderly|non-elderly
517022|NCT00956436|Liver Cancer|liver cancer
517023|NCT00956436|Hepatocellular Carcinoma|hepatocellular carcinoma
517024|NCT00956436|Sorafenib|sorafenib
517025|NCT00956436|HCC|hcc
517026|NCT00956436|BIIB022|biib022
517027|NCT00956436|Open-Label|open-label
517028|NCT00956436|IGF-1R|igf-1r
517029|NCT00956436|Nexavar|nexavar
517030|NCT00956423|obstructive sleep apnea|obstructive sleep apnea
517031|NCT00956423|exercise training|exercise training
517032|NCT00956423|aerobic exercise|aerobic exercise
517033|NCT00956423|resistance exercise|resistance exercise
517034|NCT00956410|Active immunization|active immunization
517035|NCT00956410|Alzheimer disease|alzheimer disease
517036|NCT00956410|Antibody|antibody
517037|NCT00956410|Central Nervous System Diseases|central nervous system diseases
517038|NCT00956410|Neurodegenerative diseases|neurodegenerative diseases
517039|NCT00956410|Vaccine|vaccine
517040|NCT00956397|Functional Dyspepsia|functional dyspepsia
517041|NCT00956397|Small Intestinal Bacterial Overgrowth|small intestinal bacterial overgrowth
517042|NCT00956397|chronic abdominal discomfort|chronic abdominal discomfort
517043|NCT00956384|Breast reconstruction|breast reconstruction
517044|NCT00956384|Early stage|early stage
517045|NCT00956384|Skin-saving mastectomy|skin-saving mastectomy
517046|NCT00956384|Prophylactic mastectomy|prophylactic mastectomy
517047|NCT00956384|Acellular dermal matrix|acellular dermal matrix
517048|NCT00956384|BRCA Mutation Carriers|brca mutation carriers
517049|NCT00956371|ONO-7746|ono-7746
517050|NCT00956371|Healthy adult subjects|healthy adult subjects
517051|NCT00956358|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
517052|NCT00956332|Peripheral arterial disease (PAD)|peripheral arterial disease (pad)
517053|NCT00956332|Peripheral vascular disease (PVD)|peripheral vascular disease (pvd)
517054|NCT00956332|Critical limb ischemia (CLI)|critical limb ischemia (cli)
517055|NCT00956332|Cell therapy|cell therapy
517056|NCT00956332|Gene therapy|gene therapy
517057|NCT00956332|Endothelial cells|endothelial cells
517058|NCT00956332|Smooth muscle cells|smooth muscle cells
517059|NCT00956332|Angiogenesis|angiogenesis
517060|NCT00956332|Arteriogenesis|arteriogenesis
517061|NCT00956332|amputation|amputation
517062|NCT00956332|diabetic foot|diabetic foot
517063|NCT00956319|Insomnia|insomnia
517064|NCT00956319|Zolpidem|zolpidem
517065|NCT00956319|Estazolam|estazolam
517066|NCT00956306|Udenafil,DA-8159,hepatic impairment,healthy volunteers|udenafil,da-8159,hepatic impairment,healthy volunteers
517067|NCT00956280|The frequency and type of KRAS mutation in a sample of the Brazilian population with advanced NSCLC|the frequency and type of kras mutation in a sample of the brazilian population with advanced nsclc
517068|NCT00956280|KRAS mutation in population with advanced NSCLC|kras mutation in population with advanced nsclc
517069|NCT00956267|Polycystic ovary syndrome|polycystic ovary syndrome
517070|NCT00956267|clomiphene resistance|clomiphene resistance
517071|NCT00956267|letrozole|letrozole
517072|NCT00956267|Laparoscopic ovarian diathermy|laparoscopic ovarian diathermy
517073|NCT00956254|mucositis|mucositis
517074|NCT00956254|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
517075|NCT00956254|pain|pain
517076|NCT00956241|rectal cancer|rectal cancer
517077|NCT00956241|colonic pouch|colonic pouch
517078|NCT00956241|side-to-end anastomosis|side-to-end anastomosis
517079|NCT00956241|preoperative radiotherapy|preoperative radiotherapy
517080|NCT00956215|post operative|post operative
517081|NCT00956215|obese|obese
517084|NCT00956202|Swine-origin A/H1N1 Influenza|swine-origin a/h1n1 influenza
517085|NCT00956202|Inactivated split-virion vaccine|inactivated split-virion vaccine
517086|NCT00956202|Adjuvant|adjuvant
517087|NCT00956189|Antipsychotic Agents|antipsychotic agents
517088|NCT00956189|Metabolic Syndrome X|metabolic syndrome x
517089|NCT00956189|Identification|identification
517090|NCT00956189|Prediction|prediction
517091|NCT00956176|Cidofovir|cidofovir
517092|NCT00956176|Vistide|vistide
517093|NCT00956176|Adenovirus|adenovirus
517094|NCT00956176|BK virus infections|bk virus infections
517095|NCT00956176|HSCT|hsct
517096|NCT00956176|Hemorrhagic Cystitis|hemorrhagic cystitis
517097|NCT00956176|Foley catheter|foley catheter
517098|NCT00956176|Viral infection|viral infection
517099|NCT00956176|Bladder instillation|bladder instillation
517100|NCT00956176|Intravesical|intravesical
517101|NCT00956176|Transurethral catheter|transurethral catheter
517102|NCT00956176|Transplantation|transplantation
517103|NCT00956150|Chronic Multisymptom Complex|chronic multisymptom complex
517104|NCT00956150|Small Intestinal Bacterial Overgrowth|small intestinal bacterial overgrowth
517105|NCT00956150|Gulf War Syndrome|gulf war syndrome
517106|NCT00956150|Chronic Multisymptom Illness Complex|chronic multisymptom illness complex
517107|NCT00956137|spinal anesthesia|spinal anesthesia
517108|NCT00956137|ultrasound|ultrasound
517109|NCT00956137|palpation|palpation
517110|NCT00956137|knee|knee
517111|NCT00956137|hip|hip
517112|NCT00956137|surgery|surgery
517113|NCT00956137|intervertebral space|intervertebral space
517114|NCT00956111|Novel Influenza A/H1N1 Vaccine|novel influenza a/h1n1 vaccine
517115|NCT00956111|Immunogenictiy|immunogenictiy
517116|NCT00956111|Safety|safety
517117|NCT00956085|OCD|ocd
517118|NCT00956072|gastrointestinal stromal tumor|gastrointestinal stromal tumor
517119|NCT00956059|focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
517120|NCT00956059|prednisone|prednisone
517121|NCT00956059|mycophenolate mofetil|mycophenolate mofetil
517122|NCT00956059|FK506|fk506
517123|NCT00956046|Influenza|influenza
517124|NCT00956046|Pandemic Flu|pandemic flu
517125|NCT00956046|Swine-origin A/H1N1 Influenza|swine-origin a/h1n1 influenza
517126|NCT00956046|Swine-origin Influenza Virus|swine-origin influenza virus
517127|NCT00956046|Infants|infants
517128|NCT00956033|Cancer|cancer
517129|NCT00956033|Peripheral Neuropathy|peripheral neuropathy
517130|NCT00956033|Bortezomib|bortezomib
517131|NCT00956020|platelet rich plasma|platelet rich plasma
517132|NCT00956020|fibrin matrix|fibrin matrix
517133|NCT00956020|dermal filler|dermal filler
517134|NCT00956007|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
517135|NCT00956007|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
517136|NCT00956007|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
517137|NCT00956007|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
517138|NCT00956007|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
517139|NCT00956007|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
517140|NCT00956007|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
517141|NCT00956007|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
517142|NCT00956007|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
517143|NCT00956007|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
517144|NCT00956007|tongue cancer|tongue cancer
517145|NCT00955968|HIV Infection|hiv infection
517146|NCT00955968|HAART|haart
517147|NCT00955968|Maternal Health|maternal health
517148|NCT00955955|Depression|depression
517149|NCT00955955|Medical food|medical food
517150|NCT00955942|radiation toxicity|radiation toxicity
517151|NCT00955942|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
517152|NCT00955942|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
517153|NCT00955942|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
517154|NCT00955942|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
517155|NCT00955929|Penis|penis
517156|NCT00955929|PLACEBO|placebo
517157|NCT00955929|SILDENAFIL CITRATE|sildenafil citrate
517158|NCT00955929|TRIMIX|trimix
517159|NCT00955929|Bimix|bimix
517160|NCT00955929|Viagra|viagra
517161|NCT00955929|09-005|09-005
517162|NCT00955929|Erectile Dysfunction following Bilateral Nerve-Sparing|erectile dysfunction following bilateral nerve-sparing
517163|NCT00955916|relapsed|relapsed
517164|NCT00955916|refractory|refractory
517165|NCT00955916|acute|acute
517166|NCT00955916|myeloid|myeloid
517168|NCT00955916|CML|cml
517169|NCT00955916|blast crisis|blast crisis
517170|NCT00955903|glucose|glucose
517171|NCT00955903|insulin|insulin
517172|NCT00955903|lipids|lipids
517173|NCT00955903|C-reactive protein|c-reactive protein
517174|NCT00955903|adiponectin|adiponectin
517175|NCT00955903|leptin|leptin
517176|NCT00955903|TNF alpha|tnf alpha
517177|NCT00955903|IL-6|il-6
517178|NCT00955903|Quality of Life|quality of life
517179|NCT00955903|functional status|functional status
517180|NCT00955890|cardioprotection|cardioprotection
517181|NCT00955890|anthracycline chemotherapy|anthracycline chemotherapy
517182|NCT00955890|breast cancer|breast cancer
517183|NCT00955877|extended-release epidural morphine|extended-release epidural morphine
517184|NCT00955877|DepoDur|depodur
517185|NCT00955877|Spastic Cerebral Palsy|spastic cerebral palsy
517186|NCT00955864|Cervix|cervix
517187|NCT00955864|Colposcope|colposcope
517188|NCT00955864|Polarized Light|polarized light
517189|NCT00955864|Cervix Structure|cervix structure
517190|NCT00955864|Collagen|collagen
517191|NCT00955864|HV|hv
517192|NCT00955864|Healthy Volunteer|healthy volunteer
517193|NCT00955864|Healthy Women|healthy women
517194|NCT00955825|allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
517195|NCT00955812|OPB-31121|opb-31121
517196|NCT00955812|Advanced Solid Tumor|advanced solid tumor
517197|NCT00955812|STAT3|stat3
517198|NCT00955812|IL-6-induced STAT3 phosphorylation|il-6-induced stat3 phosphorylation
517199|NCT00955799|Subjective, Tinnitus|subjective, tinnitus
517200|NCT00955786|Solid Tumors|solid tumors
517201|NCT00955786|Lymphoma|lymphoma
517202|NCT00955786|G-Quadruplex|g-quadruplex
517203|NCT00955773|GSK1120212, everolimus, solid tumors, pancreatic cancer, non-small lung cancer, KRAS-mutant|gsk1120212, everolimus, solid tumors, pancreatic cancer, non-small lung cancer, kras-mutant
517204|NCT00955773|cancer|cancer
517205|NCT00955760|Healthy subjects|healthy subjects
517206|NCT00955734|wrist|wrist
517207|NCT00955734|fracture|fracture
517208|NCT00955734|motion|motion
517209|NCT00955734|surgery|surgery
517210|NCT00955721|Cholangiocarcinoma|cholangiocarcinoma
517211|NCT00955721|Biliary Tract Cancer|biliary tract cancer
517212|NCT00955721|Gallbladder Cancer|gallbladder cancer
517213|NCT00955695|adenocarcinoma of the lung|adenocarcinoma of the lung
517214|NCT00955695|adenosquamous cell lung cancer|adenosquamous cell lung cancer
517215|NCT00955695|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
517216|NCT00955695|large cell lung cancer|large cell lung cancer
517217|NCT00955695|squamous cell lung cancer|squamous cell lung cancer
517218|NCT00955695|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
517219|NCT00955695|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
517220|NCT00955682|Meningococcal vaccine GSK134612|meningococcal vaccine gsk134612
517221|NCT00955669|mesenchymal stem cells|mesenchymal stem cells
517222|NCT00955669|mononuclear cells|mononuclear cells
517223|NCT00955656|Characteristics of medical practices|characteristics of medical practices
517224|NCT00955656|Practitioners providing care to children with asthma|practitioners providing care to children with asthma
517225|NCT00955656|Medically underserved and impoverished Arkansas Delta region|medically underserved and impoverished arkansas delta region
517226|NCT00955656|Characteristics of medical practices and practitioners|characteristics of medical practices and practitioners
517227|NCT00955656|Disadvantaged populations|disadvantaged populations
517228|NCT00955643|periodontitis|periodontitis
517229|NCT00955643|hyperbaric oxygen therapy|hyperbaric oxygen therapy
517230|NCT00955630|Histoplasmosis|histoplasmosis
517231|NCT00955630|Lucentis|lucentis
517232|NCT00955630|Ranibizumab|ranibizumab
517233|NCT00955630|OHS|ohs
517234|NCT00955617|Dotarem|dotarem
517235|NCT00955617|Gadovist|gadovist
517236|NCT00955617|Peripheral arterial disease|peripheral arterial disease
517237|NCT00955617|MRA|mra
517238|NCT00955604|Parkinson's Disease|parkinson's disease
517239|NCT00955604|Serotonin Toxicity|serotonin toxicity
517240|NCT00955604|Rasagiline|rasagiline
517241|NCT00955604|Antidepressants|antidepressants
517242|NCT00955604|Chart Review|chart review
517243|NCT00955604|Retrospective|retrospective
517244|NCT00955591|human papilloma virus infection|human papilloma virus infection
517245|NCT00955591|anal cancer|anal cancer
517246|NCT00955591|HIV infection|hiv infection
517247|NCT00955552|osteoarthritis (OA)|osteoarthritis (oa)
517248|NCT00955552|knee|knee
517249|NCT00955539|Heart Failure|heart failure
517250|NCT00955539|Cardiac resynchronization therapy|cardiac resynchronization therapy
517251|NCT00955539|Optimization|optimization
517252|NCT00955539|Viability|viability
517253|NCT00955539|Mechanical dyssynchrony|mechanical dyssynchrony
517254|NCT00955526|Parkinson's disease|parkinson's disease
517255|NCT00955526|levodopa|levodopa
517256|NCT00955526|end of dose wearing off|end of dose wearing off
517257|NCT00955526|OFF time|off time
517258|NCT00955513|Ankle sprain|ankle sprain
517259|NCT00955513|soft tissue injury|soft tissue injury
517260|NCT00955500|Hepatic encephalopathy|hepatic encephalopathy
517261|NCT00955500|Cirrhosis|cirrhosis
517262|NCT00955500|Proteins of the diet|proteins of the diet
517263|NCT00955500|Branched-chain amino acids|branched-chain amino acids
517264|NCT00955487|Premature Newborns|premature newborns
517265|NCT00955487|Inhaled Nitric Oxide|inhaled nitric oxide
517266|NCT00955448|Anterior pelvic organ prolapse|anterior pelvic organ prolapse
517267|NCT00955448|Surgical repair|surgical repair
517268|NCT00955448|Pelvic floor surgery|pelvic floor surgery
517269|NCT00955448|Randomized clinical trial|randomized clinical trial
517270|NCT00955435|adenocarcinoma of the prostate|adenocarcinoma of the prostate
517271|NCT00955435|stage I prostate cancer|stage i prostate cancer
517272|NCT00955435|stage IIB prostate cancer|stage iib prostate cancer
517273|NCT00955435|stage IIA prostate cancer|stage iia prostate cancer
517274|NCT00955435|stage III prostate cancer|stage iii prostate cancer
517275|NCT00955422|Diagnosis|diagnosis
517276|NCT00955422|Alzheimer's Disease|alzheimer's disease
517277|NCT00955422|Memory Disorder|memory disorder
517278|NCT00955422|Dementia|dementia
517279|NCT00955422|Alzheimer Disease|alzheimer disease
517280|NCT00955422|Memory Loss|memory loss
517281|NCT00955396|sodium channel blocker|sodium channel blocker
517282|NCT00955396|ambulatory blood pressure|ambulatory blood pressure
517283|NCT00955383|Japanese|japanese
517284|NCT00955370|Uncertainty|uncertainty
517285|NCT00955370|Undiagnosed|undiagnosed
517286|NCT00955370|Rare Diseases|rare diseases
517287|NCT00955370|Parents|parents
517288|NCT00955370|Multiple Abnormalities|multiple abnormalities
517289|NCT00955357|Epilepsy Treatment|epilepsy treatment
517290|NCT00955357|Anti-epileptic drugs|anti-epileptic drugs
517291|NCT00955357|Seizures|seizures
517292|NCT00955357|Vimpat|vimpat
517293|NCT00955344|colorectal cancer screening|colorectal cancer screening
517294|NCT00955344|American Board of Internal Medicine Maintenance of Certification program|american board of internal medicine maintenance of certification program
517295|NCT00955344|Currently enrolled in or plan to enroll in the American Board of Internal Medicine Maintenance of Certification program|currently enrolled in or plan to enroll in the american board of internal medicine maintenance of certification program
517296|NCT00955305|Non-Small Cell Lung Cancer|non-small cell lung cancer
517297|NCT00955305|cixutumumab|cixutumumab
517298|NCT00955292|Solid Tumors|solid tumors
517299|NCT00955292|Lymphoma|lymphoma
517300|NCT00955292|G-Quadruplex|g-quadruplex
517301|NCT00955279|Ustekinumab|ustekinumab
517302|NCT00955279|CNTO 1275|cnto 1275
517303|NCT00955279|Stelara|stelara
517304|NCT00955279|Golimumab|golimumab
517305|NCT00955279|CNTO 148|cnto 148
517306|NCT00955279|Simponi|simponi
517307|NCT00955279|Sarcoidosis|sarcoidosis
517308|NCT00955279|Sarcoid|sarcoid
517309|NCT00955279|Pulmonary Sarcoidosis|pulmonary sarcoidosis
517310|NCT00955279|Skin Sarcoidosis|skin sarcoidosis
517311|NCT00955266|Separation|separation
517312|NCT00955266|Cardiopulmonary bypass|cardiopulmonary bypass
517313|NCT00955266|Calcium chloride|calcium chloride
517314|NCT00955253|Neglect|neglect
517315|NCT00955253|Attention|attention
517316|NCT00955253|Vigilance|vigilance
517317|NCT00955253|Stroke|stroke
517318|NCT00955253|Hemineglect|hemineglect
517319|NCT00955253|Unilateral Neglect|unilateral neglect
517320|NCT00955253|Spatial Neglect|spatial neglect
517321|NCT00955240|stage II anal cancer|stage ii anal cancer
517322|NCT00955240|stage IIIA anal cancer|stage iiia anal cancer
517323|NCT00955240|stage IIIB anal cancer|stage iiib anal cancer
517324|NCT00955240|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
517325|NCT00955227|Omega-3 Fatty acid|omega-3 fatty acid
517326|NCT00955227|ALA (alpha linolenic acid)|ala (alpha linolenic acid)
517327|NCT00955227|Ezetimibe|ezetimibe
517328|NCT00955227|Flaxseed oil capsules|flaxseed oil capsules
517329|NCT00955214|TAXUS Liberté|taxus liberté
517330|NCT00955214|Small coronary artery disease|small coronary artery disease
517331|NCT00955214|Paclitaxel-eluting stent|paclitaxel-eluting stent
517332|NCT00955201|diabetes mellitus|diabetes mellitus
517333|NCT00955201|diabetic neuropathies|diabetic neuropathies
517334|NCT00955201|Aerobic Exercise|aerobic exercise
517335|NCT00955201|Exercise Therapy|exercise therapy
517336|NCT00955201|electromyography|electromyography
517337|NCT00955201|United States Veterans|united states veterans
517338|NCT00955188|colon cancer|colon cancer
517339|NCT00955188|rectal cancer|rectal cancer
517340|NCT00955175|stage I non-small cell lung cancer|stage i non-small cell lung cancer
517341|NCT00955175|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
517342|NCT00955175|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
517343|NCT00955175|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
517344|NCT00955162|Substance Abuse, Intravenous|substance abuse, intravenous
517345|NCT00955162|Buprenorphine|buprenorphine
517346|NCT00955149|Primary sclerosing cholangitis|primary sclerosing cholangitis
517347|NCT00955149|Trisomy 7|trisomy 7
517348|NCT00955149|Cholangiocarcinoma|cholangiocarcinoma
517349|NCT00955149|Chemoprevention|chemoprevention
517350|NCT00955149|Erlotinib|erlotinib
517351|NCT00955136|ST elevated myocardial infarction|st elevated myocardial infarction
517352|NCT00955136|Acute coronary syndrome|acute coronary syndrome
517353|NCT00955136|MRX 801|mrx 801
517354|NCT00955136|Echocardiography|echocardiography
517355|NCT00955123|Inflammation|inflammation
517356|NCT00955123|Urea synthesis|urea synthesis
517357|NCT00955123|Catabolism|catabolism
517358|NCT00955123|Nitrogen balance|nitrogen balance
517359|NCT00955110|Opioid|opioid
517360|NCT00955110|Recreational|recreational
517361|NCT00955110|Oxymorphone|oxymorphone
517362|NCT00955110|Oxycodone|oxycodone
517363|NCT00955110|Extended Release|extended release
517364|NCT00955110|Healthy NonDependent Recreational Opioid Users|healthy nondependent recreational opioid users
517365|NCT00955097|Definity|definity
517366|NCT00955097|liver tumors|liver tumors
517367|NCT00955097|intra operative contrast|intra operative contrast
517368|NCT00955097|liver cancer|liver cancer
517369|NCT00955097|hepatic tumors|hepatic tumors
517370|NCT00955097|identify liver tumors|identify liver tumors
517371|NCT00955097|surgery liver tumors|surgery liver tumors
517372|NCT00955097|Patients with known hepatic tumors|patients with known hepatic tumors
517373|NCT00955071|exercise|exercise
517374|NCT00955071|physical activity|physical activity
517375|NCT00955071|diet|diet
517376|NCT00955071|metabolic risk|metabolic risk
517377|NCT00955071|visceral fat|visceral fat
517378|NCT00955071|Insulin Resistance|insulin resistance
517379|NCT00955058|PSA|psa
517380|NCT00955058|PCO|pco
517381|NCT00955058|PCOS|pcos
517382|NCT00955045|long-term tolerability and safety|long-term tolerability and safety
517383|NCT00955045|istradefylline treatment|istradefylline treatment
517384|NCT00955045|levodopa/carbidopa|levodopa/carbidopa
517385|NCT00955032|Parkinson's disease|parkinson's disease
517386|NCT00955032|Apathy|apathy
517387|NCT00955032|rTMS|rtms
517388|NCT00955032|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
517389|NCT00955032|Depression|depression
517390|NCT00955019|Barrett's|barrett's
517391|NCT00955019|Esophagus|esophagus
517392|NCT00955019|Reflux|reflux
517393|NCT00955019|dysplasia|dysplasia
517394|NCT00955019|adenocarcinoma|adenocarcinoma
517395|NCT00955006|HIV Seronegativity|hiv seronegativity
517396|NCT00955006|HIV Preventive Vaccine|hiv preventive vaccine
517397|NCT00954993|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
517398|NCT00954993|Vaniprevir|vaniprevir
517399|NCT00954993|MK-7009|mk-7009
517400|NCT00954980|Varicose Veins|varicose veins
517401|NCT00954980|Superficial Thrombophlebitis|superficial thrombophlebitis
517402|NCT00954980|Deep Vein Thrombosis|deep vein thrombosis
517403|NCT00954980|Ulceration|ulceration
517404|NCT00954980|leg pain|leg pain
517405|NCT00954980|leg swelling|leg swelling
517406|NCT00954967|Diabetes Mellitus|diabetes mellitus
517407|NCT00954967|Smoking Cessation|smoking cessation
517408|NCT00954967|Primary Health Care|primary health care
517409|NCT00954967|Motivational Interview|motivational interview
517410|NCT00954954|Arthroplasty|arthroplasty
517411|NCT00954954|Replacement|replacement
517412|NCT00954954|Knee|knee
517413|NCT00954954|Range of Motion|range of motion
517414|NCT00954941|Hematologic Disorder|hematologic disorder
517415|NCT00954941|Acute myelogenous leukemia|acute myelogenous leukemia
517416|NCT00954941|AML|aml
517417|NCT00954941|High-risk myelodysplastic syndrome|high-risk myelodysplastic syndrome
517418|NCT00954941|HR-MDS|hr-mds
517419|NCT00954941|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
517420|NCT00954941|CML|cml
517421|NCT00954941|Ondansetron|ondansetron
517422|NCT00954941|Zofran|zofran
517423|NCT00954941|Aprepitant|aprepitant
517424|NCT00954941|Emend|emend
517425|NCT00954941|L 754030|l 754030
517426|NCT00954941|MK 869|mk 869
517427|NCT00954941|Emesis|emesis
517428|NCT00954941|Nausea|nausea
517429|NCT00954941|Vomiting|vomiting
517430|NCT00954928|hand|hand
517431|NCT00954928|wrist|wrist
517432|NCT00954928|anticoagulation|anticoagulation
517433|NCT00954928|surgery|surgery
517434|NCT00954928|patients on anticoagulant medication|patients on anticoagulant medication
517435|NCT00954915|chronic plaque psoriasis|chronic plaque psoriasis
517436|NCT00954915|psoriatic arthritis|psoriatic arthritis
517437|NCT00954902|Spice|spice
517438|NCT00954902|responses to stress|responses to stress
517439|NCT00954902|Inflammatory|inflammatory
517440|NCT00954837|Thyroid cancer|thyroid cancer
517441|NCT00954837|thyroid FNA|thyroid fna
517442|NCT00954837|repeat FNA|repeat fna
517443|NCT00954837|thyroid screening|thyroid screening
517444|NCT00954837|thyroid ultrasonography|thyroid ultrasonography
517445|NCT00954837|FNA screening|fna screening
517446|NCT00954811|pregnancy|pregnancy
517447|NCT00954798|Influenza|influenza
517448|NCT00954798|Pandemic Flu|pandemic flu
517449|NCT00954798|Swine-origin Influenza|swine-origin influenza
517450|NCT00954798|Inactivated split-virion vaccine|inactivated split-virion vaccine
517451|NCT00954798|Adjuvant|adjuvant
517452|NCT00954798|Adult|adult
517453|NCT00954785|ankle|ankle
517454|NCT00954785|ligament|ligament
517455|NCT00954785|sprain|sprain
517456|NCT00954785|non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
517457|NCT00954785|treatment|treatment
517458|NCT00954785|Acute ankle ligament sprain|acute ankle ligament sprain
517459|NCT00954772|Staged versus Simultaneous Bilateral DBS|staged versus simultaneous bilateral dbs
517460|NCT00954759|Infantile colic|infantile colic
517461|NCT00954759|Chiropractic|chiropractic
517462|NCT00954759|Manipulation|manipulation
517463|NCT00954759|Randomized controlled trial|randomized controlled trial
517464|NCT00954746|Advanced Dupuytren's Disease|advanced dupuytren's disease
517465|NCT00954746|Muscular Diseases|muscular diseases
517466|NCT00954746|Musculoskeletal Diseases|musculoskeletal diseases
517467|NCT00954746|Contracture Joint Diseases|contracture joint diseases
517468|NCT00954746|Connective Tissue Diseases|connective tissue diseases
517469|NCT00954746|Dupuytren's Contracture|dupuytren's contracture
517470|NCT00954733|Hysteroscopic surgery|hysteroscopic surgery
517471|NCT00954733|Hypoventilation|hypoventilation
517472|NCT00954733|Co2|co2
517473|NCT00954733|Transcutaneous Co2 Monitor|transcutaneous co2 monitor
517474|NCT00954720|AML|aml
517475|NCT00954720|ALL|all
517476|NCT00954720|MDS|mds
517477|NCT00954720|iron overload|iron overload
517478|NCT00954707|Atherosclerosis|atherosclerosis
517479|NCT00954681|Cannabis|cannabis
517480|NCT00954681|quetiapine|quetiapine
517481|NCT00954668|Non-ST-elevation myocardial infarction|non-st-elevation myocardial infarction
517482|NCT00954668|angiography|angiography
517483|NCT00954668|percutaneous coronary intervention|percutaneous coronary intervention
517484|NCT00954668|timing|timing
517485|NCT00954655|gastrointestinal stromal tumor|gastrointestinal stromal tumor
517486|NCT00954642|Solid Tumor|solid tumor
517487|NCT00954642|Locally Advanced Solid Tumor|locally advanced solid tumor
517488|NCT00954642|Avastin|avastin
517489|NCT00954629|Osteoarthritis|osteoarthritis
517490|NCT00954629|Pain|pain
517491|NCT00954629|Knee|knee
517492|NCT00954616|Inappropriate Medications Associated|inappropriate medications associated
517493|NCT00954616|Alzheimer's disease|alzheimer's disease
517494|NCT00954603|delirium rating scale|delirium rating scale
517495|NCT00954603|clinical global improvement|clinical global improvement
517496|NCT00954603|extrapyramidal side effect|extrapyramidal side effect
517497|NCT00954577|obesity|obesity
517498|NCT00954577|diabetes|diabetes
517499|NCT00954577|exercise|exercise
517500|NCT00954577|education|education
517501|NCT00954577|child|child
517502|NCT00954564|arthralgia|arthralgia
517503|NCT00954564|stage I breast cancer|stage i breast cancer
517504|NCT00954564|stage II breast cancer|stage ii breast cancer
517505|NCT00954564|stage IIIA breast cancer|stage iiia breast cancer
517506|NCT00954525|Pancreatic Cancer|pancreatic cancer
517507|NCT00954512|Antibodies, neoplasm|antibodies, neoplasm
517508|NCT00954499|tactile stimulation|tactile stimulation
517509|NCT00954499|pain|pain
517510|NCT00954499|immunization|immunization
517511|NCT00954499|infant|infant
517512|NCT00954460|VPRIV|vpriv
517513|NCT00954460|Enzyme Replacement Therapy|enzyme replacement therapy
517514|NCT00954460|Gaucher disease|gaucher disease
517515|NCT00954460|glucocerebrosidase|glucocerebrosidase
517516|NCT00954460|beta-glucocerebrosidase|beta-glucocerebrosidase
517517|NCT00954460|Acid beta-glucocerebrosidase|acid beta-glucocerebrosidase
517518|NCT00954460|glucosylceramidase|glucosylceramidase
517519|NCT00954460|D-glucosyl-N-acylsphingosine glucohydrolase|d-glucosyl-n-acylsphingosine glucohydrolase
517520|NCT00954460|gene activation|gene activation
517521|NCT00954460|human|human
517522|NCT00954395|vitamin K antagonists, D-dimer,|vitamin k antagonists, d-dimer,
517523|NCT00954395|deep vein thrombosis, pulmonary embolism,|deep vein thrombosis, pulmonary embolism,
517524|NCT00954382|Down syndrome|down syndrome
517525|NCT00954382|IQ|iq
517526|NCT00954382|mental age|mental age
517527|NCT00954382|neuropsychological function|neuropsychological function
517528|NCT00954369|Alzheimer's disease|alzheimer's disease
517529|NCT00954369|AD|ad
517530|NCT00954369|W372|w372
517531|NCT00954369|W372000|w372000
517532|NCT00954369|[F-18]W372|[f-18]w372
517533|NCT00954369|exploratory|exploratory
517534|NCT00954369|imaging|imaging
517535|NCT00954356|Pain following 3rd molar/wisdom tooth extraction|pain following 3rd molar/wisdom tooth extraction
517536|NCT00954343|Foot Ulcers|foot ulcers
517537|NCT00954343|Extracorporeal Shockwave|extracorporeal shockwave
517538|NCT00954343|Chronic wound|chronic wound
517539|NCT00954330|rct, intervention, surgery, lateral ligament injury of the ankle|rct, intervention, surgery, lateral ligament injury of the ankle
517540|NCT00954330|REturn to pre-injury level|return to pre-injury level
517541|NCT00954317|epidural|epidural
517542|NCT00954317|labour analgesia|labour analgesia
517543|NCT00954304|Pgp inhibitor|pgp inhibitor
517544|NCT00954304|P-glycoprotein inhibitor|p-glycoprotein inhibitor
517545|NCT00954291|antinauseant and antiemetic|antinauseant and antiemetic
517546|NCT00954278|non small cell lung cancer|non small cell lung cancer
517547|NCT00954278|phase 1|phase 1
517548|NCT00954278|sorafenib|sorafenib
517549|NCT00954278|intrapatient dose escalation|intrapatient dose escalation
517550|NCT00954265|pregnancy occurence|pregnancy occurence
517551|NCT00954265|OHSS|ohss
517552|NCT00954226|Head & Neck squamous cell carcinoma|head & neck squamous cell carcinoma
517553|NCT00954226|HN cancer|hn cancer
517554|NCT00954226|Surgery|surgery
517555|NCT00954226|Erlotinib|erlotinib
517556|NCT00954226|Biomarkers|biomarkers
517557|NCT00954226|Phosphorylation of AKT|phosphorylation of akt
517558|NCT00954161|First aid|first aid
517559|NCT00954161|Helping behaviour|helping behaviour
517560|NCT00954161|Health education|health education
517561|NCT00954161|Myocardial infarction|myocardial infarction
517562|NCT00954161|Emergencies|emergencies
517563|NCT00954148|cancer|cancer
517564|NCT00954148|colorectal|colorectal
517565|NCT00954148|head/neck|head/neck
517566|NCT00954148|lung|lung
517567|NCT00954148|PET/CT|pet/ct
517665|NCT00953563|Venous Leg Ulcers|venous leg ulcers
517568|NCT00954135|neoadjuvant therapy, sorafenib, letrozolo, cyclophosphamide|neoadjuvant therapy, sorafenib, letrozolo, cyclophosphamide
517569|NCT00954122|Acute schizophrenia|acute schizophrenia
517570|NCT00954109|Insulin Resistance|insulin resistance
517571|NCT00954109|Type 2 Diabetes|type 2 diabetes
517572|NCT00954070|gastroesophageal reflux disease|gastroesophageal reflux disease
517573|NCT00954057|TED|ted
517574|NCT00954044|randomized clinical trial|randomized clinical trial
517575|NCT00954044|prostate cancer|prostate cancer
517576|NCT00954044|partnered exercise|partnered exercise
517577|NCT00954005|relapsed indolent lymphoma|relapsed indolent lymphoma
517578|NCT00954005|gemcitabine|gemcitabine
517579|NCT00954005|oxaliplatin|oxaliplatin
517580|NCT00954005|rituximab|rituximab
517581|NCT00953992|acute kidney disease|acute kidney disease
517582|NCT00953992|prognosis|prognosis
517583|NCT00953992|oxidative stress|oxidative stress
517584|NCT00953992|inflammation|inflammation
517585|NCT00953992|gene polymorphism|gene polymorphism
517586|NCT00953979|ankylosing spondylitis|ankylosing spondylitis
517587|NCT00953979|treatment|treatment
517588|NCT00953979|Sulfasalazine|sulfasalazine
517589|NCT00953979|kunxian capsule|kunxian capsule
517590|NCT00953914|pyridostigmine|pyridostigmine
517591|NCT00953914|autonomic modulation|autonomic modulation
517592|NCT00953914|diabetes mellitus|diabetes mellitus
517593|NCT00953914|heart rate variability|heart rate variability
517594|NCT00953888|Healthy volunteer|healthy volunteer
517595|NCT00953888|Single ascending dose|single ascending dose
517596|NCT00953888|Safety|safety
517597|NCT00953888|Tolerability|tolerability
517598|NCT00953888|Healthy volunteer study|healthy volunteer study
517599|NCT00953862|ADHD|adhd
517600|NCT00953862|Substance Use Disorder|substance use disorder
517601|NCT00953862|Residential Treatment Facility|residential treatment facility
517602|NCT00953849|Calcitriol|calcitriol
517603|NCT00953849|Celecoxib|celecoxib
517604|NCT00953849|Immunotherapy|immunotherapy
517605|NCT00953836|kinetics|kinetics
517606|NCT00953836|alkylresorcinol metabolites|alkylresorcinol metabolites
517607|NCT00953836|rye fiber|rye fiber
517608|NCT00953823|Thiamin supplementation|thiamin supplementation
517609|NCT00953823|Thiamin deficiency|thiamin deficiency
517610|NCT00953823|Heart failure|heart failure
517611|NCT00953823|Heart function|heart function
517612|NCT00953823|Vitamin B1 supplementation|vitamin b1 supplementation
517613|NCT00953810|heart failure|heart failure
517614|NCT00953810|education|education
517615|NCT00953810|non-pharmacological management|non-pharmacological management
517616|NCT00953810|prognosis|prognosis
517617|NCT00953797|Resistant Hypertension|resistant hypertension
517618|NCT00953797|Endothelial dysfunction|endothelial dysfunction
517619|NCT00953797|Enhanced External Counterpulsation|enhanced external counterpulsation
517620|NCT00953784|surgery|surgery
517621|NCT00953784|wound infections|wound infections
517622|NCT00953784|colorectal|colorectal
517623|NCT00953771|TTP|ttp
517624|NCT00953771|Thrombotic Thrombocytopenic Purpura|thrombotic thrombocytopenic purpura
517625|NCT00953758|Chronic Myeloid Leukemia Myelofibrosis Myelodysplastic Syndrome Acute myeloid Leukemia Hedgehog inhibitor|chronic myeloid leukemia myelofibrosis myelodysplastic syndrome acute myeloid leukemia hedgehog inhibitor
517626|NCT00953745|Depression|depression
517627|NCT00953745|Neuroimaging|neuroimaging
517628|NCT00953745|Aripiprazole|aripiprazole
517629|NCT00953745|Mood disorder|mood disorder
517630|NCT00953745|PET Scan|pet scan
517631|NCT00953745|fMRI|fmri
517632|NCT00953732|Peplin|peplin
517633|NCT00953732|Actinic keratosis|actinic keratosis
517634|NCT00953732|PEP005|pep005
517635|NCT00953719|Hip arthroplasty|hip arthroplasty
517636|NCT00953719|Acetabular cup|acetabular cup
517637|NCT00953719|Ceramic-on-polyethylene|ceramic-on-polyethylene
517638|NCT00953706|Fibrosis|fibrosis
517639|NCT00953706|Pancreatic Diseases|pancreatic diseases
517640|NCT00953706|Digestive System Diseases|digestive system diseases
517641|NCT00953706|Lung Diseases|lung diseases
517642|NCT00953706|Respiratory Tract Diseases|respiratory tract diseases
517643|NCT00953706|Genetic Diseases, Inborn|genetic diseases, inborn
517644|NCT00953706|Infant, Newborn, Diseases|infant, newborn, diseases
517645|NCT00953706|Pathologic Processes|pathologic processes
517646|NCT00953693|Induced pluripotent stem cells|induced pluripotent stem cells
517647|NCT00953693|Hepatic disorders|hepatic disorders
517648|NCT00953693|Eye disorders|eye disorders
517649|NCT00953693|Blood groups|blood groups
517650|NCT00953654|Generalized Anxiety Disorder|generalized anxiety disorder
517651|NCT00953654|Exercise Training|exercise training
517652|NCT00953654|Strength Training|strength training
517653|NCT00953654|Mental Health|mental health
517654|NCT00953641|Vaginal Misoprostol|vaginal misoprostol
517655|NCT00953641|Cervical ripening|cervical ripening
517656|NCT00953641|Endometrial biopsy|endometrial biopsy
517657|NCT00953628|endometrium|endometrium
517658|NCT00953628|histology|histology
517659|NCT00953628|pregnancy|pregnancy
517660|NCT00953615|PSC|psc
517661|NCT00953615|Thalidomide|thalidomide
517662|NCT00953589|treatment naive|treatment naive
517663|NCT00953576|castration resistant prostate cancer|castration resistant prostate cancer
517664|NCT00953576|KHAD|khad
517666|NCT00953537|stage IV breast cancer|stage iv breast cancer
517667|NCT00953524|Influenza|influenza
517668|NCT00953524|Pandemic Flu|pandemic flu
517669|NCT00953524|Swine-origin A/H1N1 Influenza|swine-origin a/h1n1 influenza
517670|NCT00953524|Adult|adult
517671|NCT00953511|esophagus|esophagus
517672|NCT00953511|chemoradiation|chemoradiation
517673|NCT00953511|excision repair cross-complementing gene|excision repair cross-complementing gene
517674|NCT00953511|polymorphism|polymorphism
517675|NCT00953511|response prediction|response prediction
517676|NCT00953498|diabetes|diabetes
517677|NCT00953498|glitazones|glitazones
517678|NCT00953498|HDL|hdl
517679|NCT00953485|Sjogren's Syndrome|sjogren's syndrome
517680|NCT00953485|Mesenchymal Stem Cells|mesenchymal stem cells
517681|NCT00953485|Transplantation|transplantation
517682|NCT00953472|hypertension treatment|hypertension treatment
517683|NCT00953459|extensive stage small cell lung cancer|extensive stage small cell lung cancer
517684|NCT00953459|recurrent small cell lung cancer|recurrent small cell lung cancer
517685|NCT00953446|metastatic renal cell carcinoma|metastatic renal cell carcinoma
517686|NCT00953446|ASL MRI|asl mri
517687|NCT00953446|sunitinib|sunitinib
517688|NCT00953446|AMG386|amg386
517689|NCT00953433|Intratracheal|intratracheal
517690|NCT00953420|nasopharyngeal carcinoma|nasopharyngeal carcinoma
517691|NCT00953420|Carboplatin|carboplatin
517692|NCT00953420|Docetaxel|docetaxel
517693|NCT00953420|Epstein-Barr Virus|epstein-barr virus
517694|NCT00953420|T Lymphocytes|t lymphocytes
517695|NCT00953420|EBV-CTLs|ebv-ctls
517696|NCT00953394|octreotide LAR|octreotide lar
517697|NCT00953394|neuroendocrine carcinoma|neuroendocrine carcinoma
517698|NCT00953394|metronomic 5fluorouracil|metronomic 5fluorouracil
517699|NCT00953381|Ilaprazole|ilaprazole
517700|NCT00953381|Proton pump inhibitor|proton pump inhibitor
517701|NCT00953381|Duodenal ulcer|duodenal ulcer
517702|NCT00953381|Acid suppression|acid suppression
517703|NCT00953381|Randomized trial|randomized trial
517704|NCT00953368|remote ischemic preconditioning|remote ischemic preconditioning
517705|NCT00953368|cognitive function|cognitive function
517706|NCT00953368|off-pump coronary artery bypass graft|off-pump coronary artery bypass graft
517707|NCT00953342|AEROBIC EXERCISE|aerobic exercise
517708|NCT00953342|ASTHMA CONTROL|asthma control
517709|NCT00953342|ASTHMA QUALITY OF LIFE|asthma quality of life
517710|NCT00953342|INFLAMMATION|inflammation
517711|NCT00953342|TREATMENT|treatment
517712|NCT00953303|heart failure|heart failure
517713|NCT00953303|prednisone|prednisone
517714|NCT00953303|cardiovascular mortality|cardiovascular mortality
517715|NCT00953303|renal function|renal function
517716|NCT00953290|Cellulite|cellulite
517717|NCT00953290|Adipose tissue|adipose tissue
517718|NCT00953290|Circumference|circumference
517719|NCT00953290|Reduction|reduction
517720|NCT00953290|Thigh|thigh
517721|NCT00953277|Nerve Repair|nerve repair
517722|NCT00953277|Erectile Function|erectile function
517723|NCT00953277|Prostate Cancer|prostate cancer
517724|NCT00953277|Robot Assisted Laparoscopic Prostatectomy|robot assisted laparoscopic prostatectomy
517725|NCT00953277|Continence|continence
517726|NCT00953251|high sensitive troponin T; non-STEMI; early detection.|high sensitive troponin t; non-stemi; early detection.
517727|NCT00953251|To detect non-STEMI in a cohort of patients with acute coronary syndrome|to detect non-stemi in a cohort of patients with acute coronary syndrome
517728|NCT00953225|prostate cancer|prostate cancer
517729|NCT00953225|vitamin D|vitamin d
517730|NCT00953212|atrial fibrillation|atrial fibrillation
517731|NCT00953212|cardiac surgery|cardiac surgery
517732|NCT00953212|open heart surgery|open heart surgery
517733|NCT00953199|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
517734|NCT00953199|ERCP|ercp
517735|NCT00953199|pancreatitis|pancreatitis
517736|NCT00953199|lidocaine|lidocaine
517737|NCT00953199|post-ERCP pancreatitis|post-ercp pancreatitis
517738|NCT00953186|Diabetes|diabetes
517739|NCT00953186|Foot ulcer|foot ulcer
517740|NCT00953186|Neuropathy|neuropathy
517741|NCT00953186|Ischemia|ischemia
517742|NCT00953160|Cellulite|cellulite
517743|NCT00953160|Adipose tissue|adipose tissue
517744|NCT00953160|Circumference|circumference
517745|NCT00953160|Reduction|reduction
517746|NCT00953160|Thigh|thigh
517747|NCT00953160|Abdomen|abdomen
517748|NCT00953160|Flank|flank
517749|NCT00953134|periconceptional|periconceptional
517750|NCT00953134|iron|iron
517751|NCT00953134|folic acid|folic acid
517752|NCT00953134|supplementation|supplementation
517753|NCT00953121|irinotecan|irinotecan
517754|NCT00953121|carboplatin|carboplatin
517755|NCT00953121|bevacizumab|bevacizumab
517756|NCT00953121|Avastin|avastin
517757|NCT00953095|Autism Spectrum Disorder|autism spectrum disorder
517758|NCT00953095|treatment|treatment
517759|NCT00953095|joint attention|joint attention
517760|NCT00953095|communication|communication
517761|NCT00953095|language|language
517762|NCT00953043|lubiprostone|lubiprostone
517763|NCT00953043|colon|colon
517764|NCT00953043|motility|motility
517765|NCT00953043|sensation|sensation
517859|NCT00952640|post-partum|post-partum
517766|NCT00953017|Efficacy of bowel cleansing|efficacy of bowel cleansing
517767|NCT00953017|Patient tolerability|patient tolerability
517768|NCT00953017|Amitiza|amitiza
517769|NCT00953017|Dulcolax|dulcolax
517770|NCT00953017|Miralax|miralax
517771|NCT00953017|Colonoscopy preparation|colonoscopy preparation
517772|NCT00953017|Bowel preparation|bowel preparation
517773|NCT00953017|Screening colonoscopy|screening colonoscopy
517774|NCT00953004|dietary fiber|dietary fiber
517775|NCT00953004|obesity|obesity
517776|NCT00953004|apparent energy digestibility|apparent energy digestibility
517777|NCT00952978|Ilaprazole|ilaprazole
517778|NCT00952978|Proton pump inhibitor|proton pump inhibitor
517779|NCT00952978|Duodenal ulcer|duodenal ulcer
517780|NCT00952978|Acid suppression|acid suppression
517781|NCT00952978|Randomized trial|randomized trial
517782|NCT00952965|BP|bp
517783|NCT00952939|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
517784|NCT00952939|iris melanoma|iris melanoma
517785|NCT00952939|intraocular melanoma|intraocular melanoma
517786|NCT00952939|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
517787|NCT00952926|Watchful Waiting|watchful waiting
517788|NCT00952926|Rectal cancer|rectal cancer
517789|NCT00952926|Observation|observation
517790|NCT00952926|Avoid operation|avoid operation
517791|NCT00952900|TMJMD|tmjmd
517792|NCT00952900|Acute Pain|acute pain
517793|NCT00952900|RDC/TMD|rdc/tmd
517794|NCT00952900|Community Treatment Clinics|community treatment clinics
517795|NCT00952900|RCT|rct
517796|NCT00952900|Evidence-Based Outcomes|evidence-based outcomes
517797|NCT00952900|Short- and long-term follow-up|short- and long-term follow-up
517798|NCT00952900|Biopsychosocial|biopsychosocial
517799|NCT00952900|Assessment and Treatment|assessment and treatment
517800|NCT00952900|Ability to read and write English|ability to read and write english
517801|NCT00952900|6 months' or less duration of TMD|6 months' or less duration of tmd
517802|NCT00952900|No other pain-related conditions|no other pain-related conditions
517803|NCT00952874|anal cancer|anal cancer
517804|NCT00952874|Molecular biology|molecular biology
517805|NCT00952874|HIV status|hiv status
517806|NCT00952874|HPV infection|hpv infection
517807|NCT00952874|Microsatellite instability|microsatellite instability
517808|NCT00952874|Biopsy proven Squamous Cell carcinoma of the Anus|biopsy proven squamous cell carcinoma of the anus
517809|NCT00952874|Squamous Cell carcinoma of the Anus|squamous cell carcinoma of the anus
517810|NCT00952861|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
517811|NCT00952861|Infection|infection
517812|NCT00952861|Antibiotics|antibiotics
517813|NCT00952848|pain|pain
517814|NCT00952848|neurotoxicity|neurotoxicity
517815|NCT00952848|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
517816|NCT00952848|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
517817|NCT00952848|peripheral neuropathy|peripheral neuropathy
517818|NCT00952835|Asthma|asthma
517819|NCT00952835|rhinitis|rhinitis
517820|NCT00952835|EIB|eib
517821|NCT00952835|Exhaled Nitric oxide|exhaled nitric oxide
517822|NCT00952835|lung function|lung function
517823|NCT00952835|vitamin d|vitamin d
517824|NCT00952796|intra-abdominal infection|intra-abdominal infection
517825|NCT00952796|moxifloxacin|moxifloxacin
517826|NCT00952796|ampicillin/sulbactam|ampicillin/sulbactam
517827|NCT00952783|Peplin|peplin
517828|NCT00952783|Actinic keratosis|actinic keratosis
517829|NCT00952783|PEP005|pep005
517830|NCT00952770|Coronary artery disease|coronary artery disease
517831|NCT00952770|Coronary intervention|coronary intervention
517832|NCT00952770|intima-media thickness|intima-media thickness
517833|NCT00952757|APS-related hyperprolactinaemia|aps-related hyperprolactinaemia
517834|NCT00952757|Quetiapine|quetiapine
517835|NCT00952757|Schizophrenia|schizophrenia
517836|NCT00952757|Bipolar|bipolar
517837|NCT00952744|acute myocardial infarction|acute myocardial infarction
517838|NCT00952744|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
517839|NCT00952744|STEMI|stemi
517840|NCT00952744|non-ST-segment elevation myocardial infarction|non-st-segment elevation myocardial infarction
517841|NCT00952744|NSTEMI|nstemi
517842|NCT00952744|unstable angina|unstable angina
517843|NCT00952744|unstable angina pectoris|unstable angina pectoris
517844|NCT00952744|UA|ua
517845|NCT00952744|UAP|uap
517846|NCT00952692|breast cancer|breast cancer
517847|NCT00952692|HER2|her2
517848|NCT00952692|Lapatinib|lapatinib
517849|NCT00952692|dHER2 ASCI|dher2 asci
517850|NCT00952692|overexpressing HER2|overexpressing her2
517851|NCT00952692|refractory to trastuzumab|refractory to trastuzumab
517852|NCT00952679|The investigators evaluated the new method by comparing lymph nodes defined by CT and traditional ways.|the investigators evaluated the new method by comparing lymph nodes defined by ct and traditional ways.
517853|NCT00952666|Prostate Cancer|prostate cancer
517854|NCT00952666|Transrectal Ultrasound Imaging of Prostate|transrectal ultrasound imaging of prostate
517855|NCT00952666|Neurovascular Bundles|neurovascular bundles
517856|NCT00952666|Robot Assisted Laparoscopic Radical Prostatectomy|robot assisted laparoscopic radical prostatectomy
517857|NCT00952653|depression|depression
517858|NCT00952640|vitamin A|vitamin a
517860|NCT00952640|infant|infant
517861|NCT00952640|acute phase response|acute phase response
517862|NCT00952627|Cardiac fibrosis|cardiac fibrosis
517863|NCT00952627|Diastolic dysfunction|diastolic dysfunction
517864|NCT00952627|Hypertension|hypertension
517865|NCT00952614|retinal vein occlusion|retinal vein occlusion
517866|NCT00952614|sustained drug delivery implant|sustained drug delivery implant
517867|NCT00952614|steroid|steroid
517868|NCT00952614|macular edema|macular edema
517869|NCT00952601|Tourette|tourette
517870|NCT00952601|Atkins|atkins
517871|NCT00952601|Ketosis|ketosis
517872|NCT00952601|Tic|tic
517873|NCT00952588|Acute Myeloid Leukaemia,|acute myeloid leukaemia,
517874|NCT00952588|AML|aml
517875|NCT00952575|Prevention of foeto-maternal allo-immunisation|prevention of foeto-maternal allo-immunisation
517876|NCT00952562|vitamin d|vitamin d
517877|NCT00952562|calcium|calcium
517878|NCT00952562|blood pressure|blood pressure
517879|NCT00952536|Randomised controlled trial|randomised controlled trial
517880|NCT00952536|Double blind fully masked|double blind fully masked
517881|NCT00952536|Dietary supplement|dietary supplement
517882|NCT00952523|acne|acne
517883|NCT00952523|irritation|irritation
517884|NCT00952523|objective sensory methods|objective sensory methods
517885|NCT00952510|Range of motion, articular|range of motion, articular
517886|NCT00952510|Cervical spine|cervical spine
517887|NCT00952497|Gastric Cancer|gastric cancer
517888|NCT00952497|Gastro-Esophageal Cancer|gastro-esophageal cancer
517889|NCT00952497|GE-Junction|ge-junction
517890|NCT00952497|Advanced Gastric Cancer|advanced gastric cancer
517891|NCT00952484|Hypophosphatasia|hypophosphatasia
517892|NCT00952484|HPP|hpp
517893|NCT00952484|Bone Disease|bone disease
517894|NCT00952484|Soft Bones|soft bones
517895|NCT00952484|Low Alkaline Phosphatase|low alkaline phosphatase
517896|NCT00952484|genetic metabolic disorder|genetic metabolic disorder
517897|NCT00952484|alkaline phosphatase|alkaline phosphatase
517898|NCT00952484|tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
517899|NCT00952484|rickets|rickets
517900|NCT00952484|osteomalacia|osteomalacia
517901|NCT00952471|Asthma|asthma
517902|NCT00952471|Children|children
517903|NCT00952471|CPOE|cpoe
517904|NCT00952471|Decision Support|decision support
517905|NCT00952471|Framing|framing
517906|NCT00952471|Heuristic|heuristic
517907|NCT00952471|Order Sets|order sets
517908|NCT00952458|Safety|safety
517909|NCT00952458|Midazolam and propofol sedation|midazolam and propofol sedation
517910|NCT00952458|ERCP|ercp
517911|NCT00952458|Bispectral Index monitoring|bispectral index monitoring
517912|NCT00952432|Carpal Tunnel Syndrome|carpal tunnel syndrome
517913|NCT00952432|Multiple Excitability Test|multiple excitability test
517914|NCT00952432|Nerve Conduction Study|nerve conduction study
517915|NCT00952432|QtracW|qtracw
517916|NCT00952432|carbamazepine|carbamazepine
517917|NCT00952432|Acupuncture|acupuncture
517918|NCT00952419|Influenza|influenza
517919|NCT00952419|Pandemic Flu|pandemic flu
517920|NCT00952419|Swine-origin A/H1N1 Influenza|swine-origin a/h1n1 influenza
517921|NCT00952419|Children|children
517922|NCT00952406|Pelvic Floor Disorders|pelvic floor disorders
517923|NCT00952406|Sexual Function|sexual function
517924|NCT00952406|Incontinence|incontinence
517925|NCT00952406|Pelvic Organ Prolapse|pelvic organ prolapse
517926|NCT00952393|receptors nicotinic|receptors nicotinic
517927|NCT00952380|VTE|vte
517928|NCT00952354|Down syndrome|down syndrome
517929|NCT00952354|MLU|mlu
517930|NCT00952354|language development|language development
517931|NCT00952354|language assessment|language assessment
517932|NCT00952341|CINV|cinv
517933|NCT00952328|breastfeeding outcomes|breastfeeding outcomes
517934|NCT00952328|breastfeeding self-efficacy|breastfeeding self-efficacy
517935|NCT00952328|infant weight loss|infant weight loss
517936|NCT00952315|kidney stones|kidney stones
517937|NCT00952315|intracorporeal lithotriptors|intracorporeal lithotriptors
517938|NCT00952315|kidney stone removal|kidney stone removal
517939|NCT00952302|Hypoxia|hypoxia
517940|NCT00952302|Iron|iron
517941|NCT00952302|Hypoxia-Inducible Factor 1|hypoxia-inducible factor 1
517942|NCT00952302|Chronic mountain sickness|chronic mountain sickness
517943|NCT00952289|Myelofibrosis|myelofibrosis
517944|NCT00952289|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
517945|NCT00952289|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
517946|NCT00952276|Influenza Pandemic Flu Swine-origin A/H1N1 Influenza Adults|influenza pandemic flu swine-origin a/h1n1 influenza adults
517947|NCT00952263|Hepatitis C|hepatitis c
517948|NCT00952263|Phase I|phase i
517949|NCT00952263|Infusion|infusion
517950|NCT00952263|Pharmacokinetics|pharmacokinetics
517951|NCT00952263|MBL-HCV1|mbl-hcv1
517952|NCT00952263|Monoclonal antibody|monoclonal antibody
517953|NCT00952263|Safety Assessment|safety assessment
517954|NCT00952250|quality improvement|quality improvement
517955|NCT00952237|Autologous Peripheral Blood Stem Cell Transplant|autologous peripheral blood stem cell transplant
517956|NCT00952237|IL-2|il-2
517957|NCT00952237|GM-CSF|gm-csf
517958|NCT00952224|myocardial salvage|myocardial salvage
517959|NCT00952224|cardiovascular magnetic resonance|cardiovascular magnetic resonance
517960|NCT00952224|magnetic resonance imaging|magnetic resonance imaging
517961|NCT00952224|myocardial infarction|myocardial infarction
517962|NCT00952224|prognosis|prognosis
517963|NCT00952211|stroke|stroke
517964|NCT00952211|obstructive sleep apnea|obstructive sleep apnea
517965|NCT00952211|fatigue|fatigue
517966|NCT00952211|quality of life|quality of life
517967|NCT00952185|viral infection|viral infection
517968|NCT00952185|aplastic anemia|aplastic anemia
517969|NCT00952185|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
517970|NCT00952185|acute undifferentiated leukemia|acute undifferentiated leukemia
517971|NCT00952185|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
517972|NCT00952185|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
517973|NCT00952185|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
517974|NCT00952185|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
517975|NCT00952185|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
517976|NCT00952185|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
517977|NCT00952185|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
517978|NCT00952185|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
517979|NCT00952185|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
517980|NCT00952185|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
517981|NCT00952185|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
517982|NCT00952185|mast cell leukemia|mast cell leukemia
517983|NCT00952185|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
517984|NCT00952185|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
517985|NCT00952185|prolymphocytic leukemia|prolymphocytic leukemia
517986|NCT00952185|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
517987|NCT00952185|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
517988|NCT00952185|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
517989|NCT00952185|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
517990|NCT00952185|refractory hairy cell leukemia|refractory hairy cell leukemia
517991|NCT00952185|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
517992|NCT00952185|secondary acute myeloid leukemia|secondary acute myeloid leukemia
517993|NCT00952185|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
517994|NCT00952185|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
517995|NCT00952185|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
517996|NCT00952185|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
517997|NCT00952185|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
517998|NCT00952185|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
517999|NCT00952185|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
518000|NCT00952185|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
518001|NCT00952185|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
518002|NCT00952185|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
518003|NCT00952185|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
518004|NCT00952185|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
518005|NCT00952185|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
518006|NCT00952185|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
518007|NCT00952185|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
518008|NCT00952185|anaplastic large cell lymphoma|anaplastic large cell lymphoma
518009|NCT00952185|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
518010|NCT00952185|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
518011|NCT00952185|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
518012|NCT00952185|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
518013|NCT00952185|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
518014|NCT00952185|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
518015|NCT00952185|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
518016|NCT00952185|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
518017|NCT00952185|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
518018|NCT00952185|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
518019|NCT00952185|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
518020|NCT00952185|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
518021|NCT00952185|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
518022|NCT00952185|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
518023|NCT00952185|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
518024|NCT00952185|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
518025|NCT00952185|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
518026|NCT00952185|splenic marginal zone lymphoma|splenic marginal zone lymphoma
518027|NCT00952185|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
518028|NCT00952185|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
518029|NCT00952185|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
518030|NCT00952185|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
518031|NCT00952185|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
518032|NCT00952185|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
518033|NCT00952185|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
518034|NCT00952185|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
518035|NCT00952185|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
518036|NCT00952185|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
518037|NCT00952185|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
518038|NCT00952185|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
518039|NCT00952185|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
518040|NCT00952185|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
518041|NCT00952185|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
518042|NCT00952185|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
518043|NCT00952185|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
518044|NCT00952185|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
518045|NCT00952185|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
518046|NCT00952185|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
518047|NCT00952185|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
518048|NCT00952185|stage I mantle cell lymphoma|stage i mantle cell lymphoma
518049|NCT00952185|stage I marginal zone lymphoma|stage i marginal zone lymphoma
518050|NCT00952185|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
518051|NCT00952185|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
518052|NCT00952185|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
518053|NCT00952185|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
518054|NCT00952185|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
518055|NCT00952185|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
518056|NCT00952185|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
518057|NCT00952185|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
518058|NCT00952185|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
518059|NCT00952185|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
518060|NCT00952185|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
518061|NCT00952185|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
518062|NCT00952185|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
518063|NCT00952185|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
518064|NCT00952185|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
518065|NCT00952185|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
518066|NCT00952185|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
518067|NCT00952185|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
518068|NCT00952185|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
518069|NCT00952185|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
518070|NCT00952185|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
518071|NCT00952185|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
518072|NCT00952185|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
518073|NCT00952185|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
518074|NCT00952185|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
518075|NCT00952185|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
518076|NCT00952185|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
518077|NCT00952185|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
518078|NCT00952185|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
518079|NCT00952185|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
518080|NCT00952185|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
518081|NCT00952185|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
518082|NCT00952185|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
518083|NCT00952185|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
518084|NCT00952185|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
518085|NCT00952185|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
518170|NCT00951938|Trinity Evolution|trinity evolution
518086|NCT00952185|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
518087|NCT00952185|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
518088|NCT00952185|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
518089|NCT00952185|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
518090|NCT00952185|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
518091|NCT00952185|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
518092|NCT00952185|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
518093|NCT00952185|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
518094|NCT00952185|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
518095|NCT00952185|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
518096|NCT00952185|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
518097|NCT00952185|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
518098|NCT00952185|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
518099|NCT00952185|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
518100|NCT00952185|intraocular lymphoma|intraocular lymphoma
518101|NCT00952185|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
518102|NCT00952185|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
518103|NCT00952185|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
518104|NCT00952185|chronic eosinophilic leukemia|chronic eosinophilic leukemia
518105|NCT00952185|chronic neutrophilic leukemia|chronic neutrophilic leukemia
518106|NCT00952185|primary myelofibrosis|primary myelofibrosis
518107|NCT00952185|essential thrombocythemia|essential thrombocythemia
518108|NCT00952185|polycythemia vera|polycythemia vera
518109|NCT00952185|extramedullary plasmacytoma|extramedullary plasmacytoma
518110|NCT00952185|isolated plasmacytoma of bone|isolated plasmacytoma of bone
518111|NCT00952185|stage I multiple myeloma|stage i multiple myeloma
518112|NCT00952185|stage II multiple myeloma|stage ii multiple myeloma
518113|NCT00952185|stage III multiple myeloma|stage iii multiple myeloma
518114|NCT00952185|primary systemic amyloidosis|primary systemic amyloidosis
518115|NCT00952185|refractory multiple myeloma|refractory multiple myeloma
518116|NCT00952185|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
518117|NCT00952185|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
518118|NCT00952185|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
518119|NCT00952185|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
518120|NCT00952172|Stair stepping training|stair stepping training
518121|NCT00952172|OSAS|osas
518122|NCT00952172|cardiopulmonary fitness|cardiopulmonary fitness
518123|NCT00952172|sleep disturbance|sleep disturbance
518124|NCT00952172|Actigraphy|actigraphy
518125|NCT00952159|tramadol|tramadol
518126|NCT00952159|CYP2D6|cyp2d6
518127|NCT00952159|O-demethyl-tramadol|o-demethyl-tramadol
518128|NCT00952159|poor metabolizer|poor metabolizer
518129|NCT00952159|genotyping|genotyping
518130|NCT00952159|phenotyping|phenotyping
518131|NCT00952146|NOTES|notes
518132|NCT00952146|Transgastric|transgastric
518133|NCT00952146|Appendectomy|appendectomy
518134|NCT00952146|Safety|safety
518135|NCT00952146|Feasibility|feasibility
518136|NCT00952133|PONV|ponv
518137|NCT00952133|Outpatient surgery|outpatient surgery
518138|NCT00952133|Laparoscopic abdominal surgery|laparoscopic abdominal surgery
518139|NCT00952133|Laparoscopic gynecologic surgery|laparoscopic gynecologic surgery
518140|NCT00952120|Wound healing|wound healing
518141|NCT00952120|Negative pressure wound therapy|negative pressure wound therapy
518142|NCT00952120|Skin graft|skin graft
518143|NCT00952107|breast cancer|breast cancer
518144|NCT00952107|breast reconstructive surgery|breast reconstructive surgery
518145|NCT00952107|flap assessment|flap assessment
518146|NCT00952094|Healthy volunteer|healthy volunteer
518147|NCT00952081|Hypertension|hypertension
518148|NCT00952081|Neurosurgery|neurosurgery
518149|NCT00952081|bloodpressure control|bloodpressure control
518150|NCT00952081|brain tumor resection|brain tumor resection
518151|NCT00952081|epilepsy focus resection|epilepsy focus resection
518152|NCT00952068|Back Pain|back pain
518153|NCT00952055|neopterin|neopterin
518154|NCT00952055|macrophage|macrophage
518155|NCT00952055|inflammation|inflammation
518156|NCT00952042|Tendinopathy, Achilles, Eccentric training, Heavy slow resistance training|tendinopathy, achilles, eccentric training, heavy slow resistance training
518157|NCT00952029|stage IV colon cancer|stage iv colon cancer
518158|NCT00952029|stage IV rectal cancer|stage iv rectal cancer
518159|NCT00952016|colorectal cancer|colorectal cancer
518160|NCT00952016|MSH2|msh2
518161|NCT00952016|metastatic|metastatic
518162|NCT00952003|Avastin|avastin
518163|NCT00952003|Campto|campto
518164|NCT00952003|Oxaliplatin|oxaliplatin
518165|NCT00952003|Taxotere|taxotere
518166|NCT00951977|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
518167|NCT00951977|Transplantation|transplantation
518168|NCT00951977|Living Kidney Donation|living kidney donation
518169|NCT00951977|Kidney Transplant|kidney transplant
518171|NCT00951938|Anterior Cervical Discectomy and Fusion|anterior cervical discectomy and fusion
518172|NCT00951938|Allograft|allograft
518173|NCT00951925|diagnostic bone marrow biopsies|diagnostic bone marrow biopsies
518174|NCT00951925|bone marrow harvesting for autologous BMT|bone marrow harvesting for autologous bmt
518175|NCT00951912|genistein|genistein
518176|NCT00951912|daidzein|daidzein
518177|NCT00951912|impaired glucose regulation|impaired glucose regulation
518178|NCT00951912|glucose metabolism|glucose metabolism
518179|NCT00951912|lipids metabolism|lipids metabolism
518180|NCT00951912|inflammation|inflammation
518181|NCT00951912|women|women
518182|NCT00951899|Incretins|incretins
518183|NCT00951899|colesevelam|colesevelam
518184|NCT00951899|hepatobiliary circulation|hepatobiliary circulation
518185|NCT00951886|Ataxia Teleangiectasia|ataxia teleangiectasia
518186|NCT00951886|Spirometry|spirometry
518187|NCT00951886|Respiratory rare diseases|respiratory rare diseases
518188|NCT00951860|Fullterm Birth|fullterm birth
518189|NCT00951860|Neonate|neonate
518190|NCT00951860|Prematurity|prematurity
518191|NCT00951860|Neurodevelopment|neurodevelopment
518192|NCT00951860|Autonomic Nervous System activity|autonomic nervous system activity
518193|NCT00951847|Oxcarbazepine oral suspension fed study|oxcarbazepine oral suspension fed study
518194|NCT00951834|Alzheimer´s Disease|alzheimer´s disease
518195|NCT00951834|Epigallocatechin-Gallate|epigallocatechin-gallate
518196|NCT00951834|Neuroprotection|neuroprotection
518197|NCT00951834|ADAS-COG|adas-cog
518198|NCT00951834|early stage of Alzheimer's Disease|early stage of alzheimer's disease
518199|NCT00951821|Suicidal Ideation|suicidal ideation
518200|NCT00951821|Suicide Attempts|suicide attempts
518201|NCT00951808|Anemia, Sickle Cell|anemia, sickle cell
518202|NCT00951808|Acute Chest Syndrome|acute chest syndrome
518203|NCT00951808|Secretory phospholipase A2(sPLA2)|secretory phospholipase a2(spla2)
518204|NCT00951795|HIV|hiv
518205|NCT00951795|AIDS|aids
518206|NCT00951795|CD4|cd4
518207|NCT00951782|COPD|copd
518208|NCT00951756|Dietary fat|dietary fat
518209|NCT00951756|Microbiome composition|microbiome composition
518210|NCT00951756|Controlled feeding experiment|controlled feeding experiment
518211|NCT00951743|AIDS|aids
518212|NCT00951743|HIV|hiv
518213|NCT00951743|mDAPTA|mdapta
518214|NCT00951730|Down Syndrome|down syndrome
518215|NCT00951730|Adult|adult
518216|NCT00951730|Children|children
518217|NCT00951730|Sleep apnea|sleep apnea
518218|NCT00951730|Sleep hypopnea|sleep hypopnea
518219|NCT00951730|Polysomnography|polysomnography
518220|NCT00951717|Postpartum Depressive Symptoms|postpartum depressive symptoms
518221|NCT00951717|Physical Symptoms|physical symptoms
518222|NCT00951717|Emotional Symptoms|emotional symptoms
518223|NCT00951717|Infant Colic|infant colic
518224|NCT00951717|Social Support|social support
518225|NCT00951717|Breastfeeding|breastfeeding
518226|NCT00951704|CPR|cpr
518227|NCT00951704|Tissue Perfusion|tissue perfusion
518228|NCT00951704|invasive arterial pressure|invasive arterial pressure
518229|NCT00951704|exhaled carbon dioxide|exhaled carbon dioxide
518230|NCT00951704|Quality of life|quality of life
518231|NCT00951704|Quality of chest compressions|quality of chest compressions
518232|NCT00951704|Epidemiology of sudden cardiac arrest(OHCA)|epidemiology of sudden cardiac arrest(ohca)
518233|NCT00951691|Elderly|elderly
518234|NCT00951691|Acute Medical Rehabilitation|acute medical rehabilitation
518235|NCT00951678|ultrasound|ultrasound
518236|NCT00951678|femoral vein|femoral vein
518237|NCT00951678|internal jugular vein|internal jugular vein
518238|NCT00951665|Trastuzumab DM1 (T-DM1)|trastuzumab dm1 (t-dm1)
518239|NCT00951665|Trastuzumab emtansine|trastuzumab emtansine
518240|NCT00951665|Armed Herceptin|armed herceptin
518241|NCT00951665|HER2|her2
518242|NCT00951665|HER2+|her2+
518243|NCT00951665|HER2 Positive Breast Cancer|her2 positive breast cancer
518244|NCT00951652|CBT|cbt
518245|NCT00951652|GAD|gad
518246|NCT00951652|Interpersonal Therapy|interpersonal therapy
518247|NCT00951652|Emotion-Focused Therapy|emotion-focused therapy
518248|NCT00951639|Cassia|cassia
518249|NCT00951639|Cinnamon|cinnamon
518250|NCT00951639|Blood Glucose|blood glucose
518251|NCT00951639|Endurance exercise|endurance exercise
518252|NCT00951639|Acute exercise|acute exercise
518253|NCT00951639|Overweight|overweight
518254|NCT00951639|Obesity|obesity
518255|NCT00951639|Women|women
518256|NCT00951626|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
518257|NCT00951626|therapy-related toxicity|therapy-related toxicity
518258|NCT00951626|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
518259|NCT00951626|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
518260|NCT00951626|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
518261|NCT00951626|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
518262|NCT00951626|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
518263|NCT00951626|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
518264|NCT00951626|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
518265|NCT00951626|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
518266|NCT00951626|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
518267|NCT00951626|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
518268|NCT00951626|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
518269|NCT00951626|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
518270|NCT00951626|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
518271|NCT00951626|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
518272|NCT00951626|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
518273|NCT00951626|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
518274|NCT00951626|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
518275|NCT00951626|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
518276|NCT00951626|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
518277|NCT00951626|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
518278|NCT00951626|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
518279|NCT00951626|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
518280|NCT00951626|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
518281|NCT00951626|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
518282|NCT00951626|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
518283|NCT00951626|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
518284|NCT00951626|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
518285|NCT00951626|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
518286|NCT00951626|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
518287|NCT00951626|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
518288|NCT00951626|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
518289|NCT00951626|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
518290|NCT00951626|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
518291|NCT00951626|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
518292|NCT00951626|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
518293|NCT00951626|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
518294|NCT00951626|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
518295|NCT00951626|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
518296|NCT00951626|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
518297|NCT00951626|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
518298|NCT00951626|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
518299|NCT00951626|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
518300|NCT00951626|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
518301|NCT00951626|splenic marginal zone lymphoma|splenic marginal zone lymphoma
518302|NCT00951626|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
518303|NCT00951626|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
518304|NCT00951626|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
518305|NCT00951626|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
518306|NCT00951626|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
518307|NCT00951626|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
518308|NCT00951626|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
518309|NCT00951626|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
518310|NCT00951626|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
518311|NCT00951626|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
518312|NCT00951626|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
518313|NCT00951626|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
518314|NCT00951626|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
518315|NCT00951626|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
518316|NCT00951626|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
518317|NCT00951626|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
518318|NCT00951626|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
518319|NCT00951626|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
518320|NCT00951626|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
518321|NCT00951626|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
518322|NCT00951626|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
518323|NCT00951626|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
518324|NCT00951626|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
518325|NCT00951626|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
518517|NCT00950911|Denosumab|denosumab
518326|NCT00951626|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
518327|NCT00951626|refractory hairy cell leukemia|refractory hairy cell leukemia
518328|NCT00951626|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
518329|NCT00951626|secondary acute myeloid leukemia|secondary acute myeloid leukemia
518330|NCT00951626|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
518331|NCT00951626|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
518332|NCT00951626|chronic eosinophilic leukemia|chronic eosinophilic leukemia
518333|NCT00951626|primary myelofibrosis|primary myelofibrosis
518334|NCT00951626|chronic neutrophilic leukemia|chronic neutrophilic leukemia
518335|NCT00951626|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
518336|NCT00951626|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
518337|NCT00951626|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
518338|NCT00951626|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
518339|NCT00951626|refractory multiple myeloma|refractory multiple myeloma
518340|NCT00951613|small cell lung cancer|small cell lung cancer
518341|NCT00951613|carcinoma, lung|carcinoma, lung
518342|NCT00951613|Sensitive-relapsed or refractory-relapsed small cell lung cancer|sensitive-relapsed or refractory-relapsed small cell lung cancer
518343|NCT00951600|Oxcarbazepine oral suspension fasting study|oxcarbazepine oral suspension fasting study
518344|NCT00951587|Colonic Diseases|colonic diseases
518345|NCT00951574|thromboembolism|thromboembolism
518346|NCT00951574|cancer|cancer
518347|NCT00951574|chemotherapy|chemotherapy
518348|NCT00951574|low-molecular-weight-heparin|low-molecular-weight-heparin
518349|NCT00951574|nadroparin|nadroparin
518350|NCT00951561|Dysmenorrhea|dysmenorrhea
518351|NCT00951548|Probiotics|probiotics
518352|NCT00951548|VSL#3|vsl#3
518353|NCT00951548|Double-blind|double-blind
518354|NCT00951548|Placebo controlled|placebo controlled
518355|NCT00951535|stage I prostate cancer|stage i prostate cancer
518356|NCT00951535|stage IIB prostate cancer|stage iib prostate cancer
518357|NCT00951535|stage IIA prostate cancer|stage iia prostate cancer
518358|NCT00951535|stage III prostate cancer|stage iii prostate cancer
518359|NCT00951522|Cystic Fibrosis|cystic fibrosis
518361|NCT00951522|Mucociliary Clearance|mucociliary clearance
518362|NCT00951522|Epithelial Sodium Channel Inhibitor|epithelial sodium channel inhibitor
518363|NCT00951522|ENaC Inhibitor|enac inhibitor
518364|NCT00951522|Airway Hydration|airway hydration
518365|NCT00951522|Amiloride|amiloride
518366|NCT00951509|Electric power wheelchair driving|electric power wheelchair driving
518367|NCT00951509|rehabilitation|rehabilitation
518368|NCT00951509|driving assessments|driving assessments
518369|NCT00951483|Cardiovascular Biomarkers|cardiovascular biomarkers
518370|NCT00951483|Depression|depression
518371|NCT00951483|Quetiapine|quetiapine
518372|NCT00951470|Head and neck lymphedema|head and neck lymphedema
518373|NCT00951470|Complete Decongestive Therapy|complete decongestive therapy
518374|NCT00951470|CDT|cdt
518375|NCT00951470|Oral cavity cancer|oral cavity cancer
518376|NCT00951470|Oropharyngeal cancer|oropharyngeal cancer
518377|NCT00951457|CLL|cll
518378|NCT00951457|pretreated|pretreated
518379|NCT00951457|immune therapy|immune therapy
518380|NCT00951457|dose escalation|dose escalation
518381|NCT00951457|maintenance therapy|maintenance therapy
518382|NCT00951457|Bendamustine|bendamustine
518383|NCT00951457|Alemtuzumab|alemtuzumab
518384|NCT00951444|adenosquamous cell lung cancer|adenosquamous cell lung cancer
518385|NCT00951444|squamous cell lung cancer|squamous cell lung cancer
518386|NCT00951444|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
518387|NCT00951444|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
518388|NCT00951444|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
518389|NCT00951431|Functional dyspepsia|functional dyspepsia
518390|NCT00951431|PPI|ppi
518391|NCT00951431|postprandial fullness|postprandial fullness
518392|NCT00951431|delayed gastric emptying|delayed gastric emptying
518393|NCT00951418|clozapine|clozapine
518394|NCT00951418|schizophrenia|schizophrenia
518395|NCT00951418|cognition|cognition
518396|NCT00951418|t-wave morphology|t-wave morphology
518397|NCT00951392|Insulin sensitivity|insulin sensitivity
518398|NCT00951392|aging|aging
518399|NCT00951392|lipid metabolism|lipid metabolism
518400|NCT00951392|hyperinsulinemic clamp|hyperinsulinemic clamp
518401|NCT00951392|gene expression|gene expression
518402|NCT00951392|sirtuins|sirtuins
518403|NCT00951366|premature birth|premature birth
518404|NCT00951366|neonatal respiratory distress|neonatal respiratory distress
518405|NCT00951366|chronic lung disease|chronic lung disease
518406|NCT00951366|epidemiologicfactors|epidemiologicfactors
518407|NCT00951366|genetic factors|genetic factors
518408|NCT00951353|Transplantation|transplantation
518409|NCT00951353|Kidney Failure|kidney failure
518410|NCT00951353|End Stage Renal Disease|end stage renal disease
518411|NCT00951353|Pediatric|pediatric
518412|NCT00951340|CBT|cbt
518413|NCT00951340|Emotional-Focused Therapy|emotional-focused therapy
518414|NCT00951340|Interpersonal Therapy|interpersonal therapy
518415|NCT00951327|Primary sclerosing cholangitis|primary sclerosing cholangitis
518416|NCT00951314|Genetic Polymorphisms|genetic polymorphisms
518417|NCT00951314|Metabotropic Glutamate Receptors|metabotropic glutamate receptors
518418|NCT00951314|Positron Emission Tomograhy (PET)|positron emission tomograhy (pet)
518419|NCT00951314|Cocaine Dependence|cocaine dependence
518420|NCT00951314|Cue-Induced Craving|cue-induced craving
518421|NCT00951314|Drug Abuse|drug abuse
518422|NCT00951288|AMD|amd
518423|NCT00951288|Retinal Function|retinal function
518424|NCT00951288|Neuroprotection|neuroprotection
518425|NCT00951262|life review|life review
518426|NCT00951262|quality of life|quality of life
518427|NCT00951262|advanced cancer patients|advanced cancer patients
518428|NCT00951249|MSM|msm
518429|NCT00951249|HIV infections|hiv infections
518430|NCT00951249|HIV Seronegativity|hiv seronegativity
518431|NCT00951236|Trigger Finger|trigger finger
518432|NCT00951236|Trigger Thumb|trigger thumb
518433|NCT00951210|Peripheral Artery Disease|peripheral artery disease
518434|NCT00951210|Peripheral Vascular Disease|peripheral vascular disease
518435|NCT00951210|Critical limb ischemia|critical limb ischemia
518436|NCT00951210|PAD|pad
518437|NCT00951210|CLI|cli
518438|NCT00951197|dementia|dementia
518439|NCT00951197|Alzheimer's Disease|alzheimer's disease
518440|NCT00951197|diagnostic|diagnostic
518441|NCT00951197|biomarkers|biomarkers
518442|NCT00951197|neuroimaging|neuroimaging
518443|NCT00951197|PET|pet
518444|NCT00951197|MRI|mri
518445|NCT00951197|mild cognitive impairment|mild cognitive impairment
518446|NCT00951184|depression|depression
518447|NCT00951184|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
518448|NCT00951158|Conjugated Linoleic Acid|conjugated linoleic acid
518449|NCT00951158|Clarinol|clarinol
518450|NCT00951158|S14 Expression|s14 expression
518451|NCT00951132|Inflammation|inflammation
518452|NCT00951132|Atherosclerosis|atherosclerosis
518453|NCT00951132|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
518454|NCT00951119|type 2 diabetes|type 2 diabetes
518455|NCT00951119|hypertension|hypertension
518456|NCT00951119|treatment|treatment
518457|NCT00951119|non-medical|non-medical
518458|NCT00951106|Peru|peru
518459|NCT00951106|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
518460|NCT00951106|Drug resistance|drug resistance
518461|NCT00951093|GERD|gerd
518462|NCT00951093|Gastric bypass|gastric bypass
518463|NCT00951080|ulcer|ulcer
518464|NCT00951080|venous|venous
518465|NCT00951080|diabetic|diabetic
518466|NCT00951080|wounds and injuries|wounds and injuries
518467|NCT00951067|Lymphedema|lymphedema
518468|NCT00951067|Breast Cancer|breast cancer
518469|NCT00951067|Upper Extremity|upper extremity
518470|NCT00951067|Arm|arm
518471|NCT00951054|breast cancer|breast cancer
518472|NCT00951054|triple negative|triple negative
518473|NCT00951054|ER-negative|er-negative
518474|NCT00951054|PR-negative|pr-negative
518475|NCT00951054|HER2-negative|her2-negative
518476|NCT00951054|ER-, PR-, HER2- (Triple Negative) breast cancer|er-, pr-, her2- (triple negative) breast cancer
518477|NCT00951041|influenza infection|influenza infection
518478|NCT00951041|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
518479|NCT00951028|Adherence|adherence
518480|NCT00951015|GSK1349572|gsk1349572
518481|NCT00951015|emtricitabine|emtricitabine
518482|NCT00951015|tenofovir|tenofovir
518483|NCT00951015|efavirenz|efavirenz
518484|NCT00951015|abacavir|abacavir
518485|NCT00951015|antiretroviral therapy naive|antiretroviral therapy naive
518486|NCT00951015|dose selection|dose selection
518487|NCT00951015|HIV-1 Infection|hiv-1 infection
518488|NCT00951015|integrase inhibitor|integrase inhibitor
518489|NCT00951015|HIV infection|hiv infection
518490|NCT00951015|once daily|once daily
518491|NCT00951015|lamivudine|lamivudine
518492|NCT00951002|anal fistula|anal fistula
518493|NCT00951002|acellular dermal matrix|acellular dermal matrix
518494|NCT00951002|treatment|treatment
518495|NCT00951002|postoperative complications|postoperative complications
518496|NCT00951002|recurrence|recurrence
518497|NCT00950989|Autoimmune Diseases|autoimmune diseases
518498|NCT00950989|Musculoskeletal Diseases|musculoskeletal diseases
518499|NCT00950989|Joint Diseases|joint diseases
518500|NCT00950989|Arthritis|arthritis
518501|NCT00950989|Connective Tissue Diseases|connective tissue diseases
518502|NCT00950989|Arthritis, Rheumatoid|arthritis, rheumatoid
518503|NCT00950989|Rheumatic Diseases|rheumatic diseases
518504|NCT00950963|Diabetes, Nurse phone intervention, lipid control|diabetes, nurse phone intervention, lipid control
518505|NCT00950950|Amgen|amgen
518506|NCT00950950|Postmenopausal|postmenopausal
518507|NCT00950950|Bone Density|bone density
518508|NCT00950924|Hyperopia|hyperopia
518509|NCT00950924|Refractive Error|refractive error
518510|NCT00950924|Ocular Biometrics|ocular biometrics
518511|NCT00950924|Axial Length|axial length
518512|NCT00950924|Contact Lenses|contact lenses
518513|NCT00950924|Bifocal Contact Lenses|bifocal contact lenses
518514|NCT00950911|Bone metastases|bone metastases
518515|NCT00950911|Hormone-refractory prostate cancer|hormone-refractory prostate cancer
518516|NCT00950911|Multiple myeloma|multiple myeloma
518518|NCT00950911|Breast cancer|breast cancer
518519|NCT00950911|20050103|20050103
518520|NCT00950911|20050136|20050136
518521|NCT00950911|20050244|20050244
518522|NCT00950911|Advanced cancer|advanced cancer
518523|NCT00950911|Tumor|tumor
518524|NCT00950911|Prostate cancer|prostate cancer
518525|NCT00950911|Zoledronic acid|zoledronic acid
518526|NCT00950898|coffee|coffee
518527|NCT00950898|caffeine|caffeine
518528|NCT00950898|glucose metabolism|glucose metabolism
518529|NCT00950898|insulin sensitivity|insulin sensitivity
518530|NCT00950898|diabetes|diabetes
518531|NCT00950885|sleep|sleep
518532|NCT00950885|alertness|alertness
518533|NCT00950885|performance|performance
518534|NCT00950885|vigilance|vigilance
518535|NCT00950885|circadian|circadian
518536|NCT00950859|treatment experienced|treatment experienced
518537|NCT00950859|HIV Infection|hiv infection
518538|NCT00950859|raltegravir resistance|raltegravir resistance
518539|NCT00950859|GSK1349572|gsk1349572
518540|NCT00950859|optimized background regimen|optimized background regimen
518541|NCT00950859|integrase inhibitor|integrase inhibitor
518542|NCT00950846|Congenital Pediatric Disorders|congenital pediatric disorders
518543|NCT00950846|Umbilical Cord Blood Transplant|umbilical cord blood transplant
518544|NCT00950846|Congenital Abnormalities|congenital abnormalities
518545|NCT00950846|Cord Blood Stem Cell Transplantation|cord blood stem cell transplantation
518546|NCT00950846|Busulfan|busulfan
518547|NCT00950846|Cytoxan|cytoxan
518548|NCT00950846|Cyclophosphamide|cyclophosphamide
518549|NCT00950846|Fludarabine|fludarabine
518550|NCT00950833|Catch-up vaccination|catch-up vaccination
518551|NCT00950833|Pneumococcal vaccine|pneumococcal vaccine
518552|NCT00950833|Immune memory|immune memory
518553|NCT00950833|Nasopharyngeal carriage|nasopharyngeal carriage
518554|NCT00950833|Immunogenicity|immunogenicity
518555|NCT00950833|Pneumococcal disease|pneumococcal disease
518556|NCT00950833|Safety|safety
518557|NCT00950820|Open-label|open-label
518558|NCT00950820|Phase-II-Study|phase-ii-study
518559|NCT00950820|Randomized|randomized
518560|NCT00950820|Metastatic|metastatic
518561|NCT00950820|Colorectal|colorectal
518562|NCT00950820|Cancer|cancer
518563|NCT00950820|Panitumumab|panitumumab
518564|NCT00950820|Vectibix®|vectibix®
518565|NCT00950820|second-line-treatment|second-line-treatment
518566|NCT00950820|KRAS|kras
518567|NCT00950807|Dose ranging|dose ranging
518568|NCT00950807|Chronic Bronchitis|chronic bronchitis
518569|NCT00950807|Long-acting muscarinic antagonist|long-acting muscarinic antagonist
518570|NCT00950807|cross-over|cross-over
518571|NCT00950807|COPD|copd
518572|NCT00950807|Emphysema|emphysema
518573|NCT00950807|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
518574|NCT00950807|anticholinergic|anticholinergic
518575|NCT00950794|Long acting beta2-agonist|long acting beta2-agonist
518576|NCT00950781|Menopause|menopause
518577|NCT00950781|Cortisol|cortisol
518578|NCT00950781|ACTH|acth
518579|NCT00950768|Myeloma|myeloma
518580|NCT00950768|Melphalan|melphalan
518581|NCT00950768|Autologous transplantation|autologous transplantation
518582|NCT00950729|car driving simulator|car driving simulator
518583|NCT00950729|orthopedic leg immobilisation|orthopedic leg immobilisation
518584|NCT00950729|braking time|braking time
518585|NCT00950729|braking force|braking force
518586|NCT00950716|type II diabetes|type ii diabetes
518587|NCT00950716|peer support|peer support
518588|NCT00950716|empowerment|empowerment
518589|NCT00950703|Assessing the perceptions of Canadian Primary care physicians towards global Cardiovascular risk assessment.|assessing the perceptions of canadian primary care physicians towards global cardiovascular risk assessment.
518590|NCT00950690|observational safety study|observational safety study
518591|NCT00950677|Diabetes|diabetes
518592|NCT00950677|pramlintide|pramlintide
518593|NCT00950677|Symlin|symlin
518594|NCT00950677|exenatide|exenatide
518595|NCT00950677|byetta|byetta
518596|NCT00950677|glucagon|glucagon
518597|NCT00950677|gastric emptying|gastric emptying
518598|NCT00950664|cervical dystonia|cervical dystonia
518599|NCT00950664|botulinum toxin|botulinum toxin
518600|NCT00950638|AMD|amd
518601|NCT00950625|intraperitoneal analgesia|intraperitoneal analgesia
518602|NCT00950625|laparoscopic cholecystectomy|laparoscopic cholecystectomy
518603|NCT00950625|lignocaine|lignocaine
518604|NCT00950625|bupevacaine|bupevacaine
518605|NCT00950612|Tuberculosis vaccine|tuberculosis vaccine
518606|NCT00950586|Drug interaction|drug interaction
518607|NCT00950586|Saftey|saftey
518608|NCT00950586|Pharmacokinetics|pharmacokinetics
518609|NCT00950586|Cognition|cognition
518610|NCT00950573|cardiovascular disease|cardiovascular disease
518611|NCT00950573|endstage renal disease|endstage renal disease
518612|NCT00950547|Blood Transfusion|blood transfusion
518613|NCT00950547|Cell Saver|cell saver
518614|NCT00950547|Cardiac Surgery|cardiac surgery
518615|NCT00950547|Evaluate the efficacy of cell salvage CardioPAT routinely used in cardiac surgery in reducing blood transfusions.|evaluate the efficacy of cell salvage cardiopat routinely used in cardiac surgery in reducing blood transfusions.
518616|NCT00950521|Stroke|stroke
518617|NCT00950521|Stem Cell|stem cell
518618|NCT00950521|Cell Therapy|cell therapy
518619|NCT00950521|CD34 Stem cell|cd34 stem cell
518620|NCT00950521|Peripheral blood Stem cell|peripheral blood stem cell
518621|NCT00950495|Parallel design|parallel design
518622|NCT00950495|Oral appliance|oral appliance
518623|NCT00950495|Mandibular advancement device|mandibular advancement device
518624|NCT00950495|Continuous positive airway pressure|continuous positive airway pressure
518625|NCT00950495|Placebo|placebo
518626|NCT00950495|Therapy|therapy
518627|NCT00950495|Side-effects|side-effects
518628|NCT00950495|Compliance|compliance
518629|NCT00950482|Menopause|menopause
518630|NCT00950482|Acupuncture|acupuncture
518631|NCT00950482|Hotflash|hotflash
518632|NCT00950469|high sensitive troponin T; cardiac necrosis; early detection; myoglobin; h-FABP|high sensitive troponin t; cardiac necrosis; early detection; myoglobin; h-fabp
518633|NCT00950469|early identification and risk stratification of patients with suspicious acute coronary syndrome|early identification and risk stratification of patients with suspicious acute coronary syndrome
518634|NCT00950443|Upper airway obstruction|upper airway obstruction
518635|NCT00950443|child|child
518636|NCT00950443|acoustic reflection method|acoustic reflection method
518637|NCT00950443|endoscopy|endoscopy
518638|NCT00950443|work of breathing|work of breathing
518639|NCT00950443|sleep study|sleep study
518640|NCT00950443|CT scan|ct scan
518641|NCT00950430|Imaging|imaging
518642|NCT00950430|PET|pet
518643|NCT00950430|PiB|pib
518644|NCT00950430|FDG|fdg
518645|NCT00950430|MCI|mci
518646|NCT00950430|Dementia|dementia
518647|NCT00950430|Alzheimer's Disease|alzheimer's disease
518648|NCT00950430|Brain Amyloid|brain amyloid
518649|NCT00950417|nimotuzumab esophageal chemo-radiotherapy|nimotuzumab esophageal chemo-radiotherapy
518650|NCT00950404|Bioavailability Pharmacokinetic Formulation|bioavailability pharmacokinetic formulation
518651|NCT00950391|peripheral nerve injury|peripheral nerve injury
518652|NCT00950391|peripheral nerve surgery|peripheral nerve surgery
518653|NCT00950391|nerve repair|nerve repair
518654|NCT00950391|nerve graft|nerve graft
518655|NCT00950378|edema|edema
518656|NCT00950378|blood supply|blood supply
518657|NCT00950378|lower legs|lower legs
518658|NCT00950378|venous stasis|venous stasis
518659|NCT00950365|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
518660|NCT00950365|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
518661|NCT00950365|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
518662|NCT00950365|progressive or recurrent stage III or stage IV non-small cell lung cancer|progressive or recurrent stage iii or stage iv non-small cell lung cancer
518663|NCT00950352|methamphetamine|methamphetamine
518664|NCT00950352|Citicoline|citicoline
518665|NCT00950352|CDP-Choline|cdp-choline
518666|NCT00950352|Neuroimaging|neuroimaging
518667|NCT00950352|MRI|mri
518668|NCT00950352|Brain|brain
518669|NCT00950352|MRS|mrs
518670|NCT00950352|DTI|dti
518671|NCT00950339|GI bleeding|gi bleeding
518672|NCT00950339|clopidogrel|clopidogrel
518673|NCT00950339|aspirin|aspirin
518674|NCT00950339|prevention|prevention
518675|NCT00950339|angiography|angiography
518676|NCT00950326|osteoarthritis|osteoarthritis
518677|NCT00950326|hydrotherapy|hydrotherapy
518678|NCT00950326|affusion|affusion
518679|NCT00950326|conventional physiotherapy|conventional physiotherapy
518680|NCT00950326|comparison|comparison
518681|NCT00950313|Diabetes|diabetes
518682|NCT00950313|Screening|screening
518683|NCT00950313|Risk|risk
518684|NCT00950313|Self assessment|self assessment
518685|NCT00950287|apnea-bradycardias|apnea-bradycardias
518686|NCT00950287|preterm infants|preterm infants
518687|NCT00950274|Cell therapy|cell therapy
518688|NCT00950274|Bone marrow|bone marrow
518689|NCT00950274|CD133|cd133
518690|NCT00950274|Bypass surgery|bypass surgery
518691|NCT00950274|Stem cells|stem cells
518692|NCT00950274|Myocardial infarction|myocardial infarction
518693|NCT00950274|Myocardial ischemia|myocardial ischemia
518694|NCT00950261|Cervical neoplasms|cervical neoplasms
518695|NCT00950261|Cisplatin|cisplatin
518696|NCT00950261|Concurrent Chemoradiation|concurrent chemoradiation
518697|NCT00950248|Idebenone|idebenone
518698|NCT00950248|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
518699|NCT00950248|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
518700|NCT00950248|Mitochondrial Enhancer|mitochondrial enhancer
518701|NCT00950248|Multiple Sclerosis|multiple sclerosis
518702|NCT00950248|MS|ms
518703|NCT00950248|Primary Progressive Multiple Sclerosis|primary progressive multiple sclerosis
518704|NCT00950235|obese|obese
518705|NCT00950235|pregnant|pregnant
518706|NCT00950235|large for gestational age|large for gestational age
518707|NCT00950235|large for gestational age baby|large for gestational age baby
518708|NCT00950222|Intensive care unit|intensive care unit
518709|NCT00950222|Ventilator associated pneumonia|ventilator associated pneumonia
518710|NCT00950222|Gram negative bacilli infection|gram negative bacilli infection
518711|NCT00950222|Empirical antibiotic therapy|empirical antibiotic therapy
518712|NCT00950222|Pharmacokinetic / pharmacodynamic|pharmacokinetic / pharmacodynamic
518713|NCT00950222|Imipenem|imipenem
518714|NCT00950222|Amikacin|amikacin
518715|NCT00950222|Gram negative bacilli|gram negative bacilli
518716|NCT00950209|type 2 diabetic patients in the fed state|type 2 diabetic patients in the fed state
518717|NCT00950183|cryotherapy|cryotherapy
518718|NCT00950183|postoperative pain|postoperative pain
518719|NCT00950183|Iceman|iceman
518720|NCT00950183|primary first metatarsal osteotomy (PMO)|primary first metatarsal osteotomy (pmo)
518721|NCT00950183|lateral ankle ligament reconstruction (LAR)|lateral ankle ligament reconstruction (lar)
518722|NCT00950170|ReFacto AF|refacto af
518723|NCT00950170|factor VIII|factor viii
518724|NCT00950170|inhibitors|inhibitors
518725|NCT00950170|antibodies|antibodies
518726|NCT00950144|pain|pain
518727|NCT00950144|depression|depression
518728|NCT00950144|fatigue|fatigue
518729|NCT00950144|stage III colon cancer|stage iii colon cancer
518730|NCT00950144|stage IV colon cancer|stage iv colon cancer
518731|NCT00950144|recurrent colon cancer|recurrent colon cancer
518732|NCT00950144|stage III rectal cancer|stage iii rectal cancer
518733|NCT00950144|stage IV rectal cancer|stage iv rectal cancer
518734|NCT00950144|recurrent rectal cancer|recurrent rectal cancer
518735|NCT00950144|stage III pancreatic cancer|stage iii pancreatic cancer
518736|NCT00950144|stage IV pancreatic cancer|stage iv pancreatic cancer
518737|NCT00950144|recurrent pancreatic cancer|recurrent pancreatic cancer
518738|NCT00950144|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
518739|NCT00950144|advanced adult primary liver cancer|advanced adult primary liver cancer
518740|NCT00950144|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
518741|NCT00950144|recurrent adult primary liver cancer|recurrent adult primary liver cancer
518742|NCT00950118|Congenital Diaphragmatic Hernia (CDH)|congenital diaphragmatic hernia (cdh)
518743|NCT00950118|Genes|genes
518744|NCT00950118|Genetic|genetic
518745|NCT00950118|Genetic testing|genetic testing
518746|NCT00950118|exome sequencing|exome sequencing
518747|NCT00950118|genome sequencing|genome sequencing
518748|NCT00950118|RNAseq|rnaseq
518749|NCT00950105|CPSI2364|cpsi2364
518750|NCT00950105|Semapimod|semapimod
518751|NCT00950105|Anti TNF alpha|anti tnf alpha
518752|NCT00950105|Crohn's Disease|crohn's disease
518753|NCT00950105|Safety|safety
518754|NCT00950105|Tolerability|tolerability
518755|NCT00950105|Pharmacokinetics|pharmacokinetics
518756|NCT00950092|AF|af
518757|NCT00950092|atrial fibrillation|atrial fibrillation
518758|NCT00950092|ablation|ablation
518759|NCT00950092|surgical ablation|surgical ablation
518760|NCT00950092|afib|afib
518761|NCT00950092|coagulation|coagulation
518762|NCT00950092|RF|rf
518763|NCT00950092|epicardial|epicardial
518764|NCT00950092|Arrhythmias|arrhythmias
518765|NCT00950079|sodium bicarbonate|sodium bicarbonate
518766|NCT00950079|diabetes mellitus|diabetes mellitus
518767|NCT00950079|coronary angiography or intervention|coronary angiography or intervention
518768|NCT00950040|At-risk drinking|at-risk drinking
518769|NCT00950040|Type 2 diabetes|type 2 diabetes
518770|NCT00950040|Treatment adherence|treatment adherence
518771|NCT00950040|At-risk drinking among Type 2 diabetic patients|at-risk drinking among type 2 diabetic patients
518772|NCT00950014|Numeracy|numeracy
518773|NCT00950001|Brain tumors|brain tumors
518774|NCT00950001|Metastatic brain disease|metastatic brain disease
518775|NCT00950001|Post-surgical|post-surgical
518776|NCT00950001|Stereotactic radiosurgery|stereotactic radiosurgery
518777|NCT00950001|SRS|srs
518778|NCT00950001|Whole brain radiotherapy|whole brain radiotherapy
518779|NCT00950001|MRI|mri
518780|NCT00950001|Magnetic Resonance Imaging|magnetic resonance imaging
518781|NCT00950001|Outpatient radiation procedure|outpatient radiation procedure
518782|NCT00949988|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
518783|NCT00949988|CLL|cll
518784|NCT00949988|Dasatinib|dasatinib
518785|NCT00949988|Rituximab|rituximab
518786|NCT00949988|Relapsed|relapsed
518787|NCT00949988|Refractory|refractory
518788|NCT00949975|Chronic|chronic
518789|NCT00949975|Obstructive|obstructive
518790|NCT00949975|Pulmonary|pulmonary
518791|NCT00949975|Lung|lung
518792|NCT00949975|Respiratory disease|respiratory disease
518793|NCT00949975|Efficacy|efficacy
518794|NCT00949975|Safety and tolerability|safety and tolerability
518795|NCT00949975|Placebo-controlled|placebo-controlled
518796|NCT00949975|Pharmacokinetics|pharmacokinetics
518797|NCT00949975|COPD|copd
518798|NCT00949962|stage I prostate cancer|stage i prostate cancer
518799|NCT00949962|stage IIB prostate cancer|stage iib prostate cancer
518800|NCT00949962|stage IIA prostate cancer|stage iia prostate cancer
518801|NCT00949962|stage III prostate cancer|stage iii prostate cancer
518802|NCT00949936|Spine surgery|spine surgery
518803|NCT00949923|Postmenopausal women|postmenopausal women
518804|NCT00949923|Suspicious for breast ca|suspicious for breast ca
518805|NCT00949897|Adult Acquired Flatfoot|adult acquired flatfoot
518806|NCT00949897|Biofoam Porous Metal Implant|biofoam porous metal implant
518807|NCT00949897|Allograft Bone Wedge|allograft bone wedge
518808|NCT00949871|stage I breast cancer|stage i breast cancer
518809|NCT00949871|stage II breast cancer|stage ii breast cancer
518810|NCT00949871|stage IIIA breast cancer|stage iiia breast cancer
519208|NCT00948883|cancer|cancer
518811|NCT00949871|stage IIIB breast cancer|stage iiib breast cancer
518812|NCT00949871|stage IIIC breast cancer|stage iiic breast cancer
518813|NCT00949871|stage IV breast cancer|stage iv breast cancer
518814|NCT00949871|cancer survivor|cancer survivor
518815|NCT00949858|Sleep Disorders|sleep disorders
518816|NCT00949858|Obstructive Sleep Apnea|obstructive sleep apnea
518817|NCT00949858|Restless Leg Syndrome|restless leg syndrome
518818|NCT00949858|Insomnia|insomnia
518819|NCT00949858|Actigraphy|actigraphy
518820|NCT00949845|Effect of Inflammatory challenge on depressed mood|effect of inflammatory challenge on depressed mood
518821|NCT00949845|Effect of inflammatory challenge on social pain|effect of inflammatory challenge on social pain
518822|NCT00949832|rickets|rickets
518823|NCT00949832|calcium|calcium
518824|NCT00949832|vitamin D|vitamin d
518825|NCT00949832|nutrition|nutrition
518826|NCT00949832|child|child
518827|NCT00949819|Prostate Cancer|prostate cancer
518828|NCT00949819|Low risk|low risk
518829|NCT00949819|Gleason 6|gleason 6
518830|NCT00949819|Active surveillance|active surveillance
518831|NCT00949806|Botulinum toxin|botulinum toxin
518832|NCT00949793|Pathology|pathology
518833|NCT00949793|Microscopy, Confocal|microscopy, confocal
518834|NCT00949793|Microscopy, Fluorescence|microscopy, fluorescence
518835|NCT00949793|Intraoperative Procedures|intraoperative procedures
518836|NCT00949780|ABR|abr
518837|NCT00949780|Chloral Hydrate|chloral hydrate
518838|NCT00949780|Sedation|sedation
518839|NCT00949780|Children|children
518840|NCT00949754|honeybee venom|honeybee venom
518841|NCT00949754|osteoarthritis|osteoarthritis
518842|NCT00949754|pain|pain
518843|NCT00949754|knees|knees
518844|NCT00949728|Pterygium|pterygium
518845|NCT00949728|Autologous Transplantation|autologous transplantation
518846|NCT00949728|Conjunctiva|conjunctiva
518847|NCT00949728|Fibrin Tissue Adhesive|fibrin tissue adhesive
518848|NCT00949728|Recurrence|recurrence
518849|NCT00949715|Pacemaker|pacemaker
518850|NCT00949715|Implantable Pulse Generator (IPG)|implantable pulse generator (ipg)
518851|NCT00949715|AV Conduction Disturbance|av conduction disturbance
518852|NCT00949715|Selective Site Pacing|selective site pacing
518853|NCT00949689|adolescence|adolescence
518854|NCT00949689|insomnia|insomnia
518855|NCT00949689|depression|depression
518856|NCT00949689|sleep problems|sleep problems
518857|NCT00949689|cognitive therapy|cognitive therapy
518858|NCT00949663|Diabetes|diabetes
518859|NCT00949663|Blood Sugar|blood sugar
518860|NCT00949663|Xenin-25|xenin-25
518861|NCT00949663|GIP|gip
518862|NCT00949663|Insulin|insulin
518863|NCT00949637|obesity prevention|obesity prevention
518864|NCT00949637|girl scouts|girl scouts
518865|NCT00949637|physical activity|physical activity
518866|NCT00949637|family meals|family meals
518867|NCT00949637|fruits and vegetables|fruits and vegetables
518868|NCT00949637|health promotion|health promotion
518869|NCT00949624|PDGFr Inhibition;|pdgfr inhibition;
518870|NCT00949624|VEGFr inhibition;|vegfr inhibition;
518871|NCT00949624|targeted therapy|targeted therapy
518872|NCT00949611|Decision Aid|decision aid
518873|NCT00949611|Shared Decision Making|shared decision making
518874|NCT00949611|Shared Medical Decision Making|shared medical decision making
518875|NCT00949598|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
518876|NCT00949598|stage IA breast cancer|stage ia breast cancer
518877|NCT00949598|stage IB breast cancer|stage ib breast cancer
518878|NCT00949598|stage II breast cancer|stage ii breast cancer
518879|NCT00949598|stage IIIA breast cancer|stage iiia breast cancer
518880|NCT00949585|randomized, controlled feeding study;|randomized, controlled feeding study;
518881|NCT00949585|crossover design|crossover design
518882|NCT00949585|potassium intake|potassium intake
518883|NCT00949572|mucosal immunity|mucosal immunity
518884|NCT00949572|immunization|immunization
518885|NCT00949572|sublingual|sublingual
518886|NCT00949520|patients|patients
518887|NCT00949520|functional evaluation|functional evaluation
518888|NCT00949520|known coronary artery lesion|known coronary artery lesion
518889|NCT00949494|knee osteoarthritis, synvisc, hyaluronan, dGEMRIC,cartilage|knee osteoarthritis, synvisc, hyaluronan, dgemric,cartilage
518890|NCT00949481|postpartum|postpartum
518891|NCT00949481|family planning|family planning
518892|NCT00949481|job aid|job aid
518893|NCT00949481|immunization|immunization
518894|NCT00949481|pregnancy test|pregnancy test
518895|NCT00949468|Keratitis|keratitis
518896|NCT00949455|stage IV bladder cancer|stage iv bladder cancer
518897|NCT00949455|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
518898|NCT00949429|postoperative pain|postoperative pain
518899|NCT00949429|cardiac surgery|cardiac surgery
518900|NCT00949429|risk factors|risk factors
518901|NCT00949416|genetic|genetic
518902|NCT00949403|Non-Alcoholic Fatty Liver disease|non-alcoholic fatty liver disease
518903|NCT00949390|Advanced Cancer|advanced cancer
518904|NCT00949390|Advanced Malignancy|advanced malignancy
518905|NCT00949390|Complementary and Alternative Medicine|complementary and alternative medicine
518906|NCT00949390|CAM|cam
518907|NCT00949390|Investigational Cancer Therapeutics|investigational cancer therapeutics
518908|NCT00949390|Phase I Clinical Trials|phase i clinical trials
518909|NCT00949377|Constipation|constipation
518910|NCT00949377|opioid|opioid
518911|NCT00949364|Myeloproliferative Neoplasms|myeloproliferative neoplasms
518912|NCT00949364|Pomalidomide|pomalidomide
518913|NCT00949364|Fibrotic Stage|fibrotic stage
518914|NCT00949364|Patients with Myeloproliferative Neoplasms in Fibrotic Stage|patients with myeloproliferative neoplasms in fibrotic stage
518915|NCT00949351|ACEI, ARB, DN, aliskiren, proteinuria|acei, arb, dn, aliskiren, proteinuria
518916|NCT00949338|stage I prostate cancer|stage i prostate cancer
518917|NCT00949338|stage IIB prostate cancer|stage iib prostate cancer
518918|NCT00949338|stage IIA prostate cancer|stage iia prostate cancer
518919|NCT00949338|stage III prostate cancer|stage iii prostate cancer
518920|NCT00949338|stage IV prostate cancer|stage iv prostate cancer
518921|NCT00949338|recurrent prostate cancer|recurrent prostate cancer
518922|NCT00949325|osteosarcoma|osteosarcoma
518923|NCT00949325|soft tissue sarcoma|soft tissue sarcoma
518924|NCT00949325|rhabdomyosarcoma|rhabdomyosarcoma
518925|NCT00949325|leiomyosarcoma|leiomyosarcoma
518926|NCT00949325|Ewing's sarcoma|ewing's sarcoma
518927|NCT00949325|chondrosarcoma|chondrosarcoma
518928|NCT00949325|liposarcoma|liposarcoma
518929|NCT00949325|malignant fibrous histiocytoma|malignant fibrous histiocytoma
518930|NCT00949325|malignant peripheral nerve sheath tumor|malignant peripheral nerve sheath tumor
518931|NCT00949325|pleiomorphic sarcoma|pleiomorphic sarcoma
518932|NCT00949325|spindle cell sarcoma|spindle cell sarcoma
518933|NCT00949325|synovial sarcoma|synovial sarcoma
518934|NCT00949325|cancer stem cell|cancer stem cell
518935|NCT00949312|stage II colon cancer|stage ii colon cancer
518936|NCT00949286|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
518937|NCT00949273|cylindrical abdominoperineal resection|cylindrical abdominoperineal resection
518938|NCT00949273|rectal cancer|rectal cancer
518939|NCT00949273|acellular dermal matrix|acellular dermal matrix
518940|NCT00949273|pelvic reconstruction|pelvic reconstruction
518941|NCT00949273|circumferential resection margin|circumferential resection margin
518942|NCT00949273|overall survival|overall survival
518943|NCT00949260|PIH|pih
518944|NCT00949260|pregnancy induced hypertension|pregnancy induced hypertension
518945|NCT00949260|pregnancy|pregnancy
518946|NCT00949260|bioimpedance|bioimpedance
518947|NCT00949260|noninvasive monitoring|noninvasive monitoring
518948|NCT00949260|Cardiac Output|cardiac output
518949|NCT00949260|Blood Pressure|blood pressure
518950|NCT00949247|stage I breast cancer|stage i breast cancer
518951|NCT00949247|stage II breast cancer|stage ii breast cancer
518952|NCT00949247|stage IIIA breast cancer|stage iiia breast cancer
518953|NCT00949247|stage IIIB breast cancer|stage iiib breast cancer
518954|NCT00949247|stage IIIC breast cancer|stage iiic breast cancer
518955|NCT00949247|HER2-positive breast cancer|her2-positive breast cancer
518956|NCT00949234|post exposure prophylaxis|post exposure prophylaxis
518957|NCT00949234|biomedical prevention|biomedical prevention
518958|NCT00949234|HIV seronegativity|hiv seronegativity
518959|NCT00949221|Type 1 diabetes|type 1 diabetes
518960|NCT00949221|Paediatric|paediatric
518961|NCT00949221|Real Time Continuous Glucose Monitoring|real time continuous glucose monitoring
518962|NCT00949221|Glycemic control|glycemic control
518963|NCT00949221|Therapeutic education|therapeutic education
518964|NCT00949208|Healthy people|healthy people
518965|NCT00949195|COPD|copd
518966|NCT00949195|healthy patients|healthy patients
518967|NCT00949195|PAP|pap
518968|NCT00949195|CPX|cpx
518969|NCT00949195|SSE|sse
518970|NCT00949195|hsCRP|hscrp
518971|NCT00949195|FMD|fmd
518972|NCT00949182|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
518973|NCT00949182|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
518974|NCT00949169|Atherosclerosis|atherosclerosis
518975|NCT00949169|Carotid IMT|carotid imt
518976|NCT00949169|Multidetector CT|multidetector ct
518977|NCT00949169|Type 2 diabetes|type 2 diabetes
518978|NCT00949156|Craniopharyngiomas|craniopharyngiomas
518979|NCT00949156|Classification|classification
518980|NCT00949156|Membranous structure|membranous structure
518981|NCT00949156|Pituitary stalk|pituitary stalk
518982|NCT00949156|Obesity|obesity
518983|NCT00949156|panhypopituitarism|panhypopituitarism
518984|NCT00949143|wheelchair user|wheelchair user
518985|NCT00949117|malnutrition|malnutrition
518986|NCT00949117|weight changes|weight changes
518987|NCT00949117|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
518988|NCT00949117|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
518989|NCT00949117|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
518990|NCT00949117|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
518991|NCT00949117|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
518992|NCT00949117|untreated childhood acute myeloid leukemia|untreated childhood acute myeloid leukemia
518993|NCT00949117|other myeloid malignancies|other myeloid malignancies
518994|NCT00949117|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
518995|NCT00949117|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
518996|NCT00949117|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
518997|NCT00949117|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
518998|NCT00949117|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
518999|NCT00949117|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
519000|NCT00949117|stage I childhood anaplastic large cell lymphoma|stage i childhood anaplastic large cell lymphoma
519001|NCT00949117|stage II childhood anaplastic large cell lymphoma|stage ii childhood anaplastic large cell lymphoma
519002|NCT00949117|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
519003|NCT00949117|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
519004|NCT00949117|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
519005|NCT00949117|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
519006|NCT00949117|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
519007|NCT00949117|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
519008|NCT00949117|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
519009|NCT00949117|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
519010|NCT00949117|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
519011|NCT00949117|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
519012|NCT00949117|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
519013|NCT00949117|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
519014|NCT00949117|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
519015|NCT00949117|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
519016|NCT00949117|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
519017|NCT00949117|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
519018|NCT00949117|childhood Burkitt lymphoma|childhood burkitt lymphoma
519019|NCT00949117|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
519020|NCT00949117|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
519021|NCT00949117|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
519022|NCT00949117|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
519023|NCT00949117|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
519024|NCT00949117|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
519025|NCT00949117|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
519026|NCT00949117|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
519027|NCT00949117|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
519028|NCT00949117|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
519029|NCT00949104|Sucrose|sucrose
519030|NCT00949104|pain|pain
519031|NCT00949104|neonate|neonate
519032|NCT00949104|preterm|preterm
519033|NCT00949104|orogastric tube|orogastric tube
519034|NCT00949091|Diabetes Mellitus, Non Insulin Dependent|diabetes mellitus, non insulin dependent
519035|NCT00949091|Diabetes Mellitus, Type II|diabetes mellitus, type ii
519036|NCT00949091|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
519037|NCT00949091|Drug Therapy|drug therapy
519038|NCT00949078|peanut|peanut
519039|NCT00949078|allergy|allergy
519040|NCT00949065|complex regional pain syndrome|complex regional pain syndrome
519041|NCT00949065|sympathetic reflex dystrophy|sympathetic reflex dystrophy
519042|NCT00949065|intravenous immunoglobulins|intravenous immunoglobulins
519043|NCT00949065|autoimmune disease|autoimmune disease
519044|NCT00949052|cancer survivor|cancer survivor
519045|NCT00949052|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
519046|NCT00949052|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
519047|NCT00949052|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
519048|NCT00949052|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
519049|NCT00949052|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
519050|NCT00949052|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
519051|NCT00949052|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
519052|NCT00949052|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
519053|NCT00949052|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
519054|NCT00949052|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
519055|NCT00949052|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
519056|NCT00949052|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
519057|NCT00949052|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
519058|NCT00949052|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
519059|NCT00949052|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
519060|NCT00949052|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
519061|NCT00949052|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
519062|NCT00949052|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
519063|NCT00949052|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
519209|NCT00948883|biobank|biobank
519064|NCT00949052|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
519065|NCT00949052|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
519066|NCT00949052|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
519067|NCT00949052|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
519068|NCT00949052|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
519069|NCT00949052|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
519070|NCT00949052|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
519071|NCT00949052|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
519072|NCT00949052|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
519073|NCT00949052|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
519074|NCT00949052|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
519075|NCT00949052|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
519076|NCT00949052|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
519077|NCT00949052|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
519078|NCT00949052|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
519079|NCT00949052|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
519080|NCT00949052|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
519081|NCT00949052|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
519082|NCT00949052|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
519083|NCT00949052|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
519084|NCT00949052|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
519085|NCT00949052|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
519086|NCT00949052|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
519087|NCT00949052|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
519088|NCT00949052|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
519089|NCT00949052|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
519090|NCT00949052|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
519091|NCT00949052|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
519092|NCT00949052|splenic marginal zone lymphoma|splenic marginal zone lymphoma
519093|NCT00949052|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
519094|NCT00949052|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
519095|NCT00949052|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
519096|NCT00949052|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
519097|NCT00949052|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
519098|NCT00949052|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
519099|NCT00949052|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
519100|NCT00949052|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
519101|NCT00949052|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
519102|NCT00949052|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
519103|NCT00949052|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
519104|NCT00949052|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
519105|NCT00949052|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
519106|NCT00949052|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
519107|NCT00949052|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
519108|NCT00949052|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
519109|NCT00949052|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
519110|NCT00949052|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
519111|NCT00949052|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
519112|NCT00949052|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
519113|NCT00949052|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
519114|NCT00949052|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
519115|NCT00949052|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
519116|NCT00949052|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
519117|NCT00949052|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
519118|NCT00949052|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
519119|NCT00949052|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
519120|NCT00949052|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
519121|NCT00949052|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
519122|NCT00949052|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
519123|NCT00949052|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
519124|NCT00949052|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
519125|NCT00949052|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
519126|NCT00949052|refractory hairy cell leukemia|refractory hairy cell leukemia
519127|NCT00949052|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
519128|NCT00949052|secondary acute myeloid leukemia|secondary acute myeloid leukemia
519129|NCT00949052|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
519130|NCT00949052|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
519131|NCT00949052|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
519132|NCT00949052|chronic eosinophilic leukemia|chronic eosinophilic leukemia
519133|NCT00949052|primary myelofibrosis|primary myelofibrosis
519134|NCT00949052|chronic neutrophilic leukemia|chronic neutrophilic leukemia
519135|NCT00949052|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
519136|NCT00949052|disseminated neuroblastoma|disseminated neuroblastoma
519137|NCT00949052|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
519138|NCT00949052|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
519139|NCT00949052|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
519140|NCT00949052|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
519141|NCT00949052|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
519142|NCT00949052|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
519143|NCT00949052|recurrent neuroblastoma|recurrent neuroblastoma
519144|NCT00949052|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
519145|NCT00949052|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
519146|NCT00949052|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
519147|NCT00949052|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
519148|NCT00949052|stage I multiple myeloma|stage i multiple myeloma
519149|NCT00949052|stage II multiple myeloma|stage ii multiple myeloma
519150|NCT00949052|stage III multiple myeloma|stage iii multiple myeloma
519151|NCT00949052|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
519152|NCT00949052|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
519153|NCT00949052|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
519154|NCT00949052|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
519155|NCT00949052|stage IIIA breast cancer|stage iiia breast cancer
519156|NCT00949052|stage IIIB breast cancer|stage iiib breast cancer
519157|NCT00949052|stage IIIC breast cancer|stage iiic breast cancer
519158|NCT00949052|stage IV breast cancer|stage iv breast cancer
519159|NCT00949052|refractory multiple myeloma|refractory multiple myeloma
519160|NCT00949026|Brain Cancer|brain cancer
519161|NCT00949026|Brain Neoplasms, Malignant|brain neoplasms, malignant
519162|NCT00949013|stage IA breast cancer|stage ia breast cancer
519163|NCT00949013|stage IB breast cancer|stage ib breast cancer
519164|NCT00949013|stage II breast cancer|stage ii breast cancer
519165|NCT00949013|stage IIIA breast cancer|stage iiia breast cancer
519166|NCT00949013|stage IIIB breast cancer|stage iiib breast cancer
519167|NCT00949013|stage IIIC breast cancer|stage iiic breast cancer
519168|NCT00948987|aspirin resistance|aspirin resistance
519169|NCT00948987|cardiovascular risk|cardiovascular risk
519170|NCT00948987|prostaglandins|prostaglandins
519171|NCT00948987|platelet inhibition|platelet inhibition
519172|NCT00948974|social anxiety|social anxiety
519173|NCT00948974|treatment|treatment
519174|NCT00948974|Cognitive Behavioral Therapy|cognitive behavioral therapy
519175|NCT00948974|Acceptance and Commitment Therapy|acceptance and commitment therapy
519176|NCT00948974|Cognitive Therapy|cognitive therapy
519177|NCT00948961|NYESO1|nyeso1
519178|NCT00948961|cancer vaccine|cancer vaccine
519179|NCT00948961|immunotherapy|immunotherapy
519180|NCT00948961|breast cancer|breast cancer
519181|NCT00948961|ovarian cancer|ovarian cancer
519182|NCT00948961|non-small cell lung cancer|non-small cell lung cancer
519183|NCT00948961|myeloma|myeloma
519184|NCT00948961|sarcoma|sarcoma
519185|NCT00948961|melanoma|melanoma
519186|NCT00948961|Resiquimod|resiquimod
519187|NCT00948961|Poly-ICLC|poly-iclc
519188|NCT00948961|Hiltonol|hiltonol
519189|NCT00948961|esophageal cancer|esophageal cancer
519190|NCT00948961|bladder cancer|bladder cancer
519191|NCT00948961|chondrosarcoma|chondrosarcoma
519192|NCT00948961|adenocarcinoma|adenocarcinoma
519193|NCT00948935|Biliary Cancer|biliary cancer
519194|NCT00948935|Cholangiocarcinoma|cholangiocarcinoma
519195|NCT00948935|Panitumumab|panitumumab
519196|NCT00948922|multiple myeloma|multiple myeloma
519197|NCT00948922|myeloma|myeloma
519198|NCT00948922|myeloma proteins|myeloma proteins
519199|NCT00948922|autologous|autologous
519200|NCT00948922|allogeneic|allogeneic
519201|NCT00948896|Chemoprevention|chemoprevention
519202|NCT00948896|Uganda|uganda
519203|NCT00948896|Malaria|malaria
519204|NCT00948896|Trimethoprim-sulfamethoxazole|trimethoprim-sulfamethoxazole
519205|NCT00948896|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
519206|NCT00948896|Dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
519207|NCT00948883|organ transplant|organ transplant
519210|NCT00948883|immunosuppressive drugs|immunosuppressive drugs
519211|NCT00948883|lymphoma|lymphoma
519212|NCT00948870|alternative medicine|alternative medicine
519213|NCT00948857|DHEA|dhea
519214|NCT00948857|POF|pof
519215|NCT00948857|Pregnancy|pregnancy
519216|NCT00948857|Ovarian Failure|ovarian failure
519217|NCT00948857|Otherwise Unexplained infertility|otherwise unexplained infertility
519218|NCT00948857|Ovarian aging|ovarian aging
519219|NCT00948844|falls|falls
519220|NCT00948844|Missteps|missteps
519221|NCT00948831|biologics|biologics
519222|NCT00948831|fusion rates|fusion rates
519223|NCT00948831|lumbar fusion|lumbar fusion
519224|NCT00948831|ALIF|alif
519225|NCT00948818|Irritable Bowel Syndrome|irritable bowel syndrome
519226|NCT00948818|Constipation|constipation
519227|NCT00948818|Linaclotide|linaclotide
519228|NCT00948805|corpus luteum rescue|corpus luteum rescue
519229|NCT00948805|Gonadotropin Releasing Hormone (GnRH agonist)|gonadotropin releasing hormone (gnrh agonist)
519230|NCT00948805|human Chorionic Gonadotropin (hCG)|human chorionic gonadotropin (hcg)
519231|NCT00948805|infertility|infertility
519232|NCT00948805|pregnancy rate|pregnancy rate
519233|NCT00948792|platelets|platelets
519234|NCT00948792|transfusion|transfusion
519235|NCT00948792|thrombocytopenia|thrombocytopenia
519236|NCT00948779|Patient education|patient education
519237|NCT00948779|Antibiotic|antibiotic
519238|NCT00948779|Child|child
519239|NCT00948779|Respiratory tract infection|respiratory tract infection
519240|NCT00948779|Patient satisfaction|patient satisfaction
519241|NCT00948779|Parental knowledge|parental knowledge
519242|NCT00948779|Adherence|adherence
519243|NCT00948766|Alzheimer's disease|alzheimer's disease
519244|NCT00948766|dementia|dementia
519245|NCT00948766|Alzheimer's type|alzheimer's type
519246|NCT00948753|Graft-versus-host disease|graft-versus-host disease
519247|NCT00948753|GVHD|gvhd
519248|NCT00948753|Maraviroc|maraviroc
519249|NCT00948753|non-myeloablative allogeneic stem-cell transplantation|non-myeloablative allogeneic stem-cell transplantation
519250|NCT00948753|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
519251|NCT00948740|vitamin D|vitamin d
519252|NCT00948701|Breast cancer|breast cancer
519253|NCT00948701|Exercise|exercise
519254|NCT00948701|Physical activity|physical activity
519255|NCT00948701|Community volunteers|community volunteers
519256|NCT00948701|Peer mentors|peer mentors
519257|NCT00948701|Peer coaches|peer coaches
519258|NCT00948701|Social support|social support
519259|NCT00948688|Zolinza|zolinza
519260|NCT00948675|Advanced Non-Small Cell Lung Cancer of Nonsquamous Histology|advanced non-small cell lung cancer of nonsquamous histology
519261|NCT00948675|Advanced Lung Cancer|advanced lung cancer
519262|NCT00948675|Non-Small Cell Lung Cancer|non-small cell lung cancer
519263|NCT00948675|Lung Cancer|lung cancer
519264|NCT00948662|Safety|safety
519265|NCT00948662|tolerability|tolerability
519266|NCT00948662|ascending single doses|ascending single doses
519267|NCT00948662|healthy subjects|healthy subjects
519268|NCT00948649|Varenicline, Working memory|varenicline, working memory
519269|NCT00948623|COPD|copd
519270|NCT00948623|physical activity|physical activity
519271|NCT00948623|pulmonary rehabilitation|pulmonary rehabilitation
519272|NCT00948623|counseling|counseling
519273|NCT00948610|Rheumatoid Arthritis|rheumatoid arthritis
519274|NCT00948597|propofol|propofol
519275|NCT00948597|elective surgical procedure|elective surgical procedure
519276|NCT00948597|Obese subjects|obese subjects
519277|NCT00948584|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
519278|NCT00948584|Insulin dose titration system|insulin dose titration system
519279|NCT00948571|Vital capacity, FEV1, airway resistance|vital capacity, fev1, airway resistance
519280|NCT00948571|perioperative changes in lung function|perioperative changes in lung function
519281|NCT00948558|citrate anticoagulation|citrate anticoagulation
519282|NCT00948558|pharmacokinetic|pharmacokinetic
519283|NCT00948558|critically ill|critically ill
519284|NCT00948558|acute kidney failure|acute kidney failure
519285|NCT00948545|Autonomic nervous system|autonomic nervous system
519286|NCT00948545|Bariatric surgery|bariatric surgery
519287|NCT00948545|Observational study for individuals having bariatric surgery|observational study for individuals having bariatric surgery
519288|NCT00948532|degenerative disc disease|degenerative disc disease
519289|NCT00948532|lumbar spine|lumbar spine
519290|NCT00948532|XLIF|xlif
519291|NCT00948532|Degenerative conditions|degenerative conditions
519292|NCT00948519|Rhinosinusitis, sinusitis, chronic, nasal polyps, phototherapy, laser,laser therapy, antibiotic, safety laser, ICG, indocyanine green|rhinosinusitis, sinusitis, chronic, nasal polyps, phototherapy, laser,laser therapy, antibiotic, safety laser, icg, indocyanine green
519293|NCT00948519|Chronic Rhinosinusitis with or without nasal polyposis|chronic rhinosinusitis with or without nasal polyposis
519294|NCT00948493|diabetes|diabetes
519295|NCT00948493|insulin therapy|insulin therapy
519296|NCT00948480|autologous tumor cell vaccine|autologous tumor cell vaccine
519297|NCT00948480|metastatic melanoma|metastatic melanoma
519298|NCT00948480|sargramostim (GM-CSF)|sargramostim (gm-csf)
519299|NCT00948467|Advanced nonhematologic malignancies|advanced nonhematologic malignancies
519300|NCT00948467|Advanced metastatic melanoma|advanced metastatic melanoma
519301|NCT00948467|BRAF gene|braf gene
519302|NCT00948454|smoking|smoking
519303|NCT00948441|intestinal insufficiency|intestinal insufficiency
519304|NCT00948441|central venous catheter|central venous catheter
519305|NCT00948441|Catheter-Related Infections|catheter-related infections
519306|NCT00948441|pediatrics|pediatrics
519307|NCT00948441|ethanol|ethanol
519308|NCT00948428|actinic keratoses|actinic keratoses
519309|NCT00948428|imiquimod|imiquimod
519310|NCT00948428|therapeutic equivalence|therapeutic equivalence
519311|NCT00948428|bioequivalence|bioequivalence
519312|NCT00948415|Obesity|obesity
519313|NCT00948415|Weight loss|weight loss
519314|NCT00948415|Internet|internet
519315|NCT00948402|PED/PEA-15 protein|ped/pea-15 protein
519316|NCT00948402|PCOS|pcos
519317|NCT00948402|IR|ir
519318|NCT00948402|metformin|metformin
519319|NCT00948402|OCP|ocp
519320|NCT00948402|Oral Contraceptive|oral contraceptive
519321|NCT00948376|Natural history|natural history
519322|NCT00948376|IFT80|ift80
519323|NCT00948376|short ribs|short ribs
519324|NCT00948376|multivisceral involvement|multivisceral involvement
519325|NCT00948363|Kiwi fruits|kiwi fruits
519326|NCT00948363|Blood pressure|blood pressure
519327|NCT00948363|Endothelial function|endothelial function
519328|NCT00948363|Antioxidant capacity|antioxidant capacity
519329|NCT00948350|cervical instability|cervical instability
519330|NCT00948350|awake intubation|awake intubation
519331|NCT00948350|laryngeal anesthesia|laryngeal anesthesia
519332|NCT00948324|ype 2 diabetes mellitus, continuous subcutaneous insulin infusion,|ype 2 diabetes mellitus, continuous subcutaneous insulin infusion,
519333|NCT00948324|α-lipoic acid ,rosiglitazone ,metformin，therapy|α-lipoic acid ,rosiglitazone ,metformin，therapy
519334|NCT00948298|cardiovascular disease|cardiovascular disease
519335|NCT00948298|vitamin D|vitamin d
519336|NCT00948298|african american|african american
519337|NCT00948298|low vitamin D levels|low vitamin d levels
519338|NCT00948285|breast cancer|breast cancer
519339|NCT00948285|magnetic resonance imaging|magnetic resonance imaging
519340|NCT00948272|Rabies|rabies
519341|NCT00948272|Rabies virus|rabies virus
519342|NCT00948272|Purified Vero Rabies Vaccine|purified vero rabies vaccine
519343|NCT00948272|Serum Free|serum free
519344|NCT00948259|safety|safety
519345|NCT00948259|GSK inhibitor|gsk inhibitor
519346|NCT00948259|Alzheimer|alzheimer
519347|NCT00948233|Tobacco|tobacco
519348|NCT00948233|Smoking Cessation|smoking cessation
519349|NCT00948233|Prevention|prevention
519350|NCT00948233|Smokeless tobacco|smokeless tobacco
519351|NCT00948233|Habit|habit
519352|NCT00948220|HCV|hcv
519353|NCT00948220|hepatitis C virus|hepatitis c virus
519354|NCT00948220|CHC|chc
519355|NCT00948220|chronic hepatitis c|chronic hepatitis c
519356|NCT00948220|interferon|interferon
519357|NCT00948220|ribavirin|ribavirin
519358|NCT00948220|DEXA|dexa
519359|NCT00948220|BMD|bmd
519360|NCT00948220|bone mineral density|bone mineral density
519361|NCT00948220|osteoporosis|osteoporosis
519362|NCT00948220|osteopenia|osteopenia
519363|NCT00948220|osteodystrophy|osteodystrophy
519364|NCT00948220|osteodensitometry|osteodensitometry
519365|NCT00948220|Bone Density|bone density
519366|NCT00948220|Hepatitis, Viral, Human|hepatitis, viral, human
519367|NCT00948220|Anti-Infective Agents|anti-infective agents
519368|NCT00948220|peginterferon alfa-2a|peginterferon alfa-2a
519369|NCT00948207|Metastatic Cancer|metastatic cancer
519370|NCT00948207|Recurrent Cancer|recurrent cancer
519371|NCT00948207|Distributed Hematological Cancer|distributed hematological cancer
519372|NCT00948207|Advanced Cancer|advanced cancer
519373|NCT00948207|Terminal Cancer|terminal cancer
519374|NCT00948207|Stage III Cancer|stage iii cancer
519375|NCT00948207|Stage IV Cancer|stage iv cancer
519376|NCT00948194|Extended Donor Criteria|extended donor criteria
519377|NCT00948181|Epinephrine, Norepinephrine, normetanephrine|epinephrine, norepinephrine, normetanephrine
519378|NCT00948181|Catecholamine concentrations during surgery|catecholamine concentrations during surgery
519379|NCT00948168|T2DM|t2dm
519380|NCT00948168|exenatide|exenatide
519381|NCT00948168|HbA1c|hba1c
519382|NCT00948168|weight|weight
519383|NCT00948168|waist circumference|waist circumference
519384|NCT00948168|insulin sensitivity|insulin sensitivity
519385|NCT00948168|beta-cell function|beta-cell function
519386|NCT00948155|smoking|smoking
519387|NCT00948155|nicotine|nicotine
519388|NCT00948155|varenicline|varenicline
519389|NCT00948142|Acute Bacterial Skin and Skin Struction Infections; Bacterial Skin Diseases; Staphylococcal Skin Infections; MRSA|acute bacterial skin and skin struction infections; bacterial skin diseases; staphylococcal skin infections; mrsa
519390|NCT00948129|Smoking Cessation|smoking cessation
519391|NCT00948129|Low-Income|low-income
519392|NCT00948129|Cigarette smoking|cigarette smoking
519393|NCT00948129|Uninsured and underinsured|uninsured and underinsured
519394|NCT00948129|NRT|nrt
519395|NCT00948129|Nicoderm CQ|nicoderm cq
519396|NCT00948129|Habits|habits
519397|NCT00948116|Diabetes mellitus|diabetes mellitus
519398|NCT00948116|Renal Impairment|renal impairment
519399|NCT00948116|Acute Kidney Injury|acute kidney injury
519400|NCT00948116|Coronary revascularisation|coronary revascularisation
519401|NCT00948116|eGFR <60ml/min|egfr <60ml/min
519402|NCT00948103|Nitrous Oxide|nitrous oxide
519403|NCT00948103|Administration, Intravesical Drug|administration, intravesical drug
519404|NCT00948103|Botulinum toxin|botulinum toxin
519405|NCT00948090|Hodgkin Lymphoma|hodgkin lymphoma
519406|NCT00948090|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
519407|NCT00948090|Bone marrow transplant|bone marrow transplant
519408|NCT00948090|stem cell transplant|stem cell transplant
519409|NCT00948090|busulfan|busulfan
519410|NCT00948090|cyclophosphamide|cyclophosphamide
519411|NCT00948090|etoposide|etoposide
519412|NCT00948077|tuberculosis|tuberculosis
519413|NCT00948077|pharmacokinetic|pharmacokinetic
519414|NCT00948077|first-line drugs|first-line drugs
519415|NCT00948064|Leukemia|leukemia
519416|NCT00948064|Acute Myelogenous Leukemia|acute myelogenous leukemia
519417|NCT00948064|AML|aml
519418|NCT00948064|Myelodysplastic Syndrome|myelodysplastic syndrome
519419|NCT00948064|MDS|mds
519420|NCT00948064|Vorinostat|vorinostat
519421|NCT00948064|SAHA|saha
519422|NCT00948064|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
519423|NCT00948064|MSK-390|msk-390
519424|NCT00948064|Zolinza|zolinza
519425|NCT00948064|Azacitidine|azacitidine
519426|NCT00948064|5-Azacitidine|5-azacitidine
519427|NCT00948064|5-Aza|5-aza
519428|NCT00948064|Vidaza|vidaza
519429|NCT00948064|5-AZC|5-azc
519430|NCT00948064|AZA-CR|aza-cr
519431|NCT00948064|Ladakamycin|ladakamycin
519432|NCT00948064|NSC-102816|nsc-102816
519433|NCT00948038|Inflammation|inflammation
519434|NCT00948038|Oxidative stress|oxidative stress
519435|NCT00948025|Peripheral Nerve Repair|peripheral nerve repair
519436|NCT00948025|Conduit|conduit
519437|NCT00948025|AVANCE|avance
519438|NCT00948025|Neuroma Resection|neuroma resection
519439|NCT00948025|Nerve Gap Repair|nerve gap repair
519440|NCT00948025|Digital Nerve Repair|digital nerve repair
519441|NCT00948012|Sickle Cell Anemia|sickle cell anemia
519442|NCT00948012|Pulmonary Hypertension|pulmonary hypertension
519443|NCT00948012|Exercise echocardiography|exercise echocardiography
519444|NCT00948012|Echocardiography|echocardiography
519445|NCT00947973|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
519446|NCT00947973|ADHD|adhd
519447|NCT00947973|School Based|school based
519448|NCT00947973|Intervention|intervention
519449|NCT00947973|Psychosocial|psychosocial
519450|NCT00947973|Academic Intervention|academic intervention
519451|NCT00947973|Behavioral|behavioral
519452|NCT00947960|Adult Polyglucosan Body Disease (APBD)|adult polyglucosan body disease (apbd)
519453|NCT00947960|Glycogen Brancher Enzyme (GBE1) Deficiency|glycogen brancher enzyme (gbe1) deficiency
519454|NCT00947947|condom use|condom use
519455|NCT00947947|HIV prevention|hiv prevention
519456|NCT00947947|African American|african american
519457|NCT00947947|Behavioral intervention|behavioral intervention
519458|NCT00947947|HIV Seronegativity|hiv seronegativity
519459|NCT00947934|Alzheimer disease,hypothalamus,Deep Brain Stimulation|alzheimer disease,hypothalamus,deep brain stimulation
519460|NCT00947921|Functional MItral regurgitation|functional mitral regurgitation
519461|NCT00947908|Hymenoptera venom allergy|hymenoptera venom allergy
519462|NCT00947908|Dendritic cells (DC)|dendritic cells (dc)
519463|NCT00947895|ACTH|acth
519464|NCT00947895|Acthar gel|acthar gel
519465|NCT00947895|adrenocorticotropin|adrenocorticotropin
519466|NCT00947895|methylprednisolone|methylprednisolone
519467|NCT00947895|solumedrol|solumedrol
519468|NCT00947895|MS|ms
519469|NCT00947895|multiple|multiple
519470|NCT00947895|sclerosis|sclerosis
519471|NCT00947895|relapse|relapse
519472|NCT00947895|exacerbation|exacerbation
519473|NCT00947895|sub-responsive|sub-responsive
519474|NCT00947895|IV|iv
519475|NCT00947856|Antibodies, Monoclonal|antibodies, monoclonal
519476|NCT00947856|Antibody-Drug Conjugate|antibody-drug conjugate
519477|NCT00947856|Antigens, CD30|antigens, cd30
519478|NCT00947856|Drug Therapy|drug therapy
519479|NCT00947856|Hematologic Diseases|hematologic diseases
519480|NCT00947856|Immunotherapy|immunotherapy
519481|NCT00947856|Monomethylauristatin E|monomethylauristatin e
519482|NCT00947843|CHD|chd
519483|NCT00947843|CHD equivalents|chd equivalents
519484|NCT00947830|CML|cml
519485|NCT00947830|intracellular imatinib level|intracellular imatinib level
519486|NCT00947830|OCT-1|oct-1
519487|NCT00947804|Acute Coronary Artery Syndrome Risk Stratification Score|acute coronary artery syndrome risk stratification score
519488|NCT00947791|Bipolar Disorder|bipolar disorder
519489|NCT00947791|Depression|depression
519490|NCT00947791|Treatment-Resistant|treatment-resistant
519491|NCT00947791|ketamine|ketamine
519492|NCT00947791|antidepressant|antidepressant
519493|NCT00947791|glutamate|glutamate
519494|NCT00947765|Tennis Elbow|tennis elbow
519495|NCT00947765|Epicondylitis, Lateral Humeral|epicondylitis, lateral humeral
519496|NCT00947752|Multiple Sclerosis|multiple sclerosis
519497|NCT00947752|Relapsing Remitting Multiple Sclerosis (RRMS)|relapsing remitting multiple sclerosis (rrms)
519498|NCT00947752|Glatiramer Acetate (GA)|glatiramer acetate (ga)
519499|NCT00947739|CZ|cz
519500|NCT00947739|Stehlin|stehlin
519501|NCT00947739|Lymphomas|lymphomas
519502|NCT00947713|Human chorionic gonadotropin|human chorionic gonadotropin
519503|NCT00947713|Clomiphene citrate|clomiphene citrate
519504|NCT00947713|chronic anovulation|chronic anovulation
519505|NCT00947713|Polycystic Ovary Syndrome|polycystic ovary syndrome
519506|NCT00947713|Follicolugenesis|follicolugenesis
519507|NCT00947700|Infants|infants
519508|NCT00947700|Risk markers|risk markers
519509|NCT00947700|ERP|erp
519510|NCT00947700|Parent child interaction|parent child interaction
519511|NCT00947700|Promoting First Relations|promoting first relations
519512|NCT00947700|Social Communication|social communication
519513|NCT00947687|influenza|influenza
519514|NCT00947687|healthy subject|healthy subject
519515|NCT00947687|virus inoculation|virus inoculation
519516|NCT00947687|symptom scores|symptom scores
519517|NCT00947687|viral shedding|viral shedding
519518|NCT00947687|bioaerosol output|bioaerosol output
519519|NCT00947674|Cellsorba EX|cellsorba ex
519520|NCT00947661|glaucoma latanoprost|glaucoma latanoprost
519521|NCT00947648|acute myelogenous leukemia|acute myelogenous leukemia
519522|NCT00947648|AML|aml
519523|NCT00947648|myelodysplastic syndrome|myelodysplastic syndrome
519524|NCT00947648|MDS|mds
519525|NCT00947648|Neutropenia|neutropenia
519526|NCT00947648|raw fruits and vegetables|raw fruits and vegetables
519527|NCT00947635|Type 1 diabetes|type 1 diabetes
519528|NCT00947635|Transplants|transplants
519529|NCT00947635|Immunosuppression|immunosuppression
519530|NCT00947635|Hyperlipidemia|hyperlipidemia
519531|NCT00947635|Nutrition Therapy|nutrition therapy
519532|NCT00947622|Fibromyalgia|fibromyalgia
519533|NCT00947622|Neuromodulation|neuromodulation
519534|NCT00947622|Transcranial Direct Current Stimulation|transcranial direct current stimulation
519535|NCT00947622|Occipital|occipital
519536|NCT00947609|Latent tuberculosis|latent tuberculosis
519537|NCT00947609|HIV|hiv
519538|NCT00947609|Children|children
519539|NCT00947609|Interferon gamma release assays|interferon gamma release assays
519540|NCT00947609|Thailand|thailand
519541|NCT00947609|QuantiFERON TB Gold In-tube|quantiferon tb gold in-tube
519542|NCT00947609|T-Spot.TB|t-spot.tb
519543|NCT00947596|Atropine|atropine
519544|NCT00947596|Aerosol|aerosol
519545|NCT00947596|Inhaler|inhaler
519546|NCT00947596|Dry Powder|dry powder
519547|NCT00947583|fusion rates|fusion rates
519548|NCT00947583|TLIF|tlif
519549|NCT00947583|Osteocel Plus|osteocel plus
519550|NCT00947583|biologics|biologics
519551|NCT00947583|lumbar fusion|lumbar fusion
519552|NCT00947570|Cognitive Behavioral Therapy|cognitive behavioral therapy
519553|NCT00947570|Functional Brain Imaging|functional brain imaging
519554|NCT00947570|Psychotherapy|psychotherapy
519555|NCT00947570|Treatment|treatment
519556|NCT00947570|Brain Imaging|brain imaging
519557|NCT00947544|Urea Cycle Disorder|urea cycle disorder
519558|NCT00947544|UCD|ucd
519559|NCT00947544|GT4P|gt4p
519560|NCT00947544|Buphenyl|buphenyl
519561|NCT00947544|hyperammonemia|hyperammonemia
519562|NCT00947544|sodium phenylbutyrate|sodium phenylbutyrate
519563|NCT00947518|chlorhexidine|chlorhexidine
519564|NCT00947518|preterm|preterm
519565|NCT00947518|newborn|newborn
519566|NCT00947518|skin condition|skin condition
519567|NCT00947518|temperature|temperature
519568|NCT00947518|skin flora|skin flora
519569|NCT00947505|Androgenetic alopecia|androgenetic alopecia
519570|NCT00947505|Hair loss|hair loss
519571|NCT00947505|Male Pattern baldness|male pattern baldness
519572|NCT00947492|Rheumatoid Arthritis patients|rheumatoid arthritis patients
519573|NCT00947492|treated with new immunosuppressive drugs : Orencia* (abatacept) and RoActemra* (tocilizumab).|treated with new immunosuppressive drugs : orencia* (abatacept) and roactemra* (tocilizumab).
519574|NCT00947479|obstructive sleep apnea|obstructive sleep apnea
519575|NCT00947479|pulse-wave velocity,|pulse-wave velocity,
519576|NCT00947479|acute kidney injury|acute kidney injury
519577|NCT00947479|biomarkers of acute kidney injury|biomarkers of acute kidney injury
519578|NCT00947466|Buprenorphine transdermal patch (BTDS)|buprenorphine transdermal patch (btds)
519579|NCT00947466|Moderate to severe mouth pain|moderate to severe mouth pain
519580|NCT00947466|Chemotherapy induced mucositis|chemotherapy induced mucositis
519581|NCT00947466|Pharmacokinetic|pharmacokinetic
519582|NCT00947453|asthma|asthma
519583|NCT00947453|montelukast|montelukast
519584|NCT00947440|Phase 1|phase 1
519585|NCT00947440|Bioavailability|bioavailability
519586|NCT00947427|type 1 diabetes|type 1 diabetes
519587|NCT00947427|newly diagnosed T1D|newly diagnosed t1d
519588|NCT00947427|T1D|t1d
519589|NCT00947427|canakinumab|canakinumab
519590|NCT00947427|anti IL-1|anti il-1
519717|NCT00946881|Prostatic disease|prostatic disease
519591|NCT00947414|cellulite; shockwave; microcirculation; skin|cellulite; shockwave; microcirculation; skin
519592|NCT00947401|Surgery, elective|surgery, elective
519593|NCT00947401|Fluids|fluids
519594|NCT00947401|Post Anesthesia Care Unit|post anesthesia care unit
519595|NCT00947401|PACU|pacu
519596|NCT00947401|Fluid management|fluid management
519597|NCT00947388|Refractory Chronic Lymphocytic Leukemia|refractory chronic lymphocytic leukemia
519598|NCT00947388|Bendamustine|bendamustine
519599|NCT00947388|Alemtuzumab|alemtuzumab
519600|NCT00947388|Phase I|phase i
519601|NCT00947388|CLL|cll
519602|NCT00947375|schizophrenia|schizophrenia
519603|NCT00947375|lamictal TM|lamictal tm
519604|NCT00947375|haloperidol decanoate|haloperidol decanoate
519605|NCT00947323|simvastatin|simvastatin
519606|NCT00947323|endothelial dysfunction|endothelial dysfunction
519607|NCT00947323|erectile dysfunction|erectile dysfunction
519608|NCT00947310|Inappropriate therapy|inappropriate therapy
519609|NCT00947310|ICD therapy|icd therapy
519610|NCT00947310|Primary prevention|primary prevention
519611|NCT00947297|Urea Cycle Disorder|urea cycle disorder
519612|NCT00947297|UCD|ucd
519613|NCT00947297|hyperammonemia|hyperammonemia
519614|NCT00947297|Buphenyl|buphenyl
519615|NCT00947297|Sodium Phenylbutyrate|sodium phenylbutyrate
519616|NCT00947271|STD|std
519617|NCT00947271|STI|sti
519618|NCT00947271|Sexual Behavior|sexual behavior
519619|NCT00947271|Prevention|prevention
519620|NCT00947271|HIV seronegativity|hiv seronegativity
519621|NCT00947258|Muscle Strength|muscle strength
519622|NCT00947258|Torque|torque
519623|NCT00947258|Muscle Stretching Exercises|muscle stretching exercises
519624|NCT00947258|Range of Motion|range of motion
519625|NCT00947232|major depressive disorder|major depressive disorder
519626|NCT00947232|physical activity|physical activity
519627|NCT00947232|aging with physical disability|aging with physical disability
519628|NCT00947232|motivational interviewing|motivational interviewing
519629|NCT00947219|Androgenetic Alopecia|androgenetic alopecia
519630|NCT00947219|Hair Loss|hair loss
519631|NCT00947219|Male Pattern Baldness|male pattern baldness
519632|NCT00947206|Chinese Americans|chinese americans
519633|NCT00947206|lay health worker outreach|lay health worker outreach
519634|NCT00947206|colorectal cancer screening|colorectal cancer screening
519635|NCT00947193|Hemophilia A|hemophilia a
519636|NCT00947193|Hemophilia B|hemophilia b
519637|NCT00947193|Factor VIII|factor viii
519638|NCT00947193|Factor IX|factor ix
519639|NCT00947193|FVIII|fviii
519640|NCT00947193|FIX|fix
519641|NCT00947193|Nonsense mutation|nonsense mutation
519642|NCT00947193|Premature stop codon|premature stop codon
519643|NCT00947193|HA|ha
519644|NCT00947193|HB|hb
519645|NCT00947193|PTC124|ptc124
519646|NCT00947193|Ataluren|ataluren
519647|NCT00947180|Biofeedback|biofeedback
519648|NCT00947180|Pelvic floor|pelvic floor
519649|NCT00947180|Levator ani syndrome|levator ani syndrome
519650|NCT00947180|Chronic proctalgia|chronic proctalgia
519651|NCT00947180|Electrogalvanic stimulation|electrogalvanic stimulation
519652|NCT00947180|Massage|massage
519653|NCT00947154|trichotillomania|trichotillomania
519654|NCT00947154|aripiprazole|aripiprazole
519655|NCT00947154|treatment|treatment
519656|NCT00947141|Optimising treatment of cytomegalovirus infection|optimising treatment of cytomegalovirus infection
519657|NCT00947128|Antiemetic|antiemetic
519658|NCT00947115|Cervical cancer|cervical cancer
519659|NCT00947115|HPV vaccine|hpv vaccine
519660|NCT00947102|pancreatic tubular adenocarcinoma|pancreatic tubular adenocarcinoma
519661|NCT00947102|gemcitabine|gemcitabine
519662|NCT00947102|gene expression|gene expression
519663|NCT00947102|immunological status|immunological status
519664|NCT00947102|serological status|serological status
519665|NCT00947102|pancreatic tubular adenocarcinoma adjuvant setting|pancreatic tubular adenocarcinoma adjuvant setting
519666|NCT00947089|ORC (oxidized regenerated cellulose)|orc (oxidized regenerated cellulose)
519667|NCT00947089|SSI (Surgical site infections)|ssi (surgical site infections)
519668|NCT00947076|Antidepressant|antidepressant
519669|NCT00947063|Antihistamine|antihistamine
519670|NCT00947050|CAD|cad
519671|NCT00947050|prompt physical exercise|prompt physical exercise
519672|NCT00947050|collateral function|collateral function
519673|NCT00947011|Healthy volunteers|healthy volunteers
519674|NCT00947011|GLP-1|glp-1
519675|NCT00947011|Januvia|januvia
519676|NCT00947011|Sitagliptin|sitagliptin
519677|NCT00946998|Chronic Kidney Disease|chronic kidney disease
519678|NCT00946998|Depression|depression
519679|NCT00946998|Antidepressants|antidepressants
519680|NCT00946998|randomized controlled trial|randomized controlled trial
519681|NCT00946998|treatment|treatment
519682|NCT00946998|Sertraline|sertraline
519683|NCT00946985|Schizophrenia|schizophrenia
519684|NCT00946985|Risperidone|risperidone
519685|NCT00946985|Risperdal|risperdal
519686|NCT00946985|Paliperidone Palmitate|paliperidone palmitate
519687|NCT00946985|Invega Sustenna|invega sustenna
519688|NCT00946972|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
519689|NCT00946959|cardiac surgery|cardiac surgery
519690|NCT00946959|angioplasty|angioplasty
519691|NCT00946959|cognitive decline|cognitive decline
519692|NCT00946946|Randomized|randomized
519693|NCT00946946|Crohn's Disease|crohn's disease
519694|NCT00946946|Prevention|prevention
519695|NCT00946946|Azathioprine|azathioprine
519696|NCT00946946|mesalazine|mesalazine
519697|NCT00946946|mesalamine|mesalamine
519698|NCT00946946|TPMT|tpmt
519699|NCT00946933|acid-base balance|acid-base balance
519700|NCT00946933|ventilatory control|ventilatory control
519701|NCT00946933|dyspnea|dyspnea
519702|NCT00946933|exercise|exercise
519703|NCT00946933|modified rebreathing procedure|modified rebreathing procedure
519704|NCT00946933|Normal|normal
519705|NCT00946933|older|older
519706|NCT00946907|acute pericarditis|acute pericarditis
519707|NCT00946907|treatment|treatment
519708|NCT00946907|recurrence|recurrence
519709|NCT00946894|Total thyroidectomy|total thyroidectomy
519710|NCT00946894|Subtotal thyroidectomy|subtotal thyroidectomy
519711|NCT00946894|Dunhill operation|dunhill operation
519712|NCT00946894|Recurrent nodular goiter|recurrent nodular goiter
519713|NCT00946894|Completion thyroidectomy|completion thyroidectomy
519714|NCT00946894|Recurrent laryngeal nerve palsy|recurrent laryngeal nerve palsy
519715|NCT00946894|Hypoparathyroidism following thyroidectomy|hypoparathyroidism following thyroidectomy
519716|NCT00946894|Recurrent goiter|recurrent goiter
519718|NCT00946881|genital neoplasm, male|genital neoplasm, male
519719|NCT00946881|Urogenital neoplasm|urogenital neoplasm
519720|NCT00946881|Genital disease|genital disease
519721|NCT00946881|male|male
519722|NCT00946881|Male urogenital disease|male urogenital disease
519723|NCT00946881|Neoplasms|neoplasms
519724|NCT00946881|Neoplasm by site|neoplasm by site
519725|NCT00946881|prostatic neoplasm|prostatic neoplasm
519726|NCT00946881|Carcinoma|carcinoma
519727|NCT00946868|intermittent claudication|intermittent claudication
519728|NCT00946868|metabolic syndrome|metabolic syndrome
519729|NCT00946855|soccer|soccer
519730|NCT00946855|laboratory|laboratory
519731|NCT00946855|reference|reference
519732|NCT00946855|exercise|exercise
519733|NCT00946855|variability|variability
519734|NCT00946855|season|season
519735|NCT00946855|elite athletes|elite athletes
519736|NCT00946855|Define reference blood parameters in elite athletes|define reference blood parameters in elite athletes
519737|NCT00946842|Healthy|healthy
519738|NCT00946842|Bioavailability|bioavailability
519739|NCT00946842|Relative bioavailability|relative bioavailability
519740|NCT00946842|TMC207|tmc207
519741|NCT00946842|Fed condition|fed condition
519742|NCT00946842|Fasted condition|fasted condition
519743|NCT00946803|Pain|pain
519744|NCT00946803|Fatigue|fatigue
519745|NCT00946803|Sleep|sleep
519746|NCT00946803|Cancer|cancer
519747|NCT00946803|Complementary therapies|complementary therapies
519748|NCT00946790|Immunosuppressant and Antirheumatic|immunosuppressant and antirheumatic
519749|NCT00946777|Dry Eye Signs|dry eye signs
519750|NCT00946777|barrier function|barrier function
519751|NCT00946764|Antidepressant|antidepressant
519752|NCT00946751|Anticonvulsant|anticonvulsant
519753|NCT00946738|Raynaud's phenomenon|raynaud's phenomenon
519754|NCT00946738|biofeedback|biofeedback
519755|NCT00946738|deep oscillation|deep oscillation
519756|NCT00946738|systemic sclerosis|systemic sclerosis
519757|NCT00946738|physiotherapy|physiotherapy
519758|NCT00946725|Angina (Chest Pain)|angina (chest pain)
519759|NCT00946725|Hypertension|hypertension
519760|NCT00946660|Contingency Management|contingency management
519761|NCT00946660|Drug Self-Administration|drug self-administration
519762|NCT00946647|Myelodysplastic Syndromes|myelodysplastic syndromes
519763|NCT00946647|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
519764|NCT00946647|Acute Myeloid Leukemia|acute myeloid leukemia
519765|NCT00946647|hypomethylating therapy|hypomethylating therapy
519766|NCT00946647|deacetylase inhibitor|deacetylase inhibitor
519767|NCT00946647|MDS|mds
519768|NCT00946647|CMML|cmml
519769|NCT00946647|AML|aml
519770|NCT00946608|Antihistamine|antihistamine
519771|NCT00946595|Undetectable|undetectable
519772|NCT00946595|HIV infections|hiv infections
519773|NCT00946595|Monotherapy|monotherapy
519774|NCT00946595|Lopinavir/ritonavir|lopinavir/ritonavir
519775|NCT00946595|Protease inhibitor|protease inhibitor
519776|NCT00946595|Treatment experienced|treatment experienced
519777|NCT00946582|parenting management program|parenting management program
519778|NCT00946582|ADHD|adhd
519779|NCT00946569|Asthma|asthma
519780|NCT00946569|Persistent asthma|persistent asthma
519781|NCT00946569|Adults with persistent asthma|adults with persistent asthma
519782|NCT00946569|Chronic asthma|chronic asthma
519783|NCT00946569|JNJ-39758979|jnj-39758979
519784|NCT00946569|Placebo|placebo
519785|NCT00946556|herpes simplex virus type 2|herpes simplex virus type 2
519786|NCT00946556|HIV|hiv
519787|NCT00946556|genital immunology|genital immunology
519788|NCT00946556|CD4+ T cell|cd4+ t cell
519789|NCT00946556|valacyclovir|valacyclovir
519790|NCT00946556|HIV seronegativity|hiv seronegativity
519791|NCT00946543|stage IIB prostate cancer|stage iib prostate cancer
519792|NCT00946543|stage IIA prostate cancer|stage iia prostate cancer
519793|NCT00946543|stage III prostate cancer|stage iii prostate cancer
519794|NCT00946543|stage IV prostate cancer|stage iv prostate cancer
519795|NCT00946491|Typical Antipsychotic|typical antipsychotic
519796|NCT00946478|atopic dermatitis|atopic dermatitis
519797|NCT00946478|elidel|elidel
519798|NCT00946478|pimecrolimus|pimecrolimus
519799|NCT00946478|CASM981|casm981
519800|NCT00946478|immunity|immunity
519801|NCT00946478|cathelicidin|cathelicidin
519802|NCT00946478|antimicrobial peptide|antimicrobial peptide
519803|NCT00946478|eczema|eczema
519804|NCT00946452|Control|control
519805|NCT00946452|Satisfaction|satisfaction
519806|NCT00946439|training exercise gait|training exercise gait
519807|NCT00946413|CBT, Depressed and suicidal adolescents|cbt, depressed and suicidal adolescents
519808|NCT00946400|Heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
519809|NCT00946400|HIT|hit
519810|NCT00946400|4Ts|4ts
519811|NCT00946400|Chong scale|chong scale
519812|NCT00946400|interobserver variability|interobserver variability
519813|NCT00946387|Antiemetic|antiemetic
519814|NCT00946374|Mantle-Cell-Lymphoma|mantle-cell-lymphoma
519815|NCT00946374|MCL|mcl
519816|NCT00946374|Non Hodgkin´s Lymphoma|non hodgkin´s lymphoma
519817|NCT00946374|NHL|nhl
519818|NCT00946374|Immunochemotherapy|immunochemotherapy
519819|NCT00946374|R-CHOP|r-chop
519820|NCT00946374|CHOP|chop
519821|NCT00946374|High-dose chemotherapy|high-dose chemotherapy
519822|NCT00946374|BEAM|beam
519823|NCT00946374|HD-BEAM|hd-beam
519824|NCT00946374|Autologous stem cell transplantation|autologous stem cell transplantation
519825|NCT00946374|Reduced conditioning regimen|reduced conditioning regimen
519826|NCT00946374|Unrelated donor|unrelated donor
519827|NCT00946374|Sibling donor|sibling donor
519828|NCT00946374|Total Body Irradiation|total body irradiation
519829|NCT00946374|TBI|tbi
519830|NCT00946374|Allogenic stem cell transplantation|allogenic stem cell transplantation
519831|NCT00946374|ABSCT|absct
519832|NCT00946374|ASCT|asct
519833|NCT00946374|Fludarabine+TBI|fludarabine+tbi
519834|NCT00946348|Dronabinol|dronabinol
519835|NCT00946348|Schizophrenia|schizophrenia
519836|NCT00946348|Dual Diagnosis|dual diagnosis
519837|NCT00946348|Substance Abuse|substance abuse
519838|NCT00946348|Cannabis Use Disorder|cannabis use disorder
519839|NCT00946322|post-traumatic stress disorder|post-traumatic stress disorder
519840|NCT00946322|alcohol-related disorders|alcohol-related disorders
519841|NCT00946322|substance use disorders|substance use disorders
519842|NCT00946322|couple therapy|couple therapy
519843|NCT00946296|Graves Disease|graves disease
519844|NCT00946283|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
520060|NCT00945789|EEG|eeg
519845|NCT00946283|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
519846|NCT00946283|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
519847|NCT00946283|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
519848|NCT00946283|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
519849|NCT00946283|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
519850|NCT00946283|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
519851|NCT00946283|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
519852|NCT00946283|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
519853|NCT00946283|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
519854|NCT00946283|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
519855|NCT00946283|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
519856|NCT00946283|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
519857|NCT00946283|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
519858|NCT00946283|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
519859|NCT00946283|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
519860|NCT00946283|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
519861|NCT00946283|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
519862|NCT00946283|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
519863|NCT00946283|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
519864|NCT00946283|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
519865|NCT00946283|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
519866|NCT00946283|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
519867|NCT00946283|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
519868|NCT00946283|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
519869|NCT00946283|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
519870|NCT00946283|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
519871|NCT00946283|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
519872|NCT00946283|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
519873|NCT00946283|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
519874|NCT00946283|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
519875|NCT00946283|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
519876|NCT00946283|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
519877|NCT00946283|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
519878|NCT00946283|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
519879|NCT00946283|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
519880|NCT00946283|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
519881|NCT00946283|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
519882|NCT00946283|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
519883|NCT00946283|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
519884|NCT00946283|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
519885|NCT00946283|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
519886|NCT00946283|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
519887|NCT00946283|splenic marginal zone lymphoma|splenic marginal zone lymphoma
519888|NCT00946283|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
519889|NCT00946283|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
519890|NCT00946283|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
519891|NCT00946283|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
519892|NCT00946283|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
519893|NCT00946283|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
519894|NCT00946283|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
519895|NCT00946283|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
519896|NCT00946283|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
519897|NCT00946283|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
519898|NCT00946283|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
519899|NCT00946283|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
519900|NCT00946283|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
519901|NCT00946283|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
519902|NCT00946283|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
519903|NCT00946283|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
519904|NCT00946283|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
519905|NCT00946283|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
519906|NCT00946283|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
519907|NCT00946283|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
519908|NCT00946283|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
519909|NCT00946283|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
519910|NCT00946283|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
519911|NCT00946283|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
519912|NCT00946283|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
519913|NCT00946283|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
519914|NCT00946283|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
519915|NCT00946283|refractory hairy cell leukemia|refractory hairy cell leukemia
519916|NCT00946283|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
519917|NCT00946283|secondary acute myeloid leukemia|secondary acute myeloid leukemia
519918|NCT00946283|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
519919|NCT00946283|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
519920|NCT00946283|chronic eosinophilic leukemia|chronic eosinophilic leukemia
519921|NCT00946283|primary myelofibrosis|primary myelofibrosis
519922|NCT00946283|chronic neutrophilic leukemia|chronic neutrophilic leukemia
519923|NCT00946283|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
519924|NCT00946283|disseminated neuroblastoma|disseminated neuroblastoma
519925|NCT00946283|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
519926|NCT00946283|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
519927|NCT00946283|recurrent neuroblastoma|recurrent neuroblastoma
519928|NCT00946283|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
519929|NCT00946283|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
519930|NCT00946283|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
519931|NCT00946283|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
519932|NCT00946283|stage II multiple myeloma|stage ii multiple myeloma
519933|NCT00946283|stage III multiple myeloma|stage iii multiple myeloma
519934|NCT00946283|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
519935|NCT00946283|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
520061|NCT00945789|Brain MRI|brain mri
519936|NCT00946283|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
519937|NCT00946283|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
519938|NCT00946283|stage IIIA breast cancer|stage iiia breast cancer
519939|NCT00946283|stage IIIB breast cancer|stage iiib breast cancer
519940|NCT00946283|stage IIIC breast cancer|stage iiic breast cancer
519941|NCT00946283|stage IV breast cancer|stage iv breast cancer
519942|NCT00946283|refractory multiple myeloma|refractory multiple myeloma
519943|NCT00946270|CC-4047|cc-4047
519944|NCT00946270|Pomalidomide|pomalidomide
519945|NCT00946270|polycythemia vera|polycythemia vera
519946|NCT00946270|essential thrombocythemia myelofibrosis|essential thrombocythemia myelofibrosis
519947|NCT00946257|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
519948|NCT00946244|Early intervention|early intervention
519949|NCT00946244|Mother-child interaction|mother-child interaction
519950|NCT00946244|Neurodevelopment|neurodevelopment
519951|NCT00946244|Parenting|parenting
519952|NCT00946244|Prematurity|prematurity
519953|NCT00946244|Preschool age|preschool age
519954|NCT00946231|Heart Failure|heart failure
519955|NCT00946231|BNP|bnp
519956|NCT00946231|B-type natriuretic peptide|b-type natriuretic peptide
519957|NCT00946231|home testing|home testing
519958|NCT00946205|rectal prolapse|rectal prolapse
519959|NCT00946205|laparoscopic rectopexy|laparoscopic rectopexy
519960|NCT00946205|obstructed defecation|obstructed defecation
519961|NCT00946192|Amenorrhea|amenorrhea
519962|NCT00946192|Adolescent|adolescent
519963|NCT00946192|Endurance|endurance
519964|NCT00946192|Athletes|athletes
519965|NCT00946192|Females|females
519966|NCT00946192|Osteopenia|osteopenia
519967|NCT00946192|Osteoporosis|osteoporosis
519968|NCT00946192|Estrogen|estrogen
519969|NCT00946179|Influenza|influenza
519970|NCT00946179|Influenza virus vaccine|influenza virus vaccine
519971|NCT00946179|Split virion|split virion
519972|NCT00946166|pneumonia|pneumonia
519973|NCT00946166|statins|statins
519974|NCT00946166|cytokines|cytokines
519975|NCT00946153|Carcinoma|carcinoma
519976|NCT00946153|Hepatocellular|hepatocellular
519977|NCT00946140|Ovary|ovary
519978|NCT00946140|MRI|mri
519979|NCT00946140|08-132|08-132
519980|NCT00946127|Normal Pressure Hydrocephalus|normal pressure hydrocephalus
519981|NCT00946127|Communicating Hydrocephalus|communicating hydrocephalus
519982|NCT00946127|Gait disorder|gait disorder
519983|NCT00946127|Cognition|cognition
519984|NCT00946127|Shunt|shunt
519985|NCT00946127|Endoscopic Third Ventriculostomy.|endoscopic third ventriculostomy.
519986|NCT00946101|randomized, double-blind, placebo-controlled|randomized, double-blind, placebo-controlled
519987|NCT00946062|low vision|low vision
519988|NCT00946062|ophthalmology|ophthalmology
519989|NCT00946062|randomised controlled trial|randomised controlled trial
519990|NCT00946062|mobility|mobility
519991|NCT00946062|orientation|orientation
519992|NCT00946062|cane|cane
519993|NCT00946062|aged|aged
519994|NCT00946049|Checking clinical antibacterial effect of Vicryl Plus compared to conventional Vicryl in intraoral surgery|checking clinical antibacterial effect of vicryl plus compared to conventional vicryl in intraoral surgery
519995|NCT00946049|Bacteria|bacteria
519996|NCT00946023|lymphoma|lymphoma
519997|NCT00946023|non hodgkin lymphoma|non hodgkin lymphoma
519998|NCT00946023|allogeneic|allogeneic
519999|NCT00946023|bone marrow transplantation|bone marrow transplantation
520000|NCT00946023|nonmyeloablative|nonmyeloablative
520001|NCT00946023|cyclophosphamide|cyclophosphamide
520002|NCT00946023|rituximab|rituximab
520003|NCT00946010|Hepatitis B|hepatitis b
520004|NCT00946010|Hepatitis C|hepatitis c
520005|NCT00946010|genotype|genotype
520006|NCT00946010|DNA level|dna level
520007|NCT00946010|RNA level|rna level
520008|NCT00946010|Taiwan|taiwan
520009|NCT00945997|misoprostol|misoprostol
520010|NCT00945997|mifepristone|mifepristone
520011|NCT00945997|medical abortion|medical abortion
520012|NCT00945997|randomised controlled trial|randomised controlled trial
520013|NCT00945984|Localized renal cell carcinoma|localized renal cell carcinoma
520014|NCT00945971|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
520015|NCT00945971|Catecholamine|catecholamine
520016|NCT00945971|Children|children
520017|NCT00945971|Physical Activity|physical activity
520018|NCT00945958|Glaucoma|glaucoma
520019|NCT00945958|Ocular hypertension|ocular hypertension
520020|NCT00945945|Osteoarthritis, Knee|osteoarthritis, knee
520021|NCT00945945|Pain|pain
520022|NCT00945932|asthma|asthma
520023|NCT00945932|GW870086X|gw870086x
520024|NCT00945932|Efficacy|efficacy
520025|NCT00945932|FEV1|fev1
520026|NCT00945932|repeat-dose|repeat-dose
520027|NCT00945919|Oral morphine|oral morphine
520028|NCT00945919|oxycodone|oxycodone
520029|NCT00945919|OPANA|opana
520030|NCT00945919|Oxymorphone|oxymorphone
520031|NCT00945919|pain|pain
520032|NCT00945919|nociceptive|nociceptive
520033|NCT00945919|neuropathic|neuropathic
520034|NCT00945919|rotation|rotation
520035|NCT00945919|titration|titration
520036|NCT00945919|mixed origin non-cancer pain|mixed origin non-cancer pain
520037|NCT00945906|Hereditary Factor XIII deficiency|hereditary factor xiii deficiency
520038|NCT00945906|Factor XIII|factor xiii
520039|NCT00945880|HCV|hcv
520040|NCT00945880|Hepatitis C|hepatitis c
520041|NCT00945880|Hepatitis|hepatitis
520042|NCT00945867|flecainide|flecainide
520043|NCT00945867|pharmacogenetics|pharmacogenetics
520044|NCT00945854|wholegrain cereals|wholegrain cereals
520045|NCT00945854|glycemic index|glycemic index
520046|NCT00945854|metabolic syndrome|metabolic syndrome
520047|NCT00945854|insulin sensitivity|insulin sensitivity
520048|NCT00945841|influenza vaccine|influenza vaccine
520049|NCT00945841|vaccine|vaccine
520050|NCT00945828|pediatric cancer, neurocognitive outcomes for pediatric cancer|pediatric cancer, neurocognitive outcomes for pediatric cancer
520345|NCT00944736|Probiotic|probiotic
520051|NCT00945828|acute lymphoblastic leukemia|acute lymphoblastic leukemia
520052|NCT00945828|central nervous system tumors|central nervous system tumors
520053|NCT00945828|lymphoma|lymphoma
520054|NCT00945815|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
520055|NCT00945815|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
520056|NCT00945815|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
520057|NCT00945815|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
520058|NCT00945789|Asphyxia neonatorum|asphyxia neonatorum
520059|NCT00945789|Infants|infants
520062|NCT00945789|Nitric oxide|nitric oxide
520063|NCT00945776|OSA|osa
520064|NCT00945776|CPAP|cpap
520065|NCT00945763|Dental Pain|dental pain
520066|NCT00945737|hypercholesterolemia|hypercholesterolemia
520067|NCT00945737|cholesterol|cholesterol
520068|NCT00945737|soy|soy
520069|NCT00945711|dual diagnosis|dual diagnosis
520070|NCT00945698|Stunting|stunting
520071|NCT00945698|Growth failure|growth failure
520072|NCT00945698|Malnutrition|malnutrition
520073|NCT00945698|Lipid based nutrient supplement|lipid based nutrient supplement
520074|NCT00945698|LNS|lns
520075|NCT00945698|Prevention|prevention
520076|NCT00945698|Malawi|malawi
520077|NCT00945698|Sub-Saharan Africa|sub-saharan africa
520078|NCT00945698|Dietary supplementation|dietary supplementation
520079|NCT00945698|Efficacy|efficacy
520080|NCT00945685|Skin Aging|skin aging
520081|NCT00945685|Skin Wrinkling|skin wrinkling
520082|NCT00945672|Alzheimer's disease amyloid imaging antibody|alzheimer's disease amyloid imaging antibody
520083|NCT00945633|Obesity|obesity
520084|NCT00945633|unhealthy weight gain|unhealthy weight gain
520085|NCT00945620|Trans-abdominis block|trans-abdominis block
520086|NCT00945620|post-cesarean|post-cesarean
520087|NCT00945607|Complementary Medicine|complementary medicine
520088|NCT00945607|Alternative Medicine|alternative medicine
520089|NCT00945607|Breast Cancer|breast cancer
520090|NCT00945594|flexible cystoscopy|flexible cystoscopy
520091|NCT00945594|rigid cystoscopy|rigid cystoscopy
520092|NCT00945594|bladder|bladder
520093|NCT00945594|outcome assessment|outcome assessment
520094|NCT00945594|pain measurement|pain measurement
520095|NCT00945581|Healthy Elderly volunteers|healthy elderly volunteers
520096|NCT00945568|QOL|qol
520097|NCT00945568|liver|liver
520098|NCT00945555|Antibacterials|antibacterials
520099|NCT00945555|Classification of antibacterial agent|classification of antibacterial agent
520100|NCT00945555|Febrile neutropenia|febrile neutropenia
520101|NCT00945555|Turkey|turkey
520102|NCT00945542|Trauma|trauma
520103|NCT00945542|Coagulopathy|coagulopathy
520104|NCT00945542|Transfusion|transfusion
520105|NCT00945542|Plasma|plasma
520106|NCT00945542|Massive Transfusion|massive transfusion
520107|NCT00945529|Fontan|fontan
520108|NCT00945516|Metal stent|metal stent
520109|NCT00945516|Bile duct stricture|bile duct stricture
520110|NCT00945516|Stent migration|stent migration
520111|NCT00945516|Feasibility|feasibility
520112|NCT00945516|Safety|safety
520113|NCT00945516|Removability|removability
520114|NCT00945503|Glycine Tranporter|glycine tranporter
520115|NCT00945503|MRI|mri
520116|NCT00945503|PET|pet
520117|NCT00945490|Benign prostatic hyperplasia|benign prostatic hyperplasia
520118|NCT00945490|BPH|bph
520119|NCT00945490|Enlarged prostate|enlarged prostate
520120|NCT00945451|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
520121|NCT00945451|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
520122|NCT00945451|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
520123|NCT00945438|Influenza|influenza
520124|NCT00945438|Influenza virus vaccine|influenza virus vaccine
520125|NCT00945438|Split virion|split virion
520126|NCT00945438|Intradermal|intradermal
520127|NCT00945425|Phase I|phase i
520128|NCT00945425|Volunteer|volunteer
520129|NCT00945412|microdebrider tonsillotomy|microdebrider tonsillotomy
520130|NCT00945412|Post-tonsillectomy hemorrhage|post-tonsillectomy hemorrhage
520131|NCT00945386|children|children
520132|NCT00945386|critically ill|critically ill
520133|NCT00945386|furosemide|furosemide
520134|NCT00945386|acoustic emission|acoustic emission
520135|NCT00945373|rosacea|rosacea
520136|NCT00945373|telangiectasias|telangiectasias
520137|NCT00945373|topical treatment|topical treatment
520138|NCT00945373|pulsed dye laser|pulsed dye laser
520139|NCT00945360|Leiomyoma|leiomyoma
520140|NCT00945360|perimenopause|perimenopause
520141|NCT00945360|aromatase inhibitor|aromatase inhibitor
520142|NCT00945347|Cystic fibrosis|cystic fibrosis
520143|NCT00945347|miglustat|miglustat
520144|NCT00945347|nasal instillation|nasal instillation
520145|NCT00945347|nasal potential difference|nasal potential difference
520146|NCT00945334|Constipation predominant Irritable Bowel Syndrome|constipation predominant irritable bowel syndrome
520147|NCT00945308|Primary PCI|primary pci
520148|NCT00945308|Acute myocardial infarction|acute myocardial infarction
520149|NCT00945308|Myocardial blush|myocardial blush
520150|NCT00945308|Primary coronary intervention in acute myocardial infarction|primary coronary intervention in acute myocardial infarction
520344|NCT00944736|Permeability|permeability
520151|NCT00945308|focusing on the effect of the study drug on the immediate TIMI|focusing on the effect of the study drug on the immediate timi
520152|NCT00945308|flow at the infarct related artery and on the myocardial|flow at the infarct related artery and on the myocardial
520153|NCT00945308|perfusion evaluated by the TIMI myocardial perfusion grade or|perfusion evaluated by the timi myocardial perfusion grade or
520154|NCT00945308|blush|blush
520155|NCT00945295|Cerebrovascular Accident/Rehabilitation|cerebrovascular accident/rehabilitation
520156|NCT00945295|Muscle Spasticity|muscle spasticity
520157|NCT00945295|Botulinum Neurotoxin Type A|botulinum neurotoxin type a
520158|NCT00945295|Post-stroke focal upper limb spasticity|post-stroke focal upper limb spasticity
520159|NCT00945282|IDX12899|idx12899
520160|NCT00945282|adaptive|adaptive
520161|NCT00945282|monotherapy|monotherapy
520162|NCT00945282|pharmacokinetics|pharmacokinetics
520163|NCT00945282|Treatment-naive|treatment-naive
520164|NCT00945282|HIV-1|hiv-1
520165|NCT00945282|GSK2248761|gsk2248761
520166|NCT00945282|NNRTI|nnrti
520167|NCT00945282|HIV Infections|hiv infections
520168|NCT00945282|treatment naive|treatment naive
520169|NCT00945256|metabolism|metabolism
520170|NCT00945256|exercise|exercise
520171|NCT00945256|sodium nitroprusside|sodium nitroprusside
520172|NCT00945243|SCDD|scdd
520173|NCT00945230|Neurosurgical outcome|neurosurgical outcome
520174|NCT00945230|Actigraphy|actigraphy
520175|NCT00945230|Treatment Response Measurement|treatment response measurement
520176|NCT00945217|Atherogenic dyslipidemia|atherogenic dyslipidemia
520177|NCT00945217|Non-HDL-C|non-hdl-c
520178|NCT00945217|Postmenopausal women|postmenopausal women
520179|NCT00945217|SAH gene family|sah gene family
520180|NCT00945204|type 2 diabetes|type 2 diabetes
520181|NCT00945204|intermediate care|intermediate care
520182|NCT00945204|primary care|primary care
520183|NCT00945204|randomised controlled trial|randomised controlled trial
520184|NCT00945191|ovarian|ovarian
520185|NCT00945191|cancer|cancer
520186|NCT00945191|metastatic|metastatic
520187|NCT00945191|locally|locally
520188|NCT00945191|advanced|advanced
520189|NCT00945191|chemotherapy|chemotherapy
520190|NCT00945191|neoplasm|neoplasm
520191|NCT00945178|Safety|safety
520192|NCT00945178|Tolerability|tolerability
520193|NCT00945178|Healthy|healthy
520194|NCT00945178|Pharmacokinetics|pharmacokinetics
520195|NCT00945165|Continuous Glucose Monitoring System|continuous glucose monitoring system
520196|NCT00945165|Exercise|exercise
520197|NCT00945152|Elimination of MRSA in open wounds|elimination of mrsa in open wounds
520198|NCT00945152|MRSA infected open wounds|mrsa infected open wounds
520199|NCT00945126|Allogeneic stem cell transplantation in pediatric patients|allogeneic stem cell transplantation in pediatric patients
520200|NCT00945126|CD3/CD19 depleted stem cells|cd3/cd19 depleted stem cells
520201|NCT00945126|malignant and non-malignant high risk diseases|malignant and non-malignant high risk diseases
520202|NCT00945113|pilot|pilot
520203|NCT00945113|stammer|stammer
520204|NCT00945113|stutter|stutter
520205|NCT00945113|children|children
520206|NCT00945113|randomised controlled trial|randomised controlled trial
520207|NCT00945113|RCT|rct
520208|NCT00945113|Speech and Language Therapy|speech and language therapy
520209|NCT00945113|Stuttering|stuttering
520210|NCT00945100|Amblyopia|amblyopia
520211|NCT00945100|patching|patching
520212|NCT00945100|occlusion|occlusion
520213|NCT00945087|bacteriophage|bacteriophage
520214|NCT00945087|bacteriophage preparation|bacteriophage preparation
520215|NCT00945087|bacterial infection|bacterial infection
520216|NCT00945087|antibiotic-resistant infection|antibiotic-resistant infection
520217|NCT00945087|multidrug-resistant bacteria|multidrug-resistant bacteria
520218|NCT00945087|MRSA|mrsa
520219|NCT00945074|Acupuncture|acupuncture
520220|NCT00945074|Moxibustion|moxibustion
520221|NCT00945074|Traditional Chinese Medicine|traditional chinese medicine
520222|NCT00945074|Complementary Medicine|complementary medicine
520223|NCT00945074|Irritable Bowel Syndrome|irritable bowel syndrome
520224|NCT00945074|IBS|ibs
520225|NCT00945061|ductal breast carcinoma in situ|ductal breast carcinoma in situ
520226|NCT00945061|recurrent breast cancer|recurrent breast cancer
520227|NCT00945061|invasive ductal breast carcinoma|invasive ductal breast carcinoma
520228|NCT00945061|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
520229|NCT00945061|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
520230|NCT00945061|papillary ductal breast carcinoma|papillary ductal breast carcinoma
520231|NCT00945061|tubular ductal breast carcinoma|tubular ductal breast carcinoma
520232|NCT00945061|male breast cancer|male breast cancer
520233|NCT00945022|General Surgery|general surgery
520234|NCT00944996|PACAP (Pituitary Adenylate Cyclase Activating Polypeptide)|pacap (pituitary adenylate cyclase activating polypeptide)
520235|NCT00944996|Major Depression|major depression
520236|NCT00944996|Receptors|receptors
520237|NCT00944996|Gene polymorphism|gene polymorphism
520238|NCT00944996|PACAP signaling system|pacap signaling system
520239|NCT00944996|Etiology of major depression|etiology of major depression
520240|NCT00944996|Mechanism of antidepressants action|mechanism of antidepressants action
520241|NCT00944996|PACAP receptors gene polymorphism|pacap receptors gene polymorphism
520242|NCT00944996|Pathogenesis of major depression|pathogenesis of major depression
520243|NCT00944996|Responsiveness to the antidepressant drugs|responsiveness to the antidepressant drugs
520244|NCT00944983|Hypertension|hypertension
520245|NCT00944983|Hypotension|hypotension
520246|NCT00944983|Clinical Validation|clinical validation
520247|NCT00944983|Blood Pressure Accuracy|blood pressure accuracy
520248|NCT00944983|ISO 81600 Standard|iso 81600 standard
520249|NCT00944983|British Hypertension Society|british hypertension society
520250|NCT00944983|European Society of Hypertension|european society of hypertension
520251|NCT00944983|International Protocol|international protocol
520252|NCT00944970|Coronary artery disease|coronary artery disease
520253|NCT00944970|Angina|angina
520254|NCT00944970|Anginal symptoms|anginal symptoms
520255|NCT00944970|Ischemic heart disease|ischemic heart disease
520256|NCT00944970|Ischemia|ischemia
520257|NCT00944970|Single photon emission computed tomography|single photon emission computed tomography
520258|NCT00944970|Pharmacologic stress|pharmacologic stress
520259|NCT00944970|Myocardial perfusion imaging|myocardial perfusion imaging
520260|NCT00944970|Suspected coronary artery disease|suspected coronary artery disease
520261|NCT00944970|known coronary artery disease|known coronary artery disease
520262|NCT00944970|typical or atypical anginal symptoms|typical or atypical anginal symptoms
520263|NCT00944957|Raltegravir|raltegravir
520264|NCT00944957|efavirenz|efavirenz
520265|NCT00944957|anxiety|anxiety
520266|NCT00944957|depression|depression
520267|NCT00944957|sleep quality|sleep quality
520268|NCT00944957|HIV|hiv
520269|NCT00944957|NNRTI|nnrti
520270|NCT00944957|Tritherapy|tritherapy
520271|NCT00944957|compliance|compliance
520272|NCT00944957|stocrin|stocrin
520273|NCT00944957|treatment experienced|treatment experienced
520274|NCT00944944|CORPUS UTERI,|corpus uteri,
520275|NCT00944944|ENDOMETRIUM|endometrium
520276|NCT00944944|FALLOPIAN TUBE|fallopian tube
520277|NCT00944944|OVARY|ovary
520278|NCT00944944|VAGINA|vagina
520279|NCT00944944|Lymphedema|lymphedema
520280|NCT00944944|Questionnaire|questionnaire
520281|NCT00944944|Quality of Life|quality of life
520282|NCT00944944|09-077|09-077
520283|NCT00944944|Fallopian Tubes|fallopian tubes
520284|NCT00944931|Cerebral Cortex|cerebral cortex
520285|NCT00944931|Cognition|cognition
520286|NCT00944931|Motor Cortex|motor cortex
520287|NCT00944931|Cognitive Enhancement|cognitive enhancement
520288|NCT00944931|Prefrontal Cortex|prefrontal cortex
520289|NCT00944931|Healthy Volunteer|healthy volunteer
520290|NCT00944918|Breast Cancer|breast cancer
520291|NCT00944879|HIV|hiv
520292|NCT00944879|vaccine|vaccine
520293|NCT00944879|prevention|prevention
520294|NCT00944879|HPV|hpv
520295|NCT00944879|adolescents|adolescents
520296|NCT00944853|zinc supplement|zinc supplement
520297|NCT00944853|prevention|prevention
520298|NCT00944853|zinc deficiency|zinc deficiency
520299|NCT00944853|plasma zinc concentration|plasma zinc concentration
520300|NCT00944840|Intermittent Preventive Treatment|intermittent preventive treatment
520301|NCT00944840|Home based management of malaria|home based management of malaria
520302|NCT00944827|Green Tea Extract|green tea extract
520303|NCT00944827|Catechins|catechins
520304|NCT00944827|Statin|statin
520305|NCT00944827|atorvastatin|atorvastatin
520306|NCT00944827|body composition|body composition
520307|NCT00944827|visceral fat|visceral fat
520308|NCT00944827|steatosis|steatosis
520309|NCT00944827|oxidative stress|oxidative stress
520310|NCT00944827|quality of life|quality of life
520311|NCT00944827|OGTT|ogtt
520312|NCT00944827|OGIS|ogis
520313|NCT00944827|ISI matsuda|isi matsuda
520314|NCT00944814|Lipid-based nutrient supplement|lipid-based nutrient supplement
520315|NCT00944814|Prevention of malnutrition|prevention of malnutrition
520316|NCT00944814|Prevention of micronutrient deficiencies|prevention of micronutrient deficiencies
520317|NCT00944814|Zinc|zinc
520318|NCT00944801|glioblastoma|glioblastoma
520319|NCT00944801|first-line|first-line
520320|NCT00944801|clinical trial|clinical trial
520321|NCT00944801|PEG-liposomal doxorubicin|peg-liposomal doxorubicin
520322|NCT00944801|temozolomide|temozolomide
520323|NCT00944801|radiotherapy|radiotherapy
520324|NCT00944801|phase 1|phase 1
520325|NCT00944801|phase 2|phase 2
520326|NCT00944788|physical activity|physical activity
520327|NCT00944788|aging|aging
520328|NCT00944788|inpatients|inpatients
520329|NCT00944788|quality of life|quality of life
520330|NCT00944788|depression|depression
520331|NCT00944775|Exercise|exercise
520332|NCT00944775|Dialysis|dialysis
520333|NCT00944775|Non-invasive cardiac measures|non-invasive cardiac measures
520334|NCT00944775|Exercise trained patients|exercise trained patients
520335|NCT00944775|Controls|controls
520336|NCT00944762|Stroke|stroke
520337|NCT00944749|H- ATG|h- atg
520338|NCT00944749|Anti -Thymocyte Globulin|anti -thymocyte globulin
520339|NCT00944749|Lymphocyte Immune Globulin|lymphocyte immune globulin
520340|NCT00944749|Aplastic Anemia|aplastic anemia
520341|NCT00944736|Crohn's Disease|crohn's disease
520342|NCT00944736|Pediatric|pediatric
520343|NCT00944736|VSL#3|vsl#3
520346|NCT00944736|Zonulin|zonulin
520347|NCT00944723|zinc fortification|zinc fortification
520348|NCT00944723|zinc supplementation|zinc supplementation
520349|NCT00944723|plasma zinc concentration|plasma zinc concentration
520350|NCT00944710|Amblyopia|amblyopia
520351|NCT00944710|atropine|atropine
520352|NCT00944710|Plano lens|plano lens
520353|NCT00944684|Chronic hepatitis C|chronic hepatitis c
520354|NCT00944684|Antiviral treatment|antiviral treatment
520355|NCT00944684|Ribavirin|ribavirin
520356|NCT00944684|Sustained virological response|sustained virological response
520357|NCT00944684|Hemolytic anemia|hemolytic anemia
520358|NCT00944684|Erythropoetin|erythropoetin
520359|NCT00944658|Ankylosing spondylitis|ankylosing spondylitis
520360|NCT00944658|Imaging|imaging
520361|NCT00944580|MAGE-A1|mage-a1
520362|NCT00944580|MAGE-A3|mage-a3
520363|NCT00944580|NY-ESO-1|ny-eso-1
520364|NCT00944580|antigen|antigen
520365|NCT00944580|vaccine|vaccine
520366|NCT00944580|dendritic cells|dendritic cells
520367|NCT00944580|immunohistochemistry|immunohistochemistry
520368|NCT00944580|immunology|immunology
520369|NCT00944567|Primary Mediastinal B-Cell Lymphoma|primary mediastinal b-cell lymphoma
520370|NCT00944567|Positron emission tomography|positron emission tomography
520371|NCT00944554|Relapse|relapse
520372|NCT00944554|Smoking Cessation|smoking cessation
520373|NCT00944554|Substance Abuse|substance abuse
520374|NCT00944541|maraviroc|maraviroc
520375|NCT00944541|immune restoration|immune restoration
520376|NCT00944541|treatment intensification|treatment intensification
520377|NCT00944528|Cancer of Breast|cancer of breast
520378|NCT00944528|Cancer of the Breast|cancer of the breast
520379|NCT00944528|Neoplasms, Breast|neoplasms, breast
520380|NCT00944528|Single dose radiation|single dose radiation
520381|NCT00944528|Radiotherapy|radiotherapy
520382|NCT00944528|Preoperative|preoperative
520383|NCT00944515|sinusitis|sinusitis
520384|NCT00944515|azithromycin|azithromycin
520385|NCT00944502|Neuralgy|neuralgy
520386|NCT00944502|Dexamethasone|dexamethasone
520387|NCT00944502|Complex Vitamins|complex vitamins
520388|NCT00944502|Injection|injection
520389|NCT00944502|Symptoms of neuralgy of various origins|symptoms of neuralgy of various origins
520390|NCT00944489|Hypertension|hypertension
520391|NCT00944489|Health-Related Quality of Life Adherence to the antihypertension treatment|health-related quality of life adherence to the antihypertension treatment
520392|NCT00944489|Ambulatory Patients|ambulatory patients
520393|NCT00944489|MINICHAL score|minichal score
520394|NCT00944489|Treatment Adherence Scale (MMAS)|treatment adherence scale (mmas)
520395|NCT00944489|Quality of life|quality of life
520396|NCT00944489|Adherence to treatment|adherence to treatment
520397|NCT00944476|Sarcoma|sarcoma
520398|NCT00944476|soft tissue|soft tissue
520399|NCT00944476|MRI|mri
520400|NCT00944476|Questionnaire|questionnaire
520401|NCT00944476|09-078|09-078
520402|NCT00944463|advanced pancreatic cancer|advanced pancreatic cancer
520403|NCT00944463|gemcitabine|gemcitabine
520404|NCT00944463|simvastatin|simvastatin
520405|NCT00944463|placebo|placebo
520406|NCT00944437|Ventilation, Mechanical|ventilation, mechanical
520407|NCT00944437|Positive-Pressure Respiration|positive-pressure respiration
520408|NCT00944437|Continuous Positive Airway Pressure|continuous positive airway pressure
520409|NCT00944424|Vitamin D in patients with metastatic breast cancer|vitamin d in patients with metastatic breast cancer
520410|NCT00944398|Zinc fortification|zinc fortification
520411|NCT00944398|Plasma zinc concentration|plasma zinc concentration
520412|NCT00944398|Assessment of zinc status|assessment of zinc status
520413|NCT00944372|Tumor|tumor
520414|NCT00944372|somatostatin receptor|somatostatin receptor
520415|NCT00944359|zinc supplementation|zinc supplementation
520416|NCT00944359|diarrhea management|diarrhea management
520417|NCT00944359|zinc deficiency|zinc deficiency
520418|NCT00944359|malaria|malaria
520419|NCT00944333|second generation DES|second generation des
520420|NCT00944333|clopidogrel|clopidogrel
520421|NCT00944333|dual platelet therapy|dual platelet therapy
520422|NCT00944333|patients with documented silent ischemia|patients with documented silent ischemia
520423|NCT00944333|unstable angina pectoris (Braunwald Classification)|unstable angina pectoris (braunwald classification)
520424|NCT00944333|Diagnosis of angina pectoris (CCS)|diagnosis of angina pectoris (ccs)
520425|NCT00944307|HIV|hiv
520426|NCT00944307|antiretroviral|antiretroviral
520427|NCT00944307|drug interaction|drug interaction
520428|NCT00944307|human immunodeficiency virus|human immunodeficiency virus
520429|NCT00944294|Coronary artery disease|coronary artery disease
520430|NCT00944294|Angina|angina
520431|NCT00944294|Anginal symptoms|anginal symptoms
520432|NCT00944294|Ischemic heart disease|ischemic heart disease
520433|NCT00944294|Ischemia|ischemia
520434|NCT00944294|Single photon emission computed tomography|single photon emission computed tomography
520435|NCT00944294|Pharmacologic stress|pharmacologic stress
520436|NCT00944294|Myocardial perfusion imaging|myocardial perfusion imaging
520437|NCT00944294|typical or atypical anginal symptoms|typical or atypical anginal symptoms
520438|NCT00944294|Suspected coronary artery disease|suspected coronary artery disease
520439|NCT00944294|known coronary artery disease|known coronary artery disease
520541|NCT00943943|BAY 43-9006|bay 43-9006
520440|NCT00944281|point-of-use fortification|point-of-use fortification
520441|NCT00944281|zinc supplement|zinc supplement
520442|NCT00944281|lipid-based nutrient supplement|lipid-based nutrient supplement
520443|NCT00944281|zinc deficiency|zinc deficiency
520444|NCT00944281|micronutrient deficiency|micronutrient deficiency
520445|NCT00944281|anemia|anemia
520446|NCT00944268|Passiflora, Crataegus and Salix|passiflora, crataegus and salix
520447|NCT00944268|Mild and Moderate anxiety|mild and moderate anxiety
520448|NCT00944268|Tablet|tablet
520449|NCT00944268|To evaluate the efficacy and tolerability of the combination|to evaluate the efficacy and tolerability of the combination
520450|NCT00944229|Heart Failure|heart failure
520451|NCT00944229|omega 3|omega 3
520452|NCT00944229|lovaza|lovaza
520453|NCT00944229|VO2 max|vo2 max
520454|NCT00944216|keratosis pilaris|keratosis pilaris
520455|NCT00944203|jellyfish|jellyfish
520456|NCT00944203|jellyfish venom|jellyfish venom
520457|NCT00944203|jellyfish dermatitis|jellyfish dermatitis
520458|NCT00944203|jellyfish stings|jellyfish stings
520459|NCT00944203|Ipomea pes-caprae|ipomea pes-caprae
520460|NCT00944190|pain|pain
520461|NCT00944190|fatigue|fatigue
520462|NCT00944190|depression|depression
520463|NCT00944190|cognitive difficulties|cognitive difficulties
520464|NCT00944190|self-management|self-management
520465|NCT00944151|pain|pain
520466|NCT00944151|UCSD|ucsd
520467|NCT00944151|catheter|catheter
520468|NCT00944151|nerve block|nerve block
520469|NCT00944151|hernia|hernia
520470|NCT00944151|post-surgery pain|post-surgery pain
520471|NCT00944151|abdominal pain|abdominal pain
520472|NCT00944151|pelvic pain|pelvic pain
520473|NCT00944151|Transversus abdominal plane|transversus abdominal plane
520474|NCT00944151|Hernia Repair|hernia repair
520475|NCT00944151|Transversus Abdominal Plane Block|transversus abdominal plane block
520476|NCT00944138|Obesity|obesity
520477|NCT00944138|meditation|meditation
520478|NCT00944138|chronic kidney disease|chronic kidney disease
520479|NCT00944112|Intensive care|intensive care
520480|NCT00944112|Blood Transfusion|blood transfusion
520481|NCT00944112|Anemia|anemia
520482|NCT00944099|intervention studies|intervention studies
520483|NCT00944099|feeding behavior|feeding behavior
520484|NCT00944099|eating frequency|eating frequency
520485|NCT00944099|weight loss|weight loss
520486|NCT00944099|dietary intake|dietary intake
520487|NCT00944086|Recruitment|recruitment
520488|NCT00944086|Oxygen Concentration|oxygen concentration
520489|NCT00944086|pneumoperitoneum|pneumoperitoneum
520490|NCT00944086|laparoscopy|laparoscopy
520491|NCT00944073|H1N1, influenza A viruses, vaccine, infants, children|h1n1, influenza a viruses, vaccine, infants, children
520492|NCT00944047|invasive breast cancer|invasive breast cancer
520493|NCT00944047|HER2|her2
520494|NCT00944047|primary breast cancer|primary breast cancer
520495|NCT00944047|neo-adjuvant therapy|neo-adjuvant therapy
520496|NCT00944047|Trastuzumab|trastuzumab
520497|NCT00944047|Nab-paclitaxel|nab-paclitaxel
520498|NCT00944034|Meningococcal meningitis|meningococcal meningitis
520499|NCT00944034|prevention|prevention
520500|NCT00944034|vaccination|vaccination
520501|NCT00944034|toddler|toddler
520502|NCT00944021|Early Bactericidal Activity|early bactericidal activity
520503|NCT00944021|EBA|eba
520504|NCT00944021|Pulmonary Tuberculosis|pulmonary tuberculosis
520505|NCT00944021|PA-824|pa-824
520506|NCT00944021|pretomanid|pretomanid
520507|NCT00944008|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
520508|NCT00944008|Depocyte®|depocyte®
520509|NCT00944008|Neuromeningeal relapse|neuromeningeal relapse
520510|NCT00944008|Between 16 and 30 years old|between 16 and 30 years old
520511|NCT00944008|Standard risk|standard risk
520512|NCT00943995|End Stage Kidney Disease|end stage kidney disease
520513|NCT00943995|Kidney Failure|kidney failure
520514|NCT00943995|Short stature|short stature
520515|NCT00943995|Growth Hormone therapy|growth hormone therapy
520516|NCT00943982|Cystoid Macular Edema|cystoid macular edema
520517|NCT00943982|Intermediate Uveitis|intermediate uveitis
520518|NCT00943982|Uveitis|uveitis
520519|NCT00943982|OCT|oct
520520|NCT00943982|Interferon-Gamma (IFN-Gamma)|interferon-gamma (ifn-gamma)
520521|NCT00943969|obesity|obesity
520522|NCT00943969|gastric bypass|gastric bypass
520523|NCT00943969|morphine|morphine
520524|NCT00943969|pharmacokinetic|pharmacokinetic
520525|NCT00943969|absorption|absorption
520526|NCT00943956|stage III prostate cancer|stage iii prostate cancer
520527|NCT00943956|stage IV prostate cancer|stage iv prostate cancer
520528|NCT00943943|acute myelogenous leukemia|acute myelogenous leukemia
520529|NCT00943943|AML|aml
520530|NCT00943943|Leukemia|leukemia
520531|NCT00943943|myeloid leukemias|myeloid leukemias
520532|NCT00943943|mutated fms-like tyrosine kinase receptor-3|mutated fms-like tyrosine kinase receptor-3
520533|NCT00943943|FLT3 Mutations|flt3 mutations
520534|NCT00943943|G-CSF|g-csf
520535|NCT00943943|Granulocyte Colony Stimulating Factor|granulocyte colony stimulating factor
520536|NCT00943943|Filgrastim|filgrastim
520537|NCT00943943|Neupogen|neupogen
520538|NCT00943943|Plerixafor|plerixafor
520539|NCT00943943|Mobozil|mobozil
520540|NCT00943943|Sorafenib|sorafenib
520542|NCT00943904|urinary leakage associated with urinary urgency|urinary leakage associated with urinary urgency
520543|NCT00943904|unable to fully empty bladder|unable to fully empty bladder
520544|NCT00943904|Comparison: Motor&Sensory Response to Interstim Stimulation|comparison: motor&sensory response to interstim stimulation
520545|NCT00943878|H1N1, influenza A viruses, vaccine, elderly, TIV|h1n1, influenza a viruses, vaccine, elderly, tiv
520546|NCT00943865|metabolic syndrome|metabolic syndrome
520547|NCT00943865|lifestyle|lifestyle
520548|NCT00943865|exercise|exercise
520549|NCT00943865|endothelial dysfunction|endothelial dysfunction
520550|NCT00943865|insulin sensitivity|insulin sensitivity
520551|NCT00943865|lipids|lipids
520552|NCT00943839|stage IV renal cell cancer|stage iv renal cell cancer
520553|NCT00943813|communication|communication
520554|NCT00943813|survey|survey
520555|NCT00943813|video|video
520556|NCT00943813|09-043|09-043
520557|NCT00943800|Appropriate candidate for transplantation|appropriate candidate for transplantation
520803|NCT00942812|Recovery|recovery
520558|NCT00943800|An HLA-identical related or unrelated donor cannot be identified within an appropriate time frame.|an hla-identical related or unrelated donor cannot be identified within an appropriate time frame.
520559|NCT00943774|Physiology|physiology
520560|NCT00943774|Phenotype|phenotype
520561|NCT00943774|Genetics|genetics
520562|NCT00943774|Genomics|genomics
520564|NCT00943774|Baroreflex|baroreflex
520565|NCT00943774|Blood Pressure|blood pressure
520566|NCT00943774|Arterial stiffness|arterial stiffness
520567|NCT00943761|hepatitis C|hepatitis c
520568|NCT00943735|Overactive Bladder Incontinence Adherence Behavioral interventions|overactive bladder incontinence adherence behavioral interventions
520569|NCT00943709|hyperglycemia|hyperglycemia
520570|NCT00943709|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
520571|NCT00943709|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
520572|NCT00943709|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
520573|NCT00943709|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
520574|NCT00943709|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
520575|NCT00943709|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
520576|NCT00943709|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
520577|NCT00943709|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
520578|NCT00943709|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
520579|NCT00943670|MBC|mbc
520580|NCT00943670|TDM1|tdm1
520581|NCT00943670|Armed Herceptin|armed herceptin
520582|NCT00943670|Herceptin|herceptin
520583|NCT00943670|Trastuzumab emtansine|trastuzumab emtansine
520584|NCT00943644|MBI|mbi
520585|NCT00943644|Breast|breast
520586|NCT00943644|Breast Cancer|breast cancer
520587|NCT00943631|H1N1, influenza A viruses, vaccine, elderly|h1n1, influenza a viruses, vaccine, elderly
520588|NCT00943618|Smoking Cessation|smoking cessation
520589|NCT00943618|Nicotine Withdrawal|nicotine withdrawal
520590|NCT00943618|Smoking Reduction|smoking reduction
520591|NCT00943618|Varenicline|varenicline
520592|NCT00943618|Chantix|chantix
520593|NCT00943618|Bupropion|bupropion
520594|NCT00943618|Zyban|zyban
520595|NCT00943605|Mastectomy|mastectomy
520596|NCT00943605|PlasmaBlade|plasmablade
520597|NCT00943605|Electrosurgery|electrosurgery
520598|NCT00943605|PEAK Surgical|peak surgical
520599|NCT00943605|Medtronic Advanced Energy|medtronic advanced energy
520600|NCT00943605|Medtronic|medtronic
520601|NCT00943592|Melphalan|melphalan
520602|NCT00943592|Alemtuzumab|alemtuzumab
520603|NCT00943592|Clofarabine|clofarabine
520604|NCT00943579|autism|autism
520605|NCT00943579|autistic disorder|autistic disorder
520606|NCT00943579|tetrahydrobiopterin|tetrahydrobiopterin
520607|NCT00943579|sapropterin|sapropterin
520608|NCT00943579|treatment|treatment
520609|NCT00943566|Pain|pain
520610|NCT00943566|Cancer|cancer
520611|NCT00943566|Morphine|morphine
520612|NCT00943553|AML|aml
520613|NCT00943540|pharmacokinetics|pharmacokinetics
520614|NCT00943540|single dose|single dose
520615|NCT00943540|raltegravir|raltegravir
520616|NCT00943540|Treatment experienced|treatment experienced
520617|NCT00943527|Breast|breast
520618|NCT00943527|Menstrual Cycle|menstrual cycle
520619|NCT00943527|Breast Cancer|breast cancer
520620|NCT00943527|Hormone|hormone
520621|NCT00943527|MBI|mbi
520622|NCT00943527|Molecular Breast Imaging|molecular breast imaging
520623|NCT00943527|Breast Imaging|breast imaging
520624|NCT00943514|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
520625|NCT00943514|Variant Cystic Fibrosis|variant cystic fibrosis
520626|NCT00943514|Bronchopulmonary Mycosis|bronchopulmonary mycosis
520627|NCT00943514|Airway Infection Susceptibility|airway infection susceptibility
520628|NCT00943514|Chronic Respiratory Infection|chronic respiratory infection
520629|NCT00943514|Bronchiectasis|bronchiectasis
520630|NCT00943488|influenza A viruses, H1N1, elderly|influenza a viruses, h1n1, elderly
520631|NCT00943475|DPNB, pain, hemodynamics effects, circumcision|dpnb, pain, hemodynamics effects, circumcision
520632|NCT00943449|Hepatocellular Carcinoma|hepatocellular carcinoma
520633|NCT00943449|Sorafenib|sorafenib
520634|NCT00943449|HDAC|hdac
520635|NCT00943449|4SC-201|4sc-201
520636|NCT00943449|Phase II|phase ii
520637|NCT00943449|Resminostat|resminostat
520638|NCT00943436|Exercise|exercise
520639|NCT00943436|Sedentary|sedentary
520640|NCT00943436|Energy Expenditure|energy expenditure
520641|NCT00943436|Energy Balance|energy balance
520642|NCT00943436|Macronutrient Intake|macronutrient intake
520643|NCT00943436|Energy and Macronutrient intake|energy and macronutrient intake
520644|NCT00943436|Exercise and Energy Balance|exercise and energy balance
520645|NCT00943423|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
520646|NCT00943423|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
520647|NCT00943410|HER2-positive breast cancer|her2-positive breast cancer
520648|NCT00943410|inflammatory breast cancer|inflammatory breast cancer
520649|NCT00943410|recurrent breast cancer|recurrent breast cancer
520650|NCT00943410|stage IIIA breast cancer|stage iiia breast cancer
520651|NCT00943410|stage IIIB breast cancer|stage iiib breast cancer
520652|NCT00943410|stage IIIC breast cancer|stage iiic breast cancer
520653|NCT00943410|stage IV breast cancer|stage iv breast cancer
520654|NCT00943358|influenza|influenza
520655|NCT00943358|immunogenicity|immunogenicity
520656|NCT00943358|vaccine|vaccine
520657|NCT00943345|GI|gi
520658|NCT00943345|gastrointestinal|gastrointestinal
520659|NCT00943345|permeability|permeability
520660|NCT00943345|indometacin|indometacin
520661|NCT00943345|indomethacin|indomethacin
520662|NCT00943345|coeliac|coeliac
520663|NCT00943332|Orthopedic Procedures|orthopedic procedures
520664|NCT00943332|Fracture Fixation, Internal|fracture fixation, internal
520665|NCT00943332|Fracture Fixation, External|fracture fixation, external
520666|NCT00943332|femur fracture|femur fracture
520667|NCT00943332|pediatrics|pediatrics
520668|NCT00943319|Cancers of the blood|cancers of the blood
520669|NCT00943306|Homozygous|homozygous
520670|NCT00943306|Familial|familial
520671|NCT00943306|Hypercholesterolemia|hypercholesterolemia
520672|NCT00943306|MTP|mtp
520673|NCT00943306|Apheresis|apheresis
520674|NCT00943306|lomitapide|lomitapide
520675|NCT00943306|Homozygous Familial Hypercholesterolemia (HoFH)|homozygous familial hypercholesterolemia (hofh)
520676|NCT00943293|GVHD|gvhd
520677|NCT00943280|probability of patient participation in each of the Groups 1, 2 and 3.|probability of patient participation in each of the groups 1, 2 and 3.
520678|NCT00943280|Identification of factors predicting poor participation in screening for Barrett's esophagus.|identification of factors predicting poor participation in screening for barrett's esophagus.
520679|NCT00943267|Activated Protein C|activated protein c
520680|NCT00943267|Lipopolysaccharides|lipopolysaccharides
520681|NCT00943267|Inflammation, Pulmonary|inflammation, pulmonary
520682|NCT00943254|Metabolic Cardiovascular Syndrome|metabolic cardiovascular syndrome
520683|NCT00943241|Breast|breast
520684|NCT00943241|Breast Cancer|breast cancer
520685|NCT00943241|MBI|mbi
520686|NCT00943241|Molecular Breast Imaging|molecular breast imaging
520687|NCT00943241|Molecular Imaging|molecular imaging
520688|NCT00943228|Renal transplantation|renal transplantation
520689|NCT00943228|Adequate exposure|adequate exposure
520690|NCT00943228|Acute rejection|acute rejection
520691|NCT00943228|mycophenolate mofetil|mycophenolate mofetil
520692|NCT00943228|immunosuppression|immunosuppression
520693|NCT00943215|CALERIE II Follow-up|calerie ii follow-up
520694|NCT00943202|H1N1, influenza A viruses, TIV, vaccine, infants, children|h1n1, influenza a viruses, tiv, vaccine, infants, children
520695|NCT00943189|Fetal anomalies scan at the time of NT study|fetal anomalies scan at the time of nt study
520696|NCT00943176|Fatigue|fatigue
520697|NCT00943163|cyclorotation|cyclorotation
520698|NCT00943163|pupil|pupil
520699|NCT00943163|laser refractive surgery|laser refractive surgery
520700|NCT00943150|Abdominoplasty|abdominoplasty
520701|NCT00943150|PlasmaBlade|plasmablade
520702|NCT00943150|Electrosurgery|electrosurgery
520703|NCT00943150|PEAK Surgical|peak surgical
520704|NCT00943150|Medtronic Advanced Energy|medtronic advanced energy
520705|NCT00943150|Medtronic|medtronic
520706|NCT00943111|Gaucher disease,|gaucher disease,
520707|NCT00943111|Genz-112638,|genz-112638,
520708|NCT00943111|beta-glucosidase,|beta-glucosidase,
520709|NCT00943111|acid ß-glucosidase,|acid ß-glucosidase,
520710|NCT00943111|glucocerebrosidase,|glucocerebrosidase,
520711|NCT00943111|glucosylceramide,|glucosylceramide,
520712|NCT00943111|D-glucosyl-N-acylsphingosine glucohydrolase,|d-glucosyl-n-acylsphingosine glucohydrolase,
520713|NCT00943111|substrate reduction therapy|substrate reduction therapy
520714|NCT00943085|Early Signs of Bipolar Disorder|early signs of bipolar disorder
520715|NCT00943085|High Risk Youth|high risk youth
520716|NCT00943085|Adolescence|adolescence
520717|NCT00943085|Childhood|childhood
520718|NCT00943072|Macular edema|macular edema
520719|NCT00943072|Retinal vein occlusion|retinal vein occlusion
520720|NCT00943072|CRVO|crvo
520721|NCT00943072|VEGF Trap-Eye|vegf trap-eye
520722|NCT00943072|best-corrected visual acuity|best-corrected visual acuity
520723|NCT00943072|Regeneron|regeneron
520724|NCT00943072|COPERNICUS|copernicus
520725|NCT00943059|Mitochondrial function|mitochondrial function
520726|NCT00943059|Diabetes|diabetes
520727|NCT00943059|Cardiomyopathy|cardiomyopathy
520728|NCT00943059|insulin resistance|insulin resistance
520729|NCT00943059|lipid lowering|lipid lowering
520730|NCT00943059|triglycerides|triglycerides
520731|NCT00943059|Acipimox|acipimox
520732|NCT00943046|leads|leads
520733|NCT00943046|pacemaker|pacemaker
520734|NCT00943046|efficacy|efficacy
520735|NCT00943046|safety|safety
520736|NCT00943033|MBCT|mbct
520737|NCT00943033|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
520738|NCT00943033|Mindfulness|mindfulness
520739|NCT00943033|Meditation|meditation
520740|NCT00943033|Relapse Prevention|relapse prevention
520741|NCT00943033|Recurrent Depression|recurrent depression
520742|NCT00943033|Depression|depression
520743|NCT00943033|Major Depressive Disorder|major depressive disorder
520744|NCT00943020|Dietary supplement|dietary supplement
520745|NCT00943020|Carbohydrate loading|carbohydrate loading
520746|NCT00943020|Healthy volunteers|healthy volunteers
520747|NCT00943020|Anaesthesia|anaesthesia
520748|NCT00943020|Surgery|surgery
520749|NCT00943020|Glutamine|glutamine
520750|NCT00942994|Hypertension|hypertension
520751|NCT00942994|Aliskiren|aliskiren
520752|NCT00942994|Amlodipine|amlodipine
520753|NCT00942994|HCTZ|hctz
520754|NCT00942994|Systolic blood pressure|systolic blood pressure
520755|NCT00942994|Diastolic blood pressure|diastolic blood pressure
520756|NCT00942994|Stage II|stage ii
520757|NCT00942994|Combination|combination
520758|NCT00942981|PET Study|pet study
520759|NCT00942981|(18F) Fallypride|(18f) fallypride
520760|NCT00942981|(11C)NNC-112|(11c)nnc-112
520761|NCT00942981|Schizoaffective Disorder|schizoaffective disorder
520762|NCT00942981|Schizophrenia|schizophrenia
520763|NCT00942981|Healthy Volunteer|healthy volunteer
520764|NCT00942981|HV|hv
520765|NCT00942929|anorexia nervosa|anorexia nervosa
520766|NCT00942929|adolescents|adolescents
520767|NCT00942929|lung function tests|lung function tests
520768|NCT00942929|refeeding|refeeding
520769|NCT00942916|Make sure the difference of the serum inflammatory marker between the two groups|make sure the difference of the serum inflammatory marker between the two groups
520770|NCT00942903|HME|hme
520771|NCT00942903|Provox|provox
520772|NCT00942903|voice prosthesis|voice prosthesis
520773|NCT00942903|laryngectomy|laryngectomy
520774|NCT00942890|Case Management|case management
520775|NCT00942890|Amputation|amputation
520776|NCT00942890|Muscle strength|muscle strength
520777|NCT00942890|phantom limb pain|phantom limb pain
520778|NCT00942877|VEGF|vegf
520779|NCT00942877|Antiangiogenesis|antiangiogenesis
520780|NCT00942877|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
520781|NCT00942877|Advanced Cancer|advanced cancer
520782|NCT00942877|Alveolar Soft Part Sarcoma|alveolar soft part sarcoma
520783|NCT00942877|Sarcoma|sarcoma
520784|NCT00942851|Dystonia|dystonia
520785|NCT00942851|Blepharospasm|blepharospasm
520786|NCT00942851|Botulinum Toxin|botulinum toxin
520787|NCT00942851|Treatment|treatment
520788|NCT00942851|Clinical Trial|clinical trial
520789|NCT00942851|Focal Dystonia|focal dystonia
520790|NCT00942838|Recurrent Ovarian Carcinoma|recurrent ovarian carcinoma
520791|NCT00942838|Cancer|cancer
520792|NCT00942825|NSCL|nscl
520793|NCT00942825|non-squamous non small cell lung cancer|non-squamous non small cell lung cancer
520794|NCT00942825|Lung Cancer|lung cancer
520795|NCT00942825|Lung|lung
520796|NCT00942825|non-squamous|non-squamous
520797|NCT00942825|metastatic|metastatic
520798|NCT00942825|pleural effusion|pleural effusion
520799|NCT00942825|Stage IIIb|stage iiib
520800|NCT00942825|Stage IV|stage iv
520801|NCT00942825|NSCLC|nsclc
520802|NCT00942812|Children|children
520804|NCT00942812|Diarrhea Pack|diarrhea pack
520805|NCT00942812|Social Marketing|social marketing
520806|NCT00942799|Genz-644282|genz-644282
520807|NCT00942799|Topoisomerase I inhibitors|topoisomerase i inhibitors
520808|NCT00942799|Top1|top1
520809|NCT00942799|solid tumors|solid tumors
520810|NCT00942799|dose-escalation|dose-escalation
520811|NCT00942799|pharmacokinetic (PK)|pharmacokinetic (pk)
520812|NCT00942799|MTD (Maximum Tolerated Dose)|mtd (maximum tolerated dose)
520813|NCT00942799|oncology|oncology
520814|NCT00942799|cancer|cancer
520815|NCT00942786|natriuretic peptides|natriuretic peptides
520816|NCT00942786|emergency non-cardiac surgery|emergency non-cardiac surgery
520817|NCT00942773|Healthy volunteer|healthy volunteer
520818|NCT00942747|temsirolimus, primary CNS lymphoma, PCNSL, salvage treatment|temsirolimus, primary cns lymphoma, pcnsl, salvage treatment
520819|NCT00942734|Head and Neck|head and neck
520820|NCT00942734|Squamous Cell Carcinoma|squamous cell carcinoma
520821|NCT00942734|RAD001|rad001
520822|NCT00942734|Erlotinib|erlotinib
520823|NCT00942734|Everolimus|everolimus
520824|NCT00942734|OSI-774|osi-774
520825|NCT00942734|Tarceva|tarceva
520826|NCT00942721|Web-based Intervention|web-based intervention
520827|NCT00942721|CBT Treatment|cbt treatment
520828|NCT00942708|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
520829|NCT00942708|Pulmonary Hypertension|pulmonary hypertension
520830|NCT00942695|pistachio|pistachio
520831|NCT00942695|nuts|nuts
520832|NCT00942695|energy value|energy value
520833|NCT00942695|cardiovascular disease|cardiovascular disease
520834|NCT00942695|phytonutrient|phytonutrient
520835|NCT00942695|gene expression|gene expression
520836|NCT00942695|energy value of pistachio nuts|energy value of pistachio nuts
520837|NCT00942682|sorafenib|sorafenib
520838|NCT00942682|RAD001|rad001
520839|NCT00942669|Sleep Apnea Syndrome|sleep apnea syndrome
520840|NCT00942669|SAS|sas
520841|NCT00942669|SleepStrip OTC|sleepstrip otc
520842|NCT00942656|trans fatty acids|trans fatty acids
520843|NCT00942656|ruminant|ruminant
520844|NCT00942656|cardiovascular disease|cardiovascular disease
520845|NCT00942630|percutaneous|percutaneous
520846|NCT00942630|transhepatic|transhepatic
520847|NCT00942630|biliary|biliary
520848|NCT00942630|drainage|drainage
520849|NCT00942630|cholangioscopy|cholangioscopy
520850|NCT00942617|platelet aggregation|platelet aggregation
520851|NCT00942617|granule secretion|granule secretion
520852|NCT00942617|thromboxane production|thromboxane production
520853|NCT00942617|cyclooxygenase-1|cyclooxygenase-1
520854|NCT00942617|ATP release|atp release
520855|NCT00942617|aspirin resistance|aspirin resistance
520856|NCT00942617|platelet activation|platelet activation
520857|NCT00942617|flow cytometry|flow cytometry
520858|NCT00942617|Platelet aggregation in healthy volunteers|platelet aggregation in healthy volunteers
520859|NCT00942604|Peplin|peplin
520860|NCT00942604|Actinic keratosis|actinic keratosis
520861|NCT00942604|PEP005|pep005
520862|NCT00942591|multiple sclerosis|multiple sclerosis
520863|NCT00942591|interferon beta|interferon beta
520864|NCT00942591|atorvastatin|atorvastatin
520865|NCT00942578|Dual Antiangiogenic Combination Therapy for mCRPC|dual antiangiogenic combination therapy for mcrpc
520866|NCT00942578|Efficacy and Toxicity Profile|efficacy and toxicity profile
520867|NCT00942578|Single Stage Phase 2 With Early Stopping, Run In Phase For Toxicity|single stage phase 2 with early stopping, run in phase for toxicity
520868|NCT00942578|Correlative Measurements|correlative measurements
520869|NCT00942578|Overall Survival Assessment|overall survival assessment
520870|NCT00942578|Metastatic Prostate Cancer|metastatic prostate cancer
520871|NCT00942578|Prostate Cancer|prostate cancer
520872|NCT00942565|Open gynecological surgery|open gynecological surgery
520873|NCT00942539|Neonates|neonates
520874|NCT00942526|esophageal cancer|esophageal cancer
520875|NCT00942526|anastomotic leakage|anastomotic leakage
520876|NCT00942526|Prevention of anastomotic leakage after esophageal surgery|prevention of anastomotic leakage after esophageal surgery
520877|NCT00942513|substrate absorption|substrate absorption
520878|NCT00942513|substrate oxidation|substrate oxidation
520879|NCT00942513|glucose regulation|glucose regulation
520880|NCT00942513|whey protein|whey protein
520881|NCT00942513|soy protein|soy protein
520882|NCT00942513|sucrose|sucrose
520883|NCT00942513|fructose|fructose
520884|NCT00942513|lactose|lactose
520885|NCT00942500|Post-conditioning|post-conditioning
520886|NCT00942500|ST-elevation myocardial infarction|st-elevation myocardial infarction
520887|NCT00942500|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
520888|NCT00942487|arterial hypertension|arterial hypertension
520889|NCT00942474|The focus of the study is to assess the ability of the nerve access tool to facilitate nerve lead placement|the focus of the study is to assess the ability of the nerve access tool to facilitate nerve lead placement
520890|NCT00942461|a-defensins|a-defensins
520891|NCT00942461|TLRs|tlrs
520892|NCT00942461|Inflammatory Cytokines|inflammatory cytokines
520893|NCT00942461|CRP|crp
520894|NCT00942461|No metastases|no metastases
520895|NCT00942461|No other obvious inflammation|no other obvious inflammation
520896|NCT00942461|No chronic diseases|no chronic diseases
520897|NCT00942435|YM150|ym150
520898|NCT00942435|Bleeding|bleeding
520899|NCT00942435|VTE|vte
520900|NCT00942435|FXa inhibitor|fxa inhibitor
520901|NCT00942435|Deep Vein Thrombosis|deep vein thrombosis
520902|NCT00942435|Venous thromboembolism|venous thromboembolism
520903|NCT00942422|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
520904|NCT00942422|smoldering multiple myeloma|smoldering multiple myeloma
520905|NCT00942396|Mammography|mammography
520906|NCT00942383|liver tumor|liver tumor
520907|NCT00942383|liver tumors|liver tumors
520908|NCT00942383|liver cancer|liver cancer
520909|NCT00942383|hepatocellular carcinoma|hepatocellular carcinoma
520910|NCT00942383|metastatic colorectal cancer|metastatic colorectal cancer
520911|NCT00942383|metastatic cancer to the liver|metastatic cancer to the liver
520912|NCT00942383|metastatic cancer|metastatic cancer
520913|NCT00942383|metastatic neuroendocrine cancer|metastatic neuroendocrine cancer
520914|NCT00942383|liver|liver
520915|NCT00942383|liver surgery|liver surgery
520916|NCT00942383|radiofrequency ablation|radiofrequency ablation
520917|NCT00942383|microwave ablation|microwave ablation
520918|NCT00942370|mechanography|mechanography
520919|NCT00942370|electromyography|electromyography
520920|NCT00942370|effort cough|effort cough
520921|NCT00942344|Amlodipine|amlodipine
520922|NCT00942344|Losartan|losartan
520923|NCT00942344|Hypertension|hypertension
520924|NCT00942318|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
521053|NCT00941928|Interleukin-2|interleukin-2
520925|NCT00942318|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
520926|NCT00942318|Insulin external pump|insulin external pump
520927|NCT00942318|Multiple daily injections|multiple daily injections
520928|NCT00942318|Basal-bolus regimen|basal-bolus regimen
520929|NCT00942318|Education|education
520930|NCT00942305|Allogeneic stem cell transplant|allogeneic stem cell transplant
520931|NCT00942305|CMV seropositive (R+)|cmv seropositive (r+)
520932|NCT00942305|transplant|transplant
520933|NCT00942305|Allogeneic stem cell transplant recipients who were CMV seropositive (R+) at the time of transplant will be eligible for enrollment|allogeneic stem cell transplant recipients who were cmv seropositive (r+) at the time of transplant will be eligible for enrollment
520934|NCT00942292|Hepatic|hepatic
520935|NCT00942292|colorectal|colorectal
520936|NCT00942292|metastases|metastases
520937|NCT00942292|TPN|tpn
520938|NCT00942292|Fish oil|fish oil
520939|NCT00942253|RLS|rls
520940|NCT00942253|Muscle|muscle
520941|NCT00942253|Dialysis|dialysis
520942|NCT00942253|exercise|exercise
520943|NCT00942253|dopamine agonist|dopamine agonist
520944|NCT00942253|Sleep|sleep
520945|NCT00942227|Sciatica|sciatica
520946|NCT00942227|Radiculopathy|radiculopathy
520947|NCT00942227|Physical therapy modalities|physical therapy modalities
520948|NCT00942227|Rehabilitation|rehabilitation
520949|NCT00942214|Multiple sclerosis|multiple sclerosis
520950|NCT00942214|natalizumab|natalizumab
520951|NCT00942214|pharmacogenomics|pharmacogenomics
520952|NCT00942201|Asthma|asthma
520953|NCT00942201|Dexamethasone|dexamethasone
520954|NCT00942201|Emergency Department|emergency department
520955|NCT00942188|Diabetes|diabetes
520956|NCT00942188|Type 2 Diabetes|type 2 diabetes
520957|NCT00942175|Pharmacology|pharmacology
520958|NCT00942175|Stomach Ulcer|stomach ulcer
520959|NCT00942175|Esophagitis, Peptic|esophagitis, peptic
520960|NCT00942175|Zollinger-Ellison Syndrome|zollinger-ellison syndrome
520961|NCT00942175|Platelet function|platelet function
520962|NCT00942175|PPI|ppi
520963|NCT00942175|clopidogrel|clopidogrel
520964|NCT00942175|Pharmacokinetics and Pharmacodynamics|pharmacokinetics and pharmacodynamics
520965|NCT00942162|PREDICT|predict
520966|NCT00942162|ASCI|asci
520967|NCT00942162|Tumor antigen|tumor antigen
520968|NCT00942162|Melanoma|melanoma
520969|NCT00942162|Immunotherapeutic|immunotherapeutic
520970|NCT00942149|Infants|infants
520971|NCT00942149|Daptomycin|daptomycin
520972|NCT00942136|HIV|hiv
520973|NCT00942136|GSK1349572|gsk1349572
520974|NCT00942136|omeprazole|omeprazole
520975|NCT00942136|Prilosec|prilosec
520976|NCT00942136|supratherapeutic dose|supratherapeutic dose
520977|NCT00942136|pharmacokinetics|pharmacokinetics
520978|NCT00942136|drug interaction|drug interaction
520979|NCT00942136|HIV Infections|hiv infections
520980|NCT00942110|Postprandial glucose, lipid metabolism|postprandial glucose, lipid metabolism
520981|NCT00942110|humoral factors|humoral factors
520982|NCT00942097|Homeopathy|homeopathy
520983|NCT00942097|overweight|overweight
520984|NCT00942097|obesity|obesity
520985|NCT00942097|mental disorder|mental disorder
520986|NCT00942097|pregnancy|pregnancy
520987|NCT00942097|Overweight pregnant women with suspicious mental disorder|overweight pregnant women with suspicious mental disorder
520988|NCT00942084|HSV|hsv
520989|NCT00942084|Acyclovir|acyclovir
520990|NCT00942084|Pharmacokinetics|pharmacokinetics
520991|NCT00942084|Neonate|neonate
520992|NCT00942084|Premature|premature
520993|NCT00942084|Sepsis|sepsis
520994|NCT00942071|Influenza|influenza
520995|NCT00942071|Vaccine|vaccine
520996|NCT00942058|biological markers|biological markers
520997|NCT00942058|CA9 protein|ca9 protein
520998|NCT00942058|metastatic conventional renal cell cancer|metastatic conventional renal cell cancer
520999|NCT00942058|kidney cancer|kidney cancer
521000|NCT00942045|cervical spine|cervical spine
521001|NCT00942045|ACDF|acdf
521002|NCT00942045|biologics|biologics
521003|NCT00942045|fusion rates|fusion rates
521004|NCT00942019|BMI|bmi
521005|NCT00942019|obesity|obesity
521006|NCT00942019|CO|co
521007|NCT00942019|tobacco smoking|tobacco smoking
521008|NCT00942019|adolescents|adolescents
521009|NCT00942006|Lyme neuroborreliosis|lyme neuroborreliosis
521010|NCT00942006|Lyme borreliosis|lyme borreliosis
521011|NCT00942006|erythema migrans|erythema migrans
521012|NCT00942006|doxycycline treatment|doxycycline treatment
521013|NCT00942006|ceftriaxone treatment|ceftriaxone treatment
521014|NCT00942006|outcome|outcome
521015|NCT00942006|subjective symptoms|subjective symptoms
521016|NCT00941980|biologics|biologics
521017|NCT00941980|fusion rates|fusion rates
521018|NCT00941980|PLIF|plif
521019|NCT00941980|lumbar fusion|lumbar fusion
521020|NCT00941967|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
521021|NCT00941967|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
521022|NCT00941967|recurrent adult primary liver cancer|recurrent adult primary liver cancer
521023|NCT00941967|advanced adult primary liver cancer|advanced adult primary liver cancer
521024|NCT00941954|Physical activity|physical activity
521025|NCT00941954|Diabetes|diabetes
521026|NCT00941954|Prevention|prevention
521027|NCT00941954|Pedometer|pedometer
521028|NCT00941954|Walking|walking
521029|NCT00941954|Structured education|structured education
521030|NCT00941954|Randomized|randomized
521031|NCT00941954|Risk score|risk score
521032|NCT00941954|Impaired glucose regulation|impaired glucose regulation
521033|NCT00941941|Inguinal|inguinal
521034|NCT00941941|Hernia|hernia
521035|NCT00941941|Hernia-repair|hernia-repair
521036|NCT00941941|Non-mesh|non-mesh
521037|NCT00941941|Mesh|mesh
521038|NCT00941941|Desarda|desarda
521039|NCT00941941|Lichtenstein|lichtenstein
521040|NCT00941928|Blood And Marrow Transplantation|blood and marrow transplantation
521041|NCT00941928|Relapsed Acute Lymphoblastic Leukemia|relapsed acute lymphoblastic leukemia
521042|NCT00941928|ALL|all
521043|NCT00941928|Leukemia|leukemia
521044|NCT00941928|Pediatrics|pediatrics
521045|NCT00941928|Haploidentical NK cells|haploidentical nk cells
521046|NCT00941928|Cyclophosphamide|cyclophosphamide
521047|NCT00941928|Cytoxan|cytoxan
521048|NCT00941928|Neosar|neosar
521049|NCT00941928|Epratuzumab|epratuzumab
521050|NCT00941928|Fludarabine|fludarabine
521051|NCT00941928|Fludarabine Phosphate|fludarabine phosphate
521052|NCT00941928|Fludara|fludara
521054|NCT00941928|IL-2|il-2
521055|NCT00941928|Proleukin|proleukin
521056|NCT00941928|Low-dose interleukin|low-dose interleukin
521057|NCT00941928|Mesna|mesna
521058|NCT00941928|Mesnex|mesnex
521059|NCT00941928|Natural Killer Cells|natural killer cells
521060|NCT00941928|NK Cells Transplant|nk cells transplant
521062|NCT00941915|SBRT|sbrt
521063|NCT00941915|Prostate|prostate
521064|NCT00941915|ExacTrac|exactrac
521065|NCT00941915|Calypso|calypso
521066|NCT00941915|IMRT|imrt
521067|NCT00941915|Radiation|radiation
521068|NCT00941915|Cancer of Prostate|cancer of prostate
521069|NCT00941915|Prostatic Neoplasms|prostatic neoplasms
521070|NCT00941902|human asialoglycoprotein receptor (ASGPR)|human asialoglycoprotein receptor (asgpr)
521071|NCT00941902|hepatocytes|hepatocytes
521072|NCT00941902|bariatric surgery|bariatric surgery
521073|NCT00941889|HIV|hiv
521074|NCT00941889|HPV|hpv
521075|NCT00941889|Anal condylomata|anal condylomata
521076|NCT00941889|Vaccine|vaccine
521077|NCT00941889|HIV positive patients|hiv positive patients
521078|NCT00941889|Anal condylomata or anal warts|anal condylomata or anal warts
521079|NCT00941876|AE|ae
521080|NCT00941876|adverse event|adverse event
521081|NCT00941876|AIDS|aids
521082|NCT00941876|acquired immunodeficiency syndrome|acquired immunodeficiency syndrome
521083|NCT00941876|ALT (SGPT)|alt (sgpt)
521084|NCT00941876|alanine aminotransferase|alanine aminotransferase
521085|NCT00941876|ART|art
521086|NCT00941876|antiretroviral therapy|antiretroviral therapy
521087|NCT00941876|AST (SGOT)|ast (sgot)
521088|NCT00941876|aspartate aminotransferase|aspartate aminotransferase
521089|NCT00941876|DCF|dcf
521090|NCT00941876|data collection forms|data collection forms
521091|NCT00941876|DMC|dmc
521092|NCT00941876|Data Monitoring Committee|data monitoring committee
521093|NCT00941876|FDA|fda
521094|NCT00941876|(U.S.) Food and Drug Administration|(u.s.) food and drug administration
521095|NCT00941876|GCP|gcp
521096|NCT00941876|Good Clinical Practice guidelines|good clinical practice guidelines
521097|NCT00941876|HB sAg|hb sag
521098|NCT00941876|Hepatitis B surface antigen|hepatitis b surface antigen
521099|NCT00941876|ICH|ich
521100|NCT00941876|International Conference of Harmonisation|international conference of harmonisation
521101|NCT00941876|IND|ind
521102|NCT00941876|Investigational New Drug Application|investigational new drug application
521103|NCT00941876|IRB|irb
521104|NCT00941876|Institutional Review Board|institutional review board
521105|NCT00941876|IU|iu
521106|NCT00941876|International units|international units
521107|NCT00941876|mg|mg
521108|NCT00941876|milligram(s)|milligram(s)
521109|NCT00941876|mm3|mm3
521110|NCT00941876|cubic millimeter(s)|cubic millimeter(s)
521111|NCT00941876|PCR|pcr
521112|NCT00941876|polymerase chain reaction|polymerase chain reaction
521113|NCT00941876|SAE|sae
521114|NCT00941876|serious adverse event|serious adverse event
521115|NCT00941876|µg|µg
521116|NCT00941876|microgram|microgram
521117|NCT00941876|ULN|uln
521118|NCT00941876|upper limit of the normal range|upper limit of the normal range
521119|NCT00941876|WB|wb
521120|NCT00941876|Western Blot|western blot
521121|NCT00941876|To inform the Ministry of Health strategy for integrating FP and HIV/AIDS Care and Treatment Services in Tanzania|to inform the ministry of health strategy for integrating fp and hiv/aids care and treatment services in tanzania
521122|NCT00941876|HIV seronegativity|hiv seronegativity
521123|NCT00941863|Sorafenib|sorafenib
521124|NCT00941863|Advanced Solid Tumors|advanced solid tumors
521125|NCT00941863|Maximum tolerated dose|maximum tolerated dose
521126|NCT00941863|Carboplatin and paclitaxel chemotherapy combination|carboplatin and paclitaxel chemotherapy combination
521127|NCT00941850|Cardiac resynchronizton therapy|cardiac resynchronizton therapy
521128|NCT00941850|CRT|crt
521129|NCT00941850|Heart failure|heart failure
521130|NCT00941850|Dyssynchrony|dyssynchrony
521131|NCT00941850|Echocardiography|echocardiography
521132|NCT00941850|Pacemakers|pacemakers
521133|NCT00941850|Nonresponders|nonresponders
521134|NCT00941837|Palm olein|palm olein
521135|NCT00941837|homocsyteine|homocsyteine
521136|NCT00941837|Cholesterol|cholesterol
521137|NCT00941837|lipoproteins|lipoproteins
521138|NCT00941837|Interleukins|interleukins
521139|NCT00941837|CRP|crp
521140|NCT00941837|Blood Pressure|blood pressure
521141|NCT00941837|Total homocystein|total homocystein
521142|NCT00941837|Serum lipid profile|serum lipid profile
521143|NCT00941837|Serum apolipoproteins|serum apolipoproteins
521144|NCT00941837|Inflammatory markers|inflammatory markers
521145|NCT00941824|pharmacokinetic|pharmacokinetic
521146|NCT00941824|mycophénolate acid|mycophénolate acid
521147|NCT00941824|kidney transplantation|kidney transplantation
521148|NCT00941798|Asthma|asthma
521149|NCT00941798|LABA|laba
521150|NCT00941798|Safety|safety
521151|NCT00941785|Malaria|malaria
521152|NCT00941785|Intermittent Preventive Treatment|intermittent preventive treatment
521153|NCT00941785|IPTc|iptc
521154|NCT00941785|sIPTc|siptc
521155|NCT00941785|Burkina Faso|burkina faso
521156|NCT00941772|Nasogastric tube verification with ultrasonography|nasogastric tube verification with ultrasonography
521157|NCT00941772|ultrasonography|ultrasonography
521158|NCT00941759|Breast|breast
521159|NCT00941759|Blood and tissue collection|blood and tissue collection
521160|NCT00941759|Epidemiologic|epidemiologic
521161|NCT00941759|Questionnaire|questionnaire
521162|NCT00941759|TBCRC (Translational Breast Cancer Research Consortium)|tbcrc (translational breast cancer research consortium)
521163|NCT00941759|09-056|09-056
521164|NCT00941733|BTK|btk
521165|NCT00941733|CLI|cli
521166|NCT00941733|PTA|pta
521167|NCT00941720|stage I multiple myeloma|stage i multiple myeloma
521168|NCT00941720|stage II multiple myeloma|stage ii multiple myeloma
521169|NCT00941720|stage III multiple myeloma|stage iii multiple myeloma
521170|NCT00941707|Rheumatoid Arthritis|rheumatoid arthritis
521171|NCT00941707|JNJ-38518168|jnj-38518168
521172|NCT00941694|asthma|asthma
521173|NCT00941694|aged|aged
521174|NCT00941694|self care|self care
521175|NCT00941681|omecamtiv mecarbil|omecamtiv mecarbil
521176|NCT00941655|Gastric Carcinoma|gastric carcinoma
521177|NCT00941655|Chemotherapy|chemotherapy
521178|NCT00941655|Liver Tumors|liver tumors
521179|NCT00941655|Peritoneal Tumors|peritoneal tumors
521180|NCT00941655|Metastatic Gastric Cancer|metastatic gastric cancer
521181|NCT00941655|Stomach Cancer|stomach cancer
521182|NCT00941655|Gastric Cancer|gastric cancer
521183|NCT00941642|Nonalcoholic Fatty Liver Disease (NAFLD)|nonalcoholic fatty liver disease (nafld)
521184|NCT00941642|Lovaza|lovaza
521185|NCT00941642|Steatosis|steatosis
521186|NCT00941642|Non-Alcoholic steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
521187|NCT00941629|PTSD|ptsd
521188|NCT00941629|Telemedicine|telemedicine
521189|NCT00941629|Clinical Trial|clinical trial
521190|NCT00941629|Psychotherapy|psychotherapy
521191|NCT00941616|Von Willebrand Disease|von willebrand disease
521192|NCT00941590|tick borne encephalitis|tick borne encephalitis
521193|NCT00941590|clinical outcome|clinical outcome
521194|NCT00941590|postencephalitic symptoms|postencephalitic symptoms
521195|NCT00941577|Hypersensitivity|hypersensitivity
521196|NCT00941577|Lung Diseases, Obstructive|lung diseases, obstructive
521197|NCT00941577|Immune System Diseases|immune system diseases
521198|NCT00941577|Respiratory Tract Diseases|respiratory tract diseases
521199|NCT00941577|Bronchial Diseases|bronchial diseases
521200|NCT00941577|Lung Diseases|lung diseases
521201|NCT00941577|Hypersensitivity, Immediate|hypersensitivity, immediate
521202|NCT00941577|Asthma|asthma
521203|NCT00941577|Respiratory Hypersensitivity|respiratory hypersensitivity
521204|NCT00941551|Thyroid lobectomy,|thyroid lobectomy,
521205|NCT00941551|prophylactic levothyroxine treatment,|prophylactic levothyroxine treatment,
521206|NCT00941551|recurrent nodular goiter,|recurrent nodular goiter,
521207|NCT00941551|iodine deficiency,|iodine deficiency,
521208|NCT00941551|long-term follow-up,|long-term follow-up,
521209|NCT00941551|completion thyroidectomy|completion thyroidectomy
521210|NCT00941538|nasopharyngeal cancer|nasopharyngeal cancer
521211|NCT00941538|screening|screening
521212|NCT00941538|biomarker|biomarker
521213|NCT00941538|early detection|early detection
521214|NCT00941538|epidemiological survey|epidemiological survey
521215|NCT00941525|Central corneal thickness|central corneal thickness
521216|NCT00941525|24hour fluctuation of intraocular pressure|24hour fluctuation of intraocular pressure
521217|NCT00941525|Open angle glaucoma|open angle glaucoma
521218|NCT00941525|Ocular hypertension|ocular hypertension
521219|NCT00941512|Colposcopy|colposcopy
521220|NCT00941499|Advanced Cancers|advanced cancers
521221|NCT00941499|Liver|liver
521222|NCT00941499|Oxaliplatin|oxaliplatin
521223|NCT00941499|Eloxatin|eloxatin
521224|NCT00941499|Bevacizumab|bevacizumab
521225|NCT00941499|Avastin|avastin
521226|NCT00941499|Anit-VEGF monoclonal antibody|anit-vegf monoclonal antibody
521227|NCT00941499|rhuMAb-VEGF|rhumab-vegf
521228|NCT00941499|5-fluorouracil|5-fluorouracil
521229|NCT00941499|5-FU|5-fu
521230|NCT00941499|Adrucil|adrucil
521231|NCT00941499|Efudex|efudex
521232|NCT00941499|Leucovorin|leucovorin
521233|NCT00941499|Citrovorum|citrovorum
521234|NCT00941499|Wellcovorin|wellcovorin
521235|NCT00941499|Cetuximab|cetuximab
521236|NCT00941499|C225|c225
521237|NCT00941499|Erbitux|erbitux
521238|NCT00941499|IMC-C225|imc-c225
521239|NCT00941473|Epidural Injection|epidural injection
521240|NCT00941473|Bone Density|bone density
521241|NCT00941460|progressive or recurrent glioblastoma|progressive or recurrent glioblastoma
521242|NCT00941460|temozolomide|temozolomide
521243|NCT00941460|dose intensification|dose intensification
521244|NCT00941460|comparison of two dosing regimens|comparison of two dosing regimens
521245|NCT00941447|Type 2 Diabetes|type 2 diabetes
521246|NCT00941447|Obesity|obesity
521247|NCT00941447|Self-Regulation|self-regulation
521248|NCT00941447|Self-Efficacy|self-efficacy
521249|NCT00941434|RUTF|rutf
521250|NCT00941434|SAM|sam
521251|NCT00941434|Nutributter|nutributter
521252|NCT00941395|Cancer Prevention|cancer prevention
521253|NCT00941395|College students|college students
521254|NCT00941395|Prevention intervention|prevention intervention
521255|NCT00941395|Smoking|smoking
521256|NCT00941395|Tobacco|tobacco
521257|NCT00941395|Internet-based|internet-based
521258|NCT00941395|Cognitive Behavioral Therapy|cognitive behavioral therapy
521259|NCT00941395|Nicotine lozenges|nicotine lozenges
521260|NCT00941382|sibutramine|sibutramine
521261|NCT00941382|metformin|metformin
521262|NCT00941382|obesity|obesity
521263|NCT00941356|MRSA nasal colonisation|mrsa nasal colonisation
521264|NCT00941356|Probiotics|probiotics
521265|NCT00941330|Breast, Male|breast, male
521266|NCT00941330|Breast, Female|breast, female
521267|NCT00941317|onychomycosis|onychomycosis
521268|NCT00941317|micro-drilling|micro-drilling
521269|NCT00941291|idiopathic macular hole|idiopathic macular hole
521270|NCT00941291|cataract|cataract
521271|NCT00941291|edema|edema
521272|NCT00941291|Reopening|reopening
521273|NCT00941265|treatment of anomia|treatment of anomia
521274|NCT00941265|levodopa|levodopa
521275|NCT00941265|"patient with aphasia hospitalised at the Service de neurorehabilitation with presence of anomia"|"patient with aphasia hospitalised at the service de neurorehabilitation with presence of anomia"
521276|NCT00941239|Metformin ER|metformin er
521277|NCT00941239|Pharmacokinetics|pharmacokinetics
521278|NCT00941239|Tolerability|tolerability
521279|NCT00941239|Healthy volunteers|healthy volunteers
521280|NCT00941226|Cerebral Palsy|cerebral palsy
521281|NCT00941226|Caregivers|caregivers
521282|NCT00941226|Quality of Life|quality of life
521283|NCT00941213|fractures of vertebral bodies Th10-L2|fractures of vertebral bodies th10-l2
521284|NCT00941213|(AO A1 with kyphosis, A2.3, B or C-type)|(ao a1 with kyphosis, a2.3, b or c-type)
521285|NCT00941187|pulmonary embolism|pulmonary embolism
521286|NCT00941187|pulmonary capillary blood volume|pulmonary capillary blood volume
521287|NCT00941187|double diffusion NO/CO method|double diffusion no/co method
521288|NCT00941174|(13C5) Calcium Leucovorin|(13c5) calcium leucovorin
521289|NCT00941174|Folate absorption across the large intestine|folate absorption across the large intestine
521290|NCT00941174|Folate Bioavailability|folate bioavailability
521291|NCT00941122|MRSA, VRE|mrsa, vre
521292|NCT00941109|MDS|mds
521293|NCT00941096|Glaucoma|glaucoma
521294|NCT00941096|Ocular Hypertension|ocular hypertension
521295|NCT00941096|Lumigan|lumigan
521296|NCT00941096|Ganfort|ganfort
521297|NCT00941083|Simplification from protease inhibitors to raltegravir|simplification from protease inhibitors to raltegravir
521298|NCT00941083|Treatment Experienced|treatment experienced
521299|NCT00941083|HIV-1 Infections|hiv-1 infections
521300|NCT00941044|non-invasive ventilation|non-invasive ventilation
521301|NCT00941044|diaphragm|diaphragm
521302|NCT00941044|electrical activity|electrical activity
521303|NCT00941044|neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
521304|NCT00941044|volunteers|volunteers
521305|NCT00941031|Moderate to severe chronic plaque-type psoriasis|moderate to severe chronic plaque-type psoriasis
521306|NCT00941031|AIN457|ain457
521307|NCT00941031|dermatology|dermatology
521308|NCT00941018|Resolvins|resolvins
521309|NCT00941018|RvE1|rve1
521310|NCT00941018|Healthy volunteers|healthy volunteers
521311|NCT00940979|Integuseal microbial sealant|integuseal microbial sealant
521312|NCT00940979|Infection prophylaxis|infection prophylaxis
521313|NCT00940979|Postoperative wound infection|postoperative wound infection
521314|NCT00940979|Arterial bypass surgery|arterial bypass surgery
521315|NCT00940966|ADA diet|ada diet
521316|NCT00940966|low carbohydrate diet|low carbohydrate diet
521317|NCT00940966|Metabolic syndrome|metabolic syndrome
521318|NCT00940927|Albuterol|albuterol
521319|NCT00940927|Forced expiratory volume in one second|forced expiratory volume in one second
521320|NCT00940927|Dose at fifty percent of maximum effect|dose at fifty percent of maximum effect
521321|NCT00940927|Maximum effective dose|maximum effective dose
521322|NCT00940927|Metered dose inhaler|metered dose inhaler
521323|NCT00940927|Nebulizer|nebulizer
521324|NCT00940914|Parkinson's disease|parkinson's disease
521325|NCT00940914|pain|pain
521326|NCT00940914|dopamine transporters imaging|dopamine transporters imaging
521327|NCT00940901|priapism|priapism
521328|NCT00940901|sickle cell disease|sickle cell disease
521329|NCT00940901|sildenafil|sildenafil
521330|NCT00940901|phosphodiesterase type 5 inhibitor|phosphodiesterase type 5 inhibitor
521331|NCT00940888|ICD|icd
521332|NCT00940888|CRTD|crtd
521333|NCT00940888|Heart Failure|heart failure
521334|NCT00940888|DF4|df4
521335|NCT00940862|psoriasis|psoriasis
521336|NCT00940862|vascular inflammation|vascular inflammation
521337|NCT00940862|coronary atherosclerosis|coronary atherosclerosis
521338|NCT00940836|Anti-cold|anti-cold
521339|NCT00940836|Cold preparation|cold preparation
521340|NCT00940836|RCT|rct
521341|NCT00940823|Glaucoma Drainage Device|glaucoma drainage device
521342|NCT00940823|Aqueous Shunt Implant|aqueous shunt implant
521343|NCT00940823|Ahmed Valve|ahmed valve
521344|NCT00940823|Baerveldt Tube|baerveldt tube
521345|NCT00940823|Refractory Glaucoma|refractory glaucoma
521346|NCT00940797|diabetes|diabetes
521347|NCT00940797|Type 2|type 2
521348|NCT00940797|monotherapy|monotherapy
521349|NCT00940797|antidiabetics|antidiabetics
521350|NCT00940797|metformin|metformin
521351|NCT00940771|HIV|hiv
521352|NCT00940771|Lipids|lipids
521353|NCT00940771|Atazanavir|atazanavir
521354|NCT00940771|Pediatric|pediatric
521355|NCT00940771|treatment experienced|treatment experienced
521356|NCT00940745|HICH|hich
521357|NCT00940745|Suction drainages|suction drainages
521358|NCT00940745|TTAC|ttac
521359|NCT00940732|Help-seeking|help-seeking
521360|NCT00940732|Mental Health|mental health
521361|NCT00940732|Athletes|athletes
521362|NCT00940719|Multiple Sclerosis|multiple sclerosis
521363|NCT00940719|Regulatory T cell function|regulatory t cell function
521364|NCT00940719|Vitamin D|vitamin d
521365|NCT00940719|Vitamin D3|vitamin d3
521366|NCT00940719|25-hydroxyvitamin D|25-hydroxyvitamin d
521367|NCT00940706|Cerebral Palsy|cerebral palsy
521368|NCT00940706|Activity monitoring|activity monitoring
521369|NCT00940706|Treadmill|treadmill
521370|NCT00940706|Group training|group training
521371|NCT00940706|Physical active life style|physical active life style
521372|NCT00940693|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
521373|NCT00940693|Duloxetine|duloxetine
521374|NCT00940693|Adult|adult
521375|NCT00940693|ADDH|addh
521376|NCT00940693|ADHD|adhd
521377|NCT00940680|Amlodipine|amlodipine
521378|NCT00940680|Losartan|losartan
521379|NCT00940680|hypertension|hypertension
521380|NCT00940667|Amlodipine|amlodipine
521381|NCT00940667|Losartan|losartan
521382|NCT00940667|hypertension|hypertension
521383|NCT00940654|Fever|fever
521384|NCT00940654|Antipyretic|antipyretic
521385|NCT00940654|Infection|infection
521386|NCT00940654|Mortality|mortality
521387|NCT00940654|Cooling|cooling
521388|NCT00940654|Non steroid anti inflammatory drugs|non steroid anti inflammatory drugs
521389|NCT00940654|Acetaminophen|acetaminophen
521390|NCT00940654|Steroid|steroid
521391|NCT00940654|ICU|icu
521392|NCT00940654|Intensive care|intensive care
521393|NCT00940654|Critically ill|critically ill
521394|NCT00940641|Healthy Volunteer|healthy volunteer
521395|NCT00940615|traumatic brain injury|traumatic brain injury
521396|NCT00940615|aerobic exercise|aerobic exercise
521397|NCT00940615|Diffusion Tensor Imaging|diffusion tensor imaging
521398|NCT00940615|Neuropsychology|neuropsychology
521399|NCT00940615|Rehabilitation|rehabilitation
521400|NCT00940602|TELESTO|telesto
521401|NCT00940602|MDS Study|mds study
521402|NCT00940602|Myelodysplastic Syndromes|myelodysplastic syndromes
521403|NCT00940602|Myelodysplastic Syndromes (low-int-1 risk)|myelodysplastic syndromes (low-int-1 risk)
521404|NCT00940589|Alzheimer's Disease|alzheimer's disease
521405|NCT00940589|Acetylcholinesterase inhibitor|acetylcholinesterase inhibitor
521406|NCT00940589|cognitive function|cognitive function
521407|NCT00940589|Circadin|circadin
521408|NCT00940589|Sleep disturbances|sleep disturbances
521409|NCT00940576|mare's milk, Crohn's disease, ulcerative colitis, clinical|mare's milk, crohn's disease, ulcerative colitis, clinical
521410|NCT00940563|GIST|gist
521411|NCT00940563|imatinib|imatinib
521412|NCT00940563|advanced GIST|advanced gist
521413|NCT00940537|Obese|obese
521414|NCT00940537|MRS|mrs
521415|NCT00940537|hepatic triglyceride content|hepatic triglyceride content
521416|NCT00940537|MR spectroscopy|mr spectroscopy
521417|NCT00940524|Leukemia|leukemia
521418|NCT00940524|ALL|all
521419|NCT00940524|ALLOPURINOL|allopurinol
521420|NCT00940524|CARMUSTINE (BCNU)|carmustine (bcnu)
521421|NCT00940524|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
521422|NCT00940524|CYTARABINE (ARA-C)|cytarabine (ara-c)
521423|NCT00940524|DACTINOMYCIN|dactinomycin
521424|NCT00940524|DASATINIB|dasatinib
521425|NCT00940524|DEXAMETHASONE|dexamethasone
521426|NCT00940524|DOXORUBICIN/ADRIAMYCIN|doxorubicin/adriamycin
521427|NCT00940524|ETOPOSIDE (VP-16)|etoposide (vp-16)
521428|NCT00940524|MERCAPTOPURINE|mercaptopurine
521429|NCT00940524|METHOTREXATE|methotrexate
521430|NCT00940524|MITOXANTRONE|mitoxantrone
521431|NCT00940524|PEGASPERGASE|pegaspergase
521432|NCT00940524|VINCRISTINE|vincristine
521433|NCT00940511|All conditions faced by disabled Medicaid recipients|all conditions faced by disabled medicaid recipients
521434|NCT00940498|Phase 1|phase 1
521435|NCT00940498|Dose Finding|dose finding
521436|NCT00940498|Solid Tumors|solid tumors
521437|NCT00940498|Tumors|tumors
521438|NCT00940498|PF-05212384|pf-05212384
521439|NCT00940472|type 2 diabetes|type 2 diabetes
521440|NCT00940472|monotherapy|monotherapy
521441|NCT00940472|antidiabetics|antidiabetics
521442|NCT00940472|metformin|metformin
521443|NCT00940459|contact lenses|contact lenses
521444|NCT00940459|conjunctival staining|conjunctival staining
521445|NCT00940459|contact lens wear|contact lens wear
521446|NCT00940446|Insorb staples|insorb staples
521447|NCT00940446|Metal Staples|metal staples
521448|NCT00940433|Minimally invasive|minimally invasive
521449|NCT00940433|Inguinal hernia|inguinal hernia
521450|NCT00940433|Pro-peritoneal repair|pro-peritoneal repair
521451|NCT00940407|dry AMD|dry amd
521452|NCT00940407|light treatment|light treatment
521453|NCT00940407|ARMD|armd
521454|NCT00940407|photobiomodulation|photobiomodulation
521455|NCT00940407|macular|macular
521456|NCT00940407|eye disease|eye disease
521457|NCT00940407|ageing eye disease|ageing eye disease
521458|NCT00940394|mutual support group|mutual support group
521459|NCT00940394|psychoeducation group|psychoeducation group
521460|NCT00940394|family caregivers|family caregivers
521461|NCT00940394|schizophrenia|schizophrenia
521462|NCT00940381|Advanced Malignancies|advanced malignancies
521463|NCT00940381|Sirolimus|sirolimus
521464|NCT00940381|Rapamune|rapamune
521465|NCT00940381|Cetuximab|cetuximab
521466|NCT00940381|C225|c225
521467|NCT00940381|Erbitux|erbitux
521468|NCT00940381|IMC-225|imc-225
521469|NCT00940368|Nausea|nausea
521470|NCT00940368|Vomiting|vomiting
521471|NCT00940368|Chemotherapy|chemotherapy
521472|NCT00940355|COPD|copd
521473|NCT00940355|Health Status|health status
521474|NCT00940355|Intervention|intervention
521475|NCT00940355|Secondary prevention|secondary prevention
521476|NCT00940355|patient-tailored treatment|patient-tailored treatment
521477|NCT00940342|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
521478|NCT00940342|Rituximab|rituximab
521479|NCT00940342|Leukemia|leukemia
521480|NCT00940342|Sargramostim|sargramostim
521481|NCT00940342|GM-CSF|gm-csf
521482|NCT00940329|Drug interactions|drug interactions
521483|NCT00940329|Pharmacodynamic interactions|pharmacodynamic interactions
521484|NCT00940329|Pharmacokinetic interactions|pharmacokinetic interactions
521485|NCT00940329|Formoterol|formoterol
521486|NCT00940329|Healthy subjects|healthy subjects
521487|NCT00940329|Phase I study|phase i study
521488|NCT00940329|Roflumilast|roflumilast
521489|NCT00940316|recurrent colon cancer|recurrent colon cancer
521490|NCT00940316|stage IV colon cancer|stage iv colon cancer
521491|NCT00940316|recurrent rectal cancer|recurrent rectal cancer
521492|NCT00940316|stage IV rectal cancer|stage iv rectal cancer
521493|NCT00940290|practice guideline as topic|practice guideline as topic
521494|NCT00940290|decision making|decision making
521495|NCT00940290|evidence based medicine|evidence based medicine
521496|NCT00940277|women couples counseling groups support intervention marriage|women couples counseling groups support intervention marriage
521497|NCT00940264|symptomatic cholecystolithiasis|symptomatic cholecystolithiasis
521498|NCT00940251|Ayurvedic formulation|ayurvedic formulation
521499|NCT00940251|type 2 diabetes mellitus|type 2 diabetes mellitus
521500|NCT00940251|secondary failure to oral hypoglycemic agents|secondary failure to oral hypoglycemic agents
521501|NCT00940251|antidiabetic|antidiabetic
521502|NCT00940225|Breast Cancer|breast cancer
521503|NCT00940225|Melanoma|melanoma
521504|NCT00940225|Stomach or Gastroesophageal Junction Carcinoma|stomach or gastroesophageal junction carcinoma
521505|NCT00940225|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
521506|NCT00940225|Small Cell Lung Cancer (SCLC)|small cell lung cancer (sclc)
521507|NCT00940225|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
521508|NCT00940225|Ovarian Cancer|ovarian cancer
521509|NCT00940225|Pancreatic Cancer|pancreatic cancer
521510|NCT00940225|Prostate Cancer|prostate cancer
521511|NCT00940212|Safety|safety
521512|NCT00940212|tolerability|tolerability
521513|NCT00940212|healthy|healthy
521514|NCT00940212|pharmacokinetics|pharmacokinetics
521515|NCT00940199|Breast cancer, sentinel lymph node mapping, biopsy|breast cancer, sentinel lymph node mapping, biopsy
521516|NCT00940173|xenotransplantation|xenotransplantation
521517|NCT00940173|type I diabetes|type i diabetes
521518|NCT00940173|porcine islets|porcine islets
521519|NCT00940160|Asthma|asthma
521520|NCT00940134|obesity|obesity
521521|NCT00940134|energy expenditure|energy expenditure
521522|NCT00940134|incretins|incretins
521523|NCT00940134|appetite regulation|appetite regulation
521524|NCT00940134|GLP-1|glp-1
521525|NCT00940134|PYY|pyy
521526|NCT00940134|ad libitum energy intake|ad libitum energy intake
521527|NCT00940121|Healthy volunteer subjects|healthy volunteer subjects
521528|NCT00940121|pharmacokinetics|pharmacokinetics
521529|NCT00940121|YM178|ym178
521530|NCT00940121|mirabegron|mirabegron
521531|NCT00940121|IV infusion|iv infusion
521532|NCT00940121|oral administration|oral administration
521533|NCT00940095|Aneurysmal|aneurysmal
521534|NCT00940095|Subarachnoid|subarachnoid
521535|NCT00940095|Hemorrhage|hemorrhage
521536|NCT00940095|vasospasm|vasospasm
521537|NCT00940095|clazosentan|clazosentan
521538|NCT00940095|PIVLAZ|pivlaz
521539|NCT00940095|Actelion|actelion
521540|NCT00940095|surgical clipping|surgical clipping
521541|NCT00940082|Diabetes;|diabetes;
521542|NCT00940082|Echocardiography;|echocardiography;
521543|NCT00940082|High-sensitive C-reactive protein;|high-sensitive c-reactive protein;
521544|NCT00940082|homocysteine;|homocysteine;
521545|NCT00940082|TNF-α|tnf-α
521546|NCT00940069|TS|ts
521547|NCT00940069|polymorphism|polymorphism
521548|NCT00940069|lung cancer|lung cancer
521549|NCT00940069|adenocarcinoma|adenocarcinoma
521550|NCT00940069|pemetrexed|pemetrexed
521551|NCT00940056|Atrial fibrillation|atrial fibrillation
521552|NCT00940056|Ablation|ablation
521553|NCT00940056|Thoracoscopy|thoracoscopy
521554|NCT00940056|Atrial function|atrial function
521555|NCT00940043|bedside test|bedside test
521556|NCT00940043|interleukins|interleukins
521557|NCT00940043|inflammation|inflammation
521558|NCT00940043|vaginal secretions|vaginal secretions
521559|NCT00940030|Mechanical Bowel Preparation (MBP)|mechanical bowel preparation (mbp)
521560|NCT00940030|enema|enema
521561|NCT00940017|PK|pk
521562|NCT00940017|fungal infection|fungal infection
521563|NCT00940004|dendritic cell vaccination|dendritic cell vaccination
521564|NCT00940004|melanoma|melanoma
521565|NCT00940004|toll like receptor ligands|toll like receptor ligands
521566|NCT00940004|vaccines|vaccines
521567|NCT00939991|GBM|gbm
521568|NCT00939965|localized unresectable neuroblastoma|localized unresectable neuroblastoma
521569|NCT00939965|recurrent neuroblastoma|recurrent neuroblastoma
521570|NCT00939965|stage 4S neuroblastoma|stage 4s neuroblastoma
521571|NCT00939952|ertapenem|ertapenem
521572|NCT00939952|CAPD|capd
521573|NCT00939952|dialysis|dialysis
521574|NCT00939913|contrast nephropathy|contrast nephropathy
521575|NCT00939913|intravenous n-acetlycysteine|intravenous n-acetlycysteine
521576|NCT00939900|avascular necrosis of femoral head|avascular necrosis of femoral head
521577|NCT00939900|bisphosphonate|bisphosphonate
521578|NCT00939900|collapse|collapse
521579|NCT00939874|HIV+|hiv+
521580|NCT00939874|Raltegravir|raltegravir
521581|NCT00939874|Tenofovir|tenofovir
521582|NCT00939874|osteopenia|osteopenia
521583|NCT00939874|osteoporosis|osteoporosis
521584|NCT00939874|bone markers|bone markers
521585|NCT00939874|treatment experienced|treatment experienced
521586|NCT00939861|colorectal endometriosis, laparoscopy, laparotomy|colorectal endometriosis, laparoscopy, laparotomy
521587|NCT00939861|gynecologic and digestive symptoms|gynecologic and digestive symptoms
521588|NCT00939861|quality of life (SF-36 questionnaire)|quality of life (sf-36 questionnaire)
521589|NCT00939861|morbidity|morbidity
521590|NCT00939861|fertility|fertility
521591|NCT00939848|Disease-Free Survival|disease-free survival
521592|NCT00939770|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
521593|NCT00939770|recurrent neuroblastoma|recurrent neuroblastoma
521594|NCT00939770|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
521595|NCT00939770|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
521596|NCT00939770|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
521597|NCT00939770|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
521598|NCT00939770|recurrent childhood anaplastic astrocytoma|recurrent childhood anaplastic astrocytoma
521599|NCT00939770|recurrent childhood anaplastic oligoastrocytoma|recurrent childhood anaplastic oligoastrocytoma
521600|NCT00939770|recurrent childhood anaplastic oligodendroglioma|recurrent childhood anaplastic oligodendroglioma
521601|NCT00939770|recurrent childhood fibrillary astrocytoma|recurrent childhood fibrillary astrocytoma
521602|NCT00939770|recurrent childhood gemistocytic astrocytoma|recurrent childhood gemistocytic astrocytoma
521603|NCT00939770|recurrent childhood giant cell glioblastoma|recurrent childhood giant cell glioblastoma
521604|NCT00939770|recurrent childhood glioblastoma|recurrent childhood glioblastoma
521605|NCT00939770|recurrent childhood gliomatosis cerebri|recurrent childhood gliomatosis cerebri
521606|NCT00939770|recurrent childhood gliosarcoma|recurrent childhood gliosarcoma
521607|NCT00939770|recurrent childhood oligoastrocytoma|recurrent childhood oligoastrocytoma
521608|NCT00939770|recurrent childhood oligodendroglioma|recurrent childhood oligodendroglioma
521609|NCT00939770|recurrent childhood pilocytic astrocytoma|recurrent childhood pilocytic astrocytoma
521610|NCT00939770|recurrent childhood pilomyxoid astrocytoma|recurrent childhood pilomyxoid astrocytoma
521611|NCT00939770|recurrent childhood pleomorphic xanthoastrocytoma|recurrent childhood pleomorphic xanthoastrocytoma
521612|NCT00939770|recurrent childhood protoplasmic astrocytoma|recurrent childhood protoplasmic astrocytoma
521613|NCT00939770|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
521614|NCT00939770|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
521615|NCT00939770|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
521616|NCT00939770|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
521617|NCT00939770|recurrent childhood ependymoma|recurrent childhood ependymoma
521618|NCT00939770|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
521619|NCT00939770|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
521620|NCT00939770|childhood choroid plexus tumor|childhood choroid plexus tumor
521621|NCT00939770|childhood craniopharyngioma|childhood craniopharyngioma
521622|NCT00939770|childhood ependymoblastoma|childhood ependymoblastoma
521623|NCT00939770|childhood medulloepithelioma|childhood medulloepithelioma
521624|NCT00939770|childhood grade I meningioma|childhood grade i meningioma
521625|NCT00939770|childhood grade II meningioma|childhood grade ii meningioma
521626|NCT00939770|childhood grade III meningioma|childhood grade iii meningioma
521627|NCT00939770|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
521628|NCT00939770|recurrent childhood spinal cord neoplasm|recurrent childhood spinal cord neoplasm
521629|NCT00939770|childhood infratentorial ependymoma|childhood infratentorial ependymoma
521630|NCT00939770|childhood supratentorial ependymoma|childhood supratentorial ependymoma
521631|NCT00939770|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
521632|NCT00939770|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
521633|NCT00939770|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
521634|NCT00939770|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
521635|NCT00939770|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
521636|NCT00939757|Healthy volunteer subjects|healthy volunteer subjects
521637|NCT00939757|pharmacokinetics|pharmacokinetics
521638|NCT00939757|YM178|ym178
521639|NCT00939757|mirabegron|mirabegron
521640|NCT00939757|food|food
521641|NCT00939744|contractile activity|contractile activity
521642|NCT00939744|eicosanoids|eicosanoids
521643|NCT00939744|pregnant women|pregnant women
521644|NCT00939744|obstetrics complications|obstetrics complications
521645|NCT00939731|bioavailability, capsule, tablet, healthy volunteer|bioavailability, capsule, tablet, healthy volunteer
521646|NCT00939718|depression;vitamin B12;randomized control trial|depression;vitamin b12;randomized control trial
521647|NCT00939679|obesity|obesity
521648|NCT00939679|bariatric surgery|bariatric surgery
521649|NCT00939679|energy expenditure|energy expenditure
521650|NCT00939679|incretins|incretins
521651|NCT00939679|appetite regulation|appetite regulation
521652|NCT00939679|body composition|body composition
521653|NCT00939679|GLP-1|glp-1
521654|NCT00939666|Rectal cancer|rectal cancer
521655|NCT00939666|Chemoradiation|chemoradiation
521656|NCT00939666|Response|response
521657|NCT00939666|Wait-and-see policy|wait-and-see policy
521658|NCT00939666|Transanal endoscopic microsurgery|transanal endoscopic microsurgery
521659|NCT00939653|relapsed|relapsed
521660|NCT00939653|relapse|relapse
521661|NCT00939653|refractory|refractory
521662|NCT00939653|AML|aml
521663|NCT00939653|Acute myelogenous leukemia|acute myelogenous leukemia
521664|NCT00939653|Relapsed AML|relapsed aml
521665|NCT00939640|Diet|diet
521666|NCT00939640|Sodium|sodium
521667|NCT00939640|Hypertension|hypertension
521668|NCT00939640|Potassium|potassium
521669|NCT00939640|Antioxidants|antioxidants
521670|NCT00939640|congestive heart failure|congestive heart failure
521671|NCT00939640|Heart failure with normal ejection fraction|heart failure with normal ejection fraction
521672|NCT00939640|Heart failure with preserved systolic function|heart failure with preserved systolic function
521673|NCT00939601|Obstructive Sleep Apnea|obstructive sleep apnea
521674|NCT00939601|OSA|osa
521675|NCT00939601|Adherence|adherence
521676|NCT00939601|CPAP|cpap
521677|NCT00939601|Cognition|cognition
521678|NCT00939588|Aliskiren,|aliskiren,
521679|NCT00939588|hypertension,|hypertension,
521680|NCT00939588|renin-angiotensin-aldosterone system|renin-angiotensin-aldosterone system
521681|NCT00939575|preeclampsia, metabolomics, blood, urine|preeclampsia, metabolomics, blood, urine
521682|NCT00939562|Bioequivalence|bioequivalence
521683|NCT00939549|High dose cyclophosphamide|high dose cyclophosphamide
521684|NCT00939523|recurrent nonfunctioning adenoma|recurrent nonfunctioning adenoma
521685|NCT00939523|prolactinomas|prolactinomas
521686|NCT00939523|resistant pituitary tumors|resistant pituitary tumors
521687|NCT00939523|aggressive pituitary tumors|aggressive pituitary tumors
521688|NCT00939523|malignant pituitary adenomas|malignant pituitary adenomas
521689|NCT00939510|adenocarcinoma of the prostate|adenocarcinoma of the prostate
521690|NCT00939510|hormone-resistant prostate cancer|hormone-resistant prostate cancer
521691|NCT00939510|recurrent prostate cancer|recurrent prostate cancer
521692|NCT00939510|stage IV prostate cancer|stage iv prostate cancer
521693|NCT00939432|incontinence|incontinence
521694|NCT00939432|urinary|urinary
521695|NCT00939432|taboo|taboo
521696|NCT00939432|shame|shame
521697|NCT00939432|embarrassment|embarrassment
521698|NCT00939432|treatment|treatment
521699|NCT00939432|depression|depression
521700|NCT00939432|cancer|cancer
521701|NCT00939419|Tuberculosis care|tuberculosis care
521702|NCT00939419|community tuberculosis care|community tuberculosis care
521703|NCT00939419|Health facility based tuberculosis care|health facility based tuberculosis care
521798|NCT00939016|Social Desirability|social desirability
521704|NCT00939380|hematopoietic stem cell transplant|hematopoietic stem cell transplant
521705|NCT00939380|bone marrow transplant|bone marrow transplant
521706|NCT00939380|children|children
521707|NCT00939380|parents|parents
521708|NCT00939380|counseling|counseling
521709|NCT00939380|depression|depression
521710|NCT00939354|Asthma in subjects over the age of 65|asthma in subjects over the age of 65
521711|NCT00939341|Symbicort SMART|symbicort smart
521712|NCT00939328|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
521713|NCT00939328|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
521714|NCT00939315|Glioma, diagnosis|glioma, diagnosis
521715|NCT00939315|Imaging|imaging
521716|NCT00939315|Positron emission tomography|positron emission tomography
521717|NCT00939315|Magnetic resonance imaging|magnetic resonance imaging
521718|NCT00939315|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
521719|NCT00939289|Continuous glucose monitoring|continuous glucose monitoring
521720|NCT00939276|cataract surgery|cataract surgery
521721|NCT00939276|macular edema|macular edema
521722|NCT00939276|prevention|prevention
521723|NCT00939263|deglutition disorders|deglutition disorders
521724|NCT00939263|esophageal diseases|esophageal diseases
521725|NCT00939263|eosinophilia|eosinophilia
521726|NCT00939250|Diabetes|diabetes
521727|NCT00939250|Depression|depression
521728|NCT00939250|Disease Self Management|disease self management
521729|NCT00939250|Measurement Based Care|measurement based care
521730|NCT00939237|Coronary heart disease|coronary heart disease
521731|NCT00939237|Carotid intima-media thickness|carotid intima-media thickness
521732|NCT00939237|Biomarkers|biomarkers
521733|NCT00939224|Near-infrared spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
521734|NCT00939224|Regional oxygen saturation|regional oxygen saturation
521735|NCT00939224|Pediatrics|pediatrics
521736|NCT00939224|Cardiac catheterization|cardiac catheterization
521737|NCT00939224|Congenital heart disease|congenital heart disease
521738|NCT00939211|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
521739|NCT00939211|efficacy|efficacy
521740|NCT00939211|safety|safety
521741|NCT00939211|inhalation|inhalation
521742|NCT00939211|long-acting muscarinic receptor antagonist (LAMA)|long-acting muscarinic receptor antagonist (lama)
521743|NCT00939198|Hookworm|hookworm
521744|NCT00939198|Allergy|allergy
521745|NCT00939198|Vaccine|vaccine
521746|NCT00939198|Skin Test|skin test
521747|NCT00939198|Immediate-type hypersensitivity to Na-ASP-2 hookworm antigen|immediate-type hypersensitivity to na-asp-2 hookworm antigen
521748|NCT00939185|Compliance and Safety Study in Children with Upper and Lower Respiratory Tract Infections|compliance and safety study in children with upper and lower respiratory tract infections
521749|NCT00939172|Advanced Refractory Solid Malignancies|advanced refractory solid malignancies
521750|NCT00939172|Solid tumor|solid tumor
521751|NCT00939172|Lymphoma|lymphoma
521752|NCT00939172|TTP607|ttp607
521753|NCT00939159|Low or Intermediate-1 Risk Myelodysplastic Syndrome|low or intermediate-1 risk myelodysplastic syndrome
521754|NCT00939159|MDS|mds
521755|NCT00939159|Cancer|cancer
521756|NCT00939159|LBH589|lbh589
521757|NCT00939146|self management|self management
521758|NCT00939146|quality of life|quality of life
521759|NCT00939146|end of life|end of life
521760|NCT00939133|acne|acne
521761|NCT00939133|tretinoin|tretinoin
521762|NCT00939133|isotretinoin|isotretinoin
521763|NCT00939133|recurrence|recurrence
521764|NCT00939133|Retin A micro|retin a micro
521765|NCT00939120|Benign prostatic hyperplasia (BPH)|benign prostatic hyperplasia (bph)
521766|NCT00939120|dutasteride|dutasteride
521767|NCT00939120|tolterodine ER|tolterodine er
521768|NCT00939107|low back pain|low back pain
521769|NCT00939107|Intervertebral disc|intervertebral disc
521770|NCT00939107|McKenzie|mckenzie
521771|NCT00939107|Physical Therapy|physical therapy
521772|NCT00939107|Spinal manipulation|spinal manipulation
521773|NCT00939107|Chiropractics|chiropractics
521774|NCT00939107|Patient education|patient education
521775|NCT00939107|Exercise therapy|exercise therapy
521776|NCT00939107|Random allocation|random allocation
521777|NCT00939094|Pain, Mechanical Hypersensitivity|pain, mechanical hypersensitivity
521778|NCT00939094|Allodynia|allodynia
521779|NCT00939094|Efficacy|efficacy
521780|NCT00939094|analgesia|analgesia
521781|NCT00939094|Neuropathic|neuropathic
521782|NCT00939081|Obesity|obesity
521783|NCT00939081|Women's health|women's health
521784|NCT00939081|Minority health|minority health
521785|NCT00939081|Obesity prevention|obesity prevention
521786|NCT00939068|Chronic hepatitis B, Telbivudine, Intrauterine transmission|chronic hepatitis b, telbivudine, intrauterine transmission
521787|NCT00939029|tobacco use|tobacco use
521788|NCT00939029|smokeless tobacco|smokeless tobacco
521789|NCT00939029|chewing tobacco|chewing tobacco
521790|NCT00939029|snuff|snuff
521791|NCT00939029|nicotine replacement|nicotine replacement
521792|NCT00939029|tobacco dependence|tobacco dependence
521793|NCT00939029|tobacco cessation|tobacco cessation
521794|NCT00939029|tobacco abstinence|tobacco abstinence
521795|NCT00939016|Dietary Assessment|dietary assessment
521796|NCT00939016|24-hour dietary recall|24-hour dietary recall
521797|NCT00939016|Dietary Restraint|dietary restraint
522539|NCT00936117|Prophylaxis|prophylaxis
521799|NCT00939016|Portion estimation|portion estimation
521800|NCT00939016|Underreporting|underreporting
521801|NCT00938977|Obesity Hypoventilation syndrome|obesity hypoventilation syndrome
521802|NCT00938977|cytokines|cytokines
521803|NCT00938977|Adipokines|adipokines
521804|NCT00938977|continuous positive airway pressure|continuous positive airway pressure
521805|NCT00938977|bilevel support ventilation|bilevel support ventilation
521806|NCT00938977|Response to continuous positive airway pressure|response to continuous positive airway pressure
521807|NCT00938964|Cognition|cognition
521808|NCT00938951|Dry Eye|dry eye
521809|NCT00938951|Visual Performance|visual performance
521810|NCT00938938|risk communication|risk communication
521811|NCT00938938|medical reporting|medical reporting
521812|NCT00938938|Mass media|mass media
521813|NCT00938925|aggressive debridement|aggressive debridement
521814|NCT00938925|nail lacquer|nail lacquer
521815|NCT00938925|onychomycosis|onychomycosis
521816|NCT00938925|podiatry|podiatry
521817|NCT00938925|chiropody|chiropody
521818|NCT00938925|podiatry care|podiatry care
521819|NCT00938912|Lacosamide (VIMPAT)|lacosamide (vimpat)
521820|NCT00938899|TMC435350-TiDP16-C101|tmc435350-tidp16-c101
521821|NCT00938899|TMC435350-C101|tmc435350-c101
521822|NCT00938899|TMC435350|tmc435350
521823|NCT00938899|HCV|hcv
521824|NCT00938873|MBCT|mbct
521825|NCT00938873|identity|identity
521826|NCT00938873|depression|depression
521827|NCT00938873|recurrent|recurrent
521828|NCT00938873|homework|homework
521829|NCT00938860|Hepatitis C|hepatitis c
521830|NCT00938860|liver transplantation|liver transplantation
521831|NCT00938860|anti-viral therapy|anti-viral therapy
521832|NCT00938847|left ventricular dysfunction|left ventricular dysfunction
521833|NCT00938847|myocardial infarction|myocardial infarction
521834|NCT00938847|left ventricular dysfunction (LVDF) after acute myocardial infarction|left ventricular dysfunction (lvdf) after acute myocardial infarction
521835|NCT00938808|Osteoarthritis|osteoarthritis
521836|NCT00938808|Obesity|obesity
521837|NCT00938808|Weight loss|weight loss
521838|NCT00938808|Dietary instruction|dietary instruction
521839|NCT00938808|Formula diet|formula diet
521840|NCT00938808|Attention|attention
521841|NCT00938795|liver disease|liver disease
521842|NCT00938795|uncertainty|uncertainty
521843|NCT00938795|self management|self management
521844|NCT00938769|cancer|cancer
521845|NCT00938769|caregiver|caregiver
521846|NCT00938769|symptom|symptom
521847|NCT00938769|self management|self management
521848|NCT00938756|leptomeningeal metastases|leptomeningeal metastases
521849|NCT00938756|male breast cancer|male breast cancer
521850|NCT00938756|stage IV breast cancer|stage iv breast cancer
521851|NCT00938756|tumors metastatic to brain|tumors metastatic to brain
521852|NCT00938756|adult meningioma|adult meningioma
521853|NCT00938743|ADHD|adhd
521854|NCT00938743|adults|adults
521855|NCT00938743|driving performance|driving performance
521856|NCT00938743|atomoxetine|atomoxetine
521857|NCT00938730|Nonvalvular Atrial Fibrillation (NVAF)|nonvalvular atrial fibrillation (nvaf)
521858|NCT00938730|Factor Xa Inhibitor|factor xa inhibitor
521859|NCT00938730|Stroke|stroke
521860|NCT00938730|Thromboembolism|thromboembolism
521861|NCT00938730|Transient Ischemic attack|transient ischemic attack
521862|NCT00938730|Anticoagulants|anticoagulants
521863|NCT00938730|Prevention|prevention
521864|NCT00938730|YM150|ym150
521865|NCT00938730|Warfarin|warfarin
521866|NCT00938717|IBS|ibs
521867|NCT00938691|Scar|scar
521868|NCT00938691|Appearance|appearance
521869|NCT00938691|Spread|spread
521870|NCT00938678|Healthy volunteers|healthy volunteers
521871|NCT00938665|Alzheimer|alzheimer
521872|NCT00938665|Memory disorder|memory disorder
521873|NCT00938665|dementia|dementia
521874|NCT00938665|cognitive behavioral decline|cognitive behavioral decline
521875|NCT00938665|vascular dementia|vascular dementia
521876|NCT00938665|front temporal dementia|front temporal dementia
521877|NCT00938652|triple negative breast cancer|triple negative breast cancer
521878|NCT00938652|metastatic breast cancer|metastatic breast cancer
521879|NCT00938652|Triple negative metastatic breast cancer|triple negative metastatic breast cancer
521880|NCT00938626|refractory multiple myeloma|refractory multiple myeloma
521881|NCT00938626|stage I multiple myeloma|stage i multiple myeloma
521882|NCT00938626|stage II multiple myeloma|stage ii multiple myeloma
521883|NCT00938626|stage III multiple myeloma|stage iii multiple myeloma
521884|NCT00938613|SAR|sar
521885|NCT00938600|pharmacokinetics|pharmacokinetics
521886|NCT00938600|safety|safety
521887|NCT00938587|Rheumatoid Arthritis Glucocorticoids Prednisone|rheumatoid arthritis glucocorticoids prednisone
521888|NCT00938561|Chronic Kidney Disease|chronic kidney disease
521889|NCT00938561|Glomerular Filtration Rate|glomerular filtration rate
521890|NCT00938561|Kidney function|kidney function
521891|NCT00938561|Markers|markers
521892|NCT00938548|mastectomy|mastectomy
521893|NCT00938548|pain, postoperative|pain, postoperative
521894|NCT00938548|pregabalin|pregabalin
521895|NCT00938535|Obesity|obesity
521896|NCT00938535|Women's health|women's health
521897|NCT00938535|Minority health|minority health
521898|NCT00938535|Obesity prevention|obesity prevention
521899|NCT00938522|Cilostazol loading|cilostazol loading
521900|NCT00938522|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
521901|NCT00938509|IBUPROFEN|ibuprofen
521902|NCT00938509|CHILDREN|children
521903|NCT00938509|FEVER|fever
521904|NCT00938483|infant formula|infant formula
521905|NCT00938483|cow's milk allergy|cow's milk allergy
521906|NCT00938470|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
521907|NCT00938470|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
521908|NCT00938470|stage IIIA gastric cancer|stage iiia gastric cancer
521909|NCT00938470|stage IIIB gastric cancer|stage iiib gastric cancer
521910|NCT00938470|stage IIIC gastric cancer|stage iiic gastric cancer
521911|NCT00938470|stage IIIA esophageal cancer|stage iiia esophageal cancer
521912|NCT00938470|stage IIIB esophageal cancer|stage iiib esophageal cancer
521913|NCT00938470|stage IIIC esophageal cancer|stage iiic esophageal cancer
521914|NCT00938457|protocol specific|protocol specific
521915|NCT00938444|Patients with moderate to severe RA|patients with moderate to severe ra
521916|NCT00938431|Lacosamide|lacosamide
521917|NCT00938431|Vimpat|vimpat
521918|NCT00938431|Children|children
521919|NCT00938431|Epilepsy|epilepsy
521920|NCT00938431|Seizures|seizures
521921|NCT00938431|Anti-epileptic|anti-epileptic
521922|NCT00938405|type 1 diabetes mellitus|type 1 diabetes mellitus
521923|NCT00938405|colesevelam|colesevelam
521924|NCT00938405|LDL|ldl
521925|NCT00938405|cholesterol|cholesterol
521926|NCT00938405|A1c|a1c
521927|NCT00938405|target range glucose values|target range glucose values
521928|NCT00938392|influenza infection|influenza infection
521929|NCT00938392|GSK Bio's influenza vaccine GSK2186877A|gsk bio's influenza vaccine gsk2186877a
521930|NCT00938379|mosquito|mosquito
521931|NCT00938379|repellent|repellent
521932|NCT00938379|vector control|vector control
521933|NCT00938379|malaria|malaria
521934|NCT00938353|Moderate croup (Westley score 3-8)|moderate croup (westley score 3-8)
521935|NCT00938340|Cardiovascular Disease|cardiovascular disease
521936|NCT00938327|Gastroenteritis|gastroenteritis
521937|NCT00938301|healthy volunteer, first in human, safety and tolerability|healthy volunteer, first in human, safety and tolerability
521938|NCT00938288|Antithrombin|antithrombin
521939|NCT00938288|Thrombosis|thrombosis
521940|NCT00938288|Pharmacokinetics|pharmacokinetics
521941|NCT00938288|Hereditary Antithrombin Deficiency|hereditary antithrombin deficiency
521942|NCT00938288|Congenital Antithrombin Deficiency|congenital antithrombin deficiency
521943|NCT00938249|Moderately Elevated Serum Triglyceride|moderately elevated serum triglyceride
521944|NCT00938236|lung transplant|lung transplant
521945|NCT00938236|lung transplant recipient|lung transplant recipient
521946|NCT00938236|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
521947|NCT00938236|bronchiolitis obliterans|bronchiolitis obliterans
521948|NCT00938236|single lung transplant|single lung transplant
521949|NCT00938236|double lung transplant|double lung transplant
521950|NCT00938236|heart-lung transplant|heart-lung transplant
521951|NCT00938236|Aerosol|aerosol
521952|NCT00938223|melanoma|melanoma
521953|NCT00938223|peptide|peptide
521954|NCT00938223|vaccine|vaccine
521955|NCT00938223|adjuvant|adjuvant
521956|NCT00938223|advanced|advanced
521957|NCT00938210|Colonic surgery|colonic surgery
521958|NCT00938210|Postoperative care|postoperative care
521959|NCT00938210|Fatigue|fatigue
521960|NCT00938210|Physical function|physical function
521961|NCT00938210|Quality of life|quality of life
521962|NCT00938197|Fimasartan|fimasartan
521963|NCT00938197|Drug interaction|drug interaction
521964|NCT00938184|tolerance|tolerance
521965|NCT00938184|single dose|single dose
521966|NCT00938184|paroxetine|paroxetine
521967|NCT00938184|controlled-release tablet|controlled-release tablet
521968|NCT00938184|safety|safety
521969|NCT00938184|pharmacokinetics|pharmacokinetics
521970|NCT00938184|Japanese healthy male subjects|japanese healthy male subjects
521971|NCT00938171|Cytokine|cytokine
521972|NCT00938171|Anesthesia|anesthesia
521973|NCT00938171|Local anesthesia|local anesthesia
521974|NCT00938171|surgery|surgery
521975|NCT00938171|breast cancer|breast cancer
521976|NCT00938158|albiglutide|albiglutide
521977|NCT00938158|hemodialysis|hemodialysis
521978|NCT00938158|pharmacokinetics|pharmacokinetics
521979|NCT00938158|renal|renal
521980|NCT00938145|recurrent bladder cancer|recurrent bladder cancer
521981|NCT00938145|stage II bladder cancer|stage ii bladder cancer
521982|NCT00938145|stage III bladder cancer|stage iii bladder cancer
521983|NCT00938145|stage IV bladder cancer|stage iv bladder cancer
521984|NCT00938132|fimasartan|fimasartan
521985|NCT00938132|drug interaction|drug interaction
521986|NCT00938119|Cardiovascular disease|cardiovascular disease
521987|NCT00938119|Diabetes|diabetes
521988|NCT00938106|Intra-uterine Brachytherapy|intra-uterine brachytherapy
521989|NCT00938106|cervix cancer|cervix cancer
521990|NCT00938106|Patients suitable for intra-uterine brachytherapy for invasive carcinoma of the cervix.|patients suitable for intra-uterine brachytherapy for invasive carcinoma of the cervix.
521991|NCT00938067|Injuries, Trauma|injuries, trauma
521992|NCT00938054|Outcome|outcome
521993|NCT00938054|Autism|autism
522642|NCT00935688|malaria|malaria
521994|NCT00938054|Pervasive Developmental Disorder|pervasive developmental disorder
521995|NCT00938028|microbiome|microbiome
521996|NCT00938028|metabolome|metabolome
521997|NCT00938028|stool|stool
521998|NCT00938028|fecal samples|fecal samples
521999|NCT00938028|handling|handling
522000|NCT00938028|toddler|toddler
522001|NCT00938015|postmarketing surveillance|postmarketing surveillance
522002|NCT00938015|Enbrel|enbrel
522003|NCT00938015|psoriatic arthritis|psoriatic arthritis
522004|NCT00937989|ductal breast carcinoma in situ|ductal breast carcinoma in situ
522005|NCT00937989|lobular breast carcinoma in situ|lobular breast carcinoma in situ
522006|NCT00937989|male breast cancer|male breast cancer
522007|NCT00937989|stage I breast cancer|stage i breast cancer
522008|NCT00937989|stage II breast cancer|stage ii breast cancer
522009|NCT00937989|stage IIIA breast cancer|stage iiia breast cancer
522010|NCT00937989|stage IIIB breast cancer|stage iiib breast cancer
522011|NCT00937989|stage IIIC breast cancer|stage iiic breast cancer
522012|NCT00937976|Hemodialysis and peritoneal dialysis|hemodialysis and peritoneal dialysis
522013|NCT00937963|cholesterol|cholesterol
522014|NCT00937963|cardiovascular|cardiovascular
522015|NCT00937963|CVD|cvd
522016|NCT00937963|Triglycerides|triglycerides
522017|NCT00937963|Heart|heart
522018|NCT00937950|HPV|hpv
522019|NCT00937950|Papillomavirus|papillomavirus
522020|NCT00937950|Human papillomavirus|human papillomavirus
522021|NCT00937950|Cervical cancer|cervical cancer
522022|NCT00937950|HPV vaccine|hpv vaccine
522023|NCT00937924|EUS|eus
522024|NCT00937924|ERCP|ercp
522025|NCT00937924|Sedation Level|sedation level
522026|NCT00937924|Adverse Symptoms|adverse symptoms
522027|NCT00937924|Recovery time|recovery time
522028|NCT00937911|YM150|ym150
522029|NCT00937911|Bleeding|bleeding
522030|NCT00937911|Anticoagulant|anticoagulant
522031|NCT00937911|Venous thromboembolism|venous thromboembolism
522032|NCT00937911|FXa inhibitor|fxa inhibitor
522033|NCT00937898|lean beef|lean beef
522034|NCT00937898|cholesterol|cholesterol
522035|NCT00937898|lipids|lipids
522036|NCT00937898|diet intervention|diet intervention
522037|NCT00937885|Reminiscence|reminiscence
522038|NCT00937885|Nursing home staff|nursing home staff
522039|NCT00937885|Nursing home residents|nursing home residents
522040|NCT00937885|Elderly|elderly
522041|NCT00937846|Cognitive impairment|cognitive impairment
522042|NCT00937846|Schizophrenia|schizophrenia
522043|NCT00937846|Alzheimer's Disease|alzheimer's disease
522044|NCT00937846|PET|pet
522045|NCT00937833|prostate cancer|prostate cancer
522046|NCT00937833|prostatectomy|prostatectomy
522047|NCT00937833|incontinence|incontinence
522048|NCT00937820|YM150|ym150
522049|NCT00937820|Bleeding|bleeding
522050|NCT00937820|VTE|vte
522051|NCT00937820|FXa inhibitor|fxa inhibitor
522052|NCT00937820|Venous thromboembolism|venous thromboembolism
522053|NCT00937807|hemodynamic stability|hemodynamic stability
522054|NCT00937807|xenon|xenon
522055|NCT00937807|carotid surgery|carotid surgery
522056|NCT00937807|general anesthesia|general anesthesia
522057|NCT00937781|stage III melanoma|stage iii melanoma
522058|NCT00937781|recurrent melanoma|recurrent melanoma
522059|NCT00937755|schizophrenia|schizophrenia
522060|NCT00937755|antipsychotics|antipsychotics
522061|NCT00937755|glucose homeostasis|glucose homeostasis
522062|NCT00937755|metabolic disturbance|metabolic disturbance
522063|NCT00937742|cardiovascular disease|cardiovascular disease
522064|NCT00937742|Lycopene|lycopene
522065|NCT00937742|Tomato|tomato
522066|NCT00937729|uncompliant patients with virological failure|uncompliant patients with virological failure
522067|NCT00937729|Treatment experienced|treatment experienced
522068|NCT00937716|schizophrenia|schizophrenia
522069|NCT00937716|treatment response|treatment response
522070|NCT00937716|risperidone|risperidone
522071|NCT00937716|functional magnetic resonance|functional magnetic resonance
522072|NCT00937716|functional magnetic spectroscopy|functional magnetic spectroscopy
522073|NCT00937690|melanoma|melanoma
522074|NCT00937690|cutaneous|cutaneous
522075|NCT00937690|imaging|imaging
522076|NCT00937677|Tysabri|tysabri
522077|NCT00937677|VWMTR|vwmtr
522078|NCT00937664|Phase I|phase i
522079|NCT00937664|cancer|cancer
522080|NCT00937664|solid tumors|solid tumors
522081|NCT00937664|advanced solid malignancies|advanced solid malignancies
522082|NCT00937664|dose escalation|dose escalation
522083|NCT00937664|combination treatment|combination treatment
522084|NCT00937664|CHK inhibitor|chk inhibitor
522085|NCT00937664|Japanese|japanese
522086|NCT00937651|Fimasartan|fimasartan
522087|NCT00937651|Essential Hypertension|essential hypertension
522088|NCT00937638|Metabolic syndrome|metabolic syndrome
522089|NCT00937638|Lean Beef|lean beef
522090|NCT00937638|CVD|cvd
522091|NCT00937612|Head and Neck Neoplasms|head and neck neoplasms
522092|NCT00937612|Chemotherapy|chemotherapy
522093|NCT00937612|Radiotherapy, Adjuvant|radiotherapy, adjuvant
522094|NCT00937612|Surgery|surgery
522095|NCT00937599|obese|obese
522096|NCT00937599|brazil nuts|brazil nuts
522097|NCT00937599|oxidative stress|oxidative stress
523132|NCT00934206|Exercise|exercise
522098|NCT00937599|microcirculatory|microcirculatory
522099|NCT00937599|metabolic profile|metabolic profile
522100|NCT00937586|Metastatic Prostate Cancer|metastatic prostate cancer
522101|NCT00937586|Prostate Cancer Risk Assessment|prostate cancer risk assessment
522102|NCT00937573|stents|stents
522103|NCT00937573|mortality|mortality
522104|NCT00937573|revascularization|revascularization
522105|NCT00937573|stent thrombosis|stent thrombosis
522106|NCT00937573|Drug-Eluting Stents|drug-eluting stents
522107|NCT00937547|cervical cancer|cervical cancer
522108|NCT00937547|Human Papillomavirus Infection|human papillomavirus infection
522109|NCT00937534|Fimasartan|fimasartan
522110|NCT00937534|healthy elderly and young male volunteer|healthy elderly and young male volunteer
522111|NCT00937534|pharmacokinetic|pharmacokinetic
522112|NCT00937521|Immunogenicity|immunogenicity
522113|NCT00937521|Meningitis|meningitis
522114|NCT00937521|Antibody|antibody
522115|NCT00937521|Infants|infants
522116|NCT00937508|smoking|smoking
522117|NCT00937508|quitting|quitting
522118|NCT00937508|varenicline|varenicline
522119|NCT00937508|preoperative|preoperative
522120|NCT00937508|long term abstinence|long term abstinence
522121|NCT00937469|Social skills training for children with ADHD|social skills training for children with adhd
522122|NCT00937469|Children with ADHD|children with adhd
522123|NCT00937456|Esophagus|esophagus
522124|NCT00937456|Cancer|cancer
522125|NCT00937456|Surgery|surgery
522126|NCT00937456|Laparoscopy|laparoscopy
522127|NCT00937456|Randomized trial|randomized trial
522128|NCT00937456|Esophageal cancer deemed to be resectable|esophageal cancer deemed to be resectable
522129|NCT00937443|Physical Activity|physical activity
522130|NCT00937443|Cardiac Heart Failure|cardiac heart failure
522131|NCT00937443|Exercise Regimen|exercise regimen
522132|NCT00937443|Cardioreparative Factors|cardioreparative factors
522133|NCT00937430|Pelvic organ prolapse|pelvic organ prolapse
522134|NCT00937430|Bowel preparation|bowel preparation
522135|NCT00937417|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
522136|NCT00937417|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
522137|NCT00937417|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
522138|NCT00937417|stage IV breast cancer|stage iv breast cancer
522139|NCT00937417|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
522140|NCT00937417|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
522141|NCT00937417|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
522142|NCT00937417|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
522143|NCT00937417|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
522144|NCT00937417|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
522145|NCT00937417|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
522146|NCT00937417|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
522147|NCT00937417|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
522148|NCT00937417|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
522149|NCT00937417|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
522150|NCT00937417|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
522151|NCT00937417|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
522152|NCT00937417|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
522153|NCT00937417|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
522154|NCT00937417|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
522383|NCT00936741|Cushings|cushings
522155|NCT00937417|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
522156|NCT00937417|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
522157|NCT00937417|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
522158|NCT00937417|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
522159|NCT00937417|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
522160|NCT00937417|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
522161|NCT00937417|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
522162|NCT00937417|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
522163|NCT00937417|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
522164|NCT00937417|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
522165|NCT00937417|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
522166|NCT00937417|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
522167|NCT00937417|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
523231|NCT00933608|AD|ad
522168|NCT00937417|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
522169|NCT00937417|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
522170|NCT00937417|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
522171|NCT00937417|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
522172|NCT00937417|recurrent salivary gland cancer|recurrent salivary gland cancer
522173|NCT00937417|stage IV salivary gland cancer|stage iv salivary gland cancer
522174|NCT00937417|anaplastic thyroid cancer|anaplastic thyroid cancer
522175|NCT00937417|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
522176|NCT00937417|insular thyroid cancer|insular thyroid cancer
522177|NCT00937417|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
522178|NCT00937417|recurrent thyroid cancer|recurrent thyroid cancer
522179|NCT00937417|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
522180|NCT00937417|recurrent prostate cancer|recurrent prostate cancer
522181|NCT00937417|hormone-resistant prostate cancer|hormone-resistant prostate cancer
522182|NCT00937417|recurrent breast cancer|recurrent breast cancer
522183|NCT00937417|stage IV prostate cancer|stage iv prostate cancer
522184|NCT00937417|male breast cancer|male breast cancer
522186|NCT00937391|MRI agents|mri agents
522187|NCT00937391|Magnevist|magnevist
522188|NCT00937365|Pregnancy|pregnancy
522189|NCT00937365|Pain|pain
522190|NCT00937365|Low back pain|low back pain
522191|NCT00937365|Pubic symphysis pain|pubic symphysis pain
522192|NCT00937365|CAM|cam
522193|NCT00937365|Complementary & Alternative Medicine|complementary & alternative medicine
522194|NCT00937365|Exercise|exercise
522195|NCT00937365|Chiropractic|chiropractic
522196|NCT00937365|Spinal manipulation|spinal manipulation
522197|NCT00937365|Adjustments|adjustments
522198|NCT00937365|Neuroemotional technique|neuroemotional technique
522199|NCT00937365|Mind body|mind body
522200|NCT00937365|Mind body therapy|mind body therapy
522201|NCT00937365|Attachment|attachment
522202|NCT00937365|Maternal Fetal relationship|maternal fetal relationship
522203|NCT00937365|Intrauterine attachment|intrauterine attachment
522204|NCT00937365|Heart rate variability|heart rate variability
522205|NCT00937365|VAS|vas
522206|NCT00937365|Visual analog scale|visual analog scale
522207|NCT00937365|Roland Morris Disability Index|roland morris disability index
522208|NCT00937352|Mild to moderate Alzheimer's disease|mild to moderate alzheimer's disease
522209|NCT00937339|cerebrovascular accident|cerebrovascular accident
522210|NCT00937339|bone|bone
522211|NCT00937339|muscle|muscle
522212|NCT00937339|vibration|vibration
522213|NCT00937287|HPV|hpv
522214|NCT00937287|African American|african american
522215|NCT00937287|Rural|rural
522216|NCT00937274|ETEC EPEC diarrhoea|etec epec diarrhoea
522217|NCT00937274|phage therapy|phage therapy
522218|NCT00937274|ORS|ors
522219|NCT00937248|Cone Beam CT in rectal cancer patients|cone beam ct in rectal cancer patients
522220|NCT00937248|Immobilizing rectal cancer patients|immobilizing rectal cancer patients
522221|NCT00937248|Image guided radiotherapy in rectal cancer patients|image guided radiotherapy in rectal cancer patients
522222|NCT00937235|Smoking Cessation|smoking cessation
522223|NCT00937235|Anxiety|anxiety
522224|NCT00937235|Behavior Therapy|behavior therapy
522225|NCT00937235|Varenicline|varenicline
522226|NCT00937222|diabetes|diabetes
522227|NCT00937222|cholesterol|cholesterol
522228|NCT00937222|peanuts|peanuts
522229|NCT00937222|peanut butter|peanut butter
522230|NCT00937222|dietary intervention|dietary intervention
522231|NCT00937222|HDL cholesterol|hdl cholesterol
522232|NCT00937183|Waldenström macroglobulinemia|waldenström macroglobulinemia
522233|NCT00937183|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
522234|NCT00937183|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
522235|NCT00937183|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
522236|NCT00937183|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
522237|NCT00937183|stage II grade 1 follicular lymphoma|stage ii grade 1 follicular lymphoma
522238|NCT00937183|stage II grade 2 follicular lymphoma|stage ii grade 2 follicular lymphoma
522239|NCT00937183|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
522240|NCT00937183|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
522241|NCT00937183|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
522242|NCT00937183|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
522243|NCT00937183|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
522244|NCT00937183|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
522245|NCT00937183|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
522246|NCT00937183|stage I marginal zone lymphoma|stage i marginal zone lymphoma
522247|NCT00937183|stage II marginal zone lymphoma|stage ii marginal zone lymphoma
522248|NCT00937183|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
522249|NCT00937183|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
522250|NCT00937183|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
522251|NCT00937183|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
522252|NCT00937183|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
522253|NCT00937183|stage I mantle cell lymphoma|stage i mantle cell lymphoma
522254|NCT00937183|stage II mantle cell lymphoma|stage ii mantle cell lymphoma
522255|NCT00937183|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
522256|NCT00937183|stage I multiple myeloma|stage i multiple myeloma
522257|NCT00937183|stage II multiple myeloma|stage ii multiple myeloma
522258|NCT00937183|stage III multiple myeloma|stage iii multiple myeloma
522259|NCT00937183|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
522260|NCT00937183|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
522261|NCT00937183|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
522262|NCT00937183|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
522263|NCT00937170|Total Knee Replacement|total knee replacement
522264|NCT00937170|Gender Specific Design|gender specific design
522265|NCT00937157|Inflammation|inflammation
522266|NCT00937157|Multiple Sclerosis|multiple sclerosis
522267|NCT00937157|Glatiramer Acetate|glatiramer acetate
522268|NCT00937157|Gd enhancing lesions|gd enhancing lesions
522269|NCT00937157|1.5T protocol|1.5t protocol
522270|NCT00937157|3T protocol|3t protocol
522271|NCT00937157|Magnetization transfer imaging (MTI)|magnetization transfer imaging (mti)
522272|NCT00937157|Lesion activity analysis|lesion activity analysis
522273|NCT00937157|Copaxone|copaxone
522274|NCT00937144|endothelial function|endothelial function
522275|NCT00937144|endothelial progenitor stem cells|endothelial progenitor stem cells
522276|NCT00937118|laparotomy|laparotomy
522277|NCT00937118|duodenal injury|duodenal injury
522278|NCT00937118|pancreatic injury|pancreatic injury
522279|NCT00937118|trauma|trauma
522280|NCT00937092|Heart Failure|heart failure
522281|NCT00937092|Dopamine|dopamine
522282|NCT00937092|Furosemide|furosemide
522283|NCT00937092|Worsening Renal Function|worsening renal function
522284|NCT00937092|Hypokalemia|hypokalemia
522285|NCT00937092|Outcomes|outcomes
522286|NCT00937092|Prognosis|prognosis
522287|NCT00937079|Glucagon-like peptide-1 receptor targeting|glucagon-like peptide-1 receptor targeting
522288|NCT00937079|Insulinoma imaging|insulinoma imaging
522289|NCT00937079|Exendin-4|exendin-4
522290|NCT00937079|molecular imaging|molecular imaging
522291|NCT00937066|Cost-effectiveness analysis|cost-effectiveness analysis
522292|NCT00937066|Symbicort|symbicort
522293|NCT00937053|Neutropenia|neutropenia
522294|NCT00937053|Transfusions|transfusions
522295|NCT00937053|Hemoglobin|hemoglobin
522296|NCT00937053|Bone marrow transplant|bone marrow transplant
522297|NCT00937053|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
522298|NCT00937040|Osmotic Release Oral System (OROS®) Extended Release Methylphenidate HCl|osmotic release oral system (oros®) extended release methylphenidate hcl
522299|NCT00937040|CONCERTA® (OROS MPH)|concerta® (oros mph)
522300|NCT00937027|Antifolate|antifolate
522301|NCT00937027|Psoriasis|psoriasis
522302|NCT00937027|Antiinflammatory drug|antiinflammatory drug
522303|NCT00937027|Autoimmune disease|autoimmune disease
522304|NCT00937027|Treatment|treatment
522305|NCT00937014|infant formula|infant formula
522306|NCT00937014|growth|growth
522307|NCT00937014|weight|weight
522308|NCT00937001|myopathy|myopathy
522309|NCT00937001|respiratory failure|respiratory failure
522310|NCT00937001|cognitive impairment|cognitive impairment
522311|NCT00937001|delirium|delirium
522312|NCT00936988|Hyperparathyroidism, Primary|hyperparathyroidism, primary
522313|NCT00936988|cinacalcet|cinacalcet
522314|NCT00936962|Meningococcal C vaccine|meningococcal c vaccine
522315|NCT00936962|Meningitis study|meningitis study
522316|NCT00936962|Canadian vaccine schedule|canadian vaccine schedule
522317|NCT00936962|Prevention of Meningococcal C disease|prevention of meningococcal c disease
522318|NCT00936949|total hip arthroplasty|total hip arthroplasty
522319|NCT00936949|posterolateral|posterolateral
522320|NCT00936949|modified lateral|modified lateral
522321|NCT00936936|Testis|testis
522322|NCT00936936|Relapsed Testicular Cancer|relapsed testicular cancer
522323|NCT00936936|Bevacizumab|bevacizumab
522324|NCT00936936|Avastin|avastin
522325|NCT00936936|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
522326|NCT00936936|rhuMAb-VEGF|rhumab-vegf
522327|NCT00936936|Carboplatin|carboplatin
522328|NCT00936936|Paraplatin|paraplatin
522329|NCT00936936|Docetaxel|docetaxel
522330|NCT00936936|Taxotere|taxotere
522331|NCT00936936|Etoposide|etoposide
522332|NCT00936936|VePesid|vepesid
522333|NCT00936936|Gemcitabine|gemcitabine
522334|NCT00936936|Gemcitabine Hydrochloride|gemcitabine hydrochloride
522335|NCT00936936|Gemzar|gemzar
522336|NCT00936936|Ifosfamide|ifosfamide
522337|NCT00936936|Ifex|ifex
522338|NCT00936936|Melphalan|melphalan
522339|NCT00936936|Alkeran|alkeran
522340|NCT00936923|CAPD|capd
522341|NCT00936923|Diuretics|diuretics
522342|NCT00936923|Residual Renal Function|residual renal function
522343|NCT00936923|furosemide|furosemide
522344|NCT00936910|central line fungal infections|central line fungal infections
522345|NCT00936910|antifungal lock therapy|antifungal lock therapy
522346|NCT00936910|Ambisome lock therapy|ambisome lock therapy
522347|NCT00936884|Opioid Induced Constipation|opioid induced constipation
522348|NCT00936871|lersivirine QT QTc ECG HIV NNRTI|lersivirine qt qtc ecg hiv nnrti
522349|NCT00936858|radioiodine refractory thyroid cancer|radioiodine refractory thyroid cancer
522350|NCT00936858|RAD001|rad001
522351|NCT00936832|stage IV rectal cancer|stage iv rectal cancer
522352|NCT00936832|adenocarcinoma of the rectum|adenocarcinoma of the rectum
522353|NCT00936832|liver metastases|liver metastases
522354|NCT00936832|lung metastases|lung metastases
522355|NCT00936819|Stent|stent
522356|NCT00936819|endothelial progenitor cells|endothelial progenitor cells
522357|NCT00936819|nitric oxide|nitric oxide
522358|NCT00936819|myocardial infarction|myocardial infarction
522359|NCT00936819|MRI|mri
522360|NCT00936806|Intracranial tumor patients|intracranial tumor patients
522361|NCT00936793|Drug Interaction|drug interaction
522362|NCT00936793|Asthma|asthma
522363|NCT00936793|HIV|hiv
522364|NCT00936793|Beclomethasone|beclomethasone
522365|NCT00936793|Protease Inhibitors|protease inhibitors
522366|NCT00936793|HV|hv
522367|NCT00936793|Healthy Volunteer|healthy volunteer
522368|NCT00936793|HIV Infections|hiv infections
522369|NCT00936780|Coronary Artery Disease|coronary artery disease
522370|NCT00936780|Restenosis|restenosis
522371|NCT00936780|Stent thrombosis|stent thrombosis
522372|NCT00936780|Coronary stents|coronary stents
522373|NCT00936780|Angioplasty|angioplasty
522374|NCT00936780|Drug Eluting Stents (DES)|drug eluting stents (des)
522375|NCT00936767|falciparum malaria|falciparum malaria
522376|NCT00936767|artemisone|artemisone
522377|NCT00936767|artesunate|artesunate
522378|NCT00936767|resistance|resistance
522379|NCT00936754|Glycemic index|glycemic index
522380|NCT00936754|Reduction of glycemic index of ingested foods|reduction of glycemic index of ingested foods
522381|NCT00936741|Cushing's Disease|cushing's disease
522382|NCT00936741|Cushing's Syndrome|cushing's syndrome
522384|NCT00936741|Pituitary|pituitary
522385|NCT00936741|ACTH|acth
522386|NCT00936741|Adrenocorticotropic hormone|adrenocorticotropic hormone
522387|NCT00936741|Ectopic|ectopic
522388|NCT00936741|Adrenal adenoma|adrenal adenoma
522389|NCT00936741|Adrenal carcinoma|adrenal carcinoma
522390|NCT00936741|Adrenal autonomy|adrenal autonomy
522391|NCT00936741|Cortisol|cortisol
522392|NCT00936741|Hypercortisolemia|hypercortisolemia
522393|NCT00936741|Cushingoid|cushingoid
522394|NCT00936741|Moon facies|moon facies
522395|NCT00936741|Dorsocervical fat|dorsocervical fat
522396|NCT00936741|Plethora|plethora
522397|NCT00936741|Hirsutism|hirsutism
522398|NCT00936741|Violaceous striae|violaceous striae
522399|NCT00936741|Hormone|hormone
522400|NCT00936741|Contraceptive|contraceptive
522401|NCT00936741|Endocrine|endocrine
522402|NCT00936741|Cushing Syndrome|cushing syndrome
522403|NCT00936741|Ectopic ACTH Secretion|ectopic acth secretion
522404|NCT00936715|prevention of chronic hepatitis B recurrence|prevention of chronic hepatitis b recurrence
522405|NCT00936715|post orthotopic liver transplant|post orthotopic liver transplant
522406|NCT00936715|prevention of chronic hepatitis B recurrence in patients who have undergone orthotopic liver transplant|prevention of chronic hepatitis b recurrence in patients who have undergone orthotopic liver transplant
522407|NCT00936702|Newly Diagnosed Carcinoma of Unknown Primary Origin|newly diagnosed carcinoma of unknown primary origin
522408|NCT00936702|Squamous Cell Carcinoma of Unknown Primary Origin|squamous cell carcinoma of unknown primary origin
522409|NCT00936702|Undifferentiated Carcinoma of Unknown Primary|undifferentiated carcinoma of unknown primary
522410|NCT00936702|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
522411|NCT00936689|Hepatocellular carcinoma;|hepatocellular carcinoma;
522412|NCT00936689|Chemoembolization;|chemoembolization;
522413|NCT00936689|DC-Beads.|dc-beads.
522414|NCT00936676|parkinson's|parkinson's
522415|NCT00936676|long-term effects|long-term effects
522416|NCT00936676|adagio|adagio
522417|NCT00936676|rasagiline|rasagiline
522418|NCT00936676|delayed start|delayed start
522419|NCT00936663|Diabetes|diabetes
522420|NCT00936663|Kidney Transplant|kidney transplant
522421|NCT00936663|Sitagliptin|sitagliptin
522422|NCT00936650|Hyperparathyroidism, Primary|hyperparathyroidism, primary
522423|NCT00936650|cinacalcet|cinacalcet
522424|NCT00936624|Persistent asthma|persistent asthma
522425|NCT00936611|LBH589|lbh589
522426|NCT00936611|WM|wm
522427|NCT00936611|panobinostat|panobinostat
522428|NCT00936611|relapsed|relapsed
522429|NCT00936611|waldenstrom|waldenstrom
522430|NCT00936611|macroglobulinemia|macroglobulinemia
522431|NCT00936598|Sleep|sleep
522432|NCT00936598|Endometrial Neoplasms|endometrial neoplasms
522433|NCT00936598|Pain|pain
522434|NCT00936585|Crohn's Disease|crohn's disease
522435|NCT00936585|Infusion|infusion
522436|NCT00936585|Anti IL-17 Monoclonal Antibody|anti il-17 monoclonal antibody
522437|NCT00936585|Placebo|placebo
522438|NCT00936585|Crohn Disease|crohn disease
522439|NCT00936585|Inflammatory Bowel Disease|inflammatory bowel disease
522440|NCT00936572|Probiotics|probiotics
522441|NCT00936572|La1|la1
522442|NCT00936572|BB536|bb536
522443|NCT00936572|Colorectal surgery|colorectal surgery
522444|NCT00936572|Intestinal immunity|intestinal immunity
522445|NCT00936572|Dendritic cells|dendritic cells
522446|NCT00936572|Lymphocyte|lymphocyte
522447|NCT00936572|Microbiota|microbiota
522448|NCT00936559|rotator cuff tear repair|rotator cuff tear repair
522449|NCT00936559|open surgical technique|open surgical technique
522450|NCT00936559|safety|safety
522451|NCT00936520|Diabetic Macular Edema|diabetic macular edema
522452|NCT00936520|DME|dme
522453|NCT00936520|Pars Plana Vitrectomy|pars plana vitrectomy
522454|NCT00936520|Ocular Inflammation|ocular inflammation
522455|NCT00936507|energy density|energy density
522456|NCT00936507|portion size|portion size
522457|NCT00936507|child feeding|child feeding
522458|NCT00936494|obstructive sleep apnea|obstructive sleep apnea
522459|NCT00936494|sleep related breathing disorder|sleep related breathing disorder
522460|NCT00936494|snoring|snoring
522461|NCT00936494|disturbed sleeping|disturbed sleeping
522462|NCT00936494|open mouth breathing|open mouth breathing
522463|NCT00936494|upper airway resistance syndrome|upper airway resistance syndrome
522464|NCT00936481|OSA|osa
522465|NCT00936468|Elderly influenza vaccine|elderly influenza vaccine
522466|NCT00936455|telemedicine|telemedicine
522467|NCT00936455|telephone|telephone
522468|NCT00936455|outcomes|outcomes
522469|NCT00936442|Compliance|compliance
522470|NCT00936442|Early Breast Cancer|early breast cancer
522471|NCT00936429|Dengue fever|dengue fever
522472|NCT00936429|Dengue hemorrhagic fever|dengue hemorrhagic fever
522473|NCT00936429|Dengue shock syndrome|dengue shock syndrome
522474|NCT00936429|Vaccine|vaccine
522475|NCT00936429|Hawaii Biotech|hawaii biotech
522476|NCT00936416|Glomerular Filtration Rate|glomerular filtration rate
522477|NCT00936416|Renal Blood Flow|renal blood flow
522478|NCT00936416|MRI|mri
522479|NCT00936416|Inulin|inulin
522480|NCT00936416|Para-Aminohippuric Acid|para-aminohippuric acid
522481|NCT00936390|adenocarcinoma of the prostate|adenocarcinoma of the prostate
522482|NCT00936390|stage IIB prostate cancer|stage iib prostate cancer
522483|NCT00936390|stage IIA prostate cancer|stage iia prostate cancer
522484|NCT00936351|schizophrenia|schizophrenia
522485|NCT00936351|intervention studies|intervention studies
522486|NCT00936351|mindfulness meditation|mindfulness meditation
522487|NCT00936351|vocational rehabilitation|vocational rehabilitation
522488|NCT00936351|schizoaffective disorder|schizoaffective disorder
522489|NCT00936351|psychotic disorders|psychotic disorders
522490|NCT00936338|anterior disc displacement without reduction of temporomandibular disorders|anterior disc displacement without reduction of temporomandibular disorders
522491|NCT00936325|SCLS|scls
522492|NCT00936325|Systemic Capillary Leak Syndrome|systemic capillary leak syndrome
522493|NCT00936299|Adolescents|adolescents
522494|NCT00936299|Substance Use Disorder|substance use disorder
522495|NCT00936299|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
522496|NCT00936299|Cognitive Behavioral Therapy|cognitive behavioral therapy
522497|NCT00936286|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
522498|NCT00936286|Respiratory Muscle Training|respiratory muscle training
522499|NCT00936286|Normocapnic Hyperpnea|normocapnic hyperpnea
522500|NCT00936286|SpiroTiger|spirotiger
522501|NCT00936286|Polysomnography|polysomnography
522502|NCT00936273|Sleep apnea syndrome|sleep apnea syndrome
522503|NCT00936273|SAS|sas
522504|NCT00936273|double loop gain|double loop gain
522505|NCT00936273|DLI|dli
522506|NCT00936273|double loop index|double loop index
522507|NCT00936273|periodic breathing|periodic breathing
522508|NCT00936273|polysomnography|polysomnography
522509|NCT00936260|osteoporosis|osteoporosis
522510|NCT00936260|postmenopausal|postmenopausal
522511|NCT00936260|alendronate|alendronate
522512|NCT00936234|CAD|cad
522513|NCT00936234|diabetes|diabetes
522514|NCT00936234|SDF-1|sdf-1
522515|NCT00936234|endothelial function|endothelial function
522516|NCT00936221|BRAF mutation positive|braf mutation positive
522517|NCT00936221|advanced melanoma|advanced melanoma
522518|NCT00936221|Advanced cutaneous melanoma|advanced cutaneous melanoma
522519|NCT00936221|Unknown primary melanoma|unknown primary melanoma
522520|NCT00936195|HIV|hiv
522521|NCT00936195|pregnancy|pregnancy
522522|NCT00936195|breastfeeding|breastfeeding
522523|NCT00936195|PMTCT|pmtct
522524|NCT00936195|ARV treatment|arv treatment
522525|NCT00936195|treatment naive|treatment naive
522526|NCT00936169|Patients with at least one complex lesion suitable for implantation of a drug-eluting stent|patients with at least one complex lesion suitable for implantation of a drug-eluting stent
522527|NCT00936143|Spondylitis, Ankylosing|spondylitis, ankylosing
522528|NCT00936143|infliximab|infliximab
522529|NCT00936143|Antibodies, Monoclonal|antibodies, monoclonal
522530|NCT00936130|Roux-en-Y gastric bypass surgery|roux-en-y gastric bypass surgery
522531|NCT00936130|Sleeve gastrectomy (SGx) surgery|sleeve gastrectomy (sgx) surgery
522532|NCT00936130|Gastric banding (GBx) surgery|gastric banding (gbx) surgery
522533|NCT00936130|Low calorie diet program|low calorie diet program
522534|NCT00936117|Cancer of the Blood|cancer of the blood
522535|NCT00936117|Cancer of Bone Marrow|cancer of bone marrow
522536|NCT00936117|Acute Leukemia|acute leukemia
522537|NCT00936117|AML|aml
522538|NCT00936117|Fungal infection|fungal infection
522540|NCT00936117|Posaconazole|posaconazole
522541|NCT00936117|SCH 56592|sch 56592
522542|NCT00936117|Noxafil|noxafil
522543|NCT00936117|Chemotherapy|chemotherapy
522544|NCT00936104|pancreas|pancreas
522545|NCT00936104|cancer|cancer
522546|NCT00936104|stem cell|stem cell
522547|NCT00936091|intestinal parasitic infections|intestinal parasitic infections
522548|NCT00936091|malnutrition|malnutrition
522549|NCT00936091|Anemia|anemia
522550|NCT00936078|kidney transplantation|kidney transplantation
522551|NCT00936078|cohort study|cohort study
522552|NCT00936078|qualitative research|qualitative research
522553|NCT00936078|health services research|health services research
522554|NCT00936078|hypertension|hypertension
522555|NCT00936065|Etanercept|etanercept
522556|NCT00936065|Acitretin|acitretin
522557|NCT00936065|Psoriasis|psoriasis
522558|NCT00936052|glioblastomas|glioblastomas
522559|NCT00936052|GBM|gbm
522560|NCT00936052|gliosarcoma|gliosarcoma
522561|NCT00936052|blastoma|blastoma
522562|NCT00936052|sarcoma|sarcoma
522563|NCT00936013|novel influenza A(H1N1)|novel influenza a(h1n1)
522564|NCT00936013|chinese medicinal herbs|chinese medicinal herbs
522565|NCT00936000|alcohol abuse|alcohol abuse
522566|NCT00936000|alveolar capillary permeability|alveolar capillary permeability
522567|NCT00935987|Primary Myelofibrosis|primary myelofibrosis
522568|NCT00935987|Post-Polycythemia Vera|post-polycythemia vera
522569|NCT00935987|Post-Essential Thrombocythemia|post-essential thrombocythemia
522570|NCT00935987|CYT387|cyt387
522571|NCT00935961|CISPLATIN|cisplatin
522572|NCT00935961|RAD001|rad001
522573|NCT00935961|TAXOTERE (DOCETAXEL)|taxotere (docetaxel)
522574|NCT00935961|09-028|09-028
522575|NCT00935961|Squamous Cell Carcinoma|squamous cell carcinoma
522576|NCT00935961|Local-Regional Advanced Head and Neck|local-regional advanced head and neck
522577|NCT00935948|hemorrhoids|hemorrhoids
522578|NCT00935948|hemorrhoidal disease|hemorrhoidal disease
522579|NCT00935948|water smartweed|water smartweed
522580|NCT00935948|hamamelis|hamamelis
522581|NCT00935948|RCT|rct
522582|NCT00935935|Treatment experienced|treatment experienced
522583|NCT00935922|Flaxseed|flaxseed
522584|NCT00935922|Weight loss|weight loss
522585|NCT00935922|Heart health|heart health
522586|NCT00935922|Diabetes|diabetes
522587|NCT00935909|IV cannulation|iv cannulation
522588|NCT00935896|Ventilator-associated lung injury|ventilator-associated lung injury
522589|NCT00935896|Tumor necrosis factor-alpha|tumor necrosis factor-alpha
522590|NCT00935896|Interleukin-8|interleukin-8
522591|NCT00935896|Mechanical ventilation|mechanical ventilation
522592|NCT00935896|Low tidal volume ventilation|low tidal volume ventilation
522593|NCT00935896|Normal lungs|normal lungs
522594|NCT00935883|Age Related macular Degeneration|age related macular degeneration
522595|NCT00935883|Macular Degeneration|macular degeneration
522596|NCT00935883|Drusen|drusen
522597|NCT00935883|Geographic atrophy|geographic atrophy
522598|NCT00935883|Eculizumab|eculizumab
522599|NCT00935883|Soliris|soliris
522600|NCT00935857|Balloon Enteroscopy|balloon enteroscopy
522601|NCT00935857|Looping|looping
522602|NCT00935844|Advanced solid tumors|advanced solid tumors
522603|NCT00935844|Lymphoma|lymphoma
522604|NCT00935831|Tolerability|tolerability
522605|NCT00935831|Safety|safety
522606|NCT00935831|Pharmacokinetics|pharmacokinetics
522607|NCT00935831|Pharmacodynamics|pharmacodynamics
522608|NCT00935818|smoking|smoking
522609|NCT00935818|nicotine|nicotine
522610|NCT00935818|tobacco|tobacco
522611|NCT00935818|dependence|dependence
522612|NCT00935818|cessation|cessation
522613|NCT00935818|abstinence|abstinence
522614|NCT00935805|Diabetes Mellitus|diabetes mellitus
522615|NCT00935805|Arterial Hypertension|arterial hypertension
522616|NCT00935805|Treatment|treatment
522617|NCT00935805|Primary Care|primary care
522618|NCT00935792|hematopoietic cancer|hematopoietic cancer
522619|NCT00935792|lymphoid cancer|lymphoid cancer
522620|NCT00935779|Stomach Neoplasms|stomach neoplasms
522621|NCT00935779|Peritoneum|peritoneum
522622|NCT00935766|Latinos Using Cardio Health Actions to Reduce Risk|latinos using cardio health actions to reduce risk
522623|NCT00935766|Omega three Fatty Acids|omega three fatty acids
522624|NCT00935766|Vascular Function and Inflammation|vascular function and inflammation
522625|NCT00935753|Lesch-Nyhan Disease|lesch-nyhan disease
522626|NCT00935753|self-mutilating behavior|self-mutilating behavior
522627|NCT00935740|thromboembolic disease|thromboembolic disease
522628|NCT00935740|thromboplastin|thromboplastin
522629|NCT00935740|hypercoagulability|hypercoagulability
522630|NCT00935740|congestive heart failure|congestive heart failure
522631|NCT00935727|renal transplant|renal transplant
522632|NCT00935727|ultrasound|ultrasound
522633|NCT00935727|elastography|elastography
522634|NCT00935714|Arm|arm
522635|NCT00935714|Lymphedema|lymphedema
522636|NCT00935714|Breast Cancer|breast cancer
522637|NCT00935714|Exercise|exercise
522638|NCT00935714|Breast Cancer related Lymphedema|breast cancer related lymphedema
522639|NCT00935701|Autism Spectrum Disorder|autism spectrum disorder
522640|NCT00935701|Acupressure|acupressure
522641|NCT00935701|Acupuncture|acupuncture
522643|NCT00935688|rapid diagnostic tests|rapid diagnostic tests
522644|NCT00935688|afghanistan|afghanistan
522645|NCT00935688|Non-specific fever|non-specific fever
522646|NCT00935675|Patients with head and neck squamous cell carcinomas|patients with head and neck squamous cell carcinomas
522647|NCT00935675|head and neck squamous cell carcinomas|head and neck squamous cell carcinomas
522648|NCT00935662|First time in man|first time in man
522649|NCT00935662|Safety study|safety study
522650|NCT00935662|AZD8329|azd8329
522651|NCT00935649|Toenail Fungus|toenail fungus
522652|NCT00935649|PinPointe|pinpointe
522653|NCT00935649|FootLaser|footlaser
522654|NCT00935649|Onychomycosis|onychomycosis
522655|NCT00935649|Fungal nails|fungal nails
522656|NCT00935636|Intubation|intubation
522657|NCT00935623|Malaria, Plasmodium vivax|malaria, plasmodium vivax
522658|NCT00935610|Elderly persons|elderly persons
522659|NCT00935610|Muscle function and strength|muscle function and strength
522660|NCT00935610|Body composition|body composition
522661|NCT00935610|Inflammatory cytokine levels|inflammatory cytokine levels
522662|NCT00935610|Cognitive functions|cognitive functions
522663|NCT00935610|Cysteine-rich whey protein isolate|cysteine-rich whey protein isolate
522664|NCT00935610|Immunocal|immunocal
522665|NCT00935610|Resistance training|resistance training
522666|NCT00935610|Improved muscle function|improved muscle function
522667|NCT00935610|Improved quality of life|improved quality of life
522668|NCT00935610|Aging processes|aging processes
522669|NCT00935610|Quality of life|quality of life
522670|NCT00935597|Relapsed Non-Hodgkin's Lymphoma|relapsed non-hodgkin's lymphoma
522671|NCT00935597|Hodgkin's Disease|hodgkin's disease
522672|NCT00935597|Multiple Myeloma|multiple myeloma
522673|NCT00935597|Chronic Lymphocytic Lymphoma|chronic lymphocytic lymphoma
522674|NCT00935597|Relapsed Non-Hodgkin's lymphoma (excluding follicular lymphoma and marginal zone lymphoma)|relapsed non-hodgkin's lymphoma (excluding follicular lymphoma and marginal zone lymphoma)
522675|NCT00935584|Communication|communication
522676|NCT00935584|Doctor-patient relations|doctor-patient relations
522677|NCT00935584|medical informatics|medical informatics
522678|NCT00935584|patient-centered care|patient-centered care
522679|NCT00935584|medical records systems, computerized|medical records systems, computerized
522680|NCT00935558|dendritic cell|dendritic cell
522681|NCT00935558|cancer vaccine|cancer vaccine
522682|NCT00935558|breast cancer|breast cancer
522683|NCT00935558|aromatase inhibitor|aromatase inhibitor
522684|NCT00935558|Zadaxin|zadaxin
522685|NCT00935545|Brain Tumors|brain tumors
522686|NCT00935545|High Grade|high grade
522687|NCT00935545|CNS|cns
522688|NCT00935532|diabetes; exenatide once weekly; Byetta; glargine; Lantus; Amylin; Lilly|diabetes; exenatide once weekly; byetta; glargine; lantus; amylin; lilly
522689|NCT00935519|total hip arthroplasty, ceramic, survival|total hip arthroplasty, ceramic, survival
522690|NCT00935493|guanfacine|guanfacine
522691|NCT00935493|aging|aging
522692|NCT00935493|cognitive aging|cognitive aging
522693|NCT00935493|prefrontal cognitive function|prefrontal cognitive function
522694|NCT00935493|executive function|executive function
522695|NCT00935493|prefrontal cortex|prefrontal cortex
522696|NCT00935480|HIV|hiv
522697|NCT00935480|INTEGRASE INHIBITOR|integrase inhibitor
522698|NCT00935480|Inhibitor on the lymphoid reservoir|inhibitor on the lymphoid reservoir
522699|NCT00935480|Residual HIV replication|residual hiv replication
522700|NCT00935480|treatment experienced|treatment experienced
522701|NCT00935454|hepatocyte matrix implantation|hepatocyte matrix implantation
522702|NCT00935454|endstage liver disease|endstage liver disease
522703|NCT00935454|liver cirrhosis|liver cirrhosis
522704|NCT00935454|impaired liver parenchyma|impaired liver parenchyma
522705|NCT00935454|improvement of liver function|improvement of liver function
522706|NCT00935441|Diabetes mellitus|diabetes mellitus
522707|NCT00935441|chronic care|chronic care
522708|NCT00935441|case management|case management
522709|NCT00935441|telemedicine|telemedicine
522710|NCT00935428|Equestrian injury|equestrian injury
522711|NCT00935428|Horse injury|horse injury
522712|NCT00935428|Trauma|trauma
522713|NCT00935428|Horse|horse
522714|NCT00935428|Equestrian|equestrian
522715|NCT00935415|asthma|asthma
522716|NCT00935415|exercise-induced bronchoconstriction|exercise-induced bronchoconstriction
522717|NCT00935415|montelukast|montelukast
522718|NCT00935415|clinical protection|clinical protection
522719|NCT00935415|children|children
522720|NCT00935415|time effect|time effect
522721|NCT00935402|Energy balance|energy balance
522722|NCT00935402|Weight management|weight management
522723|NCT00935402|Food intake|food intake
522724|NCT00935402|Energy expenditure|energy expenditure
522725|NCT00935376|Sleep Management|sleep management
522726|NCT00935376|Awareness Training Programs|awareness training programs
522727|NCT00935376|Mindfulness Meditation|mindfulness meditation
522728|NCT00935376|Mind Body Bridging|mind body bridging
522729|NCT00935363|glyburide|glyburide
522730|NCT00935363|pharmacokinetics|pharmacokinetics
522731|NCT00935363|pharmacodynamics|pharmacodynamics
522732|NCT00935363|drug interaction|drug interaction
522733|NCT00935363|Healthy Volunteers|healthy volunteers
522734|NCT00935350|viscous|viscous
522735|NCT00935350|fibre|fibre
522736|NCT00935350|polysaccharide|polysaccharide
522737|NCT00935350|blood glucose|blood glucose
522738|NCT00935350|postprandial|postprandial
522739|NCT00935337|Sleep problems|sleep problems
522740|NCT00935337|Awareness training program|awareness training program
522741|NCT00935337|Mind body bridging|mind body bridging
522742|NCT00935324|allo-SCT, GvHD, CK18-F|allo-sct, gvhd, ck18-f
522743|NCT00935298|Renal Transplantation|renal transplantation
522744|NCT00935298|Tacrolimus|tacrolimus
522745|NCT00935298|CYP3A5|cyp3a5
522746|NCT00935298|Genotyping|genotyping
522747|NCT00935285|Ventilator-associated pneumonia (VAP)|ventilator-associated pneumonia (vap)
522748|NCT00935285|Intensive care unit (ICU)|intensive care unit (icu)
522749|NCT00935285|Toll-like receptors|toll-like receptors
522750|NCT00935259|Hypercholesterolemia, Dyslipidemia, simvastatin, Zocor|hypercholesterolemia, dyslipidemia, simvastatin, zocor
522751|NCT00935246|Genomic devices|genomic devices
522752|NCT00935246|Prediction of Escitalopram Response|prediction of escitalopram response
522753|NCT00935246|Depressed Patients|depressed patients
522754|NCT00935233|ductal breast carcinoma in situ|ductal breast carcinoma in situ
522755|NCT00935207|Pain|pain
522756|NCT00935207|Pediatric Pain|pediatric pain
522757|NCT00935207|Pain Diary|pain diary
522758|NCT00935207|Pediatric Pain Measurement|pediatric pain measurement
522759|NCT00935207|Pain Measurement|pain measurement
522760|NCT00935194|Novel Influenza A(H1N1)|novel influenza a(h1n1)
522761|NCT00935194|Oseltamivir|oseltamivir
522762|NCT00935194|Chinese Medicinal Herbs|chinese medicinal herbs
522763|NCT00935181|COPD|copd
522764|NCT00935181|diaphragm|diaphragm
522765|NCT00935181|muscle|muscle
522766|NCT00935181|stretching|stretching
522767|NCT00935181|exercises|exercises
522768|NCT00935181|dyspnea|dyspnea
522769|NCT00935181|respiratory muscle stretching|respiratory muscle stretching
522770|NCT00935181|pulmonary rehabilitation|pulmonary rehabilitation
522771|NCT00935181|exercise training|exercise training
522772|NCT00935181|improved exercise capacity, dyspnea, quality of life|improved exercise capacity, dyspnea, quality of life
522773|NCT00935168|Intensive Care|intensive care
522774|NCT00935168|Fluid Resuscitation|fluid resuscitation
522775|NCT00935168|Saline|saline
522776|NCT00935168|Hydroxy-ethyl starch|hydroxy-ethyl starch
522777|NCT00935155|exercise therapy|exercise therapy
522778|NCT00935155|Knee arthroplasty|knee arthroplasty
522779|NCT00935155|Acupuncture Analgesia|acupuncture analgesia
522780|NCT00935155|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
522781|NCT00935155|rehabilitation|rehabilitation
522782|NCT00935142|stage IV cancer with no treatment options|stage iv cancer with no treatment options
522783|NCT00935142|non-curative|non-curative
522784|NCT00935129|Treatment satisfaction|treatment satisfaction
522785|NCT00935129|OmniPod|omnipod
522786|NCT00935129|Insulin pump|insulin pump
522787|NCT00935129|diabetes|diabetes
522788|NCT00935103|Addiction|addiction
522789|NCT00935103|Psychoeducation|psychoeducation
522790|NCT00935103|Risk reduction behaviour|risk reduction behaviour
522791|NCT00935103|Drop in center (DIC)|drop in center (dic)
522792|NCT00935090|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
522793|NCT00935090|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
522794|NCT00935090|acute undifferentiated leukemia|acute undifferentiated leukemia
522795|NCT00935090|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
522796|NCT00935090|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
522797|NCT00935090|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
522798|NCT00935090|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
522799|NCT00935090|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
522800|NCT00935090|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
522801|NCT00935090|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
522802|NCT00935090|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
522803|NCT00935090|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
522804|NCT00935090|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
522805|NCT00935090|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
522806|NCT00935090|mast cell leukemia|mast cell leukemia
522807|NCT00935090|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
522808|NCT00935090|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
522809|NCT00935090|prolymphocytic leukemia|prolymphocytic leukemia
522810|NCT00935090|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
522811|NCT00935090|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
522812|NCT00935090|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
522813|NCT00935090|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
522814|NCT00935090|refractory hairy cell leukemia|refractory hairy cell leukemia
522815|NCT00935090|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
522816|NCT00935090|secondary acute myeloid leukemia|secondary acute myeloid leukemia
522817|NCT00935090|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
523232|NCT00933595|HIV|hiv
522818|NCT00935090|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
522819|NCT00935090|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
522820|NCT00935090|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
522821|NCT00935090|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
522822|NCT00935090|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
522823|NCT00935090|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
522824|NCT00935090|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
522825|NCT00935090|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
522826|NCT00935090|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
522827|NCT00935090|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
522828|NCT00935090|untreated hairy cell leukemia|untreated hairy cell leukemia
522829|NCT00935090|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
522830|NCT00935090|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
522831|NCT00935090|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
522832|NCT00935090|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
522833|NCT00935090|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
522834|NCT00935090|anaplastic large cell lymphoma|anaplastic large cell lymphoma
522835|NCT00935090|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
522836|NCT00935090|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
522837|NCT00935090|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
522838|NCT00935090|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
522839|NCT00935090|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
522840|NCT00935090|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
522841|NCT00935090|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
522842|NCT00935090|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
522843|NCT00935090|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
522844|NCT00935090|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
522845|NCT00935090|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
522846|NCT00935090|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
522847|NCT00935090|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
522848|NCT00935090|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
522849|NCT00935090|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
522850|NCT00935090|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
522851|NCT00935090|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
522852|NCT00935090|splenic marginal zone lymphoma|splenic marginal zone lymphoma
522853|NCT00935090|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
522854|NCT00935090|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
522855|NCT00935090|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
522856|NCT00935090|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
522857|NCT00935090|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
522858|NCT00935090|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
522859|NCT00935090|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
522860|NCT00935090|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
522861|NCT00935090|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
522862|NCT00935090|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
522863|NCT00935090|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
522864|NCT00935090|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
522865|NCT00935090|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
522866|NCT00935090|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
522867|NCT00935090|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
522868|NCT00935090|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
522869|NCT00935090|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
522870|NCT00935090|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
522871|NCT00935090|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
522872|NCT00935090|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
522873|NCT00935090|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
522874|NCT00935090|stage I mantle cell lymphoma|stage i mantle cell lymphoma
522875|NCT00935090|stage I marginal zone lymphoma|stage i marginal zone lymphoma
522876|NCT00935090|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
522877|NCT00935090|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
522878|NCT00935090|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
522879|NCT00935090|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
522880|NCT00935090|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
522881|NCT00935090|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
522882|NCT00935090|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
522883|NCT00935090|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
522884|NCT00935090|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
522885|NCT00935090|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
522886|NCT00935090|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
522887|NCT00935090|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
522888|NCT00935090|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
522889|NCT00935090|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
522890|NCT00935090|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
522891|NCT00935090|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
522892|NCT00935090|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
522893|NCT00935090|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
522894|NCT00935090|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
522895|NCT00935090|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
522896|NCT00935090|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
522897|NCT00935090|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
522898|NCT00935090|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
522899|NCT00935090|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
522900|NCT00935090|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
522901|NCT00935090|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
522902|NCT00935090|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
522903|NCT00935090|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
522904|NCT00935090|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
522905|NCT00935090|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
522906|NCT00935090|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
522907|NCT00935090|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
522908|NCT00935090|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
522909|NCT00935090|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
522910|NCT00935090|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
522911|NCT00935090|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
522912|NCT00935090|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
522913|NCT00935090|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
522914|NCT00935090|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
522915|NCT00935090|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
522916|NCT00935090|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
522917|NCT00935090|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
522918|NCT00935090|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
522919|NCT00935090|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
522920|NCT00935090|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
522921|NCT00935090|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
522922|NCT00935090|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
522923|NCT00935090|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
522924|NCT00935090|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
522925|NCT00935090|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
522926|NCT00935090|intraocular lymphoma|intraocular lymphoma
522927|NCT00935090|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
522928|NCT00935090|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
522929|NCT00935090|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
522930|NCT00935090|chronic eosinophilic leukemia|chronic eosinophilic leukemia
522931|NCT00935090|chronic neutrophilic leukemia|chronic neutrophilic leukemia
522932|NCT00935090|primary myelofibrosis|primary myelofibrosis
522933|NCT00935090|essential thrombocythemia|essential thrombocythemia
522934|NCT00935090|polycythemia vera|polycythemia vera
522935|NCT00935090|extramedullary plasmacytoma|extramedullary plasmacytoma
522936|NCT00935090|isolated plasmacytoma of bone|isolated plasmacytoma of bone
522937|NCT00935090|stage I multiple myeloma|stage i multiple myeloma
522938|NCT00935090|stage II multiple myeloma|stage ii multiple myeloma
522939|NCT00935090|stage III multiple myeloma|stage iii multiple myeloma
522940|NCT00935090|primary systemic amyloidosis|primary systemic amyloidosis
522941|NCT00935090|refractory multiple myeloma|refractory multiple myeloma
522942|NCT00935090|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
522943|NCT00935090|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
522944|NCT00935090|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
522945|NCT00935090|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
522946|NCT00935077|Hypertension|hypertension
522947|NCT00935077|Pharmacist Physician Collaborative Management of Hypertension|pharmacist physician collaborative management of hypertension
522948|NCT00935064|Diabetes|diabetes
522949|NCT00935051|type 1 diabetes|type 1 diabetes
522950|NCT00935051|type 2 diabetes|type 2 diabetes
522951|NCT00935051|Diabetic foot ulcer|diabetic foot ulcer
522952|NCT00935025|Phase I|phase i
522953|NCT00935025|Japanese healthy volunteer|japanese healthy volunteer
522954|NCT00935025|AZD1305|azd1305
522955|NCT00935025|Japanese and Caucasian|japanese and caucasian
522956|NCT00934986|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
522957|NCT00934986|NK Cells|nk cells
522958|NCT00934973|irritable bowel syndrome|irritable bowel syndrome
522959|NCT00934973|treatment|treatment
522960|NCT00934960|vision|vision
522961|NCT00934960|Intraocular lenses|intraocular lenses
522962|NCT00934947|Burns|burns
522963|NCT00934947|Pain|pain
522964|NCT00934934|Candida|candida
522965|NCT00934934|ventilator associated pneumonia|ventilator associated pneumonia
522966|NCT00934934|respiratory tract infection|respiratory tract infection
522967|NCT00934934|antifungal|antifungal
522968|NCT00934934|biomarker|biomarker
522969|NCT00934921|Bioequivalence|bioequivalence
522970|NCT00934908|Zyprexa®|zyprexa®
522971|NCT00934908|Green Tea|green tea
522972|NCT00934908|ALL|all
522973|NCT00934895|stage IIIA breast cancer|stage iiia breast cancer
522974|NCT00934895|stage IIIB breast cancer|stage iiib breast cancer
522975|NCT00934895|stage IIIC breast cancer|stage iiic breast cancer
522976|NCT00934895|stage IV breast cancer|stage iv breast cancer
522977|NCT00934895|HER2-negative breast cancer|her2-negative breast cancer
522978|NCT00934895|recurrent breast cancer|recurrent breast cancer
522979|NCT00934882|Colorectal cancer|colorectal cancer
522980|NCT00934882|Targeted therapy|targeted therapy
522981|NCT00934882|Multi-kinase inhibitor|multi-kinase inhibitor
522982|NCT00934882|FOLFOX|folfox
522983|NCT00934882|FOLFIRI|folfiri
522984|NCT00934843|Cardiopulmonary Bypass (CPB)|cardiopulmonary bypass (cpb)
522985|NCT00934843|System Inflammatory Response|system inflammatory response
522986|NCT00934843|Low Cardiac Output Syndrome (LCOS) in Neonates|low cardiac output syndrome (lcos) in neonates
522987|NCT00934843|Methylprednisolone|methylprednisolone
522988|NCT00934843|Cardiopulmonary Bypass (CPB) in Neonates|cardiopulmonary bypass (cpb) in neonates
522989|NCT00934843|Glucocorticoid Use in Neonatal Cardiac Surgery|glucocorticoid use in neonatal cardiac surgery
522990|NCT00934843|Steroid|steroid
522991|NCT00934830|Antibiotic|antibiotic
522992|NCT00934830|Ultrasound|ultrasound
522993|NCT00934830|Efficacy|efficacy
522994|NCT00934830|Treatment|treatment
522995|NCT00934817|Volunteer|volunteer
522996|NCT00934804|refractive surgery|refractive surgery
522997|NCT00934791|Kidney Transplant|kidney transplant
522998|NCT00934791|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
522999|NCT00934791|Polycystic liver disease|polycystic liver disease
523000|NCT00934778|Confocal microscopy|confocal microscopy
523001|NCT00934778|Endocytoscopy|endocytoscopy
523002|NCT00934778|Diffuse lung disease|diffuse lung disease
523003|NCT00934778|Minimally invasive|minimally invasive
523004|NCT00934778|Lung cancer and dysplasia|lung cancer and dysplasia
523005|NCT00934765|overweight, obesity, male, fertility|overweight, obesity, male, fertility
523006|NCT00934752|de novo stenotic lesions|de novo stenotic lesions
523007|NCT00934739|High-Risk Oral Cavity Cancer,|high-risk oral cavity cancer,
523008|NCT00934739|Anti-Angiogenesis|anti-angiogenesis
523009|NCT00934726|Quality of Life|quality of life
523010|NCT00934726|Patient satisfaction|patient satisfaction
523011|NCT00934726|Schizophrenia|schizophrenia
523012|NCT00934726|Investigate quality of life in schizophrenia|investigate quality of life in schizophrenia
523013|NCT00934713|montelukast, very young children, lung function tests|montelukast, very young children, lung function tests
523014|NCT00934700|perinatal asphyxia|perinatal asphyxia
523015|NCT00934700|encephalopathy|encephalopathy
523016|NCT00934700|neuroprotection|neuroprotection
523017|NCT00934687|depression|depression
523018|NCT00934687|depressive|depressive
523019|NCT00934687|botulinum|botulinum
523020|NCT00934687|botox|botox
523021|NCT00934674|Healthy Subjects|healthy subjects
523022|NCT00934661|hip resurfacing|hip resurfacing
523023|NCT00934661|hip arthroplasty|hip arthroplasty
523024|NCT00934635|D2-receptor occupancy|d2-receptor occupancy
523025|NCT00934635|Antipsychotic drugs|antipsychotic drugs
523026|NCT00934635|Paliperidone ER, Oral risperidone|paliperidone er, oral risperidone
523027|NCT00934635|Dopamine|dopamine
523028|NCT00934635|Fallypride|fallypride
523029|NCT00934635|Plasma concentration|plasma concentration
523030|NCT00934635|Therapeutic window, Healthy controls|therapeutic window, healthy controls
523031|NCT00934622|AcrySof|acrysof
523032|NCT00934622|ReSTOR|restor
523033|NCT00934622|Aspheric IOL|aspheric iol
523034|NCT00934622|Cataract|cataract
523035|NCT00934609|Exercise|exercise
523036|NCT00934609|heart failure|heart failure
523037|NCT00934609|dilated cardiomyopathy|dilated cardiomyopathy
523038|NCT00934609|Endurance training|endurance training
523039|NCT00934596|Cardiac de-airing|cardiac de-airing
523040|NCT00934596|CO2 insufflation|co2 insufflation
523041|NCT00934596|Air emboli|air emboli
523042|NCT00934596|Trans cranial doppler|trans cranial doppler
523043|NCT00934596|Intraoperative echocardiography|intraoperative echocardiography
523044|NCT00934583|Bulimia Nervosa|bulimia nervosa
523045|NCT00934583|Binge Eating|binge eating
523046|NCT00934583|Binge-Eating Disorder|binge-eating disorder
523047|NCT00934570|Obesity|obesity
523048|NCT00934570|Metformin|metformin
523049|NCT00934570|Physical activity|physical activity
523050|NCT00934570|Cardiovascular health|cardiovascular health
523051|NCT00934544|Myelofibrosis|myelofibrosis
523052|NCT00934544|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
523053|NCT00934544|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
523054|NCT00934531|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
523055|NCT00934531|Falls|falls
523056|NCT00934531|donepezil|donepezil
523057|NCT00934531|gait variability|gait variability
523058|NCT00934518|Squamous cell carcinoma, Head and Neck cancer|squamous cell carcinoma, head and neck cancer
523059|NCT00934505|Positron-Emission Tomography|positron-emission tomography
523060|NCT00934505|PET Scan|pet scan
523061|NCT00934505|FDG|fdg
523062|NCT00934505|oesophageal cancer|oesophageal cancer
523063|NCT00934505|chemo-Radiation Oncology|chemo-radiation oncology
523064|NCT00934505|SUV|suv
523065|NCT00934492|Malnutrition|malnutrition
523066|NCT00934492|Wasting|wasting
523067|NCT00934492|Kwashiorkor|kwashiorkor
523068|NCT00934492|Immune deficiency|immune deficiency
523069|NCT00934492|Infection|infection
523070|NCT00934492|Prophylaxis|prophylaxis
523071|NCT00934492|Mortality|mortality
523072|NCT00934492|Kenya|kenya
523073|NCT00934479|Chronic Constipation|chronic constipation
523074|NCT00934479|Constipation Predominant Irritable Bowel Syndrome|constipation predominant irritable bowel syndrome
523075|NCT00934479|Intestinal Microecology|intestinal microecology
523076|NCT00934453|Healthy adult volunteers|healthy adult volunteers
523077|NCT00934453|Lactobacillus rhamnosus GG|lactobacillus rhamnosus gg
523078|NCT00934453|probiotic|probiotic
523079|NCT00934453|dietary supplement|dietary supplement
523080|NCT00934453|safety|safety
523081|NCT00934453|Safety Assessment|safety assessment
523082|NCT00934440|kidney cancer|kidney cancer
523083|NCT00934440|renal cell|renal cell
523084|NCT00934427|Raynaud's|raynaud's
523085|NCT00934427|scleroderma|scleroderma
523086|NCT00934427|nitroglycerin|nitroglycerin
523087|NCT00934427|MQX-503|mqx-503
523088|NCT00934427|treatment|treatment
523089|NCT00934401|FLT|flt
523090|NCT00934401|fluorolabeled thymidine|fluorolabeled thymidine
523091|NCT00934401|breast cancer|breast cancer
523092|NCT00934401|Positron-Emission Mammography|positron-emission mammography
523093|NCT00934388|Sportsmans groin, Gilmores groin|sportsmans groin, gilmores groin
523094|NCT00934375|Mild Cognitive Impairment|mild cognitive impairment
523095|NCT00934349|Comoro Island|comoro island
523096|NCT00934349|vit B1 intake|vit b1 intake
523097|NCT00934349|Thiamine status|thiamine status
523098|NCT00934349|Genetic factor|genetic factor
523099|NCT00934323|volunteer|volunteer
523100|NCT00934310|Patient Safety|patient safety
523101|NCT00934310|Team work|team work
523102|NCT00934310|Communication|communication
523103|NCT00934310|Ambulatory surgical patients|ambulatory surgical patients
523104|NCT00934297|MRI visible breast lesions that are occult under ultrasound|mri visible breast lesions that are occult under ultrasound
523105|NCT00934284|sciatic neuropathy|sciatic neuropathy
523106|NCT00934284|physical therapy|physical therapy
523107|NCT00934284|spinal injections|spinal injections
523108|NCT00934271|acromegaly|acromegaly
523109|NCT00934271|irradiation|irradiation
523110|NCT00934271|remission|remission
523111|NCT00934271|pituitary function|pituitary function
523112|NCT00934258|genes|genes
523113|NCT00934258|rosuvastatin|rosuvastatin
523114|NCT00934258|fenofibrate|fenofibrate
523115|NCT00934258|Cardiovascular (CV) diseases|cardiovascular (cv) diseases
523116|NCT00934258|dyslipidemia|dyslipidemia
523117|NCT00934258|metabolic syndrome|metabolic syndrome
523118|NCT00934258|identify genetic determinants of the wide range of interindividual variability in phenotypic and clinical response to the lipid-lowering drug classes|identify genetic determinants of the wide range of interindividual variability in phenotypic and clinical response to the lipid-lowering drug classes
523119|NCT00934258|identify genetic susceptibility to drug-related side effects.|identify genetic susceptibility to drug-related side effects.
523120|NCT00934245|Influenza|influenza
523121|NCT00934245|India|india
523122|NCT00934245|Children|children
523123|NCT00934245|Trivalent Influenza Vaccine (TIV)|trivalent influenza vaccine (tiv)
523124|NCT00934245|Inactivated poliovirus vaccine (IPV)|inactivated poliovirus vaccine (ipv)
523125|NCT00934245|Direct vaccine effectiveness|direct vaccine effectiveness
523126|NCT00934245|Indirect vaccine effectiveness|indirect vaccine effectiveness
523127|NCT00934232|cancer|cancer
523128|NCT00934232|myeloma|myeloma
523129|NCT00934219|hypertriglyceridemia|hypertriglyceridemia
523130|NCT00934219|triglycerides|triglycerides
523131|NCT00934219|familial hypertriglyceridemia|familial hypertriglyceridemia
523133|NCT00934206|healthy subjects|healthy subjects
523134|NCT00934180|Bioequivalence|bioequivalence
523135|NCT00934154|multiple myeloma|multiple myeloma
523136|NCT00934154|thalidomide|thalidomide
523137|NCT00934154|melphalan|melphalan
523138|NCT00934154|prednisolone|prednisolone
523139|NCT00934154|newly diagnosed|newly diagnosed
523140|NCT00934154|elderly|elderly
523141|NCT00934154|not eligible for transplantation|not eligible for transplantation
523142|NCT00934141|Organizational change|organizational change
523143|NCT00934141|process improvement|process improvement
523144|NCT00934141|addiction treatment|addiction treatment
523145|NCT00934141|cost effectiveness study|cost effectiveness study
523146|NCT00934128|Advanced Cancer|advanced cancer
523147|NCT00934128|Persistent Dyspnea|persistent dyspnea
523148|NCT00934128|Shortness of breath|shortness of breath
523149|NCT00934128|Specialized breathing devices|specialized breathing devices
523150|NCT00934128|Bilevel positive airway pressure device|bilevel positive airway pressure device
523151|NCT00934128|BIPAP|bipap
523152|NCT00934128|High flow oxygen delivery device|high flow oxygen delivery device
523153|NCT00934128|VapoTherm|vapotherm
523154|NCT00934128|Edmonton Symptom Assessment Scale|edmonton symptom assessment scale
523155|NCT00934128|ESAS|esas
523156|NCT00934115|To define the incidence, categories of infections by organ systems, etiologic agents and risk|to define the incidence, categories of infections by organ systems, etiologic agents and risk
523157|NCT00934037|Coronary Artery Disease|coronary artery disease
523158|NCT00934037|Computed Tomography|computed tomography
523159|NCT00934037|Myoperfusion|myoperfusion
523160|NCT00934037|Angiography|angiography
523161|NCT00934037|SPECT|spect
523162|NCT00934024|nicotine dependence|nicotine dependence
523163|NCT00934024|tobacco|tobacco
523164|NCT00934024|smoking|smoking
523165|NCT00934011|C-reactive protein|c-reactive protein
523166|NCT00934011|procalcitonin|procalcitonin
523167|NCT00934011|sepsis|sepsis
523168|NCT00934011|antibiotic therapy|antibiotic therapy
523169|NCT00933998|DPN|dpn
523170|NCT00933959|Sleep problems|sleep problems
523171|NCT00933959|Awareness training program|awareness training program
523172|NCT00933959|Mind body bridging|mind body bridging
523173|NCT00933920|Aliskiren,|aliskiren,
523174|NCT00933920|hypertension,|hypertension,
523175|NCT00933920|renin-angiotensin-aldosterone system,|renin-angiotensin-aldosterone system,
523176|NCT00933920|pharmacokinetics,|pharmacokinetics,
523177|NCT00933920|pharmacodynamics|pharmacodynamics
523178|NCT00933894|VX-950-TiDP24-C133|vx-950-tidp24-c133
523179|NCT00933894|VX-950-C133|vx-950-c133
523180|NCT00933894|VX950|vx950
523181|NCT00933894|HCV|hcv
523182|NCT00933894|telaprevir|telaprevir
523183|NCT00933894|escitalopram|escitalopram
523184|NCT00933881|GDM|gdm
523185|NCT00933868|A stroke that occurred three months to four years ago|a stroke that occurred three months to four years ago
523186|NCT00933855|Training Workshop|training workshop
523187|NCT00933855|Communication|communication
523188|NCT00933855|Questionnaires|questionnaires
523189|NCT00933855|Multiple Diseases|multiple diseases
523190|NCT00933829|absorbable sutures|absorbable sutures
523191|NCT00933829|non-absorbable sutures|non-absorbable sutures
523192|NCT00933829|wound management|wound management
523193|NCT00933816|sorafenib|sorafenib
523194|NCT00933816|intraarterial infusion chemotherapy|intraarterial infusion chemotherapy
523195|NCT00933816|Low dose FP|low dose fp
523196|NCT00933816|cisplatin|cisplatin
523197|NCT00933816|fluorouracil|fluorouracil
523198|NCT00933790|TB|tb
523199|NCT00933790|HIV|hiv
523200|NCT00933790|ARR|arr
523201|NCT00933790|Short course chemotherapy|short course chemotherapy
523202|NCT00933790|Drug resistance|drug resistance
523203|NCT00933751|central venous oxygen saturation|central venous oxygen saturation
523204|NCT00933751|oxygen transport|oxygen transport
523205|NCT00933751|physiologic monitoring|physiologic monitoring
523206|NCT00933751|tissue oxygenation|tissue oxygenation
523207|NCT00933751|Patients before high risk abdominal surgery|patients before high risk abdominal surgery
523208|NCT00933738|Patients needing OAT (Oral Anticoagulation Therapy)|patients needing oat (oral anticoagulation therapy)
523209|NCT00933725|menopausal syndrome|menopausal syndrome
523210|NCT00933725|TCM intervention|tcm intervention
523211|NCT00933673|NK/T cell lymphoma|nk/t cell lymphoma
523212|NCT00933673|DICE|dice
523213|NCT00933673|L-asparaginase|l-asparaginase
523214|NCT00933660|Education|education
523215|NCT00933660|Retention|retention
523216|NCT00933660|Retrieval|retrieval
523217|NCT00933647|Camellia sinensis|camellia sinensis
523218|NCT00933647|Ilex paraguariensis|ilex paraguariensis
523219|NCT00933647|Green tea|green tea
523220|NCT00933647|Yerba mate tea|yerba mate tea
523221|NCT00933647|Maté|maté
523222|NCT00933647|Dyslipidemia|dyslipidemia
523223|NCT00933647|Inflammation|inflammation
523224|NCT00933647|Obesity|obesity
523225|NCT00933634|atrial fibrillation|atrial fibrillation
523226|NCT00933634|electrical cardioversion|electrical cardioversion
523227|NCT00933634|pharmacological cardioversion|pharmacological cardioversion
523228|NCT00933608|subjective memory complaints|subjective memory complaints
523229|NCT00933608|cognitively healthy|cognitively healthy
523230|NCT00933608|family history|family history
523233|NCT00933595|Lung|lung
523234|NCT00933582|Osteoarthritis, Knee|osteoarthritis, knee
523235|NCT00933582|Knee Pain|knee pain
523236|NCT00933582|Pain Measurement|pain measurement
523237|NCT00933582|Naproxen|naproxen
523238|NCT00933582|Placebo|placebo
523239|NCT00933582|Treatment Outcome|treatment outcome
523240|NCT00933556|infection|infection
523241|NCT00933556|probiotics|probiotics
523242|NCT00933543|Acne Vulgaris|acne vulgaris
523243|NCT00933543|Moderate to severe|moderate to severe
523244|NCT00933517|breast cancer, neoadjuvant therapies, chemotherapy, targeted therapy|breast cancer, neoadjuvant therapies, chemotherapy, targeted therapy
523245|NCT00933491|healthy|healthy
523246|NCT00933478|Patulous Eustachian Tube Dysfunction|patulous eustachian tube dysfunction
523247|NCT00933465|Fecal incontinence|fecal incontinence
523248|NCT00933452|duloxetine|duloxetine
523249|NCT00933452|pharmacokinetics|pharmacokinetics
523250|NCT00933452|antidepressant|antidepressant
523251|NCT00933452|antidepressive agents|antidepressive agents
523252|NCT00933452|depression|depression
523253|NCT00933452|psychotropic drugs|psychotropic drugs
523254|NCT00933452|safety|safety
523255|NCT00933452|Chinese|chinese
523256|NCT00933452|HAN|han
523257|NCT00933452|BDNF|bdnf
523258|NCT00933439|Depression|depression
523259|NCT00933439|Major Depressive Disorder|major depressive disorder
523260|NCT00933439|Cognitive Function|cognitive function
523261|NCT00933439|Psychosocial Function|psychosocial function
523262|NCT00933426|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
523263|NCT00933426|CRPC|crpc
523264|NCT00933426|Prostate|prostate
523265|NCT00933426|Lenalidomide|lenalidomide
523266|NCT00933426|Revlimid|revlimid
523267|NCT00933426|CC-5103|cc-5103
523268|NCT00933426|Paclitaxel|paclitaxel
523269|NCT00933426|Taxol|taxol
523270|NCT00933426|Taxanes|taxanes
523271|NCT00933400|Computed Tomography|computed tomography
523272|NCT00933400|CTA|cta
523273|NCT00933400|Cardiac CT|cardiac ct
523274|NCT00933400|CT|ct
523275|NCT00933400|Cardiac CTA|cardiac cta
523276|NCT00933400|Chest Pain|chest pain
523277|NCT00933400|Heart Attack|heart attack
523278|NCT00933400|Emergency Department|emergency department
523279|NCT00933400|Myocardial Infarction|myocardial infarction
523280|NCT00933400|Cost Effectiveness|cost effectiveness
523281|NCT00933400|Acute Coronary Event|acute coronary event
523282|NCT00933400|Heart Imaging|heart imaging
523283|NCT00933387|oral squamous cell carcinoma|oral squamous cell carcinoma
523284|NCT00933387|neoadjuvant bio-chemotherapy|neoadjuvant bio-chemotherapy
523285|NCT00933387|concurrent bio-radiotherapy|concurrent bio-radiotherapy
523286|NCT00933387|biomarker|biomarker
523287|NCT00933374|bladder cancer|bladder cancer
523288|NCT00933374|RAD001|rad001
523289|NCT00933374|Paclitaxel|paclitaxel
523290|NCT00933361|Adult|adult
523291|NCT00933348|ulcer|ulcer
523292|NCT00933348|venous|venous
523293|NCT00933348|pressure|pressure
523294|NCT00933348|wound|wound
523295|NCT00933348|treatment|treatment
523296|NCT00933322|ruminant|ruminant
523297|NCT00933322|industrial|industrial
523298|NCT00933322|endothelial function|endothelial function
523299|NCT00933322|flow-mediated dilation|flow-mediated dilation
523300|NCT00933322|blood lipids|blood lipids
523301|NCT00933322|nutrition|nutrition
523302|NCT00933322|trans fatty acids|trans fatty acids
523303|NCT00933322|coronary disease|coronary disease
523304|NCT00933322|endothelial function of the brachial artery|endothelial function of the brachial artery
523305|NCT00933322|inflammation|inflammation
523306|NCT00933322|insulin resistancy|insulin resistancy
523307|NCT00933322|coagulation|coagulation
523308|NCT00933309|Breast|breast
523309|NCT00933309|Obese|obese
523310|NCT00933309|Obesity Treatment|obesity treatment
523311|NCT00933309|Exemestane|exemestane
523312|NCT00933309|Aromasin|aromasin
523313|NCT00933309|Metformin and Rosiglitazone|metformin and rosiglitazone
523314|NCT00933309|Avandamet|avandamet
523315|NCT00933309|Postmenopausal|postmenopausal
523316|NCT00933309|Hormone-sensitive|hormone-sensitive
523317|NCT00933309|Hormone-receptive-positive breast cancer|hormone-receptive-positive breast cancer
523318|NCT00933296|Schnitzler syndrome|schnitzler syndrome
523319|NCT00933296|Waldentsröm's disease|waldentsröm's disease
523320|NCT00933296|anakinra|anakinra
523321|NCT00933283|Healthy participants|healthy participants
523322|NCT00933283|Pharmacokinetics|pharmacokinetics
523323|NCT00933283|Pharmacodynamic|pharmacodynamic
523324|NCT00933283|Potential interaction|potential interaction
523325|NCT00933283|VX-950-TiDP24-C135|vx-950-tidp24-c135
523326|NCT00933283|VX-950|vx-950
523327|NCT00933283|Methadone|methadone
523328|NCT00933283|Telaprevir|telaprevir
523329|NCT00933283|Steady-state|steady-state
523330|NCT00933270|Superficial Femoral Artery or SFA|superficial femoral artery or sfa
523331|NCT00933244|Vitamin D|vitamin d
523332|NCT00933244|Cholecalciferol|cholecalciferol
523333|NCT00933244|Parathyroid Hormone|parathyroid hormone
523334|NCT00933244|Calcium Absorption|calcium absorption
523335|NCT00933244|Bone Mineral Density|bone mineral density
523336|NCT00933244|Muscle Function|muscle function
523337|NCT00933231|Tacrolimus|tacrolimus
523338|NCT00933231|Kidney Transplantation|kidney transplantation
523339|NCT00933231|Advagraf|advagraf
523340|NCT00933231|Immunosuppression|immunosuppression
523341|NCT00933231|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors
523342|NCT00933179|Prevention of pregnancy|prevention of pregnancy
523343|NCT00933153|Elderly|elderly
523344|NCT00933153|Malnutrition|malnutrition
523345|NCT00933153|Oral Nutrition Supplement|oral nutrition supplement
523346|NCT00933153|Meals on Wheels|meals on wheels
523347|NCT00933140|HIV|hiv
523348|NCT00933140|women|women
523349|NCT00933140|anal cytology|anal cytology
523350|NCT00933127|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
523351|NCT00933127|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
523352|NCT00933127|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
523353|NCT00933127|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
523354|NCT00933127|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
523355|NCT00933127|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
523356|NCT00933127|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
523357|NCT00933127|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
523358|NCT00933127|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
523359|NCT00933127|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
523360|NCT00933127|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
523361|NCT00933127|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
523362|NCT00933114|DCE MRI|dce mri
523363|NCT00933114|PET|pet
523364|NCT00933114|Perfusion|perfusion
523365|NCT00933114|Permeability|permeability
523366|NCT00933114|Cancer of the head and neck|cancer of the head and neck
523367|NCT00933114|Head, Neck neoplasms|head, neck neoplasms
523368|NCT00933088|adolescent coping strategies|adolescent coping strategies
523369|NCT00933088|stress response|stress response
523370|NCT00933088|breast cancer|breast cancer
523371|NCT00933049|Efficacy|efficacy
523372|NCT00933049|children|children
523373|NCT00933049|pneumonia|pneumonia
523374|NCT00933049|cotrimoxazole|cotrimoxazole
523375|NCT00933049|amoxicillin|amoxicillin
523376|NCT00933036|Osteoporosis|osteoporosis
523377|NCT00933036|VCF|vcf
523378|NCT00933036|PVA|pva
523379|NCT00933036|Vertebroplasty|vertebroplasty
523380|NCT00933036|Kyphoplasty|kyphoplasty
523381|NCT00933036|Vertebral fracture|vertebral fracture
523382|NCT00933036|Pathologic fracture|pathologic fracture
523383|NCT00933036|Vertebral augmentation|vertebral augmentation
523384|NCT00933010|metabolic syndrome|metabolic syndrome
523385|NCT00933010|lipids|lipids
523386|NCT00933010|waist circumference|waist circumference
523387|NCT00933010|HDL|hdl
523388|NCT00933010|hypertension|hypertension
523389|NCT00932997|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
523390|NCT00932997|stage I breast cancer|stage i breast cancer
523391|NCT00932997|stage II breast cancer|stage ii breast cancer
523392|NCT00932997|stage IIIA breast cancer|stage iiia breast cancer
523393|NCT00932997|cancer survivor|cancer survivor
523394|NCT00932958|Myocardial Infarction|myocardial infarction
523395|NCT00932919|Agoraphobia|agoraphobia
523396|NCT00932919|Cognitive therapy|cognitive therapy
523397|NCT00932919|Thought field therapy|thought field therapy
523398|NCT00932919|Psychotherapy research|psychotherapy research
523399|NCT00932906|Education|education
523400|NCT00932906|Retention|retention
523401|NCT00932906|Retrieval|retrieval
523402|NCT00932906|Self training|self training
523403|NCT00932893|Lung Neoplasms ALK gene crizotinib|lung neoplasms alk gene crizotinib
523404|NCT00932867|Arterial Hypertension|arterial hypertension
523405|NCT00932854|Mediastinal lymphadenopathy|mediastinal lymphadenopathy
523406|NCT00932854|EBUS|ebus
523407|NCT00932854|Bronchoscopy|bronchoscopy
523408|NCT00932854|Sarcoidosis|sarcoidosis
523409|NCT00932828|Peanut allergy|peanut allergy
523410|NCT00932802|Non-Interventional|non-interventional
523411|NCT00932802|Observational|observational
523412|NCT00932802|NIS|nis
523413|NCT00932802|Moxifloxacin|moxifloxacin
523414|NCT00932802|MXF|mxf
523415|NCT00932802|Avelox|avelox
523416|NCT00932802|AECB|aecb
523417|NCT00932750|Body composition|body composition
523418|NCT00932750|Weight loss|weight loss
523419|NCT00932750|Weight management|weight management
523420|NCT00932750|Beverages|beverages
523421|NCT00932750|Diet|diet
523422|NCT00932724|Metastatic|metastatic
523423|NCT00932724|Colorectal|colorectal
523424|NCT00932724|Cancer|cancer
523425|NCT00932724|refractory|refractory
523426|NCT00932724|Phase II|phase ii
523427|NCT00932724|randomised|randomised
523428|NCT00932724|double-blind|double-blind
523429|NCT00932724|controlled|controlled
523430|NCT00932724|multicenter|multicenter
523431|NCT00932724|CY-503|cy-503
523432|NCT00932724|Cytavis|cytavis
523433|NCT00932711|COPD|copd
523434|NCT00932698|Relapsed multiple myeloma|relapsed multiple myeloma
523435|NCT00932698|Refractory multiple myeloma|refractory multiple myeloma
523436|NCT00932698|IXAZOMIB Proteasome inhibitor|ixazomib proteasome inhibitor
523437|NCT00932685|pediatric emergence agitation and pain|pediatric emergence agitation and pain
523438|NCT00932672|Prostate Cancer|prostate cancer
523439|NCT00932672|Atkins|atkins
523440|NCT00932659|End-Stage Renal Disease|end-stage renal disease
523441|NCT00932659|Hemodialysis|hemodialysis
523442|NCT00932659|Cardiac Arrhythmias|cardiac arrhythmias
523443|NCT00932633|neonatal brain injury|neonatal brain injury
523444|NCT00932633|congenital heart disease|congenital heart disease
523445|NCT00932633|magnetic resonance imaging|magnetic resonance imaging
523446|NCT00932633|cardiopulmonary bypass|cardiopulmonary bypass
523447|NCT00932633|neurodevelopmental outcome|neurodevelopmental outcome
523448|NCT00932620|hypercholesterolemia|hypercholesterolemia
523449|NCT00932620|statins|statins
523450|NCT00932620|simvastatin|simvastatin
523451|NCT00932620|ezetimibe|ezetimibe
523452|NCT00932620|LDL particles|ldl particles
523453|NCT00932607|seasonal|seasonal
523454|NCT00932607|rhinitis|rhinitis
523455|NCT00932607|rhinoconjunctivitis|rhinoconjunctivitis
523456|NCT00932607|birch pollen|birch pollen
523457|NCT00932607|immunotherapy|immunotherapy
523458|NCT00932607|sublingual|sublingual
523459|NCT00932594|Create the New Serial Treatment of TMD|create the new serial treatment of tmd
523460|NCT00932594|Promote the Classification of Biodynamics in the TMD|promote the classification of biodynamics in the tmd
523461|NCT00932594|Evaluate the Effect of Adjusting TMJ Treatment|evaluate the effect of adjusting tmj treatment
523462|NCT00932594|Establish the New Standard of the TMJ Treatment|establish the new standard of the tmj treatment
523463|NCT00932594|Invent New Device to Measure Pressure without Trauma|invent new device to measure pressure without trauma
523464|NCT00932581|Parkinson's Disease|parkinson's disease
523465|NCT00932581|Movement Disorders|movement disorders
523466|NCT00932581|Unified Parkinson's Disease Rating Scale|unified parkinson's disease rating scale
523467|NCT00932581|Short Parkinson's Evaluation Scale|short parkinson's evaluation scale
523468|NCT00932581|Scales for Outcomes in Parkinson's Disease|scales for outcomes in parkinson's disease
523469|NCT00932581|Motor Evaluation|motor evaluation
523470|NCT00932581|Schwab and England activities of daily living|schwab and england activities of daily living
523471|NCT00932581|Bradykinesia|bradykinesia
523472|NCT00932581|psychometrics|psychometrics
523473|NCT00932581|order effects|order effects
523474|NCT00932581|hoehn yahr aging|hoehn yahr aging
523475|NCT00932581|assessments|assessments
523476|NCT00932555|Octocog alfa|octocog alfa
523477|NCT00932555|Hemophilia A|hemophilia a
523478|NCT00932542|Hemorrhoidectomy|hemorrhoidectomy
523479|NCT00932529|Antipsychotic drugs|antipsychotic drugs
523480|NCT00932529|Treatment effectiveness|treatment effectiveness
523481|NCT00932529|Randomized controlled trial|randomized controlled trial
523482|NCT00932516|South Beach Diet™|south beach diet™
523483|NCT00932516|overweight|overweight
523484|NCT00932516|obesity|obesity
523485|NCT00932516|satiety|satiety
523486|NCT00932516|weight loss|weight loss
523487|NCT00932503|Vicryl plus|vicryl plus
523488|NCT00932503|wound infection|wound infection
523489|NCT00932503|coated suture material|coated suture material
523490|NCT00932503|open abdominal surgery|open abdominal surgery
523491|NCT00932503|transverse laparotomy|transverse laparotomy
523492|NCT00932451|Lung Neoplasms ALK gene Crizotinib|lung neoplasms alk gene crizotinib
523493|NCT00932438|colon cancer|colon cancer
523494|NCT00932438|liver metastases|liver metastases
523495|NCT00932425|Stroke|stroke
523496|NCT00932425|Cryptogenic|cryptogenic
523497|NCT00932425|Cardioembolic|cardioembolic
523498|NCT00932425|Atrial Fibrillation|atrial fibrillation
523499|NCT00932412|Younger Patients with Newly-Diagnosed Acute Myeloid Leukemia (AML).|younger patients with newly-diagnosed acute myeloid leukemia (aml).
523500|NCT00932386|Lower extremity surgery with tourniquet use|lower extremity surgery with tourniquet use
523501|NCT00932373|HER2-positive breast cancer|her2-positive breast cancer
523502|NCT00932373|MBC|mbc
523503|NCT00932373|Trastuzumab emtansine|trastuzumab emtansine
523504|NCT00932373|Herceptin|herceptin
523505|NCT00932373|T-DM1|t-dm1
523506|NCT00932360|Fibromyalgia|fibromyalgia
523507|NCT00932360|Transcutaneous Electrical Nerve Stimulation (TENS)|transcutaneous electrical nerve stimulation (tens)
523508|NCT00932347|Camellia sinensis|camellia sinensis
523509|NCT00932347|volatile sulfur compounds|volatile sulfur compounds
523510|NCT00932334|kidney|kidney
523511|NCT00932334|transplant|transplant
523512|NCT00932334|donation|donation
523513|NCT00932321|Contraception|contraception
523514|NCT00932295|tobacco|tobacco
523515|NCT00932295|cigarette|cigarette
523516|NCT00932295|nicotine|nicotine
523517|NCT00932282|Peanut|peanut
523518|NCT00932282|Allergy|allergy
523519|NCT00932282|Hypersensitivity|hypersensitivity
523520|NCT00932269|Diphtheria|diphtheria
523521|NCT00932269|Tetanus|tetanus
523522|NCT00932269|Pertussis|pertussis
523523|NCT00932269|Polio|polio
523524|NCT00932269|Haemophilus influenzae type B|haemophilus influenzae type b
523525|NCT00932269|Hib|hib
523526|NCT00932269|Measles|measles
523527|NCT00932269|Mumps|mumps
523528|NCT00932269|Rubella|rubella
523529|NCT00932269|Hepatitis B|hepatitis b
523530|NCT00932269|Vaccine|vaccine
523531|NCT00932269|Vaccination|vaccination
523532|NCT00932269|Immunity|immunity
523533|NCT00932269|Vaccination program|vaccination program
523534|NCT00932269|Sweden|sweden
523535|NCT00932269|ELISA|elisa
523536|NCT00932256|Rhinitis, Allergic, Seasonal|rhinitis, allergic, seasonal
523537|NCT00932243|bacteremia|bacteremia
523538|NCT00932243|sepsis|sepsis
523539|NCT00932243|Toll-Like-Receptors (TLRs)|toll-like-receptors (tlrs)
523540|NCT00932204|obsessive-compulsive disorder|obsessive-compulsive disorder
523541|NCT00932204|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
523542|NCT00932204|right dorsolateral prefrontal cortex|right dorsolateral prefrontal cortex
523543|NCT00932204|supplementary motor area (SMA)|supplementary motor area (sma)
523544|NCT00932191|Cataract|cataract
523545|NCT00932191|Corneal endothelial cell loss|corneal endothelial cell loss
523546|NCT00932191|Ultrasound power|ultrasound power
523547|NCT00932191|Corneal endothelium|corneal endothelium
523548|NCT00932178|Anxiety|anxiety
523549|NCT00932178|Worry|worry
523550|NCT00932178|nervousness|nervousness
523551|NCT00932178|Older Adult|older adult
523552|NCT00932152|advanced non-small cell lung cancer|advanced non-small cell lung cancer
523553|NCT00932152|postmenopausal|postmenopausal
523554|NCT00932152|bevacizumab|bevacizumab
523555|NCT00932152|fulvestrant|fulvestrant
523556|NCT00932152|anastrozole|anastrozole
523557|NCT00932139|Hypertension|hypertension
523558|NCT00932139|blood pressure|blood pressure
523559|NCT00932139|arrhythmias|arrhythmias
523560|NCT00932139|mild to moderate hypertension|mild to moderate hypertension
523561|NCT00932126|Phase 1 dose escalation dose finding pharmacokinetic and pharmacodynamic study|phase 1 dose escalation dose finding pharmacokinetic and pharmacodynamic study
523562|NCT00932113|tumor necrosis factor (TNF) inhibitor|tumor necrosis factor (tnf) inhibitor
523690|NCT00931541|Tolerability|tolerability
523563|NCT00932113|tumor necrosis factor (TNF) blockade|tumor necrosis factor (tnf) blockade
523564|NCT00932113|Methotrexate|methotrexate
523565|NCT00932113|treatment|treatment
523566|NCT00932113|mechanism|mechanism
523567|NCT00932113|psoriasis|psoriasis
523568|NCT00932100|ACS|acs
523569|NCT00932100|Acute Coronary Syndrome|acute coronary syndrome
523570|NCT00932100|Catheterization|catheterization
523571|NCT00932087|Platelet function|platelet function
523572|NCT00932087|diabetes|diabetes
523573|NCT00932087|metabolic syndrome|metabolic syndrome
523574|NCT00932074|Atopic Dermatitis|atopic dermatitis
523575|NCT00932061|Fibromyalgia|fibromyalgia
523576|NCT00932061|Healthy controls|healthy controls
523577|NCT00932061|Acupuncture|acupuncture
523578|NCT00932061|Sham Acupuncture|sham acupuncture
523579|NCT00932061|fMRI|fmri
523580|NCT00932061|Biological marker|biological marker
523581|NCT00932048|Diabetes Mellitus|diabetes mellitus
523582|NCT00932048|Statins|statins
523583|NCT00932048|PET|pet
523584|NCT00932035|breast cancer|breast cancer
523585|NCT00932035|axillary mapping|axillary mapping
523586|NCT00932035|lymphedema|lymphedema
523587|NCT00932009|Human papillomavirus infection|human papillomavirus infection
523588|NCT00932009|Tanzanian men|tanzanian men
523589|NCT00932009|Prevalence|prevalence
523590|NCT00931996|schizophrenia|schizophrenia
523591|NCT00931996|antipsychotic|antipsychotic
523592|NCT00931996|risperidone|risperidone
523593|NCT00931983|Incomplete spinal cord injuries|incomplete spinal cord injuries
523594|NCT00931983|Walking|walking
523595|NCT00931983|Treadmill|treadmill
523596|NCT00931983|Training|training
523597|NCT00931970|Hemodialysis|hemodialysis
523598|NCT00931970|Peritoneal dialysis|peritoneal dialysis
523599|NCT00931970|Mortality|mortality
523600|NCT00931970|Prospective cohort|prospective cohort
523601|NCT00931970|Clinical study|clinical study
523602|NCT00931957|Etanercept|etanercept
523603|NCT00931957|Behcet's syndrome|behcet's syndrome
523604|NCT00931957|Behcet's Disease|behcet's disease
523605|NCT00931957|Ocular Lesions|ocular lesions
523606|NCT00931957|Uveitis|uveitis
523607|NCT00931957|Retinal Vasculitis|retinal vasculitis
523608|NCT00931944|ALS|als
523609|NCT00931944|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
523610|NCT00931944|Lou Gehrig|lou gehrig
523611|NCT00931944|Lou Gehrig's|lou gehrig's
523612|NCT00931944|Lou Gehrig's disease|lou gehrig's disease
523613|NCT00931944|Motor Neuron Disease|motor neuron disease
523614|NCT00931944|Nervous System Diseases|nervous system diseases
523615|NCT00931944|KNS-760704|kns-760704
523616|NCT00931944|RTPB|rtpb
523617|NCT00931905|This study included workers exposed to lead.|this study included workers exposed to lead.
523618|NCT00931892|celiac disease|celiac disease
523619|NCT00931892|gluten challenge|gluten challenge
523620|NCT00931866|diclofenac|diclofenac
523621|NCT00931866|acute pain|acute pain
523622|NCT00931866|topical|topical
523623|NCT00931866|patch|patch
523624|NCT00931866|Acute Pain due to Mild to Moderate Soft Tissue Injury|acute pain due to mild to moderate soft tissue injury
523625|NCT00931840|EZN-2208 (PEG-SN38)|ezn-2208 (peg-sn38)
523626|NCT00931827|Contraception|contraception
523627|NCT00931814|Depression|depression
523628|NCT00931814|physical function|physical function
523629|NCT00931814|Quality of life|quality of life
523630|NCT00931801|AIDS|aids
523631|NCT00931801|HIV|hiv
523632|NCT00931801|Atazanavir|atazanavir
523633|NCT00931801|Raltegravir|raltegravir
523634|NCT00931801|Tenofovir|tenofovir
523635|NCT00931801|protease inhibitors|protease inhibitors
523636|NCT00931788|Management of hypertension and cholesterol|management of hypertension and cholesterol
523637|NCT00931788|stroke|stroke
523638|NCT00931788|TIA|tia
523639|NCT00931775|Major depressive disorder, citalopram, pindolol, HDRS|major depressive disorder, citalopram, pindolol, hdrs
523640|NCT00931762|Bone marrow|bone marrow
523641|NCT00931762|Myelofibrosis|myelofibrosis
523642|NCT00931762|JAK2mutation|jak2mutation
523643|NCT00931762|Post-Polycythemia Vera|post-polycythemia vera
523644|NCT00931762|Post-Essential Thrombocytopenia|post-essential thrombocytopenia
523645|NCT00931749|ultrasound therapy|ultrasound therapy
523646|NCT00931749|knee cartilage thickness|knee cartilage thickness
523647|NCT00931749|knee cartilage volume|knee cartilage volume
523648|NCT00931749|mild knee osteoarthritis|mild knee osteoarthritis
523649|NCT00931749|moderate knee osteoarthritis|moderate knee osteoarthritis
523650|NCT00931736|Tuberculosis|tuberculosis
523651|NCT00931723|Acute Mania|acute mania
523652|NCT00931723|Mania, Adults|mania, adults
523653|NCT00931723|Seroquel|seroquel
523654|NCT00931723|Acute Mania in Adult Patients|acute mania in adult patients
523655|NCT00931710|Hypertension|hypertension
523656|NCT00931710|combination therapy|combination therapy
523657|NCT00931710|valsartan|valsartan
523658|NCT00931710|cardiovascular diseases|cardiovascular diseases
523659|NCT00931697|Mefloquine|mefloquine
523660|NCT00931697|Malaria|malaria
523661|NCT00931697|(+) Mefloquine|(+) mefloquine
523662|NCT00931697|Pharmacokinetics|pharmacokinetics
523663|NCT00931671|Physical fitness|physical fitness
523664|NCT00931671|Cerebral circulation|cerebral circulation
523665|NCT00931671|Walking|walking
523666|NCT00931645|Chronic lymphocytic leukemia,|chronic lymphocytic leukemia,
523667|NCT00931645|autologous stem cell transplantation|autologous stem cell transplantation
523668|NCT00931632|Bronchopulmonary Dysplasia, BPD|bronchopulmonary dysplasia, bpd
523669|NCT00931619|Fluorine-18 Fluorodeoxyglucose|fluorine-18 fluorodeoxyglucose
523670|NCT00931619|Epilepsy|epilepsy
523671|NCT00931619|Epileptic Focus|epileptic focus
523672|NCT00931619|Temporal Lobe Epilepsy|temporal lobe epilepsy
523673|NCT00931619|Depression|depression
523674|NCT00931619|Major Depressive Disorder|major depressive disorder
523675|NCT00931619|Healthy Volunteer|healthy volunteer
523676|NCT00931619|HV|hv
523677|NCT00931606|anemia|anemia
523678|NCT00931606|metastatic|metastatic
523679|NCT00931606|breast|breast
523680|NCT00931606|cancer|cancer
523681|NCT00931593|Transient lower esophageal sphincter relaxation|transient lower esophageal sphincter relaxation
523682|NCT00931593|high resolution manometry|high resolution manometry
523683|NCT00931593|dentsleeve probe|dentsleeve probe
523684|NCT00931593|healthy volunteers|healthy volunteers
523685|NCT00931580|Vitamin D|vitamin d
523686|NCT00931580|Adolescent|adolescent
523687|NCT00931580|African American|african american
523688|NCT00931580|White|white
523689|NCT00931541|Safety|safety
523691|NCT00931541|Healthy|healthy
523692|NCT00931528|sexual dysfunction|sexual dysfunction
523693|NCT00931528|stage IIB prostate cancer|stage iib prostate cancer
523694|NCT00931528|stage IIA prostate cancer|stage iia prostate cancer
523695|NCT00931528|adenocarcinoma of the prostate|adenocarcinoma of the prostate
523696|NCT00931515|DDD|ddd
523697|NCT00931502|Stent thrombosis|stent thrombosis
523698|NCT00931502|Acute Coronary Syndrome|acute coronary syndrome
523699|NCT00931502|ACS|acs
523700|NCT00931502|Stenting|stenting
523701|NCT00931502|Interventional Cardiology|interventional cardiology
523702|NCT00931502|Cardiology|cardiology
523703|NCT00931502|Cardiovascular Research|cardiovascular research
523704|NCT00931502|Registry|registry
523705|NCT00931489|Age Related Macular Degeneration|age related macular degeneration
523706|NCT00931489|Lucentis|lucentis
523707|NCT00931489|Ranibizumab|ranibizumab
523708|NCT00931489|Antibodies|antibodies
523709|NCT00931489|Retinal and RPE Autoimmunity|retinal and rpe autoimmunity
523710|NCT00931463|second line therapy|second line therapy
523711|NCT00931463|combination antiretroviral therapy|combination antiretroviral therapy
523712|NCT00931463|first-line failure|first-line failure
523713|NCT00931463|AIDS|aids
523714|NCT00931463|treatment experienced|treatment experienced
523715|NCT00931450|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
523716|NCT00931450|HER2-negative breast cancer|her2-negative breast cancer
523717|NCT00931450|stage IA breast cancer|stage ia breast cancer
523718|NCT00931450|stage IB breast cancer|stage ib breast cancer
523719|NCT00931450|stage II breast cancer|stage ii breast cancer
523720|NCT00931450|stage IIIA breast cancer|stage iiia breast cancer
523721|NCT00931450|stage IIIB breast cancer|stage iiib breast cancer
523722|NCT00931437|vitamin K|vitamin k
523723|NCT00931437|Bio-availability|bio-availability
523724|NCT00931424|Primary Chronic Venous Insufficiency|primary chronic venous insufficiency
523725|NCT00931424|surgery|surgery
523726|NCT00931424|reconstruction|reconstruction
523727|NCT00931424|valve|valve
523728|NCT00931411|Atopic Dermatitis|atopic dermatitis
523729|NCT00931411|Vitamin B3|vitamin b3
523730|NCT00931372|Insulin release|insulin release
523731|NCT00931372|Diabetes mellitus type 2|diabetes mellitus type 2
523732|NCT00931372|GLP-1 agonist|glp-1 agonist
523733|NCT00931359|axillary|axillary
523734|NCT00931359|hyperhidrosis|hyperhidrosis
523735|NCT00931359|primary focal|primary focal
523736|NCT00931346|HIV|hiv
523737|NCT00931346|Human Immunodeficiency Virus|human immunodeficiency virus
523738|NCT00931333|Vertebroplasty|vertebroplasty
523739|NCT00931333|spine|spine
523740|NCT00931333|vertebra height|vertebra height
523741|NCT00931333|adverse events|adverse events
523742|NCT00931333|calcium phosphate bone cement|calcium phosphate bone cement
523743|NCT00931320|Ratio improvement|ratio improvement
523744|NCT00931320|LDL-C|ldl-c
523745|NCT00931320|HDL-C|hdl-c
523746|NCT00931320|Ratio of Low Density Lipoprotein Cholesterol to High Density Lipoprotein Cholesterol Improvement|ratio of low density lipoprotein cholesterol to high density lipoprotein cholesterol improvement
523747|NCT00931320|High Density Lipoprotein Cholesterol|high density lipoprotein cholesterol
523748|NCT00931281|Multiple Ascending Doses|multiple ascending doses
523749|NCT00931268|Lipoatrophy|lipoatrophy
523750|NCT00931268|Buttock treatment|buttock treatment
523751|NCT00931255|kidney transplant|kidney transplant
523752|NCT00931255|tacrolimus|tacrolimus
523753|NCT00931255|sirolimus|sirolimus
523754|NCT00931255|delayed graft function|delayed graft function
523755|NCT00931255|Graft survival|graft survival
523756|NCT00931255|Acute rejection|acute rejection
523757|NCT00931255|Chronic allograft nephropathy|chronic allograft nephropathy
523758|NCT00931242|eczema|eczema
523759|NCT00931242|dermatitis|dermatitis
523760|NCT00931242|TNF blockade|tnf blockade
523761|NCT00931242|PDE4 inhibitor|pde4 inhibitor
523762|NCT00931242|T cell inhibitor|t cell inhibitor
523763|NCT00931229|hepatitis B reactivation|hepatitis b reactivation
523764|NCT00931216|PMTCT|pmtct
523765|NCT00931216|Vertical transmission of HIV|vertical transmission of hiv
523766|NCT00931216|Pregnant women|pregnant women
523767|NCT00931216|Infant HIV testing|infant hiv testing
523768|NCT00931216|Kenya|kenya
523769|NCT00931216|AIDS|aids
523770|NCT00931164|phase I/II study|phase i/ii study
523771|NCT00931164|effects of sodium oxybate|effects of sodium oxybate
523772|NCT00931164|cohort of 6 children and young adults|cohort of 6 children and young adults
523773|NCT00931164|AHC|ahc
523774|NCT00931138|Acute Myeloid Leukemia in adults|acute myeloid leukemia in adults
523775|NCT00931138|Newly-diagnosed untreated AML|newly-diagnosed untreated aml
523776|NCT00931138|Patient aged 50 to 70 years|patient aged 50 to 70 years
523777|NCT00931125|Severe proliferative diabetic retinopathy|severe proliferative diabetic retinopathy
523778|NCT00931112|Peripheral Arterial Disease|peripheral arterial disease
523779|NCT00931112|Walking ability|walking ability
523780|NCT00931112|Quality of life|quality of life
523781|NCT00931112|Exercise training|exercise training
523782|NCT00931099|pregnancy|pregnancy
523783|NCT00931099|sleep disordered breathing|sleep disordered breathing
523784|NCT00931099|obstructive sleep apnea|obstructive sleep apnea
523785|NCT00931086|Rheumatoid Arthritis|rheumatoid arthritis
523786|NCT00931086|RA|ra
523787|NCT00931073|Drug Interactions|drug interactions
523788|NCT00931073|pharmacokinetics|pharmacokinetics
523789|NCT00931073|CYP2D6|cyp2d6
523790|NCT00931073|CYP2C19|cyp2c19
523791|NCT00931073|ketoconazole|ketoconazole
523792|NCT00931073|omeprazole|omeprazole
523793|NCT00931060|Ammonia|ammonia
523794|NCT00931060|Citric acid cycle|citric acid cycle
523795|NCT00931060|Branched Chain Amino Acids|branched chain amino acids
523796|NCT00931034|South Beach Diet™|south beach diet™
523797|NCT00931034|overweight|overweight
523798|NCT00931034|obesity|obesity
523799|NCT00931034|satiety|satiety
523800|NCT00931034|weight loss|weight loss
523801|NCT00931034|diabetes|diabetes
523802|NCT00931008|Locally Advanced or Metastatic Non-Small Cell Lung Cancer|locally advanced or metastatic non-small cell lung cancer
523803|NCT00930982|Ciprofloxacin|ciprofloxacin
523804|NCT00930982|Airway infection|airway infection
523805|NCT00930982|Bronchiectasis|bronchiectasis
523806|NCT00930969|Cardiac Ischemia|cardiac ischemia
523807|NCT00930969|ST segment elevated Myocardial Infarction (STEMI)|st segment elevated myocardial infarction (stemi)
523808|NCT00930969|Non-ST Segment elevated Myocardial Infarction (NSTEMI)|non-st segment elevated myocardial infarction (nstemi)
523809|NCT00930969|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
523810|NCT00930969|Cardiac Electrogram (EGM)|cardiac electrogram (egm)
523811|NCT00930969|Coronary Artery Disease (CAD)|coronary artery disease (cad)
523812|NCT00930956|Diabetes|diabetes
523813|NCT00930956|Obesity|obesity
523814|NCT00930956|Hyperglycemia|hyperglycemia
523815|NCT00930956|Dietary Fiber|dietary fiber
523816|NCT00930956|Wheat|wheat
523817|NCT00930956|Grain|grain
523818|NCT00930943|opioid tolerant|opioid tolerant
523819|NCT00930943|chronic pain|chronic pain
523820|NCT00930930|triple-negative breast cancer|triple-negative breast cancer
523821|NCT00930930|stage II breast cancer|stage ii breast cancer
524016|NCT00930124|morbidity|morbidity
523822|NCT00930930|stage IIIA breast cancer|stage iiia breast cancer
523823|NCT00930930|stage IIIB breast cancer|stage iiib breast cancer
523824|NCT00930930|stage IIIC breast cancer|stage iiic breast cancer
523825|NCT00930930|male breast cancer|male breast cancer
523826|NCT00930917|delivery room, polyethylene cap, preterm infant, temperature|delivery room, polyethylene cap, preterm infant, temperature
523827|NCT00930891|Extensive-Disease Small-Cell Lung Cancer|extensive-disease small-cell lung cancer
523828|NCT00930878|registry|registry
523829|NCT00930878|drug eluting coronary stent system|drug eluting coronary stent system
523830|NCT00930878|observational|observational
523831|NCT00930878|prospective|prospective
523832|NCT00930878|open-label|open-label
523833|NCT00930852|Migraine|migraine
523834|NCT00930852|Children|children
523835|NCT00930852|Primary headache disorders|primary headache disorders
523836|NCT00930852|Appetite|appetite
523837|NCT00930852|Obesity|obesity
523838|NCT00930852|Feeding Behavior|feeding behavior
523839|NCT00930839|Niacin|niacin
523840|NCT00930839|Prostaglandin D2|prostaglandin d2
523841|NCT00930839|Flushing|flushing
523842|NCT00930839|Nicotinic acid stimulated release of prostaglandin D2|nicotinic acid stimulated release of prostaglandin d2
523843|NCT00930826|The effect of bronchial asthma on school performance|the effect of bronchial asthma on school performance
523844|NCT00930813|Drug coated balloon|drug coated balloon
523845|NCT00930813|SFA disease|sfa disease
523846|NCT00930813|Femoropopliteal disease|femoropopliteal disease
523847|NCT00930813|Angioplasty|angioplasty
523848|NCT00930813|PAD|pad
523849|NCT00930813|Paclitaxel|paclitaxel
523850|NCT00930813|Tubulin modulators|tubulin modulators
523851|NCT00930813|Antineoplastic Agents|antineoplastic agents
523852|NCT00930813|Mitosis Modulators|mitosis modulators
523853|NCT00930813|Balloon angioplasty|balloon angioplasty
523854|NCT00930813|Local drug delivery|local drug delivery
523855|NCT00930813|Restenosis|restenosis
523856|NCT00930813|Drug-coated balloon|drug-coated balloon
523857|NCT00930800|Exercise capacity|exercise capacity
523858|NCT00930800|Physical activity|physical activity
523859|NCT00930800|Quality of life|quality of life
523860|NCT00930787|hernia repair, surgical mesh, co-morbidities|hernia repair, surgical mesh, co-morbidities
523861|NCT00930774|traumatic brain injury|traumatic brain injury
523862|NCT00930774|rehabilitation|rehabilitation
523863|NCT00930774|auditory processing disorder|auditory processing disorder
523864|NCT00930761|breast feeding|breast feeding
523865|NCT00930761|music therapy|music therapy
523866|NCT00930761|maternal welfare|maternal welfare
523867|NCT00930761|infant, newborn|infant, newborn
523868|NCT00930722|Quinapril non-interventional/observational study safety|quinapril non-interventional/observational study safety
523869|NCT00930709|Botulinum Toxin Type A|botulinum toxin type a
523870|NCT00930709|Exercise|exercise
523871|NCT00930709|Randomized Controlled Trial|randomized controlled trial
523872|NCT00930709|Muscle Stretching Exercises|muscle stretching exercises
523873|NCT00930709|Strength Training|strength training
523874|NCT00930709|Treatment Outcome|treatment outcome
523875|NCT00930696|endometriosis|endometriosis
523876|NCT00930696|abdominal lavage|abdominal lavage
523877|NCT00930696|bowel perforation|bowel perforation
523878|NCT00930696|discoid resection|discoid resection
523879|NCT00930696|laparoscopy|laparoscopy
523880|NCT00930670|ranitidine|ranitidine
523881|NCT00930670|pantoprazole|pantoprazole
523882|NCT00930670|esomeprazole|esomeprazole
523883|NCT00930670|omeprazole|omeprazole
523884|NCT00930670|atorvastatin|atorvastatin
523885|NCT00930670|rosuvastatin|rosuvastatin
523886|NCT00930670|statin|statin
523887|NCT00930670|clopidogrel resistance|clopidogrel resistance
523888|NCT00930670|antiplatelet therapy|antiplatelet therapy
523889|NCT00930670|coronary artery disease|coronary artery disease
523890|NCT00930670|percutaneous coronary intervention|percutaneous coronary intervention
523891|NCT00930670|stent|stent
523892|NCT00930670|clopidogrel|clopidogrel
523893|NCT00930670|proton pump inhibitors|proton pump inhibitors
523894|NCT00930670|drug interactions|drug interactions
523895|NCT00930670|drug resistance|drug resistance
523896|NCT00930670|genetic polymorphism|genetic polymorphism
523897|NCT00930657|Panic Disorder|panic disorder
523898|NCT00930657|Separation Anxiety|separation anxiety
523899|NCT00930657|Familial|familial
523900|NCT00930657|Risk|risk
523901|NCT00930657|Respiratory Physiology|respiratory physiology
523902|NCT00930644|short bowel syndrome|short bowel syndrome
523903|NCT00930644|parenteral nutrition|parenteral nutrition
523904|NCT00930644|PN|pn
523905|NCT00930644|HPN|hpn
523906|NCT00930644|TPN|tpn
523907|NCT00930644|SBS|sbs
523908|NCT00930631|CAD|cad
523909|NCT00930631|Pharmacokinetics|pharmacokinetics
523910|NCT00930631|BMS747158|bms747158
523911|NCT00930618|Prolonged pregnancy|prolonged pregnancy
523912|NCT00930618|Nulliparity|nulliparity
523913|NCT00930618|Cervical ripening|cervical ripening
523914|NCT00930618|Induced labor|induced labor
523915|NCT00930618|Cesarean section|cesarean section
523916|NCT00930592|Psoriasis|psoriasis
523917|NCT00930592|Metabolic Syndrome|metabolic syndrome
523918|NCT00930592|Cardiovascular Risk|cardiovascular risk
524314|NCT00929006|pubertal|pubertal
523919|NCT00930566|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
523920|NCT00930566|Extracorporeal Photopheresis|extracorporeal photopheresis
523921|NCT00930553|Multiple Sclerosis|multiple sclerosis
523922|NCT00930501|chemotherapy|chemotherapy
523923|NCT00930501|cancer|cancer
523924|NCT00930501|AMH|amh
523925|NCT00930501|gonadotoxicity|gonadotoxicity
523926|NCT00930501|ovarian reserve|ovarian reserve
523927|NCT00930501|patients exposed to chemotherapy|patients exposed to chemotherapy
523928|NCT00930488|Moxifloxacin|moxifloxacin
523929|NCT00930488|MXF|mxf
523930|NCT00930488|Avelox|avelox
523931|NCT00930488|Sinusitis|sinusitis
523932|NCT00930488|Acute bacterial sinusitis, ABS|acute bacterial sinusitis, abs
523933|NCT00930462|colonoscopy|colonoscopy
523934|NCT00930462|cap|cap
523935|NCT00930462|hood|hood
523936|NCT00930462|cecal intubation time|cecal intubation time
523937|NCT00930462|polyp detection rate|polyp detection rate
523938|NCT00930462|performance|performance
523939|NCT00930449|Pediatrics|pediatrics
523940|NCT00930449|Attention-Deficit Hyperactivity Disorder|attention-deficit hyperactivity disorder
523941|NCT00930449|Learning Disorder|learning disorder
523942|NCT00930449|Computerized Working Memory Training Program|computerized working memory training program
523943|NCT00930436|chronic kidney disease|chronic kidney disease
523944|NCT00930410|pancreas neoplasms|pancreas neoplasms
523945|NCT00930410|bile duct diseases|bile duct diseases
523946|NCT00930410|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
523947|NCT00930410|ERCP|ercp
523948|NCT00930397|Pre-eclampsia|pre-eclampsia
523949|NCT00930397|UTERO-placental unit vascularization|utero-placental unit vascularization
523950|NCT00930397|Hypertension, pregnancy- induced|hypertension, pregnancy- induced
523951|NCT00930397|IUGR|iugr
523952|NCT00930397|Screening|screening
523953|NCT00930397|3D Doppler Ultrasound|3d doppler ultrasound
523954|NCT00930384|psoriasis|psoriasis
523955|NCT00930384|fatty liver|fatty liver
523956|NCT00930384|metabolic syndrome|metabolic syndrome
523957|NCT00930371|fatty liver|fatty liver
523958|NCT00930371|insulin resistance|insulin resistance
523959|NCT00930371|diet|diet
523960|NCT00930371|inflammation|inflammation
523961|NCT00930371|oxidative stress|oxidative stress
523962|NCT00930358|Sedation|sedation
523963|NCT00930358|Colonoscopy|colonoscopy
523964|NCT00930358|General anesthesia|general anesthesia
523965|NCT00930345|Renal cell carcinoma|renal cell carcinoma
523966|NCT00930345|Antiangiogenics|antiangiogenics
523967|NCT00930345|Biomarkers|biomarkers
523968|NCT00930345|Imagery|imagery
523969|NCT00930332|sleep disorders|sleep disorders
523970|NCT00930332|nausea and vomiting|nausea and vomiting
523971|NCT00930332|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
523972|NCT00930332|pain|pain
523973|NCT00930306|Chronic Pain|chronic pain
523974|NCT00930306|AZD2066|azd2066
523975|NCT00930293|Interpersonal Psychotherapy|interpersonal psychotherapy
523976|NCT00930280|stroke|stroke
523977|NCT00930280|brain attack|brain attack
523978|NCT00930280|hemorrhagic stroke|hemorrhagic stroke
523979|NCT00930280|risk factors|risk factors
523980|NCT00930267|fever|fever
523981|NCT00930267|children|children
523982|NCT00930267|cancer|cancer
523983|NCT00930267|leukemia|leukemia
523984|NCT00930267|stem cell transplantation|stem cell transplantation
523985|NCT00930267|infections in pediatric cancer patients presenting with fever during or following chemotherapy.|infections in pediatric cancer patients presenting with fever during or following chemotherapy.
523986|NCT00930254|pediatric nursing|pediatric nursing
523987|NCT00930254|peripheral catheterization|peripheral catheterization
523988|NCT00930254|ultrasonics|ultrasonics
523989|NCT00930254|intravenous infusions|intravenous infusions
523990|NCT00930241|Lung Transplantation|lung transplantation
523991|NCT00930241|Tacrolimus|tacrolimus
523992|NCT00930241|Deterioration of graft function|deterioration of graft function
523993|NCT00930228|Luteinizing hormone|luteinizing hormone
523994|NCT00930228|Testosterone|testosterone
523995|NCT00930215|Healthy volunteer|healthy volunteer
523996|NCT00930215|Japanese males|japanese males
523997|NCT00930215|homo-EM|homo-em
523998|NCT00930215|Bioequivalence study|bioequivalence study
523999|NCT00930202|Traumatic Brain Injury|traumatic brain injury
524000|NCT00930202|Conivaptan|conivaptan
524001|NCT00930202|Vaprisol|vaprisol
524002|NCT00930202|Sodium|sodium
524003|NCT00930189|age related macular degeneration|age related macular degeneration
524004|NCT00930163|Adult Asthma|adult asthma
524005|NCT00930150|Schizoaffective Disorder|schizoaffective disorder
524006|NCT00930137|Cardiovascular disease|cardiovascular disease
524007|NCT00930137|Trans fatty acids|trans fatty acids
524008|NCT00930137|Ruminant|ruminant
524009|NCT00930137|Blood lipids|blood lipids
524010|NCT00930137|Lipoproteins|lipoproteins
524011|NCT00930137|Women|women
524012|NCT00930124|cleft lip and palate|cleft lip and palate
524013|NCT00930124|distraction osteogenesis|distraction osteogenesis
524014|NCT00930124|conventional orthognathic surgery|conventional orthognathic surgery
524015|NCT00930124|stability|stability
524017|NCT00930124|soft tissue changes|soft tissue changes
524018|NCT00930124|psychological adjustment|psychological adjustment
524019|NCT00930124|speech changes|speech changes
524020|NCT00930124|velopharyngeal function|velopharyngeal function
524021|NCT00930111|inpatient|inpatient
524022|NCT00930111|hospitalists|hospitalists
524023|NCT00930111|residency|residency
524024|NCT00930111|job satisfaction|job satisfaction
524025|NCT00930111|burnout, professional|burnout, professional
524026|NCT00930111|professional practice|professional practice
524027|NCT00930111|medical education|medical education
524028|NCT00930098|acute lymphoblastic leukemia|acute lymphoblastic leukemia
524029|NCT00930098|clolar|clolar
524030|NCT00930098|evoltra|evoltra
524031|NCT00930098|clofarabine|clofarabine
524032|NCT00930098|refractory/relapsed acute leukemia|refractory/relapsed acute leukemia
524033|NCT00930098|pediatric acute leukemia|pediatric acute leukemia
524034|NCT00930085|sepsis|sepsis
524035|NCT00930085|septic shock|septic shock
524036|NCT00930059|Alzheimer's disease|alzheimer's disease
524037|NCT00930059|PF-04447943|pf-04447943
524038|NCT00930059|efficacy|efficacy
524039|NCT00930059|safety|safety
524040|NCT00930059|plasma concentrations|plasma concentrations
524041|NCT00930046|ropivacaine|ropivacaine
524042|NCT00930046|pediatric|pediatric
524043|NCT00930046|children|children
524044|NCT00930046|continuous|continuous
524045|NCT00930046|wound|wound
524046|NCT00930046|catheter|catheter
524047|NCT00930046|infusion|infusion
524048|NCT00930046|pyeloplasty|pyeloplasty
524049|NCT00930033|Nephrectomy,|nephrectomy,
524050|NCT00930033|metastatic renal cell carcinoma,|metastatic renal cell carcinoma,
524051|NCT00930033|sunitinib|sunitinib
524052|NCT00930020|ischemic stroke recovery|ischemic stroke recovery
524053|NCT00930020|minocycline|minocycline
524054|NCT00930020|neuroprotection|neuroprotection
524055|NCT00930020|acute stroke|acute stroke
524056|NCT00930007|Luteinizing hormone|luteinizing hormone
524057|NCT00930007|Puberty|puberty
524058|NCT00929994|cardiac rehab|cardiac rehab
524059|NCT00929981|Contact Dermatitis|contact dermatitis
524060|NCT00929981|Allergic Dermatitis|allergic dermatitis
524061|NCT00929968|Allergic rhinitis,|allergic rhinitis,
524062|NCT00929968|atopic patients,|atopic patients,
524063|NCT00929968|seasonal allergy,|seasonal allergy,
524064|NCT00929968|ragweed allergy|ragweed allergy
524065|NCT00929955|Anti inflammatory|anti inflammatory
524066|NCT00929955|Schizophrenia|schizophrenia
524067|NCT00929955|Simvastatin|simvastatin
524068|NCT00929955|ondansetron|ondansetron
524069|NCT00929942|lung transplantation|lung transplantation
524070|NCT00929942|bronchial stenosis|bronchial stenosis
524071|NCT00929942|biodegradable stent|biodegradable stent
524072|NCT00929929|Aging|aging
524073|NCT00929929|Functionality|functionality
524074|NCT00929929|Sarcopenia|sarcopenia
524075|NCT00929929|Leucine|leucine
524076|NCT00929929|Progressive resistance exercise|progressive resistance exercise
524077|NCT00929916|colonoscopy|colonoscopy
524078|NCT00929916|MoviPrep|moviprep
524079|NCT00929890|Obesity|obesity
524080|NCT00929890|Exercise|exercise
524081|NCT00929890|Diet|diet
524082|NCT00929890|Lifestyle|lifestyle
524083|NCT00929890|Vascular reactivity|vascular reactivity
524084|NCT00929890|Body composition|body composition
524085|NCT00929890|Lipids|lipids
524086|NCT00929890|Glucose|glucose
524087|NCT00929890|Insulin resistance|insulin resistance
524088|NCT00929838|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
524089|NCT00929838|Diabetes Mellitus, Adult-Onset|diabetes mellitus, adult-onset
524090|NCT00929838|Diabetes Mellitus, Non-Insulin-Dependent|diabetes mellitus, non-insulin-dependent
524091|NCT00929838|African Americans|african americans
524092|NCT00929838|Blacks|blacks
524093|NCT00929838|Randomized Controlled Trial|randomized controlled trial
524094|NCT00929838|Controlled Clinical Trial|controlled clinical trial
524095|NCT00929838|Behavioral Research|behavioral research
524096|NCT00929838|Behavioral Medicine|behavioral medicine
524097|NCT00929825|Salivary stimulation|salivary stimulation
524098|NCT00929825|Transplantation of hematopoietic stem cells|transplantation of hematopoietic stem cells
524099|NCT00929825|Hyperboloid|hyperboloid
524100|NCT00929825|Transcutaneous Electrical Stimulation|transcutaneous electrical stimulation
524101|NCT00929812|obesity|obesity
524102|NCT00929812|food intake|food intake
524103|NCT00929812|glucagon|glucagon
524104|NCT00929812|ghrelin|ghrelin
524105|NCT00929812|glucose|glucose
524106|NCT00929812|insulin|insulin
524107|NCT00929786|Plasma levels isoniazid rifampicin pyrazinamide|plasma levels isoniazid rifampicin pyrazinamide
524108|NCT00929760|Chronic Kidney disease|chronic kidney disease
524109|NCT00929760|Nephrologists|nephrologists
524110|NCT00929760|Primary Care|primary care
524111|NCT00929760|Death|death
524112|NCT00929760|Renal Replacement Therapy|renal replacement therapy
524113|NCT00929760|Specialised renal care|specialised renal care
524114|NCT00929747|Cataract|cataract
524115|NCT00929747|Toric|toric
524116|NCT00929747|IOL|iol
524117|NCT00929747|AcrySof, LRI|acrysof, lri
524118|NCT00929734|Inflammation|inflammation
524119|NCT00929734|Atherosclerosis|atherosclerosis
524120|NCT00929734|Hydroxymethylglutaryl-coenzyme A Reductase Inhibitors|hydroxymethylglutaryl-coenzyme a reductase inhibitors
524121|NCT00929721|CAP|cap
524122|NCT00929708|COPD|copd
524123|NCT00929708|Efficacy|efficacy
524124|NCT00929708|Safety|safety
524125|NCT00929708|Inhalation|inhalation
524126|NCT00929682|Labor|labor
524127|NCT00929682|Epidural analgesia|epidural analgesia
524128|NCT00929682|Local anesthetics|local anesthetics
524129|NCT00929682|Levobupivacaine|levobupivacaine
524130|NCT00929682|Opiates|opiates
524131|NCT00929682|Patient-controlled|patient-controlled
524132|NCT00929682|Active spontaneous labor requiring epidural analgesia|active spontaneous labor requiring epidural analgesia
524133|NCT00929669|pituitary tumor|pituitary tumor
524134|NCT00929669|endocrine|endocrine
524135|NCT00929656|Rehabilitation|rehabilitation
524136|NCT00929656|Neurophysiology|neurophysiology
524137|NCT00929656|Upper Extremity|upper extremity
524138|NCT00929643|health care costs|health care costs
524139|NCT00929643|Intra-Abdominal Infection|intra-abdominal infection
524140|NCT00929630|fibrin glue|fibrin glue
524141|NCT00929630|transsphincteric anal fistulas|transsphincteric anal fistulas
524142|NCT00929630|seton|seton
524143|NCT00929630|incontinence|incontinence
524144|NCT00929630|prospective randomised trial|prospective randomised trial
524145|NCT00929617|breast cancer|breast cancer
524146|NCT00929617|physical activity|physical activity
524147|NCT00929617|exercise|exercise
524148|NCT00929617|quality of life|quality of life
524149|NCT00929617|doubly labeled water|doubly labeled water
524150|NCT00929604|HIV|hiv
524151|NCT00929604|AIDS|aids
524152|NCT00929604|Zambia|zambia
524153|NCT00929604|viral load|viral load
524154|NCT00929604|antiretroviral therapy|antiretroviral therapy
524155|NCT00929604|cluster randomization|cluster randomization
524156|NCT00929604|ART monitoring|art monitoring
524157|NCT00929604|treatment failure|treatment failure
524158|NCT00929604|randomized clinical trial|randomized clinical trial
524159|NCT00929604|treatment naive|treatment naive
524160|NCT00929591|stage II breast cancer|stage ii breast cancer
524161|NCT00929591|stage IIIA breast cancer|stage iiia breast cancer
524162|NCT00929578|Psoriasis|psoriasis
524163|NCT00929578|T-lymphocytes|t-lymphocytes
524164|NCT00929578|Fluphenazine|fluphenazine
524165|NCT00929565|hemoptysis|hemoptysis
524166|NCT00929552|Blood pressure|blood pressure
524167|NCT00929552|Insulin sensitivity|insulin sensitivity
524168|NCT00929552|Blood lipid profile|blood lipid profile
524169|NCT00929539|Diabetes|diabetes
524170|NCT00929526|HPV vaccine|hpv vaccine
524171|NCT00929526|cervical intraepithelial neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
524172|NCT00929526|including new onset of autoimmune disease [NOAD])|including new onset of autoimmune disease [noad])
524173|NCT00929526|new onset of chronic disease (NOCD)|new onset of chronic disease (nocd)
524174|NCT00929526|medically significant condition (MSC)|medically significant condition (msc)
524175|NCT00929487|contact lens wear|contact lens wear
524176|NCT00929487|contact lens solution|contact lens solution
524177|NCT00929487|corneal staining|corneal staining
524178|NCT00929461|omega-3 fatty acids|omega-3 fatty acids
524179|NCT00929461|lactate|lactate
524180|NCT00929461|surgery|surgery
524181|NCT00929461|gastric cancer|gastric cancer
524182|NCT00929461|address the effect of postoperative administration of omega-3 fatty acids on cellular hypoperfusion associated with major gastric surgery.|address the effect of postoperative administration of omega-3 fatty acids on cellular hypoperfusion associated with major gastric surgery.
524183|NCT00929448|Traumatic brain injury|traumatic brain injury
524184|NCT00929435|MRSA|mrsa
524185|NCT00929435|Contact isolation|contact isolation
524186|NCT00929435|Incidence|incidence
524187|NCT00929422|spinal cord injury|spinal cord injury
524188|NCT00929422|PET|pet
524189|NCT00929422|cerebral function|cerebral function
524190|NCT00929422|cortical reorganization|cortical reorganization
524191|NCT00929409|Postpartum anemia, iron-deficiency|postpartum anemia, iron-deficiency
524192|NCT00929396|Tuberculosis|tuberculosis
524193|NCT00929396|Vaccine|vaccine
524194|NCT00929396|Ag85B|ag85b
524195|NCT00929396|ESAT-6|esat-6
524196|NCT00929396|IC31|ic31
524197|NCT00929383|Intracranial Atherosclerosis|intracranial atherosclerosis
524198|NCT00929383|Stenosis|stenosis
524199|NCT00929383|ICAD|icad
524200|NCT00929383|atherosclerotic lesions|atherosclerotic lesions
524201|NCT00929383|stenting|stenting
524202|NCT00929370|Schizophrenia|schizophrenia
524203|NCT00929370|GSK1018921|gsk1018921
524204|NCT00929370|GlyT-1 inhibitor|glyt-1 inhibitor
524205|NCT00929370|Healthy Volunteers|healthy volunteers
524206|NCT00929370|CSF|csf
524207|NCT00929370|Patient|patient
524208|NCT00929370|Midazolam|midazolam
524209|NCT00929344|Alcohol|alcohol
524210|NCT00929344|Alcohol treatment|alcohol treatment
524211|NCT00929344|Alcoholism|alcoholism
524212|NCT00929344|Alcohol Abuse|alcohol abuse
524213|NCT00929344|Alcohol Dependence|alcohol dependence
524214|NCT00929331|Influenza|influenza
524215|NCT00929331|Fluviral®|fluviral®
524216|NCT00929305|chronic pain|chronic pain
524217|NCT00929305|neck|neck
524218|NCT00929305|shoulder|shoulder
524400|NCT00928720|depression|depression
524219|NCT00929305|musculoskeletal origin|musculoskeletal origin
524220|NCT00929292|Infant formula|infant formula
524221|NCT00929292|Alpha-lactalbumin|alpha-lactalbumin
524222|NCT00929292|Protein composition|protein composition
524223|NCT00929292|Colic|colic
524224|NCT00929292|Probiotics|probiotics
524225|NCT00929279|Acute coronary syndrome|acute coronary syndrome
524226|NCT00929279|Abciximab|abciximab
524227|NCT00929279|Bolus|bolus
524228|NCT00929279|Infusion|infusion
524229|NCT00929279|platelet inhibition|platelet inhibition
524230|NCT00929279|Non ST segment elevation acute coronary syndrome|non st segment elevation acute coronary syndrome
524231|NCT00929266|peripheral stem cells (PSC) donors|peripheral stem cells (psc) donors
524232|NCT00929266|cultured red blood cells|cultured red blood cells
524233|NCT00929266|In vivo half life|in vivo half life
524234|NCT00929253|Opioid Dependence|opioid dependence
524235|NCT00929253|Opiates|opiates
524236|NCT00929253|Hydrocodone|hydrocodone
524237|NCT00929253|Oxycodone|oxycodone
524238|NCT00929253|Oxycontin|oxycontin
524239|NCT00929253|Narcotic Abuse|narcotic abuse
524240|NCT00929227|Atherosclerosis|atherosclerosis
524241|NCT00929227|Myocardial Ischemia|myocardial ischemia
524242|NCT00929227|Diagnostic Testing|diagnostic testing
524243|NCT00929227|Cardiac Commuted Tomography|cardiac commuted tomography
524244|NCT00929227|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
524245|NCT00929227|Coronary Artery Disease|coronary artery disease
524246|NCT00929214|Breast Cancer|breast cancer
524247|NCT00929214|Metastasized|metastasized
524248|NCT00929214|Limited bone-only metastasis|limited bone-only metastasis
524249|NCT00929214|Local Therapy|local therapy
524250|NCT00929214|Radiation|radiation
524251|NCT00929214|Radiation Therapy|radiation therapy
524252|NCT00929214|RT|rt
524253|NCT00929214|Surgery|surgery
524254|NCT00929214|Standard Therapy|standard therapy
524255|NCT00929214|Chemotherapy|chemotherapy
524256|NCT00929214|Endocrine Therapy|endocrine therapy
524257|NCT00929188|Moderate to severe chronic, cancer-related pain related to an active cancer|moderate to severe chronic, cancer-related pain related to an active cancer
524258|NCT00929188|Cancer-related pain|cancer-related pain
524259|NCT00929188|Moderate to severe chronic pain|moderate to severe chronic pain
524260|NCT00929188|JNJ-42160443|jnj-42160443
524261|NCT00929175|Hypertension|hypertension
524262|NCT00929175|Resistant Hypertension|resistant hypertension
524263|NCT00929175|Sleep apnea syndrome|sleep apnea syndrome
524264|NCT00929175|Treatment|treatment
524265|NCT00929162|ovarian|ovarian
524266|NCT00929162|cancer|cancer
524267|NCT00929162|chemotherapy|chemotherapy
524268|NCT00929162|sensitive|sensitive
524269|NCT00929162|ZD4054|zd4054
524270|NCT00929136|Endotoxin|endotoxin
524271|NCT00929136|Insulin resistance|insulin resistance
524272|NCT00929136|Lipolysis|lipolysis
524273|NCT00929136|Proteolysis|proteolysis
524274|NCT00929136|Intracellular Insulin Signaling|intracellular insulin signaling
524275|NCT00929136|Regional effects of inflammation/endotoxin|regional effects of inflammation/endotoxin
524276|NCT00929123|manual therapy|manual therapy
524277|NCT00929123|carpal tunnel syndrome|carpal tunnel syndrome
524278|NCT00929123|central sensitization|central sensitization
524279|NCT00929110|COPD|copd
524280|NCT00929110|NVA237|nva237
524281|NCT00929110|glycopyrronium bromide|glycopyrronium bromide
524282|NCT00929097|Colorectal Neoplasms, (Hereditary Nonpolyposis)|colorectal neoplasms, (hereditary nonpolyposis)
524283|NCT00929097|Guideline|guideline
524284|NCT00929097|Health Plan Implementation|health plan implementation
524285|NCT00929097|Decision Support Techniques|decision support techniques
524286|NCT00929097|Risk assessment|risk assessment
524287|NCT00929097|Familial colorectal cancer risk|familial colorectal cancer risk
524288|NCT00929097|Risk assessment tool|risk assessment tool
524289|NCT00929084|Race Disparities|race disparities
524290|NCT00929084|Breast Cancer|breast cancer
524291|NCT00929084|Quality of Life|quality of life
524292|NCT00929084|Treatment Adherence|treatment adherence
524293|NCT00929071|wrinkles|wrinkles
524294|NCT00929071|dermal filler|dermal filler
524295|NCT00929071|collagen|collagen
524296|NCT00929071|soft tissue augmentation|soft tissue augmentation
524297|NCT00929071|lidocaine|lidocaine
524298|NCT00929071|aesthetic|aesthetic
524299|NCT00929045|Growth Hormone replacement|growth hormone replacement
524300|NCT00929045|subject 8 to 21|subject 8 to 21
524301|NCT00929045|moderate to severe traumatic brain injury|moderate to severe traumatic brain injury
524302|NCT00929045|growth hormone deficient|growth hormone deficient
524303|NCT00929032|Liver Transplantation|liver transplantation
524304|NCT00929032|Immunosystem of the Liver|immunosystem of the liver
524305|NCT00929032|Marginal and Non-marginal grafts|marginal and non-marginal grafts
524306|NCT00929019|uveal melanoma|uveal melanoma
524307|NCT00929019|chromosome 3|chromosome 3
524308|NCT00929019|high risk|high risk
524309|NCT00929019|immunotherapy|immunotherapy
524310|NCT00929019|adjuvant|adjuvant
524429|NCT00928590|pigment dispersion|pigment dispersion
524311|NCT00929019|high risk genetic profile|high risk genetic profile
524312|NCT00929019|loss of chromosome 3|loss of chromosome 3
524313|NCT00929006|hyperandrogenemia|hyperandrogenemia
524315|NCT00929006|polycystic ovary syndrome|polycystic ovary syndrome
524316|NCT00928993|actigraphy|actigraphy
524317|NCT00928993|polysomnography|polysomnography
524318|NCT00928993|pediatrics|pediatrics
524319|NCT00928993|sleep|sleep
524320|NCT00928993|To validate Actigraphy against polysomnography|to validate actigraphy against polysomnography
524321|NCT00928980|Recurrent Major Depressive Disorder|recurrent major depressive disorder
524322|NCT00928980|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
524323|NCT00928980|Cost-effectiveness|cost-effectiveness
524324|NCT00928980|Antidepressant medication|antidepressant medication
524325|NCT00928980|Randomized Controlled Trial|randomized controlled trial
524326|NCT00928967|Multiple Sclerosis|multiple sclerosis
524327|NCT00928967|Quality of life|quality of life
524328|NCT00928954|gabapentin|gabapentin
524329|NCT00928954|memantine|memantine
524330|NCT00928954|nystagmus|nystagmus
524331|NCT00928954|Drug treatment|drug treatment
524332|NCT00928941|PTSD|ptsd
524333|NCT00928941|rehabilitation|rehabilitation
524334|NCT00928928|Lipid peroxidation|lipid peroxidation
524335|NCT00928928|Protein peroxidation|protein peroxidation
524336|NCT00928928|DNA peroxidation|dna peroxidation
524337|NCT00928928|RNA peroxidation|rna peroxidation
524338|NCT00928928|Cytokines|cytokines
524339|NCT00928928|hsCRP|hscrp
524340|NCT00928928|Oxidative stress markers|oxidative stress markers
524341|NCT00928928|Open surgery|open surgery
524342|NCT00928928|Laparoscopic surgery|laparoscopic surgery
524343|NCT00928915|Intracranial Hemorrhages|intracranial hemorrhages
524344|NCT00928915|Vitamin-K antagonist|vitamin-k antagonist
524345|NCT00928915|Hemostatic treatment|hemostatic treatment
524346|NCT00928915|Prothrombin complex|prothrombin complex
524347|NCT00928915|Fresh frozen plasma|fresh frozen plasma
524348|NCT00928915|Intracranial Hemorrhages related to vitamin-K antagonist|intracranial hemorrhages related to vitamin-k antagonist
524349|NCT00928902|melanoma|melanoma
524350|NCT00928902|vaccine|vaccine
524351|NCT00928902|peptides|peptides
524352|NCT00928902|adjuvant|adjuvant
524353|NCT00928902|immunogenicity|immunogenicity
524354|NCT00928902|stage IIB, stage III or resected stage IV|stage iib, stage iii or resected stage iv
524355|NCT00928889|diabetes mellitus, type 2|diabetes mellitus, type 2
524356|NCT00928889|nateglinide|nateglinide
524357|NCT00928889|acarbose|acarbose
524358|NCT00928889|hyperglycemia|hyperglycemia
524359|NCT00928889|dyslipidemias|dyslipidemias
524360|NCT00928889|C-reactive protein|c-reactive protein
524361|NCT00928876|anakinra|anakinra
524362|NCT00928876|Diabetes mellitus, type 2|diabetes mellitus, type 2
524363|NCT00928876|Insulin resistance|insulin resistance
524364|NCT00928876|Interleukin-1beta|interleukin-1beta
524365|NCT00928863|haemorrhagia postpartum|haemorrhagia postpartum
524366|NCT00928863|implementation guidelines|implementation guidelines
524367|NCT00928863|maternal morbidity|maternal morbidity
524368|NCT00928863|management of obstetrics and trauma|management of obstetrics and trauma
524369|NCT00928850|Prostate|prostate
524370|NCT00928850|Radical Prostatectomy|radical prostatectomy
524371|NCT00928850|urethral irrigation|urethral irrigation
524372|NCT00928850|fascial suturing|fascial suturing
524373|NCT00928850|09-051|09-051
524374|NCT00928811|Simulect|simulect
524375|NCT00928811|de novo kidney transplant subjects|de novo kidney transplant subjects
524376|NCT00928811|calcineurin inhibitors|calcineurin inhibitors
524377|NCT00928811|Prograf|prograf
524378|NCT00928785|Tetanus Vaccine|tetanus vaccine
524379|NCT00928785|Tdap-IPV vaccine|tdap-ipv vaccine
524380|NCT00928772|Cranial Electro Stimulation|cranial electro stimulation
524381|NCT00928772|First Eye Cataract Surgery|first eye cataract surgery
524382|NCT00928772|Preoperative sedation|preoperative sedation
524383|NCT00928772|Perioperative sedation|perioperative sedation
524384|NCT00928759|Obesity|obesity
524385|NCT00928759|Polycystic Ovary Syndrome|polycystic ovary syndrome
524386|NCT00928733|Permeability|permeability
524387|NCT00928733|tight junctions|tight junctions
524388|NCT00928733|cytokines|cytokines
524389|NCT00928733|inflammatory bowel diseases|inflammatory bowel diseases
524390|NCT00928733|The effect of alcohol on the intestinal permeability may have major consequences on health.|the effect of alcohol on the intestinal permeability may have major consequences on health.
524391|NCT00928733|It's generally accepted that an increased intestinal permeability in alcoholic subjects lead|it's generally accepted that an increased intestinal permeability in alcoholic subjects lead
524392|NCT00928733|to translocation of bacterial endotoxins from the gut lumen into the portal vein and then to the liver.|to translocation of bacterial endotoxins from the gut lumen into the portal vein and then to the liver.
524393|NCT00928733|In the liver, endotoxins trigger the immune system and activate the resident macrophages, Kupffer cells.|in the liver, endotoxins trigger the immune system and activate the resident macrophages, kupffer cells.
524394|NCT00928733|Activation of Kupffer cells leads to production of chemokines (IL-8) and|activation of kupffer cells leads to production of chemokines (il-8) and
524395|NCT00928733|proinflammatory cytokines (IL-1, TNFα),resulting in hepatocytes damage, inflammation, fibrosis and finally cirrhosis.|proinflammatory cytokines (il-1, tnfα),resulting in hepatocytes damage, inflammation, fibrosis and finally cirrhosis.
524396|NCT00928720|fibromyalgia|fibromyalgia
524397|NCT00928720|pain|pain
524398|NCT00928720|sleep disturbance|sleep disturbance
524399|NCT00928720|fatigue|fatigue
524401|NCT00928720|functional magnetic resonance imaging|functional magnetic resonance imaging
524402|NCT00928707|Polycythemia Vera|polycythemia vera
524403|NCT00928707|GIVINOSTAT|givinostat
524404|NCT00928707|ITF2357|itf2357
524405|NCT00928655|apnea|apnea
524406|NCT00928655|sleep|sleep
524407|NCT00928655|altitude|altitude
524408|NCT00928655|hypoxia|hypoxia
524409|NCT00928655|treatment|treatment
524410|NCT00928655|CPAP|cpap
524411|NCT00928642|ovarian|ovarian
524412|NCT00928642|cancer|cancer
524413|NCT00928642|peritoneal|peritoneal
524414|NCT00928642|endometrioid|endometrioid
524415|NCT00928642|mucinous|mucinous
524416|NCT00928642|serous|serous
524417|NCT00928642|clear cell|clear cell
524418|NCT00928629|Peripheral Arterial Disease|peripheral arterial disease
524419|NCT00928629|Cardiovascular Disease|cardiovascular disease
524420|NCT00928629|Vascular Disease|vascular disease
524421|NCT00928616|hyperlipidemia|hyperlipidemia
524422|NCT00928616|plant sterols|plant sterols
524423|NCT00928616|monocytes|monocytes
524424|NCT00928603|prostate cancer|prostate cancer
524425|NCT00928603|therapy|therapy
524426|NCT00928590|open-angle glaucoma|open-angle glaucoma
524427|NCT00928590|ocular hypertension|ocular hypertension
524428|NCT00928590|pseudoexfoliation|pseudoexfoliation
524430|NCT00928577|Smallpox|smallpox
524431|NCT00928577|Smallpox Vaccine|smallpox vaccine
524432|NCT00928577|Vaccinia virus|vaccinia virus
524433|NCT00928577|Military|military
524434|NCT00928564|Pelvic floor muscle spasm|pelvic floor muscle spasm
524435|NCT00928564|Pelvic pain|pelvic pain
524436|NCT00928564|physical therapy|physical therapy
524437|NCT00928564|pudendal block|pudendal block
524438|NCT00928538|Female Contraception|female contraception
524439|NCT00928538|Home Visits|home visits
524440|NCT00928538|CONTRACEPTIVE AGENTS|contraceptive agents
524441|NCT00928538|CONTRACEPTIVE DEVICES|contraceptive devices
524442|NCT00928525|PDGFr alpha|pdgfr alpha
524443|NCT00928525|PDGFr beta|pdgfr beta
524444|NCT00928525|KIT|kit
524445|NCT00928512|Rheumatoid Arthritis, RA, ACR, inflammatory joints|rheumatoid arthritis, ra, acr, inflammatory joints
524446|NCT00928499|urge/frequency|urge/frequency
524447|NCT00928499|urge incontinence|urge incontinence
524448|NCT00928499|Interstim|interstim
524449|NCT00928499|after success Interstim planning IPG placement|after success interstim planning ipg placement
524450|NCT00928460|Electrocardiogram|electrocardiogram
524451|NCT00928460|Electrocardiography|electrocardiography
524452|NCT00928460|Perioperative care|perioperative care
524453|NCT00928460|Preoperative care|preoperative care
524454|NCT00928460|Preanesthesia Evaluation|preanesthesia evaluation
524455|NCT00928460|Acute Coronary Syndrome|acute coronary syndrome
524456|NCT00928460|Postoperative Myocardial Infarction|postoperative myocardial infarction
524457|NCT00928460|Myocardial ischaemia|myocardial ischaemia
524458|NCT00928460|Postoperative Cardiac Death|postoperative cardiac death
524459|NCT00928460|Intraoperative complications|intraoperative complications
524460|NCT00928460|Postoperative complications|postoperative complications
524461|NCT00928460|Cost-effectiveness analysis|cost-effectiveness analysis
524462|NCT00928447|rHuPH20|rhuph20
524463|NCT00928447|Recombinant Human hyaluronidase|recombinant human hyaluronidase
524464|NCT00928421|Varicose Veins|varicose veins
524465|NCT00928395|Urgent PC|urgent pc
524466|NCT00928395|Overactive Bladder|overactive bladder
524467|NCT00928395|SUmiT Trial|sumit trial
524468|NCT00928395|Overactive Urinary Bladder|overactive urinary bladder
524469|NCT00928382|Spinal Cord|spinal cord
524470|NCT00928382|Healthy Volunteer|healthy volunteer
524471|NCT00928382|Metastasis|metastasis
524472|NCT00928382|Samples|samples
524473|NCT00928382|Spinal Cord Vertebrae|spinal cord vertebrae
524474|NCT00928382|Cancer|cancer
524475|NCT00928382|HV|hv
524476|NCT00928356|Coronary Artery Disease|coronary artery disease
524477|NCT00928356|Robotic Coronary Artery Bypass Surgery|robotic coronary artery bypass surgery
524478|NCT00928356|Percutaneous Coronary Intervention|percutaneous coronary intervention
524479|NCT00928356|Hybrid Coronary Revascularization|hybrid coronary revascularization
524480|NCT00928343|Safety|safety
524481|NCT00928343|Tolerability|tolerability
524482|NCT00928343|Pharmacokinetics|pharmacokinetics
524483|NCT00928330|TDM-1|tdm-1
524484|NCT00928330|HER2|her2
524485|NCT00928330|HER2+|her2+
524486|NCT00928330|HER2+ Breast Cancer|her2+ breast cancer
524487|NCT00928330|HER-2|her-2
524488|NCT00928330|MBC|mbc
524489|NCT00928330|Trastuzumab emtansine|trastuzumab emtansine
524490|NCT00928304|Amyloid beta-protein|amyloid beta-protein
524491|NCT00928304|Down Syndrome|down syndrome
524492|NCT00928291|procalcitonin|procalcitonin
524493|NCT00928291|neutropenia|neutropenia
524494|NCT00928291|febrile neutropenia|febrile neutropenia
524495|NCT00928291|antibiotic therapy|antibiotic therapy
524496|NCT00928291|neutropenic patients|neutropenic patients
524497|NCT00928265|intracranial|intracranial
524498|NCT00928265|stenting|stenting
524499|NCT00928265|endovascular treatment|endovascular treatment
524500|NCT00928265|stent-assisted coiling|stent-assisted coiling
524501|NCT00928265|cerebrovascular disease|cerebrovascular disease
524502|NCT00928252|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
524503|NCT00928252|Castrate Resistant Prostate Cancer|castrate resistant prostate cancer
524504|NCT00928239|vaginal vault prolapse|vaginal vault prolapse
524505|NCT00928239|laparoscopic sacropexy|laparoscopic sacropexy
524506|NCT00928213|Preeclampsia|preeclampsia
524507|NCT00928213|IUGR|iugr
524508|NCT00928213|GH|gh
524509|NCT00928213|PP13|pp13
524510|NCT00928213|Doppler|doppler
524511|NCT00928213|placenta|placenta
524512|NCT00928213|PTD|ptd
524513|NCT00928213|Preterm delivery|preterm delivery
524514|NCT00928200|Relapsed|relapsed
524515|NCT00928200|Allergy|allergy
524516|NCT00928200|Erwinia|erwinia
524517|NCT00928200|Acute|acute
524518|NCT00928200|Lymphoblastic|lymphoblastic
524519|NCT00928200|Leukemia|leukemia
524520|NCT00928187|HIV|hiv
524521|NCT00928187|Second line treatment|second line treatment
524522|NCT00928187|WHO recommendations|who recommendations
524523|NCT00928187|Africa|africa
524524|NCT00928187|Treatment strategies|treatment strategies
524525|NCT00928187|treatment experienced|treatment experienced
524526|NCT00928174|Androgen insensitive prostate cancer|androgen insensitive prostate cancer
524527|NCT00928161|Reflux Disease|reflux disease
524528|NCT00928161|Acid-reflux|acid-reflux
524529|NCT00928161|Head and Neck Cancer|head and neck cancer
524530|NCT00928161|HNC|hnc
524531|NCT00928161|Radiation Therapy|radiation therapy
524532|NCT00928161|Mucositis|mucositis
524533|NCT00928161|Radiation-induced xerostomia|radiation-induced xerostomia
524534|NCT00928161|RIX|rix
524535|NCT00928161|Dry Mouth|dry mouth
524536|NCT00928161|Heartburn|heartburn
524537|NCT00928161|Dexlansoprazole|dexlansoprazole
524538|NCT00928161|Prevacid|prevacid
524539|NCT00928161|Prevacid Solu-Tab|prevacid solu-tab
524540|NCT00928161|GERD|gerd
524541|NCT00928109|eating disorders|eating disorders
524542|NCT00928109|couples therapy|couples therapy
524543|NCT00928096|Lymphoma|lymphoma
524544|NCT00928096|Radiotherapy|radiotherapy
524545|NCT00928096|Positron-Emission Tomography|positron-emission tomography
524546|NCT00928096|CT scan|ct scan
524547|NCT00928083|Phase I|phase i
524548|NCT00928083|Safety and tolerability|safety and tolerability
524549|NCT00928083|Pharmacokinetic|pharmacokinetic
524550|NCT00928083|synthetic peroxide|synthetic peroxide
524551|NCT00928083|trioxolane|trioxolane
524552|NCT00928083|treatment of erythrocytic stages of malaria|treatment of erythrocytic stages of malaria
524553|NCT00928070|Urgency Urinary Incontinence OAB|urgency urinary incontinence oab
524554|NCT00928057|Pen Needle|pen needle
524555|NCT00928057|Diabetes|diabetes
524556|NCT00928057|Insulin|insulin
524557|NCT00928057|Glycemic|glycemic
524558|NCT00928057|Pain|pain
524559|NCT00928057|Fructosamine|fructosamine
524560|NCT00928057|Leakage|leakage
524561|NCT00928057|Hypoglycemia|hypoglycemia
524562|NCT00928057|Hyperglycemia|hyperglycemia
524563|NCT00928018|allogeneic stem cell transplant|allogeneic stem cell transplant
524564|NCT00928018|reduced intensity conditioning|reduced intensity conditioning
524565|NCT00928018|graft versus host disease|graft versus host disease
524566|NCT00928018|GVHD|gvhd
524567|NCT00928018|RIC transplantation|ric transplantation
524568|NCT00928005|Weight loss diet|weight loss diet
524569|NCT00928005|Exercise training|exercise training
524570|NCT00928005|Type 2 diabetes|type 2 diabetes
524571|NCT00928005|Prediabetes|prediabetes
524572|NCT00928005|Cardiovascular health|cardiovascular health
524573|NCT00927966|RAD001|rad001
524574|NCT00927966|CP-751,871|cp-751,871
524575|NCT00927966|advanced sarcoma|advanced sarcoma
524576|NCT00927966|advanced malignant solid tumor|advanced malignant solid tumor
524577|NCT00927953|West Nile virus|west nile virus
524578|NCT00927953|WNV|wnv
524579|NCT00927953|Encephalitis|encephalitis
524580|NCT00927953|Meningitis|meningitis
524581|NCT00927953|Acute Flaccid Paralysis|acute flaccid paralysis
524582|NCT00927953|Monoclonal Antibody|monoclonal antibody
524583|NCT00927953|WNND|wnnd
524584|NCT00927953|West Nile Fever|west nile fever
524585|NCT00927953|WNF|wnf
524586|NCT00927940|TARGET VESSEL REVASCULARIZATION (TVR)|target vessel revascularization (tvr)
524587|NCT00927940|MYOCARDIAL INFARCTION (MI)|myocardial infarction (mi)
524588|NCT00927940|TARGET VESSEL FAILURE (TVF)|target vessel failure (tvf)
524589|NCT00927940|TARGET LESION REVASCULARIZATION (TLR)|target lesion revascularization (tlr)
524590|NCT00927940|TARGET LESION FAILURE (TLF)|target lesion failure (tlf)
524591|NCT00927940|STENT THROMBOSIS|stent thrombosis
524592|NCT00927940|RESTENOTIC LESION|restenotic lesion
524593|NCT00927940|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
524594|NCT00927901|QAB149|qab149
524595|NCT00927901|asthma|asthma
524596|NCT00927901|indacaterol salts (acetate, maleate, and xinafoate)|indacaterol salts (acetate, maleate, and xinafoate)
524597|NCT00927901|orally inhaled indacaterol salts|orally inhaled indacaterol salts
524598|NCT00927901|persistent asthma|persistent asthma
524599|NCT00927862|warfarin metabolism|warfarin metabolism
524600|NCT00927862|CYP2C9|cyp2c9
524601|NCT00927862|genotyping|genotyping
524602|NCT00927862|VKORC1|vkorc1
524603|NCT00927862|anticoagulation|anticoagulation
524604|NCT00927862|atrial fibrillation|atrial fibrillation
524605|NCT00927862|deep vein thrombosis|deep vein thrombosis
524606|NCT00927862|pulmonary embolism|pulmonary embolism
524607|NCT00927862|Patients initiating warfarin for thromboembolic conditions|patients initiating warfarin for thromboembolic conditions
524608|NCT00927849|anal hypertonia|anal hypertonia
524609|NCT00927849|sphincterotomy|sphincterotomy
524610|NCT00927849|incontinence|incontinence
524611|NCT00927849|manometry|manometry
524612|NCT00927810|Gout|gout
524613|NCT00927810|Gouty arthritis|gouty arthritis
524614|NCT00927810|Gout flares|gout flares
524615|NCT00927810|Anti-interleukin-1β monoclonal antibody|anti-interleukin-1β monoclonal antibody
524616|NCT00927797|immunochemotherapy|immunochemotherapy
524617|NCT00927797|Pentostatin|pentostatin
524618|NCT00927797|Cyclophosphamide|cyclophosphamide
524619|NCT00927797|Rituximab|rituximab
524620|NCT00927797|Maintenance|maintenance
524621|NCT00927797|indolent B-NHL|indolent b-nhl
524622|NCT00927797|B-CLL|b-cll
524623|NCT00927797|B-NHL|b-nhl
524624|NCT00927784|Mesenchymal Precursor Cells|mesenchymal precursor cells
524625|NCT00927784|Left Ventricular Assist Device|left ventricular assist device
524626|NCT00927784|LVAD|lvad
524627|NCT00927784|Congestive Heart Failure|congestive heart failure
524628|NCT00927784|Stem Cells|stem cells
524629|NCT00927771|melanosis|melanosis
524630|NCT00927771|melasma|melasma
524631|NCT00927771|azelaic acid|azelaic acid
524632|NCT00927771|hydroquinone|hydroquinone
524633|NCT00927745|Respiration Artificial|respiration artificial
524634|NCT00927745|Positive-Pressure Respiration|positive-pressure respiration
524635|NCT00927745|Critical Care|critical care
524636|NCT00927745|Intensive Care Units|intensive care units
524637|NCT00927732|Brugada|brugada
524638|NCT00927732|hydroquinidine|hydroquinidine
524639|NCT00927732|ventricular arrhythmia|ventricular arrhythmia
524640|NCT00927732|patients with Brugada syndrome, high cardiac arrhythmic risk and implanted with an implantable cardioverter defibrillator|patients with brugada syndrome, high cardiac arrhythmic risk and implanted with an implantable cardioverter defibrillator
524641|NCT00927719|Smallpox|smallpox
524642|NCT00927719|Smallpox Vaccine|smallpox vaccine
524643|NCT00927719|Vaccinia virus|vaccinia virus
524644|NCT00927719|Military|military
524645|NCT00927706|Assistive Technology|assistive technology
524646|NCT00927706|Mobility Limitation|mobility limitation
524647|NCT00927706|Physical Disability|physical disability
524648|NCT00927706|Caregiver|caregiver
524649|NCT00927706|Participation|participation
524650|NCT00927693|Atherosclerosis|atherosclerosis
524651|NCT00927693|Coronary Artery Disease|coronary artery disease
524652|NCT00927693|Cardiac Risk Factors|cardiac risk factors
524653|NCT00927693|Coronary Calcium Scan|coronary calcium scan
524654|NCT00927693|Prevention|prevention
524655|NCT00927680|Colorectal Cancer|colorectal cancer
524656|NCT00927680|Familial Colorectal Cancer|familial colorectal cancer
524657|NCT00927680|Genetics|genetics
524658|NCT00927680|Hispanics|hispanics
524659|NCT00927667|Hemophilia A|hemophilia a
524660|NCT00927667|Joint Status|joint status
524661|NCT00927667|Bleeds|bleeds
524662|NCT00927667|Magnetic Resonce Imaging|magnetic resonce imaging
524663|NCT00927654|Iloprost|iloprost
524664|NCT00927654|pulmonary hypertension|pulmonary hypertension
524665|NCT00927654|cardio pulmonary morbidity|cardio pulmonary morbidity
524666|NCT00927654|high risk cardiac surgical patients|high risk cardiac surgical patients
524667|NCT00927641|Ankle Sprain|ankle sprain
524668|NCT00927628|vitrectomy|vitrectomy
524669|NCT00927628|macular hole|macular hole
524670|NCT00927628|ILM peeling|ilm peeling
524671|NCT00927615|myocardial infarction|myocardial infarction
524672|NCT00927615|glycoprotein IIb/IIIa|glycoprotein iib/iiia
524673|NCT00927615|percutaneous coronary intervention|percutaneous coronary intervention
524674|NCT00927615|thrombus aspiration|thrombus aspiration
524675|NCT00927615|myocardial perfusion|myocardial perfusion
524676|NCT00927602|renal failure|renal failure
524677|NCT00927602|medical patient|medical patient
524678|NCT00927602|venous thromboembolism|venous thromboembolism
524679|NCT00927602|prophylaxis|prophylaxis
524680|NCT00927602|fondaparinux|fondaparinux
524681|NCT00927589|HER2+ Metastatic Cancer|her2+ metastatic cancer
524682|NCT00927589|HER2+ Locally Advanced Inoperable Cancer|her2+ locally advanced inoperable cancer
524683|NCT00927589|HER2+ Solid Malignancy|her2+ solid malignancy
524684|NCT00927576|cognitive training|cognitive training
524685|NCT00927576|neuroplasticity|neuroplasticity
524686|NCT00927576|cognitive impairment|cognitive impairment
524687|NCT00927576|recovery of function|recovery of function
524688|NCT00927576|memory|memory
524689|NCT00927576|attention|attention
524690|NCT00927563|Gambling|gambling
524691|NCT00927563|Addiction|addiction
524692|NCT00927550|resistant depression|resistant depression
524693|NCT00927550|lithium|lithium
524695|NCT00927550|lithium therapy|lithium therapy
524696|NCT00927550|standard therapy|standard therapy
524697|NCT00927537|Hypertension|hypertension
524698|NCT00927524|Insulin analogs|insulin analogs
524699|NCT00927524|diabetes|diabetes
524700|NCT00927511|metastatic hormone-responsive breast cancer menopausal women|metastatic hormone-responsive breast cancer menopausal women
524701|NCT00927498|Acute myeloid Leukemia|acute myeloid leukemia
524702|NCT00927498|patient aged 50 to 70 years|patient aged 50 to 70 years
524703|NCT00927485|Familial Adenomatous Polyposis (FAP)|familial adenomatous polyposis (fap)
524704|NCT00927485|Curcumin|curcumin
524705|NCT00927485|Colorectal polyps|colorectal polyps
524706|NCT00927485|Duodenal polyps|duodenal polyps
524707|NCT00927472|Head Lice|head lice
524708|NCT00927459|cholesterol|cholesterol
524709|NCT00927459|coronary artery disease|coronary artery disease
524710|NCT00927446|esophageal cancer|esophageal cancer
524711|NCT00927446|head and neck cancer|head and neck cancer
524712|NCT00927446|narrow band imaging|narrow band imaging
524713|NCT00927446|endoscopy|endoscopy
524714|NCT00927446|screening|screening
524715|NCT00927433|Fatigue|fatigue
524716|NCT00927433|Cancer|cancer
524717|NCT00927433|Radiation therapy|radiation therapy
524718|NCT00927433|Chemotherapy|chemotherapy
524719|NCT00927433|Hormones|hormones
524720|NCT00927433|Surgery|surgery
524721|NCT00927433|Breast cancer|breast cancer
524722|NCT00927420|Bipolar disorder|bipolar disorder
524723|NCT00927420|adherence|adherence
524724|NCT00927420|treatment|treatment
524725|NCT00927420|real life practice|real life practice
524726|NCT00927407|Head Lice|head lice
524727|NCT00927394|Hypertension, Type II Diabetes, Aliskiren, Valsartan,|hypertension, type ii diabetes, aliskiren, valsartan,
524728|NCT00927394|Systolic blood pressure, Diastolic blood pressure,|systolic blood pressure, diastolic blood pressure,
524729|NCT00927394|Stage II, Combination|stage ii, combination
524730|NCT00927368|TKA|tka
524731|NCT00927368|total knee replacement|total knee replacement
524732|NCT00927355|pioglitazone|pioglitazone
524733|NCT00927355|human bone marrow stem cells|human bone marrow stem cells
524734|NCT00927355|adipocytes|adipocytes
524735|NCT00927355|osteoblasts|osteoblasts
524736|NCT00927355|bone mineral density|bone mineral density
524737|NCT00927355|adiponectin|adiponectin
524738|NCT00927355|leptin|leptin
524739|NCT00927355|CTX|ctx
524740|NCT00927355|P1NP|p1np
524741|NCT00927355|Osteocalcin|osteocalcin
524742|NCT00927342|Air leak|air leak
524743|NCT00927342|Thoracic Surgery|thoracic surgery
524744|NCT00927342|Sealants|sealants
524745|NCT00927329|Dermatophagoides|dermatophagoides
524746|NCT00927329|farinae|farinae
524747|NCT00927329|allergen|allergen
524748|NCT00927329|dust|dust
524749|NCT00927329|allergic|allergic
524750|NCT00927329|mite|mite
524751|NCT00927329|allergy|allergy
524752|NCT00927316|Report of Urinary Tract Infection episode|report of urinary tract infection episode
524753|NCT00927303|retinal thickness|retinal thickness
524754|NCT00927303|threshold algorithm|threshold algorithm
524755|NCT00927303|optical coherence tomography|optical coherence tomography
524756|NCT00927290|hepatitis C; insulin resistance; glitazones; pioglitazone; steatosis; viral kinetics; antiviral response|hepatitis c; insulin resistance; glitazones; pioglitazone; steatosis; viral kinetics; antiviral response
524757|NCT00927264|tobacco smoke exposure smoking|tobacco smoke exposure smoking
524758|NCT00927251|heart failure|heart failure
524759|NCT00927251|cardiac pacing|cardiac pacing
524760|NCT00927251|cardiac resynchronization therapy|cardiac resynchronization therapy
524761|NCT00927251|left ventricular lead|left ventricular lead
524762|NCT00927238|Single Level|single level
524763|NCT00927238|Lumbar Disc Disease|lumbar disc disease
524764|NCT00927238|DDD|ddd
524765|NCT00927199|High-Oleic Canola Oil|high-oleic canola oil
524766|NCT00927199|Flaxseed Oil|flaxseed oil
524767|NCT00927199|Monounsaturated Fatty Acids|monounsaturated fatty acids
524768|NCT00927199|Polyunsaturated Fatty Acids|polyunsaturated fatty acids
524769|NCT00927199|Alpha Linolenic Acid|alpha linolenic acid
524770|NCT00927199|Cardiovascular|cardiovascular
524771|NCT00927199|Hypercholesterolemia|hypercholesterolemia
524772|NCT00927199|Lipids|lipids
524773|NCT00927199|Inflammation|inflammation
524774|NCT00927199|Metabolism|metabolism
524775|NCT00927186|osteoporosis|osteoporosis
524776|NCT00927186|teriparatide|teriparatide
524777|NCT00927186|zoledronic acid|zoledronic acid
524778|NCT00927186|histomorphometry|histomorphometry
524779|NCT00927186|bone biopsy|bone biopsy
524780|NCT00927186|postmenopausal|postmenopausal
524781|NCT00927173|TMS|tms
524782|NCT00927173|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
524783|NCT00927173|MDD|mdd
524784|NCT00927173|Major Depressive Disorder|major depressive disorder
524785|NCT00927160|Mobile Acute Care of the Elderly Unit|mobile acute care of the elderly unit
524786|NCT00927160|Geriatric Models of Care|geriatric models of care
524787|NCT00927147|head and neck cancer|head and neck cancer
524788|NCT00927147|boron neutron capture therapy|boron neutron capture therapy
524789|NCT00927147|cetuximab|cetuximab
524790|NCT00927147|epidermal growth factor receptor|epidermal growth factor receptor
524791|NCT00927147|safety|safety
524792|NCT00927147|efficacy|efficacy
524793|NCT00927147|survival|survival
524794|NCT00927134|Chronic Granulomatous Disease in children (=or< 18 years)|chronic granulomatous disease in children (=or< 18 years)
524795|NCT00927108|Adult Progenitor Stem cells|adult progenitor stem cells
524796|NCT00927108|Alzheimer's disease|alzheimer's disease
524797|NCT00927108|Parkinson's disease|parkinson's disease
524798|NCT00927108|Multiple sclerosis|multiple sclerosis
524799|NCT00927095|PMDD|pmdd
524800|NCT00927095|Oral contraceptives|oral contraceptives
524801|NCT00927095|steroid hormones|steroid hormones
524802|NCT00927095|neurosteroids|neurosteroids
524803|NCT00927069|Adalimumab|adalimumab
524804|NCT00927030|Autism|autism
524805|NCT00927030|children|children
524806|NCT00927030|sleep|sleep
524807|NCT00927030|insomnia|insomnia
524808|NCT00927017|Healthy volunteers|healthy volunteers
524809|NCT00927004|mechanical hyperalgesia|mechanical hyperalgesia
524810|NCT00927004|cold hyperalgesia|cold hyperalgesia
524811|NCT00927004|chronic pain|chronic pain
524812|NCT00926978|Thyroid|thyroid
524813|NCT00926978|I-124|i-124
524814|NCT00926965|tardive dyskinesia|tardive dyskinesia
524815|NCT00926965|neurocognitive function|neurocognitive function
524816|NCT00926952|Actinic keratoses|actinic keratoses
524817|NCT00926952|actinic keratosis|actinic keratosis
524818|NCT00926952|methylamonolevulinate|methylamonolevulinate
524819|NCT00926952|photodynamic therapy|photodynamic therapy
524820|NCT00926952|without occlusion|without occlusion
524821|NCT00926952|short incubation|short incubation
524822|NCT00926939|Cigarette|cigarette
524823|NCT00926939|Nicotine|nicotine
524824|NCT00926939|Smoking|smoking
524825|NCT00926939|Contingency Management|contingency management
524826|NCT00926939|Voucher reinforcement|voucher reinforcement
524827|NCT00926939|Smoking Abstinence|smoking abstinence
524828|NCT00926939|Internet-based treatment|internet-based treatment
524829|NCT00926926|Healthy volunteer|healthy volunteer
524830|NCT00926913|Macular Degeneration|macular degeneration
524831|NCT00926900|Alcoholism|alcoholism
524832|NCT00926900|D-cycloserine|d-cycloserine
524833|NCT00926900|extinction|extinction
524834|NCT00926900|cue-exposure|cue-exposure
524835|NCT00926874|ischaemic stroke|ischaemic stroke
524836|NCT00926874|acute coronary syndrome|acute coronary syndrome
524837|NCT00926874|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
524838|NCT00926874|brachial endothelial function|brachial endothelial function
524839|NCT00926874|blood pressure|blood pressure
524840|NCT00926874|aortic stiffness|aortic stiffness
524841|NCT00926861|age-related macular degeneration|age-related macular degeneration
524842|NCT00926861|detachment of the posterior hyaloid|detachment of the posterior hyaloid
524843|NCT00926861|AMD|amd
524844|NCT00926848|coronary heart disease|coronary heart disease
524845|NCT00926848|cardiac rehabilitation|cardiac rehabilitation
524846|NCT00926848|lifestyle change|lifestyle change
524847|NCT00926848|coronary artery bypass graft|coronary artery bypass graft
524848|NCT00926848|social support|social support
524849|NCT00926848|social cognitive learning theory|social cognitive learning theory
524850|NCT00926809|endoscopic mucosal resection|endoscopic mucosal resection
524851|NCT00926809|iatrogenic|iatrogenic
524852|NCT00926796|gonorrhea, gonococcal infections, Neisseria gonorrhoeae|gonorrhea, gonococcal infections, neisseria gonorrhoeae
524853|NCT00926783|paroxysmal|paroxysmal
524854|NCT00926783|persistent|persistent
524855|NCT00926783|targeted|targeted
524856|NCT00926783|generalized|generalized
524857|NCT00926783|CFAE|cfae
524858|NCT00926757|lymphoma|lymphoma
524859|NCT00926757|CD20|cd20
524860|NCT00926757|Hepatitis B virus|hepatitis b virus
524861|NCT00926757|reactivation|reactivation
524862|NCT00926757|Rituximab|rituximab
524863|NCT00926744|physical activity|physical activity
524864|NCT00926744|nutrition|nutrition
524865|NCT00926744|cardiovascular diseases|cardiovascular diseases
524866|NCT00926744|musculo-skeletal problems|musculo-skeletal problems
524867|NCT00926731|Acute Myeloid Leukaemia (AML)|acute myeloid leukaemia (aml)
524868|NCT00926718|BIS monitor|bis monitor
524869|NCT00926718|rocuronium|rocuronium
524870|NCT00926718|The effect of the neuromuscular blocking drug rocuronium on the response of the Composite Variability Index to laryngoscopy|the effect of the neuromuscular blocking drug rocuronium on the response of the composite variability index to laryngoscopy
524871|NCT00926705|Dexmedetomidine|dexmedetomidine
524872|NCT00926705|Fentanyl|fentanyl
524873|NCT00926705|Pain|pain
524874|NCT00926705|Pediatrics|pediatrics
524875|NCT00926692|B-cells|b-cells
524876|NCT00926692|CD5+|cd5+
524877|NCT00926692|B1 Cells|b1 cells
524878|NCT00926692|Healthy Controls|healthy controls
524879|NCT00926666|Ageing|ageing
524880|NCT00926666|Pain|pain
524881|NCT00926666|Pharmacology|pharmacology
524882|NCT00926666|Imaging|imaging
524883|NCT00926666|Anaesthesiology|anaesthesiology
524884|NCT00926666|Musculoskeletal disease|musculoskeletal disease
524885|NCT00926653|Geriatric Depression|geriatric depression
524886|NCT00926640|Solid Tumors|solid tumors
524887|NCT00926640|Histone deacetylase inhibitors|histone deacetylase inhibitors
524888|NCT00926640|EP &amp; Belinostat|ep &amp; belinostat
524889|NCT00926640|Phase I|phase i
524890|NCT00926640|SCLC|sclc
524891|NCT00926640|Small Cell Lung Cancer|small cell lung cancer
524892|NCT00926627|endothelin receptor antagonist|endothelin receptor antagonist
524893|NCT00926627|bosentan|bosentan
524894|NCT00926614|GT1|gt1
524895|NCT00926614|HCV|hcv
524896|NCT00926614|non responder|non responder
524897|NCT00926614|relapser|relapser
524898|NCT00926588|Pain|pain
524899|NCT00926588|Telecare|telecare
524900|NCT00926588|Collaborative care|collaborative care
524901|NCT00926575|BDP|bdp
524902|NCT00926575|orBec|orbec
524903|NCT00926575|GVHD|gvhd
524904|NCT00926575|beclomethasone dipropionate|beclomethasone dipropionate
524905|NCT00926575|bone marrow transplant|bone marrow transplant
524906|NCT00926575|hematopoietic cell transplant|hematopoietic cell transplant
524907|NCT00926575|HCT|hct
524908|NCT00926575|stem cell transplant|stem cell transplant
524909|NCT00926575|marrow transplant|marrow transplant
524910|NCT00926575|SCT|sct
524911|NCT00926575|beclomethasone 17,21-dipropionate|beclomethasone 17,21-dipropionate
524912|NCT00926562|Contrast Induced Nephropathy|contrast induced nephropathy
524913|NCT00926562|CIN|cin
524914|NCT00926562|Cardiac Catheterization|cardiac catheterization
524915|NCT00926549|spectral domain-OCT|spectral domain-oct
524916|NCT00926549|macular thickness|macular thickness
524917|NCT00926549|myopia|myopia
524918|NCT00926549|hypermetropia|hypermetropia
524919|NCT00926549|normal|normal
524920|NCT00926523|Pulmonary Hypertension|pulmonary hypertension
524921|NCT00926523|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
524922|NCT00926523|Interstitial Lung Disease|interstitial lung disease
524923|NCT00926523|MIF|mif
524924|NCT00926497|antibiotic therapy|antibiotic therapy
524925|NCT00926497|early-onset sepsis|early-onset sepsis
524926|NCT00926497|interventions study|interventions study
524927|NCT00926497|procalcitonin|procalcitonin
524928|NCT00926497|term and near-term neonates|term and near-term neonates
524929|NCT00926484|Dentin hypersensitivity|dentin hypersensitivity
524930|NCT00926484|Tooth Mousse|tooth mousse
524931|NCT00926484|fluoride varnish|fluoride varnish
524932|NCT00926471|Autism|autism
524933|NCT00926471|Anxiety|anxiety
524934|NCT00926471|Autism Spectrum Disorders with Comorbid Anxiety|autism spectrum disorders with comorbid anxiety
524935|NCT00926458|stress echocardiography|stress echocardiography
524936|NCT00926458|coronary angiography|coronary angiography
524937|NCT00926458|coronary artery disease|coronary artery disease
524938|NCT00926445|Pain behavior|pain behavior
524939|NCT00926432|Balance|balance
524940|NCT00926432|Spine disorders|spine disorders
524941|NCT00926432|equilibrium|equilibrium
524942|NCT00926419|Varicella|varicella
524943|NCT00926419|Hepatitis A|hepatitis a
524944|NCT00926419|Vaccine|vaccine
524945|NCT00926419|Injector|injector
524946|NCT00926419|Fractional dose|fractional dose
524947|NCT00926419|Intradermal|intradermal
524948|NCT00926419|Children|children
524949|NCT00926406|Environmental lead exposure, maintenance hemodialysis; blood lead levels, EDTA chelating agents, malnutrition, anemia, inflammation, mortality.|environmental lead exposure, maintenance hemodialysis; blood lead levels, edta chelating agents, malnutrition, anemia, inflammation, mortality.
524950|NCT00926406|To determine whether lead chelation therapy improves the anemia, malnutrition, inflammation, morbidity or mortality in hemodialysis patients.|to determine whether lead chelation therapy improves the anemia, malnutrition, inflammation, morbidity or mortality in hemodialysis patients.
524951|NCT00926393|inpatient|inpatient
524952|NCT00926393|bipolar depression|bipolar depression
524953|NCT00926393|quetiapine|quetiapine
524954|NCT00926393|Seroquel IR|seroquel ir
524955|NCT00926393|Seroquel XR|seroquel xr
524956|NCT00926393|safety|safety
524957|NCT00926393|tolerability|tolerability
524958|NCT00926380|osteoporosis|osteoporosis
524959|NCT00926380|postmenopausal|postmenopausal
524960|NCT00926380|denosumab|denosumab
524961|NCT00926380|teriparatide|teriparatide
524962|NCT00926380|Forteo®|forteo®
524963|NCT00926380|DXA|dxa
524964|NCT00926380|Bone Mineral Density|bone mineral density
524965|NCT00926380|pQCT|pqct
524966|NCT00926367|Acne|acne
524967|NCT00926341|Metabolic syndrome|metabolic syndrome
524968|NCT00926341|inflammatory markers|inflammatory markers
524969|NCT00926341|Thiazolidinediones|thiazolidinediones
524970|NCT00926341|Angiotensin receptor blockers|angiotensin receptor blockers
524971|NCT00926328|Gingivitis and Plaque|gingivitis and plaque
524972|NCT00926315|Breast Neoplasms|breast neoplasms
524973|NCT00926315|Calcitriol|calcitriol
524974|NCT00926315|Postmenopausal|postmenopausal
524975|NCT00926315|Cell Proliferation|cell proliferation
524976|NCT00926315|Gene Expression Profiling|gene expression profiling
524977|NCT00926302|The bioequivalence of Levetiracetam vs. Keppra|the bioequivalence of levetiracetam vs. keppra
524978|NCT00926302|volunteer|volunteer
524979|NCT00926276|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
524980|NCT00926276|Bronchopulmonary Dysplasia (BPD)|bronchopulmonary dysplasia (bpd)
524981|NCT00926276|Fundoplication|fundoplication
524982|NCT00926263|Pharmacokinetics|pharmacokinetics
524983|NCT00926263|Pharmacodynamics|pharmacodynamics
524984|NCT00926263|QTc interval prolongation|qtc interval prolongation
524985|NCT00926250|Sarcopenia|sarcopenia
524986|NCT00926237|Tinnitus|tinnitus
524987|NCT00926237|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
524988|NCT00926237|TMS|tms
524989|NCT00926237|rTMS|rtms
524990|NCT00926224|Adult patients with chronic liver disease scheduled for a liver biopsy and a BMI superior or equal to 28 kg/m²|adult patients with chronic liver disease scheduled for a liver biopsy and a bmi superior or equal to 28 kg/m²
524991|NCT00926198|Upper airway infections|upper airway infections
524992|NCT00926198|pharyngotonsillitis|pharyngotonsillitis
524993|NCT00926198|GABHS|gabhs
524994|NCT00926185|Dry Eye|dry eye
524995|NCT00926185|ophthalmic delivery|ophthalmic delivery
524996|NCT00926172|Magnetic resonance angiography|magnetic resonance angiography
524997|NCT00926172|Intracranial aneurysm|intracranial aneurysm
524998|NCT00926172|cerebral aneurysm|cerebral aneurysm
524999|NCT00926172|unruptured aneurysm|unruptured aneurysm
525000|NCT00926172|Epidemiology|epidemiology
525001|NCT00926172|Magnetic Resonance Imaging|magnetic resonance imaging
525002|NCT00926159|Cardiomyopathies|cardiomyopathies
525003|NCT00926146|Hepatitis B and C|hepatitis b and c
525004|NCT00926146|HIV|hiv
525005|NCT00926146|nurse case management|nurse case management
525006|NCT00926146|HIV seronegativity|hiv seronegativity
525007|NCT00926120|Chronic Hepatitis C|chronic hepatitis c
525008|NCT00926081|Peripheral Artery Disease|peripheral artery disease
525009|NCT00926081|Quality of Life|quality of life
525010|NCT00926081|Outcome|outcome
525011|NCT00926081|Endothelial Progenitor Cells|endothelial progenitor cells
525012|NCT00926081|Microcirculation|microcirculation
525013|NCT00926068|Diabetes Mellitus|diabetes mellitus
525014|NCT00926068|Foot Ulcer|foot ulcer
525015|NCT00926068|DFU|dfu
525016|NCT00926068|Wound healing|wound healing
525017|NCT00926055|high risk patients in atherosclerosis|high risk patients in atherosclerosis
525018|NCT00926042|Healthy|healthy
525019|NCT00926042|volunteer|volunteer
525020|NCT00926042|Healthy controls|healthy controls
525021|NCT00926042|Normal controls|normal controls
525022|NCT00926016|Hepatitis C|hepatitis c
525023|NCT00926003|HIV|hiv
525024|NCT00926003|Children|children
525025|NCT00926003|Africa|africa
525026|NCT00926003|Neuropsychology|neuropsychology
525027|NCT00926003|cognitive rehabilitation|cognitive rehabilitation
525028|NCT00926003|computers|computers
525029|NCT00925990|HCV|hcv
525030|NCT00925990|interferon-naive|interferon-naive
525031|NCT00925977|treatment satisfaction|treatment satisfaction
525032|NCT00925977|insulin Glargine|insulin glargine
525033|NCT00925977|insulin Apidra|insulin apidra
525034|NCT00925977|NPH insulin|nph insulin
525035|NCT00925951|Persistent Non-specific Low Back Pain|persistent non-specific low back pain
525036|NCT00925951|wet cupping|wet cupping
525037|NCT00925951|cupping|cupping
525038|NCT00925951|Numerical Rating Scale|numerical rating scale
525039|NCT00925938|Hysteroscopy|hysteroscopy
525040|NCT00925938|Cervical priming|cervical priming
525041|NCT00925938|Cervical dilatation|cervical dilatation
525042|NCT00925938|Misoprostol|misoprostol
525043|NCT00925938|Endoscopy, uterine|endoscopy, uterine
525044|NCT00925925|Low birth weight|low birth weight
525045|NCT00925925|small for gestational age|small for gestational age
525046|NCT00925925|B-cell function|b-cell function
525047|NCT00925925|epigenetics|epigenetics
525048|NCT00925925|B1a|b1a
525049|NCT00925925|B1b|b1b
525050|NCT00925925|CD19|cd19
525051|NCT00925925|CD5|cd5
525052|NCT00925912|Hemorrhoidectomy|hemorrhoidectomy
525053|NCT00925912|perianal block|perianal block
525054|NCT00925912|local anesthesia|local anesthesia
525055|NCT00925912|spinal anesthesia|spinal anesthesia
525056|NCT00925899|Melatonin|melatonin
525057|NCT00925899|Palliative care|palliative care
525058|NCT00925899|Advanced cancer|advanced cancer
525059|NCT00925899|Symptoms|symptoms
525060|NCT00925899|Quality of life|quality of life
525061|NCT00925899|Randomized controlled trial|randomized controlled trial
525062|NCT00925886|Astigmatism|astigmatism
525063|NCT00925886|Cataract|cataract
525064|NCT00925873|Fludarabine|fludarabine
525065|NCT00925873|AML|aml
525066|NCT00925873|elderly patients|elderly patients
525067|NCT00925847|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
525068|NCT00925847|Lithium|lithium
525069|NCT00925847|Survival|survival
525070|NCT00925834|Coronary angiography|coronary angiography
525071|NCT00925834|Placebo effect|placebo effect
525072|NCT00925834|Suggestion|suggestion
525073|NCT00925821|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
525074|NCT00925821|Lenalidomide|lenalidomide
525075|NCT00925821|IMiD|imid
525076|NCT00925808|Unsuspected Venous Thromboembolism|unsuspected venous thromboembolism
525077|NCT00925808|VTE|vte
525078|NCT00925808|Routine Computed Tomography|routine computed tomography
525079|NCT00925808|CT Scans|ct scans
525080|NCT00925795|HIV|hiv
525081|NCT00925795|atherosclerosis|atherosclerosis
525082|NCT00925795|extra virgin olive oil|extra virgin olive oil
525083|NCT00925795|Alternative therapies|alternative therapies
525084|NCT00925795|Treatment experienced+|treatment experienced+
525085|NCT00925782|autologous stem cell transplantation|autologous stem cell transplantation
525086|NCT00925756|HIV|hiv
525087|NCT00925756|low CD4 recovery|low cd4 recovery
525088|NCT00925756|Low CD4 recovery despite HIV control|low cd4 recovery despite hiv control
525089|NCT00925756|Treatment experienced|treatment experienced
525090|NCT00925743|Phase 1|phase 1
525091|NCT00925743|XRP6258|xrp6258
525092|NCT00925743|cisplatin|cisplatin
525093|NCT00925743|Antineoplastic Combined Chemotherapy Protocols|antineoplastic combined chemotherapy protocols
525094|NCT00925730|Atopic dermatitis|atopic dermatitis
525095|NCT00925730|AD|ad
525096|NCT00925730|pimecrolimus|pimecrolimus
525097|NCT00925730|blood|blood
525098|NCT00925730|absorption|absorption
525099|NCT00925730|systemic|systemic
525100|NCT00925717|ADA recommendation|ada recommendation
525101|NCT00925665|Intubation|intubation
525102|NCT00925665|Glidescope|glidescope
525103|NCT00925665|Macintosh|macintosh
525104|NCT00925665|Abscess|abscess
525105|NCT00925665|Difficult intubations in patients with odontogenic abscesses|difficult intubations in patients with odontogenic abscesses
525106|NCT00925652|CM|cm
525107|NCT00925652|bevacizumab|bevacizumab
525108|NCT00925652|cyclophosphamide|cyclophosphamide
525109|NCT00925652|methotrexate|methotrexate
525110|NCT00925652|exercise intervention|exercise intervention
525111|NCT00925652|diet intervention|diet intervention
525112|NCT00925639|phytoestrogen|phytoestrogen
525113|NCT00925639|coagulation|coagulation
525114|NCT00925639|menopause|menopause
525115|NCT00925639|ddimer|ddimer
525116|NCT00925639|antithrombin|antithrombin
525117|NCT00925639|hypercoagulation|hypercoagulation
525118|NCT00925613|Exchanging double lumen tube with laryngeal mask Proseal|exchanging double lumen tube with laryngeal mask proseal
525119|NCT00925613|Exchange double lumen tube with tracheal tube|exchange double lumen tube with tracheal tube
525120|NCT00925613|Exchange double lumen tube before emergence decrease cough|exchange double lumen tube before emergence decrease cough
525121|NCT00925613|thoracoscopy and postoperative respiratory complications|thoracoscopy and postoperative respiratory complications
525122|NCT00925613|thoracostomy and postoperative respiratory complications|thoracostomy and postoperative respiratory complications
525123|NCT00925613|postoperative cough|postoperative cough
525124|NCT00925613|postoperative respiratory complications|postoperative respiratory complications
525125|NCT00925613|laryngeal mask and postoperative respiratory complications|laryngeal mask and postoperative respiratory complications
525126|NCT00925600|Lens Opacification|lens opacification
525127|NCT00925600|Bone Loss|bone loss
525128|NCT00925600|Androgen Deprivation Therapy|androgen deprivation therapy
525129|NCT00925600|Non-metastatic prostate cancer|non-metastatic prostate cancer
525130|NCT00925587|CKD|ckd
525131|NCT00925587|Anemia|anemia
525132|NCT00925587|correction|correction
525133|NCT00925587|darbepoetin alfa|darbepoetin alfa
525134|NCT00925574|CNTO 1959|cnto 1959
525135|NCT00925574|Healthy Volunteers|healthy volunteers
525136|NCT00925574|Psoriasis|psoriasis
525137|NCT00925561|Coronary Artery Calcification|coronary artery calcification
525138|NCT00925548|Phase III trial|phase iii trial
525139|NCT00925548|randomized|randomized
525140|NCT00925548|cancer vaccine|cancer vaccine
525141|NCT00925548|MUC1|muc1
525142|NCT00925548|BLP25|blp25
525143|NCT00925548|advanced breast cancer|advanced breast cancer
525144|NCT00925548|postmenopausal breast cancer|postmenopausal breast cancer
525145|NCT00925548|immunotherapy of breast cancer|immunotherapy of breast cancer
525146|NCT00925548|Inoperable locally advanced, recurrent, or metastatic endocrine-sensitive Breast Cancer|inoperable locally advanced, recurrent, or metastatic endocrine-sensitive breast cancer
525147|NCT00925535|Pharmacokinetics HIV Tuberculosis Lersivirine UK-453|pharmacokinetics hiv tuberculosis lersivirine uk-453
525148|NCT00925535|061 Rifabutin|061 rifabutin
525149|NCT00925535|HIV Infections|hiv infections
525150|NCT00925509|upper digestive tract cancer|upper digestive tract cancer
525151|NCT00925509|implants|implants
525152|NCT00925509|implants insertion|implants insertion
525153|NCT00925509|radio-surgical guidance|radio-surgical guidance
525154|NCT00925509|accuracy of implants insertion|accuracy of implants insertion
525155|NCT00925509|cranial/facial radiotherapy or brachytherapy and/or microvascular fibula transfer.|cranial/facial radiotherapy or brachytherapy and/or microvascular fibula transfer.
525156|NCT00925509|Bone volume sufficient to support an implant|bone volume sufficient to support an implant
525157|NCT00925496|Omarthrosis shoulder joint|omarthrosis shoulder joint
525158|NCT00925483|left ventricular mass|left ventricular mass
525159|NCT00925483|cardiac MRI|cardiac mri
525160|NCT00925483|long dialysis|long dialysis
525161|NCT00925483|daily dialysis|daily dialysis
525162|NCT00925470|Target organs impairment|target organs impairment
525163|NCT00925470|High blood pressure|high blood pressure
525164|NCT00925470|Evaluation of target organs impairment on patients suffering from high blood pressure without known cardiovascular or renal disease|evaluation of target organs impairment on patients suffering from high blood pressure without known cardiovascular or renal disease
525165|NCT00925457|Serious ventricular arrhythmia|serious ventricular arrhythmia
525166|NCT00925457|Sudden cardiac death|sudden cardiac death
525167|NCT00925457|Domperidone|domperidone
525168|NCT00925457|Case-control study|case-control study
525169|NCT00925457|Saskatchewan residents|saskatchewan residents
525170|NCT00925457|Observational Study|observational study
525171|NCT00925444|Absorbable implants|absorbable implants
525172|NCT00925444|Humans|humans
525173|NCT00925444|Alginates|alginates
525174|NCT00925444|Pneumonectomy/methods|pneumonectomy/methods
525175|NCT00925444|Pneumonectomy/instrumentation|pneumonectomy/instrumentation
525176|NCT00925444|Surgical Stapling|surgical stapling
525177|NCT00925444|Thoracic surgery|thoracic surgery
525178|NCT00925444|Tissue Adhesives|tissue adhesives
525179|NCT00925444|Prospective studies|prospective studies
525180|NCT00925418|Neoplasm|neoplasm
525181|NCT00925418|breast Neoplasm|breast neoplasm
525182|NCT00925418|docetaxel|docetaxel
525183|NCT00925418|Glove|glove
525184|NCT00925405|Breast Cancer|breast cancer
525185|NCT00925405|Hodgkin's lymphoma|hodgkin's lymphoma
525186|NCT00925405|Mantle-field Irradiation|mantle-field irradiation
525187|NCT00925405|Mammogram|mammogram
525188|NCT00925405|Magnetic resonance imaging|magnetic resonance imaging
525189|NCT00925405|MRI Breast Cancer Screening|mri breast cancer screening
525190|NCT00925392|doripenem|doripenem
525191|NCT00925392|epithelial lining fluid|epithelial lining fluid
525192|NCT00925392|alveolar macrophages|alveolar macrophages
525193|NCT00925392|pharmacokinetics|pharmacokinetics
525194|NCT00925392|Healthy adult subjects|healthy adult subjects
525195|NCT00925366|Shoulder|shoulder
525196|NCT00925366|MRI|mri
525197|NCT00925366|MR arthrography|mr arthrography
525198|NCT00925366|CT arthrography|ct arthrography
525199|NCT00925366|Rotator cuff tear|rotator cuff tear
525200|NCT00925366|Arthroscopy|arthroscopy
525201|NCT00925353|lidocaine|lidocaine
525202|NCT00925353|pre-medication|pre-medication
525203|NCT00925353|mammography|mammography
525204|NCT00925353|pain|pain
525205|NCT00925353|safety|safety
525206|NCT00925340|Alcohol|alcohol
525207|NCT00925340|Substance Abuse|substance abuse
525208|NCT00925340|Adolescent|adolescent
525209|NCT00925340|Family functioning|family functioning
525210|NCT00925314|Stage III Melanoma|stage iii melanoma
525211|NCT00925314|Melanoma|melanoma
525212|NCT00925314|TLI|tli
525213|NCT00925314|Transgenic Lymphocyte Immunization|transgenic lymphocyte immunization
525214|NCT00925314|CB-10-01-02|cb-10-01-02
525215|NCT00925301|AmicusTherapeutics|amicustherapeutics
525216|NCT00925301|AT1001|at1001
525217|NCT00925301|Migalastat|migalastat
525218|NCT00925301|Pharmacokinetics|pharmacokinetics
525219|NCT00925301|Substrate|substrate
525220|NCT00925288|Female sex worker|female sex worker
525221|NCT00925288|Peru|peru
525222|NCT00925288|Cervical infection|cervical infection
525223|NCT00925288|Cervical abnormality|cervical abnormality
525224|NCT00925288|Serum antibody|serum antibody
525225|NCT00925288|Vaccine acceptance|vaccine acceptance
525226|NCT00925288|Alternative schedule|alternative schedule
525227|NCT00925288|Viral infections|viral infections
525228|NCT00925288|Human papillomavirus vaccine|human papillomavirus vaccine
525229|NCT00925288|Human papillomavirus (HPV)|human papillomavirus (hpv)
525230|NCT00925288|non inferiority|non inferiority
525231|NCT00925275|Solid tumors|solid tumors
525232|NCT00925275|Refractory|refractory
525233|NCT00925275|Relapsed|relapsed
525234|NCT00925275|Radiation|radiation
525235|NCT00925275|Dosimetry|dosimetry
525236|NCT00925275|Radiopharmaceutical|radiopharmaceutical
525237|NCT00925275|Biodistribution|biodistribution
525238|NCT00925275|Pharmacokinetics|pharmacokinetics
525239|NCT00925275|Cancer|cancer
525240|NCT00925275|Phase I|phase i
525241|NCT00925262|mental health|mental health
525242|NCT00925262|randomized controlled trial|randomized controlled trial
525243|NCT00925262|torture|torture
525244|NCT00925249|rheumatoid arthritis|rheumatoid arthritis
525245|NCT00925249|RA|ra
525246|NCT00925249|TB|tb
525247|NCT00925249|tuberculosis|tuberculosis
525248|NCT00925249|anti-TNF therapy|anti-tnf therapy
525249|NCT00925249|biologic therapy|biologic therapy
525250|NCT00925249|quantiferon|quantiferon
525251|NCT00925249|IGRA|igra
525252|NCT00925249|Newly diagnosed rheumatoid arthritis (RA) in the Tricare system|newly diagnosed rheumatoid arthritis (ra) in the tricare system
525253|NCT00925236|MYH9 gene|myh9 gene
525254|NCT00925236|macrothrombocytopenia|macrothrombocytopenia
525255|NCT00925236|leukocyte inclusions|leukocyte inclusions
525256|NCT00925236|cataracts deafness|cataracts deafness
525257|NCT00925236|nephritis|nephritis
525258|NCT00925236|MYH9 Related Disorders|myh9 related disorders
525259|NCT00925223|IBS|ibs
525260|NCT00925223|BDNf|bdnf
525261|NCT00925223|visceral hypersensitivity|visceral hypersensitivity
525262|NCT00925210|Endobronchial ultrasound|endobronchial ultrasound
525263|NCT00925210|Electromagnetic Navigation Bronchoscopy|electromagnetic navigation bronchoscopy
525264|NCT00925210|Bronchoscopy|bronchoscopy
525265|NCT00925210|Ultrasonography|ultrasonography
525266|NCT00925197|anticoagulation|anticoagulation
525267|NCT00925197|fluindione|fluindione
525268|NCT00925197|patient self-testing|patient self-testing
525269|NCT00925197|coaguchek|coaguchek
525270|NCT00925197|inratio|inratio
525271|NCT00925197|Post operative antivitamin K therapy|post operative antivitamin k therapy
525272|NCT00925184|questionnaire, medical education, medical students.|questionnaire, medical education, medical students.
525273|NCT00925171|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
525274|NCT00925171|Pulmonary rehabilitation|pulmonary rehabilitation
525275|NCT00925171|Chronic Respiratory Questionnaire|chronic respiratory questionnaire
525276|NCT00925158|Rhytidoplasty|rhytidoplasty
525277|NCT00925158|Video-Assisted Surgery|video-assisted surgery
525278|NCT00925158|Surgical instruments|surgical instruments
525279|NCT00925158|Dissection|dissection
525280|NCT00925158|Innovative therapies|innovative therapies
525281|NCT00925158|Face|face
525282|NCT00925158|Aging|aging
525283|NCT00925158|Premature aging|premature aging
525284|NCT00925158|Rejuvenation|rejuvenation
525285|NCT00925132|Metastatic|metastatic
525286|NCT00925132|Melanoma|melanoma
525287|NCT00925132|Epigenetic|epigenetic
525288|NCT00925132|Temozolomide|temozolomide
525289|NCT00925132|Decitabine|decitabine
525290|NCT00925132|Panobinostat|panobinostat
525291|NCT00925132|LBH589|lbh589
525292|NCT00925119|Diabetes|diabetes
525293|NCT00925119|Atenolol|atenolol
525294|NCT00925119|Genetic|genetic
525295|NCT00925106|Bioavailability, pharmacokinetics, celecoxib|bioavailability, pharmacokinetics, celecoxib
525296|NCT00925093|vancomycin|vancomycin
525297|NCT00925093|teicoplanin|teicoplanin
525298|NCT00925093|linezolid|linezolid
525299|NCT00925093|intravenous|intravenous
525300|NCT00925093|cerebrospinal fluid|cerebrospinal fluid
525301|NCT00925093|CSF|csf
525302|NCT00925093|pharmacokinetics|pharmacokinetics
525303|NCT00925093|penetration|penetration
525304|NCT00925093|blood-brain barrier|blood-brain barrier
525305|NCT00925093|Pharmacokinetics of three antibiotics in relation to cerebrospinal fluid|pharmacokinetics of three antibiotics in relation to cerebrospinal fluid
525306|NCT00925067|Inguinal hernia|inguinal hernia
525307|NCT00925067|Laparoscopic repair|laparoscopic repair
525308|NCT00925067|Prostheses|prostheses
525309|NCT00925067|Male fertility|male fertility
525310|NCT00925054|PKU|pku
525311|NCT00925054|PEG PAL|peg pal
525312|NCT00925054|BioMarin|biomarin
525313|NCT00924989|ACC|acc
525314|NCT00924989|Adrenocortical carcinoma|adrenocortical carcinoma
525315|NCT00924989|OSI-906|osi-906
525316|NCT00924989|Insulin-like growth factor-1 receptor (IGF-1R)|insulin-like growth factor-1 receptor (igf-1r)
525317|NCT00924989|GALACCTIC|galacctic
525318|NCT00924963|Pain of venipuncture or IV insertion|pain of venipuncture or iv insertion
525319|NCT00924950|Psoriasis|psoriasis
525320|NCT00924950|Plaque psoriasis, with bilateral symmetrical lesions.|plaque psoriasis, with bilateral symmetrical lesions.
525321|NCT00924950|A diagnosis of stable plaque-type psoriasis vulgaris|a diagnosis of stable plaque-type psoriasis vulgaris
525322|NCT00924950|with at least one pair of symmetric lesions on either|with at least one pair of symmetric lesions on either
525323|NCT00924950|the trunk, arms, or legs that would serve as target lesions.|the trunk, arms, or legs that would serve as target lesions.
525324|NCT00924937|Cardiovascular events|cardiovascular events
525325|NCT00924937|Blood pressure|blood pressure
525326|NCT00924937|Incidence of Cancer|incidence of cancer
525327|NCT00924937|Cognitive decline|cognitive decline
525328|NCT00924937|Mediterranean Diet|mediterranean diet
525329|NCT00924937|Secondary Prevention|secondary prevention
525330|NCT00924937|Low fat diet|low fat diet
525331|NCT00924924|health promotion|health promotion
525332|NCT00924924|prevention|prevention
525333|NCT00924924|worksite wellness|worksite wellness
525334|NCT00924924|behavior change|behavior change
525335|NCT00924924|healthy volunteers|healthy volunteers
525336|NCT00924911|GSK1322322, relative bioavailability, single dose, food effect, H2 blocker, healthy subjects, open label, PIB, tablet|gsk1322322, relative bioavailability, single dose, food effect, h2 blocker, healthy subjects, open label, pib, tablet
525337|NCT00924898|Acute HIV|acute hiv
525338|NCT00924898|HIV|hiv
525339|NCT00924898|Acute Infections|acute infections
525340|NCT00924898|Acute Infection|acute infection
525341|NCT00924885|Reproductive Medicine|reproductive medicine
525342|NCT00924885|Fertilization in Vitro|fertilization in vitro
525343|NCT00924885|Oocyte retrieval|oocyte retrieval
525344|NCT00924885|Local anaesthesia|local anaesthesia
525345|NCT00924885|Aspiration needle|aspiration needle
525346|NCT00924872|stroke|stroke
525347|NCT00924872|power wheelchair skills|power wheelchair skills
525348|NCT00924872|training|training
525349|NCT00924872|safety|safety
525350|NCT00924859|cerebral venous thrombosis|cerebral venous thrombosis
525351|NCT00924859|stroke|stroke
525352|NCT00924859|coagulation|coagulation
525353|NCT00924846|high frequency oscillatory ventilation|high frequency oscillatory ventilation
525354|NCT00924846|respiratory failure|respiratory failure
525355|NCT00924846|children|children
525356|NCT00924846|inhaled nitric oxide|inhaled nitric oxide
525357|NCT00924833|hypoxia|hypoxia
525358|NCT00924833|autonomic nervous system|autonomic nervous system
525359|NCT00924833|blood pressure|blood pressure
525360|NCT00924833|heart rate|heart rate
525361|NCT00924833|exercise|exercise
525362|NCT00924833|heart failure|heart failure
525363|NCT00924833|receptors, adrenergic, beta.|receptors, adrenergic, beta.
525364|NCT00924820|Neoplastic Meningitis|neoplastic meningitis
525365|NCT00924820|NM|nm
525366|NCT00924820|Advanced Cancers|advanced cancers
525367|NCT00924820|Brain Cancer|brain cancer
525368|NCT00924820|Advanced Cancer|advanced cancer
525369|NCT00924820|Brain Diseases|brain diseases
525370|NCT00924820|Central Nervous System Disorders|central nervous system disorders
525371|NCT00924820|CNS|cns
525372|NCT00924820|Bevacizumab|bevacizumab
525373|NCT00924820|Avastin|avastin
525374|NCT00924820|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
525375|NCT00924820|rhuMAb-VEGF|rhumab-vegf
525376|NCT00924820|Spinal Cord|spinal cord
525377|NCT00924820|meninges|meninges
525680|NCT00923741|NSCLC|nsclc
525378|NCT00924820|cerebrospinal fluid|cerebrospinal fluid
525379|NCT00924820|CSF|csf
525380|NCT00924807|Prostate Cancer|prostate cancer
525381|NCT00924807|Combined Androgen Blockade|combined androgen blockade
525382|NCT00924807|Radiotherapy|radiotherapy
525383|NCT00924807|Sorafenib|sorafenib
525384|NCT00924781|Anemia associated with chronic kidney disease (CKD)|anemia associated with chronic kidney disease (ckd)
525385|NCT00924781|Hemodialysis|hemodialysis
525386|NCT00924768|Otherwise healthy current cigarette smokers|otherwise healthy current cigarette smokers
525387|NCT00924768|current cigarette smokers|current cigarette smokers
525388|NCT00924755|Surgical mesh|surgical mesh
525389|NCT00924742|The PK of Tapimycin|the pk of tapimycin
525390|NCT00924742|volunteer|volunteer
525391|NCT00924690|Colon|colon
525392|NCT00924690|Cancer|cancer
525393|NCT00924690|Screening|screening
525394|NCT00924690|Prevention|prevention
525395|NCT00924690|Information|information
525396|NCT00924677|genicular nerve|genicular nerve
525397|NCT00924677|osteoarthritis|osteoarthritis
525398|NCT00924677|knee|knee
525399|NCT00924677|neurotomy|neurotomy
525400|NCT00924664|low back pain monoclonal antibody nerve growth factor|low back pain monoclonal antibody nerve growth factor
525401|NCT00924651|fatigue|fatigue
525402|NCT00924651|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
525403|NCT00924638|atrial fibrillation|atrial fibrillation
525404|NCT00924638|cryptogenic stroke|cryptogenic stroke
525405|NCT00924638|continuous monitoring|continuous monitoring
525406|NCT00924638|implantable loop recorder|implantable loop recorder
525407|NCT00924638|insertable cardiac monitor|insertable cardiac monitor
525408|NCT00924612|Primary hypogonadism|primary hypogonadism
525409|NCT00924612|Secondary hypogonadism|secondary hypogonadism
525410|NCT00924599|Recurring Gestational Diabetes|recurring gestational diabetes
525411|NCT00924599|Prevention|prevention
525412|NCT00924573|Glimepiride|glimepiride
525413|NCT00924573|Metformin|metformin
525414|NCT00924573|Combination Drug Therapy|combination drug therapy
525415|NCT00924560|Adolescents|adolescents
525416|NCT00924560|Bone Mineral Density|bone mineral density
525417|NCT00924560|Oral Contraceptive|oral contraceptive
525418|NCT00924547|Cystic Fibrosis|cystic fibrosis
525419|NCT00924547|Docosahexanoic Acid|docosahexanoic acid
525420|NCT00924547|DHA|dha
525421|NCT00924547|isoprostanes|isoprostanes
525422|NCT00924547|fatty acid|fatty acid
525423|NCT00924534|type 2 diabetes|type 2 diabetes
525424|NCT00924534|interventional|interventional
525425|NCT00924534|placebo|placebo
525426|NCT00924534|controlled|controlled
525427|NCT00924534|PK|pk
525428|NCT00924534|PD|pd
525429|NCT00924534|safety|safety
525430|NCT00924521|grains|grains
525431|NCT00924521|fiber|fiber
525432|NCT00924521|metabolic syndrome|metabolic syndrome
525433|NCT00924521|insulin|insulin
525434|NCT00924508|eczema|eczema
525435|NCT00924508|at least 3 patches of eczema|at least 3 patches of eczema
525436|NCT00924495|low back pain|low back pain
525437|NCT00924495|motor control|motor control
525438|NCT00924495|cortical regulation|cortical regulation
525439|NCT00924495|transcranial magnetic stimulation|transcranial magnetic stimulation
525440|NCT00924482|cardiac output|cardiac output
525441|NCT00924482|ECOM|ecom
525442|NCT00924482|Endotracheal Cardiac Output Monitor|endotracheal cardiac output monitor
525443|NCT00924482|Perioperative medical care|perioperative medical care
525444|NCT00924469|Prostate cancer|prostate cancer
525445|NCT00924469|Abiraterone acetate|abiraterone acetate
525446|NCT00924469|Leuprolide acetate|leuprolide acetate
525447|NCT00924469|Prednisone|prednisone
525448|NCT00924469|CB7630|cb7630
525449|NCT00924469|Testosterone|testosterone
525450|NCT00924456|Transcendental Meditation|transcendental meditation
525451|NCT00924456|blood pressure|blood pressure
525452|NCT00924456|psychological distress|psychological distress
525453|NCT00924456|high psychological distress|high psychological distress
525454|NCT00924443|acute myelogenous leukemia|acute myelogenous leukemia
525455|NCT00924443|acute myeloid leukemia|acute myeloid leukemia
525456|NCT00924443|clolar|clolar
525457|NCT00924443|evoltra|evoltra
525458|NCT00924443|clofarabine|clofarabine
525459|NCT00924443|untreated acute leukemia|untreated acute leukemia
525460|NCT00924443|adult acute leukemia|adult acute leukemia
525461|NCT00924430|Interaction SLV337 and simvastatin|interaction slv337 and simvastatin
525462|NCT00924430|Type 2 diabetes mellitus|type 2 diabetes mellitus
525463|NCT00924417|Pain associated with peripheral intravenous line placement|pain associated with peripheral intravenous line placement
525464|NCT00924404|Xylitol vs. Saline|xylitol vs. saline
525465|NCT00924404|nasal washes|nasal washes
525466|NCT00924404|sinusitis|sinusitis
525467|NCT00924391|cholesterol|cholesterol
525468|NCT00924391|plant sterols|plant sterols
525469|NCT00924391|cholesterol absorption|cholesterol absorption
525470|NCT00924365|Children|children
525471|NCT00924365|AIDS|aids
525472|NCT00924365|Toxicity|toxicity
525473|NCT00924365|Development|development
525474|NCT00924365|Puberty|puberty
525475|NCT00924365|HIV|hiv
525476|NCT00924365|Pediatrics|pediatrics
525477|NCT00924365|HIV Infections|hiv infections
525681|NCT00923728|AVN - 944|avn - 944
525478|NCT00924352|Metastatic Breast Cancer|metastatic breast cancer
525479|NCT00924339|soy protein|soy protein
525480|NCT00924339|familial hypercholesterolaemia|familial hypercholesterolaemia
525481|NCT00924339|children and adolescents|children and adolescents
525482|NCT00924339|isoflavones|isoflavones
525483|NCT00924339|FH|fh
525484|NCT00924326|B Cell Malignancies|b cell malignancies
525485|NCT00924326|T Cell Persistence|t cell persistence
525486|NCT00924326|Immunotherapy|immunotherapy
525487|NCT00924326|Cell Transfer|cell transfer
525488|NCT00924326|Leukemia|leukemia
525489|NCT00924326|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
525490|NCT00924326|CLL|cll
525491|NCT00924326|Lymphoma|lymphoma
525492|NCT00924313|Prostate Cancer|prostate cancer
525493|NCT00924313|MRI|mri
525494|NCT00924313|C-11 Acetate|c-11 acetate
525495|NCT00924313|PET|pet
525496|NCT00924300|feasibility of MEG in pediatric populations|feasibility of meg in pediatric populations
525497|NCT00924287|Metastatic Cancer|metastatic cancer
525498|NCT00924287|Tumor Regression|tumor regression
525499|NCT00924287|Immunotherapy|immunotherapy
525500|NCT00924287|Safety|safety
525501|NCT00924287|Cancer|cancer
525502|NCT00924261|hip|hip
525503|NCT00924261|gait|gait
525504|NCT00924261|walking|walking
525505|NCT00924261|falls|falls
525506|NCT00924261|stretching|stretching
525507|NCT00924261|Flexibility|flexibility
525508|NCT00924261|Aged|aged
525509|NCT00924248|Liver MRI|liver mri
525510|NCT00924209|Neoadjuvant|neoadjuvant
525511|NCT00924209|Stage IIIA (N2)|stage iiia (n2)
525512|NCT00924209|Cisplatin|cisplatin
525513|NCT00924209|Gemcitabine|gemcitabine
525514|NCT00924209|Bevacizumab|bevacizumab
525515|NCT00924209|Non-Small Cell Lung Cancer|non-small cell lung cancer
525516|NCT00924209|NSCLC|nsclc
525517|NCT00924196|Plexiform Neurofibroma|plexiform neurofibroma
525518|NCT00924196|Optic Pathway Tumor|optic pathway tumor
525519|NCT00924196|Neurofibroma|neurofibroma
525520|NCT00924196|Malignant Peripheral Nerve Sheath Tumor|malignant peripheral nerve sheath tumor
525521|NCT00924196|Volumetric MRI|volumetric mri
525522|NCT00924196|Neurofibromatosis Type 1|neurofibromatosis type 1
525523|NCT00924196|NF1|nf1
525524|NCT00924196|Optic Glioma|optic glioma
525525|NCT00924183|Depression|depression
525526|NCT00924183|Symptom scales|symptom scales
525527|NCT00924183|Symptom measures|symptom measures
525528|NCT00924183|Vancouver Semi-Structured Interview for Depression|vancouver semi-structured interview for depression
525529|NCT00924183|V-SID|v-sid
525530|NCT00924183|VSID|vsid
525531|NCT00924183|treatment-as-usual|treatment-as-usual
525532|NCT00924183|treatment as usual|treatment as usual
525533|NCT00924183|open-label|open-label
525534|NCT00924183|open label|open label
525535|NCT00924183|Major Depressive Episode|major depressive episode
525536|NCT00924183|MDE|mde
525537|NCT00924170|Immunotoxin|immunotoxin
525538|NCT00924170|CD25|cd25
525539|NCT00924170|Immunogenicity|immunogenicity
525540|NCT00924170|Neutralization|neutralization
525541|NCT00924170|Neutralizing Antibodies|neutralizing antibodies
525542|NCT00924170|Adult T-Cell Leukemia|adult t-cell leukemia
525543|NCT00924170|Leukemia|leukemia
525544|NCT00924170|ATL|atl
525545|NCT00924131|Late Effects|late effects
525546|NCT00924131|Radiation|radiation
525547|NCT00924131|Chemotherapy|chemotherapy
525548|NCT00924131|Hodgkin's Disease|hodgkin's disease
525549|NCT00924131|Lymphoma|lymphoma
525550|NCT00924131|Hodgkin Disease|hodgkin disease
525551|NCT00924118|Acute myocardial infarction|acute myocardial infarction
525552|NCT00924118|Reperfusion injury|reperfusion injury
525553|NCT00924118|Nitric oxide|nitric oxide
525554|NCT00924092|Immunotherapy|immunotherapy
525555|NCT00924092|Lung Cancer|lung cancer
525556|NCT00924092|Colorectal Cancer|colorectal cancer
525557|NCT00924092|Head and Neck Cancer|head and neck cancer
525558|NCT00924092|Prostate|prostate
525559|NCT00924092|Breast Cancer|breast cancer
525560|NCT00924079|Analysis of plasma concentration of nalbuphine|analysis of plasma concentration of nalbuphine
525561|NCT00924066|Ixabepilone|ixabepilone
525562|NCT00924066|BMS-247550|bms-247550
525563|NCT00924066|Ixempra|ixempra
525564|NCT00924066|Cervical Cancer|cervical cancer
525565|NCT00924066|Epothilone|epothilone
525566|NCT00924053|Diabetes Mellitus Type 2|diabetes mellitus type 2
525567|NCT00924040|BL22 in HCL after Immunotoxin|bl22 in hcl after immunotoxin
525568|NCT00924040|Hairy Cell Leukemia|hairy cell leukemia
525569|NCT00924040|Leukemia|leukemia
525570|NCT00924027|Radiation|radiation
525571|NCT00924027|Cancer|cancer
525572|NCT00924027|HDR|hdr
525573|NCT00924027|Brachytherapy|brachytherapy
525574|NCT00924027|Training|training
525575|NCT00924014|heart failure|heart failure
525576|NCT00924001|Clinical Response|clinical response
525577|NCT00924001|Immunotherapy|immunotherapy
525578|NCT00924001|Cancer|cancer
525579|NCT00924001|Cytokines|cytokines
525580|NCT00924001|Adoptive Cell Therapy|adoptive cell therapy
525581|NCT00924001|Melanoma|melanoma
525582|NCT00924001|Metastatic Melanoma|metastatic melanoma
525583|NCT00923988|Secondhand smoke|secondhand smoke
525584|NCT00923988|passive smoking|passive smoking
525585|NCT00923988|platelet function|platelet function
525586|NCT00923988|endothelial function|endothelial function
525587|NCT00923962|Basic science|basic science
525588|NCT00923962|Type 2 Diabetes mellitus|type 2 diabetes mellitus
525589|NCT00923962|Glucagon like peptid-1|glucagon like peptid-1
525590|NCT00923962|Coronary Bloodflow|coronary bloodflow
525591|NCT00923962|Metabolite uptake|metabolite uptake
525592|NCT00923949|NSCLC Stage Ia-IIb|nsclc stage ia-iib
525593|NCT00923949|Resectable NSCLC|resectable nsclc
525594|NCT00923949|Non-Small Cell Lung Cancer|non-small cell lung cancer
525595|NCT00923949|NSCLC|nsclc
525596|NCT00923936|Kaposi's Sarcoma|kaposi's sarcoma
525597|NCT00923936|HIV|hiv
525598|NCT00923936|Doxil|doxil
525599|NCT00923936|VEGF|vegf
525600|NCT00923936|Bevacizumab|bevacizumab
525601|NCT00923923|stress reactivity|stress reactivity
525602|NCT00923923|PTSD|ptsd
525603|NCT00923923|alcohol dependence|alcohol dependence
525604|NCT00923923|drinking|drinking
525605|NCT00923923|craving|craving
525606|NCT00923910|WT1 Peptide Dendritic Cell Vaccine|wt1 peptide dendritic cell vaccine
525607|NCT00923910|Hematologic Malignancies|hematologic malignancies
525608|NCT00923910|Relapse After Allogeneic Stem Cell Transplantation|relapse after allogeneic stem cell transplantation
525609|NCT00923910|Donor Lymphocyte Infusions|donor lymphocyte infusions
525610|NCT00923910|WT1-Positive|wt1-positive
525611|NCT00923910|Dendritic Cell Vaccine|dendritic cell vaccine
525612|NCT00923910|Tumor Immunotherapy|tumor immunotherapy
525613|NCT00923910|Allogeneic Adoptive Immunotherapy|allogeneic adoptive immunotherapy
525614|NCT00923910|Hodgkins Lymphoma|hodgkins lymphoma
525615|NCT00923910|Leukemia|leukemia
525616|NCT00923910|Acute Myelogenous Leukemia|acute myelogenous leukemia
525617|NCT00923910|AML|aml
525618|NCT00923910|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
525619|NCT00923910|ALL|all
525620|NCT00923910|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
525621|NCT00923910|CML|cml
525622|NCT00923910|Myelodysplasia Syndrome|myelodysplasia syndrome
525623|NCT00923910|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
525624|NCT00923897|Hepatocellular Carcinoma|hepatocellular carcinoma
525625|NCT00923897|Hepatic Metastasis|hepatic metastasis
525626|NCT00923897|Palliative Radiation Therapy|palliative radiation therapy
525627|NCT00923897|Locally advanced HCC and Hepatic Metastasis|locally advanced hcc and hepatic metastasis
525628|NCT00923884|NSCLC|nsclc
525629|NCT00923884|Genotype|genotype
525630|NCT00923884|SCLC|sclc
525631|NCT00923884|Lung Cancer|lung cancer
525632|NCT00923884|Non-Small Cell Lung Cancer|non-small cell lung cancer
525633|NCT00923884|Small Cell Lung Cancer|small cell lung cancer
525634|NCT00923871|CBCT|cbct
525635|NCT00923871|Breast Cancer|breast cancer
525636|NCT00923858|Rotator Cuff|rotator cuff
525637|NCT00923858|Ultrasound|ultrasound
525638|NCT00923858|Pain|pain
525639|NCT00923858|Tear Progression|tear progression
525640|NCT00923845|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
525641|NCT00923845|Allogeneic Hematopoietic Stem Cell Transplant|allogeneic hematopoietic stem cell transplant
525642|NCT00923845|Th2 Cells|th2 cells
525643|NCT00923845|Sirolimus|sirolimus
525644|NCT00923845|Pentostatin|pentostatin
525645|NCT00923845|Kidney Cancer|kidney cancer
525646|NCT00923845|Renal Cell Carcinoma|renal cell carcinoma
525647|NCT00923845|Metastatic Renal Cell Cancer|metastatic renal cell cancer
525648|NCT00923832|Fungal Infections|fungal infections
525649|NCT00923832|PCR Assays|pcr assays
525650|NCT00923832|Cell Wall Derived Biomarkers|cell wall derived biomarkers
525651|NCT00923832|EORTC/MSG Definitions|eortc/msg definitions
525652|NCT00923832|Molecular Assays|molecular assays
525653|NCT00923832|Lung Fungal Infection|lung fungal infection
525654|NCT00923832|Invasive Pulmonary Fungal Infection|invasive pulmonary fungal infection
525655|NCT00923832|Invasive Pulmonary Aspegillosis|invasive pulmonary aspegillosis
525656|NCT00923832|Invasive Pulmonary Zycomycosis|invasive pulmonary zycomycosis
525657|NCT00923819|Adolescents|adolescents
525658|NCT00923819|Gastric Bypass|gastric bypass
525659|NCT00923819|Quality of Life|quality of life
525660|NCT00923819|Mental Health|mental health
525661|NCT00923819|Lifestyle|lifestyle
525662|NCT00923806|Metastatic Cancer|metastatic cancer
525663|NCT00923806|Tumor Regression|tumor regression
525664|NCT00923806|Safety|safety
525665|NCT00923806|Immunotherapy|immunotherapy
525666|NCT00923793|skull defects|skull defects
525667|NCT00923793|Hydroxylapatite implant|hydroxylapatite implant
525668|NCT00923793|Titanium implant|titanium implant
525669|NCT00923793|calotte defects without the possibility to be covered with the missing own bone|calotte defects without the possibility to be covered with the missing own bone
525670|NCT00923780|Tissue Acquisition|tissue acquisition
525671|NCT00923780|Gene Expression|gene expression
525672|NCT00923780|Class Predictor Model|class predictor model
525673|NCT00923780|Endocrine Tumor|endocrine tumor
525674|NCT00923741|Lung Cancer|lung cancer
525675|NCT00923741|Immunity|immunity
525676|NCT00923741|Clinical Response|clinical response
525677|NCT00923741|Cytokines|cytokines
525678|NCT00923741|Elispot Assay|elispot assay
525679|NCT00923741|Non-Small Cell Lung Cancer|non-small cell lung cancer
525682|NCT00923728|Phase I|phase i
525683|NCT00923728|Adult Solid Tumors|adult solid tumors
525684|NCT00923728|Cancer|cancer
525685|NCT00923728|Solid Tumor|solid tumor
525686|NCT00923676|Hyperlipidemia|hyperlipidemia
525687|NCT00923676|LDL-cholesterol|ldl-cholesterol
525688|NCT00923676|HDL-cholesterol|hdl-cholesterol
525689|NCT00923676|triglycerides|triglycerides
525690|NCT00923676|IIEF|iief
525691|NCT00923676|FSFI|fsfi
525692|NCT00923676|Male and female sexual dysfunctions|male and female sexual dysfunctions
525693|NCT00923663|MALT lymphoma|malt lymphoma
525694|NCT00923663|Advanced or Helicobacter pylori-refractory MALT lymphoma|advanced or helicobacter pylori-refractory malt lymphoma
525695|NCT00923650|Informed Consent|informed consent
525696|NCT00923650|Pediatric Phase I Clinical Trials|pediatric phase i clinical trials
525697|NCT00923650|Assent|assent
525698|NCT00923650|Questionnaires|questionnaires
525699|NCT00923650|Osteosarcoma|osteosarcoma
525700|NCT00923650|Ewing's Sarcoma|ewing's sarcoma
525701|NCT00923650|Neuroblastoma|neuroblastoma
525702|NCT00923650|Brain Tumors|brain tumors
525703|NCT00923650|Leukemia|leukemia
525704|NCT00923637|Non small cell lung cancer|non small cell lung cancer
525705|NCT00923637|video assisted thoracic surgery|video assisted thoracic surgery
525706|NCT00923637|Adjuvant chemotherapy|adjuvant chemotherapy
525707|NCT00923637|Pemetrexed|pemetrexed
525708|NCT00923637|Oxaliplatin|oxaliplatin
525709|NCT00923624|electronic medical record|electronic medical record
525710|NCT00923624|antiretroviral medication adherence|antiretroviral medication adherence
525711|NCT00923611|Hypertension|hypertension
525712|NCT00923611|Fimasartan|fimasartan
525713|NCT00923598|TKA|tka
525714|NCT00923598|Bilateral|bilateral
525715|NCT00923598|Cleveland Clinic|cleveland clinic
525716|NCT00923598|UCSD|ucsd
525717|NCT00923598|Catheter|catheter
525718|NCT00923598|Nerve block|nerve block
525719|NCT00923598|Postoperative pain|postoperative pain
525720|NCT00923598|Femoral Catheter|femoral catheter
525721|NCT00923598|Bilateral Total Knee Arthroplasty|bilateral total knee arthroplasty
525722|NCT00923598|Bilateral Femoral Catheter|bilateral femoral catheter
525723|NCT00923572|Oral contraceptive|oral contraceptive
525724|NCT00923533|Fimasartan|fimasartan
525725|NCT00923533|Drug interaction|drug interaction
525726|NCT00923520|Solid Tumors|solid tumors
525727|NCT00923520|Phase I|phase i
525728|NCT00923520|Lymphoma|lymphoma
525729|NCT00923520|Dimethane Sulfonate (DMS612, NSC 281612)|dimethane sulfonate (dms612, nsc 281612)
525730|NCT00923520|Cancer|cancer
525731|NCT00923520|Solid Tumor|solid tumor
525732|NCT00923520|Renal Cell Cancer|renal cell cancer
525733|NCT00923520|Kidney Cancer|kidney cancer
525734|NCT00923520|Breast Cancer|breast cancer
525735|NCT00923520|Colon Cancer|colon cancer
525736|NCT00923520|Lung Disease|lung disease
525737|NCT00923520|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
525738|NCT00923520|NHL|nhl
525739|NCT00923507|Gene Expression|gene expression
525740|NCT00923507|Prognosis|prognosis
525741|NCT00923507|Watch and Wait|watch and wait
525742|NCT00923507|Molecular Genetics|molecular genetics
525743|NCT00923507|Biologic Markers|biologic markers
525744|NCT00923507|Leukemia|leukemia
525745|NCT00923507|Lymphoma|lymphoma
525746|NCT00923494|Anesthesia|anesthesia
525747|NCT00923481|Multi-Kinase Inhibitor|multi-kinase inhibitor
525748|NCT00923481|Neoplasms|neoplasms
525749|NCT00923481|Advanced Cancer|advanced cancer
525750|NCT00923481|Kidney Cancer|kidney cancer
525751|NCT00923481|Liver Cancer|liver cancer
525752|NCT00923481|Pheochromocytoma|pheochromocytoma
525753|NCT00923481|Non-Small Cell Lung Cancer|non-small cell lung cancer
525754|NCT00923481|Colorectal Cancer|colorectal cancer
525755|NCT00923481|Head and Neck Cancer|head and neck cancer
525756|NCT00923468|Pharmacokinetics|pharmacokinetics
525757|NCT00923468|Phase I Trials|phase i trials
525758|NCT00923468|Children|children
525759|NCT00923468|Relaspsed Solid Tumors|relaspsed solid tumors
525760|NCT00923468|Relapsed Leukemia|relapsed leukemia
525761|NCT00923468|Relapsed Brain Tumors|relapsed brain tumors
525762|NCT00923442|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
525763|NCT00923442|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
525764|NCT00923442|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
525765|NCT00923442|Hodgkins Lymphoma|hodgkins lymphoma
525766|NCT00923442|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
525767|NCT00923429|Manual therapy|manual therapy
525768|NCT00923429|Low back pain|low back pain
525769|NCT00923429|Pain|pain
525770|NCT00923429|Return to work|return to work
525771|NCT00923416|Intra-Prostate Markers|intra-prostate markers
525772|NCT00923416|Transrectal Ultrasound|transrectal ultrasound
525773|NCT00923416|Prostate Cancer Patients|prostate cancer patients
525774|NCT00923403|plant sterols|plant sterols
525775|NCT00923403|diet|diet
525776|NCT00923403|soymilk|soymilk
525777|NCT00923403|cholesterol|cholesterol
525778|NCT00923390|Renal Cancer|renal cancer
525779|NCT00923390|Immunotherapy|immunotherapy
525780|NCT00923390|Clinical Response|clinical response
525781|NCT00923390|Toxicity|toxicity
525782|NCT00923390|Gene Therapy|gene therapy
525783|NCT00923390|Kidney Cancer|kidney cancer
525784|NCT00923377|Breast Cancer|breast cancer
525785|NCT00923377|Breast Cancer Prevention|breast cancer prevention
525786|NCT00923377|High Risk|high risk
525787|NCT00923377|Breast Stem Cells|breast stem cells
525788|NCT00923377|Mammographic Density|mammographic density
525789|NCT00923377|Breast Cancer Risk|breast cancer risk
525790|NCT00923364|GATA2|gata2
525791|NCT00923364|Transplant|transplant
525792|NCT00923364|Immunodeficiency|immunodeficiency
525793|NCT00923364|Myelodysplasia|myelodysplasia
525794|NCT00923364|MonoMAC|monomac
525795|NCT00923351|Vaccine|vaccine
525796|NCT00923351|Immunotherapy|immunotherapy
525797|NCT00923351|Cancer|cancer
525798|NCT00923351|Chemotherapy|chemotherapy
525799|NCT00923351|Tumor Lysate/KLH Pulsed Dendritic Cell Vaccine|tumor lysate/klh pulsed dendritic cell vaccine
525800|NCT00923351|Neuroblastoma|neuroblastoma
525801|NCT00923351|Autologous Lymphocyte Infusion|autologous lymphocyte infusion
525802|NCT00923351|Ewing's Sarcoma|ewing's sarcoma
525803|NCT00923351|Rhabdomyosarcoma|rhabdomyosarcoma
525804|NCT00923338|fistula|fistula
525805|NCT00923338|vesico-vaginal fistula|vesico-vaginal fistula
525806|NCT00923325|Biomarker Analysis|biomarker analysis
525807|NCT00923325|Sarcomas|sarcomas
525808|NCT00923325|Ewing's Sarcoma|ewing's sarcoma
525809|NCT00923325|Osteosarcoma|osteosarcoma
525810|NCT00923325|Rhabdomyosarcoma|rhabdomyosarcoma
525811|NCT00923325|Synovial Sarcoma|synovial sarcoma
525812|NCT00923325|Other Sarcoma|other sarcoma
525813|NCT00923299|stage IV pancreatic cancer|stage iv pancreatic cancer
525814|NCT00923299|recurrent pancreatic cancer|recurrent pancreatic cancer
525815|NCT00923299|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
525816|NCT00923273|Pemetrexed|pemetrexed
525817|NCT00923273|Sirolimus|sirolimus
525818|NCT00923273|Non-Small Cell Lung Cancer|non-small cell lung cancer
525819|NCT00923273|Phase I/II|phase i/ii
525820|NCT00923273|mTOR Inhibitor|mtor inhibitor
525821|NCT00923273|NSCLC|nsclc
525822|NCT00923273|Lung Cancer|lung cancer
525823|NCT00923260|Omentectomy|omentectomy
525824|NCT00923260|metabolic syndrome|metabolic syndrome
525825|NCT00923260|acute phase reactants|acute phase reactants
525826|NCT00923247|Vandetanib|vandetanib
525827|NCT00923247|Bortezomib|bortezomib
525828|NCT00923247|Medullary Thyroid|medullary thyroid
525829|NCT00923247|Proteasome Inhibitor|proteasome inhibitor
525830|NCT00923247|Cancer|cancer
525831|NCT00923247|Solid Tumor|solid tumor
525832|NCT00923247|Thyroid Cancer|thyroid cancer
525833|NCT00923247|Medullary Thyroid Cancer|medullary thyroid cancer
525834|NCT00923234|monosomy 5|monosomy 5
525835|NCT00923234|del5q|del5q
525836|NCT00923234|lenalidomide|lenalidomide
525837|NCT00923234|azacitidine|azacitidine
525838|NCT00923221|Blood|blood
525839|NCT00923221|Prostate Cancer|prostate cancer
525840|NCT00923221|Genotyping|genotyping
525841|NCT00923195|Metastatic Melanoma|metastatic melanoma
525842|NCT00923195|Tumor Regression|tumor regression
525843|NCT00923195|Safety|safety
525844|NCT00923195|Immunotherapy|immunotherapy
525845|NCT00923182|Relapsed or Refractory Chronic Lymphocytic Leukemia,|relapsed or refractory chronic lymphocytic leukemia,
525846|NCT00923182|CLL|cll
525847|NCT00923169|Renal Cell|renal cell
525848|NCT00923169|Melanoma|melanoma
525849|NCT00923169|Monoclonal Antibodies|monoclonal antibodies
525850|NCT00923169|Phase I|phase i
525851|NCT00923169|TGF-B|tgf-b
525852|NCT00923156|Heart failure|heart failure
525853|NCT00923156|Systolic|systolic
525854|NCT00923156|Aliskiren|aliskiren
525855|NCT00923156|Ramipril|ramipril
525856|NCT00923156|Angiotensin II|angiotensin ii
525857|NCT00923156|Ang II|ang ii
525858|NCT00923156|Plasma Renin Activity|plasma renin activity
525859|NCT00923156|PRA|pra
525860|NCT00923156|Plasma Renin Concentration|plasma renin concentration
525861|NCT00923156|PR,|pr,
525862|NCT00923156|brain natriuretic peptide|brain natriuretic peptide
525863|NCT00923156|BNP|bnp
525864|NCT00923156|urinary aldosterone|urinary aldosterone
525865|NCT00923156|Escape|escape
525866|NCT00923156|Pharmacokinetic|pharmacokinetic
525867|NCT00923156|PK|pk
525868|NCT00923130|Renal Cell Carcinoma|renal cell carcinoma
525869|NCT00923130|Bevacizumab|bevacizumab
525870|NCT00923130|Ixabepilone|ixabepilone
525871|NCT00923130|Phase II|phase ii
525872|NCT00923117|Glioblastoma|glioblastoma
525873|NCT00923117|Chemotherapy|chemotherapy
525874|NCT00923117|Anti-Angiogenesis|anti-angiogenesis
525875|NCT00923117|Radiation|radiation
525876|NCT00923117|Brain Tumor|brain tumor
525877|NCT00923117|Malignant Glioma|malignant glioma
525878|NCT00923117|Glioblastoma Multiforme|glioblastoma multiforme
525879|NCT00923104|Radiation|radiation
525880|NCT00923104|Blister|blister
525881|NCT00923104|Healthy Volunteer|healthy volunteer
525882|NCT00923104|Samples|samples
525883|NCT00923104|Prostate Cancer|prostate cancer
525884|NCT00923104|Breast Cancer|breast cancer
525885|NCT00923104|HV|hv
525886|NCT00923091|triple combination|triple combination
525887|NCT00923091|parallel group|parallel group
525888|NCT00923091|dual combination|dual combination
526094|NCT00922181|surgery|surgery
525889|NCT00923078|schizophrenia|schizophrenia
525890|NCT00923078|cognitive remediation|cognitive remediation
525891|NCT00923078|rehabilitation|rehabilitation
525892|NCT00923078|electrophysiology|electrophysiology
525893|NCT00923078|neuropsychology|neuropsychology
525894|NCT00923065|Cancer|cancer
525895|NCT00923065|Oncology|oncology
525896|NCT00923065|Standard Care|standard care
525897|NCT00923052|Cancer Stem Cells|cancer stem cells
525898|NCT00923052|Biomarkers|biomarkers
525899|NCT00923052|Surgery|surgery
525900|NCT00923052|Solid Organ Cancers|solid organ cancers
525901|NCT00923052|Natural History|natural history
525902|NCT00923052|Cancer|cancer
525903|NCT00923052|Solid Organ Cancer|solid organ cancer
525904|NCT00923052|Liver Cancer|liver cancer
525905|NCT00923052|Colorectal Cancer|colorectal cancer
525906|NCT00923052|Breast Cancer|breast cancer
525907|NCT00923052|Gastric Cancer|gastric cancer
525908|NCT00923052|Pancreatic Ductal Cancer|pancreatic ductal cancer
525909|NCT00923039|The early origin of cardiovascular disease|the early origin of cardiovascular disease
525910|NCT00923026|Gene Therapy|gene therapy
525911|NCT00923026|Follow-Up|follow-up
525912|NCT00923026|Delayed Toxicity|delayed toxicity
525913|NCT00923026|Adenocarcinoma|adenocarcinoma
525914|NCT00923026|Melanoma|melanoma
525915|NCT00923026|Neuroendocrine Tumors|neuroendocrine tumors
525916|NCT00923026|Carcinoma|carcinoma
525917|NCT00923013|Hairy Cell Leukemia|hairy cell leukemia
525918|NCT00923013|Cladribine|cladribine
525919|NCT00923013|Rituximab|rituximab
525920|NCT00923013|Minimal Residual Disease|minimal residual disease
525921|NCT00923013|Leukemia|leukemia
525922|NCT00923000|Herb Drug|herb drug
525923|NCT00923000|volunteers|volunteers
525924|NCT00922987|lyrica pregabalin epilepsy partial seizures|lyrica pregabalin epilepsy partial seizures
525925|NCT00922974|spinal bone metastases|spinal bone metastases
525926|NCT00922974|pain|pain
525927|NCT00922961|brachytherapy, late cutaneous toxicity|brachytherapy, late cutaneous toxicity
525928|NCT00922948|Radiofrequency ablation|radiofrequency ablation
525929|NCT00922948|Cryosurgery|cryosurgery
525930|NCT00922948|Renal cancers|renal cancers
525931|NCT00922896|Gemcitabine|gemcitabine
525932|NCT00922896|Cisplatin|cisplatin
525933|NCT00922896|Erlotinib|erlotinib
525934|NCT00922883|Promacta|promacta
525935|NCT00922883|SAA|saa
525936|NCT00922883|Aplastic Anemia|aplastic anemia
525937|NCT00922883|Thrombocytopenia|thrombocytopenia
525938|NCT00922857|Respiratory Insufficiency|respiratory insufficiency
525939|NCT00922857|Muscular Atrophy|muscular atrophy
525940|NCT00922857|Respiratory rehabilitation|respiratory rehabilitation
525941|NCT00922844|hypotension|hypotension
525942|NCT00922844|low blood pressure|low blood pressure
525943|NCT00922844|vasopressor need|vasopressor need
525944|NCT00922831|Cognition, Affective MS symptoms|cognition, affective ms symptoms
525945|NCT00922818|Perineal|perineal
525946|NCT00922818|Prostatectomy|prostatectomy
525947|NCT00922818|Nerve|nerve
525948|NCT00922818|Anatomic|anatomic
525949|NCT00922818|Surgery|surgery
525950|NCT00922818|Neoplasms, Prostatic|neoplasms, prostatic
525951|NCT00922818|Prostate Cancer|prostate cancer
525952|NCT00922818|Prostate Neoplasms|prostate neoplasms
525953|NCT00922818|Prostatic Cancer|prostatic cancer
525954|NCT00922818|Prostate|prostate
525955|NCT00922818|Cancer|cancer
525956|NCT00922818|Recurrent|recurrent
525957|NCT00922805|Pediatrics, short bowel syndrome, soluble fiber|pediatrics, short bowel syndrome, soluble fiber
525958|NCT00922766|dalteparin non-ST segment elevated acute coronary syndromes|dalteparin non-st segment elevated acute coronary syndromes
525959|NCT00922753|Preoxygenation|preoxygenation
525960|NCT00922753|Inspiratory|inspiratory
525961|NCT00922753|Support|support
525962|NCT00922753|Healthy|healthy
525963|NCT00922753|EndtidalO2|endtidalo2
525964|NCT00922740|Nocturia|nocturia
525965|NCT00922740|Pharmacokinetics|pharmacokinetics
525966|NCT00922740|Pharmacodynamics|pharmacodynamics
525967|NCT00922740|Water-loading|water-loading
525968|NCT00922740|Elderly|elderly
525969|NCT00922740|Males|males
525970|NCT00922727|L. reuteri|l. reuteri
525971|NCT00922727|Cytokines|cytokines
525972|NCT00922727|Toll like receptors|toll like receptors
525973|NCT00922727|Healthy Adults|healthy adults
525974|NCT00922727|Probiotics|probiotics
525975|NCT00922714|Glutamine|glutamine
525976|NCT00922714|ICU patients|icu patients
525977|NCT00922714|Critically ill|critically ill
525978|NCT00922714|Nutrition|nutrition
525979|NCT00922701|Peritoneal dialysis|peritoneal dialysis
525980|NCT00922701|L-carnitine|l-carnitine
525981|NCT00922688|Dipeptide Alanyl-Glutamine|dipeptide alanyl-glutamine
525982|NCT00922688|Insulin sensitivity|insulin sensitivity
525983|NCT00922688|Intracellular signaling|intracellular signaling
525984|NCT00922688|Antioxidant/oxidant parameters|antioxidant/oxidant parameters
525985|NCT00922688|Lipolysis|lipolysis
525986|NCT00922688|Inflammatory response in the liver|inflammatory response in the liver
525987|NCT00922675|ST-elevation myocardial infarction|st-elevation myocardial infarction
525988|NCT00922662|coronary artery disease|coronary artery disease
525989|NCT00922662|chest pain|chest pain
525990|NCT00922662|CCTA|ccta
525991|NCT00922623|Nasolabial folds|nasolabial folds
525992|NCT00922597|Continuous infusion|continuous infusion
525993|NCT00922597|Surgery|surgery
525994|NCT00922597|Severe haemophilia A|severe haemophilia a
525995|NCT00922584|non-small cell lung cancer|non-small cell lung cancer
525996|NCT00922584|Sorafenib|sorafenib
525997|NCT00922584|targeted therapy|targeted therapy
525998|NCT00922571|Cataract|cataract
525999|NCT00922571|Femtosecond laser|femtosecond laser
526000|NCT00922558|tetra-axiametric posturography|tetra-axiametric posturography
526001|NCT00922558|postural control|postural control
526002|NCT00922558|tetrax|tetrax
526003|NCT00922558|children|children
526004|NCT00922545|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
526005|NCT00922545|Quality of life|quality of life
526006|NCT00922545|Primary health care|primary health care
526007|NCT00922532|Hypoxic Respiratory Failure (HRF), Pulmonary Hypertension|hypoxic respiratory failure (hrf), pulmonary hypertension
526008|NCT00922519|Positron Emission Tomography|positron emission tomography
526009|NCT00922519|Sodium 18F-Fluoride|sodium 18f-fluoride
526010|NCT00922519|99mTc-MDP|99mtc-mdp
526011|NCT00922519|Bone Scan|bone scan
526012|NCT00922506|Overactive bladder|overactive bladder
526013|NCT00922506|Benign prostate hyperplasia|benign prostate hyperplasia
526014|NCT00922506|Doxazosin|doxazosin
526015|NCT00922506|Tolterodine|tolterodine
526016|NCT00922493|weaning|weaning
526017|NCT00922493|inspiratory muscle training|inspiratory muscle training
526018|NCT00922493|maximum inspiratory pressure (MIP)|maximum inspiratory pressure (mip)
526019|NCT00922493|index of Tobin (IT)|index of tobin (it)
526020|NCT00922493|intubated|intubated
526021|NCT00922493|intensive care unit|intensive care unit
526022|NCT00922493|elderly|elderly
526023|NCT00922480|Hypertension|hypertension
526024|NCT00922480|Losartan|losartan
526025|NCT00922454|patients will be matched based on AAA neck length and neck and iliac angulation|patients will be matched based on aaa neck length and neck and iliac angulation
526026|NCT00922441|Fimasartan|fimasartan
526027|NCT00922441|Essential Hypertension|essential hypertension
526028|NCT00922441|24hour ABPM|24hour abpm
526029|NCT00922441|Population PK|population pk
526030|NCT00922428|rheumatism|rheumatism
526031|NCT00922428|arthralgia|arthralgia
526032|NCT00922428|myalgia|myalgia
526033|NCT00922428|lumbago|lumbago
526034|NCT00922428|homoeopathy|homoeopathy
526035|NCT00922428|injection|injection
526036|NCT00922428|PASCOE-Agil HOM Injektopas|pascoe-agil hom injektopas
526037|NCT00922428|efficacy|efficacy
526038|NCT00922428|tolerability|tolerability
526039|NCT00922428|acceptance|acceptance
526040|NCT00922428|safety|safety
526041|NCT00922415|Crohn's disease|crohn's disease
526042|NCT00922415|calprotectin|calprotectin
526043|NCT00922402|Acute|acute
526044|NCT00922402|heart failure|heart failure
526045|NCT00922402|hyperglycemia|hyperglycemia
526046|NCT00922402|Acute heart failure with high levels of glycemia|acute heart failure with high levels of glycemia
526047|NCT00922389|Diabetes Complications|diabetes complications
526048|NCT00922389|Lower limb ischemia|lower limb ischemia
526049|NCT00922389|Adult stem cells|adult stem cells
526050|NCT00922389|peripheral blood stem cells|peripheral blood stem cells
526051|NCT00922376|Diabetes|diabetes
526052|NCT00922376|self- management|self- management
526053|NCT00922376|glycemic control|glycemic control
526054|NCT00922376|telehealth|telehealth
526055|NCT00922376|mhealth|mhealth
526056|NCT00922363|safety|safety
526057|NCT00922363|vaccine|vaccine
526058|NCT00922363|tuberculosis|tuberculosis
526059|NCT00922363|CAF01|caf01
526060|NCT00922363|Ag85B-ESAT-6|ag85b-esat-6
526061|NCT00922363|prevention|prevention
526062|NCT00922350|asthma|asthma
526063|NCT00922350|heliox|heliox
526064|NCT00922350|bronchodilators|bronchodilators
526065|NCT00922350|posture|posture
526066|NCT00922337|distal embolization|distal embolization
526067|NCT00922337|thrombotic lesions|thrombotic lesions
526068|NCT00922337|AMI|ami
526069|NCT00922337|ACS|acs
526070|NCT00922337|SVG|svg
526071|NCT00922324|Healthy volunteers|healthy volunteers
526072|NCT00922311|Proteinuria|proteinuria
526073|NCT00922285|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
526074|NCT00922285|health status unknown|health status unknown
526075|NCT00922272|Schizophrenia|schizophrenia
526076|NCT00922259|Flu|flu
526077|NCT00922259|Influenza|influenza
526078|NCT00922259|Vaccine|vaccine
526079|NCT00922259|Prevention|prevention
526080|NCT00922246|overuse injuries|overuse injuries
526081|NCT00922246|conscript|conscript
526082|NCT00922246|prevention|prevention
526083|NCT00922233|Contraception|contraception
526084|NCT00922220|low back pain|low back pain
526085|NCT00922220|spinal manipulation|spinal manipulation
526086|NCT00922220|central sensitization|central sensitization
526087|NCT00922220|manual therapy|manual therapy
526088|NCT00922194|Type 2 diabetes|type 2 diabetes
526089|NCT00922194|Obesity|obesity
526090|NCT00922194|Extended Release Metformin|extended release metformin
526091|NCT00922181|malignancy|malignancy
526092|NCT00922181|liver|liver
526093|NCT00922181|microwave|microwave
526095|NCT00922168|Sleep|sleep
526096|NCT00922168|apnea|apnea
526097|NCT00922168|obstructive|obstructive
526098|NCT00922168|central|central
526099|NCT00922155|endobronchial ultrasound|endobronchial ultrasound
526100|NCT00922155|guide sheath|guide sheath
526101|NCT00922155|peripheral pulmonary lesions|peripheral pulmonary lesions
526102|NCT00922129|Sirolimus|sirolimus
526103|NCT00922129|Calcineurin inhibitor|calcineurin inhibitor
526104|NCT00922129|prostate cancer|prostate cancer
526105|NCT00922103|Colitis, Ulcerative|colitis, ulcerative
526106|NCT00922103|Ileo Neo Rectal Anastomosis|ileo neo rectal anastomosis
526107|NCT00922103|Ileal Pouch Anal Anastomosis|ileal pouch anal anastomosis
526108|NCT00922103|Quality of Life|quality of life
526109|NCT00922103|functional results|functional results
526110|NCT00922103|reconstructive surgery|reconstructive surgery
526111|NCT00922103|surgery|surgery
526112|NCT00922090|Schizophrenia|schizophrenia
526113|NCT00922090|Seroquel XR|seroquel xr
526114|NCT00922090|CGI-CB|cgi-cb
526115|NCT00922090|SWN-K|swn-k
526116|NCT00922051|COPD|copd
526117|NCT00922051|FEV1|fev1
526118|NCT00922051|beta endorphin|beta endorphin
526119|NCT00922051|TENS|tens
526120|NCT00922051|acupuncture|acupuncture
526121|NCT00922025|NSCLC|nsclc
526122|NCT00922025|Male|male
526123|NCT00922025|Smoking Pattern|smoking pattern
526124|NCT00922025|Efficacy|efficacy
526125|NCT00922012|Electromagnetic Stimulation Therapy|electromagnetic stimulation therapy
526126|NCT00922012|Chronic Prostatitis|chronic prostatitis
526127|NCT00922012|Chronic Pelvic Pain Syndrome|chronic pelvic pain syndrome
526128|NCT00921999|Chickenpox|chickenpox
526129|NCT00921999|Shingles|shingles
526130|NCT00921999|Varicella|varicella
526131|NCT00921999|Zoster|zoster
526132|NCT00921999|Vaccine|vaccine
526133|NCT00921986|genetics|genetics
526134|NCT00921986|biorepository|biorepository
526135|NCT00921986|cardiac death|cardiac death
526136|NCT00921986|atrial fibrillation|atrial fibrillation
526137|NCT00921986|ventricular fibrillation|ventricular fibrillation
526138|NCT00921986|ventricular tachycardia|ventricular tachycardia
526139|NCT00921986|supraventricular tachycardias|supraventricular tachycardias
526140|NCT00921986|premature ventricular complexes|premature ventricular complexes
526141|NCT00921986|premature atrial complexes|premature atrial complexes
526142|NCT00921986|atrioventricular and intraventricular blocks|atrioventricular and intraventricular blocks
526143|NCT00921986|sinus node dysfunction|sinus node dysfunction
526144|NCT00921986|syncope|syncope
526145|NCT00921986|vasovagal reactivity|vasovagal reactivity
526146|NCT00921986|postural orthostatic tachycardia syndrome|postural orthostatic tachycardia syndrome
526147|NCT00921973|influenza|influenza
526148|NCT00921973|universal influenza vaccine|universal influenza vaccine
526149|NCT00921960|Left ventricular dysfunction|left ventricular dysfunction
526150|NCT00921960|Left ventricular systolic dysfunction|left ventricular systolic dysfunction
526151|NCT00921960|Left ventricular diastolic dysfunction|left ventricular diastolic dysfunction
526152|NCT00921960|Myocardial Infarction|myocardial infarction
526153|NCT00921960|Hypertension|hypertension
526154|NCT00921960|Diabetes|diabetes
526155|NCT00921960|Obesity|obesity
526156|NCT00921960|Dyslipidaemia|dyslipidaemia
526157|NCT00921960|Heart Failure|heart failure
526158|NCT00921960|Prevention|prevention
526159|NCT00921960|Screening|screening
526160|NCT00921960|Cardiovascular Risk Factors|cardiovascular risk factors
526161|NCT00921960|Echocardiography|echocardiography
526162|NCT00921960|Natriuretic Peptides|natriuretic peptides
526163|NCT00921947|influenza vaccine|influenza vaccine
526164|NCT00921947|M2e|m2e
526165|NCT00921947|Universal influenza vaccine|universal influenza vaccine
526166|NCT00921934|Herpes|herpes
526167|NCT00921934|Shingles|shingles
526168|NCT00921934|virus disease|virus disease
526169|NCT00921934|vitamin C|vitamin c
526170|NCT00921934|ascorbic acid|ascorbic acid
526171|NCT00921934|antioxidant|antioxidant
526172|NCT00921934|oxidative stress|oxidative stress
526173|NCT00921908|total hip arthroplasty|total hip arthroplasty
526174|NCT00921895|Pink Eye,|pink eye,
526175|NCT00921895|Viral conjunctivitis|viral conjunctivitis
526176|NCT00921895|Adenoviral conjunctivitis|adenoviral conjunctivitis
526177|NCT00921895|Keratoconjunctivitis|keratoconjunctivitis
526178|NCT00921882|Type 2 diabetes|type 2 diabetes
526179|NCT00921882|Post-partum screening|post-partum screening
526180|NCT00921869|Cancer|cancer
526181|NCT00921869|Gastrointestinal Cancer|gastrointestinal cancer
526182|NCT00921856|Acetylcholine|acetylcholine
526183|NCT00921843|Pediatric patients undergoing surgery|pediatric patients undergoing surgery
526184|NCT00921830|ibuprofen|ibuprofen
526185|NCT00921830|healthy volunteers|healthy volunteers
526186|NCT00921830|bioavailability|bioavailability
526187|NCT00921830|pharmacokinetics|pharmacokinetics
526188|NCT00921830|suppository|suppository
526189|NCT00921817|healthy children|healthy children
526190|NCT00921804|Schizophrenia|schizophrenia
526191|NCT00921804|Hallucinations|hallucinations
526192|NCT00921804|Paranoia|paranoia
526193|NCT00921804|Inpatient schizophrenia clinical trial|inpatient schizophrenia clinical trial
526194|NCT00921791|Hypertension|hypertension
526195|NCT00921791|Blood pressure|blood pressure
526196|NCT00921791|Home Blood Pressure Monitoring|home blood pressure monitoring
526197|NCT00921791|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
526198|NCT00921791|Pharmaceutical care|pharmaceutical care
526199|NCT00921778|Laparoscopic supracervical hysterectomy|laparoscopic supracervical hysterectomy
526200|NCT00921778|Vaginal bleeding|vaginal bleeding
526201|NCT00921778|Patient satisfaction|patient satisfaction
526202|NCT00921778|vaginal bleeding after laparoscopic hysterectomy|vaginal bleeding after laparoscopic hysterectomy
526203|NCT00921765|Pain|pain
526204|NCT00921765|Naloxone|naloxone
526205|NCT00921765|Ketamine|ketamine
526206|NCT00921765|Third Molar|third molar
526207|NCT00921765|Surgery|surgery
526208|NCT00921752|Lipid therapy|lipid therapy
526209|NCT00921752|high CV risk|high cv risk
526210|NCT00921752|lipid goal attainment|lipid goal attainment
526211|NCT00921752|High cardiovascular risk patients|high cardiovascular risk patients
526212|NCT00921739|Non small cell lung cancer|non small cell lung cancer
526213|NCT00921739|Small cell lung cancer|small cell lung cancer
526214|NCT00921739|Thymoma unresectable|thymoma unresectable
526215|NCT00921739|Thymic carcinoma unresectable|thymic carcinoma unresectable
526216|NCT00921726|Drug Interaction|drug interaction
526217|NCT00921713|Early cancer care|early cancer care
526218|NCT00921700|Paracetamol|paracetamol
526219|NCT00921700|Acetaminophen|acetaminophen
526220|NCT00921700|Ibuprofen|ibuprofen
526221|NCT00921700|Pain|pain
526222|NCT00921700|Postoperative pain|postoperative pain
526223|NCT00921700|third molar|third molar
526224|NCT00921674|therapeutic equivalency|therapeutic equivalency
526225|NCT00921674|pharmacokinetics|pharmacokinetics
526226|NCT00921674|food|food
526227|NCT00921674|Healthy Volunteers|healthy volunteers
526228|NCT00921661|oxaliplatin|oxaliplatin
526229|NCT00921661|5-FU|5-fu
526230|NCT00921661|Folinic Acid|folinic acid
526231|NCT00921648|EEG|eeg
526232|NCT00921648|general paresis|general paresis
526233|NCT00921648|MRI|mri
526234|NCT00921648|neurosyphilis|neurosyphilis
526235|NCT00921635|Haemoglobin|haemoglobin
526236|NCT00921622|Blood pressure|blood pressure
526237|NCT00921622|Vitamin C|vitamin c
526238|NCT00921622|Vitamin D|vitamin d
526239|NCT00921609|Acromegaly|acromegaly
526240|NCT00921609|OGTT|ogtt
526241|NCT00921609|post-op|post-op
526242|NCT00921596|Surgical Procedures, Cardiac|surgical procedures, cardiac
526243|NCT00921596|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
526244|NCT00921596|Thoracoscopes|thoracoscopes
526245|NCT00921596|Cardiopulmonary Bypass|cardiopulmonary bypass
526246|NCT00921583|survival rate|survival rate
526247|NCT00921583|success rate|success rate
526248|NCT00921570|TWEAK|tweak
526249|NCT00921570|FMD|fmd
526250|NCT00921570|PTX3|ptx3
526251|NCT00921570|Valsartan|valsartan
526252|NCT00921570|Amlodipine|amlodipine
526253|NCT00921570|Renin Angiotensin System|renin angiotensin system
526254|NCT00921557|Bone mineral density|bone mineral density
526255|NCT00921544|ROP|rop
526256|NCT00921544|sucrose|sucrose
526257|NCT00921544|pain|pain
526258|NCT00921531|Hepatocellular carcinoma|hepatocellular carcinoma
526259|NCT00921531|thalidomide|thalidomide
526260|NCT00921531|TACE|tace
526261|NCT00921531|Child-Pugh Class A or B|child-pugh class a or b
526262|NCT00921518|Cardiac surgery|cardiac surgery
526263|NCT00921518|Sodium bicarbonate|sodium bicarbonate
526264|NCT00921518|Acute kidney injury|acute kidney injury
526265|NCT00921518|Saline|saline
526266|NCT00921505|Acetaminophen|acetaminophen
526267|NCT00921505|Ibuprofen|ibuprofen
526268|NCT00921505|Platelets|platelets
526269|NCT00921505|Leukocytes|leukocytes
526270|NCT00921505|Oxygen species|oxygen species
526271|NCT00921505|Humans|humans
526272|NCT00921505|Blood Platelets|blood platelets
526273|NCT00921505|Reactive Oxygen Species|reactive oxygen species
526274|NCT00921505|Platelet Activation|platelet activation
526275|NCT00921492|Luteinizing hormone|luteinizing hormone
526276|NCT00921492|Cortisol|cortisol
526277|NCT00921492|HPA axis|hpa axis
526278|NCT00921492|HPO axis|hpo axis
526279|NCT00921492|Ovulation|ovulation
526280|NCT00921492|Heart rate variability|heart rate variability
526281|NCT00921492|Psychological distress and quality of life|psychological distress and quality of life
526282|NCT00921479|third molar|third molar
526283|NCT00921479|quality of life|quality of life
526284|NCT00921479|postoperative swelling|postoperative swelling
526285|NCT00921479|postoperative pain|postoperative pain
526286|NCT00921479|Surgical Procedures, Operative|surgical procedures, operative
526287|NCT00921479|Postoperative Period|postoperative period
526288|NCT00921466|Evaluate the clinical content of the e-SSRS-IVR|evaluate the clinical content of the e-ssrs-ivr
526289|NCT00921453|Internet|internet
526290|NCT00921453|Information supply|information supply
526291|NCT00921453|Tailoring|tailoring
526292|NCT00921453|Patient empowerment|patient empowerment
526293|NCT00921453|Headaches|headaches
526294|NCT00921453|Meta-search|meta-search
526295|NCT00921453|Consumer Health Information|consumer health information
526296|NCT00921453|Information Services|information services
526297|NCT00921453|Information Storage and Retrieval|information storage and retrieval
526298|NCT00921453|Information Systems|information systems
526299|NCT00921440|coronary artery|coronary artery
526300|NCT00921440|stenosis|stenosis
526301|NCT00921427|Hemianopia|hemianopia
526302|NCT00921427|Rehabilitation|rehabilitation
526303|NCT00921427|Transcranial direct current stimulation|transcranial direct current stimulation
526304|NCT00921427|Visual field|visual field
526305|NCT00921414|Mantle cell lymphoma|mantle cell lymphoma
526306|NCT00921414|R DHAP|r dhap
526307|NCT00921414|ASCT|asct
526308|NCT00921414|Rituximab Maintenance|rituximab maintenance
526309|NCT00921388|Smoking Cessation|smoking cessation
526310|NCT00921388|Exercise|exercise
526311|NCT00921388|Postmenopausal women|postmenopausal women
526312|NCT00921388|CHANTIX|chantix
526313|NCT00921388|varenicline|varenicline
526314|NCT00921362|Schizophrenia|schizophrenia
526315|NCT00921349|Prophylaxis|prophylaxis
526316|NCT00921349|ligation|ligation
526317|NCT00921349|beta blockers|beta blockers
526318|NCT00921349|First bleeding rate|first bleeding rate
526319|NCT00921336|subjects with advanced Solid tumor who have not responded to standard therapy or for whom no standard therapy is available|subjects with advanced solid tumor who have not responded to standard therapy or for whom no standard therapy is available
526320|NCT00921323|Obesity|obesity
526321|NCT00921323|Physical activity|physical activity
526322|NCT00921323|pedometers|pedometers
526323|NCT00921323|children|children
526324|NCT00921310|Temsirolimus and pemetrexed for recurrent or refractory NSCLC|temsirolimus and pemetrexed for recurrent or refractory nsclc
526325|NCT00921297|Alzheimer's Disease|alzheimer's disease
526326|NCT00921297|vision impairment|vision impairment
526327|NCT00921297|cataract|cataract
526328|NCT00921297|quality of life|quality of life
526329|NCT00921297|retinal nerve fiber layer|retinal nerve fiber layer
526330|NCT00921271|Compartment syndrome|compartment syndrome
526331|NCT00921258|latent prostate cancer|latent prostate cancer
526332|NCT00921258|Patient with latent prostate cancer|patient with latent prostate cancer
526333|NCT00921258|PSA ≤ 10 ng/ml|psa ≤ 10 ng/ml
526334|NCT00921258|Clinical stage T1c or T2a|clinical stage t1c or t2a
526335|NCT00921258|Patient who accept just be control|patient who accept just be control
526336|NCT00921245|Overactive Bladder|overactive bladder
526337|NCT00921232|Life-ending patient|life-ending patient
526338|NCT00921232|caregiver|caregiver
526339|NCT00921219|therapeutic equivalency|therapeutic equivalency
526340|NCT00921219|pharmacokinetics|pharmacokinetics
526341|NCT00921219|food|food
526342|NCT00921219|Healthy volunteers|healthy volunteers
526343|NCT00921206|influenza|influenza
526344|NCT00921206|influenza vaccine|influenza vaccine
526345|NCT00921206|universal influenza vaccine|universal influenza vaccine
526346|NCT00921206|Matrix 2e protein|matrix 2e protein
526347|NCT00921206|M2e|m2e
526348|NCT00921206|Immune response|immune response
526349|NCT00921193|Prostate|prostate
526350|NCT00921193|fiducials|fiducials
526351|NCT00921193|radiation Therapy|radiation therapy
526352|NCT00921193|Tracking|tracking
526353|NCT00921193|Localization|localization
526354|NCT00921180|Hepatitis B, chronic|hepatitis b, chronic
526355|NCT00921180|Peginterferon alfa-2a|peginterferon alfa-2a
526356|NCT00921180|Entecavir|entecavir
526357|NCT00921167|Glioblastoma|glioblastoma
526358|NCT00921167|Astrocytoma|astrocytoma
526359|NCT00921167|Chemotherapy|chemotherapy
526360|NCT00921154|therapeutic equivalency|therapeutic equivalency
526361|NCT00921154|pharmacokinetics|pharmacokinetics
526362|NCT00921154|fasting|fasting
526363|NCT00921154|Healthy Volunteers|healthy volunteers
526364|NCT00921141|Implantable central venous access ports, cancer|implantable central venous access ports, cancer
526365|NCT00921128|Muscimol|muscimol
526366|NCT00921128|Convection-Enhanced Delivery|convection-enhanced delivery
526367|NCT00921128|Parkinson's Disease|parkinson's disease
526368|NCT00921128|Deep Brain Stimulation|deep brain stimulation
526369|NCT00921128|Parkinson Disease|parkinson disease
526370|NCT00921128|PD|pd
526371|NCT00921115|hormone receptor positive|hormone receptor positive
526372|NCT00921115|invasive breast cancer|invasive breast cancer
526373|NCT00921115|endocrine therapy|endocrine therapy
526374|NCT00921115|Anastrazole|anastrazole
526375|NCT00921115|Fulvestrant|fulvestrant
526376|NCT00921115|breast tumors|breast tumors
526377|NCT00921115|postmenopausal|postmenopausal
526378|NCT00921102|Atropine|atropine
526379|NCT00921102|Morphine|morphine
526380|NCT00921102|Analgesics, Opioid|analgesics, opioid
526381|NCT00921102|Antiemetics|antiemetics
526382|NCT00921089|Atherosclerosis|atherosclerosis
526383|NCT00921089|Cardiovascular disease|cardiovascular disease
526384|NCT00921089|Hemodialysis|hemodialysis
526385|NCT00921089|Inflammation|inflammation
526386|NCT00921089|Vascular calcification|vascular calcification
526387|NCT00921050|subclinical hypothyroidism|subclinical hypothyroidism
526388|NCT00921050|elderly|elderly
526389|NCT00921050|mild cognitive impairment|mild cognitive impairment
526390|NCT00921050|neuropsychological test|neuropsychological test
526391|NCT00921050|NEUROPSI|neuropsi
526392|NCT00921037|Neurofibromatosis Type 1|neurofibromatosis type 1
526948|NCT00919113|IC/PBS|ic/pbs
526393|NCT00921037|Morbus Recklinghausen|morbus recklinghausen
526394|NCT00921037|cutaneous neurofibromas|cutaneous neurofibromas
526395|NCT00921037|Erbium-YAG-Laser|erbium-yag-laser
526396|NCT00921037|Vaporisation|vaporisation
526397|NCT00921037|Thermal Necrosis|thermal necrosis
526398|NCT00921024|Complicated Urinary Tract Infection|complicated urinary tract infection
526399|NCT00921024|Pyelonephritis|pyelonephritis
526400|NCT00921024|Antimicrobial|antimicrobial
526401|NCT00921024|Cephalosporin|cephalosporin
526402|NCT00921024|Intravenous|intravenous
526403|NCT00921011|hypertension|hypertension
526404|NCT00921011|diabetes|diabetes
526405|NCT00921011|smoking|smoking
526406|NCT00921011|hyperlipidemia|hyperlipidemia
526407|NCT00921011|atherosclerosis risk|atherosclerosis risk
526408|NCT00920998|Z-338|z-338
526409|NCT00920998|YM443|ym443
526410|NCT00920998|healthy volunteers|healthy volunteers
526411|NCT00920985|Pregnancy prevention|pregnancy prevention
526412|NCT00920985|Female contraception|female contraception
526413|NCT00920985|Patch|patch
526414|NCT00920972|Bone marrow|bone marrow
526415|NCT00920972|Transplant|transplant
526416|NCT00920972|Transplantation|transplantation
526417|NCT00920972|Hematopoietic|hematopoietic
526418|NCT00920972|Umbilical cord|umbilical cord
526419|NCT00920972|Related|related
526420|NCT00920972|Unrelated|unrelated
526421|NCT00920972|Reduced|reduced
526422|NCT00920972|Non-myeloablative|non-myeloablative
526423|NCT00920972|Nonmyeloablative|nonmyeloablative
526424|NCT00920972|Non-malignant|non-malignant
526425|NCT00920972|Nonmalignant|nonmalignant
526426|NCT00920946|Huntington|huntington
526427|NCT00920946|Dimebon|dimebon
526428|NCT00920946|HD|hd
526429|NCT00920946|Huntingtin|huntingtin
526430|NCT00920933|Ozone challenge|ozone challenge
526431|NCT00920933|airway neutrophilia|airway neutrophilia
526432|NCT00920933|induced sputum|induced sputum
526433|NCT00920933|Healthy volunteers|healthy volunteers
526434|NCT00920920|3D-4D MRI-based Brachytherapy|3d-4d mri-based brachytherapy
526435|NCT00920920|Cervical Cancer|cervical cancer
526436|NCT00920920|Multicenter Clinical Study|multicenter clinical study
526437|NCT00920920|Locally advanced cervical cancer|locally advanced cervical cancer
526438|NCT00920881|Continuous glucose monitoring|continuous glucose monitoring
526439|NCT00920881|Accuracy|accuracy
526440|NCT00920881|Continuous glucose-error grid analysis|continuous glucose-error grid analysis
526441|NCT00920868|Phase I|phase i
526442|NCT00920868|Solid Tumor|solid tumor
526443|NCT00920868|Colorectal|colorectal
526444|NCT00920868|Dasatinib|dasatinib
526445|NCT00920868|Sprycel|sprycel
526446|NCT00920868|Bevacizumab|bevacizumab
526447|NCT00920868|Avastin|avastin
526448|NCT00920868|Oxaliplatin|oxaliplatin
526449|NCT00920868|Eloxatin|eloxatin
526450|NCT00920868|Capecitabine|capecitabine
526451|NCT00920868|Xeloda|xeloda
526452|NCT00920868|Duke|duke
526453|NCT00920868|Any Solid Tumor (Phase I)|any solid tumor (phase i)
526454|NCT00920868|Metastatic Colorectal Cancer (Expanded Cohort)|metastatic colorectal cancer (expanded cohort)
526455|NCT00920842|metabolic syndrome|metabolic syndrome
526456|NCT00920842|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
526457|NCT00920842|cardiovascular complications|cardiovascular complications
526458|NCT00920842|cancer survivor|cancer survivor
526459|NCT00920842|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
526460|NCT00920842|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
526461|NCT00920842|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
526462|NCT00920842|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
526463|NCT00920842|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
526464|NCT00920842|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
526465|NCT00920842|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
526466|NCT00920842|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
526467|NCT00920829|Alcohol Dependence|alcohol dependence
526468|NCT00920829|Alcoholism|alcoholism
526469|NCT00920829|Naltrexone|naltrexone
526470|NCT00920829|Substance Abuse|substance abuse
526471|NCT00920829|Genetics|genetics
526472|NCT00920816|Axitinib in First & Second Line Treatment of Patients With Metastatic Renal Cell Cancer|axitinib in first & second line treatment of patients with metastatic renal cell cancer
526473|NCT00920777|CBT|cbt
526474|NCT00920777|Fukuda criteria|fukuda criteria
526475|NCT00920777|Mental functioning|mental functioning
526476|NCT00920777|Physical functioning|physical functioning
526477|NCT00920764|CKD Stages 3&4|ckd stages 3&4
526478|NCT00920764|Endothelin antagonist|endothelin antagonist
526479|NCT00920764|Proteinuria|proteinuria
526480|NCT00920751|water infusion|water infusion
526481|NCT00920751|air insufflation|air insufflation
526482|NCT00920751|colonoscopy|colonoscopy
526483|NCT00920751|colorectal cancer screening|colorectal cancer screening
526484|NCT00920738|metabolic syndrome|metabolic syndrome
526485|NCT00920738|cancer survivor|cancer survivor
526486|NCT00920738|childhood soft tissue sarcoma|childhood soft tissue sarcoma
526487|NCT00920738|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
526488|NCT00920738|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
526489|NCT00920738|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
526490|NCT00920738|childhood Hodgkin lymphoma|childhood hodgkin lymphoma
526491|NCT00920738|childhood non-Hodgkin lymphoma|childhood non-hodgkin lymphoma
526492|NCT00920738|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
526493|NCT00920738|chronic lymphocytic leukemia|chronic lymphocytic leukemia
526494|NCT00920738|childhood brain stem glioma|childhood brain stem glioma
526495|NCT00920738|childhood cerebellar astrocytoma|childhood cerebellar astrocytoma
526496|NCT00920738|childhood cerebral astrocytoma/malignant glioma|childhood cerebral astrocytoma/malignant glioma
526497|NCT00920738|childhood choroid plexus tumor|childhood choroid plexus tumor
526498|NCT00920738|childhood craniopharyngioma|childhood craniopharyngioma
526499|NCT00920738|childhood embryonal tumor|childhood embryonal tumor
526500|NCT00920738|childhood ependymoma|childhood ependymoma
526501|NCT00920738|childhood oligodendroglioma|childhood oligodendroglioma
526502|NCT00920738|childhood pineal parenchymal tumor|childhood pineal parenchymal tumor
526503|NCT00920738|childhood mixed glioma|childhood mixed glioma
526504|NCT00920738|childhood subependymal giant cell astrocytoma|childhood subependymal giant cell astrocytoma
526505|NCT00920738|childhood visual pathway and hypothalamic glioma|childhood visual pathway and hypothalamic glioma
526506|NCT00920725|DKA|dka
526507|NCT00920712|chronic atrophic gastritis|chronic atrophic gastritis
526508|NCT00920712|Traditional Chinese Medicine|traditional chinese medicine
526509|NCT00920686|Migraine|migraine
526510|NCT00920686|aura|aura
526511|NCT00920673|child|child
526512|NCT00920647|hunters syndrome|hunters syndrome
526513|NCT00920647|hunter's syndrome|hunter's syndrome
526514|NCT00920647|hunter disease|hunter disease
526515|NCT00920647|hunters disease|hunters disease
526516|NCT00920647|hunter's disease|hunter's disease
526517|NCT00920647|Mucopolysaccharidosis(MPS) II|mucopolysaccharidosis(mps) ii
526518|NCT00920647|Mucopolysaccharidosis(MPS)2|mucopolysaccharidosis(mps)2
526519|NCT00920647|Mucopolysaccharidosis (MPS) 2|mucopolysaccharidosis (mps) 2
526520|NCT00920647|Mucopolysaccharidosis (mps) ii|mucopolysaccharidosis (mps) ii
526521|NCT00920647|mucopolysaccharides|mucopolysaccharides
526522|NCT00920647|lysosomal storage disease|lysosomal storage disease
526523|NCT00920647|lysosomal storage disorder|lysosomal storage disorder
526524|NCT00920647|chronic ear infection|chronic ear infection
526525|NCT00920647|enlarged adenoids|enlarged adenoids
526526|NCT00920647|mps symptoms|mps symptoms
526527|NCT00920647|mps diagnosis|mps diagnosis
526528|NCT00920647|ert treatment|ert treatment
526529|NCT00920647|elaprase|elaprase
526530|NCT00920647|idursulfase|idursulfase
526531|NCT00920647|iduronate sulfatase|iduronate sulfatase
526532|NCT00920647|iduronate 2 sulfatase|iduronate 2 sulfatase
526533|NCT00920647|enzyme replacement therapy|enzyme replacement therapy
526534|NCT00920647|hunter syndrome treatment|hunter syndrome treatment
526535|NCT00920647|hunter's syndrome treatment|hunter's syndrome treatment
526536|NCT00920647|hunter syndrome therapy|hunter syndrome therapy
526537|NCT00920647|hunter's disease treatment|hunter's disease treatment
526538|NCT00920647|mps society|mps society
526539|NCT00920621|Asthma|asthma
526540|NCT00920621|Vitamin D|vitamin d
526541|NCT00920621|Randomized Control Trial|randomized control trial
526542|NCT00920608|AZD9056|azd9056
526543|NCT00920608|Pharmacokinetics|pharmacokinetics
526544|NCT00920608|interaction|interaction
526545|NCT00920608|Methotrexate|methotrexate
526546|NCT00920608|Rheumatoid Arthritis|rheumatoid arthritis
526547|NCT00920595|Cancer|cancer
526548|NCT00920582|Teplizumab|teplizumab
526549|NCT00920582|Protege|protege
526550|NCT00920582|Protege Encore|protege encore
526551|NCT00920582|MGA031|mga031
526552|NCT00920582|Monoclonal antibody|monoclonal antibody
526553|NCT00920582|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
526554|NCT00920582|T1DM|t1dm
526555|NCT00920582|MacroGenics|macrogenics
526556|NCT00920582|Recent Onset Diabetes|recent onset diabetes
526557|NCT00920582|hOKT3γ1 (Ala-Ala)|hokt3γ1 (ala-ala)
526558|NCT00920582|Encore|encore
526559|NCT00920569|cardiac output|cardiac output
526560|NCT00920569|recirculation|recirculation
526561|NCT00920569|oxygenator blood volume|oxygenator blood volume
526562|NCT00920569|venoarterial extracorporeal membrane oxygenation|venoarterial extracorporeal membrane oxygenation
526563|NCT00920569|venovenous extracorporeal membrane oxygenation|venovenous extracorporeal membrane oxygenation
526564|NCT00920530|Screening|screening
526565|NCT00920530|real time PCR|real time pcr
526566|NCT00920530|Streptococcus agalactiae|streptococcus agalactiae
526567|NCT00920530|Pregnant women|pregnant women
526568|NCT00920504|Mesh: patient education as topic|mesh: patient education as topic
526569|NCT00920504|Mesh: neoplasms|mesh: neoplasms
526570|NCT00920504|Mesh: medication therapy management|mesh: medication therapy management
526571|NCT00920504|pain self management|pain self management
526572|NCT00920504|symptom management|symptom management
526573|NCT00920504|education of patients with pain from neoplasm metastases|education of patients with pain from neoplasm metastases
526574|NCT00920491|Chief complaint|chief complaint
526575|NCT00920491|non-specific symptoms|non-specific symptoms
526671|NCT00920101|hypercholesterolemia|hypercholesterolemia
526576|NCT00920491|general weakness / general deterioration|general weakness / general deterioration
526577|NCT00920491|risk assessment in ED patients with non-specific symptoms|risk assessment in ed patients with non-specific symptoms
526578|NCT00920478|Rheumatoid arthritis|rheumatoid arthritis
526579|NCT00920478|Musculoskeletal Ultrasound|musculoskeletal ultrasound
526580|NCT00920478|Synovitis|synovitis
526581|NCT00920478|DMARD|dmard
526582|NCT00920478|Etanercept|etanercept
526583|NCT00920478|Biomarkers|biomarkers
526584|NCT00920478|Undifferentiated Inflammatory Polyarthritis|undifferentiated inflammatory polyarthritis
526585|NCT00920452|implantable cardioverter defibrillator (ICD)|implantable cardioverter defibrillator (icd)
526586|NCT00920452|defibrillation leads, cardiac resynchronization therapy (CRT)|defibrillation leads, cardiac resynchronization therapy (crt)
526587|NCT00920439|Poliomyelitis Vaccines|poliomyelitis vaccines
526588|NCT00920439|IPV|ipv
526589|NCT00920426|HIV|hiv
526590|NCT00920426|naive|naive
526591|NCT00920426|Phase II|phase ii
526592|NCT00920426|integrase inhibitor|integrase inhibitor
526593|NCT00920426|GSK1265744|gsk1265744
526594|NCT00920426|newly diagnosed|newly diagnosed
526595|NCT00920426|pharmacokinetics|pharmacokinetics
526596|NCT00920426|AIDS|aids
526597|NCT00920426|integrase|integrase
526598|NCT00920426|HIV Infections|hiv infections
526599|NCT00920426|Treatment naive|treatment naive
526600|NCT00920387|Anxiety|anxiety
526601|NCT00920387|quality of life|quality of life
526602|NCT00920387|psychotherapy|psychotherapy
526603|NCT00920387|potentially fatal illness|potentially fatal illness
526604|NCT00920387|lysergic acid diethylamide|lysergic acid diethylamide
526605|NCT00920374|Influenza|influenza
526606|NCT00920348|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
526607|NCT00920348|COPD|copd
526608|NCT00920348|Cohort study|cohort study
526609|NCT00920348|prospective longitudinal study|prospective longitudinal study
526610|NCT00920348|tissue bank|tissue bank
526611|NCT00920335|Adult intracranial ependymoma|adult intracranial ependymoma
526612|NCT00920322|Depression|depression
526613|NCT00920322|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
526614|NCT00920309|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
526615|NCT00920309|rapamycin|rapamycin
526616|NCT00920309|ADPKD|adpkd
526617|NCT00920296|drug interaction|drug interaction
526618|NCT00920296|integrase inhibitor|integrase inhibitor
526619|NCT00920283|Stents|stents
526620|NCT00920283|Bare Metal Stents|bare metal stents
526621|NCT00920283|PCI|pci
526622|NCT00920283|Coronary Artery Disease|coronary artery disease
526623|NCT00920283|Coronary Artery Stenosis|coronary artery stenosis
526624|NCT00920283|Stent Thrombosis|stent thrombosis
526625|NCT00920283|Vascular Disease|vascular disease
526626|NCT00920283|Myocardial Ischemia|myocardial ischemia
526627|NCT00920270|Hospital-Acquired Pneumonia|hospital-acquired pneumonia
526628|NCT00920270|Gram Negative Bacteria|gram negative bacteria
526629|NCT00920257|oncology|oncology
526630|NCT00920257|breast cancer|breast cancer
526631|NCT00920257|AKT inhibitor|akt inhibitor
526632|NCT00920257|first time in human|first time in human
526633|NCT00920257|lymphoma|lymphoma
526634|NCT00920257|endometrial cancer|endometrial cancer
526635|NCT00920257|GSK2141795|gsk2141795
526636|NCT00920257|solid tumors|solid tumors
526637|NCT00920244|Resuscitation|resuscitation
526638|NCT00920244|Cardiac arrest|cardiac arrest
526639|NCT00920244|State-transitions|state-transitions
526640|NCT00920244|Markov|markov
526641|NCT00920218|Vaccine|vaccine
526642|NCT00920218|Safety|safety
526643|NCT00920218|Herpes Zoster|herpes zoster
526644|NCT00920218|Immunogenicity|immunogenicity
526645|NCT00920218|Stem cell transplantation|stem cell transplantation
526646|NCT00920205|MPC-3100|mpc-3100
526647|NCT00920205|HSP90 inhibitor|hsp90 inhibitor
526648|NCT00920205|oral drug|oral drug
526649|NCT00920205|cancer|cancer
526650|NCT00920192|c-MET|c-met
526651|NCT00920192|VEGFR2|vegfr2
526652|NCT00920192|Advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
526653|NCT00920179|dry eye, in vivo confocal microscopy, inflammation, acinar unit density, lacrimal gland|dry eye, in vivo confocal microscopy, inflammation, acinar unit density, lacrimal gland
526654|NCT00920166|Infant formula|infant formula
526655|NCT00920166|Alpha-lactalbumin|alpha-lactalbumin
526656|NCT00920166|Symbiotic|symbiotic
526657|NCT00920166|Allergy|allergy
526658|NCT00920166|Gastrointestinal tolerance|gastrointestinal tolerance
526659|NCT00920166|Bacterial colonization|bacterial colonization
526660|NCT00920166|Faecal IgA analysis|faecal iga analysis
526661|NCT00920153|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
526662|NCT00920153|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
526663|NCT00920153|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
526664|NCT00920153|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
526665|NCT00920140|Oncology, GSK1120212, MEK inhibitor, hematological malignancies, AML|oncology, gsk1120212, mek inhibitor, hematological malignancies, aml
526666|NCT00920140|CMML|cmml
526667|NCT00920140|MDS|mds
526668|NCT00920127|AKL1|akl1
526669|NCT00920127|COPD|copd
526670|NCT00920101|atherosclerotic plaques|atherosclerotic plaques
526775|NCT00919672|Motility|motility
526672|NCT00920101|HMG-CoA reductase inhibitor|hmg-coa reductase inhibitor
526673|NCT00920101|statin|statin
526674|NCT00920101|lipid-lowering therapy|lipid-lowering therapy
526675|NCT00920088|probes|probes
526676|NCT00920088|NNRTI|nnrti
526677|NCT00920088|drug interaction|drug interaction
526678|NCT00920088|protease inhitibor|protease inhitibor
526679|NCT00920075|Juvenile Osteoporosis|juvenile osteoporosis
526680|NCT00920075|Bone Mineral Density|bone mineral density
526681|NCT00920075|Fosamax|fosamax
526682|NCT00920075|Dual Energy X-Ray Absorptiometry|dual energy x-ray absorptiometry
526683|NCT00920075|Fracture|fracture
526684|NCT00920062|recirculation|recirculation
526685|NCT00920062|ultrasound dilution|ultrasound dilution
526686|NCT00920062|venovenous extracorporeal membrane oxygenation|venovenous extracorporeal membrane oxygenation
526687|NCT00920049|Driving|driving
526688|NCT00920049|Injury|injury
526689|NCT00920049|Prevention|prevention
526690|NCT00920049|Intervention|intervention
526691|NCT00920049|Parents|parents
526692|NCT00920036|PTSD|ptsd
526693|NCT00920036|Combat|combat
526694|NCT00920036|Biofeedback|biofeedback
526695|NCT00920036|Psychophysiology|psychophysiology
526696|NCT00920023|SPIO MRI|spio mri
526697|NCT00920023|Feridex|feridex
526698|NCT00920010|non-small cell lung cancer|non-small cell lung cancer
526699|NCT00920010|small cell lung cancer|small cell lung cancer
526700|NCT00919997|human papilloma virus infection|human papilloma virus infection
526701|NCT00919997|HIV infection|hiv infection
526702|NCT00919997|HIV Infections|hiv infections
526703|NCT00919984|OVARIAN NEOPLASMS|ovarian neoplasms
526704|NCT00919984|ADJUVANT CHEMOTHERAPY|adjuvant chemotherapy
526705|NCT00919984|INTRAPERITONEAL CHEMOTHERAPY|intraperitoneal chemotherapy
526706|NCT00919971|Bi spectral Index|bi spectral index
526707|NCT00919971|Sedation depth monitoring|sedation depth monitoring
526708|NCT00919971|Out of hospital ventilated patients|out of hospital ventilated patients
526709|NCT00919958|Peripheral Artery Disease|peripheral artery disease
526710|NCT00919958|Peripheral Vascular Disease|peripheral vascular disease
526711|NCT00919958|Critical limb ischemia|critical limb ischemia
526712|NCT00919945|Neonates|neonates
526713|NCT00919945|Congenital Heart Disease|congenital heart disease
526714|NCT00919945|Postoperative Feeding|postoperative feeding
526715|NCT00919945|Splanchnic Blood Flow|splanchnic blood flow
526716|NCT00919932|Depression|depression
526717|NCT00919932|CBT|cbt
526718|NCT00919932|Texting|texting
526719|NCT00919932|SMS|sms
526720|NCT00919919|menopause|menopause
526721|NCT00919919|Endometrial Thickness|endometrial thickness
526722|NCT00919919|progesterone|progesterone
526723|NCT00919906|haptic|haptic
526724|NCT00919906|rehabilitation|rehabilitation
526725|NCT00919906|fine-motor skill|fine-motor skill
526726|NCT00919906|handwriting|handwriting
526727|NCT00919893|chronic prostatitis symptom index|chronic prostatitis symptom index
526728|NCT00919893|male|male
526729|NCT00919893|inflammatory|inflammatory
526730|NCT00919893|CP-CPPS|cp-cpps
526731|NCT00919893|Cernilton|cernilton
526732|NCT00919893|pelvic pain|pelvic pain
526733|NCT00919893|symptoms|symptoms
526734|NCT00919867|Normal, healthy volunteers (for this Phase 1 study)|normal, healthy volunteers (for this phase 1 study)
526735|NCT00919854|Human immunodeficiency virus 1|human immunodeficiency virus 1
526736|NCT00919854|HIV-1|hiv-1
526737|NCT00919854|Darunavir|darunavir
526738|NCT00919854|Ritonavir|ritonavir
526739|NCT00919854|Norvir|norvir
526740|NCT00919841|postpartum|postpartum
526741|NCT00919841|involution|involution
526742|NCT00919841|three-dimension sonography|three-dimension sonography
526743|NCT00919841|size of the uterus|size of the uterus
526744|NCT00919815|Leprosy|leprosy
526745|NCT00919815|Type 1 Reactions|type 1 reactions
526746|NCT00919815|Prednisolone|prednisolone
526747|NCT00919815|Ciclosporin|ciclosporin
526748|NCT00919802|Interstitial cystitis (IC)|interstitial cystitis (ic)
526749|NCT00919802|Oxytocin|oxytocin
526750|NCT00919802|Bladder|bladder
526751|NCT00919802|Void|void
526752|NCT00919776|Leprosy|leprosy
526753|NCT00919776|ENL|enl
526754|NCT00919776|Erythema Nodosum Leprosum|erythema nodosum leprosum
526755|NCT00919776|Prednisolone|prednisolone
526756|NCT00919776|Ciclosporin|ciclosporin
526757|NCT00919763|Atopic Dermatitis|atopic dermatitis
526758|NCT00919737|NPC-08|npc-08
526759|NCT00919737|carmustine|carmustine
526760|NCT00919737|nitrosourea|nitrosourea
526761|NCT00919737|safety|safety
526762|NCT00919724|AIDS|aids
526763|NCT00919724|Endothelial Function|endothelial function
526764|NCT00919724|Inflammation|inflammation
526765|NCT00919724|Immune Activation|immune activation
526766|NCT00919724|treatment naive|treatment naive
526767|NCT00919711|Menopausal Osteoporosis|menopausal osteoporosis
526768|NCT00919698|Hypnotics and Sedatives|hypnotics and sedatives
526769|NCT00919698|Respiration, Artificial|respiration, artificial
526770|NCT00919698|Ventilators, Mechanical|ventilators, mechanical
526771|NCT00919698|Critical care|critical care
526772|NCT00919698|Intensive care|intensive care
526773|NCT00919672|Irritable bowel syndrome|irritable bowel syndrome
526774|NCT00919672|Sacral nerve stimulation|sacral nerve stimulation
526776|NCT00919672|Pain perception|pain perception
526777|NCT00919672|GSRS-IBS|gsrs-ibs
526778|NCT00919672|IBS-IS|ibs-is
526779|NCT00919659|parenteral nutrition|parenteral nutrition
526780|NCT00919659|cancer cachexia|cancer cachexia
526781|NCT00919659|pancreatic cancer|pancreatic cancer
526782|NCT00919633|hepatitis C|hepatitis c
526783|NCT00919633|HCV|hcv
526784|NCT00919633|genotype|genotype
526785|NCT00919633|sustained virological response|sustained virological response
526786|NCT00919633|rapid virological response|rapid virological response
526787|NCT00919633|interferon|interferon
526788|NCT00919620|Psychotic disorders|psychotic disorders
526789|NCT00919620|Psychoses|psychoses
526790|NCT00919607|quetiapine fumarate(SEROQUEL) extended-release(XR) China PK Study|quetiapine fumarate(seroquel) extended-release(xr) china pk study
526791|NCT00919607|pharmacokinetics parameters|pharmacokinetics parameters
526792|NCT00919594|Interpersonal Psychotherapy|interpersonal psychotherapy
526793|NCT00919594|Depression|depression
526794|NCT00919594|Mothers|mothers
526795|NCT00919581|Spinal cord injury|spinal cord injury
526796|NCT00919555|ALS Treatment|als treatment
526797|NCT00919555|Tretinoin|tretinoin
526798|NCT00919555|Pioglitazone HCL|pioglitazone hcl
526799|NCT00919555|Actos|actos
526800|NCT00919555|Tau levels|tau levels
526801|NCT00919555|ALS|als
526802|NCT00919542|Leprosy|leprosy
526803|NCT00919542|ENL|enl
526804|NCT00919542|Erythema Nodosum Leprosum|erythema nodosum leprosum
526805|NCT00919542|Prednisolone|prednisolone
526806|NCT00919542|Ciclosporin|ciclosporin
526807|NCT00919516|Bone marrow transplantation|bone marrow transplantation
526808|NCT00919516|Ischemia|ischemia
526809|NCT00919516|Neoangiogenesis|neoangiogenesis
526810|NCT00919516|Peripheral arterial disease|peripheral arterial disease
526811|NCT00919516|Stem cell therapy|stem cell therapy
526812|NCT00919503|nonmalignant diseases|nonmalignant diseases
526813|NCT00919503|nonmalignant inherited disorders|nonmalignant inherited disorders
526814|NCT00919503|primary immunodeficiency diseases|primary immunodeficiency diseases
526815|NCT00919503|primary immune deficiency disorders|primary immune deficiency disorders
526816|NCT00919503|chronic granulomatous|chronic granulomatous
526817|NCT00919503|disease|disease
526818|NCT00919503|IPEX syndrome|ipex syndrome
526819|NCT00919503|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
526820|NCT00919503|Wiskott Aldrich Syndrome|wiskott aldrich syndrome
526821|NCT00919503|bone marrow failure syndromes|bone marrow failure syndromes
526822|NCT00919503|Shwachman Diamond Syndrome|shwachman diamond syndrome
526823|NCT00919503|Dyskeratosis Congenita|dyskeratosis congenita
526824|NCT00919503|Diamond Blackfan Anemia|diamond blackfan anemia
526825|NCT00919503|inborn errors of metabolism|inborn errors of metabolism
526826|NCT00919503|metabolic diseases|metabolic diseases
526827|NCT00919503|hemoglobinopathies|hemoglobinopathies
526828|NCT00919503|sickle cell disease|sickle cell disease
526829|NCT00919503|thalassemia|thalassemia
526830|NCT00919503|reduced intensity transplantation|reduced intensity transplantation
526831|NCT00919503|hematopoietic cell transplantation|hematopoietic cell transplantation
526832|NCT00919503|bone marrow transplantation|bone marrow transplantation
526833|NCT00919503|umbilical cord blood transplantation|umbilical cord blood transplantation
526834|NCT00919490|Healthy Volunteers|healthy volunteers
526835|NCT00919477|Prostate cancer|prostate cancer
526836|NCT00919477|Casodex|casodex
526837|NCT00919477|Monotherapy|monotherapy
526838|NCT00919464|Compartment pressure|compartment pressure
526839|NCT00919464|compartment syndrome|compartment syndrome
526840|NCT00919464|femur fracture|femur fracture
526841|NCT00919451|Leprosy|leprosy
526842|NCT00919451|Type 1 Reaction|type 1 reaction
526843|NCT00919451|Prednisolone|prednisolone
526844|NCT00919451|Ciclosporin|ciclosporin
526845|NCT00919425|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
526846|NCT00919425|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
526847|NCT00919425|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
526848|NCT00919425|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
526849|NCT00919425|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
526850|NCT00919425|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
526851|NCT00919425|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
526852|NCT00919425|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
526853|NCT00919425|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
526854|NCT00919425|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
526855|NCT00919425|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
526856|NCT00919425|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
526857|NCT00919425|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
526858|NCT00919425|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
526859|NCT00919425|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
526860|NCT00919425|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
526861|NCT00919425|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
526947|NCT00919113|GAG replacement therapy|gag replacement therapy
526862|NCT00919425|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
526863|NCT00919425|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
526864|NCT00919425|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
526865|NCT00919425|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
526866|NCT00919425|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
526867|NCT00919425|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
526868|NCT00919425|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
526869|NCT00919425|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
526870|NCT00919425|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
526871|NCT00919425|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
526872|NCT00919425|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
526873|NCT00919425|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
526874|NCT00919425|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
526875|NCT00919425|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
526876|NCT00919425|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
526877|NCT00919425|secondary acute myeloid leukemia|secondary acute myeloid leukemia
526878|NCT00919425|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
526879|NCT00919425|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
526880|NCT00919425|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
526881|NCT00919425|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
526882|NCT00919425|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
526883|NCT00919412|Non Invasive Biomarkers Preterm Delivery|non invasive biomarkers preterm delivery
526884|NCT00919399|breast cancer|breast cancer
526885|NCT00919399|locally advanced|locally advanced
526886|NCT00919399|Menopausal patient|menopausal patient
526887|NCT00919399|aromasin|aromasin
526888|NCT00919399|tamoxifen|tamoxifen
526889|NCT00919399|efficacy|efficacy
526890|NCT00919386|Ureteric Measurement|ureteric measurement
526891|NCT00919373|Catheter Ablation|catheter ablation
526892|NCT00919373|Defibrillators, Implantable|defibrillators, implantable
526893|NCT00919347|Cardiovascular Autonomic Neuropathy|cardiovascular autonomic neuropathy
526894|NCT00919347|Diabetic Autonomic Neuropathy|diabetic autonomic neuropathy
526895|NCT00919347|Autonomic Dysfunction|autonomic dysfunction
526896|NCT00919334|Myopia progression|myopia progression
526897|NCT00919334|Myopia control|myopia control
526898|NCT00919334|Simultaneous vision|simultaneous vision
526899|NCT00919334|Myopic defocus|myopic defocus
526900|NCT00919321|CLL|cll
526901|NCT00919321|PPV|ppv
526902|NCT00919321|PCV|pcv
526903|NCT00919308|Simulation|simulation
526904|NCT00919308|Invasive procedures|invasive procedures
526905|NCT00919295|Fibromyalgia syndrome|fibromyalgia syndrome
526906|NCT00919295|mirtazapine|mirtazapine
526907|NCT00919295|randomized controlled trial|randomized controlled trial
526908|NCT00919295|pilot study|pilot study
526909|NCT00919282|pancreatic cancer|pancreatic cancer
526910|NCT00919282|gemcitabine|gemcitabine
526911|NCT00919282|combination|combination
526912|NCT00919243|prednisone|prednisone
526913|NCT00919243|allopurinol|allopurinol
526914|NCT00919243|heart failure|heart failure
526915|NCT00919243|hyperuricemia|hyperuricemia
526916|NCT00919230|Hip fracture|hip fracture
526917|NCT00919230|iron therapy|iron therapy
526918|NCT00919230|anaemia|anaemia
526919|NCT00919217|Multiple Sclerosis|multiple sclerosis
526921|NCT00919217|Relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
526922|NCT00919217|RR-MS|rr-ms
526923|NCT00919217|Women|women
526924|NCT00919204|AG-013736, axitinib, pharmacokinetics, healthy, Chinese|ag-013736, axitinib, pharmacokinetics, healthy, chinese
526925|NCT00919191|acne|acne
526926|NCT00919191|irritation|irritation
526927|NCT00919191|objective sensory methods|objective sensory methods
526928|NCT00919178|Dengue virus|dengue virus
526929|NCT00919178|Vaccine|vaccine
526930|NCT00919178|DEN4|den4
526931|NCT00919178|Dengue|dengue
526932|NCT00919165|carotid stenting|carotid stenting
526933|NCT00919165|cognitive function|cognitive function
526934|NCT00919165|pre and post stent|pre and post stent
526935|NCT00919165|severe carotid artery stenosis|severe carotid artery stenosis
526936|NCT00919152|stress ulcer prophylaxis|stress ulcer prophylaxis
526937|NCT00919152|intensive care|intensive care
526938|NCT00919152|Critically ill|critically ill
526939|NCT00919152|proton pump inhibitors|proton pump inhibitors
526940|NCT00919152|pharmacoeconomics|pharmacoeconomics
526941|NCT00919139|multiple myeloma|multiple myeloma
526942|NCT00919139|Waldenström macroglobulinemia|waldenström macroglobulinemia
526943|NCT00919139|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
526944|NCT00919139|primary systemic amyloidosis|primary systemic amyloidosis
526945|NCT00919126|Xenon in Anaesthesia|xenon in anaesthesia
526946|NCT00919113|Bladder Pain|bladder pain
526949|NCT00919100|pediatric|pediatric
526950|NCT00919100|venipuncture|venipuncture
526951|NCT00919100|pain|pain
526952|NCT00919100|vibration|vibration
526953|NCT00919100|vapocoolant|vapocoolant
526954|NCT00919074|Patients undergoing endoscopic retrograde cholangiopancreatography for the first time|patients undergoing endoscopic retrograde cholangiopancreatography for the first time
526955|NCT00919074|Particular focus on patients who meet predefined criteria for a difficult bile duct cannulation|particular focus on patients who meet predefined criteria for a difficult bile duct cannulation
526956|NCT00919061|GALL BLADDER|gall bladder
526957|NCT00919061|BILE DUCTS|bile ducts
526958|NCT00919061|BAY 43-9006|bay 43-9006
526959|NCT00919061|SORAFENIB|sorafenib
526960|NCT00919061|CISPLATIN|cisplatin
526961|NCT00919061|GEMCITABINE|gemcitabine
526962|NCT00919061|09-029|09-029
526963|NCT00919035|prostate cancer|prostate cancer
526964|NCT00919035|androgen-independent prostate cancer (AIPC) Prostate Cancer|androgen-independent prostate cancer (aipc) prostate cancer
526965|NCT00919022|Inoperable Prostate Cancer|inoperable prostate cancer
526966|NCT00919022|Erectile Dysfunction|erectile dysfunction
526967|NCT00919009|TACE|tace
526968|NCT00919009|Sorafenib|sorafenib
526969|NCT00918996|Cesarean Section|cesarean section
526970|NCT00918996|Bladder Flap|bladder flap
526971|NCT00918996|Operating time|operating time
526972|NCT00918983|Benign prostatic hyperplasia|benign prostatic hyperplasia
526973|NCT00918983|BPH|bph
526974|NCT00918983|Enlarged prostate|enlarged prostate
526975|NCT00918970|autonomous nervous system|autonomous nervous system
526976|NCT00918970|brain death|brain death
526977|NCT00918970|organs transplantation|organs transplantation
526978|NCT00918957|Tobramycin Inhalation Powder|tobramycin inhalation powder
526979|NCT00918957|Cystic fibrosis|cystic fibrosis
526980|NCT00918957|Lung diseases|lung diseases
526981|NCT00918957|Anti-Bacterial Agents|anti-bacterial agents
526982|NCT00918957|Treatment of infections with P. aeruginosa in cystic fibrosis subjects|treatment of infections with p. aeruginosa in cystic fibrosis subjects
526983|NCT00918944|clinical decision support tool|clinical decision support tool
526984|NCT00918944|electronic health record|electronic health record
526985|NCT00918944|control tool|control tool
526986|NCT00918944|spirometry|spirometry
526987|NCT00918944|quality of life survey|quality of life survey
526988|NCT00918944|provider survey|provider survey
526989|NCT00918931|Leukemia|leukemia
526990|NCT00918931|Systemic Mastocytosis|systemic mastocytosis
526991|NCT00918931|SM|sm
526992|NCT00918931|Obatoclax mesylate|obatoclax mesylate
526993|NCT00918931|GX15-070MS|gx15-070ms
526994|NCT00918918|Alcohol Consumption|alcohol consumption
526995|NCT00918918|High Density Lipoprotein (HDL)|high density lipoprotein (hdl)
526996|NCT00918918|lipopolysaccharides (LPS)|lipopolysaccharides (lps)
526997|NCT00918918|Apolipoproteins|apolipoproteins
526998|NCT00918918|Inflammation|inflammation
526999|NCT00918905|pervasive healthcare|pervasive healthcare
527000|NCT00918905|telecare|telecare
527001|NCT00918905|telemedicine|telemedicine
527002|NCT00918905|COPD|copd
527003|NCT00918892|breast cancer|breast cancer
527004|NCT00918892|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
527005|NCT00918892|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
527006|NCT00918892|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
527007|NCT00918892|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
527008|NCT00918892|triple-negative breast cancer|triple-negative breast cancer
527009|NCT00918892|HER2-negative breast cancer|her2-negative breast cancer
527010|NCT00918892|HER2-positive breast cancer|her2-positive breast cancer
527011|NCT00918879|DPP-4 inhibitors|dpp-4 inhibitors
527012|NCT00918879|HbA1c|hba1c
527013|NCT00918879|Incretins|incretins
527014|NCT00918866|Phase 4|phase 4
527015|NCT00918866|DEFINITY®|definity®
527016|NCT00918866|hemodynamics|hemodynamics
527017|NCT00918866|pulmonary artery pressure|pulmonary artery pressure
527018|NCT00918853|pancreas|pancreas
527019|NCT00918853|adenocarcinoma|adenocarcinoma
527020|NCT00918840|HIV|hiv
527021|NCT00918840|Vaccine|vaccine
527022|NCT00918840|Immune Therapy|immune therapy
527023|NCT00918840|DermaVir|dermavir
527024|NCT00918840|Treatment experienced|treatment experienced
527025|NCT00918827|adenocarcinoma of the colon|adenocarcinoma of the colon
527026|NCT00918827|stage III colon cancer|stage iii colon cancer
527027|NCT00918801|T1DM|t1dm
527028|NCT00918801|MRI|mri
527029|NCT00918788|breast cancer|breast cancer
527030|NCT00918775|Renal Cell Carcinoma|renal cell carcinoma
527031|NCT00918775|RCC|rcc
527032|NCT00918775|Kidney|kidney
527033|NCT00918775|Metastasectomy|metastasectomy
527034|NCT00918775|Surgery|surgery
527035|NCT00918775|Tumor Removal|tumor removal
527036|NCT00918762|perioperative/postoperative complications|perioperative/postoperative complications
527037|NCT00918762|precancerous condition|precancerous condition
527038|NCT00918762|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
527039|NCT00918762|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
527040|NCT00918762|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
527041|NCT00918762|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
527042|NCT00918762|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
527043|NCT00918762|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
527044|NCT00918762|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
527045|NCT00918762|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
527046|NCT00918762|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
527047|NCT00918762|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
527048|NCT00918762|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
527049|NCT00918762|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
527050|NCT00918762|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
527051|NCT00918762|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
527052|NCT00918762|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
527053|NCT00918762|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
527054|NCT00918762|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
527055|NCT00918762|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
527056|NCT00918762|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
527057|NCT00918762|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
527058|NCT00918762|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
527059|NCT00918736|Ankle joint|ankle joint
527060|NCT00918736|Balance|balance
527061|NCT00918736|Hyaluronic acid|hyaluronic acid
527062|NCT00918736|Osteoarthritis|osteoarthritis
527063|NCT00918710|Squamous cell carcinoma of Oropharynx|squamous cell carcinoma of oropharynx
527064|NCT00918710|Human papillomavirus.|human papillomavirus.
527065|NCT00918710|Biological prognostic markers.|biological prognostic markers.
527066|NCT00918697|photorefractive keratectomy|photorefractive keratectomy
527067|NCT00918697|PRK|prk
527068|NCT00918697|alcohol-assisted debridement|alcohol-assisted debridement
527069|NCT00918697|mechanical debridement|mechanical debridement
527070|NCT00918697|confocal scan|confocal scan
527071|NCT00918697|confocal microscopy|confocal microscopy
527072|NCT00918684|Depression|depression
527073|NCT00918671|Headache|headache
527074|NCT00918671|Medication overuse|medication overuse
527075|NCT00918671|chronic|chronic
527076|NCT00918671|relapse|relapse
527077|NCT00918658|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
527078|NCT00918658|chronic myelogenous leukemia|chronic myelogenous leukemia
527079|NCT00918658|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
527080|NCT00918658|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
527081|NCT00918658|adult acute myeloid leukemia|adult acute myeloid leukemia
527082|NCT00918658|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
527083|NCT00918658|multiple myeloma|multiple myeloma
527084|NCT00918645|stage IV prostate cancer|stage iv prostate cancer
527085|NCT00918645|recurrent prostate cancer|recurrent prostate cancer
527086|NCT00918645|bone metastases|bone metastases
527087|NCT00918632|food-effect pharmacokinetics AG-013736 food fasting|food-effect pharmacokinetics ag-013736 food fasting
527088|NCT00918619|randomized,|randomized,
527089|NCT00918619|controlled,|controlled,
527090|NCT00918619|haemostatic agents,|haemostatic agents,
527091|NCT00918619|Sangustop,|sangustop,
527092|NCT00918619|Tachosil,|tachosil,
527093|NCT00918619|liver resection,|liver resection,
527094|NCT00918619|haemostasis|haemostasis
527095|NCT00918593|Metastases|metastases
527096|NCT00918593|Cutaneous|cutaneous
527097|NCT00918593|Ulcerating|ulcerating
527098|NCT00918593|Palliative|palliative
527099|NCT00918593|ulcerating metastases|ulcerating metastases
527100|NCT00918567|ADHD|adhd
527101|NCT00918567|impact of atomoxetine with and and without behavior therapy at school and home|impact of atomoxetine with and and without behavior therapy at school and home
527102|NCT00918554|Sarcoid-associated uveitis|sarcoid-associated uveitis
527103|NCT00918554|Macular oedema|macular oedema
527104|NCT00918554|Methotrexate|methotrexate
527105|NCT00918554|Conventional corticosteroids sparing agent.|conventional corticosteroids sparing agent.
527106|NCT00918541|atherosclerotic disease|atherosclerotic disease
527107|NCT00918541|progression|progression
527108|NCT00918541|natural progression of atherosclerotic disease|natural progression of atherosclerotic disease
527109|NCT00918541|natural history of atherosclerosis at the level of the carotid artery as evaluated by MRI|natural history of atherosclerosis at the level of the carotid artery as evaluated by mri
527110|NCT00918528|Urethral stricture|urethral stricture
527111|NCT00918528|Mitomycin C|mitomycin c
527112|NCT00918528|Internal Urethrotomy|internal urethrotomy
527113|NCT00918515|Sedation|sedation
527114|NCT00918515|Anaesthesia|anaesthesia
527115|NCT00918515|Safety|safety
527116|NCT00918515|tolerability|tolerability
527117|NCT00918515|pharmacokinetics|pharmacokinetics
527118|NCT00918515|pharmacodynamics|pharmacodynamics
527119|NCT00918515|healthy male volunteers|healthy male volunteers
527120|NCT00918489|soft tissue sarcoma|soft tissue sarcoma
527121|NCT00918489|metastatic|metastatic
527122|NCT00918489|vorinostat|vorinostat
527123|NCT00918463|lymphoma|lymphoma
527124|NCT00918463|diffuse|diffuse
527125|NCT00918463|refractory|refractory
527126|NCT00918437|uvulopalatoplasty|uvulopalatoplasty
527127|NCT00918437|postoperative pain|postoperative pain
527128|NCT00918437|quality of life|quality of life
527129|NCT00918411|diarrhea|diarrhea
527130|NCT00918411|IBS|ibs
527131|NCT00918411|Colonic diseases|colonic diseases
527132|NCT00918411|YM060|ym060
527133|NCT00918385|hormone resistant prostate cancer|hormone resistant prostate cancer
527134|NCT00918385|castration resistant prostate cancer|castration resistant prostate cancer
527135|NCT00918385|hormone refractory prostate cancer|hormone refractory prostate cancer
527136|NCT00918385|metastatic prostate cancer|metastatic prostate cancer
527137|NCT00918385|hormonal therapy|hormonal therapy
527138|NCT00918385|antiandrogen therapy|antiandrogen therapy
527139|NCT00918385|androgen receptor|androgen receptor
527140|NCT00918385|nilutamide|nilutamide
527141|NCT00918385|dasatinib|dasatinib
527142|NCT00918385|genomics|genomics
527143|NCT00918385|genomic signature|genomic signature
527144|NCT00918385|genomic predictor|genomic predictor
527145|NCT00918385|genomic analysis|genomic analysis
527146|NCT00918385|genomic expression profile|genomic expression profile
527147|NCT00918372|MSCTA|mscta
527148|NCT00918372|Marathon runners|marathon runners
527149|NCT00918346|Ocular hypertension|ocular hypertension
527150|NCT00918320|Temozolomide|temozolomide
527151|NCT00918320|Topotecan|topotecan
527152|NCT00918320|paediatric solid tumours|paediatric solid tumours
527153|NCT00918320|Miscellaneous other solid tumours|miscellaneous other solid tumours
527154|NCT00918307|Tobacco Dependence|tobacco dependence
527155|NCT00918307|HIV infection|hiv infection
527156|NCT00918307|varenicline|varenicline
527157|NCT00918294|CRT|crt
527158|NCT00918294|heart failure|heart failure
527159|NCT00918294|optimization|optimization
527160|NCT00918294|Timing cycle optimization methods|timing cycle optimization methods
527161|NCT00918268|Influenza vaccine|influenza vaccine
527162|NCT00918255|Hidradenitis Suppurativa|hidradenitis suppurativa
527163|NCT00918255|Adalimumab|adalimumab
527164|NCT00918255|Nodule|nodule
527165|NCT00918255|Abscess|abscess
527166|NCT00918255|Fistula|fistula
527167|NCT00918255|Physicians Global Assessment|physicians global assessment
527168|NCT00918255|Hurley Stage|hurley stage
527169|NCT00918255|Sartorius Scale|sartorius scale
527170|NCT00918242|Coronary Heart Disease|coronary heart disease
527171|NCT00918242|computed tomography|computed tomography
527172|NCT00918242|prevalence of coronary artery disease|prevalence of coronary artery disease
527173|NCT00918229|Prostate|prostate
527174|NCT00918229|cancer|cancer
527175|NCT00918229|radiation|radiation
527176|NCT00918229|biodegradable implantable balloon|biodegradable implantable balloon
527177|NCT00918229|intrarectal balloon|intrarectal balloon
527178|NCT00918216|breast cancer|breast cancer
527179|NCT00918203|Lung neoplasms|lung neoplasms
527180|NCT00918203|IMC-3G3|imc-3g3
527181|NCT00918203|carboplatin|carboplatin
527182|NCT00918203|paclitaxel|paclitaxel
527183|NCT00918203|PDGFr|pdgfr
527184|NCT00918190|Postoperative nausea and vomiting|postoperative nausea and vomiting
527185|NCT00918190|Pediatric|pediatric
527186|NCT00918190|Strabismus|strabismus
527187|NCT00918190|Late onset postoperative nausea and vomiting|late onset postoperative nausea and vomiting
527188|NCT00918112|Parkinson's Disease|parkinson's disease
527189|NCT00918099|Mesh|mesh
527190|NCT00918099|vaginal prolapse|vaginal prolapse
527191|NCT00918099|Recurrence rate|recurrence rate
527192|NCT00918086|Vitamin D|vitamin d
527193|NCT00918086|Tuberculosis|tuberculosis
527194|NCT00918073|HIV infected smokers|hiv infected smokers
527195|NCT00918073|HIV|hiv
527196|NCT00918034|BPH|bph
527197|NCT00918034|LUTS|luts
527198|NCT00918034|talaporfin sodium|talaporfin sodium
527199|NCT00918008|URINARY BLADDER|urinary bladder
527200|NCT00918008|Bladder|bladder
527201|NCT00918008|Blood sample|blood sample
527202|NCT00918008|Lymph Nodes|lymph nodes
527203|NCT00917995|parastomal hernia|parastomal hernia
527204|NCT00917995|prophylactic mesh|prophylactic mesh
527205|NCT00917995|colostomy|colostomy
527206|NCT00917995|hernia|hernia
527207|NCT00917956|Lithium|lithium
527208|NCT00917956|IBM|ibm
527209|NCT00917956|InclusionIBM|inclusionibm
527210|NCT00917956|Myositis|myositis
527211|NCT00917943|smoking|smoking
527212|NCT00917943|pregnancy|pregnancy
527213|NCT00917943|counseling|counseling
527214|NCT00917943|prevention|prevention
527215|NCT00917943|tailored intervention|tailored intervention
527216|NCT00917943|postpartum|postpartum
527217|NCT00917943|women|women
527218|NCT00917943|cessation|cessation
527219|NCT00917930|exercise training|exercise training
527220|NCT00917930|functional recovery|functional recovery
527221|NCT00917930|heart diseases|heart diseases
527222|NCT00917930|altered glucose metabolism early after an acute cardiac event|altered glucose metabolism early after an acute cardiac event
527223|NCT00917930|non diabetes CAD patients|non diabetes cad patients
527224|NCT00917930|glycometabolic state|glycometabolic state
527225|NCT00917917|Metabolic syndrome|metabolic syndrome
527226|NCT00917917|exercise training|exercise training
527227|NCT00917917|abdominal fat mass|abdominal fat mass
527228|NCT00917917|endothelial function|endothelial function
527229|NCT00917917|diastolic function|diastolic function
527230|NCT00917904|HIV Infections|hiv infections
527231|NCT00917904|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
527232|NCT00917904|Healthy|healthy
527233|NCT00917904|HIV seronegativity|hiv seronegativity
527234|NCT00917891|HIV Infections|hiv infections
527235|NCT00917891|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
527236|NCT00917891|Healthy|healthy
527237|NCT00917891|HIV seronegativity|hiv seronegativity
527238|NCT00917878|Milk|milk
527239|NCT00917878|Postprandial hyperlipidemia|postprandial hyperlipidemia
527240|NCT00917878|Postprandial inflammation|postprandial inflammation
527241|NCT00917878|Overweight|overweight
527242|NCT00917852|aorta|aorta
527243|NCT00917852|trauma|trauma
527244|NCT00917852|transection|transection
527245|NCT00917839|neuroprotection|neuroprotection
527246|NCT00917839|multiple sclerosis|multiple sclerosis
527247|NCT00917839|brain atrophy|brain atrophy
527248|NCT00917839|mr-spectroscopy|mr-spectroscopy
527249|NCT00917813|HIV|hiv
527250|NCT00917813|monoclonal antibody|monoclonal antibody
527251|NCT00917813|KD-247|kd-247
527252|NCT00917813|treatment naive|treatment naive
527253|NCT00917800|angiography|angiography
527254|NCT00917800|exercise testing|exercise testing
527255|NCT00917800|high frequency ECG|high frequency ecg
527256|NCT00917800|coronary artery disease|coronary artery disease
527257|NCT00917787|Asthma|asthma
527258|NCT00917774|gender specific knee|gender specific knee
527259|NCT00917774|osteoarthritis|osteoarthritis
527260|NCT00917774|total knee arthroplasty|total knee arthroplasty
527261|NCT00917761|Hepatitis B, chronic|hepatitis b, chronic
527262|NCT00917761|Peginterferon alfa-2a|peginterferon alfa-2a
527263|NCT00917761|Entecavir|entecavir
527264|NCT00917735|Green tea|green tea
527265|NCT00917735|Breast cancer|breast cancer
527266|NCT00917735|Prevention|prevention
527267|NCT00917735|COMT genotype|comt genotype
527268|NCT00917735|EGCG (Epigallocatechin gallate)|egcg (epigallocatechin gallate)
527269|NCT00917735|Mammographic density|mammographic density
527270|NCT00917735|Reproductive hormones|reproductive hormones
527271|NCT00917735|IGF axis proteins|igf axis proteins
527272|NCT00917735|Oxidative stress|oxidative stress
527273|NCT00917722|Parkinson's Disease|parkinson's disease
527274|NCT00917722|STN DBS|stn dbs
527275|NCT00917722|Deep Brain Stimulation|deep brain stimulation
527276|NCT00917709|dementia with Lewy bodies|dementia with lewy bodies
527277|NCT00917709|imaging|imaging
527278|NCT00917709|acetylcholine|acetylcholine
527279|NCT00917709|dopamine|dopamine
527280|NCT00917709|IBVM|ibvm
527281|NCT00917709|DATSCAN|datscan
527282|NCT00917670|trabecular meshwork|trabecular meshwork
527283|NCT00917670|electron microscopy|electron microscopy
527284|NCT00917657|photorefractive keratectomy|photorefractive keratectomy
527285|NCT00917657|hyperopia|hyperopia
527286|NCT00917657|radial keratotomy|radial keratotomy
527287|NCT00917657|refractive surgery|refractive surgery
527288|NCT00917644|Bioqeuivalence, Pharmacokinetics, Atorvastatin|bioqeuivalence, pharmacokinetics, atorvastatin
527289|NCT00917631|Co-bedding|co-bedding
527290|NCT00917631|Procedural pain|procedural pain
527291|NCT00917631|Twin|twin
527292|NCT00917631|Comfort|comfort
527293|NCT00917631|RCT|rct
527294|NCT00917618|osteoarthritis|osteoarthritis
527295|NCT00917618|knee|knee
527296|NCT00917618|exercise|exercise
527297|NCT00917618|cycling|cycling
527298|NCT00917592|Diverticulitis|diverticulitis
527299|NCT00917579|Bioequivalence, pharmacokinetics, atorvastatin|bioequivalence, pharmacokinetics, atorvastatin
527300|NCT00917566|Airtraq|airtraq
527301|NCT00917566|Pediatric|pediatric
527302|NCT00917553|diabetic retinopathy|diabetic retinopathy
527303|NCT00917553|diabetes|diabetes
527304|NCT00917553|diabetic eye studies|diabetic eye studies
527305|NCT00917527|Subjects with family history of coronary heart disease|subjects with family history of coronary heart disease
527306|NCT00917514|Dosing Tool|dosing tool
527307|NCT00917514|Compliance|compliance
527308|NCT00917514|User Friendly|user friendly
527309|NCT00917514|Crohn's Disease|crohn's disease
527310|NCT00917514|Ulcerative Colitis|ulcerative colitis
527311|NCT00917501|Mania|mania
527312|NCT00917501|Adolescents at risk for Mania|adolescents at risk for mania
527313|NCT00917488|Allergen extract Standardization|allergen extract standardization
527314|NCT00917475|preterm infants|preterm infants
527315|NCT00917462|ESOPHAGUS|esophagus
527316|NCT00917462|BAY 43-9006 (SORAFENIB)|bay 43-9006 (sorafenib)
527317|NCT00917462|09-016|09-016
527318|NCT00917462|Nexavar®.|nexavar®.
527319|NCT00917449|Metabolic Syndrome|metabolic syndrome
527320|NCT00917449|Impaired glucose tolerance|impaired glucose tolerance
527321|NCT00917449|Type 2 diabetes mellitus|type 2 diabetes mellitus
527322|NCT00917449|Endothelial dysfunction|endothelial dysfunction
527323|NCT00917449|L-arginine|l-arginine
527324|NCT00917449|Insulin resistance|insulin resistance
527325|NCT00917423|Anorexia Nervosa|anorexia nervosa
527326|NCT00917423|Exercise|exercise
527327|NCT00917423|Physical Activity|physical activity
527328|NCT00917397|Traumatized refugee|traumatized refugee
527329|NCT00917397|treatment|treatment
527330|NCT00917397|antidepressants|antidepressants
527331|NCT00917397|psychotherapy|psychotherapy
527332|NCT00917397|PTSD in traumatized refugees|ptsd in traumatized refugees
527333|NCT00917384|IMC-1121B|imc-1121b
527334|NCT00917384|Monoclonal antibody (MAb)|monoclonal antibody (mab)
527335|NCT00917384|Vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
527336|NCT00917384|Human vascular endothelial growth factor receptor-2 (VEGFR-2)|human vascular endothelial growth factor receptor-2 (vegfr-2)
527337|NCT00917384|Platinum resistant|platinum resistant
527338|NCT00917384|platinum refractory|platinum refractory
527339|NCT00917384|Gastric|gastric
527340|NCT00917384|Gastroesophageal Junction Adenocarcinoma|gastroesophageal junction adenocarcinoma
527341|NCT00917384|metastatic|metastatic
527342|NCT00917384|Angiogenesis|angiogenesis
527343|NCT00917371|adults with attention-deficit hyperactivity disorder|adults with attention-deficit hyperactivity disorder
527344|NCT00917371|atomoxetine|atomoxetine
527345|NCT00917371|neuropsychological functioning|neuropsychological functioning
527346|NCT00917371|brain imaging studies|brain imaging studies
527347|NCT00917358|Hepatitis C|hepatitis c
527348|NCT00917358|Dialysis|dialysis
527349|NCT00917358|Interferon|interferon
527350|NCT00917345|ARC|arc
527351|NCT00917345|PRA|pra
527352|NCT00917345|primary aldosteronism|primary aldosteronism
527353|NCT00917345|captopril test|captopril test
527354|NCT00917345|aldosterone-renin ratio|aldosterone-renin ratio
527355|NCT00917345|Primary aldosteronism (PA) than PRA and establish thresholds for the diagnosis using ARC.|primary aldosteronism (pa) than pra and establish thresholds for the diagnosis using arc.
527356|NCT00917332|pain|pain
527357|NCT00917332|childbirth|childbirth
527358|NCT00917332|relaxation|relaxation
527359|NCT00917332|guided imagery|guided imagery
527360|NCT00917332|VAS|vas
527361|NCT00917332|epidural|epidural
527362|NCT00917306|Peplin|peplin
527363|NCT00917306|Actinic keratosis|actinic keratosis
527364|NCT00917306|PEP005|pep005
527365|NCT00917293|Tardive Dyskinesia|tardive dyskinesia
527366|NCT00917293|Schizophrenia|schizophrenia
527367|NCT00917293|Pyridoxal 5'-phosphate|pyridoxal 5'-phosphate
527368|NCT00917280|Parkinson's Disease|parkinson's disease
527369|NCT00917267|diabetes|diabetes
527370|NCT00917267|exenatide|exenatide
527371|NCT00917267|once weekly|once weekly
527372|NCT00917267|Byetta|byetta
527373|NCT00917267|Amylin|amylin
527374|NCT00917267|Lilly|lilly
527375|NCT00917254|YM150|ym150
527376|NCT00917254|Thrombosis|thrombosis
527377|NCT00917254|VTE|vte
527378|NCT00917254|Knee Replacement|knee replacement
527379|NCT00917254|Anticoagulant|anticoagulant
527380|NCT00917254|FXa inhibitor|fxa inhibitor
527381|NCT00917241|Graves' disease|graves' disease
527382|NCT00917241|dexamethasone|dexamethasone
527383|NCT00917241|relapse|relapse
527384|NCT00917241|methimazole|methimazole
527385|NCT00917215|Asthma|asthma
527386|NCT00917215|Acupuncture|acupuncture
527387|NCT00917215|Pulmonary function|pulmonary function
527388|NCT00917215|Quality of life|quality of life
527389|NCT00917189|VCFS|vcfs
527390|NCT00917189|Chromosome 22q Deletion Syndrome|chromosome 22q deletion syndrome
527391|NCT00917189|Learning Disorders|learning disorders
527392|NCT00917163|coronary artery disease|coronary artery disease
527393|NCT00917163|restenosis|restenosis
527394|NCT00917163|stent thrombosis|stent thrombosis
527395|NCT00917163|coronary stents|coronary stents
527396|NCT00917163|angioplasty|angioplasty
527397|NCT00917163|drug eluting stents|drug eluting stents
527398|NCT00917150|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
527399|NCT00917150|COPD|copd
527400|NCT00917150|emphysema|emphysema
527401|NCT00917137|Lung cancer|lung cancer
527402|NCT00917137|Lung nodule|lung nodule
527403|NCT00917137|Transbronchial needle aspiration|transbronchial needle aspiration
527404|NCT00917137|Transbronchial lung biopsy|transbronchial lung biopsy
527405|NCT00917137|Bronchoscopy|bronchoscopy
527406|NCT00917124|cerebral oximetry|cerebral oximetry
527407|NCT00917124|NIRS|nirs
527408|NCT00917124|INVOS|invos
527409|NCT00917111|Randomized|randomized
527410|NCT00917111|Double-Blind|double-blind
527411|NCT00917111|Multi-Center|multi-center
527412|NCT00917111|Placebo-Controlled|placebo-controlled
527413|NCT00917111|Phase II|phase ii
527414|NCT00917111|Nasal Carbon Dioxide|nasal carbon dioxide
527415|NCT00917111|Carbon Dioxide|carbon dioxide
527416|NCT00917111|Efficacy|efficacy
527417|NCT00917111|Safety|safety
527418|NCT00917111|Total Nasal Symptom Score|total nasal symptom score
527419|NCT00917098|Behavior Therapy|behavior therapy
527420|NCT00917098|Supportive Counseling|supportive counseling
527421|NCT00917098|Child|child
527422|NCT00917098|Adolescent|adolescent
527423|NCT00917098|Hair Pulling|hair pulling
527424|NCT00917098|CBT|cbt
527425|NCT00917085|Preterm infant|preterm infant
527426|NCT00917085|Skin-to-skin contact|skin-to-skin contact
527427|NCT00917085|kangaroo care|kangaroo care
527428|NCT00917085|temperature|temperature
527429|NCT00917085|behavioral state|behavioral state
527430|NCT00917072|Clinical Handoff|clinical handoff
527431|NCT00917072|Medical Education|medical education
527432|NCT00917072|Simulation|simulation
527433|NCT00917072|Residency and Internship|residency and internship
527434|NCT00917059|Major Depressive Disorder|major depressive disorder
527435|NCT00917059|SSRI|ssri
527436|NCT00917059|EEG|eeg
527437|NCT00917046|All-cause heart failure patients|all-cause heart failure patients
527438|NCT00917046|coronary artery disease etiology|coronary artery disease etiology
527439|NCT00917046|dilated cardiomyopathy etiology|dilated cardiomyopathy etiology
527440|NCT00917020|Randomized|randomized
527441|NCT00917020|Double-Blind|double-blind
527442|NCT00917020|Multi-Center|multi-center
527443|NCT00917020|Phase II|phase ii
527444|NCT00917020|Nasal Carbon Dioxide|nasal carbon dioxide
527445|NCT00917020|Carbon Dioxide|carbon dioxide
527446|NCT00917020|Efficacy|efficacy
527447|NCT00917020|Safety|safety
527448|NCT00917020|Total Nasal Symptom Score|total nasal symptom score
527449|NCT00917007|ABO incompatibility|abo incompatibility
527450|NCT00917007|hemolysis|hemolysis
527451|NCT00917007|jaundice|jaundice
527452|NCT00917007|hyperbilirubinemia|hyperbilirubinemia
527453|NCT00917007|newborn|newborn
527454|NCT00916994|Rotator Cuff Tear|rotator cuff tear
527455|NCT00916981|pseudarthrosis|pseudarthrosis
527456|NCT00916981|Treatment|treatment
527457|NCT00916981|osteoblast grafting|osteoblast grafting
527458|NCT00916981|cell therapy|cell therapy
527459|NCT00916981|nonunion|nonunion
527460|NCT00916968|Gender specific|gender specific
527461|NCT00916968|cruciate retaining|cruciate retaining
527462|NCT00916968|total knee arthroplasty|total knee arthroplasty
527463|NCT00916968|Bilateral Osteoarthritis of the knee joint|bilateral osteoarthritis of the knee joint
527464|NCT00916955|22q11.2 deletion syndrome|22q11.2 deletion syndrome
527465|NCT00916955|velo-cardio-facial syndrome|velo-cardio-facial syndrome
527466|NCT00916955|congenital anomalies|congenital anomalies
527467|NCT00916955|mental illness|mental illness
527468|NCT00916955|congenital heart disease|congenital heart disease
527469|NCT00916942|Tolerability study|tolerability study
527470|NCT00916916|Acromegaly|acromegaly
527471|NCT00916916|Lanreotide|lanreotide
527472|NCT00916903|Talus|talus
527473|NCT00916903|Neuroserpin|neuroserpin
527474|NCT00916903|mental retardation|mental retardation
527475|NCT00916903|epilepsy|epilepsy
527476|NCT00916903|FENIB|fenib
527477|NCT00916903|XLMR|xlmr
527478|NCT00916890|Opioid pharmacogenetics|opioid pharmacogenetics
527479|NCT00916890|Opioid pharmacokinetic|opioid pharmacokinetic
527480|NCT00916890|Long-term opioid treatment|long-term opioid treatment
527481|NCT00916890|Cancer pain|cancer pain
527482|NCT00916877|Prophylactic Cranial Irradiation|prophylactic cranial irradiation
527483|NCT00916877|Her-2-positive met breast cancer|her-2-positive met breast cancer
527484|NCT00916851|attention-deficit hyperactivity disorder|attention-deficit hyperactivity disorder
527485|NCT00916851|autism spectrum disorders|autism spectrum disorders
527486|NCT00916851|normally developing children and adolescents|normally developing children and adolescents
527487|NCT00916851|cognitive functions|cognitive functions
527488|NCT00916851|emotion/behaviors|emotion/behaviors
527489|NCT00916851|brain imaging|brain imaging
527490|NCT00916851|genotypes|genotypes
527491|NCT00916838|Type 1 Diabetes Mellitis|type 1 diabetes mellitis
527492|NCT00916838|MRI|mri
527493|NCT00916825|breast cancer|breast cancer
527494|NCT00916825|quality of life|quality of life
527495|NCT00916825|children of somatically ill parents|children of somatically ill parents
527496|NCT00916825|psychological adaptation|psychological adaptation
527497|NCT00916812|Difficult intubation|difficult intubation
527498|NCT00916812|Hyomental distance|hyomental distance
527499|NCT00916812|Obstetric|obstetric
527500|NCT00916812|Mallampati classification|mallampati classification
527501|NCT00916812|Thyromental distance|thyromental distance
527502|NCT00916812|Sternomental distance|sternomental distance
527503|NCT00916799|telehealth|telehealth
527504|NCT00916799|oximetry|oximetry
527505|NCT00916799|copd|copd
527506|NCT00916786|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
527507|NCT00916786|pharmacogenetics|pharmacogenetics
527508|NCT00916786|molecular genetics|molecular genetics
527509|NCT00916786|medication response|medication response
527510|NCT00916773|Obstructive sleep apnea|obstructive sleep apnea
527511|NCT00916773|Airway inflammation|airway inflammation
527512|NCT00916773|Exercise-induced bronchoconstriction|exercise-induced bronchoconstriction
527513|NCT00916773|Continuous positive airway pressure|continuous positive airway pressure
527514|NCT00916760|allergic, rhinoconjunctivitis, Immunotherapy|allergic, rhinoconjunctivitis, immunotherapy
527515|NCT00916747|Progeria|progeria
527516|NCT00916734|McKenzie|mckenzie
527517|NCT00916734|thrust manipulation|thrust manipulation
527518|NCT00916734|clinical prediction rule|clinical prediction rule
527519|NCT00916721|Smoking cessation|smoking cessation
527520|NCT00916721|propranolol|propranolol
527521|NCT00916721|memory reconsolidation blockade|memory reconsolidation blockade
527522|NCT00916721|craving|craving
527523|NCT00916708|endometrial cancer|endometrial cancer
527524|NCT00916708|follow up|follow up
527525|NCT00916708|relapse|relapse
527526|NCT00916695|Stents|stents
527527|NCT00916695|Angioplasty|angioplasty
527528|NCT00916695|Coronary Artery Disease|coronary artery disease
527529|NCT00916695|Bifurcation Coronary Lesions|bifurcation coronary lesions
527530|NCT00916669|SCLC|sclc
527531|NCT00916669|enoxaparin sodium|enoxaparin sodium
527532|NCT00916669|cisplatin|cisplatin
527533|NCT00916669|etoposide|etoposide
527534|NCT00916656|Congenital fibrinogen deficiency|congenital fibrinogen deficiency
527535|NCT00916643|Hypercholesterolemia|hypercholesterolemia
527536|NCT00916643|FH|fh
527537|NCT00916643|LDL-C|ldl-c
527538|NCT00916643|CHD|chd
527539|NCT00916630|recurrent|recurrent
527540|NCT00916630|alimta|alimta
527541|NCT00916630|pemetrexed|pemetrexed
527542|NCT00916630|CNS lymphoma|cns lymphoma
527543|NCT00916630|Primary CNS lymphoma|primary cns lymphoma
527544|NCT00916630|Metastatic lymphoma to brain|metastatic lymphoma to brain
527545|NCT00916617|open-label|open-label
527546|NCT00916617|safety|safety
527547|NCT00916617|antibody|antibody
527548|NCT00916604|AZD1656|azd1656
527549|NCT00916604|Safety|safety
527550|NCT00916604|Pharmacokinetics|pharmacokinetics
527551|NCT00916604|Pharmacodynamic|pharmacodynamic
527552|NCT00916604|Multiple ascending doses|multiple ascending doses
527553|NCT00916604|Japanese|japanese
527554|NCT00916604|T2DM|t2dm
527555|NCT00916591|gastroesophageal reflux|gastroesophageal reflux
527556|NCT00916591|respiratory aspiration|respiratory aspiration
527557|NCT00916578|Advanced Inflammatory Breast Cancer|advanced inflammatory breast cancer
527558|NCT00916578|Non-Inflammatory Breast Cancer|non-inflammatory breast cancer
527559|NCT00916578|Capecitabine|capecitabine
527560|NCT00916578|Xeloda|xeloda
527561|NCT00916578|Concomitant Radiation|concomitant radiation
527562|NCT00916578|Radiation Therapy|radiation therapy
527563|NCT00916578|Radiotherapy|radiotherapy
527564|NCT00916578|Women|women
527565|NCT00916565|optimize nutritional content of infant formula|optimize nutritional content of infant formula
527566|NCT00916565|Infant|infant
527567|NCT00916552|Erythropoietin|erythropoietin
527568|NCT00916552|Epo|epo
527569|NCT00916552|depression|depression
527570|NCT00916552|bipolar disorder|bipolar disorder
527571|NCT00916552|cognition|cognition
527572|NCT00916552|cognitive function|cognitive function
527573|NCT00916552|antidepressant|antidepressant
527574|NCT00916526|Chronic cough|chronic cough
527575|NCT00916526|Inhaled corticosteroid treatment|inhaled corticosteroid treatment
527576|NCT00916526|Bronchial provocation test with mannitol|bronchial provocation test with mannitol
527577|NCT00916526|Methacholine|methacholine
527578|NCT00916513|Diabetes|diabetes
527579|NCT00916513|Treatment Satisfaction|treatment satisfaction
527580|NCT00916513|Quality of Life|quality of life
527581|NCT00916513|HbA1c levels and goals|hba1c levels and goals
527582|NCT00916513|Healthcare resources consumption|healthcare resources consumption
527583|NCT00916500|CERVICAL CANCER, CONCURRENT CHEMORADIATION, CISPLATIN|cervical cancer, concurrent chemoradiation, cisplatin
527584|NCT00916461|First episode psychosis|first episode psychosis
527585|NCT00916461|Schizophrenia|schizophrenia
527586|NCT00916461|Minocycline|minocycline
527587|NCT00916461|neuroprotection|neuroprotection
527588|NCT00916461|First episode non affective psychosis|first episode non affective psychosis
527589|NCT00916461|With in first five years of illness|with in first five years of illness
527590|NCT00916448|Endotoxin|endotoxin
527591|NCT00916448|Bilirubin|bilirubin
527592|NCT00916448|Inflammation|inflammation
527593|NCT00916448|Sepsis|sepsis
527594|NCT00916448|Multi organ dysfunction syndrome|multi organ dysfunction syndrome
527595|NCT00916448|Oxidative Stress|oxidative stress
527596|NCT00916448|Heme oxygenase|heme oxygenase
527597|NCT00916435|Arrhythmia|arrhythmia
527598|NCT00916435|Cardiac Arrest|cardiac arrest
527599|NCT00916435|Cardiomyopathy|cardiomyopathy
527600|NCT00916435|Heart Failure|heart failure
527601|NCT00916422|Immunotherapy|immunotherapy
527602|NCT00916422|Allergoid|allergoid
527603|NCT00916422|Depigmented|depigmented
527604|NCT00916422|Polymerized|polymerized
527605|NCT00916422|Allergen-extract|allergen-extract
527606|NCT00916422|Rhinoconjunctivitis|rhinoconjunctivitis
527607|NCT00916409|Glioblastoma Multiforme|glioblastoma multiforme
527608|NCT00916409|Glioblastoma|glioblastoma
527609|NCT00916409|GBM|gbm
527610|NCT00916409|Brain tumor|brain tumor
527611|NCT00916409|Treatment|treatment
527612|NCT00916409|Minimal toxicity|minimal toxicity
527613|NCT00916409|Newly Diagnosed|newly diagnosed
527614|NCT00916409|TTFields|ttfields
527615|NCT00916409|Tumor Treating Fields|tumor treating fields
527616|NCT00916409|NovoCure|novocure
527617|NCT00916383|Skin Irritation|skin irritation
527618|NCT00916383|Donepezil Transdermal Patch System|donepezil transdermal patch system
527619|NCT00916383|Elderly|elderly
527620|NCT00916383|Alzheimer's subjects|alzheimer's subjects
527621|NCT00916383|Skin Irritation in elderly Alzheimer's subjects|skin irritation in elderly alzheimer's subjects
527622|NCT00916370|drug eluting stents|drug eluting stents
527623|NCT00916370|stents|stents
527624|NCT00916370|Angioplasty|angioplasty
527625|NCT00916370|myocardial ischemia|myocardial ischemia
527626|NCT00916370|coronary artery stenosis|coronary artery stenosis
527627|NCT00916370|Coronary Disease|coronary disease
527628|NCT00916370|Coronary Artery Disease|coronary artery disease
527629|NCT00916370|Coronary Restenosis|coronary restenosis
527630|NCT00916370|Long lesion|long lesion
527631|NCT00916357|recombinant human hyaluronidase PH20 (rHuPH20)|recombinant human hyaluronidase ph20 (rhuph20)
527632|NCT00916357|Insulin lispro|insulin lispro
527633|NCT00916357|Regular human insulin|regular human insulin
527634|NCT00916331|total knee replacement arthroplasty|total knee replacement arthroplasty
527635|NCT00916331|subcutaneous indwelling|subcutaneous indwelling
527636|NCT00916331|blood loss|blood loss
527637|NCT00916331|complications|complications
527638|NCT00916331|functional status|functional status
527639|NCT00916305|deafness noise tinnitus hearingloss|deafness noise tinnitus hearingloss
527640|NCT00916292|Diabetes|diabetes
527641|NCT00916292|dermal ulcers|dermal ulcers
527642|NCT00916279|Bare Metal In-Stent Restenosis|bare metal in-stent restenosis
527643|NCT00916279|Paclitaxel Coated Balloon Catheter|paclitaxel coated balloon catheter
527644|NCT00916279|Drug Coated Balloon|drug coated balloon
527645|NCT00916279|Coronary Artery Disease|coronary artery disease
527646|NCT00916266|Seizure frequency|seizure frequency
527647|NCT00916266|Hippocampal volume|hippocampal volume
527648|NCT00916266|Adverse effects|adverse effects
527649|NCT00916253|Sleep|sleep
527650|NCT00916253|real driving|real driving
527651|NCT00916253|simulated driving|simulated driving
527652|NCT00916253|MWT|mwt
527653|NCT00916240|Adolescents|adolescents
527654|NCT00916240|African American|african american
527655|NCT00916227|Low or Intermediate-1 Risk Myelodysplastic Syndrome|low or intermediate-1 risk myelodysplastic syndrome
527656|NCT00916201|schizophrenia|schizophrenia
527657|NCT00916188|Black Tea|black tea
527658|NCT00916188|Oxidative Stress|oxidative stress
527659|NCT00916188|Blood Lipids|blood lipids
527660|NCT00916188|Insulin Sensitivity|insulin sensitivity
527661|NCT00916175|hyperglycemia|hyperglycemia
527662|NCT00916175|overweight|overweight
527663|NCT00916175|functional food|functional food
527664|NCT00916175|aloe vera|aloe vera
527665|NCT00916175|cnidoscolus chayamansa|cnidoscolus chayamansa
527666|NCT00916162|aromatase inhibitor|aromatase inhibitor
527667|NCT00916149|Epilepsy|epilepsy
527668|NCT00916149|Cognition|cognition
527669|NCT00916149|Lamictal|lamictal
527670|NCT00916149|Lamotrigine|lamotrigine
527671|NCT00916149|Keppra|keppra
527672|NCT00916149|Levetiracetam|levetiracetam
527673|NCT00916136|Pre-operative Traction|pre-operative traction
527674|NCT00916136|Traction|traction
527675|NCT00916136|Proximal Femur Fracture|proximal femur fracture
527676|NCT00916136|Femoral Fractures|femoral fractures
527677|NCT00916136|Femoral Fracture|femoral fracture
527678|NCT00916136|Skeletal Traction|skeletal traction
527679|NCT00916136|Cutaneous Traction|cutaneous traction
527680|NCT00916123|castrate-resistant prostate cancer|castrate-resistant prostate cancer
527681|NCT00916123|CRPC|crpc
527682|NCT00916110|healthy subjects|healthy subjects
527683|NCT00916071|Bulimia Nervosa|bulimia nervosa
527684|NCT00916071|Eating Disorder NOS|eating disorder nos
527685|NCT00916071|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
527686|NCT00916071|ADHD|adhd
527687|NCT00916058|Multiple Myeloma|multiple myeloma
527688|NCT00916058|Autologous Stem Cell Transplant|autologous stem cell transplant
527689|NCT00916058|ASCT|asct
527690|NCT00916058|MM|mm
527691|NCT00916019|gene expression|gene expression
527692|NCT00916019|skeletal muscle|skeletal muscle
527693|NCT00916019|Healthy men|healthy men
527694|NCT00916006|Peplin|peplin
527695|NCT00916006|Actinic keratosis|actinic keratosis
527696|NCT00916006|PEP005|pep005
527697|NCT00915993|stage IV renal cell cancer|stage iv renal cell cancer
527698|NCT00915993|recurrent renal cell cancer|recurrent renal cell cancer
527699|NCT00915980|Meal-test|meal-test
527700|NCT00915980|reduced OGTT|reduced ogtt
527701|NCT00915980|gastric bypass surgery and glucose metabolism|gastric bypass surgery and glucose metabolism
527702|NCT00915980|Glucose metabolism before and after gastric bypass|glucose metabolism before and after gastric bypass
527703|NCT00915980|Different OGTT|different ogtt
527704|NCT00915980|New meal- test|new meal- test
527705|NCT00915967|Infection|infection
527706|NCT00915967|Vancomycin|vancomycin
527707|NCT00915967|Neurosurgery|neurosurgery
527708|NCT00915967|Stimulator|stimulator
527709|NCT00915967|Pump|pump
527710|NCT00915967|Deep Brain Stimulation|deep brain stimulation
527711|NCT00915967|Intrathecal Pump|intrathecal pump
527712|NCT00915954|Acromegaly|acromegaly
527713|NCT00915954|Type 2 diabetes mellitus|type 2 diabetes mellitus
527714|NCT00915954|recombinant human IGF1|recombinant human igf1
527715|NCT00915954|oral glucose tolerance test|oral glucose tolerance test
527716|NCT00915915|Female contraception|female contraception
527717|NCT00915915|Ovulation inhibition|ovulation inhibition
527718|NCT00915889|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
527719|NCT00915889|stage IA cervical cancer|stage ia cervical cancer
527720|NCT00915889|stage IB cervical cancer|stage ib cervical cancer
527721|NCT00915889|stage IIA cervical cancer|stage iia cervical cancer
527722|NCT00915889|stage IIB cervical cancer|stage iib cervical cancer
527723|NCT00915889|stage III cervical cancer|stage iii cervical cancer
527724|NCT00915889|cancer survivor|cancer survivor
527725|NCT00915876|chronic kidney disease|chronic kidney disease
527726|NCT00915876|Vitamin D|vitamin d
527727|NCT00915863|pancreaticoduodenectomy|pancreaticoduodenectomy
527728|NCT00915863|pancreatic fistula|pancreatic fistula
527729|NCT00915863|reconstruction|reconstruction
527730|NCT00915863|isolated Roux-en-Y|isolated roux-en-y
527731|NCT00915837|DME|dme
527732|NCT00915824|Drug therapy|drug therapy
527733|NCT00915824|Prescribing|prescribing
527734|NCT00915824|Appropriateness|appropriateness
527735|NCT00915824|Randomized controlled trial|randomized controlled trial
527736|NCT00915824|STOPP/START criteria|stopp/start criteria
527737|NCT00915824|Appropriateness of prescribing in older patients|appropriateness of prescribing in older patients
527738|NCT00915824|Prescription Drugs|prescription drugs
527739|NCT00915811|Myelodysplastic Syndromes|myelodysplastic syndromes
527740|NCT00915811|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
527741|NCT00915811|Haematopoietic stem cell transplantation|haematopoietic stem cell transplantation
527742|NCT00915811|Fludarabine|fludarabine
527743|NCT00915811|Busulphan|busulphan
527744|NCT00915811|Thymoglobuline|thymoglobuline
527745|NCT00915759|ProKera|prokera
527746|NCT00915759|Amniotic membrane|amniotic membrane
527747|NCT00915759|Photorefractive Keratectomy|photorefractive keratectomy
527748|NCT00915759|PRK|prk
527749|NCT00915759|time to re-epithelialization|time to re-epithelialization
527750|NCT00915746|Phase I|phase i
527751|NCT00915746|ketoconazole|ketoconazole
527752|NCT00915746|CYP3A4 inhibitor|cyp3a4 inhibitor
527753|NCT00915746|drug interaction|drug interaction
527754|NCT00915746|metabolism|metabolism
527755|NCT00915746|Healthly Volunteer|healthly volunteer
527756|NCT00915746|JNJ-31001074|jnj-31001074
527757|NCT00915733|acute myocardial infarction|acute myocardial infarction
527758|NCT00915733|inhibition of platelet aggregation|inhibition of platelet aggregation
527759|NCT00915733|triple antiplatelet therapy|triple antiplatelet therapy
527760|NCT00915733|high maintenance-dose clopidogrel.|high maintenance-dose clopidogrel.
527761|NCT00915733|CYP2C19 polymorphism|cyp2c19 polymorphism
527762|NCT00915733|High posttreatment platelet reactivity|high posttreatment platelet reactivity
527763|NCT00915733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
527764|NCT00915733|CYP2C19, human|cyp2c19, human
527765|NCT00915720|Atrial Fibrillation|atrial fibrillation
527766|NCT00915720|Surgical Ablation|surgical ablation
527767|NCT00915720|Implanted loop recorder|implanted loop recorder
527768|NCT00915720|Atrial Fibrillation Ablation|atrial fibrillation ablation
527769|NCT00915707|obesity|obesity
527770|NCT00915707|diabetes, risk|diabetes, risk
527771|NCT00915707|obesity, diabetes risk related to sleep|obesity, diabetes risk related to sleep
527772|NCT00915694|adult giant cell glioblastoma|adult giant cell glioblastoma
527773|NCT00915694|adult gliosarcoma|adult gliosarcoma
527774|NCT00915694|adult glioblastoma|adult glioblastoma
527775|NCT00915681|amatoxin|amatoxin
527776|NCT00915681|amanita|amanita
527777|NCT00915681|mushroom poisoning|mushroom poisoning
527778|NCT00915681|hepatic failure|hepatic failure
527779|NCT00915681|milk thistle|milk thistle
527780|NCT00915681|Silibinin|silibinin
527781|NCT00915681|Legalon|legalon
527782|NCT00915668|Healthy women|healthy women
527783|NCT00915668|Non-childbearing potential|non-childbearing potential
527784|NCT00915668|Drug-drug interaction|drug-drug interaction
527785|NCT00915668|Oral contraceptive|oral contraceptive
527786|NCT00915668|OC|oc
527787|NCT00915668|Ovral-L|ovral-l
527788|NCT00915668|ethinyl estradiol|ethinyl estradiol
527789|NCT00915668|EE|ee
527790|NCT00915668|levonorgestrel|levonorgestrel
527791|NCT00915668|JNJ-31001074|jnj-31001074
527792|NCT00915655|HIV Infections|hiv infections
527793|NCT00915655|TMC114-TiDP29-C230|tmc114-tidp29-c230
527794|NCT00915655|TMC114-C230|tmc114-c230
527795|NCT00915655|TMC114|tmc114
527796|NCT00915655|HIV-1|hiv-1
527797|NCT00915655|Darunavir|darunavir
527798|NCT00915655|Ritonavir|ritonavir
527799|NCT00915655|NRTI|nrti
527800|NCT00915655|Treatment Naive|treatment naive
527801|NCT00915642|Obesity|obesity
527802|NCT00915642|Weight loss rate|weight loss rate
527803|NCT00915642|Sleep|sleep
527804|NCT00915642|Vigil|vigil
527805|NCT00915642|Metabolism|metabolism
527806|NCT00915642|Actigraphy|actigraphy
527807|NCT00915642|Normal|normal
527808|NCT00915603|Metastatic Breast Cancer|metastatic breast cancer
527809|NCT00915603|Paclitaxel|paclitaxel
527810|NCT00915603|Bevacizumab|bevacizumab
527811|NCT00915603|Everolimus|everolimus
527812|NCT00915577|Multiple Sclerosis|multiple sclerosis
527813|NCT00915577|interferon beta-1a|interferon beta-1a
527814|NCT00915577|Avonex|avonex
527815|NCT00915577|liquid Avonex|liquid avonex
527816|NCT00915564|Hepatitis C|hepatitis c
527817|NCT00915564|HCV|hcv
527818|NCT00915564|Hepatitis C Virus|hepatitis c virus
527819|NCT00915564|HCV negative|hcv negative
528403|NCT00912964|YM178|ym178
527820|NCT00915564|Protease inhibitor|protease inhibitor
527821|NCT00915564|Methadone|methadone
527822|NCT00915564|TMC435|tmc435
527823|NCT00915551|Peplin|peplin
527824|NCT00915551|Actinic keratosis|actinic keratosis
527825|NCT00915551|PEP005|pep005
527826|NCT00915538|Asthma|asthma
527827|NCT00915538|Formoterol|formoterol
527828|NCT00915538|LABA|laba
527829|NCT00915538|Symbicort|symbicort
527830|NCT00915538|Aerochamber|aerochamber
527831|NCT00915512|Schizophrenia|schizophrenia
527832|NCT00915512|Paliperidone|paliperidone
527833|NCT00915512|Invega|invega
527834|NCT00915486|Diabetic|diabetic
527835|NCT00915486|ulcer|ulcer
527836|NCT00915486|topical|topical
527837|NCT00915486|PDGF|pdgf
527838|NCT00915486|GSoC|gsoc
527839|NCT00915460|Multiple Sclerosis|multiple sclerosis
527840|NCT00915460|Avonex|avonex
527841|NCT00915460|Interferon beta-1a|interferon beta-1a
527842|NCT00915460|patients at high risk to develop multiple sclerosis|patients at high risk to develop multiple sclerosis
527843|NCT00915447|Cat Allergic Rhinitis|cat allergic rhinitis
527844|NCT00915434|Healthy volunteer|healthy volunteer
527845|NCT00915434|Phase I|phase i
527846|NCT00915434|Non-childbearing potential|non-childbearing potential
527847|NCT00915434|JNJ-31001074|jnj-31001074
527848|NCT00915434|Food|food
527849|NCT00915434|Pharmacokinetics|pharmacokinetics
527850|NCT00915421|cardiac arrest|cardiac arrest
527851|NCT00915421|therapeutic hypothermia|therapeutic hypothermia
527852|NCT00915421|Postresuscitative disease|postresuscitative disease
527853|NCT00915408|Multiple Myeloma|multiple myeloma
527854|NCT00915408|Cyclophosphamide|cyclophosphamide
527855|NCT00915408|Dexamethasone|dexamethasone
527856|NCT00915408|Lenalidomide|lenalidomide
527857|NCT00915356|AZD1305|azd1305
527858|NCT00915356|intravenous cardioversion of Atrial Fibrillation|intravenous cardioversion of atrial fibrillation
527859|NCT00915343|Adrenal insufficiency|adrenal insufficiency
527860|NCT00915343|Primary adrenal insufficiency|primary adrenal insufficiency
527861|NCT00915343|Addison's disease|addison's disease
527862|NCT00915343|Hydrocortisone|hydrocortisone
527863|NCT00915343|Modified release|modified release
527864|NCT00915330|Transbronchial needle aspiration|transbronchial needle aspiration
527865|NCT00915330|Bronchoscopy|bronchoscopy
527866|NCT00915330|Rapid on-site cytopathologic evaluation|rapid on-site cytopathologic evaluation
527867|NCT00915330|Mediastinal lymphadenopathy|mediastinal lymphadenopathy
527868|NCT00915330|Hilar Lymphadenopathy|hilar lymphadenopathy
527869|NCT00915304|Clinical Decision Support System|clinical decision support system
527870|NCT00915304|Automatic reminder|automatic reminder
527871|NCT00915304|Primary care|primary care
527872|NCT00915304|Evidence-Based Medicine|evidence-based medicine
527873|NCT00915291|medical education|medical education
527874|NCT00915291|clinical decisionmaking|clinical decisionmaking
527875|NCT00915291|pharmaceutical marketing|pharmaceutical marketing
527876|NCT00915278|Neoplasms|neoplasms
527877|NCT00915278|monoclonal antibody|monoclonal antibody
527878|NCT00915278|PF-04605412|pf-04605412
527879|NCT00915278|advanced metastatic solid tumors|advanced metastatic solid tumors
527880|NCT00915265|Epidural analgesia|epidural analgesia
527881|NCT00915265|Continuous preperitoneal analgesia|continuous preperitoneal analgesia
527882|NCT00915265|Surgery|surgery
527883|NCT00915265|Open colorectal surgery|open colorectal surgery
527884|NCT00915265|Fast-track surgery|fast-track surgery
527885|NCT00915265|ERAS|eras
527886|NCT00915252|Acute Myeloid Leukemia|acute myeloid leukemia
527887|NCT00915252|azacitidine|azacitidine
527888|NCT00915252|elderly|elderly
527889|NCT00915252|demethylating agent|demethylating agent
527890|NCT00915252|flt3|flt3
527891|NCT00915252|AML|aml
527892|NCT00915239|volunteers|volunteers
527893|NCT00915226|Optic disk|optic disk
527894|NCT00915226|Regional blood flow|regional blood flow
527895|NCT00915226|Autoregulation|autoregulation
527896|NCT00915213|E. Coli|e. coli
527897|NCT00915213|Prostate Biopsy|prostate biopsy
527898|NCT00915200|Diabetic Nephropathies|diabetic nephropathies
527899|NCT00915200|Proteinuria|proteinuria
527900|NCT00915200|Renal Insufficiency, Chronic|renal insufficiency, chronic
527901|NCT00915200|Monocytes|monocytes
527902|NCT00915200|Oxidative stress|oxidative stress
527903|NCT00915200|Inflammation|inflammation
527904|NCT00915200|Antioxidants|antioxidants
527905|NCT00915200|Glutathione|glutathione
527906|NCT00915200|Silymarin|silymarin
527907|NCT00915200|Acetylcysteine|acetylcysteine
527908|NCT00915200|Dietary Supplements|dietary supplements
527909|NCT00915200|Complementary Therapies|complementary therapies
527910|NCT00915187|Vaccination, influenza prevention|vaccination, influenza prevention
527911|NCT00915174|drug-drug interaction study|drug-drug interaction study
527912|NCT00915161|ventilation|ventilation
527913|NCT00915161|oxygenation|oxygenation
527914|NCT00915148|Prolonged labor|prolonged labor
527915|NCT00915148|Ultrasound|ultrasound
527916|NCT00915148|Caeserian section|caeserian section
527917|NCT00915135|Insomnia|insomnia
527918|NCT00915135|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
527919|NCT00915135|Drug Therapy|drug therapy
529087|NCT00910247|Monotherapy|monotherapy
527920|NCT00915122|IMRT treatment for Prostate cancer patients|imrt treatment for prostate cancer patients
527921|NCT00915122|Radiation treatment for prostate cancer|radiation treatment for prostate cancer
527922|NCT00915122|cancer of the prostate|cancer of the prostate
527923|NCT00915122|Patients with high risk adenocarcinoma of the prostate|patients with high risk adenocarcinoma of the prostate
527924|NCT00915109|amputees|amputees
527925|NCT00915109|lower limb|lower limb
527926|NCT00915096|Follicular Lymphoma|follicular lymphoma
527927|NCT00915096|PET|pet
527928|NCT00915096|GELA|gela
527929|NCT00915070|BQ-123|bq-123
527930|NCT00915070|Optic Nerve Head Blood Flow|optic nerve head blood flow
527931|NCT00915070|Intraocular Pressure|intraocular pressure
527932|NCT00915070|Regional Blood Flow|regional blood flow
527933|NCT00915070|Ocular Physiology|ocular physiology
527934|NCT00915070|Optic Disk|optic disk
527935|NCT00915044|IBD|ibd
527936|NCT00915031|Robotic prostatectomy|robotic prostatectomy
527937|NCT00915031|Hypothermia|hypothermia
527938|NCT00915031|Potency|potency
527939|NCT00915018|ErbB-2 positive advanced breast cancer|erbb-2 positive advanced breast cancer
527940|NCT00915018|HKI-272|hki-272
527941|NCT00915018|Neratinib|neratinib
527942|NCT00915018|Nerlynx|nerlynx
527943|NCT00915018|HER2|her2
527944|NCT00915018|PB-272|pb-272
527945|NCT00915018|metastatic breast cancer|metastatic breast cancer
527946|NCT00915005|Locally-advanced non-small-cell lung carcinoma|locally-advanced non-small-cell lung carcinoma
527947|NCT00915005|NSCLC|nsclc
527948|NCT00915005|Lung Cancer|lung cancer
527949|NCT00915005|Image-Guided Adaptive Conformal Photon|image-guided adaptive conformal photon
527950|NCT00915005|Proton Therapy|proton therapy
527951|NCT00915005|Chemotherapy|chemotherapy
527952|NCT00915005|Treatment Related Pneumonitis|treatment related pneumonitis
527953|NCT00914992|optic disk|optic disk
527954|NCT00914992|regional blood flow|regional blood flow
527955|NCT00914992|autoregulation|autoregulation
527956|NCT00914979|Angiosculpt|angiosculpt
527957|NCT00914979|Bifurcation Lesion|bifurcation lesion
527958|NCT00914979|Side branch|side branch
527959|NCT00914979|IVUS|ivus
527960|NCT00914953|social isolation|social isolation
527961|NCT00914953|cooperative behavior|cooperative behavior
527962|NCT00914953|depression|depression
527963|NCT00914953|loneliness|loneliness
527964|NCT00914953|happiness|happiness
527965|NCT00914953|empathy|empathy
527966|NCT00914940|graft versus host disease|graft versus host disease
527967|NCT00914940|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
527968|NCT00914940|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
527969|NCT00914940|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
527970|NCT00914940|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
527971|NCT00914940|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
527972|NCT00914940|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
527973|NCT00914940|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
527974|NCT00914940|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
527975|NCT00914940|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
527976|NCT00914940|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
527977|NCT00914940|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
527978|NCT00914940|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
527979|NCT00914940|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
527980|NCT00914940|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
527981|NCT00914940|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
527982|NCT00914940|refractory anemia with excess blasts|refractory anemia with excess blasts
527983|NCT00914940|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
527984|NCT00914940|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
527985|NCT00914927|Thrombocytopenia|thrombocytopenia
527986|NCT00914927|chronic liver disease|chronic liver disease
527987|NCT00914901|Asthma|asthma
527988|NCT00914901|Doping|doping
527989|NCT00914901|Salmeterol|salmeterol
527990|NCT00914901|Beta-agonist|beta-agonist
527991|NCT00914901|Urine concentrations|urine concentrations
527992|NCT00914888|children|children
527993|NCT00914888|pediatry|pediatry
527994|NCT00914888|pneumonia|pneumonia
527995|NCT00914888|intra-abdominal|intra-abdominal
527996|NCT00914888|infection|infection
527997|NCT00914875|kidney function tests|kidney function tests
527998|NCT00914875|anti-inflammatory agents, non-steroidal|anti-inflammatory agents, non-steroidal
527999|NCT00914875|laparoscopic cholecystectomy|laparoscopic cholecystectomy
528000|NCT00914875|adult|adult
528001|NCT00914862|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
528002|NCT00914862|Drug Therapy|drug therapy
528003|NCT00914836|shoulder|shoulder
528004|NCT00914836|subacromion|subacromion
528005|NCT00914836|corticosteroid|corticosteroid
528006|NCT00914836|bursitis|bursitis
528007|NCT00914836|tendinitis|tendinitis
528008|NCT00914836|calcific tendonitis|calcific tendonitis
528009|NCT00914836|subacromial bursitis|subacromial bursitis
528010|NCT00914836|rotator cuff tendinitis|rotator cuff tendinitis
528011|NCT00914810|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
528012|NCT00914810|Vitamin D|vitamin d
528013|NCT00914810|Cholecalciferol|cholecalciferol
528014|NCT00914810|Skeletal muscle|skeletal muscle
528015|NCT00914797|Asthma|asthma
528016|NCT00914797|Doping|doping
528017|NCT00914797|Beta agonist|beta agonist
528018|NCT00914797|Terbutaline|terbutaline
528019|NCT00914797|Pharmacokinetics|pharmacokinetics
528020|NCT00914784|TRALI|trali
528021|NCT00914784|Transfusion|transfusion
528022|NCT00914784|dyspnea|dyspnea
528023|NCT00914784|pulmonary infiltrates|pulmonary infiltrates
528024|NCT00914771|Pandemic Influenza|pandemic influenza
528025|NCT00914771|H5N1|h5n1
528026|NCT00914771|Adults and Elderly|adults and elderly
528027|NCT00914771|antigen dose|antigen dose
528028|NCT00914758|multiple sclerosis|multiple sclerosis
528029|NCT00914758|cognition|cognition
528030|NCT00914758|cognitive functioning|cognitive functioning
528031|NCT00914758|Campath|campath
528032|NCT00914758|Rebif|rebif
528033|NCT00914758|alemtuzumab|alemtuzumab
528034|NCT00914758|interferon|interferon
528035|NCT00914732|IMVAMUNE®, smallpox, vaccine|imvamune®, smallpox, vaccine
528036|NCT00914719|sexual risk behavior among adolescents|sexual risk behavior among adolescents
528037|NCT00914719|alcohol and drug use among adolescents|alcohol and drug use among adolescents
528038|NCT00914706|Diabetes|diabetes
528039|NCT00914693|Fertility control|fertility control
528040|NCT00914693|Contraception|contraception
528041|NCT00914667|Overactive Bladder Urgency Frequency|overactive bladder urgency frequency
528042|NCT00914654|Asthma|asthma
528043|NCT00914654|Doping|doping
528044|NCT00914654|Formoterol|formoterol
528045|NCT00914654|Urinary concentrations|urinary concentrations
528046|NCT00914654|Beta-agonists|beta-agonists
528047|NCT00914641|formulation; sustained release; modified release; extended release|formulation; sustained release; modified release; extended release
528048|NCT00914628|high risk acute leukemia|high risk acute leukemia
528049|NCT00914628|HSV-TK|hsv-tk
528050|NCT00914628|Haploidentical HCT|haploidentical hct
528051|NCT00914628|GvHD|gvhd
528052|NCT00914628|GvL|gvl
528053|NCT00914628|Immunoreconstitution|immunoreconstitution
528054|NCT00914615|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
528055|NCT00914615|Liver Metastasis from colorectal cancer|liver metastasis from colorectal cancer
528056|NCT00914615|Patients with Liver Metastasis|patients with liver metastasis
528057|NCT00914576|Endotoxin, Escherichia Coli|endotoxin, escherichia coli
528058|NCT00914576|Retina|retina
528059|NCT00914576|Regional Blood Flow|regional blood flow
528060|NCT00914563|Burned shock|burned shock
528061|NCT00914563|Volume resuscitative patterns|volume resuscitative patterns
528062|NCT00914563|Non-invasive hemodynamic monitoring|non-invasive hemodynamic monitoring
528063|NCT00914550|Pneumonia|pneumonia
528064|NCT00914550|Lung Infiltrates|lung infiltrates
528065|NCT00914550|Antibiotic discontinuation|antibiotic discontinuation
528066|NCT00914550|De-escalation therapy|de-escalation therapy
528067|NCT00914537|Anal Cancer|anal cancer
528068|NCT00914537|AIN|ain
528069|NCT00914537|HPV|hpv
528070|NCT00914537|Cytology|cytology
528071|NCT00914537|HIV|hiv
528072|NCT00914537|HIV Positive|hiv positive
528073|NCT00914524|Chronic Glomerulonephritis|chronic glomerulonephritis
528074|NCT00914524|Diabetic Nephropathy|diabetic nephropathy
528075|NCT00914524|Angiotensin II Receptor Blocker|angiotensin ii receptor blocker
528076|NCT00914524|Urinary Protein|urinary protein
528077|NCT00914511|Semen|semen
528078|NCT00914511|Sperm|sperm
528079|NCT00914511|Avanafil|avanafil
528080|NCT00914511|Pharmacokinetics|pharmacokinetics
528081|NCT00914511|Elderly|elderly
528082|NCT00914498|Xylocaine|xylocaine
528083|NCT00914498|Casarean section|casarean section
528084|NCT00914498|Post operative pain|post operative pain
528085|NCT00914498|Scar quality|scar quality
528086|NCT00914472|Preventing the thrombi formation|preventing the thrombi formation
528087|NCT00914459|hemophilia A|hemophilia a
528088|NCT00914446|Steatohepatitis|steatohepatitis
528089|NCT00914433|COPD|copd
528090|NCT00914420|OCT|oct
528091|NCT00914420|Reendothelialisation|reendothelialisation
528092|NCT00914420|Intrepide|intrepide
528093|NCT00914420|Trapidil|trapidil
528094|NCT00914420|Taxus|taxus
528095|NCT00914407|Ocular physiology|ocular physiology
528096|NCT00914394|L-NG-Monomethyl Arginine|l-ng-monomethyl arginine
528097|NCT00914394|Optic Nerve Head Blood Flow|optic nerve head blood flow
528098|NCT00914394|Intraocular Pressure|intraocular pressure
528099|NCT00914394|Regional Blood Flow|regional blood flow
528100|NCT00914394|Ocular Physiology|ocular physiology
528101|NCT00914394|Optic Disk|optic disk
528102|NCT00914381|Community reinforcement approach|community reinforcement approach
528103|NCT00914381|Contingency management|contingency management
528104|NCT00914381|12-step facilitation counseling|12-step facilitation counseling
528105|NCT00914381|Cocaine dependence|cocaine dependence
528106|NCT00914381|Women|women
529275|NCT00909584|Apoptosis|apoptosis
528107|NCT00914368|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
528108|NCT00914368|Aspirin|aspirin
528109|NCT00914368|Clopidogrel|clopidogrel
528110|NCT00914368|Pathologic Processes|pathologic processes
528111|NCT00914368|Disease|disease
528112|NCT00914368|Therapeutic Uses|therapeutic uses
528113|NCT00914368|Syndrome|syndrome
528114|NCT00914368|Hematologic Agents|hematologic agents
528115|NCT00914368|Cardiovascular Diseases|cardiovascular diseases
528116|NCT00914368|Pharmacologic Actions|pharmacologic actions
528117|NCT00914355|Hepatocellular Carcinoma|hepatocellular carcinoma
528118|NCT00914355|Stereotactic Body Radiation|stereotactic body radiation
528119|NCT00914355|Unresectable liver cancer|unresectable liver cancer
528120|NCT00914355|Patients with Hepatocellular Carcinoma|patients with hepatocellular carcinoma
528121|NCT00914342|Gerd|gerd
528122|NCT00914342|GerdQ questionnaire|gerdq questionnaire
528123|NCT00914342|work productivity|work productivity
528124|NCT00914342|Greece|greece
528125|NCT00914329|stress provoked|stress provoked
528126|NCT00914329|healthy volunteers|healthy volunteers
528127|NCT00914329|gelsemium|gelsemium
528128|NCT00914329|homeopathy|homeopathy
528129|NCT00914316|Lower leg claudication|lower leg claudication
528130|NCT00914316|Poor circulation of the leg muscles|poor circulation of the leg muscles
528131|NCT00914316|Cramping or discomfort in the lower legs|cramping or discomfort in the lower legs
528132|NCT00914316|Lower leg pain|lower leg pain
528133|NCT00914316|PAD (Peripheral arterial disease)|pad (peripheral arterial disease)
528134|NCT00914303|Safety|safety
528135|NCT00914303|tolerability|tolerability
528136|NCT00914303|healthy|healthy
528137|NCT00914303|Healthy volunteer study|healthy volunteer study
528138|NCT00914277|Rho-kinase inhibitor|rho-kinase inhibitor
528139|NCT00914277|male impotence|male impotence
528140|NCT00914264|chronic obstructive airway disease|chronic obstructive airway disease
528141|NCT00914264|obstructive sleep apnea|obstructive sleep apnea
528142|NCT00914264|continuous positive airway pressure|continuous positive airway pressure
528143|NCT00914251|endothelial|endothelial
528144|NCT00914251|metabolic syndrome|metabolic syndrome
528145|NCT00914251|hesperidin|hesperidin
528146|NCT00914238|Randomized clinical trial|randomized clinical trial
528147|NCT00914238|first episode psychosis of schizophrenia and schizotypal disorder|first episode psychosis of schizophrenia and schizotypal disorder
528148|NCT00914238|rehabilitation|rehabilitation
528149|NCT00914238|psychosocial|psychosocial
528150|NCT00914238|health service research|health service research
528151|NCT00914238|schizotypal Disorder|schizotypal disorder
528152|NCT00914225|Human immunodeficiency virus|human immunodeficiency virus
528153|NCT00914225|malaria|malaria
528154|NCT00914225|plasmodium falciparum|plasmodium falciparum
528155|NCT00914225|diarrhea|diarrhea
528156|NCT00914225|helminth|helminth
528158|NCT00914225|Treatment naive|treatment naive
528159|NCT00914199|PCI|pci
528160|NCT00914199|Bifurcation lesion|bifurcation lesion
528161|NCT00914186|Atopic Dermatitis|atopic dermatitis
528162|NCT00914186|Pruritus|pruritus
528163|NCT00914160|Anti-inflammatory|anti-inflammatory
528164|NCT00914147|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
528165|NCT00914134|Parkinson's disease|parkinson's disease
528166|NCT00914134|Autonomic nervous system|autonomic nervous system
528167|NCT00914134|Levodopa infusion|levodopa infusion
528168|NCT00914108|Preterm Infants|preterm infants
528169|NCT00914108|Developmental Care|developmental care
528170|NCT00914108|NIDCAP|nidcap
528171|NCT00914108|Intrauterine Growth Restriction|intrauterine growth restriction
528172|NCT00914108|APIB|apib
528173|NCT00914108|EEG|eeg
528174|NCT00914108|Neurobehavior|neurobehavior
528175|NCT00914095|Parkinson's disease|parkinson's disease
528176|NCT00914095|Freezing of Gait|freezing of gait
528177|NCT00914095|Methylphenidate|methylphenidate
528178|NCT00914095|Dopamine transporter inhibitor|dopamine transporter inhibitor
528179|NCT00914095|Noradrenaline|noradrenaline
528180|NCT00914082|Self hypnosis|self hypnosis
528181|NCT00914082|Hypnosis|hypnosis
528182|NCT00914082|mental training|mental training
528183|NCT00914082|antenatal training|antenatal training
528184|NCT00914082|pregnancy|pregnancy
528185|NCT00914082|pain control|pain control
528186|NCT00914082|Childbirth|childbirth
528187|NCT00914082|Analgesia|analgesia
528188|NCT00914043|fatigue|fatigue
528189|NCT00914043|HER2-negative breast cancer|her2-negative breast cancer
528190|NCT00914043|stage II breast cancer|stage ii breast cancer
528191|NCT00914043|stage IIIA breast cancer|stage iiia breast cancer
528192|NCT00914043|stage IIIB breast cancer|stage iiib breast cancer
528193|NCT00914030|Visual perception|visual perception
528194|NCT00914030|Local/global processing|local/global processing
528195|NCT00914030|Attention|attention
528196|NCT00914030|Visual priming|visual priming
528197|NCT00914030|Collinearity|collinearity
528198|NCT00914030|Grouping|grouping
528199|NCT00914017|Breast Cancer|breast cancer
528200|NCT00914017|Breast Cancer Prevention|breast cancer prevention
528201|NCT00914017|Mammographic Density|mammographic density
528202|NCT00914017|Breast Density|breast density
528203|NCT00914017|Breast Cancer Biomarkers|breast cancer biomarkers
528204|NCT00914004|Antidepressant|antidepressant
528205|NCT00913991|Nitric Oxide|nitric oxide
528206|NCT00913978|Normothermia|normothermia
528207|NCT00913978|Colorectal Surgery|colorectal surgery
528208|NCT00913978|Bair Huggers|bair huggers
528209|NCT00913978|VitaHeat|vitaheat
528210|NCT00913952|Antidepressant|antidepressant
528211|NCT00913939|Prostate Cancer|prostate cancer
528212|NCT00913939|HDR Brachytherapy|hdr brachytherapy
528213|NCT00913939|Prostate Brachytherapy|prostate brachytherapy
528214|NCT00913926|Climacteric symptoms|climacteric symptoms
528215|NCT00913913|Renal Cell Carcinoma|renal cell carcinoma
528216|NCT00913900|Arterial Occlusive Diseases|arterial occlusive diseases
528217|NCT00913900|Vascular Disease|vascular disease
528218|NCT00913887|Anti-Inflammatory|anti-inflammatory
528219|NCT00913861|endoscopy|endoscopy
528220|NCT00913861|comfort|comfort
528221|NCT00913861|non-pharmacological|non-pharmacological
528222|NCT00913848|Treatment of Epilepsy and Bipolar Disorder|treatment of epilepsy and bipolar disorder
528223|NCT00913835|Liposomal Doxorubicin|liposomal doxorubicin
528224|NCT00913835|IMC-3G3|imc-3g3
528225|NCT00913835|3G3|3g3
528226|NCT00913835|Platinum resistant|platinum resistant
528227|NCT00913835|Platinum refractory|platinum refractory
528228|NCT00913835|Ovary|ovary
528229|NCT00913835|Neoplasm|neoplasm
528230|NCT00913835|PDGFr|pdgfr
528231|NCT00913822|Antidepressant|antidepressant
528232|NCT00913809|Antidepressant|antidepressant
528233|NCT00913796|Renal transplantation|renal transplantation
528234|NCT00913796|Metabolic acidosis|metabolic acidosis
528235|NCT00913796|Physical capacity|physical capacity
528236|NCT00913796|Bone histology|bone histology
528237|NCT00913796|Bone histomorphometry|bone histomorphometry
528238|NCT00913796|Parathyroid function|parathyroid function
528239|NCT00913796|Calcium and phosphate metabolism|calcium and phosphate metabolism
528240|NCT00913783|Antidepressant|antidepressant
528241|NCT00913770|opioid dependence|opioid dependence
528242|NCT00913770|buprenorphine|buprenorphine
528243|NCT00913770|brief intervention|brief intervention
528244|NCT00913757|Hepatocellular Carcinoma|hepatocellular carcinoma
528245|NCT00913757|Liver Cancer|liver cancer
528246|NCT00913757|Chronic Liver Disease|chronic liver disease
528247|NCT00913757|Genome Wide Association Study|genome wide association study
528248|NCT00913757|Gene Expression Profiling|gene expression profiling
528249|NCT00913744|AMD|amd
528250|NCT00913731|Psychotic symptom assessments|psychotic symptom assessments
528251|NCT00913731|Observational assessments of patients with acute psychotic symptoms|observational assessments of patients with acute psychotic symptoms
528252|NCT00913705|NATCH|natch
528253|NCT00913705|LUNG|lung
528254|NCT00913705|OPERABLE NSCLC|operable nsclc
528255|NCT00913705|SURGERY PLUS ADJUVANT THERAPY|surgery plus adjuvant therapy
528256|NCT00913705|SURGERY PLUS NEOADJUVANT THERAPY|surgery plus neoadjuvant therapy
528257|NCT00913692|Glutamine|glutamine
528258|NCT00913692|Herpes Labialis|herpes labialis
528259|NCT00913692|Herpes Simplex Virus|herpes simplex virus
528260|NCT00913692|Cold Sore|cold sore
528261|NCT00913679|osteonecrosis|osteonecrosis
528262|NCT00913679|femoral neck fracture|femoral neck fracture
528263|NCT00913679|implant fixation|implant fixation
528264|NCT00913679|implant failure|implant failure
528265|NCT00913679|periprosthetic bone mineral density|periprosthetic bone mineral density
528266|NCT00913679|gait function|gait function
528267|NCT00913679|gait analysis|gait analysis
528268|NCT00913679|patient recovery|patient recovery
528269|NCT00913666|Multiple Sclerosis|multiple sclerosis
528270|NCT00913653|Heart failure|heart failure
528271|NCT00913653|LCZ696|lcz696
528272|NCT00913640|Prospective Memory Performance|prospective memory performance
528273|NCT00913640|Prospective Memory Outcome|prospective memory outcome
528274|NCT00913640|Parkinson's Disease|parkinson's disease
528275|NCT00913627|Extended-release|extended-release
528276|NCT00913627|ibuprofen|ibuprofen
528277|NCT00913614|insomnia pediatric safety|insomnia pediatric safety
528278|NCT00913601|Idiopathic Fecal Incontinence|idiopathic fecal incontinence
528279|NCT00913601|Fecal Incontinence|fecal incontinence
528280|NCT00913601|Sacral Nerve Stimulation|sacral nerve stimulation
528281|NCT00913601|Sacral Nerve Neuromodulation|sacral nerve neuromodulation
528282|NCT00913575|neuromuscular training|neuromuscular training
528283|NCT00913575|preoperative exercise|preoperative exercise
528284|NCT00913575|physiotherapy|physiotherapy
528285|NCT00913575|total knee replacement|total knee replacement
528286|NCT00913575|knee osteoarthritis|knee osteoarthritis
528287|NCT00913562|Ocular Physiology|ocular physiology
528288|NCT00913562|Regional Blood Flow|regional blood flow
528289|NCT00913549|Antihistamine|antihistamine
528290|NCT00913536|Bladder Cancer|bladder cancer
528291|NCT00913536|Cone Beam CT|cone beam ct
528292|NCT00913536|On-line image guidance|on-line image guidance
528293|NCT00913536|Radiation therapy in bladder cancer patients|radiation therapy in bladder cancer patients
528294|NCT00913523|tampons|tampons
528295|NCT00913523|Glycerol Monolaurate|glycerol monolaurate
528296|NCT00913523|vaginal microflora|vaginal microflora
528297|NCT00913523|microbes|microbes
528298|NCT00913523|Vaginal Tampon|vaginal tampon
529373|NCT00909129|HIV-1|hiv-1
528299|NCT00913497|Type 1 diabetes mellitus in children|type 1 diabetes mellitus in children
528300|NCT00913497|insulin glulisine|insulin glulisine
528301|NCT00913497|insulin aspart|insulin aspart
528302|NCT00913497|post prandial|post prandial
528303|NCT00913484|Disulfiram|disulfiram
528304|NCT00913484|Buprenorphine|buprenorphine
528305|NCT00913484|Cocaine dependence|cocaine dependence
528306|NCT00913484|Opioid dependence|opioid dependence
528307|NCT00913484|Dopamine-Beta-Hydroxylase|dopamine-beta-hydroxylase
528308|NCT00913471|Spinal cord injury|spinal cord injury
528309|NCT00913471|SCI|sci
528310|NCT00913471|Neuropathic pain|neuropathic pain
528311|NCT00913471|Pain|pain
528312|NCT00913445|Appendicitis|appendicitis
528313|NCT00913445|appendicectomy|appendicectomy
528314|NCT00913445|stitches|stitches
528315|NCT00913445|wound healing|wound healing
528316|NCT00913445|cosmetic results|cosmetic results
528317|NCT00913432|rheumatoid arthritis|rheumatoid arthritis
528318|NCT00913432|methotrexate|methotrexate
528319|NCT00913432|DMARD|dmard
528320|NCT00913432|c-kit inhibitor|c-kit inhibitor
528321|NCT00913419|Antidepressant|antidepressant
528322|NCT00913406|Effect of lutein fortification growth healthy term infants|effect of lutein fortification growth healthy term infants
528323|NCT00913367|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
528324|NCT00913354|infertility|infertility
528325|NCT00913354|ivf|ivf
528326|NCT00913354|acupuncture|acupuncture
528327|NCT00913328|Asthma|asthma
528328|NCT00913328|Airway responsiveness|airway responsiveness
528329|NCT00913328|Dose-response plateau|dose-response plateau
528330|NCT00913328|Montelukast|montelukast
528331|NCT00913328|Add-on to inhaled corticosteroids|add-on to inhaled corticosteroids
528332|NCT00913315|prostatitis|prostatitis
528333|NCT00913315|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists
528334|NCT00913315|tolterodine|tolterodine
528335|NCT00913302|Ankylosing Spondylitis|ankylosing spondylitis
528336|NCT00913302|Education|education
528337|NCT00913302|Physical fitness|physical fitness
528338|NCT00913289|Liver Cirrhosis|liver cirrhosis
528339|NCT00913263|Prostate cancer|prostate cancer
528340|NCT00913250|Multiple Sclerosis|multiple sclerosis
528341|NCT00913250|Interferon beta-1a|interferon beta-1a
528342|NCT00913237|Antidepressant|antidepressant
528343|NCT00913224|Anti-inflammatory|anti-inflammatory
528344|NCT00913198|Pancreas|pancreas
528345|NCT00913198|Advanced adenocarcinoma|advanced adenocarcinoma
528346|NCT00913198|CP-4126|cp-4126
528347|NCT00913185|Acne|acne
528348|NCT00913172|TB|tb
528349|NCT00913172|cost|cost
528350|NCT00913172|HEWs|hews
528351|NCT00913172|Cost-effectiveness|cost-effectiveness
528352|NCT00913172|treatment success rate|treatment success rate
528353|NCT00913159|Renal stones|renal stones
528354|NCT00913159|lithotripsy|lithotripsy
528355|NCT00913159|stone free rate|stone free rate
528356|NCT00913146|Management of fever|management of fever
528357|NCT00913146|Malaria|malaria
528358|NCT00913146|Malaria rapid diagnostic test|malaria rapid diagnostic test
528359|NCT00913146|Clinical trial|clinical trial
528360|NCT00913133|Anticoagulation|anticoagulation
528361|NCT00913133|Prophylaxis|prophylaxis
528362|NCT00913133|Desirudin|desirudin
528363|NCT00913133|Direct thrombin inhibitor|direct thrombin inhibitor
528364|NCT00913133|Heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
528365|NCT00913120|YM150|ym150
528366|NCT00913120|FXa inhibitor|fxa inhibitor
528367|NCT00913120|Thrombosis|thrombosis
528368|NCT00913120|Anticoagulant|anticoagulant
528369|NCT00913120|Venous thromboembolism|venous thromboembolism
528370|NCT00913120|Arthroplasty, replacement, hip|arthroplasty, replacement, hip
528371|NCT00913107|Trigeminal Neuralgia|trigeminal neuralgia
528372|NCT00913107|Lamotrigine|lamotrigine
528373|NCT00913107|Carbamazepine|carbamazepine
528374|NCT00913107|Lamictal®|lamictal®
528375|NCT00913107|Tegretol®|tegretol®
528376|NCT00913094|Hypertension|hypertension
528377|NCT00913081|Skin|skin
528378|NCT00913081|pharmacology|pharmacology
528379|NCT00913081|metabolism|metabolism
528380|NCT00913081|lipid|lipid
528381|NCT00913068|radical prostatectomy|radical prostatectomy
528382|NCT00913055|S-LAR|s-lar
528383|NCT00913055|Octreotide|octreotide
528384|NCT00913055|Implant|implant
528385|NCT00913042|Febrile neutropenia|febrile neutropenia
528386|NCT00913042|Blood culture|blood culture
528387|NCT00913042|Bacteremia|bacteremia
528388|NCT00913042|Bacterial DNA testing|bacterial dna testing
528389|NCT00913029|primary open angle glaucoma (POAG)|primary open angle glaucoma (poag)
528390|NCT00913029|OAG|oag
528391|NCT00913029|glaucoma|glaucoma
528392|NCT00913016|hormonal therapy(letrozole)|hormonal therapy(letrozole)
528393|NCT00913016|postmenopausal breast cancer|postmenopausal breast cancer
528394|NCT00913016|quality of life|quality of life
528395|NCT00913003|Lidocaine|lidocaine
528396|NCT00913003|Mastectomy|mastectomy
528397|NCT00913003|Pain|pain
528398|NCT00912990|Pediatric|pediatric
528399|NCT00912977|Parkinsons disease|parkinsons disease
528400|NCT00912977|dyskinesia|dyskinesia
528401|NCT00912977|measurement|measurement
528402|NCT00912964|Urgency|urgency
528404|NCT00912964|Urinary incontinence|urinary incontinence
528405|NCT00912964|Mirabegron|mirabegron
528406|NCT00912964|Micturition|micturition
528407|NCT00912964|Frequency|frequency
528408|NCT00912964|Urinary urgency incontinence|urinary urgency incontinence
528409|NCT00912964|Overactive Bladder|overactive bladder
528410|NCT00912938|metastatic breast cancer|metastatic breast cancer
528411|NCT00912938|bone remodeling markers|bone remodeling markers
528412|NCT00912938|zoledronic acid|zoledronic acid
528413|NCT00912912|Genitourinary|genitourinary
528414|NCT00912912|Testis|testis
528415|NCT00912912|Refractory Germ Cell Tumors|refractory germ cell tumors
528416|NCT00912912|Advanced germ cell tumors|advanced germ cell tumors
528417|NCT00912912|GCTs|gcts
528418|NCT00912912|Sunitinib Malate|sunitinib malate
528419|NCT00912912|Sutent|sutent
528420|NCT00912912|SU011248|su011248
528421|NCT00912899|Refractory Multiple Myeloma|refractory multiple myeloma
528422|NCT00912899|CB3304|cb3304
528423|NCT00912899|Noscapine HCl|noscapine hcl
528424|NCT00912899|Multiple Myeloma|multiple myeloma
528425|NCT00912886|alzheimer|alzheimer
528426|NCT00912886|memory|memory
528427|NCT00912886|neurosteroids|neurosteroids
528428|NCT00912873|pain|pain
528429|NCT00912873|catheter|catheter
528430|NCT00912873|nerve block|nerve block
528431|NCT00912873|UCSD|ucsd
528432|NCT00912873|range of motion|range of motion
528433|NCT00912873|hip surgery|hip surgery
528434|NCT00912873|psoas compartment|psoas compartment
528435|NCT00912860|multiple sclerosis|multiple sclerosis
528436|NCT00912860|interferon beta-1a|interferon beta-1a
528437|NCT00912860|avonex|avonex
528438|NCT00912847|HBV carriers|hbv carriers
528439|NCT00912834|hematuria|hematuria
528440|NCT00912834|urinary tract infection|urinary tract infection
528441|NCT00912821|Renal Replacement Therapy|renal replacement therapy
528442|NCT00912821|Peritoneal dialysis|peritoneal dialysis
528443|NCT00912808|parkinsons disease|parkinsons disease
528444|NCT00912808|falling|falling
528445|NCT00912795|Smoking Cessation|smoking cessation
528446|NCT00912795|technology|technology
528447|NCT00912795|developing countries|developing countries
528448|NCT00912782|ESRD|esrd
528449|NCT00912782|Vitamin D|vitamin d
528450|NCT00912782|Arteriovenous Fistulae|arteriovenous fistulae
528451|NCT00912782|Dialysis Vascular Access|dialysis vascular access
528452|NCT00912769|Total knee replacement|total knee replacement
528453|NCT00912769|Subvastus|subvastus
528454|NCT00912769|Midvastus|midvastus
528455|NCT00912769|Isokinetic|isokinetic
528456|NCT00912769|Quadriceps|quadriceps
528457|NCT00912756|endovascular therapy|endovascular therapy
528458|NCT00912756|restenosis|restenosis
528459|NCT00912756|cilostazol|cilostazol
528460|NCT00912756|femoropopliteal artery lesions|femoropopliteal artery lesions
528461|NCT00912756|Chronic arteriosclerosis obliterans afflicting the femoropopliteal artery area|chronic arteriosclerosis obliterans afflicting the femoropopliteal artery area
528462|NCT00912743|Colorectal cancer|colorectal cancer
528463|NCT00912743|Olaparib|olaparib
528464|NCT00912743|MSI status|msi status
528465|NCT00912743|Stage IV|stage iv
528466|NCT00912743|Measurable Colorectal Cancer|measurable colorectal cancer
528467|NCT00912743|Stratified by MSI Status|stratified by msi status
528468|NCT00912730|melanoma|melanoma
528469|NCT00912730|imaging|imaging
528470|NCT00912730|sentinel node|sentinel node
528471|NCT00912730|biopsy|biopsy
528472|NCT00912704|Hemodialysis patients|hemodialysis patients
528473|NCT00912704|Kidney|kidney
528474|NCT00912704|Physician attitudes|physician attitudes
528475|NCT00912704|Family wishes|family wishes
528476|NCT00912704|30 numbers require maximum|30 numbers require maximum
528477|NCT00912691|Autism|autism
528478|NCT00912678|Kidney transplantation|kidney transplantation
528479|NCT00912678|Old for old kidney transplantation|old for old kidney transplantation
528480|NCT00912678|European senior program|european senior program
528481|NCT00912678|Calcineurin inhibitor free immunosuppression|calcineurin inhibitor free immunosuppression
528482|NCT00912665|Optic Nerve Head Blood Flow|optic nerve head blood flow
528483|NCT00912665|Intraocular Pressure|intraocular pressure
528484|NCT00912665|Regional Blood Flow|regional blood flow
528485|NCT00912665|Ocular Physiology|ocular physiology
528486|NCT00912665|Optic Disk|optic disk
528487|NCT00912652|obesity|obesity
528488|NCT00912652|rural health|rural health
528489|NCT00912652|exercise|exercise
528490|NCT00912639|recurrent breast cancer|recurrent breast cancer
528491|NCT00912639|Genexol-PM|genexol-pm
528492|NCT00912626|siblings|siblings
528493|NCT00912626|family|family
528494|NCT00912626|child behavior|child behavior
528495|NCT00912626|critical illness|critical illness
528496|NCT00912626|social support|social support
528497|NCT00912613|Critical illness|critical illness
528498|NCT00912613|ICU Diaries|icu diaries
528499|NCT00912613|Post Traumatic Stress Disorder|post traumatic stress disorder
528500|NCT00912613|Incidence|incidence
528501|NCT00912600|Intensive Care Units|intensive care units
528502|NCT00912600|Triage|triage
528503|NCT00912600|Aged, 80 and over|aged, 80 and over
528504|NCT00912600|Death|death
529468|NCT00908583|Nephrology|nephrology
528505|NCT00912600|Activities of Daily Living|activities of daily living
528506|NCT00912600|Health Services Research|health services research
528507|NCT00912600|Health Care Quality, Access, and Evaluation|health care quality, access, and evaluation
528508|NCT00912574|Melanoma|melanoma
528509|NCT00912574|adjuvant|adjuvant
528510|NCT00912574|dendritic cells|dendritic cells
528511|NCT00912574|vaccine|vaccine
528512|NCT00912561|chronic brain ischaemia|chronic brain ischaemia
528513|NCT00912561|stroke prevention|stroke prevention
528514|NCT00912561|exercise|exercise
528515|NCT00912561|physical training|physical training
528516|NCT00912561|Chronic, extra- or intracranial stenoses of brain supplying arteries|chronic, extra- or intracranial stenoses of brain supplying arteries
528517|NCT00912548|premenopause|premenopause
528518|NCT00912548|ovarian function suppression|ovarian function suppression
528519|NCT00912548|tamoxifen|tamoxifen
528520|NCT00912535|Primary Anxiety Disorders|primary anxiety disorders
528521|NCT00912535|Mood Disorders with Comorbid Anxiety Symptoms|mood disorders with comorbid anxiety symptoms
528522|NCT00912522|reward|reward
528523|NCT00912522|TMS|tms
528524|NCT00912522|cognition|cognition
528525|NCT00912522|Motivation|motivation
528526|NCT00912522|Perception|perception
528527|NCT00912522|Decision making|decision making
528528|NCT00912509|infectious keratitis|infectious keratitis
528529|NCT00912509|cross linking|cross linking
528530|NCT00912509|corneal ulcer|corneal ulcer
528531|NCT00912509|corneal infection|corneal infection
528532|NCT00912509|collagen cross linking|collagen cross linking
528533|NCT00912496|Influenza, H5N1, vaccine, avian influenza|influenza, h5n1, vaccine, avian influenza
528534|NCT00912483|VTE|vte
528535|NCT00912470|genetic vascular risc factors|genetic vascular risc factors
528536|NCT00912470|ocular blood flow|ocular blood flow
528537|NCT00912470|progressive glaucoma|progressive glaucoma
528538|NCT00912457|sleep apnea|sleep apnea
528539|NCT00912457|donepezil|donepezil
528540|NCT00912457|pharmacological|pharmacological
528541|NCT00912457|cholinergic|cholinergic
528542|NCT00912444|Breast Neoplasms|breast neoplasms
528543|NCT00912444|Neoadjuvant|neoadjuvant
528544|NCT00912444|Chemotherapy|chemotherapy
528545|NCT00912444|Docetaxel|docetaxel
528546|NCT00912444|Cyclophosphamide|cyclophosphamide
528547|NCT00912444|Anthracycline|anthracycline
528548|NCT00912431|Healthy Volunteers|healthy volunteers
528549|NCT00912418|melanoma|melanoma
528550|NCT00912418|vaccine|vaccine
528551|NCT00912418|IL2 low dose|il2 low dose
528552|NCT00912405|Patients diagnosed with Chronic Sinusitis undergoing functional endoscopic surgery (FESS)|patients diagnosed with chronic sinusitis undergoing functional endoscopic surgery (fess)
528553|NCT00912366|VATS|vats
528554|NCT00912366|Lung cancer|lung cancer
528555|NCT00912366|NSCLC|nsclc
528556|NCT00912353|Phase I|phase i
528557|NCT00912353|Japanese healthy volunteer|japanese healthy volunteer
528558|NCT00912353|AZD7268|azd7268
528559|NCT00912340|Breast Cancer|breast cancer
528560|NCT00912327|Colorectal|colorectal
528561|NCT00912327|KRAS mutation|kras mutation
528562|NCT00912327|Stage IV|stage iv
528563|NCT00912327|Imprime PGG|imprime pgg
528564|NCT00912327|Cetuximab|cetuximab
528565|NCT00912327|Immunotherapy|immunotherapy
528566|NCT00912314|OAB|oab
528567|NCT00912314|overactive bladder|overactive bladder
528568|NCT00912314|ptns|ptns
528569|NCT00912314|posterior tibial nerve stimulation|posterior tibial nerve stimulation
528570|NCT00912314|percutaneous tibial nerve stimulation|percutaneous tibial nerve stimulation
528571|NCT00912301|chenodeoxycholate, IBS, transit, colon, constipation|chenodeoxycholate, ibs, transit, colon, constipation
528572|NCT00912288|Alzheimer disease moderate-to-severe memantine safety and efficacy|alzheimer disease moderate-to-severe memantine safety and efficacy
528573|NCT00912262|Analgesics|analgesics
528574|NCT00912262|Capsaicin|capsaicin
528575|NCT00912249|Horticulture Therapy|horticulture therapy
528576|NCT00912249|Psychiatric Rehabilitation|psychiatric rehabilitation
528577|NCT00912249|Nature-assisted psychotherapy|nature-assisted psychotherapy
528578|NCT00912249|Day Care|day care
528579|NCT00912236|Obesity|obesity
528580|NCT00912236|HDL|hdl
528581|NCT00912236|HDL functionality|hdl functionality
528582|NCT00912223|Follicular Non-Hodgkin's Lymphoma|follicular non-hodgkin's lymphoma
528583|NCT00912223|Hematopoietic Stem Cell Transplant (HSCT)|hematopoietic stem cell transplant (hsct)
528584|NCT00912223|Non-Myeloablative Transplant (NST)|non-myeloablative transplant (nst)
528585|NCT00912184|Kidney failure, acute|kidney failure, acute
528586|NCT00912184|Shock|shock
528587|NCT00912184|Toxins, biological|toxins, biological
528588|NCT00912184|Hemofiltration|hemofiltration
528589|NCT00912184|High cut off/super high flux membranes|high cut off/super high flux membranes
528590|NCT00912171|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
528591|NCT00912171|snoring|snoring
528592|NCT00912171|adenotonsillar hypertrophy|adenotonsillar hypertrophy
528593|NCT00912171|polysomnography|polysomnography
528594|NCT00912171|intranasal steroids|intranasal steroids
528595|NCT00912171|Anti-leukotrienes|anti-leukotrienes
528596|NCT00912158|CPE|cpe
528597|NCT00912158|CPAP|cpap
528598|NCT00912158|BiPAP|bipap
528599|NCT00912158|non invasive mechanical ventilation|non invasive mechanical ventilation
528600|NCT00912132|Fetal Growth|fetal growth
528601|NCT00912132|Pregnancy|pregnancy
528602|NCT00912119|craniofacial surgery|craniofacial surgery
528603|NCT00912119|pharmacokinetics|pharmacokinetics
528604|NCT00912119|cranial vault abnormalities|cranial vault abnormalities
528605|NCT00912119|homologous blood products|homologous blood products
528606|NCT00912119|wide scalp dissections|wide scalp dissections
528607|NCT00912119|transfusion requirements|transfusion requirements
528608|NCT00912106|osteoarthritis|osteoarthritis
528609|NCT00912106|HA|ha
528610|NCT00912106|synovial fluid|synovial fluid
528611|NCT00912106|lubrication|lubrication
528612|NCT00912093|HAE|hae
528613|NCT00912093|Type I HAE|type i hae
528614|NCT00912093|Type II HAE|type ii hae
528615|NCT00912080|genomic signature|genomic signature
528616|NCT00912080|lymph nodes|lymph nodes
528617|NCT00912080|no metastases|no metastases
528618|NCT00912054|OAG|oag
528619|NCT00912054|OH|oh
528620|NCT00912041|Brain computer interface|brain computer interface
528621|NCT00912041|Assistive device|assistive device
528622|NCT00912041|Environmental control|environmental control
528623|NCT00912041|Communication device|communication device
528624|NCT00912041|quadriplegia|quadriplegia
528625|NCT00912041|tetraplegia|tetraplegia
528626|NCT00911989|Obesity|obesity
528627|NCT00911989|Weight Loss|weight loss
528628|NCT00911976|Coronary artery bypass|coronary artery bypass
528629|NCT00911976|Stents|stents
528630|NCT00911976|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
528631|NCT00911976|Coronary Restenosis|coronary restenosis
528632|NCT00911976|Everolimus|everolimus
528633|NCT00911976|Saphenous vein grafts|saphenous vein grafts
528634|NCT00911963|VX-222|vx-222
528635|NCT00911937|incontinence OAB urgency nocturia|incontinence oab urgency nocturia
528636|NCT00911924|primary open angle glaucoma (POAG)|primary open angle glaucoma (poag)
528637|NCT00911924|OAG|oag
528638|NCT00911924|glaucoma|glaucoma
528639|NCT00911911|Breast cancer|breast cancer
528640|NCT00911911|Neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
528641|NCT00911911|Proteomic|proteomic
528642|NCT00911911|Histological response|histological response
528643|NCT00911898|Her2 amplified solid tumors|her2 amplified solid tumors
528644|NCT00911898|Breast Cancer|breast cancer
528645|NCT00911898|Her3/ErbB3|her3/erbb3
528646|NCT00911898|Bispecific Antibody|bispecific antibody
528647|NCT00911885|Weight|weight
528648|NCT00911885|Diet|diet
528649|NCT00911885|Lipids|lipids
528650|NCT00911872|wrinkles|wrinkles
528651|NCT00911872|dermal filler|dermal filler
528652|NCT00911872|collagen|collagen
528653|NCT00911872|soft tissue augmentation|soft tissue augmentation
528654|NCT00911872|aesthetic|aesthetic
528655|NCT00911859|Multiple Myeloma|multiple myeloma
528656|NCT00911859|CNTO328|cnto328
528657|NCT00911859|Interleukin-6 (IL-6)|interleukin-6 (il-6)
528658|NCT00911859|Monoclonal antibody|monoclonal antibody
528659|NCT00911859|Anti-IL-6 monoclonal antibody|anti-il-6 monoclonal antibody
528660|NCT00911859|Bortezomib|bortezomib
528661|NCT00911859|Velcade|velcade
528662|NCT00911859|Melphalan|melphalan
528663|NCT00911859|Prednisone|prednisone
528664|NCT00911846|opioid dependence substitution buprenorphine methadone|opioid dependence substitution buprenorphine methadone
528665|NCT00911846|"substitution"|"substitution"
528666|NCT00911833|Trust|trust
528667|NCT00911807|Clinical Trial, Phase II|clinical trial, phase ii
528668|NCT00911807|Randomized Controlled Trial|randomized controlled trial
528669|NCT00911807|Multicenter Study|multicenter study
528670|NCT00911807|Cerebrolysin|cerebrolysin
528671|NCT00911807|Donepezil|donepezil
528672|NCT00911794|Dyspnea|dyspnea
528673|NCT00911794|Written Disclosure Therapy|written disclosure therapy
528674|NCT00911794|COPD|copd
528675|NCT00911794|Pulmonary Fibrosis|pulmonary fibrosis
528676|NCT00911794|Chronic Lung Diseases|chronic lung diseases
528677|NCT00911794|Pulmonary Rehabilitation|pulmonary rehabilitation
528678|NCT00911781|Infantile hemangioma|infantile hemangioma
528679|NCT00911768|Xerostomia|xerostomia
528680|NCT00911768|Panax ginseng(Korean Red Ginseng)|panax ginseng(korean red ginseng)
528681|NCT00911768|Visual Analogue Scale|visual analogue scale
528682|NCT00911768|Salivary Flow Rates|salivary flow rates
528683|NCT00911755|Laryngoscopy|laryngoscopy
528684|NCT00911755|Glidescope|glidescope
528685|NCT00911729|paraganglioma|paraganglioma
528686|NCT00911729|pheochromocytoma|pheochromocytoma
528687|NCT00911716|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
528688|NCT00911716|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
528689|NCT00911716|HER2-negative breast cancer|her2-negative breast cancer
528690|NCT00911716|stage IA breast cancer|stage ia breast cancer
528691|NCT00911716|stage IB breast cancer|stage ib breast cancer
528692|NCT00911716|stage II breast cancer|stage ii breast cancer
528693|NCT00911716|stage IIIA breast cancer|stage iiia breast cancer
528694|NCT00911716|male breast cancer|male breast cancer
528695|NCT00911690|Dementia|dementia
528696|NCT00911690|Alzheimers Disease|alzheimers disease
528697|NCT00911690|Cognitive Disorders|cognitive disorders
528698|NCT00911690|Tissue Banking|tissue banking
528699|NCT00911677|Delirium (MeSH Unique ID D003693)|delirium (mesh unique id d003693)
528700|NCT00911677|Cognition Disorders (MeSH Unique ID D003072)|cognition disorders (mesh unique id d003072)
528701|NCT00911677|Postoperative Complications (MeSH Unique ID D011183)|postoperative complications (mesh unique id d011183)
528702|NCT00911677|Apolipoproteins E (MeSH Unique ID D001057)|apolipoproteins e (mesh unique id d001057)
528703|NCT00911664|Vitamin D|vitamin d
528704|NCT00911664|HIV-Infected children|hiv-infected children
528705|NCT00911664|CD4 count|cd4 count
528706|NCT00911651|COPD|copd
528707|NCT00911651|salbutamol|salbutamol
528708|NCT00911651|ipratropium bromide|ipratropium bromide
528709|NCT00911651|computational fluid dynamics|computational fluid dynamics
528710|NCT00911651|functional imaging|functional imaging
528711|NCT00911651|central and peripheral airways|central and peripheral airways
528712|NCT00911638|Patient decision aids|patient decision aids
528713|NCT00911638|Patient preferences|patient preferences
528714|NCT00911638|Osteoarthritis|osteoarthritis
528715|NCT00911638|Joint replacement|joint replacement
528716|NCT00911638|Waiting times|waiting times
528717|NCT00911625|glargine|glargine
528718|NCT00911625|glulisine|glulisine
528719|NCT00911625|type 2 diabetes|type 2 diabetes
528720|NCT00911625|renal insufficiency|renal insufficiency
528721|NCT00911612|bile acid|bile acid
528722|NCT00911612|malabsorption|malabsorption
528723|NCT00911612|permeability|permeability
528724|NCT00911612|diarrhea|diarrhea
528725|NCT00911612|IBS|ibs
528726|NCT00911612|stool|stool
528727|NCT00911599|Individuals undergoing unilateral total hip replacement.|individuals undergoing unilateral total hip replacement.
528728|NCT00911573|pediatry|pediatry
528729|NCT00911573|children|children
528730|NCT00911573|skin|skin
528731|NCT00911573|bacteria|bacteria
528732|NCT00911573|MRSA|mrsa
528733|NCT00911560|BETA-D-GLUCAN|beta-d-glucan
528734|NCT00911560|OPT-821|opt-821
528735|NCT00911560|GD2-KLH|gd2-klh
528736|NCT00911560|GD3-KLH|gd3-klh
528737|NCT00911560|QS 21|qs 21
528738|NCT00911560|Vaccine|vaccine
528739|NCT00911560|05-075|05-075
528740|NCT00911547|chronic asthma|chronic asthma
528741|NCT00911534|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
528742|NCT00911534|GERD|gerd
528743|NCT00911521|human papillomavirus|human papillomavirus
528744|NCT00911521|vaccine|vaccine
528745|NCT00911521|lupus|lupus
528746|NCT00911508|Atrial Fibrillation|atrial fibrillation
528747|NCT00911508|Left Atrial Ablation|left atrial ablation
528748|NCT00911508|Pulmonary Vein Isolation|pulmonary vein isolation
528749|NCT00911508|Catheter Ablation|catheter ablation
528750|NCT00911508|Antiarrhythmic Drug Therapy|antiarrhythmic drug therapy
528751|NCT00911495|Sickle Cell Disease|sickle cell disease
528752|NCT00911482|Type 2 Diabetes|type 2 diabetes
528753|NCT00911482|Dyslipidemia|dyslipidemia
528754|NCT00911482|FFA|ffa
528755|NCT00911482|Triglycerides|triglycerides
528756|NCT00911482|Tracers|tracers
528757|NCT00911469|Knee osteoarthritis|knee osteoarthritis
528758|NCT00911469|fibroblast growth factor 18|fibroblast growth factor 18
528759|NCT00911430|Staphylococcus Aureus (S. Areus)|staphylococcus aureus (s. areus)
528760|NCT00911430|Recurrent Staphylococcal Infection|recurrent staphylococcal infection
528761|NCT00911430|Atopic Dermatitis|atopic dermatitis
528762|NCT00911430|Immunodeficiency|immunodeficiency
528763|NCT00911430|Community Associated Staphylococcal Infection|community associated staphylococcal infection
528764|NCT00911430|Staphylococcal Infection|staphylococcal infection
528765|NCT00911430|Invasive Staphylococcal Infection|invasive staphylococcal infection
528766|NCT00911430|Staph Infection|staph infection
528767|NCT00911417|peripheral arterial disease|peripheral arterial disease
528768|NCT00911417|peripheral vascular disease|peripheral vascular disease
528769|NCT00911404|Gestational diabetes|gestational diabetes
528770|NCT00911404|Carbohydrate|carbohydrate
528771|NCT00911404|Diet|diet
528772|NCT00911404|Insulin|insulin
528773|NCT00911391|Doppler|doppler
528774|NCT00911391|Colectomy|colectomy
528775|NCT00911391|ERAS|eras
528776|NCT00911391|Fluid|fluid
528777|NCT00911391|Perioperative Care|perioperative care
528778|NCT00911378|weaning|weaning
528779|NCT00911378|mechanical ventilation|mechanical ventilation
528780|NCT00911365|voluntary participants|voluntary participants
528781|NCT00911365|75 years old or less|75 years old or less
528782|NCT00911352|Cryotherapy|cryotherapy
528783|NCT00911352|Hand toxicity|hand toxicity
528784|NCT00911352|Nail toxicity|nail toxicity
528785|NCT00911352|Infection control|infection control
528786|NCT00911326|HNSCC|hnscc
528787|NCT00911313|Polycystic ovary syndrome|polycystic ovary syndrome
528788|NCT00911313|clomiphene resistance|clomiphene resistance
528789|NCT00911313|letrozole|letrozole
528790|NCT00911300|Cardioversion, Electric|cardioversion, electric
528791|NCT00911300|Pathological Conditions, Sings and Symptoms|pathological conditions, sings and symptoms
528792|NCT00911300|Cardiovascular Diseases|cardiovascular diseases
528793|NCT00911300|Heart Diseases|heart diseases
528794|NCT00911300|Atrial Fibrillation|atrial fibrillation
528795|NCT00911300|Arrhythmias, Cardiac|arrhythmias, cardiac
528796|NCT00911300|Pathologic Processes|pathologic processes
528797|NCT00911300|Anticoagulants|anticoagulants
528798|NCT00911287|Chronic pain|chronic pain
528799|NCT00911287|Extended Release|extended release
528800|NCT00911287|Long-Acting Opioid|long-acting opioid
528801|NCT00911287|Opioid|opioid
528802|NCT00911287|Opioid-Naive|opioid-naive
528803|NCT00911287|Oxymorphone|oxymorphone
528804|NCT00911274|Bioequivalence|bioequivalence
528805|NCT00911274|Healthy Subjects|healthy subjects
528806|NCT00911261|Cancer Pain|cancer pain
528807|NCT00911261|Neuropathic Pain|neuropathic pain
528808|NCT00911261|Extended Release|extended release
528809|NCT00911261|Long-Acting Opioid|long-acting opioid
528810|NCT00911261|Oxymorphone|oxymorphone
528811|NCT00911248|Angiogenesis|angiogenesis
528812|NCT00911248|Neurofibromatosis|neurofibromatosis
528813|NCT00911248|Post-transcriptional control|post-transcriptional control
528814|NCT00911248|PTC299|ptc299
528815|NCT00911248|VEGF|vegf
528816|NCT00911235|The Effect Of Fluconazole On Pharmacokinetics Of Fesoterodine In Healthy Subjects|the effect of fluconazole on pharmacokinetics of fesoterodine in healthy subjects
528817|NCT00911222|antiemetic therapy|antiemetic therapy
528818|NCT00911222|emesis|emesis
528819|NCT00911222|vomiting|vomiting
528820|NCT00911222|nausea|nausea
528821|NCT00911222|moderately and highly emetogenic chemotherapy|moderately and highly emetogenic chemotherapy
528822|NCT00911222|cisplatin|cisplatin
528823|NCT00911222|carboplatin|carboplatin
528824|NCT00911222|oxaliplatin|oxaliplatin
528825|NCT00911222|anthracycline|anthracycline
528826|NCT00911222|cyclophosphamid|cyclophosphamid
528827|NCT00911209|Heart Disease|heart disease
528828|NCT00911209|Obesity|obesity
528829|NCT00911196|Prognosis|prognosis
528830|NCT00911196|Markers|markers
528831|NCT00911196|Expression analysis|expression analysis
528832|NCT00911196|Hepatocellular carcinoma|hepatocellular carcinoma
528833|NCT00911183|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
528834|NCT00911183|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
528835|NCT00911183|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
528836|NCT00911183|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
528837|NCT00911170|adenocarcinoma of the colon or rectum|adenocarcinoma of the colon or rectum
528838|NCT00911170|febrile neutropenia|febrile neutropenia
528839|NCT00911170|Bevacizumab|bevacizumab
528840|NCT00911170|Avastin|avastin
528841|NCT00911170|5-fluorouracil, Oxaliplatin, Leucovorin (FOLFOX)|5-fluorouracil, oxaliplatin, leucovorin (folfox)
528842|NCT00911170|5-fluorouracil, Irinotecan, Leucovorin (FOLFIRI)|5-fluorouracil, irinotecan, leucovorin (folfiri)
528843|NCT00911157|Pulmonary thromboembolism|pulmonary thromboembolism
528844|NCT00911157|contrast-enhanced MDCT|contrast-enhanced mdct
528845|NCT00911157|Deep Vein Thrombosis|deep vein thrombosis
528846|NCT00911157|Fondaparinux sodium|fondaparinux sodium
528847|NCT00911144|Safety|safety
528848|NCT00911144|Pneumococcal vaccine|pneumococcal vaccine
528849|NCT00911144|Immunogenicity|immunogenicity
528850|NCT00911144|Pneumococcal disease|pneumococcal disease
528851|NCT00911144|Booster vaccination|booster vaccination
528852|NCT00911131|Small grade esophageal varices|small grade esophageal varices
528853|NCT00911131|capsule endoscopy|capsule endoscopy
528854|NCT00911131|PillCam ESO|pillcam eso
528855|NCT00911131|abdominal binder|abdominal binder
528856|NCT00911118|prostate|prostate
528857|NCT00911118|radiation|radiation
528858|NCT00911118|09-035|09-035
528859|NCT00911105|Multiple Myeloma|multiple myeloma
528860|NCT00911105|Non-interventional study|non-interventional study
528861|NCT00911105|Lenalidomide|lenalidomide
528862|NCT00911105|Dexamethasone|dexamethasone
528863|NCT00911105|Observational|observational
528864|NCT00911105|Time to progression|time to progression
528865|NCT00911105|Clinical routine|clinical routine
528866|NCT00911105|Germany|germany
528867|NCT00911105|Plasmacytoma|plasmacytoma
528868|NCT00911092|Oesophageal cancer|oesophageal cancer
528869|NCT00911092|exclusive concomitant radiochemotherapy|exclusive concomitant radiochemotherapy
528870|NCT00911079|Stage III, IV cervical cancer|stage iii, iv cervical cancer
528871|NCT00911079|Rising prostate specific antigen (PSA) after local therapy|rising prostate specific antigen (psa) after local therapy
528872|NCT00911053|melatonin|melatonin
528873|NCT00911053|sleep|sleep
528874|NCT00911053|blindness|blindness
528875|NCT00911053|blind individuals|blind individuals
528876|NCT00911027|Prostate|prostate
528877|NCT00911027|Cancer|cancer
528878|NCT00911027|Biopsy|biopsy
528879|NCT00911027|Guided|guided
528880|NCT00911027|Contrast|contrast
528881|NCT00911027|Enhanced|enhanced
528882|NCT00911027|SonoVue|sonovue
528883|NCT00911027|Suspicion of prostate cancer|suspicion of prostate cancer
528884|NCT00911001|Arthroplasty|arthroplasty
528885|NCT00911001|Antithrombotic prophylaxis treatment|antithrombotic prophylaxis treatment
528886|NCT00911001|Replacement|replacement
528887|NCT00911001|Knee|knee
528888|NCT00910988|healthy|healthy
528889|NCT00910988|sedentary|sedentary
528890|NCT00910988|men|men
528891|NCT00910988|acute effects of antipsychotic|acute effects of antipsychotic
528892|NCT00910988|blood sugar|blood sugar
528893|NCT00910988|insulin sensitivity|insulin sensitivity
528894|NCT00910975|Hepatitis C virus|hepatitis c virus
528895|NCT00910975|Real-time PCR|real-time pcr
528896|NCT00910975|Treatment|treatment
528897|NCT00910962|NSTEMI, acute coronary syndrome, p38 MAPK inhibitor, GW856553, percutaneous coronary intervention|nstemi, acute coronary syndrome, p38 mapk inhibitor, gw856553, percutaneous coronary intervention
528898|NCT00910949|persistent pain|persistent pain
528899|NCT00910949|neuropathic pain|neuropathic pain
528900|NCT00910949|Thoracotomy|thoracotomy
528901|NCT00910949|Chronic Pain|chronic pain
528902|NCT00910936|HIV|hiv
528903|NCT00910936|Exercise|exercise
528904|NCT00910936|Inflammation|inflammation
528905|NCT00910936|Quality of life|quality of life
528906|NCT00910936|Lipodystrophia|lipodystrophia
528907|NCT00910923|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
528908|NCT00910897|Newly Diagnosed|newly diagnosed
528909|NCT00910897|multiple myeloma|multiple myeloma
528910|NCT00910897|induction|induction
528911|NCT00910897|Thalidomide|thalidomide
528912|NCT00910884|stage I breast cancer|stage i breast cancer
528913|NCT00910884|stage II breast cancer|stage ii breast cancer
528914|NCT00910884|stage IIIA breast cancer|stage iiia breast cancer
528915|NCT00910884|male breast cancer|male breast cancer
528916|NCT00910871|Tuberculosis|tuberculosis
528917|NCT00910871|TMC207-TiDP13-C209|tmc207-tidp13-c209
528918|NCT00910871|TMC207-C209|tmc207-c209
528919|NCT00910871|TMC207|tmc207
528920|NCT00910871|TB|tb
528921|NCT00910871|MDR-TB|mdr-tb
528922|NCT00910832|Dyschesia treatment|dyschesia treatment
528923|NCT00910832|Rehabilitation|rehabilitation
528924|NCT00910832|Dyschesia|dyschesia
528925|NCT00910819|Colorectal Cancer|colorectal cancer
528926|NCT00910819|Advanced Colorectal Cancer|advanced colorectal cancer
528927|NCT00910819|Epidemiology|epidemiology
528928|NCT00910819|Health Services Research|health services research
528929|NCT00910819|Germany|germany
528930|NCT00910819|Registry|registry
528931|NCT00910819|Palliative Care|palliative care
528932|NCT00910819|Palliative Treatment|palliative treatment
528933|NCT00910819|Adjuvant Drug Therapy|adjuvant drug therapy
528934|NCT00910819|Nutrition Assessment|nutrition assessment
528935|NCT00910819|Physical Activity|physical activity
528936|NCT00910806|TMC207-TiDP13-C117|tmc207-tidp13-c117
528937|NCT00910806|TMC207-C110|tmc207-c110
528938|NCT00910806|TMC207|tmc207
528939|NCT00910806|drug-drug interaction|drug-drug interaction
528940|NCT00910806|Tuberculosis|tuberculosis
528941|NCT00910806|HIV|hiv
528942|NCT00910806|nevirapine|nevirapine
528943|NCT00910806|open-label|open-label
528944|NCT00910806|Pharmacokinetics|pharmacokinetics
528945|NCT00910793|Asthma|asthma
528946|NCT00910793|Formoterol|formoterol
528947|NCT00910793|Beclomethasone Dipropionate|beclomethasone dipropionate
528948|NCT00910793|Computational Fluid Dynamics|computational fluid dynamics
528949|NCT00910793|Functional Imaging|functional imaging
528950|NCT00910793|Central and Peripheral Airways|central and peripheral airways
528951|NCT00910754|Prostate neoplasms|prostate neoplasms
528952|NCT00910754|Metastatic castration resistant prostate cancer|metastatic castration resistant prostate cancer
528953|NCT00910754|Abiraterone acetate|abiraterone acetate
528954|NCT00910754|CB7630|cb7630
528955|NCT00910741|pancreatic cancer|pancreatic cancer
528956|NCT00910741|Gemcitabine|gemcitabine
528957|NCT00910728|Primary Myelofibrosis (PMF)|primary myelofibrosis (pmf)
528958|NCT00910728|Post-Polycythaemia Vera/Essential Thrombocythaemia Myelofibrosis (Post-PV/ET MF)|post-polycythaemia vera/essential thrombocythaemia myelofibrosis (post-pv/et mf)
528959|NCT00910728|Myeloproliferative diseases|myeloproliferative diseases
528960|NCT00910728|Phase I|phase i
528961|NCT00910728|Phase II|phase ii
528962|NCT00910728|Bone marrow|bone marrow
528963|NCT00910715|erythema migrans|erythema migrans
528964|NCT00910715|Lyme borreliosis|lyme borreliosis
528965|NCT00910715|doxycycline treatment|doxycycline treatment
528966|NCT00910715|outcome|outcome
528967|NCT00910715|subjective symptoms|subjective symptoms
528968|NCT00910702|retinal detachment, vitreous body substitute|retinal detachment, vitreous body substitute
528969|NCT00910689|Migraine Headache|migraine headache
528970|NCT00910689|Preventive Therapy|preventive therapy
528971|NCT00910689|Beta Blocker Medication|beta blocker medication
528972|NCT00910689|Behavior Therapy|behavior therapy
528973|NCT00910689|Clinical Trial|clinical trial
528974|NCT00910676|EGF-R inhibitors|egf-r inhibitors
528975|NCT00910663|Bioequivalence|bioequivalence
528976|NCT00910663|Healthy Subjects|healthy subjects
528977|NCT00910650|Adoptive transfer therapy|adoptive transfer therapy
528978|NCT00910650|Dendritic cell vaccines|dendritic cell vaccines
528979|NCT00910637|Pregnancy prevention|pregnancy prevention
528980|NCT00910637|Female contraception|female contraception
528981|NCT00910637|Patch|patch
528982|NCT00910611|pediatric|pediatric
528983|NCT00910611|immunization|immunization
528984|NCT00910611|pain|pain
528985|NCT00910611|analgesia|analgesia
528986|NCT00910611|Immunization pain|immunization pain
528987|NCT00910598|clinically isolated syndrome|clinically isolated syndrome
528988|NCT00910598|relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
528989|NCT00910598|glatiramer acetate|glatiramer acetate
528990|NCT00910598|Optical Coherence Tomography|optical coherence tomography
528991|NCT00910585|childhood|childhood
528992|NCT00910585|asthma|asthma
528993|NCT00910572|Yttrium-90|yttrium-90
528994|NCT00910572|Radiation|radiation
528995|NCT00910572|Radioembolization|radioembolization
528996|NCT00910572|Hepatoma|hepatoma
528997|NCT00910572|BCLC classification|bclc classification
528998|NCT00910572|Hepatic loco-regional treatments|hepatic loco-regional treatments
528999|NCT00910572|Yttrium|yttrium
529000|NCT00910572|Microspheres|microspheres
529001|NCT00910559|Autism Spectrum Disorder|autism spectrum disorder
529002|NCT00910559|Autism|autism
529003|NCT00910559|Asperger Syndrome|asperger syndrome
529004|NCT00910559|Pervasive Developmental Disorders- Not Otherwise Specified|pervasive developmental disorders- not otherwise specified
529005|NCT00910546|Lung Cancer|lung cancer
529006|NCT00910546|Stereotactic radiotherapy|stereotactic radiotherapy
529007|NCT00910546|Image guidance|image guidance
529008|NCT00910546|breathing adaption|breathing adaption
529009|NCT00910546|tumor motion|tumor motion
529010|NCT00910546|implanted marker|implanted marker
529011|NCT00910533|Lyme neuroborreliosis|lyme neuroborreliosis
529012|NCT00910507|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
529013|NCT00910507|Exercise|exercise
529014|NCT00910507|Counseling|counseling
529015|NCT00910507|Behavior|behavior
529016|NCT00910494|Rectal neoplasm C04.588.274.476.411.307.790|rectal neoplasm c04.588.274.476.411.307.790
529017|NCT00910494|Intraoperative Radiotherapy|intraoperative radiotherapy
529018|NCT00910481|Coronary Artery Disease|coronary artery disease
529019|NCT00910481|Percutaneous Transluminal Coronary Angioplasty|percutaneous transluminal coronary angioplasty
529020|NCT00910481|Intraaortic Balloon Pumping|intraaortic balloon pumping
529021|NCT00910481|Left Ventricular Dysfunction|left ventricular dysfunction
529022|NCT00910481|High Risk|high risk
529023|NCT00910455|Phase 1|phase 1
529024|NCT00910455|Safety|safety
529025|NCT00910455|Tolerability|tolerability
529026|NCT00910455|Pharmacokinetics|pharmacokinetics
529027|NCT00910429|Chronic thromboembolic Hypertension|chronic thromboembolic hypertension
529028|NCT00910429|PH|ph
529029|NCT00910429|soluble Guanylate Cyclase Stimulator|soluble guanylate cyclase stimulator
529030|NCT00910429|sGC|sgc
529031|NCT00910416|Anesthesia|anesthesia
529032|NCT00910416|Monitoring, Intraoperative|monitoring, intraoperative
529033|NCT00910416|Electroencephalography/*drug effects|electroencephalography/*drug effects
529034|NCT00910403|Presbyopia|presbyopia
529035|NCT00910403|LASIK|lasik
529036|NCT00910403|Hyperopes|hyperopes
529037|NCT00910390|IVF|ivf
529038|NCT00910390|embryo cryopreservation|embryo cryopreservation
529039|NCT00910390|vitrification|vitrification
529040|NCT00910390|Human Embryo|human embryo
529041|NCT00910390|Embryonic development|embryonic development
529042|NCT00910390|Pregnancy rate|pregnancy rate
529043|NCT00910377|breastfeeding|breastfeeding
529044|NCT00910377|exclusive breastfeeding|exclusive breastfeeding
529045|NCT00910377|lactation counseling|lactation counseling
529046|NCT00910377|teenagers|teenagers
529047|NCT00910377|complementary food|complementary food
529048|NCT00910377|adolescent|adolescent
529049|NCT00910377|caregivers|caregivers
529050|NCT00910364|Lower extremity DVT|lower extremity dvt
529051|NCT00910364|Clot|clot
529052|NCT00910364|leg clot|leg clot
529053|NCT00910364|Deep vein thrombosis|deep vein thrombosis
529054|NCT00910364|Thrombosis|thrombosis
529055|NCT00910364|Warfarin|warfarin
529056|NCT00910351|Cystic Fibrosis|cystic fibrosis
529057|NCT00910351|Pharmacokinetics|pharmacokinetics
529058|NCT00910351|Pediatrics|pediatrics
529059|NCT00910351|Inhalation|inhalation
529060|NCT00910351|Sputum|sputum
529061|NCT00910338|Pelvic Floor Muscle Training|pelvic floor muscle training
529062|NCT00910338|Extracorporeal Biofeedback|extracorporeal biofeedback
529063|NCT00910325|Female|female
529064|NCT00910325|Cholelithiasis|cholelithiasis
529065|NCT00910325|Natural Orifice Surgery|natural orifice surgery
529066|NCT00910325|Laparoscopic- Assisted|laparoscopic- assisted
529067|NCT00910325|Transvaginal|transvaginal
529068|NCT00910299|Clopidogrel|clopidogrel
529069|NCT00910299|VerifyNow|verifynow
529070|NCT00910299|PRU Measurements|pru measurements
529071|NCT00910299|Drug Eluting Stents (DES)|drug eluting stents (des)
529072|NCT00910299|Heart Disease|heart disease
529073|NCT00910299|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
529074|NCT00910299|P2Y12|p2y12
529075|NCT00910299|Platelets|platelets
529076|NCT00910299|Platelet Reactivity|platelet reactivity
529077|NCT00910286|Pressure support ventilation|pressure support ventilation
529078|NCT00910286|cycling off criteria|cycling off criteria
529079|NCT00910286|expiratory trigger|expiratory trigger
529080|NCT00910286|patient-ventilator interaction|patient-ventilator interaction
529081|NCT00910286|patient comfort|patient comfort
529082|NCT00910273|IMT evaluation in AS patients treated with etanercept|imt evaluation in as patients treated with etanercept
529083|NCT00910260|vitamin D level under phototherapy|vitamin d level under phototherapy
529084|NCT00910247|Seizures|seizures
529085|NCT00910247|Epilepsy|epilepsy
529086|NCT00910247|Anticonvulsant|anticonvulsant
529088|NCT00910247|Epilepsy with simple or complete partial onset seizures|epilepsy with simple or complete partial onset seizures
529089|NCT00910234|Periventricular leukomalacia (PVL)|periventricular leukomalacia (pvl)
529090|NCT00910234|Erythropoietin (EPO)|erythropoietin (epo)
529091|NCT00910234|Retinopathy of prematurity (ROP)|retinopathy of prematurity (rop)
529092|NCT00910234|Hypoxia-ischemia|hypoxia-ischemia
529093|NCT00910221|Cardiac surgery|cardiac surgery
529094|NCT00910221|Cardiopulmonary bypass|cardiopulmonary bypass
529095|NCT00910221|Oxidative stress|oxidative stress
529096|NCT00910221|Acute renal dysfunction|acute renal dysfunction
529097|NCT00910221|Atorvastatin|atorvastatin
529098|NCT00910208|Pain|pain
529099|NCT00910208|Analgesia|analgesia
529100|NCT00910208|Analgesia, Patient-controlled|analgesia, patient-controlled
529101|NCT00910208|Emergency Medicine|emergency medicine
529102|NCT00910195|Obstructive sleep apnea|obstructive sleep apnea
529103|NCT00910195|CPAP|cpap
529104|NCT00910195|Bi-Level|bi-level
529105|NCT00910182|Splenic rupture|splenic rupture
529106|NCT00910182|abdominal injuries|abdominal injuries
529107|NCT00910182|Surgery|surgery
529108|NCT00910182|Angiography|angiography
529109|NCT00910182|Embolisation|embolisation
529110|NCT00910182|Computed tomography|computed tomography
529111|NCT00910182|Classification|classification
529112|NCT00910169|Anorexia nervosa|anorexia nervosa
529113|NCT00910169|treatment|treatment
529114|NCT00910169|inpatient|inpatient
529115|NCT00910169|efficacy|efficacy
529116|NCT00910169|outcome|outcome
529117|NCT00910143|Rectal cancer|rectal cancer
529118|NCT00910143|Colorectal Surgery|colorectal surgery
529119|NCT00910143|Surgery|surgery
529120|NCT00910143|Local neoplasm recurrence|local neoplasm recurrence
529121|NCT00910143|survival|survival
529122|NCT00910143|Follow-up Study|follow-up study
529123|NCT00910130|Retinol Binding Protein 4|retinol binding protein 4
529124|NCT00910130|Insulin Resistance|insulin resistance
529125|NCT00910130|Diabetes|diabetes
529126|NCT00910130|End Stage Renal Disease|end stage renal disease
529127|NCT00910130|Dialysis|dialysis
529128|NCT00910130|Nutrition|nutrition
529129|NCT00910117|HNSCC|hnscc
529130|NCT00910117|induction chemotherapy|induction chemotherapy
529131|NCT00910117|nimotuzumab|nimotuzumab
529132|NCT00910104|PNALD|pnald
529133|NCT00910104|Omegaven|omegaven
529134|NCT00910104|Parenteral Nutrition Associated Liver Disease|parenteral nutrition associated liver disease
529135|NCT00910104|Cholestasis|cholestasis
529136|NCT00910104|Short Bowel Syndrome|short bowel syndrome
529137|NCT00910091|Endometrial cancer|endometrial cancer
529138|NCT00910091|Antitumour efficacy in women with advanced endometrial cancer|antitumour efficacy in women with advanced endometrial cancer
529139|NCT00910078|Total kappa and lambda ratio|total kappa and lambda ratio
529140|NCT00910078|Stem cell transplantation|stem cell transplantation
529141|NCT00910078|Serum immunofixation|serum immunofixation
529142|NCT00910065|Acute Coronary Syndrome|acute coronary syndrome
529143|NCT00910065|ACS|acs
529144|NCT00910065|Aspirin|aspirin
529145|NCT00910052|randomised|randomised
529146|NCT00910052|controlled|controlled
529147|NCT00910052|double blinded|double blinded
529148|NCT00910039|cognitive/functional effects|cognitive/functional effects
529149|NCT00910039|tumors metastatic to brain|tumors metastatic to brain
529150|NCT00910039|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
529151|NCT00910026|EBC and mechanical ventilation|ebc and mechanical ventilation
529152|NCT00910026|low tidal volume ventilation|low tidal volume ventilation
529153|NCT00910026|high tidal volume ventilation|high tidal volume ventilation
529154|NCT00910026|inflammatory and oxidative stress EBC biomarkers|inflammatory and oxidative stress ebc biomarkers
529155|NCT00910026|Ventilator induced lung injury|ventilator induced lung injury
529156|NCT00910013|TKR|tkr
529157|NCT00910013|Femoral block|femoral block
529158|NCT00910013|Ropivacaïne|ropivacaïne
529159|NCT00910013|intra-articular ropivacaïne|intra-articular ropivacaïne
529160|NCT00910013|post-operative analgesia|post-operative analgesia
529161|NCT00910000|carboplatin|carboplatin
529162|NCT00910000|gemcitabine|gemcitabine
529163|NCT00910000|vorinostat|vorinostat
529164|NCT00909987|rectum|rectum
529165|NCT00909987|intermediate risk cancer rectum|intermediate risk cancer rectum
529166|NCT00909987|neoadjuvant|neoadjuvant
529167|NCT00909974|multiple micronutrients|multiple micronutrients
529168|NCT00909974|energy deficiency|energy deficiency
529169|NCT00909961|Osteoporosis|osteoporosis
529170|NCT00909961|Bone Mineral Density|bone mineral density
529171|NCT00909961|Biomarkers|biomarkers
529172|NCT00909948|Related stem cell transplant,|related stem cell transplant,
529173|NCT00909948|TBI,|tbi,
529174|NCT00909948|Mismatched stem cell transplant|mismatched stem cell transplant
529175|NCT00909948|Fludarabine|fludarabine
529176|NCT00909948|Non-myeloablative|non-myeloablative
529177|NCT00909948|Lymphoma|lymphoma
529178|NCT00909948|Multiple myeloma|multiple myeloma
529179|NCT00909935|To determine pharmacokinetics of dexmedetomidine in children|to determine pharmacokinetics of dexmedetomidine in children
529180|NCT00909922|Amputation|amputation
529181|NCT00909922|Amputees|amputees
529182|NCT00909922|Artificial Limbs|artificial limbs
529183|NCT00909922|Leg Length Inequality|leg length inequality
529184|NCT00909922|Lower Extremity|lower extremity
529185|NCT00909922|Pelvis|pelvis
529186|NCT00909922|Posture|posture
529187|NCT00909922|Prostheses|prostheses
529188|NCT00909922|Range of Motion|range of motion
529189|NCT00909922|Trunk Muscles|trunk muscles
529190|NCT00909909|ductal breast carcinoma in situ|ductal breast carcinoma in situ
529191|NCT00909909|invasive ductal breast carcinoma|invasive ductal breast carcinoma
529192|NCT00909909|invasive lobular breast carcinoma|invasive lobular breast carcinoma
529193|NCT00909909|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
529194|NCT00909909|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
529195|NCT00909909|papillary ductal breast carcinoma|papillary ductal breast carcinoma
529196|NCT00909909|tubular ductal breast carcinoma|tubular ductal breast carcinoma
529197|NCT00909909|stage I breast cancer|stage i breast cancer
529198|NCT00909909|stage II breast cancer|stage ii breast cancer
529199|NCT00909909|stage IIIA breast cancer|stage iiia breast cancer
529200|NCT00909896|endometrial|endometrial
529201|NCT00909896|pain|pain
529202|NCT00909883|Idiopathic Parkinson's disease|idiopathic parkinson's disease
529203|NCT00909883|Foot (Tiptoe) dystonia|foot (tiptoe) dystonia
529204|NCT00909883|Botulinum Toxin|botulinum toxin
529205|NCT00909883|Muscles : Flexor digitorum longus/ Flexor digitorum brevis/ quadratus plantae|muscles : flexor digitorum longus/ flexor digitorum brevis/ quadratus plantae
529206|NCT00909870|Venous leg ulcer|venous leg ulcer
529207|NCT00909870|randomized trial|randomized trial
529208|NCT00909870|clinical trial|clinical trial
529209|NCT00909870|Dermagraft|dermagraft
529210|NCT00909870|compression therapy|compression therapy
529211|NCT00909870|surgical debridement|surgical debridement
529212|NCT00909870|venous stasis|venous stasis
529213|NCT00909870|chronic ulcer|chronic ulcer
529214|NCT00909870|chronic wound|chronic wound
529215|NCT00909870|fibroblasts|fibroblasts
529216|NCT00909857|Primary Dysmenorrhea|primary dysmenorrhea
529217|NCT00909857|Oral Contraception|oral contraception
529218|NCT00909831|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
529219|NCT00909805|dermabond glue|dermabond glue
529220|NCT00909805|suture|suture
529221|NCT00909805|children|children
529222|NCT00909779|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
529223|NCT00909779|respiratory|respiratory
529224|NCT00909779|long-acting beta agonist (LABA)|long-acting beta agonist (laba)
529225|NCT00909753|Bioequivalence|bioequivalence
529226|NCT00909753|Healthy Subjects|healthy subjects
529227|NCT00909740|Solid Tumor|solid tumor
529228|NCT00909740|Cancer|cancer
529229|NCT00909727|Fibrosis|fibrosis
529230|NCT00909727|Pancreatic Diseases|pancreatic diseases
529231|NCT00909727|Digestive System Diseases|digestive system diseases
529232|NCT00909727|Lung Diseases|lung diseases
529233|NCT00909727|Respiratory Tract Diseases|respiratory tract diseases
529234|NCT00909727|Genetic Diseases, Inborn|genetic diseases, inborn
529235|NCT00909727|Infant, Newborn, Diseases|infant, newborn, diseases
529236|NCT00909727|Pathologic Processes|pathologic processes
529237|NCT00909714|stroke|stroke
529238|NCT00909714|non-invasive cortical stimulation|non-invasive cortical stimulation
529239|NCT00909714|motor recovery|motor recovery
529240|NCT00909714|cortical plasticity|cortical plasticity
529241|NCT00909714|TDCS|tdcs
529242|NCT00909701|Dietary supplement|dietary supplement
529243|NCT00909701|healthy volunteers|healthy volunteers
529244|NCT00909701|Anaesthesia for surgery|anaesthesia for surgery
529245|NCT00909688|Healthy Subjects|healthy subjects
529246|NCT00909662|cognitive/functional effects|cognitive/functional effects
529247|NCT00909662|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
529248|NCT00909662|fatigue|fatigue
529249|NCT00909662|stage I breast cancer|stage i breast cancer
529250|NCT00909662|stage II breast cancer|stage ii breast cancer
529251|NCT00909662|stage IIIA breast cancer|stage iiia breast cancer
529252|NCT00909662|stage IIIB breast cancer|stage iiib breast cancer
529253|NCT00909662|stage IIIC breast cancer|stage iiic breast cancer
529254|NCT00909649|fibrin glue|fibrin glue
529255|NCT00909649|seroma|seroma
529256|NCT00909649|mastectomy|mastectomy
529257|NCT00909636|multiple ascending doses (MAD)|multiple ascending doses (mad)
529258|NCT00909610|Bioequivalence|bioequivalence
529259|NCT00909610|Healthy Subjects|healthy subjects
529260|NCT00909584|Hematology|hematology
529261|NCT00909584|Neutropenia|neutropenia
529262|NCT00909584|SCN|scn
529263|NCT00909584|Severe Chronic Neutropenia|severe chronic neutropenia
529264|NCT00909584|Idiopathic|idiopathic
529265|NCT00909584|Telintra|telintra
529266|NCT00909584|ezatiostat hydrochloride|ezatiostat hydrochloride
529267|NCT00909584|ezatiostat|ezatiostat
529268|NCT00909584|TLK199|tlk199
529269|NCT00909584|Glutathione|glutathione
529270|NCT00909584|Glutathione analog|glutathione analog
529271|NCT00909584|Glutathione Transferase|glutathione transferase
529272|NCT00909584|Glutathione Transferase inhibitor|glutathione transferase inhibitor
529273|NCT00909584|Glutathione Transferase P1-1 inhibitor|glutathione transferase p1-1 inhibitor
529274|NCT00909584|GSTp1-1 inhibitor|gstp1-1 inhibitor
529276|NCT00909584|Differentiation|differentiation
529277|NCT00909584|Enzyme inhibitor|enzyme inhibitor
529278|NCT00909571|FK506E|fk506e
529279|NCT00909571|MR4|mr4
529280|NCT00909571|Prograf|prograf
529281|NCT00909571|Tacrolimus|tacrolimus
529282|NCT00909571|Living Liver Transplantation|living liver transplantation
529283|NCT00909558|metastatic malignancies|metastatic malignancies
529284|NCT00909558|tumor markers|tumor markers
529285|NCT00909558|chemotherapy|chemotherapy
529286|NCT00909558|cancer|cancer
529287|NCT00909558|breast cancer|breast cancer
529288|NCT00909558|glioma|glioma
529289|NCT00909558|hepatocellular cancer|hepatocellular cancer
529290|NCT00909558|squamous cell lung cancer|squamous cell lung cancer
529291|NCT00909558|pancreatic cancer|pancreatic cancer
529292|NCT00909558|colon cancer|colon cancer
529293|NCT00909558|prostate cancer|prostate cancer
529294|NCT00909545|Early Parkinson disease|early parkinson disease
529295|NCT00909532|Fibrosis|fibrosis
529296|NCT00909532|Pancreatic Diseases|pancreatic diseases
529297|NCT00909532|Lung Diseases|lung diseases
529298|NCT00909532|Respiratory Tract Diseases|respiratory tract diseases
529299|NCT00909532|Genetic Diseases, Inborn|genetic diseases, inborn
529300|NCT00909532|Infant, Newborn, Diseases|infant, newborn, diseases
529301|NCT00909532|Pathologic Processes|pathologic processes
529302|NCT00909493|Improvement of patient care as measured by self-rated health and improve physician satisfaction with chronic pain management|improvement of patient care as measured by self-rated health and improve physician satisfaction with chronic pain management
529303|NCT00909454|Vitamin D deficiency|vitamin d deficiency
529304|NCT00909454|Adolescents|adolescents
529305|NCT00909454|African Americans|african americans
529306|NCT00909454|Overweight|overweight
529307|NCT00909454|Obesity|obesity
529308|NCT00909441|Breast Cancer|breast cancer
529309|NCT00909441|Node Positive Breast Cancer|node positive breast cancer
529310|NCT00909441|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
529311|NCT00909441|Breast Surgery|breast surgery
529312|NCT00909441|Axillary Lymph Node Dissection|axillary lymph node dissection
529313|NCT00909441|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
529314|NCT00909428|Bladder|bladder
529315|NCT00909428|Urinary Urgency|urinary urgency
529316|NCT00909428|Solifenacin|solifenacin
529317|NCT00909428|Vesicare(R)|vesicare(r)
529318|NCT00909415|patients with anorectal malformation|patients with anorectal malformation
529319|NCT00909376|Pregnancy|pregnancy
529320|NCT00909376|Ultrasonography|ultrasonography
529321|NCT00909376|outcome|outcome
529322|NCT00909376|adverse|adverse
529323|NCT00909350|Barrett's esophagus|barrett's esophagus
529324|NCT00909350|BE|be
529325|NCT00909350|esophageal adenocarcinoma|esophageal adenocarcinoma
529326|NCT00909350|Micro-RNA|micro-rna
529327|NCT00909350|miR expression|mir expression
529328|NCT00909324|Post LASIK dry eye|post lasik dry eye
529329|NCT00909324|Pre LASIK dry eye|pre lasik dry eye
529330|NCT00909324|Hypromellose|hypromellose
529331|NCT00909311|Food effect|food effect
529332|NCT00909298|Left ventricular assist devices|left ventricular assist devices
529333|NCT00909298|Cardiac Disease|cardiac disease
529334|NCT00909298|Heart Failure|heart failure
529335|NCT00909298|Anticoagulant for Left Ventricular Assist Devices|anticoagulant for left ventricular assist devices
529336|NCT00909285|Alzheimer|alzheimer
529337|NCT00909285|TMS|tms
529338|NCT00909285|cognitive training|cognitive training
529339|NCT00909272|ultrasound|ultrasound
529340|NCT00909272|diagnostic|diagnostic
529341|NCT00909272|lumbar|lumbar
529342|NCT00909272|median branch|median branch
529343|NCT00909272|block|block
529344|NCT00909272|Lumbar facet joint pain|lumbar facet joint pain
529345|NCT00909259|Sleep Disordered Breathing|sleep disordered breathing
529346|NCT00909259|Periodic Breathing|periodic breathing
529347|NCT00909259|Cheyne-Stokes Respiration|cheyne-stokes respiration
529348|NCT00909259|Sleep Apnea|sleep apnea
529349|NCT00909233|Erectile dysfunction,|erectile dysfunction,
529350|NCT00909233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors
529351|NCT00909220|Major Depressive Disorder, EEG, Negativity bias|major depressive disorder, eeg, negativity bias
529352|NCT00909207|Advanced Cancers|advanced cancers
529353|NCT00909207|Hematologic Disorders|hematologic disorders
529354|NCT00909207|Solid Tumors|solid tumors
529355|NCT00909207|Cognitive Interview|cognitive interview
529356|NCT00909207|Patient-Reported Outcomes|patient-reported outcomes
529357|NCT00909207|PRO|pro
529358|NCT00909207|Common Terminology Criteria for Adverse Events|common terminology criteria for adverse events
529359|NCT00909207|CTCAE|ctcae
529360|NCT00909207|PRO-CTCAE|pro-ctcae
529361|NCT00909207|Cancer Symptoms|cancer symptoms
529362|NCT00909207|Interview|interview
529363|NCT00909194|Juvenile Primary Fibromyalgia|juvenile primary fibromyalgia
529364|NCT00909194|Adolescents|adolescents
529365|NCT00909194|Psychiatry|psychiatry
529366|NCT00909168|Induction chemotherapy|induction chemotherapy
529367|NCT00909168|Fludarabine|fludarabine
529368|NCT00909168|Gemtuzumab Ozogamicin|gemtuzumab ozogamicin
529369|NCT00909155|Major Depressive Disorder|major depressive disorder
529370|NCT00909142|Breast cancer|breast cancer
529371|NCT00909142|Prostate cancer|prostate cancer
529372|NCT00909142|Multiple myeloma|multiple myeloma
529374|NCT00909129|Chronic hepatitis C|chronic hepatitis c
529375|NCT00909129|Immune activation|immune activation
529376|NCT00909129|HCV kinetics|hcv kinetics
529377|NCT00909129|IP-10|ip-10
529378|NCT00909116|ODS|ods
529379|NCT00909116|chronic constipation|chronic constipation
529380|NCT00909116|internal rectal prolapse|internal rectal prolapse
529381|NCT00909116|rectocele|rectocele
529382|NCT00909116|Stapled Transanal Rectal Resection|stapled transanal rectal resection
529383|NCT00909116|Contour Transtar|contour transtar
529384|NCT00909116|STARR|starr
529385|NCT00909103|Endoscopic Ultrasound Elastography|endoscopic ultrasound elastography
529386|NCT00909103|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
529387|NCT00909103|Chronic Pancreatitis|chronic pancreatitis
529388|NCT00909090|macular pigment|macular pigment
529389|NCT00909090|glare disability|glare disability
529390|NCT00909090|lutein|lutein
529391|NCT00909090|photostress|photostress
529392|NCT00909077|ITP-Rituximab-dexamethasone|itp-rituximab-dexamethasone
529393|NCT00909051|Diabetes Mellitus|diabetes mellitus
529394|NCT00909012|phenylketonuria|phenylketonuria
529395|NCT00909012|docosahexaenoic acid|docosahexaenoic acid
529396|NCT00909012|visually evoked potential|visually evoked potential
529397|NCT00909012|choice-reaction time|choice-reaction time
529398|NCT00908999|anosognosia fMRI amnestic MCI Alzheimer|anosognosia fmri amnestic mci alzheimer
529399|NCT00908999|anosognosia in AD and MCI|anosognosia in ad and mci
529400|NCT00908986|Lupus Membranous Nephritis|lupus membranous nephritis
529401|NCT00908973|Obesity|obesity
529402|NCT00908973|Gastric bypass|gastric bypass
529403|NCT00908973|Gut hormone|gut hormone
529404|NCT00908973|Intestinal transit time|intestinal transit time
529405|NCT00908960|enoxaparin|enoxaparin
529406|NCT00908947|SFA|sfa
529407|NCT00908947|Stent|stent
529408|NCT00908947|Popliteal|popliteal
529409|NCT00908947|infrainguinal|infrainguinal
529410|NCT00908947|LifeStent|lifestent
529411|NCT00908947|Peripheral|peripheral
529412|NCT00908947|Arterial|arterial
529413|NCT00908934|Relative Bioavailability|relative bioavailability
529414|NCT00908934|AZD9056|azd9056
529415|NCT00908908|Advanced Solid Tumors|advanced solid tumors
529416|NCT00908908|Failure of Multiple Prior Chemotherapy Regimens|failure of multiple prior chemotherapy regimens
529417|NCT00908895|Radius fractures|radius fractures
529418|NCT00908895|Radio-radial fixator|radio-radial fixator
529419|NCT00908895|Percutaneous pinning|percutaneous pinning
529420|NCT00908895|Grip strength|grip strength
529421|NCT00908882|Nursing Care|nursing care
529422|NCT00908882|Veterans|veterans
529423|NCT00908869|advanced neoplasm|advanced neoplasm
529424|NCT00908869|adult advanced neoplasm|adult advanced neoplasm
529425|NCT00908856|stroke cell therapy repair autologous|stroke cell therapy repair autologous
529426|NCT00908843|Contrast nephropathy|contrast nephropathy
529427|NCT00908843|Renal failure|renal failure
529428|NCT00908817|postoperative sore throat|postoperative sore throat
529429|NCT00908817|tracheal intubation|tracheal intubation
529430|NCT00908817|lubrication|lubrication
529431|NCT00908817|triamcinolone|triamcinolone
529432|NCT00908804|acute appendicitis|acute appendicitis
529433|NCT00908791|Conjugated Linoleic Acid|conjugated linoleic acid
529434|NCT00908791|Proof of Principle|proof of principle
529435|NCT00908791|Lipogenic Pathway|lipogenic pathway
529436|NCT00908791|Clarinol|clarinol
529437|NCT00908778|Diabetic Retinopathy|diabetic retinopathy
529438|NCT00908765|Exercise Training COPD|exercise training copd
529439|NCT00908752|HCC|hcc
529440|NCT00908739|stage I renal cell cancer|stage i renal cell cancer
529441|NCT00908739|stage III renal cell cancer|stage iii renal cell cancer
529442|NCT00908739|recurrent renal cell cancer|recurrent renal cell cancer
529443|NCT00908739|clear cell renal cell carcinoma|clear cell renal cell carcinoma
529444|NCT00908739|childhood renal cell carcinoma|childhood renal cell carcinoma
529445|NCT00908713|Severe CAP|severe cap
529446|NCT00908713|Adjuvant therapy|adjuvant therapy
529447|NCT00908713|Glucocorticoids|glucocorticoids
529448|NCT00908713|CAP Fine V with C-reactive protein >= 15 mg/100 mL|cap fine v with c-reactive protein >= 15 mg/100 ml
529449|NCT00908700|Atrial fibrillation|atrial fibrillation
529450|NCT00908700|Stroke|stroke
529451|NCT00908700|left atrial appendage|left atrial appendage
529452|NCT00908700|Re-exploration for bleeding|re-exploration for bleeding
529453|NCT00908661|Parastomal, hernia|parastomal, hernia
529454|NCT00908648|screening colonoscopy|screening colonoscopy
529455|NCT00908648|narrow band imaging|narrow band imaging
529456|NCT00908635|sepsis|sepsis
529457|NCT00908635|organ failure|organ failure
529458|NCT00908622|Percutaneous implantation of autologous myoblasts|percutaneous implantation of autologous myoblasts
529459|NCT00908609|Breast Cancer Diagnosis|breast cancer diagnosis
529460|NCT00908609|Optical Imaging|optical imaging
529461|NCT00908609|Ultrasound Imaging|ultrasound imaging
529462|NCT00908609|Monitoring Neoadjuvant Chemotherapy Response|monitoring neoadjuvant chemotherapy response
529463|NCT00908596|Nephrogenic Systemic Fibrosis (NSF)|nephrogenic systemic fibrosis (nsf)
529464|NCT00908596|Primovist / Eovist|primovist / eovist
529465|NCT00908583|Alloantibody|alloantibody
529466|NCT00908583|Desensitization|desensitization
529467|NCT00908583|Kidney Transplantation|kidney transplantation
529469|NCT00908583|Plasma Cells|plasma cells
529470|NCT00908583|Translational Research/Science|translational research/science
529471|NCT00908570|estrogen|estrogen
529472|NCT00908570|estriol|estriol
529473|NCT00908570|cream|cream
529474|NCT00908570|vagina|vagina
529475|NCT00908570|infection prevention|infection prevention
529476|NCT00908557|Lexicosyntactic readability improvement|lexicosyntactic readability improvement
529477|NCT00908557|phase II/III trials|phase ii/iii trials
529478|NCT00908557|ethic|ethic
529479|NCT00908557|Informed consent|informed consent
529480|NCT00908544|HIV-infection|hiv-infection
529481|NCT00908544|Primary HIV-infection|primary hiv-infection
529482|NCT00908544|Proviral DNA|proviral dna
529483|NCT00908544|Eradication|eradication
529484|NCT00908544|Multi drug class HAART|multi drug class haart
529485|NCT00908531|Breast neoplasms|breast neoplasms
529486|NCT00908531|Randomised trial|randomised trial
529487|NCT00908531|Aromatase Inhibitors|aromatase inhibitors
529488|NCT00908531|Preoperative care|preoperative care
529489|NCT00908531|Age 60 or older|age 60 or older
529490|NCT00908531|Hormone receptor positive tumor|hormone receptor positive tumor
529491|NCT00908531|Tumor lager than 2 cm|tumor lager than 2 cm
529492|NCT00908531|No distant metastasis|no distant metastasis
529493|NCT00908518|Cognitive dysfunction|cognitive dysfunction
529494|NCT00908518|Cardiac morbidity|cardiac morbidity
529495|NCT00908518|anesthesia|anesthesia
529496|NCT00908505|Cystic fibrosis|cystic fibrosis
529497|NCT00908505|physiotherapy|physiotherapy
529498|NCT00908505|pulmonary function test|pulmonary function test
529499|NCT00908492|Randomized control trial|randomized control trial
529500|NCT00908492|Dementia caregivers|dementia caregivers
529501|NCT00908492|Occupational Therapy|occupational therapy
529502|NCT00908492|Caregivers|caregivers
529503|NCT00908479|Exercise|exercise
529504|NCT00908479|Rehabilitation|rehabilitation
529505|NCT00908479|leg function|leg function
529506|NCT00908479|in patient|in patient
529507|NCT00908479|RCT|rct
529508|NCT00908466|Non-infectious|non-infectious
529509|NCT00908466|Uveitis|uveitis
529510|NCT00908466|Panuveitis|panuveitis
529511|NCT00908453|NPC-06|npc-06
529512|NCT00908453|fosphenytoin|fosphenytoin
529513|NCT00908453|phenytoin|phenytoin
529514|NCT00908453|pharmacokinetics|pharmacokinetics
529515|NCT00908453|safety|safety
529516|NCT00908440|Decision Aid|decision aid
529517|NCT00908440|Posttraumatic Stress Disorder|posttraumatic stress disorder
529518|NCT00908440|evidence-based treatments|evidence-based treatments
529519|NCT00908427|benign prostatic hyperplasia|benign prostatic hyperplasia
529520|NCT00908427|KTP laser|ktp laser
529521|NCT00908427|transurethral resection of prostate|transurethral resection of prostate
529522|NCT00908427|urinary bladder neck obstruction|urinary bladder neck obstruction
529523|NCT00908414|PEPI-TiDP23-C104|pepi-tidp23-c104
529524|NCT00908414|PEPI-C104|pepi-c104
529525|NCT00908414|PEPI|pepi
529526|NCT00908414|TMC589337|tmc589337
529527|NCT00908414|TMC589354|tmc589354
529528|NCT00908414|TMC310911|tmc310911
529529|NCT00908414|Healthy Volunteers|healthy volunteers
529530|NCT00908401|breastmilk|breastmilk
529531|NCT00908401|oral sucrose|oral sucrose
529532|NCT00908401|analgesia|analgesia
529533|NCT00908401|preterm neonates|preterm neonates
529534|NCT00908401|Neonates|neonates
529535|NCT00908388|Acute, Complicated Type B Dissection|acute, complicated type b dissection
529536|NCT00908375|Pregabalin|pregabalin
529537|NCT00908375|Radicular pain|radicular pain
529538|NCT00908375|Failed back surgery|failed back surgery
529539|NCT00908375|Of greater than 3 months duration|of greater than 3 months duration
529540|NCT00908362|Dendritic cells|dendritic cells
529541|NCT00908362|Airway|airway
529542|NCT00908362|Smoker|smoker
529543|NCT00908362|COPD|copd
529544|NCT00908336|Adenocarcinoma|adenocarcinoma
529545|NCT00908336|Carcinoma, Non-Small Cell|carcinoma, non-small cell
529546|NCT00908336|Lung Neoplasms|lung neoplasms
529547|NCT00908336|Docetaxel|docetaxel
529548|NCT00908336|Erlotinib|erlotinib
529549|NCT00908336|Chemotherapy|chemotherapy
529550|NCT00908323|HIV Seronegativity|hiv seronegativity
529551|NCT00908323|HIV Preventive Vaccine|hiv preventive vaccine
529552|NCT00908310|CKD - Chronic Kidney Disease|ckd - chronic kidney disease
529553|NCT00908310|GBCA - Gadolinium-based contrast agent|gbca - gadolinium-based contrast agent
529554|NCT00908310|GFR - Glomerular Filtration Rate|gfr - glomerular filtration rate
529555|NCT00908310|MRI - Magnetic Resonance Imaging|mri - magnetic resonance imaging
529556|NCT00908310|NSF - Nephrogenic Systemic Fibrosis|nsf - nephrogenic systemic fibrosis
529557|NCT00908310|Known or suspected CKD with an eGFR greater than or equal to 30mL & less than 60 mL/min/1.73m2 as measured within 30 days prior to the OMNISCAN.|known or suspected ckd with an egfr greater than or equal to 30ml & less than 60 ml/min/1.73m2 as measured within 30 days prior to the omniscan.
529558|NCT00908297|Cardiovascular disease|cardiovascular disease
529559|NCT00908297|End stage renal disease|end stage renal disease
529560|NCT00908297|Atherosclerosis|atherosclerosis
529561|NCT00908297|Oxidative stress|oxidative stress
529562|NCT00908297|Antioxidants|antioxidants
529563|NCT00908284|AIDS|aids
529564|NCT00908284|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
529565|NCT00908284|Human Immunodeficiency Virus|human immunodeficiency virus
529566|NCT00908284|Exercise Physiology|exercise physiology
529567|NCT00908284|Endothelial Dysfunction|endothelial dysfunction
529568|NCT00908245|Preconditioning|preconditioning
529569|NCT00908245|Hepatectomy|hepatectomy
529570|NCT00908245|Clamping|clamping
529571|NCT00908232|multiple myeloma|multiple myeloma
529572|NCT00908232|bortezomib|bortezomib
529573|NCT00908232|hematology|hematology
529574|NCT00908232|bone marrow cancer|bone marrow cancer
529575|NCT00908232|immunoglobulin|immunoglobulin
529576|NCT00908232|refractory|refractory
529577|NCT00908232|progression|progression
529578|NCT00908232|dexamethasone|dexamethasone
529579|NCT00908232|lenalidomide|lenalidomide
529580|NCT00908232|cyclophosphamide|cyclophosphamide
529581|NCT00908219|malignant ascites|malignant ascites
529582|NCT00908219|bevacizumab|bevacizumab
529583|NCT00908219|vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
529584|NCT00908219|paracentesis|paracentesis
529585|NCT00908206|Alcoholism|alcoholism
529586|NCT00908206|Craving|craving
529587|NCT00908206|Dependence|dependence
529588|NCT00908206|Alcohol|alcohol
529589|NCT00908193|Treatment of abdominal ruptured|treatment of abdominal ruptured
529590|NCT00908193|Digestive system disease|digestive system disease
529591|NCT00908193|Coelioscopy|coelioscopy
529592|NCT00908193|Assistance robotics|assistance robotics
529593|NCT00908193|Medical device|medical device
529594|NCT00908193|DA VINCI Robot|da vinci robot
529595|NCT00908193|Pain patient|pain patient
529596|NCT00908193|Morphine consumption|morphine consumption
529597|NCT00908193|Comparative Randomized study|comparative randomized study
529598|NCT00908193|patient over 18 years|patient over 18 years
529599|NCT00908193|with ruptured abdominal|with ruptured abdominal
529600|NCT00908193|with an indication of treatment of ruptured|with an indication of treatment of ruptured
529601|NCT00908180|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
529602|NCT00908167|sorafenib|sorafenib
529603|NCT00908167|cytarabine|cytarabine
529604|NCT00908167|clofarabine|clofarabine
529605|NCT00908167|acute myeloid leukemia|acute myeloid leukemia
529606|NCT00908167|acute promyelocytic leukemia|acute promyelocytic leukemia
529607|NCT00908167|acute lymphoblastic leukemia|acute lymphoblastic leukemia
529608|NCT00908154|sodium channel blocker|sodium channel blocker
529609|NCT00908154|bipolar disorder|bipolar disorder
529610|NCT00908154|repeat dose|repeat dose
529611|NCT00908141|adenocarcinoma of the prostate|adenocarcinoma of the prostate
529612|NCT00908141|recurrent prostate cancer|recurrent prostate cancer
529613|NCT00908128|Bioequivalence|bioequivalence
529614|NCT00908128|Healthy Subjects|healthy subjects
529615|NCT00908102|low back pain|low back pain
529616|NCT00908102|recurrent|recurrent
529617|NCT00908102|subacute|subacute
529618|NCT00908102|secondary prevention|secondary prevention
529619|NCT00908102|primary care|primary care
529620|NCT00908102|occupational health|occupational health
529621|NCT00908102|back book|back book
529622|NCT00908102|rehabilitation|rehabilitation
529623|NCT00908089|rheumatoid arthritis|rheumatoid arthritis
529624|NCT00908089|methotrexate|methotrexate
529625|NCT00908089|sulfasalazine|sulfasalazine
529626|NCT00908089|hydroxychloroquine|hydroxychloroquine
529627|NCT00908089|infliximab|infliximab
529628|NCT00908076|constipation|constipation
529629|NCT00908076|Parkinson's disease|parkinson's disease
529630|NCT00908063|TBI|tbi
529631|NCT00908063|Traumatic Brain Injury|traumatic brain injury
529632|NCT00908050|bruxism, botulinum toxin, sleep study|bruxism, botulinum toxin, sleep study
529633|NCT00908037|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
529634|NCT00908037|ITP|itp
529635|NCT00908037|pharmacokinetics|pharmacokinetics
529636|NCT00908037|chronic ITP|chronic itp
529637|NCT00908037|eltrombopag|eltrombopag
529638|NCT00908037|thrombocytopenia|thrombocytopenia
529639|NCT00908037|pharmacodynamics|pharmacodynamics
529640|NCT00908037|pediatrics|pediatrics
529641|NCT00908011|Hypercholesterolemia|hypercholesterolemia
529642|NCT00908011|HIV|hiv
529643|NCT00908011|Ezetimibe|ezetimibe
529644|NCT00908011|Statin|statin
529645|NCT00908011|Apolipoprotein B100/Apolipoprotein A1 ratio|apolipoprotein b100/apolipoprotein a1 ratio
529646|NCT00907998|Coronary heart disease|coronary heart disease
529647|NCT00907998|APL180|apl180
529648|NCT00907985|Healthy Volunteer|healthy volunteer
529649|NCT00907985|Resting motor threshold (rMT)|resting motor threshold (rmt)
529650|NCT00907985|Transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
529651|NCT00907972|Parkinson's Disease|parkinson's disease
529652|NCT00907972|Parkinson Disease|parkinson disease
529653|NCT00907972|PD|pd
529654|NCT00907972|Movement Disorder|movement disorder
529655|NCT00907946|Renal stones|renal stones
529656|NCT00907907|Bioequivalence|bioequivalence
529657|NCT00907907|Subjects|subjects
529658|NCT00907894|Chronic hepatitis B,|chronic hepatitis b,
529659|NCT00907894|telbivudine,|telbivudine,
529660|NCT00907894|pharmacokinetics,|pharmacokinetics,
529661|NCT00907894|safety,|safety,
529662|NCT00907894|tolerability,|tolerability,
529663|NCT00907894|pediatric|pediatric
529664|NCT00907868|ductal breast carcinoma in situ|ductal breast carcinoma in situ
529665|NCT00907855|Ischemic Heart Disease|ischemic heart disease
529666|NCT00907855|Duke Activity Status Index|duke activity status index
529667|NCT00907855|Stress Myocardial Perfusion Imaging|stress myocardial perfusion imaging
529668|NCT00907842|stoma|stoma
529669|NCT00907829|stroke|stroke
529670|NCT00907829|fingertip force|fingertip force
529671|NCT00907829|muscle coordination|muscle coordination
529672|NCT00907816|this study does not look at patient conditions|this study does not look at patient conditions
529673|NCT00907803|Orthopoxvirus|orthopoxvirus
529674|NCT00907803|Smallpox|smallpox
529675|NCT00907803|This is a safety study only|this is a safety study only
529676|NCT00907803|ST-246 is being studied for treatment of Orthopoxviruses|st-246 is being studied for treatment of orthopoxviruses
529677|NCT00907790|Irritable Bowel Syndrome|irritable bowel syndrome
529678|NCT00907790|Cognitive Therapy|cognitive therapy
529679|NCT00907790|Abdominal Pain|abdominal pain
529680|NCT00907790|Quality of Life|quality of life
529681|NCT00907777|Haemophilus influenzae|haemophilus influenzae
529682|NCT00907777|Streptococcus pneumoniae|streptococcus pneumoniae
529683|NCT00907777|safety|safety
529684|NCT00907777|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
529685|NCT00907777|immunogenicity|immunogenicity
529686|NCT00907725|medical abortion|medical abortion
529687|NCT00907725|serum BhCG follow-up|serum bhcg follow-up
529688|NCT00907725|ultrasonographic follow-up|ultrasonographic follow-up
529689|NCT00907725|follow-up methods|follow-up methods
529690|NCT00907712|amputation|amputation
529691|NCT00907712|vascular|vascular
529692|NCT00907712|below knee|below knee
529693|NCT00907712|above knee|above knee
529694|NCT00907712|cardiovascular|cardiovascular
529695|NCT00907712|echo|echo
529696|NCT00907712|cardiovascular assessment|cardiovascular assessment
529697|NCT00907699|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
529698|NCT00907699|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
529699|NCT00907699|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
529700|NCT00907686|Transfusion Transmitted Cytomegalovirus (TT-CMV)|transfusion transmitted cytomegalovirus (tt-cmv)
529701|NCT00907686|Low birthweight infants (LBWIs)|low birthweight infants (lbwis)
529702|NCT00907686|Leukoreduction and filter failure|leukoreduction and filter failure
529703|NCT00907686|CMV Seronegative blood products|cmv seronegative blood products
529704|NCT00907660|Obesity|obesity
529705|NCT00907660|Weight loss|weight loss
529706|NCT00907660|Meal replacements|meal replacements
529707|NCT00907660|Health services research|health services research
529708|NCT00907634|cervix|cervix
529709|NCT00907634|cervical|cervical
529710|NCT00907634|radiation|radiation
529711|NCT00907621|Infant Colic|infant colic
529712|NCT00907621|Acupuncture|acupuncture
529713|NCT00907621|General Practice|general practice
529714|NCT00907595|Huntington's chorea|huntington's chorea
529715|NCT00907595|Huntington's Disease|huntington's disease
529716|NCT00907595|Parkinson's Disease|parkinson's disease
529717|NCT00907595|Parkinsonism|parkinsonism
529718|NCT00907595|Dementia|dementia
529719|NCT00907595|Dementia with Lewy Bodies|dementia with lewy bodies
529720|NCT00907595|Actigraphy|actigraphy
529721|NCT00907595|Circadian dysregulation|circadian dysregulation
529722|NCT00907595|Sleep Disorders|sleep disorders
529723|NCT00907595|Circadian rhythm|circadian rhythm
529724|NCT00907582|PCR negative|pcr negative
529725|NCT00907569|Small cell lung cancer|small cell lung cancer
529726|NCT00907569|radiotherapy dose escalation|radiotherapy dose escalation
529727|NCT00907543|esophageal carcinoma|esophageal carcinoma
529728|NCT00907543|chemotherapy|chemotherapy
529729|NCT00907543|radiation|radiation
529730|NCT00907543|surgery|surgery
529731|NCT00907543|randomized clinical trial|randomized clinical trial
529732|NCT00907543|Clinical Trial|clinical trial
529733|NCT00907543|Radiotherapy|radiotherapy
529734|NCT00907491|Cough|cough
529735|NCT00907491|Wheeze Rate|wheeze rate
529736|NCT00907491|Respiratory Function Tests|respiratory function tests
529737|NCT00907478|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
529738|NCT00907478|Idiopathic Thrombocytopenia Purpura|idiopathic thrombocytopenia purpura
529739|NCT00907478|Immune Thrombocytopenic Purpura|immune thrombocytopenic purpura
529740|NCT00907478|Immune Thrombocytopenia|immune thrombocytopenia
529741|NCT00907478|ITP|itp
529742|NCT00907452|Pharmacogenomics|pharmacogenomics
529743|NCT00907452|prediction response|prediction response
529744|NCT00907452|prediction adverse event|prediction adverse event
529745|NCT00907439|Diastole, physiopathology|diastole, physiopathology
529746|NCT00907439|coronary artery disease|coronary artery disease
529747|NCT00907439|volatile anesthetic|volatile anesthetic
529748|NCT00907439|sevoflurane|sevoflurane
529749|NCT00907426|eyelashes|eyelashes
529750|NCT00907413|cancer|cancer
529751|NCT00907413|bile duct|bile duct
529752|NCT00907400|Phase 1|phase 1
529753|NCT00907400|Healthy Volunteer|healthy volunteer
529754|NCT00907400|Healthy Volunteer Study|healthy volunteer study
529755|NCT00907387|Lateral Canthal Lines|lateral canthal lines
529756|NCT00907387|Crow's Feet|crow's feet
529757|NCT00907387|Facial Wrinkles|facial wrinkles
529758|NCT00907374|Microalbuminuria|microalbuminuria
529759|NCT00907374|Carotid intima media thickness|carotid intima media thickness
529760|NCT00907374|Endothelial dysfunction|endothelial dysfunction
529761|NCT00907374|Renin angiotensin system|renin angiotensin system
529762|NCT00907374|Diabetic nephropathy|diabetic nephropathy
529763|NCT00907361|pacemaker|pacemaker
529764|NCT00907361|ICD|icd
529765|NCT00907361|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
529766|NCT00907361|MRI|mri
529767|NCT00907361|Magnetic Resonance Imaging|magnetic resonance imaging
529768|NCT00907348|NHL|nhl
529769|NCT00907348|Non Hodgkin Lymphoma|non hodgkin lymphoma
529770|NCT00907348|Follicular Lymphoma|follicular lymphoma
529771|NCT00907335|acne|acne
529772|NCT00907335|irritation|irritation
529773|NCT00907335|objective sensory methods|objective sensory methods
529774|NCT00907322|oral, single ascending doses; CYP2D6 metabolizer status; healthy subjects; safety, tolerability, pharmacokinetics|oral, single ascending doses; cyp2d6 metabolizer status; healthy subjects; safety, tolerability, pharmacokinetics
529775|NCT00907309|alcohol abuse|alcohol abuse
529776|NCT00907309|marijuana abuse|marijuana abuse
529777|NCT00907309|drug abuse|drug abuse
529778|NCT00907309|tobacco use|tobacco use
529779|NCT00907309|tobacco dependence|tobacco dependence
529780|NCT00907296|Fracture Healing|fracture healing
529781|NCT00907296|Tibial Diaphyseal Fracture|tibial diaphyseal fracture
529782|NCT00907283|NBIA|nbia
529783|NCT00907283|Iron overload AND brain|iron overload and brain
529784|NCT00907283|Iron chelation AND neurodegeneration|iron chelation and neurodegeneration
529785|NCT00907283|Brain iron Overload|brain iron overload
529786|NCT00907283|Neurodegeneration|neurodegeneration
529787|NCT00907283|Brain iron Accumulation|brain iron accumulation
529788|NCT00907257|acne|acne
529789|NCT00907257|irritation|irritation
529790|NCT00907257|objective sensory methods|objective sensory methods
529791|NCT00907218|ADHD|adhd
529792|NCT00907218|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
529793|NCT00907218|ADHD medication|adhd medication
529794|NCT00907218|Chantix|chantix
529795|NCT00907218|varenicline|varenicline
529796|NCT00907218|smoking|smoking
529797|NCT00907218|smoking cessation|smoking cessation
529798|NCT00907218|quit smoking|quit smoking
529799|NCT00907205|Advanced Solid Tumors|advanced solid tumors
529800|NCT00907205|Metastatic Solid Tumors|metastatic solid tumors
529801|NCT00907205|PI3K|pi3k
529802|NCT00907205|PI3K Inhibitors|pi3k inhibitors
529803|NCT00907205|PI3 Kinase Inhibitors|pi3 kinase inhibitors
529804|NCT00907205|mTORC inhibitor|mtorc inhibitor
529805|NCT00907205|mTORC1 inhibitor|mtorc1 inhibitor
529806|NCT00907205|mTORC2 inhibitor|mtorc2 inhibitor
529807|NCT00907205|vascular targeted|vascular targeted
529808|NCT00907205|conjugate|conjugate
529809|NCT00907192|Cancer|cancer
529810|NCT00907192|Opioid analgesic prescriptions|opioid analgesic prescriptions
529811|NCT00907192|Narcotic pain drugs|narcotic pain drugs
529812|NCT00907192|Self-report|self-report
529813|NCT00907192|Questionnaire|questionnaire
529814|NCT00907192|Interview|interview
529815|NCT00907192|Actual use|actual use
529816|NCT00907192|Doctor-prescribed use|doctor-prescribed use
529817|NCT00907192|Frequency of deviation|frequency of deviation
529818|NCT00907166|Cornerstone Pharmaceuticals, Inc.|cornerstone pharmaceuticals, inc.
529819|NCT00907166|CPI-613|cpi-613
529820|NCT00907166|Altered Energy Metabolism Directed Compound|altered energy metabolism directed compound
529821|NCT00907166|Phase I|phase i
529822|NCT00907166|Phase II|phase ii
529823|NCT00907166|Cancer|cancer
529824|NCT00907166|Carcinoma of the Pancreas|carcinoma of the pancreas
529825|NCT00907166|Pancreatic Cancer|pancreatic cancer
529826|NCT00907166|Pancreatic Carcinoma|pancreatic carcinoma
529827|NCT00907153|Polycystic Ovary Syndrome|polycystic ovary syndrome
529828|NCT00907153|Vitamin D|vitamin d
529829|NCT00907153|Insulin resistance|insulin resistance
529830|NCT00907153|Inflammation|inflammation
529831|NCT00907140|Cervical Cancer|cervical cancer
529832|NCT00907140|Positron Emission Tomography|positron emission tomography
529833|NCT00907140|Fluorodeoxyglucose|fluorodeoxyglucose
529834|NCT00907127|Metabolic|metabolic
529835|NCT00907127|Syndrome|syndrome
529836|NCT00907127|CAN|can
529837|NCT00907114|proliferative diabetic retinopathy|proliferative diabetic retinopathy
529838|NCT00907114|macular edema|macular edema
529839|NCT00907114|panphotocoagulation|panphotocoagulation
529840|NCT00907114|topic ketorolac|topic ketorolac
529841|NCT00907114|efficacy|efficacy
529842|NCT00907114|treatment|treatment
529843|NCT00907088|Iron depletion|iron depletion
529844|NCT00907088|Children|children
529845|NCT00907088|Educational intervention|educational intervention
529846|NCT00907088|Office-based|office-based
529847|NCT00907075|diabetes|diabetes
529848|NCT00907075|nutrition|nutrition
529849|NCT00907075|diet|diet
529850|NCT00907075|foods|foods
529851|NCT00907062|vitiligo|vitiligo
529852|NCT00907062|leucoderma|leucoderma
529853|NCT00907049|quality of sleep|quality of sleep
529854|NCT00907049|neck pain|neck pain
529855|NCT00907049|disability|disability
529856|NCT00907049|catastrophizing|catastrophizing
529857|NCT00907049|depression|depression
529858|NCT00907036|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
529859|NCT00907023|solid organ transplant|solid organ transplant
529860|NCT00907023|hospital discharge|hospital discharge
529861|NCT00907010|Ageing|ageing
529862|NCT00907010|Sarcopenia|sarcopenia
529863|NCT00907010|Muscular contraction|muscular contraction
529864|NCT00906997|Colorectal cancer|colorectal cancer
529865|NCT00906997|Screening|screening
529866|NCT00906997|Prevention|prevention
529867|NCT00906997|Fecal occult blood test|fecal occult blood test
529868|NCT00906997|Colonoscopy|colonoscopy
529869|NCT00906997|Colorectal neoplasm|colorectal neoplasm
529870|NCT00906997|Randomized clinical trial|randomized clinical trial
529871|NCT00906984|Hepatocellular carcinoma|hepatocellular carcinoma
529872|NCT00906984|Liver cancer|liver cancer
529873|NCT00906984|Primary liver cancer|primary liver cancer
529874|NCT00906984|Unresectable liver cancer|unresectable liver cancer
529875|NCT00906984|Unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
529876|NCT00906984|TheraSphere|therasphere
529877|NCT00906971|Physical Therapy|physical therapy
529878|NCT00906971|Chronic Functional Constipation|chronic functional constipation
529879|NCT00906971|Children|children
529880|NCT00906945|stem cell mobilization|stem cell mobilization
529881|NCT00906945|chemosensitization|chemosensitization
529882|NCT00906945|CXCR4|cxcr4
529883|NCT00906945|SDF-1|sdf-1
529884|NCT00906945|CXCL-12|cxcl-12
529885|NCT00906932|Fiberoptic intubation|fiberoptic intubation
529886|NCT00906932|direct laryngoscopy|direct laryngoscopy
529887|NCT00906932|Trachview|trachview
529888|NCT00906932|Comparison of a fiberoptic intubating videoscope to direct laryngoscopy.|comparison of a fiberoptic intubating videoscope to direct laryngoscopy.
529889|NCT00906919|self-efficacy|self-efficacy
529890|NCT00906919|health behavior|health behavior
529891|NCT00906919|patient education|patient education
529892|NCT00906919|health education|health education
529893|NCT00906893|[18F]-FMISO uptake|[18f]-fmiso uptake
529894|NCT00906893|Glioblastoma|glioblastoma
529895|NCT00906893|Hypoxia|hypoxia
529896|NCT00906893|tumours|tumours
529897|NCT00906880|Human African Trypanosomiasis|human african trypanosomiasis
529898|NCT00906880|HAT|hat
529899|NCT00906880|sleeping sickness|sleeping sickness
529900|NCT00906880|combination treatment|combination treatment
529901|NCT00906880|nifurtimox|nifurtimox
529902|NCT00906880|eflornithine|eflornithine
529903|NCT00906880|Human African Trypanosomiasis in the meningo-encephalitic phase (stage 2 HAT)|human african trypanosomiasis in the meningo-encephalitic phase (stage 2 hat)
529904|NCT00906867|Vocal cord dysfunction|vocal cord dysfunction
529905|NCT00906867|Laryngoscopy|laryngoscopy
529906|NCT00906867|Methacholine challenge|methacholine challenge
529907|NCT00906867|Pulmonary function testing|pulmonary function testing
529908|NCT00906854|urinary incontinence|urinary incontinence
529909|NCT00906854|physical exercise|physical exercise
529910|NCT00906841|Disseminated diffuse large B-cell lymphoma|disseminated diffuse large b-cell lymphoma
529911|NCT00906841|first line treatment|first line treatment
529912|NCT00906841|R CHOP|r chop
529913|NCT00906841|90Y-DOTA-hLL2|90y-dota-hll2
529914|NCT00906841|Patients older than 60 years|patients older than 60 years
529915|NCT00906828|Levodopa/carbidopa infusion|levodopa/carbidopa infusion
529916|NCT00906828|entacapone|entacapone
529917|NCT00906828|tolcapone|tolcapone
529918|NCT00906828|efficacy|efficacy
529919|NCT00906828|pharmacokinetic|pharmacokinetic
529920|NCT00906828|pharmacodynamics|pharmacodynamics
529921|NCT00906802|pancreaticoduodenectomy|pancreaticoduodenectomy
529922|NCT00906802|reconstruction|reconstruction
529923|NCT00906789|Lung Cancer|lung cancer
529924|NCT00906789|Chest Radiograph|chest radiograph
529925|NCT00906789|Computer-aided Detection|computer-aided detection
529926|NCT00906789|Image processing|image processing
529927|NCT00906763|Parkinson's disease|parkinson's disease
529928|NCT00906763|Neurodegenerative Disorders|neurodegenerative disorders
529929|NCT00906763|Biogenic amines|biogenic amines
529930|NCT00906763|Chocolate|chocolate
529931|NCT00906763|Cocoa|cocoa
529932|NCT00906750|FLuMIST|flumist
529933|NCT00906750|Inactivated influenza vaccine|inactivated influenza vaccine
529934|NCT00906750|Study of FluMist versus inactivated influenza vaccine in children with cancer|study of flumist versus inactivated influenza vaccine in children with cancer
529935|NCT00906737|Multiple Sclerosis|multiple sclerosis
529936|NCT00906737|Gait|gait
529937|NCT00906737|foot-drop|foot-drop
529938|NCT00906737|Ankle-Bot|ankle-bot
529939|NCT00906737|Physical Therapy|physical therapy
529940|NCT00906737|Gait Abnormalities|gait abnormalities
529941|NCT00906711|Aging|aging
529942|NCT00906711|Postural Balance|postural balance
529943|NCT00906685|CRVO|crvo
529944|NCT00906685|anti-VEGF|anti-vegf
529945|NCT00906685|Macular edema|macular edema
529946|NCT00906672|Dermal substitute Integra®|dermal substitute integra®
529947|NCT00906672|Flap|flap
529948|NCT00906672|graft|graft
529949|NCT00906672|traumatic wound|traumatic wound
529950|NCT00906672|medico economic costs|medico economic costs
529951|NCT00906672|esthetical and functional scar results|esthetical and functional scar results
530052|NCT00906152|disability|disability
529952|NCT00906659|center point thickness|center point thickness
529953|NCT00906659|diabetic retinopathy|diabetic retinopathy
529954|NCT00906659|diabetic macular edema|diabetic macular edema
529955|NCT00906659|macular volume|macular volume
529956|NCT00906659|visual capacity|visual capacity
529957|NCT00906659|visual function|visual function
529958|NCT00906646|cardiac|cardiac
529959|NCT00906646|surgery|surgery
529960|NCT00906646|metabolic|metabolic
529961|NCT00906646|supplements|supplements
529962|NCT00906646|antioxidant|antioxidant
529963|NCT00906633|antifungal therapies|antifungal therapies
529964|NCT00906620|Data on student's healthy and at-risk lifestyles and their relation with health measured by well-being, depression and suicidality|data on student's healthy and at-risk lifestyles and their relation with health measured by well-being, depression and suicidality
529965|NCT00906607|Urinary Incontinence|urinary incontinence
529966|NCT00906581|Depression|depression
529967|NCT00906568|Cystic fibrosis|cystic fibrosis
529968|NCT00906568|Sensitization to Aspergillus|sensitization to aspergillus
529969|NCT00906568|Bronchial allergen challenge|bronchial allergen challenge
529970|NCT00906568|Induced Sputum|induced sputum
529971|NCT00906568|Bronchial inflammation|bronchial inflammation
529972|NCT00906568|Small airways disease (SAD)|small airways disease (sad)
529973|NCT00906542|acute stroke|acute stroke
529974|NCT00906542|ischemic stroke|ischemic stroke
529975|NCT00906542|pneumonia|pneumonia
529976|NCT00906542|chest infection|chest infection
529977|NCT00906542|brain lesion|brain lesion
529978|NCT00906542|lesion topology|lesion topology
529979|NCT00906542|dysphagia|dysphagia
529980|NCT00906542|sympathetic activation|sympathetic activation
529981|NCT00906542|immunosuppression|immunosuppression
529982|NCT00906529|Type 2 Diabetes|type 2 diabetes
529983|NCT00906529|Inpatient|inpatient
529984|NCT00906529|Length of Stay|length of stay
529985|NCT00906529|Blood Glucose Control|blood glucose control
529986|NCT00906516|Recurrent Glioblastoma multiforme (GBM)|recurrent glioblastoma multiforme (gbm)
529987|NCT00906516|Recurrent Brain Tumor|recurrent brain tumor
529988|NCT00906516|Recurrent Brain Disease|recurrent brain disease
529989|NCT00906516|Neuradiab|neuradiab
529990|NCT00906516|Avastin|avastin
529991|NCT00906516|Bevacizumab|bevacizumab
529992|NCT00906503|pulmonary nodule|pulmonary nodule
529993|NCT00906490|Glucose Monitoring|glucose monitoring
529994|NCT00906490|Accurate Blood Glucose Monitoring in critical care setting|accurate blood glucose monitoring in critical care setting
529995|NCT00906451|myocardial infarction|myocardial infarction
529996|NCT00906451|inflammation|inflammation
529997|NCT00906451|endothelial dysfunction|endothelial dysfunction
529998|NCT00906425|Dental Implant|dental implant
529999|NCT00906412|Essential Tremor|essential tremor
530000|NCT00906399|interferon|interferon
530001|NCT00906399|injectable|injectable
530002|NCT00906399|MS|ms
530003|NCT00906399|SC|sc
530004|NCT00906399|PEGylated|pegylated
530005|NCT00906399|Interferon beta-1a|interferon beta-1a
530006|NCT00906399|relapsing|relapsing
530007|NCT00906399|PEG|peg
530008|NCT00906399|multiple sclerosis|multiple sclerosis
530009|NCT00906399|subcutaneous|subcutaneous
530010|NCT00906386|Varenicline|varenicline
530011|NCT00906373|Hepatocellular Carcinoma|hepatocellular carcinoma
530012|NCT00906373|Liver Neoplasms|liver neoplasms
530013|NCT00906373|Antibodies, Monoclonal|antibodies, monoclonal
530014|NCT00906347|Labor augmentation|labor augmentation
530015|NCT00906347|Oral misoprostol|oral misoprostol
530016|NCT00906334|Myelodysplastic Syndrome|myelodysplastic syndrome
530017|NCT00906334|Trisomy 8|trisomy 8
530018|NCT00906334|Intermediate-2 Risk Group|intermediate-2 risk group
530019|NCT00906334|High-Risk Group|high-risk group
530020|NCT00906334|azacitidine|azacitidine
530021|NCT00906334|azacytidine|azacytidine
530022|NCT00906334|Vidaza|vidaza
530023|NCT00906334|decitabine|decitabine
530024|NCT00906334|Dacogen|dacogen
530025|NCT00906321|Web-Based Decision Support|web-based decision support
530026|NCT00906321|Breast Cancer Risk|breast cancer risk
530027|NCT00906295|Hemoglobin|hemoglobin
530028|NCT00906295|Ambulation|ambulation
530029|NCT00906282|neoadjuvant NSCLC|neoadjuvant nsclc
530030|NCT00906282|NSCLC|nsclc
530031|NCT00906282|pemetrexed|pemetrexed
530032|NCT00906269|impotence|impotence
530033|NCT00906269|prostatic neoplasms|prostatic neoplasms
530034|NCT00906269|hyperbaric oxygenation|hyperbaric oxygenation
530035|NCT00906269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors
530036|NCT00906256|Hepatitis C|hepatitis c
530037|NCT00906256|Pharmacokinetics|pharmacokinetics
530038|NCT00906256|AZD7295|azd7295
530039|NCT00906256|Healthy volunteers|healthy volunteers
530040|NCT00906217|colonoscopy|colonoscopy
530041|NCT00906217|preparation|preparation
530042|NCT00906217|safety|safety
530043|NCT00906217|elderly|elderly
530044|NCT00906204|Renal transplantation|renal transplantation
530045|NCT00906204|Kidney transplantation|kidney transplantation
530046|NCT00906178|HIV prevention|hiv prevention
530047|NCT00906178|technology|technology
530048|NCT00906178|adolescent|adolescent
530049|NCT00906178|developing countries|developing countries
530050|NCT00906152|quality of sleep|quality of sleep
530051|NCT00906152|low back pain|low back pain
530053|NCT00906152|catastrophizing|catastrophizing
530054|NCT00906152|depression|depression
530055|NCT00906139|Propofol|propofol
530056|NCT00906139|Midazolam|midazolam
530057|NCT00906139|Cirrhosis|cirrhosis
530058|NCT00906139|Gastrointestinal endoscopy|gastrointestinal endoscopy
530059|NCT00906139|Complications|complications
530060|NCT00906139|Sedation|sedation
530061|NCT00906126|oral misoprostol|oral misoprostol
530062|NCT00906126|labor augmentation|labor augmentation
530063|NCT00906126|arrest of dilation|arrest of dilation
530064|NCT00906126|nulliparous|nulliparous
530065|NCT00906113|Retinoblastoma|retinoblastoma
530066|NCT00906100|Biventricular ICD|biventricular icd
530067|NCT00906100|AV delay|av delay
530068|NCT00906087|Myocilin gene|myocilin gene
530069|NCT00906087|Glaucoma|glaucoma
530070|NCT00906087|dorzolamide and timolol combination eyedrop|dorzolamide and timolol combination eyedrop
530071|NCT00906074|Surgical Wound Infection|surgical wound infection
530072|NCT00906074|Surgical Site Infection|surgical site infection
530073|NCT00906074|Abdominal Surgery|abdominal surgery
530074|NCT00906061|Carcinoma, Small Cell|carcinoma, small cell
530075|NCT00906061|Lung Neoplasms|lung neoplasms
530076|NCT00906061|Docetaxel|docetaxel
530077|NCT00906061|Gemcitabine|gemcitabine
530078|NCT00906061|ECOG 2|ecog 2
530079|NCT00906035|Peripheral Arterial Disease|peripheral arterial disease
530080|NCT00906035|PAD|pad
530081|NCT00906035|Claudication|claudication
530082|NCT00906035|Peripheral Vascular Disease|peripheral vascular disease
530083|NCT00906022|Below the Knee|below the knee
530084|NCT00906022|Infrapopliteal arteries|infrapopliteal arteries
530085|NCT00906022|nitinol|nitinol
530086|NCT00906022|limb ischemia|limb ischemia
530087|NCT00906022|claudication|claudication
530088|NCT00906022|self-expanding stent|self-expanding stent
530089|NCT00906022|duplex|duplex
530090|NCT00906022|angiography|angiography
530091|NCT00905983|Carcinoma, Non-Small-Cell|carcinoma, non-small-cell
530092|NCT00905983|Elderly patients|elderly patients
530093|NCT00905983|Docetaxel|docetaxel
530094|NCT00905983|Gemcitabine|gemcitabine
530095|NCT00905957|transversus abdominis plane block|transversus abdominis plane block
530096|NCT00905957|relief|relief
530097|NCT00905944|Left ventricular failure|left ventricular failure
530098|NCT00905944|chronic heart failure|chronic heart failure
530099|NCT00905944|Pacemaker|pacemaker
530100|NCT00905944|Resynchronisation therapy|resynchronisation therapy
530101|NCT00905944|Exercise|exercise
530102|NCT00905944|Endurance exercise|endurance exercise
530103|NCT00905931|Aneurysmal subarachnoid hemorrhage (aSAH)|aneurysmal subarachnoid hemorrhage (asah)
530104|NCT00905931|Cerebral vasospasm|cerebral vasospasm
530105|NCT00905931|impaired cerebral autoregulation|impaired cerebral autoregulation
530106|NCT00905931|transient hyperaemic response test|transient hyperaemic response test
530107|NCT00905931|delayed ischaemic neurological deficits|delayed ischaemic neurological deficits
530108|NCT00905918|colon cancer|colon cancer
530109|NCT00905918|rectal cancer|rectal cancer
530110|NCT00905905|myocardial infarction|myocardial infarction
530111|NCT00905905|systemic inflammatory activity|systemic inflammatory activity
530112|NCT00905905|endothelial function|endothelial function
530113|NCT00905892|overfeeding|overfeeding
530114|NCT00905892|stable isotopes|stable isotopes
530115|NCT00905892|lipoprotein metabolism|lipoprotein metabolism
530116|NCT00905892|lipid oxidation|lipid oxidation
530117|NCT00905892|fat distribution|fat distribution
530118|NCT00905892|gene expression|gene expression
530119|NCT00905892|endotoxemia|endotoxemia
530120|NCT00905892|mass spectrometry/gas chromatography|mass spectrometry/gas chromatography
530121|NCT00905879|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
530122|NCT00905879|Observational study|observational study
530123|NCT00905879|Gadobutrol|gadobutrol
530124|NCT00905866|Quality of life|quality of life
530125|NCT00905866|Hyperparathyroidism|hyperparathyroidism
530126|NCT00905853|Ventricular Tachycardia|ventricular tachycardia
530127|NCT00905853|Catheter Ablation|catheter ablation
530128|NCT00905853|ICD therapy|icd therapy
530129|NCT00905853|Antiarrhythmic Drug Therapy|antiarrhythmic drug therapy
530130|NCT00905853|Ischemic Heart Disease|ischemic heart disease
530131|NCT00905827|suicide|suicide
530132|NCT00905827|assessment|assessment
530133|NCT00905827|management|management
530134|NCT00905827|Provider Training|provider training
530135|NCT00905827|health services|health services
530136|NCT00905814|Bioequivalence|bioequivalence
530137|NCT00905801|Non small cell lung cancer|non small cell lung cancer
530138|NCT00905801|NSCLC|nsclc
530139|NCT00905801|CTP|ctp
530140|NCT00905801|Perfusion|perfusion
530141|NCT00905801|Imaging|imaging
530142|NCT00905788|Embryo transfer|embryo transfer
530143|NCT00905788|IVF/ICSI|ivf/icsi
530144|NCT00905788|Embryo expulsion|embryo expulsion
530145|NCT00905775|Isoflurane;|isoflurane;
530146|NCT00905775|Propofol|propofol
530147|NCT00905775|Renal functions tests|renal functions tests
530148|NCT00905775|Cardiovascular tests|cardiovascular tests
530149|NCT00905775|revascularization surgery of the myocardium|revascularization surgery of the myocardium
530150|NCT00905775|extracorporeal circulation|extracorporeal circulation
530251|NCT00905333|felodipine|felodipine
530151|NCT00905762|pharmacokinetics|pharmacokinetics
530152|NCT00905736|tendon|tendon
530153|NCT00905736|healing|healing
530154|NCT00905736|microcurrent|microcurrent
530155|NCT00905736|chronic tennis elbow|chronic tennis elbow
530156|NCT00905723|climacterium|climacterium
530157|NCT00905723|sexual life|sexual life
530158|NCT00905723|isoflavone|isoflavone
530159|NCT00905723|estrogen|estrogen
530160|NCT00905723|McCoy's sexual questionnaire|mccoy's sexual questionnaire
530161|NCT00905723|Kupperman index|kupperman index
530162|NCT00905710|colorectal adenomas|colorectal adenomas
530163|NCT00905710|colorectal cancer|colorectal cancer
530164|NCT00905710|Lynch syndrome|lynch syndrome
530165|NCT00905710|chromoendoscopy|chromoendoscopy
530166|NCT00905697|Living donor lung transplantation|living donor lung transplantation
530167|NCT00905697|Health-related quality of life|health-related quality of life
530168|NCT00905697|Prognosis|prognosis
530169|NCT00905697|Patient reported outcome|patient reported outcome
530170|NCT00905684|Compliance|compliance
530171|NCT00905684|Hormonal Contraception|hormonal contraception
530172|NCT00905671|Lipid Core Plaque|lipid core plaque
530173|NCT00905671|LCP|lcp
530174|NCT00905671|Bifurcation|bifurcation
530175|NCT00905671|Stenosis|stenosis
530176|NCT00905671|Lesion|lesion
530177|NCT00905671|Angioplasty|angioplasty
530178|NCT00905658|stage IVA cervical cancer|stage iva cervical cancer
530179|NCT00905658|stage IVB cervical cancer|stage ivb cervical cancer
530180|NCT00905658|fallopian tube cancer|fallopian tube cancer
530181|NCT00905658|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
530182|NCT00905658|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
530183|NCT00905658|ovarian sarcoma|ovarian sarcoma
530184|NCT00905658|ovarian stromal cancer|ovarian stromal cancer
530185|NCT00905658|stage IV endometrial carcinoma|stage iv endometrial carcinoma
530186|NCT00905658|stage IV uterine sarcoma|stage iv uterine sarcoma
530187|NCT00905658|stage IVA vaginal cancer|stage iva vaginal cancer
530188|NCT00905658|stage IVB vaginal cancer|stage ivb vaginal cancer
530189|NCT00905658|stage IV vulvar cancer|stage iv vulvar cancer
530190|NCT00905645|Breast Augmentation|breast augmentation
530191|NCT00905645|Breast Reconstruction|breast reconstruction
530192|NCT00905645|Breast Revision|breast revision
530193|NCT00905645|Silicone breast implants|silicone breast implants
530194|NCT00905606|Bioequivalence|bioequivalence
530195|NCT00905606|Healthy Subjects|healthy subjects
530196|NCT00905593|chronic myeloid leukemia,|chronic myeloid leukemia,
530197|NCT00905593|blast crisis,|blast crisis,
530198|NCT00905593|accelerated phase,|accelerated phase,
530199|NCT00905593|nilotinib,|nilotinib,
530200|NCT00905593|imatinib,|imatinib,
530201|NCT00905593|resistant,|resistant,
530202|NCT00905593|intolerant,|intolerant,
530203|NCT00905593|chronic phase|chronic phase
530204|NCT00905580|thyroidectomy|thyroidectomy
530205|NCT00905580|pain, postoperative|pain, postoperative
530206|NCT00905580|pregabalin|pregabalin
530207|NCT00905567|Bioequivalence|bioequivalence
530208|NCT00905567|Healthy Subjects|healthy subjects
530209|NCT00905554|sedation|sedation
530210|NCT00905554|warm water|warm water
530211|NCT00905528|type 2 diabetes mellitus|type 2 diabetes mellitus
530212|NCT00905528|endothelial function|endothelial function
530213|NCT00905528|renal hemodynamics|renal hemodynamics
530214|NCT00905515|Kidney Transplantation|kidney transplantation
530215|NCT00905515|Immunosuppressive Agents|immunosuppressive agents
530216|NCT00905502|Obesity|obesity
530217|NCT00905502|fluid management|fluid management
530218|NCT00905502|postoperative complications|postoperative complications
530219|NCT00905502|bariatric surgery|bariatric surgery
530220|NCT00905502|hemostasis|hemostasis
530221|NCT00905476|NPPV|nppv
530222|NCT00905476|Prognosis|prognosis
530223|NCT00905476|Health-related quality of life|health-related quality of life
530224|NCT00905476|Patient reported outcomes|patient reported outcomes
530225|NCT00905463|Lung transplant candidates|lung transplant candidates
530226|NCT00905463|Health-related quality of life|health-related quality of life
530227|NCT00905463|patient reported outcome|patient reported outcome
530228|NCT00905463|Prognosis|prognosis
530229|NCT00905450|Surgery|surgery
530230|NCT00905437|perioperative|perioperative
530231|NCT00905437|pregabalin|pregabalin
530232|NCT00905437|total hip replacement|total hip replacement
530233|NCT00905437|post-operative pain|post-operative pain
530234|NCT00905411|Overweight|overweight
530235|NCT00905411|blood pressure|blood pressure
530236|NCT00905411|DASH diet|dash diet
530237|NCT00905411|Pacific|pacific
530238|NCT00905411|children|children
530239|NCT00905398|Leukemia|leukemia
530240|NCT00905398|Lymphoblastic|lymphoblastic
530241|NCT00905398|Acute|acute
530242|NCT00905398|Philadelphia|philadelphia
530243|NCT00905398|BCR-ABL|bcr-abl
530244|NCT00905398|Nilotinib|nilotinib
530245|NCT00905398|Treatment|treatment
530246|NCT00905385|nontypeable Haemophilus influenzae, NTHi|nontypeable haemophilus influenzae, nthi
530247|NCT00905346|Bioequivalence|bioequivalence
530248|NCT00905346|Healthy Subjects|healthy subjects
530249|NCT00905333|pharmacokinetics|pharmacokinetics
530250|NCT00905333|candesartan|candesartan
530252|NCT00905333|test formulations|test formulations
530253|NCT00905333|Atacand®|atacand®
530254|NCT00905333|Splendil®|splendil®
530255|NCT00905333|healthy volunteers|healthy volunteers
530256|NCT00905333|blood samples|blood samples
530257|NCT00905333|after meal intake interaction|after meal intake interaction
530258|NCT00905333|Kinetic interaction amongst test formulations of Candesartan and Felodipine and the brands Atacand® and Splendil® in healthy volunteers after a fasting period.|kinetic interaction amongst test formulations of candesartan and felodipine and the brands atacand® and splendil® in healthy volunteers after a fasting period.
530259|NCT00905320|Hernia repair|hernia repair
530260|NCT00905307|Schizophrenia|schizophrenia
530261|NCT00905307|Relapsed|relapsed
530262|NCT00905281|Metastatic breast cancer|metastatic breast cancer
530263|NCT00905281|Supportive care|supportive care
530264|NCT00905281|Third or fourth line of chemotherapy|third or fourth line of chemotherapy
530265|NCT00905281|Quality of life|quality of life
530266|NCT00905281|Treatment preferences|treatment preferences
530267|NCT00905268|FRDA|frda
530268|NCT00905268|idebenone|idebenone
530269|NCT00905268|FRDA disease|frda disease
530270|NCT00905255|hyperglycemia|hyperglycemia
530271|NCT00905255|GLP-1|glp-1
530272|NCT00905242|Kidney Transplantation|kidney transplantation
530273|NCT00905242|Gastrointestinal Agents|gastrointestinal agents
530274|NCT00905229|hip fracture|hip fracture
530275|NCT00905229|warfarin|warfarin
530276|NCT00905229|vitamin k|vitamin k
530277|NCT00905229|Phytonadione|phytonadione
530278|NCT00905229|INR level|inr level
530279|NCT00905216|heparin|heparin
530280|NCT00905203|Postmenopausal women|postmenopausal women
530281|NCT00905203|Diabetes|diabetes
530282|NCT00905203|Skin microcirculation|skin microcirculation
530283|NCT00905203|Exercise capacity|exercise capacity
530284|NCT00905203|Skeletal muscle oxygenation|skeletal muscle oxygenation
530285|NCT00905203|Dose-response relationship|dose-response relationship
530286|NCT00905203|postmenopausal diabetic women|postmenopausal diabetic women
530287|NCT00905177|Atrial Fibrillation|atrial fibrillation
530288|NCT00905177|deep vein thrombosis|deep vein thrombosis
530289|NCT00905177|anticoagulation|anticoagulation
530290|NCT00905177|warfarin|warfarin
530291|NCT00905177|coumadin|coumadin
530292|NCT00905164|Bioequivalence|bioequivalence
530293|NCT00905164|Healthy Subjects|healthy subjects
530294|NCT00905151|HIV positive|hiv positive
530295|NCT00905151|AIDS|aids
530296|NCT00905151|antiretroviral|antiretroviral
530297|NCT00905151|Kidney disease|kidney disease
530298|NCT00905151|Antiretroviral Therapy|antiretroviral therapy
530299|NCT00905138|Safety|safety
530300|NCT00905138|Tolerability|tolerability
530301|NCT00905138|Pharmacokinetics|pharmacokinetics
530302|NCT00905125|influenza, trivalent, vaccine, pregnant women|influenza, trivalent, vaccine, pregnant women
530303|NCT00905112|Pregnancy|pregnancy
530304|NCT00905112|Pain|pain
530305|NCT00905112|Musculoskeletal manipulations|musculoskeletal manipulations
530306|NCT00905112|Exercise|exercise
530307|NCT00905086|cognitive/functional effects|cognitive/functional effects
530308|NCT00905086|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
530309|NCT00905086|stage I breast cancer|stage i breast cancer
530310|NCT00905086|stage II breast cancer|stage ii breast cancer
530311|NCT00905086|stage IIIA breast cancer|stage iiia breast cancer
530312|NCT00905086|stage IIIB breast cancer|stage iiib breast cancer
530313|NCT00905086|stage IIIC breast cancer|stage iiic breast cancer
530314|NCT00905086|stage I colon cancer|stage i colon cancer
530315|NCT00905086|stage II colon cancer|stage ii colon cancer
530316|NCT00905086|stage III colon cancer|stage iii colon cancer
530317|NCT00905086|stage I rectal cancer|stage i rectal cancer
530318|NCT00905086|stage II rectal cancer|stage ii rectal cancer
530319|NCT00905086|stage III rectal cancer|stage iii rectal cancer
530320|NCT00905086|stage I non-small cell lung cancer|stage i non-small cell lung cancer
530321|NCT00905086|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
530322|NCT00905086|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
530323|NCT00905086|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
530324|NCT00905086|stage I prostate cancer|stage i prostate cancer
530325|NCT00905086|stage II prostate cancer|stage ii prostate cancer
530326|NCT00905086|stage III prostate cancer|stage iii prostate cancer
530327|NCT00905086|extensive stage small cell lung cancer|extensive stage small cell lung cancer
530328|NCT00905086|limited stage small cell lung cancer|limited stage small cell lung cancer
530329|NCT00905073|type 1 diabetes mellitus|type 1 diabetes mellitus
530330|NCT00905073|cyclosporin|cyclosporin
530331|NCT00905073|methotrexate|methotrexate
530332|NCT00905073|renal function|renal function
530333|NCT00905060|Newly Diagnosed Glioblastoma Multiforme, vaccine|newly diagnosed glioblastoma multiforme, vaccine
530334|NCT00905047|colo-rectal cancer|colo-rectal cancer
530335|NCT00905047|advanced|advanced
530336|NCT00905047|metastatic|metastatic
530337|NCT00905047|locally advanced or metastatic colo-rectal cancer|locally advanced or metastatic colo-rectal cancer
530338|NCT00905034|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
530339|NCT00905034|ALL|all
530340|NCT00905034|Leukemia|leukemia
530341|NCT00905034|Methotrexate|methotrexate
530342|NCT00905034|Vincristine|vincristine
530343|NCT00905034|PEG-l-asparaginase|peg-l-asparaginase
530344|NCT00905034|PEG asparaginase|peg asparaginase
530345|NCT00905034|Pegaspargase|pegaspargase
530346|NCT00905034|Oncaspar|oncaspar
530347|NCT00905034|Polyethylene Glycol Conjugated Lasparaginase-H|polyethylene glycol conjugated lasparaginase-h
530348|NCT00905034|Dexamethasone|dexamethasone
530349|NCT00905034|Decadron|decadron
530350|NCT00905034|Rituximab|rituximab
530351|NCT00905034|Rituxan|rituxan
530352|NCT00905021|Breast Cancer|breast cancer
530353|NCT00905021|Metastatic|metastatic
530354|NCT00905021|Hormone Receptor Positive|hormone receptor positive
530355|NCT00905008|drug-eluting stent|drug-eluting stent
530356|NCT00905008|bare-metal stent|bare-metal stent
530357|NCT00905008|long-term safety|long-term safety
530358|NCT00905008|mortality|mortality
530359|NCT00905008|stent thrombosis|stent thrombosis
530360|NCT00905008|Angioplasty|angioplasty
530361|NCT00905008|Transluminal|transluminal
530362|NCT00905008|Percutaneous Coronary|percutaneous coronary
530363|NCT00904995|Leukemia|leukemia
530364|NCT00904995|Cancer of the blood|cancer of the blood
530365|NCT00904995|Cancer of the bone marrow|cancer of the bone marrow
530366|NCT00904995|Hematologic malignancy|hematologic malignancy
530367|NCT00904995|Invasive fungal infection|invasive fungal infection
530368|NCT00904995|Voriconazole|voriconazole
530370|NCT00904995|antifungal prophylaxis|antifungal prophylaxis
530371|NCT00904982|warfarin|warfarin
530372|NCT00904982|coumadin|coumadin
530373|NCT00904982|adherence|adherence
530374|NCT00904982|mechanical heart valves|mechanical heart valves
530375|NCT00904969|Urinary Incontinence, Stress|urinary incontinence, stress
530376|NCT00904969|Intrinsic sphincter deficiency|intrinsic sphincter deficiency
530377|NCT00904969|Secondary|secondary
530378|NCT00904969|Transurethral Resection (TUR)|transurethral resection (tur)
530379|NCT00904969|Transurethral Resection of the Prostate (TURP)|transurethral resection of the prostate (turp)
530380|NCT00904969|Radical prostatectomy|radical prostatectomy
530381|NCT00904969|Open prostatectomy|open prostatectomy
530382|NCT00904969|Post-suprapubic prostatectomy|post-suprapubic prostatectomy
530383|NCT00904956|Latent Tuberculosis Infection|latent tuberculosis infection
530384|NCT00904956|High Resolution Scanners|high resolution scanners
530385|NCT00904956|Dynamic Hypothesis of Latent Tuberculosis Infection|dynamic hypothesis of latent tuberculosis infection
530386|NCT00904943|Bioequivalence|bioequivalence
530387|NCT00904943|Healthy Subjects|healthy subjects
530388|NCT00904930|Tooth mobility assessment|tooth mobility assessment
530389|NCT00904930|Splinting|splinting
530390|NCT00904930|Splint Rigidity|splint rigidity
530391|NCT00904917|African American Mothers|african american mothers
530392|NCT00904917|Children|children
530393|NCT00904917|African American Families|african american families
530394|NCT00904917|Parental Depression|parental depression
530395|NCT00904917|Preventive Intervention|preventive intervention
530396|NCT00904891|Adolescents|adolescents
530397|NCT00904891|Prevention|prevention
530398|NCT00904891|Bibliotherapy|bibliotherapy
530399|NCT00904878|pregnant IBD patients|pregnant ibd patients
530400|NCT00904865|Single port access|single port access
530401|NCT00904865|Laparoscopy|laparoscopy
530402|NCT00904865|cholecystectomy|cholecystectomy
530403|NCT00904865|cholangiography|cholangiography
530404|NCT00904865|cosmesis|cosmesis
530405|NCT00904826|NMO|nmo
530406|NCT00904826|Devic's disease|devic's disease
530407|NCT00904826|Neuromyelitis optica|neuromyelitis optica
530408|NCT00904826|NMO-IgG|nmo-igg
530409|NCT00904826|Aquaporin-4 antibody|aquaporin-4 antibody
530410|NCT00904826|Eculizumab|eculizumab
530411|NCT00904826|Complement|complement
530412|NCT00904813|Rectal cancer|rectal cancer
530413|NCT00904813|Preoperative radiotherapy|preoperative radiotherapy
530414|NCT00904813|Timing of Surgery|timing of surgery
530415|NCT00904813|Prognosis|prognosis
530416|NCT00904800|Phase I|phase i
530417|NCT00904800|Healthy volunteers|healthy volunteers
530418|NCT00904787|Leukemia|leukemia
530419|NCT00904787|Hematologic neoplasms|hematologic neoplasms
530420|NCT00904774|bronchopulmonary dysplasia|bronchopulmonary dysplasia
530421|NCT00904774|neonates|neonates
530422|NCT00904774|lung development|lung development
530423|NCT00904774|prematurity|prematurity
530424|NCT00904761|diabetes mellitus|diabetes mellitus
530425|NCT00904761|autonomic neuropathy|autonomic neuropathy
530426|NCT00904761|exercise training|exercise training
530427|NCT00904761|exercise capacity|exercise capacity
530428|NCT00904761|heart rate variability|heart rate variability
530429|NCT00904748|Sildenafil|sildenafil
530430|NCT00904748|Bio-equivalence|bio-equivalence
530431|NCT00904735|adult grade I meningioma|adult grade i meningioma
530432|NCT00904735|adult grade II meningioma|adult grade ii meningioma
530433|NCT00904735|adult anaplastic meningioma|adult anaplastic meningioma
530434|NCT00904735|adult papillary meningioma|adult papillary meningioma
530435|NCT00904735|recurrent adult brain tumor|recurrent adult brain tumor
530436|NCT00904722|Follicular lymphoma|follicular lymphoma
530437|NCT00904722|Immunotherapy|immunotherapy
530438|NCT00904722|CT-011|ct-011
530439|NCT00904722|Monoclonal Antibody CT-011|monoclonal antibody ct-011
530440|NCT00904722|Rituximab|rituximab
530441|NCT00904722|Rituxan|rituxan
530442|NCT00904696|Irritable bowel syndrome|irritable bowel syndrome
530443|NCT00904696|probiotics|probiotics
530444|NCT00904670|Hyperactivity Attention Deficit Disorder|hyperactivity attention deficit disorder
530445|NCT00904670|ADHD|adhd
530446|NCT00904670|Pediatric Patients|pediatric patients
530447|NCT00904670|Quillivant|quillivant
530448|NCT00904670|methylphenidate|methylphenidate
530449|NCT00904657|pharmacokinetic/pharmacodynamic modeling|pharmacokinetic/pharmacodynamic modeling
530450|NCT00904657|biomarkers (growth factors) as a possible tool of drug effect|biomarkers (growth factors) as a possible tool of drug effect
530451|NCT00904644|HIV|hiv
530452|NCT00904644|antiretroviral treatment|antiretroviral treatment
530453|NCT00904644|Swiss HIV Cohort Study|swiss hiv cohort study
530454|NCT00904644|drug resistance|drug resistance
530455|NCT00904644|integrase inhibitor|integrase inhibitor
530456|NCT00904644|Treatment|treatment
530457|NCT00904618|Suburethral slings|suburethral slings
530458|NCT00904618|Urethra|urethra
530459|NCT00904618|Urinary incontinence|urinary incontinence
530460|NCT00904618|Urinary stress incontinence|urinary stress incontinence
530461|NCT00904592|diabetic retinopathy|diabetic retinopathy
530462|NCT00904592|traditional chinese medicine|traditional chinese medicine
530463|NCT00904579|Organ Transplants|organ transplants
530464|NCT00904579|Immunosuppression|immunosuppression
530465|NCT00904579|Cancer|cancer
530466|NCT00904579|End Stage Renal Disease|end stage renal disease
530467|NCT00904579|ESRD|esrd
530468|NCT00904579|Cancer Risk|cancer risk
530469|NCT00904566|microarray|microarray
530470|NCT00904566|gene expression profiling|gene expression profiling
530471|NCT00904566|MammaPrint|mammaprint
530472|NCT00904566|breast cancer|breast cancer
530473|NCT00904553|Brain|brain
530474|NCT00904553|metastases|metastases
530475|NCT00904527|Relaxation (Schultz)|relaxation (schultz)
530476|NCT00904527|Migraine|migraine
530477|NCT00904527|antipain center|antipain center
530478|NCT00904514|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
530479|NCT00904514|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
530480|NCT00904514|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
530481|NCT00904514|Waldenström macroglobulinemia|waldenström macroglobulinemia
530482|NCT00904514|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
530483|NCT00904514|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
530484|NCT00904514|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
530485|NCT00904514|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
530486|NCT00904514|refractory hairy cell leukemia|refractory hairy cell leukemia
530487|NCT00904514|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
530488|NCT00904514|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
530489|NCT00904514|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
530490|NCT00904514|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
530491|NCT00904514|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
530492|NCT00904514|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
530493|NCT00904514|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
530494|NCT00904514|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
530495|NCT00904514|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
530496|NCT00904514|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
530497|NCT00904514|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
530498|NCT00904514|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
530499|NCT00904514|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
530500|NCT00904514|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
530501|NCT00904514|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
530502|NCT00904514|prolymphocytic leukemia|prolymphocytic leukemia
530503|NCT00904514|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
530504|NCT00904514|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
530505|NCT00904514|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
530506|NCT00904514|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
530507|NCT00904514|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
530508|NCT00904514|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
530509|NCT00904514|splenic marginal zone lymphoma|splenic marginal zone lymphoma
530510|NCT00904514|stage IV colon cancer|stage iv colon cancer
530511|NCT00904514|stage IV breast cancer|stage iv breast cancer
530512|NCT00904514|recurrent breast cancer|recurrent breast cancer
530513|NCT00904514|stage IV gastric cancer|stage iv gastric cancer
530514|NCT00904514|recurrent gastric cancer|recurrent gastric cancer
530515|NCT00904514|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
530516|NCT00904514|recurrent pancreatic cancer|recurrent pancreatic cancer
530517|NCT00904514|recurrent colon cancer|recurrent colon cancer
530788|NCT00903422|Eltrombopag|eltrombopag
530518|NCT00904514|stage IV esophageal cancer|stage iv esophageal cancer
530519|NCT00904514|recurrent esophageal cancer|recurrent esophageal cancer
530520|NCT00904514|recurrent bladder cancer|recurrent bladder cancer
530521|NCT00904514|stage IV bladder cancer|stage iv bladder cancer
530522|NCT00904514|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
530523|NCT00904514|epithelial mesothelioma|epithelial mesothelioma
530524|NCT00904514|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
530525|NCT00904514|recurrent salivary gland cancer|recurrent salivary gland cancer
530526|NCT00904514|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
530527|NCT00904514|stage III cervical cancer|stage iii cervical cancer
530528|NCT00904514|recurrent cervical cancer|recurrent cervical cancer
530529|NCT00904514|stage IVB cervical cancer|stage ivb cervical cancer
530530|NCT00904514|stage IVA cervical cancer|stage iva cervical cancer
530531|NCT00904514|squamous cell lung cancer|squamous cell lung cancer
530532|NCT00904514|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
530533|NCT00904514|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
530534|NCT00904514|advanced malignant mesothelioma|advanced malignant mesothelioma
530535|NCT00904514|recurrent malignant mesothelioma|recurrent malignant mesothelioma
530536|NCT00904514|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
530537|NCT00904514|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
530538|NCT00904514|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
530539|NCT00904514|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
530540|NCT00904514|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
530541|NCT00904514|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
530542|NCT00904514|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
530543|NCT00904514|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
530544|NCT00904514|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
530545|NCT00904514|cervical squamous cell carcinoma|cervical squamous cell carcinoma
530546|NCT00904514|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
530547|NCT00904514|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
530548|NCT00904514|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
530549|NCT00904514|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
530550|NCT00904514|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
530551|NCT00904514|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
530552|NCT00904514|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
530553|NCT00904514|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
530554|NCT00904514|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
530555|NCT00904514|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
530556|NCT00904514|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
530557|NCT00904514|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
530558|NCT00904514|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
530559|NCT00904514|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
530560|NCT00904514|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
530561|NCT00904514|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
530562|NCT00904514|fallopian tube cancer|fallopian tube cancer
530563|NCT00904514|primary peritoneal cavity cancer|primary peritoneal cavity cancer
530564|NCT00904514|ovarian carcinosarcoma|ovarian carcinosarcoma
530565|NCT00904514|Brenner tumor|brenner tumor
530566|NCT00904514|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
530567|NCT00904514|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
530568|NCT00904514|stage III salivary gland cancer|stage iii salivary gland cancer
530569|NCT00904514|stage IV salivary gland cancer|stage iv salivary gland cancer
530570|NCT00904514|stage II pancreatic cancer|stage ii pancreatic cancer
530571|NCT00904514|stage III pancreatic cancer|stage iii pancreatic cancer
530572|NCT00904514|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
530573|NCT00904514|stage IV pancreatic cancer|stage iv pancreatic cancer
530574|NCT00904514|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
530575|NCT00904514|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
530576|NCT00904514|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
530577|NCT00904514|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
530578|NCT00904514|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
530579|NCT00904514|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
530580|NCT00904501|Limb ischemia|limb ischemia
530581|NCT00904501|Cell Therapy|cell therapy
530582|NCT00904488|Acute Decompensated Heart Failure|acute decompensated heart failure
530583|NCT00904488|Diuretics|diuretics
530584|NCT00904436|Tetraplegia|tetraplegia
530585|NCT00904436|Breathing Patterns|breathing patterns
530586|NCT00904436|Dyspnea|dyspnea
530587|NCT00904410|adenocarcinoma|adenocarcinoma
530588|NCT00904410|breast|breast
530589|NCT00904384|HIV+|hiv+
530590|NCT00904384|COPD|copd
530591|NCT00904384|emphysema|emphysema
530592|NCT00904358|internal jugular vein|internal jugular vein
530593|NCT00904358|cross sectional area|cross sectional area
530594|NCT00904358|ultrasound|ultrasound
530595|NCT00904358|central venous pressure|central venous pressure
530596|NCT00904345|SCC Head and Neck Cancer|scc head and neck cancer
530597|NCT00904332|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
530598|NCT00904332|Electroencephalogram (EEG)|electroencephalogram (eeg)
530599|NCT00904332|Motor Learning|motor learning
530600|NCT00904332|Health Volunteer|health volunteer
530601|NCT00904332|HV|hv
530602|NCT00904319|osteoarthritis|osteoarthritis
530603|NCT00904319|knee pain|knee pain
530604|NCT00904319|power training|power training
530605|NCT00904319|rehabilitation|rehabilitation
530606|NCT00904306|binge eating|binge eating
530607|NCT00904306|chromium|chromium
530608|NCT00904306|mood|mood
530609|NCT00904306|glucose|glucose
530610|NCT00904306|appetite|appetite
530611|NCT00904293|warfarin|warfarin
530612|NCT00904293|CYP2C9|cyp2c9
530613|NCT00904293|VKOR|vkor
530614|NCT00904293|Coumadin|coumadin
530615|NCT00904293|pharmacogenetics|pharmacogenetics
530616|NCT00904293|pharmacogenomics|pharmacogenomics
530617|NCT00904293|anticoagulation|anticoagulation
530618|NCT00904293|genotype-guided therapy|genotype-guided therapy
530619|NCT00904254|cerebrovascular disorders|cerebrovascular disorders
530620|NCT00904254|symptomatic carotid artery stenosis|symptomatic carotid artery stenosis
530621|NCT00904254|asymptomatic carotid artery stenosis|asymptomatic carotid artery stenosis
530622|NCT00904254|monoclonal antibody|monoclonal antibody
530623|NCT00904254|diagnostics|diagnostics
530624|NCT00904254|molecular target|molecular target
530625|NCT00904254|immunoglobulin Fab fragments|immunoglobulin fab fragments
530626|NCT00904254|physiological effects of drugs|physiological effects of drugs
530627|NCT00904254|Tc99m-pertechnetate|tc99m-pertechnetate
530628|NCT00904254|Fab-fragment of Anti-human CD4|fab-fragment of anti-human cd4
530629|NCT00904254|Antibodies, Monoclonal|antibodies, monoclonal
530630|NCT00904254|Antibodies|antibodies
530631|NCT00904228|hypothermia|hypothermia
530632|NCT00904228|euthermia|euthermia
530633|NCT00904228|hyperthermia|hyperthermia
530634|NCT00904228|mortality|mortality
530635|NCT00904228|morbidity|morbidity
530636|NCT00904228|sepsis|sepsis
530637|NCT00904228|bronchopulmonary dysplasia|bronchopulmonary dysplasia
530638|NCT00904228|intraventricular hemorrhage|intraventricular hemorrhage
530639|NCT00904228|ventilator days|ventilator days
530640|NCT00904150|menstruation|menstruation
530641|NCT00904150|migraine|migraine
530642|NCT00904150|menstrual migraine|menstrual migraine
530643|NCT00904150|genetics|genetics
530644|NCT00904137|Supracondylar fracture|supracondylar fracture
530645|NCT00904137|humerus|humerus
530646|NCT00904137|elbow|elbow
530647|NCT00904124|Dietary fiber|dietary fiber
530648|NCT00904124|guar gum|guar gum
530649|NCT00904124|alginate|alginate
530650|NCT00904124|cellulose|cellulose
530651|NCT00904124|food intake|food intake
530652|NCT00904124|eating behaviour|eating behaviour
530653|NCT00904098|migraine|migraine
530654|NCT00904072|CDSS|cdss
530655|NCT00904072|prescribing error|prescribing error
530656|NCT00904072|prescribing errors influenced by CDSS|prescribing errors influenced by cdss
530657|NCT00904072|CPOE|cpoe
530658|NCT00904046|Uric acid|uric acid
530659|NCT00904046|Nephrolithiasis|nephrolithiasis
530660|NCT00904007|Educational Technology|educational technology
530661|NCT00904007|Hypertension|hypertension
530662|NCT00904007|Education, Professional|education, professional
530663|NCT00903994|Acute Pain|acute pain
530664|NCT00903968|refractory|refractory
530665|NCT00903968|relapsed|relapsed
530666|NCT00903968|bortezomib|bortezomib
530667|NCT00903968|AMD3100|amd3100
530668|NCT00903968|plerixafor|plerixafor
530669|NCT00903955|Mucus|mucus
530670|NCT00903955|COPD|copd
530671|NCT00903955|Chronic Bronchitis|chronic bronchitis
530672|NCT00903916|antipsychotic|antipsychotic
530673|NCT00903916|ghrelin|ghrelin
530674|NCT00903916|PYY|pyy
530675|NCT00903916|appetite|appetite
530676|NCT00903916|weight gain|weight gain
530677|NCT00903903|active synovitis|active synovitis
530678|NCT00903838|Parkinson's disease|parkinson's disease
530679|NCT00903825|femoral artery puncture|femoral artery puncture
530680|NCT00903825|local anesthesia|local anesthesia
530681|NCT00903825|ultrasound guided|ultrasound guided
530682|NCT00903799|Drug-refractory gastroparesis|drug-refractory gastroparesis
530683|NCT00903799|diabetes mellitus induced gastroparesis|diabetes mellitus induced gastroparesis
530684|NCT00903799|Gastric electrical stimulation|gastric electrical stimulation
530685|NCT00903799|Long-term multicenter study|long-term multicenter study
530686|NCT00903786|Seizure|seizure
530687|NCT00903786|epilepsy|epilepsy
530688|NCT00903773|VX-950-TiDP24-C132|vx-950-tidp24-c132
530689|NCT00903773|VX-950-C132|vx-950-c132
530690|NCT00903773|VX-950|vx-950
530691|NCT00903773|HCV|hcv
530692|NCT00903760|Myelodysplastic Syndrome|myelodysplastic syndrome
530693|NCT00903760|MDS|mds
530694|NCT00903760|Leukemia|leukemia
530695|NCT00903760|Decitabine|decitabine
530696|NCT00903760|clofarabine|clofarabine
530697|NCT00903760|Dacogen®|dacogen®
530698|NCT00903760|Clolar®|clolar®
530699|NCT00903747|Prucalopride|prucalopride
530700|NCT00903747|safety study|safety study
530701|NCT00903734|Metastatic Cancer|metastatic cancer
530702|NCT00903734|Histology-independent|histology-independent
530703|NCT00903734|EGFR Mutation|egfr mutation
530704|NCT00903734|EGFR inhibitor-sensitive mutation|egfr inhibitor-sensitive mutation
530705|NCT00903734|Erlotinib Hydrochloride|erlotinib hydrochloride
530706|NCT00903734|Tarceva|tarceva
530707|NCT00903734|OSI-774|osi-774
530708|NCT00903734|Cetuximab|cetuximab
530709|NCT00903734|Bortezomib|bortezomib
530710|NCT00903734|Dasatinib|dasatinib
530711|NCT00903708|Advanced Cancers|advanced cancers
530712|NCT00903708|LY2275796|ly2275796
530713|NCT00903708|Eukaryotic initiation factor 4E|eukaryotic initiation factor 4e
530714|NCT00903708|eIF-4E|eif-4e
530715|NCT00903695|Memory XL|memory xl
530716|NCT00903695|Mild Cognitive Impairment|mild cognitive impairment
530717|NCT00903695|cognitive status|cognitive status
530718|NCT00903682|HIV|hiv
530719|NCT00903682|Intelence|intelence
530720|NCT00903682|etravirine|etravirine
530721|NCT00903682|ETR|etr
530722|NCT00903682|TMC125|tmc125
530723|NCT00903682|Sustiva|sustiva
530724|NCT00903682|efavirenz|efavirenz
530725|NCT00903682|EFV|efv
530726|NCT00903682|Non-nucleoside Reverse Transcriptase Inhibitor|non-nucleoside reverse transcriptase inhibitor
530727|NCT00903682|NNRTI|nnrti
530728|NCT00903682|treatment-naive|treatment-naive
530729|NCT00903669|Facial paralysis|facial paralysis
530730|NCT00903669|Muscle tonus|muscle tonus
530731|NCT00903669|Rehabilitation|rehabilitation
530732|NCT00903669|Myofunctional|myofunctional
530733|NCT00903669|Stomatognathic system|stomatognathic system
530734|NCT00903656|metastatic breast cancer|metastatic breast cancer
530735|NCT00903656|Her2|her2
530736|NCT00903656|Lapatinib|lapatinib
530737|NCT00903656|Caelyx|caelyx
530738|NCT00903656|cardiotoxic|cardiotoxic
530739|NCT00903643|Painful Bladder Syndrome|painful bladder syndrome
530740|NCT00903643|Urinary Bladder|urinary bladder
530741|NCT00903630|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
530742|NCT00903630|fallopian tube cancer|fallopian tube cancer
530743|NCT00903630|peritoneal cavity cancer|peritoneal cavity cancer
530744|NCT00903617|lipids|lipids
530745|NCT00903617|HM74A|hm74a
530746|NCT00903604|Cardiac surgery|cardiac surgery
530747|NCT00903604|coronary artery bypass grafting|coronary artery bypass grafting
530748|NCT00903604|valve surgery|valve surgery
530749|NCT00903604|aortic root or ascending aortic aneurysm repair surgery|aortic root or ascending aortic aneurysm repair surgery
530750|NCT00903604|Acute kidney injury|acute kidney injury
530751|NCT00903591|Breast|breast
530752|NCT00903591|cancer|cancer
530753|NCT00903591|09-040|09-040
530754|NCT00903591|blood sample|blood sample
530755|NCT00903591|saliva sample|saliva sample
530756|NCT00903591|WECARE|wecare
530757|NCT00903591|GWA|gwa
530758|NCT00903578|FGF-23|fgf-23
530759|NCT00903578|vitamin D|vitamin d
530760|NCT00903578|phosphate|phosphate
530761|NCT00903578|allograft dysfunction|allograft dysfunction
530762|NCT00903578|mortality|mortality
530763|NCT00903565|genomic profiling|genomic profiling
530764|NCT00903565|gene expression|gene expression
530765|NCT00903565|ColoPrint|coloprint
530766|NCT00903565|adenocarcinoma colon|adenocarcinoma colon
530767|NCT00903565|recurrence risk assessment|recurrence risk assessment
530768|NCT00903565|prospective|prospective
530769|NCT00903539|Peripherally Inserted Central Catheter|peripherally inserted central catheter
530770|NCT00903539|Central Venous Catheter|central venous catheter
530771|NCT00903539|Intravenous Catheter|intravenous catheter
530772|NCT00903539|StatLock|statlock
530773|NCT00903539|Patients indicated to have an intravenous catheter placed|patients indicated to have an intravenous catheter placed
530774|NCT00903526|fungal susceptibility|fungal susceptibility
530775|NCT00903474|anxiety disorder|anxiety disorder
530776|NCT00903474|depression|depression
530777|NCT00903474|cognitive/functional effects|cognitive/functional effects
530778|NCT00903474|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
530779|NCT00903474|cancer survivor|cancer survivor
530780|NCT00903474|breast cancer|breast cancer
530781|NCT00903448|Normal Healthy Subject Population|normal healthy subject population
530782|NCT00903435|Cystitis|cystitis
530783|NCT00903435|Urinary|urinary
530784|NCT00903435|Bladder|bladder
530785|NCT00903422|Advanced Myelodysplastic Syndrome|advanced myelodysplastic syndrome
530786|NCT00903422|Thrombocytopenia|thrombocytopenia
530787|NCT00903422|sAML/MDS|saml/mds
530789|NCT00903422|TPO-R agonist|tpo-r agonist
530790|NCT00903422|de novo AML|de novo aml
530791|NCT00903422|Thrombopoietin|thrombopoietin
530792|NCT00903422|MDS|mds
530793|NCT00903422|Thrombopoietin receptor agonist|thrombopoietin receptor agonist
530794|NCT00903422|secondary Acute Myeloid Leukemia after MDS|secondary acute myeloid leukemia after mds
530795|NCT00903422|Platelets|platelets
530796|NCT00903409|High triglycerides|high triglycerides
530797|NCT00903409|Lovaza|lovaza
530798|NCT00903409|simvastatin|simvastatin
530799|NCT00903409|omega-3-acid ethyl esters|omega-3-acid ethyl esters
530800|NCT00903396|nausea and vomiting|nausea and vomiting
530801|NCT00903396|gastrointestinal carcinoid tumor|gastrointestinal carcinoid tumor
530802|NCT00903396|anal cancer|anal cancer
530803|NCT00903396|carcinoma of the appendix|carcinoma of the appendix
530804|NCT00903396|colon cancer|colon cancer
530805|NCT00903396|rectal cancer|rectal cancer
530806|NCT00903396|extrahepatic bile duct cancer|extrahepatic bile duct cancer
530807|NCT00903396|gallbladder cancer|gallbladder cancer
530808|NCT00903396|gastric cancer|gastric cancer
530809|NCT00903396|liver and intrahepatic biliary tract cancer|liver and intrahepatic biliary tract cancer
530810|NCT00903396|pancreatic cancer|pancreatic cancer
530811|NCT00903396|small intestine cancer|small intestine cancer
530812|NCT00903396|primary peritoneal cavity cancer|primary peritoneal cavity cancer
530813|NCT00903370|Mitral Valve Regurgitation|mitral valve regurgitation
530814|NCT00903370|Mitral Valve Surgery|mitral valve surgery
530815|NCT00903370|Mitral Valve Disease|mitral valve disease
530816|NCT00903370|Ablation, Catheter|ablation, catheter
530817|NCT00903370|Catheter Ablation, Radiofrequency|catheter ablation, radiofrequency
530818|NCT00903357|Atopic dermatitis|atopic dermatitis
530819|NCT00903357|Montelukast|montelukast
530820|NCT00903331|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
530821|NCT00903331|MUSIC|music
530822|NCT00903318|Endocrine|endocrine
530823|NCT00903318|Environmental Chemicals|environmental chemicals
530824|NCT00903318|Male:Female Birth Ratio|male:female birth ratio
530825|NCT00903318|Phthalate Exposure|phthalate exposure
530826|NCT00903318|Generational sex ratio trends|generational sex ratio trends
530827|NCT00903318|Mexican American|mexican american
530828|NCT00903318|Baytown|baytown
530829|NCT00903318|Rio Grande Valley|rio grande valley
530830|NCT00903318|Hidalgo County|hidalgo county
530831|NCT00903318|Texas|texas
530832|NCT00903305|pain|pain
530833|NCT00903305|fatigue|fatigue
530834|NCT00903305|nausea and vomiting|nausea and vomiting
530835|NCT00903305|stage I breast cancer|stage i breast cancer
530836|NCT00903305|stage II breast cancer|stage ii breast cancer
530837|NCT00903305|stage IIIA breast cancer|stage iiia breast cancer
530838|NCT00903305|stage IIIB breast cancer|stage iiib breast cancer
530839|NCT00903305|stage IIIC breast cancer|stage iiic breast cancer
530840|NCT00903292|EGFR|egfr
530841|NCT00903292|NSCLC|nsclc
530842|NCT00903292|EGFR mutation rate|egfr mutation rate
530843|NCT00903279|MRSA colonization|mrsa colonization
530844|NCT00903279|Orthopedic Surgery|orthopedic surgery
530845|NCT00903279|Altabax|altabax
530846|NCT00903279|Placebo|placebo
530847|NCT00903266|Aphasia|aphasia
530848|NCT00903266|Speech Impairment|speech impairment
530849|NCT00903266|Stroke|stroke
530850|NCT00903266|Cerebrovascular Accident|cerebrovascular accident
530851|NCT00903266|Cerebral Infarction|cerebral infarction
530852|NCT00903266|Brain Ischemia|brain ischemia
530853|NCT00903266|Brain Infarction|brain infarction
530854|NCT00903266|Cerebrovascular Disorder|cerebrovascular disorder
530855|NCT00903227|Asthma|asthma
530856|NCT00903227|Allergic rhinitis|allergic rhinitis
530857|NCT00903227|fluticasone|fluticasone
530858|NCT00903227|methacholine|methacholine
530859|NCT00903214|stage I breast cancer|stage i breast cancer
530860|NCT00903214|stage II breast cancer|stage ii breast cancer
530861|NCT00903214|stage IIIA breast cancer|stage iiia breast cancer
530862|NCT00903201|cystic fibrosis|cystic fibrosis
530863|NCT00903188|Renal Transplantation|renal transplantation
530864|NCT00903188|graft function|graft function
530865|NCT00903188|cardiovascular events|cardiovascular events
530866|NCT00903188|malignancy|malignancy
530867|NCT00903188|cyclosporin|cyclosporin
530868|NCT00903188|steroids|steroids
530869|NCT00903188|mycophenolate|mycophenolate
530870|NCT00903188|everolimus|everolimus
530871|NCT00903188|renal biopsies|renal biopsies
530872|NCT00903188|pharmacokinetics|pharmacokinetics
530873|NCT00903175|RAD001|rad001
530874|NCT00903175|everolimus|everolimus
530875|NCT00903175|sunitinib|sunitinib
530876|NCT00903175|renal cell carcinoma|renal cell carcinoma
530877|NCT00903175|kidney cancer|kidney cancer
530878|NCT00903175|metastatic renal cell cancer|metastatic renal cell cancer
530879|NCT00903175|advanced kidney cancer|advanced kidney cancer
530880|NCT00903162|hormone-receptor positive|hormone-receptor positive
530881|NCT00903162|tamoxifen|tamoxifen
530882|NCT00903162|letrozole|letrozole
530883|NCT00903162|zoledronic acid|zoledronic acid
530884|NCT00903162|leuprolide|leuprolide
530885|NCT00903149|Premature babies|premature babies
530886|NCT00903149|Social interaction|social interaction
531391|NCT00901277|Post MI|post mi
530887|NCT00903149|Psychoeducative intervention|psychoeducative intervention
530888|NCT00903149|Mother Infant Transaction Program|mother infant transaction program
530889|NCT00903149|Three years follow-up|three years follow-up
530890|NCT00903149|Late preterm|late preterm
530891|NCT00903149|Cognitive development|cognitive development
530892|NCT00903149|Social development|social development
530893|NCT00903149|Emotional development|emotional development
530894|NCT00903149|Motor development|motor development
530895|NCT00903149|Children born preterm and their parents|children born preterm and their parents
530896|NCT00903136|Barrett esophagus|barrett esophagus
530897|NCT00903136|esophageal cancer|esophageal cancer
530898|NCT00903136|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
530899|NCT00903084|Pharmacokinetics in Hair|pharmacokinetics in hair
530900|NCT00903084|Tenofovir|tenofovir
530901|NCT00903084|Pharmacokinetics|pharmacokinetics
530902|NCT00903084|Concentrations|concentrations
530903|NCT00903084|Hair|hair
530904|NCT00903071|Hypertension|hypertension
530905|NCT00903071|Primary Care|primary care
530906|NCT00903071|Physician Learning|physician learning
530907|NCT00903045|Overactive bladder|overactive bladder
530908|NCT00903045|Propiverin|propiverin
530909|NCT00903032|compliance/adherence|compliance/adherence
530910|NCT00903019|Homebound|homebound
530911|NCT00903019|Older Adults|older adults
530912|NCT00903019|Disability|disability
530913|NCT00903019|Videoconferencing|videoconferencing
530914|NCT00903006|Breast|breast
530915|NCT00903006|Hormone receptor-positive metastatic breast cancer|hormone receptor-positive metastatic breast cancer
530916|NCT00903006|Fulvestrant|fulvestrant
530917|NCT00903006|Faslodex|faslodex
530918|NCT00903006|MK-0646|mk-0646
530919|NCT00903006|Dasatinib|dasatinib
530920|NCT00903006|BMS-354825|bms-354825
530921|NCT00903006|Sprycel|sprycel
530922|NCT00903006|Adjuvant hormonal therapy|adjuvant hormonal therapy
530923|NCT00902993|MAD|mad
530924|NCT00902993|NNR|nnr
530925|NCT00902993|to investigate safety and tolerability in a multiple ascending dose study in Healthy subjects|to investigate safety and tolerability in a multiple ascending dose study in healthy subjects
530926|NCT00902993|AZD1446|azd1446
530927|NCT00902980|Kidney transplantation|kidney transplantation
530928|NCT00902980|Tacrolimus|tacrolimus
530929|NCT00902980|Immunosuppression|immunosuppression
530930|NCT00902967|Postoperative pain|postoperative pain
530931|NCT00902967|atorvastatin|atorvastatin
530932|NCT00902967|analgesic|analgesic
530933|NCT00902967|antiinflammatory|antiinflammatory
530934|NCT00902954|Disease free survival|disease free survival
530935|NCT00902954|Distant disease free survival|distant disease free survival
530936|NCT00902954|Toxicity|toxicity
530937|NCT00902954|Overall survival|overall survival
530938|NCT00902941|Parkinson´s disease|parkinson´s disease
530939|NCT00902941|olfaction|olfaction
530940|NCT00902941|rasagiline|rasagiline
530941|NCT00902941|smell testing|smell testing
530942|NCT00902928|Elective hip replacement surgery|elective hip replacement surgery
530943|NCT00902928|Factor Xa|factor xa
530944|NCT00902928|Venous Thromboembolism|venous thromboembolism
530945|NCT00902928|Thrombosis|thrombosis
530946|NCT00902928|Anticoagulants|anticoagulants
530947|NCT00902928|Prevention|prevention
530948|NCT00902928|YM150|ym150
531071|NCT00902343|Cancer|cancer
530949|NCT00902915|multiple myeloma renal insufficiency|multiple myeloma renal insufficiency
530950|NCT00902902|Hepatocellular carcinoma|hepatocellular carcinoma
530951|NCT00902889|Globus pallidus|globus pallidus
530952|NCT00902889|Huntington's Disease|huntington's disease
530953|NCT00902889|Deep Brain Stimulation|deep brain stimulation
530954|NCT00902889|Movement Disorders|movement disorders
530955|NCT00902876|root coverage|root coverage
530956|NCT00902876|gingival recession|gingival recession
530957|NCT00902876|keratinized gingiva|keratinized gingiva
530958|NCT00902863|chronic pain|chronic pain
530959|NCT00902863|mindfulness|mindfulness
530960|NCT00902863|yoga|yoga
530961|NCT00902863|quality of life|quality of life
530962|NCT00902863|stress|stress
530963|NCT00902837|randomised|randomised
530964|NCT00902837|double-blind|double-blind
530965|NCT00902837|double-dummy|double-dummy
530966|NCT00902837|parallel-group|parallel-group
530967|NCT00902837|non-inferiority|non-inferiority
530968|NCT00902837|pain locomotor function|pain locomotor function
530969|NCT00902837|improvement in symptoms of constipation|improvement in symptoms of constipation
530970|NCT00902837|moderate to severe pain due to osteoarthritis (OA)|moderate to severe pain due to osteoarthritis (oa)
530971|NCT00902837|OXN PR|oxn pr
530972|NCT00902837|OxyPR|oxypr
530973|NCT00902837|Moderate to severe chronic nonmalignant OA|moderate to severe chronic nonmalignant oa
530974|NCT00902824|HIV|hiv
530975|NCT00902811|uncomplicated falciparum malaria|uncomplicated falciparum malaria
530976|NCT00902811|artemisinin combination therapy|artemisinin combination therapy
530977|NCT00902798|Autism|autism
530978|NCT00902798|Autism Spectrum Disorders|autism spectrum disorders
530979|NCT00902798|Asperger's Syndrome|asperger's syndrome
530980|NCT00902798|Pervasive Developmental Disorder|pervasive developmental disorder
530981|NCT00902798|Cognition|cognition
530982|NCT00902798|Social Cognition|social cognition
530983|NCT00902798|Psychosocial Treatment|psychosocial treatment
530984|NCT00902798|Cognitive Enhancement Therapy|cognitive enhancement therapy
530985|NCT00902798|Enriched Supportive Therapy|enriched supportive therapy
530986|NCT00902798|Therapy|therapy
530987|NCT00902798|Psychotherapy|psychotherapy
530988|NCT00902785|exploratory|exploratory
530989|NCT00902785|observational|observational
530990|NCT00902785|non-interventional study age-related macular degeneration (AMD) choroidal neovascularization (CNV)|non-interventional study age-related macular degeneration (amd) choroidal neovascularization (cnv)
530991|NCT00902772|Recreational CNS depressant|recreational cns depressant
530992|NCT00902772|Abuse liability|abuse liability
530993|NCT00902772|Abuse potential|abuse potential
530994|NCT00902772|Healthy Recreational CNS Depressant Users|healthy recreational cns depressant users
530995|NCT00902759|Surgery|surgery
530996|NCT00902759|Chemotherapy|chemotherapy
530997|NCT00902759|Radiation Therapy|radiation therapy
530998|NCT00902759|Pancreatic cancer|pancreatic cancer
530999|NCT00902759|Fatigue|fatigue
531000|NCT00902733|pain|pain
531001|NCT00902733|fatigue|fatigue
531002|NCT00902733|nausea and vomiting|nausea and vomiting
531003|NCT00902733|recurrent pancreatic cancer|recurrent pancreatic cancer
531004|NCT00902733|stage I pancreatic cancer|stage i pancreatic cancer
531005|NCT00902733|stage II pancreatic cancer|stage ii pancreatic cancer
531006|NCT00902733|stage III pancreatic cancer|stage iii pancreatic cancer
531007|NCT00902733|stage IV pancreatic cancer|stage iv pancreatic cancer
531008|NCT00902720|Ovarian|ovarian
531009|NCT00902720|Tissue|tissue
531010|NCT00902720|Cryopreservation|cryopreservation
531011|NCT00902707|healthy nonsmokers|healthy nonsmokers
531012|NCT00902694|Serious Mental Illness|serious mental illness
531013|NCT00902694|Weight Loss|weight loss
531014|NCT00902681|Bioequivalence, Pharmacokinetics|bioequivalence, pharmacokinetics
531015|NCT00902668|radiation toxicity|radiation toxicity
531016|NCT00902668|stage IA breast cancer|stage ia breast cancer
531017|NCT00902668|stage IB breast cancer|stage ib breast cancer
531018|NCT00902668|stage II breast cancer|stage ii breast cancer
531019|NCT00902668|breast cancer in situ|breast cancer in situ
531020|NCT00902655|Nocturnal polyuria|nocturnal polyuria
531021|NCT00902655|Nocturnal bladder capacity|nocturnal bladder capacity
531022|NCT00902642|Physical therapy,|physical therapy,
531023|NCT00902642|musculoskeletal pain,|musculoskeletal pain,
531024|NCT00902642|psychosocial factors,|psychosocial factors,
531025|NCT00902642|dissimilation,|dissimilation,
531026|NCT00902642|evidence based,|evidence based,
531027|NCT00902642|education|education
531028|NCT00902629|Epiretinal Fibrosis|epiretinal fibrosis
531029|NCT00902629|Macular Pucker|macular pucker
531030|NCT00902616|Type 2 diabetes|type 2 diabetes
531031|NCT00902616|Peripheral neuropathy|peripheral neuropathy
531032|NCT00902616|Microcirculation|microcirculation
531033|NCT00902603|pulmonary arterial hypertension|pulmonary arterial hypertension
531034|NCT00902603|Ventavis®|ventavis®
531035|NCT00902603|iloprost|iloprost
531036|NCT00902590|renal pelvis|renal pelvis
531037|NCT00902590|ureter|ureter
531038|NCT00902590|bladder|bladder
531039|NCT00902590|09-025|09-025
531040|NCT00902590|Renal Pelvis, Ureter, Bladder Cancer|renal pelvis, ureter, bladder cancer
531041|NCT00902564|Generalized Anxiety Disorder|generalized anxiety disorder
531042|NCT00902564|GAD|gad
531043|NCT00902564|Antidepressant|antidepressant
531044|NCT00902564|Anxiolytic|anxiolytic
531045|NCT00902551|DNA cytometry|dna cytometry
531046|NCT00902551|Cytology|cytology
531047|NCT00902551|Diagnosis accuracy|diagnosis accuracy
531048|NCT00902538|Add on treatment|add on treatment
531049|NCT00902538|essential hypertension|essential hypertension
531050|NCT00902525|two sequential doses of 90Y-Ibritumomab Tiuxetan|two sequential doses of 90y-ibritumomab tiuxetan
531051|NCT00902499|functional magnetic resonance imaging|functional magnetic resonance imaging
531052|NCT00902486|Rheumatoid arthritis|rheumatoid arthritis
531053|NCT00902473|Topiramate fed study|topiramate fed study
531054|NCT00902460|drug interactions CYP3A4 CYP3A5 midazolam anti-rheumatic agents|drug interactions cyp3a4 cyp3a5 midazolam anti-rheumatic agents
531055|NCT00902447|Human Blood Cell Disorders|human blood cell disorders
531056|NCT00902447|lymphoid, myeloid and erythroid proliferative disease|lymphoid, myeloid and erythroid proliferative disease
531057|NCT00902434|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
531058|NCT00902421|Overactive bladder|overactive bladder
531059|NCT00902421|SSRI|ssri
531060|NCT00902421|Antimuscarinics|antimuscarinics
531061|NCT00902395|Preschool children|preschool children
531062|NCT00902382|Infertility|infertility
531063|NCT00902382|Ovulation stimulation|ovulation stimulation
531064|NCT00902382|Pregnancy|pregnancy
531065|NCT00902369|AK106-001616|ak106-001616
531066|NCT00902356|Amgen|amgen
531067|NCT00902356|Phase 1|phase 1
531068|NCT00902356|First in Human|first in human
531069|NCT00902356|Postmenopausal|postmenopausal
531070|NCT00902343|Liver|liver
531072|NCT00902343|Primary|primary
531073|NCT00902343|Metastatic|metastatic
531074|NCT00902343|transfusions|transfusions
531075|NCT00902343|08-158|08-158
531076|NCT00902330|depression|depression
531077|NCT00902330|anxiety disorder|anxiety disorder
531078|NCT00902330|fatigue|fatigue
531079|NCT00902330|pain|pain
531080|NCT00902330|sleep disorders|sleep disorders
531081|NCT00902330|stage IA breast cancer|stage ia breast cancer
531082|NCT00902330|stage IB breast cancer|stage ib breast cancer
531083|NCT00902330|stage II breast cancer|stage ii breast cancer
531084|NCT00902330|stage IIIA breast cancer|stage iiia breast cancer
531085|NCT00902304|Hypertension|hypertension
531086|NCT00902304|valsartan|valsartan
531087|NCT00902291|Clinical Trial, Phase II|clinical trial, phase ii
531088|NCT00902291|Combination Drug Therapy|combination drug therapy
531089|NCT00902291|Gemcitabine|gemcitabine
531090|NCT00902291|AGS-1C4D4|ags-1c4d4
531091|NCT00902291|Pancreatic Cancer|pancreatic cancer
531092|NCT00902278|influenzavirus A|influenzavirus a
531093|NCT00902278|influenzavirus B|influenzavirus b
531094|NCT00902278|human influenza|human influenza
531095|NCT00902278|T lymphocytes|t lymphocytes
531096|NCT00902278|influenza vaccines|influenza vaccines
531097|NCT00902226|Social Anxiety Disorder|social anxiety disorder
531098|NCT00902226|SAD|sad
531099|NCT00902226|Antidepressant|antidepressant
531100|NCT00902226|Anxiolytic|anxiolytic
531101|NCT00902200|Glaucoma|glaucoma
531102|NCT00902200|Intraocular pressure|intraocular pressure
531103|NCT00902187|Bioequivalence|bioequivalence
531104|NCT00902174|Pulmonary arterial hypertension|pulmonary arterial hypertension
531105|NCT00902174|Imatinib|imatinib
531106|NCT00902174|6MWD|6mwd
531107|NCT00902174|Borg scale|borg scale
531108|NCT00902174|Pulmonary hypertension|pulmonary hypertension
531109|NCT00902148|Surgery|surgery
531110|NCT00902148|Colectomy|colectomy
531111|NCT00902148|Proctocolectomy|proctocolectomy
531112|NCT00902148|Adhesions|adhesions
531113|NCT00902135|Multiple Sclerosis|multiple sclerosis
531114|NCT00902135|Interferon beta-1b|interferon beta-1b
531115|NCT00902122|p53 gene|p53 gene
531116|NCT00902122|thyroid|thyroid
531117|NCT00902122|gene therapy|gene therapy
531118|NCT00902122|malignant tumors|malignant tumors
531119|NCT00902109|visual field|visual field
531120|NCT00902109|perimetry|perimetry
531121|NCT00902109|progression|progression
531122|NCT00902109|POAG|poag
531123|NCT00902109|glaucoma|glaucoma
531124|NCT00902096|cord blood|cord blood
531125|NCT00902096|IgE|ige
531126|NCT00902096|prenatal|prenatal
531127|NCT00902096|predictor|predictor
531128|NCT00902083|p53 gene|p53 gene
531129|NCT00902083|Oral and Maxillofacial|oral and maxillofacial
531130|NCT00902083|gene therapy|gene therapy
531131|NCT00902083|malignant tumors|malignant tumors
531132|NCT00902044|Refractory Sarcoma|refractory sarcoma
531133|NCT00902044|Metastatic Sarcoma|metastatic sarcoma
531134|NCT00902044|Sarcoma|sarcoma
531135|NCT00902044|HER2-positive|her2-positive
531136|NCT00902044|Gene Therapy|gene therapy
531137|NCT00902044|HER2-specific T cells|her2-specific t cells
531138|NCT00902031|Docusate|docusate
531139|NCT00902031|Constipation|constipation
531140|NCT00902031|Colace|colace
531141|NCT00902031|Palliative Care|palliative care
531142|NCT00902031|Sennoside|sennoside
531143|NCT00902031|Senokot|senokot
531144|NCT00902031|Terminally Ill|terminally ill
531145|NCT00902031|Stool|stool
531146|NCT00902031|Randomized Trial|randomized trial
531147|NCT00902018|ITP|itp
531148|NCT00902005|Endothelial dysfunction|endothelial dysfunction
531149|NCT00902005|Bone and cartilage markers|bone and cartilage markers
531150|NCT00902005|Inflammatory disease activity|inflammatory disease activity
531151|NCT00902005|Rheumatoid arthritis|rheumatoid arthritis
531152|NCT00902005|Psoriatic arthritis|psoriatic arthritis
531153|NCT00902005|Ankylosing Spondylitis|ankylosing spondylitis
531154|NCT00901992|type 2 diabetes|type 2 diabetes
531155|NCT00901992|education|education
531156|NCT00901992|self-management|self-management
531157|NCT00901992|insulin therapy|insulin therapy
531158|NCT00901979|Type 2 Diabetes|type 2 diabetes
531159|NCT00901966|Melanoma|melanoma
531160|NCT00901966|Sun Exposure History|sun exposure history
531161|NCT00901966|Sun Exposure|sun exposure
531162|NCT00901953|migraine|migraine
531163|NCT00901953|migrainous vertigo|migrainous vertigo
531164|NCT00901953|vestibular evoked myogenic potentials|vestibular evoked myogenic potentials
531165|NCT00901953|vestibular function test|vestibular function test
531166|NCT00901953|vestibular disorders|vestibular disorders
531167|NCT00901927|Lymphoma|lymphoma
531168|NCT00901927|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
531169|NCT00901927|Untreated High Risk Follicular Lymphoma|untreated high risk follicular lymphoma
531170|NCT00901927|Bendamustine hydrochloride|bendamustine hydrochloride
531171|NCT00901927|Bendamustine HCI|bendamustine hci
531172|NCT00901927|Bendamustine|bendamustine
531173|NCT00901927|CEP-18083|cep-18083
531174|NCT00901927|SDX-105|sdx-105
531175|NCT00901927|Treanda|treanda
531176|NCT00901927|Mitoxantrone|mitoxantrone
531177|NCT00901927|Novantrone|novantrone
531178|NCT00901927|Rituximab|rituximab
531179|NCT00901927|Rituxan|rituxan
531180|NCT00901914|Hypersensitivity|hypersensitivity
531181|NCT00901914|Allergy|allergy
531182|NCT00901914|Birch, allergy, Sublingual Immunotherapy|birch, allergy, sublingual immunotherapy
531183|NCT00901901|Sorafenib (Nexavar)|sorafenib (nexavar)
531184|NCT00901901|Erlotinib (Tarceva)|erlotinib (tarceva)
531185|NCT00901901|First Line|first line
531186|NCT00901901|HCC|hcc
531187|NCT00901888|Renin Angiotensin System|renin angiotensin system
531188|NCT00901875|Buprenorphine|buprenorphine
531189|NCT00901875|Naloxone|naloxone
531190|NCT00901875|Suboxone|suboxone
531191|NCT00901862|Migraine|migraine
531192|NCT00901862|therapy|therapy
531193|NCT00901862|magnetic therapy|magnetic therapy
531194|NCT00901862|prophylaxis|prophylaxis
531195|NCT00901862|prevention|prevention
531196|NCT00901836|Sarcoma|sarcoma
531197|NCT00901810|Length Determination|length determination
531198|NCT00901810|Working Length|working length
531199|NCT00901810|Electronic Apex Locator|electronic apex locator
531200|NCT00901810|Root Canal Therapy|root canal therapy
531201|NCT00901810|Endodontics|endodontics
531202|NCT00901797|ABD|abd
531203|NCT00901797|ABDuction|abduction
531204|NCT00901797|ABR|abr
531205|NCT00901797|Arthroscopic Bankart Repair|arthroscopic bankart repair
531206|NCT00901797|ACJ|acj
531207|NCT00901797|AcromioClavicular Joint|acromioclavicular joint
531208|NCT00901797|AD|ad
531209|NCT00901797|Anterior Drawer|anterior drawer
531210|NCT00901797|ARIC|aric
531211|NCT00901797|Arthroscopic Rotator Interval Closure|arthroscopic rotator interval closure
531212|NCT00901797|BL|bl
531213|NCT00901797|Bankart Lesion|bankart lesion
531214|NCT00901797|CHL|chl
531215|NCT00901797|CoracoHumeral Ligament|coracohumeral ligament
531216|NCT00901797|ER|er
531217|NCT00901797|External Rotation|external rotation
531218|NCT00901797|FF|ff
531219|NCT00901797|Forward Flexion|forward flexion
531220|NCT00901797|GHJ|ghj
531221|NCT00901797|GlenoHumeral Joint|glenohumeral joint
531222|NCT00901797|HSL|hsl
531223|NCT00901797|HillSacs Lesion|hillsacs lesion
531224|NCT00901797|IR|ir
531225|NCT00901797|Internal Rotation|internal rotation
531226|NCT00901797|ISP|isp
531227|NCT00901797|InfraSPinatus|infraspinatus
531228|NCT00901797|PD|pd
531229|NCT00901797|Posterior Drawer|posterior drawer
531230|NCT00901797|RI|ri
531231|NCT00901797|Rotator Interval|rotator interval
531232|NCT00901797|ROM|rom
531233|NCT00901797|Range Of Motion|range of motion
531234|NCT00901797|SGHL|sghl
531235|NCT00901797|Superior GlenoHumeral Ligament|superior glenohumeral ligament
531236|NCT00901797|SSC|ssc
531237|NCT00901797|SubSCapularis|subscapularis
531238|NCT00901797|SSP|ssp
531239|NCT00901797|SupraSPinatus|supraspinatus
531240|NCT00901784|Topiramate fasting study|topiramate fasting study
531241|NCT00901771|Sleep|sleep
531242|NCT00901771|Sleep Apnea, Obstructive|sleep apnea, obstructive
531243|NCT00901771|OSA|osa
531244|NCT00901771|OSAH|osah
531245|NCT00901745|Renin angiotensin system|renin angiotensin system
531246|NCT00901745|Apelin|apelin
531247|NCT00901745|Vasodilatation|vasodilatation
531248|NCT00901745|Heart disease|heart disease
531249|NCT00901745|Vascular biology|vascular biology
531250|NCT00901732|Caphosol|caphosol
531251|NCT00901732|Oral Mucositis|oral mucositis
531252|NCT00901732|Eusa Pharma|eusa pharma
531253|NCT00901732|Moffitt Cancer Center|moffitt cancer center
531254|NCT00901719|Renin angiotensin system|renin angiotensin system
531255|NCT00901719|Apelin|apelin
531256|NCT00901719|Cardiac output|cardiac output
531257|NCT00901719|Vasodilatation|vasodilatation
531258|NCT00901706|Self-Neglect|self-neglect
531259|NCT00901706|Comprehensive Geriatric Assessment (CGA)|comprehensive geriatric assessment (cga)
531260|NCT00901706|Geriatric Syndromes|geriatric syndromes
531261|NCT00901706|Quality of Life|quality of life
531262|NCT00901706|Basic Activities of Daily Living|basic activities of daily living
531263|NCT00901706|Instrumental Activities of Daily Living|instrumental activities of daily living
531264|NCT00901693|pink eye|pink eye
531265|NCT00901693|eye infection|eye infection
531266|NCT00901693|conjunctivitis|conjunctivitis
531267|NCT00901680|Tissue Bank|tissue bank
531268|NCT00901654|Vaccination|vaccination
531269|NCT00901654|Diarrhea|diarrhea
531270|NCT00901654|Traveler's Diarrhea|traveler's diarrhea
531271|NCT00901654|ETEC|etec
531272|NCT00901654|Enterotoxigenic E. coli|enterotoxigenic e. coli
531273|NCT00901641|cognitive training|cognitive training
531274|NCT00901641|insomnia|insomnia
531275|NCT00901628|periarticular multimodal drug injection|periarticular multimodal drug injection
531276|NCT00901615|lymphoma|lymphoma
531277|NCT00901615|lenalidomide|lenalidomide
531278|NCT00901615|gela|gela
531279|NCT00901602|streptococcus pneumoniae|streptococcus pneumoniae
531280|NCT00901602|pneumococcus|pneumococcus
531281|NCT00901602|pneumonia|pneumonia
531282|NCT00901602|meningitis|meningitis
531283|NCT00901602|serotypes|serotypes
531284|NCT00901602|bacteremia|bacteremia
531285|NCT00901602|sepsis|sepsis
531286|NCT00901589|n-3 PUFAs|n-3 pufas
531287|NCT00901589|menopause|menopause
531288|NCT00901589|adipose tissue|adipose tissue
531289|NCT00901589|estrogens|estrogens
531290|NCT00901589|Incorporation of fishoil in pre- and postmenopausal women|incorporation of fishoil in pre- and postmenopausal women
531390|NCT00901290|oral contraceptive|oral contraceptive
531291|NCT00901589|Marine n-3 PUFAs influence on female hormones in blood|marine n-3 pufas influence on female hormones in blood
531292|NCT00901576|Healthy volunteers|healthy volunteers
531293|NCT00901563|Gap Junctions|gap junctions
531294|NCT00901563|Rotigaptide|rotigaptide
531295|NCT00901563|Ischaemia reperfusion|ischaemia reperfusion
531296|NCT00901563|t-PA|t-pa
531297|NCT00901563|Fibrinolysis|fibrinolysis
531298|NCT00901563|Endothelial function|endothelial function
531299|NCT00901563|Venous occlusion plethysmography|venous occlusion plethysmography
531300|NCT00901550|MTX|mtx
531301|NCT00901550|anti-TNF|anti-tnf
531302|NCT00901550|Early RA|early ra
531303|NCT00901537|Non-small Cell Lung Cancer|non-small cell lung cancer
531304|NCT00901537|Head and Neck Cancer|head and neck cancer
531305|NCT00901537|Azacitidine|azacitidine
531306|NCT00901537|Vidaza|vidaza
531307|NCT00901537|Cisplatin|cisplatin
531308|NCT00901524|HCV Genotype 1, 4|hcv genotype 1, 4
531309|NCT00901524|Virological response|virological response
531310|NCT00901524|Ribavirin|ribavirin
531311|NCT00901524|PegPegIFN- alpha 2a|pegpegifn- alpha 2a
531312|NCT00901524|Viral Hepatitis (HCV)|viral hepatitis (hcv)
531313|NCT00901511|Whole lung lavage|whole lung lavage
531314|NCT00901511|Pulmonary surfactant|pulmonary surfactant
531315|NCT00901511|GM-CSF|gm-csf
531316|NCT00901511|Autoantibodies anti GM-CSF|autoantibodies anti gm-csf
531317|NCT00901485|Respiratory insufficiency|respiratory insufficiency
531318|NCT00901485|Hypercapnia|hypercapnia
531319|NCT00901485|Hypoventilation|hypoventilation
531320|NCT00901485|Sleep|sleep
531321|NCT00901485|Polysomnography|polysomnography
531322|NCT00901485|Hypoxia|hypoxia
531323|NCT00901485|Titration|titration
531324|NCT00901485|Non Invasive Ventilation|non invasive ventilation
531325|NCT00901472|Type 2 diabetes,|type 2 diabetes,
531326|NCT00901472|obstructive sleep apnea|obstructive sleep apnea
531327|NCT00901459|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
531328|NCT00901459|Cigarette Smoker|cigarette smoker
531329|NCT00901459|Cigarette Dependence|cigarette dependence
531577|NCT00900588|immunogenictiy|immunogenictiy
531330|NCT00901459|To block cue-elicited craving in dependent cigarette smokers|to block cue-elicited craving in dependent cigarette smokers
531331|NCT00901433|Asthma|asthma
531332|NCT00901433|Wheeze Rate|wheeze rate
531333|NCT00901433|Respiratory Function Tests|respiratory function tests
531334|NCT00901420|Prostate|prostate
531335|NCT00901420|Urodynamic Evaluation|urodynamic evaluation
531336|NCT00901420|Prostatectomy|prostatectomy
531337|NCT00901420|Salvage prostatectomy|salvage prostatectomy
531338|NCT00901420|Bladder compliance|bladder compliance
531339|NCT00901420|Radiation Therapy|radiation therapy
531340|NCT00901420|External beam radiation therapy|external beam radiation therapy
531341|NCT00901420|Quality-of-life|quality-of-life
531342|NCT00901407|augmentation|augmentation
531343|NCT00901407|depression|depression
531344|NCT00901407|resistance|resistance
531345|NCT00901394|Nitrous oxide|nitrous oxide
531346|NCT00901394|cobalamin|cobalamin
531347|NCT00901394|homocysteine|homocysteine
531348|NCT00901394|vitamin B12|vitamin b12
531349|NCT00901394|folate|folate
531350|NCT00901394|No specific diseases targeted|no specific diseases targeted
531351|NCT00901381|Ischemic stroke|ischemic stroke
531352|NCT00901381|Stem cells|stem cells
531353|NCT00901381|Colony-stimulating factors|colony-stimulating factors
531354|NCT00901381|Filgrastim|filgrastim
531355|NCT00901381|Randomized controlled trial|randomized controlled trial
531356|NCT00901355|Blood pressure|blood pressure
531357|NCT00901355|Arterial stiffness|arterial stiffness
531358|NCT00901355|Morbidity|morbidity
531359|NCT00901355|Mortality|mortality
531360|NCT00901355|Elderly|elderly
531361|NCT00901342|Androgen independent prostate cancer (AIPC)|androgen independent prostate cancer (aipc)
531362|NCT00901342|CRPC|crpc
531363|NCT00901342|prostate cancer|prostate cancer
531364|NCT00901342|prostate|prostate
531365|NCT00901342|immune therapy|immune therapy
531366|NCT00901342|immunotherapy|immunotherapy
531367|NCT00901342|vaccine|vaccine
531368|NCT00901342|dendritic cells|dendritic cells
531369|NCT00901342|antigen-presenting cells|antigen-presenting cells
531370|NCT00901342|antigen presenting cells|antigen presenting cells
531371|NCT00901342|cancer vaccine|cancer vaccine
531372|NCT00901342|prostate specific antigen (PSA)|prostate specific antigen (psa)
531373|NCT00901342|prostatic adenocarcinoma|prostatic adenocarcinoma
531374|NCT00901329|TKA|tka
531375|NCT00901329|functional outcome|functional outcome
531376|NCT00901329|pain|pain
531377|NCT00901329|ROM|rom
531378|NCT00901329|gait|gait
531379|NCT00901316|Skin and Soft Tissue Infections|skin and soft tissue infections
531380|NCT00901316|Abscesses|abscesses
531381|NCT00901316|Boils|boils
531382|NCT00901316|Clorox Baths|clorox baths
531383|NCT00901316|Colonization|colonization
531384|NCT00901316|Staph|staph
531385|NCT00901316|MRSA|mrsa
531386|NCT00901316|MSSA|mssa
531387|NCT00901316|Recurrent Infections|recurrent infections
531388|NCT00901316|Prevention CA-SA Infections|prevention ca-sa infections
531389|NCT00901316|Community-Acquired Staphylococcus in Children|community-acquired staphylococcus in children
531392|NCT00901264|Chemosensitivity, chemotherapy, all cancers, personalized chemotherapy, personalized cancer treatment|chemosensitivity, chemotherapy, all cancers, personalized chemotherapy, personalized cancer treatment
531393|NCT00901264|Cancer Patients for whom chemotherapy is planned.|cancer patients for whom chemotherapy is planned.
531394|NCT00901251|OABSS|oabss
531395|NCT00901238|retinoblastoma|retinoblastoma
531396|NCT00901238|intra-arterial chemotherapy|intra-arterial chemotherapy
531397|NCT00901238|chemosurgery|chemosurgery
531398|NCT00901238|melphalan|melphalan
531399|NCT00901238|topotecan|topotecan
531400|NCT00901225|NHL|nhl
531401|NCT00901212|Heart Failure|heart failure
531402|NCT00901212|resynchronisation|resynchronisation
531403|NCT00901212|ICD|icd
531404|NCT00901199|Thalassemia|thalassemia
531405|NCT00901199|Chelation|chelation
531406|NCT00901199|Iron Overload|iron overload
531407|NCT00901199|Thalassemia patients with Iron overload|thalassemia patients with iron overload
531408|NCT00901186|Diabetic Macular Edema|diabetic macular edema
531409|NCT00901186|Ranibizumab|ranibizumab
531410|NCT00901186|Laser Treatment|laser treatment
531411|NCT00901186|Visual impairment|visual impairment
531412|NCT00901173|Case-Control Study|case-control study
531413|NCT00901173|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
531414|NCT00901173|Risk Factors|risk factors
531415|NCT00901160|thromboelastography|thromboelastography
531416|NCT00901160|post-operative complications|post-operative complications
531417|NCT00901160|anti-platelet agents|anti-platelet agents
531418|NCT00901160|prospective|prospective
531419|NCT00901160|pilot|pilot
531420|NCT00901160|patients taking anti-platelet agents|patients taking anti-platelet agents
531421|NCT00901147|t-cell lymphoma|t-cell lymphoma
531422|NCT00901147|peripheral t-cell lymphoma|peripheral t-cell lymphoma
531423|NCT00901147|nk/t-cell lymphoma, nasal type|nk/t-cell lymphoma, nasal type
531424|NCT00901147|bortezomib|bortezomib
531425|NCT00901147|velcade|velcade
531426|NCT00901147|panobinostat|panobinostat
531427|NCT00901147|LBH589b|lbh589b
531428|NCT00901147|histone deacetylase inhibitor|histone deacetylase inhibitor
531429|NCT00901147|proteasome inhibitor|proteasome inhibitor
531430|NCT00901134|therapeutic hypothermia after cardiac arrest|therapeutic hypothermia after cardiac arrest
531431|NCT00901121|maxillary sinus lift|maxillary sinus lift
531432|NCT00901121|Histomorphometric evaluation|histomorphometric evaluation
531433|NCT00901121|bone graft|bone graft
531434|NCT00901121|bone augmentation|bone augmentation
531435|NCT00901108|open angle glaucoma|open angle glaucoma
531436|NCT00901108|trabectome|trabectome
531437|NCT00901108|trabeculectomy|trabeculectomy
531438|NCT00901108|cataract|cataract
531439|NCT00901082|chronic pain|chronic pain
531440|NCT00901082|anxiety|anxiety
531441|NCT00901082|intervention|intervention
531442|NCT00901082|information|information
531443|NCT00901082|relaxation|relaxation
531444|NCT00901056|ED|ed
531445|NCT00901056|Erectile Dysfunction|erectile dysfunction
531446|NCT00901056|Erectile dysfunction treated with PDE-5 inhibitors|erectile dysfunction treated with pde-5 inhibitors
531447|NCT00901030|platelet function|platelet function
531448|NCT00901030|perioperative complications|perioperative complications
531449|NCT00901030|thromboelastography|thromboelastography
531450|NCT00901030|coronary stents|coronary stents
531451|NCT00901030|non-cardiac surgery|non-cardiac surgery
531452|NCT00901004|Minimal Change|minimal change
531453|NCT00901004|GERD|gerd
531454|NCT00901004|GERDQ|gerdq
531455|NCT00900991|Pandemic Influenza A Vaccine|pandemic influenza a vaccine
531456|NCT00900991|Immunogenictiy|immunogenictiy
531457|NCT00900991|Safety|safety
531458|NCT00900978|Streptococcus pneumoniae|streptococcus pneumoniae
531459|NCT00900978|carriage|carriage
531460|NCT00900978|Resistance|resistance
531461|NCT00900978|Serotype|serotype
531462|NCT00900978|vaccination|vaccination
531463|NCT00900978|Colonization of S. pneumoniae|colonization of s. pneumoniae
531464|NCT00900965|irritable bowel syndrome|irritable bowel syndrome
531465|NCT00900965|IBS|ibs
531466|NCT00900965|fMRI|fmri
531467|NCT00900965|acupuncture|acupuncture
531468|NCT00900965|functional|functional
531469|NCT00900965|brain|brain
531470|NCT00900900|Cigarette Smokers|cigarette smokers
531471|NCT00900900|DHEA|dhea
531472|NCT00900900|dehydroepiandrosterone|dehydroepiandrosterone
531473|NCT00900900|pregnenolone|pregnenolone
531474|NCT00900900|Nicotine withdrawal symptoms|nicotine withdrawal symptoms
531475|NCT00900887|diabetic retinopathy|diabetic retinopathy
531476|NCT00900887|clinically significant macular edema|clinically significant macular edema
531477|NCT00900887|selective photocoagulation|selective photocoagulation
531478|NCT00900887|topic ketorolac|topic ketorolac
531479|NCT00900887|topic nepafenac|topic nepafenac
531480|NCT00900887|efficacy|efficacy
531481|NCT00900887|treatment|treatment
531482|NCT00900874|Formoterol|formoterol
531483|NCT00900874|Rapid bronchodilation|rapid bronchodilation
531484|NCT00900861|asthma control level|asthma control level
531485|NCT00900861|visual analogue scale|visual analogue scale
531486|NCT00900848|Posterior tibial artery bypass|posterior tibial artery bypass
531487|NCT00900848|Iliofemoral artery injury|iliofemoral artery injury
531488|NCT00900848|Shock|shock
531489|NCT00900848|Reconstruction|reconstruction
531490|NCT00900835|fatigue|fatigue
531491|NCT00900835|pain|pain
531492|NCT00900835|recurrent breast cancer|recurrent breast cancer
531493|NCT00900835|stage I breast cancer|stage i breast cancer
531494|NCT00900835|stage II breast cancer|stage ii breast cancer
531495|NCT00900835|stage IIIA breast cancer|stage iiia breast cancer
531496|NCT00900835|stage IIIB breast cancer|stage iiib breast cancer
531497|NCT00900835|stage IIIC breast cancer|stage iiic breast cancer
531498|NCT00900835|stage IV breast cancer|stage iv breast cancer
531499|NCT00900835|recurrent prostate cancer|recurrent prostate cancer
531500|NCT00900835|stage I prostate cancer|stage i prostate cancer
531501|NCT00900835|stage II prostate cancer|stage ii prostate cancer
531502|NCT00900835|stage III prostate cancer|stage iii prostate cancer
531503|NCT00900835|stage IV prostate cancer|stage iv prostate cancer
531504|NCT00900835|recurrent colon cancer|recurrent colon cancer
531505|NCT00900835|stage I colon cancer|stage i colon cancer
531506|NCT00900835|stage II colon cancer|stage ii colon cancer
531507|NCT00900835|stage III colon cancer|stage iii colon cancer
531508|NCT00900835|stage IV colon cancer|stage iv colon cancer
531509|NCT00900835|extensive stage small cell lung cancer|extensive stage small cell lung cancer
531510|NCT00900835|limited stage small cell lung cancer|limited stage small cell lung cancer
531511|NCT00900835|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
531512|NCT00900835|recurrent small cell lung cancer|recurrent small cell lung cancer
531513|NCT00900835|stage I non-small cell lung cancer|stage i non-small cell lung cancer
531514|NCT00900835|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
531515|NCT00900835|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
531516|NCT00900835|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
531517|NCT00900835|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
531518|NCT00900822|bone grafting|bone grafting
531519|NCT00900822|sinus elevation|sinus elevation
531520|NCT00900822|sinus augmentation|sinus augmentation
531521|NCT00900809|Acute Myeloid Leukemia|acute myeloid leukemia
531522|NCT00900809|Neukoplast™|neukoplast™
531523|NCT00900809|NK-92|nk-92
531524|NCT00900809|Refractory|refractory
531525|NCT00900809|Refractory or Relapsed Acute Myeloid Leukemia|refractory or relapsed acute myeloid leukemia
531526|NCT00900796|Ankylosing spondylitis;predictive factors|ankylosing spondylitis;predictive factors
531527|NCT00900783|herpes zoster|herpes zoster
531528|NCT00900783|shingles|shingles
531529|NCT00900783|Phase II|phase ii
531530|NCT00900783|FV-100|fv-100
531531|NCT00900783|Inhibitex|inhibitex
531532|NCT00900770|dementia|dementia
531533|NCT00900770|mild cognitive impairment|mild cognitive impairment
531534|NCT00900770|beta amyloid|beta amyloid
531535|NCT00900757|Primary Glioma|primary glioma
531536|NCT00900757|Palonosetron|palonosetron
531537|NCT00900757|Standard Radiotherapy|standard radiotherapy
531538|NCT00900757|Temozolomide|temozolomide
531539|NCT00900744|Tamoxifen|tamoxifen
531540|NCT00900744|Breast Cancer|breast cancer
531541|NCT00900731|COPD|copd
531542|NCT00900731|indacaterol|indacaterol
531543|NCT00900731|beta 2 agonist|beta 2 agonist
531544|NCT00900731|tiotropium|tiotropium
531545|NCT00900692|Excessive pronation|excessive pronation
531546|NCT00900692|CVA|cva
531547|NCT00900692|Forearm|forearm
531548|NCT00900692|Excessive pronation following CVA|excessive pronation following cva
531549|NCT00900679|transitional care planning|transitional care planning
531550|NCT00900679|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
531551|NCT00900679|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
531552|NCT00900679|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
531553|NCT00900679|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
531554|NCT00900666|Stiff knee gait|stiff knee gait
531555|NCT00900666|Gait analysis|gait analysis
531556|NCT00900666|Traumatic Brain Injury|traumatic brain injury
531557|NCT00900666|Acquired Brain Injury|acquired brain injury
531558|NCT00900653|urinary tract infections|urinary tract infections
531559|NCT00900653|postmenopause|postmenopause
531560|NCT00900653|lactobacillus|lactobacillus
531561|NCT00900653|estriol|estriol
531562|NCT00900627|Cancer|cancer
531563|NCT00900627|Tumour|tumour
531564|NCT00900627|Breast cancer|breast cancer
531565|NCT00900627|Metastatic|metastatic
531566|NCT00900627|Secondary|secondary
531567|NCT00900614|Hematologic malignancy|hematologic malignancy
531568|NCT00900614|Prostate carcinoma|prostate carcinoma
531569|NCT00900614|Hematologic cancer|hematologic cancer
531570|NCT00900614|Prostate cancer|prostate cancer
531571|NCT00900601|Sacroiliac pain|sacroiliac pain
531572|NCT00900601|Sacroiliac instability|sacroiliac instability
531573|NCT00900601|Pelvic girdle pain|pelvic girdle pain
531574|NCT00900601|Sacroiliac arthrodesis|sacroiliac arthrodesis
531575|NCT00900601|Arthrodesis|arthrodesis
531576|NCT00900601|Surgery|surgery
531578|NCT00900588|safety|safety
531579|NCT00900588|pandemic influenza A vaccine|pandemic influenza a vaccine
531580|NCT00900575|cervical cancer|cervical cancer
531581|NCT00900575|LEEP|leep
531582|NCT00900575|colposcopy|colposcopy
531583|NCT00900562|Zalypsis|zalypsis
531584|NCT00900562|Cancer|cancer
531585|NCT00900562|Endometrial|endometrial
531586|NCT00900562|Uterine Cervical|uterine cervical
531587|NCT00900562|PharmaMar|pharmamar
531588|NCT00900549|Heart failure|heart failure
531589|NCT00900549|Cardiac resynchronization therapy|cardiac resynchronization therapy
531590|NCT00900549|ICD|icd
531591|NCT00900536|clear cell renal cell carcinoma|clear cell renal cell carcinoma
531592|NCT00900536|stage I renal cell cancer|stage i renal cell cancer
531593|NCT00900536|stage II renal cell cancer|stage ii renal cell cancer
531594|NCT00900536|stage III renal cell cancer|stage iii renal cell cancer
531595|NCT00900536|stage IV renal cell cancer|stage iv renal cell cancer
531596|NCT00900536|papillary renal cell carcinoma|papillary renal cell carcinoma
531597|NCT00900523|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
531598|NCT00900523|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
531599|NCT00900523|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
531600|NCT00900523|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
531601|NCT00900523|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
531602|NCT00900510|subcutaneous abscess|subcutaneous abscess
531603|NCT00900510|Incision and drainage|incision and drainage
531604|NCT00900510|Methicillin-resistant staphylococcus aureus|methicillin-resistant staphylococcus aureus
531605|NCT00900497|granulocytes|granulocytes
531606|NCT00900497|Graft-vs-Host-Disease|graft-vs-host-disease
531607|NCT00900484|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
531608|NCT00900484|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
531609|NCT00900484|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
531610|NCT00900484|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
531611|NCT00900484|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
531612|NCT00900484|stage II adult diffuse small cleaved cell lymphoma|stage ii adult diffuse small cleaved cell lymphoma
531613|NCT00900484|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
531614|NCT00900484|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
531615|NCT00900484|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
531616|NCT00900484|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
531617|NCT00900484|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
531618|NCT00900484|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
531619|NCT00900484|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
531620|NCT00900484|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
531621|NCT00900484|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
531622|NCT00900484|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
531623|NCT00900484|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
531624|NCT00900484|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
531625|NCT00900484|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
531626|NCT00900484|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
531627|NCT00900484|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
531628|NCT00900484|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
531629|NCT00900484|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
531630|NCT00900484|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
531631|NCT00900484|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
531632|NCT00900484|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
531633|NCT00900484|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
531634|NCT00900484|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
531635|NCT00900471|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
531636|NCT00900471|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
531637|NCT00900458|preeclampsia|preeclampsia
531638|NCT00900458|low vs high plasma volume|low vs high plasma volume
531639|NCT00900445|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
531640|NCT00900445|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
531641|NCT00900432|recurrent colon cancer|recurrent colon cancer
531642|NCT00900432|stage I colon cancer|stage i colon cancer
531643|NCT00900432|stage II colon cancer|stage ii colon cancer
531644|NCT00900432|stage III colon cancer|stage iii colon cancer
531645|NCT00900432|stage IV colon cancer|stage iv colon cancer
531646|NCT00900419|non-small cell lung cancer|non-small cell lung cancer
531647|NCT00900419|small cell lung cancer|small cell lung cancer
531648|NCT00900419|squamous lung dysplasia|squamous lung dysplasia
531649|NCT00900419|hypopharyngeal cancer|hypopharyngeal cancer
531650|NCT00900419|laryngeal cancer|laryngeal cancer
531651|NCT00900419|lip and oral cavity cancer|lip and oral cavity cancer
531652|NCT00900419|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
531653|NCT00900419|nasopharyngeal cancer|nasopharyngeal cancer
531654|NCT00900419|oropharyngeal cancer|oropharyngeal cancer
531655|NCT00900419|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
531656|NCT00900419|salivary gland cancer|salivary gland cancer
531657|NCT00900419|esophageal cancer|esophageal cancer
531658|NCT00900419|pulmonary carcinoid tumor|pulmonary carcinoid tumor
531659|NCT00900419|tongue cancer|tongue cancer
531660|NCT00900380|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
531661|NCT00900380|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
531662|NCT00900380|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
531663|NCT00900380|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
531664|NCT00900380|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
531665|NCT00900380|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
531666|NCT00900380|secondary acute myeloid leukemia|secondary acute myeloid leukemia
531667|NCT00900380|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
531668|NCT00900380|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
531669|NCT00900380|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
531670|NCT00900380|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
531671|NCT00900380|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
531672|NCT00900380|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
531673|NCT00900380|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
531674|NCT00900380|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
531675|NCT00900367|breast cancer|breast cancer
531676|NCT00900354|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
531677|NCT00900341|adult soft tissue sarcoma|adult soft tissue sarcoma
531678|NCT00900341|childhood soft tissue sarcoma|childhood soft tissue sarcoma
531679|NCT00900328|adenocarcinoma of the lung|adenocarcinoma of the lung
531680|NCT00900328|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
531681|NCT00900328|stage 0 non-small cell lung cancer|stage 0 non-small cell lung cancer
531682|NCT00900328|stage I non-small cell lung cancer|stage i non-small cell lung cancer
531683|NCT00900328|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
531684|NCT00900328|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
531685|NCT00900328|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
531686|NCT00900328|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
531687|NCT00900302|male breast cancer|male breast cancer
531688|NCT00900302|recurrent breast cancer|recurrent breast cancer
531689|NCT00900302|stage IA breast cancer|stage ia breast cancer
531690|NCT00900302|stage IB breast cancer|stage ib breast cancer
531691|NCT00900302|stage II breast cancer|stage ii breast cancer
531692|NCT00900302|stage IIIA breast cancer|stage iiia breast cancer
531693|NCT00900302|stage IIIB breast cancer|stage iiib breast cancer
531694|NCT00900302|stage IIIC breast cancer|stage iiic breast cancer
531695|NCT00900302|stage IV breast cancer|stage iv breast cancer
531696|NCT00900302|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
531697|NCT00900302|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
531698|NCT00900302|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
531699|NCT00900302|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
531700|NCT00900302|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
531701|NCT00900302|squamous cell carcinoma of the gallbladder|squamous cell carcinoma of the gallbladder
531702|NCT00900302|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
531703|NCT00900302|squamous cell carcinoma of the vulva|squamous cell carcinoma of the vulva
531704|NCT00900302|squamous cell lung cancer|squamous cell lung cancer
531705|NCT00900302|vaginal squamous cell carcinoma|vaginal squamous cell carcinoma
531706|NCT00900302|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
531707|NCT00900302|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
531708|NCT00900302|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
531709|NCT00900302|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
531710|NCT00900302|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
531711|NCT00900302|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
531712|NCT00900302|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
531713|NCT00900302|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
531714|NCT00900302|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
531715|NCT00900302|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
531716|NCT00900302|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
531717|NCT00900302|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
531718|NCT00900302|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
531719|NCT00900302|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
531720|NCT00900302|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
531721|NCT00900302|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
531722|NCT00900302|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
531723|NCT00900302|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
531724|NCT00900302|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
531725|NCT00900302|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
531726|NCT00900302|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
531727|NCT00900302|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
531728|NCT00900302|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
531729|NCT00900302|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
531730|NCT00900302|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
531731|NCT00900302|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
531732|NCT00900302|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
531733|NCT00900302|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
531734|NCT00900302|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
531735|NCT00900302|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
531736|NCT00900302|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
531737|NCT00900302|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
531738|NCT00900302|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
531739|NCT00900302|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
531740|NCT00900302|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
531741|NCT00900302|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
531742|NCT00900302|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
531743|NCT00900302|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
531744|NCT00900302|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
531745|NCT00900302|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
531746|NCT00900302|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
531747|NCT00900302|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
531748|NCT00900302|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
531749|NCT00900302|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
531750|NCT00900302|stage I salivary gland cancer|stage i salivary gland cancer
531751|NCT00900302|stage II salivary gland cancer|stage ii salivary gland cancer
531752|NCT00900302|stage III salivary gland cancer|stage iii salivary gland cancer
531753|NCT00900302|stage IV salivary gland cancer|stage iv salivary gland cancer
531754|NCT00900302|recurrent salivary gland cancer|recurrent salivary gland cancer
531755|NCT00900302|squamous cell carcinoma of unknown primary|squamous cell carcinoma of unknown primary
531756|NCT00900302|cervical squamous cell carcinoma|cervical squamous cell carcinoma
531757|NCT00900302|penile squamous cell carcinoma|penile squamous cell carcinoma
531758|NCT00900302|recurrent anal cancer|recurrent anal cancer
531759|NCT00900302|stage I anal cancer|stage i anal cancer
531760|NCT00900302|stage II anal cancer|stage ii anal cancer
531761|NCT00900302|stage IIIA anal cancer|stage iiia anal cancer
531762|NCT00900302|stage IIIB anal cancer|stage iiib anal cancer
531763|NCT00900302|stage IV anal cancer|stage iv anal cancer
531764|NCT00900302|recurrent bladder cancer|recurrent bladder cancer
531765|NCT00900302|stage I bladder cancer|stage i bladder cancer
531766|NCT00900302|stage II bladder cancer|stage ii bladder cancer
531767|NCT00900302|stage III bladder cancer|stage iii bladder cancer
531768|NCT00900302|stage IV bladder cancer|stage iv bladder cancer
531769|NCT00900302|recurrent esophageal cancer|recurrent esophageal cancer
531770|NCT00900302|stage I esophageal cancer|stage i esophageal cancer
531771|NCT00900302|stage II esophageal cancer|stage ii esophageal cancer
531772|NCT00900302|stage III esophageal cancer|stage iii esophageal cancer
531773|NCT00900302|stage IV esophageal cancer|stage iv esophageal cancer
531774|NCT00900302|localized gallbladder cancer|localized gallbladder cancer
531775|NCT00900302|recurrent gallbladder cancer|recurrent gallbladder cancer
531776|NCT00900302|unresectable gallbladder cancer|unresectable gallbladder cancer
531777|NCT00900302|recurrent vulvar cancer|recurrent vulvar cancer
531778|NCT00900302|stage I vulvar cancer|stage i vulvar cancer
531779|NCT00900302|stage II vulvar cancer|stage ii vulvar cancer
531780|NCT00900302|stage III vulvar cancer|stage iii vulvar cancer
531781|NCT00900302|stage IV vulvar cancer|stage iv vulvar cancer
531782|NCT00900302|recurrent cervical cancer|recurrent cervical cancer
531783|NCT00900302|stage IA cervical cancer|stage ia cervical cancer
531784|NCT00900302|stage IB cervical cancer|stage ib cervical cancer
531785|NCT00900302|stage IIA cervical cancer|stage iia cervical cancer
531786|NCT00900302|stage IIB cervical cancer|stage iib cervical cancer
531787|NCT00900302|stage III cervical cancer|stage iii cervical cancer
531788|NCT00900302|stage IVA cervical cancer|stage iva cervical cancer
531789|NCT00900302|stage IVB cervical cancer|stage ivb cervical cancer
531790|NCT00900302|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
531791|NCT00900302|stage I non-small cell lung cancer|stage i non-small cell lung cancer
531792|NCT00900302|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
531793|NCT00900302|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
531794|NCT00900302|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
531795|NCT00900302|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
531796|NCT00900302|recurrent skin cancer|recurrent skin cancer
531797|NCT00900302|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
531798|NCT00900302|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
531799|NCT00900302|recurrent penile cancer|recurrent penile cancer
531800|NCT00900302|stage I penile cancer|stage i penile cancer
531801|NCT00900302|stage II penile cancer|stage ii penile cancer
531802|NCT00900302|stage III penile cancer|stage iii penile cancer
531803|NCT00900302|stage IV penile cancer|stage iv penile cancer
531804|NCT00900302|recurrent melanoma|recurrent melanoma
531805|NCT00900302|stage IA melanoma|stage ia melanoma
531806|NCT00900302|stage IB melanoma|stage ib melanoma
531807|NCT00900302|stage IIA melanoma|stage iia melanoma
531808|NCT00900302|stage IIB melanoma|stage iib melanoma
531809|NCT00900302|stage IIC melanoma|stage iic melanoma
531810|NCT00900302|stage IIIA melanoma|stage iiia melanoma
531811|NCT00900302|stage IIIB melanoma|stage iiib melanoma
531812|NCT00900302|stage IIIC melanoma|stage iiic melanoma
531813|NCT00900302|stage IV melanoma|stage iv melanoma
531814|NCT00900289|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
531815|NCT00900289|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
531816|NCT00900289|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
531817|NCT00900289|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
531818|NCT00900289|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
531819|NCT00900289|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
531820|NCT00900289|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
531821|NCT00900289|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
531822|NCT00900276|localized transitional cell cancer of the renal pelvis and ureter|localized transitional cell cancer of the renal pelvis and ureter
531823|NCT00900276|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
531824|NCT00900276|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
531825|NCT00900276|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
531826|NCT00900276|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
531827|NCT00900276|stage I renal cell cancer|stage i renal cell cancer
531828|NCT00900276|stage II renal cell cancer|stage ii renal cell cancer
531829|NCT00900276|recurrent renal cell cancer|recurrent renal cell cancer
531830|NCT00900276|recurrent bladder cancer|recurrent bladder cancer
531831|NCT00900276|stage I bladder cancer|stage i bladder cancer
531832|NCT00900276|stage II bladder cancer|stage ii bladder cancer
531833|NCT00900276|stage III bladder cancer|stage iii bladder cancer
531834|NCT00900276|stage IV bladder cancer|stage iv bladder cancer
531835|NCT00900276|anterior urethral cancer|anterior urethral cancer
531836|NCT00900276|posterior urethral cancer|posterior urethral cancer
531837|NCT00900276|recurrent urethral cancer|recurrent urethral cancer
531838|NCT00900276|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
531839|NCT00900263|stage I multiple myeloma|stage i multiple myeloma
531840|NCT00900263|isolated plasmacytoma of bone|isolated plasmacytoma of bone
531841|NCT00900263|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
531842|NCT00900237|Partial|partial
531843|NCT00900237|Epilepsy|epilepsy
531844|NCT00900237|Eslicarbazepine acetate|eslicarbazepine acetate
531845|NCT00900237|Pharmacokinetics|pharmacokinetics
531846|NCT00900237|Tolerability|tolerability
531847|NCT00900224|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
531848|NCT00900224|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
531849|NCT00900224|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
531850|NCT00900224|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
531851|NCT00900224|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
531852|NCT00900224|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
531853|NCT00900224|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
531854|NCT00900224|secondary acute myeloid leukemia|secondary acute myeloid leukemia
531855|NCT00900211|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
531856|NCT00900211|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
531857|NCT00900211|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
534258|NCT00896831|Treatment|treatment
531858|NCT00900211|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
531859|NCT00900211|adult synovial sarcoma|adult synovial sarcoma
531860|NCT00900211|adult angiosarcoma|adult angiosarcoma
531861|NCT00900211|adult epithelioid sarcoma|adult epithelioid sarcoma
531862|NCT00900211|adult extraskeletal chondrosarcoma|adult extraskeletal chondrosarcoma
531863|NCT00900211|adult leiomyosarcoma|adult leiomyosarcoma
531864|NCT00900211|adult liposarcoma|adult liposarcoma
531865|NCT00900211|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
531866|NCT00900211|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
531867|NCT00900211|adult malignant mesenchymoma|adult malignant mesenchymoma
531868|NCT00900211|adult fibrosarcoma|adult fibrosarcoma
531869|NCT00900211|adult neurofibrosarcoma|adult neurofibrosarcoma
531870|NCT00900198|Tissue Collection|tissue collection
531871|NCT00900198|Biospecimen|biospecimen
531872|NCT00900198|Assay Development|assay development
531873|NCT00900198|Tissue Acquisition|tissue acquisition
531874|NCT00900198|Tissue Biopsies|tissue biopsies
531875|NCT00900185|recurrent prostate cancer|recurrent prostate cancer
531876|NCT00900185|stage I prostate cancer|stage i prostate cancer
531877|NCT00900185|stage IIB prostate cancer|stage iib prostate cancer
531878|NCT00900185|stage IIA prostate cancer|stage iia prostate cancer
531879|NCT00900185|stage III prostate cancer|stage iii prostate cancer
531880|NCT00900185|stage IV prostate cancer|stage iv prostate cancer
531881|NCT00900172|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
531882|NCT00900172|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
531883|NCT00900172|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
531884|NCT00900172|adenocarcinoma of the lung|adenocarcinoma of the lung
531885|NCT00900172|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
531886|NCT00900159|Shift-work|shift-work
531887|NCT00900159|SWSD|swsd
531888|NCT00900159|eszopiclone|eszopiclone
531889|NCT00900159|MWT|mwt
531890|NCT00900159|shiftworkers|shiftworkers
531891|NCT00900146|type 2 diabetes|type 2 diabetes
531892|NCT00900146|canakinumab|canakinumab
531893|NCT00900133|stage I breast cancer|stage i breast cancer
531894|NCT00900133|stage II breast cancer|stage ii breast cancer
531895|NCT00900133|stage IIIA breast cancer|stage iiia breast cancer
531896|NCT00900133|stage IIIB breast cancer|stage iiib breast cancer
531897|NCT00900133|stage IIIC breast cancer|stage iiic breast cancer
531898|NCT00900120|aplastic anemia|aplastic anemia
531899|NCT00900120|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
531900|NCT00900120|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
531901|NCT00900120|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
531902|NCT00900120|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
531903|NCT00900120|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
531904|NCT00900120|acute undifferentiated leukemia|acute undifferentiated leukemia
531905|NCT00900120|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
531906|NCT00900120|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
531907|NCT00900120|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
531908|NCT00900120|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
531909|NCT00900120|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
531910|NCT00900120|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
531911|NCT00900120|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
531912|NCT00900120|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
531913|NCT00900120|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
531914|NCT00900120|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
531915|NCT00900120|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
531916|NCT00900120|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
531917|NCT00900120|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
531918|NCT00900120|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
531919|NCT00900120|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
531920|NCT00900120|mast cell leukemia|mast cell leukemia
531921|NCT00900120|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
531922|NCT00900120|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
531923|NCT00900120|prolymphocytic leukemia|prolymphocytic leukemia
531924|NCT00900120|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
531925|NCT00900120|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
531926|NCT00900120|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
531927|NCT00900120|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
531928|NCT00900120|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
531929|NCT00900120|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
531930|NCT00900120|refractory hairy cell leukemia|refractory hairy cell leukemia
532566|NCT00899717|Myofascial pain|myofascial pain
531931|NCT00900120|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
531932|NCT00900120|secondary acute myeloid leukemia|secondary acute myeloid leukemia
531933|NCT00900120|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
531934|NCT00900120|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
531935|NCT00900120|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
531936|NCT00900120|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
531937|NCT00900120|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
531938|NCT00900120|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
531939|NCT00900120|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
531940|NCT00900120|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
531941|NCT00900120|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
531942|NCT00900120|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
531943|NCT00900120|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
531944|NCT00900120|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
531945|NCT00900120|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
531946|NCT00900120|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
531947|NCT00900120|untreated hairy cell leukemia|untreated hairy cell leukemia
531948|NCT00900120|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
531949|NCT00900120|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
531950|NCT00900120|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
531951|NCT00900120|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
531952|NCT00900120|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
531953|NCT00900120|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
531954|NCT00900120|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
531955|NCT00900120|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
531956|NCT00900120|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
531957|NCT00900120|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
531958|NCT00900120|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
531959|NCT00900120|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
531960|NCT00900120|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
531961|NCT00900120|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
531962|NCT00900120|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
531963|NCT00900120|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
531964|NCT00900120|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
531965|NCT00900120|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
531966|NCT00900120|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
531967|NCT00900120|anaplastic large cell lymphoma|anaplastic large cell lymphoma
531968|NCT00900120|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
531969|NCT00900120|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
531970|NCT00900120|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
531971|NCT00900120|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
531972|NCT00900120|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
531973|NCT00900120|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
531974|NCT00900120|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
531975|NCT00900120|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
531976|NCT00900120|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
531977|NCT00900120|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
531978|NCT00900120|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
531979|NCT00900120|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
531980|NCT00900120|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
531981|NCT00900120|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
531982|NCT00900120|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
531983|NCT00900120|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
531984|NCT00900120|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
531985|NCT00900120|splenic marginal zone lymphoma|splenic marginal zone lymphoma
531986|NCT00900120|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
531987|NCT00900120|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
531988|NCT00900120|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
531989|NCT00900120|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
531990|NCT00900120|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
531991|NCT00900120|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
531992|NCT00900120|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
531993|NCT00900120|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
531994|NCT00900120|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
531995|NCT00900120|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
531996|NCT00900120|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
531997|NCT00900120|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
531998|NCT00900120|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
531999|NCT00900120|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
532000|NCT00900120|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
532001|NCT00900120|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
532002|NCT00900120|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
532003|NCT00900120|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
532004|NCT00900120|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
532005|NCT00900120|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
532006|NCT00900120|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
532007|NCT00900120|stage I mantle cell lymphoma|stage i mantle cell lymphoma
532008|NCT00900120|stage I marginal zone lymphoma|stage i marginal zone lymphoma
532009|NCT00900120|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
532010|NCT00900120|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
532011|NCT00900120|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
532012|NCT00900120|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
532013|NCT00900120|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
532014|NCT00900120|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
532015|NCT00900120|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
532016|NCT00900120|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
532017|NCT00900120|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
532018|NCT00900120|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
532019|NCT00900120|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
532020|NCT00900120|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
532021|NCT00900120|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
532022|NCT00900120|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
532023|NCT00900120|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
532024|NCT00900120|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
532025|NCT00900120|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
532026|NCT00900120|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
532027|NCT00900120|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
532028|NCT00900120|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
532029|NCT00900120|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
532030|NCT00900120|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
532031|NCT00900120|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
532032|NCT00900120|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
532033|NCT00900120|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
532034|NCT00900120|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
532035|NCT00900120|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
532036|NCT00900120|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
532037|NCT00900120|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
532038|NCT00900120|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
532039|NCT00900120|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
532040|NCT00900120|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
532041|NCT00900120|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
532042|NCT00900120|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
532043|NCT00900120|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
532044|NCT00900120|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
532045|NCT00900120|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
532046|NCT00900120|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
532047|NCT00900120|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
532048|NCT00900120|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
532049|NCT00900120|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
532050|NCT00900120|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
532051|NCT00900120|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
532052|NCT00900120|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
532053|NCT00900120|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
532054|NCT00900120|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
532055|NCT00900120|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
532056|NCT00900120|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
532057|NCT00900120|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
532058|NCT00900120|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
532059|NCT00900120|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
532060|NCT00900120|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
532061|NCT00900120|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
532062|NCT00900120|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
532063|NCT00900120|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
532064|NCT00900120|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
532065|NCT00900120|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
532066|NCT00900120|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
532067|NCT00900120|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
532068|NCT00900120|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
532069|NCT00900120|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
532070|NCT00900120|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
532071|NCT00900120|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
532072|NCT00900120|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
532073|NCT00900120|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
532074|NCT00900120|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
532075|NCT00900120|Burkitt lymphoma|burkitt lymphoma
532076|NCT00900120|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
532077|NCT00900120|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
532078|NCT00900120|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
532079|NCT00900120|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
532080|NCT00900120|intraocular lymphoma|intraocular lymphoma
532081|NCT00900120|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
532082|NCT00900120|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
532083|NCT00900120|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
532084|NCT00900120|chronic eosinophilic leukemia|chronic eosinophilic leukemia
532085|NCT00900120|chronic neutrophilic leukemia|chronic neutrophilic leukemia
532086|NCT00900120|primary myelofibrosis|primary myelofibrosis
532087|NCT00900120|essential thrombocythemia|essential thrombocythemia
532088|NCT00900120|polycythemia vera|polycythemia vera
532089|NCT00900120|extramedullary plasmacytoma|extramedullary plasmacytoma
532090|NCT00900120|isolated plasmacytoma of bone|isolated plasmacytoma of bone
532091|NCT00900120|stage I multiple myeloma|stage i multiple myeloma
532092|NCT00900120|stage II multiple myeloma|stage ii multiple myeloma
532093|NCT00900120|stage III multiple myeloma|stage iii multiple myeloma
532094|NCT00900120|primary systemic amyloidosis|primary systemic amyloidosis
532095|NCT00900120|refractory multiple myeloma|refractory multiple myeloma
532096|NCT00900120|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
532097|NCT00900120|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
532098|NCT00900120|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
532099|NCT00900120|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
532100|NCT00900120|stage I childhood anaplastic large cell lymphoma|stage i childhood anaplastic large cell lymphoma
532101|NCT00900120|stage II childhood anaplastic large cell lymphoma|stage ii childhood anaplastic large cell lymphoma
532102|NCT00900120|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
532103|NCT00900120|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
532104|NCT00900094|stage I breast cancer|stage i breast cancer
532105|NCT00900094|stage II breast cancer|stage ii breast cancer
532106|NCT00900094|stage IIIA breast cancer|stage iiia breast cancer
532107|NCT00900094|stage IIIB breast cancer|stage iiib breast cancer
532108|NCT00900094|stage IV breast cancer|stage iv breast cancer
532109|NCT00900094|adenocarcinoma of the colon|adenocarcinoma of the colon
532110|NCT00900094|stage I colon cancer|stage i colon cancer
532111|NCT00900094|stage II colon cancer|stage ii colon cancer
532112|NCT00900094|stage III colon cancer|stage iii colon cancer
532113|NCT00900094|stage IV colon cancer|stage iv colon cancer
532114|NCT00900094|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
532115|NCT00900094|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
532116|NCT00900094|stage I esophageal cancer|stage i esophageal cancer
532117|NCT00900094|stage II esophageal cancer|stage ii esophageal cancer
532118|NCT00900094|stage III esophageal cancer|stage iii esophageal cancer
532119|NCT00900094|stage IV esophageal cancer|stage iv esophageal cancer
532120|NCT00900094|stage I non-small cell lung cancer|stage i non-small cell lung cancer
532121|NCT00900094|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
532122|NCT00900094|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
532123|NCT00900094|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
532124|NCT00900094|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
532125|NCT00900094|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
532126|NCT00900094|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
532127|NCT00900094|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
532128|NCT00900094|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
532129|NCT00900094|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
532130|NCT00900094|advanced adult primary liver cancer|advanced adult primary liver cancer
532131|NCT00900094|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
532132|NCT00900094|stage II pancreatic cancer|stage ii pancreatic cancer
532133|NCT00900094|stage III pancreatic cancer|stage iii pancreatic cancer
532134|NCT00900094|extensive stage small cell lung cancer|extensive stage small cell lung cancer
532135|NCT00900094|stage IIIC breast cancer|stage iiic breast cancer
532136|NCT00900094|stage IV pancreatic cancer|stage iv pancreatic cancer
532137|NCT00900094|recurrent breast cancer|recurrent breast cancer
532138|NCT00900094|recurrent colon cancer|recurrent colon cancer
532139|NCT00900094|recurrent esophageal cancer|recurrent esophageal cancer
532140|NCT00900094|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
532141|NCT00900094|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
532142|NCT00900094|recurrent adult primary liver cancer|recurrent adult primary liver cancer
532143|NCT00900094|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
532144|NCT00900094|recurrent small cell lung cancer|recurrent small cell lung cancer
532145|NCT00900081|cervical squamous cell carcinoma|cervical squamous cell carcinoma
532146|NCT00900081|stage IA cervical cancer|stage ia cervical cancer
532147|NCT00900081|stage 0 cervical cancer|stage 0 cervical cancer
532148|NCT00900081|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
532149|NCT00900081|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
532150|NCT00900081|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
532151|NCT00900068|nausea and vomiting|nausea and vomiting
532152|NCT00900068|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
532153|NCT00900068|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
532154|NCT00900068|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
532155|NCT00900068|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
532156|NCT00900068|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
532157|NCT00900068|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
532158|NCT00900068|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
532159|NCT00900068|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
532160|NCT00900068|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
532161|NCT00900068|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
532162|NCT00900068|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
532163|NCT00900068|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
532164|NCT00900068|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
532165|NCT00900068|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
532166|NCT00900068|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
532167|NCT00900068|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
532168|NCT00900068|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
532169|NCT00900068|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
532170|NCT00900068|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
532171|NCT00900068|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
532172|NCT00900068|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
532173|NCT00900068|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
532174|NCT00900068|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
532175|NCT00900068|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
532176|NCT00900068|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
532177|NCT00900068|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
532178|NCT00900068|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
532179|NCT00900068|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
532180|NCT00900068|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
532181|NCT00900068|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
532182|NCT00900068|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
532183|NCT00900068|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
532184|NCT00900068|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
532185|NCT00900068|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
532186|NCT00900068|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
532187|NCT00900068|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
532188|NCT00900068|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
532189|NCT00900068|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
532190|NCT00900068|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
532191|NCT00900068|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
532192|NCT00900068|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
532193|NCT00900068|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
532194|NCT00900068|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
532195|NCT00900068|splenic marginal zone lymphoma|splenic marginal zone lymphoma
532196|NCT00900068|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
532197|NCT00900068|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
532198|NCT00900068|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
532199|NCT00900068|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
532200|NCT00900068|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
532201|NCT00900068|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
532202|NCT00900068|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
532203|NCT00900068|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
532204|NCT00900068|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
532205|NCT00900068|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
532206|NCT00900068|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
532207|NCT00900068|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
532208|NCT00900068|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
532209|NCT00900068|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
532210|NCT00900068|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
532211|NCT00900068|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
532212|NCT00900068|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
532213|NCT00900068|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
532214|NCT00900068|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
532215|NCT00900068|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
532216|NCT00900068|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
532217|NCT00900068|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
532218|NCT00900068|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
532219|NCT00900068|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
532220|NCT00900068|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
532221|NCT00900068|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
532222|NCT00900068|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
532223|NCT00900068|refractory hairy cell leukemia|refractory hairy cell leukemia
532224|NCT00900068|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
532225|NCT00900068|secondary acute myeloid leukemia|secondary acute myeloid leukemia
532226|NCT00900068|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
532227|NCT00900068|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
532228|NCT00900068|chronic eosinophilic leukemia|chronic eosinophilic leukemia
532229|NCT00900068|primary myelofibrosis|primary myelofibrosis
532230|NCT00900068|chronic neutrophilic leukemia|chronic neutrophilic leukemia
532231|NCT00900068|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
532232|NCT00900068|disseminated neuroblastoma|disseminated neuroblastoma
532233|NCT00900068|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
532234|NCT00900068|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
532235|NCT00900068|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
532236|NCT00900068|recurrent neuroblastoma|recurrent neuroblastoma
532237|NCT00900068|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
532238|NCT00900068|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
532239|NCT00900068|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
532240|NCT00900068|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
532241|NCT00900068|stage I multiple myeloma|stage i multiple myeloma
532242|NCT00900068|stage II multiple myeloma|stage ii multiple myeloma
532243|NCT00900068|stage III multiple myeloma|stage iii multiple myeloma
532244|NCT00900068|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
532245|NCT00900068|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
532246|NCT00900068|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
532247|NCT00900068|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
532248|NCT00900068|stage IIIA breast cancer|stage iiia breast cancer
532249|NCT00900068|stage IIIB breast cancer|stage iiib breast cancer
532250|NCT00900068|stage IIIC breast cancer|stage iiic breast cancer
532251|NCT00900068|stage IV breast cancer|stage iv breast cancer
532252|NCT00900068|refractory multiple myeloma|refractory multiple myeloma
532253|NCT00900055|Fanconi anemia|fanconi anemia
532254|NCT00900055|multiple myeloma and other plasma cell neoplasms|multiple myeloma and other plasma cell neoplasms
532255|NCT00900055|chronic myeloproliferative disorders|chronic myeloproliferative disorders
532256|NCT00900055|myelodysplastic/myeloproliferative neoplasms|myelodysplastic/myeloproliferative neoplasms
532257|NCT00900042|stage IV renal cell cancer|stage iv renal cell cancer
532258|NCT00900029|Venous Leg Ulcer|venous leg ulcer
532259|NCT00900029|Venous Stasis Ulcer|venous stasis ulcer
532260|NCT00900029|VLU|vlu
532261|NCT00900029|VSU|vsu
532262|NCT00900029|Leg Ulcer|leg ulcer
532263|NCT00900029|Leg Wound|leg wound
532264|NCT00900016|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
532265|NCT00900016|recurrent pancreatic cancer|recurrent pancreatic cancer
532266|NCT00900016|stage I pancreatic cancer|stage i pancreatic cancer
532267|NCT00900016|stage II pancreatic cancer|stage ii pancreatic cancer
532268|NCT00900003|stage I pancreatic cancer|stage i pancreatic cancer
532269|NCT00900003|stage II pancreatic cancer|stage ii pancreatic cancer
532270|NCT00900003|stage III pancreatic cancer|stage iii pancreatic cancer
532271|NCT00900003|stage IV pancreatic cancer|stage iv pancreatic cancer
532272|NCT00899977|refractory hypertension|refractory hypertension
532273|NCT00899977|hypertension|hypertension
532274|NCT00899951|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
532275|NCT00899951|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
532276|NCT00899951|acute undifferentiated leukemia|acute undifferentiated leukemia
532277|NCT00899951|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
532278|NCT00899951|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
532279|NCT00899951|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
532280|NCT00899951|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
532281|NCT00899951|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
532282|NCT00899951|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
532283|NCT00899951|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
532284|NCT00899951|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
532285|NCT00899951|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
532286|NCT00899951|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
532287|NCT00899951|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
532288|NCT00899951|mast cell leukemia|mast cell leukemia
532289|NCT00899951|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
532290|NCT00899951|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
532291|NCT00899951|prolymphocytic leukemia|prolymphocytic leukemia
532292|NCT00899951|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
532293|NCT00899951|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
532294|NCT00899951|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
532295|NCT00899951|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
532296|NCT00899951|refractory hairy cell leukemia|refractory hairy cell leukemia
532297|NCT00899951|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
532298|NCT00899951|secondary acute myeloid leukemia|secondary acute myeloid leukemia
532299|NCT00899951|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
532300|NCT00899951|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
532301|NCT00899951|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
532302|NCT00899951|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
532303|NCT00899951|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
532304|NCT00899951|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
532305|NCT00899951|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
532306|NCT00899951|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
532307|NCT00899951|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
532308|NCT00899951|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
532309|NCT00899951|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
532310|NCT00899951|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
532311|NCT00899951|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
532312|NCT00899951|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
532313|NCT00899951|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
532314|NCT00899951|anaplastic large cell lymphoma|anaplastic large cell lymphoma
532315|NCT00899951|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
532316|NCT00899951|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
532317|NCT00899951|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
532318|NCT00899951|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
532319|NCT00899951|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
532320|NCT00899951|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
532321|NCT00899951|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
532322|NCT00899951|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
532323|NCT00899951|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
532324|NCT00899951|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
532325|NCT00899951|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
532326|NCT00899951|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
532327|NCT00899951|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
532328|NCT00899951|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
532329|NCT00899951|Waldenström macroglobulinemia|waldenström macroglobulinemia
532330|NCT00899951|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
532331|NCT00899951|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
532332|NCT00899951|splenic marginal zone lymphoma|splenic marginal zone lymphoma
532333|NCT00899951|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
532334|NCT00899951|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
532335|NCT00899951|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
532336|NCT00899951|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
532337|NCT00899951|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
532338|NCT00899951|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
532339|NCT00899951|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
532340|NCT00899951|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
532341|NCT00899951|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
532342|NCT00899951|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
532343|NCT00899951|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
532344|NCT00899951|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
532345|NCT00899951|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
532346|NCT00899951|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
532347|NCT00899951|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
532348|NCT00899951|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
532349|NCT00899951|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
532350|NCT00899951|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
532351|NCT00899951|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
532352|NCT00899951|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
532353|NCT00899951|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
532354|NCT00899951|stage I mantle cell lymphoma|stage i mantle cell lymphoma
532355|NCT00899951|stage I marginal zone lymphoma|stage i marginal zone lymphoma
532356|NCT00899951|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
532357|NCT00899951|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
532358|NCT00899951|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
532359|NCT00899951|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
532360|NCT00899951|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
532361|NCT00899951|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
532362|NCT00899951|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
532363|NCT00899951|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
532364|NCT00899951|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
532365|NCT00899951|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
532366|NCT00899951|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
532367|NCT00899951|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
532368|NCT00899951|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
532369|NCT00899951|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
532370|NCT00899951|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
532371|NCT00899951|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
532372|NCT00899951|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
532373|NCT00899951|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
532374|NCT00899951|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
532375|NCT00899951|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
532376|NCT00899951|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
532377|NCT00899951|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
532378|NCT00899951|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
532379|NCT00899951|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
532380|NCT00899951|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
532381|NCT00899951|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
532382|NCT00899951|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
532383|NCT00899951|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
532384|NCT00899951|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
532385|NCT00899951|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
532386|NCT00899951|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
532387|NCT00899951|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
532388|NCT00899951|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
532389|NCT00899951|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
532390|NCT00899951|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
532391|NCT00899951|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
532392|NCT00899951|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
532393|NCT00899951|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
532394|NCT00899951|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
532395|NCT00899951|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
532396|NCT00899951|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
532397|NCT00899951|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
532398|NCT00899951|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
532399|NCT00899951|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
532400|NCT00899951|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
532401|NCT00899951|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
532402|NCT00899951|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
532403|NCT00899951|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
532404|NCT00899951|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
532405|NCT00899951|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
532406|NCT00899951|intraocular lymphoma|intraocular lymphoma
532407|NCT00899951|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
532408|NCT00899951|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
532409|NCT00899951|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
532410|NCT00899951|chronic eosinophilic leukemia|chronic eosinophilic leukemia
532411|NCT00899951|chronic neutrophilic leukemia|chronic neutrophilic leukemia
532412|NCT00899951|primary myelofibrosis|primary myelofibrosis
532413|NCT00899951|essential thrombocythemia|essential thrombocythemia
532414|NCT00899951|polycythemia vera|polycythemia vera
532415|NCT00899951|extramedullary plasmacytoma|extramedullary plasmacytoma
532416|NCT00899951|isolated plasmacytoma of bone|isolated plasmacytoma of bone
532417|NCT00899951|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
532418|NCT00899951|stage I multiple myeloma|stage i multiple myeloma
532419|NCT00899951|stage II multiple myeloma|stage ii multiple myeloma
532420|NCT00899951|stage III multiple myeloma|stage iii multiple myeloma
532421|NCT00899951|primary systemic amyloidosis|primary systemic amyloidosis
532422|NCT00899951|refractory multiple myeloma|refractory multiple myeloma
532423|NCT00899951|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
532424|NCT00899951|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
532425|NCT00899951|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
532426|NCT00899951|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
532427|NCT00899951|pain|pain
532428|NCT00899912|stage IIB prostate cancer|stage iib prostate cancer
532429|NCT00899912|stage IIA prostate cancer|stage iia prostate cancer
532430|NCT00899912|adenocarcinoma of the prostate|adenocarcinoma of the prostate
532431|NCT00899899|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
532432|NCT00899899|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
532433|NCT00899899|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
532434|NCT00899899|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
532435|NCT00899873|chronic lymphocytic leukemia|chronic lymphocytic leukemia
532436|NCT00899860|recurrent renal cell cancer|recurrent renal cell cancer
532437|NCT00899860|stage I renal cell cancer|stage i renal cell cancer
532438|NCT00899860|stage II renal cell cancer|stage ii renal cell cancer
532439|NCT00899860|stage III renal cell cancer|stage iii renal cell cancer
532440|NCT00899860|stage IV renal cell cancer|stage iv renal cell cancer
532441|NCT00899834|adult brain stem glioma|adult brain stem glioma
532442|NCT00899834|childhood brain stem glioma|childhood brain stem glioma
532443|NCT00899821|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
532444|NCT00899821|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
532445|NCT00899821|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
532446|NCT00899821|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
532447|NCT00899821|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
532448|NCT00899821|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
532567|NCT00899717|TMD treatment|tmd treatment
532568|NCT00899717|Pain|pain
532449|NCT00899821|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
532450|NCT00899821|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
532451|NCT00899821|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
532452|NCT00899821|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
532453|NCT00899821|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
532454|NCT00899821|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
532455|NCT00899821|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
532456|NCT00899821|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
532457|NCT00899821|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
532458|NCT00899821|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
532459|NCT00899821|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
532460|NCT00899821|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
532461|NCT00899821|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
532462|NCT00899821|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
532463|NCT00899821|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
532464|NCT00899821|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
532465|NCT00899821|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
532466|NCT00899821|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
532467|NCT00899821|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
532468|NCT00899821|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
532469|NCT00899821|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
532470|NCT00899821|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
532471|NCT00899821|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
532472|NCT00899821|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
532473|NCT00899821|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
532474|NCT00899821|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
532475|NCT00899821|recurrent salivary gland cancer|recurrent salivary gland cancer
532476|NCT00899821|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
532477|NCT00899821|stage I salivary gland cancer|stage i salivary gland cancer
532478|NCT00899821|stage II salivary gland cancer|stage ii salivary gland cancer
532479|NCT00899821|stage III salivary gland cancer|stage iii salivary gland cancer
532480|NCT00899821|stage IV salivary gland cancer|stage iv salivary gland cancer
532481|NCT00899808|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
532482|NCT00899808|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
532483|NCT00899808|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
532484|NCT00899795|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
532485|NCT00899795|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
532486|NCT00899795|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
532487|NCT00899795|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
532488|NCT00899795|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
532489|NCT00899795|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
532490|NCT00899795|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
532491|NCT00899795|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
532492|NCT00899795|secondary acute myeloid leukemia|secondary acute myeloid leukemia
532493|NCT00899795|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
532494|NCT00899795|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
532495|NCT00899795|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
532496|NCT00899769|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
532497|NCT00899769|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
532498|NCT00899769|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
532499|NCT00899769|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
532500|NCT00899769|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
532501|NCT00899769|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
532502|NCT00899769|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
532503|NCT00899769|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
532504|NCT00899769|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
532505|NCT00899769|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
532506|NCT00899769|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
532507|NCT00899769|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
532508|NCT00899769|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
532509|NCT00899769|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
532510|NCT00899769|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
532511|NCT00899769|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
532512|NCT00899769|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
532513|NCT00899769|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
532514|NCT00899769|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
532515|NCT00899769|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
532516|NCT00899769|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
532517|NCT00899769|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
532518|NCT00899769|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
532519|NCT00899769|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
532520|NCT00899769|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
532521|NCT00899769|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
532522|NCT00899769|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
532523|NCT00899769|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
532524|NCT00899769|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
532525|NCT00899769|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
532526|NCT00899769|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
532527|NCT00899769|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
532528|NCT00899769|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
532529|NCT00899769|recurrent salivary gland cancer|recurrent salivary gland cancer
532530|NCT00899769|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
532531|NCT00899769|stage I salivary gland cancer|stage i salivary gland cancer
532532|NCT00899769|stage II salivary gland cancer|stage ii salivary gland cancer
532533|NCT00899769|stage III salivary gland cancer|stage iii salivary gland cancer
532534|NCT00899769|stage IV salivary gland cancer|stage iv salivary gland cancer
532535|NCT00899756|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
532536|NCT00899756|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
532537|NCT00899756|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
532538|NCT00899756|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
532539|NCT00899743|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
532540|NCT00899743|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
532541|NCT00899743|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
532542|NCT00899743|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
532543|NCT00899743|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
532544|NCT00899743|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
532545|NCT00899743|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
532546|NCT00899743|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
532547|NCT00899743|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
532548|NCT00899743|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
532549|NCT00899743|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
532550|NCT00899743|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
532551|NCT00899743|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
532552|NCT00899743|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
532553|NCT00899717|Temporomandibular Joint Disorders (TMD)|temporomandibular joint disorders (tmd)
532554|NCT00899717|Orofacial pain|orofacial pain
532555|NCT00899717|Limited mouth opening|limited mouth opening
532556|NCT00899717|Craniomandibular dysfunction syndrome|craniomandibular dysfunction syndrome
532557|NCT00899717|Axiography|axiography
532558|NCT00899717|Gnatography|gnatography
532559|NCT00899717|Preferred chewing side|preferred chewing side
532560|NCT00899717|Occlusal adjustment|occlusal adjustment
532561|NCT00899717|Selective grinding|selective grinding
532562|NCT00899717|Handedness|handedness
532563|NCT00899717|Bruxism|bruxism
532564|NCT00899717|TMD|tmd
532565|NCT00899717|Costen's Syndrome|costen's syndrome
532569|NCT00899704|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
532570|NCT00899704|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
532571|NCT00899704|tongue cancer|tongue cancer
532572|NCT00899691|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
532573|NCT00899678|Certolizumab Pegol|certolizumab pegol
532574|NCT00899678|Cimzia ®|cimzia ®
532575|NCT00899678|Crohn's Disease|crohn's disease
532576|NCT00899665|stage IV prostate cancer|stage iv prostate cancer
532577|NCT00899665|bone metastases|bone metastases
532578|NCT00899665|anemia|anemia
532579|NCT00899665|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
532580|NCT00899665|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
532581|NCT00899665|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
532582|NCT00899665|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
532583|NCT00899652|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
532584|NCT00899652|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
532585|NCT00899652|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
532586|NCT00899652|secondary acute myeloid leukemia|secondary acute myeloid leukemia
532587|NCT00899652|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
532588|NCT00899652|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
532589|NCT00899652|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
532590|NCT00899652|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
532591|NCT00899639|stage I breast cancer|stage i breast cancer
532592|NCT00899639|stage II breast cancer|stage ii breast cancer
532593|NCT00899639|stage IIIA breast cancer|stage iiia breast cancer
532594|NCT00899639|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
532595|NCT00899639|male breast cancer|male breast cancer
532596|NCT00899626|colon cancer|colon cancer
532597|NCT00899626|esophageal cancer|esophageal cancer
532598|NCT00899626|gastric cancer|gastric cancer
532599|NCT00899626|pancreatic cancer|pancreatic cancer
532600|NCT00899626|adenomatous polyp|adenomatous polyp
532601|NCT00899613|localized malignant mesothelioma|localized malignant mesothelioma
532602|NCT00899613|lung metastases|lung metastases
532603|NCT00899613|malignant pleural effusion|malignant pleural effusion
532604|NCT00899600|chronic pain|chronic pain
532605|NCT00899600|back surgery|back surgery
532606|NCT00899600|opioid dependent|opioid dependent
532607|NCT00899600|NMDA receptor antagonism|nmda receptor antagonism
532608|NCT00899600|Ketamine|ketamine
532609|NCT00899600|Central sensitization|central sensitization
532610|NCT00899574|toll-like receptor|toll-like receptor
532611|NCT00899574|toll-like receptor agonist|toll-like receptor agonist
532612|NCT00899574|recurrent breast cancer|recurrent breast cancer
532613|NCT00899574|breast cancer metastasized to skin and/or chestwall|breast cancer metastasized to skin and/or chestwall
532614|NCT00899574|immunomodulator|immunomodulator
532615|NCT00899561|Chronic rhinosinusitis|chronic rhinosinusitis
532616|NCT00899561|Computed tomography|computed tomography
532617|NCT00899561|Histology|histology
532618|NCT00899561|Middle turbinate|middle turbinate
532619|NCT00899561|Morphometry|morphometry
532620|NCT00899561|osteomyelitis|osteomyelitis
532621|NCT00899561|polyps|polyps
532622|NCT00899548|stage IV breast cancer|stage iv breast cancer
532623|NCT00899548|recurrent breast cancer|recurrent breast cancer
532624|NCT00899535|adenocarcinoma of the lung|adenocarcinoma of the lung
532625|NCT00899535|large cell lung cancer|large cell lung cancer
532626|NCT00899535|squamous cell lung cancer|squamous cell lung cancer
532627|NCT00899535|stage I non-small cell lung cancer|stage i non-small cell lung cancer
532628|NCT00899535|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
532629|NCT00899522|Fanconi anemia|fanconi anemia
532630|NCT00899522|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
532631|NCT00899522|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
532632|NCT00899509|stage II breast cancer|stage ii breast cancer
532633|NCT00899509|stage IIIA breast cancer|stage iiia breast cancer
532634|NCT00899496|stage IV bladder cancer|stage iv bladder cancer
532635|NCT00899496|stage IV colon cancer|stage iv colon cancer
532636|NCT00899496|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
532637|NCT00899496|stage IV pancreatic cancer|stage iv pancreatic cancer
532638|NCT00899496|stage IV rectal cancer|stage iv rectal cancer
532639|NCT00899496|stage IV renal cell cancer|stage iv renal cell cancer
532640|NCT00899496|stage IV melanoma|stage iv melanoma
532641|NCT00899496|stage III multiple myeloma|stage iii multiple myeloma
532642|NCT00899496|extensive stage small cell lung cancer|extensive stage small cell lung cancer
532643|NCT00899496|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
532644|NCT00899496|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
532645|NCT00899496|stage IV breast cancer|stage iv breast cancer
532646|NCT00899496|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
532647|NCT00899496|stage IV prostate cancer|stage iv prostate cancer
532648|NCT00899496|stage IV endometrial carcinoma|stage iv endometrial carcinoma
532649|NCT00899496|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
532650|NCT00899496|metastatic osteosarcoma|metastatic osteosarcoma
532651|NCT00899496|stage IV uterine sarcoma|stage iv uterine sarcoma
532652|NCT00899496|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
532653|NCT00899496|ovarian sarcoma|ovarian sarcoma
532654|NCT00899496|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
532655|NCT00899496|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
532656|NCT00899496|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
532657|NCT00899496|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
532658|NCT00899496|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
532659|NCT00899496|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
532660|NCT00899496|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
532661|NCT00899496|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
532662|NCT00899496|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
532663|NCT00899496|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
532664|NCT00899496|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
532665|NCT00899496|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
532666|NCT00899496|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
532667|NCT00899496|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
532668|NCT00899496|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
532669|NCT00899496|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
532670|NCT00899496|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
532671|NCT00899496|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
532672|NCT00899496|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
532673|NCT00899496|splenic marginal zone lymphoma|splenic marginal zone lymphoma
532674|NCT00899496|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
532675|NCT00899496|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
532676|NCT00899496|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
532677|NCT00899496|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
532678|NCT00899496|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
532679|NCT00899496|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
532680|NCT00899496|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
532681|NCT00899496|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
532682|NCT00899496|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
532683|NCT00899496|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
532684|NCT00899496|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
532685|NCT00899496|anaplastic large cell lymphoma|anaplastic large cell lymphoma
532686|NCT00899496|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
532687|NCT00899496|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
532688|NCT00899496|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
532689|NCT00899496|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
532690|NCT00899496|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
532691|NCT00899496|intraocular lymphoma|intraocular lymphoma
532692|NCT00899457|squamous cell lung cancer|squamous cell lung cancer
532693|NCT00899457|non-small cell lung cancer|non-small cell lung cancer
532694|NCT00899457|small cell lung cancer|small cell lung cancer
532695|NCT00899457|healthy, no evidence of disease|healthy, no evidence of disease
532696|NCT00899431|Nonmyeloablative Stem Cell Transplantation|nonmyeloablative stem cell transplantation
532697|NCT00899431|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
532698|NCT00899431|CLL|cll
532699|NCT00899431|Immunomanipulation|immunomanipulation
532700|NCT00899431|Fludarabine|fludarabine
532701|NCT00899431|Lenalidomide|lenalidomide
532702|NCT00899431|Rituximab|rituximab
532703|NCT00899431|Thymoglobulin|thymoglobulin
532704|NCT00899431|Stem Cell Transplantation|stem cell transplantation
532705|NCT00899418|recurrent breast cancer|recurrent breast cancer
532706|NCT00899418|stage IV breast cancer|stage iv breast cancer
532707|NCT00899405|lung cancer|lung cancer
532708|NCT00899392|consent|consent
532709|NCT00899392|Anxiety|anxiety
532710|NCT00899392|Satisfaction|satisfaction
532711|NCT00899392|Efficiency|efficiency
532712|NCT00899392|Questions|questions
532713|NCT00899392|Attainment of Informed Consent (Consent-20)|attainment of informed consent (consent-20)
532714|NCT00899392|Procedural State Anxiety (STAI)|procedural state anxiety (stai)
532715|NCT00899392|Subject Satisfaction (mGHAA-9)|subject satisfaction (mghaa-9)
532716|NCT00899392|Duration in Endoscopy Suite|duration in endoscopy suite
532717|NCT00899392|Number of questions asked|number of questions asked
532718|NCT00899366|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
532719|NCT00899366|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
532794|NCT00899132|pancreatic cancer|pancreatic cancer
532720|NCT00899366|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
532721|NCT00899366|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
532722|NCT00899366|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
532723|NCT00899366|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
532724|NCT00899366|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
532725|NCT00899366|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
532726|NCT00899353|ES-CLL|es-cll
532727|NCT00899353|MGUS|mgus
532729|NCT00899353|Early Stage - Chronic Lymphocytic Leukemia|early stage - chronic lymphocytic leukemia
532730|NCT00899340|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
532731|NCT00899340|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
532732|NCT00899340|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
532733|NCT00899340|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
532734|NCT00899340|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
532735|NCT00899327|myelodysplastic syndromes|myelodysplastic syndromes
532736|NCT00899327|acute myeloid leukemia|acute myeloid leukemia
532737|NCT00899301|breast cancer|breast cancer
532738|NCT00899301|stage IA breast cancer|stage ia breast cancer
532739|NCT00899301|stage IB breast cancer|stage ib breast cancer
532740|NCT00899301|stage II breast cancer|stage ii breast cancer
532741|NCT00899301|stage IIIA breast cancer|stage iiia breast cancer
532742|NCT00899301|stage IIIB breast cancer|stage iiib breast cancer
532743|NCT00899301|stage IIIC breast cancer|stage iiic breast cancer
532744|NCT00899301|stage IV breast cancer|stage iv breast cancer
532745|NCT00899288|osteoporosis|osteoporosis
532746|NCT00899288|stage I breast cancer|stage i breast cancer
532747|NCT00899288|stage II breast cancer|stage ii breast cancer
532748|NCT00899288|stage IIIA breast cancer|stage iiia breast cancer
532749|NCT00899275|osteosarcoma|osteosarcoma
532750|NCT00899262|lung cancer|lung cancer
532751|NCT00899262|tobacco use disorder|tobacco use disorder
532752|NCT00899210|liver metastases|liver metastases
532753|NCT00899210|adenocarcinoma of the colon|adenocarcinoma of the colon
532754|NCT00899210|stage IV colon cancer|stage iv colon cancer
532755|NCT00899210|adenocarcinoma of the rectum|adenocarcinoma of the rectum
532756|NCT00899210|stage IV rectal cancer|stage iv rectal cancer
532757|NCT00899210|recurrent colon cancer|recurrent colon cancer
532758|NCT00899210|recurrent rectal cancer|recurrent rectal cancer
532759|NCT00899197|stage I breast cancer|stage i breast cancer
532760|NCT00899197|stage II breast cancer|stage ii breast cancer
532761|NCT00899197|stage IIIA breast cancer|stage iiia breast cancer
532762|NCT00899197|stage IIIB breast cancer|stage iiib breast cancer
532763|NCT00899184|recurrent prostate cancer|recurrent prostate cancer
532764|NCT00899184|stage IV prostate cancer|stage iv prostate cancer
532765|NCT00899184|stage I prostate cancer|stage i prostate cancer
532766|NCT00899184|stage IIB prostate cancer|stage iib prostate cancer
532767|NCT00899184|stage IIA prostate cancer|stage iia prostate cancer
532768|NCT00899184|stage III prostate cancer|stage iii prostate cancer
532769|NCT00899171|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
532770|NCT00899171|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
532771|NCT00899171|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
532772|NCT00899171|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
532773|NCT00899171|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
532774|NCT00899171|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
532775|NCT00899171|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
532776|NCT00899171|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
532777|NCT00899171|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
532778|NCT00899171|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
532779|NCT00899171|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
532780|NCT00899171|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
532781|NCT00899171|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
532782|NCT00899171|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
532783|NCT00899171|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
532784|NCT00899171|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
532785|NCT00899171|secondary acute myeloid leukemia|secondary acute myeloid leukemia
532786|NCT00899158|recurrent pancreatic cancer|recurrent pancreatic cancer
532787|NCT00899158|stage I pancreatic cancer|stage i pancreatic cancer
532788|NCT00899158|stage II pancreatic cancer|stage ii pancreatic cancer
532789|NCT00899158|stage III pancreatic cancer|stage iii pancreatic cancer
532790|NCT00899158|stage IV pancreatic cancer|stage iv pancreatic cancer
532791|NCT00899158|cachexia|cachexia
532792|NCT00899132|skin cancer|skin cancer
532793|NCT00899132|small intestine cancer|small intestine cancer
532795|NCT00899132|malignant testicular germ cell tumor|malignant testicular germ cell tumor
532796|NCT00899132|testicular teratoma|testicular teratoma
532797|NCT00899119|Waldenström macroglobulinemia|waldenström macroglobulinemia
532798|NCT00899080|stage I multiple myeloma|stage i multiple myeloma
532799|NCT00899080|stage II multiple myeloma|stage ii multiple myeloma
532800|NCT00899080|stage III multiple myeloma|stage iii multiple myeloma
532801|NCT00899041|Prosthesis|prosthesis
532802|NCT00899028|stage 0 non-small cell lung cancer|stage 0 non-small cell lung cancer
532803|NCT00899028|stage I non-small cell lung cancer|stage i non-small cell lung cancer
532804|NCT00899028|extensive stage small cell lung cancer|extensive stage small cell lung cancer
532805|NCT00899028|limited stage small cell lung cancer|limited stage small cell lung cancer
532806|NCT00899028|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
532807|NCT00899028|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
532808|NCT00899028|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
532809|NCT00899028|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
532810|NCT00899015|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
532811|NCT00899015|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
532812|NCT00899015|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
532813|NCT00899015|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
532814|NCT00899015|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
532815|NCT00899015|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
532816|NCT00899015|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
532817|NCT00899015|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
532818|NCT00899015|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
532819|NCT00899002|childhood hepatocellular carcinoma|childhood hepatocellular carcinoma
532820|NCT00899002|childhood liver cancer|childhood liver cancer
532821|NCT00899002|adult primary liver cancer|adult primary liver cancer
532822|NCT00899002|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
532823|NCT00898976|stage I breast cancer|stage i breast cancer
532824|NCT00898976|stage II breast cancer|stage ii breast cancer
532825|NCT00898976|stage IV breast cancer|stage iv breast cancer
532826|NCT00898976|stage IIIA breast cancer|stage iiia breast cancer
532827|NCT00898976|breast cancer in situ|breast cancer in situ
532828|NCT00898976|recurrent breast cancer|recurrent breast cancer
532829|NCT00898976|stage IIIB breast cancer|stage iiib breast cancer
532830|NCT00898976|inflammatory breast cancer|inflammatory breast cancer
532831|NCT00898976|stage IIIC breast cancer|stage iiic breast cancer
532832|NCT00898963|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
532833|NCT00898963|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
532834|NCT00898963|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
532835|NCT00898963|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
532836|NCT00898963|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
532837|NCT00898963|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
532838|NCT00898950|diabetes|diabetes
532839|NCT00898950|aspirin|aspirin
532840|NCT00898950|oxidative stress|oxidative stress
532841|NCT00898950|insulin resistance|insulin resistance
532842|NCT00898950|endothelial function|endothelial function
532843|NCT00898950|inflammation|inflammation
532844|NCT00898950|photoplethysmography|photoplethysmography
532845|NCT00898950|dysglycaemia|dysglycaemia
532846|NCT00898937|breast cancer|breast cancer
532847|NCT00898924|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
532848|NCT00898924|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
532849|NCT00898911|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
532850|NCT00898911|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
532851|NCT00898911|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
532852|NCT00898911|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
532853|NCT00898911|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
532854|NCT00898911|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
532855|NCT00898911|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
532856|NCT00898911|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
532857|NCT00898911|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
532858|NCT00898911|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
532859|NCT00898911|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
532860|NCT00898911|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
532861|NCT00898911|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
532862|NCT00898911|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
532863|NCT00898911|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
532864|NCT00898911|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
532865|NCT00898911|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
532866|NCT00898911|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
532867|NCT00898911|recurrent salivary gland cancer|recurrent salivary gland cancer
532868|NCT00898911|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
532869|NCT00898911|stage IV salivary gland cancer|stage iv salivary gland cancer
532870|NCT00898898|stage IA breast cancer|stage ia breast cancer
532871|NCT00898898|stage IB breast cancer|stage ib breast cancer
532872|NCT00898898|stage II breast cancer|stage ii breast cancer
532873|NCT00898898|stage IIIA breast cancer|stage iiia breast cancer
532874|NCT00898898|HER2-positive breast cancer|her2-positive breast cancer
532875|NCT00898885|oral manifestations|oral manifestations
532876|NCT00898885|bone marrow transplantation|bone marrow transplantation
532877|NCT00898885|adverse effects|adverse effects
532878|NCT00898872|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
532879|NCT00898872|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
532880|NCT00898872|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
532881|NCT00898872|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
532882|NCT00898872|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
532883|NCT00898872|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
532884|NCT00898872|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
532885|NCT00898872|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
532886|NCT00898872|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
532887|NCT00898872|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
532888|NCT00898872|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
532889|NCT00898872|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
532890|NCT00898872|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
532891|NCT00898872|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
532892|NCT00898872|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
532893|NCT00898872|splenic marginal zone lymphoma|splenic marginal zone lymphoma
532894|NCT00898872|Waldenström macroglobulinemia|waldenström macroglobulinemia
532895|NCT00898872|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
532896|NCT00898872|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
532897|NCT00898872|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
532898|NCT00898872|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
532899|NCT00898872|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
532900|NCT00898872|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
532901|NCT00898872|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
532902|NCT00898872|childhood Burkitt lymphoma|childhood burkitt lymphoma
532903|NCT00898872|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
532904|NCT00898859|ADAM|adam
532905|NCT00898859|epithelial|epithelial
532906|NCT00898859|COPD|copd
532907|NCT00898846|stage II colon cancer|stage ii colon cancer
532908|NCT00898846|stage II rectal cancer|stage ii rectal cancer
532909|NCT00898846|adenocarcinoma of the colon|adenocarcinoma of the colon
532910|NCT00898846|adenocarcinoma of the rectum|adenocarcinoma of the rectum
532911|NCT00898833|recurrent prostate cancer|recurrent prostate cancer
532912|NCT00898833|stage III prostate cancer|stage iii prostate cancer
532913|NCT00898833|stage IV prostate cancer|stage iv prostate cancer
532914|NCT00898833|adenocarcinoma of the prostate|adenocarcinoma of the prostate
532915|NCT00898820|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
532916|NCT00898820|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
532917|NCT00898820|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
532918|NCT00898807|neuropsychiatric symptoms|neuropsychiatric symptoms
532919|NCT00898807|aggression|aggression
532920|NCT00898807|mood lability|mood lability
532921|NCT00898794|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
532922|NCT00898794|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
532923|NCT00898781|male breast cancer|male breast cancer
532924|NCT00898781|stage IV breast cancer|stage iv breast cancer
532925|NCT00898781|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
532926|NCT00898781|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
532927|NCT00898781|stage IV pancreatic cancer|stage iv pancreatic cancer
532928|NCT00898781|stage IV colon cancer|stage iv colon cancer
532929|NCT00898781|ovarian sarcoma|ovarian sarcoma
532930|NCT00898768|Lynch syndrome|lynch syndrome
532931|NCT00898768|HNPCC|hnpcc
532932|NCT00898768|Capsule endoscopy|capsule endoscopy
532933|NCT00898768|Small bowel cancer|small bowel cancer
532934|NCT00898768|Double balloon endoscopy|double balloon endoscopy
532935|NCT00898755|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
532936|NCT00898755|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
532937|NCT00898755|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
532938|NCT00898755|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
532939|NCT00898755|childhood choroid plexus tumor|childhood choroid plexus tumor
532940|NCT00898755|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
532941|NCT00898755|childhood craniopharyngioma|childhood craniopharyngioma
532942|NCT00898755|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
532943|NCT00898755|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
532944|NCT00898755|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
532945|NCT00898755|childhood infratentorial ependymoma|childhood infratentorial ependymoma
532946|NCT00898755|childhood teratoma|childhood teratoma
532947|NCT00898755|childhood grade I meningioma|childhood grade i meningioma
532948|NCT00898755|childhood grade II meningioma|childhood grade ii meningioma
532949|NCT00898755|childhood grade III meningioma|childhood grade iii meningioma
532950|NCT00898755|childhood supratentorial ependymoma|childhood supratentorial ependymoma
532951|NCT00898755|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
532952|NCT00898755|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
532953|NCT00898755|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
532954|NCT00898755|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
532955|NCT00898755|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
532956|NCT00898755|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
532957|NCT00898755|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
532958|NCT00898755|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
532959|NCT00898755|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
532960|NCT00898755|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
532961|NCT00898755|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
532962|NCT00898755|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
532963|NCT00898755|recurrent childhood ependymoma|recurrent childhood ependymoma
532964|NCT00898755|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
532965|NCT00898755|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
532966|NCT00898755|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
532967|NCT00898755|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
532968|NCT00898755|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
532969|NCT00898755|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
532970|NCT00898755|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
532971|NCT00898755|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
532972|NCT00898755|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
532973|NCT00898755|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
532974|NCT00898755|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
532975|NCT00898755|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
532976|NCT00898755|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
532977|NCT00898755|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
532978|NCT00898755|stage I childhood liver cancer|stage i childhood liver cancer
532979|NCT00898755|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
532980|NCT00898755|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
532981|NCT00898755|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
532982|NCT00898755|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
532983|NCT00898755|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
532984|NCT00898755|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
532985|NCT00898755|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
532986|NCT00898755|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
532987|NCT00898755|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
532988|NCT00898755|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
532989|NCT00898755|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
532990|NCT00898755|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
532991|NCT00898755|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
532992|NCT00898755|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
532993|NCT00898755|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
532994|NCT00898755|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
532995|NCT00898755|untreated childhood brain stem glioma|untreated childhood brain stem glioma
532996|NCT00898755|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
532997|NCT00898755|untreated childhood medulloblastoma|untreated childhood medulloblastoma
532998|NCT00898755|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
532999|NCT00898755|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
533000|NCT00898755|childhood hepatoblastoma|childhood hepatoblastoma
533001|NCT00898755|extraosseous Ewing sarcoma/peripheral primitive neuroectodermal tumor|extraosseous ewing sarcoma/peripheral primitive neuroectodermal tumor
533002|NCT00898755|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
533003|NCT00898755|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
533004|NCT00898755|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
533005|NCT00898755|childhood hepatocellular carcinoma|childhood hepatocellular carcinoma
533006|NCT00898755|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
533007|NCT00898755|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
533008|NCT00898755|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
533009|NCT00898755|childhood Langerhans cell histiocytosis|childhood langerhans cell histiocytosis
533010|NCT00898755|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
533011|NCT00898755|childhood Burkitt lymphoma|childhood burkitt lymphoma
533012|NCT00898755|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
533013|NCT00898755|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
533014|NCT00898755|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
533015|NCT00898755|disseminated neuroblastoma|disseminated neuroblastoma
533016|NCT00898755|localized resectable neuroblastoma|localized resectable neuroblastoma
533017|NCT00898755|localized unresectable neuroblastoma|localized unresectable neuroblastoma
533018|NCT00898755|recurrent neuroblastoma|recurrent neuroblastoma
533019|NCT00898755|regional neuroblastoma|regional neuroblastoma
533020|NCT00898755|stage 4S neuroblastoma|stage 4s neuroblastoma
533021|NCT00898755|childhood germ cell tumor|childhood germ cell tumor
533022|NCT00898755|recurrent childhood liver cancer|recurrent childhood liver cancer
533023|NCT00898755|localized osteosarcoma|localized osteosarcoma
533024|NCT00898755|metastatic osteosarcoma|metastatic osteosarcoma
533025|NCT00898755|recurrent osteosarcoma|recurrent osteosarcoma
533026|NCT00898755|extraocular retinoblastoma|extraocular retinoblastoma
533027|NCT00898755|intraocular retinoblastoma|intraocular retinoblastoma
533028|NCT00898755|recurrent retinoblastoma|recurrent retinoblastoma
533029|NCT00898755|stage I Wilms tumor|stage i wilms tumor
533030|NCT00898755|stage II Wilms tumor|stage ii wilms tumor
533031|NCT00898755|stage III Wilms tumor|stage iii wilms tumor
533032|NCT00898755|stage IV Wilms tumor|stage iv wilms tumor
533033|NCT00898755|stage II childhood liver cancer|stage ii childhood liver cancer
533034|NCT00898755|stage III childhood liver cancer|stage iii childhood liver cancer
533035|NCT00898755|stage IV childhood liver cancer|stage iv childhood liver cancer
533036|NCT00898755|unusual cancers of childhood|unusual cancers of childhood
533037|NCT00898755|stage V Wilms tumor|stage v wilms tumor
533038|NCT00898755|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
533039|NCT00898755|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
533040|NCT00898755|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
533041|NCT00898755|childhood extracranial germ cell tumor|childhood extracranial germ cell tumor
533042|NCT00898755|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
533043|NCT00898755|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
533044|NCT00898755|recurrent childhood central nervous system embryonal tumor|recurrent childhood central nervous system embryonal tumor
533045|NCT00898755|childhood central nervous system germinoma|childhood central nervous system germinoma
533046|NCT00898755|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
533047|NCT00898755|childhood central nervous system teratoma|childhood central nervous system teratoma
533048|NCT00898755|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
533049|NCT00898742|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
533050|NCT00898742|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
533051|NCT00898742|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
533052|NCT00898742|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
533053|NCT00898742|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
533054|NCT00898742|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
533055|NCT00898742|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
533056|NCT00898742|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
533057|NCT00898742|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
533058|NCT00898742|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
533059|NCT00898742|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
533060|NCT00898742|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
533116|NCT00898664|recurrent salivary gland cancer|recurrent salivary gland cancer
533061|NCT00898742|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
533062|NCT00898742|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
533063|NCT00898742|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
533064|NCT00898742|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
533065|NCT00898742|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
533066|NCT00898742|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
533067|NCT00898742|recurrent salivary gland cancer|recurrent salivary gland cancer
533068|NCT00898742|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
533069|NCT00898742|stage IV salivary gland cancer|stage iv salivary gland cancer
533070|NCT00898703|breast cancer|breast cancer
533071|NCT00898690|stage I breast cancer|stage i breast cancer
533072|NCT00898690|stage II breast cancer|stage ii breast cancer
533073|NCT00898690|stage IIIA breast cancer|stage iiia breast cancer
533074|NCT00898690|stage IIIB breast cancer|stage iiib breast cancer
533075|NCT00898690|stage IIIC breast cancer|stage iiic breast cancer
533076|NCT00898690|stage IV breast cancer|stage iv breast cancer
533077|NCT00898690|recurrent breast cancer|recurrent breast cancer
533078|NCT00898664|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
533079|NCT00898664|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
533080|NCT00898664|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
533081|NCT00898664|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
533082|NCT00898664|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
533083|NCT00898664|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
533084|NCT00898664|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
533085|NCT00898664|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
533086|NCT00898664|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
533087|NCT00898664|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
533088|NCT00898664|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
533089|NCT00898664|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
533090|NCT00898664|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
533091|NCT00898664|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
533092|NCT00898664|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
533093|NCT00898664|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
533094|NCT00898664|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
533095|NCT00898664|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
533096|NCT00898664|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
533097|NCT00898664|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
533098|NCT00898664|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
533099|NCT00898664|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
533100|NCT00898664|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
533101|NCT00898664|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
533102|NCT00898664|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
533103|NCT00898664|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
533104|NCT00898664|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
533105|NCT00898664|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
533106|NCT00898664|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
533107|NCT00898664|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
533275|NCT00898612|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
533108|NCT00898664|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
533109|NCT00898664|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
533110|NCT00898664|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
533111|NCT00898664|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
533112|NCT00898664|stage I salivary gland cancer|stage i salivary gland cancer
533113|NCT00898664|stage II salivary gland cancer|stage ii salivary gland cancer
533114|NCT00898664|stage III salivary gland cancer|stage iii salivary gland cancer
533115|NCT00898664|stage IV salivary gland cancer|stage iv salivary gland cancer
534881|NCT00894543|Menopause|menopause
533117|NCT00898638|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
533118|NCT00898638|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
533119|NCT00898638|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
533120|NCT00898638|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
533121|NCT00898638|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
533122|NCT00898638|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
533123|NCT00898638|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
533124|NCT00898638|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
533125|NCT00898638|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
533126|NCT00898638|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
533127|NCT00898638|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
533128|NCT00898638|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
533129|NCT00898638|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
533130|NCT00898638|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
533131|NCT00898638|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
533132|NCT00898638|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
533133|NCT00898638|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
533134|NCT00898638|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
533135|NCT00898638|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
533136|NCT00898638|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
533137|NCT00898638|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
533138|NCT00898638|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
533139|NCT00898638|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
533140|NCT00898638|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
533141|NCT00898638|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
533142|NCT00898638|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
533143|NCT00898638|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
533144|NCT00898638|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
533145|NCT00898638|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
533146|NCT00898638|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
533147|NCT00898638|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
533148|NCT00898638|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
533149|NCT00898638|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
533150|NCT00898638|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
533151|NCT00898638|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
533152|NCT00898638|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
533153|NCT00898638|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
533154|NCT00898638|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
533155|NCT00898638|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
533156|NCT00898638|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
533157|NCT00898638|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
533158|NCT00898638|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
533159|NCT00898638|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
533160|NCT00898638|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
533161|NCT00898638|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
533162|NCT00898638|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
533163|NCT00898638|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
533164|NCT00898638|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
533165|NCT00898638|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
533166|NCT00898638|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
533167|NCT00898638|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
533168|NCT00898638|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
533169|NCT00898638|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
533170|NCT00898638|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
533171|NCT00898638|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
533172|NCT00898638|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
533173|NCT00898638|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
533174|NCT00898638|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
533175|NCT00898638|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
533176|NCT00898638|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
533177|NCT00898638|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
533178|NCT00898638|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
533179|NCT00898638|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
533180|NCT00898638|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
533181|NCT00898638|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
533182|NCT00898638|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
533183|NCT00898638|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
533184|NCT00898638|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
533185|NCT00898638|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
533186|NCT00898638|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
533187|NCT00898638|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
533188|NCT00898638|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
533276|NCT00898612|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
533189|NCT00898638|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
533190|NCT00898638|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
533191|NCT00898638|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
533192|NCT00898638|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
533193|NCT00898638|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
533194|NCT00898638|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
533195|NCT00898638|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
533196|NCT00898638|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
533197|NCT00898638|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
533198|NCT00898638|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
533199|NCT00898638|stage I salivary gland cancer|stage i salivary gland cancer
533200|NCT00898638|stage II salivary gland cancer|stage ii salivary gland cancer
533201|NCT00898638|stage III salivary gland cancer|stage iii salivary gland cancer
533202|NCT00898638|stage IV salivary gland cancer|stage iv salivary gland cancer
533203|NCT00898638|recurrent salivary gland cancer|recurrent salivary gland cancer
533204|NCT00898638|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
533205|NCT00898612|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
533206|NCT00898612|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
533207|NCT00898612|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
533208|NCT00898612|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
533209|NCT00898612|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
533210|NCT00898612|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
533211|NCT00898612|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
533212|NCT00898612|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
533213|NCT00898612|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
533214|NCT00898612|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
533215|NCT00898612|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
533216|NCT00898612|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
533217|NCT00898612|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
533218|NCT00898612|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
533219|NCT00898612|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
533220|NCT00898612|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
533221|NCT00898612|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
533222|NCT00898612|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
533223|NCT00898612|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
534001|NCT00897416|stage IIIA breast cancer|stage iiia breast cancer
533224|NCT00898612|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
533225|NCT00898612|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
533226|NCT00898612|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
533227|NCT00898612|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
533228|NCT00898612|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
533229|NCT00898612|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
533230|NCT00898612|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
533231|NCT00898612|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
533232|NCT00898612|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
533233|NCT00898612|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
533234|NCT00898612|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
533235|NCT00898612|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
533236|NCT00898612|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
533237|NCT00898612|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
533238|NCT00898612|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
533239|NCT00898612|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
533240|NCT00898612|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
533241|NCT00898612|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
533242|NCT00898612|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
533243|NCT00898612|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
533244|NCT00898612|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
533245|NCT00898612|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
533246|NCT00898612|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
533247|NCT00898612|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
533248|NCT00898612|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
533249|NCT00898612|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
533250|NCT00898612|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
533251|NCT00898612|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
533252|NCT00898612|splenic marginal zone lymphoma|splenic marginal zone lymphoma
533253|NCT00898612|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
533254|NCT00898612|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
533255|NCT00898612|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
533256|NCT00898612|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
533257|NCT00898612|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
533258|NCT00898612|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
533259|NCT00898612|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
533260|NCT00898612|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
533261|NCT00898612|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
533262|NCT00898612|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
533263|NCT00898612|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
533264|NCT00898612|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
533265|NCT00898612|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
533266|NCT00898612|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
533267|NCT00898612|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
533268|NCT00898612|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
533269|NCT00898612|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
533270|NCT00898612|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
533271|NCT00898612|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
533272|NCT00898612|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
533273|NCT00898612|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
533274|NCT00898612|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
533921|NCT00897754|stage IV colon cancer|stage iv colon cancer
533277|NCT00898612|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
533278|NCT00898612|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
533279|NCT00898612|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
533280|NCT00898612|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
533281|NCT00898612|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
533282|NCT00898612|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
533283|NCT00898612|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
533284|NCT00898612|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
533285|NCT00898612|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
533286|NCT00898612|refractory hairy cell leukemia|refractory hairy cell leukemia
533287|NCT00898612|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
533288|NCT00898612|secondary acute myeloid leukemia|secondary acute myeloid leukemia
533289|NCT00898612|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
533290|NCT00898612|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
533291|NCT00898612|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
533292|NCT00898612|chronic eosinophilic leukemia|chronic eosinophilic leukemia
533293|NCT00898612|primary myelofibrosis|primary myelofibrosis
533294|NCT00898612|chronic neutrophilic leukemia|chronic neutrophilic leukemia
533295|NCT00898612|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
533296|NCT00898612|disseminated neuroblastoma|disseminated neuroblastoma
533297|NCT00898612|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
533298|NCT00898612|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
533299|NCT00898612|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
533300|NCT00898612|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
533301|NCT00898612|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
533302|NCT00898612|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
533303|NCT00898612|recurrent neuroblastoma|recurrent neuroblastoma
533304|NCT00898612|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
533305|NCT00898612|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
533306|NCT00898612|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
533307|NCT00898612|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
533308|NCT00898612|stage I multiple myeloma|stage i multiple myeloma
533309|NCT00898612|stage II multiple myeloma|stage ii multiple myeloma
533310|NCT00898612|stage III multiple myeloma|stage iii multiple myeloma
533311|NCT00898612|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
533312|NCT00898612|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
533313|NCT00898612|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
533314|NCT00898612|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
533315|NCT00898612|stage IIIA breast cancer|stage iiia breast cancer
533316|NCT00898612|stage IIIB breast cancer|stage iiib breast cancer
533317|NCT00898612|stage IIIC breast cancer|stage iiic breast cancer
533318|NCT00898612|stage IV breast cancer|stage iv breast cancer
533319|NCT00898612|refractory multiple myeloma|refractory multiple myeloma
533320|NCT00898573|breast cancer|breast cancer
533321|NCT00898560|Partial|partial
533322|NCT00898560|Epilepsy|epilepsy
533323|NCT00898560|Eslicarbazepine acetate|eslicarbazepine acetate
533324|NCT00898560|Combined oral contraceptive|combined oral contraceptive
533325|NCT00898560|Pharmacokinetics|pharmacokinetics
533326|NCT00898560|Tolerability|tolerability
533327|NCT00898547|advanced malignant mesothelioma|advanced malignant mesothelioma
533328|NCT00898547|recurrent malignant mesothelioma|recurrent malignant mesothelioma
533329|NCT00898547|epithelial mesothelioma|epithelial mesothelioma
533330|NCT00898547|sarcomatous mesothelioma|sarcomatous mesothelioma
533331|NCT00898534|Pediatrics|pediatrics
533332|NCT00898534|Hemoglobin A1c|hemoglobin a1c
533333|NCT00898534|Point of Care testing|point of care testing
533334|NCT00898508|invasive ductal breast carcinoma|invasive ductal breast carcinoma
533335|NCT00898508|invasive lobular breast carcinoma|invasive lobular breast carcinoma
533336|NCT00898508|ductal breast carcinoma in situ|ductal breast carcinoma in situ
533337|NCT00898508|lobular breast carcinoma in situ|lobular breast carcinoma in situ
533338|NCT00898508|stage I breast cancer|stage i breast cancer
533339|NCT00898508|stage II breast cancer|stage ii breast cancer
533340|NCT00898508|stage IIIA breast cancer|stage iiia breast cancer
533341|NCT00898508|stage IIIB breast cancer|stage iiib breast cancer
533342|NCT00898508|stage IIIC breast cancer|stage iiic breast cancer
533343|NCT00898508|stage IV breast cancer|stage iv breast cancer
533344|NCT00898495|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
533345|NCT00898495|stage II esophageal cancer|stage ii esophageal cancer
533346|NCT00898495|stage III esophageal cancer|stage iii esophageal cancer
533347|NCT00898495|stage IV esophageal cancer|stage iv esophageal cancer
533348|NCT00898495|stage I esophageal cancer|stage i esophageal cancer
533349|NCT00898482|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
533350|NCT00898482|recurrent pancreatic cancer|recurrent pancreatic cancer
533351|NCT00898482|stage I pancreatic cancer|stage i pancreatic cancer
533352|NCT00898482|stage II pancreatic cancer|stage ii pancreatic cancer
533353|NCT00898482|stage III pancreatic cancer|stage iii pancreatic cancer
533354|NCT00898482|stage IV pancreatic cancer|stage iv pancreatic cancer
533355|NCT00898469|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
533356|NCT00898456|adult acute myeloid leukemia|adult acute myeloid leukemia
533357|NCT00898456|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
533358|NCT00898456|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
533359|NCT00898456|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
533360|NCT00898456|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
533361|NCT00898456|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
533362|NCT00898456|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
533363|NCT00898456|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
533364|NCT00898456|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
533365|NCT00898456|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
533366|NCT00898456|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
533367|NCT00898456|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
533368|NCT00898456|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
533369|NCT00898456|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
533370|NCT00898456|adult acute basophilic leukemia|adult acute basophilic leukemia
533371|NCT00898456|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
533372|NCT00898430|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
533373|NCT00898430|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
533374|NCT00898430|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
533375|NCT00898430|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
533376|NCT00898430|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
533377|NCT00898430|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
533378|NCT00898430|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
533379|NCT00898430|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
533380|NCT00898430|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
533381|NCT00898430|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
533382|NCT00898430|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
533383|NCT00898430|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
533384|NCT00898430|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
533385|NCT00898430|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
533386|NCT00898430|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
533387|NCT00898430|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
533388|NCT00898430|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
533389|NCT00898430|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
533390|NCT00898430|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
533391|NCT00898430|stage III salivary gland cancer|stage iii salivary gland cancer
533392|NCT00898430|stage IV salivary gland cancer|stage iv salivary gland cancer
533393|NCT00898417|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
533394|NCT00898417|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
533395|NCT00898417|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
533396|NCT00898417|adenocarcinoma of the lung|adenocarcinoma of the lung
533397|NCT00898417|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
533398|NCT00898378|healthy, no evidence of disease|healthy, no evidence of disease
533399|NCT00898378|stage I colon cancer|stage i colon cancer
533400|NCT00898378|stage II colon cancer|stage ii colon cancer
533401|NCT00898378|stage III colon cancer|stage iii colon cancer
533402|NCT00898378|stage IV colon cancer|stage iv colon cancer
533403|NCT00898378|stage I rectal cancer|stage i rectal cancer
533404|NCT00898378|stage II rectal cancer|stage ii rectal cancer
533405|NCT00898378|stage III rectal cancer|stage iii rectal cancer
533406|NCT00898378|stage IV rectal cancer|stage iv rectal cancer
533407|NCT00898378|recurrent rectal cancer|recurrent rectal cancer
533408|NCT00898378|recurrent colon cancer|recurrent colon cancer
533409|NCT00898378|adenomatous polyp|adenomatous polyp
533410|NCT00898352|stage III vulvar cancer|stage iii vulvar cancer
533411|NCT00898352|squamous cell carcinoma of the vulva|squamous cell carcinoma of the vulva
533412|NCT00898326|stage I prostate cancer|stage i prostate cancer
533413|NCT00898326|stage IIB prostate cancer|stage iib prostate cancer
533414|NCT00898326|stage IIA prostate cancer|stage iia prostate cancer
533415|NCT00898313|lung cancer|lung cancer
533416|NCT00898300|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
533417|NCT00898300|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
533418|NCT00898300|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
533419|NCT00898300|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
533420|NCT00898300|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
533421|NCT00898300|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
533422|NCT00898300|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
534002|NCT00897416|stage IIIB breast cancer|stage iiib breast cancer
533423|NCT00898300|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
533424|NCT00898300|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
533425|NCT00898300|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
533426|NCT00898300|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
533427|NCT00898300|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
533428|NCT00898300|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
533429|NCT00898300|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
533430|NCT00898300|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
533431|NCT00898300|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
533432|NCT00898300|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
533433|NCT00898300|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
533434|NCT00898300|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
533435|NCT00898300|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
533436|NCT00898300|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
533437|NCT00898300|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
533438|NCT00898300|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
533439|NCT00898300|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
533440|NCT00898300|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
533441|NCT00898300|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
533442|NCT00898300|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
533443|NCT00898300|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
533444|NCT00898300|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
533445|NCT00898300|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
533446|NCT00898300|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
533447|NCT00898300|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
533448|NCT00898300|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
533449|NCT00898300|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
533450|NCT00898300|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
533451|NCT00898300|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
533452|NCT00898300|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
533453|NCT00898300|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
533454|NCT00898300|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
533455|NCT00898300|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
533456|NCT00898300|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
533457|NCT00898300|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
533458|NCT00898300|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
533459|NCT00898300|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
533460|NCT00898300|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
533461|NCT00898300|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
533462|NCT00898300|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
533463|NCT00898300|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
533464|NCT00898300|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
533465|NCT00898300|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
533466|NCT00898300|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
533467|NCT00898300|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
533468|NCT00898300|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
533469|NCT00898300|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
533470|NCT00898300|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
533471|NCT00898300|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
533472|NCT00898300|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
533473|NCT00898300|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
533474|NCT00898300|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
533537|NCT00898118|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
534983|NCT00894127|Lung Cancer|lung cancer
533475|NCT00898300|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
533476|NCT00898300|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
533477|NCT00898300|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
533478|NCT00898300|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
533479|NCT00898300|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
533480|NCT00898300|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
533481|NCT00898300|stage I salivary gland cancer|stage i salivary gland cancer
533482|NCT00898300|stage II salivary gland cancer|stage ii salivary gland cancer
533483|NCT00898300|stage III salivary gland cancer|stage iii salivary gland cancer
533484|NCT00898300|stage IV salivary gland cancer|stage iv salivary gland cancer
533485|NCT00898300|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
533486|NCT00898300|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
533487|NCT00898300|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
533488|NCT00898300|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
533489|NCT00898300|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
533490|NCT00898300|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
533491|NCT00898300|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
533492|NCT00898300|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
533493|NCT00898300|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
533494|NCT00898300|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
533495|NCT00898300|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
533496|NCT00898300|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
533497|NCT00898300|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
533498|NCT00898300|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
533499|NCT00898300|recurrent salivary gland cancer|recurrent salivary gland cancer
533500|NCT00898300|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
533501|NCT00898300|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
533502|NCT00898300|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
533503|NCT00898287|Locally advanced or metastatic adenocarcinoma of pancreas|locally advanced or metastatic adenocarcinoma of pancreas
533504|NCT00898274|prostate cancer|prostate cancer
533505|NCT00898274|high grade prostatic intraepithelial neoplasia|high grade prostatic intraepithelial neoplasia
533506|NCT00898261|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
533507|NCT00898235|primary systemic amyloidosis|primary systemic amyloidosis
533508|NCT00898222|healthy volunteers|healthy volunteers
533509|NCT00898222|aspirin|aspirin
533510|NCT00898222|Normal healthy subjects|normal healthy subjects
533511|NCT00898209|stage I non-small cell lung cancer|stage i non-small cell lung cancer
533512|NCT00898209|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
533513|NCT00898209|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
533514|NCT00898209|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
533515|NCT00898209|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
533516|NCT00898183|stage III melanoma|stage iii melanoma
533517|NCT00898183|stage IV melanoma|stage iv melanoma
533518|NCT00898183|recurrent melanoma|recurrent melanoma
533519|NCT00898170|myoma|myoma
533520|NCT00898170|hypertension|hypertension
533521|NCT00898170|erythropoetin|erythropoetin
533522|NCT00898170|blood pressure|blood pressure
533523|NCT00898170|erythropoetin level|erythropoetin level
533524|NCT00898157|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
533525|NCT00898157|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
533526|NCT00898157|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
533527|NCT00898157|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
533528|NCT00898157|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
533529|NCT00898157|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
533530|NCT00898144|cervical cancer|cervical cancer
533531|NCT00898144|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
533532|NCT00898144|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
533533|NCT00898144|cervical adenocarcinoma|cervical adenocarcinoma
533534|NCT00898144|atypical squamous cells of undetermined significance|atypical squamous cells of undetermined significance
533535|NCT00898131|breast cancer|breast cancer
533536|NCT00898118|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
533538|NCT00898118|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
533539|NCT00898118|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
533540|NCT00898092|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
533541|NCT00898092|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
533542|NCT00898092|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
533543|NCT00898092|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
533544|NCT00898092|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
533545|NCT00898092|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
533546|NCT00898092|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
533547|NCT00898092|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
533548|NCT00898092|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
533549|NCT00898092|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
533550|NCT00898092|adult acute basophilic leukemia|adult acute basophilic leukemia
533551|NCT00898092|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
533552|NCT00898066|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
533553|NCT00898066|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
533554|NCT00898066|primary systemic amyloidosis|primary systemic amyloidosis
533555|NCT00898066|stage I multiple myeloma|stage i multiple myeloma
533556|NCT00898066|stage II multiple myeloma|stage ii multiple myeloma
533557|NCT00898066|stage III multiple myeloma|stage iii multiple myeloma
533558|NCT00898040|stage I multiple myeloma|stage i multiple myeloma
533559|NCT00898040|stage II multiple myeloma|stage ii multiple myeloma
533560|NCT00898040|stage III multiple myeloma|stage iii multiple myeloma
533561|NCT00898040|refractory multiple myeloma|refractory multiple myeloma
533562|NCT00898027|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
533563|NCT00898014|stage IV breast cancer|stage iv breast cancer
533564|NCT00897988|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
533565|NCT00897988|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
533566|NCT00897988|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
533567|NCT00897988|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
533568|NCT00897988|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
533569|NCT00897975|statin associated myalgias|statin associated myalgias
533570|NCT00897975|hyperlipidemia|hyperlipidemia
533571|NCT00897975|red yeast rice|red yeast rice
533572|NCT00897975|phytosterols|phytosterols
533573|NCT00897975|therapeutic lifestyle changes|therapeutic lifestyle changes
533574|NCT00897975|compliance|compliance
533575|NCT00897962|stage IV breast cancer|stage iv breast cancer
533576|NCT00897936|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
533577|NCT00897936|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
533578|NCT00897936|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
533579|NCT00897936|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
533580|NCT00897936|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
533581|NCT00897936|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
533582|NCT00897936|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
533583|NCT00897936|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
533584|NCT00897923|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
533585|NCT00897923|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
533586|NCT00897923|anaplastic large cell lymphoma|anaplastic large cell lymphoma
533587|NCT00897923|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
533588|NCT00897923|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
533589|NCT00897923|intraocular lymphoma|intraocular lymphoma
533590|NCT00897923|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
533591|NCT00897923|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
533592|NCT00897923|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
533593|NCT00897923|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
533594|NCT00897923|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
533595|NCT00897923|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
533596|NCT00897923|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
533597|NCT00897923|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
533598|NCT00897923|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
533599|NCT00897923|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
533600|NCT00897923|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
533601|NCT00897923|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
533602|NCT00897923|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
533912|NCT00897767|prolymphocytic leukemia|prolymphocytic leukemia
533603|NCT00897923|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
533604|NCT00897923|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
533605|NCT00897923|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
533606|NCT00897923|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
533607|NCT00897923|small intestine lymphoma|small intestine lymphoma
533608|NCT00897923|splenic marginal zone lymphoma|splenic marginal zone lymphoma
533609|NCT00897923|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
533610|NCT00897923|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
533611|NCT00897923|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
533612|NCT00897923|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
533613|NCT00897923|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
533614|NCT00897923|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
533615|NCT00897923|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
533616|NCT00897923|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
533617|NCT00897923|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
533618|NCT00897923|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
533619|NCT00897923|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
533620|NCT00897923|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
533621|NCT00897923|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
533622|NCT00897923|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
533623|NCT00897923|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
533624|NCT00897923|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
533625|NCT00897923|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
533626|NCT00897923|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
533627|NCT00897923|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
533628|NCT00897923|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
533629|NCT00897923|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
533630|NCT00897923|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
533631|NCT00897923|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
533632|NCT00897923|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
533633|NCT00897923|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
533634|NCT00897923|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
533635|NCT00897923|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
533636|NCT00897923|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
533637|NCT00897923|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
533638|NCT00897923|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
533639|NCT00897923|Waldenström macroglobulinemia|waldenström macroglobulinemia
533640|NCT00897923|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
533641|NCT00897923|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
533642|NCT00897923|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
533643|NCT00897923|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
533644|NCT00897923|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
533645|NCT00897923|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
533646|NCT00897923|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
533647|NCT00897923|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
533648|NCT00897923|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
533649|NCT00897923|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
533650|NCT00897923|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
533651|NCT00897923|stage I mantle cell lymphoma|stage i mantle cell lymphoma
533652|NCT00897923|stage I marginal zone lymphoma|stage i marginal zone lymphoma
533653|NCT00897923|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
533654|NCT00897923|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
533655|NCT00897923|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
533656|NCT00897923|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
533657|NCT00897923|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
533658|NCT00897923|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
533659|NCT00897923|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
533660|NCT00897923|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
533661|NCT00897923|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
533662|NCT00897923|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
533663|NCT00897923|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
533664|NCT00897923|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
533665|NCT00897923|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
534984|NCT00894127|Porphyrin|porphyrin
533666|NCT00897923|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
533667|NCT00897923|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
533668|NCT00897923|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
533669|NCT00897923|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
533670|NCT00897923|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
533671|NCT00897923|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
533672|NCT00897923|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
533673|NCT00897923|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
533674|NCT00897923|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
533675|NCT00897923|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
533676|NCT00897923|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
533677|NCT00897923|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
533678|NCT00897923|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
533679|NCT00897923|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
533680|NCT00897923|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
533681|NCT00897923|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
533682|NCT00897923|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
533683|NCT00897923|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
533684|NCT00897923|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
533685|NCT00897910|stage I multiple myeloma|stage i multiple myeloma
533686|NCT00897910|stage II multiple myeloma|stage ii multiple myeloma
533687|NCT00897910|stage III multiple myeloma|stage iii multiple myeloma
533688|NCT00897910|refractory multiple myeloma|refractory multiple myeloma
533689|NCT00897897|Uterine Leiomyomas|uterine leiomyomas
533690|NCT00897897|Fibroids|fibroids
533691|NCT00897897|HIFU|hifu
533692|NCT00897897|Ablation|ablation
533693|NCT00897897|High Intensity Focused Ultrasound|high intensity focused ultrasound
533694|NCT00897884|breast cancer|breast cancer
533695|NCT00897884|metformin|metformin
533696|NCT00897884|breast surgery|breast surgery
533697|NCT00897871|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
533698|NCT00897858|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
533699|NCT00897858|childhood choroid plexus tumor|childhood choroid plexus tumor
533700|NCT00897858|childhood grade I meningioma|childhood grade i meningioma
533701|NCT00897858|childhood grade II meningioma|childhood grade ii meningioma
533702|NCT00897858|childhood grade III meningioma|childhood grade iii meningioma
533703|NCT00897858|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
533704|NCT00897858|untreated childhood visual pathway glioma|untreated childhood visual pathway glioma
533705|NCT00897858|childhood infratentorial ependymoma|childhood infratentorial ependymoma
533706|NCT00897858|childhood supratentorial ependymoma|childhood supratentorial ependymoma
533707|NCT00897858|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
533708|NCT00897858|childhood craniopharyngioma|childhood craniopharyngioma
533709|NCT00897858|untreated childhood medulloblastoma|untreated childhood medulloblastoma
533710|NCT00897858|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
533711|NCT00897858|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
533712|NCT00897858|untreated childhood brain stem glioma|untreated childhood brain stem glioma
533713|NCT00897858|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
533714|NCT00897858|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
533715|NCT00897858|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
533716|NCT00897858|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
533717|NCT00897858|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
533718|NCT00897858|childhood central nervous system germinoma|childhood central nervous system germinoma
533719|NCT00897858|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
533720|NCT00897858|childhood central nervous system teratoma|childhood central nervous system teratoma
533721|NCT00897858|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
533722|NCT00897845|stage II breast cancer|stage ii breast cancer
533723|NCT00897845|stage IIIA breast cancer|stage iiia breast cancer
533724|NCT00897845|stage IIIB breast cancer|stage iiib breast cancer
533725|NCT00897832|pancreatic cancer|pancreatic cancer
533726|NCT00897819|recurrent colon cancer|recurrent colon cancer
533727|NCT00897819|recurrent rectal cancer|recurrent rectal cancer
533728|NCT00897819|stage III colon cancer|stage iii colon cancer
533729|NCT00897819|stage III rectal cancer|stage iii rectal cancer
533730|NCT00897819|stage IV colon cancer|stage iv colon cancer
533731|NCT00897819|stage IV rectal cancer|stage iv rectal cancer
533732|NCT00897819|adenocarcinoma of the colon|adenocarcinoma of the colon
533733|NCT00897819|adenocarcinoma of the rectum|adenocarcinoma of the rectum
533734|NCT00897806|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
533735|NCT00897806|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
533736|NCT00897806|peritoneal cavity cancer|peritoneal cavity cancer
533737|NCT00897793|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
533738|NCT00897793|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
533739|NCT00897793|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
533740|NCT00897793|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
533741|NCT00897793|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
533742|NCT00897793|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
533743|NCT00897793|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
533744|NCT00897793|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
533745|NCT00897793|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
533746|NCT00897793|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
533747|NCT00897793|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
533748|NCT00897793|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
533749|NCT00897793|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
533750|NCT00897793|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
533751|NCT00897793|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
533752|NCT00897793|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
533753|NCT00897793|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
533754|NCT00897793|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
533755|NCT00897793|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
533756|NCT00897793|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
533757|NCT00897793|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
533758|NCT00897793|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
533759|NCT00897793|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
533760|NCT00897793|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
533761|NCT00897793|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
533762|NCT00897793|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
533763|NCT00897793|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
533764|NCT00897793|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
533765|NCT00897793|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
533766|NCT00897793|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
533767|NCT00897793|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
533768|NCT00897793|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
533769|NCT00897793|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
533770|NCT00897793|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
533771|NCT00897793|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
533772|NCT00897793|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
533773|NCT00897793|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
533774|NCT00897793|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
533775|NCT00897793|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
533776|NCT00897793|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
533777|NCT00897793|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
533778|NCT00897793|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
533779|NCT00897793|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
533780|NCT00897793|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
533781|NCT00897793|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
533782|NCT00897793|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
533783|NCT00897793|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
533784|NCT00897793|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
533785|NCT00897793|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
533786|NCT00897793|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
533787|NCT00897793|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
533788|NCT00897793|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
533789|NCT00897793|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
533790|NCT00897793|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
533791|NCT00897793|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
533792|NCT00897793|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
533793|NCT00897793|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
533794|NCT00897793|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
533795|NCT00897793|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
533796|NCT00897793|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
533797|NCT00897793|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
533798|NCT00897793|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
533799|NCT00897793|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
533800|NCT00897793|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
533801|NCT00897793|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
533802|NCT00897793|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
533803|NCT00897793|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
533804|NCT00897793|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
533805|NCT00897793|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
533806|NCT00897793|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
533807|NCT00897793|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
533808|NCT00897793|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
533809|NCT00897793|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
533810|NCT00897793|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
533811|NCT00897793|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
533812|NCT00897793|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
533813|NCT00897793|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
533814|NCT00897793|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
533815|NCT00897793|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
533816|NCT00897793|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
533817|NCT00897793|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
533818|NCT00897793|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
533819|NCT00897793|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
533820|NCT00897793|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
533821|NCT00897793|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
533822|NCT00897793|recurrent salivary gland cancer|recurrent salivary gland cancer
533823|NCT00897793|salivary gland acinic cell tumor|salivary gland acinic cell tumor
533824|NCT00897793|salivary gland adenocarcinoma|salivary gland adenocarcinoma
533825|NCT00897793|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
533826|NCT00897793|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
533827|NCT00897793|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
533828|NCT00897793|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
533829|NCT00897793|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
533830|NCT00897793|stage I salivary gland cancer|stage i salivary gland cancer
533831|NCT00897793|stage II salivary gland cancer|stage ii salivary gland cancer
533832|NCT00897793|stage III salivary gland cancer|stage iii salivary gland cancer
533833|NCT00897793|stage IV salivary gland cancer|stage iv salivary gland cancer
533834|NCT00897793|limited stage small cell lung cancer|limited stage small cell lung cancer
533835|NCT00897793|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
533836|NCT00897793|recurrent small cell lung cancer|recurrent small cell lung cancer
533837|NCT00897793|stage I non-small cell lung cancer|stage i non-small cell lung cancer
533838|NCT00897793|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
533839|NCT00897793|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
533840|NCT00897793|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
533841|NCT00897793|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
534000|NCT00897416|stage II breast cancer|stage ii breast cancer
533842|NCT00897793|extensive stage small cell lung cancer|extensive stage small cell lung cancer
533843|NCT00897793|male breast cancer|male breast cancer
533844|NCT00897793|recurrent breast cancer|recurrent breast cancer
533845|NCT00897793|stage I breast cancer|stage i breast cancer
533846|NCT00897793|stage II breast cancer|stage ii breast cancer
533847|NCT00897793|stage IIIA breast cancer|stage iiia breast cancer
533848|NCT00897793|stage IIIB breast cancer|stage iiib breast cancer
533849|NCT00897793|stage IIIC breast cancer|stage iiic breast cancer
533850|NCT00897793|stage IV breast cancer|stage iv breast cancer
533851|NCT00897793|recurrent colon cancer|recurrent colon cancer
533852|NCT00897793|stage I colon cancer|stage i colon cancer
533853|NCT00897793|stage II colon cancer|stage ii colon cancer
533854|NCT00897793|stage III colon cancer|stage iii colon cancer
533855|NCT00897793|stage IV colon cancer|stage iv colon cancer
533856|NCT00897793|recurrent rectal cancer|recurrent rectal cancer
533857|NCT00897793|stage I rectal cancer|stage i rectal cancer
533858|NCT00897793|stage II rectal cancer|stage ii rectal cancer
533859|NCT00897793|stage III rectal cancer|stage iii rectal cancer
533860|NCT00897793|stage IV rectal cancer|stage iv rectal cancer
533861|NCT00897793|recurrent prostate cancer|recurrent prostate cancer
533862|NCT00897793|stage I prostate cancer|stage i prostate cancer
533863|NCT00897793|stage II prostate cancer|stage ii prostate cancer
533864|NCT00897793|stage III prostate cancer|stage iii prostate cancer
533865|NCT00897793|stage IV prostate cancer|stage iv prostate cancer
533866|NCT00897780|Headache|headache
533867|NCT00897780|Pediatric|pediatric
533868|NCT00897780|Virtual Reality|virtual reality
533869|NCT00897780|Biofeedback|biofeedback
533870|NCT00897767|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
533871|NCT00897767|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
533872|NCT00897767|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
533873|NCT00897767|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
533874|NCT00897767|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
533875|NCT00897767|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
533876|NCT00897767|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
533877|NCT00897767|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
533878|NCT00897767|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
533879|NCT00897767|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
533880|NCT00897767|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
533881|NCT00897767|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
533882|NCT00897767|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
533883|NCT00897767|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
533884|NCT00897767|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
533885|NCT00897767|refractory hairy cell leukemia|refractory hairy cell leukemia
533886|NCT00897767|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
533887|NCT00897767|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
533888|NCT00897767|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
533889|NCT00897767|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
533890|NCT00897767|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
533891|NCT00897767|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
533892|NCT00897767|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
533893|NCT00897767|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
533894|NCT00897767|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
533895|NCT00897767|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
533896|NCT00897767|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
533897|NCT00897767|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
533898|NCT00897767|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
533899|NCT00897767|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
533900|NCT00897767|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
533901|NCT00897767|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
533902|NCT00897767|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
533903|NCT00897767|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
533904|NCT00897767|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
533905|NCT00897767|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
533906|NCT00897767|secondary acute myeloid leukemia|secondary acute myeloid leukemia
533907|NCT00897767|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
533908|NCT00897767|acute undifferentiated leukemia|acute undifferentiated leukemia
533909|NCT00897767|mast cell leukemia|mast cell leukemia
533910|NCT00897767|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
533911|NCT00897767|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
533913|NCT00897767|untreated hairy cell leukemia|untreated hairy cell leukemia
533914|NCT00897754|adenocarcinoma of the colon|adenocarcinoma of the colon
533915|NCT00897754|adenocarcinoma of the rectum|adenocarcinoma of the rectum
533916|NCT00897754|recurrent rectal cancer|recurrent rectal cancer
533917|NCT00897754|stage III rectal cancer|stage iii rectal cancer
533918|NCT00897754|stage IV rectal cancer|stage iv rectal cancer
533919|NCT00897754|recurrent colon cancer|recurrent colon cancer
533920|NCT00897754|stage III colon cancer|stage iii colon cancer
533922|NCT00897741|recurrent pancreatic cancer|recurrent pancreatic cancer
533923|NCT00897741|stage IV pancreatic cancer|stage iv pancreatic cancer
533924|NCT00897728|stage IA breast cancer|stage ia breast cancer
533925|NCT00897728|stage IB breast cancer|stage ib breast cancer
533926|NCT00897728|stage II breast cancer|stage ii breast cancer
533927|NCT00897728|stage IIIA breast cancer|stage iiia breast cancer
533928|NCT00897728|stage IIIB breast cancer|stage iiib breast cancer
533929|NCT00897728|stage IIIC breast cancer|stage iiic breast cancer
533930|NCT00897728|HER2-positive breast cancer|her2-positive breast cancer
533931|NCT00897728|triple-negative breast cancer|triple-negative breast cancer
533932|NCT00897728|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
533933|NCT00897715|CKD|ckd
533934|NCT00897715|inflammation|inflammation
533935|NCT00897715|CVD|cvd
533936|NCT00897702|recurrent breast cancer|recurrent breast cancer
533937|NCT00897702|male breast cancer|male breast cancer
533938|NCT00897702|stage IV breast cancer|stage iv breast cancer
533939|NCT00897676|Hyperinsulinism|hyperinsulinism
533940|NCT00897676|Hypoglycemia|hypoglycemia
533941|NCT00897676|KATP channel|katp channel
533942|NCT00897663|adult giant cell glioblastoma|adult giant cell glioblastoma
533943|NCT00897663|adult gliosarcoma|adult gliosarcoma
533944|NCT00897663|adult glioblastoma|adult glioblastoma
533945|NCT00897650|lung cancer|lung cancer
533946|NCT00897624|metastatic intraocular melanoma|metastatic intraocular melanoma
533947|NCT00897624|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
533948|NCT00897624|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
533949|NCT00897611|adult anaplastic astrocytoma|adult anaplastic astrocytoma
533950|NCT00897611|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
533951|NCT00897611|adult giant cell glioblastoma|adult giant cell glioblastoma
533952|NCT00897611|recurrent adult brain tumor|recurrent adult brain tumor
533953|NCT00897611|adult glioblastoma|adult glioblastoma
533954|NCT00897611|adult gliosarcoma|adult gliosarcoma
533955|NCT00897559|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
533956|NCT00897546|recurrent melanoma|recurrent melanoma
533957|NCT00897546|stage IV melanoma|stage iv melanoma
533958|NCT00897546|stage IA melanoma|stage ia melanoma
533959|NCT00897546|stage IB melanoma|stage ib melanoma
533960|NCT00897546|stage IIA melanoma|stage iia melanoma
533961|NCT00897546|stage IIB melanoma|stage iib melanoma
533962|NCT00897546|stage IIC melanoma|stage iic melanoma
533963|NCT00897546|stage IIIA melanoma|stage iiia melanoma
533964|NCT00897546|stage IIIB melanoma|stage iiib melanoma
533965|NCT00897546|stage IIIC melanoma|stage iiic melanoma
533966|NCT00897533|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
533967|NCT00897533|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
533968|NCT00897533|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
533969|NCT00897533|adenocarcinoma of the lung|adenocarcinoma of the lung
533970|NCT00897533|squamous cell lung cancer|squamous cell lung cancer
533971|NCT00897533|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
533972|NCT00897520|stage II melanoma|stage ii melanoma
533973|NCT00897520|stage III melanoma|stage iii melanoma
533974|NCT00897520|stage IV melanoma|stage iv melanoma
533975|NCT00897507|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
533976|NCT00897507|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
533977|NCT00897494|stage I pancreatic cancer|stage i pancreatic cancer
533978|NCT00897494|stage II pancreatic cancer|stage ii pancreatic cancer
533979|NCT00897494|stage III pancreatic cancer|stage iii pancreatic cancer
533980|NCT00897494|stage IV pancreatic cancer|stage iv pancreatic cancer
533981|NCT00897481|stage IV melanoma|stage iv melanoma
533982|NCT00897481|recurrent melanoma|recurrent melanoma
533983|NCT00897481|stage IA melanoma|stage ia melanoma
533984|NCT00897481|stage IB melanoma|stage ib melanoma
533985|NCT00897481|stage IIA melanoma|stage iia melanoma
533986|NCT00897481|stage IIB melanoma|stage iib melanoma
533987|NCT00897481|stage IIC melanoma|stage iic melanoma
533988|NCT00897481|stage IIIA melanoma|stage iiia melanoma
533989|NCT00897481|stage IIIB melanoma|stage iiib melanoma
533990|NCT00897481|stage IIIC melanoma|stage iiic melanoma
533991|NCT00897468|breast cancer|breast cancer
533992|NCT00897455|breast cancer|breast cancer
533993|NCT00897455|BRCA1 mutation carrier|brca1 mutation carrier
533994|NCT00897455|BRCA2 mutation carrier|brca2 mutation carrier
533995|NCT00897429|stage IIA colon cancer|stage iia colon cancer
533996|NCT00897429|stage IIB colon cancer|stage iib colon cancer
533997|NCT00897429|stage IIC colon cancer|stage iic colon cancer
533998|NCT00897416|breast cancer|breast cancer
533999|NCT00897416|stage I breast cancer|stage i breast cancer
534003|NCT00897416|stage IIIC breast cancer|stage iiic breast cancer
534004|NCT00897416|stage IV breast cancer|stage iv breast cancer
534005|NCT00897403|colon cancer|colon cancer
534006|NCT00897403|health status unknown|health status unknown
534007|NCT00897364|non-small cell lung cancer|non-small cell lung cancer
534008|NCT00897364|small cell lung cancer|small cell lung cancer
534009|NCT00897364|squamous lung dysplasia|squamous lung dysplasia
534010|NCT00897351|recurrent prostate cancer|recurrent prostate cancer
534011|NCT00897338|stage IV breast cancer|stage iv breast cancer
534012|NCT00897312|stage IV melanoma|stage iv melanoma
534013|NCT00897312|hepatitis C infection|hepatitis c infection
534014|NCT00897312|melanoma (skin)|melanoma (skin)
534015|NCT00897312|precancerous/nonmalignant condition|precancerous/nonmalignant condition
534016|NCT00897299|estrogen receptor|estrogen receptor
534017|NCT00897299|HER-2|her-2
534018|NCT00897299|PgR|pgr
534019|NCT00897299|stage II breast cancer|stage ii breast cancer
534020|NCT00897299|stage IIIA breast cancer|stage iiia breast cancer
534021|NCT00897299|stage IIIB breast cancer|stage iiib breast cancer
534022|NCT00897286|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
534023|NCT00897286|childhood choroid plexus tumor|childhood choroid plexus tumor
534024|NCT00897286|childhood medulloblastoma|childhood medulloblastoma
534025|NCT00897286|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
534026|NCT00897286|childhood infratentorial ependymoma|childhood infratentorial ependymoma
534027|NCT00897286|childhood supratentorial ependymoma|childhood supratentorial ependymoma
534028|NCT00897286|recurrent childhood ependymoma|recurrent childhood ependymoma
534029|NCT00897286|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
534030|NCT00897286|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
534031|NCT00897286|gliomas|gliomas
534032|NCT00897273|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
534033|NCT00897273|oropharyngeal cancer|oropharyngeal cancer
534034|NCT00897273|oropharyngeal squamous cell carcinoma|oropharyngeal squamous cell carcinoma
534035|NCT00897273|infection|infection
534036|NCT00897273|precancerous condition|precancerous condition
534037|NCT00897273|human papilloma virus infection|human papilloma virus infection
534038|NCT00897260|Unrelated Umbilical Cord Blood Transplant|unrelated umbilical cord blood transplant
534039|NCT00897260|Multiple cord blood|multiple cord blood
534040|NCT00897247|malignant mesothelioma|malignant mesothelioma
534041|NCT00897247|pulmonary complications|pulmonary complications
534042|NCT00897234|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
534043|NCT00897234|stage I non-small cell lung cancer|stage i non-small cell lung cancer
534044|NCT00897234|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
534045|NCT00897234|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
534046|NCT00897234|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
534047|NCT00897234|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
534048|NCT00897221|Friedreich's ataxia|friedreich's ataxia
534049|NCT00897208|breast cancer|breast cancer
534050|NCT00897208|ductal breast carcinoma in situ|ductal breast carcinoma in situ
534051|NCT00897208|breast cancer in situ|breast cancer in situ
534052|NCT00897208|stage IA breast cancer|stage ia breast cancer
534053|NCT00897208|stage IB breast cancer|stage ib breast cancer
534054|NCT00897208|stage II breast cancer|stage ii breast cancer
534055|NCT00897182|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
534056|NCT00897182|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
534057|NCT00897182|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
534058|NCT00897182|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
534059|NCT00897182|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
534060|NCT00897182|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
534061|NCT00897182|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
534062|NCT00897182|secondary acute myeloid leukemia|secondary acute myeloid leukemia
534063|NCT00897182|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
534064|NCT00897182|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
534065|NCT00897143|non-small cell lung cancer|non-small cell lung cancer
534066|NCT00897143|malignant pleural effusion|malignant pleural effusion
534067|NCT00897143|small cell lung cancer|small cell lung cancer
534068|NCT00897130|low-risk (IPSS 0-INT1) MDS according to WHO classification|low-risk (ipss 0-int1) mds according to who classification
534069|NCT00897117|stage I non-small cell lung cancer|stage i non-small cell lung cancer
534070|NCT00897117|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
534071|NCT00897091|stage II breast cancer|stage ii breast cancer
534072|NCT00897091|stage IIIA breast cancer|stage iiia breast cancer
534073|NCT00897078|cancer survivor|cancer survivor
534074|NCT00897078|healthy, no evidence of disease|healthy, no evidence of disease
534075|NCT00897078|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
534076|NCT00897078|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
535384|NCT00892411|Prognosis|prognosis
534077|NCT00897065|stage IA breast cancer|stage ia breast cancer
534078|NCT00897065|stage IB breast cancer|stage ib breast cancer
534079|NCT00897065|stage II breast cancer|stage ii breast cancer
534080|NCT00897065|stage IIIA breast cancer|stage iiia breast cancer
534081|NCT00897065|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
534082|NCT00897065|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
534083|NCT00897052|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
534084|NCT00897052|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
534085|NCT00897052|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
534086|NCT00897052|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
534087|NCT00897052|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
534088|NCT00897052|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
534089|NCT00897052|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
534090|NCT00897052|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
534091|NCT00897052|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
534092|NCT00897052|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
534093|NCT00897052|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
534094|NCT00897052|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
534095|NCT00897039|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
534096|NCT00897039|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
534097|NCT00897039|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
534098|NCT00897039|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
534099|NCT00897039|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
534100|NCT00897039|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
534101|NCT00897039|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
534102|NCT00897039|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
534103|NCT00897039|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
534104|NCT00897039|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
534105|NCT00897039|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
534106|NCT00897039|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
534107|NCT00897039|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
534108|NCT00897039|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
534109|NCT00897039|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
534110|NCT00897039|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
534111|NCT00897039|stage IA primary peritoneal cavity cancer|stage ia primary peritoneal cavity cancer
534112|NCT00897039|stage IB primary peritoneal cavity cancer|stage ib primary peritoneal cavity cancer
534113|NCT00897039|stage IC primary peritoneal cavity cancer|stage ic primary peritoneal cavity cancer
534114|NCT00897039|stage IIA primary peritoneal cavity cancer|stage iia primary peritoneal cavity cancer
534115|NCT00897039|stage IIB primary peritoneal cavity cancer|stage iib primary peritoneal cavity cancer
534116|NCT00897039|stage IIC primary peritoneal cavity cancer|stage iic primary peritoneal cavity cancer
534117|NCT00897039|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
534118|NCT00897039|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
534119|NCT00897039|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
534120|NCT00897039|recurrent fallopian tube cancer|recurrent fallopian tube cancer
534121|NCT00897039|stage IA fallopian tube cancer|stage ia fallopian tube cancer
534122|NCT00897039|stage IB fallopian tube cancer|stage ib fallopian tube cancer
534123|NCT00897039|stage IC fallopian tube cancer|stage ic fallopian tube cancer
534124|NCT00897039|stage IIA fallopian tube cancer|stage iia fallopian tube cancer
534125|NCT00897039|stage IIB fallopian tube cancer|stage iib fallopian tube cancer
534126|NCT00897039|stage IIC fallopian tube cancer|stage iic fallopian tube cancer
534127|NCT00897039|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
534128|NCT00897039|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
534129|NCT00897039|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
534130|NCT00897026|stage II breast cancer|stage ii breast cancer
534131|NCT00897026|stage IIIA breast cancer|stage iiia breast cancer
534132|NCT00896987|Epilepsy|epilepsy
534133|NCT00896987|lamotrigine|lamotrigine
534134|NCT00896987|cognitive function|cognitive function
534135|NCT00896948|head and neck cancer|head and neck cancer
534136|NCT00896935|cancer|cancer
534137|NCT00896922|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
534138|NCT00896922|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
534139|NCT00896922|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
534140|NCT00896922|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
534141|NCT00896922|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
534142|NCT00896922|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
535566|NCT00891696|Muscle|muscle
534143|NCT00896922|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
534144|NCT00896922|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
534145|NCT00896922|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
534146|NCT00896922|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
534147|NCT00896922|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
534148|NCT00896922|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
534149|NCT00896909|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
534150|NCT00896909|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
534151|NCT00896909|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
534152|NCT00896896|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
534153|NCT00896896|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
534154|NCT00896896|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
534155|NCT00896896|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
534156|NCT00896896|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
534157|NCT00896896|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
534158|NCT00896896|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
534159|NCT00896896|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
534160|NCT00896896|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
534161|NCT00896896|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
534162|NCT00896896|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
534163|NCT00896896|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
534164|NCT00896896|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
534165|NCT00896896|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
534166|NCT00896896|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
534167|NCT00896896|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
534168|NCT00896896|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
534169|NCT00896896|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
534170|NCT00896896|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
534171|NCT00896896|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
534172|NCT00896896|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
534173|NCT00896896|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
534174|NCT00896896|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
534175|NCT00896896|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
534176|NCT00896896|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
534177|NCT00896896|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
534178|NCT00896896|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
534179|NCT00896896|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
534180|NCT00896896|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
534181|NCT00896896|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
534182|NCT00896896|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
534183|NCT00896896|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
534184|NCT00896896|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
534185|NCT00896896|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
534186|NCT00896896|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
534187|NCT00896896|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
534188|NCT00896896|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
534189|NCT00896896|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
534190|NCT00896896|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
534191|NCT00896896|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
534192|NCT00896896|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
534193|NCT00896896|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
534194|NCT00896896|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
534195|NCT00896896|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
534196|NCT00896896|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
534197|NCT00896896|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
534198|NCT00896896|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
534257|NCT00896831|quality of life|quality of life
534199|NCT00896896|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
534200|NCT00896896|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
534201|NCT00896896|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
534202|NCT00896896|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
534203|NCT00896896|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
534204|NCT00896896|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
534205|NCT00896896|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
534206|NCT00896896|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
534207|NCT00896896|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
534208|NCT00896896|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
534209|NCT00896896|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
534210|NCT00896896|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
534211|NCT00896896|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
534212|NCT00896896|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
534213|NCT00896896|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
534214|NCT00896896|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
534215|NCT00896896|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
534529|NCT00895869|Prematurity|prematurity
534216|NCT00896896|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
534217|NCT00896896|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
534218|NCT00896896|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
534219|NCT00896896|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
534220|NCT00896896|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
534221|NCT00896896|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
534222|NCT00896896|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
534223|NCT00896896|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
534224|NCT00896896|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
534225|NCT00896896|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
534226|NCT00896896|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
534227|NCT00896896|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
534228|NCT00896896|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
534229|NCT00896896|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
534230|NCT00896896|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
534231|NCT00896896|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
534232|NCT00896896|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
534233|NCT00896896|stage I salivary gland cancer|stage i salivary gland cancer
534234|NCT00896896|stage II salivary gland cancer|stage ii salivary gland cancer
534235|NCT00896896|stage III salivary gland cancer|stage iii salivary gland cancer
534236|NCT00896896|stage IV salivary gland cancer|stage iv salivary gland cancer
534237|NCT00896896|recurrent salivary gland cancer|recurrent salivary gland cancer
534238|NCT00896896|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
534239|NCT00896896|recurrent colon cancer|recurrent colon cancer
534240|NCT00896896|stage IV colon cancer|stage iv colon cancer
534241|NCT00896896|recurrent rectal cancer|recurrent rectal cancer
534242|NCT00896896|stage IV rectal cancer|stage iv rectal cancer
534243|NCT00896896|adenocarcinoma of the colon|adenocarcinoma of the colon
534244|NCT00896883|turbinate|turbinate
534245|NCT00896883|implant|implant
534246|NCT00896883|sinus surgery|sinus surgery
534247|NCT00896883|Turbinates|turbinates
534248|NCT00896857|breast cancer|breast cancer
534249|NCT00896857|ductal breast carcinoma in situ|ductal breast carcinoma in situ
534250|NCT00896844|emotional disclosure|emotional disclosure
534251|NCT00896844|expressive writing|expressive writing
534252|NCT00896844|students|students
534253|NCT00896831|minimal hepatic encephalopathy|minimal hepatic encephalopathy
534254|NCT00896831|L-ornithine-L-aspartate|l-ornithine-l-aspartate
534255|NCT00896831|psychometric test|psychometric test
534256|NCT00896831|critical flicker frequency|critical flicker frequency
534259|NCT00896831|Health-related quality of life|health-related quality of life
534260|NCT00896818|breast cancer|breast cancer
534261|NCT00896792|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
534262|NCT00896792|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
534263|NCT00896766|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
534264|NCT00896766|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
534265|NCT00896753|stage IV colon cancer|stage iv colon cancer
534266|NCT00896753|liver metastases|liver metastases
534267|NCT00896753|lung metastases|lung metastases
534268|NCT00896753|recurrent colon cancer|recurrent colon cancer
534269|NCT00896740|Fanconi anemia|fanconi anemia
534270|NCT00896727|stage IA breast cancer|stage ia breast cancer
534271|NCT00896727|stage IB breast cancer|stage ib breast cancer
534272|NCT00896727|stage II breast cancer|stage ii breast cancer
534273|NCT00896727|stage IIIA breast cancer|stage iiia breast cancer
534274|NCT00896701|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
534275|NCT00896701|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
534276|NCT00896701|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
534277|NCT00896701|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
534278|NCT00896701|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
534279|NCT00896701|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
534280|NCT00896701|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
534281|NCT00896688|cervical branch block|cervical branch block
534282|NCT00896688|fluoroscopic guidance|fluoroscopic guidance
534283|NCT00896688|ultrasound guidance|ultrasound guidance
534284|NCT00896675|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
534285|NCT00896675|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
534286|NCT00896675|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
534287|NCT00896675|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
534288|NCT00896675|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
534289|NCT00896675|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
534290|NCT00896675|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
534291|NCT00896675|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
534292|NCT00896675|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
534293|NCT00896675|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
534294|NCT00896675|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
534295|NCT00896675|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
534296|NCT00896675|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
534297|NCT00896675|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
534298|NCT00896675|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
534299|NCT00896675|stage IV salivary gland cancer|stage iv salivary gland cancer
534300|NCT00896675|recurrent salivary gland cancer|recurrent salivary gland cancer
534301|NCT00896662|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
534302|NCT00896662|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
534303|NCT00896662|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
534304|NCT00896662|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
534305|NCT00896662|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
534306|NCT00896662|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
534530|NCT00895869|Pain|pain
534307|NCT00896662|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
534308|NCT00896662|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
534309|NCT00896662|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
534310|NCT00896662|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
534311|NCT00896662|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
534312|NCT00896662|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
534313|NCT00896662|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
534314|NCT00896662|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
534315|NCT00896662|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
534316|NCT00896662|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
534317|NCT00896662|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
534318|NCT00896662|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
534319|NCT00896662|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
534320|NCT00896662|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
535567|NCT00891696|mTOR|mtor
534321|NCT00896662|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
534322|NCT00896662|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
534323|NCT00896662|splenic marginal zone lymphoma|splenic marginal zone lymphoma
534324|NCT00896662|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
534325|NCT00896662|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
534326|NCT00896662|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
534327|NCT00896662|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
534328|NCT00896662|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
534329|NCT00896649|breast cancer|breast cancer
534330|NCT00896636|breast cancer|breast cancer
534331|NCT00896636|healthy, no evidence of disease|healthy, no evidence of disease
534332|NCT00896623|stage I breast cancer|stage i breast cancer
534333|NCT00896623|stage II breast cancer|stage ii breast cancer
534334|NCT00896610|Diabetes Mellitus|diabetes mellitus
534335|NCT00896610|Type 1 Diabetes|type 1 diabetes
534336|NCT00896610|Complications|complications
534337|NCT00896610|Anti Beta-Cell Autoantibodies|anti beta-cell autoantibodies
534338|NCT00896610|T-Lymphocyte Assays|t-lymphocyte assays
534339|NCT00896610|Type 2 Diabetes|type 2 diabetes
534340|NCT00896610|Autoimmune Diabetes|autoimmune diabetes
534341|NCT00896610|At Risk Diabetes|at risk diabetes
534342|NCT00896584|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
534343|NCT00896584|Hypoxemia|hypoxemia
534344|NCT00896584|Pre-flight evaluation|pre-flight evaluation
534345|NCT00896584|Hypobaria|hypobaria
534347|NCT00896584|Pulseoximetry|pulseoximetry
534348|NCT00896584|Air travel|air travel
534349|NCT00896584|Exercise desaturation|exercise desaturation
534350|NCT00896571|Fertility control|fertility control
534351|NCT00896571|Contraception|contraception
534352|NCT00896558|GSK1322322, repeat dose, healthy subjects, elderly, drug-drug interaction, probe, midazolam, double-blind|gsk1322322, repeat dose, healthy subjects, elderly, drug-drug interaction, probe, midazolam, double-blind
534353|NCT00896519|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
534354|NCT00896519|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
534355|NCT00896519|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
534356|NCT00896519|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
534357|NCT00896519|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
534358|NCT00896519|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
534359|NCT00896480|ASCI (Antigen-Specific Cancer Immunotherapeutic)|asci (antigen-specific cancer immunotherapeutic)
534360|NCT00896480|Cancer immunotherapeutic|cancer immunotherapeutic
534361|NCT00896480|Malignant melanoma|malignant melanoma
534362|NCT00896480|MAGE-A3|mage-a3
534363|NCT00896467|anxiety disorder|anxiety disorder
534364|NCT00896467|depression|depression
534365|NCT00896467|stage IV breast cancer|stage iv breast cancer
534366|NCT00896467|stage IV renal cell cancer|stage iv renal cell cancer
534367|NCT00896467|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
534368|NCT00896467|extensive stage small cell lung cancer|extensive stage small cell lung cancer
534369|NCT00896467|stage IV gastric cancer|stage iv gastric cancer
534370|NCT00896467|stage IV anal cancer|stage iv anal cancer
534371|NCT00896467|stage IV pancreatic cancer|stage iv pancreatic cancer
534372|NCT00896467|stage IV esophageal cancer|stage iv esophageal cancer
534373|NCT00896467|advanced adult primary liver cancer|advanced adult primary liver cancer
534374|NCT00896467|unresectable gallbladder cancer|unresectable gallbladder cancer
534375|NCT00896467|small intestine cancer|small intestine cancer
534376|NCT00896454|hypercalcemia|hypercalcemia
534377|NCT00896454|calcium|calcium
534378|NCT00896454|bisphosphonates|bisphosphonates
534379|NCT00896454|denosumab|denosumab
534380|NCT00896454|amgen|amgen
534381|NCT00896454|malignancy|malignancy
534382|NCT00896454|20070315|20070315
534383|NCT00896454|HMC|hmc
534384|NCT00896454|oncology|oncology
534385|NCT00896454|hematology|hematology
534386|NCT00896428|Asthma|asthma
534387|NCT00896428|gallopamil|gallopamil
534388|NCT00896428|airway remodelling|airway remodelling
534389|NCT00896428|smooth muscle|smooth muscle
534390|NCT00896415|on two models of CT scanner acquire CT images of the abdomen pelvis and midthigh in 20 Postmenopausal female volunteers|on two models of ct scanner acquire ct images of the abdomen pelvis and midthigh in 20 postmenopausal female volunteers
534391|NCT00896402|chloraprep|chloraprep
534392|NCT00896402|betadine|betadine
534393|NCT00896402|colonization|colonization
534394|NCT00896402|femoral catheter|femoral catheter
534395|NCT00896389|hypertension|hypertension
534396|NCT00896389|hydrochlorothiazide|hydrochlorothiazide
534397|NCT00896389|HCTZ|hctz
534398|NCT00896389|Salt sensitivity|salt sensitivity
534399|NCT00896389|Hydrochlorothiazide induced hyperglycemia|hydrochlorothiazide induced hyperglycemia
534400|NCT00896376|stage IV breast cancer|stage iv breast cancer
534401|NCT00896376|HER2-positive breast cancer|her2-positive breast cancer
534402|NCT00896363|anti-depressant|anti-depressant
534403|NCT00896363|Severe Depression|severe depression
534404|NCT00896363|Efficacy|efficacy
534405|NCT00896363|Major Depressive Disorder|major depressive disorder
534406|NCT00896363|Major Depressive Episode|major depressive episode
534407|NCT00896350|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
534408|NCT00896350|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
534409|NCT00896350|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
534410|NCT00896350|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
534411|NCT00896350|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
534412|NCT00896350|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
534413|NCT00896350|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
534414|NCT00896350|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
534415|NCT00896350|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
534416|NCT00896350|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
534417|NCT00896350|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
534418|NCT00896350|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
534419|NCT00896350|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
534420|NCT00896350|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
534421|NCT00896350|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
534422|NCT00896350|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
534423|NCT00896350|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
534424|NCT00896350|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
534425|NCT00896350|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
534426|NCT00896350|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
534427|NCT00896350|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
534428|NCT00896350|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
534429|NCT00896350|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
534430|NCT00896350|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
534431|NCT00896350|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
534432|NCT00896350|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
534433|NCT00896350|tongue cancer|tongue cancer
534434|NCT00896337|iliac artery stenosis|iliac artery stenosis
534435|NCT00896337|claudication|claudication
534436|NCT00896337|atherosclerotic iliac disease|atherosclerotic iliac disease
534437|NCT00896337|peripheral vascular disease|peripheral vascular disease
534438|NCT00896324|Quality of life|quality of life
534439|NCT00896298|Lipodystrophy|lipodystrophy
534440|NCT00896298|Insulin secretory response|insulin secretory response
534441|NCT00896285|Pleural malignancy|pleural malignancy
534442|NCT00896285|pleural effusion|pleural effusion
534443|NCT00896285|pleurodesis|pleurodesis
534444|NCT00896285|chest tube|chest tube
534445|NCT00896285|cancer|cancer
534446|NCT00896285|cancer pain management|cancer pain management
534447|NCT00896272|Klinefelter Syndrome|klinefelter syndrome
534448|NCT00896272|47,XXY|47,xxy
534449|NCT00896272|XXY|xxy
534450|NCT00896259|Unilateral total hip arthroplasty|unilateral total hip arthroplasty
534451|NCT00896233|Staging of liver fibrosis prior to clinical trials for treatment of Hepatitis C Virus|staging of liver fibrosis prior to clinical trials for treatment of hepatitis c virus
534452|NCT00896220|chronic critical illness|chronic critical illness
534453|NCT00896220|mechanical ventilation|mechanical ventilation
534454|NCT00896220|outcomes|outcomes
534455|NCT00896220|weakness|weakness
534456|NCT00896220|quality of life|quality of life
534457|NCT00896220|Critically Ill patients and their family caregiver|critically ill patients and their family caregiver
534458|NCT00896194|Overweight|overweight
534459|NCT00896194|Obesity|obesity
534460|NCT00896194|Self-Efficacy|self-efficacy
534461|NCT00896194|Treatment Adherence|treatment adherence
534462|NCT00896168|Arthritis, Rheumatoid|arthritis, rheumatoid
534463|NCT00896168|Infliximab|infliximab
534464|NCT00896168|Methotrexate|methotrexate
534465|NCT00896155|Breast cancer|breast cancer
534466|NCT00896155|Pulmonary fibrosis|pulmonary fibrosis
534467|NCT00896155|tamoxifen|tamoxifen
534468|NCT00896155|radiotherapy|radiotherapy
534469|NCT00896142|ischemic cardiomyopathy|ischemic cardiomyopathy
534470|NCT00896142|cardiac resynchronization therapy|cardiac resynchronization therapy
534471|NCT00896142|LV structure and function|lv structure and function
534472|NCT00896129|Health Outcomes Research|health outcomes research
534473|NCT00896129|CML|cml
534474|NCT00896077|healthy subjects|healthy subjects
534475|NCT00896064|Pneumococcal vaccine|pneumococcal vaccine
534476|NCT00896064|Streptococcus pneumoniae|streptococcus pneumoniae
534477|NCT00896064|Young adults|young adults
534478|NCT00896051|HIV Infections|hiv infections
534479|NCT00896051|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
534480|NCT00896051|TMC125-TiDP2-C238|tmc125-tidp2-c238
534481|NCT00896051|TMC125-C238|tmc125-c238
534482|NCT00896051|Etravirine|etravirine
534483|NCT00896051|Intelence|intelence
534484|NCT00896051|HIV|hiv
534485|NCT00896051|HIV-1|hiv-1
534486|NCT00896051|Pharmacokinetics|pharmacokinetics
534487|NCT00896038|Alcohol Dependence|alcohol dependence
534488|NCT00896038|Alcohol Treatment|alcohol treatment
534489|NCT00896038|Alcoholics|alcoholics
534490|NCT00896038|Alcoholism|alcoholism
534491|NCT00896038|Posttraumatic Stress Disorder|posttraumatic stress disorder
534492|NCT00896038|PTSD|ptsd
534493|NCT00896025|Liver disease|liver disease
534494|NCT00896012|Kidney Transplant|kidney transplant
534495|NCT00896012|Immunosuppression drugs|immunosuppression drugs
534496|NCT00896012|Rapamune|rapamune
534497|NCT00896012|tacrolimus|tacrolimus
534498|NCT00896012|calcineurin inhibitor|calcineurin inhibitor
534499|NCT00896012|Kidney Biopsy, Needle|kidney biopsy, needle
534500|NCT00895986|Diabetes|diabetes
534501|NCT00895986|Education|education
534502|NCT00895960|Brain|brain
534503|NCT00895960|CNS Disease|cns disease
534504|NCT00895960|CNS|cns
534505|NCT00895960|Intracranial Supratentorial GBM|intracranial supratentorial gbm
534506|NCT00895960|Gliosarcoma|gliosarcoma
534507|NCT00895960|GS|gs
534508|NCT00895960|Glioblastoma|glioblastoma
534509|NCT00895960|GBM|gbm
534510|NCT00895960|Dasatinib|dasatinib
534511|NCT00895960|Sprycel|sprycel
534512|NCT00895960|Temozolomide|temozolomide
534513|NCT00895960|TMZ|tmz
534514|NCT00895960|Temodar|temodar
534515|NCT00895960|Radiation Therapy|radiation therapy
534516|NCT00895960|Radiotherapy|radiotherapy
534517|NCT00895960|RT|rt
534518|NCT00895947|Prophylaxis|prophylaxis
534519|NCT00895947|Treatment|treatment
534520|NCT00895947|Symptoms|symptoms
534521|NCT00895947|Winter Colds and Flu|winter colds and flu
534522|NCT00895921|Insulin Resistance|insulin resistance
534523|NCT00895921|Antipsychotic Medications|antipsychotic medications
534524|NCT00895908|ADHD|adhd
534525|NCT00895908|Psychosocial Intervention|psychosocial intervention
534526|NCT00895908|Social Skills Training|social skills training
534527|NCT00895869|Screening|screening
534528|NCT00895869|Retinopathy|retinopathy
534531|NCT00895856|Physiotherapy|physiotherapy
534532|NCT00895856|Aged|aged
534533|NCT00895856|Functionality|functionality
534534|NCT00895856|Physiotherapic assistance|physiotherapic assistance
534535|NCT00895856|Functional capacity|functional capacity
534536|NCT00895843|Third molar|third molar
534537|NCT00895817|Eosinophilic esophagitis|eosinophilic esophagitis
534538|NCT00895817|acid reflux|acid reflux
534539|NCT00895804|MDMA|mdma
534540|NCT00895804|beta adrenergic|beta adrenergic
534541|NCT00895804|Ecstasy|ecstasy
534542|NCT00895791|coronary bifurcation|coronary bifurcation
534543|NCT00895791|stent implantation|stent implantation
534544|NCT00895791|PCI|pci
534545|NCT00895791|Optical Coherence Tomography|optical coherence tomography
534546|NCT00895778|Neuromuscular blockade|neuromuscular blockade
534547|NCT00895778|post-operative pain|post-operative pain
534548|NCT00895778|post-operative pulmonary function|post-operative pulmonary function
534549|NCT00895765|Melamine|melamine
534550|NCT00895765|Calculus|calculus
534551|NCT00895765|Kidney|kidney
534552|NCT00895765|Child|child
534553|NCT00895739|aplastic anemia|aplastic anemia
534554|NCT00895726|cachexia|cachexia
534555|NCT00895726|neoplasms|neoplasms
534556|NCT00895713|Hepatitis B|hepatitis b
534557|NCT00895713|HBV|hbv
534558|NCT00895713|Anti-hepatitis B antibodies|anti-hepatitis b antibodies
534559|NCT00895713|Immunoglobulins|immunoglobulins
534560|NCT00895713|liver transplantation|liver transplantation
534561|NCT00895713|Protective levels|protective levels
534562|NCT00895713|Recurrence|recurrence
534563|NCT00895713|Intramuscular|intramuscular
534564|NCT00895700|Anxiety|anxiety
534565|NCT00895700|ICD concerns|icd concerns
534566|NCT00895700|Quality of life|quality of life
534567|NCT00895687|Metastatic Cancer|metastatic cancer
534568|NCT00895687|Bortezomib|bortezomib
534569|NCT00895687|Velcade|velcade
534570|NCT00895687|Erlotinib|erlotinib
534571|NCT00895687|Erlotinib Hydrochloride|erlotinib hydrochloride
534572|NCT00895687|Tarceva|tarceva
534573|NCT00895687|EGFR|egfr
534574|NCT00895687|EGFR mutations|egfr mutations
534575|NCT00895674|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
534576|NCT00895661|rituximab|rituximab
534577|NCT00895648|Meso|meso
534578|NCT00895648|mesothelioma|mesothelioma
534579|NCT00895648|pleura|pleura
534580|NCT00895648|pleural|pleural
534581|NCT00895635|Claudication|claudication
534582|NCT00895635|Peripheral Arterial Disease|peripheral arterial disease
534583|NCT00895635|Exercise Rehabilitation|exercise rehabilitation
534584|NCT00895635|Cardiovascular Function|cardiovascular function
534585|NCT00895622|adult grade I meningioma|adult grade i meningioma
534586|NCT00895622|adult grade II meningioma|adult grade ii meningioma
534587|NCT00895622|adult grade III meningioma|adult grade iii meningioma
534588|NCT00895622|adult anaplastic meningioma|adult anaplastic meningioma
534589|NCT00895622|adult papillary meningioma|adult papillary meningioma
534590|NCT00895622|recurrent adult brain tumor|recurrent adult brain tumor
534591|NCT00895609|Residual neuromuscular block|residual neuromuscular block
534592|NCT00895609|post-operative residual curarization|post-operative residual curarization
534593|NCT00895609|PORC|porc
534594|NCT00895609|sugammadex|sugammadex
534595|NCT00895609|neostigmine|neostigmine
534596|NCT00895609|Shallow neuromuscular block (TOF-ratio of 0.5)|shallow neuromuscular block (tof-ratio of 0.5)
534597|NCT00895596|Chronic hepatitis B|chronic hepatitis b
534598|NCT00895596|Lamivudine resistant|lamivudine resistant
534599|NCT00895596|YMDD mutant type|ymdd mutant type
534600|NCT00895583|renal transplant|renal transplant
534601|NCT00895583|immunosuppression|immunosuppression
534602|NCT00895583|sirolimus/rapamune|sirolimus/rapamune
534603|NCT00895583|planned transition|planned transition
534604|NCT00895570|sleep restriction|sleep restriction
534605|NCT00895570|glucose metabolism|glucose metabolism
534606|NCT00895570|modafinil|modafinil
534607|NCT00895570|euglycemic clamp|euglycemic clamp
534608|NCT00895570|insulin sensitivity|insulin sensitivity
534609|NCT00895570|insulin release|insulin release
534610|NCT00895557|varenicline|varenicline
534611|NCT00895557|cocaine|cocaine
534612|NCT00895557|brain imaging|brain imaging
534613|NCT00895531|Knee Replacement, Total|knee replacement, total
534614|NCT00895531|Morphine|morphine
534615|NCT00895518|PTSD|ptsd
534616|NCT00895505|DVT|dvt
534617|NCT00895505|Venous thromboembolism|venous thromboembolism
534618|NCT00895505|D-Dimer|d-dimer
534619|NCT00895505|thrombophilia|thrombophilia
534620|NCT00895505|secondary prophylaxis|secondary prophylaxis
534621|NCT00895505|secondary prophylaxis using oral anticoagulant treatment (OAT)|secondary prophylaxis using oral anticoagulant treatment (oat)
534622|NCT00895505|higher risk of recurrence in patients showing increased levels|higher risk of recurrence in patients showing increased levels
534623|NCT00895505|of D-Dimer after withdrawal of OAT|of d-dimer after withdrawal of oat
534624|NCT00895505|D-Dimer-based treatment|d-dimer-based treatment
534625|NCT00895492|diarrhea|diarrhea
534626|NCT00895492|rotavirus|rotavirus
534627|NCT00895492|genotype|genotype
534628|NCT00895492|VP4|vp4
534629|NCT00895492|VP7|vp7
534630|NCT00895479|End Stage Renal Disease|end stage renal disease
534631|NCT00895479|ESRD|esrd
534632|NCT00895479|Hemodialysis|hemodialysis
534633|NCT00895479|Access Graft|access graft
534634|NCT00895466|prostatic diseases|prostatic diseases
534635|NCT00895466|neoplasms|neoplasms
534636|NCT00895466|prostatic neoplasms|prostatic neoplasms
534637|NCT00895466|hormones|hormones
534638|NCT00895466|androgen antagonists|androgen antagonists
534639|NCT00895466|vaccines|vaccines
534640|NCT00895466|peptide vaccines|peptide vaccines
534641|NCT00895466|adjuvants, immunological|adjuvants, immunological
534642|NCT00895453|recurrent vulvovaginal candidiasis|recurrent vulvovaginal candidiasis
534643|NCT00895453|itraconazole|itraconazole
534644|NCT00895453|classic homeopathy|classic homeopathy
534645|NCT00895440|Diabetes|diabetes
534646|NCT00895440|Diabetic neuropathy|diabetic neuropathy
534647|NCT00895440|neuropad|neuropad
534648|NCT00895440|Painless peripheral diabetic neuropathy|painless peripheral diabetic neuropathy
534649|NCT00895440|Painful peripheral diabetic neuropathy|painful peripheral diabetic neuropathy
534650|NCT00895440|Autonomic peripheral neuropathy|autonomic peripheral neuropathy
534651|NCT00895440|Charcot neuroarthropathy|charcot neuroarthropathy
534652|NCT00895427|Coronary artery calcification|coronary artery calcification
534653|NCT00895414|stage I breast cancer|stage i breast cancer
534654|NCT00895414|stage II breast cancer|stage ii breast cancer
534655|NCT00895414|stage IIIA breast cancer|stage iiia breast cancer
534656|NCT00895414|stage IIIB breast cancer|stage iiib breast cancer
534657|NCT00895414|stage IIIC breast cancer|stage iiic breast cancer
534658|NCT00895414|stage IV breast cancer|stage iv breast cancer
534659|NCT00895401|Nutritional supplement|nutritional supplement
534660|NCT00895401|Malnutrition|malnutrition
534661|NCT00895401|Hemodialysis|hemodialysis
534662|NCT00895401|Nepro with Carb Steady|nepro with carb steady
534663|NCT00895388|Urinary function|urinary function
534664|NCT00895388|Anal function|anal function
534665|NCT00895375|Dermatology|dermatology
534666|NCT00895375|Skin|skin
534667|NCT00895375|Psoriasis|psoriasis
534668|NCT00895375|Sleep|sleep
534669|NCT00895375|Wake Forest|wake forest
534670|NCT00895375|Insomnia|insomnia
534671|NCT00895362|Advanced Cancer|advanced cancer
534672|NCT00895362|EGFR mutation|egfr mutation
534673|NCT00895362|Erlotinib|erlotinib
534674|NCT00895362|Erlotinib Hydrochloride|erlotinib hydrochloride
534675|NCT00895362|Tarceva|tarceva
534676|NCT00895362|OSI-774|osi-774
534677|NCT00895362|Cetuximab|cetuximab
534678|NCT00895362|C225|c225
534679|NCT00895362|Erbitux|erbitux
534680|NCT00895362|IMC-C225|imc-c225
534681|NCT00895349|Positron Emission Tomography (PET)|positron emission tomography (pet)
534682|NCT00895349|Diagnostic Intervention|diagnostic intervention
534683|NCT00895349|Locally Advanced Cervical Cancer|locally advanced cervical cancer
536093|NCT00890110|sunitinib|sunitinib
534684|NCT00895336|Pediatric Ulcerative Colitis|pediatric ulcerative colitis
534685|NCT00895323|stage I colon cancer|stage i colon cancer
534686|NCT00895323|stage II colon cancer|stage ii colon cancer
534687|NCT00895323|stage III colon cancer|stage iii colon cancer
534688|NCT00895323|stage IV colon cancer|stage iv colon cancer
534689|NCT00895323|stage I rectal cancer|stage i rectal cancer
534690|NCT00895323|stage II rectal cancer|stage ii rectal cancer
534691|NCT00895323|stage III rectal cancer|stage iii rectal cancer
534692|NCT00895323|stage IV rectal cancer|stage iv rectal cancer
534693|NCT00895323|recurrent colon cancer|recurrent colon cancer
534694|NCT00895323|recurrent rectal cancer|recurrent rectal cancer
534695|NCT00895310|PSA|psa
534696|NCT00895310|Ketoconazole|ketoconazole
534697|NCT00895310|Prostate Cancer|prostate cancer
534698|NCT00895310|Hormone Refractory|hormone refractory
534699|NCT00895310|Chemotherapy Regimen|chemotherapy regimen
534700|NCT00895297|Relapsing after allogeneic transplantation|relapsing after allogeneic transplantation
534701|NCT00895297|Dasatinib|dasatinib
534702|NCT00895297|Sprycel|sprycel
534703|NCT00895297|Philadelphia Chromosomes|philadelphia chromosomes
534704|NCT00895284|robotic|robotic
534705|NCT00895284|laparoscopic surgical procedures|laparoscopic surgical procedures
534706|NCT00895271|Primary Immunodeficiency|primary immunodeficiency
534707|NCT00895271|Immunodysregulation|immunodysregulation
534708|NCT00895271|Skin Biopsy|skin biopsy
534709|NCT00895271|Induced Pluripotent Stem Cell (iPS)|induced pluripotent stem cell (ips)
534710|NCT00895271|Lymphocyte|lymphocyte
534711|NCT00895271|Common Variable Immunodeficiency|common variable immunodeficiency
534712|NCT00895271|Severe Combined Immunodeficiency|severe combined immunodeficiency
534713|NCT00895271|Healthy Volunteer|healthy volunteer
534714|NCT00895271|HV|hv
534715|NCT00895258|Schizoaffective Disorder|schizoaffective disorder
534716|NCT00895258|Major Depressive Disorder|major depressive disorder
534717|NCT00895258|Supported Employment|supported employment
534718|NCT00895258|Work|work
534719|NCT00895258|Rehabilitation|rehabilitation
534720|NCT00895258|Severe Mental Illness|severe mental illness
534721|NCT00895258|Cognitive Training|cognitive training
534722|NCT00895258|Cognitive Rehabilitation|cognitive rehabilitation
534723|NCT00895258|Cognitive Remediation|cognitive remediation
534724|NCT00895219|Hyperventilation|hyperventilation
534725|NCT00895219|Dysfunctional breathing|dysfunctional breathing
534726|NCT00895219|Physiotherapy|physiotherapy
534727|NCT00895219|Musculoskeletal techniques|musculoskeletal techniques
534728|NCT00895193|Niacin|niacin
534729|NCT00895193|Hypercholesterolemia|hypercholesterolemia
534730|NCT00895193|Flushing|flushing
534731|NCT00895180|recurrent adult brain tumor|recurrent adult brain tumor
534732|NCT00895180|adult glioblastoma|adult glioblastoma
534733|NCT00895180|adult giant cell glioblastoma|adult giant cell glioblastoma
534734|NCT00895180|adult gliosarcoma|adult gliosarcoma
534735|NCT00895167|Heme Oxygenase|heme oxygenase
534736|NCT00895167|Genetic Polymorphism|genetic polymorphism
534737|NCT00895167|Healthy Subjects|healthy subjects
534738|NCT00895154|Sickle Cell Disease|sickle cell disease
534739|NCT00895154|Sickle Cell|sickle cell
534740|NCT00895154|Memory|memory
534741|NCT00895154|Learning|learning
534742|NCT00895154|Achievement|achievement
534743|NCT00895141|Saturated fat|saturated fat
534744|NCT00895141|LDL size|ldl size
534745|NCT00895141|Large LDL|large ldl
534746|NCT00895141|Large HDL|large hdl
534747|NCT00895128|Advanced Cancer|advanced cancer
534748|NCT00895128|EGFR mutations|egfr mutations
534749|NCT00895128|Dasatinib|dasatinib
534750|NCT00895128|Sprycel|sprycel
534751|NCT00895128|Erlotinib|erlotinib
534752|NCT00895128|Erlotinib Hydrochloride|erlotinib hydrochloride
534753|NCT00895128|Tarceva|tarceva
534754|NCT00895115|prostate cancer|prostate cancer
534755|NCT00895102|Bioavailability (BA)|bioavailability (ba)
534756|NCT00895102|Single Ascending Dose (SAD)|single ascending dose (sad)
534757|NCT00895089|liver abscess|liver abscess
534758|NCT00895089|moxifloxacin|moxifloxacin
534759|NCT00895089|ceftriaxone|ceftriaxone
534760|NCT00895089|treatment|treatment
534761|NCT00895063|Spasmodic Dysphonia|spasmodic dysphonia
534762|NCT00895063|Botulinum Toxin|botulinum toxin
534763|NCT00895063|Vocal Exercise|vocal exercise
534764|NCT00895024|Caregiver|caregiver
534765|NCT00895024|Questionnaire|questionnaire
534766|NCT00895024|Home Hospice Care|home hospice care
534767|NCT00895024|Family Evaluation of Hospice Care|family evaluation of hospice care
534768|NCT00895024|FEHC|fehc
534769|NCT00895024|The Texas Revised Inventory of Grief|the texas revised inventory of grief
534770|NCT00895024|TRIG|trig
534771|NCT00895024|Cross-ethnic differences|cross-ethnic differences
534772|NCT00895024|Parenteral Hydration|parenteral hydration
534773|NCT00895024|Grief|grief
534774|NCT00895011|Erectile Dysfunction|erectile dysfunction
534775|NCT00895011|E.D.|e.d.
534776|NCT00894998|heparin cardiac surgery|heparin cardiac surgery
534777|NCT00894985|heparin cardiac surgery|heparin cardiac surgery
534778|NCT00894959|heparin cardiac surgery|heparin cardiac surgery
534779|NCT00894946|recurrent IVF implantation failure|recurrent ivf implantation failure
534780|NCT00894933|Prostate Cancer|prostate cancer
534781|NCT00894933|Radical Prostatectomy|radical prostatectomy
534782|NCT00894933|Vesico-Urethral Anastomosis|vesico-urethral anastomosis
534783|NCT00894920|biotin|biotin
534784|NCT00894920|deficiency|deficiency
534785|NCT00894920|pregnancy|pregnancy
534786|NCT00894920|lymphocyte propionyl-CoA carboxylase|lymphocyte propionyl-coa carboxylase
534787|NCT00894907|Severe pancreatitis|severe pancreatitis
534788|NCT00894907|acute pancreatitis|acute pancreatitis
534789|NCT00894907|haemodynamic monitoring|haemodynamic monitoring
534790|NCT00894907|PiCCO|picco
534791|NCT00894894|MP470|mp470
534792|NCT00894894|MP-470|mp-470
534793|NCT00894894|SuperGen|supergen
534794|NCT00894894|Tyrosine|tyrosine
534795|NCT00894894|Kinase|kinase
534796|NCT00894894|Inhibitor|inhibitor
534797|NCT00894894|Solid Malignancies|solid malignancies
534798|NCT00894894|Oncology|oncology
534799|NCT00894881|colonoscopy|colonoscopy
534800|NCT00894881|Healthy individuals before colonoscopy|healthy individuals before colonoscopy
534801|NCT00894868|Congestive Heart Failure|congestive heart failure
534802|NCT00894868|CHF, vildagliptin|chf, vildagliptin
534803|NCT00894868|metabolic disease|metabolic disease
534804|NCT00894868|cardiovascular disease|cardiovascular disease
534805|NCT00894868|T2DM|t2dm
534806|NCT00894855|skin cancer prevention|skin cancer prevention
534807|NCT00894855|SHADE|shade
534808|NCT00894855|Beach|beach
534809|NCT00894842|Schizophrenia|schizophrenia
534810|NCT00894842|Pregnenolone|pregnenolone
534811|NCT00894842|Neurocognition|neurocognition
534812|NCT00894829|heparin cardiac surgery|heparin cardiac surgery
534813|NCT00894816|Prevention|prevention
534814|NCT00894816|Probiotics|probiotics
534815|NCT00894816|Eczema|eczema
534816|NCT00894816|Allergy|allergy
534817|NCT00894816|Asthma|asthma
534818|NCT00894816|Obesity|obesity
534819|NCT00894816|Caries|caries
534820|NCT00894816|Gut microbiota|gut microbiota
534821|NCT00894803|acute ischemic stroke|acute ischemic stroke
534822|NCT00894803|stroke|stroke
534823|NCT00894803|rt-PA, thrombolytic|rt-pa, thrombolytic
534824|NCT00894803|t-PA|t-pa
534825|NCT00894803|recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
534826|NCT00894803|Activase|activase
534827|NCT00894803|eptifibatide|eptifibatide
534828|NCT00894803|Integrilin|integrilin
534829|NCT00894803|fibrinolytic agents|fibrinolytic agents
534830|NCT00894803|clot dissolving|clot dissolving
534831|NCT00894803|blood clot|blood clot
534832|NCT00894790|Treatment of the acute pain due to cervical|treatment of the acute pain due to cervical
534833|NCT00894790|sprain|sprain
534834|NCT00894790|Celecoxib|celecoxib
534835|NCT00894790|NSAID|nsaid
534836|NCT00894790|Diclofenac|diclofenac
534837|NCT00894777|Psoriasis|psoriasis
534838|NCT00894764|Childhood|childhood
534839|NCT00894764|Pneumonia|pneumonia
534840|NCT00894764|Pneumococcal|pneumococcal
534841|NCT00894764|pneumococcus|pneumococcus
534842|NCT00894764|Carriage|carriage
534843|NCT00894751|dexmedetomidine and propofol for MRI|dexmedetomidine and propofol for mri
534844|NCT00894751|quality of care between two anesthetic agents for MRI|quality of care between two anesthetic agents for mri
534845|NCT00894738|pediatric|pediatric
534846|NCT00894738|mental illness|mental illness
534847|NCT00894738|antipsychotic|antipsychotic
534848|NCT00894738|cardiometabolic risk|cardiometabolic risk
534849|NCT00894738|Antipsychotic agents|antipsychotic agents
534850|NCT00894738|Mental disorders diagnosed in childhood|mental disorders diagnosed in childhood
534851|NCT00894725|left colon cancer|left colon cancer
534852|NCT00894712|Radiation Therapy|radiation therapy
534853|NCT00894699|procedural sedation|procedural sedation
534854|NCT00894673|heparin cardiac surgery|heparin cardiac surgery
534855|NCT00894660|Bioequivalence, Healthy Volunteers|bioequivalence, healthy volunteers
534856|NCT00894647|actinic keratosis|actinic keratosis
534857|NCT00894647|skin disease|skin disease
534858|NCT00894621|Shock|shock
534859|NCT00894621|Respiration, artificial|respiration, artificial
534860|NCT00894621|Norepinephrine|norepinephrine
534861|NCT00894608|letrozole|letrozole
534862|NCT00894608|ovarian stimulation|ovarian stimulation
534863|NCT00894608|PCOS|pcos
534864|NCT00894608|IVF-ET|ivf-et
534865|NCT00894595|Incidence of ACL injury|incidence of acl injury
534866|NCT00894595|Risk factors for ACL injury|risk factors for acl injury
534867|NCT00894595|Prevention of ACL injury or any acute knee injury|prevention of acl injury or any acute knee injury
534868|NCT00894582|massive ventral hernia|massive ventral hernia
534869|NCT00894582|abdominal volume|abdominal volume
534870|NCT00894582|pulmonary function|pulmonary function
534871|NCT00894582|components separation|components separation
534872|NCT00894582|abdominal compartments syndrome|abdominal compartments syndrome
534873|NCT00894569|carcinoma of unknown primary|carcinoma of unknown primary
534874|NCT00894569|cancer of unknown primary|cancer of unknown primary
534875|NCT00894569|CUP|cup
534876|NCT00894569|carboplatin|carboplatin
534877|NCT00894569|paclitaxel|paclitaxel
534878|NCT00894569|cetuximab|cetuximab
534879|NCT00894556|Treatment of acute migraine with or without aura in adults|treatment of acute migraine with or without aura in adults
534880|NCT00894543|Hot flashes|hot flashes
534882|NCT00894543|Vasomotor symptoms|vasomotor symptoms
534883|NCT00894504|Metastatic Breast Cancer|metastatic breast cancer
534884|NCT00894504|Triple Negative|triple negative
534885|NCT00894504|Panitumumab|panitumumab
534886|NCT00894504|Vectibix|vectibix
534887|NCT00894504|Gemcitabine|gemcitabine
534888|NCT00894504|Gemzar|gemzar
534889|NCT00894504|Carboplatin|carboplatin
534890|NCT00894491|alternative medicine|alternative medicine
534891|NCT00894491|complementary medicine|complementary medicine
534892|NCT00894491|acupuncture|acupuncture
534893|NCT00894491|Chinese herbals|chinese herbals
534894|NCT00894478|MRI-Negative|mri-negative
534895|NCT00894478|Diffusion tensor imaging|diffusion tensor imaging
534896|NCT00894478|Localization-related epilepsy|localization-related epilepsy
534897|NCT00894478|Partial Epilepsy|partial epilepsy
534898|NCT00894478|Children|children
534899|NCT00894465|Midazolam|midazolam
534900|NCT00894465|VCUG|vcug
534901|NCT00894465|Anxiety|anxiety
534902|NCT00894452|Methadone|methadone
534903|NCT00894452|CYP|cyp
534904|NCT00894452|OPRM1|oprm1
534905|NCT00894452|MDR1|mdr1
534906|NCT00894452|COMT|comt
534907|NCT00894452|Midazolam challenge|midazolam challenge
534908|NCT00894426|COPD|copd
534909|NCT00894426|Symptom|symptom
534910|NCT00894426|Morning activity|morning activity
534911|NCT00894426|Questionnaire|questionnaire
534912|NCT00894400|AF|af
534913|NCT00894400|catheter ablation|catheter ablation
534914|NCT00894400|fractionated electrogram|fractionated electrogram
534915|NCT00894400|complex fractionated atrial electrogram (CFAE)|complex fractionated atrial electrogram (cfae)
534916|NCT00894387|elevated BNP|elevated bnp
534917|NCT00894387|reduced LVEF|reduced lvef
534918|NCT00894387|Acute Heart Failure|acute heart failure
534919|NCT00894387|Cardiovascular death|cardiovascular death
534920|NCT00894387|CHF|chf
534921|NCT00894387|hospitalization|hospitalization
534922|NCT00894387|morbi-mortality trial|morbi-mortality trial
534923|NCT00894387|outcome study|outcome study
534924|NCT00894387|endpoint driven|endpoint driven
534925|NCT00894387|plasma renin activity|plasma renin activity
534926|NCT00894387|renin angiotensin|renin angiotensin
534927|NCT00894387|aldosterone system|aldosterone system
534928|NCT00894387|direct renin inhibitors|direct renin inhibitors
534929|NCT00894387|BNP|bnp
534930|NCT00894387|KCCQ|kccq
534931|NCT00894387|eGFR|egfr
534932|NCT00894374|Bio-equivalence, Healthy Volunteers|bio-equivalence, healthy volunteers
534933|NCT00894361|knee arthritis|knee arthritis
534934|NCT00894361|total knee arthroplasty|total knee arthroplasty
534935|NCT00894361|total knee replacement|total knee replacement
534936|NCT00894361|mobile bearing design|mobile bearing design
534937|NCT00894361|all-polyethylene tibia|all-polyethylene tibia
534938|NCT00894348|ERCP|ercp
534939|NCT00894348|Positive Biliary Brush Cytology|positive biliary brush cytology
534940|NCT00894335|retroperitoneoscopic adrenalectomy|retroperitoneoscopic adrenalectomy
534941|NCT00894335|intraoperative arterial-alveolar Carbon dioxide Difference|intraoperative arterial-alveolar carbon dioxide difference
534942|NCT00894322|diabetes|diabetes
534943|NCT00894322|exenatide once weekly|exenatide once weekly
534944|NCT00894322|Byetta|byetta
534945|NCT00894322|Amylin|amylin
534946|NCT00894322|Lilly|lilly
534947|NCT00894296|MEG|meg
534948|NCT00894296|schizophrenia|schizophrenia
534949|NCT00894296|negative symptoms|negative symptoms
534950|NCT00894283|DVT|dvt
534951|NCT00894283|PE|pe
534952|NCT00894283|MRV|mrv
534953|NCT00894283|bariatric surgery|bariatric surgery
534954|NCT00894270|Diabetes|diabetes
534955|NCT00894270|Injection|injection
534956|NCT00894270|Needle|needle
534957|NCT00894257|HCV infected pregnant women|hcv infected pregnant women
534958|NCT00894244|None- Normal healthy upper arm skin will be used.|none- normal healthy upper arm skin will be used.
534959|NCT00894205|neuropsychological function|neuropsychological function
534960|NCT00894205|cognitive function|cognitive function
534961|NCT00894205|exercise|exercise
534962|NCT00894205|older adult|older adult
534963|NCT00894192|This study tests functional ability of patients with refractive error or normal vision while using different types of eyeglasses.|this study tests functional ability of patients with refractive error or normal vision while using different types of eyeglasses.
534964|NCT00894179|coronary artery disease|coronary artery disease
534965|NCT00894179|stress echocardiography|stress echocardiography
534966|NCT00894179|regadenoson|regadenoson
534967|NCT00894179|atropine|atropine
534968|NCT00894179|coronary angiogram|coronary angiogram
534969|NCT00894166|Smoking Cessation|smoking cessation
534970|NCT00894166|Chantix|chantix
534971|NCT00894166|varenicline|varenicline
534972|NCT00894166|Nicotine Replacement Therapy|nicotine replacement therapy
534973|NCT00894166|Nicotine Patches|nicotine patches
534974|NCT00894166|Zyban|zyban
534975|NCT00894166|bupropion|bupropion
534976|NCT00894166|Quit Smoking|quit smoking
534977|NCT00894153|p53 gene|p53 gene
534978|NCT00894153|head and neck malignent tumors|head and neck malignent tumors
534979|NCT00894153|gene therapy|gene therapy
534980|NCT00894140|Hip|hip
534981|NCT00894140|Cementless|cementless
534982|NCT00894140|Conservative|conservative
534985|NCT00894127|Fluorescence|fluorescence
534986|NCT00894127|Diagnostic|diagnostic
534987|NCT00894127|Sputum Cytology|sputum cytology
534988|NCT00894127|Early Detection|early detection
534989|NCT00894075|genetic metabolic disorder|genetic metabolic disorder
534990|NCT00894075|alkaline phosphatase|alkaline phosphatase
534991|NCT00894075|tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
534992|NCT00894075|rickets|rickets
534993|NCT00894075|osteomalacia|osteomalacia
534994|NCT00894036|esbl children Switzerland|esbl children switzerland
534995|NCT00894036|Colonization|colonization
534996|NCT00894036|ESBL-producing gram-negative bacilli|esbl-producing gram-negative bacilli
534997|NCT00894036|Infection|infection
534998|NCT00894023|Patients with AMI|patients with ami
534999|NCT00894010|Photosensitive epilepsy|photosensitive epilepsy
535000|NCT00894010|Photosensitivity|photosensitivity
535001|NCT00894010|Seizures|seizures
535002|NCT00894010|Epilepsy|epilepsy
535003|NCT00893997|myelodysplastic syndrome|myelodysplastic syndrome
535004|NCT00893997|MDS|mds
535005|NCT00893997|PR1 Peptide Vaccine|pr1 peptide vaccine
535006|NCT00893984|Intolerance|intolerance
535007|NCT00893984|Beta blocker|beta blocker
535008|NCT00893971|Healthy Volunteers|healthy volunteers
535009|NCT00893932|SIRS leptin outcome sepsis|sirs leptin outcome sepsis
535010|NCT00893906|influenza|influenza
535011|NCT00893906|influenza vaccine|influenza vaccine
535012|NCT00893906|vaccine effectiveness|vaccine effectiveness
535013|NCT00893906|cluster randomized|cluster randomized
535014|NCT00893906|Africa|africa
535015|NCT00893893|Obesity|obesity
535016|NCT00893893|Lipid metabolism|lipid metabolism
535017|NCT00893893|VLDL|vldl
535018|NCT00893880|Tinea Pedis|tinea pedis
535019|NCT00893880|Athletes Foot|athletes foot
535020|NCT00893880|Nitric Oxide|nitric oxide
535021|NCT00893867|acute ischemic stroke|acute ischemic stroke
535022|NCT00893867|neuroprotective agent|neuroprotective agent
535023|NCT00893841|bipolar|bipolar
535024|NCT00893841|bipolar depression|bipolar depression
535025|NCT00893841|bipolar disorder|bipolar disorder
535026|NCT00893841|depression|depression
535027|NCT00893841|quetiapine|quetiapine
535028|NCT00893841|pramipexole|pramipexole
535029|NCT00893841|Seroquel XR|seroquel xr
535030|NCT00893841|Mirapex|mirapex
535031|NCT00893815|HIV|hiv
535032|NCT00893815|Neurocognitive function|neurocognitive function
535033|NCT00893802|periodontal disease|periodontal disease
535034|NCT00893802|pregnancy|pregnancy
535035|NCT00893802|periodontal treatment|periodontal treatment
535036|NCT00893763|Nosocomial (Hospital-Acquired) Infections|nosocomial (hospital-acquired) infections
535037|NCT00893763|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
535038|NCT00893763|Mechanical ventilation|mechanical ventilation
535039|NCT00893763|Endotracheal intubation|endotracheal intubation
535040|NCT00893750|Vulnerable Youths in Northern Uganda|vulnerable youths in northern uganda
535041|NCT00893750|Formerly Abducted Children|formerly abducted children
535042|NCT00893750|Reintegration and Reconciliation|reintegration and reconciliation
535043|NCT00893750|Trauma Treatment|trauma treatment
535044|NCT00893750|Narrative Exposure Therapy|narrative exposure therapy
535045|NCT00893750|Reconciliation|reconciliation
535046|NCT00893750|Revenge Feelings|revenge feelings
535047|NCT00893737|Migraine|migraine
535048|NCT00893737|Headache, Migraine|headache, migraine
535049|NCT00893724|DME|dme
535050|NCT00893724|NAMD|namd
535051|NCT00893724|Oxidative damage|oxidative damage
535052|NCT00893724|Nutritional supplements/vitamins|nutritional supplements/vitamins
535053|NCT00893724|DNA repair|dna repair
535054|NCT00893724|NAMD/wet AMD|namd/wet amd
535055|NCT00893711|infantile colic|infantile colic
535056|NCT00893711|lactobacillus|lactobacillus
535057|NCT00893711|gut microflora|gut microflora
535058|NCT00893711|FISH|fish
535059|NCT00893711|toll like receptor|toll like receptor
535060|NCT00893711|T reg|t reg
535061|NCT00893685|Telemedicine|telemedicine
535062|NCT00893672|Radiography, Thoracic|radiography, thoracic
535063|NCT00893672|Intensive Care Units|intensive care units
535064|NCT00893672|Ventilation, mechanical|ventilation, mechanical
535065|NCT00893672|Matched-Pair Analysis|matched-pair analysis
535066|NCT00893659|Beta-glucan|beta-glucan
535067|NCT00893659|faecal microflora|faecal microflora
535068|NCT00893659|polypectomized|polypectomized
535069|NCT00893659|Precancerous Nonmalignant Condition|precancerous nonmalignant condition
535070|NCT00893646|abdominal obesity|abdominal obesity
535071|NCT00893646|weight reduction|weight reduction
535072|NCT00893646|diet|diet
535073|NCT00893646|exercise training|exercise training
535074|NCT00893646|lifestyle activity|lifestyle activity
535075|NCT00893646|health-related fitness|health-related fitness
535076|NCT00893646|walking|walking
535077|NCT00893646|actigraphy|actigraphy
535078|NCT00893646|lifestyle modification|lifestyle modification
535079|NCT00893646|sleep|sleep
535080|NCT00893646|sleep hygiene|sleep hygiene
535081|NCT00893646|alertness|alertness
535082|NCT00893646|daytime sleepiness|daytime sleepiness
535083|NCT00893646|metabolic syndrome|metabolic syndrome
535084|NCT00893646|counselling|counselling
535085|NCT00893646|health education|health education
535086|NCT00893646|truck drivers|truck drivers
535087|NCT00893646|bus drivers|bus drivers
535088|NCT00893646|randomized controlled trial|randomized controlled trial
535089|NCT00893633|neuromuscular diseases|neuromuscular diseases
535090|NCT00893633|critical illness|critical illness
535091|NCT00893633|mechanical ventilation|mechanical ventilation
535092|NCT00893633|phrenic nerve|phrenic nerve
535093|NCT00893633|nerve conduction studies|nerve conduction studies
535094|NCT00893620|iliac aneurysm|iliac aneurysm
535095|NCT00893620|endovascular repair|endovascular repair
535096|NCT00893594|migraine|migraine
535097|NCT00893594|migraine with aura|migraine with aura
535098|NCT00893594|headache|headache
535099|NCT00893581|mania|mania
535100|NCT00893581|adolescent|adolescent
535101|NCT00893581|bipolar|bipolar
535102|NCT00893568|Post traumatic stress disorder PTSD|post traumatic stress disorder ptsd
535103|NCT00893555|Invasive fungal infection|invasive fungal infection
535104|NCT00893555|hematological malignancy|hematological malignancy
535105|NCT00893555|voriconazole|voriconazole
535106|NCT00893555|therapeutic drug monitoring|therapeutic drug monitoring
535107|NCT00893529|overweight|overweight
535108|NCT00893529|children|children
535109|NCT00893529|intervention|intervention
535110|NCT00893529|sugar-sweetened beverages|sugar-sweetened beverages
535111|NCT00893516|non cutaneous peripheral t-cell lymphoma with nodal involvement|non cutaneous peripheral t-cell lymphoma with nodal involvement
535112|NCT00893477|stage II grade 1 follicular lymphoma|stage ii grade 1 follicular lymphoma
535113|NCT00893477|stage II grade 2 follicular lymphoma|stage ii grade 2 follicular lymphoma
535114|NCT00893477|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
535115|NCT00893477|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
535116|NCT00893477|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
535117|NCT00893477|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
535118|NCT00893477|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
535119|NCT00893477|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
535120|NCT00893477|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
535121|NCT00893451|renal disease|renal disease
535122|NCT00893451|renal impairment|renal impairment
535123|NCT00893451|chronic kidney disease stage 3-4|chronic kidney disease stage 3-4
535124|NCT00893451|25(OH) vitamin D|25(oh) vitamin d
535125|NCT00893451|cholecalciferol|cholecalciferol
535126|NCT00893451|vitamin D deficiency|vitamin d deficiency
535127|NCT00893451|insulin resistance|insulin resistance
535128|NCT00893451|insulin-glucose clamp|insulin-glucose clamp
535129|NCT00893451|non-diabetic|non-diabetic
535130|NCT00893438|Chronic Fatigue Syndrome (CFS)|chronic fatigue syndrome (cfs)
535131|NCT00893438|Adolescence|adolescence
535132|NCT00893438|Cognitive behaviour therapy (CBT)|cognitive behaviour therapy (cbt)
535133|NCT00893438|Web-based|web-based
535134|NCT00893438|Internet|internet
535135|NCT00893438|Efficacy|efficacy
535136|NCT00893425|CD95|cd95
535137|NCT00893425|ADMA|adma
535138|NCT00893425|proteinuria|proteinuria
535139|NCT00893425|diabetic nephropathy|diabetic nephropathy
535140|NCT00893425|CD95 and ADMA levels|cd95 and adma levels
535141|NCT00893412|HSG|hsg
535142|NCT00893412|analgesia|analgesia
535143|NCT00893412|tramadol|tramadol
535144|NCT00893412|metal cannula|metal cannula
535145|NCT00893412|balloon catheter|balloon catheter
535146|NCT00893399|adult patients|adult patients
535147|NCT00893399|NPM1 mutation|npm1 mutation
535148|NCT00893386|Extraction|extraction
535149|NCT00893386|Removal|removal
535150|NCT00893386|Lead|lead
535151|NCT00893386|Heart Failure|heart failure
535152|NCT00893373|AML|aml
535153|NCT00893373|sorafenib|sorafenib
535154|NCT00893360|Adult Stem cells|adult stem cells
535155|NCT00893360|Cardiosphere derived stem cells|cardiosphere derived stem cells
535156|NCT00893360|Myocardial infarction|myocardial infarction
535157|NCT00893347|Mild traumatic brain injury|mild traumatic brain injury
535158|NCT00893347|Concussion|concussion
535159|NCT00893347|Post-Concussion Syndrome|post-concussion syndrome
535160|NCT00893347|Cognitive-Behavioural Therapy|cognitive-behavioural therapy
535161|NCT00893334|Duchenne and Becker muscular dystrophy|duchenne and becker muscular dystrophy
535162|NCT00893334|muscular dystrophy|muscular dystrophy
535163|NCT00893295|colon cancer|colon cancer
535164|NCT00893295|rectal cancer|rectal cancer
535165|NCT00893282|renal|renal
535166|NCT00893282|calculi|calculi
535167|NCT00893282|kidney|kidney
535168|NCT00893282|stones|stones
535169|NCT00893269|marijuana|marijuana
535170|NCT00893269|cannabis|cannabis
535171|NCT00893269|dependence|dependence
535172|NCT00893269|withdrawal|withdrawal
535173|NCT00893256|schizophrenia|schizophrenia
535174|NCT00893256|risperidone|risperidone
535175|NCT00893256|citalopram|citalopram
535176|NCT00893256|secondary negative symptoms|secondary negative symptoms
535177|NCT00893230|atopic dermatitis|atopic dermatitis
535178|NCT00893230|chemokines|chemokines
535179|NCT00893230|probiotics|probiotics
535180|NCT00893178|eNOS Polymorphism|enos polymorphism
535181|NCT00893178|TNF alpha polymorphism|tnf alpha polymorphism
535182|NCT00893178|pulmonary pressure|pulmonary pressure
535183|NCT00893178|polymorphism of vasoactive substances|polymorphism of vasoactive substances
535184|NCT00893165|inflammation|inflammation
535185|NCT00893165|cardiovascular disease|cardiovascular disease
535186|NCT00893139|Dry Eye|dry eye
535187|NCT00893126|psoriasis|psoriasis
535188|NCT00893126|coronary arteriosclerosis|coronary arteriosclerosis
535189|NCT00893126|coronary events|coronary events
535190|NCT00893126|rheumatoid arthritis|rheumatoid arthritis
535191|NCT00893126|arthritis|arthritis
535192|NCT00893087|Ventilatory care, children, intensive care, asynchrony, triggering|ventilatory care, children, intensive care, asynchrony, triggering
535193|NCT00893087|Children needing ventilatory care|children needing ventilatory care
535194|NCT00893074|withdrawal|withdrawal
535195|NCT00893074|acute effects|acute effects
535196|NCT00893074|cognitive performance|cognitive performance
535197|NCT00893074|Marijuana Use|marijuana use
535198|NCT00893074|Marijuana Abstinence|marijuana abstinence
535199|NCT00893061|stage IA breast cancer|stage ia breast cancer
535200|NCT00893061|stage IB breast cancer|stage ib breast cancer
535201|NCT00893061|stage II breast cancer|stage ii breast cancer
535202|NCT00893061|stage IIIA breast cancer|stage iiia breast cancer
535203|NCT00893061|stage IIIB breast cancer|stage iiib breast cancer
535204|NCT00893061|stage IIIC breast cancer|stage iiic breast cancer
535205|NCT00893061|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
535206|NCT00893061|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
535207|NCT00893048|prednisone|prednisone
535208|NCT00893048|cellulitis|cellulitis
535209|NCT00893048|erysipelas|erysipelas
535210|NCT00893048|steroids|steroids
535211|NCT00893048|oral|oral
535212|NCT00893035|Radiotherapy|radiotherapy
535213|NCT00893035|Late side effects|late side effects
535214|NCT00893035|Predictive assay|predictive assay
535215|NCT00893009|Forced expiratory volume in one second|forced expiratory volume in one second
535216|NCT00893009|Inspiratory capacity|inspiratory capacity
535217|NCT00893009|endurance time|endurance time
535218|NCT00893009|residual volume|residual volume
535219|NCT00892996|Intrathecal morphine|intrathecal morphine
535220|NCT00892996|Cesarean section|cesarean section
535221|NCT00892996|Nausea and vomiting|nausea and vomiting
535222|NCT00892996|Prevention|prevention
535223|NCT00892983|Obesity|obesity
535224|NCT00892983|Sleep|sleep
535225|NCT00892983|Physical activity|physical activity
535226|NCT00892983|Breast feeding|breast feeding
535227|NCT00892983|Depression|depression
535228|NCT00892957|Vascular Surgery|vascular surgery
535229|NCT00892957|Arterio-arterial bypasses|arterio-arterial bypasses
535230|NCT00892957|Arterio-venous (AV) shunts|arterio-venous (av) shunts
535231|NCT00892944|Positron Emission Tomography|positron emission tomography
535232|NCT00892944|Phase 1|phase 1
535233|NCT00892944|Healthy volunteers|healthy volunteers
535234|NCT00892944|AZD2516|azd2516
535235|NCT00892931|Glioblastoma|glioblastoma
535236|NCT00892931|Brain Neoplasms|brain neoplasms
535237|NCT00892931|Recurrence|recurrence
535238|NCT00892918|pterygium|pterygium
535239|NCT00892918|gatifloxacin|gatifloxacin
535240|NCT00892918|moxifloxacin|moxifloxacin
535241|NCT00892918|corneal epithelial defect|corneal epithelial defect
535242|NCT00892905|coagulation|coagulation
535243|NCT00892905|INR|inr
535244|NCT00892905|aPTT|aptt
535245|NCT00892905|point of care|point of care
535246|NCT00892905|laboratory|laboratory
535247|NCT00892905|CABG|cabg
535248|NCT00892905|surgery|surgery
535249|NCT00892892|sympatholytic treatment|sympatholytic treatment
535250|NCT00892892|sympathetic nerve activity|sympathetic nerve activity
535251|NCT00892853|calcification|calcification
535252|NCT00892853|osteoporosis|osteoporosis
535253|NCT00892827|Rituximab|rituximab
535254|NCT00892827|Mabthera|mabthera
535255|NCT00892827|FFP|ffp
535256|NCT00892827|Fresh Frozen Plasma|fresh frozen plasma
535257|NCT00892827|CLL|cll
535258|NCT00892827|Complement|complement
535259|NCT00892827|Response|response
535260|NCT00892827|Overall response rate of FFP+Rituximab combined therapy|overall response rate of ffp+rituximab combined therapy
535261|NCT00892827|Analysis of complement activation pathways prior to, during and|analysis of complement activation pathways prior to, during and
535262|NCT00892827|after the study treatment.|after the study treatment.
535263|NCT00892827|Time to disease progression|time to disease progression
535264|NCT00892827|Time to re-treatment (See Appendix I).|time to re-treatment (see appendix i).
535265|NCT00892827|Safety of the combination treatment of FFP and RTX.|safety of the combination treatment of ffp and rtx.
535266|NCT00892801|tumors metastatic to brain|tumors metastatic to brain
535267|NCT00892801|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
535268|NCT00892801|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
535269|NCT00892788|Overweight|overweight
535270|NCT00892788|Obesity|obesity
535271|NCT00892788|Contingency Management|contingency management
535272|NCT00892775|Working seed virus|working seed virus
535273|NCT00892775|Rubella|rubella
535274|NCT00892775|Mumps|mumps
535275|NCT00892775|Varicella|varicella
535276|NCT00892775|Combined measles-mumps-rubella-varicella vaccine|combined measles-mumps-rubella-varicella vaccine
535277|NCT00892775|Pediatric immunization|pediatric immunization
535278|NCT00892775|Measles|measles
535279|NCT00892762|Open Angle Glaucoma|open angle glaucoma
535280|NCT00892762|Ocular hypertension|ocular hypertension
535282|NCT00892762|OH|oh
535283|NCT00892749|hyperphosphatemia|hyperphosphatemia
535284|NCT00892749|hemodialysis|hemodialysis
535285|NCT00892749|CKD|ckd
535286|NCT00892749|ASP1585|asp1585
535287|NCT00892723|AZX100|azx100
535288|NCT00892723|Patient and Observer Scar Assessment Scale|patient and observer scar assessment scale
535289|NCT00892723|POSAS|posas
535290|NCT00892723|Visual Analog Scale|visual analog scale
535291|NCT00892723|VAS|vas
535292|NCT00892723|Keloid|keloid
535293|NCT00892723|Scarring|scarring
535294|NCT00892723|Scar reduction|scar reduction
535295|NCT00892723|Scar prevention|scar prevention
535296|NCT00892710|Non small cell lung cancer|non small cell lung cancer
535297|NCT00892710|NSCLC|nsclc
535298|NCT00892710|Pemetrexed|pemetrexed
535299|NCT00892710|Bevacizumab|bevacizumab
535300|NCT00892710|Avastin|avastin
535301|NCT00892710|Carboplatin|carboplatin
535302|NCT00892710|Stage IIIB/IV|stage iiib/iv
535303|NCT00892697|hepatitis C|hepatitis c
535304|NCT00892697|FNA|fna
535305|NCT00892697|intrahepatic|intrahepatic
535306|NCT00892684|Randomized|randomized
535307|NCT00892684|Placebo controlled|placebo controlled
535308|NCT00892684|Double blind|double blind
535309|NCT00892684|Omega-3 fatty acids|omega-3 fatty acids
535310|NCT00892684|Pregnancy|pregnancy
535311|NCT00892684|Childhood allergy|childhood allergy
535312|NCT00892684|Cytokines|cytokines
535313|NCT00892684|Eicosanoids|eicosanoids
535314|NCT00892684|Polyunsaturated fatty acids|polyunsaturated fatty acids
535315|NCT00892671|Perceived effectiveness|perceived effectiveness
535316|NCT00892658|Sorafenib|sorafenib
535317|NCT00892658|Hepatocellular carcinoma|hepatocellular carcinoma
535318|NCT00892632|Biliary Strictures|biliary strictures
535319|NCT00892632|Cholangiocarcinoma|cholangiocarcinoma
535320|NCT00892632|ERCP|ercp
535321|NCT00892619|Epiretinal Membrane|epiretinal membrane
535322|NCT00892619|Vitreomacular traction|vitreomacular traction
535323|NCT00892619|MVR blade|mvr blade
535324|NCT00892619|Tano brush|tano brush
535325|NCT00892619|ILM forceps|ilm forceps
535326|NCT00892619|surgical technique|surgical technique
535327|NCT00892606|Surgery, Orthopedic|surgery, orthopedic
535328|NCT00892606|Pain, Postoperative|pain, postoperative
535329|NCT00892593|colon|colon
535330|NCT00892593|neoplasia|neoplasia
535331|NCT00892593|polyp|polyp
535332|NCT00892593|adenoma|adenoma
535333|NCT00892593|FIT|fit
535334|NCT00892593|cancer|cancer
535335|NCT00892580|fragile X syndrome|fragile x syndrome
535336|NCT00892580|biomarkers|biomarkers
535337|NCT00892567|breast cancer|breast cancer
535338|NCT00892567|peptide vaccine|peptide vaccine
535339|NCT00892567|immunotherapy|immunotherapy
535340|NCT00892554|Phenylketonurias|phenylketonurias
535341|NCT00892554|Docosahexaenoic Acids|docosahexaenoic acids
535342|NCT00892554|Neuropsychological Tests|neuropsychological tests
535343|NCT00892554|Female|female
535344|NCT00892554|Adolescent|adolescent
535345|NCT00892554|Adult|adult
535346|NCT00892541|Schizophrenia|schizophrenia
535347|NCT00892541|Mood disorders|mood disorders
535348|NCT00892541|Antipsychotic drugs|antipsychotic drugs
535349|NCT00892541|Renal secretion|renal secretion
535350|NCT00892541|ER OROS paliperidone|er oros paliperidone
535351|NCT00892515|breast cancer|breast cancer
535352|NCT00892515|healthy, no evidence of disease|healthy, no evidence of disease
535353|NCT00892502|haematology|haematology
535354|NCT00892502|haematological|haematological
535355|NCT00892502|hematology|hematology
535356|NCT00892502|hematological|hematological
535357|NCT00892502|malignancy|malignancy
535358|NCT00892502|lymphoma|lymphoma
535359|NCT00892502|myeloma|myeloma
535360|NCT00892502|leukemia|leukemia
535361|NCT00892502|blood diseases|blood diseases
535362|NCT00892502|malignant|malignant
535363|NCT00892502|bismuth|bismuth
535364|NCT00892489|Schizophrenia, Mood disorders, Antipsychotics|schizophrenia, mood disorders, antipsychotics
535365|NCT00892489|ER OROS Paliperidone|er oros paliperidone
535366|NCT00892476|myopia|myopia
535367|NCT00892476|calcium supplementation|calcium supplementation
535368|NCT00892476|prematurity|prematurity
535369|NCT00892463|Major Depressive Disorder|major depressive disorder
535370|NCT00892463|Seroquel XR|seroquel xr
535371|NCT00892463|Quetiapine|quetiapine
535372|NCT00892450|Overactive bladder symptoms|overactive bladder symptoms
535373|NCT00892450|Parkinson's disease|parkinson's disease
535374|NCT00892450|darifenacin|darifenacin
535375|NCT00892450|oxybutynin|oxybutynin
535376|NCT00892450|cognition|cognition
535377|NCT00892437|HIV|hiv
535378|NCT00892437|HIV-1|hiv-1
535379|NCT00892437|Antiretroviral Treatment-Naive|antiretroviral treatment-naive
535380|NCT00892424|Liver metastasis|liver metastasis
535381|NCT00892424|sorafenib|sorafenib
535382|NCT00892424|Liver metastasis from cancer|liver metastasis from cancer
535383|NCT00892411|Neuroplasticity|neuroplasticity
535385|NCT00892398|Trabeculectomy|trabeculectomy
535386|NCT00892398|Vascular Endothelial Growth Factor A|vascular endothelial growth factor a
535387|NCT00892398|Wound Healing|wound healing
535388|NCT00892398|Angiogenesis Inhibitors|angiogenesis inhibitors
535389|NCT00892385|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
535390|NCT00892372|body weight|body weight
535391|NCT00892372|glycohemoglobin|glycohemoglobin
535392|NCT00892359|pharmacokinetics|pharmacokinetics
535393|NCT00892359|renal replacement therapy|renal replacement therapy
535394|NCT00892359|hemofiltration|hemofiltration
535395|NCT00892359|anidulafungin|anidulafungin
535396|NCT00892346|autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
535397|NCT00892346|maintenance|maintenance
535398|NCT00892333|Repair of a large hernia with SurgiMend 3.0, a biologic mesh|repair of a large hernia with surgimend 3.0, a biologic mesh
535399|NCT00892320|Schizophrenia, mood stabilizers, antipsychotics|schizophrenia, mood stabilizers, antipsychotics
535400|NCT00892320|ER OROS paliperidone|er oros paliperidone
535401|NCT00892307|Diagnostic Imaging|diagnostic imaging
535402|NCT00892307|Dual Source Multidetector Computed Tomography|dual source multidetector computed tomography
535403|NCT00892307|Computed Tomography|computed tomography
535404|NCT00892307|CT|ct
535405|NCT00892307|Single Photon Emission Computed Tomography|single photon emission computed tomography
535406|NCT00892307|SPECT|spect
535407|NCT00892307|Myocardial Perfusion|myocardial perfusion
535408|NCT00892307|Atherosclerosis|atherosclerosis
535409|NCT00892268|menopausal symptoms|menopausal symptoms
535410|NCT00892268|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
535411|NCT00892268|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
535412|NCT00892268|breast cancer|breast cancer
535413|NCT00892268|pain|pain
535414|NCT00892255|Liver cancer|liver cancer
535415|NCT00892255|Tumors|tumors
535416|NCT00892242|Neoadjuvant zoledronic acid in resectable pancreas cancer|neoadjuvant zoledronic acid in resectable pancreas cancer
535417|NCT00892229|First trimester missed abortion|first trimester missed abortion
535418|NCT00892229|Misoprostol|misoprostol
535419|NCT00892229|buccal|buccal
535420|NCT00892229|vaginal|vaginal
535421|NCT00892229|cervical ripening|cervical ripening
535422|NCT00892229|first trimester|first trimester
535423|NCT00892229|missed abortion|missed abortion
535424|NCT00892216|PONV|ponv
535425|NCT00892216|NUSS procedure|nuss procedure
535426|NCT00892216|Acupressure|acupressure
535427|NCT00892216|Pectus Excavatum|pectus excavatum
535428|NCT00892203|Migraine|migraine
535429|NCT00892203|Headache|headache
535430|NCT00892190|AML|aml
535431|NCT00892190|Dasatinib|dasatinib
535432|NCT00892190|all trans retinoic acid|all trans retinoic acid
535433|NCT00892190|relapsed AML|relapsed aml
535434|NCT00892190|refractory AML|refractory aml
535435|NCT00892190|Relapsed/Refractory Acute myelogenous leukemia|relapsed/refractory acute myelogenous leukemia
535436|NCT00892190|Elderly subjects (age 65 or older) with acute myelogenous leukemia|elderly subjects (age 65 or older) with acute myelogenous leukemia
535437|NCT00892190|Myelodysplastic Syndrome|myelodysplastic syndrome
535438|NCT00892190|MDS|mds
535439|NCT00892177|adult giant cell glioblastoma|adult giant cell glioblastoma
535440|NCT00892177|adult glioblastoma|adult glioblastoma
535441|NCT00892177|adult gliosarcoma|adult gliosarcoma
535442|NCT00892177|adult mixed glioma|adult mixed glioma
535443|NCT00892177|recurrent adult brain tumor|recurrent adult brain tumor
535444|NCT00892177|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
535445|NCT00892177|adult oligodendroglioma|adult oligodendroglioma
535446|NCT00892177|adult anaplastic astrocytoma|adult anaplastic astrocytoma
535447|NCT00892164|thyroid surgery|thyroid surgery
535448|NCT00892164|total thyroidectomy|total thyroidectomy
535449|NCT00892164|harmonic scalpel|harmonic scalpel
535450|NCT00892164|electrothermal bipolar vessel sealer|electrothermal bipolar vessel sealer
535451|NCT00892164|hemostatic device|hemostatic device
535452|NCT00892138|mindfulness training|mindfulness training
535453|NCT00892138|medical students|medical students
535454|NCT00892138|psychology students|psychology students
535455|NCT00892138|stress management|stress management
535456|NCT00892138|personal development|personal development
535457|NCT00892138|stress|stress
535458|NCT00892125|Schizophrenia|schizophrenia
535459|NCT00892125|Bipolar I disorder|bipolar i disorder
535460|NCT00892125|mood disorders|mood disorders
535461|NCT00892125|antipsychotic drugs|antipsychotic drugs
535462|NCT00892125|enzyme inducer|enzyme inducer
535463|NCT00892125|Paliperidone ER|paliperidone er
535464|NCT00892112|Immunoglobulins, Intravenous|immunoglobulins, intravenous
535465|NCT00892112|Cardiomyopathies|cardiomyopathies
535466|NCT00892112|Parvo B19, Human|parvo b19, human
535467|NCT00892099|end stage renal disease|end stage renal disease
535468|NCT00892099|hemodialysis|hemodialysis
535469|NCT00892086|geriatric syndrome|geriatric syndrome
535470|NCT00892086|immobility|immobility
535471|NCT00892073|Craniopharyngioma surgery|craniopharyngioma surgery
535472|NCT00892073|Hypothalamic Obesity|hypothalamic obesity
535473|NCT00892073|Children|children
535474|NCT00892073|Combined Diazoxide and Metformin|combined diazoxide and metformin
535475|NCT00892047|Depression|depression
535476|NCT00892047|Aripiprazole|aripiprazole
535477|NCT00892047|Venlafaxine|venlafaxine
535478|NCT00892047|Partial Remission|partial remission
535479|NCT00892047|Augmentation strategy|augmentation strategy
535480|NCT00892047|Treatment resistance|treatment resistance
535481|NCT00892047|Elderly|elderly
535482|NCT00892047|Late-life|late-life
535483|NCT00892008|pregabalin|pregabalin
535484|NCT00892008|neuropathic pain|neuropathic pain
535485|NCT00892008|safety|safety
535486|NCT00891995|Type 1 Diabetes|type 1 diabetes
535487|NCT00891995|Closed Loop Therapy|closed loop therapy
535488|NCT00891995|Continuous Glucose Monitor|continuous glucose monitor
535489|NCT00891982|Acne Vulgaris|acne vulgaris
535490|NCT00891969|stage I breast cancer|stage i breast cancer
535491|NCT00891969|stage II breast cancer|stage ii breast cancer
535492|NCT00891969|stage IIIA breast cancer|stage iiia breast cancer
535493|NCT00891956|Rett Syndrome|rett syndrome
535494|NCT00891943|Obesity|obesity
535495|NCT00891943|Overweight|overweight
535496|NCT00891943|Randomised controlled trial|randomised controlled trial
535497|NCT00891943|Primary Care|primary care
535498|NCT00891943|Weight|weight
535499|NCT00891943|Cardiovascular Risk|cardiovascular risk
535500|NCT00891943|Diabetes|diabetes
535501|NCT00891943|Quality of life|quality of life
535502|NCT00891930|wild-type KRAS|wild-type kras
535503|NCT00891930|panitumumab|panitumumab
535504|NCT00891930|biomarker|biomarker
535505|NCT00891930|mechanisms of acquired resistance|mechanisms of acquired resistance
535506|NCT00891930|metastatic colorectal cancer|metastatic colorectal cancer
535507|NCT00891917|Down syndrome|down syndrome
535508|NCT00891917|coenzyme Q10|coenzyme q10
535509|NCT00891917|language function|language function
535510|NCT00891917|behavior|behavior
535511|NCT00891904|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
535512|NCT00891904|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
535513|NCT00891904|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
535514|NCT00891904|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
535515|NCT00891904|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
535516|NCT00891904|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
535517|NCT00891891|spina bifida, psychosocial adjustment, adolescence, emerging adulthood|spina bifida, psychosocial adjustment, adolescence, emerging adulthood
535518|NCT00891878|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
535519|NCT00891878|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
535520|NCT00891878|recurrent esophageal cancer|recurrent esophageal cancer
535521|NCT00891878|stage IV esophageal cancer|stage iv esophageal cancer
535522|NCT00891878|stage III esophageal cancer|stage iii esophageal cancer
535523|NCT00891865|lung transplant|lung transplant
535524|NCT00891865|BOS|bos
535526|NCT00891865|Respiratory Viral Infection (RVI)|respiratory viral infection (rvi)
535527|NCT00891865|Lung disease|lung disease
535528|NCT00891826|Bipolar disorders|bipolar disorders
535529|NCT00891826|Omega-3 fatty acids|omega-3 fatty acids
535530|NCT00891826|Heart rate|heart rate
535531|NCT00891800|Cancer|cancer
535532|NCT00891800|Breast|breast
535533|NCT00891800|Liver|liver
535534|NCT00891787|Probiotics|probiotics
535535|NCT00891787|Isoagglutinins|isoagglutinins
535536|NCT00891787|Anti-A|anti-a
535537|NCT00891787|Anti-B|anti-b
535538|NCT00891787|Hemolysis|hemolysis
535539|NCT00891787|Healthy Volunteer|healthy volunteer
535540|NCT00891787|HV|hv
535541|NCT00891761|cisplatin|cisplatin
535542|NCT00891761|nausea|nausea
535543|NCT00891761|vomiting|vomiting
535544|NCT00891761|cancer|cancer
535545|NCT00891761|lung cancer|lung cancer
535546|NCT00891735|Lucentis|lucentis
535547|NCT00891735|AMD|amd
535548|NCT00891735|Age-related macular degeneration|age-related macular degeneration
535549|NCT00891735|Subfoveal neovascular age-related macular degeneration|subfoveal neovascular age-related macular degeneration
535550|NCT00891735|Wet AMD|wet amd
535551|NCT00891735|Macular degeneration|macular degeneration
535552|NCT00891735|Ranibizumab|ranibizumab
535553|NCT00891722|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
535554|NCT00891722|untreated childhood brain stem glioma|untreated childhood brain stem glioma
535555|NCT00891722|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
535556|NCT00891722|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
535557|NCT00891722|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
535558|NCT00891722|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
535559|NCT00891722|childhood oligodendroglioma|childhood oligodendroglioma
535560|NCT00891722|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
535561|NCT00891722|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
535562|NCT00891722|childhood mixed glioma|childhood mixed glioma
535563|NCT00891696|Sarcopenia|sarcopenia
535564|NCT00891696|Aging|aging
535565|NCT00891696|Metabolism|metabolism
535568|NCT00891696|Essential Amino Acids|essential amino acids
535569|NCT00891696|Exercise|exercise
535570|NCT00891696|Rapamycin|rapamycin
535571|NCT00891683|Diabetic|diabetic
535572|NCT00891683|peripheral|peripheral
535573|NCT00891683|neuropathy|neuropathy
535574|NCT00891683|pain|pain
535575|NCT00891683|hyperalgesia|hyperalgesia
535576|NCT00891683|allodynia|allodynia
535577|NCT00891670|CYP2C19 polymorphism|cyp2c19 polymorphism
535578|NCT00891670|platelet|platelet
535579|NCT00891670|Adjunctive cilostazol|adjunctive cilostazol
535580|NCT00891670|high maintenance dose clopidogrel|high maintenance dose clopidogrel
535581|NCT00891670|P2Y12 Reaction Unit|p2y12 reaction unit
535582|NCT00891657|Adhesion|adhesion
535583|NCT00891657|Fibroid|fibroid
535584|NCT00891657|Myoma|myoma
535585|NCT00891657|Leiomyoma|leiomyoma
535586|NCT00891657|Myomectomy|myomectomy
535587|NCT00891644|HIV|hiv
535588|NCT00891644|Care-seeking|care-seeking
535589|NCT00891631|tobacco|tobacco
535590|NCT00891631|alcohol|alcohol
535591|NCT00891631|marijuana|marijuana
535592|NCT00891631|drug use|drug use
535593|NCT00891631|seat-belt|seat-belt
535594|NCT00891631|weapons|weapons
535595|NCT00891631|depression|depression
535596|NCT00891631|suicidality|suicidality
535597|NCT00891631|sexual risk behaviors|sexual risk behaviors
535598|NCT00891618|Lymphoma|lymphoma
535599|NCT00891618|Myeloma|myeloma
535600|NCT00891618|Multiple Myeloma|multiple myeloma
535601|NCT00891618|MM|mm
535602|NCT00891618|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
535603|NCT00891618|NHL|nhl
535604|NCT00891618|Acupuncture|acupuncture
535605|NCT00891618|Treatment-induced Peripheral Neuropathy|treatment-induced peripheral neuropathy
535606|NCT00891618|Thalidomide|thalidomide
535607|NCT00891618|Bortezomib|bortezomib
535608|NCT00891618|Neuropathy|neuropathy
535609|NCT00891618|Peripheral Neuropathy|peripheral neuropathy
535610|NCT00891605|Paclitaxel|paclitaxel
535611|NCT00891605|Solid Tumors|solid tumors
535612|NCT00891592|AML|aml
535613|NCT00891592|MDS|mds
535614|NCT00891592|ALL|all
535615|NCT00891592|NHL|nhl
535616|NCT00891592|Multiple Myeloma|multiple myeloma
535617|NCT00891592|Hodgkin's|hodgkin's
535618|NCT00891579|NSCLC|nsclc
535619|NCT00891579|EGFR|egfr
535620|NCT00891579|Pemetrexed|pemetrexed
535621|NCT00891579|Gefitinib|gefitinib
535622|NCT00891579|without EGFR mutations|without egfr mutations
535623|NCT00891566|medium to large tear|medium to large tear
535624|NCT00891566|rotator cuff tear|rotator cuff tear
535625|NCT00891566|arthroscopic repair|arthroscopic repair
535626|NCT00891566|repair integrity|repair integrity
535627|NCT00891566|immobilization|immobilization
535628|NCT00891553|bone mineral density|bone mineral density
535629|NCT00891553|calcium-sensing receptor antagonist|calcium-sensing receptor antagonist
535630|NCT00891553|ronacaleret|ronacaleret
535631|NCT00891553|postmenopausal osteoporosis|postmenopausal osteoporosis
535632|NCT00891527|Pulmonary Vein Stenosis,|pulmonary vein stenosis,
535633|NCT00891527|Avastin and Gleevec,|avastin and gleevec,
535634|NCT00891527|Targeting VEGF and PDGF|targeting vegf and pdgf
535635|NCT00891514|Exercise|exercise
535636|NCT00891514|Inflammation|inflammation
535637|NCT00891514|Insulin Sensitivity|insulin sensitivity
535638|NCT00891501|autologous bone marrow mesenchymal stem cells|autologous bone marrow mesenchymal stem cells
535639|NCT00891501|cartilage repair|cartilage repair
535640|NCT00891501|osteoarthritis|osteoarthritis
535641|NCT00891501|osteochondral defects|osteochondral defects
535642|NCT00891488|VO2 max|vo2 max
535643|NCT00891488|stress|stress
535644|NCT00891488|cortisol|cortisol
535645|NCT00891488|fitness|fitness
535646|NCT00891475|metastatic renal cell carcinoma|metastatic renal cell carcinoma
535647|NCT00891475|radiofrequency ablation|radiofrequency ablation
535648|NCT00891462|COPD|copd
535649|NCT00891462|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
535650|NCT00891462|Chronic Bronchitis|chronic bronchitis
535651|NCT00891462|Emphysema|emphysema
535652|NCT00891462|Airflow Obstruction, Chronic|airflow obstruction, chronic
535653|NCT00891462|Chronic Airflow Obstruction|chronic airflow obstruction
535654|NCT00891462|Chronic Obstructive Airway Disease|chronic obstructive airway disease
535655|NCT00891462|Chronic Obstructive Lung Disease|chronic obstructive lung disease
535656|NCT00891449|space flight simulation study|space flight simulation study
535657|NCT00891449|medical research study|medical research study
535658|NCT00891449|bed rest|bed rest
535659|NCT00891449|microgravity|microgravity
535660|NCT00891449|weightlessness|weightlessness
535661|NCT00891449|The effects of long duration microgravity on humans|the effects of long duration microgravity on humans
535662|NCT00891423|Meropenem|meropenem
535663|NCT00891423|extended infusion|extended infusion
535664|NCT00891423|prolonged infusion|prolonged infusion
535665|NCT00891423|Time above MIC|time above mic
535666|NCT00891397|CPRS|cprs
535667|NCT00891397|stellate ganglion block|stellate ganglion block
535668|NCT00891397|pregabalin|pregabalin
535669|NCT00891397|pain|pain
535670|NCT00891397|Type I|type i
535671|NCT00891384|Multiple Myeloma|multiple myeloma
535672|NCT00891384|maintenance therapy|maintenance therapy
535673|NCT00891384|lenalidomide|lenalidomide
535674|NCT00891371|symptomatic treatment of patients with refractory diarrhea|symptomatic treatment of patients with refractory diarrhea
535675|NCT00891358|Adolescent Medicine Trials Network for HIV/AIDS Interventions|adolescent medicine trials network for hiv/aids interventions
535676|NCT00891358|Human Immunodeficiency Virus|human immunodeficiency virus
535677|NCT00891358|HIV seronegativity|hiv seronegativity
535678|NCT00891345|hormone-refractory prostate cancer|hormone-refractory prostate cancer
535679|NCT00891345|Immunotherapy|immunotherapy
535680|NCT00891319|hand|hand
535681|NCT00891319|stroke|stroke
535682|NCT00891319|hemiplegia|hemiplegia
535683|NCT00891319|electrical stimulation|electrical stimulation
535684|NCT00891319|recovery|recovery
535685|NCT00891306|LPLD, Lipoprotein Lipase Deficiency|lpld, lipoprotein lipase deficiency
535686|NCT00891306|Chylomicronemia|chylomicronemia
535687|NCT00891306|Gene therapy|gene therapy
535688|NCT00891306|AAV|aav
535689|NCT00891306|Lipoprotein Lipase|lipoprotein lipase
535690|NCT00891306|Alipogene tiparvovec|alipogene tiparvovec
535691|NCT00891306|AMT-011|amt-011
535692|NCT00891293|omega-3-acid ethyl esters|omega-3-acid ethyl esters
535693|NCT00891293|Very high triglycerides|very high triglycerides
535694|NCT00891293|Lovaza|lovaza
535695|NCT00891293|fenofibrate|fenofibrate
535696|NCT00891280|Inflammatory breast cancer|inflammatory breast cancer
535697|NCT00891280|Castleman's Disease|castleman's disease
535698|NCT00891280|Multiple Myeloma|multiple myeloma
535699|NCT00891280|Breast cancer|breast cancer
535700|NCT00891280|Solid tumors|solid tumors
535701|NCT00891280|CK2 inhibitor|ck2 inhibitor
535702|NCT00891267|Inflammatory markers|inflammatory markers
535703|NCT00891267|Vascular protection|vascular protection
535704|NCT00891267|OM Effect|om effect
535705|NCT00891267|Metabolic syndrome|metabolic syndrome
535706|NCT00891267|Hypertension|hypertension
535707|NCT00891254|Incisional hernia|incisional hernia
535708|NCT00891254|Intraperitoneal mesh repair|intraperitoneal mesh repair
535709|NCT00891254|On-lay repair|on-lay repair
535710|NCT00891254|Prosthetic mesh|prosthetic mesh
535711|NCT00891254|First repair (no recurrent hernia will be included)|first repair (no recurrent hernia will be included)
535712|NCT00891254|Recurrence|recurrence
535713|NCT00891254|Complications|complications
535714|NCT00891241|Heart Failure, PET Imaging, Implantable Cardioverter-Defibrillator, Dosimetry|heart failure, pet imaging, implantable cardioverter-defibrillator, dosimetry
535715|NCT00891228|Contraception|contraception
535716|NCT00891228|Male Contraception|male contraception
535717|NCT00891228|Suppression of Sperm Production|suppression of sperm production
535718|NCT00891202|Gaucher,|gaucher,
535719|NCT00891202|beta-glucosidase,|beta-glucosidase,
535720|NCT00891202|acid ß-glucosidase,|acid ß-glucosidase,
535721|NCT00891202|glucocerebrosidase,|glucocerebrosidase,
535722|NCT00891202|glucosylceramide,|glucosylceramide,
535723|NCT00891202|D-glucosyl-N-acylsphingosine glucohydrolase,|d-glucosyl-n-acylsphingosine glucohydrolase,
535724|NCT00891202|substrate reduction therapy|substrate reduction therapy
535725|NCT00891189|Circadian Rhythm|circadian rhythm
535726|NCT00891176|Conjugate vaccines|conjugate vaccines
535727|NCT00891176|Meningococcal serogroup C vaccine|meningococcal serogroup c vaccine
535728|NCT00891176|Antibody persistence|antibody persistence
535729|NCT00891176|Pneumococcal vaccine|pneumococcal vaccine
535730|NCT00891176|Haemophilus Influenzae type b vaccine|haemophilus influenzae type b vaccine
535731|NCT00891163|Topical anesthesia|topical anesthesia
535732|NCT00891163|Analgesia|analgesia
535733|NCT00891137|adult acute myeloid leukemia 11q23 (MLL) abnormalities|adult acute myeloid leukemia 11q23 (mll) abnormalities
535734|NCT00891137|adult acute myeloid leukemia inv(16)(p13;q22)|adult acute myeloid leukemia inv(16)(p13;q22)
535735|NCT00891137|adult acute myeloid leukemia t(15;17)(q22;q12)|adult acute myeloid leukemia t(15;17)(q22;q12)
535736|NCT00891137|adult acute myeloid leukemia t(16;16)(p13;q22)|adult acute myeloid leukemia t(16;16)(p13;q22)
535737|NCT00891137|adult acute myeloid leukemia t(8;21)(q22;q22)|adult acute myeloid leukemia t(8;21)(q22;q22)
535738|NCT00891137|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
535739|NCT00891137|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
535740|NCT00891137|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
535741|NCT00891137|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
535742|NCT00891137|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
535743|NCT00891137|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
535744|NCT00891137|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
535745|NCT00891137|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
535746|NCT00891137|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
535747|NCT00891137|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
535748|NCT00891137|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
535749|NCT00891137|extranodal marginal zone B-cell lymphoma|extranodal marginal zone b-cell lymphoma
535750|NCT00891137|mucosa-associated lymphoid tissue|mucosa-associated lymphoid tissue
535751|NCT00891137|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
535752|NCT00891137|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
535753|NCT00891137|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
535754|NCT00891137|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
535755|NCT00891137|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
535756|NCT00891137|noncontiguous stage II adult immunoblastic|noncontiguous stage ii adult immunoblastic
535757|NCT00891137|contiguous stage II adult immunoblastic|contiguous stage ii adult immunoblastic
535758|NCT00891137|large cell lymphoma|large cell lymphoma
535759|NCT00891137|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
535760|NCT00891137|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
535761|NCT00891137|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
535762|NCT00891137|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
535763|NCT00891137|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
535764|NCT00891137|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
535765|NCT00891137|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
535766|NCT00891137|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
535767|NCT00891137|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
535768|NCT00891137|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
535769|NCT00891137|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
535770|NCT00891137|refractory multiple myeloma|refractory multiple myeloma
535771|NCT00891137|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
535772|NCT00891137|secondary acute myeloid leukemia|secondary acute myeloid leukemia
535773|NCT00891137|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
535774|NCT00891137|splenic marginal zone lymphoma|splenic marginal zone lymphoma
535775|NCT00891137|stage I multiple myeloma|stage i multiple myeloma
535776|NCT00891137|stage II multiple myeloma|stage ii multiple myeloma
535777|NCT00891137|stage III multiple myeloma|stage iii multiple myeloma
535778|NCT00891137|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
535779|NCT00891137|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
535780|NCT00891137|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
535781|NCT00891137|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
535782|NCT00891137|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
535783|NCT00891137|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
535784|NCT00891137|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
535785|NCT00891137|refractory anemia with excess blasts|refractory anemia with excess blasts
535786|NCT00891137|refractory anemia|refractory anemia
535787|NCT00891137|prolymphocytic leukemia|prolymphocytic leukemia
535788|NCT00891137|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
535789|NCT00891137|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
535790|NCT00891137|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
535791|NCT00891137|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
535792|NCT00891137|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
535793|NCT00891137|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
535794|NCT00891137|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
535795|NCT00891137|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
535796|NCT00891137|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
535797|NCT00891137|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
535798|NCT00891137|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
535799|NCT00891137|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
535800|NCT00891137|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
535801|NCT00891137|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
535802|NCT00891137|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
535803|NCT00891137|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
535804|NCT00891137|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
535805|NCT00891137|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
535806|NCT00891137|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
535807|NCT00891137|stage I mantle cell lymphoma|stage i mantle cell lymphoma
535808|NCT00891137|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
535809|NCT00891137|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
535810|NCT00891137|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
535811|NCT00891137|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
535812|NCT00891137|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
535813|NCT00891137|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
535814|NCT00891137|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
535815|NCT00891137|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
535816|NCT00891137|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
536357|NCT00889265|Bone Graft|bone graft
535817|NCT00891137|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
535818|NCT00891137|Burkitt lymphoma|burkitt lymphoma
535819|NCT00891124|Hypertension|hypertension
535820|NCT00891124|Type II DM|type ii dm
535821|NCT00891124|Hyperlipidemia|hyperlipidemia
535822|NCT00891124|Glycemia|glycemia
535823|NCT00891124|ADA 2008 guideline|ada 2008 guideline
535824|NCT00891124|Patient Consultation|patient consultation
535825|NCT00891111|Health Risk Assessment|health risk assessment
535826|NCT00891111|Incentives|incentives
535827|NCT00891111|Preventative Healthcare|preventative healthcare
535828|NCT00891111|Encouraging Health Risk Assessments|encouraging health risk assessments
535829|NCT00891085|ventilation|ventilation
535830|NCT00891085|ards|ards
535831|NCT00891085|ali|ali
535832|NCT00891085|trauma|trauma
535833|NCT00891085|Trauma Patients with ISS > 25|trauma patients with iss > 25
535834|NCT00891059|Cognitive Impairment|cognitive impairment
535835|NCT00891059|Diskus Inhaler|diskus inhaler
535836|NCT00891059|Nursing Home|nursing home
535837|NCT00891046|Flare|flare
535838|NCT00891046|arthritis|arthritis
535839|NCT00891046|IL-1beta antagonist|il-1beta antagonist
535840|NCT00891046|systemic juvenile idiopathic arthritis|systemic juvenile idiopathic arthritis
535841|NCT00891046|CHAQ|chaq
535842|NCT00891046|steroids|steroids
535843|NCT00891046|ACR pediatric response|acr pediatric response
535844|NCT00891046|Systemic juvenile idiopathic arthritis with active flare|systemic juvenile idiopathic arthritis with active flare
535845|NCT00891033|cancer|cancer
535846|NCT00891007|Measles|measles
535847|NCT00891007|Virus Disease|virus disease
535848|NCT00891007|Paediatric Diseases|paediatric diseases
535849|NCT00891007|Paramyoxyviridae|paramyoxyviridae
535850|NCT00890994|MBI|mbi
535851|NCT00890994|Molecular Breast Imaging|molecular breast imaging
535852|NCT00890994|Breast Cancer|breast cancer
535853|NCT00890994|DCIS|dcis
535854|NCT00890994|Breast|breast
535855|NCT00890994|Calcifications|calcifications
535856|NCT00890994|Microcalcifications|microcalcifications
535857|NCT00890968|hand dermatitis|hand dermatitis
535858|NCT00890968|hand eczema|hand eczema
535859|NCT00890968|triamcinolone acetonide|triamcinolone acetonide
535860|NCT00890955|Solid tumors|solid tumors
535861|NCT00890942|pruritus|pruritus
535862|NCT00890942|intrathecal morphine|intrathecal morphine
535863|NCT00890929|Acute myeloid leukemia|acute myeloid leukemia
535864|NCT00890929|Acute myeloblastic leukemia|acute myeloblastic leukemia
535865|NCT00890929|AML|aml
535866|NCT00890916|spinal cord injury|spinal cord injury
535867|NCT00890916|neuroprosthesis|neuroprosthesis
535868|NCT00890916|functional electrical stimulation|functional electrical stimulation
535869|NCT00890916|quadriplegia|quadriplegia
535870|NCT00890903|NSCLC|nsclc
535871|NCT00890903|non small cell lung carcinoma|non small cell lung carcinoma
535872|NCT00890903|metastatic breast cancer|metastatic breast cancer
535873|NCT00890903|MBC|mbc
535874|NCT00890903|advanced breast cancer|advanced breast cancer
535875|NCT00890903|Navelbine|navelbine
535876|NCT00890903|Navelbine-ORAL|navelbine-oral
535877|NCT00890903|Vinorelbine|vinorelbine
535878|NCT00890903|Vinorelbine-ORAL|vinorelbine-oral
535879|NCT00890903|daily routine|daily routine
535880|NCT00890903|concomitant antiemetic therapy|concomitant antiemetic therapy
535881|NCT00890903|patient compliance|patient compliance
535882|NCT00890903|germany|germany
535883|NCT00890903|non-interventional study|non-interventional study
535884|NCT00890903|oral anti cancer therapy|oral anti cancer therapy
535885|NCT00890903|quality of life|quality of life
535886|NCT00890877|asthma|asthma
535887|NCT00890877|treatment|treatment
535888|NCT00890877|placebo|placebo
535889|NCT00890877|efficacy|efficacy
535890|NCT00890877|safety|safety
535891|NCT00890864|Breast screening|breast screening
535892|NCT00890864|Mammogram|mammogram
535893|NCT00890864|Routine screening programme|routine screening programme
535894|NCT00890851|Radiofrequency|radiofrequency
535895|NCT00890851|Mini invasin surgery|mini invasin surgery
535896|NCT00890851|Outpatient treatment|outpatient treatment
535897|NCT00890851|Men health|men health
535898|NCT00890838|IVFO|ivfo
535899|NCT00890838|Inflammation|inflammation
535900|NCT00890838|Valvular surgery|valvular surgery
535901|NCT00890838|Inflammatory status|inflammatory status
535902|NCT00890838|Infectious complications|infectious complications
535903|NCT00890825|Non small cell lung cancer (NSCLC)|non small cell lung cancer (nsclc)
535904|NCT00890825|KRAS mutation|kras mutation
535905|NCT00890812|Acute Ischemic Stroke|acute ischemic stroke
535906|NCT00890799|transcatheter closure|transcatheter closure
535907|NCT00890799|ventricular septal defects|ventricular septal defects
535908|NCT00890760|Malaria|malaria
535909|NCT00890760|Vaccine|vaccine
535910|NCT00890747|HIV Infections|hiv infections
535911|NCT00890747|treatment experienced|treatment experienced
535912|NCT00890721|Hemorrhoid|hemorrhoid
535913|NCT00890721|Hemorrhoidectomy|hemorrhoidectomy
535914|NCT00890721|Postoperative pain|postoperative pain
535915|NCT00890721|Analgesia|analgesia
535916|NCT00890695|supplementary feeding|supplementary feeding
535917|NCT00890695|moderate malnutrition|moderate malnutrition
535918|NCT00890695|acute infection|acute infection
535919|NCT00890695|developing country|developing country
535920|NCT00890695|children|children
535921|NCT00890682|Bunion|bunion
535922|NCT00890682|Bunionectomy|bunionectomy
535923|NCT00890682|Osteotomy|osteotomy
535924|NCT00890669|treadmill training|treadmill training
535925|NCT00890669|body load|body load
535926|NCT00890669|quality of life|quality of life
535927|NCT00890669|Parkinson's disease|parkinson's disease
535928|NCT00890669|Motor Symptoms|motor symptoms
535929|NCT00890656|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
535930|NCT00890656|ALL|all
535931|NCT00890656|Leukemia|leukemia
535932|NCT00890656|Hyper-CVAD|hyper-cvad
535933|NCT00890643|Stress disorders, post-traumatic|stress disorders, post-traumatic
535934|NCT00890643|Combat Disorders|combat disorders
535935|NCT00890643|prazosin|prazosin
535936|NCT00890643|cognition|cognition
535937|NCT00890643|neurophysiology|neurophysiology
535938|NCT00890617|lung metastases|lung metastases
535939|NCT00890617|stage I non-small cell lung cancer|stage i non-small cell lung cancer
535940|NCT00890591|hypertension|hypertension
535941|NCT00890591|angiotensin II type 1 receptor blocker|angiotensin ii type 1 receptor blocker
535942|NCT00890591|olmesartan|olmesartan
535943|NCT00890578|Histoacryl|histoacryl
535944|NCT00890578|closure of surgical incisions|closure of surgical incisions
535945|NCT00890565|Electrocardiogram|electrocardiogram
535946|NCT00890565|Effect on electrocardiogram|effect on electrocardiogram
535947|NCT00890565|Granisetron|granisetron
535948|NCT00890565|Moxifloxacin|moxifloxacin
535949|NCT00890565|Pharmacokinetic profile|pharmacokinetic profile
535950|NCT00890565|Sancuso® patch|sancuso® patch
535951|NCT00890565|Transdermal|transdermal
535952|NCT00890526|Tinnitus Retraining Therapy (TRT)|tinnitus retraining therapy (trt)
535953|NCT00890474|Breech presentation at 34 to 36 weeks of gestation|breech presentation at 34 to 36 weeks of gestation
535954|NCT00890461|ECG|ecg
535955|NCT00890461|ICD|icd
535956|NCT00890448|Alanine Transaminase elevation|alanine transaminase elevation
535957|NCT00890448|Genetic Markers|genetic markers
535958|NCT00890448|DNA Markers|dna markers
535959|NCT00890435|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
535960|NCT00890435|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
535961|NCT00890435|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
535962|NCT00890435|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
535963|NCT00890435|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
535964|NCT00890435|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
535965|NCT00890435|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
535966|NCT00890435|recurrent childhood ependymoma|recurrent childhood ependymoma
535967|NCT00890435|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
535968|NCT00890435|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
535969|NCT00890435|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
535970|NCT00890435|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
535971|NCT00890435|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
535972|NCT00890435|childhood choroid plexus tumor|childhood choroid plexus tumor
535973|NCT00890435|childhood craniopharyngioma|childhood craniopharyngioma
535974|NCT00890435|childhood ependymoblastoma|childhood ependymoblastoma
535975|NCT00890435|childhood medulloepithelioma|childhood medulloepithelioma
535976|NCT00890435|childhood meningioma|childhood meningioma
535977|NCT00890435|childhood mixed glioma|childhood mixed glioma
535978|NCT00890435|childhood oligodendroglioma|childhood oligodendroglioma
535979|NCT00890435|adult astrocytic tumors|adult astrocytic tumors
535980|NCT00890435|adult brain stem glioma|adult brain stem glioma
535981|NCT00890435|adult choroid plexus tumor|adult choroid plexus tumor
535982|NCT00890435|adult craniopharyngioma|adult craniopharyngioma
535983|NCT00890435|adult ependymoblastoma|adult ependymoblastoma
535984|NCT00890435|adult medulloblastoma|adult medulloblastoma
535985|NCT00890435|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
535986|NCT00890435|adult ependymal tumors|adult ependymal tumors
535987|NCT00890435|adult meningeal tumor|adult meningeal tumor
535988|NCT00890435|adult mixed glioma|adult mixed glioma
535989|NCT00890435|adult oligodendroglial tumors|adult oligodendroglial tumors
535990|NCT00890435|adult pineal parenchymal tumor|adult pineal parenchymal tumor
535991|NCT00890435|recurrent adult brain tumor|recurrent adult brain tumor
535992|NCT00890435|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
535993|NCT00890435|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
535994|NCT00890435|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
535995|NCT00890435|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
535996|NCT00890435|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
535997|NCT00890435|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
535998|NCT00890435|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
535999|NCT00890435|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
536000|NCT00890435|secondary acute myeloid leukemia|secondary acute myeloid leukemia
536001|NCT00890435|acute undifferentiated leukemia|acute undifferentiated leukemia
536002|NCT00890435|mast cell leukemia|mast cell leukemia
536003|NCT00890435|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
536004|NCT00890435|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
536005|NCT00890435|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
536006|NCT00890435|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
536007|NCT00890435|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
536008|NCT00890435|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
536009|NCT00890435|refractory hairy cell leukemia|refractory hairy cell leukemia
536010|NCT00890435|prolymphocytic leukemia|prolymphocytic leukemia
536011|NCT00890422|encephalitis|encephalitis
536012|NCT00890422|FSME|fsme
536013|NCT00890422|central european encephalitis|central european encephalitis
536014|NCT00890409|hypothermia|hypothermia
536015|NCT00890409|neonate|neonate
536016|NCT00890409|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
536017|NCT00890409|efficacy|efficacy
536018|NCT00890409|safety|safety
536019|NCT00890396|Sickle Cell Anemia|sickle cell anemia
536020|NCT00890396|Hydroxyurea|hydroxyurea
536021|NCT00890383|trauma resuscitation|trauma resuscitation
536022|NCT00890383|abdominal hypertension|abdominal hypertension
536023|NCT00890383|abdominal compartment syndrome|abdominal compartment syndrome
536024|NCT00890370|Cystic fibrosis|cystic fibrosis
536025|NCT00890370|Airway clearance|airway clearance
536026|NCT00890344|PeaPod|peapod
536028|NCT00890344|Anthropometry|anthropometry
536029|NCT00890344|Body Composition|body composition
536030|NCT00890344|Fat Mass|fat mass
536031|NCT00890344|Total Body Water|total body water
536032|NCT00890344|Neonatology|neonatology
536033|NCT00890305|Metastatic colorectal cancer|metastatic colorectal cancer
536034|NCT00890305|FOLFOX chemotherapy|folfox chemotherapy
536035|NCT00890292|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
536036|NCT00890292|ADHD|adhd
536037|NCT00890292|JNJ-31001074|jnj-31001074
536038|NCT00890279|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
536039|NCT00890279|Hypertension|hypertension
536040|NCT00890279|Angiotensin-II Receptor Blocker|angiotensin-ii receptor blocker
536041|NCT00890279|Calcium Channel Blocker|calcium channel blocker
536042|NCT00890279|Angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
536043|NCT00890279|Kidney Volume|kidney volume
536044|NCT00890279|eGFR|egfr
536045|NCT00890266|keratoconus|keratoconus
536046|NCT00890266|collagen cross-linking|collagen cross-linking
536047|NCT00890266|riboflavin|riboflavin
536048|NCT00890266|UV light|uv light
536049|NCT00890253|Renal impairment|renal impairment
536050|NCT00890253|Liver transplantation|liver transplantation
536051|NCT00890253|Chronic Renal Insufficiency|chronic renal insufficiency
536052|NCT00890240|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
536053|NCT00890240|ADHD|adhd
536054|NCT00890240|JNJ-31001074|jnj-31001074
536055|NCT00890227|scoliosis|scoliosis
536056|NCT00890227|kyphosis|kyphosis
536057|NCT00890227|Surgical treatment|surgical treatment
536058|NCT00890214|Anticoagulation|anticoagulation
536059|NCT00890214|Prostacyclin|prostacyclin
536060|NCT00890214|Heparin|heparin
536061|NCT00890214|Renal Replacement Therapy|renal replacement therapy
536062|NCT00890214|Kidney failure acute|kidney failure acute
536063|NCT00890214|Platelet aggregation|platelet aggregation
536064|NCT00890201|Pancreaticobiliary reflux|pancreaticobiliary reflux
536065|NCT00890201|Normal pancreaticobiliary junction|normal pancreaticobiliary junction
536066|NCT00890201|Gallstones|gallstones
536067|NCT00890201|Cholelithiasis|cholelithiasis
536068|NCT00890201|Cholecystectomy|cholecystectomy
536069|NCT00890188|THALIDOMIDE|thalidomide
536070|NCT00890188|UFUR|ufur
536071|NCT00890188|Colorectal cancer|colorectal cancer
536072|NCT00890188|Oxaliplatin|oxaliplatin
536073|NCT00890175|Asthma, Staccato loxapine|asthma, staccato loxapine
536074|NCT00890162|Omalizumab|omalizumab
536075|NCT00890162|Idiopathic Anaphylaxis|idiopathic anaphylaxis
536076|NCT00890162|Serum Tryptase|serum tryptase
536077|NCT00890162|Placebo-Controlled|placebo-controlled
536078|NCT00890162|Adult|adult
536079|NCT00890162|Anaphylaxis|anaphylaxis
536080|NCT00890162|Allergic Reaction|allergic reaction
536081|NCT00890149|alcohol abuse|alcohol abuse
536082|NCT00890149|binge drinking|binge drinking
536083|NCT00890149|severe drinking|severe drinking
536084|NCT00890149|alcoholism|alcoholism
536085|NCT00890149|heavy drinking|heavy drinking
536086|NCT00890136|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
536087|NCT00890123|Omega 3 Fatty Acids|omega 3 fatty acids
536088|NCT00890123|Inflammation|inflammation
536089|NCT00890123|Hip Surgery|hip surgery
536090|NCT00890123|Inflammatory status|inflammatory status
536091|NCT00890123|Infectious complications|infectious complications
536092|NCT00890110|Renal cell cancer|renal cell cancer
536094|NCT00890110|autologous vaccine|autologous vaccine
536095|NCT00890110|metastatic RCC|metastatic rcc
536096|NCT00890097|Geographic Atrophy|geographic atrophy
536097|NCT00890097|GA|ga
536098|NCT00890097|Age-Related Macular Degeneration|age-related macular degeneration
536099|NCT00890097|AMD|amd
536100|NCT00890071|Fluid responsiveness|fluid responsiveness
536101|NCT00890071|Ultrasound|ultrasound
536102|NCT00890071|Cardiac output|cardiac output
536103|NCT00890058|Arthritis|arthritis
536104|NCT00890058|Synovitis|synovitis
536105|NCT00890058|Aromatase Inhibitor|aromatase inhibitor
536106|NCT00890058|Arthralgia Syndrome|arthralgia syndrome
536107|NCT00890045|Vascular access hemodialysis|vascular access hemodialysis
536108|NCT00890045|ePTFE graft|eptfe graft
536109|NCT00890045|Graft-eligible|graft-eligible
536110|NCT00890045|Long-term vascular access for hemodialysis|long-term vascular access for hemodialysis
536111|NCT00890032|adult giant cell glioblastoma|adult giant cell glioblastoma
536112|NCT00890032|adult glioblastoma|adult glioblastoma
536113|NCT00890032|adult gliosarcoma|adult gliosarcoma
536114|NCT00890032|adult astrocytoma|adult astrocytoma
536115|NCT00890032|recurrent adult brain tumor|recurrent adult brain tumor
536116|NCT00890006|Prostate cancer|prostate cancer
536117|NCT00890006|Magnetic resonance imaging|magnetic resonance imaging
536118|NCT00889993|Food intake|food intake
536119|NCT00889993|Gut hormones|gut hormones
536120|NCT00889993|Fiber|fiber
536121|NCT00889993|Visual analog scales|visual analog scales
536122|NCT00889967|Pseudomonas aeruginosa|pseudomonas aeruginosa
536123|NCT00889967|antimicrobial|antimicrobial
536124|NCT00889967|inhalation|inhalation
536125|NCT00889967|ciprofloxacin|ciprofloxacin
536126|NCT00889967|Non-Cystic Fibrosis Bronchiectasis|non-cystic fibrosis bronchiectasis
536127|NCT00889954|EBV+|ebv+
536128|NCT00889954|Her2|her2
536129|NCT00889954|TGFBeta|tgfbeta
536130|NCT00889954|EBV positive|ebv positive
536131|NCT00889954|HER 2 positive malignancy|her 2 positive malignancy
536132|NCT00889954|cytotoxic T lymphocytes|cytotoxic t lymphocytes
536133|NCT00889928|gallbladder disease|gallbladder disease
536134|NCT00889928|cholecystectomy|cholecystectomy
536135|NCT00889928|gallbladder disease indicated for cholecystectomy|gallbladder disease indicated for cholecystectomy
536136|NCT00889915|ADHD|adhd
536137|NCT00889915|Methylphenidate|methylphenidate
536138|NCT00889915|Amphetamine|amphetamine
536139|NCT00889902|Molecular Markers|molecular markers
536140|NCT00889902|Cervical Cancer|cervical cancer
536141|NCT00889902|Screening|screening
536142|NCT00889902|Makov|makov
536143|NCT00889889|Influenza|influenza
536144|NCT00889889|Phase II|phase ii
536145|NCT00889889|Placebo-controlled|placebo-controlled
536146|NCT00889876|Obesity|obesity
536147|NCT00889876|Adolescents|adolescents
536148|NCT00889876|Nocturnal blood pressure reduction|nocturnal blood pressure reduction
536149|NCT00889876|Insulin metabolism|insulin metabolism
536150|NCT00889876|Cardiovascular structure and function|cardiovascular structure and function
536151|NCT00889876|Treatment|treatment
536152|NCT00889876|Exercise|exercise
536153|NCT00889876|Metformin|metformin
536154|NCT00889876|Insulin|insulin
536155|NCT00889876|Blood glucose|blood glucose
536156|NCT00889876|Impaired nocturnal blood pressure reduction|impaired nocturnal blood pressure reduction
536157|NCT00889863|Flare|flare
536158|NCT00889863|arthritis|arthritis
536159|NCT00889863|IL-1beta antagonist|il-1beta antagonist
536160|NCT00889863|systemic juvenile idiopathic arthritis|systemic juvenile idiopathic arthritis
536161|NCT00889863|Juvenile rheumatoid|juvenile rheumatoid
536162|NCT00889850|Healthy|healthy
536163|NCT00889850|Bioavailability|bioavailability
536164|NCT00889850|Bioequivalence|bioequivalence
536165|NCT00889850|Esomeprazole|esomeprazole
536166|NCT00889850|Bioavailability, Therapeutical Indication Not Studied|bioavailability, therapeutical indication not studied
536167|NCT00889837|Staccato Loxapine|staccato loxapine
536168|NCT00889837|COPD|copd
536169|NCT00889837|pulmonary safety|pulmonary safety
536170|NCT00889824|Chronic imbalance|chronic imbalance
536171|NCT00889824|vestibular disorders|vestibular disorders
536172|NCT00889824|balance prosthesis|balance prosthesis
536173|NCT00889811|OPCAB|opcab
536174|NCT00889811|RIPC|ripc
536175|NCT00889798|Malignant lymphatic disease|malignant lymphatic disease
536176|NCT00889798|therapy-reality|therapy-reality
536177|NCT00889798|observation|observation
536178|NCT00889798|registry|registry
536179|NCT00889798|therapy sequences|therapy sequences
536180|NCT00889798|NHL|nhl
536181|NCT00889798|CLL|cll
536182|NCT00889798|Germany|germany
536183|NCT00889798|lenalidomide|lenalidomide
536184|NCT00889798|alemtuzumab|alemtuzumab
536185|NCT00889798|rituximab|rituximab
536186|NCT00889798|bendamustin|bendamustin
536187|NCT00889798|thalidomide|thalidomide
536188|NCT00889798|bortezomib|bortezomib
536189|NCT00889798|ibritumomab-tiuxetan|ibritumomab-tiuxetan
536190|NCT00889798|G-CSF (Granulocyte-Colony Stimulating Factor)|g-csf (granulocyte-colony stimulating factor)
536191|NCT00889798|chronic lymphocytic leukaemia|chronic lymphocytic leukaemia
536192|NCT00889798|follicular lymphoma|follicular lymphoma
536358|NCT00889265|Periodontal Surgery|periodontal surgery
536359|NCT00889239|ceramic|ceramic
536193|NCT00889798|gastric MALT lymphoma (Mucosa Associated Lymphoid Tissue)|gastric malt lymphoma (mucosa associated lymphoid tissue)
536194|NCT00889798|nongastric MALT lymphoma (Mucosa Associated Lymphoid Tissue)|nongastric malt lymphoma (mucosa associated lymphoid tissue)
536195|NCT00889798|nodal marginal zone lymphoma|nodal marginal zone lymphoma
536196|NCT00889798|splenic marginal zone lymphoma|splenic marginal zone lymphoma
536197|NCT00889798|mantle cell lymphoma|mantle cell lymphoma
536198|NCT00889798|diffuse large b-cell lymphoma|diffuse large b-cell lymphoma
536199|NCT00889785|Adolescents|adolescents
536200|NCT00889785|Type 2 Diabetes|type 2 diabetes
536201|NCT00889785|Behavioral Research|behavioral research
536202|NCT00889772|Respiratory distress, adult|respiratory distress, adult
536203|NCT00889772|risk|risk
536204|NCT00889772|emergency room|emergency room
536205|NCT00889772|high risk surgery|high risk surgery
536206|NCT00889772|sepsis|sepsis
536207|NCT00889772|trauma|trauma
536208|NCT00889772|aspiration|aspiration
536209|NCT00889772|pneumonia|pneumonia
536210|NCT00889759|Tuberculosis|tuberculosis
536211|NCT00889759|Outbreaks|outbreaks
536212|NCT00889720|smoking cessation|smoking cessation
536213|NCT00889720|varenicline|varenicline
536214|NCT00889720|elective surgery|elective surgery
536215|NCT00889720|wound infections|wound infections
536216|NCT00889720|post-operative complications|post-operative complications
536217|NCT00889707|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
536218|NCT00889707|BPH|bph
536219|NCT00889707|Enlarged Prostate|enlarged prostate
536220|NCT00889668|Glucose monitoring|glucose monitoring
536221|NCT00889668|GlucoTrack|glucotrack
536222|NCT00889668|Self glucose monitoring|self glucose monitoring
536223|NCT00889655|efficacy of bowel cleansing|efficacy of bowel cleansing
536224|NCT00889655|patient tolerability|patient tolerability
536225|NCT00889655|Golytely|golytely
536226|NCT00889655|MiraLax|miralax
536227|NCT00889655|colonoscopy preparation|colonoscopy preparation
536228|NCT00889655|bowel preparation|bowel preparation
536229|NCT00889655|screening colonoscopy|screening colonoscopy
536230|NCT00889629|kidney transplantation|kidney transplantation
536231|NCT00889629|kidney transplant recipients|kidney transplant recipients
536232|NCT00889616|Malaria|malaria
536233|NCT00889616|Asexual Blood Stafe|asexual blood stafe
536234|NCT00889616|Plasmodium Falciparum|plasmodium falciparum
536235|NCT00889616|Immunogenicity|immunogenicity
536236|NCT00889616|Safety|safety
536237|NCT00889616|Vaccine|vaccine
536238|NCT00889603|Aricept® Evess|aricept® evess
536239|NCT00889603|non-interventional study|non-interventional study
536240|NCT00889603|Alzheimer's Disease|alzheimer's disease
536241|NCT00889603|Vascular Dementia|vascular dementia
536242|NCT00889603|efficacy|efficacy
536243|NCT00889603|tolerability|tolerability
536244|NCT00889603|safety.|safety.
536246|NCT00889590|Bisfosfonates|bisfosfonates
536247|NCT00889564|Vascular access for hemodialysis|vascular access for hemodialysis
536248|NCT00889564|Catheter dependent patients|catheter dependent patients
536249|NCT00889564|Access challenged patients|access challenged patients
536250|NCT00889564|Bacteremia|bacteremia
536251|NCT00889564|HeRO Vascular Access Device|hero vascular access device
536252|NCT00889538|Autism|autism
536253|NCT00889538|Severe Behavior Disorder|severe behavior disorder
536254|NCT00889538|Glutathione|glutathione
536255|NCT00889538|Antioxidants|antioxidants
536256|NCT00889525|Cabergoline|cabergoline
536257|NCT00889486|gastroparesis|gastroparesis
536258|NCT00889486|diabetes mellitus|diabetes mellitus
536259|NCT00889486|delayed gastric emptying|delayed gastric emptying
536260|NCT00889473|larazotide acetate|larazotide acetate
536261|NCT00889473|gluten|gluten
536262|NCT00889460|rBet v 1|rbet v 1
536263|NCT00889460|Birch pollen allergy|birch pollen allergy
536264|NCT00889460|Sublingual Immunotherapy|sublingual immunotherapy
536265|NCT00889447|Chronic Obstructive Pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
536266|NCT00889434|Cystic fibrosis|cystic fibrosis
536267|NCT00889434|splicing mutations|splicing mutations
536268|NCT00889434|molecular therapy|molecular therapy
536269|NCT00889434|EGCG|egcg
536270|NCT00889434|Tocotrienol|tocotrienol
536271|NCT00889434|Splicing-mutation-mediated Cystic Fibrosis|splicing-mutation-mediated cystic fibrosis
536272|NCT00889421|uveitis|uveitis
536273|NCT00889421|apremilast|apremilast
536274|NCT00889408|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
536275|NCT00889408|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
536276|NCT00889408|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
536277|NCT00889408|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
536278|NCT00889408|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
536279|NCT00889408|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
536280|NCT00889408|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
536281|NCT00889408|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
536282|NCT00889408|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
536283|NCT00889408|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
536284|NCT00889408|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
536285|NCT00889408|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
536286|NCT00889408|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
536287|NCT00889408|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
536288|NCT00889408|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
536289|NCT00889408|secondary acute myeloid leukemia|secondary acute myeloid leukemia
536290|NCT00889408|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
536291|NCT00889408|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
536292|NCT00889408|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
536293|NCT00889408|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
536294|NCT00889408|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
536295|NCT00889408|Waldenström macroglobulinemia|waldenström macroglobulinemia
536296|NCT00889408|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
536297|NCT00889408|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
536298|NCT00889408|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
536299|NCT00889408|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
536300|NCT00889408|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
536301|NCT00889408|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
536302|NCT00889408|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
536303|NCT00889408|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
536304|NCT00889408|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
536305|NCT00889408|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
536306|NCT00889408|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
536307|NCT00889408|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
536308|NCT00889408|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
536309|NCT00889408|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
536310|NCT00889408|splenic marginal zone lymphoma|splenic marginal zone lymphoma
536311|NCT00889408|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
536312|NCT00889408|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
536313|NCT00889408|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
536314|NCT00889408|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
536315|NCT00889408|childhood Burkitt lymphoma|childhood burkitt lymphoma
536316|NCT00889408|intraocular lymphoma|intraocular lymphoma
536317|NCT00889408|noncutaneous extranodal lymphoma|noncutaneous extranodal lymphoma
536318|NCT00889408|prolymphocytic leukemia|prolymphocytic leukemia
536319|NCT00889395|MISC|misc
536320|NCT00889395|caregivers|caregivers
536321|NCT00889395|children|children
536322|NCT00889395|psychosocial gains|psychosocial gains
536323|NCT00889395|cognitive benefits|cognitive benefits
536324|NCT00889382|Ovarian Cancer|ovarian cancer
536325|NCT00889382|Ovarian|ovarian
536326|NCT00889382|Paclitaxel|paclitaxel
536327|NCT00889382|OSI-906|osi-906
536328|NCT00889382|IGF-1R|igf-1r
536329|NCT00889382|Solid Tumors|solid tumors
536330|NCT00889369|depression|depression
536331|NCT00889369|duloxetine|duloxetine
536332|NCT00889369|menopause|menopause
536333|NCT00889369|imaging|imaging
536334|NCT00889369|FMRI|fmri
536335|NCT00889369|Menopausal staging|menopausal staging
536336|NCT00889369|vasomotor symptoms|vasomotor symptoms
536337|NCT00889343|Second-line therapy of metastatic colorectal cancer|second-line therapy of metastatic colorectal cancer
536338|NCT00889343|Sorafenib|sorafenib
536339|NCT00889343|Colorectal Neoplasms|colorectal neoplasms
536340|NCT00889343|palliative therapy|palliative therapy
536341|NCT00889343|after progression of firstline therapy with an Oxaliplatin- or Irinotecan based Fluoropyrimidine containing regimen ± bevacizumab|after progression of firstline therapy with an oxaliplatin- or irinotecan based fluoropyrimidine containing regimen ± bevacizumab
536342|NCT00889304|HTO, high tibial osteotomy, open wedge, medial arthritis|hto, high tibial osteotomy, open wedge, medial arthritis
536343|NCT00889291|End stage renal disease|end stage renal disease
536344|NCT00889291|Bacteremia|bacteremia
536345|NCT00889291|HeRO Vascular Access Device|hero vascular access device
536346|NCT00889291|Access challenged|access challenged
536347|NCT00889291|Catheter dependent|catheter dependent
536348|NCT00889291|End stage renal disease requiring vascular access. See HeRO device instructions for use for appropriate patient population|end stage renal disease requiring vascular access. see hero device instructions for use for appropriate patient population
536349|NCT00889278|Lymphoma|lymphoma
536350|NCT00889278|Autologous Peripheral Blood Stem Cell Transplant|autologous peripheral blood stem cell transplant
536351|NCT00889278|APBSCT|apbsct
536352|NCT00889278|Pneumococcal Conjugate Vaccine|pneumococcal conjugate vaccine
536353|NCT00889265|Alveolar Bone Augmentation|alveolar bone augmentation
536354|NCT00889265|Implant Surgery|implant surgery
536355|NCT00889265|Guided Bone Regeneration (GBR)|guided bone regeneration (gbr)
536356|NCT00889265|Guided Tissue Regeneration (GTR)|guided tissue regeneration (gtr)
536360|NCT00889239|wear rate|wear rate
536361|NCT00889239|opposing enamel|opposing enamel
536362|NCT00889226|pitavastatin|pitavastatin
536363|NCT00889226|PWV|pwv
536364|NCT00889226|ESPRIT|esprit
536365|NCT00889226|Pitavastatin and Atorvastatin|pitavastatin and atorvastatin
536366|NCT00889226|Adiponectin|adiponectin
536367|NCT00889226|fasting insulin|fasting insulin
536368|NCT00889226|hs-CRP|hs-crp
536369|NCT00889226|baPWV|bapwv
536370|NCT00889213|pancreatectomy|pancreatectomy
536371|NCT00889213|fistula|fistula
536372|NCT00889213|fibrin glue|fibrin glue
536373|NCT00889213|falciform patch|falciform patch
536374|NCT00889213|surgery|surgery
536375|NCT00889213|complications|complications
536376|NCT00889187|radiation therapy|radiation therapy
536377|NCT00889187|capecitabine|capecitabine
536378|NCT00889174|Genetic Disorders of the White Matter|genetic disorders of the white matter
536379|NCT00889174|Leukodystrophies|leukodystrophies
536380|NCT00889174|Myelin|myelin
536381|NCT00889174|White Matter Disorder|white matter disorder
536382|NCT00889174|Genetic Disorder|genetic disorder
536383|NCT00889161|Crohn's disease|crohn's disease
536384|NCT00889161|ulcerative colitis|ulcerative colitis
536385|NCT00889161|curcumin|curcumin
536386|NCT00889161|pediatric|pediatric
536387|NCT00889161|inflammatory bowel disease|inflammatory bowel disease
536388|NCT00889148|hip|hip
536389|NCT00889148|arthroplasty|arthroplasty
536390|NCT00889148|postoperative pain|postoperative pain
536391|NCT00889148|gabapentin|gabapentin
536392|NCT00889122|Obesity|obesity
536393|NCT00889122|Exergames|exergames
536394|NCT00889122|Videogames|videogames
536395|NCT00889122|Prevention|prevention
536396|NCT00889122|Family|family
536397|NCT00889122|Dance Dance Revolution|dance dance revolution
536398|NCT00889122|Pedometer|pedometer
536399|NCT00889096|memory|memory
536400|NCT00889096|heart rate|heart rate
536401|NCT00889096|skin conductance|skin conductance
536402|NCT00889096|α-amylase|α-amylase
536403|NCT00889096|propranolol|propranolol
536404|NCT00889096|tolerability|tolerability
536405|NCT00889083|Sepsis|sepsis
536406|NCT00889083|Peritonitis|peritonitis
536407|NCT00889083|Mitochondria|mitochondria
536408|NCT00889083|Liver|liver
536409|NCT00889057|osteosarcoma|osteosarcoma
536410|NCT00889057|sorafenib|sorafenib
536411|NCT00889057|target therapy|target therapy
536412|NCT00889031|CLL|cll
536413|NCT00889018|intraocular retinoblastoma|intraocular retinoblastoma
536414|NCT00889018|chemotherapy|chemotherapy
536415|NCT00889005|Post-traumatic Stress Disorder|post-traumatic stress disorder
536416|NCT00889005|Acute Stress Disorder|acute stress disorder
536417|NCT00889005|Cognitive behavioral therapy|cognitive behavioral therapy
536418|NCT00889005|Secondary Prevention|secondary prevention
536419|NCT00889005|Anxiety disorders|anxiety disorders
536420|NCT00889005|Service Delivery|service delivery
536421|NCT00888992|Smoking|smoking
536422|NCT00888992|Cessation|cessation
536423|NCT00888992|Quitline|quitline
536424|NCT00888992|Counseling|counseling
536425|NCT00888979|Smoking Cessation during Pregnancy|smoking cessation during pregnancy
536426|NCT00888979|Nicotrol Inhaler|nicotrol inhaler
536427|NCT00888966|heart arrest|heart arrest
536428|NCT00888966|oxidative stress|oxidative stress
536429|NCT00888966|lactic acid|lactic acid
536430|NCT00888966|outcome|outcome
536431|NCT00888953|Falls|falls
536432|NCT00888953|Nursing Homes|nursing homes
536433|NCT00888953|Elderly|elderly
536434|NCT00888953|Prevention|prevention
536435|NCT00888953|Spain|spain
536436|NCT00888953|Cluster Randomized Clinical Trial|cluster randomized clinical trial
536437|NCT00888927|T-Cell Lymphoma|t-cell lymphoma
536438|NCT00888927|PTCL|ptcl
536439|NCT00888927|CTCL|ctcl
536440|NCT00888914|Lateral Canthal Lines|lateral canthal lines
536441|NCT00888914|Crow's Feet|crow's feet
536442|NCT00888914|Facial Wrinkles|facial wrinkles
536443|NCT00888901|ITP|itp
536444|NCT00888901|eltrombopag|eltrombopag
536445|NCT00888901|platelet function|platelet function
536446|NCT00888901|thrombocytopenia|thrombocytopenia
536447|NCT00888901|Platelet function in patients with cAITP on eltrombopag|platelet function in patients with caitp on eltrombopag
536448|NCT00888888|Acute appendicitis|acute appendicitis
536449|NCT00888888|Colonic diverticulitis|colonic diverticulitis
536450|NCT00888888|Colonic tumors|colonic tumors
536451|NCT00888888|Colonic resections|colonic resections
536452|NCT00888875|i-gel|i-gel
536453|NCT00888875|Fastrach|fastrach
536454|NCT00888875|intubation|intubation
536455|NCT00888875|fiberoptic|fiberoptic
536456|NCT00888875|difficult airway|difficult airway
536457|NCT00888875|Patients undergoing elective surgery requiring tracheal intubation|patients undergoing elective surgery requiring tracheal intubation
536458|NCT00888875|Presenting at least one sign of difficult intubation|presenting at least one sign of difficult intubation
536459|NCT00888862|depression|depression
536460|NCT00888862|desvenlafaxine|desvenlafaxine
536461|NCT00888862|menopause|menopause
536462|NCT00888862|imaging|imaging
536463|NCT00888862|FMRI|fmri
536464|NCT00888849|Stapling|stapling
536765|NCT00887458|rising PSA|rising psa
536465|NCT00888849|hand sutured anastamosis|hand sutured anastamosis
536466|NCT00888849|colorectal disease|colorectal disease
536467|NCT00888836|bariatric surgery|bariatric surgery
536468|NCT00888836|GBP|gbp
536469|NCT00888836|BPD|bpd
536470|NCT00888836|type 2 diabetes|type 2 diabetes
536471|NCT00888823|Fractionated stereotactic radiotherapy|fractionated stereotactic radiotherapy
536472|NCT00888823|Medically inoperable|medically inoperable
536473|NCT00888823|Image-guided radiotherapy|image-guided radiotherapy
536474|NCT00888810|ovarian - cancer - relapse - topotecan - lapatinib|ovarian - cancer - relapse - topotecan - lapatinib
536475|NCT00888771|Colorectal cancer|colorectal cancer
536476|NCT00888771|polyps|polyps
536477|NCT00888771|colonoscopy|colonoscopy
536478|NCT00888771|advanced imaging|advanced imaging
536479|NCT00888758|Stents|stents
536480|NCT00888745|RA|ra
536481|NCT00888732|Diabetes|diabetes
536482|NCT00888680|Migraine|migraine
536483|NCT00888680|Headaches|headaches
536484|NCT00888680|Migraine headaches|migraine headaches
536485|NCT00888680|Head pain|head pain
536486|NCT00888667|ICD patients with PVCs and EGM recordings|icd patients with pvcs and egm recordings
536487|NCT00888654|adenocarcinoma of the prostate|adenocarcinoma of the prostate
536488|NCT00888654|stage I prostate cancer|stage i prostate cancer
536489|NCT00888654|stage II prostate cancer|stage ii prostate cancer
536490|NCT00888628|Type I diabetes|type i diabetes
536491|NCT00888628|Islet after Kidney Transplant|islet after kidney transplant
536492|NCT00888628|Islet transplantation|islet transplantation
536493|NCT00888589|MBI|mbi
536494|NCT00888589|Molecular Breast Imaging|molecular breast imaging
536495|NCT00888589|Breast|breast
536496|NCT00888589|Breast Cancer|breast cancer
536497|NCT00888589|Molecular Imaging|molecular imaging
536498|NCT00888563|Fatigue|fatigue
536499|NCT00888563|Depression|depression
536500|NCT00888563|Healthy Volunteer|healthy volunteer
536501|NCT00888563|HV|hv
536502|NCT00888537|Decision aid|decision aid
536503|NCT00888537|Heart attack|heart attack
536504|NCT00888537|myocardial infarction|myocardial infarction
536505|NCT00888524|head out water immersion,|head out water immersion,
536506|NCT00888524|high intensity exercise,|high intensity exercise,
536507|NCT00888524|evidence-based physiotherapy;|evidence-based physiotherapy;
536508|NCT00888524|aquatics;|aquatics;
536509|NCT00888524|hydrotherapy|hydrotherapy
536510|NCT00888524|aquatics therapy|aquatics therapy
536511|NCT00888524|exercise therapy|exercise therapy
536512|NCT00888511|Lung cancer|lung cancer
536513|NCT00888511|Non-small cell lung cancer|non-small cell lung cancer
536514|NCT00888511|Tarceva|tarceva
536515|NCT00888511|Radiotherapy|radiotherapy
536516|NCT00888511|Local-regionally advanced non-small cell lung cancer|local-regionally advanced non-small cell lung cancer
536517|NCT00888498|Sprains and Strains|sprains and strains
536518|NCT00888498|Ankle|ankle
536519|NCT00888498|Manual Therapies|manual therapies
536520|NCT00888498|Outcome Studies|outcome studies
536521|NCT00888472|Extracorporeal leukocytapheresis|extracorporeal leukocytapheresis
536522|NCT00888459|tobacco|tobacco
536523|NCT00888459|chew|chew
536524|NCT00888459|nrt|nrt
536525|NCT00888459|nicotine lozenges|nicotine lozenges
536526|NCT00888459|self-help|self-help
536527|NCT00888446|HIV|hiv
536528|NCT00888446|HIV seronegativity|hiv seronegativity
536529|NCT00888446|preventative vaccine|preventative vaccine
536530|NCT00888433|hypertension|hypertension
536531|NCT00888433|renal denervation|renal denervation
536532|NCT00888433|sympathetic nervous system|sympathetic nervous system
536533|NCT00888433|RDN|rdn
536534|NCT00888420|Chronic Pain|chronic pain
536535|NCT00888407|Asian American Health|asian american health
536536|NCT00888407|Cancer|cancer
536537|NCT00888407|Hepatitis|hepatitis
536538|NCT00888407|Hepatitis B|hepatitis b
536539|NCT00888407|Liver Cancer|liver cancer
536540|NCT00888394|chiropody|chiropody
536541|NCT00888394|podiatry|podiatry
536542|NCT00888394|insoles|insoles
536543|NCT00888394|foot orthesis|foot orthesis
536544|NCT00888342|Pulmonary Disease|pulmonary disease
536545|NCT00888342|Chronic Obstructive|chronic obstructive
536546|NCT00888342|Hypercapnia|hypercapnia
536547|NCT00888342|Hypoxemia|hypoxemia
536548|NCT00888342|Arrhythmias, Cardiac|arrhythmias, cardiac
536549|NCT00888342|Polysomnography|polysomnography
536550|NCT00888342|Capnography|capnography
536551|NCT00888342|Electrocardiography, Holter|electrocardiography, holter
536552|NCT00888329|Elective hysterectomy|elective hysterectomy
536553|NCT00888316|iron overload|iron overload
536554|NCT00888290|metabolic acidosis|metabolic acidosis
536555|NCT00888290|chronic kidney disease|chronic kidney disease
536556|NCT00888290|Estimated GFR 15-45|estimated gfr 15-45
536557|NCT00888264|Antipsychotics|antipsychotics
536558|NCT00888264|Bipolar Disorder|bipolar disorder
536559|NCT00888264|Depressive episodes|depressive episodes
536560|NCT00888264|Bipolar I or II Disorders|bipolar i or ii disorders
536561|NCT00888251|Obesity|obesity
536562|NCT00888251|Meal replacement|meal replacement
536563|NCT00888251|Obesity treatment|obesity treatment
536564|NCT00888251|Weight management|weight management
536565|NCT00888225|Tennis elbow|tennis elbow
536566|NCT00888225|Epicondylitis|epicondylitis
536567|NCT00888225|Pain|pain
536568|NCT00888225|Muscle strength|muscle strength
536569|NCT00888225|Quality of life|quality of life
536570|NCT00888225|RCT|rct
536571|NCT00888225|Tendinitis|tendinitis
536572|NCT00888225|Chronic tennis elbow|chronic tennis elbow
536573|NCT00888199|amputation|amputation
536574|NCT00888199|amputee|amputee
536575|NCT00888199|prosthetic|prosthetic
536576|NCT00888199|foot|foot
536577|NCT00888199|prosthesis|prosthesis
536578|NCT00888199|Tensegrity|tensegrity
536579|NCT00888199|Prosthetics|prosthetics
536580|NCT00888199|K3 Promoter|k3 promoter
536581|NCT00888186|Dyskinesias|dyskinesias
536582|NCT00888186|Duodenal levodopa infusion|duodenal levodopa infusion
536583|NCT00888186|Dose optimization|dose optimization
536584|NCT00888186|Pharmacokinetics|pharmacokinetics
536585|NCT00888186|Pharmacodynamics|pharmacodynamics
536586|NCT00888147|Tube feeding|tube feeding
536587|NCT00888147|Fiber|fiber
536588|NCT00888147|Constipation|constipation
536589|NCT00888095|deep brain stimulation|deep brain stimulation
536590|NCT00888095|caudal Zona incerta|caudal zona incerta
536591|NCT00888095|Nucleus subthalamicus|nucleus subthalamicus
536592|NCT00888095|Parkinson's disease|parkinson's disease
536593|NCT00888095|randomized|randomized
536594|NCT00888095|blinded|blinded
536595|NCT00888095|Movement disorder|movement disorder
536596|NCT00888082|adjuvant chemotherapy|adjuvant chemotherapy
536597|NCT00888082|breast cancer|breast cancer
536598|NCT00888082|goserelin acetate|goserelin acetate
536599|NCT00888082|ovarian function|ovarian function
536600|NCT00888082|Chemotherapy|chemotherapy
536601|NCT00888082|Primary invasive breast cancer|primary invasive breast cancer
536602|NCT00888069|Parathyroid Diseases|parathyroid diseases
536603|NCT00888069|Renal Insufficiency|renal insufficiency
536604|NCT00888069|Kidney Failure, Chronic|kidney failure, chronic
536605|NCT00888069|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
536606|NCT00888069|Vitamin D|vitamin d
536607|NCT00888069|Hyperparathyroidism|hyperparathyroidism
536608|NCT00888069|Renal Insufficiency, Chronic|renal insufficiency, chronic
536609|NCT00888069|Kidney Diseases|kidney diseases
536610|NCT00888069|Kidney Failure|kidney failure
536611|NCT00888043|solid tumors|solid tumors
536612|NCT00888043|avastin|avastin
536613|NCT00888043|Phase I|phase i
536614|NCT00888043|combination therapy|combination therapy
536615|NCT00888043|bevacizumab|bevacizumab
536616|NCT00888030|p-cresol|p-cresol
536617|NCT00888030|indoxyl sulfate|indoxyl sulfate
536618|NCT00888030|chronic kidney disease|chronic kidney disease
536619|NCT00888030|outcome|outcome
536620|NCT00888017|bone density|bone density
536621|NCT00888017|proton pump inhibitors|proton pump inhibitors
536622|NCT00888017|premature infants|premature infants
536623|NCT00888004|Parkinson's|parkinson's
536624|NCT00888004|L-dopa|l-dopa
536625|NCT00888004|dyskinesia|dyskinesia
536626|NCT00887991|Randomised trial|randomised trial
536627|NCT00887991|breast pumps|breast pumps
536628|NCT00887991|efficacy|efficacy
536629|NCT00887991|preterm|preterm
536630|NCT00887991|Mothers of preterm infants who plan to express milk for their infants.|mothers of preterm infants who plan to express milk for their infants.
536631|NCT00887965|Low Bone Mass|low bone mass
536632|NCT00887965|Low Bone Mineral Density|low bone mineral density
536633|NCT00887965|Osteoporosis|osteoporosis
536634|NCT00887965|Postmenopausal Osteoporosis|postmenopausal osteoporosis
536635|NCT00887965|Bone Biopsy|bone biopsy
536636|NCT00887965|Transiliac Crest Bone Histology|transiliac crest bone histology
536637|NCT00887965|Histomorphometry|histomorphometry
536638|NCT00887952|Deep caries lesion|deep caries lesion
536639|NCT00887952|dentine caries removal|dentine caries removal
536640|NCT00887952|dental restoration|dental restoration
536641|NCT00887952|stepwise excavation|stepwise excavation
536642|NCT00887939|Physical Urticaria|physical urticaria
536643|NCT00887939|Pathogenesis|pathogenesis
536644|NCT00887939|Inflammasome|inflammasome
536645|NCT00887939|IL-1|il-1
536646|NCT00887939|Mast Cell|mast cell
536647|NCT00887939|Urticaria|urticaria
536649|NCT00887926|Leukemia|leukemia
536650|NCT00887926|Acute Myeloid Leukemia|acute myeloid leukemia
536651|NCT00887926|Antibodies, Monoclonal|antibodies, monoclonal
536652|NCT00887900|lamellar keratoplasty|lamellar keratoplasty
536653|NCT00887900|keratoconus|keratoconus
536654|NCT00887900|penetrated keratoplasty|penetrated keratoplasty
536655|NCT00887900|Visual acuity|visual acuity
536656|NCT00887887|liver surgery|liver surgery
536657|NCT00887887|gene polymorphisms|gene polymorphisms
536658|NCT00887887|innate immune response|innate immune response
536659|NCT00887887|infectious complications|infectious complications
536660|NCT00887887|post-resectional liver failure|post-resectional liver failure
536661|NCT00887887|mortality|mortality
536662|NCT00887861|epilepsy|epilepsy
536663|NCT00887861|seizure|seizure
536664|NCT00887861|monotherapy trials|monotherapy trials
536665|NCT00887861|partial seizure|partial seizure
536666|NCT00887861|Partial seizures and undergoing evaluation for epilepsy surgery|partial seizures and undergoing evaluation for epilepsy surgery
536667|NCT00887848|Child|child
536668|NCT00887848|Robotic-assisted treadmill training|robotic-assisted treadmill training
536669|NCT00887848|Rehabilitation|rehabilitation
536670|NCT00887835|PERPOS fusion|perpos fusion
536671|NCT00887809|Bevacizumab (avastin)|bevacizumab (avastin)
536672|NCT00887809|Gemcitabine|gemcitabine
536673|NCT00887809|Taxotere (docetaxel)|taxotere (docetaxel)
536674|NCT00887809|09-015|09-015
536675|NCT00887809|Soft tissue|soft tissue
536676|NCT00887783|Induction chemotherapy|induction chemotherapy
536677|NCT00887783|Non-small cell lung cancer|non-small cell lung cancer
536678|NCT00887783|Randomized phase II study|randomized phase ii study
536679|NCT00887783|Navelbine Oral (R)|navelbine oral (r)
536680|NCT00887783|3D-conformal radiotherapy|3d-conformal radiotherapy
536681|NCT00887783|Chemo-radiotherapy|chemo-radiotherapy
536682|NCT00887783|Local-regionally advanced non-small cell lung cancer|local-regionally advanced non-small cell lung cancer
536683|NCT00887770|QTcF|qtcf
536684|NCT00887770|Crossover|crossover
536685|NCT00887770|ICH E14|ich e14
536686|NCT00887770|QT/QTc prolongation|qt/qtc prolongation
536687|NCT00887770|Moxifloxacin|moxifloxacin
536688|NCT00887770|QT/QTc Interval|qt/qtc interval
536689|NCT00887744|Degenerative Lumbar Spinal Stenosis|degenerative lumbar spinal stenosis
536690|NCT00887744|Neurogenic Intermittent Claudication|neurogenic intermittent claudication
536691|NCT00887744|Interpinous Device|interpinous device
536692|NCT00887744|Percutaneous|percutaneous
536693|NCT00887731|closed loop oxygen controller|closed loop oxygen controller
536694|NCT00887731|premature infants|premature infants
536695|NCT00887731|oxygen exposure|oxygen exposure
536696|NCT00887718|PET scan and Hodgkin's Lymphoma|pet scan and hodgkin's lymphoma
536697|NCT00887718|PET scan and Non Hodgkin's Lymphoma|pet scan and non hodgkin's lymphoma
536698|NCT00887718|PET scan|pet scan
536699|NCT00887705|COPD|copd
536700|NCT00887705|Pulmonary Rehabilitation|pulmonary rehabilitation
536701|NCT00887705|ADL-Training|adl-training
536702|NCT00887705|COPD Rehabilitation|copd rehabilitation
536703|NCT00887679|Escitalopram|escitalopram
536704|NCT00887679|Anxiety Disorder|anxiety disorder
536705|NCT00887679|HIV and AIDS|hiv and aids
536706|NCT00887679|treatment experienced|treatment experienced
536707|NCT00887640|metastatic|metastatic
536708|NCT00887640|Temsirolimus|temsirolimus
536709|NCT00887640|prostate|prostate
536710|NCT00887640|cancer|cancer
536711|NCT00887627|Pharmacokinetics|pharmacokinetics
536712|NCT00887627|Protein Binding|protein binding
536713|NCT00887627|Conivaptan|conivaptan
536714|NCT00887627|Vaprisol|vaprisol
536715|NCT00887627|Kidney Diseases|kidney diseases
536716|NCT00887614|mindfulness|mindfulness
536717|NCT00887614|meditation|meditation
536718|NCT00887614|stress|stress
536719|NCT00887614|rumination|rumination
536720|NCT00887614|emotion regulation|emotion regulation
536721|NCT00887614|sleep quality|sleep quality
536722|NCT00887614|spirituality|spirituality
536723|NCT00887614|quality of life|quality of life
536724|NCT00887588|Chronic heart failure|chronic heart failure
536725|NCT00887588|preserved ejection fraction|preserved ejection fraction
536726|NCT00887588|cardiovascular disease|cardiovascular disease
536727|NCT00887588|NT-proBNP|nt-probnp
536728|NCT00887588|biomarkers|biomarkers
536729|NCT00887588|Heart failure with preserved left-ventricular ejection|heart failure with preserved left-ventricular ejection
536730|NCT00887588|fraction|fraction
536731|NCT00887575|Breast Cancer|breast cancer
536732|NCT00887575|Triple-Negative|triple-negative
536733|NCT00887575|Paclitaxel|paclitaxel
536734|NCT00887575|Carboplatin|carboplatin
536735|NCT00887575|Sunitinib|sunitinib
536736|NCT00887575|Sutent|sutent
536737|NCT00887575|Neoadjuvant|neoadjuvant
536738|NCT00887536|National Surgical Adjuvant Breast and Bowel Project (NSABP)|national surgical adjuvant breast and bowel project (nsabp)
536739|NCT00887536|Taxotere|taxotere
536740|NCT00887536|Docetaxel|docetaxel
536741|NCT00887536|Doxorubicin|doxorubicin
536742|NCT00887536|Cyclophosphamide|cyclophosphamide
536743|NCT00887536|Bevacizumab|bevacizumab
536744|NCT00887536|Breast Neoplasms|breast neoplasms
536745|NCT00887536|Adenocarcinoma|adenocarcinoma
536746|NCT00887536|Breast Diseases|breast diseases
536747|NCT00887536|Carcinoma|carcinoma
536748|NCT00887536|HER2 negative|her2 negative
536749|NCT00887536|Node negative|node negative
536750|NCT00887536|High risk node positive|high risk node positive
536751|NCT00887536|Adjuvant Therapy|adjuvant therapy
536752|NCT00887510|Metabolic Syndrome|metabolic syndrome
536753|NCT00887510|High Blood Pressure|high blood pressure
536754|NCT00887510|Abdominal Obesity|abdominal obesity
536755|NCT00887510|Impaired Glucose Tolerance|impaired glucose tolerance
536756|NCT00887484|Acne|acne
536757|NCT00887484|Acne Vulgaris|acne vulgaris
536758|NCT00887471|Sleep-disordered breathing|sleep-disordered breathing
536759|NCT00887471|Obstructive sleep apnea|obstructive sleep apnea
536760|NCT00887471|Polysomnography|polysomnography
536761|NCT00887471|Tonsillectomy|tonsillectomy
536762|NCT00887471|Microdebrider assisted partial intracapsular tonsillectomy|microdebrider assisted partial intracapsular tonsillectomy
536763|NCT00887458|metastatic prostate cancer|metastatic prostate cancer
536764|NCT00887458|castration resistant prostate cancer|castration resistant prostate cancer
536766|NCT00887445|First in Man|first in man
536767|NCT00887445|SLV341|slv341
536768|NCT00887445|diabetes|diabetes
536769|NCT00887419|chronic back pain|chronic back pain
536770|NCT00887419|spinal cord stimulator implant|spinal cord stimulator implant
536771|NCT00887406|first time in human study|first time in human study
536772|NCT00887406|COPD|copd
536773|NCT00887406|long-acting bronchodilator|long-acting bronchodilator
536774|NCT00887393|morbid obesity|morbid obesity
536775|NCT00887393|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
536776|NCT00887393|bariatric surgery|bariatric surgery
536777|NCT00887393|low fat diet|low fat diet
536778|NCT00887393|low carbohydrate diet|low carbohydrate diet
536779|NCT00887380|Breast Cancer|breast cancer
536780|NCT00887380|Timing of Radiotherapy|timing of radiotherapy
536781|NCT00887380|Local control|local control
536782|NCT00887367|Healthy volunteers|healthy volunteers
536783|NCT00887367|Substance dependence|substance dependence
536784|NCT00887367|Alcohol dependence|alcohol dependence
536785|NCT00887354|Low bone mass|low bone mass
536786|NCT00887354|Recent pertrochanteric hip fracture|recent pertrochanteric hip fracture
536787|NCT00887328|ischemic stroke|ischemic stroke
536788|NCT00887328|ischemic penumbra|ischemic penumbra
536789|NCT00887328|magnetic resonance imaging|magnetic resonance imaging
536791|NCT00887328|diffusion imaging|diffusion imaging
536792|NCT00887328|DWI|dwi
536793|NCT00887328|perfusion imaging|perfusion imaging
536794|NCT00887328|PWI|pwi
536795|NCT00887328|thrombolysis|thrombolysis
536796|NCT00887328|alteplase|alteplase
536797|NCT00887328|tPA|tpa
536798|NCT00887328|EPITHET|epithet
536799|NCT00887315|NSCLC|nsclc
536800|NCT00887315|Metastatic Stage IV NSCLC|metastatic stage iv nsclc
536801|NCT00887315|Limited Volume Stage IV Non-small Cell Lung Cancer|limited volume stage iv non-small cell lung cancer
536802|NCT00887276|Ampicillin|ampicillin
536803|NCT00887276|Amoxicillin|amoxicillin
536804|NCT00887276|Moxifloxacin|moxifloxacin
536805|NCT00887276|Community-Acquired Pneumonia|community-acquired pneumonia
536806|NCT00887237|Heart failure|heart failure
536807|NCT00887237|Cardiac resynchronization|cardiac resynchronization
536808|NCT00887237|Triple site ventricular pacing|triple site ventricular pacing
536809|NCT00887224|Major Depressive Disorder|major depressive disorder
536810|NCT00887211|stent|stent
536811|NCT00887211|coronary artery disease|coronary artery disease
536812|NCT00887198|Prostate cancer|prostate cancer
536813|NCT00887198|Abiraterone acetate|abiraterone acetate
536814|NCT00887198|CB7630|cb7630
536815|NCT00887198|CRPC|crpc
536816|NCT00887198|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
536817|NCT00887198|hormone refractory prostate cancer|hormone refractory prostate cancer
536818|NCT00887185|Surgical Simulation|surgical simulation
536819|NCT00887185|Surgical skills training|surgical skills training
536820|NCT00887185|Temporal bone surgery|temporal bone surgery
536821|NCT00887185|Computer simulation|computer simulation
536822|NCT00887172|Acute upper respiratory tract infections|acute upper respiratory tract infections
536823|NCT00887146|adult anaplastic astrocytoma|adult anaplastic astrocytoma
536824|NCT00887146|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
536825|NCT00887146|adult mixed glioma|adult mixed glioma
536826|NCT00887120|Second line treatment|second line treatment
536827|NCT00887120|therapeutic drug monitoring|therapeutic drug monitoring
536828|NCT00887120|Asia|asia
536829|NCT00887120|LPV|lpv
536830|NCT00887120|children|children
536831|NCT00887120|pharmacokinetic|pharmacokinetic
536832|NCT00887120|To study the pharmacokinetics of low-dose and standard dose, lopinavir/ritonavir in Protease inhibitor (PI)- naive HIV-1 infected Thai patients.|to study the pharmacokinetics of low-dose and standard dose, lopinavir/ritonavir in protease inhibitor (pi)- naive hiv-1 infected thai patients.
536954|NCT00886730|Depressive disorder|depressive disorder
536955|NCT00886730|Primary care|primary care
536833|NCT00887120|To study clinical and immunological efficacy after 48-weeks of lopinavir/ritonavir-based antiretroviral therapy in PI naive HIV-1 infected Thai patients.|to study clinical and immunological efficacy after 48-weeks of lopinavir/ritonavir-based antiretroviral therapy in pi naive hiv-1 infected thai patients.
536834|NCT00887094|Diabetes mellitus|diabetes mellitus
536835|NCT00887094|Exercise|exercise
536836|NCT00887094|Endurance|endurance
536837|NCT00887094|Resistance|resistance
536838|NCT00887094|Continuous glucose monitoring system|continuous glucose monitoring system
536839|NCT00887081|antiviral treatment in hemoglobinopathies|antiviral treatment in hemoglobinopathies
536840|NCT00887081|management of chronic viral hepatitis C infection|management of chronic viral hepatitis c infection
536841|NCT00887081|antiviral treatment|antiviral treatment
536842|NCT00887068|Leukemia|leukemia
536843|NCT00887068|Acute myelogenous leukemia|acute myelogenous leukemia
536845|NCT00887068|Myelodysplastic syndrome|myelodysplastic syndrome
536846|NCT00887068|MDS|mds
536847|NCT00887068|Remission|remission
536848|NCT00887068|Allogeneic stem cell transplant|allogeneic stem cell transplant
536849|NCT00887068|Allotx|allotx
536850|NCT00887068|Azacitidine|azacitidine
536851|NCT00887068|5-Azacitidine|5-azacitidine
536852|NCT00887068|5-aza|5-aza
536853|NCT00887068|Vidaza|vidaza
536854|NCT00887068|5-AZC|5-azc
536855|NCT00887068|AZA-CR|aza-cr
536856|NCT00887068|Ladakamycin|ladakamycin
536857|NCT00887068|NSC-102816|nsc-102816
536858|NCT00887042|Acute myeloid leukemia|acute myeloid leukemia
536859|NCT00887042|Cord blood transplantation|cord blood transplantation
536860|NCT00887042|Pediatric|pediatric
536861|NCT00887029|Topical prostaglandin analogue|topical prostaglandin analogue
536862|NCT00887029|glaucoma|glaucoma
536863|NCT00887029|POAG|poag
536864|NCT00887029|OHT|oht
536865|NCT00887029|OAG|oag
536866|NCT00887029|ocular hypertension|ocular hypertension
536867|NCT00887029|fixed combination protaglandin analogue therapy|fixed combination protaglandin analogue therapy
536868|NCT00887029|DuoTrav|duotrav
536869|NCT00887029|timolol|timolol
536870|NCT00887029|travoprost|travoprost
536871|NCT00887029|24 hour post dose|24 hour post dose
536872|NCT00887029|IOP|iop
536873|NCT00887029|dosing preference|dosing preference
536874|NCT00887003|epidural|epidural
536875|NCT00887003|volume|volume
536876|NCT00887003|dose|dose
536877|NCT00887003|pain relief|pain relief
536878|NCT00887003|steroid|steroid
536879|NCT00886990|single- and double-boosted PI|single- and double-boosted pi
536880|NCT00886990|second line regimen|second line regimen
536881|NCT00886990|NNRTI failure|nnrti failure
536882|NCT00886990|HIV-infected children|hiv-infected children
536883|NCT00886990|Compare virological efficacy and safety of single- or double-boosted PI regimens as second line therapy in children with NNRTI-based treatment failure|compare virological efficacy and safety of single- or double-boosted pi regimens as second line therapy in children with nnrti-based treatment failure
536884|NCT00886990|treatment experienced|treatment experienced
536885|NCT00886977|ALS|als
536886|NCT00886964|HBV vaccine|hbv vaccine
536887|NCT00886964|HIV children|hiv children
536888|NCT00886964|immune recovery|immune recovery
536889|NCT00886964|HBV antibody|hbv antibody
536890|NCT00886964|Intradermal|intradermal
536891|NCT00886964|Intramuscular|intramuscular
536892|NCT00886964|antibody response after HBV vaccine|antibody response after hbv vaccine
536893|NCT00886964|treatment experienced|treatment experienced
536894|NCT00886938|tinnitus|tinnitus
536895|NCT00886925|Hepatic encephalopathy|hepatic encephalopathy
536896|NCT00886925|Cirrhosis|cirrhosis
536897|NCT00886925|Albumin|albumin
536898|NCT00886912|mountain sickness|mountain sickness
536899|NCT00886899|CTO|cto
536900|NCT00886899|chronic total occlusion|chronic total occlusion
536901|NCT00886899|CAD|cad
536902|NCT00886899|coronary artery disease|coronary artery disease
536903|NCT00886899|interventional cardiology|interventional cardiology
536904|NCT00886899|revascularization|revascularization
536905|NCT00886899|recanalization|recanalization
536906|NCT00886886|MDMA|mdma
536907|NCT00886886|norepinephrine|norepinephrine
536908|NCT00886886|Ecstasy|ecstasy
536909|NCT00886886|stimulant|stimulant
536910|NCT00886873|Uterine fibroids|uterine fibroids
536911|NCT00886873|Mifepristone|mifepristone
536912|NCT00886873|Antiprogestins|antiprogestins
536913|NCT00886860|Efficacy|efficacy
536914|NCT00886860|Cervical ripening/Labor induction|cervical ripening/labor induction
536915|NCT00886860|Titrated oral misoprostol/Conventional oral misoprostol|titrated oral misoprostol/conventional oral misoprostol
536916|NCT00886860|Term pregnancy|term pregnancy
536917|NCT00886847|Lung|lung
536918|NCT00886847|Lymphadenopathy|lymphadenopathy
536919|NCT00886847|Enlarged hilar or/and mediastinal lymph adenopathy|enlarged hilar or/and mediastinal lymph adenopathy
536920|NCT00886847|Benign|benign
536921|NCT00886847|Malignant|malignant
536922|NCT00886847|Mediastinal lymph nodes|mediastinal lymph nodes
536923|NCT00886847|Hilar lymph nodes|hilar lymph nodes
536924|NCT00886847|Fine Needle Aspiration|fine needle aspiration
536925|NCT00886847|FNA|fna
536926|NCT00886847|Fine Needle Capillary Sampling|fine needle capillary sampling
536927|NCT00886847|FNC|fnc
536928|NCT00886847|Endobronchial Ultrasound-Guided Biopsy|endobronchial ultrasound-guided biopsy
536929|NCT00886847|EBUS|ebus
536930|NCT00886847|Tissue Sample|tissue sample
536931|NCT00886847|Suction|suction
536932|NCT00886834|IUD insertion|iud insertion
536933|NCT00886834|Nulliparous women|nulliparous women
536934|NCT00886834|Contraception|contraception
536935|NCT00886834|Family Planning|family planning
536936|NCT00886834|IUD insertion in nulliparous women|iud insertion in nulliparous women
536937|NCT00886821|Phase 1 Type 2 diabetes CVX-096 diabetes mellitus|phase 1 type 2 diabetes cvx-096 diabetes mellitus
536938|NCT00886821|adult-onset diabetes mellitus|adult-onset diabetes mellitus
536939|NCT00886821|non-insulin dependent|non-insulin dependent
536940|NCT00886808|DME, Diabetic Retinopathy, Diabetic Macular Edema|dme, diabetic retinopathy, diabetic macular edema
536941|NCT00886795|hives|hives
536942|NCT00886795|rash|rash
536943|NCT00886795|pruritis|pruritis
536944|NCT00886782|Advanced and/or Metastatic solid cancers|advanced and/or metastatic solid cancers
536945|NCT00886769|Flare|flare
536946|NCT00886769|arthritis|arthritis
536947|NCT00886769|IL-1beta antagonist|il-1beta antagonist
536948|NCT00886769|systemic juvenile idiopathic arthritis|systemic juvenile idiopathic arthritis
536949|NCT00886769|Juvenile Rheumatoid|juvenile rheumatoid
536950|NCT00886769|Systemic juvenile idiopathic arthritis with active flare|systemic juvenile idiopathic arthritis with active flare
536951|NCT00886756|Phase I|phase i
536952|NCT00886756|Japanese healthy volunteer|japanese healthy volunteer
536953|NCT00886756|AZD8529|azd8529
536956|NCT00886730|Internet|internet
536957|NCT00886730|Social support|social support
536958|NCT00886730|Feasibility|feasibility
536959|NCT00886717|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
536960|NCT00886717|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
536961|NCT00886717|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
536962|NCT00886717|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
536963|NCT00886717|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
536964|NCT00886717|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
536965|NCT00886717|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
536966|NCT00886717|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
536967|NCT00886704|Omega-3 fatty acids|omega-3 fatty acids
536968|NCT00886704|dietary supplementation|dietary supplementation
536969|NCT00886704|atherosclerosis|atherosclerosis
536970|NCT00886691|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
536971|NCT00886691|recurrent fallopian tube cancer|recurrent fallopian tube cancer
536972|NCT00886691|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
536973|NCT00886678|Non-Small Cell Lung Cancer|non-small cell lung cancer
536974|NCT00886678|pemetrexed|pemetrexed
536975|NCT00886678|radiation|radiation
536976|NCT00886665|Diabetic Neuropathy|diabetic neuropathy
536977|NCT00886665|Nerve Conduction Studies|nerve conduction studies
536978|NCT00886665|Clinical Trial|clinical trial
536979|NCT00886652|Scoliosis|scoliosis
536980|NCT00886652|Muscle Strength|muscle strength
536981|NCT00886652|Respiratory function tests|respiratory function tests
536982|NCT00886652|Exercise therapy|exercise therapy
536983|NCT00886639|COPD III/IV|copd iii/iv
536984|NCT00886639|Oxygen Supply|oxygen supply
536985|NCT00886639|Six-Minute-Walking-Test|six-minute-walking-test
536986|NCT00886639|Oxygen Responder|oxygen responder
536987|NCT00886626|Obesity|obesity
536988|NCT00886626|Impaired Glucose Tolerance|impaired glucose tolerance
536989|NCT00886626|Children|children
536990|NCT00886587|eczema|eczema
536991|NCT00886574|Cilostazol versus Aspirin|cilostazol versus aspirin
536992|NCT00886574|Anti-PLT drug|anti-plt drug
536993|NCT00886574|Primary Prevention of Atherosclerotic Events|primary prevention of atherosclerotic events
536994|NCT00886574|Type 2 DM|type 2 dm
536995|NCT00886574|Intima media thickness (IMT)|intima media thickness (imt)
536996|NCT00886561|HIV prevention, female sex workers|hiv prevention, female sex workers
536997|NCT00886561|HIV seronegativity|hiv seronegativity
536998|NCT00886535|breast cancer|breast cancer
536999|NCT00886535|hot flashes|hot flashes
537000|NCT00886535|tamoxifen|tamoxifen
537001|NCT00886522|Anti-thymocyte globulin Fresenius|anti-thymocyte globulin fresenius
537002|NCT00886522|Busulfan|busulfan
537003|NCT00886522|Cord blood|cord blood
537004|NCT00886522|Cyclophosphamide|cyclophosphamide
537005|NCT00886522|Fludarabine|fludarabine
537006|NCT00886522|Human Leucocyte Antigen|human leucocyte antigen
537007|NCT00886522|Hematopoietic Stem Cell|hematopoietic stem cell
537008|NCT00886522|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
537009|NCT00886522|Graft-versus-Host-Disease|graft-versus-host-disease
537010|NCT00886522|Graft-versus-Host-Disease prophylaxis|graft-versus-host-disease prophylaxis
537011|NCT00886522|Intrabone infusion|intrabone infusion
537012|NCT00886522|Thiotepa|thiotepa
537013|NCT00886509|Coronary Artery Disease|coronary artery disease
537014|NCT00886509|Stable|stable
537015|NCT00886509|Coronary Collaterals|coronary collaterals
537016|NCT00886509|Therapeutic Collateral Promotion (TCP)|therapeutic collateral promotion (tcp)
537017|NCT00886496|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
537018|NCT00886496|fever, sweats, and hot flashes|fever, sweats, and hot flashes
537019|NCT00886496|neutropenia|neutropenia
537020|NCT00886496|infection|infection
537021|NCT00886496|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
537022|NCT00886496|stage I and II childhood small noncleaved cell lymphoma|stage i and ii childhood small noncleaved cell lymphoma
537023|NCT00886496|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
537024|NCT00886496|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
537025|NCT00886496|stage III and IV childhood small noncleaved cell lymphoma|stage iii and iv childhood small noncleaved cell lymphoma
537026|NCT00886496|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
537027|NCT00886496|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
537028|NCT00886496|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
537029|NCT00886496|stage I and II childhood lymphoblastic lymphoma|stage i and ii childhood lymphoblastic lymphoma
537030|NCT00886496|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
537031|NCT00886496|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
537032|NCT00886496|stage III and IV childhood lymphoblastic lymphoma|stage iii and iv childhood lymphoblastic lymphoma
537033|NCT00886496|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
537034|NCT00886496|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
537035|NCT00886496|childhood Burkitt lymphoma|childhood burkitt lymphoma
537036|NCT00886496|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
537037|NCT00886496|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
537038|NCT00886496|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
537039|NCT00886496|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
537040|NCT00886496|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
537041|NCT00886496|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
537042|NCT00886496|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
537043|NCT00886496|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
537044|NCT00886496|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
537045|NCT00886496|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
537046|NCT00886496|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
537047|NCT00886496|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
537048|NCT00886496|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
537049|NCT00886496|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
537050|NCT00886496|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
537051|NCT00886496|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
537052|NCT00886496|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
537053|NCT00886496|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
537054|NCT00886496|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
537055|NCT00886496|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
537056|NCT00886496|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
537057|NCT00886496|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
537058|NCT00886496|stage III and IV childhood large cell lymphoma|stage iii and iv childhood large cell lymphoma
537059|NCT00886496|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
537060|NCT00886496|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
537061|NCT00886483|Neurofeedback|neurofeedback
537062|NCT00886470|cytokines|cytokines
537063|NCT00886470|pain|pain
537064|NCT00886470|scarring|scarring
537065|NCT00886470|vascularity|vascularity
537066|NCT00886457|Biopsy proven cancer, which is metastatic or unresectable|biopsy proven cancer, which is metastatic or unresectable
537067|NCT00886431|IVF|ivf
537068|NCT00886431|embryo cryopreservation|embryo cryopreservation
537069|NCT00886431|vitrification|vitrification
537070|NCT00886431|slow cooling|slow cooling
537071|NCT00886431|slow freezing|slow freezing
537072|NCT00886431|surplus embryos|surplus embryos
537073|NCT00886431|Human Reproduction|human reproduction
537074|NCT00886405|Nitroglycerin|nitroglycerin
537075|NCT00886405|Locally advanced non small-cell lung cancer|locally advanced non small-cell lung cancer
537076|NCT00886405|Vascular endothelial growth factor|vascular endothelial growth factor
537077|NCT00886405|Hypoxia Inducible Factor|hypoxia inducible factor
537078|NCT00886405|Clinical stage IIIA and/or IIIB (without pleural effusion)|clinical stage iiia and/or iiib (without pleural effusion)
537079|NCT00886392|Clinically Significant Macular Edema|clinically significant macular edema
537080|NCT00886392|Diabetic Macular Edema|diabetic macular edema
537081|NCT00886392|Optical Coherence Tomography|optical coherence tomography
537082|NCT00886392|Diabetic Retinopathy|diabetic retinopathy
537083|NCT00886392|Severity|severity
537084|NCT00886379|vitamin d|vitamin d
537085|NCT00886379|children|children
537086|NCT00886379|Mongolia|mongolia
537087|NCT00886366|Type II Diabetes|type ii diabetes
537088|NCT00886353|RAS|ras
537089|NCT00886353|ACE2|ace2
537090|NCT00886353|Cardiovascular|cardiovascular
537091|NCT00886353|Pulmonary|pulmonary
537092|NCT00886353|Angiotensin II|angiotensin ii
537093|NCT00886353|Angiotensin 1-7|angiotensin 1-7
537094|NCT00886340|diabetes prevention, primary care|diabetes prevention, primary care
537095|NCT00886327|Colonic capsule endoscopy|colonic capsule endoscopy
537096|NCT00886327|Crohn's disease|crohn's disease
537097|NCT00886327|Capsule endoscopy|capsule endoscopy
537098|NCT00886314|children|children
537099|NCT00886314|surgery|surgery
537100|NCT00886314|anxiety|anxiety
537101|NCT00886301|overweight|overweight
537102|NCT00886301|obesity|obesity
537103|NCT00886301|steatohepatitis|steatohepatitis
537104|NCT00886301|ectopic fat|ectopic fat
537105|NCT00886275|Postoperative sedation in intensive care|postoperative sedation in intensive care
537106|NCT00886262|liver transplantation|liver transplantation
537107|NCT00886262|vasopressin|vasopressin
537108|NCT00886262|renal function|renal function
537109|NCT00886262|hypotension|hypotension
537110|NCT00886262|creatinine|creatinine
537111|NCT00886262|urine output|urine output
537112|NCT00886262|diuretics|diuretics
537113|NCT00886262|vasopressors|vasopressors
537114|NCT00886262|hemodynamic stability|hemodynamic stability
537115|NCT00886249|Vision|vision
537116|NCT00886249|Eye|eye
537117|NCT00886249|Cataract|cataract
537309|NCT00885456|stroke|stroke
537118|NCT00886236|Gastric Bypass|gastric bypass
537119|NCT00886236|Gabapentin|gabapentin
537120|NCT00886236|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
537121|NCT00886236|Analgesics, Opioids|analgesics, opioids
537122|NCT00886236|Sleep Apnea, Obstructive|sleep apnea, obstructive
537123|NCT00886236|Respiratory Depression|respiratory depression
537124|NCT00886236|Oximetry|oximetry
537125|NCT00886223|vaginal vault prolapse repair|vaginal vault prolapse repair
537126|NCT00886223|robot-assisted laparoscopic sacropexy|robot-assisted laparoscopic sacropexy
537127|NCT00886223|robot-assisted laparoscopic sacrocolpopexy|robot-assisted laparoscopic sacrocolpopexy
537128|NCT00886223|robotic laparoscopic sacropexy|robotic laparoscopic sacropexy
537129|NCT00886210|drain|drain
537130|NCT00886210|laparoscopic cholecystectomy|laparoscopic cholecystectomy
537131|NCT00886210|pneumoperitonum|pneumoperitonum
537132|NCT00886197|reflux|reflux
537133|NCT00886197|GERD|gerd
537134|NCT00886184|Hypothermia|hypothermia
537135|NCT00886184|Cardiac arrest|cardiac arrest
537136|NCT00886184|Biomarkers|biomarkers
537137|NCT00886184|Pre hospital cardiac arrest|pre hospital cardiac arrest
537138|NCT00886171|social skills|social skills
537139|NCT00886171|physical activity|physical activity
537140|NCT00886171|peer relationships|peer relationships
537141|NCT00886171|childhood obesity|childhood obesity
537142|NCT00886171|changes in physical activity|changes in physical activity
537143|NCT00886171|changes in social involvement|changes in social involvement
537144|NCT00886158|Organ Transplants|organ transplants
537145|NCT00886145|Spinal Cord Injuries|spinal cord injuries
537146|NCT00886145|Mechanical Stimulation|mechanical stimulation
537147|NCT00886145|Vibration Plate|vibration plate
537148|NCT00886132|Phase 2 Study|phase 2 study
537149|NCT00886132|Sunitinib|sunitinib
537150|NCT00886132|Recurrent|recurrent
537151|NCT00886132|Metastatic|metastatic
537152|NCT00886132|Adenoid Cystic Carcinoma|adenoid cystic carcinoma
537153|NCT00886132|Salivary Glands|salivary glands
537154|NCT00886132|Metastasis|metastasis
537155|NCT00886106|Capsaicin|capsaicin
537156|NCT00886106|Remifentanil|remifentanil
537157|NCT00886106|Hyperalgesia|hyperalgesia
537158|NCT00886093|pharmacokinetics, single dose, crossover, fed vs fasted state|pharmacokinetics, single dose, crossover, fed vs fasted state
537159|NCT00886080|Atrial fibrillation|atrial fibrillation
537160|NCT00886080|Health related Quality of Life|health related quality of life
537161|NCT00886080|Add-on surgery|add-on surgery
537162|NCT00886080|Ablation|ablation
537163|NCT00886080|Randomised controlled trial|randomised controlled trial
537164|NCT00886080|SF-36|sf-36
537165|NCT00886080|EuroQoL|euroqol
537166|NCT00886080|MFI-20|mfi-20
537167|NCT00886067|AZD1446|azd1446
537168|NCT00886067|PET examination|pet examination
537169|NCT00886054|Transcranial Doppler|transcranial doppler
537170|NCT00886054|Transcranial color-coded duplex sonography|transcranial color-coded duplex sonography
537171|NCT00886054|Neurocritical patients|neurocritical patients
537172|NCT00886041|laparoscopy|laparoscopy
537173|NCT00886041|unexplained infertility|unexplained infertility
537174|NCT00886028|Malignant pleural mesothelioma|malignant pleural mesothelioma
537175|NCT00886028|Liposomal doxorubicin|liposomal doxorubicin
537176|NCT00886028|Progression free survival|progression free survival
537177|NCT00886028|Patients who received LD 60mg/m2 plus cisplatin 80 mg/m2 every 4 weeks for 6 cycles|patients who received ld 60mg/m2 plus cisplatin 80 mg/m2 every 4 weeks for 6 cycles
537178|NCT00886028|Patients with epithelial, sarcomatoid or biphasic histological confirmed diagnosis of MPM|patients with epithelial, sarcomatoid or biphasic histological confirmed diagnosis of mpm
537179|NCT00886015|Trachoma|trachoma
537180|NCT00886015|trichiasis|trichiasis
537181|NCT00886015|bilamellar tarsal rotation procedure|bilamellar tarsal rotation procedure
537182|NCT00886002|Healthy volunteers|healthy volunteers
537183|NCT00885989|SLV338|slv338
537184|NCT00885989|phase I|phase i
537185|NCT00885989|healthy volunteers|healthy volunteers
537186|NCT00885950|colorectal liver metastases|colorectal liver metastases
537187|NCT00885950|neoadjuvant chemotherapy|neoadjuvant chemotherapy
537188|NCT00885950|oxaliplatin|oxaliplatin
537189|NCT00885950|sinusoidal obstruction syndrome|sinusoidal obstruction syndrome
537190|NCT00885950|anticoagulants|anticoagulants
537191|NCT00885937|Dexpanthenol|dexpanthenol
537192|NCT00885937|Safety,|safety,
537193|NCT00885937|New formulation|new formulation
537194|NCT00885937|Topical administration|topical administration
537195|NCT00885924|postoperative Hemorrhage|postoperative hemorrhage
537196|NCT00885924|Hemorrhage|hemorrhage
537197|NCT00885924|Vasopressin|vasopressin
537198|NCT00885924|Blood Loss, Surgical|blood loss, surgical
537199|NCT00885911|Intubating laryngeal airway|intubating laryngeal airway
537200|NCT00885911|pediatric|pediatric
537201|NCT00885911|observational study|observational study
537202|NCT00885898|Respiratory Insufficiency|respiratory insufficiency
537203|NCT00885898|Respiratory Failure|respiratory failure
537204|NCT00885885|Colorectal Cancer|colorectal cancer
537205|NCT00885885|Panitumumab|panitumumab
537206|NCT00885885|FOLFOX-4|folfox-4
537207|NCT00885885|FOLFIRI|folfiri
537208|NCT00885846|Qigong|qigong
537209|NCT00885846|Breathing management|breathing management
537210|NCT00885846|Glucose|glucose
537411|NCT00884988|edema|edema
537211|NCT00885833|Wiskott-Aldrich syndrome|wiskott-aldrich syndrome
537212|NCT00885833|HSCT|hsct
537213|NCT00885820|Kidney Transplantation|kidney transplantation
537214|NCT00885820|Tacrolimus|tacrolimus
537215|NCT00885820|Immunosuppression|immunosuppression
537216|NCT00885820|Graft Survival|graft survival
537217|NCT00885807|ADHD|adhd
537218|NCT00885807|WFIRS|wfirs
537219|NCT00885807|WSR|wsr
537220|NCT00885794|Clinically Significant Diabetic Macular Edema|clinically significant diabetic macular edema
537221|NCT00885794|Focal Laser|focal laser
537222|NCT00885794|GRID-Laser|grid-laser
537223|NCT00885794|Ranibizumab|ranibizumab
537224|NCT00885794|Lucentis|lucentis
537225|NCT00885794|Microperimetry|microperimetry
537226|NCT00885794|High-Definition OCT|high-definition oct
537227|NCT00885794|Randomized|randomized
537228|NCT00885794|Observer-Blinded|observer-blinded
537229|NCT00885794|Ineffective Treatment with Focal Laser or GRID-Laser|ineffective treatment with focal laser or grid-laser
537230|NCT00885768|RAS(renal Artery Stenosis)|ras(renal artery stenosis)
537231|NCT00885768|Atherosclerosis|atherosclerosis
537232|NCT00885768|angiography|angiography
537233|NCT00885742|Hereditary Factor XIII deficiency|hereditary factor xiii deficiency
537234|NCT00885742|Factor XIII|factor xiii
537235|NCT00885729|Cartilage defect|cartilage defect
537236|NCT00885729|chondrocytes|chondrocytes
537237|NCT00885729|mesenchymal stem cells (MSC)|mesenchymal stem cells (msc)
537238|NCT00885729|femoral condyle|femoral condyle
537239|NCT00885729|knee|knee
537240|NCT00885703|CM|cm
537241|NCT00885703|HIV|hiv
537242|NCT00885703|Meningitis|meningitis
537243|NCT00885690|Schizophrenia|schizophrenia
537244|NCT00885690|Antipsychotic|antipsychotic
537245|NCT00885690|Cognition|cognition
537246|NCT00885664|HIV|hiv
537247|NCT00885664|immune reconstitution|immune reconstitution
537248|NCT00885664|treatment naive|treatment naive
537249|NCT00885651|SNP|snp
537250|NCT00885651|catecholamines|catecholamines
537251|NCT00885651|metoprolole|metoprolole
537252|NCT00885651|healthy subjects|healthy subjects
537253|NCT00885651|physiological stress|physiological stress
537254|NCT00885638|GLP-1|glp-1
537255|NCT00885638|Insulin secretion|insulin secretion
537256|NCT00885638|Macronutrients|macronutrients
537257|NCT00885625|invasive pneumococcal disease|invasive pneumococcal disease
537258|NCT00885625|pneumococcal conjugated vaccine|pneumococcal conjugated vaccine
537259|NCT00885612|CHD-Risk|chd-risk
537260|NCT00885612|Breast Cancer|breast cancer
537261|NCT00885612|Aromatase Inhibitors|aromatase inhibitors
537262|NCT00885612|postmenopausal early breast cancer|postmenopausal early breast cancer
537263|NCT00885599|gingivitis|gingivitis
537264|NCT00885599|natural remedy|natural remedy
537265|NCT00885599|inflammation|inflammation
537266|NCT00885599|C-reactive protein|c-reactive protein
537267|NCT00885599|mouthwash|mouthwash
537268|NCT00885586|herpes zoster|herpes zoster
537269|NCT00885586|neuropathic pain|neuropathic pain
537270|NCT00885586|acupuncture|acupuncture
537271|NCT00885586|randomised controlled trial|randomised controlled trial
537272|NCT00885586|acute herpes zoster|acute herpes zoster
537273|NCT00885573|sleep apnea|sleep apnea
537274|NCT00885573|pharyngeal sensitivity|pharyngeal sensitivity
537275|NCT00885573|pharyngeal dilator reflex|pharyngeal dilator reflex
537276|NCT00885573|diagnosis algorithm|diagnosis algorithm
537277|NCT00885573|patients with suspected sleep apnea syndrome|patients with suspected sleep apnea syndrome
537278|NCT00885560|ADHD|adhd
537279|NCT00885560|SNAP 25|snap 25
537280|NCT00885560|amphetamine|amphetamine
537281|NCT00885560|methylphenidate|methylphenidate
537282|NCT00885534|skin cancer|skin cancer
537283|NCT00885534|CISPLATIN|cisplatin
537284|NCT00885534|TEMOZOLOMIDE|temozolomide
537285|NCT00885534|VINBLASTINE|vinblastine
537286|NCT00885534|09-017|09-017
537287|NCT00885508|MDS|mds
537288|NCT00885508|AML|aml
537289|NCT00885508|deletion 5q|deletion 5q
537290|NCT00885508|Documented diagnosis of MDS, or CMML|documented diagnosis of mds, or cmml
537291|NCT00885508|with WBC < 13,000/mm3 that meets IPSS criteria for intermediate-2|with wbc < 13,000/mm3 that meets ipss criteria for intermediate-2
537292|NCT00885508|or high-risk disease, or AML with an associated del 5q[31]|or high-risk disease, or aml with an associated del 5q[31]
537293|NCT00885508|(the deleted chromosomal region must include 5q[31]),|(the deleted chromosomal region must include 5q[31]),
537294|NCT00885508|with or without additional cytogenetic abnormalities|with or without additional cytogenetic abnormalities
537295|NCT00885495|HIV|hiv
537296|NCT00885495|dyslipidemia|dyslipidemia
537297|NCT00885495|statins|statins
537298|NCT00885495|protease inhibitors|protease inhibitors
537299|NCT00885482|HIV/AIDS|hiv/aids
537300|NCT00885482|HAART|haart
537301|NCT00885482|Simplification|simplification
537302|NCT00885482|Atazanavir|atazanavir
537303|NCT00885482|Lamivudine|lamivudine
537304|NCT00885482|treatment experienced|treatment experienced
537560|NCT00884429|Chest physiotherapy|chest physiotherapy
537305|NCT00885469|known Barrett's Esophagus|known barrett's esophagus
537306|NCT00885469|Suspected Barrett's Esophagus|suspected barrett's esophagus
537307|NCT00885469|chronic GERD|chronic gerd
537308|NCT00885469|known Barrett's Esophagus or chronic GERD|known barrett's esophagus or chronic gerd
537310|NCT00885456|secondary prevention|secondary prevention
537311|NCT00885456|vascular risk|vascular risk
537312|NCT00885456|behavioral change|behavioral change
537313|NCT00885456|exercise|exercise
537314|NCT00885456|lifestyle modification|lifestyle modification
537315|NCT00885443|propofol|propofol
537316|NCT00885443|sevoflurane|sevoflurane
537317|NCT00885443|pediatric|pediatric
537318|NCT00885443|emergence delirium|emergence delirium
537319|NCT00885443|Induction of sedation|induction of sedation
537320|NCT00885430|colonoscopy|colonoscopy
537321|NCT00885430|preparation|preparation
537322|NCT00885417|Helicobacter pylori|helicobacter pylori
537323|NCT00885417|sequential therapy|sequential therapy
537324|NCT00885417|levofloxacin|levofloxacin
537325|NCT00885417|clarithromycin|clarithromycin
537326|NCT00885417|rescue|rescue
537327|NCT00885417|salvage|salvage
537328|NCT00885417|treatment failure|treatment failure
537329|NCT00885417|For those who fail from one standard eradication therapy for H. pylori infection|for those who fail from one standard eradication therapy for h. pylori infection
537330|NCT00885404|chloride|chloride
537331|NCT00885404|acidosis|acidosis
537332|NCT00885391|Atrial Fibrillation|atrial fibrillation
537333|NCT00885391|Cardioversion|cardioversion
537334|NCT00885391|Direct Current Cardioversion|direct current cardioversion
537335|NCT00885391|QT Interval|qt interval
537336|NCT00885365|cystic fibrosis|cystic fibrosis
537337|NCT00885365|P. aeruginosa|p. aeruginosa
537338|NCT00885365|tobramycin|tobramycin
537339|NCT00885339|Colonic Diseases|colonic diseases
537340|NCT00885326|recurrent neuroblastoma|recurrent neuroblastoma
537341|NCT00885313|NAFLD|nafld
537342|NCT00885313|NASH|nash
537343|NCT00885313|fibrosis|fibrosis
537344|NCT00885287|uncomplicated malaria|uncomplicated malaria
537345|NCT00885287|HIV/AIDS|hiv/aids
537346|NCT00885287|drug interactions|drug interactions
537347|NCT00885287|antimalarial drug efficacy|antimalarial drug efficacy
537348|NCT00885287|antiretrovirals|antiretrovirals
537349|NCT00885287|pharmacovigilance|pharmacovigilance
537350|NCT00885287|Tanzania|tanzania
537351|NCT00885261|chronic pain and metabolic syndrome|chronic pain and metabolic syndrome
537352|NCT00885248|pancreatic cancer|pancreatic cancer
537353|NCT00885248|integrated PET-CT|integrated pet-ct
537354|NCT00885235|Bowel Diseases|bowel diseases
537355|NCT00885222|Parkinson's disease|parkinson's disease
537356|NCT00885222|Major depressive disorder|major depressive disorder
537357|NCT00885222|Deep brain stimulation|deep brain stimulation
537358|NCT00885209|Colonic Diseases|colonic diseases
537359|NCT00885196|Psoriasis|psoriasis
537360|NCT00885196|plaque psoriasis|plaque psoriasis
537361|NCT00885196|inflammatory skin disease|inflammatory skin disease
537362|NCT00885196|scaly patches|scaly patches
537363|NCT00885196|AEB071|aeb071
537364|NCT00885183|breast cancer|breast cancer
537365|NCT00885183|chemotherapy|chemotherapy
537366|NCT00885183|adjuvant therapy|adjuvant therapy
537367|NCT00885183|acupuncture|acupuncture
537368|NCT00885183|fatigue|fatigue
537369|NCT00885183|Early stage breast cancer patients|early stage breast cancer patients
537370|NCT00885157|Poliomyelitis|poliomyelitis
537371|NCT00885157|intradermal|intradermal
537372|NCT00885144|Stunting|stunting
537373|NCT00885144|Growth failure|growth failure
537374|NCT00885144|Malnutrition|malnutrition
537375|NCT00885144|Lipid based nutrient supplement|lipid based nutrient supplement
537376|NCT00885144|LNS|lns
537377|NCT00885144|Prevention|prevention
537378|NCT00885144|Malawi|malawi
537379|NCT00885144|Sub-Saharan Africa|sub-saharan africa
537380|NCT00885144|Dietary supplementation|dietary supplementation
537381|NCT00885131|Reward Processing|reward processing
537382|NCT00885131|Motor Cortex|motor cortex
537383|NCT00885131|HV|hv
537384|NCT00885131|Healthy Volunteer|healthy volunteer
537385|NCT00885105|Fluzone® vaccine|fluzone® vaccine
537386|NCT00885105|Influenza|influenza
537387|NCT00885092|Contact lenses|contact lenses
537388|NCT00885092|Disinfecting solutions|disinfecting solutions
537389|NCT00885066|stage III pancreatic cancer|stage iii pancreatic cancer
537390|NCT00885066|stage IV pancreatic cancer|stage iv pancreatic cancer
537391|NCT00885066|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
537392|NCT00885066|recurrent pancreatic cancer|recurrent pancreatic cancer
537393|NCT00885053|Inflammation|inflammation
537394|NCT00885053|Fatty acids, Omega 3|fatty acids, omega 3
537395|NCT00885053|Leukotrienes|leukotrienes
537396|NCT00885053|Adiponectin|adiponectin
537397|NCT00885053|Adipose tissue|adipose tissue
537398|NCT00885053|RNA, Messenger|rna, messenger
537399|NCT00885040|Neurofeedback|neurofeedback
537400|NCT00885040|Tourette Syndrome|tourette syndrome
537401|NCT00885040|Healthy Volunteer|healthy volunteer
537402|NCT00885040|Movement Disorder|movement disorder
537403|NCT00885040|Brain Activity|brain activity
537404|NCT00885040|fMRI|fmri
537405|NCT00885040|HV|hv
537406|NCT00885014|Depressive disorder|depressive disorder
537407|NCT00885014|Behavior therapy|behavior therapy
537408|NCT00885014|Workplace|workplace
537409|NCT00885014|Subthreshold depression|subthreshold depression
537410|NCT00884988|ankle fracture|ankle fracture
537412|NCT00884988|surgical repair|surgical repair
537413|NCT00884988|homeopathy|homeopathy
537414|NCT00884988|lymphomyosot|lymphomyosot
537415|NCT00884975|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
537416|NCT00884975|exacerbations|exacerbations
537417|NCT00884975|quality of life|quality of life
537418|NCT00884975|emphysema|emphysema
537419|NCT00884962|emphysema|emphysema
537420|NCT00884962|aeris|aeris
537421|NCT00884962|PLVR|plvr
537422|NCT00884962|BLVR|blvr
537423|NCT00884962|germany|germany
537424|NCT00884962|treatment|treatment
537425|NCT00884962|device|device
537426|NCT00884962|breathing|breathing
537427|NCT00884949|Mucopolysaccharidosis IV type A|mucopolysaccharidosis iv type a
537428|NCT00884949|MPS IV Type A|mps iv type a
537429|NCT00884949|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
537430|NCT00884949|MPS IVA|mps iva
537431|NCT00884949|Morquio A Syndrome|morquio a syndrome
537432|NCT00884949|Lysosomal Storage Disorder|lysosomal storage disorder
537433|NCT00884949|LSD|lsd
537434|NCT00884949|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
537435|NCT00884949|N-acetylgalactosamine-6-sulfate sulfatase|n-acetylgalactosamine-6-sulfate sulfatase
537436|NCT00884949|galactose-6-sulfatase|galactose-6-sulfatase
537437|NCT00884949|GALNS|galns
537438|NCT00884949|enzyme replacement therapy|enzyme replacement therapy
537439|NCT00884949|ERT|ert
537440|NCT00884936|Skin|skin
537441|NCT00884936|Aging|aging
537442|NCT00884936|Dermogenomics|dermogenomics
537443|NCT00884936|Genetic|genetic
537444|NCT00884936|Biomarker|biomarker
537445|NCT00884936|Dermatology|dermatology
537446|NCT00884910|laryngectomy|laryngectomy
537447|NCT00884910|Provox Vega|provox vega
537448|NCT00884910|voice prosthesis|voice prosthesis
537449|NCT00884897|Social Cognition|social cognition
537450|NCT00884897|Schizophrenia|schizophrenia
537451|NCT00884897|Oxytocin|oxytocin
537452|NCT00884884|Alcohol dependence|alcohol dependence
537453|NCT00884884|alcohol abuse|alcohol abuse
537454|NCT00884884|topiramate|topiramate
537455|NCT00884884|aripiprazole|aripiprazole
537456|NCT00884871|pelvic floor disorders|pelvic floor disorders
537457|NCT00884871|weight loss|weight loss
537458|NCT00884858|HIV-1|hiv-1
537459|NCT00884858|CD4|cd4
537460|NCT00884858|INR|inr
537461|NCT00884858|HIV-1 infection|hiv-1 infection
537462|NCT00884858|extreme immunological compromission|extreme immunological compromission
537463|NCT00884858|treatment experienced|treatment experienced
537464|NCT00884845|PM2734|pm2734
537465|NCT00884845|Tumors|tumors
537466|NCT00884845|PharmaMar|pharmamar
537467|NCT00884845|Erlotinib|erlotinib
537468|NCT00884845|Tarceva|tarceva
537469|NCT00884832|fecal incontinence|fecal incontinence
537470|NCT00884832|stool leakage|stool leakage
537471|NCT00884832|incontinence|incontinence
537472|NCT00884832|FI|fi
537473|NCT00884832|Urge predominant fecal incontinence|urge predominant fecal incontinence
537474|NCT00884819|polycystic ovary syndrome|polycystic ovary syndrome
537475|NCT00884819|hepatic adiposity|hepatic adiposity
537476|NCT00884819|diabetes|diabetes
537477|NCT00884819|hormones|hormones
537478|NCT00884819|cardiovascular disease|cardiovascular disease
537479|NCT00884806|Contact lenses|contact lenses
537480|NCT00884806|Disinfecting solutions|disinfecting solutions
537481|NCT00884793|HIV|hiv
537482|NCT00884793|persistence|persistence
537483|NCT00884793|reservoirs|reservoirs
537484|NCT00884793|residual replication|residual replication
537485|NCT00884793|gut|gut
537486|NCT00884793|gut-associated lymphoid tissue|gut-associated lymphoid tissue
537487|NCT00884793|treatment experienced|treatment experienced
537488|NCT00884780|Electronic Diary|electronic diary
537489|NCT00884780|Body Map|body map
537490|NCT00884780|Electronic Measure of Pediatric Pain|electronic measure of pediatric pain
537491|NCT00884767|neurotoxicity|neurotoxicity
537492|NCT00884767|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
537493|NCT00884767|recurrent colon cancer|recurrent colon cancer
537494|NCT00884767|stage I colon cancer|stage i colon cancer
537495|NCT00884767|stage II colon cancer|stage ii colon cancer
537496|NCT00884767|stage III colon cancer|stage iii colon cancer
537497|NCT00884767|stage IV colon cancer|stage iv colon cancer
537498|NCT00884767|recurrent rectal cancer|recurrent rectal cancer
537499|NCT00884767|stage I rectal cancer|stage i rectal cancer
537500|NCT00884767|stage II rectal cancer|stage ii rectal cancer
537501|NCT00884767|stage III rectal cancer|stage iii rectal cancer
537502|NCT00884767|stage IV rectal cancer|stage iv rectal cancer
537503|NCT00884728|Scabies|scabies
537504|NCT00884728|Impetigo|impetigo
537505|NCT00884728|Pyoderma|pyoderma
537506|NCT00884728|Streptococcal infections|streptococcal infections
537507|NCT00884702|Sleep|sleep
537508|NCT00884702|14C-Leucine|14c-leucine
537509|NCT00884702|Cerebral Protein Synthesis|cerebral protein synthesis
537510|NCT00884702|Memory|memory
537511|NCT00884702|Positron Emission Tomography (PET)|positron emission tomography (pet)
537512|NCT00884702|HV|hv
537513|NCT00884702|Healthy Volunteer|healthy volunteer
537514|NCT00884689|Symbicort SMART|symbicort smart
538310|NCT00881153|Antibiotic|antibiotic
537515|NCT00884689|Free Combination GCS/LABA treatment|free combination gcs/laba treatment
537516|NCT00884676|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
537517|NCT00884650|Pain|pain
537518|NCT00884650|Pain management|pain management
537519|NCT00884650|Cerebral Palsy|cerebral palsy
537520|NCT00884637|HMP|hmp
537521|NCT00884637|CNV|cnv
537522|NCT00884637|AMD|amd
537523|NCT00884637|PHP|php
537524|NCT00884637|HPHP|hphp
537525|NCT00884637|foresee home|foresee home
537526|NCT00884624|Bowel Diseases|bowel diseases
537527|NCT00884598|adult tumors metastatic to brain|adult tumors metastatic to brain
537528|NCT00884598|extensive stage small cell lung cancer|extensive stage small cell lung cancer
537529|NCT00884598|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
537530|NCT00884559|Leadership|leadership
537531|NCT00884559|Team building|team building
537532|NCT00884559|Resuscitation|resuscitation
537533|NCT00884533|QTc|qtc
537534|NCT00884533|pharmacokinetics|pharmacokinetics
537535|NCT00884533|rosiglitazone XR|rosiglitazone xr
537536|NCT00884533|cardiac conduction|cardiac conduction
537537|NCT00884533|healthy volunteers|healthy volunteers
537538|NCT00884520|[F-18]VM4-037|[f-18]vm4-037
537539|NCT00884520|VM4-037|vm4-037
537540|NCT00884520|hypoxia|hypoxia
537541|NCT00884520|CA-IX|ca-ix
537542|NCT00884520|CAIX|caix
537543|NCT00884520|carbonic anhydrase IX|carbonic anhydrase ix
537544|NCT00884520|hypoxia marker|hypoxia marker
537545|NCT00884520|lung cancer|lung cancer
537546|NCT00884520|renal carcinoma|renal carcinoma
537547|NCT00884520|squamous cell carcinoma|squamous cell carcinoma
537548|NCT00884520|hepatic carcinoma|hepatic carcinoma
537549|NCT00884520|head and neck cancer|head and neck cancer
537550|NCT00884520|advanced stage lung cancer|advanced stage lung cancer
537551|NCT00884520|exploratory|exploratory
537552|NCT00884494|Obesity|obesity
537553|NCT00884494|Insulin resistance|insulin resistance
537554|NCT00884494|Ghrelin|ghrelin
537555|NCT00884468|Anxiety and depression in patients with psoriatic arthritis|anxiety and depression in patients with psoriatic arthritis
537556|NCT00884455|tissue banking, research|tissue banking, research
537557|NCT00884442|Healthy|healthy
537558|NCT00884442|Bioavailability|bioavailability
537559|NCT00884442|Nifedipine|nifedipine
537561|NCT00884416|high grade glioma|high grade glioma
537562|NCT00884416|glioblastoma|glioblastoma
537563|NCT00884416|gliosarcoma|gliosarcoma
537564|NCT00884416|anaplastic astrocytoma|anaplastic astrocytoma
537565|NCT00884416|anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
537566|NCT00884416|anaplastic oligodendroglioma|anaplastic oligodendroglioma
537567|NCT00884416|phase I|phase i
537568|NCT00884416|first line treatment|first line treatment
537569|NCT00884416|sorafenib|sorafenib
537570|NCT00884416|temozolomide|temozolomide
537571|NCT00884416|radiation therapy|radiation therapy
537572|NCT00884416|safety|safety
537573|NCT00884416|tolerability|tolerability
537574|NCT00884416|protein kinase inhibitors|protein kinase inhibitors
537575|NCT00884403|abortion|abortion
537576|NCT00884403|pregnancy dating|pregnancy dating
537577|NCT00884403|gestational age|gestational age
537578|NCT00884403|ultrasound|ultrasound
537579|NCT00884390|Hemophilia A|hemophilia a
537580|NCT00884364|Lymphoma|lymphoma
537581|NCT00884364|Leukemia|leukemia
537582|NCT00884364|Multiple myeloma|multiple myeloma
537583|NCT00884364|Hodgkin´s disease|hodgkin´s disease
537584|NCT00884364|Exercise|exercise
537585|NCT00884364|Sport|sport
537586|NCT00884364|Fatigue|fatigue
537587|NCT00884364|Hematological neoplastic diseases|hematological neoplastic diseases
537588|NCT00884351|Epilepsy|epilepsy
537589|NCT00884351|MEG|meg
537590|NCT00884351|Seizures|seizures
537591|NCT00884338|Fatigue|fatigue
537592|NCT00884338|Cancer|cancer
537593|NCT00884338|Cognitive impairment|cognitive impairment
537594|NCT00884338|Exercise|exercise
537595|NCT00884338|Sport|sport
537596|NCT00884338|Peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
537597|NCT00884338|High-dose chemotherapy|high-dose chemotherapy
537598|NCT00884325|Itching|itching
537599|NCT00884325|Atopic Dermatitis|atopic dermatitis
537600|NCT00884312|Multiple myeloma|multiple myeloma
537601|NCT00884312|proteasome|proteasome
537602|NCT00884312|Hematological|hematological
537603|NCT00884312|carfilzomib|carfilzomib
537604|NCT00884312|PR-171|pr-171
537605|NCT00884299|Lung function|lung function
537606|NCT00884299|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
537607|NCT00884299|Antioxidants|antioxidants
537608|NCT00884286|Aplidin|aplidin
537609|NCT00884286|Aggressive Non Hodgkin Lymphoma|aggressive non hodgkin lymphoma
537610|NCT00884286|Leukemia-Lymphoma, Adult T-Cell and B-cell|leukemia-lymphoma, adult t-cell and b-cell
537611|NCT00884260|Contraception|contraception
537612|NCT00884260|Intrauterine contraception system|intrauterine contraception system
537613|NCT00884247|GERD|gerd
537614|NCT00884247|Quality of life|quality of life
537615|NCT00884247|Structured treatment|structured treatment
537616|NCT00884234|Lateral Canthal Lines|lateral canthal lines
537617|NCT00884234|Crow's Feet|crow's feet
537618|NCT00884234|Facial Wrinkles|facial wrinkles
537619|NCT00884234|Lateral Canthal Area|lateral canthal area
537620|NCT00884195|Obesity|obesity
537621|NCT00884182|Influenza|influenza
537622|NCT00884182|Orthomyxoviruses|orthomyxoviruses
537623|NCT00884182|Split Virion Pandemic Influenza Vaccine|split virion pandemic influenza vaccine
537624|NCT00884182|A/H5N1|a/h5n1
537625|NCT00884143|tamoxifen|tamoxifen
537626|NCT00884143|arimidex|arimidex
537627|NCT00884143|adjuvant hormonal therapies|adjuvant hormonal therapies
537628|NCT00884143|breast cancer|breast cancer
537629|NCT00884143|post-menopausal|post-menopausal
537630|NCT00884143|Adjuvant hormonal therapy in patients post menopausal with breast cancer|adjuvant hormonal therapy in patients post menopausal with breast cancer
537631|NCT00884130|Laparoscopy|laparoscopy
537632|NCT00884130|Colorectal surgery|colorectal surgery
537633|NCT00884130|Quality of life|quality of life
537634|NCT00884130|economic analysis|economic analysis
537635|NCT00884130|Patients undergoing laparoscopic colorectal surgery|patients undergoing laparoscopic colorectal surgery
537636|NCT00884104|Solifenacin|solifenacin
537637|NCT00884104|Tamsulosin|tamsulosin
537638|NCT00884104|OAB|oab
537639|NCT00884091|Chinese|chinese
537640|NCT00884091|Glucagon-like peptide 1|glucagon-like peptide 1
537641|NCT00884091|Glucagon|glucagon
537642|NCT00884091|Insulin|insulin
537643|NCT00884091|Mixed meals|mixed meals
537644|NCT00884091|Healthy Adults|healthy adults
537645|NCT00884078|Self harm in south asian women|self harm in south asian women
537646|NCT00884078|depression|depression
537647|NCT00884078|suicidal ideations|suicidal ideations
537648|NCT00884078|problem solving training|problem solving training
537649|NCT00884065|Physiotherapy|physiotherapy
537650|NCT00884065|Manual therapy|manual therapy
537651|NCT00884065|Painful Shoulder|painful shoulder
537652|NCT00884065|Diacutaneous Fibrolysis|diacutaneous fibrolysis
537653|NCT00884052|Neonatal seizures|neonatal seizures
537654|NCT00884039|cornea|cornea
537655|NCT00884039|transplant|transplant
537656|NCT00884039|intraocular pressure|intraocular pressure
537657|NCT00884039|steroid response|steroid response
537658|NCT00884026|Cesarean delivery|cesarean delivery
537659|NCT00884026|hypotension|hypotension
537660|NCT00884026|Augmentation Index|augmentation index
537661|NCT00884026|Pulse Wave analysis|pulse wave analysis
537662|NCT00884026|spinal anesthesia|spinal anesthesia
537663|NCT00884026|Hypotension following spinal anesthesia for cesarean delivery|hypotension following spinal anesthesia for cesarean delivery
537664|NCT00884013|Pay for Quality|pay for quality
537665|NCT00884013|Provider|provider
537666|NCT00884013|Clinical Decision Support|clinical decision support
537667|NCT00884013|Quality Reporting|quality reporting
537668|NCT00884013|Quality Measurement|quality measurement
537669|NCT00883974|preterm bith|preterm bith
537670|NCT00883974|neurodevelopment|neurodevelopment
537671|NCT00883974|sensitivity training|sensitivity training
537672|NCT00883974|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
537673|NCT00883974|Infant neurodevelopment following preterm birth|infant neurodevelopment following preterm birth
537674|NCT00883961|High-dose chemotherapy|high-dose chemotherapy
537675|NCT00883961|Hematological neoplasties|hematological neoplasties
537676|NCT00883961|Fatigue|fatigue
537677|NCT00883961|Cancer|cancer
537678|NCT00883961|Exercise|exercise
537679|NCT00883961|Sport|sport
537680|NCT00883961|Hematologic neoplastic disorders|hematologic neoplastic disorders
537681|NCT00883948|Acute Lung Injury|acute lung injury
537682|NCT00883948|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
537683|NCT00883948|Feeding|feeding
537684|NCT00883948|Critical Care|critical care
537685|NCT00883948|Ventilator|ventilator
537686|NCT00883935|GSK1349572|gsk1349572
537687|NCT00883935|Atazanavir|atazanavir
537688|NCT00883935|Ritonavir|ritonavir
537689|NCT00883935|Reyataz|reyataz
537690|NCT00883935|Norvir|norvir
537691|NCT00883935|healthy|healthy
537692|NCT00883935|pharmacokinetic|pharmacokinetic
537693|NCT00883909|Prostate Cancer|prostate cancer
537694|NCT00883909|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
537695|NCT00883896|Rheumatoid Arthritis|rheumatoid arthritis
537696|NCT00883896|ACR|acr
537697|NCT00883896|Methotrexate|methotrexate
537698|NCT00883896|Interleukin-22|interleukin-22
537699|NCT00883883|Antibiotic|antibiotic
537700|NCT00883870|mesenchymal stem cells|mesenchymal stem cells
537701|NCT00883870|critical limb ischemia|critical limb ischemia
537702|NCT00883844|Hepatitis B|hepatitis b
537703|NCT00883844|sustained response|sustained response
537704|NCT00883844|peginterferon|peginterferon
537705|NCT00883844|nucleos(t)ide analogues|nucleos(t)ide analogues
537706|NCT00883831|Acupuncture|acupuncture
537707|NCT00883831|Hemodialysis|hemodialysis
537708|NCT00883831|Symptom|symptom
537709|NCT00883831|end stage renal disease|end stage renal disease
537710|NCT00883831|chronic kidney disease|chronic kidney disease
537711|NCT00883831|supportive care|supportive care
537712|NCT00883818|Overactive bladder|overactive bladder
537713|NCT00883818|Mycoplasma|mycoplasma
537714|NCT00883805|Metal Ion Concentration|metal ion concentration
537715|NCT00883805|Osteolysis|osteolysis
537716|NCT00883766|Polycystic Ovary Syndrome|polycystic ovary syndrome
537717|NCT00883766|GnRH Antagonist|gnrh antagonist
537718|NCT00883766|Long Agonist Protocol|long agonist protocol
537719|NCT00883766|OHSS|ohss
537720|NCT00883740|Fibromyalgia sleep maintenance disturbance pregabalin|fibromyalgia sleep maintenance disturbance pregabalin
537721|NCT00883727|mesenchymal stem cells|mesenchymal stem cells
537722|NCT00883727|myocardial infarction|myocardial infarction
537723|NCT00883714|Exercise|exercise
537724|NCT00883714|sport|sport
537725|NCT00883714|Allogeneic blood stem cell transplantation|allogeneic blood stem cell transplantation
537726|NCT00883714|Blood stem cell transplantation|blood stem cell transplantation
537727|NCT00883714|Fatigue|fatigue
537728|NCT00883714|Cancer|cancer
537729|NCT00883714|Physical performance|physical performance
537730|NCT00883714|Mood|mood
537731|NCT00883714|Complications|complications
537732|NCT00883701|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
537733|NCT00883701|exacerbations|exacerbations
537734|NCT00883701|perforin|perforin
537735|NCT00883701|granzymes|granzymes
537736|NCT00883688|Brain Tumor|brain tumor
537737|NCT00883688|Recurrent Ependymoma|recurrent ependymoma
537738|NCT00883688|Refractory Ependymoma|refractory ependymoma
537739|NCT00883688|Intracranial ependymoma|intracranial ependymoma
537740|NCT00883688|Ependymoblastoma|ependymoblastoma
537741|NCT00883688|Subependymoma|subependymoma
537742|NCT00883688|Myxopapillary|myxopapillary
537743|NCT00883688|Clear cell|clear cell
537744|NCT00883688|Anaplastic|anaplastic
537745|NCT00883688|Bevacizumab|bevacizumab
537746|NCT00883688|Avastin|avastin
537747|NCT00883688|Anti-VEGF Monoclonal Antibody|anti-vegf monoclonal antibody
537748|NCT00883688|rhuMAb-VEGF|rhumab-vegf
537749|NCT00883688|Lapatinib|lapatinib
537750|NCT00883688|Tykerb|tykerb
537751|NCT00883688|GW572016|gw572016
537752|NCT00883675|Lung cancer|lung cancer
537753|NCT00883675|Adjuvant therapy|adjuvant therapy
537754|NCT00883649|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
537755|NCT00883649|Dry Eyes|dry eyes
537756|NCT00883649|Post-menopausal|post-menopausal
537757|NCT00883636|Podocyte Protein|podocyte protein
537758|NCT00883636|Podocyte Mutation|podocyte mutation
537759|NCT00883623|AL-Amyloidosis|al-amyloidosis
537760|NCT00883623|Lenalidomide|lenalidomide
537761|NCT00883610|QT Interval|qt interval
537762|NCT00883610|Dual Chamber Pacemaker|dual chamber pacemaker
537763|NCT00883610|Atrial Fibrillation|atrial fibrillation
537764|NCT00883584|Proof of Concept|proof of concept
537765|NCT00883584|Inflammatory Markers|inflammatory markers
537766|NCT00883584|Lung Function|lung function
537767|NCT00883584|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
537768|NCT00883584|COPD|copd
537769|NCT00883571|anal stenosis|anal stenosis
537770|NCT00883571|flaps|flaps
537771|NCT00883571|anoplasty|anoplasty
537772|NCT00883558|recombinant human hyaluronidase (rHuPH20)|recombinant human hyaluronidase (rhuph20)
537773|NCT00883558|Insulin lispro|insulin lispro
537774|NCT00883558|regular human insulin|regular human insulin
537775|NCT00883545|Adherence to screening colonoscopy in women|adherence to screening colonoscopy in women
537776|NCT00883532|Preterm infant|preterm infant
537777|NCT00883532|Respiratory distress syndrome|respiratory distress syndrome
537778|NCT00883532|chronic lung disease|chronic lung disease
537779|NCT00883532|budesonide|budesonide
537780|NCT00883532|surfactant|surfactant
537781|NCT00883493|Acute bipolar depression|acute bipolar depression
537782|NCT00883493|Lithium carbonate|lithium carbonate
537783|NCT00883493|quetiapine fumarate|quetiapine fumarate
537784|NCT00883493|MADRS|madrs
537785|NCT00883480|NSCLC|nsclc
537786|NCT00883467|Ischemic Preconditioning|ischemic preconditioning
537787|NCT00883467|functional MRI|functional mri
537788|NCT00883467|BOLD|bold
537789|NCT00883467|Reperfusion|reperfusion
537790|NCT00883454|hepatocellular carcinoma|hepatocellular carcinoma
537791|NCT00883454|liver tumor|liver tumor
537792|NCT00883454|cirrhosis|cirrhosis
537793|NCT00883454|liver resection|liver resection
537794|NCT00883454|tumor staging|tumor staging
537795|NCT00883454|liver disease staging|liver disease staging
537796|NCT00883441|IMPLEMENTATION RESEARCH|implementation research
537797|NCT00883441|AEDES|aedes
537798|NCT00883441|VECTOR CONTROL|vector control
537799|NCT00883428|low back pain|low back pain
537800|NCT00883428|pelvic pain|pelvic pain
537801|NCT00883428|pregnancy|pregnancy
537802|NCT00883415|metabolism|metabolism
537803|NCT00883415|myocardium|myocardium
537804|NCT00883415|chronic kidney disease|chronic kidney disease
537805|NCT00883402|Carotid stenosis|carotid stenosis
537806|NCT00883402|CEA|cea
537807|NCT00883402|CAS|cas
537808|NCT00883402|Stenting|stenting
537809|NCT00883389|patient safety|patient safety
537810|NCT00883389|chronic kidney disease|chronic kidney disease
537811|NCT00883389|med-alert|med-alert
537812|NCT00883376|Classification of Stanford for Snoring|classification of stanford for snoring
537813|NCT00883376|OSAS|osas
537814|NCT00883376|Apnea-Hipopnea Index|apnea-hipopnea index
537815|NCT00883363|precondition|precondition
537816|NCT00883363|ruptured abdominal aortic aneurysm|ruptured abdominal aortic aneurysm
538408|NCT00880815|FBR|fbr
537817|NCT00883363|myocardial infarction|myocardial infarction
537818|NCT00883350|Body weight changes|body weight changes
537819|NCT00883350|Overweight|overweight
537820|NCT00883350|Obesity|obesity
537821|NCT00883337|Relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
537823|NCT00883324|fetal fibronectin|fetal fibronectin
537824|NCT00883324|non-speculum|non-speculum
537825|NCT00883324|risk of preterm delivery|risk of preterm delivery
537826|NCT00883311|Efficacy|efficacy
537827|NCT00883298|temozolomide|temozolomide
537828|NCT00883298|bevacizumab|bevacizumab
537829|NCT00883298|Temodar|temodar
537830|NCT00883298|Avastin|avastin
537831|NCT00883298|glioblastoma multiforme|glioblastoma multiforme
537832|NCT00883298|gliosarcoma|gliosarcoma
537833|NCT00883298|glioma|glioma
537834|NCT00883298|GBM|gbm
537835|NCT00883298|brain tumor|brain tumor
537836|NCT00883272|Menopause|menopause
537837|NCT00883272|Thrombophilia|thrombophilia
537838|NCT00883272|factor V Leiden|factor v leiden
537839|NCT00883272|Estrogen Replacement Therapy|estrogen replacement therapy
537840|NCT00883272|Hypercoagulability|hypercoagulability
537841|NCT00883272|Venous Thrombosis|venous thrombosis
537842|NCT00883259|High-risk patients|high-risk patients
537843|NCT00883259|Metformin|metformin
537844|NCT00883259|PCOS|pcos
537845|NCT00883259|Pregnancy complications|pregnancy complications
537846|NCT00883259|Previous gestational DM|previous gestational dm
537847|NCT00883246|PAD|pad
537848|NCT00883233|Acne|acne
537849|NCT00883220|self management|self management
537850|NCT00883220|chronic condition|chronic condition
537851|NCT00883220|urinary catheter|urinary catheter
537852|NCT00883207|Depression|depression
537853|NCT00883207|family therapy|family therapy
537854|NCT00883207|dialogical processes|dialogical processes
537855|NCT00883207|Developing couple therapy for depression|developing couple therapy for depression
537856|NCT00883194|Experimental Pain Model|experimental pain model
537857|NCT00883155|Antidepressant|antidepressant
537858|NCT00883142|Lokomat|lokomat
537859|NCT00883142|Suspended walking|suspended walking
537860|NCT00883142|Body Weight Supported|body weight supported
537861|NCT00883142|Treadmill Training|treadmill training
537862|NCT00883129|Systemic Sclerosis|systemic sclerosis
537863|NCT00883129|Mycophenolate Mofetil|mycophenolate mofetil
537864|NCT00883129|Cyclophosphamide|cyclophosphamide
537865|NCT00883129|High Resolution Computerized Tomography|high resolution computerized tomography
537866|NCT00883129|Pulmonary Function|pulmonary function
537867|NCT00883129|Dyspnea|dyspnea
537868|NCT00883129|Health Related Quality of Life|health related quality of life
537869|NCT00883103|female urethral catheterization|female urethral catheterization
537870|NCT00883103|Lidocaine|lidocaine
537871|NCT00883103|lubricant|lubricant
537872|NCT00883103|Q-tip test|q-tip test
537873|NCT00883103|Q tip test|q tip test
537874|NCT00883103|K-Y jelly|k-y jelly
537875|NCT00883103|pain perception|pain perception
537876|NCT00883103|straight catheterization|straight catheterization
537877|NCT00883090|Factor XIII|factor xiii
537878|NCT00883077|permeability|permeability
537879|NCT00883077|inflammatory bowel disease|inflammatory bowel disease
537880|NCT00883077|confocal laser endomicroscopy|confocal laser endomicroscopy
537881|NCT00883077|irritable bowel syndrome|irritable bowel syndrome
537882|NCT00883051|COL-144|col-144
537883|NCT00883051|acute treatment|acute treatment
537884|NCT00883051|migraine|migraine
537885|NCT00883038|insulin resistance|insulin resistance
537886|NCT00883038|vegetarian diet|vegetarian diet
537887|NCT00883025|Friedman Classification|friedman classification
537888|NCT00883025|Apnea-Hypopnea Index|apnea-hypopnea index
537889|NCT00883025|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
537890|NCT00883012|Viral-confirmed|viral-confirmed
537891|NCT00882999|Relapsing|relapsing
537892|NCT00882999|Remitting|remitting
537893|NCT00882999|Multiple Sclerosis|multiple sclerosis
537894|NCT00882999|Multiple|multiple
537895|NCT00882999|Sclerosis|sclerosis
537896|NCT00882999|MS|ms
537897|NCT00882999|LY2127399|ly2127399
537898|NCT00882986|insulin resistance|insulin resistance
537899|NCT00882960|pre-hospital|pre-hospital
537900|NCT00882960|intra-nasal fentanyl|intra-nasal fentanyl
537901|NCT00882960|patients requiring analgesia|patients requiring analgesia
537902|NCT00882947|Primary Pulmonary Hypertension (PPH)|primary pulmonary hypertension (pph)
537903|NCT00882934|Placebo|placebo
537904|NCT00882934|Placebo Effect|placebo effect
537905|NCT00882934|Sexual Dysfunction|sexual dysfunction
537906|NCT00882934|Erectile Dysfunction|erectile dysfunction
537907|NCT00882934|Clinical Trial|clinical trial
537908|NCT00882921|Hunter syndrome|hunter syndrome
537909|NCT00882921|hunters syndrome|hunters syndrome
537910|NCT00882921|hunter's syndrome|hunter's syndrome
537911|NCT00882921|hunter disease|hunter disease
537912|NCT00882921|hunters disease|hunters disease
537913|NCT00882921|hunter's disease|hunter's disease
537914|NCT00882921|MPS II|mps ii
537915|NCT00882921|MPSII|mpsii
537916|NCT00882921|MPS2|mps2
537917|NCT00882921|MPS 2|mps 2
537918|NCT00882921|mucopolysaccharides|mucopolysaccharides
537919|NCT00882921|lysosomal storage disease|lysosomal storage disease
537920|NCT00882921|lysosomal storage disorder|lysosomal storage disorder
537921|NCT00882921|chronic ear infection|chronic ear infection
537922|NCT00882921|enlarged adenoids|enlarged adenoids
537923|NCT00882921|mps symptoms|mps symptoms
537924|NCT00882921|mps diagnosis|mps diagnosis
537925|NCT00882921|mps ii therapy|mps ii therapy
537926|NCT00882921|MPS II treatment|mps ii treatment
537927|NCT00882921|ert treatment|ert treatment
537928|NCT00882921|elaprase|elaprase
537929|NCT00882921|idursulfase|idursulfase
537930|NCT00882921|iduronate sulfatase|iduronate sulfatase
537931|NCT00882921|iduronate 2 sulfatase|iduronate 2 sulfatase
537932|NCT00882921|enzyme replacement therapy|enzyme replacement therapy
537933|NCT00882921|hunter syndrome treatment|hunter syndrome treatment
537934|NCT00882921|hunter's syndrome treatment|hunter's syndrome treatment
537935|NCT00882921|hunter syndrome therapy|hunter syndrome therapy
537936|NCT00882921|hunter's disease treatment|hunter's disease treatment
537937|NCT00882921|mps society|mps society
537938|NCT00882908|Hepatitis C|hepatitis c
537939|NCT00882908|TMC435|tmc435
537940|NCT00882908|Peginterferon alpha-2a|peginterferon alpha-2a
537941|NCT00882908|PegIFNalpha-2a|pegifnalpha-2a
537942|NCT00882908|RBV|rbv
537943|NCT00882908|Ribavirin|ribavirin
537944|NCT00882908|Placebo|placebo
537945|NCT00882895|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
537946|NCT00882895|Transplantation, Autologous|transplantation, autologous
537947|NCT00882895|Transplantation, Homologous|transplantation, homologous
537948|NCT00882895|Total Lymphoid Irradiation|total lymphoid irradiation
537949|NCT00882895|Anti-thymocyte globulin|anti-thymocyte globulin
537950|NCT00882869|Advanced Hepatocellular carcinoma|advanced hepatocellular carcinoma
537951|NCT00882869|liver|liver
537952|NCT00882869|cancer|cancer
537953|NCT00882869|antisense|antisense
537954|NCT00882869|sorafenib|sorafenib
537955|NCT00882856|Clozapine|clozapine
537956|NCT00882856|Sinustachycardia|sinustachycardia
537957|NCT00882856|Heartrate variability|heartrate variability
537958|NCT00882856|Cardiomyopathy|cardiomyopathy
537959|NCT00882843|Vibrating plate|vibrating plate
537960|NCT00882843|Mechanical Stimulation|mechanical stimulation
537961|NCT00882843|Osteoporosis|osteoporosis
537962|NCT00882830|ICU|icu
537963|NCT00882830|myopathy|myopathy
537964|NCT00882830|neuropathy|neuropathy
537965|NCT00882830|EMS|ems
537966|NCT00882830|critical illness polyneuromyopathy|critical illness polyneuromyopathy
537967|NCT00882830|NIRS|nirs
537968|NCT00882830|muscle biopsy|muscle biopsy
537969|NCT00882830|microdialysis|microdialysis
537970|NCT00882830|CIPNM|cipnm
537971|NCT00882817|ILD|ild
537972|NCT00882804|hemin, heme oxygenase, humans, HO-1|hemin, heme oxygenase, humans, ho-1
537973|NCT00882791|Skin Cancer|skin cancer
537974|NCT00882791|Basal Cell|basal cell
537975|NCT00882791|Mohs surgery|mohs surgery
537976|NCT00882765|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
537977|NCT00882765|stage I pancreatic cancer|stage i pancreatic cancer
537978|NCT00882765|stage II pancreatic cancer|stage ii pancreatic cancer
537979|NCT00882765|stage III pancreatic cancer|stage iii pancreatic cancer
537980|NCT00882752|Ulcerative Colitis (UC)|ulcerative colitis (uc)
537981|NCT00882739|angiography|angiography
537982|NCT00882739|percutaneous coronary intervention|percutaneous coronary intervention
537983|NCT00882739|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
537984|NCT00882739|Platelet Function Tests|platelet function tests
537985|NCT00882726|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
537986|NCT00882726|CNTO 3649|cnto 3649
537987|NCT00882726|safety|safety
537988|NCT00882726|Phase I|phase i
537989|NCT00882726|healthy adults|healthy adults
537990|NCT00882726|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
537991|NCT00882700|Antibiotic|antibiotic
537992|NCT00882661|Neck Pain|neck pain
537993|NCT00882661|Arm Pain|arm pain
537994|NCT00882648|Drug dependence during pregnancy|drug dependence during pregnancy
537995|NCT00882635|STEMI|stemi
537996|NCT00882635|acute coronary syndromes|acute coronary syndromes
537997|NCT00882635|primary percutaneous coronary intervention|primary percutaneous coronary intervention
537998|NCT00882622|Ischemic Preconditioning|ischemic preconditioning
537999|NCT00882622|Cardiac Surgery|cardiac surgery
538000|NCT00882609|bone metastasis|bone metastasis
538001|NCT00882609|bone metastases|bone metastases
538002|NCT00882609|Sodium Fluoride|sodium fluoride
538003|NCT00882609|F18 Fluoride|f18 fluoride
538004|NCT00882609|bone scan|bone scan
538005|NCT00882596|Contura|contura
538006|NCT00882596|Cancer|cancer
538007|NCT00882596|Accelerated|accelerated
538008|NCT00882596|Partial|partial
538009|NCT00882596|Breast|breast
538010|NCT00882596|Irradiation|irradiation
538011|NCT00882583|HNSCC|hnscc
538012|NCT00882583|Dasatinib|dasatinib
538013|NCT00882583|Cetuximab|cetuximab
538014|NCT00882583|Cisplatin|cisplatin
538015|NCT00882570|Antibiotic|antibiotic
538016|NCT00882557|End-stage renal disease|end-stage renal disease
538017|NCT00882557|hemodialysis|hemodialysis
538018|NCT00882557|chronic renal failure|chronic renal failure
538019|NCT00882544|hydronephrosis|hydronephrosis
538020|NCT00882544|robotic pyeloplasty|robotic pyeloplasty
538021|NCT00882544|pediatric pyeloplasty|pediatric pyeloplasty
538022|NCT00882518|Quetiapine Fumarate (SEROQUEL) Extended-Release (XR)|quetiapine fumarate (seroquel) extended-release (xr)
538023|NCT00882518|qualified PANSS assessment|qualified panss assessment
538024|NCT00882492|Cardiac|cardiac
538025|NCT00882492|Surgery|surgery
538026|NCT00882492|Glycemia|glycemia
538027|NCT00882466|erythropoietin|erythropoietin
538028|NCT00882453|Physical Activity|physical activity
538029|NCT00882453|Fatigue|fatigue
538030|NCT00882453|RRMS|rrms
538031|NCT00882453|CIS|cis
538032|NCT00882427|algorithm|algorithm
538033|NCT00882427|tight glycemic control|tight glycemic control
538034|NCT00882427|glucose control|glucose control
538035|NCT00882427|intensive care|intensive care
538036|NCT00882427|insulin|insulin
538037|NCT00882427|ICU|icu
538038|NCT00882414|ferric carboxymaltose|ferric carboxymaltose
538039|NCT00882414|platelet|platelet
538040|NCT00882414|thrombocyte|thrombocyte
538041|NCT00882414|ferritin|ferritin
538042|NCT00882414|hemoglobin|hemoglobin
538043|NCT00882414|transferrin|transferrin
538044|NCT00882388|celecoxib|celecoxib
538045|NCT00882388|platelet|platelet
538046|NCT00882388|thrombosis|thrombosis
538047|NCT00882388|Volunteers|volunteers
538048|NCT00882375|Smoking Cessation|smoking cessation
538049|NCT00882336|Cardiovascular risk management|cardiovascular risk management
538050|NCT00882336|Hyperlipidemia|hyperlipidemia
538051|NCT00882336|Hypertension|hypertension
538052|NCT00882336|Diabetes|diabetes
538053|NCT00882336|Obesity|obesity
538054|NCT00882310|Pancreatic cancer|pancreatic cancer
538055|NCT00882310|Gemzar|gemzar
538056|NCT00882310|Taxotere|taxotere
538057|NCT00882310|Xeloda|xeloda
538058|NCT00882310|GTX|gtx
538059|NCT00882297|Ultrasoundography|ultrasoundography
538060|NCT00882297|catheterization|catheterization
538061|NCT00882297|central venous subclavian vein methods|central venous subclavian vein methods
538062|NCT00882284|NICHD Neonatal Research Network|nichd neonatal research network
538063|NCT00882284|Blood Pressure Management|blood pressure management
538064|NCT00882271|Fibromyalgia|fibromyalgia
538065|NCT00882271|Acupuncture|acupuncture
538066|NCT00882271|Pain|pain
538067|NCT00882258|Uterine fibroids|uterine fibroids
538068|NCT00882232|prostate|prostate
538069|NCT00882232|cancer|cancer
538070|NCT00882232|cross-linked|cross-linked
538071|NCT00882232|hyaluronan|hyaluronan
538072|NCT00882232|gel|gel
538073|NCT00882232|Hylaform|hylaform
538074|NCT00882232|rectal|rectal
538075|NCT00882232|toxicity|toxicity
538076|NCT00882219|Drug eluting stent|drug eluting stent
538077|NCT00882219|Stents|stents
538078|NCT00882219|Angioplasty|angioplasty
538079|NCT00882219|Chronic coronary occlusion|chronic coronary occlusion
538080|NCT00882219|Stent thrombosis|stent thrombosis
538081|NCT00882219|Vascular disease|vascular disease
538082|NCT00882219|Myocardial ischemia|myocardial ischemia
538083|NCT00882219|Coronary artery stenosis|coronary artery stenosis
538084|NCT00882219|Coronary Disease|coronary disease
538085|NCT00882219|Coronary Artery Disease|coronary artery disease
538086|NCT00882219|Coronary Restenosis|coronary restenosis
538087|NCT00882206|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
538088|NCT00882206|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
538089|NCT00882206|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
538090|NCT00882206|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
538091|NCT00882193|Chronic hepatitis C|chronic hepatitis c
538092|NCT00882193|Genotype 1|genotype 1
538093|NCT00882193|Nonresponder|nonresponder
538094|NCT00882193|Relapser|relapser
538095|NCT00882193|Betaine|betaine
538096|NCT00882193|Antiviral therapy|antiviral therapy
538097|NCT00882180|Liver|liver
538098|NCT00882180|Solid Tumors|solid tumors
538099|NCT00882180|Advanced Solid Tumors with Liver Involvement|advanced solid tumors with liver involvement
538100|NCT00882154|Antibiotic|antibiotic
538101|NCT00882141|Exercise|exercise
538102|NCT00882141|Obesity|obesity
538103|NCT00882141|Insulin Sensitivity|insulin sensitivity
538104|NCT00882128|Asthma seasonal respiratory symptoms|asthma seasonal respiratory symptoms
538105|NCT00882128|Asthmatic patients with increase of respiratory symptoms|asthmatic patients with increase of respiratory symptoms
538106|NCT00882115|DEP|dep
538107|NCT00882115|Broccoli Sprout Extract|broccoli sprout extract
538108|NCT00882115|Allergies|allergies
538109|NCT00882102|Acute Myelogenous Leukemia|acute myelogenous leukemia
538110|NCT00882102|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
538111|NCT00882102|AML|aml
538112|NCT00882102|MDS|mds
538113|NCT00882102|Leukemia|leukemia
538114|NCT00882102|Decitabine|decitabine
538115|NCT00882102|Gemtuzumab Ozogamicin|gemtuzumab ozogamicin
538116|NCT00882102|Dacogen|dacogen
538117|NCT00882102|Mylotarg|mylotarg
538118|NCT00882089|Contura|contura
538119|NCT00882089|Cancer|cancer
538120|NCT00882089|Accelerated|accelerated
538121|NCT00882089|Partial|partial
538122|NCT00882089|Breast|breast
538123|NCT00882089|Irradiation|irradiation
538124|NCT00882076|acute lymphoblastic leukemia|acute lymphoblastic leukemia
538125|NCT00882076|chronic lymphocytic leukemia|chronic lymphocytic leukemia
538126|NCT00882063|Multiple Myeloma|multiple myeloma
538127|NCT00882037|Methamphetamine Dependence|methamphetamine dependence
538128|NCT00882037|Substance Abuse Treatment|substance abuse treatment
538129|NCT00882037|Rural and Urban|rural and urban
538130|NCT00882037|Latino and Non-Latino|latino and non-latino
538131|NCT00882024|Rheumatoid arthritis|rheumatoid arthritis
538132|NCT00882011|T-lymphoblastic lymphoma|t-lymphoblastic lymphoma
538133|NCT00882011|Intensive chemo/radiotherapy|intensive chemo/radiotherapy
538134|NCT00882011|Intensive chemotherapy|intensive chemotherapy
538135|NCT00882011|Transplant|transplant
538136|NCT00882011|Adult patients|adult patients
538137|NCT00881998|Evaluate early functional outcomes of two anterior approaches to total hip arthroplasty|evaluate early functional outcomes of two anterior approaches to total hip arthroplasty
538138|NCT00881985|obstructive sleep apnea|obstructive sleep apnea
538139|NCT00881985|resistant hypertension|resistant hypertension
538140|NCT00881985|refractory hypertension|refractory hypertension
538141|NCT00881985|continuous positive airway pressure|continuous positive airway pressure
538142|NCT00881985|blood pressure control|blood pressure control
538143|NCT00881959|exposed Root Surface or Tooth|exposed root surface or tooth
538144|NCT00881959|Tooth Sensitivity Miller Class I|tooth sensitivity miller class i
538145|NCT00881959|Miller Class II|miller class ii
538146|NCT00881959|Gingival Margin|gingival margin
538147|NCT00881946|chronic lymphocytic leukemia|chronic lymphocytic leukemia
538148|NCT00881946|aggressive lymphoma|aggressive lymphoma
538149|NCT00881946|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
538150|NCT00881946|Hodgkin's lymphoma|hodgkin's lymphoma
538151|NCT00881946|chronic myelogenous leukemia|chronic myelogenous leukemia
538152|NCT00881946|multiple myeloma|multiple myeloma
538153|NCT00881946|acute lymphoblastic leukemia|acute lymphoblastic leukemia
538154|NCT00881946|acute myeloid leukemia|acute myeloid leukemia
538155|NCT00881933|Fludarabine, Cyclophosphamide, TBI, severe aplastic anemia,|fludarabine, cyclophosphamide, tbi, severe aplastic anemia,
538156|NCT00881933|cord blood transplantation, pediatric|cord blood transplantation, pediatric
538157|NCT00881920|Lymphocytic|lymphocytic
538158|NCT00881920|Leukemia|leukemia
538159|NCT00881920|B Cell|b cell
538160|NCT00881920|Non-Hodgkin|non-hodgkin
538161|NCT00881920|Multiple Myeloma|multiple myeloma
538162|NCT00881920|Lymphoma|lymphoma
538163|NCT00881907|Regeneration (revascularization) of dental pulp|regeneration (revascularization) of dental pulp
538164|NCT00881907|Immature Permanent Tooth With a Diagnosis of Pulpal Necrosis|immature permanent tooth with a diagnosis of pulpal necrosis
538165|NCT00881894|Rotigotine|rotigotine
538166|NCT00881894|Neupro®|neupro®
538167|NCT00881894|Transdermal Patch|transdermal patch
538168|NCT00881855|Antibiotics|antibiotics
538169|NCT00881842|Influenza|influenza
538170|NCT00881842|Vaccine|vaccine
538171|NCT00881842|CHMP criteria|chmp criteria
538172|NCT00881829|Pulse Oximetry|pulse oximetry
538173|NCT00881829|Temperature|temperature
538174|NCT00881829|Respiratory Rate|respiratory rate
538175|NCT00881829|Respiratory Gases|respiratory gases
538176|NCT00881829|This study determine the measurement accuracy of the physiological parameters|this study determine the measurement accuracy of the physiological parameters
538177|NCT00881816|Liposomal Paclitaxel|liposomal paclitaxel
538178|NCT00881816|Capecitabine|capecitabine
538179|NCT00881816|Maximum tolerated dose|maximum tolerated dose
538180|NCT00881816|Dose limiting toxicity|dose limiting toxicity
538181|NCT00881803|Spinal Cord Injuries|spinal cord injuries
538182|NCT00881803|Ascorbic Acid|ascorbic acid
538183|NCT00881803|Vitamin C|vitamin c
538184|NCT00881803|Iron|iron
538185|NCT00881803|Dietary Supplements|dietary supplements
538186|NCT00881777|Heart Failure|heart failure
538187|NCT00881777|Cardiomyopathy|cardiomyopathy
538188|NCT00881777|Ventricular Dysfunction|ventricular dysfunction
538189|NCT00881777|Heart Disease|heart disease
538190|NCT00881764|Anesthesia|anesthesia
538191|NCT00881764|New York|new york
538192|NCT00881764|Columbia|columbia
538193|NCT00881764|Children|children
538194|NCT00881764|Neurodevelopment|neurodevelopment
538195|NCT00881764|Child development|child development
538196|NCT00881764|Pediatric|pediatric
538197|NCT00881751|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
538198|NCT00881751|advanced adult primary liver cancer|advanced adult primary liver cancer
538199|NCT00881751|recurrent adult primary liver cancer|recurrent adult primary liver cancer
538200|NCT00881738|Antibiotic|antibiotic
538201|NCT00881725|Metformin|metformin
538202|NCT00881725|Prostate Cancer|prostate cancer
538203|NCT00881725|Radical Prostatectomy|radical prostatectomy
538204|NCT00881725|Neoadjuvant Intervention|neoadjuvant intervention
538205|NCT00881725|PTEN/AKT Pathway|pten/akt pathway
538206|NCT00881725|Tumour Expression|tumour expression
538207|NCT00881725|Ki67 Expression|ki67 expression
538208|NCT00881712|Non-small cell lung Cancer|non-small cell lung cancer
538209|NCT00881712|Proton Radiation|proton radiation
538210|NCT00881712|Stage III|stage iii
538211|NCT00881699|HIV Information|hiv information
538212|NCT00881699|HIV Prevention|hiv prevention
538213|NCT00881699|Severe Mental Illness|severe mental illness
538214|NCT00881699|HIV seronegativity|hiv seronegativity
538215|NCT00881686|Ischemic Preconditioning, Myocardial|ischemic preconditioning, myocardial
538216|NCT00881686|Adenosine|adenosine
538217|NCT00881673|Conjunctivitis|conjunctivitis
538218|NCT00881660|Fetal Tracheal Occlusion|fetal tracheal occlusion
538219|NCT00881660|congenital diaphragmatic hernia|congenital diaphragmatic hernia
538220|NCT00881660|FETO plug-unplug|feto plug-unplug
538221|NCT00881660|Goldvalve balloon|goldvalve balloon
538222|NCT00881660|Severe Congenital Diaphragmatic Hernia|severe congenital diaphragmatic hernia
538223|NCT00881660|Extremely Severe Congenital Diaphragmatic Hernia|extremely severe congenital diaphragmatic hernia
538224|NCT00881660|Goldbal balloon|goldbal balloon
538225|NCT00881660|FETO|feto
538226|NCT00881647|PTSD|ptsd
538227|NCT00881647|Insomnia Disorder|insomnia disorder
538228|NCT00881647|Insomnia|insomnia
538229|NCT00881647|CBT|cbt
538230|NCT00881621|Pancreas cancer|pancreas cancer
538231|NCT00881621|lapatinib|lapatinib
538232|NCT00881621|capecitabine|capecitabine
538233|NCT00881608|Menstruation|menstruation
538234|NCT00881595|Sarcomas|sarcomas
538235|NCT00881595|High-Risk Soft Tissue Sarcomas|high-risk soft tissue sarcomas
538236|NCT00881582|Hepatitis c|hepatitis c
538237|NCT00881582|Renal transplantation|renal transplantation
538238|NCT00881582|Pegylated interferon|pegylated interferon
538239|NCT00881556|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
538240|NCT00881556|AlloSCT|allosct
538241|NCT00881556|RDEB|rdeb
538242|NCT00881556|recessive dystrophic epidermolysis bullosa|recessive dystrophic epidermolysis bullosa
538243|NCT00881543|Sitagliptin|sitagliptin
538244|NCT00881543|Diets|diets
538245|NCT00881543|Diabetes type 2|diabetes type 2
538246|NCT00881543|Näive patients|näive patients
538247|NCT00881517|human cytomegalovirus|human cytomegalovirus
538248|NCT00881517|immune globulin|immune globulin
538249|NCT00881517|congenital infection|congenital infection
538250|NCT00881517|prevention|prevention
538251|NCT00881517|pregnancy|pregnancy
538252|NCT00881504|Biliary|biliary
538253|NCT00881504|Oxaliplatin|oxaliplatin
538254|NCT00881504|Bevacizumab|bevacizumab
538255|NCT00881491|Regeneration (revascularization) of dental pulp|regeneration (revascularization) of dental pulp
538256|NCT00881491|Immature permanent tooth with a diagnosis of|immature permanent tooth with a diagnosis of
538257|NCT00881478|Obesity|obesity
538258|NCT00881478|Children|children
538259|NCT00881478|Dyslipidemia|dyslipidemia
538260|NCT00881478|Hypertension|hypertension
538261|NCT00881465|Obsessive compulsive disorder|obsessive compulsive disorder
538262|NCT00881452|Autism|autism
538263|NCT00881439|Heart failure|heart failure
538264|NCT00881439|Renal Failure|renal failure
538265|NCT00881439|Cardiorenal Syndrome|cardiorenal syndrome
538266|NCT00881439|Renin inhibition|renin inhibition
538267|NCT00881439|Aliskiren|aliskiren
538268|NCT00881426|Antibiotic|antibiotic
538269|NCT00881413|Peptic ulcer bleeding|peptic ulcer bleeding
538270|NCT00881413|Proton pump inhibitor|proton pump inhibitor
538271|NCT00881413|Esomeprazole|esomeprazole
538272|NCT00881413|Pantoprazole|pantoprazole
538273|NCT00881413|Recurrent bleeding|recurrent bleeding
538274|NCT00881413|bleeding|bleeding
538275|NCT00881400|Antibiotic|antibiotic
538276|NCT00881387|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
538277|NCT00881387|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
538278|NCT00881387|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
538279|NCT00881387|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
538280|NCT00881387|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
538281|NCT00881361|stage II breast cancer|stage ii breast cancer
538282|NCT00881361|stage IIIA breast cancer|stage iiia breast cancer
538283|NCT00881361|stage IIIB breast cancer|stage iiib breast cancer
538284|NCT00881335|geriatric|geriatric
538285|NCT00881335|pulmonary disease|pulmonary disease
538286|NCT00881335|flutter|flutter
538287|NCT00881335|sputum|sputum
538288|NCT00881335|physical therapy techniques|physical therapy techniques
538289|NCT00881296|Elder Patients|elder patients
538290|NCT00881296|Non-Small Cell Lung Cancer|non-small cell lung cancer
538291|NCT00881296|Previously Untreated|previously untreated
538292|NCT00881296|Advanced|advanced
538293|NCT00881283|Cushing's disease|cushing's disease
538294|NCT00881257|Peripheral Vascular Disease|peripheral vascular disease
538295|NCT00881257|Peripheral Artery Disease|peripheral artery disease
538296|NCT00881257|Radiofrequency|radiofrequency
538297|NCT00881218|myocardial ischemia, perfusion imaging, cardiac MRI|myocardial ischemia, perfusion imaging, cardiac mri
538298|NCT00881205|Multiple Sclerosis|multiple sclerosis
538299|NCT00881205|Cognition|cognition
538300|NCT00881205|Rivastigmine|rivastigmine
538301|NCT00881205|Patch|patch
538302|NCT00881192|CABG|cabg
538303|NCT00881192|coronary surgery|coronary surgery
538304|NCT00881192|intra-aortic balloon pump|intra-aortic balloon pump
538305|NCT00881192|CABG operation|cabg operation
538306|NCT00881179|Antibiotic|antibiotic
538307|NCT00881166|MP-470|mp-470
538308|NCT00881166|Multi-targeted Tyrosine Kinase Inhibitor|multi-targeted tyrosine kinase inhibitor
538309|NCT00881166|Malignant disease|malignant disease
538311|NCT00881140|oral mifepristone|oral mifepristone
538312|NCT00881140|vaginal tablets|vaginal tablets
538313|NCT00881114|Head and neck cancer|head and neck cancer
538314|NCT00881114|pharmacogenetics|pharmacogenetics
538315|NCT00881114|chemoradiotherapy|chemoradiotherapy
538316|NCT00881101|Liposomal Paclitaxel|liposomal paclitaxel
538317|NCT00881101|Maximum tolerated dose|maximum tolerated dose
538318|NCT00881101|Dose limiting toxicity|dose limiting toxicity
538319|NCT00881088|Deep vein trombosis|deep vein trombosis
538320|NCT00881088|Profylaxis|profylaxis
538321|NCT00881088|Below knee plaster cast|below knee plaster cast
538322|NCT00881088|Ankle fracture|ankle fracture
538323|NCT00881075|Magnetic resonance imaging|magnetic resonance imaging
538324|NCT00881075|Heart diseases|heart diseases
538325|NCT00881075|myocardial infarction|myocardial infarction
538326|NCT00881075|contrast agents|contrast agents
538327|NCT00881075|manganese|manganese
538328|NCT00881062|ABSORPTION|absorption
538329|NCT00881062|METABOLISM|metabolism
538330|NCT00881062|EXCRETION|excretion
538331|NCT00881049|metastatic acral or mucosal melanoma with c-kit mutation or copy number increase|metastatic acral or mucosal melanoma with c-kit mutation or copy number increase
538332|NCT00881036|Hepatitis B|hepatitis b
538333|NCT00881010|Breast Cancer|breast cancer
538334|NCT00881010|Pain Intervention|pain intervention
538335|NCT00881010|Underserved minority patients|underserved minority patients
538336|NCT00881010|African American|african american
538337|NCT00881010|Hispanic|hispanic
538338|NCT00881010|Automated Telephone System for measuring symptoms|automated telephone system for measuring symptoms
538339|NCT00881010|Interactive voice response|interactive voice response
538341|NCT00880997|Cocaine Dependence|cocaine dependence
538342|NCT00880997|Substance Related Disorders|substance related disorders
538343|NCT00880984|Colon Anastomosis|colon anastomosis
538344|NCT00880984|Rectum Anastomosis|rectum anastomosis
538345|NCT00880984|Intestine|intestine
538346|NCT00880984|Colorectal Surgery|colorectal surgery
538347|NCT00880984|Colorectal Anastomosis|colorectal anastomosis
538348|NCT00880971|Lung|lung
538349|NCT00880971|Carcinoma|carcinoma
538350|NCT00880971|radiotherapy|radiotherapy
538351|NCT00880971|Surgery|surgery
538352|NCT00880945|FBS|fbs
538353|NCT00880945|coin lesions|coin lesions
538354|NCT00880945|ENB|enb
538355|NCT00880945|ROSE|rose
538356|NCT00880932|warfarin|warfarin
538357|NCT00880932|NSAID|nsaid
538358|NCT00880932|The condition is the concomitant prescription of|the condition is the concomitant prescription of
538359|NCT00880919|Borderline Personality Disorder|borderline personality disorder
538360|NCT00880919|BPD|bpd
538361|NCT00880919|Seroquel|seroquel
538362|NCT00880919|Seroquel XR|seroquel xr
538363|NCT00880919|quetiapine|quetiapine
538364|NCT00880919|quetiapine extended-release|quetiapine extended-release
538365|NCT00880906|eosinophilic esophagitis|eosinophilic esophagitis
538366|NCT00880906|esophageal food impaction|esophageal food impaction
538367|NCT00880906|dysphagia|dysphagia
538368|NCT00880893|Dengue virus|dengue virus
538369|NCT00880893|Dengue fever|dengue fever
538370|NCT00880893|Dengue hemorrhagic fever|dengue hemorrhagic fever
538371|NCT00880893|Dengue diseases|dengue diseases
538372|NCT00880893|Sanofi Pasteur's CYD Dengue Vaccine|sanofi pasteur's cyd dengue vaccine
538373|NCT00880880|urinary incontinence|urinary incontinence
538374|NCT00880880|fecal incontinence|fecal incontinence
538375|NCT00880880|communication|communication
538376|NCT00880867|Low Grade Recurrent B and T Cell Lymphoma|low grade recurrent b and t cell lymphoma
538377|NCT00880854|bladder cancer|bladder cancer
538378|NCT00880854|BCG-resistant localized transitional cell of the bladder|bcg-resistant localized transitional cell of the bladder
538379|NCT00880841|healthy normals, phase 1|healthy normals, phase 1
538380|NCT00880841|phase 1a study for healthy normals|phase 1a study for healthy normals
538381|NCT00880828|Cervical Radiculopathy|cervical radiculopathy
538382|NCT00880828|Radicular Pain|radicular pain
538383|NCT00880828|Acute neck pain|acute neck pain
538384|NCT00880828|Cervicobrachial pain|cervicobrachial pain
538385|NCT00880828|Far-infrared ray|far-infrared ray
538386|NCT00880828|FIR|fir
538387|NCT00880828|Cervical collar|cervical collar
538388|NCT00880828|Cervical device|cervical device
538389|NCT00880828|FIR Device|fir device
538390|NCT00880815|Leukemia|leukemia
538391|NCT00880815|Lymphoma|lymphoma
538392|NCT00880815|Lymphoid Malignancies|lymphoid malignancies
538393|NCT00880815|Non-myeloablative Allogeneic Conditioning|non-myeloablative allogeneic conditioning
538394|NCT00880815|Non-myeloablative Allogeneic Hematopoietic Transplantation|non-myeloablative allogeneic hematopoietic transplantation
538395|NCT00880815|Stem Cell Transplant|stem cell transplant
538396|NCT00880815|SCT|sct
538397|NCT00880815|Bendamustine HCI|bendamustine hci
538398|NCT00880815|Bendamustine|bendamustine
538399|NCT00880815|Bendamustine Hydrochloride|bendamustine hydrochloride
538400|NCT00880815|CEP-18083|cep-18083
538401|NCT00880815|SDX-105|sdx-105
538402|NCT00880815|Treanda|treanda
538403|NCT00880815|Fludarabine|fludarabine
538404|NCT00880815|Fludarabine Phosphate|fludarabine phosphate
538405|NCT00880815|Fludara|fludara
538406|NCT00880815|Rituximab|rituximab
538407|NCT00880815|Rituxan|rituxan
538409|NCT00880815|Graft-versus-host disease|graft-versus-host disease
538410|NCT00880815|GVHD|gvhd
538411|NCT00880802|Acute Coronary Syndromes|acute coronary syndromes
538412|NCT00880802|Non ST-Segment Elevation Myocardial Infarction|non st-segment elevation myocardial infarction
538413|NCT00880802|ST-Segment Elevation Myocardial Infarction|st-segment elevation myocardial infarction
538414|NCT00880802|Unstable Angina|unstable angina
538415|NCT00880789|Cord Blood Transplant|cord blood transplant
538416|NCT00880789|cytomegalovirus|cytomegalovirus
538417|NCT00880789|CMV|cmv
538418|NCT00880789|Adenovirus|adenovirus
538419|NCT00880789|ADV|adv
538420|NCT00880750|End stage Renal disease|end stage renal disease
538421|NCT00880724|COPD|copd
538422|NCT00880724|Emphysema|emphysema
538423|NCT00880724|Bronchoscopic Treatment|bronchoscopic treatment
538424|NCT00880724|Interventional Bronchoscopy|interventional bronchoscopy
538425|NCT00880711|Fiona|fiona
538426|NCT00880711|Faslodex|faslodex
538427|NCT00880711|Advanced Breast Cancer|advanced breast cancer
538428|NCT00880711|Real life data|real life data
538429|NCT00880711|Collect real life data in clinical practice across Austria|collect real life data in clinical practice across austria
538430|NCT00880698|Rotavirus|rotavirus
538431|NCT00880698|Rotavirus vaccine|rotavirus vaccine
538432|NCT00880685|Compulsive Stealing|compulsive stealing
538433|NCT00880685|Compulsive Shoplifting|compulsive shoplifting
538434|NCT00880672|prostate, dutasteride|prostate, dutasteride
538435|NCT00880672|vascular endothelial growth factor|vascular endothelial growth factor
538436|NCT00880672|hypoxia inducible factor|hypoxia inducible factor
538437|NCT00880659|Influenza|influenza
538438|NCT00880659|secondary transmission|secondary transmission
538439|NCT00880659|handwashing|handwashing
538440|NCT00880633|EUS|eus
538441|NCT00880633|periampullary neoplasms|periampullary neoplasms
538442|NCT00880620|Parkinson's disease|parkinson's disease
538443|NCT00880607|Pain|pain
538444|NCT00880607|Pediatric|pediatric
538445|NCT00880607|Spinal Fusion|spinal fusion
538446|NCT00880607|pain management|pain management
538447|NCT00880555|Magnetic Resonance Imaging|magnetic resonance imaging
538448|NCT00880555|Alzheimer disease|alzheimer disease
538449|NCT00880555|Mild cognitive impairment|mild cognitive impairment
538450|NCT00880555|Continuous arterial spin labeling|continuous arterial spin labeling
538451|NCT00880555|Semantic memory|semantic memory
538452|NCT00880542|localized osteosarcoma|localized osteosarcoma
538453|NCT00880542|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
538454|NCT00880542|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
538455|NCT00880529|rib fractures|rib fractures
538456|NCT00880529|ventilator|ventilator
538457|NCT00880529|ON-Q|on-q
538458|NCT00880529|analgesia|analgesia
538459|NCT00880503|Multidrug Resistance Molecular Target Analysis|multidrug resistance molecular target analysis
538460|NCT00880490|COPD|copd
538461|NCT00880464|autologous vaccination|autologous vaccination
538462|NCT00880464|GM-CSF|gm-csf
538463|NCT00880464|adenoviral mediated gene transfer|adenoviral mediated gene transfer
538464|NCT00880464|Stage IV breast cancer|stage iv breast cancer
538465|NCT00880451|Children and Adolescents|children and adolescents
538466|NCT00880451|Aging|aging
538467|NCT00880451|Brain Imaging|brain imaging
538468|NCT00880451|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
538469|NCT00880412|safety|safety
538470|NCT00880412|efficacy|efficacy
538471|NCT00880412|Alzheimer's disease|alzheimer's disease
538472|NCT00880412|treatment|treatment
538473|NCT00880412|phase II|phase ii
538474|NCT00880412|study|study
538475|NCT00880412|cholinesterase inhibitor|cholinesterase inhibitor
538476|NCT00880399|depression|depression
538477|NCT00880399|QIDS-SR|qids-sr
538478|NCT00880399|HAMD-17|hamd-17
538479|NCT00880399|orvepitant|orvepitant
538480|NCT00880399|MDD|mdd
538481|NCT00880399|neurokinin-1 antagonist|neurokinin-1 antagonist
538482|NCT00880399|double-blind|double-blind
538483|NCT00880399|Phase II|phase ii
538484|NCT00880399|randomized|randomized
538485|NCT00880399|efficacy|efficacy
538486|NCT00880399|placebo|placebo
538487|NCT00880399|safety|safety
538488|NCT00880386|dyspnea|dyspnea
538489|NCT00880386|stage I non-small cell lung cancer|stage i non-small cell lung cancer
538490|NCT00880386|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
538491|NCT00880386|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
538492|NCT00880386|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
538493|NCT00880386|pulmonary complications|pulmonary complications
538494|NCT00880386|radiation fibrosis|radiation fibrosis
538495|NCT00880373|Sickle Cell Disease|sickle cell disease
538496|NCT00880373|Pain|pain
538497|NCT00880373|Ibuprofen|ibuprofen
538498|NCT00880373|Morphine|morphine
538499|NCT00880373|Diamorphine|diamorphine
538500|NCT00880373|Patient Controlled Analgesia|patient controlled analgesia
538501|NCT00880360|Epithelial Ovarian Cancer|epithelial ovarian cancer
538502|NCT00880360|FIGO (International Fed of Gyn and Ob)Stage III or Stage IV|figo (international fed of gyn and ob)stage iii or stage iv
538503|NCT00880360|Extraovarian Peritoneal Cancer|extraovarian peritoneal cancer
538504|NCT00880360|Fallopian Tube Carcinoma Failing|fallopian tube carcinoma failing
538505|NCT00880347|Alzheimer's disease|alzheimer's disease
538506|NCT00880347|Other dementia|other dementia
538507|NCT00880347|Vascular dementia|vascular dementia
538508|NCT00880347|Mixed dementia|mixed dementia
538509|NCT00880347|Parkinson's Disease dementia|parkinson's disease dementia
538510|NCT00880347|Lewy bodies dementia|lewy bodies dementia
538511|NCT00880347|Frontotemporal dementia|frontotemporal dementia
538512|NCT00880347|Blood signature|blood signature
538513|NCT00880347|Diagnosis|diagnosis
538514|NCT00880347|SpliceArray (tm)|splicearray (tm)
538515|NCT00880347|Alzheimer's Disease and other non-AD dementia|alzheimer's disease and other non-ad dementia
538516|NCT00880334|TCC|tcc
538517|NCT00880334|Zactima|zactima
538518|NCT00880334|docetaxel|docetaxel
538519|NCT00880334|ZD6474|zd6474
538520|NCT00880334|taxotere|taxotere
538521|NCT00880321|first time in human|first time in human
538522|NCT00880321|BRAF inhibitor|braf inhibitor
538523|NCT00880321|dose escalation|dose escalation
538524|NCT00880308|Advanced tumors|advanced tumors
538525|NCT00880308|hedgehog|hedgehog
538526|NCT00880308|smoothened inhibitor|smoothened inhibitor
538527|NCT00880269|Acute myeloid leukemia|acute myeloid leukemia
538528|NCT00880269|AML|aml
538529|NCT00880269|relapsed acute myeloid leukemia|relapsed acute myeloid leukemia
538530|NCT00880269|refractory AML|refractory aml
538531|NCT00880269|refractory de novo AML|refractory de novo aml
538532|NCT00880269|refractory secondary AML|refractory secondary aml
538533|NCT00880269|secondary AML|secondary aml
538534|NCT00880269|AML following myelodysplastic syndrome (MDS)|aml following myelodysplastic syndrome (mds)
538535|NCT00880269|AML following antecedent hematological disorder (AHD)|aml following antecedent hematological disorder (ahd)
538536|NCT00880269|AML resistant to therapy|aml resistant to therapy
538537|NCT00880256|irritable bowel|irritable bowel
538538|NCT00880256|mindfulness|mindfulness
538539|NCT00880256|stress|stress
538540|NCT00880256|meditation|meditation
538541|NCT00880243|Acute myeloid leukemia|acute myeloid leukemia
538542|NCT00880243|Priming|priming
538543|NCT00880243|GM-CSF|gm-csf
538544|NCT00880243|Timed-sequential chemotherapy|timed-sequential chemotherapy
538545|NCT00880243|Prognosis|prognosis
538546|NCT00880230|Iliac Artery Stenting|iliac artery stenting
538547|NCT00880230|Peripheral Artery Disease|peripheral artery disease
538548|NCT00880217|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
538549|NCT00880217|Attention Deficit Disorders with Hyperactivity|attention deficit disorders with hyperactivity
538550|NCT00880217|Adult ADHD|adult adhd
538551|NCT00880217|JNJ-31001074|jnj-31001074
538552|NCT00880204|Cluster Randomized Trial|cluster randomized trial
538553|NCT00880204|ESS-EMCH|ess-emch
538554|NCT00880204|Neonatal|neonatal
538555|NCT00880204|Maternal|maternal
538556|NCT00880204|Life threatening emergency event|life threatening emergency event
538557|NCT00880191|nausea and vomiting|nausea and vomiting
538558|NCT00880191|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
538559|NCT00880178|Simvastatin|simvastatin
538560|NCT00880178|Niacin|niacin
538561|NCT00880178|Vascular Disease|vascular disease
538562|NCT00880178|Magnetic Resonance Imaging|magnetic resonance imaging
538563|NCT00880178|High Density Lipoprotein|high density lipoprotein
538564|NCT00880178|Oxidation|oxidation
538565|NCT00880178|Proteomics|proteomics
538566|NCT00880178|Stroke|stroke
538567|NCT00880178|Cerebrovascular Accident|cerebrovascular accident
538568|NCT00880165|Polysomnogram|polysomnogram
538569|NCT00880165|Continuous positive airway pressure|continuous positive airway pressure
538570|NCT00880152|stress|stress
538571|NCT00880152|mindfulness|mindfulness
538572|NCT00880152|trauma|trauma
538573|NCT00880139|Diabetes mellitus, type 1|diabetes mellitus, type 1
538574|NCT00880139|Inflammation|inflammation
538575|NCT00880139|Cytokines|cytokines
538576|NCT00880139|Vascular reactivity|vascular reactivity
538577|NCT00880126|Individualized Implementation|individualized implementation
538578|NCT00880126|Community Development Teams|community development teams
538579|NCT00880113|CT-perfusion|ct-perfusion
538580|NCT00880113|CT-angiography|ct-angiography
538581|NCT00880100|Steatorrhea|steatorrhea
538582|NCT00880100|Malabsorption of fat|malabsorption of fat
538583|NCT00880100|Pancreatic enzymes|pancreatic enzymes
538584|NCT00880100|Abdominal pain|abdominal pain
538585|NCT00880100|Greasy stools|greasy stools
538586|NCT00880087|Cardiac Arrest|cardiac arrest
538587|NCT00880087|Cardiopulmonary Arrest|cardiopulmonary arrest
538588|NCT00880087|Pediatric Cardiac Arrest|pediatric cardiac arrest
538589|NCT00880087|VABS|vabs
538590|NCT00880087|Vineland Adaptive Behavior Scale|vineland adaptive behavior scale
538591|NCT00880087|POPC/PCPC|popc/pcpc
538592|NCT00880087|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
538593|NCT00880074|Advanced Cancers|advanced cancers
538594|NCT00880074|FLT-PET|flt-pet
538595|NCT00880074|Positron Emission Tomography|positron emission tomography
538597|NCT00880074|[18F] fluorothymidine|[18f] fluorothymidine
538598|NCT00880074|[F-18]-fluoro-L-thymidine|[f-18]-fluoro-l-thymidine
538599|NCT00880074|FLT|flt
538600|NCT00880061|Diffuse Infiltrating Pontine Glioma|diffuse infiltrating pontine glioma
538811|NCT00879203|Cognition|cognition
538601|NCT00880061|Supratentorial High Grade Glioma|supratentorial high grade glioma
538602|NCT00880061|Convection-Enhanced Delivery|convection-enhanced delivery
538603|NCT00880061|Pediatric Brain Tumor|pediatric brain tumor
538604|NCT00880061|Brain Tumor|brain tumor
538605|NCT00880061|Glioma|glioma
538606|NCT00880048|depression|depression
538607|NCT00880048|safety|safety
538608|NCT00880048|HAMD|hamd
538609|NCT00880048|QIDS-SR|qids-sr
538610|NCT00880048|NK-1 antagonist|nk-1 antagonist
538611|NCT00880048|efficacy|efficacy
538612|NCT00880048|orvepitant|orvepitant
538613|NCT00880048|placebo|placebo
538614|NCT00880048|MDD|mdd
538615|NCT00880048|video-rating|video-rating
538616|NCT00880035|sedative drug|sedative drug
538617|NCT00880035|stress|stress
538618|NCT00880035|music|music
538619|NCT00880035|mechanical ventilation|mechanical ventilation
538620|NCT00880035|IL-6|il-6
538621|NCT00880035|cortisol|cortisol
538622|NCT00880035|prolactin|prolactin
538623|NCT00880035|CRP|crp
538624|NCT00880035|copeptin|copeptin
538625|NCT00880022|compression|compression
538626|NCT00880022|Flexitouch|flexitouch
538627|NCT00880022|breast cancer|breast cancer
538628|NCT00880022|lymphedema|lymphedema
538629|NCT00879996|Opiate Addiction|opiate addiction
538630|NCT00879996|Narcotic Addiction|narcotic addiction
538631|NCT00879996|Drug Addiction|drug addiction
538632|NCT00879996|Pain|pain
538633|NCT00879983|azithromycin, pharmacokinetics|azithromycin, pharmacokinetics
538634|NCT00879970|Cardiovascular Outcomes|cardiovascular outcomes
538635|NCT00879957|Infant, Premature|infant, premature
538636|NCT00879957|Infant|infant
538637|NCT00879957|Central venous catheterization|central venous catheterization
538638|NCT00879957|Anticoagulants|anticoagulants
538639|NCT00879944|Psoriasis|psoriasis
538640|NCT00879944|Obesity|obesity
538641|NCT00879944|BMI|bmi
538642|NCT00879944|Atopic Dermatitis|atopic dermatitis
538643|NCT00879918|Cigarette Smoking in African Americans|cigarette smoking in african americans
538644|NCT00879905|Phase I|phase i
538645|NCT00879905|Adults|adults
538646|NCT00879905|HSP990|hsp990
538647|NCT00879905|Advanced Solid Tumors|advanced solid tumors
538648|NCT00879905|Hsp90 inhibitor|hsp90 inhibitor
538649|NCT00879905|Cancer|cancer
538650|NCT00879892|xenon|xenon
538651|NCT00879892|hypothermia|hypothermia
538652|NCT00879892|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
538653|NCT00879879|precancerous condition|precancerous condition
538654|NCT00879866|NSCLC|nsclc
538655|NCT00879866|immunocytokine|immunocytokine
538656|NCT00879866|radiation|radiation
538657|NCT00879866|interleukin-2|interleukin-2
538658|NCT00879866|immunotherapy|immunotherapy
538659|NCT00879866|maintenance therapy|maintenance therapy
538660|NCT00879853|PTSD|ptsd
538661|NCT00879853|Depression|depression
538662|NCT00879853|Anger|anger
538663|NCT00879853|Domestic Violence|domestic violence
538664|NCT00879853|Refugee|refugee
538665|NCT00879853|Asylum Seeker|asylum seeker
538666|NCT00879853|Community Therapist|community therapist
538667|NCT00879853|Paraprofessional Therapists|paraprofessional therapists
538668|NCT00879840|Screening|screening
538669|NCT00879840|Modalities|modalities
538670|NCT00879840|Gynecological Cancers|gynecological cancers
538671|NCT00879801|prevention of diabetes|prevention of diabetes
538672|NCT00879801|susceptibility genes|susceptibility genes
538673|NCT00879801|type 2 diabetes|type 2 diabetes
538674|NCT00879801|insulin resistance|insulin resistance
538675|NCT00879801|beta-cell funtion|beta-cell funtion
538676|NCT00879788|Ramipril fed condition|ramipril fed condition
538677|NCT00879775|Pain|pain
538678|NCT00879775|Cancer patients|cancer patients
538679|NCT00879775|Caffeine|caffeine
538680|NCT00879775|Adjuvant analgesics|adjuvant analgesics
538681|NCT00879775|Sedation|sedation
538682|NCT00879775|Confusion|confusion
538683|NCT00879775|Quality of life|quality of life
538684|NCT00879775|Fatigue|fatigue
538685|NCT00879762|smallpox, vaccine, IMVAMUNE®|smallpox, vaccine, imvamune®
538686|NCT00879736|Doctor-patient communication|doctor-patient communication
538687|NCT00879736|Encounters|encounters
538688|NCT00879736|Patient education training|patient education training
538689|NCT00879723|post-burn recovery|post-burn recovery
538690|NCT00879723|oxidative stress|oxidative stress
538691|NCT00879723|micronutrient protocol|micronutrient protocol
538692|NCT00879710|Diabetes Mellitus|diabetes mellitus
538693|NCT00879710|Hypercholesterolemia|hypercholesterolemia
538694|NCT00879710|Simvastatin|simvastatin
538695|NCT00879710|Ezetimibe.|ezetimibe.
538696|NCT00879697|peripheral arterial disease|peripheral arterial disease
538697|NCT00879697|exercise|exercise
538698|NCT00879697|resistance training|resistance training
538699|NCT00879697|cardiac rehabilitation|cardiac rehabilitation
538700|NCT00879684|Phase 1|phase 1
538701|NCT00879684|Tumors|tumors
538702|NCT00879684|CVX-060|cvx-060
538703|NCT00879671|lutein|lutein
538704|NCT00879671|nonexudative AMD|nonexudative amd
538705|NCT00879671|MPOD|mpod
538706|NCT00879671|Supplementary Concepts|supplementary concepts
538707|NCT00879658|Multiple Sclerosis|multiple sclerosis
538708|NCT00879658|Relapsing-Remitting|relapsing-remitting
538709|NCT00879658|Demyelinating Autoimmune Diseases|demyelinating autoimmune diseases
538710|NCT00879645|Renal Impairment|renal impairment
538711|NCT00879645|Renal Disease|renal disease
538712|NCT00879645|Sodium Sulfide|sodium sulfide
538713|NCT00879606|Sepsis|sepsis
538714|NCT00879606|Acute Lung Injury|acute lung injury
538715|NCT00879606|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
538716|NCT00879606|ALI/ARDS|ali/ards
538717|NCT00879606|Lung Disease|lung disease
538718|NCT00879580|aneurysm|aneurysm
538719|NCT00879580|stent|stent
538720|NCT00879580|intracranial aneurysm|intracranial aneurysm
538721|NCT00879580|Ruptured Intracranial Aneurysm|ruptured intracranial aneurysm
538722|NCT00879554|Phase 1|phase 1
538723|NCT00879554|Solid Tumors|solid tumors
538724|NCT00879554|CVX-045|cvx-045
538725|NCT00879541|Hemophilia A|hemophilia a
538726|NCT00879528|Hodgkin's Lymphoma|hodgkin's lymphoma
538727|NCT00879528|stem cell reinfusion|stem cell reinfusion
538728|NCT00879515|Fragile X Premutation|fragile x premutation
538729|NCT00879515|Fragile X Syndrome|fragile x syndrome
538730|NCT00879515|Down Syndrome|down syndrome
538731|NCT00879502|Fragile X Premutation|fragile x premutation
538732|NCT00879502|FMR1|fmr1
538733|NCT00879502|Premutation|premutation
538734|NCT00879502|Fragile X|fragile x
538735|NCT00879502|Brain Function|brain function
538736|NCT00879489|Stage IV histologically proven breast cancer|stage iv histologically proven breast cancer
538737|NCT00879476|Bioequivalence ramipril fasting condition|bioequivalence ramipril fasting condition
538738|NCT00879463|Blood transfusion in cardiac operations under CPB|blood transfusion in cardiac operations under cpb
538739|NCT00879463|Infrared spectrophotoscopy|infrared spectrophotoscopy
538740|NCT00879450|Congenital muscular torticollis|congenital muscular torticollis
538741|NCT00879437|brain tumor|brain tumor
538742|NCT00879437|bevacizumab|bevacizumab
538743|NCT00879437|valproic acid|valproic acid
538744|NCT00879437|radiation therapy|radiation therapy
538745|NCT00879424|vitamin D|vitamin d
538746|NCT00879424|atopic dermatitis|atopic dermatitis
538747|NCT00879424|eczema|eczema
538748|NCT00879424|winter|winter
538749|NCT00879385|KRAS wild-type|kras wild-type
538750|NCT00879385|Colon|colon
538751|NCT00879385|Cancer|cancer
538752|NCT00879385|colorectal|colorectal
538753|NCT00879385|metastatic colorectal|metastatic colorectal
538754|NCT00879385|advanced colorectal|advanced colorectal
538755|NCT00879372|Bipolar Disorder|bipolar disorder
538756|NCT00879372|cognitive impairment|cognitive impairment
538757|NCT00879372|depression|depression
538758|NCT00879346|Healthy Volunteers|healthy volunteers
538759|NCT00879346|ADME|adme
538760|NCT00879346|Healthy male volunteers|healthy male volunteers
538761|NCT00879333|Gastric cancer,|gastric cancer,
538762|NCT00879333|advanced gastric cancer,|advanced gastric cancer,
538763|NCT00879333|stomach neoplasm,|stomach neoplasm,
538764|NCT00879333|stomach disease,|stomach disease,
538765|NCT00879333|adenocarcinoma of stomach,|adenocarcinoma of stomach,
538766|NCT00879333|GI neoplasm|gi neoplasm
538767|NCT00879320|ADHD|adhd
538768|NCT00879320|health|health
538769|NCT00879320|healthy lifestyle|healthy lifestyle
538770|NCT00879294|Perforated appendicitis|perforated appendicitis
538771|NCT00879294|Ruptured appendicitis|ruptured appendicitis
538772|NCT00879294|Acute appendicitis with perforation|acute appendicitis with perforation
538773|NCT00879281|COPD|copd
538774|NCT00879281|emphysema|emphysema
538775|NCT00879281|chronic bronchitis|chronic bronchitis
538776|NCT00879268|Liver Transplantation|liver transplantation
538777|NCT00879268|Organ Preservation|organ preservation
538778|NCT00879268|Liver Preservation|liver preservation
538779|NCT00879268|Machine Perfusion|machine perfusion
538780|NCT00879268|Vasosol|vasosol
538781|NCT00879268|Machine Preservation|machine preservation
538782|NCT00879255|cognitive processing therapy|cognitive processing therapy
538783|NCT00879255|combat|combat
538784|NCT00879255|veterans|veterans
538785|NCT00879255|PTSD|ptsd
538786|NCT00879255|Telemental Health|telemental health
538787|NCT00879255|Videoteleconference|videoteleconference
538788|NCT00879255|outcome|outcome
538789|NCT00879255|Rural|rural
538790|NCT00879255|Remote|remote
538791|NCT00879255|CPT|cpt
538792|NCT00879255|VTC|vtc
538793|NCT00879242|Thalassemia|thalassemia
538794|NCT00879242|cardiac MRI T2*|cardiac mri t2*
538795|NCT00879229|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
538796|NCT00879229|Pulmonary Hypertension|pulmonary hypertension
538797|NCT00879229|PH|ph
538798|NCT00879229|IPF|ipf
538799|NCT00879229|Ambrisentan|ambrisentan
538800|NCT00879229|ERA|era
538801|NCT00879229|Endothelin Receptor Antagonist|endothelin receptor antagonist
538802|NCT00879229|Cardiovascular|cardiovascular
538803|NCT00879216|Nocturia|nocturia
538804|NCT00879216|Hyptotension|hyptotension
538805|NCT00879216|Elderly|elderly
538806|NCT00879216|Males|males
538807|NCT00879203|Type 1 Diabetes Mellitis|type 1 diabetes mellitis
538808|NCT00879203|Youth|youth
538809|NCT00879203|Hypoglycemia|hypoglycemia
538810|NCT00879203|Hyperglycemia|hyperglycemia
538812|NCT00879203|Memory|memory
538813|NCT00879203|Brain Growth & Development|brain growth & development
538814|NCT00879203|Magnetic Resonance Imaging|magnetic resonance imaging
538815|NCT00879177|smoking|smoking
538816|NCT00879177|varenicline|varenicline
538817|NCT00879177|behavioral therapy|behavioral therapy
538818|NCT00879177|ABPM|abpm
538819|NCT00879177|hypertension|hypertension
538820|NCT00879164|hot flashes|hot flashes
538821|NCT00879125|Gastric by-pass on patients with T2DM|gastric by-pass on patients with t2dm
538822|NCT00879112|Hyperlipidemia|hyperlipidemia
538823|NCT00879099|Interaction|interaction
538824|NCT00879099|healthy volunteers|healthy volunteers
538825|NCT00879099|Interaction study for healthy volunteers|interaction study for healthy volunteers
538826|NCT00879086|Breast Cancer|breast cancer
538827|NCT00879086|Oncology|oncology
538828|NCT00879073|Brain and Nervous System|brain and nervous system
538829|NCT00879060|Fibrosis|fibrosis
538830|NCT00879060|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
538831|NCT00879060|MRI|mri
538832|NCT00879060|To evaluate the efficacy of spironolactone in decreasing myocardial fibrosis in Hypertrophic cardiomyopathy|to evaluate the efficacy of spironolactone in decreasing myocardial fibrosis in hypertrophic cardiomyopathy
538833|NCT00879047|HIV|hiv
538834|NCT00879047|Hepatitis C|hepatitis c
538835|NCT00879034|Hutchinson-Gilford Progeria Syndrome|hutchinson-gilford progeria syndrome
538836|NCT00879034|HGPS|hgps
538837|NCT00879034|Progeria|progeria
538838|NCT00879034|FTI|fti
538839|NCT00879034|Farnesyltransferase Inhibitor|farnesyltransferase inhibitor
538840|NCT00879034|Lonafarnib|lonafarnib
538841|NCT00879034|Zoledronic Acid|zoledronic acid
538842|NCT00879034|Pravastatin|pravastatin
538843|NCT00879021|The outcome is to prevent Central Neuropathic Pain|the outcome is to prevent central neuropathic pain
538844|NCT00879021|participants will have suffered spinal cord trauma|participants will have suffered spinal cord trauma
538845|NCT00879008|Disease Exacerbation|disease exacerbation
538846|NCT00879008|Acute Exacerbations of Chronic Bronchitis|acute exacerbations of chronic bronchitis
538847|NCT00879008|AECB|aecb
538848|NCT00879008|Avelox|avelox
538849|NCT00879008|Bronchitis|bronchitis
538850|NCT00878995|stage IIB cervical cancer|stage iib cervical cancer
538851|NCT00878995|stage III cervical cancer|stage iii cervical cancer
538852|NCT00878995|recurrent cervical cancer|recurrent cervical cancer
538853|NCT00878995|cachexia|cachexia
538854|NCT00878995|advanced head/neck carcinoma|advanced head/neck carcinoma
538855|NCT00878995|recurrent head/neck carcinoma|recurrent head/neck carcinoma
538856|NCT00878969|Hemodialysis|hemodialysis
538857|NCT00878969|fibrinolysis|fibrinolysis
538858|NCT00878969|oxidative stress|oxidative stress
538859|NCT00878969|systemic inflammatory reaction|systemic inflammatory reaction
538860|NCT00878969|endothelial dysfunction|endothelial dysfunction
538861|NCT00878969|carotid intima media thickness (IMT|carotid intima media thickness (imt
538862|NCT00878969|angiotensin receptor blockade|angiotensin receptor blockade
538863|NCT00878969|angiotensin converting enzyme inhibition|angiotensin converting enzyme inhibition
538864|NCT00878956|Cardiac surgery|cardiac surgery
538865|NCT00878956|Cardiopulmonary bypass|cardiopulmonary bypass
538866|NCT00878956|Oxidative stress|oxidative stress
538867|NCT00878956|Acute renal dysfunction|acute renal dysfunction
538868|NCT00878956|Sodium bicarbonate|sodium bicarbonate
538869|NCT00878943|Open label access|open label access
538870|NCT00878943|sildenafil|sildenafil
538871|NCT00878943|pulmonary arterial hypertension|pulmonary arterial hypertension
538872|NCT00878930|Breast cancer|breast cancer
538873|NCT00878930|Fulvestrant|fulvestrant
538874|NCT00878930|Faslodex|faslodex
538875|NCT00878930|Acceptability|acceptability
538876|NCT00878930|Compliance|compliance
538877|NCT00878930|Efficacy|efficacy
538878|NCT00878917|Equivalence Study|equivalence study
538879|NCT00878917|Eye Drops Solution|eye drops solution
538880|NCT00878917|Dorzolamide|dorzolamide
538881|NCT00878917|Open Angle Glaucoma|open angle glaucoma
538882|NCT00878917|Ocular Hypertension|ocular hypertension
538883|NCT00878904|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
538884|NCT00878891|Microdialysis|microdialysis
538885|NCT00878891|realtime|realtime
538886|NCT00878891|glucose sensor|glucose sensor
538887|NCT00878891|coronary artery bypass|coronary artery bypass
538888|NCT00878878|Pulmonary artery systolic pressure (PASP)|pulmonary artery systolic pressure (pasp)
538889|NCT00878878|Pulmonary Vascular Resistance (PVR)|pulmonary vascular resistance (pvr)
538890|NCT00878878|Right Heart Catheterization|right heart catheterization
538891|NCT00878878|Pulmonary hemodynamics|pulmonary hemodynamics
538892|NCT00878865|Alprazolam|alprazolam
538893|NCT00878865|bioequivalence|bioequivalence
538894|NCT00878839|Cataract|cataract
538895|NCT00878839|Toric IOL|toric iol
538896|NCT00878839|Corneal Aberration|corneal aberration
538897|NCT00878839|Astigmatism|astigmatism
538898|NCT00878839|AcrySof|acrysof
538899|NCT00878813|Copeptin|copeptin
538900|NCT00878813|Vasopressin|vasopressin
538901|NCT00878813|Stroke|stroke
538902|NCT00878813|Transient ischemic attack|transient ischemic attack
538903|NCT00878813|Thrombolytic therapy|thrombolytic therapy
538904|NCT00878813|Prognosis|prognosis
538905|NCT00878813|Complications|complications
538906|NCT00878800|Phase I/II trial|phase i/ii trial
538907|NCT00878800|Solid tumors|solid tumors
538908|NCT00878800|Soft tissue sarcoma|soft tissue sarcoma
538909|NCT00878800|PXD101|pxd101
538910|NCT00878800|Doxorubicin|doxorubicin
538911|NCT00878774|Ragweed allergy|ragweed allergy
538912|NCT00878774|Immunotherapy|immunotherapy
538913|NCT00878774|Rhinoconjunctivitis|rhinoconjunctivitis
538914|NCT00878774|Toleromune Ragweed|toleromune ragweed
538915|NCT00878761|Renal transplant|renal transplant
538916|NCT00878761|Interstitial fibrosis and tubular atrophy|interstitial fibrosis and tubular atrophy
538917|NCT00878761|Chronic allograft dysfunction|chronic allograft dysfunction
538918|NCT00878761|Chronic allograft nephropathy|chronic allograft nephropathy
538919|NCT00878761|kidney transplant|kidney transplant
538920|NCT00878735|Meditation|meditation
538921|NCT00878735|Mindfulness|mindfulness
538922|NCT00878735|fMRI|fmri
538923|NCT00878735|cancer|cancer
538924|NCT00878735|stress|stress
538925|NCT00878735|anxiety|anxiety
538926|NCT00878735|depression|depression
538927|NCT00878735|attention|attention
538928|NCT00878735|Neuroscience|neuroscience
538929|NCT00878735|Neuroimaging|neuroimaging
538930|NCT00878735|Psychobiology|psychobiology
538931|NCT00878735|Healthy volunteers (regular meditators and non-meditators)|healthy volunteers (regular meditators and non-meditators)
538932|NCT00878722|Acute Myeloid Leukemia|acute myeloid leukemia
538933|NCT00878722|PXD101|pxd101
538934|NCT00878722|Belinostat|belinostat
538935|NCT00878722|Idarubicin|idarubicin
538936|NCT00878709|HER-2/erbB-2 positive breast cancer|her-2/erbb-2 positive breast cancer
538937|NCT00878709|breast cancer|breast cancer
538938|NCT00878709|adjuvant therapy|adjuvant therapy
538939|NCT00878709|neratinib|neratinib
538940|NCT00878709|HKI-272|hki-272
538941|NCT00878709|Nerlynx|nerlynx
538942|NCT00878709|PB-272|pb-272
538943|NCT00878657|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
538944|NCT00878657|stage III pancreatic cancer|stage iii pancreatic cancer
538945|NCT00878644|Cardiac Arrest|cardiac arrest
538946|NCT00878644|Cardiopulmonary Arrest|cardiopulmonary arrest
538947|NCT00878644|Pediatric Cardiac Arrest|pediatric cardiac arrest
538948|NCT00878644|VABS|vabs
538949|NCT00878644|Vineland Adaptive Behavior Survey|vineland adaptive behavior survey
538950|NCT00878644|POPC/PCPC|popc/pcpc
538951|NCT00878644|hypoxic-ichemic encephalopathy|hypoxic-ichemic encephalopathy
538952|NCT00878631|emergency medical services|emergency medical services
538953|NCT00878631|traumatic brain injury|traumatic brain injury
538954|NCT00878631|hypertonic saline with dextran|hypertonic saline with dextran
538955|NCT00878631|fluid resuscitation|fluid resuscitation
538956|NCT00878618|Healthy volunteers|healthy volunteers
538957|NCT00878605|Diabetes|diabetes
538958|NCT00878605|Cyclo-Z|cyclo-z
538959|NCT00878592|Post liver transplant|post liver transplant
538960|NCT00878592|weight reduction classes|weight reduction classes
538961|NCT00878592|obesity|obesity
538962|NCT00878592|weight management|weight management
538963|NCT00878592|dietary and lifestyle modification|dietary and lifestyle modification
538964|NCT00878579|back pain|back pain
538965|NCT00878579|Spine|spine
538966|NCT00878579|Spinal|spinal
538967|NCT00878579|Lower back pain|lower back pain
538968|NCT00878579|Lumbar|lumbar
538969|NCT00878579|Lumbar Pain|lumbar pain
538970|NCT00878579|DDD|ddd
538971|NCT00878579|Degenerative Disc Disease|degenerative disc disease
538972|NCT00878566|hypertension|hypertension
538973|NCT00878566|pharmacists|pharmacists
538974|NCT00878566|rural health|rural health
538975|NCT00878566|prescribing|prescribing
538976|NCT00878553|insomnia|insomnia
538977|NCT00878553|middle of the night|middle of the night
538978|NCT00878553|sleep maintenance|sleep maintenance
538979|NCT00878540|mirtazapine|mirtazapine
538980|NCT00878540|metabolism|metabolism
538981|NCT00878540|depression|depression
538982|NCT00878540|Healthy males|healthy males
538983|NCT00878527|Heart Failure|heart failure
538984|NCT00878527|Partial Circulatory Assist|partial circulatory assist
538985|NCT00878527|NYHA Class IIIb|nyha class iiib
538986|NCT00878527|NYHA Class IV|nyha class iv
538987|NCT00878527|Ventricular Assist Device|ventricular assist device
538988|NCT00878527|VAD|vad
538989|NCT00878514|Alprazolam|alprazolam
538990|NCT00878514|Bioequivalence|bioequivalence
538991|NCT00878501|Phase II|phase ii
538992|NCT00878501|Pain|pain
538993|NCT00878475|Quantitative Capnometry|quantitative capnometry
538994|NCT00878475|N-Terminal Pro-Brain Natriuretic Peptide|n-terminal pro-brain natriuretic peptide
538995|NCT00878475|Acute Heart Failure|acute heart failure
538996|NCT00878475|Diagnostic Accuracy|diagnostic accuracy
538997|NCT00878436|histone deacetylase inhibitor|histone deacetylase inhibitor
538998|NCT00878436|hormone therapy|hormone therapy
538999|NCT00878436|androgen-independent|androgen-independent
539000|NCT00878436|PSA|psa
539001|NCT00878436|androgen receptor|androgen receptor
539002|NCT00878423|HSP90|hsp90
539003|NCT00878423|Metastatic solid tumor including lymphoma which are|metastatic solid tumor including lymphoma which are
539004|NCT00878423|refractory to standard therapy|refractory to standard therapy
539005|NCT00878397|malaria|malaria
539103|NCT00877994|Parenting|parenting
539006|NCT00878397|long lasting insecticide nets|long lasting insecticide nets
539007|NCT00878397|anaemia|anaemia
539008|NCT00878397|schools|schools
539009|NCT00878384|Atrial Fibrillation|atrial fibrillation
539010|NCT00878384|Heart Failure|heart failure
539011|NCT00878384|Heart Rate Control|heart rate control
539012|NCT00878384|Catheter Ablation|catheter ablation
539013|NCT00878371|morphine|morphine
539014|NCT00878371|blood brain barrier|blood brain barrier
539015|NCT00878371|surgery induced peripheral inflammatory response|surgery induced peripheral inflammatory response
539016|NCT00878358|Osteoarthritis|osteoarthritis
539017|NCT00878358|Total knee replacement|total knee replacement
539018|NCT00878345|Pediatric sedation|pediatric sedation
539019|NCT00878345|Pentobarbital|pentobarbital
539020|NCT00878345|Dexmedetomidine|dexmedetomidine
539021|NCT00878345|Procedural sedation in children|procedural sedation in children
539022|NCT00878332|edentulous|edentulous
539023|NCT00878332|fixed dental rehabilitation|fixed dental rehabilitation
539024|NCT00878332|insufficient bone height|insufficient bone height
539025|NCT00878332|Partially edentulous patients|partially edentulous patients
539026|NCT00878332|Patients interested in fixed non removable dental rehabilitation by dental implants.|patients interested in fixed non removable dental rehabilitation by dental implants.
539027|NCT00878332|The recipient bone with insufficient bone height for dental implant insertion.|the recipient bone with insufficient bone height for dental implant insertion.
539028|NCT00878332|Adult patients|adult patients
539029|NCT00878319|Humeral|humeral
539030|NCT00878319|diaphyseal (mid-shaft)|diaphyseal (mid-shaft)
539031|NCT00878319|fracture|fracture
539032|NCT00878319|operative|operative
539033|NCT00878319|non-operative|non-operative
539034|NCT00878306|Treatment of drug dependency with HIV medications|treatment of drug dependency with hiv medications
539035|NCT00878306|HIV|hiv
539036|NCT00878293|analgesic|analgesic
539037|NCT00878293|diabetes mellitus|diabetes mellitus
539038|NCT00878293|chronic neuropathic pain|chronic neuropathic pain
539039|NCT00878293|painful polyneuropathy caused by diabetes mellitus type I or II|painful polyneuropathy caused by diabetes mellitus type i or ii
539040|NCT00878267|Cancer|cancer
539041|NCT00878267|Computer Program|computer program
539042|NCT00878267|Palliative Care|palliative care
539043|NCT00878267|Patient-Reported Outcomes|patient-reported outcomes
539044|NCT00878267|PRO|pro
539045|NCT00878267|Palliative and Hospice Care Practice|palliative and hospice care practice
539046|NCT00878267|Electronic Health Record|electronic health record
539047|NCT00878267|EHR|ehr
539048|NCT00878267|Interview|interview
539049|NCT00878254|Mantle Cell Lymphoma|mantle cell lymphoma
539050|NCT00878254|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
539051|NCT00878254|MCL|mcl
539052|NCT00878254|NHL|nhl
539053|NCT00878241|Colon Anastomosis|colon anastomosis
539054|NCT00878241|Rectum Anastomosis|rectum anastomosis
539055|NCT00878241|Intestine|intestine
539056|NCT00878241|Colorectal Surgery|colorectal surgery
539057|NCT00878241|Colorectal Anastomosis|colorectal anastomosis
539058|NCT00878215|Image Guided Liver Surgery|image guided liver surgery
539059|NCT00878189|Phase 1 dose escalation study in advanced solid tumor malignancy and leukemia|phase 1 dose escalation study in advanced solid tumor malignancy and leukemia
539060|NCT00878176|sacral neuromodulation therapy|sacral neuromodulation therapy
539061|NCT00878176|urinary retention|urinary retention
539062|NCT00878176|screening|screening
539063|NCT00878176|non obstructive urinary retention|non obstructive urinary retention
539064|NCT00878150|traumatic brain injury|traumatic brain injury
539065|NCT00878150|TBI|tbi
539066|NCT00878150|head injury|head injury
539067|NCT00878150|brain injury|brain injury
539068|NCT00878150|depression|depression
539069|NCT00878150|major depressive disorder|major depressive disorder
539070|NCT00878150|cognitive behavioral therapy|cognitive behavioral therapy
539071|NCT00878150|CBT|cbt
539072|NCT00878150|counseling|counseling
539073|NCT00878124|Poor ovarian response|poor ovarian response
539074|NCT00878124|Chromosomal aberrations|chromosomal aberrations
539075|NCT00878124|poor pregnancy outcome|poor pregnancy outcome
539076|NCT00878124|Late maternal age|late maternal age
539077|NCT00878111|NGR-hTNF|ngr-htnf
539078|NCT00878111|Solid tumours|solid tumours
539079|NCT00878111|High doses|high doses
539080|NCT00878098|DDT|ddt
539081|NCT00878098|Malaria|malaria
539082|NCT00878098|Pregnancy Outcome|pregnancy outcome
539083|NCT00878098|Spontaneous Abortion|spontaneous abortion
539084|NCT00878098|HIV|hiv
539085|NCT00878098|Pregnancy|pregnancy
539086|NCT00878085|Robot Therapy|robot therapy
539087|NCT00878085|Upper Limb|upper limb
539088|NCT00878085|Stroke|stroke
539089|NCT00878085|Rehabilitation|rehabilitation
539090|NCT00878085|fMRI|fmri
539091|NCT00878085|DTI|dti
539092|NCT00878072|Herpes labialis|herpes labialis
539093|NCT00878072|cold sores|cold sores
539094|NCT00878072|herpes simplex type 1|herpes simplex type 1
539095|NCT00878046|Hip|hip
539096|NCT00878046|Cementless|cementless
539097|NCT00878046|Conservative|conservative
539098|NCT00878007|Anaemia|anaemia
539099|NCT00878007|Malaria|malaria
539100|NCT00878007|Literacy|literacy
539101|NCT00878007|Kenya|kenya
539102|NCT00877994|Disordered Eating|disordered eating
539104|NCT00877994|Mothers|mothers
539105|NCT00877981|hyperparathyroidism|hyperparathyroidism
539106|NCT00877981|surgery|surgery
539107|NCT00877981|minimal invasive|minimal invasive
539108|NCT00877981|videoassited|videoassited
539109|NCT00877968|Pea flour|pea flour
539110|NCT00877968|Glycemic response|glycemic response
539111|NCT00877968|Diabetes|diabetes
539112|NCT00877968|Sensory|sensory
539113|NCT00877968|Functional food|functional food
539114|NCT00877968|Diabetes control and prevention|diabetes control and prevention
539115|NCT00877955|bioequivalence|bioequivalence
539116|NCT00877955|pharmacokinetic|pharmacokinetic
539117|NCT00877955|alprazolam|alprazolam
539118|NCT00877955|sublingual|sublingual
539119|NCT00877903|Acute myocardial infarction|acute myocardial infarction
539120|NCT00877903|AMI|ami
539121|NCT00877903|Myocardial infarction|myocardial infarction
539122|NCT00877903|Heart attack|heart attack
539123|NCT00877903|Mesenchymal stem cells|mesenchymal stem cells
539124|NCT00877903|MSC|msc
539125|NCT00877903|Adult human stem cells|adult human stem cells
539126|NCT00877903|Osiris|osiris
539127|NCT00877890|diabetes|diabetes
539128|NCT00877890|exenatide once weekly|exenatide once weekly
539129|NCT00877890|Byetta|byetta
539130|NCT00877890|Amylin|amylin
539131|NCT00877890|Lilly|lilly
539132|NCT00877890|Bydureon|bydureon
539133|NCT00877877|HPV vaccine|hpv vaccine
539134|NCT00877877|cervical cancer|cervical cancer
539135|NCT00877864|diabetes|diabetes
539136|NCT00877864|exercise|exercise
539137|NCT00877864|printed materials|printed materials
539138|NCT00877851|Diet|diet
539139|NCT00877851|Physical activity|physical activity
539140|NCT00877851|Self management|self management
539141|NCT00877851|Goal setting|goal setting
539142|NCT00877838|Headache|headache
539143|NCT00877838|Migraine|migraine
539144|NCT00877838|Aura|aura
539145|NCT00877838|Acute|acute
539146|NCT00877838|Attack|attack
539147|NCT00877838|Clinical|clinical
539148|NCT00877838|Trial|trial
539149|NCT00877838|Intervention|intervention
539150|NCT00877838|Nitrogen Oxide|nitrogen oxide
539151|NCT00877838|NOS|nos
539152|NCT00877838|nNOS|nnos
539153|NCT00877838|Triptan|triptan
539154|NCT00877838|5HT|5ht
539155|NCT00877838|Serotonin|serotonin
539156|NCT00877825|Diet Therapy|diet therapy
539157|NCT00877812|Vitamin B6|vitamin b6
539158|NCT00877812|Vitamin B6 deficiency|vitamin b6 deficiency
539159|NCT00877812|Amino acids|amino acids
539160|NCT00877812|pyridoxine|pyridoxine
539161|NCT00877799|pain|pain
539162|NCT00877799|acute pain|acute pain
539163|NCT00877799|visceral pain|visceral pain
539164|NCT00877799|kappa agonist|kappa agonist
539165|NCT00877799|opioid analgesics|opioid analgesics
539166|NCT00877799|peripheral nervous system agents|peripheral nervous system agents
539167|NCT00877799|physiological effects of drugs|physiological effects of drugs
539168|NCT00877799|surgery|surgery
539169|NCT00877799|hysterectomy|hysterectomy
539170|NCT00877799|post-operative|post-operative
539171|NCT00877799|post-operative complications|post-operative complications
539172|NCT00877773|Advanced cancer|advanced cancer
539173|NCT00877773|Advanced Cancer with genetic mutation|advanced cancer with genetic mutation
539174|NCT00877773|Phosphoinositides 3-kinase|phosphoinositides 3-kinase
539175|NCT00877773|PI3K|pi3k
539176|NCT00877773|PIK3 mutations|pik3 mutations
539177|NCT00877773|Temsirolimus|temsirolimus
539178|NCT00877773|CCI-779|cci-779
539179|NCT00877773|Torisel|torisel
539180|NCT00877773|mTOR inhibitor|mtor inhibitor
539181|NCT00877760|Hepatitis B Entecavir pegylated interferon a-2a|hepatitis b entecavir pegylated interferon a-2a
539182|NCT00877747|PET|pet
539183|NCT00877734|alcohol dependence|alcohol dependence
539184|NCT00877734|baclofen|baclofen
539185|NCT00877734|pharmacotherapy|pharmacotherapy
539186|NCT00877734|women|women
539187|NCT00877721|Postural Control|postural control
539188|NCT00877721|Gait|gait
539189|NCT00877721|Falls|falls
539190|NCT00877721|Elderly|elderly
539191|NCT00877721|Old adults (65 years old and older) with low risk of falls|old adults (65 years old and older) with low risk of falls
539192|NCT00877708|E. Coli|e. coli
539193|NCT00877708|isolates|isolates
539194|NCT00877695|HIV|hiv
539195|NCT00877695|HIV Seronegativity|hiv seronegativity
539196|NCT00877695|prevention|prevention
539197|NCT00877695|Hispanic|hispanic
539198|NCT00877695|Latino|latino
539199|NCT00877695|MSM|msm
539200|NCT00877695|men|men
539201|NCT00877682|Prostate Cancer|prostate cancer
539202|NCT00877682|Prostate Tumor|prostate tumor
539203|NCT00877682|Adenocarcinoma of the Prostate|adenocarcinoma of the prostate
539204|NCT00877682|PCA|pca
539205|NCT00877682|Regional Prostate Cryoablation|regional prostate cryoablation
539206|NCT00877682|Cryotherapy|cryotherapy
539207|NCT00877682|Cryoablation|cryoablation
539208|NCT00877682|Health Related Quality of Life|health related quality of life
539209|NCT00877682|HRQOL|hrqol
539210|NCT00877617|Quality of Life|quality of life
539211|NCT00877617|QOL|qol
539212|NCT00877617|Questionnaire|questionnaire
539514|NCT00876577|Avelox|avelox
539213|NCT00877617|High Risk localized Prostate Cancer|high risk localized prostate cancer
539214|NCT00877617|HRLPC|hrlpc
539215|NCT00877617|Neoadjuvant Investigational Therapy|neoadjuvant investigational therapy
539216|NCT00877617|Radical Prostatectomy|radical prostatectomy
539217|NCT00877604|ALS|als
539218|NCT00877604|Therapy|therapy
539219|NCT00877604|Tauroursodeoxycholic acid|tauroursodeoxycholic acid
539220|NCT00877604|TUDCA|tudca
539221|NCT00877604|antioxidant|antioxidant
539222|NCT00877604|antiapoptotic drug|antiapoptotic drug
539223|NCT00877604|neuroprotective drug|neuroprotective drug
539224|NCT00877591|Interaction of Buprenorphine with HIV and TB Medications|interaction of buprenorphine with hiv and tb medications
539225|NCT00877578|elderly patient|elderly patient
539226|NCT00877578|malnutrition|malnutrition
539227|NCT00877578|new nutritional support|new nutritional support
539228|NCT00877578|micronutrients|micronutrients
539229|NCT00877578|elderly patient malnutrition|elderly patient malnutrition
539230|NCT00877565|LVF|lvf
539231|NCT00877565|Left ventricular systolic function|left ventricular systolic function
539232|NCT00877552|Schizophrenia|schizophrenia
539233|NCT00877552|brain development|brain development
539234|NCT00877552|MRI|mri
539235|NCT00877539|Asthma Allergen Challenge|asthma allergen challenge
539236|NCT00877513|Smoking|smoking
539237|NCT00877513|Insulin resistance|insulin resistance
539238|NCT00877513|Metabolic syndrome|metabolic syndrome
539239|NCT00877513|Body fat distribution|body fat distribution
539240|NCT00877513|Cigarette smoking|cigarette smoking
539241|NCT00877500|HER2/neu-negative Breast Cancer|her2/neu-negative breast cancer
539242|NCT00877500|Residual Breast Cancer|residual breast cancer
539243|NCT00877500|Surgery|surgery
539244|NCT00877500|Neoadjuvant Systemic Therapy|neoadjuvant systemic therapy
539245|NCT00877500|NST|nst
539246|NCT00877500|Ixabepilone|ixabepilone
539247|NCT00877500|BMS-247550|bms-247550
539248|NCT00877500|Epothilone B analogue|epothilone b analogue
539249|NCT00877487|ADHD|adhd
539250|NCT00877474|PM01183|pm01183
539251|NCT00877474|Solid tumors|solid tumors
539252|NCT00877474|PharmaMar USA|pharmamar usa
539253|NCT00877448|INFLUENZA|influenza
539254|NCT00877448|VACCINE|vaccine
539255|NCT00877448|UNIVERSAL|universal
539256|NCT00877448|SAFETY|safety
539257|NCT00877422|vitamin deficiency|vitamin deficiency
539258|NCT00877409|Acnase|acnase
539259|NCT00877409|Acne Vulgaris|acne vulgaris
539260|NCT00877409|Safety|safety
539261|NCT00877409|Efficacy|efficacy
539262|NCT00877383|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
539263|NCT00877383|COPD|copd
539264|NCT00877383|indacaterol|indacaterol
539265|NCT00877383|tiotropium|tiotropium
539266|NCT00877383|bronchodilation|bronchodilation
539267|NCT00877370|ertapenem|ertapenem
539268|NCT00877370|continuous hemodialysis|continuous hemodialysis
539269|NCT00877370|pharmacokinetics|pharmacokinetics
539270|NCT00877357|Vaccine|vaccine
539271|NCT00877357|Prevention|prevention
539272|NCT00877357|Diphtheria|diphtheria
539273|NCT00877357|Tetanus|tetanus
539274|NCT00877357|Pertussis|pertussis
539275|NCT00877357|Hepatitis B|hepatitis b
539276|NCT00877357|Haemophilus influenzae type b|haemophilus influenzae type b
539277|NCT00877357|Lot Consistency|lot consistency
539278|NCT00877357|Long Term Immunogenicity|long term immunogenicity
539279|NCT00877357|Reactogenicity|reactogenicity
539280|NCT00877357|Healthy infants|healthy infants
539281|NCT00877344|Pregnancy|pregnancy
539282|NCT00877344|IUC|iuc
539283|NCT00877344|abortion|abortion
539284|NCT00877344|contraception|contraception
539285|NCT00877331|Drug Abuse|drug abuse
539286|NCT00877331|Drug Addiction|drug addiction
539287|NCT00877331|Drug Dependence|drug dependence
539288|NCT00877331|Drug Usage|drug usage
539289|NCT00877331|Drug Use Disorders|drug use disorders
539290|NCT00877331|Substance Abuse|substance abuse
539291|NCT00877331|Substance Addiction|substance addiction
539292|NCT00877331|Substance Dependence|substance dependence
539293|NCT00877331|Substance Use Disorders|substance use disorders
539294|NCT00877305|Ischemic Preconditioning|ischemic preconditioning
539295|NCT00877305|Cognitive function|cognitive function
539296|NCT00877292|Down Syndrome|down syndrome
539297|NCT00877292|trisomy 21|trisomy 21
539298|NCT00877292|prenatal testing|prenatal testing
539299|NCT00877292|pregnant women|pregnant women
539300|NCT00877279|Facial wrinkles|facial wrinkles
539301|NCT00877279|Nasolabial folds|nasolabial folds
539302|NCT00877266|catheter|catheter
539303|NCT00877266|ultrasound guidance|ultrasound guidance
539304|NCT00877266|nerve stimulation|nerve stimulation
539305|NCT00877266|electrical stimulation|electrical stimulation
539306|NCT00877266|nerve block|nerve block
539307|NCT00877266|UCSD|ucsd
539308|NCT00877266|timed placement|timed placement
539309|NCT00877266|surgery|surgery
539310|NCT00877266|Catheter Placement Time|catheter placement time
539311|NCT00877227|CVA|cva
539312|NCT00877227|stroke|stroke
539313|NCT00877227|newborns|newborns
539314|NCT00877227|homocysteine|homocysteine
539315|NCT00877227|folinic acid|folinic acid
539316|NCT00877214|Bendamustine|bendamustine
539317|NCT00877214|Rituximab|rituximab
539318|NCT00877214|Significance of maintenance therapy|significance of maintenance therapy
539319|NCT00877214|Efficacy and safety|efficacy and safety
539320|NCT00877201|Accommodation|accommodation
539321|NCT00877201|visual display terminal (VDT)|visual display terminal (vdt)
539322|NCT00877201|antioxidant|antioxidant
539323|NCT00877188|breast cancer|breast cancer
539324|NCT00877188|exercise|exercise
539325|NCT00877188|upper extremity function|upper extremity function
539326|NCT00877188|quality of life|quality of life
539327|NCT00877175|preterm infants|preterm infants
539328|NCT00877175|mydriasis|mydriasis
539329|NCT00877175|pupil dilation|pupil dilation
539330|NCT00877162|Cognitive and behavioural intervention|cognitive and behavioural intervention
539331|NCT00877162|trial|trial
539332|NCT00877162|group|group
539333|NCT00877162|Behavioral sleep problems|behavioral sleep problems
539334|NCT00877149|Chronic HBV|chronic hbv
539335|NCT00877136|Liver tumors|liver tumors
539336|NCT00877136|Liver cancer|liver cancer
539337|NCT00877136|Adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
539338|NCT00877136|HCC|hcc
539339|NCT00877136|Hepatoma|hepatoma
539340|NCT00877136|Neoplasms|neoplasms
539341|NCT00877123|fasting glucose|fasting glucose
539342|NCT00877123|obesity|obesity
539343|NCT00877123|arab women|arab women
539344|NCT00877123|interleukin|interleukin
539345|NCT00877123|diabetes|diabetes
539346|NCT00877123|impaired fasting glucose (IFG)|impaired fasting glucose (ifg)
539347|NCT00877110|BETA-D-GLUCAN|beta-d-glucan
539348|NCT00877110|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
539349|NCT00877110|MAB 131 I - 3F8|mab 131 i - 3f8
539350|NCT00877110|TOPOTECAN|topotecan
539351|NCT00877110|VINCRISTINE|vincristine
539352|NCT00877110|Neuroblastoma|neuroblastoma
539353|NCT00877110|09-011|09-011
539354|NCT00877097|osteoporosis|osteoporosis
539355|NCT00877097|Bone mineral density|bone mineral density
539356|NCT00877097|clodronate|clodronate
539357|NCT00877097|HRT|hrt
539358|NCT00877097|postmenopausal|postmenopausal
539359|NCT00877084|exacerbation|exacerbation
539360|NCT00877084|COPD|copd
539361|NCT00877084|Resistance training|resistance training
539362|NCT00877084|Muscle force|muscle force
539363|NCT00877058|Frailty|frailty
539364|NCT00877058|health promotion|health promotion
539365|NCT00877058|prevention|prevention
539366|NCT00877058|self management|self management
539367|NCT00877058|intervention|intervention
539368|NCT00877045|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
539369|NCT00877045|GIST|gist
539370|NCT00877045|tyrosine kinase inhibitors|tyrosine kinase inhibitors
539371|NCT00877045|Imatinib|imatinib
539372|NCT00877045|Gleevec|gleevec
539373|NCT00877045|Suntinib|suntinib
539374|NCT00877045|Sutent|sutent
539375|NCT00877032|Phase 1|phase 1
539376|NCT00877032|Dry Age Related Macular Degeneration|dry age related macular degeneration
539377|NCT00877032|RN6G|rn6g
539378|NCT00877019|sonic brushes|sonic brushes
539379|NCT00877019|time effectiveness|time effectiveness
539380|NCT00877019|brush head design|brush head design
539381|NCT00877019|ADA-toothbrush|ada-toothbrush
539382|NCT00877019|professional brushing|professional brushing
539383|NCT00877019|time dependence|time dependence
539384|NCT00877019|efficacy|efficacy
539385|NCT00877019|toothbrush|toothbrush
539386|NCT00876980|Obstructive sleep apnea|obstructive sleep apnea
539387|NCT00876980|Type II diabetes mellitus|type ii diabetes mellitus
539388|NCT00876980|Randomized controlled trial|randomized controlled trial
539389|NCT00876967|anesthesiology|anesthesiology
539390|NCT00876967|randomized|randomized
539391|NCT00876967|laryngoscope|laryngoscope
539392|NCT00876967|intubation|intubation
539393|NCT00876967|laryngeal exposition|laryngeal exposition
539394|NCT00876967|laryngoscope blades|laryngoscope blades
539395|NCT00876967|plastic single use blade|plastic single use blade
539396|NCT00876967|metallic single use blade|metallic single use blade
539397|NCT00876967|metallic reusable blade|metallic reusable blade
539398|NCT00876967|success to intubation at first attempt|success to intubation at first attempt
539399|NCT00876967|Cormack and lehanne modify grade|cormack and lehanne modify grade
539400|NCT00876941|Drug|drug
539401|NCT00876941|Drug Use|drug use
539402|NCT00876941|Screening|screening
539403|NCT00876941|Brief Intervention|brief intervention
539404|NCT00876941|Primary Care|primary care
539405|NCT00876941|Utilization|utilization
539406|NCT00876928|pre-diabetes|pre-diabetes
539407|NCT00876928|minorities|minorities
539408|NCT00876928|oral glucose tolerance test|oral glucose tolerance test
539409|NCT00876928|disposition index|disposition index
539410|NCT00876928|insulin secretion|insulin secretion
539411|NCT00876928|insulin sensitivity|insulin sensitivity
539412|NCT00876928|diabetes|diabetes
539413|NCT00876915|prevention of VTE and PE in high risk cancer patients|prevention of vte and pe in high risk cancer patients
539414|NCT00876902|liver transplantation|liver transplantation
539415|NCT00876902|cadaveric liver transplantation|cadaveric liver transplantation
539416|NCT00876902|ischemic reperfusion injury|ischemic reperfusion injury
539417|NCT00876902|primary non-function|primary non-function
539515|NCT00876577|Bronchitis|bronchitis
539418|NCT00876902|delayed non-Function|delayed non-function
539419|NCT00876902|poor early graft function|poor early graft function
539420|NCT00876902|YSPSL|yspsl
539421|NCT00876902|recombinant PSGL-Ig|recombinant psgl-ig
539422|NCT00876889|spinal cord injury|spinal cord injury
539423|NCT00876889|riluzole|riluzole
539424|NCT00876889|pharmacokinetics|pharmacokinetics
539425|NCT00876889|Acute Traumatic Spinal Cord Injury|acute traumatic spinal cord injury
539426|NCT00876876|hypervolemic hyponatremia|hypervolemic hyponatremia
539427|NCT00876876|serum sodium|serum sodium
539428|NCT00876876|fluid overload|fluid overload
539429|NCT00876876|heartfailure|heartfailure
539430|NCT00876876|acute heart failure|acute heart failure
539431|NCT00876876|vasopressin antagonist|vasopressin antagonist
539432|NCT00876863|Alzheimer's disease|alzheimer's disease
539433|NCT00876863|Dementia|dementia
539434|NCT00876863|Memory loss|memory loss
539435|NCT00876863|Cognitive impairment|cognitive impairment
539436|NCT00876863|Nerve growth factor|nerve growth factor
539437|NCT00876863|NGF|ngf
539438|NCT00876863|Neurotrophic factors|neurotrophic factors
539439|NCT00876863|Gene therapy|gene therapy
539440|NCT00876850|cSSI|cssi
539441|NCT00876850|Abscess|abscess
539442|NCT00876850|Would|would
539443|NCT00876850|Cellulitis|cellulitis
539444|NCT00876850|Complicated Skin and Skin Structure Infections (cSSSI)|complicated skin and skin structure infections (csssi)
539445|NCT00876824|Black Fever|black fever
539446|NCT00876824|Kala-Azar|kala-azar
539447|NCT00876824|Amphotericin B lipid emulsion|amphotericin b lipid emulsion
539448|NCT00876824|Liposomal Amphotericin B|liposomal amphotericin b
539449|NCT00876811|raspberry|raspberry
539450|NCT00876811|fruit|fruit
539451|NCT00876811|antioxidants|antioxidants
539452|NCT00876811|polyphenols|polyphenols
539453|NCT00876811|oxidative stress|oxidative stress
539454|NCT00876811|dietary intervention|dietary intervention
539455|NCT00876798|Euvolemic Hyponatremia|euvolemic hyponatremia
539456|NCT00876798|SIADH|siadh
539457|NCT00876798|Serum Sodium|serum sodium
539458|NCT00876785|Rye bread satiety breakfast|rye bread satiety breakfast
539459|NCT00876772|ALS|als
539460|NCT00876772|olanazapine|olanazapine
539461|NCT00876772|Loss of Apptetite|loss of apptetite
539462|NCT00876772|Appetite Loss|appetite loss
539463|NCT00876772|Malnutrition|malnutrition
539464|NCT00876772|Cachexia|cachexia
539465|NCT00876772|Zyprexa|zyprexa
539466|NCT00876759|cerebral metastases|cerebral metastases
539467|NCT00876746|Pain|pain
539468|NCT00876746|surgery|surgery
539469|NCT00876746|catheter|catheter
539470|NCT00876746|nerve block|nerve block
539471|NCT00876746|supraclavicular|supraclavicular
539472|NCT00876746|infraclavicular|infraclavicular
539473|NCT00876746|UCSD|ucsd
539474|NCT00876746|moderate-to-severe pain|moderate-to-severe pain
539475|NCT00876746|Supraclavicular catheter|supraclavicular catheter
539476|NCT00876746|Infraclavicular catheter|infraclavicular catheter
539477|NCT00876720|Tinnitus|tinnitus
539478|NCT00876720|chronic subjective tinnitus|chronic subjective tinnitus
539479|NCT00876720|transcranial magnetic stimulation|transcranial magnetic stimulation
539480|NCT00876720|sensation disorders|sensation disorders
539481|NCT00876720|hearing disorders|hearing disorders
539482|NCT00876707|wavefront|wavefront
539483|NCT00876707|multifocal IOL|multifocal iol
539484|NCT00876707|modulation transfer function|modulation transfer function
539485|NCT00876707|intraocular lenses|intraocular lenses
539486|NCT00876707|wavefront data|wavefront data
539487|NCT00876707|Visual performance|visual performance
539488|NCT00876694|COPD, Chronic Obstructive Pulmonary Disease, Indacaterol, long acting β2-agonist|copd, chronic obstructive pulmonary disease, indacaterol, long acting β2-agonist
539489|NCT00876681|Catheter|catheter
539490|NCT00876681|Ultrasound-guidance|ultrasound-guidance
539491|NCT00876681|Nerve Stimulation|nerve stimulation
539492|NCT00876681|Electrical stimulation|electrical stimulation
539493|NCT00876681|nerve block|nerve block
539494|NCT00876681|UCSD|ucsd
539495|NCT00876681|Orthopedic surgery|orthopedic surgery
539496|NCT00876681|Foot/ankle pain|foot/ankle pain
539497|NCT00876681|Foot/ankle numbness|foot/ankle numbness
539498|NCT00876681|Popliteal-Sciatic Catheters|popliteal-sciatic catheters
539499|NCT00876668|Peripheral Vascular diseases|peripheral vascular diseases
539500|NCT00876668|Microcirculation|microcirculation
539501|NCT00876668|fluorescence angiography|fluorescence angiography
539502|NCT00876642|Radiation dermatitis|radiation dermatitis
539503|NCT00876642|best supportive care|best supportive care
539504|NCT00876642|Aloe vera gel|aloe vera gel
539505|NCT00876642|phase III study was to assess the effectiveness of aloe vera and vitamin E.|phase iii study was to assess the effectiveness of aloe vera and vitamin e.
539506|NCT00876629|MR Elastography|mr elastography
539507|NCT00876629|kidney|kidney
539508|NCT00876629|fibrosis|fibrosis
539509|NCT00876616|lupus nephritis;multi-target therapy; MMF; FK506|lupus nephritis;multi-target therapy; mmf; fk506
539510|NCT00876603|cervical spondylotic myelopathy|cervical spondylotic myelopathy
539511|NCT00876603|anterior decompression and fusion|anterior decompression and fusion
539512|NCT00876603|cervical laminoplasty|cervical laminoplasty
539513|NCT00876577|Acute Exacerbations of Chronic Bronchitis|acute exacerbations of chronic bronchitis
539516|NCT00876564|Triage precision|triage precision
539517|NCT00876551|Negative-Pressure Wound Therapy|negative-pressure wound therapy
539518|NCT00876551|Endoscopic/endoluminal V.A.C. therapy|endoscopic/endoluminal v.a.c. therapy
539519|NCT00876551|Esophagectomy|esophagectomy
539520|NCT00876551|Anastomotic leakage|anastomotic leakage
539521|NCT00876551|Anastomosis, Surgical|anastomosis, surgical
539522|NCT00876538|Chemotherapy Induced Peripheral Neuropathy|chemotherapy induced peripheral neuropathy
539523|NCT00876538|TR019622|tr019622
539524|NCT00876538|Trophos|trophos
539525|NCT00876525|Heart diseases.|heart diseases.
539526|NCT00876525|Aortic valve diseases.|aortic valve diseases.
539527|NCT00876525|Aortic valve insufficiency.|aortic valve insufficiency.
539528|NCT00876525|Aortic valve stenosis.|aortic valve stenosis.
539529|NCT00876512|thienopyridine resistance|thienopyridine resistance
539530|NCT00876512|stable effort angina|stable effort angina
539531|NCT00876512|platelet activation|platelet activation
539532|NCT00876512|ADAMTS13|adamts13
539533|NCT00876512|von Willebrand Factor|von willebrand factor
539534|NCT00876499|Primary Brain Tumor|primary brain tumor
539535|NCT00876499|PBT|pbt
539536|NCT00876499|Brain Cancer|brain cancer
539537|NCT00876499|Primary glioma|primary glioma
539538|NCT00876499|Astrocytoma|astrocytoma
539539|NCT00876499|Oligodendroglioma|oligodendroglioma
539540|NCT00876499|Oligo-astrocytoma|oligo-astrocytoma
539541|NCT00876499|Ependymoma|ependymoma
539542|NCT00876499|Anaplastic astrocytoma|anaplastic astrocytoma
539543|NCT00876499|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
539544|NCT00876499|Anaplastic oligo-astrocytoma|anaplastic oligo-astrocytoma
539545|NCT00876499|Anaplastic ependymoma|anaplastic ependymoma
539546|NCT00876499|Fatigue|fatigue
539547|NCT00876499|Cytokines|cytokines
539548|NCT00876499|Questionnaires|questionnaires
539549|NCT00876499|Actigraphy|actigraphy
539550|NCT00876499|Sleep Disturbance|sleep disturbance
539551|NCT00876499|Radiation Therapy|radiation therapy
539552|NCT00876473|CPAP|cpap
539553|NCT00876473|Acute Respiratory Failure|acute respiratory failure
539554|NCT00876434|Sirolimus|sirolimus
539555|NCT00876434|Anterior Uveitis|anterior uveitis
539556|NCT00876434|Autoimmune Disease|autoimmune disease
539557|NCT00876434|Uveitis|uveitis
539558|NCT00876421|ONO-8539|ono-8539
539559|NCT00876421|Overactive bladder|overactive bladder
539560|NCT00876421|OAB|oab
539561|NCT00876408|RT-PCR molecular profiling assay|rt-pcr molecular profiling assay
539562|NCT00876408|Molecular Profiling-Real Time Polymerase Chain Reaction|molecular profiling-real time polymerase chain reaction
539563|NCT00876408|Unknown Primary|unknown primary
539564|NCT00876408|UPC|upc
539565|NCT00876408|CUP|cup
539566|NCT00876395|Breast Cancer|breast cancer
539567|NCT00876395|HER2+|her2+
539568|NCT00876395|mTOR|mtor
539569|NCT00876395|everolimus|everolimus
539571|NCT00876395|first line|first line
539572|NCT00876395|metastatic|metastatic
539573|NCT00876395|locally advanced|locally advanced
539574|NCT00876382|advanced renal cell carcinoma|advanced renal cell carcinoma
539575|NCT00876382|renal cancer|renal cancer
539576|NCT00876382|renal cell|renal cell
539577|NCT00876382|Sorafenib|sorafenib
539578|NCT00876382|Nexavar|nexavar
539579|NCT00876382|Bevacizumab|bevacizumab
539580|NCT00876382|Avastin|avastin
539581|NCT00876382|Sunitinib|sunitinib
539582|NCT00876382|Sutent|sutent
539583|NCT00876369|urticaria|urticaria
539584|NCT00876369|angioedema|angioedema
539585|NCT00876369|vitamin D|vitamin d
539586|NCT00876369|allergy|allergy
539587|NCT00876356|Asthma|asthma
539588|NCT00876356|Conjugated Linoleic Acid (CLA)|conjugated linoleic acid (cla)
539589|NCT00876356|dietary supplement|dietary supplement
539590|NCT00876330|Clinical Decision Support Systems|clinical decision support systems
539591|NCT00876330|Hyperlipidemia|hyperlipidemia
539592|NCT00876330|Hypertension|hypertension
539593|NCT00876317|Tenosynovitis|tenosynovitis
539594|NCT00876317|Bursitis|bursitis
539595|NCT00876304|PF-04802540 multiple dose safety study|pf-04802540 multiple dose safety study
539596|NCT00876278|Cataract|cataract
539597|NCT00876278|Intraocular Lens (IOL)|intraocular lens (iol)
539598|NCT00876278|Mesotest II|mesotest ii
539599|NCT00876278|Evaluation of usability of Mesotest II for assessment of night driving capacity of pseudo-phakic patients|evaluation of usability of mesotest ii for assessment of night driving capacity of pseudo-phakic patients
539600|NCT00876265|Facial wrinkles|facial wrinkles
539601|NCT00876265|Nasolabial fold|nasolabial fold
539602|NCT00876226|Citalopram|citalopram
539603|NCT00876226|Pharmacokinetics|pharmacokinetics
539604|NCT00876226|Short Bowel Syndrome|short bowel syndrome
539605|NCT00876213|Amylin|amylin
539606|NCT00876213|GLP-1|glp-1
539607|NCT00876213|gastric emptying|gastric emptying
539608|NCT00876213|appetite and food intake|appetite and food intake
539609|NCT00876200|Williams Beuren syndrome|williams beuren syndrome
539610|NCT00876200|Cardiovascular abnormalities|cardiovascular abnormalities
539611|NCT00876200|Cardiovascular structure|cardiovascular structure
539612|NCT00876187|randomized controlled trial|randomized controlled trial
539613|NCT00876187|monoclonal antibody|monoclonal antibody
539614|NCT00876187|nerve growth factor|nerve growth factor
539615|NCT00876187|naproxen|naproxen
539616|NCT00876174|Chronic hepatitis C|chronic hepatitis c
539617|NCT00876174|Genotype 1|genotype 1
539618|NCT00876161|Healthy Adults|healthy adults
539619|NCT00876148|Incidence of hepatitis B after allografting|incidence of hepatitis b after allografting
539620|NCT00876148|Risk of hepatitis B reactivation|risk of hepatitis b reactivation
539621|NCT00876148|Lamivudine prophylaxis|lamivudine prophylaxis
539622|NCT00876122|NHL|nhl
539623|NCT00876122|Metastatic Solid Tumors|metastatic solid tumors
539624|NCT00876122|PI3K Inhibitors|pi3k inhibitors
539625|NCT00876122|PI3K|pi3k
539626|NCT00876109|Metastatic Solid Tumors|metastatic solid tumors
539627|NCT00876109|PI3K|pi3k
539628|NCT00876109|PI3K Inhibitors|pi3k inhibitors
539629|NCT00876096|Diagnosis, Differential|diagnosis, differential
539630|NCT00876083|Drug utilization review|drug utilization review
539631|NCT00876070|Metastatic Breast Cancer|metastatic breast cancer
539632|NCT00876070|Breast Cancer|breast cancer
539633|NCT00876070|MBC|mbc
539634|NCT00876070|Abraxane|abraxane
539635|NCT00876070|Paclitaxel|paclitaxel
539636|NCT00876070|Taxol|taxol
539637|NCT00876070|Docetaxel|docetaxel
539638|NCT00876070|Taxotere|taxotere
539639|NCT00876057|psychological well-being|psychological well-being
539640|NCT00876057|recovery|recovery
539641|NCT00876057|time in hospital|time in hospital
539642|NCT00876057|sick-leave|sick-leave
539643|NCT00876057|complications|complications
539644|NCT00876057|Sexual well-being|sexual well-being
539645|NCT00876031|pediatric soft tissue sarcoma|pediatric soft tissue sarcoma
539646|NCT00876031|rhabdomyosarcoma|rhabdomyosarcoma
539647|NCT00876031|extraosseous Ewing family tumours|extraosseous ewing family tumours
539648|NCT00876031|synovial sarcoma|synovial sarcoma
539649|NCT00876031|undifferentiated sarcoma|undifferentiated sarcoma
539650|NCT00876018|physical performance|physical performance
539651|NCT00876018|micronutrients|micronutrients
539652|NCT00876018|physical fitness|physical fitness
539653|NCT00876018|healthy children|healthy children
539654|NCT00876005|Wound infection|wound infection
539655|NCT00875979|MBC|mbc
539656|NCT00875979|Breast Cancer|breast cancer
539657|NCT00875979|HER2+|her2+
539658|NCT00875979|HER2+ breast cancer|her2+ breast cancer
539659|NCT00875979|HER2 positive breast cancer|her2 positive breast cancer
539660|NCT00875979|herceptin|herceptin
539661|NCT00875979|Trastuzumab emtansine|trastuzumab emtansine
539662|NCT00875953|squamous cell carcinoma|squamous cell carcinoma
539663|NCT00875953|head and neck cancer|head and neck cancer
539664|NCT00875953|neck dissection|neck dissection
539665|NCT00875927|Halitosis|halitosis
539666|NCT00875914|AV-node reentry tachycardia|av-node reentry tachycardia
539667|NCT00875914|radiofrequency ablation|radiofrequency ablation
539668|NCT00875914|magnetic navigation system|magnetic navigation system
539669|NCT00875901|Lung Cancer|lung cancer
539670|NCT00875901|Stage I Non-Small Cell Lung Cancer|stage i non-small cell lung cancer
539671|NCT00875901|Proton Radiation|proton radiation
539672|NCT00875901|HypoIGRT|hypoigrt
539673|NCT00875875|Diarrhea, travelers|diarrhea, travelers
539674|NCT00875875|Acute travelers' diarrhea|acute travelers' diarrhea
539675|NCT00875862|UCSD|ucsd
539676|NCT00875862|pain|pain
539677|NCT00875862|quality-of-life|quality-of-life
539678|NCT00875862|range-of-motion|range-of-motion
539679|NCT00875862|interscalene catheter|interscalene catheter
539680|NCT00875862|nerve block|nerve block
539681|NCT00875862|shoulder|shoulder
539682|NCT00875862|Shoulder Manipulation|shoulder manipulation
539683|NCT00875849|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
539684|NCT00875849|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
539685|NCT00875849|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
539686|NCT00875849|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
539687|NCT00875849|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
539688|NCT00875849|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
539689|NCT00875849|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
539690|NCT00875849|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
539691|NCT00875849|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
539692|NCT00875849|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
539693|NCT00875849|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
539694|NCT00875849|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
539695|NCT00875849|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
539696|NCT00875849|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
539697|NCT00875849|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
539698|NCT00875849|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
539699|NCT00875849|tongue cancer|tongue cancer
539700|NCT00875836|Marijuana|marijuana
539701|NCT00875836|Buspirone|buspirone
539702|NCT00875836|Contingency management|contingency management
539703|NCT00875836|Motivational enhancement therapy|motivational enhancement therapy
539704|NCT00875823|PH|ph
539705|NCT00875823|Primary Hyperoxaluria|primary hyperoxaluria
539706|NCT00875823|Type I|type i
539707|NCT00875823|Type II|type ii
539708|NCT00875823|NonI-NonII|noni-nonii
539709|NCT00875823|Kidney stones|kidney stones
539710|NCT00875823|oxalate|oxalate
539711|NCT00875823|oxalosis|oxalosis
539712|NCT00875797|enteral|enteral
539713|NCT00875797|parenteral|parenteral
539714|NCT00875797|glutamine|glutamine
539715|NCT00875797|intestinal permeability|intestinal permeability
539716|NCT00875797|infection|infection
539717|NCT00875784|Sumatriptan exposure|sumatriptan exposure
539718|NCT00875771|metastatic colorectal cancer|metastatic colorectal cancer
539719|NCT00875771|BEVACIZUMAB|bevacizumab
539720|NCT00875771|CAPECITABINE|capecitabine
539721|NCT00875771|IRINOTECAN|irinotecan
539722|NCT00875758|preterm infants|preterm infants
539723|NCT00875758|IVH|ivh
539724|NCT00875758|germinal matrix|germinal matrix
539725|NCT00875758|intraventricular hemorrhage|intraventricular hemorrhage
539726|NCT00875758|hydrocephalus|hydrocephalus
539727|NCT00875732|Resynchronization|resynchronization
539728|NCT00875732|Device|device
539729|NCT00875732|Bradycardia|bradycardia
539730|NCT00875732|atrioventricular block|atrioventricular block
539731|NCT00875732|Cardiac Resynchronization|cardiac resynchronization
539732|NCT00875719|COPD patients with respiratory failure|copd patients with respiratory failure
539733|NCT00875706|Nursing Homes|nursing homes
539734|NCT00875706|Implementation of innovative programs|implementation of innovative programs
539735|NCT00875706|Nursing staff|nursing staff
539736|NCT00875706|Nurses' aides|nurses' aides
539737|NCT00875706|Educational models|educational models
539738|NCT00875693|AML|aml
539739|NCT00875693|leukemia|leukemia
539740|NCT00875693|MDS|mds
539741|NCT00875667|Mantle Cell Lymphoma|mantle cell lymphoma
539742|NCT00875667|Relapsed Mantle Cell Lymphoma|relapsed mantle cell lymphoma
539743|NCT00875667|Refractory Mantle Cell Lymphoma|refractory mantle cell lymphoma
539744|NCT00875667|Lymphoma|lymphoma
539745|NCT00875667|MCL|mcl
539746|NCT00875654|Cell therapy|cell therapy
539747|NCT00875654|Stroke|stroke
539748|NCT00875654|Neuronal Plasticity|neuronal plasticity
539749|NCT00875654|Recovery|recovery
539750|NCT00875654|Mesenchymal Stem Cells|mesenchymal stem cells
539751|NCT00875654|Transplantation|transplantation
539752|NCT00875628|Japanese Healthy volunteers HCV pharmacokinetics PF-00868554 filibuvir|japanese healthy volunteers hcv pharmacokinetics pf-00868554 filibuvir
539753|NCT00875615|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
539754|NCT00875615|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
539755|NCT00875615|advanced adult primary liver cancer|advanced adult primary liver cancer
539756|NCT00875602|All hospitalized patients in a general Med/ Surg unit|all hospitalized patients in a general med/ surg unit
539757|NCT00875589|Traumatic Brain Injury|traumatic brain injury
539758|NCT00875589|Eye movement recording|eye movement recording
539759|NCT00875576|social influences|social influences
539760|NCT00875576|meals|meals
539761|NCT00875576|obesity|obesity
539762|NCT00875576|amount of food consumed|amount of food consumed
539763|NCT00875550|Intubated and mechanically ventilated PICU subjects|intubated and mechanically ventilated picu subjects
539764|NCT00875537|Burning mouth syndrome|burning mouth syndrome
539765|NCT00875537|neuropathy|neuropathy
539766|NCT00875537|inflammation|inflammation
539767|NCT00875537|tongue mucosa|tongue mucosa
539768|NCT00875537|tongue innervation|tongue innervation
539769|NCT00875537|dysgeusia|dysgeusia
539770|NCT00875524|Dengue virus|dengue virus
539771|NCT00875524|Dengue fever|dengue fever
539772|NCT00875524|Dengue hemorrhagic fever|dengue hemorrhagic fever
539773|NCT00875524|Dengue diseases|dengue diseases
539774|NCT00875524|Dengue vaccine|dengue vaccine
539775|NCT00875511|peer rejection|peer rejection
539776|NCT00875511|obesity|obesity
539777|NCT00875511|amount of food chosen|amount of food chosen
539778|NCT00875511|amount of social time chosen|amount of social time chosen
539779|NCT00875498|iTBS|itbs
539780|NCT00875498|Negative Symptoms|negative symptoms
539781|NCT00875485|Monovalent Hepatitis A|monovalent hepatitis a
539782|NCT00875485|hepatitis B vaccine|hepatitis b vaccine
539783|NCT00875485|Belgium and Czech Republic|belgium and czech republic
539784|NCT00875472|social influences|social influences
539785|NCT00875472|food purchases|food purchases
539786|NCT00875472|childhood obesity|childhood obesity
539787|NCT00875472|amount of energy dense food and beverage items purchased|amount of energy dense food and beverage items purchased
539788|NCT00875472|amount of nutrient dense food and beverage items purchased|amount of nutrient dense food and beverage items purchased
539789|NCT00875420|hot flashes|hot flashes
539790|NCT00875420|hot flushes|hot flushes
539791|NCT00875420|vasomotor symptoms|vasomotor symptoms
539792|NCT00875420|postmenopausal|postmenopausal
539793|NCT00875381|Melanocytes|melanocytes
539794|NCT00875368|HIV-1|hiv-1
539795|NCT00875368|HAART|haart
539796|NCT00875368|CD4 cell|cd4 cell
541459|NCT00869011|Cancer|cancer
539797|NCT00875368|Immunologic non-responders|immunologic non-responders
539798|NCT00875368|Immunology|immunology
539799|NCT00875368|treatment experienced|treatment experienced
539800|NCT00875355|tumors metastatic to brain|tumors metastatic to brain
539801|NCT00875355|stage IV breast cancer|stage iv breast cancer
539802|NCT00875342|Traumatic Event|traumatic event
539803|NCT00875342|Trauma Survivor|trauma survivor
539804|NCT00875342|Exposure Therapy|exposure therapy
539805|NCT00875342|PTSD DCS|ptsd dcs
539806|NCT00875342|Telemedicine|telemedicine
539807|NCT00875342|Telepsychiatry|telepsychiatry
539808|NCT00875342|Telemental health|telemental health
539809|NCT00875329|Brain Injury|brain injury
539810|NCT00875316|Parkinson's disease|parkinson's disease
539812|NCT00875303|Parents' plans to discipline their children|parents' plans to discipline their children
539813|NCT00875290|Diabetes Mellitus, Type I|diabetes mellitus, type i
539814|NCT00875290|Children|children
539815|NCT00875290|Insulin pump therapy|insulin pump therapy
539816|NCT00875290|Continuous glucose monitor|continuous glucose monitor
539817|NCT00875264|CEP-11981|cep-11981
539818|NCT00875264|TIE-2|tie-2
539819|NCT00875264|VEGF-R|vegf-r
539820|NCT00875251|body composition|body composition
539821|NCT00875251|preterm infant|preterm infant
539822|NCT00875251|anthropometry|anthropometry
539823|NCT00875238|cardiac toxicity|cardiac toxicity
539824|NCT00875238|cardiovascular complications|cardiovascular complications
539825|NCT00875238|stage I breast cancer|stage i breast cancer
539826|NCT00875238|stage II breast cancer|stage ii breast cancer
539827|NCT00875238|stage IIIA breast cancer|stage iiia breast cancer
539828|NCT00875238|stage IIIB breast cancer|stage iiib breast cancer
539829|NCT00875238|stage IIIC breast cancer|stage iiic breast cancer
539830|NCT00875225|Hypertension|hypertension
539831|NCT00875225|Adherence to medications|adherence to medications
539832|NCT00875212|Calcium glycerophosphate|calcium glycerophosphate
539833|NCT00875212|Fluoride|fluoride
539834|NCT00875212|Dentifrice|dentifrice
539835|NCT00875212|Biofilm|biofilm
539836|NCT00875212|Dental caries|dental caries
539837|NCT00875199|Overweight|overweight
539838|NCT00875199|Obesity|obesity
539839|NCT00875199|Contingency Management|contingency management
539840|NCT00875186|bariatric surgery|bariatric surgery
539841|NCT00875186|co-morbidities|co-morbidities
539842|NCT00875186|aerobic physical exercise|aerobic physical exercise
539843|NCT00875173|Selenium|selenium
539844|NCT00875173|Chagas disease|chagas disease
539845|NCT00875173|Chagasic cardiopathy|chagasic cardiopathy
539846|NCT00875147|neoadjuvant chemotherapy|neoadjuvant chemotherapy
539847|NCT00875147|bevacizumab|bevacizumab
539848|NCT00875121|Food reinforcement|food reinforcement
539849|NCT00875121|social reinforcers|social reinforcers
539850|NCT00875121|overweight|overweight
539851|NCT00875121|children|children
539852|NCT00875095|sperm DNA integrity|sperm dna integrity
539853|NCT00875095|Toluidine blue staining|toluidine blue staining
539854|NCT00875082|Asthma|asthma
539855|NCT00875082|Children|children
539856|NCT00875082|Remodelling|remodelling
539857|NCT00875082|Metalloproteinases|metalloproteinases
539858|NCT00875082|Montelukast|montelukast
539859|NCT00875069|Nosocomial infection|nosocomial infection
539860|NCT00875069|Catheterization|catheterization
539861|NCT00875069|Central Venous Ethanol|central venous ethanol
539862|NCT00875069|lock solution|lock solution
539863|NCT00875069|intensive care units|intensive care units
539864|NCT00875069|Renal replacement therapy in ICU|renal replacement therapy in icu
539865|NCT00875043|ischemic optic neuropathy|ischemic optic neuropathy
539866|NCT00875043|cortical blindness|cortical blindness
539867|NCT00875030|Bioequivalence study-artesunate sachets-arsuamoon tablet|bioequivalence study-artesunate sachets-arsuamoon tablet
539868|NCT00875004|anemia|anemia
539869|NCT00875004|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
539870|NCT00874991|Cardiac deformation|cardiac deformation
539871|NCT00874991|Cardiopulmonary bypass|cardiopulmonary bypass
539872|NCT00874991|TEE|tee
539873|NCT00874991|Cardiac Surgery|cardiac surgery
539874|NCT00874991|Left ventricular function|left ventricular function
539875|NCT00874991|Pulmonary Artery catheter|pulmonary artery catheter
539876|NCT00874991|Tissue Doppler|tissue doppler
539877|NCT00874991|Left ventricular function in cardiac surgery|left ventricular function in cardiac surgery
539878|NCT00874978|Lenalidomide|lenalidomide
539879|NCT00874978|myelodysplastic syndromes|myelodysplastic syndromes
539880|NCT00874965|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
539881|NCT00874965|Electrostimulation|electrostimulation
539882|NCT00874965|Muscle function|muscle function
539883|NCT00874965|Exercise ventilation|exercise ventilation
539884|NCT00874965|Anabolism/catabolism pathway|anabolism/catabolism pathway
539885|NCT00874952|Metabolic syndrome|metabolic syndrome
539886|NCT00874952|Lipids|lipids
539887|NCT00874952|Waist Circumference|waist circumference
539888|NCT00874952|HDL|hdl
539889|NCT00874952|hypertension|hypertension
539890|NCT00874926|Octocog alfa|octocog alfa
539891|NCT00874926|Haemophilia A|haemophilia a
539892|NCT00874913|blood flow|blood flow
542052|NCT00866593|MADRS|madrs
539893|NCT00874913|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
539894|NCT00874913|normal tension glaucoma|normal tension glaucoma
539895|NCT00874874|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
539896|NCT00874874|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
539897|NCT00874874|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
539898|NCT00874874|adult angiosarcoma|adult angiosarcoma
539899|NCT00874861|cancer|cancer
539900|NCT00874861|brain|brain
539901|NCT00874861|tumor|tumor
539902|NCT00874861|vaccine|vaccine
539903|NCT00874848|Imprime PGG|imprime pgg
539904|NCT00874848|NSCLC|nsclc
539905|NCT00874848|Cetuximab|cetuximab
539906|NCT00874835|Endothelial Keratoplasty|endothelial keratoplasty
539907|NCT00874835|EK|ek
539908|NCT00874835|Descemet Stripping Endothelial Keratoplasty|descemet stripping endothelial keratoplasty
539909|NCT00874835|Corneal Transplantation|corneal transplantation
539910|NCT00874835|Keratoplasty|keratoplasty
539911|NCT00874835|DSEK|dsek
539912|NCT00874835|DSAEK|dsaek
539913|NCT00874809|insulin pump|insulin pump
539914|NCT00874809|DM Type 2|dm type 2
539915|NCT00874809|CGMS|cgms
539916|NCT00874809|basal rate|basal rate
539917|NCT00874796|apoptosis|apoptosis
539918|NCT00874796|liver inflammation|liver inflammation
539919|NCT00874796|hepatitis C|hepatitis c
539920|NCT00874783|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
539921|NCT00874783|Familial Dysautonomia|familial dysautonomia
539922|NCT00874783|Parkinson's Disease|parkinson's disease
539923|NCT00874783|Alzheimer's Disease|alzheimer's disease
539924|NCT00874783|Age Related Macular Degeneration|age related macular degeneration
539925|NCT00874783|Retinitis Pigmentosa|retinitis pigmentosa
539926|NCT00874783|Huntington's Disease|huntington's disease
539927|NCT00874783|Machado - Joseph Disease|machado - joseph disease
539928|NCT00874783|SMA - Spinal Muscular Atrophy|sma - spinal muscular atrophy
539929|NCT00874783|Ataxia Telangiectasia|ataxia telangiectasia
539930|NCT00874770|Antivirals|antivirals
539931|NCT00874757|Statins, anti-inflammatory|statins, anti-inflammatory
539932|NCT00874757|Healthy subjects study|healthy subjects study
539933|NCT00874744|Diabetic macular edema|diabetic macular edema
539934|NCT00874744|intravitreal injection|intravitreal injection
539935|NCT00874744|Pharmacological treatment|pharmacological treatment
539936|NCT00874718|repetitive strain injury|repetitive strain injury
539937|NCT00874718|quality of life|quality of life
539938|NCT00874718|functional capacity|functional capacity
539939|NCT00874718|workers|workers
539940|NCT00874692|tap water temperature|tap water temperature
539941|NCT00874692|social housing|social housing
539942|NCT00874692|scald reduction|scald reduction
539943|NCT00874692|Temperature (degrees Celsius) of hot tap water at point of delivery.|temperature (degrees celsius) of hot tap water at point of delivery.
539944|NCT00874666|garlic|garlic
539945|NCT00874666|allicin|allicin
539946|NCT00874666|allyl methyl sulfide|allyl methyl sulfide
539947|NCT00874666|healthy persons|healthy persons
539948|NCT00874640|Drug utilization review|drug utilization review
539949|NCT00874627|children > 5 years old|children > 5 years old
539950|NCT00874627|IgE-mediated|ige-mediated
539951|NCT00874627|cow milk allergy|cow milk allergy
539952|NCT00874627|IgE-mediated cow milk allergy persisting after 5 years|ige-mediated cow milk allergy persisting after 5 years
539953|NCT00874614|radiotherapy|radiotherapy
539954|NCT00874614|MIBG|mibg
539955|NCT00874614|Azedra|azedra
539956|NCT00874614|neuroendocrine tumors|neuroendocrine tumors
539957|NCT00874614|Iobenguane I 131|iobenguane i 131
539958|NCT00874614|progenics|progenics
539959|NCT00874601|acute ischemic stroke|acute ischemic stroke
539960|NCT00874601|blood pressure|blood pressure
539961|NCT00874601|valsartan|valsartan
539962|NCT00874601|death|death
539963|NCT00874601|dependancy|dependancy
539964|NCT00874575|HMB|hmb
539965|NCT00874575|Vitamin D|vitamin d
539966|NCT00874575|Older Adults|older adults
539967|NCT00874562|rapamycin|rapamycin
539968|NCT00874562|corticosteroid|corticosteroid
539969|NCT00874562|ALL|all
539970|NCT00874549|Meningococcal Vaccine|meningococcal vaccine
539971|NCT00874549|Menactra®|menactra®
539972|NCT00874549|Menomune®|menomune®
539973|NCT00874536|ADHD|adhd
539974|NCT00874536|methylphenidate|methylphenidate
539975|NCT00874536|omega-3|omega-3
539976|NCT00874523|raltegravir|raltegravir
539977|NCT00874523|atazanavir|atazanavir
539978|NCT00874523|HIV infections|hiv infections
539979|NCT00874523|pharmacokinetics|pharmacokinetics
539980|NCT00874523|antiretroviral agents|antiretroviral agents
539981|NCT00874523|treatment experienced|treatment experienced
539982|NCT00874510|sleep deprivation|sleep deprivation
539983|NCT00874510|fatigue|fatigue
539984|NCT00874458|ductal breast carcinoma in situ|ductal breast carcinoma in situ
539985|NCT00874432|cardiovascular disease|cardiovascular disease
539986|NCT00874432|angiotensin converting enzyme inhibitors|angiotensin converting enzyme inhibitors
539987|NCT00874432|chronic kidney disease|chronic kidney disease
539988|NCT00874432|cardiovascular disease in elderly patients with CKD|cardiovascular disease in elderly patients with ckd
539989|NCT00874419|EGFR mutation|egfr mutation
539990|NCT00874419|EGFR-TKI|egfr-tki
539991|NCT00874419|Chemotherapy|chemotherapy
539992|NCT00874406|colorectal cancer|colorectal cancer
539993|NCT00874406|liver metastasis|liver metastasis
539994|NCT00874406|neoadjuvant chemotherapy|neoadjuvant chemotherapy
539995|NCT00874393|NICHD Neonatal Research Network|nichd neonatal research network
539996|NCT00874393|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
539997|NCT00874393|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
539998|NCT00874393|Prematurity|prematurity
539999|NCT00874393|Blood Pressure Management|blood pressure management
540000|NCT00874393|Dopamine|dopamine
540001|NCT00874393|Hydrocortisone|hydrocortisone
540002|NCT00874380|Fiber|fiber
540003|NCT00874380|Dialysis|dialysis
540004|NCT00874380|Renal Replacement Therapy|renal replacement therapy
540005|NCT00874380|Food Frequency Questionnaire|food frequency questionnaire
540006|NCT00874380|FFQ|ffq
540007|NCT00874380|Dietary counseling|dietary counseling
540008|NCT00874367|NICHD Neonatal Research Network|nichd neonatal research network
540009|NCT00874367|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
540010|NCT00874367|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
540011|NCT00874367|Prematurity|prematurity
540012|NCT00874367|Early Onset Sepsis|early onset sepsis
540013|NCT00874354|Myocardial Infarction|myocardial infarction
540014|NCT00874354|Heart Attack|heart attack
540015|NCT00874354|Infarct|infarct
540016|NCT00874354|Stem Cells|stem cells
540017|NCT00874354|Bone Marrow Derived Mononuclear Cells|bone marrow derived mononuclear cells
540018|NCT00874354|CHF|chf
540019|NCT00874354|Congestive Heart Failure|congestive heart failure
540020|NCT00874354|Stent|stent
540021|NCT00874354|PCI|pci
540022|NCT00874354|Percutaneous Coronary Intervention|percutaneous coronary intervention
540023|NCT00874341|Fruit|fruit
540024|NCT00874341|Vegetables|vegetables
540025|NCT00874341|Intervention|intervention
540026|NCT00874341|Insulin resistance|insulin resistance
540027|NCT00874341|Cardiovascular disease risk|cardiovascular disease risk
540028|NCT00874341|Dose response|dose response
540029|NCT00874341|High risk of cardiovascular disease|high risk of cardiovascular disease
540030|NCT00874328|Non small cell lung cancer|non small cell lung cancer
540031|NCT00874328|Irinotecan plus Cisplatin plus S-1|irinotecan plus cisplatin plus s-1
540032|NCT00874328|Phase I/II trial|phase i/ii trial
540033|NCT00874315|recurrent or refractory neuroblastoma|recurrent or refractory neuroblastoma
540034|NCT00874302|Uterine fibroids|uterine fibroids
540035|NCT00874289|NGAL|ngal
540036|NCT00874289|Heart failure|heart failure
540037|NCT00874276|DCA|dca
540038|NCT00874276|Dichloroacetate|dichloroacetate
540039|NCT00874276|Trichloroacetate|trichloroacetate
540040|NCT00874263|Probe-based imaging of GI pre-malignant or malignant lesions|probe-based imaging of gi pre-malignant or malignant lesions
540041|NCT00874237|Staccato loxapine|staccato loxapine
540042|NCT00874237|QTc|qtc
540043|NCT00874237|healthy volunteers|healthy volunteers
540044|NCT00874224|Colorectal cancer liver metastasis|colorectal cancer liver metastasis
540045|NCT00874224|Benign liver disease|benign liver disease
540046|NCT00874211|bone metastases|bone metastases
540047|NCT00874211|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
540048|NCT00874211|refractory multiple myeloma|refractory multiple myeloma
540049|NCT00874211|stage I multiple myeloma|stage i multiple myeloma
540050|NCT00874211|stage II multiple myeloma|stage ii multiple myeloma
540051|NCT00874211|stage III multiple myeloma|stage iii multiple myeloma
540052|NCT00874211|male breast cancer|male breast cancer
540053|NCT00874211|recurrent breast cancer|recurrent breast cancer
540054|NCT00874211|stage IA breast cancer|stage ia breast cancer
540055|NCT00874211|stage IB breast cancer|stage ib breast cancer
540056|NCT00874211|stage II breast cancer|stage ii breast cancer
540057|NCT00874211|stage IIIA breast cancer|stage iiia breast cancer
540058|NCT00874211|stage IIIB breast cancer|stage iiib breast cancer
540059|NCT00874211|stage IIIC breast cancer|stage iiic breast cancer
540060|NCT00874211|stage IV breast cancer|stage iv breast cancer
540061|NCT00874211|recurrent prostate cancer|recurrent prostate cancer
540062|NCT00874211|stage I prostate cancer|stage i prostate cancer
540063|NCT00874211|stage IIB prostate cancer|stage iib prostate cancer
540064|NCT00874211|stage IIA prostate cancer|stage iia prostate cancer
540065|NCT00874211|stage III prostate cancer|stage iii prostate cancer
540066|NCT00874211|stage IV prostate cancer|stage iv prostate cancer
540067|NCT00874211|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
540068|NCT00874211|stage I non-small cell lung cancer|stage i non-small cell lung cancer
540069|NCT00874211|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
540070|NCT00874211|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
540071|NCT00874211|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
540072|NCT00874211|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
540073|NCT00874211|extensive stage small cell lung cancer|extensive stage small cell lung cancer
540074|NCT00874211|limited stage small cell lung cancer|limited stage small cell lung cancer
540075|NCT00874211|recurrent small cell lung cancer|recurrent small cell lung cancer
540076|NCT00874198|normal pressure hydrocephalus|normal pressure hydrocephalus
540077|NCT00874198|cerebrospinal fluid dynamic test|cerebrospinal fluid dynamic test
540078|NCT00874198|cerebrospinal fluid outflow resistance|cerebrospinal fluid outflow resistance
540079|NCT00874198|cerebrospinal compliance|cerebrospinal compliance
540080|NCT00874198|outcome|outcome
540081|NCT00874198|shunt surgery|shunt surgery
540082|NCT00874198|normal pressure hydrocephalus guidelines|normal pressure hydrocephalus guidelines
540083|NCT00874198|biomarkers|biomarkers
540084|NCT00874198|shunt surgery selection|shunt surgery selection
540085|NCT00874198|Outcome measures|outcome measures
540086|NCT00874198|Outcomes assessment|outcomes assessment
540087|NCT00874198|Outcome and process assessment|outcome and process assessment
540088|NCT00874185|satisfaction|satisfaction
540089|NCT00874172|Anemia|anemia
540090|NCT00874172|Sickle Cell|sickle cell
540091|NCT00874172|Analgesic|analgesic
540092|NCT00874172|Pain|pain
540093|NCT00874172|Emergency treatment|emergency treatment
540094|NCT00874172|Quality of life|quality of life
540095|NCT00874107|NSCLC|nsclc
540096|NCT00874107|Phase 2|phase 2
540097|NCT00874107|Randomized|randomized
540098|NCT00874107|Efficacy|efficacy
540099|NCT00874107|Safety|safety
540100|NCT00874107|Imprime PGG|imprime pgg
540101|NCT00874107|Bevacizumab|bevacizumab
540102|NCT00874094|nasolabial folds|nasolabial folds
540103|NCT00874094|platelet rich plasma|platelet rich plasma
540104|NCT00874094|fibrin matrix|fibrin matrix
540105|NCT00874094|facial rhytids|facial rhytids
540106|NCT00874094|dermal filler|dermal filler
540107|NCT00874068|term infants|term infants
540108|NCT00874068|preterm infants|preterm infants
540109|NCT00874068|bone strength|bone strength
540110|NCT00874068|Speed of sound (SOS)|speed of sound (sos)
540111|NCT00874068|Ultrasound|ultrasound
540112|NCT00874055|social influence|social influence
540113|NCT00874055|friends|friends
540114|NCT00874055|eating behavior|eating behavior
540115|NCT00874055|childhood overweight|childhood overweight
540116|NCT00874042|dose escalation|dose escalation
540117|NCT00874042|safety|safety
540118|NCT00874042|tolerability|tolerability
540119|NCT00874042|tumor|tumor
540120|NCT00874042|PK|pk
540121|NCT00874029|Uterine Fibroids|uterine fibroids
540122|NCT00874029|Myomas|myomas
540123|NCT00874016|intubation|intubation
540124|NCT00874016|Airtraq|airtraq
540125|NCT00874016|pediatric|pediatric
540126|NCT00874016|airway|airway
540127|NCT00874003|alcohol dependence|alcohol dependence
540128|NCT00874003|anti-depressant|anti-depressant
540129|NCT00874003|5-HT|5-ht
540130|NCT00874003|NE|ne
540131|NCT00873990|fissure sealant|fissure sealant
540132|NCT00873990|self etch|self etch
540133|NCT00873990|total etch|total etch
540134|NCT00873977|Adherence|adherence
540135|NCT00873977|Continuous Positive Airway Pressure|continuous positive airway pressure
540136|NCT00873964|Metabolic Syndrome|metabolic syndrome
540137|NCT00873964|Obesity|obesity
540138|NCT00873964|Elderly|elderly
540139|NCT00873964|Insulin Resistance|insulin resistance
540140|NCT00873938|Artesunate-Amodiaquine|artesunate-amodiaquine
540141|NCT00873938|Compliance|compliance
540142|NCT00873938|Malaria|malaria
540143|NCT00873925|Type 1 Diabetes|type 1 diabetes
540144|NCT00873912|influenza|influenza
540145|NCT00873912|FluMist|flumist
540146|NCT00873899|Heart Failure|heart failure
540147|NCT00873899|Implantable defibrillator|implantable defibrillator
540148|NCT00873899|Remote Monitoring|remote monitoring
540149|NCT00873873|Asthma Progression|asthma progression
540150|NCT00873873|Airway Wall Thickness|airway wall thickness
540151|NCT00873873|Corticosteroid Resistance|corticosteroid resistance
540152|NCT00873873|Biomarkers|biomarkers
540153|NCT00873873|Pulmonary Physiology|pulmonary physiology
540154|NCT00873860|CAT-354|cat-354
540155|NCT00873860|Tralokinumab|tralokinumab
540156|NCT00873860|Asthma|asthma
540157|NCT00873847|NICHD Neonatal Research Network|nichd neonatal research network
540158|NCT00873847|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
540159|NCT00873847|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
540160|NCT00873847|Prematurity|prematurity
540161|NCT00873847|Amplitude-integrated Electroencephalography (aEEG)|amplitude-integrated electroencephalography (aeeg)
540162|NCT00873834|autism|autism
540163|NCT00873834|fluoxetine|fluoxetine
540164|NCT00873834|Comparative|comparative
540165|NCT00873834|double blind|double blind
540166|NCT00873834|placebo|placebo
540167|NCT00873834|controlled trial|controlled trial
540168|NCT00873834|anatomy-functional imaging|anatomy-functional imaging
540169|NCT00873834|children|children
540170|NCT00873834|DSM-IV-R criteria for autism and CARS score (of 30 or above)|dsm-iv-r criteria for autism and cars score (of 30 or above)
540171|NCT00873808|breast cancer|breast cancer
540172|NCT00873795|efficacy|efficacy
540173|NCT00873795|tolerability|tolerability
540174|NCT00873795|combination of aripiprazole and SSRI(sertraline)|combination of aripiprazole and ssri(sertraline)
540175|NCT00873782|Limb Perfusion|limb perfusion
540176|NCT00873782|Gene Therapy|gene therapy
540177|NCT00873769|Staccato Loxapine|staccato loxapine
540178|NCT00873769|pharmacokinetics|pharmacokinetics
540179|NCT00873769|smokers|smokers
540180|NCT00873769|non-smokers|non-smokers
540181|NCT00873756|CRC|crc
540182|NCT00873756|Colon Cancer|colon cancer
540183|NCT00873756|Avastin|avastin
540184|NCT00873756|Apo2L/TRAIL|apo2l/trail
540185|NCT00873743|lower pain intensity with combination drug after cesarian section in first 48h postoperatively|lower pain intensity with combination drug after cesarian section in first 48h postoperatively
540186|NCT00873730|Effect of etanercept in subjects with ankylosing spondylitis|effect of etanercept in subjects with ankylosing spondylitis
540187|NCT00873717|elderly|elderly
540188|NCT00873717|long-term facilities|long-term facilities
540189|NCT00873717|nutritional status|nutritional status
540190|NCT00873691|Patients indicated for an ICD/ CRT-D|patients indicated for an icd/ crt-d
540191|NCT00873678|Molar tooth|molar tooth
540192|NCT00873678|AHI1 gene|ahi1 gene
540193|NCT00873678|CEP290 gene|cep290 gene
540194|NCT00873678|ciliopathies|ciliopathies
540195|NCT00873652|Hepatitis B vaccine|hepatitis b vaccine
540196|NCT00873652|Booster dose|booster dose
540197|NCT00873652|Persistence|persistence
540198|NCT00873652|Immune response|immune response
540199|NCT00873652|Healthy children|healthy children
540200|NCT00873626|Urinary tract infection|urinary tract infection
540201|NCT00873626|treatment duration|treatment duration
540202|NCT00873626|acute pyelonephritis|acute pyelonephritis
540203|NCT00873626|good use of antibiotics|good use of antibiotics
540204|NCT00873600|cognitive/functional effects|cognitive/functional effects
540205|NCT00873600|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
540206|NCT00873600|stage I breast cancer|stage i breast cancer
540207|NCT00873600|stage II breast cancer|stage ii breast cancer
540208|NCT00873600|stage IIIA breast cancer|stage iiia breast cancer
540209|NCT00873600|stage IIIB breast cancer|stage iiib breast cancer
540210|NCT00873600|stage IIIC breast cancer|stage iiic breast cancer
540211|NCT00873600|adenocarcinoma of the colon|adenocarcinoma of the colon
540212|NCT00873600|stage I colon cancer|stage i colon cancer
540213|NCT00873600|stage II colon cancer|stage ii colon cancer
540214|NCT00873600|stage III colon cancer|stage iii colon cancer
540215|NCT00873587|Thoracotomy|thoracotomy
540216|NCT00873587|Inspiration|inspiration
540217|NCT00873587|Expiration|expiration
540218|NCT00873587|Chest Tube|chest tube
540219|NCT00873587|pneumothorax|pneumothorax
540220|NCT00873587|Method of chest tube removal|method of chest tube removal
540221|NCT00873574|Familial myeloproliferative disorders|familial myeloproliferative disorders
540222|NCT00873574|JAK-STAT|jak-stat
540223|NCT00873574|V617|v617
540224|NCT00873574|JAK2|jak2
540225|NCT00873561|diabetes|diabetes
540226|NCT00873561|type 1|type 1
540227|NCT00873561|adult|adult
540228|NCT00873561|adolescent|adolescent
540229|NCT00873561|new onset|new onset
540230|NCT00873535|Nicotine|nicotine
540231|NCT00873535|Nicotine dependence|nicotine dependence
540232|NCT00873535|Smoking cessation|smoking cessation
540233|NCT00873535|Alcohol|alcohol
540234|NCT00873535|Alcohol dependence|alcohol dependence
540235|NCT00873535|Alcohol cessation|alcohol cessation
540236|NCT00873535|Treatment|treatment
540237|NCT00873535|Smoking|smoking
540238|NCT00873535|Cigarette|cigarette
540239|NCT00873535|Heavy drinkers|heavy drinkers
540240|NCT00873535|Social drinkers|social drinkers
540241|NCT00873535|Co-morbidity of alcohol and nicotine dependence|co-morbidity of alcohol and nicotine dependence
540242|NCT00873535|Nicotine receptor|nicotine receptor
540243|NCT00873535|Nicotinic receptor|nicotinic receptor
540244|NCT00873535|Nicotinic acetycholine receptor|nicotinic acetycholine receptor
540245|NCT00873535|Alpha-4-beta-2 nicotinic acetycholine receptor|alpha-4-beta-2 nicotinic acetycholine receptor
540246|NCT00873535|Cholinergic receptor|cholinergic receptor
540247|NCT00873535|Dopamine|dopamine
540248|NCT00873535|Craving|craving
540249|NCT00873535|Diary|diary
540250|NCT00873535|Cue induced|cue induced
540251|NCT00873535|Pharmacotherapy|pharmacotherapy
540252|NCT00873535|Varenicline|varenicline
540253|NCT00873535|Chantix|chantix
540254|NCT00873535|Champix|champix
540255|NCT00873522|pneumonia|pneumonia
540256|NCT00873509|Autism|autism
540257|NCT00873496|Sjögren's Syndrome|sjögren's syndrome
540258|NCT00873496|hyposalivation|hyposalivation
540259|NCT00873496|mouth dryness|mouth dryness
540260|NCT00873496|complications|complications
540261|NCT00873483|Pregnancy prevention|pregnancy prevention
540262|NCT00873483|female contraception|female contraception
540263|NCT00873483|patch|patch
540264|NCT00873457|B-Cell Chronic Lymphocytic Leukemia|b-cell chronic lymphocytic leukemia
540265|NCT00873457|Leukemia|leukemia
540266|NCT00873444|Hip|hip
540267|NCT00873444|Cementless|cementless
540268|NCT00873444|Ceramic-on-Metal|ceramic-on-metal
540269|NCT00873444|Metal-on-Metal|metal-on-metal
540270|NCT00873431|Prevention of pneumococcal infections|prevention of pneumococcal infections
540271|NCT00873418|Heart Failure|heart failure
540272|NCT00873418|Intervention|intervention
540273|NCT00873418|Cognitive Behavior Therapy|cognitive behavior therapy
540274|NCT00873418|Quality of Life|quality of life
540275|NCT00873405|Type 2 diabetes mellitus|type 2 diabetes mellitus
540276|NCT00873405|Metabolic control|metabolic control
540277|NCT00873405|Bariatric Surgery|bariatric surgery
540278|NCT00873405|Weight Loss|weight loss
540279|NCT00873405|Sleeve gastrectomy|sleeve gastrectomy
540280|NCT00873405|BMI reduction|bmi reduction
540281|NCT00873405|Waist circumference reduction|waist circumference reduction
540282|NCT00873405|Percentage of excess BMI loss|percentage of excess bmi loss
540283|NCT00873405|Glucose homeostasis|glucose homeostasis
540284|NCT00873392|Parkinson's disease|parkinson's disease
540285|NCT00873392|Motor fluctuation|motor fluctuation
540286|NCT00873392|Nicotine|nicotine
540287|NCT00873392|Drug treatment|drug treatment
540288|NCT00873392|neuroprotection|neuroprotection
540289|NCT00873366|stage I breast cancer|stage i breast cancer
540290|NCT00873366|stage II breast cancer|stage ii breast cancer
540291|NCT00873366|stage IIIA breast cancer|stage iiia breast cancer
540292|NCT00873366|stage IIIB breast cancer|stage iiib breast cancer
540293|NCT00873366|stage IIIC breast cancer|stage iiic breast cancer
540294|NCT00873353|Metastatic Adenocarcinoma of the Pancreas|metastatic adenocarcinoma of the pancreas
540295|NCT00873340|MS|ms
540296|NCT00873340|Multiple Sclerosis|multiple sclerosis
540297|NCT00873340|Betaferon|betaferon
540298|NCT00873340|Colombia|colombia
540299|NCT00873327|presumed sepsis|presumed sepsis
540300|NCT00873301|vulvodynia|vulvodynia
540301|NCT00873301|vestibulectomy|vestibulectomy
540302|NCT00873301|surgery|surgery
540303|NCT00873301|vestibulitis|vestibulitis
540304|NCT00873288|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
540305|NCT00873288|atypical squamous cells of undetermined significance|atypical squamous cells of undetermined significance
540306|NCT00873288|high-grade squamous intraepithelial lesion|high-grade squamous intraepithelial lesion
540307|NCT00873288|low-grade squamous intraepithelial lesion|low-grade squamous intraepithelial lesion
540308|NCT00873275|stage IV colon cancer|stage iv colon cancer
540309|NCT00873275|stage IV rectal cancer|stage iv rectal cancer
540310|NCT00873275|recurrent colon cancer|recurrent colon cancer
540311|NCT00873275|recurrent rectal cancer|recurrent rectal cancer
540312|NCT00873275|adenocarcinoma of the colon|adenocarcinoma of the colon
540313|NCT00873275|adenocarcinoma of the rectum|adenocarcinoma of the rectum
540314|NCT00873262|PreMenstrual Syndrome|premenstrual syndrome
540315|NCT00873262|Hormones|hormones
540316|NCT00873262|Skin tests|skin tests
540317|NCT00873262|Desensitization|desensitization
540318|NCT00873262|Allergen Immunotherapy|allergen immunotherapy
540319|NCT00873249|Schizophrenia|schizophrenia
540320|NCT00873249|Therapeutic adherence|therapeutic adherence
540321|NCT00873249|Short message system|short message system
540322|NCT00873249|Mobile phone|mobile phone
540323|NCT00873236|stage III renal cell cancer|stage iii renal cell cancer
540324|NCT00873236|stage IV renal cell cancer|stage iv renal cell cancer
540325|NCT00873210|renal cell carcinoma|renal cell carcinoma
540326|NCT00873210|sunitinib malate|sunitinib malate
540327|NCT00873197|Co-administration of transdermal and intravenous granisetron|co-administration of transdermal and intravenous granisetron
540328|NCT00873197|Granisetron|granisetron
540329|NCT00873197|Healthy subjects|healthy subjects
540330|NCT00873197|Intravenous|intravenous
540331|NCT00873197|Pharmacokinetic profile|pharmacokinetic profile
540332|NCT00873197|Sancuso® patch|sancuso® patch
540333|NCT00873197|Transdermal|transdermal
540334|NCT00873197|Pharmacokinetics|pharmacokinetics
540335|NCT00873184|massage therapy in patients with brain tumors|massage therapy in patients with brain tumors
540336|NCT00873171|Osteopathic Manipulation|osteopathic manipulation
540337|NCT00873158|Adhesive Capsulitis|adhesive capsulitis
540338|NCT00873158|ROM|rom
540339|NCT00873158|Dynasplint|dynasplint
540340|NCT00873145|Survival|survival
540341|NCT00873145|Function|function
540342|NCT00873145|Infection|infection
540343|NCT00873145|Revision|revision
540344|NCT00873145|Loosening|loosening
540345|NCT00873119|Belinostat|belinostat
540346|NCT00873119|PXD101|pxd101
540347|NCT00873119|Carboplatin|carboplatin
540348|NCT00873119|Paclitaxel|paclitaxel
540349|NCT00873119|CUP|cup
540350|NCT00873119|Carcinoma of unknown primary|carcinoma of unknown primary
540351|NCT00873119|Occult primary|occult primary
540352|NCT00873080|reliability|reliability
540353|NCT00873080|photogrammetry|photogrammetry
540354|NCT00873067|Atrial fibrillation|atrial fibrillation
540355|NCT00873067|Complex fractionated electrograms|complex fractionated electrograms
540356|NCT00873067|CFAE|cfae
540357|NCT00873041|Thalassemia|thalassemia
540358|NCT00873041|thalassemia intermedia|thalassemia intermedia
540359|NCT00873041|alpha-thalassemia|alpha-thalassemia
540360|NCT00873041|beta-thalassemia|beta-thalassemia
540361|NCT00873041|deferasirox|deferasirox
540362|NCT00873041|iron overload|iron overload
540363|NCT00873041|non-transfusion dependent|non-transfusion dependent
540364|NCT00873028|Physical therapy|physical therapy
540365|NCT00873028|Inspiratory muscles|inspiratory muscles
540366|NCT00873028|Exercise|exercise
540367|NCT00873015|Cerebral aneurysm|cerebral aneurysm
540368|NCT00873015|Subarachnoid hemorrhage|subarachnoid hemorrhage
540369|NCT00873015|Nitrite|nitrite
540370|NCT00873002|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
540371|NCT00873002|advanced adult primary liver cancer|advanced adult primary liver cancer
540372|NCT00873002|recurrent adult primary liver cancer|recurrent adult primary liver cancer
540373|NCT00873002|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
540374|NCT00872989|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
540375|NCT00872989|recurrent fallopian tube cancer|recurrent fallopian tube cancer
540376|NCT00872989|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
540377|NCT00872963|malaria vaccine|malaria vaccine
540378|NCT00872963|RTS,S,|rts,s,
540379|NCT00872950|LEMS|lems
540380|NCT00872950|CMS|cms
540381|NCT00872950|3,4 DIAMINOPYRIDINE|3,4 diaminopyridine
540382|NCT00872950|3,4 DAP|3,4 dap
540383|NCT00872924|Bioequivalence|bioequivalence
540384|NCT00872911|Sarcopenia|sarcopenia
540385|NCT00872911|nutrition|nutrition
540386|NCT00872911|aging|aging
540387|NCT00872911|metabolism|metabolism
540388|NCT00872911|exercise|exercise
540389|NCT00872898|autism|autism
540390|NCT00872898|memantine|memantine
540391|NCT00872898|pediatric|pediatric
540392|NCT00872898|Forest Laboratories|forest laboratories
540393|NCT00872898|Autism in pediatric patients|autism in pediatric patients
540394|NCT00872885|analgesic|analgesic
540395|NCT00872885|bunionectomy|bunionectomy
540396|NCT00872885|surgery|surgery
540397|NCT00872885|post operative pain|post operative pain
540398|NCT00872885|single Hallux valgus repair|single hallux valgus repair
540399|NCT00872872|NVP|nvp
540400|NCT00872872|PMTCT|pmtct
540401|NCT00872872|pregnancy|pregnancy
540402|NCT00872872|resistance|resistance
540403|NCT00872859|Breast Cancer|breast cancer
540404|NCT00872859|Cancer of Breast|cancer of breast
540405|NCT00872859|Reconstructive Surgery|reconstructive surgery
540406|NCT00872846|Body weight|body weight
540407|NCT00872846|Signs and symptoms|signs and symptoms
540408|NCT00872846|Obesity|obesity
540409|NCT00872846|Metabolic disease|metabolic disease
540410|NCT00872846|Diabetes mellitus type 2|diabetes mellitus type 2
540411|NCT00872846|Diabetes mellitus|diabetes mellitus
540412|NCT00872846|Nutrition disorder|nutrition disorder
540413|NCT00872846|Endocrine system diseases|endocrine system diseases
540414|NCT00872846|Overweight|overweight
540415|NCT00872846|Overnutrition|overnutrition
540416|NCT00872846|Glucose metabolic disorder|glucose metabolic disorder
540417|NCT00872833|Transfusion-Dependant Thalassemia|transfusion-dependant thalassemia
540418|NCT00872833|Pain|pain
540419|NCT00872833|Mild Pain|mild pain
540420|NCT00872820|Social Anxiety|social anxiety
540421|NCT00872820|Social Anxiety Treatment|social anxiety treatment
540422|NCT00872820|Cognitive Therapy|cognitive therapy
540423|NCT00872820|Mindfulness|mindfulness
540424|NCT00872820|Social Phobia|social phobia
540425|NCT00872820|Social Phobia Treatment|social phobia treatment
540426|NCT00872807|childhood|childhood
540427|NCT00872807|therapy|therapy
540428|NCT00872807|life style|life style
540429|NCT00872807|motor activity|motor activity
540430|NCT00872807|obesity|obesity
540431|NCT00872807|overweight|overweight
540432|NCT00872807|body mass index|body mass index
540433|NCT00872807|treatment|treatment
540434|NCT00872794|Hip|hip
540435|NCT00872794|Conservative|conservative
540436|NCT00872794|Metal on Metal|metal on metal
540437|NCT00872794|Resurfacing|resurfacing
540438|NCT00872781|Bioequivalence fixed dose combination of Quinapril HCl 20 mg and Hydrochlorothiazide 25 mg tablets|bioequivalence fixed dose combination of quinapril hcl 20 mg and hydrochlorothiazide 25 mg tablets
540439|NCT00872742|Impulse Control Disorders|impulse control disorders
540440|NCT00872742|Behavior Therapy|behavior therapy
540441|NCT00872742|Acceptance|acceptance
540442|NCT00872742|Habit Reversal|habit reversal
540443|NCT00872729|cystinosis|cystinosis
540444|NCT00872729|cysteamine|cysteamine
540445|NCT00872729|inheritable disease|inheritable disease
540446|NCT00872729|orphan disease|orphan disease
540447|NCT00872729|CTNS protein, human|ctns protein, human
540448|NCT00872729|nephropathic cystinosis|nephropathic cystinosis
540449|NCT00872716|specific phobia|specific phobia
540450|NCT00872716|simple phobia|simple phobia
540451|NCT00872716|anxiety disorder|anxiety disorder
540452|NCT00872703|CMV|cmv
540453|NCT00872703|Prenatal Diagnosis|prenatal diagnosis
540454|NCT00872703|Ultrasound|ultrasound
540455|NCT00872703|MRI|mri
540456|NCT00872690|Multiple Trauma|multiple trauma
540457|NCT00872690|Blast Injuries|blast injuries
540458|NCT00872690|Brain Injuries|brain injuries
540459|NCT00872690|Rehabilitation, Vocational|rehabilitation, vocational
540460|NCT00872690|Consumer participation|consumer participation
540461|NCT00872677|weight changes|weight changes
540462|NCT00872677|obesity|obesity
540463|NCT00872677|stage I breast cancer|stage i breast cancer
540464|NCT00872677|stage II breast cancer|stage ii breast cancer
540465|NCT00872677|stage IIIA breast cancer|stage iiia breast cancer
540466|NCT00872664|ROP|rop
540467|NCT00872664|anti-oxidants|anti-oxidants
540468|NCT00872664|carotenoids|carotenoids
540469|NCT00872651|Glaucoma|glaucoma
540470|NCT00872651|intraocular pressure|intraocular pressure
540471|NCT00872651|travoprost/timolol|travoprost/timolol
540472|NCT00872651|timolol|timolol
540473|NCT00872638|wound edge eversion|wound edge eversion
540474|NCT00872638|cosmetic outcomes|cosmetic outcomes
542053|NCT00866593|HAMA|hama
540475|NCT00872638|surgical incisions|surgical incisions
540476|NCT00872625|stage IA breast cancer|stage ia breast cancer
540477|NCT00872625|stage IB breast cancer|stage ib breast cancer
540478|NCT00872625|stage II breast cancer|stage ii breast cancer
540479|NCT00872625|stage IIIA breast cancer|stage iiia breast cancer
540480|NCT00872625|stage IIIB breast cancer|stage iiib breast cancer
540481|NCT00872625|stage IIIC breast cancer|stage iiic breast cancer
540482|NCT00872625|recurrent breast cancer|recurrent breast cancer
540483|NCT00872612|Sarcoidosis|sarcoidosis
540484|NCT00872612|Diagnosis|diagnosis
540485|NCT00872612|Non-caseating granulomas|non-caseating granulomas
540486|NCT00872612|BAL|bal
540487|NCT00872612|EUS-FNA|eus-fna
540488|NCT00872612|EBUS-TBNA|ebus-tbna
540489|NCT00872612|TBLB|tblb
540490|NCT00872599|Hypertension|hypertension
540491|NCT00872599|Phenotyping|phenotyping
540492|NCT00872599|High Salt intake|high salt intake
540493|NCT00872599|frequently sampled IV glucose tolerance test(FSIVGTT)|frequently sampled iv glucose tolerance test(fsivgtt)
540494|NCT00872599|fenofibrate|fenofibrate
540495|NCT00872599|epoxyeicosatrienoic acids|epoxyeicosatrienoic acids
540496|NCT00872599|hydroxyeicosatetraenoic acids|hydroxyeicosatetraenoic acids
540497|NCT00872599|dihydroxyeicosatrienoic acid|dihydroxyeicosatrienoic acid
540498|NCT00872599|PPAR Alpha Agonist|ppar alpha agonist
540499|NCT00872599|CYP Monooxygenase Activity|cyp monooxygenase activity
540500|NCT00872573|Hip|hip
540501|NCT00872573|Cemented|cemented
540502|NCT00872547|Hip|hip
540503|NCT00872547|Resurfacing|resurfacing
540504|NCT00872547|Metal-on-Metal|metal-on-metal
540505|NCT00872547|Large Heads|large heads
540506|NCT00872547|XL Head|xl head
540507|NCT00872547|ASR - osteoarthritis (primary)|asr - osteoarthritis (primary)
540508|NCT00872534|To evaluate the acute gastrointestinal safety of PL-2100.|to evaluate the acute gastrointestinal safety of pl-2100.
540509|NCT00872521|Multiple Myeloma|multiple myeloma
540510|NCT00872521|transplant eligible|transplant eligible
540511|NCT00872521|doxorubicin|doxorubicin
540512|NCT00872521|dexamethasone|dexamethasone
540513|NCT00872521|bortezomib|bortezomib
540514|NCT00872521|bortezomib resistance|bortezomib resistance
540515|NCT00872521|PAD induction|pad induction
540516|NCT00872521|PIMMS Trial|pimms trial
540517|NCT00872495|Urothelial Cancer|urothelial cancer
540518|NCT00872495|Cancer|cancer
540519|NCT00872495|Bladder Neoplasms|bladder neoplasms
540520|NCT00872495|Urinary Bladder Cancer|urinary bladder cancer
540521|NCT00872482|non-small cell lung cancer|non-small cell lung cancer
540522|NCT00872482|NSCLC|nsclc
540523|NCT00872482|Brain metastases|brain metastases
540524|NCT00872482|nimotuzumab|nimotuzumab
540525|NCT00872482|TheraCIM|theracim
540526|NCT00872482|h-R3|h-r3
540527|NCT00872482|Radiation|radiation
540528|NCT00872469|Postpartum haemorrhage|postpartum haemorrhage
540529|NCT00872469|randomised controlled trial|randomised controlled trial
540530|NCT00872469|tranexamic acid|tranexamic acid
540531|NCT00872469|antifibrinolytic|antifibrinolytic
540532|NCT00872456|Diabetes Mellitus|diabetes mellitus
540533|NCT00872456|Cardiovascular Disease|cardiovascular disease
540534|NCT00872456|Haptoglobin|haptoglobin
540535|NCT00872430|constipation|constipation
540536|NCT00872430|RCT|rct
540537|NCT00872430|phytotherapy|phytotherapy
540538|NCT00872417|HIV/AIDS|hiv/aids
540539|NCT00872417|antiretroviral therapy|antiretroviral therapy
540540|NCT00872417|immune reconstitution|immune reconstitution
540541|NCT00872404|CP-751,871|cp-751,871
540542|NCT00872404|squamous cell carcinoma|squamous cell carcinoma
540543|NCT00872404|recurrent or metastatic|recurrent or metastatic
540544|NCT00872404|after 1st line chemotherapy|after 1st line chemotherapy
540545|NCT00872378|Morbid Obesity|morbid obesity
540546|NCT00872378|LAP Band|lap band
540547|NCT00872378|Adjustable Gastric Band|adjustable gastric band
540548|NCT00872378|Exenatide|exenatide
540549|NCT00872378|Byetta|byetta
540550|NCT00872378|Weight Loss|weight loss
540551|NCT00872378|Bariatric Surgery|bariatric surgery
540552|NCT00872365|Pregnancy|pregnancy
540553|NCT00872365|Exercise|exercise
540554|NCT00872365|Nutrition|nutrition
540555|NCT00872365|Micronutrients|micronutrients
540556|NCT00872365|non-transmissible chronic diseases|non-transmissible chronic diseases
540557|NCT00872365|Endothelium|endothelium
540558|NCT00872352|Multiple Myeloma|multiple myeloma
540559|NCT00872352|Bortezomib|bortezomib
540560|NCT00872352|Peripheral Neuropathy|peripheral neuropathy
540561|NCT00872352|evaluation|evaluation
540562|NCT00872352|evaluation of electrophysiological changes related to the dose and time of bortezomib administration|evaluation of electrophysiological changes related to the dose and time of bortezomib administration
540563|NCT00872352|investigation of correlation between the incidence of BIPN and the subtype of myeloma|investigation of correlation between the incidence of bipn and the subtype of myeloma
540564|NCT00872339|Transfusion-Dependent Thalassemia|transfusion-dependent thalassemia
540565|NCT00872339|Non-Transfusion-Dependent Thalassemia|non-transfusion-dependent thalassemia
540566|NCT00872326|Diabetes Complications|diabetes complications
540567|NCT00872326|Lower limb ischemia|lower limb ischemia
540568|NCT00872326|Adult stem cells|adult stem cells
540569|NCT00872313|Labor|labor
540570|NCT00872313|Psychology|psychology
540571|NCT00872313|Postpartum Psychology|postpartum psychology
540572|NCT00872287|minimally invasive surgery|minimally invasive surgery
540573|NCT00872287|scarless cholecystectomy|scarless cholecystectomy
540574|NCT00872287|new techniques in laparoscopy|new techniques in laparoscopy
540575|NCT00872287|invisible scar|invisible scar
540576|NCT00872287|single port access|single port access
540577|NCT00872287|abdominal pain|abdominal pain
540578|NCT00872287|shoulder pain|shoulder pain
540579|NCT00872274|Bioequivalence|bioequivalence
540580|NCT00872261|Clinical Trials as Topic|clinical trials as topic
540581|NCT00872261|Adolescent Psychology|adolescent psychology
540582|NCT00872261|Patient Acceptance of Health Care|patient acceptance of health care
540583|NCT00872261|HIV Risk Behaviors|hiv risk behaviors
540584|NCT00872261|Adolescents|adolescents
540585|NCT00872261|Clinical Trial Recruitment|clinical trial recruitment
540586|NCT00872261|Microbicide Acceptability|microbicide acceptability
540587|NCT00872261|Ethics|ethics
540588|NCT00872261|Mixed Methods|mixed methods
540590|NCT00872248|Restless leg syndrome|restless leg syndrome
540591|NCT00872248|Spinal anesthesia|spinal anesthesia
540592|NCT00872248|Epidural anesthesia|epidural anesthesia
540593|NCT00872248|Neuraxial block|neuraxial block
540594|NCT00872235|Bioequivalence fixed-dose combination of quinapril 20 mg and hydrochlorothiazide 25 mg tablets|bioequivalence fixed-dose combination of quinapril 20 mg and hydrochlorothiazide 25 mg tablets
540595|NCT00872222|Hip|hip
540596|NCT00872222|Cementless|cementless
540597|NCT00872222|Ceramic-on-Ceramic|ceramic-on-ceramic
540598|NCT00872209|swimmer's ear|swimmer's ear
540599|NCT00872209|ear drops|ear drops
540600|NCT00872209|ear foam|ear foam
540601|NCT00872209|otic foam|otic foam
540602|NCT00872209|ear infection|ear infection
540603|NCT00872209|ear pain|ear pain
540604|NCT00872209|ear inflammation|ear inflammation
540605|NCT00872183|Motor Learning|motor learning
540606|NCT00872183|Mirror Neurons|mirror neurons
540607|NCT00872183|Healthy Volunteer|healthy volunteer
540608|NCT00872183|HV|hv
540609|NCT00872170|Pulmonary Hypertension|pulmonary hypertension
540610|NCT00872157|Castrate-Resistant Prostate Cancer|castrate-resistant prostate cancer
540611|NCT00872157|Prostate|prostate
540612|NCT00872157|High-Volume Osseous Metastases|high-volume osseous metastases
540613|NCT00872157|BMTP-11|bmtp-11
540614|NCT00872157|Prostate State Antigen|prostate state antigen
540615|NCT00872157|PSA|psa
540616|NCT00872131|Anxiety|anxiety
540617|NCT00872131|Social Phobia|social phobia
540618|NCT00872131|Generalized Social Anxiety Disorder|generalized social anxiety disorder
540619|NCT00872118|alcohol consumption|alcohol consumption
540620|NCT00872118|social anxiety|social anxiety
540621|NCT00872118|brief intervention|brief intervention
540622|NCT00872118|motivational interviewing|motivational interviewing
540623|NCT00872118|cognitive behavioral|cognitive behavioral
540624|NCT00872105|clavicle|clavicle
540625|NCT00872105|fractures|fractures
540626|NCT00872105|distal|distal
540627|NCT00872092|small bowel|small bowel
540628|NCT00872092|bacterial overgrowth|bacterial overgrowth
540629|NCT00872079|warfarin|warfarin
540630|NCT00872079|pharmacokinetics|pharmacokinetics
540631|NCT00872079|pharmacodynamics|pharmacodynamics
540632|NCT00872066|Hip|hip
540633|NCT00872066|Bone Cement|bone cement
540634|NCT00872053|robot|robot
540635|NCT00872053|treadmill|treadmill
540636|NCT00872053|foot drop|foot drop
540637|NCT00872053|rehabilitation|rehabilitation
540638|NCT00872053|gait|gait
540639|NCT00872040|Sexual function|sexual function
540640|NCT00872040|Pelvic floor disorders|pelvic floor disorders
540641|NCT00872040|Delivery mode|delivery mode
540642|NCT00872027|Critical Illness|critical illness
540643|NCT00872027|Intensive Care Unit|intensive care unit
540644|NCT00872027|Acute Respiratory Failure|acute respiratory failure
540645|NCT00872027|Prolonged Mechanical Ventilation|prolonged mechanical ventilation
540646|NCT00871975|LUTS|luts
540647|NCT00871975|OAB|oab
540648|NCT00871962|long-term oxygen therapy|long-term oxygen therapy
540649|NCT00871962|COPD patients on necessity of long-term oxygen therapy|copd patients on necessity of long-term oxygen therapy
540650|NCT00871949|Safety tolerability pharmacokinetics PK first in human FIH|safety tolerability pharmacokinetics pk first in human fih
540651|NCT00871923|Non-small cell lung cancer|non-small cell lung cancer
540652|NCT00871923|NSCLC|nsclc
540653|NCT00871923|Brain Metastases|brain metastases
540654|NCT00871923|Brain Cancer|brain cancer
540655|NCT00871923|Lung Cancer|lung cancer
540656|NCT00871923|Tarceva|tarceva
540657|NCT00871923|Erlotinib Hydrochloride|erlotinib hydrochloride
540658|NCT00871923|OSI-774|osi-774
540659|NCT00871923|Radiation Therapy|radiation therapy
540660|NCT00871923|Whole Brain Radiation Therapy|whole brain radiation therapy
540661|NCT00871923|WBRT|wbrt
540662|NCT00871897|Neuropsychology|neuropsychology
540663|NCT00871897|Cardiac Rehabilitation|cardiac rehabilitation
540664|NCT00871884|Post Concussion Syndrome|post concussion syndrome
540665|NCT00871884|Cognitive Behavioral Therapy|cognitive behavioral therapy
540666|NCT00871884|Anxiety Sensitivity|anxiety sensitivity
540667|NCT00871884|Mild Head Injury|mild head injury
540668|NCT00871884|Psychotherapy|psychotherapy
540669|NCT00871884|Chronic Post Concussion Symptoms|chronic post concussion symptoms
540670|NCT00871858|stage II breast cancer|stage ii breast cancer
540671|NCT00871858|stage IIIA breast cancer|stage iiia breast cancer
540672|NCT00871858|stage IIIB breast cancer|stage iiib breast cancer
540673|NCT00871858|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
540674|NCT00871858|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
540676|NCT00871845|hepatitis C|hepatitis c
540677|NCT00871845|insulin resistance|insulin resistance
540678|NCT00871845|metabolic syndrome|metabolic syndrome
540679|NCT00871832|hyperglycemia|hyperglycemia
540680|NCT00871832|HgA1c|hga1c
540681|NCT00871832|mortality|mortality
540682|NCT00871819|Spinal Cord Stimulation|spinal cord stimulation
540683|NCT00871806|Pharmacokinetics|pharmacokinetics
540684|NCT00871806|eletriptan|eletriptan
540685|NCT00871806|bioavailability|bioavailability
540686|NCT00871806|oral disintegrating tablet|oral disintegrating tablet
540687|NCT00871780|TYSABRI naive|tysabri naive
540688|NCT00871780|Relapsing-remitting multiple sclerosis (RRMS)|relapsing-remitting multiple sclerosis (rrms)
540689|NCT00871767|AZD5672|azd5672
540690|NCT00871767|relative bioavailability|relative bioavailability
540691|NCT00871767|rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
540692|NCT00871754|Bladder Cancer|bladder cancer
540693|NCT00871754|Cancer, bladder|cancer, bladder
540694|NCT00871754|Urinary Bladder Cancer|urinary bladder cancer
540695|NCT00871741|Combined vaccine|combined vaccine
540696|NCT00871741|Primary vaccination|primary vaccination
540697|NCT00871728|Onychomycosis, Toe|onychomycosis, toe
540698|NCT00871728|Itraconazole|itraconazole
540699|NCT00871728|Sporanox|sporanox
540700|NCT00871715|stroke|stroke
540701|NCT00871715|hemiparesis|hemiparesis
540702|NCT00871715|physical therapy|physical therapy
540703|NCT00871715|occupational therapy|occupational therapy
540704|NCT00871715|neurorehabilitation|neurorehabilitation
540705|NCT00871715|patient focused|patient focused
540706|NCT00871715|motor learning|motor learning
540707|NCT00871715|motor control|motor control
540708|NCT00871715|skill acquisition|skill acquisition
540709|NCT00871715|skill training|skill training
540710|NCT00871715|motor recovery|motor recovery
540711|NCT00871715|task oriented training|task oriented training
540712|NCT00871715|task specific training|task specific training
540713|NCT00871715|arm function|arm function
540714|NCT00871715|hand function|hand function
540715|NCT00871715|upper extremity|upper extremity
540716|NCT00871715|arm therapy|arm therapy
540717|NCT00871715|physical rehabilitation|physical rehabilitation
540718|NCT00871715|arm rehabilitation|arm rehabilitation
540719|NCT00871715|motor function|motor function
540720|NCT00871702|Leukemia|leukemia
540721|NCT00871702|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
540722|NCT00871702|Hodgkin Disease|hodgkin disease
540723|NCT00871702|Myelodysplastic Syndromes|myelodysplastic syndromes
540724|NCT00871702|Multiple Myeloma|multiple myeloma
540725|NCT00871689|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
540726|NCT00871689|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
540727|NCT00871689|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
540728|NCT00871689|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
540729|NCT00871689|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
540730|NCT00871689|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
540731|NCT00871689|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
540732|NCT00871689|secondary acute myeloid leukemia|secondary acute myeloid leukemia
540733|NCT00871689|childhood acute myeloid leukemia with 11q23 (MLL) abnormalities|childhood acute myeloid leukemia with 11q23 (mll) abnormalities
540734|NCT00871689|childhood acute myeloid leukemia with inv(16)(p13;q22)|childhood acute myeloid leukemia with inv(16)(p13;q22)
540735|NCT00871689|childhood acute myeloid leukemia with t(15;17)(q22;q12)|childhood acute myeloid leukemia with t(15;17)(q22;q12)
540736|NCT00871689|childhood acute myeloid leukemia with t(16;16)(p13;q22)|childhood acute myeloid leukemia with t(16;16)(p13;q22)
540737|NCT00871689|childhood acute myeloid leukemia with t(8;21)(q22;q22)|childhood acute myeloid leukemia with t(8;21)(q22;q22)
540738|NCT00871650|Post Traumatic Stress Disorder|post traumatic stress disorder
540739|NCT00871650|PTSD|ptsd
540740|NCT00871650|Brain|brain
540741|NCT00871650|Imaging|imaging
540742|NCT00871650|PET|pet
540743|NCT00871650|Neural|neural
540744|NCT00871650|Sleep|sleep
540745|NCT00871650|REM Sleep|rem sleep
540746|NCT00871637|Pulmonary disease, chronic obstructive|pulmonary disease, chronic obstructive
540747|NCT00871637|Airway macrophages|airway macrophages
540748|NCT00871637|Sputum milieu|sputum milieu
540749|NCT00871637|Airway inflammation|airway inflammation
540750|NCT00871637|Occupational diseases|occupational diseases
540751|NCT00871611|Hereditary|hereditary
540752|NCT00871611|Anderson-Fabry|anderson-fabry
540753|NCT00871611|prevalence|prevalence
540754|NCT00871611|heart|heart
540755|NCT00871611|hypertrophy|hypertrophy
540756|NCT00871611|urine|urine
540757|NCT00871611|globotriaosylceramide|globotriaosylceramide
540758|NCT00871611|isoforms|isoforms
540759|NCT00871611|α - Galactosidase|α - galactosidase
540760|NCT00871598|plaque psoriasis|plaque psoriasis
540761|NCT00871598|BTT1023|btt1023
540762|NCT00871598|safety|safety
540763|NCT00871598|pharmacokinetics|pharmacokinetics
540764|NCT00871585|bicalutamide|bicalutamide
540765|NCT00871585|PSA|psa
540766|NCT00871585|advanced prostate cancer|advanced prostate cancer
540767|NCT00871572|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
540768|NCT00871533|Biochemical Marker|biochemical marker
540769|NCT00871533|Biochemical Markers|biochemical markers
540770|NCT00871533|Biologic Marker|biologic marker
540771|NCT00871533|Biologic Markers|biologic markers
540772|NCT00871533|Biomarkers|biomarkers
540773|NCT00871533|Clinical Marker|clinical marker
540774|NCT00871533|Clinical Markers|clinical markers
540775|NCT00871533|Immune Marker|immune marker
540776|NCT00871533|Immune Markers|immune markers
540777|NCT00871533|Immunologic Marker|immunologic marker
540778|NCT00871533|Immunologic Markers|immunologic markers
540779|NCT00871533|Laboratory Marker|laboratory marker
540780|NCT00871533|Laboratory Markers|laboratory markers
540781|NCT00871533|Marker, Biochemical|marker, biochemical
540782|NCT00871533|Marker, Biological|marker, biological
540783|NCT00871533|Marker, Clinical|marker, clinical
540784|NCT00871533|Marker, Immunologic|marker, immunologic
540785|NCT00871533|Marker, Laboratory|marker, laboratory
540786|NCT00871533|Marker, Serum|marker, serum
540787|NCT00871533|Marker, Surrogate|marker, surrogate
540788|NCT00871533|Markers, Biochemical|markers, biochemical
540789|NCT00871533|Markers, Biological|markers, biological
540790|NCT00871533|Markers, Clinical|markers, clinical
540791|NCT00871533|Markers, Immunologic|markers, immunologic
540792|NCT00871533|Markers, Laboratory|markers, laboratory
540793|NCT00871533|Markers, Serum|markers, serum
540794|NCT00871533|Markers, Surrogate|markers, surrogate
540795|NCT00871533|Markers, Viral|markers, viral
540796|NCT00871533|Serum Marker|serum marker
540797|NCT00871533|Serum Markers|serum markers
540798|NCT00871533|Surrogate End Point|surrogate end point
540799|NCT00871533|Surrogate End Points|surrogate end points
540800|NCT00871533|Surrogate Endpoint|surrogate endpoint
540801|NCT00871533|Surrogate Endpoints|surrogate endpoints
540802|NCT00871533|Surrogate Marker|surrogate marker
540803|NCT00871533|Surrogate Markers|surrogate markers
540804|NCT00871533|Viral Marker|viral marker
540805|NCT00871533|Viral Markers|viral markers
540806|NCT00871520|Palliative Care|palliative care
540807|NCT00871520|Predictive Value of Tests|predictive value of tests
540808|NCT00871520|Prospective Studies|prospective studies
540809|NCT00871520|Survival Analysis|survival analysis
540810|NCT00871520|Survival prediction|survival prediction
540811|NCT00871507|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
540812|NCT00871455|Spinal Cord Injury|spinal cord injury
540813|NCT00871455|Baclofen|baclofen
540814|NCT00871455|Growth Hormone, Pituitary|growth hormone, pituitary
540815|NCT00871455|Insulin-Like Growth Factor I|insulin-like growth factor i
540816|NCT00871442|PCEA|pcea
540817|NCT00871442|labor and delivery|labor and delivery
540818|NCT00871442|pain|pain
540819|NCT00871442|epidural|epidural
540820|NCT00871442|anesthesia|anesthesia
540821|NCT00871442|pregnant women|pregnant women
540822|NCT00871429|skin toxicity|skin toxicity
540823|NCT00871429|cancer patients|cancer patients
540824|NCT00871429|adverse effects|adverse effects
540825|NCT00871403|GW786034|gw786034
540826|NCT00871403|pazopanib|pazopanib
540827|NCT00871403|pemetrexed|pemetrexed
540828|NCT00871403|cisplatin|cisplatin
540829|NCT00871403|non-small cell lung cancer|non-small cell lung cancer
540830|NCT00871403|NSCLC|nsclc
540831|NCT00871390|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
540832|NCT00871390|Permanent/Persistent Atrial Fibrillation|permanent/persistent atrial fibrillation
540833|NCT00871377|epilepsy|epilepsy
540834|NCT00871377|cardiac risk factors|cardiac risk factors
540835|NCT00871377|memory|memory
540836|NCT00871377|cognition|cognition
540837|NCT00871377|n-3 fatty acids|n-3 fatty acids
540838|NCT00871377|fish oil|fish oil
540839|NCT00871377|EPA|epa
540840|NCT00871377|DHA|dha
540841|NCT00871377|seizures|seizures
540842|NCT00871364|Bioequivalence|bioequivalence
540843|NCT00871364|venlafaxine|venlafaxine
540844|NCT00871364|Healthy subjects|healthy subjects
540845|NCT00871338|combined|combined
540846|NCT00871338|Vaccines|vaccines
540847|NCT00871325|Gastric emptying|gastric emptying
540848|NCT00871325|Small bowel transit|small bowel transit
540849|NCT00871325|Colonic transit|colonic transit
540850|NCT00871325|Whole gut transit|whole gut transit
540851|NCT00871325|Postoperative Ileus|postoperative ileus
540852|NCT00871312|diabetes|diabetes
540853|NCT00871312|diabetic|diabetic
540854|NCT00871312|wound|wound
540855|NCT00871312|ulcer|ulcer
540856|NCT00871312|lower extremity|lower extremity
540857|NCT00871312|foot|foot
540858|NCT00871312|oxygen|oxygen
540859|NCT00871312|hyperbaric|hyperbaric
540860|NCT00871312|topical wound oxygen|topical wound oxygen
540861|NCT00871299|Treatment-resistant depression, meditation, mindfulness|treatment-resistant depression, meditation, mindfulness
540862|NCT00871286|Chronic rhinosinusitis|chronic rhinosinusitis
540863|NCT00871286|Chronic sinusitis|chronic sinusitis
540864|NCT00871286|CRS|crs
540865|NCT00871273|capecitabine|capecitabine
540866|NCT00871273|total gastrectomy|total gastrectomy
540867|NCT00871273|pharmacokinetic|pharmacokinetic
540868|NCT00871260|Coronary Disease|coronary disease
540869|NCT00871260|Stress Testing|stress testing
540870|NCT00871260|Lexiscan (regadenoson)|lexiscan (regadenoson)
540871|NCT00871260|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
540872|NCT00871247|Bioequivalence|bioequivalence
540873|NCT00871247|finasteride|finasteride
540874|NCT00871247|Healthy subjects|healthy subjects
540875|NCT00871234|HIV|hiv
540876|NCT00871234|Endothelial function|endothelial function
540877|NCT00871234|Etravirine|etravirine
540878|NCT00871208|Atopic Dermatitis|atopic dermatitis
540879|NCT00871208|pruritus|pruritus
540880|NCT00871208|quality of life|quality of life
540881|NCT00871195|Rhesus D|rhesus d
540882|NCT00871195|RHD|rhd
540883|NCT00871195|genotype|genotype
540884|NCT00871195|phenotype|phenotype
540885|NCT00871195|neonatal|neonatal
540886|NCT00871195|noninvasive|noninvasive
540887|NCT00871195|fetal|fetal
540888|NCT00871195|MassARRAY|massarray
540889|NCT00871195|DNA|dna
540890|NCT00871182|COPD|copd
540891|NCT00871182|obstructive lung diseases|obstructive lung diseases
540892|NCT00871182|Tiotropium|tiotropium
540893|NCT00871169|Irinotecan|irinotecan
540894|NCT00871169|Oxaliplatin|oxaliplatin
540895|NCT00871169|Cetuximab|cetuximab
540896|NCT00871169|Advanced or metastatic pancreatic cancer|advanced or metastatic pancreatic cancer
540897|NCT00871156|Drug-Drug Interaction|drug-drug interaction
540898|NCT00871143|CBT|cbt
540899|NCT00871143|BDD|bdd
540900|NCT00871130|Thyroid gland|thyroid gland
540901|NCT00871130|bariatric surgery|bariatric surgery
540902|NCT00871130|weight loss|weight loss
540903|NCT00871130|thyroid hormones|thyroid hormones
540904|NCT00871130|adult|adult
540905|NCT00871130|morbid obesity|morbid obesity
540906|NCT00871130|cohort|cohort
540907|NCT00871117|Co-administration|co-administration
540908|NCT00871117|Immunization|immunization
540909|NCT00871117|Preschool|preschool
540910|NCT00871117|Booster|booster
540911|NCT00871104|Infective endocarditis|infective endocarditis
540912|NCT00871091|CAD/CAM|cad/cam
540913|NCT00871091|orthodontics|orthodontics
540914|NCT00871091|fixed appliance|fixed appliance
540915|NCT00871091|tooth movement|tooth movement
540916|NCT00871065|Cerebral Vasospasm|cerebral vasospasm
540917|NCT00871065|Vasospasm|vasospasm
540918|NCT00871065|Subarachnoid Hemorrhage|subarachnoid hemorrhage
540919|NCT00871065|Sildenafil citrate|sildenafil citrate
540920|NCT00871065|Aneurysm|aneurysm
540921|NCT00871065|Intracranial aneurysm|intracranial aneurysm
540922|NCT00871052|Polymorphic light eruption|polymorphic light eruption
540923|NCT00871052|UV radiation|uv radiation
540924|NCT00871052|Vitamin D|vitamin d
540925|NCT00871052|Immune suppression|immune suppression
540926|NCT00871052|Prevention|prevention
540927|NCT00871039|Alcoholism|alcoholism
540928|NCT00871039|Mechanical ventilation|mechanical ventilation
540929|NCT00871026|CAD/CAM|cad/cam
540930|NCT00871026|orthodontics|orthodontics
540931|NCT00871026|fixed appliance|fixed appliance
540932|NCT00871026|tooth movement|tooth movement
540933|NCT00871026|Adverse Effects|adverse effects
540934|NCT00871026|Time Factors|time factors
540935|NCT00871026|Treatment Outcome|treatment outcome
540936|NCT00871013|This study is being done in an attempt to improve the remission rate and the survival time for participants with high-risk myeloma|this study is being done in an attempt to improve the remission rate and the survival time for participants with high-risk myeloma
540937|NCT00871000|Boostrix Polio|boostrix polio
540938|NCT00871000|dTpa-IPV|dtpa-ipv
540939|NCT00870987|Malaria|malaria
540940|NCT00870987|Vaccine|vaccine
540941|NCT00870974|Parkinson|parkinson
540942|NCT00870974|Huntington's|huntington's
540943|NCT00870974|Fragile X|fragile x
540944|NCT00870974|Autistic Spectrum|autistic spectrum
540945|NCT00870974|Alzheimer's|alzheimer's
540946|NCT00870974|MCI|mci
540947|NCT00870961|colon cancer|colon cancer
540948|NCT00870961|rectal cancer|rectal cancer
540949|NCT00870961|adenomatous polyp|adenomatous polyp
540950|NCT00870948|Open Label|open label
540951|NCT00870948|Healthy Volunteers|healthy volunteers
540952|NCT00870935|Balloon catheter|balloon catheter
540953|NCT00870935|Cervical vacuum cup|cervical vacuum cup
540954|NCT00870935|Hysterosalpingography|hysterosalpingography
540955|NCT00870935|Infertility|infertility
540956|NCT00870935|Pain|pain
540957|NCT00870935|Fallopian Tube Patency Tests|fallopian tube patency tests
540958|NCT00870935|Female Infertility|female infertility
540959|NCT00870896|capsaicin|capsaicin
540960|NCT00870896|COPD|copd
540961|NCT00870896|COPD with chronic bronchitis|copd with chronic bronchitis
540962|NCT00870870|Tumors|tumors
540963|NCT00870870|Antibodies, Monoclonal|antibodies, monoclonal
540964|NCT00870870|Stage IIIb Metastatic Non-Small Cell Lung Cancer|stage iiib metastatic non-small cell lung cancer
542054|NCT00866593|VAS-PI|vas-pi
540965|NCT00870870|Stage IV Metastatic Non-Small Cell Lung Cancer|stage iv metastatic non-small cell lung cancer
540966|NCT00870857|Lungs|lungs
540967|NCT00870857|antiretrovirals|antiretrovirals
540968|NCT00870857|HIV|hiv
540969|NCT00870857|COPD|copd
540970|NCT00870844|Acute ischemic stroke|acute ischemic stroke
540971|NCT00870844|Erythropoietin|erythropoietin
540972|NCT00870844|Carbamylated|carbamylated
540973|NCT00870844|Neuroprotection|neuroprotection
540974|NCT00870831|diabetes|diabetes
540975|NCT00870818|Teplizumab|teplizumab
540976|NCT00870818|Protege|protege
540977|NCT00870818|MGA031|mga031
540978|NCT00870818|Monoclonal antibody|monoclonal antibody
540979|NCT00870818|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
540980|NCT00870818|T1DM|t1dm
540981|NCT00870818|MacroGenics|macrogenics
540982|NCT00870792|HIV|hiv
540983|NCT00870792|antiretroviral therapy|antiretroviral therapy
540984|NCT00870792|medication adherence|medication adherence
540985|NCT00870792|Treatment Experienced|treatment experienced
540986|NCT00870779|Fluorescence|fluorescence
540987|NCT00870779|Brain Tumor|brain tumor
540988|NCT00870779|Malignant Glioma|malignant glioma
540989|NCT00870779|Pituitary Tumor|pituitary tumor
540990|NCT00870779|Skull Base Tumor|skull base tumor
540991|NCT00870779|Brain Lesions|brain lesions
540992|NCT00870779|Brain Metastases|brain metastases
540993|NCT00870779|Meningioma|meningioma
540994|NCT00870753|Eating disorders|eating disorders
540995|NCT00870753|yoga|yoga
540996|NCT00870753|body awareness|body awareness
540997|NCT00870753|depression|depression
540998|NCT00870753|anxiety|anxiety
540999|NCT00870740|MS|ms
541000|NCT00870740|Multiple Sclerosis|multiple sclerosis
541001|NCT00870727|PDD NOS|pdd nos
541002|NCT00870714|Prostate Cancer|prostate cancer
541003|NCT00870714|Neoadjuvant|neoadjuvant
541004|NCT00870701|sarcoma|sarcoma
541005|NCT00870701|soft tissue|soft tissue
541006|NCT00870701|members|members
541007|NCT00870701|radiotherapy|radiotherapy
541008|NCT00870701|absence of radiotherapy|absence of radiotherapy
541009|NCT00870688|valproate|valproate
541010|NCT00870688|epilepsy|epilepsy
541011|NCT00870688|compliance|compliance
541012|NCT00870688|sustained released minitablet|sustained released minitablet
541013|NCT00870688|Orfiril long|orfiril long
541014|NCT00870675|Ventriculomegaly|ventriculomegaly
541015|NCT00870675|ultrasound|ultrasound
541016|NCT00870675|MRI|mri
541017|NCT00870675|fetus|fetus
541018|NCT00870649|Schistosomiasis vaccine|schistosomiasis vaccine
541019|NCT00870649|therapeutic vaccine|therapeutic vaccine
541020|NCT00870649|Bilhvax|bilhvax
541021|NCT00870636|Pan-Vascular Endothelial Growth Factor Blockade|pan-vascular endothelial growth factor blockade
541022|NCT00870636|Safety|safety
541023|NCT00870636|ROP|rop
541024|NCT00870636|Bevacizumab|bevacizumab
541025|NCT00870636|Avastin|avastin
541026|NCT00870610|jugular venous oxygen saturation|jugular venous oxygen saturation
541027|NCT00870610|hypothermia|hypothermia
541028|NCT00870597|Floaters|floaters
541029|NCT00870597|multifocal IOL|multifocal iol
541030|NCT00870597|visual complaints|visual complaints
541031|NCT00870597|vitrectomy|vitrectomy
541032|NCT00870584|Asthma; asthma management; asthma impairment ; Xolair ; omalizumab|asthma; asthma management; asthma impairment ; xolair ; omalizumab
541033|NCT00870571|Bioequivalence|bioequivalence
541034|NCT00870571|amlodipine besylate|amlodipine besylate
541035|NCT00870571|amlodipine|amlodipine
541036|NCT00870571|Healthy subjects|healthy subjects
541037|NCT00870558|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
541038|NCT00870558|advanced adult primary liver cancer|advanced adult primary liver cancer
541039|NCT00870558|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
541040|NCT00870558|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
541041|NCT00870545|spouses|spouses
541042|NCT00870545|social support|social support
541043|NCT00870545|reintegration|reintegration
541044|NCT00870545|families|families
541045|NCT00870545|military|military
541046|NCT00870545|post deployment|post deployment
541047|NCT00870545|OEF/OIF|oef/oif
541048|NCT00870532|Phase I|phase i
541049|NCT00870532|Combination|combination
541050|NCT00870532|Anti-angiogenic|anti-angiogenic
541051|NCT00870532|Sorafenib|sorafenib
541052|NCT00870532|Metronomic oral vinorelbine|metronomic oral vinorelbine
541053|NCT00870519|Alzheimer disease|alzheimer disease
541054|NCT00870506|Randomized Controlled Trial|randomized controlled trial
541055|NCT00870506|Healthcare Disparities|healthcare disparities
541056|NCT00870493|proteinuria|proteinuria
541057|NCT00870493|renal failure|renal failure
541058|NCT00870493|glomerulonephritis|glomerulonephritis
541059|NCT00870480|Bioequivalence|bioequivalence
541060|NCT00870480|finasteride|finasteride
541061|NCT00870480|Healthy subjects|healthy subjects
541062|NCT00870467|Rheumatoid Arthritis|rheumatoid arthritis
541063|NCT00870454|Diabetic neuropathies|diabetic neuropathies
541064|NCT00870454|Diabetic neuropathy, painful|diabetic neuropathy, painful
541065|NCT00870454|Carisbamate|carisbamate
541066|NCT00870454|Neurotherapeutic agents|neurotherapeutic agents
541067|NCT00870441|ASP2151|asp2151
541068|NCT00870441|Valacyclovir|valacyclovir
541069|NCT00870441|Healthy Volunteers|healthy volunteers
541070|NCT00870428|Preeclampsia|preeclampsia
541071|NCT00870428|proteinuria|proteinuria
541072|NCT00870415|stage IA breast cancer|stage ia breast cancer
541073|NCT00870415|stage IB breast cancer|stage ib breast cancer
541074|NCT00870415|stage II breast cancer|stage ii breast cancer
541075|NCT00870415|stage IIIA breast cancer|stage iiia breast cancer
541076|NCT00870415|stage IIIC breast cancer|stage iiic breast cancer
541077|NCT00870415|ductal breast carcinoma|ductal breast carcinoma
541078|NCT00870415|invasive ductal breast carcinoma|invasive ductal breast carcinoma
541079|NCT00870402|aldosterone|aldosterone
541080|NCT00870402|albuminuria|albuminuria
541081|NCT00870402|diastolic disfunction|diastolic disfunction
541082|NCT00870402|hyperkalemia|hyperkalemia
541083|NCT00870376|lower urinary tract symptoms|lower urinary tract symptoms
541084|NCT00870376|biomarkers|biomarkers
541085|NCT00870376|urodynamic studies|urodynamic studies
541086|NCT00870363|HIV|hiv
541087|NCT00870363|HIV positive|hiv positive
541088|NCT00870363|Gastrointestinal Associated Lymphoid Tissue (GALT)|gastrointestinal associated lymphoid tissue (galt)
541089|NCT00870363|GALT Immune Reconstruction|galt immune reconstruction
541090|NCT00870363|treatment naive|treatment naive
541091|NCT00870350|immunogenicity|immunogenicity
541092|NCT00870350|safety|safety
541093|NCT00870350|tetanus|tetanus
541094|NCT00870350|diphtheria|diphtheria
541095|NCT00870350|acellular|acellular
541096|NCT00870350|pertussis|pertussis
541097|NCT00870350|vaccine|vaccine
541098|NCT00870350|booster|booster
541099|NCT00870350|adverse event|adverse event
541100|NCT00870350|adverse reaction|adverse reaction
541101|NCT00870350|DT1aP|dt1ap
541102|NCT00870350|DT5ap|dt5ap
541103|NCT00870350|FHA|fha
541104|NCT00870350|fimbriae|fimbriae
541105|NCT00870350|pertactin|pertactin
541106|NCT00870350|SMI|smi
541107|NCT00870350|Smittskyddsinstitutet|smittskyddsinstitutet
541108|NCT00870350|Immune response and safety profile to a Tdap booster|immune response and safety profile to a tdap booster
541109|NCT00870337|recurrent endometrial carcinoma|recurrent endometrial carcinoma
541110|NCT00870337|stage IV endometrial carcinoma|stage iv endometrial carcinoma
541111|NCT00870337|endometrial adenocarcinoma|endometrial adenocarcinoma
541112|NCT00870324|ICD|icd
541113|NCT00870324|Tachyarrhythmias|tachyarrhythmias
541114|NCT00870324|Atrial Fibrillation|atrial fibrillation
541115|NCT00870324|Patients who meets current ICD or CRT-D implant indications|patients who meets current icd or crt-d implant indications
541116|NCT00870311|Lithium|lithium
541117|NCT00870311|Neuroprotection|neuroprotection
541118|NCT00870311|Neurotrophic|neurotrophic
541119|NCT00870311|bcl2|bcl2
541120|NCT00870311|gsk3|gsk3
541121|NCT00870311|pkc|pkc
541122|NCT00870311|MRI|mri
541123|NCT00870311|myoinositol|myoinositol
541124|NCT00870311|MRS|mrs
541125|NCT00870311|Alzheimers Disease|alzheimers disease
541126|NCT00870298|drug orders|drug orders
541127|NCT00870285|Psoriasis|psoriasis
541128|NCT00870285|Biologic|biologic
541129|NCT00870285|Ustekinumab|ustekinumab
541130|NCT00870285|UVB-311nm narrowband|uvb-311nm narrowband
541131|NCT00870285|phototherapy|phototherapy
541132|NCT00870285|half-side comparison|half-side comparison
541133|NCT00870272|Medical Abortion|medical abortion
541134|NCT00870272|Mifepristone|mifepristone
541135|NCT00870272|Misoprostol|misoprostol
541136|NCT00870272|Sublingual administration|sublingual administration
541137|NCT00870272|Buccal administration|buccal administration
541138|NCT00870259|Weight loss|weight loss
541139|NCT00870259|Weight maintenance|weight maintenance
541140|NCT00870246|COPD|copd
541141|NCT00870246|pulmonary emphysema|pulmonary emphysema
541142|NCT00870233|Gynecologic cancers|gynecologic cancers
541143|NCT00870233|Quality of Life|quality of life
541144|NCT00870233|08-155|08-155
541145|NCT00870233|Surgery|surgery
541146|NCT00870220|Turner's Syndrome|turner's syndrome
541147|NCT00870207|Feasibility of implementing TSSC in worksite environment|feasibility of implementing tssc in worksite environment
541148|NCT00870194|diabetes|diabetes
541149|NCT00870194|exenatide|exenatide
541150|NCT00870194|Byetta|byetta
541151|NCT00870194|sitagliptin|sitagliptin
541152|NCT00870194|Januvia|januvia
541153|NCT00870194|Amylin|amylin
541154|NCT00870194|Lilly|lilly
541155|NCT00870168|stage IV breast cancer|stage iv breast cancer
541156|NCT00870168|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
541157|NCT00870168|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
541158|NCT00870142|Bioequivalence|bioequivalence
541159|NCT00870142|amlodipine besylate|amlodipine besylate
541160|NCT00870142|amlodipine|amlodipine
541161|NCT00870142|Healthy subjects|healthy subjects
541162|NCT00870129|brain tumor|brain tumor
541163|NCT00870129|radiation|radiation
541164|NCT00870129|MRI|mri
541165|NCT00870129|09-009|09-009
541166|NCT00870116|SBRT|sbrt
541167|NCT00870116|non-operated|non-operated
541168|NCT00870116|non-metastatic|non-metastatic
541169|NCT00870116|non-small-cell lung cancer|non-small-cell lung cancer
542055|NCT00866593|SDS|sds
541170|NCT00870116|conformational radiotherapy|conformational radiotherapy
541171|NCT00870116|non-operated non-metastatic non-small-cell lung cancer|non-operated non-metastatic non-small-cell lung cancer
541172|NCT00870103|Cataract|cataract
541173|NCT00870077|Intrahepatic fat|intrahepatic fat
541174|NCT00870077|obesity|obesity
541175|NCT00870077|body fat|body fat
541176|NCT00870077|impaired glucose tolerance|impaired glucose tolerance
541177|NCT00870064|Surgical Procedures, Operative|surgical procedures, operative
541178|NCT00870064|Fractures, Open|fractures, open
541179|NCT00870064|Fracture Fixation|fracture fixation
541180|NCT00870051|Endurant|endurant
541181|NCT00870051|Stent Graft|stent graft
541182|NCT00870051|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
541183|NCT00870038|PCI|pci
541184|NCT00870038|stent|stent
541185|NCT00870038|drug eluting stent|drug eluting stent
541186|NCT00870038|reendothelialization|reendothelialization
541187|NCT00870038|restenosis|restenosis
541188|NCT00870038|Percutaneous Coronary Angioplasty|percutaneous coronary angioplasty
541189|NCT00870025|androgens|androgens
541190|NCT00870025|hCG|hcg
541191|NCT00870025|low response|low response
541192|NCT00870025|IVF|ivf
541193|NCT00870025|Ovarian response in women with previous low response|ovarian response in women with previous low response
541194|NCT00869999|rituximab|rituximab
541195|NCT00869999|everolimus|everolimus
541196|NCT00869999|DLBCL|dlbcl
541197|NCT00869999|mTOR|mtor
541198|NCT00869973|aprepitant|aprepitant
541199|NCT00869973|delayed emesis|delayed emesis
541200|NCT00869973|cyclophosphamide plus anthracyclines|cyclophosphamide plus anthracyclines
541201|NCT00869973|breast cancer|breast cancer
541202|NCT00869973|antiemetic|antiemetic
541203|NCT00869960|Healthy Volunteers|healthy volunteers
541204|NCT00869947|Unilateral below the knee amputation|unilateral below the knee amputation
541205|NCT00869934|Insomnia|insomnia
541206|NCT00869934|Sleep disorders|sleep disorders
541207|NCT00869934|Treatment|treatment
541208|NCT00869934|Sleep disturbances|sleep disturbances
541209|NCT00869895|Advanced solid tumors|advanced solid tumors
541210|NCT00869882|Spondylolisthesis|spondylolisthesis
541211|NCT00869882|degeneration|degeneration
541212|NCT00869882|spinal fusion|spinal fusion
541213|NCT00869869|Heart Failure|heart failure
541214|NCT00869869|Sleep Disorders|sleep disorders
541215|NCT00869869|Melatonin|melatonin
541216|NCT00869869|Antioxidants|antioxidants
541217|NCT00869869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
541218|NCT00869869|Nervous System Diseases|nervous system diseases
541219|NCT00869869|Physiological Effects of Drugs|physiological effects of drugs
541220|NCT00869869|Vascular Diseases|vascular diseases
541221|NCT00869869|Central Nervous System Depressants|central nervous system depressants
541222|NCT00869869|Protective Agents|protective agents
541223|NCT00869869|Pharmacologic Actions|pharmacologic actions
541224|NCT00869869|Signs and Symptoms|signs and symptoms
541225|NCT00869869|Mental Disorders|mental disorders
541226|NCT00869869|Therapeutic Uses|therapeutic uses
541227|NCT00869869|Neurologic Manifestations|neurologic manifestations
541228|NCT00869869|Cardiovascular Diseases|cardiovascular diseases
541229|NCT00869869|Central Nervous System Agents|central nervous system agents
541230|NCT00869856|Treatment associated with CRI|treatment associated with cri
541231|NCT00869843|Metastatic colorectal cancer|metastatic colorectal cancer
541232|NCT00869830|Biofeedback|biofeedback
541233|NCT00869830|constipation|constipation
541234|NCT00869830|Parkinson's disease|parkinson's disease
541235|NCT00869817|Alzheimer's disease|alzheimer's disease
541236|NCT00869817|antecedent biomarkers|antecedent biomarkers
541237|NCT00869817|Amyloid Precursor Protein (APP) mutation|amyloid precursor protein (app) mutation
541238|NCT00869817|presenilin I (PS1) mutation|presenilin i (ps1) mutation
541239|NCT00869817|presenilin 2 (PS2) mutation|presenilin 2 (ps2) mutation
541240|NCT00869817|Autosomal Dominant Alzheimer's Disease|autosomal dominant alzheimer's disease
541241|NCT00869804|breast cancer|breast cancer
541242|NCT00869804|chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
541243|NCT00869804|exercise|exercise
541244|NCT00869791|Parkinson's|parkinson's
541245|NCT00869778|Chronic Hepatitis B|chronic hepatitis b
541246|NCT00869778|HBeAg positive|hbeag positive
541247|NCT00869778|Therapeutic HBV Vaccine|therapeutic hbv vaccine
541248|NCT00869778|HBV-specific Cytotoxic T Lymphocyte|hbv-specific cytotoxic t lymphocyte
541249|NCT00869765|Depression|depression
541250|NCT00869765|Treatment|treatment
541251|NCT00869765|Transcranial direct current stimulation|transcranial direct current stimulation
541252|NCT00869765|D-cycloserine|d-cycloserine
541253|NCT00869752|combined type small cell lung cancer|combined type small cell lung cancer
541254|NCT00869752|fusiform type small cell lung cancer|fusiform type small cell lung cancer
541255|NCT00869752|polygonal type small cell lung cancer|polygonal type small cell lung cancer
541256|NCT00869752|lymphocyte-like type small cell lung cancer|lymphocyte-like type small cell lung cancer
541257|NCT00869752|extensive stage small cell lung cancer|extensive stage small cell lung cancer
541258|NCT00869739|cancer survivor|cancer survivor
541259|NCT00869739|depression|depression
541260|NCT00869739|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
541261|NCT00869739|male erectile disorder|male erectile disorder
541262|NCT00869739|urinary complications|urinary complications
541263|NCT00869739|gastrointestinal complications|gastrointestinal complications
541264|NCT00869739|stage I prostate cancer|stage i prostate cancer
541265|NCT00869739|stage IIB prostate cancer|stage iib prostate cancer
541266|NCT00869739|stage IIA prostate cancer|stage iia prostate cancer
541267|NCT00869739|stage III prostate cancer|stage iii prostate cancer
541268|NCT00869713|Hemorrhagic Fever|hemorrhagic fever
541269|NCT00869713|Viral Infections|viral infections
541270|NCT00869713|Neurologic diseases|neurologic diseases
541271|NCT00869713|Arbovirus Infections|arbovirus infections
541272|NCT00869713|RVF|rvf
541273|NCT00869700|HIV|hiv
541274|NCT00869700|Malaria|malaria
541275|NCT00869700|Pharmacokinetics|pharmacokinetics
541276|NCT00869700|Treatment Experienced|treatment experienced
541277|NCT00869674|GeneSearch|genesearch
541278|NCT00869674|Breast cancer|breast cancer
541279|NCT00869648|Airway|airway
541280|NCT00869648|Anaesthesia|anaesthesia
541281|NCT00869648|Resuscitation|resuscitation
541282|NCT00869648|Ventilation|ventilation
541283|NCT00869635|Cholangiocarcinoma|cholangiocarcinoma
541284|NCT00869635|Photodynamic therapy|photodynamic therapy
541285|NCT00869635|S-1|s-1
541286|NCT00869622|osteoporosis|osteoporosis
541287|NCT00869622|bone mineral density|bone mineral density
541288|NCT00869622|fracture|fracture
541289|NCT00869622|antiepileptic drug|antiepileptic drug
541290|NCT00869622|seizure|seizure
541291|NCT00869622|Prevention of bone loss|prevention of bone loss
541292|NCT00869622|Prevention of osteoporosis|prevention of osteoporosis
541293|NCT00869622|Prevention of Fractures|prevention of fractures
541294|NCT00869609|Diabetes Prevention|diabetes prevention
541295|NCT00869609|CVD Risk Reduction|cvd risk reduction
541296|NCT00869609|Lifestyle Intervention|lifestyle intervention
541297|NCT00869596|Sputum inflammatory biomarkers|sputum inflammatory biomarkers
541298|NCT00869583|Women|women
541299|NCT00869583|Physical Activity|physical activity
541300|NCT00869583|Hispanic|hispanic
541301|NCT00869583|Overweight|overweight
541302|NCT00869570|adenocarcinoma of the rectum|adenocarcinoma of the rectum
541303|NCT00869570|stage II rectal cancer|stage ii rectal cancer
541304|NCT00869570|stage III rectal cancer|stage iii rectal cancer
541305|NCT00869557|HIV|hiv
541306|NCT00869557|HIV-1|hiv-1
541307|NCT00869557|Antiretroviral Treatment-Naive|antiretroviral treatment-naive
541308|NCT00869557|treatment naive|treatment naive
541309|NCT00869544|HIV|hiv
541310|NCT00869544|smoker|smoker
541311|NCT00869544|emphysema|emphysema
541312|NCT00869544|antiretrovirals|antiretrovirals
541313|NCT00869544|COPD|copd
541314|NCT00869531|Obesity|obesity
541315|NCT00869531|wholegrain|wholegrain
541316|NCT00869531|wheat|wheat
541317|NCT00869531|cardiovascular disease|cardiovascular disease
541318|NCT00869518|Staphylococcus aureus|staphylococcus aureus
541319|NCT00869518|colonization|colonization
541320|NCT00869518|eradication|eradication
541321|NCT00869518|HIV|hiv
541322|NCT00869518|rifabutin|rifabutin
541323|NCT00869505|To evaluate the effectiveness of memantine as an augmenting agent for standard intensive residential treatment of severe obsessive-compulsive disorder (OCD)|to evaluate the effectiveness of memantine as an augmenting agent for standard intensive residential treatment of severe obsessive-compulsive disorder (ocd)
541324|NCT00869492|Acne|acne
541325|NCT00869492|Nadifloxacin|nadifloxacin
541326|NCT00869492|benzoyl peroxide|benzoyl peroxide
541327|NCT00869479|Nephrogenic Systemic Fibrosis|nephrogenic systemic fibrosis
541328|NCT00869479|Screening|screening
541329|NCT00869466|weight changes|weight changes
541330|NCT00869466|stage IA breast cancer|stage ia breast cancer
541331|NCT00869466|stage IB breast cancer|stage ib breast cancer
541332|NCT00869466|stage II breast cancer|stage ii breast cancer
541333|NCT00869466|stage IIIA breast cancer|stage iiia breast cancer
541334|NCT00869466|stage IIIB breast cancer|stage iiib breast cancer
541335|NCT00869466|stage IIIC breast cancer|stage iiic breast cancer
541336|NCT00869453|Gut hormone|gut hormone
541337|NCT00869453|hyperglycaemic clamp|hyperglycaemic clamp
541338|NCT00869453|glucose turnver|glucose turnver
541339|NCT00869440|CNS 7056|cns 7056
541340|NCT00869440|Procedural Sedation|procedural sedation
541341|NCT00869440|Sedation|sedation
541342|NCT00869440|Endoscopy|endoscopy
541343|NCT00869427|UVI|uvi
541344|NCT00869427|Spinal cord injury|spinal cord injury
541345|NCT00869427|Prevention|prevention
541346|NCT00869427|Vitamin C|vitamin c
541347|NCT00869414|hypoglycemia|hypoglycemia
541348|NCT00869414|type 1 diabetes|type 1 diabetes
541349|NCT00869414|split dosing insulin glargine|split dosing insulin glargine
541350|NCT00869414|continuous glucose monitoring|continuous glucose monitoring
541351|NCT00869401|adult giant cell glioblastoma|adult giant cell glioblastoma
541352|NCT00869401|adult glioblastoma|adult glioblastoma
541353|NCT00869401|adult gliosarcoma|adult gliosarcoma
541354|NCT00869388|malignant|malignant
541355|NCT00869388|resistant|resistant
541356|NCT00869388|solid tumor|solid tumor
541357|NCT00869375|acute or critical limb ischemia with angiographic thrombus|acute or critical limb ischemia with angiographic thrombus
542056|NCT00866593|CGI|cgi
541358|NCT00869349|Rheumatoid Arthritis|rheumatoid arthritis
541359|NCT00869349|IFS|ifs
541360|NCT00869349|psychosocial|psychosocial
541361|NCT00869349|social support|social support
541362|NCT00869336|Tinea Pedis|tinea pedis
541363|NCT00869336|Athlete's Foot|athlete's foot
541364|NCT00869323|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
541365|NCT00869310|aprepitant|aprepitant
541366|NCT00869310|delayed emesis|delayed emesis
541367|NCT00869310|cisplatin|cisplatin
541368|NCT00869310|antiemetic|antiemetic
541369|NCT00869284|High-dose chemotherapy|high-dose chemotherapy
541370|NCT00869284|aggressive NHL|aggressive nhl
541371|NCT00869284|high-risk|high-risk
541372|NCT00869284|PBSC|pbsc
541373|NCT00869271|liver metastasis|liver metastasis
541374|NCT00869271|colorectal cancer|colorectal cancer
541375|NCT00869258|Pancreatic cancer|pancreatic cancer
541376|NCT00869258|Gemcitabine|gemcitabine
541377|NCT00869258|Docetaxel|docetaxel
541378|NCT00869258|Capecitabine|capecitabine
541379|NCT00869245|ACS|acs
541380|NCT00869245|Acute Coronary Syndrome|acute coronary syndrome
541381|NCT00869245|Chest pain|chest pain
541382|NCT00869245|Cardiac MRI|cardiac mri
541383|NCT00869245|CMR|cmr
541384|NCT00869245|Risk Stratification|risk stratification
541385|NCT00869245|Emergency Department|emergency department
541386|NCT00869232|Multiple Myeloma|multiple myeloma
541387|NCT00869219|Pain|pain
541388|NCT00869219|Pain after eyedrops|pain after eyedrops
541389|NCT00869206|pain|pain
541390|NCT00869206|Prostate Adenocarcinoma|prostate adenocarcinoma
541391|NCT00869206|urinary complications|urinary complications
541392|NCT00869206|stage IV breast cancer|stage iv breast cancer
541393|NCT00869206|Recurrent Breast Carcinoma|recurrent breast carcinoma
541394|NCT00869206|stage IV prostate cancer|stage iv prostate cancer
541395|NCT00869206|recurrent prostate cancer|recurrent prostate cancer
541396|NCT00869206|Recurrent Prostate Carcinoma|recurrent prostate carcinoma
541397|NCT00869206|stage I multiple myeloma|stage i multiple myeloma
541398|NCT00869206|stage II multiple myeloma|stage ii multiple myeloma
541399|NCT00869206|Refractory Plasma Cell Myeloma|refractory plasma cell myeloma
541400|NCT00869206|bone metastases|bone metastases
541401|NCT00869193|Blood pressure|blood pressure
541402|NCT00869193|Grape seed|grape seed
541403|NCT00869180|diclofenac|diclofenac
541404|NCT00869180|ankle sprain|ankle sprain
541405|NCT00869180|acute pain|acute pain
541406|NCT00869180|topical|topical
541407|NCT00869180|patch|patch
541408|NCT00869180|Acute Pain due to Mild to Moderate Ankle Sprain|acute pain due to mild to moderate ankle sprain
541409|NCT00869154|Mild TBI|mild tbi
541410|NCT00869154|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
541411|NCT00869154|Traumatic Brain Injury|traumatic brain injury
541412|NCT00869154|Injury, Brain, Traumatic|injury, brain, traumatic
541413|NCT00869154|Injuries, Acute Brain|injuries, acute brain
541414|NCT00869154|Brain Injuries, Traumatic|brain injuries, traumatic
541415|NCT00869154|Acute Brain Injuries|acute brain injuries
541416|NCT00869141|Glaucoma tube shunt procedure|glaucoma tube shunt procedure
541417|NCT00869128|melatonin|melatonin
541418|NCT00869128|insomnia|insomnia
541419|NCT00869128|diabetes|diabetes
541420|NCT00869128|sleep|sleep
541421|NCT00869115|Digoxin|digoxin
541422|NCT00869115|Inotropes|inotropes
541423|NCT00869115|Lusitropic agents|lusitropic agents
541424|NCT00869115|Istaroxime|istaroxime
541425|NCT00869115|Debio 0614|debio 0614
541426|NCT00869102|IGT|igt
541427|NCT00869102|IFG|ifg
541428|NCT00869089|PN|pn
541429|NCT00869076|Diabetes Mellitus|diabetes mellitus
541430|NCT00869076|Pharmacist|pharmacist
541431|NCT00869063|wrist|wrist
541432|NCT00869063|sprain|sprain
541433|NCT00869063|strain|strain
541434|NCT00869063|contusion|contusion
541435|NCT00869063|diclofenac|diclofenac
541436|NCT00869063|patch|patch
541437|NCT00869063|acute pain|acute pain
541438|NCT00869063|acute pain due to mild to moderate wrist sprain, strain or contusion|acute pain due to mild to moderate wrist sprain, strain or contusion
541439|NCT00869050|Pancreatic cancer|pancreatic cancer
541440|NCT00869050|Neuroendocrine tumors|neuroendocrine tumors
541441|NCT00869050|Carcinoid tumors|carcinoid tumors
541442|NCT00869050|Pheochromocytomas|pheochromocytomas
541443|NCT00869050|Gastrinomas|gastrinomas
541444|NCT00869050|Zollinger-Ellison syndrome|zollinger-ellison syndrome
541445|NCT00869050|MEN Type I/II|men type i/ii
541446|NCT00869050|Somatostatinomas|somatostatinomas
541447|NCT00869050|VIPomas|vipomas
541448|NCT00869050|Merkel cell tumors|merkel cell tumors
541449|NCT00869050|medullary thyroid carcinoma|medullary thyroid carcinoma
541450|NCT00869037|Randomized controlled study|randomized controlled study
541451|NCT00869037|Total knee arthroplasty|total knee arthroplasty
541452|NCT00869037|Post operative pain|post operative pain
541453|NCT00869037|Continuous Femoral Nerve Block|continuous femoral nerve block
541454|NCT00869037|Posterior Capsular injection|posterior capsular injection
541455|NCT00869037|Periarticular injection|periarticular injection
541456|NCT00869024|Heart failure|heart failure
541457|NCT00869024|Left ventricular assist device|left ventricular assist device
541458|NCT00869024|Stem cells|stem cells
541460|NCT00869011|renal cell carcinoma|renal cell carcinoma
541461|NCT00869011|fatigue|fatigue
541462|NCT00869011|exercise|exercise
541463|NCT00868998|Biliary Cancer|biliary cancer
541464|NCT00868972|Renal Artery Obstruction|renal artery obstruction
541465|NCT00868972|renovascular hypertension|renovascular hypertension
541466|NCT00868972|stent|stent
541467|NCT00868972|Kidney Failure|kidney failure
541468|NCT00868972|embolic protection|embolic protection
541469|NCT00868959|Bipolar|bipolar
541470|NCT00868959|Depression|depression
541471|NCT00868959|Lurasidone|lurasidone
541472|NCT00868959|Latuda|latuda
541473|NCT00868946|Ribavirin|ribavirin
541474|NCT00868946|Hemorrhagic Fever with Renal Syndrome|hemorrhagic fever with renal syndrome
541475|NCT00868946|Dobrava Virus|dobrava virus
541476|NCT00868946|Puumala Virus|puumala virus
541477|NCT00868881|Hypertension|hypertension
541478|NCT00868881|Therapeutic diagnostic attitude|therapeutic diagnostic attitude
541479|NCT00868881|Blood pressure|blood pressure
541480|NCT00868868|Pedometer|pedometer
541481|NCT00868868|Prostate|prostate
541482|NCT00868868|Cancer|cancer
541483|NCT00868868|Hormonotherapy|hormonotherapy
541484|NCT00868868|Exercise|exercise
541485|NCT00868855|Coronary Artery Disease|coronary artery disease
541486|NCT00868842|Penicillin|penicillin
541487|NCT00868842|Allergy|allergy
541488|NCT00868842|Prevention|prevention
541489|NCT00868842|Anaphylaxis|anaphylaxis
541490|NCT00868842|Clinically proven history of penicillin allergy|clinically proven history of penicillin allergy
541491|NCT00868842|preventing anaphylaxis|preventing anaphylaxis
541492|NCT00868829|Stent|stent
541493|NCT00868829|FireBird2|firebird2
541494|NCT00868829|Coronary Heart Disease|coronary heart disease
541495|NCT00868816|oxaliplatine|oxaliplatine
541496|NCT00868816|colorectal cancer|colorectal cancer
541497|NCT00868816|chemotherapy|chemotherapy
541498|NCT00868803|prostate cancer|prostate cancer
541499|NCT00868777|Implant site development|implant site development
541500|NCT00868777|Bone grafting|bone grafting
541501|NCT00868777|Dental implants|dental implants
541502|NCT00868764|Effect of age|effect of age
541503|NCT00868764|Effect of body fat|effect of body fat
541504|NCT00868764|Granisetron|granisetron
541505|NCT00868764|Pharmacokinetic profile|pharmacokinetic profile
541506|NCT00868764|Sancuso® patch|sancuso® patch
541507|NCT00868764|Transdermal|transdermal
541508|NCT00868751|Antibodies, Monoclonal|antibodies, monoclonal
541509|NCT00868751|Interleukin 6|interleukin 6
541510|NCT00868738|Calcium|calcium
541511|NCT00868738|Vitamin D|vitamin d
541512|NCT00868738|Magnesium|magnesium
541513|NCT00868738|Zinc|zinc
541514|NCT00868725|oral cavity|oral cavity
541515|NCT00868725|carcinoma|carcinoma
541516|NCT00868725|thermal imaging|thermal imaging
541517|NCT00868712|coronary calcification|coronary calcification
541518|NCT00868712|vitamin K dependent proteins|vitamin k dependent proteins
541519|NCT00868712|warfarin|warfarin
541520|NCT00868699|Bipolar I, Depression|bipolar i, depression
541521|NCT00868673|Role of Fructose in overweight and obesity|role of fructose in overweight and obesity
541522|NCT00868673|Fructose and metabolic syndrome|fructose and metabolic syndrome
541523|NCT00868673|Low fructose diet study|low fructose diet study
541524|NCT00868673|Effects of fructose in blood pressure and hypertension|effects of fructose in blood pressure and hypertension
541525|NCT00868673|Somatometry changes observed in fructose diets|somatometry changes observed in fructose diets
541526|NCT00868673|Fructose induced overweight and obesity|fructose induced overweight and obesity
541527|NCT00868673|Fructose induced metabolic syndrome|fructose induced metabolic syndrome
541528|NCT00868673|Fructose induced hyperuricemia|fructose induced hyperuricemia
541529|NCT00868608|Refractory Indolent NHL|refractory indolent nhl
541530|NCT00868608|lymphoma|lymphoma
541531|NCT00868582|Patients with proven or suspected cancer referred for NaF-18 PET to identify bone metastasis|patients with proven or suspected cancer referred for naf-18 pet to identify bone metastasis
541532|NCT00868569|liver metastasis|liver metastasis
541533|NCT00868569|colorectal cancer|colorectal cancer
541534|NCT00868569|oxaliplatine|oxaliplatine
541535|NCT00868569|transartery chemotherapy|transartery chemotherapy
541536|NCT00868569|embolision|embolision
541537|NCT00868569|Unresectable Liver Metastasis of Colorectal Cancer|unresectable liver metastasis of colorectal cancer
541538|NCT00868556|fMRI scans|fmri scans
541539|NCT00868556|episodic migraine sufferers|episodic migraine sufferers
541540|NCT00868556|chronic migraine sufferers|chronic migraine sufferers
541541|NCT00868556|non migraine sufferers (controls)|non migraine sufferers (controls)
541542|NCT00868543|Gastric bypass|gastric bypass
541543|NCT00868543|obesity|obesity
541544|NCT00868543|superobese|superobese
541545|NCT00868530|On-demand treatment; Hemostatic Efficacy Assessments; Factor VIII recovery; Factor VIII Inhibitor; Chinese|on-demand treatment; hemostatic efficacy assessments; factor viii recovery; factor viii inhibitor; chinese
541546|NCT00868517|Veterans|veterans
541547|NCT00868517|Operation Iraqi Freedom|operation iraqi freedom
541548|NCT00868517|Operation Enduring Freedom|operation enduring freedom
541549|NCT00868517|Combat Disorders|combat disorders
541550|NCT00868517|Acupuncture|acupuncture
541551|NCT00868517|Complementary Therapies|complementary therapies
541552|NCT00868504|GI tract|gi tract
541553|NCT00868504|Tumors|tumors
541554|NCT00868504|Temperatures|temperatures
541555|NCT00868491|head and neck cancer|head and neck cancer
541556|NCT00868491|inoperable|inoperable
541557|NCT00868491|induction chemotherapy|induction chemotherapy
541558|NCT00868491|concomitant radiochemotherapy|concomitant radiochemotherapy
541559|NCT00868491|biological agent|biological agent
541560|NCT00868491|efficacy|efficacy
541561|NCT00868491|toxicity|toxicity
541562|NCT00868478|humanized monoclonal antibody|humanized monoclonal antibody
541563|NCT00868452|Bipolar I|bipolar i
541564|NCT00868452|Latuda|latuda
541565|NCT00868452|Lurasidone|lurasidone
541567|NCT00868439|Heart failure|heart failure
541568|NCT00868439|hyperkalemia|hyperkalemia
541569|NCT00868439|chronic kidney disease|chronic kidney disease
541570|NCT00868439|prevention of hyperkalemia in heart failure participants|prevention of hyperkalemia in heart failure participants
541571|NCT00868426|Healthy volunteer study|healthy volunteer study
541572|NCT00868400|Preoperative care|preoperative care
541573|NCT00868400|colorectal surgery|colorectal surgery
541574|NCT00868400|carbohydrate|carbohydrate
541575|NCT00868400|fasting|fasting
541576|NCT00868387|weight reduction|weight reduction
541577|NCT00868387|low-carbohydrate|low-carbohydrate
541578|NCT00868387|body fat|body fat
541579|NCT00868387|telemedicine|telemedicine
541580|NCT00868387|cardiovascular risk markers|cardiovascular risk markers
541581|NCT00868361|Mass Balance|mass balance
541582|NCT00868361|Talampanel|talampanel
541583|NCT00868361|Pharmacokinetics|pharmacokinetics
541584|NCT00868361|Metabolism|metabolism
541585|NCT00868361|Metabolites|metabolites
541586|NCT00868361|Healthy Volunteers|healthy volunteers
541587|NCT00868348|Total Knee Arthroplasty|total knee arthroplasty
541588|NCT00868335|Cervical degenerative disc disease|cervical degenerative disc disease
541589|NCT00868335|Anterior cervical discectomy|anterior cervical discectomy
541590|NCT00868335|Cervical disc prosthesis|cervical disc prosthesis
541591|NCT00868335|Activ-C|activ-c
541592|NCT00868335|Mobility|mobility
541593|NCT00868335|Movement|movement
541594|NCT00868309|Snake Bite|snake bite
541595|NCT00868309|Venom and antivenom kinetics|venom and antivenom kinetics
541596|NCT00868296|Safety|safety
541597|NCT00868257|AIDS|aids
541598|NCT00868257|Adherence to Antiretroviral Therapy|adherence to antiretroviral therapy
541599|NCT00868257|Pediatric|pediatric
541600|NCT00868257|Resource Limited Setting|resource limited setting
541601|NCT00868257|Treatment experienced|treatment experienced
541602|NCT00868244|facial patterns|facial patterns
541603|NCT00868244|bruxism|bruxism
541604|NCT00868244|masticatory muscles|masticatory muscles
541605|NCT00868231|COPD|copd
541606|NCT00868231|Antimuscarinic|antimuscarinic
541607|NCT00868218|Influenza A|influenza a
541608|NCT00868218|pandemic|pandemic
541609|NCT00868218|vaccine|vaccine
541610|NCT00868218|immunogenicity|immunogenicity
541611|NCT00868218|Virus|virus
541612|NCT00868218|H5N1|h5n1
541613|NCT00868205|oxidative stress|oxidative stress
541614|NCT00868205|Comet assay|comet assay
541615|NCT00868205|antioxidants|antioxidants
541616|NCT00868179|Thrombosis|thrombosis
541617|NCT00868179|total knee replacement|total knee replacement
541618|NCT00868166|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
541619|NCT00868166|TRO19622|tro19622
541620|NCT00868166|Trophos|trophos
541621|NCT00868127|Hyperlipidemia|hyperlipidemia
541622|NCT00868127|Drug Therapy|drug therapy
541623|NCT00868127|Dyslipidemia|dyslipidemia
541624|NCT00868114|Inoperable pancreatic cancer|inoperable pancreatic cancer
541625|NCT00868114|Dendritic Cell Vaccine|dendritic cell vaccine
541626|NCT00868114|Locally advanced or low volume metatstatic pancreatic cancer|locally advanced or low volume metatstatic pancreatic cancer
541627|NCT00868101|ischemic|ischemic
541628|NCT00868101|preconditioning|preconditioning
541629|NCT00868101|congenital heart disease|congenital heart disease
541630|NCT00868088|AC|ac
541631|NCT00868088|SCC|scc
541632|NCT00868088|SCC-is|scc-is
541633|NCT00868088|PDT|pdt
541634|NCT00868088|Mohs|mohs
541635|NCT00868075|Physiotherapy|physiotherapy
541636|NCT00868075|Rehabilitation|rehabilitation
541637|NCT00868075|Bronchiectasis|bronchiectasis
541638|NCT00868062|The responses of patients to 1L infusions of Gelofusine (succinylated gelatine 40g/L) and Voluven (6% hydroxyethyl starch in 0.9% saline) intraoperatively.|the responses of patients to 1l infusions of gelofusine (succinylated gelatine 40g/l) and voluven (6% hydroxyethyl starch in 0.9% saline) intraoperatively.
541639|NCT00868049|chewing|chewing
541640|NCT00868049|deglutition|deglutition
541641|NCT00868049|orofacial motricity|orofacial motricity
541642|NCT00868049|obesity|obesity
541643|NCT00868036|urticaria|urticaria
541644|NCT00868036|hives|hives
541645|NCT00868036|dermatitis|dermatitis
541646|NCT00868036|rash|rash
541647|NCT00868036|contact dermatitis|contact dermatitis
541648|NCT00868036|contact|contact
541649|NCT00868036|contact sensitization|contact sensitization
541650|NCT00868036|allergy|allergy
541651|NCT00868036|allergen|allergen
541652|NCT00868036|patch testing|patch testing
541653|NCT00868036|IgG|igg
541654|NCT00868036|delayed-hypersensitivity reaction|delayed-hypersensitivity reaction
541655|NCT00868036|hypersensitivity|hypersensitivity
541656|NCT00868010|stroke|stroke
541657|NCT00868010|donepezil|donepezil
541658|NCT00868010|recovery|recovery
541659|NCT00867997|Noncarious Cervical Lesions|noncarious cervical lesions
541660|NCT00867997|Hypersensitivity|hypersensitivity
541661|NCT00867997|Teeth|teeth
541662|NCT00867997|Dentistry|dentistry
541663|NCT00867997|Practice-based research network|practice-based research network
541664|NCT00867984|CRT, resynchronization,|crt, resynchronization,
541665|NCT00867958|Colon Anastomosis|colon anastomosis
541666|NCT00867958|Rectum Anastomosis|rectum anastomosis
541667|NCT00867958|Intestine|intestine
541668|NCT00867958|Colorectal Surgery|colorectal surgery
541669|NCT00867958|Colorectal Anastomosis|colorectal anastomosis
541670|NCT00867932|Paroxysmal Nocturnal Hemoglobinuria (PNH)|paroxysmal nocturnal hemoglobinuria (pnh)
541671|NCT00867906|Cat allergy|cat allergy
541672|NCT00867906|Immunotherapy|immunotherapy
541673|NCT00867906|Cat-PAD|cat-pad
541674|NCT00867880|To evaluate the Pharmacokinetic Profile of IVIb|to evaluate the pharmacokinetic profile of ivib
541675|NCT00867867|Iron deficiency anemia|iron deficiency anemia
541676|NCT00867867|Helicobacter pylori|helicobacter pylori
541677|NCT00867867|Iron absorption|iron absorption
541678|NCT00867867|Iron fortification|iron fortification
541679|NCT00867867|ferrous sulphate|ferrous sulphate
541680|NCT00867867|ferrous fumarate|ferrous fumarate
541681|NCT00867854|de-intensification|de-intensification
541682|NCT00867854|HAART|haart
541683|NCT00867854|monotherapy|monotherapy
541684|NCT00867854|persistent low-level viremia (LLV)|persistent low-level viremia (llv)
541685|NCT00867854|treatment experienced|treatment experienced
541686|NCT00867841|pneumonia, community-acquired|pneumonia, community-acquired
541687|NCT00867841|polymerase chain reaction|polymerase chain reaction
541688|NCT00867841|pneumococcus|pneumococcus
541689|NCT00867841|mycoplasma|mycoplasma
541690|NCT00867841|chlamydophila|chlamydophila
541691|NCT00867841|anti-bacterial agents|anti-bacterial agents
541692|NCT00867828|Decline of global cognitive function|decline of global cognitive function
541693|NCT00867828|Neuropsychological Test Battery (NTB)|neuropsychological test battery (ntb)
541694|NCT00867828|Early stage Alzheimer's disease|early stage alzheimer's disease
541695|NCT00867815|Non-arteritic Anterior Ischemic Optic Neuropathy|non-arteritic anterior ischemic optic neuropathy
541696|NCT00867815|NAION|naion
541697|NCT00867815|PDE5 inhibitors|pde5 inhibitors
541698|NCT00867815|vardenafil|vardenafil
541699|NCT00867815|Levitra|levitra
541700|NCT00867815|sildenafil|sildenafil
541701|NCT00867815|Viagra|viagra
541702|NCT00867815|Tadalafil|tadalafil
541703|NCT00867815|Cialis|cialis
541704|NCT00867815|acute vision loss|acute vision loss
541705|NCT00867815|vision loss|vision loss
541706|NCT00867815|blurred vision|blurred vision
541707|NCT00867815|optic neuropathy|optic neuropathy
541708|NCT00867815|erectile dysfunction.|erectile dysfunction.
541709|NCT00867802|MICAS|micas
541710|NCT00867802|MBSR|mbsr
541711|NCT00867789|abscess|abscess
541712|NCT00867789|outcomes|outcomes
541713|NCT00867789|antibiotics|antibiotics
541714|NCT00867789|incision and drainage|incision and drainage
541715|NCT00867789|skin abscess|skin abscess
541716|NCT00867776|Depression|depression
541717|NCT00867776|African Americans|african americans
541718|NCT00867776|Exercise|exercise
541719|NCT00867776|Culturally tailored intervention|culturally tailored intervention
541720|NCT00867776|Health disparities|health disparities
541721|NCT00867763|Polycystic ovaries,|polycystic ovaries,
541722|NCT00867763|Tubal occlusion|tubal occlusion
541723|NCT00867763|Unexplained infertility|unexplained infertility
541724|NCT00867763|Low ovarian reserve|low ovarian reserve
541725|NCT00867763|Male factor infertility|male factor infertility
541727|NCT00867750|RE|re
541728|NCT00867750|Yttrium-90|yttrium-90
541729|NCT00867750|SIR-Spheres microspheres|sir-spheres microspheres
541730|NCT00867750|TACE|tace
541731|NCT00867750|Radioembolisation|radioembolisation
541732|NCT00867750|Transarterial Chemoembolisation|transarterial chemoembolisation
541733|NCT00867737|Asthma|asthma
541734|NCT00867737|Forced Oscillation|forced oscillation
541735|NCT00867737|Impulse Oscillometry|impulse oscillometry
541736|NCT00867737|Electrical-equivalent respiratory system model|electrical-equivalent respiratory system model
541737|NCT00867724|polyp|polyp
541738|NCT00867698|Hepatic encephalopathy|hepatic encephalopathy
541739|NCT00867698|Mild hepatic encephalopathy|mild hepatic encephalopathy
541740|NCT00867698|HE|he
541741|NCT00867698|MHE|mhe
541742|NCT00867698|Cognitive impairment|cognitive impairment
541743|NCT00867698|Cognitive dysfunction|cognitive dysfunction
541744|NCT00867698|Liver Disease|liver disease
541745|NCT00867698|Cirrhosis|cirrhosis
541746|NCT00867685|Healthy Volunteers|healthy volunteers
541747|NCT00867672|Acute Myeloid Leukemia|acute myeloid leukemia
541748|NCT00867672|Low-dose Decitabine|low-dose decitabine
541749|NCT00867672|Valproic acid|valproic acid
541750|NCT00867672|All-trans retinoic acid|all-trans retinoic acid
541751|NCT00867672|Older Patients|older patients
541752|NCT00867659|ovarian hyperstimulation syndrome|ovarian hyperstimulation syndrome
541753|NCT00867659|cetrotide acetate|cetrotide acetate
541754|NCT00867659|GnRH antagonist|gnrh antagonist
541755|NCT00867659|oocyte donors|oocyte donors
541756|NCT00867646|PT|pt
541757|NCT00867646|DVT|dvt
541758|NCT00867633|urothelial carinoma|urothelial carinoma
541759|NCT00867633|aristolochic acid|aristolochic acid
541760|NCT00867633|DNA|dna
541761|NCT00867633|adduct|adduct
541762|NCT00867607|Contact dermatitis|contact dermatitis
541763|NCT00867607|Eczema|eczema
541764|NCT00867581|middle cerebral artery|middle cerebral artery
541765|NCT00867581|infarction|infarction
541766|NCT00867581|chronic stage|chronic stage
541767|NCT00867581|hippocampal volume|hippocampal volume
541768|NCT00867581|MRI|mri
541769|NCT00867581|MRS|mrs
541770|NCT00867581|neuropsychologic assessment|neuropsychologic assessment
541771|NCT00867568|Relapsed Neuroblastoma|relapsed neuroblastoma
541772|NCT00867568|Refractory Neuroblastoma|refractory neuroblastoma
541773|NCT00867568|Relapsed Medulloblastoma|relapsed medulloblastoma
541774|NCT00867568|Refractory Medulloblastoma|refractory medulloblastoma
541775|NCT00867542|past IUGR|past iugr
541776|NCT00867542|ECC|ecc
541777|NCT00867542|oral findings in children with past IUGR|oral findings in children with past iugr
541778|NCT00867503|ovarian cancer|ovarian cancer
541779|NCT00867503|bendamustine|bendamustine
541780|NCT00867490|Hypertension|hypertension
541781|NCT00867490|aliskiren|aliskiren
541782|NCT00867490|cardiovascular diseases|cardiovascular diseases
541783|NCT00867477|Cancer of esophagus|cancer of esophagus
541784|NCT00867477|Gastrointestine|gastrointestine
541785|NCT00867477|esophagus cancer|esophagus cancer
541786|NCT00867477|Positron emission tomography|positron emission tomography
541787|NCT00867477|PET scan|pet scan
541788|NCT00867477|Nitric oxide|nitric oxide
541789|NCT00867477|NO|no
541790|NCT00867477|NO Breathing Test|no breathing test
541791|NCT00867477|Respiratory symptoms questionnaire|respiratory symptoms questionnaire
541792|NCT00867464|Vaccine Efficacy|vaccine efficacy
541793|NCT00867464|Long-Term Protection|long-term protection
541794|NCT00867464|Immune Response|immune response
541795|NCT00867464|Human Papillomavirus|human papillomavirus
541796|NCT00867464|HPV|hpv
541797|NCT00867464|Vaccine|vaccine
541798|NCT00867451|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
541799|NCT00867438|ulcerative colitis|ulcerative colitis
541800|NCT00867438|Left-sided, mild to moderate ulcerative colitis|left-sided, mild to moderate ulcerative colitis
541801|NCT00867425|Diabetes|diabetes
541802|NCT00867425|Internet|internet
541803|NCT00867425|Obesity|obesity
541804|NCT00867425|Obesity with high cardiovascular risks|obesity with high cardiovascular risks
541805|NCT00867412|NSCLC|nsclc
541806|NCT00867412|PET/CT|pet/ct
541807|NCT00867412|Surgery|surgery
541808|NCT00867412|FDG|fdg
541809|NCT00867412|staging|staging
541810|NCT00867373|Obesity|obesity
541811|NCT00867373|Weight perceptions|weight perceptions
541812|NCT00867347|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
541813|NCT00867347|stage II bladder cancer|stage ii bladder cancer
541814|NCT00867347|stage III bladder cancer|stage iii bladder cancer
541815|NCT00867334|colorectal neoplasm|colorectal neoplasm
541816|NCT00867334|colorectal cancer|colorectal cancer
541817|NCT00867334|imatinib mesylate|imatinib mesylate
541818|NCT00867334|Gleevec|gleevec
541819|NCT00867334|Physiological Effects of Drugs|physiological effects of drugs
541820|NCT00867334|panitumumab|panitumumab
541821|NCT00867334|Vectibix|vectibix
541822|NCT00867334|c-kit receptor|c-kit receptor
541823|NCT00867334|Receptor|receptor
541824|NCT00867334|Platelet-Derived Growth Factor alpha|platelet-derived growth factor alpha
541825|NCT00867321|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
541826|NCT00867321|advanced adult primary liver cancer|advanced adult primary liver cancer
541827|NCT00867321|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
541828|NCT00867321|recurrent adult primary liver cancer|recurrent adult primary liver cancer
541829|NCT00867308|IPSS Int-2|ipss int-2
541830|NCT00867308|high risk myelodysplastic syndrome|high risk myelodysplastic syndrome
541831|NCT00867308|MDS)|mds)
541832|NCT00867308|5q31.1 deletions|5q31.1 deletions
541833|NCT00867295|implantable catheters|implantable catheters
541834|NCT00867295|Indwelling Catheters|indwelling catheters
541835|NCT00867295|infection|infection
541836|NCT00867295|cefazolin sodium|cefazolin sodium
541837|NCT00867295|prophylactic|prophylactic
541838|NCT00867295|antibiotic|antibiotic
541839|NCT00867295|totally implantable venous access device|totally implantable venous access device
541840|NCT00867295|cancer patients|cancer patients
541841|NCT00867269|Idiopathic Lymphocytopenia|idiopathic lymphocytopenia
541842|NCT00867269|Opportunistic Infection|opportunistic infection
541843|NCT00867269|Immunodeficiency Syndrome|immunodeficiency syndrome
541844|NCT00867269|Autoimmune Disease|autoimmune disease
541845|NCT00867269|CD4+ Lymphocytes|cd4+ lymphocytes
541846|NCT00867269|Idiopathic CD4 Lymphocytopenia|idiopathic cd4 lymphocytopenia
541847|NCT00867243|Hepatitis C virus|hepatitis c virus
541848|NCT00867243|HCV|hcv
541849|NCT00867243|Hepatitis C (and cirrhosis)|hepatitis c (and cirrhosis)
541945|NCT00866801|coronary blood flow|coronary blood flow
541850|NCT00867243|Liver cirrhosis not due to HCV infection|liver cirrhosis not due to hcv infection
541851|NCT00867230|Myelodysplastic Syndrome|myelodysplastic syndrome
541852|NCT00867230|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
541853|NCT00867230|Acute Myeloid Leukemia|acute myeloid leukemia
541854|NCT00867230|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
541855|NCT00867230|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
541856|NCT00867230|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
541857|NCT00867230|Agnogenic Myeloid Metaplasia|agnogenic myeloid metaplasia
541858|NCT00867230|FTS|fts
541859|NCT00867230|S-Trans, Trans-Farnesylthiosalicylic Acid|s-trans, trans-farnesylthiosalicylic acid
541860|NCT00867204|ERCP|ercp
541861|NCT00867204|Study focus was to compare the performance of the ERCP short-wire device versus the Long-wire device.|study focus was to compare the performance of the ercp short-wire device versus the long-wire device.
541862|NCT00867165|heterozygous familial hypercholesterolemia|heterozygous familial hypercholesterolemia
541863|NCT00867165|nonfamilial hypercholesterolemia|nonfamilial hypercholesterolemia
541864|NCT00867152|ritonavir|ritonavir
541865|NCT00867152|GSK1349572|gsk1349572
541866|NCT00867152|integrase|integrase
541867|NCT00867152|lopinavir|lopinavir
541868|NCT00867152|darunavir|darunavir
541869|NCT00867152|etravirine|etravirine
541870|NCT00867139|Influenza|influenza
541871|NCT00867139|Immunocompromised|immunocompromised
541872|NCT00867139|Antiviral|antiviral
541873|NCT00867126|stage IV pancreatic cancer|stage iv pancreatic cancer
541874|NCT00867126|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
541875|NCT00867126|recurrent pancreatic cancer|recurrent pancreatic cancer
541876|NCT00867113|Imatinib|imatinib
541877|NCT00867113|Protein Kinase Inhibitors|protein kinase inhibitors
541878|NCT00867113|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
541879|NCT00867113|Digestive System Diseases|digestive system diseases
541880|NCT00867113|Digestive System Neoplasms|digestive system neoplasms
541881|NCT00867113|Gastrointestinal Diseases|gastrointestinal diseases
541882|NCT00867113|Gastrointestinal Neoplasms|gastrointestinal neoplasms
541883|NCT00867113|Adjuvant|adjuvant
541884|NCT00867113|PERSIST|persist
541885|NCT00867113|PERSIS-5|persis-5
541886|NCT00867087|Diffuse large b-cell lymphoma|diffuse large b-cell lymphoma
541887|NCT00867087|inotuzumab ozogamicin|inotuzumab ozogamicin
541888|NCT00867087|autologous stem cell transplant|autologous stem cell transplant
541889|NCT00867061|Myelodysplastic|myelodysplastic
541890|NCT00867061|IPSS Intermediate 1|ipss intermediate 1
541891|NCT00867061|IPSS Intermediate 2|ipss intermediate 2
541892|NCT00867061|IPSS High risk|ipss high risk
541893|NCT00867048|highly active antiretroviral therapy (HAART)|highly active antiretroviral therapy (haart)
541894|NCT00867048|CD4 Count|cd4 count
541895|NCT00867048|Early Intervention|early intervention
541896|NCT00867048|HIV|hiv
541897|NCT00867048|HIV Infection|hiv infection
541898|NCT00867048|HIV Infections|hiv infections
541899|NCT00867048|treatment naive|treatment naive
541900|NCT00867022|Inflammatory factors|inflammatory factors
541901|NCT00867022|Coagulation factors|coagulation factors
541902|NCT00867022|Sympathetic activity|sympathetic activity
541903|NCT00866996|Attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
541904|NCT00866996|Methylphenidate|methylphenidate
541905|NCT00866996|Atomoxetine|atomoxetine
541906|NCT00866996|Concerta|concerta
541907|NCT00866983|Open label|open label
541908|NCT00866983|sildenafil|sildenafil
541909|NCT00866983|PAH|pah
541910|NCT00866983|Brazil|brazil
541911|NCT00866970|Lung Cancer|lung cancer
541912|NCT00866970|Fatigue|fatigue
541913|NCT00866970|Cachexia|cachexia
541914|NCT00866944|Colorectal carcinoma|colorectal carcinoma
541915|NCT00866944|Liver metastases (only)|liver metastases (only)
541916|NCT00866944|R0 resection|r0 resection
541917|NCT00866944|R0 resection of liver metastases from colorectal cancer|r0 resection of liver metastases from colorectal cancer
541918|NCT00866905|Breast Cancer|breast cancer
541919|NCT00866905|Ixabepilone|ixabepilone
541920|NCT00866905|Ixempra|ixempra
541921|NCT00866905|Cyclophosphamide|cyclophosphamide
541922|NCT00866905|Cytoxan|cytoxan
541923|NCT00866905|Neoadjuvant Therapy|neoadjuvant therapy
541924|NCT00866879|Sirolimus|sirolimus
541925|NCT00866879|Rapamune|rapamune
541926|NCT00866879|Immunosuppression|immunosuppression
541927|NCT00866879|Renal allograft function|renal allograft function
541928|NCT00866879|Lymphocytes function|lymphocytes function
541929|NCT00866853|TMC435350|tmc435350
541930|NCT00866853|HCV|hcv
541931|NCT00866853|Hepatitis C|hepatitis c
541932|NCT00866853|TMC435|tmc435
541933|NCT00866853|protease inhibitor|protease inhibitor
541934|NCT00866853|CYP|cyp
541935|NCT00866853|Cooperstown 5+1 cocktail|cooperstown 5+1 cocktail
541936|NCT00866840|stage III melanoma|stage iii melanoma
541937|NCT00866840|stage IV melanoma|stage iv melanoma
541938|NCT00866840|recurrent melanoma|recurrent melanoma
541939|NCT00866827|Airway|airway
541940|NCT00866827|Hemangiomas|hemangiomas
541941|NCT00866827|Venous Malformations|venous malformations
541942|NCT00866827|Lymphatic Malformations|lymphatic malformations
541943|NCT00866814|hernia|hernia
541944|NCT00866814|open|open
542051|NCT00866593|HAMD|hamd
541946|NCT00866801|coronary flow reserve|coronary flow reserve
541947|NCT00866801|cardiac sympathetic innervation|cardiac sympathetic innervation
541948|NCT00866801|general anesthesia|general anesthesia
541949|NCT00866801|thoracic epidural|thoracic epidural
541950|NCT00866801|autonomic dysfunction|autonomic dysfunction
541951|NCT00866801|autonomic neuropathy|autonomic neuropathy
541952|NCT00866788|Xolair|xolair
541953|NCT00866788|CIU|ciu
541954|NCT00866775|Seizure|seizure
541955|NCT00866775|Epilepsy|epilepsy
541956|NCT00866775|Anticonvulsant|anticonvulsant
541957|NCT00866775|Historical Control|historical control
541958|NCT00866775|Monotherapy|monotherapy
541959|NCT00866762|Polycythaemia Vera|polycythaemia vera
541960|NCT00866762|Polycythemia Vera|polycythemia vera
541961|NCT00866762|Essential Thrombocythaemia|essential thrombocythaemia
541962|NCT00866762|Essential Thrombocythemia|essential thrombocythemia
541963|NCT00866762|HDAC-inhibitor|hdac-inhibitor
541964|NCT00866762|Haematology|haematology
541965|NCT00866762|Hematology|hematology
541966|NCT00866762|Haematological disorder|haematological disorder
541967|NCT00866762|Haematological disease|haematological disease
541968|NCT00866762|Hematological disorder|hematological disorder
541969|NCT00866762|Hematological disease|hematological disease
541970|NCT00866749|acute lymphoblastic leukemia|acute lymphoblastic leukemia
541971|NCT00866749|acute lymphoblastic lymphoma|acute lymphoblastic lymphoma
541972|NCT00866749|Leukemia|leukemia
541973|NCT00866749|ALL|all
541974|NCT00866749|6-Thioguanine|6-thioguanine
541975|NCT00866749|Cyclophosphamide|cyclophosphamide
541976|NCT00866749|Cytarabine|cytarabine
541977|NCT00866749|Daunorubicin|daunorubicin
541978|NCT00866749|Doxorubicin|doxorubicin
541979|NCT00866749|Methotrexate|methotrexate
541980|NCT00866749|PEG-L-Asparaginase|peg-l-asparaginase
541981|NCT00866749|Vincristine|vincristine
541982|NCT00866749|Intrathecal Methotrexate|intrathecal methotrexate
541983|NCT00866749|Mercaptopurine|mercaptopurine
541984|NCT00866736|chronic myeloid leukemia|chronic myeloid leukemia
541985|NCT00866736|dasatinib|dasatinib
541986|NCT00866736|chronic phase myeloid leukemia|chronic phase myeloid leukemia
541987|NCT00866723|Avastin|avastin
541988|NCT00866723|bevacizumab|bevacizumab
541989|NCT00866697|fallopian tube cancer|fallopian tube cancer
541990|NCT00866697|pazopanib|pazopanib
541991|NCT00866697|anti-angiogenesis|anti-angiogenesis
541992|NCT00866697|ovarian cancer|ovarian cancer
541993|NCT00866697|primary peritoneal cancer|primary peritoneal cancer
541994|NCT00866697|tyrosine kinase inhibitors|tyrosine kinase inhibitors
541995|NCT00866697|gynecologic cancer|gynecologic cancer
541996|NCT00866684|renal transplant-patients with high-risk for skin cancer|renal transplant-patients with high-risk for skin cancer
541997|NCT00866671|T-ALL|t-all
541998|NCT00866671|Safety|safety
541999|NCT00866671|Post Authorisation Safety Study|post authorisation safety study
542000|NCT00866671|T-LBL|t-lbl
542001|NCT00866671|Lymphoblastic Lymphoma|lymphoblastic lymphoma
542002|NCT00866671|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
542003|NCT00866658|hyperglycemia|hyperglycemia
542004|NCT00866658|GLP-1|glp-1
542005|NCT00866658|sulfonylurea|sulfonylurea
542006|NCT00866658|insulin|insulin
542007|NCT00866645|Agitation|agitation
542008|NCT00866645|Schizophrenia|schizophrenia
542009|NCT00866645|Randomized|randomized
542010|NCT00866645|Blind|blind
542011|NCT00866645|Parallel|parallel
542012|NCT00866645|Intramuscular Haloperidol|intramuscular haloperidol
542013|NCT00866645|Controlled|controlled
542014|NCT00866645|Multicenter|multicenter
542015|NCT00866645|Clinical Trial|clinical trial
542016|NCT00866645|Efficacy|efficacy
542017|NCT00866645|Safety|safety
542018|NCT00866645|Intramuscular Levosulpiride|intramuscular levosulpiride
542019|NCT00866645|Chinese|chinese
542020|NCT00866645|PANSS-EC|panss-ec
542021|NCT00866645|ACES|aces
542022|NCT00866645|CGI|cgi
542023|NCT00866645|BPRS|bprs
542024|NCT00866645|PANSS|panss
542025|NCT00866645|RSESE|rsese
542026|NCT00866645|BAS|bas
542027|NCT00866632|Depression|depression
542028|NCT00866632|Anxiety|anxiety
542029|NCT00866632|Brain Injury|brain injury
542030|NCT00866632|Cognitive Therapy|cognitive therapy
542031|NCT00866632|Coping Skills|coping skills
542032|NCT00866606|On-demand treatment|on-demand treatment
542033|NCT00866606|Hemostatic efficacy|hemostatic efficacy
542034|NCT00866606|Factor IX activity|factor ix activity
542035|NCT00866606|Factor IX recovery|factor ix recovery
542036|NCT00866606|Factor IX inhibitor|factor ix inhibitor
542037|NCT00866606|Chinese|chinese
542038|NCT00866593|major depressive disorder(MDD)|major depressive disorder(mdd)
542039|NCT00866593|depression|depression
542040|NCT00866593|antidepressant|antidepressant
542041|NCT00866593|escitalpram oxalate|escitalpram oxalate
542042|NCT00866593|generic|generic
542043|NCT00866593|innovator|innovator
542044|NCT00866593|Lexapro|lexapro
542045|NCT00866593|efficacy|efficacy
542046|NCT00866593|safety|safety
542047|NCT00866593|multicenter|multicenter
542048|NCT00866593|double-blind|double-blind
542049|NCT00866593|randomized|randomized
542050|NCT00866593|chinese|chinese
542057|NCT00866580|Pandemic influenza|pandemic influenza
542058|NCT00866567|prematurity|prematurity
542059|NCT00866567|VLBW|vlbw
542060|NCT00866567|sepsis|sepsis
542061|NCT00866567|innate immunity|innate immunity
542062|NCT00866554|Prostate|prostate
542063|NCT00866554|Brachytherapy|brachytherapy
542064|NCT00866554|Cytoreduction|cytoreduction
542065|NCT00866554|Sexual function|sexual function
542066|NCT00866554|Toxicity|toxicity
542067|NCT00866541|resistance|resistance
542068|NCT00866541|flow proportional pressure support|flow proportional pressure support
542069|NCT00866541|pressure support ventilation|pressure support ventilation
542070|NCT00866541|volunteers|volunteers
542071|NCT00866541|assistant breathing|assistant breathing
542072|NCT00866541|breathing comfort and objective breathing data|breathing comfort and objective breathing data
542073|NCT00866528|paclitaxel|paclitaxel
542074|NCT00866528|NSCLC|nsclc
542075|NCT00866528|pazopanib|pazopanib
542076|NCT00866528|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
542077|NCT00866528|non-small cell lung cancer|non-small cell lung cancer
542078|NCT00866528|Advanced Solid Tumor|advanced solid tumor
542079|NCT00866528|GW786034|gw786034
542080|NCT00866528|Metastatic Non-Small Cell Lung Cancer|metastatic non-small cell lung cancer
542081|NCT00866515|Healthy volunteer|healthy volunteer
542082|NCT00866515|pharmacodynamics|pharmacodynamics
542083|NCT00866515|Ketoconazole|ketoconazole
542084|NCT00866515|Drug Interaction|drug interaction
542085|NCT00866515|pharmacokinetcs|pharmacokinetcs
542086|NCT00866515|GW642444M|gw642444m
542087|NCT00866515|pharmacokinetics|pharmacokinetics
542088|NCT00866502|Parkinson|parkinson
542089|NCT00866502|Safety|safety
542090|NCT00866502|PDGF|pdgf
542091|NCT00866502|Intracerebroventricular|intracerebroventricular
542092|NCT00866502|Infusion|infusion
542093|NCT00866502|Device|device
542094|NCT00866489|Experimental|experimental
542095|NCT00866476|Shigella|shigella
542096|NCT00866476|Vaccine|vaccine
542097|NCT00866476|Mucosal immunity|mucosal immunity
542098|NCT00866463|Sildenafil, Pharmacokinetics, Healthy Volunteer|sildenafil, pharmacokinetics, healthy volunteer
542099|NCT00866437|PMS|pms
542100|NCT00866437|Hormones|hormones
542101|NCT00866437|Skin tests|skin tests
542102|NCT00866437|Allergen Immunotherapy|allergen immunotherapy
542103|NCT00866424|trigeminal neuralgia|trigeminal neuralgia
542104|NCT00866424|pain|pain
542105|NCT00866424|HBO|hbo
542106|NCT00866424|VAS|vas
542107|NCT00866424|MGPQ|mgpq
542108|NCT00866411|cranial electrotherapy stimulation|cranial electrotherapy stimulation
542109|NCT00866411|anxiety|anxiety
542110|NCT00866411|depression|depression
542111|NCT00866411|pain|pain
542112|NCT00866411|sleep disturbance|sleep disturbance
542113|NCT00866411|combat exposure|combat exposure
542114|NCT00866411|post traumatic stress|post traumatic stress
542115|NCT00866411|health status|health status
542116|NCT00866411|medication use|medication use
542117|NCT00866411|soldiers|soldiers
542118|NCT00866398|coronary heart disease|coronary heart disease
542119|NCT00866398|chd|chd
542120|NCT00866398|stent|stent
542121|NCT00866385|Healthy Volunteer|healthy volunteer
542122|NCT00866385|AZD8566|azd8566
542123|NCT00866385|Food Effect|food effect
542124|NCT00866385|Microtracer|microtracer
542125|NCT00866346|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
542126|NCT00866346|CML|cml
542127|NCT00866346|Allogeneic Hematopoietic Transplantation|allogeneic hematopoietic transplantation
542128|NCT00866346|Bone Marrow Transplant|bone marrow transplant
542129|NCT00866346|PR1-Specific Cytotoxic T-Lymphocyte Infusion|pr1-specific cytotoxic t-lymphocyte infusion
542130|NCT00866333|Hodgkin's Lymphoma|hodgkin's lymphoma
542131|NCT00866333|Relapsed Hodgkin's Lymphoma|relapsed hodgkin's lymphoma
542132|NCT00866333|Refractory Hodgkin's Lymphoma|refractory hodgkin's lymphoma
542133|NCT00866320|clear cell renal cell carcinoma|clear cell renal cell carcinoma
542134|NCT00866320|recurrent renal cell cancer|recurrent renal cell cancer
542135|NCT00866320|stage IV renal cell cancer|stage iv renal cell cancer
542136|NCT00866294|Immediate-release formulation of paroxetine (paroxetine IR)|immediate-release formulation of paroxetine (paroxetine ir)
542137|NCT00866294|HAM-D (17 items)|ham-d (17 items)
542138|NCT00866294|Controlled-release formulation of paroxetine (paroxetine CR)|controlled-release formulation of paroxetine (paroxetine cr)
542139|NCT00866281|Acute Myeloid Leukemia|acute myeloid leukemia
542140|NCT00866281|AML|aml
542141|NCT00866281|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
542142|NCT00866281|ALL|all
542143|NCT00866281|midostaurin|midostaurin
542144|NCT00866281|PKC412|pkc412
542145|NCT00866281|Pediatric relapsed or refractory FLT3 positive Acute Myeloid Leukemia|pediatric relapsed or refractory flt3 positive acute myeloid leukemia
542146|NCT00866281|Pediatric relapsed or refractory Mixed-lineage leukemia gene rearranged Acute Lymphoblastic leukemia|pediatric relapsed or refractory mixed-lineage leukemia gene rearranged acute lymphoblastic leukemia
542147|NCT00866268|Blood loss|blood loss
542148|NCT00866268|Total knee arthroplasty|total knee arthroplasty
542149|NCT00866268|Adults|adults
542150|NCT00866268|Drain|drain
542151|NCT00866268|Drainage system|drainage system
542152|NCT00866255|endotracheal tube|endotracheal tube
542250|NCT00865969|PXD101|pxd101
542153|NCT00866255|endotracheal pressure|endotracheal pressure
542154|NCT00866255|airway pressure|airway pressure
542155|NCT00866255|pressure drop|pressure drop
542156|NCT00866255|calculation|calculation
542157|NCT00866255|continuous calculation|continuous calculation
542158|NCT00866242|Shigella|shigella
542159|NCT00866242|Vaccine|vaccine
542160|NCT00866242|Mucosal immunity|mucosal immunity
542161|NCT00866190|Mycobacterium tuberculosis, SQ109|mycobacterium tuberculosis, sq109
542162|NCT00866164|back pain|back pain
542163|NCT00866164|intractable pain|intractable pain
542164|NCT00866164|implantable infusion pump|implantable infusion pump
542165|NCT00866164|morphine|morphine
542166|NCT00866151|genetic biomarker|genetic biomarker
542167|NCT00866151|biomarker|biomarker
542168|NCT00866151|molecular diagnostics|molecular diagnostics
542169|NCT00866151|genes|genes
542170|NCT00866151|genetics|genetics
542171|NCT00866151|overweight management|overweight management
542172|NCT00866151|weight management|weight management
542173|NCT00866151|weight reduction|weight reduction
542174|NCT00866151|SNPs|snps
542175|NCT00866151|single nucleotide polymorphisms|single nucleotide polymorphisms
542176|NCT00866138|multiple myeloma|multiple myeloma
542177|NCT00866138|t(4/14)|t(4/14)
542178|NCT00866138|relapsing|relapsing
542179|NCT00866138|refractory|refractory
542180|NCT00866125|Polymyositis|polymyositis
542181|NCT00866125|Dermatomyositis|dermatomyositis
542182|NCT00866125|Grip force|grip force
542183|NCT00866125|Quality of life|quality of life
542184|NCT00866125|Activity performance|activity performance
542185|NCT00866112|Wheelchair use|wheelchair use
542186|NCT00866112|Spinal cord injury|spinal cord injury
542187|NCT00866112|Multiple sclerosis|multiple sclerosis
542188|NCT00866112|Muscular dystrophy|muscular dystrophy
542189|NCT00866112|Cerebral palsy|cerebral palsy
542190|NCT00866112|Spina bifida|spina bifida
542191|NCT00866112|Amputation|amputation
542192|NCT00866112|Arthritis|arthritis
542193|NCT00866112|Stroke|stroke
542194|NCT00866099|Dementia|dementia
542195|NCT00866099|primary care|primary care
542196|NCT00866099|early diagnosis|early diagnosis
542197|NCT00866099|psychosocial interventions|psychosocial interventions
542198|NCT00866099|cholinesterase inhibitors|cholinesterase inhibitors
542199|NCT00866086|stage I non-small cell lung cancer|stage i non-small cell lung cancer
542200|NCT00866086|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
542201|NCT00866086|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
542202|NCT00866086|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
542203|NCT00866086|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
542204|NCT00866086|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
542205|NCT00866086|pulmonary carcinoid tumor|pulmonary carcinoid tumor
542206|NCT00866086|extensive stage small cell lung cancer|extensive stage small cell lung cancer
542207|NCT00866086|limited stage small cell lung cancer|limited stage small cell lung cancer
542208|NCT00866086|recurrent small cell lung cancer|recurrent small cell lung cancer
542210|NCT00866073|Acute myeloid leukemia|acute myeloid leukemia
542211|NCT00866073|Decitabine|decitabine
542212|NCT00866060|donepezil|donepezil
542213|NCT00866060|memantine|memantine
542214|NCT00866060|moderately severe Alzheimer's disease|moderately severe alzheimer's disease
542215|NCT00866060|severe Alzheimer's disease|severe alzheimer's disease
542216|NCT00866047|Antigens, CD30|antigens, cd30
542217|NCT00866047|Antibody-Drug Conjugate|antibody-drug conjugate
542218|NCT00866047|Antibodies, Monoclonal|antibodies, monoclonal
542219|NCT00866047|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
542220|NCT00866047|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
542221|NCT00866047|monomethyl auristatin E|monomethyl auristatin e
542222|NCT00866047|Drug Therapy|drug therapy
542223|NCT00866047|Immunotherapy|immunotherapy
542224|NCT00866047|Hematologic Diseases|hematologic diseases
542225|NCT00866047|Lymphoma|lymphoma
542226|NCT00866034|Cetrotide|cetrotide
542227|NCT00866034|IVF|ivf
542228|NCT00866034|ICSI|icsi
542229|NCT00866034|Treatment protocol|treatment protocol
542230|NCT00866021|HIV infection|hiv infection
542231|NCT00866021|HCV infection|hcv infection
542232|NCT00866021|treatment experienced|treatment experienced
542233|NCT00866008|IVF|ivf
542234|NCT00866008|In vitro implantation|in vitro implantation
542235|NCT00866008|Preimplantation genetic screening|preimplantation genetic screening
542236|NCT00866008|Aneuploidy|aneuploidy
542237|NCT00865995|pepsin|pepsin
542238|NCT00865995|aspiration|aspiration
542239|NCT00865995|GE reflux|ge reflux
542240|NCT00865982|adenocarcinoma of the stomach, gastro-esophageal junction or distal esophagus|adenocarcinoma of the stomach, gastro-esophageal junction or distal esophagus
542241|NCT00865982|gastric cancer|gastric cancer
542242|NCT00865982|esophageal cancer|esophageal cancer
542243|NCT00865982|gastro-esophageal junction|gastro-esophageal junction
542244|NCT00865982|docetaxel|docetaxel
542245|NCT00865982|capecitabine|capecitabine
542246|NCT00865982|cisplatin|cisplatin
542247|NCT00865982|perioperative chemotherapy|perioperative chemotherapy
542248|NCT00865969|Belinostat|belinostat
542249|NCT00865969|peripheral T-cell lymphoma|peripheral t-cell lymphoma
542251|NCT00865969|PTCL|ptcl
542252|NCT00865969|HDAC inhibitor|hdac inhibitor
542253|NCT00865969|histone deacetylase inhibitor|histone deacetylase inhibitor
542254|NCT00865956|disease management|disease management
542255|NCT00865956|substance use disorders|substance use disorders
542256|NCT00865956|behavioral incentives|behavioral incentives
542257|NCT00865943|Bioequivalence|bioequivalence
542258|NCT00865943|Citalopram|citalopram
542259|NCT00865943|Healthy subjects|healthy subjects
542260|NCT00865917|POTS|pots
542261|NCT00865904|∆F508|∆f508
542262|NCT00865904|F508del|f508del
542263|NCT00865904|Cystic Fibrosis Transmembrane Conductance Regulator|cystic fibrosis transmembrane conductance regulator
542264|NCT00865904|CFTR|cftr
542265|NCT00865904|Pancreatic diseases|pancreatic diseases
542266|NCT00865904|Lung diseases|lung diseases
542267|NCT00865904|Genetic disease, inborn|genetic disease, inborn
542268|NCT00865904|Infant, newborn, diseases|infant, newborn, diseases
542269|NCT00865891|Bioequivalence|bioequivalence
542270|NCT00865891|Nifedipine|nifedipine
542271|NCT00865891|Healthy subjects|healthy subjects
542272|NCT00865878|Actinic Keratoses|actinic keratoses
542273|NCT00865878|Skin Neoplasms|skin neoplasms
542274|NCT00865878|Photodynamic Therapy|photodynamic therapy
542275|NCT00865878|Transplants|transplants
542276|NCT00865865|Knee|knee
542277|NCT00865865|Computer|computer
542278|NCT00865865|Gap|gap
542279|NCT00865865|Soft tissue|soft tissue
542280|NCT00865865|Balancing|balancing
542281|NCT00865865|Replacement|replacement
542282|NCT00865865|Arthroplasty|arthroplasty
542283|NCT00865852|Bioequivalence|bioequivalence
542284|NCT00865852|Metformin|metformin
542285|NCT00865852|Healthy subjects|healthy subjects
542286|NCT00865839|Bioequivalence|bioequivalence
542287|NCT00865839|Metformin|metformin
542288|NCT00865839|Healthy subjects|healthy subjects
542289|NCT00865826|Pulmonary Tuberculosis|pulmonary tuberculosis
542290|NCT00865826|Myobacterium Infections|myobacterium infections
542291|NCT00865813|Punch biopsy,|punch biopsy,
542292|NCT00865813|periocular|periocular
542293|NCT00865813|tumors.|tumors.
542294|NCT00865774|Trauma|trauma
542295|NCT00865774|Alcohol|alcohol
542296|NCT00865774|Brief Intervention|brief intervention
542297|NCT00865761|Bioequivalence|bioequivalence
542298|NCT00865761|Alprazolam|alprazolam
542299|NCT00865761|Healthy subjects|healthy subjects
542300|NCT00865748|Bioequivalence|bioequivalence
542301|NCT00865748|Metformin|metformin
542302|NCT00865748|Healthy subjects|healthy subjects
542303|NCT00865722|Remote Postconditioning|remote postconditioning
542304|NCT00865722|Myocardial reperfusion Injury|myocardial reperfusion injury
542305|NCT00865722|Myocardial Infarction|myocardial infarction
542306|NCT00865722|Primary PCI|primary pci
542307|NCT00865709|Colorectal Cancer|colorectal cancer
542308|NCT00865709|Metastasis|metastasis
542309|NCT00865709|Stage IV|stage iv
542310|NCT00865709|Liver Metastasis|liver metastasis
542311|NCT00865696|Bioequivalence|bioequivalence
542312|NCT00865696|Mirtazapine|mirtazapine
542313|NCT00865696|Healthy subjects|healthy subjects
542314|NCT00865683|Gestational Diabetes|gestational diabetes
542315|NCT00865683|Pregnancy|pregnancy
542316|NCT00865683|Docosahexaenoic Acid|docosahexaenoic acid
542317|NCT00865683|DHA|dha
542318|NCT00865683|Maternal-Fetal Exchange|maternal-fetal exchange
542319|NCT00865657|Bioequivalence|bioequivalence
542320|NCT00865657|Alprazolam|alprazolam
542321|NCT00865657|Healthy subjects|healthy subjects
542322|NCT00865644|imiquimod 5% cream|imiquimod 5% cream
542323|NCT00865631|Bioequivalence|bioequivalence
542324|NCT00865631|Gabapentin|gabapentin
542325|NCT00865631|Healthy subjects|healthy subjects
542326|NCT00865605|bioequivalence|bioequivalence
542327|NCT00865605|Vasoconstriction|vasoconstriction
542328|NCT00865605|Halobetasol|halobetasol
542329|NCT00865605|Healthy subjects|healthy subjects
542330|NCT00865592|diabetes|diabetes
542331|NCT00865592|DPP4 inhibitor|dpp4 inhibitor
542332|NCT00865592|dutogliptin|dutogliptin
542333|NCT00865592|PHX1149|phx1149
542334|NCT00865579|MAO inhibitors|mao inhibitors
542335|NCT00865579|motor fluctuations|motor fluctuations
542336|NCT00865579|dyskinesia|dyskinesia
542337|NCT00865579|Parkinson's Disease|parkinson's disease
542338|NCT00865566|HIV Seronegativity|hiv seronegativity
542339|NCT00865566|HIV Preventive Vaccine|hiv preventive vaccine
542340|NCT00865566|HIV Treatment Vaccine|hiv treatment vaccine
542341|NCT00865566|Adenovirus|adenovirus
542342|NCT00865553|tobacco use disorder|tobacco use disorder
542343|NCT00865540|cataract|cataract
542344|NCT00865540|pupillary dilation|pupillary dilation
542345|NCT00865540|anti-inflammatory|anti-inflammatory
542346|NCT00865540|therapeutic use|therapeutic use
542347|NCT00865527|Colorectal cancer|colorectal cancer
542348|NCT00865527|Colon cancer|colon cancer
542349|NCT00865527|Adenomatous polyps|adenomatous polyps
542350|NCT00865527|Screening|screening
542351|NCT00865527|Fecal occult blood test|fecal occult blood test
542352|NCT00865527|Computed tomographic colonography|computed tomographic colonography
542353|NCT00865527|Colonoscopy|colonoscopy
542354|NCT00865514|dichloroacetate|dichloroacetate
542355|NCT00865514|tyrosine|tyrosine
542356|NCT00865514|maleylacetoacetate|maleylacetoacetate
542357|NCT00865514|trichloroethylene|trichloroethylene
542358|NCT00865514|leucine|leucine
542359|NCT00865514|haplotype|haplotype
542360|NCT00865501|primary hypertension|primary hypertension
542361|NCT00865501|aldosterone|aldosterone
542362|NCT00865501|left ventricular hypertrophy|left ventricular hypertrophy
542363|NCT00865475|HIV infection|hiv infection
542364|NCT00865475|Treatment Experienced|treatment experienced
542365|NCT00865462|Bioequivalence|bioequivalence
542366|NCT00865462|Bupropion|bupropion
542367|NCT00865462|Healthy subjects|healthy subjects
542368|NCT00865449|spironolactone|spironolactone
542369|NCT00865449|peritoneal fibrosis|peritoneal fibrosis
542370|NCT00865449|peritoneal dialysis|peritoneal dialysis
542371|NCT00865436|Bioequivalence|bioequivalence
542372|NCT00865436|Metformin|metformin
542373|NCT00865436|Glyburide|glyburide
542374|NCT00865436|Healthy subjects|healthy subjects
542375|NCT00865423|Bioequivalence|bioequivalence
542376|NCT00865423|Gabapentin|gabapentin
542377|NCT00865423|Healthy subjects|healthy subjects
542378|NCT00865410|Bioequivalence|bioequivalence
542379|NCT00865410|Bupropion|bupropion
542380|NCT00865410|Healthy subjects|healthy subjects
542381|NCT00865384|Bioequivalence|bioequivalence
542382|NCT00865384|Mirtazapine|mirtazapine
542383|NCT00865384|Healthy subjects|healthy subjects
542384|NCT00865371|Bioequivalence|bioequivalence
542385|NCT00865371|Bupropion|bupropion
542386|NCT00865371|Healthy subjects|healthy subjects
542387|NCT00865358|yoga|yoga
542388|NCT00865358|complementary alternative medicine|complementary alternative medicine
542389|NCT00865358|low back pain|low back pain
542390|NCT00865358|minority health|minority health
542391|NCT00865358|health care disparities|health care disparities
542392|NCT00865358|community health centers|community health centers
542393|NCT00865345|blood sugar|blood sugar
542394|NCT00865345|glucose|glucose
542395|NCT00865345|sensor|sensor
542396|NCT00865332|PET|pet
542397|NCT00865332|fMRI|fmri
542398|NCT00865332|D-Amphetamine|d-amphetamine
542399|NCT00865332|Cocaine Addiction|cocaine addiction
542400|NCT00865332|Methylphenidate|methylphenidate
542401|NCT00865319|Non Small Cell Lung Cancer|non small cell lung cancer
542402|NCT00865319|Spect CT Imaging|spect ct imaging
542403|NCT00865319|PET CT Imaging as Comparator|pet ct imaging as comparator
542404|NCT00865306|Cognitive behavioral therapy|cognitive behavioral therapy
542405|NCT00865306|Anxiety|anxiety
542406|NCT00865306|Preschoolers|preschoolers
542407|NCT00865306|Young Children|young children
542408|NCT00865306|Parents|parents
542409|NCT00865306|At-risk|at-risk
542410|NCT00865306|Behavioral Inhibition|behavioral inhibition
542411|NCT00865293|Obesity|obesity
542412|NCT00865293|expiratory flow limitation|expiratory flow limitation
542413|NCT00865293|EFL|efl
542414|NCT00865293|posture|posture
542415|NCT00865293|small airways obstruction|small airways obstruction
542416|NCT00865293|FOT|fot
542417|NCT00865280|CSSI|cssi
542418|NCT00865280|Abscess|abscess
542419|NCT00865280|Wound|wound
542420|NCT00865280|Cellulitis|cellulitis
542421|NCT00865280|Complicated Skin and Skin Structure Infections (cSSSI)|complicated skin and skin structure infections (csssi)
542422|NCT00865267|Vasoconstriction|vasoconstriction
542423|NCT00865267|Halobetasol|halobetasol
542424|NCT00865267|Healthy adult subjects|healthy adult subjects
542425|NCT00865254|Nicotine Dependence|nicotine dependence
542426|NCT00865254|Smoking|smoking
542427|NCT00865254|Smoking Cessation|smoking cessation
542428|NCT00865254|Contingency Management|contingency management
542429|NCT00865241|Bioequivalence|bioequivalence
542430|NCT00865241|Metformin|metformin
542431|NCT00865241|Glyburide|glyburide
542432|NCT00865241|Healthy subjects|healthy subjects
542433|NCT00865228|Hyperlipidemia|hyperlipidemia
542434|NCT00865228|Dyslipidemia|dyslipidemia
542435|NCT00865228|High Cholesterol|high cholesterol
542436|NCT00865228|Drug Therapy|drug therapy
542437|NCT00865215|Bioequivalence|bioequivalence
542438|NCT00865215|Propranolol|propranolol
542439|NCT00865215|Healthy subjects|healthy subjects
542440|NCT00865202|delirium|delirium
542441|NCT00865202|surgery|surgery
542442|NCT00865202|operation|operation
542443|NCT00865202|geriatric|geriatric
542444|NCT00865202|complication|complication
542445|NCT00865163|Percutaneous Coronary Intervention|percutaneous coronary intervention
542446|NCT00865163|anticoagulation|anticoagulation
542447|NCT00865163|PCI|pci
542448|NCT00865150|Prematurity|prematurity
542449|NCT00865150|Neonatal screening|neonatal screening
542450|NCT00865150|Parenteral nutrition|parenteral nutrition
542451|NCT00865150|Amino acids|amino acids
542452|NCT00865150|Acylcarnitine|acylcarnitine
542453|NCT00865137|Kidney Transplantation|kidney transplantation
542454|NCT00865137|Pharmacokinetics|pharmacokinetics
542455|NCT00865137|Tacrolimus modified release|tacrolimus modified release
542456|NCT00865137|FK506E|fk506e
542457|NCT00865111|Bioequivalence|bioequivalence
542458|NCT00865111|Bupropion|bupropion
542459|NCT00865111|Healthy subjects|healthy subjects
542460|NCT00865098|Newly diagnosed locally advanced squamous cell carcinoma of the head and neck (SCCHN)|newly diagnosed locally advanced squamous cell carcinoma of the head and neck (scchn)
542461|NCT00865085|Bioequivalence|bioequivalence
542462|NCT00865085|Citalopram|citalopram
542463|NCT00865085|Healthy subjects|healthy subjects
542464|NCT00865072|Bioequivalence|bioequivalence
542465|NCT00865072|Metformin|metformin
542466|NCT00865072|Healthy subjects|healthy subjects
542467|NCT00865059|Bioequivalence|bioequivalence
542468|NCT00865059|Gabapentin|gabapentin
542469|NCT00865059|Healthy subjects|healthy subjects
542470|NCT00865046|acupuncture|acupuncture
542471|NCT00865020|Hypertension|hypertension
542472|NCT00865020|ABPM|abpm
542473|NCT00865020|systolic blood pressure|systolic blood pressure
542474|NCT00865020|diastolic blood pressure|diastolic blood pressure
542475|NCT00865020|cardiovascular disease|cardiovascular disease
542476|NCT00865020|aliskiren|aliskiren
542477|NCT00865020|telmisartan|telmisartan
542478|NCT00865007|Lipodystrophy|lipodystrophy
542479|NCT00865007|treatment experienced|treatment experienced
542480|NCT00864994|COPD|copd
542481|NCT00864994|Inflammation|inflammation
542482|NCT00864994|Smoking|smoking
542483|NCT00864994|Multiorgan pathology|multiorgan pathology
542484|NCT00864994|Extra pulmonary manifestations|extra pulmonary manifestations
542485|NCT00864968|Bioequivalence|bioequivalence
542486|NCT00864968|Nabumetone|nabumetone
542487|NCT00864968|Healthy subjects|healthy subjects
542488|NCT00864955|UV-A irradiation|uv-a irradiation
542489|NCT00864955|Cyclobutane-Pyrimidine Dimer|cyclobutane-pyrimidine dimer
542490|NCT00864955|Oxidative lesions|oxidative lesions
542491|NCT00864955|cutaneous phototype|cutaneous phototype
542492|NCT00864955|UV-B irradiation|uv-b irradiation
542493|NCT00864955|DNA damages|dna damages
542494|NCT00864942|CLL|cll
542495|NCT00864942|NHL|nhl
542496|NCT00864942|lymphoma|lymphoma
542497|NCT00864929|Non-interventional study|non-interventional study
542498|NCT00864929|Vietnam|vietnam
542499|NCT00864929|inappropriate treatment|inappropriate treatment
542500|NCT00864929|nosocomial infection|nosocomial infection
542501|NCT00864916|Endothelial Function|endothelial function
542502|NCT00864916|Pentoxifylline|pentoxifylline
542503|NCT00864916|Antiretroviral Therapy|antiretroviral therapy
542504|NCT00864916|Inflammation|inflammation
542505|NCT00864903|enterovirus|enterovirus
542506|NCT00864903|aseptic meningitis|aseptic meningitis
542507|NCT00864903|real time PCR|real time pcr
542508|NCT00864903|diagnostics|diagnostics
542509|NCT00864890|Bioequivalence|bioequivalence
542510|NCT00864890|Citalopram|citalopram
542511|NCT00864890|Healthy subjects|healthy subjects
542512|NCT00864877|retrospective|retrospective
542513|NCT00864877|comparison|comparison
542514|NCT00864877|biodegradable|biodegradable
542515|NCT00864877|implant|implant
542516|NCT00864877|ankle fracture|ankle fracture
542517|NCT00864864|sunitinib|sunitinib
542518|NCT00864838|intraocular pressure|intraocular pressure
542519|NCT00864838|bevacizumab|bevacizumab
542520|NCT00864838|acetazolamide|acetazolamide
542521|NCT00864838|brimonidine|brimonidine
542522|NCT00864838|anterior chamber paracentesis|anterior chamber paracentesis
542523|NCT00864825|Schizophrenia|schizophrenia
542524|NCT00864825|Allopurinol|allopurinol
542525|NCT00864825|Add-on-treatment|add-on-treatment
542526|NCT00864799|Abortion|abortion
542527|NCT00864799|Misoprostol|misoprostol
542528|NCT00864799|Mifepristone|mifepristone
542529|NCT00864799|Pregnancy|pregnancy
542530|NCT00864799|Fetus|fetus
542531|NCT00864786|Multiple dose safety and pharmacokinetics study|multiple dose safety and pharmacokinetics study
542532|NCT00864760|Bioequivalence|bioequivalence
542533|NCT00864760|Gabapentin|gabapentin
542534|NCT00864760|Healthy subjects|healthy subjects
542535|NCT00864747|Bioequivalence|bioequivalence
542536|NCT00864747|Propranolol|propranolol
542537|NCT00864747|Healthy subjects|healthy subjects
542538|NCT00864734|Bioequivalence|bioequivalence
542539|NCT00864734|Metformin|metformin
542540|NCT00864734|Glyburide|glyburide
542541|NCT00864734|Healthy subjects|healthy subjects
542542|NCT00864721|Untreated NSCLC in patients > 70|untreated nsclc in patients > 70
542543|NCT00864708|Functional Electrical Stimulation|functional electrical stimulation
542544|NCT00864695|Anesthesia|anesthesia
542545|NCT00864695|Ethics|ethics
542546|NCT00864695|Trends|trends
542547|NCT00864695|Manpower|manpower
542548|NCT00864695|Perioperative care|perioperative care
542549|NCT00864682|propofol|propofol
542550|NCT00864682|lidocaine|lidocaine
542551|NCT00864682|injection pain|injection pain
542552|NCT00864669|Bioequivalence|bioequivalence
542553|NCT00864669|Metformin|metformin
542554|NCT00864669|Healthy subjects|healthy subjects
542555|NCT00864656|adrenergic alpha-agonists|adrenergic alpha-agonists
542556|NCT00864656|phenylephrine|phenylephrine
542557|NCT00864656|drug effects|drug effects
542558|NCT00864656|diagnostic use|diagnostic use
542559|NCT00864643|Hyperlipidemia|hyperlipidemia
542560|NCT00864643|Drug Therapy|drug therapy
542561|NCT00864643|Dyslipidemia|dyslipidemia
542562|NCT00864617|Bioequivalence|bioequivalence
542563|NCT00864617|Nifedipine|nifedipine
542564|NCT00864617|Healthy subjects|healthy subjects
542565|NCT00864604|Bioequivalence|bioequivalence
542566|NCT00864604|Nabumetone|nabumetone
542567|NCT00864604|Healthy subjects|healthy subjects
542568|NCT00864591|SPECT Imaging|spect imaging
542569|NCT00864591|Stress adenosine CMR|stress adenosine cmr
542570|NCT00864578|POAG|poag
542572|NCT00864578|Forskolin|forskolin
542573|NCT00864578|Food supplement|food supplement
542574|NCT00864565|Bioequivalence|bioequivalence
542575|NCT00864565|Fentanyl|fentanyl
542576|NCT00864565|Healthy subjects|healthy subjects
542577|NCT00864552|Hemophilia A|hemophilia a
542578|NCT00864552|Recombinant Factor VIII|recombinant factor viii
542579|NCT00864539|vitamin D fortification|vitamin d fortification
542580|NCT00864539|milk|milk
542581|NCT00864539|orange juice|orange juice
542582|NCT00864539|supplement|supplement
542583|NCT00864539|efficacy|efficacy
542584|NCT00864526|Bioequivalence|bioequivalence
542585|NCT00864526|Oxycodone|oxycodone
542586|NCT00864526|Ibuprofen|ibuprofen
542587|NCT00864526|Healthy subjects|healthy subjects
542588|NCT00864513|pancreas|pancreas
542589|NCT00864513|metastatic|metastatic
542590|NCT00864513|recurrent|recurrent
542591|NCT00864500|Bio-Equivalence|bio-equivalence
542592|NCT00864500|Vasoconstriction|vasoconstriction
542593|NCT00864500|Clobetasol|clobetasol
542594|NCT00864500|Healthy adult females|healthy adult females
542595|NCT00864461|Down syndrome|down syndrome
542596|NCT00864461|Metabolic syndrome X|metabolic syndrome x
542597|NCT00864461|Insulin resistance|insulin resistance
542598|NCT00864448|Bioequivalence|bioequivalence
542599|NCT00864448|Ramipril|ramipril
542600|NCT00864448|Healthy subjects|healthy subjects
542601|NCT00864435|Bioequivalence|bioequivalence
542602|NCT00864435|Carvedilol|carvedilol
542603|NCT00864435|Healthy subjects|healthy subjects
542604|NCT00864422|low back pain|low back pain
542605|NCT00864422|motor training|motor training
542606|NCT00864422|motor cortex|motor cortex
542607|NCT00864422|brain plasticity|brain plasticity
542608|NCT00864409|postoperative pain|postoperative pain
542609|NCT00864409|total hip arthroplasty|total hip arthroplasty
542610|NCT00864396|Laryngopharyngeal reflux|laryngopharyngeal reflux
542611|NCT00864396|Gastroesophageal reflux disease|gastroesophageal reflux disease
542612|NCT00864396|GERD|gerd
542613|NCT00864370|Psychiatry|psychiatry
542614|NCT00864370|Pregnancy|pregnancy
542615|NCT00864370|Bipolar Disorder|bipolar disorder
542616|NCT00864357|Bioequivalence|bioequivalence
542617|NCT00864357|Oxycodone|oxycodone
542618|NCT00864357|Ibuprofen|ibuprofen
542619|NCT00864357|Healthy subjects|healthy subjects
542620|NCT00864344|Bioequivalence|bioequivalence
542621|NCT00864344|Sertralin|sertralin
542622|NCT00864344|Healthy subjectse|healthy subjectse
542623|NCT00864331|lung cancer|lung cancer
542624|NCT00864331|nonsmall cell lung cancer|nonsmall cell lung cancer
542625|NCT00864331|radiation therapy|radiation therapy
542626|NCT00864331|chemotherapy|chemotherapy
542627|NCT00864331|Locally advanced and metastatic nonsmall cell lung cancer|locally advanced and metastatic nonsmall cell lung cancer
542628|NCT00864318|refractory|refractory
542629|NCT00864318|germ cell tumors|germ cell tumors
542630|NCT00864318|relapse|relapse
542631|NCT00864318|bad prognosis|bad prognosis
542632|NCT00864318|Refractory germ cell tumors with relapse and bad prognosis|refractory germ cell tumors with relapse and bad prognosis
542633|NCT00864305|Bioequivalence|bioequivalence
542634|NCT00864305|Gabapentin|gabapentin
542635|NCT00864305|Healthy subjects|healthy subjects
542636|NCT00864279|Bioequivalence|bioequivalence
542637|NCT00864279|Cetirizine|cetirizine
542638|NCT00864279|Healthy subjects|healthy subjects
542639|NCT00864266|Non small cell lung carcinoma|non small cell lung carcinoma
542640|NCT00864266|Chemotherapy|chemotherapy
542641|NCT00864266|Response prediction|response prediction
542642|NCT00864253|Melanoma|melanoma
542643|NCT00864253|Malignant|malignant
542644|NCT00864253|Abraxane|abraxane
542645|NCT00864253|ABI-007|abi-007
542646|NCT00864253|Dacarbazine|dacarbazine
542647|NCT00864253|Dtic-Dome|dtic-dome
542648|NCT00864240|Vasoconstriction|vasoconstriction
542649|NCT00864240|Clobetasol|clobetasol
542650|NCT00864240|Healthy adult females|healthy adult females
542651|NCT00864227|Acute Lymphoblastic Leukemia/Lymphoma|acute lymphoblastic leukemia/lymphoma
542652|NCT00864227|Acute Myelogenous Leukemia|acute myelogenous leukemia
542653|NCT00864227|Mantel-Cell Lymphoma|mantel-cell lymphoma
542654|NCT00864227|Hematopoietic Transplant|hematopoietic transplant
542655|NCT00864227|Umbilical Cord Blood (UCB)|umbilical cord blood (ucb)
542656|NCT00864227|Non-Myeloablative Transplant|non-myeloablative transplant
542657|NCT00864214|bioidentical hormone|bioidentical hormone
542658|NCT00864214|menopause|menopause
542659|NCT00864214|estrogen|estrogen
542660|NCT00864214|progesterone|progesterone
542661|NCT00864188|skin health|skin health
542662|NCT00864188|probiotics|probiotics
542663|NCT00864188|dairy|dairy
542664|NCT00864188|oral|oral
542665|NCT00864162|Bioequivalence|bioequivalence
542666|NCT00864162|Ramipril|ramipril
542667|NCT00864162|Healthy subjects|healthy subjects
542668|NCT00864149|Bioequivalence|bioequivalence
542669|NCT00864149|Carvedilol|carvedilol
542670|NCT00864149|Healthy subjects|healthy subjects
542671|NCT00864123|Obsessive-compulsive disorder|obsessive-compulsive disorder
542672|NCT00864110|Non small cell lung cancer|non small cell lung cancer
542673|NCT00864110|SPECT CT imaging|spect ct imaging
542674|NCT00864110|Pharmacokinetic|pharmacokinetic
542675|NCT00864110|Radiation Dosimetry|radiation dosimetry
542676|NCT00864110|PET CT comparison|pet ct comparison
542677|NCT00864097|Arthritis monoclonal antibody nerve growth factor (NGF) anti-NGF tanezumab PF-04383119 RN-624 OA|arthritis monoclonal antibody nerve growth factor (ngf) anti-ngf tanezumab pf-04383119 rn-624 oa
542678|NCT00864071|Bioequivalence|bioequivalence
542679|NCT00864071|Griseofulvin|griseofulvin
542680|NCT00864071|Healthy subjects|healthy subjects
542681|NCT00864058|Bioequivalence|bioequivalence
542682|NCT00864058|Gabapentin|gabapentin
542683|NCT00864058|Healthy subjects|healthy subjects
542684|NCT00864032|Soft tissue sarcoma of the extremity and body wall|soft tissue sarcoma of the extremity and body wall
542685|NCT00864019|Bioequivalence|bioequivalence
542686|NCT00864019|Sertraline|sertraline
542687|NCT00864019|Healthy subjects|healthy subjects
542688|NCT00863980|angiotensin|angiotensin
542689|NCT00863980|receptor|receptor
542690|NCT00863980|vulnerable plaque|vulnerable plaque
542691|NCT00863980|coronary artery|coronary artery
542692|NCT00863967|physical examination|physical examination
542693|NCT00863967|diagnostic techniques and procedures|diagnostic techniques and procedures
542694|NCT00863967|diagnosis|diagnosis
542695|NCT00863967|immunologic tests|immunologic tests
542696|NCT00863967|diagnostic tests|diagnostic tests
542697|NCT00863967|causality|causality
542698|NCT00863967|genetic test|genetic test
542699|NCT00863967|biomarker|biomarker
542700|NCT00863941|Bioequivalence|bioequivalence
542701|NCT00863941|Bupropion|bupropion
542702|NCT00863941|Healthy subjects|healthy subjects
542703|NCT00863915|Bioequivalence|bioequivalence
542704|NCT00863915|Ramipril|ramipril
542705|NCT00863915|Healthy subjects|healthy subjects
542706|NCT00863902|Bioequivalence|bioequivalence
542707|NCT00863902|Cetirizine|cetirizine
542708|NCT00863902|Healthy subjects|healthy subjects
542709|NCT00863876|wavefront measurements of the entire eye|wavefront measurements of the entire eye
542710|NCT00863863|Bioequivalence|bioequivalence
542711|NCT00863863|Griseofulvin|griseofulvin
542712|NCT00863863|Healthy subjects|healthy subjects
542713|NCT00863837|Acute variceal bleeding|acute variceal bleeding
542714|NCT00863837|banding ligation|banding ligation
542715|NCT00863837|vasoconstrictor|vasoconstrictor
542716|NCT00863837|proton pump inhibitor|proton pump inhibitor
542717|NCT00863824|NNAL|nnal
542718|NCT00863824|Cotinine|cotinine
542719|NCT00863824|Second hand smoke|second hand smoke
542720|NCT00863824|NNAL is a known lung carcinogen. So, we are studying an agent that can potentially cause lung cancer.|nnal is a known lung carcinogen. so, we are studying an agent that can potentially cause lung cancer.
542721|NCT00863811|POAG|poag
542722|NCT00863811|IOP|iop
542723|NCT00863811|Forskolin|forskolin
542724|NCT00863811|beta-blockers|beta-blockers
542725|NCT00863811|prostaglandins|prostaglandins
542726|NCT00863798|Major Depressive Disorder|major depressive disorder
542727|NCT00863785|Acute Alcoholic Hepatitis|acute alcoholic hepatitis
542728|NCT00863785|Cirrhosis|cirrhosis
542729|NCT00863785|Alcohol|alcohol
542730|NCT00863785|Alcoholic Liver disease|alcoholic liver disease
542731|NCT00863759|intra-ocular lenses|intra-ocular lenses
542732|NCT00863759|comparative study|comparative study
542733|NCT00863759|Ocular aberrations|ocular aberrations
542734|NCT00863759|Contrast Sensitivity|contrast sensitivity
542735|NCT00863746|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
542736|NCT00863746|Sorafenib|sorafenib
542737|NCT00863707|regadenoson|regadenoson
542738|NCT00863707|chronic kidney disease stage III|chronic kidney disease stage iii
542739|NCT00863707|chronic kidney disease stage IV|chronic kidney disease stage iv
542740|NCT00863707|renal impairment|renal impairment
542741|NCT00863707|coronary artery disease|coronary artery disease
542742|NCT00863694|cystic fibrosis|cystic fibrosis
542743|NCT00863694|calprotectin|calprotectin
542744|NCT00863694|elastase|elastase
542745|NCT00863681|Pulmonary arterial hypertension|pulmonary arterial hypertension
542746|NCT00863681|PH|ph
542747|NCT00863681|Stimulator|stimulator
542748|NCT00863668|Infection|infection
542749|NCT00863668|HIV 1|hiv 1
542750|NCT00863668|HIV|hiv
542751|NCT00863668|treatment naive|treatment naive
542752|NCT00863655|Breast Cancer|breast cancer
542753|NCT00863655|Estrogen Receptor positive|estrogen receptor positive
542754|NCT00863655|ER+|er+
542755|NCT00863655|exemestane|exemestane
542756|NCT00863655|mTOR|mtor
542757|NCT00863655|everolimus|everolimus
542758|NCT00863655|refractory|refractory
542759|NCT00863655|NSAI|nsai
542760|NCT00863642|Early cholecystectomy|early cholecystectomy
542761|NCT00863642|gallstone pancreatitis|gallstone pancreatitis
542762|NCT00863629|myocardial infarction|myocardial infarction
542854|NCT00863252|proteinuria|proteinuria
542763|NCT00863629|oxidative stress|oxidative stress
542764|NCT00863629|stem cells|stem cells
542765|NCT00863629|glycemic control|glycemic control
542766|NCT00863616|COPD|copd
542767|NCT00863616|Mucus hypersecretion|mucus hypersecretion
542768|NCT00863616|HRQL|hrql
542769|NCT00863616|ESWT|eswt
542770|NCT00863616|HFCWO|hfcwo
542771|NCT00863603|Supplemental oxygen|supplemental oxygen
542772|NCT00863603|Intimal hyperplasia|intimal hyperplasia
542773|NCT00863603|Graft patency|graft patency
542774|NCT00863577|Healthy volunteers|healthy volunteers
542775|NCT00863564|Postprandial Period|postprandial period
542776|NCT00863564|Postprandial Lipaemia|postprandial lipaemia
542777|NCT00863564|Incretins|incretins
542778|NCT00863564|Subclinical Inflammation|subclinical inflammation
542779|NCT00863564|Obesity|obesity
542780|NCT00863564|Atherosclerosis|atherosclerosis
542781|NCT00863564|Triglyceride|triglyceride
542782|NCT00863564|Lipoproteins|lipoproteins
542783|NCT00863564|Postprandial inflammation|postprandial inflammation
542784|NCT00863538|Spinocerebellar degeneration|spinocerebellar degeneration
542785|NCT00863538|Thyrotropin-Releasing Hormone (TRH)|thyrotropin-releasing hormone (trh)
542786|NCT00863538|SCD|scd
542787|NCT00863512|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
542788|NCT00863512|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
542789|NCT00863512|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
542790|NCT00863512|adenocarcinoma of the lung|adenocarcinoma of the lung
542791|NCT00863512|adenosquamous cell lung cancer|adenosquamous cell lung cancer
542792|NCT00863512|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
542793|NCT00863512|large cell lung cancer|large cell lung cancer
542794|NCT00863512|squamous cell lung cancer|squamous cell lung cancer
542795|NCT00863499|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
542796|NCT00863499|Attention Deficit Disorder|attention deficit disorder
542797|NCT00863499|ADHD|adhd
542798|NCT00863499|ADD|add
542799|NCT00863499|iSPOT|ispot
542800|NCT00863473|Proximal Humerus Fracture in elderly|proximal humerus fracture in elderly
542801|NCT00863421|Sleep disordered breathing|sleep disordered breathing
542802|NCT00863421|Prevalence|prevalence
542803|NCT00863421|Chronic heart failure|chronic heart failure
542804|NCT00863421|Incidence|incidence
542805|NCT00863421|Sleep apnea|sleep apnea
542806|NCT00863421|Cheyne-Stokes-Breathing|cheyne-stokes-breathing
542807|NCT00863408|Mosquito|mosquito
542808|NCT00863408|Human Landing Collection|human landing collection
542809|NCT00863408|Malaria|malaria
542810|NCT00863395|pruritis|pruritis
542811|NCT00863395|itch|itch
542812|NCT00863395|CTCL|ctcl
542813|NCT00863382|atrial fibrillation|atrial fibrillation
542814|NCT00863369|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
542815|NCT00863369|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
542816|NCT00863369|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
542817|NCT00863369|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
542818|NCT00863369|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
542819|NCT00863369|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
542820|NCT00863369|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
542821|NCT00863369|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
542822|NCT00863369|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
542823|NCT00863369|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
542824|NCT00863356|Epistaxis|epistaxis
542825|NCT00863356|Chitosan|chitosan
542826|NCT00863356|Hemostatic|hemostatic
542827|NCT00863356|Nose bleed|nose bleed
542828|NCT00863356|Nasal bleeding|nasal bleeding
542829|NCT00863356|Nasal pack|nasal pack
542830|NCT00863356|Sealant|sealant
542831|NCT00863356|ChitoFlex®|chitoflex®
542832|NCT00863356|HemCon|hemcon
542833|NCT00863356|HemCon® ChitoFlex Surgical Dressing|hemcon® chitoflex surgical dressing
542834|NCT00863356|HemCon® Nasal Plugs|hemcon® nasal plugs
542835|NCT00863356|Biocompatible dressing|biocompatible dressing
542836|NCT00863343|Influenza infections|influenza infections
542837|NCT00863343|Orthomyxoviridae infections|orthomyxoviridae infections
542838|NCT00863330|stage IV melanoma|stage iv melanoma
542839|NCT00863330|recurrent melanoma|recurrent melanoma
542840|NCT00863317|Bronchiolitis|bronchiolitis
542841|NCT00863317|montelukast|montelukast
542842|NCT00863317|leukotriene inhibitor|leukotriene inhibitor
542843|NCT00863304|monoclonal antibody RN624 PF-04383119 nerve growth factor anti-nerve growth factor OA pain arthritis|monoclonal antibody rn624 pf-04383119 nerve growth factor anti-nerve growth factor oa pain arthritis
542844|NCT00863291|Depression|depression
542845|NCT00863291|suicidality|suicidality
542846|NCT00863291|buprenorphine|buprenorphine
542847|NCT00863265|Phytosterols|phytosterols
542848|NCT00863265|Ezetimibe|ezetimibe
542849|NCT00863265|Cholesterol Excretion|cholesterol excretion
542850|NCT00863265|Cholesterol Absorption|cholesterol absorption
542851|NCT00863265|Diet|diet
542852|NCT00863265|Mass Spectrometry|mass spectrometry
542853|NCT00863265|Deuterium|deuterium
542855|NCT00863252|creatinine|creatinine
542856|NCT00863252|kidney survival|kidney survival
542857|NCT00863252|ESRD|esrd
542858|NCT00863239|treatment naive|treatment naive
542859|NCT00863239|genotype 1|genotype 1
542860|NCT00863226|Quality of Life issues in Parkinson's disease|quality of life issues in parkinson's disease
542861|NCT00863213|Catheter Ablation, Radiofrequency|catheter ablation, radiofrequency
542862|NCT00863213|Atrial fibrillation|atrial fibrillation
542863|NCT00863213|Antiarrhythmic Drugs|antiarrhythmic drugs
542864|NCT00863200|Depression|depression
542865|NCT00863200|Cancer|cancer
542866|NCT00863200|African Americans|african americans
542867|NCT00863200|Latinos|latinos
542868|NCT00863200|Hispanics|hispanics
542869|NCT00863200|Interactive voice response|interactive voice response
542870|NCT00863200|IVR|ivr
542871|NCT00863200|Behavioral Intervention|behavioral intervention
542872|NCT00863174|Multiple myeloma|multiple myeloma
542873|NCT00863174|Bio-equivalence|bio-equivalence
542874|NCT00863161|Safety|safety
542875|NCT00863161|tolerability|tolerability
542876|NCT00863161|exposure|exposure
542877|NCT00863161|healthy|healthy
542878|NCT00863161|renally impaired subjects|renally impaired subjects
542879|NCT00863148|MDS|mds
542880|NCT00863148|AML|aml
542881|NCT00863148|ALL|all
542882|NCT00863148|RIC|ric
542883|NCT00863148|clofarabine|clofarabine
542884|NCT00863148|allo-HSCT|allo-hsct
542885|NCT00863148|high-risk MDS/AML|high-risk mds/aml
542886|NCT00863135|obstructive sleep apnea|obstructive sleep apnea
542887|NCT00863135|refractory arterial hypertension|refractory arterial hypertension
542888|NCT00863135|continuous positive airways pressure|continuous positive airways pressure
542889|NCT00863122|Lapatinib|lapatinib
542890|NCT00863122|Tykerb|tykerb
542891|NCT00863122|EGFR inhibitor|egfr inhibitor
542892|NCT00863122|ErbB2 inhibitor|erbb2 inhibitor
542893|NCT00863122|Pharmacokinetics|pharmacokinetics
542894|NCT00863096|HPV|hpv
542895|NCT00863096|acceptability|acceptability
542896|NCT00863083|pediatric obesity|pediatric obesity
542897|NCT00863083|pediatric overweight|pediatric overweight
542898|NCT00863083|multi-family group weight management intervention|multi-family group weight management intervention
542899|NCT00863083|financial rewards|financial rewards
542900|NCT00863070|Bladder exstrophy|bladder exstrophy
542901|NCT00863070|Abnormal gait|abnormal gait
542902|NCT00863070|anatomy|anatomy
542903|NCT00863070|urinary bladder disease|urinary bladder disease
542904|NCT00863070|urogenital abnormalities|urogenital abnormalities
542905|NCT00863057|HIV Infections|hiv infections
542906|NCT00863057|Neuropathy|neuropathy
542907|NCT00863057|Pain|pain
542908|NCT00863044|off pump coronary bypass|off pump coronary bypass
542909|NCT00863044|high frequency ventilation|high frequency ventilation
542910|NCT00863044|cerebral oxygen saturation|cerebral oxygen saturation
542911|NCT00863044|vasopressors used|vasopressors used
542912|NCT00863044|right and left ventricular function|right and left ventricular function
542913|NCT00863044|arterial blood pressure|arterial blood pressure
542914|NCT00863044|heart rate|heart rate
542915|NCT00863031|mental health|mental health
542916|NCT00863031|problem-solving therapy|problem-solving therapy
542917|NCT00863031|elderly|elderly
542918|NCT00863031|health-related quality of life|health-related quality of life
542919|NCT00863031|primary care|primary care
542920|NCT00863031|Chinese|chinese
542921|NCT00863018|Corneal endothelial cell|corneal endothelial cell
542922|NCT00863018|Specular microscopy|specular microscopy
542923|NCT00863018|Glaucoma implant surgery|glaucoma implant surgery
542924|NCT00863018|Ahmed glaucoma valve|ahmed glaucoma valve
542925|NCT00863018|Trabeculectomy|trabeculectomy
542926|NCT00862992|schizophrenia|schizophrenia
542927|NCT00862992|antipsychotics|antipsychotics
542928|NCT00862992|dopamine D3/D2 antagonist|dopamine d3/d2 antagonist
542929|NCT00862979|Heart Transplantation|heart transplantation
542930|NCT00862979|Cardiac Transplantation|cardiac transplantation
542931|NCT00862979|CNI-sparing|cni-sparing
542932|NCT00862979|renal function|renal function
542933|NCT00862979|CNI|cni
542934|NCT00862979|Cyclosporine A|cyclosporine a
542935|NCT00862979|Everolimus|everolimus
542936|NCT00862979|enteric coated mycophenolic acid|enteric coated mycophenolic acid
542937|NCT00862953|low carbohydrate|low carbohydrate
542938|NCT00862953|high protein diet|high protein diet
542939|NCT00862940|Memantine|memantine
542940|NCT00862940|Neuroimaging|neuroimaging
542941|NCT00862940|MRI|mri
542942|NCT00862940|Brain atrophy|brain atrophy
542943|NCT00862927|Smoking Cessation|smoking cessation
542944|NCT00862927|Cigarette Smoking|cigarette smoking
542945|NCT00862927|Tobacco Smoking|tobacco smoking
542946|NCT00862927|Cue Reactivity|cue reactivity
542947|NCT00862927|Virtual Reality|virtual reality
542948|NCT00862927|VR|vr
542949|NCT00862927|Contextual Cues|contextual cues
542950|NCT00862927|Explicit Smoking Cues|explicit smoking cues
542951|NCT00862927|Craving|craving
542952|NCT00862927|Physiological Arousal|physiological arousal
542953|NCT00862927|Nicotine Dependence|nicotine dependence
542954|NCT00862927|Breath Sample|breath sample
542955|NCT00862927|Saliva Test|saliva test
542956|NCT00862927|Questionnaire|questionnaire
542957|NCT00862914|Skin|skin
542958|NCT00862914|MicroRNA|microrna
542959|NCT00862914|miRNA|mirna
542960|NCT00862914|Dicer|dicer
542961|NCT00862914|Malignant Melanoma|malignant melanoma
542962|NCT00862901|cancer|cancer
542963|NCT00862901|skin metastases|skin metastases
542964|NCT00862901|chest wall progression of breast cancer|chest wall progression of breast cancer
542965|NCT00862901|malignant melanoma|malignant melanoma
542966|NCT00862901|photodynamic therapy|photodynamic therapy
542967|NCT00862901|photophrin|photophrin
542968|NCT00862901|satellite and in-transit metastases of malignant melanoma|satellite and in-transit metastases of malignant melanoma
542969|NCT00862901|skin cancer|skin cancer
542970|NCT00862875|Insulin initiation|insulin initiation
542971|NCT00862875|oral therapy failure|oral therapy failure
542972|NCT00862862|infection|infection
542973|NCT00862862|staphylococcus aureus|staphylococcus aureus
542974|NCT00862862|vancomycin|vancomycin
542975|NCT00862862|pharmacodynammics|pharmacodynammics
542976|NCT00862849|rHuPH20|rhuph20
542977|NCT00862849|Recombinant Human Hyaluronidase|recombinant human hyaluronidase
542978|NCT00862849|Insulin Lispro|insulin lispro
542979|NCT00862849|Regular Human Insulin|regular human insulin
542980|NCT00862836|ZD6474|zd6474
542981|NCT00862836|Vandetanib|vandetanib
542982|NCT00862836|Zactima|zactima
542983|NCT00862836|Ovarian Cancer|ovarian cancer
542984|NCT00862836|Phase I|phase i
542985|NCT00862836|Phase II|phase ii
542986|NCT00862836|Randomized|randomized
542987|NCT00862836|Safety|safety
542988|NCT00862823|Healthy Volunteers|healthy volunteers
542989|NCT00862810|Human papillomavirus|human papillomavirus
542990|NCT00862810|Cervical cancer|cervical cancer
542991|NCT00862810|Genital warts|genital warts
542992|NCT00862810|Vaccine|vaccine
542993|NCT00862810|Immunogenicity|immunogenicity
542994|NCT00862797|endotracheal tube|endotracheal tube
542995|NCT00862797|swallowing|swallowing
542996|NCT00862797|aspiration|aspiration
542997|NCT00862797|cuff pressure|cuff pressure
542998|NCT00862797|pneumonia|pneumonia
542999|NCT00862784|Colorectal carcinoma|colorectal carcinoma
543000|NCT00862784|CRC|crc
543001|NCT00862784|Colon Cancer|colon cancer
543002|NCT00862758|juvenile idiopathic arthritis|juvenile idiopathic arthritis
543003|NCT00862732|active suicidal ideation|active suicidal ideation
543004|NCT00862732|cognitive behavioural therapy|cognitive behavioural therapy
543005|NCT00862732|Sri Lanka|sri lanka
543006|NCT00862732|RCT|rct
543007|NCT00862706|Chronic HBV|chronic hbv
543008|NCT00862693|Immunoglobulin A|immunoglobulin a
543009|NCT00862693|Antibodies|antibodies
543010|NCT00862693|treatment|treatment
543011|NCT00862680|Lung Colorectum|lung colorectum
543012|NCT00862680|Colorectal cancer|colorectal cancer
543013|NCT00862680|Lung Cancer|lung cancer
543014|NCT00862680|Liver Cancer|liver cancer
543015|NCT00862680|Non-small cell lung cancer|non-small cell lung cancer
543016|NCT00862680|NSCLC|nsclc
543017|NCT00862680|4D PET/CT Imaging|4d pet/ct imaging
543018|NCT00862680|Positron emission tomography/computed tomography|positron emission tomography/computed tomography
543019|NCT00862680|PET/CT scan|pet/ct scan
543020|NCT00862680|Breathing motion|breathing motion
543021|NCT00862667|Pharmacokinetics|pharmacokinetics
543022|NCT00862641|regadenoson|regadenoson
543023|NCT00862641|CVT 3146|cvt 3146
543024|NCT00862641|asthma|asthma
543025|NCT00862641|coronary artery disease|coronary artery disease
543026|NCT00862641|pulmonary disease, chronic obstructive|pulmonary disease, chronic obstructive
543027|NCT00862615|Ageing|ageing
543028|NCT00862615|Inflammation|inflammation
543029|NCT00862615|Muscle protein synthesis|muscle protein synthesis
543030|NCT00862615|Osteopenia|osteopenia
543031|NCT00862615|Sarcopenia|sarcopenia
543032|NCT00862602|GDM|gdm
543033|NCT00862602|gestational diabetes|gestational diabetes
543034|NCT00862602|pregnancy|pregnancy
543035|NCT00862602|diabetes|diabetes
543036|NCT00862602|walking|walking
543037|NCT00862602|exercise|exercise
543038|NCT00862602|pedometer|pedometer
543039|NCT00862602|online|online
543040|NCT00862589|glucagon|glucagon
543041|NCT00862589|GLP-1|glp-1
543042|NCT00862589|hyperglycemia|hyperglycemia
543043|NCT00862576|Burning Mouth Syndrome|burning mouth syndrome
543044|NCT00862576|Sleep|sleep
543045|NCT00862576|Neuropathic pain|neuropathic pain
543046|NCT00862576|Glossodynia|glossodynia
543047|NCT00862576|Chronic pain|chronic pain
543048|NCT00862576|Orofacial pain|orofacial pain
543049|NCT00862563|Alcoholism|alcoholism
543050|NCT00862563|Alcohol Dependence|alcohol dependence
543051|NCT00862563|Alcohol Abuse|alcohol abuse
543052|NCT00862563|Substance Abuse|substance abuse
543053|NCT00862563|Alcoholic Intoxication|alcoholic intoxication
543054|NCT00862550|Head and Neck Cancer|head and neck cancer
543055|NCT00862550|HNC|hnc
543056|NCT00862550|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
543057|NCT00862550|Acupuncture|acupuncture
543058|NCT00862550|Radiation-Induced Xerostomia|radiation-induced xerostomia
543059|NCT00862550|Xerostomia|xerostomia
543060|NCT00862550|Dry Mouth|dry mouth
543061|NCT00862550|Radiation|radiation
543062|NCT00862511|metal ion concentration|metal ion concentration
543063|NCT00862511|total knee arthroplasty|total knee arthroplasty
543064|NCT00862511|metal hypersensitivity|metal hypersensitivity
543065|NCT00862498|PTSD|ptsd
543066|NCT00862498|Written Disclosure|written disclosure
543067|NCT00862498|Written Emotional Disclosure|written emotional disclosure
543068|NCT00862498|Narrative Exposure|narrative exposure
543069|NCT00862498|Narrative Writing|narrative writing
543070|NCT00862498|Motor Vehicle Accident|motor vehicle accident
543071|NCT00862472|open-angle glaucoma|open-angle glaucoma
543072|NCT00862472|ocular hypertension|ocular hypertension
543073|NCT00862472|open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component)|open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component)
543074|NCT00862459|Contrast Agents|contrast agents
543075|NCT00862446|Parenteral nutrition associate liver disease|parenteral nutrition associate liver disease
543076|NCT00862446|TPN cholestasis|tpn cholestasis
543077|NCT00862446|TPN Associated Liver Disease|tpn associated liver disease
543078|NCT00862433|Vitamin C|vitamin c
543079|NCT00862433|Antioxidant|antioxidant
543080|NCT00862433|Lipid Peroxidation|lipid peroxidation
543081|NCT00862433|Non-Insulin Requiring Diabetics|non-insulin requiring diabetics
543082|NCT00862433|Alpha-Tocopherol|alpha-tocopherol
543083|NCT00862433|Health Volunteer|health volunteer
543084|NCT00862433|HV|hv
543085|NCT00862433|Normal Weight|normal weight
543086|NCT00862433|Overweight|overweight
543087|NCT00862433|Type 2 Diabetes|type 2 diabetes
543088|NCT00862420|Platelet aggregation inhibitors|platelet aggregation inhibitors
543089|NCT00862420|Peripheral arterial disease (PAD)|peripheral arterial disease (pad)
543090|NCT00862407|Cardiopulmonary bypass|cardiopulmonary bypass
543091|NCT00862407|Non-pulsatile perfusion|non-pulsatile perfusion
543092|NCT00862407|Pulsatile perfusion|pulsatile perfusion
543093|NCT00862407|plasma proteins|plasma proteins
543094|NCT00862381|shock|shock
543095|NCT00862381|Tracheal Intubation|tracheal intubation
543096|NCT00862381|reanimation|reanimation
543097|NCT00862381|suprarenal insufficiency|suprarenal insufficiency
543098|NCT00862381|Etomidate|etomidate
543099|NCT00862381|Adrenocorticotropic Hormone|adrenocorticotropic hormone
543100|NCT00862381|hydrocortisone|hydrocortisone
543101|NCT00862368|Motivational Interviewing|motivational interviewing
543102|NCT00862368|Pediatric Asthma|pediatric asthma
543103|NCT00862368|Smoking Cessation|smoking cessation
543104|NCT00862368|Environmental Tobacco Smoke|environmental tobacco smoke
543105|NCT00862368|Second hand smoke|second hand smoke
543106|NCT00862368|Biomarker|biomarker
543107|NCT00862368|Asthma|asthma
543108|NCT00862368|Asthma Education|asthma education
543109|NCT00862368|Family Intervention|family intervention
543110|NCT00862368|Smoking|smoking
543111|NCT00862368|Nicotine Patch|nicotine patch
543112|NCT00862368|Parents|parents
543113|NCT00862368|Caregivers|caregivers
543114|NCT00862368|Child Wellness|child wellness
543115|NCT00862355|Carcinoma|carcinoma
543116|NCT00862355|Ovary|ovary
543117|NCT00862355|Carcinoma Ovary|carcinoma ovary
543118|NCT00862342|colorectal cancer|colorectal cancer
543119|NCT00862342|Bevacizumab|bevacizumab
543120|NCT00862329|Healthy subjects|healthy subjects
543121|NCT00862316|Eligible for Unicompartmental Knee Arthritis|eligible for unicompartmental knee arthritis
543122|NCT00862303|autologous cytokine induced killer cells|autologous cytokine induced killer cells
543123|NCT00862303|dendritic cell|dendritic cell
543124|NCT00862303|vaccine|vaccine
543125|NCT00862303|renal cell carcinoma|renal cell carcinoma
543126|NCT00862290|sepsis|sepsis
543127|NCT00862290|microRNA|microrna
543128|NCT00862277|Menactra®|menactra®
543129|NCT00862277|Menomune®|menomune®
543130|NCT00862277|Meningitis|meningitis
543131|NCT00862277|Meningococcal Infections|meningococcal infections
543132|NCT00862251|cardiovascular disorder|cardiovascular disorder
543133|NCT00862225|rhinomanometry|rhinomanometry
543134|NCT00862225|mode of action|mode of action
543135|NCT00862225|grass pollen|grass pollen
543136|NCT00862212|anxiety|anxiety
543137|NCT00862212|social anxiety|social anxiety
543138|NCT00862212|social anxiety disorder|social anxiety disorder
543139|NCT00862212|coping behaviors|coping behaviors
543140|NCT00862212|alcohol abuse|alcohol abuse
543141|NCT00862186|Neoplasms|neoplasms
543142|NCT00862186|Fatigue|fatigue
543143|NCT00862186|Self Care|self care
543144|NCT00862173|Gene-expression profile|gene-expression profile
543145|NCT00862173|Central nervous system metastasis|central nervous system metastasis
543146|NCT00862173|Non-small-cell lung cancer|non-small-cell lung cancer
543147|NCT00862160|coronary artery bypass surgery|coronary artery bypass surgery
543148|NCT00862160|cardiopulmonary bypass|cardiopulmonary bypass
543149|NCT00862160|heart lung machine|heart lung machine
543150|NCT00862160|acute cerebrovascular event|acute cerebrovascular event
543151|NCT00862160|intracranial embolism|intracranial embolism
543152|NCT00862160|embolism, air|embolism, air
543153|NCT00862160|outcome assessment (health care)|outcome assessment (health care)
543154|NCT00862160|neuropsychological tests|neuropsychological tests
543155|NCT00862160|magnetic resonance imaging|magnetic resonance imaging
543156|NCT00862160|saccadic eye movement test|saccadic eye movement test
543157|NCT00862147|Child psychosocial Functioning|child psychosocial functioning
543158|NCT00862108|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
543159|NCT00862108|Polymorphism, Single Nucleotide|polymorphism, single nucleotide
543160|NCT00862108|SLC6A2 protein, human|slc6a2 protein, human
543161|NCT00862108|ADRA2A protein, human|adra2a protein, human
543162|NCT00862056|asymptomatic|asymptomatic
543163|NCT00862056|coronary artery disease|coronary artery disease
543164|NCT00862043|Secondary Pulmonary Hypertension|secondary pulmonary hypertension
543165|NCT00862043|Valvular Heart Disease|valvular heart disease
543166|NCT00862043|Phosphodiesterase-Inhibitors|phosphodiesterase-inhibitors
543167|NCT00862043|Sildenafil|sildenafil
543168|NCT00862043|Outcomes Research|outcomes research
543169|NCT00862030|Palliative radiotherapy|palliative radiotherapy
543170|NCT00862030|Treatment planning|treatment planning
543171|NCT00862030|Non-small cell lung cancer|non-small cell lung cancer
543172|NCT00862017|Physiology|physiology
543173|NCT00862004|video-assisted thoracoscopic surgery (VATS)|video-assisted thoracoscopic surgery (vats)
543174|NCT00862004|systematic node dissection (SND)|systematic node dissection (snd)
543175|NCT00862004|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
543176|NCT00861991|medical communication|medical communication
543177|NCT00861991|empathy|empathy
543178|NCT00861991|medical education|medical education
543179|NCT00861991|standardized patients|standardized patients
543180|NCT00861991|"enhancing patient satisfaction"|"enhancing patient satisfaction"
543181|NCT00861978|mild to moderate depression with atypical features according to DSM-IV|mild to moderate depression with atypical features according to dsm-iv
543182|NCT00861965|Leukemia|leukemia
543183|NCT00861965|Lymphoma|lymphoma
543184|NCT00861965|Multiple Myeloma|multiple myeloma
543185|NCT00861952|Diabetic peripheral neuropathies|diabetic peripheral neuropathies
543186|NCT00861952|Neuralgia|neuralgia
543187|NCT00861952|Complementary medicine|complementary medicine
543188|NCT00861952|Analgesia|analgesia
543189|NCT00861926|Maintenance and Reliever Treatments|maintenance and reliever treatments
543190|NCT00861887|Clostridium difficile|clostridium difficile
543191|NCT00861887|colitis|colitis
543192|NCT00861887|recurrence|recurrence
543193|NCT00861887|relapse|relapse
543194|NCT00861887|Vancomycin|vancomycin
543195|NCT00861861|Pitavastatin|pitavastatin
543196|NCT00861861|Atorvastatin|atorvastatin
543197|NCT00861861|CAD|cad
543198|NCT00861861|HDL-C|hdl-c
543199|NCT00861861|Adiponectin|adiponectin
543200|NCT00861822|Anemia|anemia
543201|NCT00861822|Cardiac surgery|cardiac surgery
543202|NCT00861822|RBC transfusion|rbc transfusion
543203|NCT00861822|Acute Kidney Injury|acute kidney injury
543204|NCT00861822|Cardiac surgery with cardiopulmonary bypass|cardiac surgery with cardiopulmonary bypass
543205|NCT00861809|single dose|single dose
543206|NCT00861809|gut motility|gut motility
543207|NCT00861809|Type I Diabetes Mellitus patients|type i diabetes mellitus patients
543208|NCT00861809|tolerability|tolerability
543209|NCT00861809|phase II|phase ii
543210|NCT00861809|13C octanoic acid breath test|13c octanoic acid breath test
543211|NCT00861809|pharmacodynamics|pharmacodynamics
543212|NCT00861809|gastric emtpying|gastric emtpying
543213|NCT00861809|pharmacokinetics|pharmacokinetics
543214|NCT00861783|oxaliplatin|oxaliplatin
543215|NCT00861783|diaminocyclohexane oxalatoplatinum|diaminocyclohexane oxalatoplatinum
543216|NCT00861783|oxalatoplatin|oxalatoplatin
543217|NCT00861783|oxalatoplatinum|oxalatoplatinum
543218|NCT00861783|Eloxatin|eloxatin
543219|NCT00861770|Congestive Heart Failure|congestive heart failure
543220|NCT00861770|Ultrafiltration|ultrafiltration
543221|NCT00861770|Blood Volume Measurement|blood volume measurement
543222|NCT00861744|Measles, Mumps, Rubella, Varicella Vaccine|measles, mumps, rubella, varicella vaccine
543223|NCT00861744|Children|children
543224|NCT00861744|Immunogenicity|immunogenicity
543225|NCT00861744|Safety|safety
543226|NCT00861744|Humans|humans
543227|NCT00861744|Combined Vaccine|combined vaccine
543228|NCT00861744|Vaccines|vaccines
543229|NCT00861731|chronic renal failure|chronic renal failure
543230|NCT00861731|proteinuria|proteinuria
543231|NCT00861731|apolipoprotein|apolipoprotein
543232|NCT00861731|c reactive protein|c reactive protein
543233|NCT00861718|Phase 1|phase 1
543234|NCT00861718|Healthy Volunteer|healthy volunteer
543235|NCT00861692|Argatroban|argatroban
543236|NCT00861692|heparin induced thrombocytopenia (HIT)|heparin induced thrombocytopenia (hit)
543237|NCT00861692|direct thrombin inhibitor (DTI)|direct thrombin inhibitor (dti)
543238|NCT00861679|HSCT|hsct
543239|NCT00861679|ALL|all
543240|NCT00861679|GvHD|gvhd
543241|NCT00861666|Forgiveness|forgiveness
543242|NCT00861666|Writing|writing
543243|NCT00861666|PTSD|ptsd
543244|NCT00861666|OEF|oef
543245|NCT00861666|OIF|oif
543246|NCT00861666|Veterans|veterans
543247|NCT00861653|Atherosclerosis|atherosclerosis
543248|NCT00861653|Subjects diagnosed with atherosclerosis|subjects diagnosed with atherosclerosis
543249|NCT00861640|rabeprazole|rabeprazole
543250|NCT00861640|omeprazole|omeprazole
543251|NCT00861640|upper gastrointestinal bleeding|upper gastrointestinal bleeding
543252|NCT00861627|REOLYSIN|reolysin
543253|NCT00861627|reovirus|reovirus
543254|NCT00861627|non-small cell lung cancer|non-small cell lung cancer
543255|NCT00861627|carcinoma|carcinoma
543256|NCT00861627|oncolytics virus|oncolytics virus
543257|NCT00861627|chemotherapy|chemotherapy
543258|NCT00861627|paclitaxel|paclitaxel
543259|NCT00861627|carboplatin|carboplatin
543260|NCT00861588|complementary & alternative medicine|complementary & alternative medicine
543261|NCT00861588|randomized control trial|randomized control trial
543262|NCT00861588|uroflowmetry|uroflowmetry
543263|NCT00861588|quality of life|quality of life
543264|NCT00861588|benign prostate hyperplasia|benign prostate hyperplasia
543265|NCT00861575|Cardiovascular|cardiovascular
543266|NCT00861562|constipation|constipation
543267|NCT00861562|hemorrhoids|hemorrhoids
543268|NCT00861562|water smartweed|water smartweed
543269|NCT00861562|RCT|rct
543270|NCT00861549|Bioavailability|bioavailability
543271|NCT00861549|Pharmacokinetics|pharmacokinetics
543272|NCT00861549|Safety Evaluation|safety evaluation
543273|NCT00861536|risk factors|risk factors
543274|NCT00861536|immunology|immunology
543275|NCT00861523|nausea|nausea
543276|NCT00861523|vomiting|vomiting
543277|NCT00861523|pregnancy|pregnancy
543278|NCT00861523|thiamine|thiamine
543279|NCT00861523|promethazine|promethazine
543280|NCT00861523|nausea and vomiting in pregnancy|nausea and vomiting in pregnancy
543281|NCT00861510|Small Lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
543282|NCT00861510|Prolymphocytic Lymphoma (PLL)|prolymphocytic lymphoma (pll)
543283|NCT00861510|Hairy Cell Leukemia (HCL)|hairy cell leukemia (hcl)
543284|NCT00861510|Mantle Cell Lymphoma|mantle cell lymphoma
543285|NCT00861510|MCL|mcl
543286|NCT00861510|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
543287|NCT00861510|CLL|cll
543288|NCT00861510|Multiple Myeloma|multiple myeloma
543289|NCT00861510|MM|mm
543290|NCT00861497|Open-label|open-label
543291|NCT00861497|Flexible-dose|flexible-dose
543292|NCT00861497|Extension|extension
543293|NCT00861497|Safety study|safety study
543294|NCT00861471|hormone refractory prostate cancer|hormone refractory prostate cancer
543295|NCT00861471|tyrosine kinase inhibitor|tyrosine kinase inhibitor
543296|NCT00861471|Gleevec|gleevec
543297|NCT00861471|PSA|psa
543298|NCT00861471|prostate specific antigen|prostate specific antigen
543299|NCT00861471|growth factor receptor inhibitor|growth factor receptor inhibitor
543300|NCT00861471|androgen independent|androgen independent
543301|NCT00861445|Lacosamide, Vimpat®|lacosamide, vimpat®
543302|NCT00861432|Life quality|life quality
543303|NCT00861432|questionnaire|questionnaire
543304|NCT00861432|tumor patients|tumor patients
543305|NCT00861419|AMG 386|amg 386
543306|NCT00861419|AMG 706|amg 706
543307|NCT00861419|Bevacizumab|bevacizumab
543308|NCT00861419|Sorafenib|sorafenib
543309|NCT00861419|Angiogenesis Inhibitors|angiogenesis inhibitors
543310|NCT00861419|Combination Therapy|combination therapy
543311|NCT00861419|Peptibody|peptibody
543312|NCT00861419|Sunitinib|sunitinib
543313|NCT00861406|Melanoma|melanoma
543314|NCT00861406|Stage II melanoma|stage ii melanoma
543315|NCT00861406|Pegylated Interferon-alfa 2b|pegylated interferon-alfa 2b
543316|NCT00861406|PEG Interferon alfa-2b|peg interferon alfa-2b
543317|NCT00861406|PEG Intron|peg intron
543318|NCT00861406|Melanoma Peptide Vaccine|melanoma peptide vaccine
543319|NCT00861406|GP100 Vaccine|gp100 vaccine
543320|NCT00861406|gp100|gp100
543321|NCT00861406|peptide vaccine|peptide vaccine
543322|NCT00861406|Leukapheresis|leukapheresis
543323|NCT00861406|Immune-cell response|immune-cell response
543324|NCT00861380|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
543325|NCT00861380|Invasive disease|invasive disease
543326|NCT00861380|Respiratory tract infections|respiratory tract infections
543327|NCT00861380|Haemophilus influenzae|haemophilus influenzae
543328|NCT00861380|Streptococcus pneumoniae|streptococcus pneumoniae
543329|NCT00861380|Acute otitis media|acute otitis media
543330|NCT00861380|Pneumonia|pneumonia
543331|NCT00861367|aspirin|aspirin
543332|NCT00861367|blood loss|blood loss
543333|NCT00861367|transurethral surgery|transurethral surgery
543334|NCT00861354|atrial fibrillation|atrial fibrillation
543335|NCT00861354|home blood pressure monitoring|home blood pressure monitoring
543336|NCT00861341|Pioglitazone|pioglitazone
543337|NCT00861341|Thiazolidinediones|thiazolidinediones
543338|NCT00861341|Platelet Function|platelet function
543339|NCT00861341|Platelet aggregation|platelet aggregation
543340|NCT00861341|Diabetic|diabetic
543341|NCT00861341|Aspirin.|aspirin.
543342|NCT00861328|Phase 1|phase 1
543343|NCT00861328|maximum tolerated dose|maximum tolerated dose
543344|NCT00861328|oxaliplatin|oxaliplatin
543345|NCT00861328|irinotecan|irinotecan
543346|NCT00861328|ON 01910.Na|on 01910.na
543347|NCT00861315|Pneumonia|pneumonia
543348|NCT00861315|Nebulization|nebulization
543349|NCT00861315|Amikacin|amikacin
543350|NCT00861276|Smoking Cessation|smoking cessation
543351|NCT00861276|Nicotine|nicotine
543352|NCT00861276|Administration and dosage|administration and dosage
543353|NCT00861276|Randomized Controlled Trial|randomized controlled trial
543354|NCT00861250|Bortezomib plus dexamethasone induction therapy|bortezomib plus dexamethasone induction therapy
543355|NCT00861250|Autologous stem cell transplantation|autologous stem cell transplantation
543356|NCT00861250|Molecular remission|molecular remission
543357|NCT00861237|Nux vomica|nux vomica
543358|NCT00861237|homeopathy|homeopathy
543359|NCT00861237|heart lung machine|heart lung machine
543360|NCT00861237|heart surgery|heart surgery
543361|NCT00861237|postoperatively studied|postoperatively studied
543362|NCT00861211|asthma|asthma
543363|NCT00861211|inflammation|inflammation
543364|NCT00861211|bronchoconstriction|bronchoconstriction
543365|NCT00861211|allergen challenge|allergen challenge
543366|NCT00861211|KCa3.1|kca3.1
543367|NCT00861185|bronchospasm|bronchospasm
543368|NCT00861185|exercise asthma|exercise asthma
543369|NCT00861185|inflammation|inflammation
543370|NCT00861185|KCa3.1|kca3.1
543371|NCT00861172|Multiple sclerosis|multiple sclerosis
543372|NCT00861172|Active plaque|active plaque
543373|NCT00861172|Multimodal analysis|multimodal analysis
543374|NCT00861172|3T MRI|3t mri
543375|NCT00861172|Weekly follow-up|weekly follow-up
543376|NCT00861172|Physiopathology|physiopathology
543377|NCT00861172|Physiopathology of active lesions formation in Multiple Sclerosis using multimodal MR sequences|physiopathology of active lesions formation in multiple sclerosis using multimodal mr sequences
543378|NCT00861159|RLIP76 Auto Antibodies|rlip76 auto antibodies
543379|NCT00861146|nicotine dependence|nicotine dependence
543380|NCT00861146|tobacco dependence|tobacco dependence
543381|NCT00861146|smoking cessation|smoking cessation
543382|NCT00861146|alcoholism|alcoholism
543383|NCT00861146|self-efficacy|self-efficacy
543384|NCT00861146|relapse|relapse
543385|NCT00861133|cardiac monitor|cardiac monitor
543386|NCT00861133|loop recorder|loop recorder
543387|NCT00861133|stroke|stroke
543388|NCT00861133|ECG|ecg
543389|NCT00861133|Implantable Loop Recorder|implantable loop recorder
543390|NCT00861133|cryptogenic|cryptogenic
543391|NCT00861133|ILR|ilr
543392|NCT00861120|Ovarian cancer|ovarian cancer
543393|NCT00861120|KRAS wildtype|kras wildtype
543394|NCT00861120|Platinum resistant|platinum resistant
543395|NCT00861107|Colorectal cancer|colorectal cancer
543396|NCT00861107|Breast Cancer|breast cancer
543397|NCT00861107|Melanoma|melanoma
543398|NCT00861107|GI cancer|gi cancer
543399|NCT00861107|Prostate cancer|prostate cancer
543400|NCT00861107|Kidney cancer|kidney cancer
543401|NCT00861107|Lung cancer|lung cancer
543402|NCT00861107|all types metastatic cancer where at least one tumor lesion is accessable for percutaneous cryoablation|all types metastatic cancer where at least one tumor lesion is accessable for percutaneous cryoablation
543403|NCT00861094|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
543404|NCT00861094|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
543405|NCT00861094|stage IIA esophageal cancer|stage iia esophageal cancer
543406|NCT00861094|stage IIB esophageal cancer|stage iib esophageal cancer
543407|NCT00861094|stage IIIA esophageal cancer|stage iiia esophageal cancer
543408|NCT00861094|stage IIIB esophageal cancer|stage iiib esophageal cancer
543409|NCT00861094|stage IIIC esophageal cancer|stage iiic esophageal cancer
543410|NCT00861094|stage IV esophageal cancer|stage iv esophageal cancer
543411|NCT00861081|Group Clinics|group clinics
543412|NCT00861081|Self Management|self management
543413|NCT00861068|Lacosamide, Vimpat®|lacosamide, vimpat®
543414|NCT00861042|Lacosamide, Vimpat®|lacosamide, vimpat®
543415|NCT00861029|GW786034, pazopanib, moxifloxacin, ECG intervals and morphology, QTc, Holter monitor, pharmacokinetics, safety, cancer|gw786034, pazopanib, moxifloxacin, ecg intervals and morphology, qtc, holter monitor, pharmacokinetics, safety, cancer
543416|NCT00861016|Post marketing study|post marketing study
543417|NCT00861003|schizophrenia|schizophrenia
543418|NCT00861003|adherence|adherence
543420|NCT00860977|Herpes simplex virus type II|herpes simplex virus type ii
543421|NCT00860977|Genital herpes|genital herpes
543422|NCT00860977|Treatment Naive|treatment naive
543423|NCT00860964|estradiol valerate|estradiol valerate
543424|NCT00860964|Medroxyprogesterone|medroxyprogesterone
543425|NCT00860964|menopause|menopause
543426|NCT00860964|Lipid|lipid
543427|NCT00860964|Bone mineral density|bone mineral density
543428|NCT00860964|Body Composition|body composition
543429|NCT00860951|Normal|normal
543430|NCT00860938|Inhaled corticosteroids|inhaled corticosteroids
543431|NCT00860938|COPD|copd
543432|NCT00860938|mannitol|mannitol
543433|NCT00860925|Randomized Controlled Trial|randomized controlled trial
543434|NCT00860925|Blinded|blinded
543435|NCT00860925|Clonidine|clonidine
543436|NCT00860925|acetyl-salicylic acid (ASA)|acetyl-salicylic acid (asa)
543437|NCT00860925|Perioperative vascular complications|perioperative vascular complications
543438|NCT00860925|Noncardiac surgery|noncardiac surgery
543439|NCT00860912|Veritas|veritas
543440|NCT00860912|Cystocele|cystocele
543441|NCT00860912|Prolapse|prolapse
543442|NCT00860899|clonidine|clonidine
543443|NCT00860899|levobupivacaine|levobupivacaine
543444|NCT00860899|preoperative analgesia|preoperative analgesia
543445|NCT00860899|postoperative pain|postoperative pain
543446|NCT00860899|systemic inflammatory stress response|systemic inflammatory stress response
543447|NCT00860899|epidural analgesia|epidural analgesia
543448|NCT00860899|Anesthetics, Local|anesthetics, local
543449|NCT00860886|Mongolia|mongolia
543450|NCT00860886|Asia|asia
543451|NCT00860886|GROWTH FACTORS|growth factors
543452|NCT00860886|Hormones|hormones
543453|NCT00860886|Premenopausal|premenopausal
543454|NCT00860886|Breast Cancer|breast cancer
543455|NCT00860860|radioimmunotherapy|radioimmunotherapy
543456|NCT00860860|pretargeting|pretargeting
543457|NCT00860860|bispecific antibody|bispecific antibody
543458|NCT00860860|lutetium 177|lutetium 177
543459|NCT00860860|phase I clinical trial|phase i clinical trial
543460|NCT00860847|Progression of Atherosclerosis|progression of atherosclerosis
543461|NCT00860847|Aged garlic extract|aged garlic extract
543462|NCT00860847|Biomarkers of inflammation|biomarkers of inflammation
543463|NCT00860847|Coronary Plaque Volume and coronary Stenosis|coronary plaque volume and coronary stenosis
543464|NCT00860847|Vascular function|vascular function
543465|NCT00860834|Consumer Participation|consumer participation
543466|NCT00860834|Telephone Coaching Program|telephone coaching program
543467|NCT00860821|Healthy subjects|healthy subjects
543468|NCT00860821|LPS|lps
543469|NCT00860821|Effect|effect
543470|NCT00860821|Intranasally|intranasally
543471|NCT00860808|tinnitus|tinnitus
543472|NCT00860795|Echinacea|echinacea
543473|NCT00860795|prevention|prevention
543474|NCT00860795|immune modulation|immune modulation
543475|NCT00860782|Sickle Cell Disease|sickle cell disease
543476|NCT00860782|Educational Outcomes|educational outcomes
543477|NCT00860782|Neurodevelopmental Functioning|neurodevelopmental functioning
543478|NCT00860756|sleep|sleep
543479|NCT00860756|disturbance|disturbance
543480|NCT00860756|deployment|deployment
543481|NCT00860756|intervention|intervention
543482|NCT00860756|actigraph|actigraph
543483|NCT00860743|intermittent hypoxia|intermittent hypoxia
543484|NCT00860743|ventilatory long-term facilitation|ventilatory long-term facilitation
543485|NCT00860743|autonomic nervous system plasticity|autonomic nervous system plasticity
543486|NCT00860730|Aortic valve replacement|aortic valve replacement
543487|NCT00860730|Aortic stenosis|aortic stenosis
543488|NCT00860730|Biological valve|biological valve
543489|NCT00860730|Sutureless valve|sutureless valve
543490|NCT00860730|Stented valve|stented valve
543491|NCT00860730|Aortic Valve Disease|aortic valve disease
543492|NCT00860717|Leprosy|leprosy
543493|NCT00860717|Ulcers|ulcers
543494|NCT00860717|Laser|laser
543495|NCT00860704|goal directed fluid therapy|goal directed fluid therapy
543496|NCT00860704|lean patients|lean patients
543497|NCT00860704|obese patients|obese patients
543498|NCT00860704|crystalloids|crystalloids
543499|NCT00860704|Esophageal Doppler|esophageal doppler
543500|NCT00860704|tissue oxygenation|tissue oxygenation
543501|NCT00860704|Fluid management during surgery|fluid management during surgery
543502|NCT00860704|Fluid management|fluid management
543503|NCT00860691|Curative surgical resection|curative surgical resection
543504|NCT00860691|Laparoscopic technique|laparoscopic technique
543505|NCT00860665|colorectal cancer|colorectal cancer
543506|NCT00860665|prevention|prevention
543507|NCT00860665|colonoscopy|colonoscopy
543508|NCT00860665|screening|screening
543509|NCT00860665|quality assessment|quality assessment
543510|NCT00860665|colorectal cancer prevention|colorectal cancer prevention
543511|NCT00860652|Oncology|oncology
543512|NCT00860652|Prostate Cancer|prostate cancer
543513|NCT00860652|Radiotherapy|radiotherapy
543514|NCT00860652|Radical Prostatectomy|radical prostatectomy
543515|NCT00860652|Prior Radical Prostatectomy (RP)|prior radical prostatectomy (rp)
543516|NCT00860652|Histological Confirmation of adenocarcinoma of the prostate|histological confirmation of adenocarcinoma of the prostate
543517|NCT00860652|Positive margins and/or extraprostatic extension (EPE)|positive margins and/or extraprostatic extension (epe)
543518|NCT00860639|AML|aml
543519|NCT00860639|gemtuzumab ozogamycin|gemtuzumab ozogamycin
543520|NCT00860613|gestational diabetes|gestational diabetes
543521|NCT00860613|medical nutrition therapy program|medical nutrition therapy program
543522|NCT00860613|glucose monitoring|glucose monitoring
543523|NCT00860613|metabolic control|metabolic control
543524|NCT00860613|nutritional status|nutritional status
543525|NCT00860613|cost effectiveness|cost effectiveness
543526|NCT00860600|Idiopathic Thrombocytopenic Purpura (ITP)|idiopathic thrombocytopenic purpura (itp)
543527|NCT00860600|Platelet Response|platelet response
543528|NCT00860600|PG2 Treatment|pg2 treatment
543529|NCT00860600|Quality of Life|quality of life
543530|NCT00860600|Fatigue|fatigue
543531|NCT00860600|WHO Bleeding score|who bleeding score
543532|NCT00860587|Antibiotic resistance|antibiotic resistance
543533|NCT00860587|Antibiotic treatment|antibiotic treatment
543534|NCT00860561|Efficacy profile|efficacy profile
543535|NCT00860561|Safety profile|safety profile
543536|NCT00860561|Faslodex|faslodex
543537|NCT00860522|relapsed leukemia|relapsed leukemia
543538|NCT00860522|refractory leukemia|refractory leukemia
543539|NCT00860509|phytosterols|phytosterols
543540|NCT00860509|cholesterol excretion|cholesterol excretion
543541|NCT00860509|cholesterol absorption|cholesterol absorption
543543|NCT00860509|mass spectrometry|mass spectrometry
543544|NCT00860509|deuterium|deuterium
543545|NCT00860496|Immunosuppression, JAK3 inhibitor, calcineurin inhibitors, tacrolimus, cyclosporine, pharmacokinetics, safety, tolerability|immunosuppression, jak3 inhibitor, calcineurin inhibitors, tacrolimus, cyclosporine, pharmacokinetics, safety, tolerability
543546|NCT00860483|Comparison of experienced and novice laparoscopic surgeons|comparison of experienced and novice laparoscopic surgeons
543547|NCT00860470|micronutrients|micronutrients
543548|NCT00860470|deficiency|deficiency
543549|NCT00860470|pregnancy|pregnancy
543550|NCT00860470|birth outcomes|birth outcomes
543551|NCT00860470|infant mortality|infant mortality
543552|NCT00860470|neonatal mortality|neonatal mortality
543553|NCT00860470|malnutrition|malnutrition
543554|NCT00860470|antenatal|antenatal
543555|NCT00860457|Leukemia|leukemia
543556|NCT00860444|Primary Care|primary care
543557|NCT00860444|Diet|diet
543558|NCT00860444|Physical Activity|physical activity
543559|NCT00860418|asthma|asthma
543560|NCT00860418|feedback|feedback
543561|NCT00860418|anti-inflammatory|anti-inflammatory
543562|NCT00860418|ED visits|ed visits
543563|NCT00860366|Acute ischemic stroke|acute ischemic stroke
543564|NCT00860366|thrombolysis|thrombolysis
543565|NCT00860366|alteplase|alteplase
543566|NCT00860366|uric acid|uric acid
543567|NCT00860366|neuroprotection|neuroprotection
543568|NCT00860366|oxidative stress|oxidative stress
543569|NCT00860353|Healthy Volunteer|healthy volunteer
543570|NCT00860353|Single Ascending Dose|single ascending dose
543571|NCT00860353|Safety|safety
543572|NCT00860353|Tolerability|tolerability
543573|NCT00860353|AZD2551|azd2551
543574|NCT00860353|Healthy Volunteer Study|healthy volunteer study
543575|NCT00860340|Congestive Heart Failure|congestive heart failure
543576|NCT00860340|Hemodynamics|hemodynamics
543577|NCT00860340|Echocardiographs|echocardiographs
543578|NCT00860327|Pediatric Heart Disease|pediatric heart disease
543579|NCT00860327|Congenital Heart Disease|congenital heart disease
543580|NCT00860327|Congenital Heart Defects|congenital heart defects
543581|NCT00860327|Developmental Biology|developmental biology
543582|NCT00860327|Contractile Function|contractile function
543583|NCT00860314|external electrical cardioversion|external electrical cardioversion
543584|NCT00860314|typical atrial flutter|typical atrial flutter
543585|NCT00860314|electrode position|electrode position
543586|NCT00860314|antero-lateral|antero-lateral
543587|NCT00860314|antero-posterior|antero-posterior
543588|NCT00860314|biphasic cardioversion|biphasic cardioversion
543589|NCT00860314|step-up protocol|step-up protocol
543590|NCT00860301|infantile colic|infantile colic
543591|NCT00860288|Type 2 Diabetes|type 2 diabetes
543592|NCT00860288|vildagliptin|vildagliptin
543593|NCT00860249|education|education
543594|NCT00860249|preventive service|preventive service
543595|NCT00860249|screening|screening
543596|NCT00860249|Colorectal Cancer Screening|colorectal cancer screening
543597|NCT00860249|Prevention & Control|prevention & control
543598|NCT00860236|CFS|cfs
543599|NCT00860236|Giardia|giardia
543600|NCT00860236|Fatigue|fatigue
543601|NCT00860236|Cognitive behavioural therapy|cognitive behavioural therapy
543602|NCT00860236|CBT|cbt
543603|NCT00860236|Chronic fatigue syndrome|chronic fatigue syndrome
543604|NCT00860223|Healthy Subjects|healthy subjects
543605|NCT00860197|Coffee|coffee
543606|NCT00860197|Elderly|elderly
543607|NCT00860197|Immune response|immune response
543608|NCT00860197|Inflammatory status|inflammatory status
543609|NCT00860184|carotid artery|carotid artery
543610|NCT00860184|atherosclerosis|atherosclerosis
543611|NCT00860184|stroke|stroke
543612|NCT00860184|transient ischemic attack|transient ischemic attack
543613|NCT00860184|MRI|mri
543614|NCT00860184|software|software
543615|NCT00860184|risk|risk
543616|NCT00860145|epilepsy|epilepsy
543617|NCT00860145|radiosurgery|radiosurgery
543618|NCT00860145|temporal lobectomy|temporal lobectomy
543619|NCT00860132|hip fracture elderly orthogeriatric|hip fracture elderly orthogeriatric
543620|NCT00860132|cost effectiveness of hip fracture patients|cost effectiveness of hip fracture patients
543621|NCT00860119|Bioequivalence, Pharmacokinetics, Alprazolam, Sublingual|bioequivalence, pharmacokinetics, alprazolam, sublingual
543622|NCT00860106|VTE|vte
543623|NCT00860106|VKA treatment|vka treatment
543624|NCT00860106|VKA treatment cessation|vka treatment cessation
543625|NCT00860093|Kidney Calculi|kidney calculi
543626|NCT00860093|Urolithiasis|urolithiasis
543627|NCT00860093|Lithotripsy|lithotripsy
543628|NCT00860093|potassium compounds|potassium compounds
543629|NCT00860093|magnesium compounds|magnesium compounds
543630|NCT00860080|post-surgery adhesion formation|post-surgery adhesion formation
543631|NCT00860067|influenza, FluMist, adults, vaccine|influenza, flumist, adults, vaccine
543632|NCT00860054|phytosterols|phytosterols
543633|NCT00860054|cholesterol excretion|cholesterol excretion
543634|NCT00860054|cholesterol absorption|cholesterol absorption
543635|NCT00860054|diet|diet
543636|NCT00860054|mass spectrometry|mass spectrometry
543637|NCT00860054|deuterium|deuterium
543638|NCT00860041|pain|pain
543639|NCT00860041|neurotoxicity|neurotoxicity
543640|NCT00860041|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
543738|NCT00859586|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
543641|NCT00860041|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
543642|NCT00860028|Smoking cessation|smoking cessation
543643|NCT00860028|Smoking|smoking
543644|NCT00860028|Tobacco|tobacco
543645|NCT00860028|Varenicline|varenicline
543646|NCT00860028|Alcohol|alcohol
543647|NCT00860002|myomectomy|myomectomy
543648|NCT00860002|uterine artery occlusion|uterine artery occlusion
543649|NCT00860002|uterine vessel occlusion|uterine vessel occlusion
543650|NCT00860002|fibroids|fibroids
543651|NCT00860002|leiomyomas|leiomyomas
543652|NCT00860002|Surgical technique, patient suffering and outcomes|surgical technique, patient suffering and outcomes
543653|NCT00859989|breast cancer|breast cancer
543654|NCT00859989|weight changes|weight changes
543655|NCT00859989|obesity|obesity
543656|NCT00859976|BoneMaster|bonemaster
543657|NCT00859976|Total Hip Replacement|total hip replacement
543658|NCT00859976|Bone Density|bone density
543659|NCT00859976|Patients suitable for Total Hip Replacement|patients suitable for total hip replacement
543660|NCT00859963|Press fit tibial tray|press fit tibial tray
543661|NCT00859950|Sleep Apnea|sleep apnea
543662|NCT00859950|Vascular Occlusion|vascular occlusion
543663|NCT00859950|Nocturnal Polysomnography|nocturnal polysomnography
543664|NCT00859950|Continuous Positive Airway Pressure|continuous positive airway pressure
543665|NCT00859911|micronutrients|micronutrients
543666|NCT00859898|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
543667|NCT00859898|Diabetes Mellitus|diabetes mellitus
543668|NCT00859898|Endocrine System Diseases|endocrine system diseases
543669|NCT00859898|Glucose Metabolism Disorders|glucose metabolism disorders
543670|NCT00859898|Metabolic Diseases|metabolic diseases
543671|NCT00859898|Metformin|metformin
543672|NCT00859898|Dapagliflozin|dapagliflozin
543673|NCT00859898|Hypoglycemic Agents|hypoglycemic agents
543674|NCT00859898|Pharmacologic Actions|pharmacologic actions
543675|NCT00859898|Physiological Effects of Drugs|physiological effects of drugs
543676|NCT00859885|patent foramen ovale|patent foramen ovale
543677|NCT00859885|ischemic stroke|ischemic stroke
543678|NCT00859885|transient ischemic attack|transient ischemic attack
543679|NCT00859885|secondary prevention|secondary prevention
543680|NCT00859885|medical treatment|medical treatment
543681|NCT00859885|percutaneous device closure|percutaneous device closure
543682|NCT00859872|acute psychotic agitation|acute psychotic agitation
543683|NCT00859872|schizophrenia|schizophrenia
543684|NCT00859872|risperidone oral solution|risperidone oral solution
543685|NCT00859872|clonazepam|clonazepam
543686|NCT00859872|haloperidol|haloperidol
543687|NCT00859846|Arterial line|arterial line
543688|NCT00859846|Ultrasound|ultrasound
543689|NCT00859846|Anesthesia|anesthesia
543690|NCT00859846|Pediatric|pediatric
543691|NCT00859833|adenosine|adenosine
543692|NCT00859833|regadenoson|regadenoson
543693|NCT00859833|adenosine receptor subtypes|adenosine receptor subtypes
543694|NCT00859807|Amodiaquine suspension|amodiaquine suspension
543695|NCT00859807|Flavoquine tablets|flavoquine tablets
543696|NCT00859807|Bioequivalence study|bioequivalence study
543697|NCT00859794|Epilepsy|epilepsy
543698|NCT00859794|fMRI|fmri
543699|NCT00859794|Electrophysiology|electrophysiology
543700|NCT00859794|Cortical Mapping|cortical mapping
543701|NCT00859794|Neurosurgery|neurosurgery
543702|NCT00859781|Prostate|prostate
543703|NCT00859768|Cancer|cancer
543704|NCT00859729|DNA|dna
543705|NCT00859729|Vaccine|vaccine
543706|NCT00859729|Electroporation|electroporation
543707|NCT00859729|xenogenic|xenogenic
543708|NCT00859729|PSA|psa
543709|NCT00859716|Vaccination|vaccination
543710|NCT00859716|Diarrhea|diarrhea
543711|NCT00859716|Traveler's Diarrhea|traveler's diarrhea
543712|NCT00859716|Campylobacter jejuni|campylobacter jejuni
543713|NCT00859716|C. jejuni|c. jejuni
543714|NCT00859716|Campylobacter|campylobacter
543715|NCT00859716|Campy|campy
543716|NCT00859703|Aromatase inhibitor treatment|aromatase inhibitor treatment
543717|NCT00859703|osteoporosis|osteoporosis
543718|NCT00859703|breast cancer|breast cancer
543719|NCT00859703|bisphosphonates|bisphosphonates
543720|NCT00859690|Obstructive Sleep Apnea|obstructive sleep apnea
543721|NCT00859690|Thrombosis|thrombosis
543722|NCT00859690|Adenosine Deaminase|adenosine deaminase
543723|NCT00859690|Sleep Disorder|sleep disorder
543724|NCT00859677|HIV|hiv
543725|NCT00859677|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
543726|NCT00859677|HIV and Staphylococcus aureus infection|hiv and staphylococcus aureus infection
543727|NCT00859651|breast cancer chemoprevention|breast cancer chemoprevention
543728|NCT00859651|vitamin D|vitamin d
543729|NCT00859651|breast density|breast density
543730|NCT00859625|colonoscopy|colonoscopy
543731|NCT00859625|adenoma detection rate|adenoma detection rate
543732|NCT00859599|Monochromatic Phototherapy|monochromatic phototherapy
543733|NCT00859599|Diabetic Foot Ulcers|diabetic foot ulcers
543734|NCT00859599|Wound healing|wound healing
543735|NCT00859599|Bacterial colonisation|bacterial colonisation
543736|NCT00859586|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
543737|NCT00859586|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
543837|NCT00858949|Costs|costs
543739|NCT00859586|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
543740|NCT00859586|Acute Myelogenous Leukemia|acute myelogenous leukemia
543741|NCT00859586|AML|aml
543742|NCT00859586|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
543743|NCT00859586|ALL|all
543744|NCT00859586|Myelodysplastic Syndrome|myelodysplastic syndrome
543745|NCT00859586|MDS|mds
543746|NCT00859560|Breast cancer|breast cancer
543747|NCT00859560|post-menopausal women|post-menopausal women
543748|NCT00859560|Arimidex|arimidex
543749|NCT00859560|bone fracture|bone fracture
543750|NCT00859534|Solar Urticaria|solar urticaria
543751|NCT00859521|Bioequivalence|bioequivalence
543752|NCT00859521|Healthy Subjects|healthy subjects
543753|NCT00859508|dura repair following cranial surgery|dura repair following cranial surgery
543754|NCT00859482|natalizumab|natalizumab
543755|NCT00859482|multiple sclerosis|multiple sclerosis
543756|NCT00859469|Mesothelioma|mesothelioma
543757|NCT00859430|Bioequivalence|bioequivalence
543758|NCT00859430|Healthy Subjects|healthy subjects
543759|NCT00859417|correction of anterior prolapse|correction of anterior prolapse
543760|NCT00859417|prosthetic trans-obturator way kit|prosthetic trans-obturator way kit
543761|NCT00859417|randomized study|randomized study
543762|NCT00859404|Mild to moderate persistent asthma|mild to moderate persistent asthma
543763|NCT00859391|Celiac Disease|celiac disease
543764|NCT00859378|Hip|hip
543765|NCT00859378|Hip endoprosthesis|hip endoprosthesis
543766|NCT00859378|Hip fracture|hip fracture
543767|NCT00859378|Femoral fracture|femoral fracture
543768|NCT00859378|Bone cement|bone cement
543769|NCT00859378|Non-cemented|non-cemented
543770|NCT00859365|back pain|back pain
543771|NCT00859365|neck pain|neck pain
543772|NCT00859365|anxiety|anxiety
543773|NCT00859365|range of motion|range of motion
543774|NCT00859339|TCC|tcc
543775|NCT00859300|myocardial infarction|myocardial infarction
543776|NCT00859300|ventricular fibrillation|ventricular fibrillation
543777|NCT00859300|sudden death|sudden death
543778|NCT00859300|polymorphism|polymorphism
543779|NCT00859287|Reflux esophagitis|reflux esophagitis
543780|NCT00859287|Omepral®|omepral®
543781|NCT00859287|QOLRAD|qolrad
543782|NCT00859235|Percutaneous endoscopic gastrostomy|percutaneous endoscopic gastrostomy
543783|NCT00859235|peristomal wound infection|peristomal wound infection
543784|NCT00859235|antibiotic mouth wash solution|antibiotic mouth wash solution
543785|NCT00859235|prophylaxis prior Percutaneous endoscopic gastrostomy (PEG)|prophylaxis prior percutaneous endoscopic gastrostomy (peg)
543786|NCT00859222|LBH589|lbh589
543787|NCT00859222|bevacizumab|bevacizumab
543788|NCT00859222|Avastin|avastin
543789|NCT00859222|Panobinostat|panobinostat
543790|NCT00859209|HVF|hvf
543791|NCT00859209|Premature infants|premature infants
543792|NCT00859209|ETCO2|etco2
543793|NCT00859196|Wound healing|wound healing
543794|NCT00859196|Cell proliferation|cell proliferation
543795|NCT00859196|Gene expression|gene expression
543796|NCT00859183|in-stent restenosis|in-stent restenosis
543797|NCT00859183|stents|stents
543798|NCT00859183|sirolimus|sirolimus
543799|NCT00859170|kidney stones|kidney stones
543800|NCT00859170|ureter|ureter
543801|NCT00859170|laser lithotripsy|laser lithotripsy
543802|NCT00859157|perioperative/postoperative complications|perioperative/postoperative complications
543803|NCT00859157|pain|pain
543804|NCT00859157|ductal breast carcinoma in situ|ductal breast carcinoma in situ
543805|NCT00859157|invasive ductal breast carcinoma|invasive ductal breast carcinoma
543806|NCT00859157|invasive lobular breast carcinoma|invasive lobular breast carcinoma
543807|NCT00859157|stage IA breast cancer|stage ia breast cancer
543808|NCT00859157|stage IB breast cancer|stage ib breast cancer
543809|NCT00859157|stage II breast cancer|stage ii breast cancer
543810|NCT00859157|stage IIIA breast cancer|stage iiia breast cancer
543811|NCT00859157|stage IIIB breast cancer|stage iiib breast cancer
543812|NCT00859144|HIV Prevention|hiv prevention
543813|NCT00859144|Youth|youth
543814|NCT00859144|Adolescent|adolescent
543815|NCT00859144|Community Collaboration|community collaboration
543816|NCT00859144|Community Mentorship|community mentorship
543817|NCT00859144|Minority|minority
543818|NCT00859144|Urban|urban
543819|NCT00859144|Sexual Risk Behaviors|sexual risk behaviors
543820|NCT00859144|HIV seronegativity|hiv seronegativity
543821|NCT00859079|diabetes mellitus type 2, GLP-1, insulin infusion|diabetes mellitus type 2, glp-1, insulin infusion
543822|NCT00859040|recurrent intracranial meningioma(s)|recurrent intracranial meningioma(s)
543823|NCT00859040|progressive intracranial meningioma(s)|progressive intracranial meningioma(s)
543824|NCT00859027|Non-metastatic|non-metastatic
543825|NCT00858975|renal tumor|renal tumor
543826|NCT00858975|cryotherapy|cryotherapy
543827|NCT00858975|cytokine|cytokine
543828|NCT00858962|HIV|hiv
543829|NCT00858962|Pharmacokinetics|pharmacokinetics
543830|NCT00858962|Pharmacodynamics|pharmacodynamics
543831|NCT00858962|Buprenorphine|buprenorphine
543832|NCT00858962|Raltegravir|raltegravir
543833|NCT00858962|HIV seronegativity|hiv seronegativity
543834|NCT00858962|Interaction|interaction
543835|NCT00858949|Outpatient surgery|outpatient surgery
543836|NCT00858949|Postoperative nausea and vomiting|postoperative nausea and vomiting
543838|NCT00858949|Observational|observational
543839|NCT00858936|CABG(coronary artery bypass graft)|cabg(coronary artery bypass graft)
543840|NCT00858936|Ischemia|ischemia
543841|NCT00858936|Heart surgery|heart surgery
543842|NCT00858936|Heart damage|heart damage
543843|NCT00858923|Extracorporeal Photophoresis|extracorporeal photophoresis
543844|NCT00858923|immuno-therapy|immuno-therapy
543845|NCT00858923|treatment naive|treatment naive
543846|NCT00858910|Motor imagery|motor imagery
543847|NCT00858910|Motor skill|motor skill
543848|NCT00858910|Performance improvement|performance improvement
543849|NCT00858897|Glutathione|glutathione
543850|NCT00858884|Systemic lupus erythematosus|systemic lupus erythematosus
543851|NCT00858884|Libman-Sacks endocarditis|libman-sacks endocarditis
543852|NCT00858884|Stroke|stroke
543853|NCT00858884|Transient ischemic attack|transient ischemic attack
543854|NCT00858884|Neuropsychiatric systemic lupus erythematosus|neuropsychiatric systemic lupus erythematosus
543855|NCT00858884|Transesophageal echocardiography|transesophageal echocardiography
543856|NCT00858884|Magnetic resonance imaging|magnetic resonance imaging
543857|NCT00858845|Leg Weakness|leg weakness
543858|NCT00858845|Skeletal Myopathy|skeletal myopathy
543859|NCT00858845|Sympathetic Nerve Activity|sympathetic nerve activity
543860|NCT00858819|Osteoporosis|osteoporosis
543861|NCT00858819|Fractures|fractures
543862|NCT00858819|Bone Mineral Density|bone mineral density
543863|NCT00858819|Quantitative Computed Tomography|quantitative computed tomography
543864|NCT00858793|AIDS|aids
543865|NCT00858793|HIV|hiv
543866|NCT00858793|Lymphoma|lymphoma
543867|NCT00858793|Stem Cell Transplantation|stem cell transplantation
543868|NCT00858793|gene-modified Stem Cells|gene-modified stem cells
543869|NCT00858793|treatment experienced|treatment experienced
543870|NCT00858767|vitamin K2|vitamin k2
543871|NCT00858767|absorption|absorption
543872|NCT00858767|efficacy|efficacy
543873|NCT00858754|opioid induced constipation|opioid induced constipation
543874|NCT00858754|Cancer patients|cancer patients
543875|NCT00858754|methylnaltrexone|methylnaltrexone
543876|NCT00858741|bone metastases from any histological subtype.|bone metastases from any histological subtype.
543877|NCT00858728|Natural killer cell cytotoxicity|natural killer cell cytotoxicity
543878|NCT00858728|Antibody response|antibody response
543879|NCT00858728|Tetanus toxoid vaccination|tetanus toxoid vaccination
543880|NCT00858728|Pneumovax II vaccination|pneumovax ii vaccination
543881|NCT00858728|Total serum immunoglobulins|total serum immunoglobulins
543882|NCT00858728|IgG subclasses|igg subclasses
543883|NCT00858715|Clopidogrel|clopidogrel
543884|NCT00858715|Aspirin|aspirin
543885|NCT00858715|Antithrombotic therapy|antithrombotic therapy
543886|NCT00858715|Platelet function testing|platelet function testing
543887|NCT00858702|Essential hypertension|essential hypertension
543888|NCT00858702|Combination therapy|combination therapy
543889|NCT00858689|Clinical Drug Trial|clinical drug trial
543890|NCT00858676|acarbose|acarbose
543891|NCT00858676|diabetes mellitus|diabetes mellitus
543892|NCT00858676|impaired glucose tolerance|impaired glucose tolerance
543893|NCT00858676|coronary artery disease|coronary artery disease
543894|NCT00858663|RAD001(Everolimus)|rad001(everolimus)
543895|NCT00858663|Cisplatin|cisplatin
543896|NCT00858663|08-138|08-138
543897|NCT00858650|registry|registry
543898|NCT00858650|natural history|natural history
543899|NCT00858637|Chronic Kidney Disease|chronic kidney disease
543900|NCT00858637|Dialysis|dialysis
543901|NCT00858637|Dyslipidemia|dyslipidemia
543902|NCT00858637|Bile acid sequestrant|bile acid sequestrant
543903|NCT00858624|Cough|cough
543904|NCT00858624|Cough reflex|cough reflex
543905|NCT00858624|NMDA receptor|nmda receptor
543906|NCT00858624|central sensitisation|central sensitisation
543907|NCT00858611|Influenza|influenza
543908|NCT00858611|Healthy|healthy
543909|NCT00858611|Immunity|immunity
543910|NCT00858611|Preventive|preventive
543911|NCT00858611|Flu|flu
543912|NCT00858611|Healthy Volunteer|healthy volunteer
543914|NCT00858598|Total Knee Arthroplasty|total knee arthroplasty
543915|NCT00858598|Revision|revision
543916|NCT00858598|Tibial|tibial
543917|NCT00858598|Void|void
543918|NCT00858598|Bone Filler|bone filler
543919|NCT00858585|Bone metastasis, SNP concordance|bone metastasis, snp concordance
543920|NCT00858572|Synta|synta
543921|NCT00858572|STA-9090|sta-9090
543922|NCT00858572|AML|aml
543923|NCT00858572|CML|cml
543924|NCT00858572|MDS|mds
543925|NCT00858572|myeloproliferative disorder|myeloproliferative disorder
543926|NCT00858572|hematologic malignancy|hematologic malignancy
543927|NCT00858572|ganetespib|ganetespib
543928|NCT00858559|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
543929|NCT00858559|Remote monitoring|remote monitoring
543930|NCT00858559|Follow-up|follow-up
543931|NCT00858533|early intervention|early intervention
543932|NCT00858533|sickness absence|sickness absence
543933|NCT00858533|return to work|return to work
543934|NCT00858533|primary care|primary care
543935|NCT00858520|COPD|copd
543936|NCT00858520|Lung cancer|lung cancer
543937|NCT00858520|genes|genes
543938|NCT00858520|DNA|dna
543939|NCT00858494|upper respiratory tract infection|upper respiratory tract infection
543940|NCT00858494|children|children
543941|NCT00858494|homeopathic|homeopathic
543942|NCT00858481|Pediculosis capitis|pediculosis capitis
543943|NCT00858481|Head Lice|head lice
543944|NCT00858468|Influenza|influenza
543945|NCT00858468|Influenza vaccine|influenza vaccine
543946|NCT00858455|Healthy Volunteers|healthy volunteers
543947|NCT00858455|Drug interation, Pharmacokinetics|drug interation, pharmacokinetics
543948|NCT00858442|Burn sequelae|burn sequelae
543949|NCT00858442|PRP|prp
543950|NCT00858442|Children|children
543951|NCT00858429|advanced adult primary liver cancer|advanced adult primary liver cancer
543952|NCT00858429|liver metastases|liver metastases
543953|NCT00858429|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
543954|NCT00858403|Advanced Non-small Cell Lung Cancer|advanced non-small cell lung cancer
543955|NCT00858377|Amgen|amgen
543956|NCT00858377|Phase 1|phase 1
543957|NCT00858377|First in Human|first in human
543958|NCT00858377|Advanced Solid Tumors|advanced solid tumors
543959|NCT00858377|Clinical Trial|clinical trial
543960|NCT00858377|Aurora kinase inhibitor|aurora kinase inhibitor
543961|NCT00858377|Open-label|open-label
543962|NCT00858377|Oncology|oncology
543963|NCT00858364|darbepoetin alfa|darbepoetin alfa
543964|NCT00858364|non-small cell lung cancer|non-small cell lung cancer
543965|NCT00858364|Aranesp|aranesp
543966|NCT00858364|chemotherapy|chemotherapy
543967|NCT00858364|chemotherapy induce anemia|chemotherapy induce anemia
543968|NCT00858364|advanced lung cancer|advanced lung cancer
543969|NCT00858364|malignant pleural effusion|malignant pleural effusion
543970|NCT00858364|metastatic lung cancer|metastatic lung cancer
543971|NCT00858364|NSCLC|nsclc
543972|NCT00858364|anemia|anemia
543973|NCT00858364|lung cancer|lung cancer
543974|NCT00858364|pleural effusion|pleural effusion
543975|NCT00858364|Stage IIIB lung cancer|stage iiib lung cancer
543976|NCT00858364|Stage IV lung cancer|stage iv lung cancer
543977|NCT00858351|Diabetes|diabetes
543978|NCT00858351|Neuropathy|neuropathy
543979|NCT00858351|Peripheral|peripheral
543980|NCT00858351|Painful|painful
543981|NCT00858351|Thermal|thermal
543982|NCT00858351|Temperature|temperature
543983|NCT00858351|Biofeedback|biofeedback
543984|NCT00858351|Relaxation|relaxation
543985|NCT00858351|Diabetic|diabetic
543986|NCT00858338|stomach cancer|stomach cancer
543987|NCT00858338|gastroesophageal junction cancer|gastroesophageal junction cancer
543988|NCT00858338|GEJ cancer|gej cancer
543989|NCT00858338|intraperitoneal|intraperitoneal
543990|NCT00858338|adjuvant chemoradiation therapy|adjuvant chemoradiation therapy
543991|NCT00858338|resection of advanced stomach cancer|resection of advanced stomach cancer
543992|NCT00858338|locally advanced stomach cancer|locally advanced stomach cancer
543993|NCT00858325|Cubicin|cubicin
543994|NCT00858325|PK|pk
543995|NCT00858325|China Registration|china registration
543996|NCT00858325|Pharmacokinetics|pharmacokinetics
543997|NCT00858312|dairy foods|dairy foods
543998|NCT00858312|weight loss|weight loss
543999|NCT00858312|fat loss|fat loss
544000|NCT00858312|metabolic regulation|metabolic regulation
544001|NCT00858299|proteinuria|proteinuria
544002|NCT00858299|chronic kidney disease|chronic kidney disease
544003|NCT00858299|renin-angiotensin system|renin-angiotensin system
544004|NCT00858299|angiotensinogen|angiotensinogen
544005|NCT00858273|Glutathione|glutathione
544006|NCT00858260|Klotho|klotho
544007|NCT00858260|calcium|calcium
544008|NCT00858260|phosphate|phosphate
544009|NCT00858260|parathormone|parathormone
544010|NCT00858260|survival|survival
544011|NCT00858260|dialysis|dialysis
544012|NCT00858260|Adult patients undergoing maintenance dialysis since at leat three months|adult patients undergoing maintenance dialysis since at leat three months
544013|NCT00858247|vitamin D|vitamin d
544014|NCT00858247|Obesity|obesity
544015|NCT00858247|Insulin sensitivity|insulin sensitivity
544016|NCT00858247|Adolescent Obesity|adolescent obesity
544017|NCT00858221|obesity|obesity
544018|NCT00858221|genes|genes
544019|NCT00858221|polymorphisms|polymorphisms
544020|NCT00858221|weight loss|weight loss
544021|NCT00858221|haplotype|haplotype
544022|NCT00858221|diplotype|diplotype
544023|NCT00858208|efficacy and safety of Macugen in routine clinical practice|efficacy and safety of macugen in routine clinical practice
544024|NCT00858195|Anti-inflammatory|anti-inflammatory
544025|NCT00858182|L-Carnitine|l-carnitine
544026|NCT00858182|Xylitol|xylitol
544027|NCT00858182|Peritoneal Dialysis|peritoneal dialysis
544028|NCT00858169|three-dimensional power Doppler ultrasonography|three-dimensional power doppler ultrasonography
544029|NCT00858169|wrist|wrist
544030|NCT00858169|knee|knee
544031|NCT00858169|rheumatoid arthritis|rheumatoid arthritis
544032|NCT00858156|Pharmacokinetics|pharmacokinetics
544033|NCT00858143|Open-label, national, prospective, observational, non-interventional, multi-center, post marketing surveillance study|open-label, national, prospective, observational, non-interventional, multi-center, post marketing surveillance study
544034|NCT00858130|Veinoplus|veinoplus
544035|NCT00858130|post thrombotic syndrome|post thrombotic syndrome
544036|NCT00858130|deep vein thrombosis|deep vein thrombosis
544037|NCT00858130|electrical muscle stimulator|electrical muscle stimulator
544038|NCT00858130|Venous stasis syndrome|venous stasis syndrome
544039|NCT00858130|venous insufficiency syndrome|venous insufficiency syndrome
544040|NCT00858130|Postphlebitic syndrome|postphlebitic syndrome
544041|NCT00858130|history of deep vein thrombosis|history of deep vein thrombosis
544042|NCT00858117|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
544043|NCT00858117|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
544044|NCT00858117|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
544045|NCT00858117|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
544046|NCT00858117|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
544047|NCT00858078|Qualitative Research|qualitative research
544048|NCT00858078|Semi-Structured Telephone Interview|semi-structured telephone interview
544049|NCT00858078|BRCA 1/2|brca 1/2
544050|NCT00858078|Psychosocial/Behavioral Research|psychosocial/behavioral research
544051|NCT00858078|Hereditary Cancer Risk|hereditary cancer risk
544052|NCT00858078|BRCA|brca
544053|NCT00858078|BRCA1 Gene|brca1 gene
544054|NCT00858078|BRCA2 Gene|brca2 gene
544055|NCT00858065|Adolescent alcohol and other drug use|adolescent alcohol and other drug use
544056|NCT00858065|Choice|choice
544057|NCT00858065|Family-based|family-based
544058|NCT00858065|Prevention|prevention
544059|NCT00858052|breast implants|breast implants
544060|NCT00858052|saline|saline
544061|NCT00858026|weaning|weaning
544062|NCT00858026|breastfeeding|breastfeeding
544063|NCT00858026|infant formula|infant formula
544064|NCT00858026|fermented formula|fermented formula
544065|NCT00858013|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
544066|NCT00858013|Nateglinide|nateglinide
544067|NCT00858013|Pancreatic beta cell function|pancreatic beta cell function
544068|NCT00858000|markers|markers
544069|NCT00858000|expression analysis|expression analysis
544070|NCT00857987|IRA, Guaifenesin, Etaphedrine, Doxilamine|ira, guaifenesin, etaphedrine, doxilamine
544071|NCT00857974|Physical Activity|physical activity
544072|NCT00857974|Renal Transplant Candidate|renal transplant candidate
544073|NCT00857974|Physical Function|physical function
544074|NCT00857974|Body Composition|body composition
544075|NCT00857948|head lice|head lice
544076|NCT00857948|Pediculus humanus capitis|pediculus humanus capitis
544077|NCT00857948|ivermectin|ivermectin
544078|NCT00857935|Pediculosis Capitis|pediculosis capitis
544079|NCT00857935|Head Lice|head lice
544080|NCT00857922|Neurological|neurological
544081|NCT00857922|Neurosurgical|neurosurgical
544082|NCT00857896|Study of fesoterodine in pediatric overactive bladder patients|study of fesoterodine in pediatric overactive bladder patients
544083|NCT00857883|Obesity|obesity
544084|NCT00857883|Food Effect|food effect
544085|NCT00857883|Pharmacokinetics|pharmacokinetics
544086|NCT00857883|First-Time-In-Humans|first-time-in-humans
544087|NCT00857883|Pharmacodynamics|pharmacodynamics
544088|NCT00857883|Healthy Volunteers|healthy volunteers
544089|NCT00857857|asthma|asthma
544090|NCT00857857|late phase response|late phase response
544091|NCT00857857|allergen|allergen
544092|NCT00857857|challenge|challenge
544093|NCT00857857|GW870086X|gw870086x
544094|NCT00857844|Chronic Nephrotoxicity|chronic nephrotoxicity
544095|NCT00857844|Kidney dysfunction post liver transplant|kidney dysfunction post liver transplant
544096|NCT00857844|Urinary biomarkers of chronic nephrotoxicity from CI|urinary biomarkers of chronic nephrotoxicity from ci
544097|NCT00857831|spinal cord injury|spinal cord injury
544098|NCT00857831|Vitamin D deficiency|vitamin d deficiency
544099|NCT00857831|Functional Electrical Stimulation|functional electrical stimulation
544100|NCT00857805|Transarterial chemoembolization|transarterial chemoembolization
544101|NCT00857805|Carcinoma, Hepatocellular|carcinoma, hepatocellular
544102|NCT00857805|Proton Beam Radiotherapy|proton beam radiotherapy
544103|NCT00857792|Coronary Disease|coronary disease
544104|NCT00857792|Cardiac CT Imaging|cardiac ct imaging
544105|NCT00857792|Stress Testing|stress testing
544106|NCT00857792|Lexiscan (regadenoson)|lexiscan (regadenoson)
544107|NCT00857779|allergen immunotherapy|allergen immunotherapy
544108|NCT00857779|allergy to grass pollen|allergy to grass pollen
544109|NCT00857766|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
544110|NCT00857766|arterial stiffness|arterial stiffness
544111|NCT00857766|Computed Tomography|computed tomography
544112|NCT00857766|pulse wave velocity|pulse wave velocity
544113|NCT00857766|Pulse wave analysis|pulse wave analysis
544114|NCT00857727|Dexmedetomidine|dexmedetomidine
544115|NCT00857727|Emergence Delirium|emergence delirium
544116|NCT00857727|Agitation|agitation
544117|NCT00857727|Pediatric|pediatric
544118|NCT00857727|Anesthesia|anesthesia
544119|NCT00857714|DCIS|dcis
544120|NCT00857714|breast|breast
544121|NCT00857701|total knee arthroplasty|total knee arthroplasty
544122|NCT00857701|Dynamic Splinting|dynamic splinting
544123|NCT00857701|Knee extension|knee extension
544124|NCT00857701|knee|knee
544125|NCT00857701|Reduced knee flexion after total knee arthroscopy|reduced knee flexion after total knee arthroscopy
544126|NCT00857688|aphtous|aphtous
544127|NCT00857688|bismuth|bismuth
544128|NCT00857688|procain|procain
544129|NCT00857688|neomycin|neomycin
544130|NCT00857688|Efficacy of the Association in Treatment of Aphtous|efficacy of the association in treatment of aphtous
544131|NCT00857675|HBV DNA suppression|hbv dna suppression
544132|NCT00857675|ALT normalisation|alt normalisation
544133|NCT00857675|Viral resistance|viral resistance
544134|NCT00857675|HBeAg seroconversion|hbeag seroconversion
544135|NCT00857662|US Multicenter|us multicenter
544136|NCT00857662|Randomized|randomized
544137|NCT00857662|Onyx|onyx
544138|NCT00857662|Brain Arteriovenous Malformation (BAVMs)|brain arteriovenous malformation (bavms)
544139|NCT00857649|Alzheimer's Disease|alzheimer's disease
544140|NCT00857636|Ethnic minority women|ethnic minority women
544141|NCT00857636|Cancer screening|cancer screening
544142|NCT00857636|Health literacy|health literacy
544143|NCT00857636|Behavioral intervention|behavioral intervention
544144|NCT00857636|Breast Cancer screening|breast cancer screening
544145|NCT00857636|Cervical Cancer screening|cervical cancer screening
544146|NCT00857623|Pain|pain
544147|NCT00857623|Diabetic Neuropathy|diabetic neuropathy
544148|NCT00857623|PDN|pdn
544149|NCT00857623|Analgesia|analgesia
544150|NCT00857623|Efficacy|efficacy
544151|NCT00857610|Aged skin|aged skin
544152|NCT00857610|Photoaged skin|photoaged skin
544153|NCT00857610|Retinol|retinol
544154|NCT00857610|Topical retinoids|topical retinoids
544155|NCT00857597|GERD|gerd
544156|NCT00857597|endoscopic|endoscopic
544157|NCT00857597|fundoplication|fundoplication
544158|NCT00857597|Proton Pump Inhibitors|proton pump inhibitors
544159|NCT00857597|heartburn|heartburn
544160|NCT00857597|anti-reflux surgery|anti-reflux surgery
544161|NCT00857584|Bipolar disorder|bipolar disorder
544162|NCT00857584|Bipolar depression|bipolar depression
544163|NCT00857584|quetiapine|quetiapine
544164|NCT00857584|sertraline|sertraline
544165|NCT00857571|Dose Response Bioavailability Study|dose response bioavailability study
544166|NCT00857532|amyloid burden|amyloid burden
544167|NCT00857532|Parkinson's disease|parkinson's disease
544168|NCT00857532|florbetapir PET|florbetapir pet
544169|NCT00857532|amyloid PET imaging|amyloid pet imaging
544170|NCT00857519|retinoblastoma|retinoblastoma
544171|NCT00857519|Intraarterial|intraarterial
544172|NCT00857519|Chemotherapy|chemotherapy
544173|NCT00857519|Melphalan|melphalan
544174|NCT00857519|Carboplatin|carboplatin
544175|NCT00857506|Cognitive outcome|cognitive outcome
544176|NCT00857506|18F-AV-45 PET scan|18f-av-45 pet scan
544177|NCT00857506|Amyloid PET scan|amyloid pet scan
544178|NCT00857506|Florbetapir F 18 amyloid PET scan|florbetapir f 18 amyloid pet scan
544179|NCT00857506|Normal cognition|normal cognition
544180|NCT00857506|Change in cognitive status in relation to brain amyloid on PET|change in cognitive status in relation to brain amyloid on pet
544181|NCT00857415|florbetapir F 18 PET|florbetapir f 18 pet
544182|NCT00857415|amyloid imaging|amyloid imaging
544183|NCT00857415|Amyloid pathology in the brain|amyloid pathology in the brain
544184|NCT00857402|Arginine|arginine
544185|NCT00857402|Nitric oxide|nitric oxide
544186|NCT00857402|Peanuts|peanuts
544187|NCT00857402|Sedimentation rate|sedimentation rate
544188|NCT00857389|Cancer|cancer
544189|NCT00857389|Blood And Marrow Transplantation|blood and marrow transplantation
544190|NCT00857389|Stem Cell|stem cell
544191|NCT00857389|Leukemia|leukemia
544192|NCT00857389|Lymphoma|lymphoma
544193|NCT00857389|Pediatrics|pediatrics
544194|NCT00857389|Bone marrow|bone marrow
544195|NCT00857389|Lymph node system|lymph node system
544196|NCT00857389|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
544197|NCT00857389|ASCT|asct
544198|NCT00857389|Busulfan|busulfan
544199|NCT00857389|Busulfex|busulfex
544200|NCT00857389|Myleran|myleran
544201|NCT00857389|Clofarabine|clofarabine
544202|NCT00857389|Clofarex|clofarex
544203|NCT00857389|Clolar|clolar
544204|NCT00857389|Thiotepa|thiotepa
544205|NCT00857389|Antithymocyte globulin|antithymocyte globulin
544206|NCT00857389|ATG|atg
544207|NCT00857389|Thymoglobulin|thymoglobulin
544208|NCT00857389|G-CSF|g-csf
544209|NCT00857389|Filgrastim|filgrastim
544210|NCT00857389|Neupogen|neupogen
544211|NCT00857389|Cyclophosphamide|cyclophosphamide
544212|NCT00857389|Cytoxan|cytoxan
544213|NCT00857389|Neosar|neosar
544214|NCT00857389|Mesna|mesna
544215|NCT00857389|Mesnex|mesnex
544216|NCT00857389|Tacrolimus|tacrolimus
544217|NCT00857389|Prograf|prograf
544218|NCT00857389|Methotrexate|methotrexate
544219|NCT00857376|Heart disease risk factors|heart disease risk factors
544220|NCT00857376|Risk factor management|risk factor management
544221|NCT00857376|Pre-Diabetes|pre-diabetes
544222|NCT00857376|Hypertension|hypertension
544223|NCT00857376|obesity|obesity
544224|NCT00857376|glucose intolerance|glucose intolerance
544225|NCT00857376|high cholesterol|high cholesterol
544226|NCT00857376|abdominal obesity|abdominal obesity
544227|NCT00857376|enlarged waist|enlarged waist
544228|NCT00857363|capsule|capsule
544229|NCT00857363|constipation|constipation
544230|NCT00857363|whole gut transit|whole gut transit
544231|NCT00857363|colonic transit|colonic transit
544232|NCT00857363|gastric emptying|gastric emptying
544331|NCT00856973|Insomnia|insomnia
544233|NCT00857363|small bowel transit|small bowel transit
544234|NCT00857350|HIV|hiv
544235|NCT00857350|resistance|resistance
544236|NCT00857350|opioid dependence|opioid dependence
544237|NCT00857324|Refractory or relapsed patients|refractory or relapsed patients
544238|NCT00857324|dose-finding|dose-finding
544239|NCT00857324|Vorinostat|vorinostat
544240|NCT00857298|HIV|hiv
544241|NCT00857298|Metabolic Syndrome|metabolic syndrome
544242|NCT00857298|Obesity|obesity
544243|NCT00857298|Treatment Experienced|treatment experienced
544244|NCT00857272|colonoscopy|colonoscopy
544245|NCT00857272|bowel preparation|bowel preparation
544246|NCT00857259|AMD|amd
544247|NCT00857259|macular degeneration|macular degeneration
544248|NCT00857259|Everolimus|everolimus
544249|NCT00857259|Lucentis|lucentis
544250|NCT00857259|Ranibizumab|ranibizumab
544251|NCT00857259|Choroidal Neo-Vascular (CNV) age-onset macular degeneration|choroidal neo-vascular (cnv) age-onset macular degeneration
544252|NCT00857259|Age-related Macular Degeneration (AMD)|age-related macular degeneration (amd)
544253|NCT00857246|stomach cancer|stomach cancer
544254|NCT00857246|biologics|biologics
544255|NCT00857246|antibody|antibody
544256|NCT00857246|chemotherapy|chemotherapy
544257|NCT00857246|chemoradiation|chemoradiation
544258|NCT00857246|adjuvant therapy|adjuvant therapy
544259|NCT00857246|neoadjuvant therapy|neoadjuvant therapy
544260|NCT00857246|epidermal growth factor receptor|epidermal growth factor receptor
544261|NCT00857246|combination therapy|combination therapy
544262|NCT00857233|Alzheimer's Disease|alzheimer's disease
544263|NCT00857220|Hypnotic|hypnotic
544264|NCT00857220|Eszopiclone|eszopiclone
544265|NCT00857220|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
544266|NCT00857220|Insomnia|insomnia
544267|NCT00857220|Children|children
544268|NCT00857220|Adolescent|adolescent
544269|NCT00857207|Cognitive Therapy|cognitive therapy
544270|NCT00857207|Outcomes Assessment|outcomes assessment
544271|NCT00857194|Coronary Heart Disease|coronary heart disease
544272|NCT00857194|spinal cord injury|spinal cord injury
544273|NCT00857194|risk factor|risk factor
544274|NCT00857194|postprandial lipemia|postprandial lipemia
544275|NCT00857181|Liver Cirrhosis|liver cirrhosis
544276|NCT00857181|Infection|infection
544277|NCT00857181|Inflammation|inflammation
544278|NCT00857181|Cytokines|cytokines
544279|NCT00857155|Coronary Artery Disease|coronary artery disease
544280|NCT00857155|CABG|cabg
544281|NCT00857155|Clopidogrel|clopidogrel
544282|NCT00857155|Aspirin|aspirin
544283|NCT00857155|Point of Care devices|point of care devices
544284|NCT00857129|"normal birth"|"normal birth"
544285|NCT00857129|"birth outcome"|"birth outcome"
544286|NCT00857129|"low risk birth"|"low risk birth"
544287|NCT00857129|"low risk units"|"low risk units"
544288|NCT00857129|If type of birth care unit have effect on birth outcome|if type of birth care unit have effect on birth outcome
544289|NCT00857129|Apgar score|apgar score
544290|NCT00857129|breast feeding frequency|breast feeding frequency
544291|NCT00857129|patient satisfaction|patient satisfaction
544292|NCT00857116|Deworming|deworming
544293|NCT00857116|Tuberculosis|tuberculosis
544294|NCT00857116|TB-score|tb-score
544295|NCT00857116|Albendazole|albendazole
544296|NCT00857116|Helminths|helminths
544297|NCT00857103|computer support|computer support
544298|NCT00857103|patient-provider communication|patient-provider communication
544299|NCT00857103|patient-centered care|patient-centered care
544300|NCT00857103|cancer|cancer
544301|NCT00857090|Urinary Calculi|urinary calculi
544302|NCT00857090|Urinary Stones|urinary stones
544303|NCT00857090|Urinary Tract Stones|urinary tract stones
544304|NCT00857090|Renal Calculi|renal calculi
544305|NCT00857090|Kidney Stones|kidney stones
544306|NCT00857090|Calculi|calculi
544307|NCT00857090|Urolithotomy|urolithotomy
544308|NCT00857090|Ureteroscopy|ureteroscopy
544309|NCT00857077|incidence of anaemia|incidence of anaemia
544310|NCT00857064|Schizophrenia|schizophrenia
544311|NCT00857064|antipsychotics|antipsychotics
544312|NCT00857064|social functioning|social functioning
544313|NCT00857064|subjective well being|subjective well being
544314|NCT00857064|Patients suffering from Schizophrenia|patients suffering from schizophrenia
544315|NCT00857051|Stress|stress
544316|NCT00857038|COPD|copd
544317|NCT00857038|Inflammation|inflammation
544318|NCT00857038|Neutrophilic|neutrophilic
544319|NCT00857038|Myeloperoxidase|myeloperoxidase
544320|NCT00857038|Doxycycline|doxycycline
544321|NCT00857025|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
544322|NCT00857025|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
544323|NCT00857025|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
544324|NCT00857025|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
544325|NCT00857012|Primary early MCa|primary early mca
544326|NCT00857012|Arimidex|arimidex
544327|NCT00856999|Glabellar lines of moderate severity at maximum frown|glabellar lines of moderate severity at maximum frown
544328|NCT00856973|Hypnotic|hypnotic
544329|NCT00856973|Eszopiclone|eszopiclone
544330|NCT00856973|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
544332|NCT00856973|Children|children
544333|NCT00856973|Adolescent|adolescent
544334|NCT00856973|Polysomnography|polysomnography
544335|NCT00856973|Actigraphy|actigraphy
544336|NCT00856947|wheeze|wheeze
544337|NCT00856947|infections|infections
544338|NCT00856947|allergy|allergy
544339|NCT00856947|eczema|eczema
544340|NCT00856947|vitamin D|vitamin d
544341|NCT00856934|Skin graft donor site healing|skin graft donor site healing
544342|NCT00856934|skin|skin
544343|NCT00856934|wound|wound
544344|NCT00856934|platelet concentrate|platelet concentrate
544345|NCT00856934|keratinocytes|keratinocytes
544346|NCT00856934|burns|burns
544347|NCT00856921|Relationship between achalasia and AAAS gene|relationship between achalasia and aaas gene
544348|NCT00856908|Type II Diabetes|type ii diabetes
544349|NCT00856895|Improved Life Quality|improved life quality
544350|NCT00856856|Bioabsorbable|bioabsorbable
544351|NCT00856856|Coronary Stent|coronary stent
544352|NCT00856856|Everolimus|everolimus
544353|NCT00856856|drug eluting stents|drug eluting stents
544354|NCT00856856|stents|stents
544355|NCT00856856|angioplasty|angioplasty
544356|NCT00856856|coronary artery disease|coronary artery disease
544357|NCT00856856|total coronary occlusion|total coronary occlusion
544358|NCT00856856|coronary artery restenosis|coronary artery restenosis
544359|NCT00856856|stent thrombosis|stent thrombosis
544360|NCT00856856|vascular disease|vascular disease
544361|NCT00856856|myocardial ischemia|myocardial ischemia
544362|NCT00856856|coronary artery stenosis|coronary artery stenosis
544363|NCT00856856|CAD|cad
544364|NCT00856856|CAOD|caod
544365|NCT00856843|colonoscopy|colonoscopy
544366|NCT00856843|bowel preparation|bowel preparation
544367|NCT00856830|Small cell lung cancer|small cell lung cancer
544368|NCT00856830|Chemonaive|chemonaive
544369|NCT00856830|Bendamustine|bendamustine
544370|NCT00856830|Irinotecan|irinotecan
544371|NCT00856830|Etoposide|etoposide
544372|NCT00856830|Carboplatin|carboplatin
544373|NCT00856804|Thalidomide|thalidomide
544374|NCT00856804|Hepatitis C|hepatitis c
544375|NCT00856804|Interferon resistance|interferon resistance
544376|NCT00856804|Immunomodulators|immunomodulators
544377|NCT00856791|Ovarian|ovarian
544378|NCT00856791|Cancer|cancer
544379|NCT00856791|Cisplatin|cisplatin
544380|NCT00856791|Carboplatin|carboplatin
544381|NCT00856778|Male sling|male sling
544382|NCT00856778|stress urinary incontinence|stress urinary incontinence
544383|NCT00856778|urinary incontinence|urinary incontinence
544384|NCT00856739|obesity|obesity
544385|NCT00856739|arthritis|arthritis
544386|NCT00856700|GLP-1|glp-1
544387|NCT00856700|Endothelial Function|endothelial function
544388|NCT00856700|Metabolic Syndrome|metabolic syndrome
544389|NCT00856687|Asthma Allergen Challenge|asthma allergen challenge
544390|NCT00856674|IgA nephropathy|iga nephropathy
544391|NCT00856674|chemokine fusion protein|chemokine fusion protein
544392|NCT00856674|leukocyte population modulator|leukocyte population modulator
544393|NCT00856674|phase-1|phase-1
544394|NCT00856661|Acute ischemic stroke|acute ischemic stroke
544395|NCT00856661|Angiography|angiography
544396|NCT00856661|Desmoteplase|desmoteplase
544397|NCT00856661|Thrombolytic|thrombolytic
544398|NCT00856622|open-angle glaucoma ocular hypertension glaucoma|open-angle glaucoma ocular hypertension glaucoma
544399|NCT00856609|Weight Loss|weight loss
544400|NCT00856609|Byetta (Exenatide)|byetta (exenatide)
544401|NCT00856609|Energy Expenditure|energy expenditure
544402|NCT00856609|Food Intake|food intake
544403|NCT00856609|Obesity|obesity
544404|NCT00856596|Tinea pedis|tinea pedis
544405|NCT00856596|Fungus|fungus
544406|NCT00856596|Pruritus|pruritus
544407|NCT00856596|Dermatophyte|dermatophyte
544408|NCT00856596|Athlete's foot|athlete's foot
544409|NCT00856596|Dermatomycosis|dermatomycosis
544410|NCT00856596|Skin manifestation|skin manifestation
544411|NCT00856596|Infectious skin disease|infectious skin disease
544412|NCT00856596|Foot diseases|foot diseases
544413|NCT00856570|YM178|ym178
544414|NCT00856570|Mirabegron|mirabegron
544415|NCT00856570|DDI|ddi
544416|NCT00856570|Phase I|phase i
544417|NCT00856570|Warfarin|warfarin
544418|NCT00856570|Pharmacokinetics|pharmacokinetics
544419|NCT00856557|Patients with complex psychosocial needs|patients with complex psychosocial needs
544420|NCT00856544|Arthritis|arthritis
544421|NCT00856544|Rheumatoid|rheumatoid
544422|NCT00856544|Antirheumatic Agents|antirheumatic agents
544423|NCT00856544|Clinical Trial|clinical trial
544424|NCT00856531|Möbius syndrome|möbius syndrome
544425|NCT00856531|Language|language
544426|NCT00856531|Speech, Language and Hearing Sciences|speech, language and hearing sciences
544427|NCT00856518|Multiple Sclerosis|multiple sclerosis
544428|NCT00856518|Parkinson's disease|parkinson's disease
544429|NCT00856518|Dysphagia|dysphagia
544430|NCT00856505|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
544431|NCT00856505|Drug Therapy, Combination|drug therapy, combination
544432|NCT00856505|Immunosuppression|immunosuppression
544433|NCT00856492|inflammatory breast cancer|inflammatory breast cancer
544434|NCT00856492|stage II breast cancer|stage ii breast cancer
544435|NCT00856492|stage IIIA breast cancer|stage iiia breast cancer
544436|NCT00856492|stage IIIB breast cancer|stage iiib breast cancer
544437|NCT00856492|HER2-negative breast cancer|her2-negative breast cancer
544438|NCT00856492|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
544439|NCT00856492|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
544440|NCT00856492|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
544441|NCT00856492|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
544442|NCT00856492|stage IIIC breast cancer|stage iiic breast cancer
544443|NCT00856479|Infuse|infuse
544444|NCT00856479|cost analysis|cost analysis
544445|NCT00856479|Non union diaphyseal fracture|non union diaphyseal fracture
544446|NCT00856479|The efficacy of Infuse BMP 2 in Non union diaphyseal fractures. Also the cost analysis with the amount of time spent in hospital post op.|the efficacy of infuse bmp 2 in non union diaphyseal fractures. also the cost analysis with the amount of time spent in hospital post op.
544447|NCT00856453|fatigue|fatigue
544448|NCT00856453|depression|depression
544449|NCT00856453|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
544450|NCT00856453|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
544451|NCT00856453|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
544452|NCT00856453|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
544453|NCT00856453|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
544454|NCT00856453|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
544455|NCT00856453|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
544456|NCT00856453|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
544457|NCT00856453|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
544458|NCT00856453|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
544459|NCT00856440|SCI|sci
544460|NCT00856427|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
544461|NCT00856427|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
544462|NCT00856427|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
544463|NCT00856427|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
544464|NCT00856427|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
544465|NCT00856427|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
544466|NCT00856401|hypoparathyroidism|hypoparathyroidism
544467|NCT00856401|hypopara|hypopara
544468|NCT00856401|PTH|pth
544469|NCT00856401|parathyroid hormone|parathyroid hormone
544470|NCT00856401|CL-11-040|cl-11-040
544471|NCT00856401|CL1-11 Study|cl1-11 study
544472|NCT00856401|NPSP 558|npsp 558
544473|NCT00856401|RELAY|relay
544474|NCT00856401|RACE|race
544475|NCT00856401|REPLACE|replace
544476|NCT00856401|HEXT|hext
544477|NCT00856401|c10-007|c10-007
544478|NCT00856401|c10-008|c10-008
544479|NCT00856401|NPSP558|npsp558
544480|NCT00856401|Columbia study|columbia study
544481|NCT00856401|Columbia studies|columbia studies
544482|NCT00856401|HPTH|hpth
544483|NCT00856401|PTH1-84|pth1-84
544484|NCT00856375|colorectal cancer|colorectal cancer
544485|NCT00856375|Colorectal cancer, second line|colorectal cancer, second line
544486|NCT00856362|Healthy Subjects|healthy subjects
544487|NCT00856349|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
544488|NCT00856349|Cardiac Resynchronization Therapy-Defibrillator (CRT-D)|cardiac resynchronization therapy-defibrillator (crt-d)
544489|NCT00856349|Lead Integrity Alert (LIA)|lead integrity alert (lia)
544490|NCT00856349|Therapy Programming Report (TPR)|therapy programming report (tpr)
544491|NCT00856323|Methamphetamine|methamphetamine
544492|NCT00856323|HIV|hiv
544493|NCT00856323|Post-exposure prophylaxis|post-exposure prophylaxis
544494|NCT00856323|HIV seronegativity|hiv seronegativity
544495|NCT00856310|Healthy volunteers|healthy volunteers
544496|NCT00856297|Meningococcal|meningococcal
544497|NCT00856297|ACWY|acwy
544498|NCT00856297|Conjugate Vaccine|conjugate vaccine
544499|NCT00856297|Meningitis|meningitis
544500|NCT00856297|Adolescents|adolescents
544501|NCT00856297|Persistence|persistence
544502|NCT00856284|Diabetes Mellitus|diabetes mellitus
544503|NCT00856284|Drug Therapy|drug therapy
544504|NCT00856284|Hyperinsulinism|hyperinsulinism
544505|NCT00856284|Hyperglycemia|hyperglycemia
544506|NCT00856284|Glucose Intolerance|glucose intolerance
544507|NCT00856258|Multiple dose in healthy volunteers|multiple dose in healthy volunteers
544508|NCT00856245|non-Hodgkins|non-hodgkins
544509|NCT00856245|lymphoma|lymphoma
544510|NCT00856245|stem cell transplant|stem cell transplant
544511|NCT00856232|Headache|headache
544512|NCT00856232|Cephalgia|cephalgia
544513|NCT00856232|Migraine|migraine
544514|NCT00856219|Immune System|immune system
544515|NCT00856206|Metabolism, Inborn Errors|metabolism, inborn errors
544516|NCT00856206|Allopurinol|allopurinol
544517|NCT00856206|Metabolic Disease|metabolic disease
544518|NCT00856206|Genetic Diseases, Inborn|genetic diseases, inborn
544519|NCT00856206|Musculoskeletal Diseases|musculoskeletal diseases
544520|NCT00856206|Joint Diseases|joint diseases
544521|NCT00856206|Arthritis|arthritis
544522|NCT00856206|Rheumatic Diseases|rheumatic diseases
544716|NCT00855335|ritonavir|ritonavir
544523|NCT00856206|Metabolic disorder|metabolic disorder
544524|NCT00856206|Purine Pyrimidine Metabolism, Inborn Errors|purine pyrimidine metabolism, inborn errors
544525|NCT00856206|Gout|gout
544526|NCT00856206|Intercritical Gout|intercritical gout
544527|NCT00856193|COPD|copd
544528|NCT00856193|Bronchodilator|bronchodilator
544529|NCT00856180|avastin|avastin
544530|NCT00856180|bevacizumab|bevacizumab
544531|NCT00856180|cyclophosphamide|cyclophosphamide
544532|NCT00856180|cytoxan|cytoxan
544533|NCT00856180|mullerian malignancies|mullerian malignancies
544534|NCT00856167|temporomandibular dysfunction|temporomandibular dysfunction
544535|NCT00856167|TMD|tmd
544536|NCT00856167|TMJ|tmj
544537|NCT00856167|Traditional Chinese Medicine|traditional chinese medicine
544538|NCT00856167|TCM|tcm
544539|NCT00856154|HIV-1|hiv-1
544540|NCT00856154|HLA-A2|hla-a2
544541|NCT00856154|Therapeutic|therapeutic
544542|NCT00856154|Vaccine|vaccine
544543|NCT00856154|treatment vaccine|treatment vaccine
544544|NCT00856154|treatment naive|treatment naive
544545|NCT00856141|IOP measurement|iop measurement
544546|NCT00856141|IOP fluctuation|iop fluctuation
544547|NCT00856141|in-vivo IOP measuring device|in-vivo iop measuring device
544548|NCT00856141|intraocular pressure measurement|intraocular pressure measurement
544549|NCT00856115|stage I colon cancer|stage i colon cancer
544550|NCT00856115|stage II colon cancer|stage ii colon cancer
544551|NCT00856115|stage III colon cancer|stage iii colon cancer
544552|NCT00856115|stage IV colon cancer|stage iv colon cancer
544553|NCT00856115|stage I rectal cancer|stage i rectal cancer
544554|NCT00856115|stage II rectal cancer|stage ii rectal cancer
544555|NCT00856115|stage III rectal cancer|stage iii rectal cancer
544556|NCT00856115|stage IV rectal cancer|stage iv rectal cancer
544557|NCT00856076|Venous thromboembolism|venous thromboembolism
544558|NCT00856076|Intrauterine fetal death|intrauterine fetal death
544559|NCT00856076|Risk factor|risk factor
544560|NCT00856076|Thrombophilia|thrombophilia
544561|NCT00856076|Venous thromboembolism (in pregnancy)|venous thromboembolism (in pregnancy)
544562|NCT00856063|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
544563|NCT00856063|Atomoxetine|atomoxetine
544564|NCT00856063|Electrodermal Response|electrodermal response
544565|NCT00856063|Impulsivity|impulsivity
544566|NCT00856063|Preschool Children|preschool children
544567|NCT00856050|estrogen receptor positive|estrogen receptor positive
544568|NCT00856050|progesterone receptor positive|progesterone receptor positive
544569|NCT00856050|letrozole|letrozole
544570|NCT00855998|Thymidine Kinase 1|thymidine kinase 1
544571|NCT00855998|BRCA1 and BRCA2 mutations|brca1 and brca2 mutations
544572|NCT00855998|hereditary breast/ovarian cancer|hereditary breast/ovarian cancer
544573|NCT00855985|Pancreatic anastomosis|pancreatic anastomosis
544574|NCT00855985|Whipple operation|whipple operation
544575|NCT00855959|Asthma|asthma
544576|NCT00855959|Pulmicort Respules|pulmicort respules
544577|NCT00855946|tumor response|tumor response
544578|NCT00855946|rectal adenocarcinoma|rectal adenocarcinoma
544579|NCT00855946|preoperative radiochemotherapy|preoperative radiochemotherapy
544580|NCT00855946|Proteomic analysis|proteomic analysis
544581|NCT00855946|MALDI-TOF-TOF|maldi-tof-tof
544582|NCT00855946|rectal adenocarcinoma, tumor response after preoperative radiochemotherapy|rectal adenocarcinoma, tumor response after preoperative radiochemotherapy
544583|NCT00855920|Metabolism, Inborn Errors|metabolism, inborn errors
544584|NCT00855920|Allopurinol|allopurinol
544585|NCT00855920|Metabolic Diseases|metabolic diseases
544586|NCT00855920|Genetic Diseases, Inborn|genetic diseases, inborn
544587|NCT00855920|Musculoskeletal Diseases|musculoskeletal diseases
544588|NCT00855920|Joint Diseases|joint diseases
544589|NCT00855920|Arthritis|arthritis
544590|NCT00855920|Rheumatic Diseases|rheumatic diseases
544591|NCT00855920|Metabolic disorder|metabolic disorder
544592|NCT00855920|Purine-Pyrimidine Metabolism, Inborn Errors|purine-pyrimidine metabolism, inborn errors
544593|NCT00855920|Gout|gout
544594|NCT00855920|Flare|flare
544595|NCT00855907|IBD|ibd
544596|NCT00855907|inflammatory bowel disease|inflammatory bowel disease
544597|NCT00855907|fatty liver|fatty liver
544598|NCT00855894|Tarceva|tarceva
544599|NCT00855894|NSCLC|nsclc
544600|NCT00855881|adjuvant chemotherapy for head and neck cancer|adjuvant chemotherapy for head and neck cancer
544601|NCT00855868|Amyloid imaging|amyloid imaging
544602|NCT00855868|Positron Emission Tomography|positron emission tomography
544603|NCT00855868|18F-AV-45|18f-av-45
544604|NCT00855868|florbetapir F 18|florbetapir f 18
544605|NCT00855868|Diagnostic imaging|diagnostic imaging
544606|NCT00855855|Diphtheria|diphtheria
544607|NCT00855855|Tetanus|tetanus
544608|NCT00855855|Pertussis|pertussis
544609|NCT00855855|Poliovirus types 1-3|poliovirus types 1-3
544610|NCT00855855|Haemophilus influenzae type b|haemophilus influenzae type b
544611|NCT00855855|Pentacel®|pentacel®
544612|NCT00855842|second trimester abortion|second trimester abortion
544613|NCT00855842|labor induction abortion|labor induction abortion
544614|NCT00855842|second trimester medical abortion|second trimester medical abortion
544615|NCT00855842|pregnancy|pregnancy
544616|NCT00855803|spinal cord metastases|spinal cord metastases
544717|NCT00855335|etravirine|etravirine
544617|NCT00855803|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
544618|NCT00855803|pain|pain
544619|NCT00855790|evaluate the effectiveness of one bite polypectomy with the RJ3 biopsy forcep versus the RJ4 biopsy forcep|evaluate the effectiveness of one bite polypectomy with the rj3 biopsy forcep versus the rj4 biopsy forcep
544620|NCT00855777|third molar extraction|third molar extraction
544621|NCT00855777|etoricoxib|etoricoxib
544622|NCT00855777|ibuprofen|ibuprofen
544623|NCT00855777|analgesic efficacy|analgesic efficacy
544624|NCT00855777|pain|pain
544625|NCT00855738|epilepsy antiepileptic biotherapy|epilepsy antiepileptic biotherapy
544626|NCT00855725|Epilepsy|epilepsy
544627|NCT00855725|Depression|depression
544628|NCT00855725|Neurology|neurology
544629|NCT00855725|fMRI|fmri
544630|NCT00855725|Healthy Controls|healthy controls
544631|NCT00855712|Heart Failure|heart failure
544632|NCT00855712|Transplant|transplant
544633|NCT00855712|Warm Perfusion|warm perfusion
544634|NCT00855712|Organ Care|organ care
544635|NCT00855712|Resting Mode|resting mode
544636|NCT00855699|Alcohol detoxification|alcohol detoxification
544637|NCT00855686|Memantine|memantine
544638|NCT00855686|Cognition|cognition
544639|NCT00855686|Parkinson's Disease Dementia|parkinson's disease dementia
544640|NCT00855686|Dementia With Lewy Bodies|dementia with lewy bodies
544641|NCT00855673|Claudication|claudication
544642|NCT00855673|Peripheral Arterial Disease|peripheral arterial disease
544643|NCT00855673|Intermittent Compression|intermittent compression
544644|NCT00855673|Mechanical Compression|mechanical compression
544645|NCT00855673|Flowmedic|flowmedic
544646|NCT00855660|Bone Metabolism|bone metabolism
544647|NCT00855634|Pancreatic cancer|pancreatic cancer
544648|NCT00855634|metastasis|metastasis
544649|NCT00855634|venous infiltration|venous infiltration
544650|NCT00855634|Pancreatic cancer with minimal metastatic disease or venous infiltration|pancreatic cancer with minimal metastatic disease or venous infiltration
544651|NCT00855621|deep brain stimulation|deep brain stimulation
544652|NCT00855621|subthalamic nucleus|subthalamic nucleus
544653|NCT00855608|choroidal neovascularization|choroidal neovascularization
544654|NCT00855608|diabetic retinopathy|diabetic retinopathy
544655|NCT00855608|uveitis|uveitis
544656|NCT00855608|refractory cases of uveitis|refractory cases of uveitis
544657|NCT00855595|Rosacea|rosacea
544658|NCT00855582|Erectile Dysfunction|erectile dysfunction
544659|NCT00855582|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
544660|NCT00855569|allografting|allografting
544661|NCT00855530|Depression|depression
544662|NCT00855504|preeclampsia|preeclampsia
544663|NCT00855504|periodontitis|periodontitis
544664|NCT00855504|cytokines|cytokines
544665|NCT00855491|PCO|pco
544666|NCT00855491|POCO|poco
544667|NCT00855465|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
544668|NCT00855465|PH|ph
544669|NCT00855465|soluble Guanylate Cyclase Stimulator|soluble guanylate cyclase stimulator
544670|NCT00855465|sGC|sgc
544671|NCT00855452|GVL|gvl
544672|NCT00855452|rIL-2(LAK)|ril-2(lak)
544673|NCT00855452|GVHD|gvhd
544674|NCT00855452|MST|mst
544675|NCT00855452|alloCT|alloct
544676|NCT00855452|alloBMT|allobmt
544677|NCT00855439|Diabetes|diabetes
544678|NCT00855439|Neuropathy|neuropathy
544679|NCT00855439|Glucose|glucose
544680|NCT00855439|Control|control
544681|NCT00855439|Peripheral|peripheral
544682|NCT00855439|Autonomic|autonomic
544683|NCT00855413|Acute HIV|acute hiv
544684|NCT00855413|HIV|hiv
544685|NCT00855413|Treatment Naive|treatment naive
544686|NCT00855413|Acute Infections|acute infections
544687|NCT00855400|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
544688|NCT00855400|Bone marrow|bone marrow
544689|NCT00855400|Stem cells|stem cells
544690|NCT00855400|Autologous|autologous
544691|NCT00855400|Safety|safety
544692|NCT00855387|Clinical outcome (complications), in-hospital costs|clinical outcome (complications), in-hospital costs
544693|NCT00855387|The influence and impact of postoperative complications on in-hospital costs|the influence and impact of postoperative complications on in-hospital costs
544694|NCT00855361|Gastroesophageal Reflux|gastroesophageal reflux
544695|NCT00855361|Erosive Gastroesophageal Reflux Disease|erosive gastroesophageal reflux disease
544696|NCT00855361|Ulcerative Gastroesophageal Reflux Disease|ulcerative gastroesophageal reflux disease
544697|NCT00855361|Endoscopy|endoscopy
544698|NCT00855361|Pediatrics|pediatrics
544699|NCT00855361|GERD|gerd
544700|NCT00855361|Rabeprazole, Rabeprazole sodium|rabeprazole, rabeprazole sodium
544701|NCT00855361|AcipHex|aciphex
544702|NCT00855348|colorectal cancer|colorectal cancer
544703|NCT00855348|early detection|early detection
544704|NCT00855348|methylation, biomarker|methylation, biomarker
544705|NCT00855335|HIV-1|hiv-1
544706|NCT00855335|HIV|hiv
544707|NCT00855335|Pregnancy|pregnancy
544708|NCT00855335|Postpartum|postpartum
544709|NCT00855335|Human immunodeficiency virus|human immunodeficiency virus
544710|NCT00855335|PREZISTA|prezista
544711|NCT00855335|INTELENCE|intelence
544712|NCT00855335|NORVIR|norvir
544713|NCT00855335|TMC114|tmc114
544714|NCT00855335|TMC125|tmc125
544715|NCT00855335|darunavir|darunavir
544718|NCT00855335|rilpivirine|rilpivirine
544719|NCT00855335|TMC278|tmc278
544720|NCT00855335|Cobicistat|cobicistat
544721|NCT00855335|treatment experienced|treatment experienced
544722|NCT00855322|Arthritis, Rheumatoid|arthritis, rheumatoid
544723|NCT00855322|Exercise|exercise
544724|NCT00855322|Biological Therapy|biological therapy
544725|NCT00855309|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
544726|NCT00855309|renal toxicity|renal toxicity
544727|NCT00855309|infection|infection
544728|NCT00855309|neutropenia|neutropenia
544729|NCT00855270|PTSD|ptsd
544730|NCT00855257|Acid nicotinique|acid nicotinique
544731|NCT00855257|FLOW MEDIATED DILATATION (FMD)|flow mediated dilatation (fmd)
544732|NCT00855257|HDL-C< 0.4 G/L|hdl-c< 0.4 g/l
544733|NCT00855244|Bone marrow transplantation|bone marrow transplantation
544734|NCT00855231|Acute coronary syndrome|acute coronary syndrome
544735|NCT00855231|Coronary artery disease|coronary artery disease
544736|NCT00855231|cardiac imaging|cardiac imaging
544737|NCT00855231|computed tomography|computed tomography
544738|NCT00855218|Sorafenib|sorafenib
544739|NCT00855218|TACE|tace
544740|NCT00855218|DC bead|dc bead
544741|NCT00855218|Combination|combination
544742|NCT00855205|pulmonary sarcoidosis|pulmonary sarcoidosis
544743|NCT00855192|anxiety|anxiety
544744|NCT00855192|depression|depression
544745|NCT00855192|pregnancy|pregnancy
544746|NCT00855192|antenatal|antenatal
544747|NCT00855192|prenatal|prenatal
544748|NCT00855192|mindfulness-based therapy|mindfulness-based therapy
544749|NCT00855192|interpersonal therapy|interpersonal therapy
544750|NCT00855192|support groups|support groups
544751|NCT00855166|Dapagliflozin|dapagliflozin
544752|NCT00855166|Metformin|metformin
544753|NCT00855166|Type 2 diabetes|type 2 diabetes
544754|NCT00855166|body weight|body weight
544755|NCT00855153|PTSD|ptsd
544756|NCT00855153|burns|burns
544757|NCT00855153|virtual reality exposure|virtual reality exposure
544758|NCT00855153|D-Cycloserine|d-cycloserine
544759|NCT00855153|Combat related psychological trauma in burned servicemembers|combat related psychological trauma in burned servicemembers
544760|NCT00855140|Insomnia|insomnia
544761|NCT00855140|Primary insomnia|primary insomnia
544762|NCT00855140|Insomnia disorder|insomnia disorder
544763|NCT00855140|Acupuncture|acupuncture
544764|NCT00855127|Biological Markers|biological markers
544765|NCT00855127|Renal Replacement Therapy|renal replacement therapy
544766|NCT00855127|Mortality|mortality
544767|NCT00855114|stage II breast cancer|stage ii breast cancer
544768|NCT00855114|stage III breast cancer|stage iii breast cancer
544769|NCT00855114|stage IIIA breast cancer|stage iiia breast cancer
544770|NCT00855101|Pharmacokinetics and safety of voriconazole intravenous oral adults|pharmacokinetics and safety of voriconazole intravenous oral adults
544771|NCT00855088|HIV seronegativity|hiv seronegativity
544772|NCT00855075|Sedation|sedation
544773|NCT00855075|Analgesia|analgesia
544774|NCT00855075|Mechanical ventilation|mechanical ventilation
544775|NCT00855075|Cerebral State Monitor|cerebral state monitor
544776|NCT00855075|Cerebral State Index|cerebral state index
544777|NCT00855062|Human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
544778|NCT00855062|HIV associated cognitive impairment|hiv associated cognitive impairment
544779|NCT00855062|HIV dementia|hiv dementia
544781|NCT00855062|Acquired immune deficiency syndrome (AIDS)|acquired immune deficiency syndrome (aids)
544782|NCT00855062|Treatment Naive|treatment naive
544783|NCT00855049|Pharmacokinetics|pharmacokinetics
544784|NCT00855049|Acetaminophen|acetaminophen
544785|NCT00855049|Intranasal|intranasal
544786|NCT00855049|Absorption|absorption
544787|NCT00855036|blunt renal injury|blunt renal injury
544788|NCT00855036|kidney laceration|kidney laceration
544789|NCT00855023|anterior cruciate ligament|anterior cruciate ligament
544790|NCT00855023|Knee Joint|knee joint
544791|NCT00855010|Pioglitazone|pioglitazone
544792|NCT00855010|prediabetes|prediabetes
544793|NCT00855010|diabetes|diabetes
544794|NCT00855010|obesity|obesity
544795|NCT00855010|Pancreatic fat|pancreatic fat
544796|NCT00854997|Obstructive sleep apnea; myocardial infarction|obstructive sleep apnea; myocardial infarction
544797|NCT00854984|Depression|depression
544798|NCT00854984|diabetes|diabetes
544799|NCT00854984|Coronary heart disease|coronary heart disease
544800|NCT00854984|CBT|cbt
544801|NCT00854984|Cognitive behavioural therapy|cognitive behavioural therapy
544802|NCT00854971|NKCell|nkcell
544803|NCT00854971|FOLFOX-4|folfox-4
544804|NCT00854971|advanced or unresectable colorectal cancer|advanced or unresectable colorectal cancer
544805|NCT00854958|Oral|oral
544806|NCT00854958|Allergy|allergy
544807|NCT00854958|Syndrome|syndrome
544808|NCT00854958|Food|food
544809|NCT00854958|Pollen|pollen
544810|NCT00854945|Myelodysplastic Syndrome|myelodysplastic syndrome
544811|NCT00854945|Refractory Cytopenia|refractory cytopenia
544812|NCT00854945|Refractory Anemia|refractory anemia
544813|NCT00854945|Dysplasia|dysplasia
544814|NCT00854945|Acute Myeloid Leukemia|acute myeloid leukemia
544815|NCT00854932|procalcitonin|procalcitonin
544816|NCT00854932|sepsis|sepsis
544817|NCT00854932|newborn|newborn
544818|NCT00854932|intervention study|intervention study
544819|NCT00854919|obsessive-compulsive disorder|obsessive-compulsive disorder
544820|NCT00854919|augmentation treatment|augmentation treatment
544821|NCT00854919|SSRI-refractory|ssri-refractory
544822|NCT00854906|dry eye|dry eye
544823|NCT00854906|keratometer|keratometer
544824|NCT00854906|fluorescein|fluorescein
544825|NCT00854893|stroke|stroke
544826|NCT00854893|aphasia|aphasia
544827|NCT00854893|aging|aging
544828|NCT00854893|language learning|language learning
544829|NCT00854880|Erosive Gastritis|erosive gastritis
544830|NCT00854867|Solid tumour neoplastic meningitis|solid tumour neoplastic meningitis
544831|NCT00854867|STNM|stnm
544832|NCT00854867|leptomeningeal metastases|leptomeningeal metastases
544833|NCT00854867|DepoCyte|depocyte
544834|NCT00854867|WBRT|wbrt
544835|NCT00854867|Whole Brain Radiotherapy|whole brain radiotherapy
544836|NCT00854867|Liposomal cytarabine intrathecal|liposomal cytarabine intrathecal
544837|NCT00854867|Solid Tumour Neoplastic Meningitis with or without brain metastasis|solid tumour neoplastic meningitis with or without brain metastasis
544838|NCT00854854|NKCell|nkcell
544839|NCT00854854|FOLFOX-4|folfox-4
544840|NCT00854854|gastric cancer|gastric cancer
544841|NCT00854841|CML|cml
544842|NCT00854841|suboptimal response|suboptimal response
544843|NCT00854841|dasatinib|dasatinib
544844|NCT00854841|imatinib|imatinib
544845|NCT00854828|Symptomatic 40-80 y/o w/lumbar Cobb of 30 degrees|symptomatic 40-80 y/o w/lumbar cobb of 30 degrees
544846|NCT00854828|All Participants must be reasonable surgical candidate at enrollment|all participants must be reasonable surgical candidate at enrollment
544847|NCT00854815|Perforated appendicitis|perforated appendicitis
544848|NCT00854815|laparoscopic appendectomy|laparoscopic appendectomy
544849|NCT00854815|children|children
544850|NCT00854815|irrigation|irrigation
544851|NCT00854802|Hepatitis|hepatitis
544852|NCT00854802|Hepatitis C|hepatitis c
544853|NCT00854789|Breast cancer|breast cancer
544854|NCT00854776|aspirin|aspirin
544855|NCT00854776|clopidogrel|clopidogrel
544856|NCT00854776|proton pump inhibitor|proton pump inhibitor
544857|NCT00854776|peptic ulcer|peptic ulcer
544858|NCT00854776|ulcer complications|ulcer complications
544859|NCT00854750|Multiple Sclerosis, hx of unilateral ON, evidence of thermal sensitivity, and no evidence of an ocular motor syndrome|multiple sclerosis, hx of unilateral on, evidence of thermal sensitivity, and no evidence of an ocular motor syndrome
544860|NCT00854750|Multiple Sclerosis, no evidence of ON, and evidence of thermal sensitivity|multiple sclerosis, no evidence of on, and evidence of thermal sensitivity
544861|NCT00854750|Healthy age/gender matched controls|healthy age/gender matched controls
544862|NCT00854737|bipolar disorder|bipolar disorder
544863|NCT00854737|bipolar depression|bipolar depression
544864|NCT00854737|bipolar mania|bipolar mania
544865|NCT00854737|manic depression|manic depression
544866|NCT00854737|depression|depression
544867|NCT00854737|mania|mania
544868|NCT00854737|hypomania|hypomania
544869|NCT00854711|ST elevated Myocardical infraction|st elevated myocardical infraction
544870|NCT00854698|THE LEFT VENTRICULAR REMODELING AFTER MECHANICAL AORTIC VALVE REPLACEMENT|the left ventricular remodeling after mechanical aortic valve replacement
544871|NCT00854698|exercise training|exercise training
544872|NCT00854672|Sarcoidosis|sarcoidosis
544873|NCT00854672|muscle strength|muscle strength
544874|NCT00854672|exercise intolerance|exercise intolerance
544875|NCT00854672|QOL|qol
544876|NCT00854646|ON 01910.Na|on 01910.na
544877|NCT00854646|refractory|refractory
544878|NCT00854646|leukemia|leukemia
544879|NCT00854646|myelodysplastic|myelodysplastic
544880|NCT00854646|cell cycle|cell cycle
544881|NCT00854633|Pre-term infants|pre-term infants
544882|NCT00854633|Pre-term infants 750 to 1500 grams|pre-term infants 750 to 1500 grams
544883|NCT00854594|Diabetes|diabetes
544884|NCT00854594|Telemedicine|telemedicine
544885|NCT00854594|Shared Medical Appointments|shared medical appointments
544886|NCT00854581|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
544887|NCT00854581|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
544888|NCT00854581|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
544889|NCT00854581|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
544890|NCT00854581|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
544891|NCT00854581|HTLV-1 infection|htlv-1 infection
544892|NCT00854568|B-cell lymphoma|b-cell lymphoma
544893|NCT00854568|CHOP|chop
544894|NCT00854568|CEOP|ceop
544895|NCT00854568|Cardiotoxicity|cardiotoxicity
544896|NCT00854555|incomplete spinal cord injury|incomplete spinal cord injury
544897|NCT00854555|locomotor activity|locomotor activity
544898|NCT00854555|walking function|walking function
544899|NCT00854555|gait|gait
544900|NCT00854542|Telepsychiatry|telepsychiatry
544901|NCT00854542|Culturally Sensitive Collaborative Treatment|culturally sensitive collaborative treatment
544902|NCT00854542|Chinese Americans|chinese americans
544903|NCT00854542|Depression|depression
544904|NCT00854529|bevacizumab|bevacizumab
544905|NCT00854529|subconjunctival injection|subconjunctival injection
544906|NCT00854529|trabeculectomy|trabeculectomy
544907|NCT00854529|bleb|bleb
544908|NCT00854529|mitomycin c|mitomycin c
544909|NCT00854516|compression therapy|compression therapy
545013|NCT00854087|Relapser|relapser
544911|NCT00854503|Statins administration in diabetic dyslipidemia|statins administration in diabetic dyslipidemia
544912|NCT00854477|capecitabine|capecitabine
544913|NCT00854477|Post whipples|post whipples
544914|NCT00854477|pancreatico-duodenectomy|pancreatico-duodenectomy
544915|NCT00854477|pancreatic adenocarcinoma|pancreatic adenocarcinoma
544916|NCT00854477|pharmacokinetic|pharmacokinetic
544917|NCT00854464|Arsenic Methylation Capability|arsenic methylation capability
544918|NCT00854464|Arsenic Methylation Enzymes|arsenic methylation enzymes
544919|NCT00854464|Cigarette Metabolites|cigarette metabolites
544920|NCT00854464|Cigarette Metabolic Enzymes|cigarette metabolic enzymes
544921|NCT00854464|DNA Repair Enzymes|dna repair enzymes
544922|NCT00854464|Inflammatory Factors|inflammatory factors
544923|NCT00854464|Urothelial Carcinoma|urothelial carcinoma
544924|NCT00854451|Helicobacter pylori|helicobacter pylori
544925|NCT00854451|CYP2C19 genotype|cyp2c19 genotype
544926|NCT00854451|intragastric pH|intragastric ph
544927|NCT00854451|dual therapy|dual therapy
544928|NCT00854451|antibiotic resistance|antibiotic resistance
544929|NCT00854438|anticholinergic drugs|anticholinergic drugs
544930|NCT00854438|adverse events|adverse events
544931|NCT00854438|elderly|elderly
544932|NCT00854438|clinical pharmacist|clinical pharmacist
544933|NCT00854438|Evaluate the clinical effects of reducing anticholinergic in elderly|evaluate the clinical effects of reducing anticholinergic in elderly
544934|NCT00854412|Obesity|obesity
544935|NCT00854412|Weight loss|weight loss
544936|NCT00854412|Very low-calorie diet|very low-calorie diet
544937|NCT00854412|Mannose-binding lectin|mannose-binding lectin
544938|NCT00854412|Insulin resistance|insulin resistance
544939|NCT00854386|fluid management|fluid management
544940|NCT00854386|VATS|vats
544941|NCT00854386|ALI|ali
544942|NCT00854386|ARDS|ards
544943|NCT00854373|Infertility|infertility
544944|NCT00854373|Pregnancy|pregnancy
544945|NCT00854373|in vitro fertilization|in vitro fertilization
544946|NCT00854360|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
544947|NCT00854360|Hayfever|hayfever
544948|NCT00854347|hyperglycemia|hyperglycemia
544949|NCT00854347|diabetes|diabetes
544950|NCT00854347|intensive care|intensive care
544951|NCT00854347|prevalence|prevalence
544952|NCT00854334|Sleep|sleep
544953|NCT00854334|Overweight|overweight
544954|NCT00854334|Physical activity|physical activity
544955|NCT00854334|Appetite|appetite
544956|NCT00854334|NEAT|neat
544957|NCT00854321|rheumatoid arthritis|rheumatoid arthritis
544958|NCT00854321|rituximab|rituximab
544959|NCT00854321|therapy|therapy
544960|NCT00854308|Tarceva|tarceva
544961|NCT00854308|Lung Cancer|lung cancer
544962|NCT00854308|NSCLC|nsclc
544963|NCT00854295|arthritis|arthritis
544964|NCT00854295|osteoarthritis|osteoarthritis
544965|NCT00854295|degenerative knee disease|degenerative knee disease
544966|NCT00854295|avascular necrosis|avascular necrosis
544967|NCT00854295|total knee replacement|total knee replacement
544968|NCT00854295|TKA|tka
544969|NCT00854256|glaucoma|glaucoma
544970|NCT00854230|HIV|hiv
544971|NCT00854230|alcohol|alcohol
544972|NCT00854230|naltrexone|naltrexone
544973|NCT00854230|Treatment Experienced|treatment experienced
544974|NCT00854204|Innovation-TiFP4-C101|innovation-tifp4-c101
544975|NCT00854204|Innovation-C101|innovation-c101
544976|NCT00854204|Innovation|innovation
544977|NCT00854204|TMC114/TMC41629|tmc114/tmc41629
544978|NCT00854204|controlled-release coformulations|controlled-release coformulations
544979|NCT00854204|immediate-release coformulation|immediate-release coformulation
544980|NCT00854204|Pharmacokinetics|pharmacokinetics
544981|NCT00854191|mechanical simulator|mechanical simulator
544982|NCT00854191|ERCP|ercp
544983|NCT00854191|training|training
544984|NCT00854178|isoflurane|isoflurane
544985|NCT00854178|propofol|propofol
544986|NCT00854178|genotoxicity|genotoxicity
544987|NCT00854178|gene expression|gene expression
544988|NCT00854178|cytokines|cytokines
544989|NCT00854178|apoptosis|apoptosis
544990|NCT00854165|lung transplantation|lung transplantation
544991|NCT00854165|respiratory failure|respiratory failure
544992|NCT00854165|ECMO|ecmo
544993|NCT00854165|Lung transplants in respiratory failure patients|lung transplants in respiratory failure patients
544994|NCT00854152|NHL|nhl
544995|NCT00854152|Tumors|tumors
544996|NCT00854152|Carcinogenic Tumors|carcinogenic tumors
544997|NCT00854139|Multiple myeloma|multiple myeloma
544998|NCT00854139|Renal failure|renal failure
544999|NCT00854139|Kidney transplant|kidney transplant
545000|NCT00854126|NHL|nhl
545001|NCT00854126|Solid Tumors|solid tumors
545002|NCT00854126|Carcinogenic Tumors|carcinogenic tumors
545003|NCT00854113|Diabetes Mellitus Type 2|diabetes mellitus type 2
545004|NCT00854100|Adjunctive|adjunctive
545005|NCT00854100|Depression|depression
545006|NCT00854100|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
545007|NCT00854087|Hepatitis C Virus|hepatitis c virus
545008|NCT00854087|HCV|hcv
545009|NCT00854087|Herbal treatment|herbal treatment
545010|NCT00854087|Herbs|herbs
545011|NCT00854087|San Diego|san diego
545012|NCT00854087|Non responder|non responder
545014|NCT00854087|Treatment failure|treatment failure
545015|NCT00854087|Antifibrotic|antifibrotic
545016|NCT00854087|Anti-fibrotic|anti-fibrotic
545017|NCT00854087|Fibrosis|fibrosis
545018|NCT00854087|Failure of previous Interferon based therapy|failure of previous interferon based therapy
545019|NCT00854087|Refuse Interferon based therapy|refuse interferon based therapy
545020|NCT00854087|Intolerance to Interferon|intolerance to interferon
545021|NCT00854087|Male or female 18-70 years of age|male or female 18-70 years of age
545022|NCT00854074|Post-operative Paralytic Ileus|post-operative paralytic ileus
545023|NCT00854074|Neuromodulation|neuromodulation
545024|NCT00854074|Neurostimulation|neurostimulation
545025|NCT00854074|Extended loss of functional bowel motility|extended loss of functional bowel motility
545026|NCT00854048|Pediatric|pediatric
545027|NCT00854048|Oxygen Saturation|oxygen saturation
545028|NCT00854048|Cardiopulmonary bypass|cardiopulmonary bypass
545029|NCT00854035|MK-0431/ONO-5435|mk-0431/ono-5435
545030|NCT00854035|Type 2 diabetes mellitus|type 2 diabetes mellitus
545031|NCT00854009|Healthy Subjects|healthy subjects
545032|NCT00853983|Healthy Volunteers|healthy volunteers
545033|NCT00853983|ADME|adme
545034|NCT00853970|Pain and Inflammation as a function of cataract surgery|pain and inflammation as a function of cataract surgery
545035|NCT00853957|Hypertension|hypertension
545036|NCT00853957|African Americans|african americans
545037|NCT00853957|Aliskiren|aliskiren
545038|NCT00853957|Amlodipine|amlodipine
545039|NCT00853957|Systolic blood pressure|systolic blood pressure
545040|NCT00853957|Diastolic blood pressure|diastolic blood pressure
545041|NCT00853957|Stage II|stage ii
545042|NCT00853957|Combination|combination
545043|NCT00853944|islet transplantation|islet transplantation
545044|NCT00853944|type 1 diabetes|type 1 diabetes
545045|NCT00853944|incretin|incretin
545046|NCT00853931|KRAS wild type|kras wild type
545047|NCT00853931|metastatic colorectal cancer|metastatic colorectal cancer
545048|NCT00853931|KRAS wild type metastatic colorectal cancer with no prior exposure to EGFR inhibitors|kras wild type metastatic colorectal cancer with no prior exposure to egfr inhibitors
545049|NCT00853918|Physician survey|physician survey
545050|NCT00853918|Mail survey|mail survey
545051|NCT00853918|Response rate|response rate
545052|NCT00853905|open angle glaucoma (POAG)|open angle glaucoma (poag)
545053|NCT00853905|angle closure glaucoma (PACG)|angle closure glaucoma (pacg)
545054|NCT00853905|pigmentary glaucoma|pigmentary glaucoma
545055|NCT00853905|pseudoexfoliation glaucoma|pseudoexfoliation glaucoma
545056|NCT00853905|neovascular glaucoma|neovascular glaucoma
545057|NCT00853905|traumatic glaucoma|traumatic glaucoma
545058|NCT00853892|Healthy Subjects|healthy subjects
545059|NCT00853892|Bioequivalence|bioequivalence
545060|NCT00853866|stroke|stroke
545061|NCT00853866|reboxetine|reboxetine
545062|NCT00853866|noradrenaline|noradrenaline
545063|NCT00853866|motor cortex|motor cortex
545064|NCT00853866|transcranial direct current stimulation|transcranial direct current stimulation
545065|NCT00853866|motor function|motor function
545066|NCT00853866|rehabilitation|rehabilitation
545067|NCT00853866|Jebsen Taylor test|jebsen taylor test
545068|NCT00853853|Hemorrhoidectomy|hemorrhoidectomy
545069|NCT00853853|Hemorrhoids|hemorrhoids
545070|NCT00853840|pharmacodynamics. maraviroc, vardenafil, blood pressure|pharmacodynamics. maraviroc, vardenafil, blood pressure
545071|NCT00853827|CAD|cad
545072|NCT00853827|coronary artery disease|coronary artery disease
545073|NCT00853827|coronary atherosclerosis|coronary atherosclerosis
545074|NCT00853827|coronary angiography|coronary angiography
545075|NCT00853827|IVUS|ivus
545076|NCT00853827|intravascular ultrasound|intravascular ultrasound
545077|NCT00853827|plasma renin activity|plasma renin activity
545078|NCT00853827|renin angiotensin aldosterone system,|renin angiotensin aldosterone system,
545079|NCT00853827|direct renin inhibitors|direct renin inhibitors
545080|NCT00853827|coronary atheroma|coronary atheroma
545081|NCT00853814|adolescence|adolescence
545082|NCT00853814|obesity|obesity
545083|NCT00853814|physical activity|physical activity
545084|NCT00853814|built environment|built environment
545085|NCT00853814|neighborhood environment|neighborhood environment
545086|NCT00853814|children|children
545087|NCT00853814|youth|youth
545088|NCT00853814|increasing physical activity|increasing physical activity
545089|NCT00853814|changing dietary intake|changing dietary intake
545090|NCT00853814|reducing zBMI|reducing zbmi
545091|NCT00853801|Pre-Diabetes|pre-diabetes
545092|NCT00853801|Metabolic Syndrome|metabolic syndrome
545093|NCT00853801|Type 2 Diabetes|type 2 diabetes
545094|NCT00853801|Diabetes Prevention|diabetes prevention
545095|NCT00853801|Lifestyle Modification|lifestyle modification
545096|NCT00853801|Diet Therapy|diet therapy
545097|NCT00853801|Provider Education|provider education
545098|NCT00853788|systemic sclerosis|systemic sclerosis
545099|NCT00853788|biomarkers|biomarkers
545100|NCT00853788|microarray|microarray
545101|NCT00853775|heart disease|heart disease
545102|NCT00853775|cardiovascular disease|cardiovascular disease
545103|NCT00853775|lipoproteins|lipoproteins
545104|NCT00853775|lipoprotein(a)|lipoprotein(a)
545105|NCT00853775|Lp(a)|lp(a)
545106|NCT00853775|apolipoprotein(a)|apolipoprotein(a)
545107|NCT00853775|apo(a)|apo(a)
545108|NCT00853775|fats|fats
545109|NCT00853775|proteins|proteins
545110|NCT00853775|metabolism|metabolism
545111|NCT00853749|Immune response|immune response
545112|NCT00853749|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
545113|NCT00853749|polysaccharide|polysaccharide
545114|NCT00853736|Healthy Subjects|healthy subjects
545115|NCT00853736|Bioequivalence|bioequivalence
545116|NCT00853723|osteoporosis|osteoporosis
545117|NCT00853723|post-menopausal|post-menopausal
545118|NCT00853723|bone anabolic agents|bone anabolic agents
545119|NCT00853710|Prostate-Specific Antigen|prostate-specific antigen
545120|NCT00853710|Prostate Cancer|prostate cancer
545121|NCT00853710|Cancer|cancer
545122|NCT00853710|Assay|assay
545123|NCT00853697|Prostate|prostate
545124|NCT00853697|DUTASTERIDE|dutasteride
545125|NCT00853697|TESTOSTERONE|testosterone
545126|NCT00853697|09-008|09-008
545127|NCT00853697|Consortium Protocol LOI# c09-028|consortium protocol loi# c09-028
545128|NCT00853684|Advanced Colorectal Cancer|advanced colorectal cancer
545129|NCT00853684|Oxaliplatin|oxaliplatin
545130|NCT00853684|Capecitabine|capecitabine
545131|NCT00853684|Endostar|endostar
545132|NCT00853684|efficacy|efficacy
545133|NCT00853671|Coronary Artery Disease|coronary artery disease
545134|NCT00853671|Multidetector Computed Tomography|multidetector computed tomography
545135|NCT00853671|Myocardial Perfusion Imaging|myocardial perfusion imaging
545136|NCT00853658|Chronic Heart Failure|chronic heart failure
545137|NCT00853658|Cardiovascular death|cardiovascular death
545138|NCT00853658|CHF hospitalization|chf hospitalization
545139|NCT00853658|morbi-mortality trial|morbi-mortality trial
545140|NCT00853658|outcome study|outcome study
545141|NCT00853658|endpoint driven|endpoint driven
545142|NCT00853658|plasma renin activity|plasma renin activity
545143|NCT00853658|renin angiotensin aldosterone system|renin angiotensin aldosterone system
545144|NCT00853658|direct renin inhibitors|direct renin inhibitors
545145|NCT00853658|BNP|bnp
545146|NCT00853658|KCCQ|kccq
545147|NCT00853658|eGFR|egfr
545148|NCT00853658|(NYHA class II to IV) with elevated|(nyha class ii to iv) with elevated
545149|NCT00853658|BNP and reduced LVEF|bnp and reduced lvef
545150|NCT00853632|Mitral valve|mitral valve
545151|NCT00853632|pericardial bioprostheses|pericardial bioprostheses
545152|NCT00853632|PERIMOUNT|perimount
545153|NCT00853632|bovine pericardial leaflets|bovine pericardial leaflets
545154|NCT00853632|mitral valve replacement|mitral valve replacement
545155|NCT00853632|mitral valve regurgitation|mitral valve regurgitation
545156|NCT00853632|Heart valve disease|heart valve disease
545157|NCT00853619|clinical decision support|clinical decision support
545158|NCT00853619|knowledge management|knowledge management
545159|NCT00853619|knowledge representation|knowledge representation
545160|NCT00853619|clinical guidelines|clinical guidelines
545161|NCT00853619|coronary artery disease|coronary artery disease
545162|NCT00853619|myocardial ischemia|myocardial ischemia
545163|NCT00853619|diabetes mellitus|diabetes mellitus
545164|NCT00853619|hypertension|hypertension
545165|NCT00853606|ED|ed
545166|NCT00853606|Erectile Dysfunction|erectile dysfunction
545167|NCT00853606|Dysfunction|dysfunction
545168|NCT00853606|Erectile|erectile
545169|NCT00853593|heart failure|heart failure
545170|NCT00853593|cardiac pacing|cardiac pacing
545171|NCT00853593|cardiac resynchronization therapy|cardiac resynchronization therapy
545172|NCT00853593|left ventricular lead|left ventricular lead
545173|NCT00853580|Neurofibromatosis Type 1, Neurocognitive, Phase II|neurofibromatosis type 1, neurocognitive, phase ii
545174|NCT00853567|Uterine Fibroids|uterine fibroids
545175|NCT00853554|Healthy Subjects|healthy subjects
545176|NCT00853554|Bioequivalence|bioequivalence
545177|NCT00853541|renal impairment|renal impairment
545178|NCT00853541|heart failure|heart failure
545179|NCT00853541|hyperphosphatemia|hyperphosphatemia
545180|NCT00853541|coronary artery calcification|coronary artery calcification
545181|NCT00853528|spinal cord metastases|spinal cord metastases
545182|NCT00853502|anorexia nervosa|anorexia nervosa
545183|NCT00853502|testosterone|testosterone
545184|NCT00853502|disordered eating|disordered eating
545185|NCT00853502|hypogonadism|hypogonadism
545186|NCT00853502|bone|bone
545187|NCT00853489|Open tibia fractures|open tibia fractures
545188|NCT00853489|rhBMP-2|rhbmp-2
545189|NCT00853489|critical size defects|critical size defects
545190|NCT00853489|bone grafting|bone grafting
545191|NCT00853463|Pulmonary Embolism|pulmonary embolism
545192|NCT00853463|Deep Vein Thrombosis|deep vein thrombosis
545193|NCT00853463|Prophylaxis|prophylaxis
545194|NCT00853463|Venous thromboembolism|venous thromboembolism
545195|NCT00853463|Prevention|prevention
545196|NCT00853463|Medical patients|medical patients
545197|NCT00853450|Antiplatelet|antiplatelet
545198|NCT00853437|Comparison of CO by new method to clinician's estimate and implied CO from the measurement of arteriovenous oxygen content difference.|comparison of co by new method to clinician's estimate and implied co from the measurement of arteriovenous oxygen content difference.
545199|NCT00853424|diabetic retinopathy|diabetic retinopathy
545200|NCT00853424|diabetic macular edema|diabetic macular edema
545201|NCT00853424|type 1 diabetes|type 1 diabetes
545202|NCT00853424|intensive medical therapy|intensive medical therapy
545203|NCT00853424|islet cell transplantation|islet cell transplantation
545204|NCT00853424|visual acuity|visual acuity
545205|NCT00853424|diabetic eye disease|diabetic eye disease
545206|NCT00853411|Moderate to severe asthma|moderate to severe asthma
545207|NCT00853398|Primary Osteoarthritis of the knee.|primary osteoarthritis of the knee.
545208|NCT00853385|oral DMARD|oral dmard
545209|NCT00853385|JAK inhibitor|jak inhibitor
545210|NCT00853385|clinical trial|clinical trial
545211|NCT00853346|Depression|depression
545212|NCT00853346|Parkinson's Disease|parkinson's disease
545213|NCT00853346|Major Depression|major depression
545214|NCT00853346|Cognitive Behavioral Therapy|cognitive behavioral therapy
545215|NCT00853333|Pain|pain
545216|NCT00853333|Propofol|propofol
545217|NCT00853333|Dexmedetomidine|dexmedetomidine
545218|NCT00853333|Midazolam|midazolam
545219|NCT00853333|Effects of sedation on pain perception.|effects of sedation on pain perception.
545220|NCT00853320|Healthy Subjects|healthy subjects
545221|NCT00853320|Bioequivalence|bioequivalence
545222|NCT00853307|Drug therapy|drug therapy
545223|NCT00853294|Healthy Subjects|healthy subjects
545224|NCT00853294|Bioequivalence|bioequivalence
545225|NCT00853281|Forest malaria prevention|forest malaria prevention
545226|NCT00853281|Long-lasting insecticidal hammocks|long-lasting insecticidal hammocks
545227|NCT00853281|Cluster randomized trial|cluster randomized trial
545228|NCT00853281|Central Vietnam|central vietnam
545229|NCT00853268|Healthy Subjects|healthy subjects
545230|NCT00853268|Bioequivalence|bioequivalence
545231|NCT00853255|Bird Flu|bird flu
545232|NCT00853242|Chronic Kidney Disease|chronic kidney disease
545233|NCT00853242|Phosphate Binder|phosphate binder
545234|NCT00853242|Phosphate|phosphate
545235|NCT00853242|Hyperphosphatemia|hyperphosphatemia
545236|NCT00853229|vulvodynia|vulvodynia
545237|NCT00853229|vulvar vestibulitis|vulvar vestibulitis
545238|NCT00853229|chronic vulvar pain|chronic vulvar pain
545239|NCT00853229|generalized vulvodynia|generalized vulvodynia
545240|NCT00853229|localized vulvodynia|localized vulvodynia
545241|NCT00853216|Healthy Subjects|healthy subjects
545242|NCT00853216|Bioequivalence|bioequivalence
545243|NCT00853203|Colorectal Cancer|colorectal cancer
545244|NCT00853203|Rectal Cancer|rectal cancer
545245|NCT00853203|Psychosocial|psychosocial
545246|NCT00853203|Expressive Disclosure|expressive disclosure
545247|NCT00853203|Questionnaires|questionnaires
545248|NCT00853203|Quality of life|quality of life
545249|NCT00853203|QOL|qol
545250|NCT00853203|Electronically Activated Recorder|electronically activated recorder
545251|NCT00853203|EAR|ear
545252|NCT00853190|Healthy Subjects|healthy subjects
545253|NCT00853177|Oocyte retrieval|oocyte retrieval
545254|NCT00853177|pain|pain
545255|NCT00853177|surgery|surgery
545256|NCT00853177|anaesthesiology|anaesthesiology
545257|NCT00853177|Assisted Reproductive Technologies|assisted reproductive technologies
545258|NCT00853164|prostate cancer|prostate cancer
545259|NCT00853164|aerobic exercise|aerobic exercise
545260|NCT00853164|resistance training|resistance training
545261|NCT00853138|cognitive-behavioral therapy|cognitive-behavioral therapy
545262|NCT00853138|chronic pain|chronic pain
545263|NCT00853138|randomized controlled trial|randomized controlled trial
545264|NCT00853138|pediatrics|pediatrics
545265|NCT00853125|clear cell renal cell carcinoma|clear cell renal cell carcinoma
545266|NCT00853125|stage IV renal cell cancer|stage iv renal cell cancer
545267|NCT00853112|PAH pulmonary hypertension pulmonary arterial hypertension|pah pulmonary hypertension pulmonary arterial hypertension
545268|NCT00853099|Ulcerative Colitis|ulcerative colitis
545269|NCT00853073|failing blebs|failing blebs
545270|NCT00853073|failing express shunt|failing express shunt
545271|NCT00853073|avastin|avastin
545272|NCT00853073|bevacizumab|bevacizumab
545273|NCT00853073|glaucoma|glaucoma
545274|NCT00853073|prior trabeculectomy|prior trabeculectomy
545275|NCT00853073|Express shunt placed under a scleral flap|express shunt placed under a scleral flap
545276|NCT00853073|subsequent filtration failure|subsequent filtration failure
545277|NCT00853060|energy expenditure|energy expenditure
545278|NCT00853060|mechanical ventilation|mechanical ventilation
545279|NCT00853060|weaning|weaning
545280|NCT00853060|pressure support ventilation|pressure support ventilation
545281|NCT00853060|T-tube|t-tube
545282|NCT00853034|gastrointestinal effects|gastrointestinal effects
545283|NCT00853034|prebiotic|prebiotic
545284|NCT00853021|clear cell renal cell carcinoma|clear cell renal cell carcinoma
545285|NCT00853021|recurrent renal cell cancer|recurrent renal cell cancer
545286|NCT00853021|stage IV renal cell cancer|stage iv renal cell cancer
545287|NCT00853008|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
545288|NCT00853008|High-Risk (HR)|high-risk (hr)
545289|NCT00853008|Philadelphia Chromosome-Negative|philadelphia chromosome-negative
545290|NCT00852995|Venous Leg Ulcer (VLU)|venous leg ulcer (vlu)
545291|NCT00852995|Venous Stasis Ulcer (VSU)|venous stasis ulcer (vsu)
545292|NCT00852995|VLU|vlu
545293|NCT00852995|VSU|vsu
545294|NCT00852995|Leg Ulcer|leg ulcer
545295|NCT00852995|Leg Wound|leg wound
545296|NCT00852982|Exercise|exercise
545297|NCT00852982|Risk factors|risk factors
545298|NCT00852982|Primary health care|primary health care
545299|NCT00852969|Chronic Kidney Disease|chronic kidney disease
545300|NCT00852969|Niacin|niacin
545301|NCT00852969|HDL|hdl
545302|NCT00852969|Endothelial Function|endothelial function
545303|NCT00852956|Betahistine|betahistine
545304|NCT00852956|Olanzapine|olanzapine
545305|NCT00852956|Safety of co-administration of Betahistien and Olanzapine|safety of co-administration of betahistien and olanzapine
545306|NCT00852943|Mast Cells|mast cells
545307|NCT00852943|Piebaldism|piebaldism
545308|NCT00852943|Anaphylaxis|anaphylaxis
545309|NCT00852943|Allergy|allergy
545310|NCT00852943|Genetics|genetics
545311|NCT00852930|lymphedema|lymphedema
545312|NCT00852930|quality of life|quality of life
545313|NCT00852930|breast cancer|breast cancer
545314|NCT00852930|symptoms|symptoms
545315|NCT00852930|lymphedema in breast cancer survivors|lymphedema in breast cancer survivors
545316|NCT00852917|Pain due to Osteoarthritis of the Knee|pain due to osteoarthritis of the knee
545317|NCT00852904|Childhood Growth and Development|childhood growth and development
545318|NCT00852904|Genetics|genetics
545319|NCT00852904|Children|children
545320|NCT00852904|Environment|environment
545321|NCT00852904|Longitudinal Study|longitudinal study
545322|NCT00852904|National Children's Study|national children's study
545323|NCT00852891|weaning|weaning
545324|NCT00852891|echocardiogram|echocardiogram
545325|NCT00852891|diastolic dysfunction|diastolic dysfunction
545326|NCT00852891|Mechanical ventilation|mechanical ventilation
545327|NCT00852878|Recurrent Abdominal Pain|recurrent abdominal pain
545328|NCT00852878|Biofeedback|biofeedback
545329|NCT00852878|Heart Rate Variability|heart rate variability
545330|NCT00852865|Inflammation|inflammation
545331|NCT00852865|Pain|pain
545332|NCT00852852|ESRA-C 2|esra-c 2
545333|NCT00852852|computerized assessment|computerized assessment
545334|NCT00852839|Dry mouth|dry mouth
545335|NCT00852839|Sjogren's syndrome|sjogren's syndrome
545336|NCT00852839|Xerostomia|xerostomia
545337|NCT00852826|axillary seroma|axillary seroma
545338|NCT00852826|axillary lymphadenectomy|axillary lymphadenectomy
545339|NCT00852826|morbidity|morbidity
545340|NCT00852826|morbidity postlymphadenectomy|morbidity postlymphadenectomy
545341|NCT00852826|Lymphadenectomy|lymphadenectomy
545342|NCT00852813|tolerance|tolerance
545343|NCT00852813|prebiotic|prebiotic
545344|NCT00852813|gastrointestinal effects|gastrointestinal effects
545345|NCT00852800|spontaneous bacterial peritonitis|spontaneous bacterial peritonitis
545346|NCT00852800|albumin|albumin
545347|NCT00852800|renal impairment|renal impairment
545348|NCT00852800|mortality|mortality
545349|NCT00852787|Digoxin like substances|digoxin like substances
545350|NCT00852787|digibind|digibind
545351|NCT00852787|digoxin immune fab|digoxin immune fab
545352|NCT00852787|end-stage-renal-disease|end-stage-renal-disease
545353|NCT00852787|marinobufagenin|marinobufagenin
545354|NCT00852761|Psoriasis|psoriasis
545355|NCT00852748|headache|headache
545356|NCT00852735|Cardiovascular diseases|cardiovascular diseases
545357|NCT00852735|Rapeseed oil|rapeseed oil
545358|NCT00852735|Micronutriments|micronutriments
545359|NCT00852735|HDL cholesterol|hdl cholesterol
545360|NCT00852735|Oxidative stress|oxidative stress
545361|NCT00852735|Tocopherols|tocopherols
545362|NCT00852735|Sterols|sterols
545363|NCT00852735|Prevention of cardiovascular diseases|prevention of cardiovascular diseases
545364|NCT00852722|Multiple sclerosis|multiple sclerosis
545365|NCT00852722|Diet|diet
545366|NCT00852709|Myelodysplastic syndrome that has transformed to AML (AML/MDS)|myelodysplastic syndrome that has transformed to aml (aml/mds)
545367|NCT00852709|Treatment-related AML|treatment-related aml
545368|NCT00852709|AML evolving from myeloproliferative disorders (MPD)|aml evolving from myeloproliferative disorders (mpd)
545369|NCT00852709|Acute lymphocytic leukemia (ALL)|acute lymphocytic leukemia (all)
545370|NCT00852709|Acute promyelocytic leukemia (APL) refractory to arsenic therapy or retinoic acid therapy|acute promyelocytic leukemia (apl) refractory to arsenic therapy or retinoic acid therapy
545371|NCT00852709|Relapsed and/or refractory acute leukemia with progressive disease since last therapy|relapsed and/or refractory acute leukemia with progressive disease since last therapy
545372|NCT00852709|Chronic myelogenous leukemia (CML) in accelerated phase or blast crisis refractory to imatinib|chronic myelogenous leukemia (cml) in accelerated phase or blast crisis refractory to imatinib
545373|NCT00852709|High-risk MPD including myelofibrosis, chronic myelomonocytic leukemia (CMML, and relapsed or refractory juvenile myelomonocytic leukemia (JMML).|high-risk mpd including myelofibrosis, chronic myelomonocytic leukemia (cmml, and relapsed or refractory juvenile myelomonocytic leukemia (jmml).
545374|NCT00852696|Overactive Bladder|overactive bladder
545375|NCT00852696|Incontinence|incontinence
545376|NCT00852696|Solifenacin|solifenacin
545377|NCT00852696|Women|women
545378|NCT00852696|Postoperative|postoperative
545379|NCT00852657|Rotator cuff tear|rotator cuff tear
545380|NCT00852657|surgical repair|surgical repair
545381|NCT00852657|Physiotherapy|physiotherapy
545382|NCT00852657|Treatment benefit|treatment benefit
545383|NCT00852657|Surgery|surgery
545384|NCT00852644|stage I non-small cell lung cancer|stage i non-small cell lung cancer
545385|NCT00852644|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
545386|NCT00852631|Quetiapine efficacy in schizophrenia|quetiapine efficacy in schizophrenia
545387|NCT00852618|HIV Integrase Inhibitors|hiv integrase inhibitors
545388|NCT00852618|HIV Nucleoside Reverse Transcriptase Inhibitors|hiv nucleoside reverse transcriptase inhibitors
545389|NCT00852618|Treatment Naive|treatment naive
545390|NCT00852618|Viral Load|viral load
545391|NCT00852605|Acute Lung Injury after allogeneic transplantation|acute lung injury after allogeneic transplantation
545392|NCT00852592|Bipolar Disorder Depression Midday Light Therapy|bipolar disorder depression midday light therapy
545393|NCT00852592|Bipolar Disorder Type I or II|bipolar disorder type i or ii
545395|NCT00852579|Smoker|smoker
545396|NCT00852579|Macrolide|macrolide
545397|NCT00852566|Chronic myeloid leukemia|chronic myeloid leukemia
545398|NCT00852566|tyrosine kinase inhibitor|tyrosine kinase inhibitor
545399|NCT00852566|stem cell|stem cell
545400|NCT00852566|Philadelphia chromosome|philadelphia chromosome
545401|NCT00852566|dasatinib|dasatinib
545402|NCT00852553|intestinal|intestinal
545403|NCT00852553|smooth|smooth
545404|NCT00852553|muscle|muscle
545405|NCT00852553|GI|gi
545406|NCT00852553|motility|motility
545407|NCT00852540|impetigo|impetigo
545408|NCT00852540|methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
545409|NCT00852540|linezolid|linezolid
545410|NCT00852540|secondarily-infected traumatic lesion|secondarily-infected traumatic lesion
545411|NCT00852540|uncomplicated skin infection|uncomplicated skin infection
545412|NCT00852540|retapamulin|retapamulin
545413|NCT00852527|Traumatic Brain Injury|traumatic brain injury
545414|NCT00852527|Screening|screening
545415|NCT00852527|Diagnosis|diagnosis
545416|NCT00852527|Rehabilitation Outcome|rehabilitation outcome
545417|NCT00852514|Bioimpedance|bioimpedance
545418|NCT00852514|ultrafiltration|ultrafiltration
545419|NCT00852514|blood pressure|blood pressure
545420|NCT00852514|pulse pressure|pulse pressure
545421|NCT00852501|Non-functioning pituitary adenoma|non-functioning pituitary adenoma
545422|NCT00852501|RTPCR|rtpcr
545423|NCT00852501|Hormonal receptors|hormonal receptors
545424|NCT00852475|MUFA|mufa
545425|NCT00852475|PUFA|pufa
545426|NCT00852475|MOVE! program|move! program
545427|NCT00852462|SAMI|sami
545428|NCT00852462|Symptom Assessment and Management Intervention Program|symptom assessment and management intervention program
545429|NCT00852449|Intraoperative fluid|intraoperative fluid
545430|NCT00852449|Monitoring|monitoring
545431|NCT00852449|Oesophageal Doppler|oesophageal doppler
545432|NCT00852449|Abdominal surgery|abdominal surgery
545433|NCT00852449|major abdominal surgery|major abdominal surgery
545434|NCT00852436|neuropathic pain|neuropathic pain
545435|NCT00852436|orofacial pain|orofacial pain
545436|NCT00852436|clinical trials|clinical trials
545437|NCT00852436|pregabalin|pregabalin
545438|NCT00852436|randomized controlled trial|randomized controlled trial
545439|NCT00852423|Malaria in pregnancy|malaria in pregnancy
545440|NCT00852423|Sub-saharan Africa|sub-saharan africa
545441|NCT00852423|Treatment|treatment
545442|NCT00852423|Artemisinin containing Therapy|artemisinin containing therapy
545443|NCT00852423|Efficacy|efficacy
545444|NCT00852423|Safety|safety
545445|NCT00852410|Endoscopic sinus surgery|endoscopic sinus surgery
545446|NCT00852384|Anesthesia induction|anesthesia induction
545447|NCT00852384|Obese patients|obese patients
545448|NCT00852384|Noninvasive ventilation|noninvasive ventilation
545449|NCT00852384|Alveolar recruitment|alveolar recruitment
545450|NCT00852371|Malaria|malaria
545451|NCT00852371|Intermittent preventive treatment|intermittent preventive treatment
545452|NCT00852371|Efficacy|efficacy
545453|NCT00852371|Safety|safety
545454|NCT00852371|Tolerability|tolerability
545455|NCT00852371|Schoolchildren|schoolchildren
545456|NCT00852371|Uganda|uganda
545457|NCT00852358|mucopolysaccharidosis|mucopolysaccharidosis
545458|NCT00852358|Hurler-Scheie|hurler-scheie
545459|NCT00852358|Scheie|scheie
545460|NCT00852358|laronidase|laronidase
545461|NCT00852358|cognitive decline|cognitive decline
545462|NCT00852358|central nervous system|central nervous system
545463|NCT00852358|enzyme replacement therapy|enzyme replacement therapy
545464|NCT00852358|intrathecal|intrathecal
545465|NCT00852358|LA Biomed|la biomed
545466|NCT00852345|multibacillary leprosy|multibacillary leprosy
545467|NCT00852345|leprosy|leprosy
545468|NCT00852345|clofazamine|clofazamine
545469|NCT00852332|male breast cancer|male breast cancer
545470|NCT00852332|stage IIIB breast cancer|stage iiib breast cancer
545471|NCT00852332|stage IIIC breast cancer|stage iiic breast cancer
545472|NCT00852332|stage IV breast cancer|stage iv breast cancer
545473|NCT00852332|recurrent breast cancer|recurrent breast cancer
545474|NCT00852332|stage IIIA breast cancer|stage iiia breast cancer
545475|NCT00852332|HER2-negative breast cancer|her2-negative breast cancer
545476|NCT00852319|Interpregnancy Care|interpregnancy care
545477|NCT00852319|Preconceptual Care|preconceptual care
545478|NCT00852319|Premature Birth|premature birth
545479|NCT00852319|Preterm Delivery|preterm delivery
545480|NCT00852306|oocyte freezing|oocyte freezing
545481|NCT00852306|vitrification|vitrification
545482|NCT00852306|slow freeze|slow freeze
545483|NCT00852306|fertility preservation|fertility preservation
545484|NCT00852293|liver disease|liver disease
545849|NCT00851032|IMPACT|impact
545485|NCT00852293|Chitinase 3 like-1 protein|chitinase 3 like-1 protein
545486|NCT00852280|scars|scars
545487|NCT00852280|late effect of burn|late effect of burn
545488|NCT00852280|burn|burn
545489|NCT00852280|pulsed-dye laser|pulsed-dye laser
545490|NCT00852267|cholesterol|cholesterol
545491|NCT00852267|diet|diet
545492|NCT00852267|protein|protein
545493|NCT00852267|carbohydrate|carbohydrate
545494|NCT00852267|saturated fat|saturated fat
545495|NCT00852267|LDL subclass|ldl subclass
545496|NCT00852267|healthy volunteers|healthy volunteers
545497|NCT00852254|Cardiac Index|cardiac index
545498|NCT00852254|Ultrasound Dilution|ultrasound dilution
545499|NCT00852254|Accuracy of ultrasound dilution cardiac index.|accuracy of ultrasound dilution cardiac index.
545500|NCT00852228|colorectal cancer|colorectal cancer
545501|NCT00852228|unresectable metastases|unresectable metastases
545502|NCT00852228|neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
545503|NCT00852228|liver metastases|liver metastases
545504|NCT00852228|chronotherapy|chronotherapy
545505|NCT00852228|cetuximab|cetuximab
545506|NCT00852228|irinotecan|irinotecan
545507|NCT00852228|oxaliplatin|oxaliplatin
545508|NCT00852228|5-fluorouracil|5-fluorouracil
545509|NCT00852228|hepatic artery infusion|hepatic artery infusion
545510|NCT00852228|Unresectable hepatic lesions|unresectable hepatic lesions
545511|NCT00852228|1 to 3 prior chemotherapy regimens|1 to 3 prior chemotherapy regimens
545512|NCT00852215|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
545513|NCT00852215|Paclitaxel-eluting stent|paclitaxel-eluting stent
545514|NCT00852215|Vision stent|vision stent
545515|NCT00852202|bipolar|bipolar
545516|NCT00852202|depression|depression
545517|NCT00852189|Cancer|cancer
545518|NCT00852189|Phase 1|phase 1
545519|NCT00852189|EC0489|ec0489
545520|NCT00852189|EC20|ec20
545521|NCT00852189|Refractory|refractory
545522|NCT00852189|Metastatic|metastatic
545523|NCT00852189|Experimental|experimental
545524|NCT00852176|Coronary brachytherapy|coronary brachytherapy
545525|NCT00852176|Coronary restenosis|coronary restenosis
545526|NCT00852176|Coronary in stent restenosis|coronary in stent restenosis
545527|NCT00852163|conditioning, preparative|conditioning, preparative
545528|NCT00852163|clofarabine; transplant|clofarabine; transplant
545529|NCT00852163|Busulfan|busulfan
545530|NCT00852163|leukemia|leukemia
545531|NCT00852163|myelodysplastic syndrome|myelodysplastic syndrome
545532|NCT00852150|gastritis|gastritis
545533|NCT00852150|duodenitis|duodenitis
545534|NCT00852150|inter-rater reliability|inter-rater reliability
545535|NCT00852150|intra-rater reliablity|intra-rater reliablity
545536|NCT00852150|gastroscopy|gastroscopy
545537|NCT00852150|duodenoscopy|duodenoscopy
545538|NCT00852137|Peplin|peplin
545539|NCT00852137|PEP005|pep005
545540|NCT00852137|Actinic Keratosis|actinic keratosis
545541|NCT00852124|Asthma|asthma
545542|NCT00852124|Probiotic|probiotic
545543|NCT00852124|VSL#3|vsl#3
545544|NCT00852111|Fatigue|fatigue
545545|NCT00852111|Radiotherapy|radiotherapy
545546|NCT00852111|Cancer Therapy|cancer therapy
545547|NCT00852111|Cancer|cancer
545548|NCT00852098|Fundoplication|fundoplication
545549|NCT00852098|gastroesophageal reflux|gastroesophageal reflux
545550|NCT00852098|gastric vessels|gastric vessels
545551|NCT00852098|surgery|surgery
545552|NCT00852085|Counseling|counseling
545553|NCT00852085|Crime|crime
545554|NCT00852085|Adolescent|adolescent
545555|NCT00852072|common bile duct stones|common bile duct stones
545556|NCT00852072|mechanical lithotripsy|mechanical lithotripsy
545557|NCT00852072|balloon sphincteroplasty|balloon sphincteroplasty
545558|NCT00852059|ADHD|adhd
545559|NCT00852059|children|children
545560|NCT00852059|adolescents|adolescents
545561|NCT00852059|methylphenidate|methylphenidate
545562|NCT00852059|adherence|adherence
545563|NCT00852059|immediate release|immediate release
545564|NCT00852059|extended release|extended release
545565|NCT00852059|efficacy|efficacy
545566|NCT00852046|Mechanical ventilation|mechanical ventilation
545567|NCT00852033|alcoholism|alcoholism
545568|NCT00852033|alcohol abuse|alcohol abuse
545569|NCT00852033|prevention|prevention
545570|NCT00852033|behavior modification|behavior modification
545571|NCT00852033|parent offspring interaction|parent offspring interaction
545572|NCT00852033|university student|university student
545573|NCT00852033|substance abuse related behavior|substance abuse related behavior
545574|NCT00852033|adolescence|adolescence
545575|NCT00852007|prostate cancer|prostate cancer
545576|NCT00852007|dendritic cells|dendritic cells
545577|NCT00852007|MUC-1|muc-1
545578|NCT00852007|immune therapy|immune therapy
545579|NCT00851994|Patients having surgery|patients having surgery
545580|NCT00851981|Alcohol Liver Disease|alcohol liver disease
545581|NCT00851968|hepatectomy|hepatectomy
545582|NCT00851968|Selective HepaticVascular Clamping|selective hepaticvascular clamping
545583|NCT00851942|Volunteer|volunteer
545584|NCT00851942|Hypoadrenalism|hypoadrenalism
545585|NCT00851942|Hypopituitarism|hypopituitarism
545586|NCT00851942|Healthy volunteers|healthy volunteers
545587|NCT00851929|sarcoidosis|sarcoidosis
545588|NCT00851929|pulmonary hypertension|pulmonary hypertension
545589|NCT00851929|dyspnea|dyspnea
545590|NCT00851929|sarcoidosis associated pulmonary hypertension|sarcoidosis associated pulmonary hypertension
545591|NCT00851877|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
545592|NCT00851877|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
545593|NCT00851877|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
545594|NCT00851877|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
545595|NCT00851877|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
545596|NCT00851877|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
545597|NCT00851877|tongue cancer|tongue cancer
545598|NCT00851864|anticoagulation|anticoagulation
545599|NCT00851864|pregnancy|pregnancy
545600|NCT00851851|Surgical patients|surgical patients
545601|NCT00851838|Peritoneal dialysis|peritoneal dialysis
545602|NCT00851838|L-carnitine|l-carnitine
545603|NCT00851825|autonomic modulation|autonomic modulation
545604|NCT00851825|heart rate|heart rate
545605|NCT00851825|pressure support ventilation|pressure support ventilation
545606|NCT00851825|T-tube|t-tube
545607|NCT00851825|Mechanical ventilation|mechanical ventilation
545608|NCT00851812|Exercise|exercise
545609|NCT00851812|Breast cancer|breast cancer
545610|NCT00851812|fatigue|fatigue
545611|NCT00851799|ART|art
545612|NCT00851799|Antiretroviral therapy|antiretroviral therapy
545613|NCT00851799|Treatment naive|treatment naive
545614|NCT00851799|Highly active antiretroviral therapy (HAART)|highly active antiretroviral therapy (haart)
545615|NCT00851786|Herpes Zoster Vaccine|herpes zoster vaccine
545616|NCT00851786|Herpes Zoster Virus|herpes zoster virus
545617|NCT00851786|HIV|hiv
545618|NCT00851721|Hemophilia A|hemophilia a
545619|NCT00851721|Factor VIII Inhibitor|factor viii inhibitor
545620|NCT00851721|Factor IX Inhibitor|factor ix inhibitor
545621|NCT00851721|Hemophilia B|hemophilia b
545622|NCT00851708|kidney|kidney
545623|NCT00851708|deceased kidney transplant|deceased kidney transplant
545624|NCT00851708|oxidative stress|oxidative stress
545625|NCT00851708|renal function measurements|renal function measurements
545626|NCT00851695|Lung Function Decline|lung function decline
545627|NCT00851695|Lung Function|lung function
545628|NCT00851695|Allergy|allergy
545629|NCT00851695|COPD|copd
545630|NCT00851695|Vitamin D|vitamin d
545631|NCT00851682|Prostate Cancer|prostate cancer
545632|NCT00851682|Dynamic Contrast Enhanced MRI|dynamic contrast enhanced mri
545633|NCT00851682|Non-invasive Prostate Cancer Detection|non-invasive prostate cancer detection
545634|NCT00851669|depression|depression
545635|NCT00851669|alcohol dependence|alcohol dependence
545636|NCT00851669|women|women
545637|NCT00851669|psychotherapy|psychotherapy
545638|NCT00851669|men|men
545639|NCT00851630|HIV|hiv
545640|NCT00851630|Tuberculosis|tuberculosis
545641|NCT00851630|Treatment Naive|treatment naive
545642|NCT00851617|Mechanical ventilator weaning|mechanical ventilator weaning
545643|NCT00851617|Respiratory Muscle Training|respiratory muscle training
545644|NCT00851617|Ventilator dependent|ventilator dependent
545645|NCT00851604|ProGRP|progrp
545646|NCT00851604|CgA|cga
545647|NCT00851604|NSE|nse
545648|NCT00851604|TUM2-PK|tum2-pk
545649|NCT00851604|Neuroendocrine Tumors|neuroendocrine tumors
545650|NCT00851591|fenugreek|fenugreek
545651|NCT00851591|galactogogue|galactogogue
545652|NCT00851591|breastmilk|breastmilk
545653|NCT00851591|Trigonella foenum-graecum|trigonella foenum-graecum
545654|NCT00851591|Bird's Foot|bird's foot
545655|NCT00851591|Greek Clover|greek clover
545656|NCT00851591|Greek Hay|greek hay
545657|NCT00851591|Hu Lu Ba|hu lu ba
545658|NCT00851591|Trigonella|trigonella
545659|NCT00851578|AF|af
545660|NCT00851578|atrial fibrillation|atrial fibrillation
545661|NCT00851578|LAA occlusion|laa occlusion
545662|NCT00851552|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
545663|NCT00851552|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
545664|NCT00851552|anaplastic large cell lymphoma|anaplastic large cell lymphoma
545665|NCT00851539|HIV|hiv
545666|NCT00851539|Teenagers|teenagers
545667|NCT00851539|Adolescent|adolescent
545668|NCT00851539|HIV Testing|hiv testing
545669|NCT00851539|HIV Seronegativity|hiv seronegativity
545670|NCT00851526|Coronary bifurcation lesion|coronary bifurcation lesion
545671|NCT00851526|Drug-eluting stent|drug-eluting stent
545672|NCT00851513|Pudendal neuralgia|pudendal neuralgia
545673|NCT00851513|pudendal nerve|pudendal nerve
545674|NCT00851513|Alcock's canal syndrome|alcock's canal syndrome
545675|NCT00851513|Canal syndrome|canal syndrome
545676|NCT00851513|neuropathic pain|neuropathic pain
545677|NCT00851513|infiltration|infiltration
545678|NCT00851513|randomized protocol|randomized protocol
545679|NCT00851513|pain scales|pain scales
545680|NCT00851500|atherosclerosis|atherosclerosis
545681|NCT00851500|carotid artery disease|carotid artery disease
545682|NCT00851487|ARI|ari
545683|NCT00851487|LRTI|lrti
545684|NCT00851474|COstatus(R)|costatus(r)
545685|NCT00851474|Ultrasound Dilution|ultrasound dilution
545686|NCT00851474|Cardiac Output|cardiac output
545687|NCT00851474|Blood Volumes|blood volumes
545688|NCT00851474|Comparison of COstatus(R) cardiac output with other methods|comparison of costatus(r) cardiac output with other methods
545689|NCT00851461|Spinobulbar muscular atrophy|spinobulbar muscular atrophy
545690|NCT00851461|Kennedy's disease|kennedy's disease
545691|NCT00851461|Goserelin|goserelin
545692|NCT00851461|Electrophysiologic study|electrophysiologic study
545693|NCT00851461|Inclusion body|inclusion body
545694|NCT00851435|Pneumonia|pneumonia
545695|NCT00851435|Nosocomial pneumonia|nosocomial pneumonia
545696|NCT00851435|Pseudomonas aeruginosa|pseudomonas aeruginosa
545697|NCT00851435|Monoclonal antibody|monoclonal antibody
545698|NCT00851435|Hospital-Acquired Pneumonia|hospital-acquired pneumonia
545699|NCT00851422|Ultrasound Dilution|ultrasound dilution
545700|NCT00851422|Cardiac Output|cardiac output
545701|NCT00851422|Validation of measured ultrasound dilution cardiac output|validation of measured ultrasound dilution cardiac output
545702|NCT00851396|Vitamin D deficiency|vitamin d deficiency
545703|NCT00851396|Insulin resistance|insulin resistance
545704|NCT00851396|Glucose- Insulin dynamics|glucose- insulin dynamics
545705|NCT00851396|Obese adolescents|obese adolescents
545706|NCT00851383|HIV|hiv
545707|NCT00851383|Human Immunodeficiency Virus|human immunodeficiency virus
545708|NCT00851383|HIV Seronegativity|hiv seronegativity
545709|NCT00851383|Preventive Vaccine|preventive vaccine
545710|NCT00851370|COPD|copd
545711|NCT00851370|Exacerbation|exacerbation
545712|NCT00851357|Nicotine Replacement Therapy|nicotine replacement therapy
545713|NCT00851357|Nicotine Patch|nicotine patch
545714|NCT00851357|Smoking cessation|smoking cessation
545715|NCT00851357|Telephone|telephone
545716|NCT00851357|Tobacco cessation|tobacco cessation
545717|NCT00851357|Counseling|counseling
545718|NCT00851357|Nicotine|nicotine
545719|NCT00851357|Self-Help|self-help
545720|NCT00851357|Smoking abstinence|smoking abstinence
545721|NCT00851357|Tobacco Use Disorder|tobacco use disorder
545722|NCT00851344|Proof-of-Concept|proof-of-concept
545723|NCT00851344|Allergic Rhinitis|allergic rhinitis
545724|NCT00851331|Benign childhood epilepsy|benign childhood epilepsy
545725|NCT00851318|Rheumatoid Arthritis|rheumatoid arthritis
545726|NCT00851318|Certolizumab Pegol|certolizumab pegol
545727|NCT00851318|Cimzia|cimzia
545728|NCT00851305|Stomach|stomach
545729|NCT00851305|endoscopy|endoscopy
545730|NCT00851305|neoplasms|neoplasms
545731|NCT00851292|prostate cancer|prostate cancer
545732|NCT00851292|biopsy|biopsy
545733|NCT00851292|TRUS|trus
545734|NCT00851292|diagnosis|diagnosis
545735|NCT00851279|arrhythmia|arrhythmia
545736|NCT00851279|ventricular tachycardia|ventricular tachycardia
545737|NCT00851279|ablation|ablation
545738|NCT00851279|mapping|mapping
545739|NCT00851279|electrophysiology|electrophysiology
545740|NCT00851253|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
545741|NCT00851253|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
545742|NCT00851253|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
545743|NCT00851253|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
545744|NCT00851253|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
545745|NCT00851253|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
545746|NCT00851253|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
545747|NCT00851253|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
545748|NCT00851253|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
545749|NCT00851253|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
545750|NCT00851253|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
545751|NCT00851253|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
545752|NCT00851253|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
545866|NCT00850954|Mexican American|mexican american
545753|NCT00851253|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
545754|NCT00851253|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
545755|NCT00851253|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
545756|NCT00851253|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
545757|NCT00851253|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
545758|NCT00851253|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
545759|NCT00851253|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
545760|NCT00851253|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
545761|NCT00851253|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
545762|NCT00851253|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
546255|NCT00849433|epithelial|epithelial
545763|NCT00851253|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
545764|NCT00851253|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
545765|NCT00851253|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
545766|NCT00851253|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
545767|NCT00851253|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
545768|NCT00851253|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
545769|NCT00851253|recurrent salivary gland cancer|recurrent salivary gland cancer
545770|NCT00851253|salivary gland acinic cell tumor|salivary gland acinic cell tumor
545771|NCT00851253|salivary gland adenocarcinoma|salivary gland adenocarcinoma
545772|NCT00851253|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
545773|NCT00851253|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
545774|NCT00851253|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
545775|NCT00851253|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
545776|NCT00851253|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
545777|NCT00851253|stage II salivary gland cancer|stage ii salivary gland cancer
545778|NCT00851253|stage III salivary gland cancer|stage iii salivary gland cancer
545779|NCT00851253|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
545780|NCT00851253|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
545781|NCT00851253|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
545782|NCT00851253|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
545783|NCT00851253|stage IV salivary gland cancer|stage iv salivary gland cancer
545784|NCT00851253|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
545785|NCT00851253|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
545786|NCT00851253|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
545787|NCT00851253|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
545788|NCT00851253|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
545789|NCT00851240|rheumatoid arthritis|rheumatoid arthritis
545790|NCT00851240|safety|safety
545791|NCT00851227|Pharmacokinetics|pharmacokinetics
545792|NCT00851227|Protein Binding|protein binding
545793|NCT00851227|Conivaptan|conivaptan
545794|NCT00851227|Vaprisol|vaprisol
545795|NCT00851227|Liver Disease|liver disease
545796|NCT00851214|Non-invasive hemodynamic monitoring|non-invasive hemodynamic monitoring
545797|NCT00851214|Emergency Department patients|emergency department patients
545798|NCT00851214|trauma with an ISS>15|trauma with an iss>15
545799|NCT00851214|Non-invasive continuous hemodynamic monitoring|non-invasive continuous hemodynamic monitoring
545800|NCT00851201|children|children
545801|NCT00851201|obesity|obesity
545802|NCT00851201|weight loss|weight loss
545803|NCT00851201|prevention|prevention
545804|NCT00851201|diabetes risk|diabetes risk
545805|NCT00851201|cardiometabolic|cardiometabolic
545806|NCT00851162|Bone defect|bone defect
545807|NCT00851162|Benign bone lesions|benign bone lesions
545808|NCT00851162|Stem cells|stem cells
545809|NCT00851149|aorta|aorta
545810|NCT00851149|disease|disease
545811|NCT00851149|abdominal|abdominal
545812|NCT00851149|surgery|surgery
545813|NCT00851149|Osteoarthritis, Hip|osteoarthritis, hip
545814|NCT00851149|replacement|replacement
545815|NCT00851149|blood|blood
545816|NCT00851149|autolog|autolog
545817|NCT00851149|transfusion|transfusion
545818|NCT00851149|cytokines|cytokines
545819|NCT00851136|CRC|crc
545820|NCT00851136|Colon cancer|colon cancer
545821|NCT00851136|Avastin|avastin
545822|NCT00851136|APM4566g|apm4566g
545823|NCT00851123|Stroke|stroke
545824|NCT00851123|arm paresis|arm paresis
545825|NCT00851123|mCIMT|mcimt
545826|NCT00851123|bimanual training|bimanual training
545827|NCT00851123|rehabilitation|rehabilitation
545828|NCT00851110|high dose|high dose
545829|NCT00851110|breast cancer|breast cancer
545830|NCT00851110|adjuvant|adjuvant
545831|NCT00851084|Angiogenesis|angiogenesis
545832|NCT00851084|Colon cancer|colon cancer
545833|NCT00851084|Rectal cancer|rectal cancer
545834|NCT00851084|Oxaliplatin|oxaliplatin
545835|NCT00851071|Anxiety|anxiety
545836|NCT00851071|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
545837|NCT00851071|Defibrillators, Implantable|defibrillators, implantable
545838|NCT00851058|Behavioral research|behavioral research
545839|NCT00851058|Motivational counseling|motivational counseling
545840|NCT00851058|Group Counseling|group counseling
545841|NCT00851058|Motivational Interviewing|motivational interviewing
545842|NCT00851058|Vicarious Learning|vicarious learning
545843|NCT00851058|Risky alcohol use|risky alcohol use
545844|NCT00851058|Recidivism|recidivism
545845|NCT00851058|Motor Vehicles|motor vehicles
545846|NCT00851058|Crime|crime
545847|NCT00851032|Advanced Cancer|advanced cancer
545848|NCT00851032|Initiative for Molecular Profiling in Advanced Cancer Therapy|initiative for molecular profiling in advanced cancer therapy
545850|NCT00851032|Molecular Profile-Based Study|molecular profile-based study
545851|NCT00851032|Investigational Cancer Therapeutics Program|investigational cancer therapeutics program
545852|NCT00851032|Molecular profiling|molecular profiling
545853|NCT00851032|Phase I Therapies|phase i therapies
545854|NCT00851032|Tissue Bank|tissue bank
545855|NCT00851019|Exercise|exercise
545856|NCT00851019|Video game|video game
545857|NCT00851019|Type 2 diabetes|type 2 diabetes
545858|NCT00851019|Dance|dance
545859|NCT00851006|Depression|depression
545860|NCT00851006|Females|females
545861|NCT00851006|Adolescents|adolescents
545862|NCT00850993|Hemolysis|hemolysis
545863|NCT00850954|Lung Cancer|lung cancer
545864|NCT00850954|Cancer|cancer
545865|NCT00850954|Smoke|smoke
545867|NCT00850954|Indoor Air Policy|indoor air policy
545868|NCT00850954|Secondhand smoke|secondhand smoke
545869|NCT00850954|SHS|shs
545870|NCT00850954|Smoking cessation programs|smoking cessation programs
545871|NCT00850954|Smokers|smokers
545872|NCT00850954|Tobacco|tobacco
545873|NCT00850954|Nicotine|nicotine
545874|NCT00850954|Chronic diseases|chronic diseases
545875|NCT00850954|Transtheoretical model of change|transtheoretical model of change
545876|NCT00850954|TTM|ttm
545877|NCT00850941|Registry|registry
545878|NCT00850941|Research Database|research database
545879|NCT00850941|Prostate cancer|prostate cancer
545880|NCT00850941|Casodex|casodex
545881|NCT00850941|Flutamide|flutamide
545882|NCT00850941|Goserelin Acetate|goserelin acetate
545883|NCT00850941|Leuprolide Acetate|leuprolide acetate
545884|NCT00850941|Radiation|radiation
545885|NCT00850941|PSA|psa
545886|NCT00850941|Post-prostatectomy|post-prostatectomy
545887|NCT00850941|Radiation Therapy|radiation therapy
545888|NCT00850941|Prostate Specific Antigen|prostate specific antigen
545889|NCT00850941|Adenocarcinoma|adenocarcinoma
545890|NCT00850941|Radical Prostatectomy|radical prostatectomy
545891|NCT00850941|Bicalutamide|bicalutamide
545892|NCT00850941|Zoladex|zoladex
545893|NCT00850941|Lupron Depot|lupron depot
545894|NCT00850941|Tissue banking|tissue banking
545895|NCT00850941|Hormones|hormones
545896|NCT00850928|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
545897|NCT00850928|MCI|mci
545898|NCT00850928|Mild Cognitive Impairment|mild cognitive impairment
545899|NCT00850928|Aβ40|aβ40
545900|NCT00850928|Aβ42|aβ42
545901|NCT00850928|Apolipoprotein E|apolipoprotein e
545902|NCT00850928|Inflammatory Markers|inflammatory markers
545903|NCT00850928|Apolipoprotein E Profile|apolipoprotein e profile
545904|NCT00850928|Serum Beta Amyloid Profile|serum beta amyloid profile
545905|NCT00850928|Inflammatory Markers Profile|inflammatory markers profile
545906|NCT00850915|tuberculosis|tuberculosis
545907|NCT00850915|community IPT|community ipt
545908|NCT00850915|isoniazid adverse events|isoniazid adverse events
545909|NCT00850915|tuberculosis incidence|tuberculosis incidence
545910|NCT00850902|ELBW|elbw
545911|NCT00850902|Humidity|humidity
545912|NCT00850902|BPD|bpd
545913|NCT00850889|Aesthetic correction of nasolabial folds|aesthetic correction of nasolabial folds
545914|NCT00850863|COPD|copd
545915|NCT00850863|Inflammation|inflammation
545916|NCT00850863|Smoking|smoking
545917|NCT00850863|Susceptibility|susceptibility
545918|NCT00850850|PACU|pacu
545919|NCT00850850|Physostigmine|physostigmine
545920|NCT00850850|Recovery|recovery
545921|NCT00850850|Postanesthesia Nursing|postanesthesia nursing
545922|NCT00850850|Wakefulness|wakefulness
545923|NCT00850850|General anesthesia|general anesthesia
545924|NCT00850850|General Anesthetics|general anesthetics
545925|NCT00850850|Postoperative Period|postoperative period
545926|NCT00850837|Microbicide|microbicide
545927|NCT00850837|HIV Seronegativity|hiv seronegativity
545928|NCT00850824|T2DM|t2dm
545929|NCT00850811|Peplin|peplin
545930|NCT00850811|PEP005|pep005
545931|NCT00850798|Type 2 diabetes|type 2 diabetes
545932|NCT00850798|Elder patients|elder patients
545933|NCT00850798|Glycemic control|glycemic control
545934|NCT00850798|Men or women aged ≥80 years at time of randomization. There is no upper age limit.|men or women aged ≥80 years at time of randomization. there is no upper age limit.
545935|NCT00850798|Be able to walk by themselves|be able to walk by themselves
545936|NCT00850798|They had their first diagnosis of type 2 diabetes mellitus at age 30 years or older.|they had their first diagnosis of type 2 diabetes mellitus at age 30 years or older.
545937|NCT00850772|Enteral nutrition|enteral nutrition
545938|NCT00850772|Ovarian cancer|ovarian cancer
545939|NCT00850772|Peritoneal cancer|peritoneal cancer
545940|NCT00850772|Fallopian tube cancer|fallopian tube cancer
545941|NCT00850772|Malnutrition|malnutrition
545942|NCT00850772|Surgery|surgery
545943|NCT00850772|Gynecological Cancer|gynecological cancer
545944|NCT00850772|Suspected advanced epithelial ovarian cancer|suspected advanced epithelial ovarian cancer
545945|NCT00850759|pedestrian safety|pedestrian safety
545946|NCT00850759|street-crossing ability|street-crossing ability
545947|NCT00850759|road-crossing|road-crossing
545948|NCT00850759|children|children
545949|NCT00850759|injury prevention|injury prevention
545950|NCT00850746|QT interval|qt interval
545951|NCT00850746|Cardiac Repolarization|cardiac repolarization
545952|NCT00850746|Cardiac Conduction|cardiac conduction
545953|NCT00850746|Healthy Subjects|healthy subjects
545954|NCT00850746|YM443 (Z-338, acotiamide hydrochloride)|ym443 (z-338, acotiamide hydrochloride)
545955|NCT00850746|Evaluation of QT Interval|evaluation of qt interval
545956|NCT00850720|Biological Response Modifiers|biological response modifiers
545957|NCT00850720|Bypass Surgery|bypass surgery
545958|NCT00850720|Cardiology|cardiology
545959|NCT00850720|Congenital Heart Disease|congenital heart disease
545960|NCT00850720|Endocrinology|endocrinology
545961|NCT00850720|Hormone Dysfunction|hormone dysfunction
545962|NCT00850720|Hormones|hormones
545963|NCT00850720|Neuroendocrinology|neuroendocrinology
545964|NCT00850720|Pediatric Surgery|pediatric surgery
545965|NCT00850707|AVF|avf
545966|NCT00850707|AVG|avg
545967|NCT00850707|TCC|tcc
545968|NCT00850707|inflammation|inflammation
545969|NCT00850707|monocite senescence|monocite senescence
545970|NCT00850694|Vitamin D deficiency|vitamin d deficiency
545971|NCT00850694|Obesity|obesity
545972|NCT00850694|Insulin resistance|insulin resistance
545973|NCT00850694|Glucose tolerance|glucose tolerance
545974|NCT00850681|Peplin|peplin
545975|NCT00850681|PEP005|pep005
545976|NCT00850668|Food Allergy|food allergy
545977|NCT00850668|Peanut Allergy|peanut allergy
545978|NCT00850642|Sputum cell counts|sputum cell counts
545979|NCT00850642|Neutrophils|neutrophils
545980|NCT00850642|Severe Asthma|severe asthma
545981|NCT00850642|ICS|ics
545982|NCT00850642|Inhaled corticosteroids|inhaled corticosteroids
545983|NCT00850629|weight regain|weight regain
545984|NCT00850629|endocrine counterregulation|endocrine counterregulation
545985|NCT00850616|HIV|hiv
545986|NCT00850616|HIV Seronegativity|hiv seronegativity
545987|NCT00850616|Preventive Vaccine|preventive vaccine
545988|NCT00850603|Menomune® - A/C/Y/W-135|menomune® - a/c/y/w-135
545989|NCT00850603|Meningococcal Infections|meningococcal infections
545990|NCT00850603|Meningitis|meningitis
545991|NCT00850564|growth hormone releasing hormone|growth hormone releasing hormone
545992|NCT00850551|Early Intervention|early intervention
545993|NCT00850551|Pulmonary Exacerbation|pulmonary exacerbation
545994|NCT00850551|Cystic Fibrosis|cystic fibrosis
545995|NCT00850551|Lung Function|lung function
545996|NCT00850551|Spirometry|spirometry
545997|NCT00850551|Phillips Telemonitor|phillips telemonitor
545998|NCT00850551|Home Spirometry|home spirometry
545999|NCT00850551|PiKo-6|piko-6
546000|NCT00850551|Home Monitoring|home monitoring
546001|NCT00850538|Bone Marrow Lesion|bone marrow lesion
546002|NCT00850538|BML|bml
546003|NCT00850538|Arthroplasty|arthroplasty
546004|NCT00850538|Replacement|replacement
546005|NCT00850538|Knee|knee
546006|NCT00850538|Discarded tissue|discarded tissue
546007|NCT00850486|women|women
546008|NCT00850486|ischemic heart disease|ischemic heart disease
546009|NCT00850486|high frequency ECG|high frequency ecg
546010|NCT00850486|exercise stress testing|exercise stress testing
546011|NCT00850486|signal processing|signal processing
546012|NCT00850486|ischemic heart disease in women|ischemic heart disease in women
546013|NCT00850473|PET|pet
546014|NCT00850473|CT|ct
546015|NCT00850473|Heart Attack|heart attack
546016|NCT00850473|Coronary Artery disease|coronary artery disease
546017|NCT00850473|Cardiac Catheterization|cardiac catheterization
546018|NCT00850447|Posttraumatic stress disorder|posttraumatic stress disorder
546019|NCT00850447|Cognition|cognition
546020|NCT00850447|Neuropsychological Tests|neuropsychological tests
546021|NCT00850421|migraine headache|migraine headache
546022|NCT00850421|Botulinum Toxin Type A|botulinum toxin type a
546023|NCT00850421|BOTOX|botox
546024|NCT00850421|BTX-A|btx-a
546025|NCT00850408|Stroke|stroke
546026|NCT00850408|rTMS|rtms
546027|NCT00850408|TMS|tms
546028|NCT00850408|Rehabilitation|rehabilitation
546029|NCT00850408|Upper Extremity|upper extremity
546030|NCT00850395|HIV-1|hiv-1
546031|NCT00850395|non-interventional|non-interventional
546032|NCT00850395|CCR-5 tropic virus|ccr-5 tropic virus
546033|NCT00850395|therapy experienced patients|therapy experienced patients
546034|NCT00850382|CBF AML|cbf aml
546035|NCT00850382|Dasatinib|dasatinib
546036|NCT00850382|Core Binding Factor (CBF)|core binding factor (cbf)
546037|NCT00850369|Pulmonary hypertension|pulmonary hypertension
546038|NCT00850369|Sickle cell disease|sickle cell disease
546039|NCT00850356|Bariatric Surgery|bariatric surgery
546040|NCT00850356|Body Weight|body weight
546041|NCT00850356|Health care costs|health care costs
546042|NCT00850356|Obesity|obesity
546043|NCT00850356|Obesity Complications|obesity complications
546044|NCT00850356|Prolonged wait times|prolonged wait times
546045|NCT00850356|Quality of Life|quality of life
546046|NCT00850343|Rheumatoid Arthritis|rheumatoid arthritis
546047|NCT00850343|Certolizumab Pegol|certolizumab pegol
546048|NCT00850343|Cimzia|cimzia
546049|NCT00850330|Drug interactions|drug interactions
546050|NCT00850330|Drug interaction software|drug interaction software
546051|NCT00850330|Older patients|older patients
546052|NCT00850330|Hospitalization|hospitalization
546053|NCT00850304|AML|aml
546054|NCT00850291|Partial duodenopancreatectomy using electrosurgical vessel sealing device|partial duodenopancreatectomy using electrosurgical vessel sealing device
546055|NCT00850278|Brain tumor|brain tumor
546056|NCT00850278|[18F]FLT|[18f]flt
546057|NCT00850278|[11C]MET|[11c]met
546058|NCT00850278|TEP-imaging|tep-imaging
546059|NCT00850278|tumor cell proliferation|tumor cell proliferation
546060|NCT00850265|Asthma|asthma
546061|NCT00850265|Formoterol|formoterol
546062|NCT00850265|Beclomethasone|beclomethasone
546063|NCT00850265|Extrafine formulation|extrafine formulation
546064|NCT00850265|Spacer|spacer
546065|NCT00850265|Moderate|moderate
546066|NCT00850265|Severe|severe
546067|NCT00850265|Stable|stable
546068|NCT00850252|Lifeline|lifeline
546069|NCT00850252|Tissue engineered blood vessel|tissue engineered blood vessel
546070|NCT00850252|A-V shunt|a-v shunt
546071|NCT00850239|diabetes|diabetes
546072|NCT00850239|DPP4 inhibitor|dpp4 inhibitor
546073|NCT00850239|dutogliptin|dutogliptin
546074|NCT00850226|test anxiety|test anxiety
546075|NCT00850200|Hodgkin Lymphoma, Proton Radiation|hodgkin lymphoma, proton radiation
546076|NCT00850187|Knee cartilage diseases|knee cartilage diseases
546077|NCT00850174|Bioequivalence|bioequivalence
546078|NCT00850174|Healthy Subjects|healthy subjects
546079|NCT00850161|Type 1 Diabetes|type 1 diabetes
546080|NCT00850161|Nasal Insulin|nasal insulin
546081|NCT00850161|Insulin Deficiency|insulin deficiency
546082|NCT00850161|Insulin-Dependent|insulin-dependent
546083|NCT00850148|Anwar|anwar
546084|NCT00850148|Melles|melles
546085|NCT00850148|Keratoconus|keratoconus
546086|NCT00850096|Phase 2 Study for novel insulin delivery of type 2 diabetes|phase 2 study for novel insulin delivery of type 2 diabetes
546087|NCT00850083|Fever|fever
546088|NCT00850083|Children|children
546089|NCT00850070|autism|autism
546090|NCT00850044|FIH|fih
546091|NCT00850044|SAD|sad
546092|NCT00850031|Presbyopia|presbyopia
546093|NCT00850031|Accommodation|accommodation
546094|NCT00850031|Near visual acuity|near visual acuity
546095|NCT00850031|LASIK|lasik
546096|NCT00850018|Sickle Cell Disease|sickle cell disease
546097|NCT00850018|Sickle Cell Anemia|sickle cell anemia
546098|NCT00850018|Hemoglobin SS|hemoglobin ss
546099|NCT00850018|Hemoglobin SB0|hemoglobin sb0
546100|NCT00850005|neuropathic pain|neuropathic pain
546101|NCT00850005|resistant|resistant
546102|NCT00850005|neuroinflammation|neuroinflammation
546103|NCT00850005|neuroinflammatory markers|neuroinflammatory markers
546104|NCT00850005|Neuropathic pain that has not responded to standard therapy|neuropathic pain that has not responded to standard therapy
546105|NCT00849992|Actinic cheilitis|actinic cheilitis
546106|NCT00849992|Imiquimod 5%|imiquimod 5%
546107|NCT00849992|Photodynamic therapy|photodynamic therapy
546108|NCT00849979|Colorectal|colorectal
546109|NCT00849979|Gastric|gastric
546110|NCT00849979|Gastrointestinal|gastrointestinal
546111|NCT00849979|GI|gi
546112|NCT00849979|Liver|liver
546113|NCT00849979|Pancreas|pancreas
546114|NCT00849979|Gastrointestinal Cancers|gastrointestinal cancers
546115|NCT00849979|Gastro-Intestinal Chemotherapy|gastro-intestinal chemotherapy
546116|NCT00849979|M.D. Anderson Symptom Inventory|m.d. anderson symptom inventory
546117|NCT00849979|MDASI-GI|mdasi-gi
546118|NCT00849979|Medical Oncology|medical oncology
546119|NCT00849966|Celebrex|celebrex
546120|NCT00849966|celecoxib|celecoxib
546121|NCT00849966|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors
546122|NCT00849966|Anti-Inflammatory Agents Non-Steroidal|anti-inflammatory agents non-steroidal
546123|NCT00849966|Adverse drug events|adverse drug events
546124|NCT00849966|quality of life|quality of life
546125|NCT00849966|Pain Postoperative|pain postoperative
546126|NCT00849966|Tonsillectomy|tonsillectomy
546127|NCT00849966|Adenotonsillectomy|adenotonsillectomy
546128|NCT00849966|Otologic Surgical Procedures|otologic surgical procedures
546129|NCT00849940|Spectroscopy|spectroscopy
546130|NCT00849940|Near infrared|near infrared
546131|NCT00849940|Oximetry|oximetry
546132|NCT00849940|Hypoxemia|hypoxemia
546133|NCT00849940|Tissue oxygenation|tissue oxygenation
546134|NCT00849940|Pediatric|pediatric
546135|NCT00849927|shoulder instability|shoulder instability
546136|NCT00849927|labral lesions|labral lesions
546137|NCT00849927|arthroscopic labral repair|arthroscopic labral repair
546138|NCT00849927|SLAP|slap
546139|NCT00849927|triple labrum|triple labrum
546140|NCT00849927|circumferential labrum|circumferential labrum
546141|NCT00849927|Pan-labral lesion|pan-labral lesion
546142|NCT00849888|Thymus Transplantation|thymus transplantation
546143|NCT00849888|DiGeorge Anomaly|digeorge anomaly
546144|NCT00849888|Athymia|athymia
546145|NCT00849888|Low T cell numbers|low t cell numbers
546146|NCT00849888|Immunoreconstitution|immunoreconstitution
546147|NCT00849888|Immunodeficiency|immunodeficiency
546148|NCT00849875|ASCI|asci
546149|NCT00849875|Dacarbazine|dacarbazine
546150|NCT00849875|Cancer immunotherapeutic|cancer immunotherapeutic
546151|NCT00849875|MAGE-A3|mage-a3
546152|NCT00849875|Malignant melanoma|malignant melanoma
546153|NCT00849862|Bioequivalence|bioequivalence
546154|NCT00849862|Healthy Subjects|healthy subjects
546155|NCT00849849|postgestational diabetes|postgestational diabetes
546156|NCT00849849|diabetes mellitus|diabetes mellitus
546157|NCT00849849|OGTT|ogtt
546158|NCT00849849|insulin sensitivity|insulin sensitivity
546159|NCT00849849|insulin secretion|insulin secretion
546160|NCT00849823|African American|african american
546161|NCT00849823|Men|men
546162|NCT00849823|Condoms|condoms
546163|NCT00849823|Randomization|randomization
546164|NCT00849823|Brief Intervention|brief intervention
546165|NCT00849823|HIV|hiv
546166|NCT00849823|HIV Seronegativity|hiv seronegativity
546167|NCT00849810|Hypertension|hypertension
546168|NCT00849810|Beta-blockers|beta-blockers
546169|NCT00849810|Ambulatory blood pressure|ambulatory blood pressure
546170|NCT00849810|Basal metabolic rate|basal metabolic rate
546171|NCT00849810|Quality of life|quality of life
546172|NCT00849797|Bioequivalence|bioequivalence
546173|NCT00849797|Healthy Subjects|healthy subjects
546174|NCT00849771|Displaced Scapula Fracture|displaced scapula fracture
546175|NCT00849771|Scapula Fracture|scapula fracture
546176|NCT00849771|Extraarticular Scapula Fractures|extraarticular scapula fractures
546177|NCT00849771|Clavicle|clavicle
546178|NCT00849758|breast cancer|breast cancer
546179|NCT00849758|elderly|elderly
546180|NCT00849758|biomarker|biomarker
546181|NCT00849745|severe autoimmune diseases|severe autoimmune diseases
546182|NCT00849745|allogeneic stem cell transplant|allogeneic stem cell transplant
546183|NCT00849732|HIV Seronegativity|hiv seronegativity
546184|NCT00849732|Preventive Vaccine|preventive vaccine
546185|NCT00849719|visual analog scale|visual analog scale
546186|NCT00849719|patient controlled analgesia|patient controlled analgesia
546187|NCT00849719|post operative pain|post operative pain
546188|NCT00849719|rescue drug|rescue drug
546189|NCT00849706|sleep deprivation|sleep deprivation
546190|NCT00849706|workload|workload
546191|NCT00849706|increased workload|increased workload
546192|NCT00849680|HIV Seronegativity|hiv seronegativity
546193|NCT00849680|Preventive Vaccine|preventive vaccine
546194|NCT00849667|ovarian cancer|ovarian cancer
546195|NCT00849667|relapsed ovarian cancer|relapsed ovarian cancer
546196|NCT00849667|Platinum-sensitive Ovarian Cancer|platinum-sensitive ovarian cancer
546197|NCT00849654|PCI-32765|pci-32765
546198|NCT00849654|Lymphoma|lymphoma
546199|NCT00849654|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
546200|NCT00849654|Lymphoma, B-Cell|lymphoma, b-cell
546201|NCT00849654|Burkitt Lymphoma|burkitt lymphoma
546202|NCT00849654|Lymphoma, B-Cell, Marginal Zone|lymphoma, b-cell, marginal zone
546203|NCT00849654|Lymphoma, B-Cell, Diffuse|lymphoma, b-cell, diffuse
546204|NCT00849654|Lymphoma, Follicular|lymphoma, follicular
546205|NCT00849654|Lymphoma, Mantle Cell|lymphoma, mantle cell
546206|NCT00849654|Leukemia, Lymphoid|leukemia, lymphoid
546207|NCT00849654|Leukemia, B-Cell|leukemia, b-cell
546208|NCT00849654|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
546209|NCT00849654|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
546210|NCT00849641|decompensation|decompensation
546211|NCT00849641|septic shock|septic shock
546212|NCT00849641|tissue oxygenation|tissue oxygenation
546213|NCT00849641|near infrared spectroscopy|near infrared spectroscopy
546214|NCT00849628|Aged|aged
546215|NCT00849628|Polypharmacy|polypharmacy
546216|NCT00849628|Adverse effects|adverse effects
546217|NCT00849628|Nursing homes|nursing homes
546218|NCT00849589|Screening|screening
546219|NCT00849589|Brief intervention|brief intervention
546220|NCT00849589|Underage drinking|underage drinking
546221|NCT00849563|predictive genomics|predictive genomics
546222|NCT00849563|personalized medicine|personalized medicine
546223|NCT00849563|personal genomics|personal genomics
546224|NCT00849563|genetic knowledge|genetic knowledge
546225|NCT00849563|genetic attitudes|genetic attitudes
546226|NCT00849563|prevention|prevention
546227|NCT00849563|health outcomes|health outcomes
546228|NCT00849563|behavioral|behavioral
546229|NCT00849550|Advanced Solid Tumors|advanced solid tumors
546230|NCT00849550|Cancer|cancer
546231|NCT00849550|Capecitabine|capecitabine
546232|NCT00849550|XELOX|xelox
546233|NCT00849550|Neoplasms|neoplasms
546234|NCT00849550|Oxaliplatin|oxaliplatin
546235|NCT00849550|Bevacizumab|bevacizumab
546236|NCT00849550|RAD001|rad001
546237|NCT00849537|Triamcinolon|triamcinolon
546238|NCT00849537|Cataract|cataract
546239|NCT00849537|Diabetic retinopathy|diabetic retinopathy
546240|NCT00849537|non-proliferative retinopathy|non-proliferative retinopathy
546241|NCT00849511|Migraine prevention|migraine prevention
546242|NCT00849511|Crossover|crossover
546243|NCT00849511|Melatonin|melatonin
546244|NCT00849485|Bioequivalence|bioequivalence
546245|NCT00849485|Healthy Subjects|healthy subjects
546246|NCT00849472|Neoadjuvant Breast Cancer|neoadjuvant breast cancer
546247|NCT00849472|Pazopanib (GW786034)|pazopanib (gw786034)
546248|NCT00849472|NSABP Foundation, Inc.|nsabp foundation, inc.
546249|NCT00849472|cyclophosphamide|cyclophosphamide
546250|NCT00849472|Paclitaxel|paclitaxel
546251|NCT00849472|Doxorubicin|doxorubicin
546252|NCT00849459|recurrent breast cancer|recurrent breast cancer
546253|NCT00849459|stage IV breast cancer|stage iv breast cancer
546254|NCT00849433|Inflammation|inflammation
546256|NCT00849433|integrity|integrity
546257|NCT00849433|ECIS|ecis
546258|NCT00849394|bevacizumab|bevacizumab
546259|NCT00849394|proteinuria|proteinuria
546260|NCT00849381|HPV|hpv
546261|NCT00849381|HPV vaccine|hpv vaccine
546262|NCT00849381|papillomavirus|papillomavirus
546263|NCT00849381|cervical cancer|cervical cancer
546264|NCT00849381|human papillomavirus|human papillomavirus
546265|NCT00849329|lapatinib (GW572016), subject, pharmacokinetic, esomeprazole, proton-pump inhibitor, drug interaction, Phase 1|lapatinib (gw572016), subject, pharmacokinetic, esomeprazole, proton-pump inhibitor, drug interaction, phase 1
546266|NCT00849303|stroke|stroke
546267|NCT00849303|rehabilitation|rehabilitation
546268|NCT00849303|gait|gait
546269|NCT00849303|timing|timing
546270|NCT00849303|transcranial magnetic stimulation|transcranial magnetic stimulation
546271|NCT00849277|Respiratory Tract Infections|respiratory tract infections
546272|NCT00849277|Influenza, Human|influenza, human
546273|NCT00849277|Probiotics|probiotics
546274|NCT00849264|hepatocellular carcinoma|hepatocellular carcinoma
546275|NCT00849264|portal vein tumor thrombus|portal vein tumor thrombus
546276|NCT00849264|surgical comprehensive treatment|surgical comprehensive treatment
546277|NCT00849212|Seizures|seizures
546278|NCT00849212|epilepsy|epilepsy
546279|NCT00849199|screening|screening
546280|NCT00849199|early detection|early detection
546281|NCT00849199|prevention|prevention
546282|NCT00849199|cancer|cancer
546283|NCT00849199|high risk|high risk
546284|NCT00849199|ovarian cancer|ovarian cancer
546285|NCT00849199|breast cancer|breast cancer
546286|NCT00849186|stage I renal cell cancer|stage i renal cell cancer
546287|NCT00849186|stage II renal cell cancer|stage ii renal cell cancer
546288|NCT00849186|stage III renal cell cancer|stage iii renal cell cancer
546289|NCT00849186|stage IV renal cell cancer|stage iv renal cell cancer
546290|NCT00849173|Endometriosis|endometriosis
546291|NCT00849173|Infertility|infertility
546292|NCT00849173|Tubal Ligation|tubal ligation
546293|NCT00849173|Chronic Pelvic Pain|chronic pelvic pain
546294|NCT00849173|Quality of Life|quality of life
546295|NCT00849160|Treatment Experienced|treatment experienced
546296|NCT00849147|Acute Lymphoblastic Leukemia/Lymphoma|acute lymphoblastic leukemia/lymphoma
546297|NCT00849147|Acute Myelogenous Leukemia|acute myelogenous leukemia
546298|NCT00849147|Mantel-Cell Lymphoma|mantel-cell lymphoma
546299|NCT00849147|Hematopoietic Transplant|hematopoietic transplant
546300|NCT00849147|Haplo-Identical Transplant|haplo-identical transplant
546301|NCT00849147|Non-Myeloablative Transplant|non-myeloablative transplant
546302|NCT00849134|First-Time-in-Human|first-time-in-human
546303|NCT00849134|Tolerability|tolerability
546304|NCT00849134|Pharmacodynamics|pharmacodynamics
546305|NCT00849134|Safety|safety
546306|NCT00849134|Food Effect|food effect
546307|NCT00849134|Pharmacokinetics|pharmacokinetics
546308|NCT00849134|Healthy Volunteers|healthy volunteers
546309|NCT00849121|Vaccine|vaccine
546310|NCT00849121|pTVG-HP|ptvg-hp
546311|NCT00849121|Prostate Cancer|prostate cancer
546312|NCT00849121|Castrate Resistant|castrate resistant
546313|NCT00849108|Myocardial Perfusion|myocardial perfusion
546314|NCT00849108|PET imaging|pet imaging
546315|NCT00849108|SPECT imaging|spect imaging
546316|NCT00849108|Coronary artery disease|coronary artery disease
546317|NCT00849108|Subjects that are male and nonpregnant female patients|subjects that are male and nonpregnant female patients
546318|NCT00849108|presenting with reversible ischemia as characterized by a|presenting with reversible ischemia as characterized by a
546319|NCT00849108|rest/stress SPECT imaging study using|rest/stress spect imaging study using
546320|NCT00849108|Technetium(99mTc)-labeled tracers|technetium(99mtc)-labeled tracers
546321|NCT00849095|Adult|adult
546322|NCT00849095|Asthma|asthma
546323|NCT00849095|Bronchodilator Agents|bronchodilator agents
546324|NCT00849095|Budesonide|budesonide
546325|NCT00849095|Double-Blind Method|double-blind method
546326|NCT00849095|Drug Therapy, Combination|drug therapy, combination
546327|NCT00849095|Ethanolamines|ethanolamines
546328|NCT00849095|Female|female
546329|NCT00849095|Forced Expiratory Volume|forced expiratory volume
546330|NCT00849095|Humans|humans
546331|NCT00849095|Male|male
546332|NCT00849095|Terbutaline|terbutaline
546333|NCT00849082|stage IIB prostate cancer|stage iib prostate cancer
546334|NCT00849082|stage IIA prostate cancer|stage iia prostate cancer
546335|NCT00849082|stage III prostate cancer|stage iii prostate cancer
546336|NCT00849082|stage IV prostate cancer|stage iv prostate cancer
546337|NCT00849069|Streptococcus pneumoniae|streptococcus pneumoniae
546338|NCT00849069|Vaccine|vaccine
546339|NCT00849069|Non-typable Haemophilus influenza|non-typable haemophilus influenza
546340|NCT00849069|Adults and Elderly Adults|adults and elderly adults
546341|NCT00849056|diabetes|diabetes
546342|NCT00849043|obstructive sleep apnea hypopnea|obstructive sleep apnea hypopnea
546343|NCT00849043|OSA|osa
546344|NCT00849043|OSAH|osah
546345|NCT00849017|placebo|placebo
546346|NCT00849017|albiglutide|albiglutide
546347|NCT00849017|monotherapy|monotherapy
546348|NCT00849017|diabetes|diabetes
546349|NCT00849004|keloid|keloid
546350|NCT00849004|silicone sheet|silicone sheet
546351|NCT00849004|silicone gel|silicone gel
546352|NCT00849004|paper tape|paper tape
546353|NCT00849004|steri-strip|steri-strip
546354|NCT00848991|precedex|precedex
546355|NCT00848991|propofol|propofol
546356|NCT00848978|Functional capacity|functional capacity
546357|NCT00848978|Quality of life|quality of life
546358|NCT00848978|Depression|depression
546359|NCT00848978|Falls|falls
546360|NCT00848978|Body composition|body composition
546361|NCT00848978|Physical activity|physical activity
546362|NCT00848965|fluticasone propionate|fluticasone propionate
546363|NCT00848965|Vienna Challenge Chamber|vienna challenge chamber
546364|NCT00848965|glucocorticosteroids|glucocorticosteroids
546365|NCT00848965|allergic rhinitis|allergic rhinitis
546366|NCT00848939|systemic sclerosis|systemic sclerosis
546367|NCT00848939|scleroderma|scleroderma
546368|NCT00848939|pharmacokinetics|pharmacokinetics
546369|NCT00848939|treprostinil diethanolamine|treprostinil diethanolamine
546370|NCT00848926|Antigens, CD30|antigens, cd30
546371|NCT00848926|Antibody-Drug Conjugate|antibody-drug conjugate
546372|NCT00848926|Antibodies, Monoclonal|antibodies, monoclonal
546373|NCT00848926|Disease, Hodgkin|disease, hodgkin
546374|NCT00848926|Hematologic Diseases|hematologic diseases
546375|NCT00848926|Lymphoma|lymphoma
546376|NCT00848926|monomethylauristatin E|monomethylauristatin e
546377|NCT00848926|Drug Therapy|drug therapy
546378|NCT00848926|Immunotherapy|immunotherapy
546379|NCT00848913|strength deficit|strength deficit
546380|NCT00848913|physical function|physical function
546381|NCT00848887|Influenza|influenza
546382|NCT00848887|Flu|flu
546383|NCT00848887|Vaccine|vaccine
546384|NCT00848887|Adjuvant|adjuvant
546385|NCT00848861|propofol sedation|propofol sedation
546386|NCT00848861|colonoscopy|colonoscopy
546387|NCT00848861|recovery time|recovery time
546388|NCT00848861|recovery time after sedation for colonoscopy|recovery time after sedation for colonoscopy
546389|NCT00848848|Influenza|influenza
546390|NCT00848848|Flu|flu
546391|NCT00848848|Vaccine|vaccine
546392|NCT00848848|Intradermal|intradermal
546393|NCT00848848|Adjuvant|adjuvant
546394|NCT00848835|defibrillator|defibrillator
546395|NCT00848822|Pediatrics|pediatrics
546396|NCT00848822|Sleep|sleep
546397|NCT00848822|Glucose regulation|glucose regulation
546398|NCT00848822|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
546399|NCT00848809|Acute kidney injury|acute kidney injury
546400|NCT00848809|Vancomycin therapy|vancomycin therapy
546401|NCT00848809|Slow-low efficiency daily dialysis|slow-low efficiency daily dialysis
546402|NCT00848809|Intermittent Hemodialysis|intermittent hemodialysis
546403|NCT00848809|Kidney|kidney
546404|NCT00848809|Vancomycin|vancomycin
546405|NCT00848809|Hemofiltration|hemofiltration
546406|NCT00848796|Heparin Leo|heparin leo
546407|NCT00848796|Hepalean|hepalean
546408|NCT00848796|CPB Cardiopuilmonary Bypass|cpb cardiopuilmonary bypass
546409|NCT00848796|CABG Coronary Artery Bypass Grafting|cabg coronary artery bypass grafting
546410|NCT00848796|Anticoagulation efficacy|anticoagulation efficacy
546411|NCT00848783|gastric cancer|gastric cancer
546412|NCT00848783|gastroesophageal junction|gastroesophageal junction
546413|NCT00848783|stomach cancer|stomach cancer
546414|NCT00848783|intraperitoneal infusion|intraperitoneal infusion
546415|NCT00848783|capecitabine|capecitabine
546416|NCT00848783|irinotecan|irinotecan
546417|NCT00848783|cisplatin|cisplatin
546418|NCT00848783|floxuridine|floxuridine
546419|NCT00848770|Stroke, Acute|stroke, acute
546420|NCT00848770|Systolic Pressure of Blood|systolic pressure of blood
546421|NCT00848757|Diabetes|diabetes
546422|NCT00848757|Lifestyle Intervention|lifestyle intervention
546423|NCT00848744|Acne|acne
546424|NCT00848731|pulmonary hypertension|pulmonary hypertension
546425|NCT00848731|venous thromboembolism|venous thromboembolism
546426|NCT00848718|Tumors, cancer|tumors, cancer
546427|NCT00848705|type 1 diabetes, adolescent, self-management|type 1 diabetes, adolescent, self-management
546428|NCT00848692|Chronic Fatigue Syndrome|chronic fatigue syndrome
546429|NCT00848692|CFS|cfs
546430|NCT00848692|Myalgic Encephalomyelitis|myalgic encephalomyelitis
546431|NCT00848692|Rituximab|rituximab
546432|NCT00848692|B-lymphocyte depletion|b-lymphocyte depletion
546433|NCT00848692|B-cell depletion|b-cell depletion
546434|NCT00848679|Pre-eclampsia|pre-eclampsia
546435|NCT00848679|Pregnancy|pregnancy
546436|NCT00848679|Uteroplacental blood flow|uteroplacental blood flow
546437|NCT00848679|Epidural|epidural
546438|NCT00848679|Anesthesia|anesthesia
546439|NCT00848627|Bladder cancer|bladder cancer
546440|NCT00848627|Smokers|smokers
546441|NCT00848627|Hematuria|hematuria
546442|NCT00848601|SGI-1776|sgi-1776
546443|NCT00848601|PIM|pim
546444|NCT00848601|Hormone & Docetaxel refractory Prostate Cancer|hormone & docetaxel refractory prostate cancer
546445|NCT00848601|Refractory non-Hodgkin's Lymphoma|refractory non-hodgkin's lymphoma
546446|NCT00848588|agonal breathing|agonal breathing
546447|NCT00848588|cardiac arrest|cardiac arrest
546448|NCT00848588|9-1-1 call taker|9-1-1 call taker
546449|NCT00848588|survey|survey
546450|NCT00848562|sudden cardiac death|sudden cardiac death
546451|NCT00848549|Epilepsy|epilepsy
546452|NCT00848549|Monotherapy|monotherapy
546453|NCT00848536|OAG|oag
546454|NCT00848536|OHT|oht
546455|NCT00848523|LBH859|lbh859
546456|NCT00848523|Panobinostat|panobinostat
546457|NCT00848523|GBM|gbm
546458|NCT00848523|Glioma|glioma
546459|NCT00848523|Glioblastoma|glioblastoma
546460|NCT00848523|Astrocytoma|astrocytoma
546461|NCT00848523|oligodendroglioma|oligodendroglioma
546462|NCT00848523|oligoastrocytoma|oligoastrocytoma
546463|NCT00848523|gliosarcoma|gliosarcoma
546464|NCT00848523|anaplastic|anaplastic
546465|NCT00848497|hormone replacement therapy|hormone replacement therapy
546466|NCT00848497|radical prostatectomy|radical prostatectomy
546467|NCT00848497|erectile dysfunctions|erectile dysfunctions
546468|NCT00848497|scheduled for removal of prostate gland|scheduled for removal of prostate gland
546469|NCT00848471|Indirect calorimeter|indirect calorimeter
546470|NCT00848471|Validation|validation
546471|NCT00848471|Energy expenditure|energy expenditure
546472|NCT00848471|Healthy volunteers|healthy volunteers
546473|NCT00848458|Azelaic Acid|azelaic acid
546474|NCT00848458|Iontophoresis|iontophoresis
546475|NCT00848432|Schizophrenia|schizophrenia
546476|NCT00848432|Risperidone|risperidone
546477|NCT00848432|Maintenance treatment|maintenance treatment
546478|NCT00848432|Relapse|relapse
546479|NCT00848419|Epidural|epidural
546480|NCT00848419|Analgesia|analgesia
546481|NCT00848419|Methadone|methadone
546482|NCT00848419|Morphine|morphine
546483|NCT00848419|Pharmacokinetic-pharmacodynamic|pharmacokinetic-pharmacodynamic
546484|NCT00848419|Experimental pain - analgesic response|experimental pain - analgesic response
546485|NCT00848406|bronchial|bronchial
546486|NCT00848406|COPD|copd
546487|NCT00848406|Asthma|asthma
546488|NCT00848406|sputum|sputum
546489|NCT00848406|biopsies|biopsies
546490|NCT00848393|pediatric cardiac surgery|pediatric cardiac surgery
546491|NCT00848393|stress response|stress response
546492|NCT00848393|early extubation|early extubation
546493|NCT00848393|Dexmedetomidine|dexmedetomidine
546494|NCT00848393|TOF|tof
546495|NCT00848393|VSD|vsd
546496|NCT00848393|AVSD|avsd
546497|NCT00848380|Hypertension|hypertension
546498|NCT00848380|hyperlipidemia|hyperlipidemia
546499|NCT00848354|enbrel|enbrel
546500|NCT00848354|moderate arthritis|moderate arthritis
546501|NCT00848354|severe arthritis|severe arthritis
546502|NCT00848354|rheumatoid arthritis|rheumatoid arthritis
546503|NCT00848328|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
546504|NCT00848328|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
546505|NCT00848328|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
546506|NCT00848328|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
546507|NCT00848315|cognitive behavioral intervention|cognitive behavioral intervention
546508|NCT00848315|low literate/illiterate Hispanic patients|low literate/illiterate hispanic patients
546509|NCT00848302|peripheral vascular disease|peripheral vascular disease
546510|NCT00848302|endothelial dysfunction|endothelial dysfunction
546511|NCT00848302|intravascular ultrasound|intravascular ultrasound
546512|NCT00848302|L-Arginine|l-arginine
546513|NCT00848289|Bladder cancer|bladder cancer
546514|NCT00848289|Genetic susceptibility|genetic susceptibility
546515|NCT00848289|Increased Risk|increased risk
546516|NCT00848276|PCSK9|pcsk9
546517|NCT00848276|Lipoprotein metabolism|lipoprotein metabolism
546518|NCT00848276|testosterone|testosterone
546519|NCT00848276|estradiol|estradiol
546520|NCT00848263|Fracture|fracture
546521|NCT00848263|Radius|radius
546522|NCT00848263|Surgery|surgery
546523|NCT00848263|Osteosynthesis|osteosynthesis
546524|NCT00848250|Cardiopulmonary Bypass|cardiopulmonary bypass
546525|NCT00848250|ACE inhibitor|ace inhibitor
546526|NCT00848250|Pediatrics|pediatrics
546527|NCT00848237|Barrett's Esophagus|barrett's esophagus
546528|NCT00848237|Dysplasia|dysplasia
546529|NCT00848237|Intestinal Metaplasia|intestinal metaplasia
546530|NCT00848224|coronary heart disease|coronary heart disease
546531|NCT00848224|lipid lowering medication|lipid lowering medication
546532|NCT00848224|NCEP guidelines|ncep guidelines
546533|NCT00848211|HIV|hiv
546534|NCT00848211|vaccine|vaccine
546535|NCT00848211|lipopeptide|lipopeptide
546536|NCT00848211|Tat|tat
546537|NCT00848211|TUTI-16|tuti-16
546538|NCT00848211|THYMON|thymon
546539|NCT00848211|Treatment Naive|treatment naive
546540|NCT00848198|Dry Eye Disease|dry eye disease
546541|NCT00848198|Dry Eye Syndrome|dry eye syndrome
546542|NCT00848198|Dry Eye|dry eye
546543|NCT00848185|VEGF|vegf
546544|NCT00848185|Trigger|trigger
546545|NCT00848185|OHSS|ohss
546546|NCT00848172|Essential Tremor|essential tremor
546547|NCT00848172|Octanol|octanol
546548|NCT00848172|Octanoic Acid|octanoic acid
546549|NCT00848172|Ethanol|ethanol
546550|NCT00848172|Accelerometry|accelerometry
546551|NCT00848159|Osteoporosis|osteoporosis
546552|NCT00848159|kyphosis|kyphosis
546553|NCT00848159|photogrammetry|photogrammetry
546554|NCT00848107|systemic sclerosis|systemic sclerosis
546555|NCT00848107|scleroderma|scleroderma
546556|NCT00848107|digital ulcers|digital ulcers
546557|NCT00848107|vasculopathy|vasculopathy
546558|NCT00848094|hepatocellular carcinoma|hepatocellular carcinoma
546559|NCT00848094|radiation therapy|radiation therapy
546560|NCT00848094|3-dimensional conformal radiation therapy (3-DCRT)|3-dimensional conformal radiation therapy (3-dcrt)
546561|NCT00848094|intensity modulated radiation therapy (IMRT)|intensity modulated radiation therapy (imrt)
546562|NCT00848094|active breathing control|active breathing control
546563|NCT00848081|Prostate|prostate
546564|NCT00848081|BPH|bph
546565|NCT00848081|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
546566|NCT00848081|BPH-LUTS|bph-luts
546567|NCT00848081|LUTS|luts
546568|NCT00848081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors
546569|NCT00848081|tadalafil|tadalafil
546570|NCT00848081|alpha blockers|alpha blockers
546571|NCT00848068|lipid layer thickness|lipid layer thickness
546572|NCT00848042|cancer|cancer
546573|NCT00848042|head and neck|head and neck
546574|NCT00848042|laser|laser
546575|NCT00848042|ablation|ablation
546576|NCT00848029|Influenza vaccine|influenza vaccine
546577|NCT00848003|Probiotics|probiotics
546578|NCT00848003|BB-12|bb-12
546579|NCT00848003|Yogurt|yogurt
546580|NCT00848003|Antibiotics|antibiotics
546581|NCT00847990|Down syndrome|down syndrome
546582|NCT00847990|aneuploidy|aneuploidy
546583|NCT00847990|chromosome abnormality|chromosome abnormality
546584|NCT00847990|amniocentesis|amniocentesis
546585|NCT00847990|chorionic villus sampling|chorionic villus sampling
546586|NCT00847990|Laboratory Developed Test (LDT)|laboratory developed test (ldt)
546587|NCT00847977|Acute head trauma|acute head trauma
546588|NCT00847964|Heart Failure|heart failure
546589|NCT00847951|renal|renal
546590|NCT00847951|neonates|neonates
546591|NCT00847938|neostigmine|neostigmine
546592|NCT00847938|neuromuscular blocking agent|neuromuscular blocking agent
546593|NCT00847938|train of four|train of four
546594|NCT00847938|anesthesia|anesthesia
546595|NCT00847912|NMSC|nmsc
546596|NCT00847912|nonmelanoma skin cancer|nonmelanoma skin cancer
546597|NCT00847912|topical 5-FU 5% cream|topical 5-fu 5% cream
546598|NCT00847912|Neoplasms|neoplasms
546599|NCT00847912|Antineoplastic Agents|antineoplastic agents
546600|NCT00847912|Therapeutic Uses|therapeutic uses
546601|NCT00847912|Dermatologic Agents|dermatologic agents
546602|NCT00847912|Neoplasms by Site|neoplasms by site
546603|NCT00847912|carcinoma, basal cell|carcinoma, basal cell
546604|NCT00847912|carcinoma, squamous cell|carcinoma, squamous cell
546605|NCT00847899|hypertension|hypertension
546606|NCT00847899|impaired glucose tolerance|impaired glucose tolerance
546607|NCT00847899|s-EH enzyme inhibition|s-eh enzyme inhibition
546608|NCT00847899|pre-diabetes|pre-diabetes
546609|NCT00847873|intimate partner violence|intimate partner violence
546610|NCT00847873|domestic violence|domestic violence
546611|NCT00847873|alcohol abuse|alcohol abuse
546612|NCT00847873|alcohol dependence|alcohol dependence
546613|NCT00847873|drug abuse|drug abuse
546614|NCT00847873|drug dependence|drug dependence
546615|NCT00847873|addiction|addiction
546616|NCT00847860|cognition|cognition
546617|NCT00847847|ALS|als
546618|NCT00847847|Motor neuron|motor neuron
546619|NCT00847847|Pathophysiology|pathophysiology
546620|NCT00847847|Neuromuscular junction|neuromuscular junction
546621|NCT00847847|Neuromuscular transmission|neuromuscular transmission
546622|NCT00847847|Microelectrodes|microelectrodes
546623|NCT00847808|Esophageal Reflux|esophageal reflux
546624|NCT00847808|Gastro-Esophageal Reflux|gastro-esophageal reflux
546625|NCT00847808|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
546626|NCT00847808|GERD|gerd
546627|NCT00847808|Regurgitation, Gastric|regurgitation, gastric
546628|NCT00847808|Heartburn|heartburn
546629|NCT00847808|Drug Therapy|drug therapy
546630|NCT00847769|Ankle Sprain|ankle sprain
546631|NCT00847756|Otitis media|otitis media
546632|NCT00847756|demography|demography
546633|NCT00847756|Streptococcus pneumoniae|streptococcus pneumoniae
546634|NCT00847756|Haemophilus influenzae|haemophilus influenzae
546635|NCT00847756|Moraxella catarrhalis|moraxella catarrhalis
546636|NCT00847756|rhinovirus|rhinovirus
546637|NCT00847756|children, 0-5 years of age|children, 0-5 years of age
546638|NCT00847756|diagnosed rAOM, COME or CSOM by an otorhinolaryngologist|diagnosed raom, come or csom by an otorhinolaryngologist
546639|NCT00847756|primary and secondary hospital Nijmegen, the Netherlands|primary and secondary hospital nijmegen, the netherlands
546640|NCT00847743|oxidative stress|oxidative stress
546641|NCT00847743|aging|aging
546642|NCT00847743|ischemia-reperfusion|ischemia-reperfusion
546643|NCT00847730|Ease of dressing application, dressing conformability and ease of dressing removal on diabetic foot ulcers using the ActiVAC therapy|ease of dressing application, dressing conformability and ease of dressing removal on diabetic foot ulcers using the activac therapy
546644|NCT00847717|Oral|oral
546645|NCT00847717|cancer|cancer
546646|NCT00847717|surgery|surgery
546647|NCT00847717|neck dissection|neck dissection
546648|NCT00847717|spinal accessory nerve|spinal accessory nerve
546649|NCT00847704|Stroke|stroke
546650|NCT00847704|Rehabilitation|rehabilitation
546651|NCT00847704|Robotics|robotics
546652|NCT00847691|economic evaluation|economic evaluation
546653|NCT00847691|diagnostics|diagnostics
546654|NCT00847691|sarcoma|sarcoma
546655|NCT00847678|Cryptococcal Meningitis|cryptococcal meningitis
546656|NCT00847665|Pressure ulcers|pressure ulcers
546657|NCT00847665|Repositioning|repositioning
546658|NCT00847665|Prevention|prevention
546659|NCT00847665|Mechanical Ventilation|mechanical ventilation
546660|NCT00847665|Critical care|critical care
546661|NCT00847639|Multiple Myeloma|multiple myeloma
546662|NCT00847639|lenalidomide|lenalidomide
546663|NCT00847639|Revlimid|revlimid
546664|NCT00847639|Allogeneic Hematopoietic Cell Transplantation|allogeneic hematopoietic cell transplantation
546665|NCT00847626|Hypertensive|hypertensive
546666|NCT00847626|Blood Pressure, High|blood pressure, high
546667|NCT00847626|Vascular Disease|vascular disease
546668|NCT00847626|Cardiovascular Disease|cardiovascular disease
546669|NCT00847626|Drug Therapy|drug therapy
546670|NCT00847613|double-blind placebo-controlled investigational drug oral therapy safety and efficacy hand and feet x-rays|double-blind placebo-controlled investigational drug oral therapy safety and efficacy hand and feet x-rays
546671|NCT00847600|Schizophrenia|schizophrenia
546672|NCT00847600|Neurosteroids|neurosteroids
546673|NCT00847600|Pregnenolone|pregnenolone
546674|NCT00847600|Augmentation|augmentation
546675|NCT00847587|Contraceptive|contraceptive
546676|NCT00847587|Implant|implant
546677|NCT00847587|Postpartum period|postpartum period
546678|NCT00847587|etonogestrel-releasing|etonogestrel-releasing
546679|NCT00847587|lactogenesis|lactogenesis
546680|NCT00847587|Breastfeeding|breastfeeding
546681|NCT00847574|Weight loss|weight loss
546682|NCT00847574|Weight maintenance|weight maintenance
546683|NCT00847574|Weight management|weight management
546684|NCT00847574|Cardiovascular disease risk|cardiovascular disease risk
546685|NCT00847574|Dietary Guidelines|dietary guidelines
546686|NCT00847574|Diet and exercise|diet and exercise
546687|NCT00847574|Prevention|prevention
546688|NCT00847561|Anxiety|anxiety
546689|NCT00847548|intimate partner violence|intimate partner violence
546690|NCT00847548|domestic violence|domestic violence
546691|NCT00847548|substance abuse|substance abuse
546692|NCT00847548|alcohol abuse|alcohol abuse
546693|NCT00847548|drug abuse|drug abuse
546694|NCT00847548|addiction|addiction
546695|NCT00847522|melanoma|melanoma
546696|NCT00847522|skin cancer|skin cancer
546697|NCT00847522|lymph node|lymph node
546698|NCT00847522|sentinel lymph node|sentinel lymph node
546699|NCT00847522|malignant melanoma|malignant melanoma
546700|NCT00847522|mapping|mapping
546701|NCT00847509|lung cancer|lung cancer
546702|NCT00847509|head and neck cancer|head and neck cancer
546703|NCT00847509|radiotherapy|radiotherapy
546704|NCT00847509|chemoradiotherapy|chemoradiotherapy
546705|NCT00847509|radiation|radiation
546706|NCT00847509|chemoradiation|chemoradiation
546707|NCT00847509|FLT|flt
546708|NCT00847509|[F-18]FLT|[f-18]flt
546709|NCT00847509|FDG|fdg
546710|NCT00847509|[F-18]FDG|[f-18]fdg
546711|NCT00847496|Partial Thickness burn|partial thickness burn
546712|NCT00847496|Biological Dressing|biological dressing
546713|NCT00847483|glaucoma|glaucoma
546714|NCT00847483|ocular hypertension|ocular hypertension
546715|NCT00847483|latanoprost|latanoprost
546716|NCT00847483|travoprost|travoprost
546717|NCT00847483|bimatoprost|bimatoprost
546718|NCT00847470|Dental caries|dental caries
546719|NCT00847470|Assessments|assessments
546720|NCT00847470|dental materials|dental materials
546721|NCT00847457|Exercise|exercise
546722|NCT00847457|Stretching|stretching
546723|NCT00847457|Adolescents|adolescents
546724|NCT00847431|Subthalamic Nucleus|subthalamic nucleus
546725|NCT00847431|Deep Brain Stimulation|deep brain stimulation
546726|NCT00847431|Depression|depression
546727|NCT00847431|Anxiety|anxiety
546728|NCT00847431|Parkinson's Disease|parkinson's disease
546729|NCT00847418|pharmacokinetics|pharmacokinetics
546730|NCT00847418|ketamine|ketamine
546731|NCT00847418|Anesthetics, Dissociative|anesthetics, dissociative
546732|NCT00847405|Bioequivalence|bioequivalence
546733|NCT00847405|Healthy Subjects|healthy subjects
546734|NCT00847392|Urethral catheterization|urethral catheterization
546735|NCT00847392|Emergency Department|emergency department
546736|NCT00847392|Ultrasound|ultrasound
546737|NCT00847392|Urinary tract infection|urinary tract infection
546738|NCT00847392|Pediatric|pediatric
546739|NCT00847379|Duchenne muscular dystrophy|duchenne muscular dystrophy
546740|NCT00847379|Becker muscular dystrophy|becker muscular dystrophy
546741|NCT00847379|Nonsense mutation|nonsense mutation
546742|NCT00847379|Premature stop codon|premature stop codon
546743|NCT00847379|DMD|dmd
546744|NCT00847379|BMD|bmd
546745|NCT00847379|Ataluren|ataluren
546746|NCT00847379|PTC124|ptc124
546747|NCT00847366|Perifosine|perifosine
546748|NCT00847353|high frequency ECG|high frequency ecg
546749|NCT00847353|normal values|normal values
546750|NCT00847353|asymptomatic|asymptomatic
546751|NCT00847353|obese|obese
546752|NCT00847340|Genital warts|genital warts
546753|NCT00847340|HPV typing|hpv typing
546754|NCT00847340|HPV infections|hpv infections
546755|NCT00847340|Condyloma Acuminata|condyloma acuminata
546756|NCT00847327|Type 1 Diabetes|type 1 diabetes
546757|NCT00847327|Parenting|parenting
546758|NCT00847327|Young Children|young children
546759|NCT00847314|Hypogonadism|hypogonadism
546760|NCT00847314|Abdominal obesity|abdominal obesity
546761|NCT00847314|Physical exercise|physical exercise
546762|NCT00847314|Testosterone|testosterone
546763|NCT00847288|Heart Failure|heart failure
546764|NCT00847288|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
546765|NCT00847288|Cardiac Resynchronization Therapy with Defibrillator (CRT D)|cardiac resynchronization therapy with defibrillator (crt d)
546766|NCT00847288|OptiVol®|optivol®
546767|NCT00847275|Elderly patients|elderly patients
546768|NCT00847275|renal insufficiency|renal insufficiency
546769|NCT00847275|gerontologic evaluation|gerontologic evaluation
546770|NCT00847262|Hypertension|hypertension
546771|NCT00847262|Abdominal obesity|abdominal obesity
546772|NCT00847262|Diabetes|diabetes
546773|NCT00847262|Treatment|treatment
546774|NCT00847249|safety|safety
546775|NCT00847249|tolerability|tolerability
546776|NCT00847249|healthy|healthy
546777|NCT00847249|inhalation|inhalation
546778|NCT00847249|Healthy males|healthy males
546779|NCT00847236|Polymyalgia Rheumatica|polymyalgia rheumatica
546780|NCT00847236|Rheumatoid Arthritis|rheumatoid arthritis
546781|NCT00847236|Rheumatic Disease|rheumatic disease
546782|NCT00847236|PMR|pmr
546783|NCT00847223|Mantle cell lymphoma|mantle cell lymphoma
546784|NCT00847223|Lymphoma|lymphoma
546785|NCT00847223|relapsed, refractory or progressive MCL|relapsed, refractory or progressive mcl
546786|NCT00847223|Mantle cell lymphoma (relapsed, refractory or progressive)|mantle cell lymphoma (relapsed, refractory or progressive)
546787|NCT00847210|Esophageal Reflux|esophageal reflux
546788|NCT00847210|Gastro-Esophageal Reflux|gastro-esophageal reflux
546789|NCT00847210|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
546790|NCT00847210|GERD|gerd
546791|NCT00847210|Regurgitation, Gastric|regurgitation, gastric
546792|NCT00847210|Heartburn|heartburn
546793|NCT00847210|Drug Therapy|drug therapy
546794|NCT00847210|Adolescent|adolescent
546795|NCT00847184|nasal intubation|nasal intubation
546796|NCT00847184|Aitraq|aitraq
546797|NCT00847184|difficult intubation|difficult intubation
546798|NCT00847171|male breast cancer|male breast cancer
546799|NCT00847171|stage II breast cancer|stage ii breast cancer
546800|NCT00847171|stage IIIA breast cancer|stage iiia breast cancer
546801|NCT00847171|stage IIIB breast cancer|stage iiib breast cancer
546802|NCT00847171|stage IIIC breast cancer|stage iiic breast cancer
546803|NCT00847171|stage IV breast cancer|stage iv breast cancer
546804|NCT00847171|HER2-positive breast cancer|her2-positive breast cancer
546805|NCT00847158|POAG|poag
546806|NCT00847158|Combination glaucoma & cataract procedure|combination glaucoma & cataract procedure
546807|NCT00847158|trabecular micro-bypass stent|trabecular micro-bypass stent
546808|NCT00847158|iStent|istent
546809|NCT00847145|toddler|toddler
546810|NCT00847145|Meningococcal disease|meningococcal disease
546811|NCT00847145|prevention|prevention
546812|NCT00847145|vaccination|vaccination
546813|NCT00847132|Collaborative Care|collaborative care
546814|NCT00847119|rectum|rectum
546815|NCT00847119|adenocarcinoma|adenocarcinoma
546816|NCT00847119|neoadjuvant|neoadjuvant
546817|NCT00847119|bevacizumab|bevacizumab
546818|NCT00847119|capecitabine|capecitabine
546819|NCT00847119|radiotherapy|radiotherapy
546820|NCT00847119|locally|locally
546821|NCT00847119|advanced|advanced
546822|NCT00847119|resectable|resectable
546823|NCT00847119|resectable locally advanced adenocarcinoma of the rectum|resectable locally advanced adenocarcinoma of the rectum
546824|NCT00847119|xeberecto|xeberecto
546825|NCT00847106|Dendritic Cells|dendritic cells
546826|NCT00847106|Regulatory T cells|regulatory t cells
546827|NCT00847106|CD25|cd25
546828|NCT00847106|Melanoma|melanoma
546829|NCT00847106|Immunotherapy|immunotherapy
546830|NCT00847106|Daclizumab|daclizumab
546831|NCT00847106|Stage IV Melanoma|stage iv melanoma
546832|NCT00847080|Reactive hypoglycemia|reactive hypoglycemia
546833|NCT00847080|Sitagliptin|sitagliptin
546834|NCT00847080|Glucagon-Like Peptide 1|glucagon-like peptide 1
546835|NCT00847080|Incretins|incretins
546836|NCT00847080|Prediabetes|prediabetes
546837|NCT00847054|Solid Tumor|solid tumor
546838|NCT00847054|Endosialin|endosialin
546839|NCT00847028|Newborn|newborn
546840|NCT00847028|Pain|pain
546841|NCT00847028|glucose solution|glucose solution
546842|NCT00847028|venipuncture|venipuncture
546843|NCT00847028|non-pharmacologic pain relief.|non-pharmacologic pain relief.
546844|NCT00847015|Bladder|bladder
546845|NCT00847015|Urinary|urinary
546846|NCT00847015|CISPLATIN|cisplatin
546847|NCT00847015|GEMCITABINE|gemcitabine
546848|NCT00847015|SU011248 (Sunitinib Malate)|su011248 (sunitinib malate)
546849|NCT00847015|08-159|08-159
546850|NCT00847002|Flexitouch system|flexitouch system
546851|NCT00847002|FarrowWrap|farrowwrap
546852|NCT00847002|venous stasis ulcer|venous stasis ulcer
546853|NCT00846989|glaucoma,|glaucoma,
546854|NCT00846989|primary open-angle glaucoma (POAG),|primary open-angle glaucoma (poag),
546855|NCT00846989|ocular hypertension (OH),|ocular hypertension (oh),
547445|NCT00844493|vaccine|vaccine
546856|NCT00846989|intraocular pressure (IOP)|intraocular pressure (iop)
546857|NCT00846976|Safety|safety
546858|NCT00846963|parenteral nutrition associated cholestasis in neonates|parenteral nutrition associated cholestasis in neonates
546859|NCT00846963|parenteral nutrition induced cholestasis in preterms|parenteral nutrition induced cholestasis in preterms
546860|NCT00846963|Bile duct obstruction|bile duct obstruction
546861|NCT00846963|biliary stasis|biliary stasis
546862|NCT00846950|H1-antagonist|h1-antagonist
546863|NCT00846950|Event Related Potentials|event related potentials
546864|NCT00846950|Memory|memory
546865|NCT00846950|Information processing|information processing
546866|NCT00846950|The effects of an H1 antagonist (dexchlorpheniramine) on human cognition|the effects of an h1 antagonist (dexchlorpheniramine) on human cognition
546867|NCT00846937|Cholesterol|cholesterol
546868|NCT00846937|Plant stanolester|plant stanolester
546869|NCT00846937|Beverage|beverage
546870|NCT00846937|Ileostoma|ileostoma
546871|NCT00846937|Serum cholesterol level|serum cholesterol level
546872|NCT00846937|serum LDL-cholesterol level|serum ldl-cholesterol level
546873|NCT00846937|Intestinal cholesterol absorption efficiency|intestinal cholesterol absorption efficiency
546874|NCT00846924|Stroke|stroke
546875|NCT00846924|Transient Ischemic Attack|transient ischemic attack
546876|NCT00846924|Atrial fibrillation|atrial fibrillation
546877|NCT00846924|Atrial flutter|atrial flutter
546878|NCT00846911|Acute Exacerbation of Chronic Bronchitis (AECB) patients|acute exacerbation of chronic bronchitis (aecb) patients
546879|NCT00846898|blood sugar|blood sugar
546880|NCT00846898|cholesterol|cholesterol
546881|NCT00846898|cinnamon|cinnamon
546882|NCT00846898|HbA1c|hba1c
546883|NCT00846885|Bioequivalence|bioequivalence
546884|NCT00846885|Healthy Subjects|healthy subjects
546885|NCT00846872|GHRP-3|ghrp-3
546886|NCT00846872|Insulin Resistance|insulin resistance
546887|NCT00846872|Markers of inflammation|markers of inflammation
546888|NCT00846872|Endothelial Dysfunction|endothelial dysfunction
546889|NCT00846872|Flow Mediated Dilation|flow mediated dilation
546890|NCT00846872|GH/IGF-1 axis|gh/igf-1 axis
546891|NCT00846872|Post menopausal|post menopausal
546892|NCT00846859|alcohol dependence|alcohol dependence
546893|NCT00846859|nicotine dependence|nicotine dependence
546894|NCT00846859|alcohol abuse|alcohol abuse
546895|NCT00846859|varenicline|varenicline
546896|NCT00846859|Champix|champix
546897|NCT00846859|Chantix|chantix
546898|NCT00846859|smoking|smoking
546899|NCT00846859|drinking|drinking
546900|NCT00846859|snuffing|snuffing
546901|NCT00846859|diary|diary
546902|NCT00846859|phosphatidyl ethanol|phosphatidyl ethanol
546903|NCT00846859|PEth|peth
546904|NCT00846833|Melanoma, Experimental|melanoma, experimental
546905|NCT00846755|Thyroid|thyroid
546906|NCT00846755|Pregnancy|pregnancy
546907|NCT00846742|Hodgkin Lymphoma|hodgkin lymphoma
546908|NCT00846716|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
546909|NCT00846716|Diabetic Nephropathy|diabetic nephropathy
546910|NCT00846716|Diabetic Retinopathy|diabetic retinopathy
546911|NCT00846716|pioglitazone|pioglitazone
546912|NCT00846690|topical anesthetics|topical anesthetics
546913|NCT00846690|topical anesthesia|topical anesthesia
546914|NCT00846690|20% benzocaine|20% benzocaine
546915|NCT00846690|TAC alternate gel|tac alternate gel
546916|NCT00846690|combination topical anesthetics|combination topical anesthetics
546917|NCT00846690|dental anesthesia|dental anesthesia
546918|NCT00846677|Healthy|healthy
546919|NCT00846677|Infants|infants
546920|NCT00846677|Vitamin D|vitamin d
546921|NCT00846651|spinal anesthesia|spinal anesthesia
546922|NCT00846651|cesarean section|cesarean section
546923|NCT00846638|Risk drinking|risk drinking
546924|NCT00846638|Women|women
546925|NCT00846638|Medical problems|medical problems
546926|NCT00846625|Biomedical research|biomedical research
546927|NCT00846625|Macular Edema|macular edema
546928|NCT00846625|Uveitis|uveitis
546929|NCT00846625|Ranibizumab|ranibizumab
546930|NCT00846625|Steroids|steroids
546931|NCT00846612|refractory|refractory
546932|NCT00846612|avastin|avastin
546933|NCT00846612|doxil|doxil
546934|NCT00846612|relapsed|relapsed
546935|NCT00846612|ovarian cancer|ovarian cancer
546936|NCT00846612|platinum-resistant|platinum-resistant
546937|NCT00846599|brachial artery ultrasound|brachial artery ultrasound
546938|NCT00846599|brachial artery reactivity|brachial artery reactivity
546939|NCT00846599|HIV|hiv
546940|NCT00846599|human immunodeficiency virus|human immunodeficiency virus
546941|NCT00846599|cardiovascular risk|cardiovascular risk
546942|NCT00846599|omega three|omega three
546943|NCT00846599|saturated fat|saturated fat
546944|NCT00846599|sustiva|sustiva
546945|NCT00846599|atripla|atripla
546946|NCT00846599|kaletra|kaletra
546947|NCT00846599|treatment naive|treatment naive
546948|NCT00846586|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
546949|NCT00846586|COPD|copd
546950|NCT00846586|indacaterol|indacaterol
546951|NCT00846586|tiotropium|tiotropium
546952|NCT00846586|bronchodilation|bronchodilation
546953|NCT00846573|Helium|helium
546954|NCT00846573|MRI|mri
546955|NCT00846573|Hyperpolarized Helium|hyperpolarized helium
547528|NCT00844116|COPD|copd
546956|NCT00846573|Hyperpolarized Noble Gas|hyperpolarized noble gas
546957|NCT00846547|Autism|autism
546958|NCT00846547|Autism Spectrum Disorders|autism spectrum disorders
546959|NCT00846547|irritability|irritability
546960|NCT00846547|aberrant behavior|aberrant behavior
546961|NCT00846534|Oxidative stress markers|oxidative stress markers
546962|NCT00846534|Cardiac surgery|cardiac surgery
546963|NCT00846534|Atrial Fibrillation|atrial fibrillation
546964|NCT00846521|Pediatric Obesity|pediatric obesity
546965|NCT00846521|Insulin Resistance|insulin resistance
546966|NCT00846521|Glucose Tolerance|glucose tolerance
546967|NCT00846521|Adolescents|adolescents
546968|NCT00846521|Acarbose|acarbose
546969|NCT00846521|Continuous Glucose Monitoring (CGMS)|continuous glucose monitoring (cgms)
546970|NCT00846521|Endothelial Dysfunction|endothelial dysfunction
546971|NCT00846508|cervical cancer|cervical cancer
546972|NCT00846508|Cisplatin|cisplatin
546973|NCT00846508|chemoradiation|chemoradiation
546974|NCT00846495|Migraine|migraine
546975|NCT00846495|Migraine prevention|migraine prevention
546976|NCT00846495|Prodrome|prodrome
546977|NCT00846495|Premonitory phase|premonitory phase
546978|NCT00846495|Preemptive therapy|preemptive therapy
546979|NCT00846482|Colorectal cancer|colorectal cancer
546980|NCT00846482|Oxaliplatin|oxaliplatin
546981|NCT00846482|ERCC-1|ercc-1
546982|NCT00846456|Tumor setm cell|tumor setm cell
546983|NCT00846443|non-small cell lung cancer|non-small cell lung cancer
546984|NCT00846430|Neurofibromas|neurofibromas
546985|NCT00846430|Neurofibromatosis 1|neurofibromatosis 1
546986|NCT00846430|Celecoxib|celecoxib
546987|NCT00846430|Celebrex|celebrex
546988|NCT00846430|Peg-Interferon alpha-2b|peg-interferon alpha-2b
546989|NCT00846430|PEG-Intron|peg-intron
546990|NCT00846430|Temozolomide|temozolomide
546991|NCT00846430|Temodar|temodar
546992|NCT00846430|Vincristine Sulfate|vincristine sulfate
546993|NCT00846430|Oncovin|oncovin
546994|NCT00846417|myocardial infarction|myocardial infarction
546995|NCT00846417|heart failure|heart failure
546996|NCT00846417|arrhythmia|arrhythmia
546997|NCT00846404|heart failure|heart failure
546998|NCT00846404|cardiomyopathy|cardiomyopathy
546999|NCT00846404|diastolic dysfunction|diastolic dysfunction
547000|NCT00846378|ST segment elevation myocardial infarction (STEMI)|st segment elevation myocardial infarction (stemi)
547001|NCT00846378|timed balloon inflations|timed balloon inflations
547002|NCT00846378|post conditioning|post conditioning
547003|NCT00846365|Essential Hypertension|essential hypertension
547004|NCT00846365|Hypertensive|hypertensive
547005|NCT00846365|Blood Pressure, High|blood pressure, high
547006|NCT00846365|Vascular Disease|vascular disease
547007|NCT00846365|Cardiovascular Disease|cardiovascular disease
547008|NCT00846365|Drug Therapy|drug therapy
547009|NCT00846352|Bone Marrow Transplantation|bone marrow transplantation
547010|NCT00846352|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
547011|NCT00846352|Bronchoscopy|bronchoscopy
547012|NCT00846339|Smoking cessation|smoking cessation
547013|NCT00846339|Bupropion|bupropion
547014|NCT00846326|allergic rhinitis|allergic rhinitis
547015|NCT00846326|rhinitis medicamentosa|rhinitis medicamentosa
547016|NCT00846326|imidazolines|imidazolines
547017|NCT00846326|corticosteroid|corticosteroid
547018|NCT00846313|Dietary intake|dietary intake
547019|NCT00846313|Dietary counseling|dietary counseling
547020|NCT00846313|Weight loss|weight loss
547021|NCT00846313|Body composition|body composition
547022|NCT00846313|Resting energy expenditure|resting energy expenditure
547023|NCT00846313|Quality of life|quality of life
547024|NCT00846300|Patient compliance|patient compliance
547025|NCT00846300|Hispanics|hispanics
547026|NCT00846300|Health Behavior|health behavior
547027|NCT00846300|Family Physicians|family physicians
547028|NCT00846300|Primary Healthcare|primary healthcare
547029|NCT00846287|COPD|copd
547030|NCT00846287|aformoterol|aformoterol
547031|NCT00846287|Helium|helium
547032|NCT00846287|Hyperpolarized helium|hyperpolarized helium
547033|NCT00846287|Hyperpolarized Noble Gas|hyperpolarized noble gas
547035|NCT00846274|Healthy Male subjects|healthy male subjects
547036|NCT00846261|infected|infected
547037|NCT00846261|Ilizarov|ilizarov
547038|NCT00846248|diabetes|diabetes
547039|NCT00846248|insulin resistance|insulin resistance
547040|NCT00846248|chromium|chromium
547041|NCT00846248|healthy volunteers|healthy volunteers
547042|NCT00846235|Dermatitis|dermatitis
547043|NCT00846235|Atopic|atopic
547044|NCT00846235|Moisturising cream|moisturising cream
547045|NCT00846235|Skin|skin
547046|NCT00846209|prescription drug|prescription drug
547047|NCT00846209|warnings|warnings
547048|NCT00846209|health literacy|health literacy
547049|NCT00846209|enhanced language|enhanced language
547050|NCT00846183|local injury|local injury
547051|NCT00846183|implantation rate|implantation rate
547052|NCT00846183|endometrial receptivity|endometrial receptivity
547053|NCT00846183|IVF|ivf
547054|NCT00846170|Irritable bowel syndrome probiotics|irritable bowel syndrome probiotics
547055|NCT00846157|natural killer cell|natural killer cell
547056|NCT00846157|DLBCL (Diffuse Large B Cell Lymphoma)|dlbcl (diffuse large b cell lymphoma)
547057|NCT00846144|Glucose stimulated insulin secretion|glucose stimulated insulin secretion
547058|NCT00846144|copper|copper
547059|NCT00846144|cytokines|cytokines
547060|NCT00846144|diabetes|diabetes
547061|NCT00846144|Reduction in insulin secretion|reduction in insulin secretion
547062|NCT00846131|Subjects with primary hepatocellular carcinoma, intended for liver transplantation.|subjects with primary hepatocellular carcinoma, intended for liver transplantation.
547063|NCT00846118|Pitavastatin|pitavastatin
547064|NCT00846118|Hemodialysis|hemodialysis
547065|NCT00846118|Mortality|mortality
547066|NCT00846118|Cardiovascular disease|cardiovascular disease
547067|NCT00846105|methicillin resistant Staphylococcus aureus|methicillin resistant staphylococcus aureus
547068|NCT00846105|MRSA|mrsa
547069|NCT00846105|cross-infection|cross-infection
547070|NCT00846105|staphylococcal infection|staphylococcal infection
547071|NCT00846105|infection control|infection control
547072|NCT00846092|Diabetic Retinopathy|diabetic retinopathy
547073|NCT00846092|Diabetic Macular Edema|diabetic macular edema
547074|NCT00846092|NIR|nir
547075|NCT00846092|Near-infrared Light Therapy|near-infrared light therapy
547076|NCT00846079|coronary artery disease|coronary artery disease
547077|NCT00846079|stress testing|stress testing
547078|NCT00846066|educational research,|educational research,
547079|NCT00846066|instructional methods,|instructional methods,
547080|NCT00846066|Hands on training,|hands on training,
547081|NCT00846066|Web based training,|web based training,
547082|NCT00846066|pediatric residents|pediatric residents
547083|NCT00846066|preventive oral health,|preventive oral health,
547084|NCT00846066|dental caries,|dental caries,
547085|NCT00846066|Instructional strategies in Preventive Oral health|instructional strategies in preventive oral health
547086|NCT00846066|Web-based training on Preventive Oral Health|web-based training on preventive oral health
547087|NCT00846066|Hands on Training on Preventive Oral Health|hands on training on preventive oral health
547088|NCT00846040|Obesity|obesity
547089|NCT00846040|Weight Loss|weight loss
547090|NCT00846040|Carbohydrate|carbohydrate
547091|NCT00846040|Fat|fat
547092|NCT00846040|Macronutrient Balance|macronutrient balance
547093|NCT00846040|Healthy Volunteer|healthy volunteer
547094|NCT00846014|asthma|asthma
547095|NCT00846014|exacerbation|exacerbation
547096|NCT00846014|Helium|helium
547097|NCT00846014|MRI|mri
547098|NCT00846014|Lung imaging|lung imaging
547099|NCT00846001|Resynchronization Therapy|resynchronization therapy
547100|NCT00845988|Bipolar disorder|bipolar disorder
547101|NCT00845988|metabolic complication|metabolic complication
547102|NCT00845988|Aripiprazole|aripiprazole
547103|NCT00845988|Weight gain|weight gain
547104|NCT00845988|Clinical Trial|clinical trial
547105|NCT00845988|Antipsychotic|antipsychotic
547106|NCT00845988|Metabolic syndrome|metabolic syndrome
547107|NCT00845988|Psychopharmacology|psychopharmacology
547108|NCT00845988|Open Label|open label
547109|NCT00845962|bupivacaine|bupivacaine
547110|NCT00845962|chloroprocaine|chloroprocaine
547111|NCT00845962|spinal|spinal
547112|NCT00845962|anesthesia|anesthesia
547113|NCT00845962|elective surgery|elective surgery
547114|NCT00845962|ambulatory surgery|ambulatory surgery
547115|NCT00845949|chemokines synovium|chemokines synovium
547116|NCT00845936|Atypical antipsychotics|atypical antipsychotics
547117|NCT00845936|Weight|weight
547118|NCT00845936|adolecsents|adolecsents
547119|NCT00845936|pediatric|pediatric
547120|NCT00845936|Metformin|metformin
547121|NCT00845923|Postherpetic neuralgia of at least 6 months|postherpetic neuralgia of at least 6 months
547122|NCT00845897|Diabetes mellitus|diabetes mellitus
547123|NCT00845897|plantar ulcers|plantar ulcers
547124|NCT00845897|peripheral neuropathy|peripheral neuropathy
547125|NCT00845884|Gastric|gastric
547126|NCT00845884|Cancer|cancer
547127|NCT00845884|Advanced|advanced
547128|NCT00845884|Docetaxel|docetaxel
547129|NCT00845884|Cisplatin|cisplatin
547130|NCT00845884|Capecitabine|capecitabine
547131|NCT00845884|Bevacizumab|bevacizumab
547132|NCT00845871|Exjade|exjade
547133|NCT00845871|deferasirox|deferasirox
547134|NCT00845871|palatability|palatability
547135|NCT00845871|tolerability|tolerability
547136|NCT00845871|food|food
547137|NCT00845871|iron overload|iron overload
547138|NCT00845871|Serum Iron overload due to transfusions|serum iron overload due to transfusions
547139|NCT00845858|Gastroparesis|gastroparesis
547140|NCT00845858|Diabetic Gastroparesis|diabetic gastroparesis
547141|NCT00845858|Diabetes|diabetes
547142|NCT00845858|Diabetes Mellitus|diabetes mellitus
547143|NCT00845858|Delayed Gastric Emptying|delayed gastric emptying
547144|NCT00845845|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
547145|NCT00845845|Omega-3 fatty acids|omega-3 fatty acids
547146|NCT00845845|MRI|mri
547147|NCT00845845|NASH|nash
547148|NCT00845819|oral mucositis|oral mucositis
547149|NCT00845819|intensive chemotherapy|intensive chemotherapy
547150|NCT00845819|stem cell transplantation|stem cell transplantation
547151|NCT00845819|epidermal growth factor|epidermal growth factor
547152|NCT00845806|Diacritics|diacritics
547153|NCT00845806|Neuronal Processing|neuronal processing
547154|NCT00845806|fMRI|fmri
547155|NCT00845806|Arabic|arabic
547156|NCT00845793|Type 2 diabetes|type 2 diabetes
547157|NCT00845793|Nutrition|nutrition
547158|NCT00845793|Lifestyle modifications|lifestyle modifications
547159|NCT00845780|persistent atrial fibrillation|persistent atrial fibrillation
547160|NCT00845780|amiodarone|amiodarone
547161|NCT00845780|late recurrence atrial fibrillation|late recurrence atrial fibrillation
547162|NCT00845780|adverse events|adverse events
547163|NCT00845767|Nitric Oxide|nitric oxide
547164|NCT00845767|Nitric Oxide Synthase|nitric oxide synthase
547165|NCT00845767|Air Pollution|air pollution
547166|NCT00845767|Endothelial Dysfunction|endothelial dysfunction
547167|NCT00845767|Diesel Exhaust|diesel exhaust
547168|NCT00845754|Post-operative febrile morbidity|post-operative febrile morbidity
547169|NCT00845754|Post-operative pain management|post-operative pain management
547170|NCT00845728|Indacaterol|indacaterol
547171|NCT00845728|Tiotropium|tiotropium
547172|NCT00845728|COPD|copd
547173|NCT00845715|rotator cuff|rotator cuff
547174|NCT00845715|rehabilitation|rehabilitation
547175|NCT00845715|range of motion|range of motion
547176|NCT00845702|Renal artery stenosis|renal artery stenosis
547177|NCT00845702|Contrast agent|contrast agent
547178|NCT00845702|MRA|mra
547179|NCT00845689|liver surgery|liver surgery
547180|NCT00845676|Hepatitis C virus|hepatitis c virus
547181|NCT00845676|Acute hepatitis C infection|acute hepatitis c infection
547182|NCT00845676|HIV|hiv
547183|NCT00845676|HCV|hcv
547184|NCT00845663|certolizumab pegol|certolizumab pegol
547185|NCT00845663|Cimzia|cimzia
547186|NCT00845663|bioequivalence|bioequivalence
547187|NCT00845663|Comparison Bioequivalence Study|comparison bioequivalence study
547188|NCT00845650|Anthrax|anthrax
547189|NCT00845650|Human Anthrax Immune Globulin Intravenous|human anthrax immune globulin intravenous
547190|NCT00845650|Safety|safety
547191|NCT00845650|Pharmacokinetics|pharmacokinetics
547192|NCT00845637|eggplant|eggplant
547193|NCT00845637|dyslipidemia|dyslipidemia
547194|NCT00845637|postprandial lipemia|postprandial lipemia
547195|NCT00845624|oxygen saturation|oxygen saturation
547196|NCT00845624|retinopathy of prematurity|retinopathy of prematurity
547197|NCT00845624|long term outcomes|long term outcomes
547198|NCT00845624|hypoxia|hypoxia
547199|NCT00845624|hyperoxia|hyperoxia
547200|NCT00845611|peptide vaccine|peptide vaccine
547201|NCT00845611|URLC10|urlc10
547202|NCT00845598|Allergic Rhinitis|allergic rhinitis
547203|NCT00845585|arterial reconstruction|arterial reconstruction
547204|NCT00845585|bypass|bypass
547205|NCT00845585|below knee|below knee
547206|NCT00845585|PZFE|pzfe
547207|NCT00845585|Ovine graft|ovine graft
547208|NCT00845585|Omniflow II|omniflow ii
547209|NCT00845585|graft patency|graft patency
547210|NCT00845572|Schizophrenia|schizophrenia
547211|NCT00845572|Schizoaffective|schizoaffective
547212|NCT00845572|Risperdal Consta|risperdal consta
547213|NCT00845572|Medication Adherence|medication adherence
547214|NCT00845572|Antipsychotic|antipsychotic
547215|NCT00845559|Childhood Obesity|childhood obesity
547216|NCT00845559|Insulin resistance|insulin resistance
547217|NCT00845559|Impaired Glucose Tolerance|impaired glucose tolerance
547218|NCT00845559|Cardiovascular Disease|cardiovascular disease
547219|NCT00845559|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
547220|NCT00845559|Continuous Glucose Monitoring (CGMS)|continuous glucose monitoring (cgms)
547221|NCT00845559|Exenatide|exenatide
547222|NCT00845559|Oral Glucose Tolerance Test|oral glucose tolerance test
547223|NCT00845546|Bioequivalence 10 mg Loratadine 240 mg Pseudoephedrine Sulfate Extended Release Tablets|bioequivalence 10 mg loratadine 240 mg pseudoephedrine sulfate extended release tablets
547224|NCT00845507|weight gain|weight gain
547225|NCT00845494|Medication history|medication history
547226|NCT00845494|medication errors|medication errors
547227|NCT00845494|Reduction of admission medication history errors|reduction of admission medication history errors
547228|NCT00845468|coronary flow reserve|coronary flow reserve
547229|NCT00845468|diabetes mellitus|diabetes mellitus
547230|NCT00845468|acute myocardial infarction|acute myocardial infarction
547231|NCT00845468|transthoracic echocardiography|transthoracic echocardiography
547232|NCT00845442|Bilateral vocal cord paralyses|bilateral vocal cord paralyses
547233|NCT00845442|Implanted laryngeal stimulator|implanted laryngeal stimulator
547234|NCT00845442|vocal cord opening|vocal cord opening
547235|NCT00845442|pulmonary function tests|pulmonary function tests
547236|NCT00845429|Influenza|influenza
547237|NCT00845429|Orthomyxoviruses|orthomyxoviruses
547238|NCT00845429|Split-virion inactivated influenza vaccine|split-virion inactivated influenza vaccine
547239|NCT00845429|cell-based vaccine|cell-based vaccine
547240|NCT00845429|Adults|adults
547241|NCT00845416|TREC|trec
547242|NCT00845416|T cell|t cell
547243|NCT00845416|Primary Immunodeficiency|primary immunodeficiency
547244|NCT00845416|PID|pid
547245|NCT00845416|Navajo|navajo
547246|NCT00845416|SCID|scid
547247|NCT00845403|Hepatitis B carrier|hepatitis b carrier
547248|NCT00845377|Depression|depression
547249|NCT00845377|Aging|aging
547250|NCT00845377|Psychological well-being|psychological well-being
547251|NCT00845377|Psychosocial intervention|psychosocial intervention
547252|NCT00845364|Perhexiline|perhexiline
547529|NCT00844116|spirometry|spirometry
547253|NCT00845364|Coronary artery bypass|coronary artery bypass
547254|NCT00845364|Myocardial reperfusion injury|myocardial reperfusion injury
547255|NCT00845364|Cardiac output, low|cardiac output, low
547256|NCT00845364|Troponin|troponin
547257|NCT00845351|Cushing's|cushing's
547258|NCT00845338|Darifenacin|darifenacin
547259|NCT00845338|Multiple Sclerosis|multiple sclerosis
547260|NCT00845338|Open Label Study|open label study
547261|NCT00845325|Carpal tunnel release|carpal tunnel release
547262|NCT00845325|Rehabilitation|rehabilitation
547263|NCT00845325|Early motion|early motion
547264|NCT00845312|Age|age
547265|NCT00845312|Mortality|mortality
547266|NCT00845299|glaucoma|glaucoma
547267|NCT00845299|ocular hypertension|ocular hypertension
547268|NCT00845286|exercise, myocardial dysfunction, endothelial dysfunction,|exercise, myocardial dysfunction, endothelial dysfunction,
547269|NCT00845286|polymorphism|polymorphism
547270|NCT00845273|Subfoveal choroidal neovascularization secondary to age-related macular degeneration|subfoveal choroidal neovascularization secondary to age-related macular degeneration
547271|NCT00845247|Case Management|case management
547272|NCT00845234|behavioral intervention|behavioral intervention
547273|NCT00845234|implantable cardioverter defibrillator|implantable cardioverter defibrillator
547274|NCT00845234|psychosocial education|psychosocial education
547275|NCT00845234|anxiety|anxiety
547276|NCT00845234|depression|depression
547277|NCT00845208|Network Support|network support
547278|NCT00845208|AA|aa
547279|NCT00845208|Contingency Management|contingency management
547280|NCT00845195|Rhinitis|rhinitis
547281|NCT00845195|Allergy|allergy
547282|NCT00845195|Nasal Spray|nasal spray
547283|NCT00845195|Antihistamine|antihistamine
547284|NCT00845195|Intranasal Corticosteroid|intranasal corticosteroid
547285|NCT00845182|Type 2 diabetes pathogenesis, thiazolidinediones|type 2 diabetes pathogenesis, thiazolidinediones
547286|NCT00845182|impaired glucose tolerance|impaired glucose tolerance
547287|NCT00845182|Incretins|incretins
547288|NCT00845182|Insulin secretion|insulin secretion
547289|NCT00845169|Air Pollution|air pollution
547290|NCT00845169|Nitric Oxide|nitric oxide
547291|NCT00845169|Nitric Oxide Synthase|nitric oxide synthase
547292|NCT00845169|Diesel exhaust|diesel exhaust
547293|NCT00845169|endothelial dysfunction|endothelial dysfunction
547294|NCT00845156|Diabetes|diabetes
547295|NCT00845156|Insulin resistance|insulin resistance
547296|NCT00845156|healthy controls|healthy controls
547297|NCT00845156|anti oxidants|anti oxidants
547298|NCT00845143|Non-small cell lung cancer|non-small cell lung cancer
547299|NCT00845143|surgery|surgery
547300|NCT00845143|lung function|lung function
547301|NCT00845130|Diabetes|diabetes
547302|NCT00845130|MR imaging|mr imaging
547303|NCT00845130|Vitamin C|vitamin c
547304|NCT00845117|Aniridia,|aniridia,
547305|NCT00845117|Steven Johnsons Syndrome,|steven johnsons syndrome,
547306|NCT00845117|Ocular burns,|ocular burns,
547307|NCT00845117|Pterygium|pterygium
547308|NCT00845091|Parasympathetic activity|parasympathetic activity
547309|NCT00845091|Exercise|exercise
547310|NCT00845091|Education|education
547311|NCT00845091|Arrhythmias|arrhythmias
547312|NCT00845091|Defibrillators, Implantable|defibrillators, implantable
547313|NCT00845078|Breast|breast
547314|NCT00845078|Radiotherapy|radiotherapy
547315|NCT00845078|Esthetics|esthetics
547316|NCT00845078|Treatment Outcome|treatment outcome
547317|NCT00845078|Reconstructive Surgical Procedures|reconstructive surgical procedures
547318|NCT00845052|Housestaff|housestaff
547319|NCT00845052|Patient Safety|patient safety
547320|NCT00845052|Patient Care|patient care
547321|NCT00845052|Focus of Study: To assess safety climate amongst housestaff|focus of study: to assess safety climate amongst housestaff
547322|NCT00845039|Tumors|tumors
547323|NCT00845039|Antibodies, Monoclonal|antibodies, monoclonal
547324|NCT00845039|Colorectal Neoplasms|colorectal neoplasms
547325|NCT00845039|Metastatic K-RAS Wild-Type Carcinoma of the Colon or Rectum|metastatic k-ras wild-type carcinoma of the colon or rectum
547326|NCT00845013|HIV infection|hiv infection
547327|NCT00845013|pulmonary hypertension|pulmonary hypertension
547328|NCT00845013|endothelial function|endothelial function
547329|NCT00845013|antiretroviral medication|antiretroviral medication
547330|NCT00845013|Treatment Experienced|treatment experienced
547331|NCT00844987|PDGF|pdgf
547332|NCT00844987|HGF|hgf
547333|NCT00844987|VEGF|vegf
547334|NCT00844987|ACS|acs
547335|NCT00844987|markers of myocardial injury|markers of myocardial injury
547336|NCT00844987|Vascular Endothelial Growth Factor|vascular endothelial growth factor
547337|NCT00844987|Hepatocyte Growth Factor|hepatocyte growth factor
547338|NCT00844987|Platelet Derived Growth Factor|platelet derived growth factor
547339|NCT00844987|Strategies in ACS|strategies in acs
547340|NCT00844961|IBS|ibs
547341|NCT00844961|CBT|cbt
547342|NCT00844961|Internet treatment|internet treatment
547343|NCT00844961|Cognitive behavior therapy|cognitive behavior therapy
547344|NCT00844948|Depression|depression
547345|NCT00844935|Heart rate variability, mechanical ventilation, weaning,|heart rate variability, mechanical ventilation, weaning,
547346|NCT00844935|spontaneous breathing trial|spontaneous breathing trial
547347|NCT00844909|CNTO 136|cnto 136
547348|NCT00844909|safety|safety
547349|NCT00844909|pharmacokinetics|pharmacokinetics
547350|NCT00844909|healthy Japanese|healthy japanese
547351|NCT00844909|healthy Caucasian|healthy caucasian
547352|NCT00844909|Phase I|phase i
547353|NCT00844909|antibody|antibody
547354|NCT00844909|male.|male.
547355|NCT00844896|Pathological stress & PTSD in preschool children & parents|pathological stress & ptsd in preschool children & parents
547356|NCT00844896|Child and parent resilience after burn trauma|child and parent resilience after burn trauma
547357|NCT00844883|primary liver cancer|primary liver cancer
547358|NCT00844883|sorafenib|sorafenib
547359|NCT00844883|Nexavar|nexavar
547360|NCT00844883|doxorubicin|doxorubicin
547361|NCT00844883|drug eluting beads|drug eluting beads
547362|NCT00844883|transarterial chemoembolization|transarterial chemoembolization
547363|NCT00844870|rehabilitation, reaching, stroke|rehabilitation, reaching, stroke
547364|NCT00844857|Bipolar I Depression|bipolar i depression
547365|NCT00844844|aHUS|ahus
547366|NCT00844831|Constipation|constipation
547367|NCT00844831|small intestinal bacterial overgrowth|small intestinal bacterial overgrowth
547368|NCT00844831|stool bacteria|stool bacteria
547369|NCT00844818|smoking cessation|smoking cessation
547370|NCT00844818|parents|parents
547371|NCT00844792|Male Urogenital Diseases|male urogenital diseases
547372|NCT00844792|Antioxidants|antioxidants
547373|NCT00844792|Vitamin E|vitamin e
547374|NCT00844792|Vitamin D|vitamin d
547375|NCT00844792|Lycopene|lycopene
547376|NCT00844792|Selenium|selenium
547377|NCT00844779|Metabolic syndrome- hepatic steatosis- steatohepatitis - gene expression|metabolic syndrome- hepatic steatosis- steatohepatitis - gene expression
547378|NCT00844779|Non alcoholic fatty liver disease (NFALD)|non alcoholic fatty liver disease (nfald)
547379|NCT00844766|Lactose intolerance|lactose intolerance
547380|NCT00844766|Lactose|lactose
547381|NCT00844766|Home-screening test|home-screening test
547382|NCT00844766|Validate|validate
547383|NCT00844753|Autism|autism
547384|NCT00844753|PDD NOS|pdd nos
547385|NCT00844753|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
547386|NCT00844753|Parent Management Training|parent management training
547387|NCT00844740|Familial hypophosphatemic rickets|familial hypophosphatemic rickets
547388|NCT00844740|Cinacalcet|cinacalcet
547389|NCT00844740|hyperparathyroidism|hyperparathyroidism
547390|NCT00844714|endothelial function|endothelial function
547391|NCT00844714|rheumatoid arthritis|rheumatoid arthritis
547392|NCT00844714|cardiovascular risk|cardiovascular risk
547393|NCT00844714|rituxan therapy|rituxan therapy
547394|NCT00844701|nicotine|nicotine
547395|NCT00844701|addiction|addiction
547396|NCT00844701|fMRI|fmri
547397|NCT00844701|neuroimaging|neuroimaging
547398|NCT00844701|neurobiology|neurobiology
547399|NCT00844701|craving|craving
547400|NCT00844688|Hepatocellular Carcinoma|hepatocellular carcinoma
547401|NCT00844688|Sorafenib|sorafenib
547402|NCT00844688|Gemcitabine|gemcitabine
547403|NCT00844675|endoscopic mucosal resection|endoscopic mucosal resection
547404|NCT00844675|Proton Pump Inhibitor|proton pump inhibitor
547405|NCT00844675|gastrointestinal hemorrhage|gastrointestinal hemorrhage
547406|NCT00844675|rabeprazole|rabeprazole
547407|NCT00844662|Hyperphosphataemia|hyperphosphataemia
547408|NCT00844662|phosphate binder|phosphate binder
547409|NCT00844636|Needlestick injuries|needlestick injuries
547410|NCT00844636|Glove perforations|glove perforations
547411|NCT00844636|Blunt Needles|blunt needles
547412|NCT00844636|Glove perforations of surgeons, assistants|glove perforations of surgeons, assistants
547413|NCT00844636|Needlestick injuries of same|needlestick injuries of same
547414|NCT00844623|primary liver cancer, hepatoma|primary liver cancer, hepatoma
547415|NCT00844584|Atrial fibrillation|atrial fibrillation
547416|NCT00844584|radiofrequency|radiofrequency
547417|NCT00844584|totally thoracoscope|totally thoracoscope
547418|NCT00844584|epicardial|epicardial
547419|NCT00844571|child abuse and neglect|child abuse and neglect
547420|NCT00844571|child maltreatment|child maltreatment
547421|NCT00844571|non accidental injury|non accidental injury
547422|NCT00844571|training|training
547423|NCT00844571|educational program|educational program
547424|NCT00844558|osteoarthritis|osteoarthritis
547425|NCT00844558|knee pain|knee pain
547426|NCT00844558|gait training|gait training
547427|NCT00844558|power training|power training
547428|NCT00844558|rehabilitation|rehabilitation
547429|NCT00844558|physical therapy|physical therapy
547430|NCT00844545|aHUS|ahus
547431|NCT00844532|Atherosclerosis|atherosclerosis
547432|NCT00844532|Peripheral artery disease|peripheral artery disease
547433|NCT00844532|Peripheral vascular disease|peripheral vascular disease
547434|NCT00844532|PAD|pad
547435|NCT00844532|Claudication|claudication
547436|NCT00844532|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
547437|NCT00844532|Stent|stent
547438|NCT00844532|PAOD|paod
547439|NCT00844532|PVD|pvd
547440|NCT00844519|Treatment Experienced|treatment experienced
547441|NCT00844519|CCR5 receptor|ccr5 receptor
547442|NCT00844519|maraviroc|maraviroc
547443|NCT00844506|Ovarian cancer patients with recurrent disease|ovarian cancer patients with recurrent disease
547444|NCT00844493|diarrhea|diarrhea
547446|NCT00844493|enterotoxigenic E coli|enterotoxigenic e coli
547447|NCT00844493|colonization factor antigen|colonization factor antigen
547448|NCT00844493|volunteer study|volunteer study
547449|NCT00844480|spinal cord injury|spinal cord injury
547450|NCT00844480|osteoporosis|osteoporosis
547451|NCT00844480|bone loss|bone loss
547452|NCT00844480|zoledronic acid|zoledronic acid
547453|NCT00844480|bisphosphonate|bisphosphonate
547454|NCT00844467|Risk factors|risk factors
547455|NCT00844467|Case fatality|case fatality
547456|NCT00844467|disease burden|disease burden
547457|NCT00844467|Resistance|resistance
547458|NCT00844467|Benefits of pneumococcal vaccination|benefits of pneumococcal vaccination
547459|NCT00844454|hepatocellular carcinoma|hepatocellular carcinoma
547460|NCT00844454|PEI|pei
547461|NCT00844454|RF ablation|rf ablation
547462|NCT00844454|tumor ablation|tumor ablation
547463|NCT00844441|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
547464|NCT00844441|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
547465|NCT00844441|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
547466|NCT00844441|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
547467|NCT00844441|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
547468|NCT00844441|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
547469|NCT00844441|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
547470|NCT00844441|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
547471|NCT00844441|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
547472|NCT00844441|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
547473|NCT00844441|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
547474|NCT00844441|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
547475|NCT00844441|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
547476|NCT00844441|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
547477|NCT00844441|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
547478|NCT00844441|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
547479|NCT00844441|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
547480|NCT00844441|adult acute basophilic leukemia|adult acute basophilic leukemia
547481|NCT00844441|acute myeloid leukemia with multilineage dysplasia following myelodysplastic syndrome|acute myeloid leukemia with multilineage dysplasia following myelodysplastic syndrome
547482|NCT00844441|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
547483|NCT00844441|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
547484|NCT00844402|Cholestasis|cholestasis
547485|NCT00844402|Atherosclerosis|atherosclerosis
547486|NCT00844402|Statins|statins
547487|NCT00844402|Vascular function|vascular function
547488|NCT00844389|Open Angle Glaucoma|open angle glaucoma
547489|NCT00844389|Biophotomodulation|biophotomodulation
547490|NCT00844389|Near to Infrared light stimulation|near to infrared light stimulation
547491|NCT00844389|Neuroprotection|neuroprotection
547492|NCT00844376|Cardiovascular Diseases|cardiovascular diseases
547493|NCT00844350|Oxytocin|oxytocin
547494|NCT00844350|Letrozole|letrozole
547495|NCT00844350|Induction of ovulation|induction of ovulation
547496|NCT00844337|antibiotic regimens|antibiotic regimens
547497|NCT00844337|sepsis|sepsis
547498|NCT00844337|young infants|young infants
547499|NCT00844337|Bangladeshi|bangladeshi
547500|NCT00844337|outpatient treatment|outpatient treatment
547501|NCT00844337|Suspected sepsis in young infants|suspected sepsis in young infants
547502|NCT00844324|Candesartan|candesartan
547503|NCT00844324|Bioequivalence|bioequivalence
547505|NCT00844311|human chorionic gonadotropin|human chorionic gonadotropin
547506|NCT00844298|Philadelphia chromosome positive adult precursor acute lymphoblastic leukemia|philadelphia chromosome positive adult precursor acute lymphoblastic leukemia
547507|NCT00844298|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
547508|NCT00844285|Certolizumab Pegol, Cimzia ®|certolizumab pegol, cimzia ®
547509|NCT00844285|Crohn's Disease|crohn's disease
547510|NCT00844272|Opiate Dependence|opiate dependence
547511|NCT00844272|Chronic Hepatitis C|chronic hepatitis c
547512|NCT00844259|Down syndrome|down syndrome
547513|NCT00844259|Pragmatics|pragmatics
547514|NCT00844259|Language Development|language development
547515|NCT00844246|Developmental delays|developmental delays
547516|NCT00844246|Early intervention services|early intervention services
547517|NCT00844220|Suspected coronary artery disease|suspected coronary artery disease
547518|NCT00844207|Bioavailability|bioavailability
547519|NCT00844155|Prevention or treatment of influenza in ventilated patients|prevention or treatment of influenza in ventilated patients
547520|NCT00844142|ankylosing spondylitis|ankylosing spondylitis
547521|NCT00844142|axial spondyloarthritis|axial spondyloarthritis
547522|NCT00844142|magnetic resonance imaging|magnetic resonance imaging
547523|NCT00844142|etanercept|etanercept
547524|NCT00844142|sulfasalazine|sulfasalazine
547525|NCT00844129|neurofibromatosis type 1|neurofibromatosis type 1
547526|NCT00844129|spinal abnormalities|spinal abnormalities
547527|NCT00844129|scoliosis|scoliosis
547530|NCT00844116|Telematic spirometry|telematic spirometry
547531|NCT00844103|Volunteer|volunteer
547532|NCT00844103|Safety|safety
547533|NCT00844103|Tolerability|tolerability
547534|NCT00844103|AZD8566|azd8566
547535|NCT00844090|Apathy|apathy
547536|NCT00844090|Diabetes|diabetes
547537|NCT00844090|Self-care behaviors|self-care behaviors
547538|NCT00844077|Barrett's Intestinal Metaplasia|barrett's intestinal metaplasia
547539|NCT00844064|Pancreatic cancer|pancreatic cancer
547540|NCT00844064|Metastatic melanoma|metastatic melanoma
547541|NCT00844064|Advanced tumor|advanced tumor
547542|NCT00844064|Targeted therapy|targeted therapy
547543|NCT00844064|Antisense|antisense
547544|NCT00844064|Transforming Growth Factor beta 2|transforming growth factor beta 2
547545|NCT00844064|Dose escalation|dose escalation
547546|NCT00844051|Influenza|influenza
547547|NCT00844051|influenza vaccination|influenza vaccination
547548|NCT00844051|school-based vaccination|school-based vaccination
547549|NCT00844038|Steven-Johnson syndrome|steven-johnson syndrome
547550|NCT00844038|erythema multiform|erythema multiform
547551|NCT00844038|autoimmune disease|autoimmune disease
547552|NCT00844025|Adverse drug reaction|adverse drug reaction
547553|NCT00844025|Inappropriate medication|inappropriate medication
547554|NCT00844025|Pharmacist|pharmacist
547555|NCT00844025|Pharmaceutical care|pharmaceutical care
547556|NCT00843986|hyponatremia|hyponatremia
547557|NCT00843986|euvolemic hyponatremia|euvolemic hyponatremia
547558|NCT00843986|hypervolemic hyponatremia|hypervolemic hyponatremia
547559|NCT00843986|acute decompensated heart failure|acute decompensated heart failure
547560|NCT00843986|conivaptan|conivaptan
547561|NCT00843986|Vaprisol|vaprisol
547562|NCT00843973|Iliac Crest Bone Graft|iliac crest bone graft
547563|NCT00843973|Reamer Irrigator Aspirator|reamer irrigator aspirator
547564|NCT00843934|Carcinoma, Hepatocellular|carcinoma, hepatocellular
547565|NCT00843934|Trans arterial chemoembolization|trans arterial chemoembolization
547566|NCT00843934|Epirubicin|epirubicin
547567|NCT00843934|Cisplatin|cisplatin
547568|NCT00843921|Hyperammonemia|hyperammonemia
547569|NCT00843908|Stress incontinence|stress incontinence
547570|NCT00843908|Surgical Treatments|surgical treatments
547571|NCT00843908|Minislings|minislings
547572|NCT00843895|Laboratory based study|laboratory based study
547573|NCT00843895|antibiotic susceptibilty|antibiotic susceptibilty
547574|NCT00843895|invasive strains|invasive strains
547575|NCT00843843|Circadian Rhythms|circadian rhythms
547576|NCT00843817|cystic fibrosis|cystic fibrosis
547577|NCT00843804|nosocomial infection|nosocomial infection
547578|NCT00843804|bloodstream infection|bloodstream infection
547579|NCT00843804|central venous catheter|central venous catheter
547580|NCT00843804|invasive Aspergillosis|invasive aspergillosis
547581|NCT00843804|Clostridium difficile associated disease|clostridium difficile associated disease
547582|NCT00843791|obesity|obesity
547583|NCT00843778|Rheumatoid Arthritis|rheumatoid arthritis
547584|NCT00843778|Moderate to Low Disease Activity|moderate to low disease activity
547585|NCT00843778|Certolizumab Pegol|certolizumab pegol
547586|NCT00843765|Stroke|stroke
547587|NCT00843765|Traditional Chinese Medicine|traditional chinese medicine
547588|NCT00843765|Rehabilitation|rehabilitation
547589|NCT00843739|Breathing|breathing
547590|NCT00843739|Cough|cough
547591|NCT00843739|Speech|speech
547592|NCT00843739|Swallow|swallow
547593|NCT00843739|Parkinson's disease|parkinson's disease
547594|NCT00843726|stage I non-small cell lung cancer|stage i non-small cell lung cancer
547595|NCT00843726|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
547596|NCT00843713|HIV|hiv
547597|NCT00843713|endothelium|endothelium
547598|NCT00843713|inflammation|inflammation
547599|NCT00843713|Treatment Experienced|treatment experienced
547600|NCT00843687|Schizophrenia|schizophrenia
547601|NCT00843687|Risperidone|risperidone
547602|NCT00843687|Long-acting injectable|long-acting injectable
547603|NCT00843687|Intramuscular injection|intramuscular injection
547604|NCT00843687|Pharmacokinetics|pharmacokinetics
547605|NCT00843661|Treatment Experienced|treatment experienced
547606|NCT00843648|antibody immune profile|antibody immune profile
547607|NCT00843648|preterm|preterm
547608|NCT00843648|c-section|c-section
547609|NCT00843648|breastfeeding|breastfeeding
547610|NCT00843635|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
547611|NCT00843635|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
547612|NCT00843635|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
547613|NCT00843635|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
547614|NCT00843635|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
547615|NCT00843635|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
547616|NCT00843635|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
547617|NCT00843635|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
547618|NCT00843635|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
547902|NCT00842543|Pediatric|pediatric
547619|NCT00843635|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
547620|NCT00843635|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
547621|NCT00843635|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
547622|NCT00843622|Smoking|smoking
547623|NCT00843622|Smoking cessation|smoking cessation
547624|NCT00843622|Smokeless tobacco|smokeless tobacco
547625|NCT00843622|Snus|snus
547626|NCT00843609|diabetes mellitus, type 1|diabetes mellitus, type 1
547627|NCT00843609|hypoglycemia|hypoglycemia
547628|NCT00843609|continuous glucose monitoring|continuous glucose monitoring
547629|NCT00843609|HbA1c|hba1c
547630|NCT00843609|glycemic variability|glycemic variability
547631|NCT00843596|cardiac surgery requiring ECC|cardiac surgery requiring ecc
547632|NCT00843583|prevalence|prevalence
547633|NCT00843583|obstructive sleep apnea|obstructive sleep apnea
547634|NCT00843583|resistant hypertension|resistant hypertension
547635|NCT00843570|IVF|ivf
547636|NCT00843570|Frozen Embryo Replacement|frozen embryo replacement
547637|NCT00843557|critical illness|critical illness
547638|NCT00843557|intensive care|intensive care
547639|NCT00843557|nosocomial infection|nosocomial infection
547640|NCT00843531|neuroendocrine|neuroendocrine
547641|NCT00843531|islet cell|islet cell
547642|NCT00843531|carcinoid|carcinoid
547643|NCT00843531|pancreatic neuroendocrine|pancreatic neuroendocrine
547644|NCT00843531|paraganglioma|paraganglioma
547645|NCT00843531|pheochromocytoma|pheochromocytoma
547646|NCT00843531|RAD001|rad001
547647|NCT00843531|everolimus|everolimus
547648|NCT00843531|erlotinib|erlotinib
547649|NCT00843531|Tarceva|tarceva
547650|NCT00843518|Agitation and Aggression|agitation and aggression
547651|NCT00843505|Smoking Cessation|smoking cessation
547652|NCT00843505|Motivational Interviewing|motivational interviewing
547653|NCT00843505|Quitline|quitline
547654|NCT00843505|Telemedicine|telemedicine
547655|NCT00843505|Stop Smoking Medication|stop smoking medication
547656|NCT00843492|deep vein thrombosis|deep vein thrombosis
547657|NCT00843492|immobilization|immobilization
547658|NCT00843492|nadroparin|nadroparin
547659|NCT00843492|isolated lower-extremity injuries distal to the knee|isolated lower-extremity injuries distal to the knee
547660|NCT00843492|plaster cast|plaster cast
547661|NCT00843492|non-surgical leg injury|non-surgical leg injury
547662|NCT00843492|venous thromboembolism|venous thromboembolism
547663|NCT00843492|bleeding events|bleeding events
547664|NCT00843492|fondaparinux|fondaparinux
547665|NCT00843479|diabetes mellitus, type 2|diabetes mellitus, type 2
547666|NCT00843479|Insulin resistance|insulin resistance
547667|NCT00843479|Aging|aging
547668|NCT00843479|Incretins|incretins
547669|NCT00843479|DPP-IV protein, human|dpp-iv protein, human
547670|NCT00843479|Glucagon-Like Peptide 1|glucagon-like peptide 1
547671|NCT00843479|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
547672|NCT00843479|insulin|insulin
547673|NCT00843479|glucagon|glucagon
547674|NCT00843479|ghrelin|ghrelin
547675|NCT00843466|Hand dermatitis|hand dermatitis
547676|NCT00843453|vitamin B12 deficiency|vitamin b12 deficiency
547677|NCT00843453|cyanocobalamin deficiency|cyanocobalamin deficiency
547678|NCT00843453|proton pump inhibitors|proton pump inhibitors
547679|NCT00843453|omeprazole|omeprazole
547680|NCT00843440|Antiangiogenic therapies|antiangiogenic therapies
547681|NCT00843440|Bevacuzimab|bevacuzimab
547682|NCT00843440|Hemorrhagic Hereditary Telangiectasia (HHT) with severe liver involvement|hemorrhagic hereditary telangiectasia (hht) with severe liver involvement
547683|NCT00843427|aphasia|aphasia
547684|NCT00843427|stroke|stroke
547685|NCT00843427|functional magnetic resonance imaging|functional magnetic resonance imaging
547686|NCT00843427|fMRI|fmri
547687|NCT00843427|language recovery after stroke|language recovery after stroke
547688|NCT00843427|constraint-induced aphasia therapy|constraint-induced aphasia therapy
547689|NCT00843427|CIAT|ciat
547690|NCT00843414|Emphysema|emphysema
547691|NCT00843414|Sarcoidosis|sarcoidosis
547692|NCT00843414|Interstitial Pulmonary Fibrosis|interstitial pulmonary fibrosis
547693|NCT00843401|Low oxygen saturation|low oxygen saturation
547694|NCT00843401|Anticipated need for pulse oximetry monitoring|anticipated need for pulse oximetry monitoring
547695|NCT00843401|Arterial line in place as indicated per patient's clinical management needs|arterial line in place as indicated per patient's clinical management needs
547696|NCT00843401|Availability to analyze arterial blood saturation by Co-Oximeter or|availability to analyze arterial blood saturation by co-oximeter or
547697|NCT00843401|Blood Gas Analyzer|blood gas analyzer
547698|NCT00843349|Phosphorus|phosphorus
547699|NCT00843349|Fibroblast Growth Factor-23|fibroblast growth factor-23
547700|NCT00843349|Kidney Disease|kidney disease
547701|NCT00843336|fertility monitoring|fertility monitoring
547702|NCT00843336|contraception|contraception
547703|NCT00843310|multiple myeloma|multiple myeloma
547704|NCT00843310|frontline treatment|frontline treatment
547705|NCT00843310|first-line treatment|first-line treatment
547706|NCT00843297|Sudden Cardiac Arrest|sudden cardiac arrest
547707|NCT00843297|Hypothermia|hypothermia
547708|NCT00843297|Outcome, neurological|outcome, neurological
547709|NCT00843297|Coolgard|coolgard
547710|NCT00843297|ArcticSun|arcticsun
547711|NCT00843284|neuropathic, pain, pregabalin, Lyrica|neuropathic, pain, pregabalin, lyrica
547712|NCT00843271|COPD MESA LUNG BIOMARKERS|copd mesa lung biomarkers
547713|NCT00843258|therapy|therapy
547714|NCT00843258|ultrasound|ultrasound
547715|NCT00843258|mild dysplasia|mild dysplasia
547716|NCT00843245|Heart Failure|heart failure
547717|NCT00843245|Electric bioimpedance|electric bioimpedance
547718|NCT00843245|Body composition|body composition
547719|NCT00843245|Diagnosis|diagnosis
547720|NCT00843245|monitoring|monitoring
547721|NCT00843245|Prognosis|prognosis
547722|NCT00843245|Total body water|total body water
547723|NCT00843232|diabetes mellitus, type 2|diabetes mellitus, type 2
547724|NCT00843232|Insulin resistance|insulin resistance
547725|NCT00843232|Aging|aging
547726|NCT00843232|Incretins|incretins
547727|NCT00843232|DPP-IV protein, human|dpp-iv protein, human
547728|NCT00843232|Glucagon-Like Peptide 1|glucagon-like peptide 1
547729|NCT00843232|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
547730|NCT00843232|insulin|insulin
547731|NCT00843232|glucagon|glucagon
547732|NCT00843232|ghrelin|ghrelin
547733|NCT00843219|Lung|lung
547734|NCT00843219|Lung Cancer|lung cancer
547735|NCT00843219|Non-small cell Lung Cancer|non-small cell lung cancer
547736|NCT00843219|NSCLC|nsclc
547737|NCT00843219|Motion Correction|motion correction
547738|NCT00843219|PET/CT Scan|pet/ct scan
547740|NCT00843219|Positron Emission Tomography|positron emission tomography
547741|NCT00843219|CT|ct
547742|NCT00843219|Computed Tomography|computed tomography
547743|NCT00843219|Amplitude Gating|amplitude gating
547744|NCT00843193|Asthma|asthma
547745|NCT00843193|Asthma control questionnaire|asthma control questionnaire
547746|NCT00843180|Bone Marrow Transplant|bone marrow transplant
547747|NCT00843180|Massage|massage
547748|NCT00843180|Pediatric Oncology|pediatric oncology
547749|NCT00843180|children undergoing bone marrow transplantation|children undergoing bone marrow transplantation
547750|NCT00843167|mammography|mammography
547751|NCT00843167|biopsy|biopsy
547752|NCT00843167|ductal breast carcinoma in situ|ductal breast carcinoma in situ
547753|NCT00843167|atypical ductal breast hyperplasia|atypical ductal breast hyperplasia
547754|NCT00843154|Natriuretic Peptide, Brain|natriuretic peptide, brain
547755|NCT00843154|Biological Markers|biological markers
547756|NCT00843154|Biomarkers|biomarkers
547757|NCT00843154|Cardiac Failure|cardiac failure
547758|NCT00843154|Congestive Heart Failure|congestive heart failure
547759|NCT00843154|Heart Decompensation|heart decompensation
547760|NCT00843154|Drug Therapy|drug therapy
547761|NCT00843141|ADHD|adhd
547762|NCT00843141|Executive functions|executive functions
547763|NCT00843141|Quality of life|quality of life
547764|NCT00843115|Alzheimer's Disease, naturalistic study|alzheimer's disease, naturalistic study
547765|NCT00843102|atherosclerosis|atherosclerosis
547766|NCT00843102|pulmonary hypertension|pulmonary hypertension
547767|NCT00843089|coronary artery disease|coronary artery disease
547768|NCT00843089|CABG|cabg
547769|NCT00843063|pantoprazole|pantoprazole
547770|NCT00843063|famotidine|famotidine
547771|NCT00843063|aspirin|aspirin
547772|NCT00843063|dyspepsia|dyspepsia
547773|NCT00843063|gastrointestinal bleeding|gastrointestinal bleeding
547774|NCT00843063|peptic ulcer / erosion|peptic ulcer / erosion
547775|NCT00843050|CKD inhibitor|ckd inhibitor
547776|NCT00843050|Mantle Cell Lymphoma|mantle cell lymphoma
547777|NCT00843037|PARAGANGLIOMA|paraganglioma
547778|NCT00843037|PHEOCHROMOCYTOMA|pheochromocytoma
547779|NCT00843037|SUNITINIB|sunitinib
547780|NCT00843037|PHASE II|phase ii
547781|NCT00843037|Metastatic or locally advanced malignant paraganglioma|metastatic or locally advanced malignant paraganglioma
547782|NCT00843037|Metastatic or locally advanced malignant pheochromocytoma|metastatic or locally advanced malignant pheochromocytoma
547783|NCT00843024|Migraine with or without aura|migraine with or without aura
547784|NCT00843024|Migraine efficacy|migraine efficacy
547785|NCT00843024|Migraine|migraine
547786|NCT00843024|Migraine headache|migraine headache
547787|NCT00843024|Adolescent migraine|adolescent migraine
547788|NCT00843024|TREXIMET|treximet
547789|NCT00843024|Sumatriptan succinate|sumatriptan succinate
547790|NCT00843024|Naproxen sodium|naproxen sodium
547791|NCT00843024|Migraine, acute|migraine, acute
547792|NCT00843011|formulation|formulation
547793|NCT00843011|safety and tolerability|safety and tolerability
547794|NCT00843011|pharmacokinetics|pharmacokinetics
547795|NCT00843011|NK1 antagonist|nk1 antagonist
547796|NCT00843011|effect of food|effect of food
547797|NCT00842998|breast cancer|breast cancer
547798|NCT00842998|HER2|her2
547799|NCT00842998|Trastuzumab|trastuzumab
547800|NCT00842998|Lapatinib|lapatinib
547801|NCT00842998|HER2 gene-amplification|her2 gene-amplification
547802|NCT00842985|Cannabis Abuse|cannabis abuse
547803|NCT00842985|Cannabis Dependence|cannabis dependence
547804|NCT00842985|Cannabis-Related Disorder|cannabis-related disorder
547805|NCT00842985|Marijuana Dependence|marijuana dependence
547806|NCT00842985|Marihuana Abuse|marihuana abuse
547807|NCT00842959|Improvement of adjustment accuracy of intraocular lenses and imaging quality|improvement of adjustment accuracy of intraocular lenses and imaging quality
547808|NCT00842933|Septic shock|septic shock
547809|NCT00842933|Acute adrenal insufficiency|acute adrenal insufficiency
547810|NCT00842920|amnestic MCI|amnestic mci
547811|NCT00842907|Brazil|brazil
547812|NCT00842907|isotretinoin|isotretinoin
547813|NCT00842907|photodamage|photodamage
547814|NCT00842907|photoaging|photoaging
547815|NCT00842881|Healingstone|healingstone
547816|NCT00842868|atherosclerosis|atherosclerosis
547817|NCT00842868|contrast induced nephropathy|contrast induced nephropathy
547818|NCT00842868|renal impairment|renal impairment
547819|NCT00842868|catheterization|catheterization
547820|NCT00842855|GERD|gerd
547821|NCT00842855|PPI|ppi
547822|NCT00842855|partial responders|partial responders
547823|NCT00842842|surgical fixation devices|surgical fixation devices
547824|NCT00842842|postoperative pain|postoperative pain
547825|NCT00842842|ventral hernia|ventral hernia
547826|NCT00842842|fibrin tissue adhesive|fibrin tissue adhesive
547827|NCT00842842|laparoscopy|laparoscopy
547828|NCT00842842|quality of life|quality of life
547829|NCT00842842|fatigue|fatigue
547830|NCT00842829|Breakthrough Cancer Pain|breakthrough cancer pain
547831|NCT00842816|Dementia|dementia
547832|NCT00842816|Alzheimer Type Senile Dementia|alzheimer type senile dementia
547833|NCT00842816|Cognitive impairment|cognitive impairment
547834|NCT00842803|Liver|liver
547835|NCT00842803|transplant|transplant
547836|NCT00842803|albumin|albumin
547837|NCT00842803|outcome|outcome
547838|NCT00842803|Liver transplant recipients canadian transplant status 1 or 2|liver transplant recipients canadian transplant status 1 or 2
547839|NCT00842790|Carcinoma, Renal Cell [C04.557.470.200.025.390]|carcinoma, renal cell [c04.557.470.200.025.390]
547840|NCT00842790|Angiogenesis Inhibitors [D27.505.954.248.025]|angiogenesis inhibitors [d27.505.954.248.025]
547841|NCT00842790|Tomography Scanners, X-Ray Computed [E07.913]|tomography scanners, x-ray computed [e07.913]
547842|NCT00842790|Magnetic Resonance Imaging [E01.370.350.825.500]|magnetic resonance imaging [e01.370.350.825.500]
547843|NCT00842790|Diffusion Magnetic Resonance Imaging [E01.370.350.825.500.150]|diffusion magnetic resonance imaging [e01.370.350.825.500.150]
547844|NCT00842790|Perfusion [E05.680]|perfusion [e05.680]
547845|NCT00842777|Childhood obesity|childhood obesity
547846|NCT00842777|Quality of life|quality of life
547847|NCT00842777|Self-esteem|self-esteem
547848|NCT00842777|BMI|bmi
547849|NCT00842777|parental group treatment|parental group treatment
547850|NCT00842777|Body image|body image
547851|NCT00842764|eyelid fat pads|eyelid fat pads
547852|NCT00842751|5α-reductase|5α-reductase
547853|NCT00842751|androgen|androgen
547854|NCT00842751|dihydrotestosterone (DHT)|dihydrotestosterone (dht)
547855|NCT00842751|drug delivery|drug delivery
547856|NCT00842751|oestradiol|oestradiol
547857|NCT00842738|Screening|screening
547858|NCT00842738|Cervical cancer|cervical cancer
547859|NCT00842738|Cervical dysplasia|cervical dysplasia
547860|NCT00842738|Adverse psychosocial effects|adverse psychosocial effects
547861|NCT00842738|Alternative treatment|alternative treatment
547862|NCT00842712|First-line treatment for subjects with advanced NSCLC,|first-line treatment for subjects with advanced nsclc,
547863|NCT00842712|integrin receptor antagonist, EGFR chimerized monoclonal antibody, chemotherapy|integrin receptor antagonist, egfr chimerized monoclonal antibody, chemotherapy
547864|NCT00842712|safety run-in + randomization part, MTD, PFS, Overall survival time, best overall response|safety run-in + randomization part, mtd, pfs, overall survival time, best overall response
547865|NCT00842686|rectal cancer|rectal cancer
547866|NCT00842686|capecitabine|capecitabine
547867|NCT00842686|bevacizumab|bevacizumab
547868|NCT00842686|radiotherapy|radiotherapy
547869|NCT00842673|Dementia|dementia
547870|NCT00842673|Alzheimer Type Senile Dementia|alzheimer type senile dementia
547871|NCT00842673|Cognitive impairment|cognitive impairment
547872|NCT00842660|Cervical cancer|cervical cancer
547873|NCT00842660|concurrent chemoradiotherapy|concurrent chemoradiotherapy
547874|NCT00842660|gemcitabine|gemcitabine
547875|NCT00842647|Sensitivity|sensitivity
547876|NCT00842647|specificity|specificity
547877|NCT00842647|positive rate|positive rate
547878|NCT00842647|negative rate|negative rate
547879|NCT00842634|HIV|hiv
547880|NCT00842634|Treatment Experienced|treatment experienced
547881|NCT00842621|Sickle Cell Disease, Hemolytic Anemia|sickle cell disease, hemolytic anemia
547882|NCT00842621|Hemolysis|hemolysis
547883|NCT00842608|confusion|confusion
547884|NCT00842608|dementia|dementia
547885|NCT00842595|relapsed aggressive B-cell lymphoma|relapsed aggressive b-cell lymphoma
547886|NCT00842595|Chemotherapy|chemotherapy
547887|NCT00842582|Ovarian cancer|ovarian cancer
547888|NCT00842582|chemotherapy|chemotherapy
547889|NCT00842582|azacitidine|azacitidine
547890|NCT00842569|obesity|obesity
547891|NCT00842569|cognitive process|cognitive process
547892|NCT00842569|reward|reward
547893|NCT00842569|P300|p300
547894|NCT00842569|ERP|erp
547895|NCT00842569|Event-related potential during oddball paradigm|event-related potential during oddball paradigm
547896|NCT00842569|brain electrophysiological patterns|brain electrophysiological patterns
547897|NCT00842569|externalizing factor|externalizing factor
547898|NCT00842543|Nutrition|nutrition
547899|NCT00842543|Oxidative Stress|oxidative stress
547900|NCT00842543|Insulin Resistance|insulin resistance
547901|NCT00842543|Whole Food Supplement|whole food supplement
547903|NCT00842543|Retinoids|retinoids
547904|NCT00842543|Antioxidants|antioxidants
547905|NCT00842543|Dietary Supplements|dietary supplements
547906|NCT00842530|Dengue virus|dengue virus
547907|NCT00842530|Dengue fever|dengue fever
547908|NCT00842530|Dengue hemorrhagic fever|dengue hemorrhagic fever
547909|NCT00842530|Dengue diseases|dengue diseases
547910|NCT00842530|Dengue vaccine|dengue vaccine
547911|NCT00842517|Cocaine Dependence|cocaine dependence
547912|NCT00842517|Cocaine Abuse|cocaine abuse
547913|NCT00842517|Substance Abuse|substance abuse
547914|NCT00842517|Contingency Management|contingency management
547915|NCT00842517|Drug Treatment|drug treatment
547916|NCT00842504|Anti-fungal|anti-fungal
547917|NCT00842504|Immunocompromised|immunocompromised
547918|NCT00842504|Pharmacokinetic|pharmacokinetic
547919|NCT00842504|Prophylaxis|prophylaxis
547920|NCT00842504|Pharmacokinetics|pharmacokinetics
547921|NCT00842465|Breast diseases,|breast diseases,
547922|NCT00842465|human mutation,|human mutation,
547923|NCT00842465|prolactin receptor;|prolactin receptor;
547924|NCT00842465|breast cancer|breast cancer
547925|NCT00842452|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
547926|NCT00842452|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
547927|NCT00842452|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
547928|NCT00842452|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
547929|NCT00842452|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
547930|NCT00842452|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
547931|NCT00842452|recurrent endometrial carcinoma|recurrent endometrial carcinoma
547932|NCT00842452|stage III endometrial carcinoma|stage iii endometrial carcinoma
547933|NCT00842452|stage IV endometrial carcinoma|stage iv endometrial carcinoma
547934|NCT00842452|recurrent uterine sarcoma|recurrent uterine sarcoma
547935|NCT00842452|stage III uterine sarcoma|stage iii uterine sarcoma
547936|NCT00842452|stage IV uterine sarcoma|stage iv uterine sarcoma
547937|NCT00842452|recurrent vaginal cancer|recurrent vaginal cancer
547938|NCT00842452|stage III vaginal cancer|stage iii vaginal cancer
547939|NCT00842452|stage IVA vaginal cancer|stage iva vaginal cancer
547940|NCT00842452|stage IVB vaginal cancer|stage ivb vaginal cancer
547941|NCT00842452|recurrent vulvar cancer|recurrent vulvar cancer
547942|NCT00842452|stage III vulvar cancer|stage iii vulvar cancer
547943|NCT00842452|stage IV vulvar cancer|stage iv vulvar cancer
547944|NCT00842452|recurrent cervical cancer|recurrent cervical cancer
547945|NCT00842452|stage III cervical cancer|stage iii cervical cancer
547946|NCT00842452|stage IVA cervical cancer|stage iva cervical cancer
547947|NCT00842452|stage IVB cervical cancer|stage ivb cervical cancer
547948|NCT00842452|fallopian tube cancer|fallopian tube cancer
547949|NCT00842452|ovarian sarcoma|ovarian sarcoma
547950|NCT00842452|ovarian stromal cancer|ovarian stromal cancer
547951|NCT00842439|aggression|aggression
547952|NCT00842439|Prevention and treatment of youth aggression|prevention and treatment of youth aggression
547953|NCT00842426|Diabetes|diabetes
547954|NCT00842426|Cardiovascular disease|cardiovascular disease
547955|NCT00842426|Metabolic syndrome|metabolic syndrome
547956|NCT00842426|Cardiometabolic|cardiometabolic
547957|NCT00842413|Prefrontal cortex|prefrontal cortex
547958|NCT00842413|visual consciousness|visual consciousness
547959|NCT00842413|focal lesions|focal lesions
547960|NCT00842413|action perception|action perception
547961|NCT00842400|Obesity|obesity
547962|NCT00842387|gastroesophageal reflux disease|gastroesophageal reflux disease
547963|NCT00842387|reflux, heartburn|reflux, heartburn
547964|NCT00842387|regurgitation|regurgitation
547965|NCT00842387|acid control|acid control
547966|NCT00842387|PPI|ppi
547967|NCT00842387|antiacid|antiacid
547968|NCT00842387|primary care|primary care
547969|NCT00842387|esophagitis|esophagitis
547970|NCT00842348|Lanreotide|lanreotide
547971|NCT00842348|Somatuline|somatuline
547972|NCT00842348|Neuroendocrine tumour|neuroendocrine tumour
547973|NCT00842348|NET|net
547974|NCT00842335|solid tumors|solid tumors
547975|NCT00842335|angiogenesis inhibitor|angiogenesis inhibitor
547976|NCT00842335|dose escalation|dose escalation
547977|NCT00842335|maximum tolerated dose|maximum tolerated dose
547978|NCT00842335|JI-101|ji-101
547979|NCT00842322|chronic kidney disease|chronic kidney disease
547980|NCT00842322|transplantation|transplantation
547981|NCT00842322|kidney function|kidney function
547982|NCT00842322|fluid intake|fluid intake
547983|NCT00842322|osmolarity|osmolarity
547984|NCT00842296|GSV|gsv
547985|NCT00842296|RadioFrequency|radiofrequency
547986|NCT00842283|dermatologic diseases|dermatologic diseases
547987|NCT00842270|severe asthma|severe asthma
547988|NCT00842270|corticosteroids dependent|corticosteroids dependent
547989|NCT00842270|asthma exacerbation|asthma exacerbation
547990|NCT00842270|weaning|weaning
547991|NCT00842270|tyrosine kinase inhibitor|tyrosine kinase inhibitor
547992|NCT00842270|severe persistent corticosteroid dependent asthma|severe persistent corticosteroid dependent asthma
547993|NCT00842257|panitumumab|panitumumab
547994|NCT00842257|cetuximab|cetuximab
547995|NCT00842257|KRAS wild-type|kras wild-type
547996|NCT00842231|Corneal astigmatism|corneal astigmatism
547997|NCT00842231|post-cataract surgery|post-cataract surgery
547998|NCT00842231|visual performance|visual performance
547999|NCT00842231|Corneal astigmatism 0.5-0.75 Diopter|corneal astigmatism 0.5-0.75 diopter
548000|NCT00842218|Gait|gait
548001|NCT00842218|scoliosis|scoliosis
548002|NCT00842218|energy|energy
548003|NCT00842218|mechanics|mechanics
548004|NCT00842205|hepatitis C|hepatitis c
548005|NCT00842205|NASH|nash
548006|NCT00842205|Hem Oxygenase|hem oxygenase
548007|NCT00842205|Gene polymorphism|gene polymorphism
548008|NCT00842179|Perclose|perclose
548009|NCT00842153|Psoriasis|psoriasis
548010|NCT00842153|Plaque Type Psoriasis|plaque type psoriasis
548011|NCT00842140|Polycystic ovary syndrome|polycystic ovary syndrome
548012|NCT00842140|Oral Contraceptives, Hormonal|oral contraceptives, hormonal
548013|NCT00842140|Cardiovascular Disease|cardiovascular disease
548014|NCT00842140|Endothelium|endothelium
548015|NCT00842127|Methylphenidate|methylphenidate
548016|NCT00842127|ADHD|adhd
548017|NCT00842127|Multidrug resistance(MDR)polymorphism|multidrug resistance(mdr)polymorphism
548018|NCT00842127|OROS methylphenidate|oros methylphenidate
548019|NCT00842114|Intermediate-high FLIPI score|intermediate-high flipi score
548020|NCT00842114|Follicular Lymphoma|follicular lymphoma
548021|NCT00842114|Progression free survival|progression free survival
548022|NCT00842101|Intramedullary nails|intramedullary nails
548023|NCT00842101|Compartmental syndrome|compartmental syndrome
548024|NCT00842101|Fractures|fractures
548025|NCT00842075|type 1 diabetes|type 1 diabetes
548026|NCT00842075|adolescents|adolescents
548027|NCT00842075|post prandial glucose|post prandial glucose
548028|NCT00842049|Subarachnoid haemorrhage|subarachnoid haemorrhage
548029|NCT00842049|Aneurysm|aneurysm
548030|NCT00842049|Cerebrospinal fluid drainage|cerebrospinal fluid drainage
548031|NCT00842036|Family Therapy|family therapy
548032|NCT00842036|Relationship Dysfunction|relationship dysfunction
548033|NCT00842036|Family Dysfunction|family dysfunction
548034|NCT00842036|Family Relations|family relations
548035|NCT00842036|Stimulant Dependence|stimulant dependence
548036|NCT00842036|Opiate Dependence|opiate dependence
548037|NCT00842036|Alcohol Dependence|alcohol dependence
548038|NCT00842036|Behavior Therapy|behavior therapy
548039|NCT00842036|Drug Treatment|drug treatment
548040|NCT00842036|Substance Abuse|substance abuse
548041|NCT00842036|Drug Addiction|drug addiction
548042|NCT00842023|Natriuretic peptides|natriuretic peptides
548043|NCT00842023|BNP|bnp
548044|NCT00842023|Heart Failure|heart failure
548045|NCT00842023|Nitoglycerin|nitoglycerin
548046|NCT00842023|Biomarkers|biomarkers
548047|NCT00842010|Diabetes|diabetes
548048|NCT00842010|Inpatient|inpatient
548049|NCT00842010|Hospital|hospital
548050|NCT00842010|Hyperglycemia|hyperglycemia
548051|NCT00841984|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
548052|NCT00841984|neurological diseases|neurological diseases
548053|NCT00841984|metabolic|metabolic
548054|NCT00841984|inborn errors of metabolism|inborn errors of metabolism
548055|NCT00841984|Complex neurological diseases of unknown cause|complex neurological diseases of unknown cause
548056|NCT00841945|Diffuse B larg cell lymphoma|diffuse b larg cell lymphoma
548057|NCT00841945|Chemotherapy|chemotherapy
548058|NCT00841945|Radiotherapy|radiotherapy
548059|NCT00841932|Fractional Flow Reserve|fractional flow reserve
548060|NCT00841932|Without anticoagulation|without anticoagulation
548061|NCT00841919|Diabetes|diabetes
548062|NCT00841919|Inpatient|inpatient
548063|NCT00841919|Insulin|insulin
548064|NCT00841919|Insulin pen|insulin pen
548065|NCT00841893|Thermogenesis|thermogenesis
548066|NCT00841893|Meal-induced thermogenesis|meal-induced thermogenesis
548067|NCT00841893|Energy expenditure|energy expenditure
548068|NCT00841893|Fat oxidation|fat oxidation
548069|NCT00841893|Carbohydrate oxidation|carbohydrate oxidation
548070|NCT00841893|Bioactive ingredient|bioactive ingredient
548071|NCT00841893|Spice|spice
548072|NCT00841867|Impaired Glucose Tolerance|impaired glucose tolerance
548073|NCT00841867|Diabetes|diabetes
548074|NCT00841854|Helicobacter pylori|helicobacter pylori
548075|NCT00841854|Bismuth|bismuth
548076|NCT00841854|Salvage treatment|salvage treatment
548077|NCT00841854|Metronidazole|metronidazole
548078|NCT00841841|Analgesia|analgesia
548079|NCT00841841|molar third|molar third
548080|NCT00841841|acetaminophen|acetaminophen
548081|NCT00841841|dipyrone|dipyrone
548082|NCT00841815|Bioequivalence|bioequivalence
548083|NCT00841815|Healthy Subjects|healthy subjects
548084|NCT00841802|Chronic sinusitis|chronic sinusitis
548085|NCT00841802|Chronic rhinosinusitis|chronic rhinosinusitis
548086|NCT00841802|Nasal polyps|nasal polyps
548087|NCT00841789|Etanercept|etanercept
548088|NCT00841776|Acne Vulgaris|acne vulgaris
548089|NCT00841776|Acne|acne
548090|NCT00841763|virus|virus
548091|NCT00841763|pandemic influenza|pandemic influenza
548092|NCT00841763|vaccine|vaccine
548093|NCT00841750|Chest Tubes|chest tubes
548094|NCT00841750|Thoracic Surgery, Video-Assisted|thoracic surgery, video-assisted
548095|NCT00841750|Lung Diseases, Interstitial|lung diseases, interstitial
548096|NCT00841750|Pulmonary Nodule, Solitary|pulmonary nodule, solitary
548097|NCT00841737|Depressive Disorders;|depressive disorders;
548098|NCT00841737|Primary Health Care;|primary health care;
548099|NCT00841737|Nurses;|nurses;
548100|NCT00841737|Health education.|health education.
548101|NCT00841724|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
548102|NCT00841724|Reduced-intensity conditioning|reduced-intensity conditioning
548103|NCT00841724|Reduced-toxicity conditioning|reduced-toxicity conditioning
548104|NCT00841724|Hematological malignancies|hematological malignancies
548105|NCT00841724|IV Busulfan|iv busulfan
548107|NCT00841711|AIDS|aids
548108|NCT00841711|Buprenorphine|buprenorphine
548109|NCT00841711|Intensive Case Management|intensive case management
548110|NCT00841711|Money Management|money management
548111|NCT00841711|Rapid Testing|rapid testing
548112|NCT00841711|Substance Abuse|substance abuse
548113|NCT00841711|Opioid Dependance|opioid dependance
548114|NCT00841711|Inmate Population|inmate population
548115|NCT00841698|Bioequivalence|bioequivalence
548116|NCT00841698|Healthy Subjects|healthy subjects
548117|NCT00841672|Hypertension|hypertension
548118|NCT00841672|systolic blood pressure|systolic blood pressure
548119|NCT00841672|cardiovascular disease|cardiovascular disease
548120|NCT00841672|aliskiren|aliskiren
548121|NCT00841672|amlodipine|amlodipine
548122|NCT00841659|Bioequivalence|bioequivalence
548123|NCT00841659|Healthy Subjects|healthy subjects
548124|NCT00841646|Influenza vaccine|influenza vaccine
548125|NCT00841633|subarachnoid hemorrhage|subarachnoid hemorrhage
548126|NCT00841633|ischemia|ischemia
548127|NCT00841633|vasospasm|vasospasm
548128|NCT00841633|CT|ct
548129|NCT00841633|perfusion|perfusion
548130|NCT00841633|induced hypertension|induced hypertension
548131|NCT00841633|delayed cerebral ischemia|delayed cerebral ischemia
548132|NCT00841620|Symptoms|symptoms
548133|NCT00841620|Postoperative pain|postoperative pain
548134|NCT00841620|Postoperative complications|postoperative complications
548135|NCT00841620|Milligan|milligan
548136|NCT00841620|Anopxy|anopxy
548137|NCT00841607|whipple|whipple
548138|NCT00841607|pancreas|pancreas
548139|NCT00841607|reconstruction|reconstruction
548140|NCT00841607|leak|leak
548141|NCT00841607|fistula|fistula
548142|NCT00841594|healthy volunteers|healthy volunteers
548143|NCT00841581|Age Related Macular Degeneration|age related macular degeneration
548144|NCT00841581|Pigment Epithelial Detachment|pigment epithelial detachment
548145|NCT00841581|Intravitreal Detachment|intravitreal detachment
548146|NCT00841581|Anti-VEGF|anti-vegf
548147|NCT00841568|ADPKD|adpkd
548148|NCT00841568|Tolvaptan|tolvaptan
548149|NCT00841555|adult giant cell glioblastoma|adult giant cell glioblastoma
548150|NCT00841555|adult gliosarcoma|adult gliosarcoma
548151|NCT00841555|adult anaplastic astrocytoma|adult anaplastic astrocytoma
548152|NCT00841555|adult glioblastoma|adult glioblastoma
548153|NCT00841555|GBM/AA|gbm/aa
548154|NCT00841542|Bioequivalence|bioequivalence
548155|NCT00841542|Healthy Subjects|healthy subjects
548156|NCT00841529|left atrial appendage|left atrial appendage
548157|NCT00841529|LAA|laa
548158|NCT00841529|atrial fibrillation|atrial fibrillation
548159|NCT00841529|AF|af
548160|NCT00841516|Specific immunotherapy|specific immunotherapy
548161|NCT00841516|SIT|sit
548162|NCT00841516|SCIT|scit
548163|NCT00841516|recombinant|recombinant
548164|NCT00841516|Type 1 - Allergy|type 1 - allergy
548165|NCT00841503|functional food study|functional food study
548166|NCT00841490|Helicobacter pylori|helicobacter pylori
548167|NCT00841490|Oral Health|oral health
548168|NCT00841490|Intellectually & Developmentally Disabled|intellectually & developmentally disabled
548169|NCT00841477|druguser,HB vaccine adherence, HBV, HCV, HIV incidence|druguser,hb vaccine adherence, hbv, hcv, hiv incidence
548170|NCT00841464|Parkinson's disease|parkinson's disease
548171|NCT00841464|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
548172|NCT00841451|Atrial Fibrillation|atrial fibrillation
548173|NCT00841451|Persistent|persistent
548174|NCT00841451|Paroxysmal|paroxysmal
548175|NCT00841451|Pulmonary Vein isolation|pulmonary vein isolation
548176|NCT00841451|Omega three fatty acids|omega three fatty acids
548177|NCT00841451|Fish Oils|fish oils
548178|NCT00841438|Angioplasty|angioplasty
548179|NCT00841438|Transluminal|transluminal
548180|NCT00841438|Percutaneous Coronary|percutaneous coronary
548181|NCT00841412|Usual Care Control Group|usual care control group
548182|NCT00841399|Breast cancer|breast cancer
548183|NCT00841386|Cornea|cornea
548184|NCT00841386|Keratoconus|keratoconus
548185|NCT00841386|Ectasia|ectasia
548186|NCT00841386|Riboflavin|riboflavin
548187|NCT00841386|Collagen cross-linking|collagen cross-linking
548188|NCT00841373|Retinal ischemia: Iris/Angle Neovascularization|retinal ischemia: iris/angle neovascularization
548189|NCT00841360|Social network|social network
548190|NCT00841360|Asymptomatic HIV|asymptomatic hiv
548191|NCT00841347|Obesity|obesity
548192|NCT00841347|Glucose metabolism disorders|glucose metabolism disorders
548193|NCT00841347|Appetite regulation|appetite regulation
548194|NCT00841347|Sleep|sleep
548195|NCT00841347|Adolescent|adolescent
548196|NCT00841347|Randomized controlled trials|randomized controlled trials
548197|NCT00841334|Adolescent|adolescent
548198|NCT00841334|Overweight|overweight
548199|NCT00841334|Obesity|obesity
548200|NCT00841334|Weight loss|weight loss
548201|NCT00841334|Nutrition|nutrition
548202|NCT00841334|Physical activity|physical activity
548203|NCT00841334|Community-based participatory research|community-based participatory research
548204|NCT00841334|School-based|school-based
548205|NCT00841334|Primary Care|primary care
548206|NCT00841334|Motivational interviewing|motivational interviewing
548207|NCT00841321|Ginkgo biloba|ginkgo biloba
548208|NCT00841321|Multiple Sclerosis|multiple sclerosis
548209|NCT00841321|Cognition|cognition
548210|NCT00841321|Neuropsychological Tests|neuropsychological tests
548211|NCT00841321|Neurobehavioral Manifestations|neurobehavioral manifestations
548212|NCT00841321|Quality of life|quality of life
548213|NCT00841321|Randomized Controlled Trials|randomized controlled trials
548214|NCT00841321|Placebos|placebos
548215|NCT00841321|Double-Blind Method|double-blind method
548216|NCT00841282|Colorectal cancer screening|colorectal cancer screening
548217|NCT00841282|Optical colonoscopy|optical colonoscopy
548218|NCT00841282|Water method|water method
548219|NCT00841282|Sedation|sedation
548220|NCT00841269|Bipolar Manic Depression|bipolar manic depression
548221|NCT00841256|specific immunotherapy|specific immunotherapy
548222|NCT00841256|SIT|sit
548223|NCT00841256|SLIT|slit
548224|NCT00841256|sublingual|sublingual
548225|NCT00841243|Hepatitis C|hepatitis c
548226|NCT00841243|Antiviral therapy|antiviral therapy
548227|NCT00841243|weight loss|weight loss
548228|NCT00841243|dietary support|dietary support
548229|NCT00841243|dietary advise|dietary advise
548230|NCT00841230|Tinnitus|tinnitus
548231|NCT00841217|Drug treatment|drug treatment
548232|NCT00841191|Resistant to anti-EGFR|resistant to anti-egfr
548233|NCT00841191|Interleukin-6|interleukin-6
548234|NCT00841191|Neoplasms by Histologic Type|neoplasms by histologic type
548235|NCT00841191|Immunologic Factors|immunologic factors
548236|NCT00841191|Mol Physiological Effects of Drugs|mol physiological effects of drugs
548237|NCT00841191|KRAS protein, human|kras protein, human
548238|NCT00841191|CNTO 328|cnto 328
548239|NCT00841178|Randomised controlled trial|randomised controlled trial
548240|NCT00841178|Venous insufficiency|venous insufficiency
548241|NCT00841178|Varicose veins|varicose veins
548242|NCT00841178|Quality of Life|quality of life
548243|NCT00841178|Clinical effectiveness|clinical effectiveness
548244|NCT00841178|Cost effectiveness|cost effectiveness
548245|NCT00841165|Carbon Monoxide Toxicity|carbon monoxide toxicity
548246|NCT00841165|Carbon|carbon
548247|NCT00841165|Monoxide|monoxide
548248|NCT00841165|Poisoning|poisoning
548249|NCT00841165|Toxicity|toxicity
548250|NCT00841165|Treatment|treatment
548251|NCT00841165|CPAP|cpap
548252|NCT00841165|Hyperbaric|hyperbaric
548253|NCT00841165|Oxygen|oxygen
548254|NCT00841152|Bone tumors|bone tumors
548255|NCT00841152|Surgery|surgery
548256|NCT00841152|Bone graft substitutes|bone graft substitutes
548257|NCT00841152|Bioactive glass|bioactive glass
548258|NCT00841152|Bioceramics|bioceramics
548259|NCT00841152|Bone autograft|bone autograft
548260|NCT00841152|Bone allograft|bone allograft
548261|NCT00841139|perhexiline|perhexiline
548262|NCT00841139|idiopathic dilated cardiomyopathy|idiopathic dilated cardiomyopathy
548263|NCT00841139|magnetic resonance spectroscopy|magnetic resonance spectroscopy
548264|NCT00841139|cardiac energetics|cardiac energetics
548265|NCT00841126|Hyperphosphatemia|hyperphosphatemia
548266|NCT00841126|Phosphate binder|phosphate binder
548267|NCT00841113|Prostate cancer|prostate cancer
548268|NCT00841113|Advanced|advanced
548269|NCT00841113|Metastatic|metastatic
548270|NCT00841100|PKU|pku
548271|NCT00841100|Kuvan|kuvan
548272|NCT00841100|BH4|bh4
548273|NCT00841100|tetrahydrobiopterin|tetrahydrobiopterin
548274|NCT00841074|Pneumonia|pneumonia
548275|NCT00841074|Elderly|elderly
548276|NCT00841074|Chlorhexidine|chlorhexidine
548277|NCT00841074|Respiratory pathogens|respiratory pathogens
548278|NCT00841048|Safety and tolerability|safety and tolerability
548279|NCT00841035|Pancreatic|pancreatic
548280|NCT00841035|Cancer|cancer
548281|NCT00841035|Assay|assay
548282|NCT00841035|Biomarkers|biomarkers
548283|NCT00841022|anxiety|anxiety
548284|NCT00841022|anaesthesia|anaesthesia
548285|NCT00841022|child|child
548286|NCT00841022|RCT|rct
548287|NCT00841022|Elective surgery|elective surgery
548288|NCT00841009|gastric bypass|gastric bypass
548289|NCT00841009|obesity|obesity
548290|NCT00840996|Spine Surgery|spine surgery
548291|NCT00840996|Intraocular pressure|intraocular pressure
548292|NCT00840996|Lidocaine|lidocaine
548293|NCT00840996|Epidural Anesthetic|epidural anesthetic
548294|NCT00840983|delayed cord clamping|delayed cord clamping
548295|NCT00840983|very low birthweight infant|very low birthweight infant
548296|NCT00840983|bronchopulmonary dysplasia|bronchopulmonary dysplasia
548297|NCT00840983|intraventricular hemorrhage|intraventricular hemorrhage
548298|NCT00840983|motor function|motor function
548299|NCT00840944|gonadotropin releasing hormone agonist|gonadotropin releasing hormone agonist
548300|NCT00840944|growth hormone|growth hormone
548301|NCT00840944|final height|final height
548671|NCT00839306|Reflux|reflux
548302|NCT00840944|bone density|bone density
548303|NCT00840944|puberty|puberty
548304|NCT00840931|Myeloid|myeloid
548305|NCT00840931|Monocytic|monocytic
548306|NCT00840931|Immunotherapy|immunotherapy
548307|NCT00840931|Vaccine|vaccine
548308|NCT00840931|MDS|mds
548309|NCT00840931|High Risk Myelodysplastic Syndrome|high risk myelodysplastic syndrome
548310|NCT00840918|Cardiac surgery|cardiac surgery
548311|NCT00840918|Lidocaine|lidocaine
548312|NCT00840918|Quality of life|quality of life
548313|NCT00840905|HPV|hpv
548314|NCT00840879|Bioequivalence|bioequivalence
548315|NCT00840879|Healthy Subjects|healthy subjects
548316|NCT00840866|Bioequivalence|bioequivalence
548317|NCT00840866|Healthy Subjects|healthy subjects
548318|NCT00840853|Stem cell transplant|stem cell transplant
548319|NCT00840853|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
548320|NCT00840853|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
548321|NCT00840853|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
548322|NCT00840853|Cytotoxic T lymphocytes|cytotoxic t lymphocytes
548323|NCT00840853|CTL|ctl
548324|NCT00840853|CD-19|cd-19
548325|NCT00840853|chimeric receptor|chimeric receptor
548326|NCT00840840|Bioequivalence|bioequivalence
548327|NCT00840840|Healthy Subjects|healthy subjects
548328|NCT00840827|stage (IPSS low and INT-1)|stage (ipss low and int-1)
548329|NCT00840827|RBC transfusion-dependent|rbc transfusion-dependent
548330|NCT00840827|non-del 5q MDS|non-del 5q mds
548331|NCT00840814|lymphedema|lymphedema
548332|NCT00840814|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
548333|NCT00840814|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
548334|NCT00840814|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
548335|NCT00840814|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
548336|NCT00840814|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
548337|NCT00840814|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
548338|NCT00840814|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
548339|NCT00840814|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
548340|NCT00840814|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
548458|NCT00840359|Photodynamic therapy|photodynamic therapy
548341|NCT00840814|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
548342|NCT00840814|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
548343|NCT00840814|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
548344|NCT00840814|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
548345|NCT00840814|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
548346|NCT00840814|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
548347|NCT00840814|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
548348|NCT00840814|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
548349|NCT00840814|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
548350|NCT00840814|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
548351|NCT00840814|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
548352|NCT00840814|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
548353|NCT00840814|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
548354|NCT00840814|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
548355|NCT00840814|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
548356|NCT00840814|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
548357|NCT00840814|stage I salivary gland cancer|stage i salivary gland cancer
548358|NCT00840814|stage II salivary gland cancer|stage ii salivary gland cancer
548359|NCT00840814|stage III salivary gland cancer|stage iii salivary gland cancer
548360|NCT00840788|skin adhesive|skin adhesive
548361|NCT00840788|tissue adhesive|tissue adhesive
548362|NCT00840788|mediolateral episiotomy|mediolateral episiotomy
548363|NCT00840788|perineal repair|perineal repair
548364|NCT00840788|labor and delivery|labor and delivery
548365|NCT00840788|repair|repair
548366|NCT00840775|Stent|stent
548367|NCT00840775|interventional cardiology|interventional cardiology
548368|NCT00840775|catheterization|catheterization
548369|NCT00840775|symptomatic ischemic heart disease|symptomatic ischemic heart disease
548370|NCT00840762|HIV-1|hiv-1
548372|NCT00840762|HIV Genotypic testing|hiv genotypic testing
548373|NCT00840762|resistance|resistance
548374|NCT00840749|STARS|stars
548375|NCT00840749|Early Stage Non Small Cell Lung Cancer|early stage non small cell lung cancer
548376|NCT00840749|NSCLC|nsclc
548377|NCT00840749|CyberKnife|cyberknife
548378|NCT00840749|Surgery|surgery
548379|NCT00840749|Accuray|accuray
548380|NCT00840736|VBG|vbg
548381|NCT00840736|LAGB|lagb
548382|NCT00840736|long term results|long term results
548383|NCT00840736|Weight loss|weight loss
548384|NCT00840736|Complications|complications
548385|NCT00840736|Reoperations|reoperations
548386|NCT00840736|Conversion|conversion
548387|NCT00840723|Healthy smokers|healthy smokers
548388|NCT00840723|Current cigarette smokers|current cigarette smokers
548389|NCT00840723|No lung disease|no lung disease
548390|NCT00840710|women in active labor|women in active labor
548391|NCT00840697|low back pain|low back pain
548392|NCT00840697|neck pain|neck pain
548393|NCT00840697|return to work|return to work
548394|NCT00840697|exercises|exercises
548395|NCT00840697|cognitive intervention|cognitive intervention
548396|NCT00840684|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
548397|NCT00840684|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
548398|NCT00840671|Cerebrolysin|cerebrolysin
548399|NCT00840671|Alteplase|alteplase
548400|NCT00840671|Ischemic Stroke|ischemic stroke
548401|NCT00840671|Modified Rankin Scale|modified rankin scale
548402|NCT00840671|NIH Stroke Scale|nih stroke scale
548403|NCT00840671|Barthel Index|barthel index
548404|NCT00840671|Glasgow Outcome Score|glasgow outcome score
548405|NCT00840658|HIV|hiv
548406|NCT00840658|Injection drug users|injection drug users
548407|NCT00840658|Female sex workers|female sex workers
548408|NCT00840658|STIs|stis
548409|NCT00840658|HIV Seronegativity|hiv seronegativity
548410|NCT00840645|YM178|ym178
548411|NCT00840645|Urinary Bladder, Overactive|urinary bladder, overactive
548412|NCT00840645|Mirabegron|mirabegron
548413|NCT00840632|Bioequivalence|bioequivalence
548414|NCT00840632|Healthy Subjects|healthy subjects
548415|NCT00840606|Bioequivalence|bioequivalence
548416|NCT00840606|Healthy Subjects|healthy subjects
548417|NCT00840593|Acromioclavicular Joint|acromioclavicular joint
548418|NCT00840593|Dislocation|dislocation
548419|NCT00840593|Trials, Randomized Clinical|trials, randomized clinical
548420|NCT00840593|Surgical Procedures, Operative|surgical procedures, operative
548421|NCT00840580|Cataract, Cornea, Vigamox, Cravit|cataract, cornea, vigamox, cravit
548422|NCT00840567|Stem cells|stem cells
548423|NCT00840554|Fatigue|fatigue
548424|NCT00840554|Cancer-related fatigue|cancer-related fatigue
548425|NCT00840554|High grade glioma|high grade glioma
548426|NCT00840554|Quality of life|quality of life
548427|NCT00840554|Exercise|exercise
548428|NCT00840554|Physical Therapy|physical therapy
548429|NCT00840554|HGG|hgg
548430|NCT00840554|QOL|qol
548431|NCT00840528|ozone|ozone
548432|NCT00840502|malaria|malaria
548433|NCT00840502|ultrasound|ultrasound
548434|NCT00840502|pregnancy|pregnancy
548435|NCT00840502|Pregnant women (infected with malaria and without)|pregnant women (infected with malaria and without)
548436|NCT00840476|Bioequivalence|bioequivalence
548437|NCT00840476|Healthy Subjects|healthy subjects
548438|NCT00840463|Pulmonary Hypertension|pulmonary hypertension
548439|NCT00840463|Diastolic Heart Failure|diastolic heart failure
548440|NCT00840450|ovarian cancer|ovarian cancer
548441|NCT00840450|recurrent|recurrent
548442|NCT00840450|Gleevec|gleevec
548443|NCT00840450|Paclitaxel|paclitaxel
548444|NCT00840450|Taxane|taxane
548445|NCT00840450|mullerian|mullerian
548446|NCT00840437|angina|angina
548447|NCT00840437|health related quality of life|health related quality of life
548448|NCT00840411|Bioequivalence|bioequivalence
548449|NCT00840411|Healthy Subjects|healthy subjects
548450|NCT00840398|Bioequivalence|bioequivalence
548451|NCT00840398|Healthy Subjects|healthy subjects
548452|NCT00840385|Peripheral T-cell lymphomas (PTCL)|peripheral t-cell lymphomas (ptcl)
548453|NCT00840385|Fludarabine|fludarabine
548454|NCT00840372|Blunt needles|blunt needles
548455|NCT00840372|Semi-blunt needles|semi-blunt needles
548456|NCT00840372|Buttonhole cannulation method|buttonhole cannulation method
548457|NCT00840359|Cutaneous leishmaniasis|cutaneous leishmaniasis
548459|NCT00840346|Acute Myeloblastic Leukaemia (AML)|acute myeloblastic leukaemia (aml)
548460|NCT00840346|Panobinostat|panobinostat
548462|NCT00840320|tolerability|tolerability
548463|NCT00840307|Obesity|obesity
548464|NCT00840307|Type 2 Diabetes|type 2 diabetes
548465|NCT00840307|Gastric Banding|gastric banding
548466|NCT00840294|Men with Elevated PSA|men with elevated psa
548467|NCT00840281|Bioequivalence|bioequivalence
548468|NCT00840281|Healthy Subjects|healthy subjects
548469|NCT00840268|OSDI|osdi
548470|NCT00840268|corneal staining|corneal staining
548471|NCT00840268|Dry Eye|dry eye
548472|NCT00840268|Dry Eye Signs and Symptoms in Dry Eye Patients|dry eye signs and symptoms in dry eye patients
548473|NCT00840255|Chronic Insomnia lasting more than 1 month|chronic insomnia lasting more than 1 month
548474|NCT00840229|adhesive capsulitis|adhesive capsulitis
548475|NCT00840229|corticosteroids|corticosteroids
548476|NCT00840229|injection|injection
548477|NCT00840229|pain|pain
548478|NCT00840216|Bioequivalence|bioequivalence
548479|NCT00840216|Healthy Subjects|healthy subjects
548480|NCT00840203|Bioequivalence|bioequivalence
548481|NCT00840203|Healthy Subjects|healthy subjects
548482|NCT00840177|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
548483|NCT00840177|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
548484|NCT00840177|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
548485|NCT00840177|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
548486|NCT00840177|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
548487|NCT00840177|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
548488|NCT00840164|small-fiber sensory neuropathy|small-fiber sensory neuropathy
548489|NCT00840164|nerve pathology|nerve pathology
548490|NCT00840164|vasculature pathology|vasculature pathology
548491|NCT00840164|amputation|amputation
548492|NCT00840164|diabetic foot wound|diabetic foot wound
548493|NCT00840164|sensory neuropathy|sensory neuropathy
548494|NCT00840164|below knee amputation|below knee amputation
548495|NCT00840151|Substance Abuse|substance abuse
548496|NCT00840151|Contingency Management|contingency management
548497|NCT00840125|NSCLC|nsclc
548498|NCT00840125|ERLOTINIB|erlotinib
548499|NCT00840125|DOCETAXEL|docetaxel
548500|NCT00840125|first line treatment|first line treatment
548501|NCT00840125|Stage IIIB /IV|stage iiib /iv
548502|NCT00840125|not previously treated|not previously treated
548503|NCT00840125|ECOG PS 2 or age over 65|ecog ps 2 or age over 65
548504|NCT00840112|Long-chain 3-hydroxyacyl CoA dehydrogenase (LCHAD)|long-chain 3-hydroxyacyl coa dehydrogenase (lchad)
548505|NCT00840112|Mitochondrial trifunctional protein (TFP)|mitochondrial trifunctional protein (tfp)
548506|NCT00840112|LCHAD/TFP deficiency with peripheral neuropathy|lchad/tfp deficiency with peripheral neuropathy
548507|NCT00840099|Bioequivalence|bioequivalence
548508|NCT00840099|Healthy Subjects|healthy subjects
548509|NCT00840073|Bioequivalence|bioequivalence
548510|NCT00840073|Healthy Subjects|healthy subjects
548511|NCT00840047|Pediatric brain tumor|pediatric brain tumor
548512|NCT00840047|Pediatric solid tumor|pediatric solid tumor
548513|NCT00840047|Pediatric solid neoplasms|pediatric solid neoplasms
548514|NCT00840008|peptic ulcer bleeding|peptic ulcer bleeding
548515|NCT00840008|upper GI hemorrhage|upper gi hemorrhage
548516|NCT00840008|adherence to guidelines|adherence to guidelines
548517|NCT00840008|knowledge transfer|knowledge transfer
548518|NCT00839995|To determine the efficacy of ROTEM on assessing coagulation profiles.|to determine the efficacy of rotem on assessing coagulation profiles.
548519|NCT00839969|overactive bladder syndrome|overactive bladder syndrome
548520|NCT00839969|voiding|voiding
548521|NCT00839969|pressure flow studies|pressure flow studies
548522|NCT00839969|urethral dilatation|urethral dilatation
548523|NCT00839943|ozone|ozone
548524|NCT00839943|clean air|clean air
548525|NCT00839930|Bioequivalence|bioequivalence
548526|NCT00839930|Healthy Subjects|healthy subjects
548527|NCT00839917|Measles|measles
548528|NCT00839917|Mumps|mumps
548529|NCT00839917|Rubella|rubella
548530|NCT00839917|Varicella|varicella
548531|NCT00839904|children|children
548532|NCT00839904|cancer|cancer
548533|NCT00839904|exercise|exercise
548534|NCT00839904|fitness|fitness
548535|NCT00839904|body composition|body composition
548536|NCT00839891|TQT, QTc|tqt, qtc
548537|NCT00839865|Evidence-based evaluation|evidence-based evaluation
548538|NCT00839865|Multi-center randomized controlled clinical trials|multi-center randomized controlled clinical trials
548539|NCT00839865|Traditional Chinese Medicine|traditional chinese medicine
548540|NCT00839865|therapy|therapy
548541|NCT00839865|diabetic foot ulcer|diabetic foot ulcer
548542|NCT00839865|clinical trails|clinical trails
548543|NCT00839839|infertility|infertility
548544|NCT00839839|egg freezing|egg freezing
548545|NCT00839839|fertility preservation|fertility preservation
548546|NCT00839826|Prevention of Thromboembolism after total hip replacement|prevention of thromboembolism after total hip replacement
548547|NCT00839813|Yoga|yoga
548548|NCT00839813|Posttraumatic Stress Disorder|posttraumatic stress disorder
548549|NCT00839813|PTSD|ptsd
548550|NCT00839813|women's health|women's health
548551|NCT00839800|Asthma|asthma
548552|NCT00839800|Symbicort Turbuhaler|symbicort turbuhaler
548553|NCT00839774|Peas|peas
548554|NCT00839774|Cardiovascular|cardiovascular
548555|NCT00839774|Diabetes|diabetes
548556|NCT00839774|Insulin|insulin
548557|NCT00839774|Insulin resistance|insulin resistance
548558|NCT00839774|Abdominal fat|abdominal fat
548559|NCT00839748|asthma|asthma
548560|NCT00839748|registry for future asthmatic studies|registry for future asthmatic studies
548561|NCT00839748|questionnaires|questionnaires
548562|NCT00839748|lung function tests|lung function tests
548563|NCT00839735|COPD|copd
548564|NCT00839722|Uterine embolization|uterine embolization
548565|NCT00839722|leiomyomas|leiomyomas
548566|NCT00839722|fertility|fertility
548567|NCT00839722|myomectomies|myomectomies
548568|NCT00839709|liver disease|liver disease
548569|NCT00839709|liver transplantation|liver transplantation
548570|NCT00839709|depletion immunosuppression|depletion immunosuppression
548571|NCT00839709|non-depletion immunosuppression|non-depletion immunosuppression
548572|NCT00839696|Breast|breast
548573|NCT00839696|Estrogens|estrogens
548574|NCT00839696|Mammography|mammography
548670|NCT00839306|Gastroesophageal|gastroesophageal
548575|NCT00839670|1- Constraint induced therapy|1- constraint induced therapy
548576|NCT00839670|2- Stroke|2- stroke
548577|NCT00839670|3- Upper limb|3- upper limb
548578|NCT00839670|4- Rehabilitation|4- rehabilitation
548579|NCT00839670|5- Motor training|5- motor training
548580|NCT00839670|1- First time clinical ischemic or hemorrhagic stroke|1- first time clinical ischemic or hemorrhagic stroke
548581|NCT00839670|2- At least 10° of active wrist extension|2- at least 10° of active wrist extension
548582|NCT00839670|3- At least 10° of thumb abduction/ extension|3- at least 10° of thumb abduction/ extension
548583|NCT00839670|4- At least 10° of extension in at least 2 additional digits|4- at least 10° of extension in at least 2 additional digits
548584|NCT00839670|3- Adequate balance while wearing the restraint.|3- adequate balance while wearing the restraint.
548585|NCT00839657|Embolism|embolism
548586|NCT00839657|Thrombosis|thrombosis
548587|NCT00839644|cystic fibrosis|cystic fibrosis
548588|NCT00839644|Chest Wall Oscillation|chest wall oscillation
548589|NCT00839644|drainage, postural|drainage, postural
548590|NCT00839644|Medication Adherence|medication adherence
548591|NCT00839644|patient dropouts|patient dropouts
548592|NCT00839631|subjects with advanced solid tumors refractory to standard therapy or for whom no effective therapy is available.|subjects with advanced solid tumors refractory to standard therapy or for whom no effective therapy is available.
548593|NCT00839605|Thoracic surgery one lung ventilation|thoracic surgery one lung ventilation
548594|NCT00839605|airway reconstruction|airway reconstruction
548595|NCT00839592|Insomnia|insomnia
548596|NCT00839592|Acupuncture|acupuncture
548597|NCT00839592|Electroacupuncture|electroacupuncture
548598|NCT00839592|Randomized Clinical Trial|randomized clinical trial
548599|NCT00839592|Traditional Chinese Medicine|traditional chinese medicine
548600|NCT00839579|slightly overweight|slightly overweight
548601|NCT00839579|males 35-45 years|males 35-45 years
548602|NCT00839566|Atrial Fibrillation|atrial fibrillation
548603|NCT00839566|Heart Failure|heart failure
548604|NCT00839540|candidemia|candidemia
548605|NCT00839540|echinocandin|echinocandin
548606|NCT00839540|micafungin|micafungin
548607|NCT00839540|caspofungin|caspofungin
548608|NCT00839527|diabetes|diabetes
548609|NCT00839514|Parkinson's disease|parkinson's disease
548610|NCT00839514|Trichloroethylene|trichloroethylene
548611|NCT00839488|pantoprazole|pantoprazole
548612|NCT00839488|famotidine|famotidine
548613|NCT00839488|stomach ulcer|stomach ulcer
548614|NCT00839488|digestive system surgical procedure|digestive system surgical procedure
548615|NCT00839475|colposcopy|colposcopy
548616|NCT00839475|Cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
548617|NCT00839475|cervical cancer|cervical cancer
548618|NCT00839475|cervical precancer|cervical precancer
548619|NCT00839462|Thermal Erythema|thermal erythema
548620|NCT00839462|Dexpanthenol|dexpanthenol
548621|NCT00839462|Erythema|erythema
548622|NCT00839462|Efficacy|efficacy
548623|NCT00839449|subarachnoid hemorrhage|subarachnoid hemorrhage
548624|NCT00839449|cerebral vasospasm|cerebral vasospasm
548625|NCT00839449|eicosapentaenoic acid|eicosapentaenoic acid
548626|NCT00839436|Idiopathic CD4+ T-Lymphocytopenia|idiopathic cd4+ t-lymphocytopenia
548627|NCT00839436|Interleukin-7|interleukin-7
548628|NCT00839436|Clinical Trial|clinical trial
548629|NCT00839436|T-Lymphocytes|t-lymphocytes
548630|NCT00839436|Idiopathic CD4 Lymphocytopenia (ICL)|idiopathic cd4 lymphocytopenia (icl)
548631|NCT00839436|ICL|icl
548632|NCT00839423|Major depressive disorder|major depressive disorder
548633|NCT00839423|Placebo-controlled|placebo-controlled
548634|NCT00839423|Active reference|active reference
548635|NCT00839423|Multicenter study|multicenter study
548636|NCT00839423|Randomised study|randomised study
548637|NCT00839423|Acute treatment|acute treatment
548638|NCT00839410|skin cancer|skin cancer
548639|NCT00839410|melanoma|melanoma
548640|NCT00839410|sentinel lymph node biopsy|sentinel lymph node biopsy
548641|NCT00839410|bio bank|bio bank
548642|NCT00839410|genetic polymorphism|genetic polymorphism
548643|NCT00839410|prospective cohort|prospective cohort
548644|NCT00839410|cohort|cohort
548645|NCT00839410|sentinel lymph nodes|sentinel lymph nodes
548646|NCT00839410|tissue samples|tissue samples
548647|NCT00839371|bispectral analysis|bispectral analysis
548648|NCT00839371|bronchoscopy|bronchoscopy
548649|NCT00839371|midazolam|midazolam
548650|NCT00839371|propofol|propofol
548651|NCT00839371|recovery|recovery
548652|NCT00839371|sedation|sedation
548653|NCT00839358|cirrhosis|cirrhosis
548654|NCT00839358|renal failure|renal failure
548655|NCT00839358|midodrine|midodrine
548656|NCT00839358|albumine|albumine
548657|NCT00839345|platelet|platelet
548658|NCT00839345|clopidogrel|clopidogrel
548659|NCT00839345|VerifyNow|verifynow
548660|NCT00839345|ticlopidine|ticlopidine
548661|NCT00839345|thrombosis|thrombosis
548662|NCT00839332|Pancreas|pancreas
548663|NCT00839332|metastatic cancer|metastatic cancer
548664|NCT00839332|advanced cancer|advanced cancer
548665|NCT00839332|Pancreatic cancer|pancreatic cancer
548666|NCT00839319|hCG|hcg
548667|NCT00839319|testosterone|testosterone
548668|NCT00839319|Acyline|acyline
548669|NCT00839319|Intratesticular hormone|intratesticular hormone
548672|NCT00839306|Disease|disease
548673|NCT00839306|GERD|gerd
548674|NCT00839293|Bioavailability|bioavailability
548675|NCT00839280|Dry skin|dry skin
548676|NCT00839280|Dexpanthenol|dexpanthenol
548677|NCT00839280|Moisturizing effect|moisturizing effect
548678|NCT00839267|platelet|platelet
548679|NCT00839267|VASP|vasp
548680|NCT00839267|clopidogrel|clopidogrel
548681|NCT00839267|cardiogenic shock|cardiogenic shock
548682|NCT00839267|myocardial infarction|myocardial infarction
548683|NCT00839267|percutaneous coronary intervention|percutaneous coronary intervention
548684|NCT00839254|Streptococcus pneumoniae|streptococcus pneumoniae
548685|NCT00839254|acute otitis media|acute otitis media
548686|NCT00839254|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
548687|NCT00839254|nasopharyngeal carriage|nasopharyngeal carriage
548688|NCT00839254|Haemophilus influenzae|haemophilus influenzae
548689|NCT00839254|immunogenicity|immunogenicity
548690|NCT00839254|invasive disease|invasive disease
548691|NCT00839228|diastolic dysfunction|diastolic dysfunction
548692|NCT00839228|cardiac energetics|cardiac energetics
548693|NCT00839228|perhexiline|perhexiline
548694|NCT00839228|magnetic resonance spectroscopy|magnetic resonance spectroscopy
548695|NCT00839202|factor VIII|factor viii
548696|NCT00839202|hemophilia A|hemophilia a
548697|NCT00839202|assay|assay
548698|NCT00839189|CCRE|ccre
548699|NCT00839189|endotoxin|endotoxin
548700|NCT00839189|LPS|lps
548701|NCT00839189|asthma|asthma
548702|NCT00839189|allergies|allergies
548703|NCT00839189|allergic rhinitis|allergic rhinitis
548704|NCT00839176|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
548705|NCT00839176|Serdaxin|serdaxin
548706|NCT00839176|Rexahn|rexahn
548707|NCT00839163|Embolism and Thrombosis|embolism and thrombosis
548708|NCT00839163|Pulmonary embolism|pulmonary embolism
548709|NCT00839163|Embolism|embolism
548710|NCT00839163|Thrombosis|thrombosis
548711|NCT00839150|Diabetic retinopathy|diabetic retinopathy
548712|NCT00839150|Color vision|color vision
548713|NCT00839150|Contrast sensitivity|contrast sensitivity
548714|NCT00839150|Electroretinogram|electroretinogram
548715|NCT00839150|Flicker-induced vasodilatation|flicker-induced vasodilatation
548716|NCT00839150|Dynamic Vessel Analyzer|dynamic vessel analyzer
548717|NCT00839137|asthma|asthma
548718|NCT00839137|exercise therapy|exercise therapy
548719|NCT00839124|normal volunteer|normal volunteer
548720|NCT00839124|healthy control volunteer|healthy control volunteer
548721|NCT00839124|healthy subjects|healthy subjects
548722|NCT00839124|asthma|asthma
548723|NCT00839124|allergy|allergy
548724|NCT00839124|allergic asthma|allergic asthma
548725|NCT00839111|Progression free survival|progression free survival
548726|NCT00839111|Toxicity|toxicity
548727|NCT00839111|Response rate|response rate
548728|NCT00839111|overall survival|overall survival
548729|NCT00839098|power wheelchairs|power wheelchairs
548730|NCT00839098|assistive technology|assistive technology
548731|NCT00839098|rehabilitation|rehabilitation
548732|NCT00839085|CABG|cabg
548733|NCT00839085|on pump|on pump
548734|NCT00839085|Grape seed extract|grape seed extract
548735|NCT00839085|Vit C|vit c
548736|NCT00839085|Oxidative stress|oxidative stress
548737|NCT00839072|bioavailability|bioavailability
548738|NCT00839072|pharmacokinetics|pharmacokinetics
548739|NCT00839072|healthy|healthy
548740|NCT00839072|crossover|crossover
548741|NCT00839072|trazodone|trazodone
548742|NCT00839059|AML|aml
548743|NCT00839059|lenalidomide|lenalidomide
548744|NCT00839046|Pediatric Asthma|pediatric asthma
548745|NCT00839046|Air Filters|air filters
548746|NCT00839046|Indoor Particulate Matter|indoor particulate matter
548747|NCT00839033|Cough assisted device|cough assisted device
548748|NCT00839033|Neuromuscular disease|neuromuscular disease
548749|NCT00839033|Respiratory exacerbation|respiratory exacerbation
548750|NCT00839033|Invasive ventilation,|invasive ventilation,
548751|NCT00839033|Chest physiotherapy|chest physiotherapy
548752|NCT00839033|Congenital myopathies|congenital myopathies
548753|NCT00839020|Surgical Procedures, Minimally Invasive|surgical procedures, minimally invasive
548754|NCT00839020|Range of Motion|range of motion
548755|NCT00839020|Articular Arthroplasty, Replacement, Knee|articular arthroplasty, replacement, knee
548756|NCT00839007|ADHF|adhf
548757|NCT00839007|AHF|ahf
548758|NCT00839007|HF|hf
548759|NCT00838994|Insomnia|insomnia
548760|NCT00838994|Depression|depression
548761|NCT00838994|Electroacupuncture|electroacupuncture
548762|NCT00838994|Acupuncture|acupuncture
548763|NCT00838994|Randomized Clinical Trial|randomized clinical trial
548764|NCT00838994|Traditional Chinese Medicine|traditional chinese medicine
548765|NCT00838981|Treatment for addiction|treatment for addiction
548766|NCT00838981|Methadone given for opioid dependence|methadone given for opioid dependence
548767|NCT00838981|Cocaine|cocaine
548768|NCT00838981|Opiates|opiates
548769|NCT00838968|hepatocellular carcinoma|hepatocellular carcinoma
548770|NCT00838968|interferon-alpha|interferon-alpha
548771|NCT00838968|p48|p48
548772|NCT00838955|Hodgkin's lymphoma|hodgkin's lymphoma
548773|NCT00838955|relapsed Hodgkin's lymphoma|relapsed hodgkin's lymphoma
548774|NCT00838955|refractory Hodgkin's lymphoma|refractory hodgkin's lymphoma
548775|NCT00838955|Temsirolimus|temsirolimus
548776|NCT00838942|Eyes disease and dementia.|eyes disease and dementia.
548777|NCT00838942|Cataract surgery in the patient with dementia.|cataract surgery in the patient with dementia.
548778|NCT00838942|Visual hallucinations|visual hallucinations
548779|NCT00838942|Visual acuity,|visual acuity,
548780|NCT00838942|Specific eye pathologies in Alzheimer's disease.|specific eye pathologies in alzheimer's disease.
548781|NCT00838942|Improvement of behaviour,|improvement of behaviour,
548782|NCT00838942|Improvement of autonomy|improvement of autonomy
548783|NCT00838942|Improvement of mood|improvement of mood
548784|NCT00838942|Cataract extraction in Alzheimer disease patient|cataract extraction in alzheimer disease patient
548785|NCT00838929|brain metastases|brain metastases
548786|NCT00838929|radiation|radiation
548787|NCT00838929|vorinostat|vorinostat
548788|NCT00838929|lung cancer|lung cancer
548789|NCT00838929|breast cancer|breast cancer
548790|NCT00838916|diabetes|diabetes
548791|NCT00838903|diabetes|diabetes
548792|NCT00838877|Alzheimer's Disease|alzheimer's disease
548793|NCT00838877|PET|pet
548794|NCT00838877|Phase 1|phase 1
548795|NCT00838877|Positron Emission Tomography|positron emission tomography
548796|NCT00838864|variceal bleeding|variceal bleeding
548797|NCT00838864|antibiotic prophylaxis|antibiotic prophylaxis
548798|NCT00838864|ceftrioxone|ceftrioxone
548799|NCT00838851|endotoxin|endotoxin
548800|NCT00838851|CCRE|ccre
548801|NCT00838851|LPS|lps
548802|NCT00838838|Testosterone replacement therapy|testosterone replacement therapy
548803|NCT00838838|Hypogonadism|hypogonadism
548804|NCT00838838|Osteoporosis|osteoporosis
548805|NCT00838838|Immobilisation|immobilisation
548806|NCT00838838|Paraplegia|paraplegia
548807|NCT00838838|Testosterone|testosterone
548808|NCT00838825|diabetes|diabetes
548809|NCT00838825|chronic care management|chronic care management
548810|NCT00838825|resource utilization|resource utilization
548811|NCT00838825|outcome|outcome
548812|NCT00838825|glycohemoglobin|glycohemoglobin
548813|NCT00838825|hospitalization|hospitalization
548814|NCT00838812|clindamycin|clindamycin
548815|NCT00838812|tretinoin|tretinoin
548816|NCT00838812|acne vulgaris|acne vulgaris
548817|NCT00838812|Acne vulgaris mild to moderate|acne vulgaris mild to moderate
548818|NCT00838799|diabetic|diabetic
548819|NCT00838799|peripheral|peripheral
548820|NCT00838799|neuropathic|neuropathic
548821|NCT00838799|pain|pain
548822|NCT00838799|chronic|chronic
548823|NCT00838799|diabetes|diabetes
548824|NCT00838760|PEPI-TiDP23-C103|pepi-tidp23-c103
548825|NCT00838760|PEPI-C103|pepi-c103
548826|NCT00838760|PEPI|pepi
548827|NCT00838760|TMC558445|tmc558445
548828|NCT00838760|TMC310911|tmc310911
548829|NCT00838760|Darunavir, Healthy volunteers|darunavir, healthy volunteers
548830|NCT00838760|Pharmacokinetics|pharmacokinetics
548831|NCT00838760|HIV Infections|hiv infections
548832|NCT00838747|folate receptor|folate receptor
548833|NCT00838747|blood samples|blood samples
548834|NCT00838747|ovarian cancer|ovarian cancer
548835|NCT00838747|development of measure of folate receptor in blood samples|development of measure of folate receptor in blood samples
548836|NCT00838747|possible selection of patients for treatment with FR targeted agents|possible selection of patients for treatment with fr targeted agents
548837|NCT00838734|CORNEAL TOPOGRAPHY|corneal topography
548838|NCT00838734|KERATOPLASTY|keratoplasty
548839|NCT00838721|Open Angle Glaucoma|open angle glaucoma
548840|NCT00838721|Ocular Hypertension|ocular hypertension
548841|NCT00838721|Laser Trabeculoplasty|laser trabeculoplasty
548842|NCT00838695|Hand vein sensitivity|hand vein sensitivity
548843|NCT00838695|phenylephrine|phenylephrine
548844|NCT00838695|nitroglycerin|nitroglycerin
548845|NCT00838682|peptic ulcer bleeding|peptic ulcer bleeding
548846|NCT00838682|rabeprazole|rabeprazole
548847|NCT00838682|proton pump inhibitor|proton pump inhibitor
548848|NCT00838669|Schizophrenia|schizophrenia
548849|NCT00838669|Mood disorders|mood disorders
548850|NCT00838669|Antipsychotic drugs|antipsychotic drugs
548851|NCT00838669|Extended release OROS paliperidone|extended release oros paliperidone
548852|NCT00838656|ovarian carcinosarcoma|ovarian carcinosarcoma
548853|NCT00838656|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
548854|NCT00838656|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
548855|NCT00838656|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
548856|NCT00838656|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
548857|NCT00838656|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
548858|NCT00838656|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
548859|NCT00838656|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
548860|NCT00838656|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
548861|NCT00838656|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
548862|NCT00838656|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
548863|NCT00838656|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
548864|NCT00838656|stage IV fallopian tube cancer|stage iv fallopian tube cancer
549151|NCT00837564|CBASP|cbasp
548865|NCT00838643|allogeneic transplantation|allogeneic transplantation
548866|NCT00838643|Invasive aspergillosis|invasive aspergillosis
548867|NCT00838630|Bioequivalence|bioequivalence
548868|NCT00838630|Healthy Subjects|healthy subjects
548869|NCT00838617|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
548870|NCT00838617|Ultrasonography|ultrasonography
548871|NCT00838617|Atrophy|atrophy
548872|NCT00838591|MN-221|mn-221
548873|NCT00838591|Asthma|asthma
548874|NCT00838591|Acute|acute
548875|NCT00838591|Exacerbation|exacerbation
548876|NCT00838578|KRN330|krn330
548877|NCT00838578|Colorectal Cancer|colorectal cancer
548878|NCT00838578|Antimetabolites|antimetabolites
548879|NCT00838578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic
548880|NCT00838578|Digestive System Neoplasms|digestive system neoplasms
548881|NCT00838578|Immunologic Factors|immunologic factors
548882|NCT00838578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
548883|NCT00838578|Antineoplastic Agents|antineoplastic agents
548884|NCT00838578|Gastrointestinal Diseases|gastrointestinal diseases
548885|NCT00838578|Physiological Effects of Drugs|physiological effects of drugs
548886|NCT00838578|Colonic Diseases|colonic diseases
548887|NCT00838578|Irinotecan|irinotecan
548888|NCT00838578|Enzyme Inhibitors|enzyme inhibitors
548889|NCT00838578|Intestinal Diseases|intestinal diseases
548890|NCT00838578|Immunosuppressive Agents|immunosuppressive agents
548891|NCT00838578|Rectal Diseases|rectal diseases
548892|NCT00838578|Pharmacologic Actions|pharmacologic actions
548893|NCT00838578|Intestinal Neoplasms|intestinal neoplasms
548894|NCT00838578|Neoplasms by Site|neoplasms by site
548895|NCT00838578|Digestive System Diseases|digestive system diseases
548896|NCT00838578|Therapeutic Uses|therapeutic uses
548897|NCT00838578|Fluorouracil|fluorouracil
548898|NCT00838578|Neoplasms|neoplasms
548899|NCT00838578|Gastrointestinal Neoplasms|gastrointestinal neoplasms
548900|NCT00838578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic
548901|NCT00838578|Colorectal Neoplasms|colorectal neoplasms
548902|NCT00838565|Safety and tolerability Pharmacokinetics Pharmacodynamics PF-04236921|safety and tolerability pharmacokinetics pharmacodynamics pf-04236921
548903|NCT00838552|asthma inflammation bronchoscopy|asthma inflammation bronchoscopy
548904|NCT00838539|Neratinib|neratinib
548905|NCT00838539|solid tumors|solid tumors
548906|NCT00838539|phase 1|phase 1
548907|NCT00838539|dose finding study|dose finding study
548908|NCT00838539|HKI-272|hki-272
548909|NCT00838539|Nerlynx|nerlynx
548910|NCT00838539|Temsirolimus|temsirolimus
548911|NCT00838539|PB-272|pb-272
548912|NCT00838526|Gastroesophageal|gastroesophageal
548913|NCT00838526|Reflux|reflux
548914|NCT00838526|Disease|disease
548915|NCT00838526|GERD|gerd
548916|NCT00838513|aHUS|ahus
548917|NCT00838500|Venous insufficiency|venous insufficiency
548918|NCT00838500|Leg ulcer|leg ulcer
548919|NCT00838500|balneology|balneology
548920|NCT00838500|hydrotherapy|hydrotherapy
548921|NCT00838500|Modified Rutherford score|modified rutherford score
548922|NCT00838500|Euroquol EQ 5d scale|euroquol eq 5d scale
548923|NCT00838500|CIVIQ2 scale|civiq2 scale
548924|NCT00838500|Visual analogic Scale|visual analogic scale
548925|NCT00838500|SPA treatment|spa treatment
548926|NCT00838487|chondroitin|chondroitin
548927|NCT00838487|glucosamine|glucosamine
548928|NCT00838487|osteoarthritis|osteoarthritis
548929|NCT00838474|metabolic rate|metabolic rate
548930|NCT00838474|music|music
548931|NCT00838474|preterm infants|preterm infants
548932|NCT00838474|energy expenditure|energy expenditure
548933|NCT00838474|NIDCA|nidca
548934|NCT00838448|exercise|exercise
548935|NCT00838448|cannabis use|cannabis use
548936|NCT00838448|visual cues|visual cues
548937|NCT00838435|Phenylketonuria|phenylketonuria
548938|NCT00838435|PKU|pku
548939|NCT00838435|Kuvan|kuvan
548940|NCT00838435|Phenoptin|phenoptin
548941|NCT00838435|Biopten|biopten
548942|NCT00838435|Neurocognitive Function|neurocognitive function
548943|NCT00838435|Phenylalanine|phenylalanine
548944|NCT00838383|multi-center, placebo-controlled, randomized study of sitaxsentan administered to subjects post-cross-clamp release and 12 hours post-CPB|multi-center, placebo-controlled, randomized study of sitaxsentan administered to subjects post-cross-clamp release and 12 hours post-cpb
548945|NCT00838370|Pharmacogenetics|pharmacogenetics
548946|NCT00838370|cost-benefit analysis|cost-benefit analysis
548947|NCT00838370|toxicity|toxicity
548948|NCT00838370|antineoplastic drugs|antineoplastic drugs
548949|NCT00838370|Dihydropyrimidine Dehydrogenase|dihydropyrimidine dehydrogenase
548950|NCT00838357|Mobilisation stem cells|mobilisation stem cells
548951|NCT00838357|G-CSF Mobilisation Regimen|g-csf mobilisation regimen
548952|NCT00838357|Lymphoma|lymphoma
548953|NCT00838357|Multiple Myeloma|multiple myeloma
548954|NCT00838344|medication adherence|medication adherence
548955|NCT00838344|medication persistence|medication persistence
548956|NCT00838344|pharmacist interventions|pharmacist interventions
548957|NCT00838344|diabetes|diabetes
548958|NCT00838344|persistence|persistence
548959|NCT00838344|adherence|adherence
548960|NCT00838331|Blood Transfusions|blood transfusions
549448|NCT00836368|Allergy|allergy
548961|NCT00838318|Colorectal CancerScreening|colorectal cancerscreening
548962|NCT00838318|CRC|crc
548963|NCT00838318|Hispanic|hispanic
548964|NCT00838318|CRC Patients|crc patients
548965|NCT00838318|First-Degree Relatives|first-degree relatives
548966|NCT00838318|FDRs|fdrs
548967|NCT00838318|Interviews|interviews
548968|NCT00838318|Colorectal cancer screening|colorectal cancer screening
548969|NCT00838318|CRCS|crcs
548970|NCT00838318|Key Informants|key informants
548971|NCT00838305|MDMA|mdma
548972|NCT00838305|citalopram|citalopram
548973|NCT00838305|serotonin|serotonin
548974|NCT00838305|psychedelic|psychedelic
548975|NCT00838292|food supplementation|food supplementation
548976|NCT00838292|HIV|hiv
548977|NCT00838292|malnutrition|malnutrition
548978|NCT00838279|Bioequivalence|bioequivalence
548979|NCT00838279|Healthy Subjects|healthy subjects
548980|NCT00838266|mouthrinse|mouthrinse
548981|NCT00838266|grape seed extract|grape seed extract
548982|NCT00838266|fluor|fluor
548983|NCT00838266|plaque index|plaque index
548984|NCT00838253|Acute Heart Failure|acute heart failure
548985|NCT00838253|Inotropes|inotropes
548986|NCT00838253|Lusitropic agents|lusitropic agents
548987|NCT00838253|Istaroxime|istaroxime
548988|NCT00838253|Debio 0614|debio 0614
548989|NCT00838240|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
548990|NCT00838240|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
548991|NCT00838240|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
548992|NCT00838240|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
548993|NCT00838240|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
548994|NCT00838240|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
548995|NCT00838240|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
548996|NCT00838240|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
548997|NCT00838240|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
548998|NCT00838240|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
548999|NCT00838240|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
549000|NCT00838240|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
549001|NCT00838240|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
549002|NCT00838240|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
549003|NCT00838240|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
549004|NCT00838240|secondary acute myeloid leukemia|secondary acute myeloid leukemia
549005|NCT00838227|Schizophrenia|schizophrenia
549006|NCT00838227|Cognition|cognition
549007|NCT00838227|Obesity|obesity
549008|NCT00838227|Sedation|sedation
549009|NCT00838201|Androgen deprivation therapy for non-metastatic prostate cancer|androgen deprivation therapy for non-metastatic prostate cancer
549010|NCT00838188|Metabolic rate|metabolic rate
549011|NCT00838188|indirect calorimetry|indirect calorimetry
549012|NCT00838188|oral feeding|oral feeding
549013|NCT00838175|Peripheral Venous Catheterization|peripheral venous catheterization
549014|NCT00838162|Human immunodeficiency virus type 1|human immunodeficiency virus type 1
549015|NCT00838162|HIV-1|hiv-1
549016|NCT00838162|HIV-1 treatment-naive|hiv-1 treatment-naive
549017|NCT00838162|TMC310911|tmc310911
549018|NCT00838162|Protease inhibitor|protease inhibitor
549019|NCT00838162|Ritonavir|ritonavir
549020|NCT00838162|Antiviral Activity|antiviral activity
549021|NCT00838162|HIV Infections|hiv infections
549022|NCT00838162|Treatment Naive|treatment naive
549023|NCT00838136|Bioequivalence|bioequivalence
549024|NCT00838136|Healthy Subjects|healthy subjects
549025|NCT00838110|Alzheimer's Disease|alzheimer's disease
549026|NCT00838110|Dimebon|dimebon
549027|NCT00838110|Safety|safety
549028|NCT00838110|Tolerability|tolerability
549029|NCT00838097|CKD|ckd
549030|NCT00838097|Paediatric|paediatric
549031|NCT00838097|Darbepoetin Alfa|darbepoetin alfa
549032|NCT00838071|Hepatitis B|hepatitis b
549033|NCT00838071|HBV|hbv
549034|NCT00838071|Anti-hepatitis B antibodies|anti-hepatitis b antibodies
549035|NCT00838071|Immunoglobulins|immunoglobulins
549036|NCT00838071|liver transplantation|liver transplantation
549037|NCT00838071|Protective levels|protective levels
549038|NCT00838071|Recurrence|recurrence
549039|NCT00838071|Intravenous|intravenous
549040|NCT00838058|pharmacology formulation normal healthy volunteers food effect|pharmacology formulation normal healthy volunteers food effect
549041|NCT00838032|acute schizophrenic patients|acute schizophrenic patients
549042|NCT00838006|post-traumatic stress disorder|post-traumatic stress disorder
549043|NCT00838006|post-deployment|post-deployment
549044|NCT00838006|prediction|prediction
549045|NCT00838006|prevention|prevention
549046|NCT00837993|Advanced Stage Serous Carcinoma of the Ovary|advanced stage serous carcinoma of the ovary
549047|NCT00837993|serous ovarian carcinoma|serous ovarian carcinoma
549048|NCT00837993|Ovary|ovary
549049|NCT00837993|GOG Protocol 158|gog protocol 158
549050|NCT00837993|Survival Analysis|survival analysis
549051|NCT00837993|Pathology Slides|pathology slides
549052|NCT00837993|Two-tier Grading System|two-tier grading system
549053|NCT00837993|Ancillary Study|ancillary study
549054|NCT00837980|head and neck cancer|head and neck cancer
549055|NCT00837980|DW MRI|dw mri
549056|NCT00837980|PET|pet
549057|NCT00837980|DCE MRI|dce mri
549058|NCT00837980|functional imaging|functional imaging
549059|NCT00837980|IMRT|imrt
549060|NCT00837967|Asthma|asthma
549061|NCT00837967|Symbicort Turbuhaler|symbicort turbuhaler
549062|NCT00837954|PTFE Graft|ptfe graft
549063|NCT00837954|Suture Hole Bleeding|suture hole bleeding
549064|NCT00837954|Hemostasis|hemostasis
549065|NCT00837928|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
549066|NCT00837928|tumors metastatic to brain|tumors metastatic to brain
549067|NCT00837915|Bioequivaelnce Loratadine 10mg /Pseudoephedrine Sulfate 240 mg Extended Release Tablets|bioequivaelnce loratadine 10mg /pseudoephedrine sulfate 240 mg extended release tablets
549068|NCT00837902|Atenolol|atenolol
549069|NCT00837902|Exercise|exercise
549070|NCT00837902|Genotype|genotype
549071|NCT00837902|Healthy volunteers|healthy volunteers
549072|NCT00837889|cognition|cognition
549073|NCT00837889|decompensation|decompensation
549074|NCT00837889|heart failure|heart failure
549075|NCT00837889|recompensation|recompensation
549076|NCT00837876|recurrent pancreatic cancer|recurrent pancreatic cancer
549077|NCT00837876|stage III pancreatic cancer|stage iii pancreatic cancer
549078|NCT00837876|stage IV pancreatic cancer|stage iv pancreatic cancer
549079|NCT00837876|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
549080|NCT00837850|total hip arthroplasty|total hip arthroplasty
549081|NCT00837850|Charnley stem|charnley stem
549082|NCT00837850|RSA|rsa
549083|NCT00837850|non-inflammatory arthritis|non-inflammatory arthritis
549084|NCT00837837|pharmacokinetics|pharmacokinetics
549085|NCT00837837|children|children
549086|NCT00837837|adolescents|adolescents
549087|NCT00837837|antihistamine|antihistamine
549088|NCT00837824|Fabry Disease patients with Severe Renal Disease|fabry disease patients with severe renal disease
549089|NCT00837811|Arthritis|arthritis
549090|NCT00837772|Alignment|alignment
549091|NCT00837759|Type I Diabetes|type i diabetes
549092|NCT00837759|Preserve Beta Cell Function|preserve beta cell function
549093|NCT00837759|Sitagliptin|sitagliptin
549094|NCT00837759|Lansoprazole|lansoprazole
549095|NCT00837759|GAD65 (Diamyd)|gad65 (diamyd)
549096|NCT00837759|Diabetes|diabetes
549097|NCT00837759|Type 1 Diabetes|type 1 diabetes
549098|NCT00837759|T1DM|t1dm
549099|NCT00837733|Endometrial biopsy|endometrial biopsy
549100|NCT00837733|IVF/ICSI|ivf/icsi
549101|NCT00837733|Pregnancy outcome|pregnancy outcome
549102|NCT00837733|Recurrent implantation failure|recurrent implantation failure
549103|NCT00837720|hypertension|hypertension
549104|NCT00837720|blood pressure|blood pressure
549105|NCT00837720|Atacand®|atacand®
549106|NCT00837720|candesartan|candesartan
549107|NCT00837707|aripiprazole|aripiprazole
549108|NCT00837707|Tardive Dyskinesia|tardive dyskinesia
549109|NCT00837694|BMI|bmi
549110|NCT00837694|obesity|obesity
549111|NCT00837694|sensitization|sensitization
549112|NCT00837694|food reinforcement|food reinforcement
549113|NCT00837694|snack food|snack food
549114|NCT00837694|Portion size of daily snacks|portion size of daily snacks
549115|NCT00837694|Weight status|weight status
549116|NCT00837681|Bone Marrow Transplant|bone marrow transplant
549117|NCT00837681|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
549118|NCT00837668|sarcoidosis|sarcoidosis
549119|NCT00837668|stromal gene expression|stromal gene expression
549120|NCT00837668|pulmonary sarcoidosis|pulmonary sarcoidosis
549121|NCT00837668|bronchoscopy|bronchoscopy
549122|NCT00837655|Chronic kidney disease|chronic kidney disease
549123|NCT00837655|End-stage renal disease|end-stage renal disease
549124|NCT00837655|phosphate binder|phosphate binder
549125|NCT00837655|insulin resistance|insulin resistance
549126|NCT00837655|glucose intolerance|glucose intolerance
549127|NCT00837655|sevelamer|sevelamer
549128|NCT00837642|Vascular function in offspring of ART|vascular function in offspring of art
549129|NCT00837629|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
549130|NCT00837629|COPD|copd
549131|NCT00837629|Symbicort Turbuhaler|symbicort turbuhaler
549132|NCT00837616|Turner Syndrome|turner syndrome
549133|NCT00837616|Hypogonadism|hypogonadism
549134|NCT00837616|GH|gh
549135|NCT00837616|Estrogen|estrogen
549136|NCT00837616|Estrogen Patches|estrogen patches
549137|NCT00837616|IGF-I|igf-i
549138|NCT00837616|Body Composition|body composition
549139|NCT00837616|Protein Metabolism|protein metabolism
549140|NCT00837616|Lipid Oxidation|lipid oxidation
549141|NCT00837616|Estradiol assay by LCMSMS|estradiol assay by lcmsms
549142|NCT00837616|Recombinant Cell Bioassay|recombinant cell bioassay
549143|NCT00837603|tga|tga
549144|NCT00837603|atrial switch|atrial switch
549145|NCT00837603|training|training
549146|NCT00837590|Vascular function|vascular function
549147|NCT00837590|Glucose tolerance|glucose tolerance
549148|NCT00837590|Obesity|obesity
549149|NCT00837590|Pre-diabetes|pre-diabetes
549150|NCT00837564|chronic depression|chronic depression
549152|NCT00837564|Escitalopram|escitalopram
549153|NCT00837564|depression|depression
549154|NCT00837564|trauma|trauma
549155|NCT00837551|Non-steroid|non-steroid
549156|NCT00837551|Small molecule|small molecule
549157|NCT00837551|Topical cream|topical cream
549158|NCT00837551|Inflammatory disease|inflammatory disease
549159|NCT00837551|Skin|skin
549160|NCT00837538|Spinal sagittal range of motion|spinal sagittal range of motion
549161|NCT00837538|Intersegmental range of motion|intersegmental range of motion
549162|NCT00837538|Spinal Mouse|spinal mouse
549163|NCT00837512|microneedle continuous subcutaneous insulin infusion|microneedle continuous subcutaneous insulin infusion
549164|NCT00837499|Breast|breast
549165|NCT00837499|Breast Cancer|breast cancer
549166|NCT00837499|Risk Factors|risk factors
549167|NCT00837499|Mexican Women|mexican women
549168|NCT00837499|Mexican-American Women|mexican-american women
549169|NCT00837499|African-American Women|african-american women
549170|NCT00837499|Epidemiological|epidemiological
549171|NCT00837499|Questionnaire|questionnaire
549172|NCT00837499|Survey|survey
549173|NCT00837499|Interview|interview
549174|NCT00837486|Treatment Resistant Depression|treatment resistant depression
549175|NCT00837486|Treatment Refractory Depression|treatment refractory depression
549176|NCT00837486|Deep Brain Stimulation|deep brain stimulation
549177|NCT00837486|Depression|depression
549178|NCT00837473|Bone Void Filler|bone void filler
549179|NCT00837473|Iliac Crest Bone Void Filler|iliac crest bone void filler
549180|NCT00837473|Back Surgery and Autograft Bone|back surgery and autograft bone
549181|NCT00837473|Autograft Bone|autograft bone
549182|NCT00837473|Allograft Bone|allograft bone
549183|NCT00837460|Hand|hand
549184|NCT00837460|Rehabilitation|rehabilitation
549185|NCT00837434|tumor necrosis factor (TNF) blockade|tumor necrosis factor (tnf) blockade
549186|NCT00837434|inflammatory autoimmune disorder|inflammatory autoimmune disorder
549187|NCT00837421|sepsis|sepsis
549188|NCT00837421|registry|registry
549189|NCT00837408|Diabetes|diabetes
549190|NCT00837408|Genetics|genetics
549191|NCT00837408|Asians|asians
549192|NCT00837408|Type 2 Diabetes|type 2 diabetes
549193|NCT00837395|premenstrual increase in asthma symptoms|premenstrual increase in asthma symptoms
549194|NCT00837369|Stress echocardiography|stress echocardiography
549195|NCT00837369|SPECT|spect
549196|NCT00837369|Myocardial perfusion imaging|myocardial perfusion imaging
549197|NCT00837343|Bipolar disorder|bipolar disorder
549198|NCT00837330|polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
549199|NCT00837330|choroidal neovascularization|choroidal neovascularization
549200|NCT00837330|ranibizumab|ranibizumab
549201|NCT00837330|Lucentis|lucentis
549202|NCT00837317|Phenols|phenols
549203|NCT00837317|Laser-Doppler|laser-doppler
549204|NCT00837317|Olive Oil|olive oil
549205|NCT00837317|Sunflower Oil|sunflower oil
549206|NCT00837317|Dimethylpolysiloxane|dimethylpolysiloxane
549207|NCT00837317|Postprandial|postprandial
549208|NCT00837317|Inflammation|inflammation
549209|NCT00837317|Oxidative Stress|oxidative stress
549210|NCT00837291|osteoarthritis|osteoarthritis
549211|NCT00837291|knee|knee
549212|NCT00837291|CF101|cf101
549213|NCT00837278|IVF|ivf
549214|NCT00837278|angiogenic factors|angiogenic factors
549215|NCT00837278|cytokines|cytokines
549216|NCT00837265|Breast Cancer Supportive Care Neutropenia|breast cancer supportive care neutropenia
549217|NCT00837252|Central Serous Chorioretinopathy|central serous chorioretinopathy
549218|NCT00837252|Finasteride|finasteride
549219|NCT00837252|Proscar|proscar
549220|NCT00837252|Retinal Eye Disease|retinal eye disease
549221|NCT00837239|HuaChanSu|huachansu
549222|NCT00837239|HCS|hcs
549223|NCT00837239|Gastrointestinal|gastrointestinal
549224|NCT00837239|Gastrointestinal Disease|gastrointestinal disease
549225|NCT00837239|Metastases|metastases
549226|NCT00837239|Cancer|cancer
549227|NCT00837239|Pancreatic cancer|pancreatic cancer
549228|NCT00837239|Placebo|placebo
549229|NCT00837239|Gemcitabine|gemcitabine
549230|NCT00837239|Gemcitabine Hydrocholoride|gemcitabine hydrocholoride
549231|NCT00837239|Gemzar|gemzar
549232|NCT00837239|Fudan UniversityCancer Hospital|fudan universitycancer hospital
549233|NCT00837213|Acne|acne
549234|NCT00837200|lymphoma|lymphoma
549235|NCT00837200|myeloma|myeloma
549236|NCT00837187|dexmedetomidine|dexmedetomidine
549237|NCT00837187|intranasal|intranasal
549238|NCT00837187|pharmacokinetics|pharmacokinetics
549239|NCT00837187|pharmacodynamics|pharmacodynamics
549240|NCT00837174|non-Hodgkin Lymphoma|non-hodgkin lymphoma
549241|NCT00837174|aggressive lymphoma|aggressive lymphoma
549242|NCT00837174|indolent lymphoma|indolent lymphoma
549243|NCT00837174|B cell lymphoma|b cell lymphoma
549244|NCT00837174|T cell lymphoma|t cell lymphoma
549245|NCT00837174|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
549246|NCT00837174|anaplastic large B cell lymphoma|anaplastic large b cell lymphoma
549247|NCT00837174|lymphoblastic lymphoma|lymphoblastic lymphoma
549248|NCT00837174|Burkitt's lymphoma|burkitt's lymphoma
549249|NCT00837174|transformed follicular center cell lymphoma|transformed follicular center cell lymphoma
549250|NCT00837174|transformed marginal zone lymphoma|transformed marginal zone lymphoma
549251|NCT00837174|transformed small lymphocytic lymphoma|transformed small lymphocytic lymphoma
549252|NCT00837174|grade 3 follicular center cell lymphoma|grade 3 follicular center cell lymphoma
549253|NCT00837174|blastic form marginal zone lymphoma|blastic form marginal zone lymphoma
549254|NCT00837174|transformed cutaneous T cell lymphoma|transformed cutaneous t cell lymphoma
549255|NCT00837174|mycosis fungoides stage IV|mycosis fungoides stage iv
549256|NCT00837174|angioimmunoblastic lymphadenopathy-like T-cell lymphoma|angioimmunoblastic lymphadenopathy-like t-cell lymphoma
549257|NCT00837174|nasal NK/T cell lymphoma|nasal nk/t cell lymphoma
549258|NCT00837174|peripheral T-cell lymphoma|peripheral t-cell lymphoma
549259|NCT00837174|small lymphocytic lymphoma|small lymphocytic lymphoma
549260|NCT00837174|lymphoplasmacytic lymphoma|lymphoplasmacytic lymphoma
549261|NCT00837174|follicular center cell lymphoma grade 1|follicular center cell lymphoma grade 1
549262|NCT00837174|follicular center cell lymphoma grade 2|follicular center cell lymphoma grade 2
549263|NCT00837174|mantle cell lymphoma|mantle cell lymphoma
549264|NCT00837174|marginal zone lymphoma|marginal zone lymphoma
549265|NCT00837174|mycosis fungoides|mycosis fungoides
549266|NCT00837161|High Intensity Focused Ultrasound Ablation|high intensity focused ultrasound ablation
549267|NCT00837161|Uterine Fibroids|uterine fibroids
549268|NCT00837161|Leiomyomata|leiomyomata
549269|NCT00837161|Non-Invasive Treatment of Uterine Fibroids|non-invasive treatment of uterine fibroids
549270|NCT00837161|MRI-Guided|mri-guided
549271|NCT00837161|Fibroids|fibroids
549272|NCT00837161|Uterine Leiomyomata|uterine leiomyomata
549273|NCT00837148|Sarcoma|sarcoma
549274|NCT00837148|Bone|bone
549275|NCT00837148|BAY 43-9006 (SORAFENIB)|bay 43-9006 (sorafenib)
549276|NCT00837148|DACARBAZINE|dacarbazine
549277|NCT00837148|08-068|08-068
549278|NCT00837135|Pancreatic Cancer|pancreatic cancer
549279|NCT00837122|Diabetes|diabetes
549280|NCT00837122|Genetics|genetics
549281|NCT00837122|Type 2 Diabetes|type 2 diabetes
549282|NCT00837083|hypercholesterolemia|hypercholesterolemia
549283|NCT00837083|cholesterol|cholesterol
549284|NCT00837083|LDL-cholesterol|ldl-cholesterol
549285|NCT00837083|rosuvastatin|rosuvastatin
549286|NCT00837083|Crestor|crestor
549287|NCT00837070|Zygapophyseal|zygapophyseal
549288|NCT00837070|joint|joint
549289|NCT00837070|cyst|cyst
549290|NCT00837070|Fluoroscopy|fluoroscopy
549291|NCT00837070|guided|guided
549292|NCT00837070|percutaneous|percutaneous
549293|NCT00837070|Lumbar|lumbar
549294|NCT00837031|Pancreatic|pancreatic
549295|NCT00837031|Pancreatic Cancer|pancreatic cancer
549296|NCT00837031|Lenalidomide|lenalidomide
549297|NCT00837031|Revlimid|revlimid
549298|NCT00837031|Gemcitabine|gemcitabine
549299|NCT00837018|OSAS|osas
549300|NCT00837018|exercise|exercise
549301|NCT00837018|metabolic|metabolic
549302|NCT00837018|cardio-vascular|cardio-vascular
549303|NCT00837005|dobutamine stress|dobutamine stress
549304|NCT00837005|inducible ischemia|inducible ischemia
549305|NCT00837005|CAD|cad
549306|NCT00836992|anal cancer|anal cancer
549307|NCT00836992|colon cancer|colon cancer
549308|NCT00836992|rectal cancer|rectal cancer
549309|NCT00836992|esophageal cancer|esophageal cancer
549310|NCT00836992|extrahepatic bile duct cancer|extrahepatic bile duct cancer
549311|NCT00836992|gallbladder cancer|gallbladder cancer
549312|NCT00836992|gastric cancer|gastric cancer
549313|NCT00836992|adult primary liver cancer|adult primary liver cancer
549314|NCT00836992|pancreatic cancer|pancreatic cancer
549315|NCT00836992|small intestine cancer|small intestine cancer
549316|NCT00836992|non-small cell lung cancer|non-small cell lung cancer
549317|NCT00836992|small cell lung cancer|small cell lung cancer
549318|NCT00836992|head and neck cancer|head and neck cancer
549319|NCT00836979|Urinary Incontinence|urinary incontinence
549320|NCT00836979|Incontinence|incontinence
549321|NCT00836979|bladder problems|bladder problems
549322|NCT00836979|bladder dysfunction|bladder dysfunction
549323|NCT00836953|Influenza|influenza
549324|NCT00836953|Fluzone®|fluzone®
549325|NCT00836953|Children|children
549326|NCT00836940|Type 2 diabetes mellitus|type 2 diabetes mellitus
549327|NCT00836940|GRC 8200|grc 8200
549328|NCT00836914|Allergic Rhinitis|allergic rhinitis
549329|NCT00836914|Allergy|allergy
549330|NCT00836914|Phosphatidylinositol 3-kinase|phosphatidylinositol 3-kinase
549331|NCT00836901|Bioequivalence|bioequivalence
549332|NCT00836901|Healthy Subjects|healthy subjects
549333|NCT00836888|ONO-4538|ono-4538
549334|NCT00836888|MDX-1106|mdx-1106
549335|NCT00836888|solid tumors|solid tumors
549336|NCT00836875|Pediatrics voriconazole invasive fungal infection invasive aspergillosis immunocompromized|pediatrics voriconazole invasive fungal infection invasive aspergillosis immunocompromized
549337|NCT00836862|Hemodialysis|hemodialysis
549338|NCT00836862|Vascular access|vascular access
549339|NCT00836862|Arteriovenous fistula|arteriovenous fistula
549340|NCT00836849|Bioequivalence|bioequivalence
549341|NCT00836849|Healthy Subjects|healthy subjects
549342|NCT00836836|Childhood epilepsy|childhood epilepsy
549343|NCT00836836|ketogenic diet|ketogenic diet
549344|NCT00836823|Patient-reported most bothersome symptom|patient-reported most bothersome symptom
549345|NCT00836823|Patient-reported symptom-specific goal achievement|patient-reported symptom-specific goal achievement
549346|NCT00836823|Medical treatment|medical treatment
549347|NCT00836810|Circadian variations of cytokines in PMR|circadian variations of cytokines in pmr
549348|NCT00836810|effect of TRT Prednisone in cytokines|effect of trt prednisone in cytokines
549349|NCT00836797|Alveolar Bone Loss|alveolar bone loss
549350|NCT00836797|Alveolar ridge|alveolar ridge
549351|NCT00836797|Alveolar Process|alveolar process
549352|NCT00836784|Old tooth brush|old tooth brush
549353|NCT00836784|Plaque removal|plaque removal
549354|NCT00836771|Infant formula|infant formula
549355|NCT00836771|Probiotic microorganisms|probiotic microorganisms
549356|NCT00836771|prebiotic|prebiotic
549357|NCT00836745|Advanced renal cell Cancer|advanced renal cell cancer
549358|NCT00836745|Non interventional study|non interventional study
549359|NCT00836745|Renal Cancer|renal cancer
549360|NCT00836745|Sutent|sutent
549361|NCT00836745|Metastatic|metastatic
549362|NCT00836745|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
549363|NCT00836732|celle therapy|celle therapy
549364|NCT00836732|cell culture|cell culture
549365|NCT00836732|mesenchymal stem cells|mesenchymal stem cells
549366|NCT00836719|Multiple sclerosis|multiple sclerosis
549367|NCT00836719|safety|safety
549368|NCT00836719|open label|open label
549369|NCT00836719|Polyphenon E|polyphenon e
549370|NCT00836719|EGCG|egcg
549371|NCT00836719|NAA|naa
549372|NCT00836719|N-acetyl-aspartate|n-acetyl-aspartate
549373|NCT00836719|MRI|mri
549374|NCT00836706|Bioequivalence|bioequivalence
549375|NCT00836706|Healthy Subjects|healthy subjects
549376|NCT00836693|Erectile Dysfunction|erectile dysfunction
549377|NCT00836667|Bioequivalence|bioequivalence
549378|NCT00836667|Healthy Subjects|healthy subjects
549379|NCT00836654|EpCAM positive tumor|epcam positive tumor
549380|NCT00836654|malignant ascites|malignant ascites
549381|NCT00836654|intraperitoneal|intraperitoneal
549382|NCT00836641|preschool asthma|preschool asthma
549383|NCT00836641|sequential pneumococcal immunization|sequential pneumococcal immunization
549384|NCT00836641|immunogenicity|immunogenicity
549385|NCT00836641|safety|safety
549386|NCT00836589|Long-term safety and reliability of ICD leads|long-term safety and reliability of icd leads
549387|NCT00836576|Bioequivalence|bioequivalence
549388|NCT00836576|Healthy Subjects|healthy subjects
549389|NCT00836563|Hemodialysis|hemodialysis
549390|NCT00836563|Arteriovenous Graft|arteriovenous graft
549391|NCT00836550|HIV|hiv
549392|NCT00836550|HIV knowledge measure|hiv knowledge measure
549393|NCT00836550|Teen HIV testing|teen hiv testing
549394|NCT00836550|HIV Seronegativity|hiv seronegativity
549395|NCT00836537|Bioequivalence|bioequivalence
549396|NCT00836537|Healthy Subjects|healthy subjects
549397|NCT00836524|IUGR|iugr
549398|NCT00836524|Preeclampsia|preeclampsia
549399|NCT00836524|ultrasound|ultrasound
549400|NCT00836524|YKL-40|ykl-40
549401|NCT00836472|Bioequivalence|bioequivalence
549402|NCT00836472|Healthy Subjects|healthy subjects
549403|NCT00836459|Humans|humans
549404|NCT00836459|Middle Aged|middle aged
549405|NCT00836459|Behavior Therapy|behavior therapy
549406|NCT00836459|Directive Counseling|directive counseling
549407|NCT00836459|Health Behavior|health behavior
549408|NCT00836459|Interview, Psychological|interview, psychological
549409|NCT00836459|Motivation|motivation
549410|NCT00836459|Exercise|exercise
549411|NCT00836459|Physical Fitness|physical fitness
549412|NCT00836459|Self Efficacy|self efficacy
549413|NCT00836459|Life Style|life style
549414|NCT00836459|Health Promotion|health promotion
549415|NCT00836459|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
549416|NCT00836459|Body Mass Index|body mass index
549417|NCT00836459|Monitoring, Ambulatory|monitoring, ambulatory
549418|NCT00836459|Walking|walking
549419|NCT00836446|school-aged|school-aged
549420|NCT00836446|children|children
549421|NCT00836446|obesity|obesity
549422|NCT00836446|cardiovascular risk|cardiovascular risk
549423|NCT00836446|physical activity|physical activity
549424|NCT00836433|staff education|staff education
549425|NCT00836433|complexity science|complexity science
549426|NCT00836433|social constructivist theory|social constructivist theory
549427|NCT00836420|ammonia|ammonia
549428|NCT00836420|acute liver failure|acute liver failure
549429|NCT00836420|brain edema|brain edema
549430|NCT00836420|oxidative metabolism|oxidative metabolism
549431|NCT00836420|intracranial pressure|intracranial pressure
549432|NCT00836407|pancreatic cancer|pancreatic cancer
549433|NCT00836407|vaccine|vaccine
549434|NCT00836407|immunotherapy|immunotherapy
549435|NCT00836407|antibody|antibody
549436|NCT00836407|CTLA-4|ctla-4
549437|NCT00836394|arthritis|arthritis
549438|NCT00836394|juvenile idiopathic arthritis|juvenile idiopathic arthritis
549439|NCT00836394|pediatric|pediatric
549440|NCT00836394|intervention|intervention
549441|NCT00836394|vibration therapy|vibration therapy
549442|NCT00836394|JIA|jia
549443|NCT00836381|Overactive bladder|overactive bladder
549444|NCT00836381|Antimuscarinics|antimuscarinics
549445|NCT00836381|Patient-reported goal achievement|patient-reported goal achievement
549446|NCT00836368|Asthma|asthma
549447|NCT00836368|Asthmatic|asthmatic
549449|NCT00836368|Allergic|allergic
549450|NCT00836368|Gamma-tocopherol|gamma-tocopherol
549451|NCT00836368|Vitamin|vitamin
549452|NCT00836368|Vitamin E|vitamin e
549453|NCT00836355|stroke|stroke
549454|NCT00836355|magnetic resonance imaging|magnetic resonance imaging
549455|NCT00836355|enoxaparin|enoxaparin
549456|NCT00836355|minocycline|minocycline
549457|NCT00836355|NIH stroke scale|nih stroke scale
549458|NCT00836355|modified Rankin scale|modified rankin scale
549459|NCT00836355|neuroprotection|neuroprotection
549460|NCT00836342|Non-melanoma skin cancer|non-melanoma skin cancer
549461|NCT00836342|Basal cell carcinoma|basal cell carcinoma
549462|NCT00836342|Squamous cell carcinoma|squamous cell carcinoma
549463|NCT00836329|Neurologic|neurologic
549464|NCT00836329|Diabetes|diabetes
549465|NCT00836329|Cardiac Surgery|cardiac surgery
549466|NCT00836329|Stroke|stroke
549467|NCT00836316|laparoscopic cholecystectomy|laparoscopic cholecystectomy
549468|NCT00836290|risk reduction|risk reduction
549469|NCT00836290|HIV prevention|hiv prevention
549470|NCT00836290|HIV education|hiv education
549471|NCT00836290|HIV Seronegativity|hiv seronegativity
549472|NCT00836277|Panitumumab|panitumumab
549473|NCT00836277|Irinotecan|irinotecan
549474|NCT00836277|Esophageal Adenocarcinoma|esophageal adenocarcinoma
549475|NCT00836277|Phase II|phase ii
549476|NCT00836264|Morphine|morphine
549477|NCT00836264|Phenotype|phenotype
549478|NCT00836264|Genotype|genotype
549479|NCT00836264|Tonsillectomy|tonsillectomy
549480|NCT00836264|Adenoidectomy|adenoidectomy
549481|NCT00836264|Opioid Receptors|opioid receptors
549482|NCT00836264|Genome-Wide Association|genome-wide association
549483|NCT00836264|Pharmacokinetics|pharmacokinetics
549484|NCT00836251|energy expenditure|energy expenditure
549485|NCT00836251|schizophrenia|schizophrenia
549486|NCT00836238|Prostate Cancer|prostate cancer
549487|NCT00836238|Neural Functioning Assessment|neural functioning assessment
549488|NCT00836238|Physical Assessment|physical assessment
549489|NCT00836238|Questionnaire|questionnaire
549490|NCT00836238|Objective Measures of Functional Status|objective measures of functional status
549491|NCT00836238|Physical Function|physical function
549492|NCT00836238|Symptom Assessment Interview|symptom assessment interview
549493|NCT00836238|Elderly|elderly
549494|NCT00836225|diabetes|diabetes
549495|NCT00836225|SGLT2 inhibitor|sglt2 inhibitor
549496|NCT00836212|HIV|hiv
549497|NCT00836212|Adjusting Antiretroviral Therapy|adjusting antiretroviral therapy
549498|NCT00836212|Dosage using Therapeutic Drug Monitoring|dosage using therapeutic drug monitoring
549499|NCT00836212|Swiss HIV Cohort Study|swiss hiv cohort study
549500|NCT00836212|HIV Geneva|hiv geneva
549501|NCT00836212|lopinavir|lopinavir
549502|NCT00836212|efavirenz|efavirenz
549503|NCT00836212|Treatment Experienced|treatment experienced
549504|NCT00836199|smoking cessation|smoking cessation
549505|NCT00836199|NicVAX|nicvax
549506|NCT00836199|smoking vaccine|smoking vaccine
549507|NCT00836199|smoking abstinence|smoking abstinence
549508|NCT00836199|smoking|smoking
549509|NCT00836199|tobacco cessation|tobacco cessation
549510|NCT00836173|CARBOPLATIN|carboplatin
549511|NCT00836173|DEXAMETHASONE|dexamethasone
549512|NCT00836173|DIFFUSE LARGE B-CELL LYMPHOMA|diffuse large b-cell lymphoma
549513|NCT00836173|ETOPOSIDE|etoposide
549514|NCT00836173|GALLIUM NITRATE|gallium nitrate
549515|NCT00836173|IFOSFAMIDE|ifosfamide
549516|NCT00836173|PHASE II|phase ii
549517|NCT00836173|RELAPSED OR REFRACTORY|relapsed or refractory
549518|NCT00836173|RITUXIMAB|rituximab
549519|NCT00836160|EGFR-TKI therapy|egfr-tki therapy
549520|NCT00836160|NSCLC|nsclc
549521|NCT00836160|Efficacy|efficacy
549522|NCT00836134|pain relief after umbilical hernia repair|pain relief after umbilical hernia repair
549523|NCT00836134|morphine consumption|morphine consumption
549524|NCT00836134|plasma bupivacaine levels|plasma bupivacaine levels
549525|NCT00836121|Teratoma|teratoma
549526|NCT00836121|Mediastinum|mediastinum
549527|NCT00836108|Lung Diseases, Obstructive|lung diseases, obstructive
549528|NCT00836108|Breathing Exercises|breathing exercises
549529|NCT00836108|Exercise Tolerance|exercise tolerance
549530|NCT00836108|Dyspnea|dyspnea
549531|NCT00836108|Arm Exercise|arm exercise
549532|NCT00836095|laryngeal mask, proseal|laryngeal mask, proseal
549533|NCT00836082|Healthy volunteers|healthy volunteers
549534|NCT00836069|Generalized Anxiety Disorder|generalized anxiety disorder
549535|NCT00836056|Bioequivalence|bioequivalence
549536|NCT00836056|Healthy Subjects|healthy subjects
549537|NCT00836043|CLL|cll
549538|NCT00836043|alemtuzumab|alemtuzumab
549539|NCT00836004|Bioequivalence|bioequivalence
549540|NCT00836004|Healthy Subjects|healthy subjects
549541|NCT00835991|Bioequivalence|bioequivalence
549542|NCT00835991|Healthy Subjects|healthy subjects
549543|NCT00835978|axitinib or AG-013736 dose titration (increase) renal cell carcinoma|axitinib or ag-013736 dose titration (increase) renal cell carcinoma
549544|NCT00835978|kidney cancer|kidney cancer
549545|NCT00835965|Laparoscopic|laparoscopic
549546|NCT00835965|Surgery|surgery
549547|NCT00835965|Postoperative|postoperative
549548|NCT00835965|Nausea|nausea
549549|NCT00835965|Vomiting|vomiting
549550|NCT00835965|Aprepitant|aprepitant
549551|NCT00835965|Dexamethasone|dexamethasone
549552|NCT00835965|Postoperative Nausea, Postoperative Vomiting|postoperative nausea, postoperative vomiting
549553|NCT00835939|Achilles|achilles
549554|NCT00835939|Tendinopathy|tendinopathy
549555|NCT00835939|Sclerotherapy|sclerotherapy
549556|NCT00835939|Neovascularisation|neovascularisation
549557|NCT00835939|sports medicine|sports medicine
549558|NCT00835939|interventional radiology|interventional radiology
549559|NCT00835926|Influenza|influenza
549560|NCT00835926|Fluzone®|fluzone®
549561|NCT00835913|Autonomic nervous system|autonomic nervous system
549562|NCT00835913|Sepsis shock|sepsis shock
549563|NCT00835913|severe sepsis|severe sepsis
549564|NCT00835913|sinusal change|sinusal change
549565|NCT00835913|Myocardiac fixing|myocardiac fixing
549566|NCT00835913|NTproBNP|ntprobnp
549567|NCT00835913|Patient in intensive care unit with sepsis shock or severe|patient in intensive care unit with sepsis shock or severe
549568|NCT00835913|Sepsis|sepsis
549569|NCT00835900|smoking cessation|smoking cessation
549570|NCT00835900|varenicline|varenicline
549571|NCT00835900|smoking cessation treatment|smoking cessation treatment
549572|NCT00835874|probiotic|probiotic
549573|NCT00835874|preterm|preterm
549574|NCT00835874|lactation|lactation
549575|NCT00835874|breast feeding|breast feeding
549576|NCT00835874|necrotizing enterocolitis|necrotizing enterocolitis
549577|NCT00835874|sepsis|sepsis
549578|NCT00835874|bacterial cultures|bacterial cultures
549579|NCT00835874|lactating mother|lactating mother
549580|NCT00835874|breast feeding of at least 50% of enteric feeding volume|breast feeding of at least 50% of enteric feeding volume
549581|NCT00835874|Infant, very low birth weight|infant, very low birth weight
549582|NCT00835861|Non Insulin Dependent Diabetes|non insulin dependent diabetes
549583|NCT00835861|Pregnancy|pregnancy
549584|NCT00835848|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
549585|NCT00835848|Primary PCI|primary pci
549586|NCT00835848|Postconditioning|postconditioning
549587|NCT00835835|Multiple Sclerosis|multiple sclerosis
549588|NCT00835835|gait|gait
549589|NCT00835835|falls|falls
549590|NCT00835835|lokomat|lokomat
549591|NCT00835835|body-weight support treadmill training|body-weight support treadmill training
549592|NCT00835822|Chronic Venous Insufficiency, Venocur Triplex®|chronic venous insufficiency, venocur triplex®
549593|NCT00835809|Acute respiratory insufficiency respiratory|acute respiratory insufficiency respiratory
549594|NCT00835809|Biomarkers|biomarkers
549595|NCT00835809|Emergency|emergency
549596|NCT00835809|Intensive care unit|intensive care unit
549597|NCT00835809|Prospective|prospective
549598|NCT00835809|Patient hospitalize in emergency or in intensive care unit|patient hospitalize in emergency or in intensive care unit
549599|NCT00835809|for acute respiratory insufficiency|for acute respiratory insufficiency
549600|NCT00835796|Bioequivalence|bioequivalence
549601|NCT00835796|Healthy Subjects|healthy subjects
549602|NCT00835770|relapsing|relapsing
549603|NCT00835770|multiple sclerosis|multiple sclerosis
549604|NCT00835770|remitting|remitting
549605|NCT00835770|oral|oral
549606|NCT00835744|ovulation induction|ovulation induction
549607|NCT00835744|clomiphene citrate|clomiphene citrate
549608|NCT00835744|gonadotropins|gonadotropins
549609|NCT00835731|induced abortion|induced abortion
549610|NCT00835731|misoprostol|misoprostol
549611|NCT00835731|cervical ripening|cervical ripening
549612|NCT00835731|second trimester abortion|second trimester abortion
549613|NCT00835731|Dilapan-S|dilapan-s
549614|NCT00835705|Bioequivalence|bioequivalence
549615|NCT00835705|Healthy Subjects|healthy subjects
549616|NCT00835692|Bioequivalence|bioequivalence
549617|NCT00835692|Healthy Subjects|healthy subjects
549618|NCT00835666|Bioequivalence|bioequivalence
549619|NCT00835666|Healthy Subjects|healthy subjects
549620|NCT00835640|Bioequivalence|bioequivalence
549621|NCT00835640|Healthy Subjects|healthy subjects
549622|NCT00835627|Treatment|treatment
549623|NCT00835627|Cognitive Behavior Therapy|cognitive behavior therapy
549624|NCT00835627|pharmacotherapy|pharmacotherapy
549625|NCT00835627|psychogenic nonepileptic seizures|psychogenic nonepileptic seizures
549626|NCT00835627|pseudoseizures|pseudoseizures
549627|NCT00835627|dissociative seizures|dissociative seizures
549628|NCT00835627|conversion disorder|conversion disorder
549629|NCT00835614|Bioequivalence|bioequivalence
549630|NCT00835614|Healthy Subjects|healthy subjects
549631|NCT00835588|Bioequivalence|bioequivalence
549632|NCT00835588|Healthy Subjects|healthy subjects
549633|NCT00835575|Bioequivalence|bioequivalence
549634|NCT00835575|Healthy Subjects|healthy subjects
549635|NCT00835562|Shoulder fractures|shoulder fractures
549636|NCT00835562|Proximal humeral fractures|proximal humeral fractures
549637|NCT00835562|Randomised clinical trial|randomised clinical trial
549638|NCT00835562|elderly|elderly
549639|NCT00835562|Displaced four-part fractures of the proximal humerus|displaced four-part fractures of the proximal humerus
549640|NCT00835549|Bioequivalence|bioequivalence
549641|NCT00835549|Healthy Subjects|healthy subjects
549642|NCT00835536|Bioequivalence|bioequivalence
549643|NCT00835536|Healthy Subjects|healthy subjects
549745|NCT00835068|post marketing study|post marketing study
549644|NCT00835523|frozen-thawed embryo replacement|frozen-thawed embryo replacement
549645|NCT00835523|GnRH agonist|gnrh agonist
549646|NCT00835523|GnRH antagonist|gnrh antagonist
549647|NCT00835523|ovarian hyperstimulation|ovarian hyperstimulation
549648|NCT00835510|Tinea pedis|tinea pedis
549649|NCT00835497|Bioequivalence|bioequivalence
549650|NCT00835497|Healthy Subjects|healthy subjects
549651|NCT00835484|Bioequivalence|bioequivalence
549652|NCT00835484|Healthy Subjects|healthy subjects
549653|NCT00835471|Lung cancer|lung cancer
549654|NCT00835471|non-small-cell|non-small-cell
549655|NCT00835471|erlotinib|erlotinib
549656|NCT00835471|chemotherapy|chemotherapy
549657|NCT00835458|gastric fistula|gastric fistula
549658|NCT00835458|perforation|perforation
549659|NCT00835458|endoscopy|endoscopy
549660|NCT00835458|closure|closure
549661|NCT00835458|endolumenal|endolumenal
549662|NCT00835432|Lateral augmentation|lateral augmentation
549663|NCT00835432|GBR|gbr
549664|NCT00835432|BoneCeramic|boneceramic
549665|NCT00835432|collagen membrane|collagen membrane
549666|NCT00835432|histomorphometry|histomorphometry
549667|NCT00835432|morphometry|morphometry
549668|NCT00835432|reentry|reentry
549669|NCT00835432|biopsy|biopsy
549670|NCT00835419|metastatic malignant melanoma with cyclin D1 positivity|metastatic malignant melanoma with cyclin d1 positivity
549671|NCT00835406|Bioequivalence|bioequivalence
549672|NCT00835406|Healthy Subjects|healthy subjects
549673|NCT00835393|Bioequivalence|bioequivalence
549674|NCT00835393|Healthy Subjects|healthy subjects
549675|NCT00835367|Bioequivalence|bioequivalence
549676|NCT00835367|Healthy Subjects|healthy subjects
549677|NCT00835354|Bioequivalence|bioequivalence
549678|NCT00835354|Healthy Subjects|healthy subjects
549679|NCT00835341|oral epithelial dysplasia|oral epithelial dysplasia
549680|NCT00835341|p16 methylation|p16 methylation
549681|NCT00835341|prognosis|prognosis
549682|NCT00835341|malignant transformation|malignant transformation
549683|NCT00835341|oral squamous cell carcinoma|oral squamous cell carcinoma
549684|NCT00835328|hyperinsulinism|hyperinsulinism
549685|NCT00835328|hypoglycemia|hypoglycemia
549686|NCT00835328|ATP- sensitive potassium channel (KATP)|atp- sensitive potassium channel (katp)
549687|NCT00835315|interdigital psoriasis (psoriasis alba)|interdigital psoriasis (psoriasis alba)
549688|NCT00835302|Cervical|cervical
549689|NCT00835302|Thoracic|thoracic
549690|NCT00835302|Manipulation|manipulation
549691|NCT00835302|Mobilization|mobilization
549692|NCT00835302|Clinical prediction rule|clinical prediction rule
549693|NCT00835302|Shoulder pain.|shoulder pain.
549694|NCT00835289|Clinical Trials, Randomized|clinical trials, randomized
549695|NCT00835276|Bioequivalence|bioequivalence
549696|NCT00835276|Healthy Subjects|healthy subjects
549697|NCT00835263|Bioequivalence|bioequivalence
549698|NCT00835263|Healthy Subjects|healthy subjects
549699|NCT00835250|Transvaginal cholecystectomy|transvaginal cholecystectomy
549700|NCT00835250|NOTES|notes
549701|NCT00835250|Minilaparoscopy|minilaparoscopy
549702|NCT00835250|Endoscopic surgery|endoscopic surgery
549703|NCT00835250|Cholecystectomy|cholecystectomy
549704|NCT00835250|Surgical translumenal endoscopic surgery|surgical translumenal endoscopic surgery
549705|NCT00835250|Transvaginal translumenal endoscopic surgery|transvaginal translumenal endoscopic surgery
549706|NCT00835237|Boostrix®|boostrix®
549707|NCT00835237|adults|adults
549708|NCT00835224|Spinal Cord Injury|spinal cord injury
549709|NCT00835224|Orthostatic Hypotension|orthostatic hypotension
549710|NCT00835224|Blood Pressure|blood pressure
549711|NCT00835224|Midodrine Hydrochloride|midodrine hydrochloride
549712|NCT00835224|L-NAME|l-name
549713|NCT00835211|Bioequivalence|bioequivalence
549714|NCT00835211|Healthy Subjects|healthy subjects
549715|NCT00835185|Antibodies, Monoclonal|antibodies, monoclonal
549716|NCT00835185|Colorectal Neoplasms|colorectal neoplasms
549717|NCT00835172|Bioequivalence|bioequivalence
549718|NCT00835172|Healthy Subjects|healthy subjects
549719|NCT00835159|Postoperative Delirium|postoperative delirium
549720|NCT00835159|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
549721|NCT00835159|Rivastigmine|rivastigmine
549722|NCT00835159|Exelon|exelon
549723|NCT00835159|Memory impairment|memory impairment
549724|NCT00835159|Delirium|delirium
549725|NCT00835159|Cognitive function|cognitive function
549726|NCT00835146|Bioequivalence|bioequivalence
549727|NCT00835146|Healthy Subjects|healthy subjects
549728|NCT00835133|family|family
549729|NCT00835133|history|history
549730|NCT00835133|pancreas|pancreas
549731|NCT00835133|cancer|cancer
549732|NCT00835133|melanoma|melanoma
549733|NCT00835133|genetic|genetic
549734|NCT00835107|Bipolar Depression|bipolar depression
549735|NCT00835107|Sleep|sleep
549736|NCT00835107|Polysomnograph|polysomnograph
549737|NCT00835107|Slow Wave Sleep|slow wave sleep
549738|NCT00835107|Ziprasidone|ziprasidone
549739|NCT00835107|Antipsychotic|antipsychotic
549740|NCT00835107|Placebo|placebo
549741|NCT00835081|Bioequivalence|bioequivalence
549742|NCT00835081|Healthy Subjects|healthy subjects
549743|NCT00835068|Hemophilia B|hemophilia b
549744|NCT00835068|observational|observational
549746|NCT00835055|rectal cancer with neoadjuvant treatment|rectal cancer with neoadjuvant treatment
549747|NCT00835055|standardized clinical tests|standardized clinical tests
549748|NCT00835055|tumor markers on tumor tissue|tumor markers on tumor tissue
549749|NCT00835042|Bioequivalence|bioequivalence
549750|NCT00835042|Healthy Subjects|healthy subjects
549751|NCT00835029|oral|oral
549752|NCT00835029|candida|candida
549753|NCT00835029|denture|denture
549754|NCT00835029|clotrimazole|clotrimazole
549755|NCT00835029|slow releases|slow releases
549756|NCT00835016|Early psychosocial stimulation, RCT, Depressed mother|early psychosocial stimulation, rct, depressed mother
549757|NCT00835003|Neonatal admission|neonatal admission
549758|NCT00835003|Elective Caesarean Section|elective caesarean section
549759|NCT00835003|Timing|timing
549760|NCT00835003|Choice behavior|choice behavior
549761|NCT00835003|Intraoperative complications|intraoperative complications
549762|NCT00835003|Postoperative complications|postoperative complications
549763|NCT00834990|Bioequivalence|bioequivalence
549764|NCT00834990|Healthy Subjects|healthy subjects
549765|NCT00834977|Bioequivalence|bioequivalence
549766|NCT00834977|Healthy Subjects|healthy subjects
549767|NCT00834964|Bioequivalence|bioequivalence
549768|NCT00834964|Healthy Subjects|healthy subjects
549769|NCT00834951|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
549770|NCT00834951|Elderly patients|elderly patients
549771|NCT00834951|Low dose total body irradiation|low dose total body irradiation
549772|NCT00834951|RCHOP14|rchop14
549773|NCT00834938|diabetes mellitus, type 2|diabetes mellitus, type 2
549774|NCT00834938|Insulin resistance|insulin resistance
549775|NCT00834938|bariatric surgery|bariatric surgery
549776|NCT00834938|Glucagon-Like Peptide 1|glucagon-like peptide 1
549777|NCT00834938|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
549778|NCT00834938|insulin|insulin
549779|NCT00834938|glucagon|glucagon
549780|NCT00834938|ghrelin|ghrelin
549781|NCT00834938|adiponectin|adiponectin
549782|NCT00834938|Cytokines|cytokines
549783|NCT00834938|gastric bypass|gastric bypass
549784|NCT00834938|Obesity|obesity
549785|NCT00834925|atrial fibrillation with rapid ventricular response|atrial fibrillation with rapid ventricular response
549786|NCT00834912|Healthy Subjects|healthy subjects
549787|NCT00834899|Sickle cell disease|sickle cell disease
549788|NCT00834899|Pain crisis|pain crisis
549789|NCT00834899|Acute pain episode|acute pain episode
549790|NCT00834899|Eptifibatide|eptifibatide
549791|NCT00834899|Antiplatelet therapy|antiplatelet therapy
549792|NCT00834899|Safety|safety
549793|NCT00834899|Treatment|treatment
549794|NCT00834873|Bioequivalence|bioequivalence
549795|NCT00834873|Healthy Subjects|healthy subjects
549796|NCT00834860|chronic hepatitis C|chronic hepatitis c
549797|NCT00834860|sustained virological response|sustained virological response
549798|NCT00834860|peginterferon|peginterferon
549799|NCT00834860|ribavirin|ribavirin
549800|NCT00834860|neoplasm|neoplasm
549801|NCT00834847|Bioequivalence|bioequivalence
549802|NCT00834847|Healthy Subjects|healthy subjects
549803|NCT00834834|Suicidal and Self-Injurious Behavior|suicidal and self-injurious behavior
549804|NCT00834821|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
549805|NCT00834821|ADHD, Predominantly Inattentive Type|adhd, predominantly inattentive type
549806|NCT00834821|Inattention|inattention
549807|NCT00834821|Psychosocial Intervention|psychosocial intervention
549808|NCT00834821|Behavioral Intervention|behavioral intervention
549809|NCT00834808|Healthy volunteers|healthy volunteers
549810|NCT00834795|Bioequivalence|bioequivalence
549811|NCT00834795|Healthy Subjects|healthy subjects
549812|NCT00834782|PK|pk
549813|NCT00834782|IOP|iop
549814|NCT00834756|Bioequivalence|bioequivalence
549815|NCT00834756|Healthy Subjects|healthy subjects
549816|NCT00834743|Bioequivalence|bioequivalence
549817|NCT00834743|Healthy Subjects|healthy subjects
549818|NCT00834717|Bioequivalence|bioequivalence
549819|NCT00834717|Healthy Subjects|healthy subjects
549820|NCT00834704|PEGPH20|pegph20
549821|NCT00834704|PEGylated recombinant human hyaluronidase|pegylated recombinant human hyaluronidase
549822|NCT00834704|Metastatic or locally advanced solid tumor|metastatic or locally advanced solid tumor
549823|NCT00834691|Inflammation|inflammation
549824|NCT00834691|Oxidative stress|oxidative stress
549825|NCT00834691|Estimated glomerular filtration rate|estimated glomerular filtration rate
549826|NCT00834678|male breast cancer|male breast cancer
549827|NCT00834678|recurrent breast cancer|recurrent breast cancer
549828|NCT00834678|stage IIIB breast cancer|stage iiib breast cancer
549829|NCT00834678|stage IIIC breast cancer|stage iiic breast cancer
549830|NCT00834678|stage IV breast cancer|stage iv breast cancer
549831|NCT00834678|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
549832|NCT00834678|HER2-negative breast cancer|her2-negative breast cancer
549833|NCT00834678|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
549834|NCT00834678|triple-negative breast cancer|triple-negative breast cancer
549835|NCT00834652|Metabolic Diseases|metabolic diseases
549836|NCT00834652|Depressive Disorder, Major|depressive disorder, major
549837|NCT00834652|Depressive Disorder|depressive disorder
550037|NCT00833599|Genetic|genetic
549838|NCT00834652|Glucose Metabolism Disorders|glucose metabolism disorders
549839|NCT00834652|Depression Recurrence|depression recurrence
549840|NCT00834639|Bioequivalence|bioequivalence
549841|NCT00834639|Healthy Subjects|healthy subjects
549842|NCT00834626|Ileal Interposition|ileal interposition
549843|NCT00834626|Sleeve Gastrectomy|sleeve gastrectomy
549844|NCT00834626|Type-2 Diabetes|type-2 diabetes
549845|NCT00834613|Bioequivalence|bioequivalence
549846|NCT00834613|Healthy Subjects|healthy subjects
549847|NCT00834587|Bioequivalence|bioequivalence
549848|NCT00834587|Healthy Subjects|healthy subjects
549849|NCT00834574|Bioequivalence|bioequivalence
549850|NCT00834574|Healthy Subjects|healthy subjects
549851|NCT00834561|Bioequivalence|bioequivalence
549852|NCT00834561|Healthy Subjects|healthy subjects
549853|NCT00834548|Magnetic resonance|magnetic resonance
549854|NCT00834548|whole body|whole body
549855|NCT00834548|angiography|angiography
549856|NCT00834548|hybrid protocol|hybrid protocol
549857|NCT00834548|MRI|mri
549858|NCT00834535|Bioequivalence|bioequivalence
549859|NCT00834535|Healthy Subjects|healthy subjects
549860|NCT00834522|Bioequivalence|bioequivalence
549861|NCT00834522|Healthy Subjects|healthy subjects
549862|NCT00834483|Safety|safety
549863|NCT00834483|Efficacy|efficacy
549864|NCT00834483|Cost-savings|cost-savings
549865|NCT00834483|Cosmesis|cosmesis
549866|NCT00834483|Safety and efficacy of wound closure|safety and efficacy of wound closure
549867|NCT00834483|Cost-savings potential|cost-savings potential
549868|NCT00834483|Cosmesis of the wound/scar|cosmesis of the wound/scar
549869|NCT00834457|AIDS-related Kaposi's sarcoma|aids-related kaposi's sarcoma
549870|NCT00834457|antiretroviral therapy|antiretroviral therapy
549871|NCT00834444|Bioequivalence|bioequivalence
549872|NCT00834444|Healthy Subjects|healthy subjects
549873|NCT00834431|Bioequivalence|bioequivalence
549874|NCT00834431|Healthy Subjects|healthy subjects
549875|NCT00834418|Bioequivalence|bioequivalence
549876|NCT00834418|Healthy Subjects|healthy subjects
549877|NCT00834405|Bioequivalence|bioequivalence
549878|NCT00834405|Healthy Subjects|healthy subjects
549879|NCT00834379|Bioequivalence|bioequivalence
549880|NCT00834379|Healthy Subjects|healthy subjects
549881|NCT00834366|Healthy volunteers|healthy volunteers
549882|NCT00834340|Bioequivalence|bioequivalence
549883|NCT00834340|Healthy Subjects|healthy subjects
549884|NCT00834327|Restless Legs Syndrome|restless legs syndrome
549885|NCT00834301|End Stage Renal Disease|end stage renal disease
549886|NCT00834301|Inflammation|inflammation
549887|NCT00834288|Healthy subjects|healthy subjects
549888|NCT00834288|Pharmacokinetics|pharmacokinetics
549889|NCT00834288|Bioavailability|bioavailability
549890|NCT00834275|Bioequivalence|bioequivalence
549891|NCT00834275|Healthy Subjects|healthy subjects
549892|NCT00834249|Bioequivalence|bioequivalence
549893|NCT00834249|Healthy Subjects|healthy subjects
549894|NCT00834236|gastric cancer|gastric cancer
549895|NCT00834236|proteomics|proteomics
549896|NCT00834236|gastric juice|gastric juice
549897|NCT00834223|refractory chronic forms of open angle glaucoma (OAG)|refractory chronic forms of open angle glaucoma (oag)
549898|NCT00834223|OAG|oag
549899|NCT00834223|glaucoma|glaucoma
549900|NCT00834197|Bioequivalence|bioequivalence
549901|NCT00834197|Healthy Subjects|healthy subjects
549902|NCT00834184|nikkomycin Z|nikkomycin z
549903|NCT00834184|evaluate safety, tolerance and pharmacokinetics of nikkomycin Z|evaluate safety, tolerance and pharmacokinetics of nikkomycin z
549904|NCT00834158|Hepatocellular Carcinoma|hepatocellular carcinoma
549905|NCT00834158|Hepatitis B|hepatitis b
549906|NCT00834158|Transarterial chemoembolization (TACE)|transarterial chemoembolization (tace)
549907|NCT00834158|Portal vein embolization (PVE)|portal vein embolization (pve)
549908|NCT00834158|Surgical resection|surgical resection
549909|NCT00834158|Disease-free survival|disease-free survival
549910|NCT00834158|Overall survival|overall survival
549911|NCT00834145|Edema|edema
549912|NCT00834145|Right heart failure|right heart failure
549913|NCT00834145|Cor pulmonale|cor pulmonale
549914|NCT00834145|Pump|pump
549915|NCT00834145|Leg compression|leg compression
549916|NCT00834132|Bioequivalence|bioequivalence
549917|NCT00834132|Healthy Subjects|healthy subjects
549918|NCT00834106|HPV 6/11/16/18 Infection|hpv 6/11/16/18 infection
549919|NCT00834093|Epstein-Barr Virus|epstein-barr virus
549920|NCT00834093|NPC|npc
549921|NCT00834093|EBV|ebv
549922|NCT00834093|immunotherapy|immunotherapy
549923|NCT00834080|opioid dependence|opioid dependence
549924|NCT00834080|VIVITROL|vivitrol
549925|NCT00834080|opioid-related disorders|opioid-related disorders
549926|NCT00834067|Bioequivalence|bioequivalence
549927|NCT00834067|Healthy Subjects|healthy subjects
549928|NCT00834041|aliskiren|aliskiren
549929|NCT00834041|pediatric|pediatric
549930|NCT00834041|hypertension|hypertension
549931|NCT00834041|pharmacokinetics (PK)|pharmacokinetics (pk)
549932|NCT00834041|pharmacodynamics (PD)|pharmacodynamics (pd)
549933|NCT00834041|plasma renin activity|plasma renin activity
549934|NCT00834041|mini-tablet formulation|mini-tablet formulation
549935|NCT00834028|hepatocellular carcinoma|hepatocellular carcinoma
549936|NCT00834028|vascular endothelial growth factor|vascular endothelial growth factor
549937|NCT00834028|angiopoietin|angiopoietin
549938|NCT00834028|cathepsin|cathepsin
549939|NCT00834015|spinal fusion|spinal fusion
549940|NCT00834015|pain|pain
549941|NCT00834015|disability|disability
549942|NCT00834015|muscle strength|muscle strength
549943|NCT00834015|mobility|mobility
549944|NCT00834015|quality of life|quality of life
549945|NCT00834015|lumbar|lumbar
549946|NCT00834015|isthmic or degenerative spondylolisthesis|isthmic or degenerative spondylolisthesis
549947|NCT00834002|AML in remission|aml in remission
549948|NCT00833950|Tinnitus|tinnitus
549949|NCT00833950|Phase Out|phase out
549950|NCT00833937|Bioequivalence|bioequivalence
549951|NCT00833937|Healthy Subjects|healthy subjects
549952|NCT00833924|Low Profile|low profile
549953|NCT00833924|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
549954|NCT00833924|Endovascular|endovascular
549955|NCT00833911|Moderate to severe symptomatic osteoarthritis of the knee|moderate to severe symptomatic osteoarthritis of the knee
549956|NCT00833898|depression|depression
549957|NCT00833898|stress|stress
549958|NCT00833898|caregiving|caregiving
549959|NCT00833898|anxiety|anxiety
549960|NCT00833898|psychoeducation intervention|psychoeducation intervention
549961|NCT00833898|psycho-oncology|psycho-oncology
549962|NCT00833885|Non pharmaceutical measures|non pharmaceutical measures
549963|NCT00833859|stereotactic radiosurgery|stereotactic radiosurgery
549964|NCT00833859|borderline resectable pancreatic cancer|borderline resectable pancreatic cancer
549965|NCT00833859|gastrointestinal|gastrointestinal
549966|NCT00833859|pancreas|pancreas
549967|NCT00833846|Mitochondria in Platelets|mitochondria in platelets
549968|NCT00833846|Mitochondria in Diabetes|mitochondria in diabetes
549969|NCT00833846|Insulin Resistance and Mitochondria|insulin resistance and mitochondria
549970|NCT00833846|Diabetes|diabetes
549971|NCT00833846|Insulin Resistance|insulin resistance
549973|NCT00833820|transcranial brain stimulation|transcranial brain stimulation
549974|NCT00833807|Melanoma|melanoma
549975|NCT00833807|Metastatic Melanoma to the Liver|metastatic melanoma to the liver
549976|NCT00833807|Liver metastasis|liver metastasis
549977|NCT00833807|Nab-paclitaxel|nab-paclitaxel
549978|NCT00833807|Abraxane|abraxane
549979|NCT00833807|Paclitaxel (protein-bound)|paclitaxel (protein-bound)
549980|NCT00833807|intraarterial intrahepatic administration|intraarterial intrahepatic administration
549981|NCT00833807|Hepatic Artery|hepatic artery
549982|NCT00833807|Hepatic Arterial Infusion|hepatic arterial infusion
549983|NCT00833807|Hepatic Administration|hepatic administration
549984|NCT00833781|HIV vaccine|hiv vaccine
549985|NCT00833781|Dendritic cells|dendritic cells
549986|NCT00833781|treatment experienced|treatment experienced
549987|NCT00833755|Pain|pain
549988|NCT00833755|Chronic pain|chronic pain
549989|NCT00833755|Opioid induced hyperalgesia|opioid induced hyperalgesia
549990|NCT00833755|Opioid therapy|opioid therapy
549991|NCT00833742|somatization|somatization
549992|NCT00833742|psychosomatic|psychosomatic
549993|NCT00833742|short-term|short-term
549994|NCT00833742|dynamic|dynamic
549995|NCT00833742|psychotherapy|psychotherapy
549996|NCT00833729|psoriasis|psoriasis
549997|NCT00833729|etanercept|etanercept
549998|NCT00833729|adalimumab|adalimumab
549999|NCT00833729|moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
550000|NCT00833703|cyanotic congenital heart disease|cyanotic congenital heart disease
550001|NCT00833703|shunt palliation|shunt palliation
550002|NCT00833703|thrombosis|thrombosis
550003|NCT00833703|clopidogrel|clopidogrel
550004|NCT00833690|Parkinson's disease|parkinson's disease
550005|NCT00833690|Parkinson disease|parkinson disease
550006|NCT00833690|PD|pd
550007|NCT00833690|inosine|inosine
550008|NCT00833690|urate|urate
550009|NCT00833690|uric acid|uric acid
550010|NCT00833690|cerebrospinal fluid|cerebrospinal fluid
550011|NCT00833677|Coping skills|coping skills
550012|NCT00833677|Chinese|chinese
550013|NCT00833677|Immigrant|immigrant
550014|NCT00833677|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
550015|NCT00833677|Family research|family research
550016|NCT00833664|Bioequivalence|bioequivalence
550017|NCT00833664|Healthy Subjects|healthy subjects
550018|NCT00833651|Transplant|transplant
550019|NCT00833651|Immunology|immunology
550020|NCT00833651|Immunosuppression|immunosuppression
550021|NCT00833638|Erectile Dysfunction|erectile dysfunction
550022|NCT00833625|Gastrointestinal|gastrointestinal
550023|NCT00833625|Esophagus|esophagus
550024|NCT00833625|Cancer of the esophagus|cancer of the esophagus
550025|NCT00833625|Biopsy|biopsy
550026|NCT00833625|EGD|egd
550027|NCT00833625|Esophagogastroduodenoscopy|esophagogastroduodenoscopy
550028|NCT00833625|PET/CT|pet/ct
550029|NCT00833625|Positive Emission Tomography/Computerized Tomography|positive emission tomography/computerized tomography
550030|NCT00833625|Esophageal Cancer|esophageal cancer
550031|NCT00833625|Chemoradiation|chemoradiation
550032|NCT00833625|Chemotherapy|chemotherapy
550033|NCT00833625|Radiation Therapy|radiation therapy
550034|NCT00833612|IABC|iabc
550035|NCT00833612|AMI|ami
550036|NCT00833599|Lymphedema|lymphedema
550038|NCT00833599|Lymphatic Disorder|lymphatic disorder
550039|NCT00833599|Lipedema|lipedema
550040|NCT00833599|Vascular Malformation|vascular malformation
550041|NCT00833599|Vascular Anomaly|vascular anomaly
550042|NCT00833599|Dercum Disease|dercum disease
550043|NCT00833586|Bioequivalence|bioequivalence
550044|NCT00833586|Healthy Subjects|healthy subjects
550045|NCT00833573|GERD digestive expression|gerd digestive expression
550046|NCT00833573|ages|ages
550047|NCT00833560|Multiple Myeloma|multiple myeloma
550048|NCT00833560|Untreated multiple myeloma|untreated multiple myeloma
550049|NCT00833560|Bortezomib|bortezomib
550050|NCT00833560|VELCADE|velcade
550051|NCT00833560|Cyclophosphamide|cyclophosphamide
550052|NCT00833560|Dexamethasone|dexamethasone
550053|NCT00833560|Chemotherapy|chemotherapy
550054|NCT00833560|Remission therapy|remission therapy
550055|NCT00833560|Induction therapy|induction therapy
550056|NCT00833560|Stem Cell Transplantation|stem cell transplantation
550057|NCT00833547|sleep|sleep
550058|NCT00833547|schizophrenia|schizophrenia
550059|NCT00833547|procedural learning|procedural learning
550060|NCT00833547|motor skill|motor skill
550061|NCT00833534|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
550062|NCT00833534|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
550063|NCT00833534|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
550064|NCT00833534|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
550065|NCT00833534|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
550066|NCT00833534|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
550067|NCT00833534|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
550068|NCT00833534|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
550069|NCT00833534|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
550070|NCT00833521|Bioequivalence|bioequivalence
550071|NCT00833521|Healthy Subjects|healthy subjects
550072|NCT00833508|Exercise capacity|exercise capacity
550073|NCT00833508|Chemoradiotherapy|chemoradiotherapy
550074|NCT00833508|Colorectal cancer|colorectal cancer
550075|NCT00833469|women|women
550076|NCT00833469|postpartum depression|postpartum depression
550077|NCT00833469|anxiety|anxiety
550078|NCT00833456|schizophrenia|schizophrenia
550079|NCT00833456|Seroquel SR|seroquel sr
550080|NCT00833456|atypical antipsychotics|atypical antipsychotics
550081|NCT00833456|assessment of functioning|assessment of functioning
550082|NCT00833456|GAF scale|gaf scale
550083|NCT00833443|Methamphetamine|methamphetamine
550084|NCT00833443|Addiction|addiction
550085|NCT00833443|Pharmacogenomics|pharmacogenomics
550086|NCT00833443|Amphetamine|amphetamine
550087|NCT00833443|Bupropion|bupropion
550088|NCT00833443|Meth|meth
550089|NCT00833443|Crank|crank
550090|NCT00833443|Crystal|crystal
550091|NCT00833430|AVN|avn
550092|NCT00833430|Femoral Head Collapse|femoral head collapse
550093|NCT00833417|BCC|bcc
550094|NCT00833417|Hedgehog Pathway Inhibitor|hedgehog pathway inhibitor
550095|NCT00833417|Hedgehog|hedgehog
550096|NCT00833417|Basal Cell Cancer|basal cell cancer
550097|NCT00833404|Smoking|smoking
550098|NCT00833404|Smoking Cessation|smoking cessation
550099|NCT00833404|Quit Smoking|quit smoking
550100|NCT00833404|Stop Smoking|stop smoking
550101|NCT00833404|Nicotine Patch|nicotine patch
550102|NCT00833404|Nicotine Replacement Therapy|nicotine replacement therapy
550103|NCT00833404|Sexual Functioning|sexual functioning
550104|NCT00833404|Erectile Functioning|erectile functioning
550105|NCT00833404|Sexual Health|sexual health
550106|NCT00833391|healthy volunteer|healthy volunteer
550107|NCT00833391|formulations|formulations
550108|NCT00833391|bioavailability|bioavailability
550109|NCT00833391|pharmacokinetics|pharmacokinetics
550110|NCT00833378|Drug interaction, SB-497115 (eltrombopag), Kaletra (Lopinavir, Ritonavir),thrombocytopenia, pharmacokinetics|drug interaction, sb-497115 (eltrombopag), kaletra (lopinavir, ritonavir),thrombocytopenia, pharmacokinetics
550111|NCT00833365|premature infants|premature infants
550112|NCT00833365|PDA|pda
550113|NCT00833365|ibuprofen|ibuprofen
550114|NCT00833313|Atrial fibrillation|atrial fibrillation
550115|NCT00833313|Gene expression|gene expression
550116|NCT00833313|Genetic|genetic
550117|NCT00833300|Delirium|delirium
550118|NCT00833300|Agitation|agitation
550119|NCT00833300|Intensive Care|intensive care
550120|NCT00833300|Critical Care|critical care
550121|NCT00833300|Antipsychotics|antipsychotics
550122|NCT00833300|Olanzapine|olanzapine
550123|NCT00833300|Haloperidol|haloperidol
550124|NCT00833287|immunoregulatory|immunoregulatory
550125|NCT00833287|dysfunction|dysfunction
550126|NCT00833287|obesity|obesity
550127|NCT00833261|recurrent hypopharynx Cancer|recurrent hypopharynx cancer
550128|NCT00833261|recurrent larynx Cancer|recurrent larynx cancer
550129|NCT00833261|recurrent verrucous carcinoma|recurrent verrucous carcinoma
550130|NCT00833261|squamous cell carcinoma|squamous cell carcinoma
550131|NCT00833261|recurrent oral cavity cancer|recurrent oral cavity cancer
550132|NCT00833261|recurrent metastatic occult primary cancer|recurrent metastatic occult primary cancer
550426|NCT00832026|sleep apnea|sleep apnea
550133|NCT00833261|recurrent oropharynx cacner|recurrent oropharynx cacner
550134|NCT00833261|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
550135|NCT00833261|tongue cancer|tongue cancer
550136|NCT00833222|premature birth|premature birth
550137|NCT00833209|Orbitofrontal cortex|orbitofrontal cortex
550138|NCT00833209|Medication Overuse Headache|medication overuse headache
550139|NCT00833209|Chronic headache|chronic headache
550140|NCT00833209|withdrawal|withdrawal
550141|NCT00833170|pediatric inflammatory bowel disease|pediatric inflammatory bowel disease
550142|NCT00833170|multiple site study|multiple site study
550143|NCT00833157|Knee Osteoarthritis|knee osteoarthritis
550144|NCT00833157|exercise|exercise
550145|NCT00833157|strength training|strength training
550146|NCT00833157|Glucosamine|glucosamine
550147|NCT00833157|Dietary supplement|dietary supplement
550148|NCT00833157|Ibuprofen|ibuprofen
550149|NCT00833157|NSAID|nsaid
550150|NCT00833144|heart failure|heart failure
550151|NCT00833144|dyspnea|dyspnea
550152|NCT00833144|ultrasound|ultrasound
550153|NCT00833131|Rectal cancer|rectal cancer
550154|NCT00833131|Preoperative radiotherapy and consolidating chemotherapy|preoperative radiotherapy and consolidating chemotherapy
550155|NCT00833118|Surgery|surgery
550156|NCT00833118|General Anesthesia|general anesthesia
550157|NCT00833118|Intubation|intubation
550158|NCT00833105|Incomplete Spinal Cord Injury|incomplete spinal cord injury
550159|NCT00833105|Rehabilitation|rehabilitation
550160|NCT00833105|Upper Extremity|upper extremity
550161|NCT00833105|AMES device|ames device
550162|NCT00833105|Incomplete SCI|incomplete sci
550163|NCT00833105|Quadriplegia|quadriplegia
550164|NCT00833092|magnesium|magnesium
550165|NCT00833092|Nutritional Requirements|nutritional requirements
550166|NCT00833092|Sleep|sleep
550167|NCT00833079|Atopic Dermatitis|atopic dermatitis
550168|NCT00833066|hay fever|hay fever
550169|NCT00833066|grass pollen allergy|grass pollen allergy
550170|NCT00833040|Cancer breakthrough pain|cancer breakthrough pain
550171|NCT00833001|Anterior vaginal prolapse (medial, lateral,apical cystocele)|anterior vaginal prolapse (medial, lateral,apical cystocele)
550172|NCT00833001|Posterior vaginal prolapse (rectocele and/or enterocele)|posterior vaginal prolapse (rectocele and/or enterocele)
550173|NCT00833001|Vault prolapse (enterocele, uterine/vaginal vault prolapse)|vault prolapse (enterocele, uterine/vaginal vault prolapse)
550174|NCT00832988|pacing thresholds|pacing thresholds
550175|NCT00832988|sensing|sensing
550176|NCT00832988|impedance|impedance
550177|NCT00832962|Rhesus D|rhesus d
550178|NCT00832962|Anti-D allo-immunization|anti-d allo-immunization
550179|NCT00832962|Fetal RHD genotyping|fetal rhd genotyping
550180|NCT00832962|anti-D immunoglobulins|anti-d immunoglobulins
550181|NCT00832962|anti-D prophylaxis|anti-d prophylaxis
550182|NCT00832949|Mixed methods research (qualitative and quantitative)|mixed methods research (qualitative and quantitative)
550183|NCT00832949|Peer support|peer support
550184|NCT00832949|Early inflammatory arthritis|early inflammatory arthritis
550185|NCT00832949|Self-management|self-management
550186|NCT00832949|Patient education|patient education
550187|NCT00832923|parental empowerment|parental empowerment
550188|NCT00832923|parent self-efficacy|parent self-efficacy
550189|NCT00832910|Body image|body image
550190|NCT00832910|Rheumatoid Arthritis|rheumatoid arthritis
550191|NCT00832897|Keratoconus|keratoconus
550192|NCT00832897|riboflavin|riboflavin
550193|NCT00832897|cornea|cornea
550194|NCT00832897|crosslinking|crosslinking
550195|NCT00832884|partial|partial
550196|NCT00832884|onset|onset
550197|NCT00832884|epilepsy|epilepsy
550198|NCT00832884|pediatric|pediatric
550199|NCT00832884|lacosamide|lacosamide
550200|NCT00832884|partial onset epilepsy|partial onset epilepsy
550201|NCT00832884|vimpat|vimpat
550202|NCT00832871|Mifepristone|mifepristone
550203|NCT00832871|RU-486|ru-486
550204|NCT00832871|Compassionate Use|compassionate use
550205|NCT00832871|Antiprogesterone|antiprogesterone
550206|NCT00832845|Late-life schizophrenia (LLS)|late-life schizophrenia (lls)
550207|NCT00832845|Cognitive Behavioural Social Skills Training (CBSST)|cognitive behavioural social skills training (cbsst)
550208|NCT00832845|Randomized|randomized
550209|NCT00832832|Glaucoma|glaucoma
550210|NCT00832832|Eye drop|eye drop
550211|NCT00832832|Intraocular pressure|intraocular pressure
550212|NCT00832832|Eyelid closure|eyelid closure
550213|NCT00832819|Cancer|cancer
550214|NCT00832819|Lung Cancer|lung cancer
550215|NCT00832806|smoking|smoking
550216|NCT00832806|Champix|champix
550217|NCT00832806|Integrated Voice Response technology|integrated voice response technology
550218|NCT00832793|Mixed methods research (qualitative and quantitative)|mixed methods research (qualitative and quantitative)
550219|NCT00832793|Peer support|peer support
550220|NCT00832793|Early inflammatory arthritis|early inflammatory arthritis
550221|NCT00832793|Self-management|self-management
550222|NCT00832793|Patient education|patient education
550223|NCT00832780|Lung cancer|lung cancer
550224|NCT00832780|radiation therapy|radiation therapy
550225|NCT00832780|SBRT|sbrt
550226|NCT00832780|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
550227|NCT00832780|Tomotherapy|tomotherapy
550228|NCT00832780|other solid tumors|other solid tumors
550229|NCT00832767|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
550230|NCT00832767|Single Incision Laparoscopic Surgery|single incision laparoscopic surgery
550231|NCT00832767|Surgical Procedures, Minimally Invasive|surgical procedures, minimally invasive
550232|NCT00832754|malaria|malaria
550233|NCT00832754|rapid diagnostic test|rapid diagnostic test
550234|NCT00832754|artemisinin|artemisinin
550235|NCT00832754|Ghana|ghana
550236|NCT00832741|GLP-1|glp-1
550237|NCT00832741|Type 1 diabetes|type 1 diabetes
550238|NCT00832741|Glycemic control|glycemic control
550239|NCT00832741|Incretin hormone|incretin hormone
550240|NCT00832715|Lung|lung
550241|NCT00832715|Lung Cancer|lung cancer
550242|NCT00832715|NSCLC|nsclc
550243|NCT00832715|Non Small Cell Lung Cancer|non small cell lung cancer
550244|NCT00832715|Squamous Cell|squamous cell
550245|NCT00832715|Adenocarcinoma|adenocarcinoma
550246|NCT00832715|Large Cell|large cell
550247|NCT00832715|Endobronchial Ultrasound Transbronchial Needle Aspiration|endobronchial ultrasound transbronchial needle aspiration
550248|NCT00832715|Mediastinal lymph node negative disease|mediastinal lymph node negative disease
550249|NCT00832715|Mediastinal Nodal Metastasis|mediastinal nodal metastasis
550250|NCT00832715|EBUS-FNA|ebus-fna
550251|NCT00832715|Endobronchial Ultrasound Fine Needle Aspiration|endobronchial ultrasound fine needle aspiration
550252|NCT00832715|EBUS guided needle mediastinal lymph node biopsy|ebus guided needle mediastinal lymph node biopsy
550253|NCT00832715|Biopsy|biopsy
550254|NCT00832715|PET scan|pet scan
550255|NCT00832715|Positron Emission Tomography|positron emission tomography
550256|NCT00832715|CT Scans|ct scans
550257|NCT00832715|Computed Tomography Scans|computed tomography scans
550258|NCT00832715|Lymph node|lymph node
550259|NCT00832715|Mediastinoscopy|mediastinoscopy
550260|NCT00832715|Bronchoscope|bronchoscope
550261|NCT00832702|Cardiac|cardiac
550262|NCT00832702|MRI|mri
550263|NCT00832702|Coronary Vascular Dysfunction|coronary vascular dysfunction
550264|NCT00832689|toxicity|toxicity
550265|NCT00832676|Mixed methods research (qualitative and quantitative)|mixed methods research (qualitative and quantitative)
550266|NCT00832676|Peer support|peer support
550267|NCT00832676|Early inflammatory arthritis|early inflammatory arthritis
550268|NCT00832676|Self-management|self-management
550269|NCT00832676|Patient education|patient education
550270|NCT00832663|Muscle regeneration|muscle regeneration
550271|NCT00832663|Satellite cells|satellite cells
550272|NCT00832663|electrical stimulation|electrical stimulation
550273|NCT00832663|eccentric contractions|eccentric contractions
550274|NCT00832663|myogenic precursor cells|myogenic precursor cells
550275|NCT00832650|Healthy; Fesoterodine; Solifenacin|healthy; fesoterodine; solifenacin
550276|NCT00832637|Liver|liver
550277|NCT00832637|Gallbladder|gallbladder
550278|NCT00832637|Bile duct|bile duct
550279|NCT00832637|Gemzar|gemzar
550280|NCT00832637|Eloxatin|eloxatin
550281|NCT00832637|Tarceva|tarceva
550282|NCT00832637|erlotinib|erlotinib
550283|NCT00832637|Gem-ox|gem-ox
550284|NCT00832611|Lung Disease|lung disease
550285|NCT00832611|Chronic Airflow Obstruction|chronic airflow obstruction
550286|NCT00832611|Chronic Bronchitis|chronic bronchitis
550287|NCT00832611|Chronic Emphysema|chronic emphysema
550288|NCT00832598|18F-FACBC|18f-facbc
550289|NCT00832598|PET scan imaging|pet scan imaging
550290|NCT00832598|08-142|08-142
550291|NCT00832585|Atopic|atopic
550292|NCT00832585|Dermatitis|dermatitis
550293|NCT00832585|chronic|chronic
550294|NCT00832585|skin|skin
550295|NCT00832572|Coronary Artery Disease|coronary artery disease
550296|NCT00832572|Pain|pain
550297|NCT00832572|Peripheral Neuropathy|peripheral neuropathy
550298|NCT00832572|Polyneuropathy|polyneuropathy
550299|NCT00832559|CAVATAK|cavatak
550300|NCT00832559|Coxsackievirus A21|coxsackievirus a21
550301|NCT00832559|CVA21|cva21
550302|NCT00832559|Oncolytic virotherapy|oncolytic virotherapy
550303|NCT00832533|Vitamin D|vitamin d
550304|NCT00832533|Serum 25-Hydroxyvitamin D|serum 25-hydroxyvitamin d
550305|NCT00832533|UV exposure|uv exposure
550306|NCT00832533|Ultraviolet Light Exposure|ultraviolet light exposure
550307|NCT00832533|Skin Melanoma Advanced|skin melanoma advanced
550308|NCT00832520|Advanced cancer|advanced cancer
550309|NCT00832520|weight loss|weight loss
550310|NCT00832520|Remeron|remeron
550311|NCT00832520|body weight|body weight
550312|NCT00832507|PAH|pah
550313|NCT00832507|pulmonary hypertension|pulmonary hypertension
550314|NCT00832507|cicletanine|cicletanine
550315|NCT00832507|cicletanine HCL|cicletanine hcl
550316|NCT00832507|cardiovascular|cardiovascular
550317|NCT00832507|endothelin receptor antagonist|endothelin receptor antagonist
550318|NCT00832507|ERA|era
550319|NCT00832507|monotherapy|monotherapy
550320|NCT00832507|combination therapy|combination therapy
550321|NCT00832507|phosphodiesterase type-5 inhibitor|phosphodiesterase type-5 inhibitor
550322|NCT00832507|PDE5i|pde5i
550323|NCT00832507|parenteral prostanoid|parenteral prostanoid
550324|NCT00832507|PH|ph
550325|NCT00832507|pulmonary|pulmonary
550326|NCT00832481|Repaglinide|repaglinide
550327|NCT00832481|Metformin|metformin
550328|NCT00832468|insomnia|insomnia
550329|NCT00832468|ear acupressure|ear acupressure
550330|NCT00832442|Beta blocker|beta blocker
550331|NCT00832442|Heart Failure|heart failure
550332|NCT00832442|Meta analysis|meta analysis
550333|NCT00832442|Individual patient data|individual patient data
550334|NCT00832429|Sebaceous Gland Carcinoma of the Eyelid|sebaceous gland carcinoma of the eyelid
550335|NCT00832429|Eyelid Sebaceous Gland Carcinoma|eyelid sebaceous gland carcinoma
550336|NCT00832429|Cancer of the eyelid|cancer of the eyelid
550337|NCT00832429|Eye Cancer|eye cancer
550338|NCT00832429|Tumors of the Eye|tumors of the eye
550339|NCT00832429|Sentinel Lymph Node Localization and Biopsy|sentinel lymph node localization and biopsy
550340|NCT00832429|SLN|sln
550341|NCT00832429|Metastatic Disease|metastatic disease
550342|NCT00832429|Metastatic Cancer of the Eyelid|metastatic cancer of the eyelid
550343|NCT00832429|Lymphatic Mapping|lymphatic mapping
550344|NCT00832429|SLN Mapping/Biopsy|sln mapping/biopsy
550345|NCT00832429|SLN Biopsy Procedure|sln biopsy procedure
550346|NCT00832429|SLN Biopsy|sln biopsy
550347|NCT00832429|Lymph Nodes|lymph nodes
550348|NCT00832429|Tc99m-Sulfur Colloid|tc99m-sulfur colloid
550349|NCT00832429|Single Photon Emission Computed Tomography|single photon emission computed tomography
550350|NCT00832429|Computed Tomography|computed tomography
550351|NCT00832429|SPECT/CT|spect/ct
550352|NCT00832403|atrophic rhinitis|atrophic rhinitis
550353|NCT00832403|implants|implants
550354|NCT00832403|Polytetrafluoroethylene|polytetrafluoroethylene
550355|NCT00832364|Psoriasis|psoriasis
550356|NCT00832364|Moderate to Severe Plaque Psoriasis|moderate to severe plaque psoriasis
550357|NCT00832351|Stroke|stroke
550358|NCT00832351|Brain infarction|brain infarction
550359|NCT00832351|Intracerebral hemorrhage|intracerebral hemorrhage
550360|NCT00832351|Early Mobilisation|early mobilisation
550361|NCT00832338|Breast cancer|breast cancer
550362|NCT00832338|Tumors, Breast|tumors, breast
550363|NCT00832338|Cancer of the breast|cancer of the breast
550364|NCT00832325|Childhood Survivor|childhood survivor
550365|NCT00832325|survivors|survivors
550366|NCT00832325|Young Adult Cancer Survivors|young adult cancer survivors
550367|NCT00832325|Childhood cancers|childhood cancers
550368|NCT00832325|09-001|09-001
550369|NCT00832312|Osteoarthritis|osteoarthritis
550370|NCT00832312|Knee|knee
550371|NCT00832312|Pain management|pain management
550372|NCT00832312|Ozone therapy|ozone therapy
550373|NCT00832312|Intraarticular injection|intraarticular injection
550374|NCT00832286|genomic techniques,intestinal microbiome|genomic techniques,intestinal microbiome
550375|NCT00832273|Expanded access to ELAD® in patients with liver failure|expanded access to elad® in patients with liver failure
550376|NCT00832247|Hepatitis C|hepatitis c
550377|NCT00832247|Cirrhosis|cirrhosis
550378|NCT00832247|Stem cell|stem cell
550379|NCT00832234|Morbus Waldenstrom|morbus waldenstrom
550380|NCT00832234|Waldenstroms Macroglobulinemia|waldenstroms macroglobulinemia
550381|NCT00832234|Therapy|therapy
550382|NCT00832234|Rituximab|rituximab
550383|NCT00832234|Dexamethasone|dexamethasone
550384|NCT00832234|Bortezomib|bortezomib
550385|NCT00832221|PET|pet
550386|NCT00832221|Phase 1|phase 1
550387|NCT00832221|Depression|depression
550388|NCT00832221|SEROQUEL|seroquel
550389|NCT00832221|Positron Emission Tomography|positron emission tomography
550390|NCT00832221|Drug profile comparison|drug profile comparison
550391|NCT00832195|running|running
550392|NCT00832195|injury|injury
550393|NCT00832195|pronation|pronation
550394|NCT00832195|footwear.|footwear.
550395|NCT00832169|Pain|pain
550396|NCT00832156|Burns|burns
550397|NCT00832156|Cultured autologous keratinocytes|cultured autologous keratinocytes
550398|NCT00832156|Wound healing|wound healing
550399|NCT00832156|Wound closure|wound closure
550400|NCT00832156|Scar quality|scar quality
550401|NCT00832143|neonatal illness|neonatal illness
550402|NCT00832143|qualified care seeking|qualified care seeking
550403|NCT00832143|Behaviour change|behaviour change
550404|NCT00832143|Urban slums|urban slums
550405|NCT00832143|India|india
550406|NCT00832143|Neonatal morbidity|neonatal morbidity
550407|NCT00832143|Care seeking for neonatal illnesses|care seeking for neonatal illnesses
550408|NCT00832143|Qualified medical care seeking|qualified medical care seeking
550409|NCT00832143|Integrated management of neonatal and childhood illnesses (IMNCI)|integrated management of neonatal and childhood illnesses (imnci)
550410|NCT00832117|Lung Cancer (NSCLC)|lung cancer (nsclc)
550411|NCT00832091|Venous Stasis Ulcers|venous stasis ulcers
550412|NCT00832091|venous insufficiency|venous insufficiency
550413|NCT00832091|leg ulcers|leg ulcers
550414|NCT00832091|Thymosin Beta 4|thymosin beta 4
550415|NCT00832091|Laminin-5|laminin-5
550416|NCT00832065|Sleep Apnea Syndrome|sleep apnea syndrome
550417|NCT00832065|Sleep Apnea|sleep apnea
550418|NCT00832065|CPAP|cpap
550419|NCT00832065|Low testosterone|low testosterone
550420|NCT00832065|Sexual Dysfunction|sexual dysfunction
550421|NCT00832052|elderly, multi-dose, safety, efficacy|elderly, multi-dose, safety, efficacy
550422|NCT00832039|sepsis|sepsis
550423|NCT00832039|adjunctive therapy|adjunctive therapy
550424|NCT00832039|sodium-selenite|sodium-selenite
550425|NCT00832039|procalcitonin|procalcitonin
550427|NCT00832026|snoring|snoring
550428|NCT00832026|sleep apnea treatment|sleep apnea treatment
550429|NCT00832026|TNI|tni
550430|NCT00832026|Trans nasal insuflation|trans nasal insuflation
550431|NCT00832026|Open CPAP|open cpap
550432|NCT00832013|Propofol|propofol
550433|NCT00832013|sedation|sedation
550434|NCT00832013|pediatric|pediatric
550435|NCT00832013|Induction of sedation|induction of sedation
550436|NCT00831987|Fluzone®|fluzone®
550437|NCT00831987|Influenza|influenza
550438|NCT00831987|Adults|adults
550439|NCT00831974|mastocytosis|mastocytosis
550440|NCT00831974|indolent|indolent
550441|NCT00831974|handicap|handicap
550442|NCT00831974|wild-type|wild-type
550443|NCT00831974|systemic|systemic
550444|NCT00831974|not D816V mutated|not d816v mutated
550445|NCT00831961|Antibiotic resistance, Conjunctival flora, Intravitreal injections|antibiotic resistance, conjunctival flora, intravitreal injections
550446|NCT00831935|Acoustic properties of voice in depression|acoustic properties of voice in depression
550447|NCT00831922|Rheumatoid Arthritis|rheumatoid arthritis
550448|NCT00831922|DMARD failure|dmard failure
550449|NCT00831922|ACR|acr
550450|NCT00831909|Lung Cancer|lung cancer
550451|NCT00831909|NSCLC management|nsclc management
550452|NCT00831909|NSCLC use of health care resources|nsclc use of health care resources
550453|NCT00831883|Adolescent|adolescent
550454|NCT00831883|Adolescent behavior|adolescent behavior
550455|NCT00831883|Health behavior|health behavior
550456|NCT00831883|Sexual Behavior|sexual behavior
550457|NCT00831883|Incarceration|incarceration
550458|NCT00831883|Behavioral Intervention|behavioral intervention
550459|NCT00831883|Risk Reduction Behavior|risk reduction behavior
550460|NCT00831870|EndoSure Sensor|endosure sensor
550461|NCT00831870|s2 Sensor|s2 sensor
550462|NCT00831870|abdominal aortic aneurysm|abdominal aortic aneurysm
550463|NCT00831831|perinatal|perinatal
550464|NCT00831831|intimate partner violence|intimate partner violence
550465|NCT00831831|randomized controlled trial|randomized controlled trial
550466|NCT00831831|preterm|preterm
550467|NCT00831831|hemorrhage|hemorrhage
550468|NCT00831831|safety|safety
550469|NCT00831818|breastfeeding|breastfeeding
550470|NCT00831818|ghrelin|ghrelin
550471|NCT00831818|PYY|pyy
550472|NCT00831818|appetite-regulation|appetite-regulation
550473|NCT00831805|geriatrics|geriatrics
550474|NCT00831805|psycho-cognitive troubles|psycho-cognitive troubles
550475|NCT00831805|elderly|elderly
550476|NCT00831805|mobile unit|mobile unit
550477|NCT00831805|elderly patients|elderly patients
550478|NCT00831792|Prostate Cancer|prostate cancer
550479|NCT00831792|Advanced Prostate Cancer|advanced prostate cancer
550480|NCT00831792|Castrate Resistant Prostate Cancer|castrate resistant prostate cancer
550481|NCT00831792|Prostate Specific Antigen|prostate specific antigen
550482|NCT00831792|PSA|psa
550483|NCT00831792|Castration-Resistant Prostate Cancer Patients|castration-resistant prostate cancer patients
550484|NCT00831792|TK1258|tk1258
550485|NCT00831792|CHIR-258|chir-258
550486|NCT00831766|Hematopoietic|hematopoietic
550487|NCT00831766|Myeloid and Monocytic Leukemia|myeloid and monocytic leukemia
550488|NCT00831766|AML|aml
550489|NCT00831753|Diphtheria|diphtheria
550490|NCT00831753|Tetanus|tetanus
550491|NCT00831753|Pertussis|pertussis
550492|NCT00831753|whooping cough|whooping cough
550493|NCT00831753|Haemophilus influenzae type b|haemophilus influenzae type b
550494|NCT00831753|Hepatitis B|hepatitis b
550495|NCT00831753|Poliomyelitis|poliomyelitis
550496|NCT00831740|Stroke|stroke
550497|NCT00831740|Communication|communication
550498|NCT00831740|Speech and Language Therapy|speech and language therapy
550499|NCT00831727|expressive writing|expressive writing
550500|NCT00831727|trauma|trauma
550501|NCT00831727|intervention|intervention
550502|NCT00831727|posttraumatic stress|posttraumatic stress
550503|NCT00831714|Prophylaxis of Venous Thromboembolism|prophylaxis of venous thromboembolism
550504|NCT00831701|Adrenergic alpha antagonists|adrenergic alpha antagonists
550505|NCT00831701|drug therapy|drug therapy
550506|NCT00831701|tamsulosin|tamsulosin
550507|NCT00831701|ureter|ureter
550508|NCT00831688|Meniere|meniere
550509|NCT00831688|vertigo|vertigo
550510|NCT00831688|overpressure treatment|overpressure treatment
550511|NCT00831688|caloric irrigation|caloric irrigation
550512|NCT00831688|hearing levels|hearing levels
550513|NCT00831688|vertigo severity|vertigo severity
550514|NCT00831688|functional disability scale|functional disability scale
550515|NCT00831675|Influenza|influenza
550516|NCT00831675|Fluzone® vaccine|fluzone® vaccine
550517|NCT00831675|Infants|infants
550518|NCT00831675|Toddlers|toddlers
550519|NCT00831636|CP-4055|cp-4055
550520|NCT00831636|Cancer|cancer
550521|NCT00831636|Metastatic|metastatic
550522|NCT00831636|Solid tumors|solid tumors
550523|NCT00831636|advanced ovarian cancer|advanced ovarian cancer
550524|NCT00831636|stage III and IV ovarian cancer|stage iii and iv ovarian cancer
550525|NCT00831636|advanced epithelian ovarian cancer|advanced epithelian ovarian cancer
550526|NCT00831623|hypofractionation|hypofractionation
550527|NCT00831623|proton beam radiation|proton beam radiation
550528|NCT00831610|bariatric surgery|bariatric surgery
550529|NCT00831610|plastic surgery|plastic surgery
550530|NCT00831610|abdominal wall|abdominal wall
550531|NCT00831610|skin|skin
550532|NCT00831610|sensation|sensation
550533|NCT00831610|abdominoplasty|abdominoplasty
550534|NCT00831597|Lymphoma|lymphoma
550535|NCT00831597|B-Cell|b-cell
550536|NCT00831571|oxaliplatin|oxaliplatin
550537|NCT00831571|hypersensitivity|hypersensitivity
550538|NCT00831532|Dimebon Hepatic Impairment|dimebon hepatic impairment
550539|NCT00831506|digoxin dimebon drug-drug interaction study|digoxin dimebon drug-drug interaction study
550540|NCT00831493|Pancreas|pancreas
550541|NCT00831493|Pancreatic Cancer|pancreatic cancer
550542|NCT00831493|Locally Advanced Pancreatic Cancer|locally advanced pancreatic cancer
550543|NCT00831493|LAPC|lapc
550544|NCT00831493|Non-Metastatic|non-metastatic
550545|NCT00831493|Unresectable|unresectable
550546|NCT00831493|Vorinostat|vorinostat
550547|NCT00831493|XRT|xrt
550548|NCT00831493|RT|rt
550549|NCT00831493|Radiation Therapy|radiation therapy
550550|NCT00831493|SAHA|saha
550551|NCT00831493|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
550552|NCT00831493|MSK-390|msk-390
550553|NCT00831480|Renal cell carcinoma|renal cell carcinoma
550554|NCT00831480|Everolimus|everolimus
550555|NCT00831480|Neoadjuvant|neoadjuvant
550556|NCT00831480|advanced kidney cancer|advanced kidney cancer
550557|NCT00831467|Hormonal refractory prostate cancer|hormonal refractory prostate cancer
550558|NCT00831467|RNA vaccine|rna vaccine
550559|NCT00831441|NOS|nos
550560|NCT00831428|asthma|asthma
550561|NCT00831428|rhinitis|rhinitis
550562|NCT00831428|swimmers|swimmers
550563|NCT00831428|mannitol|mannitol
550564|NCT00831415|Open-label Long-term extension study|open-label long-term extension study
550565|NCT00831402|woman|woman
550566|NCT00831376|Asthma|asthma
550567|NCT00831376|Genotype|genotype
550568|NCT00831376|Beta2adrenoreceptor|beta2adrenoreceptor
550569|NCT00831376|Levosalbutamol|levosalbutamol
550570|NCT00831363|gait analysis|gait analysis
550571|NCT00831363|minimal invasive approach|minimal invasive approach
550572|NCT00831363|transgluteal approach|transgluteal approach
550573|NCT00831363|THA|tha
550574|NCT00831350|RVO|rvo
550575|NCT00831350|PVD|pvd
550576|NCT00831337|VSL3|vsl3
550577|NCT00831337|Probiotics|probiotics
550578|NCT00831337|Gut microbiota|gut microbiota
550579|NCT00831337|Cytokines|cytokines
550580|NCT00831337|Portal hypertension|portal hypertension
550581|NCT00831337|Chemokines|chemokines
550582|NCT00831337|Liver cirrhosis|liver cirrhosis
550583|NCT00831311|Diphtheria|diphtheria
550584|NCT00831311|Tetanus|tetanus
550585|NCT00831311|Pertussis|pertussis
550586|NCT00831311|Whooping cough|whooping cough
550587|NCT00831311|Hepatitis B|hepatitis b
550588|NCT00831311|Poliomyelitis|poliomyelitis
550589|NCT00831311|Haemophilus influenzae type b|haemophilus influenzae type b
550590|NCT00831298|alzheimer disease|alzheimer disease
550591|NCT00831298|sleep disturbance|sleep disturbance
550592|NCT00831298|apathy|apathy
550593|NCT00831298|memory loss|memory loss
550594|NCT00831285|Healthy volunteers|healthy volunteers
550595|NCT00831259|stroke|stroke
550596|NCT00831259|PFO|pfo
550597|NCT00831259|embolism|embolism
550598|NCT00831246|Ileus,|ileus,
550599|NCT00831246|Gynecologic surgery,|gynecologic surgery,
550600|NCT00831246|Post-operative,|post-operative,
550601|NCT00831246|Flatus|flatus
550602|NCT00831220|COPD|copd
550603|NCT00831220|exacerbations|exacerbations
550604|NCT00831220|EPCs|epcs
550605|NCT00831220|Erythropoietin|erythropoietin
550606|NCT00831220|C-RP|c-rp
550607|NCT00831220|COPD and endothelial dysfunction|copd and endothelial dysfunction
550608|NCT00831207|B-2 microglobulin|b-2 microglobulin
550609|NCT00831207|Serum cytokines|serum cytokines
550610|NCT00831207|HIV-1|hiv-1
550611|NCT00831207|Resistance|resistance
550612|NCT00831207|HAART|haart
550613|NCT00831207|Therapeutic failure|therapeutic failure
550614|NCT00831207|Genotyping.|genotyping.
550615|NCT00831194|Type 2 Diabetes|type 2 diabetes
550616|NCT00831194|Obesity|obesity
550617|NCT00831194|Weight loss|weight loss
550618|NCT00831194|PDA|pda
550619|NCT00831194|Stress|stress
550620|NCT00831194|Dietary lapse|dietary lapse
550621|NCT00831194|salivary alpha amylase|salivary alpha amylase
550622|NCT00831181|stage II rectal cancer|stage ii rectal cancer
550623|NCT00831181|stage III rectal cancer|stage iii rectal cancer
550624|NCT00831181|adenocarcinoma of the rectum|adenocarcinoma of the rectum
550625|NCT00831168|neonatal|neonatal
550626|NCT00831168|premature babies|premature babies
550627|NCT00831168|healthcare research|healthcare research
550628|NCT00831168|Babies born before 27 weeks gestation|babies born before 27 weeks gestation
550629|NCT00831155|smoking|smoking
550630|NCT00831155|nicotine patches|nicotine patches
550631|NCT00831155|extinction based treatment|extinction based treatment
550632|NCT00831142|Prostate Cancer|prostate cancer
550633|NCT00831142|MRI|mri
550634|NCT00831142|Prostatectomy|prostatectomy
550635|NCT00831116|near infrared spectroscopy|near infrared spectroscopy
550636|NCT00831116|LipiScan|lipiscan
550637|NCT00831116|lipid core|lipid core
550638|NCT00831116|percutaneous coronary intervention|percutaneous coronary intervention
550639|NCT00831116|myocardial infarction|myocardial infarction
550640|NCT00831116|NIRS|nirs
550641|NCT00831116|intravascular imaging|intravascular imaging
550642|NCT00831103|EPB348|epb348
550643|NCT00831103|Valomaciclovir Stearate|valomaciclovir stearate
550644|NCT00831103|Valacyclovir|valacyclovir
550645|NCT00831103|Herpes Zoster|herpes zoster
550646|NCT00831103|Shingles|shingles
550647|NCT00831077|Healthy volunteers|healthy volunteers
550648|NCT00831064|bowel preparation quality|bowel preparation quality
550649|NCT00831064|colonoscopy|colonoscopy
550650|NCT00831051|Bunionectomy|bunionectomy
550651|NCT00831038|pulmonary function tests|pulmonary function tests
550652|NCT00831038|infants|infants
550653|NCT00831038|chronic lung disease|chronic lung disease
550654|NCT00831038|dysphagia|dysphagia
550655|NCT00831038|chronic aspiration|chronic aspiration
550656|NCT00831025|Immunotherapy|immunotherapy
550657|NCT00831025|Allergoid|allergoid
550658|NCT00831025|Depigmented|depigmented
550659|NCT00831025|Polymerized|polymerized
550660|NCT00831025|Allergen-extract|allergen-extract
550661|NCT00831025|Rhinoconjunctivitis|rhinoconjunctivitis
550662|NCT00831012|Dengue Vaccine|dengue vaccine
550663|NCT00831012|Dengue Virus|dengue virus
550664|NCT00831012|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
550665|NCT00831012|Dengue Shock Syndrome|dengue shock syndrome
550666|NCT00830999|fat metabolism|fat metabolism
550667|NCT00830999|exercise|exercise
550668|NCT00830999|liver|liver
550669|NCT00830999|lipoproteins|lipoproteins
550670|NCT00830999|triglycerides|triglycerides
550671|NCT00830986|Mental Cognition Change|mental cognition change
550672|NCT00830986|Fat Embolism|fat embolism
550673|NCT00830986|Bone Marrow Debris Emboli|bone marrow debris emboli
550674|NCT00830986|Computer Assisted Total Knee Arthroplasty|computer assisted total knee arthroplasty
550675|NCT00830986|Conventional Instrumented Total Knee Arthroplasty|conventional instrumented total knee arthroplasty
550676|NCT00830973|Estrogen Antagonists|estrogen antagonists
550677|NCT00830973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal
550678|NCT00830973|Hormone Antagonists|hormone antagonists
550679|NCT00830973|Hormones|hormones
550680|NCT00830973|Hormone Substitutes|hormone substitutes
550681|NCT00830973|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators
550682|NCT00830973|Estrogen Receptor Modulators|estrogen receptor modulators
550683|NCT00830973|Neoplasms|neoplasms
550684|NCT00830973|Neoplasms by Site|neoplasms by site
550685|NCT00830947|Orthodontic|orthodontic
550686|NCT00830947|Extraction|extraction
550687|NCT00830947|Device|device
550688|NCT00830947|Space Closure|space closure
550689|NCT00830947|Orthodontic malocclusion|orthodontic malocclusion
550690|NCT00830934|pelvic girdle pain|pelvic girdle pain
550691|NCT00830934|symphysio pubic dysfunction|symphysio pubic dysfunction
550692|NCT00830934|group care|group care
550693|NCT00830934|individual care|individual care
550694|NCT00830921|Histocytologically proven thoracic malignancy|histocytologically proven thoracic malignancy
550695|NCT00830908|seborrheic dermatitis|seborrheic dermatitis
550696|NCT00830895|Renal cell carcinoma|renal cell carcinoma
550697|NCT00830895|Non-clear cell|non-clear cell
550698|NCT00830895|RAD001|rad001
550699|NCT00830895|Metastatic, non-clear cell, renal cell carcinoma|metastatic, non-clear cell, renal cell carcinoma
550700|NCT00830882|asthma|asthma
550701|NCT00830882|levosalbutamol|levosalbutamol
550702|NCT00830882|genotype|genotype
550703|NCT00830882|bronchoprotection|bronchoprotection
550704|NCT00830856|Cryptococcal Meningitis|cryptococcal meningitis
550705|NCT00830856|HIV|hiv
550706|NCT00830856|Fluconazole|fluconazole
550707|NCT00830856|Antiretroviral therapy|antiretroviral therapy
550708|NCT00830856|Africa|africa
550709|NCT00830856|treatment naive|treatment naive
550710|NCT00830843|SAH|sah
550711|NCT00830843|sedation|sedation
550712|NCT00830843|anesthesia|anesthesia
550713|NCT00830817|Topical cream application|topical cream application
550714|NCT00830817|Mild to moderate psoriasis|mild to moderate psoriasis
550715|NCT00830804|Treatment Naive|treatment naive
550716|NCT00830778|pancreas|pancreas
550717|NCT00830778|surgery|surgery
550718|NCT00830778|cancer|cancer
550719|NCT00830778|pancreaticoduodenectomy (PD)|pancreaticoduodenectomy (pd)
550720|NCT00830778|peri-ampullary tumours (ampulla, duodenum, distal bile duct, and miscellaneous tumours)|peri-ampullary tumours (ampulla, duodenum, distal bile duct, and miscellaneous tumours)
550721|NCT00830778|pancreatic tumors|pancreatic tumors
550722|NCT00830778|peri-ampullary tumors|peri-ampullary tumors
550723|NCT00830752|alexithymia|alexithymia
550724|NCT00830739|Smoking Cessation|smoking cessation
550725|NCT00830739|Dopamine|dopamine
550726|NCT00830739|Cognitive Control|cognitive control
550727|NCT00830739|Reward Processing|reward processing
550728|NCT00830739|Varenicline|varenicline
550729|NCT00830726|Aquaporin|aquaporin
550730|NCT00830726|Epithelial Sodium Channels|epithelial sodium channels
550731|NCT00830726|Heart Failure|heart failure
550732|NCT00830726|Valvular heart disease|valvular heart disease
550733|NCT00830726|Ischemic heart disease|ischemic heart disease
550734|NCT00830713|vitiligo|vitiligo
550735|NCT00830713|skin transplantation|skin transplantation
550736|NCT00830713|non-cultured|non-cultured
550737|NCT00830713|melanocyte|melanocyte
550738|NCT00830713|surgery|surgery
550739|NCT00830700|ADHD|adhd
550740|NCT00830700|telemental health|telemental health
550741|NCT00830700|TMH|tmh
550742|NCT00830700|telepsychiatry|telepsychiatry
550743|NCT00830700|rural mental health services for children|rural mental health services for children
550744|NCT00830687|subcapital femoral fractures|subcapital femoral fractures
550745|NCT00830687|transcervical femoral fractures|transcervical femoral fractures
550746|NCT00830687|TARGON FN|targon fn
550747|NCT00830674|XLH|xlh
550748|NCT00830661|transsphincteric anal fistula|transsphincteric anal fistula
550749|NCT00830661|cryptoglandular origin|cryptoglandular origin
550750|NCT00830661|anal fistula repair|anal fistula repair
550751|NCT00830661|Ligation of Intersphincteric Fistula Track (LIFT) procedure|ligation of intersphincteric fistula track (lift) procedure
550752|NCT00830661|anal fistula plug (Plug)|anal fistula plug (plug)
550753|NCT00830661|surgical repair|surgical repair
550754|NCT00830648|varicella-zoster virus|varicella-zoster virus
550755|NCT00830648|varicella|varicella
550756|NCT00830635|long-term effects of cancer treatment|long-term effects of cancer treatment
550757|NCT00830635|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
550758|NCT00830635|depression|depression
550759|NCT00830635|stage IA breast cancer|stage ia breast cancer
550760|NCT00830635|stage IB breast cancer|stage ib breast cancer
550761|NCT00830635|stage II breast cancer|stage ii breast cancer
550762|NCT00830635|stage I prostate cancer|stage i prostate cancer
550763|NCT00830635|stage II prostate cancer|stage ii prostate cancer
550764|NCT00830622|HIV/AIDS|hiv/aids
550765|NCT00830622|Adherence|adherence
550766|NCT00830622|Antiretroviral Therapy, ART, ARV|antiretroviral therapy, art, arv
550767|NCT00830622|Mobile phone, cell phone, telephone|mobile phone, cell phone, telephone
550768|NCT00830622|Text message, SMS|text message, sms
550769|NCT00830622|Telemedicine|telemedicine
550770|NCT00830622|Africa|africa
550771|NCT00830622|Resource-limited setting|resource-limited setting
550772|NCT00830622|Counseling, support|counseling, support
550773|NCT00830622|treatment experienced|treatment experienced
550774|NCT00830609|Chronic Hepatitis C|chronic hepatitis c
550775|NCT00830609|Genotype 3|genotype 3
550776|NCT00830609|High viral load|high viral load
550777|NCT00830570|CYP2C9|cyp2c9
550778|NCT00830570|VKORC1|vkorc1
550779|NCT00830570|polymorphism|polymorphism
550780|NCT00830570|warfarin|warfarin
550781|NCT00830570|Coumadin|coumadin
550782|NCT00830557|recurrent pancreatic cancer|recurrent pancreatic cancer
550783|NCT00830557|stage I pancreatic cancer|stage i pancreatic cancer
550784|NCT00830557|stage II pancreatic cancer|stage ii pancreatic cancer
550785|NCT00830557|stage III pancreatic cancer|stage iii pancreatic cancer
550786|NCT00830557|stage IV pancreatic cancer|stage iv pancreatic cancer
550787|NCT00830557|recurrent islet cell carcinoma|recurrent islet cell carcinoma
550788|NCT00830557|pancreatic alpha cell carcinoma|pancreatic alpha cell carcinoma
550789|NCT00830557|pancreatic beta islet cell carcinoma|pancreatic beta islet cell carcinoma
550790|NCT00830557|pancreatic delta cell carcinoma|pancreatic delta cell carcinoma
550791|NCT00830557|pancreatic G-cell carcinoma|pancreatic g-cell carcinoma
550792|NCT00830544|neoadjuvant chemotherapy breast cancer|neoadjuvant chemotherapy breast cancer
550793|NCT00830544|Breast cancer patients with tumors over one cm|breast cancer patients with tumors over one cm
550794|NCT00830531|Hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
550795|NCT00830531|Neonatal stroke|neonatal stroke
550796|NCT00830531|Intracranial hemorrhage|intracranial hemorrhage
550797|NCT00830531|Perinatal asphyxia|perinatal asphyxia
550798|NCT00830531|Neonatal Seizures|neonatal seizures
550799|NCT00830518|Drug therapy|drug therapy
550800|NCT00830505|fluticasone|fluticasone
550801|NCT00830505|salmeterol|salmeterol
550802|NCT00830505|bronchoprotection|bronchoprotection
550803|NCT00830492|clomiphene citrate|clomiphene citrate
550804|NCT00830492|GnRH agonist|gnrh agonist
550805|NCT00830492|GnRH antagonist|gnrh antagonist
550806|NCT00830492|in vitro fertilization|in vitro fertilization
550807|NCT00830492|clinical pregnancy|clinical pregnancy
550808|NCT00830492|pregnancy|pregnancy
550809|NCT00830466|port wine stain|port wine stain
550810|NCT00830453|Brain injury with sequelae from stroke, anoxia, or trauma|brain injury with sequelae from stroke, anoxia, or trauma
550811|NCT00830427|asthma bronchial diseases|asthma bronchial diseases
550812|NCT00830414|Bioequivalence|bioequivalence
550813|NCT00830414|Healthy Subjects|healthy subjects
550814|NCT00830401|intra-uterine abnormalities|intra-uterine abnormalities
550815|NCT00830401|intracavitary pathology|intracavitary pathology
550816|NCT00830401|hysteroscopy|hysteroscopy
550817|NCT00830401|IVF|ivf
550818|NCT00830401|ICSI|icsi
550819|NCT00830401|polyp|polyp
550820|NCT00830401|myoma|myoma
550821|NCT00830401|adhesion|adhesion
550822|NCT00830401|septum|septum
550823|NCT00830401|endometritis|endometritis
550824|NCT00830388|tinea versicolor|tinea versicolor
550825|NCT00830388|ketoconazole|ketoconazole
550826|NCT00830375|Buying|buying
550827|NCT00830375|Shopping|shopping
550828|NCT00830375|Impulse Control|impulse control
550829|NCT00830362|cocaine|cocaine
550830|NCT00830362|cocaine-dependent|cocaine-dependent
550831|NCT00830362|propranolol|propranolol
550832|NCT00830362|craving|craving
550833|NCT00830362|beta-blockade|beta-blockade
550834|NCT00830362|cue exposure|cue exposure
550835|NCT00830362|drug|drug
550836|NCT00830362|addiction|addiction
550837|NCT00830362|memory|memory
550838|NCT00830362|addictive behavior|addictive behavior
550839|NCT00830349|Bioequivalence|bioequivalence
550840|NCT00830349|Healthy Subjects|healthy subjects
550841|NCT00830336|Bioequivalence|bioequivalence
550842|NCT00830336|Healthy Subjects|healthy subjects
550843|NCT00830310|Patient Non-Adherence|patient non-adherence
550844|NCT00830310|Patient Non-Compliance|patient non-compliance
550845|NCT00830310|Patient Nonadherence|patient nonadherence
550846|NCT00830310|Patient Noncompliance|patient noncompliance
550847|NCT00830310|Patient Refusal of Treatment|patient refusal of treatment
550848|NCT00830310|Refusal of Treatment|refusal of treatment
550849|NCT00830310|Treatment Refusal|treatment refusal
550850|NCT00830297|TIP|tip
550851|NCT00830297|NODAT|nodat
550852|NCT00830297|hyperglycemia|hyperglycemia
550853|NCT00830297|long-acting insulin|long-acting insulin
550854|NCT00830297|post-transplant hyperglycemia|post-transplant hyperglycemia
550855|NCT00830284|Pediatric Acute Respiratory Distress Syndrome (ARDS)|pediatric acute respiratory distress syndrome (ards)
550856|NCT00830284|Pediatric Acute Lung Injury (ALI)|pediatric acute lung injury (ali)
550857|NCT00830271|surgical site infection|surgical site infection
550858|NCT00830271|wound complications|wound complications
550859|NCT00830271|suture|suture
550860|NCT00830271|antiseptic|antiseptic
550861|NCT00830271|wound closure|wound closure
550862|NCT00830258|Bioequivalence|bioequivalence
550863|NCT00830258|Healthy Subjects|healthy subjects
550864|NCT00830245|EGFR mutation|egfr mutation
550865|NCT00830245|Erlotinib|erlotinib
550866|NCT00830245|Lung cancer|lung cancer
550867|NCT00830245|leptomeningeal carcinomatosis in EGFR mutation positive non-small cell lung cancer|leptomeningeal carcinomatosis in egfr mutation positive non-small cell lung cancer
550868|NCT00830232|Stroke|stroke
550869|NCT00830232|Carotid stenosis|carotid stenosis
550870|NCT00830232|stents|stents
550871|NCT00830219|Bioequivalence|bioequivalence
550872|NCT00830219|Healthy Subjects|healthy subjects
550873|NCT00830206|Bioequivalence|bioequivalence
550874|NCT00830206|Healthy Subjects|healthy subjects
550875|NCT00830193|N-acetylcysteine|n-acetylcysteine
550876|NCT00830193|prevention|prevention
550877|NCT00830193|contrast-induced nephropathy|contrast-induced nephropathy
550878|NCT00830193|critically ill adults|critically ill adults
550879|NCT00830180|Cancer pain|cancer pain
550880|NCT00830180|NGF|ngf
550881|NCT00830180|open-label extension|open-label extension
550882|NCT00830154|stutter|stutter
550883|NCT00830154|stuttering|stuttering
550884|NCT00830154|Adults with a history of stuttering|adults with a history of stuttering
550885|NCT00830141|Ghrelin|ghrelin
550886|NCT00830141|obesity|obesity
550887|NCT00830141|idiopathic short stature (ISS)|idiopathic short stature (iss)
550888|NCT00830115|PPI therapy|ppi therapy
550889|NCT00830115|Pantoprazole|pantoprazole
550890|NCT00830115|eGERD (Erosive Gastroesophageal Reflux Disease)|egerd (erosive gastroesophageal reflux disease)
550891|NCT00830115|NERD (Non-Erosive Reflux Disease)|nerd (non-erosive reflux disease)
550892|NCT00830102|Mild to Moderate Asthma|mild to moderate asthma
550893|NCT00830089|Transversus abdominis plane block|transversus abdominis plane block
550894|NCT00830089|Laparoscopic colorectal surgery|laparoscopic colorectal surgery
550895|NCT00830089|Analgesia|analgesia
550896|NCT00830063|monoclonal antibody|monoclonal antibody
550897|NCT00830063|RN624|rn624
550898|NCT00830063|PF-04383119|pf-04383119
550899|NCT00830063|nerve growth factor|nerve growth factor
550900|NCT00830063|anti-nerve growth factor|anti-nerve growth factor
550901|NCT00830063|OA|oa
550902|NCT00830063|pain|pain
550903|NCT00830050|fMRI functional magnetic resonance imaging Pain|fmri functional magnetic resonance imaging pain
550904|NCT00830037|anemia|anemia
550905|NCT00830037|iron|iron
550906|NCT00830037|kidney disease|kidney disease
550907|NCT00830037|progression|progression
550908|NCT00830037|glomerular filtration rate|glomerular filtration rate
550909|NCT00830024|Bioequivalence|bioequivalence
550910|NCT00830024|Healthy Subjects|healthy subjects
550911|NCT00830011|diabetes|diabetes
550912|NCT00830011|neuropathy|neuropathy
550913|NCT00830011|chronic pain|chronic pain
550914|NCT00830011|Cognitive behavioral therapy|cognitive behavioral therapy
550915|NCT00829998|Bioequivalence|bioequivalence
550916|NCT00829998|Healthy Subjects|healthy subjects
550917|NCT00829985|Rhinitis, Allergic, Perennial|rhinitis, allergic, perennial
550918|NCT00829985|Rhinitis, Allergic, Seasonal|rhinitis, allergic, seasonal
550919|NCT00829985|Immunotherapy|immunotherapy
550920|NCT00829985|Asthma|asthma
550921|NCT00829985|Nasal Allergies|nasal allergies
550922|NCT00829985|Hypersensitivity|hypersensitivity
550923|NCT00829959|Ovary, Cancer|ovary, cancer
550924|NCT00829959|Ovarian Cancer|ovarian cancer
550925|NCT00829959|Breast Cancer|breast cancer
551130|NCT00829114|ICH|ich
550926|NCT00829959|Hereditary Breast and Ovarian Cancer Syndrome|hereditary breast and ovarian cancer syndrome
550927|NCT00829959|HBOC|hboc
550928|NCT00829959|Genetic testing|genetic testing
550929|NCT00829959|Pregnancy|pregnancy
550930|NCT00829959|Fertility|fertility
550931|NCT00829959|Prenatal diagnostic testing|prenatal diagnostic testing
550932|NCT00829946|Strength training|strength training
550933|NCT00829946|Anorexia|anorexia
550934|NCT00829946|Girls|girls
550935|NCT00829946|Quality of life|quality of life
550936|NCT00829946|Functional mobility|functional mobility
550937|NCT00829933|Atrial fibrillation|atrial fibrillation
550938|NCT00829933|Factor Xa inhibition|factor xa inhibition
550939|NCT00829920|Bladder cancer|bladder cancer
550940|NCT00829907|Healthy volunteer study|healthy volunteer study
550941|NCT00829894|Bioequivalence|bioequivalence
550942|NCT00829894|Healthy Subjects|healthy subjects
550943|NCT00829881|Attention|attention
550944|NCT00829868|Bioequivalence|bioequivalence
550945|NCT00829868|Healthy Subjects|healthy subjects
550946|NCT00829855|pulmonary edema|pulmonary edema
550947|NCT00829855|hypertension|hypertension
550948|NCT00829855|echocardiography|echocardiography
550949|NCT00829842|chlorexidine|chlorexidine
550950|NCT00829842|ventilator-associated pneumonia|ventilator-associated pneumonia
550951|NCT00829842|nosocomial pneumonia|nosocomial pneumonia
550952|NCT00829842|heart surgery|heart surgery
550953|NCT00829842|oral hygiene|oral hygiene
550954|NCT00829829|Metabolism, Inborn Errors|metabolism, inborn errors
550955|NCT00829829|Allopurinol|allopurinol
550956|NCT00829829|Metabolic Diseases|metabolic diseases
550957|NCT00829829|Genetic Diseases, Inborn|genetic diseases, inborn
550958|NCT00829829|Musculoskeletal Diseases|musculoskeletal diseases
550959|NCT00829829|Joint Diseases|joint diseases
550960|NCT00829829|Arthritis|arthritis
550961|NCT00829829|Rheumatic Diseases|rheumatic diseases
550962|NCT00829829|Metabolic disorder|metabolic disorder
550963|NCT00829829|Purine-Pyrimidine Metabolism, Inborn Errors|purine-pyrimidine metabolism, inborn errors
550964|NCT00829829|Gout|gout
550965|NCT00829816|Alzheimers disease|alzheimers disease
550966|NCT00829816|donepezil|donepezil
550967|NCT00829816|memantine|memantine
550968|NCT00829803|To acquire developmental data to prospectively support SNAP|to acquire developmental data to prospectively support snap
550969|NCT00829803|II index ranges at the studied anesthetic states.|ii index ranges at the studied anesthetic states.
550970|NCT00829790|Bioequivalence|bioequivalence
550971|NCT00829790|Healthy Subjects|healthy subjects
550972|NCT00829777|Naloxone|naloxone
550973|NCT00829777|6β-Naltrexol|6β-naltrexol
550974|NCT00829777|Opioid-dependent|opioid-dependent
550975|NCT00829777|Pharmacokinetics|pharmacokinetics
550976|NCT00829777|peripheral effects of withdrawal|peripheral effects of withdrawal
550977|NCT00829777|central effects of withdrawal|central effects of withdrawal
550978|NCT00829764|Bioequivalence|bioequivalence
550979|NCT00829764|Healthy Subjects|healthy subjects
550980|NCT00829751|staining|staining
550981|NCT00829751|toxicity|toxicity
550982|NCT00829751|fluorometry|fluorometry
550983|NCT00829751|dye diffusion|dye diffusion
550984|NCT00829751|anterior chamber|anterior chamber
550985|NCT00829738|PPI therapy|ppi therapy
550986|NCT00829738|pantoprazole|pantoprazole
550987|NCT00829738|GERD (Erosive Gastroesophageal Reflux Disease)|gerd (erosive gastroesophageal reflux disease)
550988|NCT00829725|subcapital femoral fractures|subcapital femoral fractures
550989|NCT00829725|transcervical femoral fractures|transcervical femoral fractures
550990|NCT00829725|TARGON FN|targon fn
550991|NCT00829712|Bioequivalence|bioequivalence
550992|NCT00829712|Healthy Subjects|healthy subjects
550993|NCT00829699|endothelial function|endothelial function
550994|NCT00829699|fibrinolytic balance|fibrinolytic balance
550995|NCT00829686|abscess|abscess
550996|NCT00829686|cellulitis|cellulitis
550997|NCT00829686|antibiotics|antibiotics
550998|NCT00829686|MRSA|mrsa
550999|NCT00829673|Bioequivalence|bioequivalence
551000|NCT00829673|Healthy Subjects|healthy subjects
551001|NCT00829660|Acarbose|acarbose
551002|NCT00829647|CLL|cll
551003|NCT00829647|dasatinib|dasatinib
551004|NCT00829647|lenalidomide|lenalidomide
551005|NCT00829647|sprycel|sprycel
551006|NCT00829647|revlimid|revlimid
551007|NCT00829647|CLL relapsed or refractory to fludarabine|cll relapsed or refractory to fludarabine
551008|NCT00829634|methamphetamine|methamphetamine
551009|NCT00829634|inpatient|inpatient
551010|NCT00829634|d-MA|d-ma
551011|NCT00829634|l-MA|l-ma
551012|NCT00829634|APRL|aprl
551013|NCT00829634|San Francisco|san francisco
551014|NCT00829634|metabolism|metabolism
551015|NCT00829634|Metabolism of methamphetamine|metabolism of methamphetamine
551016|NCT00829621|BMP-2|bmp-2
551017|NCT00829621|Incisional Vacuum Assisted Closure (IVAC)|incisional vacuum assisted closure (ivac)
551018|NCT00829608|RRP|rrp
551019|NCT00829608|Recurrent Respiratory Papillomatosis|recurrent respiratory papillomatosis
551020|NCT00829608|HPV vaccine|hpv vaccine
551021|NCT00829608|HPV|hpv
551022|NCT00829595|inflammatory bowel disease|inflammatory bowel disease
551023|NCT00829595|Crohn disease|crohn disease
551024|NCT00829595|ulcerative colitis|ulcerative colitis
551025|NCT00829595|immunosuppression|immunosuppression
551026|NCT00829595|anti tumor necrosis alpha|anti tumor necrosis alpha
551027|NCT00829595|pneumovax|pneumovax
551028|NCT00829595|pneumococcal vaccine|pneumococcal vaccine
551029|NCT00829569|Intralipid|intralipid
551030|NCT00829569|Omegaven|omegaven
551031|NCT00829569|fish oil|fish oil
551032|NCT00829569|hyperinsulinemic isoglycemic clamps|hyperinsulinemic isoglycemic clamps
551033|NCT00829569|C-peptide glucagon test|c-peptide glucagon test
551034|NCT00829569|indirect calorimetry|indirect calorimetry
551035|NCT00829569|F2-isoprostanes|f2-isoprostanes
551036|NCT00829543|Spodyloarthropathy|spodyloarthropathy
551037|NCT00829543|Guide-free sacroiliac injection|guide-free sacroiliac injection
551038|NCT00829530|Bioequivalence|bioequivalence
551039|NCT00829530|Healthy Subjects|healthy subjects
551040|NCT00829517|Contraception|contraception
551041|NCT00829517|sexually transmitted diseases|sexually transmitted diseases
551042|NCT00829504|Bioequivalence|bioequivalence
551043|NCT00829504|Healthy Subjects|healthy subjects
551044|NCT00829491|Cardiovascular Disease Prevention|cardiovascular disease prevention
551045|NCT00829491|Behavior change|behavior change
551046|NCT00829491|Risk Reduction|risk reduction
551047|NCT00829478|Atrial fibrillation|atrial fibrillation
551048|NCT00829478|Cerebrovascular accident|cerebrovascular accident
551049|NCT00829478|Anticoagulation|anticoagulation
551050|NCT00829478|Decision-making|decision-making
551051|NCT00829452|Bioequivalence|bioequivalence
551052|NCT00829452|Healthy Subjects|healthy subjects
551053|NCT00829439|Angelman syndrome|angelman syndrome
551054|NCT00829439|Levodopa|levodopa
551055|NCT00829439|Carbidopa|carbidopa
551056|NCT00829439|L-dopa|l-dopa
551057|NCT00829426|Bioequivalence|bioequivalence
551058|NCT00829426|Healthy Subjects|healthy subjects
551059|NCT00829400|Neuropsychology|neuropsychology
551060|NCT00829400|Cognitive Remediation|cognitive remediation
551061|NCT00829400|Vocational Rehabilitation|vocational rehabilitation
551062|NCT00829400|Schizophrenia|schizophrenia
551063|NCT00829400|Severe and persistent mental illness|severe and persistent mental illness
551064|NCT00829400|Chronic and disabling mental illness|chronic and disabling mental illness
551065|NCT00829387|Diabetes|diabetes
551066|NCT00829387|Pain|pain
551067|NCT00829387|Neuropathic Pain|neuropathic pain
551068|NCT00829374|Alzheimer's disease|alzheimer's disease
551069|NCT00829374|clinical trial|clinical trial
551070|NCT00829374|mitochondria|mitochondria
551071|NCT00829374|memory loss|memory loss
551072|NCT00829374|neurodegenerative disease|neurodegenerative disease
551073|NCT00829374|dementia|dementia
551074|NCT00829374|investigational drug|investigational drug
551075|NCT00829361|Telemedicine|telemedicine
551076|NCT00829361|Acute stroke|acute stroke
551077|NCT00829361|Rural|rural
551078|NCT00829361|thrombosis|thrombosis
551079|NCT00829361|consultation|consultation
551080|NCT00829361|Stroke|stroke
551081|NCT00829361|Cerebral Infarction|cerebral infarction
551082|NCT00829361|Vascular diseases|vascular diseases
551083|NCT00829361|brain ischemia|brain ischemia
551084|NCT00829361|brain infarction|brain infarction
551085|NCT00829361|brain diseases|brain diseases
551086|NCT00829361|cerebrovascular disorders|cerebrovascular disorders
551087|NCT00829348|Compliance|compliance
551088|NCT00829348|Chronic|chronic
551089|NCT00829348|Pharmacotherapy|pharmacotherapy
551090|NCT00829348|Statins|statins
551091|NCT00829335|Intraoperative ultrasound|intraoperative ultrasound
551092|NCT00829335|Segmentectomy|segmentectomy
551094|NCT00829309|Bioequivalence|bioequivalence
551095|NCT00829309|Healthy Subjects|healthy subjects
551096|NCT00829296|diabetes|diabetes
551097|NCT00829296|hypertension|hypertension
551098|NCT00829296|aortic impedance|aortic impedance
551099|NCT00829283|Experimental|experimental
551100|NCT00829283|Comparator|comparator
551101|NCT00829244|Infertility|infertility
551102|NCT00829244|Assisted reproductive technology|assisted reproductive technology
551103|NCT00829231|Liver disease|liver disease
551104|NCT00829218|Irritable Bowel Syndrome|irritable bowel syndrome
551105|NCT00829218|Fibromyalgia|fibromyalgia
551106|NCT00829218|Glutamate|glutamate
551107|NCT00829218|Diet|diet
551108|NCT00829218|Food additives|food additives
551109|NCT00829205|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
551110|NCT00829192|Actinic keratoses (AK)|actinic keratoses (ak)
551111|NCT00829192|Squamous cell carcinomas (SCC)|squamous cell carcinomas (scc)
551112|NCT00829192|CUV1647|cuv1647
551113|NCT00829192|Afamelanotide|afamelanotide
551114|NCT00829192|Clinuvel|clinuvel
551115|NCT00829192|Photoprotection|photoprotection
551116|NCT00829192|Organ transplant|organ transplant
551117|NCT00829179|Asthma|asthma
551118|NCT00829153|Fistula patency|fistula patency
551119|NCT00829127|volunteers|volunteers
551120|NCT00829114|AE|ae
551121|NCT00829114|AIDS|aids
551122|NCT00829114|ALT|alt
551123|NCT00829114|ART|art
551124|NCT00829114|AST|ast
551125|NCT00829114|DCF|dcf
551126|NCT00829114|DMC|dmc
551127|NCT00829114|FDA|fda
551128|NCT00829114|GCP|gcp
551129|NCT00829114|HB sAg|hb sag
551131|NCT00829114|IND|ind
551132|NCT00829114|IRB|irb
551133|NCT00829114|IU|iu
551134|NCT00829114|mg|mg
551135|NCT00829114|mm3|mm3
551136|NCT00829114|PCR|pcr
551137|NCT00829114|SAE|sae
551138|NCT00829114|ULN|uln
551139|NCT00829114|WB|wb
551140|NCT00829114|COC|coc
551141|NCT00829114|Combined Oral Contraceptives|combined oral contraceptives
551142|NCT00829101|unilateral cleft lip and palate|unilateral cleft lip and palate
551143|NCT00829101|primary palatal surgery|primary palatal surgery
551144|NCT00829101|articulation|articulation
551145|NCT00829101|phonology|phonology
551146|NCT00829101|one stage palatal repair|one stage palatal repair
551147|NCT00829101|two stage palatal repair|two stage palatal repair
551148|NCT00829088|Mass balance|mass balance
551149|NCT00829088|AZD2066|azd2066
551150|NCT00829088|Pain|pain
551151|NCT00829088|Pain conditions|pain conditions
551152|NCT00829062|Type 1 diabetes|type 1 diabetes
551153|NCT00829062|Insulin pump|insulin pump
551154|NCT00829062|Glycemic variability|glycemic variability
551155|NCT00829036|Rehabilitation|rehabilitation
551156|NCT00829036|Sensory Aid|sensory aid
551157|NCT00829023|Positive aerobic or anaerobic cultures|positive aerobic or anaerobic cultures
551158|NCT00829010|Human Immunodeficiency Virus|human immunodeficiency virus
551159|NCT00829010|Booster vaccination|booster vaccination
551160|NCT00829010|Safety|safety
551161|NCT00829010|Primary vaccination|primary vaccination
551162|NCT00829010|Pneumococcal vaccine|pneumococcal vaccine
551163|NCT00829010|Immunogenicity|immunogenicity
551164|NCT00829010|Pneumococcal disease|pneumococcal disease
551165|NCT00828997|rheumatoid arthritis|rheumatoid arthritis
551166|NCT00828997|spondylarthropathy|spondylarthropathy
551167|NCT00828997|immunological response following vaccination with Prevenar|immunological response following vaccination with prevenar
551168|NCT00828971|Complicated skin and skin structure infections|complicated skin and skin structure infections
551169|NCT00828971|cSSSI|csssi
551170|NCT00828958|schizophrenia|schizophrenia
551171|NCT00828958|Risperidone|risperidone
551172|NCT00828958|Long acting injectable|long acting injectable
551173|NCT00828958|Intradeltoidal injection|intradeltoidal injection
551174|NCT00828919|VEGFR inhibitor|vegfr inhibitor
551175|NCT00828919|angi-angiogenic|angi-angiogenic
551176|NCT00828919|tyrosine kinase inhibitor|tyrosine kinase inhibitor
551177|NCT00828906|Glaucoma|glaucoma
551178|NCT00828906|IOP|iop
551179|NCT00828906|DuoTrav|duotrav
551180|NCT00828893|drain under scanner|drain under scanner
551181|NCT00828867|healthy subjects|healthy subjects
551182|NCT00828867|FTIH, single dose, food effect, healthy subjects, double-blind|ftih, single dose, food effect, healthy subjects, double-blind
551183|NCT00828854|breast cancer|breast cancer
551184|NCT00828854|estrogen receptor postive|estrogen receptor postive
551185|NCT00828828|Influenza Vaccine|influenza vaccine
551186|NCT00828828|Sarcoidosis|sarcoidosis
551187|NCT00828828|Antibody|antibody
551188|NCT00828815|HIV-negative|hiv-negative
551189|NCT00828815|buprenorphine/nalaxone|buprenorphine/nalaxone
551190|NCT00828815|norbuprenorphine|norbuprenorphine
551191|NCT00828815|opioid-dependent|opioid-dependent
551192|NCT00828815|TMC125-TiDP2-C188|tmc125-tidp2-c188
551193|NCT00828815|TMC125-C188|tmc125-c188
551194|NCT00828815|TMC125|tmc125
551195|NCT00828815|HIV Infections|hiv infections
551196|NCT00828802|Myelodysplastic Syndromes|myelodysplastic syndromes
551197|NCT00828802|MDS|mds
551198|NCT00828789|Hepatitis C|hepatitis c
551199|NCT00828789|HCV|hcv
551200|NCT00828789|HIV|hiv
551201|NCT00828789|AIDS|aids
551202|NCT00828789|Telaprevir|telaprevir
551203|NCT00828789|Efavirenz|efavirenz
551204|NCT00828789|Tenofovir disproxil fumarate|tenofovir disproxil fumarate
551205|NCT00828789|Healthy volunteer|healthy volunteer
551206|NCT00828789|VX-950-C134|vx-950-c134
551207|NCT00828789|VX-950-TiDP24-C134|vx-950-tidp24-c134
551208|NCT00828789|HIV Infections|hiv infections
551209|NCT00828776|TTPa|ttpa
551210|NCT00828776|Anti-Xa|anti-xa
551211|NCT00828776|Adverse Reactions|adverse reactions
551212|NCT00828763|healthy volunteer|healthy volunteer
551213|NCT00828763|radiolabelled|radiolabelled
551214|NCT00828750|eltrombopag|eltrombopag
551215|NCT00828750|thrombopoietin receptor agonist|thrombopoietin receptor agonist
551216|NCT00828750|ITP|itp
551217|NCT00828750|blood platelet|blood platelet
551218|NCT00828711|Misoprostol vaginal insert|misoprostol vaginal insert
551219|NCT00828711|Induction of labor|induction of labor
551220|NCT00828711|Cervical ripening|cervical ripening
551221|NCT00828711|Rate of cesarean section|rate of cesarean section
551222|NCT00828698|Death, sudden|death, sudden
551223|NCT00828698|All cause mortality|all cause mortality
551224|NCT00828685|Return to Work|return to work
551225|NCT00828685|CRPP|crpp
551226|NCT00828685|ORIF|orif
551227|NCT00828685|Distal Radius|distal radius
551228|NCT00828672|assess activity|assess activity
551229|NCT00828672|bevacizumab|bevacizumab
551230|NCT00828672|capecitabine|capecitabine
551231|NCT00828672|radiation therapy|radiation therapy
551232|NCT00828672|oxaliplatin|oxaliplatin
551233|NCT00828672|pre-operative treatment|pre-operative treatment
551665|NCT00827125|progression|progression
551234|NCT00828672|TME (total mesorectal excision).|tme (total mesorectal excision).
551235|NCT00828659|Abuse potential|abuse potential
551236|NCT00828646|Healthy Subjects|healthy subjects
551237|NCT00828633|stage I prostate cancer|stage i prostate cancer
551238|NCT00828633|stage II prostate cancer|stage ii prostate cancer
551239|NCT00828607|Contrast Enhanced Ultrasound (CEUS)|contrast enhanced ultrasound (ceus)
551240|NCT00828607|Liver tumors|liver tumors
551241|NCT00828607|Hepatocellular carcinoma|hepatocellular carcinoma
551242|NCT00828607|Hemangioma|hemangioma
551243|NCT00828607|Focal Nodular Hyperplasia|focal nodular hyperplasia
551244|NCT00828607|Hepatic metastases|hepatic metastases
551245|NCT00828594|Hepatocellular carcinoma|hepatocellular carcinoma
551246|NCT00828594|dose-finding study|dose-finding study
551247|NCT00828594|randomized trial|randomized trial
551248|NCT00828594|medical treatment|medical treatment
551249|NCT00828594|RAD001|rad001
551250|NCT00828594|sorafenib|sorafenib
551251|NCT00828594|Advanced hepatocellular cancer (HCC)|advanced hepatocellular cancer (hcc)
551252|NCT00828568|Actinic Keratosis|actinic keratosis
551253|NCT00828555|HPV vaccine|hpv vaccine
551254|NCT00828555|Tdap vaccine|tdap vaccine
551255|NCT00828542|Adverse Effects|adverse effects
551256|NCT00828542|Etonogestrel|etonogestrel
551257|NCT00828542|Postpartum period|postpartum period
551258|NCT00828542|Contraception|contraception
551259|NCT00828542|Hemostasis|hemostasis
551260|NCT00828542|Metabolism|metabolism
551261|NCT00828529|TMC207-TiDP13-C110|tmc207-tidp13-c110
551262|NCT00828529|TMC207-C110|tmc207-c110
551263|NCT00828529|TMC207|tmc207
551264|NCT00828529|Drug-drug interaction|drug-drug interaction
551265|NCT00828529|Tuberculosis|tuberculosis
551266|NCT00828529|HIV|hiv
551267|NCT00828529|Kaletra|kaletra
551268|NCT00828529|Lopinavir|lopinavir
551269|NCT00828529|Ritonavir|ritonavir
551270|NCT00828529|Open-label|open-label
551271|NCT00828529|HIV Infections|hiv infections
551272|NCT00828516|lymphedema|lymphedema
551273|NCT00828516|male breast cancer|male breast cancer
551274|NCT00828516|stage IA breast cancer|stage ia breast cancer
551275|NCT00828516|stage IB breast cancer|stage ib breast cancer
551276|NCT00828516|stage II breast cancer|stage ii breast cancer
551277|NCT00828516|recurrent breast cancer|recurrent breast cancer
551278|NCT00828516|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
551279|NCT00828516|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
551280|NCT00828516|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
551281|NCT00828516|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
551282|NCT00828516|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
551283|NCT00828516|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
551284|NCT00828516|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
551285|NCT00828516|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
551286|NCT00828516|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
551287|NCT00828516|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
551288|NCT00828516|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
551289|NCT00828516|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
551290|NCT00828516|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
551291|NCT00828516|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
551292|NCT00828516|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
551293|NCT00828516|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
551294|NCT00828516|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
551295|NCT00828516|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
551296|NCT00828516|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
551297|NCT00828516|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
551298|NCT00828516|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
551299|NCT00828516|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
551300|NCT00828516|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
551301|NCT00828516|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
551302|NCT00828516|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
551303|NCT00828516|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
551304|NCT00828516|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
551409|NCT00828126|AJCC stage IV Melanoma|ajcc stage iv melanoma
551305|NCT00828516|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
551306|NCT00828516|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
551307|NCT00828516|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
551739|NCT00826930|Brain Tumor|brain tumor
551308|NCT00828516|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
551309|NCT00828516|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
551310|NCT00828516|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
551311|NCT00828516|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
551312|NCT00828516|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
551313|NCT00828516|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
551314|NCT00828516|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
551315|NCT00828516|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
551316|NCT00828516|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
551317|NCT00828516|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
551318|NCT00828516|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
551319|NCT00828516|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
551320|NCT00828516|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
551321|NCT00828516|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
551322|NCT00828516|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
551323|NCT00828516|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
551324|NCT00828516|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
551325|NCT00828516|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
551326|NCT00828516|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
551327|NCT00828516|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
551328|NCT00828516|recurrent salivary gland cancer|recurrent salivary gland cancer
551329|NCT00828516|salivary gland acinic cell tumor|salivary gland acinic cell tumor
551330|NCT00828516|salivary gland adenocarcinoma|salivary gland adenocarcinoma
551331|NCT00828516|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
551332|NCT00828516|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
551333|NCT00828516|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
551334|NCT00828516|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
551335|NCT00828516|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
551336|NCT00828516|stage I salivary gland cancer|stage i salivary gland cancer
551337|NCT00828516|stage II salivary gland cancer|stage ii salivary gland cancer
551338|NCT00828516|tongue cancer|tongue cancer
551339|NCT00828503|Certi-CMV|certi-cmv
551340|NCT00828503|immunosuppressive switch (to Certican)|immunosuppressive switch (to certican)
551341|NCT00828503|renal transplant|renal transplant
551342|NCT00828490|Fraud and Abuse|fraud and abuse
551343|NCT00828490|opioids|opioids
551344|NCT00828464|Dermatosis, Dermatitis, Dry skin, Irritated skin|dermatosis, dermatitis, dry skin, irritated skin
551345|NCT00828451|newborn|newborn
551346|NCT00828451|necrotizing enterocolitis|necrotizing enterocolitis
551347|NCT00828451|genetics|genetics
551348|NCT00828451|growth factors|growth factors
551349|NCT00828451|metabolism|metabolism
551350|NCT00828425|Diabetes Mellitus|diabetes mellitus
551351|NCT00828425|retinopathy|retinopathy
551352|NCT00828425|Management of diabetic patients with retinopathy|management of diabetic patients with retinopathy
551353|NCT00828399|Radiotherapy|radiotherapy
551354|NCT00828399|Diarrhoea|diarrhoea
551355|NCT00828399|Glutamine|glutamine
551356|NCT00828399|Oxydative stress|oxydative stress
551357|NCT00828399|Calprotectin|calprotectin
551358|NCT00828399|Citrulline|citrulline
551359|NCT00828386|Nasopharyngeal cancers|nasopharyngeal cancers
551360|NCT00828386|induction chemotherapy|induction chemotherapy
551361|NCT00828386|radiochemotherapy|radiochemotherapy
551362|NCT00828360|Heart Failure|heart failure
551364|NCT00828360|Dobutamine echocardiography|dobutamine echocardiography
551365|NCT00828334|transcatheter occlusion of patent ductus arteriosus|transcatheter occlusion of patent ductus arteriosus
551366|NCT00828321|Bioequivalency|bioequivalency
551367|NCT00828321|Healthy Volunteers|healthy volunteers
551368|NCT00828308|localized|localized
551369|NCT00828308|high risk|high risk
551370|NCT00828308|prostate cancer|prostate cancer
551371|NCT00828308|neoadjuvant treatment|neoadjuvant treatment
551372|NCT00828295|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
551373|NCT00828295|palonosetron|palonosetron
551374|NCT00828295|pediatric|pediatric
551375|NCT00828282|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
551376|NCT00828282|Simvastatin|simvastatin
551377|NCT00828282|Zocor|zocor
551378|NCT00828269|Patients with Chronic Hepatitis C|patients with chronic hepatitis c
551379|NCT00828256|arthroscopic repair|arthroscopic repair
551380|NCT00828256|rotator cuff|rotator cuff
551381|NCT00828256|tears|tears
551382|NCT00828256|shoulder|shoulder
551383|NCT00828256|chronic tear of rotator cuff|chronic tear of rotator cuff
551384|NCT00828243|Pulmonary surfactants|pulmonary surfactants
551385|NCT00828243|Pulmonary surfactant associated protein B|pulmonary surfactant associated protein b
551386|NCT00828243|Pulmonary surfactant associated protein C|pulmonary surfactant associated protein c
551387|NCT00828243|ATP-binding cassette protein sub member family A3|atp-binding cassette protein sub member family a3
551388|NCT00828230|budesonide|budesonide
551389|NCT00828230|placebo|placebo
551390|NCT00828230|acute radiation proctitis|acute radiation proctitis
551391|NCT00828230|late radiation proctitis|late radiation proctitis
551392|NCT00828230|Prevention of acute radiation proctitis|prevention of acute radiation proctitis
551393|NCT00828230|Prevention of late radiation proctitis|prevention of late radiation proctitis
551394|NCT00828217|adapted physical activity|adapted physical activity
551395|NCT00828217|hospital|hospital
551396|NCT00828217|health-related quality of life|health-related quality of life
551397|NCT00828217|satisfaction with care|satisfaction with care
551398|NCT00828217|child|child
551399|NCT00828217|adolescent|adolescent
551400|NCT00828217|randomized controlled trial|randomized controlled trial
551401|NCT00828217|physical activity|physical activity
551402|NCT00828217|quality of life|quality of life
551403|NCT00828191|Luteal support in IVF|luteal support in ivf
551404|NCT00828178|SLE|sle
551405|NCT00828178|atherosclerosis|atherosclerosis
551406|NCT00828178|omega-3|omega-3
551407|NCT00828126|Metastatic Melanoma|metastatic melanoma
551408|NCT00828126|AJCC Stage III Melanoma|ajcc stage iii melanoma
551411|NCT00828126|Positron Emission Tomography-Computed Tomography|positron emission tomography-computed tomography
551412|NCT00828126|Contrast-enhanced Computed Tomography Scan|contrast-enhanced computed tomography scan
551413|NCT00828126|CT|ct
551414|NCT00828126|Conventional Imaging|conventional imaging
551415|NCT00828126|False Positive Rate|false positive rate
551416|NCT00828126|Fluorodeoxyglucose|fluorodeoxyglucose
551417|NCT00828126|FDG|fdg
551418|NCT00828126|Surgery|surgery
551419|NCT00828113|smoking|smoking
551420|NCT00828113|relapse|relapse
551421|NCT00828113|withdrawal|withdrawal
551422|NCT00828087|acute myocardial infarction|acute myocardial infarction
551423|NCT00828087|primary percutaneous coronary intervention|primary percutaneous coronary intervention
551424|NCT00828087|drug-eluting stent|drug-eluting stent
551425|NCT00828074|stage IV breast cancer|stage iv breast cancer
551426|NCT00828074|recurrent breast cancer|recurrent breast cancer
551427|NCT00828035|robotics|robotics
551428|NCT00828035|laparoscopy|laparoscopy
551429|NCT00828035|surgery|surgery
551430|NCT00828035|computer assisted|computer assisted
551431|NCT00828022|measles-positive NSCLC|measles-positive nsclc
551432|NCT00828022|measles vaccine|measles vaccine
551433|NCT00828022|consolidation|consolidation
551434|NCT00828022|Stage 3B with pleural effusion or stage 4 non-small cell lung cancer in remission|stage 3b with pleural effusion or stage 4 non-small cell lung cancer in remission
551435|NCT00828009|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
551436|NCT00828009|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
551437|NCT00828009|adenocarcinoma of the lung|adenocarcinoma of the lung
551438|NCT00828009|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
551439|NCT00828009|large cell lung cancer|large cell lung cancer
551440|NCT00827996|Apocrine glands|apocrine glands
551441|NCT00827996|abcesses|abcesses
551442|NCT00827983|Luteal Phase Support in IVF patients|luteal phase support in ivf patients
551443|NCT00827970|mass screening|mass screening
551444|NCT00827957|Hypothermia|hypothermia
551445|NCT00827957|Internal cooling|internal cooling
551446|NCT00827957|External cooling|external cooling
551447|NCT00827957|Cardiac arrest|cardiac arrest
551448|NCT00827944|Uncomplicated primary inguinal hernias|uncomplicated primary inguinal hernias
551449|NCT00827931|tranexamic acid|tranexamic acid
551450|NCT00827931|major abdominal surgery|major abdominal surgery
551451|NCT00827931|blood loss|blood loss
551452|NCT00827918|Acute Exacerbation of Schizophrenia|acute exacerbation of schizophrenia
551453|NCT00827905|Non-Contact|non-contact
551454|NCT00827905|Radar|radar
551455|NCT00827905|Respiratory|respiratory
551456|NCT00827905|Respiration|respiration
551457|NCT00827905|Breathing|breathing
551458|NCT00827905|Rate|rate
551459|NCT00827905|Frequency|frequency
551460|NCT00827905|Respiratory Mechanics|respiratory mechanics
551461|NCT00827905|Respiratory Rate Measurement|respiratory rate measurement
551462|NCT00827892|Intracerebral Hemorrhage|intracerebral hemorrhage
551463|NCT00827892|Treatment|treatment
551464|NCT00827892|MRI|mri
551465|NCT00827879|Intimate partner aggression|intimate partner aggression
551466|NCT00827879|Couples intervention|couples intervention
551467|NCT00827879|PTSD|ptsd
551468|NCT00827879|Veterans|veterans
551469|NCT00827879|Prevention|prevention
551470|NCT00827879|Violence Prevention|violence prevention
551471|NCT00827879|Prevention of pertetration of intimate partner aggression.|prevention of pertetration of intimate partner aggression.
551472|NCT00827866|Tobacco quitline|tobacco quitline
551473|NCT00827866|Childhood cancer survivors|childhood cancer survivors
551474|NCT00827866|Adult-onset cancer survivors|adult-onset cancer survivors
551475|NCT00827853|Diabetes|diabetes
551476|NCT00827853|Peripheral Vascular Disease (PVD)|peripheral vascular disease (pvd)
551477|NCT00827853|Superficial Femoral Artery (SFA)|superficial femoral artery (sfa)
551478|NCT00827853|Cryoplasty|cryoplasty
551479|NCT00827853|Restenosis|restenosis
551480|NCT00827827|Stroke|stroke
551481|NCT00827827|Exercise|exercise
551482|NCT00827827|Strength Training|strength training
551483|NCT00827827|Skeletal Muscle|skeletal muscle
551484|NCT00827827|Insulin Sensitivity|insulin sensitivity
551485|NCT00827801|Cancer|cancer
551486|NCT00827801|Heart Failure|heart failure
551487|NCT00827801|HF|hf
551488|NCT00827801|Cancer and Concurrent Heart Failure|cancer and concurrent heart failure
551489|NCT00827801|MDASI-HF Symptom Management Program|mdasi-hf symptom management program
551490|NCT00827801|MDASI-HF|mdasi-hf
551491|NCT00827801|MDASI-HF questionnaire|mdasi-hf questionnaire
551492|NCT00827801|M. D. Anderson Symptom Inventory - Heart Failure|m. d. anderson symptom inventory - heart failure
551493|NCT00827801|Questionnaire|questionnaire
551494|NCT00827801|Symptom Management Gap|symptom management gap
551495|NCT00827788|contrast media|contrast media
551496|NCT00827788|angiography|angiography
551497|NCT00827788|percutaneous coronary intervention|percutaneous coronary intervention
551498|NCT00827775|Hypertension|hypertension
551499|NCT00827775|Hemodialysis|hemodialysis
551500|NCT00827762|phenylketonuria|phenylketonuria
551501|NCT00827762|Kuvan|kuvan
551502|NCT00827762|sapropterin|sapropterin
551503|NCT00827762|behavior|behavior
551504|NCT00827762|cognition|cognition
551505|NCT00827762|executive abilities|executive abilities
551506|NCT00827762|attention|attention
551507|NCT00827749|swallowing disorders|swallowing disorders
551508|NCT00827749|geriatrics|geriatrics
551509|NCT00827736|anal fissure|anal fissure
551510|NCT00827736|fissura ani|fissura ani
551511|NCT00827736|botox|botox
551512|NCT00827736|ISDN|isdn
551513|NCT00827736|Nitric oxide donor|nitric oxide donor
551514|NCT00827723|Hepatic functional reserve|hepatic functional reserve
551515|NCT00827723|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
551516|NCT00827723|Indocyanine Green retention rate at 15 minutes (ICG-R15')|indocyanine green retention rate at 15 minutes (icg-r15')
551517|NCT00827723|Portal Pressure (PP)|portal pressure (pp)
551518|NCT00827723|Hepatic Portal Venous Gradient (HPVG)|hepatic portal venous gradient (hpvg)
551519|NCT00827723|Alcoholic and Viral Cirrhosis|alcoholic and viral cirrhosis
551520|NCT00827723|Makuuchi criteria|makuuchi criteria
551521|NCT00827723|Barcelona Clinic of Liver Cancer (BCLC)|barcelona clinic of liver cancer (bclc)
551522|NCT00827723|Hepatic resection|hepatic resection
551523|NCT00827710|diabetes|diabetes
551524|NCT00827710|registry|registry
551525|NCT00827710|computer|computer
551526|NCT00827710|self management|self management
551527|NCT00827697|Gonorrhea|gonorrhea
551528|NCT00827697|Chlamydia|chlamydia
551529|NCT00827697|Rectal|rectal
551530|NCT00827684|KRAS mutation|kras mutation
551531|NCT00827658|anesthesia, local|anesthesia, local
551532|NCT00827658|ulnar nerve|ulnar nerve
551533|NCT00827658|hand|hand
551534|NCT00827658|surgery, plastic|surgery, plastic
551535|NCT00827658|blinded|blinded
551536|NCT00827658|randomized|randomized
551537|NCT00827658|prospective|prospective
551538|NCT00827658|local anesthesia|local anesthesia
551539|NCT00827658|volar wrist block|volar wrist block
551540|NCT00827658|hypothenar palm block|hypothenar palm block
551541|NCT00827658|hand surgery|hand surgery
551542|NCT00827632|Ovarian Suppression|ovarian suppression
551543|NCT00827632|Oral Contraceptives|oral contraceptives
551544|NCT00827632|Obese and Normal BMI|obese and normal bmi
551545|NCT00827619|Peripheral Arterial Disease|peripheral arterial disease
551546|NCT00827606|pediatric heterozygous familial hypercholesterolemia|pediatric heterozygous familial hypercholesterolemia
551548|NCT00827580|patients with breast or colon cancer receiving capecitabine|patients with breast or colon cancer receiving capecitabine
551549|NCT00827567|Breast cancer|breast cancer
551550|NCT00827567|metastatic breast|metastatic breast
551551|NCT00827567|triple negative|triple negative
551552|NCT00827567|ER/PR negative|er/pr negative
551553|NCT00827567|Her2 Neu negative|her2 neu negative
551554|NCT00827554|Liver Neoplasms|liver neoplasms
551555|NCT00827554|Liver Diseases|liver diseases
551556|NCT00827554|Digestive System Diseases|digestive system diseases
551557|NCT00827554|Digestive System Neoplasms|digestive system neoplasms
551558|NCT00827554|Carcinoma, Hepatocellular|carcinoma, hepatocellular
551559|NCT00827554|Gastrointestinal Neoplasms|gastrointestinal neoplasms
551560|NCT00827554|Adenocarcinoma|adenocarcinoma
551561|NCT00827554|Hepatocellular carcinoma|hepatocellular carcinoma
551562|NCT00827554|Neoplasms|neoplasms
551563|NCT00827554|Transarterial chemoembolization|transarterial chemoembolization
551564|NCT00827554|Nadroparin|nadroparin
551565|NCT00827554|low-molecular-weight heparin|low-molecular-weight heparin
551566|NCT00827554|chemoembolization|chemoembolization
551567|NCT00827541|tigecycline|tigecycline
551568|NCT00827541|complicated intra-abdominal infections (cIAI)|complicated intra-abdominal infections (ciai)
551738|NCT00826930|High Grade Glioma|high grade glioma
551569|NCT00827541|complicated skin and soft tissue infections (cSSTI).|complicated skin and soft tissue infections (cssti).
551570|NCT00827528|Pelvic Organ Prolapse|pelvic organ prolapse
551571|NCT00827528|Surgical Treatment|surgical treatment
551572|NCT00827515|Relative Bioavailability Effect of food|relative bioavailability effect of food
551573|NCT00827502|TRULIMAX (AZITHROMYCIN ) NON-INTERVENTIONAL STUDY|trulimax (azithromycin ) non-interventional study
551574|NCT00827489|schizophrenia|schizophrenia
551575|NCT00827476|ovary|ovary
551576|NCT00827476|human|human
551577|NCT00827476|transplantaion|transplantaion
551578|NCT00827476|ovarian failure|ovarian failure
551579|NCT00827463|aneamia|aneamia
551580|NCT00827463|aneamia during the maternity|aneamia during the maternity
551581|NCT00827450|hepatic steatosis|hepatic steatosis
551582|NCT00827450|coffee|coffee
551583|NCT00827450|fructose|fructose
551584|NCT00827450|lipids|lipids
551585|NCT00827424|physical activity (PA)|physical activity (pa)
551586|NCT00827424|obesity|obesity
551587|NCT00827424|life style modification|life style modification
551588|NCT00827424|physical activity|physical activity
551589|NCT00827424|diet|diet
551590|NCT00827424|BMI reduction|bmi reduction
551591|NCT00827424|clinical and metabolic measure|clinical and metabolic measure
551592|NCT00827424|health expenditure|health expenditure
551593|NCT00827424|improvement of patient readiness for lifestyle change|improvement of patient readiness for lifestyle change
551594|NCT00827411|Drug Eluting Stent|drug eluting stent
551595|NCT00827411|Percutaneous coronary intervention|percutaneous coronary intervention
551596|NCT00827411|Oral antiplatelet therapy|oral antiplatelet therapy
551597|NCT00827411|Clopidogrel/Aspirin|clopidogrel/aspirin
551598|NCT00827411|Acute Coronary Syndrome|acute coronary syndrome
551599|NCT00827398|MSC|msc
551600|NCT00827398|GVHD|gvhd
551601|NCT00827398|Adults|adults
551602|NCT00827398|Children|children
551603|NCT00827398|steroid refractory acute GVHD occurring after allogeneic stem cell transplantation|steroid refractory acute gvhd occurring after allogeneic stem cell transplantation
551604|NCT00827359|everolimus|everolimus
551605|NCT00827333|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
551606|NCT00827333|stage I non-small cell lung cancer|stage i non-small cell lung cancer
551607|NCT00827333|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
551608|NCT00827333|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
551609|NCT00827333|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
551610|NCT00827333|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
551611|NCT00827307|breast carcinoma; goserelin; Mammographic density|breast carcinoma; goserelin; mammographic density
551612|NCT00827294|Phantom limb pain|phantom limb pain
551613|NCT00827294|Mirror therapy|mirror therapy
551614|NCT00827294|amputation|amputation
551615|NCT00827294|Limb loss|limb loss
551616|NCT00827294|treatment|treatment
551617|NCT00827281|DCS|dcs
551618|NCT00827281|CBT|cbt
551619|NCT00827281|smoking|smoking
551620|NCT00827281|tobacco|tobacco
551621|NCT00827268|Dyslexia|dyslexia
551622|NCT00827268|Reading|reading
551623|NCT00827268|Aphasia|aphasia
551624|NCT00827268|Stroke|stroke
551625|NCT00827242|Signs and Symptoms|signs and symptoms
551626|NCT00827242|Prostatic Hyperplasia|prostatic hyperplasia
551627|NCT00827242|Hyperplasia|hyperplasia
551628|NCT00827242|Genital Diseases, Male|genital diseases, male
551629|NCT00827242|Prostatic Diseases|prostatic diseases
551630|NCT00827242|BPH-LUTS|bph-luts
551631|NCT00827229|Active labor|active labor
551632|NCT00827229|Term pregnancy|term pregnancy
551633|NCT00827229|Vertex presentation|vertex presentation
551634|NCT00827229|Single fetus|single fetus
551635|NCT00827216|Gastric emptying|gastric emptying
551636|NCT00827216|emergency anesthesia|emergency anesthesia
551637|NCT00827216|intravenous erythromycin|intravenous erythromycin
551638|NCT00827203|cancer|cancer
551639|NCT00827203|metastatic|metastatic
551640|NCT00827203|Elesclomol Sodium|elesclomol sodium
551641|NCT00827203|tumor|tumor
551642|NCT00827203|Advanced solid tumors that are metastatic and unresectable|advanced solid tumors that are metastatic and unresectable
551643|NCT00827190|Acute Ischemic Stroke|acute ischemic stroke
551644|NCT00827177|dose escalation|dose escalation
551645|NCT00827177|safety|safety
551646|NCT00827177|tolerability|tolerability
551647|NCT00827177|tumor|tumor
551648|NCT00827177|PK|pk
551649|NCT00827177|hepatocellular carcinoma|hepatocellular carcinoma
551650|NCT00827177|renal cell carcinoma|renal cell carcinoma
551651|NCT00827177|melanoma|melanoma
551652|NCT00827177|non-small cell lung cancer|non-small cell lung cancer
551653|NCT00827177|breast cancer|breast cancer
551654|NCT00827164|head and neck cancer|head and neck cancer
551655|NCT00827164|resistance training|resistance training
551656|NCT00827164|nutrition counseling|nutrition counseling
551657|NCT00827164|radiation therapy|radiation therapy
551658|NCT00827164|pharyngeal or laryngeal cancer|pharyngeal or laryngeal cancer
551659|NCT00827151|amenorrhea|amenorrhea
551660|NCT00827151|athletes|athletes
551661|NCT00827151|bone loss|bone loss
551662|NCT00827151|eumenorrhea|eumenorrhea
551663|NCT00827125|active stage|active stage
551664|NCT00827125|labor|labor
551666|NCT00827125|pregnant woman during active phases of labor|pregnant woman during active phases of labor
551667|NCT00827112|CCR5-tropic HIV-1 virus|ccr5-tropic hiv-1 virus
551668|NCT00827099|accelerated phase cml|accelerated phase cml
551669|NCT00827099|adult ALL in remission|adult all in remission
551670|NCT00827099|adult AML in remission|adult aml in remission
551671|NCT00827099|adult AML with 11q23 (MLL) abnormalities|adult aml with 11q23 (mll) abnormalities
551672|NCT00827099|adult AML with inv(16)(p13;q22)|adult aml with inv(16)(p13;q22)
551673|NCT00827099|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
551674|NCT00827099|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
551675|NCT00827099|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
551676|NCT00827099|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
551677|NCT00827099|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
551678|NCT00827099|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
551679|NCT00827099|prolymphocytic leukemia|prolymphocytic leukemia
551680|NCT00827099|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
551681|NCT00827099|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
551682|NCT00827099|secondary acute myeloid leukemia|secondary acute myeloid leukemia
551683|NCT00827099|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
551684|NCT00827099|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
551685|NCT00827099|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
551686|NCT00827099|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
551687|NCT00827099|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
551688|NCT00827099|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
551689|NCT00827099|anaplastic large cell lymphoma|anaplastic large cell lymphoma
551690|NCT00827099|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
551691|NCT00827099|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
551692|NCT00827099|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
551693|NCT00827099|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
551694|NCT00827099|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
551695|NCT00827099|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
551696|NCT00827099|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
551697|NCT00827099|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
551698|NCT00827099|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
551699|NCT00827099|splenic marginal zone lymphoma|splenic marginal zone lymphoma
551700|NCT00827099|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
551701|NCT00827099|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
551702|NCT00827099|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
551703|NCT00827099|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
551704|NCT00827099|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
551705|NCT00827099|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
551706|NCT00827099|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
551707|NCT00827099|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
551708|NCT00827099|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
551709|NCT00827099|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
551710|NCT00827099|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
551711|NCT00827099|stage I multiple myeloma|stage i multiple myeloma
551712|NCT00827099|stage II multiple myeloma|stage ii multiple myeloma
551713|NCT00827099|stage III multiple myeloma|stage iii multiple myeloma
551714|NCT00827099|refractory multiple myeloma|refractory multiple myeloma
551715|NCT00827099|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
551716|NCT00827099|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
551717|NCT00827099|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
551718|NCT00827086|influencing factors (smoking, nutrition, education)|influencing factors (smoking, nutrition, education)
551719|NCT00827060|primary care|primary care
551720|NCT00827060|procalcitonin|procalcitonin
551721|NCT00827060|acute respiratory tract infection|acute respiratory tract infection
551722|NCT00827047|hepatocellular carcinoma|hepatocellular carcinoma
551723|NCT00827047|Surgical resection|surgical resection
551724|NCT00827047|total hemihepatic vascular exclusion|total hemihepatic vascular exclusion
551725|NCT00827047|occlusion|occlusion
551726|NCT00827047|bleeding|bleeding
551727|NCT00827047|overall survival|overall survival
551728|NCT00827034|Dimebon Warfarin Drug-Drug Interaction|dimebon warfarin drug-drug interaction
551729|NCT00826995|patient Education|patient education
551730|NCT00826995|dermatology Patient Education|dermatology patient education
551731|NCT00826995|melanoma|melanoma
551732|NCT00826995|melanoma education|melanoma education
551733|NCT00826995|malignant melanoma|malignant melanoma
551734|NCT00826995|melanoma detection|melanoma detection
551735|NCT00826969|Asthma|asthma
551736|NCT00826969|Ciclesonide|ciclesonide
551737|NCT00826943|Allergic Rhinitis|allergic rhinitis
551740|NCT00826930|Solid Tumor|solid tumor
551741|NCT00826930|Partial Debulking|partial debulking
551742|NCT00826930|Tumor Resection|tumor resection
551743|NCT00826930|Tumor Tissue Hypoxia|tumor tissue hypoxia
551744|NCT00826930|Radiation Sensitizer|radiation sensitizer
551745|NCT00826930|Cancerous Tumor|cancerous tumor
551746|NCT00826917|3D, 2D, ultrasound, volumetry, multiplanar, VOCALTM, XI VOCALTM, fetal, gestational sac, placenta|3d, 2d, ultrasound, volumetry, multiplanar, vocaltm, xi vocaltm, fetal, gestational sac, placenta
551747|NCT00826904|Fetal programming|fetal programming
551748|NCT00826904|Fetal macrosomia|fetal macrosomia
551749|NCT00826904|Fetal health|fetal health
551750|NCT00826904|Gestational diabetes|gestational diabetes
551751|NCT00826904|Maternal health|maternal health
551752|NCT00826904|Maternal obesity|maternal obesity
551753|NCT00826878|tivozanib|tivozanib
551754|NCT00826878|AV-951|av-951
551755|NCT00826839|In vitro fertilization|in vitro fertilization
551756|NCT00826839|Poor responder patients|poor responder patients
551757|NCT00826839|Randomized clinical trial|randomized clinical trial
551758|NCT00826839|Estrogen patch|estrogen patch
551759|NCT00826839|Gonadotropin-releasing hormone antagonist|gonadotropin-releasing hormone antagonist
551760|NCT00826839|Oral contraceptive pill|oral contraceptive pill
551761|NCT00826839|Microdose lupron|microdose lupron
551762|NCT00826826|Atrial fibrillation|atrial fibrillation
551763|NCT00826826|Amiodarone|amiodarone
551764|NCT00826826|Arrhythmias, Cardiac|arrhythmias, cardiac
551765|NCT00826826|Catheter ablation|catheter ablation
551766|NCT00826813|Dysphagia|dysphagia
551767|NCT00826813|esophageal cancer|esophageal cancer
551768|NCT00826813|stent|stent
551769|NCT00826813|brachytherapy|brachytherapy
551770|NCT00826800|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
551771|NCT00826800|FLUOROURACIL|fluorouracil
551772|NCT00826800|LEUCOVORIN|leucovorin
551773|NCT00826800|OXALIPLATIN|oxaliplatin
551774|NCT00826800|Chemotherapy|chemotherapy
551775|NCT00826774|Body Weight|body weight
551776|NCT00826774|Overweight|overweight
551777|NCT00826774|Hypertension|hypertension
551778|NCT00826774|Hyperglycemia|hyperglycemia
551779|NCT00826748|COPD|copd
551780|NCT00826748|inhaled steroids|inhaled steroids
551781|NCT00826748|gene expression|gene expression
551782|NCT00826748|smoker's lungs|smoker's lungs
551783|NCT00826735|third stage of labor|third stage of labor
551784|NCT00826735|bleeding|bleeding
551785|NCT00826735|guided imagery|guided imagery
551786|NCT00826735|childbirth|childbirth
551787|NCT00826696|preeclampsia|preeclampsia
551788|NCT00826683|Non-small cell lung cancer|non-small cell lung cancer
551789|NCT00826683|Endothelial cell progenitor|endothelial cell progenitor
551790|NCT00826683|Angiogenesis|angiogenesis
551791|NCT00826683|Vascular endothelial cell growth factor|vascular endothelial cell growth factor
551792|NCT00826683|Healthy control|healthy control
551793|NCT00826683|COPD patients|copd patients
551794|NCT00826683|NSCLC patients|nsclc patients
551795|NCT00826670|Antibiotic resistance|antibiotic resistance
551796|NCT00826670|ESBL carriage|esbl carriage
551797|NCT00826657|B12 deficiency|b12 deficiency
551798|NCT00826657|methylmalonic acid|methylmalonic acid
551799|NCT00826657|homocystein|homocystein
551800|NCT00826657|vitamin B12 supplementation intervention|vitamin b12 supplementation intervention
551801|NCT00826644|Small cell lung cancer|small cell lung cancer
551802|NCT00826644|Camptothecin|camptothecin
551803|NCT00826644|Response rate|response rate
551804|NCT00826631|weight|weight
551805|NCT00826631|metabolism|metabolism
551806|NCT00826631|cholesterol|cholesterol
551807|NCT00826631|insulin|insulin
551808|NCT00826618|Uveitis|uveitis
551809|NCT00826618|Cystoid Macular Edema|cystoid macular edema
551810|NCT00826605|Weight loss, urobilinogen|weight loss, urobilinogen
551811|NCT00826592|patient education|patient education
551812|NCT00826592|dermatology patient education|dermatology patient education
551813|NCT00826592|atopic dermatitis|atopic dermatitis
551814|NCT00826592|atopic dermatitis education|atopic dermatitis education
551815|NCT00826592|atopic eczema|atopic eczema
551816|NCT00826592|infantile eczema|infantile eczema
551817|NCT00826592|hand eczema|hand eczema
551818|NCT00826579|Sentinel lymph node|sentinel lymph node
551819|NCT00826579|Lymph node analysis|lymph node analysis
551820|NCT00826579|Bone marrow analysis|bone marrow analysis
551821|NCT00826566|COPD|copd
551822|NCT00826566|caffeine|caffeine
551823|NCT00826566|chronic systemic inflammation|chronic systemic inflammation
551824|NCT00826566|oxidative stress|oxidative stress
551825|NCT00826566|supplementation|supplementation
551826|NCT00826566|stable COPD GOLD stage II with CRP levels ≥ 3 mg/l|stable copd gold stage ii with crp levels ≥ 3 mg/l
551827|NCT00826553|sedative|sedative
551828|NCT00826553|GABA|gaba
551829|NCT00826553|alpha 2 agonist|alpha 2 agonist
551830|NCT00826553|propofol|propofol
551831|NCT00826553|midazolam|midazolam
551832|NCT00826553|lorazepam|lorazepam
551833|NCT00826553|dexmedetomidine|dexmedetomidine
551834|NCT00826553|sleep|sleep
551835|NCT00826553|electroencephalogram|electroencephalogram
551836|NCT00826553|polysomnogram|polysomnogram
551837|NCT00826553|ICU|icu
551838|NCT00826514|Chronic Prostatis|chronic prostatis
551839|NCT00826488|Breast Cancer|breast cancer
551840|NCT00826488|Mammography|mammography
551841|NCT00826488|Benign masses|benign masses
551842|NCT00826488|Breast Lump|breast lump
551843|NCT00826488|Breast Biopsy|breast biopsy
551844|NCT00826488|Breast Mass|breast mass
551845|NCT00826475|Migraine|migraine
551846|NCT00826475|Headache|headache
551847|NCT00826462|Randomised|randomised
551848|NCT00826462|Placebo-controlled|placebo-controlled
551849|NCT00826462|double blind|double blind
551850|NCT00826462|Intervention study|intervention study
551851|NCT00826462|Primary health care|primary health care
551852|NCT00826449|Advanced Solid Tumors|advanced solid tumors
551853|NCT00826449|Advanced Cancer|advanced cancer
551854|NCT00826449|Non-Small Cell Lung Cancer|non-small cell lung cancer
551855|NCT00826449|NSCLC|nsclc
551856|NCT00826449|Solid Tumor Malignancy|solid tumor malignancy
551857|NCT00826449|Dasatinib|dasatinib
551858|NCT00826449|BMS-354825|bms-354825
551859|NCT00826449|Sprycel®|sprycel®
551860|NCT00826449|Erlotinib|erlotinib
551861|NCT00826449|Erlotinib hydrochloride|erlotinib hydrochloride
551862|NCT00826449|Tarceva|tarceva
551863|NCT00826449|OSI-774|osi-774
551864|NCT00826423|treatment with Triple antibiotic therapy|treatment with triple antibiotic therapy
551865|NCT00826410|Laparotomy|laparotomy
551866|NCT00826410|Surgical site infection|surgical site infection
551867|NCT00826410|Drainage|drainage
551868|NCT00826397|Aromatase Inhibitors|aromatase inhibitors
551869|NCT00826397|Joint Pain|joint pain
551870|NCT00826397|Symptoms Control|symptoms control
551871|NCT00826397|Acupuncture|acupuncture
551872|NCT00826384|hepatocellular carcinoma|hepatocellular carcinoma
551873|NCT00826384|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
551874|NCT00826384|overall survival|overall survival
551875|NCT00826371|AMD|amd
551876|NCT00826371|Ranibizumab|ranibizumab
551877|NCT00826358|Adverse events|adverse events
551878|NCT00826358|Pharmacokinetic|pharmacokinetic
551879|NCT00826345|Peripheral Neuropathy|peripheral neuropathy
551880|NCT00826345|Neuropathy|neuropathy
551881|NCT00826345|HIV|hiv
551882|NCT00826345|AIDS|aids
551883|NCT00826345|DSP|dsp
551884|NCT00826345|alternative therapies|alternative therapies
551885|NCT00826332|ultrasound|ultrasound
551886|NCT00826332|IVF|ivf
551887|NCT00826332|Embryo transfer|embryo transfer
551888|NCT00826332|Pregnancy rate|pregnancy rate
551889|NCT00826332|female patient undergoing IVF|female patient undergoing ivf
551890|NCT00826319|Chronic Kidney Disease|chronic kidney disease
551891|NCT00826319|Renal Insufficiency|renal insufficiency
551892|NCT00826319|Biomarkers|biomarkers
551893|NCT00826319|Observational|observational
551894|NCT00826306|patient education|patient education
551895|NCT00826306|dermatology patient education|dermatology patient education
551896|NCT00826306|sunscreen|sunscreen
551897|NCT00826306|sunscreen education|sunscreen education
551898|NCT00826306|skin cancer|skin cancer
551899|NCT00826280|pharmacologic stress|pharmacologic stress
551900|NCT00826280|ischemia|ischemia
551901|NCT00826280|coronary artery disease (CAD)|coronary artery disease (cad)
551902|NCT00826254|vitamin K|vitamin k
551903|NCT00826254|Bone Mineral Density|bone mineral density
551904|NCT00826254|undercarboxylated osteocalcin|undercarboxylated osteocalcin
551905|NCT00826241|Brain Tumor|brain tumor
551906|NCT00826241|Central Nervous System|central nervous system
551907|NCT00826241|CNS|cns
551908|NCT00826241|Spinal Cord Tumor|spinal cord tumor
551909|NCT00826241|Anaplastic Ependymoma|anaplastic ependymoma
551910|NCT00826241|Supratentorial Ependymoma|supratentorial ependymoma
551911|NCT00826241|Infratentorial Ependymoma|infratentorial ependymoma
551912|NCT00826241|Spinal Cord Ependymoma|spinal cord ependymoma
551913|NCT00826241|Lapatinib|lapatinib
551914|NCT00826241|GW572016|gw572016
551915|NCT00826241|Temozolomide|temozolomide
551916|NCT00826241|Temodar|temodar
551917|NCT00826215|mechanical|mechanical
551918|NCT00826215|neck pain|neck pain
551919|NCT00826215|chronic|chronic
551920|NCT00826215|acupuncture|acupuncture
551921|NCT00826215|chronic mechanical neck pain|chronic mechanical neck pain
551922|NCT00826202|schizophrenia|schizophrenia
551923|NCT00826202|d-serine|d-serine
551924|NCT00826202|prodrome|prodrome
551925|NCT00826189|Probiotics|probiotics
551926|NCT00826189|Asthma|asthma
551927|NCT00826189|Allergic Rhinitis|allergic rhinitis
551928|NCT00826150|ovarian cancer|ovarian cancer
551929|NCT00826150|H19 gene|h19 gene
551930|NCT00826150|plasmid|plasmid
551931|NCT00826137|prebiotics|prebiotics
551932|NCT00826137|Antibiotic-associated diarrhea|antibiotic-associated diarrhea
551933|NCT00826124|low back pain|low back pain
551934|NCT00826124|radiculopathy|radiculopathy
551935|NCT00826124|sciatica|sciatica
551936|NCT00826111|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
551937|NCT00826111|Glutamate|glutamate
551938|NCT00826111|Glutamine|glutamine
551939|NCT00826111|GABA|gaba
551940|NCT00826111|Lexapro|lexapro
551941|NCT00826111|Lunesta|lunesta
551942|NCT00826111|Escitalopram|escitalopram
551943|NCT00826111|Eszopiclone|eszopiclone
551944|NCT00826098|Total knee replacement|total knee replacement
551945|NCT00826098|Platelet Rich Plasma|platelet rich plasma
551946|NCT00826098|PRP|prp
551947|NCT00826098|Biologic|biologic
551948|NCT00826098|Randomized|randomized
551949|NCT00826085|Breast Cancer|breast cancer
551950|NCT00826085|Recurrent Chest Wall Cancer|recurrent chest wall cancer
551951|NCT00826085|Loco-regional Recurrent Breast Cancer|loco-regional recurrent breast cancer
551952|NCT00826085|Breast Cancer Recurrence at the Chest Wall|breast cancer recurrence at the chest wall
551953|NCT00826072|Single Nucleotide Polymorphism|single nucleotide polymorphism
551954|NCT00826072|cardiopulmonary bypass|cardiopulmonary bypass
551955|NCT00826072|cardiac surgery|cardiac surgery
551956|NCT00826059|acute ischemic stroke|acute ischemic stroke
551957|NCT00826059|randomized clinical trial|randomized clinical trial
551958|NCT00826059|effectiveness|effectiveness
551959|NCT00826059|safety|safety
551960|NCT00826046|GVHD|gvhd
551961|NCT00826046|Prochymal|prochymal
551962|NCT00826046|Graft vs Host Disease|graft vs host disease
551963|NCT00826033|Fluorine-18-α-methyltyrosine|fluorine-18-α-methyltyrosine
551964|NCT00826033|Positron emission tomography|positron emission tomography
551965|NCT00826033|Lung cancer|lung cancer
551966|NCT00826033|chemotherapy|chemotherapy
551967|NCT00826033|monitoring|monitoring
551968|NCT00826020|PN|pn
551969|NCT00826020|parenteral nutrition|parenteral nutrition
551970|NCT00826020|fat emulsions|fat emulsions
551971|NCT00826020|omega-6 fatty acid|omega-6 fatty acid
551972|NCT00826020|liver disease|liver disease
551973|NCT00826020|fatty acid deficiency|fatty acid deficiency
551974|NCT00826007|perioperative hypoglycemia diabetes surgery|perioperative hypoglycemia diabetes surgery
551975|NCT00826007|surgery|surgery
551976|NCT00825994|menopause|menopause
551977|NCT00825994|perimenopause|perimenopause
551978|NCT00825994|postmenopause|postmenopause
551979|NCT00825994|depression|depression
551980|NCT00825994|mood|mood
551981|NCT00825994|sleep|sleep
551982|NCT00825994|hot flashes|hot flashes
551983|NCT00825968|Electrophysiological|electrophysiological
551984|NCT00825968|Heart Disease|heart disease
551985|NCT00825968|Cardiology|cardiology
551986|NCT00825968|Atrial Fibrillation|atrial fibrillation
551987|NCT00825968|Risk Factors|risk factors
551988|NCT00825968|Follow-up|follow-up
551989|NCT00825968|Outcomes|outcomes
551990|NCT00825942|Asteroid hyalosis|asteroid hyalosis
551991|NCT00825942|Opthalmic Study|opthalmic study
551992|NCT00825929|pharmacokinetics|pharmacokinetics
551993|NCT00825929|pregnancy|pregnancy
551994|NCT00825929|antiretrovirals|antiretrovirals
551995|NCT00825929|neonates|neonates
551996|NCT00825929|HIV|hiv
551997|NCT00825929|treatment experienced|treatment experienced
551998|NCT00825916|AZX100|azx100
551999|NCT00825916|Patient and Observer Scar Assessment Scale|patient and observer scar assessment scale
552000|NCT00825916|POSAS|posas
552001|NCT00825916|Visual Analog Scale|visual analog scale
552002|NCT00825916|VAS|vas
552003|NCT00825916|Keloid|keloid
552004|NCT00825916|Scarring|scarring
552005|NCT00825916|Scar reduction|scar reduction
552006|NCT00825916|Scar prevention|scar prevention
552007|NCT00825903|aquatic exercise|aquatic exercise
552008|NCT00825903|asthma|asthma
552009|NCT00825890|high cup disc ratio|high cup disc ratio
552010|NCT00825890|glaucoma suspect|glaucoma suspect
552011|NCT00825877|Hepatitis C|hepatitis c
552012|NCT00825877|Sustained Virological Response|sustained virological response
552013|NCT00825877|HALT-C|halt-c
552014|NCT00825877|Peginterferon and Ribavirin|peginterferon and ribavirin
552015|NCT00825877|HCV RNA|hcv rna
552016|NCT00825838|Body weight|body weight
552017|NCT00825838|Body composition|body composition
552018|NCT00825838|Resting metabolic rate and fat oxidation in men|resting metabolic rate and fat oxidation in men
552019|NCT00825838|class I obese|class i obese
552020|NCT00825825|Citalopram|citalopram
552021|NCT00825825|Escitalopram|escitalopram
552022|NCT00825825|Celexa|celexa
552023|NCT00825825|Lexapro|lexapro
552024|NCT00825825|fMRI|fmri
552025|NCT00825825|antidepressant|antidepressant
552026|NCT00825825|healthy volunteers|healthy volunteers
552027|NCT00825799|biomarker|biomarker
552028|NCT00825799|depression|depression
552029|NCT00825799|blood test|blood test
552030|NCT00825786|surgery for arm hand or elbow|surgery for arm hand or elbow
552031|NCT00825786|mepivacaine|mepivacaine
552032|NCT00825786|ropivacaine|ropivacaine
552033|NCT00825786|hand surgery|hand surgery
552034|NCT00825786|elbow surgery|elbow surgery
552035|NCT00825786|forearm surgery|forearm surgery
552036|NCT00825773|TVF|tvf
552037|NCT00825773|TLF|tlf
552038|NCT00825773|MACE|mace
552039|NCT00825773|Ischemia-driven Target Vessel Failure (TVF) at 12 months.|ischemia-driven target vessel failure (tvf) at 12 months.
552040|NCT00825773|Ischemia-driven Target Lesion Failure (TLF) at 12 months defined as a|ischemia-driven target lesion failure (tlf) at 12 months defined as a
552041|NCT00825773|composite of cardiac death that can not be clearly attributed to a vessel|composite of cardiac death that can not be clearly attributed to a vessel
552042|NCT00825773|other than the target vessel, target vessel MI (Q and Non-Q wave) and|other than the target vessel, target vessel mi (q and non-q wave) and
552043|NCT00825773|ischemia-driven TLR.|ischemia-driven tlr.
552044|NCT00825773|Rates of stent thrombosis, defined (per ARC definition) as definite or probable|rates of stent thrombosis, defined (per arc definition) as definite or probable
552045|NCT00825773|and categorized as early, late or very late.|and categorized as early, late or very late.
552046|NCT00825773|Major Adverse Cardiac Events (MACE) defined as cardiac death, target|major adverse cardiac events (mace) defined as cardiac death, target
552047|NCT00825773|vessel MI (Q and Non-Q wave), or target lesion revascularization (TLR) at 30|vessel mi (q and non-q wave), or target lesion revascularization (tlr) at 30
552048|NCT00825773|days, 6 months, 12 months and 2 to 5 years annually.|days, 6 months, 12 months and 2 to 5 years annually.
552049|NCT00825760|Antimicrobial Photodynamic Therapy|antimicrobial photodynamic therapy
552050|NCT00825760|Photodynamic Therapy|photodynamic therapy
552051|NCT00825760|PDT|pdt
552052|NCT00825760|Red light|red light
552053|NCT00825760|Visible light|visible light
552054|NCT00825760|Antimicrobial|antimicrobial
552055|NCT00825760|Antibacterial|antibacterial
552056|NCT00825760|Wound healing|wound healing
552057|NCT00825760|Wound management|wound management
552058|NCT00825760|Leg ulcer|leg ulcer
552059|NCT00825760|Chronic venous leg ulcer|chronic venous leg ulcer
552060|NCT00825760|Chronic wound|chronic wound
552061|NCT00825760|Wound therapy|wound therapy
552062|NCT00825760|Antimicrobial therapy|antimicrobial therapy
552063|NCT00825747|Cataract|cataract
552064|NCT00825747|Cataract surgery|cataract surgery
552065|NCT00825747|intraocular lens|intraocular lens
552066|NCT00825747|Aspheric lens|aspheric lens
552067|NCT00825734|Metastatic Breast Cancer|metastatic breast cancer
552068|NCT00825734|Sorafenib|sorafenib
552069|NCT00825734|Nexavar|nexavar
552070|NCT00825734|Ixabepilone|ixabepilone
552071|NCT00825734|Ixempra|ixempra
552072|NCT00825721|Cataract Study|cataract study
552073|NCT00825721|Ophthalmic Study|ophthalmic study
552074|NCT00825721|Agerelated cataract|agerelated cataract
552075|NCT00825721|Nuclear Cataract|nuclear cataract
552076|NCT00825721|Low grade nuclear cataracts|low grade nuclear cataracts
552077|NCT00825708|ADHD|adhd
552078|NCT00825682|Breast cancer|breast cancer
552079|NCT00825682|Radiation therapy|radiation therapy
552080|NCT00825682|Reflexology|reflexology
552081|NCT00825682|Fatigue|fatigue
552082|NCT00825682|Quality of life|quality of life
552083|NCT00825682|Sleep disturbance|sleep disturbance
552084|NCT00825669|hepatocellular carcinoma|hepatocellular carcinoma
552085|NCT00825669|Portal vein tumor thrombus|portal vein tumor thrombus
552086|NCT00825669|laser ablation|laser ablation
552087|NCT00825656|Allergic Rhinitis|allergic rhinitis
552088|NCT00825656|Capsaicin|capsaicin
552089|NCT00825656|Homeopathic|homeopathic
552090|NCT00825656|Sinol|sinol
552091|NCT00825656|Sinol-M|sinol-m
552092|NCT00825630|HP|hp
552093|NCT00825630|UBT|ubt
552094|NCT00825630|PPI|ppi
552095|NCT00825617|TS|ts
552096|NCT00825617|HRT|hrt
552097|NCT00825617|Liver function tests|liver function tests
552098|NCT00825604|stable coronary artery disease|stable coronary artery disease
552099|NCT00825604|quality of life|quality of life
552100|NCT00825604|target achievement|target achievement
552101|NCT00825604|physical training|physical training
552102|NCT00825604|percutaneous coronary intervention|percutaneous coronary intervention
552103|NCT00825591|optic nerve hypoplasia|optic nerve hypoplasia
552104|NCT00825591|septo-optic dysplasia|septo-optic dysplasia
552105|NCT00825591|melatonin|melatonin
552106|NCT00825591|circadian rhythm|circadian rhythm
552107|NCT00825578|intrabronchial valve|intrabronchial valve
552108|NCT00825578|heterogeneous emphysema|heterogeneous emphysema
552109|NCT00825578|non-upper lobe|non-upper lobe
552110|NCT00825565|Epidermolysis bullosa|epidermolysis bullosa
552111|NCT00825552|Risperidone|risperidone
552112|NCT00825552|Severe mood dysregulation|severe mood dysregulation
552113|NCT00825552|bipolar|bipolar
552114|NCT00825552|children|children
552115|NCT00825539|Schizophrenia|schizophrenia
552116|NCT00825539|Manic depression|manic depression
552117|NCT00825539|anxiety|anxiety
552118|NCT00825526|Mindfulness Based Stress Reduction (MBSR)|mindfulness based stress reduction (mbsr)
552119|NCT00825526|Stress Reduction|stress reduction
552120|NCT00825526|hypertension|hypertension
552121|NCT00825526|high blood pressure|high blood pressure
552122|NCT00825526|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
552123|NCT00825500|Migraine headache|migraine headache
552124|NCT00825500|Loxapine|loxapine
552125|NCT00825500|Staccato|staccato
552126|NCT00825487|metastatic|metastatic
552127|NCT00825487|hematologic|hematologic
552128|NCT00825487|malignancy|malignancy
552129|NCT00825487|multiple|multiple
552130|NCT00825487|myeloma|myeloma
552131|NCT00825487|malignant|malignant
552132|NCT00825487|lymphoma|lymphoma
552133|NCT00825487|chronic|chronic
552134|NCT00825487|lymphocytic|lymphocytic
552135|NCT00825487|leukemia|leukemia
552136|NCT00825487|acute|acute
552137|NCT00825487|myelogenous|myelogenous
552138|NCT00825487|promyelocytic|promyelocytic
552139|NCT00825487|dose escalation|dose escalation
552140|NCT00825487|safety|safety
552141|NCT00825487|tolerability|tolerability
552142|NCT00825487|pharmacodynamics|pharmacodynamics
552143|NCT00825487|tumor|tumor
552144|NCT00825487|PK|pk
552145|NCT00825474|small hepatocellular carcinoma|small hepatocellular carcinoma
552146|NCT00825474|partial hepatectomy|partial hepatectomy
552147|NCT00825474|TACE plus PEI|tace plus pei
552148|NCT00825461|Anorexia Nervosa|anorexia nervosa
552149|NCT00825448|alcohol addiction|alcohol addiction
552150|NCT00825435|Coronary CT angiogram|coronary ct angiogram
552151|NCT00825435|Cardiac imaging|cardiac imaging
552152|NCT00825435|Cost analysis|cost analysis
552153|NCT00825435|acute chest pain|acute chest pain
552154|NCT00825435|risk stratification|risk stratification
552155|NCT00825435|cumulative costs over 90-days of providing treatment services|cumulative costs over 90-days of providing treatment services
552156|NCT00825422|Posterior lumbar arthrodesis|posterior lumbar arthrodesis
552157|NCT00825422|Degenerative spine|degenerative spine
552158|NCT00825422|Postoperative analgesia|postoperative analgesia
552159|NCT00825422|Local anesthesic|local anesthesic
552160|NCT00825422|Continuous wound infusion catheter|continuous wound infusion catheter
552161|NCT00825422|Pain|pain
552162|NCT00825422|lumbar vertebrae|lumbar vertebrae
552163|NCT00825422|Spinal fusion|spinal fusion
552164|NCT00825383|Diabetes|diabetes
552165|NCT00825383|lipids|lipids
552166|NCT00825383|fiber|fiber
552167|NCT00825370|Hydromorphone|hydromorphone
552168|NCT00825370|acute pain|acute pain
552169|NCT00825370|Protocolized|protocolized
552170|NCT00825370|Efficacy|efficacy
552171|NCT00825370|Safety|safety
552172|NCT00825357|biological markers|biological markers
552173|NCT00825357|sepsis|sepsis
552174|NCT00825357|acute lung injury|acute lung injury
552175|NCT00825344|postoperative pain|postoperative pain
552176|NCT00825344|inguinal hernia|inguinal hernia
552177|NCT00825344|chronic postsurgical pain|chronic postsurgical pain
552178|NCT00825344|cytokine|cytokine
552179|NCT00825344|preemptive analgesia|preemptive analgesia
552180|NCT00825344|patients with inguinal hernia scheduled for surgery|patients with inguinal hernia scheduled for surgery
552181|NCT00825331|guide wire|guide wire
552182|NCT00825331|cardiac catheterization|cardiac catheterization
552183|NCT00825331|ultrasound-guided examination of the access site|ultrasound-guided examination of the access site
552184|NCT00825331|graduated scheme|graduated scheme
552185|NCT00825331|elective and non elective cardiac catheterization|elective and non elective cardiac catheterization
552186|NCT00825318|End-stage renal disease|end-stage renal disease
552187|NCT00825318|Chronic kidney disease|chronic kidney disease
552188|NCT00825318|Hemodialysis|hemodialysis
552189|NCT00825305|vaccine|vaccine
552190|NCT00825305|prevention|prevention
552191|NCT00825305|rabies|rabies
552192|NCT00825305|Rabies disease|rabies disease
552193|NCT00825292|colon polyps, colon adenomas|colon polyps, colon adenomas
552194|NCT00825279|Biodegradable polymer|biodegradable polymer
552195|NCT00825279|Drug Eluting Stent|drug eluting stent
552196|NCT00825279|In stent restenosis|in stent restenosis
552197|NCT00825279|stent thrombosis|stent thrombosis
552198|NCT00825279|Bare Metal Stent|bare metal stent
552199|NCT00825266|pulmonary hypertension & insulin resistance|pulmonary hypertension & insulin resistance
552200|NCT00825240|Colorectal Cancer|colorectal cancer
552201|NCT00825240|Cancer Survivorship Study|cancer survivorship study
552202|NCT00825240|Questionnaires|questionnaires
552203|NCT00825240|Survivorship|survivorship
552204|NCT00825240|Survivor Health|survivor health
552205|NCT00825240|Health Promotion|health promotion
552206|NCT00825240|Behavior Changes|behavior changes
552207|NCT00825240|Computer-assisted intervention program|computer-assisted intervention program
552208|NCT00825227|Cancer|cancer
552209|NCT00825227|Fatigue|fatigue
552210|NCT00825227|Taxanes|taxanes
552211|NCT00825201|peritoneal carcinomatosis|peritoneal carcinomatosis
552212|NCT00825201|peritoneal cavity cancer|peritoneal cavity cancer
552213|NCT00825201|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
552214|NCT00825201|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
552215|NCT00825201|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
552216|NCT00825175|Down syndrome|down syndrome
552217|NCT00825175|Gait|gait
552218|NCT00825175|Motor Development|motor development
552219|NCT00825175|Orthoses|orthoses
552220|NCT00825136|Panic Disorder|panic disorder
552221|NCT00825136|Temperature Biofeedback|temperature biofeedback
552222|NCT00825136|Internet|internet
552223|NCT00825123|healthy individuals|healthy individuals
552224|NCT00825110|colorectal|colorectal
552225|NCT00825110|cancer|cancer
552226|NCT00825110|gene expression|gene expression
552227|NCT00825110|biomarker|biomarker
552228|NCT00825110|genomic mismatch repair|genomic mismatch repair
552229|NCT00825097|Spastic equinovarus foot|spastic equinovarus foot
552230|NCT00825097|Stroke|stroke
552231|NCT00825097|Tibial neurotomy|tibial neurotomy
552232|NCT00825097|Botulinum toxin type A|botulinum toxin type a
552233|NCT00825097|Selective tibial neurotomy|selective tibial neurotomy
552234|NCT00825084|Dimebon, Japanese and Western population, pharmacokinetics|dimebon, japanese and western population, pharmacokinetics
552235|NCT00825071|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
552236|NCT00825071|Ondansetron|ondansetron
552237|NCT00825071|Dexamethasone|dexamethasone
552238|NCT00825058|Depression|depression
552239|NCT00825045|dopamine|dopamine
552240|NCT00825045|D2|d2
552241|NCT00825045|D3|d3
552242|NCT00825045|caudate|caudate
552243|NCT00825045|putamen|putamen
552244|NCT00825045|globus pallidus|globus pallidus
552245|NCT00825045|antipsychotic|antipsychotic
552246|NCT00825045|risperidone|risperidone
552247|NCT00825045|geriatric|geriatric
552248|NCT00825045|Brief Psychiatric Rating Scale|brief psychiatric rating scale
552249|NCT00825045|PET|pet
552250|NCT00825045|radiotracer|radiotracer
552251|NCT00825045|[11C]-(+)-PHNO|[11c]-(+)-phno
552252|NCT00825045|[11C]-raclopride|[11c]-raclopride
552253|NCT00825032|Pulmonary disease, chronic obstructive|pulmonary disease, chronic obstructive
552254|NCT00825032|Upper extremity|upper extremity
552255|NCT00825032|Exercise therapy|exercise therapy
552256|NCT00825019|Depression|depression
552257|NCT00825006|Cardiac resynchronization therapy|cardiac resynchronization therapy
552258|NCT00825006|Anodal stimulation|anodal stimulation
552259|NCT00824993|Blood Cancer|blood cancer
552260|NCT00824993|Calcium|calcium
552261|NCT00824993|Vitamin D|vitamin d
552262|NCT00824993|Ibandronate|ibandronate
552263|NCT00824993|Boniva|boniva
552264|NCT00824993|Hematological Malignancies|hematological malignancies
552265|NCT00824993|Bone Marrow Transplantation|bone marrow transplantation
552267|NCT00824993|Osteoporosis|osteoporosis
552268|NCT00824993|Bone Loss|bone loss
552269|NCT00824993|Allogeneic Bone Marrow Transplantation|allogeneic bone marrow transplantation
552270|NCT00824954|0 to 30 years|0 to 30 years
552271|NCT00824954|Refractory Acute GVHD|refractory acute gvhd
552272|NCT00824941|Abdominal Pain|abdominal pain
552273|NCT00824941|Women's Health and Disease|women's health and disease
552274|NCT00824941|Gut|gut
552275|NCT00824941|Symptoms|symptoms
552276|NCT00824941|Brain|brain
552277|NCT00824941|Chronic Abdominal Pain|chronic abdominal pain
552278|NCT00824928|Prostate Cancer|prostate cancer
552279|NCT00824928|Recurrent Prostate Cancer|recurrent prostate cancer
552280|NCT00824928|Prostate Cancer Recurrence|prostate cancer recurrence
552281|NCT00824928|Radiation Failure|radiation failure
552282|NCT00824928|Salvage Cryotherapy|salvage cryotherapy
552283|NCT00824915|Lead Integrity Algorithm|lead integrity algorithm
552284|NCT00824902|Prostate Cancer|prostate cancer
552285|NCT00824902|Prostate|prostate
552286|NCT00824902|Radical Prostatectomy|radical prostatectomy
552287|NCT00824902|Tissue Elastography|tissue elastography
552288|NCT00824902|Tissue Elastography Imaging|tissue elastography imaging
552289|NCT00824902|Software Program Measuring Prostate Elasticity|software program measuring prostate elasticity
552290|NCT00824902|Elasticity/Tissue Strain-Hardening Imaging|elasticity/tissue strain-hardening imaging
552291|NCT00824902|Ultrasound|ultrasound
552292|NCT00824876|Mammae cancer patients|mammae cancer patients
552293|NCT00824863|pityrosporum folliculitis|pityrosporum folliculitis
552294|NCT00824863|ketoconazole 2% foam|ketoconazole 2% foam
552295|NCT00824850|Single site|single site
552296|NCT00824850|single dose|single dose
552297|NCT00824850|Participated in Wyeth D118-P8|participated in wyeth d118-p8
552298|NCT00824837|beta 2 microglobulin|beta 2 microglobulin
552299|NCT00824837|haemodialysis|haemodialysis
552300|NCT00824837|albumin|albumin
552301|NCT00824824|Retinal Vascular Autoregulation|retinal vascular autoregulation
552302|NCT00824811|Epiphora|epiphora
552303|NCT00824811|Breast Cancer|breast cancer
552304|NCT00824811|Lung Cancer|lung cancer
552305|NCT00824811|Prostate Cancer|prostate cancer
552306|NCT00824811|Non-small cell lung cancer|non-small cell lung cancer
552307|NCT00824811|Bladder Cancer|bladder cancer
552308|NCT00824811|Esophageal Cancer|esophageal cancer
552309|NCT00824811|Head and Neck Cancer|head and neck cancer
552310|NCT00824811|HNC|hnc
552311|NCT00824811|Small Cell Lung Cancer|small cell lung cancer
552312|NCT00824811|SCLC|sclc
552313|NCT00824811|Ovarian Cancer|ovarian cancer
552314|NCT00824811|Stomach Cancer|stomach cancer
552315|NCT00824811|Canalicular Stenosis|canalicular stenosis
552316|NCT00824811|Excessive tearing|excessive tearing
552317|NCT00824811|Eye inflammation|eye inflammation
552318|NCT00824811|Cyclosporine Ophthalmic Emulsion 0.05%|cyclosporine ophthalmic emulsion 0.05%
552319|NCT00824811|Docetaxel|docetaxel
552320|NCT00824811|Taxotere|taxotere
552321|NCT00824811|Restasis®|restasis®
552322|NCT00824811|Cyclosporine|cyclosporine
552323|NCT00824811|Cyclosporine eye drops|cyclosporine eye drops
552324|NCT00824811|FML Forte®|fml forte®
552325|NCT00824811|Fluorometholone 0.25% ophthalmic suspension|fluorometholone 0.25% ophthalmic suspension
552326|NCT00824811|Fluorometholone eye drops|fluorometholone eye drops
552327|NCT00824811|Fluorometholone|fluorometholone
552328|NCT00824811|Refresh Endura™|refresh endura™
552329|NCT00824811|Lubricant eye drops|lubricant eye drops
552330|NCT00824811|Eye drops|eye drops
552331|NCT00824798|gait|gait
552332|NCT00824798|haemophilia|haemophilia
552333|NCT00824798|arthropathy|arthropathy
552334|NCT00824785|epirubicin|epirubicin
552335|NCT00824785|oxaliplatin|oxaliplatin
552336|NCT00824785|capecitabine|capecitabine
552337|NCT00824785|panitumumab|panitumumab
552338|NCT00824772|pharmacogenetics|pharmacogenetics
552339|NCT00824759|Healthy subjects|healthy subjects
552340|NCT00824759|CABG|cabg
552341|NCT00824759|Patients undergoing coronary artery bypass graft under cardiopulmonary bypass|patients undergoing coronary artery bypass graft under cardiopulmonary bypass
552342|NCT00824746|Gefitinib|gefitinib
552343|NCT00824746|Recurrence|recurrence
552344|NCT00824746|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
552345|NCT00824733|recurrent breast cancer|recurrent breast cancer
552346|NCT00824733|stage IV breast cancer|stage iv breast cancer
552347|NCT00824733|stage IIIA breast cancer|stage iiia breast cancer
552348|NCT00824733|stage IIIB breast cancer|stage iiib breast cancer
552349|NCT00824733|stage IIIC breast cancer|stage iiic breast cancer
552350|NCT00824733|HER2-positive breast cancer|her2-positive breast cancer
552351|NCT00824733|male breast cancer|male breast cancer
552352|NCT00824707|primary liver cancer|primary liver cancer
552353|NCT00824707|hepatitis B virus|hepatitis b virus
552354|NCT00824707|anti-virus therapy|anti-virus therapy
552355|NCT00824694|Glucose|glucose
552356|NCT00824694|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
552357|NCT00824694|HbA1c|hba1c
552358|NCT00824681|Psychological adjustment of family|psychological adjustment of family
552359|NCT00824681|family of patients|family of patients
552360|NCT00824681|children of patients|children of patients
552361|NCT00824681|intensive care unit|intensive care unit
552362|NCT00824681|burn|burn
552363|NCT00824681|music therapy|music therapy
552364|NCT00824681|music|music
552365|NCT00824681|music program|music program
552366|NCT00824681|anxiety|anxiety
552367|NCT00824681|coping|coping
552368|NCT00824681|adjustment|adjustment
552369|NCT00824681|psychological stressor|psychological stressor
552370|NCT00824681|emotional stressor|emotional stressor
552371|NCT00824655|Healthy Subjects|healthy subjects
552372|NCT00824655|Vaccines|vaccines
552373|NCT00824655|Pneumococcal|pneumococcal
552374|NCT00824642|Asthma|asthma
552375|NCT00824642|Exercise training|exercise training
552376|NCT00824642|TENS|tens
552377|NCT00824642|Acupuncture|acupuncture
552378|NCT00824642|FEV1|fev1
552379|NCT00824629|Embryo transfer|embryo transfer
552380|NCT00824629|IVF|ivf
552381|NCT00824629|Ultrasound embryo transfer|ultrasound embryo transfer
552382|NCT00824590|Dimebon|dimebon
552383|NCT00824590|renal impairment|renal impairment
552384|NCT00824590|pharmacokinetics|pharmacokinetics
552385|NCT00824577|heart rate variability|heart rate variability
552386|NCT00824577|autonomic function|autonomic function
552387|NCT00824577|heart function|heart function
552388|NCT00824564|Tranexamic Acid|tranexamic acid
552389|NCT00824564|Blood Loss|blood loss
552390|NCT00824564|Long Bone Fracture Surgery|long bone fracture surgery
552391|NCT00824551|Acute Thermal Burns|acute thermal burns
552392|NCT00824551|Hyperbaric Oxygen Therapy|hyperbaric oxygen therapy
552393|NCT00824551|Burns conversion|burns conversion
552394|NCT00824538|stage IA breast cancer|stage ia breast cancer
552395|NCT00824538|stage IB breast cancer|stage ib breast cancer
552396|NCT00824538|stage II breast cancer|stage ii breast cancer
552397|NCT00824538|stage IIIA breast cancer|stage iiia breast cancer
552398|NCT00824538|stage IIIB breast cancer|stage iiib breast cancer
552399|NCT00824538|stage IIIC breast cancer|stage iiic breast cancer
552400|NCT00824486|child|child
552401|NCT00824486|injury prevention|injury prevention
552402|NCT00824460|Hemodialysis|hemodialysis
552403|NCT00824447|randomised|randomised
552404|NCT00824447|double-blind|double-blind
552405|NCT00824447|placebo-controlled|placebo-controlled
552406|NCT00824447|long-term efficacy and safety|long-term efficacy and safety
552407|NCT00824447|Oralgen® Grass Pollen|oralgen® grass pollen
552408|NCT00824447|allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
552409|NCT00824447|Allergy|allergy
552410|NCT00824447|Rhinoconjunctivitis|rhinoconjunctivitis
552411|NCT00824447|Immunotherapy|immunotherapy
552412|NCT00824447|Grass pollen extract|grass pollen extract
552413|NCT00824434|Atherosclerosis|atherosclerosis
552414|NCT00824434|Coronary Artery Disease|coronary artery disease
552415|NCT00824421|HIV-1. Treatment Naive|hiv-1. treatment naive
552416|NCT00824421|HIV Infections|hiv infections
552417|NCT00824421|treatment naive|treatment naive
552418|NCT00824395|diabetes|diabetes
552419|NCT00824395|type 1|type 1
552420|NCT00824395|type 2|type 2
552421|NCT00824395|metabolic syndrome|metabolic syndrome
552422|NCT00824395|mitochondria|mitochondria
552423|NCT00824369|HIV-1|hiv-1
552424|NCT00824369|Rollover|rollover
552425|NCT00824369|Safety.|safety.
552426|NCT00824369|HIV Infections|hiv infections
552427|NCT00824369|treatment experienced|treatment experienced
552428|NCT00824356|Allergic Rhinitis|allergic rhinitis
552429|NCT00824356|Proof-of-Concept|proof-of-concept
552430|NCT00824330|Aging|aging
552431|NCT00824330|Type 2 diabetes|type 2 diabetes
552432|NCT00824330|exercise|exercise
552433|NCT00824330|walking|walking
552434|NCT00824330|glucose metabolism|glucose metabolism
552435|NCT00824330|arterial baroreceptors|arterial baroreceptors
552436|NCT00824330|heart rate variability|heart rate variability
552437|NCT00824330|cerebral autoregulation|cerebral autoregulation
552438|NCT00824330|tilt table study|tilt table study
552439|NCT00824330|transcranial Doppler|transcranial doppler
552440|NCT00824330|autonomic nervous system|autonomic nervous system
552441|NCT00824304|cognitive performance|cognitive performance
552442|NCT00824304|growth|growth
552443|NCT00824304|iron|iron
552444|NCT00824304|zinc|zinc
552445|NCT00824291|Major Depressive Disorder|major depressive disorder
552446|NCT00824278|Pediatrics|pediatrics
552447|NCT00824278|Distresss Screening|distresss screening
552448|NCT00824278|Cancer|cancer
552449|NCT00824278|Neurofibromatosis|neurofibromatosis
552450|NCT00824278|HIV|hiv
552451|NCT00824278|Pediatric Cancer|pediatric cancer
552452|NCT00824278|Distress Screening|distress screening
552453|NCT00824265|Relapsed|relapsed
552454|NCT00824265|Oncology|oncology
552455|NCT00824265|Safety|safety
552456|NCT00824265|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
552457|NCT00824265|Ofatumumab|ofatumumab
552458|NCT00824265|Efficacy|efficacy
552459|NCT00824252|Head And Neck Cancer|head and neck cancer
552460|NCT00824252|HNC|hnc
552461|NCT00824252|Radiation Therapy|radiation therapy
552462|NCT00824252|Spousal Support|spousal support
552463|NCT00824252|Emotional Disclosure|emotional disclosure
552464|NCT00824252|Observational|observational
552465|NCT00824252|Social Constraints|social constraints
552466|NCT00824252|Questionnaires|questionnaires
552467|NCT00824252|Videotaped Interview|videotaped interview
552468|NCT00824252|Quality of Life|quality of life
552469|NCT00824239|critical care|critical care
552470|NCT00824239|sedation|sedation
552471|NCT00824239|Mechanically ventilated patients|mechanically ventilated patients
552472|NCT00824226|primary hypoparathyroidism|primary hypoparathyroidism
552473|NCT00824226|secondary hypoparathyroidism|secondary hypoparathyroidism
552474|NCT00824226|magnesium|magnesium
552475|NCT00824213|Whole Body SPECT imaging|whole body spect imaging
552476|NCT00824200|Sleep|sleep
552477|NCT00824200|Quality of life|quality of life
552478|NCT00824200|nocturia|nocturia
552479|NCT00824187|Premenstrual Dysphoric Disorder ( PMDD)|premenstrual dysphoric disorder ( pmdd)
552480|NCT00824187|Oral contraceptive|oral contraceptive
552481|NCT00824174|Questionnaire|questionnaire
552482|NCT00824174|Head and Neck Cancer|head and neck cancer
552483|NCT00824174|Skin Cancer|skin cancer
552484|NCT00824174|Body Image|body image
552485|NCT00824174|Surgical Treatment|surgical treatment
552486|NCT00824174|Oral Cavity Cancer|oral cavity cancer
552487|NCT00824174|Cutaneous Cancer|cutaneous cancer
552488|NCT00824148|Real-time glucose monitoring system|real-time glucose monitoring system
552489|NCT00824148|HbA1c|hba1c
552490|NCT00824148|Quality of life|quality of life
552491|NCT00824148|Hypoglycemia|hypoglycemia
552492|NCT00824135|Stem Cell Transplantation, Hematopoietic|stem cell transplantation, hematopoietic
552493|NCT00824135|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
552494|NCT00824135|Maximal Tolerated Dose|maximal tolerated dose
552495|NCT00824135|Clofarabine|clofarabine
552496|NCT00824135|Hematological Malignancies|hematological malignancies
552497|NCT00824135|Apheresis|apheresis
552498|NCT00824109|Aneurysmal disease of the abdominal aorta|aneurysmal disease of the abdominal aorta
552499|NCT00824109|Occlusive disease of the abdominal aorta|occlusive disease of the abdominal aorta
552500|NCT00824096|endotracheal intubation|endotracheal intubation
552501|NCT00824096|cuff-leak test|cuff-leak test
552502|NCT00824096|post-extubation stridor|post-extubation stridor
552503|NCT00824096|bronchoscopy|bronchoscopy
552504|NCT00824096|corticosteroids|corticosteroids
552505|NCT00824096|Cuff-leak volume less than 24%|cuff-leak volume less than 24%
552506|NCT00824083|bone tumors|bone tumors
552507|NCT00824083|long-term function|long-term function
552508|NCT00824083|daily activity|daily activity
552509|NCT00824083|late sequelae|late sequelae
552510|NCT00824070|Bioavailability|bioavailability
552511|NCT00824057|Phase I|phase i
552512|NCT00824044|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
552513|NCT00824044|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
552514|NCT00824044|Escitalopram|escitalopram
552515|NCT00824044|Quantitative EEG (QEEG)|quantitative eeg (qeeg)
552516|NCT00824031|schizophrenia|schizophrenia
552517|NCT00824031|medical mental care|medical mental care
552518|NCT00824031|caregiver|caregiver
552519|NCT00824031|Sapin|sapin
552520|NCT00824005|Congestive Heart Failure|congestive heart failure
552521|NCT00824005|Regional Wall Motion|regional wall motion
552522|NCT00824005|Perfusion Defects|perfusion defects
552523|NCT00823979|HIV-1 NNRTI Treatment Experienced|hiv-1 nnrti treatment experienced
552524|NCT00823979|may have Protease inhibitor experience|may have protease inhibitor experience
552525|NCT00823953|diabetes type 2|diabetes type 2
552526|NCT00823940|FTIH|ftih
552527|NCT00823940|Glucagon|glucagon
552528|NCT00823940|Safety|safety
552529|NCT00823940|GSK1362885|gsk1362885
552530|NCT00823940|Pharmacokinetics|pharmacokinetics
552531|NCT00823940|Tolerability|tolerability
552532|NCT00823940|Pharmacodynamics|pharmacodynamics
552533|NCT00823927|lung damage|lung damage
552534|NCT00823927|cigarette smoking|cigarette smoking
552535|NCT00823927|HIV-seropositive|hiv-seropositive
552536|NCT00823927|emphysema|emphysema
552537|NCT00823914|Psoriasis|psoriasis
552538|NCT00823914|Quality of Life|quality of life
552539|NCT00823901|rosacea|rosacea
552540|NCT00823901|clindamycin|clindamycin
552541|NCT00823901|tretinoin|tretinoin
552542|NCT00823901|clinical study|clinical study
552543|NCT00823901|treatment|treatment
552544|NCT00823888|Knee Osteoarthritis|knee osteoarthritis
552545|NCT00823888|pneumatic bracing|pneumatic bracing
552546|NCT00823862|HCV|hcv
552547|NCT00823862|Immunostimulatory sequence (ISS)|immunostimulatory sequence (iss)
552548|NCT00823862|TLR9 (toll-like receptor 9)|tlr9 (toll-like receptor 9)
552549|NCT00823862|interferon (IFN)|interferon (ifn)
552550|NCT00823862|ribavirin|ribavirin
552551|NCT00823849|type 2 diabetes mellitus, with Arteriosclerosis obliterans|type 2 diabetes mellitus, with arteriosclerosis obliterans
552552|NCT00823836|Ropinirole, advanced Parkinson's disease, L-dopa adjunctive therapy|ropinirole, advanced parkinson's disease, l-dopa adjunctive therapy
552553|NCT00823823|Casting techniques|casting techniques
552554|NCT00823823|Bivalved cast|bivalved cast
552555|NCT00823823|Circumferential cast|circumferential cast
552556|NCT00823823|Displaced distal radius fracture|displaced distal radius fracture
552557|NCT00823823|Children|children
552558|NCT00823810|Colorectal cancer|colorectal cancer
552559|NCT00823810|Response to treatment|response to treatment
552560|NCT00823810|FDG PET/CT|fdg pet/ct
552561|NCT00823784|hemorrhoids|hemorrhoids
552562|NCT00823784|stapler|stapler
552563|NCT00823784|Doppler|doppler
552564|NCT00823784|artery ligation|artery ligation
552565|NCT00823784|outcome|outcome
552566|NCT00823784|recurrence|recurrence
552567|NCT00823758|Acetaminophen|acetaminophen
552568|NCT00823758|Liver|liver
552569|NCT00823758|Centers for Education and Research on Therapeutics|centers for education and research on therapeutics
552570|NCT00823758|CERTS|certs
552571|NCT00823758|Over-the-counter Acetaminophen|over-the-counter acetaminophen
552572|NCT00823758|OTC|otc
552573|NCT00823758|Self-administration|self-administration
552574|NCT00823758|Parental administration|parental administration
552575|NCT00823758|Houston|houston
552576|NCT00823758|Texas|texas
552577|NCT00823758|Liver toxicity|liver toxicity
552578|NCT00823758|Qualitative study|qualitative study
552579|NCT00823758|Pharmacists|pharmacists
552580|NCT00823758|Adolescents|adolescents
552581|NCT00823758|Primary care physicians|primary care physicians
552582|NCT00823758|Family Practitioners|family practitioners
552583|NCT00823758|General Internist|general internist
552584|NCT00823732|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
552585|NCT00823732|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
552586|NCT00823732|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
552587|NCT00823719|Salvage chemotherapy|salvage chemotherapy
552588|NCT00823719|relapsed|relapsed
552589|NCT00823719|grade 3B follicular lymphoma|grade 3b follicular lymphoma
552590|NCT00823719|efficacy|efficacy
552591|NCT00823719|safety|safety
552592|NCT00823719|DHAP|dhap
552593|NCT00823719|ofatumumab|ofatumumab
552594|NCT00823719|refractory|refractory
552595|NCT00823719|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
552596|NCT00823719|Diffuse Large B Cell Lymphoma (DLBCL)|diffuse large b cell lymphoma (dlbcl)
552597|NCT00823719|Oncology|oncology
552598|NCT00823719|ICE|ice
552599|NCT00823719|Transformed follicular lymphoma|transformed follicular lymphoma
552600|NCT00823706|chronic angle closure hyperopia|chronic angle closure hyperopia
552601|NCT00823667|stage I non-small cell lung cancer|stage i non-small cell lung cancer
552602|NCT00823667|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
552603|NCT00823667|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
552604|NCT00823654|Breast|breast
552605|NCT00823654|Questionaires|questionaires
552606|NCT00823654|Blood draw|blood draw
552607|NCT00823654|BRCA1|brca1
552608|NCT00823654|BRCA2|brca2
552609|NCT00823654|08-156|08-156
552610|NCT00823641|HAM/TSP|ham/tsp
552611|NCT00823641|HTLV-I|htlv-i
552612|NCT00823602|GnRH antagonist|gnrh antagonist
552613|NCT00823602|GnRH agonist|gnrh agonist
552614|NCT00823602|pregnancy rate|pregnancy rate
552615|NCT00823602|Ovarian stimulation|ovarian stimulation
552616|NCT00823589|ELDERLY POPULATION|elderly population
552617|NCT00823576|Arthodeses rachis lombar|arthodeses rachis lombar
552618|NCT00823576|Spinal Surgery|spinal surgery
552619|NCT00823550|Chronic hepatitis B|chronic hepatitis b
552620|NCT00823550|Advanced fibrosis|advanced fibrosis
552621|NCT00823550|Lamivudine|lamivudine
552622|NCT00823550|Entecavir|entecavir
552623|NCT00823524|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
552624|NCT00823524|acute undifferentiated leukemia|acute undifferentiated leukemia
552625|NCT00823524|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
552626|NCT00823524|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
552627|NCT00823524|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
552628|NCT00823524|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
552629|NCT00823524|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
552630|NCT00823524|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
552631|NCT00823524|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
552632|NCT00823524|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
552633|NCT00823524|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
552634|NCT00823524|mast cell leukemia|mast cell leukemia
552635|NCT00823524|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
552636|NCT00823524|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
552637|NCT00823524|prolymphocytic leukemia|prolymphocytic leukemia
552638|NCT00823524|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
552639|NCT00823524|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
552640|NCT00823524|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
552641|NCT00823524|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
552642|NCT00823524|refractory hairy cell leukemia|refractory hairy cell leukemia
552643|NCT00823524|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
552644|NCT00823524|secondary acute myeloid leukemia|secondary acute myeloid leukemia
552645|NCT00823524|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
552646|NCT00823524|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
552647|NCT00823524|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
552648|NCT00823524|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
552649|NCT00823524|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
552650|NCT00823524|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
552651|NCT00823524|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
552652|NCT00823524|anaplastic large cell lymphoma|anaplastic large cell lymphoma
552653|NCT00823524|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
552654|NCT00823524|splenic marginal zone lymphoma|splenic marginal zone lymphoma
552655|NCT00823524|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
552656|NCT00823524|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
552657|NCT00823524|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
552658|NCT00823524|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
552659|NCT00823524|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
552660|NCT00823524|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
552661|NCT00823524|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
552662|NCT00823524|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
552663|NCT00823524|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
552664|NCT00823524|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
552665|NCT00823524|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
552666|NCT00823524|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
552667|NCT00823524|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
552668|NCT00823524|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
552669|NCT00823524|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
552670|NCT00823524|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
552671|NCT00823524|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
552672|NCT00823524|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
552673|NCT00823524|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
552674|NCT00823524|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
552675|NCT00823524|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
552676|NCT00823524|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
552677|NCT00823524|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
552678|NCT00823524|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
552679|NCT00823524|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
552680|NCT00823524|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
552681|NCT00823524|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
552682|NCT00823524|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
552683|NCT00823524|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
552684|NCT00823524|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
552685|NCT00823524|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
552686|NCT00823524|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
552687|NCT00823524|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
552688|NCT00823524|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
552689|NCT00823524|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
552690|NCT00823524|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
552691|NCT00823524|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
552692|NCT00823524|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
552693|NCT00823524|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
552694|NCT00823524|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
552695|NCT00823524|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
552696|NCT00823524|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
552697|NCT00823524|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
552698|NCT00823524|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
552699|NCT00823524|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
552700|NCT00823524|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
552701|NCT00823524|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
552702|NCT00823524|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
552703|NCT00823524|intraocular lymphoma|intraocular lymphoma
552704|NCT00823524|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
552705|NCT00823524|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
552706|NCT00823524|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
552707|NCT00823524|chronic eosinophilic leukemia|chronic eosinophilic leukemia
552708|NCT00823524|chronic neutrophilic leukemia|chronic neutrophilic leukemia
552709|NCT00823524|primary myelofibrosis|primary myelofibrosis
552710|NCT00823524|essential thrombocythemia|essential thrombocythemia
552711|NCT00823524|polycythemia vera|polycythemia vera
552712|NCT00823524|extramedullary plasmacytoma|extramedullary plasmacytoma
552713|NCT00823524|isolated plasmacytoma of bone|isolated plasmacytoma of bone
552714|NCT00823524|stage II multiple myeloma|stage ii multiple myeloma
552715|NCT00823524|stage III multiple myeloma|stage iii multiple myeloma
552716|NCT00823524|primary systemic amyloidosis|primary systemic amyloidosis
552717|NCT00823524|refractory multiple myeloma|refractory multiple myeloma
552718|NCT00823524|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
552719|NCT00823524|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
552720|NCT00823524|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
552721|NCT00823524|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
552722|NCT00823524|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
552723|NCT00823524|Waldenström macroglobulinemia|waldenström macroglobulinemia
552724|NCT00823524|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
552725|NCT00823511|HPV|hpv
552726|NCT00823511|Human Papillomavirus Infection|human papillomavirus infection
552727|NCT00823511|Cervix Uteri|cervix uteri
552728|NCT00823511|Cancer Control|cancer control
552729|NCT00823511|Risk Assessment, Detection & Intervention|risk assessment, detection & intervention
552730|NCT00823511|Sexually Transmitted|sexually transmitted
552731|NCT00823511|Neoplasia|neoplasia
552732|NCT00823511|Carcinogenesis|carcinogenesis
552733|NCT00823511|Cervix|cervix
552734|NCT00823498|Cancer Prevention|cancer prevention
552735|NCT00823498|African American|african american
552736|NCT00823498|African American Parents|african american parents
552737|NCT00823498|African American Youth|african american youth
552738|NCT00823498|Public Housing|public housing
552739|NCT00823498|Physical Activity|physical activity
552740|NCT00823498|Focus Groups|focus groups
552741|NCT00823498|Housing Developments|housing developments
552742|NCT00823498|Houston Public Housing|houston public housing
552743|NCT00823498|Photovoice Project|photovoice project
552744|NCT00823498|Prevention|prevention
552745|NCT00823472|embryonic structures|embryonic structures
552746|NCT00823472|sperm injections, intracytoplasmic|sperm injections, intracytoplasmic
552747|NCT00823472|IVF|ivf
552748|NCT00823472|GnRH antagonist|gnrh antagonist
552749|NCT00823472|ovarian stimulation|ovarian stimulation
552750|NCT00823472|cycle day 2 versus cycle day 5|cycle day 2 versus cycle day 5
552751|NCT00823459|Low-grade glioma|low-grade glioma
552752|NCT00823459|astrocytoma|astrocytoma
552753|NCT00823459|oligodendroglioma|oligodendroglioma
552754|NCT00823459|mixed oligoastrocytoma|mixed oligoastrocytoma
552755|NCT00823433|Penicillin|penicillin
552756|NCT00823433|Group B Streptococcus|group b streptococcus
552757|NCT00823433|Pregnancy|pregnancy
552758|NCT00823433|Labor|labor
552759|NCT00823420|PCOS and normal ovulatory patients|pcos and normal ovulatory patients
552760|NCT00823420|aneuploidy|aneuploidy
552761|NCT00823420|in-vitro maturation of oocytes|in-vitro maturation of oocytes
552762|NCT00823407|MDA|mda
552763|NCT00823407|MDMA|mdma
552764|NCT00823407|Ecstasy|ecstasy
552765|NCT00823407|entactogen|entactogen
552766|NCT00823407|pharmacokinetics|pharmacokinetics
552767|NCT00823407|pharmacodynamics|pharmacodynamics
552768|NCT00823407|Pharmacokinetics and pharmacodynamics of MDA studies in healthy volunteers|pharmacokinetics and pharmacodynamics of mda studies in healthy volunteers
552769|NCT00823394|African American|african american
552770|NCT00823394|Adults|adults
552771|NCT00823394|African American Cancer Prevention Project|african american cancer prevention project
552772|NCT00823394|Health Disparities|health disparities
552773|NCT00823394|Questionnaire|questionnaire
552774|NCT00823394|Body Measurements|body measurements
552775|NCT00823394|Self-help|self-help
552776|NCT00823394|Cancer Rates|cancer rates
552777|NCT00823394|Prevention|prevention
552778|NCT00823381|obesity|obesity
552779|NCT00823381|metabolic syndrome|metabolic syndrome
552780|NCT00823381|diabetes|diabetes
552781|NCT00823381|aging|aging
552782|NCT00823381|calorie restriction|calorie restriction
552783|NCT00823381|resveratrol|resveratrol
552784|NCT00823381|antioxidant|antioxidant
552785|NCT00823368|fragile X syndrome|fragile x syndrome
552786|NCT00823368|biomarkers|biomarkers
552787|NCT00823342|HBe, Hepatitis, Vireda (TENOFOVIR, CLEVUDINE), HBV, HBe Ag negative|hbe, hepatitis, vireda (tenofovir, clevudine), hbv, hbe ag negative
552788|NCT00823329|measurement of energy expenditure of physical activity|measurement of energy expenditure of physical activity
552789|NCT00823329|analysis of body composition and hydration status|analysis of body composition and hydration status
552790|NCT00823316|Mesenchymal Stem Cells|mesenchymal stem cells
552791|NCT00823316|Allogeneic Transplantation|allogeneic transplantation
552792|NCT00823316|Engraftment|engraftment
552793|NCT00823316|GvHD|gvhd
552794|NCT00823316|Childhood|childhood
552795|NCT00823316|unrelated HSCT|unrelated hsct
552796|NCT00823303|PTH|pth
552797|NCT00823303|Active Vitamin D|active vitamin d
552798|NCT00823303|hypercalcemia|hypercalcemia
552799|NCT00823303|Chronic Kidney Disease|chronic kidney disease
552800|NCT00823290|HCC|hcc
552801|NCT00823290|sorafenib|sorafenib
552802|NCT00823290|HDAC|hdac
552803|NCT00823290|LBH589|lbh589
552804|NCT00823290|Panobinostat|panobinostat
552805|NCT00823264|Anticonvulsants|anticonvulsants
552806|NCT00823264|Toxicology|toxicology
552807|NCT00823264|multidose charcoal|multidose charcoal
552808|NCT00823264|phenytoin|phenytoin
552809|NCT00823225|Diabetes|diabetes
552810|NCT00823225|urokinase|urokinase
552811|NCT00823225|ulcer healing|ulcer healing
552812|NCT00823225|major amputation|major amputation
552813|NCT00823225|survival|survival
552814|NCT00823212|drug-eluting stents|drug-eluting stents
552815|NCT00823212|DES|des
552816|NCT00823212|atherosclerotic|atherosclerotic
552817|NCT00823186|cervical carcinoma|cervical carcinoma
552818|NCT00823186|neoadjuvant chemotherapy|neoadjuvant chemotherapy
552819|NCT00823173|Uveitis|uveitis
552820|NCT00823173|TNF-alpha|tnf-alpha
552821|NCT00823173|Topical|topical
552822|NCT00823173|ESBA105|esba105
552823|NCT00823173|scFv antibody fragment|scfv antibody fragment
552824|NCT00823173|ocular inflammation|ocular inflammation
552825|NCT00823160|Pericardial window|pericardial window
552826|NCT00823160|Sternotomy|sternotomy
552827|NCT00823160|Haemopericardium|haemopericardium
552828|NCT00823147|Pain|pain
552829|NCT00823147|Systemic Inflammation|systemic inflammation
552830|NCT00823147|Pain Catastrophizing|pain catastrophizing
552831|NCT00823121|Fresh embryo transfer|fresh embryo transfer
552832|NCT00823121|frozen- thawed embryo transfer|frozen- thawed embryo transfer
552833|NCT00823121|vitrification|vitrification
552834|NCT00823121|endometrial receptivity|endometrial receptivity
552835|NCT00823121|implantation rate|implantation rate
552836|NCT00823121|pregnancy|pregnancy
552837|NCT00823121|ART|art
552838|NCT00823108|GIK, septic shock, sepsis|gik, septic shock, sepsis
552839|NCT00823095|chronic cutaneous ulcers|chronic cutaneous ulcers
552840|NCT00823095|Nitric Oxide|nitric oxide
552841|NCT00823095|topically applied|topically applied
552842|NCT00823095|Biofilm|biofilm
552843|NCT00823095|Colonized chronic non-healing ulcers|colonized chronic non-healing ulcers
552844|NCT00823082|antithrombin|antithrombin
552845|NCT00823082|ATIII|atiii
552846|NCT00823082|acquired deficiency|acquired deficiency
552847|NCT00823082|anticoagulants|anticoagulants
552848|NCT00823082|cardiopulmonary bypass|cardiopulmonary bypass
552849|NCT00823082|surgery|surgery
552850|NCT00823082|complications|complications
552851|NCT00823082|postoperative outcomes|postoperative outcomes
552852|NCT00823069|Correction of Nasolabial Folds|correction of nasolabial folds
552853|NCT00823056|Probiotics|probiotics
552854|NCT00823056|Infections|infections
552855|NCT00823056|Children|children
552856|NCT00823030|Interstitial Cystitis|interstitial cystitis
552857|NCT00823030|Intravesical Lidocaine|intravesical lidocaine
552858|NCT00823017|ICU environment|icu environment
552859|NCT00823017|Auditory stimulation|auditory stimulation
552860|NCT00823017|Properties of relaxation music|properties of relaxation music
552861|NCT00823017|music|music
552862|NCT00823017|music therapy|music therapy
552863|NCT00823017|pain|pain
552864|NCT00823017|anxiety|anxiety
552865|NCT00823017|cortisol|cortisol
552866|NCT00823017|IgA|iga
552867|NCT00823017|biomarkers|biomarkers
552868|NCT00823017|relaxation music|relaxation music
552869|NCT00823004|controlled ovarian hyperstimulation|controlled ovarian hyperstimulation
552870|NCT00823004|pregnancy rate|pregnancy rate
552871|NCT00823004|Poor responders|poor responders
552872|NCT00823004|GnRH antagonist|gnrh antagonist
552873|NCT00823004|GnRH agonist|gnrh agonist
552874|NCT00823004|letrozole|letrozole
552875|NCT00823004|in vitro fertilization|in vitro fertilization
552876|NCT00822991|Sonazoid|sonazoid
552877|NCT00822991|Early detection|early detection
552878|NCT00822991|Hepatocellular carcinoma|hepatocellular carcinoma
552879|NCT00822991|Liver cirrhosis|liver cirrhosis
552880|NCT00822978|healthy|healthy
552881|NCT00822978|volunteers|volunteers
552882|NCT00822978|subjects|subjects
552883|NCT00822965|Pacemakers|pacemakers
552884|NCT00822965|PM|pm
552885|NCT00822965|Implantable cardioverter-defibrillators|implantable cardioverter-defibrillators
552886|NCT00822965|ICD|icd
552887|NCT00822965|Implantable pulse generators|implantable pulse generators
552888|NCT00822965|Educational Interventions|educational interventions
552889|NCT00822913|Botulinum A toxin|botulinum a toxin
552890|NCT00822913|Parkinson's disease|parkinson's disease
552891|NCT00822900|Trauma|trauma
552892|NCT00822900|Brain Injury|brain injury
552893|NCT00822887|malignant|malignant
552894|NCT00822887|gliomas|gliomas
552895|NCT00822874|PCOS and normal ovulatory patients|pcos and normal ovulatory patients
552896|NCT00822874|aneuploidy|aneuploidy
552897|NCT00822874|in-vitro maturation of oocytes|in-vitro maturation of oocytes
552898|NCT00822848|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
552899|NCT00822848|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
552900|NCT00822822|Questionnaire|questionnaire
552901|NCT00822822|Electronic Health History|electronic health history
552902|NCT00822809|Cancer|cancer
552903|NCT00822809|Neoplasms|neoplasms
552904|NCT00822809|Carcinoma|carcinoma
552905|NCT00822809|Malignant Ascites|malignant ascites
552906|NCT00822809|Drug therapy|drug therapy
552907|NCT00822809|Antineoplastic Protocols|antineoplastic protocols
552908|NCT00822809|Immunotherapy|immunotherapy
552909|NCT00822809|Phase III|phase iii
552910|NCT00822809|trifunctional antibody|trifunctional antibody
552911|NCT00822809|monoclonal antibody|monoclonal antibody
552912|NCT00822809|EpCAM|epcam
552913|NCT00822796|Hypothermia|hypothermia
552914|NCT00822796|Severe burns|severe burns
552915|NCT00822796|Warming catheter|warming catheter
552916|NCT00822796|Thermogard™|thermogard™
552917|NCT00822796|Coagulopathy|coagulopathy
552918|NCT00822783|Serum IgE levels|serum ige levels
552919|NCT00822783|inflammatory cells in the skin|inflammatory cells in the skin
552920|NCT00822783|inflammatory cells in the blood|inflammatory cells in the blood
552921|NCT00822783|IgE|ige
552922|NCT00822783|IgE depletion|ige depletion
552923|NCT00822783|atopic dermatitis|atopic dermatitis
552924|NCT00822783|atopic eczema|atopic eczema
552925|NCT00822783|Omalizumab|omalizumab
552926|NCT00822770|Blood Stem Cell Transplantation|blood stem cell transplantation
552927|NCT00822770|Bone Marrow Transplantation|bone marrow transplantation
552928|NCT00822770|Bone Marrow Cell Transplantation|bone marrow cell transplantation
552929|NCT00822770|Stem Cell Transplantation|stem cell transplantation
552930|NCT00822770|Allogeneic Hematopoietic Transplantation|allogeneic hematopoietic transplantation
552931|NCT00822770|Advanced Myeloid Leukemia|advanced myeloid leukemia
552932|NCT00822770|Acute Myeloid Leukemia|acute myeloid leukemia
552933|NCT00822770|AML|aml
552934|NCT00822770|Myelodysplastic syndrome|myelodysplastic syndrome
552935|NCT00822770|MDS|mds
552936|NCT00822770|Chronic Myeloid Leukemia|chronic myeloid leukemia
552937|NCT00822770|CML|cml
552938|NCT00822770|Graft Versus Host Disease|graft versus host disease
552939|NCT00822770|GVHD|gvhd
552940|NCT00822770|ATG|atg
552941|NCT00822770|Busulfan|busulfan
552942|NCT00822770|Busulfex™|busulfex™
552943|NCT00822770|Myleran®|myleran®
552944|NCT00822770|Filgrastim|filgrastim
552945|NCT00822770|Neupogen|neupogen
552946|NCT00822770|Fludarabine|fludarabine
552947|NCT00822770|Fludarabine Phosphate|fludarabine phosphate
552948|NCT00822770|Fludara™|fludara™
552949|NCT00822770|G-CSF|g-csf
552950|NCT00822770|Plerixafor|plerixafor
552951|NCT00822770|Antithymocyte globulin|antithymocyte globulin
552952|NCT00822770|Thymoglobulin|thymoglobulin
552953|NCT00822757|study in healthy subjects|study in healthy subjects
552954|NCT00822744|Depression|depression
552955|NCT00822744|Major Depressive Episode|major depressive episode
552956|NCT00822744|Antidepressant|antidepressant
552957|NCT00822731|Lymphoma|lymphoma
552958|NCT00822731|prognosis|prognosis
552959|NCT00822731|morbidity|morbidity
552960|NCT00822718|obestatin|obestatin
552961|NCT00822718|ghrelin|ghrelin
552962|NCT00822718|stomach cancer|stomach cancer
552963|NCT00822718|distal gastrectomy|distal gastrectomy
552964|NCT00822705|Appetite, energy consumption, gastrointestinal hormones|appetite, energy consumption, gastrointestinal hormones
552965|NCT00822692|Abscess|abscess
552966|NCT00822692|Cellulitis|cellulitis
552967|NCT00822692|Antibiotics|antibiotics
552968|NCT00822692|MRSA|mrsa
552969|NCT00822679|Acute Coronary Syndrome|acute coronary syndrome
552970|NCT00822679|cytokines|cytokines
552971|NCT00822679|pro-coagulant mediators|pro-coagulant mediators
552972|NCT00822679|sleep disorders|sleep disorders
552973|NCT00822666|Platelet aggregation|platelet aggregation
552974|NCT00822666|Platelet|platelet
552975|NCT00822666|Thrombosis|thrombosis
552976|NCT00822666|Clopidogrel|clopidogrel
552977|NCT00822653|hemodialysis treatment|hemodialysis treatment
552978|NCT00822653|pump stimulation|pump stimulation
552979|NCT00822653|reduce hypotensive episodes|reduce hypotensive episodes
552980|NCT00822640|Prosthesis Design|prosthesis design
552981|NCT00822640|Range of Motion, Articular|range of motion, articular
552982|NCT00822640|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
552983|NCT00822627|Influenza|influenza
552984|NCT00822627|vaccination|vaccination
552985|NCT00822627|Emergency Department|emergency department
552986|NCT00822614|Pain|pain
552987|NCT00822601|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
552988|NCT00822601|Supplementary Motor Area|supplementary motor area
552989|NCT00822601|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
552990|NCT00822601|Sham rTMS|sham rtms
552991|NCT00822601|Placebo-controlled|placebo-controlled
552992|NCT00822601|Randomized|randomized
552993|NCT00822601|Double-blind|double-blind
552994|NCT00822601|fMRI|fmri
552995|NCT00822601|DSM-IV Obsessive-Compulsive Disorder|dsm-iv obsessive-compulsive disorder
552996|NCT00822575|mosquito bites|mosquito bites
552997|NCT00822575|itching|itching
552998|NCT00822562|hepatocellular carcinoma|hepatocellular carcinoma
552999|NCT00822562|surgery|surgery
553000|NCT00822549|Morphine titration|morphine titration
553001|NCT00822549|Sub acute pain|sub acute pain
553002|NCT00822549|Major orthopaedic surgery|major orthopaedic surgery
553003|NCT00822549|Pharmacokinetics|pharmacokinetics
553004|NCT00822549|Pharmacodynamics|pharmacodynamics
553005|NCT00822549|Genetic polymorphism|genetic polymorphism
553006|NCT00822549|PACU|pacu
553007|NCT00822549|Patients undergoing major scheduled orthopaedic surgery|patients undergoing major scheduled orthopaedic surgery
553008|NCT00822536|Drug-eluting stent|drug-eluting stent
553009|NCT00822536|Clopidogrel|clopidogrel
553010|NCT00822536|Stent thrombosis|stent thrombosis
553011|NCT00822536|Myocardial infarction|myocardial infarction
553012|NCT00822510|Psychosocial Intervention|psychosocial intervention
553013|NCT00822510|Men with Prostate Cancer & Partners|men with prostate cancer & partners
553014|NCT00822497|music therapy|music therapy
553015|NCT00822497|pain|pain
553016|NCT00822497|anxiety|anxiety
553017|NCT00822497|muscle tension|muscle tension
553018|NCT00822471|Diabetes|diabetes
553019|NCT00822471|Self-Management Education|self-management education
553020|NCT00822471|Library|library
553021|NCT00822471|Emergency Department Visits|emergency department visits
553022|NCT00822471|African American|african american
553023|NCT00822471|CVD prevention|cvd prevention
553024|NCT00822471|Prevention|prevention
553025|NCT00822471|Uncontrolled diabetes|uncontrolled diabetes
553026|NCT00822445|Biomarker|biomarker
553027|NCT00822445|S100 protein|s100 protein
553028|NCT00822445|Traumatic brain injury|traumatic brain injury
553029|NCT00822445|Craniocerebral tomodensitometry|craniocerebral tomodensitometry
553030|NCT00822445|Neurological sequelae|neurological sequelae
553031|NCT00822432|biomarkers|biomarkers
553032|NCT00822432|ABC transporters|abc transporters
553033|NCT00822432|MRP2|mrp2
553034|NCT00822432|MTX pharmacokinetics|mtx pharmacokinetics
553035|NCT00822419|sternotomy pain|sternotomy pain
553036|NCT00822406|allergy|allergy
553037|NCT00822406|rhinitis|rhinitis
553038|NCT00822406|homeopathy|homeopathy
553039|NCT00822406|double-blind|double-blind
553040|NCT00822393|Treosulfan|treosulfan
553041|NCT00822393|Busulfan|busulfan
553042|NCT00822393|Conditioning|conditioning
553043|NCT00822393|Allogeneic|allogeneic
553044|NCT00822393|Transplantation|transplantation
553045|NCT00822380|Anemia|anemia
553046|NCT00822380|Iron|iron
553047|NCT00822380|Children|children
553048|NCT00822380|Micronutrients|micronutrients
553049|NCT00822354|Secondary Raynaud's Phenomenon|secondary raynaud's phenomenon
553050|NCT00822328|Probiotics|probiotics
553051|NCT00822328|Lactobacillus|lactobacillus
553052|NCT00822328|Intestine|intestine
553053|NCT00822328|Flora|flora
553054|NCT00822315|HIV|hiv
553055|NCT00822315|Tuberculosis|tuberculosis
553056|NCT00822315|Pharmacokinetics|pharmacokinetics
553057|NCT00822315|Raltegravir|raltegravir
553058|NCT00822315|France|france
553059|NCT00822315|Brazil|brazil
553060|NCT00822315|treatment naive|treatment naive
553061|NCT00822302|atherosclerosis|atherosclerosis
553062|NCT00822302|stroke|stroke
553063|NCT00822302|ischaemia|ischaemia
553064|NCT00822289|radioactive iodine|radioactive iodine
553065|NCT00822289|Helicobacter pylori|helicobacter pylori
553066|NCT00822289|Thyroid diseases|thyroid diseases
553067|NCT00822289|CagA|caga
553068|NCT00822276|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
553069|NCT00822276|MRSA|mrsa
553070|NCT00822276|Methicillin-sensitive Staphylococcus aureus|methicillin-sensitive staphylococcus aureus
553071|NCT00822276|MSSA|mssa
553072|NCT00822276|Atopic Dermatitis|atopic dermatitis
553073|NCT00822276|Eczema Herpeticum|eczema herpeticum
553074|NCT00822263|mild traumatic brain injury|mild traumatic brain injury
553075|NCT00822263|anti-oxidant|anti-oxidant
553076|NCT00822263|early treatment|early treatment
553077|NCT00822224|acute pain|acute pain
553078|NCT00822224|MEOPA|meopa
553079|NCT00822224|Dementia|dementia
553080|NCT00822211|Diabetes Mellitus|diabetes mellitus
553081|NCT00822211|HbA1c reduction|hba1c reduction
553082|NCT00822211|vildagliptin|vildagliptin
553083|NCT00822211|add-on to metformin|add-on to metformin
553084|NCT00822211|Chinese patients|chinese patients
553085|NCT00822198|peripheral neuropathy|peripheral neuropathy
553086|NCT00822198|diabetes|diabetes
553087|NCT00822198|plantar vibration|plantar vibration
553088|NCT00822172|Peripheral Vascular Disease|peripheral vascular disease
553089|NCT00822172|Peripheral Arterial Disease|peripheral arterial disease
553090|NCT00822172|Intermittent Claudication|intermittent claudication
553091|NCT00822172|Peak Walking Time|peak walking time
553092|NCT00822172|Claudication Onset Time|claudication onset time
553093|NCT00822172|Cilostazol|cilostazol
553094|NCT00822172|Carnitine|carnitine
553095|NCT00822159|Fixation failure|fixation failure
553096|NCT00822159|Bone strength|bone strength
553097|NCT00822159|DensiProbe|densiprobe
553098|NCT00822146|CRT|crt
553099|NCT00822133|ketamine|ketamine
553100|NCT00822133|preemption|preemption
553101|NCT00822133|postoperative|postoperative
553102|NCT00822133|pain|pain
553103|NCT00822133|safety|safety
553104|NCT00822120|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
553105|NCT00822120|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
553106|NCT00822120|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
553107|NCT00822120|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
553108|NCT00822120|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
553109|NCT00822120|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
553110|NCT00822120|HIV infection|hiv infection
553111|NCT00822107|Hypokalemia|hypokalemia
553112|NCT00822107|Bartter Syndrome|bartter syndrome
553113|NCT00822107|Salt Wasting|salt wasting
553114|NCT00822094|Acute|acute
553115|NCT00822094|Myeloid|myeloid
553116|NCT00822094|Leukemia|leukemia
553117|NCT00822094|Adult|adult
553118|NCT00822094|First|first
553119|NCT00822094|Relapse|relapse
553120|NCT00822094|AML|aml
553121|NCT00822094|Acute Myelogenous leukemia|acute myelogenous leukemia
553122|NCT00822094|Leukemia, Myeloid|leukemia, myeloid
553123|NCT00822094|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
553124|NCT00822094|Acute myelocytic leukemia|acute myelocytic leukemia
553125|NCT00822068|stroke|stroke
553126|NCT00822068|aphasia|aphasia
553127|NCT00822068|rehabilitation|rehabilitation
553128|NCT00822068|transcranial direct current stimulation|transcranial direct current stimulation
553129|NCT00822068|intensive training|intensive training
553130|NCT00822068|chronic aphasia after stroke|chronic aphasia after stroke
553131|NCT00822042|Lipodystrophy|lipodystrophy
553132|NCT00822042|Adipokines|adipokines
553133|NCT00822042|Glucocorticoids|glucocorticoids
553134|NCT00822042|Patients with glucocorticoids|patients with glucocorticoids
553135|NCT00822016|Best Supportive Care|best supportive care
553136|NCT00822016|Protocol of Standard Practice|protocol of standard practice
553137|NCT00822016|Carcinoma of the Lung|carcinoma of the lung
553138|NCT00822003|GLP-1|glp-1
553139|NCT00822003|insulin|insulin
553140|NCT00822003|glucose|glucose
553141|NCT00821990|Failed after previous chemotherapy|failed after previous chemotherapy
553142|NCT00821977|Type 2 Diabetes|type 2 diabetes
553143|NCT00821977|Vildagliptin|vildagliptin
553144|NCT00821964|Breast Cancer|breast cancer
553145|NCT00821964|Stage IV|stage iv
553146|NCT00821964|cream|cream
553147|NCT00821964|topical|topical
553148|NCT00821938|Narrow QRS|narrow qrs
553149|NCT00821938|CRT|crt
553150|NCT00821925|osteoporosis|osteoporosis
553151|NCT00821899|diabetes type 1|diabetes type 1
553152|NCT00821899|bone marrow transplantation|bone marrow transplantation
553153|NCT00821886|Breast Cancer|breast cancer
553154|NCT00821886|Neoadjuvant|neoadjuvant
553155|NCT00821886|Ixabepilone|ixabepilone
553156|NCT00821886|Carboplatin|carboplatin
553157|NCT00821886|Trastuzumab|trastuzumab
553158|NCT00821873|Cartilage injury|cartilage injury
553159|NCT00821873|OATS|oats
553160|NCT00821873|Knee injury|knee injury
553161|NCT00821873|allograft|allograft
553162|NCT00821873|autograft|autograft
553163|NCT00821860|epithelial mesothelioma|epithelial mesothelioma
553164|NCT00821860|recurrent malignant mesothelioma|recurrent malignant mesothelioma
553165|NCT00821860|sarcomatous mesothelioma|sarcomatous mesothelioma
553166|NCT00821860|malignant pleural effusion|malignant pleural effusion
553167|NCT00821860|stage IA malignant mesothelioma|stage ia malignant mesothelioma
553168|NCT00821860|stage IB malignant mesothelioma|stage ib malignant mesothelioma
553169|NCT00821860|stage II malignant mesothelioma|stage ii malignant mesothelioma
553170|NCT00821860|stage III malignant mesothelioma|stage iii malignant mesothelioma
553171|NCT00821860|stage IV malignant mesothelioma|stage iv malignant mesothelioma
553172|NCT00821847|HIV|hiv
553173|NCT00821847|glomerular filtration rate|glomerular filtration rate
553174|NCT00821847|cockcroft|cockcroft
553175|NCT00821847|MDRD formula|mdrd formula
553176|NCT00821847|creatinine|creatinine
553177|NCT00821847|cystatin C|cystatin c
553178|NCT00821847|isotopic clearance|isotopic clearance
553179|NCT00821847|EDTA-51Cr|edta-51cr
553180|NCT00821847|DEXA scan|dexa scan
553181|NCT00821834|Old Myocardial infarction|old myocardial infarction
553182|NCT00821834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
553183|NCT00821834|Angioplasty|angioplasty
553184|NCT00821834|Transluminal|transluminal
553185|NCT00821834|Percutaneous Coronary|percutaneous coronary
553186|NCT00821834|Stents|stents
553187|NCT00821795|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
553188|NCT00821795|insulin|insulin
553189|NCT00821795|therapy|therapy
553190|NCT00821782|Bacteria|bacteria
553191|NCT00821782|Oral flora bacteria|oral flora bacteria
553192|NCT00821782|Resistance|resistance
553193|NCT00821756|Suicidal behaviour|suicidal behaviour
553194|NCT00821756|Attempted suicide|attempted suicide
553195|NCT00821756|Self harm|self harm
553196|NCT00821756|Suicide|suicide
553197|NCT00821756|Health system contacts|health system contacts
553198|NCT00821756|Contacts with health system|contacts with health system
553199|NCT00821730|Mixed methods research (qualitative and quantitative)|mixed methods research (qualitative and quantitative)
553200|NCT00821730|Peer support|peer support
553201|NCT00821730|Early inflammatory arthritis|early inflammatory arthritis
553202|NCT00821730|Self-management|self-management
553203|NCT00821730|Patient education|patient education
553204|NCT00821717|Chronic Heart Failure|chronic heart failure
553205|NCT00821717|Iron deficiency|iron deficiency
553206|NCT00821717|Iron deficiency anaemia|iron deficiency anaemia
553207|NCT00821717|Anaemia|anaemia
553208|NCT00821717|Heart disease|heart disease
553209|NCT00821691|cerebral infarction|cerebral infarction
553210|NCT00821678|telemedicine|telemedicine
553211|NCT00821678|rural|rural
553212|NCT00821678|veterans|veterans
553213|NCT00821678|care management|care management
553214|NCT00821678|psychotherapy|psychotherapy
553215|NCT00821665|Type 2 diabetes|type 2 diabetes
553216|NCT00821665|Glycemic control|glycemic control
553217|NCT00821665|(postprandial) Hyperglycemia|(postprandial) hyperglycemia
553218|NCT00821665|Sucrose|sucrose
553219|NCT00821652|Tumor|tumor
553220|NCT00821652|NY-ESO-1 expression|ny-eso-1 expression
553221|NCT00821652|Tumors that often express NY-ESO-1.|tumors that often express ny-eso-1.
553222|NCT00821626|Influenza|influenza
553223|NCT00821626|Rapid flu test|rapid flu test
553224|NCT00821626|Returning travelers with fever|returning travelers with fever
553225|NCT00821600|Risperidone|risperidone
553226|NCT00821600|Antipsychotic|antipsychotic
553227|NCT00821600|Pharmacokinetic|pharmacokinetic
553228|NCT00821600|Long-acting Injectable|long-acting injectable
553229|NCT00821587|Hepatitis C Post Liver Transplant|hepatitis c post liver transplant
553230|NCT00821574|Hypertension, dyslipidemia|hypertension, dyslipidemia
553231|NCT00821561|Persistent|persistent
553232|NCT00821561|cornea|cornea
553233|NCT00821561|defect|defect
553234|NCT00821561|Nexagon|nexagon
553235|NCT00821561|Coda|coda
553236|NCT00821548|facioscapulohumeral muscular dystrophy|facioscapulohumeral muscular dystrophy
553237|NCT00821548|electrostimulation|electrostimulation
553238|NCT00821548|training|training
553239|NCT00821535|pharmacokinetics, Japanese, healthy volunteer, maraviroc|pharmacokinetics, japanese, healthy volunteer, maraviroc
553240|NCT00821522|Acute Kidney Insufficiency|acute kidney insufficiency
553241|NCT00821522|Acute Renal Insufficiency|acute renal insufficiency
553242|NCT00821522|Acute Kidney Injury|acute kidney injury
553243|NCT00821522|Cardiac Surgical Procedures|cardiac surgical procedures
553244|NCT00821522|Ischemic Preconditioning|ischemic preconditioning
553245|NCT00821509|virus infection|virus infection
553246|NCT00821509|hygiene|hygiene
553247|NCT00821509|transmission|transmission
553248|NCT00821509|intervention|intervention
553249|NCT00821496|Multiple dose administration|multiple dose administration
553250|NCT00821496|Oral Contraceptives|oral contraceptives
553251|NCT00821470|osteonecrosis|osteonecrosis
553252|NCT00821470|bone marrow|bone marrow
553253|NCT00821470|core decompression|core decompression
553254|NCT00821470|femoral head|femoral head
553255|NCT00821457|existing scars the are two to six months old|existing scars the are two to six months old
553256|NCT00821444|schizophrenia, pharmacokinetics, bioavailability, food effect|schizophrenia, pharmacokinetics, bioavailability, food effect
553257|NCT00821405|Number : 250~300 patients|number : 250~300 patients
553258|NCT00821405|Correlation between PET, glucose loading and peritoneal thickness/calcification|correlation between pet, glucose loading and peritoneal thickness/calcification
553259|NCT00821379|PCOS|pcos
553260|NCT00821379|Polycystic Ovary Syndrome|polycystic ovary syndrome
553261|NCT00821379|Pregnancy Complications|pregnancy complications
553262|NCT00821379|Gestational Diabetes|gestational diabetes
553263|NCT00821379|Pre eclampsia|pre eclampsia
553264|NCT00821379|Prediction Model|prediction model
553265|NCT00821379|Pre conceptional|pre conceptional
553266|NCT00821366|HIV/AIDS|hiv/aids
553267|NCT00821366|Food security|food security
553268|NCT00821366|treatment experienced|treatment experienced
553269|NCT00821353|Atrial fibrillation|atrial fibrillation
553270|NCT00821353|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
553271|NCT00821353|RF ablation|rf ablation
553272|NCT00821353|Antiarrhythmic drugs|antiarrhythmic drugs
553273|NCT00821340|Leber congenital amaurosis|leber congenital amaurosis
553274|NCT00821340|LCA|lca
553275|NCT00821340|RPE65|rpe65
553276|NCT00821340|RPE65-associated Leber congenital amaurosis|rpe65-associated leber congenital amaurosis
553570|NCT00820222|lapatinib|lapatinib
553277|NCT00821340|Retinal disease due to RPE65 mutations|retinal disease due to rpe65 mutations
553278|NCT00821301|Multiple myeloma|multiple myeloma
553279|NCT00821288|cancer survivorship|cancer survivorship
553280|NCT00821288|survivorship prescription|survivorship prescription
553281|NCT00821288|cancer related anxiety|cancer related anxiety
553282|NCT00821275|Uterine Artery Embolization|uterine artery embolization
553283|NCT00821275|Leiomyoma|leiomyoma
553284|NCT00821275|myomectomy|myomectomy
553285|NCT00821275|hysterectomy|hysterectomy
553286|NCT00821275|pregnancy|pregnancy
553287|NCT00821275|complication|complication
553288|NCT00821275|ovarian function|ovarian function
553289|NCT00821275|quality of life|quality of life
553290|NCT00821262|Sevoflurane|sevoflurane
553291|NCT00821262|Anesthesia|anesthesia
553292|NCT00821262|Troponin|troponin
553293|NCT00821262|Myocardial Preconditioning|myocardial preconditioning
553294|NCT00821262|Surgery, Cardiac|surgery, cardiac
553295|NCT00821262|Stents|stents
553296|NCT00821262|Non-cardiac Surgery|non-cardiac surgery
553297|NCT00821262|Surgery|surgery
553298|NCT00821249|plasma cell dyscrasia|plasma cell dyscrasia
553299|NCT00821249|plasmacytoma|plasmacytoma
553300|NCT00821249|kinesin spindle protein|kinesin spindle protein
553301|NCT00821249|anti-mitotic|anti-mitotic
553302|NCT00821236|Myopia|myopia
553303|NCT00821236|LASIK|lasik
553304|NCT00821236|Astigmatism|astigmatism
553305|NCT00821236|Laser Vision Correction|laser vision correction
553306|NCT00821236|Excimer Laser|excimer laser
553307|NCT00821223|phacoemulsification|phacoemulsification
553308|NCT00821223|manual small incision cataract surgery|manual small incision cataract surgery
553309|NCT00821223|visual acuity|visual acuity
553310|NCT00821223|contrast sensitivity|contrast sensitivity
553311|NCT00821223|quality of vision|quality of vision
553312|NCT00821210|Obstructive sleep apnea|obstructive sleep apnea
553313|NCT00821210|myocardial infarction|myocardial infarction
553314|NCT00821197|obesity|obesity
553315|NCT00821197|laparoscopy|laparoscopy
553316|NCT00821197|bariatric|bariatric
553317|NCT00821197|super obesity|super obesity
553318|NCT00821184|urinary incontinence|urinary incontinence
553319|NCT00821184|overactive bladder|overactive bladder
553320|NCT00821184|urinary frequency|urinary frequency
553321|NCT00821145|abdominal aortic aneurysms|abdominal aortic aneurysms
553322|NCT00821132|FALS|fals
553323|NCT00821132|ALS|als
553324|NCT00821132|ALS/FTD|als/ftd
553325|NCT00821132|SALS|sals
553326|NCT00821132|MND|mnd
553327|NCT00821132|PLS|pls
553328|NCT00821119|non invasive ventilation|non invasive ventilation
553329|NCT00821119|mechanical ventilation|mechanical ventilation
553330|NCT00821119|pulmonary morbidity|pulmonary morbidity
553331|NCT00821119|preterm infant|preterm infant
553332|NCT00821119|Respiratory distress syndrome|respiratory distress syndrome
553333|NCT00821119|nasal intermittent positive pressure|nasal intermittent positive pressure
553334|NCT00821119|nasal continuous positive pressure|nasal continuous positive pressure
553335|NCT00821119|bronchopulmonary dysplasia|bronchopulmonary dysplasia
553336|NCT00821106|Coronary angiography|coronary angiography
553337|NCT00821106|percutaneous coronary intervention|percutaneous coronary intervention
553338|NCT00821106|Transradial approach|transradial approach
553339|NCT00821093|respiratory|respiratory
553340|NCT00821093|dyspnea|dyspnea
553341|NCT00821093|breathlessness|breathlessness
553342|NCT00821093|COPD|copd
553343|NCT00821093|indacaterol|indacaterol
553344|NCT00821093|long-acting β2-agonist|long-acting β2-agonist
553345|NCT00821080|vandetanib|vandetanib
553346|NCT00821080|sirolimus|sirolimus
553347|NCT00821080|recurrent glioblastoma|recurrent glioblastoma
553348|NCT00019539|adult solid tumor|adult solid tumor
553349|NCT00019539|body system/site cancer|body system/site cancer
553350|NCT00019539|cancer|cancer
553351|NCT00019539|kidney tumor|kidney tumor
553352|NCT00019539|kidney/urinary cancer|kidney/urinary cancer
553353|NCT00019539|recurrent renal cell cancer|recurrent renal cell cancer
553354|NCT00019539|renal cell cancer|renal cell cancer
553355|NCT00019539|solid tumor|solid tumor
553356|NCT00019539|stage IV renal cell cancer|stage iv renal cell cancer
553357|NCT00019539|stage, renal cell cancer|stage, renal cell cancer
553358|NCT00821054|Phase I Food Effect|phase i food effect
553359|NCT00821041|insomnia|insomnia
553360|NCT00821041|online systems|online systems
553361|NCT00821028|atherosclerosis|atherosclerosis
553362|NCT00821028|angioplasty|angioplasty
553363|NCT00821028|peripheral arterial disease|peripheral arterial disease
553364|NCT00821015|cryoablation|cryoablation
553365|NCT00821015|recurring arrhythmia|recurring arrhythmia
553366|NCT00821015|stroke|stroke
553367|NCT00821015|RF ablation|rf ablation
553368|NCT00821015|LA ablation|la ablation
553369|NCT00821015|nodal ablation|nodal ablation
553370|NCT00821015|catheter ablation|catheter ablation
553371|NCT00821002|Glaucoma|glaucoma
553372|NCT00820989|Healthy Immune System|healthy immune system
553373|NCT00820976|G-CSF|g-csf
553374|NCT00820976|AML|aml
553375|NCT00820976|survival|survival
553376|NCT00820963|adult giant cell glioblastoma|adult giant cell glioblastoma
553377|NCT00820963|adult glioblastoma|adult glioblastoma
553378|NCT00820963|adult gliosarcoma|adult gliosarcoma
553379|NCT00820924|HER-2|her-2
553380|NCT00820924|Circulating Tumour Cell (CTC)|circulating tumour cell (ctc)
553381|NCT00820924|EGFR|egfr
553382|NCT00820924|Lapatinib (GW572016)|lapatinib (gw572016)
553383|NCT00820924|Breast Cancer|breast cancer
553384|NCT00820911|Kidney transplant|kidney transplant
553385|NCT00820911|AEB071|aeb071
553386|NCT00820872|male breast cancer|male breast cancer
553387|NCT00820872|stage I breast cancer|stage i breast cancer
553388|NCT00820872|stage II breast cancer|stage ii breast cancer
553389|NCT00820872|stage IIIA breast cancer|stage iiia breast cancer
553390|NCT00820872|stage IIIB breast cancer|stage iiib breast cancer
553391|NCT00820859|Cognition disorder|cognition disorder
553392|NCT00820859|nursing home residents|nursing home residents
553393|NCT00820859|agitation|agitation
553394|NCT00820859|behavior disorder|behavior disorder
553395|NCT00820846|HIV Seronegativity|hiv seronegativity
553396|NCT00820846|HIV Preventive Vaccine|hiv preventive vaccine
553397|NCT00820833|infant formula|infant formula
553398|NCT00820833|obesity|obesity
553399|NCT00820833|growth|growth
553400|NCT00820820|Atopic Dermatitis|atopic dermatitis
553401|NCT00820820|immunosuppression|immunosuppression
553402|NCT00820820|Measles vaccine|measles vaccine
553403|NCT00820820|T lymphocytes|t lymphocytes
553404|NCT00820820|Atopic Dermatitis in adults|atopic dermatitis in adults
553405|NCT00820807|dietary fiber|dietary fiber
553406|NCT00820807|fiber|fiber
553407|NCT00820807|insulin sensitivity|insulin sensitivity
553408|NCT00820807|insulin resistance|insulin resistance
553409|NCT00820807|glucose metabolism|glucose metabolism
553410|NCT00820794|Drug-drug interaction, lithium, PD 0332334, pharmacokinetics|drug-drug interaction, lithium, pd 0332334, pharmacokinetics
553411|NCT00820781|bleeding gastric varices|bleeding gastric varices
553412|NCT00820781|cirrhosis of the liver|cirrhosis of the liver
553413|NCT00820781|portacaval shunt|portacaval shunt
553414|NCT00820781|endoscopic variceal sclerotherapy|endoscopic variceal sclerotherapy
553415|NCT00820781|endoscopic variceal ligation|endoscopic variceal ligation
553416|NCT00820781|Bleeding gastric varices due to cirrhosis of the liver|bleeding gastric varices due to cirrhosis of the liver
553417|NCT00820742|A5751025|a5751025
553418|NCT00820729|interstitial lung disease|interstitial lung disease
553419|NCT00820729|pulmonary hypertension|pulmonary hypertension
553420|NCT00820729|biomarkers|biomarkers
553421|NCT00820729|NT-pro-BNP|nt-pro-bnp
553422|NCT00820729|von Willebrand factor|von willebrand factor
553423|NCT00820729|D-dimer|d-dimer
553424|NCT00820729|Exhaled NO|exhaled no
553425|NCT00820729|Troponin-t|troponin-t
553426|NCT00820716|Asthma|asthma
553427|NCT00820716|Asthmatic subjects|asthmatic subjects
553428|NCT00820716|Exercise training|exercise training
553429|NCT00820716|Constant load|constant load
553430|NCT00820716|Alternate load|alternate load
553431|NCT00820703|Nexagon|nexagon
553432|NCT00820703|CoDa|coda
553433|NCT00820703|ulcer|ulcer
553434|NCT00820703|diabetic|diabetic
553435|NCT00820703|foot|foot
553436|NCT00820690|neoadjuvant chemotherapy|neoadjuvant chemotherapy
553437|NCT00820690|advanced breast cancer|advanced breast cancer
553438|NCT00820690|microarray|microarray
553439|NCT00820690|correlation analysis|correlation analysis
553440|NCT00820690|oncoplastic surgery|oncoplastic surgery
553441|NCT00820651|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
553442|NCT00820651|Insulinresistance|insulinresistance
553443|NCT00820651|Diet and exercise|diet and exercise
553444|NCT00820651|Nutritional supplement|nutritional supplement
553445|NCT00820651|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
553446|NCT00820651|Lifestyle modifications|lifestyle modifications
553447|NCT00820638|neurorobotics|neurorobotics
553448|NCT00820638|occupational therapy|occupational therapy
553449|NCT00820599|Sapien Valve|sapien valve
553450|NCT00820599|Cardiovascular Diseases|cardiovascular diseases
553451|NCT00820599|Valvular Heart Disease|valvular heart disease
553452|NCT00820599|Aortic Stenosis|aortic stenosis
553453|NCT00820599|Heart Valve Therapy|heart valve therapy
553454|NCT00820599|Transfemoral|transfemoral
553455|NCT00820599|Transcatheter|transcatheter
553456|NCT00820586|Intramyocardial|intramyocardial
553457|NCT00820586|Autologous|autologous
553458|NCT00820586|Bone|bone
553459|NCT00820586|Marrow|marrow
553460|NCT00820586|Randomized|randomized
553461|NCT00820586|Percutaneous|percutaneous
553462|NCT00820586|CD34+|cd34+
553463|NCT00820586|Refractory|refractory
553464|NCT00820586|Angina|angina
553465|NCT00820586|Pectoris.|pectoris.
553466|NCT00820573|Diabetes|diabetes
553467|NCT00820547|inflammatory breast cancer|inflammatory breast cancer
553468|NCT00820547|stage IIIA breast cancer|stage iiia breast cancer
553469|NCT00820547|stage IIIB breast cancer|stage iiib breast cancer
553470|NCT00820547|stage IIIC breast cancer|stage iiic breast cancer
553471|NCT00820547|male breast cancer|male breast cancer
553472|NCT00820547|HER2-negative breast cancer|her2-negative breast cancer
553473|NCT00820534|cold sore|cold sore
553474|NCT00820508|Haematological disease|haematological disease
553475|NCT00820508|Lymphoid malignancy|lymphoid malignancy
553476|NCT00820508|Histone deacetylase inhibitor|histone deacetylase inhibitor
553477|NCT00820508|dose escalation|dose escalation
553478|NCT00820495|Smokeless tobacco|smokeless tobacco
553479|NCT00820495|Chewing Tobacco|chewing tobacco
553480|NCT00820495|Internet|internet
553481|NCT00820495|Adolescent|adolescent
553482|NCT00820469|Rituximab|rituximab
553483|NCT00820469|Plasma exchange|plasma exchange
553484|NCT00820469|Autoimmune diseases|autoimmune diseases
553485|NCT00820456|colorectal cancer|colorectal cancer
553486|NCT00820456|colorectal neoplasm|colorectal neoplasm
553487|NCT00820456|colorectal neoplasms|colorectal neoplasms
553488|NCT00820456|metastasis|metastasis
553489|NCT00820456|metastases|metastases
553490|NCT00820456|liver|liver
553491|NCT00820456|hepatic metastasis|hepatic metastasis
553492|NCT00820456|liver metastasis|liver metastasis
553493|NCT00820456|perfusion imaging|perfusion imaging
553494|NCT00820456|MRI|mri
553495|NCT00820456|magnetic resonance imaging|magnetic resonance imaging
553496|NCT00820456|dynamic contrast enhanced MRI|dynamic contrast enhanced mri
553497|NCT00820456|dynamic contrast enhanced magnetic resonance imaging|dynamic contrast enhanced magnetic resonance imaging
553498|NCT00820430|osteoarthritis|osteoarthritis
553499|NCT00820430|knee|knee
553500|NCT00820430|magnetic resonance imaging|magnetic resonance imaging
553501|NCT00820430|knee cartilage|knee cartilage
553502|NCT00820430|reproducibility|reproducibility
553503|NCT00820417|cetuximab|cetuximab
553504|NCT00820417|monoclonal|monoclonal
553505|NCT00820417|antibody|antibody
553506|NCT00820417|epidermal|epidermal
553507|NCT00820417|growth|growth
553508|NCT00820417|factor|factor
553509|NCT00820417|receptor|receptor
553510|NCT00820417|EGFR|egfr
553511|NCT00820417|Gefitinib|gefitinib
553512|NCT00820417|tyrosine|tyrosine
553513|NCT00820417|kinase|kinase
553514|NCT00820417|inhibitor|inhibitor
553515|NCT00820417|advanced|advanced
553516|NCT00820417|cancer|cancer
553517|NCT00820391|Post-traumatic Stress disorder (PTSD)|post-traumatic stress disorder (ptsd)
553518|NCT00820378|Aortic dimension|aortic dimension
553519|NCT00820378|Atherosclerosis|atherosclerosis
553520|NCT00820378|Vascular disease|vascular disease
553521|NCT00820378|Risk factors|risk factors
553522|NCT00820365|Inflammatory Bowel Disease (IBD)|inflammatory bowel disease (ibd)
553523|NCT00820365|Crohn's Disease|crohn's disease
553524|NCT00820365|Ulcerative Colitis|ulcerative colitis
553525|NCT00820365|SC12267|sc12267
553526|NCT00820365|4SC-101|4sc-101
553527|NCT00820365|Phase II|phase ii
553528|NCT00820352|HFNEF|hfnef
553529|NCT00820352|HFPEF|hfpef
553530|NCT00820352|Secondary Pulmonary Hypertension|secondary pulmonary hypertension
553531|NCT00820352|Endothelin Receptor Blockade|endothelin receptor blockade
553532|NCT00820339|hepatocellular carcinoma|hepatocellular carcinoma
553533|NCT00820339|hepatic vein|hepatic vein
553534|NCT00820339|Surgical resection|surgical resection
553535|NCT00820339|occlusion|occlusion
553536|NCT00820339|time to recurrence|time to recurrence
553537|NCT00820339|overall survival|overall survival
553538|NCT00820313|Coronary Heart Disease|coronary heart disease
553539|NCT00820313|Biomarkers of Cardiovascular Disease|biomarkers of cardiovascular disease
553540|NCT00820313|Health Related Quality of Life|health related quality of life
553541|NCT00820313|Diabetes|diabetes
553542|NCT00820313|Diet|diet
553543|NCT00820287|Testicular cancer|testicular cancer
553544|NCT00820287|incidence|incidence
553545|NCT00820287|young men|young men
553546|NCT00820261|Genotypes|genotypes
553547|NCT00820261|Epidemiology|epidemiology
553548|NCT00820261|Diarrhea|diarrhea
553549|NCT00820248|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
553550|NCT00820248|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
553551|NCT00820248|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
553552|NCT00820248|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
553553|NCT00820248|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
553554|NCT00820248|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
553555|NCT00820248|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
553556|NCT00820248|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
553557|NCT00820248|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
553558|NCT00820248|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
553559|NCT00820248|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
553560|NCT00820248|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
553561|NCT00820222|ErbB2|erbb2
553562|NCT00820222|HERCEPTIN|herceptin
553563|NCT00820222|XELODA|xeloda
553564|NCT00820222|ErbB1|erbb1
553565|NCT00820222|TYKERB|tykerb
553566|NCT00820222|metastatic breast cancer|metastatic breast cancer
553567|NCT00820222|trastuzumab|trastuzumab
553568|NCT00820222|breast cancer|breast cancer
553569|NCT00820222|capecitabine|capecitabine
553571|NCT00820222|brain metastases|brain metastases
553572|NCT00820222|HER2 positive|her2 positive
553573|NCT00820222|TYVERB|tyverb
553574|NCT00820196|Venous ulcer|venous ulcer
553575|NCT00820196|Nexagon|nexagon
553576|NCT00820196|CoDa|coda
553577|NCT00820183|Hypertension|hypertension
553578|NCT00820183|Intervention|intervention
553579|NCT00820183|Primary Care|primary care
553580|NCT00820183|Quality improvement|quality improvement
553581|NCT00820170|Breast|breast
553582|NCT00820170|Cancer|cancer
553583|NCT00820170|DASATINIB|dasatinib
553584|NCT00820170|TAXOL (PACLITAXEL)|taxol (paclitaxel)
553585|NCT00820170|08-122|08-122
553586|NCT00820157|Carcinoma, Hepatocellular|carcinoma, hepatocellular
553587|NCT00820157|Chemoembolization, Therapeutic|chemoembolization, therapeutic
553588|NCT00820157|Cytoreductive|cytoreductive
553589|NCT00820144|immune response|immune response
553590|NCT00820144|b-subunit of cholera toxin|b-subunit of cholera toxin
553591|NCT00820144|mucosal way|mucosal way
553592|NCT00820144|healthy volonteers|healthy volonteers
553593|NCT00820144|vaccine|vaccine
553594|NCT00820118|ANTIRETROVIRAL THERAPY|antiretroviral therapy
553595|NCT00820118|STRUCTURED TREATMENT INTERRUPTIONS|structured treatment interruptions
553596|NCT00820118|treatment naive|treatment naive
553597|NCT00820105|Migraine|migraine
553598|NCT00820105|Aura|aura
553599|NCT00820105|Migraine headache|migraine headache
553600|NCT00820092|Xerecept|xerecept
553601|NCT00820092|Pharmacokinetics|pharmacokinetics
553602|NCT00820092|Japanese versus Caucasians|japanese versus caucasians
553603|NCT00820079|Gastroesophageal reflux|gastroesophageal reflux
553604|NCT00820079|Heartburn|heartburn
553605|NCT00820079|Regurgitation|regurgitation
553606|NCT00820053|hepatocellular carcinoma|hepatocellular carcinoma
553607|NCT00820053|adjuvant therapy|adjuvant therapy
553608|NCT00820053|TACE|tace
553609|NCT00820053|time to recurrence|time to recurrence
553610|NCT00820053|overall survival|overall survival
553611|NCT00820014|ESBA105|esba105
553612|NCT00820014|scFv antibody fragment|scfv antibody fragment
553613|NCT00820014|cataract surgery|cataract surgery
553614|NCT00820014|pharmacokinetics|pharmacokinetics
553615|NCT00820014|biodistribution|biodistribution
553616|NCT00820014|Irvine-Gass syndrome|irvine-gass syndrome
553617|NCT00820001|Cognitive Behavioral Therapy|cognitive behavioral therapy
553618|NCT00820001|Multimodal Treatment|multimodal treatment
553619|NCT00820001|Physiological Parameters|physiological parameters
553620|NCT00820001|Hormone Concentration in pubertal development|hormone concentration in pubertal development
553621|NCT00820001|Treatment as usual comparison|treatment as usual comparison
553622|NCT00819988|Postoperative|postoperative
553623|NCT00819988|Perioperative|perioperative
553624|NCT00819988|Orthopedic surgery|orthopedic surgery
553625|NCT00819988|Vascular surgery|vascular surgery
553626|NCT00819988|Gabapentinoid|gabapentinoid
553627|NCT00819975|Casein|casein
553628|NCT00819975|Whey|whey
553629|NCT00819975|postprandial|postprandial
553630|NCT00819975|Triglyceride|triglyceride
553631|NCT00819975|Free fatty acids|free fatty acids
553632|NCT00819975|Retinyl palmitate|retinyl palmitate
553633|NCT00819975|Incretins|incretins
553634|NCT00819975|Type 2 Diabetes|type 2 diabetes
553635|NCT00819949|Robot|robot
553636|NCT00819949|Treadmill|treadmill
553637|NCT00819949|Rehabilitation|rehabilitation
553638|NCT00819949|Freezing of gait|freezing of gait
553639|NCT00819936|abdominal aorta surgery|abdominal aorta surgery
553640|NCT00819936|Physical Training|physical training
553641|NCT00819936|backward walking|backward walking
553642|NCT00819936|physiotherapy|physiotherapy
553643|NCT00819923|Titanium|titanium
553644|NCT00819923|everolimus|everolimus
553645|NCT00819923|drug eluting stent|drug eluting stent
553646|NCT00819923|stent thrombosis|stent thrombosis
553647|NCT00819923|restenosis|restenosis
553648|NCT00819923|percutaneous coronary intervention|percutaneous coronary intervention
553649|NCT00819923|acute coronary syndrome|acute coronary syndrome
553650|NCT00819910|Type 4 hyperlipidemia|type 4 hyperlipidemia
553651|NCT00819910|Rosiglitazone|rosiglitazone
553652|NCT00819910|Fenofibrate|fenofibrate
553653|NCT00819897|MS|ms
553654|NCT00819897|CIS|cis
553655|NCT00819897|IFN|ifn
553656|NCT00819897|MRI|mri
553657|NCT00819897|OCT|oct
553658|NCT00819897|QOL|qol
553659|NCT00819884|Type II Diabetes|type ii diabetes
553660|NCT00819884|24 hour glucose profile|24 hour glucose profile
553661|NCT00819858|weight loss|weight loss
553662|NCT00819858|weight gain|weight gain
553663|NCT00819858|malnutrition|malnutrition
553664|NCT00819858|convalescence|convalescence
553665|NCT00819858|malaria|malaria
553666|NCT00819858|RUTF|rutf
553667|NCT00819858|RUF|ruf
553668|NCT00819858|supplementation|supplementation
553669|NCT00819858|nutrition|nutrition
553670|NCT00819845|Duchenne|duchenne
553671|NCT00819845|Becker muscular dystrophy|becker muscular dystrophy
553672|NCT00819845|cardioprotective therapy|cardioprotective therapy
553673|NCT00819845|cardiac magnetic resonance|cardiac magnetic resonance
553674|NCT00819845|ultrasound tissue characterization|ultrasound tissue characterization
553675|NCT00819832|vertebral compression fractures|vertebral compression fractures
553676|NCT00819832|VCF|vcf
553677|NCT00819832|Spinal|spinal
553678|NCT00819832|Broken spinal bones|broken spinal bones
553679|NCT00819832|Kyphoplasty|kyphoplasty
553680|NCT00819832|vertebroplasty|vertebroplasty
553681|NCT00819832|Cavity SpineWand|cavity spinewand
553682|NCT00819832|Circulating Tumor Cell Burden|circulating tumor cell burden
553683|NCT00819832|CTCB|ctcb
553684|NCT00819832|Spine pain|spine pain
553685|NCT00819832|Coblation|coblation
553686|NCT00819832|plasma radiofrequency ablation|plasma radiofrequency ablation
553687|NCT00819832|Plasma-mediated ablation technology|plasma-mediated ablation technology
553688|NCT00819832|precise molecular dissociation (ablation) process|precise molecular dissociation (ablation) process
553689|NCT00819832|medical cement|medical cement
553690|NCT00819793|Cardiac Dysfunction|cardiac dysfunction
553691|NCT00819793|Failure-to-wean from CPB|failure-to-wean from cpb
553692|NCT00819793|CentriMag|centrimag
553693|NCT00819793|Levitronix|levitronix
553694|NCT00819793|Thoratec Corporation|thoratec corporation
553695|NCT00819780|Colon Cancer|colon cancer
553696|NCT00819780|Colorectal Cancer|colorectal cancer
553697|NCT00819780|Rectal Cancer|rectal cancer
553698|NCT00819780|Panitumumab|panitumumab
553699|NCT00819780|Vectibix|vectibix
553700|NCT00819780|modified FOLFOX 6|modified folfox 6
553701|NCT00819780|mFOLFOX 6|mfolfox 6
553702|NCT00819780|FOLFOX|folfox
553703|NCT00819780|Bevacizumab|bevacizumab
553704|NCT00819780|Avastin|avastin
553705|NCT00819780|First-Line|first-line
553706|NCT00819780|metastatic|metastatic
553707|NCT00819767|hypertension|hypertension
553708|NCT00819767|systolic blood pressure|systolic blood pressure
553709|NCT00819767|exercise test|exercise test
553710|NCT00819767|cardiovascular disease|cardiovascular disease
553711|NCT00819767|aliskiren|aliskiren
553712|NCT00819767|valsartan|valsartan
553713|NCT00819715|Preterm infants|preterm infants
553714|NCT00819715|small for gestational age|small for gestational age
553715|NCT00819715|electrogastrography|electrogastrography
553716|NCT00819702|child abuse prevention|child abuse prevention
553717|NCT00819702|primary care|primary care
553718|NCT00819702|professional education in primary care|professional education in primary care
553719|NCT00819650|hepatocellular carcinoma|hepatocellular carcinoma
553720|NCT00819650|adjuvant therapy|adjuvant therapy
553721|NCT00819650|Licartin|licartin
553722|NCT00819650|time to recurrence|time to recurrence
553723|NCT00819650|overall survival|overall survival
553724|NCT00819637|Acute asthma|acute asthma
553725|NCT00819637|Arformoterol|arformoterol
553726|NCT00819637|Long acting beta agonists|long acting beta agonists
553727|NCT00819624|fibromyalgia methodology pain sleep fatigue|fibromyalgia methodology pain sleep fatigue
553728|NCT00819611|Attention deficit disorder with hyperactivity|attention deficit disorder with hyperactivity
553729|NCT00819611|Working memory training|working memory training
553730|NCT00819611|Placebo|placebo
553731|NCT00819611|Behavioral symptoms|behavioral symptoms
553732|NCT00819611|Neuropsychology|neuropsychology
553733|NCT00819611|Electropsychophysiology|electropsychophysiology
553734|NCT00819585|Gout|gout
553735|NCT00819585|Chronic Gout|chronic gout
553736|NCT00819585|Gouty arthritis|gouty arthritis
553737|NCT00819585|Gout flares|gout flares
553738|NCT00819572|Osteoarthritis|osteoarthritis
553739|NCT00819572|TNF-alpha|tnf-alpha
553740|NCT00819572|DLX105|dlx105
553741|NCT00819572|scFv antibody fragment|scfv antibody fragment
553742|NCT00819572|pain|pain
553743|NCT00819572|fragment|fragment
553744|NCT00819572|antibody fragment|antibody fragment
553745|NCT00819559|Rectal neoplasm|rectal neoplasm
553746|NCT00819559|Clinical stage|clinical stage
553747|NCT00819559|T3N0|t3n0
553748|NCT00819559|Preoperative chemoradiotherapy|preoperative chemoradiotherapy
553749|NCT00819559|Laparoscopic|laparoscopic
553750|NCT00819559|Open resection|open resection
553751|NCT00819546|AML|aml
553752|NCT00819546|MDS|mds
553753|NCT00819520|pediculosis capitis|pediculosis capitis
553754|NCT00819520|pediculus|pediculus
553755|NCT00819507|Skin barrier|skin barrier
553756|NCT00819507|Atopic Dermatitis|atopic dermatitis
553757|NCT00819507|Corticosteroid|corticosteroid
553758|NCT00819507|Effects on skin severity and barrier function|effects on skin severity and barrier function
553759|NCT00819494|Contrast media skin test|contrast media skin test
553760|NCT00819494|Skin test|skin test
553761|NCT00819494|hypersensitivity|hypersensitivity
553762|NCT00819494|contrast media|contrast media
553763|NCT00819481|Total knee replacement|total knee replacement
553764|NCT00819455|Diabetes|diabetes
553765|NCT00819455|Prevention of Diabetes|prevention of diabetes
553766|NCT00819455|Lifestyle Modification|lifestyle modification
553767|NCT00819455|Text messages|text messages
553768|NCT00819442|heart failure|heart failure
553769|NCT00819442|desmin|desmin
553770|NCT00819442|ubiquitin|ubiquitin
553771|NCT00819429|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
553772|NCT00819429|Conduct Disorder|conduct disorder
553773|NCT00819429|Oppositional Defiant Disorder|oppositional defiant disorder
553774|NCT00819429|Omega 3 Supplements|omega 3 supplements
553775|NCT00819429|Social Skills Training|social skills training
553776|NCT00819429|Dietary Intake|dietary intake
553777|NCT00819429|Aggression|aggression
553778|NCT00819429|Nutrition|nutrition
553779|NCT00819429|Disruptive Behaviors Disorder|disruptive behaviors disorder
553780|NCT00819416|randomized controlled trial|randomized controlled trial
553781|NCT00819416|clinical trial|clinical trial
553782|NCT00819403|triglycerides|triglycerides
553783|NCT00819403|hypertension|hypertension
553784|NCT00819403|low hdl|low hdl
553785|NCT00819403|obesity|obesity
553786|NCT00819377|Valvular surgery|valvular surgery
553787|NCT00819377|pulmonary artery pressure|pulmonary artery pressure
553788|NCT00819364|Autism|autism
553789|NCT00819364|early intervention|early intervention
553790|NCT00819364|BCRI model|bcri model
553791|NCT00819351|acute lymphoblastic leukemia|acute lymphoblastic leukemia
553792|NCT00819351|child|child
553793|NCT00819351|PEG-Asparaginase|peg-asparaginase
553794|NCT00819351|EFS|efs
553795|NCT00819351|efficacy|efficacy
553796|NCT00819351|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
553797|NCT00819338|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
553798|NCT00819338|Polyunsaturated fatty acids|polyunsaturated fatty acids
553799|NCT00819338|Omega-3|omega-3
553800|NCT00819325|diabetes|diabetes
553801|NCT00819325|stents|stents
553802|NCT00819325|restenosis|restenosis
553803|NCT00819325|thiazolidinediones|thiazolidinediones
553804|NCT00819325|coronary atherosclerosis|coronary atherosclerosis
553805|NCT00819312|Contraceptives,|contraceptives,
553806|NCT00819312|Oral Hormonal;|oral hormonal;
553807|NCT00819312|Contraceptive Methods;|contraceptive methods;
553808|NCT00819312|Female|female
553809|NCT00819299|Presbyopia|presbyopia
553810|NCT00819299|accommodation|accommodation
553811|NCT00819299|near visual acuity|near visual acuity
553812|NCT00819299|LASIK|lasik
553813|NCT00819286|open heart surgery|open heart surgery
553814|NCT00819273|hsCRP|hscrp
553815|NCT00819260|Mammaplasty|mammaplasty
553816|NCT00819260|Electrocoagulation|electrocoagulation
553817|NCT00819260|Breast|breast
553818|NCT00819234|Leptin|leptin
553819|NCT00819234|Pramlintide|pramlintide
553820|NCT00819234|Obese|obese
553821|NCT00819234|Symlin|symlin
553822|NCT00819234|Amylin|amylin
553823|NCT00819221|advanced tumors|advanced tumors
553824|NCT00819221|solid tumors|solid tumors
553825|NCT00819221|dose escalation|dose escalation
553826|NCT00819221|combination|combination
553827|NCT00819221|AZD2281|azd2281
553828|NCT00819221|liposomal doxorubicin|liposomal doxorubicin
553829|NCT00819221|pharmacology|pharmacology
553830|NCT00819221|phase I|phase i
553831|NCT00819221|multicenter|multicenter
553832|NCT00819208|fatigue|fatigue
553833|NCT00819208|sleep disorders|sleep disorders
553834|NCT00819208|depression|depression
553835|NCT00819208|anxiety disorder|anxiety disorder
553836|NCT00819208|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
553837|NCT00819208|cognitive/functional effects|cognitive/functional effects
553838|NCT00819208|stage II colon cancer|stage ii colon cancer
553839|NCT00819208|stage III colon cancer|stage iii colon cancer
553840|NCT00819208|adenocarcinoma of the colon|adenocarcinoma of the colon
553841|NCT00819195|relapsing-remitting|relapsing-remitting
553842|NCT00819195|multiple sclerosis|multiple sclerosis
553843|NCT00819195|Copaxone|copaxone
553844|NCT00819195|glatiramer acetate|glatiramer acetate
553845|NCT00819195|MS|ms
553846|NCT00819182|Menopause|menopause
553847|NCT00819182|Breast Cancer|breast cancer
553848|NCT00819182|Hot Flash|hot flash
553849|NCT00819182|Night Sweats|night sweats
553850|NCT00819169|AMG 655|amg 655
553851|NCT00819169|AMG 479|amg 479
553852|NCT00819169|Apoptosis|apoptosis
553853|NCT00819169|Monoclonal Antibody|monoclonal antibody
553854|NCT00819169|Tumor Necrosis Factor|tumor necrosis factor
553855|NCT00819169|Insulin-like Growth Factor|insulin-like growth factor
553856|NCT00819143|Tissue Procurement|tissue procurement
553857|NCT00819143|Sample Collection|sample collection
553858|NCT00819143|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
553859|NCT00819143|Laboratory Research|laboratory research
553860|NCT00819117|Epicardial leads|epicardial leads
553861|NCT00819117|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
553862|NCT00819104|Primary hypertension|primary hypertension
553863|NCT00819104|Metoprolol XL|metoprolol xl
553864|NCT00819104|Amlodipine|amlodipine
553865|NCT00819078|adolescent|adolescent
553866|NCT00819078|bupropion|bupropion
553867|NCT00819078|smoking|smoking
553868|NCT00819078|cessation|cessation
553869|NCT00819078|depression|depression
553870|NCT00819065|Botulinum toxin A|botulinum toxin a
553871|NCT00819065|Spasticity|spasticity
553872|NCT00819065|Randomized Clinical Trial|randomized clinical trial
553873|NCT00819000|Specialty Pharmacy|specialty pharmacy
553874|NCT00819000|Therapy Management|therapy management
553875|NCT00819000|Medication Compliance|medication compliance
553876|NCT00819000|Medication Adherence|medication adherence
553877|NCT00819000|Medication Persistence|medication persistence
553878|NCT00819000|Health Outcomes|health outcomes
553879|NCT00818987|Operative|operative
553880|NCT00818987|Non operative|non operative
553881|NCT00818961|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
553882|NCT00818961|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
553883|NCT00818961|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
553884|NCT00818961|adult AML with 11q23 (MLL) abnormalities|adult aml with 11q23 (mll) abnormalities
553885|NCT00818961|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
553886|NCT00818961|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
553887|NCT00818961|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
553888|NCT00818961|prolymphocytic leukemia|prolymphocytic leukemia
553889|NCT00818961|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
553890|NCT00818961|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
553891|NCT00818961|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
553892|NCT00818961|secondary acute myeloid leukemia|secondary acute myeloid leukemia
553893|NCT00818961|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
553894|NCT00818961|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
553895|NCT00818961|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
553896|NCT00818961|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
553897|NCT00818961|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
553898|NCT00818961|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
553899|NCT00818961|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
553900|NCT00818961|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
553901|NCT00818961|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
553902|NCT00818961|anaplastic large cell lymphoma|anaplastic large cell lymphoma
553903|NCT00818961|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
553904|NCT00818961|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
553905|NCT00818961|recurrent cutaneous T-cell NHL|recurrent cutaneous t-cell nhl
553906|NCT00818961|stage I cutaneous T-cell NHL|stage i cutaneous t-cell nhl
553907|NCT00818961|stage II cutaneous T-cell NHL|stage ii cutaneous t-cell nhl
553908|NCT00818961|stage III cutaneous T-cell NHL|stage iii cutaneous t-cell nhl
553909|NCT00818961|stage IV cutaneous T-cell NHL|stage iv cutaneous t-cell nhl
553910|NCT00818961|extranodal marginal zone B-cell lymphoma of mucosal tissue|extranodal marginal zone b-cell lymphoma of mucosal tissue
553911|NCT00818961|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
553912|NCT00818961|splenic marginal zone lymphoma|splenic marginal zone lymphoma
553913|NCT00818961|contiguous st II adult diffuse large cell lymphoma|contiguous st ii adult diffuse large cell lymphoma
553914|NCT00818961|contiguous st II adult diffuse mixed cell lymphoma|contiguous st ii adult diffuse mixed cell lymphoma
553915|NCT00818961|contiguous st II adult diffuse sm cleaved cell lymphoma|contiguous st ii adult diffuse sm cleaved cell lymphoma
553916|NCT00818961|contiguous st II grade 1 follicular lymphoma|contiguous st ii grade 1 follicular lymphoma
553917|NCT00818961|contiguous st II grade 2 follicular lymphoma|contiguous st ii grade 2 follicular lymphoma
553918|NCT00818961|contiguous st II grade 3 follicular lymphoma|contiguous st ii grade 3 follicular lymphoma
553919|NCT00818961|contiguous st II mantle cell lymphoma|contiguous st ii mantle cell lymphoma
553920|NCT00818961|contiguous st II marginal zone lymphoma|contiguous st ii marginal zone lymphoma
553921|NCT00818961|contiguous st II small lymphocytic lymphoma|contiguous st ii small lymphocytic lymphoma
553922|NCT00818961|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
553923|NCT00818961|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
553924|NCT00818961|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
553925|NCT00818961|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
553926|NCT00818961|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
553927|NCT00818961|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
553928|NCT00818961|stage I mantle cell lymphoma|stage i mantle cell lymphoma
553929|NCT00818961|stage I marginal zone lymphoma|stage i marginal zone lymphoma
553930|NCT00818961|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
553931|NCT00818961|noncontiguous st II adult diffuse large cell lymphoma|noncontiguous st ii adult diffuse large cell lymphoma
553932|NCT00818961|noncontiguous st II adult diffuse mixed cell lymphoma|noncontiguous st ii adult diffuse mixed cell lymphoma
553933|NCT00818961|noncontiguous st II adult diffuse sm cleaved cell lymphoma|noncontiguous st ii adult diffuse sm cleaved cell lymphoma
553934|NCT00818961|noncontiguous st II grade 1 follicular lymphoma|noncontiguous st ii grade 1 follicular lymphoma
553935|NCT00818961|noncontiguous st II grade 2 follicular lymphoma|noncontiguous st ii grade 2 follicular lymphoma
553936|NCT00818961|noncontiguous st II grade 3 follicular lymphoma|noncontiguous st ii grade 3 follicular lymphoma
553937|NCT00818961|noncontiguous st II mantle cell lymphoma|noncontiguous st ii mantle cell lymphoma
553938|NCT00818961|noncontiguous st II marginal zone lymphoma|noncontiguous st ii marginal zone lymphoma
553939|NCT00818961|noncontiguous st II small lymphocytic lymphoma|noncontiguous st ii small lymphocytic lymphoma
553940|NCT00818961|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
553941|NCT00818961|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
553942|NCT00818961|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
554414|NCT00817362|Trastuzumab|trastuzumab
553943|NCT00818961|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
553944|NCT00818961|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
553945|NCT00818961|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
553946|NCT00818961|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
553947|NCT00818961|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
553948|NCT00818961|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
553949|NCT00818961|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
553950|NCT00818961|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
553951|NCT00818961|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
553952|NCT00818961|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
553953|NCT00818961|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
553954|NCT00818961|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
553955|NCT00818961|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
553956|NCT00818961|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
553957|NCT00818961|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
553958|NCT00818961|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
553959|NCT00818961|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
553960|NCT00818961|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
553961|NCT00818961|recurrent adult gr III lymphomatoid granulomatosis|recurrent adult gr iii lymphomatoid granulomatosis
553962|NCT00818961|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
553963|NCT00818961|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
553964|NCT00818961|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
553965|NCT00818961|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
553966|NCT00818961|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
553967|NCT00818961|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
553968|NCT00818961|de novo MDS|de novo mds
553969|NCT00818961|previously treated MDS|previously treated mds
553970|NCT00818961|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
553971|NCT00818961|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
553972|NCT00818961|myelodysplastic/myeloproliferative disease|myelodysplastic/myeloproliferative disease
553973|NCT00818948|Lupus|lupus
553974|NCT00818948|Nephritis|nephritis
553975|NCT00818909|Dry eye|dry eye
553976|NCT00818909|Systane|systane
553977|NCT00818909|Moderate to severe dry eye|moderate to severe dry eye
553978|NCT00818896|thyroid deficiency|thyroid deficiency
553979|NCT00818896|pregnancy|pregnancy
553980|NCT00818896|post-partum thyroid dysfunction|post-partum thyroid dysfunction
553981|NCT00818896|permanent hypothyroidism|permanent hypothyroidism
553982|NCT00818883|Essential Hypertension|essential hypertension
553983|NCT00818883|Hypertensive|hypertensive
553984|NCT00818883|Blood Pressure, High|blood pressure, high
553985|NCT00818883|Vascular Disease|vascular disease
553986|NCT00818883|Cardiovascular Disease|cardiovascular disease
553987|NCT00818883|Drug Therapy|drug therapy
553988|NCT00818870|Gastroesophageal Reflux|gastroesophageal reflux
553989|NCT00818870|GERD|gerd
553990|NCT00818870|Nocturnal GERD|nocturnal gerd
553991|NCT00818870|Heartburn|heartburn
553992|NCT00818870|Nighttime Heartburn|nighttime heartburn
553993|NCT00818870|Nocturnal Heartburn|nocturnal heartburn
553994|NCT00818857|cancer screening|cancer screening
553995|NCT00818857|screening disparities|screening disparities
553996|NCT00818857|underserved populations|underserved populations
553997|NCT00818844|Nepafenac|nepafenac
553998|NCT00818844|vitrectomy surgery|vitrectomy surgery
553999|NCT00818844|Epiretinal membrane surgery|epiretinal membrane surgery
554000|NCT00818831|Advanced, refractory solid tumors|advanced, refractory solid tumors
554001|NCT00818818|Leishmaniasis|leishmaniasis
554002|NCT00818818|Cutaneous leishmaniasis|cutaneous leishmaniasis
554003|NCT00818818|Leishmania braziliensis|leishmania braziliensis
554004|NCT00818818|Pentavalent antimonial|pentavalent antimonial
554005|NCT00818818|Glucantime|glucantime
554006|NCT00818805|conjunctivitis|conjunctivitis
554007|NCT00818792|Percutaneous coronary intervention|percutaneous coronary intervention
554008|NCT00818792|Drug-eluting stent|drug-eluting stent
554009|NCT00818792|Chronic kidney disease|chronic kidney disease
554010|NCT00818792|Restenosis|restenosis
554011|NCT00818779|diabetes|diabetes
554012|NCT00818779|heart disease|heart disease
554013|NCT00818779|atherosclerosis|atherosclerosis
554014|NCT00818766|Thoracic Surgery|thoracic surgery
554015|NCT00818766|Antibiotic Prophylaxis|antibiotic prophylaxis
554016|NCT00818766|Chest Tube|chest tube
554017|NCT00818727|Bone density|bone density
554018|NCT00818727|SSRI|ssri
554019|NCT00818727|newborn infants|newborn infants
554020|NCT00818714|IIIA, selected IIIB|iiia, selected iiib
554021|NCT00818714|(T1N2-3M0, T2N2-3M0, T3N1-3M0)|(t1n2-3m0, t2n2-3m0, t3n1-3m0)
554022|NCT00818701|Congestive Heart Failure|congestive heart failure
554023|NCT00818701|Congestive Heart Failure with a NYHF Class 2-3|congestive heart failure with a nyhf class 2-3
554024|NCT00818701|Ejection Fraction of 35 or less|ejection fraction of 35 or less
554025|NCT00818688|Superficial thrombophlebitis (ST)|superficial thrombophlebitis (st)
554026|NCT00818688|Deep-vein thrombosis|deep-vein thrombosis
554027|NCT00818688|Symptomatic pulmonary embolism|symptomatic pulmonary embolism
554028|NCT00818688|Symptomatic Superficial Thrombophlebitis of the lower limbs|symptomatic superficial thrombophlebitis of the lower limbs
554029|NCT00818662|Alzheimer´s|alzheimer´s
554030|NCT00818662|Dementia|dementia
554031|NCT00818662|Dementia of Alzheimer Type|dementia of alzheimer type
554032|NCT00818662|Immunoglobulins|immunoglobulins
554033|NCT00818662|Gammaglobulins|gammaglobulins
554034|NCT00818662|Immune Globulin Intravenous (IGIV)|immune globulin intravenous (igiv)
554035|NCT00818662|Intravenous Immune Globulin (IVIG)|intravenous immune globulin (ivig)
554036|NCT00818662|Antibodies|antibodies
554037|NCT00818662|Amyloid|amyloid
554038|NCT00818662|Immunotherapy|immunotherapy
554039|NCT00818649|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
554040|NCT00818649|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
554041|NCT00818649|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
554042|NCT00818649|refractory anemia with excess blasts|refractory anemia with excess blasts
554043|NCT00818649|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
554044|NCT00818649|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
554045|NCT00818649|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
554046|NCT00818649|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
554047|NCT00818649|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
554048|NCT00818649|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
554049|NCT00818649|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
554050|NCT00818649|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
554051|NCT00818649|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
554052|NCT00818649|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
554053|NCT00818649|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
554054|NCT00818649|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
554055|NCT00818649|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
554056|NCT00818649|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
554057|NCT00818649|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
554058|NCT00818636|expressive writing|expressive writing
554059|NCT00818636|ruminating|ruminating
554060|NCT00818636|ruminative thinking|ruminative thinking
554061|NCT00818636|experiential avoidance|experiential avoidance
554062|NCT00818636|depression|depression
554063|NCT00818636|alcohol|alcohol
554064|NCT00818636|drinking|drinking
554065|NCT00818636|emotional processing|emotional processing
554066|NCT00818610|Community-acquired infections|community-acquired infections
554067|NCT00818610|Pneumonia|pneumonia
554068|NCT00818610|Clinical Stability|clinical stability
554069|NCT00818610|Antibiotics|antibiotics
554070|NCT00818610|Combination therapy|combination therapy
554071|NCT00818610|Atypical bacteria|atypical bacteria
554072|NCT00818597|septic shock|septic shock
554073|NCT00818597|immunoparalysis|immunoparalysis
554074|NCT00818597|extracorporeal|extracorporeal
554075|NCT00818597|granulocyte bioreactor|granulocyte bioreactor
554076|NCT00818597|plasmapheresis|plasmapheresis
554077|NCT00818584|Micafungin|micafungin
554078|NCT00818584|Candida|candida
554079|NCT00818584|Neonates|neonates
554080|NCT00818584|Mycamine|mycamine
554081|NCT00818584|FK463|fk463
554082|NCT00818571|Renal impairment|renal impairment
554083|NCT00818571|Diabetes|diabetes
554084|NCT00818571|vildagliptin|vildagliptin
554085|NCT00818571|Galvus|galvus
554086|NCT00818571|Eucreas|eucreas
554087|NCT00818558|non small cell lung cancer|non small cell lung cancer
554088|NCT00818545|aging|aging
554089|NCT00818545|barrier function|barrier function
554090|NCT00818545|transcriptomic|transcriptomic
554091|NCT00818532|Corneal astigmatism|corneal astigmatism
554092|NCT00818532|Low diopter|low diopter
554093|NCT00818532|Corneal measurement|corneal measurement
554094|NCT00818532|Corneal astigmatism < 1 Diopter|corneal astigmatism < 1 diopter
554095|NCT00818519|Moderate Acne Vulgaris|moderate acne vulgaris
554096|NCT00818519|Oral contraceptive|oral contraceptive
554097|NCT00818519|Female|female
554098|NCT00818506|Depression|depression
554099|NCT00818506|Major depressive disorder|major depressive disorder
554100|NCT00818506|Coronary artery disease|coronary artery disease
554101|NCT00818506|White Matter Hyperintensities|white matter hyperintensities
554102|NCT00818506|White Matter Lesions|white matter lesions
554103|NCT00818506|Coronary artery calcification|coronary artery calcification
554104|NCT00818493|total knee arthroplasty|total knee arthroplasty
554105|NCT00818493|total hip arthroplasty|total hip arthroplasty
554106|NCT00818480|prostate cancer|prostate cancer
554107|NCT00818480|melanoma|melanoma
554108|NCT00818480|lymphoma|lymphoma
554109|NCT00818480|YM155|ym155
554110|NCT00818467|Skin tone|skin tone
554111|NCT00818467|Vitamin D|vitamin d
554112|NCT00818441|lung cancer adenocarcinoma HER2|lung cancer adenocarcinoma her2
554113|NCT00818428|Phonological Awareness|phonological awareness
554114|NCT00818428|Speech Articulation Disorder|speech articulation disorder
554115|NCT00818428|Development Articulation Disorder|development articulation disorder
554116|NCT00818428|Phonological Impairment|phonological impairment
554117|NCT00818428|Dyslexia|dyslexia
554118|NCT00818428|Speech Therapy|speech therapy
554119|NCT00818428|School Transition|school transition
554120|NCT00818402|Quality of life|quality of life
554121|NCT00818402|symptoms|symptoms
554122|NCT00818389|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
554123|NCT00818389|ALS|als
554124|NCT00818389|Lou Gehrig's disease|lou gehrig's disease
554125|NCT00818389|riluzole|riluzole
554126|NCT00818389|lithium|lithium
554127|NCT00818389|neurodegeneration|neurodegeneration
554128|NCT00818376|Chlorhexidine|chlorhexidine
554129|NCT00818376|adverse effects|adverse effects
554130|NCT00818376|staining|staining
554131|NCT00818376|dental calculus|dental calculus
554132|NCT00818376|dental plaque|dental plaque
554133|NCT00818363|Postoperative pain|postoperative pain
554134|NCT00818363|shoulder surgery|shoulder surgery
554135|NCT00818363|opioid|opioid
554136|NCT00818311|Light emitting diode|light emitting diode
554137|NCT00818311|tolerance|tolerance
554138|NCT00818311|photomodulation|photomodulation
554139|NCT00818298|schizophrenia|schizophrenia
554140|NCT00818298|schizoaffective disorder|schizoaffective disorder
554141|NCT00818298|PET Scan|pet scan
554142|NCT00818298|ziprasidone|ziprasidone
554143|NCT00818298|dopamine|dopamine
554144|NCT00818298|D2|d2
554145|NCT00818298|receptor|receptor
554146|NCT00818298|antagonist|antagonist
554147|NCT00818298|occupancy|occupancy
554148|NCT00818298|dissociation|dissociation
554149|NCT00818298|affinity|affinity
554150|NCT00818298|constant|constant
554151|NCT00818298|Ki|ki
554152|NCT00818298|ligand|ligand
554153|NCT00818298|raclopride|raclopride
554154|NCT00818298|half-life|half-life
554155|NCT00818298|striatal|striatal
554156|NCT00818298|plasma dynamics|plasma dynamics
554157|NCT00818298|central dynamics|central dynamics
554158|NCT00818298|plasma drug level|plasma drug level
554159|NCT00818298|compliance|compliance
554160|NCT00818298|antipsychotic|antipsychotic
554161|NCT00818298|pharmacotherapy|pharmacotherapy
554162|NCT00818298|twice daily dosing|twice daily dosing
554163|NCT00818298|BID dosing|bid dosing
554164|NCT00818298|once daily dosing|once daily dosing
554165|NCT00818298|od dosing|od dosing
554166|NCT00818298|qd dosing|qd dosing
554167|NCT00818298|dosing schedule|dosing schedule
554168|NCT00818233|dynamic contour tonometry|dynamic contour tonometry
554169|NCT00818233|variability|variability
554170|NCT00818233|pulse amplitude|pulse amplitude
554171|NCT00818233|Ocular pulse amplitude|ocular pulse amplitude
554172|NCT00818220|intraventricular hemorrhage|intraventricular hemorrhage
554173|NCT00818220|sepsis|sepsis
554174|NCT00818220|motor function|motor function
554175|NCT00818220|motor functioning at 7 months corrected age|motor functioning at 7 months corrected age
554176|NCT00818220|cytokines in cord blood and at 6 and 20 hours of age|cytokines in cord blood and at 6 and 20 hours of age
554177|NCT00818220|stem cells in cord blood and at 20 hours of age|stem cells in cord blood and at 20 hours of age
554178|NCT00818207|Smoking cessation|smoking cessation
554179|NCT00818207|quit rates|quit rates
554180|NCT00818207|reimbursement|reimbursement
554181|NCT00818207|drug coverage|drug coverage
554182|NCT00818207|effectiveness|effectiveness
554183|NCT00818207|cost-effectiveness|cost-effectiveness
554184|NCT00818207|health policy|health policy
554185|NCT00818207|drug utilization|drug utilization
554186|NCT00818207|adherence|adherence
554187|NCT00818207|urine cotinine.|urine cotinine.
554188|NCT00818194|Tacrolimus|tacrolimus
554189|NCT00818194|cyclosporine A|cyclosporine a
554190|NCT00818194|renal plasma flow|renal plasma flow
554191|NCT00818194|glomerular filtration rate|glomerular filtration rate
554192|NCT00818194|human|human
554193|NCT00818194|pharmacodynamics|pharmacodynamics
554194|NCT00818194|pharmacokinetics|pharmacokinetics
554195|NCT00818194|Pharmacodynamics of tacrolimus|pharmacodynamics of tacrolimus
554321|NCT00817726|PSP|psp
554196|NCT00818181|Type I - Allergy, rhinoconjunctivitis|type i - allergy, rhinoconjunctivitis
554197|NCT00818129|Phase I|phase i
554198|NCT00818129|Japan|japan
554199|NCT00818129|Japanese|japanese
554200|NCT00818129|oral solution|oral solution
554201|NCT00818116|Cataract|cataract
554202|NCT00818116|visual acuity|visual acuity
554203|NCT00818116|AcrySof ReSTOR Aspheric Intraoculare Lens|acrysof restor aspheric intraoculare lens
554204|NCT00818116|Bilateral cataract|bilateral cataract
554205|NCT00818103|Multiple Sclerosis,Genetics,Pathogenesis,Pathology,Therapy|multiple sclerosis,genetics,pathogenesis,pathology,therapy
554206|NCT00818090|thymic epithelial tumor|thymic epithelial tumor
554207|NCT00818090|paclitaxel|paclitaxel
554208|NCT00818090|cisplatin|cisplatin
554209|NCT00818090|thymic carcinoma|thymic carcinoma
554210|NCT00818090|invasive thymoma|invasive thymoma
554211|NCT00818051|stage IA breast cancer|stage ia breast cancer
554212|NCT00818051|stage IB breast cancer|stage ib breast cancer
554213|NCT00818051|stage II breast cancer|stage ii breast cancer
554214|NCT00818051|stage IIIA breast cancer|stage iiia breast cancer
554215|NCT00818038|RRMS|rrms
554216|NCT00818038|Relapsing Remitting|relapsing remitting
554217|NCT00818038|MS|ms
554218|NCT00818025|Transplantation|transplantation
554219|NCT00818025|Self-care agency|self-care agency
554220|NCT00818025|Self-care behaviors|self-care behaviors
554221|NCT00818025|Hand-held device|hand-held device
554222|NCT00818012|atrial fibrillation|atrial fibrillation
554223|NCT00818012|atrial electromechanical interval|atrial electromechanical interval
554224|NCT00818012|direct current cardioversion|direct current cardioversion
554225|NCT00818012|pulse wave velocity|pulse wave velocity
554226|NCT00817999|Platelet Aggregation Inhibition|platelet aggregation inhibition
554227|NCT00817986|Acute back pain in the lumbar region|acute back pain in the lumbar region
554228|NCT00817973|Whey protein|whey protein
554229|NCT00817973|gluten|gluten
554230|NCT00817973|casein|casein
554231|NCT00817973|cod protein|cod protein
554232|NCT00817973|GLP-1|glp-1
554233|NCT00817973|postprandial|postprandial
554234|NCT00817973|triglyceride|triglyceride
554235|NCT00817973|free fatty acids|free fatty acids
554236|NCT00817973|chylomicrons|chylomicrons
554237|NCT00817973|retinyl palmitate|retinyl palmitate
554238|NCT00817973|type 2 diabetes|type 2 diabetes
554239|NCT00817973|GIP|gip
554240|NCT00817973|Postprandial incretins|postprandial incretins
554241|NCT00817960|Dual tasking|dual tasking
554242|NCT00817960|Postural Control|postural control
554243|NCT00817960|Methylphenidate (Ritalin)|methylphenidate (ritalin)
554244|NCT00817960|old adults|old adults
554245|NCT00817947|Airway clearance|airway clearance
554246|NCT00817947|Cystic fibrosis|cystic fibrosis
554247|NCT00817947|High frequency chest wall oscillation|high frequency chest wall oscillation
554248|NCT00817934|Efficacy|efficacy
554249|NCT00817934|patient's tolerance|patient's tolerance
554250|NCT00817934|patient's safety|patient's safety
554251|NCT00817921|premature renal function|premature renal function
554252|NCT00817921|ibuprofen|ibuprofen
554253|NCT00817921|blood pressure|blood pressure
554254|NCT00817921|Renal function|renal function
554255|NCT00817908|liver transplant|liver transplant
554256|NCT00817908|lung transplant|lung transplant
554257|NCT00817908|kidney transplant|kidney transplant
554258|NCT00817908|heart transplant|heart transplant
554259|NCT00817908|CMV CMI|cmv cmi
554260|NCT00817908|Transplant|transplant
554261|NCT00817895|hepatocellular carcinoma|hepatocellular carcinoma
554262|NCT00817895|liver resection|liver resection
554263|NCT00817895|intraoperative chemotherapy|intraoperative chemotherapy
554264|NCT00817882|vocational|vocational
554265|NCT00817882|rehabilitation|rehabilitation
554266|NCT00817882|work|work
554267|NCT00817882|ability|ability
554268|NCT00817882|low back pain|low back pain
554269|NCT00817869|Floors and Floorcoverings|floors and floorcoverings
554270|NCT00817869|Health Services for the Aged|health services for the aged
554271|NCT00817869|Fractures, bone|fractures, bone
554272|NCT00817869|Delirium, Dementia, Amnestic, Cognitive Disorders|delirium, dementia, amnestic, cognitive disorders
554273|NCT00817869|Frail Elderly|frail elderly
554274|NCT00817869|Aged, 80 and over|aged, 80 and over
554275|NCT00817843|Postprandial hypertriglyceridemia|postprandial hypertriglyceridemia
554276|NCT00817843|Metabolic syndrome|metabolic syndrome
554277|NCT00817843|Endothelial function|endothelial function
554278|NCT00817843|Flow mediated dilatation|flow mediated dilatation
554279|NCT00817843|EndoPAT|endopat
554280|NCT00817843|Simvastatin|simvastatin
554281|NCT00817843|Ezetimibe|ezetimibe
554282|NCT00817830|Coronaropathy|coronaropathy
554283|NCT00817830|lodenafil carbonate|lodenafil carbonate
554284|NCT00817830|Erectile dysfunction|erectile dysfunction
554285|NCT00817830|Treatment|treatment
554286|NCT00817830|QT interval|qt interval
554287|NCT00817830|Phosphodiesterase inhibitors|phosphodiesterase inhibitors
554288|NCT00817830|Cardiac arrhythmia|cardiac arrhythmia
554289|NCT00817830|Effort testPhosphodiesterase 5 inhibitors|effort testphosphodiesterase 5 inhibitors
554290|NCT00817830|Cardiovascular test|cardiovascular test
554291|NCT00817804|noninvasive ventilation|noninvasive ventilation
554292|NCT00817791|CABG|cabg
554293|NCT00817791|hyperbaric oxygen|hyperbaric oxygen
554294|NCT00817791|preconditioning|preconditioning
554295|NCT00817791|S100B|s100b
554296|NCT00817791|NSE|nse
554297|NCT00817791|Troponin I|troponin i
554298|NCT00817791|CABG surgery|cabg surgery
554299|NCT00817791|neuroprotection|neuroprotection
554300|NCT00817778|Type II Diabetes|type ii diabetes
554301|NCT00817765|interaction|interaction
554302|NCT00817765|pharmacokinetics|pharmacokinetics
554303|NCT00817765|boosting|boosting
554304|NCT00817765|drug-drug interaction|drug-drug interaction
554305|NCT00817765|safety|safety
554306|NCT00817752|stress|stress
554307|NCT00817752|inflammation|inflammation
554308|NCT00817752|natural remedy|natural remedy
554309|NCT00817752|cytokines|cytokines
554310|NCT00817752|interleukin|interleukin
554311|NCT00817752|inflammatory conditions|inflammatory conditions
554312|NCT00817752|auto-immune disorders|auto-immune disorders
554313|NCT00817739|Drug therapy|drug therapy
554314|NCT00817726|Rapid Eye Movement Sleep Behavior Disorder|rapid eye movement sleep behavior disorder
554315|NCT00817726|Parkinson's Disease|parkinson's disease
554316|NCT00817726|Parkinsonian Syndromes|parkinsonian syndromes
554317|NCT00817726|Atypical Parkinson's|atypical parkinson's
554318|NCT00817726|RBD|rbd
554319|NCT00817726|PD|pd
554320|NCT00817726|fMRI|fmri
554322|NCT00817726|MSA|msa
554323|NCT00817713|Human Immunodeficiency Virus|human immunodeficiency virus
554324|NCT00817713|Helminthiasis|helminthiasis
554325|NCT00817713|treatment naive|treatment naive
554326|NCT00817713|co-infection|co-infection
554327|NCT00817713|immune modulation|immune modulation
554328|NCT00817700|Sleep|sleep
554329|NCT00817700|young adults|young adults
554330|NCT00817700|middle-age adults|middle-age adults
554331|NCT00817700|older adults|older adults
554332|NCT00817674|CKD|ckd
554333|NCT00817674|Kidney Disease|kidney disease
554334|NCT00817674|poor sleep|poor sleep
554335|NCT00817674|CKD progression|ckd progression
554336|NCT00817661|vitamin A|vitamin a
554337|NCT00817661|influenza vaccine|influenza vaccine
554338|NCT00817661|passive immunity|passive immunity
554339|NCT00817661|pregnant mothers|pregnant mothers
554340|NCT00817661|vitamin A suplementation|vitamin a suplementation
554341|NCT00817661|Influenza vaccination|influenza vaccination
554342|NCT00817661|Infant immune responses|infant immune responses
554343|NCT00817648|schizophrenia|schizophrenia
554344|NCT00817648|antipsychotics|antipsychotics
554345|NCT00817648|quetiapine|quetiapine
554346|NCT00817648|risperidone|risperidone
554347|NCT00817648|efficacy|efficacy
554348|NCT00817648|safety|safety
554349|NCT00817648|multicenter|multicenter
554350|NCT00817648|rater-blind|rater-blind
554351|NCT00817648|randomized|randomized
554352|NCT00817648|chinese|chinese
554353|NCT00817648|han|han
554354|NCT00817635|Blood Pressure|blood pressure
554355|NCT00817635|Hypertension|hypertension
554356|NCT00817635|Resistant Hypertension|resistant hypertension
554357|NCT00817622|diabetes mellitus type 2|diabetes mellitus type 2
554358|NCT00817622|EPA|epa
554359|NCT00817622|leptin|leptin
554360|NCT00817622|adiponectin|adiponectin
554361|NCT00817609|Angongniuhuang Pill|angongniuhuang pill
554362|NCT00817609|consciousness level of patients who suffered from a stroke|consciousness level of patients who suffered from a stroke
554363|NCT00817583|Phase 2 Clinical Trial|phase 2 clinical trial
554364|NCT00817583|NPC|npc
554365|NCT00817583|neoadjuvant chemotherapy|neoadjuvant chemotherapy
554366|NCT00817583|concurrent chemoradiation|concurrent chemoradiation
554367|NCT00817570|Trans Femoral Amputees Balance Reactions|trans femoral amputees balance reactions
554368|NCT00817557|Contact lenses|contact lenses
554369|NCT00817557|Loteprednol|loteprednol
554370|NCT00817557|Effect on CL dryness|effect on cl dryness
554371|NCT00817544|3098004|3098004
554372|NCT00817544|Healthy volunteers|healthy volunteers
554373|NCT00817531|Breast Cancer|breast cancer
554374|NCT00817505|Type I diabetes|type i diabetes
554375|NCT00817505|bioavailability|bioavailability
554376|NCT00817492|Sleep|sleep
554377|NCT00817492|CKD|ckd
554378|NCT00817492|kidney|kidney
554379|NCT00817492|PSG|psg
554380|NCT00817492|polysomnography|polysomnography
554381|NCT00817492|Decreased sleep time|decreased sleep time
554382|NCT00817492|Decreased sleep quality|decreased sleep quality
554383|NCT00817479|Subject has intraabdominal disease either proven or strongly|subject has intraabdominal disease either proven or strongly
554384|NCT00817479|suspected to be ovarian or primary peritoneal cancer|suspected to be ovarian or primary peritoneal cancer
554385|NCT00817466|bronchiolitis|bronchiolitis
554386|NCT00817466|infants|infants
554387|NCT00817466|racemic adrenaline|racemic adrenaline
554388|NCT00817466|inhalations|inhalations
554389|NCT00817466|treatment|treatment
554390|NCT00817453|Parkinson's Disease|parkinson's disease
554391|NCT00817440|growth hormone insulin signaltransduction signalpathways|growth hormone insulin signaltransduction signalpathways
554392|NCT00817440|growth hormone and insulin signalpathways|growth hormone and insulin signalpathways
554393|NCT00817427|Chronic Kidney Disease|chronic kidney disease
554394|NCT00817427|Poor sleep|poor sleep
554395|NCT00817427|CKD|ckd
554396|NCT00817427|Kidney Failure|kidney failure
554397|NCT00817414|Blood Pressure|blood pressure
554398|NCT00817414|Hypertension|hypertension
554399|NCT00817414|Cortisol|cortisol
554400|NCT00817401|asphyxia|asphyxia
554401|NCT00817401|hypothermia|hypothermia
554402|NCT00817401|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
554403|NCT00817401|neonates|neonates
554404|NCT00817388|Interstitial cystitis|interstitial cystitis
554405|NCT00817388|pelvic pain|pelvic pain
554406|NCT00817375|Pharmacogenomics|pharmacogenomics
554407|NCT00817375|Prediction of Antidepressant Response|prediction of antidepressant response
554408|NCT00817375|Depressed Patients|depressed patients
554409|NCT00817362|Breast Cancer|breast cancer
554410|NCT00817362|Advanced Breast Cancer|advanced breast cancer
554411|NCT00817362|Metastatic Breast Cancer|metastatic breast cancer
554412|NCT00817362|HER2 Positive Breast Cancer|her2 positive breast cancer
554413|NCT00817362|Cancer of the breast|cancer of the breast
554415|NCT00817362|Herceptin|herceptin
554416|NCT00817349|Angio-Seal|angio-seal
554417|NCT00817349|Peripheral vascular disease|peripheral vascular disease
554418|NCT00817349|Vascular closure device|vascular closure device
554419|NCT00817349|Arterial closure|arterial closure
554420|NCT00817349|Coronary artery disease|coronary artery disease
554421|NCT00817349|Arterial hemostasis|arterial hemostasis
554422|NCT00817349|Coronary cardiac catheterization|coronary cardiac catheterization
554423|NCT00817349|Percutaneous coronary intervention|percutaneous coronary intervention
554424|NCT00817349|Interventional catheterization|interventional catheterization
554425|NCT00817349|Diagnostic catheterization|diagnostic catheterization
554426|NCT00817349|Common femoral artery|common femoral artery
554427|NCT00817349|Manual compression|manual compression
554428|NCT00817349|Vascular intervention|vascular intervention
554429|NCT00817349|Angiogram|angiogram
554430|NCT00817349|Coronary intervention|coronary intervention
554431|NCT00817349|Coronary angioplasty|coronary angioplasty
554432|NCT00817349|Angiography|angiography
554433|NCT00817349|Arteriotomy|arteriotomy
554434|NCT00817349|Vascular access|vascular access
554435|NCT00817336|biomarker|biomarker
554436|NCT00817336|EEG|eeg
554437|NCT00817336|schizophrenia|schizophrenia
554438|NCT00817336|NMDA|nmda
554439|NCT00817336|D-serine|d-serine
554440|NCT00817323|bipolar depression|bipolar depression
554441|NCT00817323|atypical antipsychotic|atypical antipsychotic
554442|NCT00817323|remission|remission
554443|NCT00817323|depletion|depletion
554444|NCT00817323|mood|mood
554445|NCT00817297|noninvasive ventilation|noninvasive ventilation
554446|NCT00817284|Newly diagnosed patients with glioblastoma multiforme.|newly diagnosed patients with glioblastoma multiforme.
554447|NCT00817284|Performance status 0-2.|performance status 0-2.
554448|NCT00817271|Type II Diabetes|type ii diabetes
554449|NCT00817271|Counter-regulatory response|counter-regulatory response
554450|NCT00817271|Hypoglycemia|hypoglycemia
554451|NCT00817258|Phase 2 Clinical Trial|phase 2 clinical trial
554452|NCT00817258|NPC|npc
554453|NCT00817258|radiation therapy|radiation therapy
554454|NCT00817258|chemotherapy|chemotherapy
554455|NCT00817245|CSR|csr
554456|NCT00817245|Helicobacter pylori|helicobacter pylori
554457|NCT00817232|tennis elbow|tennis elbow
554458|NCT00817232|microcurrent|microcurrent
554459|NCT00817232|tissue healing|tissue healing
554460|NCT00817206|kidney transplantation|kidney transplantation
554461|NCT00817206|renal transplantation|renal transplantation
554462|NCT00817206|maintenance immunosuppression|maintenance immunosuppression
554463|NCT00817206|tacrolimus|tacrolimus
554464|NCT00817206|Prevention of acute allograft rejection|prevention of acute allograft rejection
554465|NCT00817193|Clinical trial|clinical trial
554466|NCT00817193|Short Physical Performance Battery|short physical performance battery
554467|NCT00817193|Disability|disability
554468|NCT00817193|Senior Housing|senior housing
554469|NCT00817193|Aging|aging
554470|NCT00817180|physiotherapy|physiotherapy
554471|NCT00817180|airway clearance techniques|airway clearance techniques
554472|NCT00817180|Positive Expiratory Pressure Technique|positive expiratory pressure technique
554473|NCT00817180|high frequency Chest Wall Oscillation|high frequency chest wall oscillation
554474|NCT00817180|vest|vest
554475|NCT00817167|Known or suspected lung disease|known or suspected lung disease
554476|NCT00817167|Candidates for non-emergency bronchoscopy|candidates for non-emergency bronchoscopy
554477|NCT00817154|Older persons with SMI|older persons with smi
554478|NCT00817128|Complex Regional Pain Syndrome Type I|complex regional pain syndrome type i
554479|NCT00817128|Sympathetic Reflex Dystrophy|sympathetic reflex dystrophy
554480|NCT00817128|Pain Exposure Physical Therapy|pain exposure physical therapy
554481|NCT00817128|Pharmacological treatment|pharmacological treatment
554482|NCT00817128|Functional recovery|functional recovery
554483|NCT00817115|Region-of-Interest Imaging|region-of-interest imaging
554484|NCT00817115|X-ray Fovea Imaging|x-ray fovea imaging
554485|NCT00817115|Cardiovascular Diseases|cardiovascular diseases
554486|NCT00817115|Radiation Dosage|radiation dosage
554487|NCT00817115|Radiographic Image Enhancement|radiographic image enhancement
554488|NCT00817115|Radiography, Interventional|radiography, interventional
554489|NCT00817102|coronary artery stenoses|coronary artery stenoses
554490|NCT00817063|retinoid treatment|retinoid treatment
554491|NCT00817063|fingertip dermatitis|fingertip dermatitis
554492|NCT00817063|hyperkeratotic hand eczema|hyperkeratotic hand eczema
554493|NCT00817063|vesicular hand eczema|vesicular hand eczema
554494|NCT00817063|pompholyx|pompholyx
554495|NCT00817037|Chronic kidney disease|chronic kidney disease
554496|NCT00817037|Proteinuria|proteinuria
554497|NCT00817037|Blood pressure|blood pressure
554498|NCT00817037|Arterial stiffness|arterial stiffness
554499|NCT00817037|Endothelin antagonist|endothelin antagonist
554500|NCT00817037|Sitaxsentan|sitaxsentan
554501|NCT00817024|Coronary Heart Disease|coronary heart disease
554502|NCT00817024|PCI|pci
554503|NCT00817024|Traditional Chinese Medicine|traditional chinese medicine
554504|NCT00817024|Quality of Life|quality of life
554505|NCT00817011|depression|depression
554506|NCT00817011|pharmacogenomics|pharmacogenomics
554507|NCT00817011|antidepressant response|antidepressant response
555142|NCT00814879|HIV|hiv
554508|NCT00817011|biological markers|biological markers
554509|NCT00817011|clinical variables|clinical variables
554510|NCT00816998|Radius fractures|radius fractures
554511|NCT00816985|Female|female
554512|NCT00816985|Lymphedema|lymphedema
554513|NCT00816959|Lymphocytic Predominant Hodgkin's Lymphoma|lymphocytic predominant hodgkin's lymphoma
554514|NCT00816959|Late, widespread and recurrent LPHD|late, widespread and recurrent lphd
554515|NCT00816946|malnutrition|malnutrition
554516|NCT00816946|growth|growth
554517|NCT00816933|pain|pain
554518|NCT00816933|operative times|operative times
554519|NCT00816933|complication|complication
554520|NCT00816933|time to return for normal life|time to return for normal life
554521|NCT00816933|pain using VAS score|pain using vas score
554522|NCT00816920|distal DVT|distal dvt
554523|NCT00816920|calf DVT|calf dvt
554524|NCT00816920|DVT diagnosis|dvt diagnosis
554525|NCT00816920|management of patients with suspected leg DVT|management of patients with suspected leg dvt
554526|NCT00816907|Schizoaffective Disorder|schizoaffective disorder
554527|NCT00816894|schizophrenia|schizophrenia
554528|NCT00816894|treatment resistance|treatment resistance
554529|NCT00816894|D-serine|d-serine
554530|NCT00816894|Olanzapine|olanzapine
554531|NCT00816894|treatment refractory schizophrenia|treatment refractory schizophrenia
554532|NCT00816881|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
554533|NCT00816881|flutter|flutter
554534|NCT00816881|airway clearance|airway clearance
554535|NCT00816881|sputum|sputum
554536|NCT00816881|Physical Therapy Techniques|physical therapy techniques
554537|NCT00816868|stage IIIB/IV adenocarcinoma non-small cell lung cancer|stage iiib/iv adenocarcinoma non-small cell lung cancer
554538|NCT00816855|Phase 2 Clinical Trial|phase 2 clinical trial
554539|NCT00816855|NPC|npc
554540|NCT00816855|neoadjuvant chemotherapy|neoadjuvant chemotherapy
554541|NCT00816855|concurrent chemoradiation|concurrent chemoradiation
554542|NCT00816842|citrulline|citrulline
554543|NCT00816842|malabsorption|malabsorption
554544|NCT00816842|Villous atrophy|villous atrophy
554545|NCT00816842|enteropathy|enteropathy
554546|NCT00816829|Dyslipidemia|dyslipidemia
554547|NCT00816829|Sleep Apnea Syndromes|sleep apnea syndromes
554548|NCT00816829|Fenofibrate|fenofibrate
554549|NCT00816829|Obese|obese
554550|NCT00816829|Overweight or obese patients|overweight or obese patients
554551|NCT00816816|Phase 2 Clinical Trial|phase 2 clinical trial
554552|NCT00816816|NPC|npc
554553|NCT00816816|neoadjuvant chemotherapy|neoadjuvant chemotherapy
554554|NCT00816816|concurrent chemoradiation|concurrent chemoradiation
554555|NCT00816803|Spinal cord injury|spinal cord injury
554556|NCT00816790|Septic shock|septic shock
554557|NCT00816790|Acute Renal Failure|acute renal failure
554558|NCT00816790|Antimicrobial|antimicrobial
554559|NCT00816790|Drug Dosing|drug dosing
554560|NCT00816790|Feasibility Study|feasibility study
554561|NCT00816777|Cancer|cancer
554562|NCT00816777|Carcinoma|carcinoma
554563|NCT00816777|Colon Cancer|colon cancer
554564|NCT00816777|Colorectal Cancer|colorectal cancer
554565|NCT00816777|Gastric Cancer|gastric cancer
554566|NCT00816777|Gastrointestinal Cancer|gastrointestinal cancer
554567|NCT00816777|Metastases|metastases
554568|NCT00816777|Metastatic Cancer|metastatic cancer
554569|NCT00816777|Metastatic Colorectal Cancer|metastatic colorectal cancer
554570|NCT00816777|Oncology|oncology
554571|NCT00816777|Rectal Cancer|rectal cancer
554572|NCT00816764|clinical trial, phase 1|clinical trial, phase 1
554573|NCT00816764|carcinoma|carcinoma
554574|NCT00816764|pharmacokinetics|pharmacokinetics
554575|NCT00816764|safety|safety
554576|NCT00816764|ovarian|ovarian
554577|NCT00816751|Local anesthesia|local anesthesia
554578|NCT00816751|Paracervical|paracervical
554579|NCT00816751|Intracervical|intracervical
554580|NCT00816751|Abortion|abortion
554581|NCT00816751|Pain|pain
554582|NCT00816751|Local anesthesia for elective first trimester abortion|local anesthesia for elective first trimester abortion
554583|NCT00816738|Nd: YAG laser|nd: yag laser
554584|NCT00816738|recurrent corneal erosions|recurrent corneal erosions
554585|NCT00816738|trauma|trauma
554586|NCT00816738|anterior stromal puncture|anterior stromal puncture
554587|NCT00816725|Postnatal Depression|postnatal depression
554588|NCT00816725|Cognitive Behavioral Therapy|cognitive behavioral therapy
554589|NCT00816725|Mood Management|mood management
554590|NCT00816725|Self-help|self-help
554591|NCT00816725|Internet|internet
554592|NCT00816712|Males with low-normal serum total testosterone levels.|males with low-normal serum total testosterone levels.
554593|NCT00816699|Anxiety|anxiety
554594|NCT00816699|preprint anesthetic risk information|preprint anesthetic risk information
554595|NCT00816686|clinical trial, phase 1|clinical trial, phase 1
554596|NCT00816686|carcinoma, advanced renal cell|carcinoma, advanced renal cell
554597|NCT00816686|kidney|kidney
554598|NCT00816686|pharmacokinetics|pharmacokinetics
554599|NCT00816686|safety|safety
554600|NCT00816686|AGS-16M18|ags-16m18
554601|NCT00816673|Insomnia|insomnia
554602|NCT00816673|Primary insomnia|primary insomnia
554603|NCT00816673|sleep latency|sleep latency
554604|NCT00816673|non restorative sleep|non restorative sleep
554605|NCT00816673|sleep quality|sleep quality
554606|NCT00816673|Double-Blind|double-blind
554607|NCT00816673|Placebo Controlled|placebo controlled
554608|NCT00816673|Parallel-Group|parallel-group
554609|NCT00816673|Sleep Laboratory Study|sleep laboratory study
554610|NCT00816647|Patella|patella
554611|NCT00816647|Dislocation|dislocation
554612|NCT00816647|Knee|knee
554613|NCT00816647|Medial Patellofemoral Ligament|medial patellofemoral ligament
554614|NCT00816634|First line chemotherapy|first line chemotherapy
554615|NCT00816634|Advanced or recurrent esophageal squamous cell carcinoma|advanced or recurrent esophageal squamous cell carcinoma
554616|NCT00816621|Internationally Adopted Children|internationally adopted children
554617|NCT00816621|Adoption|adoption
554618|NCT00816621|Attachment|attachment
554619|NCT00816621|Inattention|inattention
554620|NCT00816621|Prevention|prevention
554621|NCT00816608|diabetes|diabetes
554622|NCT00816608|prediabetes|prediabetes
554623|NCT00816608|impaired fasting glucose (IFG)|impaired fasting glucose (ifg)
554624|NCT00816608|impaired glucose tolerance (IGT)|impaired glucose tolerance (igt)
554625|NCT00816608|body weight|body weight
554626|NCT00816595|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
554627|NCT00816595|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
554628|NCT00816595|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
554629|NCT00816595|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
554630|NCT00816595|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
554631|NCT00816595|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
554632|NCT00816595|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
554633|NCT00816595|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
554634|NCT00816595|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
554635|NCT00816595|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
554636|NCT00816595|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
554637|NCT00816582|Post-menopausal hormone receptor positive recurrent/metastatic breast cancer.|post-menopausal hormone receptor positive recurrent/metastatic breast cancer.
554638|NCT00816582|PET/CT|pet/ct
554639|NCT00816582|Recurrent or metastatic|recurrent or metastatic
554640|NCT00816569|Orthokeratology|orthokeratology
554641|NCT00816569|Keratoconus|keratoconus
554642|NCT00816530|breast|breast
554643|NCT00816530|breast cancer|breast cancer
554644|NCT00816530|breast screening|breast screening
554645|NCT00816530|breast cancer screening|breast cancer screening
554646|NCT00816530|ultrasound|ultrasound
554647|NCT00816530|ultrasonography|ultrasonography
554648|NCT00816530|mammogram|mammogram
554649|NCT00816530|mammography|mammography
554650|NCT00816530|breast density|breast density
554651|NCT00816530|dense breasts|dense breasts
554652|NCT00816530|early detection|early detection
554653|NCT00816530|somo v|somo v
554654|NCT00816530|somo•v|somo•v
554655|NCT00816530|U-Systems|u-systems
554656|NCT00816530|Automated Breast Ultrasound|automated breast ultrasound
554657|NCT00816530|Ultrasonography, Mammary|ultrasonography, mammary
554658|NCT00816530|Breast Neoplasms|breast neoplasms
554659|NCT00816530|Breast Density > 50% (BI-RADS III & IV)|breast density > 50% (bi-rads iii & iv)
554660|NCT00816517|Psoriasis|psoriasis
554661|NCT00816517|Botulinum toxin|botulinum toxin
554662|NCT00816504|FSGS|fsgs
554663|NCT00816504|Permeability factor|permeability factor
554664|NCT00816504|Galactose|galactose
554665|NCT00816504|Primary FSGS, resistant to immunosuppressive medication|primary fsgs, resistant to immunosuppressive medication
554666|NCT00816491|patient with long-standing UC|patient with long-standing uc
554667|NCT00816478|FSGS|fsgs
554668|NCT00816478|Permeability factor|permeability factor
554669|NCT00816478|Galactose|galactose
554670|NCT00816478|Primary FSGS, resistant to immunosuppressive medication|primary fsgs, resistant to immunosuppressive medication
554671|NCT00816465|Hoodia gordoni|hoodia gordoni
554672|NCT00816465|NASH|nash
554673|NCT00816465|NAFLD|nafld
554674|NCT00816452|Osteoporosis|osteoporosis
554675|NCT00816452|Prostate Cancer|prostate cancer
554676|NCT00816452|Osteoporosis in male with Prostate Cancer|osteoporosis in male with prostate cancer
554677|NCT00816439|Positron Emission Tomography|positron emission tomography
554678|NCT00816439|Brain Imaging|brain imaging
554679|NCT00816439|Alcoholism|alcoholism
554680|NCT00816426|Tuberculosis|tuberculosis
554681|NCT00816426|Lesions|lesions
554682|NCT00816426|Pharmacokinetics|pharmacokinetics
554683|NCT00816426|Maldistribution|maldistribution
554684|NCT00816426|Histopathology|histopathology
554685|NCT00816413|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
554686|NCT00816413|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
554687|NCT00816413|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
554688|NCT00816413|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
554689|NCT00816413|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
554690|NCT00816413|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
554757|NCT00816374|first degree relatives|first degree relatives
554691|NCT00816413|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
554692|NCT00816413|secondary acute myeloid leukemia|secondary acute myeloid leukemia
554693|NCT00816413|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
554694|NCT00816413|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
554695|NCT00816413|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
554696|NCT00816413|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
554697|NCT00816413|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
554698|NCT00816413|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
554699|NCT00816413|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
554700|NCT00816413|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
554701|NCT00816413|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
554702|NCT00816413|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
554703|NCT00816413|essential thrombocythemia|essential thrombocythemia
554704|NCT00816413|polycythemia vera|polycythemia vera
554705|NCT00816413|primary myelofibrosis|primary myelofibrosis
554706|NCT00816413|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
554707|NCT00816413|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
554708|NCT00816413|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
554709|NCT00816413|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
554710|NCT00816413|splenic marginal zone lymphoma|splenic marginal zone lymphoma
554711|NCT00816413|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
554712|NCT00816413|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
554713|NCT00816413|aplastic anemia|aplastic anemia
554714|NCT00816413|chronic eosinophilic leukemia|chronic eosinophilic leukemia
554715|NCT00816413|chronic neutrophilic leukemia|chronic neutrophilic leukemia
554716|NCT00816413|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
554717|NCT00816413|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
554718|NCT00816413|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
554719|NCT00816413|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
554720|NCT00816413|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
554721|NCT00816413|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
554722|NCT00816413|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
554723|NCT00816413|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
554724|NCT00816413|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
554725|NCT00816413|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
554726|NCT00816413|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
554727|NCT00816413|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
554728|NCT00816413|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
554729|NCT00816413|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
554730|NCT00816413|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
554731|NCT00816413|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
554732|NCT00816413|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
554733|NCT00816413|stage I marginal zone lymphoma|stage i marginal zone lymphoma
554734|NCT00816413|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
554735|NCT00816413|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
554736|NCT00816413|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
554737|NCT00816413|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
554738|NCT00816413|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
554739|NCT00816413|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
554740|NCT00816413|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
554741|NCT00816413|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
554742|NCT00816413|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
554743|NCT00816413|stage I mantle cell lymphoma|stage i mantle cell lymphoma
554744|NCT00816413|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
554745|NCT00816413|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
554746|NCT00816413|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
554747|NCT00816413|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
554748|NCT00816413|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
554749|NCT00816413|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
554750|NCT00816413|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
554751|NCT00816374|cutaneous malignant melanoma|cutaneous malignant melanoma
554752|NCT00816374|CMM|cmm
554753|NCT00816374|total cutaneous examination|total cutaneous examination
554754|NCT00816374|TCE|tce
554755|NCT00816374|skin self-examination|skin self-examination
554756|NCT00816374|SSE|sse
554758|NCT00816374|FDR|fdr
554759|NCT00816374|skin cancer protection|skin cancer protection
554760|NCT00816374|skin cancer screening|skin cancer screening
554761|NCT00816348|Cholestasis|cholestasis
554762|NCT00816348|Parenteral Nutrition Associated Liver Disease|parenteral nutrition associated liver disease
554763|NCT00816335|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
554764|NCT00816309|physiotherapy|physiotherapy
554765|NCT00816309|bronchiectasis|bronchiectasis
554766|NCT00816296|NAFLD|nafld
554767|NCT00816296|Obesity|obesity
554768|NCT00816296|Microbiome|microbiome
554769|NCT00816283|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
554770|NCT00816283|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
554771|NCT00816283|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
554772|NCT00816283|Philadelphia chromosome positive adult precursor acute lymphoblastic leukemia|philadelphia chromosome positive adult precursor acute lymphoblastic leukemia
554773|NCT00816283|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
554774|NCT00816283|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
554775|NCT00816270|Blepharoptosis|blepharoptosis
554776|NCT00816270|Dermatochalasis|dermatochalasis
554777|NCT00816270|octyl 2-cyanoacrylate|octyl 2-cyanoacrylate
554778|NCT00816270|Suture Techniques|suture techniques
554779|NCT00816270|Tissue Adhesive|tissue adhesive
554780|NCT00816257|lung tissue repository|lung tissue repository
554781|NCT00816244|Breast cancer|breast cancer
554782|NCT00816244|Postmenopausal|postmenopausal
554783|NCT00816244|Neo-adjuvant|neo-adjuvant
554784|NCT00816244|Tumor proliferation|tumor proliferation
554785|NCT00816244|Statin|statin
554786|NCT00816244|Atorvastatin|atorvastatin
554787|NCT00816244|Ki67|ki67
554788|NCT00816244|Translational research|translational research
554789|NCT00816244|Cell cycle regulators|cell cycle regulators
554790|NCT00816244|Gene expression|gene expression
554791|NCT00816244|Genomic profiling|genomic profiling
554792|NCT00816244|Apoptosis|apoptosis
554793|NCT00816244|Window-of-opportunity|window-of-opportunity
554794|NCT00816231|Prevention Intervention|prevention intervention
554795|NCT00816231|Alcohol|alcohol
554796|NCT00816231|Tobacco|tobacco
554797|NCT00816231|Nicotine|nicotine
554798|NCT00816231|Craving|craving
554799|NCT00816231|Cue Reactivity|cue reactivity
554800|NCT00816231|Cross Cue Reactions|cross cue reactions
554801|NCT00816192|FA|fa
554802|NCT00816192|Atrial fibrillation|atrial fibrillation
554803|NCT00816192|Catheter|catheter
554804|NCT00816192|Ablation|ablation
554805|NCT00816192|RF|rf
554806|NCT00816179|Pancreatic head mass|pancreatic head mass
554807|NCT00816179|Pancreatic cancer|pancreatic cancer
554808|NCT00816179|NOTES|notes
554809|NCT00816179|Endoscopic peritoneoscopy|endoscopic peritoneoscopy
554810|NCT00816179|Whipple|whipple
554811|NCT00816179|palliative gastrojejunostomy|palliative gastrojejunostomy
554812|NCT00816166|Ischemic stroke|ischemic stroke
554813|NCT00816166|Transient Ischemic Attack|transient ischemic attack
554814|NCT00816166|Intracranial Stenting|intracranial stenting
554815|NCT00816153|Pleth variability Index|pleth variability index
554816|NCT00816153|Fluid management|fluid management
554817|NCT00816153|Fluid management during surgery|fluid management during surgery
554818|NCT00816140|Helicobacter pylori|helicobacter pylori
554819|NCT00816140|levofloxacin|levofloxacin
554820|NCT00816140|clarithromycin|clarithromycin
554821|NCT00816140|ERADICATION RATE|eradication rate
554822|NCT00816127|liver cirrhosis|liver cirrhosis
554823|NCT00816127|coagulopathy|coagulopathy
554824|NCT00816127|desmopressin|desmopressin
554825|NCT00816127|blood transfusion|blood transfusion
554826|NCT00816114|Imatinib|imatinib
554827|NCT00816114|Gleevec|gleevec
554828|NCT00816114|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
554829|NCT00816114|CML|cml
554830|NCT00816101|Curettage and electrodesiccation|curettage and electrodesiccation
554831|NCT00816101|acute wounds|acute wounds
554832|NCT00816101|partial thickness wounds|partial thickness wounds
554833|NCT00816088|chemotherapy|chemotherapy
554834|NCT00816088|Stem cell transplantation|stem cell transplantation
554835|NCT00816075|distilled water|distilled water
554836|NCT00816075|recurrent|recurrent
554837|NCT00816075|bladder|bladder
554838|NCT00816075|mitomycin|mitomycin
554839|NCT00816062|Aortic Aneurysm|aortic aneurysm
554840|NCT00816062|Aneurysm|aneurysm
554841|NCT00816062|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
554842|NCT00816062|Talent|talent
554843|NCT00816062|Medtronic|medtronic
554844|NCT00816049|acute lymphoblastic leukemia|acute lymphoblastic leukemia
554845|NCT00816049|child|child
554846|NCT00816049|6-mercaptopurine|6-mercaptopurine
554847|NCT00816049|minimal residual disease|minimal residual disease
554848|NCT00816049|efficacy|efficacy
554849|NCT00816049|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
554850|NCT00816036|Smoking Cessation|smoking cessation
554851|NCT00816036|Practice Guidelines|practice guidelines
554852|NCT00816036|Inpatient|inpatient
554853|NCT00816036|Effectiveness Trial|effectiveness trial
554854|NCT00816036|Veterans Administration|veterans administration
554855|NCT00816036|Relapse prevention|relapse prevention
554856|NCT00816010|drug compliance|drug compliance
554857|NCT00816010|lifestyle modification|lifestyle modification
554858|NCT00815997|radial artery|radial artery
554859|NCT00815997|transradial intervention|transradial intervention
554860|NCT00815997|stent|stent
554861|NCT00815984|Asthma|asthma
554862|NCT00815984|Allergic Rhinitis|allergic rhinitis
554863|NCT00815984|Atopic Dermatitis|atopic dermatitis
554864|NCT00815984|Children|children
554865|NCT00815984|lung function|lung function
554866|NCT00815984|skin prick tests|skin prick tests
554867|NCT00815984|FeNO|feno
554868|NCT00815971|EGFR mutations|egfr mutations
554869|NCT00815971|EGFR inhibitor|egfr inhibitor
554870|NCT00815971|erlotinib|erlotinib
554871|NCT00815958|knee replacement surgery|knee replacement surgery
554872|NCT00815958|Reamer-Irrigator-Aspirator|reamer-irrigator-aspirator
554873|NCT00815958|femoral reaming|femoral reaming
554874|NCT00815958|fat embolism|fat embolism
554875|NCT00815945|leiomyosarcoma|leiomyosarcoma
554876|NCT00815945|carcinosarcoma|carcinosarcoma
554877|NCT00815945|mixed epithelial mesenchymal tumor|mixed epithelial mesenchymal tumor
554878|NCT00815945|endometrial stroma sarcomas|endometrial stroma sarcomas
554879|NCT00815945|Müllerian mixed tumors|müllerian mixed tumors
554880|NCT00815945|carcinosarcoma of the uterus|carcinosarcoma of the uterus
554881|NCT00815945|mesenchymal tumors of the ovary or uterus|mesenchymal tumors of the ovary or uterus
554882|NCT00815945|mixed epithelial mesenchymal tumors of the ovary or uterus|mixed epithelial mesenchymal tumors of the ovary or uterus
554883|NCT00815919|cGVHD|cgvhd
554884|NCT00815919|Velcade|velcade
554885|NCT00815919|bortezomib|bortezomib
554886|NCT00815893|Dexmedetomidine|dexmedetomidine
554887|NCT00815893|Fiberoptic nasal intubation|fiberoptic nasal intubation
554888|NCT00815893|satisfaction|satisfaction
554889|NCT00815880|Heart Failure|heart failure
554890|NCT00815880|Device|device
554891|NCT00815880|Implantable|implantable
554892|NCT00815880|Active|active
554893|NCT00815880|Class III and Class IV|class iii and class iv
554894|NCT00815880|Counterpulsation|counterpulsation
554895|NCT00815867|kidney failure|kidney failure
554896|NCT00815867|kidney transplant|kidney transplant
554897|NCT00815867|graft function|graft function
554898|NCT00815867|haemoglobin|haemoglobin
554899|NCT00815867|epoetin|epoetin
554900|NCT00815854|Antipsychotic|antipsychotic
554901|NCT00815854|Metabolic Syndrome|metabolic syndrome
554902|NCT00815854|Insulin Resistance|insulin resistance
554903|NCT00815854|Endothelial Function|endothelial function
554904|NCT00815841|Determine the effect of MPH on a diagnostic continuous performance task that assesses attention and on a decision making test in young healthy adults|determine the effect of mph on a diagnostic continuous performance task that assesses attention and on a decision making test in young healthy adults
554905|NCT00815828|Gestational Diabetes|gestational diabetes
554906|NCT00815828|Resistance Exercise|resistance exercise
554907|NCT00815828|Pregnancy|pregnancy
554908|NCT00815828|Insulin|insulin
554909|NCT00815815|Anorexia Nervosa|anorexia nervosa
554910|NCT00815802|Children in day care centers|children in day care centers
554911|NCT00815802|cytomegalovirus excretion|cytomegalovirus excretion
554912|NCT00815776|Temporomandibular disorders|temporomandibular disorders
554913|NCT00815763|randomized trial|randomized trial
554914|NCT00815763|ischemic stroke|ischemic stroke
554915|NCT00815763|Ginsenoside-Rd|ginsenoside-rd
554916|NCT00815750|Prostate Cancer|prostate cancer
554917|NCT00815737|Lung Infection After Cerebral Hemorrhage|lung infection after cerebral hemorrhage
554918|NCT00815737|Prevention of Pneumonia|prevention of pneumonia
554919|NCT00815737|Rhubarb|rhubarb
554920|NCT00815724|Daily Inhaled Corticosteroids|daily inhaled corticosteroids
554921|NCT00815724|Distributed Learning|distributed learning
554922|NCT00815724|E-learning|e-learning
554923|NCT00815711|IPF|ipf
554924|NCT00815698|pain|pain
554925|NCT00815685|n-3 fatty acids|n-3 fatty acids
554926|NCT00815685|nutritional treatment|nutritional treatment
554927|NCT00815685|molecular pathogenesis|molecular pathogenesis
554928|NCT00815672|Exercise|exercise
554929|NCT00815672|Prostate cancer|prostate cancer
554930|NCT00815672|Fatigue|fatigue
554931|NCT00815659|plasma lipid profile|plasma lipid profile
554932|NCT00815659|metabolic syndrome|metabolic syndrome
554933|NCT00815646|Immersion pulmonary edema|immersion pulmonary edema
554934|NCT00815646|Diving|diving
554935|NCT00815646|Swimming|swimming
554936|NCT00815646|Pulmonary edema|pulmonary edema
554937|NCT00815646|Cold water immersion|cold water immersion
554938|NCT00815633|PRP|prp
554939|NCT00815633|Pityriasis Rubra Pilaris|pityriasis rubra pilaris
554940|NCT00815633|Amevive|amevive
554941|NCT00815633|Alefacept|alefacept
554942|NCT00815633|Biologic|biologic
554943|NCT00815633|Immunosuppressant|immunosuppressant
554944|NCT00815633|Severe skin disease|severe skin disease
554945|NCT00815620|neuroendocrine tumors|neuroendocrine tumors
554946|NCT00815620|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
554947|NCT00815620|selective internal radiotherapy|selective internal radiotherapy
554948|NCT00815620|surgery|surgery
554949|NCT00815620|radio-frequency ablation|radio-frequency ablation
555042|NCT00815243|joint|joint
554950|NCT00815620|peptide-receptor radiotherapy|peptide-receptor radiotherapy
554951|NCT00815620|progression-free survival|progression-free survival
554952|NCT00815620|quality of life|quality of life
554953|NCT00815620|overall survival|overall survival
554954|NCT00815620|weight|weight
554955|NCT00815620|time of hospitalization|time of hospitalization
554956|NCT00815607|melanoma|melanoma
554957|NCT00815607|biologic|biologic
554958|NCT00815607|immunotherapy|immunotherapy
554959|NCT00815607|cancer|cancer
554960|NCT00815594|bleb|bleb
554961|NCT00815594|vascular change|vascular change
554962|NCT00815594|bevacizumab|bevacizumab
554963|NCT00815594|trabeculectomy|trabeculectomy
554964|NCT00815594|Bleb vascularity associated with increased scarring activity|bleb vascularity associated with increased scarring activity
554965|NCT00815594|Conjunctival scarring finally leads to the obstruction of the fistula tract created by the filtering surgery|conjunctival scarring finally leads to the obstruction of the fistula tract created by the filtering surgery
554966|NCT00815594|the recombinant human anti-VEGF antibody could inhibit angiogenesis of conjunctiva.|the recombinant human anti-vegf antibody could inhibit angiogenesis of conjunctiva.
554967|NCT00815581|children between 1 to 10 years old|children between 1 to 10 years old
554968|NCT00815581|amblyopy|amblyopy
554969|NCT00815568|fludarabine|fludarabine
554970|NCT00815568|busulfan|busulfan
554971|NCT00815568|total body irradiation|total body irradiation
554972|NCT00815568|conditioning regimen|conditioning regimen
554973|NCT00815555|receptor positive breast cancer|receptor positive breast cancer
554974|NCT00815555|Tamoxifen treatment|tamoxifen treatment
554975|NCT00815555|CYP2D6 status|cyp2d6 status
554976|NCT00815555|relapse|relapse
554977|NCT00815529|Acupuncture|acupuncture
554978|NCT00815529|Chronic low back pain|chronic low back pain
554979|NCT00815529|Qualitative study|qualitative study
554980|NCT00815516|candidiasis|candidiasis
554981|NCT00815516|candida|candida
554982|NCT00815516|Neonate|neonate
554983|NCT00815516|candidemia|candidemia
554984|NCT00815516|Micafungin|micafungin
554985|NCT00815516|Mycamine|mycamine
554986|NCT00815516|amphotericin B deoxycholate|amphotericin b deoxycholate
554987|NCT00815503|Anesthetics|anesthetics
554988|NCT00815503|Local infiltration|local infiltration
554989|NCT00815503|Periacetabular osteotomy|periacetabular osteotomy
554990|NCT00815490|Spectroscopy, near infrared|spectroscopy, near infrared
554991|NCT00815490|Oximetry|oximetry
554992|NCT00815490|Hypoxemia|hypoxemia
554993|NCT00815490|Tissue oxygenation|tissue oxygenation
554994|NCT00815464|Chronic Hepatitis B|chronic hepatitis b
554995|NCT00815464|Liquid Acupuncture(Herb Acupoint Injection)|liquid acupuncture(herb acupoint injection)
554996|NCT00815464|Therapeutics|therapeutics
554997|NCT00815464|Herbalist|herbalist
554998|NCT00815464|Acupoint|acupoint
554999|NCT00815438|Transvaginal|transvaginal
555000|NCT00815438|Cholecystectomy|cholecystectomy
555001|NCT00815438|NOTES|notes
555002|NCT00815438|Endoscopic|endoscopic
555003|NCT00815425|African American|african american
555004|NCT00815386|mitral valve|mitral valve
555005|NCT00815386|heart failure|heart failure
555006|NCT00815386|mitral regurgitation|mitral regurgitation
555007|NCT00815386|annuloplasty|annuloplasty
555008|NCT00815386|coronary sinus|coronary sinus
555009|NCT00815373|Ocular Blood flow|ocular blood flow
555010|NCT00815373|Ocular hypertension|ocular hypertension
555011|NCT00815373|POAG|poag
555012|NCT00815373|Ocular hemodynamics|ocular hemodynamics
555013|NCT00815373|Xalacom|xalacom
555014|NCT00815373|Cosopt|cosopt
555015|NCT00815360|diabetic macular edema|diabetic macular edema
555016|NCT00815347|Asthma|asthma
555017|NCT00815334|vesicoureteral reflux|vesicoureteral reflux
555018|NCT00815334|low compliant bladder|low compliant bladder
555019|NCT00815321|chronic myeloid leukemia|chronic myeloid leukemia
555020|NCT00815321|autologous cytokine induced killer cells|autologous cytokine induced killer cells
555021|NCT00815321|Chronic myeloid leukemia in blast crisis treated with chemotherapy or kinase inhibitors|chronic myeloid leukemia in blast crisis treated with chemotherapy or kinase inhibitors
555022|NCT00815321|Chronic myeloid leukemia with mutation resistant to kinase inhibitors|chronic myeloid leukemia with mutation resistant to kinase inhibitors
555023|NCT00815321|chronic myeloid leukemia with good response to kinase inhibitor and stable persistence of residual disease|chronic myeloid leukemia with good response to kinase inhibitor and stable persistence of residual disease
555024|NCT00815308|Therapeutic|therapeutic
555025|NCT00815308|Drug Therapy, combination|drug therapy, combination
555026|NCT00815308|Radiotherapy|radiotherapy
555027|NCT00815295|squamous cell cancer, head and neck|squamous cell cancer, head and neck
555028|NCT00815269|Inhalant anesthetic|inhalant anesthetic
555029|NCT00815269|Vasodilation|vasodilation
555030|NCT00815269|General anesthesia|general anesthesia
555031|NCT00815269|Ultrasonography|ultrasonography
555032|NCT00815256|Cornea degeneration|cornea degeneration
555033|NCT00815256|keratoconus|keratoconus
555034|NCT00815256|collagen cross linking|collagen cross linking
555035|NCT00815256|CXL|cxl
555036|NCT00815256|Riboflavin|riboflavin
555037|NCT00815243|fracture|fracture
555038|NCT00815243|coxarthrosis|coxarthrosis
555039|NCT00815243|complication|complication
555040|NCT00815243|congenital abnormalities|congenital abnormalities
555041|NCT00815243|bone|bone
555043|NCT00815243|telemedicine|telemedicine
555044|NCT00815243|transportation|transportation
555045|NCT00815243|decision making|decision making
555046|NCT00815243|outcomes|outcomes
555047|NCT00815230|radiation injury|radiation injury
555048|NCT00815230|computed tomography|computed tomography
555049|NCT00815230|reactive oxygen species|reactive oxygen species
555050|NCT00815230|free radicals|free radicals
555051|NCT00815217|Lipoaspirate|lipoaspirate
555052|NCT00815217|Diabetes Mellitus|diabetes mellitus
555053|NCT00815217|Mesenchymal Stem cells|mesenchymal stem cells
555054|NCT00815217|Fat grafts|fat grafts
555055|NCT00815217|venous stasis|venous stasis
555056|NCT00815204|PTSD|ptsd
555057|NCT00815204|HPA axis|hpa axis
555058|NCT00815204|Pituitary volume|pituitary volume
555059|NCT00815191|temperature|temperature
555060|NCT00815191|surgery|surgery
555061|NCT00815191|heating device|heating device
555062|NCT00815178|inspiratory muscle weakness|inspiratory muscle weakness
555063|NCT00815178|autonomic modulation|autonomic modulation
555064|NCT00815178|diabetes mellitus|diabetes mellitus
555065|NCT00815178|heart rate variability|heart rate variability
555066|NCT00815178|functional capacity|functional capacity
555067|NCT00815165|cytomegalovirus, CMV, cell-mediated immunity, children, sub-study|cytomegalovirus, cmv, cell-mediated immunity, children, sub-study
555068|NCT00815152|high grade glioma|high grade glioma
555069|NCT00815152|Coping skills intervention|coping skills intervention
555070|NCT00815152|caregivers|caregivers
555071|NCT00815139|Coronary artery disease, stent|coronary artery disease, stent
555072|NCT00815113|Gastric cancer|gastric cancer
555073|NCT00815113|screening|screening
555074|NCT00815113|high-risk|high-risk
555075|NCT00815113|relatives|relatives
555076|NCT00815113|gastroscopy|gastroscopy
555077|NCT00815100|Ivabradine|ivabradine
555078|NCT00815100|Acute coronary syndrome.|acute coronary syndrome.
555079|NCT00815100|Inflammation|inflammation
555080|NCT00815100|C-reactive protein|c-reactive protein
555081|NCT00815100|Atherosclerosis|atherosclerosis
555082|NCT00815087|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
555083|NCT00815087|functional electrical stimulation|functional electrical stimulation
555084|NCT00815074|Military Women|military women
555085|NCT00815074|Women's Health|women's health
555086|NCT00815074|Genitourinary Symptoms|genitourinary symptoms
555087|NCT00815074|Illness Behaviors|illness behaviors
555088|NCT00815074|To determine how women manage genitourinary symptoms while deployed.|to determine how women manage genitourinary symptoms while deployed.
555089|NCT00815061|prevalence|prevalence
555090|NCT00815061|Incidence|incidence
555091|NCT00815061|crohn's disease|crohn's disease
555092|NCT00815061|ulcerative colitis|ulcerative colitis
555093|NCT00815061|Epidemiology|epidemiology
555094|NCT00815048|Remifentanil|remifentanil
555095|NCT00815048|Endotracheal intubation|endotracheal intubation
555096|NCT00815048|Premedication|premedication
555097|NCT00815048|Sedation|sedation
555098|NCT00815048|Endotracheal Intubation in Neonates|endotracheal intubation in neonates
555099|NCT00815035|Peanut Allergy|peanut allergy
555100|NCT00815022|Temperature|temperature
555101|NCT00815022|Spinal anesthesia|spinal anesthesia
555102|NCT00815022|Cesarean section|cesarean section
555103|NCT00815022|Cephalad sensory blockade|cephalad sensory blockade
555104|NCT00815022|Regional anesthesia|regional anesthesia
555105|NCT00815009|NAFLD|nafld
555106|NCT00815009|NASH|nash
555107|NCT00814983|myeloablative|myeloablative
555108|NCT00814983|stem cell|stem cell
555109|NCT00814983|naive T-cell depleted|naive t-cell depleted
555110|NCT00814983|allogeneic|allogeneic
555111|NCT00814970|PAD|pad
555112|NCT00814970|peripheral arterial disease|peripheral arterial disease
555113|NCT00814970|stent|stent
555114|NCT00814970|SFA|sfa
555115|NCT00814970|PPA|ppa
555116|NCT00814957|positron emission tomography|positron emission tomography
555117|NCT00814957|addiction|addiction
555118|NCT00814944|dry eye|dry eye
555119|NCT00814944|sirolimus|sirolimus
555120|NCT00814944|rapamycin|rapamycin
555121|NCT00814918|acne vulgaris|acne vulgaris
555122|NCT00814918|acne|acne
555123|NCT00814918|dermatalogy|dermatalogy
555124|NCT00814905|chorioamnionitis|chorioamnionitis
555125|NCT00814905|antibiotics|antibiotics
555126|NCT00814905|cesarean|cesarean
555127|NCT00814905|vaginal delivery|vaginal delivery
555128|NCT00814892|adenocarcinoma of the prostate|adenocarcinoma of the prostate
555129|NCT00814892|recurrent prostate cancer|recurrent prostate cancer
555130|NCT00814892|stage I prostate cancer|stage i prostate cancer
555131|NCT00814892|stage IIB prostate cancer|stage iib prostate cancer
555132|NCT00814892|stage IIA prostate cancer|stage iia prostate cancer
555133|NCT00814892|stage III prostate cancer|stage iii prostate cancer
555134|NCT00814892|stage IV prostate cancer|stage iv prostate cancer
555135|NCT00814879|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
555136|NCT00814879|AIDS|aids
555137|NCT00814879|Anti-Infective Agents|anti-infective agents
555138|NCT00814879|Antiretroviral|antiretroviral
555139|NCT00814879|Antiviral Agents|antiviral agents
555140|NCT00814879|Atazanavir|atazanavir
555141|NCT00814879|Human Immunodeficiency Virus|human immunodeficiency virus
555143|NCT00814879|HIV Protease Inhibitors|hiv protease inhibitors
555144|NCT00814879|NRTI|nrti
555145|NCT00814879|Nucleoside Reverse Transcriptase Inhibitors|nucleoside reverse transcriptase inhibitors
555146|NCT00814879|Raltegravir|raltegravir
555147|NCT00814879|Resistance|resistance
555148|NCT00814879|treatment experienced|treatment experienced
555149|NCT00814866|Rheumatoid arthritis|rheumatoid arthritis
555150|NCT00814866|arthritis|arthritis
555151|NCT00814866|osteoclasts|osteoclasts
555152|NCT00814866|bone|bone
555153|NCT00814853|Extubation|extubation
555154|NCT00814853|testing|testing
555155|NCT00814853|ventilator weaning|ventilator weaning
555156|NCT00814853|Pediatric extubation|pediatric extubation
555157|NCT00814840|Heart failure|heart failure
555158|NCT00814840|Dyssynchrony|dyssynchrony
555159|NCT00814840|Cardiac resynchronization|cardiac resynchronization
555160|NCT00814840|Triple-site pacing|triple-site pacing
555161|NCT00814827|Interferon-Gamma|interferon-gamma
555162|NCT00814827|Autoantibodies|autoantibodies
555163|NCT00814827|Mycobacteria|mycobacteria
555164|NCT00814827|Opportunistic Infections|opportunistic infections
555165|NCT00814827|Immunodeficiency|immunodeficiency
555166|NCT00814801|Alzheimer's Disease|alzheimer's disease
555167|NCT00814801|Cognitive dysfunction|cognitive dysfunction
555168|NCT00814801|Dementia|dementia
555169|NCT00814801|Galantamine|galantamine
555170|NCT00814801|R113675|r113675
555171|NCT00814788|stage IV prostate cancer|stage iv prostate cancer
555172|NCT00814788|adenocarcinoma of the prostate|adenocarcinoma of the prostate
555173|NCT00814788|recurrent prostate cancer|recurrent prostate cancer
555174|NCT00814775|Laryngeal mask|laryngeal mask
555175|NCT00814775|Difficult intubation|difficult intubation
555176|NCT00814762|immunogenicity|immunogenicity
555177|NCT00814762|HIV|hiv
555178|NCT00814762|reactogenicity|reactogenicity
555179|NCT00814762|safety|safety
555180|NCT00814762|vaccine|vaccine
555181|NCT00814762|HIV Infections|hiv infections
555182|NCT00814749|stress urinary incontinence|stress urinary incontinence
555183|NCT00814749|urodynamics|urodynamics
555184|NCT00814749|randomized clinical trial|randomized clinical trial
555185|NCT00814749|surgery|surgery
555186|NCT00814710|Pneumococcal disease|pneumococcal disease
555187|NCT00814710|Pneumococcal vaccine|pneumococcal vaccine
555188|NCT00814710|Safety|safety
555189|NCT00814710|Primary vaccination|primary vaccination
555190|NCT00814710|Immunogenicity|immunogenicity
555191|NCT00814697|Alzheimer|alzheimer
555192|NCT00814697|Language|language
555193|NCT00814697|Treatment|treatment
555194|NCT00814697|TMS|tms
555195|NCT00814697|rTMS|rtms
555196|NCT00814671|Tuberculosis|tuberculosis
555197|NCT00814671|Pharmacokinetics|pharmacokinetics
555198|NCT00814658|Dementia|dementia
555199|NCT00814658|Mixed Dementia|mixed dementia
555200|NCT00814658|Galantamine|galantamine
555201|NCT00814658|Reminyl ER|reminyl er
555202|NCT00814658|Nimodipine|nimodipine
555203|NCT00814632|vulvodynia|vulvodynia
555204|NCT00814632|pelvic pain|pelvic pain
555205|NCT00814632|vulvar pain|vulvar pain
555206|NCT00814619|adenocarcinoma of the rectum|adenocarcinoma of the rectum
555207|NCT00814619|stage III rectal cancer|stage iii rectal cancer
555208|NCT00814619|stage II rectal cancer|stage ii rectal cancer
555209|NCT00814606|genotype 1 hepatitis C|genotype 1 hepatitis c
555210|NCT00814606|hepatitis C|hepatitis c
555211|NCT00814606|HCV|hcv
555212|NCT00814606|liver|liver
555213|NCT00814593|adult giant cell glioblastoma|adult giant cell glioblastoma
555214|NCT00814593|adult gliosarcoma|adult gliosarcoma
555215|NCT00814593|adult glioblastoma|adult glioblastoma
555216|NCT00814580|analgesia|analgesia
555217|NCT00814580|postoperative pain|postoperative pain
555218|NCT00814580|opioid|opioid
555219|NCT00814580|rotator cuff repair|rotator cuff repair
555220|NCT00814580|labral tear repair|labral tear repair
555221|NCT00814580|Bankart procedure|bankart procedure
555222|NCT00814580|oxycodone|oxycodone
555223|NCT00814580|tapentadol|tapentadol
555224|NCT00814580|arthroscopic shoulder surgery|arthroscopic shoulder surgery
555225|NCT00814567|recurrent breast cancer|recurrent breast cancer
555226|NCT00814567|stage IA breast cancer|stage ia breast cancer
555227|NCT00814567|stage II breast cancer|stage ii breast cancer
555228|NCT00814567|invasive ductal breast carcinoma|invasive ductal breast carcinoma
555229|NCT00814567|invasive ductal breast carcinoma with predominant intraductal component|invasive ductal breast carcinoma with predominant intraductal component
555230|NCT00814554|obesity|obesity
555231|NCT00814554|nutrition|nutrition
555232|NCT00814554|cluster randomized trial|cluster randomized trial
555233|NCT00814554|high school|high school
555234|NCT00814554|primary prevention|primary prevention
555235|NCT00814541|refractory multiple myeloma|refractory multiple myeloma
555236|NCT00814541|stage I multiple myeloma|stage i multiple myeloma
555237|NCT00814541|stage II multiple myeloma|stage ii multiple myeloma
555238|NCT00814541|stage III multiple myeloma|stage iii multiple myeloma
555239|NCT00814528|actinic keratosis|actinic keratosis
555240|NCT00814528|skin lesions|skin lesions
555241|NCT00814528|5-ALA|5-ala
555242|NCT00814528|AK|ak
555243|NCT00814528|Blu-Light|blu-light
555244|NCT00814515|Moderate|moderate
555245|NCT00814515|Severe|severe
555246|NCT00814515|Dry|dry
555247|NCT00814515|Eye|eye
555248|NCT00814515|Ciclosporin|ciclosporin
555249|NCT00814515|Cyclosporine|cyclosporine
555250|NCT00814502|Alzheimer disease|alzheimer disease
555251|NCT00814502|Dementia, vascular|dementia, vascular
555252|NCT00814502|Actigraphy|actigraphy
555253|NCT00814502|Circadian dysregulation|circadian dysregulation
555254|NCT00814502|Sleep Disorders|sleep disorders
555255|NCT00814502|Circadian rhythm|circadian rhythm
555256|NCT00814489|Non-typable Haemophilus influenzae|non-typable haemophilus influenzae
555257|NCT00814489|protein vaccine|protein vaccine
555258|NCT00814489|Streptococcus pneumoniae|streptococcus pneumoniae
555259|NCT00814489|young adults|young adults
555260|NCT00814476|Medtronic CareLink|medtronic carelink
555261|NCT00814476|therapy management|therapy management
555262|NCT00814476|diabetes|diabetes
555263|NCT00814476|insulin pump|insulin pump
555264|NCT00814476|Blood glucose monitor|blood glucose monitor
555265|NCT00814463|tumors metastatic to brain|tumors metastatic to brain
555266|NCT00814463|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
555267|NCT00814450|Biopsy|biopsy
555268|NCT00814450|Fine needle aspiration|fine needle aspiration
555269|NCT00814424|EtCO2|etco2
555270|NCT00814424|supplemental oxygen delivery|supplemental oxygen delivery
555271|NCT00814424|ERCP|ercp
555272|NCT00814411|contraception|contraception
555273|NCT00814411|noninferiority|noninferiority
555274|NCT00814411|intention|intention
555275|NCT00814411|family planning counseling|family planning counseling
555276|NCT00814411|post abortion care|post abortion care
555277|NCT00814411|Family planning intention among women with unmet need|family planning intention among women with unmet need
555278|NCT00814398|Infertility|infertility
555279|NCT00814398|IVF|ivf
555280|NCT00814398|SET|set
555281|NCT00814398|DET|det
555282|NCT00814398|Blastocyst|blastocyst
555283|NCT00814359|mucositis|mucositis
555284|NCT00814359|radiation|radiation
555285|NCT00814359|magic mouthwash|magic mouthwash
555286|NCT00814359|sucralfate|sucralfate
555287|NCT00814359|benzydamine|benzydamine
555288|NCT00814359|diphenhydramine|diphenhydramine
555289|NCT00814359|dexamethasone|dexamethasone
555290|NCT00814359|nystatin|nystatin
555291|NCT00814346|Mild Alzheimer's disease (AD) patients|mild alzheimer's disease (ad) patients
555292|NCT00814346|Memory complaint patients with cognitive impairment (MC)|memory complaint patients with cognitive impairment (mc)
555293|NCT00814346|Memory complaint patients cognitively normal (CNE)|memory complaint patients cognitively normal (cne)
555294|NCT00814333|epistaxis|epistaxis
555295|NCT00814307|Antirheumatic Agents Clinical Trial|antirheumatic agents clinical trial
555296|NCT00814294|Type 2|type 2
555297|NCT00814281|particulate air pollution|particulate air pollution
555298|NCT00814281|leukotriene|leukotriene
555299|NCT00814281|asthma|asthma
555300|NCT00814281|montelukast|montelukast
555301|NCT00814281|vascular endothelial dysfunction|vascular endothelial dysfunction
555302|NCT00814281|nitric oxide(NO)endothelin (ET) system|nitric oxide(no)endothelin (et) system
555303|NCT00814255|Primary FSGS|primary fsgs
555304|NCT00814255|Steroid Resistant|steroid resistant
555305|NCT00814255|Rosiglitazone|rosiglitazone
555306|NCT00814255|Adalimumab|adalimumab
555307|NCT00814255|Resistant primary FSGS|resistant primary fsgs
555308|NCT00814255|GALACTOSE|galactose
555309|NCT00814242|Hepatocellular Carcinoma|hepatocellular carcinoma
555310|NCT00814242|Adjacent to Major Blood Vessels|adjacent to major blood vessels
555311|NCT00814242|Surgical resection|surgical resection
555312|NCT00814242|Ppercutaneous radiationfrequency ablation|ppercutaneous radiationfrequency ablation
555313|NCT00814242|Time to recurrence|time to recurrence
555314|NCT00814242|Disease-free survival|disease-free survival
555315|NCT00814242|Overall survival|overall survival
555316|NCT00814229|influenza|influenza
555317|NCT00814229|H9N2|h9n2
555318|NCT00814229|vaccine|vaccine
555319|NCT00814216|Efficacy|efficacy
555320|NCT00814216|safety|safety
555321|NCT00814216|QAV680|qav680
555322|NCT00814216|pharmacokinetics|pharmacokinetics
555323|NCT00814216|corticosteroid|corticosteroid
555324|NCT00814216|asthma|asthma
555325|NCT00814203|COPD|copd
555326|NCT00814190|Type 2 Diabetes|type 2 diabetes
555327|NCT00814190|Internet Therapeutic Intervention|internet therapeutic intervention
555328|NCT00814177|warfarin|warfarin
555329|NCT00814177|dosing|dosing
555330|NCT00814177|prothrombin time|prothrombin time
555331|NCT00814177|Heart valve prosthesis|heart valve prosthesis
555332|NCT00814164|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
555333|NCT00814164|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
555334|NCT00814164|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
555335|NCT00814164|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
555336|NCT00814164|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
555337|NCT00814164|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
555338|NCT00814164|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
555339|NCT00814164|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
555340|NCT00814164|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
555341|NCT00814164|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
555342|NCT00814164|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
555343|NCT00814164|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
555344|NCT00814164|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
555345|NCT00814164|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
555346|NCT00814164|secondary acute myeloid leukemia|secondary acute myeloid leukemia
555347|NCT00814151|Blood culture|blood culture
555348|NCT00814151|Staphylococcus aureus|staphylococcus aureus
555349|NCT00814151|Bacteremia|bacteremia
555350|NCT00814151|MRSA|mrsa
555351|NCT00814151|MSSA|mssa
555352|NCT00814151|MicroPhage|microphage
555353|NCT00814138|myasthenia gravis|myasthenia gravis
555354|NCT00814125|Endometrial|endometrial
555355|NCT00814125|Endometrial histological findings|endometrial histological findings
555356|NCT00814099|Acute Respiratory Failure|acute respiratory failure
555357|NCT00814099|Acute Lung Injury|acute lung injury
555358|NCT00814073|Mastocytosis with handicap|mastocytosis with handicap
555359|NCT00814073|Mastocytosis|mastocytosis
555360|NCT00814073|Smouldering systemic mastocytosis|smouldering systemic mastocytosis
555361|NCT00814073|Indolent systemic mastocytosis|indolent systemic mastocytosis
555362|NCT00814073|Cutaneous mastocytosis|cutaneous mastocytosis
555363|NCT00814073|Mast cell|mast cell
555364|NCT00814073|Mast cell infiltration|mast cell infiltration
555365|NCT00814073|Skin|skin
555366|NCT00814073|Bone marrow|bone marrow
555367|NCT00814073|Pruritus|pruritus
555368|NCT00814073|Flushes|flushes
555369|NCT00814073|c-kit|c-kit
555370|NCT00814073|c-kit mutation|c-kit mutation
555371|NCT00814073|Wild Type|wild type
555372|NCT00814073|Mutation Asp-816-Val(D816V)|mutation asp-816-val(d816v)
555373|NCT00814047|ultrasonography|ultrasonography
555374|NCT00814034|Aromatase Inhibitors|aromatase inhibitors
555375|NCT00814034|Coagulation parameters|coagulation parameters
555376|NCT00814034|Tamoxifen|tamoxifen
555377|NCT00814021|recurrent renal cell cancer|recurrent renal cell cancer
555378|NCT00814021|stage IV renal cell cancer|stage iv renal cell cancer
555379|NCT00814021|tumors metastatic to brain|tumors metastatic to brain
555380|NCT00813969|Mesenchymal Stem Cell|mesenchymal stem cell
555382|NCT00813969|Autologous|autologous
555383|NCT00813969|Multiple Sclerosis|multiple sclerosis
555384|NCT00813956|triple negative breast cancer|triple negative breast cancer
555385|NCT00813943|Newly diagnosed Glioblastoma (WHO Grade IV)|newly diagnosed glioblastoma (who grade iv)
555386|NCT00813943|Cilengitide|cilengitide
555387|NCT00813943|Temozolomide|temozolomide
555388|NCT00813943|Radiotherapy|radiotherapy
555389|NCT00813930|Diabetes|diabetes
555390|NCT00813930|Lifestyle Intervention|lifestyle intervention
555391|NCT00813930|Cardiovascular risk reduction|cardiovascular risk reduction
555392|NCT00813891|ranibizumab|ranibizumab
555393|NCT00813891|verteporfin|verteporfin
555394|NCT00813878|breast cancer|breast cancer
555395|NCT00813878|breast cancer in situ|breast cancer in situ
555396|NCT00813852|obstructive sleep apnea|obstructive sleep apnea
555397|NCT00813852|skeletal muscle|skeletal muscle
555398|NCT00813852|magnetic stimulation|magnetic stimulation
555399|NCT00813852|magnetic resonance spectroscopy|magnetic resonance spectroscopy
555400|NCT00813852|inflammatory markers|inflammatory markers
555401|NCT00813852|exercise|exercise
555402|NCT00813839|SmartCare|smartcare
555403|NCT00813839|Spontaneous Breathing Trials|spontaneous breathing trials
555404|NCT00813839|Mechanical Ventilation|mechanical ventilation
555405|NCT00813839|Weaning|weaning
555406|NCT00813839|Patients requiring prolonged mechanical ventilation (>72 hours)|patients requiring prolonged mechanical ventilation (>72 hours)
555408|NCT00813826|Pain after Shingles|pain after shingles
555409|NCT00813800|Smoking|smoking
555410|NCT00813800|Bipolar Disorder|bipolar disorder
555411|NCT00813800|Depression|depression
555412|NCT00813787|Magnetic Resonance Imaging|magnetic resonance imaging
555413|NCT00813787|Glioma|glioma
555414|NCT00813774|Cimzia|cimzia
555415|NCT00813774|certolizumab pegol|certolizumab pegol
555416|NCT00813774|Bioavailability|bioavailability
555417|NCT00813774|Healthy volunteers|healthy volunteers
555418|NCT00813748|Asthma|asthma
555419|NCT00813748|Anaphylaxis|anaphylaxis
555420|NCT00813735|Insomnia|insomnia
555421|NCT00813735|Major Depression|major depression
555422|NCT00813735|Geriatric|geriatric
555423|NCT00813722|adherence|adherence
555424|NCT00813722|blood pressure|blood pressure
555425|NCT00813722|hypertension|hypertension
555426|NCT00813722|compliance|compliance
555427|NCT00813722|atenolol|atenolol
555428|NCT00813722|hydrochlorothiazide|hydrochlorothiazide
555429|NCT00813722|amlodipine|amlodipine
555430|NCT00813722|losartan|losartan
555431|NCT00813709|Interferon 1-beta|interferon 1-beta
555432|NCT00813709|Clinical Definite Multiple Sclerosis|clinical definite multiple sclerosis
555433|NCT00813696|chemotherapy|chemotherapy
555434|NCT00813696|advanced cancer|advanced cancer
555435|NCT00813696|inoperable|inoperable
555436|NCT00813696|Stage II, III, IV|stage ii, iii, iv
555437|NCT00813683|Acupuncture, moxybustion,|acupuncture, moxybustion,
555438|NCT00813683|Cephalic version,|cephalic version,
555439|NCT00813683|Breech presentation|breech presentation
555440|NCT00813631|Malignant fungating wound|malignant fungating wound
555441|NCT00813631|Head and neck|head and neck
555442|NCT00813631|Ionic silver-releasing dressing|ionic silver-releasing dressing
555443|NCT00813631|Wound care|wound care
555444|NCT00813631|RCT|rct
555445|NCT00813618|Acute GvHD of at least Grade II severity|acute gvhd of at least grade ii severity
555446|NCT00813605|AMG 655|amg 655
555447|NCT00813605|AMG 479|amg 479
555448|NCT00813605|Colon Cancer|colon cancer
555449|NCT00813605|Rectal Cancer|rectal cancer
555450|NCT00813605|Monoclonal Antibody|monoclonal antibody
555451|NCT00813605|Clinical Trial|clinical trial
555452|NCT00813605|Colorectal Cancer|colorectal cancer
555453|NCT00813605|metastatic colorectal cancer|metastatic colorectal cancer
555454|NCT00813605|metastatic cancer|metastatic cancer
555455|NCT00813605|antibody-2nd line|antibody-2nd line
555456|NCT00813605|KRAS|kras
555457|NCT00813605|adenocarcinoma|adenocarcinoma
555458|NCT00813592|meningioma|meningioma
555459|NCT00813592|brain|brain
555460|NCT00813579|assess the safety of living kidney donation|assess the safety of living kidney donation
555461|NCT00813566|cancer|cancer
555462|NCT00813566|imaging|imaging
555463|NCT00813566|PET scanning|pet scanning
555464|NCT00813553|physical fitness|physical fitness
555465|NCT00813553|exercise|exercise
555466|NCT00813553|amino acid|amino acid
555467|NCT00813540|Colonic Neoplasms|colonic neoplasms
555468|NCT00813540|Aerobic Exercise|aerobic exercise
555469|NCT00813540|Weight Lifting|weight lifting
555470|NCT00813540|Body Composition|body composition
555471|NCT00813527|Drug Therapy|drug therapy
555472|NCT00813527|Lipid Metabolism Disorders|lipid metabolism disorders
555473|NCT00813527|Hyperlipidemias|hyperlipidemias
555474|NCT00813527|Hypercholesterolemia|hypercholesterolemia
555475|NCT00813527|Hypertriglyceridemia|hypertriglyceridemia
555476|NCT00813514|AMD|amd
555477|NCT00813514|VEGF genotyping|vegf genotyping
555478|NCT00813514|complement H gene polymorphism|complement h gene polymorphism
555479|NCT00813514|Vascular Endothelial Growth Factor A|vascular endothelial growth factor a
555480|NCT00813501|graft versus host disease|graft versus host disease
555481|NCT00813501|infection|infection
555482|NCT00813501|therapy-related toxicity|therapy-related toxicity
555483|NCT00813501|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
555484|NCT00813501|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
555485|NCT00813501|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
555486|NCT00813501|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
555487|NCT00813501|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
555488|NCT00813501|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
555489|NCT00813501|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
555490|NCT00813501|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
555491|NCT00813501|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
555492|NCT00813501|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
555493|NCT00813501|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
555494|NCT00813501|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
555495|NCT00813501|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
555496|NCT00813501|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
555497|NCT00813501|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
555498|NCT00813501|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
555499|NCT00813501|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
555500|NCT00813501|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
555501|NCT00813501|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
555502|NCT00813501|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
555503|NCT00813501|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
555504|NCT00813501|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
555505|NCT00813501|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
555506|NCT00813501|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
555507|NCT00813501|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
555508|NCT00813501|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
555509|NCT00813501|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
555510|NCT00813501|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
555511|NCT00813501|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
555512|NCT00813501|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
555513|NCT00813501|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
555514|NCT00813501|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
555581|NCT00813436|Empathy|empathy
555515|NCT00813501|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
555516|NCT00813501|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
555517|NCT00813501|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
555518|NCT00813501|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
555519|NCT00813501|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
555520|NCT00813501|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
555521|NCT00813501|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
555522|NCT00813501|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
555523|NCT00813501|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
555524|NCT00813501|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
555525|NCT00813501|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
555526|NCT00813501|splenic marginal zone lymphoma|splenic marginal zone lymphoma
555527|NCT00813501|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
555528|NCT00813501|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
555529|NCT00813501|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
555530|NCT00813501|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
555531|NCT00813501|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
555532|NCT00813501|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
555533|NCT00813501|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
555534|NCT00813501|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
555535|NCT00813501|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
555536|NCT00813501|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
555537|NCT00813501|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
555538|NCT00813501|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
555539|NCT00813501|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
555540|NCT00813501|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
555541|NCT00813501|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
555542|NCT00813501|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
555543|NCT00813501|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
555544|NCT00813501|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
555545|NCT00813501|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
555546|NCT00813501|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
555547|NCT00813501|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
555548|NCT00813501|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
555549|NCT00813501|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
555550|NCT00813501|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
555551|NCT00813501|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
555552|NCT00813501|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
555553|NCT00813501|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
555554|NCT00813501|refractory hairy cell leukemia|refractory hairy cell leukemia
555555|NCT00813501|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
555556|NCT00813501|secondary acute myeloid leukemia|secondary acute myeloid leukemia
555557|NCT00813501|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
555558|NCT00813501|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
555559|NCT00813501|chronic eosinophilic leukemia|chronic eosinophilic leukemia
555560|NCT00813501|primary myelofibrosis|primary myelofibrosis
555561|NCT00813501|chronic neutrophilic leukemia|chronic neutrophilic leukemia
555562|NCT00813501|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
555563|NCT00813501|disseminated neuroblastoma|disseminated neuroblastoma
555564|NCT00813501|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
555565|NCT00813501|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
555566|NCT00813501|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
555567|NCT00813501|stage I multiple myeloma|stage i multiple myeloma
555568|NCT00813501|stage II multiple myeloma|stage ii multiple myeloma
555569|NCT00813501|stage III multiple myeloma|stage iii multiple myeloma
555570|NCT00813501|refractory multiple myeloma|refractory multiple myeloma
555571|NCT00813488|Breakthrough Pain|breakthrough pain
555572|NCT00813488|Opioid-tolerant|opioid-tolerant
555573|NCT00813488|Chronic Pain|chronic pain
555574|NCT00813475|cardio vascular outcome|cardio vascular outcome
555575|NCT00813449|Endostar|endostar
555576|NCT00813449|advanced melanoma|advanced melanoma
555577|NCT00813449|combined chemotherapy|combined chemotherapy
555578|NCT00813436|ToM|tom
555579|NCT00813436|Theory of Mind|theory of mind
555580|NCT00813436|Simulation|simulation
555582|NCT00813436|Oxytocin|oxytocin
555583|NCT00813436|Schizophrenia|schizophrenia
555584|NCT00813384|Cancer|cancer
555585|NCT00813384|Solid Tumors|solid tumors
555586|NCT00813384|Phase 1|phase 1
555587|NCT00813384|C-met inhibitor|c-met inhibitor
555588|NCT00813384|Clinical Trial|clinical trial
555589|NCT00813371|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
555590|NCT00813371|acute lung injury|acute lung injury
555591|NCT00813371|Airway Pressure Release Ventilation|airway pressure release ventilation
555592|NCT00813371|ARDSnet|ardsnet
555593|NCT00813371|Bi-level|bi-level
555594|NCT00813371|respiratory failure|respiratory failure
555595|NCT00813371|trauma|trauma
555596|NCT00813371|APRV|aprv
555597|NCT00813358|Endovascular Aneurysm Repair|endovascular aneurysm repair
555598|NCT00813358|Aortic Aneurysm|aortic aneurysm
555599|NCT00813358|Thoracic|thoracic
555600|NCT00813345|anesthesia propofol ambulatory rhythm|anesthesia propofol ambulatory rhythm
555601|NCT00813332|Endostar|endostar
555602|NCT00813332|NSCLC|nsclc
555603|NCT00813332|Docetaxel|docetaxel
555604|NCT00813332|Combined therapy|combined therapy
555605|NCT00813332|second-line chemotherapy|second-line chemotherapy
555606|NCT00813319|GARDASIL|gardasil
555607|NCT00813319|HPV|hpv
555608|NCT00813319|Vaccination|vaccination
555609|NCT00813306|GERD|gerd
555610|NCT00813306|TLESR|tlesr
555611|NCT00813306|reflux|reflux
555612|NCT00813293|Hepatocellular Cancer|hepatocellular cancer
555613|NCT00813293|HCC|hcc
555614|NCT00813293|Liver Cancer|liver cancer
555615|NCT00813293|radiofrequency ablation|radiofrequency ablation
555616|NCT00813293|RFA|rfa
555617|NCT00813293|sorafenib|sorafenib
555618|NCT00813293|nexavaar|nexavaar
555619|NCT00813293|liver directed therapy|liver directed therapy
555620|NCT00813293|interventional radiology|interventional radiology
555621|NCT00813267|Mesenchymal Stem Cells|mesenchymal stem cells
555622|NCT00813267|Osteonecrosis of the Femoral Head|osteonecrosis of the femoral head
555623|NCT00813254|Platinum-Resistant Ovarian Cancer|platinum-resistant ovarian cancer
555624|NCT00813254|Platinum-based chemotherapy|platinum-based chemotherapy
555625|NCT00813254|Ovarian Cancer|ovarian cancer
555626|NCT00813254|Ovary|ovary
555627|NCT00813254|Epithelial ovarian cancer|epithelial ovarian cancer
555628|NCT00813254|Quality of Life|quality of life
555629|NCT00813254|Cost Utility Analysis|cost utility analysis
555630|NCT00813254|Sexual functioning|sexual functioning
555631|NCT00813254|Questionnaire|questionnaire
555632|NCT00813254|Caregiver|caregiver
555633|NCT00813241|Ankylosing spondylitis,Rheumatoid Arthritis,Adenomatous Polyposis Coli,Osteoarthritis,Dysmenorrhoea,pharmacokinetic study|ankylosing spondylitis,rheumatoid arthritis,adenomatous polyposis coli,osteoarthritis,dysmenorrhoea,pharmacokinetic study
555634|NCT00813228|Immune Function|immune function
555635|NCT00813228|DDP-4|ddp-4
555636|NCT00813228|Sitagliptin|sitagliptin
555637|NCT00813228|GLP-1|glp-1
555638|NCT00813228|TGF Beta|tgf beta
555639|NCT00813215|Type 2 diabetes mellitus|type 2 diabetes mellitus
555640|NCT00813215|Postprandial dysmetabolism|postprandial dysmetabolism
555641|NCT00813215|Postprandial inflammation|postprandial inflammation
555642|NCT00813215|Relatives|relatives
555643|NCT00813215|Meal challenge|meal challenge
555644|NCT00813202|Nesiritide|nesiritide
555645|NCT00813202|Natrecor|natrecor
555646|NCT00813202|Quanke|quanke
555647|NCT00813202|Acute Decompensated Heart Failure|acute decompensated heart failure
555648|NCT00813189|glucocorticoid therapy|glucocorticoid therapy
555649|NCT00813189|muscle function|muscle function
555650|NCT00813189|growth hormone treatment|growth hormone treatment
555651|NCT00813176|Obesity|obesity
555652|NCT00813176|One-Lung Ventilation|one-lung ventilation
555653|NCT00813176|Anesthesia|anesthesia
555654|NCT00813176|Thoracic|thoracic
555655|NCT00813176|One-lung ventilation in the morbidly obese patient|one-lung ventilation in the morbidly obese patient
555656|NCT00813163|Phase II study|phase ii study
555657|NCT00813163|Second line|second line
555658|NCT00813163|Pancreatic cancer|pancreatic cancer
555659|NCT00813163|Metastatic|metastatic
555660|NCT00813150|Multiple myeloma|multiple myeloma
555661|NCT00813150|Bortezomib|bortezomib
555662|NCT00813150|Dexamethasone|dexamethasone
555663|NCT00813150|Cyclophosphamide|cyclophosphamide
555664|NCT00813150|Oncology|oncology
555665|NCT00813137|Colorectal Cancer|colorectal cancer
555666|NCT00813137|chemotherapy|chemotherapy
555667|NCT00813137|recombinant human endostatin|recombinant human endostatin
555668|NCT00813124|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
555670|NCT00813124|Donor stem cell transplant|donor stem cell transplant
555671|NCT00813124|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
555672|NCT00813124|Stem cell transplant|stem cell transplant
555673|NCT00813124|ATG|atg
555674|NCT00813124|Antithymocyte globulin|antithymocyte globulin
555675|NCT00813124|Vidaza|vidaza
555676|NCT00813124|Azacitidine|azacitidine
555677|NCT00813124|5-Azacitidine|5-azacitidine
555678|NCT00813124|5-Aza|5-aza
555679|NCT00813124|5-AZC|5-azc
555680|NCT00813124|Ladakamycin|ladakamycin
555681|NCT00813124|NSC-102816|nsc-102816
555682|NCT00813124|allotx|allotx
555683|NCT00813124|Busulfan|busulfan
555684|NCT00813124|Busulfex|busulfex
555685|NCT00813124|Myleran|myleran
555686|NCT00813124|Fludarabine|fludarabine
555687|NCT00813124|Fludarabine Phosphate|fludarabine phosphate
555688|NCT00813124|Tacrolimus|tacrolimus
555689|NCT00813124|Methotrexate|methotrexate
555690|NCT00813124|Azacitidine maintenance therapy|azacitidine maintenance therapy
555691|NCT00813124|molecular remission|molecular remission
555692|NCT00813124|HLA compatible donor|hla compatible donor
555693|NCT00813124|Engraftment|engraftment
555694|NCT00813124|Chimerism|chimerism
555695|NCT00813124|Graft vs host disease|graft vs host disease
555696|NCT00813124|GVHD|gvhd
555697|NCT00813111|Postsurgical pain|postsurgical pain
555698|NCT00813111|Analgesia|analgesia
555699|NCT00813111|Breast augmentation|breast augmentation
555700|NCT00813085|Diabetes|diabetes
555701|NCT00813085|Computerized clinical decision support|computerized clinical decision support
555702|NCT00813085|shared care|shared care
555703|NCT00813085|patient self-monitoring|patient self-monitoring
555704|NCT00813085|quality of care|quality of care
555705|NCT00813085|complex interventions|complex interventions
555706|NCT00813085|composite outcomes|composite outcomes
555707|NCT00813072|Gastric Cancer|gastric cancer
555708|NCT00813072|Stomach Cancer|stomach cancer
555709|NCT00813072|Gastroesophageal|gastroesophageal
555710|NCT00813072|Gastroesophageal Junction|gastroesophageal junction
555711|NCT00813072|Esophageal Cancer|esophageal cancer
555712|NCT00813072|phase II|phase ii
555713|NCT00813072|PEP02|pep02
555714|NCT00813072|randomization|randomization
555715|NCT00813072|randomisation|randomisation
555716|NCT00813072|adenocarcinoma|adenocarcinoma
555717|NCT00813072|locally advanced|locally advanced
555718|NCT00813072|metastatic|metastatic
555719|NCT00813072|simon's two|simon's two
555720|NCT00813059|NAION|naion
555721|NCT00813059|bevacizumab|bevacizumab
555722|NCT00813033|create a patient decision aid for endoscopy|create a patient decision aid for endoscopy
555723|NCT00813033|evaluate efficacy of a patient decision aid for endoscopy|evaluate efficacy of a patient decision aid for endoscopy
555724|NCT00813007|Cervical Cancer|cervical cancer
555725|NCT00813007|Cervix|cervix
555726|NCT00813007|Questionnaire|questionnaire
555727|NCT00813007|Adenocarcinoma of uterine cervix|adenocarcinoma of uterine cervix
555728|NCT00813007|Squamous cell carcinoma of uterine cervix|squamous cell carcinoma of uterine cervix
555729|NCT00813007|Adenosquamous carcinoma of uterine cervix|adenosquamous carcinoma of uterine cervix
555730|NCT00813007|Abdominal radical trachelectomy|abdominal radical trachelectomy
555731|NCT00813007|Trachelectomy|trachelectomy
555732|NCT00813007|Quality of life|quality of life
555733|NCT00813007|Sexual functioning|sexual functioning
555734|NCT00812994|Depression|depression
555735|NCT00812994|BDNF|bdnf
555736|NCT00812994|neurotrophic factor|neurotrophic factor
555737|NCT00812994|neurosetroid|neurosetroid
555738|NCT00812994|allopregnanolone|allopregnanolone
555739|NCT00812981|Pandemic influenza|pandemic influenza
555740|NCT00812968|Myelodysplastic Syndromes|myelodysplastic syndromes
555741|NCT00812968|Lenalidomide|lenalidomide
555742|NCT00812955|Dyslipidemia|dyslipidemia
555743|NCT00812955|Hypercholesterolemia|hypercholesterolemia
555744|NCT00812955|Hypertriglyceridemia|hypertriglyceridemia
555745|NCT00812942|average-risk subjects for|average-risk subjects for
555746|NCT00812929|Asthma, Exercise Induced Asthma, Exercise Induced Bronchospasm|asthma, exercise induced asthma, exercise induced bronchospasm
555747|NCT00812916|Persistent or longstanding persistent atrial fibrillation|persistent or longstanding persistent atrial fibrillation
555748|NCT00812903|Neck|neck
555749|NCT00812903|Pain|pain
555750|NCT00812903|Exercise|exercise
555751|NCT00812903|Pilots|pilots
555752|NCT00812903|Crew|crew
555753|NCT00812877|pulp capping|pulp capping
555754|NCT00812877|MTA|mta
555755|NCT00812877|CaOH|caoh
555756|NCT00812877|Mineral Trioxide Aggregate|mineral trioxide aggregate
555757|NCT00812877|Calcium Hydroxide|calcium hydroxide
555758|NCT00812864|Capecitabine|capecitabine
555759|NCT00812864|pharmacocinetics|pharmacocinetics
555760|NCT00812864|Breast metastatic cancer|breast metastatic cancer
555761|NCT00812864|colorectal metastatic cancer|colorectal metastatic cancer
555762|NCT00812864|Elderly patients|elderly patients
555763|NCT00812851|ALS|als
555764|NCT00812851|cramps|cramps
555765|NCT00812851|THC|thc
555766|NCT00812851|Dronabinol|dronabinol
555767|NCT00812825|Safety Tolerability Pharmacokinetics/pharmacodynamics|safety tolerability pharmacokinetics/pharmacodynamics
555768|NCT00812812|paroxetine|paroxetine
555769|NCT00812812|selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
555770|NCT00812812|CDRS-R|cdrs-r
555771|NCT00812812|children and adolescents|children and adolescents
555772|NCT00812799|randomised|randomised
555773|NCT00812799|double-blind|double-blind
555774|NCT00812799|placebo-controlled|placebo-controlled
555775|NCT00812799|efficacy and safety|efficacy and safety
555776|NCT00812799|Oralgen® Grass Pollen|oralgen® grass pollen
555777|NCT00812799|allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
555778|NCT00812799|allergy|allergy
555779|NCT00812799|rhinoconjunctivitis|rhinoconjunctivitis
555780|NCT00812799|immunotherapy|immunotherapy
555781|NCT00812799|grass pollen extract|grass pollen extract
555782|NCT00812786|heart transplantation|heart transplantation
555783|NCT00812786|immunosuppressive drugs|immunosuppressive drugs
555784|NCT00812786|individual dose adjustment|individual dose adjustment
555785|NCT00812786|harmacokinetics|harmacokinetics
555786|NCT00812786|modelling|modelling
555787|NCT00812773|GSK2190915|gsk2190915
555788|NCT00812773|Repeat|repeat
555789|NCT00812773|Oral|oral
555790|NCT00812773|Dose|dose
555791|NCT00812773|Challenge|challenge
555792|NCT00812773|Asthma|asthma
555793|NCT00812773|Allergen|allergen
555794|NCT00812760|Electroretinography|electroretinography
555795|NCT00812760|levodopa|levodopa
555796|NCT00812747|surgical wound infection|surgical wound infection
555797|NCT00812747|risk factor|risk factor
555798|NCT00812734|Neuropathic pain|neuropathic pain
555799|NCT00812734|chronic pain|chronic pain
555800|NCT00812734|postoperative|postoperative
555801|NCT00812734|surgery|surgery
555802|NCT00812734|anesthesiology|anesthesiology
555803|NCT00812734|Scheduled surgery|scheduled surgery
555804|NCT00812721|higher order aberrations|higher order aberrations
555805|NCT00812721|tear blur|tear blur
555806|NCT00812708|aniridia|aniridia
555807|NCT00812708|Morcher iris diaphragms|morcher iris diaphragms
555808|NCT00812708|modified capsule tension ring|modified capsule tension ring
555809|NCT00812708|artificial iris|artificial iris
555810|NCT00812708|iris reconstruction lens|iris reconstruction lens
555811|NCT00812708|glare sensitivity|glare sensitivity
555812|NCT00812708|photophobia|photophobia
555813|NCT00812695|Obstructive sleep apnea|obstructive sleep apnea
555814|NCT00812695|Refractory hypertension|refractory hypertension
555815|NCT00812695|Heart remodeling|heart remodeling
555816|NCT00812695|Arterial stiffness|arterial stiffness
555817|NCT00812695|CPAP|cpap
555818|NCT00812682|SYMBICORT AMD|symbicort amd
555819|NCT00812669|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
555820|NCT00812669|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
555821|NCT00812669|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
555822|NCT00812669|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
555823|NCT00812669|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
555824|NCT00812669|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
555825|NCT00812643|pharmacokinetics|pharmacokinetics
555826|NCT00812630|male hormonal contraception|male hormonal contraception
555827|NCT00812630|Blood pressure, sperm concentration|blood pressure, sperm concentration
555828|NCT00812578|Type 2 diabetes|type 2 diabetes
555829|NCT00812578|Vitamin D insufficiency|vitamin d insufficiency
555830|NCT00812578|Insulin secretion|insulin secretion
555831|NCT00812578|Insulin sensitivity|insulin sensitivity
555832|NCT00812578|Pulsatility|pulsatility
555833|NCT00812539|Diabetes|diabetes
555834|NCT00812539|Blood glucose monitoring|blood glucose monitoring
555835|NCT00812539|Internet|internet
555836|NCT00812526|Choroid|choroid
555837|NCT00812526|Regional blood flow|regional blood flow
555838|NCT00812526|Autoregulation|autoregulation
555839|NCT00812526|Laser Doppler flowmetry|laser doppler flowmetry
555840|NCT00812513|rhPDGF-BB|rhpdgf-bb
555841|NCT00812513|Platelet derived growth factor|platelet derived growth factor
555842|NCT00812513|Burns|burns
555843|NCT00812513|Thermal burns|thermal burns
555844|NCT00812513|Electric burns|electric burns
555845|NCT00812500|assess the effect of age on the EAR and RDA for protein|assess the effect of age on the ear and rda for protein
555846|NCT00812487|congestive heart failure|congestive heart failure
555847|NCT00812487|diabetes mellitus|diabetes mellitus
555848|NCT00812487|hyperglycemia|hyperglycemia
555849|NCT00812474|cerebral blood flow|cerebral blood flow
555850|NCT00812461|Pharmacologic Actions|pharmacologic actions
555851|NCT00812461|Alcohol-Related Disorders|alcohol-related disorders
555852|NCT00812461|Alcoholism|alcoholism
555853|NCT00812461|Mental Disorders|mental disorders
555854|NCT00812461|Central Nervous System Agents|central nervous system agents
555855|NCT00812448|prophylaxis|prophylaxis
555856|NCT00812448|influenza infection|influenza infection
555857|NCT00812448|catechins|catechins
555858|NCT00812448|prophylaxis of influenza infection|prophylaxis of influenza infection
555859|NCT00812435|STEMI|stemi
555860|NCT00812435|Patients|patients
555861|NCT00812435|male or female|male or female
555862|NCT00812435|greater than 18 years of age|greater than 18 years of age
555863|NCT00812435|presenting with ST elevation myocardial infarction|presenting with st elevation myocardial infarction
555864|NCT00812422|Fever due to acute upper respiratory tract infection|fever due to acute upper respiratory tract infection
555865|NCT00812409|Measuring markers of metabolic syndrome in overweight and obese adults.|measuring markers of metabolic syndrome in overweight and obese adults.
555866|NCT00812396|Biomarkers of muscle anabolism|biomarkers of muscle anabolism
555867|NCT00812370|DVT|dvt
555868|NCT00812370|Deep Venous Thrombosis|deep venous thrombosis
555869|NCT00812370|UNBLOCK|unblock
555870|NCT00812370|Bivalirudin|bivalirudin
555871|NCT00812370|Angiomax|angiomax
555872|NCT00812357|Symbicort Turbuhaler|symbicort turbuhaler
555873|NCT00812357|asthma|asthma
555874|NCT00812357|cohort study|cohort study
555875|NCT00812357|France|france
555876|NCT00812344|pharmacokinetics|pharmacokinetics
555877|NCT00812331|Hepatitis C|hepatitis c
555878|NCT00812331|TMC435|tmc435
555879|NCT00812318|HIV infected subjects|hiv infected subjects
555880|NCT00812318|Healthy volunteer|healthy volunteer
555881|NCT00812318|GSK1265744.|gsk1265744.
555882|NCT00812292|TMC278|tmc278
555883|NCT00812292|TMC278-C145|tmc278-c145
555884|NCT00812292|TMC278-TiDP38-C145|tmc278-tidp38-c145
555885|NCT00812292|concept pediatric formulations of TMC278|concept pediatric formulations of tmc278
555886|NCT00812292|HIV Infections|hiv infections
555887|NCT00812279|Smokers with acceptable health conditions|smokers with acceptable health conditions
555888|NCT00812266|SCLC|sclc
555889|NCT00812266|Extensive disease|extensive disease
555890|NCT00812266|topotecan|topotecan
555891|NCT00812253|Heart failure|heart failure
555892|NCT00812253|Hyperglycemia|hyperglycemia
555893|NCT00812253|Hospital|hospital
555894|NCT00812253|Diabetes Mellitus|diabetes mellitus
555895|NCT00812240|Gastro-Intestinal Stromal Tumour|gastro-intestinal stromal tumour
555896|NCT00812240|GIST|gist
555897|NCT00812240|non resectable|non resectable
555898|NCT00812240|recurrent post-surgery|recurrent post-surgery
555899|NCT00812240|first line of treatment|first line of treatment
555900|NCT00812240|metastatic|metastatic
555901|NCT00812240|locally advanced|locally advanced
555902|NCT00812227|Depression|depression
555903|NCT00812227|Psychotherapy|psychotherapy
555904|NCT00812227|Neuroimaging|neuroimaging
555905|NCT00812227|Subjects with Major Depressive Disorder (MDD)|subjects with major depressive disorder (mdd)
555906|NCT00812214|insomnia|insomnia
555907|NCT00812214|migraine|migraine
555908|NCT00812214|eszopiclone|eszopiclone
555909|NCT00812214|insomnia in migraineurs|insomnia in migraineurs
555910|NCT00812201|Heart failure|heart failure
555911|NCT00812201|auto threshold|auto threshold
555912|NCT00812201|pacing|pacing
555913|NCT00812201|CRT-P or CRT-D recipients, threshold measurements|crt-p or crt-d recipients, threshold measurements
555914|NCT00812188|Morphea|morphea
555915|NCT00812188|Plaque morphea|plaque morphea
555916|NCT00812188|Localized Scleroderma|localized scleroderma
555917|NCT00812175|Hepatocellular Carcinoma|hepatocellular carcinoma
555918|NCT00812175|HCC|hcc
555919|NCT00812175|Sorafenib|sorafenib
555920|NCT00812149|Type-2 Deiodinase|type-2 deiodinase
555921|NCT00812149|Genetic Polymorphism|genetic polymorphism
555922|NCT00812149|Triiodothyronine (T3)|triiodothyronine (t3)
555923|NCT00812149|Thyrotropin Releasing Hormone (TRH) Test|thyrotropin releasing hormone (trh) test
555924|NCT00812136|Using Parent Mentors to Improve Asthma Care for Urban Minority Children|using parent mentors to improve asthma care for urban minority children
555925|NCT00812123|kidney transplantation|kidney transplantation
555926|NCT00812123|calcineurin inhibitor free|calcineurin inhibitor free
555927|NCT00812123|protocol biopsy|protocol biopsy
555928|NCT00812123|Cyclosporin A|cyclosporin a
555929|NCT00812123|Sirolimus|sirolimus
555930|NCT00812110|Influenza prevention|influenza prevention
555931|NCT00812097|Breast Augmentation|breast augmentation
555932|NCT00812097|Breast Reconstruction|breast reconstruction
555933|NCT00812097|Breast Revision|breast revision
555934|NCT00812097|Silicone gel|silicone gel
555935|NCT00812097|Contour Profile Gel|contour profile gel
555936|NCT00812097|Siltex®|siltex®
555937|NCT00812084|Quality of life|quality of life
555938|NCT00812084|health resources|health resources
555939|NCT00812084|costs|costs
555940|NCT00812084|community-acquired pneumonia|community-acquired pneumonia
555941|NCT00812071|volunteers|volunteers
555942|NCT00812058|Bipolar Depression|bipolar depression
555943|NCT00812058|Bipolar Disease|bipolar disease
555944|NCT00812058|Bipolar Disorder|bipolar disorder
555945|NCT00812058|Bipolar|bipolar
555946|NCT00812058|Manic Depression|manic depression
555947|NCT00812058|Manic Depressive Disorder|manic depressive disorder
555948|NCT00812045|Induced sputum|induced sputum
555949|NCT00812045|cystic fibrosis|cystic fibrosis
555950|NCT00812045|biomarker|biomarker
555951|NCT00812045|CYBER|cyber
555952|NCT00812032|NIDDM|niddm
555953|NCT00812032|Aspirin|aspirin
555954|NCT00812032|platelet inhibition|platelet inhibition
555955|NCT00812032|Aspirin treatment|aspirin treatment
555956|NCT00812019|H5N1 Influenza|h5n1 influenza
555957|NCT00812019|Pandemic Flu|pandemic flu
555958|NCT00812019|MF59 Adjuvant|mf59 adjuvant
555959|NCT00812019|Cell Culture-Derived|cell culture-derived
555960|NCT00812019|Safety|safety
555961|NCT00812019|Immunogenicity|immunogenicity
555962|NCT00812019|Vaccination|vaccination
555963|NCT00812019|H5N1 influenza pandemic|h5n1 influenza pandemic
555964|NCT00811954|Treatment naive|treatment naive
555965|NCT00811954|Treatment inexperienced|treatment inexperienced
555966|NCT00811941|Pharmacologic Actions|pharmacologic actions
555967|NCT00811941|Alcohol-Related Disorders|alcohol-related disorders
555968|NCT00811941|Alcoholism|alcoholism
555969|NCT00811941|Mental Disorders|mental disorders
555970|NCT00811941|Central Nervous System Agents|central nervous system agents
555971|NCT00811928|high-risk leukopenic patients|high-risk leukopenic patients
555972|NCT00811915|Sirolimus|sirolimus
555973|NCT00811915|Tacrolimus|tacrolimus
555974|NCT00811915|Kidney transplantation|kidney transplantation
555975|NCT00811915|Kidney Transplant Recipients|kidney transplant recipients
555976|NCT00811902|Multiple sclerosis|multiple sclerosis
555977|NCT00811876|Prostate cancer|prostate cancer
555978|NCT00811863|Nephrogenic Systemic Fibrosis|nephrogenic systemic fibrosis
555979|NCT00811863|Renal Insufficiency|renal insufficiency
555980|NCT00811863|Gadoversetamide|gadoversetamide
555981|NCT00811863|OptiMARK|optimark
555982|NCT00811863|Magnetic Resonance Imaging|magnetic resonance imaging
555983|NCT00811837|Sunburn|sunburn
555984|NCT00811837|Remifentanil|remifentanil
555985|NCT00811837|Hyperalgesia|hyperalgesia
555986|NCT00811824|Weight loss|weight loss
555987|NCT00811824|Physical activity|physical activity
555988|NCT00811824|Dietary change|dietary change
555989|NCT00811811|Hypertension|hypertension
555990|NCT00811811|Biofeedback|biofeedback
555991|NCT00811811|Relaxation training|relaxation training
555992|NCT00811798|Hong Kong|hong kong
555993|NCT00811798|Human papillomavirus|human papillomavirus
555994|NCT00811798|Safety|safety
555995|NCT00811785|Copper Deficiency|copper deficiency
555996|NCT00811785|Menkes Disease|menkes disease
555997|NCT00811785|Neurodevelopment|neurodevelopment
555998|NCT00811785|Occipital Horn Syndrome|occipital horn syndrome
555999|NCT00811772|Randomized controlled trial|randomized controlled trial
556000|NCT00811772|Bare metal stent|bare metal stent
556001|NCT00811772|Drug eluting stent|drug eluting stent
556002|NCT00811759|stage IV melanoma|stage iv melanoma
556003|NCT00811759|stage III melanoma|stage iii melanoma
556004|NCT00811759|recurrent melanoma|recurrent melanoma
556005|NCT00811746|obstructive sleep apnea|obstructive sleep apnea
556006|NCT00811746|eszopiclone|eszopiclone
556007|NCT00811746|ramelteon|ramelteon
556008|NCT00811746|polysomnography|polysomnography
556009|NCT00811733|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
556010|NCT00811733|Ofatumumab|ofatumumab
556011|NCT00811720|Alcohol-Related Disorders|alcohol-related disorders
556012|NCT00811720|Alcoholism|alcoholism
556013|NCT00811720|Mental Disorders|mental disorders
556014|NCT00811720|Central Nervous System Agents|central nervous system agents
556015|NCT00811707|ultrasound image|ultrasound image
556016|NCT00811707|epidural space|epidural space
556017|NCT00811694|glaucoma|glaucoma
556018|NCT00811694|ficker stimulation|ficker stimulation
556019|NCT00811694|ocular blood flow|ocular blood flow
556020|NCT00811681|Friedreich's ataxia|friedreich's ataxia
556021|NCT00811681|Pioglitazone|pioglitazone
556022|NCT00811668|Sleep Apnea Syndromes|sleep apnea syndromes
556023|NCT00811668|heart diseases|heart diseases
556024|NCT00811655|tumors metastatic to brain|tumors metastatic to brain
556025|NCT00811655|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
556026|NCT00811642|refractory or first line medication intolerable invasive fungal infection|refractory or first line medication intolerable invasive fungal infection
556027|NCT00811629|Receptor for advanced glycation end products (RAGE)|receptor for advanced glycation end products (rage)
556028|NCT00811629|Soluble RAGE (sRAGE)|soluble rage (srage)
556029|NCT00811629|Acute Lung Injury (ALI)|acute lung injury (ali)
556030|NCT00811629|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
556031|NCT00811629|Severe sepsis|severe sepsis
556032|NCT00811629|Septic shock|septic shock
556033|NCT00811629|Alveolar epithelium|alveolar epithelium
556034|NCT00811629|Mechanical ventilation|mechanical ventilation
556035|NCT00811629|Intensive Care Unit (ICU)|intensive care unit (icu)
556036|NCT00811616|Coronary artery disease|coronary artery disease
556037|NCT00811616|Supralimus-Core™|supralimus-core™
556038|NCT00811616|de novo native coronary artery lesion|de novo native coronary artery lesion
556039|NCT00811603|Antibiotic|antibiotic
556040|NCT00811603|Prophylaxis|prophylaxis
556041|NCT00811603|Cesarean|cesarean
556042|NCT00811603|Infection|infection
556043|NCT00811603|Antibiotic prophylaxis|antibiotic prophylaxis
556044|NCT00811590|Cancer|cancer
556045|NCT00811590|Polyps|polyps
556046|NCT00811577|AZX100|azx100
556047|NCT00811577|Patient and Observer Scar Assessment Scale|patient and observer scar assessment scale
556048|NCT00811577|POSAS|posas
556049|NCT00811577|Visual Analog Scale|visual analog scale
556051|NCT00811577|Trocar|trocar
556052|NCT00811577|Scarring|scarring
556053|NCT00811577|Scar reduction|scar reduction
556054|NCT00811577|Scar prevention|scar prevention
556055|NCT00811551|Heart Failure|heart failure
556056|NCT00811551|Impedance Monitoring|impedance monitoring
556057|NCT00811551|Wedge Pressure|wedge pressure
556058|NCT00811538|ischemic stroke|ischemic stroke
556059|NCT00811538|endovascular treatment|endovascular treatment
556060|NCT00811538|Thrombolysis|thrombolysis
556061|NCT00811538|outcome|outcome
556062|NCT00811525|Breast Augmentation|breast augmentation
556063|NCT00811525|Breast Reconstruction|breast reconstruction
556064|NCT00811525|Breast Revision|breast revision
556065|NCT00811525|Silicone gel|silicone gel
556066|NCT00811525|Contour Profile Gel|contour profile gel
556067|NCT00811525|Siltex|siltex
556068|NCT00811512|retina|retina
556069|NCT00811512|fold|fold
556070|NCT00811512|fovea|fovea
556071|NCT00811473|Bipolar Depression|bipolar depression
556072|NCT00811473|Depression|depression
556073|NCT00811473|Children|children
556074|NCT00811473|Adolescents|adolescents
556075|NCT00811473|Seroquel|seroquel
556076|NCT00811473|Bipolar Depression in Children and Adolescents|bipolar depression in children and adolescents
556077|NCT00811434|encephalopathy|encephalopathy
556078|NCT00811434|pediatric liver disease|pediatric liver disease
556079|NCT00811434|pediatric cirrhosis|pediatric cirrhosis
556080|NCT00811434|serum ammonia levels|serum ammonia levels
556081|NCT00811421|Malaria|malaria
556082|NCT00811421|Pregnancy|pregnancy
556083|NCT00811421|HIV|hiv
556084|NCT00811421|Prevention|prevention
556085|NCT00811421|Malaria prevention|malaria prevention
556086|NCT00811408|human papilloma virus infection|human papilloma virus infection
556087|NCT00811408|cervical squamous cell carcinoma|cervical squamous cell carcinoma
556088|NCT00811408|cervical adenocarcinoma|cervical adenocarcinoma
556089|NCT00811408|stage IB cervical cancer|stage ib cervical cancer
556090|NCT00811408|stage II cervical cancer|stage ii cervical cancer
556091|NCT00811408|stage III cervical cancer|stage iii cervical cancer
556092|NCT00811408|stage IVA cervical cancer|stage iva cervical cancer
556093|NCT00811382|CRT|crt
556094|NCT00811382|therapy of AF|therapy of af
556095|NCT00811382|telecardiology|telecardiology
556096|NCT00811382|home monitoring|home monitoring
556097|NCT00811382|cardiovascular hospitalization|cardiovascular hospitalization
556098|NCT00811382|cardiovascular mortality|cardiovascular mortality
556099|NCT00811369|Breast Cancer|breast cancer
556100|NCT00811369|Bone Metastases|bone metastases
556101|NCT00811369|Telopeptide|telopeptide
556102|NCT00811369|Zactima|zactima
556103|NCT00811369|Fulvestrant|fulvestrant
556104|NCT00811356|Food Effect|food effect
556105|NCT00811356|Drug-Drug Interaction|drug-drug interaction
556106|NCT00811356|Antimalarial|antimalarial
556107|NCT00811356|First Time In Human|first time in human
556108|NCT00811356|Single Dose|single dose
556109|NCT00811356|Repeat Dose|repeat dose
556110|NCT00811343|anti TNF Therapy|anti tnf therapy
556111|NCT00811343|Tuberculosis|tuberculosis
556112|NCT00811343|Tuberculin test|tuberculin test
556113|NCT00811343|QFTB-G|qftb-g
556114|NCT00811343|T-SPOT.TB|t-spot.tb
556115|NCT00811343|Need anti TNF Therapy|need anti tnf therapy
556116|NCT00811330|Left ventricular hypertrophy|left ventricular hypertrophy
556117|NCT00811330|Aortic valve stenosis|aortic valve stenosis
556118|NCT00811330|Aortic valve replacement|aortic valve replacement
556119|NCT00811330|Cardiopulmonary bypass|cardiopulmonary bypass
556120|NCT00811330|Statins|statins
556121|NCT00811330|Myocardial preconditioning|myocardial preconditioning
556122|NCT00811330|Left ventricular reverse remodeling|left ventricular reverse remodeling
556123|NCT00811317|diabetes|diabetes
556124|NCT00811317|glucose|glucose
556125|NCT00811317|hyperglycemia|hyperglycemia
556126|NCT00811317|hypoglycemia|hypoglycemia
556127|NCT00811317|insulin|insulin
556128|NCT00811317|glucagon|glucagon
556129|NCT00811317|counter-regulation|counter-regulation
556130|NCT00811317|closed-loop|closed-loop
556131|NCT00811317|feedback|feedback
556132|NCT00811317|control|control
556133|NCT00811317|dual-infusion|dual-infusion
556134|NCT00811317|subcutaneous|subcutaneous
556135|NCT00811317|automated|automated
556136|NCT00811317|artificial pancreas|artificial pancreas
556137|NCT00811317|intensive insulin therapy|intensive insulin therapy
556138|NCT00811304|ultrasound|ultrasound
556139|NCT00811304|labor epidural|labor epidural
556140|NCT00811304|failed epidural|failed epidural
556141|NCT00811304|outcome|outcome
556142|NCT00811304|Epidural insertion under realtime ultrasound guidance|epidural insertion under realtime ultrasound guidance
556143|NCT00811291|B-vitamins|b-vitamins
556144|NCT00811291|Folic-Acid|folic-acid
556145|NCT00811291|kindergarten kids|kindergarten kids
556146|NCT00811291|cognitive tests|cognitive tests
556147|NCT00811291|Healthy kids|healthy kids
556148|NCT00811291|second part low urine vitamine-B-metabolites|second part low urine vitamine-b-metabolites
556149|NCT00811278|inhaled corticosteroids|inhaled corticosteroids
556150|NCT00811265|ExAblate MRgFUS|exablate mrgfus
556151|NCT00811265|Focused ultrasound|focused ultrasound
556152|NCT00811265|Magnetic resonance imaging|magnetic resonance imaging
556153|NCT00811265|Prostate cancer|prostate cancer
556154|NCT00811265|Radical prostatectomy candidate|radical prostatectomy candidate
556155|NCT00811252|Depression|depression
556156|NCT00811252|Elderly|elderly
556157|NCT00811252|Acute treatment|acute treatment
556158|NCT00811239|antivenom|antivenom
556159|NCT00811239|snake bite|snake bite
556160|NCT00811239|Bungarus multicinctus|bungarus multicinctus
556161|NCT00811239|Vietnam|vietnam
556162|NCT00811226|Hypertension Stage I|hypertension stage i
556163|NCT00811226|Hypertension Stage II|hypertension stage ii
556164|NCT00811200|radiation|radiation
556165|NCT00811200|retinopathy|retinopathy
556166|NCT00811200|maculopathy|maculopathy
556167|NCT00811200|choroidopathy|choroidopathy
556168|NCT00811200|uveal|uveal
556169|NCT00811200|melanoma|melanoma
556170|NCT00811200|lucentis|lucentis
556171|NCT00811200|ranibizumab|ranibizumab
556172|NCT00811200|kenalog|kenalog
556173|NCT00811200|triamcinolone acetonide|triamcinolone acetonide
556174|NCT00811200|radiation retinopathy after irradiation of uveal melanoma|radiation retinopathy after irradiation of uveal melanoma
556175|NCT00811200|radiation maculopathy after irradiation of uveal melanoma|radiation maculopathy after irradiation of uveal melanoma
556176|NCT00811200|radiation choroidopathy after irradiation of uveal melanoma|radiation choroidopathy after irradiation of uveal melanoma
556177|NCT00811187|Hysteroscopy|hysteroscopy
556178|NCT00811187|Pain medication|pain medication
556179|NCT00811187|Lidocaine|lidocaine
556180|NCT00811187|Office Procedures|office procedures
556181|NCT00811161|Remodeling|remodeling
556182|NCT00811161|Airgent|airgent
556183|NCT00811161|Hyaluronic acid|hyaluronic acid
556184|NCT00811161|Collagen formation|collagen formation
556185|NCT00811148|Brain Neoplasms|brain neoplasms
556186|NCT00811148|Central Nervous System Diseases|central nervous system diseases
556187|NCT00811148|Central Nervous System Neoplasms|central nervous system neoplasms
556188|NCT00811148|Brain Diseases|brain diseases
556189|NCT00811148|Nervous System Neoplasms|nervous system neoplasms
556190|NCT00811122|Alzheimer's disease|alzheimer's disease
556192|NCT00811122|Frontotemporal dementia|frontotemporal dementia
556193|NCT00811122|FTD|ftd
556194|NCT00811109|Acute Kidney Injury|acute kidney injury
556195|NCT00811109|Critical care|critical care
556196|NCT00811109|Hypotension|hypotension
556197|NCT00811109|Renal replacement therapy|renal replacement therapy
556198|NCT00811109|Efficacy|efficacy
556199|NCT00811109|Tolerance|tolerance
556200|NCT00811109|Outcome|outcome
556201|NCT00811096|Malaria, Vivax/*drug therapy|malaria, vivax/*drug therapy
556202|NCT00811096|Tinidazole/pharmacology/*therapeutic use|tinidazole/pharmacology/*therapeutic use
556203|NCT00811096|Recurrence|recurrence
556204|NCT00811096|Plasmodium vivax/*drug effects|plasmodium vivax/*drug effects
556205|NCT00811083|autism|autism
556206|NCT00811083|toxic metals|toxic metals
556207|NCT00811083|DMSA|dmsa
556208|NCT00811083|dimercaptosuccinic acid|dimercaptosuccinic acid
556209|NCT00811083|chelation|chelation
556210|NCT00811070|CML. Chronic myelocytic leukemia. Philadelphia Chromosome. Japanese. SKI-606. Bosutinib. Imatinib resistant. Imatinib intolerant|cml. chronic myelocytic leukemia. philadelphia chromosome. japanese. ski-606. bosutinib. imatinib resistant. imatinib intolerant
556211|NCT00811057|Preterm Labor in Pregnancy|preterm labor in pregnancy
556212|NCT00811044|diabetes|diabetes
556213|NCT00811044|genetics|genetics
556214|NCT00811044|oral glucose tolerance testing|oral glucose tolerance testing
556215|NCT00811044|family history of diabetes|family history of diabetes
556216|NCT00811044|gestational diabetes|gestational diabetes
556217|NCT00811031|Prostate|prostate
556218|NCT00811031|prostate gland|prostate gland
556219|NCT00811031|prostate cancer markers|prostate cancer markers
556220|NCT00811031|Taxotere®|taxotere®
556221|NCT00811031|Docetaxel|docetaxel
556222|NCT00811031|Prednisone|prednisone
556223|NCT00811031|Castration Resistant Prostate Cancer|castration resistant prostate cancer
556224|NCT00811031|adenocarcinoma of the prostate|adenocarcinoma of the prostate
556225|NCT00811018|Open-label study|open-label study
556226|NCT00811005|acitretin|acitretin
556227|NCT00811005|fumaric acid ester|fumaric acid ester
556228|NCT00811005|pustular palmoplantar psoriasis|pustular palmoplantar psoriasis
556229|NCT00811005|PUVA|puva
556230|NCT00810992|dietary, behavior|dietary, behavior
556231|NCT00810992|IDF criteria|idf criteria
556232|NCT00810992|coronary artery disease|coronary artery disease
556233|NCT00810992|Traditional Tibetan Medicine|traditional tibetan medicine
556234|NCT00810992|coronary artery disease in patients, who have an increased cardiovascular risk profile according to the criteria by the International Diabetes Federation (IDF)|coronary artery disease in patients, who have an increased cardiovascular risk profile according to the criteria by the international diabetes federation (idf)
556235|NCT00810940|TBI|tbi
556236|NCT00810940|closed head injury|closed head injury
556237|NCT00810940|severe head trauma|severe head trauma
556238|NCT00810940|traumatic brain injury|traumatic brain injury
556239|NCT00810914|Patient controlled epidural anesthesia|patient controlled epidural anesthesia
556240|NCT00810914|Pain control in labor|pain control in labor
556241|NCT00810901|ethnic minority adolescents|ethnic minority adolescents
556242|NCT00810901|designated organ donor|designated organ donor
556243|NCT00810888|intracerebral hemorrhage|intracerebral hemorrhage
556245|NCT00810888|computed tomography angiography|computed tomography angiography
556246|NCT00810888|CTA|cta
556247|NCT00810888|recombinant activated factor seven|recombinant activated factor seven
556248|NCT00810888|rFVIIa|rfviia
556249|NCT00810888|NovoSeven|novoseven
556250|NCT00810888|recombinant activated factor VII|recombinant activated factor vii
556251|NCT00810875|pregnancy|pregnancy
556252|NCT00810875|immunity|immunity
556253|NCT00810875|cord blood|cord blood
556254|NCT00810875|influenza vaccines|influenza vaccines
556255|NCT00810875|disease transmission, vertical|disease transmission, vertical
556256|NCT00810862|African American children|african american children
556257|NCT00810849|Tuberculosis, pericardium|tuberculosis, pericardium
556258|NCT00810823|Diabetes|diabetes
556259|NCT00810823|gastric bypass|gastric bypass
556260|NCT00810823|type 2 diabetes and gastric bypass|type 2 diabetes and gastric bypass
556261|NCT00810810|Blood Component Transfusion|blood component transfusion
556262|NCT00810810|Leukoreduction|leukoreduction
556263|NCT00810810|HLA antibody|hla antibody
556264|NCT00810810|Immunosuppression|immunosuppression
556265|NCT00810797|recurrent breast cancer|recurrent breast cancer
556266|NCT00810797|stage IV breast cancer|stage iv breast cancer
556267|NCT00810784|Venous Thromboembolism|venous thromboembolism
556268|NCT00810784|Prevention|prevention
556269|NCT00810784|Quality Improvement|quality improvement
556270|NCT00810784|Education|education
556271|NCT00810784|Compliance with VTE prophylaxis|compliance with vte prophylaxis
556272|NCT00810771|Hospitals, Veterans|hospitals, veterans
556273|NCT00810771|Mass Screening/utilization|mass screening/utilization
556274|NCT00810771|Patient Preference|patient preference
556275|NCT00810771|Prevention & Control|prevention & control
556276|NCT00810771|Epidemiology|epidemiology
556277|NCT00810758|HCV|hcv
556278|NCT00810758|Toll-like receptor 7|toll-like receptor 7
556279|NCT00810758|Multiple oral dose escalation study of PF-04878691|multiple oral dose escalation study of pf-04878691
556280|NCT00810745|ODS|ods
556281|NCT00810745|stapled transanal rectal resection|stapled transanal rectal resection
556282|NCT00810732|This study is being conducted to evaluate sitaxsentan dosing in subjects with chronic kidney disease.|this study is being conducted to evaluate sitaxsentan dosing in subjects with chronic kidney disease.
556283|NCT00810732|B1321005|b1321005
556284|NCT00810719|recurrent pancreatic cancer|recurrent pancreatic cancer
556285|NCT00810719|stage IV pancreatic cancer|stage iv pancreatic cancer
556286|NCT00810706|Breast Cancer|breast cancer
556287|NCT00810706|Aromatase inhibitors|aromatase inhibitors
556288|NCT00810706|Exemestane|exemestane
556289|NCT00810706|Tamoxifen|tamoxifen
556290|NCT00810706|Lipids|lipids
556291|NCT00810693|Pulmonary arterial hypertension|pulmonary arterial hypertension
556292|NCT00810693|PH|ph
556293|NCT00810693|Stimulator|stimulator
556294|NCT00810680|chronic lymphocytic leukemia|chronic lymphocytic leukemia
556295|NCT00810680|relapsed|relapsed
556296|NCT00810680|refractory|refractory
556297|NCT00810680|valproic acid|valproic acid
556298|NCT00810680|valproate|valproate
556299|NCT00810667|Schizophrenia|schizophrenia
556300|NCT00810667|Cognition|cognition
556301|NCT00810667|BACS|bacs
556302|NCT00810667|Risperidone|risperidone
556303|NCT00810667|Augmentation therapy|augmentation therapy
556304|NCT00810667|Add-on therapy|add-on therapy
556305|NCT00810667|Lu AE58054|lu ae58054
556306|NCT00810654|Celiac disease|celiac disease
556307|NCT00810654|Coeliac disease|coeliac disease
556308|NCT00810654|treatment|treatment
556309|NCT00810654|AN-PEP|an-pep
556310|NCT00810654|prolyl endoprotease|prolyl endoprotease
556311|NCT00810654|gluten|gluten
556312|NCT00810641|BPPV(benign paroxysmal positional vertigo)|bppv(benign paroxysmal positional vertigo)
556313|NCT00810641|HC-BPPV(BPPV involving the horizontal semicircular canal)|hc-bppv(bppv involving the horizontal semicircular canal)
556314|NCT00810641|Nystagmus|nystagmus
556315|NCT00810641|Treatment outcome|treatment outcome
556316|NCT00810641|Horizontal Canal Benign Paroxysmal Positional Vertigo|horizontal canal benign paroxysmal positional vertigo
556317|NCT00810628|Parkinson's disease|parkinson's disease
556318|NCT00810628|depression|depression
556319|NCT00810628|Parkinson's disease with mild to moderate depression.|parkinson's disease with mild to moderate depression.
556320|NCT00810615|chronic TBI|chronic tbi
556321|NCT00810615|cognitive function|cognitive function
556322|NCT00810615|PTSD|ptsd
556323|NCT00810615|HBO|hbo
556324|NCT00810615|hyperbaric|hyperbaric
556325|NCT00810615|oxygen|oxygen
556326|NCT00810615|chronic brain injury|chronic brain injury
556327|NCT00810576|Relapsed T-Cell Non-Hodgkin's Lymphoma|relapsed t-cell non-hodgkin's lymphoma
556328|NCT00810576|Refractory T-Cell Non-Hodgkin's Lymphoma|refractory t-cell non-hodgkin's lymphoma
556329|NCT00810576|NHL|nhl
556330|NCT00810576|T-cell NHL|t-cell nhl
556331|NCT00810576|vorinostat|vorinostat
556332|NCT00810576|SAHA|saha
556333|NCT00810576|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
556334|NCT00810576|MSK-390|msk-390
556335|NCT00810576|Zolinza|zolinza
556336|NCT00810576|Bortezomib|bortezomib
556337|NCT00810576|Velcade|velcade
556338|NCT00810576|LDP-341|ldp-341
556339|NCT00810576|MLN341|mln341
556340|NCT00810576|PS-341|ps-341
556341|NCT00810576|Peripheral T-cell lymphoma|peripheral t-cell lymphoma
556342|NCT00810576|CD 30 + anaplastic large cell lymphoma|cd 30 + anaplastic large cell lymphoma
556343|NCT00810576|Angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
556344|NCT00810576|Angiocentric/nasal type T/NK-cell lymphoma|angiocentric/nasal type t/nk-cell lymphoma
556345|NCT00810576|Intestinal T-cell lymphoma|intestinal t-cell lymphoma
556346|NCT00810576|Hepatosplenic gamma delta T-cell lymphoma|hepatosplenic gamma delta t-cell lymphoma
556347|NCT00810576|Subcutaneous panniculitic T-cell lymphoma|subcutaneous panniculitic t-cell lymphoma
556348|NCT00810576|Transformed Mycosis fungoides|transformed mycosis fungoides
556349|NCT00810563|pain|pain
556350|NCT00810563|tubal ligation|tubal ligation
556351|NCT00810563|bupivacaine|bupivacaine
556352|NCT00810563|laparoscopy|laparoscopy
556353|NCT00810524|Chronic hepatitis B|chronic hepatitis b
556354|NCT00810524|antiviral treatment|antiviral treatment
556355|NCT00810524|long term prognosis|long term prognosis
556356|NCT00810485|Gastroesophageal reflux|gastroesophageal reflux
556357|NCT00810485|Proton pump inhibitor|proton pump inhibitor
556358|NCT00810485|Heartburn|heartburn
556359|NCT00810485|Regurgitation|regurgitation
556360|NCT00810472|Penetrating keratoplasty|penetrating keratoplasty
556361|NCT00810472|HLA matching|hla matching
556362|NCT00810472|Corneal diseases that require penetrating keratoplasty|corneal diseases that require penetrating keratoplasty
556363|NCT00810420|Hypoglycemia|hypoglycemia
556364|NCT00810420|EEG|eeg
556365|NCT00810420|type 1 diabetes|type 1 diabetes
556366|NCT00810420|neuroglycopenia|neuroglycopenia
556367|NCT00810420|Hypoglycemia is a potential dangerous condition|hypoglycemia is a potential dangerous condition
556368|NCT00810420|EEG is changed during hypoglycemia|eeg is changed during hypoglycemia
556369|NCT00810420|A hypoglycemia alarm based on EEG-measures may prevent development of severe hypoglycemia|a hypoglycemia alarm based on eeg-measures may prevent development of severe hypoglycemia
556370|NCT00810394|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
556371|NCT00810381|Nitrovasodilators|nitrovasodilators
556372|NCT00810381|ONH blood flow|onh blood flow
556373|NCT00810381|Choroidal blood flow|choroidal blood flow
556374|NCT00810381|Nitroglycerin|nitroglycerin
556375|NCT00810381|Isosorbide Dinitrate|isosorbide dinitrate
556376|NCT00810381|Sodium nitroprusside|sodium nitroprusside
556377|NCT00810381|Laser-Doppler Flowmetry|laser-doppler flowmetry
556378|NCT00810381|Regional Blood Flow|regional blood flow
556379|NCT00810368|Carnosine|carnosine
556380|NCT00810368|antioxidant|antioxidant
556381|NCT00810368|Persian Gulf War|persian gulf war
556382|NCT00810368|Gulf War Syndrome|gulf war syndrome
556383|NCT00810368|GWI|gwi
556384|NCT00810368|Gulf War Illness|gulf war illness
556385|NCT00810368|Exercise|exercise
556386|NCT00810368|Chronic Fatigue|chronic fatigue
556387|NCT00810368|Fibromyalgia|fibromyalgia
556388|NCT00810368|Veterans|veterans
556389|NCT00810368|Irritable Bowel Syndrome|irritable bowel syndrome
556390|NCT00810368|Migraine headaches|migraine headaches
556391|NCT00810368|Neuropathy|neuropathy
556392|NCT00810368|Multiple Chemical Sensitivity|multiple chemical sensitivity
556393|NCT00810355|Schizophrenia Spectrum Disorders|schizophrenia spectrum disorders
556394|NCT00810355|Cognitive Behavior Therapy|cognitive behavior therapy
556395|NCT00810355|work|work
556396|NCT00810342|physical activity standard|physical activity standard
556397|NCT00810342|exercise|exercise
556398|NCT00810329|CFS,FM,CSF,Proteomics,Pain,Fatigue,GWI,IBS,IC,MCS.|cfs,fm,csf,proteomics,pain,fatigue,gwi,ibs,ic,mcs.
556399|NCT00810316|Alprazolam|alprazolam
556400|NCT00810316|Alprazolam extended release|alprazolam extended release
556401|NCT00810316|Clonazepam|clonazepam
556402|NCT00810316|Pharmacokinetics|pharmacokinetics
556403|NCT00810316|Mexican population|mexican population
556404|NCT00810316|Healthy|healthy
556405|NCT00810290|Metabolic syndrome|metabolic syndrome
556406|NCT00810290|Latino health|latino health
556407|NCT00810290|Community participatory research|community participatory research
556408|NCT00810290|Translational Research|translational research
556409|NCT00810264|Long-term safety and reliability of a bipolar left ventricular lead on congestive heart failure patients|long-term safety and reliability of a bipolar left ventricular lead on congestive heart failure patients
556410|NCT00810251|rib fracture|rib fracture
556411|NCT00810251|flail chest|flail chest
556412|NCT00810251|plate|plate
556413|NCT00810251|chest trauma|chest trauma
556414|NCT00810251|osteosynthesis|osteosynthesis
556415|NCT00810251|mechanical ventilation|mechanical ventilation
556416|NCT00810251|respirator|respirator
556417|NCT00810238|Heart failure|heart failure
556418|NCT00810238|Cell therapy|cell therapy
556419|NCT00810225|CNDP1|cndp1
556420|NCT00810225|carnosine dipeptidase 1|carnosine dipeptidase 1
556421|NCT00810225|Persian Gulf War|persian gulf war
556422|NCT00810225|Gulf War Syndrome|gulf war syndrome
556423|NCT00810225|GWI|gwi
556424|NCT00810225|Gulf War Illness|gulf war illness
556425|NCT00810225|Exercise|exercise
556426|NCT00810225|Chronic Fatigue|chronic fatigue
556427|NCT00810225|Fibromyalgia|fibromyalgia
556428|NCT00810225|Veterans|veterans
556429|NCT00810225|Irritable Bowel Syndrome|irritable bowel syndrome
556430|NCT00810225|Migraine headaches|migraine headaches
556431|NCT00810225|Neuropathy|neuropathy
556432|NCT00810225|Multiple Chemical Sensitivity|multiple chemical sensitivity
556433|NCT00810212|Degenerative disc disease|degenerative disc disease
556434|NCT00810212|Spondylolisthesis|spondylolisthesis
556435|NCT00810212|Spinal stenosis|spinal stenosis
556436|NCT00810212|Stem cell|stem cell
556437|NCT00810212|Spinal Fusion|spinal fusion
556438|NCT00810173|type 2 diabetes|type 2 diabetes
556439|NCT00810173|physical activity|physical activity
556440|NCT00810173|behavior change|behavior change
556441|NCT00810173|profile personality|profile personality
556442|NCT00810173|phone call support|phone call support
556443|NCT00810160|probiotic|probiotic
556444|NCT00810160|prebiotic|prebiotic
556445|NCT00810160|oligosaccharides|oligosaccharides
556446|NCT00810160|GOS|gos
556447|NCT00810160|galacto oligosaccharides|galacto oligosaccharides
556448|NCT00810160|Bifidobacterium infantis|bifidobacterium infantis
556449|NCT00810160|Bifidobacterium animalis|bifidobacterium animalis
557010|NCT00807937|GAD|gad
556450|NCT00810134|Superficial femoral artery occlusion (TASC II B or C)|superficial femoral artery occlusion (tasc ii b or c)
556451|NCT00810108|HIV/AIDS|hiv/aids
556452|NCT00810108|pediatrics|pediatrics
556453|NCT00810108|resource-limited settings|resource-limited settings
556454|NCT00810108|lopinavir|lopinavir
556455|NCT00810108|ritonavir|ritonavir
556456|NCT00810108|Kaletra®|kaletra®
556457|NCT00810108|antiretroviral treatment|antiretroviral treatment
556458|NCT00810108|crushed tablets|crushed tablets
556459|NCT00810108|treatment experienced|treatment experienced
556460|NCT00810095|Cerebral Infarction|cerebral infarction
556461|NCT00810095|Stroke|stroke
556462|NCT00810095|Vascular Diseases|vascular diseases
556463|NCT00810095|Central Nervous System Diseases|central nervous system diseases
556464|NCT00810095|Penumbra|penumbra
556465|NCT00810095|Functional Outcome|functional outcome
556466|NCT00810095|Aphasia|aphasia
556467|NCT00810095|Hemiplegia|hemiplegia
556468|NCT00810095|Left sided weakness|left sided weakness
556469|NCT00810095|Right Sided weakness|right sided weakness
556470|NCT00810069|Major Depressive Disorder|major depressive disorder
556471|NCT00810069|MDD|mdd
556472|NCT00810069|Depression|depression
556473|NCT00810056|Child abuse and neglect|child abuse and neglect
556474|NCT00810056|Out-of-home care|out-of-home care
556475|NCT00810056|Mentoring|mentoring
556476|NCT00810056|Skills groups|skills groups
556477|NCT00810056|Assessment|assessment
556478|NCT00810030|ferric carboxymaltose|ferric carboxymaltose
556479|NCT00810030|iron sucrose|iron sucrose
556480|NCT00810030|Iron-Deficiency Anemia|iron-deficiency anemia
556481|NCT00810030|Crohn's Disease|crohn's disease
556482|NCT00810030|Ulcerative Colitis|ulcerative colitis
556483|NCT00810030|Ferritin|ferritin
556484|NCT00810030|Transferrin|transferrin
556485|NCT00810017|Her2 Positive|her2 positive
556486|NCT00810017|Breast Cancer|breast cancer
556487|NCT00810017|Metastatic|metastatic
556488|NCT00809991|Prostate Cancer|prostate cancer
556489|NCT00809965|Rivaroxaban|rivaroxaban
556490|NCT00809965|Acute Coronary Syndrome|acute coronary syndrome
556492|NCT00809965|Aspirin|aspirin
556493|NCT00809965|Thienopyridine|thienopyridine
556494|NCT00809965|Unstable Angina|unstable angina
556495|NCT00809965|Myocardial Infarction|myocardial infarction
556496|NCT00809965|Anticoagulation|anticoagulation
556497|NCT00809965|Clopidogrel (Plavix)|clopidogrel (plavix)
556498|NCT00809939|preterm delivery|preterm delivery
556499|NCT00809939|short cervical length|short cervical length
556500|NCT00809939|progesterone|progesterone
556501|NCT00809926|Hypertension, aliskiren and valsartan|hypertension, aliskiren and valsartan
556502|NCT00809913|Urinary Tract Infection|urinary tract infection
556503|NCT00809913|Fever|fever
556504|NCT00809913|Acute Pyelonephritis|acute pyelonephritis
556505|NCT00809913|Treatment duration|treatment duration
556506|NCT00809913|Febrile Urinary Tract Infection Treatment Duration|febrile urinary tract infection treatment duration
556507|NCT00809887|catheter fungal infections, antimicrobial lock therapy, micafungin, central venous catheter|catheter fungal infections, antimicrobial lock therapy, micafungin, central venous catheter
556508|NCT00809874|Postprandial Period|postprandial period
556509|NCT00809874|Postprandial Lipaemia|postprandial lipaemia
556510|NCT00809874|Incretins|incretins
556511|NCT00809874|Subclinical Inflammation|subclinical inflammation
556512|NCT00809874|Obesity|obesity
556513|NCT00809874|Atherosclerosis|atherosclerosis
556514|NCT00809874|Triglyceride|triglyceride
556515|NCT00809874|Lipoproteins|lipoproteins
556516|NCT00809835|Cocaine|cocaine
556517|NCT00809835|Methadone|methadone
556518|NCT00809835|CBT|cbt
556519|NCT00809822|IVIG in pemphigoid|ivig in pemphigoid
556520|NCT00809822|Patients with bullous pemphigoid unresponsive to corticosteroids|patients with bullous pemphigoid unresponsive to corticosteroids
556521|NCT00809809|Cold sores|cold sores
556522|NCT00809809|Zinc|zinc
556523|NCT00809809|HSL|hsl
556524|NCT00809809|Herpes simple labialis|herpes simple labialis
556525|NCT00809783|Tanezumab OA arthritis|tanezumab oa arthritis
556526|NCT00809770|stimulant abuse|stimulant abuse
556527|NCT00809770|drug abuse|drug abuse
556528|NCT00809770|schizophrenia|schizophrenia
556529|NCT00809770|bipolar disorder|bipolar disorder
556530|NCT00809770|major depressive disorder|major depressive disorder
556531|NCT00809770|contingency management|contingency management
556532|NCT00809770|psychosocial treatment|psychosocial treatment
556533|NCT00809757|Asthma|asthma
556534|NCT00809731|Schizophrenia remission status by 8-item PANSS|schizophrenia remission status by 8-item panss
556535|NCT00809718|Raltegravir|raltegravir
556536|NCT00809718|Pharmacokinetics|pharmacokinetics
556537|NCT00809718|Rifapentine|rifapentine
556538|NCT00809718|Drug Kinetics|drug kinetics
556539|NCT00809692|histamine biotransformation|histamine biotransformation
556540|NCT00809692|laser Doppler flowimetry|laser doppler flowimetry
556541|NCT00809692|pediatric pharmacology|pediatric pharmacology
556542|NCT00809679|Postherpetic neuralgia|postherpetic neuralgia
556543|NCT00809679|Varicella Zoster|varicella zoster
556544|NCT00809679|Shingles|shingles
556545|NCT00809679|Neuropathic pain|neuropathic pain
556546|NCT00809679|Analgesia|analgesia
556547|NCT00809679|Pain|pain
556548|NCT00809666|pregnancy|pregnancy
556549|NCT00809666|hypertension|hypertension
556550|NCT00809666|mercury sphygmomanometry|mercury sphygmomanometry
556551|NCT00809666|blood pressure|blood pressure
556552|NCT00809666|automated blood pressure|automated blood pressure
556553|NCT00809666|pre eclampsia|pre eclampsia
556554|NCT00809666|Hypertension in pregnancy|hypertension in pregnancy
556555|NCT00809653|Air pollution|air pollution
556556|NCT00809653|Face mask|face mask
556557|NCT00809653|Myocardial ischaemia|myocardial ischaemia
556558|NCT00809653|Heart rate variability|heart rate variability
556559|NCT00809653|Angina pectoris|angina pectoris
556560|NCT00809653|Coronary heart disease|coronary heart disease
556561|NCT00809640|low back pain|low back pain
556562|NCT00809640|prevention|prevention
556563|NCT00809640|schoolchildren|schoolchildren
556564|NCT00809640|education campaign|education campaign
556565|NCT00809627|headache|headache
556566|NCT00809627|caffeine|caffeine
556567|NCT00809627|pain|pain
556568|NCT00809614|Psoriatic arthritis|psoriatic arthritis
556569|NCT00809614|IgG1K monoclonal antibody|igg1k monoclonal antibody
556570|NCT00809614|Interleukin -17A neutralizing|interleukin -17a neutralizing
556571|NCT00809588|vaccination|vaccination
556572|NCT00809588|GM-CSF|gm-csf
556573|NCT00809588|autologous|autologous
556574|NCT00809588|irradiated|irradiated
556575|NCT00809575|adult|adult
556576|NCT00809575|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
556577|NCT00809575|Quality of life|quality of life
556578|NCT00809575|Patient reported outcomes|patient reported outcomes
556579|NCT00809549|Stroke|stroke
556580|NCT00809549|GCSF|gcsf
556581|NCT00809549|Hematopoeitic|hematopoeitic
556582|NCT00809549|Neupogen|neupogen
556583|NCT00809549|Filgrastim|filgrastim
556584|NCT00809536|metformin, PD 0332334, organic cation transporter, OCT2, pharmacokinetics|metformin, pd 0332334, organic cation transporter, oct2, pharmacokinetics
556585|NCT00809523|SAD|sad
556586|NCT00809523|winter depression|winter depression
556587|NCT00809497|PLC for treatment of peripheral arterial diseases|plc for treatment of peripheral arterial diseases
556588|NCT00809484|Arimidex|arimidex
556589|NCT00809484|Bone Mineral density|bone mineral density
556590|NCT00809484|Bisphosphonates|bisphosphonates
556591|NCT00809484|Aromatase Inhibitors|aromatase inhibitors
556592|NCT00809471|ED|ed
556593|NCT00809471|Erectile Dysfunction|erectile dysfunction
556594|NCT00809471|Dysfunction|dysfunction
556595|NCT00809471|Diabetic|diabetic
556596|NCT00809471|Erectile|erectile
556597|NCT00809458|Vitamin E|vitamin e
556598|NCT00809458|Prostate Cancer|prostate cancer
556599|NCT00809458|Alpha-tocopherol (α-tocopherol)|alpha-tocopherol (α-tocopherol)
556600|NCT00809432|Air pollution|air pollution
556601|NCT00809432|Heart rate|heart rate
556602|NCT00809432|Heart rate variability|heart rate variability
556603|NCT00809432|Blood pressure|blood pressure
556604|NCT00809432|Face mask|face mask
556605|NCT00809419|Brachytherapy|brachytherapy
556606|NCT00809419|EpiRad|epirad
556607|NCT00809419|Macular Degeneration|macular degeneration
556608|NCT00809419|Ranibizumab|ranibizumab
556609|NCT00809393|Antifibrinolytic|antifibrinolytic
556610|NCT00809393|Tranexamic acid|tranexamic acid
556611|NCT00809393|Cardiopulmonary bypass|cardiopulmonary bypass
556612|NCT00809393|Transfusion|transfusion
556613|NCT00809393|Hemorrhage|hemorrhage
556614|NCT00809380|Conscious sedation|conscious sedation
556615|NCT00809380|Parental presence|parental presence
556616|NCT00809380|Invasive procedure|invasive procedure
556617|NCT00809380|Children|children
556618|NCT00809380|Anxiety|anxiety
556619|NCT00809367|MDS|mds
556620|NCT00809367|AML|aml
556621|NCT00809367|banking study|banking study
556622|NCT00809354|monoclonal antibody|monoclonal antibody
556623|NCT00809354|nerve growth factor (NGF)|nerve growth factor (ngf)
556624|NCT00809354|anti-NGF|anti-ngf
556625|NCT00809354|tanezumab|tanezumab
556626|NCT00809354|PF-04383119|pf-04383119
556627|NCT00809354|RN624|rn624
556628|NCT00809354|osteoarthritis (OA)|osteoarthritis (oa)
556629|NCT00809341|B-Cell|b-cell
556630|NCT00809341|non-Hodgkin's|non-hodgkin's
556631|NCT00809341|Lymphoma|lymphoma
556632|NCT00809315|Child abuse and neglect|child abuse and neglect
556633|NCT00809315|Out-of-home care|out-of-home care
556634|NCT00809315|Mentoring|mentoring
556635|NCT00809315|Skills groups|skills groups
556636|NCT00809315|Assessment|assessment
556637|NCT00809315|Functioning as a result of maltreatment and placement in out-of-home care|functioning as a result of maltreatment and placement in out-of-home care
556638|NCT00809289|Thorough QT/QTc study|thorough qt/qtc study
556639|NCT00809276|Acute lymphocytic leukemia (ALL)|acute lymphocytic leukemia (all)
556640|NCT00809276|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
556641|NCT00809276|Acute Leukemia|acute leukemia
556642|NCT00809276|Refractory or Relapsed AML|refractory or relapsed aml
556643|NCT00809276|Myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
556644|NCT00809276|Chronic myeloid leukemia (CML)|chronic myeloid leukemia (cml)
556645|NCT00809276|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
556646|NCT00809276|Hodgkin's Lymphoma|hodgkin's lymphoma
556647|NCT00809276|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
556648|NCT00809276|Philadelphia-negative myeloproliferative disorder|philadelphia-negative myeloproliferative disorder
556649|NCT00809276|Hematologic Malignancies|hematologic malignancies
556650|NCT00809276|Transplantation|transplantation
556651|NCT00809276|Busulfan|busulfan
556652|NCT00809276|Fludarabine|fludarabine
556653|NCT00809276|Cytoxan|cytoxan
556654|NCT00809276|Bone Marrow|bone marrow
556655|NCT00809276|Allogeneic|allogeneic
556656|NCT00809276|Related donor|related donor
556657|NCT00809276|unrelated donor|unrelated donor
556658|NCT00809263|homeopathy|homeopathy
556659|NCT00809263|homeopathic drug proving|homeopathic drug proving
556660|NCT00809263|Document symptoms associated with administration of a homeopathic remedy.|document symptoms associated with administration of a homeopathic remedy.
556661|NCT00809250|vaccination|vaccination
556662|NCT00809250|AML|aml
556663|NCT00809250|CMML|cmml
556664|NCT00809250|MDS-RAEB|mds-raeb
556665|NCT00809237|Non-small cell lung cancer|non-small cell lung cancer
556666|NCT00809237|Gefitinib|gefitinib
556667|NCT00809237|Hydroxychloroquine|hydroxychloroquine
556668|NCT00809224|ALS|als
556669|NCT00809224|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
556670|NCT00809224|brain-computer interface|brain-computer interface
556671|NCT00809224|functional magnetic resonance imaging|functional magnetic resonance imaging
556672|NCT00809224|radiology|radiology
556673|NCT00809224|fMRI|fmri
556674|NCT00809211|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
556675|NCT00809211|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
556676|NCT00809198|Sodium Hyaluronate, Kynex, Carboxymethylcellulose sodium|sodium hyaluronate, kynex, carboxymethylcellulose sodium
556677|NCT00809198|Refresh Plus|refresh plus
556678|NCT00809198|Dry Eye|dry eye
556679|NCT00809198|Cornea Staining|cornea staining
556680|NCT00809198|TBUT|tbut
556681|NCT00809185|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
556682|NCT00809185|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
556683|NCT00809185|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
556684|NCT00809172|Atopic-dermatitis|atopic-dermatitis
556685|NCT00809172|scorad|scorad
556686|NCT00809172|methotrexate|methotrexate
556687|NCT00809172|ciclosporin|ciclosporin
556688|NCT00809159|ankylosing spondylitis|ankylosing spondylitis
556689|NCT00809146|Status Epilepticus|status epilepticus
556690|NCT00809146|Emergency Medical Services|emergency medical services
556691|NCT00809146|Anticonvulsants|anticonvulsants
556692|NCT00809146|Drug Administration Routes|drug administration routes
556693|NCT00809146|Seizures|seizures
556694|NCT00809120|Electrostimulation|electrostimulation
556695|NCT00809120|COPD|copd
556696|NCT00809120|Tolerance|tolerance
556697|NCT00809120|Muscle fatigue|muscle fatigue
556698|NCT00809120|Cardio-respiratory response|cardio-respiratory response
556699|NCT00809107|natural cycle|natural cycle
556700|NCT00809107|FET|fet
556701|NCT00809107|spontaneous LH pic|spontaneous lh pic
556702|NCT00809107|HCG|hcg
556703|NCT00809081|periampullar carcinoma|periampullar carcinoma
556704|NCT00809081|Pancreaticoduodenectomy|pancreaticoduodenectomy
556705|NCT00809081|Enteral feeding|enteral feeding
556706|NCT00809081|Total Parenteral Support|total parenteral support
556707|NCT00809068|Menopause|menopause
556708|NCT00809068|menopausal symptoms|menopausal symptoms
556709|NCT00809068|tibolone|tibolone
556710|NCT00809068|HDL-C|hdl-c
556711|NCT00809068|fenofibrate|fenofibrate
556712|NCT00809042|Hydroxyurea|hydroxyurea
556713|NCT00809042|magnesium chloride|magnesium chloride
556714|NCT00809042|L-carnitine|l-carnitine
556715|NCT00809042|β-thalassemia intermedia|β-thalassemia intermedia
556716|NCT00809029|GIP|gip
556717|NCT00809029|OBESITY|obesity
556718|NCT00809029|HSL|hsl
556719|NCT00809029|LPL|lpl
556720|NCT00809029|ADIPOCYTOKINES|adipocytokines
556721|NCT00809029|BARIATRIC SURGERY|bariatric surgery
556722|NCT00809016|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
556723|NCT00809016|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
556724|NCT00809016|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
556725|NCT00809016|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
556726|NCT00809016|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
556727|NCT00809016|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
556728|NCT00809016|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
556729|NCT00809016|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
556730|NCT00809016|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
556731|NCT00809016|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
556732|NCT00809016|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
556733|NCT00809016|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
556734|NCT00809016|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
556810|NCT00808795|Chronic kidney disease|chronic kidney disease
556735|NCT00809016|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
556736|NCT00809016|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
556737|NCT00809016|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
556738|NCT00809016|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
556739|NCT00809016|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
556740|NCT00809016|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
556741|NCT00809016|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
556742|NCT00809016|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
556743|NCT00809016|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
556744|NCT00809016|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
556745|NCT00809016|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
556746|NCT00809016|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
556747|NCT00809016|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
556748|NCT00809016|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
556749|NCT00809016|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
556750|NCT00809016|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
556751|NCT00809016|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
556752|NCT00809016|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
556753|NCT00809016|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
556754|NCT00809016|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
556755|NCT00809016|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
556756|NCT00809016|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
556757|NCT00809016|recurrent salivary gland cancer|recurrent salivary gland cancer
556758|NCT00809016|salivary gland acinic cell tumor|salivary gland acinic cell tumor
556759|NCT00809016|salivary gland adenocarcinoma|salivary gland adenocarcinoma
556760|NCT00809016|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
556761|NCT00809016|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
556762|NCT00809016|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
556763|NCT00809016|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
556764|NCT00809016|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
556765|NCT00809016|stage III salivary gland cancer|stage iii salivary gland cancer
556766|NCT00809016|stage IV salivary gland cancer|stage iv salivary gland cancer
556767|NCT00809003|Non dry eyed(normals)|non dry eyed(normals)
556768|NCT00808990|Non Alcoholic Fatty Liver Disease|non alcoholic fatty liver disease
556769|NCT00808990|Non Alcoholic SteatoHepatitis|non alcoholic steatohepatitis
556770|NCT00808990|Small bowel bacterial overgrowth|small bowel bacterial overgrowth
556771|NCT00808990|Probiotics|probiotics
556772|NCT00808990|Patients with Non Alcoholic Fatty Liver Disease|patients with non alcoholic fatty liver disease
556773|NCT00808964|CABG|cabg
556774|NCT00808964|anticoagulant|anticoagulant
556775|NCT00808964|Off-Pump CABG|off-pump cabg
556776|NCT00808951|Uncomplicated malaria|uncomplicated malaria
556777|NCT00808951|P falciparum|p falciparum
556778|NCT00808951|Children|children
556779|NCT00808951|National treatment protocol|national treatment protocol
556780|NCT00808951|Burkina Faso|burkina faso
556781|NCT00808951|Artemether-lumefantrine|artemether-lumefantrine
556782|NCT00808951|Artesunate-amodiaquine|artesunate-amodiaquine
556783|NCT00808951|In vivo efficacy|in vivo efficacy
556784|NCT00808951|In vitro efficacy|in vitro efficacy
556785|NCT00808925|acclimation|acclimation
556786|NCT00808925|heat|heat
556787|NCT00808925|cytokines|cytokines
556788|NCT00808925|stress|stress
556789|NCT00808925|inflammation|inflammation
556790|NCT00808912|phosphodiesterase|phosphodiesterase
556791|NCT00808912|sildenafil|sildenafil
556792|NCT00808912|pulmonary hypertension|pulmonary hypertension
556793|NCT00808912|exercise performance|exercise performance
556794|NCT00808912|air pollution|air pollution
556795|NCT00808899|Neuroblastoma|neuroblastoma
556796|NCT00808886|cataract|cataract
556797|NCT00808886|locs3|locs3
556798|NCT00808886|pentacam|pentacam
556799|NCT00808873|attempted suicide|attempted suicide
556800|NCT00808873|socio-educational intervention|socio-educational intervention
556801|NCT00808873|follow up study|follow up study
556802|NCT00808860|Herbal medicine|herbal medicine
556803|NCT00808860|Type 2 diabetes|type 2 diabetes
556804|NCT00808860|Gynostemma pentaphyllum Tea|gynostemma pentaphyllum tea
556805|NCT00808860|Insulin sensitivity|insulin sensitivity
556806|NCT00808860|add-on|add-on
556807|NCT00808808|FluMist, TIV, vaccination rates|flumist, tiv, vaccination rates
556808|NCT00808795|Acute kidney injury|acute kidney injury
556809|NCT00808795|contrast-induced nephropathy|contrast-induced nephropathy
556811|NCT00808795|Diabetes mellitus|diabetes mellitus
556812|NCT00808795|N-acetylcysteine|n-acetylcysteine
556813|NCT00808782|Pervasive Developmental Disorders|pervasive developmental disorders
556814|NCT00808782|Asperger Syndrome|asperger syndrome
556815|NCT00808782|Autism|autism
556816|NCT00808756|Carbohydrates|carbohydrates
556817|NCT00808756|Infant|infant
556818|NCT00808756|Intestine|intestine
556819|NCT00808756|Faeces|faeces
556820|NCT00808756|Growth|growth
556821|NCT00808756|Diet|diet
556822|NCT00808743|Familial adenomatous polyposis|familial adenomatous polyposis
556823|NCT00808743|Adenomatous Polyposis Coli|adenomatous polyposis coli
556824|NCT00808743|Digestive System Neoplasms|digestive system neoplasms
556825|NCT00808743|Gastrointestinal Disease|gastrointestinal disease
556826|NCT00808743|Intestinal disease|intestinal disease
556827|NCT00808743|Intestinal neoplasms|intestinal neoplasms
556828|NCT00808743|Gastrointestinal neoplasms|gastrointestinal neoplasms
556829|NCT00808743|Polyps|polyps
556830|NCT00808743|Adenoma|adenoma
556831|NCT00808743|Adenomatous Polyps|adenomatous polyps
556832|NCT00808743|Neoplastic Syndromes, Hereditary|neoplastic syndromes, hereditary
556833|NCT00808743|Digestive System Diseases|digestive system diseases
556834|NCT00808743|Genetic Diseases, Inborn|genetic diseases, inborn
556835|NCT00808743|Chemoprevention|chemoprevention
556836|NCT00808743|Celecoxib|celecoxib
556837|NCT00808743|Ursodeoxycholic acid|ursodeoxycholic acid
556838|NCT00808743|Anti-Inflammatory agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
556839|NCT00808743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors
556840|NCT00808730|Asthma, airway remodelling, smooth muscle, mitochondria|asthma, airway remodelling, smooth muscle, mitochondria
556841|NCT00808717|Myocardial Infarction|myocardial infarction
556842|NCT00808717|Coronary Angioplasty|coronary angioplasty
556843|NCT00808717|Myocardial infarction, Angioplasty, Transluminal, Percutaneous Coronary|myocardial infarction, angioplasty, transluminal, percutaneous coronary
556844|NCT00808704|asphyxia|asphyxia
556845|NCT00808704|erythropoietin|erythropoietin
556846|NCT00808704|neonates|neonates
556847|NCT00808678|Adverse Events|adverse events
556848|NCT00808665|Lumbar Fusion|lumbar fusion
556849|NCT00808665|Inflammation|inflammation
556850|NCT00808665|Dexmedetomidine|dexmedetomidine
556851|NCT00808665|Length of Hospital Stay|length of hospital stay
556852|NCT00808665|General Anesthesia|general anesthesia
556853|NCT00808665|Anti-inflammatory|anti-inflammatory
556854|NCT00808665|GPCR|gpcr
556855|NCT00808665|Cytokine|cytokine
556856|NCT00808665|Immune Response|immune response
556857|NCT00808639|pegfilgrastim|pegfilgrastim
556858|NCT00808639|MVAC|mvac
556859|NCT00808600|lung transplantation|lung transplantation
556860|NCT00808600|heart-lung transplantation|heart-lung transplantation
556861|NCT00808600|rehabilitation|rehabilitation
556862|NCT00808600|resource-activating training|resource-activating training
556863|NCT00808600|anaerobic exercise training|anaerobic exercise training
556864|NCT00808587|Genomic Scan|genomic scan
556865|NCT00808587|Personalized Medicine|personalized medicine
556866|NCT00808587|Gene testing|gene testing
556867|NCT00808574|Obstructive sleep apnea|obstructive sleep apnea
556868|NCT00808574|Internet|internet
556869|NCT00808574|Screening|screening
556870|NCT00808574|Health belief model|health belief model
556871|NCT00808548|stress|stress
556872|NCT00808548|carer's experiences|carer's experiences
556873|NCT00808548|Prader-willi syndrome|prader-willi syndrome
556874|NCT00808548|personal experiences|personal experiences
556875|NCT00808535|Endothelial dysfunction|endothelial dysfunction
556876|NCT00808535|Cardiac Perfusion MRI|cardiac perfusion mri
556877|NCT00808535|Vasomotor Stress|vasomotor stress
556878|NCT00808535|Cold Pressor Test|cold pressor test
556879|NCT00808535|Adenosine Stress|adenosine stress
556880|NCT00808522|Breast Cancer|breast cancer
556881|NCT00808522|Chemoprevention|chemoprevention
556882|NCT00808522|Tamoxifen|tamoxifen
556883|NCT00808522|Breast density|breast density
556884|NCT00808522|Hcg|hcg
556885|NCT00808509|adalimumab,Remission,drug discontinuation|adalimumab,remission,drug discontinuation
556886|NCT00808496|Magnetic resonance imaging|magnetic resonance imaging
556887|NCT00808496|Radiography|radiography
556888|NCT00808496|Randomized controlled trial|randomized controlled trial
556889|NCT00808496|Antirheumatic agents|antirheumatic agents
556890|NCT00808483|total hip arthroplasty|total hip arthroplasty
556891|NCT00808483|physical functioning|physical functioning
556892|NCT00808483|training program|training program
556893|NCT00808483|self-efficacy|self-efficacy
556894|NCT00808483|exercise therapy|exercise therapy
556895|NCT00808483|walking|walking
556896|NCT00808470|Noise|noise
556897|NCT00808470|Hearing Loss|hearing loss
556898|NCT00808470|Tinnitus|tinnitus
556899|NCT00808470|Antioxidant|antioxidant
556900|NCT00808470|Vasodilator|vasodilator
556901|NCT00808470|Beta-Carotene|beta-carotene
556902|NCT00808470|Vitamin C|vitamin c
556903|NCT00808470|Vitamin E|vitamin e
556904|NCT00808470|Magnesium|magnesium
556905|NCT00808457|chest ultrasound|chest ultrasound
556906|NCT00808457|pneumonia|pneumonia
556907|NCT00808457|X-ray|x-ray
556908|NCT00808457|CT|ct
556909|NCT00808457|Sensitivity and specificity of chest ultrasound in diagnosing pneumonia|sensitivity and specificity of chest ultrasound in diagnosing pneumonia
556910|NCT00808444|Pneumococcal vaccine|pneumococcal vaccine
556911|NCT00808444|Immunogenicity|immunogenicity
556912|NCT00808444|Primary vaccination|primary vaccination
556913|NCT00808444|Safety|safety
556914|NCT00808444|Pneumococcal disease|pneumococcal disease
556915|NCT00808431|Obesity|obesity
556916|NCT00808431|Diabetes|diabetes
556917|NCT00808431|Physical Activity|physical activity
556918|NCT00808431|Child Feeding|child feeding
556919|NCT00808431|Growth Trajectories|growth trajectories
556920|NCT00808431|Family based|family based
556921|NCT00808418|prostate|prostate
556922|NCT00808418|cancer|cancer
556923|NCT00808418|metastatic|metastatic
556924|NCT00808418|castration|castration
556925|NCT00808418|refractory|refractory
556926|NCT00808418|elesclomol|elesclomol
556927|NCT00808418|sodium|sodium
556928|NCT00808418|docetaxel|docetaxel
556929|NCT00808418|prednisone|prednisone
556930|NCT00808405|herpes simplex virus|herpes simplex virus
556931|NCT00808405|acyclovir|acyclovir
556932|NCT00808405|HSV shedding|hsv shedding
556933|NCT00808405|women|women
556934|NCT00808405|Africa|africa
556935|NCT00808392|vaccine|vaccine
556936|NCT00808392|prevention|prevention
556937|NCT00808392|haemophilus influenzae type b|haemophilus influenzae type b
556938|NCT00808392|children|children
556939|NCT00808379|Unresectable rectal cancers|unresectable rectal cancers
556940|NCT00808353|CVD|cvd
556941|NCT00808327|Cesarean section|cesarean section
556942|NCT00808327|Spinal|spinal
556943|NCT00808314|Lexiscan(TM)|lexiscan(tm)
556944|NCT00808314|Dipyridamole|dipyridamole
556945|NCT00808314|Myocardial Perfusion|myocardial perfusion
556946|NCT00808314|Positron Emission Computed Tomography|positron emission computed tomography
556947|NCT00808301|Coeliac disease|coeliac disease
556948|NCT00808301|Oat|oat
556949|NCT00808288|COPD Respiratory Long acting beta agonist|copd respiratory long acting beta agonist
556950|NCT00808275|dietary calcium|dietary calcium
556951|NCT00808275|weight loss|weight loss
556952|NCT00808262|anti-TNFa|anti-tnfa
556953|NCT00808262|immunization|immunization
556954|NCT00808262|kinoid|kinoid
556955|NCT00808262|crohn's disease|crohn's disease
556956|NCT00808249|Generalized Anxiety Disorder|generalized anxiety disorder
556957|NCT00808249|GAD|gad
556958|NCT00808249|Anxiety|anxiety
556959|NCT00808236|Cardiac Arrest|cardiac arrest
556960|NCT00808236|Pre-hospital|pre-hospital
556961|NCT00808236|Mild hypothermia|mild hypothermia
556962|NCT00808236|Resuscitation|resuscitation
556963|NCT00808223|alefacept|alefacept
556964|NCT00808223|adolescent|adolescent
556965|NCT00808223|psoriasis|psoriasis
556966|NCT00808210|RA|ra
556967|NCT00808210|Arthritis|arthritis
556968|NCT00808197|AMD|amd
556969|NCT00808197|choroidal blood flow|choroidal blood flow
556970|NCT00808197|fellow eye in patients with unilateral choroidal neovascularisation|fellow eye in patients with unilateral choroidal neovascularisation
556971|NCT00808184|Histologically or cytologically proven solid tumour for which CPT-11 given by the Folfiri regimen|histologically or cytologically proven solid tumour for which cpt-11 given by the folfiri regimen
556972|NCT00808171|lumbar punction|lumbar punction
556973|NCT00808171|myelogram|myelogram
556974|NCT00808171|pain assessment|pain assessment
556975|NCT00808171|nitrous oxide and EMLA|nitrous oxide and emla
556976|NCT00808171|Leukemia and non Hodgkin lymphoma|leukemia and non hodgkin lymphoma
556977|NCT00808145|Treatment of advanced liver cancer|treatment of advanced liver cancer
556978|NCT00808132|Postmenopausal Women|postmenopausal women
556979|NCT00808132|Bazedoxifene/Conjugated Estrogens|bazedoxifene/conjugated estrogens
556980|NCT00808106|Albinism|albinism
556981|NCT00808106|Oculocutaneous Albinism|oculocutaneous albinism
556982|NCT00808106|Pigmentation|pigmentation
556983|NCT00808106|Natural History|natural history
556984|NCT00808106|Vesical Biology|vesical biology
556985|NCT00808093|Food Effect|food effect
556986|NCT00808093|GSK256073F|gsk256073f
556987|NCT00808093|TRIS Salt|tris salt
556988|NCT00808080|AML|aml
556989|NCT00808054|Pain|pain
556990|NCT00808054|preterm neonate|preterm neonate
556991|NCT00808054|pain assessment|pain assessment
556992|NCT00808054|EMLA|emla
556993|NCT00808054|oral glucose|oral glucose
556994|NCT00808041|Neoadjuvant Treatment|neoadjuvant treatment
556995|NCT00808041|Therapy Response|therapy response
556996|NCT00808041|Breast Computed Tomography|breast computed tomography
556997|NCT00808015|Observational non-interventional trial|observational non-interventional trial
556998|NCT00808002|Maraviroc|maraviroc
556999|NCT00808002|CCR5 antagonists|ccr5 antagonists
557000|NCT00808002|Primary HIV Infection|primary hiv infection
557001|NCT00808002|HIV-1 reservoir|hiv-1 reservoir
557002|NCT00808002|eradication|eradication
557003|NCT00808002|treatment naive|treatment naive
557004|NCT00807976|Diabetes mellitus|diabetes mellitus
557005|NCT00807976|Elderly|elderly
557006|NCT00807976|Orthostatic hypotension|orthostatic hypotension
557007|NCT00807963|Pharmacokinetics|pharmacokinetics
557008|NCT00807963|rHuPH20|rhuph20
557009|NCT00807937|Generalized Anxiety Disorder|generalized anxiety disorder
557011|NCT00807937|Anxiety|anxiety
557012|NCT00807924|Fibroadenomas|fibroadenomas
557013|NCT00807924|Papillomas|papillomas
557014|NCT00807924|Breast|breast
557015|NCT00807924|Minimally invasive|minimally invasive
557016|NCT00807924|Interstitial laser therapy|interstitial laser therapy
557017|NCT00807924|Laser ablation|laser ablation
557018|NCT00807924|Benign|benign
557019|NCT00807924|Non-cancerous|non-cancerous
557020|NCT00807924|Breast lesion|breast lesion
557021|NCT00807924|Breast tumor|breast tumor
557022|NCT00807911|rectal cancer|rectal cancer
557023|NCT00807911|adjuvant chemotherapy|adjuvant chemotherapy
557024|NCT00807911|FOLFOX|folfox
557025|NCT00807898|Gardasil|gardasil
557026|NCT00807898|HPV vaccine|hpv vaccine
557027|NCT00807898|decision making|decision making
557028|NCT00807898|mother|mother
557029|NCT00807898|daughter|daughter
557030|NCT00807885|dehydration|dehydration
557031|NCT00807885|fluid therapy|fluid therapy
557032|NCT00807885|hyaluronoglucosaminidase|hyaluronoglucosaminidase
557033|NCT00807885|hyaluronidase|hyaluronidase
557034|NCT00807885|hypodermoclysis|hypodermoclysis
557035|NCT00807885|clysis|clysis
557036|NCT00807885|subcutaneous hydration|subcutaneous hydration
557037|NCT00807885|subcutaneous rehydration|subcutaneous rehydration
557038|NCT00807885|hyaluronan|hyaluronan
557039|NCT00807885|rHuPH20|rhuph20
557040|NCT00807872|Radioimmunoimaging|radioimmunoimaging
557041|NCT00807872|AL Amyloidosis|al amyloidosis
557042|NCT00807872|PET/CT|pet/ct
557043|NCT00807859|AMG 386|amg 386
557044|NCT00807859|Paclitaxel|paclitaxel
557045|NCT00807859|Trastuzumab|trastuzumab
557046|NCT00807859|Capecitabine|capecitabine
557047|NCT00807859|Lapatinib|lapatinib
557048|NCT00807859|HER2-positive|her2-positive
557049|NCT00807859|metastatic breast cancer|metastatic breast cancer
557050|NCT00807859|locally recurrent breast cancer|locally recurrent breast cancer
557051|NCT00807859|Taxol|taxol
557052|NCT00807859|Herceptin|herceptin
557053|NCT00807859|Xeloda|xeloda
557054|NCT00807859|Tykerb|tykerb
557055|NCT00807859|anti-angiogenic therapy|anti-angiogenic therapy
557056|NCT00807846|Juvenile Arthritis; Juvenile Rheumatoid Arthritis;Blood Pressure;Juvenile Idiopathic Arthritis|juvenile arthritis; juvenile rheumatoid arthritis;blood pressure;juvenile idiopathic arthritis
557057|NCT00807833|SAH|sah
557058|NCT00807833|TBI|tbi
557059|NCT00807820|Prostate Cancer|prostate cancer
557060|NCT00807807|Plasma Homocysteine Concentration|plasma homocysteine concentration
557061|NCT00807807|Folate|folate
557062|NCT00807807|Homocysteine|homocysteine
557063|NCT00807807|Supplements|supplements
557064|NCT00807807|Folic Acid|folic acid
557065|NCT00807755|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
557066|NCT00807755|extensive stage small cell lung cancer|extensive stage small cell lung cancer
557067|NCT00807755|recurrent small cell lung cancer|recurrent small cell lung cancer
557068|NCT00807742|Contingency management for smoking for substance abusers|contingency management for smoking for substance abusers
557069|NCT00807742|Contingency reinforcement for smoking abstinence|contingency reinforcement for smoking abstinence
557070|NCT00807742|Contingency Management|contingency management
557071|NCT00807742|Noncontingent Reinforcement|noncontingent reinforcement
557072|NCT00807729|Laparoscopy|laparoscopy
557073|NCT00807729|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
557074|NCT00807729|Sphincterotomy|sphincterotomy
557075|NCT00807729|Common bile duct stones|common bile duct stones
557076|NCT00807729|Laparoscoopic common bile duct exploration|laparoscoopic common bile duct exploration
557077|NCT00807729|Cost efficiency|cost efficiency
557197|NCT00807235|Pediatric|pediatric
557198|NCT00807235|Premature|premature
557078|NCT00807729|Examination of efficacy, safety, cost of intervention for patients with choleclithiasis and likely common bile duct stones|examination of efficacy, safety, cost of intervention for patients with choleclithiasis and likely common bile duct stones
557079|NCT00807716|physiotherapy|physiotherapy
557080|NCT00807716|functional outcome|functional outcome
557081|NCT00807716|activity level|activity level
557082|NCT00807716|self efficacy|self efficacy
557083|NCT00807716|task oriented exercises|task oriented exercises
557084|NCT00807703|Parkinson|parkinson
557085|NCT00807703|deep brain stimulation (DBS)|deep brain stimulation (dbs)
557086|NCT00807703|subthalamic nucleus (STN)|subthalamic nucleus (stn)
557087|NCT00807703|Parkinson patients|parkinson patients
557088|NCT00807690|vitiligo|vitiligo
557089|NCT00807690|tacrolimus ointment 0.1%|tacrolimus ointment 0.1%
557090|NCT00807690|narrowband UVB (TL01)|narrowband uvb (tl01)
557091|NCT00807677|Chronic myelogenous leukemia (CML) in chronic phase, accelerated phase, or blast crisis|chronic myelogenous leukemia (cml) in chronic phase, accelerated phase, or blast crisis
557092|NCT00807677|Intermediate or high risk myelodysplastic syndrome|intermediate or high risk myelodysplastic syndrome
557093|NCT00807677|Philadelphia chromosome-negative CML (including blast phase)|philadelphia chromosome-negative cml (including blast phase)
557094|NCT00807677|All subtypes of myeloid metaplasia with myelofibrosis; advanced polycythemia|all subtypes of myeloid metaplasia with myelofibrosis; advanced polycythemia
557095|NCT00807651|Diabetes Mellitus|diabetes mellitus
557096|NCT00807651|Stem cells|stem cells
557097|NCT00807651|Autologous stem cell transplantation|autologous stem cell transplantation
557441|NCT00806429|surgery|surgery
557098|NCT00807651|Autoimmune diseases|autoimmune diseases
557099|NCT00807625|HIV/AIDS|hiv/aids
557100|NCT00807625|Contraception|contraception
557101|NCT00807625|Birth control|birth control
557102|NCT00807625|CD4+|cd4+
557103|NCT00807625|Viral Load|viral load
557104|NCT00807625|T-cell activation|t-cell activation
557105|NCT00807625|B-cell activation|b-cell activation
557106|NCT00807625|Hormonal|hormonal
557107|NCT00807625|Intrauterine device|intrauterine device
557108|NCT00807625|Depo Provera|depo provera
557109|NCT00807625|Women|women
557110|NCT00807625|IUCD|iucd
557111|NCT00807625|treatment naive|treatment naive
557112|NCT00807612|AMG 479|amg 479
557113|NCT00807612|IGF-1R|igf-1r
557114|NCT00807612|Apoptosis|apoptosis
557115|NCT00807612|Monoclonal Antibody|monoclonal antibody
557116|NCT00807612|Advanced Squamous Non-Small Cell Lung Cancer|advanced squamous non-small cell lung cancer
557117|NCT00807612|antibody 1st-line|antibody 1st-line
557118|NCT00807599|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
557119|NCT00807599|DEXAMETHASONE|dexamethasone
557120|NCT00807599|G-CSF|g-csf
557121|NCT00807599|Lenalidomide|lenalidomide
557122|NCT00807599|MELPHALAN|melphalan
557123|NCT00807599|PEG-FILGRASTIM (NEULASTA)|peg-filgrastim (neulasta)
557124|NCT00807599|08-121|08-121
557125|NCT00807586|Atrial Fibrillation|atrial fibrillation
557126|NCT00807586|Corticosteroid|corticosteroid
557127|NCT00807586|Radiofrequency catheter ablation for atrial fibrillation|radiofrequency catheter ablation for atrial fibrillation
557128|NCT00807573|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
557129|NCT00807573|PEMETREXED (ALTIMA)|pemetrexed (altima)
557130|NCT00807573|TAXOL (PACLITAXEL)|taxol (paclitaxel)
557131|NCT00807573|08-109|08-109
557132|NCT00807560|Overweight|overweight
557133|NCT00807560|Obesity|obesity
557134|NCT00807560|Adolescents|adolescents
557135|NCT00807560|Family Therapy|family therapy
557136|NCT00807534|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
557137|NCT00807534|Exercise|exercise
557138|NCT00807534|3-min constant rate stepping test|3-min constant rate stepping test
557139|NCT00807534|3-min constant rate walking test|3-min constant rate walking test
557140|NCT00807534|Bronchodilation|bronchodilation
557141|NCT00807534|Ipratropium bromide|ipratropium bromide
557142|NCT00807495|MLN8237|mln8237
557143|NCT00807495|Alisertib|alisertib
557144|NCT00807495|Drug therapy|drug therapy
557145|NCT00807482|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
557146|NCT00807482|Mucociliary Clearance|mucociliary clearance
557147|NCT00807482|Genetic Mutation|genetic mutation
557148|NCT00807469|COPD|copd
557149|NCT00807469|smoking|smoking
557150|NCT00807469|susceptibility|susceptibility
557151|NCT00807469|inflammation|inflammation
557152|NCT00807469|genetic|genetic
557153|NCT00807443|HIV-1|hiv-1
557154|NCT00807443|integrase inhibitor (raltegravir)|integrase inhibitor (raltegravir)
557155|NCT00807443|the cell reservoir of HIV-1|the cell reservoir of hiv-1
557156|NCT00807443|treatment experienced|treatment experienced
557157|NCT00807430|Bruxism|bruxism
557158|NCT00807430|EMG|emg
557159|NCT00807430|Biofeedback|biofeedback
557160|NCT00807404|ductal intraepithelial neoplasia|ductal intraepithelial neoplasia
557161|NCT00807391|lung cancer|lung cancer
557162|NCT00807391|transbronchial biopsy|transbronchial biopsy
557163|NCT00807391|transbronchial catheter aspiration|transbronchial catheter aspiration
557164|NCT00807391|transbronchial needle aspiration|transbronchial needle aspiration
557165|NCT00807391|peripheral pulmonary lesion|peripheral pulmonary lesion
557166|NCT00807391|bronchoscopy|bronchoscopy
557167|NCT00807378|CNS viral infection|cns viral infection
557168|NCT00807378|PCR|pcr
557169|NCT00807378|HYBRIDIZATION|hybridization
557170|NCT00807365|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone
557171|NCT00807365|Growth Hormone Insufficiency|growth hormone insufficiency
557172|NCT00807365|Aging|aging
557173|NCT00807365|Growth Hormone|growth hormone
557174|NCT00807365|Physiological Effects of Drugs|physiological effects of drugs
557175|NCT00807365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
557176|NCT00807365|Hormones|hormones
557177|NCT00807352|Triage|triage
557178|NCT00807352|Pediatrics|pediatrics
557179|NCT00807352|Emergency Department|emergency department
557180|NCT00807339|CyberKnife|cyberknife
557181|NCT00807326|Antidiarrheals|antidiarrheals
557182|NCT00807313|Oligometastatic disease|oligometastatic disease
557183|NCT00807313|Colorectal cancer|colorectal cancer
557184|NCT00807313|Stereotactic body radiotherapy|stereotactic body radiotherapy
557185|NCT00807313|Tomotherapy|tomotherapy
557186|NCT00807313|Metabolic response|metabolic response
557187|NCT00807313|Stage IV|stage iv
557188|NCT00807300|percutaneous treatment|percutaneous treatment
557189|NCT00807287|jejunal tube placement|jejunal tube placement
557190|NCT00807274|Adult congenital heart disease|adult congenital heart disease
557191|NCT00807274|Heart failure|heart failure
557192|NCT00807274|Renal failure|renal failure
557193|NCT00807274|Proteinuria|proteinuria
557194|NCT00807235|Lucinactant|lucinactant
557195|NCT00807235|Nasal continuous positive airway pressure (nCPAP)|nasal continuous positive airway pressure (ncpap)
557196|NCT00807235|Respiratory distress syndrome (RDS)|respiratory distress syndrome (rds)
557199|NCT00807222|ADHD|adhd
557200|NCT00807222|Vyvanse|vyvanse
557201|NCT00807222|lisdexamfetamine dimesylate|lisdexamfetamine dimesylate
557202|NCT00807222|LDX|ldx
557203|NCT00807222|sleep|sleep
557204|NCT00807209|Pain|pain
557205|NCT00807209|postoperative|postoperative
557206|NCT00807209|thoracotomy|thoracotomy
557207|NCT00807196|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
557208|NCT00807196|Zevalin|zevalin
557209|NCT00807196|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
557210|NCT00807170|Non-small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
557211|NCT00807170|Whole Brain Radiotherapy|whole brain radiotherapy
557212|NCT00807170|metastasis|metastasis
557213|NCT00807157|PROBIOSTICK®|probiostick®
557214|NCT00807157|Probiotic|probiotic
557215|NCT00807157|Anxiety|anxiety
557216|NCT00807157|Daily stress|daily stress
557217|NCT00807144|Kidney transplant|kidney transplant
557218|NCT00807144|Rejection|rejection
557219|NCT00807144|Adherence|adherence
557220|NCT00807144|Quality of life|quality of life
557221|NCT00807131|pharmacy care|pharmacy care
557222|NCT00807131|hypertension|hypertension
557223|NCT00807131|primary care|primary care
557224|NCT00807131|adherence|adherence
557225|NCT00807118|bioequivalence, food effect|bioequivalence, food effect
557226|NCT00807105|MOOD EVALUATION|mood evaluation
557227|NCT00807079|recurrent cervical cancer|recurrent cervical cancer
557228|NCT00807079|stage IVB cervical cancer|stage ivb cervical cancer
557229|NCT00807079|stage IVA cervical cancer|stage iva cervical cancer
557230|NCT00807079|cervical adenocarcinoma|cervical adenocarcinoma
557231|NCT00807079|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
557232|NCT00807079|cervical squamous cell carcinoma|cervical squamous cell carcinoma
557233|NCT00807066|QUALITY OF LIFE|quality of life
557234|NCT00807053|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
557235|NCT00807053|Ciclesonide|ciclesonide
557236|NCT00807053|SAR|sar
557237|NCT00807040|Ischemic Mitral Regurgitation|ischemic mitral regurgitation
557238|NCT00807040|Mitral Valve Disease|mitral valve disease
557239|NCT00807040|Severe Mitral Regurgitation|severe mitral regurgitation
557240|NCT00807027|Glioblastoma|glioblastoma
557241|NCT00807027|Newly diagnosed Glioblastoma|newly diagnosed glioblastoma
557242|NCT00807014|Differin|differin
557243|NCT00807014|quality of life|quality of life
557244|NCT00807014|Acne|acne
557245|NCT00807014|Duac|duac
557246|NCT00807014|Acne Vulgaris|acne vulgaris
557247|NCT00807001|Hepatitis C, HCV, treatment-naive|hepatitis c, hcv, treatment-naive
557248|NCT00806988|Ischemic Mitral Regurgitation|ischemic mitral regurgitation
557249|NCT00806988|Mitral Valve Regurgitation|mitral valve regurgitation
557250|NCT00806910|Heart Failure|heart failure
557251|NCT00806910|conivaptan|conivaptan
557252|NCT00806910|Diuresis|diuresis
557253|NCT00806884|Cystic Fibrosis|cystic fibrosis
557254|NCT00806884|Musculoskeletal Physiotherapy|musculoskeletal physiotherapy
557255|NCT00806884|Manual therapy|manual therapy
557256|NCT00806884|Posture|posture
557257|NCT00806884|Pain|pain
557258|NCT00806845|HIV|hiv
557259|NCT00806845|B-lymphocyte|b-lymphocyte
557260|NCT00806832|Medical clowns|medical clowns
557261|NCT00806832|Cataract surgery|cataract surgery
557262|NCT00806832|Blood pressure|blood pressure
557263|NCT00806832|Heart rate|heart rate
557264|NCT00806806|pain management|pain management
557265|NCT00806806|postoperative|postoperative
557266|NCT00806780|gallstones|gallstones
557267|NCT00806780|cholangiography|cholangiography
557268|NCT00806767|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
557269|NCT00806767|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
557270|NCT00806767|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
557271|NCT00806767|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
557272|NCT00806767|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
557273|NCT00806767|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
557274|NCT00806767|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
557275|NCT00806767|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
557276|NCT00806767|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
557277|NCT00806767|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
557278|NCT00806767|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
557279|NCT00806767|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
557280|NCT00806767|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
557281|NCT00806767|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
557282|NCT00806767|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
557283|NCT00806767|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
557284|NCT00806767|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
557285|NCT00806767|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
557286|NCT00806767|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
557440|NCT00806429|appendicitis|appendicitis
557287|NCT00806767|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
557288|NCT00806767|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
557289|NCT00806767|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
557290|NCT00806767|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
557291|NCT00806767|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
557292|NCT00806767|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
557293|NCT00806767|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
557294|NCT00806767|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
557295|NCT00806767|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
557296|NCT00806767|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
557297|NCT00806767|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
557298|NCT00806767|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
557299|NCT00806767|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
557300|NCT00806767|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
557301|NCT00806767|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
557302|NCT00806767|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
557303|NCT00806767|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
557304|NCT00806767|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
557305|NCT00806767|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
557306|NCT00806767|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
557307|NCT00806767|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
557308|NCT00806767|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
557309|NCT00806767|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
557310|NCT00806767|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
557311|NCT00806767|splenic marginal zone lymphoma|splenic marginal zone lymphoma
557312|NCT00806767|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
557313|NCT00806767|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
557314|NCT00806767|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
557315|NCT00806767|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
557316|NCT00806767|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
557317|NCT00806767|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
557318|NCT00806767|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
557319|NCT00806767|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
557320|NCT00806767|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
557321|NCT00806767|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
557322|NCT00806767|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
557323|NCT00806767|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
557324|NCT00806767|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
557325|NCT00806767|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
557326|NCT00806767|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
557327|NCT00806767|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
557328|NCT00806767|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
557329|NCT00806767|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
557330|NCT00806767|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
557331|NCT00806767|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
557332|NCT00806767|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
557333|NCT00806767|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
557334|NCT00806767|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
557335|NCT00806767|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
557336|NCT00806767|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
557337|NCT00806767|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
557338|NCT00806767|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
557339|NCT00806767|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
557340|NCT00806767|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
557341|NCT00806767|refractory hairy cell leukemia|refractory hairy cell leukemia
557342|NCT00806767|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
557343|NCT00806767|secondary acute myeloid leukemia|secondary acute myeloid leukemia
557344|NCT00806767|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
557345|NCT00806767|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
557346|NCT00806767|chronic eosinophilic leukemia|chronic eosinophilic leukemia
557347|NCT00806767|primary myelofibrosis|primary myelofibrosis
557348|NCT00806767|chronic neutrophilic leukemia|chronic neutrophilic leukemia
557349|NCT00806767|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
557350|NCT00806767|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
557351|NCT00806767|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
557352|NCT00806767|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
557353|NCT00806767|stage I multiple myeloma|stage i multiple myeloma
557354|NCT00806767|stage II multiple myeloma|stage ii multiple myeloma
557355|NCT00806767|stage III multiple myeloma|stage iii multiple myeloma
557356|NCT00806767|refractory multiple myeloma|refractory multiple myeloma
557357|NCT00806754|Perennial Allergic Rhinitis|perennial allergic rhinitis
557358|NCT00806754|Ciclesonide|ciclesonide
557359|NCT00806754|PAR|par
557360|NCT00806741|L-NG-Monomethyl Arginine|l-ng-monomethyl arginine
557361|NCT00806741|Optic Nerve Head blood flow|optic nerve head blood flow
557362|NCT00806741|Intraocular Pressure|intraocular pressure
557363|NCT00806741|Regional blood flow|regional blood flow
557364|NCT00806741|Ocular Physiology|ocular physiology
557365|NCT00806741|Optic Disk|optic disk
557366|NCT00806715|hemochromatosis|hemochromatosis
557367|NCT00806715|Iron overload|iron overload
557368|NCT00806715|Stem cell transplant|stem cell transplant
557369|NCT00806715|Pediatrics|pediatrics
557370|NCT00806715|Pediatric Stem cell transplant|pediatric stem cell transplant
557371|NCT00806689|heart rhythm surveillance|heart rhythm surveillance
557372|NCT00806689|follow-up|follow-up
557373|NCT00806689|atrial fibrillation success|atrial fibrillation success
557374|NCT00806676|chronic kidney disease|chronic kidney disease
557375|NCT00806676|children|children
557376|NCT00806676|dialysis|dialysis
557377|NCT00806676|kidney transplant|kidney transplant
557378|NCT00806676|human papilloma virus|human papilloma virus
557379|NCT00806676|Gardasil|gardasil
557380|NCT00806676|Chronic kidney disease (non-dialysis, dialysis, and kidney transplant) secondary to any cause.|chronic kidney disease (non-dialysis, dialysis, and kidney transplant) secondary to any cause.
557381|NCT00806663|mCRC|mcrc
557382|NCT00806663|colorectal cancer|colorectal cancer
557383|NCT00806663|FOLFIRI|folfiri
557384|NCT00806663|sunitinib|sunitinib
557385|NCT00806663|DCE-MRI|dce-mri
557386|NCT00806663|DCE-USI|dce-usi
557387|NCT00806650|stage I renal cell cancer|stage i renal cell cancer
557388|NCT00806650|stage II renal cell cancer|stage ii renal cell cancer
557389|NCT00806650|stage III renal cell cancer|stage iii renal cell cancer
557390|NCT00806650|stage IV renal cell cancer|stage iv renal cell cancer
557391|NCT00806637|Vessel sealing system|vessel sealing system
557392|NCT00806637|uvulopalatoplasty|uvulopalatoplasty
557393|NCT00806637|UPPP|uppp
557394|NCT00806637|uvulopalatal flap|uvulopalatal flap
557395|NCT00806637|bleeding|bleeding
557396|NCT00806637|operative time|operative time
557397|NCT00806637|adverse effects|adverse effects
557398|NCT00806611|pancreatic cancer|pancreatic cancer
557399|NCT00806611|periampullary cancer|periampullary cancer
557400|NCT00806611|resectable|resectable
557401|NCT00806611|unresectable|unresectable
557402|NCT00806611|celiac plexus neurolysis|celiac plexus neurolysis
557403|NCT00806611|surgery|surgery
557404|NCT00806598|Myelodysplastic Syndrome|myelodysplastic syndrome
557405|NCT00806598|Aplastic Anemia|aplastic anemia
557406|NCT00806598|Thymoglobulin|thymoglobulin
557407|NCT00806598|Cyclosporine|cyclosporine
557408|NCT00806598|Methylprednisolone|methylprednisolone
557409|NCT00806598|G-CSF|g-csf
557410|NCT00806572|Diabetes, juvenile diabetes, teplizumab|diabetes, juvenile diabetes, teplizumab
557411|NCT00806559|effects clinical space|effects clinical space
557412|NCT00806559|follow-up appointments|follow-up appointments
557413|NCT00806520|Continuous Glucose Monitoring|continuous glucose monitoring
557414|NCT00806520|Exenatide Once Weekly or|exenatide once weekly or
557415|NCT00806520|Januvia or|januvia or
557416|NCT00806520|Actos|actos
557417|NCT00806507|Tissue Doppler Imaging|tissue doppler imaging
557418|NCT00806507|B-type natriuretic peptide|b-type natriuretic peptide
557419|NCT00806507|Advia Centaur immunoassay system|advia centaur immunoassay system
557420|NCT00806507|GE Vivid ultrasound machine|ge vivid ultrasound machine
557421|NCT00806507|Roche 2010 system|roche 2010 system
557422|NCT00806507|Echocardiography|echocardiography
557423|NCT00806507|Herceptin|herceptin
557424|NCT00806494|Fesoterodine|fesoterodine
557425|NCT00806494|Open Label|open label
557426|NCT00806494|Flexible Dose|flexible dose
557427|NCT00806494|OAB|oab
557428|NCT00806481|Phosphate|phosphate
557429|NCT00806468|nycturia|nycturia
557430|NCT00806468|Parkinson syndrome|parkinson syndrome
557431|NCT00806468|desmopressin|desmopressin
557432|NCT00806468|Nocturnal polyuria in patients with Parkinson syndrome|nocturnal polyuria in patients with parkinson syndrome
557433|NCT00806455|to determine how often exercise-induced bronchospasm|to determine how often exercise-induced bronchospasm
557434|NCT00806455|occurs in cystic fibrosis|occurs in cystic fibrosis
557435|NCT00806455|Exercise-induced bronchospasm in cystic fibrosis|exercise-induced bronchospasm in cystic fibrosis
557436|NCT00806442|Asthma|asthma
557437|NCT00806442|Fatty acids|fatty acids
557438|NCT00806442|Leukotrienes|leukotrienes
557439|NCT00806442|Diet|diet
557442|NCT00806429|laparoscopy|laparoscopy
557443|NCT00806429|natural orifice transluminal surgery|natural orifice transluminal surgery
557444|NCT00806403|thrombolysis|thrombolysis
557445|NCT00806403|primary PCI|primary pci
557446|NCT00806403|abciximab|abciximab
557447|NCT00806403|ST-segment resolution|st-segment resolution
557448|NCT00806403|TIMI flow|timi flow
557449|NCT00806390|ejection fraction|ejection fraction
557450|NCT00806390|anthracyclines|anthracyclines
557451|NCT00806390|beta-adrenergic blockade|beta-adrenergic blockade
557452|NCT00806390|Patients receiving anthracyclines|patients receiving anthracyclines
557453|NCT00806377|Electromagnetic field|electromagnetic field
557454|NCT00806377|Oversensing|oversensing
557455|NCT00806377|Non-thoracic surgery|non-thoracic surgery
557456|NCT00806364|Healthy Volunteers|healthy volunteers
557457|NCT00806364|Allergy|allergy
557458|NCT00806364|Bone Marrow|bone marrow
557459|NCT00806364|Buccal Mucosa|buccal mucosa
557460|NCT00806364|HV|hv
557461|NCT00806364|Healthy Volunteer|healthy volunteer
557462|NCT00806351|Candidiasis; Invasive Candidiasis; Candida; Candidemia; Fungal Infection; Neutropenia|candidiasis; invasive candidiasis; candida; candidemia; fungal infection; neutropenia
557463|NCT00806325|Severe Sepsis|severe sepsis
557464|NCT00806325|Acute Myeloid Leukemia|acute myeloid leukemia
557465|NCT00806325|Sepsis in patients being treated for Acute Myeloid Leukemia|sepsis in patients being treated for acute myeloid leukemia
557466|NCT00806312|MiRNA|mirna
557467|NCT00806312|pulmonary arterial hypertension|pulmonary arterial hypertension
557468|NCT00806273|debridement|debridement
557469|NCT00806273|root canal|root canal
557470|NCT00806260|Overweight|overweight
557471|NCT00806260|Obesity|obesity
557472|NCT00806260|coordination|coordination
557473|NCT00806260|psychomotor|psychomotor
557474|NCT00806247|Tapentadol|tapentadol
557475|NCT00806247|Bunionectomy|bunionectomy
557476|NCT00806247|Analgesia|analgesia
557477|NCT00806247|Acute pain|acute pain
557478|NCT00806247|Postsurgical pain|postsurgical pain
557479|NCT00806234|Weight Gain|weight gain
557480|NCT00806234|Obesity|obesity
557481|NCT00806234|IMPACT|impact
557482|NCT00806234|Antipsychotic Treatment|antipsychotic treatment
557483|NCT00806234|Excessive Weight Gain Associated With Antipsychotic Treatment|excessive weight gain associated with antipsychotic treatment
557484|NCT00806234|Hybrid Efficacy/Effectiveness Design|hybrid efficacy/effectiveness design
557485|NCT00806234|Reducing Weight Gain|reducing weight gain
557486|NCT00806234|Improving Metabolic Parameters|improving metabolic parameters
557487|NCT00806234|Aripiprazole|aripiprazole
557488|NCT00806234|Metformin|metformin
557489|NCT00806234|Risperdal|risperdal
557490|NCT00806234|Seroquel|seroquel
557491|NCT00806234|Quetiapine|quetiapine
557492|NCT00806234|Olanzapine|olanzapine
557493|NCT00806234|Zyprexa|zyprexa
557494|NCT00806234|Geodon|geodon
557495|NCT00806234|Risperidone|risperidone
557496|NCT00806234|Abilify|abilify
557497|NCT00806234|Trilafon|trilafon
557498|NCT00806234|Perphenazine|perphenazine
557499|NCT00806234|Glucophage|glucophage
557500|NCT00806234|Paliperidone|paliperidone
557501|NCT00806234|Olanzapine/fluoxetine|olanzapine/fluoxetine
557502|NCT00806221|Atopic Dermatitis|atopic dermatitis
557503|NCT00806221|Prevention|prevention
557504|NCT00806221|Skin Barrier|skin barrier
557505|NCT00806195|vaccine|vaccine
557506|NCT00806195|infants|infants
557507|NCT00806195|healthy|healthy
557508|NCT00806195|meningitis|meningitis
557509|NCT00806195|meningococcal|meningococcal
557510|NCT00806182|paraneoplastic|paraneoplastic
557511|NCT00806182|neuroblastoma|neuroblastoma
557512|NCT00806182|Kinsbourne syndrome|kinsbourne syndrome
557513|NCT00806182|autoimmune disease|autoimmune disease
557514|NCT00806182|immunotherapy|immunotherapy
557515|NCT00806182|ataxia|ataxia
557516|NCT00806169|combined therapy|combined therapy
557517|NCT00806169|DRP|drp
557518|NCT00806169|efficacy|efficacy
557519|NCT00806169|safety|safety
557520|NCT00806169|sustainability|sustainability
557521|NCT00806169|macular edema due to DRP|macular edema due to drp
557522|NCT00806143|Depression|depression
557523|NCT00806143|TMS|tms
557524|NCT00806117|Cervical cancer|cervical cancer
557525|NCT00806117|Concurrent chemoradiation|concurrent chemoradiation
557526|NCT00806117|Randomized controlled clinical trials|randomized controlled clinical trials
557527|NCT00806091|AM proteomes will be compared between smokers with and without COPD|am proteomes will be compared between smokers with and without copd
557528|NCT00806078|Healthy|healthy
557529|NCT00806078|Bioequivalence|bioequivalence
557530|NCT00806078|Pharmacokinetics|pharmacokinetics
557531|NCT00806039|Kidney Failure, Acute|kidney failure, acute
557532|NCT00806039|Renal Insufficiency, Acute|renal insufficiency, acute
557533|NCT00806039|Kidney Failure|kidney failure
557534|NCT00806039|Renal Insufficiency|renal insufficiency
557535|NCT00806026|RLS|rls
557536|NCT00806013|genotype|genotype
557537|NCT00806000|Prevalence of Exercised induced asthma in athletes|prevalence of exercised induced asthma in athletes
557538|NCT00805974|diapasom|diapasom
557539|NCT00805974|sleep quality|sleep quality
557540|NCT00805974|type I diabete|type i diabete
557541|NCT00805974|blood pressure|blood pressure
557542|NCT00805974|plasma glucose|plasma glucose
557543|NCT00805974|daytime and nighttime variations|daytime and nighttime variations
557544|NCT00805961|Glioblastoma Multiforme|glioblastoma multiforme
557545|NCT00805961|Radiation Therapy|radiation therapy
557546|NCT00805961|Temozolomide|temozolomide
557547|NCT00805961|Bevacizumab|bevacizumab
557548|NCT00805961|Everolimus|everolimus
557549|NCT00805948|thoracic aneurysm|thoracic aneurysm
557550|NCT00805948|thoracic aortic aneurysms|thoracic aortic aneurysms
557551|NCT00805948|Thoracic Endovascular Aneurysm Repair (TEVAR)|thoracic endovascular aneurysm repair (tevar)
557552|NCT00805948|Talent Thoracic Stent Graft|talent thoracic stent graft
557553|NCT00805935|pre-menopausal women|pre-menopausal women
557554|NCT00805935|PCOS|pcos
557555|NCT00805935|polycystic ovarian syndrome|polycystic ovarian syndrome
557556|NCT00805935|infertility|infertility
557557|NCT00805935|IVF|ivf
557558|NCT00805935|in vitro fertilization|in vitro fertilization
557559|NCT00805883|Prostate Neoplasm|prostate neoplasm
557560|NCT00805883|Localized|localized
557561|NCT00805883|Photothermal|photothermal
557562|NCT00805883|Radical Prostatectomy|radical prostatectomy
557563|NCT00805844|Spine|spine
557564|NCT00805844|Motor Evoked Potentials|motor evoked potentials
557565|NCT00805831|sutureless vascular bypass|sutureless vascular bypass
557566|NCT00805805|Copper|copper
557567|NCT00805805|ceruloplasmin|ceruloplasmin
557568|NCT00805805|tetrathiomolybdate|tetrathiomolybdate
557569|NCT00805792|Ischemic stroke|ischemic stroke
557570|NCT00805792|treatment|treatment
557571|NCT00805792|recovery|recovery
557572|NCT00805792|donepezil|donepezil
557573|NCT00805792|Aricept|aricept
557574|NCT00805779|Overactive Bladder|overactive bladder
557575|NCT00805779|Overactive Urinary Bladder|overactive urinary bladder
557576|NCT00805779|Bladder, Overactive|bladder, overactive
557577|NCT00805779|Overactive Detrusor|overactive detrusor
557578|NCT00805779|Detrusor, Overactive|detrusor, overactive
557579|NCT00805779|Overactive Detrusor Function|overactive detrusor function
557580|NCT00805779|Detrusor Function, Overactive|detrusor function, overactive
557581|NCT00805766|Infliximab|infliximab
557582|NCT00805766|REMICADE|remicade
557583|NCT00805766|Crohn's disease|crohn's disease
557584|NCT00805740|Candidiasis; Invasive Candidiasis; Deep Tissue Candidiasis; Candida; Candidemia; Fungal Infection|candidiasis; invasive candidiasis; deep tissue candidiasis; candida; candidemia; fungal infection
557585|NCT00805714|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
557586|NCT00805701|prostate|prostate
557587|NCT00805701|cancer|cancer
557588|NCT00805701|avodart|avodart
557589|NCT00805701|dutasteride|dutasteride
557590|NCT00805701|mitcheson|mitcheson
557591|NCT00805688|Questionnaire|questionnaire
557592|NCT00805688|Pancreas|pancreas
557593|NCT00805688|Pancreatic Cancer|pancreatic cancer
557594|NCT00805688|Metastatic Disease|metastatic disease
557595|NCT00805688|symptom outcomes|symptom outcomes
557596|NCT00805688|Biomarkers|biomarkers
557597|NCT00805688|Pedometer|pedometer
557598|NCT00805688|MDASI-GI symptom assessment|mdasi-gi symptom assessment
557599|NCT00805688|interactive voice response telephone system|interactive voice response telephone system
557600|NCT00805688|IVRS|ivrs
557601|NCT00805675|Chronic HBV|chronic hbv
557602|NCT00805675|Asian adult subjects with chronic HBV, in immune tolerant phase, and positive for hepatitis B e antigen (HBeAg)|asian adult subjects with chronic hbv, in immune tolerant phase, and positive for hepatitis b e antigen (hbeag)
557603|NCT00805662|IUI|iui
557604|NCT00805662|oxytocin|oxytocin
557605|NCT00805649|ARMD|armd
557606|NCT00805649|combined therapy|combined therapy
557607|NCT00805649|efficacy|efficacy
557608|NCT00805649|safety|safety
557609|NCT00805636|cell death|cell death
557610|NCT00805636|PET imaging|pet imaging
557611|NCT00805636|brain metastases|brain metastases
557612|NCT00805636|stereotactic radiosurgery|stereotactic radiosurgery
557613|NCT00805623|sucrose|sucrose
557614|NCT00805623|sucking|sucking
557615|NCT00805623|pain relief|pain relief
557616|NCT00805623|infant|infant
557617|NCT00805623|require venous puncture|require venous puncture
557618|NCT00805610|Liver Failure|liver failure
557619|NCT00805610|Hepatocyte Transplantation|hepatocyte transplantation
557620|NCT00805610|Liver Transplantation|liver transplantation
557621|NCT00805597|breast cancer|breast cancer
557622|NCT00805597|mastectomy|mastectomy
557623|NCT00805597|one to three positive nodes|one to three positive nodes
557624|NCT00805597|radiotherapy|radiotherapy
557625|NCT00805571|Rejection|rejection
557626|NCT00805571|Infection|infection
557627|NCT00805571|Side effect of immunosuppressive drug (nephrotoxicity)|side effect of immunosuppressive drug (nephrotoxicity)
557628|NCT00805558|Chronic Periodontitis|chronic periodontitis
557629|NCT00805558|antibiotics|antibiotics
557630|NCT00805532|PTSD|ptsd
557631|NCT00805532|depression|depression
557632|NCT00805532|behavior therapy|behavior therapy
557633|NCT00805532|veterans|veterans
557634|NCT00805532|behavioral activation|behavioral activation
557635|NCT00805532|usual care|usual care
557636|NCT00805519|Osteoarthritis of the Knee|osteoarthritis of the knee
557637|NCT00805519|Glucosamine Chondroitin sulfate|glucosamine chondroitin sulfate
557638|NCT00805519|Prednisolone|prednisolone
557639|NCT00805519|Chloroquine|chloroquine
557640|NCT00805506|continuous glucose monitoring accuracy|continuous glucose monitoring accuracy
557641|NCT00805493|Mania|mania
557642|NCT00805493|Bipolar|bipolar
557643|NCT00805493|Bipolar Disorder|bipolar disorder
557644|NCT00805493|Bipolar Manic-Depressive Illness|bipolar manic-depressive illness
557645|NCT00805493|Bipolar Mood Disorder|bipolar mood disorder
557646|NCT00805480|Plaque|plaque
557647|NCT00805480|psoriasis|psoriasis
557648|NCT00805480|inflammatory skin disease|inflammatory skin disease
557649|NCT00805480|skin condition, thickening|skin condition, thickening
557650|NCT00805480|flaking|flaking
557651|NCT00805480|scaly patches|scaly patches
557652|NCT00805480|skin disease|skin disease
557653|NCT00805467|RA|ra
557654|NCT00805454|Healthy Volunteers|healthy volunteers
557655|NCT00805454|Phase I|phase i
557656|NCT00805454|Pet Scan|pet scan
557657|NCT00805441|Alcoholic|alcoholic
557658|NCT00805415|Oral Contraceptive|oral contraceptive
557659|NCT00805415|Ovulation Inhibition|ovulation inhibition
557660|NCT00805389|Adjuvant Systems|adjuvant systems
557661|NCT00805389|Hepatitis B|hepatitis b
557662|NCT00805376|Brain|brain
557663|NCT00805376|Brain Cancer|brain cancer
557664|NCT00805376|Central Nervous System Diseases|central nervous system diseases
557665|NCT00805376|CNS|cns
557666|NCT00805376|Conditionally Replication-Competent Adenovirus|conditionally replication-competent adenovirus
557667|NCT00805376|Delta-24-RGD|delta-24-rgd
557668|NCT00805376|DNX-2401|dnx-2401
557669|NCT00805376|Recurrent Malignant Gliomas|recurrent malignant gliomas
557670|NCT00805376|malignant brain tumor|malignant brain tumor
557671|NCT00805350|Insomnia|insomnia
557672|NCT00805350|Sleep Maintenance|sleep maintenance
557673|NCT00805350|Polysomnography|polysomnography
557674|NCT00805337|Cancer amplitude-modulated electromagnetic fields|cancer amplitude-modulated electromagnetic fields
557675|NCT00805311|Internal Carotid Artery Stenosis|internal carotid artery stenosis
557676|NCT00805311|Carotid Endarterectomy|carotid endarterectomy
557677|NCT00805311|Stroke|stroke
557678|NCT00805311|Cerebrovascular|cerebrovascular
557679|NCT00805311|Atherosclerosis|atherosclerosis
557680|NCT00805298|third molar|third molar
557681|NCT00805298|postoperative pain|postoperative pain
557682|NCT00805298|thermography|thermography
557683|NCT00805298|postoperative inflammation|postoperative inflammation
557684|NCT00805298|methylprednisolone|methylprednisolone
557685|NCT00805298|local anaesthetic|local anaesthetic
557686|NCT00805298|postoperative pain after removal of lower third molars|postoperative pain after removal of lower third molars
557687|NCT00805298|inflammation after removal of lower third molars|inflammation after removal of lower third molars
557688|NCT00805285|Inflammatory Bowel Disease|inflammatory bowel disease
557689|NCT00805285|Ulcerative Colitis|ulcerative colitis
557690|NCT00805285|Budesonide|budesonide
557691|NCT00805285|Corticosteroids|corticosteroids
557692|NCT00805272|HIV|hiv
557693|NCT00805272|tuberculosis|tuberculosis
557694|NCT00805272|IGRA|igra
557695|NCT00805272|diagnosis|diagnosis
557696|NCT00805272|treatment naive|treatment naive
557697|NCT00805259|cognitive function|cognitive function
557698|NCT00805259|elderly|elderly
557699|NCT00805259|technology|technology
557700|NCT00805259|financial incentives|financial incentives
557701|NCT00805259|General maintenance of cognitive function|general maintenance of cognitive function
557702|NCT00805246|Pulmonary embolism|pulmonary embolism
557703|NCT00805246|PE|pe
557704|NCT00805246|CT|ct
557705|NCT00805246|Biomarker|biomarker
557706|NCT00805246|Prognosis|prognosis
557707|NCT00805246|Risk Prediction|risk prediction
557708|NCT00805233|Neovascular|neovascular
557709|NCT00805233|AMD|amd
557710|NCT00805233|Treatment|treatment
557711|NCT00805233|Lucentis|lucentis
557712|NCT00805233|Bromfenac|bromfenac
557713|NCT00805220|frail elderly walking capacity walk training Nordic Walking|frail elderly walking capacity walk training nordic walking
557714|NCT00805207|PCOS|pcos
557715|NCT00805207|sleep apnea|sleep apnea
557716|NCT00805207|obese|obese
557717|NCT00805207|VLDL metabolism|vldl metabolism
557718|NCT00805207|isotope tracer|isotope tracer
557719|NCT00805207|women|women
557720|NCT00805168|Gram-negative Pneumonia|gram-negative pneumonia
557721|NCT00805168|Pneumonia|pneumonia
557722|NCT00805168|Intubation|intubation
557723|NCT00805168|Mechanical ventilation|mechanical ventilation
557724|NCT00805168|Amikacin|amikacin
557725|NCT00805155|Bioequivalence|bioequivalence
557726|NCT00805155|Mometasone Furoate|mometasone furoate
557727|NCT00805142|Pain|pain
557728|NCT00805142|Cancer|cancer
557729|NCT00805142|Tapentadol|tapentadol
557730|NCT00805129|URETER|ureter
557731|NCT00805129|URINARY BLADDER|urinary bladder
557732|NCT00805129|RAD001|rad001
557733|NCT00805129|Everolimus|everolimus
557734|NCT00805129|Urothelium|urothelium
557735|NCT00805129|08-123|08-123
557736|NCT00805103|Brain Metastases|brain metastases
557737|NCT00805103|Stereotactic radiosurgery (SRS)|stereotactic radiosurgery (srs)
557738|NCT00805103|Hypofractionated stereotactic radiotherapy (HSRT)|hypofractionated stereotactic radiotherapy (hsrt)
557739|NCT00805103|Recurrent Brain Metastases|recurrent brain metastases
557740|NCT00805090|Renal|renal
557741|NCT00805090|Hepatic|hepatic
557742|NCT00805090|Healthy|healthy
557743|NCT00805077|interoperative care|interoperative care
557744|NCT00805077|Tidal volume|tidal volume
557745|NCT00805077|Postoperative complications|postoperative complications
557746|NCT00805077|Pneumonectomy|pneumonectomy
557747|NCT00805077|Lobectomy|lobectomy
557748|NCT00805077|Mechanical ventilation|mechanical ventilation
557749|NCT00805051|Aortic stenosis|aortic stenosis
557750|NCT00805051|aortic valve replacement|aortic valve replacement
557751|NCT00805051|von Willebrand disease|von willebrand disease
557752|NCT00805051|blood loss|blood loss
557753|NCT00805012|S-1|s-1
557754|NCT00805012|docetaxel|docetaxel
557755|NCT00805012|head and neck cancer|head and neck cancer
557756|NCT00805012|Recurrent or metastatic head and neck squamous cell carcinoma|recurrent or metastatic head and neck squamous cell carcinoma
557757|NCT00804999|confocal microscopy|confocal microscopy
557758|NCT00804999|contact lens wear|contact lens wear
557759|NCT00804999|contact lens solutions|contact lens solutions
557760|NCT00804999|sodium fluorescein|sodium fluorescein
557761|NCT00804973|Migraine|migraine
557762|NCT00804973|Headache|headache
557763|NCT00804960|Cost of Infertility Treatment|cost of infertility treatment
557764|NCT00804960|Ovulation Induction|ovulation induction
557765|NCT00804960|Letrozole|letrozole
557766|NCT00804960|In Vitro Fertilization|in vitro fertilization
557767|NCT00804947|Autologous transplantation|autologous transplantation
557768|NCT00804947|Multiple Myeloma|multiple myeloma
557769|NCT00804947|Intravenous Busulfan|intravenous busulfan
557770|NCT00804921|bevacizumab|bevacizumab
557771|NCT00804921|intra-ocular pressure|intra-ocular pressure
557772|NCT00804921|acetazolamide|acetazolamide
557773|NCT00804921|anterior chamber paracentesis|anterior chamber paracentesis
557774|NCT00804921|brimonidine|brimonidine
557775|NCT00804921|macular edema secondary to diabetic retinopathy or macular degeneration|macular edema secondary to diabetic retinopathy or macular degeneration
557776|NCT00804908|Temozolomide|temozolomide
557777|NCT00804908|Skin cancer|skin cancer
557778|NCT00804908|Melanoma|melanoma
557779|NCT00804908|Metastatic Melanoma|metastatic melanoma
557780|NCT00804908|ABT-888|abt-888
557781|NCT00804908|MM|mm
557782|NCT00804895|cluster headache|cluster headache
557783|NCT00804895|greater occipital nerve block|greater occipital nerve block
557784|NCT00804895|cortivazol|cortivazol
557785|NCT00804882|Metabolic syndrome|metabolic syndrome
557786|NCT00804882|Heart failure|heart failure
557787|NCT00804882|Mexican Americans|mexican americans
557788|NCT00804882|Ethnic differences|ethnic differences
557789|NCT00804882|Echocardiography|echocardiography
557790|NCT00804830|adjuvant|adjuvant
557791|NCT00804830|Anaplastic thyroid cancer|anaplastic thyroid cancer
557792|NCT00804817|self management|self management
557793|NCT00804817|adherence|adherence
557794|NCT00804817|activity enhancement|activity enhancement
557795|NCT00804817|oral mucositis prevention|oral mucositis prevention
557796|NCT00804817|and mal nutrition prevention|and mal nutrition prevention
557797|NCT00804817|cancer|cancer
557798|NCT00804817|hematopoietic stem cell transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
557799|NCT00804817|loss of activity|loss of activity
557800|NCT00804804|Sleep|sleep
557801|NCT00804804|aging|aging
557802|NCT00804804|cognitives processes|cognitives processes
557803|NCT00804804|constant routine|constant routine
557804|NCT00804791|dry eye|dry eye
557805|NCT00804791|autofluorescence|autofluorescence
557806|NCT00804791|residence time|residence time
557807|NCT00804778|CAD|cad
557808|NCT00804778|CABG|cabg
557809|NCT00804778|CO|co
557810|NCT00804778|CI|ci
557811|NCT00804778|thermodilution|thermodilution
557812|NCT00804778|USCOM|uscom
557813|NCT00804765|Prevention|prevention
557814|NCT00804765|child obesity|child obesity
557815|NCT00804765|pregnancy|pregnancy
557816|NCT00804765|overweight women|overweight women
557817|NCT00804765|obese women|obese women
557818|NCT00804752|Patients with Chronic Hepatitis C|patients with chronic hepatitis c
557819|NCT00804739|Major Depression|major depression
557820|NCT00804739|Postpartum Depression|postpartum depression
557821|NCT00804739|Perinatal Depression|perinatal depression
557822|NCT00804739|Treatment Feasibility|treatment feasibility
557823|NCT00804739|Treatment Engagement|treatment engagement
557824|NCT00804739|Treatment Adherence|treatment adherence
557825|NCT00804739|Postpartum|postpartum
557826|NCT00804739|Interpersonal Psychotherapy|interpersonal psychotherapy
557827|NCT00804739|IPT|ipt
557828|NCT00804739|Sertraline|sertraline
557829|NCT00804739|Zoloft|zoloft
557830|NCT00804726|Cataract extraction|cataract extraction
557831|NCT00804726|Phacoemulsification|phacoemulsification
557832|NCT00804713|TB|tb
557833|NCT00804713|tuberculosis diagnosis|tuberculosis diagnosis
557834|NCT00804713|TB screening|tb screening
557835|NCT00804700|synchronous|synchronous
557836|NCT00804700|exercise|exercise
557837|NCT00804700|music|music
557838|NCT00804700|heartbeat|heartbeat
557839|NCT00804700|tunes|tunes
557840|NCT00804687|Allergy|allergy
557841|NCT00804687|Rhinitis|rhinitis
557842|NCT00804687|Allergic Rhinitis|allergic rhinitis
557843|NCT00804687|JNJ-39220675|jnj-39220675
557844|NCT00804687|Pseudoephedrine|pseudoephedrine
557845|NCT00804674|bupivacain|bupivacain
557846|NCT00804674|breast|breast
557847|NCT00804674|reconstruction|reconstruction
557848|NCT00804674|diep|diep
557849|NCT00804674|pain|pain
557850|NCT00804674|postoperative|postoperative
557851|NCT00804674|catheter|catheter
557852|NCT00804674|anesthesia|anesthesia
557853|NCT00804661|sleep|sleep
557854|NCT00804661|nocturnal hypoventilation|nocturnal hypoventilation
557855|NCT00804661|sleep quality|sleep quality
557856|NCT00804661|lung function|lung function
557857|NCT00804622|HBeAg positive compensated chronic hepatitis B|hbeag positive compensated chronic hepatitis b
557858|NCT00804583|Cystic Fibrosis|cystic fibrosis
557859|NCT00804583|Liver Disease|liver disease
557860|NCT00804583|Genetic Modifiers|genetic modifiers
557861|NCT00804557|Male Urinary Disorders|male urinary disorders
557862|NCT00804557|Urinary catheterization|urinary catheterization
557863|NCT00804557|Urinary retention|urinary retention
557864|NCT00804544|Integrated SPECT/CT|integrated spect/ct
557865|NCT00804544|99mTc-sestMIBI|99mtc-sestmibi
557866|NCT00804544|Chemosensitivity|chemosensitivity
557867|NCT00804531|Low back pain|low back pain
557868|NCT00804531|steroid injection|steroid injection
557869|NCT00804531|inter-vertebral disc|inter-vertebral disc
557870|NCT00804531|randomized trial|randomized trial
557871|NCT00804531|Lack of efficacy of usual recommended treatments|lack of efficacy of usual recommended treatments
557872|NCT00804531|More than 40 on the pain numeric scale (0-100)|more than 40 on the pain numeric scale (0-100)
557873|NCT00804531|Inflammatory discopathy (MODIC I) on MRI|inflammatory discopathy (modic i) on mri
557874|NCT00804518|Aging|aging
557875|NCT00804518|Diastolic dysfunction|diastolic dysfunction
557876|NCT00804518|Systolic function|systolic function
557877|NCT00804518|Exercise|exercise
557878|NCT00804518|Echocardiography|echocardiography
557879|NCT00804518|tissue Doppler imaging|tissue doppler imaging
557880|NCT00804518|Cardiac function|cardiac function
557881|NCT00804505|Substantial equivalence to control device|substantial equivalence to control device
557882|NCT00804492|To organize a multidisciplinary team for integrated falls prevention|to organize a multidisciplinary team for integrated falls prevention
557883|NCT00804492|To draft a guideline for falls prevention in the elderly|to draft a guideline for falls prevention in the elderly
557884|NCT00804492|To set up a multidisciplinary fall clinic|to set up a multidisciplinary fall clinic
557885|NCT00804492|To set up a falls prevention classroom|to set up a falls prevention classroom
557886|NCT00804492|To enhance cooperate between hospitals and primary care units for falls prevention|to enhance cooperate between hospitals and primary care units for falls prevention
557887|NCT00804466|Human Papillomavirus|human papillomavirus
557888|NCT00804466|Natural History|natural history
557889|NCT00804466|Cervical Cancer|cervical cancer
557890|NCT00804466|Screening|screening
557891|NCT00804453|Chronic Kidney Failure|chronic kidney failure
557892|NCT00804453|Hemodialysis|hemodialysis
557893|NCT00804453|Biocompatibility|biocompatibility
557894|NCT00804440|bioequivalency|bioequivalency
557895|NCT00804440|ibuprofen|ibuprofen
557896|NCT00804427|Fish oil|fish oil
557897|NCT00804427|Triglycerides|triglycerides
557898|NCT00804427|Low-density Lipoprotein (LDL) cholesterol|low-density lipoprotein (ldl) cholesterol
557899|NCT00804427|Low-density Lipoprotein (LDL) subclass|low-density lipoprotein (ldl) subclass
557900|NCT00804427|Low-density Lipoprotein (LDL) particle size|low-density lipoprotein (ldl) particle size
557901|NCT00804427|Low-density Lipoprotein (LDL) phenotype|low-density lipoprotein (ldl) phenotype
557902|NCT00804414|Diabetes|diabetes
557903|NCT00804414|Diabetic ulcer|diabetic ulcer
557904|NCT00804414|Chronic ulcer|chronic ulcer
557905|NCT00804414|SBG|sbg
557906|NCT00804401|bioequivalency|bioequivalency
557907|NCT00804401|Naproxen|naproxen
557908|NCT00804388|Vitamine E|vitamine e
557909|NCT00804388|E-poly|e-poly
557910|NCT00804388|Hip|hip
557911|NCT00804388|Degenerative joint disease|degenerative joint disease
557912|NCT00804375|stump pain|stump pain
557913|NCT00804349|Heart Decompensation|heart decompensation
557914|NCT00804349|Heart Failure, Congestive|heart failure, congestive
557915|NCT00804349|Heart Failure, Left-Sided|heart failure, left-sided
557916|NCT00804349|Heart Failure, Right-Sided|heart failure, right-sided
557917|NCT00804349|Apnea, Sleep|apnea, sleep
557918|NCT00804349|Sleep Apnea, Mixed Central and Obstructive|sleep apnea, mixed central and obstructive
557919|NCT00804349|Sleep Hypopnea|sleep hypopnea
557920|NCT00804349|Sleep-Disordered Breathing|sleep-disordered breathing
557921|NCT00804336|pasireotide|pasireotide
557922|NCT00804336|SOM230|som230
557923|NCT00804336|RAD001|rad001
557924|NCT00804310|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
557925|NCT00804297|Hypoglycemia|hypoglycemia
557926|NCT00804297|Diabetes Mellitus|diabetes mellitus
557927|NCT00804297|Octreotide|octreotide
557928|NCT00804284|DAPTACEL®|daptacel®
557929|NCT00804284|PENTACEL®|pentacel®
557930|NCT00804284|Diphtheria|diphtheria
557931|NCT00804284|Tetanus|tetanus
557932|NCT00804284|Pertussis|pertussis
557933|NCT00804284|Haemophilus influenzae type b|haemophilus influenzae type b
557934|NCT00804258|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
557935|NCT00804258|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
557936|NCT00804258|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
557937|NCT00804258|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
557938|NCT00804258|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
557939|NCT00804258|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
557940|NCT00804258|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
557941|NCT00804258|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
557942|NCT00804258|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
557943|NCT00804258|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
557944|NCT00804245|adenocarcinoma of the prostate|adenocarcinoma of the prostate
557945|NCT00804245|stage I prostate cancer|stage i prostate cancer
557946|NCT00804245|stage II prostate cancer|stage ii prostate cancer
557947|NCT00804245|stage III prostate cancer|stage iii prostate cancer
557948|NCT00804245|stage IV prostate cancer|stage iv prostate cancer
557949|NCT00804232|Diabetes type1; children|diabetes type1; children
557950|NCT00804219|low responsiveness after vaccination|low responsiveness after vaccination
557951|NCT00804206|Intravitreal injection of Bevacizumab|intravitreal injection of bevacizumab
557952|NCT00804206|Visual acuity|visual acuity
557953|NCT00804206|central retinal thickness|central retinal thickness
557954|NCT00804206|color studies, Farnsworth-Munsell|color studies, farnsworth-munsell
557955|NCT00804206|electroretinogram studies|electroretinogram studies
557956|NCT00804193|Tinea Pedis|tinea pedis
557957|NCT00804193|Ciclopirox Olamine|ciclopirox olamine
557958|NCT00804180|anxiety|anxiety
557959|NCT00804180|injection|injection
557960|NCT00804180|needle|needle
557961|NCT00804180|pediatric|pediatric
557962|NCT00804180|youth|youth
557963|NCT00804180|children|children
557964|NCT00804180|adolescents|adolescents
557965|NCT00804180|cognitive behavioral|cognitive behavioral
557966|NCT00804180|behavioral|behavioral
557967|NCT00804180|exposure|exposure
557968|NCT00804180|group|group
557969|NCT00804180|treatment|treatment
557970|NCT00804180|chronic illness|chronic illness
557971|NCT00804180|adherence|adherence
557972|NCT00804167|Hypertensive patients aged of 75 years and older|hypertensive patients aged of 75 years and older
557973|NCT00804167|renal damage|renal damage
557974|NCT00804167|Clinical characteristics of hypertensive patients aged of 75 years and older seen in general practitioner consultation according to their renal damage|clinical characteristics of hypertensive patients aged of 75 years and older seen in general practitioner consultation according to their renal damage
557975|NCT00804154|Pain|pain
557976|NCT00804154|Vanilloid|vanilloid
557977|NCT00804154|Capsaicin|capsaicin
557978|NCT00804154|Cancer Pain|cancer pain
557979|NCT00804154|Resiniferatoxin|resiniferatoxin
557980|NCT00804141|treatment for opioid-induced constipation|treatment for opioid-induced constipation
557981|NCT00804128|ductal breast carcinoma in situ|ductal breast carcinoma in situ
557982|NCT00804115|Exfoliation Syndrome|exfoliation syndrome
557983|NCT00804115|Latanoprost|latanoprost
557984|NCT00804115|Timolol|timolol
557985|NCT00804115|Pilocarpine|pilocarpine
557986|NCT00804102|Retinitis pigmentosa|retinitis pigmentosa
557987|NCT00804102|Macula off|macula off
557988|NCT00804102|Primary open angle Glaucoma|primary open angle glaucoma
557989|NCT00804102|Hereditary Macular Degeneration|hereditary macular degeneration
557990|NCT00804102|Treated Retina detachment|treated retina detachment
557991|NCT00804102|Retinal Artery Occlusion|retinal artery occlusion
557992|NCT00804102|Retinal Vein Occlusion,|retinal vein occlusion,
557993|NCT00804102|Non-Arthritic-Anterior-Ischemic Optic-Neuropathy|non-arthritic-anterior-ischemic optic-neuropathy
557994|NCT00804102|Hereditary autosomal dominant Optic atrophy|hereditary autosomal dominant optic atrophy
557995|NCT00804102|dry Age-related Macular Degeneration|dry age-related macular degeneration
557996|NCT00804102|Ischemic Macula edema|ischemic macula edema
557997|NCT00804089|Low Back Pain, Chronic|low back pain, chronic
557998|NCT00804089|Acupuncture|acupuncture
557999|NCT00804089|Dry Needling|dry needling
558000|NCT00804089|Acupressure|acupressure
558001|NCT00804089|Acupuncture Points|acupuncture points
558002|NCT00804089|Trigger Points, Myofascial|trigger points, myofascial
558003|NCT00804076|gene therapy|gene therapy
558004|NCT00804076|replication defective HSV vector|replication defective hsv vector
558005|NCT00804076|pain|pain
558006|NCT00804076|enkephalin|enkephalin
558007|NCT00804076|intradermal|intradermal
558008|NCT00804063|glaucoma|glaucoma
558009|NCT00804063|citrate|citrate
558010|NCT00804050|Myelodysplastic Syndromes|myelodysplastic syndromes
558011|NCT00804050|Erythropoietin|erythropoietin
558012|NCT00804050|Acid 13-Cis-Retinoic|acid 13-cis-retinoic
558013|NCT00804050|Dihydroxyvitamin D3|dihydroxyvitamin d3
558014|NCT00804050|low or intermediate-1 IPSS|low or intermediate-1 ipss
558015|NCT00804050|MDS low risk|mds low risk
558016|NCT00804037|Snoring and Mild Apnea|snoring and mild apnea
558017|NCT00804024|Heart Diseases. Vascular Diseases.|heart diseases. vascular diseases.
558018|NCT00804011|Snakebite|snakebite
558019|NCT00804011|Weaning|weaning
558020|NCT00804011|Mechanical ventilation|mechanical ventilation
558021|NCT00803985|Inguinal hernia|inguinal hernia
558022|NCT00803985|TEP|tep
558023|NCT00803985|Lichtenstein|lichtenstein
558024|NCT00803985|mesh|mesh
558025|NCT00803985|Randomized|randomized
558026|NCT00803985|Chronic pain|chronic pain
558027|NCT00803985|Sexual dysfunction|sexual dysfunction
558028|NCT00803972|Humalog|humalog
558029|NCT00803972|Humulin R|humulin r
558030|NCT00803972|rHuPH20|rhuph20
558031|NCT00803972|Hylenex|hylenex
558032|NCT00803959|Stress urinary incontinence, Mixed, Urge|stress urinary incontinence, mixed, urge
558033|NCT00803946|bioequivalency|bioequivalency
558034|NCT00803946|ibuprofen|ibuprofen
558035|NCT00803933|first stage|first stage
558036|NCT00803933|Trypanosoma brucei gambiense|trypanosoma brucei gambiense
558037|NCT00803933|T. b. gambiense|t. b. gambiense
558038|NCT00803933|sleeping sickness|sleeping sickness
558039|NCT00803933|First stage T. b. gambiense sleeping sickness|first stage t. b. gambiense sleeping sickness
558040|NCT00803920|exenatide twice daily or once weekly|exenatide twice daily or once weekly
558041|NCT00803920|continuous glucose monitoring|continuous glucose monitoring
558042|NCT00803907|immunomodulator|immunomodulator
558043|NCT00803907|Carcinoma, Basal Cell|carcinoma, basal cell
558044|NCT00803894|Biomarkers of Notch inhibition|biomarkers of notch inhibition
558045|NCT00803855|single dose|single dose
558046|NCT00803855|pharmacokinetics|pharmacokinetics
558047|NCT00803855|safety|safety
558048|NCT00803855|healthy volunteers|healthy volunteers
558049|NCT00803855|food interaction|food interaction
558050|NCT00803855|AZD1446|azd1446
558051|NCT00803842|erlotinib|erlotinib
558052|NCT00803842|rash|rash
558053|NCT00803842|supportive care|supportive care
558054|NCT00803816|endogoneous|endogoneous
558055|NCT00803816|posterior|posterior
558056|NCT00803816|intermediate|intermediate
558057|NCT00803803|Pilocarpine|pilocarpine
558058|NCT00803803|POAG|poag
558059|NCT00803803|IOP|iop
558060|NCT00803803|Concentration|concentration
558061|NCT00803803|Frequency|frequency
558062|NCT00803803|Primary open-angle glaucoma|primary open-angle glaucoma
558063|NCT00803803|Primary open-angle glaucoma suspect|primary open-angle glaucoma suspect
558064|NCT00803764|bioequivalency|bioequivalency
558065|NCT00803764|naproxen|naproxen
558066|NCT00803751|Laryngoscopy [E04.580.373]|laryngoscopy [e04.580.373]
558067|NCT00803738|Vulvovaginal Candidiasis|vulvovaginal candidiasis
558068|NCT00803738|Terconazole|terconazole
558069|NCT00803725|spinal anesthesia|spinal anesthesia
558070|NCT00803725|mepivacaine|mepivacaine
558071|NCT00803725|fentanyl|fentanyl
558072|NCT00803725|duration of anesthesia|duration of anesthesia
558073|NCT00803725|knee arthroscopy|knee arthroscopy
558074|NCT00803725|regional anesthesia|regional anesthesia
558075|NCT00803725|Spinal anesthesia for knee arthroscopy|spinal anesthesia for knee arthroscopy
558076|NCT00803699|selenium|selenium
558077|NCT00803673|Healthy volunteers|healthy volunteers
558078|NCT00803673|New formulation|new formulation
558079|NCT00803660|hypertension|hypertension
558080|NCT00803660|BP|bp
558081|NCT00803660|diabetes|diabetes
558082|NCT00803660|anti-hypertensive treatment|anti-hypertensive treatment
558083|NCT00803660|ACE-I|ace-i
558084|NCT00803660|ARB|arb
558085|NCT00803647|NSABP|nsabp
558086|NCT00803647|Cetuximab|cetuximab
558087|NCT00803647|FOLFOX7|folfox7
558088|NCT00803647|Oxaliplatin|oxaliplatin
558089|NCT00803647|Leucovorin|leucovorin
558090|NCT00803647|5-FU|5-fu
558091|NCT00803647|colorectal cancer|colorectal cancer
558092|NCT00803647|KRAS wild type|kras wild type
558093|NCT00803647|metastatic colorectal cancer|metastatic colorectal cancer
558094|NCT00803647|Erbitux|erbitux
558095|NCT00803647|Eloxatin|eloxatin
558096|NCT00803647|Liver resection|liver resection
558097|NCT00803647|Liver ablation|liver ablation
558098|NCT00803647|Metastasectomy|metastasectomy
558099|NCT00803634|Hypertension|hypertension
558100|NCT00803634|Antihypertensive Agent|antihypertensive agent
558101|NCT00803634|Calcium Channel Blocker|calcium channel blocker
558102|NCT00803608|Plantar|plantar
558103|NCT00803608|Ulcer|ulcer
558104|NCT00803608|Diabetes|diabetes
558105|NCT00803595|Influenza|influenza
558106|NCT00803595|Neuraminidase inhibitor|neuraminidase inhibitor
558107|NCT00803569|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
558108|NCT00803569|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
558109|NCT00803569|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
558110|NCT00803569|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
558111|NCT00803569|fallopian tube cancer|fallopian tube cancer
558112|NCT00803569|peritoneal cavity cancer|peritoneal cavity cancer
558113|NCT00803543|HSV-2|hsv-2
558114|NCT00803543|Herpes Simplex|herpes simplex
558115|NCT00803543|HSV Type 2|hsv type 2
558116|NCT00803543|HIV|hiv
558117|NCT00803543|HIV/HSV|hiv/hsv
558118|NCT00803543|treatment experienced|treatment experienced
558119|NCT00803530|myelodysplastic syndromes|myelodysplastic syndromes
558120|NCT00803530|arsenic trioxide|arsenic trioxide
558121|NCT00803530|ascorbic acid|ascorbic acid
558122|NCT00803517|chronic central serous chorioretinopathy|chronic central serous chorioretinopathy
558123|NCT00803517|multifocal electroretinogram|multifocal electroretinogram
558124|NCT00803517|central retinal function after treatment in chronic serous chorioretinopathy|central retinal function after treatment in chronic serous chorioretinopathy
558125|NCT00803504|optic disc morphology|optic disc morphology
558126|NCT00803504|ocular blood flow|ocular blood flow
558127|NCT00803504|retina|retina
558128|NCT00803504|ocular physiology|ocular physiology
558129|NCT00803491|Rheumatic diseases|rheumatic diseases
558130|NCT00803491|Problem based learning|problem based learning
558131|NCT00803491|Health-related quality of life|health-related quality of life
558132|NCT00803491|Empowerment|empowerment
558133|NCT00803491|Self-care|self-care
558134|NCT00803478|IntraLase LASIK for primary myopia|intralase lasik for primary myopia
558135|NCT00803465|Bioequivalence|bioequivalence
558136|NCT00803465|Fluticasone Propionate|fluticasone propionate
558137|NCT00803452|Meibomian gland dysfunction|meibomian gland dysfunction
558138|NCT00803452|Lid margin disease|lid margin disease
558139|NCT00803452|doxycycline|doxycycline
558140|NCT00803452|azithromycin|azithromycin
558141|NCT00803452|essential fatty acid|essential fatty acid
558142|NCT00803439|Bioequivalence|bioequivalence
558143|NCT00803439|Clobetasol Propionate|clobetasol propionate
558144|NCT00803426|ultrasound-guided regional anesthesia|ultrasound-guided regional anesthesia
558145|NCT00803426|nerve block|nerve block
558146|NCT00803426|popliteal fossa|popliteal fossa
558147|NCT00803426|sciatic nerve|sciatic nerve
558148|NCT00803426|common peroneal nerve|common peroneal nerve
558149|NCT00803426|tibial nerve|tibial nerve
558150|NCT00803426|onset time|onset time
558151|NCT00803426|ankle surgery|ankle surgery
558152|NCT00803426|foot surgery|foot surgery
558153|NCT00803413|Chronic low back pain|chronic low back pain
558154|NCT00803413|Back School|back school
558155|NCT00803413|Walking|walking
558156|NCT00803413|Physical activity|physical activity
558157|NCT00803400|Panic disorder|panic disorder
558158|NCT00803400|Exercise|exercise
558159|NCT00803400|Alprazolam|alprazolam
558160|NCT00803400|Aerobic|aerobic
558161|NCT00803387|ocular dryness|ocular dryness
558162|NCT00803387|ocular irritation|ocular irritation
558163|NCT00803387|open-angle glaucoma|open-angle glaucoma
558164|NCT00803387|ocular hypertension|ocular hypertension
558165|NCT00803387|TravatanZ|travatanz
558166|NCT00803387|Xalatan|xalatan
558167|NCT00803361|anxiety|anxiety
558168|NCT00803348|continuous femoral nerve blockade|continuous femoral nerve blockade
558169|NCT00803348|knee arthroplasty|knee arthroplasty
558170|NCT00803348|knee replacement|knee replacement
558171|NCT00803348|regional anesthesia|regional anesthesia
558172|NCT00803348|readiness to discharge|readiness to discharge
558173|NCT00803348|Femoral nerve blockade for total knee arthroplasty|femoral nerve blockade for total knee arthroplasty
558174|NCT00803335|pelvic organ prolapse|pelvic organ prolapse
558175|NCT00803335|vaginal atrophy|vaginal atrophy
558176|NCT00803335|atrophic vaginitis|atrophic vaginitis
558177|NCT00803335|postmenopausal|postmenopausal
558178|NCT00803335|posthysterectomy|posthysterectomy
558179|NCT00803335|vaginal health|vaginal health
558180|NCT00803335|vaginal cytology|vaginal cytology
558181|NCT00803335|vaginal maturity index|vaginal maturity index
558182|NCT00803335|vaginal histology|vaginal histology
558183|NCT00803335|quality of life questionnaires|quality of life questionnaires
558184|NCT00803322|TB|tb
558185|NCT00803322|community|community
558186|NCT00803322|community health workers|community health workers
558187|NCT00803322|Ethiopia|ethiopia
558188|NCT00803322|identify suspects of pulmonary tuberculosis|identify suspects of pulmonary tuberculosis
558189|NCT00803322|collect sputum specimen for examination|collect sputum specimen for examination
558190|NCT00803322|treat smear positive cases in the community|treat smear positive cases in the community
558191|NCT00803309|Chronic HCV-genotype 2/3|chronic hcv-genotype 2/3
558192|NCT00803309|Efficacy of treatment extension|efficacy of treatment extension
558193|NCT00803309|PegIntron|pegintron
558194|NCT00803309|pegylated interferon alpha-2b|pegylated interferon alpha-2b
558195|NCT00803309|Rebetol|rebetol
558196|NCT00803309|ribavirin|ribavirin
558197|NCT00803283|Pain|pain
558198|NCT00803283|Hydromorphone hydrochloride OROS|hydromorphone hydrochloride oros
558199|NCT00803283|Morphine|morphine
558200|NCT00803270|Stress urinary incontinence, Mixed, Urge|stress urinary incontinence, mixed, urge
558201|NCT00803257|Carpal Tunnel Syndrome|carpal tunnel syndrome
558202|NCT00803257|Splint|splint
558203|NCT00803257|Hand exercises|hand exercises
558204|NCT00803244|allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
558205|NCT00803218|Bioequivalence|bioequivalence
558206|NCT00803218|Fluticasone Propionate|fluticasone propionate
558207|NCT00803205|Cystic fibrosis|cystic fibrosis
558208|NCT00803205|Nonsense mutation|nonsense mutation
558209|NCT00803205|Premature stop codon|premature stop codon
558210|NCT00803205|PTC124|ptc124
558211|NCT00803205|Ataluren|ataluren
558212|NCT00803192|bioavailability|bioavailability
558213|NCT00803192|famotidine|famotidine
558214|NCT00803179|CF|cf
558215|NCT00803166|Bioequivalence|bioequivalence
558216|NCT00803166|Halobetasol Propionate|halobetasol propionate
558217|NCT00803153|Panretinal photocoagulation|panretinal photocoagulation
558218|NCT00803153|Bruch rupture|bruch rupture
558594|NCT00801502|Omega-3|omega-3
558219|NCT00803153|Choroidal detachment|choroidal detachment
558220|NCT00803153|complication rates|complication rates
558221|NCT00803140|scarring|scarring
558222|NCT00803127|vaginal infection, color appearance|vaginal infection, color appearance
558223|NCT00803114|Postpartum perineal pain|postpartum perineal pain
558224|NCT00803114|Epidural morphine|epidural morphine
558225|NCT00803114|Randomised clinical trial|randomised clinical trial
558226|NCT00803101|Anticoagulant reversal|anticoagulant reversal
558227|NCT00803101|Prothrombin Complex Concentrate|prothrombin complex concentrate
558228|NCT00803101|Coagulopathy|coagulopathy
558229|NCT00803101|Coumarin derivatives|coumarin derivatives
558230|NCT00803101|Emergency surgery|emergency surgery
558231|NCT00803101|Invasive procedures|invasive procedures
558232|NCT00803101|Vitamin K|vitamin k
558233|NCT00803101|Reversal of coagulopathy induced by coumarin derivatives|reversal of coagulopathy induced by coumarin derivatives
558234|NCT00803101|Kcentra|kcentra
558235|NCT00803049|Multiple Sclerosis|multiple sclerosis
558236|NCT00803049|Oral treatment|oral treatment
558237|NCT00803036|spreading cortical depression|spreading cortical depression
558238|NCT00803036|electroencephalography|electroencephalography
558239|NCT00803036|traumatic brain injury|traumatic brain injury
558240|NCT00803036|intensive care|intensive care
558241|NCT00803036|vascular hypotension|vascular hypotension
558242|NCT00803036|intracranial hypertension|intracranial hypertension
558243|NCT00803010|Acute Graft Versus Host Disease (aGVHD)|acute graft versus host disease (agvhd)
558244|NCT00803010|GVHD|gvhd
558245|NCT00803010|graft-versus-host disease|graft-versus-host disease
558246|NCT00803010|tacrolimus|tacrolimus
558247|NCT00803010|sirolimus|sirolimus
558248|NCT00803010|methotrexate|methotrexate
558249|NCT00803010|combination therapy|combination therapy
558250|NCT00803010|GVHD prophylaxis|gvhd prophylaxis
558251|NCT00802971|Reactive hypoglycaemia|reactive hypoglycaemia
558252|NCT00802971|Fiber|fiber
558253|NCT00802971|Prevalence|prevalence
558254|NCT00802971|Randomised controlled trial|randomised controlled trial
558255|NCT00802971|Idiopathic reactive hypoglycemia|idiopathic reactive hypoglycemia
558256|NCT00802958|Bioequivalence|bioequivalence
558257|NCT00802958|Halobetasol Propionate|halobetasol propionate
558258|NCT00802932|breast cancer|breast cancer
558259|NCT00802932|female|female
558260|NCT00802932|metallic markers|metallic markers
558261|NCT00802932|image guided radiation therapy|image guided radiation therapy
558262|NCT00802932|IGRT|igrt
558263|NCT00802919|schizophrenia|schizophrenia
558264|NCT00802919|smoking|smoking
558265|NCT00802919|nicotine|nicotine
558266|NCT00802919|cognitive deficits|cognitive deficits
558267|NCT00802919|nicotinic receptors|nicotinic receptors
558268|NCT00802919|Cognitive Deficits in Schizophrenia|cognitive deficits in schizophrenia
558269|NCT00802906|micropulselaserphotocoagulation|micropulselaserphotocoagulation
558270|NCT00802906|bevacizumab|bevacizumab
558271|NCT00802906|CSC|csc
558272|NCT00802893|Isolated Systolic Hypertension with Endothelial Dysfunction|isolated systolic hypertension with endothelial dysfunction
558273|NCT00802867|DAPTACEL®|daptacel®
558274|NCT00802867|PENTACEL™|pentacel™
558275|NCT00802867|Diphtheria|diphtheria
558276|NCT00802867|Tetanus|tetanus
558277|NCT00802867|Pertussis|pertussis
558278|NCT00802867|Haemophilus influenzae type b|haemophilus influenzae type b
558279|NCT00802854|anidulafungin|anidulafungin
558280|NCT00802854|safety|safety
558281|NCT00802854|efficacy|efficacy
558282|NCT00802841|Chronic|chronic
558283|NCT00802841|Myelogenous|myelogenous
558284|NCT00802841|Leukemia|leukemia
558286|NCT00802841|Chronic Phase|chronic phase
558287|NCT00802841|Suboptimal Response|suboptimal response
558288|NCT00802828|bioavailability|bioavailability
558289|NCT00802828|famotidine|famotidine
558290|NCT00802763|VAGINAL INFECTION|vaginal infection
558291|NCT00802763|COLOR APPEARANCE|color appearance
558292|NCT00802763|ELEVATED Ph|elevated ph
558293|NCT00802737|Maintenance|maintenance
558294|NCT00802737|Retreatment|retreatment
558295|NCT00802737|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
558296|NCT00802737|B-Cell Chronic Lymphocytic Leukemia|b-cell chronic lymphocytic leukemia
558297|NCT00802737|Ofatumumab|ofatumumab
558298|NCT00802724|low back pain|low back pain
558299|NCT00802724|classification|classification
558300|NCT00802724|spine|spine
558301|NCT00802711|stage IA breast cancer|stage ia breast cancer
558302|NCT00802711|stage IB breast cancer|stage ib breast cancer
558303|NCT00802711|stage II breast cancer|stage ii breast cancer
558304|NCT00802711|invasive ductal breast carcinoma|invasive ductal breast carcinoma
558305|NCT00802698|Biphasic waveform|biphasic waveform
558306|NCT00802698|Central retinal artery occlusion|central retinal artery occlusion
558307|NCT00802698|To describe the effect of Transcorneal Electrical Stimulation (TES) with a non conventional biphasic bipolar waveform|to describe the effect of transcorneal electrical stimulation (tes) with a non conventional biphasic bipolar waveform
558308|NCT00802698|in central retinal artery occlusion|in central retinal artery occlusion
558309|NCT00802685|Patent ductus arteriosus|patent ductus arteriosus
558310|NCT00802685|Respiratory outcome|respiratory outcome
558311|NCT00802672|Tinea Pedis|tinea pedis
558312|NCT00802672|Ciclopirox Olamine|ciclopirox olamine
558313|NCT00802646|first-time mother|first-time mother
558314|NCT00802646|epidural request|epidural request
558315|NCT00802646|vaginal childbirth|vaginal childbirth
558316|NCT00802633|Tissue sealing device|tissue sealing device
558317|NCT00802633|Articulating stapling device|articulating stapling device
558318|NCT00802633|Radical cystectomy|radical cystectomy
558319|NCT00802620|Amniotic membrane|amniotic membrane
558320|NCT00802620|Conjunctival autograft|conjunctival autograft
558321|NCT00802620|Recurrent pterygia|recurrent pterygia
558322|NCT00802620|compare amniotic membrane associated with conjunctival autograft versus conjunctival autograft alone in the treatment of recurrent pterygia|compare amniotic membrane associated with conjunctival autograft versus conjunctival autograft alone in the treatment of recurrent pterygia
558323|NCT00802607|Bone Diseases|bone diseases
558324|NCT00802607|Connective Tissue Diseases|connective tissue diseases
558325|NCT00802594|first stage|first stage
558326|NCT00802594|T.b. gambiense|t.b. gambiense
558327|NCT00802594|sleeping sickness|sleeping sickness
558328|NCT00802594|Patients with first stage T.b. gambiense sleeping sickness|patients with first stage t.b. gambiense sleeping sickness
558329|NCT00802581|sciatic nerve block|sciatic nerve block
558330|NCT00802581|local anesthetic|local anesthetic
558331|NCT00802581|lidocaine|lidocaine
558332|NCT00802581|ankle surgery|ankle surgery
558333|NCT00802581|foot surgery|foot surgery
558334|NCT00802581|ultrasound-guided regional anesthesia|ultrasound-guided regional anesthesia
558335|NCT00802581|circumferential spread|circumferential spread
558336|NCT00802581|anesthetic infiltration|anesthetic infiltration
558337|NCT00802568|stage I multiple myeloma|stage i multiple myeloma
558338|NCT00802568|stage II multiple myeloma|stage ii multiple myeloma
558339|NCT00802568|stage III multiple myeloma|stage iii multiple myeloma
558340|NCT00802568|refractory multiple myeloma|refractory multiple myeloma
558341|NCT00802568|osteolytic lesions of multiple myeloma|osteolytic lesions of multiple myeloma
558342|NCT00802555|HCC|hcc
558343|NCT00802555|Cirrhotic Patients with Hepatocellular Carcinoma|cirrhotic patients with hepatocellular carcinoma
558344|NCT00802542|Hypertension|hypertension
558345|NCT00802542|blood pressure|blood pressure
558346|NCT00802542|Atacand|atacand
558347|NCT00802529|Meniere's disease|meniere's disease
558348|NCT00802529|transtympanic steroids|transtympanic steroids
558349|NCT00802529|Randomised controlled trial|randomised controlled trial
558350|NCT00802503|Critically ill|critically ill
558351|NCT00802503|nutrition|nutrition
558352|NCT00802503|randomised controlled clinical trial|randomised controlled clinical trial
558353|NCT00802503|human|human
558354|NCT00802503|adult|adult
558355|NCT00802503|Supplemental parenteral nutrition|supplemental parenteral nutrition
558356|NCT00802490|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
558357|NCT00802490|Electroencephalogram biofeedback|electroencephalogram biofeedback
558358|NCT00802490|Inattention|inattention
558359|NCT00802490|Brain-Computer Interface System|brain-computer interface system
558360|NCT00802477|mastectomy|mastectomy
558361|NCT00802477|seroma|seroma
558362|NCT00802477|lymph node dissection|lymph node dissection
558363|NCT00802464|Cytokine|cytokine
558364|NCT00802464|Vaccine|vaccine
558365|NCT00802464|Herpes Zoster (HZ)|herpes zoster (hz)
558366|NCT00802464|Cell mediated immunity (CMI)|cell mediated immunity (cmi)
558367|NCT00802464|Antibody response|antibody response
558368|NCT00802464|Varicella Zoster Virus (VZV)|varicella zoster virus (vzv)
558369|NCT00802464|Shingles|shingles
558370|NCT00802451|Bioavailability|bioavailability
558371|NCT00802451|Mesalamine|mesalamine
558372|NCT00802438|asthma|asthma
558373|NCT00802438|allergic inflammation|allergic inflammation
558374|NCT00802438|interleukin-5|interleukin-5
558375|NCT00802425|Sudden hearing loss|sudden hearing loss
558376|NCT00802425|Sudden deafness|sudden deafness
558377|NCT00802425|Acoustic trauma|acoustic trauma
558378|NCT00802425|Noise trauma|noise trauma
558379|NCT00802412|tobacco use disorders|tobacco use disorders
558380|NCT00802412|alcoholism|alcoholism
558381|NCT00802399|Cornea|cornea
558382|NCT00802399|Dry eye|dry eye
558383|NCT00802399|lacrimal punctual occlusion|lacrimal punctual occlusion
558384|NCT00802399|lacrimal film|lacrimal film
558385|NCT00802399|ocular surface|ocular surface
558386|NCT00802386|BACTERIAL VAGINOSIS|bacterial vaginosis
558387|NCT00802386|IUD INSERTION|iud insertion
558388|NCT00802373|Overactive Bladder|overactive bladder
558389|NCT00802360|Healthy, pre-menopausal women, age 18-42 with a history of infertility and requiring IVF|healthy, pre-menopausal women, age 18-42 with a history of infertility and requiring ivf
558390|NCT00802347|Delayed Graft Function|delayed graft function
558391|NCT00802347|Kidney Transplant|kidney transplant
558392|NCT00802347|Renal Transplant|renal transplant
558393|NCT00802347|small interfering ribonucleic acid (siRNA)|small interfering ribonucleic acid (sirna)
558394|NCT00802334|generic lopinavir/ritonavir|generic lopinavir/ritonavir
558395|NCT00802334|therapeutic drug monitoring|therapeutic drug monitoring
558396|NCT00802334|safety and efficacy|safety and efficacy
558397|NCT00802321|steroid 5AReductase|steroid 5areductase
558398|NCT00802321|genetic polymorphism|genetic polymorphism
558399|NCT00802321|GABA receptor|gaba receptor
558400|NCT00802295|Ovarian|ovarian
558401|NCT00802295|hyperstimulation|hyperstimulation
558402|NCT00802295|Embryo|embryo
558403|NCT00802295|Aneuploidy|aneuploidy
558404|NCT00802295|Ovarian hyperstimulation and Embryo Aneuploidy Rates|ovarian hyperstimulation and embryo aneuploidy rates
558405|NCT00802282|healthy volunteers|healthy volunteers
558406|NCT00802282|spirituality|spirituality
558407|NCT00802282|psilocybin|psilocybin
558408|NCT00802282|meditation|meditation
558409|NCT00802269|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
558410|NCT00802269|Laser photocoagulation|laser photocoagulation
558411|NCT00802269|Pain|pain
558412|NCT00802256|pulpotomy|pulpotomy
558413|NCT00802256|primary molar teeth|primary molar teeth
558414|NCT00802256|MTA|mta
558415|NCT00802256|NEC|nec
558416|NCT00802256|CEM|cem
558417|NCT00802256|Primary Molar Teeth Which Require Pulpotomy Treatment|primary molar teeth which require pulpotomy treatment
558418|NCT00802243|Bullous pemphigoid|bullous pemphigoid
558419|NCT00802243|leflunomide|leflunomide
558420|NCT00802243|corticosteroid treatment reduction|corticosteroid treatment reduction
558421|NCT00802243|Patients are screened by: the physicians in different departments of the hospital, the liberal dermatologists and the general practicioners.|patients are screened by: the physicians in different departments of the hospital, the liberal dermatologists and the general practicioners.
558422|NCT00802243|Phase I: Patients will be referred to the investigators of Dupuytren Hospital Dermatology Department.|phase i: patients will be referred to the investigators of dupuytren hospital dermatology department.
558423|NCT00802243|Phase II: Patients will be referred to the investigators of Purpan (Toulouse), Haut Leveque (Pessac) and Dupuytren (Limoges) Hospitals.|phase ii: patients will be referred to the investigators of purpan (toulouse), haut leveque (pessac) and dupuytren (limoges) hospitals.
558424|NCT00802217|Pharmacokinetics|pharmacokinetics
558425|NCT00802217|Safety|safety
558426|NCT00802217|Tolerability|tolerability
558427|NCT00802217|Healthy Volunteers|healthy volunteers
558428|NCT00802204|Obesity|obesity
558429|NCT00802204|Insulin Resistance|insulin resistance
558430|NCT00802204|Neuroendocrine regulation|neuroendocrine regulation
558431|NCT00802204|Eating behaviors|eating behaviors
558432|NCT00802204|Dopamine signaling|dopamine signaling
558433|NCT00802165|Asymptomatic normals|asymptomatic normals
558434|NCT00802152|Diabetes|diabetes
558435|NCT00802152|Hypertension|hypertension
558436|NCT00802139|iron deficiency anemia|iron deficiency anemia
558437|NCT00802139|pregnant women with iron deficiency anemia|pregnant women with iron deficiency anemia
558438|NCT00802113|Autologous Stem Cell Transplant|autologous stem cell transplant
558439|NCT00802113|Cord Blood Transplant|cord blood transplant
558440|NCT00802113|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
558441|NCT00802113|Relapsed Lymphoma|relapsed lymphoma
558442|NCT00802100|Schizoaffective Disorder|schizoaffective disorder
558443|NCT00802087|Hydrocodone|hydrocodone
558444|NCT00802087|Pharmacokinetics|pharmacokinetics
558445|NCT00802087|Safety & Tolerability|safety & tolerability
558446|NCT00802074|Healthy Subjects|healthy subjects
558447|NCT00802074|Pharmacokinetics study|pharmacokinetics study
558448|NCT00802074|Pharmacokinetics of medications|pharmacokinetics of medications
558449|NCT00802061|progressive glaucoma despite controlled IOP|progressive glaucoma despite controlled iop
558450|NCT00802048|Sternotomy|sternotomy
558451|NCT00802048|Postoperative hyperalgesia|postoperative hyperalgesia
558452|NCT00802048|Intralesional anesthetic infusion|intralesional anesthetic infusion
558453|NCT00802048|Ropivacaïne|ropivacaïne
558454|NCT00802048|Chronic|chronic
558455|NCT00802048|Postoperative pain|postoperative pain
558456|NCT00802048|Cardiac surgery|cardiac surgery
558457|NCT00802048|Sternum|sternum
558458|NCT00802048|Cardiac surgical procedures|cardiac surgical procedures
558459|NCT00802035|ALK29|alk29
558460|NCT00802035|Alcohol Dependence|alcohol dependence
558461|NCT00802035|Pharmacokinetics|pharmacokinetics
558462|NCT00802022|diabetic neuropathies|diabetic neuropathies
558463|NCT00802022|electric stimulation therapy|electric stimulation therapy
558464|NCT00802009|ultrasound-guided regional anesthesia|ultrasound-guided regional anesthesia
558465|NCT00802009|nerve block|nerve block
558466|NCT00802009|brachial plexus|brachial plexus
558467|NCT00802009|mepivicaine|mepivicaine
558468|NCT00802009|dexamethasone|dexamethasone
558469|NCT00802009|hand wrist surgery|hand wrist surgery
558470|NCT00802009|duration|duration
558471|NCT00802009|anesthetic duration following brachial plexus/nerve block for hand/wrist surgery|anesthetic duration following brachial plexus/nerve block for hand/wrist surgery
558472|NCT00801996|prostate cancer|prostate cancer
558473|NCT00801996|genetics|genetics
558474|NCT00801970|Fear of childbirth|fear of childbirth
558475|NCT00801970|Tokophobia|tokophobia
558476|NCT00801970|Anxiety|anxiety
558477|NCT00801970|Labor|labor
558478|NCT00801970|Pregnancy|pregnancy
558479|NCT00801970|Cognitive-behavioral|cognitive-behavioral
558480|NCT00801970|Psychoanalysis|psychoanalysis
558481|NCT00801970|Group Therapy|group therapy
558482|NCT00801970|etiology|etiology
558483|NCT00801957|atopic dermatitis|atopic dermatitis
558484|NCT00801957|meningitis|meningitis
558485|NCT00801957|vaccination|vaccination
558486|NCT00801957|tacrolimus|tacrolimus
558487|NCT00801957|steroids|steroids
558488|NCT00801957|equivalence response|equivalence response
558489|NCT00801957|meningococcal vaccine|meningococcal vaccine
558490|NCT00801944|Overactive Bladder|overactive bladder
558491|NCT00801931|Cord Blood Transplant|cord blood transplant
558492|NCT00801931|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
558493|NCT00801918|lymphoma|lymphoma
558494|NCT00801918|pediatric|pediatric
558495|NCT00801918|adolescent|adolescent
558496|NCT00801918|relapsed|relapsed
558497|NCT00801918|refractory|refractory
558498|NCT00801918|denileukin diftitox|denileukin diftitox
558499|NCT00801918|Ontak|ontak
558500|NCT00801905|Macular thickening|macular thickening
558501|NCT00801905|Macular edema|macular edema
558502|NCT00801905|Pan-retinal photocoagulation|pan-retinal photocoagulation
558503|NCT00801905|Nepafenac|nepafenac
558504|NCT00801905|Topical non-steroidal anti inflammatory agents|topical non-steroidal anti inflammatory agents
558505|NCT00801892|daytime sleepiness|daytime sleepiness
558506|NCT00801892|obstructive sleep apnea|obstructive sleep apnea
558507|NCT00801892|type 2 diabetes mellitus|type 2 diabetes mellitus
558508|NCT00801892|diabetes management|diabetes management
558509|NCT00801879|mupirocin|mupirocin
558510|NCT00801879|Staphylococcus aureus|staphylococcus aureus
558511|NCT00801879|colonization|colonization
558512|NCT00801879|infection|infection
558513|NCT00801879|HIV|hiv
558514|NCT00801866|Panretinal Photocoagulation|panretinal photocoagulation
558515|NCT00801866|Macular Edema|macular edema
558516|NCT00801866|Intravitreal Bevacizumab|intravitreal bevacizumab
558517|NCT00801853|asthma|asthma
558518|NCT00801853|allergy|allergy
558519|NCT00801853|atopy|atopy
558520|NCT00801853|atopic|atopic
558521|NCT00801853|wheeze|wheeze
558522|NCT00801827|Obesity|obesity
558523|NCT00801827|Addiction|addiction
558524|NCT00801827|PET imaging|pet imaging
558525|NCT00801814|viscous|viscous
558526|NCT00801814|fibre|fibre
558527|NCT00801814|polysaccharide|polysaccharide
558528|NCT00801814|blood glucose|blood glucose
558529|NCT00801814|post prandial|post prandial
558530|NCT00801801|Docetaxel|docetaxel
558531|NCT00801801|Sorafenib|sorafenib
558532|NCT00801775|calorimetry|calorimetry
558533|NCT00801736|Recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
558534|NCT00801736|Stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
558535|NCT00801736|Stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
558536|NCT00801723|Ulcerative Colitis|ulcerative colitis
558537|NCT00801697|HIV Seronegativity|hiv seronegativity
558538|NCT00801697|HIV Preventive Vaccine|hiv preventive vaccine
558539|NCT00801697|Adenovirus|adenovirus
558540|NCT00801684|COPD|copd
558541|NCT00801684|pulmonary|pulmonary
558542|NCT00801684|inhalation|inhalation
558543|NCT00801671|obstructive sleep apnea|obstructive sleep apnea
558544|NCT00801671|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
558545|NCT00801671|hypertension|hypertension
558546|NCT00801671|systemic hypertension|systemic hypertension
558547|NCT00801671|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
558548|NCT00801658|glaucoma|glaucoma
558549|NCT00801658|SLT|slt
558550|NCT00801658|Laser treatment|laser treatment
558551|NCT00801658|IOP|iop
558552|NCT00801658|glaucoma treated with eye drops but IOP not controlled|glaucoma treated with eye drops but iop not controlled
558553|NCT00801645|Obesity|obesity
558554|NCT00801645|Cardiovascular disease|cardiovascular disease
558555|NCT00801645|Endothelial function|endothelial function
558556|NCT00801645|Blood pressure|blood pressure
558557|NCT00801645|Exercise|exercise
558558|NCT00801645|Physical activity|physical activity
558559|NCT00801645|Metabolic syndrome|metabolic syndrome
558560|NCT00801645|Children|children
558561|NCT00801645|Pediatric|pediatric
558562|NCT00801632|renal allograft tolerance|renal allograft tolerance
558563|NCT00801632|mixed chimerism|mixed chimerism
558564|NCT00801632|kidney transplant|kidney transplant
558565|NCT00801632|bone marrow transplant|bone marrow transplant
558566|NCT00801632|antirejection|antirejection
558567|NCT00801632|immunosuppression|immunosuppression
558568|NCT00801606|Micronutrient|micronutrient
558569|NCT00801606|Childhood Tuberculosis|childhood tuberculosis
558570|NCT00801593|JIA|jia
558571|NCT00801580|relapsed ALL|relapsed all
558572|NCT00801580|refractory ALL|refractory all
558573|NCT00801580|relapsed adult acute lymphoid leukemia|relapsed adult acute lymphoid leukemia
558574|NCT00801567|Bipolar disorder|bipolar disorder
558575|NCT00801567|Schizophrenia|schizophrenia
558576|NCT00801567|Healthy volunteer|healthy volunteer
558577|NCT00801567|Brain imaging|brain imaging
558578|NCT00801567|Photic stimulation|photic stimulation
558579|NCT00801554|Autism Spectrum Disorder|autism spectrum disorder
558580|NCT00801554|ASD|asd
558581|NCT00801554|Autism|autism
558582|NCT00801554|Asperger's Syndrome|asperger's syndrome
558583|NCT00801554|PDD-NOS|pdd-nos
558584|NCT00801554|Pervasive Developmental Disorders- Not Otherwise Specified|pervasive developmental disorders- not otherwise specified
558585|NCT00801554|Adults|adults
558586|NCT00801554|Children|children
558587|NCT00801541|AMD|amd
558588|NCT00801528|ropivacaine|ropivacaine
558589|NCT00801528|diclofenac|diclofenac
558590|NCT00801528|local anesthetic instillation|local anesthetic instillation
558591|NCT00801515|Compassionate|compassionate
558592|NCT00801515|HIV|hiv
558593|NCT00801515|CCR5|ccr5
558595|NCT00801502|Oily fish|oily fish
558596|NCT00801502|Antioxidant|antioxidant
558597|NCT00801502|Selenium|selenium
558598|NCT00801502|Atopic disease|atopic disease
558599|NCT00801502|Pregnancy|pregnancy
558600|NCT00801502|Nutrient status|nutrient status
558601|NCT00801489|Leukemia|leukemia
558602|NCT00801489|Acute Myelogenous Leukemia|acute myelogenous leukemia
558603|NCT00801489|AML|aml
558604|NCT00801476|Breast Cancer|breast cancer
558605|NCT00801476|Magnetic Resonance Imaging|magnetic resonance imaging
558606|NCT00801476|Preoperative MRI|preoperative mri
558607|NCT00801463|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
558608|NCT00801463|Prednisone|prednisone
558609|NCT00801463|Tripterygium Wilfordii|tripterygium wilfordii
558610|NCT00801450|diabetes|diabetes
558611|NCT00801450|macular edema|macular edema
558612|NCT00801450|triamcinolone|triamcinolone
558613|NCT00801450|cataract|cataract
558614|NCT00801450|refractory diabetic macular edema|refractory diabetic macular edema
558615|NCT00801437|glaucoma, open-angle, non-interventional study, safety, tolerability|glaucoma, open-angle, non-interventional study, safety, tolerability
558616|NCT00801424|abdominal surgery|abdominal surgery
558617|NCT00801424|hypothermia|hypothermia
558618|NCT00801424|wound dessication|wound dessication
558619|NCT00801424|warming|warming
558620|NCT00801411|stage II breast cancer|stage ii breast cancer
558621|NCT00801398|Opioid tolerant|opioid tolerant
558622|NCT00801398|Pediatric|pediatric
558623|NCT00801398|Pain|pain
558624|NCT00801398|Non malignant|non malignant
558625|NCT00801398|Malignant|malignant
558626|NCT00801385|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
558627|NCT00801385|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
558628|NCT00801385|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
558629|NCT00801372|pregnant, healthy females older than 18 who signed an informed consent for the termination of the pregnancy.|pregnant, healthy females older than 18 who signed an informed consent for the termination of the pregnancy.
558630|NCT00801372|pregnant healthy couples older than 18 who signed an informed consent for a c-section.|pregnant healthy couples older than 18 who signed an informed consent for a c-section.
558631|NCT00801372|healthy male newborns, undergoing surgical circumcision who's parents older than 18 signed an informed consent.|healthy male newborns, undergoing surgical circumcision who's parents older than 18 signed an informed consent.
558632|NCT00801359|cataract|cataract
558633|NCT00801359|phacoemulsification|phacoemulsification
558634|NCT00801359|irrigation solution|irrigation solution
558883|NCT00800306|microcirculation|microcirculation
558635|NCT00801359|endothelial cell density|endothelial cell density
558636|NCT00801359|corneal thickness|corneal thickness
558637|NCT00801346|fatigue|fatigue
558638|NCT00801346|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
558639|NCT00801346|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
558640|NCT00801346|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
558641|NCT00801346|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
558642|NCT00801333|ALS|als
558643|NCT00801320|tumor harvest|tumor harvest
558644|NCT00801320|tumor collection|tumor collection
558645|NCT00801320|tumor storage|tumor storage
558646|NCT00801307|evaluate Inspiratory Capacity (IC) measured by spirometry|evaluate inspiratory capacity (ic) measured by spirometry
558647|NCT00801281|Lymphoma|lymphoma
558648|NCT00801281|Immunochemotherapy|immunochemotherapy
558649|NCT00801281|Induction therapy|induction therapy
558650|NCT00801281|Maintenance therapy|maintenance therapy
558651|NCT00801281|Follicular lymphoma grade 1,2,3a|follicular lymphoma grade 1,2,3a
558652|NCT00801281|Marginal zone lymphoma, including MALT type|marginal zone lymphoma, including malt type
558653|NCT00801281|Small lymphocytic lymphoma (BM inv. <30%)|small lymphocytic lymphoma (bm inv. <30%)
558654|NCT00801268|polycystic kidney disease|polycystic kidney disease
558655|NCT00801268|tripterygium wilfordii|tripterygium wilfordii
558656|NCT00801229|ADHD|adhd
558657|NCT00801229|young adults|young adults
558658|NCT00801229|driving|driving
558659|NCT00801229|Vyvanse|vyvanse
558660|NCT00801229|lisdexamfetamine|lisdexamfetamine
558661|NCT00801216|B-cell lymphomas|b-cell lymphomas
558662|NCT00801216|lymphomatous meningitis|lymphomatous meningitis
558663|NCT00801216|liposomal cytarabine|liposomal cytarabine
558664|NCT00801216|autologous transplant|autologous transplant
558665|NCT00801216|CNS involvement|cns involvement
558666|NCT00801216|Secondary CNS lymphomas|secondary cns lymphomas
558667|NCT00801203|Stress Urinary Incontinence|stress urinary incontinence
558668|NCT00801190|colloid|colloid
558669|NCT00801190|CABG|cabg
558670|NCT00801190|cardiopulmonary bypass|cardiopulmonary bypass
558671|NCT00801190|bleeding|bleeding
558672|NCT00801177|Tumors|tumors
558673|NCT00801177|Antibodies, Monoclonal|antibodies, monoclonal
558674|NCT00801164|Diabetes Type 2|diabetes type 2
558675|NCT00801164|Periodontitis|periodontitis
558676|NCT00801138|ropivacaine|ropivacaine
558677|NCT00801138|bupivacaine|bupivacaine
558678|NCT00801138|glucocorticoid|glucocorticoid
558679|NCT00801112|Bioimpedance|bioimpedance
558680|NCT00801112|Fluid status|fluid status
558681|NCT00801112|Peritoneal Dialysis|peritoneal dialysis
558682|NCT00801112|Extra-cellular fluid volume|extra-cellular fluid volume
558683|NCT00801099|Postoperative wound infection|postoperative wound infection
558684|NCT00801099|surgical site infection|surgical site infection
558685|NCT00801099|antimicrobial prophylaxis|antimicrobial prophylaxis
558686|NCT00801099|developing countries|developing countries
558687|NCT00801099|Sub-Saharan Africa|sub-saharan africa
558688|NCT00801099|reduction of SSI using preoperative antibiotics|reduction of ssi using preoperative antibiotics
558689|NCT00801086|Alopecia|alopecia
558690|NCT00801086|Hair loss|hair loss
558691|NCT00801086|Radiation|radiation
558692|NCT00801086|Whole brain radiotherapy|whole brain radiotherapy
558693|NCT00801086|Radiation-induced alopecia|radiation-induced alopecia
558694|NCT00801073|Amniotic membrane|amniotic membrane
558695|NCT00801073|Cornea|cornea
558696|NCT00801073|Scleral thinning|scleral thinning
558697|NCT00801060|Fludara|fludara
558698|NCT00801060|CD23|cd23
558699|NCT00801060|Cyclophosphamide|cyclophosphamide
558700|NCT00801060|Antibody|antibody
558701|NCT00801060|Fludarabine|fludarabine
558702|NCT00801060|CLL|cll
558703|NCT00801060|Rituximab|rituximab
558704|NCT00801060|Mabthera|mabthera
558705|NCT00801060|Biogen Idec|biogen idec
558706|NCT00801060|Lumiliximab|lumiliximab
558707|NCT00801060|Rituxan|rituxan
558708|NCT00801060|Cytoxan|cytoxan
558709|NCT00801060|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
558710|NCT00801047|Epidural|epidural
558711|NCT00801047|Labor|labor
558712|NCT00801047|Remifentanil|remifentanil
558713|NCT00801034|hypertension|hypertension
558714|NCT00801034|potassium|potassium
558715|NCT00801034|blood pressure|blood pressure
558716|NCT00801021|Cystitis|cystitis
558717|NCT00801021|Urinary Tract Infections|urinary tract infections
558718|NCT00801008|young adult|young adult
558719|NCT00801008|cancer|cancer
558720|NCT00801008|exercise|exercise
558721|NCT00801008|relaxation|relaxation
558722|NCT00800995|ARMD|armd
558723|NCT00800995|SOD|sod
558724|NCT00800982|Obese patients (BMI>30)|obese patients (bmi>30)
558725|NCT00800982|Patients with moderate to severe psoriasis|patients with moderate to severe psoriasis
558726|NCT00800969|Adenocarcinoma of the stomach and esophagogastric junction|adenocarcinoma of the stomach and esophagogastric junction
558727|NCT00800956|Radiolabel ADME study Healthy volunteers|radiolabel adme study healthy volunteers
558728|NCT00800943|Leukemia|leukemia
558729|NCT00800943|Chronic|chronic
558730|NCT00800943|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
558731|NCT00800943|CAMPATH|campath
558732|NCT00800943|Alemtuzumab|alemtuzumab
558733|NCT00800943|MabCampath|mabcampath
558734|NCT00800943|Subcutaneous|subcutaneous
558735|NCT00800943|CLL|cll
558736|NCT00800943|C-CLL|c-cll
558737|NCT00800943|Residual|residual
558738|NCT00800930|Shigellosis|shigellosis
558739|NCT00800930|sodium butyrate|sodium butyrate
558740|NCT00800930|antimicrobial peptides|antimicrobial peptides
558741|NCT00800930|LL-37|ll-37
558742|NCT00800930|innate immunity|innate immunity
558743|NCT00800930|The aims are to assess efficacy of sodium butyrate enema in|the aims are to assess efficacy of sodium butyrate enema in
558744|NCT00800930|marked improvement in clinical features|marked improvement in clinical features
558745|NCT00800930|endoscopic findings|endoscopic findings
558746|NCT00800930|histological features|histological features
558747|NCT00800930|Induction of LL-37 in the rectum.|induction of ll-37 in the rectum.
558748|NCT00800904|Asthma|asthma
558749|NCT00800904|Inhaled corticosteroid|inhaled corticosteroid
558750|NCT00800904|Thai patient eligibility|thai patient eligibility
558751|NCT00800904|Persistent asthma|persistent asthma
558752|NCT00800878|Chronic Kidney Disease|chronic kidney disease
558753|NCT00800878|Renal insufficiency|renal insufficiency
558754|NCT00800852|adiponectin|adiponectin
558755|NCT00800852|adiponectin receptor|adiponectin receptor
558756|NCT00800852|Prader-Willi syndrome|prader-willi syndrome
558884|NCT00800306|levosimendan|levosimendan
558757|NCT00800839|Post-allogeneic transplantation|post-allogeneic transplantation
558758|NCT00800839|Graft-versus-Host Disease Prophylaxis|graft-versus-host disease prophylaxis
558759|NCT00800839|Graft-versus-Host Disease|graft-versus-host disease
558760|NCT00800839|GVHD|gvhd
558761|NCT00800839|Hematologic malignancies|hematologic malignancies
558762|NCT00800839|Leukemia|leukemia
558763|NCT00800839|Lymphoma|lymphoma
558764|NCT00800839|Myeloma|myeloma
558765|NCT00800839|Human Leukocyte Antigen|human leukocyte antigen
558766|NCT00800839|HLA|hla
558767|NCT00800839|Busulfan|busulfan
558768|NCT00800839|Cyclophosphamide|cyclophosphamide
558769|NCT00800839|Fludarabine|fludarabine
558770|NCT00800839|Mesna|mesna
558771|NCT00800839|Cytoxan®|cytoxan®
558772|NCT00800839|Neosar®|neosar®
558773|NCT00800839|Busulfex|busulfex
558774|NCT00800839|Myleran®|myleran®
558775|NCT00800839|Fludarabine Phosphate|fludarabine phosphate
558776|NCT00800813|Prostate|prostate
558777|NCT00800813|Erectile function|erectile function
558778|NCT00800813|Peyronie's Plaque|peyronie's plaque
558779|NCT00800813|08-135|08-135
558780|NCT00800800|progression of aortic stenosis|progression of aortic stenosis
558880|NCT00800319|RDC-0313|rdc-0313
558781|NCT00800787|Chronic hepatitis B liver disease|chronic hepatitis b liver disease
558782|NCT00800774|LASIK|lasik
558783|NCT00800774|safety|safety
558784|NCT00800774|efficacy|efficacy
558785|NCT00800774|stability|stability
558786|NCT00800774|high anisometropia|high anisometropia
558787|NCT00800774|patients 8 to 15 years old|patients 8 to 15 years old
558788|NCT00800774|conventional treatments have failed|conventional treatments have failed
558789|NCT00800722|hypervascular anomalies|hypervascular anomalies
558790|NCT00800709|Alzheimer's Disease|alzheimer's disease
558791|NCT00800709|tau protein|tau protein
558792|NCT00800709|PET|pet
558793|NCT00800709|Memantine|memantine
558794|NCT00800696|antibiotics|antibiotics
558795|NCT00800696|Hospitalization|hospitalization
558796|NCT00800696|oral care|oral care
558797|NCT00800670|tuberculosis|tuberculosis
558798|NCT00800670|vaccine|vaccine
558799|NCT00800670|adenovirus|adenovirus
558800|NCT00800657|Cardiac Resynchronization|cardiac resynchronization
558801|NCT00800657|Dilated Cardiomyopathy|dilated cardiomyopathy
558802|NCT00800657|Stem Cells Therapy|stem cells therapy
558803|NCT00800657|Heart Failure|heart failure
558804|NCT00800657|Stem Cells/Cardiac Pacing, Artificial|stem cells/cardiac pacing, artificial
558805|NCT00800644|Cervical Cancer|cervical cancer
558806|NCT00800644|Endometrial Cancer|endometrial cancer
558807|NCT00800644|Vaginal Cancer|vaginal cancer
558808|NCT00800644|Cervix|cervix
558809|NCT00800644|Endometrial|endometrial
558810|NCT00800644|X-ray|x-ray
558811|NCT00800644|Computed tomography|computed tomography
558812|NCT00800644|Magnetic resonance imaging|magnetic resonance imaging
558813|NCT00800644|Vagina|vagina
558814|NCT00800644|Pelvic radiation therapy|pelvic radiation therapy
558815|NCT00800644|Bone density|bone density
558816|NCT00800644|Bone mineral density test|bone mineral density test
558817|NCT00800644|Pelvic fractures|pelvic fractures
558818|NCT00800644|Gynecologic Oncology|gynecologic oncology
558819|NCT00800644|Bone turnover|bone turnover
558820|NCT00800592|Sildenafil, Revatio, PAH, IV, Bolus|sildenafil, revatio, pah, iv, bolus
558821|NCT00800579|cystic fibrosis|cystic fibrosis
558822|NCT00800579|CF|cf
558823|NCT00800579|mucociliary clearance|mucociliary clearance
558824|NCT00800579|amiloride|amiloride
558825|NCT00800579|ENaC|enac
558826|NCT00800579|ENaC Inhibitor|enac inhibitor
558827|NCT00800579|airway hydration|airway hydration
558828|NCT00800579|epithelial sodium channel inhibitor|epithelial sodium channel inhibitor
558829|NCT00800566|Clofarabine|clofarabine
558830|NCT00800566|Leukemia|leukemia
558831|NCT00800566|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
558832|NCT00800553|sleep deprivation|sleep deprivation
558833|NCT00800553|fMRI|fmri
558834|NCT00800553|double blind crossover study|double blind crossover study
558835|NCT00800540|glaucoma|glaucoma
558836|NCT00800540|ocular perfusion pressure|ocular perfusion pressure
558837|NCT00800540|ocular blood flow|ocular blood flow
558838|NCT00800540|open angle glaucoma requiring more than one IOP-lowering medication|open angle glaucoma requiring more than one iop-lowering medication
558839|NCT00800527|sternotomy|sternotomy
558840|NCT00800527|pain|pain
558841|NCT00800527|paresthesia|paresthesia
558842|NCT00800527|Poststernotomy chest pain|poststernotomy chest pain
558843|NCT00800527|Poststernotomy chest paresthesia|poststernotomy chest paresthesia
558844|NCT00800514|perception of time, traumatic brain injury, amantadine|perception of time, traumatic brain injury, amantadine
558845|NCT00800501|ALS|als
558846|NCT00800501|VEGF165|vegf165
558847|NCT00800501|Safety|safety
558848|NCT00800501|Intracerebroventricular|intracerebroventricular
558849|NCT00800501|Infusion|infusion
558850|NCT00800501|Implantable|implantable
558851|NCT00800488|Fever|fever
558852|NCT00800488|Infant|infant
558853|NCT00800488|Procalcitonin|procalcitonin
558854|NCT00800488|Serious Bacterial Infection|serious bacterial infection
558855|NCT00800475|bioavailability|bioavailability
558856|NCT00800475|Gemfibrozil|gemfibrozil
558857|NCT00800449|Haptoglobin|haptoglobin
558858|NCT00800449|sepsis|sepsis
558859|NCT00800449|premature babies|premature babies
558860|NCT00800423|corneal edema|corneal edema
558861|NCT00800423|postoperative corneal edema|postoperative corneal edema
558862|NCT00800423|central corneal thickness|central corneal thickness
558863|NCT00800423|visual acuity|visual acuity
558864|NCT00800423|postoperative|postoperative
558865|NCT00800423|brimonidine|brimonidine
558866|NCT00800423|timolol|timolol
558867|NCT00800423|cataract surgery|cataract surgery
558868|NCT00800410|Randomized Controlled Trial|randomized controlled trial
558869|NCT00800371|JIA|jia
558870|NCT00800358|Secondary hyperparathyroidism|secondary hyperparathyroidism
558871|NCT00800358|End stage renal disease|end stage renal disease
558872|NCT00800358|Haemodialysis|haemodialysis
558873|NCT00800358|Peritoneal dialysis|peritoneal dialysis
558874|NCT00800358|Paricalcitol (Zemplar)|paricalcitol (zemplar)
558875|NCT00800358|Calcitriol|calcitriol
558876|NCT00800345|Gynecologic tumors|gynecologic tumors
558877|NCT00800332|Rhinoconjunctivitis due to house dust mite allergy|rhinoconjunctivitis due to house dust mite allergy
558878|NCT00800319|Alcohol dependence|alcohol dependence
558879|NCT00800319|Opioid antagonist|opioid antagonist
558881|NCT00800306|sepsis|sepsis
558882|NCT00800306|septic shock|septic shock
558885|NCT00800306|dobutamine|dobutamine
558886|NCT00800306|inotropes|inotropes
558887|NCT00800306|inhaled nitric oxide|inhaled nitric oxide
558888|NCT00800293|bioequivalence|bioequivalence
558889|NCT00800293|betamethasone dipropionate|betamethasone dipropionate
558890|NCT00800293|Bioequivalency|bioequivalency
558891|NCT00800280|cimetidine, PD 0332334, organic cation transporter, OCT2, pharmacokinetics|cimetidine, pd 0332334, organic cation transporter, oct2, pharmacokinetics
558892|NCT00800267|glaucoma|glaucoma
558893|NCT00800267|ocular hypertension|ocular hypertension
558894|NCT00800267|Fixed combination latanoprost-timolol|fixed combination latanoprost-timolol
558895|NCT00800267|latanoprost|latanoprost
558896|NCT00800267|timolol|timolol
558897|NCT00800254|electrical stimulation|electrical stimulation
558898|NCT00800254|total knee arthroplasty|total knee arthroplasty
558899|NCT00800254|quadriceps|quadriceps
558900|NCT00800254|muscle|muscle
558901|NCT00800254|arthroscopy|arthroscopy
558902|NCT00800241|Asthma|asthma
558903|NCT00800241|Symbicort SMART|symbicort smart
558904|NCT00800241|Thai patient eligibility|thai patient eligibility
558905|NCT00800241|Persistent asthma|persistent asthma
558906|NCT00800228|salt|salt
558907|NCT00800228|blood pressure|blood pressure
558908|NCT00800228|breathing|breathing
558909|NCT00800215|Epilepsy|epilepsy
558910|NCT00800150|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
558911|NCT00800150|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
558912|NCT00800150|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
558913|NCT00800150|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
558914|NCT00800150|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
558915|NCT00800150|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
558916|NCT00800150|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
558917|NCT00800150|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
558918|NCT00800150|secondary acute myeloid leukemia|secondary acute myeloid leukemia
558919|NCT00800150|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
558920|NCT00800150|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
558921|NCT00800150|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
558922|NCT00800150|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
558923|NCT00800150|anaplastic large cell lymphoma|anaplastic large cell lymphoma
558924|NCT00800150|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
558925|NCT00800150|splenic marginal zone lymphoma|splenic marginal zone lymphoma
558926|NCT00800150|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
558927|NCT00800150|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
558928|NCT00800150|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
558929|NCT00800150|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
558930|NCT00800150|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
558931|NCT00800150|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
558932|NCT00800150|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
558933|NCT00800150|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
558934|NCT00800150|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
558935|NCT00800150|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
558936|NCT00800150|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
558937|NCT00800150|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
558938|NCT00800150|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
558939|NCT00800150|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
558940|NCT00800150|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
558941|NCT00800150|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
558942|NCT00800150|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
558943|NCT00800150|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
558944|NCT00800150|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
558945|NCT00800150|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
558946|NCT00800150|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
558947|NCT00800150|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
558948|NCT00800150|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
558949|NCT00800150|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
558950|NCT00800150|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
558951|NCT00800150|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
558952|NCT00800150|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
558953|NCT00800150|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
558954|NCT00800150|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
559040|NCT00799903|CV risk|cv risk
558955|NCT00800150|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
558956|NCT00800150|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
558957|NCT00800150|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
558958|NCT00800150|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
558959|NCT00800150|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
558960|NCT00800150|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
558961|NCT00800150|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
558962|NCT00800150|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
558963|NCT00800150|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
558964|NCT00800150|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
558965|NCT00800150|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
558966|NCT00800150|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
558967|NCT00800150|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
558968|NCT00800150|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
558969|NCT00800150|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
558970|NCT00800150|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
558971|NCT00800150|intraocular lymphoma|intraocular lymphoma
558972|NCT00800150|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
558973|NCT00800150|primary myelofibrosis|primary myelofibrosis
558974|NCT00800150|stage II multiple myeloma|stage ii multiple myeloma
558975|NCT00800150|stage III multiple myeloma|stage iii multiple myeloma
558976|NCT00800150|refractory multiple myeloma|refractory multiple myeloma
558977|NCT00800150|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
558978|NCT00800150|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
558979|NCT00800150|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
558980|NCT00800150|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
558981|NCT00800150|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
558982|NCT00800150|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
558983|NCT00800137|coumadin|coumadin
558984|NCT00800137|device surgery|device surgery
558985|NCT00800137|pocket hematoma|pocket hematoma
558986|NCT00800137|Pocket hematoma and device surgery|pocket hematoma and device surgery
558987|NCT00800124|hip fracture|hip fracture
558988|NCT00800124|hemiprosthesis|hemiprosthesis
558989|NCT00800124|bone cement|bone cement
558990|NCT00800124|clinical outcome|clinical outcome
558991|NCT00800111|failed penetrating keratoplasty|failed penetrating keratoplasty
558992|NCT00800085|first degree relatives of type 1 diabetes patients|first degree relatives of type 1 diabetes patients
558993|NCT00800085|hyperglycemic clamp test|hyperglycemic clamp test
558994|NCT00800072|to verify accurrancy of data collected by the NOWOX|to verify accurrancy of data collected by the nowox
558995|NCT00800059|Relapse|relapse
558996|NCT00800059|Refractory|refractory
558997|NCT00800046|Mitral valve|mitral valve
558998|NCT00800046|Mitral regurgitation|mitral regurgitation
558999|NCT00800046|Functional mitral regurgitation|functional mitral regurgitation
559001|NCT00800046|FMR|fmr
559002|NCT00800046|Heart valve|heart valve
559003|NCT00800046|Mitral valve insufficiency|mitral valve insufficiency
559004|NCT00800046|Valve repair|valve repair
559005|NCT00800046|Valve disorder|valve disorder
559006|NCT00800046|Cardiac surgery|cardiac surgery
559007|NCT00800033|metabolic syndrome|metabolic syndrome
559008|NCT00800033|lipids|lipids
559009|NCT00800033|blood pressure|blood pressure
559010|NCT00800033|body composition|body composition
559011|NCT00800007|Hepatitis C, HCV, ANZ-521, Listeria|hepatitis c, hcv, anz-521, listeria
559012|NCT00799994|glaucoma|glaucoma
559013|NCT00799994|intraocular pressure|intraocular pressure
559014|NCT00799994|multifocal visually evoked potentials|multifocal visually evoked potentials
559015|NCT00799968|Thrombolytic therapy|thrombolytic therapy
559016|NCT00799968|Urokinase|urokinase
559017|NCT00799968|Efficacy|efficacy
559018|NCT00799968|Safety|safety
559019|NCT00799955|Cesarean delivery|cesarean delivery
559020|NCT00799955|post-operative analgesia|post-operative analgesia
559021|NCT00799955|TAP block|tap block
559022|NCT00799955|ultrasound|ultrasound
559023|NCT00799942|Nystagmus, congenital idiopathic|nystagmus, congenital idiopathic
559024|NCT00799929|IVF Research Study|ivf research study
559025|NCT00799929|Infertility Sudy|infertility sudy
559026|NCT00799929|in vitro fertilization|in vitro fertilization
559027|NCT00799929|Mini IVF|mini ivf
559028|NCT00799929|Conventional IVF|conventional ivf
559029|NCT00799916|Sepsis|sepsis
559030|NCT00799916|Fluid resuscitation|fluid resuscitation
559031|NCT00799916|Voluven|voluven
559032|NCT00799916|Colloids|colloids
559033|NCT00799916|Saline solution|saline solution
559034|NCT00799916|Crystalloids|crystalloids
559035|NCT00799916|Sublingual microcirculation|sublingual microcirculation
559036|NCT00799903|heart disease|heart disease
559037|NCT00799903|Lp-PLA2 inhibitor|lp-pla2 inhibitor
559038|NCT00799903|cardiovascular disease|cardiovascular disease
559039|NCT00799903|coronary heart disease|coronary heart disease
559041|NCT00799903|Atherosclerosis|atherosclerosis
559042|NCT00799890|primary or secondary chronic-progressive|primary or secondary chronic-progressive
559043|NCT00799890|sunphenon egcg|sunphenon egcg
559044|NCT00799890|brain atrophy|brain atrophy
559045|NCT00799890|T2 lesions|t2 lesions
559046|NCT00799877|Psoriasis|psoriasis
559047|NCT00799877|Moderate Psoriasis|moderate psoriasis
559048|NCT00799877|Severe Psoriasis|severe psoriasis
559049|NCT00799877|Chronic Plaque Psoriasis|chronic plaque psoriasis
559050|NCT00799877|Severe Chronic Plaque Psoriasis|severe chronic plaque psoriasis
559051|NCT00799877|Registry|registry
559052|NCT00799864|HIV Infection|hiv infection
559053|NCT00799864|Antiretroviral|antiretroviral
559054|NCT00799864|HIV-1|hiv-1
559055|NCT00799864|AIDS|aids
559056|NCT00799864|Children|children
559057|NCT00799864|Rilpivirine (TMC278)|rilpivirine (tmc278)
559058|NCT00799864|Pediatric|pediatric
559059|NCT00799851|advanced liver disease|advanced liver disease
559060|NCT00799851|esophageal varices|esophageal varices
559061|NCT00799851|band ligation|band ligation
559062|NCT00799851|cyanoacrylate injection|cyanoacrylate injection
559063|NCT00799825|papillomavirus|papillomavirus
559064|NCT00799825|HPV vaccine|hpv vaccine
559065|NCT00799825|cervical cancer|cervical cancer
559066|NCT00799825|HPV|hpv
559067|NCT00799825|human papillomavirus|human papillomavirus
559068|NCT00799812|antimicrobial|antimicrobial
559069|NCT00799812|antisepsis|antisepsis
559070|NCT00799799|Nk cells infusion|nk cells infusion
559071|NCT00799799|minimal residual disease in AML patients|minimal residual disease in aml patients
559072|NCT00799799|trafficking of NK cells after infusion|trafficking of nk cells after infusion
559073|NCT00799799|cytolytic effects on leukemic cells|cytolytic effects on leukemic cells
559074|NCT00799773|TTP|ttp
559075|NCT00799773|Rituximab|rituximab
559076|NCT00799773|Plasma Exchange|plasma exchange
559077|NCT00799760|influenza A|influenza a
559078|NCT00799760|neuraminidase inhibitor|neuraminidase inhibitor
559079|NCT00799760|oseltamivir|oseltamivir
559080|NCT00799760|zanamivir|zanamivir
559081|NCT00799760|treatment outcome|treatment outcome
559082|NCT00799760|resistance|resistance
559083|NCT00799760|mutation|mutation
559084|NCT00799760|combination therapy|combination therapy
559085|NCT00799760|monotherapy|monotherapy
559086|NCT00799760|pandemic|pandemic
559087|NCT00799760|primary care|primary care
559088|NCT00799760|randomized controlled trials|randomized controlled trials
559089|NCT00799760|antiviral agent|antiviral agent
559090|NCT00799747|safety|safety
559091|NCT00799747|tolerability|tolerability
559092|NCT00799747|pharmacokinetics|pharmacokinetics
559093|NCT00799747|AZD4017Japanese|azd4017japanese
559094|NCT00799734|hot flushes|hot flushes
559095|NCT00799734|night sweats|night sweats
559096|NCT00799734|menopausal symptoms|menopausal symptoms
559097|NCT00799734|osteoporosis|osteoporosis
559098|NCT00799734|complementary and alternative medicine|complementary and alternative medicine
559099|NCT00799721|ROP|rop
559100|NCT00799721|VLBW|vlbw
559101|NCT00799721|Epo|epo
559102|NCT00799721|IUGR|iugr
559103|NCT00799721|VEGF|vegf
559104|NCT00799721|sFLT-1|sflt-1
559105|NCT00799721|very low birth weight infants|very low birth weight infants
559106|NCT00799721|retinopathy of prematurity|retinopathy of prematurity
559107|NCT00799721|erythropoietin therapy and risk of ROP|erythropoietin therapy and risk of rop
559108|NCT00799708|Biomarkers of estrogen receptor beta activation|biomarkers of estrogen receptor beta activation
559109|NCT00799695|diabetic retinopathy|diabetic retinopathy
559110|NCT00799695|screening|screening
559111|NCT00799695|annual|annual
559112|NCT00799682|Dry Eye|dry eye
559113|NCT00799682|Monotherapy for Ocular Hypertension, Glaucoma|monotherapy for ocular hypertension, glaucoma
559114|NCT00799682|Ocular Hypertension|ocular hypertension
559115|NCT00799682|Chronic Open-Angle Glaucoma|chronic open-angle glaucoma
559116|NCT00799682|Chronic Angle-Closure Glaucoma|chronic angle-closure glaucoma
559117|NCT00799682|Iridotomy|iridotomy
559118|NCT00799682|Iridectomy|iridectomy
559119|NCT00799682|Pseudo Exfoliate|pseudo exfoliate
559120|NCT00799682|Pigmentary Glaucoma|pigmentary glaucoma
559121|NCT00799682|Systemic Non-Glaucoma Medications|systemic non-glaucoma medications
559122|NCT00799682|Hyperemia|hyperemia
559123|NCT00799669|hypopharyngeal cancer|hypopharyngeal cancer
559124|NCT00799669|laryngeal cancer|laryngeal cancer
559125|NCT00799669|lip and oral cavity cancer|lip and oral cavity cancer
559126|NCT00799669|nasopharyngeal cancer|nasopharyngeal cancer
559127|NCT00799669|oropharyngeal cancer|oropharyngeal cancer
559128|NCT00799669|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
559129|NCT00799669|tobacco use disorder|tobacco use disorder
559130|NCT00799656|Diabetic neuropathy|diabetic neuropathy
559131|NCT00799656|painful pain|painful pain
559132|NCT00799656|postoperative|postoperative
559133|NCT00799643|Type 2 Diabetes Mellitus (T2D)|type 2 diabetes mellitus (t2d)
559134|NCT00799643|Inflammation|inflammation
559135|NCT00799643|Obesity|obesity
559136|NCT00799643|Metabolic Syndrome|metabolic syndrome
559137|NCT00799643|Salicylates|salicylates
559138|NCT00799630|energy drink|energy drink
559139|NCT00799630|exercise|exercise
559140|NCT00799630|BCAA|bcaa
559141|NCT00799630|peripheral and central fatigue|peripheral and central fatigue
559142|NCT00799617|Testosterone|testosterone
559143|NCT00799617|Mobility disability|mobility disability
559144|NCT00799617|Decreased libido|decreased libido
559145|NCT00799617|Age associated memory impairment|age associated memory impairment
559146|NCT00799617|Low vitality|low vitality
559147|NCT00799617|Anemia|anemia
559148|NCT00799604|Hypertension|hypertension
559149|NCT00799604|Antihypertensive Agent|antihypertensive agent
559150|NCT00799604|Calcium Channel Blocker|calcium channel blocker
559151|NCT00799591|Registre MONTRAVERS|registre montravers
559152|NCT00799578|NASH, NAFLD,nonalcoholic steatohepatitis|nash, nafld,nonalcoholic steatohepatitis
559153|NCT00799565|Mitral Valve prolapse|mitral valve prolapse
559154|NCT00799565|echography|echography
559155|NCT00799565|genetic study|genetic study
559156|NCT00799565|study case-witness|study case-witness
559157|NCT00799565|Patients with a Mitral Valve Prolapse|patients with a mitral valve prolapse
559158|NCT00799552|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
559159|NCT00799552|Dry eye|dry eye
559160|NCT00799552|Resolvin|resolvin
559161|NCT00799539|Prednisone|prednisone
559162|NCT00799539|Bortezomib|bortezomib
559163|NCT00799539|Melphalan|melphalan
559164|NCT00799526|Ex Vivo Conjunctival Epithelial Cell|ex vivo conjunctival epithelial cell
559165|NCT00799526|Transplantation|transplantation
559166|NCT00799513|Lenalidomide|lenalidomide
559167|NCT00799513|revlimid|revlimid
559168|NCT00799513|large B-cell lymphoma|large b-cell lymphoma
559169|NCT00799513|relapse|relapse
559170|NCT00799487|ADHD|adhd
559171|NCT00799487|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
559172|NCT00799435|Diabetes|diabetes
559173|NCT00799435|Diastolic Heart Failure|diastolic heart failure
559174|NCT00799435|Aortic Stiffness|aortic stiffness
559175|NCT00799435|Exenatide|exenatide
559176|NCT00799422|Conjunctival Staining|conjunctival staining
559177|NCT00799422|lens parameters|lens parameters
559178|NCT00799422|lens fit|lens fit
559179|NCT00799409|ADHD|adhd
559180|NCT00799409|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
559181|NCT00799383|Risperidone|risperidone
559182|NCT00799383|hyperprolactinemia|hyperprolactinemia
559183|NCT00799383|children|children
559184|NCT00799383|adolescents|adolescents
559185|NCT00799383|antipsychotics|antipsychotics
559186|NCT00799383|prevention|prevention
559187|NCT00799383|calcium|calcium
559188|NCT00799383|vitamin D|vitamin d
559189|NCT00799383|Risperidone-induced hyperprolactinemia|risperidone-induced hyperprolactinemia
559190|NCT00799370|Osteotomy|osteotomy
559191|NCT00799370|Weight bearing|weight bearing
559192|NCT00799370|Opening wedge|opening wedge
559193|NCT00799357|ultrasound|ultrasound
559194|NCT00799344|Coronary Stent|coronary stent
559195|NCT00799331|Healthy volunteers|healthy volunteers
559196|NCT00799279|smoking|smoking
559197|NCT00799279|cessation|cessation
559198|NCT00799279|family medicine|family medicine
559199|NCT00799279|evidence-based|evidence-based
559200|NCT00799279|knowledge translation|knowledge translation
559201|NCT00799279|smoking cessation, primary care|smoking cessation, primary care
559202|NCT00799266|Osteoporosis, children and adolescents, zoledronic acid, chronic inflammation, Duchenne muscular dystrophy, glucocorticoids|osteoporosis, children and adolescents, zoledronic acid, chronic inflammation, duchenne muscular dystrophy, glucocorticoids
559203|NCT00799240|lung cancer|lung cancer
559204|NCT00799240|stage IIIb|stage iiib
559205|NCT00799240|pleural effusion|pleural effusion
559206|NCT00799240|stage IV|stage iv
559207|NCT00799240|metastatic lung cancer|metastatic lung cancer
559208|NCT00799240|non squamous lung cancer|non squamous lung cancer
559209|NCT00799240|IGF-1R|igf-1r
559210|NCT00799240|Pemetrexed|pemetrexed
559211|NCT00799240|Cisplatin|cisplatin
559212|NCT00799214|bacterial vaginosis|bacterial vaginosis
559213|NCT00799214|intravaginal|intravaginal
559214|NCT00799214|boric acid|boric acid
559215|NCT00799214|metronidazole|metronidazole
559216|NCT00799214|placebo controlled|placebo controlled
559217|NCT00799214|double-blind|double-blind
559218|NCT00799214|randomized|randomized
559219|NCT00799214|multicenter|multicenter
559220|NCT00799214|non-inferiority|non-inferiority
559221|NCT00799201|Enteral nutrition|enteral nutrition
559222|NCT00799201|Constipation|constipation
559223|NCT00799201|Gastrointestinal motility|gastrointestinal motility
559224|NCT00799201|Naloxone|naloxone
559225|NCT00799201|Docusate|docusate
559226|NCT00799201|Bowel stimulant|bowel stimulant
559227|NCT00799201|Stool softener|stool softener
559228|NCT00799188|Cardiac Transplantation|cardiac transplantation
559229|NCT00799188|Skin cancer|skin cancer
559230|NCT00799188|Everolimus|everolimus
559231|NCT00799175|Postoperative pain|postoperative pain
559232|NCT00799175|Local infiltration analgesia|local infiltration analgesia
559233|NCT00799175|Knee arthroplasty|knee arthroplasty
559234|NCT00799149|Post-operative pain|post-operative pain
559235|NCT00799149|Knee arthroscopy|knee arthroscopy
559236|NCT00799149|Gabapentin|gabapentin
559237|NCT00799149|Etoricoxib|etoricoxib
559339|NCT00798720|non small cell lung cancer|non small cell lung cancer
559238|NCT00799149|Elective ambulatory knee arthroscopy|elective ambulatory knee arthroscopy
559239|NCT00799136|Lymphoma Large B Cell Diffuse|lymphoma large b cell diffuse
559240|NCT00799136|Acquired Immunodeficiency|acquired immunodeficiency
559241|NCT00799123|NT-proBNP|nt-probnp
559242|NCT00799110|dendritic cells|dendritic cells
559243|NCT00799110|fusion vaccines|fusion vaccines
559244|NCT00799110|GM-CSF|gm-csf
559245|NCT00799110|imiquimod|imiquimod
559246|NCT00799084|symptom management|symptom management
559247|NCT00799084|cancer|cancer
559248|NCT00799084|chemotherapy treatment|chemotherapy treatment
559249|NCT00799084|Behavioral Research|behavioral research
559250|NCT00799084|Physiological Effects of Drugs|physiological effects of drugs
559251|NCT00799084|Clinical Trial, Phase II|clinical trial, phase ii
559252|NCT00799071|prophylaxis|prophylaxis
559254|NCT00799071|pharmacokinetics|pharmacokinetics
559255|NCT00799058|HIV-1 infections|hiv-1 infections
559256|NCT00799045|Migraine|migraine
559257|NCT00799045|atrial septal defects|atrial septal defects
559258|NCT00799045|transcatheter|transcatheter
559259|NCT00799045|clopidogrel|clopidogrel
559260|NCT00799032|Coronary Stent|coronary stent
559261|NCT00799019|EPO antibody mediated PRCA|epo antibody mediated prca
559262|NCT00799019|Erythropoiesis stimulating agents|erythropoiesis stimulating agents
559263|NCT00799006|Single Ascending Dose Study in Overweight subjects|single ascending dose study in overweight subjects
559264|NCT00798993|Chronic kidney failure|chronic kidney failure
559265|NCT00798993|25 hydroxyvitamin D|25 hydroxyvitamin d
559266|NCT00798993|falls|falls
559267|NCT00798993|exercise|exercise
559268|NCT00798993|quadriceps strength|quadriceps strength
559269|NCT00798980|Mirena|mirena
559270|NCT00798980|Nulliparous|nulliparous
559271|NCT00798980|Intrauterine Devices|intrauterine devices
559272|NCT00798967|SBS|sbs
559273|NCT00798967|short bowel syndrome|short bowel syndrome
559274|NCT00798967|TPN|tpn
559275|NCT00798967|parenteral nutrition|parenteral nutrition
559276|NCT00798967|PN|pn
559277|NCT00798915|Diabetes|diabetes
559278|NCT00798915|Blood Sugar|blood sugar
559279|NCT00798915|Xenin-25|xenin-25
559280|NCT00798915|GIP|gip
559281|NCT00798915|Insulin|insulin
559282|NCT00798902|DDD|ddd
559283|NCT00798902|Spondylolisthesis|spondylolisthesis
559284|NCT00798902|Spine Fusion|spine fusion
559285|NCT00798902|Lumbar Spine|lumbar spine
559286|NCT00798902|Bone Graft|bone graft
559287|NCT00798889|Solid tumors|solid tumors
559288|NCT00798863|submandibular gland|submandibular gland
559289|NCT00798863|video assisted neck surgery|video assisted neck surgery
559290|NCT00798850|Claudication|claudication
559291|NCT00798850|Vascular claudication|vascular claudication
559292|NCT00798850|Peripheral Vascular Disease|peripheral vascular disease
559293|NCT00798850|Peripheral arterial disease|peripheral arterial disease
559294|NCT00798850|Peripheral arterial occlusive disease|peripheral arterial occlusive disease
559295|NCT00798850|Angioplasty|angioplasty
559296|NCT00798850|Femoral angioplasty|femoral angioplasty
559297|NCT00798850|Superficial femoral artery|superficial femoral artery
559298|NCT00798850|Femoral arterial disease|femoral arterial disease
559299|NCT00798850|Exercise|exercise
559300|NCT00798850|Supervised exercise|supervised exercise
559301|NCT00798850|Exercise therapy|exercise therapy
559302|NCT00798850|Exercise programme|exercise programme
559303|NCT00798850|Infrainuginal|infrainuginal
559304|NCT00798850|Quality of life|quality of life
559305|NCT00798850|SF36|sf36
559306|NCT00798850|Questionnaire|questionnaire
559307|NCT00798850|VascuQol|vascuqol
559308|NCT00798850|Randomised|randomised
559309|NCT00798850|Randomised trial|randomised trial
559310|NCT00798850|Combination therapy|combination therapy
559311|NCT00798850|Intermittent Claudication due to Femoropopliteal Disease|intermittent claudication due to femoropopliteal disease
559312|NCT00798837|prostate|prostate
559313|NCT00798837|cancer|cancer
559314|NCT00798837|IMRT|imrt
559315|NCT00798837|radiation|radiation
559316|NCT00798824|tube feeding|tube feeding
559317|NCT00798824|premature infant|premature infant
559318|NCT00798811|brain tumor|brain tumor
559319|NCT00798811|high-dose chemotherapy|high-dose chemotherapy
559320|NCT00798811|autologous stem cell transplantation|autologous stem cell transplantation
559321|NCT00798811|infant|infant
559322|NCT00798785|diabetes mellitus type 1|diabetes mellitus type 1
559323|NCT00798785|pancreatic beta cell|pancreatic beta cell
559324|NCT00798785|transplantation|transplantation
559325|NCT00798772|HIV infection|hiv infection
559326|NCT00798772|Micronutrients|micronutrients
559327|NCT00798772|Antioxidants|antioxidants
559328|NCT00798759|Open-angle glaucoma|open-angle glaucoma
559329|NCT00798759|Ocular hypertension|ocular hypertension
559330|NCT00798746|Esophageal cancer|esophageal cancer
559331|NCT00798746|pyloric drainage|pyloric drainage
559332|NCT00798746|pyloric drainage procedure|pyloric drainage procedure
559333|NCT00798746|reflux|reflux
559334|NCT00798746|reflux symptoms|reflux symptoms
559335|NCT00798746|esophagectomy|esophagectomy
559336|NCT00798746|Quality of Life|quality of life
559337|NCT00798746|Health-related quality of life|health-related quality of life
559338|NCT00798746|HRQL|hrql
559340|NCT00798720|HDAC|hdac
559341|NCT00798720|proteasome inhibitor|proteasome inhibitor
559342|NCT00798707|Major Depressive Disorder|major depressive disorder
559343|NCT00798694|glaucoma|glaucoma
559344|NCT00798694|impression cytology|impression cytology
559345|NCT00798694|ocular surface changes|ocular surface changes
559346|NCT00798694|prostaglandins|prostaglandins
559347|NCT00798681|parenteral nutrition|parenteral nutrition
559348|NCT00798681|ready-to-use|ready-to-use
559349|NCT00798681|customized nutrition formulation|customized nutrition formulation
559350|NCT00798681|olive oil|olive oil
559351|NCT00798681|soybean oil|soybean oil
559352|NCT00798681|LCT/MCT|lct/mct
559353|NCT00798681|Clinoleic|clinoleic
559354|NCT00798681|oliclinomel|oliclinomel
559355|NCT00798681|number of infections associated with TPN delivery system|number of infections associated with tpn delivery system
559356|NCT00798681|BSI|bsi
559357|NCT00798681|Infection rates|infection rates
559358|NCT00798668|Endocrine and Gastrointestinal Response to Food|endocrine and gastrointestinal response to food
559359|NCT00798655|panitumumab|panitumumab
559360|NCT00798655|cisplatin|cisplatin
559361|NCT00798655|radiation|radiation
559362|NCT00798642|Hypnotherapy|hypnotherapy
559363|NCT00798642|Ulcerative Colitis|ulcerative colitis
559364|NCT00798642|Inflammatory Bowel Disease|inflammatory bowel disease
559365|NCT00798642|Gastrointestinal Diseases|gastrointestinal diseases
559366|NCT00798642|Digestive System Diseases|digestive system diseases
559367|NCT00798642|Intestinal Diseases|intestinal diseases
559368|NCT00798642|Colonic Diseases|colonic diseases
559369|NCT00798629|stage III melanoma|stage iii melanoma
559370|NCT00798629|stage IV melanoma|stage iv melanoma
559371|NCT00798629|recurrent melanoma|recurrent melanoma
559372|NCT00798629|mucosal melanoma|mucosal melanoma
559373|NCT00798616|bronchiolitis|bronchiolitis
559374|NCT00798616|steroids|steroids
559375|NCT00798616|corticosteroids|corticosteroids
559376|NCT00798616|albuterol|albuterol
559377|NCT00798616|child|child
559378|NCT00798616|infant|infant
559379|NCT00798616|pediatric|pediatric
559380|NCT00798603|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
559381|NCT00798603|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
559382|NCT00798603|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
559383|NCT00798603|adenocarcinoma of the lung|adenocarcinoma of the lung
559384|NCT00798603|adenosquamous cell lung cancer|adenosquamous cell lung cancer
559385|NCT00798590|Intensive insulin therapy (IIT)|intensive insulin therapy (iit)
559386|NCT00798590|Insulin infusion|insulin infusion
559387|NCT00798590|Tight glycemic control|tight glycemic control
559388|NCT00798590|Intensive Care Units|intensive care units
559389|NCT00798577|Bacterial Conjunctivitis|bacterial conjunctivitis
559390|NCT00798564|Exercise|exercise
559391|NCT00798564|Mannitol|mannitol
559392|NCT00798538|Buprenorphine|buprenorphine
559393|NCT00798538|HIV|hiv
559394|NCT00798538|Drug Abuse|drug abuse
559395|NCT00798538|Drug Addiction|drug addiction
559396|NCT00798538|Drug Dependence|drug dependence
559397|NCT00798538|Drug Use Disorders|drug use disorders
559398|NCT00798538|Drug Use Disorder|drug use disorder
559399|NCT00798538|Substance Abuse|substance abuse
559400|NCT00798538|Opiate Addiction|opiate addiction
559401|NCT00798538|Substance-related disorders|substance-related disorders
559402|NCT00798525|thrombocytopenia|thrombocytopenia
559403|NCT00798525|Heparin|heparin
559404|NCT00798525|Lepirudin|lepirudin
559405|NCT00798525|Argatroban|argatroban
559406|NCT00798525|critically ill patients|critically ill patients
559407|NCT00798512|carotid artery stenting|carotid artery stenting
559408|NCT00798512|cerebral protection|cerebral protection
559409|NCT00798512|stroke|stroke
559410|NCT00798512|ischemic lesion|ischemic lesion
559411|NCT00798512|DW-MRI|dw-mri
559412|NCT00798499|haemophilia|haemophilia
559413|NCT00798499|patients with haemophilia|patients with haemophilia
559414|NCT00798473|Crohn's disease|crohn's disease
559415|NCT00798473|Osteopenia|osteopenia
559416|NCT00798473|Osteoporosis|osteoporosis
559417|NCT00798473|Bisphosphonates|bisphosphonates
559418|NCT00798473|Zoledronate|zoledronate
559419|NCT00798460|Chronic hepatitis B|chronic hepatitis b
559420|NCT00798460|lamivudine resistance|lamivudine resistance
559421|NCT00798460|clevudine|clevudine
559422|NCT00798447|post OP|post op
559423|NCT00798434|Overactive bladder syndrome|overactive bladder syndrome
559424|NCT00798434|fesoterodine|fesoterodine
559425|NCT00798434|elderly|elderly
559426|NCT00798434|flexible dose regimen|flexible dose regimen
559427|NCT00798434|urgency|urgency
559428|NCT00798434|frequency|frequency
559429|NCT00798434|urge urinary incontinence|urge urinary incontinence
559430|NCT00798434|anticholinergic|anticholinergic
559431|NCT00798434|antimuscarinic|antimuscarinic
559432|NCT00798421|Influenza, transmission|influenza, transmission
559433|NCT00798408|Evaluate the effects of energy-yielding fluids and solids endocrine and metabolic response to food in the elderly|evaluate the effects of energy-yielding fluids and solids endocrine and metabolic response to food in the elderly
559434|NCT00798369|Acute flares|acute flares
559435|NCT00798369|Gout|gout
559436|NCT00798369|Anti-interleukin-1β monoclonal antibody|anti-interleukin-1β monoclonal antibody
559437|NCT00798369|Colchicine|colchicine
559438|NCT00798369|Triamcinolone acetonide|triamcinolone acetonide
559439|NCT00798356|atrial fibrillation, yoga|atrial fibrillation, yoga
559440|NCT00798343|Influenza, heterosubtypic immune responses|influenza, heterosubtypic immune responses
559441|NCT00798330|Cancer|cancer
559442|NCT00798330|Blood stream infections|blood stream infections
559443|NCT00798330|Bacteremia|bacteremia
559444|NCT00798330|Dental procedure|dental procedure
559445|NCT00798330|Central venous catheters|central venous catheters
559446|NCT00798330|Mediport|mediport
559447|NCT00798330|PICC line|picc line
559448|NCT00798304|Meningococcal B vaccine|meningococcal b vaccine
559449|NCT00798304|infants|infants
559450|NCT00798304|safety|safety
559451|NCT00798304|immunogenicity|immunogenicity
559452|NCT00798278|Empyema|empyema
559453|NCT00798278|Urokinase|urokinase
559454|NCT00798278|Thoracoscopic|thoracoscopic
559455|NCT00798278|Childhood|childhood
559456|NCT00798265|HPV Vaccination|hpv vaccination
559457|NCT00798265|HPV Immunogenicity|hpv immunogenicity
559458|NCT00798265|HIV Infection|hiv infection
559459|NCT00798265|HIV Negative|hiv negative
559460|NCT00798265|Adolescents and Young Adults|adolescents and young adults
559461|NCT00798265|Healthy Volunteer|healthy volunteer
559462|NCT00798265|HV|hv
559463|NCT00798265|Adolescent|adolescent
559464|NCT00798252|metastatic, chemotherapy combination|metastatic, chemotherapy combination
559465|NCT00798239|DDD|ddd
559466|NCT00798239|Spondylolisthesis|spondylolisthesis
559467|NCT00798239|Spine Fusion|spine fusion
559468|NCT00798239|Lumbar Spine|lumbar spine
559469|NCT00798239|Bone Graft|bone graft
559470|NCT00798226|Asthma|asthma
559471|NCT00798226|Eczema|eczema
559472|NCT00798226|Sensitization|sensitization
559473|NCT00798226|Allergy|allergy
559474|NCT00798200|Cancer|cancer
559475|NCT00798200|Oncology|oncology
559476|NCT00798200|Rehabilitation|rehabilitation
559477|NCT00798200|Endurance|endurance
559478|NCT00798200|Strength|strength
559479|NCT00798187|Prostate Cancer|prostate cancer
559480|NCT00798187|Breast Cancer|breast cancer
559481|NCT00798187|Behavioral Intervention|behavioral intervention
559482|NCT00798187|Cancer Support Programs|cancer support programs
559483|NCT00798187|Social Comparison|social comparison
559484|NCT00798187|Heterogeneous support group|heterogeneous support group
559485|NCT00798187|Homogeneous support group|homogeneous support group
559486|NCT00798174|DFT|dft
559487|NCT00798174|CHF|chf
559488|NCT00798174|ICD|icd
559489|NCT00798148|Neuroblastoma|neuroblastoma
559490|NCT00798148|MIBG|mibg
559491|NCT00798148|Autologous Peripheral Stem Cell Transplantation|autologous peripheral stem cell transplantation
559492|NCT00798122|sex|sex
559493|NCT00798122|acute coronary syndromes|acute coronary syndromes
559494|NCT00798122|normal angiogram|normal angiogram
559495|NCT00798122|no obstruction at angiography|no obstruction at angiography
559496|NCT00798122|women|women
559497|NCT00798109|Schizophrenia|schizophrenia
559498|NCT00798109|Cannabis misuse comorbidity|cannabis misuse comorbidity
559499|NCT00798109|Motivational interview|motivational interview
559500|NCT00798109|Randomised open trial|randomised open trial
559501|NCT00798096|T Cell Lymphoma|t cell lymphoma
559502|NCT00798096|Lymphoma|lymphoma
559503|NCT00798070|Lymph node positive or high risk lymph node negative breast|lymph node positive or high risk lymph node negative breast
559504|NCT00798070|cancer|cancer
559505|NCT00798057|Pituitary tumor|pituitary tumor
559506|NCT00798057|Outcomes|outcomes
559507|NCT00798057|Proton radiation|proton radiation
559508|NCT00798044|quality improvement|quality improvement
559509|NCT00798044|feedback|feedback
559510|NCT00798044|substance use disorders|substance use disorders
559511|NCT00798031|dental implant|dental implant
559512|NCT00798031|upper jaw|upper jaw
559513|NCT00798031|posterior tooth loss|posterior tooth loss
559514|NCT00798031|short dental implant|short dental implant
559515|NCT00798031|Adults, 18 years of age and older|adults, 18 years of age and older
559516|NCT00798031|Missing a minimum of two posterior teeth in their upper jaw|missing a minimum of two posterior teeth in their upper jaw
559517|NCT00798031|Subjects in need of dental implants|subjects in need of dental implants
559518|NCT00798031|the research study is survival and function of the implants|the research study is survival and function of the implants
559519|NCT00798018|lidocaine|lidocaine
559520|NCT00798018|tetracaine|tetracaine
559521|NCT00798018|tracheal intubation|tracheal intubation
559522|NCT00798018|pharyngitis|pharyngitis
559523|NCT00798005|NV1FGF|nv1fgf
559524|NCT00798005|PAOD|paod
559525|NCT00798005|CLI|cli
559526|NCT00797992|Bevacizumab|bevacizumab
559527|NCT00797992|Myopia|myopia
559528|NCT00797992|Complications|complications
559529|NCT00797992|Neovascularization|neovascularization
559530|NCT00797992|OCT|oct
559531|NCT00797979|Craniotomy|craniotomy
559532|NCT00797979|Skull fixation|skull fixation
559533|NCT00797979|Skull Grip|skull grip
559534|NCT00797979|Reconstructive cranial surgery|reconstructive cranial surgery
559535|NCT00797966|OPC-34712, Major Depressive Disorder, Adjunctive Treatment|opc-34712, major depressive disorder, adjunctive treatment
559536|NCT00797953|Angina Pectoris Treatment|angina pectoris treatment
559537|NCT00797940|GBM|gbm
559538|NCT00797940|Glioblastoma|glioblastoma
559539|NCT00797940|Glioblastoma Multiforme|glioblastoma multiforme
559540|NCT00797940|Brain Tumor|brain tumor
559541|NCT00797940|Brain Cancer|brain cancer
559542|NCT00797940|Glioma|glioma
559543|NCT00797927|schizophrenia|schizophrenia
559544|NCT00797927|quetiapine|quetiapine
559545|NCT00797927|conventional antipsychotics|conventional antipsychotics
559546|NCT00797927|magnetic resonance spectroscopy|magnetic resonance spectroscopy
559547|NCT00797914|Colonoscopy|colonoscopy
559548|NCT00797914|Instrumentation|instrumentation
559549|NCT00797914|Force Monitoring|force monitoring
559550|NCT00797914|Quality Control|quality control
559551|NCT00797914|Training|training
559552|NCT00797888|diabetes|diabetes
559553|NCT00797888|behavioral intervention|behavioral intervention
559554|NCT00797888|HbA1c|hba1c
559555|NCT00797888|health disparities|health disparities
559556|NCT00797875|proprioceptive neuromuscular facilitation stretching technique, total knee arthroplasty, range of motion|proprioceptive neuromuscular facilitation stretching technique, total knee arthroplasty, range of motion
559557|NCT00797862|Aliskiren|aliskiren
559558|NCT00797862|Amlodipine|amlodipine
559559|NCT00797862|Hypertension|hypertension
559560|NCT00797862|SPA1000|spa1000
559561|NCT00797862|Norvasc|norvasc
559562|NCT00797849|phantom limb pain|phantom limb pain
559563|NCT00797849|amputees|amputees
559564|NCT00797849|Farabloc|farabloc
559565|NCT00797849|Phantom limb pain in the missing limb of Veteran amputees|phantom limb pain in the missing limb of veteran amputees
559566|NCT00797836|Occupational Diseases|occupational diseases
559567|NCT00797836|Tuberculosis|tuberculosis
559568|NCT00797836|Tuberculin Test|tuberculin test
559569|NCT00797836|Immunoassay|immunoassay
559570|NCT00797823|diabetes|diabetes
559571|NCT00797823|pancreas|pancreas
559572|NCT00797823|beta cell|beta cell
559573|NCT00797823|glucagon|glucagon
559574|NCT00797823|insulin|insulin
559575|NCT00797823|hypoglycemia|hypoglycemia
559576|NCT00797810|Acute lymphoblastic leukemia of the mature B-cell type|acute lymphoblastic leukemia of the mature b-cell type
559577|NCT00797810|High-grade non-Hodgkin's lymphoma|high-grade non-hodgkin's lymphoma
559578|NCT00797797|fibromyalgia|fibromyalgia
559579|NCT00797797|milnacipran|milnacipran
559580|NCT00797797|pregabalin|pregabalin
559581|NCT00797797|treatment|treatment
559582|NCT00797797|Forest Research Institute|forest research institute
559583|NCT00797771|Insulin delivery|insulin delivery
559584|NCT00797758|Cord blood transplantation|cord blood transplantation
559585|NCT00797758|Conditioning regimen|conditioning regimen
559586|NCT00797758|Acute myeloid leukaemia|acute myeloid leukaemia
559587|NCT00797758|SORROR comorbidity index|sorror comorbidity index
559588|NCT00797758|Quality of life|quality of life
559589|NCT00797758|Innate immunity|innate immunity
559590|NCT00797758|Immune reconstitution post transplant|immune reconstitution post transplant
559591|NCT00797758|Umbilical Cord Blood Stem Cell Transplantation|umbilical cord blood stem cell transplantation
559592|NCT00797758|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
559593|NCT00797745|genotype 1 infection|genotype 1 infection
559594|NCT00797732|acupuncture|acupuncture
559595|NCT00797732|dysphagia|dysphagia
559596|NCT00797732|chemoradiation related effects|chemoradiation related effects
559597|NCT00797732|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
559598|NCT00797732|nasopharyngeal cancer|nasopharyngeal cancer
559599|NCT00797732|oropharynx cancer|oropharynx cancer
559600|NCT00797732|hypopharynx cancer|hypopharynx cancer
559601|NCT00797732|larynx cancer|larynx cancer
559602|NCT00797719|MPM|mpm
559603|NCT00797719|Short hemithoracic IMRT|short hemithoracic imrt
559604|NCT00797693|First trimester|first trimester
559605|NCT00797693|missed abortion|missed abortion
559606|NCT00797693|misoprostol|misoprostol
559607|NCT00797693|cervical ripening|cervical ripening
559608|NCT00797693|oral|oral
559609|NCT00797693|vaginal|vaginal
559610|NCT00797693|first trimester missed abortion|first trimester missed abortion
559611|NCT00797680|Pediatric cardiac arrest|pediatric cardiac arrest
559612|NCT00797654|Sexual Risks for HIV|sexual risks for hiv
559613|NCT00797654|Psychosocial Sequelae Relating to Childhood Sexual Abuse|psychosocial sequelae relating to childhood sexual abuse
559614|NCT00797641|bleeding|bleeding
559615|NCT00797641|ulcer|ulcer
559616|NCT00797641|hemorrhage|hemorrhage
559617|NCT00797641|gastrointestinal diseases|gastrointestinal diseases
559618|NCT00797641|digestive system disease|digestive system disease
559619|NCT00797641|peptic ulcer|peptic ulcer
559620|NCT00797641|proton pump inhibitor|proton pump inhibitor
559621|NCT00797602|Chordomas|chordomas
559622|NCT00797602|Chondrosarcomas|chondrosarcomas
559623|NCT00797602|Cancer|cancer
559624|NCT00797602|Outcomes|outcomes
559625|NCT00797602|Proton radiation|proton radiation
559626|NCT00797589|aorta valve|aorta valve
559627|NCT00797589|mitral valve|mitral valve
559628|NCT00797589|coronary artery bypass grafting surgery|coronary artery bypass grafting surgery
559629|NCT00797589|perfusion|perfusion
559630|NCT00797589|priming|priming
559631|NCT00797576|left atrial appendage thrombi|left atrial appendage thrombi
559831|NCT00796770|HIV-1|hiv-1
559632|NCT00797576|transesophageal echocardiogram|transesophageal echocardiogram
559633|NCT00797576|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
559634|NCT00797576|atrial fibrillation|atrial fibrillation
559635|NCT00797576|cardioversion|cardioversion
559636|NCT00797550|posterolateral spine fusion|posterolateral spine fusion
559637|NCT00797550|bone graft|bone graft
559638|NCT00797537|Inflammation of bone and cartilage|inflammation of bone and cartilage
559639|NCT00797511|Diphtheria|diphtheria
559640|NCT00797511|Tetanus|tetanus
559641|NCT00797511|Pertussis|pertussis
559642|NCT00797511|Poliomyelitis|poliomyelitis
559643|NCT00797498|Nasal Cavity|nasal cavity
559644|NCT00797498|Paranasal Sinuses|paranasal sinuses
559645|NCT00797498|Proton Radiation|proton radiation
559646|NCT00797498|Outcomes|outcomes
559647|NCT00797485|stage IV colon cancer|stage iv colon cancer
559648|NCT00797485|stage IV rectal cancer|stage iv rectal cancer
559649|NCT00797472|Hodgkin's Lymphoma|hodgkin's lymphoma
559650|NCT00797472|R-mabHD|r-mabhd
559651|NCT00797472|ABVD treatment|abvd treatment
559652|NCT00797472|Hodgkin's Disease|hodgkin's disease
559653|NCT00797459|Correction of Nasolabial Folds|correction of nasolabial folds
559654|NCT00797446|Oropharyngeal|oropharyngeal
559655|NCT00797446|cancer|cancer
559656|NCT00797446|proton|proton
559657|NCT00797446|radiation|radiation
559658|NCT00797446|outcomes|outcomes
559659|NCT00797433|testosterone|testosterone
559660|NCT00797433|mechanical ventilation|mechanical ventilation
559661|NCT00797420|fluconazole|fluconazole
559662|NCT00797420|pharmacokinetic|pharmacokinetic
559663|NCT00797420|candidiasis|candidiasis
559664|NCT00797420|sepsis|sepsis
559665|NCT00797420|pediatric|pediatric
559666|NCT00797420|infants|infants
559667|NCT00797420|antifungal|antifungal
559668|NCT00797420|candidemia|candidemia
559669|NCT00797420|fungemia|fungemia
559670|NCT00797420|loading dose|loading dose
559671|NCT00797407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
559672|NCT00797407|Creatine|creatine
559673|NCT00797407|Adverse Effects|adverse effects
559674|NCT00797407|Muscle Toxicity|muscle toxicity
559675|NCT00797394|prostate|prostate
559676|NCT00797394|dietary supplements|dietary supplements
559677|NCT00797394|saw palmetto|saw palmetto
559678|NCT00797394|canada|canada
559679|NCT00797381|MK-0518|mk-0518
559680|NCT00797381|HIV|hiv
559681|NCT00797381|AIDS|aids
559682|NCT00797381|hemophilia|hemophilia
559683|NCT00797381|treatment experienced|treatment experienced
559684|NCT00797368|ankle sprain|ankle sprain
559685|NCT00797368|manual therapy|manual therapy
559686|NCT00797368|exercise|exercise
559687|NCT00797368|physical therapy|physical therapy
559688|NCT00797368|Patients who have sustained an inversion ankle sprain|patients who have sustained an inversion ankle sprain
559689|NCT00797342|rheumatoid arthritis First in human safety pharmacokinetics pharmacodynamics|rheumatoid arthritis first in human safety pharmacokinetics pharmacodynamics
559690|NCT00797329|psychiatric patients with violent behavior|psychiatric patients with violent behavior
559691|NCT00797316|Hypertension|hypertension
559692|NCT00797316|Metabolic Syndrome|metabolic syndrome
559693|NCT00797316|aliskiren|aliskiren
559694|NCT00797316|hydrochlorothiazide|hydrochlorothiazide
559695|NCT00797316|systolic blood pressure|systolic blood pressure
559696|NCT00797316|diastolic blood pressure|diastolic blood pressure
559697|NCT00797316|stage 2|stage 2
559698|NCT00797303|bevacizumab|bevacizumab
559699|NCT00797303|cornea|cornea
559700|NCT00797303|neovascularization|neovascularization
559701|NCT00797290|Nasopharynx Cancer, Proton Radiation, Outcomes|nasopharynx cancer, proton radiation, outcomes
559702|NCT00797277|schizophrenia|schizophrenia
559703|NCT00797277|schizoaffective disorder|schizoaffective disorder
559704|NCT00797277|olanzapine|olanzapine
559705|NCT00797277|haloperidol|haloperidol
559706|NCT00797277|lorazepam|lorazepam
559707|NCT00797277|agitation|agitation
559708|NCT00797264|Ketamine|ketamine
559709|NCT00797264|Morphine|morphine
559710|NCT00797264|PCA|pca
559711|NCT00797264|Hyperalgesia|hyperalgesia
559712|NCT00797264|Nor-ketamine|nor-ketamine
559713|NCT00797251|Colorectal liver metastasis|colorectal liver metastasis
559714|NCT00797251|hepatocellular carcinoma|hepatocellular carcinoma
559715|NCT00797251|liver surgery|liver surgery
559716|NCT00797251|intraoperative ultrasound|intraoperative ultrasound
559717|NCT00797251|finger-compression|finger-compression
559718|NCT00797238|Gene Expression|gene expression
559719|NCT00797238|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
559720|NCT00797238|Chemotherapy|chemotherapy
559721|NCT00797225|bone mineral density|bone mineral density
559722|NCT00797225|Endometriosis|endometriosis
559723|NCT00797225|Pelvic Pain|pelvic pain
559724|NCT00797199|Breast Cancer Risk|breast cancer risk
559725|NCT00797199|Hormone Replacement Therapy|hormone replacement therapy
559726|NCT00797199|Optical Transillumination Spectroscopy|optical transillumination spectroscopy
559727|NCT00797199|Optical Breast Spectroscopy|optical breast spectroscopy
559728|NCT00797199|Transillumination Breast Spectroscopy|transillumination breast spectroscopy
559729|NCT00797186|diabetes|diabetes
559730|NCT00797186|dyslipidemia|dyslipidemia
559731|NCT00797186|microvascular dysfunction|microvascular dysfunction
559732|NCT00797186|imaging|imaging
559733|NCT00797160|propofol|propofol
559734|NCT00797160|midazolam|midazolam
559735|NCT00797160|neonate|neonate
559736|NCT00797160|tracheal intubation|tracheal intubation
559737|NCT00797121|Cholangiocarcinoma|cholangiocarcinoma
559738|NCT00797121|Drainage|drainage
559739|NCT00797095|Adolescence|adolescence
559740|NCT00797095|Obesity|obesity
559741|NCT00797095|Substance use|substance use
559742|NCT00797095|Prevalence|prevalence
559743|NCT00797095|Social and Environmental Contexts|social and environmental contexts
559744|NCT00797095|Survey|survey
559745|NCT00797082|Diabetic|diabetic
559746|NCT00797082|Coronary disease|coronary disease
559747|NCT00797082|Atherosclerosis|atherosclerosis
559748|NCT00797082|Magnetic resonance imaging|magnetic resonance imaging
559749|NCT00797082|Myocardial Perfusion Scintigraphy|myocardial perfusion scintigraphy
559750|NCT00797082|Coronary angiography|coronary angiography
559751|NCT00797056|G-CSF|g-csf
559752|NCT00797056|angiogenesis|angiogenesis
559753|NCT00797056|endothelial progenitor cell|endothelial progenitor cell
559754|NCT00797056|limb ischemia|limb ischemia
559755|NCT00797056|revascularization|revascularization
559756|NCT00797043|Carcinoma of the skin of the head and neck|carcinoma of the skin of the head and neck
559757|NCT00797043|Proton radiation|proton radiation
559758|NCT00797043|Outcomes|outcomes
559759|NCT00797030|dry eye syndromes|dry eye syndromes
559760|NCT00797030|keratoconjuntivitis sicca / drug therapy|keratoconjuntivitis sicca / drug therapy
559761|NCT00797030|cyclosporine|cyclosporine
559762|NCT00797030|ophthalmic solutions|ophthalmic solutions
559763|NCT00797030|HIV seropositivity|hiv seropositivity
559764|NCT00797017|Chronic Pain|chronic pain
559765|NCT00797017|Fentanyl Matrix|fentanyl matrix
559766|NCT00797017|Spinal disorder-related pain|spinal disorder-related pain
559767|NCT00797004|olfactory dysfunction|olfactory dysfunction
559768|NCT00796991|Untreated Advanced Melanoma|untreated advanced melanoma
559769|NCT00796978|stage I breast cancer|stage i breast cancer
559770|NCT00796978|stage II breast cancer|stage ii breast cancer
559771|NCT00796978|stage IIIA breast cancer|stage iiia breast cancer
559772|NCT00796978|stage IIIB breast cancer|stage iiib breast cancer
559773|NCT00796978|stage IIIC breast cancer|stage iiic breast cancer
559774|NCT00796978|HER2-positive breast cancer|her2-positive breast cancer
559775|NCT00796965|Phase 1|phase 1
559776|NCT00796952|Head/ neck cancer|head/ neck cancer
559777|NCT00796952|Swallowing|swallowing
559778|NCT00796952|behavioral treatment|behavioral treatment
559779|NCT00796939|Delayed Sleep Phase Syndrome|delayed sleep phase syndrome
559780|NCT00796939|Sleep|sleep
559781|NCT00796900|Hyperthermia|hyperthermia
559782|NCT00796900|subarachnoidal hemorrhage|subarachnoidal hemorrhage
559783|NCT00796900|placebo controlled|placebo controlled
559784|NCT00796900|double blinded|double blinded
559785|NCT00796900|Dantrolene|dantrolene
559786|NCT00796887|Ischemic Stroke|ischemic stroke
559787|NCT00796887|Recovery of Function|recovery of function
559788|NCT00796887|Extended-release niacin|extended-release niacin
559789|NCT00796874|stage I prostate cancer|stage i prostate cancer
559790|NCT00796874|stage II prostate cancer|stage ii prostate cancer
559791|NCT00796861|malignant ascites|malignant ascites
559792|NCT00796835|Schizophrenia|schizophrenia
559793|NCT00796835|Mood disorders|mood disorders
559794|NCT00796835|Antipsychotic drugs|antipsychotic drugs
559795|NCT00796835|ER OROS Paliperidone|er oros paliperidone
559796|NCT00796822|Endothelial Function|endothelial function
559797|NCT00796822|Inflammation|inflammation
559798|NCT00796809|TNF inhibitors|tnf inhibitors
559799|NCT00796809|Biologic agents|biologic agents
559800|NCT00796809|coccidioidomycosis|coccidioidomycosis
559801|NCT00796809|Rheumatoid arthritis|rheumatoid arthritis
559802|NCT00796796|Non-small cell lung cancer|non-small cell lung cancer
559803|NCT00796796|temsirolimus|temsirolimus
559804|NCT00796796|radiation therapy|radiation therapy
559805|NCT00796783|Cushing's Disease|cushing's disease
559806|NCT00796783|Cushing's Syndrome|cushing's syndrome
559807|NCT00796783|Cushings|cushings
559808|NCT00796783|Pituitary|pituitary
559809|NCT00796783|ACTH|acth
559810|NCT00796783|Adrenocorticotropic hormone|adrenocorticotropic hormone
559811|NCT00796783|Ectopic|ectopic
559812|NCT00796783|Adrenal adenoma|adrenal adenoma
559813|NCT00796783|Adrenal carcinoma|adrenal carcinoma
559814|NCT00796783|Adrenal autonomy|adrenal autonomy
559815|NCT00796783|Cortisol|cortisol
559816|NCT00796783|Hypercortisolemia|hypercortisolemia
559817|NCT00796783|Cushinoid|cushinoid
559818|NCT00796783|Moon facies|moon facies
559819|NCT00796783|Dorsalcervical fat|dorsalcervical fat
559820|NCT00796783|Plethora|plethora
559821|NCT00796783|Hirsutism|hirsutism
559822|NCT00796783|Violaceous striae|violaceous striae
559823|NCT00796783|Hormone|hormone
559824|NCT00796783|Contraceptive|contraceptive
559825|NCT00796783|Endocrine|endocrine
559826|NCT00796783|Cushing Syndrome|cushing syndrome
559827|NCT00796783|Ectopic ACTH Secretion|ectopic acth secretion
559828|NCT00796770|HIV|hiv
559829|NCT00796770|Vaccine|vaccine
559830|NCT00796770|HAART|haart
559832|NCT00796770|AIDS|aids
559833|NCT00796770|Dendritic Cells|dendritic cells
559834|NCT00796770|DALIA|dalia
559835|NCT00796744|Diabetes mellitus|diabetes mellitus
559836|NCT00796744|Diabetic neuropathy|diabetic neuropathy
559837|NCT00796744|Peripheral vascular disease|peripheral vascular disease
559838|NCT00796744|Infection|infection
559839|NCT00796744|Topical application|topical application
559840|NCT00796744|plantar foot ulcers|plantar foot ulcers
559841|NCT00796731|B-cell lymphoma|b-cell lymphoma
559842|NCT00796731|NHL|nhl
559843|NCT00796692|Heparin|heparin
559844|NCT00796692|Low molecular weight heparin|low molecular weight heparin
559845|NCT00796692|Safety|safety
559846|NCT00796692|Efficacy|efficacy
559847|NCT00796692|Cost effective|cost effective
559848|NCT00796679|paricalcitol|paricalcitol
559849|NCT00796679|chronic kidney disease|chronic kidney disease
559850|NCT00796679|cardiac hypertrophy|cardiac hypertrophy
559851|NCT00796666|endothelin receptor antagonist (ETRA)|endothelin receptor antagonist (etra)
559852|NCT00796666|Sitaxsentan|sitaxsentan
559853|NCT00796640|Schizophrenia|schizophrenia
559854|NCT00796640|Mood disorders|mood disorders
559855|NCT00796640|Antipsychotic drugs|antipsychotic drugs
559856|NCT00796640|ER Paliperidone|er paliperidone
559857|NCT00796627|Wound Healing|wound healing
559858|NCT00796627|Burns|burns
559859|NCT00796627|HIF-1|hif-1
559861|NCT00796614|tamsulosin|tamsulosin
559862|NCT00796614|pediatric|pediatric
559863|NCT00796614|neurogenic bladder|neurogenic bladder
559864|NCT00796601|double-blind placebo-controlled maintenance of efficacy|double-blind placebo-controlled maintenance of efficacy
559865|NCT00796588|preconditioning|preconditioning
559866|NCT00796588|remote|remote
559867|NCT00796575|multiple ascending dose healthy volunteers|multiple ascending dose healthy volunteers
559868|NCT00796575|pharmacokinetics|pharmacokinetics
559869|NCT00796575|pharmacodynamics|pharmacodynamics
559870|NCT00796562|Leukemia|leukemia
559871|NCT00796562|Lymphoma|lymphoma
559872|NCT00796562|Hematologic malignancies|hematologic malignancies
559873|NCT00796562|ALL|all
559874|NCT00796562|AML|aml
559875|NCT00796562|MDS|mds
559876|NCT00796562|Transplantation|transplantation
559877|NCT00796562|Mismatched|mismatched
559878|NCT00796562|Haploidentical|haploidentical
559879|NCT00796562|Busulfan|busulfan
559880|NCT00796562|Cyclophosphamide|cyclophosphamide
559881|NCT00796562|Cellcept|cellcept
559882|NCT00796562|Tacrolimus|tacrolimus
559883|NCT00796562|TBI|tbi
559884|NCT00796562|CMMOL|cmmol
559885|NCT00796562|CML|cml
559886|NCT00796562|JMML|jmml
559887|NCT00796536|Acute Pain|acute pain
559888|NCT00796536|Low Back Pain|low back pain
559889|NCT00796536|Back Pain|back pain
559890|NCT00796536|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
559891|NCT00796536|Cognitive Behavioral Therapy|cognitive behavioral therapy
559892|NCT00796536|Pain Education|pain education
559893|NCT00796523|colic|colic
559894|NCT00796523|crying|crying
559895|NCT00796523|clinical trial|clinical trial
559896|NCT00796510|endothelin receptor antagonist (ETRA)|endothelin receptor antagonist (etra)
559897|NCT00796510|sitaxsentan|sitaxsentan
559898|NCT00796497|Obsessive Compulsive Disorder|obsessive compulsive disorder
559899|NCT00796497|5-ht3|5-ht3
559900|NCT00796497|ondansetron|ondansetron
559901|NCT00796484|Cancer|cancer
559902|NCT00796484|Solid Tumors|solid tumors
559903|NCT00796471|Schizophrenia|schizophrenia
559904|NCT00796471|Mood Disorders|mood disorders
559905|NCT00796471|Antipsychotic drugs|antipsychotic drugs
559906|NCT00796471|Paliperidone ER|paliperidone er
559907|NCT00796458|pain|pain
559908|NCT00796458|adenocarcinoma of the prostate|adenocarcinoma of the prostate
559909|NCT00796458|recurrent prostate cancer|recurrent prostate cancer
559910|NCT00796458|stage IV prostate cancer|stage iv prostate cancer
559911|NCT00796458|stage III prostate cancer|stage iii prostate cancer
559912|NCT00796445|DERMA|derma
559913|NCT00796445|Tumor antigen|tumor antigen
559914|NCT00796445|Immunotherapeutic|immunotherapeutic
559915|NCT00796445|Adjuvant cancer therapy|adjuvant cancer therapy
559916|NCT00796445|Melanoma|melanoma
559917|NCT00796445|ASCI|asci
559918|NCT00796432|Schizophrenia|schizophrenia
559919|NCT00796432|mood disorders|mood disorders
559920|NCT00796432|antipsychotic drugs|antipsychotic drugs
559921|NCT00796432|dopamine|dopamine
559922|NCT00796432|receptor occupancy|receptor occupancy
559923|NCT00796432|OROS paliperidone|oros paliperidone
559924|NCT00796419|Acute lung injury (ALI)|acute lung injury (ali)
559925|NCT00796419|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
559926|NCT00796419|Respiratory failure|respiratory failure
559927|NCT00796367|Obesity|obesity
559928|NCT00796354|Constipation|constipation
559929|NCT00796354|Irritable Bowel Syndrome|irritable bowel syndrome
559930|NCT00796341|invitro-fertilization ,embryo transfer,endometrial injury|invitro-fertilization ,embryo transfer,endometrial injury
559931|NCT00796315|Pharmacokinetic study|pharmacokinetic study
559932|NCT00796302|Conduct Disorder|conduct disorder
559933|NCT00796302|Attention Deficit and Disruptive Behavior Disorders|attention deficit and disruptive behavior disorders
559934|NCT00796289|anovulatory/oligoovulatory infertility|anovulatory/oligoovulatory infertility
559935|NCT00796276|Schizophrenia|schizophrenia
559936|NCT00796276|Mood disorders|mood disorders
559937|NCT00796276|Antipsychotics|antipsychotics
559938|NCT00796276|Pharmacokinetics|pharmacokinetics
559939|NCT00796276|Enantiomer|enantiomer
559940|NCT00796276|IR OROS Paliperidone|ir oros paliperidone
559941|NCT00796276|ER OROS Paliperidone|er oros paliperidone
559942|NCT00796263|Acute HIV infection|acute hiv infection
559943|NCT00796237|stroke|stroke
559944|NCT00796237|bone|bone
559945|NCT00796237|gait|gait
559946|NCT00796237|muscle|muscle
559947|NCT00796237|vibration|vibration
559948|NCT00796237|motor balance|motor balance
559949|NCT00796224|azithromycin, pharmacokinetics, pediatrics|azithromycin, pharmacokinetics, pediatrics
559950|NCT00796211|Psoriasis|psoriasis
559951|NCT00796211|CRx-197|crx-197
559952|NCT00796211|nortriptyline|nortriptyline
559953|NCT00796211|loratadine|loratadine
559954|NCT00796211|CombinatoRx|combinatorx
559955|NCT00796211|Dermatology|dermatology
559956|NCT00796211|Erythema|erythema
559957|NCT00796211|Pruritus|pruritus
559958|NCT00796198|Glaucoma|glaucoma
559959|NCT00796198|Intraocular pressure|intraocular pressure
559960|NCT00796198|Ocular diastolic perfusion pressure|ocular diastolic perfusion pressure
559961|NCT00796198|Dorzolamide/timolol Fixed combination|dorzolamide/timolol fixed combination
559962|NCT00796198|Heidelberg Retina Flowmeter|heidelberg retina flowmeter
559963|NCT00796185|Schizophrenia|schizophrenia
559964|NCT00796185|Schizoaffective Disorder|schizoaffective disorder
559965|NCT00796185|Mood Disorders|mood disorders
559966|NCT00796185|Antipsychotic drugs|antipsychotic drugs
559967|NCT00796185|Paliperidone ER|paliperidone er
559968|NCT00796172|Hypertension|hypertension
559969|NCT00796172|High Blood Pressure|high blood pressure
559970|NCT00796172|Blood Lipid Management|blood lipid management
559971|NCT00796159|Efficacy; Tolerability; Safety; Essential Hypertension|efficacy; tolerability; safety; essential hypertension
559972|NCT00796133|NES/E2|nes/e2
559973|NCT00796133|transdermal gel delivery|transdermal gel delivery
559974|NCT00796133|contraception|contraception
559975|NCT00796133|ovulation|ovulation
559976|NCT00796133|bleeding patterns|bleeding patterns
559977|NCT00796120|Sarcomas|sarcomas
559978|NCT00796120|Trabectedin|trabectedin
559979|NCT00796120|Doxorubicin|doxorubicin
559980|NCT00796120|Ifosfamide|ifosfamide
559981|NCT00796120|YONDELIS|yondelis
559982|NCT00796081|Schizophrenia|schizophrenia
559983|NCT00796081|Schizoaffective disorder|schizoaffective disorder
559984|NCT00796081|Schizophreniform disorders|schizophreniform disorders
559985|NCT00796081|Mood disorders|mood disorders
559986|NCT00796081|Antipshychotic drugs|antipshychotic drugs
559987|NCT00796081|Pediatrics|pediatrics
559988|NCT00796081|ER OROS Paliperidone, Paliperidone ER|er oros paliperidone, paliperidone er
559989|NCT00796042|Pressure Ulcer|pressure ulcer
559990|NCT00796042|Bed Sores|bed sores
559991|NCT00796042|Bedsore|bedsore
559992|NCT00796042|Decubitus Ulcer|decubitus ulcer
559993|NCT00796042|Pressure Sore|pressure sore
559994|NCT00796042|Best rest|best rest
559995|NCT00796042|mobility|mobility
559996|NCT00796042|pressure management|pressure management
559997|NCT00796029|Schizophrenia|schizophrenia
559998|NCT00796029|Mood disorders|mood disorders
559999|NCT00796029|Antipsychotic drugs: 14C-paliperidone|antipsychotic drugs: 14c-paliperidone
560000|NCT00796003|Myelodysplastic syndrome|myelodysplastic syndrome
560001|NCT00796003|MDS|mds
560002|NCT00796003|Decitabine|decitabine
560003|NCT00796003|JNJ-30979754|jnj-30979754
560004|NCT00795990|Efficacy of early vs late use of ibuprofen for PDA closure|efficacy of early vs late use of ibuprofen for pda closure
560005|NCT00795977|preoperative|preoperative
560006|NCT00795977|intratumor|intratumor
560007|NCT00795977|dendritic cells|dendritic cells
560008|NCT00795977|pancreatic cancer|pancreatic cancer
560009|NCT00795977|OK-432|ok-432
560010|NCT00795964|tidal volume|tidal volume
560011|NCT00795964|predicted body weight|predicted body weight
560012|NCT00795964|lung function|lung function
560013|NCT00795964|respiratory outcome|respiratory outcome
560014|NCT00795964|Respiratory Function Tests|respiratory function tests
560015|NCT00795964|surgery|surgery
560016|NCT00795951|allergic|allergic
560017|NCT00795951|contact dermatitis|contact dermatitis
560018|NCT00795951|contact allergy|contact allergy
560019|NCT00795951|Type IV|type iv
560020|NCT00795951|Children|children
560021|NCT00795951|TRUE TEST|true test
560022|NCT00795925|propiverine|propiverine
560023|NCT00795925|anticholinergics|anticholinergics
560024|NCT00795925|urinary incontinence|urinary incontinence
560025|NCT00795925|overactive bladder|overactive bladder
560026|NCT00795925|children|children
560027|NCT00795925|dose-finding in children aged 5-10 years|dose-finding in children aged 5-10 years
560028|NCT00795912|Systolic heart failure|systolic heart failure
560029|NCT00795912|HMG CoA reductase inhibitors|hmg coa reductase inhibitors
560030|NCT00795912|B-type natriuretic peptide|b-type natriuretic peptide
560031|NCT00795912|Inflammation|inflammation
560032|NCT00795912|Myocardial collagen turnover|myocardial collagen turnover
560033|NCT00795899|Safety and efficacy of experimental treatment|safety and efficacy of experimental treatment
560034|NCT00795886|ALL|all
560035|NCT00795886|Cancer|cancer
560036|NCT00795886|Stem Cell Transplant|stem cell transplant
560037|NCT00795873|Heart failure|heart failure
560038|NCT00795873|cardiac resynchronization therapy|cardiac resynchronization therapy
560039|NCT00795860|Insulin sensitivity|insulin sensitivity
560040|NCT00795860|fat metabolism|fat metabolism
560041|NCT00795860|inflammation|inflammation
560042|NCT00795847|Hypertensive patients with morning hypertension|hypertensive patients with morning hypertension
560043|NCT00795834|polyphenolics|polyphenolics
560044|NCT00795834|flavonols|flavonols
560045|NCT00795834|lipids|lipids
560046|NCT00795834|endothelial function|endothelial function
560047|NCT00795834|vascular risk factors|vascular risk factors
560048|NCT00795808|Polycystic ovary syndrome|polycystic ovary syndrome
560049|NCT00795808|PCOS|pcos
560050|NCT00795808|Anovulation|anovulation
560051|NCT00795808|Infertility|infertility
560052|NCT00795808|Anovulatory polycystic ovary syndrome (PCOS)|anovulatory polycystic ovary syndrome (pcos)
560053|NCT00795795|Chromosomal abnormalities in preimplantation embryos|chromosomal abnormalities in preimplantation embryos
560054|NCT00795782|Papillary thyroid carcinoma|papillary thyroid carcinoma
560055|NCT00795782|Lymph node dissection|lymph node dissection
560056|NCT00795782|Lymph node metastasis|lymph node metastasis
560057|NCT00795782|Prophylactic node dissection|prophylactic node dissection
560058|NCT00795782|Central lymph node metastasis|central lymph node metastasis
560059|NCT00795756|Adults|adults
560060|NCT00795756|Central nervous system prophylaxis|central nervous system prophylaxis
560061|NCT00795756|Minimal residual disease|minimal residual disease
560062|NCT00795743|Central Venous Catheterization|central venous catheterization
560063|NCT00795743|coagulopathy|coagulopathy
560064|NCT00795743|thromboelastography|thromboelastography
560065|NCT00795730|Alzheimer's Disease|alzheimer's disease
560066|NCT00795730|schizophrenia|schizophrenia
560067|NCT00795717|HIV|hiv
560068|NCT00795717|cardiovascular risk|cardiovascular risk
560069|NCT00795717|atherogenic lipid profile|atherogenic lipid profile
560070|NCT00795717|brachial artery reactivity|brachial artery reactivity
560071|NCT00795717|omega three fatty acids|omega three fatty acids
560072|NCT00795704|Herbal Supplement|herbal supplement
560073|NCT00795704|Type 2 Diabetes|type 2 diabetes
560074|NCT00795704|Mulberry|mulberry
560075|NCT00795704|Hemoglobin A1C|hemoglobin a1c
560076|NCT00795691|diabetes|diabetes
560077|NCT00795691|low-carbohydrate diet|low-carbohydrate diet
560078|NCT00795691|weight loss|weight loss
560079|NCT00795691|obesity|obesity
560080|NCT00795691|dietary intervention|dietary intervention
560081|NCT00795678|tumors metastatic to brain|tumors metastatic to brain
560082|NCT00795678|stage IV breast cancer|stage iv breast cancer
560083|NCT00795665|adult anaplastic astrocytoma|adult anaplastic astrocytoma
560084|NCT00795665|adult glioblastoma|adult glioblastoma
560085|NCT00795665|adult gliosarcoma|adult gliosarcoma
560086|NCT00795665|adult giant cell glioblastoma|adult giant cell glioblastoma
560087|NCT00795665|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
560088|NCT00795665|adult mixed glioma|adult mixed glioma
560089|NCT00795665|recurrent adult brain tumor|recurrent adult brain tumor
560090|NCT00795652|Postpartum depression|postpartum depression
560091|NCT00795652|Distance therapy|distance therapy
560092|NCT00795652|depression|depression
560093|NCT00795652|Distance Treatment|distance treatment
560094|NCT00795652|Barriers to care|barriers to care
560095|NCT00795639|Sitaxsentan|sitaxsentan
560096|NCT00795639|endothelin receptor antagonist|endothelin receptor antagonist
560097|NCT00795626|nursing education|nursing education
560098|NCT00795626|cardiovascular risk factors|cardiovascular risk factors
560099|NCT00795626|coronary heart disease|coronary heart disease
560100|NCT00795613|PET|pet
560101|NCT00795574|Hidradenitis Suppurativa|hidradenitis suppurativa
560102|NCT00795561|Hyperemesis gravidarum|hyperemesis gravidarum
560103|NCT00795561|nausea|nausea
560104|NCT00795561|vomiting|vomiting
560105|NCT00795561|pregnancy|pregnancy
560106|NCT00795561|day care|day care
560107|NCT00795561|inpatient management|inpatient management
560108|NCT00795561|Nausea and vomiting of pregnancy|nausea and vomiting of pregnancy
560109|NCT00795548|Myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
560110|NCT00795548|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
560111|NCT00795548|Stem cell transplantation|stem cell transplantation
560112|NCT00795548|5-Azacitidine|5-azacitidine
560113|NCT00795548|Donor lymphocyte infusion|donor lymphocyte infusion
560114|NCT00795548|MDS or AML relapsed after stem cell transplantation|mds or aml relapsed after stem cell transplantation
560115|NCT00795535|Injury|injury
560116|NCT00795496|Atopic dermatitis|atopic dermatitis
560117|NCT00795496|Bronchial hyperreactivity|bronchial hyperreactivity
560118|NCT00795496|Skin prick tests|skin prick tests
560119|NCT00795496|Serum IgE|serum ige
560120|NCT00795496|Mantoux test|mantoux test
560121|NCT00795483|Osteoporosis|osteoporosis
560122|NCT00795483|HIV infection|hiv infection
560123|NCT00795483|Bisphosphonates|bisphosphonates
560124|NCT00795483|Zoledronic acid|zoledronic acid
560514|NCT00793702|CFP-10|cfp-10
560125|NCT00795470|urinary tract infection|urinary tract infection
560126|NCT00795470|critically ill|critically ill
560127|NCT00795470|ICU|icu
560128|NCT00795470|antimicrobial|antimicrobial
560129|NCT00795470|Catheter associated urinary tract infections|catheter associated urinary tract infections
560130|NCT00795457|vaccine|vaccine
560131|NCT00795457|WHO Grade II Astrocytoma|who grade ii astrocytoma
560132|NCT00795457|WHO Grade II Oligo-Astrocytoma|who grade ii oligo-astrocytoma
560133|NCT00795444|HIV-1|hiv-1
560134|NCT00795444|CCR5 coreceptor antagonist (Maraviroc)|ccr5 coreceptor antagonist (maraviroc)
560135|NCT00795444|the cell reservoir of HIV-1|the cell reservoir of hiv-1
560136|NCT00795418|Active immunization|active immunization
560137|NCT00795418|Alzheimer's disease|alzheimer's disease
560138|NCT00795418|Antibody|antibody
560139|NCT00795418|Vaccine|vaccine
560140|NCT00795418|Central Nervous System Diseases|central nervous system diseases
560141|NCT00795418|Neurodegenerative diseases|neurodegenerative diseases
560142|NCT00795405|sporting events|sporting events
560143|NCT00795405|stress|stress
560144|NCT00795405|myocardial ischemia|myocardial ischemia
560145|NCT00795405|ST-segment depression|st-segment depression
560146|NCT00795405|blood pressure|blood pressure
560147|NCT00795392|Psychology|psychology
560148|NCT00795392|Postoperative outcome|postoperative outcome
560149|NCT00795392|Surgical Operation|surgical operation
560150|NCT00795379|Psychotherapy|psychotherapy
560151|NCT00795366|TBI, trauma, brain|tbi, trauma, brain
560152|NCT00795353|plaque psoriasis|plaque psoriasis
560153|NCT00795353|psoriasis|psoriasis
560154|NCT00795353|alefacept|alefacept
560155|NCT00795353|Amevive|amevive
560156|NCT00795340|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
560157|NCT00795340|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
560158|NCT00795340|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
560159|NCT00795314|Opioids|opioids
560160|NCT00795314|General anesthesia|general anesthesia
560161|NCT00795301|tumor|tumor
560162|NCT00795288|subarachnoid hemorrhage|subarachnoid hemorrhage
560163|NCT00795288|vasospasm|vasospasm
560164|NCT00795288|cerebral blood flow|cerebral blood flow
560165|NCT00795288|cerebral metabolism|cerebral metabolism
560166|NCT00795288|autoregulation|autoregulation
560167|NCT00795288|statin|statin
560168|NCT00795288|Vasospasm associated with Subarachnoid hemorrhage|vasospasm associated with subarachnoid hemorrhage
560169|NCT00795275|pre-diabetes|pre-diabetes
560170|NCT00795275|isotopes|isotopes
560171|NCT00795275|insulin secretion|insulin secretion
560172|NCT00795275|insulin action|insulin action
560173|NCT00795275|GLP-1|glp-1
560174|NCT00795275|simple obesity|simple obesity
560175|NCT00795275|impaired fasting glucose|impaired fasting glucose
560176|NCT00795262|brachial artery reactivity|brachial artery reactivity
560177|NCT00795236|melatonin|melatonin
560178|NCT00795210|HIV lipodystrophy|hiv lipodystrophy
560179|NCT00795210|growth hormone|growth hormone
560180|NCT00795210|growth hormone releasing hormone|growth hormone releasing hormone
560181|NCT00795197|Gaucher Disease,|gaucher disease,
560182|NCT00795197|acid B-glucosidase,|acid b-glucosidase,
560183|NCT00795197|gluco cerebrosidase,|gluco cerebrosidase,
560184|NCT00795197|glucosylceramide,|glucosylceramide,
560185|NCT00795184|Barrett's Esophagus|barrett's esophagus
560186|NCT00795184|EsoGastroDuodenoscopy|esogastroduodenoscopy
560187|NCT00795184|Barrett's Carcinoma|barrett's carcinoma
560188|NCT00795184|adenocarcinoma|adenocarcinoma
560189|NCT00795184|Cellvizio|cellvizio
560190|NCT00795184|endomicroscopy|endomicroscopy
560191|NCT00795184|random biopsy|random biopsy
560192|NCT00795145|Linezolid, QTc interval, pharmacokinetics, therapeutic dose, supra-therapeutic dose|linezolid, qtc interval, pharmacokinetics, therapeutic dose, supra-therapeutic dose
560193|NCT00795132|cancer|cancer
560194|NCT00795132|Hematologic Malignancies|hematologic malignancies
560195|NCT00795132|Hematopoietic Cell Transplantation|hematopoietic cell transplantation
560196|NCT00795119|Near Infrared Spectroscopy|near infrared spectroscopy
560197|NCT00795119|Diagnosis|diagnosis
560198|NCT00795119|Children|children
560199|NCT00795106|Capsaicin|capsaicin
560200|NCT00795106|hydrogel|hydrogel
560201|NCT00795106|myofascial pain syndrome|myofascial pain syndrome
560202|NCT00795106|neck pain|neck pain
560203|NCT00795093|GERD|gerd
560204|NCT00795093|PPI|ppi
560205|NCT00795093|partial responders|partial responders
560206|NCT00795080|CVJ malformations|cvj malformations
560207|NCT00795054|Stem cell transplantation|stem cell transplantation
560208|NCT00795054|Financial impact|financial impact
560209|NCT00795041|vitrification|vitrification
560210|NCT00795041|ovarian stimulation|ovarian stimulation
560211|NCT00795041|reproductive medicine|reproductive medicine
560212|NCT00795028|older women|older women
560213|NCT00795028|hip fracture|hip fracture
560214|NCT00795028|exercise intervention|exercise intervention
560215|NCT00795015|postoperative blood glucose control|postoperative blood glucose control
560216|NCT00795015|IV insulin infusion|iv insulin infusion
560217|NCT00794989|breast cancer|breast cancer
560218|NCT00794989|atypical ductal breast hyperplasia|atypical ductal breast hyperplasia
560219|NCT00794989|lobular breast carcinoma in situ|lobular breast carcinoma in situ
560220|NCT00794989|ductal breast carcinoma in situ|ductal breast carcinoma in situ
560221|NCT00794989|breast cancer prevention|breast cancer prevention
560222|NCT00794989|high risk breast cancer|high risk breast cancer
560223|NCT00794950|Bladder Cancer|bladder cancer
560224|NCT00794950|High Risk Non-muscle Invasive Lower Urinary Tract Urothelial Carcinoma|high risk non-muscle invasive lower urinary tract urothelial carcinoma
560225|NCT00794924|probiotics|probiotics
560226|NCT00794924|elderly|elderly
560227|NCT00794924|motility|motility
560228|NCT00794924|diarrhea|diarrhea
560229|NCT00794911|Liver Transplantation|liver transplantation
560230|NCT00794911|Quality of Life|quality of life
560231|NCT00794911|Chronic HCV|chronic hcv
560232|NCT00794911|Hepatitis C Virus|hepatitis c virus
560233|NCT00794911|Cirrhosis|cirrhosis
560234|NCT00794911|Liver disease|liver disease
560235|NCT00794885|hypertension|hypertension
560236|NCT00794885|stroke|stroke
560237|NCT00794885|cardiovascular events|cardiovascular events
560238|NCT00794885|enalapril|enalapril
560239|NCT00794885|folic acid|folic acid
560240|NCT00794885|randomized controlled trial|randomized controlled trial
560241|NCT00794885|MTHFR C677T genotype|mthfr c677t genotype
560242|NCT00794872|Cardiovascular autonomic neuropathy|cardiovascular autonomic neuropathy
560243|NCT00794872|Chemoreflex sensitivity|chemoreflex sensitivity
560244|NCT00794872|Chronic kidney disease|chronic kidney disease
560245|NCT00794872|Sudden cardiac arrest|sudden cardiac arrest
560246|NCT00794820|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
560247|NCT00794820|CLL|cll
560248|NCT00794820|Leukemia|leukemia
560249|NCT00794820|Fludarabine phosphate|fludarabine phosphate
560250|NCT00794820|Cyclophosphamide|cyclophosphamide
560251|NCT00794820|Rituximab|rituximab
560252|NCT00794820|FCR|fcr
560253|NCT00794820|Cytoxan®|cytoxan®
560254|NCT00794820|Neosar®|neosar®
560255|NCT00794820|Rituxan®|rituxan®
560256|NCT00794807|Alefacept|alefacept
560257|NCT00794807|Skin Diseases|skin diseases
560258|NCT00794807|Psoriasis|psoriasis
560259|NCT00794807|Skin Diseases, Papulosquamos|skin diseases, papulosquamos
560260|NCT00794807|Therapeutic Uses|therapeutic uses
560261|NCT00794807|Dermatologic Agents|dermatologic agents
560262|NCT00794781|Cancer|cancer
560263|NCT00794781|solid tumors|solid tumors
560264|NCT00794755|Vitamin K|vitamin k
560265|NCT00794755|Vitamin K1 (Phytonadione)|vitamin k1 (phytonadione)
560266|NCT00794755|Unstable INR|unstable inr
560267|NCT00794755|VTE or Thrombosis|vte or thrombosis
560268|NCT00794755|Warfarin|warfarin
560269|NCT00794755|Anticoagulation Control|anticoagulation control
560270|NCT00794755|Patients on warfarin with unstable anticoagulation control|patients on warfarin with unstable anticoagulation control
560271|NCT00794742|Burn|burn
560272|NCT00794742|Antimicrobial|antimicrobial
560273|NCT00794742|Bacteria|bacteria
560274|NCT00794742|Resistance|resistance
560275|NCT00794742|Biofilm|biofilm
560276|NCT00794742|Pathogen|pathogen
560277|NCT00794729|Healthy Volunteers|healthy volunteers
560278|NCT00794729|Consents|consents
560279|NCT00794703|Antifungal|antifungal
560280|NCT00794703|micafungin|micafungin
560281|NCT00794703|itraconazole|itraconazole
560282|NCT00794690|cimicifuga racemosa|cimicifuga racemosa
560283|NCT00794690|liver blood flow and functions|liver blood flow and functions
560284|NCT00794677|Hypercholesterolemia|hypercholesterolemia
560285|NCT00794677|Oxysterol|oxysterol
560286|NCT00794677|Ezetimibe|ezetimibe
560287|NCT00794677|Zetia|zetia
560288|NCT00794651|osteoarthritis|osteoarthritis
560289|NCT00794651|testing kit|testing kit
560290|NCT00794651|knee|knee
560291|NCT00794638|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
560292|NCT00794638|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
560293|NCT00794638|Mantle cell Lymphoma|mantle cell lymphoma
560294|NCT00794638|Transformed lymphoma, transformed to diffuse large B-cell lymphoma|transformed lymphoma, transformed to diffuse large b-cell lymphoma
560295|NCT00794638|Follicular Lymphoma|follicular lymphoma
560296|NCT00794625|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
560297|NCT00794625|Aggressive Behavior|aggressive behavior
560298|NCT00794625|Oppositional Defiant Disorder|oppositional defiant disorder
560299|NCT00794625|Conduct Disorder|conduct disorder
560300|NCT00794586|cystic fibrosis|cystic fibrosis
560301|NCT00794586|CF|cf
560302|NCT00794586|inhaled antibiotic|inhaled antibiotic
560303|NCT00794586|antipseudomonal antibiotic|antipseudomonal antibiotic
560304|NCT00794586|tobramycin|tobramycin
560305|NCT00794586|fosfomycin|fosfomycin
560306|NCT00794586|lung infection|lung infection
560307|NCT00794586|pseudomonal infection|pseudomonal infection
560308|NCT00794586|FTI|fti
560309|NCT00794573|Smoking Cessation|smoking cessation
560310|NCT00794573|Cardiac Population|cardiac population
560311|NCT00794573|Acute Coronary Syndrome|acute coronary syndrome
560312|NCT00794573|Varenicline|varenicline
560313|NCT00794573|Champix|champix
560314|NCT00794560|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight
560315|NCT00794560|compliance|compliance
560316|NCT00794560|drug safety|drug safety
560317|NCT00794560|self-administration|self-administration
560318|NCT00794560|ambulatory Care|ambulatory care
560319|NCT00794560|Pharmaceutical Services|pharmaceutical services
560320|NCT00794547|lung cancer; nsclc|lung cancer; nsclc
560321|NCT00794508|Severe Combined Immune Deficiency|severe combined immune deficiency
560322|NCT00794508|Adenosine Deaminase Deficiency|adenosine deaminase deficiency
560323|NCT00794508|Gene Therapy|gene therapy
560324|NCT00794508|Hematopoietic Stem Cells|hematopoietic stem cells
560325|NCT00794508|Retroviral Vector|retroviral vector
560326|NCT00794508|ADA-deficient SCID|ada-deficient scid
560327|NCT00794469|Resting metabolic rate|resting metabolic rate
560328|NCT00794456|Passiflora|passiflora
560329|NCT00794456|Crataegus|crataegus
560330|NCT00794456|Herbal|herbal
560331|NCT00794456|Valeriana|valeriana
560332|NCT00794456|anxiety|anxiety
560333|NCT00794443|ONO-5920|ono-5920
560334|NCT00794443|YM529|ym529
560335|NCT00794443|Bone mineral density|bone mineral density
560336|NCT00794443|Minodronic acid|minodronic acid
560337|NCT00794430|Safety|safety
560338|NCT00794430|Tolerability|tolerability
560339|NCT00794430|Efficacy|efficacy
560340|NCT00794430|Patients|patients
560341|NCT00794430|Diabetic peripheral neuropathic pain.|diabetic peripheral neuropathic pain.
560342|NCT00794417|advanced cancer|advanced cancer
560343|NCT00794417|lung cancer|lung cancer
560344|NCT00794417|NSCLC|nsclc
560345|NCT00794417|Non-small Cell Lung Cancer|non-small cell lung cancer
560346|NCT00794417|aflibercept|aflibercept
560347|NCT00794417|chemotherapy|chemotherapy
560348|NCT00794391|Vulnerable Populations|vulnerable populations
560349|NCT00794391|Injecting drug users|injecting drug users
560350|NCT00794391|IDU|idu
560475|NCT00793910|Gabapentin|gabapentin
560351|NCT00794391|Risky injecting practices|risky injecting practices
560352|NCT00794391|Psychotherapy, brief|psychotherapy, brief
560353|NCT00794391|Motivational interviewing|motivational interviewing
560354|NCT00794391|Educational activities|educational activities
560355|NCT00794391|Clinical trial|clinical trial
560356|NCT00794391|Risk behavior|risk behavior
560357|NCT00794391|risk reduction behavior|risk reduction behavior
560358|NCT00794365|Smoking; smoking cessation; Philippines; Varenicline|smoking; smoking cessation; philippines; varenicline
560359|NCT00794352|Inflammation|inflammation
560360|NCT00794352|Multiple Sclerosis|multiple sclerosis
560361|NCT00794352|Neuroimmunology|neuroimmunology
560362|NCT00794352|Immune Disorder|immune disorder
560363|NCT00794352|Neuroimaging|neuroimaging
560364|NCT00794352|Central Nervous System Disease|central nervous system disease
560365|NCT00794352|Healthy Volunteers|healthy volunteers
560366|NCT00794352|HV|hv
560367|NCT00794339|cervical squamous cell carcinoma|cervical squamous cell carcinoma
560368|NCT00794339|stage IIB cervical cancer|stage iib cervical cancer
560369|NCT00794339|stage III cervical cancer|stage iii cervical cancer
560370|NCT00794339|stage IV cervical cancer|stage iv cervical cancer
560371|NCT00794339|stage IVA cervical cancer|stage iva cervical cancer
560372|NCT00794339|stage IB cervical cancer|stage ib cervical cancer
560373|NCT00794339|stage IIA cervical cancer|stage iia cervical cancer
560374|NCT00794326|Chronic Kidney Failure|chronic kidney failure
560375|NCT00794326|Peritoneal Dialysis|peritoneal dialysis
560376|NCT00794326|Low sodium solution|low sodium solution
560377|NCT00794326|Hypertension|hypertension
560378|NCT00794326|Total Body Water|total body water
560379|NCT00794313|Parkinsons disease|parkinsons disease
560380|NCT00794313|dyskinesia|dyskinesia
560381|NCT00794313|amantadine|amantadine
560382|NCT00794313|efficacy|efficacy
560383|NCT00794300|reproducibility|reproducibility
560384|NCT00794300|contrast agent|contrast agent
560385|NCT00794300|magnetic resonance imaging|magnetic resonance imaging
560386|NCT00794300|infarct size|infarct size
560387|NCT00794300|myocardial salvage index|myocardial salvage index
560388|NCT00794300|myocardial salvage assessment|myocardial salvage assessment
560389|NCT00794274|Sarcodiosis|sarcodiosis
560390|NCT00794274|tumor necrosis factor|tumor necrosis factor
560391|NCT00794261|Myeloma|myeloma
560392|NCT00794261|lymphoma|lymphoma
560393|NCT00794261|high-dose chemotherapy|high-dose chemotherapy
560394|NCT00794261|PSC infusion, autologous|psc infusion, autologous
560395|NCT00794261|neutropenia|neutropenia
560396|NCT00794261|thrombocytopenia|thrombocytopenia
560397|NCT00794261|hospital stay|hospital stay
560398|NCT00794261|infection|infection
560399|NCT00794261|Autologous PSC transplantation for patients with lymphoma or myeloma treated with high-dose chemotherapy|autologous psc transplantation for patients with lymphoma or myeloma treated with high-dose chemotherapy
560400|NCT00794222|Cellular phones|cellular phones
560401|NCT00794222|mental health|mental health
560402|NCT00794222|Early intervention|early intervention
560403|NCT00794222|prevention|prevention
560404|NCT00794222|momentary sampling|momentary sampling
560405|NCT00794222|Adolescent|adolescent
560406|NCT00794209|AeroLEF, fentanyl, liposome encapsulated, opioid|aerolef, fentanyl, liposome encapsulated, opioid
560407|NCT00794196|Medication adherence|medication adherence
560408|NCT00794196|Antidepressive agents|antidepressive agents
560409|NCT00794196|Primary care|primary care
560410|NCT00794196|Pharmaceutical care|pharmaceutical care
560411|NCT00794183|heart failure|heart failure
560412|NCT00794183|CRT|crt
560413|NCT00794183|CHF|chf
560414|NCT00794170|Treatment Compliance|treatment compliance
560415|NCT00794157|COPD|copd
560416|NCT00794157|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
560417|NCT00794157|indacaterol|indacaterol
560418|NCT00794157|long acting β2-agonist|long acting β2-agonist
560419|NCT00794144|Allergic Rhinitis|allergic rhinitis
560420|NCT00794144|Pediatric|pediatric
560421|NCT00794144|PATANASE|patanase
560422|NCT00794131|cancer|cancer
560423|NCT00794131|vaccinia virus|vaccinia virus
560424|NCT00794131|vaccinia|vaccinia
560425|NCT00794131|oncolytic|oncolytic
560426|NCT00794131|oncolytic virus|oncolytic virus
560427|NCT00794131|biological|biological
560428|NCT00794131|imaging|imaging
560429|NCT00794105|Gas|gas
560430|NCT00794105|Middle ear|middle ear
560431|NCT00794079|Healthy volunteers|healthy volunteers
560432|NCT00794079|young adults|young adults
560433|NCT00794079|Aged|aged
560434|NCT00794066|PAD|pad
560435|NCT00794066|Stroke|stroke
560436|NCT00794066|ICH|ich
560437|NCT00794066|prevalence|prevalence
560438|NCT00794053|Sentinel lymph node|sentinel lymph node
560439|NCT00794053|thyroid cancer|thyroid cancer
560440|NCT00794053|neck dissection|neck dissection
560441|NCT00794040|Irritability|irritability
560442|NCT00794040|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
560443|NCT00794040|Explosive|explosive
560444|NCT00794040|Tantrums|tantrums
560445|NCT00794040|Bipolar Mood Disorder|bipolar mood disorder
560446|NCT00794040|Mood Disorder|mood disorder
560447|NCT00794040|Childhood Mood Disorder|childhood mood disorder
560448|NCT00794040|ADHD|adhd
560449|NCT00794027|heart failure|heart failure
560450|NCT00794027|yoga|yoga
560451|NCT00794027|quality of life|quality of life
560452|NCT00794014|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
560453|NCT00794001|myocardial infarction|myocardial infarction
560454|NCT00794001|angioplasty|angioplasty
560455|NCT00794001|data feedback|data feedback
560456|NCT00794001|continuous quality improvement|continuous quality improvement
560457|NCT00794001|STEMI|stemi
560458|NCT00794001|Feedback|feedback
560459|NCT00794001|Quality Assurance, Health Care|quality assurance, health care
560460|NCT00794001|Emergency service hospital|emergency service hospital
560461|NCT00793988|vibration|vibration
560462|NCT00793988|local anaesthesia|local anaesthesia
560463|NCT00793988|ptosis surgery|ptosis surgery
560464|NCT00793988|blepharoplasty|blepharoplasty
560465|NCT00793988|Upper eyelid surgery|upper eyelid surgery
560466|NCT00793988|dermatochalasis +/- blepharoptosis|dermatochalasis +/- blepharoptosis
560467|NCT00793975|Tumors|tumors
560468|NCT00793975|Antibodies, Monoclonal|antibodies, monoclonal
560469|NCT00793962|breast cancer|breast cancer
560470|NCT00793962|mastectomy|mastectomy
560471|NCT00793962|radiotherapy|radiotherapy
560472|NCT00793962|fractionation|fractionation
560473|NCT00793936|Right Double Lumen Tube|right double lumen tube
560474|NCT00793923|Exudative Age Related Macular Degeneration|exudative age related macular degeneration
560476|NCT00793910|PRK|prk
560477|NCT00793910|pain|pain
560478|NCT00793897|Subjects with Advanced or Metastatic Solid Tumors or Neoplasms|subjects with advanced or metastatic solid tumors or neoplasms
560479|NCT00793884|Diabetes|diabetes
560480|NCT00793884|Latino population|latino population
560481|NCT00793871|sunitinib|sunitinib
560482|NCT00793871|Phase IV|phase iv
560483|NCT00793871|gastrointestinal stomal tumor|gastrointestinal stomal tumor
560484|NCT00793871|imatinib resistant or intolerant|imatinib resistant or intolerant
560485|NCT00793871|Chinese|chinese
560486|NCT00793845|tandem high-dose chemotherapy for high-risk neuroblastoma|tandem high-dose chemotherapy for high-risk neuroblastoma
560487|NCT00793832|weight loss|weight loss
560488|NCT00793819|nocturia|nocturia
560489|NCT00793819|BPH|bph
560490|NCT00793819|benign prostate hyperplasia|benign prostate hyperplasia
560491|NCT00793819|nocturia in men with benign prostate hyperplasia|nocturia in men with benign prostate hyperplasia
560492|NCT00793806|chronic kidney disease|chronic kidney disease
560493|NCT00793780|obesity|obesity
560494|NCT00793780|schizophrenia|schizophrenia
560495|NCT00793780|schizoaffective disorder|schizoaffective disorder
560496|NCT00793780|weight loss|weight loss
560497|NCT00793767|Erythropoietin|erythropoietin
560498|NCT00793767|human muscle tissue|human muscle tissue
560499|NCT00793767|insulin sensitivity|insulin sensitivity
560500|NCT00793767|substrate metabolism|substrate metabolism
560501|NCT00793741|Type 1 diabetes|type 1 diabetes
560502|NCT00793741|Hypoglycemia unawareness|hypoglycemia unawareness
560503|NCT00793741|Islet transplant|islet transplant
560504|NCT00793728|Morbid obesity|morbid obesity
560505|NCT00793728|High risk|high risk
560506|NCT00793715|acute pancreatitis|acute pancreatitis
560507|NCT00793715|abdominal compartment syndrome|abdominal compartment syndrome
560508|NCT00793715|decompressive laparotomy|decompressive laparotomy
560509|NCT00793715|percutaneous abdominal puncture|percutaneous abdominal puncture
560510|NCT00793715|Mortality of patients treated in both arms|mortality of patients treated in both arms
560511|NCT00793702|tuberculosis|tuberculosis
560512|NCT00793702|diagnosis|diagnosis
560513|NCT00793702|ESAT-6|esat-6
560515|NCT00793702|skin test|skin test
560516|NCT00793702|Skin test for the diagnosis of tuberculosis infection|skin test for the diagnosis of tuberculosis infection
560517|NCT00793689|parathyroid|parathyroid
560518|NCT00793689|thyroidectomy|thyroidectomy
560519|NCT00793689|hypoparathyroidism|hypoparathyroidism
560520|NCT00793689|Parathyroid function after total thyroidectomy|parathyroid function after total thyroidectomy
560521|NCT00793676|GPCR expression|gpcr expression
560522|NCT00793676|transcriptomic|transcriptomic
560523|NCT00793676|white blood cells|white blood cells
560524|NCT00793676|diagnostic|diagnostic
560525|NCT00793676|Control|control
560526|NCT00793663|Xenon|xenon
560527|NCT00793663|Sevoflurane|sevoflurane
560528|NCT00793663|Postoperative Nausea and vomiting|postoperative nausea and vomiting
560529|NCT00793663|Depth of anaesthesia|depth of anaesthesia
560530|NCT00793650|Cancer|cancer
560531|NCT00793650|Multiple Myeloma|multiple myeloma
560532|NCT00793650|Peripheral Blood Stem Cell Transplant|peripheral blood stem cell transplant
560533|NCT00793637|Angular stable locking system|angular stable locking system
560534|NCT00793637|Handling test|handling test
560535|NCT00793637|Complications|complications
560536|NCT00793611|Overactive Bladder|overactive bladder
560537|NCT00793611|Hypnotherapy|hypnotherapy
560538|NCT00793598|CMX001|cmx001
560539|NCT00793598|Kidney transplant|kidney transplant
560540|NCT00793598|HSCT transplant|hsct transplant
560541|NCT00793598|BK Virus|bk virus
560542|NCT00793598|Post kidney transplant patients with BK virus viruria > 10^4|post kidney transplant patients with bk virus viruria > 10^4
560543|NCT00793598|Post HSCT transplant patients with BK virus viruria > 10^4|post hsct transplant patients with bk virus viruria > 10^4
560544|NCT00793585|IgA nephropathy|iga nephropathy
560545|NCT00793559|septic shock refractory to catecholamines|septic shock refractory to catecholamines
560546|NCT00793546|Bosutinib|bosutinib
560547|NCT00793546|Exemestane|exemestane
560548|NCT00793546|postmenopausal|postmenopausal
560549|NCT00793546|breast cancer|breast cancer
560550|NCT00793520|fibromyalgia|fibromyalgia
560551|NCT00793520|milnacipran|milnacipran
560552|NCT00793520|Forest Laboratories|forest laboratories
560553|NCT00793507|childhood caries|childhood caries
560554|NCT00793494|Irritable bowel syndrome|irritable bowel syndrome
560555|NCT00793494|Children|children
560556|NCT00793494|Pediatrics|pediatrics
560557|NCT00793494|Probiotics|probiotics
560558|NCT00793481|Metabolic Syndrome|metabolic syndrome
560559|NCT00793468|nicotine dependence|nicotine dependence
560560|NCT00793468|smoking|smoking
560561|NCT00793468|pharmacological treatment|pharmacological treatment
560562|NCT00793468|relapse prevention|relapse prevention
560563|NCT00793455|education|education
560564|NCT00793455|preventive service|preventive service
560565|NCT00793455|screening|screening
560566|NCT00793442|sepsis|sepsis
560567|NCT00793442|severe sepsis|severe sepsis
560568|NCT00793442|septic shock|septic shock
560569|NCT00793442|endothelium|endothelium
560570|NCT00793442|microcirculation|microcirculation
560571|NCT00793442|biomarkers|biomarkers
560572|NCT00793429|electrocardiographic safety|electrocardiographic safety
560573|NCT00793429|pharmacokinetics|pharmacokinetics
560574|NCT00793416|Normal Pressure Hydrocephalus|normal pressure hydrocephalus
560575|NCT00793416|Valve Adjustment|valve adjustment
560576|NCT00793416|Blocked Shunt in NPH patients|blocked shunt in nph patients
560577|NCT00793416|Diagnosis of blockage|diagnosis of blockage
560578|NCT00793403|Observational cohort|observational cohort
560579|NCT00793403|prospectives|prospectives
560580|NCT00793403|multicentre|multicentre
560581|NCT00793403|the Italian study RA patient CLARA and PRO-CLARA|the italian study ra patient clara and pro-clara
560582|NCT00793390|aggressive breast cancer|aggressive breast cancer
560583|NCT00793390|Inflammatory Breast Cancer|inflammatory breast cancer
560584|NCT00793390|IBC|ibc
560585|NCT00793364|Cholesterol, stanol-ester, mediterranean diet, cardiac risk|cholesterol, stanol-ester, mediterranean diet, cardiac risk
560586|NCT00793351|reduced intensity stem cell transplantation for neuroblastoma|reduced intensity stem cell transplantation for neuroblastoma
560587|NCT00793351|relapsed neuroblastoma after high-dose chemotherapy and autologous stem cell rescue|relapsed neuroblastoma after high-dose chemotherapy and autologous stem cell rescue
560588|NCT00793338|Heart failure|heart failure
560589|NCT00793338|Sildenafil|sildenafil
560590|NCT00793338|Cardiopulmonary exercise test|cardiopulmonary exercise test
560591|NCT00793338|quality of life|quality of life
560592|NCT00793338|6 minute walk test|6 minute walk test
560593|NCT00793286|inguinal hernia|inguinal hernia
560594|NCT00793286|laparoscopy|laparoscopy
560595|NCT00793286|mesh|mesh
560597|NCT00793234|VTE|vte
560598|NCT00793234|DVT|dvt
560599|NCT00793221|Coronary stent.|coronary stent.
560600|NCT00793221|Restenosis.|restenosis.
560601|NCT00793221|Coronary artery disease.|coronary artery disease.
560602|NCT00793221|Chronic total occlusion.|chronic total occlusion.
560603|NCT00793208|Lung cancer|lung cancer
560604|NCT00793208|non small cell|non small cell
560605|NCT00793208|vaccine|vaccine
560606|NCT00793208|carcinoma|carcinoma
560607|NCT00793208|immunization|immunization
560608|NCT00793208|autologous Tumor|autologous tumor
560609|NCT00793208|vaccination|vaccination
560610|NCT00793195|Neonates|neonates
560611|NCT00793195|Short Bowel Syndrome|short bowel syndrome
560612|NCT00793195|Intestinal Failure|intestinal failure
560613|NCT00793195|Liver Failure|liver failure
560614|NCT00793195|Parenteral Nutrition|parenteral nutrition
560615|NCT00793195|Intralipid|intralipid
560616|NCT00793195|SMOF|smof
560617|NCT00793182|Renal|renal
560618|NCT00793182|Kidney|kidney
560619|NCT00793182|Contrast Induced Nephropathy|contrast induced nephropathy
560620|NCT00793169|squamous cell carcinoma of the head or neck|squamous cell carcinoma of the head or neck
560621|NCT00793156|uremic pruritus|uremic pruritus
560622|NCT00793143|morbid obesity|morbid obesity
560623|NCT00793143|laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
560624|NCT00793143|LSG|lsg
560625|NCT00793143|laparoscopic gastric bypass|laparoscopic gastric bypass
560626|NCT00793143|LGB|lgb
560627|NCT00793143|comorbidities|comorbidities
560628|NCT00793143|diabetes|diabetes
560629|NCT00793143|excessive weight loss|excessive weight loss
560630|NCT00793143|weight loss|weight loss
560631|NCT00793130|Ulcerative|ulcerative
560632|NCT00793130|Colitis|colitis
560633|NCT00793130|Coltect|coltect
560634|NCT00793130|Curcumin|curcumin
560635|NCT00793130|Green tea|green tea
560636|NCT00793130|Selenium|selenium
560637|NCT00793130|inflammation|inflammation
560638|NCT00793130|bowel|bowel
560639|NCT00793117|chronic sinusitis|chronic sinusitis
560640|NCT00793117|FESS|fess
560641|NCT00793117|packing|packing
560642|NCT00793104|allograft|allograft
560643|NCT00793104|knee injury|knee injury
560644|NCT00793104|cartilage injury|cartilage injury
560645|NCT00793104|Osteochondral defects in the articular femoral cartilage|osteochondral defects in the articular femoral cartilage
560646|NCT00793078|sepsis|sepsis
560647|NCT00793078|arterial blood pressure|arterial blood pressure
560648|NCT00793078|complexity|complexity
560649|NCT00793078|variability|variability
560650|NCT00793065|electronic health records|electronic health records
560651|NCT00793065|health information technology|health information technology
560652|NCT00793065|physician incentives|physician incentives
560653|NCT00793065|quality of health care|quality of health care
560654|NCT00793052|trismus|trismus
560655|NCT00793052|Edema|edema
560656|NCT00793052|pain|pain
560657|NCT00793013|Acute Lung Injury|acute lung injury
560658|NCT00793013|Adult Respiratory Distress Syndrome|adult respiratory distress syndrome
560659|NCT00793013|Airway Pressure Release Ventilation|airway pressure release ventilation
560660|NCT00793013|Acute Kidney Injury|acute kidney injury
560661|NCT00793013|Pressure Trial|pressure trial
560662|NCT00793000|Safety tolerability pharmacokinetics PK first in human FIH|safety tolerability pharmacokinetics pk first in human fih
560663|NCT00792974|Cognitive behavioral education|cognitive behavioral education
560664|NCT00792974|COPD (Chronic Obstructive Pulmonary Disease), GOLD II-IV|copd (chronic obstructive pulmonary disease), gold ii-iv
560665|NCT00792961|Prostate cancer|prostate cancer
560666|NCT00792961|Robotic surgery|robotic surgery
560667|NCT00792961|Endomicroscopy|endomicroscopy
560668|NCT00792922|Trachoma|trachoma
560669|NCT00792922|Azithromycin|azithromycin
560670|NCT00792922|Mass treatment|mass treatment
560671|NCT00792909|Pneumococcal vaccine|pneumococcal vaccine
560672|NCT00792909|Pneumococcal disease|pneumococcal disease
560673|NCT00792909|Safety|safety
560674|NCT00792909|Immunogenicity|immunogenicity
560675|NCT00792883|PICU|picu
560676|NCT00792883|BIA|bia
560677|NCT00792883|Phase angle|phase angle
560678|NCT00792883|RQ|rq
560679|NCT00792883|EEM|eem
560680|NCT00792883|Compliance|compliance
560681|NCT00792883|Resistance|resistance
560682|NCT00792883|Curves|curves
560683|NCT00792883|Polymorphisms|polymorphisms
560684|NCT00792883|NF-kappa B|nf-kappa b
560685|NCT00792883|Scores|scores
560686|NCT00792883|PIM 2|pim 2
560687|NCT00792883|PRISM I|prism i
560688|NCT00792870|Obesity|obesity
560689|NCT00792870|Weight loss|weight loss
560690|NCT00792870|Internet|internet
560691|NCT00792857|Parathyroid Diseases|parathyroid diseases
560692|NCT00792857|Renal Insufficiency|renal insufficiency
560693|NCT00792857|Kidney Failure, Chronic|kidney failure, chronic
560694|NCT00792857|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
560695|NCT00792857|Vitamin D|vitamin d
560696|NCT00792857|Hyperparathyroidism|hyperparathyroidism
560697|NCT00792857|Renal Insufficiency, Chronic|renal insufficiency, chronic
560698|NCT00792857|Kidney Diseases|kidney diseases
560699|NCT00792857|Kidney Failure|kidney failure
560700|NCT00792818|Osteoarthritis, Knee, Curcumin, Multicenter, RCT|osteoarthritis, knee, curcumin, multicenter, rct
560701|NCT00792805|COPD|copd
560702|NCT00792805|indacaterol|indacaterol
560703|NCT00792805|long-acting β2-agonist|long-acting β2-agonist
560704|NCT00792805|adults|adults
560705|NCT00792792|tissue transfer|tissue transfer
560706|NCT00792779|Morbid obesity|morbid obesity
560707|NCT00792779|General anaesthesia|general anaesthesia
560708|NCT00792779|Propofol|propofol
560709|NCT00792779|Sevoflurane|sevoflurane
560710|NCT00792766|Tuberous Sclerosis Complex (TSC)|tuberous sclerosis complex (tsc)
560711|NCT00792766|Angiolipoma|angiolipoma
560712|NCT00792766|mTOR|mtor
560713|NCT00792766|Everolimus|everolimus
560714|NCT00792753|Coronary Artery Disease|coronary artery disease
560715|NCT00792727|Pain|pain
560716|NCT00792727|Knee|knee
560717|NCT00792727|Arthritis|arthritis
560718|NCT00792727|Knee pain|knee pain
560719|NCT00792701|stage I non-small cell lung cancer|stage i non-small cell lung cancer
560720|NCT00792688|burn wounds|burn wounds
560721|NCT00792688|wound healing|wound healing
560722|NCT00792675|exercise|exercise
560723|NCT00792675|disease activity|disease activity
560724|NCT00792675|inflammation|inflammation
560725|NCT00792675|resistance training|resistance training
560726|NCT00792675|rehabilitation|rehabilitation
560727|NCT00792662|Diabetes Mellitus|diabetes mellitus
560728|NCT00792662|Alzheimer's Disease|alzheimer's disease
560729|NCT00792662|Apathy|apathy
560730|NCT00792662|Methylphenidate|methylphenidate
560731|NCT00792662|Dementia|dementia
560732|NCT00792636|sumatriptan and naproxen sodium|sumatriptan and naproxen sodium
560733|NCT00792636|migraine with or without aura|migraine with or without aura
560734|NCT00792636|naproxen sodium|naproxen sodium
560735|NCT00792636|sumatriptan|sumatriptan
560736|NCT00792636|blood pressure|blood pressure
560737|NCT00792636|migraine headaches|migraine headaches
560738|NCT00792623|Varicella|varicella
560739|NCT00792623|VarilrixTM|varilrixtm
560740|NCT00792610|youth|youth
560741|NCT00792610|hepatitis B|hepatitis b
560742|NCT00792610|vaccination|vaccination
560743|NCT00792610|booster|booster
560744|NCT00792610|immunity response|immunity response
560745|NCT00792584|etravirine|etravirine
560746|NCT00792584|efavirenz|efavirenz
560747|NCT00792584|anxiety|anxiety
560748|NCT00792584|depression|depression
560749|NCT00792584|sleep quality|sleep quality
560750|NCT00792584|HIV|hiv
560751|NCT00792584|NNRTI|nnrti
560752|NCT00792584|Tritherapy|tritherapy
560753|NCT00792584|compliance|compliance
560754|NCT00792584|stocrin|stocrin
560755|NCT00792584|To replace efavirenz in long-term users with etravirine|to replace efavirenz in long-term users with etravirine
560756|NCT00792584|To investigate effect of such replacement on patient preference, sleep quality, daytime sleepiness, and anxiety|to investigate effect of such replacement on patient preference, sleep quality, daytime sleepiness, and anxiety
560757|NCT00792519|alcohol use|alcohol use
560758|NCT00792519|HIV|hiv
560759|NCT00792519|cognitive behavioral treatment|cognitive behavioral treatment
560760|NCT00792519|Kenya|kenya
560761|NCT00792519|hazardous/binge drinking|hazardous/binge drinking
560762|NCT00792519|alcohol abuse/dependence|alcohol abuse/dependence
560763|NCT00792493|Healthy volunteer study|healthy volunteer study
560764|NCT00792480|Obesity|obesity
560765|NCT00792480|Pregnancy|pregnancy
560766|NCT00792480|Exercise|exercise
560767|NCT00792480|Nutrition|nutrition
560768|NCT00792480|obesity in pregnancy|obesity in pregnancy
560769|NCT00792454|Chronic kidney disease|chronic kidney disease
560770|NCT00792454|End stage renal disease|end stage renal disease
560771|NCT00792454|Exercise|exercise
560772|NCT00792454|Cardiovascular disease|cardiovascular disease
560773|NCT00792441|Specific inspiratory muscle training(SIMT)|specific inspiratory muscle training(simt)
560774|NCT00792441|Loaded deep breathing|loaded deep breathing
560775|NCT00792441|Weaning|weaning
560776|NCT00792441|Mechanical ventilation|mechanical ventilation
560777|NCT00792441|Respiratory muscle|respiratory muscle
560778|NCT00792428|Stroke|stroke
560779|NCT00792428|Ischemia|ischemia
560780|NCT00792428|Infarction|infarction
560781|NCT00792428|Cerebrovascular Disorder|cerebrovascular disorder
560782|NCT00792428|Central Nervous System Diseases|central nervous system diseases
560783|NCT00792428|Brain Infarction|brain infarction
560784|NCT00792428|Brain Ischemia|brain ischemia
560785|NCT00792428|Rehabilitation|rehabilitation
560786|NCT00792428|Recovery|recovery
560787|NCT00792428|Neurorehabilitation|neurorehabilitation
560788|NCT00792428|Plasticity|plasticity
560789|NCT00792415|Abstinence syndrome symptoms|abstinence syndrome symptoms
560790|NCT00792415|Withdrawal symptoms|withdrawal symptoms
560791|NCT00792415|Opioid dependence|opioid dependence
560792|NCT00792402|chronic heart failure|chronic heart failure
560793|NCT00792402|Computerized clinical guidelines|computerized clinical guidelines
560794|NCT00792402|Primary care|primary care
560795|NCT00792389|Gallstones|gallstones
560796|NCT00792389|Gallbladder|gallbladder
560797|NCT00792389|Cholecystectomy|cholecystectomy
560798|NCT00792389|Gallstone disease|gallstone disease
560799|NCT00792376|NSAID|nsaid
560800|NCT00792376|tendon|tendon
560801|NCT00792376|pain|pain
560802|NCT00792376|stiffness|stiffness
560803|NCT00792376|Achilles|achilles
560804|NCT00792363|KRAS|kras
560805|NCT00792350|Carcinoma, Hepatocellular|carcinoma, hepatocellular
560806|NCT00792350|Sorafenib|sorafenib
560807|NCT00792311|Tsui test|tsui test
560808|NCT00792311|Epidural Analgesia|epidural analgesia
560809|NCT00792285|Colon cancer|colon cancer
560810|NCT00792285|Prevention|prevention
560811|NCT00792285|Screening|screening
560812|NCT00792285|Telephone|telephone
560813|NCT00792272|aspirin resistance|aspirin resistance
560814|NCT00792272|aspirin resistance in hemodialysis patients|aspirin resistance in hemodialysis patients
560815|NCT00792246|pharmacokinetics|pharmacokinetics
560816|NCT00792246|pediatric|pediatric
560817|NCT00792246|bioavailability|bioavailability
560818|NCT00792233|Poly JIA|poly jia
560819|NCT00792233|TNF|tnf
560820|NCT00792233|Remission|remission
560821|NCT00792220|stroke|stroke
560822|NCT00792220|mobile stroke unit|mobile stroke unit
560823|NCT00792220|thrombolysis|thrombolysis
560824|NCT00792220|stroke management|stroke management
560825|NCT00792220|computerized tomography|computerized tomography
560826|NCT00792194|Cystic fibrosis|cystic fibrosis
560827|NCT00792194|Exercise training|exercise training
560828|NCT00792194|Home training|home training
560829|NCT00792194|Aerobic capacity|aerobic capacity
560830|NCT00792181|The focus is the pain reduce in the first 15 minutes for patients suffering an acute myocardial infarction, treated by caregivers in Ambulance service.|the focus is the pain reduce in the first 15 minutes for patients suffering an acute myocardial infarction, treated by caregivers in ambulance service.
560831|NCT00792155|PKD|pkd
560832|NCT00792142|neurotoxicity|neurotoxicity
560833|NCT00792142|stage I multiple myeloma|stage i multiple myeloma
560834|NCT00792142|stage II multiple myeloma|stage ii multiple myeloma
560835|NCT00792142|stage III multiple myeloma|stage iii multiple myeloma
560836|NCT00792129|MIS|mis
560837|NCT00792129|Minimally invasive|minimally invasive
560838|NCT00792129|Atavi|atavi
560839|NCT00792129|Flex Posure|flex posure
560840|NCT00792129|retractor|retractor
560841|NCT00792129|Patients with chronic low back and/or leg pain who are candidates for elective lumbar interbody fusion through a posterior unilateral approach,|patients with chronic low back and/or leg pain who are candidates for elective lumbar interbody fusion through a posterior unilateral approach,
560842|NCT00792129|for inclusion in the study.|for inclusion in the study.
560843|NCT00792129|If the patient meets all of the eligibility criteria,|if the patient meets all of the eligibility criteria,
560964|NCT00791622|Cardiovascular|cardiovascular
560965|NCT00791622|Schizoaffective Disorder|schizoaffective disorder
560844|NCT00792129|they will be enrolled into the study and have either the MiLIF or open procedure depending on the surgeon they present to|they will be enrolled into the study and have either the milif or open procedure depending on the surgeon they present to
560845|NCT00792129|(i.e., what group their surgeon agreed to participate in.)|(i.e., what group their surgeon agreed to participate in.)
560846|NCT00792090|allergy|allergy
560847|NCT00792090|cow's milk|cow's milk
560848|NCT00792090|sensibilisation|sensibilisation
560849|NCT00792090|fermented milk|fermented milk
560850|NCT00792090|infant formula|infant formula
560851|NCT00792077|Leukemia|leukemia
560852|NCT00792077|Lenalidomide|lenalidomide
560853|NCT00792077|Actigraph|actigraph
560854|NCT00792077|Sleep Test Study|sleep test study
560855|NCT00792077|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
560856|NCT00792077|CC-5013|cc-5013
560857|NCT00792077|Revlimid|revlimid
560858|NCT00792064|quality of life|quality of life
560859|NCT00792064|adverse effects|adverse effects
560860|NCT00792051|influenza|influenza
560861|NCT00792051|vaccination|vaccination
560862|NCT00792051|children|children
560863|NCT00792051|Influenza-like illness|influenza-like illness
560864|NCT00792038|Psychological tests|psychological tests
560865|NCT00792038|Magnetic Resonance Imaging|magnetic resonance imaging
560866|NCT00792038|Cognitive therapy|cognitive therapy
560867|NCT00792025|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
560868|NCT00792025|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
560869|NCT00792025|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
560870|NCT00792025|stage III bladder cancer|stage iii bladder cancer
560871|NCT00792025|stage IV bladder cancer|stage iv bladder cancer
560872|NCT00792025|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
560873|NCT00792025|recurrent bladder cancer|recurrent bladder cancer
560874|NCT00792012|Glioblastoma Multiforme|glioblastoma multiforme
560875|NCT00791999|Rheumatoid Arthritis|rheumatoid arthritis
560876|NCT00791999|Certolizumab Pegol|certolizumab pegol
560877|NCT00791999|Cimzia|cimzia
560878|NCT00791986|Breathing exercise|breathing exercise
560879|NCT00791986|blood pressure|blood pressure
560880|NCT00791986|hypertension|hypertension
560881|NCT00791960|Cesarean Section|cesarean section
560882|NCT00791960|Dimenhydrinate|dimenhydrinate
560883|NCT00791960|Gravol|gravol
560884|NCT00791960|Antiemetics|antiemetics
560885|NCT00791921|Rheumatoid Arthritis|rheumatoid arthritis
560886|NCT00791921|Certolizumab Pegol|certolizumab pegol
560887|NCT00791921|Cimzia|cimzia
560888|NCT00791869|bupropion|bupropion
560889|NCT00791869|smoking|smoking
560890|NCT00791869|pharmacokinetics|pharmacokinetics
560891|NCT00791869|Pharmacokinetics of bupropion|pharmacokinetics of bupropion
560892|NCT00791843|CHF|chf
560893|NCT00791830|Residual renal function|residual renal function
560894|NCT00791830|Haemodialysis|haemodialysis
560895|NCT00791830|Applanation tonometry|applanation tonometry
560896|NCT00791830|Cardiac output|cardiac output
560897|NCT00791830|Quality of life|quality of life
560898|NCT00791830|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
560899|NCT00791817|pharmacokinetics study|pharmacokinetics study
560900|NCT00791804|Pain|pain
560901|NCT00791804|Post Op pain|post op pain
560902|NCT00791804|Fentanyl|fentanyl
560903|NCT00791804|Pain Control|pain control
560904|NCT00791804|Surgery|surgery
560905|NCT00791791|Anesthesia General|anesthesia general
560906|NCT00791791|Anesthetics Inhalation|anesthetics inhalation
560907|NCT00791791|Stress measurement|stress measurement
560908|NCT00791791|Surgical Stress|surgical stress
560909|NCT00791791|Diagnostic Techniques and Procedures|diagnostic techniques and procedures
560910|NCT00791778|Peritoneal Neoplasma|peritoneal neoplasma
560911|NCT00791765|Scalp|scalp
560912|NCT00791765|Psoriasis|psoriasis
560913|NCT00791765|Plaque Psoriasis|plaque psoriasis
560914|NCT00791765|Skin Diseases|skin diseases
560915|NCT00791765|Moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
560916|NCT00791765|etanercept|etanercept
560917|NCT00791752|Safety and Tolerability|safety and tolerability
560918|NCT00791739|fibromyalgia|fibromyalgia
560919|NCT00791739|trazodone|trazodone
560920|NCT00791739|pregabalin|pregabalin
560921|NCT00791739|Fibromyalgia Impact Questionnaire (FIQ)|fibromyalgia impact questionnaire (fiq)
560922|NCT00791739|Pittsburgh Sleep Quality Inventory (PSQI)|pittsburgh sleep quality inventory (psqi)
560923|NCT00791739|Brief Pain Inventory (BPI)|brief pain inventory (bpi)
560924|NCT00791726|microperimetry|microperimetry
560925|NCT00791726|macular edema|macular edema
560926|NCT00791726|uveitis|uveitis
560927|NCT00791726|Retinal sensitivity as measured with fundus related microperimetry|retinal sensitivity as measured with fundus related microperimetry
560928|NCT00791713|Paliperidone ER|paliperidone er
560929|NCT00791713|Antipsychotic drugs|antipsychotic drugs
560930|NCT00791713|Selective serotonin reuptake inhibitors|selective serotonin reuptake inhibitors
560931|NCT00791713|Mood disorders|mood disorders
560932|NCT00791713|Schizophrenia|schizophrenia
560933|NCT00791700|Open label pharmacokinetic safety and efficacy in HIV-1 infected pediatrics|open label pharmacokinetic safety and efficacy in hiv-1 infected pediatrics
560934|NCT00791687|Antioxidant enzymes|antioxidant enzymes
560935|NCT00791687|Glutathione|glutathione
560936|NCT00791687|Oxidative stress|oxidative stress
560937|NCT00791687|Prematurity|prematurity
560938|NCT00791687|Respiratory distress|respiratory distress
560939|NCT00791687|Non enzymatic antioxidant defense system|non enzymatic antioxidant defense system
560940|NCT00791687|Enzymatic antioxidant defense system|enzymatic antioxidant defense system
560941|NCT00791674|Opiates|opiates
560942|NCT00791674|sleep apnea|sleep apnea
560943|NCT00791674|ventilatory failure|ventilatory failure
560944|NCT00791648|aki|aki
560945|NCT00791648|delirium|delirium
560946|NCT00791648|statin|statin
560947|NCT00791648|short-term|short-term
560948|NCT00791648|cardiac|cardiac
560949|NCT00791635|Cervical Cancer|cervical cancer
560950|NCT00791635|Vaginal Cancer|vaginal cancer
560951|NCT00791635|Endometrial Cancer|endometrial cancer
560952|NCT00791635|Cervix|cervix
560953|NCT00791635|Endometrial|endometrial
560954|NCT00791635|Pelvic Exenteration|pelvic exenteration
560955|NCT00791635|Pelvic Exenteration Surgery|pelvic exenteration surgery
560956|NCT00791635|Questionnaire|questionnaire
560957|NCT00791635|Gynecologic Cancer|gynecologic cancer
560958|NCT00791635|Vagina|vagina
560959|NCT00791635|Vulva|vulva
560960|NCT00791635|Gynecologic Malignancy|gynecologic malignancy
560961|NCT00791622|Paliperidone ER|paliperidone er
560962|NCT00791622|Schizophernia|schizophernia
560963|NCT00791622|Mood Disorders, Antipsychotic drugs|mood disorders, antipsychotic drugs
560967|NCT00791596|Ergonomic intervention|ergonomic intervention
560968|NCT00791596|Musculoskeletal disorders|musculoskeletal disorders
560969|NCT00791596|Low back pain|low back pain
560970|NCT00791596|Posture|posture
560971|NCT00791596|Video display terminal|video display terminal
560972|NCT00791583|Emergency Medicine (EM)|emergency medicine (em)
560973|NCT00791583|Central Venous Catheter (CVC)|central venous catheter (cvc)
560974|NCT00791583|Maximal Barrier Precaution (MBP)|maximal barrier precaution (mbp)
560975|NCT00791583|Precaution Technique during Central Venous Cathether Placement|precaution technique during central venous cathether placement
560976|NCT00791544|monoclonal antibody, anti IGF1R|monoclonal antibody, anti igf1r
560977|NCT00791531|Methotrexate|methotrexate
560978|NCT00791531|Malaria|malaria
560979|NCT00791518|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
560980|NCT00791518|Spirometry|spirometry
560981|NCT00791505|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
560982|NCT00791505|pulmonary infection|pulmonary infection
560983|NCT00791505|antibiotic|antibiotic
560984|NCT00791492|FAP|fap
560985|NCT00791492|Familial Amyloid Polyneuropathy|familial amyloid polyneuropathy
560986|NCT00791492|ATTR-PN|attr-pn
560987|NCT00791492|transthyretin|transthyretin
560988|NCT00791492|TTR|ttr
560989|NCT00791492|amyloid|amyloid
560990|NCT00791492|polyneuropathy|polyneuropathy
560991|NCT00791492|familial|familial
560992|NCT00791492|hereditary|hereditary
560993|NCT00791492|amyloidosis|amyloidosis
560994|NCT00791492|FoldRx|foldrx
560995|NCT00791479|Diabetes, type 2 diabetes|diabetes, type 2 diabetes
560996|NCT00791466|Iodine deficiency|iodine deficiency
560997|NCT00791466|Pregnancy|pregnancy
560998|NCT00791466|Thyroid function|thyroid function
560999|NCT00791466|Infant development|infant development
561000|NCT00791466|Growth|growth
561001|NCT00791453|Diabetic patients at the Clarksdale Diabetes|diabetic patients at the clarksdale diabetes
561002|NCT00791453|and Metabolism Clinic and must be between the|and metabolism clinic and must be between the
561003|NCT00791453|ages of 18 and 64 years of age.|ages of 18 and 64 years of age.
561004|NCT00791440|Schizophrenia|schizophrenia
561005|NCT00791440|Schizoaffective|schizoaffective
561006|NCT00791440|Schizophreniform|schizophreniform
561007|NCT00791440|Psychosis|psychosis
561008|NCT00791440|Psychotic|psychotic
561009|NCT00791440|Hallucinations|hallucinations
561010|NCT00791440|Delusions|delusions
561011|NCT00791440|Paranoia|paranoia
561012|NCT00791440|Paranoid|paranoid
561013|NCT00791440|Voices|voices
561014|NCT00791440|CBT|cbt
561015|NCT00791440|Cognitive Behavior Therapy|cognitive behavior therapy
561016|NCT00791440|Cognitive Therapy|cognitive therapy
561017|NCT00791401|Schizophrenia|schizophrenia
561018|NCT00791401|Mood disorders|mood disorders
561019|NCT00791401|Antipsychotic drugs|antipsychotic drugs
561020|NCT00791401|ER OROS Paliperidone|er oros paliperidone
561021|NCT00791388|Pharmacokinetics|pharmacokinetics
561022|NCT00791375|young adult|young adult
561023|NCT00791375|cancer|cancer
561024|NCT00791375|exercise|exercise
561025|NCT00791375|physical activity|physical activity
561026|NCT00791362|accreditation|accreditation
561027|NCT00791362|cardiovascular disease|cardiovascular disease
561028|NCT00791362|primary care|primary care
561029|NCT00791349|Schizophrenia|schizophrenia
561030|NCT00791349|Schizoaffective Disorder|schizoaffective disorder
561031|NCT00791349|Mood Disorders|mood disorders
561032|NCT00791349|Antipsychotic drugs|antipsychotic drugs
561033|NCT00791349|Cardiovascular|cardiovascular
561034|NCT00791349|Immediate release (IR) Paliperidone|immediate release (ir) paliperidone
561035|NCT00791336|NSCLC|nsclc
561036|NCT00791336|chemotherapy|chemotherapy
561037|NCT00791336|radiation therapy|radiation therapy
561038|NCT00791336|nelfinavir|nelfinavir
561039|NCT00791336|NFV|nfv
561040|NCT00791310|Medical ICU|medical icu
561041|NCT00791310|Severe sepsis|severe sepsis
561042|NCT00791297|CDB-2914|cdb-2914
561043|NCT00791297|Contraceptive Vaginal Rings|contraceptive vaginal rings
561044|NCT00791297|ovulation|ovulation
561045|NCT00791297|endometrial changes|endometrial changes
561046|NCT00791297|bleeding patterns|bleeding patterns
561047|NCT00791297|normal cycling women|normal cycling women
561048|NCT00791297|Inhibition of ovulation, endometrial changes and bleeding patterns in normal cycling women|inhibition of ovulation, endometrial changes and bleeding patterns in normal cycling women
561049|NCT00791284|Schizophrenia|schizophrenia
561050|NCT00791284|Mood disorders|mood disorders
561051|NCT00791284|Antipsychotic drugs|antipsychotic drugs
561052|NCT00791284|intermediate release (IR) Paliperidone|intermediate release (ir) paliperidone
561053|NCT00791271|Melanoma|melanoma
561054|NCT00791271|Malignant melanoma|malignant melanoma
561055|NCT00791271|Unresectable|unresectable
561056|NCT00791271|Decitabine|decitabine
561057|NCT00791271|PEG Interferon Alpha-2b|peg interferon alpha-2b
561058|NCT00791271|PEG Intron|peg intron
561059|NCT00791271|5-Aza-Deoxycytidine|5-aza-deoxycytidine
561060|NCT00791271|Dacogen|dacogen
561061|NCT00791245|ISTO Technologies, Inc|isto technologies, inc
561062|NCT00791245|cartilage repair|cartilage repair
561063|NCT00791245|arthroscopy|arthroscopy
561064|NCT00791245|361 HCT/P|361 hct/p
561065|NCT00791245|human tissue|human tissue
561066|NCT00791245|biologic|biologic
561067|NCT00791245|knee|knee
561068|NCT00791232|Extended-release paliperidone|extended-release paliperidone
561069|NCT00791232|Schizophrenia, Mood disorders, Antipsychotic drugs|schizophrenia, mood disorders, antipsychotic drugs
561070|NCT00791232|ER OROS paliperidone|er oros paliperidone
561071|NCT00791219|Onychomycosis|onychomycosis
561072|NCT00791206|exercise|exercise
561073|NCT00791206|ischemia|ischemia
561074|NCT00791206|MRI|mri
561075|NCT00791206|MRI spectroscopy|mri spectroscopy
561076|NCT00791206|Ischemia preconditioning|ischemia preconditioning
561077|NCT00791193|Paliperidone ER|paliperidone er
561078|NCT00791193|Antipsychotic drugs|antipsychotic drugs
561079|NCT00791193|Schizophrenia|schizophrenia
561080|NCT00791193|Mood disorders|mood disorders
561081|NCT00791180|dynamic stabilization|dynamic stabilization
561082|NCT00791180|Dynesys|dynesys
561083|NCT00791180|fusion success|fusion success
561084|NCT00791180|Immobilization of spinal segments as an adjunct to fusion in the treatment of the following:|immobilization of spinal segments as an adjunct to fusion in the treatment of the following:
561085|NCT00791180|acute and chronic instabilities or deformities of the thoracic, lumbar, and sacral spine|acute and chronic instabilities or deformities of the thoracic, lumbar, and sacral spine
561086|NCT00791180|degenerative spondylolisthesis with objective evidence of neurologic impairment|degenerative spondylolisthesis with objective evidence of neurologic impairment
561087|NCT00791180|failed previous fusion (pseudarthrosis).|failed previous fusion (pseudarthrosis).
561088|NCT00791167|Mood Disorders, Antipsychotic drugs|mood disorders, antipsychotic drugs
561089|NCT00791167|Schizophrenia|schizophrenia
561090|NCT00791167|Paliperidone ER|paliperidone er
561091|NCT00791154|Extensive disease|extensive disease
561092|NCT00791154|Extrathoracic metasasis|extrathoracic metasasis
561093|NCT00791154|Malignant pericardial effusion|malignant pericardial effusion
561094|NCT00791154|Malignant pleural effusion|malignant pleural effusion
561095|NCT00791154|Contralateral hilar adenopathy|contralateral hilar adenopathy
561096|NCT00791141|Head and Neck Cancer|head and neck cancer
561097|NCT00791141|Radiation therapy|radiation therapy
561098|NCT00791141|Chemotherapy|chemotherapy
561099|NCT00791141|Chemoradiotherapy|chemoradiotherapy
561100|NCT00791141|adjuvant cetuximab administration|adjuvant cetuximab administration
561101|NCT00791128|Type 2 Diabetes|type 2 diabetes
561102|NCT00791115|Prostate cancer|prostate cancer
561103|NCT00791115|prostatectomy|prostatectomy
561104|NCT00791115|radiotherapy|radiotherapy
561105|NCT00791115|prostatectomy after radiotherapy|prostatectomy after radiotherapy
561106|NCT00791089|Radiofrequency Ablation|radiofrequency ablation
561107|NCT00791089|atrial fibrillation|atrial fibrillation
561108|NCT00791076|Insulin pump therapy|insulin pump therapy
561109|NCT00791076|Type 1 diabetic|type 1 diabetic
561110|NCT00791076|Chronic pancreatitis|chronic pancreatitis
561111|NCT00791076|Pancreatic resection|pancreatic resection
561112|NCT00791076|Pancreatic polypeptide|pancreatic polypeptide
561113|NCT00791063|cell death|cell death
561114|NCT00791063|Apoptosis|apoptosis
561115|NCT00791063|PET imaging|pet imaging
561116|NCT00791063|brain metastases|brain metastases
561117|NCT00791063|whole brain radiation therapy|whole brain radiation therapy
561118|NCT00791050|Hypothermia/complications/etiology|hypothermia/complications/etiology
561119|NCT00791050|coronary artery bypass/adverse effects|coronary artery bypass/adverse effects
561120|NCT00791024|Analgesia Tests|analgesia tests
561121|NCT00791024|Analog Pain Scale|analog pain scale
561122|NCT00791024|Pain Measurement|pain measurement
561123|NCT00791011|Lymphoma|lymphoma
561124|NCT00791011|AMG 655|amg 655
561125|NCT00791011|Trail receptor|trail receptor
561126|NCT00791011|Apoptosis|apoptosis
561127|NCT00791011|Vorinostat|vorinostat
561128|NCT00791011|Bortezomib|bortezomib
561129|NCT00791011|SAHA|saha
561130|NCT00791011|Velcade|velcade
561131|NCT00790998|onchocerciasis|onchocerciasis
561132|NCT00790998|river blindness|river blindness
561133|NCT00790998|onchocerca volvulus|onchocerca volvulus
561134|NCT00790998|moxidectin|moxidectin
561135|NCT00790998|ivermectin|ivermectin
561136|NCT00790972|MRSA|mrsa
561137|NCT00790972|sinofresh|sinofresh
561138|NCT00790972|nasal spray|nasal spray
561139|NCT00790959|Intimate Partner Violence|intimate partner violence
561140|NCT00790959|HIV/AIDS|hiv/aids
561141|NCT00790959|Gender|gender
561142|NCT00790959|Prevention|prevention
561143|NCT00790959|Community mobilisation|community mobilisation
561144|NCT00790959|Uganda|uganda
561145|NCT00790946|valsartan|valsartan
561146|NCT00790946|Metabolic syndrome|metabolic syndrome
561147|NCT00790933|Drug therapy|drug therapy
561148|NCT00790920|Acute ischemic stroke|acute ischemic stroke
561149|NCT00790920|Angiography|angiography
561150|NCT00790920|Desmoteplase|desmoteplase
561151|NCT00790920|Thrombolytic|thrombolytic
561152|NCT00790907|Unstable angina|unstable angina
561153|NCT00790907|Non ST elevation myocardial infarction|non st elevation myocardial infarction
561154|NCT00790907|PCI|pci
561155|NCT00790907|unfractionated heparin|unfractionated heparin
561156|NCT00790907|fondaparinux|fondaparinux
561157|NCT00790907|acute coronary syndrome|acute coronary syndrome
561158|NCT00790881|malaria|malaria
561159|NCT00790881|HIV|hiv
561160|NCT00790881|AIDS|aids
561161|NCT00790881|nevirapine|nevirapine
561162|NCT00790881|lumefantrine|lumefantrine
561163|NCT00790881|artemether|artemether
561164|NCT00790881|drug interaction|drug interaction
561165|NCT00790881|pharmacokinetics|pharmacokinetics
561166|NCT00790868|Panic Disorder|panic disorder
561167|NCT00790868|Anxiety|anxiety
561168|NCT00790868|D-cycloserine|d-cycloserine
561169|NCT00790868|DCS|dcs
561170|NCT00790868|Cognitive Behavioral Therapy|cognitive behavioral therapy
561171|NCT00790868|CBT|cbt
561172|NCT00790855|Bendamustine|bendamustine
561173|NCT00790855|Acute Leukemia|acute leukemia
561174|NCT00790855|Leukemia|leukemia
561175|NCT00790855|Acute myeloid leukemia|acute myeloid leukemia
561176|NCT00790855|Myelodysplastic Syndrome|myelodysplastic syndrome
561177|NCT00790855|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
561178|NCT00790855|Chronic myeloid leukemia|chronic myeloid leukemia
561179|NCT00790855|MDS|mds
561180|NCT00790855|ALL|all
561181|NCT00790855|AML|aml
561182|NCT00790855|CML|cml
561183|NCT00790842|Refractory Multiple Myeloma|refractory multiple myeloma
561184|NCT00790842|Relapsed Multiple Myeloma|relapsed multiple myeloma
561185|NCT00790842|Multiple Myeloma with Renal Dysfunction|multiple myeloma with renal dysfunction
561186|NCT00790842|Stage I Multiple Myeloma|stage i multiple myeloma
561187|NCT00790842|Stage II Multiple Myeloma|stage ii multiple myeloma
561188|NCT00790842|Stage III Multiple Myeloma|stage iii multiple myeloma
561189|NCT00790829|preemptive|preemptive
561190|NCT00790829|Nicotine Patch|nicotine patch
561191|NCT00790829|Open Abdominal Surgery|open abdominal surgery
561192|NCT00790816|Cancer|cancer
561193|NCT00790816|lapatinib|lapatinib
561194|NCT00790816|Combination therapy|combination therapy
561195|NCT00790816|Chronic administration|chronic administration
561196|NCT00790803|uveitis|uveitis
561197|NCT00790803|cystoid macular edema|cystoid macular edema
561198|NCT00790777|Paliperidone ER|paliperidone er
561199|NCT00790777|Schizophrenia, Mood disorders, Antipsychotic drugs|schizophrenia, mood disorders, antipsychotic drugs
561200|NCT00790751|ED|ed
561201|NCT00790751|Erectile Dysfunction|erectile dysfunction
561202|NCT00790751|Dysfunction|dysfunction
561203|NCT00790751|Erectile|erectile
561204|NCT00790738|bipolar disorder|bipolar disorder
561205|NCT00790738|depression|depression
561206|NCT00790738|treatment|treatment
561207|NCT00790738|randomized controlled trial|randomized controlled trial
561208|NCT00790699|diabetes|diabetes
561209|NCT00790699|Symlin|symlin
561210|NCT00790699|pramlintide acetate|pramlintide acetate
561211|NCT00790699|insulin|insulin
561212|NCT00790699|multiple injection port|multiple injection port
561213|NCT00790699|I-PORT|i-port
561214|NCT00790686|Ureteral obstruction|ureteral obstruction
561215|NCT00790686|Urologic surgical procedure|urologic surgical procedure
561216|NCT00790686|Stents|stents
561217|NCT00790686|Endoscopy|endoscopy
561218|NCT00790686|Urology|urology
561219|NCT00790673|Hepatitis C|hepatitis c
561220|NCT00790673|Viral hepatitis|viral hepatitis
561221|NCT00790660|ASP1941|asp1941
561222|NCT00790660|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
561223|NCT00790647|primary systemic amyloidosis|primary systemic amyloidosis
561224|NCT00790595|Prostatectomy|prostatectomy
561225|NCT00790582|ALS|als
561226|NCT00790582|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
561227|NCT00790582|Lou Gehrig's Disease|lou gehrig's disease
561228|NCT00790582|Lithium|lithium
561229|NCT00790582|Lithium Carbonate|lithium carbonate
561230|NCT00790569|bladder cancer|bladder cancer
561231|NCT00790569|cervical cancer|cervical cancer
561232|NCT00790569|esophageal cancer|esophageal cancer
561233|NCT00790569|gastric cancer|gastric cancer
561234|NCT00790569|renal cell carcinoma|renal cell carcinoma
561235|NCT00790569|adult primary liver cancer|adult primary liver cancer
561236|NCT00790569|non-small cell lung cancer|non-small cell lung cancer
561237|NCT00790569|small cell lung cancer|small cell lung cancer
561238|NCT00790569|pancreatic cancer|pancreatic cancer
561239|NCT00790569|hypopharyngeal cancer|hypopharyngeal cancer
561240|NCT00790569|laryngeal cancer|laryngeal cancer
561241|NCT00790569|lip and oral cavity cancer|lip and oral cavity cancer
561242|NCT00790569|nasopharyngeal cancer|nasopharyngeal cancer
561243|NCT00790569|oropharyngeal cancer|oropharyngeal cancer
561244|NCT00790569|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
561245|NCT00790569|adult acute myeloid leukemia|adult acute myeloid leukemia
561246|NCT00790569|tobacco use disorder|tobacco use disorder
561247|NCT00790543|Crohn's Disease|crohn's disease
561248|NCT00790543|Inflammatory Bowel Disease|inflammatory bowel disease
561249|NCT00790530|Diabetes|diabetes
561250|NCT00790530|Information Technology|information technology
561251|NCT00790530|Health Plans|health plans
561252|NCT00790517|Weight loss|weight loss
561253|NCT00790517|Diabetes prevention|diabetes prevention
561254|NCT00790517|Serious mental illness|serious mental illness
561255|NCT00790517|Antipsychotic medications|antipsychotic medications
561256|NCT00790517|Lifestyle intervention|lifestyle intervention
561257|NCT00790517|Antipsychotic Agents|antipsychotic agents
561258|NCT00790504|Pelvic floor|pelvic floor
561259|NCT00790504|Transperineal ultrasound|transperineal ultrasound
561260|NCT00790504|Multiple pregnancy|multiple pregnancy
561261|NCT00790504|Singleton pregnancy|singleton pregnancy
561262|NCT00790504|Female pelvic floor|female pelvic floor
561263|NCT00790491|reduction in risk of heart disease and diabetes|reduction in risk of heart disease and diabetes
561264|NCT00790478|Ulcerative Colitis|ulcerative colitis
561265|NCT00790478|Melatonin|melatonin
561266|NCT00790478|Gastrointestinal|gastrointestinal
561267|NCT00790478|Irritable Bowel syndrome|irritable bowel syndrome
561268|NCT00790478|Sleep|sleep
561269|NCT00790478|Pilot Study|pilot study
561270|NCT00790465|achalasia|achalasia
561271|NCT00790465|lower esophageal sphincter|lower esophageal sphincter
561272|NCT00790465|nitric oxide|nitric oxide
561273|NCT00790465|dark chocolate|dark chocolate
561274|NCT00790465|flavanols|flavanols
561275|NCT00790452|Brain|brain
561276|NCT00790452|Hematologic Disorder|hematologic disorder
561277|NCT00790452|Venous Thromboembolism|venous thromboembolism
561278|NCT00790452|Glioblastoma|glioblastoma
561279|NCT00790452|Aspirin|aspirin
561280|NCT00790452|Placebo|placebo
561281|NCT00790452|VTE|vte
561282|NCT00790452|ASA|asa
561283|NCT00790452|DVT|dvt
561284|NCT00790439|Insulin dependence|insulin dependence
561285|NCT00790426|Advanced urothelial cancer|advanced urothelial cancer
561286|NCT00790413|Radiotherapy|radiotherapy
561287|NCT00790413|Immunotherapy|immunotherapy
561288|NCT00790413|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
561289|NCT00790400|Angiomyolipoma|angiomyolipoma
561290|NCT00790400|AML|aml
561291|NCT00790400|Tuberous Sclerosis Complex|tuberous sclerosis complex
561292|NCT00790400|TSC|tsc
561293|NCT00790400|mTOR|mtor
561294|NCT00790400|RAD001|rad001
561295|NCT00790400|Mammalian Target of Rapamycin|mammalian target of rapamycin
561296|NCT00790400|Everolimus|everolimus
561297|NCT00790400|Afinitor|afinitor
561298|NCT00790400|SEGA|sega
561299|NCT00790400|Subependymal Giant Cell Astrocytoma|subependymal giant cell astrocytoma
561300|NCT00790400|Seizures|seizures
561301|NCT00790400|Tuberous sclerosis complex (TSC)|tuberous sclerosis complex (tsc)
561302|NCT00790400|Tuberous sclerosis|tuberous sclerosis
561303|NCT00790400|benign tumors of brain|benign tumors of brain
561304|NCT00790400|kidney|kidney
561305|NCT00790400|heart|heart
561306|NCT00790400|eyes|eyes
561307|NCT00790400|lungs|lungs
561308|NCT00790400|skinTSC1|skintsc1
561309|NCT00790400|TSC2|tsc2
561310|NCT00790400|hamaratin|hamaratin
561311|NCT00790400|tuberin, tumor growth suppressors|tuberin, tumor growth suppressors
561312|NCT00790400|gyri|gyri
561313|NCT00790400|tubers|tubers
561314|NCT00790400|Sporadic Lymphangioleiomyomatosis.|sporadic lymphangioleiomyomatosis.
561315|NCT00790400|Lymphangioleiomyomatosis (LAM)|lymphangioleiomyomatosis (lam)
561316|NCT00790400|rare lung disease|rare lung disease
561317|NCT00790387|enoxaparin|enoxaparin
561318|NCT00790387|tirofiban|tirofiban
561319|NCT00790387|percutaneous intervention|percutaneous intervention
561320|NCT00790387|platelet inhibition|platelet inhibition
561321|NCT00790387|CD40L|cd40l
561322|NCT00790387|Mac-1|mac-1
561323|NCT00790387|prothrombin fragment 1+2.|prothrombin fragment 1+2.
561324|NCT00790374|Pharmacodynamic profile and safety of BN83495|pharmacodynamic profile and safety of bn83495
561325|NCT00790361|cervical spondylotic myelopathy|cervical spondylotic myelopathy
561326|NCT00790361|spinal cord compression|spinal cord compression
561327|NCT00790361|magnetic resonance spectroscopy|magnetic resonance spectroscopy
561328|NCT00790361|functional magnetic resonance imaging|functional magnetic resonance imaging
561329|NCT00790361|brain plasticity|brain plasticity
561330|NCT00790335|deep vein thrombosis|deep vein thrombosis
561331|NCT00790335|deep venous thrombosis|deep venous thrombosis
561332|NCT00790335|post thrombotic syndrome|post thrombotic syndrome
561333|NCT00790335|blood clot|blood clot
561334|NCT00790335|thrombolysis|thrombolysis
561335|NCT00790335|tissue plasminogen activator|tissue plasminogen activator
561336|NCT00790335|rt-PA|rt-pa
561337|NCT00790335|Activase|activase
561338|NCT00790335|mechanical thrombectomy|mechanical thrombectomy
561339|NCT00790335|pharmacomechanical|pharmacomechanical
561340|NCT00790335|ATTRACT|attract
561341|NCT00790322|Cancer|cancer
561342|NCT00790322|Radiation therapy|radiation therapy
561343|NCT00790322|Radiotherapy|radiotherapy
561344|NCT00790322|Oral Mucositis|oral mucositis
561345|NCT00790322|SBG|sbg
561346|NCT00790309|Obesity|obesity
561347|NCT00790309|Diabetes|diabetes
561348|NCT00790309|Bariatric surgery|bariatric surgery
561349|NCT00790296|cancer fatigue|cancer fatigue
561350|NCT00790283|Treatment of de novo lesions in native coronary arteries|treatment of de novo lesions in native coronary arteries
561351|NCT00790270|Cervical strain|cervical strain
561352|NCT00790270|whiplash|whiplash
561353|NCT00790270|ibuprofen|ibuprofen
561354|NCT00790270|cyclobenzaprine|cyclobenzaprine
561355|NCT00790257|Diabetes|diabetes
561356|NCT00790257|Islets transplantation|islets transplantation
561357|NCT00790257|Encapsulation|encapsulation
561358|NCT00790244|Soft-tissue sarcomas|soft-tissue sarcomas
561359|NCT00790244|prognostic factors|prognostic factors
561360|NCT00790244|adjuvant|adjuvant
561361|NCT00790244|chemotherapy|chemotherapy
561362|NCT00790244|radiotherapy|radiotherapy
561363|NCT00790244|metastases-free survival|metastases-free survival
561364|NCT00790244|toxicity|toxicity
561365|NCT00790244|High malignancy grade|high malignancy grade
561366|NCT00790244|High-risk for metastases|high-risk for metastases
561367|NCT00790244|Adult|adult
561368|NCT00790231|urinary bladder|urinary bladder
561369|NCT00790231|thoracic epidural analgesia|thoracic epidural analgesia
561370|NCT00790231|urodynamics|urodynamics
561371|NCT00790231|open kidney surgery with lumbotomy|open kidney surgery with lumbotomy
561372|NCT00790218|Hepatocellular carcinoma|hepatocellular carcinoma
561373|NCT00790218|Hepatoma|hepatoma
561374|NCT00790218|HCC|hcc
561375|NCT00790192|Schizophrenia|schizophrenia
561376|NCT00790192|SM-13496|sm-13496
561377|NCT00790192|Latuda|latuda
561378|NCT00790192|Lurasidone|lurasidone
561379|NCT00790179|Continuous lumbar plexus,Femoral,hydromorphone|continuous lumbar plexus,femoral,hydromorphone
561380|NCT00790153|Type 2 diabetes, hormonal response|type 2 diabetes, hormonal response
561381|NCT00790140|Esophageal Cancer|esophageal cancer
561382|NCT00790140|esophagectomy|esophagectomy
561383|NCT00790140|enteral feeding|enteral feeding
561384|NCT00790140|body composition|body composition
561385|NCT00790140|immunology|immunology
561386|NCT00790114|Phase I|phase i
561387|NCT00790088|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
561388|NCT00790088|continuous glucose monitoring|continuous glucose monitoring
561389|NCT00790088|sensor-augmented pump therapy|sensor-augmented pump therapy
561390|NCT00790075|agitation|agitation
561391|NCT00790075|Episodes of agitation regardless of diagnosis|episodes of agitation regardless of diagnosis
561392|NCT00790062|Uterine atony|uterine atony
561393|NCT00790062|Postpartum hemorrhage|postpartum hemorrhage
561394|NCT00790062|clinical trial|clinical trial
561395|NCT00790062|Prophylactic oxytocin|prophylactic oxytocin
561396|NCT00790036|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
561397|NCT00790036|DLBCL|dlbcl
561398|NCT00790036|poor risk|poor risk
561399|NCT00790036|R-IPI 3-5|r-ipi 3-5
561400|NCT00790036|adjuvant therapy|adjuvant therapy
561401|NCT00790036|after R-CHOP or R-EPOCH|after r-chop or r-epoch
561402|NCT00790036|after R-CHOP|after r-chop
561403|NCT00790036|B-cell lymphoma|b-cell lymphoma
561404|NCT00790036|lymphoma|lymphoma
561405|NCT00790036|b cells|b cells
561406|NCT00790036|blood cancer|blood cancer
561407|NCT00790036|lymph nodes|lymph nodes
561408|NCT00790036|Hodgkin's|hodgkin's
561409|NCT00790036|non-Hodgkin|non-hodgkin
561410|NCT00790023|SAR|sar
561411|NCT00790010|bevacizumab|bevacizumab
561412|NCT00790010|ipilimumab|ipilimumab
561413|NCT00790010|unresectable stage III melanoma|unresectable stage iii melanoma
561414|NCT00790010|unresectable stage IV melanoma|unresectable stage iv melanoma
561415|NCT00789997|COPD Exacerbation|copd exacerbation
561416|NCT00789997|Etanercept|etanercept
561417|NCT00789997|TNF alpha|tnf alpha
561418|NCT00789997|Randomized|randomized
561419|NCT00789984|Keratic precipitates|keratic precipitates
561420|NCT00789971|orbital floor triamcinolone|orbital floor triamcinolone
561421|NCT00789971|phacoemulsification|phacoemulsification
561422|NCT00789971|post op inflammation|post op inflammation
561423|NCT00789971|cmo|cmo
561424|NCT00789958|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
561425|NCT00789958|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
561426|NCT00789958|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
561427|NCT00789958|localized gallbladder cancer|localized gallbladder cancer
561428|NCT00789958|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
561429|NCT00789958|unresectable gallbladder cancer|unresectable gallbladder cancer
561430|NCT00789958|metastatic extrahepatic bile duct cancer|metastatic extrahepatic bile duct cancer
561431|NCT00789958|metastatic gallbladder cancer|metastatic gallbladder cancer
561432|NCT00789945|type 1 diabetes|type 1 diabetes
561433|NCT00789945|continuous glucose monitoring|continuous glucose monitoring
561434|NCT00789945|Intensive Insulin therapy|intensive insulin therapy
561435|NCT00789919|Mild Preeclampsia|mild preeclampsia
561436|NCT00789906|Computerized Neuropsychological Assessment|computerized neuropsychological assessment
561437|NCT00789906|Development of Population Norms of the Computerized Neuropsychological Assessment|development of population norms of the computerized neuropsychological assessment
561438|NCT00789893|external beam pelvic radiation|external beam pelvic radiation
561439|NCT00789893|brachytherapy|brachytherapy
561440|NCT00789880|Vitamin D3|vitamin d3
561441|NCT00789880|Atopic Dermatitis|atopic dermatitis
561442|NCT00789880|Antimicrobial Peptide Expression|antimicrobial peptide expression
561443|NCT00789867|Single dose|single dose
561444|NCT00789867|Pilot|pilot
561445|NCT00789867|Safety|safety
561446|NCT00789867|Gene expression|gene expression
561447|NCT00789867|Tolerability|tolerability
561448|NCT00789867|CFTR gene|cftr gene
561449|NCT00789867|Cystic fibrosis|cystic fibrosis
561450|NCT00789867|Non-viral|non-viral
561451|NCT00789854|Depression|depression
561452|NCT00789854|MDD|mdd
561453|NCT00789854|TRD|trd
561454|NCT00789841|Neuroendocrine tumor|neuroendocrine tumor
561455|NCT00789841|Carcinoid syndrome|carcinoid syndrome
561456|NCT00789841|Motility|motility
561457|NCT00789841|Transit time|transit time
561458|NCT00789828|SEGA|sega
561459|NCT00789828|Tuberous Sclerosis|tuberous sclerosis
561460|NCT00789828|Subependymal Giant Cell Astrocytoma|subependymal giant cell astrocytoma
561461|NCT00789828|mTOR|mtor
561463|NCT00789828|Mamalian Target Rapamycin|mamalian target rapamycin
561464|NCT00789828|Everolimus|everolimus
561465|NCT00789828|TSC|tsc
561466|NCT00789815|flexible bronchoscopy|flexible bronchoscopy
561467|NCT00789815|sedation|sedation
561468|NCT00789815|bispectral index|bispectral index
561469|NCT00789802|contraception|contraception
561470|NCT00789802|progestin contraception|progestin contraception
561471|NCT00789802|intrauterine contraception|intrauterine contraception
561472|NCT00789802|unscheduled bleeding|unscheduled bleeding
561473|NCT00789802|placebo|placebo
561474|NCT00789789|Cohort|cohort
561475|NCT00789789|HIV uninfected volunteers|hiv uninfected volunteers
561476|NCT00789789|HIV preventive vaccine|hiv preventive vaccine
561477|NCT00789789|Long term safety|long term safety
561478|NCT00789763|pancreatic cancer|pancreatic cancer
561479|NCT00789763|Pancreatic cancer locally advanced|pancreatic cancer locally advanced
561480|NCT00789724|acute myocardial infarction|acute myocardial infarction
561481|NCT00789698|Schizophrenia|schizophrenia
561482|NCT00789698|SM-13496|sm-13496
561483|NCT00789698|Latuda|latuda
561484|NCT00789698|Lurasidone|lurasidone
561485|NCT00789685|Open label|open label
561486|NCT00789672|Amblyopia|amblyopia
561487|NCT00789672|Patching|patching
561488|NCT00789672|Levodopa|levodopa
561489|NCT00789659|Fracture fixation, internal|fracture fixation, internal
561490|NCT00789659|Obesity|obesity
561491|NCT00789659|Pelvis|pelvis
561492|NCT00789659|Negative pressure wound therapy|negative pressure wound therapy
561493|NCT00789659|Vacuum-assisted closure|vacuum-assisted closure
561494|NCT00789646|corneal ulcer|corneal ulcer
561495|NCT00789646|painless|painless
561496|NCT00789646|subconjunctival injection|subconjunctival injection
561497|NCT00789646|antibiotics|antibiotics
561498|NCT00789646|antifungal|antifungal
561499|NCT00789646|lidocaine|lidocaine
561500|NCT00789633|Pancreatic cancer|pancreatic cancer
561501|NCT00789633|Advanced pancreatic cancer|advanced pancreatic cancer
561502|NCT00789633|Metastatic pancreatic cancer|metastatic pancreatic cancer
561503|NCT00789633|Gemcitabine|gemcitabine
561504|NCT00789633|Chemo-naive|chemo-naive
561505|NCT00789620|intravenous lidocaine|intravenous lidocaine
561506|NCT00789620|laparoscopic urological surgery|laparoscopic urological surgery
561507|NCT00789620|hospital stay|hospital stay
561508|NCT00789620|pain|pain
561509|NCT00789620|fatigue|fatigue
561510|NCT00789620|length of stay|length of stay
561511|NCT00789607|prostate cancer|prostate cancer
561512|NCT00789607|individualized radiotherapy|individualized radiotherapy
561513|NCT00789607|fiducial markers|fiducial markers
561514|NCT00789607|MRI|mri
561515|NCT00789607|ultrasound|ultrasound
561516|NCT00789607|High-Risk Localized Prostate Cancer|high-risk localized prostate cancer
561517|NCT00789594|Monitoring|monitoring
561518|NCT00789594|Testing|testing
561519|NCT00789594|Medications|medications
561520|NCT00789594|Patients receiving medications and having laboratory tests|patients receiving medications and having laboratory tests
561521|NCT00789581|Breast Cancer|breast cancer
561522|NCT00789581|Adjuvant|adjuvant
561523|NCT00789581|Doxorubicin|doxorubicin
561524|NCT00789581|Cyclophosphamide|cyclophosphamide
561525|NCT00789581|Paclitaxel|paclitaxel
561526|NCT00789581|Ixabepilone|ixabepilone
561527|NCT00789581|TITAN|titan
561528|NCT00789568|Hyperphenylalanemia due to Phenylketonuria|hyperphenylalanemia due to phenylketonuria
561529|NCT00789555|nasal allergy|nasal allergy
561530|NCT00789555|nasal spray|nasal spray
561531|NCT00789555|seasonal allergy|seasonal allergy
561532|NCT00789555|perennial allergy|perennial allergy
561533|NCT00789542|stroke|stroke
561534|NCT00789542|deep vein thrombosis|deep vein thrombosis
561535|NCT00789542|doppler|doppler
561536|NCT00789529|Contact lenses, wettability, Contact Lens Disinfectant Solutions, pre-lens tear film|contact lenses, wettability, contact lens disinfectant solutions, pre-lens tear film
561537|NCT00789516|Coagulation markers, thalassemia disease post SCT|coagulation markers, thalassemia disease post sct
561538|NCT00789503|dietary fortification|dietary fortification
561539|NCT00789503|Vitamin D3|vitamin d3
561540|NCT00789503|Osteomalacia|osteomalacia
561541|NCT00789503|bread|bread
561542|NCT00789503|bone mineral density|bone mineral density
561543|NCT00789503|geriatrics|geriatrics
561544|NCT00789503|cholecalciferol|cholecalciferol
561545|NCT00789503|calcidiol|calcidiol
561546|NCT00789503|osteoporosis|osteoporosis
561547|NCT00789503|dual-energy photon absorptiometry|dual-energy photon absorptiometry
561548|NCT00789503|bread fortification|bread fortification
561549|NCT00789490|pregnancy|pregnancy
561550|NCT00789490|relative bioavailability|relative bioavailability
561551|NCT00789490|iron|iron
561552|NCT00789490|folic acid|folic acid
561553|NCT00789490|ferric pyrophosphate|ferric pyrophosphate
561554|NCT00789490|Study focus is to compare the relative bioavailability of SuppleFem Sprinkles to the current tradtional tablet Materna in pregnant women|study focus is to compare the relative bioavailability of supplefem sprinkles to the current tradtional tablet materna in pregnant women
561555|NCT00789464|Urinary Tract Infection|urinary tract infection
561556|NCT00789464|Probiotics|probiotics
561557|NCT00789464|Dietary Supplements|dietary supplements
561558|NCT00789464|Bacteriuria|bacteriuria
561559|NCT00789451|Ischaemia reperfusion|ischaemia reperfusion
561560|NCT00789451|t-PA|t-pa
561561|NCT00789451|Fibrinolysis|fibrinolysis
561562|NCT00789451|Endothelial function|endothelial function
561563|NCT00789438|Analgesia|analgesia
561564|NCT00789438|Sedation|sedation
561565|NCT00789438|Spinal|spinal
561566|NCT00789438|Stress|stress
561567|NCT00789438|Surgical|surgical
561568|NCT00789438|Surgical Stress|surgical stress
561569|NCT00789438|Pain|pain
561570|NCT00789425|osteoporosis|osteoporosis
561571|NCT00789425|osteopenia|osteopenia
561572|NCT00789425|olive extract|olive extract
561573|NCT00789425|oleuropein|oleuropein
561574|NCT00789412|Analgesia|analgesia
561575|NCT00789412|Sedation|sedation
561576|NCT00789412|Critical Illness|critical illness
561577|NCT00789412|Intensive Care|intensive care
561578|NCT00789399|deep vein thrombosis|deep vein thrombosis
561579|NCT00789399|coronary artery bypass surgery|coronary artery bypass surgery
561580|NCT00789399|Venous thromboembolism|venous thromboembolism
561581|NCT00789386|Capsaicin|capsaicin
561582|NCT00789386|Remifentanil|remifentanil
561583|NCT00789386|Hyperalgesia|hyperalgesia
561584|NCT00789360|Healthy volunteers|healthy volunteers
561585|NCT00789347|Neuropathic pain|neuropathic pain
561586|NCT00789347|Cortical excitability|cortical excitability
561880|NCT00788164|treatment|treatment
561587|NCT00789347|Transcranial magnetic stimulation|transcranial magnetic stimulation
561588|NCT00789347|Contact Heat evoked potential|contact heat evoked potential
561589|NCT00789347|peripheral nerve stimulation|peripheral nerve stimulation
561590|NCT00789347|neurotrophic factors|neurotrophic factors
561591|NCT00789308|Insulin dependence|insulin dependence
561592|NCT00789295|Mediterranean diet|mediterranean diet
561593|NCT00789295|Postprandial lipids|postprandial lipids
561594|NCT00789295|Postprandial glucose|postprandial glucose
561595|NCT00789295|High fibre diet|high fibre diet
561596|NCT00789295|Low- CHO diet|low- cho diet
561597|NCT00789295|High MUFA diet|high mufa diet
561598|NCT00789295|Dietary approach|dietary approach
561599|NCT00789282|chronic disease|chronic disease
561600|NCT00789282|Family Physician|family physician
561601|NCT00789282|primary care network|primary care network
561602|NCT00789282|practice-based model|practice-based model
561603|NCT00789282|type 2 diabetes|type 2 diabetes
561604|NCT00789282|complications|complications
561605|NCT00789282|sequelae|sequelae
561606|NCT00789269|lung infection after ischemic Stroke|lung infection after ischemic stroke
561607|NCT00789269|prevention of pneumonia|prevention of pneumonia
561608|NCT00789269|rhubarb|rhubarb
561609|NCT00789256|Acute Myelogenous Leukemia|acute myelogenous leukemia
561610|NCT00789256|AML|aml
561611|NCT00789256|Myelodysplastic Syndromes|myelodysplastic syndromes
561612|NCT00789256|MDS|mds
561613|NCT00789256|Melphalan|melphalan
561614|NCT00789256|Bortezomib|bortezomib
561615|NCT00789256|Velcade|velcade
561616|NCT00789243|Ischaemia reperfusion|ischaemia reperfusion
561617|NCT00789243|t-PA|t-pa
561618|NCT00789243|Fibrinolysis|fibrinolysis
561619|NCT00789243|Endothelial function|endothelial function
561620|NCT00789243|Local and remote ischaemic preconditioning|local and remote ischaemic preconditioning
561621|NCT00789230|umbilical|umbilical
561622|NCT00789230|hernia|hernia
561623|NCT00789230|mesh|mesh
561624|NCT00789217|Penicillin|penicillin
561625|NCT00789217|Beta-Lactams|beta-lactams
561626|NCT00789217|Allergy|allergy
561627|NCT00789217|Hypersensitivity|hypersensitivity
561628|NCT00789204|exercise|exercise
561629|NCT00789204|low back pain|low back pain
561630|NCT00789204|posture|posture
561631|NCT00789204|rehabilitation|rehabilitation
561632|NCT00789178|memory disturbances|memory disturbances
561633|NCT00789165|Brugada syndrome|brugada syndrome
561634|NCT00789165|quinidine|quinidine
561635|NCT00789165|Asymptomatic Brugada Syndrome|asymptomatic brugada syndrome
561636|NCT00789113|lamotrigine|lamotrigine
561637|NCT00789113|epilepsy|epilepsy
561638|NCT00789113|metabolism|metabolism
561639|NCT00789113|bipolar disorder|bipolar disorder
561640|NCT00789113|bipolar depression|bipolar depression
561641|NCT00789113|glucuronidation|glucuronidation
561642|NCT00789100|telehealth|telehealth
561643|NCT00789100|telemonitor|telemonitor
561644|NCT00789100|telemedicine|telemedicine
561645|NCT00789100|Co-morbidities|co-morbidities
561646|NCT00789087|Pleural Effusion.|pleural effusion.
561647|NCT00789087|Talc.|talc.
561648|NCT00789087|Pleurodesis.|pleurodesis.
561649|NCT00789087|Quality of Life.|quality of life.
561650|NCT00789087|Thoracoscopy.|thoracoscopy.
561651|NCT00789074|Smoking cessation|smoking cessation
561652|NCT00789074|Tobacco dependence|tobacco dependence
561653|NCT00789074|Varenicline|varenicline
561654|NCT00789074|Preloading|preloading
561655|NCT00789061|Acute hearing loss in patients with SLC26A4 mutations|acute hearing loss in patients with slc26a4 mutations
561656|NCT00789048|hip|hip
561657|NCT00789048|arthroplasty|arthroplasty
561658|NCT00789048|radiograph|radiograph
561659|NCT00789022|First-Psychotic-Episode (FPE)|first-psychotic-episode (fpe)
561660|NCT00789022|Glutamatergic system|glutamatergic system
561661|NCT00789022|Glycine|glycine
561662|NCT00789022|D-Serine|d-serine
561663|NCT00789022|Oxytocin|oxytocin
561664|NCT00789022|Estrogen|estrogen
561665|NCT00789009|HIV|hiv
561666|NCT00789009|Natural History|natural history
561667|NCT00789009|Stored Sample|stored sample
561668|NCT00789009|AIDS|aids
561669|NCT00788996|Tobacco Smoke Pollution/prevention and control|tobacco smoke pollution/prevention and control
561670|NCT00788996|Parent-Child Relations|parent-child relations
561671|NCT00788996|Environmental Tobacco Smoke (ETS)|environmental tobacco smoke (ets)
561672|NCT00788983|Induced hypoxia|induced hypoxia
561673|NCT00788983|Pulse oximeter|pulse oximeter
561674|NCT00788983|Nonin Medical|nonin medical
561675|NCT00788983|Verification of SpO2 accuracy|verification of spo2 accuracy
561676|NCT00788970|Acupressure|acupressure
561677|NCT00788970|Shiatsu|shiatsu
561678|NCT00788970|Schizophrenia|schizophrenia
561679|NCT00788957|panitumumab|panitumumab
561680|NCT00788957|vectibix|vectibix
561681|NCT00788957|AMG 102|amg 102
561682|NCT00788957|AMG 479|amg 479
561683|NCT00788957|colon cancer|colon cancer
561684|NCT00788957|rectal cancer|rectal cancer
561685|NCT00788957|colorectal cancer|colorectal cancer
561686|NCT00788957|metastatic colorectal cancer|metastatic colorectal cancer
561687|NCT00788957|EGFR inhibitor|egfr inhibitor
561688|NCT00788957|IGF inhibitor|igf inhibitor
561689|NCT00788957|c-MET inhibitor|c-met inhibitor
561690|NCT00788931|Breast Cancer|breast cancer
561691|NCT00788931|HER2 positive|her2 positive
561692|NCT00788931|adult-female|adult-female
561693|NCT00788931|LBH589|lbh589
561694|NCT00788931|HDAC inhibitor|hdac inhibitor
561695|NCT00788931|panobinostat|panobinostat
561696|NCT00788931|metastatic breast|metastatic breast
561697|NCT00788931|adult female patients|adult female patients
561698|NCT00788918|Chronic Hepatitis C|chronic hepatitis c
561699|NCT00788918|cognitive dysfunction|cognitive dysfunction
561700|NCT00788918|MRI|mri
561701|NCT00788918|MR spectroscopy|mr spectroscopy
561702|NCT00788918|interferon|interferon
561703|NCT00788918|ribavirin|ribavirin
561704|NCT00788918|sustained virologic response, major depressive disorder|sustained virologic response, major depressive disorder
561705|NCT00788905|Hemodialysis|hemodialysis
561706|NCT00788892|Acute|acute
561707|NCT00788892|Myeloid|myeloid
561708|NCT00788892|Leukemia|leukemia
561709|NCT00788892|elderly|elderly
561710|NCT00788892|Newly|newly
561711|NCT00788892|Diagnosed|diagnosed
561712|NCT00788879|Behavioral Journalism|behavioral journalism
561713|NCT00788879|Mexican-Americans|mexican-americans
561714|NCT00788879|Obesity|obesity
561715|NCT00788879|Nutrition|nutrition
561716|NCT00788879|Physical Activity|physical activity
561717|NCT00788879|Border Health|border health
561718|NCT00788866|Neuroprotection|neuroprotection
561719|NCT00788866|Antioxidants|antioxidants
561720|NCT00788866|Neonatal brain injury|neonatal brain injury
561721|NCT00788866|Pomegranate juice|pomegranate juice
561722|NCT00788853|DiabCare Asia 2008, Cross-sectional survey, Glycemic control, Psychosocial well-being, Diabetic complications, Quality of life.|diabcare asia 2008, cross-sectional survey, glycemic control, psychosocial well-being, diabetic complications, quality of life.
561723|NCT00788827|diabetes type I|diabetes type i
561724|NCT00788827|diabetes type 2|diabetes type 2
561725|NCT00788827|renal transplant|renal transplant
561726|NCT00788827|stem cells|stem cells
561727|NCT00788827|successful renal transplant|successful renal transplant
561728|NCT00788788|Airway obstruction|airway obstruction
561729|NCT00788788|Heliox|heliox
561730|NCT00788788|Different Helium content|different helium content
561731|NCT00788775|nilotinib|nilotinib
561732|NCT00788762|glaucoma|glaucoma
561733|NCT00788762|myocilin|myocilin
561734|NCT00788749|chronic rhinosinusitis|chronic rhinosinusitis
561735|NCT00788749|nasal polyps|nasal polyps
561736|NCT00788749|oral steroid|oral steroid
561737|NCT00788749|intranasal steroid|intranasal steroid
561738|NCT00788749|medical polypectomy|medical polypectomy
561739|NCT00788736|venous thromboembolism|venous thromboembolism
561740|NCT00788736|long-term oral anticoagulant therapy|long-term oral anticoagulant therapy
561741|NCT00788736|warfarin|warfarin
561742|NCT00788736|bleeding risk|bleeding risk
561743|NCT00788736|clinical prediction rule|clinical prediction rule
561744|NCT00788736|predictors|predictors
561745|NCT00788736|deep vein thrombosis|deep vein thrombosis
561746|NCT00788736|pulmonary embolism|pulmonary embolism
561747|NCT00788736|vitamin k antagonist|vitamin k antagonist
561748|NCT00788736|side effect|side effect
561749|NCT00788723|Severe Brain Injury|severe brain injury
561750|NCT00788723|Excitability|excitability
561751|NCT00788723|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
561752|NCT00788684|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
561753|NCT00788684|Rituximab|rituximab
561754|NCT00788684|Chronic Lymphoid Leukemia|chronic lymphoid leukemia
561755|NCT00788684|Hematological Malignancies|hematological malignancies
561756|NCT00788684|ABT-263|abt-263
561757|NCT00788684|Navitoclax|navitoclax
561758|NCT00788684|CD20-Positive Lymphoid Malignancies|cd20-positive lymphoid malignancies
561759|NCT00788671|Endometrioid Endometrial Carcinoma|endometrioid endometrial carcinoma
561760|NCT00788671|Complex Atypical Hyperplasia|complex atypical hyperplasia
561761|NCT00788671|Levonorgestrel Intrauterine Device|levonorgestrel intrauterine device
561762|NCT00788671|Endometrial Biopsy|endometrial biopsy
561763|NCT00788671|Endometrium|endometrium
561764|NCT00788671|Hyperplasia of lining of the uterus (womb)|hyperplasia of lining of the uterus (womb)
561765|NCT00788671|Questionnaires|questionnaires
561766|NCT00788671|Progesterone|progesterone
561767|NCT00788671|Estrogen|estrogen
561768|NCT00788671|Postmenopausal|postmenopausal
561769|NCT00788671|Endometrial|endometrial
561770|NCT00788671|Mirena|mirena
561771|NCT00788671|Intrauterine Device|intrauterine device
561772|NCT00788671|Birth control|birth control
561773|NCT00788671|IUD|iud
561774|NCT00788671|LIUD|liud
561775|NCT00788671|CAH|cah
561776|NCT00788671|G1EEC|g1eec
561777|NCT00788671|Grade 1 endometrial cancer|grade 1 endometrial cancer
561778|NCT00788671|Early endometrial cancer|early endometrial cancer
561779|NCT00788658|Obstructed constipation|obstructed constipation
561780|NCT00788658|Quality of life|quality of life
561781|NCT00788645|Smoking|smoking
561782|NCT00788645|COPD|copd
561783|NCT00788645|Chronic Obstructive Lung Disease|chronic obstructive lung disease
561784|NCT00788645|COPD Exacerbations|copd exacerbations
561785|NCT00788645|Viruses and Bacteria associated with COPD exacerbations|viruses and bacteria associated with copd exacerbations
561786|NCT00788632|Osteoporosis|osteoporosis
561787|NCT00788632|BMD|bmd
561788|NCT00788632|Bisphosphonates|bisphosphonates
561789|NCT00788632|Educational materials|educational materials
561790|NCT00788632|Patient Stories|patient stories
561791|NCT00788619|Infertility|infertility
561792|NCT00788619|Assisted reproductive technology|assisted reproductive technology
561793|NCT00788619|Nitric oxide|nitric oxide
561794|NCT00788606|diffused large B cell lymphoma, DLBCL, R-Chop, bevacizumab|diffused large b cell lymphoma, dlbcl, r-chop, bevacizumab
561795|NCT00788606|Diffuse large B-cell non-Hodgkin's lymphoma.|diffuse large b-cell non-hodgkin's lymphoma.
561796|NCT00788593|Chronic Pancreatitis|chronic pancreatitis
561797|NCT00788593|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
561798|NCT00788580|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
561799|NCT00788554|groin|groin
561800|NCT00788554|inguinal|inguinal
561801|NCT00788554|hernia|hernia
561802|NCT00788554|lichtenstein|lichtenstein
561803|NCT00788554|TEP|tep
561804|NCT00788541|Open-Angle Glaucoma|open-angle glaucoma
561805|NCT00788541|Intraocular Pressure|intraocular pressure
561806|NCT00788541|Anecortave Acetate|anecortave acetate
561807|NCT00788528|Obesity|obesity
561808|NCT00788515|insomnia|insomnia
561809|NCT00788515|sleep maintenance|sleep maintenance
561810|NCT00788489|breast cancer|breast cancer
561811|NCT00788489|FDG-PET|fdg-pet
561812|NCT00788489|MRI|mri
561813|NCT00788489|chemotherapy|chemotherapy
561814|NCT00788489|ultrasonography|ultrasonography
561815|NCT00788476|Needs Assessment Survey|needs assessment survey
561816|NCT00788476|Childhood Cancer Survivors|childhood cancer survivors
561817|NCT00788476|Parents|parents
561818|NCT00788476|Primary Caregiver|primary caregiver
561819|NCT00788476|Survey|survey
561820|NCT00788463|administration, intranasal|administration, intranasal
561821|NCT00788463|aerosol|aerosol
561822|NCT00788463|beclomethasone|beclomethasone
561823|NCT00788463|QVAR|qvar
561824|NCT00788463|corticosteroids|corticosteroids
561825|NCT00788463|nasal polyps|nasal polyps
561826|NCT00788463|rhinomanometry|rhinomanometry
561827|NCT00788463|Rhinitis Quality of Life Questionnaire|rhinitis quality of life questionnaire
561828|NCT00788463|Quality of Life|quality of life
561829|NCT00788424|AS101 Psoriasis|as101 psoriasis
561830|NCT00788385|Hydrocephalus|hydrocephalus
561831|NCT00788385|High Pressure|high pressure
561832|NCT00788385|Shunt Blockage|shunt blockage
561833|NCT00788372|Chronic pain|chronic pain
561834|NCT00788372|Fentanyl Patch|fentanyl patch
561835|NCT00788359|cystic fibrosis|cystic fibrosis
561836|NCT00788359|pulmonary exacerbation|pulmonary exacerbation
561837|NCT00788359|biomarkers|biomarkers
561838|NCT00788346|Heavily marketed medications|heavily marketed medications
561839|NCT00788346|Prescribing|prescribing
561840|NCT00788346|Health information technology|health information technology
561841|NCT00788346|Education|education
561842|NCT00788333|Advanced or Metastatic Her-2-positive Breast Cancer|advanced or metastatic her-2-positive breast cancer
561843|NCT00788320|Tuberculosis|tuberculosis
561844|NCT00788320|vitamin D|vitamin d
561845|NCT00788320|immune system|immune system
561846|NCT00788307|adenocarcinoma of the prostate|adenocarcinoma of the prostate
561847|NCT00788307|recurrent prostate cancer|recurrent prostate cancer
561848|NCT00788307|stage I prostate cancer|stage i prostate cancer
561849|NCT00788307|stage II prostate cancer|stage ii prostate cancer
561850|NCT00788294|Pharmacokinetics tanezumab subcutaneous bioavailability intravenous Japanese subjects|pharmacokinetics tanezumab subcutaneous bioavailability intravenous japanese subjects
561851|NCT00788242|Cardiac surgery|cardiac surgery
561852|NCT00788242|Cardioprotection|cardioprotection
561853|NCT00788242|Aortocoronary bypass graft|aortocoronary bypass graft
561854|NCT00788242|Aortic stenosis|aortic stenosis
561855|NCT00788229|Dry Eye Syndromes|dry eye syndromes
561856|NCT00788229|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
561857|NCT00788229|artificial tears|artificial tears
561858|NCT00788229|carboxymethylcellulose sodium|carboxymethylcellulose sodium
561859|NCT00788229|sodium hyaluronate|sodium hyaluronate
561860|NCT00788216|Radical hysterectomy|radical hysterectomy
561861|NCT00788216|Whole pelvic radiation|whole pelvic radiation
561862|NCT00788216|Brachytherapy|brachytherapy
561863|NCT00788216|Chemoradiation|chemoradiation
561864|NCT00788216|Complications|complications
561865|NCT00788216|Quality of Life|quality of life
561866|NCT00788190|Distal Radius Fracture|distal radius fracture
561867|NCT00788190|Elderly|elderly
561868|NCT00788190|Prospective randomized trial|prospective randomized trial
561869|NCT00788190|Outcomes|outcomes
561870|NCT00788190|Pain and Function|pain and function
561871|NCT00788190|Surgical Vs. conservative management|surgical vs. conservative management
561872|NCT00788190|Fractures with borderline alignment|fractures with borderline alignment
561873|NCT00788177|age-related macular degeneration|age-related macular degeneration
561874|NCT00788177|subretinal injection|subretinal injection
561875|NCT00788177|Pegaptanib|pegaptanib
561876|NCT00788177|Macugen|macugen
561877|NCT00788164|cervical cancer|cervical cancer
561878|NCT00788164|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
561879|NCT00788164|therapeutic vaccine|therapeutic vaccine
561881|NCT00788164|CIN|cin
561882|NCT00788164|HPV|hpv
561883|NCT00788164|vaccine|vaccine
561884|NCT00788164|Hopkins|hopkins
561885|NCT00788164|Trimble|trimble
561886|NCT00788151|Dengue virus|dengue virus
561887|NCT00788151|Dengue fever|dengue fever
561888|NCT00788151|Dengue hemorrhagic fever|dengue hemorrhagic fever
561889|NCT00788151|Dengue diseases|dengue diseases
561890|NCT00788151|Dengue vaccine|dengue vaccine
561891|NCT00788138|Cystic Fibrosis|cystic fibrosis
561892|NCT00788138|Vitamin D|vitamin d
561893|NCT00788138|Anti-microbial peptides|anti-microbial peptides
561894|NCT00788125|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
561895|NCT00788125|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
561896|NCT00788125|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
561897|NCT00788125|metastatic osteosarcoma|metastatic osteosarcoma
561898|NCT00788125|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
561899|NCT00788125|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
561900|NCT00788125|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
561901|NCT00788125|recurrent osteosarcoma|recurrent osteosarcoma
561902|NCT00788125|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
561903|NCT00788125|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
561904|NCT00788125|recurrent neuroblastoma|recurrent neuroblastoma
561905|NCT00788125|stage 4S neuroblastoma|stage 4s neuroblastoma
561906|NCT00788125|childhood extracranial germ cell tumor|childhood extracranial germ cell tumor
561907|NCT00788125|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
561908|NCT00788125|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
561909|NCT00788125|childhood teratoma|childhood teratoma
561910|NCT00788125|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
561911|NCT00788125|childhood renal cell carcinoma|childhood renal cell carcinoma
561912|NCT00788125|recurrent renal cell cancer|recurrent renal cell cancer
561913|NCT00788125|congenital mesoblastic nephroma|congenital mesoblastic nephroma
561914|NCT00788125|cystic nephroma|cystic nephroma
561915|NCT00788125|peripheral primitive neuroectodermal tumor of the kidney|peripheral primitive neuroectodermal tumor of the kidney
561916|NCT00788125|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
561917|NCT00788125|disseminated neuroblastoma|disseminated neuroblastoma
561918|NCT00788125|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
561919|NCT00788125|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
561920|NCT00788125|recurrent childhood liver cancer|recurrent childhood liver cancer
561921|NCT00788125|stage IV childhood liver cancer|stage iv childhood liver cancer
561922|NCT00788125|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
561923|NCT00788125|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
561924|NCT00788125|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
561925|NCT00788125|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
561926|NCT00788125|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
561927|NCT00788125|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
561928|NCT00788125|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
561929|NCT00788125|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
561930|NCT00788125|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
561931|NCT00788125|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
561932|NCT00788125|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
561933|NCT00788125|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
561934|NCT00788125|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
561935|NCT00788125|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
561936|NCT00788125|Burkitt lymphoma|burkitt lymphoma
561937|NCT00788125|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
561938|NCT00788125|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
561939|NCT00788125|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
561940|NCT00788125|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
561941|NCT00788125|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
561942|NCT00788125|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
562055|NCT00787813|Cervical cerclage|cervical cerclage
561943|NCT00788125|childhood central nervous system germinoma|childhood central nervous system germinoma
561944|NCT00788125|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
561945|NCT00788125|childhood central nervous system teratoma|childhood central nervous system teratoma
561946|NCT00788125|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
561947|NCT00788125|recurrent childhood central nervous system embryonal tumor|recurrent childhood central nervous system embryonal tumor
561948|NCT00788125|childhood choroid plexus tumor|childhood choroid plexus tumor
562188|NCT00787644|Wheezing|wheezing
561949|NCT00788125|childhood craniopharyngioma|childhood craniopharyngioma
561950|NCT00788125|childhood ependymoblastoma|childhood ependymoblastoma
561951|NCT00788125|childhood medulloepithelioma|childhood medulloepithelioma
561952|NCT00788125|childhood infratentorial ependymoma|childhood infratentorial ependymoma
561953|NCT00788125|childhood supratentorial ependymoma|childhood supratentorial ependymoma
561954|NCT00788125|childhood oligodendroglioma|childhood oligodendroglioma
561955|NCT00788125|childhood pineal parenchymal tumor|childhood pineal parenchymal tumor
561956|NCT00788125|childhood grade I meningioma|childhood grade i meningioma
561957|NCT00788125|childhood grade II meningioma|childhood grade ii meningioma
561958|NCT00788125|childhood grade III meningioma|childhood grade iii meningioma
561959|NCT00788125|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
561960|NCT00788125|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
561961|NCT00788125|recurrent childhood ependymoma|recurrent childhood ependymoma
561962|NCT00788125|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
561963|NCT00788125|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
561964|NCT00788125|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
561965|NCT00788125|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
561966|NCT00788125|recurrent uterine sarcoma|recurrent uterine sarcoma
561967|NCT00788125|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
561968|NCT00788125|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
561969|NCT00788125|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
561970|NCT00788125|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
561971|NCT00788125|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
561972|NCT00788125|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
561973|NCT00788125|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
561974|NCT00788125|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
561975|NCT00788125|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
561976|NCT00788125|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
561977|NCT00788125|recurrent childhood brain tumor|recurrent childhood brain tumor
561978|NCT00788125|recurrent childhood spinal cord neoplasm|recurrent childhood spinal cord neoplasm
561979|NCT00788112|ductal breast carcinoma in situ|ductal breast carcinoma in situ
561980|NCT00788099|Aplidin|aplidin
561981|NCT00788099|Plitidepsin|plitidepsin
561982|NCT00788099|Tumors|tumors
561983|NCT00788099|Lymphomas|lymphomas
561984|NCT00788073|fragile X syndrome|fragile x syndrome
561985|NCT00788073|irritability|irritability
561986|NCT00788073|behavior problems|behavior problems
561987|NCT00788060|Renal Cell Carcinoma|renal cell carcinoma
561988|NCT00788060|Rad001|rad001
561989|NCT00788060|Sutent|sutent
561990|NCT00788034|Relapse prevention|relapse prevention
561991|NCT00788034|GAD|gad
561992|NCT00788034|Maintenance|maintenance
561993|NCT00788034|Double-blind|double-blind
561994|NCT00788034|Multicentre|multicentre
561995|NCT00788021|Transplant|transplant
561996|NCT00788021|Immunity|immunity
561997|NCT00788021|Immunosuppression|immunosuppression
561998|NCT00788008|spinal, joint|spinal, joint
561999|NCT00787995|Mucopolysaccharidosis IV type A|mucopolysaccharidosis iv type a
562000|NCT00787995|MPS IV Type A|mps iv type a
562001|NCT00787995|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
562002|NCT00787995|MPS IVA|mps iva
562003|NCT00787995|Morquio A Syndrome|morquio a syndrome
562004|NCT00787995|Lysosomal Storage Disorder|lysosomal storage disorder
562005|NCT00787995|LSD|lsd
562006|NCT00787995|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
562007|NCT00787995|galactose-6-sulfatase|galactose-6-sulfatase
562008|NCT00787995|GALNS|galns
562009|NCT00787995|enzyme replacement therapy|enzyme replacement therapy
562010|NCT00787995|ERT|ert
562011|NCT00787982|brain|brain
562012|NCT00787982|metastasis|metastasis
562013|NCT00787982|neoplasm|neoplasm
562014|NCT00787982|tumor|tumor
562015|NCT00787982|Patients with secondary brain neoplasms|patients with secondary brain neoplasms
562016|NCT00787982|laser therapy|laser therapy
562017|NCT00787982|laser interstitial thermal therapy|laser interstitial thermal therapy
562018|NCT00787969|stage I mantle cell lymphoma|stage i mantle cell lymphoma
562019|NCT00787969|Stage II Contiguous Mantle Cell Lymphoma|stage ii contiguous mantle cell lymphoma
562020|NCT00787969|Stage II Non-Contiguous Mantle Cell Lymphoma|stage ii non-contiguous mantle cell lymphoma
562021|NCT00787969|Stage III Mantle Cell Lymphoma|stage iii mantle cell lymphoma
562022|NCT00787969|Stage IV Mantle Cell Lymphoma|stage iv mantle cell lymphoma
562023|NCT00787943|Acne|acne
562024|NCT00787930|BPD|bpd
562025|NCT00787917|Cystic Fibrosis|cystic fibrosis
562026|NCT00787917|Allergic Bronchopulmonary Aspergillosis|allergic bronchopulmonary aspergillosis
562027|NCT00787917|omalizumab|omalizumab
562028|NCT00787917|oral corticosteroid use|oral corticosteroid use
562029|NCT00787917|anti-immunoglobulin E|anti-immunoglobulin e
562030|NCT00787904|Osteoporosis, T-cells|osteoporosis, t-cells
562031|NCT00787891|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
562032|NCT00787891|Erosive Gastroesophageal Reflux Disease|erosive gastroesophageal reflux disease
562033|NCT00787891|Ulcerative Gastroesophageal Reflux Disease|ulcerative gastroesophageal reflux disease
562034|NCT00787891|Endoscopy|endoscopy
562035|NCT00787891|Pediatrics|pediatrics
562036|NCT00787891|Rabeprazole|rabeprazole
562037|NCT00787865|Diffusion Tensor Imaging|diffusion tensor imaging
562038|NCT00787865|DTI|dti
562039|NCT00787865|Newborn|newborn
562040|NCT00787865|Krabbe Disease|krabbe disease
562041|NCT00787865|Motor Development|motor development
562042|NCT00787865|Motor Disability|motor disability
562043|NCT00787852|dasatinib|dasatinib
562044|NCT00787852|radiation|radiation
562045|NCT00787852|paclitaxel|paclitaxel
562046|NCT00787852|carboplatin|carboplatin
562047|NCT00787852|NSCLC|nsclc
562048|NCT00787852|safety addition of dasatinib to chemo RT stage III NSCLC|safety addition of dasatinib to chemo rt stage iii nsclc
562049|NCT00787839|type 2 diabetes mellitus|type 2 diabetes mellitus
562050|NCT00787839|prediabetic state|prediabetic state
562051|NCT00787839|mass screening|mass screening
562052|NCT00787839|glucose tolerance test|glucose tolerance test
562053|NCT00787826|Live Vaccine Strain (LVS)|live vaccine strain (lvs)
562054|NCT00787813|N-acetyl cysteine (NAC)|n-acetyl cysteine (nac)
562056|NCT00787813|cervical cerclage for cervical insufficiency|cervical cerclage for cervical insufficiency
562057|NCT00787800|Shock prevention|shock prevention
562058|NCT00787800|Single vs. Dual Chamber|single vs. dual chamber
562059|NCT00787800|Reduce ventricular pacing|reduce ventricular pacing
562060|NCT00787800|Atrial Fibrillation|atrial fibrillation
562061|NCT00787800|Remote Monitoring|remote monitoring
562062|NCT00787800|ICD|icd
562063|NCT00787800|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
562064|NCT00787774|HIV|hiv
562065|NCT00787774|resistance|resistance
562066|NCT00787774|integrase|integrase
562067|NCT00787761|accelerated phase CML|accelerated phase cml
562068|NCT00787761|blastic phase CML|blastic phase cml
562069|NCT00787761|Philadelphia chromosome positive CML|philadelphia chromosome positive cml
562070|NCT00787761|stage I CLL|stage i cll
562071|NCT00787761|stage II CLL|stage ii cll
562072|NCT00787761|stage III CLL|stage iii cll
562073|NCT00787761|stage IV CLL|stage iv cll
562074|NCT00787761|stage I multiple myeloma|stage i multiple myeloma
562075|NCT00787761|stage II multiple myeloma|stage ii multiple myeloma
562076|NCT00787761|stage III multiple myeloma|stage iii multiple myeloma
562077|NCT00787761|adult AML with 11q23 (MLL) abnormalities|adult aml with 11q23 (mll) abnormalities
562078|NCT00787761|adult CML in remission|adult cml in remission
562079|NCT00787761|adult ALL in remission|adult all in remission
562080|NCT00787761|stage IV renal cell cancer|stage iv renal cell cancer
562081|NCT00787761|de novo MDS|de novo mds
562082|NCT00787761|previously treated MDS|previously treated mds
562083|NCT00787761|secondary MDS|secondary mds
562084|NCT00787761|atypical CML, BCR-ABL negative|atypical cml, bcr-abl negative
562085|NCT00787761|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
562086|NCT00787761|MDS/myeloproliferative neoplasm, unclassifiable|mds/myeloproliferative neoplasm, unclassifiable
562087|NCT00787761|primary myelofibrosis|primary myelofibrosis
562088|NCT00787761|chronic neutrophilic leukemia|chronic neutrophilic leukemia
562089|NCT00787761|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
562090|NCT00787761|clear cell renal cell carcinoma|clear cell renal cell carcinoma
562091|NCT00787761|adult AML with inv(16)(p13;q22)|adult aml with inv(16)(p13;q22)
562092|NCT00787761|adult AML with t(15;17)(q22;q12)|adult aml with t(15;17)(q22;q12)
562093|NCT00787761|adult AML with t(16;16)(p13;q22)|adult aml with t(16;16)(p13;q22)
562094|NCT00787761|adult AML with t(8;21)(q22;q22)|adult aml with t(8;21)(q22;q22)
562095|NCT00787761|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
562096|NCT00787761|AML/transient myeloproliferative disorder|aml/transient myeloproliferative disorder
562097|NCT00787761|Burkitt lymphoma|burkitt lymphoma
562098|NCT00787761|chronic phase CML|chronic phase cml
562099|NCT00787761|extranodal marginal zone B-cell lymphoma of mucosa tissue|extranodal marginal zone b-cell lymphoma of mucosa tissue
562100|NCT00787761|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
562101|NCT00787761|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
562102|NCT00787761|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
562103|NCT00787761|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
562104|NCT00787761|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
562105|NCT00787761|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
562106|NCT00787761|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
562107|NCT00787761|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
562108|NCT00787761|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
562109|NCT00787761|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
562110|NCT00787761|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
562111|NCT00787761|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
562112|NCT00787761|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
562113|NCT00787761|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
562189|NCT00787644|Vermont|vermont
562114|NCT00787761|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
562115|NCT00787761|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
562116|NCT00787761|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
562117|NCT00787761|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
562118|NCT00787761|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
562119|NCT00787761|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
562120|NCT00787761|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
562121|NCT00787761|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
562122|NCT00787761|contiguous st II adult diffuse small cleaved cell lymphoma|contiguous st ii adult diffuse small cleaved cell lymphoma
562123|NCT00787761|noncontiguous st II diffuse small cleaved cell lymphoma|noncontiguous st ii diffuse small cleaved cell lymphoma
562124|NCT00787761|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
562125|NCT00787761|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
562126|NCT00787761|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
562127|NCT00787761|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
562128|NCT00787761|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
562129|NCT00787761|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
562130|NCT00787761|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
562131|NCT00787761|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
562132|NCT00787761|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
562133|NCT00787761|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
562134|NCT00787761|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
562135|NCT00787761|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
562136|NCT00787761|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
562137|NCT00787761|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
562138|NCT00787761|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
562139|NCT00787761|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
562140|NCT00787761|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
562141|NCT00787761|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
562142|NCT00787761|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
562143|NCT00787761|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
562144|NCT00787761|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
562145|NCT00787761|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
562146|NCT00787761|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
562147|NCT00787761|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
562148|NCT00787761|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
562149|NCT00787761|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
562150|NCT00787761|splenic marginal zone lymphoma|splenic marginal zone lymphoma
562151|NCT00787761|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
562152|NCT00787761|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
562153|NCT00787761|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
562154|NCT00787761|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
562155|NCT00787761|anaplastic large cell lymphoma|anaplastic large cell lymphoma
562156|NCT00787761|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
562157|NCT00787748|Cardiovascular|cardiovascular
562159|NCT00787748|Population|population
562160|NCT00787748|Prevalence|prevalence
562161|NCT00787748|Underdiagnosis|underdiagnosis
562162|NCT00787722|High dose immunosuppressive therapy|high dose immunosuppressive therapy
562163|NCT00787722|Hematopoietic stem cell support|hematopoietic stem cell support
562164|NCT00787709|Obesity prevention|obesity prevention
562165|NCT00787709|Health promotion|health promotion
562166|NCT00787709|School based curriculum|school based curriculum
562167|NCT00787696|HIV prevention|hiv prevention
562168|NCT00787696|female adolescent offenders|female adolescent offenders
562169|NCT00787696|sexual risk reduction|sexual risk reduction
562170|NCT00787696|alcohol and other drug abuse|alcohol and other drug abuse
562171|NCT00787683|Patients with ventricular arrhythmias and the prevention of sudden cardiac death|patients with ventricular arrhythmias and the prevention of sudden cardiac death
562172|NCT00787670|Obese|obese
562173|NCT00787670|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
562174|NCT00787670|Gastric Bypass surgery|gastric bypass surgery
562175|NCT00787670|Risk of cardiovascular diseases|risk of cardiovascular diseases
562176|NCT00787657|Clinically Isolated Syndrome (CIS)|clinically isolated syndrome (cis)
562177|NCT00787644|Asthma|asthma
562178|NCT00787644|Adipose Tissue|adipose tissue
562179|NCT00787644|Asthmatics|asthmatics
562180|NCT00787644|Pioglitazone|pioglitazone
562181|NCT00787644|Actos|actos
562182|NCT00787644|Obesity|obesity
562183|NCT00787644|Exacerbation|exacerbation
562184|NCT00787644|Fat|fat
562185|NCT00787644|Overweight|overweight
562186|NCT00787644|Leptin|leptin
562187|NCT00787644|Adiponectin|adiponectin
562190|NCT00787644|Pulmonary|pulmonary
562191|NCT00787644|Lung|lung
562192|NCT00787631|birch pollen pollen allergy|birch pollen pollen allergy
562193|NCT00787631|oral allergy syndrome to apple|oral allergy syndrome to apple
562194|NCT00787631|cross reactivity|cross reactivity
562195|NCT00787631|bet v 1|bet v 1
562196|NCT00787631|mal d 1|mal d 1
562197|NCT00787618|Renal impairment|renal impairment
562198|NCT00787605|Hypertension, diabetes mellitus, aliskiren, hydrochlorothiazide, systolic blood pressure, diastolic blood pressure, amlodipine, stage 2|hypertension, diabetes mellitus, aliskiren, hydrochlorothiazide, systolic blood pressure, diastolic blood pressure, amlodipine, stage 2
562199|NCT00787592|Burns|burns
562200|NCT00787592|children|children
562201|NCT00787592|collagenase|collagenase
562202|NCT00787592|silver sulfadiazine|silver sulfadiazine
562203|NCT00787592|Childhood burns|childhood burns
562204|NCT00787579|Myopia, bifocal, children|myopia, bifocal, children
562205|NCT00787566|Highly emetogenic chemotherapy induced nausea and vomiting|highly emetogenic chemotherapy induced nausea and vomiting
562206|NCT00787553|hysterectomy|hysterectomy
562207|NCT00787553|antibiotic prophylaxis|antibiotic prophylaxis
562208|NCT00787553|bacterial vaginosis|bacterial vaginosis
562209|NCT00787553|tinidazole|tinidazole
562210|NCT00787553|cefazolin|cefazolin
562211|NCT00787540|Coronary disease|coronary disease
562212|NCT00787540|Psychosocial|psychosocial
562213|NCT00787540|Nursing|nursing
562214|NCT00787527|Lymphoma|lymphoma
562215|NCT00787527|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
562216|NCT00787527|SAHA|saha
562217|NCT00787527|Vorinostat|vorinostat
562218|NCT00787527|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
562219|NCT00787527|MSK-390|msk-390
562220|NCT00787527|CHOP|chop
562221|NCT00787527|Cyclophosphamide|cyclophosphamide
562222|NCT00787527|Doxorubicin|doxorubicin
562223|NCT00787527|AD|ad
562224|NCT00787527|Hydroxydaunomycin hydrochloride|hydroxydaunomycin hydrochloride
562225|NCT00787527|Cytoxan|cytoxan
562226|NCT00787527|Neosar|neosar
562227|NCT00787527|Vincristine|vincristine
562228|NCT00787527|Prednisone|prednisone
562229|NCT00787527|Untreated T-cell|untreated t-cell
562230|NCT00787527|T-cell NHL|t-cell nhl
562231|NCT00787527|Peripheral T-cell lymphoma|peripheral t-cell lymphoma
562232|NCT00787527|PTCL|ptcl
562233|NCT00787527|CD 30|cd 30
562234|NCT00787527|Anaplastic large cell lymphoma|anaplastic large cell lymphoma
562235|NCT00787527|Angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
562236|NCT00787527|Intestinal T-cell lymphoma|intestinal t-cell lymphoma
562237|NCT00787527|Subcutaneous panniculitic T-cell lymphoma|subcutaneous panniculitic t-cell lymphoma
562238|NCT00787514|ovarian cancer, folate receptor, plasma|ovarian cancer, folate receptor, plasma
562239|NCT00787501|Major Depressive Disorder|major depressive disorder
562240|NCT00787501|Depression|depression
562241|NCT00787501|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors
562242|NCT00787501|Cognitive Behavior Therapy|cognitive behavior therapy
562243|NCT00787501|Cognitive Therapy|cognitive therapy
562244|NCT00787501|antidepressant medications|antidepressant medications
562245|NCT00787488|Ovarian|ovarian
562246|NCT00787488|debulked|debulked
562247|NCT00787488|recurrent|recurrent
562248|NCT00787488|Stage III|stage iii
562249|NCT00787488|Stage IV|stage iv
562250|NCT00787475|Diabetes|diabetes
562251|NCT00787475|Community health worker|community health worker
562252|NCT00787475|Community outreach|community outreach
562253|NCT00787462|Neuropathic|neuropathic
562254|NCT00787462|Neuropathic pain|neuropathic pain
562255|NCT00787462|Nerve pain|nerve pain
562256|NCT00787462|Pain|pain
562257|NCT00787462|Chronic pain|chronic pain
562258|NCT00787462|Pregabalin|pregabalin
562259|NCT00787462|Lyrica|lyrica
562260|NCT00787462|Small fiber neuropathy|small fiber neuropathy
562261|NCT00787462|Neuropathy|neuropathy
562262|NCT00787436|portal hypertension|portal hypertension
562263|NCT00787436|Gastroesophageal|gastroesophageal
562264|NCT00787436|Varices|varices
562265|NCT00787436|Liver disease|liver disease
562266|NCT00787436|cirrhosis|cirrhosis
562267|NCT00787423|Field Tools|field tools
562268|NCT00787423|Drug Use|drug use
562269|NCT00787423|Psychological Stress|psychological stress
562270|NCT00787423|Ecological Momentary Assessment|ecological momentary assessment
562271|NCT00787423|Global Positioning Units|global positioning units
562272|NCT00787410|malignant mesothelioma|malignant mesothelioma
562273|NCT00787410|IRESSA|iressa
562274|NCT00787410|ZD1839|zd1839
562275|NCT00787397|Sleep difficulties in pediatric anxiety disorder|sleep difficulties in pediatric anxiety disorder
562276|NCT00787397|Neural correlates of pediatric anxiety disorder|neural correlates of pediatric anxiety disorder
562277|NCT00787397|Social correlates of pediatric anxiety disorder|social correlates of pediatric anxiety disorder
562278|NCT00787397|Generalized Anxiety Disorder in pediatric populations|generalized anxiety disorder in pediatric populations
562279|NCT00787397|Separation Anxiety Disorder in pediatric populations|separation anxiety disorder in pediatric populations
562280|NCT00787397|Social Phobia in pediatric populations|social phobia in pediatric populations
562281|NCT00787384|Hypereosinophilic syndrome (HES)|hypereosinophilic syndrome (hes)
562282|NCT00787384|chronic eosinophilic leukaemia (CEL)|chronic eosinophilic leukaemia (cel)
562283|NCT00787384|chronic idiopathic hypereosinophilia (CIH)|chronic idiopathic hypereosinophilia (cih)
562284|NCT00787384|Imatinib|imatinib
562285|NCT00787384|Response|response
562286|NCT00787384|Timing to response|timing to response
562287|NCT00787371|alanine transaminase|alanine transaminase
562288|NCT00787358|osteoporosis|osteoporosis
562289|NCT00787358|intertrochanteric|intertrochanteric
562290|NCT00787358|hip fracture|hip fracture
562291|NCT00787358|compression hip screw|compression hip screw
562292|NCT00787358|surgical fixation|surgical fixation
562293|NCT00787345|precaution technique during central venous catheter placement.|precaution technique during central venous catheter placement.
562294|NCT00787332|Suspected Heparin Induced Thrombocytopenia (HIT)|suspected heparin induced thrombocytopenia (hit)
562295|NCT00787319|Ophthalmology|ophthalmology
562296|NCT00787319|Age-related macular degeneration|age-related macular degeneration
562297|NCT00787319|outpatients|outpatients
562298|NCT00787306|chronic disease management|chronic disease management
562299|NCT00787306|decision aids|decision aids
562300|NCT00787306|cardiovascular risk factors|cardiovascular risk factors
562301|NCT00787293|Heart Failure|heart failure
562302|NCT00787293|Mitral Regurgitation|mitral regurgitation
562303|NCT00787293|Percutaneous|percutaneous
562304|NCT00787293|Coronary sinus|coronary sinus
562305|NCT00787280|obese|obese
562306|NCT00787280|overweight|overweight
562307|NCT00787280|fMRI|fmri
562308|NCT00787280|Diet|diet
562309|NCT00787267|NSCLC|nsclc
562310|NCT00787267|Lung Cancer|lung cancer
562311|NCT00787267|Dasatinib|dasatinib
562312|NCT00787267|Genomics|genomics
562313|NCT00787267|Genomics analysis|genomics analysis
562314|NCT00787267|Genomic signature|genomic signature
562315|NCT00787254|Curling Ulcer|curling ulcer
562316|NCT00787254|Gastric Ulcer|gastric ulcer
562317|NCT00787254|Nonsteroid anti-inflammatory drug|nonsteroid anti-inflammatory drug
562318|NCT00787254|Drug Therapy|drug therapy
562319|NCT00787241|Platelets|platelets
562320|NCT00787241|Labor|labor
562321|NCT00787241|Preeclampsia|preeclampsia
562322|NCT00787215|oral glucose tolerance test|oral glucose tolerance test
562323|NCT00787215|Hong Kong Chinese|hong kong chinese
562324|NCT00787202|treatment of ulcerative colitis; CP 690 550|treatment of ulcerative colitis; cp 690 550
562325|NCT00787189|sensorineural hearing loss|sensorineural hearing loss
562326|NCT00787189|tinnitus|tinnitus
562327|NCT00787189|word recognition|word recognition
562328|NCT00787176|Oxytocin|oxytocin
562329|NCT00787176|Labor, Obstetric|labor, obstetric
562330|NCT00787176|Non-reassuring fetal heart rate|non-reassuring fetal heart rate
562331|NCT00787176|epidural|epidural
562332|NCT00787163|pPROM|pprom
562333|NCT00787163|oligohydramnios|oligohydramnios
562334|NCT00787163|amnioinfusion|amnioinfusion
562335|NCT00787163|prematurity|prematurity
562336|NCT00787163|Early premature rupture of membranes in pregnancy|early premature rupture of membranes in pregnancy
562337|NCT00787111|Drug: Fluoxetine|drug: fluoxetine
562338|NCT00787098|therapeutic mobility|therapeutic mobility
562339|NCT00787098|acute care|acute care
562340|NCT00787098|nursing|nursing
562341|NCT00787098|inflammatory markers|inflammatory markers
562342|NCT00787085|Funguria|funguria
562343|NCT00787085|Epidemiology|epidemiology
562344|NCT00787085|Urinary Tract Infections|urinary tract infections
562345|NCT00787059|Adenylyl Cyclase|adenylyl cyclase
562346|NCT00787059|AC6|ac6
562347|NCT00787059|adenovirus|adenovirus
562348|NCT00787059|gene therapy|gene therapy
562349|NCT00787059|congestive heart failure|congestive heart failure
562350|NCT00787059|intracoronary|intracoronary
562351|NCT00787059|nitroprusside|nitroprusside
562352|NCT00787033|Focal Adhesion Kinase; Advanced Non-Hematologic Malignancies|focal adhesion kinase; advanced non-hematologic malignancies
562353|NCT00787020|Cerebrospinal Fluid|cerebrospinal fluid
562354|NCT00787020|Ventriculostomy|ventriculostomy
562355|NCT00787020|Subarachnoid hemorrhage|subarachnoid hemorrhage
562356|NCT00787020|vasospasm|vasospasm
562357|NCT00787020|Human Subjects|human subjects
562358|NCT00787007|healthy volunteers|healthy volunteers
562359|NCT00787007|pharmacokinetics|pharmacokinetics
562360|NCT00786994|Actinic Keratoses|actinic keratoses
562361|NCT00786968|mucopolysaccharidosis|mucopolysaccharidosis
562362|NCT00786968|Hurler-Scheie|hurler-scheie
562363|NCT00786968|Scheie|scheie
562364|NCT00786968|laronidase|laronidase
562365|NCT00786968|spinal cord compression|spinal cord compression
562366|NCT00786968|central nervous system|central nervous system
562367|NCT00786968|enzyme replacement therapy|enzyme replacement therapy
562368|NCT00786968|intrathecal|intrathecal
562369|NCT00786942|osteotomy|osteotomy
562370|NCT00786942|knee|knee
562371|NCT00786942|varus deformity|varus deformity
562372|NCT00786942|bone graft|bone graft
562373|NCT00786929|Conversion to more aggressive treatment of recurrent fluid collection|conversion to more aggressive treatment of recurrent fluid collection
562374|NCT00786916|pain|pain
562375|NCT00786916|propofol|propofol
562376|NCT00786916|lidocaine|lidocaine
562377|NCT00786916|sedation|sedation
562378|NCT00786916|pediatric|pediatric
562379|NCT00786890|Prediabetes (IFG, IGT)|prediabetes (ifg, igt)
562380|NCT00786890|Hong Kong Chinese|hong kong chinese
562381|NCT00786890|Cardiovascular risk factors|cardiovascular risk factors
562382|NCT00786877|pneumonia|pneumonia
562383|NCT00786864|Randomised controlled trial|randomised controlled trial
562384|NCT00786864|low back pain|low back pain
562385|NCT00786864|exercise|exercise
562386|NCT00786864|children|children
562387|NCT00786864|school-based|school-based
562388|NCT00786864|prevalence|prevalence
562389|NCT00786864|intensity|intensity
562390|NCT00786851|MANTLE CELL LYMPHOMA (MCL)|mantle cell lymphoma (mcl)
562391|NCT00786851|Lenalidomide (Len)|lenalidomide (len)
562392|NCT00786851|Dexamethasone (Dex)|dexamethasone (dex)
562393|NCT00786838|Solid tumor|solid tumor
562394|NCT00786838|Advanced solid tumor|advanced solid tumor
562395|NCT00786838|Malignant tumors|malignant tumors
562396|NCT00786838|Sarcoma|sarcoma
562397|NCT00786838|Breast tumor|breast tumor
562398|NCT00786838|Ovarian tumor|ovarian tumor
562399|NCT00786838|QT interval|qt interval
562400|NCT00786838|Trabectedin|trabectedin
562401|NCT00786838|Yondelis|yondelis
562402|NCT00786838|Ecteinascidin 743|ecteinascidin 743
562403|NCT00786838|ET743|et743
562404|NCT00786825|Type 1 diabetes|type 1 diabetes
562405|NCT00786825|Hypoglycemia unawareness|hypoglycemia unawareness
562406|NCT00786812|Leukemia|leukemia
562407|NCT00786812|adult chronic myeloid leukemia|adult chronic myeloid leukemia
562408|NCT00786812|imatinib|imatinib
562409|NCT00786812|nilotinib|nilotinib
562410|NCT00786786|Any person with a spinal cord injury|any person with a spinal cord injury
562411|NCT00786786|at least 18 years of age|at least 18 years of age
562412|NCT00786773|GERD|gerd
562413|NCT00786773|reflux symptom|reflux symptom
562414|NCT00786773|heartburn|heartburn
562415|NCT00786773|acid regurgitation|acid regurgitation
562416|NCT00786773|PPI|ppi
562417|NCT00786773|H2RA|h2ra
562418|NCT00786773|antacid|antacid
562419|NCT00786760|HPV|hpv
562420|NCT00786760|Papillomavirus|papillomavirus
562421|NCT00786760|Infection|infection
562422|NCT00786760|Sexually transmitted disease|sexually transmitted disease
562423|NCT00786760|STD|std
562424|NCT00786747|Computer-assisted instruction|computer-assisted instruction
562425|NCT00786747|Health knowledge, attitudes, practice|health knowledge, attitudes, practice
562426|NCT00786747|Mass screening|mass screening
562427|NCT00786747|Patient acceptance of health care|patient acceptance of health care
562428|NCT00786747|Patient education as topic|patient education as topic
562429|NCT00786747|Primary health care|primary health care
562430|NCT00786747|Self-efficacy|self-efficacy
562431|NCT00786734|pitavastatin|pitavastatin
562432|NCT00786734|PCI|pci
562433|NCT00786734|stable angina|stable angina
562434|NCT00786721|Mitochondria and Metabolic Syndrome|mitochondria and metabolic syndrome
562435|NCT00786708|renal|renal
562436|NCT00786708|kidney|kidney
562437|NCT00786708|lipocalin|lipocalin
562438|NCT00786708|urine|urine
562439|NCT00786708|biomarker|biomarker
562440|NCT00786708|Azotemia|azotemia
562441|NCT00786708|Renal insufficiency, chronic|renal insufficiency, chronic
562442|NCT00786708|Renal failure, acute|renal failure, acute
562443|NCT00786708|Hydronephrosis|hydronephrosis
562444|NCT00786695|noncardiac chest pain|noncardiac chest pain
562445|NCT00786695|gastroesophageal reflux disease|gastroesophageal reflux disease
562446|NCT00786695|diagnostic test|diagnostic test
562447|NCT00786695|proton pump inhibitor|proton pump inhibitor
562448|NCT00786695|esomeprazole|esomeprazole
562449|NCT00786682|stage IV prostate cancer|stage iv prostate cancer
562450|NCT00786682|recurrent prostate cancer|recurrent prostate cancer
562451|NCT00786656|Navigation|navigation
562452|NCT00786656|Coordination|coordination
562453|NCT00786656|Cancer Care|cancer care
562454|NCT00786656|Patient Experience|patient experience
562455|NCT00786656|Cancer|cancer
562456|NCT00786656|Patient Survey|patient survey
562457|NCT00786643|Gamma Interferon|gamma interferon
562458|NCT00786643|5-FU|5-fu
562459|NCT00786643|LV|lv
562460|NCT00786630|Drug treatment entry and retention|drug treatment entry and retention
562461|NCT00786630|Drug injection frequency|drug injection frequency
562462|NCT00786630|HIV risk behaviors|hiv risk behaviors
562463|NCT00786630|Hepatitis C risk behaviors|hepatitis c risk behaviors
562464|NCT00786591|Acute pancreatitis|acute pancreatitis
562465|NCT00786591|biological markers|biological markers
562466|NCT00786591|substance P|substance p
562467|NCT00786591|hydrogen sulfide|hydrogen sulfide
562468|NCT00786591|disease severity index|disease severity index
562469|NCT00786578|training|training
562470|NCT00786578|intramyocellular lipid|intramyocellular lipid
562471|NCT00786578|insulin resistance|insulin resistance
562472|NCT00786552|recurrent/advanced thyroid cancer|recurrent/advanced thyroid cancer
562473|NCT00786552|papillary or anaplastic thyroid cancer|papillary or anaplastic thyroid cancer
562474|NCT00786539|mitochondrial|mitochondrial
562475|NCT00786526|Mechanical ventilation|mechanical ventilation
562476|NCT00786526|Ventilator induced diaphragmatic dysfunction|ventilator induced diaphragmatic dysfunction
562477|NCT00786526|Weaning|weaning
562478|NCT00786526|Neuromuscular diseases- Respiratory function tests|neuromuscular diseases- respiratory function tests
562479|NCT00786526|Intubated patients in intensive care unit|intubated patients in intensive care unit
562480|NCT00786513|Cystic fibrosis|cystic fibrosis
562481|NCT00786513|Pseudomonas aeruginosa|pseudomonas aeruginosa
562482|NCT00786513|biofilm|biofilm
562483|NCT00786513|antibiotic susceptibility testing|antibiotic susceptibility testing
562484|NCT00786513|pediatrics|pediatrics
562485|NCT00786500|Herbal medicine|herbal medicine
562486|NCT00786500|Type 2 diabetes|type 2 diabetes
562487|NCT00786500|Insulin sensitivity|insulin sensitivity
562488|NCT00786500|Insulin secretion|insulin secretion
562489|NCT00786487|insulin resistance|insulin resistance
562490|NCT00786487|lipid metabolism|lipid metabolism
562491|NCT00786487|lipid infusion|lipid infusion
562492|NCT00786487|glycerol infusion|glycerol infusion
562493|NCT00786487|skeletal muscle|skeletal muscle
562494|NCT00786487|diabetes|diabetes
562495|NCT00786474|Bridging Anticoagulation|bridging anticoagulation
562496|NCT00786461|silver nitrate|silver nitrate
562497|NCT00786461|marsupialisation|marsupialisation
562498|NCT00786448|Overactive Bladder|overactive bladder
562499|NCT00786422|Embolism and Thrombosis|embolism and thrombosis
562500|NCT00786422|Pulmonary Embolism|pulmonary embolism
562501|NCT00786422|Embolism|embolism
562502|NCT00786422|Venous Thrombosis|venous thrombosis
562503|NCT00786422|Thrombosis|thrombosis
562504|NCT00786422|Enzyme Inducers|enzyme inducers
562505|NCT00786422|CYP Inducers|cyp inducers
562506|NCT00786422|Cohort Study|cohort study
562507|NCT00786422|Pharmacologic Actions|pharmacologic actions
562508|NCT00786422|Respiratory Tract Diseases|respiratory tract diseases
562509|NCT00786422|Lung Diseases|lung diseases
562510|NCT00786422|Vascular Diseases|vascular diseases
562511|NCT00786422|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
562512|NCT00786422|Neurologic disease|neurologic disease
562513|NCT00786422|Additional relevant MeSH terms:|additional relevant mesh terms:
562514|NCT00786422|Fibrin Modulating Agents|fibrin modulating agents
562515|NCT00786422|Anticoagulants|anticoagulants
562516|NCT00786422|Therapeutic Uses|therapeutic uses
562517|NCT00786422|Hematologic Agents|hematologic agents
562518|NCT00786422|Enzyme Inhibitors|enzyme inhibitors
562519|NCT00786422|Cardiovascular Diseases|cardiovascular diseases
562520|NCT00786422|Cardiovascular Agents|cardiovascular agents
562521|NCT00786409|Lupus|lupus
562522|NCT00786396|HIV|hiv
562523|NCT00786396|AIDS|aids
562524|NCT00786396|substance abuse|substance abuse
562525|NCT00786396|directly administered antiretroviral therapy|directly administered antiretroviral therapy
562526|NCT00786396|adherence|adherence
562527|NCT00786396|Substance Abuse and Dependency|substance abuse and dependency
562528|NCT00786383|Phase I|phase i
562529|NCT00786383|cancer|cancer
562530|NCT00786383|solid tumors|solid tumors
562531|NCT00786383|1121B|1121b
562532|NCT00786383|VEGFR-2|vegfr-2
562533|NCT00786383|Anti-Vascular Endothelial Growth Factor Receptor 2|anti-vascular endothelial growth factor receptor 2
562534|NCT00786370|propofol|propofol
562535|NCT00786370|dexmedetomidine|dexmedetomidine
562536|NCT00786370|cataract|cataract
562537|NCT00786370|respiratory|respiratory
562538|NCT00786370|blood pressure|blood pressure
562539|NCT00786370|Cataract surgery|cataract surgery
562540|NCT00786357|shift-work|shift-work
562541|NCT00786357|sleep|sleep
562542|NCT00786357|nurse|nurse
562543|NCT00786357|relaxation|relaxation
562544|NCT00786344|Health Promotion: Wellness Programs|health promotion: wellness programs
562545|NCT00786344|Occupational Therapy|occupational therapy
562546|NCT00786344|Quality of Life|quality of life
562547|NCT00786344|Health|health
562548|NCT00786344|Biomarkers|biomarkers
562549|NCT00786331|second line treatment|second line treatment
562550|NCT00786331|pemetrexed|pemetrexed
562551|NCT00786331|carboplatin|carboplatin
562552|NCT00786318|Psychosis|psychosis
562553|NCT00786318|Agitation|agitation
562554|NCT00786318|Delirium|delirium
562555|NCT00786305|Nebulization|nebulization
562556|NCT00786305|ceftazidime|ceftazidime
562557|NCT00786305|amikacin|amikacin
562558|NCT00786305|pneumonia|pneumonia
562559|NCT00786305|Pseudomonas aeruginosa|pseudomonas aeruginosa
562560|NCT00786305|mechanical ventilation|mechanical ventilation
562561|NCT00786305|Ventilator-associated pneumonia|ventilator-associated pneumonia
562562|NCT00786305|treatment|treatment
562563|NCT00786279|atherosclerosis|atherosclerosis
562564|NCT00786266|shift-work|shift-work
562565|NCT00786266|sleep|sleep
562566|NCT00786266|nurse|nurse
562567|NCT00786266|relaxation|relaxation
562568|NCT00786253|Erectile dysfunction|erectile dysfunction
562569|NCT00786253|Vardenafil|vardenafil
562570|NCT00786240|Bioequivalence|bioequivalence
562571|NCT00786240|Therapeutic Equivalency|therapeutic equivalency
562572|NCT00786214|Functional Dyspepsia|functional dyspepsia
562573|NCT00786214|Acupuncture|acupuncture
562574|NCT00786214|Traditional Chinese Medicine|traditional chinese medicine
562575|NCT00786201|CNTO 888|cnto 888
562576|NCT00786201|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
562577|NCT00786201|IPF|ipf
562578|NCT00786188|Menopause|menopause
562579|NCT00786188|Vasomotor Symptoms|vasomotor symptoms
562580|NCT00786188|Hot flash|hot flash
562581|NCT00786188|Perimenopause|perimenopause
562582|NCT00786188|Nonhormonal therapies|nonhormonal therapies
562583|NCT00786188|Climacteric symptoms|climacteric symptoms
562584|NCT00786188|Mesafem|mesafem
562585|NCT00786188|Low-Dose Mesylate salt of Paroxetine (LDMP)|low-dose mesylate salt of paroxetine (ldmp)
562586|NCT00786149|Underserved populations|underserved populations
562587|NCT00786149|Homelessness|homelessness
562588|NCT00786149|Nicotine replacement therapy|nicotine replacement therapy
562589|NCT00786149|Counseling|counseling
562590|NCT00786149|Cancer Prevention and control|cancer prevention and control
562591|NCT00786136|diabetes mellitus|diabetes mellitus
562592|NCT00786136|chronic kidney disease|chronic kidney disease
562593|NCT00786136|contrast induced acute kidney injury|contrast induced acute kidney injury
562594|NCT00786136|angiography|angiography
562595|NCT00786123|irritable bowel syndrome|irritable bowel syndrome
562596|NCT00786123|rectal hypersensitivity|rectal hypersensitivity
562597|NCT00786123|probiotics|probiotics
562598|NCT00786123|melatonin|melatonin
562599|NCT00786123|brain-gut axis|brain-gut axis
562600|NCT00786110|Sorafenib|sorafenib
562601|NCT00786110|Paclitaxel|paclitaxel
562602|NCT00786110|Disease free survival|disease free survival
562603|NCT00786084|Hiatal hernia|hiatal hernia
562604|NCT00786084|PEH|peh
562605|NCT00786084|paraesophageal hernia|paraesophageal hernia
562606|NCT00786084|synthetic mesh|synthetic mesh
562607|NCT00786084|small intestine submucosa|small intestine submucosa
562608|NCT00786071|Rett syndrome.|rett syndrome.
562609|NCT00786071|Nutritional status.|nutritional status.
562610|NCT00786071|Metabolic alterations.|metabolic alterations.
562611|NCT00786058|refractory pancreatic cancer|refractory pancreatic cancer
562612|NCT00786058|gemcitabine|gemcitabine
562613|NCT00786058|phase III|phase iii
562614|NCT00786058|second line|second line
562615|NCT00786045|stroke|stroke
562616|NCT00786045|rehabilitation|rehabilitation
562617|NCT00786045|walking|walking
562618|NCT00786032|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
562619|NCT00786032|Brain Computer Interface (BCI)|brain computer interface (bci)
562620|NCT00786032|Lou Gehrig's disease|lou gehrig's disease
562621|NCT00786019|Type|type
562622|NCT00786019|2|2
562623|NCT00786019|Diabetes|diabetes
562624|NCT00786019|Blood|blood
562625|NCT00786019|Vessel|vessel
562626|NCT00786019|Function|function
562627|NCT00786019|Exercise|exercise
562628|NCT00786019|Program|program
562629|NCT00786019|Intervention|intervention
562630|NCT00786019|Vitamin|vitamin
562631|NCT00786019|C|c
562632|NCT00786019|Men|men
562633|NCT00786019|Women|women
562634|NCT00786019|Blood vessel function|blood vessel function
562635|NCT00786006|pancreatic cancer|pancreatic cancer
562636|NCT00786006|gemcitabine|gemcitabine
562637|NCT00786006|oxaliplatin|oxaliplatin
562638|NCT00786006|irinotecan|irinotecan
562639|NCT00786006|fluorouracil|fluorouracil
562640|NCT00786006|Failure to gemcitabine chemotherapy|failure to gemcitabine chemotherapy
562641|NCT00785993|Egg banking, clinical outcome|egg banking, clinical outcome
562642|NCT00785980|quinine sulfate|quinine sulfate
562643|NCT00785980|ciprofloxacin|ciprofloxacin
562644|NCT00785980|drug interactions|drug interactions
562645|NCT00785980|cytochrome p450|cytochrome p450
562646|NCT00785980|male|male
562647|NCT00785980|female|female
562648|NCT00785980|adult|adult
562649|NCT00785980|pharmacokinetics|pharmacokinetics
562650|NCT00785967|V(D)J recombination; RAG-1/2 recombinase function|v(d)j recombination; rag-1/2 recombinase function
562651|NCT00785954|Heart Diseases|heart diseases
562652|NCT00785954|Myocardial Ischemia|myocardial ischemia
562653|NCT00785954|Infarction|infarction
562654|NCT00785954|Myocardial Infarction|myocardial infarction
562655|NCT00785941|Tumors|tumors
562656|NCT00785941|Antibodies, Monoclonal|antibodies, monoclonal
562657|NCT00785928|Arthritis|arthritis
562658|NCT00785915|AZD6765|azd6765
562659|NCT00785915|Japanese and Caucasian Healthy Volunteers|japanese and caucasian healthy volunteers
562660|NCT00785915|Phase I study|phase i study
562661|NCT00785915|Single and multiple Ascending Dose|single and multiple ascending dose
562662|NCT00785915|Japanese volunteers|japanese volunteers
562663|NCT00785889|Colorectal cancer screening|colorectal cancer screening
562664|NCT00785889|optical colonoscopy|optical colonoscopy
562665|NCT00785889|water method|water method
562666|NCT00785889|sedation|sedation
562667|NCT00785876|Paediatric|paediatric
562668|NCT00785876|Emergency Department|emergency department
562669|NCT00785876|Ankle|ankle
562670|NCT00785876|Injury|injury
562671|NCT00785876|Low risk ankle rule|low risk ankle rule
562672|NCT00785863|hyperalgesia|hyperalgesia
562673|NCT00785863|remifentanil|remifentanil
562674|NCT00785863|ketorolac|ketorolac
562675|NCT00785863|parecoxib|parecoxib
562676|NCT00785863|COX-1 inhibitor|cox-1 inhibitor
562677|NCT00785863|COX-2 inhibitor|cox-2 inhibitor
562678|NCT00785837|Hydrotherapy|hydrotherapy
562679|NCT00785837|Perinatal Care|perinatal care
562680|NCT00785837|Neonatology|neonatology
562681|NCT00785824|Lactation|lactation
562682|NCT00785824|Endocrine System Diseases|endocrine system diseases
562889|NCT00784992|DCR|dcr
562683|NCT00785824|Musculoskeletal System Disease|musculoskeletal system disease
562684|NCT00785824|Hormone|hormone
562685|NCT00785824|Physiological Properties|physiological properties
562686|NCT00785798|Relapsed Lymphomas|relapsed lymphomas
562687|NCT00785798|Refractory Lymphomas|refractory lymphomas
562688|NCT00785785|Unresectable GIST|unresectable gist
562689|NCT00785785|metastatic GIST|metastatic gist
562690|NCT00785785|nilotinib|nilotinib
562691|NCT00785785|AMN107|amn107
562692|NCT00785785|imatinib|imatinib
562693|NCT00785785|STI571|sti571
562694|NCT00785772|Gabapentin Pharmacokinetics|gabapentin pharmacokinetics
562695|NCT00785759|Alzheimer's Disease|alzheimer's disease
562696|NCT00785746|elderly, balance, core, strength|elderly, balance, core, strength
562697|NCT00785733|asthma|asthma
562698|NCT00785707|sensorineural hearing loss|sensorineural hearing loss
562699|NCT00785707|cochlear implant|cochlear implant
562700|NCT00785668|Asthma|asthma
562701|NCT00785668|Allergy|allergy
562702|NCT00785668|Interleukin-4|interleukin-4
562703|NCT00785668|Interleukin-13|interleukin-13
562704|NCT00785668|IL-4|il-4
562705|NCT00785668|IL-13|il-13
562706|NCT00785668|Pharmacokinetics|pharmacokinetics
562707|NCT00785668|Safety|safety
562708|NCT00785668|Tolerability|tolerability
562709|NCT00785668|Aerovance|aerovance
562710|NCT00785668|dry powder|dry powder
562711|NCT00785629|phosphorus|phosphorus
562712|NCT00785629|secondary hyperparathyroidism|secondary hyperparathyroidism
562713|NCT00785629|vascular calcification|vascular calcification
562714|NCT00785616|HIV|hiv
562715|NCT00785616|Adherence|adherence
562716|NCT00785616|MEMS|mems
562717|NCT00785603|Depression|depression
562718|NCT00785603|pain|pain
562719|NCT00785603|CYP2D6|cyp2d6
562720|NCT00785603|interactions|interactions
562721|NCT00785603|Pupillometry|pupillometry
562722|NCT00785603|Tramadol|tramadol
562723|NCT00785603|Paroxetine|paroxetine
562724|NCT00785603|MR-ratio|mr-ratio
562725|NCT00785564|T-wave memory|t-wave memory
562726|NCT00785564|Sick Sinus Syndrome|sick sinus syndrome
562727|NCT00785551|male|male
562728|NCT00785551|female|female
562729|NCT00785551|pharmacokinetics|pharmacokinetics
562730|NCT00785551|normal and impaired renal function|normal and impaired renal function
562731|NCT00785538|Tumors|tumors
562732|NCT00785538|Antibodies, Monoclonal|antibodies, monoclonal
562733|NCT00785525|Healthy Unrelated Stem Cell Donors|healthy unrelated stem cell donors
562734|NCT00785512|nebivolol|nebivolol
562735|NCT00785512|Bystolic®|bystolic®
562736|NCT00785512|Hypertension|hypertension
562737|NCT00785512|blood pressure|blood pressure
562738|NCT00785512|withdrawal|withdrawal
562739|NCT00785499|obesity|obesity
562740|NCT00785499|metabolic syndrome|metabolic syndrome
562741|NCT00785499|milk components|milk components
562742|NCT00785499|casein|casein
562743|NCT00785499|whey|whey
562744|NCT00785499|children|children
562745|NCT00785499|adolescent|adolescent
562746|NCT00785486|midazolam|midazolam
562747|NCT00785486|drug interactions|drug interactions
562748|NCT00785486|cytochrome p450|cytochrome p450
562749|NCT00785447|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
562750|NCT00785447|Respiratory Physiology|respiratory physiology
562751|NCT00785447|Mouth to mouth ventilation|mouth to mouth ventilation
562752|NCT00785447|Mouth to nose ventilation|mouth to nose ventilation
562753|NCT00785434|MDD|mdd
562754|NCT00785434|escitalopram|escitalopram
562755|NCT00785421|heparin|heparin
562756|NCT00785421|LMWH|lmwh
562757|NCT00785421|pancreatic cancer|pancreatic cancer
562758|NCT00785408|obesity|obesity
562759|NCT00785408|overweight|overweight
562760|NCT00785408|weight loss|weight loss
562761|NCT00785408|Amylin|amylin
562762|NCT00785408|AC2307|ac2307
562763|NCT00785382|Pain, Pregabalin, Lyrica, Breast surgery|pain, pregabalin, lyrica, breast surgery
562764|NCT00785369|skin disorders|skin disorders
562765|NCT00785369|skin cancer|skin cancer
562766|NCT00785369|melanoma|melanoma
562767|NCT00785369|lentigo maligna|lentigo maligna
562768|NCT00785356|Uterine fibroids|uterine fibroids
562769|NCT00785356|Anemia|anemia
562770|NCT00785343|stroke|stroke
562771|NCT00785343|acute|acute
562772|NCT00785343|arm|arm
562773|NCT00785343|robot|robot
562774|NCT00785343|therapy|therapy
562775|NCT00785343|arm paresis|arm paresis
562776|NCT00785330|rituximab|rituximab
562777|NCT00785330|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
562778|NCT00785330|diffuse large B cell lymphoma|diffuse large b cell lymphoma
562779|NCT00785330|peripheral t cell lymphoma|peripheral t cell lymphoma
562780|NCT00785330|graft-versus-host disease|graft-versus-host disease
562781|NCT00785330|graft-versus-lymphoma effect|graft-versus-lymphoma effect
562782|NCT00785330|allogeneic haematopoietic stem cell transplantation|allogeneic haematopoietic stem cell transplantation
562783|NCT00785330|relapsed or primary progressive aggressive Non-Hodgkin's lymphoma|relapsed or primary progressive aggressive non-hodgkin's lymphoma
562784|NCT00785317|Postmenopausal Hormone Replacement Therapy|postmenopausal hormone replacement therapy
562785|NCT00785278|Wheelchair Set-Up|wheelchair set-up
562786|NCT00785278|Shoulder Joint Forces|shoulder joint forces
562787|NCT00785278|Manual Wheelchair Users|manual wheelchair users
562788|NCT00785278|Paraplegia|paraplegia
562789|NCT00785278|Upper Limb Pain|upper limb pain
562790|NCT00785278|Secondary Injury to Spinal Cord Injury|secondary injury to spinal cord injury
562791|NCT00785278|Biomechanics|biomechanics
562792|NCT00785265|Live Donor Kidney Transplantation|live donor kidney transplantation
562794|NCT00785265|African Americans|african americans
562795|NCT00785265|Disparity|disparity
562796|NCT00785265|Education|education
562797|NCT00785252|Catheters, Indwelling|catheters, indwelling
562798|NCT00785239|Malignant Airway Disease|malignant airway disease
562799|NCT00785239|Benign Airway Disease|benign airway disease
562800|NCT00785239|Lung Cancer|lung cancer
562801|NCT00785239|Emphysema|emphysema
562802|NCT00785239|Chronic Bronchitis|chronic bronchitis
562803|NCT00785239|COPD|copd
562804|NCT00785239|Asthma|asthma
562805|NCT00785239|Sarcoidosis|sarcoidosis
562806|NCT00785239|Mesothelioma|mesothelioma
562807|NCT00785239|CryoSpray Ablation|cryospray ablation
562808|NCT00785239|Cryotherapy|cryotherapy
562809|NCT00785239|Cryospray|cryospray
562810|NCT00785239|Cryo|cryo
562811|NCT00785213|rosiglitazone|rosiglitazone
562812|NCT00785213|quinine sulfate|quinine sulfate
562813|NCT00785213|drug interactions|drug interactions
562814|NCT00785213|cytochrome p450|cytochrome p450
562815|NCT00785200|MRSA|mrsa
562816|NCT00785200|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
562817|NCT00785200|Chlorhexidine|chlorhexidine
562818|NCT00785200|Asymptomatic colonization|asymptomatic colonization
562819|NCT00785200|Asymptomatic colonization, MRSA|asymptomatic colonization, mrsa
562820|NCT00785200|Skin and soft tissue infections|skin and soft tissue infections
562821|NCT00785187|UVB induced skin erythema|uvb induced skin erythema
562822|NCT00785174|noninvasive ventilation, continuous posi|noninvasive ventilation, continuous posi
562823|NCT00785161|Penumbra System|penumbra system
562824|NCT00785161|Mechanical Thrombectomy|mechanical thrombectomy
562825|NCT00785161|Ischemic Stroke|ischemic stroke
562826|NCT00785161|Intervention|intervention
562827|NCT00785161|Neurovascular|neurovascular
562828|NCT00785161|Thrombus|thrombus
562829|NCT00785161|Imaging|imaging
562830|NCT00785161|Ischemic Penumbra|ischemic penumbra
562831|NCT00785161|Functional Outcome|functional outcome
562832|NCT00785135|vision, binocular|vision, binocular
562833|NCT00785135|vision disparity|vision disparity
562834|NCT00785135|headache|headache
562835|NCT00785135|dizziness|dizziness
562836|NCT00785135|anxiety|anxiety
562837|NCT00785135|neck pain|neck pain
562838|NCT00785135|learning disorders|learning disorders
562839|NCT00785135|asthenopia|asthenopia
562840|NCT00785135|motion sickness|motion sickness
562841|NCT00785135|depth perception|depth perception
562842|NCT00785135|gait disorder|gait disorder
562843|NCT00785135|diplopia|diplopia
562844|NCT00785135|photophobia|photophobia
562845|NCT00785135|agoraphobia|agoraphobia
562846|NCT00785135|panic disorder|panic disorder
562847|NCT00785122|cancer vaccine|cancer vaccine
562848|NCT00785109|aortic valve calcification|aortic valve calcification
562849|NCT00785109|vitamin K supplementation|vitamin k supplementation
562850|NCT00785096|Perception, surgical complications, patients, nurses and physicians|perception, surgical complications, patients, nurses and physicians
562851|NCT00785083|Asthma, adrenergic beta agonists, multiple sclerosis, pulmonary function tests, forced expiratory volume|asthma, adrenergic beta agonists, multiple sclerosis, pulmonary function tests, forced expiratory volume
562852|NCT00785070|Perioperative|perioperative
562853|NCT00785070|Obstructive Sleep Apnea|obstructive sleep apnea
562854|NCT00785070|Screening|screening
562855|NCT00785070|Home Sleep Testing|home sleep testing
562856|NCT00785057|Hypertension|hypertension
562857|NCT00785057|Stroke|stroke
562858|NCT00785057|Neurology|neurology
562859|NCT00785057|JNC7|jnc7
562860|NCT00785057|2007 ESH-ESC guidelines|2007 esh-esc guidelines
562861|NCT00785057|survey|survey
562862|NCT00785044|Heart Failure|heart failure
562863|NCT00785044|MIBG|mibg
562864|NCT00785044|123I-mIBG|123i-mibg
562865|NCT00785031|risk management|risk management
562866|NCT00785031|Self Management|self management
562867|NCT00785031|Self-Efficacy|self-efficacy
562868|NCT00785031|Disease management|disease management
562869|NCT00785031|nurse practitioner|nurse practitioner
562870|NCT00785031|internet|internet
562871|NCT00785031|risk factors|risk factors
562872|NCT00785031|vascular diseases|vascular diseases
562873|NCT00785031|economic evaluation|economic evaluation
562874|NCT00785018|Endotoxin|endotoxin
562875|NCT00785018|C1-inhibitor|c1-inhibitor
562876|NCT00785018|Inflammation|inflammation
562877|NCT00785018|Sepsis|sepsis
562878|NCT00785018|Multi organ dysfunction syndrome|multi organ dysfunction syndrome
562879|NCT00785018|Complement activation|complement activation
562880|NCT00785005|Diabetes|diabetes
562881|NCT00785005|Exercise|exercise
562882|NCT00785005|Women|women
562883|NCT00785005|Research|research
562884|NCT00785005|Bike|bike
562885|NCT00785005|Type|type
562886|NCT00785005|Control|control
562887|NCT00785005|Healthy|healthy
562888|NCT00784992|NLDO|nldo
562890|NCT00784992|silicone tubes|silicone tubes
562891|NCT00784992|stent|stent
562892|NCT00784979|Renal|renal
562893|NCT00784979|Transplant|transplant
562894|NCT00784979|PRA|pra
562895|NCT00784966|Islet transplantation|islet transplantation
562896|NCT00784966|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
562897|NCT00784966|Kidney Transplantation|kidney transplantation
562898|NCT00784953|Symbicort SMART|symbicort smart
562899|NCT00784953|budesonide|budesonide
562900|NCT00784953|formoterol|formoterol
562901|NCT00784953|ICS/LABA|ics/laba
562902|NCT00784953|Asthma Control Questionnaire|asthma control questionnaire
562903|NCT00784953|Not optimally controlled asthma|not optimally controlled asthma
562904|NCT00784927|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
562905|NCT00784927|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
562906|NCT00784927|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
562907|NCT00784927|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
562908|NCT00784927|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
562909|NCT00784927|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
562910|NCT00784927|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
562911|NCT00784927|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
562912|NCT00784927|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
562913|NCT00784927|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
562914|NCT00784927|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
562915|NCT00784927|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
562916|NCT00784927|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
562917|NCT00784927|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
562918|NCT00784927|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
562919|NCT00784927|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
562920|NCT00784927|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
562921|NCT00784927|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
562922|NCT00784927|splenic marginal zone lymphoma|splenic marginal zone lymphoma
562923|NCT00784927|stage I marginal zone lymphoma|stage i marginal zone lymphoma
562924|NCT00784927|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
562925|NCT00784927|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
562926|NCT00784927|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
562927|NCT00784927|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
562928|NCT00784914|adult anaplastic astrocytoma|adult anaplastic astrocytoma
562929|NCT00784914|adult diffuse astrocytoma|adult diffuse astrocytoma
562930|NCT00784914|adult craniopharyngioma|adult craniopharyngioma
562931|NCT00784914|adult choroid plexus tumor|adult choroid plexus tumor
562932|NCT00784914|adult brain stem glioma|adult brain stem glioma
562933|NCT00784914|tumors metastatic to brain|tumors metastatic to brain
562934|NCT00784914|recurrent adult brain tumor|recurrent adult brain tumor
562935|NCT00784914|adult gliosarcoma|adult gliosarcoma
562936|NCT00784914|adult giant cell glioblastoma|adult giant cell glioblastoma
562937|NCT00784914|adult ependymoblastoma|adult ependymoblastoma
562938|NCT00784914|adult medulloblastoma|adult medulloblastoma
562939|NCT00784914|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
562940|NCT00784914|adult anaplastic ependymoma|adult anaplastic ependymoma
562941|NCT00784914|adult ependymoma|adult ependymoma
562942|NCT00784914|adult myxopapillary ependymoma|adult myxopapillary ependymoma
562943|NCT00784914|adult subependymoma|adult subependymoma
562944|NCT00784914|adult mixed glioma|adult mixed glioma
562945|NCT00784914|meningeal melanocytoma|meningeal melanocytoma
562946|NCT00784914|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
562947|NCT00784914|adult grade I meningioma|adult grade i meningioma
562948|NCT00784914|adult grade II meningioma|adult grade ii meningioma
562949|NCT00784914|adult grade III meningioma|adult grade iii meningioma
562950|NCT00784914|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
562951|NCT00784914|adult oligodendroglioma|adult oligodendroglioma
562952|NCT00784914|adult pineoblastoma|adult pineoblastoma
562953|NCT00784914|adult pineocytoma|adult pineocytoma
562954|NCT00784901|Macular Thickness Analyzed by Optical Coherence Tomography in Retinitis Pigmemtosa|macular thickness analyzed by optical coherence tomography in retinitis pigmemtosa
562955|NCT00784888|aromatase inhibitor|aromatase inhibitor
562956|NCT00784888|quality of life|quality of life
562957|NCT00784888|safety|safety
562958|NCT00784888|postmenopausal breast cancer|postmenopausal breast cancer
562959|NCT00784849|Breast cancer|breast cancer
562960|NCT00784849|diagnostic|diagnostic
562961|NCT00784849|lymph nodes|lymph nodes
562962|NCT00784836|Multiple Sclerosis - Relapsing|multiple sclerosis - relapsing
562963|NCT00784810|Efficacy, tolerability, moderate/severe, oxycodone/naloxone|efficacy, tolerability, moderate/severe, oxycodone/naloxone
562964|NCT00784810|codeine/paracetamol, chronic low back pain, osteoarthritis|codeine/paracetamol, chronic low back pain, osteoarthritis
562965|NCT00784784|antiviral drugs|antiviral drugs
562966|NCT00784784|influenza vaccines|influenza vaccines
562967|NCT00784771|Hypnotherapy|hypnotherapy
562968|NCT00784771|Hypnosis|hypnosis
562969|NCT00784771|PTSD|ptsd
562970|NCT00784758|Asthma|asthma
562971|NCT00784758|Lung Diseases|lung diseases
562972|NCT00784758|Respiratory Tract Diseases|respiratory tract diseases
562973|NCT00784745|incretin effect|incretin effect
562974|NCT00784745|type 2 diabetes|type 2 diabetes
562975|NCT00784745|GLP-1|glp-1
562977|NCT00784745|dexamethasone|dexamethasone
562978|NCT00784732|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
562979|NCT00784732|Environmental Exposure Chamber|environmental exposure chamber
562980|NCT00784732|nasal lavage|nasal lavage
562981|NCT00784719|Dry eye|dry eye
562982|NCT00784706|stroke rehabilitation|stroke rehabilitation
562983|NCT00784706|perceptual deficits|perceptual deficits
562984|NCT00784706|kinematic analysis|kinematic analysis
562985|NCT00784693|Endometriosis|endometriosis
562986|NCT00784693|pain|pain
562987|NCT00784693|tanezumab|tanezumab
562988|NCT00784693|nerve growth factor|nerve growth factor
562989|NCT00784693|questionnaires|questionnaires
562990|NCT00784667|Colorectal neoplasm|colorectal neoplasm
562991|NCT00784667|Metastasis|metastasis
562992|NCT00784615|Phenotypes of Polycystic Ovary Syndrome|phenotypes of polycystic ovary syndrome
562993|NCT00784615|Cardiovascular risk factors|cardiovascular risk factors
562994|NCT00784615|Adiponectin|adiponectin
562995|NCT00784615|C Reactive Protein|c reactive protein
562996|NCT00784602|prolapse|prolapse
562997|NCT00784602|pelvic organ prolapse|pelvic organ prolapse
562998|NCT00784589|Corticothérapy|corticothérapy
562999|NCT00784589|Rituximab|rituximab
563000|NCT00784589|therapeutic efficacity|therapeutic efficacity
563001|NCT00784589|therapeutic tolerance|therapeutic tolerance
563002|NCT00784576|Delirium|delirium
563003|NCT00784576|Cardiac Surgery|cardiac surgery
563004|NCT00784576|Depression|depression
563005|NCT00784576|Cognitive Impairment|cognitive impairment
563006|NCT00784576|Diagnostic Criteria for Delirium|diagnostic criteria for delirium
563007|NCT00784576|Memorial Delirium Assessment Scale|memorial delirium assessment scale
563008|NCT00784576|Delirium Index|delirium index
563009|NCT00784563|Parkinson Disease|parkinson disease
563010|NCT00784563|Exercise/*physiology|exercise/*physiology
563011|NCT00784563|*Physical Fitness|*physical fitness
563012|NCT00784563|Rehabilitation|rehabilitation
563013|NCT00784563|Cognition|cognition
563014|NCT00784550|Spirometry|spirometry
563015|NCT00784550|COPD|copd
563016|NCT00784537|Hodgkin's lymphoma|hodgkin's lymphoma
563017|NCT00784537|ABVD|abvd
563018|NCT00784537|FDG-PET (18-Fluoro-deoxy-D-glucose Positron Emission Tomography)|fdg-pet (18-fluoro-deoxy-d-glucose positron emission tomography)
563019|NCT00784537|Radiotherapy|radiotherapy
563020|NCT00784524|stage IV breast cancer|stage iv breast cancer
563021|NCT00784524|recurrent breast cancer|recurrent breast cancer
563022|NCT00784524|metastatic breast cancer|metastatic breast cancer
563023|NCT00784511|diabetes|diabetes
563024|NCT00784511|vitamin D|vitamin d
563025|NCT00784511|African Americans|african americans
563026|NCT00784511|overweight|overweight
563027|NCT00784511|insulin sensitivity|insulin sensitivity
563028|NCT00784511|glucose control|glucose control
563029|NCT00784498|Procedural sedation and analgesia|procedural sedation and analgesia
563030|NCT00784498|Emergency Department|emergency department
563031|NCT00784498|propofol versus ketamine and midazolam|propofol versus ketamine and midazolam
563032|NCT00784498|painful orthopedic manipulations|painful orthopedic manipulations
563033|NCT00784485|Asthma|asthma
563034|NCT00784485|Respiratory Tract Diseases|respiratory tract diseases
563035|NCT00784485|Lung Diseases|lung diseases
563036|NCT00784485|Dyspnea|dyspnea
563037|NCT00784472|PCNL|pcnl
563038|NCT00784472|oxycodone|oxycodone
563039|NCT00784472|morphine|morphine
563040|NCT00784472|visceral pain|visceral pain
563041|NCT00784459|Asthma|asthma
563042|NCT00784459|Allergy|allergy
563043|NCT00784446|AIO|aio
563044|NCT00784446|colorectal cancer|colorectal cancer
563045|NCT00784446|0205|0205
563046|NCT00784446|Capecitabine|capecitabine
563047|NCT00784446|Oxaliplatin|oxaliplatin
563048|NCT00784446|Bevacizumab|bevacizumab
563049|NCT00784446|Imatinib|imatinib
563050|NCT00784433|alcohol diabetes CVD|alcohol diabetes cvd
563051|NCT00784420|Drug Interaction, Pharmacokinetics|drug interaction, pharmacokinetics
563052|NCT00784407|thyroid surgery|thyroid surgery
563053|NCT00784407|total thyroidectomy|total thyroidectomy
563054|NCT00784407|harmonic scalpel|harmonic scalpel
563055|NCT00784381|Renal failure|renal failure
563056|NCT00784381|Elderly|elderly
563057|NCT00784381|Drug Therapy Computer-Assisted|drug therapy computer-assisted
563058|NCT00784381|Quality of care|quality of care
563059|NCT00784381|Patients With Impaired Renal Function|patients with impaired renal function
563060|NCT00784381|Inappropriateness of target drug prescribed|inappropriateness of target drug prescribed
563061|NCT00784368|Mycoses|mycoses
563062|NCT00784368|Candidiasis|candidiasis
563063|NCT00784368|Aspergillosis|aspergillosis
563064|NCT00784368|Cryptococcosis|cryptococcosis
563065|NCT00784368|Blastomycosis|blastomycosis
563066|NCT00784368|Histoplasmosis|histoplasmosis
563067|NCT00784368|Neutropenia|neutropenia
563068|NCT00784368|Itraconazole|itraconazole
563069|NCT00784368|JK1211|jk1211
563070|NCT00784355|recurrence of idiopathic pancreatitis|recurrence of idiopathic pancreatitis
563071|NCT00784355|laparoscopic cholecystectomy|laparoscopic cholecystectomy
563072|NCT00784355|etiology of pancreatitis|etiology of pancreatitis
563073|NCT00784342|COPD|copd
563074|NCT00784329|Lung Cancer|lung cancer
563075|NCT00784329|Squamous Cell Lung Cancer|squamous cell lung cancer
563076|NCT00784329|Bronchial carcinoma in situ|bronchial carcinoma in situ
563077|NCT00784329|Central Airway Diseases|central airway diseases
563078|NCT00784316|Prevention|prevention
563079|NCT00784303|Thyroid Cancer|thyroid cancer
563080|NCT00784277|Pain medication|pain medication
563081|NCT00784277|Arthritis|arthritis
563082|NCT00784277|Joint pain|joint pain
563083|NCT00784277|Analgesia|analgesia
563084|NCT00784277|Analgesics|analgesics
563085|NCT00784277|tapentadol|tapentadol
563086|NCT00784277|CG5503|cg5503
563087|NCT00784277|Nucynta|nucynta
563088|NCT00784264|Asymptomatic atherosclerosis|asymptomatic atherosclerosis
563089|NCT00784264|Intima media thickness (IMT)|intima media thickness (imt)
563090|NCT00784264|central obesity|central obesity
563091|NCT00784264|cardiovascular disease|cardiovascular disease
563092|NCT00784251|Pain|pain
563093|NCT00784251|Leg pain|leg pain
563094|NCT00784251|Back pain|back pain
563095|NCT00784251|PROMIS|promis
563096|NCT00784238|Schizophrenia|schizophrenia
563097|NCT00784238|Paliperidone Extended-release|paliperidone extended-release
563098|NCT00784238|Paliperidone|paliperidone
563099|NCT00784238|R076477|r076477
563100|NCT00784225|cataract|cataract
563101|NCT00784225|advanced macular degeneration|advanced macular degeneration
563102|NCT00784212|Photosensitive Epilepsy, photic stimulation, electroencephalogram|photosensitive epilepsy, photic stimulation, electroencephalogram
563103|NCT00784199|MDD|mdd
563104|NCT00784199|Depression|depression
563105|NCT00784186|Pregnancy termination|pregnancy termination
563106|NCT00784186|abortion|abortion
563107|NCT00784186|medical abortion|medical abortion
563108|NCT00784186|2nd trimester|2nd trimester
563109|NCT00784186|mifepristone|mifepristone
563110|NCT00784186|misoprostol|misoprostol
563111|NCT00784173|Syndrome|syndrome
563112|NCT00784173|Velocardiofacial|velocardiofacial
563113|NCT00784173|Middle ear|middle ear
563114|NCT00784173|Inner ear|inner ear
563115|NCT00784173|Malformation|malformation
563116|NCT00784147|HIV|hiv
563117|NCT00784147|CD4|cd4
563118|NCT00784147|experienced|experienced
563119|NCT00784147|resistant|resistant
563120|NCT00784147|resistance|resistance
563121|NCT00784147|monoclonal|monoclonal
563122|NCT00784147|antibody|antibody
563123|NCT00784147|infusion|infusion
563124|NCT00784147|ibalizumab|ibalizumab
563125|NCT00784147|TNX355|tnx355
563126|NCT00784147|TNX-355|tnx-355
563127|NCT00784147|TMB355|tmb355
563128|NCT00784147|TMB-355|tmb-355
563129|NCT00784134|intraventricular hemorrhage thrombolysis|intraventricular hemorrhage thrombolysis
563130|NCT00784095|quality of life|quality of life
563131|NCT00784082|Sickle cell disease, hydroxyurea, inflammation|sickle cell disease, hydroxyurea, inflammation
563132|NCT00784043|Cochlear implant|cochlear implant
563133|NCT00784043|hearing loss|hearing loss
563134|NCT00784030|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
563135|NCT00784030|Polycystic Kidney Disease|polycystic kidney disease
563136|NCT00784030|Water Loading|water loading
563137|NCT00784030|Biomarkers|biomarkers
563138|NCT00784017|Children with previously untreated acute lymphoblastic leukemia|children with previously untreated acute lymphoblastic leukemia
563139|NCT00784004|breathing patterns,|breathing patterns,
563140|NCT00784004|unidirectional breathing,|unidirectional breathing,
563141|NCT00784004|mask ventilation,|mask ventilation,
563142|NCT00784004|respiratory physiology|respiratory physiology
563143|NCT00783991|IVF|ivf
563144|NCT00783991|PDA|pda
563145|NCT00783991|PC|pc
563146|NCT00783991|CAT|cat
563147|NCT00783991|COPD|copd
563148|NCT00783991|MDD|mdd
563149|NCT00783991|RA|ra
563150|NCT00783978|Surfactant protein C|surfactant protein c
563151|NCT00783978|Interstitial|interstitial
563152|NCT00783978|lung|lung
563153|NCT00783978|Children|children
563154|NCT00783965|nevoid basal cell carcinoma syndrome|nevoid basal cell carcinoma syndrome
563155|NCT00783965|basal cell carcinoma of the skin|basal cell carcinoma of the skin
563156|NCT00783952|Mixed venous oxygen saturation|mixed venous oxygen saturation
563157|NCT00783952|Tissue oxygenation|tissue oxygenation
563158|NCT00783952|Near infrared spectroscopy|near infrared spectroscopy
563159|NCT00783913|Direct Current Stimulation|direct current stimulation
563160|NCT00783913|Rehabilitation|rehabilitation
563161|NCT00783913|Motor Learning|motor learning
563162|NCT00783913|Stroke|stroke
563163|NCT00783900|Prevention|prevention
563164|NCT00783887|Cilia|cilia
563165|NCT00783887|Axoneme|axoneme
563166|NCT00783887|Dynein|dynein
563167|NCT00783887|Gene|gene
563168|NCT00783887|Ultrastructure|ultrastructure
563169|NCT00783887|Linkage analysis|linkage analysis
563170|NCT00783848|CHF|chf
563171|NCT00783835|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
563172|NCT00783835|Methylphenidate|methylphenidate
563173|NCT00783835|Concerta|concerta
563174|NCT00783835|CONQoL|conqol
563175|NCT00783822|breast neoplasms|breast neoplasms
563176|NCT00783822|genetic counseling|genetic counseling
563177|NCT00783809|intracranial pressure|intracranial pressure
563178|NCT00783809|intracranial hypertension|intracranial hypertension
563179|NCT00783809|ultrasound|ultrasound
563180|NCT00783809|emergency|emergency
563181|NCT00783809|traumatic brain injury|traumatic brain injury
563182|NCT00783809|ocular ultrasound|ocular ultrasound
563183|NCT00783796|Coronary artery disease|coronary artery disease
563184|NCT00783796|Atherosclerosis|atherosclerosis
563185|NCT00783796|Myocardial ischemia|myocardial ischemia
563186|NCT00783783|Psychiatric disorders|psychiatric disorders
563187|NCT00783783|Neurodevelopmental disorders|neurodevelopmental disorders
563188|NCT00783783|Autism|autism
563189|NCT00783783|Risperidone|risperidone
563190|NCT00783783|Pharmacogenetics|pharmacogenetics
563191|NCT00783783|Pharmacokinetics|pharmacokinetics
563192|NCT00783770|Breastfeeding|breastfeeding
563193|NCT00783770|Infant|infant
563194|NCT00783770|Preterm|preterm
563195|NCT00783770|Nutrition|nutrition
563196|NCT00783757|neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
563197|NCT00783757|TOBI|tobi
563198|NCT00783757|breast imaging|breast imaging
563199|NCT00783757|optical imaging|optical imaging
563200|NCT00783731|intubation|intubation
563201|NCT00783679|Cardiac output|cardiac output
563202|NCT00783679|Noninvasive cardiac output measurement|noninvasive cardiac output measurement
563203|NCT00783679|Thermodilution|thermodilution
563204|NCT00783653|AML|aml
563205|NCT00783653|FLT3|flt3
563206|NCT00783653|acute myeloid leukemia|acute myeloid leukemia
563207|NCT00783653|FLT 3 inhibitor|flt 3 inhibitor
563208|NCT00783653|FLT3 mutated AML|flt3 mutated aml
563209|NCT00783627|Endothelium|endothelium
563210|NCT00783627|progenitors|progenitors
563211|NCT00783627|stem cells|stem cells
563212|NCT00783627|sickle cell|sickle cell
563213|NCT00783614|HIV|hiv
563214|NCT00783614|Cardiovascular Disease|cardiovascular disease
563215|NCT00783614|Endothelial Dysfunction|endothelial dysfunction
563216|NCT00783601|Chronic Asthma|chronic asthma
563217|NCT00783588|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
563218|NCT00783588|CLL|cll
563219|NCT00783588|Leukemia|leukemia
563220|NCT00783588|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
563221|NCT00783588|Leukemia, B-Cell|leukemia, b-cell
563222|NCT00783588|Immune System Diseases|immune system diseases
563223|NCT00783588|ISF35|isf35
563224|NCT00783588|Ad-ISF35|ad-isf35
563225|NCT00783588|Immunotherapy|immunotherapy
563226|NCT00783588|Immune therapy|immune therapy
563227|NCT00783588|Active immune therapy|active immune therapy
563228|NCT00783575|Crohn's disease|crohn's disease
563229|NCT00783575|Ulcerative colitis|ulcerative colitis
563230|NCT00783575|Inflammatory bowel disease|inflammatory bowel disease
563231|NCT00783575|NOD2,CARD 15 mutations|nod2,card 15 mutations
563232|NCT00783562|Low back pain|low back pain
563233|NCT00783562|Neck pain|neck pain
563234|NCT00783562|Functional disability|functional disability
563235|NCT00783562|Nursery school teachers|nursery school teachers
563236|NCT00783562|Exercise program|exercise program
563237|NCT00783562|Prevention|prevention
563238|NCT00783549|tolerability|tolerability
563239|NCT00783549|pharmacodynamics|pharmacodynamics
563240|NCT00783549|pharmacokinetics|pharmacokinetics
563241|NCT00783549|safety|safety
563242|NCT00783536|An randomized, open label, multicenter study to compare the ef|an randomized, open label, multicenter study to compare the ef
563243|NCT00783510|JIA|jia
563244|NCT00783510|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
563245|NCT00783510|Juvenile Arthritis|juvenile arthritis
563246|NCT00783510|Polyarticular JIA|polyarticular jia
563247|NCT00783510|Polyarticular-course JIA|polyarticular-course jia
563248|NCT00783497|High Blood Pressure|high blood pressure
563249|NCT00783497|Stress|stress
563250|NCT00783484|First in Human (FIH), PF-03716539, PK enhancer|first in human (fih), pf-03716539, pk enhancer
563251|NCT00783445|Metabolic Cardiovascular Syndrome|metabolic cardiovascular syndrome
563252|NCT00783445|Metabolic Syndrome|metabolic syndrome
563253|NCT00783445|Obesity|obesity
563254|NCT00783445|Hyperglycemia|hyperglycemia
563255|NCT00783419|tubo-ovarian abscess, pelvic-inflammatory disease|tubo-ovarian abscess, pelvic-inflammatory disease
563256|NCT00783406|COPD|copd
563257|NCT00783380|Influenza vaccination|influenza vaccination
563258|NCT00783380|Subunit|subunit
563259|NCT00783380|Virosomal|virosomal
563260|NCT00783380|HIV/AIDS|hiv/aids
563261|NCT00783380|Renal Dialysis|renal dialysis
563262|NCT00783380|Kidney transplantation|kidney transplantation
563263|NCT00783380|Rheumatologic diseases|rheumatologic diseases
563264|NCT00783380|Immunogenicity|immunogenicity
563265|NCT00783380|Reactogenicity|reactogenicity
563266|NCT00783367|Revlimid|revlimid
563267|NCT00783367|Celgene brand of lenalidomide|celgene brand of lenalidomide
563268|NCT00783367|lenalidomide|lenalidomide
563269|NCT00783367|Rituxan|rituxan
563695|NCT00781742|Depression|depression
563270|NCT00783367|CD20 antibody, rituximab|cd20 antibody, rituximab
563271|NCT00783367|rituximab|rituximab
563272|NCT00783367|Follicular Lymphoma|follicular lymphoma
563273|NCT00783367|Marginal Zone B-Cell Lymphoma|marginal zone b-cell lymphoma
563274|NCT00783367|Lymphoma, Small Lymphocytic|lymphoma, small lymphocytic
563275|NCT00783367|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
563276|NCT00783367|Mantle-Cell Lymphoma|mantle-cell lymphoma
563277|NCT00783367|Antigens, CD20|antigens, cd20
563278|NCT00783367|refractory|refractory
563279|NCT00783367|resistantRefractory/progressive lymphoma less than 6 months from first rituximab dose of previous rituximab-containing regimen|resistantrefractory/progressive lymphoma less than 6 months from first rituximab dose of previous rituximab-containing regimen
563280|NCT00783367|Previously treated|previously treated
563281|NCT00783367|Treated with rituximab|treated with rituximab
563282|NCT00783328|solid tumor|solid tumor
563283|NCT00783315|Hypertension|hypertension
563284|NCT00783315|Diabetes|diabetes
563285|NCT00783315|Hypercholesterolemia|hypercholesterolemia
563286|NCT00783302|CAD|cad
563287|NCT00783302|Visipaque|visipaque
563288|NCT00783302|CCTA|ccta
563289|NCT00783250|COPD|copd
563290|NCT00783250|Respiratory Mechanics|respiratory mechanics
563291|NCT00783250|Bronchodilators|bronchodilators
563292|NCT00783250|COPD patients with poor reversibility|copd patients with poor reversibility
563293|NCT00783185|psychotic disorders|psychotic disorders
563294|NCT00783185|cannabis|cannabis
563295|NCT00783185|intervention|intervention
563296|NCT00783172|pancreas|pancreas
563297|NCT00783172|pancreatic cancer|pancreatic cancer
563298|NCT00783172|cancer|cancer
563299|NCT00783172|Opioid Growth Factor|opioid growth factor
563300|NCT00783172|OGF|ogf
563301|NCT00783172|gemcitabine|gemcitabine
563302|NCT00783172|chemotherapy|chemotherapy
563303|NCT00783159|Muscle power|muscle power
563304|NCT00783159|Frailty|frailty
563305|NCT00783159|Exercise|exercise
563306|NCT00783159|Vitamin D|vitamin d
563307|NCT00783120|schizophrenia, negative symptoms, TMS, magnetic stimulation|schizophrenia, negative symptoms, tms, magnetic stimulation
563308|NCT00783107|Gold Stage III COPD|gold stage iii copd
563309|NCT00783081|Intermittent Claudication|intermittent claudication
563310|NCT00783081|Peripheral Arterial Disease|peripheral arterial disease
563311|NCT00783068|Endotoxin|endotoxin
563312|NCT00783068|GTS-21|gts-21
563313|NCT00783068|Vagal activity|vagal activity
563314|NCT00783068|Autonomic balance|autonomic balance
563315|NCT00783055|Autonomy|autonomy
563316|NCT00783055|Older people|older people
563317|NCT00783055|Physically frail|physically frail
563318|NCT00783055|Nursing home|nursing home
563319|NCT00783055|Intervention study|intervention study
563320|NCT00783042|TTDE-CFR|ttde-cfr
563321|NCT00783042|coronary artery function|coronary artery function
563322|NCT00783042|cardiovascular biomarkers|cardiovascular biomarkers
563323|NCT00783042|rosuvastatin|rosuvastatin
563324|NCT00783042|Crestor|crestor
563325|NCT00783029|Vasodilation|vasodilation
563326|NCT00783029|Vessel Reactivity|vessel reactivity
563327|NCT00783029|Dynamic Vessel Analyzer|dynamic vessel analyzer
563328|NCT00783029|Retina|retina
563329|NCT00783016|appendicitis|appendicitis
563330|NCT00783016|diagnosis|diagnosis
563331|NCT00783003|Tolerability|tolerability
563332|NCT00783003|Muscarinic Receptor Antagonist, Anticholinergic|muscarinic receptor antagonist, anticholinergic
563333|NCT00783003|Safety|safety
563334|NCT00783003|Anticholinergic|anticholinergic
563335|NCT00783003|ß2 agonist|ß2 agonist
563336|NCT00783003|Pharmacokinetics|pharmacokinetics
563337|NCT00782990|stress urinary incontinence|stress urinary incontinence
563338|NCT00782990|female incontinence|female incontinence
563339|NCT00782990|surgical treatment|surgical treatment
563340|NCT00782990|Female stress urinary incontinence|female stress urinary incontinence
563341|NCT00782977|Apneic oxygenation|apneic oxygenation
563342|NCT00782977|Apneic diffusion oxygenation|apneic diffusion oxygenation
563343|NCT00782964|Depression|depression
563344|NCT00782964|Major Depressive Disorder|major depressive disorder
563345|NCT00782964|SSRI resistant depression|ssri resistant depression
563346|NCT00782964|strategies in depression|strategies in depression
563347|NCT00782925|Low back pain|low back pain
563348|NCT00782925|recurrence|recurrence
563349|NCT00782925|chronic low back pain|chronic low back pain
563350|NCT00782925|educational program|educational program
563351|NCT00782925|physical therapy|physical therapy
563352|NCT00782925|home exercise|home exercise
563353|NCT00782925|compliance|compliance
563354|NCT00782912|postpartum anemia, postpartum depression|postpartum anemia, postpartum depression
563355|NCT00782899|Schizophrenia|schizophrenia
563356|NCT00782899|subjective well-being|subjective well-being
563357|NCT00782899|depressive symptoms|depressive symptoms
563358|NCT00782899|schizophrenia course|schizophrenia course
563359|NCT00782886|Pathfinder|pathfinder
563360|NCT00782886|Liver|liver
563361|NCT00782886|Resection|resection
563362|NCT00782886|Surgery|surgery
563363|NCT00782886|To evaluate the effectiveness of image-guided liver surgery by measuring variables before, during and following surgery.|to evaluate the effectiveness of image-guided liver surgery by measuring variables before, during and following surgery.
563364|NCT00782886|Completeness of resection and the accuracy of the resection, as determined by preoperative predicted RLV|completeness of resection and the accuracy of the resection, as determined by preoperative predicted rlv
563365|NCT00782873|propofol|propofol
563366|NCT00782873|sedation|sedation
563367|NCT00782873|safety|safety
563368|NCT00782873|obesity|obesity
563369|NCT00782860|Early pregnancy failure|early pregnancy failure
563370|NCT00782860|Misoprostol|misoprostol
563371|NCT00782860|Gestational sac volume|gestational sac volume
563372|NCT00782847|diabetes mellitus|diabetes mellitus
563373|NCT00782847|diabetic nephropathy|diabetic nephropathy
563374|NCT00782847|hypertension|hypertension
563375|NCT00782834|GIST|gist
563376|NCT00782834|Nilotinib|nilotinib
563377|NCT00782821|Kidney|kidney
563378|NCT00782821|Renal|renal
563379|NCT00782821|Rejection|rejection
563380|NCT00782821|High risk|high risk
563381|NCT00782821|Induction|induction
563382|NCT00782821|Immunology|immunology
563383|NCT00782821|Transplantation|transplantation
563384|NCT00782821|B Cell|b cell
563385|NCT00782821|Allograft|allograft
563386|NCT00782821|Desensitization|desensitization
563387|NCT00782808|HIV DNA in Monocytes|hiv dna in monocytes
563388|NCT00782795|Chronic pancreatitis|chronic pancreatitis
563389|NCT00782795|Insulin resistance|insulin resistance
563390|NCT00782756|Radiation|radiation
563391|NCT00782756|BEVACIZUMAB|bevacizumab
563392|NCT00782756|AVASTIN|avastin
563393|NCT00782756|TEMOZOLOMIDE|temozolomide
563394|NCT00782756|newly diagnosed|newly diagnosed
563395|NCT00782756|Glioblastoma|glioblastoma
563397|NCT00782756|malignant glioma|malignant glioma
563398|NCT00782756|Radiotherapy|radiotherapy
563399|NCT00782756|08-126|08-126
563400|NCT00782743|phenprocoumon|phenprocoumon
563401|NCT00782743|anticoagulation|anticoagulation
563402|NCT00782743|acetylic salicylic acid|acetylic salicylic acid
563403|NCT00782743|Need for new anticoagulation treatment|need for new anticoagulation treatment
563404|NCT00782730|bladder volume measurement|bladder volume measurement
563405|NCT00782730|pregnancy|pregnancy
563406|NCT00782730|bladder function|bladder function
563407|NCT00782730|Postvoid residual volume assessment|postvoid residual volume assessment
563408|NCT00782730|Bladder volumes|bladder volumes
563409|NCT00782717|diabetic retinopathy|diabetic retinopathy
563410|NCT00782717|cystoid macular edema;|cystoid macular edema;
563411|NCT00782704|A self-administered questionnaire to collect data from patients, physicians and nurses about the severity of postoperative surgical complications.|a self-administered questionnaire to collect data from patients, physicians and nurses about the severity of postoperative surgical complications.
563412|NCT00782704|Based on this questionnaire we will develop the morbidity index|based on this questionnaire we will develop the morbidity index
563413|NCT00782691|FDG-PET segmentation tools|fdg-pet segmentation tools
563414|NCT00782691|Head-and-neck cancer|head-and-neck cancer
563415|NCT00782691|Histological validation|histological validation
563416|NCT00782665|postoperative|postoperative
563417|NCT00782665|infection|infection
563418|NCT00782665|c-section|c-section
563419|NCT00782652|myocaridal infarction|myocaridal infarction
563420|NCT00782652|right ventricular infarction|right ventricular infarction
563421|NCT00782652|cardiogenic shock|cardiogenic shock
563422|NCT00782652|RVAD|rvad
563423|NCT00782652|Right ventricular assist device|right ventricular assist device
563424|NCT00782652|cardiac disease|cardiac disease
563425|NCT00782652|right ventricle|right ventricle
563426|NCT00782652|cardiac shock|cardiac shock
563427|NCT00782652|heart dysfunction|heart dysfunction
563428|NCT00782626|RAD001|rad001
563429|NCT00782613|Psoriasis|psoriasis
563430|NCT00782613|The primary objective of this study will be to evaluate the|the primary objective of this study will be to evaluate the
563431|NCT00782613|efficacy of topical ALT-2074 applied twice daily for 28|efficacy of topical alt-2074 applied twice daily for 28
563432|NCT00782613|days for treatment of chronic plaque psoriasis in adult|days for treatment of chronic plaque psoriasis in adult
563433|NCT00782613|subjects.|subjects.
563434|NCT00782613|The secondary objective will be to evaluate the safety|the secondary objective will be to evaluate the safety
563435|NCT00782613|of topical ALT-2074 applied twice daily for 28 days for|of topical alt-2074 applied twice daily for 28 days for
563436|NCT00782613|treatment of chronic plaque psoriasis in adult subjects.|treatment of chronic plaque psoriasis in adult subjects.
563437|NCT00782613|Tertiary objectives will be to provide visual documentation|tertiary objectives will be to provide visual documentation
563438|NCT00782613|of the improvement of psoriatic plaques treated with|of the improvement of psoriatic plaques treated with
563439|NCT00782613|ALT-2074 using digital photography, and to determine the|alt-2074 using digital photography, and to determine the
563440|NCT00782613|extent of systemic absorption of topically applied ALT-2074|extent of systemic absorption of topically applied alt-2074
563441|NCT00782613|based on a pharmacokinetic measurement of blood|based on a pharmacokinetic measurement of blood
563442|NCT00782613|concentration.|concentration.
563443|NCT00782600|Pharmacokinetics Immediate Release Oral Suspension Controlled Release Formulation|pharmacokinetics immediate release oral suspension controlled release formulation
563444|NCT00782587|Non-Muscle-Invasive Bladder Cancer|non-muscle-invasive bladder cancer
563445|NCT00782587|Superficial Bladder Cancer|superficial bladder cancer
563446|NCT00782587|recombinant human hyaluronidase|recombinant human hyaluronidase
563447|NCT00782587|rHuPH20|rhuph20
563448|NCT00782587|Chemophase®|chemophase®
563449|NCT00782587|Mitomycin|mitomycin
563450|NCT00782574|Advanced solid tumours|advanced solid tumours
563451|NCT00782574|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
563452|NCT00782574|homologous deficiency|homologous deficiency
563453|NCT00782574|BRCA1|brca1
563454|NCT00782561|steroid resistant focal segmental glomerulosclerosis|steroid resistant focal segmental glomerulosclerosis
563455|NCT00782561|FSGS|fsgs
563456|NCT00782561|adolescent focal segmental glomerulosclerosis|adolescent focal segmental glomerulosclerosis
563457|NCT00782561|focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
563458|NCT00782548|KADIAN|kadian
563459|NCT00782548|morphine|morphine
563460|NCT00782548|Avinza|avinza
563461|NCT00782548|30 mg|30 mg
563462|NCT00782548|bioequivalence|bioequivalence
563463|NCT00782548|fed|fed
563464|NCT00782483|Diagnosis|diagnosis
563465|NCT00782483|Port Wine Stain|port wine stain
563466|NCT00782483|PWS|pws
563467|NCT00782405|antidepressant action|antidepressant action
563468|NCT00782405|clinical psychopharmacology|clinical psychopharmacology
563469|NCT00782392|Nutrition|nutrition
563470|NCT00782392|Infant Formula|infant formula
563471|NCT00782379|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
563472|NCT00782379|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
563473|NCT00782379|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
563474|NCT00782379|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
563475|NCT00782379|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
563476|NCT00782379|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
563477|NCT00782379|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
563478|NCT00782379|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
563479|NCT00782379|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
563480|NCT00782379|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
563481|NCT00782379|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
563482|NCT00782379|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
563483|NCT00782379|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
563484|NCT00782379|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
563485|NCT00782379|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
563486|NCT00782379|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
563487|NCT00782379|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
563488|NCT00782379|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
563489|NCT00782379|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
563490|NCT00782379|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
563491|NCT00782379|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
563492|NCT00782379|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
563493|NCT00782379|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
563494|NCT00782379|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
563495|NCT00782379|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
563496|NCT00782379|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
563497|NCT00782379|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
563498|NCT00782379|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
563499|NCT00782379|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
563500|NCT00782379|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
563501|NCT00782379|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
563502|NCT00782379|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
563503|NCT00782379|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
563504|NCT00782379|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
563505|NCT00782379|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
563506|NCT00782379|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
563507|NCT00782379|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
563508|NCT00782379|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
563509|NCT00782379|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
563510|NCT00782379|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
563511|NCT00782379|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
563512|NCT00782379|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
563513|NCT00782379|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
563514|NCT00782379|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
563515|NCT00782379|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
563516|NCT00782379|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
563517|NCT00782379|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
563518|NCT00782379|secondary acute myeloid leukemia|secondary acute myeloid leukemia
563519|NCT00782379|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
563520|NCT00782379|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
563521|NCT00782379|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
563522|NCT00782379|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
563523|NCT00782379|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
563524|NCT00782379|prolymphocytic leukemia|prolymphocytic leukemia
563525|NCT00782366|predictive genomics|predictive genomics
563526|NCT00782366|personalized medicine|personalized medicine
563527|NCT00782366|personal genomics|personal genomics
563528|NCT00782366|direct-to-consumer genetic testing|direct-to-consumer genetic testing
563529|NCT00782366|genetic knowledge|genetic knowledge
563530|NCT00782366|genetic attitudes|genetic attitudes
563531|NCT00782353|HCV|hcv
563532|NCT00782340|NOH|noh
563533|NCT00782340|Neurogenic Orthostatic Hypotension|neurogenic orthostatic hypotension
563534|NCT00782340|Orthostatic hypotension|orthostatic hypotension
563535|NCT00782340|PAF|paf
563536|NCT00782340|Pure Autonomic Failure|pure autonomic failure
563537|NCT00782340|MSA|msa
563538|NCT00782340|Multiple System Atrophy|multiple system atrophy
563539|NCT00782340|Neuropathy|neuropathy
563540|NCT00782340|Autonomic Failure|autonomic failure
563541|NCT00782340|Parkinson|parkinson
563542|NCT00782340|Dopamine Deficiency|dopamine deficiency
563543|NCT00782340|Dopamine|dopamine
563544|NCT00782340|Droxidopa|droxidopa
563545|NCT00782314|asthma|asthma
563546|NCT00782314|SMART|smart
563547|NCT00782314|Symbicort Turbuhaler|symbicort turbuhaler
563548|NCT00782314|asthma control|asthma control
563549|NCT00782301|HIV and Hepatitis co-infection|hiv and hepatitis co-infection
563550|NCT00782288|digitoxin|digitoxin
563551|NCT00782288|inflammatory markers|inflammatory markers
563552|NCT00782288|cytokines|cytokines
563553|NCT00782288|gene expression|gene expression
563554|NCT00782275|RCC|rcc
563555|NCT00782275|avastin|avastin
563556|NCT00782275|temsirolimus|temsirolimus
563557|NCT00782223|hips, spine, lower limb, digital radiograph measurements, TraumaCad, digital software|hips, spine, lower limb, digital radiograph measurements, traumacad, digital software
563558|NCT00782223|Measurements of orthopaedic parameters on digital X-rays using particular software|measurements of orthopaedic parameters on digital x-rays using particular software
563559|NCT00782197|osteoarthritis|osteoarthritis
563560|NCT00782197|knee|knee
563561|NCT00782197|PRGF|prgf
563562|NCT00782197|autologous plasma|autologous plasma
563563|NCT00782197|plasma preparations|plasma preparations
563564|NCT00782197|treatment|treatment
563565|NCT00782171|Dental implants|dental implants
563566|NCT00782158|HIV|hiv
563567|NCT00782158|Hepatitis B|hepatitis b
563568|NCT00782158|Coinfection|coinfection
563569|NCT00782158|Liver Fibrosis|liver fibrosis
563570|NCT00782158|Transient Elastography|transient elastography
563571|NCT00782145|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
563572|NCT00782145|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
563573|NCT00782145|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
563574|NCT00782145|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
563575|NCT00782145|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
563576|NCT00782145|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
563577|NCT00782145|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
563578|NCT00782145|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
563579|NCT00782145|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
563580|NCT00782145|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
563581|NCT00782145|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
563582|NCT00782145|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
563583|NCT00782145|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
563584|NCT00782145|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
563585|NCT00782145|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
563586|NCT00782145|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
563587|NCT00782145|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
563588|NCT00782145|secondary acute myeloid leukemia|secondary acute myeloid leukemia
563589|NCT00782145|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
563590|NCT00782145|primary myelofibrosis|primary myelofibrosis
563591|NCT00782145|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
563592|NCT00782145|disseminated neuroblastoma|disseminated neuroblastoma
563593|NCT00782145|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
563594|NCT00782145|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
563595|NCT00782145|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
563596|NCT00782145|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
563597|NCT00782145|recurrent neuroblastoma|recurrent neuroblastoma
563793|NCT00781300|Glaucoma|glaucoma
563598|NCT00782145|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
563599|NCT00782145|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
563600|NCT00782132|Infertility Services, HIV, pregnancy planning|infertility services, hiv, pregnancy planning
563601|NCT00782093|AMD|amd
563602|NCT00782080|ADHD|adhd
563603|NCT00782080|children|children
563604|NCT00782080|adolescents|adolescents
563605|NCT00782080|St. John`s Wort|st. john`s wort
563606|NCT00782080|Valerian extract|valerian extract
563607|NCT00782080|Safety|safety
563608|NCT00782080|Efficacy|efficacy
563609|NCT00782067|Aggressive systemic mastocytosis|aggressive systemic mastocytosis
563610|NCT00782067|mast cell leukemia|mast cell leukemia
563611|NCT00782067|C-Findings|c-findings
563612|NCT00782067|tyrosine kinase inhibitor|tyrosine kinase inhibitor
563613|NCT00782067|KIT mutation|kit mutation
563614|NCT00782067|AHNMD|ahnmd
563615|NCT00782067|Systemic|systemic
563616|NCT00782067|Aggressive|aggressive
563617|NCT00782054|pruritus|pruritus
563618|NCT00782054|itch|itch
563619|NCT00782054|burn|burn
563620|NCT00782054|endopeptidase|endopeptidase
563621|NCT00782054|moisturizer|moisturizer
563622|NCT00782054|randomized controlled|randomized controlled
563623|NCT00782028|primary care, high-risk families, maternal depression|primary care, high-risk families, maternal depression
563624|NCT00782015|almonds|almonds
563625|NCT00782015|heart disease|heart disease
563626|NCT00782015|vascular reactivity|vascular reactivity
563627|NCT00782015|inflammation|inflammation
563628|NCT00782015|dyslipidemia|dyslipidemia
563629|NCT00782015|oxidative stress|oxidative stress
563630|NCT00782002|Solid Tumors|solid tumors
563631|NCT00782002|VEGF-A|vegf-a
563632|NCT00782002|stromal cells|stromal cells
563633|NCT00782002|endothelial cells|endothelial cells
563634|NCT00782002|malignant cells|malignant cells
563635|NCT00781989|early rheumatoid arthritis|early rheumatoid arthritis
563636|NCT00781989|biomarkers|biomarkers
563637|NCT00781989|ultrasound|ultrasound
563638|NCT00781963|cognitive behavior therapy|cognitive behavior therapy
563639|NCT00781963|insomnia|insomnia
563640|NCT00781950|PAD|pad
563641|NCT00781950|Peripheral Arterial Disease|peripheral arterial disease
563642|NCT00781950|Diabetes|diabetes
563643|NCT00781950|Atherosclerosis|atherosclerosis
563644|NCT00781950|Flax|flax
563645|NCT00781950|Flaxseeds|flaxseeds
563646|NCT00781950|Functional Foods|functional foods
563647|NCT00781950|Essential Fatty Acids|essential fatty acids
563648|NCT00781950|Winnipeg|winnipeg
563649|NCT00781911|Islet Cell|islet cell
563650|NCT00781911|CARCINOMA, ISLET CELL|carcinoma, islet cell
563651|NCT00781911|Octreotide|octreotide
563652|NCT00781911|depot octreotide acetate|depot octreotide acetate
563653|NCT00781911|Insulin-Like Growth Factor (IGF) 1|insulin-like growth factor (igf) 1
563654|NCT00781911|Metastatic, Carcinoid or Islet Cell|metastatic, carcinoid or islet cell
563655|NCT00781911|Neuroendocrine Tumors|neuroendocrine tumors
563656|NCT00781898|Depot naltrexone|depot naltrexone
563657|NCT00781898|Parolees|parolees
563658|NCT00781898|Opioid addiction prevention|opioid addiction prevention
563659|NCT00781898|Medication Treatment Alternatives|medication treatment alternatives
563660|NCT00781898|Prevention of Relapse to Opioid Addiction|prevention of relapse to opioid addiction
563661|NCT00781872|multiple sclerosis (MS)|multiple sclerosis (ms)
563662|NCT00781872|bone marrow stromal cells|bone marrow stromal cells
563663|NCT00781872|stem cells|stem cells
563664|NCT00781833|Therapeutic Electric Stimulation|therapeutic electric stimulation
563665|NCT00781833|Functional Electric Stimulation|functional electric stimulation
563666|NCT00781833|Implantable Stimulator|implantable stimulator
563667|NCT00781833|Muscle Strength|muscle strength
563668|NCT00781833|Muscle Spasticity|muscle spasticity
563669|NCT00781820|Bifonazole|bifonazole
563670|NCT00781820|Placebo|placebo
563671|NCT00781820|Urea|urea
563672|NCT00781820|Nail fungus|nail fungus
563673|NCT00781807|Heart-Assist-Devices|heart-assist-devices
563674|NCT00781807|Rehabilitation|rehabilitation
563675|NCT00781807|Outcome Assessment (Health Care)|outcome assessment (health care)
563676|NCT00781807|Exercise Capacity|exercise capacity
563677|NCT00781807|Ergometry|ergometry
563678|NCT00781807|Social Support|social support
563679|NCT00781807|Quality of Life|quality of life
563680|NCT00781807|Nutrition Assessment|nutrition assessment
563681|NCT00781807|Nutrition Therapy|nutrition therapy
563682|NCT00781807|Neuropsychological Tests|neuropsychological tests
563683|NCT00781781|Myeloid and Lymphoid malignances|myeloid and lymphoid malignances
563684|NCT00781768|Bone Marrow Transplant|bone marrow transplant
563685|NCT00781768|Nausea|nausea
563686|NCT00781768|Vomiting|vomiting
563687|NCT00781768|NK-1 antagonist|nk-1 antagonist
563688|NCT00781768|Nausea and vommitting in the stem cell/marrow transplant population.|nausea and vommitting in the stem cell/marrow transplant population.
563689|NCT00781755|smoking cessation|smoking cessation
563690|NCT00781755|varenicline|varenicline
563691|NCT00781755|schizophrenia|schizophrenia
563692|NCT00781755|serious mental illness|serious mental illness
563693|NCT00781755|Nicotine addiction|nicotine addiction
563694|NCT00781755|Smoking Behavior|smoking behavior
563696|NCT00781742|Depressive Disorder|depressive disorder
563697|NCT00781742|MDD|mdd
563698|NCT00781729|Kyphosis|kyphosis
563699|NCT00781729|Yoga|yoga
563700|NCT00781729|Aging|aging
563701|NCT00781729|Physical performance|physical performance
563702|NCT00781729|Quality of Life|quality of life
563703|NCT00781716|ST elevation myocardial infarction|st elevation myocardial infarction
563704|NCT00781716|Drug eluting stents|drug eluting stents
563705|NCT00781690|Chronic kidney failure|chronic kidney failure
563706|NCT00781690|Heparin|heparin
563707|NCT00781690|Hemodialysis|hemodialysis
563708|NCT00781690|Biocompatibility|biocompatibility
563709|NCT00781677|Major Depressive Disorder|major depressive disorder
563710|NCT00781677|Depression|depression
563711|NCT00781677|Anxiety|anxiety
563712|NCT00781638|Pediatric UC, Adacolumn apheresis|pediatric uc, adacolumn apheresis
563713|NCT00781625|probiotics|probiotics
563714|NCT00781625|QoL|qol
563715|NCT00781625|inflammation|inflammation
563716|NCT00781625|nutritional factors|nutritional factors
563717|NCT00781625|prophylactic aid|prophylactic aid
563718|NCT00781625|Lactobacillus rhamnosus GR-1|lactobacillus rhamnosus gr-1
563719|NCT00781625|Lactobacillus reuteri RC-14|lactobacillus reuteri rc-14
563720|NCT00781625|Recurrent lower UTI in women|recurrent lower uti in women
563721|NCT00781599|African american|african american
563722|NCT00781599|smokers|smokers
563723|NCT00781599|smoking cessation|smoking cessation
563724|NCT00781599|African American smokers|african american smokers
563725|NCT00781586|Energy expenditure|energy expenditure
563726|NCT00781586|Nutritional|nutritional
563727|NCT00781586|Weight control|weight control
563728|NCT00781573|Drug Eluting Stent|drug eluting stent
563729|NCT00781573|Clopidogrel|clopidogrel
563730|NCT00781573|Optimal duration of clopidogrel post DES stent implantation|optimal duration of clopidogrel post des stent implantation
563731|NCT00781560|Hyperlipidemia|hyperlipidemia
563732|NCT00781560|Chinese National Adult Lipid Treatment Guideline (2007)|chinese national adult lipid treatment guideline (2007)
563733|NCT00781560|Crestor®|crestor®
563734|NCT00781547|growth hormone|growth hormone
563735|NCT00781547|obesity|obesity
563736|NCT00781547|abdominal obesity|abdominal obesity
563737|NCT00781534|Health Supplements|health supplements
563738|NCT00781534|Ginseng|ginseng
563739|NCT00781534|Diabetes|diabetes
563740|NCT00781508|heart failure, left sided|heart failure, left sided
563741|NCT00781508|ventricular dysfunction|ventricular dysfunction
563742|NCT00781508|diastolic dysfunction|diastolic dysfunction
563743|NCT00781508|sildenafil|sildenafil
563744|NCT00781495|insulin|insulin
563745|NCT00781482|Positron Emission Tomography|positron emission tomography
563746|NCT00781482|GABA receptor binding|gaba receptor binding
563747|NCT00781482|Hypnotic Drugs|hypnotic drugs
563748|NCT00781482|Eszopiclone|eszopiclone
563749|NCT00781482|Zolpidem|zolpidem
563750|NCT00781482|[11-C] Flumazenil|[11-c] flumazenil
563751|NCT00781482|Molecular imaging of the brain|molecular imaging of the brain
563752|NCT00781469|Rheumatoid arthritis|rheumatoid arthritis
563753|NCT00781469|RNA|rna
563754|NCT00781469|Synovium|synovium
563755|NCT00781469|Peripheral blood mononuclear cells|peripheral blood mononuclear cells
563756|NCT00781456|Migraine headache|migraine headache
563757|NCT00781456|menstrual|menstrual
563758|NCT00781456|oral contraceptive|oral contraceptive
563759|NCT00781456|Menstrually-Related Migraine Headache|menstrually-related migraine headache
563760|NCT00781443|Asthma|asthma
563761|NCT00781417|vitamin D|vitamin d
563762|NCT00781417|Chronic Kidney Disease|chronic kidney disease
563763|NCT00781417|parathyroid hormone|parathyroid hormone
563764|NCT00781417|Chronic kidney disease Stage II and III|chronic kidney disease stage ii and iii
563765|NCT00781404|adenosine|adenosine
563766|NCT00781404|angioplasty|angioplasty
563767|NCT00781404|acute myocardial infarction|acute myocardial infarction
563768|NCT00781404|acute coronary syndrome with ST segment elevation|acute coronary syndrome with st segment elevation
563769|NCT00781404|infarct size|infarct size
563770|NCT00781404|rescued myocardium|rescued myocardium
563771|NCT00781391|Systemic embolic events|systemic embolic events
563772|NCT00781378|Thrombolytic therapy|thrombolytic therapy
563773|NCT00781378|Recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
563774|NCT00781378|Efficacy|efficacy
563775|NCT00781378|Safety|safety
563776|NCT00781365|Hypertension|hypertension
563777|NCT00781365|Telemonitoring|telemonitoring
563778|NCT00781365|Pharmacy management|pharmacy management
563779|NCT00781352|nitrous oxide|nitrous oxide
563780|NCT00781352|cancer recurrence|cancer recurrence
563781|NCT00781352|colorectal surgery|colorectal surgery
563782|NCT00781339|Bacteriuria|bacteriuria
563783|NCT00781339|Catheterized|catheterized
563784|NCT00781339|Chronically Catheterized|chronically catheterized
563785|NCT00781326|Depressive Disorder, Major|depressive disorder, major
563786|NCT00781326|Cerebrovascular Disorders|cerebrovascular disorders
563787|NCT00781326|Risk Factors|risk factors
563788|NCT00781326|Nimodipine|nimodipine
563789|NCT00781300|Intraocular pressure|intraocular pressure
563790|NCT00781300|Pterygium|pterygium
563791|NCT00781300|Surgery|surgery
563792|NCT00781300|Steroids|steroids
563794|NCT00781287|human immunodeficiency virus|human immunodeficiency virus
563795|NCT00781287|raltegravir|raltegravir
563796|NCT00781287|primary HIV infection|primary hiv infection
563797|NCT00781287|HIV-1|hiv-1
563798|NCT00781261|hip|hip
563799|NCT00781261|collapse femoral head|collapse femoral head
563800|NCT00781261|bisphosphonates|bisphosphonates
563801|NCT00781261|osteonecrosis|osteonecrosis
563802|NCT00781248|enteral feeding|enteral feeding
563803|NCT00781248|Subject who requires nasogastric tube|subject who requires nasogastric tube
563804|NCT00781209|irradiation|irradiation
563805|NCT00781209|stereotactic radiosurgery|stereotactic radiosurgery
563806|NCT00781209|posterior fossa|posterior fossa
563807|NCT00781209|cerebellar metastases|cerebellar metastases
563808|NCT00781196|phenytoin|phenytoin
563809|NCT00781196|gum hyperplasia|gum hyperplasia
563810|NCT00781196|phenytoin induced gingival overgrowth|phenytoin induced gingival overgrowth
563811|NCT00781196|plaque index|plaque index
563812|NCT00781196|gingival overgrowth grade|gingival overgrowth grade
563813|NCT00781183|COPD|copd
563814|NCT00781183|rehabilitation|rehabilitation
563815|NCT00781183|walking|walking
563816|NCT00781170|Multiple Myeloma|multiple myeloma
563817|NCT00781170|Plasmocytoma|plasmocytoma
563818|NCT00781170|Stem Cell Transplantation|stem cell transplantation
563819|NCT00781157|Spinal induced hypotension in cesarean delivery|spinal induced hypotension in cesarean delivery
563820|NCT00781118|Acute Myocardial Infarction (MI)|acute myocardial infarction (mi)
563821|NCT00781118|ST Shift|st shift
563822|NCT00781118|Coronary Occlusion|coronary occlusion
563823|NCT00781118|Acute Coronary Syndrome|acute coronary syndrome
563824|NCT00781105|Chronic hepatitis B|chronic hepatitis b
563825|NCT00781105|Adult|adult
563826|NCT00781105|HBV DNA suppression|hbv dna suppression
563827|NCT00781105|Telbivudine|telbivudine
563828|NCT00781092|Dry Eyes|dry eyes
563829|NCT00781092|LASIK|lasik
563830|NCT00781092|Laser Vision Correction|laser vision correction
563831|NCT00781079|Organization Innovation|organization innovation
563832|NCT00781079|Opinion Leaders|opinion leaders
563833|NCT00781079|Schizophrenia|schizophrenia
563834|NCT00781066|POSTPARTUM HEMORRHAGE|postpartum hemorrhage
563835|NCT00781066|PREVENTION|prevention
563836|NCT00781066|CORD TRACTION|cord traction
563837|NCT00781066|THIRD STAGE LABOR|third stage labor
563838|NCT00781053|skin fibrosis|skin fibrosis
563839|NCT00781053|systemic scleroderma|systemic scleroderma
563840|NCT00781053|systemic sclerosis|systemic sclerosis
563841|NCT00781053|p144|p144
563842|NCT00781053|orphan drug|orphan drug
563843|NCT00781040|Severe sepsis in neutropenic haematological patients|severe sepsis in neutropenic haematological patients
563844|NCT00781001|neuropathic pain|neuropathic pain
563845|NCT00781001|diabetic neuropathy|diabetic neuropathy
563846|NCT00781001|cannabis|cannabis
563847|NCT00781001|marijuana|marijuana
563848|NCT00780975|Aplidin|aplidin
563849|NCT00780975|Plitidepsin|plitidepsin
563850|NCT00780975|Prostate|prostate
563851|NCT00780975|Cancer|cancer
563852|NCT00780962|NAC|nac
563853|NCT00780962|Radiocontrast Nephropathy|radiocontrast nephropathy
563854|NCT00780962|N-Acetylcysteine|n-acetylcysteine
563855|NCT00780962|RCN|rcn
563856|NCT00780962|RCIN|rcin
563857|NCT00780962|Creatinine|creatinine
563858|NCT00780962|Computerized Tomography|computerized tomography
563859|NCT00780962|CT|ct
563860|NCT00780962|Emergency Department|emergency department
563861|NCT00780962|ED|ed
563862|NCT00780949|Crohn's Disease, inflammatory bowel disease, Peyer's patches|crohn's disease, inflammatory bowel disease, peyer's patches
563863|NCT00780897|PREMATURE OVARIAN FAILURE (POF)|premature ovarian failure (pof)
563864|NCT00780897|GENETIC ANALYSIS|genetic analysis
563865|NCT00780897|PHYSIOPATHOLOGIC ANALYSIS|physiopathologic analysis
563866|NCT00780884|acupuncture|acupuncture
563867|NCT00780884|schizophrenia|schizophrenia
563868|NCT00780884|insomnia|insomnia
563869|NCT00780858|GnRH antagonist|gnrh antagonist
563870|NCT00780858|IUI|iui
563871|NCT00780845|Acute Kidney failure|acute kidney failure
563872|NCT00780845|Clinical outcomes|clinical outcomes
563873|NCT00780845|On-pump|on-pump
563874|NCT00780845|Coronary artery bypass grafting|coronary artery bypass grafting
563875|NCT00780845|Morbidity|morbidity
563876|NCT00780845|Mortality|mortality
563877|NCT00780832|overactive bladder|overactive bladder
563878|NCT00780832|dietary caffeine|dietary caffeine
563879|NCT00780832|anticholinergic medication|anticholinergic medication
563880|NCT00780832|lifestyle modification|lifestyle modification
563881|NCT00780832|incontinence|incontinence
563882|NCT00780832|urinary frequency|urinary frequency
563883|NCT00780806|MnB|mnb
563884|NCT00780806|rLP2086|rlp2086
563885|NCT00780806|blood collection|blood collection
563886|NCT00780806|vaccination|vaccination
563887|NCT00780793|Rheumatoid arthritis|rheumatoid arthritis
563888|NCT00780793|Remission|remission
563889|NCT00780793|Therapeutic strategy|therapeutic strategy
563890|NCT00780793|DMARDs|dmards
563891|NCT00780793|Biological agents|biological agents
563892|NCT00780780|triamcinolone|triamcinolone
563893|NCT00780780|nepafenac|nepafenac
563894|NCT00780780|DME|dme
564193|NCT00779454|Inoperable|inoperable
563895|NCT00780780|edema macular|edema macular
563896|NCT00780767|angiojet|angiojet
563897|NCT00780767|massive pulmonary embolism|massive pulmonary embolism
563898|NCT00780767|RHEOLYTIC THROMBECTOMY|rheolytic thrombectomy
563899|NCT00780767|patients presenting with massive pulmonary embolism|patients presenting with massive pulmonary embolism
563900|NCT00780754|prostate cancer|prostate cancer
563901|NCT00780754|chemoprevention|chemoprevention
563902|NCT00780754|dutasteride|dutasteride
563903|NCT00780741|Nasolacrimal duct obstruction|nasolacrimal duct obstruction
563904|NCT00780741|Simple probing|simple probing
563905|NCT00780715|Diabetes therapies|diabetes therapies
563906|NCT00780715|Pharmacogenetics|pharmacogenetics
563907|NCT00780702|Cocaine|cocaine
563908|NCT00780702|Treatment|treatment
563909|NCT00780702|Airpiprazole|airpiprazole
563910|NCT00780702|Methadone|methadone
563911|NCT00780702|Relapse|relapse
563912|NCT00780702|HIV|hiv
563913|NCT00780702|Ecological Momentary Assessment (EMA)|ecological momentary assessment (ema)
563914|NCT00780702|Contingency Management|contingency management
563915|NCT00780676|Dasatinib|dasatinib
563916|NCT00780676|Metastatic Breast Cancer|metastatic breast cancer
563917|NCT00780676|Sprycel|sprycel
563918|NCT00780676|BMS-354825|bms-354825
563919|NCT00780676|Genetic testing|genetic testing
563920|NCT00780676|AZD6244|azd6244
563921|NCT00780676|Selumetinib|selumetinib
563922|NCT00780663|Neuroendocrine|neuroendocrine
563923|NCT00780663|Carcinoid|carcinoid
563924|NCT00780663|NET|net
563925|NCT00780663|MEN-1|men-1
563926|NCT00780663|Islet cell|islet cell
563927|NCT00780637|Heart Transplant|heart transplant
563928|NCT00780637|Endothelial Function|endothelial function
563929|NCT00780637|Fibrinolysis|fibrinolysis
563930|NCT00780637|Transplant recipients at baseline|transplant recipients at baseline
563931|NCT00780624|RDS|rds
563932|NCT00780624|Infant, newborn|infant, newborn
563933|NCT00780624|NIPPV|nippv
563934|NCT00780624|CPAP|cpap
563935|NCT00780598|Acute Myeloid Leukemia|acute myeloid leukemia
563936|NCT00780598|AML|aml
563937|NCT00780598|Cancer|cancer
563938|NCT00780598|Hematological malignancies|hematological malignancies
563939|NCT00780598|Elderly|elderly
563940|NCT00780598|Refractory|refractory
563941|NCT00780598|Relapsed|relapsed
563942|NCT00780598|Blood disorder|blood disorder
563943|NCT00780572|Safety Management|safety management
563944|NCT00780572|Risk Management|risk management
563945|NCT00780572|surveillance|surveillance
563946|NCT00780572|triggers|triggers
563947|NCT00780559|Neuropathy|neuropathy
563948|NCT00780559|diabetes|diabetes
563949|NCT00780546|tuberculosis|tuberculosis
563950|NCT00780546|spatial epidemiology|spatial epidemiology
563951|NCT00780546|geographic information system|geographic information system
563952|NCT00780520|glutamine inflammation HSP70 sepsis|glutamine inflammation hsp70 sepsis
563953|NCT00780481|Obesity|obesity
563954|NCT00780481|Endothelial Function|endothelial function
563955|NCT00780481|Fibrinolytic Balance|fibrinolytic balance
563956|NCT00780481|Baseline|baseline
563957|NCT00780468|Weight loss|weight loss
563958|NCT00780468|Diet|diet
563959|NCT00780468|Obesity|obesity
563960|NCT00780455|KineSEP|kinesep
563961|NCT00780455|Rehabilitation|rehabilitation
563962|NCT00780455|Betaferon|betaferon
563963|NCT00780442|substance related disorders|substance related disorders
563964|NCT00780429|kidney|kidney
563965|NCT00780429|transplant|transplant
563966|NCT00780429|Mycophenolic acid|mycophenolic acid
563967|NCT00780429|Inosine monophosphate dehydrogenase|inosine monophosphate dehydrogenase
563968|NCT00780416|Chronic Hepatitis C|chronic hepatitis c
563969|NCT00780416|Protease Inhibitor|protease inhibitor
563970|NCT00780416|Telaprevir|telaprevir
563971|NCT00780416|Peginterferon Alfa-2b|peginterferon alfa-2b
563972|NCT00780416|Ribavirin|ribavirin
563973|NCT00780390|RSD|rsd
563974|NCT00780390|SCS|scs
563975|NCT00780390|CRPS|crps
563976|NCT00780390|Complex regional pain syndrome patients before undergoing spinal cord stimulator implant and under other treatments|complex regional pain syndrome patients before undergoing spinal cord stimulator implant and under other treatments
563977|NCT00780377|Heart Transplant|heart transplant
563978|NCT00780377|Fibrinolysis|fibrinolysis
563979|NCT00780377|Resting conditions|resting conditions
564227|NCT00779337|Epstein-Barr virus|epstein-barr virus
563980|NCT00780364|stroke; sour taste; cold temperature; pharyngeal swallowing|stroke; sour taste; cold temperature; pharyngeal swallowing
563981|NCT00780351|vancomycin, SLEDD-f|vancomycin, sledd-f
563982|NCT00780325|Cyclooxygenase-2|cyclooxygenase-2
563983|NCT00780325|Carbonic anhydrase|carbonic anhydrase
563984|NCT00780325|Eicosanoids|eicosanoids
563985|NCT00780325|Healthy volunteers|healthy volunteers
563986|NCT00780312|radiotherapy|radiotherapy
563987|NCT00780312|trismus|trismus
563988|NCT00780312|physiotherapy|physiotherapy
563989|NCT00780312|lymphoedema|lymphoedema
563990|NCT00780312|late side effects|late side effects
563991|NCT00780312|fibrosis|fibrosis
563992|NCT00780312|decreased cervical range of motion|decreased cervical range of motion
563993|NCT00780312|quality of life|quality of life
563994|NCT00780299|Plasma epuration|plasma epuration
563995|NCT00780299|Hemofiltration|hemofiltration
563996|NCT00780299|Cardiac arrest|cardiac arrest
563997|NCT00780299|Shock|shock
563998|NCT00780299|Inflammatory mediators|inflammatory mediators
563999|NCT00780273|subjects with edentulous mandible|subjects with edentulous mandible
564000|NCT00780260|HIV/AIDS|hiv/aids
564001|NCT00780260|African Americans|african americans
564002|NCT00780260|Women|women
564003|NCT00780260|Case Management|case management
564004|NCT00780247|Vitamin D|vitamin d
564005|NCT00780247|Sun|sun
564006|NCT00780247|Latitude|latitude
564007|NCT00780247|Vitamin D status|vitamin d status
564008|NCT00780234|chemoprevention|chemoprevention
564009|NCT00780234|lung cancer|lung cancer
564010|NCT00780234|pioglitazone|pioglitazone
564011|NCT00780221|CRP|crp
564012|NCT00780221|coronary artery disease|coronary artery disease
564013|NCT00780221|polymorphisms|polymorphisms
564014|NCT00780208|Attention Deficit Hyperactivity ADHD|attention deficit hyperactivity adhd
564015|NCT00780195|hypoglycemia|hypoglycemia
564016|NCT00780195|African Americans|african americans
564017|NCT00780182|Bioavailability|bioavailability
564018|NCT00780156|Drug eluting stent|drug eluting stent
564019|NCT00780156|Dual antiplatelet therapy|dual antiplatelet therapy
564020|NCT00780156|bleeding|bleeding
564021|NCT00780156|stent thrombosis|stent thrombosis
564022|NCT00780156|follow-up of the drug eluting stent|follow-up of the drug eluting stent
564023|NCT00780143|Tumor|tumor
564024|NCT00780143|Leukemia|leukemia
564025|NCT00780143|Plitidepsin|plitidepsin
564026|NCT00780143|Aplidin|aplidin
564027|NCT00780117|CURRARINO syndrome|currarino syndrome
564028|NCT00780117|Sacrococcygeal teratoma|sacrococcygeal teratoma
564029|NCT00780117|HLXB9 (MNX1) gene|hlxb9 (mnx1) gene
564030|NCT00780117|Alpha foeto protein|alpha foeto protein
564031|NCT00780117|Prognosis factors|prognosis factors
564032|NCT00780104|Advanced myeloid leukemias|advanced myeloid leukemias
564033|NCT00780104|AML|aml
564034|NCT00780104|Leukemia|leukemia
564035|NCT00780104|Relapsed myeloid leukemias|relapsed myeloid leukemias
564036|NCT00780104|Refractory myeloid leukemias|refractory myeloid leukemias
564037|NCT00780104|MEC|mec
564038|NCT00780104|Rapamycin|rapamycin
564039|NCT00780104|Sirolimus|sirolimus
564040|NCT00780091|optimization|optimization
564041|NCT00780091|risk scale|risk scale
564042|NCT00780091|non inferiority|non inferiority
564043|NCT00780091|cluster randomization|cluster randomization
564044|NCT00780091|monitoring strategies|monitoring strategies
564045|NCT00780078|Intensive care unit|intensive care unit
564046|NCT00780078|Extubation failure|extubation failure
564047|NCT00780078|Physiotherapist|physiotherapist
564048|NCT00780078|Pre-extubation bedside tests|pre-extubation bedside tests
564049|NCT00780078|Swallowing disorders|swallowing disorders
564050|NCT00780052|Hematologic Malignancies|hematologic malignancies
564051|NCT00780052|c-myb|c-myb
564052|NCT00780052|c-myb AS ODN|c-myb as odn
564053|NCT00780026|liver|liver
564054|NCT00780026|transplant|transplant
564055|NCT00780026|blood sugar|blood sugar
564056|NCT00780013|Bioequivalence metformin hydrochloride|bioequivalence metformin hydrochloride
564057|NCT00779987|Dry eye|dry eye
564058|NCT00779987|Autologous serum|autologous serum
564059|NCT00779987|Ocular Surface Disease Index|ocular surface disease index
564060|NCT00779974|Total Shoulder Arthroplasty|total shoulder arthroplasty
564061|NCT00779974|Osteoarthritis|osteoarthritis
564062|NCT00779961|pediatric|pediatric
564063|NCT00779961|cleft palate|cleft palate
564064|NCT00779961|plastic surgery|plastic surgery
564065|NCT00779961|palatoplasty|palatoplasty
564066|NCT00779961|pharyngoplasty|pharyngoplasty
564067|NCT00779948|Femoral Neck Fracture|femoral neck fracture
564068|NCT00779948|Internal Fixation|internal fixation
564069|NCT00779948|Dynamic Hip Screw|dynamic hip screw
564070|NCT00779922|Multiple Myeloma|multiple myeloma
564071|NCT00779922|impaired renal function|impaired renal function
564072|NCT00779909|vitamin D|vitamin d
564073|NCT00779909|gingivitis|gingivitis
564074|NCT00779909|periodontal disease|periodontal disease
564075|NCT00779909|inflammation|inflammation
564076|NCT00779896|To evaluate therapeutic potential of tazarotene 0.1% cream for the treatment of Stage I-IIA CTCL. Patients with Stage I-IIA disease are enrolled into the study|to evaluate therapeutic potential of tazarotene 0.1% cream for the treatment of stage i-iia ctcl. patients with stage i-iia disease are enrolled into the study
564077|NCT00779896|Stage I-IIA disease CTCL|stage i-iia disease ctcl
564078|NCT00779883|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
564079|NCT00779883|CLL|cll
564080|NCT00779883|Leukemia|leukemia
564081|NCT00779883|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
564082|NCT00779883|Leukemia, B-Cell|leukemia, b-cell
564083|NCT00779883|Immune System Diseases|immune system diseases
564084|NCT00779883|ISF35|isf35
564085|NCT00779883|Ad-ISF35|ad-isf35
564086|NCT00779883|Immunotherapy|immunotherapy
564087|NCT00779883|Immune therapy|immune therapy
564088|NCT00779883|Active immune therapy|active immune therapy
564089|NCT00779870|asthma severity|asthma severity
564090|NCT00779870|airway smooth muscle|airway smooth muscle
564091|NCT00779870|oxidative stress|oxidative stress
564092|NCT00779857|left atrial appendage|left atrial appendage
564093|NCT00779857|laa|laa
564094|NCT00779857|atrial fibrillation|atrial fibrillation
564095|NCT00779857|afib|afib
564096|NCT00779857|af|af
564097|NCT00779857|stroke|stroke
564098|NCT00779857|tia|tia
564099|NCT00779844|Anesthesia|anesthesia
564100|NCT00779844|Obesity|obesity
564101|NCT00779831|Bioequivalence Pseudoephedrine hydrochloride 120 mg extended release tablets|bioequivalence pseudoephedrine hydrochloride 120 mg extended release tablets
564102|NCT00779805|Bioequivalence Pseudoephedrine hydrochloride 120 mg ER tablets|bioequivalence pseudoephedrine hydrochloride 120 mg er tablets
564103|NCT00779792|Irritant contact dermatitis|irritant contact dermatitis
564104|NCT00779792|experimental contact dermatitis|experimental contact dermatitis
564105|NCT00779792|treatment|treatment
564106|NCT00779792|efficacy|efficacy
564107|NCT00779792|topical steroids|topical steroids
564108|NCT00779792|topical immune modulators|topical immune modulators
564109|NCT00779792|glycerol|glycerol
564110|NCT00779779|Gastroenteritis|gastroenteritis
564111|NCT00779766|Human papillomavirus|human papillomavirus
564113|NCT00779766|cervical cancer|cervical cancer
564114|NCT00779766|cervical infection|cervical infection
564115|NCT00779753|Parenteral Feeding|parenteral feeding
564116|NCT00779753|Neonate|neonate
564117|NCT00779753|Lysine|lysine
564118|NCT00779727|women|women
564119|NCT00779727|increased|increased
564120|NCT00779727|risk|risk
564121|NCT00779714|metastatic (AJCC stage IV)|metastatic (ajcc stage iv)
564122|NCT00779714|first-line chemotherapy|first-line chemotherapy
564123|NCT00779714|ex-vivo chemosensitivity profiling|ex-vivo chemosensitivity profiling
564124|NCT00779714|evaluation of biomarkers|evaluation of biomarkers
564125|NCT00779701|Hyperglycemia|hyperglycemia
564126|NCT00779701|Glycemic control|glycemic control
564127|NCT00779688|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
564128|NCT00779688|ERCP|ercp
564129|NCT00779688|bile duct cancer|bile duct cancer
564130|NCT00779688|pancreatic duct cancer|pancreatic duct cancer
564131|NCT00779688|gall bladder|gall bladder
564132|NCT00779688|pancreas|pancreas
564133|NCT00779688|duodenoscope|duodenoscope
564134|NCT00779688|Cellvizio|cellvizio
564135|NCT00779688|endomicroscopy|endomicroscopy
564136|NCT00779688|cholangiopancreatoscopy|cholangiopancreatoscopy
564137|NCT00779688|Biliary Tract Neoplasms (suspected)|biliary tract neoplasms (suspected)
564138|NCT00779688|Biliary Tract Mass (suspected)|biliary tract mass (suspected)
564139|NCT00779688|Biliary Tract Stricture (suspected)|biliary tract stricture (suspected)
564140|NCT00779688|Pancreatic Duct Neoplasms (suspected)|pancreatic duct neoplasms (suspected)
564141|NCT00779688|Pancreatic Duct Mass (suspected)|pancreatic duct mass (suspected)
564142|NCT00779688|Pancreatic Duct Stricture (suspected)|pancreatic duct stricture (suspected)
564143|NCT00779662|Rheumatic Heart Disease|rheumatic heart disease
564144|NCT00779662|Streptococcus|streptococcus
564145|NCT00779662|Fiji|fiji
564146|NCT00779649|Colonoscopy,|colonoscopy,
564147|NCT00779649|Prep|prep
564148|NCT00779649|MoviPrep|moviprep
564149|NCT00779649|HalfLytely|halflytely
564150|NCT00779649|The effectiveness of colonoscopy preps|the effectiveness of colonoscopy preps
564151|NCT00779597|self care|self care
564152|NCT00779597|symptom management|symptom management
564153|NCT00779597|pain|pain
564154|NCT00779597|cancer|cancer
564155|NCT00779597|nurse coaching|nurse coaching
564156|NCT00779597|patient education|patient education
564157|NCT00779571|Polycystic Ovary Syndrome|polycystic ovary syndrome
564158|NCT00779571|Morbid Obesity|morbid obesity
564159|NCT00779571|Type 2 DM|type 2 dm
564160|NCT00779571|Coronary heart disease|coronary heart disease
564161|NCT00779532|Electrocardiography|electrocardiography
564162|NCT00779532|Pharmacokinetics|pharmacokinetics
564163|NCT00779519|Obesity|obesity
564164|NCT00779519|Class 1|class 1
564165|NCT00779519|Class 2|class 2
564166|NCT00779519|Weight Loss|weight loss
564167|NCT00779519|AgRP|agrp
564168|NCT00779519|TTP435|ttp435
564169|NCT00779519|alphaMSH|alphamsh
564170|NCT00779519|Agouti-Related Protein|agouti-related protein
564171|NCT00779519|alpha-melanocyte stimulating hormone|alpha-melanocyte stimulating hormone
564172|NCT00779506|Acute schizophrenia|acute schizophrenia
564173|NCT00779506|PANSS|panss
564174|NCT00779493|irritable bowel syndrome|irritable bowel syndrome
564175|NCT00779493|constipation|constipation
564176|NCT00779493|diarrhea|diarrhea
564177|NCT00779493|gas|gas
564178|NCT00779493|bloating|bloating
564179|NCT00779493|abdominal pain|abdominal pain
564180|NCT00779493|disturbance of defecation|disturbance of defecation
564181|NCT00779493|irritable colon|irritable colon
564182|NCT00779480|Acute Myelogenous Leukemia|acute myelogenous leukemia
564183|NCT00779480|Safety|safety
564184|NCT00779480|Dose Tolerance|dose tolerance
564185|NCT00779480|Pharmacokinetics/Pharmacodynamics|pharmacokinetics/pharmacodynamics
564186|NCT00779480|FLT-3|flt-3
564187|NCT00779467|non narcotic|non narcotic
564188|NCT00779467|epidural|epidural
564189|NCT00779467|labor pain|labor pain
564190|NCT00779467|Non narcotic treatment of labor pain|non narcotic treatment of labor pain
564191|NCT00779454|KRAS wild-type|kras wild-type
564192|NCT00779454|Cholangiocarcinoma|cholangiocarcinoma
564194|NCT00779441|Bioequivalence zolpidem 10mg tablets|bioequivalence zolpidem 10mg tablets
564195|NCT00779428|This is an open-label continuing treatment protocol in patients with advanced malignancies who will receive Tanespimycin|this is an open-label continuing treatment protocol in patients with advanced malignancies who will receive tanespimycin
564196|NCT00779415|Partial Thickness|partial thickness
564197|NCT00779415|Rotator Cuff|rotator cuff
564198|NCT00779402|cancer|cancer
564199|NCT00779402|prostate cancer|prostate cancer
564200|NCT00779402|prostatectomy|prostatectomy
564201|NCT00779402|PSA|psa
564202|NCT00779402|sipuleucel-T|sipuleucel-t
564203|NCT00779402|PROVENGE|provenge
564204|NCT00779402|APC8015|apc8015
564205|NCT00779402|non-metastatic|non-metastatic
564206|NCT00779402|nonmetastatic|nonmetastatic
564207|NCT00779402|androgen-sensitive|androgen-sensitive
564208|NCT00779402|androgen sensitive|androgen sensitive
564209|NCT00779402|biochemical recurrence|biochemical recurrence
564210|NCT00779402|biochemically recurrent|biochemically recurrent
564211|NCT00779402|immune therapy|immune therapy
564212|NCT00779402|immunotherapy|immunotherapy
564213|NCT00779402|vaccine|vaccine
564214|NCT00779402|dendritic cells|dendritic cells
564215|NCT00779402|antigen-presenting cells|antigen-presenting cells
564216|NCT00779402|antigen presenting cells|antigen presenting cells
564217|NCT00779402|cancer vaccine|cancer vaccine
564218|NCT00779402|therapeutic vaccine|therapeutic vaccine
564219|NCT00779402|therapeutic cancer vaccine|therapeutic cancer vaccine
564220|NCT00779402|biologic|biologic
564221|NCT00779402|booster|booster
564222|NCT00779389|Head and Neck cancer|head and neck cancer
564223|NCT00779376|Bioequivalence|bioequivalence
564224|NCT00779363|obese,|obese,
564225|NCT00779363|Diabetes|diabetes
564226|NCT00779350|Bioequivalence sertraline 100 mg tablets fasting conditions|bioequivalence sertraline 100 mg tablets fasting conditions
564228|NCT00779337|lymphoma|lymphoma
564229|NCT00779337|immunotherapy|immunotherapy
564230|NCT00779324|traumatic brain injury|traumatic brain injury
564231|NCT00779324|irritability|irritability
564232|NCT00779324|aggression|aggression
564233|NCT00779324|amantadine|amantadine
564234|NCT00779324|behavior|behavior
564235|NCT00779311|Metastatic Colorectal Cancer|metastatic colorectal cancer
564236|NCT00779298|rye whole-meal bread|rye whole-meal bread
564237|NCT00779298|white-wheat bread|white-wheat bread
564238|NCT00779298|gastric emptying rate|gastric emptying rate
564239|NCT00779298|postprandial glucose response|postprandial glucose response
564240|NCT00779298|healthy subjects|healthy subjects
564241|NCT00779272|neoadjuvant chemotherapy|neoadjuvant chemotherapy
564242|NCT00779272|clinically postoperative outcome|clinically postoperative outcome
564243|NCT00779272|liver regeneration after liver resection|liver regeneration after liver resection
564244|NCT00779259|quinine sulfate|quinine sulfate
564245|NCT00779259|theophylline|theophylline
564246|NCT00779259|drug interactions|drug interactions
564247|NCT00779259|cytochrome p450|cytochrome p450
564249|NCT00779259|male|male
564250|NCT00779259|adult|adult
564251|NCT00779246|Methicillin resistance|methicillin resistance
564252|NCT00779246|Infection control|infection control
564253|NCT00779246|Staphylococcus aureus|staphylococcus aureus
564254|NCT00779246|Cross infection|cross infection
564255|NCT00779246|Epidemiology|epidemiology
564256|NCT00779246|Chlorhexidine|chlorhexidine
564257|NCT00779233|Bioequivalence|bioequivalence
564258|NCT00779207|obesity|obesity
564259|NCT00779207|aging|aging
564260|NCT00779207|exercise|exercise
564261|NCT00779207|diet|diet
564262|NCT00779207|weight loss|weight loss
564263|NCT00779207|physical function|physical function
564264|NCT00779207|Obesity in the Elderly|obesity in the elderly
564265|NCT00779181|Hypertension|hypertension
564266|NCT00779181|High blood pressure|high blood pressure
564267|NCT00779181|Htn|htn
564268|NCT00779181|Addrenex|addrenex
564269|NCT00779168|recurrent prostate cancer|recurrent prostate cancer
564270|NCT00779168|adenocarcinoma of the prostate|adenocarcinoma of the prostate
564271|NCT00779142|resistant diabetic macular edema|resistant diabetic macular edema
564272|NCT00779103|puberty|puberty
564273|NCT00779103|precocious puberty|precocious puberty
564274|NCT00779103|early puberty|early puberty
564275|NCT00779103|early onset puberty|early onset puberty
564276|NCT00779103|histrelin|histrelin
564277|NCT00779103|histrelin subcutaneous implant|histrelin subcutaneous implant
564278|NCT00779103|implant therapy|implant therapy
564279|NCT00779077|device characteristics|device characteristics
564280|NCT00779064|Atrial Fibrillation|atrial fibrillation
564281|NCT00779051|Bioequivalence Zolpidem 10mg tablets|bioequivalence zolpidem 10mg tablets
564282|NCT00779038|IONSYS|ionsys
564283|NCT00779038|Fentanyl Iontophoretic Transdermal System|fentanyl iontophoretic transdermal system
564284|NCT00779038|Postoperative pain|postoperative pain
564285|NCT00778986|heart failure|heart failure
564286|NCT00778986|remote patient monitoring|remote patient monitoring
564287|NCT00778986|telemonitoring|telemonitoring
564288|NCT00778986|home monitoring|home monitoring
564289|NCT00778986|randomized controlled trial|randomized controlled trial
564290|NCT00778986|self care|self care
564466|NCT00777985|Cardiovascular system|cardiovascular system
564291|NCT00778973|Bioequivalence sertraline 100 mg tablets under fed conditions|bioequivalence sertraline 100 mg tablets under fed conditions
564292|NCT00778947|Breast Reconstruction|breast reconstruction
564293|NCT00778947|Halmonic Scalpel|halmonic scalpel
564294|NCT00778947|diathermy|diathermy
564295|NCT00778947|Free Tissue Transfer|free tissue transfer
564296|NCT00778921|Aliskiren|aliskiren
564297|NCT00778921|Amlodipine|amlodipine
564298|NCT00778921|Non-responder to Amlodipine|non-responder to amlodipine
564299|NCT00778908|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
564300|NCT00778908|Locally advanced disease|locally advanced disease
564301|NCT00778908|Intensity-modulated radiation therapy|intensity-modulated radiation therapy
564302|NCT00778908|Accelerated hyperfractionation|accelerated hyperfractionation
564303|NCT00778908|Concomitant boost radiation therapy|concomitant boost radiation therapy
564304|NCT00778908|Concurrent chemotherapy|concurrent chemotherapy
564305|NCT00778895|Flu|flu
564306|NCT00778895|Safety|safety
564307|NCT00778895|Immunogenicity|immunogenicity
564308|NCT00778895|Flu vaccine|flu vaccine
564309|NCT00778895|Influenza|influenza
564310|NCT00778895|Virus|virus
564311|NCT00778882|Chronic Granulomatous Disease|chronic granulomatous disease
564312|NCT00778882|Retroviral Vector|retroviral vector
564313|NCT00778882|Gene Therapy|gene therapy
564314|NCT00778843|Chronic hepatitis C|chronic hepatitis c
564315|NCT00778843|Oxidative stress|oxidative stress
564316|NCT00778843|Antioxidant|antioxidant
564317|NCT00778843|Cytokines|cytokines
564318|NCT00778843|Nutritional supplement|nutritional supplement
564319|NCT00778830|mCRC|mcrc
564320|NCT00778804|CVD risk|cvd risk
564321|NCT00778804|self monitoring|self monitoring
564322|NCT00778804|Internet|internet
564323|NCT00778804|telemedicine|telemedicine
564324|NCT00778791|Bioequivalence metformin HC1 750 mg extended-release tablets|bioequivalence metformin hc1 750 mg extended-release tablets
564325|NCT00778778|Bioequivalence cefprozil 500mg tablets fasting conditions|bioequivalence cefprozil 500mg tablets fasting conditions
564326|NCT00778765|Bioequivalence gabapentin fed conditions|bioequivalence gabapentin fed conditions
564327|NCT00778752|Multiple Myeloma|multiple myeloma
564328|NCT00778752|Stem Cell Transplantation|stem cell transplantation
564329|NCT00778752|Revlimid|revlimid
564330|NCT00778752|Lenalidomide|lenalidomide
564331|NCT00778739|bioequivalence 1) CEFPROZIL FOR ORAL SUSPENSION USP 250 mg/ 5 mL fed conditions|bioequivalence 1) cefprozil for oral suspension usp 250 mg/ 5 ml fed conditions
564332|NCT00778726|Bioequivalence benazepril and hydrochlorothiazide tablets|bioequivalence benazepril and hydrochlorothiazide tablets
564333|NCT00778713|Bioequivalence|bioequivalence
564334|NCT00778674|Bioequivalence Benazepril HCl Hydrochlorothiazide Tablets|bioequivalence benazepril hcl hydrochlorothiazide tablets
564335|NCT00778661|Bioequivalence|bioequivalence
564336|NCT00778648|Common cold|common cold
564337|NCT00778648|prevention|prevention
564338|NCT00778648|dietary supplement|dietary supplement
564339|NCT00778609|Combined Oral Contraceptives|combined oral contraceptives
564340|NCT00778609|Pelvic Pain|pelvic pain
564341|NCT00778609|Headache|headache
564342|NCT00778596|Hepatitis B|hepatitis b
564343|NCT00778596|Telbivudine|telbivudine
564344|NCT00778596|Prednisolone|prednisolone
564345|NCT00778583|Bioequivalence Nitrofurantoin capsules|bioequivalence nitrofurantoin capsules
564346|NCT00778557|CEFPROZIL FOR ORAL SUSPENSION USP 250 mg/ 5 mL, Bioequivalence fasting conditions|cefprozil for oral suspension usp 250 mg/ 5 ml, bioequivalence fasting conditions
564347|NCT00778544|Bioequivalence amoxicillin-clavulanic acid 600 mg 42.9 mg per 5 mL oral suspension|bioequivalence amoxicillin-clavulanic acid 600 mg 42.9 mg per 5 ml oral suspension
564348|NCT00778531|injectable implant|injectable implant
564349|NCT00778531|nasolabial folds|nasolabial folds
564350|NCT00778531|Correction of nasolabial folds|correction of nasolabial folds
564351|NCT00778518|growth hormone|growth hormone
564352|NCT00778518|growth hormone deficiency|growth hormone deficiency
564353|NCT00778518|GHD|ghd
564354|NCT00778518|PEG|peg
564355|NCT00778518|pegylated|pegylated
564356|NCT00778518|IGF-1|igf-1
564357|NCT00778505|Anesthesia|anesthesia
564358|NCT00778492|Thrombelastogram|thrombelastogram
564359|NCT00778492|Microvascular bleeding|microvascular bleeding
564360|NCT00778492|antiplatelet medication|antiplatelet medication
564361|NCT00778492|cardiac surgery|cardiac surgery
564362|NCT00778492|consumption of blood products|consumption of blood products
564363|NCT00778492|preoperative platelet mapping derived from modified TEG|preoperative platelet mapping derived from modified teg
564364|NCT00778492|postoperative bleeding|postoperative bleeding
564365|NCT00778466|Bioequivalence metformin hydrochloride 1000 mg tablets fed conditions|bioequivalence metformin hydrochloride 1000 mg tablets fed conditions
564366|NCT00778453|stroke rehabilitation|stroke rehabilitation
564367|NCT00778453|kinematic analysis|kinematic analysis
564368|NCT00778453|upper extremity training|upper extremity training
564369|NCT00778453|predictors|predictors
564370|NCT00778440|Injuries|injuries
564371|NCT00778440|Traffic Injuries|traffic injuries
564372|NCT00778440|Preventive medicine|preventive medicine
564373|NCT00778440|Observational studies|observational studies
564374|NCT00778440|Primary care|primary care
564375|NCT00778427|Bioequivalence metformin hydrochloride 1000 mg tablets fasting conditions|bioequivalence metformin hydrochloride 1000 mg tablets fasting conditions
564467|NCT00777985|Sleep|sleep
564376|NCT00778414|Bioequivalence Amoxicillin Clavulanic acid 600mg 42.9 mg per 5 mL oral suspension|bioequivalence amoxicillin clavulanic acid 600mg 42.9 mg per 5 ml oral suspension
564377|NCT00778401|Bioequivalence Gabapentin tablets 800 mg fasting conditions|bioequivalence gabapentin tablets 800 mg fasting conditions
564378|NCT00778388|Pseudomonas Aeruginosa|pseudomonas aeruginosa
564379|NCT00778375|Leukemia|leukemia
564380|NCT00778375|Acute Myeloid Leukemia|acute myeloid leukemia
564381|NCT00778375|Myelodysplastic Syndrome|myelodysplastic syndrome
564382|NCT00778375|AML|aml
564383|NCT00778375|MDS|mds
564384|NCT00778375|Clofarabine|clofarabine
564385|NCT00778375|Ara-C|ara-c
564386|NCT00778375|Cytarabine|cytarabine
564387|NCT00778375|Decitabine|decitabine
564388|NCT00778362|OPSI|opsi
564389|NCT00778362|Splenectomy|splenectomy
564390|NCT00778349|Bioavailability Metformin solution 100 mg/mL|bioavailability metformin solution 100 mg/ml
564391|NCT00778336|Peripheral Thrombosis|peripheral thrombosis
564392|NCT00778336|DVT|dvt
564393|NCT00778336|Limb Ischemia|limb ischemia
564394|NCT00778336|AV Access|av access
564395|NCT00778336|AngioJet|angiojet
564396|NCT00778336|Thrombectomy|thrombectomy
564397|NCT00778323|remote ischemic preconditioning|remote ischemic preconditioning
564398|NCT00778323|cervical compression myelopathy|cervical compression myelopathy
564399|NCT00778323|spinal cord|spinal cord
564400|NCT00778323|neuron-specific enolase|neuron-specific enolase
564401|NCT00778323|s-100B|s-100b
564402|NCT00778310|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
564403|NCT00778310|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
564404|NCT00778310|ADHD|adhd
564405|NCT00778297|prevention|prevention
564406|NCT00778297|influenza|influenza
564407|NCT00778297|infection|infection
564408|NCT00778297|vaccine|vaccine
564409|NCT00778297|Influenza vaccine|influenza vaccine
564410|NCT00778297|Influenza in humans|influenza in humans
564411|NCT00778284|Bioequivalence|bioequivalence
564412|NCT00778271|Bioequivalence gabapentin 400mg capsules fasting conditions|bioequivalence gabapentin 400mg capsules fasting conditions
564413|NCT00778258|Food Allergy|food allergy
564414|NCT00778258|Milk Allergy|milk allergy
564415|NCT00778245|Bioequivalence cefprozil 500mg tablets fed conditions|bioequivalence cefprozil 500mg tablets fed conditions
564416|NCT00778232|Bioequivalence Gabapentin tablets 800 mg fed conditions|bioequivalence gabapentin tablets 800 mg fed conditions
564417|NCT00778219|heart rate variability, tracheal intubation|heart rate variability, tracheal intubation
564418|NCT00778206|Phenylketonuria|phenylketonuria
564419|NCT00778206|Hyperphenylalaninemia|hyperphenylalaninemia
564420|NCT00778206|PKU|pku
564421|NCT00778206|Phenylalanine|phenylalanine
564422|NCT00778193|NSAID|nsaid
564423|NCT00778193|ulcer|ulcer
564424|NCT00778193|gastroduodenal ulcer|gastroduodenal ulcer
564425|NCT00778193|naproxen|naproxen
564426|NCT00778193|aspirin|aspirin
564427|NCT00778193|ASA|asa
564428|NCT00778193|celecoxib|celecoxib
564429|NCT00778193|clopidogrel|clopidogrel
564430|NCT00778193|healing|healing
564431|NCT00778193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors
564432|NCT00778193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
564433|NCT00778193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
564434|NCT00778193|Wound Healing|wound healing
564435|NCT00778180|Bioequivalence furosemide 80 mg tablets|bioequivalence furosemide 80 mg tablets
564436|NCT00778141|Bioequivalecne metformin HC1 750 mg extended-release tablets|bioequivalecne metformin hc1 750 mg extended-release tablets
564437|NCT00778128|CP-4126|cp-4126
564438|NCT00778128|Cancer|cancer
564439|NCT00778128|Metastatic|metastatic
564440|NCT00778128|Solid tumours|solid tumours
564441|NCT00778128|Gemzitabine|gemzitabine
564442|NCT00778128|Gemzar|gemzar
564443|NCT00778115|Bioequivalence Loperamide HCl 2 mg and simethicone 125 mg tablets|bioequivalence loperamide hcl 2 mg and simethicone 125 mg tablets
564444|NCT00778089|skin test|skin test
564445|NCT00778089|ArteFill|artefill
564446|NCT00778089|Skin test prior to administration of ArteFill® implant|skin test prior to administration of artefill® implant
564447|NCT00778076|Knee OA, Hyaluronic acid, Gait, Pain, Synovial fluid|knee oa, hyaluronic acid, gait, pain, synovial fluid
564448|NCT00778063|dexmedetomidine|dexmedetomidine
564449|NCT00778063|pressure equalization tubes in the ear|pressure equalization tubes in the ear
564450|NCT00778063|myringotomy|myringotomy
564451|NCT00778063|sevoflurane|sevoflurane
564452|NCT00778050|Bioequivalence, amoxicillin 600mg fasting conditions|bioequivalence, amoxicillin 600mg fasting conditions
564453|NCT00778037|Bioequivalence Cyclobenzaprine hydrochloride 10 mg tablet fasting conditions|bioequivalence cyclobenzaprine hydrochloride 10 mg tablet fasting conditions
564454|NCT00778024|Bioequivalence fluoxetine HCL 40 mg capsules fasting conditions|bioequivalence fluoxetine hcl 40 mg capsules fasting conditions
564455|NCT00778011|Nausea|nausea
564456|NCT00778011|Vomiting|vomiting
564457|NCT00778011|Ondansetron|ondansetron
564458|NCT00778011|Metoclopramide|metoclopramide
564459|NCT00778011|Randomized|randomized
564460|NCT00778011|Double-Blind|double-blind
564461|NCT00778011|nausea and vomiting in the emergency department|nausea and vomiting in the emergency department
564462|NCT00777998|Multiple Myeloma|multiple myeloma
564463|NCT00777998|Stem Cell Transplantation|stem cell transplantation
564464|NCT00777998|Thalidomide|thalidomide
564465|NCT00777998|DLI|dli
564468|NCT00777985|Endothelial function|endothelial function
564469|NCT00777985|Endothelin system|endothelin system
564470|NCT00777972|Bioequivalence Fosinopril sodium and hydrochlorothiazide 20-12.5 mg tablets fasting conditions|bioequivalence fosinopril sodium and hydrochlorothiazide 20-12.5 mg tablets fasting conditions
564471|NCT00777946|Aliskiren, Amlodipine, Non-responder to aliskiren|aliskiren, amlodipine, non-responder to aliskiren
564472|NCT00777907|neurovascular embolization|neurovascular embolization
564473|NCT00777907|therapeutic embolization|therapeutic embolization
564474|NCT00777894|advanced adult primary liver cancer|advanced adult primary liver cancer
564475|NCT00777894|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
564476|NCT00777894|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
564477|NCT00777855|warfarin|warfarin
564478|NCT00777855|pharmacokinetics|pharmacokinetics
564479|NCT00777855|drug transporter|drug transporter
564480|NCT00777855|healthy volunteer|healthy volunteer
564481|NCT00777855|drug interaction|drug interaction
564482|NCT00777855|rifampin|rifampin
564483|NCT00777829|Nap|nap
564484|NCT00777829|Pharmacology|pharmacology
564485|NCT00777829|Memory|memory
564486|NCT00777829|Visual Learning|visual learning
564487|NCT00777829|Verbal Memory|verbal memory
564488|NCT00777829|Motor Learning|motor learning
564489|NCT00777816|Rheumatoid|rheumatoid
564490|NCT00777816|Arthritis|arthritis
564491|NCT00777790|Meningitis|meningitis
564492|NCT00777790|Meningococcemia|meningococcemia
564493|NCT00777790|Neisseria meningitidis|neisseria meningitidis
564494|NCT00777777|multi-vessel, therapy, surgery, CABG|multi-vessel, therapy, surgery, cabg
564495|NCT00777764|Xolair|xolair
564496|NCT00777764|Asthma|asthma
564497|NCT00777764|Skin Tests|skin tests
564498|NCT00777751|Chest Tumor|chest tumor
564499|NCT00777751|Heart|heart
564500|NCT00777751|Lung Cancer|lung cancer
564501|NCT00777751|Esophageal Cancer|esophageal cancer
564502|NCT00777751|Thymoma|thymoma
564503|NCT00777751|Radiation dose to the heart|radiation dose to the heart
564504|NCT00777751|Cardiac Enzymes|cardiac enzymes
564505|NCT00777751|Cardiac Biomarkers|cardiac biomarkers
564506|NCT00777751|Radiation Therapy|radiation therapy
564507|NCT00777751|RT|rt
564508|NCT00777751|Electrocardiograms|electrocardiograms
564509|NCT00777751|ECG|ecg
564510|NCT00777738|Advanced Waldenström's macroglobulinemia|advanced waldenström's macroglobulinemia
564511|NCT00777738|Bortezomib|bortezomib
564512|NCT00777738|Dexamethasone|dexamethasone
564513|NCT00777738|Safety|safety
564514|NCT00777738|Efficacy|efficacy
564515|NCT00777712|Wound healing|wound healing
564516|NCT00777712|diabetes|diabetes
564517|NCT00777712|inflammatory cell|inflammatory cell
564518|NCT00777712|monocyte|monocyte
564519|NCT00777712|leukocyte|leukocyte
564520|NCT00777712|macrophage|macrophage
564521|NCT00777699|Cancer|cancer
564522|NCT00777699|Solid Tumors|solid tumors
564523|NCT00777699|NSCLC|nsclc
564524|NCT00777686|Intracranial Glioblastoma|intracranial glioblastoma
564525|NCT00777686|Intracranial Gliosarcoma|intracranial gliosarcoma
564526|NCT00777686|glioblastoma|glioblastoma
564527|NCT00777686|recurrent glioblastoma|recurrent glioblastoma
564528|NCT00777686|gliosarcoma|gliosarcoma
564529|NCT00777686|brain cancer|brain cancer
564530|NCT00777686|magnetic resonance spectroscopy|magnetic resonance spectroscopy
564531|NCT00777686|MRS|mrs
564532|NCT00777686|magnetic resonance imaging|magnetic resonance imaging
564533|NCT00777686|MRI|mri
564534|NCT00777686|MRI/MRS|mri/mrs
564535|NCT00777686|Recurrent Glioblastoma Treated with Antiangiogenic agents|recurrent glioblastoma treated with antiangiogenic agents
564536|NCT00777686|contrast enhanced MRI|contrast enhanced mri
564537|NCT00777686|DCE-MRI|dce-mri
564538|NCT00777686|diffusion-weighted MRI|diffusion-weighted mri
564539|NCT00777686|DSC|dsc
564540|NCT00777686|DW-MRI|dw-mri
564541|NCT00777673|Breast Cancer|breast cancer
564542|NCT00777673|Triple Negative|triple negative
564543|NCT00777673|Neoadjuvant|neoadjuvant
564544|NCT00777673|Neoadjuvant therapy|neoadjuvant therapy
564545|NCT00777673|ER, PR and HER2 Negative|er, pr and her2 negative
564546|NCT00777634|Binge Eating Disorder|binge eating disorder
564547|NCT00777634|Eating Disorder|eating disorder
564548|NCT00777595|QTc|qtc
564549|NCT00777595|CHF 4226 HFA|chf 4226 hfa
564550|NCT00777595|pMDI|pmdi
564551|NCT00777595|Carmoterol|carmoterol
564552|NCT00777582|Poly (ADP ribose) polymerases|poly (adp ribose) polymerases
564553|NCT00777582|Homologous Recombination Deficiency (HRD)|homologous recombination deficiency (hrd)
564554|NCT00777582|Advanced solid tumours|advanced solid tumours
564555|NCT00777569|Smoking|smoking
564556|NCT00777569|PREPS|preps
564557|NCT00777569|Harm reduction|harm reduction
564558|NCT00777569|Biomarkers of tobacco exposure|biomarkers of tobacco exposure
564559|NCT00777569|Compensatory smoking|compensatory smoking
564560|NCT00777543|Bioavailability|bioavailability
564561|NCT00777543|Ferulic acid|ferulic acid
564562|NCT00777543|Phenolic compounds|phenolic compounds
564563|NCT00777543|Colonic metabolites|colonic metabolites
564564|NCT00777543|Immunomodulatory effects|immunomodulatory effects
564565|NCT00777543|No disease|no disease
564566|NCT00777517|Cardiovascular Diseases|cardiovascular diseases
564567|NCT00777504|angiogenesis|angiogenesis
564568|NCT00777504|inhibitor|inhibitor
564569|NCT00777504|duration of therapy|duration of therapy
564570|NCT00777504|GIST|gist
564571|NCT00777491|stage II bladder cancer|stage ii bladder cancer
564572|NCT00777491|stage III bladder cancer|stage iii bladder cancer
564573|NCT00777491|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
564574|NCT00777478|Sunitinib|sunitinib
564575|NCT00777478|Capecitabine|capecitabine
564576|NCT00777478|Irinotecan|irinotecan
564577|NCT00777478|colorectal cancer|colorectal cancer
564578|NCT00777465|Acute kidney injury|acute kidney injury
564579|NCT00777465|Kidney failure|kidney failure
564580|NCT00777465|Risk factors|risk factors
564581|NCT00777465|Clinical outcomes|clinical outcomes
564582|NCT00777465|Cardiac valve surgery|cardiac valve surgery
564583|NCT00777465|Coronary artery bypass grafting|coronary artery bypass grafting
564584|NCT00777465|Morbidity|morbidity
564585|NCT00777465|Mortality|mortality
564586|NCT00777452|quality of life|quality of life
564587|NCT00777452|localized prostate cancer|localized prostate cancer
564588|NCT00777452|FACT-P|fact-p
564589|NCT00777439|Dopamine|dopamine
564590|NCT00777439|Domperidone|domperidone
564591|NCT00777439|Gastroparesis|gastroparesis
564592|NCT00777439|Gastrointestinal Diseases|gastrointestinal diseases
564593|NCT00777439|Neurologic Manifestations|neurologic manifestations
564594|NCT00777439|Stomach Diseases|stomach diseases
564595|NCT00777439|Digestive System Diseases|digestive system diseases
564596|NCT00777439|Esophagitis|esophagitis
564597|NCT00777439|Esophageal Disorders|esophageal disorders
564598|NCT00777439|Paralysis|paralysis
564599|NCT00777426|HIV positive with HAD|hiv positive with had
564600|NCT00777413|Bioequiavlence Minocycline Tablets|bioequiavlence minocycline tablets
564601|NCT00777400|Kidney transplant|kidney transplant
564602|NCT00777400|T regulatory cells|t regulatory cells
564603|NCT00777400|Efalizumab|efalizumab
564604|NCT00777400|Rejection|rejection
564605|NCT00777400|Safely convert renal transplant from mycophenolate mofetil and Calcineurin inhibitor to efalizumab and sirolimus|safely convert renal transplant from mycophenolate mofetil and calcineurin inhibitor to efalizumab and sirolimus
564606|NCT00777387|human oocyte cryopreservation|human oocyte cryopreservation
564607|NCT00777387|slow-freeze|slow-freeze
564608|NCT00777387|vitrification|vitrification
564609|NCT00777361|Mass balance|mass balance
564610|NCT00777361|AZD3480, Pharmacokinetics, Healthy volunteers|azd3480, pharmacokinetics, healthy volunteers
564611|NCT00777322|keratoconus|keratoconus
564612|NCT00777322|pellucid marginal degeneration|pellucid marginal degeneration
564613|NCT00777322|corneal ectasia|corneal ectasia
564614|NCT00777322|collagen cross-linking|collagen cross-linking
564615|NCT00777322|riboflavin|riboflavin
564616|NCT00777322|UV light|uv light
564617|NCT00777322|excimer laser|excimer laser
564618|NCT00777322|Topography-Computer Assisted Treatment (T-Cat)|topography-computer assisted treatment (t-cat)
564619|NCT00777322|Wavelight Allegretto laser|wavelight allegretto laser
564620|NCT00777309|NSCLC|nsclc
564621|NCT00777296|Cystic Fibrosis|cystic fibrosis
564622|NCT00777296|Respiratory Infections|respiratory infections
564623|NCT00777296|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
564624|NCT00777296|CFTR|cftr
564625|NCT00777270|episiotomy|episiotomy
564626|NCT00777270|perineal lesion|perineal lesion
564627|NCT00777270|vaginal trauma|vaginal trauma
564628|NCT00777257|Meningitis|meningitis
564629|NCT00777257|Meningococcemia|meningococcemia
564630|NCT00777257|Pertussis|pertussis
564631|NCT00777257|Neisseria meningitidis|neisseria meningitidis
564632|NCT00777257|Tetanus|tetanus
564633|NCT00777257|Diphtheria|diphtheria
564634|NCT00777244|mitotane|mitotane
564635|NCT00777244|adjuvant therapy|adjuvant therapy
564636|NCT00777244|disease free survival|disease free survival
564637|NCT00777231|Sickle Cell|sickle cell
564638|NCT00777231|Stem Cell|stem cell
564639|NCT00777231|Tolerance|tolerance
564640|NCT00777231|Bone Marrow Transplant|bone marrow transplant
564641|NCT00777231|Total Body Irradiation (TBI)|total body irradiation (tbi)
564642|NCT00777231|Apheresis|apheresis
564643|NCT00777231|Aplastic Anemia|aplastic anemia
564644|NCT00777231|Hemoglobinopathies|hemoglobinopathies
564645|NCT00777231|Non Malignant|non malignant
564646|NCT00777218|migraine|migraine
564647|NCT00777205|Peer Support|peer support
564648|NCT00777205|Quality of Life|quality of life
564649|NCT00777205|Telephone|telephone
564650|NCT00777192|colon cancer|colon cancer
564651|NCT00777192|Cancers of the colon and rectum|cancers of the colon and rectum
564652|NCT00777192|Oxaliplatin|oxaliplatin
564653|NCT00777192|oxaliplatin chemotherapy|oxaliplatin chemotherapy
564654|NCT00777192|inflammatory cytokines|inflammatory cytokines
564655|NCT00777192|neurocognitive symptoms|neurocognitive symptoms
564656|NCT00777192|neuropsychiatric symptoms|neuropsychiatric symptoms
564657|NCT00777179|Vandetanib, NSCLC, Maintenance, Phase II|vandetanib, nsclc, maintenance, phase ii
564658|NCT00777166|oxytocin|oxytocin
564659|NCT00777166|ST depression|st depression
564660|NCT00777166|cesarean section|cesarean section
564661|NCT00777166|blood loss|blood loss
564662|NCT00777153|Cancer|cancer
564663|NCT00777153|Tumour|tumour
564664|NCT00777153|Advanced Solid Tumour|advanced solid tumour
564665|NCT00777153|GBM|gbm
564666|NCT00777153|Glioblastoma|glioblastoma
564667|NCT00777140|Stroke|stroke
564668|NCT00777140|Ischemic Stroke|ischemic stroke
564669|NCT00777140|Thrombolytic treatment|thrombolytic treatment
564670|NCT00777140|Middle cerebral artery occlusion|middle cerebral artery occlusion
564671|NCT00777140|Deferoxamine|deferoxamine
564672|NCT00777140|Iron chelator|iron chelator
564673|NCT00777140|Acute Ischemic Stroke treated with Intravenous Thrombolytic|acute ischemic stroke treated with intravenous thrombolytic
564674|NCT00777127|actinic keratosis|actinic keratosis
564675|NCT00777127|invasive SCC|invasive scc
564676|NCT00777127|in situ SCC|in situ scc
564677|NCT00777127|histological classification|histological classification
564678|NCT00777127|histological progression|histological progression
564679|NCT00777127|clinical clearance|clinical clearance
564680|NCT00777127|cryotherapy|cryotherapy
564681|NCT00777114|relapsed non-Hodgkin's lymphoma|relapsed non-hodgkin's lymphoma
564682|NCT00777101|HER2|her2
564683|NCT00777101|ErbB2|erbb2
564684|NCT00777101|metastatic|metastatic
564685|NCT00777101|neratinib|neratinib
564686|NCT00777101|lapatinib|lapatinib
564687|NCT00777101|capecitabine|capecitabine
564688|NCT00777101|HKI-272|hki-272
564689|NCT00777101|Nerlynx|nerlynx
564690|NCT00777101|PB-272|pb-272
564691|NCT00777088|neurovascular embolization|neurovascular embolization
564692|NCT00777088|therapeutic embolization|therapeutic embolization
564693|NCT00777075|nitrate|nitrate
564694|NCT00777075|nitric oxide|nitric oxide
564695|NCT00777075|asymmetric dimethylarginine|asymmetric dimethylarginine
564696|NCT00777075|blood pressure|blood pressure
564697|NCT00777075|NOS|nos
564698|NCT00777075|IIEF|iief
564699|NCT00777062|alcohol|alcohol
564700|NCT00777062|cocaine|cocaine
564701|NCT00777062|addiction|addiction
564702|NCT00777062|alcoholism|alcoholism
564703|NCT00777062|substance dependence|substance dependence
564704|NCT00777062|substance abuse|substance abuse
564705|NCT00777036|Leukemia, Pediatric|leukemia, pediatric
564706|NCT00777023|Hot Flashes|hot flashes
564707|NCT00777023|Hot Flushes|hot flushes
564708|NCT00777023|Postmenopausal symptoms|postmenopausal symptoms
564709|NCT00777023|Vasomotor symptoms|vasomotor symptoms
564710|NCT00777010|memory loss|memory loss
564711|NCT00777010|mild cognitive impairment|mild cognitive impairment
564712|NCT00777010|forgetfulness|forgetfulness
564713|NCT00776997|Gastroesophageal Reflux|gastroesophageal reflux
564714|NCT00776958|A Lynne Cohen Consortium Project|a lynne cohen consortium project
564715|NCT00776958|Multi-Center Database Registry|multi-center database registry
564716|NCT00776958|High Risk|high risk
564717|NCT00776958|Cancer|cancer
564718|NCT00776958|Breast|breast
564719|NCT00776958|BRCA1 or BRCA2 gene|brca1 or brca2 gene
564720|NCT00776958|Ovary|ovary
564721|NCT00776958|Questionnaire|questionnaire
564722|NCT00776919|Acne Vulgaris|acne vulgaris
564723|NCT00776919|Acne|acne
564724|NCT00776880|Surgical operation|surgical operation
564725|NCT00776867|Pediatric|pediatric
564726|NCT00776867|solid tumors|solid tumors
564727|NCT00776867|Pediatric solid tumors|pediatric solid tumors
564728|NCT00776867|08-091|08-091
564729|NCT00776841|Phase-I|phase-i
564730|NCT00776841|Hypercholesterolemia|hypercholesterolemia
564731|NCT00776841|Obesity|obesity
564732|NCT00776841|fatty liver|fatty liver
564733|NCT00776841|Part A: Healthy male volunteers Part B: Mildly overweight, otherwise healthy hypercholesterolemic male volunteers|part a: healthy male volunteers part b: mildly overweight, otherwise healthy hypercholesterolemic male volunteers
564734|NCT00776828|cilostazol|cilostazol
564735|NCT00776828|clopidogrel|clopidogrel
564736|NCT00776828|statin|statin
564737|NCT00776828|drug-eluting stent|drug-eluting stent
564738|NCT00776802|GCS-100|gcs-100
564739|NCT00776802|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
564740|NCT00776802|DLBCL|dlbcl
564741|NCT00776802|Relapsed or refractory DLBCL|relapsed or refractory dlbcl
564742|NCT00776802|Etoposide; Dexamethasone|etoposide; dexamethasone
564743|NCT00776789|Skin to skin contact|skin to skin contact
564744|NCT00776789|Salivary cortisol|salivary cortisol
564745|NCT00776789|Breast feeding Behavior|breast feeding behavior
564746|NCT00776776|BMI > 40|bmi > 40
564747|NCT00776776|Obesity|obesity
564748|NCT00776776|Adolescents|adolescents
564749|NCT00776776|Weight Loss Surgery|weight loss surgery
564750|NCT00776737|Attention Deficit Disorder|attention deficit disorder
564751|NCT00776737|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
564752|NCT00776737|Computer Aided Learning|computer aided learning
564753|NCT00776737|Attention Deficits|attention deficits
564754|NCT00776737|Healthy Volunteer|healthy volunteer
564755|NCT00776737|HV|hv
564756|NCT00776724|breast ca|breast ca
564757|NCT00776724|phase III|phase iii
564758|NCT00776724|Tailored neoadjuvant chemotherapy|tailored neoadjuvant chemotherapy
564759|NCT00776724|stage II/III|stage ii/iii
564760|NCT00776711|Healthy|healthy
564761|NCT00776711|Avian Influenza|avian influenza
564762|NCT00776711|Immunity|immunity
564763|NCT00776711|Preventive|preventive
564764|NCT00776711|Bird Flu|bird flu
564765|NCT00776711|Healthy Volunteer|healthy volunteer
564766|NCT00776711|HV|hv
564767|NCT00776711|Influenza|influenza
564768|NCT00776672|Bioequivalence Fosinopril Tablets|bioequivalence fosinopril tablets
564769|NCT00776659|An Observational Study of Indian Breast Cancer Patients Receiving Adjuvant Therapy with Aromasin|an observational study of indian breast cancer patients receiving adjuvant therapy with aromasin
564770|NCT00776659|Antineoplastic Hormonal Drugs|antineoplastic hormonal drugs
564771|NCT00776659|Aromasin|aromasin
564772|NCT00776646|bioequivalence hydrochlorothiazide 50 mg tablet fasting conditions|bioequivalence hydrochlorothiazide 50 mg tablet fasting conditions
564773|NCT00776633|aspirin|aspirin
564774|NCT00776633|clopidogrel|clopidogrel
564775|NCT00776633|oral anticoagulation|oral anticoagulation
564776|NCT00776633|warfarin|warfarin
564777|NCT00776633|drug eluting stent|drug eluting stent
564778|NCT00776633|phenprocoumon|phenprocoumon
564779|NCT00776620|Bioequivalence Glimepiride Tablets|bioequivalence glimepiride tablets
564780|NCT00776607|LADA|lada
564781|NCT00776607|Latent autoimmune diabetes in adults|latent autoimmune diabetes in adults
564782|NCT00776607|Type 1.5|type 1.5
564783|NCT00776607|Slowly progressive type 1 diabetes|slowly progressive type 1 diabetes
564784|NCT00776594|Androgen deprivation therapy|androgen deprivation therapy
564785|NCT00776594|ADT|adt
564786|NCT00776594|bevacizumab|bevacizumab
564787|NCT00776581|Combined spinal-epidural analgesia|combined spinal-epidural analgesia
564788|NCT00776581|Patient-controlled analgesia|patient-controlled analgesia
564789|NCT00776581|Epidural analgesia|epidural analgesia
564790|NCT00776555|Not required|not required
564791|NCT00776542|bioequivalence Minocycline Tablets|bioequivalence minocycline tablets
564792|NCT00776529|sensorimotor training|sensorimotor training
564793|NCT00776529|Strengthening|strengthening
564794|NCT00776529|Balance|balance
564795|NCT00776516|Healthy volunteer subjects|healthy volunteer subjects
564796|NCT00776516|CYP3A4 inducer|cyp3a4 inducer
564797|NCT00776516|rifampin|rifampin
564798|NCT00776516|drug interaction|drug interaction
564799|NCT00776516|pharmacokinetics|pharmacokinetics
564800|NCT00776516|YM178|ym178
564801|NCT00776516|mirabegron|mirabegron
564802|NCT00776503|Epigenetic|epigenetic
564803|NCT00776503|Myelodysplasia|myelodysplasia
564804|NCT00776503|Cytarabine|cytarabine
564805|NCT00776490|Bioequivalence Glimepiride Tablets|bioequivalence glimepiride tablets
564806|NCT00776451|AMD|amd
564807|NCT00776438|Influenza|influenza
564808|NCT00776438|Orthomyxoviruses|orthomyxoviruses
564809|NCT00776438|Myxovirus Infection|myxovirus infection
564810|NCT00776438|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
564811|NCT00776438|Adults|adults
564812|NCT00776438|Elderly|elderly
564813|NCT00776412|Immunologic Non-Responder|immunologic non-responder
564814|NCT00776412|Cardiovascular Disease|cardiovascular disease
564815|NCT00776412|D-dimer|d-dimer
564816|NCT00776412|Antiretroviral|antiretroviral
564817|NCT00776412|Mortality|mortality
564818|NCT00776412|HIV Positive|hiv positive
564819|NCT00776412|HIV Negative|hiv negative
564820|NCT00776412|Healthy Volunteer|healthy volunteer
564821|NCT00776412|HV|hv
564822|NCT00776399|Colorectal cancer|colorectal cancer
564823|NCT00776399|lung metastasis|lung metastasis
564824|NCT00776399|radiofrequency ablation|radiofrequency ablation
564825|NCT00776399|metastasectomy|metastasectomy
564826|NCT00776399|Lung metastasis from colorectal cancer|lung metastasis from colorectal cancer
564827|NCT00776373|ALL|all
564828|NCT00776373|Burkitt's Lymphoma|burkitt's lymphoma
564829|NCT00776373|Adult T-Cell leukemia/lymphoma|adult t-cell leukemia/lymphoma
564830|NCT00776373|Lymphoblastic leukemia|lymphoblastic leukemia
564831|NCT00776373|CML in lymphoid blast crisis patients|cml in lymphoid blast crisis patients
564832|NCT00776373|HiVAC|hivac
564833|NCT00776373|Rapamycin|rapamycin
564834|NCT00776360|oxytocin|oxytocin
564835|NCT00776360|gastroparesis|gastroparesis
564836|NCT00776360|diabetics|diabetics
564837|NCT00776360|The effect of oxytocin on gastric emptying|the effect of oxytocin on gastric emptying
564838|NCT00776347|Dementia with Lewy bodies (DLB)|dementia with lewy bodies (dlb)
564839|NCT00776347|FDG-PET|fdg-pet
564840|NCT00776334|bioequivalence Fosinopril Tablets|bioequivalence fosinopril tablets
564841|NCT00776321|hypercholesterolemia|hypercholesterolemia
564842|NCT00776321|dyslipidemia|dyslipidemia
564843|NCT00776321|thyroid|thyroid
564844|NCT00776321|safety|safety
564845|NCT00776308|molecular breast imaging|molecular breast imaging
564846|NCT00776308|breast cancer|breast cancer
564847|NCT00776308|mammography|mammography
564848|NCT00776295|Small Cell Lung Cancer|small cell lung cancer
564849|NCT00776295|SCLC|sclc
564850|NCT00776295|Limited Stage Small Cell Lung Cancer|limited stage small cell lung cancer
564851|NCT00776282|bioequivalence loratadine 10 mg orally disintegrating|bioequivalence loratadine 10 mg orally disintegrating
564852|NCT00776282|tablets fed conditions|tablets fed conditions
564853|NCT00776269|Argon laser|argon laser
564854|NCT00776269|Trichiasis|trichiasis
564855|NCT00776269|Radiofrequency|radiofrequency
564856|NCT00776269|Patients with trichiasis|patients with trichiasis
564857|NCT00776256|satiety|satiety
564858|NCT00776256|food intake|food intake
564859|NCT00776243|incretin|incretin
564860|NCT00776243|GLP-1|glp-1
564861|NCT00776243|GIP|gip
564862|NCT00776243|intensive insulin therapy|intensive insulin therapy
564863|NCT00776217|bioequivalence loratadine 10 mg orally disintegrating tablets fasting|bioequivalence loratadine 10 mg orally disintegrating tablets fasting
564864|NCT00776204|Coronary Artery Disease|coronary artery disease
564865|NCT00776204|Drug eluting stent|drug eluting stent
564866|NCT00776204|Percutaneous Coronary Interventions|percutaneous coronary interventions
564867|NCT00776204|Optical Coherence Tomography|optical coherence tomography
564868|NCT00776191|Physioneal 35|physioneal 35
564869|NCT00776191|Physioneal 40|physioneal 40
564870|NCT00776191|children|children
564871|NCT00776191|chronic peritoneal dialysis|chronic peritoneal dialysis
564872|NCT00776178|Survival Study|survival study
564873|NCT00776178|Bladder Cancer|bladder cancer
564874|NCT00776178|Cancer Recurrence|cancer recurrence
564875|NCT00776178|Tumor Markers/Heterogeneity|tumor markers/heterogeneity
564876|NCT00776139|Cetirizine Hydrochloride 10 mg tablet fasting conditions|cetirizine hydrochloride 10 mg tablet fasting conditions
564877|NCT00776126|Breast|breast
564878|NCT00776126|3D Digital Mammography|3d digital mammography
564879|NCT00776126|Digital Breast Tomosynthesis|digital breast tomosynthesis
564880|NCT00776113|Bioequivalence Carvedilol fasting|bioequivalence carvedilol fasting
564881|NCT00776100|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
564882|NCT00776100|adenosquamous cell lung cancer|adenosquamous cell lung cancer
564883|NCT00776100|squamous cell lung cancer|squamous cell lung cancer
564884|NCT00776100|large cell lung cancer|large cell lung cancer
564885|NCT00776100|adenocarcinoma of the lung|adenocarcinoma of the lung
564886|NCT00776100|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
564887|NCT00776087|Medical costs|medical costs
564888|NCT00776087|Telemonitoring|telemonitoring
564889|NCT00776087|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
564890|NCT00776074|Leiomyoma|leiomyoma
564891|NCT00776074|Uterine Fibroids|uterine fibroids
564892|NCT00776074|Drug Therapy|drug therapy
564893|NCT00776074|Uterine Neoplasms|uterine neoplasms
564894|NCT00776074|Fibroid Tumor|fibroid tumor
564895|NCT00776035|Obesity|obesity
564896|NCT00776035|Heart|heart
564897|NCT00776035|Failure|failure
564898|NCT00776035|PET|pet
564899|NCT00776035|radiation|radiation
564900|NCT00776035|metabolism|metabolism
564901|NCT00776022|Bioequivalence Cetirizine Hydrochloride 10 mg tablet fed conditions|bioequivalence cetirizine hydrochloride 10 mg tablet fed conditions
564902|NCT00776009|ADHD, children, subjects, laboratory classroom|adhd, children, subjects, laboratory classroom
564903|NCT00775996|bioequivalence Clorazepate Tablets|bioequivalence clorazepate tablets
564904|NCT00775970|Obesity|obesity
564905|NCT00775970|Weight loss maintenance|weight loss maintenance
564906|NCT00775970|Spontaneous physical activity|spontaneous physical activity
564907|NCT00775970|Lipid oxydation|lipid oxydation
564908|NCT00775970|Walking|walking
564909|NCT00775944|Tobacco|tobacco
564910|NCT00775944|Cigarette|cigarette
564911|NCT00775944|Smoking|smoking
564912|NCT00775944|Counselling|counselling
564913|NCT00775944|Nicotine Replacement Therapy|nicotine replacement therapy
564914|NCT00775944|Telephone|telephone
564915|NCT00775944|Quitline|quitline
564916|NCT00775944|Helpline|helpline
564917|NCT00775931|osteopetrosis|osteopetrosis
564918|NCT00775918|Bioequivalence Doxycycline monohydrate 100mg tablets fed conditions|bioequivalence doxycycline monohydrate 100mg tablets fed conditions
564919|NCT00775905|Bioequivalence amlodipine tablets fasting|bioequivalence amlodipine tablets fasting
564920|NCT00775892|ACL|acl
564921|NCT00775892|Ligament|ligament
564922|NCT00775879|Général anesthesia|général anesthesia
564923|NCT00775879|Gynecology|gynecology
564924|NCT00775866|prostate cancer, magnetic resonance imaging, guided imagery|prostate cancer, magnetic resonance imaging, guided imagery
564925|NCT00775853|Biomarkers|biomarkers
564926|NCT00775853|Catecholamines|catecholamines
564927|NCT00775853|18F-Fluoro-L-dopa|18f-fluoro-l-dopa
564928|NCT00775853|Fluorodopamine|fluorodopamine
564929|NCT00775853|Parkinson's Disease|parkinson's disease
564930|NCT00775853|Parkinson Disease|parkinson disease
564931|NCT00775853|PD|pd
564932|NCT00775840|Cardiac Failure|cardiac failure
564933|NCT00775840|Congestive Heart Failure|congestive heart failure
564934|NCT00775840|Drug Therapy|drug therapy
564935|NCT00775840|Hypertension|hypertension
564936|NCT00775840|Diabetes Mellitus|diabetes mellitus
564937|NCT00775827|bioequivalence fenofibrate tablets|bioequivalence fenofibrate tablets
564938|NCT00775814|Hypertension|hypertension
564939|NCT00775814|Drug Therapy|drug therapy
564940|NCT00775814|Blood Pressure|blood pressure
564941|NCT00775814|Insulin, Resistant|insulin, resistant
564942|NCT00775788|Fat Injection to Breast|fat injection to breast
564943|NCT00775788|Fat Grafting to Breast|fat grafting to breast
564944|NCT00775762|Symptomatic Polyvascular disease|symptomatic polyvascular disease
564945|NCT00775762|Multiple recurrent cardiovascular events|multiple recurrent cardiovascular events
564946|NCT00775749|post operative nausea and vomiting|post operative nausea and vomiting
564947|NCT00775749|gynecological surgery|gynecological surgery
564948|NCT00775749|outpatient surgery|outpatient surgery
564949|NCT00775749|nicotine patch|nicotine patch
564950|NCT00775749|laparoscopic surgery|laparoscopic surgery
564951|NCT00775723|6sulphatoxymelatonin|6sulphatoxymelatonin
564952|NCT00775723|preterm infants|preterm infants
564953|NCT00775723|melatonin is low in preterm infants at least until the age of 6 months|melatonin is low in preterm infants at least until the age of 6 months
564954|NCT00775697|wheezing|wheezing
564955|NCT00775697|children|children
564956|NCT00775697|montelukast|montelukast
564957|NCT00775697|bronchodilators|bronchodilators
564958|NCT00775697|lung function|lung function
564959|NCT00775697|Rint|rint
564960|NCT00775684|Exenatide|exenatide
564961|NCT00775684|Sitagliptin|sitagliptin
564962|NCT00775684|Glimepiride|glimepiride
564963|NCT00775684|Glucagon-Like Peptide-1|glucagon-like peptide-1
564964|NCT00775684|Impaired Fasting Glucose|impaired fasting glucose
564965|NCT00775684|Type 2 Diabetes|type 2 diabetes
564966|NCT00775684|Beta-cell Function|beta-cell function
564967|NCT00775684|Beta-cell Secretory Capacity|beta-cell secretory capacity
564968|NCT00775684|Glucose-potentiated arginine|glucose-potentiated arginine
564969|NCT00775658|allergy|allergy
564970|NCT00775658|skin testing|skin testing
564971|NCT00775658|eye drops|eye drops
564972|NCT00775658|antihistamines|antihistamines
564973|NCT00775645|neurotoxicity|neurotoxicity
564974|NCT00775645|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
564975|NCT00775645|fatigue|fatigue
564976|NCT00775645|neuropathy|neuropathy
564977|NCT00775645|stage IA breast cancer|stage ia breast cancer
564978|NCT00775645|stage IB breast cancer|stage ib breast cancer
564979|NCT00775645|stage II breast cancer|stage ii breast cancer
564980|NCT00775645|stage IIIA breast cancer|stage iiia breast cancer
564981|NCT00775645|stage IIIB breast cancer|stage iiib breast cancer
564982|NCT00775645|stage IIIC breast cancer|stage iiic breast cancer
564983|NCT00775632|Graft Versus Host Disease|graft versus host disease
564984|NCT00775632|Alemtuzumab|alemtuzumab
564985|NCT00775632|Campath|campath
564986|NCT00775632|Bone Marrow Transplants|bone marrow transplants
564987|NCT00775619|bioequivalence Carvedilol 12.5 mg tablets fed conditions|bioequivalence carvedilol 12.5 mg tablets fed conditions
564988|NCT00775606|AIDS, HIV|aids, hiv
564989|NCT00775593|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
564990|NCT00775593|adult acute basophilic leukemia|adult acute basophilic leukemia
564991|NCT00775593|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
564992|NCT00775593|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
564993|NCT00775593|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
564994|NCT00775593|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
564995|NCT00775593|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
564996|NCT00775593|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
564997|NCT00775593|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
564998|NCT00775593|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
564999|NCT00775593|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
565000|NCT00775593|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
565001|NCT00775593|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
565002|NCT00775593|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
565003|NCT00775593|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
565004|NCT00775593|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
565005|NCT00775580|bioequivalence Atenolol Tablets|bioequivalence atenolol tablets
565006|NCT00775567|Fructose|fructose
565007|NCT00775567|Intolerance|intolerance
565008|NCT00775567|Adaptation|adaptation
565009|NCT00775567|Prebiotic|prebiotic
565010|NCT00775567|Healthy men or women 18-40|healthy men or women 18-40
565011|NCT00775541|Diabetes|diabetes
565012|NCT00775541|Type 2 Diabetes|type 2 diabetes
565013|NCT00775528|Cystic Fibrosis|cystic fibrosis
565014|NCT00775528|Pancreatic Exocrine Insufficiency|pancreatic exocrine insufficiency
565015|NCT00775515|chronic|chronic
565016|NCT00775515|prostatitis|prostatitis
565017|NCT00775515|prostate|prostate
565018|NCT00775515|pain|pain
565019|NCT00775515|pelvic|pelvic
565020|NCT00775515|pelvis|pelvis
565021|NCT00775515|inflamation|inflamation
565022|NCT00775502|Multiple myeloma|multiple myeloma
565023|NCT00775502|GM-2 ganglioside|gm-2 ganglioside
565024|NCT00775502|monoclonal antibody|monoclonal antibody
565025|NCT00775502|Potelligent design|potelligent design
565026|NCT00775502|Treatment of subjects who have failed previous treatment|treatment of subjects who have failed previous treatment
565027|NCT00775489|glaucoma, steroid, nasal|glaucoma, steroid, nasal
565028|NCT00775476|Systemic lupus erythematosus (SLE), an autoimmune disease|systemic lupus erythematosus (sle), an autoimmune disease
565029|NCT00775463|Scleroderma, Diffuse|scleroderma, diffuse
565030|NCT00775463|Scleroderma, Limited|scleroderma, limited
565031|NCT00775463|Scleroderma, Systemic|scleroderma, systemic
565032|NCT00775463|Ulcer|ulcer
565033|NCT00775463|prostacyclin|prostacyclin
565034|NCT00775450|Influenza|influenza
565035|NCT00775450|Orthomyxovirus Infection|orthomyxovirus infection
565036|NCT00775450|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
565037|NCT00775450|Elderly|elderly
565038|NCT00775437|juvenile idiopathic arthritis|juvenile idiopathic arthritis
565039|NCT00775437|compassionate use|compassionate use
565040|NCT00775437|open label|open label
565041|NCT00775424|HIV infection|hiv infection
565042|NCT00775424|DNA vaccine|dna vaccine
565043|NCT00775424|IL-12 adjuvant|il-12 adjuvant
565044|NCT00775424|IL-15 adjuvant|il-15 adjuvant
565045|NCT00775398|Hemostasis|hemostasis
565046|NCT00775398|Thrombin-JMI|thrombin-jmi
565047|NCT00775398|Thrombin|thrombin
565048|NCT00775398|Blood Coagulation|blood coagulation
565049|NCT00775385|Chemotherapy, Adjuvant|chemotherapy, adjuvant
565050|NCT00775372|Bioequivalence study of clarithromycin 250mg/5mL powdder|bioequivalence study of clarithromycin 250mg/5ml powdder
565051|NCT00775359|bioequivalence fenofibrate tablets|bioequivalence fenofibrate tablets
565052|NCT00775333|Carpal Tunnel Syndrome|carpal tunnel syndrome
565053|NCT00775333|Diabetes|diabetes
565054|NCT00775333|APB strength|apb strength
565055|NCT00775333|Sensory Function|sensory function
565056|NCT00775333|Pillar Pain|pillar pain
565057|NCT00775333|Cold Intolerance|cold intolerance
565058|NCT00775333|Patient Satisfaction|patient satisfaction
565059|NCT00775320|Brain scan|brain scan
565060|NCT00775307|Non-small cell lung cancer|non-small cell lung cancer
565061|NCT00775307|Stage I|stage i
565062|NCT00775307|adjuvant therapy|adjuvant therapy
565063|NCT00775307|Adjuvant Drug Therapy|adjuvant drug therapy
565064|NCT00775281|Tachykinin receptors|tachykinin receptors
565065|NCT00775281|Protein expression|protein expression
565066|NCT00775281|Contractile proteins|contractile proteins
565067|NCT00775281|Inflammatory proteins|inflammatory proteins
565068|NCT00775268|18F Fluorothymidine|18f fluorothymidine
565069|NCT00775268|PET/CT|pet/ct
565070|NCT00775268|FLT|flt
565071|NCT00775268|Lymphoma|lymphoma
565072|NCT00775268|FDG|fdg
565073|NCT00775255|Bioequiavelnce clarithromycin|bioequiavelnce clarithromycin
565074|NCT00775242|Menopause|menopause
565075|NCT00775242|Hormone Replacement Therapy|hormone replacement therapy
565076|NCT00775242|Microspheres|microspheres
565077|NCT00775242|Progesterone|progesterone
565078|NCT00775242|Estradiol|estradiol
565079|NCT00775242|Hot flashes|hot flashes
565080|NCT00775229|hair pulling|hair pulling
565081|NCT00775203|Unipolar|unipolar
565082|NCT00775190|birth control pills|birth control pills
565083|NCT00775190|oral contraceptives|oral contraceptives
565084|NCT00775190|brand name|brand name
565085|NCT00775190|generic|generic
565086|NCT00775190|side effects|side effects
565087|NCT00775190|oral contraceptive side effects|oral contraceptive side effects
565088|NCT00775190|dysfunctional uterine bleeding|dysfunctional uterine bleeding
565089|NCT00775190|pre-menstrual symptoms|pre-menstrual symptoms
565090|NCT00775177|Bioequivalence Doxycycline monohydrate 100mg tablets fed conditions|bioequivalence doxycycline monohydrate 100mg tablets fed conditions
565091|NCT00775164|Obese children with insulin resistance|obese children with insulin resistance
565092|NCT00775151|Bioequivalence amlodipine 10 mg tablet under fed conditions|bioequivalence amlodipine 10 mg tablet under fed conditions
565093|NCT00775138|Bronchiectasis|bronchiectasis
565094|NCT00775138|Respiratory Infections|respiratory infections
565095|NCT00775138|Amikacin|amikacin
565096|NCT00775138|Genetic Diseases, Inborn|genetic diseases, inborn
565097|NCT00775138|Respiratory Tract Diseases|respiratory tract diseases
565098|NCT00775138|Cystic Fibrosis|cystic fibrosis
565099|NCT00775138|Respiratory Tract Infections|respiratory tract infections
565100|NCT00775138|Lung Diseases|lung diseases
565101|NCT00775138|Infant, Newborn, Diseases|infant, newborn, diseases
565102|NCT00775138|Pancreatic Diseases|pancreatic diseases
565103|NCT00775125|VX-950-TiDP24-C124|vx-950-tidp24-c124
565104|NCT00775125|VX-950-C124|vx-950-c124
565105|NCT00775125|HCV|hcv
565106|NCT00775125|DDI|ddi
565107|NCT00775125|telaprevir|telaprevir
565108|NCT00775125|darunavir|darunavir
565109|NCT00775125|ritonavir|ritonavir
565110|NCT00775125|fosamprenavir|fosamprenavir
565111|NCT00775125|interaction|interaction
565112|NCT00775125|pharmacokinetics|pharmacokinetics
565113|NCT00775125|steady-state|steady-state
565114|NCT00775112|supportive care|supportive care
565115|NCT00775112|lumbar puncture|lumbar puncture
565116|NCT00775112|childhood disease|childhood disease
565117|NCT00775112|pediatric hemato-oncology|pediatric hemato-oncology
565118|NCT00775099|Air Pollution|air pollution
565119|NCT00775099|Particles|particles
565120|NCT00775099|Particulate Matter|particulate matter
565121|NCT00775099|Vascular function|vascular function
565122|NCT00775099|Endothelial function|endothelial function
565123|NCT00775099|Thrombosis|thrombosis
565124|NCT00775086|ORTHO EVRA|ortho evra
565125|NCT00775086|contraception|contraception
565126|NCT00775086|NGMN|ngmn
565127|NCT00775086|contraceptive patch|contraceptive patch
565128|NCT00775086|bioequivalence|bioequivalence
565129|NCT00775086|EE|ee
565130|NCT00775086|norelgestromin|norelgestromin
565131|NCT00775086|ethinyl estradiol|ethinyl estradiol
565132|NCT00775073|Liver cancer|liver cancer
565133|NCT00775073|HCC|hcc
565134|NCT00775047|depo medroxyprogesterone acetate|depo medroxyprogesterone acetate
565135|NCT00775047|Depo Provera|depo provera
565136|NCT00775047|contraceptive compliance|contraceptive compliance
565137|NCT00775047|pharmacists|pharmacists
565138|NCT00775047|Compliance in receiving additional Depo Provera injections|compliance in receiving additional depo provera injections
565139|NCT00775047|Satisfaction in receiving Depo Provera injections at a pharmacy compared with usual clinic|satisfaction in receiving depo provera injections at a pharmacy compared with usual clinic
565140|NCT00775008|weight loss, health information, e-health|weight loss, health information, e-health
565141|NCT00774995|Engerix-B|engerix-b
565142|NCT00774995|Hepatitis B|hepatitis b
565143|NCT00774982|Crohns Disease|crohns disease
565144|NCT00774982|Pharmacokinetics|pharmacokinetics
565145|NCT00774982|Local Targeted Delivery to the Ileum|local targeted delivery to the ileum
565146|NCT00774982|Delayed Release|delayed release
565147|NCT00774982|Immunology Measurements|immunology measurements
565148|NCT00774982|Pharmacokinetics in Crohns Disease Patients|pharmacokinetics in crohns disease patients
565149|NCT00774943|Systemic lupus erythematosus|systemic lupus erythematosus
565150|NCT00774943|ICOSL|icosl
565151|NCT00774943|B7RP-1|b7rp-1
565152|NCT00774943|Costimulation|costimulation
565153|NCT00774930|Carcinoid tumor|carcinoid tumor
565154|NCT00774930|Somatuline Depot|somatuline depot
565155|NCT00774930|Lanreotide Autogel|lanreotide autogel
565156|NCT00774930|Neuroendocrine tumor|neuroendocrine tumor
565157|NCT00774930|NET|net
565158|NCT00774930|Diarrhea|diarrhea
565159|NCT00774930|Flushing|flushing
565160|NCT00774930|Carcinoid tumour|carcinoid tumour
565161|NCT00774930|Neuroendocrine tumour|neuroendocrine tumour
565162|NCT00774930|Diarrhoea|diarrhoea
565163|NCT00774917|numen|numen
565164|NCT00774917|hyperplasia|hyperplasia
565165|NCT00774904|Type 2 Diabetes|type 2 diabetes
565166|NCT00774904|Diabetic Nephropathy|diabetic nephropathy
565167|NCT00774904|Glucose Metabolism|glucose metabolism
565168|NCT00774904|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
565169|NCT00774891|Echocardiography- exercise|echocardiography- exercise
565170|NCT00774891|Echocardiography- dobutamine|echocardiography- dobutamine
565171|NCT00774891|Wall stress|wall stress
565172|NCT00774891|Ventricular volume-left|ventricular volume-left
565173|NCT00774891|Ischemia|ischemia
565174|NCT00774891|Angina|angina
565175|NCT00774891|Heart diseases|heart diseases
565176|NCT00774891|Stress echocardiography|stress echocardiography
565177|NCT00774891|Ventricular volume|ventricular volume
565178|NCT00774891|Vascular diseases|vascular diseases
565179|NCT00774878|Breast cancer|breast cancer
565180|NCT00774878|Breast Tumors|breast tumors
565181|NCT00774878|Anti IGF-1R|anti igf-1r
565182|NCT00774878|Hormonosensitivity|hormonosensitivity
565183|NCT00774865|Robotic|robotic
565184|NCT00774865|CABG|cabg
565185|NCT00774865|LITA|lita
565186|NCT00774865|Patency|patency
565187|NCT00774865|Long|long
565188|NCT00774865|Term|term
565189|NCT00774852|lupus|lupus
565190|NCT00774852|systemic lupus erythematosus|systemic lupus erythematosus
565191|NCT00774852|lupus nephritis|lupus nephritis
565192|NCT00774852|SLE|sle
565193|NCT00774852|abatacept|abatacept
565194|NCT00774852|CTLA4|ctla4
565195|NCT00774852|CTLA4Ig|ctla4ig
565196|NCT00774852|glomerulonephritis|glomerulonephritis
565197|NCT00774839|Newly Diagnosed|newly diagnosed
565198|NCT00774839|Colon|colon
565199|NCT00774839|Stage II|stage ii
565200|NCT00774839|Stage III|stage iii
565201|NCT00774826|Follicular lymphoma|follicular lymphoma
565202|NCT00774826|Rituximab|rituximab
565203|NCT00774813|Depression|depression
565204|NCT00774813|Mild|mild
565205|NCT00774813|Moderate|moderate
565206|NCT00774813|Anxiety|anxiety
565207|NCT00774813|Kalaco Scientific, Inc.|kalaco scientific, inc.
565208|NCT00774800|Recombinant Hyaluronidase|recombinant hyaluronidase
565209|NCT00774800|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
565210|NCT00774800|Humalog|humalog
565211|NCT00774800|Humulin R|humulin r
565212|NCT00774800|rHuPH20|rhuph20
565213|NCT00774800|Hylenex|hylenex
565214|NCT00774787|Combination treatment|combination treatment
565215|NCT00774787|Imiquimod|imiquimod
565216|NCT00774787|Cryotherapy|cryotherapy
565217|NCT00774774|Influenza, human|influenza, human
565218|NCT00774774|Masks|masks
565219|NCT00774774|Disease Transmission, Horizontal|disease transmission, horizontal
565220|NCT00774761|Chronic|chronic
565221|NCT00774761|Obstructive|obstructive
565222|NCT00774761|Pulmonary|pulmonary
565223|NCT00774761|Disease|disease
565224|NCT00774761|COPD|copd
565225|NCT00774761|Pharmacodynamic|pharmacodynamic
565226|NCT00774761|Pharmacokinetic|pharmacokinetic
565227|NCT00774748|low molecular weight heparin|low molecular weight heparin
565228|NCT00774748|enoxaparin|enoxaparin
565229|NCT00774748|Lovenox|lovenox
565230|NCT00774748|Insuflon|insuflon
565231|NCT00774748|subcutaneous catheter|subcutaneous catheter
565232|NCT00774748|once or twice daily dosing of subcutaneous enoxaparin|once or twice daily dosing of subcutaneous enoxaparin
565233|NCT00774735|healthy volunteer|healthy volunteer
565234|NCT00774735|darunavir|darunavir
565235|NCT00774735|lopinavir|lopinavir
565236|NCT00774735|ritonavir|ritonavir
565237|NCT00774735|GSK1349572|gsk1349572
565238|NCT00774735|integrase|integrase
565239|NCT00774735|pharmacokinetics|pharmacokinetics
565240|NCT00774709|Heart failure|heart failure
565241|NCT00774709|Preserved ejection fraction|preserved ejection fraction
565242|NCT00774709|Diastolic dysfunction|diastolic dysfunction
565243|NCT00774709|Dyssynchrony|dyssynchrony
565244|NCT00774709|Echocardiography|echocardiography
565245|NCT00774709|Patients with acute heart failure clinically|patients with acute heart failure clinically
565246|NCT00774709|diagnosed|diagnosed
565247|NCT00774709|BNP level > 100 ng / l or NT-proBNP > 300 ng /l|bnp level > 100 ng / l or nt-probnp > 300 ng /l
565248|NCT00774709|Preserved left ventricular ejection fraction(LVEF|preserved left ventricular ejection fraction(lvef
565249|NCT00774709|≥ 45%)|≥ 45%)
565250|NCT00774696|Bioequivalence study of clarithromycin|bioequivalence study of clarithromycin
565251|NCT00774683|Pilot|pilot
565252|NCT00774683|Pharmacokinetics|pharmacokinetics
565253|NCT00774683|Raltegravir|raltegravir
565254|NCT00774683|Cervicovaginal|cervicovaginal
565255|NCT00774683|HIV|hiv
565256|NCT00774683|Women|women
565257|NCT00774657|Aortic Stenosis|aortic stenosis
565258|NCT00774657|Valvular heart disease|valvular heart disease
565259|NCT00774657|Heart disease|heart disease
565260|NCT00774657|Cardiovascular disease|cardiovascular disease
565261|NCT00774657|Two dimensional echocardiography|two dimensional echocardiography
565262|NCT00774657|Three dimensional echocardiography|three dimensional echocardiography
565263|NCT00774631|Meningitis|meningitis
565264|NCT00774631|Hypothermia|hypothermia
565265|NCT00774631|Intensive care|intensive care
565266|NCT00774618|Rib Fracture|rib fracture
565267|NCT00774618|Thoracic Injuries|thoracic injuries
565268|NCT00774618|Flail Chest|flail chest
565269|NCT00774618|Rib Fracture Repair|rib fracture repair
565270|NCT00774618|Rib Fracture ORIF|rib fracture orif
565271|NCT00774618|Chronic rib fractures|chronic rib fractures
565272|NCT00774618|Non-healing rib fractures|non-healing rib fractures
565273|NCT00774618|Rib Fracture Non-union|rib fracture non-union
565274|NCT00774605|percutaneous, transcutaneous, topical, varenicline, transdermal, transdermal delivery system, patch|percutaneous, transcutaneous, topical, varenicline, transdermal, transdermal delivery system, patch
565275|NCT00774592|Adolescent Risk Reduction|adolescent risk reduction
565276|NCT00774592|HIV/AIDS Prevention|hiv/aids prevention
565277|NCT00774592|Behavioral Change|behavioral change
565278|NCT00774592|HIV|hiv
565279|NCT00774579|growth hormone|growth hormone
565280|NCT00774579|growth hormone deficiency|growth hormone deficiency
565281|NCT00774579|liver fat|liver fat
565282|NCT00774579|liver steatosis|liver steatosis
565283|NCT00774579|growth hormone replacement|growth hormone replacement
565284|NCT00774566|catheter ablation|catheter ablation
565285|NCT00774566|randomized|randomized
565286|NCT00774566|cryo|cryo
565287|NCT00774566|radiofrequency|radiofrequency
565288|NCT00774566|atrial fibrillation|atrial fibrillation
565289|NCT00774566|cryo-balloon|cryo-balloon
565290|NCT00774566|PV-Isolation|pv-isolation
565291|NCT00774553|Type 2 diabetes|type 2 diabetes
565292|NCT00774540|Acute pain|acute pain
565293|NCT00774540|Inflammatory pain|inflammatory pain
565294|NCT00774540|Inflammatory mediators|inflammatory mediators
565295|NCT00774540|Pain relief|pain relief
565296|NCT00774540|Microdialysis|microdialysis
565297|NCT00774514|Air Pollution|air pollution
565298|NCT00774514|Nitrogen Dioxide|nitrogen dioxide
565299|NCT00774514|NO2|no2
565300|NCT00774514|Endothelial dysfunction|endothelial dysfunction
565301|NCT00774501|Anesthesia|anesthesia
565302|NCT00774501|suspended ventilation|suspended ventilation
565303|NCT00774488|Euglycemic-hyperinsulinemic clamp|euglycemic-hyperinsulinemic clamp
565304|NCT00774488|fat biopsies|fat biopsies
565305|NCT00774488|microarray analysis|microarray analysis
565306|NCT00774488|quantitative real time PCR|quantitative real time pcr
565307|NCT00774488|overnutrition|overnutrition
565308|NCT00774488|low grade-inflammation|low grade-inflammation
565309|NCT00774475|Clopidogrel therapy|clopidogrel therapy
565310|NCT00774475|platelet function inhibition|platelet function inhibition
565311|NCT00774462|Myositis|myositis
565312|NCT00774462|Anti-synthetase|anti-synthetase
565313|NCT00774462|Anti-SRP|anti-srp
565314|NCT00774462|Myasthenia gravis|myasthenia gravis
565315|NCT00774462|Rituximab|rituximab
565316|NCT00774449|lung transplantation|lung transplantation
565317|NCT00774449|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
565318|NCT00774449|broncholaveolar lavage|broncholaveolar lavage
565319|NCT00774449|high-resolution computertomography|high-resolution computertomography
565320|NCT00774449|quality of life|quality of life
565321|NCT00774436|focal cryotherapy|focal cryotherapy
565322|NCT00774436|low-risk prostate cancer|low-risk prostate cancer
565323|NCT00774423|Spinal muscular atrophies (SMA)|spinal muscular atrophies (sma)
565324|NCT00774423|Degeneration of the motor neurons|degeneration of the motor neurons
565325|NCT00774423|Anterior horn of the spinal cord|anterior horn of the spinal cord
565326|NCT00774423|Riluzole|riluzole
565327|NCT00774384|Neisseria meningitidis|neisseria meningitidis
565329|NCT00774384|Vaccination|vaccination
565330|NCT00774384|Immunity|immunity
565331|NCT00774384|T cells|t cells
565332|NCT00774384|T regulatory cells|t regulatory cells
565333|NCT00774371|Overweight|overweight
565334|NCT00774371|Obese|obese
565335|NCT00774371|Breast cancer survivors|breast cancer survivors
565336|NCT00774371|Weight loss|weight loss
565337|NCT00774371|Physical activity|physical activity
565338|NCT00774371|Exercise|exercise
565339|NCT00774371|Cognitive behavioral therapy|cognitive behavioral therapy
565340|NCT00774358|Primary Immunodeficiency|primary immunodeficiency
565341|NCT00774319|HNSCC|hnscc
565342|NCT00774319|neo Adjuvant|neo adjuvant
565343|NCT00774319|Chemoradiation therapy|chemoradiation therapy
565344|NCT00774319|TPF|tpf
565345|NCT00774306|vascular risk|vascular risk
565346|NCT00774306|lipid fractions|lipid fractions
565347|NCT00774306|lipoprotein(a)|lipoprotein(a)
565348|NCT00774306|C-reactive protein|c-reactive protein
565349|NCT00774306|subarachnoid hemorrhage|subarachnoid hemorrhage
565350|NCT00774306|antiepileptic drug|antiepileptic drug
565351|NCT00774306|randomized|randomized
565352|NCT00774306|seizure|seizure
565353|NCT00774306|cholesterol|cholesterol
565354|NCT00774293|Homoeopathic treatment,|homoeopathic treatment,
565355|NCT00774293|heart surgery,|heart surgery,
565356|NCT00774293|randomized clinical trial|randomized clinical trial
565357|NCT00774254|Health Disparities|health disparities
565358|NCT00774254|Risk Communication|risk communication
565359|NCT00774254|Numeracy|numeracy
565360|NCT00774254|Doctor-Patient Communication|doctor-patient communication
565361|NCT00774254|Virtual Reality Technology|virtual reality technology
565362|NCT00774254|Communication|communication
565363|NCT00774228|Cataract or intraocular lens placement surgery|cataract or intraocular lens placement surgery
565364|NCT00774215|Pelvic Organ Prolapse|pelvic organ prolapse
565365|NCT00774215|Cystocele|cystocele
565366|NCT00774215|Rectocele|rectocele
565367|NCT00774215|Enterocele|enterocele
565368|NCT00774215|Synthetic Mesh|synthetic mesh
565369|NCT00774215|Vaginal Mesh|vaginal mesh
565370|NCT00774215|Transobturator|transobturator
565371|NCT00774202|Pts w/ Chronic ITP who have fail/relap after Rituxan rx|pts w/ chronic itp who have fail/relap after rituxan rx
565372|NCT00774189|Bioequivalence clarithromycin 250mg tablets fasting|bioequivalence clarithromycin 250mg tablets fasting
565373|NCT00774176|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
565374|NCT00774176|COPD|copd
565375|NCT00774176|COPD Exacerbation|copd exacerbation
565376|NCT00774176|Genetic markers COPD|genetic markers copd
565377|NCT00774176|Gene expression in COPD exacerbations|gene expression in copd exacerbations
565378|NCT00774176|COPD Exacerbation Symptom Reporting|copd exacerbation symptom reporting
565379|NCT00774176|COPD Exacerbation Disease Management|copd exacerbation disease management
565380|NCT00774176|COPD Treatment|copd treatment
565381|NCT00774176|Breathing disorders|breathing disorders
565382|NCT00774176|Emphysema|emphysema
565383|NCT00774176|COPD with Healthy Control comparators for genetic association studies.|copd with healthy control comparators for genetic association studies.
565384|NCT00774163|probiotics|probiotics
565385|NCT00774163|lactobacillus|lactobacillus
565386|NCT00774163|reuteri|reuteri
565387|NCT00774163|none (safety only)|none (safety only)
565388|NCT00774150|Neural correlates of pediatric anxiety disorder|neural correlates of pediatric anxiety disorder
565389|NCT00774150|Social correlates of pediatric anxiety disorder|social correlates of pediatric anxiety disorder
565390|NCT00774150|Generalized Anxiety Disorder in pediatric populations|generalized anxiety disorder in pediatric populations
565391|NCT00774150|Separation Anxiety Disorder in pediatric populations|separation anxiety disorder in pediatric populations
565392|NCT00774150|Social Phobia in pediatric populations|social phobia in pediatric populations
565393|NCT00774137|Acute Kidney Injury|acute kidney injury
565394|NCT00774137|IL-18|il-18
565395|NCT00774137|NGAL|ngal
565396|NCT00774137|Cystatin C|cystatin c
565397|NCT00774137|Biomarkers|biomarkers
565398|NCT00774137|Dialysis|dialysis
565399|NCT00774124|GDM, pregnancy, macrosomia|gdm, pregnancy, macrosomia
565400|NCT00774111|healthy volunteer|healthy volunteer
565401|NCT00774111|pharmacokinetics|pharmacokinetics
565402|NCT00774111|GSK1349572|gsk1349572
565403|NCT00774111|integrase|integrase
565404|NCT00774111|etravirine|etravirine
565405|NCT00774098|all adult patients (>18 years) planned to undergo a major liver resection|all adult patients (>18 years) planned to undergo a major liver resection
565406|NCT00774085|Schizophrenia|schizophrenia
565407|NCT00774085|Risperidone|risperidone
565408|NCT00774085|Risperdal Consta|risperdal consta
565409|NCT00774085|Propective|propective
565410|NCT00774085|Retrospective|retrospective
565411|NCT00774085|Mental disorders|mental disorders
565412|NCT00774085|Observational|observational
565413|NCT00774072|subjects with cystic fibrosis and pseudomonas aeruginosa colonization in the upper airways|subjects with cystic fibrosis and pseudomonas aeruginosa colonization in the upper airways
565414|NCT00774059|Breast ptosis, Breast lift|breast ptosis, breast lift
565415|NCT00774046|Therapy-related myelodysplastic syndrome/ Therapy -related Acute myeloid leukemia|therapy-related myelodysplastic syndrome/ therapy -related acute myeloid leukemia
565416|NCT00774046|Myelodysplastic syndrome|myelodysplastic syndrome
565417|NCT00774046|Acute myeloid leukemia|acute myeloid leukemia
565418|NCT00774033|Keratinocytes|keratinocytes
565419|NCT00774033|Cell spray|cell spray
565420|NCT00774033|Deep partial thickness burns|deep partial thickness burns
565421|NCT00774033|Full thickness burns|full thickness burns
565422|NCT00774020|Paget's Disease of Bone|paget's disease of bone
565423|NCT00774020|Serum Alkaline Phosphatase|serum alkaline phosphatase
565424|NCT00774007|Irritable bowel syndrome, abdominal pain, abdominal bloating, immune cells, mast cells|irritable bowel syndrome, abdominal pain, abdominal bloating, immune cells, mast cells
565425|NCT00773994|anterior palatal eminence|anterior palatal eminence
565426|NCT00773994|palatal elevation above the maxillary plane|palatal elevation above the maxillary plane
565427|NCT00773994|anterior uvular prolapse|anterior uvular prolapse
565428|NCT00773994|"inverted-V present in base view."|"inverted-v present in base view."
565429|NCT00773981|anastomotic leakage|anastomotic leakage
565430|NCT00773942|Medication therapy management|medication therapy management
565431|NCT00773942|Pharmacist|pharmacist
565432|NCT00773942|Chronic care|chronic care
565433|NCT00773942|Medicare|medicare
565434|NCT00773942|Medicaid|medicaid
565435|NCT00773942|Medication reconciliation|medication reconciliation
565436|NCT00773942|Adverse drug events|adverse drug events
565437|NCT00773942|Drug related problems|drug related problems
565438|NCT00773916|Attention Deficit Disorder|attention deficit disorder
565439|NCT00773916|Attention Deficit Disorders with Hyperactivity|attention deficit disorders with hyperactivity
565440|NCT00773916|Hyperkinetic Syndrome|hyperkinetic syndrome
565441|NCT00773916|Family Function|family function
565442|NCT00773916|Adverse Factors|adverse factors
565443|NCT00773916|Parental Psychopathology|parental psychopathology
565444|NCT00773877|RNFL thickness|rnfl thickness
565445|NCT00773864|Healthcare employees who work in the rehabilitation center|healthcare employees who work in the rehabilitation center
565446|NCT00773851|ventral hernia|ventral hernia
565447|NCT00773851|laparoscopy|laparoscopy
565448|NCT00773851|mesh|mesh
565449|NCT00773851|recurrence|recurrence
565450|NCT00773825|Genomic imprinting|genomic imprinting
565451|NCT00773825|Reproductive techniques, assisted|reproductive techniques, assisted
565452|NCT00773825|Beckwith-Wiedemann syndrome|beckwith-wiedemann syndrome
565453|NCT00773825|Angelman syndrome|angelman syndrome
565454|NCT00773812|Autistic Disorder|autistic disorder
565455|NCT00773812|Autism|autism
565456|NCT00773812|Mecamylamine|mecamylamine
565457|NCT00773812|Pervasive Developmental Disorder-Not Otherwise Specified|pervasive developmental disorder-not otherwise specified
565458|NCT00773799|To define activities and patient characteristics likely to lead to dissemination of resistant bacteria in rehabilitation centers and|to define activities and patient characteristics likely to lead to dissemination of resistant bacteria in rehabilitation centers and
565459|NCT00773799|To define specific risk factors for acquisition of resistant bacteria (ESBL producers and MRSA) in rehabilitation centers.|to define specific risk factors for acquisition of resistant bacteria (esbl producers and mrsa) in rehabilitation centers.
565460|NCT00773799|ESBL producers|esbl producers
565461|NCT00773799|MRSA|mrsa
565462|NCT00773786|COPD|copd
565463|NCT00773786|Bronchodilator|bronchodilator
565464|NCT00773786|arformoterol|arformoterol
565465|NCT00773786|tiotropium|tiotropium
565466|NCT00773773|Biomarkers - PSA, hK2 and solubilized|biomarkers - psa, hk2 and solubilized
565467|NCT00773773|urokinase-receptor forms (su-PAR)|urokinase-receptor forms (su-par)
565468|NCT00773773|08-114|08-114
565469|NCT00773760|opioids|opioids
565470|NCT00773760|COMT|comt
565471|NCT00773760|SNP|snp
565472|NCT00773760|analgesia|analgesia
565473|NCT00773760|postoperative pain|postoperative pain
565474|NCT00773747|Neoplasms, Plasma Cell|neoplasms, plasma cell
565475|NCT00773747|Neoplasms by Histologic Type|neoplasms by histologic type
565476|NCT00773747|Neoplasms|neoplasms
565477|NCT00773747|Hemostatic Disorders|hemostatic disorders
565478|NCT00773747|Vascular Diseases|vascular diseases
565479|NCT00773747|Cardiovascular Diseases|cardiovascular diseases
565480|NCT00773747|Paraproteinemias|paraproteinemias
565481|NCT00773747|Blood Protein Disorders|blood protein disorders
565482|NCT00773747|Hematologic Diseases|hematologic diseases
565483|NCT00773747|Hemorrhagic Disorders|hemorrhagic disorders
565484|NCT00773747|Lymphoproliferative Disorders|lymphoproliferative disorders
565485|NCT00773747|Immunoproliferative Disorders|immunoproliferative disorders
565486|NCT00773747|Immune System Diseases|immune system diseases
565487|NCT00773747|Vorinostat|vorinostat
565488|NCT00773747|Bortezomib|bortezomib
565489|NCT00773747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
565490|NCT00773747|Analgesics, Non-Narcotic|analgesics, non-narcotic
565491|NCT00773747|Analgesics|analgesics
565492|NCT00773747|Sensory System Agents|sensory system agents
565493|NCT00773747|Peripheral Nervous System Agents|peripheral nervous system agents
565494|NCT00773747|Physiological Effects of Drugs|physiological effects of drugs
565495|NCT00773747|Pharmacologic Actions|pharmacologic actions
565496|NCT00773747|Anti-Inflammatory Agents|anti-inflammatory agents
565497|NCT00773747|Therapeutic Uses|therapeutic uses
565498|NCT00773747|Antirheumatic Agents|antirheumatic agents
565499|NCT00773747|Antineoplastic Agents|antineoplastic agents
565500|NCT00773747|Enzyme Inhibitors|enzyme inhibitors
565501|NCT00773747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
565502|NCT00773747|Anticarcinogenic Agents|anticarcinogenic agents
565503|NCT00773734|moderate-to-severe plaque-type psoriasis|moderate-to-severe plaque-type psoriasis
565504|NCT00773708|HIV infection|hiv infection
565505|NCT00773708|Discordant patient|discordant patient
565506|NCT00773708|CD4 recovery|cd4 recovery
565507|NCT00773708|intensification antiretroviral therapy|intensification antiretroviral therapy
565508|NCT00773708|raltegravir|raltegravir
565509|NCT00773708|"HIV-1 infected patient classified as discordant who showed high level of CD8+HLADR+CD38+ and cell death values at the screening"|"hiv-1 infected patient classified as discordant who showed high level of cd8+hladr+cd38+ and cell death values at the screening"
565510|NCT00773682|osteoarthritis|osteoarthritis
565511|NCT00773682|hands|hands
565512|NCT00773682|mud-packs therapy|mud-packs therapy
565513|NCT00773682|balneotherapy|balneotherapy
565514|NCT00773682|Osteoarthritis of the hands|osteoarthritis of the hands
565515|NCT00773669|male breast cancer|male breast cancer
565516|NCT00773669|Male breast cancer patients diagnosed and/or|male breast cancer patients diagnosed and/or
565517|NCT00773669|treated at Summa Health System/Akron City Hospital|treated at summa health system/akron city hospital
565518|NCT00773669|from the reference year of 1995 through 2007.|from the reference year of 1995 through 2007.
565519|NCT00773656|Radiotherapy|radiotherapy
565520|NCT00773656|Biologically effective dose|biologically effective dose
565521|NCT00773656|Radiation injury|radiation injury
565522|NCT00773643|to procure human temporalis muscle, subcutaneous adipose (fat), and bone tissue samples from children with craniosynostosis,|to procure human temporalis muscle, subcutaneous adipose (fat), and bone tissue samples from children with craniosynostosis,
565523|NCT00773643|to grow cells from these tissues in vitro|to grow cells from these tissues in vitro
565524|NCT00773643|to evaluate the osteogenic potentials of these cell types.|to evaluate the osteogenic potentials of these cell types.
565525|NCT00773617|Bulimia Nervosa|bulimia nervosa
565526|NCT00773617|Treatment Efficacy|treatment efficacy
565527|NCT00773617|Integrative Cognitive Affective Therapy|integrative cognitive affective therapy
565528|NCT00773617|Cognitive Behavior Therapy|cognitive behavior therapy
565529|NCT00773604|blepharospasm|blepharospasm
565530|NCT00773604|Deep brain Stimulation|deep brain stimulation
565531|NCT00773604|cervical dystonia|cervical dystonia
565532|NCT00773604|cranial dystonia|cranial dystonia
565533|NCT00773604|generalized dystonia|generalized dystonia
565534|NCT00773604|subthalamic nucleus|subthalamic nucleus
565535|NCT00773604|DBS|dbs
565536|NCT00773591|Sleep-related breathing disorders|sleep-related breathing disorders
565537|NCT00773591|Snoring|snoring
565538|NCT00773578|Children|children
565539|NCT00773578|Tobacco smoke exposure|tobacco smoke exposure
565540|NCT00773578|Exhaled nitric oxide|exhaled nitric oxide
565541|NCT00773578|Nasal lavage|nasal lavage
565542|NCT00773578|Cytokines|cytokines
565543|NCT00773565|patients with obesity (BMI > 30 kg/m2)|patients with obesity (bmi > 30 kg/m2)
565544|NCT00773552|OAB|oab
565545|NCT00773552|overactive bladder|overactive bladder
565546|NCT00773552|urinary urge|urinary urge
565547|NCT00773552|urge incontinence|urge incontinence
565548|NCT00773552|urge|urge
565549|NCT00773539|atrial fibrillation|atrial fibrillation
565550|NCT00773539|pulmonary veins|pulmonary veins
565551|NCT00773539|ablation|ablation
565552|NCT00773500|Medication Errors|medication errors
565553|NCT00773487|Asthma GINA 1|asthma gina 1
565554|NCT00773487|Mild intermittant asthma|mild intermittant asthma
565555|NCT00773448|Cancer|cancer
565556|NCT00773448|Screening|screening
565557|NCT00773435|Upper respiratory tract infections|upper respiratory tract infections
565558|NCT00773435|Children|children
565559|NCT00773435|Echinacea|echinacea
565560|NCT00773435|Prevention|prevention
565561|NCT00773435|Immune modulation|immune modulation
565562|NCT00773422|smoking lapse behavior|smoking lapse behavior
565563|NCT00773422|smoking cessation|smoking cessation
565564|NCT00773422|varenicline|varenicline
565565|NCT00773422|naltrexone|naltrexone
565566|NCT00773422|medication effect on smoking lapse behavior|medication effect on smoking lapse behavior
565567|NCT00773370|stroke|stroke
565568|NCT00773370|exercise|exercise
565569|NCT00773357|smoking lapse behavior|smoking lapse behavior
565570|NCT00773357|smoking cessation|smoking cessation
565571|NCT00773357|guanfacine|guanfacine
565572|NCT00773357|carvedilol|carvedilol
565573|NCT00773357|medication effect on smoking lapse behavior|medication effect on smoking lapse behavior
565574|NCT00773357|medication effect on smoking cessation|medication effect on smoking cessation
565575|NCT00773357|stress|stress
565576|NCT00773357|gender differences|gender differences
565577|NCT00773344|Solid Tumors (dose escalation/Phase 1)|solid tumors (dose escalation/phase 1)
565578|NCT00773344|Breast Cancer (recommended dose phase/Phase 2)|breast cancer (recommended dose phase/phase 2)
565579|NCT00773318|LM/SL|lm/sl
565580|NCT00773318|SPECT/low-dose multislice CT|spect/low-dose multislice ct
565581|NCT00773305|seed implantation|seed implantation
565582|NCT00773292|HAM/TSP|ham/tsp
565583|NCT00773266|Aphakia|aphakia
565584|NCT00773266|Secondary IOL-Implantation|secondary iol-implantation
565585|NCT00773266|Iris-Fixated IOL|iris-fixated iol
565586|NCT00773266|Artisan|artisan
565587|NCT00773266|Anterior Segment OCT|anterior segment oct
565588|NCT00773266|Aphakia - secondary iris-fixated IOL position|aphakia - secondary iris-fixated iol position
565589|NCT00773253|dystonia|dystonia
565590|NCT00773253|cervical dystonia|cervical dystonia
565591|NCT00773253|Botox|botox
565688|NCT00772824|Breast cancer|breast cancer
565592|NCT00773253|idiopathic primary cervical dystonia|idiopathic primary cervical dystonia
565593|NCT00773227|Oculopharyngeal muscular dystrophy|oculopharyngeal muscular dystrophy
565594|NCT00773227|Swallowing disorders, dysphagia|swallowing disorders, dysphagia
565595|NCT00773227|Pharyngeal propulsion|pharyngeal propulsion
565596|NCT00773227|Upper oesophageal sphincter|upper oesophageal sphincter
565597|NCT00773227|Cricopharyngeal muscle|cricopharyngeal muscle
565598|NCT00773227|Autologous myoblasts|autologous myoblasts
565599|NCT00773227|Autograft|autograft
565600|NCT00773227|Myotomy of the upper oesophageal sphincter|myotomy of the upper oesophageal sphincter
565601|NCT00773227|Fibroscopy of swallowing|fibroscopy of swallowing
565602|NCT00773227|Videofluoroscopy of swallowing|videofluoroscopy of swallowing
565603|NCT00773214|Obesity|obesity
565604|NCT00773214|Appetite|appetite
565605|NCT00773214|Body composition|body composition
565606|NCT00773214|Energy compensation|energy compensation
565607|NCT00773201|Long QT syndrome|long qt syndrome
565608|NCT00773201|Cardiac repolarisation|cardiac repolarisation
565609|NCT00773201|Genome-wide association|genome-wide association
565610|NCT00773201|Electrophysiology|electrophysiology
565611|NCT00773201|Drugs/adverse effects|drugs/adverse effects
565612|NCT00773175|pediatric|pediatric
565613|NCT00773175|hylenex|hylenex
565614|NCT00773175|subcutaneous infusion|subcutaneous infusion
565615|NCT00773175|hyaluronidase|hyaluronidase
565616|NCT00773175|rHuPH20|rhuph20
565617|NCT00773175|recombinant human hyaluronidase|recombinant human hyaluronidase
565618|NCT00773149|Adult Acute Lymphocytic Leukemia|adult acute lymphocytic leukemia
565619|NCT00773149|Alemtuzumab|alemtuzumab
565620|NCT00773136|Bimatoprost|bimatoprost
565621|NCT00773136|Eyelash lengthening|eyelash lengthening
565622|NCT00773136|Prostaglandin Analogs|prostaglandin analogs
565623|NCT00773136|Cosmetics|cosmetics
565624|NCT00773123|RT-View|rt-view
565625|NCT00773123|Spectral domain OCT|spectral domain oct
565626|NCT00773123|Ganglion cell layer|ganglion cell layer
565627|NCT00773123|RNFL|rnfl
565628|NCT00773123|Visual field defect|visual field defect
565629|NCT00773110|hemolysis|hemolysis
565630|NCT00773110|systemic inflammatory response syndrome|systemic inflammatory response syndrome
565631|NCT00773110|cardiopulmonary bypass|cardiopulmonary bypass
565632|NCT00773110|albumin|albumin
565633|NCT00773097|Prevention|prevention
565634|NCT00773097|Colorectal Cancer|colorectal cancer
565635|NCT00773084|Diastolic Heart Failure|diastolic heart failure
565636|NCT00773084|Hispanic Americans|hispanic americans
565637|NCT00773084|Aliskiren|aliskiren
565638|NCT00773084|Spironolactone|spironolactone
565639|NCT00773084|Lisinopril|lisinopril
565640|NCT00773084|Diastolic Heart Failure in Hispanic Americans|diastolic heart failure in hispanic americans
565641|NCT00773071|Cervical cancer, vulvar cancer, LM/SL, SPECT/CT|cervical cancer, vulvar cancer, lm/sl, spect/ct
565642|NCT00773058|acute respiratory distress syndrome|acute respiratory distress syndrome
565643|NCT00773058|glucocorticoid|glucocorticoid
565644|NCT00773058|adrenal insufficiency|adrenal insufficiency
565645|NCT00773045|pain scores|pain scores
565646|NCT00773045|critically ill patients|critically ill patients
565647|NCT00773045|ICU|icu
565648|NCT00773045|pain management|pain management
565649|NCT00773045|pain measurement|pain measurement
565650|NCT00773019|infusion pump|infusion pump
565651|NCT00773019|implantable|implantable
565652|NCT00773019|performance|performance
565653|NCT00773006|coronary artery disease|coronary artery disease
565654|NCT00773006|percutaneous coronary intervention|percutaneous coronary intervention
565655|NCT00773006|anticoagulation|anticoagulation
565656|NCT00772993|glaucoma|glaucoma
565657|NCT00772993|myopia|myopia
565658|NCT00772993|myopia with glaucoma|myopia with glaucoma
565659|NCT00772993|normal control|normal control
565660|NCT00772954|Clostridium difficile diarrhea|clostridium difficile diarrhea
565661|NCT00772954|Clostridium difficile toxoid vaccine|clostridium difficile toxoid vaccine
565662|NCT00772928|Pertussis|pertussis
565663|NCT00772928|Whooping cough|whooping cough
565664|NCT00772928|Diphtheria|diphtheria
565665|NCT00772928|Tetanus|tetanus
565666|NCT00772928|Haemophilus influenzae|haemophilus influenzae
565667|NCT00772928|Poliovirus Types 1, 2, and 3.|poliovirus types 1, 2, and 3.
565668|NCT00772915|stage I multiple myeloma|stage i multiple myeloma
565669|NCT00772915|stage II multiple myeloma|stage ii multiple myeloma
565670|NCT00772915|stage III multiple myeloma|stage iii multiple myeloma
565671|NCT00772902|HIV-1|hiv-1
565673|NCT00772902|HDL|hdl
565674|NCT00772902|non-HDL cholesterol|non-hdl cholesterol
565675|NCT00772902|triglycerides|triglycerides
565676|NCT00772902|cholesterol|cholesterol
565677|NCT00772889|Elderly|elderly
565678|NCT00772889|Vaccine|vaccine
565679|NCT00772889|Influenza|influenza
565680|NCT00772876|P1446A-05|p1446a-05
565681|NCT00772876|Advanced refractory malignancies|advanced refractory malignancies
565682|NCT00772876|Phase I|phase i
565683|NCT00772850|Humeral fracture; Antegrade nailing; Rotator cuff|humeral fracture; antegrade nailing; rotator cuff
565684|NCT00772837|Functional Dyspepsia|functional dyspepsia
565685|NCT00772837|Helicobacter Pylori eradication|helicobacter pylori eradication
565686|NCT00772837|Quality of Life|quality of life
565687|NCT00772837|Dyspeptic Symptoms|dyspeptic symptoms
565785|NCT00772486|17p-|17p-
565689|NCT00772824|Chemotherapy|chemotherapy
565690|NCT00772824|Epirubicin|epirubicin
565691|NCT00772824|Glutamine|glutamine
565692|NCT00772824|FEC chemotherapy|fec chemotherapy
565693|NCT00772798|ovarian cancer|ovarian cancer
565694|NCT00772798|HDAC inhibitor|hdac inhibitor
565695|NCT00772798|vorinostat|vorinostat
565696|NCT00772785|opioid dependence|opioid dependence
565697|NCT00772785|opioid addiction|opioid addiction
565698|NCT00772785|buprenorphine|buprenorphine
565699|NCT00772785|methadone|methadone
565700|NCT00772785|heroin|heroin
565701|NCT00772785|implant|implant
565702|NCT00772785|opioid withdrawal|opioid withdrawal
565703|NCT00772785|opioid pain medication|opioid pain medication
565704|NCT00772785|suboxone|suboxone
565705|NCT00772772|Vitamin D3 repletion|vitamin d3 repletion
565706|NCT00772772|levels of endotoxin|levels of endotoxin
565707|NCT00772772|intestinal permeability|intestinal permeability
565708|NCT00772772|accelerated atherosclerosis|accelerated atherosclerosis
565709|NCT00772759|AZD3199|azd3199
565710|NCT00772759|Japanese Healthy Volunteers|japanese healthy volunteers
565711|NCT00772759|Phase I study|phase i study
565712|NCT00772759|Single and Multiple Ascending Dose|single and multiple ascending dose
565713|NCT00772759|safety|safety
565714|NCT00772759|tolerability|tolerability
565715|NCT00772759|PK|pk
565716|NCT00772746|panic|panic
565717|NCT00772746|respiration|respiration
565718|NCT00772746|anxiety|anxiety
565719|NCT00772746|exercise|exercise
565720|NCT00772746|cognition|cognition
565721|NCT00772733|Quality assurance|quality assurance
565722|NCT00772733|rehabilitation|rehabilitation
565723|NCT00772733|chronic care model|chronic care model
565724|NCT00772733|COPD|copd
565725|NCT00772707|contact lens solution|contact lens solution
565726|NCT00772707|OPTI-FREE RepleniSH|opti-free replenish
565727|NCT00772707|contact lenses|contact lenses
565728|NCT00772694|testicular cancer|testicular cancer
565729|NCT00772694|germ cell cancer|germ cell cancer
565730|NCT00772694|sorafenib|sorafenib
565731|NCT00772668|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
565732|NCT00772668|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
565733|NCT00772668|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
565734|NCT00772668|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
565735|NCT00772668|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
565736|NCT00772668|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
565737|NCT00772655|Follicular Lymphoma|follicular lymphoma
565738|NCT00772655|First line therapy|first line therapy
565739|NCT00772655|Zevalin|zevalin
565740|NCT00772655|90Yttrium-Ibritumomab Tiuxetan|90yttrium-ibritumomab tiuxetan
565741|NCT00772655|Yttrium|yttrium
565742|NCT00772655|Rituximab|rituximab
565743|NCT00772655|Radio-immuno therapy|radio-immuno therapy
565744|NCT00772642|Cross-Sectional|cross-sectional
565745|NCT00772642|Plasmodium Falciparum Malaria|plasmodium falciparum malaria
565746|NCT00772642|Cord Blood|cord blood
565747|NCT00772642|Immunology|immunology
565748|NCT00772642|Mali|mali
565749|NCT00772642|Malaria|malaria
565750|NCT00772629|Menactra®|menactra®
565751|NCT00772629|Meningitis|meningitis
565752|NCT00772629|Meningococcemia|meningococcemia
565753|NCT00772629|Neisseria meningitidis|neisseria meningitidis
565754|NCT00772616|Anesthesia|anesthesia
565755|NCT00772616|Analgesia|analgesia
565756|NCT00772616|Patient-Controlled Analgesia|patient-controlled analgesia
565757|NCT00772616|Hyperalgesia|hyperalgesia
565758|NCT00772603|Partial onset epilepsy|partial onset epilepsy
565759|NCT00772603|Partial onset seizures|partial onset seizures
565760|NCT00772590|HIV|hiv
565761|NCT00772590|antiretroviral therapy intensification|antiretroviral therapy intensification
565762|NCT00772590|suboptimal CD4+ T cell response|suboptimal cd4+ t cell response
565763|NCT00772590|virological suppression|virological suppression
565764|NCT00772590|bovine colostrum|bovine colostrum
565765|NCT00772590|raltegravir|raltegravir
565766|NCT00772577|Hypertension, Obese, aliskiren, hydrochlorothiazide, systolic blood pressure, diastolic blood pressure, ramipril, stage 2|hypertension, obese, aliskiren, hydrochlorothiazide, systolic blood pressure, diastolic blood pressure, ramipril, stage 2
565767|NCT00772564|Acute ST Elevation Myocardial Infarction|acute st elevation myocardial infarction
565768|NCT00772525|Visual acuity|visual acuity
565769|NCT00772525|Contrast sensitivity|contrast sensitivity
565770|NCT00772525|Visual Evoked Potentials|visual evoked potentials
565771|NCT00772525|Optical Coherence Tomography|optical coherence tomography
565772|NCT00772512|PF-04802540, polysomnography, REM, cross over|pf-04802540, polysomnography, rem, cross over
565773|NCT00772486|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
565774|NCT00772486|Leukemia|leukemia
565775|NCT00772486|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
565776|NCT00772486|Leukemia, B-Cell|leukemia, b-cell
565777|NCT00772486|Immune System Diseases|immune system diseases
565778|NCT00772486|Rituximab|rituximab
565779|NCT00772486|Fludarabine|fludarabine
565780|NCT00772486|Cyclophosphamide|cyclophosphamide
565781|NCT00772486|ISF35|isf35
565782|NCT00772486|Ad-ISF35|ad-isf35
565783|NCT00772486|Refractory|refractory
565784|NCT00772486|Resistant|resistant
565786|NCT00772486|del 17p|del 17p
565787|NCT00772486|17p|17p
565788|NCT00772486|Resistant CLL|resistant cll
565789|NCT00772486|Refractory CLL|refractory cll
565790|NCT00772486|17p- CLL|17p- cll
565791|NCT00772486|CLL|cll
565792|NCT00772460|patient warming|patient warming
565793|NCT00772460|convective warming|convective warming
565794|NCT00772460|conductive warming|conductive warming
565795|NCT00772460|intraoperative normothermia|intraoperative normothermia
565796|NCT00772460|accidental hypothermia|accidental hypothermia
565797|NCT00772460|intraoperative hypothermia|intraoperative hypothermia
565798|NCT00772447|Skin Infections|skin infections
565799|NCT00772447|Complicated Bacterial Skin and Skin Structure Infection due to Gram-positive Pathogens|complicated bacterial skin and skin structure infection due to gram-positive pathogens
565800|NCT00772421|Epilepsy|epilepsy
565801|NCT00772421|Recruitment rhythm|recruitment rhythm
565802|NCT00772421|DBS|dbs
565803|NCT00772408|pulmonary tuberculosis|pulmonary tuberculosis
565804|NCT00772408|Toll-like receptor 2 gene polymorphisms|toll-like receptor 2 gene polymorphisms
565805|NCT00772408|blood lymphocyte subsets|blood lymphocyte subsets
565806|NCT00772408|systemic symptoms|systemic symptoms
565807|NCT00772408|pleural effusion|pleural effusion
565808|NCT00772395|Periprosthetic bone loss risedronate bisphosphonates|periprosthetic bone loss risedronate bisphosphonates
565809|NCT00772382|Chronic Kidney Disease|chronic kidney disease
565810|NCT00772382|Dialysis|dialysis
565811|NCT00772382|Hyperphosphatemia|hyperphosphatemia
565812|NCT00772382|Phosphate binder|phosphate binder
565813|NCT00772369|Pertussis|pertussis
565814|NCT00772369|Whooping cough|whooping cough
565815|NCT00772369|Diphtheria|diphtheria
565816|NCT00772369|Tetanus|tetanus
565817|NCT00772369|Haemophilus influenzae|haemophilus influenzae
565818|NCT00772369|Poliovirus Types 1, 2, and 3.|poliovirus types 1, 2, and 3.
565819|NCT00772343|Diarrhea|diarrhea
565820|NCT00772343|Clostridium difficile infection|clostridium difficile infection
565821|NCT00772343|Clostridium difficile toxoid|clostridium difficile toxoid
565822|NCT00772330|MIDI Arrow|midi arrow
565823|NCT00772330|Glaucoma Drainage Device|glaucoma drainage device
565824|NCT00772330|GDD|gdd
565825|NCT00772330|InnFocus|innfocus
565826|NCT00772330|Glaucoma treatment|glaucoma treatment
565827|NCT00772317|Recurrent|recurrent
565828|NCT00772317|prostate cancer|prostate cancer
565829|NCT00772317|ebrt|ebrt
565830|NCT00772317|hifu|hifu
565831|NCT00772304|rhinitis|rhinitis
565832|NCT00772291|inguinal|inguinal
565833|NCT00772291|hernia|hernia
565834|NCT00772291|chronic|chronic
565835|NCT00772291|pain|pain
565836|NCT00772291|pregabalin|pregabalin
565837|NCT00772291|chronic pain after inguinal herniorraphy|chronic pain after inguinal herniorraphy
565838|NCT00772278|carotid stenosis|carotid stenosis
565839|NCT00772278|asymptomatic|asymptomatic
565840|NCT00772278|carotid stenting|carotid stenting
565841|NCT00772278|carotid endarterectomy|carotid endarterectomy
565842|NCT00772265|Bioequivalence|bioequivalence
565843|NCT00772265|pharmacokinetic|pharmacokinetic
565844|NCT00772265|Pharmacodynamic|pharmacodynamic
565845|NCT00772265|Isophane insulin|isophane insulin
565846|NCT00772252|Liver support treatment|liver support treatment
565847|NCT00772239|Coagulation Management|coagulation management
565848|NCT00772239|Cardiac surgery|cardiac surgery
565849|NCT00772239|Bleeding|bleeding
565850|NCT00772239|Rotem|rotem
565851|NCT00772226|laparoscopic cholecystectomy|laparoscopic cholecystectomy
565852|NCT00772226|pain|pain
565853|NCT00772226|PONV|ponv
565854|NCT00772226|music|music
565855|NCT00772226|therapy|therapy
565856|NCT00772226|fatigue after elective laparoscopic cholecystectomy|fatigue after elective laparoscopic cholecystectomy
565857|NCT00772213|multiple trauma|multiple trauma
565858|NCT00772213|outcome and process assessment|outcome and process assessment
565859|NCT00772187|Laparoscopic surgery (general surgery).|laparoscopic surgery (general surgery).
565860|NCT00772174|Glucose Metabolism Disorder|glucose metabolism disorder
565861|NCT00772174|Dysmetabolic Syndrome|dysmetabolic syndrome
565862|NCT00772174|Type II Diabetes|type ii diabetes
565863|NCT00772174|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
565864|NCT00772174|Dyslipidemia|dyslipidemia
565865|NCT00772174|Drug Therapy|drug therapy
565866|NCT00772161|ADHD|adhd
565867|NCT00772161|Attention Deficit Disorder|attention deficit disorder
565868|NCT00772161|Attention Deficit an Disruptive Behavior Disorders|attention deficit an disruptive behavior disorders
565869|NCT00772161|Children|children
565870|NCT00772161|Central Nervous System Stimulants|central nervous system stimulants
565871|NCT00772161|Methylphenidate|methylphenidate
565872|NCT00772161|Pharmacokinetics|pharmacokinetics
565873|NCT00772161|Area Under Curve|area under curve
565874|NCT00772161|Therapeutic Equivalency|therapeutic equivalency
565875|NCT00772161|Psychopharmacology|psychopharmacology
565876|NCT00772148|Liver|liver
565877|NCT00772148|Hepatic|hepatic
565878|NCT00772148|Transplantation|transplantation
565879|NCT00772148|Immunosuppression|immunosuppression
565880|NCT00772148|Tacrolimus|tacrolimus
565881|NCT00772148|Prograf|prograf
565882|NCT00772135|pulmonary hypertension|pulmonary hypertension
565987|NCT00771758|Tapentadol|tapentadol
565883|NCT00772135|congenital heart defects|congenital heart defects
565884|NCT00772135|exercise|exercise
565885|NCT00772135|phosphodiesterase inhibitors|phosphodiesterase inhibitors
565886|NCT00772135|Exercise induced pulmonary arterial hypertensive response in congenital heart disease|exercise induced pulmonary arterial hypertensive response in congenital heart disease
565887|NCT00772122|Recurrent Miscarriage|recurrent miscarriage
565888|NCT00772122|G-CSF|g-csf
565889|NCT00772122|pregnancy outcome|pregnancy outcome
565890|NCT00772122|pregnancy outcome of pregnancies treated with G-CSF|pregnancy outcome of pregnancies treated with g-csf
565891|NCT00772122|treatment of recurrent miscarriage|treatment of recurrent miscarriage
565892|NCT00772109|Influenza|influenza
565893|NCT00772109|Orthomyxoviruses|orthomyxoviruses
565894|NCT00772109|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
565895|NCT00772109|Fluzone®|fluzone®
565896|NCT00772109|Adults|adults
565897|NCT00772070|Menactra®|menactra®
565898|NCT00772070|Menomune®|menomune®
565899|NCT00772070|Meningitis|meningitis
565900|NCT00772070|Meningococcemia|meningococcemia
565901|NCT00772070|Neisseria meningitidis|neisseria meningitidis
565902|NCT00772044|OSA|osa
565903|NCT00772044|sleep apnea|sleep apnea
565904|NCT00772044|apnea|apnea
565905|NCT00772044|AHI|ahi
565906|NCT00772031|chronic migraine, migraine prevention, chronic headache|chronic migraine, migraine prevention, chronic headache
565907|NCT00772018|stage 0 bladder cancer|stage 0 bladder cancer
565908|NCT00771992|Asthma GINA 1|asthma gina 1
565909|NCT00771979|Healthy Volunteers|healthy volunteers
565910|NCT00771979|Relative Bioavailability|relative bioavailability
565911|NCT00771966|patients with cancer in the prostate|patients with cancer in the prostate
565912|NCT00771953|apricoxib|apricoxib
565913|NCT00771953|docetaxel|docetaxel
565914|NCT00771953|pemetrexed|pemetrexed
565915|NCT00771953|Stage IIIb or Stage IV|stage iiib or stage iv
565916|NCT00771927|Vimpat®|vimpat®
565917|NCT00771927|Lacosamide|lacosamide
565919|NCT00771927|epilepsy|epilepsy
565920|NCT00771927|epilepsies|epilepsies
565921|NCT00771927|seizure|seizure
565922|NCT00771927|partial seizure|partial seizure
565923|NCT00771927|partial onset|partial onset
565924|NCT00771927|seizure disorder|seizure disorder
565925|NCT00771927|single seizure|single seizure
565926|NCT00771927|motor seizure|motor seizure
565927|NCT00771927|convulsions|convulsions
565928|NCT00771927|add-on|add-on
565929|NCT00771927|AED|aed
565930|NCT00771927|anti-epileptic|anti-epileptic
565931|NCT00771927|anti-epileptic drug|anti-epileptic drug
565932|NCT00771927|seizure control|seizure control
565933|NCT00771927|open-label|open-label
565934|NCT00771927|post authorization|post authorization
565935|NCT00771927|PASS|pass
565936|NCT00771927|late stage|late stage
565937|NCT00771927|trial|trial
565938|NCT00771927|study|study
565939|NCT00771927|phase 4|phase 4
565940|NCT00771927|phase IV|phase iv
565941|NCT00771914|aspirin|aspirin
565942|NCT00771914|omega 3 fatty acids|omega 3 fatty acids
565943|NCT00771914|Lovaza|lovaza
565944|NCT00771914|myocardial infarction|myocardial infarction
565945|NCT00771914|aspirin resistance|aspirin resistance
565946|NCT00771914|cardiovascular disease|cardiovascular disease
565947|NCT00771901|obesity|obesity
565948|NCT00771901|insulin resistance|insulin resistance
565949|NCT00771901|type II diabetes|type ii diabetes
565950|NCT00771862|pain|pain
565951|NCT00771862|amputation|amputation
565952|NCT00771862|phantom limb|phantom limb
565953|NCT00771862|stump pain|stump pain
565954|NCT00771862|catheter|catheter
565955|NCT00771862|nerve block|nerve block
565956|NCT00771862|peripheral nerve block|peripheral nerve block
565957|NCT00771862|ucsd|ucsd
565958|NCT00771862|post-amputation phantom limb or stump pain|post-amputation phantom limb or stump pain
565959|NCT00771849|Meningitis|meningitis
565960|NCT00771849|Meningococcemia|meningococcemia
565961|NCT00771849|Neisseria meningitidis|neisseria meningitidis
565962|NCT00771836|Stem cell transplantation|stem cell transplantation
565963|NCT00771836|Airway hyper-reactivity|airway hyper-reactivity
565964|NCT00771836|methacholine|methacholine
565965|NCT00771836|pediatric|pediatric
565966|NCT00771810|Ovarian Cancer|ovarian cancer
565967|NCT00771810|Thrombocytopenia|thrombocytopenia
565968|NCT00771810|Cytopenia|cytopenia
565969|NCT00771810|Chemotherapy|chemotherapy
565970|NCT00771797|PAOD|paod
565971|NCT00771797|diabetis|diabetis
565972|NCT00771797|vascular function|vascular function
565973|NCT00771797|in diabetics with PAOD|in diabetics with paod
565974|NCT00771784|Endotracheal intubation|endotracheal intubation
565975|NCT00771784|tracheostomy|tracheostomy
565976|NCT00771784|laryngeal mask|laryngeal mask
565977|NCT00771771|Stroke|stroke
565978|NCT00771771|Rehabilitation|rehabilitation
565979|NCT00771771|Early Supported Discharge|early supported discharge
565980|NCT00771771|ESD|esd
565981|NCT00771771|RCT|rct
565982|NCT00771758|Vertebral compression fracture|vertebral compression fracture
565983|NCT00771758|Osteoporosis|osteoporosis
565984|NCT00771758|Acute pain|acute pain
565985|NCT00771758|Analgesic|analgesic
565986|NCT00771758|Oxycodone|oxycodone
565988|NCT00771732|toe nail fungus|toe nail fungus
565989|NCT00771719|VAP|vap
565990|NCT00771706|Pediatric Cough, Quality of Life|pediatric cough, quality of life
565991|NCT00771706|Drug (including placebo)|drug (including placebo)
565992|NCT00771693|NIDDM|niddm
565993|NCT00771693|Platelet Activation|platelet activation
565994|NCT00771693|Postprandial hyperglycemia|postprandial hyperglycemia
565995|NCT00771693|insulin|insulin
565996|NCT00771667|Interleukin-12|interleukin-12
565997|NCT00771667|Inflammation|inflammation
565998|NCT00771667|Research study|research study
565999|NCT00771667|Ustekinumab|ustekinumab
566000|NCT00771667|CNTO1275|cnto1275
566001|NCT00771667|Interleukin-23|interleukin-23
566002|NCT00771641|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
566003|NCT00771641|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
566004|NCT00771641|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
566005|NCT00771641|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
566006|NCT00771641|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
566007|NCT00771641|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
566008|NCT00771641|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
566009|NCT00771641|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
566010|NCT00771641|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
566011|NCT00771641|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
566012|NCT00771641|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
566013|NCT00771641|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
566014|NCT00771641|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
566015|NCT00771628|Intubation, Flex-It, stylet, GlideScope|intubation, flex-it, stylet, glidescope
566016|NCT00771615|human|human
566017|NCT00771615|Avian|avian
566018|NCT00771615|safety|safety
566019|NCT00771615|vaccines|vaccines
566020|NCT00771615|influenza|influenza
566021|NCT00771615|pandemic|pandemic
566022|NCT00771615|immunogenicity|immunogenicity
566023|NCT00771615|H5N1|h5n1
566024|NCT00771602|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
566025|NCT00771602|Leukemia|leukemia
566026|NCT00771602|CLL|cll
566027|NCT00771602|PLL|pll
566028|NCT00771602|SLL|sll
566029|NCT00771602|Rituximab|rituximab
566030|NCT00771602|Rituxan|rituxan
566031|NCT00771602|Alemtuzumab|alemtuzumab
566032|NCT00771602|Campath|campath
566033|NCT00771576|Diabetes Mellitus|diabetes mellitus
566034|NCT00771576|T1DM|t1dm
566035|NCT00771563|Non-Small Cell Lung Cancer|non-small cell lung cancer
566036|NCT00771563|chemotherapy|chemotherapy
566037|NCT00771563|Low Molecular Weight Heparin|low molecular weight heparin
566038|NCT00771537|HIV Testing|hiv testing
566039|NCT00771537|Persuasion|persuasion
566040|NCT00771537|Health Communication|health communication
566041|NCT00771537|Clinical Trials Participation|clinical trials participation
566042|NCT00771537|Attitudes toward Health|attitudes toward health
566043|NCT00771537|Diagnostic Tests|diagnostic tests
566044|NCT00771537|Behavioral Research|behavioral research
566045|NCT00771537|Intervention Studies|intervention studies
566046|NCT00771524|Pharmacokinetics|pharmacokinetics
566047|NCT00771524|Hip replacement|hip replacement
566048|NCT00771524|Ceftobiprole|ceftobiprole
566049|NCT00771498|rifampin|rifampin
566050|NCT00771498|lopinavir|lopinavir
566051|NCT00771498|drug interaction|drug interaction
566052|NCT00771498|pharmacokinetic|pharmacokinetic
566053|NCT00771459|Local infiltration analgesia|local infiltration analgesia
566054|NCT00771459|postoperative pain|postoperative pain
566055|NCT00771459|ropivacaine|ropivacaine
566056|NCT00771446|Hepatitis, acute|hepatitis, acute
566057|NCT00771446|Acute Hepatitis OR Chronic Hepatitis|acute hepatitis or chronic hepatitis
566058|NCT00771433|neutropenia|neutropenia
566059|NCT00771433|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
566060|NCT00771433|recurrent breast cancer|recurrent breast cancer
566061|NCT00771433|stage I breast cancer|stage i breast cancer
566062|NCT00771433|stage II breast cancer|stage ii breast cancer
566063|NCT00771433|stage IIIA breast cancer|stage iiia breast cancer
566064|NCT00771433|stage IIIB breast cancer|stage iiib breast cancer
566065|NCT00771433|stage IIIC breast cancer|stage iiic breast cancer
566066|NCT00771433|stage IV breast cancer|stage iv breast cancer
566067|NCT00771407|Ostomy creation|ostomy creation
566068|NCT00771407|Parastomal hernia|parastomal hernia
566069|NCT00771394|Vesicare|vesicare
566070|NCT00771394|Solifenacin succinate|solifenacin succinate
566071|NCT00771394|Tamsulosin|tamsulosin
566072|NCT00771394|Overactive Bladder|overactive bladder
566073|NCT00771394|BPH|bph
566074|NCT00771381|18F-FAZA|18f-faza
566075|NCT00771381|18F-FDG|18f-fdg
566076|NCT00771381|Positron Emission Tomography|positron emission tomography
566077|NCT00771381|Cell Hypoxia|cell hypoxia
566078|NCT00771303|Pregnancy|pregnancy
566079|NCT00771303|Pulmonary embolism|pulmonary embolism
566080|NCT00771303|MSCT|msct
566081|NCT00771290|Rectal sparing|rectal sparing
566082|NCT00771290|Colon cancer|colon cancer
566083|NCT00771277|Brain Injuries|brain injuries
566084|NCT00771277|Caregivers|caregivers
566085|NCT00771277|Volunteer Workers|volunteer workers
566086|NCT00771277|Social Networks|social networks
566087|NCT00771264|Overactive Bladder|overactive bladder
566088|NCT00771251|Rheumatoid arthritis|rheumatoid arthritis
566089|NCT00771251|Fully Human anti-TNFa monoclonal antibody|fully human anti-tnfa monoclonal antibody
566090|NCT00771251|CNTO148|cnto148
566091|NCT00771251|Golimumab|golimumab
566092|NCT00771238|pressure ulcers|pressure ulcers
566093|NCT00771238|Therapy mattresses|therapy mattresses
566094|NCT00771238|Incidence of pressure ulcers|incidence of pressure ulcers
566095|NCT00771225|genital prolapse|genital prolapse
566096|NCT00771225|surgery|surgery
566097|NCT00771225|fascial repair|fascial repair
566098|NCT00771225|mesh|mesh
566099|NCT00771225|prolift|prolift
566100|NCT00771212|Pain|pain
566101|NCT00771212|Observational|observational
566102|NCT00771212|Taiwan|taiwan
566103|NCT00771199|Cancer pain|cancer pain
566104|NCT00771199|Pain|pain
566105|NCT00771199|Fentanyl|fentanyl
566106|NCT00771199|Durogesic|durogesic
566107|NCT00771199|Cancer|cancer
566108|NCT00771199|Transdermal|transdermal
566109|NCT00771186|pediatric|pediatric
566110|NCT00771186|Laryngeal EMG|laryngeal emg
566111|NCT00771173|Phenazopyrdine|phenazopyrdine
566112|NCT00771173|post operative bladder catheritization|post operative bladder catheritization
566113|NCT00771173|VAS scores|vas scores
566114|NCT00771173|Bladder pain related to indwelling foley catheters.|bladder pain related to indwelling foley catheters.
566115|NCT00771173|Bladder irritaion related to indwelling foley catheters.|bladder irritaion related to indwelling foley catheters.
566116|NCT00771147|Advanced Renal Cell Carcinoma ( RCC)|advanced renal cell carcinoma ( rcc)
566117|NCT00771134|Depression|depression
566118|NCT00771134|Bipolar I Disorder|bipolar i disorder
566119|NCT00771134|Bipolar II Disorder|bipolar ii disorder
566120|NCT00771134|Placebo-controlled|placebo-controlled
566121|NCT00771134|Double-blind|double-blind
566122|NCT00771134|Randomised controlled|randomised controlled
566123|NCT00771134|Multicenter|multicenter
566124|NCT00771134|Clinical study|clinical study
566125|NCT00771134|Mania|mania
566126|NCT00771108|NAFLD|nafld
566127|NCT00771108|Obesity|obesity
566128|NCT00771108|Metabolic Syndrome|metabolic syndrome
566129|NCT00771108|Nonalcoholic Fatty Liver Disease|nonalcoholic fatty liver disease
566130|NCT00771095|weight loss|weight loss
566131|NCT00771095|elaboration|elaboration
566132|NCT00771095|self efficacy|self efficacy
566133|NCT00771082|inflammatory markers|inflammatory markers
566134|NCT00771082|bone markers|bone markers
566135|NCT00771082|OA|oa
566136|NCT00771069|Hypertension|hypertension
566137|NCT00771069|Type II DM|type ii dm
566138|NCT00771069|DM related complication|dm related complication
566139|NCT00771069|JNC7|jnc7
566140|NCT00771069|2007 ESH-ESC guidelines|2007 esh-esc guidelines
566141|NCT00771069|survey|survey
566142|NCT00771056|untreated|untreated
566143|NCT00771017|adenocarcinoma of the prostate|adenocarcinoma of the prostate
566144|NCT00771017|recurrent prostate cancer|recurrent prostate cancer
566145|NCT00771017|stage II prostate cancer|stage ii prostate cancer
566146|NCT00771017|stage III prostate cancer|stage iii prostate cancer
566147|NCT00771017|stage I prostate cancer|stage i prostate cancer
566148|NCT00771004|drug effects|drug effects
566149|NCT00771004|Type II Diabetes|type ii diabetes
566150|NCT00771004|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
566151|NCT00771004|Drug Therapy|drug therapy
566152|NCT00771004|Heart|heart
566153|NCT00771004|physiology|physiology
566154|NCT00771004|function|function
566155|NCT00770991|Polyp, Familial Adenomatous Polyposis, Prevention|polyp, familial adenomatous polyposis, prevention
566156|NCT00770978|ICU|icu
566157|NCT00770965|Plaque psoriasis, skin condition, thickening, flaking, skin disease, autoimmune disease|plaque psoriasis, skin condition, thickening, flaking, skin disease, autoimmune disease
566158|NCT00770952|Glucose Metabolism Disorder|glucose metabolism disorder
566159|NCT00770952|Dysmetabolic Syndrome|dysmetabolic syndrome
566160|NCT00770952|Type II Diabetes|type ii diabetes
566161|NCT00770952|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
566162|NCT00770952|Dyslipidemia|dyslipidemia
566163|NCT00770952|Drug Therapy|drug therapy
566701|NCT00769392|Eye-surgical procedures|eye-surgical procedures
566164|NCT00770939|Complete healing of chronic diabetic foot ulcers|complete healing of chronic diabetic foot ulcers
566165|NCT00770939|Platelet Rich Fibrin|platelet rich fibrin
566166|NCT00770939|Vivostat|vivostat
566167|NCT00770939|Growth factor treatment|growth factor treatment
566168|NCT00770939|Treatment of chronic diabetic foot ulcers|treatment of chronic diabetic foot ulcers
566169|NCT00770926|risk reduction|risk reduction
566170|NCT00770926|minority|minority
566171|NCT00770926|diabetes prevention|diabetes prevention
566172|NCT00770926|lifestyle program|lifestyle program
566173|NCT00770926|behavior change|behavior change
567014|NCT00767754|PET|pet
566174|NCT00770913|reflux esophagitis|reflux esophagitis
566175|NCT00770913|rabeprazole|rabeprazole
566176|NCT00770913|GERD|gerd
566177|NCT00770913|Japan|japan
566178|NCT00770887|Undesired fertility|undesired fertility
566179|NCT00770861|nebivolol|nebivolol
566180|NCT00770861|Bystolic ™|bystolic ™
566181|NCT00770861|Hypertension|hypertension
566182|NCT00770861|Hispanic|hispanic
566183|NCT00770861|Hypertension in Hispanic patients|hypertension in hispanic patients
566184|NCT00770848|CRPC|crpc
566185|NCT00770835|Glucose Metabolism Disorder|glucose metabolism disorder
566186|NCT00770835|Dysmetabolic Syndrome|dysmetabolic syndrome
566187|NCT00770835|Type II Diabetes|type ii diabetes
566188|NCT00770835|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
566189|NCT00770835|Dyslipidemia|dyslipidemia
566190|NCT00770835|Drug Therapy|drug therapy
566191|NCT00770822|Primary|primary
566192|NCT00770822|Prostate|prostate
566193|NCT00770822|Cancer|cancer
566194|NCT00770822|Primary T1c/T2a organ confined prostate cancer|primary t1c/t2a organ confined prostate cancer
566195|NCT00770822|organ-confined|organ-confined
566196|NCT00770796|Contrast induced nephropathy|contrast induced nephropathy
566197|NCT00770770|Macular edema secondary to RVO|macular edema secondary to rvo
566198|NCT00770744|Schizophrenia|schizophrenia
566199|NCT00770744|Antipsychotic|antipsychotic
566200|NCT00770744|Olanzapine|olanzapine
566201|NCT00770744|Lu 31-130|lu 31-130
566202|NCT00770731|Torisel|torisel
566203|NCT00770731|Temsirolimus|temsirolimus
566204|NCT00770731|Hycamtin|hycamtin
566205|NCT00770731|Topotecan hydrochloride|topotecan hydrochloride
566206|NCT00770731|Velcade|velcade
566207|NCT00770731|Bortezomib|bortezomib
566208|NCT00770731|FDG-PET Scans|fdg-pet scans
566209|NCT00770731|18F-Fluoro-2-Deoxyglucose Positron Emission Tomography|18f-fluoro-2-deoxyglucose positron emission tomography
566210|NCT00770718|intracranial hemorrhage|intracranial hemorrhage
566211|NCT00770718|warfarin|warfarin
566212|NCT00770718|anticoagulant|anticoagulant
566213|NCT00770718|Factor VII|factor vii
566214|NCT00770718|Prothrombin|prothrombin
566215|NCT00770692|insomnia|insomnia
566216|NCT00770692|primary insomnia|primary insomnia
566217|NCT00770692|insomnia associated with psychiatric or physical disorder(s)|insomnia associated with psychiatric or physical disorder(s)
566218|NCT00770666|Tobacco dependence treatment|tobacco dependence treatment
566219|NCT00770653|Glucose Metabolism Disorder|glucose metabolism disorder
566220|NCT00770653|Dysmetabolic Syndrome|dysmetabolic syndrome
566221|NCT00770653|Type II Diabetes|type ii diabetes
566222|NCT00770653|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
566223|NCT00770653|Dyslipidemia|dyslipidemia
566224|NCT00770653|Hyperlipidemias|hyperlipidemias
566225|NCT00770653|Drug Therapy|drug therapy
566226|NCT00770640|Glucose Metabolism Disorder|glucose metabolism disorder
566227|NCT00770640|Dysmetabolic Syndrome|dysmetabolic syndrome
566228|NCT00770640|Type II Diabetes|type ii diabetes
566229|NCT00770640|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
566230|NCT00770640|Dyslipidemia|dyslipidemia
566231|NCT00770640|Drug Therapy|drug therapy
566232|NCT00770627|160 children|160 children
566233|NCT00770627|parallel group|parallel group
566234|NCT00770614|Contrast Induced Nephropathy|contrast induced nephropathy
566235|NCT00770601|NOMID|nomid
566236|NCT00770601|CINCA Syndrome|cinca syndrome
566237|NCT00770601|Canakinumab|canakinumab
566238|NCT00770588|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
566239|NCT00770588|Gefitinib|gefitinib
566240|NCT00770575|Biological Markers|biological markers
566241|NCT00770575|Biochemical Markers|biochemical markers
566242|NCT00770575|Carotid Artery, Internal|carotid artery, internal
566243|NCT00770575|Carotid Artery, Common|carotid artery, common
566244|NCT00770575|Marker, Surrogate|marker, surrogate
566245|NCT00770575|Vascular Diseases|vascular diseases
566246|NCT00770575|Diabetes Mellitus|diabetes mellitus
566247|NCT00770575|Drug Therapy|drug therapy
566248|NCT00770536|fallopian tube cancer|fallopian tube cancer
566249|NCT00770536|Gynecological Malignancy|gynecological malignancy
566250|NCT00770536|primary peritoneal cancer of predominantly epithelial origin|primary peritoneal cancer of predominantly epithelial origin
566251|NCT00770536|Stage II to IV ovarian cancer|stage ii to iv ovarian cancer
566252|NCT00770523|patients without comorbidity|patients without comorbidity
566253|NCT00770510|Primary insomnia|primary insomnia
566254|NCT00770497|drug effects|drug effects
566255|NCT00770497|Hypertension|hypertension
566256|NCT00770497|Vascular Resistance|vascular resistance
566257|NCT00770497|Drug Therapy|drug therapy
566258|NCT00770497|physiopathology, vascular|physiopathology, vascular
566259|NCT00770484|Exercise|exercise
566260|NCT00770484|Propanolol|propanolol
566261|NCT00770484|Beta blockers|beta blockers
566262|NCT00770471|adult glioblastoma|adult glioblastoma
566263|NCT00770471|adult gliosarcoma|adult gliosarcoma
566264|NCT00770471|adult giant cell glioblastoma|adult giant cell glioblastoma
566265|NCT00770458|Down Syndrome|down syndrome
566266|NCT00770445|Glucose Metabolism Disorder|glucose metabolism disorder
566267|NCT00770445|Dysmetabolic Syndrome|dysmetabolic syndrome
566268|NCT00770445|Type II Diabetes|type ii diabetes
566269|NCT00770445|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
566270|NCT00770445|Dyslipidemia|dyslipidemia
566271|NCT00770445|Drug Therapy|drug therapy
566272|NCT00770432|Human Experimentation|human experimentation
566273|NCT00770419|depression|depression
566274|NCT00770419|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
566275|NCT00770419|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
566276|NCT00770419|acute undifferentiated leukemia|acute undifferentiated leukemia
566277|NCT00770419|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
566278|NCT00770419|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
566279|NCT00770419|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
566280|NCT00770419|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
566281|NCT00770419|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
566282|NCT00770419|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
566283|NCT00770419|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
566284|NCT00770419|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
566285|NCT00770419|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
566286|NCT00770419|mast cell leukemia|mast cell leukemia
566287|NCT00770419|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
566288|NCT00770419|prolymphocytic leukemia|prolymphocytic leukemia
566289|NCT00770419|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
566290|NCT00770419|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
566291|NCT00770419|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
566292|NCT00770419|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
566293|NCT00770419|refractory hairy cell leukemia|refractory hairy cell leukemia
566294|NCT00770419|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
566295|NCT00770419|secondary acute myeloid leukemia|secondary acute myeloid leukemia
566296|NCT00770419|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
566297|NCT00770419|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
566298|NCT00770419|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
566299|NCT00770419|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
566300|NCT00770419|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
566301|NCT00770419|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
566302|NCT00770419|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
566303|NCT00770419|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
566304|NCT00770419|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
566305|NCT00770419|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
566306|NCT00770419|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
566307|NCT00770419|anaplastic large cell lymphoma|anaplastic large cell lymphoma
566308|NCT00770419|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
566309|NCT00770419|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
566310|NCT00770419|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
566311|NCT00770419|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
566312|NCT00770419|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
566313|NCT00770419|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
566314|NCT00770419|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
566315|NCT00770419|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
566316|NCT00770419|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
566317|NCT00770419|splenic marginal zone lymphoma|splenic marginal zone lymphoma
566318|NCT00770419|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
566319|NCT00770419|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
566320|NCT00770419|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
566321|NCT00770419|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
566322|NCT00770419|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
566323|NCT00770419|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
566324|NCT00770419|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
566325|NCT00770419|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
566326|NCT00770419|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
566327|NCT00770419|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
566328|NCT00770419|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
566329|NCT00770419|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
566330|NCT00770419|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
566331|NCT00770419|intraocular lymphoma|intraocular lymphoma
566332|NCT00770419|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
566333|NCT00770419|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
566334|NCT00770419|chronic eosinophilic leukemia|chronic eosinophilic leukemia
566335|NCT00770419|chronic neutrophilic leukemia|chronic neutrophilic leukemia
566336|NCT00770419|primary myelofibrosis|primary myelofibrosis
566337|NCT00770419|primary systemic amyloidosis|primary systemic amyloidosis
566338|NCT00770419|refractory multiple myeloma|refractory multiple myeloma
566339|NCT00770419|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
566340|NCT00770419|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
566341|NCT00770419|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
566342|NCT00770393|squamous cell carcinoma of the pyriform sinus|squamous cell carcinoma of the pyriform sinus
566343|NCT00770393|laryngeal preservation|laryngeal preservation
566344|NCT00770393|patients with biopsy-proven previously untreated resectable T3 with fixed cord involvement squamous cell carcinoma of the pyriform sinus|patients with biopsy-proven previously untreated resectable t3 with fixed cord involvement squamous cell carcinoma of the pyriform sinus
566345|NCT00770380|smoking|smoking
566346|NCT00770367|Cardiovascular risk|cardiovascular risk
566347|NCT00770367|biological markers|biological markers
566348|NCT00770354|Breast cancer|breast cancer
566349|NCT00770328|Plasma PAI-1 level at 0, 4, 8 weeks|plasma pai-1 level at 0, 4, 8 weeks
566350|NCT00770328|Plasma hsCRP level at 0, 4, 8 weeks|plasma hscrp level at 0, 4, 8 weeks
566351|NCT00770328|Plasma TNF-a level at 0, 4, 8 weeks|plasma tnf-a level at 0, 4, 8 weeks
566352|NCT00770302|DPP-4 inhibitors|dpp-4 inhibitors
566353|NCT00770302|HBA1c|hba1c
566354|NCT00770302|Incretins|incretins
566355|NCT00770302|Pharmacokinetics|pharmacokinetics
566356|NCT00770276|obesity WHO I-III|obesity who i-iii
566357|NCT00770276|metabolic syndrome|metabolic syndrome
566358|NCT00770276|Framingham risk score|framingham risk score
566359|NCT00770276|subclinical atherosclerosis|subclinical atherosclerosis
566360|NCT00770276|endothelial dysfunction|endothelial dysfunction
566361|NCT00770263|any solid tumors|any solid tumors
566362|NCT00770250|asthma symptoms|asthma symptoms
566363|NCT00770250|words used by patients and physicians|words used by patients and physicians
566364|NCT00770250|express asthma symptoms|express asthma symptoms
566365|NCT00770237|Smoking|smoking
566366|NCT00770237|Nicotine|nicotine
566367|NCT00770237|Schizophrenia|schizophrenia
566368|NCT00770224|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
566369|NCT00770224|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
566370|NCT00770224|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
566371|NCT00770224|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
566372|NCT00770224|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
566373|NCT00770224|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
566374|NCT00770224|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
566375|NCT00770224|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
566376|NCT00770224|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
566377|NCT00770224|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
566378|NCT00770224|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
566818|NCT00768820|psychiatric phenotype|psychiatric phenotype
566379|NCT00770224|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
566380|NCT00770198|liver|liver
566381|NCT00770198|alcohol|alcohol
566382|NCT00770198|HCV|hcv
566383|NCT00770185|endometrial adenocarcinoma|endometrial adenocarcinoma
566384|NCT00770185|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
566385|NCT00770185|endometrial clear cell carcinoma|endometrial clear cell carcinoma
566386|NCT00770185|endometrial papillary carcinoma|endometrial papillary carcinoma
566387|NCT00770185|recurrent endometrial carcinoma|recurrent endometrial carcinoma
566388|NCT00770185|stage III endometrial carcinoma|stage iii endometrial carcinoma
566389|NCT00770185|stage IV endometrial carcinoma|stage iv endometrial carcinoma
566390|NCT00770172|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
566391|NCT00770172|neutropenia|neutropenia
566392|NCT00770172|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
566393|NCT00770120|recurrent malignant mesothelioma|recurrent malignant mesothelioma
566394|NCT00770120|stage II malignant mesothelioma|stage ii malignant mesothelioma
566395|NCT00770120|stage III malignant mesothelioma|stage iii malignant mesothelioma
566396|NCT00770120|stage IV malignant mesothelioma|stage iv malignant mesothelioma
566397|NCT00770094|LASIK|lasik
566398|NCT00770094|Laser Vision correction|laser vision correction
566399|NCT00770094|Myopia|myopia
566400|NCT00770094|Myopia with astigmatism|myopia with astigmatism
566401|NCT00770094|Nearsighted|nearsighted
566402|NCT00770081|Type 2 diabetes|type 2 diabetes
566403|NCT00770081|vildagliptin|vildagliptin
566404|NCT00770068|Mood Disorders|mood disorders
566405|NCT00770068|Major Depressive Disorder|major depressive disorder
566406|NCT00770068|Bipolar Disorder|bipolar disorder
566407|NCT00770068|Tree Pollen|tree pollen
566408|NCT00770068|Ragweed Pollen|ragweed pollen
566409|NCT00770068|Rhinitis|rhinitis
566410|NCT00770068|Allergic|allergic
566411|NCT00770068|Seasonal|seasonal
566412|NCT00770068|Allergens|allergens
567015|NCT00767741|diabetes|diabetes
566413|NCT00770055|stage IV breast cancer|stage iv breast cancer
566414|NCT00770055|recurrent breast cancer|recurrent breast cancer
566415|NCT00770016|insulin sensitivity|insulin sensitivity
566416|NCT00770016|Substrate metabolism|substrate metabolism
566417|NCT00770016|Fatty liver|fatty liver
566418|NCT00770016|intramyocellular lipid|intramyocellular lipid
566419|NCT00770016|intracellular signaling|intracellular signaling
566420|NCT00770003|patients|patients
566421|NCT00770003|allergic rhinitis|allergic rhinitis
566422|NCT00770003|tolerability|tolerability
566423|NCT00770003|safety|safety
566424|NCT00770003|nasal symptoms|nasal symptoms
566425|NCT00769990|bone metastases|bone metastases
566426|NCT00769990|pain|pain
566427|NCT00769990|recurrent breast cancer|recurrent breast cancer
566428|NCT00769990|stage IV breast cancer|stage iv breast cancer
566429|NCT00769990|recurrent prostate cancer|recurrent prostate cancer
566430|NCT00769990|stage IV prostate cancer|stage iv prostate cancer
566431|NCT00769990|recurrent melanoma|recurrent melanoma
566432|NCT00769990|stage IV melanoma|stage iv melanoma
566433|NCT00769990|recurrent renal cell cancer|recurrent renal cell cancer
566434|NCT00769990|stage IV renal cell cancer|stage iv renal cell cancer
566435|NCT00769990|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
566436|NCT00769990|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
566437|NCT00769990|extensive stage small cell lung cancer|extensive stage small cell lung cancer
566438|NCT00769990|recurrent small cell lung cancer|recurrent small cell lung cancer
566439|NCT00769964|Healthy (Dysmenorrhea)|healthy (dysmenorrhea)
566440|NCT00769951|pain|pain
566441|NCT00769951|depression|depression
566442|NCT00769951|weight changes|weight changes
566443|NCT00769951|cognitive/functional effects|cognitive/functional effects
566444|NCT00769951|malnutrition|malnutrition
566445|NCT00769951|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
566446|NCT00769951|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
566447|NCT00769951|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
566448|NCT00769938|Atrial fibrillation|atrial fibrillation
566449|NCT00769938|Percutaneous coronary stenting|percutaneous coronary stenting
566450|NCT00769938|Bleeding complications|bleeding complications
566451|NCT00769938|Triple therapy|triple therapy
566452|NCT00769925|Generalized Anxiety|generalized anxiety
566453|NCT00769925|Social Phobia|social phobia
566454|NCT00769925|Separation Anxiety|separation anxiety
566455|NCT00769925|Phobia|phobia
566456|NCT00769899|AZD7325|azd7325
566457|NCT00769899|Japanese Healthy Volunteers|japanese healthy volunteers
566458|NCT00769899|Phase I study|phase i study
566459|NCT00769899|Single Ascending Dose|single ascending dose
566460|NCT00769873|anticoagulation|anticoagulation
566461|NCT00769873|thrombosis|thrombosis
566462|NCT00769873|portal vein thrombosis|portal vein thrombosis
566463|NCT00769873|splenic vein thrombosis|splenic vein thrombosis
566464|NCT00769873|splenectomy|splenectomy
566465|NCT00769873|randomized|randomized
566466|NCT00769873|laparoscopic splenectomy|laparoscopic splenectomy
566467|NCT00769873|lovenox|lovenox
566468|NCT00769860|myositis|myositis
566469|NCT00769860|IBM|ibm
566470|NCT00769860|inclusion body myositis|inclusion body myositis
566471|NCT00769847|Endoscopic, craniosynostosis, sagittal, synostosis|endoscopic, craniosynostosis, sagittal, synostosis
566472|NCT00769834|chronic kidney disease|chronic kidney disease
566473|NCT00769834|chronic renal insufficiency|chronic renal insufficiency
566474|NCT00769834|uremia|uremia
566475|NCT00769834|disc edema|disc edema
566476|NCT00769834|papilledema|papilledema
566477|NCT00769834|idiopathic intracranial hypertension|idiopathic intracranial hypertension
566478|NCT00769834|pseudotumor cerebri|pseudotumor cerebri
566479|NCT00769821|lymphedema|lymphedema
566480|NCT00769821|perioperative/postoperative complications|perioperative/postoperative complications
566481|NCT00769821|cancer survivor|cancer survivor
566482|NCT00769821|stage I breast cancer|stage i breast cancer
566483|NCT00769821|stage II breast cancer|stage ii breast cancer
566484|NCT00769821|stage IIIA breast cancer|stage iiia breast cancer
566485|NCT00769821|stage IIIB breast cancer|stage iiib breast cancer
566486|NCT00769821|stage IIIC breast cancer|stage iiic breast cancer
566487|NCT00769821|stage IV breast cancer|stage iv breast cancer
566488|NCT00769795|prostate cancer|prostate cancer
566489|NCT00769795|prostatic neoplasm|prostatic neoplasm
566490|NCT00769795|androgen deprivation therapy|androgen deprivation therapy
566491|NCT00769795|insulin-like growth factor receptor I|insulin-like growth factor receptor i
566492|NCT00769795|neoadjuvant|neoadjuvant
566493|NCT00769795|prostatectomy|prostatectomy
566494|NCT00769782|gastrointestinal stromal tumor|gastrointestinal stromal tumor
566495|NCT00769782|liver metastases|liver metastases
566496|NCT00769769|Health Status|health status
566497|NCT00769756|Different Strategies to Fight Obesity in Families|different strategies to fight obesity in families
566498|NCT00769730|hepatocellular carcinoma|hepatocellular carcinoma
566499|NCT00769730|hepatitis B virus|hepatitis b virus
566500|NCT00769730|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
566501|NCT00769717|obesity|obesity
566502|NCT00769717|wellness|wellness
566503|NCT00769717|cardiovascular disease prevention|cardiovascular disease prevention
566504|NCT00769717|health at every size|health at every size
566505|NCT00769717|weight loss|weight loss
566506|NCT00769704|Melanoma|melanoma
566507|NCT00769704|OncoVEX^GM-CSF|oncovex^gm-csf
566508|NCT00769704|GM-CSF|gm-csf
566509|NCT00769704|Stage IIIb, IIIc and IV Disease|stage iiib, iiic and iv disease
566510|NCT00769704|oncolytic|oncolytic
566511|NCT00769704|OncoVex|oncovex
566512|NCT00769704|T-Vec|t-vec
566513|NCT00769704|talimogene laherparepvec|talimogene laherparepvec
566514|NCT00769691|Cardiac surgery|cardiac surgery
566515|NCT00769691|Cerebral blood flow autoregulation|cerebral blood flow autoregulation
566516|NCT00769678|Biventricular Pacing|biventricular pacing
566517|NCT00769665|Dry Eye|dry eye
566518|NCT00769665|re-wetting drops|re-wetting drops
566519|NCT00769652|malnutrition|malnutrition
566520|NCT00769652|non-small cell lung cancer|non-small cell lung cancer
566521|NCT00769652|small cell lung cancer|small cell lung cancer
566522|NCT00769652|stage III prostate cancer|stage iii prostate cancer
566523|NCT00769652|stage IV prostate cancer|stage iv prostate cancer
566524|NCT00769652|pancreatic cancer|pancreatic cancer
566525|NCT00769652|weight changes|weight changes
566526|NCT00769626|Low Back Pain|low back pain
566527|NCT00769626|Clinical Practice Guidelines|clinical practice guidelines
566528|NCT00769626|Spinal Manipulation|spinal manipulation
566529|NCT00769626|Physical Therapy Techniques|physical therapy techniques
566530|NCT00769613|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
566531|NCT00769613|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
566532|NCT00769613|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
566533|NCT00769613|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
566534|NCT00769613|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
566535|NCT00769613|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
566536|NCT00769613|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
566537|NCT00769613|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
566538|NCT00769613|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
566539|NCT00769613|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
566540|NCT00769613|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
566541|NCT00769613|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
566542|NCT00769613|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
566543|NCT00769613|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
566544|NCT00769613|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
566545|NCT00769613|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
566546|NCT00769613|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
566547|NCT00769613|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
566548|NCT00769613|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
566549|NCT00769613|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
566550|NCT00769613|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
566551|NCT00769613|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
566552|NCT00769613|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
566553|NCT00769613|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
566554|NCT00769613|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
566555|NCT00769613|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
566556|NCT00769613|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
566557|NCT00769613|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
566558|NCT00769613|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
566559|NCT00769613|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
566560|NCT00769613|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
566561|NCT00769613|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
566562|NCT00769613|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
566563|NCT00769613|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
566564|NCT00769613|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
566565|NCT00769613|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
566566|NCT00769613|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
566567|NCT00769613|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
566568|NCT00769613|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
566569|NCT00769613|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
566570|NCT00769613|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
566571|NCT00769613|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
566572|NCT00769613|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
566573|NCT00769613|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
566574|NCT00769613|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
566575|NCT00769613|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
567109|NCT00767195|mortality|mortality
566576|NCT00769613|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
566577|NCT00769613|splenic marginal zone lymphoma|splenic marginal zone lymphoma
566578|NCT00769613|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
566579|NCT00769613|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
566580|NCT00769613|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
566581|NCT00769613|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
566582|NCT00769613|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
566583|NCT00769613|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
566584|NCT00769613|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
566585|NCT00769613|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
566586|NCT00769613|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
566587|NCT00769613|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
566588|NCT00769613|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
566589|NCT00769613|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
566590|NCT00769613|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
566591|NCT00769613|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
566592|NCT00769613|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
566593|NCT00769613|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
566594|NCT00769613|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
566595|NCT00769613|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
566596|NCT00769613|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
566597|NCT00769613|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
566598|NCT00769613|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
566599|NCT00769613|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
566600|NCT00769613|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
566601|NCT00769613|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
566602|NCT00769613|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
566603|NCT00769613|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
566604|NCT00769613|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
566605|NCT00769613|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
566606|NCT00769613|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
566607|NCT00769613|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
566608|NCT00769613|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
566609|NCT00769613|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
566610|NCT00769613|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
566611|NCT00769613|refractory hairy cell leukemia|refractory hairy cell leukemia
566612|NCT00769613|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
566613|NCT00769613|secondary acute myeloid leukemia|secondary acute myeloid leukemia
566614|NCT00769613|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
566615|NCT00769613|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
566616|NCT00769613|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
566617|NCT00769613|chronic eosinophilic leukemia|chronic eosinophilic leukemia
566618|NCT00769613|primary myelofibrosis|primary myelofibrosis
566619|NCT00769613|chronic neutrophilic leukemia|chronic neutrophilic leukemia
566620|NCT00769613|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
566621|NCT00769613|disseminated neuroblastoma|disseminated neuroblastoma
566622|NCT00769613|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
566623|NCT00769613|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
566624|NCT00769613|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
566625|NCT00769613|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
566626|NCT00769613|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
566627|NCT00769613|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
566628|NCT00769613|recurrent neuroblastoma|recurrent neuroblastoma
566629|NCT00769613|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
566630|NCT00769613|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
566631|NCT00769613|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
566632|NCT00769613|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
566633|NCT00769613|stage I multiple myeloma|stage i multiple myeloma
566634|NCT00769613|stage II multiple myeloma|stage ii multiple myeloma
566635|NCT00769613|stage III multiple myeloma|stage iii multiple myeloma
566636|NCT00769613|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
566813|NCT00768833|Healthy subjects|healthy subjects
566637|NCT00769613|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
566638|NCT00769613|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
566639|NCT00769613|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
566640|NCT00769613|stage IIIA breast cancer|stage iiia breast cancer
566641|NCT00769613|stage IIIB breast cancer|stage iiib breast cancer
566642|NCT00769613|stage IIIC breast cancer|stage iiic breast cancer
566643|NCT00769613|stage IV breast cancer|stage iv breast cancer
566644|NCT00769613|refractory multiple myeloma|refractory multiple myeloma
566645|NCT00769613|cytomegalovirus infection|cytomegalovirus infection
566646|NCT00769600|Recurrent Non-Small Cell Lung Cancer|recurrent non-small cell lung cancer
566647|NCT00769587|aggressive systemic mastocytosis|aggressive systemic mastocytosis
566648|NCT00769587|smoldering systemic mastocytosis|smoldering systemic mastocytosis
566649|NCT00769561|Temporomandibular disorders|temporomandibular disorders
566650|NCT00769561|Biofeedback|biofeedback
566651|NCT00769561|Cognitive behavioral therapy|cognitive behavioral therapy
566652|NCT00769561|Pain|pain
566653|NCT00769548|adenocarcinoma of the prostate|adenocarcinoma of the prostate
566654|NCT00769548|stage I prostate cancer|stage i prostate cancer
566655|NCT00769548|stage IIB prostate cancer|stage iib prostate cancer
566656|NCT00769548|stage IIA prostate cancer|stage iia prostate cancer
566657|NCT00769548|stage III prostate cancer|stage iii prostate cancer
566658|NCT00769548|stage IV prostate cancer|stage iv prostate cancer
566659|NCT00769535|heat shock protein70|heat shock protein70
566660|NCT00769535|tumor necrosis factor-alpha promoter|tumor necrosis factor-alpha promoter
566661|NCT00769535|polymorphism|polymorphism
566662|NCT00769522|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
566663|NCT00769522|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
566664|NCT00769522|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
566665|NCT00769522|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
566666|NCT00769522|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
566667|NCT00769522|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
566668|NCT00769509|energy expenditure|energy expenditure
566669|NCT00769509|indirect calorimetry|indirect calorimetry
566670|NCT00769509|human milk|human milk
566671|NCT00769509|preterm formula|preterm formula
566672|NCT00769509|premature infant|premature infant
566673|NCT00769483|Pancreas|pancreas
566674|NCT00769483|Pancreatic Cancer|pancreatic cancer
566675|NCT00769483|Advanced cancer of the pancreas|advanced cancer of the pancreas
566676|NCT00769483|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
566677|NCT00769483|MK-0646|mk-0646
566678|NCT00769483|Gemcitabine|gemcitabine
566679|NCT00769483|Gemzar|gemzar
566680|NCT00769483|Erlotinib hydrochloride|erlotinib hydrochloride
566681|NCT00769483|Erlotinib|erlotinib
566682|NCT00769483|OSI-774|osi-774
566683|NCT00769483|Tarceva|tarceva
566684|NCT00769470|stage I breast cancer|stage i breast cancer
566685|NCT00769470|stage II breast cancer|stage ii breast cancer
566686|NCT00769470|stage IIIA breast cancer|stage iiia breast cancer
566687|NCT00769470|stage IIIB breast cancer|stage iiib breast cancer
566688|NCT00769470|stage IIIC breast cancer|stage iiic breast cancer
566689|NCT00769470|HER2-positive breast cancer|her2-positive breast cancer
566690|NCT00769431|stage I prostate cancer|stage i prostate cancer
566691|NCT00769431|stage IIB prostate cancer|stage iib prostate cancer
566692|NCT00769431|stage IIA prostate cancer|stage iia prostate cancer
566693|NCT00769405|recurrent colon cancer|recurrent colon cancer
566694|NCT00769405|stage IV colon cancer|stage iv colon cancer
566695|NCT00769405|recurrent rectal cancer|recurrent rectal cancer
566696|NCT00769405|stage IV rectal cancer|stage iv rectal cancer
566697|NCT00769405|peritoneal carcinomatosis|peritoneal carcinomatosis
566698|NCT00769392|Macular Degeneration|macular degeneration
566699|NCT00769392|Intravitreal injections|intravitreal injections
566700|NCT00769392|Eye anesthesia-Topical/subconjunctival|eye anesthesia-topical/subconjunctival
566702|NCT00769392|Ophthalmologic anesthesia methods|ophthalmologic anesthesia methods
566703|NCT00769327|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
566704|NCT00769327|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
566705|NCT00769301|Symptoms|symptoms
566706|NCT00769301|pain|pain
566707|NCT00769301|fatigue|fatigue
566708|NCT00769301|depression|depression
566709|NCT00769301|sleeplessness|sleeplessness
566710|NCT00769301|genetic markers|genetic markers
566711|NCT00769301|caregiver burden.|caregiver burden.
566712|NCT00769275|silent ischemia|silent ischemia
566713|NCT00769275|type 2 diabetes mellitus|type 2 diabetes mellitus
566714|NCT00769275|screening|screening
566715|NCT00769275|cardiac outcome|cardiac outcome
566716|NCT00769275|Prevalence silent myocardial ischemia|prevalence silent myocardial ischemia
566717|NCT00769275|Cardiac outcome in screened and not-screened subjects|cardiac outcome in screened and not-screened subjects
566718|NCT00769262|Premature neonates|premature neonates
566719|NCT00769262|Thermoregulation|thermoregulation
566720|NCT00769262|Isolette|isolette
566721|NCT00769262|Feeding status|feeding status
566722|NCT00769249|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
566723|NCT00769249|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
566724|NCT00769223|radiation toxicity|radiation toxicity
566725|NCT00769223|recurrent prostate cancer|recurrent prostate cancer
566726|NCT00769223|stage IIB prostate cancer|stage iib prostate cancer
566727|NCT00769223|stage IIA prostate cancer|stage iia prostate cancer
566728|NCT00769223|stage III prostate cancer|stage iii prostate cancer
566729|NCT00769223|stage I prostate cancer|stage i prostate cancer
566730|NCT00769223|stage IV prostate cancer|stage iv prostate cancer
566731|NCT00769223|adenocarcinoma of the prostate|adenocarcinoma of the prostate
566732|NCT00769197|optic disc cupping|optic disc cupping
566733|NCT00769197|cerebral palsy|cerebral palsy
566734|NCT00769197|static encephalopathy|static encephalopathy
566735|NCT00769197|optic disc|optic disc
566736|NCT00769197|optic nerve|optic nerve
566737|NCT00769197|periventricular Leukomalacia|periventricular leukomalacia
566738|NCT00769184|chronic plaque psoriasis|chronic plaque psoriasis
566739|NCT00769171|Complicated Intra-Abdominal Infections|complicated intra-abdominal infections
566740|NCT00769158|Alcohol|alcohol
566741|NCT00769158|Alcoholism|alcoholism
566742|NCT00769158|Alcohol Dependence|alcohol dependence
566743|NCT00769145|Corneal neovascularization|corneal neovascularization
566744|NCT00769145|Ranibizumab|ranibizumab
566745|NCT00769145|Corneal transplantation|corneal transplantation
566746|NCT00769119|bronchiectasis|bronchiectasis
566747|NCT00769119|Phase II|phase ii
566748|NCT00769106|hepatocellular carcinoma|hepatocellular carcinoma
566749|NCT00769106|recurrent|recurrent
566750|NCT00769106|cytokine-induced killer cell|cytokine-induced killer cell
566751|NCT00769093|ferumoxytol|ferumoxytol
566752|NCT00769093|diagnostic imaging|diagnostic imaging
566753|NCT00769080|PSP|psp
566754|NCT00769080|Standard Treatment|standard treatment
566755|NCT00769080|Standard Treatment plus PSP|standard treatment plus psp
566756|NCT00769067|Lung cancer|lung cancer
566757|NCT00769067|advanced|advanced
566758|NCT00769067|second or third line|second or third line
566759|NCT00769054|Postoperative pain|postoperative pain
566760|NCT00769054|PONV|ponv
566761|NCT00769028|Systemic sclerosis|systemic sclerosis
566762|NCT00769028|Diffuse cutaneous systemic sclerosis|diffuse cutaneous systemic sclerosis
566763|NCT00769028|Scleroderma|scleroderma
566764|NCT00769028|Biological|biological
566765|NCT00769028|Hyperimmune caprine serum|hyperimmune caprine serum
566766|NCT00769028|Goat Serum|goat serum
566767|NCT00769015|age-related macular degeneration|age-related macular degeneration
566768|NCT00769015|depression|depression
566769|NCT00769015|vision loss|vision loss
566770|NCT00769002|influenza|influenza
566771|NCT00769002|flu|flu
566772|NCT00769002|vaccine|vaccine
566773|NCT00769002|vaccination|vaccination
566774|NCT00769002|immune response|immune response
566775|NCT00769002|FluShield|flushield
566776|NCT00769002|FluMist|flumist
566777|NCT00769002|PET-CT|pet-ct
566778|NCT00769002|Healthy Volunteers|healthy volunteers
566779|NCT00768989|Combination Therapy|combination therapy
566780|NCT00768976|Participant must have participated in a clinical trial conducted by the Summa Health System Hospitals Cancer Research Program.|participant must have participated in a clinical trial conducted by the summa health system hospitals cancer research program.
566781|NCT00768976|Participant should have been registered for clinical trial participation three months prior to receiving the satisfaction survey.|participant should have been registered for clinical trial participation three months prior to receiving the satisfaction survey.
566782|NCT00768963|ranibizumab|ranibizumab
566783|NCT00768963|pterygium|pterygium
566784|NCT00768950|Seronegative spondyloarthropathies|seronegative spondyloarthropathies
566785|NCT00768950|Endoscopic capsule examination|endoscopic capsule examination
566786|NCT00768950|Small bowel and colon lesions|small bowel and colon lesions
566787|NCT00768950|Nonsteroidal anti-inflammatory drugs|nonsteroidal anti-inflammatory drugs
566788|NCT00768950|Anti TNF Alpha Drugs|anti tnf alpha drugs
566789|NCT00768937|hepatocellular carcinoma|hepatocellular carcinoma
566790|NCT00768937|sorafenib|sorafenib
566791|NCT00768937|transarterial chemoembolization|transarterial chemoembolization
566792|NCT00768937|tumor angiogenesis|tumor angiogenesis
566793|NCT00768937|angiogenic factors|angiogenic factors
566794|NCT00768924|Bone Void Filler|bone void filler
566795|NCT00768924|Post-Harvest Iliac Crest|post-harvest iliac crest
566796|NCT00768924|Ability of CopiOs to fill the post-harvest iliac crest bone void created by a surgeon during spinal fusion.|ability of copios to fill the post-harvest iliac crest bone void created by a surgeon during spinal fusion.
566797|NCT00768911|glioblastoma|glioblastoma
566798|NCT00768911|Glioblastoma multiforme (newly diagnosed)|glioblastoma multiforme (newly diagnosed)
566799|NCT00768898|conjunctival|conjunctival
566800|NCT00768898|staining|staining
566801|NCT00768872|activity, spinal cord stimulation, pain|activity, spinal cord stimulation, pain
566802|NCT00768859|breast cancer|breast cancer
566803|NCT00768859|HER2 positive|her2 positive
566804|NCT00768859|neo-adjuvant|neo-adjuvant
566805|NCT00768859|trastuzumab|trastuzumab
566806|NCT00768859|paclitaxel|paclitaxel
566807|NCT00768859|carboplatin|carboplatin
566808|NCT00768846|PCI|pci
566809|NCT00768846|Stent|stent
566810|NCT00768846|DES|des
566811|NCT00768846|CAD|cad
566812|NCT00768833|S.pneumoniae healthy subjects|s.pneumoniae healthy subjects
566814|NCT00768820|Velocardiofacial syndrome|velocardiofacial syndrome
566815|NCT00768820|Williams syndrome|williams syndrome
566816|NCT00768820|fragile X syndrome|fragile x syndrome
566817|NCT00768820|cognitive phenotype|cognitive phenotype
566819|NCT00768794|thrush|thrush
566820|NCT00768781|insomnia|insomnia
566821|NCT00768781|hyperarousal|hyperarousal
566822|NCT00768781|mindfulness meditation|mindfulness meditation
566823|NCT00768781|complementary and alternative medicine|complementary and alternative medicine
566824|NCT00768781|cognitive-behavioral therapy|cognitive-behavioral therapy
566825|NCT00768768|iontophoresis|iontophoresis
566826|NCT00768768|terbinafine|terbinafine
566827|NCT00768768|onychomycosis|onychomycosis
566828|NCT00768755|non-squamous NSCLC|non-squamous nsclc
566829|NCT00768755|axitinib|axitinib
566830|NCT00768755|pemetrexed/cisplatin|pemetrexed/cisplatin
566831|NCT00768742|Uterine Fibroid RF Ablation|uterine fibroid rf ablation
566832|NCT00768742|Intrauterine Ultrasound|intrauterine ultrasound
566833|NCT00768742|VizAblate|vizablate
566834|NCT00768729|End stage renal disease|end stage renal disease
566835|NCT00768729|Kidney transplantation|kidney transplantation
566836|NCT00768729|Renal transplantation|renal transplantation
566837|NCT00768729|Kidney failure|kidney failure
566838|NCT00768729|Children|children
566839|NCT00768729|Adolescents|adolescents
566840|NCT00768729|Sirolimus|sirolimus
566841|NCT00768729|Rapamycin|rapamycin
566842|NCT00768729|CellCept|cellcept
566843|NCT00768729|Mycophenolate mofetil (MMF)|mycophenolate mofetil (mmf)
566844|NCT00768729|Azathioprine|azathioprine
566845|NCT00768703|Congenital diaphragmatic hernia|congenital diaphragmatic hernia
566846|NCT00768703|lung-head ratio|lung-head ratio
566847|NCT00768703|percutaneous tracheal occlusion|percutaneous tracheal occlusion
566848|NCT00768703|fetal intervention|fetal intervention
566849|NCT00768677|binge eating behavior|binge eating behavior
566850|NCT00768677|adolescents|adolescents
566851|NCT00768664|recurrent or metastatic squamous cell cancer of the Head and Neck; no prior systemic therapy for recurrence|recurrent or metastatic squamous cell cancer of the head and neck; no prior systemic therapy for recurrence
566852|NCT00768638|Chronic kidney disease|chronic kidney disease
566853|NCT00768612|Acute, Schizophrenia, Phase2a, Vabicaserin|acute, schizophrenia, phase2a, vabicaserin
566854|NCT00768599|Econazole|econazole
566855|NCT00768599|Foam|foam
566856|NCT00768599|Quinnova|quinnova
566857|NCT00768573|taste test|taste test
566858|NCT00768534|Acute Otitis Media|acute otitis media
566859|NCT00768534|Serotype distribution|serotype distribution
566860|NCT00768508|Alcohol|alcohol
566861|NCT00768508|Alcohol Dependence|alcohol dependence
566862|NCT00768508|Alcoholism|alcoholism
566863|NCT00768495|revascularization|revascularization
566864|NCT00768495|claudication|claudication
566865|NCT00768495|hyperspectral|hyperspectral
566866|NCT00768495|oxygenation|oxygenation
566867|NCT00768495|limb ischemia|limb ischemia
566868|NCT00768482|opioid dependence|opioid dependence
566869|NCT00768482|opioid addiction|opioid addiction
566870|NCT00768482|buprenorphine|buprenorphine
566871|NCT00768482|methadone|methadone
566872|NCT00768482|heroin|heroin
566873|NCT00768482|implant|implant
566874|NCT00768482|opioid withdrawal|opioid withdrawal
566875|NCT00768482|opioid pain medication|opioid pain medication
566876|NCT00768482|suboxone|suboxone
566877|NCT00768469|HKI-272|hki-272
566878|NCT00768469|Paclitaxel|paclitaxel
566879|NCT00768469|Combination|combination
566880|NCT00768469|Solid Tumor|solid tumor
566881|NCT00768443|GERD|gerd
566882|NCT00768443|PPI|ppi
566883|NCT00768417|Nuts|nuts
566884|NCT00768417|Lipids|lipids
566885|NCT00768417|Mastication|mastication
566886|NCT00768417|Bioaccessibility|bioaccessibility
566887|NCT00768417|Satiety|satiety
566888|NCT00768417|Hormones|hormones
566889|NCT00768417|Human|human
566890|NCT00768391|Tumors|tumors
566891|NCT00768391|Lymphoma|lymphoma
566892|NCT00768391|Antibodies, Monoclonal|antibodies, monoclonal
566893|NCT00768378|Physical Therapy (Specialty)|physical therapy (specialty)
566894|NCT00768378|Balance dysfunction or disorder|balance dysfunction or disorder
566895|NCT00768378|Vestibular|vestibular
566896|NCT00768378|Rehabilitation|rehabilitation
566897|NCT00768365|adrenal incidentaloma|adrenal incidentaloma
566898|NCT00768365|cardiovascular risk|cardiovascular risk
566899|NCT00768352|Pediatric|pediatric
566900|NCT00768352|Resident|resident
566901|NCT00768352|Depression|depression
566902|NCT00768352|Screening|screening
566903|NCT00768352|Substance Abuse|substance abuse
566904|NCT00768352|Pediatric Resident knowledge of mental health topics|pediatric resident knowledge of mental health topics
566905|NCT00768352|Pediatric Resident current practices for screening and treating mental health disorders|pediatric resident current practices for screening and treating mental health disorders
566906|NCT00768352|Pediatric Resident mental health care competency|pediatric resident mental health care competency
566907|NCT00768339|antisense|antisense
566908|NCT00768339|AEG35156|aeg35156
566909|NCT00768339|lymphocytic|lymphocytic
566910|NCT00768339|lymphoma|lymphoma
566911|NCT00768339|leukemia|leukemia
566912|NCT00768339|B-cell|b-cell
566913|NCT00768326|Schizophrenia|schizophrenia
566914|NCT00768326|Antipsychotic|antipsychotic
566915|NCT00768326|Lu 31-130|lu 31-130
566916|NCT00768313|scoliosis correction rod strength adolescent|scoliosis correction rod strength adolescent
566917|NCT00768300|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
566918|NCT00768300|interstitial lung disease|interstitial lung disease
566919|NCT00768300|ambrisentan|ambrisentan
566920|NCT00768274|Cholesterol|cholesterol
566921|NCT00768274|High density lipoprotein|high density lipoprotein
566922|NCT00768274|Dyslipidemia|dyslipidemia
566923|NCT00768274|Atherosclerosis|atherosclerosis
566924|NCT00768274|Apolipoprotein A-I|apolipoprotein a-i
566925|NCT00768261|Dementia of the Alzheimer type|dementia of the alzheimer type
566926|NCT00768248|pain|pain
566927|NCT00768248|phantom limb|phantom limb
566928|NCT00768248|stump pain|stump pain
566929|NCT00768248|catheter|catheter
566930|NCT00768248|nerve block|nerve block
566931|NCT00768248|peripheral nerve block|peripheral nerve block
566932|NCT00768248|NMCSD|nmcsd
566933|NCT00768248|Post-Amputation Phantom Limb or Stump Pain|post-amputation phantom limb or stump pain
566934|NCT00768235|Sedentary elderly women that had medical assignment|sedentary elderly women that had medical assignment
566935|NCT00768222|wound healing|wound healing
566936|NCT00768209|Pharmacokinetics|pharmacokinetics
566937|NCT00768196|GERD|gerd
566938|NCT00768196|Korea|korea
566939|NCT00768196|typical symptom|typical symptom
566940|NCT00768196|quality of life|quality of life
566941|NCT00768196|Naturalistic|naturalistic
566942|NCT00768196|epidemiological|epidemiological
566943|NCT00768183|KADIAN|kadian
566944|NCT00768183|morphine|morphine
566945|NCT00768183|alcohol|alcohol
566946|NCT00768183|water|water
566947|NCT00768183|Ethanol|ethanol
566948|NCT00768183|solution|solution
566949|NCT00768183|fed|fed
566950|NCT00768183|fasting|fasting
566951|NCT00768157|hepatocellular carcinoma|hepatocellular carcinoma
566952|NCT00768157|hepatitis B virus|hepatitis b virus
566953|NCT00768157|surgery|surgery
566954|NCT00768157|anti-virus|anti-virus
566955|NCT00768157|recurrence|recurrence
566956|NCT00768144|Sutent|sutent
566957|NCT00768144|sunitinib|sunitinib
566958|NCT00768118|healthy, no evidence of disease|healthy, no evidence of disease
566959|NCT00768105|Type 2 diabetes|type 2 diabetes
566960|NCT00768079|Benralizumab|benralizumab
566961|NCT00768079|MEDI-563|medi-563
566962|NCT00768079|Asthma|asthma
566963|NCT00768066|Chronic Ischemic Left Ventricular Dysfunction|chronic ischemic left ventricular dysfunction
566964|NCT00768053|EULAR-RAID|eular-raid
566965|NCT00768053|active rheumatoid arthritis|active rheumatoid arthritis
566966|NCT00768053|etanercept|etanercept
566967|NCT00768040|Diabetes|diabetes
566968|NCT00768040|Macular edema|macular edema
566969|NCT00768040|Aliskiren|aliskiren
566970|NCT00768040|Diabetic retinopathy|diabetic retinopathy
566971|NCT00768040|Diabetes mellitus type 1|diabetes mellitus type 1
566972|NCT00768040|Diabetes mellitus type 2|diabetes mellitus type 2
566973|NCT00768027|hyperspectral imaging|hyperspectral imaging
566974|NCT00768027|tissue oxygenation|tissue oxygenation
566975|NCT00768027|wounds|wounds
566976|NCT00768027|wound healing|wound healing
566977|NCT00768027|prevention|prevention
566978|NCT00768027|hyperbaric|hyperbaric
566979|NCT00767988|Probiotics|probiotics
566980|NCT00767988|Spina Bifida|spina bifida
566981|NCT00767988|Dietary Supplements|dietary supplements
566982|NCT00767988|Bacteriuria|bacteriuria
566983|NCT00767988|Urinary Tract Infection (UTI)|urinary tract infection (uti)
566984|NCT00767962|recurrent primary spontaneous pneumothorax|recurrent primary spontaneous pneumothorax
566985|NCT00767949|wet|wet
566986|NCT00767949|AMD|amd
566987|NCT00767923|hyperspectral imaging|hyperspectral imaging
566988|NCT00767923|tissue oxygenation|tissue oxygenation
566989|NCT00767923|foot amputation|foot amputation
566990|NCT00767923|critical limb ischemia|critical limb ischemia
566991|NCT00767923|tissue necrosis|tissue necrosis
566992|NCT00767897|Dose response relationship|dose response relationship
566993|NCT00767897|immunity|immunity
566994|NCT00767884|panretinal photocoagulation|panretinal photocoagulation
566995|NCT00767884|diabetic retinopathy|diabetic retinopathy
566996|NCT00767884|optic nerve head changes|optic nerve head changes
566997|NCT00767871|Panic disorder|panic disorder
566998|NCT00767871|PET|pet
566999|NCT00767871|Escitaopram|escitaopram
567000|NCT00767858|Genetic|genetic
567001|NCT00767858|Genetic Literacy|genetic literacy
567002|NCT00767858|Human Genetic Research|human genetic research
567003|NCT00767858|Cultural Congruence|cultural congruence
567004|NCT00767858|Interview|interview
567005|NCT00767845|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
567006|NCT00767845|stage I prostate cancer|stage i prostate cancer
567007|NCT00767845|stage II prostate cancer|stage ii prostate cancer
567008|NCT00767845|stage III prostate cancer|stage iii prostate cancer
567009|NCT00767819|progressive GIST|progressive gist
567010|NCT00767819|progressive sarcoma|progressive sarcoma
567011|NCT00767767|anesthetic drugs, associative memory, fear|anesthetic drugs, associative memory, fear
567012|NCT00767754|panic disorder|panic disorder
567013|NCT00767754|paroxetine|paroxetine
567016|NCT00767741|post prandial glucose level|post prandial glucose level
567017|NCT00767741|insulin|insulin
567018|NCT00767741|pharmacokinetics|pharmacokinetics
567019|NCT00767741|pharmacodynamics|pharmacodynamics
567020|NCT00767728|UC|uc
567021|NCT00767728|ulcerative colitis|ulcerative colitis
567022|NCT00767728|IBD|ibd
567023|NCT00767728|Inflammatory Bowel Disease|inflammatory bowel disease
567024|NCT00767702|Genetic/Genomic Researchers|genetic/genomic researchers
567025|NCT00767702|Human Genetic Variation|human genetic variation
567026|NCT00767702|Interviews|interviews
567027|NCT00767702|Research Design|research design
567028|NCT00767702|Race/Ethnicity|race/ethnicity
567029|NCT00767702|Interview|interview
567030|NCT00767676|Contact sensitization|contact sensitization
567031|NCT00767676|Healthy Adult Volunteers|healthy adult volunteers
567032|NCT00767650|Aplastic Anemia|aplastic anemia
567033|NCT00767650|Cyclosporine|cyclosporine
567034|NCT00767650|Campath|campath
567035|NCT00767650|Neurophyschological Side Effect|neurophyschological side effect
567036|NCT00767611|Infertility|infertility
567037|NCT00767611|Sperm|sperm
567038|NCT00767611|Embryo Development|embryo development
567039|NCT00767611|In Vitro Fertilization|in vitro fertilization
567040|NCT00767598|CYP3A5|cyp3a5
567041|NCT00767598|sildenafil|sildenafil
567042|NCT00767598|udenafil|udenafil
567043|NCT00767598|vardenafil|vardenafil
567044|NCT00767585|breast cancer|breast cancer
567045|NCT00767585|aromatase inhibitors|aromatase inhibitors
567046|NCT00767585|bone mineral density|bone mineral density
567047|NCT00767585|osteoporosis|osteoporosis
567048|NCT00767572|Coarctation of the aorta|coarctation of the aorta
567049|NCT00767572|cross over design|cross over design
567050|NCT00767572|atorvastatin|atorvastatin
567051|NCT00767572|endothelial function|endothelial function
567052|NCT00767559|Deep Vein Thrombosis, anticoagulants, surgery, pulmonary embolus, warfarin, fondaparinox|deep vein thrombosis, anticoagulants, surgery, pulmonary embolus, warfarin, fondaparinox
567053|NCT00767546|seborrhic dermatitis|seborrhic dermatitis
567054|NCT00767546|parkinson's disease|parkinson's disease
567055|NCT00767546|Parkinson disease parkinsonism and seborrhic dermatitis|parkinson disease parkinsonism and seborrhic dermatitis
567056|NCT00767520|Advanced Estrogen Receptor Positive Breast Cancer|advanced estrogen receptor positive breast cancer
567057|NCT00767494|OAG|oag
567058|NCT00767494|OH|oh
567059|NCT00767494|Open-angle glaucoma or ocular hypertension|open-angle glaucoma or ocular hypertension
567060|NCT00767481|glaucoma|glaucoma
567061|NCT00767481|Patients with open-angle glaucoma or ocular hypertension|patients with open-angle glaucoma or ocular hypertension
567062|NCT00767468|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
567063|NCT00767468|advanced adult primary liver cancer|advanced adult primary liver cancer
567064|NCT00767468|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
567065|NCT00767468|recurrent adult primary liver cancer|recurrent adult primary liver cancer
567066|NCT00767455|cumulative irritation|cumulative irritation
567067|NCT00767455|healthy adult volunteers|healthy adult volunteers
567068|NCT00767429|accelerometer|accelerometer
567069|NCT00767429|fall risk|fall risk
567070|NCT00767429|target group|target group
567071|NCT00767429|field measurements|field measurements
567072|NCT00767416|MEDI-559|medi-559
567073|NCT00767416|Respiratory Syncytial Virus|respiratory syncytial virus
567074|NCT00767416|RSV|rsv
567075|NCT00767416|Pediatric|pediatric
567076|NCT00767416|Vaccine|vaccine
567077|NCT00767416|respiratory syncytial virus, RSV, pediatric, vaccine|respiratory syncytial virus, rsv, pediatric, vaccine
567078|NCT00767390|ACL Patch Placement|acl patch placement
567079|NCT00767377|Time to Progression|time to progression
567080|NCT00767377|Overall survival|overall survival
567081|NCT00767377|Response rate|response rate
567082|NCT00767377|Quality of Live|quality of live
567083|NCT00767377|Toxicities|toxicities
567084|NCT00767364|Infant|infant
567085|NCT00767338|Infertility|infertility
567086|NCT00767338|Pregnancy|pregnancy
567087|NCT00767338|Men|men
567088|NCT00767338|Palpable varicocele|palpable varicocele
567089|NCT00767338|Abnormal semen analysis|abnormal semen analysis
567090|NCT00767338|Intrauterine insemination|intrauterine insemination
567091|NCT00767338|Microsurgical varicocelectomy|microsurgical varicocelectomy
567092|NCT00767312|HIV|hiv
567093|NCT00767312|Antiretrovial Therapy|antiretrovial therapy
567094|NCT00767312|Viremia|viremia
567095|NCT00767312|Genetic Analysis|genetic analysis
567096|NCT00767312|Single Copy Assay|single copy assay
567097|NCT00767286|stage IIB prostate cancer|stage iib prostate cancer
567098|NCT00767286|stage IIA prostate cancer|stage iia prostate cancer
567099|NCT00767286|stage III prostate cancer|stage iii prostate cancer
567100|NCT00767286|stage IV prostate cancer|stage iv prostate cancer
567101|NCT00767260|type 2 diabetes mellitus|type 2 diabetes mellitus
567102|NCT00767260|bone marrow mononuclear cell|bone marrow mononuclear cell
567103|NCT00767260|hyperbaric oxygen therapy|hyperbaric oxygen therapy
567104|NCT00767247|Arterial Hypertension|arterial hypertension
567105|NCT00767208|type 2 diabetic subjects|type 2 diabetic subjects
567106|NCT00767195|pulmonary edema|pulmonary edema
567107|NCT00767195|cardiogenic|cardiogenic
567108|NCT00767195|non-cardiogenic|non-cardiogenic
567110|NCT00767195|length of stay|length of stay
567111|NCT00767182|preeclampsia|preeclampsia
567112|NCT00767182|eclampsia|eclampsia
567113|NCT00767182|retroplacental hematoma|retroplacental hematoma
567114|NCT00767182|vascular IUGR|vascular iugr
567115|NCT00767182|IUFD|iufd
567116|NCT00767182|placental volume|placental volume
567117|NCT00767169|Edentatio (Toothlessness)|edentatio (toothlessness)
567118|NCT00767156|Sea buckthorn oil, Oral and topical treatment, Skin aging|sea buckthorn oil, oral and topical treatment, skin aging
567119|NCT00767130|single nucleotide polymorphisms, SNP, LDL cholesterol, statin myopathy, atorvastatin, simvastatin, rosuvastatin|single nucleotide polymorphisms, snp, ldl cholesterol, statin myopathy, atorvastatin, simvastatin, rosuvastatin
567120|NCT00767117|TMC125-C197|tmc125-c197
567121|NCT00767117|TMC125-TiDP2-C197|tmc125-tidp2-c197
567122|NCT00767117|HIV|hiv
567123|NCT00767117|DDI|ddi
567124|NCT00767117|Lopinavir|lopinavir
567125|NCT00767117|Intelence|intelence
567126|NCT00767117|Kaletra|kaletra
567127|NCT00767117|Ritonavir|ritonavir
567128|NCT00767117|Etravirine|etravirine
567129|NCT00767117|Interaction|interaction
567130|NCT00767117|Pharmacokinetics|pharmacokinetics
567131|NCT00767117|Steady-state|steady-state
567132|NCT00767091|Parkinson's disease|parkinson's disease
567133|NCT00767091|Apathy|apathy
567134|NCT00767091|Rivastigmine|rivastigmine
567135|NCT00767091|transdermal patch|transdermal patch
567136|NCT00767091|anticholinesterasic|anticholinesterasic
567137|NCT00767091|acetylcholine|acetylcholine
567138|NCT00767052|Healthy Volunteer|healthy volunteer
567139|NCT00767052|Safety|safety
567140|NCT00767052|Tolerability|tolerability
567141|NCT00767052|Pharmacokinetics|pharmacokinetics
567142|NCT00767052|AZD1236|azd1236
567143|NCT00767039|Very Premature|very premature
567144|NCT00767039|RDS|rds
567145|NCT00767039|Surfactant|surfactant
567146|NCT00767026|Epilepsy|epilepsy
567147|NCT00767026|Caregiver Burden|caregiver burden
567148|NCT00767026|Parenting a Child with a Chronic Illness|parenting a child with a chronic illness
567149|NCT00767013|DSCT, coronary artery disease, aortic valve stenosis|dsct, coronary artery disease, aortic valve stenosis
567150|NCT00766987|coronary artery disease|coronary artery disease
567151|NCT00766987|FDG PET viability imaging|fdg pet viability imaging
567152|NCT00766987|morbidity and mortality|morbidity and mortality
567153|NCT00766987|revascularization|revascularization
567154|NCT00766987|resource utilization|resource utilization
567155|NCT00766974|Chronic Venous Disease|chronic venous disease
567156|NCT00766974|C3|c3
567157|NCT00766974|Edema|edema
567158|NCT00766974|Compression Garments|compression garments
567159|NCT00766974|Compression Stockings|compression stockings
567160|NCT00766974|Bioimpedance|bioimpedance
567161|NCT00766961|Peptic ulcer bleeding uncontrolled by endoscopic therapy.|peptic ulcer bleeding uncontrolled by endoscopic therapy.
567162|NCT00766935|Lymphedema|lymphedema
567163|NCT00766935|Bioimpedance|bioimpedance
567164|NCT00766909|Insulin pulsatility|insulin pulsatility
567165|NCT00766909|Insulin secretion|insulin secretion
567166|NCT00766909|Insulin sensitivity|insulin sensitivity
567167|NCT00766909|Calcineurin inhibitor|calcineurin inhibitor
567168|NCT00766909|Cyclosporine|cyclosporine
567169|NCT00766909|Tacrolimus|tacrolimus
567170|NCT00766896|Stroke|stroke
567171|NCT00766896|Cerebral Infarction|cerebral infarction
567172|NCT00766896|Acute Coronary Syndrome|acute coronary syndrome
567173|NCT00766896|Cardiovascular Diseases|cardiovascular diseases
567174|NCT00766896|Vascular Diseases|vascular diseases
567175|NCT00766896|Platelet Activation|platelet activation
567176|NCT00766896|Platelets|platelets
567177|NCT00766896|Platelet Function Tests|platelet function tests
567178|NCT00766896|Aspirin|aspirin
567179|NCT00766896|Atherosclerosis|atherosclerosis
567180|NCT00766896|Ischemia|ischemia
567181|NCT00766896|Thrombosis|thrombosis
567182|NCT00766883|Allogeneic HSCT|allogeneic hsct
567183|NCT00766883|Psychosocial Distress|psychosocial distress
567184|NCT00766883|Coping|coping
567185|NCT00766883|Cognitive Behavior Therapy|cognitive behavior therapy
567186|NCT00766883|Self Efficacy|self efficacy
567187|NCT00766883|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
567188|NCT00766870|Efficacy|efficacy
567189|NCT00766870|Safety|safety
567190|NCT00766870|Depression|depression
567191|NCT00766870|Interventional|interventional
567192|NCT00766870|Placebo|placebo
567193|NCT00766870|Short-term|short-term
567194|NCT00766870|Major Depressive Disorder|major depressive disorder
567195|NCT00766870|Major Depressive Episode|major depressive episode
567196|NCT00766857|Exenatide|exenatide
567197|NCT00766857|Type 2 diabetes mellitus|type 2 diabetes mellitus
567198|NCT00766857|Congestive heart failure|congestive heart failure
567199|NCT00766857|Incretin hormones|incretin hormones
567200|NCT00766857|GLP-1 agonist|glp-1 agonist
567201|NCT00766857|Cardiac metabolism|cardiac metabolism
567202|NCT00766857|Insulin resistance|insulin resistance
567203|NCT00766857|Cardiac MRI|cardiac mri
567204|NCT00766844|vasospasm|vasospasm
567205|NCT00766844|spinal cord stimulation|spinal cord stimulation
567206|NCT00766844|aneurysm|aneurysm
567207|NCT00766844|subarachnoid hemorrhage|subarachnoid hemorrhage
567208|NCT00766831|Cancer pain|cancer pain
567209|NCT00766831|Hydromorphone OROS|hydromorphone oros
567210|NCT00766831|Jurnista|jurnista
567211|NCT00766779|hematopoietic cell transplantation|hematopoietic cell transplantation
567212|NCT00766779|Acute Myeloid Leukemia|acute myeloid leukemia
567213|NCT00766779|first Complete Remission|first complete remission
567214|NCT00766766|Environmental Tobacco Exposure|environmental tobacco exposure
567215|NCT00766753|HLA-A2 positive|hla-a2 positive
567216|NCT00766753|Malignant Gliomas|malignant gliomas
567217|NCT00766753|Vaccine|vaccine
567218|NCT00766740|ST elevation myocardial infarction|st elevation myocardial infarction
567219|NCT00766740|thrombectomy|thrombectomy
567220|NCT00766740|primary PCI|primary pci
567221|NCT00766675|Pain|pain
567222|NCT00766675|Fibromyalgia|fibromyalgia
567223|NCT00766675|Ultracet|ultracet
567224|NCT00766675|Tramadol Hydrochloride|tramadol hydrochloride
567225|NCT00766675|Acetaminophen|acetaminophen
567226|NCT00766662|Malaria|malaria
567227|NCT00766662|Intermittent Preventive Treatment|intermittent preventive treatment
567228|NCT00766662|EPI vaccine coverage|epi vaccine coverage
567229|NCT00766662|Resistance of P. falciparum to Sulfadoxine- Pyrimethamine|resistance of p. falciparum to sulfadoxine- pyrimethamine
567230|NCT00766649|Age Related Macular Degeneration (AMD)|age related macular degeneration (amd)
567231|NCT00766649|Geographic Atrophy|geographic atrophy
567232|NCT00766649|Sirolimus|sirolimus
567233|NCT00766649|Age-Related Macular Degeneration|age-related macular degeneration
567234|NCT00766649|AMD|amd
567235|NCT00766636|Adenocarcinoma of the pancreatic head|adenocarcinoma of the pancreatic head
567236|NCT00766636|Pancreaticoduodenectomy|pancreaticoduodenectomy
567237|NCT00766636|Preoperative chemotherapy|preoperative chemotherapy
567238|NCT00766636|Chemoradiation|chemoradiation
567239|NCT00766636|Resectable pancreatic cancer|resectable pancreatic cancer
567240|NCT00766636|Surgical removal of the pancreas and duodenum|surgical removal of the pancreas and duodenum
567241|NCT00766636|External-beam radiation therapy|external-beam radiation therapy
567242|NCT00766636|EBRT|ebrt
567243|NCT00766636|Gemcitabine|gemcitabine
567244|NCT00766636|Erlotinib|erlotinib
567245|NCT00766623|endothelium,|endothelium,
567246|NCT00766623|postprandial|postprandial
567247|NCT00766623|microvascular|microvascular
567248|NCT00766623|macrovascular|macrovascular
567249|NCT00766597|Treatment Experienced|treatment experienced
567250|NCT00766584|Aging|aging
567251|NCT00766584|Autonomic nervous system|autonomic nervous system
567252|NCT00766584|stroke|stroke
567253|NCT00766584|Myocardiac infarction|myocardiac infarction
567254|NCT00766584|Prospective cohort|prospective cohort
567255|NCT00766584|Sleep apnea/hypopnea|sleep apnea/hypopnea
567256|NCT00766571|VACTERL Association|vacterl association
567257|NCT00766571|VATER Association|vater association
567258|NCT00766571|Multiple Congenital Anomalies|multiple congenital anomalies
567259|NCT00766571|VACTERL|vacterl
567260|NCT00766571|Congenital Defects|congenital defects
567261|NCT00766571|Birth Defects|birth defects
567262|NCT00766571|Congenital Abnormalities|congenital abnormalities
567263|NCT00766558|anorexia|anorexia
567264|NCT00766558|bulimia|bulimia
567265|NCT00766558|eating disorder not otherwise specified|eating disorder not otherwise specified
567266|NCT00766519|fluid responsiveness|fluid responsiveness
567267|NCT00766519|monitoring|monitoring
567268|NCT00766519|arterial pulse pressure|arterial pulse pressure
567269|NCT00766506|IONSYS|ionsys
567270|NCT00766506|Fentanyl|fentanyl
567271|NCT00766506|Morphine|morphine
567272|NCT00766506|PCA|pca
567273|NCT00766506|Postoperative pain|postoperative pain
567274|NCT00766506|Mobilization|mobilization
567275|NCT00766493|carotid artery stenosis|carotid artery stenosis
567276|NCT00766493|embolic protection device|embolic protection device
567277|NCT00766493|distal embolic filter|distal embolic filter
567278|NCT00766493|minimizing risks of carotid artery stenting|minimizing risks of carotid artery stenting
567279|NCT00766480|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
567280|NCT00766480|stage IIA esophageal cancer|stage iia esophageal cancer
567281|NCT00766480|stage IIB esophageal cancer|stage iib esophageal cancer
567282|NCT00766480|stage IIIA esophageal cancer|stage iiia esophageal cancer
567283|NCT00766480|stage IIIB esophageal cancer|stage iiib esophageal cancer
567284|NCT00766480|stage IIIC esophageal cancer|stage iiic esophageal cancer
567285|NCT00766467|armodafinil|armodafinil
567286|NCT00766467|Nuvigil|nuvigil
567287|NCT00766467|fatigue|fatigue
567288|NCT00766454|breast cancer|breast cancer
567289|NCT00766441|diabetes|diabetes
567290|NCT00766441|hypoglycemia|hypoglycemia
567291|NCT00766441|ramadan|ramadan
567292|NCT00766441|fasting|fasting
567293|NCT00766415|COPD|copd
567294|NCT00766415|Moderate to severe COPD|moderate to severe copd
567295|NCT00766402|Spondylitis, ankylosing|spondylitis, ankylosing
567296|NCT00766402|Pain|pain
567297|NCT00766402|Ultracet|ultracet
567298|NCT00766402|Diclofenac|diclofenac
567299|NCT00766402|Voltaren|voltaren
567300|NCT00766402|Tramadol/acetaminophen|tramadol/acetaminophen
567301|NCT00766389|Glaucoma|glaucoma
567302|NCT00766389|Retinal nerve fiber layer|retinal nerve fiber layer
567303|NCT00766389|Cirrus OCT|cirrus oct
567304|NCT00766389|Stratus OCT|stratus oct
567305|NCT00766363|Alzheimer's Disease|alzheimer's disease
567306|NCT00766363|Central Nervous System Diseases|central nervous system diseases
567307|NCT00766363|Pharmacokinetics|pharmacokinetics
567308|NCT00766363|Cognition|cognition
567309|NCT00766350|fibromyalgia|fibromyalgia
567310|NCT00766350|quetiapine|quetiapine
567311|NCT00766350|amitriptyline|amitriptyline
567312|NCT00766337|wet AMD|wet amd
567313|NCT00766298|Exercise|exercise
567314|NCT00766298|Weight Loss|weight loss
567315|NCT00766298|Physical Activity|physical activity
567316|NCT00766298|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
567317|NCT00766285|Baculovirus, influenza, stem cell transplant|baculovirus, influenza, stem cell transplant
567318|NCT00766272|Rehabilitation|rehabilitation
567319|NCT00766272|Treadmill|treadmill
567320|NCT00766272|MS|ms
567321|NCT00766272|Gait|gait
567322|NCT00766272|Robot|robot
567323|NCT00766259|methicillin-resistant Staphylococcus|methicillin-resistant staphylococcus
567324|NCT00766259|colonization|colonization
567325|NCT00766246|Non-Small Cell Lung Cancer|non-small cell lung cancer
567326|NCT00766246|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
567327|NCT00766246|Lung Cancer|lung cancer
567328|NCT00766233|Hyperthermia|hyperthermia
567329|NCT00766233|superficial tumor treatment|superficial tumor treatment
567330|NCT00766233|superficial tumors|superficial tumors
567331|NCT00766220|Colon|colon
567332|NCT00766220|Liver|liver
567333|NCT00766220|Colorectal cancer|colorectal cancer
567334|NCT00766220|Colorectal cancer metastases to the liver|colorectal cancer metastases to the liver
567335|NCT00766220|Metastases to the liver|metastases to the liver
567336|NCT00766220|Colorectal cancer mets to liver|colorectal cancer mets to liver
567337|NCT00766220|Colon cancer metastasized to liver|colon cancer metastasized to liver
567338|NCT00766220|Yttrium microspheres|yttrium microspheres
567339|NCT00766220|SIR-Spheres|sir-spheres
567340|NCT00766220|Yttrium-90|yttrium-90
567341|NCT00766220|Cetuximab|cetuximab
567342|NCT00766220|C225|c225
567343|NCT00766220|Erbitux|erbitux
567344|NCT00766220|IMC-C225|imc-c225
567345|NCT00766220|Irinotecan|irinotecan
567346|NCT00766220|CPT-11|cpt-11
567347|NCT00766220|Liver directed therapy|liver directed therapy
567348|NCT00766207|Teratogens|teratogens
567349|NCT00766207|Abnormalities, Drug-Induced|abnormalities, drug-induced
567350|NCT00766207|Contraception|contraception
567351|NCT00766181|IV placement; Parent satisfaction level|iv placement; parent satisfaction level
567352|NCT00766168|contact lens|contact lens
567353|NCT00766168|rigid gas permeable|rigid gas permeable
567354|NCT00766168|refractive index|refractive index
567355|NCT00766155|stage II rectal cancer|stage ii rectal cancer
567356|NCT00766155|stage III rectal cancer|stage iii rectal cancer
567357|NCT00766155|adenocarcinoma of the rectum|adenocarcinoma of the rectum
567358|NCT00766142|adenocarcinoma of the colon|adenocarcinoma of the colon
567359|NCT00766142|recurrent colon cancer|recurrent colon cancer
567360|NCT00766142|stage IV colon cancer|stage iv colon cancer
567361|NCT00766142|adenocarcinoma of the rectum|adenocarcinoma of the rectum
567362|NCT00766142|recurrent rectal cancer|recurrent rectal cancer
567363|NCT00766142|stage IV rectal cancer|stage iv rectal cancer
567364|NCT00766142|peritoneal carcinomatosis|peritoneal carcinomatosis
567365|NCT00766129|saphenous vein graft, TAXUS stent, Chopin stent|saphenous vein graft, taxus stent, chopin stent
567366|NCT00766116|AML|aml
567367|NCT00766103|Cerebral metabolism, perfusion, induced hypothermia|cerebral metabolism, perfusion, induced hypothermia
567368|NCT00766064|posttraumatic stress disorder|posttraumatic stress disorder
567369|NCT00766051|Neurophysiologically Based Occupational Therapy Intervention (NBOTI)|neurophysiologically based occupational therapy intervention (nboti)
567370|NCT00766051|NBOTI|nboti
567371|NCT00766051|NICU|nicu
567372|NCT00766051|NCCU|nccu
567373|NCT00766051|Developmental Biology|developmental biology
567374|NCT00766051|Critical Period|critical period
567375|NCT00766051|Brain Development|brain development
567376|NCT00766051|Sensory Integration|sensory integration
567377|NCT00766051|Neurodevelopment|neurodevelopment
567378|NCT00766051|Sensitive Period|sensitive period
567379|NCT00766038|Mood disorders|mood disorders
567380|NCT00766038|Cognitive disorders|cognitive disorders
567381|NCT00766038|Fatigue|fatigue
567382|NCT00766038|Metabolic disorders|metabolic disorders
567383|NCT00766025|Taiwanese Subjects|taiwanese subjects
567384|NCT00766025|CYP2C19|cyp2c19
567385|NCT00766025|Poor Metabolizers|poor metabolizers
567386|NCT00766025|Extensive Metabolizers|extensive metabolizers
567387|NCT00766025|Taiwanese Subjects identified as CYP2C19 Poor or Extensive Metabolizers|taiwanese subjects identified as cyp2c19 poor or extensive metabolizers
567388|NCT00766012|safety|safety
567389|NCT00766012|tolerability|tolerability
567390|NCT00766012|pharmacokinetics|pharmacokinetics
567391|NCT00766012|AZD2066|azd2066
567392|NCT00766012|Japanese|japanese
567393|NCT00765999|Constipation|constipation
567394|NCT00765999|Chronic Constipation|chronic constipation
567395|NCT00765999|Irritable Bowel Syndrome With Constipation|irritable bowel syndrome with constipation
567396|NCT00765999|Linaclotide|linaclotide
567397|NCT00765986|18F-FAZA|18f-faza
567398|NCT00765986|18F-FDG|18f-fdg
567399|NCT00765986|Positron Emission Tomography|positron emission tomography
567400|NCT00765973|Other Advanced Solid Tumors|other advanced solid tumors
567401|NCT00765960|Vision|vision
567402|NCT00765947|Essential Hypertension ( mild to moderate)|essential hypertension ( mild to moderate)
567403|NCT00765934|Healthy|healthy
567404|NCT00765921|glaucoma, neovascular|glaucoma, neovascular
567405|NCT00765921|macular edema|macular edema
567406|NCT00765921|eye enucleation|eye enucleation
567407|NCT00765921|antibodies, monoclonal|antibodies, monoclonal
567408|NCT00765921|radiation oncology|radiation oncology
567409|NCT00765895|idiopathic gastroparesis|idiopathic gastroparesis
567410|NCT00765882|Constipation|constipation
567411|NCT00765882|Chronic Constipation|chronic constipation
567412|NCT00765882|Linaclotide|linaclotide
567413|NCT00765869|Decision support techniques|decision support techniques
567414|NCT00765856|Opioid tolerant|opioid tolerant
567415|NCT00765856|Pediatric|pediatric
567416|NCT00765856|Male 6-17 years of age|male 6-17 years of age
567417|NCT00765856|Female 6-17 years of age|female 6-17 years of age
567418|NCT00765856|Pain|pain
567419|NCT00765856|Non malignant|non malignant
567420|NCT00765856|Malignant|malignant
567421|NCT00765843|heel pain|heel pain
567422|NCT00765830|Type 2 diabetes, vildagliptin|type 2 diabetes, vildagliptin
567423|NCT00765817|diabetes|diabetes
567424|NCT00765817|exenatide|exenatide
567425|NCT00765817|Amylin|amylin
567426|NCT00765817|Lilly|lilly
567427|NCT00765817|metformin|metformin
567428|NCT00765817|pioglitazone|pioglitazone
567429|NCT00765817|insulin glargine|insulin glargine
567430|NCT00765804|Dry Eye|dry eye
567431|NCT00765804|Iontophoresis|iontophoresis
567432|NCT00765804|Ophthalmic Delivery|ophthalmic delivery
567433|NCT00765791|head and neck cancer|head and neck cancer
567434|NCT00765791|oral cancer|oral cancer
567435|NCT00765791|oropharyngeal cancer|oropharyngeal cancer
567436|NCT00765791|laryngeal cancer|laryngeal cancer
567437|NCT00765791|selective neck dissection|selective neck dissection
567438|NCT00765791|submuscular recess|submuscular recess
567439|NCT00765791|level 2b|level 2b
567440|NCT00765778|resistant bacteria rehabilitation centers|resistant bacteria rehabilitation centers
567441|NCT00765765|stage IV breast cancer|stage iv breast cancer
567442|NCT00765765|recurrent breast cancer|recurrent breast cancer
567443|NCT00765765|male breast cancer|male breast cancer
567444|NCT00765752|Insomnia|insomnia
567445|NCT00765752|depression|depression
567446|NCT00765752|GABA|gaba
567447|NCT00765752|magnetic resonance spectroscopy|magnetic resonance spectroscopy
567448|NCT00765752|MRS|mrs
567449|NCT00765752|Sleep|sleep
567450|NCT00765752|antidepressant medication use|antidepressant medication use
567451|NCT00765739|muscle fibers|muscle fibers
567452|NCT00765739|aging|aging
567453|NCT00765726|hemophilia|hemophilia
567454|NCT00765726|hemophilia A|hemophilia a
567455|NCT00765726|ReFacto|refacto
567456|NCT00765726|Xyntha|xyntha
567457|NCT00765726|moroctocog alfa|moroctocog alfa
567458|NCT00765726|bleeding disorder|bleeding disorder
567459|NCT00765713|Sleep apnea|sleep apnea
567460|NCT00765713|CPAP|cpap
567461|NCT00765713|Ventricular arrhythmias|ventricular arrhythmias
567462|NCT00765713|Defibrillator therapies|defibrillator therapies
567463|NCT00765700|Sprain|sprain
567464|NCT00765700|Strain|strain
567465|NCT00765700|Pain|pain
567466|NCT00765700|Ankle Pain|ankle pain
567467|NCT00765700|Shoulder Pain|shoulder pain
567468|NCT00765700|Elbow Pain|elbow pain
567469|NCT00765700|Tennis Elbow|tennis elbow
567470|NCT00765700|Knee pain|knee pain
567471|NCT00765700|Wrist Pain|wrist pain
567472|NCT00765700|Hand Pain|hand pain
567473|NCT00765700|Muscle, Bone and Cartilage Disorders|muscle, bone and cartilage disorders
567474|NCT00765674|aliskiren|aliskiren
567475|NCT00765674|antihypertensive|antihypertensive
567476|NCT00765674|hypertension|hypertension
567477|NCT00765674|renin inhibitor|renin inhibitor
567478|NCT00765674|moderate-severe hypertension|moderate-severe hypertension
567479|NCT00765661|Kidney|kidney
567480|NCT00765661|Transplantation|transplantation
567481|NCT00765661|Immunosuppression|immunosuppression
567482|NCT00765661|Tacrolimus|tacrolimus
567483|NCT00765661|Prograf|prograf
567484|NCT00765648|hypertension|hypertension
567485|NCT00765648|emergency department|emergency department
567486|NCT00765648|Nicardipine|nicardipine
567487|NCT00765648|Labetalol|labetalol
567488|NCT00765648|hypertensive emergency|hypertensive emergency
567489|NCT00765648|hypertensive urgency|hypertensive urgency
567490|NCT00765635|complete occlusion of the ear canal due to cerumen|complete occlusion of the ear canal due to cerumen
567491|NCT00765622|Urinary incontinence|urinary incontinence
567492|NCT00765622|pelvic floor|pelvic floor
567493|NCT00765622|functional evaluation|functional evaluation
567494|NCT00765609|Paediatric|paediatric
567495|NCT00765609|Analgesic|analgesic
567496|NCT00765609|Prescribing|prescribing
567497|NCT00765609|Parents|parents
567498|NCT00765596|Obesity|obesity
567499|NCT00765596|Insulin resistance|insulin resistance
567500|NCT00765596|Gastric tube|gastric tube
567501|NCT00765596|Ghrelin|ghrelin
567502|NCT00765583|Wrinkles (Nasolabial Folds)|wrinkles (nasolabial folds)
567503|NCT00765570|large tumors in the head & neck, lung, abdomen or pelvis|large tumors in the head & neck, lung, abdomen or pelvis
567504|NCT00765557|To determine if laxative therapy can resolve Urge Syndrome, and if so, in which patients.|to determine if laxative therapy can resolve urge syndrome, and if so, in which patients.
567505|NCT00765557|To determine usefulness of KUB, an abdominal X-ray of the kidneys, ureters, and bladder.|to determine usefulness of kub, an abdominal x-ray of the kidneys, ureters, and bladder.
567506|NCT00765557|To predict the bowel activity of children with Urge Syndrome, who are most likely to respond to laxatives, with the use of the Bowel/Bladder questionnaire.|to predict the bowel activity of children with urge syndrome, who are most likely to respond to laxatives, with the use of the bowel/bladder questionnaire.
567507|NCT00765544|MS|ms
567508|NCT00765544|Rehabilitation|rehabilitation
567509|NCT00765544|Treadmill|treadmill
567510|NCT00765544|Robot|robot
567511|NCT00765544|Foot-drop|foot-drop
567512|NCT00765531|To determine the prevalence of genetic mutations in a population.|to determine the prevalence of genetic mutations in a population.
567513|NCT00765531|To identify stone formers with significant family history of stones.|to identify stone formers with significant family history of stones.
567514|NCT00765531|To follow a cohort of pediatric stone formers an their families to report the long-term recurrence rats and therapeutic outcomes.|to follow a cohort of pediatric stone formers an their families to report the long-term recurrence rats and therapeutic outcomes.
567515|NCT00765518|Ischemic Dilated Cardiomyopathy|ischemic dilated cardiomyopathy
567516|NCT00765518|Non-Ischemic Dilated Cardiomyopathy|non-ischemic dilated cardiomyopathy
567517|NCT00765518|ixmyelocel-T|ixmyelocel-t
567518|NCT00765505|Insulin Resistance|insulin resistance
567519|NCT00765505|Obesity|obesity
567520|NCT00765505|Exercise Training|exercise training
567521|NCT00765505|Physical Activity|physical activity
567522|NCT00765492|Phase I|phase i
567523|NCT00765479|stage IIB prostate cancer|stage iib prostate cancer
567524|NCT00765479|stage IIA prostate cancer|stage iia prostate cancer
567525|NCT00765466|Explore the effect of AVR118 4.0 mL, given subcutaneously on appetite|explore the effect of avr118 4.0 ml, given subcutaneously on appetite
567526|NCT00765453|Heart attack|heart attack
567527|NCT00765453|Anterior Myocardial infarction (MI)|anterior myocardial infarction (mi)
567528|NCT00765453|adult stem cells|adult stem cells
567529|NCT00765453|bone marrow progenitor cells|bone marrow progenitor cells
567530|NCT00765453|bone marrow stem cells|bone marrow stem cells
567531|NCT00765453|autologous|autologous
567532|NCT00765453|left ventricular function|left ventricular function
567533|NCT00765453|intracoronary injection|intracoronary injection
567534|NCT00765440|infection|infection
567535|NCT00765440|malnutrition|malnutrition
567536|NCT00765440|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
567537|NCT00765440|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
567538|NCT00765440|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
567539|NCT00765440|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
567540|NCT00765440|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
567541|NCT00765440|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
567542|NCT00765440|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
567543|NCT00765440|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
567544|NCT00765440|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
567545|NCT00765440|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
567546|NCT00765440|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
567547|NCT00765440|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
567548|NCT00765440|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
567549|NCT00765440|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
567550|NCT00765440|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
567551|NCT00765440|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
567552|NCT00765440|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
567553|NCT00765440|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
567554|NCT00765440|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
567555|NCT00765440|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
567556|NCT00765440|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
567557|NCT00765440|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
567558|NCT00765440|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
567559|NCT00765440|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
567560|NCT00765440|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
567561|NCT00765440|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
567562|NCT00765440|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
567563|NCT00765440|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
567564|NCT00765440|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
567565|NCT00765440|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
567566|NCT00765440|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
567567|NCT00765440|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
567568|NCT00765440|tongue cancer|tongue cancer
567569|NCT00765401|Abdominal Pain|abdominal pain
567570|NCT00765401|Cystic Fibrosis|cystic fibrosis
567571|NCT00765401|H. pylori|h. pylori
567572|NCT00765401|Children|children
567573|NCT00765388|urostomy, 1-piece, cross-over, randomised, preference|urostomy, 1-piece, cross-over, randomised, preference
567575|NCT00765375|Botox|botox
567576|NCT00765375|cosmetic treatments|cosmetic treatments
567577|NCT00765336|Spermatogenesis in Healthy Males|spermatogenesis in healthy males
567578|NCT00765323|Octreotide|octreotide
567579|NCT00765323|Sandostatin LAR|sandostatin lar
567580|NCT00765323|Growth hormone|growth hormone
567581|NCT00765323|IGF-1|igf-1
567582|NCT00765310|atherosclerosis|atherosclerosis
567583|NCT00765310|lipoic acid|lipoic acid
567584|NCT00765310|thioctic acid|thioctic acid
567585|NCT00765310|triglycerides|triglycerides
567586|NCT00765310|overweight|overweight
567587|NCT00765310|obesity|obesity
567588|NCT00765310|oxidative stress|oxidative stress
567589|NCT00765310|inflammation|inflammation
567590|NCT00765297|fall risk|fall risk
567591|NCT00765297|movement characteristics|movement characteristics
567592|NCT00765297|stumble detection|stumble detection
567593|NCT00765297|accelerometry|accelerometry
567594|NCT00765284|HDL|hdl
567595|NCT00765284|RCT|rct
567596|NCT00765284|Cholesterol|cholesterol
567597|NCT00765245|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
567598|NCT00765245|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
567599|NCT00765245|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
567600|NCT00765245|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
567601|NCT00765245|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
567602|NCT00765232|laparoscopic|laparoscopic
567603|NCT00765232|donor|donor
567604|NCT00765232|nephrectomy|nephrectomy
567605|NCT00765219|Generalized Anxiety Disorder|generalized anxiety disorder
567606|NCT00765219|Geriatric|geriatric
567607|NCT00765180|colonoscopy|colonoscopy
567608|NCT00765180|hood|hood
567609|NCT00765180|NBI|nbi
567610|NCT00765141|wound debridement|wound debridement
567611|NCT00765141|removed orthopedic implants|removed orthopedic implants
567612|NCT00765141|removed catheters or shunts|removed catheters or shunts
567613|NCT00765141|excised tonsils|excised tonsils
567614|NCT00765141|amputated tissue|amputated tissue
567615|NCT00765141|sputum, stool|sputum, stool
567616|NCT00765141|or other excretions.|or other excretions.
567617|NCT00765128|Percutaneous|percutaneous
567618|NCT00765128|Nephrolithotomy|nephrolithotomy
567619|NCT00765128|Kidney stones|kidney stones
567620|NCT00765102|Multiple Myelonoma|multiple myelonoma
567621|NCT00765102|Romidepsin|romidepsin
567622|NCT00765102|Bortezomib|bortezomib
567623|NCT00765076|Vaccine|vaccine
567624|NCT00765076|Elderly|elderly
567625|NCT00765076|Influenza|influenza
567626|NCT00765063|Diabetic Foot Ulcers Neuroischaemic|diabetic foot ulcers neuroischaemic
567627|NCT00765050|Cellular therapy|cellular therapy
567628|NCT00765050|CD133+|cd133+
567629|NCT00765024|strongyloidiasis, ivermectin, albendazole|strongyloidiasis, ivermectin, albendazole
567630|NCT00765011|Head and Neck Cancer|head and neck cancer
567631|NCT00764998|Influenza|influenza
567632|NCT00764998|HIV|hiv
567633|NCT00764998|Influenza Vaccine|influenza vaccine
567634|NCT00764998|Efficacy|efficacy
567635|NCT00764985|Syncope|syncope
567636|NCT00764985|Pre-Syncope|pre-syncope
567637|NCT00764985|Fainting|fainting
567638|NCT00764972|To evaluate the use of sorafenib added to vinorelbine chemotherapy, to find out which are the doses of two drugs can be safely combined|to evaluate the use of sorafenib added to vinorelbine chemotherapy, to find out which are the doses of two drugs can be safely combined
567639|NCT00764933|information programme|information programme
567640|NCT00764933|anxiety reduction|anxiety reduction
567641|NCT00764933|multicenter trial|multicenter trial
567642|NCT00764933|intensive care|intensive care
567643|NCT00764933|critical care|critical care
567644|NCT00764920|human skin|human skin
567645|NCT00764907|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
567646|NCT00764907|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
567647|NCT00764907|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
567648|NCT00764881|Oral contraceptive|oral contraceptive
567649|NCT00764881|Sexual dysfunction|sexual dysfunction
567650|NCT00764881|Libido|libido
567651|NCT00764829|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
567652|NCT00764829|fludarabine|fludarabine
567653|NCT00764829|mycophenolate mofetil|mycophenolate mofetil
567654|NCT00764829|mycophenolic acid|mycophenolic acid
567655|NCT00764829|biomarkers|biomarkers
567656|NCT00764816|Chronic kidney disease, stages 3 and 4|chronic kidney disease, stages 3 and 4
567657|NCT00764816|phosphaturia|phosphaturia
567658|NCT00764816|phosphorus|phosphorus
567659|NCT00764816|PTH|pth
567660|NCT00764816|FGF23|fgf23
567661|NCT00764816|Dietary protein source|dietary protein source
567662|NCT00764777|Peripheral Vascular Disease|peripheral vascular disease
567663|NCT00764777|Intermittent Claudication|intermittent claudication
567664|NCT00764777|Critical limb Ischemia|critical limb ischemia
567665|NCT00764777|TASC A|tasc a
567666|NCT00764777|TASC B|tasc b
567667|NCT00764777|TASC C|tasc c
567668|NCT00764777|TASC D|tasc d
567669|NCT00764777|balloon-expandable stent|balloon-expandable stent
567670|NCT00764777|Self-expanding stent|self-expanding stent
567671|NCT00764777|TASC|tasc
567672|NCT00764764|shoulder pain|shoulder pain
567673|NCT00764764|rotator cuff|rotator cuff
567674|NCT00764764|impingement|impingement
567675|NCT00764764|cervical referred pain|cervical referred pain
567676|NCT00764764|neural tension|neural tension
567677|NCT00764738|ARMD|armd
567678|NCT00764738|AMD|amd
567679|NCT00764738|exudative AMD|exudative amd
567680|NCT00764712|Tight glycemia control|tight glycemia control
567681|NCT00764712|cardiac surgery patients|cardiac surgery patients
567682|NCT00764699|poor growth|poor growth
567683|NCT00764699|inflammatory bowel disease|inflammatory bowel disease
567684|NCT00764686|Exercise|exercise
567685|NCT00764686|Education|education
567686|NCT00764686|Hydrotherapy|hydrotherapy
567687|NCT00764686|Physical Therapy Modalities|physical therapy modalities
567688|NCT00764647|family caregivers|family caregivers
567689|NCT00764647|caregiver education|caregiver education
567690|NCT00764647|caregiver burden|caregiver burden
567691|NCT00764647|caregiver hardiness|caregiver hardiness
567692|NCT00764647|caregiver depressive symptoms|caregiver depressive symptoms
567693|NCT00764621|Gadolinium ethoxybenzyl DTPA|gadolinium ethoxybenzyl dtpa
567694|NCT00764621|Contrast media|contrast media
567695|NCT00764621|Outcome Assessment (Health Care)|outcome assessment (health care)
567696|NCT00764621|Magnetic Resonance Imaging|magnetic resonance imaging
567697|NCT00764621|Tomography, X-Ray Computed|tomography, x-ray computed
567698|NCT00764621|Liver|liver
567699|NCT00764595|gastrointestinal stromal tumor|gastrointestinal stromal tumor
567700|NCT00764595|liver metastases|liver metastases
567701|NCT00764582|Corneal penetration of levofloxacin and moxifloxacin|corneal penetration of levofloxacin and moxifloxacin
567702|NCT00764569|oral tissue|oral tissue
567703|NCT00764556|Glucose|glucose
567704|NCT00764556|Insulin|insulin
567705|NCT00764556|COPD|copd
567706|NCT00764556|Exacerbations|exacerbations
567707|NCT00764556|Tight glycaemic control|tight glycaemic control
567708|NCT00764556|Acute hospital ward|acute hospital ward
567709|NCT00764543|To measure 24-hour ambulatory blood pressure in children who have unilateral hydronephrosis or multicystic-dysplastic kidneys|to measure 24-hour ambulatory blood pressure in children who have unilateral hydronephrosis or multicystic-dysplastic kidneys
567710|NCT00764543|To compare these blood pressure measurements between the children who require surgical correction and those who do not need surgical correction.|to compare these blood pressure measurements between the children who require surgical correction and those who do not need surgical correction.
567711|NCT00764465|Healthy Subjects|healthy subjects
567712|NCT00764465|Pharmacokinetics study|pharmacokinetics study
567713|NCT00764465|Pharmacokinetics of medications|pharmacokinetics of medications
567714|NCT00764426|alcoholic beverages|alcoholic beverages
567715|NCT00764426|non-alcoholic beverages|non-alcoholic beverages
567716|NCT00764426|inflammation|inflammation
567717|NCT00764426|Serum concentration of inflammatory markers before and after intervention|serum concentration of inflammatory markers before and after intervention
567718|NCT00764413|EDSS|edss
567719|NCT00764413|methylprednisolone|methylprednisolone
567720|NCT00764413|circadian rhythms|circadian rhythms
567721|NCT00764413|MSFC|msfc
567722|NCT00764400|aphasia|aphasia
567723|NCT00764400|anomia|anomia
567724|NCT00764400|speech therapy|speech therapy
567725|NCT00764400|rehabilitation|rehabilitation
567726|NCT00764387|Neoplastic CNS lesions|neoplastic cns lesions
567727|NCT00764387|Contrast enhanced MRI|contrast enhanced mri
567728|NCT00764387|Comparison|comparison
567729|NCT00764374|YM443|ym443
567730|NCT00764374|Z-338|z-338
567731|NCT00764374|Acotiamide|acotiamide
567732|NCT00764374|Rome III|rome iii
567733|NCT00764374|Signs and symptoms, digestive|signs and symptoms, digestive
567734|NCT00764361|Diabetic|diabetic
567735|NCT00764361|Ulcer|ulcer
567736|NCT00764361|Wound|wound
567737|NCT00764348|Acute and Chronic Wounds|acute and chronic wounds
567738|NCT00764322|menopausal symptoms|menopausal symptoms
567739|NCT00764322|recurrent breast cancer|recurrent breast cancer
567740|NCT00764322|stage I breast cancer|stage i breast cancer
567741|NCT00764322|stage II breast cancer|stage ii breast cancer
567742|NCT00764322|stage IIIA breast cancer|stage iiia breast cancer
567743|NCT00764322|stage IIIB breast cancer|stage iiib breast cancer
567744|NCT00764322|stage IIIC breast cancer|stage iiic breast cancer
567745|NCT00764322|stage IV breast cancer|stage iv breast cancer
567746|NCT00764322|ductal breast carcinoma in situ|ductal breast carcinoma in situ
567747|NCT00764322|breast cancer in situ|breast cancer in situ
567748|NCT00764296|acute wounds and chronic wounds|acute wounds and chronic wounds
567749|NCT00764270|atherosclerosis|atherosclerosis
567750|NCT00764270|lipoic acid|lipoic acid
567751|NCT00764270|thioctic acid|thioctic acid
567752|NCT00764270|triglycerides|triglycerides
567753|NCT00764270|overweight|overweight
567754|NCT00764270|obesity|obesity
567755|NCT00764270|oxidative stress|oxidative stress
567756|NCT00764270|inflammation|inflammation
567757|NCT00764244|Diabetes|diabetes
567758|NCT00764244|Macular edema|macular edema
567759|NCT00764244|Optical Coherence tomography|optical coherence tomography
567760|NCT00764244|VitrectomyLaser therapy|vitrectomylaser therapy
567761|NCT00764244|Intravitreal triamcinolone injection|intravitreal triamcinolone injection
567762|NCT00764231|acute myeloid leukemia|acute myeloid leukemia
567763|NCT00764231|exercise|exercise
567764|NCT00764231|fatigue|fatigue
567765|NCT00764231|quality of life|quality of life
567766|NCT00764231|home-based|home-based
567767|NCT00764231|AML|aml
567768|NCT00764218|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
567769|NCT00764218|Hypertension|hypertension
567770|NCT00764218|Cardiovascular phenotype|cardiovascular phenotype
567771|NCT00764205|ACS|acs
567772|NCT00764205|non STEMI|non stemi
567773|NCT00764205|ECG troponin|ecg troponin
567774|NCT00764205|iSTAT|istat
567775|NCT00764205|Acute coronary syndrome without ST-segment elevation|acute coronary syndrome without st-segment elevation
567776|NCT00764192|hemodialysis|hemodialysis
567777|NCT00764192|Flow-mediated dilation|flow-mediated dilation
567778|NCT00764192|nictric oxide|nictric oxide
567779|NCT00764192|endothelial function|endothelial function
567780|NCT00764179|Neonates with intra-uterine growth delay|neonates with intra-uterine growth delay
567781|NCT00764166|PSA (biochemical)|psa (biochemical)
567782|NCT00764166|Progression- free Survival|progression- free survival
567783|NCT00764166|Clinical progress|clinical progress
567784|NCT00764166|Overall survival|overall survival
567785|NCT00764166|Tolerance to the treatment|tolerance to the treatment
567786|NCT00764166|Quality of Live|quality of live
567787|NCT00764153|Displaced Femoral Neck Fractures|displaced femoral neck fractures
567788|NCT00764153|Treatment|treatment
567789|NCT00764153|Function|function
567790|NCT00764153|Pain|pain
567791|NCT00764153|Quality of life|quality of life
567792|NCT00764153|Complications|complications
567793|NCT00764153|Reoperations|reoperations
567794|NCT00764153|Internal Fixation|internal fixation
567795|NCT00764153|Hemiarthroplasty|hemiarthroplasty
567796|NCT00764153|Activities of Daily Living|activities of daily living
567797|NCT00764140|tumor growth factor|tumor growth factor
567798|NCT00764127|adolescent|adolescent
567799|NCT00764127|obesity|obesity
567800|NCT00764127|bariatric surgery|bariatric surgery
567801|NCT00764127|eating|eating
567802|NCT00764114|Spondylodiscitis|spondylodiscitis
567803|NCT00764114|Duration treatment|duration treatment
567804|NCT00764114|Antibiotic|antibiotic
567805|NCT00764114|men or women more than 18 years|men or women more than 18 years
567806|NCT00764114|proved bacterial spondylodiscitis|proved bacterial spondylodiscitis
567807|NCT00764114|patient for which is decided a treatment antibiotic|patient for which is decided a treatment antibiotic
567808|NCT00764114|the diagnosis on clinical|the diagnosis on clinical
567809|NCT00764114|Radiological|radiological
567810|NCT00764114|microbiological criteria|microbiological criteria
567811|NCT00764088|full Thickness wounds|full thickness wounds
567812|NCT00764075|heart failure; EF<35%; NYHA II, III or IV|heart failure; ef<35%; nyha ii, iii or iv
567813|NCT00764062|Amoxicillin|amoxicillin
567814|NCT00764062|Drug resistance, microbial|drug resistance, microbial
567815|NCT00764062|Streptococcus|streptococcus
567816|NCT00764062|Surgery, oral|surgery, oral
567817|NCT00764049|Albumin dialysis|albumin dialysis
567818|NCT00764049|Artificial liver support|artificial liver support
567819|NCT00764049|Acute on chronic liver failure|acute on chronic liver failure
567820|NCT00764036|phase I|phase i
567821|NCT00764036|safety|safety
567822|NCT00764023|wound debridement|wound debridement
567823|NCT00764023|removed orthopedic implants|removed orthopedic implants
567824|NCT00764023|removed catheters or shunts|removed catheters or shunts
567825|NCT00764023|excised tonsils, amputated tissue|excised tonsils, amputated tissue
567826|NCT00764023|sputum|sputum
567827|NCT00764023|stool|stool
567828|NCT00764023|other excretions.|other excretions.
567829|NCT00763997|dipyrone|dipyrone
567830|NCT00763997|platelet aggregation|platelet aggregation
567831|NCT00763997|neuraxial blockage|neuraxial blockage
567832|NCT00763997|ibuprofen|ibuprofen
567833|NCT00763997|platelet aggregation under dipyrone compared to ibuprofen, acetaminophen and parecoxib/valdecoxib|platelet aggregation under dipyrone compared to ibuprofen, acetaminophen and parecoxib/valdecoxib
567834|NCT00763997|neuraxial blockage in patients receiving ibuprofen is critical in special circumstances, but traditionally not fpr dipyrone|neuraxial blockage in patients receiving ibuprofen is critical in special circumstances, but traditionally not fpr dipyrone
567835|NCT00763984|Bladder Control for Women|bladder control for women
567836|NCT00763984|Exercising Your Pelvic Muscles|exercising your pelvic muscles
567837|NCT00763984|Kegel Exercises: How to Strengthen Pelvic Floor Muscles|kegel exercises: how to strengthen pelvic floor muscles
567838|NCT00763984|Kegel Exercises for Your Pelvic Muscles|kegel exercises for your pelvic muscles
567839|NCT00763984|Pelvic Floor Disorders|pelvic floor disorders
567840|NCT00763984|Pelvic Support Problems|pelvic support problems
567841|NCT00763984|Pregnancy|pregnancy
567842|NCT00763984|Pregnancy Childbirth and Bladder Control|pregnancy childbirth and bladder control
567843|NCT00763984|Urinary Incontinence|urinary incontinence
567844|NCT00763984|Urinary Incontinence: Embarrassing but Treatable|urinary incontinence: embarrassing but treatable
567845|NCT00763958|opiates|opiates
567846|NCT00763958|HIV|hiv
567847|NCT00763945|Acute coronary Syndrome|acute coronary syndrome
567848|NCT00763945|STEMI|stemi
567849|NCT00763945|NSTEMI|nstemi
567850|NCT00763945|Registry|registry
567851|NCT00763919|Patient Non-Adherence|patient non-adherence
567852|NCT00763919|Patient Non-Compliance|patient non-compliance
567853|NCT00763919|Patient Nonadherence|patient nonadherence
567854|NCT00763919|Patient Noncompliance|patient noncompliance
567855|NCT00763919|Patient Refusal of Treatment|patient refusal of treatment
567856|NCT00763919|Refusal of Treatment|refusal of treatment
567857|NCT00763919|Treatment Refusal|treatment refusal
567858|NCT00763906|septic shock|septic shock
567859|NCT00763906|fuzzy logic|fuzzy logic
567860|NCT00763906|norepinephrine weaning|norepinephrine weaning
567861|NCT00763893|Marfan syndrome|marfan syndrome
567862|NCT00763893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
567863|NCT00763893|Aortic Aneurysm, Thoracic|aortic aneurysm, thoracic
567864|NCT00763880|Hematoma block|hematoma block
567865|NCT00763880|Lidocaine|lidocaine
567866|NCT00763880|Forearm fracture|forearm fracture
567867|NCT00763880|Radius fracture|radius fracture
567868|NCT00763880|Ulna fracture|ulna fracture
567869|NCT00763880|Ketamine|ketamine
567870|NCT00763880|Midazolam|midazolam
567871|NCT00763880|Procedural sedation|procedural sedation
567872|NCT00763867|Heart Failure, Diastolic|heart failure, diastolic
567873|NCT00763867|Decompensated Heart Failure|decompensated heart failure
567874|NCT00763867|Sildenafil|sildenafil
567875|NCT00763867|Exercise Capacity|exercise capacity
567876|NCT00763841|Auditory hallucinations|auditory hallucinations
567877|NCT00763828|Myocardial Infarction|myocardial infarction
567878|NCT00763828|Hypothermia, Induced|hypothermia, induced
567879|NCT00763815|hyperglycemia GLP-1 pioglitazone|hyperglycemia glp-1 pioglitazone
567880|NCT00763789|conscious sedation|conscious sedation
567881|NCT00763789|remifentanil|remifentanil
567882|NCT00763789|hysteroscopic surgery|hysteroscopic surgery
567883|NCT00763789|anesthesia recovery period|anesthesia recovery period
567884|NCT00763789|ambulatory surgery|ambulatory surgery
567885|NCT00763789|patient satisfaction|patient satisfaction
567886|NCT00763789|length of stay|length of stay
567887|NCT00763776|Liver cirrhosis|liver cirrhosis
567888|NCT00763776|Hepatectomy|hepatectomy
567889|NCT00763776|Liver parenchyma transection|liver parenchyma transection
567890|NCT00763776|Randomized controlled trial|randomized controlled trial
567891|NCT00763763|Imatinib mesylate|imatinib mesylate
567892|NCT00763763|Combination therapy|combination therapy
567893|NCT00763763|Leukemia, Lymphocytic, Acute|leukemia, lymphocytic, acute
567894|NCT00763763|Philadelphia Chromosome|philadelphia chromosome
567895|NCT00763763|Blast Crisis|blast crisis
567896|NCT00763763|Leukemia, Myeloid, Chronic|leukemia, myeloid, chronic
567897|NCT00763750|glioblastoma multiforme or anaplastic glioma|glioblastoma multiforme or anaplastic glioma
567898|NCT00763737|congenital diaphragmatic hernia|congenital diaphragmatic hernia
567899|NCT00763737|fetal surgery|fetal surgery
567900|NCT00763737|pulmonary hypoplasia|pulmonary hypoplasia
567901|NCT00763737|observed/expected lung to head ratio|observed/expected lung to head ratio
567902|NCT00763737|liver position|liver position
567903|NCT00763737|feto|feto
567904|NCT00763737|fetoscopic endoluminal tracheal occlusion|fetoscopic endoluminal tracheal occlusion
567905|NCT00763737|standardized neonatal care|standardized neonatal care
567906|NCT00763711|Urinary Incontinence|urinary incontinence
567907|NCT00763711|ISD|isd
567908|NCT00763698|Left heart pacing lead|left heart pacing lead
567909|NCT00763698|Cardiac resynchronization therapy (CRT)|cardiac resynchronization therapy (crt)
567910|NCT00763698|Heart failure|heart failure
567911|NCT00763698|ICD|icd
567912|NCT00763685|preoperative pain prophylaxis|preoperative pain prophylaxis
567913|NCT00763685|postoperative pain|postoperative pain
567914|NCT00763672|Preeclampsia|preeclampsia
567915|NCT00763672|Hypertension|hypertension
567916|NCT00763672|Intra uterine growth retardation|intra uterine growth retardation
567917|NCT00763672|Antiangiogenic factor|antiangiogenic factor
567918|NCT00763672|Prevention|prevention
567919|NCT00763646|Gastric or Gastroesophageal Junction Adenocarcinoma|gastric or gastroesophageal junction adenocarcinoma
567920|NCT00763633|nausea|nausea
567921|NCT00763633|vomiting|vomiting
567922|NCT00763633|pregnancy|pregnancy
567923|NCT00763633|B6|b6
567924|NCT00763620|Community acquired pneumonia|community acquired pneumonia
567925|NCT00763620|Nosocomial pneumonia|nosocomial pneumonia
567926|NCT00763620|Mini bronchoalveolar lavage|mini bronchoalveolar lavage
567927|NCT00763620|Endotracheal aspirates|endotracheal aspirates
567928|NCT00763620|Expectorated sputum|expectorated sputum
567929|NCT00763607|non small cell lung cancer patients|non small cell lung cancer patients
567930|NCT00763594|Major Depression|major depression
567931|NCT00763594|Interpersonal Psychotherapy|interpersonal psychotherapy
567932|NCT00763594|Brief Relational Therapy|brief relational therapy
567933|NCT00763594|Outcome research|outcome research
567934|NCT00763581|Patient Non-Adherence|patient non-adherence
567935|NCT00763581|Patient Non-Compliance|patient non-compliance
567936|NCT00763581|Patient Nonadherence|patient nonadherence
567937|NCT00763581|Patient Noncompliance|patient noncompliance
567938|NCT00763581|Patient Refusal of Treatment|patient refusal of treatment
567939|NCT00763581|Treatment Refusal|treatment refusal
567940|NCT00763581|Refusal of Treatment|refusal of treatment
567941|NCT00763568|Chronic hepatitis C|chronic hepatitis c
567942|NCT00763568|Viral hepatitis|viral hepatitis
567943|NCT00763555|psoriasis|psoriasis
567944|NCT00763555|spray|spray
567945|NCT00763555|calcitriol|calcitriol
567946|NCT00763516|Pancreatic Cancer|pancreatic cancer
567947|NCT00763516|Proton radiation|proton radiation
567948|NCT00763516|Chemotherapy|chemotherapy
567949|NCT00763516|Xeloda|xeloda
567950|NCT00763516|Gemzar|gemzar
567951|NCT00763516|Resectable|resectable
567952|NCT00763516|Surgery|surgery
567953|NCT00763503|psoriasis|psoriasis
567954|NCT00763503|PK|pk
567955|NCT00763503|calcitriol|calcitriol
567956|NCT00763490|umbilical cord blood|umbilical cord blood
567957|NCT00763490|stem cell transplant|stem cell transplant
567958|NCT00763490|leukemia|leukemia
567959|NCT00763490|multiple myeloma|multiple myeloma
567960|NCT00763490|lymphoma|lymphoma
567961|NCT00763477|Cystic fibrosis|cystic fibrosis
567962|NCT00763477|Weight|weight
567963|NCT00763477|Appetite|appetite
567964|NCT00763477|Ghrelin|ghrelin
567965|NCT00763477|Cystic fibrosis with low BMI|cystic fibrosis with low bmi
567966|NCT00763464|Coronary Artery Disease|coronary artery disease
567967|NCT00763464|ischemia diagnostic|ischemia diagnostic
567968|NCT00763451|hyperglycemia, GLP-1|hyperglycemia, glp-1
567969|NCT00763438|Schizophrenia|schizophrenia
567970|NCT00763438|Sertindole|sertindole
567971|NCT00763438|Safety study|safety study
567972|NCT00763425|polypectomy|polypectomy
567973|NCT00763425|colonic polyp|colonic polyp
567974|NCT00763425|colorectal polyp|colorectal polyp
567975|NCT00763425|colorectal cancer prevention|colorectal cancer prevention
567976|NCT00763412|Cystic Fibrosis|cystic fibrosis
567977|NCT00763412|Diabetes|diabetes
567978|NCT00763412|Cystic Fibrosis Related Diabetes|cystic fibrosis related diabetes
567979|NCT00763412|Pre-diabetes|pre-diabetes
567980|NCT00763412|oral hypoglycemic agents|oral hypoglycemic agents
567981|NCT00763412|Repaglinide|repaglinide
567982|NCT00763412|treatment|treatment
567983|NCT00763412|inflammatory markers|inflammatory markers
567984|NCT00763412|Lung function|lung function
567985|NCT00763412|nutrition|nutrition
567986|NCT00763399|probiotics|probiotics
567987|NCT00763386|Total Knee Arthroplasty|total knee arthroplasty
567988|NCT00763386|Osteoarthritis|osteoarthritis
567989|NCT00763386|Knee|knee
567990|NCT00763373|Lower respiratory infection|lower respiratory infection
567991|NCT00763373|Upper respiratory infection|upper respiratory infection
567992|NCT00763373|Urinary tract infection|urinary tract infection
567993|NCT00763373|Soft tissue infection|soft tissue infection
567994|NCT00763373|Hepatobiliary infection|hepatobiliary infection
567995|NCT00763360|Cataract|cataract
567996|NCT00763347|Glucose Metabolism Disorder|glucose metabolism disorder
567997|NCT00763347|Dysmetabolic Syndrome|dysmetabolic syndrome
567998|NCT00763347|Type II Diabetes|type ii diabetes
567999|NCT00763347|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
568000|NCT00763347|Dyslipidemia|dyslipidemia
568001|NCT00763347|Drug Therapy|drug therapy
568002|NCT00763321|Effect on sleep interference by pain|effect on sleep interference by pain
568003|NCT00763308|Weight|weight
568004|NCT00763308|Blood Pressure|blood pressure
568005|NCT00763308|Smoking Status|smoking status
568006|NCT00763308|Cardiovascular Risk Profile|cardiovascular risk profile
568007|NCT00763295|latent tuberculosis|latent tuberculosis
568008|NCT00763295|HIV|hiv
568009|NCT00763295|IFN-γ based assay|ifn-γ based assay
568010|NCT00763282|Spinal cord injuries|spinal cord injuries
568011|NCT00763282|Pressure ulcers|pressure ulcers
568012|NCT00763282|Health behavior|health behavior
568013|NCT00763282|self management|self management
568014|NCT00763282|Rehabilitation|rehabilitation
568015|NCT00763282|Outcome assessment|outcome assessment
568016|NCT00763282|QUERI|queri
568017|NCT00763282|Veterans|veterans
568018|NCT00763243|profound bilateral hearing loss with cochlear implants|profound bilateral hearing loss with cochlear implants
568019|NCT00763230|Depression|depression
568020|NCT00763230|Treatment|treatment
568021|NCT00763230|Transcranial direct current stimulation|transcranial direct current stimulation
568022|NCT00763217|inflammation|inflammation
568023|NCT00763217|coagulation|coagulation
568024|NCT00763217|neuroprotection|neuroprotection
568025|NCT00763217|drugs|drugs
568026|NCT00763217|clinical neurology|clinical neurology
568027|NCT00763217|pharmacology|pharmacology
568028|NCT00763217|biological factors|biological factors
568029|NCT00763204|Plaque Type Psoriasis|plaque type psoriasis
568030|NCT00763204|Topical|topical
568031|NCT00763178|PTSD|ptsd
568032|NCT00763152|prostate|prostate
568033|NCT00763152|prostate bed|prostate bed
568034|NCT00763152|periprostatic|periprostatic
568035|NCT00763139|RA|ra
568036|NCT00763139|Rheumatoid Arthritis|rheumatoid arthritis
568037|NCT00763126|parturient|parturient
568038|NCT00763126|epidural analgesia|epidural analgesia
568039|NCT00763126|labor|labor
568040|NCT00763126|spouse|spouse
568041|NCT00763126|Stress levels|stress levels
568042|NCT00763126|Salivary amylase|salivary amylase
568043|NCT00763100|Breast cancer|breast cancer
568044|NCT00763100|Three dimensional versus two dimensional|three dimensional versus two dimensional
568045|NCT00763100|Breast cancer surveillance|breast cancer surveillance
568046|NCT00763100|Tomosynthesis|tomosynthesis
568047|NCT00763087|diabetes mellitus|diabetes mellitus
568048|NCT00763087|peripheral neuropathy|peripheral neuropathy
568049|NCT00763087|exercise|exercise
568050|NCT00763074|Intra-Abdominal Fat|intra-abdominal fat
568051|NCT00763074|Adipokines|adipokines
568052|NCT00763074|Exercise|exercise
568053|NCT00763074|Diet therapy|diet therapy
568054|NCT00763061|Glaucoma|glaucoma
568055|NCT00763035|Coronary Artery Disease|coronary artery disease
568056|NCT00763035|Coronary Vessels|coronary vessels
568057|NCT00763035|Myocardial Ischemia|myocardial ischemia
568058|NCT00763035|Coronary Disease|coronary disease
568059|NCT00763035|Ischemic heart disease|ischemic heart disease
568060|NCT00763035|asthma|asthma
568061|NCT00763035|copd|copd
568062|NCT00763022|Glucose Metabolism Disorder|glucose metabolism disorder
568063|NCT00763022|Dysmetabolic Syndrome|dysmetabolic syndrome
568064|NCT00763022|Type II Diabetes|type ii diabetes
568065|NCT00763022|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
568066|NCT00763022|Dyslipidemia|dyslipidemia
568067|NCT00763022|Drug Therapy|drug therapy
568068|NCT00762957|Glucose Metabolism Disorder|glucose metabolism disorder
568069|NCT00762957|Dysmetabolic Syndrome|dysmetabolic syndrome
568070|NCT00762957|Type II Diabetes|type ii diabetes
568071|NCT00762957|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
568072|NCT00762957|Dyslipidemia|dyslipidemia
568073|NCT00762957|Drug Therapy|drug therapy
568074|NCT00762944|Patients requiring total joint reconstruction due to:|patients requiring total joint reconstruction due to:
568075|NCT00762944|Arthritis (osteo-, rheumatoid, traumatic) malignancy|arthritis (osteo-, rheumatoid, traumatic) malignancy
568076|NCT00762944|Ankylosis functional deformity|ankylosis functional deformity
568077|NCT00762944|Avascular necrosis revisions|avascular necrosis revisions
568078|NCT00762944|Benign neoplasms fracture|benign neoplasms fracture
568079|NCT00762944|Multiple operated joints|multiple operated joints
568080|NCT00762931|bronchoconstriction|bronchoconstriction
568081|NCT00762931|neuromodulation|neuromodulation
568082|NCT00762931|neurostimulation|neurostimulation
568083|NCT00762931|vagus nerve stimulation|vagus nerve stimulation
568084|NCT00762931|vagal nerve stimulation|vagal nerve stimulation
568085|NCT00762931|nVNS|nvns
568086|NCT00762931|VNS|vns
568087|NCT00762931|non invasive|non invasive
568088|NCT00762931|gammacore|gammacore
568089|NCT00762918|cystic fibrosis|cystic fibrosis
568090|NCT00762918|vitamin d|vitamin d
568091|NCT00762918|inflammation|inflammation
568092|NCT00762905|cyanoacrylate|cyanoacrylate
568093|NCT00762905|LiquiBand Laparoscopic|liquiband laparoscopic
568094|NCT00762905|Dermabond|dermabond
568095|NCT00762905|The rate of complete dermal apposition|the rate of complete dermal apposition
568096|NCT00762905|The rate of wound infections and wound dehiscence|the rate of wound infections and wound dehiscence
568097|NCT00762905|The rate of optimal cosmesis|the rate of optimal cosmesis
568098|NCT00762892|Raltegravir|raltegravir
568099|NCT00762892|Integrase inhibitor|integrase inhibitor
568100|NCT00762892|Protease inhibitor|protease inhibitor
568101|NCT00762892|Naive patients|naive patients
568102|NCT00762892|HIV disease|hiv disease
568103|NCT00762892|Lipids|lipids
568104|NCT00762892|Treatment Naïve|treatment naïve
568105|NCT00762879|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
568106|NCT00762879|JIA|jia
568107|NCT00762879|Arthritis|arthritis
568108|NCT00762879|Osteoporosis|osteoporosis
568109|NCT00762879|Osteoporosis in Children|osteoporosis in children
568110|NCT00762866|Major Depressive Disorder|major depressive disorder
568111|NCT00762866|Depression|depression
568112|NCT00762866|Bipolar I Disorder|bipolar i disorder
568113|NCT00762866|Bipolar II Disorder|bipolar ii disorder
568114|NCT00762866|Bipolar Disorder NOS|bipolar disorder nos
568115|NCT00762866|Psychotic Disorder|psychotic disorder
568116|NCT00762866|Schizophrenia|schizophrenia
568117|NCT00762866|Schizoaffective Disorder|schizoaffective disorder
568118|NCT00762840|Periapical lesions|periapical lesions
568119|NCT00762840|Apical Periodontitis|apical periodontitis
568120|NCT00762840|endodontic procedure|endodontic procedure
568121|NCT00762840|root canal treatment|root canal treatment
568122|NCT00762814|Parkinson disease|parkinson disease
568123|NCT00762814|Individuals|individuals
568124|NCT00762814|frequent|frequent
568125|NCT00762814|freezing|freezing
568126|NCT00762814|during|during
568127|NCT00762814|gait|gait
568128|NCT00762801|RLIP76|rlip76
568129|NCT00762801|Cancer|cancer
568130|NCT00762801|apoptosis|apoptosis
568131|NCT00762775|Bone resorption|bone resorption
568132|NCT00762775|Calcium homeostasis|calcium homeostasis
568133|NCT00762775|Bone markers|bone markers
568134|NCT00762775|Calcium and Vitamin D supplementation|calcium and vitamin d supplementation
568135|NCT00762775|Parathyroid hormone levels|parathyroid hormone levels
568136|NCT00762775|Interaction between calcium and vitamin D supplementation|interaction between calcium and vitamin d supplementation
568137|NCT00762736|Glucose Metabolism Disorder|glucose metabolism disorder
568138|NCT00762736|Dysmetabolic Syndrome|dysmetabolic syndrome
568139|NCT00762736|Type II Diabetes|type ii diabetes
568140|NCT00762736|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
568141|NCT00762736|Dyslipidemia|dyslipidemia
568142|NCT00762736|Drug Therapy|drug therapy
568143|NCT00762723|Degenerative Disc Disease|degenerative disc disease
568144|NCT00762723|Spinal Stenosis|spinal stenosis
568145|NCT00762723|Spondylolisthesis|spondylolisthesis
568146|NCT00762723|ALIF|alif
568147|NCT00762723|fusion success|fusion success
568148|NCT00762723|Anterior Lumbar Plate|anterior lumbar plate
568149|NCT00762723|fixed versus variable screw configurations|fixed versus variable screw configurations
568150|NCT00762723|Anterior Lumbar Interbody Fusion to treat spinal instability|anterior lumbar interbody fusion to treat spinal instability
568151|NCT00762710|Alcohol|alcohol
568152|NCT00762710|Abuse|abuse
568153|NCT00762710|Use|use
568154|NCT00762710|Disorder|disorder
568155|NCT00762710|Dependence|dependence
568156|NCT00762710|Symptoms|symptoms
568157|NCT00762710|Alcoholic|alcoholic
568158|NCT00762710|Alcoholism|alcoholism
568159|NCT00762710|Prazosin|prazosin
568160|NCT00762710|Drug|drug
568161|NCT00762710|Medicine|medicine
568162|NCT00762710|Medication|medication
568163|NCT00762710|Treatment|treatment
568164|NCT00762710|Study|study
568165|NCT00762710|Placebo|placebo
568166|NCT00762710|Medical|medical
568167|NCT00762710|Management|management
568168|NCT00762710|Craving|craving
568169|NCT00762710|Consumption|consumption
568170|NCT00762710|Binge|binge
568171|NCT00762710|Drinking|drinking
568172|NCT00762710|Drink|drink
568173|NCT00762710|Heavy|heavy
568174|NCT00762697|diabetic, venous insufficiency|diabetic, venous insufficiency
568175|NCT00762684|Glucose Metabolism Disorder|glucose metabolism disorder
568176|NCT00762684|Dysmetabolic Syndrome|dysmetabolic syndrome
568177|NCT00762684|Type II Diabetes|type ii diabetes
568178|NCT00762684|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
568179|NCT00762684|Dyslipidemia|dyslipidemia
568180|NCT00762658|Plaque Type Psoriasis|plaque type psoriasis
568181|NCT00762658|Topical|topical
568182|NCT00762645|IOP lowering efficacy|iop lowering efficacy
568183|NCT00762645|CACG|cacg
568184|NCT00762632|patients with c-kit+ AML|patients with c-kit+ aml
568185|NCT00762606|Cataract|cataract
568186|NCT00762593|urinary stress incontinence|urinary stress incontinence
568187|NCT00762593|urinary stress incontinence in women|urinary stress incontinence in women
568188|NCT00762580|rotator cuff|rotator cuff
568189|NCT00762580|rehabilitation|rehabilitation
568190|NCT00762554|analgesia|analgesia
568191|NCT00762554|cesarean section|cesarean section
568192|NCT00762554|fentanyl|fentanyl
568193|NCT00762554|Depodur|depodur
568194|NCT00762554|Post-cesarean section analgesia|post-cesarean section analgesia
568195|NCT00762541|Myopia|myopia
568196|NCT00762541|Laser In Situ Keratomileusis|laser in situ keratomileusis
568197|NCT00762541|Laser Therapy|laser therapy
568198|NCT00762541|Laser Corneal Surgery|laser corneal surgery
568199|NCT00762541|Refractive Surgical Procedures|refractive surgical procedures
568200|NCT00762541|Ophthalmologic Surgical Procedure|ophthalmologic surgical procedure
568201|NCT00762541|Operative Surgical Procedures|operative surgical procedures
568202|NCT00762541|Therapeutics|therapeutics
568203|NCT00762489|Temporal artery thermometry|temporal artery thermometry
568204|NCT00762489|Rectal temperature|rectal temperature
568205|NCT00762489|Axillary temperature|axillary temperature
568206|NCT00762489|Newborns|newborns
568207|NCT00762489|Temperature measurement|temperature measurement
568208|NCT00762476|cold, common|cold, common
568209|NCT00762476|rhinovirus|rhinovirus
568210|NCT00762424|Kidney stone|kidney stone
568211|NCT00762424|Ureterolithiasis|ureterolithiasis
568212|NCT00762424|Tamsulosin|tamsulosin
568213|NCT00762424|Flowmax|flowmax
568214|NCT00762424|Emergency Department|emergency department
568215|NCT00762411|Alzheimer's Disease|alzheimer's disease
568216|NCT00762398|Major surgery, excpected blood loss, arterial line|major surgery, excpected blood loss, arterial line
568217|NCT00762372|anesthesia|anesthesia
568218|NCT00762372|desflurane|desflurane
568219|NCT00762359|Curling Ulcer|curling ulcer
568220|NCT00762359|Gastric Ulcer|gastric ulcer
568221|NCT00762359|Aspirin|aspirin
568222|NCT00762359|Acetylsalicylic Acid|acetylsalicylic acid
568223|NCT00762359|Drug Therapy|drug therapy
568224|NCT00762346|non small cell lung cancer|non small cell lung cancer
568225|NCT00762346|NTX|ntx
568226|NCT00762346|zometa|zometa
568227|NCT00762320|HIV|hiv
568228|NCT00762320|Kaletra|kaletra
568229|NCT00762320|treatment Experienced|treatment experienced
568230|NCT00762294|breast cancer|breast cancer
568231|NCT00762294|arimidex|arimidex
568232|NCT00762294|femara|femara
568233|NCT00762294|bone health|bone health
568234|NCT00762281|Hyperopia|hyperopia
568235|NCT00762281|Laser In Situ Keratomileusis|laser in situ keratomileusis
568236|NCT00762281|Laser Therapy|laser therapy
568237|NCT00762281|Laser Corneal Surgery|laser corneal surgery
568238|NCT00762281|Refractive Surgical Procedures|refractive surgical procedures
568239|NCT00762281|Ophthalmologic Surgical Procedure|ophthalmologic surgical procedure
568240|NCT00762281|Operative Surgical Procedures|operative surgical procedures
568241|NCT00762281|Therapeutics|therapeutics
568242|NCT00762268|SAMe|same
568243|NCT00762268|alternative treatments|alternative treatments
568244|NCT00762268|bipolar disorder|bipolar disorder
568245|NCT00762268|depression|depression
568246|NCT00762268|bipolar depression|bipolar depression
568247|NCT00762268|treatment-resistant depression|treatment-resistant depression
568248|NCT00762255|recurrent glioblastoma|recurrent glioblastoma
568249|NCT00762255|multiple agents|multiple agents
568250|NCT00762255|immunotherapy|immunotherapy
568251|NCT00762255|chemotherapy|chemotherapy
568252|NCT00762255|brain and nervous system|brain and nervous system
568253|NCT00762242|metabolomics|metabolomics
568254|NCT00762242|flow-mediated vasodilation|flow-mediated vasodilation
568255|NCT00762229|Cholesterol|cholesterol
568256|NCT00762229|Ezetimibe|ezetimibe
568257|NCT00762216|Cataract|cataract
568258|NCT00762190|Glucose Metabolism Disorder|glucose metabolism disorder
568259|NCT00762190|Dysmetabolic Syndrome|dysmetabolic syndrome
568260|NCT00762190|Type II Diabetes|type ii diabetes
568261|NCT00762190|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
568262|NCT00762190|Dyslipidemia|dyslipidemia
568263|NCT00762190|Drug Therapy|drug therapy
568264|NCT00762164|Hypercholesterolemia|hypercholesterolemia
568265|NCT00762164|Statins|statins
568266|NCT00762164|Ezetimibe|ezetimibe
568267|NCT00762151|Dental Plaque|dental plaque
568268|NCT00762138|Platelet rich plasma|platelet rich plasma
568269|NCT00762138|wounds|wounds
568270|NCT00762138|leg ulcers|leg ulcers
568271|NCT00762138|pressure ulcers|pressure ulcers
568272|NCT00762138|diabetic ulcers|diabetic ulcers
568273|NCT00762138|management of mechanically or surgically-debrided wounds|management of mechanically or surgically-debrided wounds
568274|NCT00762125|Fibromyalgia Syndrome|fibromyalgia syndrome
568275|NCT00762125|FMS|fms
568276|NCT00762125|Physical Therapy|physical therapy
568277|NCT00762125|Psychotherapy|psychotherapy
568278|NCT00762125|Group Counseling|group counseling
568279|NCT00762125|Individual Counseling|individual counseling
568280|NCT00762125|Chronic Pain|chronic pain
568281|NCT00762112|Glucose Metabolism Disorder|glucose metabolism disorder
568282|NCT00762112|Dysmetabolic Syndrome|dysmetabolic syndrome
568283|NCT00762112|Type II Diabetes|type ii diabetes
568284|NCT00762112|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
568285|NCT00762112|Dyslipidemia|dyslipidemia
568286|NCT00762112|Drug Therapy.|drug therapy.
568287|NCT00762099|Arthroplasty, Hip|arthroplasty, hip
568288|NCT00762099|Hip replacement|hip replacement
568289|NCT00762099|Pain Management|pain management
568290|NCT00762099|Functional Rehabilitation|functional rehabilitation
568291|NCT00762099|Anxiety|anxiety
568292|NCT00762099|Perioperative|perioperative
568293|NCT00762099|Pregabalin|pregabalin
568294|NCT00762099|Arthroplasty|arthroplasty
568295|NCT00762086|Peripheral Arterial Disease|peripheral arterial disease
568296|NCT00762086|intermittent pneumatic compression treatment|intermittent pneumatic compression treatment
568297|NCT00762086|Initial claudication|initial claudication
568298|NCT00762073|eosinophilic esophagitis|eosinophilic esophagitis
568299|NCT00762060|colorectal surgery|colorectal surgery
568300|NCT00762047|Fecal Incontinence|fecal incontinence
568301|NCT00762021|cataract|cataract
568302|NCT00762008|biomarkers|biomarkers
568303|NCT00761995|Raised IOP|raised iop
568304|NCT00761969|peripheral arterial disease|peripheral arterial disease
568305|NCT00761969|secondary prevention|secondary prevention
568306|NCT00761969|cardiovascular /atherothrombotic events|cardiovascular /atherothrombotic events
568307|NCT00761969|European guidelines|european guidelines
568308|NCT00761969|Cardiovascular disease prevention|cardiovascular disease prevention
568309|NCT00761956|Total Knee Arthroplasty|total knee arthroplasty
568310|NCT00761956|Osteoarthritis|osteoarthritis
568311|NCT00761956|Knee|knee
568312|NCT00761943|Adhesive Capsulitis|adhesive capsulitis
568313|NCT00761943|Bursitis|bursitis
568314|NCT00761943|Frozen Shoulder|frozen shoulder
568315|NCT00761904|hypertension|hypertension
568316|NCT00761904|hyperlipidemia|hyperlipidemia
568317|NCT00761904|free generic samples|free generic samples
568318|NCT00761891|aspirin|aspirin
568319|NCT00761891|cyclooxygenase-1|cyclooxygenase-1
568320|NCT00761891|aspirin resistance|aspirin resistance
568321|NCT00761891|aspirin nonresponse|aspirin nonresponse
568322|NCT00761891|platelet|platelet
568323|NCT00761891|Normal volunteers|normal volunteers
568324|NCT00761878|Skin aging|skin aging
568325|NCT00761878|Skin wrinkling|skin wrinkling
568326|NCT00761865|Lateral Ankle Sprin|lateral ankle sprin
568327|NCT00761865|Air Cast Stirrup Brace|air cast stirrup brace
568328|NCT00761865|High Tide Fracture Boot|high tide fracture boot
568329|NCT00761839|wound healing|wound healing
568330|NCT00761839|self-management|self-management
568331|NCT00761839|patient education|patient education
568332|NCT00761826|Mixed Astigmatism|mixed astigmatism
568333|NCT00761826|Laser In Situ Keratomileusis|laser in situ keratomileusis
568334|NCT00761826|Laser Therapy|laser therapy
568335|NCT00761826|Laser Corneal Surgery|laser corneal surgery
568336|NCT00761826|Refractive Surgical Procedures|refractive surgical procedures
568337|NCT00761826|Ophthalmologic Surgical Procedure|ophthalmologic surgical procedure
568338|NCT00761826|Operative Surgical Procedures|operative surgical procedures
568339|NCT00761826|Therapeutics|therapeutics
568340|NCT00761813|Sliding Hip Screw Fixation|sliding hip screw fixation
568341|NCT00761813|Cannulated Screw Fixation|cannulated screw fixation
568342|NCT00761787|allograft|allograft
568343|NCT00761787|rejection|rejection
568344|NCT00761787|biopsy|biopsy
568345|NCT00761787|gene|gene
568346|NCT00761787|expression|expression
568347|NCT00761787|cardiology|cardiology
568348|NCT00761787|heart|heart
568349|NCT00761787|transplant|transplant
568350|NCT00761774|Epilepsy|epilepsy
568351|NCT00761774|Monotherapy|monotherapy
568352|NCT00761774|Partial Onset Seizures|partial onset seizures
568353|NCT00761761|Sensoril|sensoril
568354|NCT00761761|Bipolar Illness|bipolar illness
568355|NCT00761761|Cognitive enhancement|cognitive enhancement
568356|NCT00761748|Urostomy,|urostomy,
568357|NCT00761748|2-piece,|2-piece,
568358|NCT00761748|preference,|preference,
568359|NCT00761722|Acute Myeloid Leukemia|acute myeloid leukemia
568360|NCT00761722|Myelodysplastic Syndromes|myelodysplastic syndromes
568361|NCT00761722|Lymphoma|lymphoma
568362|NCT00761722|Multiple Myeloma|multiple myeloma
568363|NCT00761722|Chronic Myelomonocytic Leukemia (CMML)|chronic myelomonocytic leukemia (cmml)
568364|NCT00761709|Open Angle Glaucoma|open angle glaucoma
568365|NCT00761709|Ocular Hypertension|ocular hypertension
568366|NCT00761696|solid tumor malignancies|solid tumor malignancies
568367|NCT00761683|Endometriosis|endometriosis
568368|NCT00761657|Kidney|kidney
568369|NCT00761657|Chronic Kidney Disease|chronic kidney disease
568370|NCT00761657|CKD|ckd
568371|NCT00761657|Stage 3 or 4 Chronic Kidney Disease|stage 3 or 4 chronic kidney disease
568372|NCT00761657|Renal|renal
568373|NCT00761657|Anemia|anemia
568374|NCT00761657|Oral anemia treatment|oral anemia treatment
568375|NCT00761657|Hemoglobin levels|hemoglobin levels
568376|NCT00761657|Blood count|blood count
568377|NCT00761657|Erythropoietin|erythropoietin
568378|NCT00761644|Metastatic cancer|metastatic cancer
568379|NCT00761644|Doxil|doxil
568380|NCT00761644|Liposomal doxorubicin|liposomal doxorubicin
568381|NCT00761644|Doxorubicin hydrochloride (liposomal)|doxorubicin hydrochloride (liposomal)
568382|NCT00761644|Avastin|avastin
568383|NCT00761644|Bevacizumab|bevacizumab
568384|NCT00761644|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
568385|NCT00761644|rhuMAb-VEGF|rhumab-vegf
568386|NCT00761644|Torisel|torisel
568387|NCT00761644|Temsirolimus|temsirolimus
568388|NCT00761644|CCI-779|cci-779
568389|NCT00761644|Dynamic contrast-enhanced magnetic resonance imaging|dynamic contrast-enhanced magnetic resonance imaging
568390|NCT00761644|DCE-MRI scan|dce-mri scan
568391|NCT00761618|Intrapleural catheter|intrapleural catheter
568392|NCT00761618|IPC|ipc
568393|NCT00761618|Pleurodesis|pleurodesis
568394|NCT00761618|PD|pd
568395|NCT00761618|Pleural effusion|pleural effusion
568396|NCT00761618|Fluid in the chest cavity|fluid in the chest cavity
568397|NCT00761618|Recurrent malignant pleural effusion|recurrent malignant pleural effusion
568398|NCT00761618|MPE|mpe
568399|NCT00761618|Pleural inflammatory response|pleural inflammatory response
568400|NCT00761605|Schizophrenia|schizophrenia
568401|NCT00761605|Paliperidone|paliperidone
568402|NCT00761605|Paliperidone extended-release|paliperidone extended-release
568403|NCT00761605|Antipsychotics Agents|antipsychotics agents
568404|NCT00761579|Schizophrenia|schizophrenia
568405|NCT00761579|Paliperidone|paliperidone
568406|NCT00761579|Antipsychotics Agents|antipsychotics agents
568407|NCT00761566|Elite swimmers|elite swimmers
568408|NCT00761566|Exercise|exercise
568409|NCT00761566|Preconditioning|preconditioning
568410|NCT00761553|The study is designed to determine the effects of food supplements and strength training.|the study is designed to determine the effects of food supplements and strength training.
568411|NCT00761501|Phase I|phase i
568412|NCT00761501|Healthy Volunteer|healthy volunteer
568413|NCT00761488|Visual acuity,|visual acuity,
568414|NCT00761488|corneal and|corneal and
568415|NCT00761488|refractive|refractive
568416|NCT00761488|cylinder|cylinder
568417|NCT00761488|following|following
568418|NCT00761488|implantation of the|implantation of the
568419|NCT00761488|AcrySof® Toric|acrysof® toric
568420|NCT00761475|incisional hernia|incisional hernia
568421|NCT00761462|Pediatrics|pediatrics
568422|NCT00761462|Safety|safety
568423|NCT00761462|Musculoskeletal System|musculoskeletal system
568424|NCT00761462|Neurologic Manifestations|neurologic manifestations
568425|NCT00761462|Joint Diseases|joint diseases
568426|NCT00761462|Joint Deformities, Acquired|joint deformities, acquired
568427|NCT00761449|MDS|mds
568428|NCT00761449|AML|aml
568429|NCT00761449|Lenalidomide|lenalidomide
568430|NCT00761449|monosomy 5|monosomy 5
568431|NCT00761449|del5q|del5q
568432|NCT00761410|Arthroplasty|arthroplasty
568433|NCT00761410|Knee|knee
568434|NCT00761410|Replacement|replacement
568435|NCT00761410|High Flexion|high flexion
568436|NCT00761410|PFC Sigma RP-F|pfc sigma rp-f
568437|NCT00761397|Oropharyngeal cancer|oropharyngeal cancer
568438|NCT00761397|Dysphagic|dysphagic
568439|NCT00761397|Swallowing exercises|swallowing exercises
568440|NCT00761397|Swallowing rehabilitative regimens|swallowing rehabilitative regimens
568441|NCT00761397|PREPARE|prepare
568442|NCT00761397|Patients' Radiation Expectations|patients' radiation expectations
568443|NCT00761397|Prevention, Adherence, Rehabilitative Exercises|prevention, adherence, rehabilitative exercises
568444|NCT00761384|B-cell lymphoma|b-cell lymphoma
568445|NCT00761384|Refractory|refractory
568446|NCT00761384|Recurrent|recurrent
568447|NCT00761384|90Y-ibritumomab|90y-ibritumomab
568448|NCT00761384|Stem cells support|stem cells support
568449|NCT00761384|Dosimetry study|dosimetry study
568450|NCT00761371|external genital and perianal warts|external genital and perianal warts
568451|NCT00761358|Acotiamide|acotiamide
568452|NCT00761345|pancreatic cancer|pancreatic cancer
568453|NCT00761345|locally advanced|locally advanced
568454|NCT00761345|unresectable|unresectable
568455|NCT00761345|metastatic pancreatic cancer|metastatic pancreatic cancer
568456|NCT00761319|Open-angle glaucoma|open-angle glaucoma
568457|NCT00761319|ocular hypertension|ocular hypertension
568458|NCT00761306|Major Depressive Disorder|major depressive disorder
568459|NCT00761306|Long-term|long-term
568460|NCT00761306|Safety|safety
568461|NCT00761306|Open-label|open-label
568462|NCT00761280|Anaplastic astrocytoma|anaplastic astrocytoma
568463|NCT00761280|Glioblastoma|glioblastoma
568464|NCT00761280|Antisense|antisense
568465|NCT00761280|Cancer|cancer
568466|NCT00761280|Transforming Growth Factor beta 2|transforming growth factor beta 2
568467|NCT00761280|Targeted therapy|targeted therapy
568468|NCT00761280|Brain tumor|brain tumor
568469|NCT00761280|Glioma|glioma
568470|NCT00761280|Central Nervous System (CNS)|central nervous system (cns)
568471|NCT00761280|Convection Enhanced Delivery (CED)|convection enhanced delivery (ced)
568472|NCT00761280|Intratumoral administration|intratumoral administration
568473|NCT00761267|Anidulafungin|anidulafungin
568474|NCT00761267|pediatrics|pediatrics
568475|NCT00761267|candidemia|candidemia
568476|NCT00761267|invasive candidiasis|invasive candidiasis
568477|NCT00761267|safety|safety
568478|NCT00761254|Domperidone|domperidone
568479|NCT00761254|Gastroparesis|gastroparesis
568480|NCT00761241|pancreas cancer|pancreas cancer
568481|NCT00761241|combined modality therapy|combined modality therapy
568482|NCT00761228|Vegetative State|vegetative state
568483|NCT00761228|Minimally Conscious State|minimally conscious state
568484|NCT00761228|Coma|coma
568485|NCT00761228|Traumatic Brain Injury|traumatic brain injury
568486|NCT00761215|Skin|skin
568487|NCT00761215|Infection|infection
568488|NCT00761215|Complicated Skin and Skin Structure Infection|complicated skin and skin structure infection
568489|NCT00761189|Paliperidone|paliperidone
568490|NCT00761189|R076477|r076477
568491|NCT00761189|Schizophrenia|schizophrenia
568492|NCT00761176|Diabetes|diabetes
568493|NCT00761176|Ulcers|ulcers
568494|NCT00761176|Wounds|wounds
568495|NCT00761163|The purpose of this study is to identify the body's response to aerobic vs. resistance exercise|the purpose of this study is to identify the body's response to aerobic vs. resistance exercise
568496|NCT00761150|Effect on sleep interference by pain|effect on sleep interference by pain
568497|NCT00761137|sialorrhea|sialorrhea
568498|NCT00761137|drooling|drooling
568499|NCT00761137|excessive salivation|excessive salivation
568500|NCT00761137|parkinson's disease|parkinson's disease
568501|NCT00761124|PSA screening|psa screening
568502|NCT00761124|Prostate cancer and Latino men|prostate cancer and latino men
568503|NCT00761111|information booklet|information booklet
568504|NCT00761111|low back beliefs|low back beliefs
568505|NCT00761111|education|education
568506|NCT00761111|disc hernia|disc hernia
568507|NCT00761111|discectomy|discectomy
568508|NCT00761111|A common monoradicular sciatica|a common monoradicular sciatica
568509|NCT00761111|on a slipped disc|on a slipped disc
568510|NCT00761111|with a clinical radio|with a clinical radio
568511|NCT00761111|agreement requiring a surgical treatment|agreement requiring a surgical treatment
568512|NCT00761111|carried out|carried out
568513|NCT00761111|one duration|one duration
568514|NCT00761111|of evolution higher|of evolution higher
568515|NCT00761111|than four weeks|than four weeks
568516|NCT00761111|at naive subjects|at naive subjects
568517|NCT00761111|of any rachidian interventional treatment|of any rachidian interventional treatment
568518|NCT00761111|after failure of an good ambulatory|after failure of an good ambulatory
568519|NCT00761098|Cirrhosis|cirrhosis
568520|NCT00761098|SBP|sbp
568521|NCT00761072|Propofol|propofol
568522|NCT00761072|Remifentanil|remifentanil
568523|NCT00761072|Total Intravenous Anesthesia|total intravenous anesthesia
568524|NCT00761059|analgesia|analgesia
568525|NCT00761059|infant, premature|infant, premature
568526|NCT00761059|glucose|glucose
568527|NCT00761059|nasopharyngeal suctioning|nasopharyngeal suctioning
568528|NCT00761033|children undergoing intravenous placement in the pediatric emergency department|children undergoing intravenous placement in the pediatric emergency department
568529|NCT00761020|Malaria|malaria
568530|NCT00761020|Diagnosis|diagnosis
568531|NCT00761020|Biomarker|biomarker
568532|NCT00761007|Irritable Bowel Syndrome|irritable bowel syndrome
568533|NCT00761007|Bowel disease|bowel disease
568534|NCT00760994|Alcohol|alcohol
568535|NCT00760994|Alcoholic|alcoholic
568536|NCT00760994|Alcoholism|alcoholism
568537|NCT00760994|Post-traumatic stress disorder|post-traumatic stress disorder
568538|NCT00760994|PTSD|ptsd
568539|NCT00760994|Experiential acceptance|experiential acceptance
568540|NCT00760994|Mindfulness|mindfulness
568541|NCT00760994|Meditation|meditation
568542|NCT00760994|Meditate|meditate
568543|NCT00760994|Cognitive restructuring|cognitive restructuring
568544|NCT00760994|Cognitive|cognitive
568545|NCT00760994|Behavioral|behavioral
568546|NCT00760994|Therapy|therapy
568547|NCT00760994|Treatment|treatment
568548|NCT00760994|Study|study
568549|NCT00760994|Intervention|intervention
568550|NCT00760968|Rheumatoid Arthritis|rheumatoid arthritis
568551|NCT00760968|Drug Therapy|drug therapy
568552|NCT00760955|Asymmetric Diabetic Proximal Motor Neuropathy|asymmetric diabetic proximal motor neuropathy
568553|NCT00760955|Diabetic Amyotrophy|diabetic amyotrophy
568554|NCT00760955|Diabetic Autonomic Neuropathy|diabetic autonomic neuropathy
568555|NCT00760955|Diabetic Polyneuropathy|diabetic polyneuropathy
568556|NCT00760955|Neuralgia, Diabetic|neuralgia, diabetic
568557|NCT00760955|Symmetric Diabetic Proximal Motor Neuropathy|symmetric diabetic proximal motor neuropathy
568558|NCT00760955|Drug Therapy|drug therapy
568559|NCT00760942|Low birth weight|low birth weight
568560|NCT00760942|neonates|neonates
568561|NCT00760942|premature infants|premature infants
568562|NCT00760942|nutrition|nutrition
568563|NCT00760942|human milk fortification|human milk fortification
568564|NCT00760942|Infant|infant
568565|NCT00760916|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
568566|NCT00760903|Moderate brain trauma|moderate brain trauma
568567|NCT00760890|Iron, breastfed infant|iron, breastfed infant
568568|NCT00760877|MYELOGENOUS|myelogenous
568569|NCT00760877|LEUKEMIA|leukemia
568570|NCT00760877|Chronic Phase|chronic phase
568571|NCT00760877|CML|cml
568572|NCT00760864|Rheumatoid Arthritis|rheumatoid arthritis
568573|NCT00760864|Drug Therapy|drug therapy
568574|NCT00760851|Probiotics|probiotics
568575|NCT00760851|Child, preschool|child, preschool
568576|NCT00760851|Child Day Care Centers|child day care centers
568577|NCT00760851|Health|health
568578|NCT00760851|Immune system|immune system
568579|NCT00760838|Inadequately controlled severe asthma|inadequately controlled severe asthma
568580|NCT00760825|cholera|cholera
568581|NCT00760825|vibrios|vibrios
568582|NCT00760825|oral cholera vaccine|oral cholera vaccine
568583|NCT00760812|Autism|autism
568584|NCT00760812|Autism Spectrum Disorders|autism spectrum disorders
568585|NCT00760812|Pervasive Developmental Disorders|pervasive developmental disorders
568586|NCT00760812|Toddlers|toddlers
568587|NCT00760812|Intervention|intervention
568588|NCT00760799|Lumbar Disc Herniation|lumbar disc herniation
568589|NCT00760786|IVUS-VH|ivus-vh
568590|NCT00760786|Plaque characterization|plaque characterization
568591|NCT00760786|Omega3-fatty acid|omega3-fatty acid
568592|NCT00760786|Atorvastatin|atorvastatin
568593|NCT00760773|Probiotic treatment|probiotic treatment
568594|NCT00760773|Daycare attendance|daycare attendance
568595|NCT00760773|Pediatric|pediatric
568596|NCT00760773|Emergency department|emergency department
568597|NCT00760747|ADHD|adhd
568598|NCT00760747|Children|children
568599|NCT00760747|Stimulant|stimulant
568600|NCT00760747|Atomoxetine|atomoxetine
568601|NCT00760747|Adolescents|adolescents
568602|NCT00760734|Chronic traumatic brain injury|chronic traumatic brain injury
568603|NCT00760734|Post concussion syndrome|post concussion syndrome
568604|NCT00760734|Post traumatic stress disorder|post traumatic stress disorder
568605|NCT00760734|Chronic post traumatic stress disorder|chronic post traumatic stress disorder
568606|NCT00760721|Hepatitis B Screening|hepatitis b screening
568607|NCT00760721|Korean Americans|korean americans
568608|NCT00760708|nucleosides|nucleosides
568609|NCT00760708|neurotransmitter|neurotransmitter
568610|NCT00760708|myocardial ischemia|myocardial ischemia
568611|NCT00760708|Adenosine|adenosine
568612|NCT00760695|anorexia nervosa|anorexia nervosa
568613|NCT00760695|chronic|chronic
568614|NCT00760695|dronabinol|dronabinol
568615|NCT00760695|weight gain|weight gain
568616|NCT00760695|EDI|edi
568617|NCT00760682|osteoradionecrosis|osteoradionecrosis
568618|NCT00760682|hyperbaric oxygen|hyperbaric oxygen
568619|NCT00760682|sequestrectomy|sequestrectomy
568620|NCT00760669|Spondylitis, Ankylosing|spondylitis, ankylosing
568621|NCT00760669|Arthritis, Rheumatoid|arthritis, rheumatoid
568622|NCT00760669|Psoriasis|psoriasis
568623|NCT00760669|Arthritis, Psoriatic|arthritis, psoriatic
568624|NCT00760669|Infliximab|infliximab
568625|NCT00760669|Remicade|remicade
568626|NCT00760656|Health outcomes in adults who survived pediatric cancer|health outcomes in adults who survived pediatric cancer
568627|NCT00760656|Survivors of Pediatric Cancer|survivors of pediatric cancer
568628|NCT00760630|abnormal stress test|abnormal stress test
568629|NCT00760630|fractional flow reserve|fractional flow reserve
568630|NCT00760630|pressure drop coefficient|pressure drop coefficient
568631|NCT00760630|lesion flow coefficient|lesion flow coefficient
568632|NCT00760617|Influenza|influenza
568633|NCT00760617|Elderly|elderly
568634|NCT00760604|Esophageal neoplasms|esophageal neoplasms
568635|NCT00760604|Esophagectomy|esophagectomy
568636|NCT00760591|Acute kidney failure|acute kidney failure
568637|NCT00760591|Colonoscopy|colonoscopy
568638|NCT00760591|Neutrophil gelatinase-associated lipocalin|neutrophil gelatinase-associated lipocalin
568639|NCT00760552|Hypertension|hypertension
568640|NCT00760552|Adherence|adherence
568641|NCT00760552|Pharmacist|pharmacist
568642|NCT00760552|Interdisciplinary|interdisciplinary
568643|NCT00760552|Randomized Controlled|randomized controlled
568644|NCT00760552|Primary Care|primary care
568645|NCT00760539|Glaucoma|glaucoma
568646|NCT00760539|Hypertension|hypertension
568647|NCT00760526|Continuous Glucose Monitor|continuous glucose monitor
568771|NCT00760006|Unasyn|unasyn
568648|NCT00760513|non alcoholic fatty liver disease|non alcoholic fatty liver disease
568649|NCT00760513|NAFLD|nafld
568650|NCT00760513|fish oil|fish oil
568651|NCT00760513|intervention|intervention
568652|NCT00760513|RCT|rct
568653|NCT00760513|biomarkers|biomarkers
568654|NCT00760487|Cataract AcrySof Toric IOL|cataract acrysof toric iol
568655|NCT00760487|Bilateral cataract|bilateral cataract
568656|NCT00760474|Fibromyalgia; fMRI; pain; pregabalin; Lyrica; imaging|fibromyalgia; fmri; pain; pregabalin; lyrica; imaging
568657|NCT00760435|Kawasaki disease|kawasaki disease
568658|NCT00760435|Infliximab|infliximab
568659|NCT00760435|Remicade|remicade
568660|NCT00760435|Pediatrics|pediatrics
568661|NCT00760409|recurrent tumor|recurrent tumor
568662|NCT00760396|healthy volunteers|healthy volunteers
568663|NCT00760383|Total Knee Arthroplasty|total knee arthroplasty
568664|NCT00760383|Osteoarthritis|osteoarthritis
568665|NCT00760383|Muscle Metabolism|muscle metabolism
568666|NCT00760383|Rehabilitation|rehabilitation
568667|NCT00760383|Physical Therapy|physical therapy
568668|NCT00760370|bone marker|bone marker
568669|NCT00760370|bisphosphonate|bisphosphonate
568670|NCT00760370|Zometa|zometa
568671|NCT00760370|retention|retention
568672|NCT00760370|breast cancer|breast cancer
568673|NCT00760370|multiple myeloma|multiple myeloma
568674|NCT00760370|CTX|ctx
568675|NCT00760370|bone specific ALP|bone specific alp
568676|NCT00760357|Critical Ischemia|critical ischemia
568677|NCT00760344|Glucose Metabolism Disorder|glucose metabolism disorder
568678|NCT00760344|Dysmetabolic Syndrome|dysmetabolic syndrome
568679|NCT00760344|Type II Diabetes|type ii diabetes
568680|NCT00760344|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
568681|NCT00760344|Dyslipidemia|dyslipidemia
568682|NCT00760344|Drug Therapy|drug therapy
568683|NCT00760331|HNF1B|hnf1b
568684|NCT00760331|TCF2|tcf2
568685|NCT00760331|MODY-5|mody-5
568686|NCT00760331|CAKUT|cakut
568687|NCT00760331|Anomaly of renal development|anomaly of renal development
568688|NCT00760318|cervical dystonia, keppra, botox, spasmodic torticollis|cervical dystonia, keppra, botox, spasmodic torticollis
568689|NCT00760305|cancer pain|cancer pain
568690|NCT00760305|bone metastasis|bone metastasis
568691|NCT00760305|patient education|patient education
568692|NCT00760305|psychoeducational education|psychoeducational education
568693|NCT00760305|side effects|side effects
568694|NCT00760305|analgesics|analgesics
568695|NCT00760292|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
568696|NCT00760292|Genetic Variants|genetic variants
568697|NCT00760292|SNP|snp
568698|NCT00760292|DNA microarray|dna microarray
568699|NCT00760279|Bacterial infection|bacterial infection
568700|NCT00760279|Azithromycin|azithromycin
568701|NCT00760266|Hypertension|hypertension
568702|NCT00760266|older population|older population
568703|NCT00760266|aliskiren|aliskiren
568704|NCT00760266|hydrochlorothiazide|hydrochlorothiazide
568705|NCT00760266|systolic blood pressure|systolic blood pressure
568706|NCT00760266|diastolic blood pressure|diastolic blood pressure
568707|NCT00760266|amlodipine, stage 2|amlodipine, stage 2
568708|NCT00760253|target control infusion|target control infusion
568709|NCT00760253|alfentanyl|alfentanyl
568710|NCT00760253|propofol|propofol
568711|NCT00760253|BIS|bis
568712|NCT00760240|compliance|compliance
568713|NCT00760240|eyedrop instillation|eyedrop instillation
568714|NCT00760240|How patients with low vision due to glaucoma or retinal pathology instill eyedrops into their own eyes.|how patients with low vision due to glaucoma or retinal pathology instill eyedrops into their own eyes.
568715|NCT00760214|Essential Hypertension|essential hypertension
568716|NCT00760214|Hypertension|hypertension
568717|NCT00760214|Drug Therapy|drug therapy
568718|NCT00760214|Blood Pressure, High|blood pressure, high
568719|NCT00760214|Vascular Disease|vascular disease
568720|NCT00760214|Cardiovascular Disease|cardiovascular disease
568721|NCT00760201|executive|executive
568722|NCT00760201|administrator|administrator
568723|NCT00760201|perceptions|perceptions
568724|NCT00760201|legal counsel|legal counsel
568725|NCT00760201|end of life|end of life
568726|NCT00760188|knee replacement|knee replacement
568727|NCT00760175|Lung transplant Recipients|lung transplant recipients
568728|NCT00760175|Vaxigrip|vaxigrip
568729|NCT00760162|Chronic Kidney failure stage three and four|chronic kidney failure stage three and four
568730|NCT00760162|Probiotics|probiotics
568731|NCT00760162|Kibow Biotics|kibow biotics
568732|NCT00760162|Enteric Dialysis|enteric dialysis
568733|NCT00760162|Gut based removal uremic toxin removal|gut based removal uremic toxin removal
568734|NCT00760149|tuberculosis|tuberculosis
568735|NCT00760149|rifampicin|rifampicin
568736|NCT00760149|pharmacokinetics|pharmacokinetics
568737|NCT00760149|pharmacodynamics|pharmacodynamics
568738|NCT00760136|patellofemoral pain|patellofemoral pain
568739|NCT00760136|quadriceps contraction|quadriceps contraction
568740|NCT00760123|Lymphedema|lymphedema
568741|NCT00760123|Prevention|prevention
568742|NCT00760123|Breast cancer|breast cancer
568743|NCT00760123|Physical therapy|physical therapy
568744|NCT00760110|Morning BP|morning bp
568745|NCT00760110|Clinic BP|clinic bp
568746|NCT00760110|micro- and macrovascular complications|micro- and macrovascular complications
568747|NCT00760084|Acute Myelogenous Leukemia|acute myelogenous leukemia
568748|NCT00760084|Myelodysplastic Syndrome|myelodysplastic syndrome
568749|NCT00760084|Dacogen|dacogen
568750|NCT00760084|Decitabine|decitabine
568751|NCT00760071|cystic fibrosis,|cystic fibrosis,
568752|NCT00760071|lung disease,|lung disease,
568753|NCT00760071|MRI,|mri,
568754|NCT00760071|morphology,|morphology,
568755|NCT00760071|function|function
568756|NCT00760071|morphological MRI|morphological mri
568757|NCT00760071|functional MRI|functional mri
568758|NCT00760071|correlation to clinical data|correlation to clinical data
568759|NCT00760058|cataract, intraocular lens|cataract, intraocular lens
568760|NCT00760032|Cirrhosis|cirrhosis
568761|NCT00760032|Ascites|ascites
568762|NCT00760032|Lipopolysaccharide binding protein|lipopolysaccharide binding protein
568763|NCT00760032|Infections|infections
568764|NCT00760032|Cytokines|cytokines
568765|NCT00760032|Ciprofloxacin|ciprofloxacin
568766|NCT00760019|vascular inflammation|vascular inflammation
568767|NCT00760019|endothelium-dependent flow-mediated blood vessel function|endothelium-dependent flow-mediated blood vessel function
568768|NCT00760006|cleft secondary palate|cleft secondary palate
568769|NCT00760006|primary closure of secondary cleft palate|primary closure of secondary cleft palate
568770|NCT00760006|Prophylactic Antibiotics|prophylactic antibiotics
568772|NCT00760006|Cleft Palate|cleft palate
568773|NCT00759993|weight gain|weight gain
568774|NCT00759993|Obesity|obesity
568775|NCT00759993|Psychiatry|psychiatry
568776|NCT00759993|Medication|medication
568777|NCT00759993|Induced|induced
568778|NCT00759980|Thrombocytopenia|thrombocytopenia
568779|NCT00759980|Platelet transfusion|platelet transfusion
568780|NCT00759967|Randomized|randomized
568781|NCT00759967|Cross-Over|cross-over
568782|NCT00759967|Conventional|conventional
568783|NCT00759967|Daily|daily
568784|NCT00759967|Hemodialysis|hemodialysis
568785|NCT00759954|bioequivalence|bioequivalence
568786|NCT00759954|morphine sulfate sustained release capsules|morphine sulfate sustained release capsules
568787|NCT00759954|KADIAN capsules|kadian capsules
568788|NCT00759954|200 mg|200 mg
568789|NCT00759954|applesauce|applesauce
568790|NCT00759941|Glaucoma|glaucoma
568791|NCT00759928|Refractory Solid Tumors|refractory solid tumors
568792|NCT00759928|Unresectable Stage III/IV|unresectable stage iii/iv
568793|NCT00759928|Sorafenib|sorafenib
568794|NCT00759928|Erlotinib|erlotinib
568795|NCT00759928|Pharmacokinetics|pharmacokinetics
568796|NCT00759915|10 mg|10 mg
568797|NCT00759915|KADIAN capsules|kadian capsules
568798|NCT00759915|20 mg|20 mg
568799|NCT00759915|fed conditions|fed conditions
568800|NCT00759915|bioequivalence|bioequivalence
568801|NCT00759902|bioequivalence|bioequivalence
568802|NCT00759902|10 mg|10 mg
568803|NCT00759902|KADIAN capsules|kadian capsules
568804|NCT00759902|20 mg|20 mg
568805|NCT00759902|under fasted conditions|under fasted conditions
568806|NCT00759889|venous leg ulcer|venous leg ulcer
568807|NCT00759876|Duchenne muscular dystrophy|duchenne muscular dystrophy
568808|NCT00759876|Nonsense mutation|nonsense mutation
568809|NCT00759876|Premature stop codon|premature stop codon
568810|NCT00759876|DMD|dmd
568811|NCT00759876|PTC124|ptc124
568812|NCT00759876|Ataluren|ataluren
568813|NCT00759850|Acute Myocardial Infarction|acute myocardial infarction
568814|NCT00759850|Drug Eluting Stent|drug eluting stent
568815|NCT00759850|Primary PCI|primary pci
568816|NCT00759824|Small cell lung carcinoma|small cell lung carcinoma
568817|NCT00759824|Valproic acid|valproic acid
568818|NCT00759824|Adriamycin|adriamycin
568819|NCT00759824|Cyclophosphamide|cyclophosphamide
568820|NCT00759824|Vindesine|vindesine
568821|NCT00759824|Second-line chemotherapy|second-line chemotherapy
568822|NCT00759811|Heart Failure|heart failure
568823|NCT00759811|Myocardial Ischemia|myocardial ischemia
568824|NCT00759811|Methotrexate|methotrexate
568825|NCT00759811|Inflammation|inflammation
568826|NCT00759811|Anti-Inflammatory Agents|anti-inflammatory agents
568827|NCT00759811|Inflammation Mediators|inflammation mediators
568828|NCT00759798|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
568829|NCT00759798|Leukemia|leukemia
568830|NCT00759798|FCR|fcr
568831|NCT00759798|Fludarabine|fludarabine
568832|NCT00759798|Cyclophosphamide|cyclophosphamide
568833|NCT00759798|Rituximab|rituximab
568834|NCT00759772|Anorexia Nervosa|anorexia nervosa
568835|NCT00759772|Disordered Eating|disordered eating
568836|NCT00759772|Osteoporosis|osteoporosis
568837|NCT00759772|Parathyroid Hormone|parathyroid hormone
568838|NCT00759772|Bone|bone
568839|NCT00759759|bioequivalence|bioequivalence
568840|NCT00759759|morphine sulfate sustained release capsules|morphine sulfate sustained release capsules
568841|NCT00759759|KADIAN capsules|kadian capsules
568842|NCT00759759|200 mg|200 mg
568843|NCT00759746|Weight loss maintenance|weight loss maintenance
568844|NCT00759733|pregnancy|pregnancy
568845|NCT00759733|heart disease|heart disease
568846|NCT00759733|heart function testing|heart function testing
568847|NCT00759733|echocardiography|echocardiography
568848|NCT00759733|B-type natriuretic peptide|b-type natriuretic peptide
568849|NCT00759733|obstetrical care|obstetrical care
568850|NCT00759720|Glucose Metabolism Disorder|glucose metabolism disorder
568851|NCT00759720|Dysmetabolic Syndrome|dysmetabolic syndrome
568852|NCT00759720|Type II Diabetes|type ii diabetes
568853|NCT00759720|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
568854|NCT00759720|Dyslipidemia|dyslipidemia
568855|NCT00759720|Drug Therapy|drug therapy
568856|NCT00759707|saphenous vein bypass grafts|saphenous vein bypass grafts
568857|NCT00759707|flow-mediated vasodilation|flow-mediated vasodilation
568858|NCT00759681|Arterial Surgery|arterial surgery
568859|NCT00759681|Open vascular Surgery|open vascular surgery
568860|NCT00759681|Sealant|sealant
568861|NCT00759655|hemophilia A|hemophilia a
568862|NCT00759655|Xyntha|xyntha
568863|NCT00759655|ReFacto|refacto
568864|NCT00759655|moroctocog alfa|moroctocog alfa
568865|NCT00759655|bleeding disorder|bleeding disorder
568866|NCT00759642|breast cancer|breast cancer
568867|NCT00759642|hormone receptor positive|hormone receptor positive
568868|NCT00759642|HER-2 negative|her-2 negative
568869|NCT00759616|Knee Replacement|knee replacement
568870|NCT00759603|Leukemia|leukemia
568871|NCT00759603|CLL|cll
568872|NCT00759603|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
568873|NCT00759603|SLL|sll
568874|NCT00759603|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
568875|NCT00759603|Lenalidomide|lenalidomide
568876|NCT00759603|Revlimid|revlimid
568877|NCT00759603|Rituximab|rituximab
568878|NCT00759603|Rituxan|rituxan
568879|NCT00759551|Blood Pressure|blood pressure
568880|NCT00759551|Drug Therapy|drug therapy
568881|NCT00759551|Systolic Pressure|systolic pressure
568882|NCT00759551|Diastolic Pressure|diastolic pressure
568883|NCT00759551|Vascular Diseases|vascular diseases
568884|NCT00759538|Lung Transplantation|lung transplantation
568885|NCT00759538|Pulmonary Rehabilitation|pulmonary rehabilitation
568886|NCT00759538|Exercise tolerance|exercise tolerance
568887|NCT00759538|Quality of Life|quality of life
568888|NCT00759499|study of debridement tissue for research purposes.|study of debridement tissue for research purposes.
568889|NCT00759499|open wound|open wound
568890|NCT00759486|craniofacial fracture|craniofacial fracture
568891|NCT00759486|Subjects who are in the active phase of craniofacial skeletal growth, and have sustained a craniofacial fracture|subjects who are in the active phase of craniofacial skeletal growth, and have sustained a craniofacial fracture
568892|NCT00759473|substance-related disorders|substance-related disorders
568893|NCT00759460|Schizophrenia|schizophrenia
568894|NCT00759434|Varicose veins|varicose veins
568895|NCT00759434|Chronic venous insufficiency|chronic venous insufficiency
568896|NCT00759434|Venous ulceration|venous ulceration
568897|NCT00759434|Surgery|surgery
568898|NCT00759434|Endovenous Laser|endovenous laser
568899|NCT00759421|Schizophrenia|schizophrenia
568900|NCT00759408|primary pulmonary hypertension|primary pulmonary hypertension
568901|NCT00759408|secondary pulmonary hypertension due to left heart failure|secondary pulmonary hypertension due to left heart failure
568902|NCT00759408|secondary pulmonary hypertension due to other causes|secondary pulmonary hypertension due to other causes
568903|NCT00759408|patients without pulmonary disease or pulmonary hypertension|patients without pulmonary disease or pulmonary hypertension
568904|NCT00759395|Anxious Major Depressive Disorder|anxious major depressive disorder
568905|NCT00759382|Non small cell lung carcinoma|non small cell lung carcinoma
568906|NCT00759382|PET scan|pet scan
568907|NCT00759382|Observational study|observational study
568908|NCT00759382|Non metastatic|non metastatic
568909|NCT00759382|treated|treated
568910|NCT00759382|curative intent|curative intent
568911|NCT00759369|ADPKD|adpkd
568912|NCT00759356|bioavailability|bioavailability
568913|NCT00759356|KADIAN|kadian
568914|NCT00759356|200 mg|200 mg
568915|NCT00759356|morphine sulfate sustained release capsules|morphine sulfate sustained release capsules
568916|NCT00759356|100 mg|100 mg
568917|NCT00759356|fed conditions|fed conditions
568918|NCT00759343|Kidney stones|kidney stones
568919|NCT00759343|urinary stone disease|urinary stone disease
568920|NCT00759343|urinary stones|urinary stones
568921|NCT00759343|urine|urine
568922|NCT00759343|serum|serum
568923|NCT00759330|Flurbiprofen, low back pain, chronic low back pain|flurbiprofen, low back pain, chronic low back pain
568924|NCT00759317|normal controls|normal controls
568925|NCT00759304|Aging|aging
568926|NCT00759304|cardiovascular risk factors|cardiovascular risk factors
568927|NCT00759304|Autonomic nervous system|autonomic nervous system
568928|NCT00759304|stroke|stroke
568929|NCT00759304|Myocardiac infarction|myocardiac infarction
568930|NCT00759304|Neuropsychological evaluation|neuropsychological evaluation
568931|NCT00759304|Prospective cohort|prospective cohort
568932|NCT00759291|free fatty acids|free fatty acids
568933|NCT00759291|insulin-mediated|insulin-mediated
568934|NCT00759291|endothelium-dependent vasodilation|endothelium-dependent vasodilation
568935|NCT00759291|metabolic syndrome|metabolic syndrome
568936|NCT00759278|pregnancy|pregnancy
568937|NCT00759278|umbilical artery systolic to diastolic flow ratio|umbilical artery systolic to diastolic flow ratio
568938|NCT00759278|middle cerebral artery peak systolic flow|middle cerebral artery peak systolic flow
568939|NCT00759278|antihypertensive medication|antihypertensive medication
568940|NCT00759265|Muscle strength|muscle strength
568941|NCT00759265|Physical activity|physical activity
568942|NCT00759265|Mobility|mobility
568943|NCT00759265|Gait analysis|gait analysis
568944|NCT00759252|diagnosis of dementia|diagnosis of dementia
568945|NCT00759252|perceptions of risk|perceptions of risk
568946|NCT00759252|dementia screening|dementia screening
568947|NCT00759239|Open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component), or ocular hypertension|open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component), or ocular hypertension
568948|NCT00759226|esophageal cancer|esophageal cancer
568949|NCT00759226|Gemcitabine|gemcitabine
568950|NCT00759226|Cisplatin|cisplatin
568951|NCT00759226|5-FU|5-fu
568952|NCT00759226|Folinic Acid|folinic acid
568953|NCT00759226|inoperable esophageal cancer|inoperable esophageal cancer
568954|NCT00759213|Discharge planning|discharge planning
568955|NCT00759213|Family needs|family needs
568956|NCT00759213|Family concerns|family concerns
568957|NCT00759213|NICU|nicu
568958|NCT00759213|Infants|infants
568959|NCT00759200|Chronic hepatitis C|chronic hepatitis c
568960|NCT00759200|genotype 2|genotype 2
568961|NCT00759200|genotype 3|genotype 3
568962|NCT00759200|albumin interferon alfa-2b|albumin interferon alfa-2b
568963|NCT00759200|alb-interferon|alb-interferon
568964|NCT00759174|Optic Neuropathy Acute NAION PDE5 Inhibitor|optic neuropathy acute naion pde5 inhibitor
568965|NCT00759161|Plaque Type Psoriasis|plaque type psoriasis
568966|NCT00759161|Topical|topical
568967|NCT00759148|pink eye|pink eye
568968|NCT00759148|conjunctivitis|conjunctivitis
568969|NCT00759148|moxifloxacin|moxifloxacin
568970|NCT00759148|fluoroquinolone|fluoroquinolone
568971|NCT00759135|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
568972|NCT00759135|BPH|bph
568973|NCT00759135|Enlarged Prostate|enlarged prostate
568974|NCT00759122|mdd|mdd
568975|NCT00759122|major depressive disorder|major depressive disorder
568976|NCT00759122|depression|depression
568977|NCT00759096|bilateral implantation|bilateral implantation
568978|NCT00759096|ReSTOR Aspheric IOL|restor aspheric iol
568979|NCT00759096|uniocular unaided distance|uniocular unaided distance
568980|NCT00759096|binocular unaided distance|binocular unaided distance
568981|NCT00759096|intermediate visual acuity|intermediate visual acuity
568982|NCT00759096|near visual acuity|near visual acuity
568983|NCT00759083|HIT|hit
568984|NCT00759083|HITTS|hitts
568985|NCT00759070|Treatment Naïve|treatment naïve
568986|NCT00759057|Spinal Stenosis|spinal stenosis
568987|NCT00759057|Spinal Instability|spinal instability
568988|NCT00759057|Leg Pain|leg pain
568989|NCT00759018|GVHD|gvhd
568990|NCT00759018|Prochymal|prochymal
568991|NCT00759018|Graft vs Host Disease|graft vs host disease
568992|NCT00758992|gene transfer|gene transfer
568993|NCT00758966|OCD,|ocd,
568994|NCT00758966|naltrexone,|naltrexone,
568995|NCT00758966|fluoxetine,|fluoxetine,
568996|NCT00758966|obsessive-compulsive disorder|obsessive-compulsive disorder
568997|NCT00758940|Clinical|clinical
568998|NCT00758940|assessment|assessment
568999|NCT00758940|of visual|of visual
569000|NCT00758940|function|function
569001|NCT00758940|with the Acrysof ReSTOR|with the acrysof restor
569002|NCT00758940|multifocal IOL|multifocal iol
569003|NCT00758927|diabetes mellitus|diabetes mellitus
569004|NCT00758927|combined hyperlipidemia|combined hyperlipidemia
569005|NCT00758927|OMACOR|omacor
569006|NCT00758927|small dense LDL|small dense ldl
569007|NCT00758927|HDL subfraction|hdl subfraction
569008|NCT00758914|Vitamin E|vitamin e
569009|NCT00758849|NOH|noh
569010|NCT00758849|Orthostatic hypotension|orthostatic hypotension
569011|NCT00758849|PAF|paf
569012|NCT00758849|MSA|msa
569013|NCT00758849|Shy-Drager syndrome|shy-drager syndrome
569014|NCT00758849|Olivopontocerebellar atrophy|olivopontocerebellar atrophy
569303|NCT00757393|Calcium|calcium
569015|NCT00758849|Striatonigral degeneration|striatonigral degeneration
569016|NCT00758849|Autonomic Failure|autonomic failure
569017|NCT00758849|Parkinson|parkinson
569018|NCT00758849|Fipamezole|fipamezole
569019|NCT00758849|JP-1730|jp-1730
569020|NCT00758823|head lice|head lice
569021|NCT00758810|Health Education|health education
569022|NCT00758810|Myocardial Infarction|myocardial infarction
569023|NCT00758810|Acute Coronary Syndrome|acute coronary syndrome
569024|NCT00758810|Quality of Life|quality of life
569025|NCT00758797|metastatic melanoma|metastatic melanoma
569026|NCT00758758|Anterior Cervical Discectomy and Fusion,|anterior cervical discectomy and fusion,
569027|NCT00758758|Degenerative Disc Disease,|degenerative disc disease,
569028|NCT00758758|Cervical Spine,|cervical spine,
569029|NCT00758758|Herniated Disc|herniated disc
569030|NCT00758745|Cataract|cataract
569031|NCT00758745|Patients|patients
569032|NCT00758745|bilateral|bilateral
569033|NCT00758745|age related|age related
569034|NCT00758745|undergoing|undergoing
569035|NCT00758745|phacoemulsification|phacoemulsification
569036|NCT00758732|Cancer|cancer
569037|NCT00758732|Ovarian cancer|ovarian cancer
569038|NCT00758732|Chemotherapy|chemotherapy
569039|NCT00758732|Docetaxel|docetaxel
569040|NCT00758732|Carboplatin|carboplatin
569041|NCT00758732|Pegylated doxorubicin|pegylated doxorubicin
569042|NCT00758732|Platinum sensitive|platinum sensitive
569043|NCT00758719|Spinal Fusion|spinal fusion
569044|NCT00758719|DDD|ddd
569045|NCT00758706|COPD|copd
569046|NCT00758693|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
569047|NCT00758693|Bendamustine|bendamustine
569048|NCT00758693|Treanda|treanda
569049|NCT00758693|Rituximab|rituximab
569050|NCT00758693|Rituxan|rituxan
569051|NCT00758667|capsular contracture|capsular contracture
569052|NCT00758667|capsulectomy|capsulectomy
569053|NCT00758667|mesna|mesna
569054|NCT00758667|Capsular contracture after breast implant placement|capsular contracture after breast implant placement
569055|NCT00758654|myocardial strain|myocardial strain
569056|NCT00758654|Strain-Encoded MRI|strain-encoded mri
569057|NCT00758654|dobutamine stress MRI|dobutamine stress mri
569058|NCT00758654|ischemia|ischemia
569059|NCT00758654|strain rate reserve|strain rate reserve
569060|NCT00758641|plantar fasciitis|plantar fasciitis
569061|NCT00758641|platelet rich plasma|platelet rich plasma
569062|NCT00758641|GPS|gps
569063|NCT00758615|Obesity|obesity
569064|NCT00758615|Physical activity|physical activity
569065|NCT00758615|Injury Prevention|injury prevention
569066|NCT00758615|Pedestrian safety|pedestrian safety
569067|NCT00758615|Self efficacy|self efficacy
569068|NCT00758615|School|school
569069|NCT00758615|Walking School Bus|walking school bus
569070|NCT00758615|Safe Routes to School|safe routes to school
569071|NCT00758589|Asthma|asthma
569072|NCT00758576|Cataract|cataract
569073|NCT00758550|Visual function;|visual function;
569074|NCT00758550|Refractive cylinder;|refractive cylinder;
569075|NCT00758550|AcrySof® Toric;|acrysof® toric;
569076|NCT00758550|AcrySof® Natural|acrysof® natural
569077|NCT00758537|Assessment of tryptophan and tryptophan catabolites and IDO-activity in patients with chronic kidney disease|assessment of tryptophan and tryptophan catabolites and ido-activity in patients with chronic kidney disease
569078|NCT00758524|Essential hypertension|essential hypertension
569079|NCT00758524|phase 2 study|phase 2 study
569080|NCT00758524|antihypertensive agent|antihypertensive agent
569081|NCT00758511|cortisol|cortisol
569082|NCT00758511|pain|pain
569083|NCT00758511|pain management|pain management
569084|NCT00758511|preterm infants|preterm infants
569085|NCT00758511|sucrose|sucrose
569086|NCT00758511|facilitated tucking|facilitated tucking
569087|NCT00758459|COPD|copd
569088|NCT00758433|Adverse Events|adverse events
569089|NCT00758433|Erythema Rating|erythema rating
569090|NCT00758433|Pharmacokinetics|pharmacokinetics
569091|NCT00758433|Civamide|civamide
569092|NCT00758433|Phase 1|phase 1
569093|NCT00758433|Pain|pain
569094|NCT00758433|Patch|patch
569095|NCT00758420|Varicose Veins|varicose veins
569096|NCT00758407|Fatigue, Cancer, Methylphenidate,|fatigue, cancer, methylphenidate,
569097|NCT00758381|pancreatic cancer|pancreatic cancer
569098|NCT00758381|advanced or metastatic|advanced or metastatic
569099|NCT00758381|sorafenib|sorafenib
569100|NCT00758368|Parkinson's disease|parkinson's disease
569101|NCT00758368|PD|pd
569102|NCT00758368|pulsatile apomorphine|pulsatile apomorphine
569103|NCT00758368|dyskinesia|dyskinesia
569104|NCT00758368|apomorphine|apomorphine
569105|NCT00758368|continuous dopaminergic stimulation|continuous dopaminergic stimulation
569106|NCT00758342|IOP lowering efficacy and safety of Azopt plus Travatan|iop lowering efficacy and safety of azopt plus travatan
569107|NCT00758316|Malignant|malignant
569108|NCT00758316|Pleural|pleural
569109|NCT00758316|Effusions|effusions
569110|NCT00758316|Thoracoscopy|thoracoscopy
569111|NCT00758316|Catheter|catheter
569112|NCT00758303|Triglycerides|triglycerides
569113|NCT00758303|Cholesterol|cholesterol
569114|NCT00758277|prevention of alcohol relapse|prevention of alcohol relapse
569115|NCT00758264|Safety|safety
569304|NCT00757393|Exercise|exercise
569116|NCT00758264|Routine infancy vaccination|routine infancy vaccination
569117|NCT00758264|Meningococcal vaccine|meningococcal vaccine
569118|NCT00758264|Immunogenicity|immunogenicity
569119|NCT00758264|Pneumococcal vaccine|pneumococcal vaccine
569120|NCT00758251|Schizophrenia|schizophrenia
569121|NCT00758251|Seroquel XR|seroquel xr
569122|NCT00758251|CGI|cgi
569123|NCT00758238|hypertension|hypertension
569124|NCT00758238|self-management|self-management
569125|NCT00758238|e-health|e-health
569126|NCT00758225|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
569127|NCT00758225|DMD|dmd
569128|NCT00758225|Duchenne|duchenne
569129|NCT00758225|Idebenone|idebenone
569130|NCT00758212|Influenza in Humans|influenza in humans
569131|NCT00758212|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
569132|NCT00758212|Immunization, Active|immunization, active
569133|NCT00758186|Colorectal cancer|colorectal cancer
569134|NCT00758186|Endoscopic stent|endoscopic stent
569135|NCT00758186|Intestinal obstruction|intestinal obstruction
569136|NCT00758186|Laparoscopy|laparoscopy
569137|NCT00758173|prostate cancer|prostate cancer
569138|NCT00758160|Attention Deficit Disorder With Hyperactivity|attention deficit disorder with hyperactivity
569139|NCT00758160|Methylphenidate|methylphenidate
569140|NCT00758160|Concerta|concerta
569141|NCT00758147|force feedback joystick|force feedback joystick
569142|NCT00758147|stroke|stroke
569143|NCT00758147|haptics|haptics
569144|NCT00758147|kinematics|kinematics
569145|NCT00758147|rehabilitation|rehabilitation
569146|NCT00758147|robotics|robotics
569514|NCT00756548|screening|screening
569147|NCT00758147|Force feedback joystick in stroke rehabilitation|force feedback joystick in stroke rehabilitation
569148|NCT00758108|Genotype/Phenotype Correlation|genotype/phenotype correlation
569149|NCT00758108|Energy Homeostasis|energy homeostasis
569150|NCT00758108|Nociception|nociception
569152|NCT00758108|Behavior and Neurocognition|behavior and neurocognition
569153|NCT00758108|WAGR Syndrome|wagr syndrome
569154|NCT00758108|Wilm's Tumor|wilm's tumor
569155|NCT00758108|Aniridia|aniridia
569156|NCT00758108|Mental Retardation|mental retardation
569157|NCT00758108|Urogenital Abnormalities|urogenital abnormalities
569158|NCT00758108|Healthy Volunteer|healthy volunteer
569159|NCT00758082|type 1 diabetes|type 1 diabetes
569160|NCT00758082|PDA phone (Personal Digital Assistant)|pda phone (personal digital assistant)
569161|NCT00758082|HbA1c|hba1c
569162|NCT00758056|endometrial cancer|endometrial cancer
569163|NCT00758043|Genotype 1|genotype 1
569164|NCT00758030|Schizophrenia|schizophrenia
569165|NCT00758030|Paliperidone|paliperidone
569166|NCT00758017|low back pain|low back pain
569167|NCT00758017|acupuncture|acupuncture
569168|NCT00758004|Cardiovascular Diseases|cardiovascular diseases
569169|NCT00757991|healthy, no evidence of disease|healthy, no evidence of disease
569170|NCT00757978|Schizophrenia|schizophrenia
569171|NCT00757978|negative symptoms|negative symptoms
569172|NCT00757978|clozapine|clozapine
569173|NCT00757965|colon cancer|colon cancer
569174|NCT00757965|rectal cancer|rectal cancer
569175|NCT00757952|ovarian epithelial cancer|ovarian epithelial cancer
569176|NCT00757939|Alzheimer's Disease, MRI, PET|alzheimer's disease, mri, pet
569177|NCT00757900|influenza, human|influenza, human
569178|NCT00757887|malaria|malaria
569179|NCT00757887|plasmodium|plasmodium
569180|NCT00757887|falciparum|falciparum
569181|NCT00757887|human|human
569182|NCT00757887|experimental infection|experimental infection
569183|NCT00757874|Female urogenital disease|female urogenital disease
569184|NCT00757874|skin disease|skin disease
569185|NCT00757848|cystic fibrosis|cystic fibrosis
569186|NCT00757835|24-hour IOP|24-hour iop
569187|NCT00757835|exfoliative glaucoma|exfoliative glaucoma
569188|NCT00757835|travoprost/timolol|travoprost/timolol
569189|NCT00757835|latanoprost/timolol|latanoprost/timolol
569190|NCT00757835|fixed combinations|fixed combinations
569191|NCT00757783|HIV|hiv
569192|NCT00757783|AIDS|aids
569193|NCT00757783|Immunodeficiency Virus, Human|immunodeficiency virus, human
569194|NCT00757783|PREZISTA|prezista
569195|NCT00757783|darunavir|darunavir
569196|NCT00757783|TMC114|tmc114
569197|NCT00757783|Protease Inhibitor|protease inhibitor
569198|NCT00757783|Truvada|truvada
569199|NCT00757783|Atazanavir|atazanavir
569200|NCT00757783|REYATAZ|reyataz
569201|NCT00757783|HIV Infections|hiv infections
569202|NCT00757783|Treatment Naïve|treatment naïve
569203|NCT00757770|Gastroenteritis|gastroenteritis
569204|NCT00757757|Prostate cancer|prostate cancer
569205|NCT00757757|bone metastases|bone metastases
569206|NCT00757757|anti-M-CSF|anti-m-csf
569207|NCT00757757|M-CSF antibody|m-csf antibody
569208|NCT00757757|M-CSF|m-csf
569209|NCT00757757|Prostate Cancer with bone metastases|prostate cancer with bone metastases
569210|NCT00757744|drug counseling|drug counseling
569211|NCT00757744|HIV risks|hiv risks
569212|NCT00757744|methadone maintenance|methadone maintenance
569213|NCT00757744|HIV Seronegativity|hiv seronegativity
569214|NCT00757718|Sleep Disordered Breathing|sleep disordered breathing
569215|NCT00757718|Obstructive Sleep Apnea|obstructive sleep apnea
569216|NCT00757718|Gestational Hypertension|gestational hypertension
569217|NCT00757718|Preeclampsia|preeclampsia
569218|NCT00757705|Schizophrenia|schizophrenia
569219|NCT00757705|Paliperidone Extended-Release|paliperidone extended-release
569220|NCT00757692|Vandetanib (ZD6474)|vandetanib (zd6474)
569221|NCT00757692|Hormone|hormone
569222|NCT00757692|Refractory|refractory
569223|NCT00757692|Prostate Cancer|prostate cancer
569224|NCT00757692|Chemotherapy|chemotherapy
569225|NCT00757692|Naïve|naïve
569226|NCT00757666|Pacemaker|pacemaker
569227|NCT00757640|gastric cancer, surgery, prophylactic cholecystectomy|gastric cancer, surgery, prophylactic cholecystectomy
569228|NCT00757614|AIDS-related lymphoma|aids-related lymphoma
569229|NCT00757614|cutaneous lymphoma|cutaneous lymphoma
569230|NCT00757614|adult Hodgkin lymphoma|adult hodgkin lymphoma
569231|NCT00757614|adult non-Hodgkin lymphoma|adult non-hodgkin lymphoma
569232|NCT00757614|intraocular lymphoma|intraocular lymphoma
569233|NCT00757614|adult T-cell leukemia/lymphoma|adult t-cell leukemia/lymphoma
569234|NCT00757614|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
569235|NCT00757614|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
569236|NCT00757614|noncutaneous extranodal lymphoma|noncutaneous extranodal lymphoma
569237|NCT00757614|adult astrocytic tumors|adult astrocytic tumors
569238|NCT00757614|adult brain stem glioma|adult brain stem glioma
569239|NCT00757614|adult choroid plexus tumor|adult choroid plexus tumor
569240|NCT00757614|adult craniopharyngioma|adult craniopharyngioma
569241|NCT00757614|adult embryonal tumor|adult embryonal tumor
569242|NCT00757614|adult ependymal tumors|adult ependymal tumors
569243|NCT00757614|adult meningeal tumor|adult meningeal tumor
569244|NCT00757614|adult oligodendroglial tumors|adult oligodendroglial tumors
569245|NCT00757614|adult pineal parenchymal tumor|adult pineal parenchymal tumor
569246|NCT00757614|adult brain tumor|adult brain tumor
569247|NCT00757614|intraocular melanoma|intraocular melanoma
569248|NCT00757614|bladder cancer|bladder cancer
569249|NCT00757614|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
569250|NCT00757614|congenital mesoblastic nephroma|congenital mesoblastic nephroma
569251|NCT00757614|esophageal cancer|esophageal cancer
569252|NCT00757614|melanoma|melanoma
569253|NCT00757614|pancreatic cancer|pancreatic cancer
569254|NCT00757614|peripheral primitive neuroectodermal tumor of the kidney|peripheral primitive neuroectodermal tumor of the kidney
569255|NCT00757614|renal cell carcinoma|renal cell carcinoma
569256|NCT00757614|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
569257|NCT00757614|transitional cell cancer of the renal pelvis and ureter|transitional cell cancer of the renal pelvis and ureter
569258|NCT00757575|PNEUMONET JAPAN STUDY|pneumonet japan study
569259|NCT00757549|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
569260|NCT00757549|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
569261|NCT00757549|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
569262|NCT00757549|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
569263|NCT00757549|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
569264|NCT00757549|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
569265|NCT00757549|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
569266|NCT00757549|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
569267|NCT00757549|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
569268|NCT00757536|Rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
569269|NCT00757536|primary vitrectomy|primary vitrectomy
569270|NCT00757536|encircling band|encircling band
569271|NCT00757536|endolaser treatment|endolaser treatment
569272|NCT00757523|Acne Vulgaris|acne vulgaris
569273|NCT00757523|Akne|akne
569274|NCT00757523|Acne|acne
569275|NCT00757523|Akne Vulgaris|akne vulgaris
569276|NCT00757510|Congenital Heart Disease|congenital heart disease
569277|NCT00757497|Treatment Study|treatment study
569278|NCT00757497|Psychosis|psychosis
569279|NCT00757497|Electrical Stimulation|electrical stimulation
569280|NCT00757497|Refractory|refractory
569281|NCT00757497|Novel|novel
569282|NCT00757497|Childhood Onset Psychotic Disorders|childhood onset psychotic disorders
569283|NCT00757497|Schizophrenia|schizophrenia
569284|NCT00757471|Macular hole surgery|macular hole surgery
569285|NCT00757471|membranepeeling|membranepeeling
569286|NCT00757471|closure rate|closure rate
569287|NCT00757471|vitreoretinal dyes|vitreoretinal dyes
569288|NCT00757458|Propofol|propofol
569289|NCT00757458|Bacterial growth|bacterial growth
569290|NCT00757458|Fungal growth|fungal growth
569291|NCT00757458|EDTA|edta
569292|NCT00757458|Target controlled infusion|target controlled infusion
569293|NCT00757445|Antibiotic therapy|antibiotic therapy
569294|NCT00757445|Microbiological diagnosis|microbiological diagnosis
569295|NCT00757419|Safety|safety
569296|NCT00757419|tolerability|tolerability
569297|NCT00757419|healthy subjects|healthy subjects
569298|NCT00757406|Lymphedema|lymphedema
569299|NCT00757406|Bioimpedance|bioimpedance
569300|NCT00757393|Growth hormone|growth hormone
569301|NCT00757393|Pediatrics|pediatrics
569302|NCT00757393|Vitamin D|vitamin d
569305|NCT00757380|epiretinal membranes|epiretinal membranes
569306|NCT00757380|vitreoretinal dyes|vitreoretinal dyes
569307|NCT00757380|membranepeeling|membranepeeling
569308|NCT00757367|Healthy subjects|healthy subjects
569309|NCT00757367|insulin|insulin
569310|NCT00757367|bronchoscope|bronchoscope
569311|NCT00757367|serum insulin|serum insulin
569312|NCT00757367|serum C-Peptide|serum c-peptide
569313|NCT00757367|BAL fluid|bal fluid
569314|NCT00757367|FDKP|fdkp
569315|NCT00757328|Bipolar depression Treatment|bipolar depression treatment
569316|NCT00757315|acne keloidalis nuchae|acne keloidalis nuchae
569317|NCT00757315|NdYag laser|ndyag laser
569318|NCT00757315|AKN|akn
569319|NCT00757315|acne keloidalis|acne keloidalis
569320|NCT00757315|AK|ak
569321|NCT00757315|dermatitis papillaris capillitii|dermatitis papillaris capillitii
569322|NCT00757315|folliculitis keloidalis nuchae|folliculitis keloidalis nuchae
569323|NCT00757315|sycosis nuchae|sycosis nuchae
569324|NCT00757315|acne keloid|acne keloid
569325|NCT00757315|keloidal folliculitis|keloidal folliculitis
569326|NCT00757315|lichen keloidalis nuchae|lichen keloidalis nuchae
569327|NCT00757315|folliculitis nuchae scleroticans|folliculitis nuchae scleroticans
569328|NCT00757315|sycosis framboesiformis|sycosis framboesiformis
569329|NCT00757302|breast cancer|breast cancer
569330|NCT00757302|CarolIReS|carolires
569331|NCT00757302|intraoperative gamma camera|intraoperative gamma camera
569332|NCT00757302|lymphoscintigraphy|lymphoscintigraphy
569333|NCT00757302|sentinel lymph node|sentinel lymph node
569334|NCT00757302|Hundred and ten patients with infiltrative breast cancer or ductal carcinoma in situ (DCIS), diagnosed preoperatively by core biopsy or cytology.|hundred and ten patients with infiltrative breast cancer or ductal carcinoma in situ (dcis), diagnosed preoperatively by core biopsy or cytology.
569335|NCT00757289|Tennis Elbow|tennis elbow
569336|NCT00757276|Copeptin|copeptin
569337|NCT00757276|Diabetes insipidus|diabetes insipidus
569338|NCT00757276|diagnostic marker|diagnostic marker
569339|NCT00757276|Vasopressin|vasopressin
569340|NCT00757276|antidiuretic hormone (ADH)|antidiuretic hormone (adh)
569341|NCT00757263|ovarian epithelial cancer|ovarian epithelial cancer
569342|NCT00757263|ovarian germ cell tumor|ovarian germ cell tumor
569343|NCT00757263|ovarian sarcoma|ovarian sarcoma
569344|NCT00757263|ovarian stromal cancer|ovarian stromal cancer
569345|NCT00757250|HIV|hiv
569346|NCT00757250|AIDS|aids
569347|NCT00757250|Human Immunodeficiency Virus|human immunodeficiency virus
569348|NCT00757250|CD4+ T-lymphocytes|cd4+ t-lymphocytes
569349|NCT00757250|treatment Experienced|treatment experienced
569350|NCT00757237|aztreonam lysine|aztreonam lysine
569351|NCT00757237|tobramycin inhalation solution|tobramycin inhalation solution
569352|NCT00757237|tobramycin nebuliser solution|tobramycin nebuliser solution
569353|NCT00757237|cystic fibrosis|cystic fibrosis
569354|NCT00757237|pseudomonas aeruginosa|pseudomonas aeruginosa
569355|NCT00757237|lung infection|lung infection
569356|NCT00757237|CFQ-R|cfq-r
569357|NCT00757237|inhaled antibiotic|inhaled antibiotic
569358|NCT00757211|breast cancer|breast cancer
569359|NCT00757211|male breast cancer|male breast cancer
569360|NCT00757198|pain, postoperative, opioid, PCA, cardiac surgery|pain, postoperative, opioid, pca, cardiac surgery
569361|NCT00757185|skin blood flow|skin blood flow
569362|NCT00757185|microcirculation|microcirculation
569363|NCT00757172|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
569364|NCT00757172|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
569365|NCT00757172|stage II esophageal cancer|stage ii esophageal cancer
569366|NCT00757172|stage III esophageal cancer|stage iii esophageal cancer
569367|NCT00757172|stage IV esophageal cancer|stage iv esophageal cancer
569368|NCT00757159|Periodontal disease|periodontal disease
569369|NCT00757159|Hydroxyapatite|hydroxyapatite
569370|NCT00757159|Enamel matrix protein|enamel matrix protein
569371|NCT00757159|Regeneration|regeneration
569372|NCT00757159|Human|human
569373|NCT00757146|chronic lung disease|chronic lung disease
569374|NCT00757146|bronchopulmonary dysplasia|bronchopulmonary dysplasia
569375|NCT00757146|inhaled nitric oxide|inhaled nitric oxide
569376|NCT00757146|premature infants|premature infants
569377|NCT00757120|COPD|copd
569378|NCT00757120|Cigarette Smoke-Induced Inflammation|cigarette smoke-induced inflammation
569379|NCT00757120|EMMPRIN|emmprin
569380|NCT00757120|Matrix Metalloproteinase|matrix metalloproteinase
569381|NCT00757107|Short femoral stem|short femoral stem
569382|NCT00757107|Stress shielding|stress shielding
569383|NCT00757107|Stem migration|stem migration
569384|NCT00757107|Implant Survival|implant survival
569385|NCT00757107|DEXA|dexa
569386|NCT00757107|Radiostereometric analysis|radiostereometric analysis
569387|NCT00757094|Fasting|fasting
569388|NCT00757094|Chemotherapy|chemotherapy
569389|NCT00757094|Cancer|cancer
569390|NCT00757068|Non-smoking|non-smoking
569391|NCT00757068|Women|women
569392|NCT00757068|Pregnancy|pregnancy
569393|NCT00757068|Treatment|treatment
569394|NCT00757068|Mood|mood
569395|NCT00757068|Weight|weight
569396|NCT00757068|Supportive|supportive
569397|NCT00757068|Adjustment|adjustment
569398|NCT00757055|Heart failure|heart failure
569399|NCT00757055|Diastolic heart failure|diastolic heart failure
569400|NCT00757055|Heart failure with preserved systolic function|heart failure with preserved systolic function
569401|NCT00757055|Heart failure with normal ejection fraction|heart failure with normal ejection fraction
569402|NCT00757055|Ivabradine|ivabradine
569403|NCT00757055|Diastolic dysfunction|diastolic dysfunction
569404|NCT00757042|atopic dermatitis|atopic dermatitis
569405|NCT00757042|skin diseases|skin diseases
569406|NCT00757042|healthy volunteer|healthy volunteer
569407|NCT00757029|ADHD,|adhd,
569408|NCT00757029|norepinephrine transporter|norepinephrine transporter
569409|NCT00757029|pharmacogenetics|pharmacogenetics
569410|NCT00757016|low back pain|low back pain
569411|NCT00757016|randomised controlled trial|randomised controlled trial
569412|NCT00757016|slow release corticosteroid|slow release corticosteroid
569413|NCT00757016|injection treatment|injection treatment
569414|NCT00756977|Colonoscopy|colonoscopy
569415|NCT00756977|screening|screening
569416|NCT00756964|cardiac surgery|cardiac surgery
569417|NCT00756964|hyperuricemia|hyperuricemia
569418|NCT00756951|SCV-07|scv-07
569419|NCT00756951|Oral Mucositis|oral mucositis
569420|NCT00756925|CRH|crh
569421|NCT00756925|cocaine|cocaine
569422|NCT00756925|functional magnetic resonance imaging|functional magnetic resonance imaging
569423|NCT00756925|gender differences|gender differences
569424|NCT00756912|ANC|anc
569425|NCT00756912|BMT|bmt
569426|NCT00756912|graft versus leukemia|graft versus leukemia
569427|NCT00756912|graft vs. host disease|graft vs. host disease
569428|NCT00756912|MD2 (endotoxin binding-protein)|md2 (endotoxin binding-protein)
569429|NCT00756912|undergo allogeneic BMT|undergo allogeneic bmt
569430|NCT00756912|myeloablative|myeloablative
569431|NCT00756912|conditioning|conditioning
569432|NCT00756912|therapy|therapy
569433|NCT00756899|Vitamin D deficiency, insulin resistance, obesity, bone|vitamin d deficiency, insulin resistance, obesity, bone
569434|NCT00756873|Elective tonsillectomy|elective tonsillectomy
569435|NCT00756847|Solid Tumors|solid tumors
569436|NCT00756847|NSCLC|nsclc
569437|NCT00756847|Ovarian Cancer|ovarian cancer
569438|NCT00756847|Endometrial Cancer|endometrial cancer
569439|NCT00756821|Spinal Muscular Atrophy|spinal muscular atrophy
569440|NCT00756821|Blood Biomarkers|blood biomarkers
569441|NCT00756821|Urine Biomarkers|urine biomarkers
569442|NCT00756821|Type I Spinal Muscular Atrophy|type i spinal muscular atrophy
569443|NCT00756821|Type II Spinal Muscular Atrophy|type ii spinal muscular atrophy
569444|NCT00756821|Type III Spinal Muscular Atrophy|type iii spinal muscular atrophy
569445|NCT00756821|Modified Hammersmith Functional Motor Scale|modified hammersmith functional motor scale
569446|NCT00756821|Disease severity|disease severity
569447|NCT00756821|Biomarkers|biomarkers
569448|NCT00756808|latent tuberculosis in elderly|latent tuberculosis in elderly
569449|NCT00756782|hepatocellular carcinoma|hepatocellular carcinoma
569450|NCT00756756|G-CSF|g-csf
569451|NCT00756756|Myocardial infarction|myocardial infarction
569452|NCT00756743|PF-04802540 multiple dose safety study|pf-04802540 multiple dose safety study
569453|NCT00756730|lopinavir|lopinavir
569454|NCT00756730|ritonavir|ritonavir
569455|NCT00756730|atazanavir|atazanavir
569456|NCT00756730|fosamprenavir|fosamprenavir
569457|NCT00756730|darunavir|darunavir
569458|NCT00756730|anti-retroviral|anti-retroviral
569459|NCT00756730|AIDS|aids
569460|NCT00756730|HIV|hiv
569461|NCT00756730|LARD|lard
569462|NCT00756730|triglyceride|triglyceride
569463|NCT00756730|protease inhibitors|protease inhibitors
569464|NCT00756730|treatment Experienced|treatment experienced
569465|NCT00756717|MK-0752|mk-0752
569466|NCT00756717|Tamoxifen|tamoxifen
569467|NCT00756717|Letroxole|letroxole
569468|NCT00756704|Smoking Cessation|smoking cessation
569469|NCT00756704|Emergency Medicine|emergency medicine
569470|NCT00756704|Emergency Nursing|emergency nursing
569471|NCT00756704|Effectiveness Trial|effectiveness trial
569472|NCT00756704|Implementation|implementation
569473|NCT00756704|Relapse prevention|relapse prevention
569474|NCT00756691|18F-FAZA|18f-faza
569475|NCT00756691|Positron Emission Tomography|positron emission tomography
569476|NCT00756691|Radiation dosimetry|radiation dosimetry
569477|NCT00756691|Pharmacokinetics|pharmacokinetics
569478|NCT00756665|prostate|prostate
569479|NCT00756665|cancer|cancer
569480|NCT00756639|small cell carcinoma of the bladder|small cell carcinoma of the bladder
569481|NCT00756639|urothelial carcinoma|urothelial carcinoma
569482|NCT00756639|genitourinary bladder|genitourinary bladder
569483|NCT00756639|urothelium|urothelium
569484|NCT00756639|bladder|bladder
569485|NCT00756639|bladder cancer|bladder cancer
569486|NCT00756639|prophylactic cranial irradiation|prophylactic cranial irradiation
569487|NCT00756639|PCI|pci
569488|NCT00756639|brain metastasis|brain metastasis
569489|NCT00756639|genitourinary|genitourinary
569490|NCT00756639|radiation|radiation
569491|NCT00756639|TCC|tcc
569492|NCT00756639|adenocarcinoma|adenocarcinoma
569493|NCT00756626|Bottle Weaning|bottle weaning
569494|NCT00756626|Bottle Feeding|bottle feeding
569495|NCT00756626|Overweight in toddlers|overweight in toddlers
569496|NCT00756626|Bottle use|bottle use
569497|NCT00756626|excess weight for length|excess weight for length
569498|NCT00756600|Infants|infants
569499|NCT00756600|scheduled|scheduled
569500|NCT00756600|unilateral|unilateral
569501|NCT00756600|bilateral|bilateral
569502|NCT00756600|repair|repair
569503|NCT00756587|Cup Feeding|cup feeding
569504|NCT00756587|late Preterm|late preterm
569505|NCT00756574|N95|n95
569506|NCT00756574|Respirator|respirator
569507|NCT00756574|mask|mask
569508|NCT00756574|influenza|influenza
569509|NCT00756574|efficacy|efficacy
569510|NCT00756561|Fine Needle Aspiration|fine needle aspiration
569511|NCT00756561|Male Health|male health
569512|NCT00756561|Male Contraception|male contraception
569513|NCT00756548|colonoscopy|colonoscopy
569515|NCT00756535|Exercise Therapy|exercise therapy
569516|NCT00756535|Length of Stay|length of stay
569517|NCT00756535|Disability Evaluation|disability evaluation
569518|NCT00756522|COPD|copd
569519|NCT00756509|unresectable or metastatic GIST|unresectable or metastatic gist
569520|NCT00756509|1st. line treatment|1st. line treatment
569521|NCT00756483|Resistance|resistance
569522|NCT00756483|Exercise|exercise
569523|NCT00756470|Breast Cancer|breast cancer
569524|NCT00756470|Inflammatory Breast Cancer|inflammatory breast cancer
569526|NCT00756470|ErbB2 overexpression|erbb2 overexpression
569527|NCT00756470|Lapatinib|lapatinib
569528|NCT00756470|Paclitaxel|paclitaxel
569529|NCT00756470|5-Fluorouracil|5-fluorouracil
569530|NCT00756470|Epirubicin|epirubicin
569531|NCT00756470|Cyclophosphamide|cyclophosphamide
569532|NCT00756470|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
569533|NCT00756457|PTTD|pttd
569534|NCT00756457|Tendinopathy|tendinopathy
569535|NCT00756457|Tendon Injuries|tendon injuries
569536|NCT00756457|Muscular Diseases|muscular diseases
569537|NCT00756457|Foot Diseases|foot diseases
569538|NCT00756444|PK Study, Metastatic Recurrent|pk study, metastatic recurrent
569539|NCT00756405|Adults|adults
569540|NCT00756405|Antioxidants|antioxidants
569541|NCT00756405|Inflammatory markers|inflammatory markers
569542|NCT00756405|Diet|diet
569543|NCT00756405|Supplements|supplements
569544|NCT00756392|3T MR Spectroscopy|3t mr spectroscopy
569545|NCT00756392|Prostate Imaging|prostate imaging
569546|NCT00756379|Cardiovascular disease|cardiovascular disease
569547|NCT00756379|Atherosclerosis|atherosclerosis
569548|NCT00756379|Coronary artery disease|coronary artery disease
569549|NCT00756379|Coronary perfusion defect|coronary perfusion defect
569550|NCT00756379|Absolute coronary flow|absolute coronary flow
569551|NCT00756379|Lifestyle management|lifestyle management
569552|NCT00756379|Cardiovascular rehabilitation|cardiovascular rehabilitation
569553|NCT00756379|Cardiovascular dietary guidelines|cardiovascular dietary guidelines
569554|NCT00756366|positron emission tomography|positron emission tomography
569555|NCT00756366|myocardial energetics|myocardial energetics
569556|NCT00756366|sympathetic nerve function|sympathetic nerve function
569557|NCT00756353|Heroin|heroin
569558|NCT00756353|Buprenorphine use|buprenorphine use
569559|NCT00756327|pediatric eyes|pediatric eyes
569560|NCT00756327|bilateral cataract|bilateral cataract
569561|NCT00756327|IOL implantation|iol implantation
569562|NCT00756327|Aqualase capsule wash|aqualase capsule wash
569563|NCT00756327|posterior capsule opacification|posterior capsule opacification
569564|NCT00756314|Ambulatory Care Facilities|ambulatory care facilities
569565|NCT00756314|abortion care|abortion care
569566|NCT00756314|contraception|contraception
569567|NCT00756314|counseling|counseling
569568|NCT00756314|outpatient clinic|outpatient clinic
569569|NCT00756288|Actinic Keratoses|actinic keratoses
569570|NCT00756288|Blue light therapy|blue light therapy
569571|NCT00756288|photosensitizer|photosensitizer
569572|NCT00756288|Retinoid|retinoid
569573|NCT00756275|Tobacco Smoking|tobacco smoking
569574|NCT00756275|Smoking Cessation|smoking cessation
569575|NCT00756275|Nicotine Dependence|nicotine dependence
569576|NCT00756275|Tobacco Use Disorder|tobacco use disorder
569577|NCT00756262|Vancomycin Resistant enterococcal colonization|vancomycin resistant enterococcal colonization
569578|NCT00756262|Probiotics|probiotics
569579|NCT00756262|LGG|lgg
569580|NCT00756262|Lactobacillus rhamnosus|lactobacillus rhamnosus
569581|NCT00756249|Acute ischemic stroke|acute ischemic stroke
569582|NCT00756249|Erythropoietin|erythropoietin
569583|NCT00756249|Carbamylated|carbamylated
569584|NCT00756249|Neuroprotection|neuroprotection
569585|NCT00756197|Radiation Proctitis|radiation proctitis
569586|NCT00756197|Radiation Induced Proctitis|radiation induced proctitis
569587|NCT00756184|Glaucoma|glaucoma
569588|NCT00756184|Adherence|adherence
569589|NCT00756184|Teaching|teaching
569590|NCT00756171|Cholestatic|cholestatic
569591|NCT00756171|pruritus|pruritus
569592|NCT00756171|of any cause|of any cause
569593|NCT00756158|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
569594|NCT00756158|dopaminergic|dopaminergic
569595|NCT00756158|noradrenergic|noradrenergic
569596|NCT00756158|endophenotype|endophenotype
569597|NCT00756158|molecular genetics|molecular genetics
569598|NCT00756158|candidate gene|candidate gene
569599|NCT00756158|Family-based Association study|family-based association study
569600|NCT00756145|stage V|stage v
569601|NCT00756145|treated|treated
569602|NCT00756145|hemodiafiltration|hemodiafiltration
569603|NCT00756132|Breast|breast
569604|NCT00756132|Neoplasm|neoplasm
569605|NCT00756132|Locally Advanced|locally advanced
569606|NCT00756132|Stage IV|stage iv
569607|NCT00756132|Stage III|stage iii
569608|NCT00756132|Cognitive Function|cognitive function
569609|NCT00756132|Cytokines|cytokines
569610|NCT00756132|Inflammatory|inflammatory
569611|NCT00756132|Node positive|node positive
569612|NCT00756106|adult glioblastoma|adult glioblastoma
569613|NCT00756106|adult giant cell glioblastoma|adult giant cell glioblastoma
569614|NCT00756106|adult gliosarcoma|adult gliosarcoma
569615|NCT00756106|adult anaplastic astrocytoma|adult anaplastic astrocytoma
569616|NCT00756106|adult anaplastic ependymoma|adult anaplastic ependymoma
569617|NCT00756106|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
569618|NCT00756106|adult mixed glioma|adult mixed glioma
569619|NCT00756093|Dry Eye, Artificial Tears,|dry eye, artificial tears,
569620|NCT00756067|Streptococcus pneumoniae|streptococcus pneumoniae
569621|NCT00756067|pneumococcal vaccine|pneumococcal vaccine
569622|NCT00756041|Diabetic Mononeuropathy|diabetic mononeuropathy
569623|NCT00756041|Diabetic Neuralgia|diabetic neuralgia
569624|NCT00756041|Mononeuropathy, Diabetic|mononeuropathy, diabetic
569625|NCT00756041|Neuralgia, Diabetic|neuralgia, diabetic
569626|NCT00756041|Diabetic Polyneuropathy|diabetic polyneuropathy
569627|NCT00756041|Drug Therapy|drug therapy
569628|NCT00756028|OHSS|ohss
569629|NCT00756028|quality of life|quality of life
569630|NCT00756028|IVF|ivf
569631|NCT00756028|ICSI|icsi
569632|NCT00756028|GnRH-agonist|gnrh-agonist
569633|NCT00756028|GnRH-antagonist|gnrh-antagonist
569634|NCT00756015|rotator cuff|rotator cuff
569635|NCT00756015|post-operative immobilization protocol|post-operative immobilization protocol
569636|NCT00756015|post-operative early motion protocol|post-operative early motion protocol
569637|NCT00756015|physical therapy|physical therapy
569638|NCT00756015|cuff repair integrity|cuff repair integrity
569639|NCT00756015|ultrasound|ultrasound
569640|NCT00756002|Chronic Insomnia|chronic insomnia
569641|NCT00756002|DIMS (Disorders of Initiating and Maintaining Sleep)|dims (disorders of initiating and maintaining sleep)
569642|NCT00756002|Disorders of Initiating and Maintaining Sleep|disorders of initiating and maintaining sleep
569643|NCT00756002|Insomnia Disorder Sleep Initiation Dysfunction|insomnia disorder sleep initiation dysfunction
569644|NCT00756002|Transient Insomnia|transient insomnia
569645|NCT00756002|Drug Therapy|drug therapy
569646|NCT00756002|Sleep Disorders, Intrinsic|sleep disorders, intrinsic
569647|NCT00755976|stage IV melanoma|stage iv melanoma
569648|NCT00755950|Acute|acute
569649|NCT00755950|Hepatitis|hepatitis
569650|NCT00755950|Silymarin|silymarin
569651|NCT00755950|Global Health|global health
569652|NCT00755911|dental|dental
569653|NCT00755911|tooth|tooth
569654|NCT00755911|implant|implant
569655|NCT00755911|extraction|extraction
569656|NCT00755911|Oral|oral
569657|NCT00755911|Surgical|surgical
569658|NCT00755911|Procedures|procedures
569659|NCT00755898|cancer|cancer
569660|NCT00755898|diagnostic test|diagnostic test
569661|NCT00755898|urine|urine
569662|NCT00755898|amantadine acetylation|amantadine acetylation
569663|NCT00755885|stage IIIA breast cancer|stage iiia breast cancer
569664|NCT00755885|stage IIIB breast cancer|stage iiib breast cancer
569665|NCT00755885|stage IIIC breast cancer|stage iiic breast cancer
569666|NCT00755885|stage IV breast cancer|stage iv breast cancer
569667|NCT00755885|recurrent breast cancer|recurrent breast cancer
569668|NCT00755885|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
569669|NCT00755885|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
569670|NCT00755859|IgA nephropathy|iga nephropathy
569671|NCT00755859|steroids|steroids
569672|NCT00755859|azathioprine|azathioprine
569673|NCT00755859|chronic kidney disease progression|chronic kidney disease progression
569674|NCT00755859|proteinuria|proteinuria
569675|NCT00755846|Diabetes Mellitus|diabetes mellitus
569676|NCT00755846|Drug Therapy|drug therapy
569677|NCT00755846|Diabetes Mellitus, Type II|diabetes mellitus, type ii
569678|NCT00755846|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
569679|NCT00755846|Hyperinsulinism|hyperinsulinism
569680|NCT00755846|Insulin Resistance|insulin resistance
569681|NCT00755807|Central Neuropathic Pain|central neuropathic pain
569682|NCT00755807|Multiple Sclerosis|multiple sclerosis
569683|NCT00755781|lung transplant|lung transplant
569684|NCT00755781|lung transplant recipient|lung transplant recipient
569685|NCT00755781|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
569686|NCT00755781|bronchiolitis obliterans|bronchiolitis obliterans
569687|NCT00755781|single lung transplant|single lung transplant
569688|NCT00755781|double lung transplant|double lung transplant
569689|NCT00755781|heart-lung transplant|heart-lung transplant
569690|NCT00755781|Aerosol|aerosol
569691|NCT00755768|hemodialysis|hemodialysis
569692|NCT00755768|phosphate|phosphate
569693|NCT00755768|calcium phosphate product|calcium phosphate product
569694|NCT00755768|dietician|dietician
569695|NCT00755768|dietetic advice|dietetic advice
569696|NCT00755742|obesity|obesity
569697|NCT00755742|insulin resistance|insulin resistance
569698|NCT00755742|metabolic syndrome|metabolic syndrome
569699|NCT00755742|hepatitis C|hepatitis c
569700|NCT00755742|adipokine|adipokine
569701|NCT00755742|TNF|tnf
569702|NCT00755742|leptin|leptin
569703|NCT00755742|adiponectin|adiponectin
569704|NCT00755742|fatigue|fatigue
569705|NCT00755742|mood|mood
569706|NCT00755742|depression|depression
569707|NCT00755742|exercise|exercise
569708|NCT00755742|diet|diet
569709|NCT00755742|counseling|counseling
569710|NCT00755742|behavior modification|behavior modification
569711|NCT00755729|Preoperative oral carbohydrate|preoperative oral carbohydrate
569712|NCT00755729|Insulin resistance|insulin resistance
569713|NCT00755729|phosphatidylinositol-3-kinase|phosphatidylinositol-3-kinase
569714|NCT00755716|nicotine patch|nicotine patch
569715|NCT00755716|smoking|smoking
569716|NCT00755716|topiramate|topiramate
569717|NCT00755703|Influenza|influenza
569718|NCT00755703|Vaccine|vaccine
569719|NCT00755703|Pandemic|pandemic
569720|NCT00755703|Avian influenza|avian influenza
569721|NCT00755703|Adenovirus strain 5|adenovirus strain 5
569722|NCT00755703|Vectored vaccine|vectored vaccine
569723|NCT00755703|Intranasal|intranasal
569724|NCT00755703|Tissue-culture derived|tissue-culture derived
569725|NCT00755703|Non-replicating|non-replicating
569726|NCT00755690|Chronic Kidney Disease|chronic kidney disease
569727|NCT00755690|CKD|ckd
569728|NCT00755690|Diet|diet
569729|NCT00755690|Dietary Phosphate|dietary phosphate
569730|NCT00755690|Mineral Metabolism|mineral metabolism
569731|NCT00755690|FGF-23|fgf-23
569732|NCT00755664|homocysteine|homocysteine
569733|NCT00755664|folate acid,|folate acid,
569734|NCT00755664|vitamin B|vitamin b
569735|NCT00755664|random controlled trail|random controlled trail
569736|NCT00755651|Menorrhagia|menorrhagia
569737|NCT00755651|Uterine fibroids|uterine fibroids
569738|NCT00755651|Endometrial polyps|endometrial polyps
569739|NCT00755651|Endometrial cancer|endometrial cancer
569740|NCT00755599|Papanicolaou Smear|papanicolaou smear
569741|NCT00755599|Vaginitis|vaginitis
569742|NCT00755599|Patient Satisfaction|patient satisfaction
569743|NCT00755586|Brachial plexus|brachial plexus
569744|NCT00755586|Muscle denervation|muscle denervation
569745|NCT00755586|Stem cell transplantation|stem cell transplantation
569746|NCT00755586|Bone marrow cells|bone marrow cells
569747|NCT00755586|Satellite cells|satellite cells
569748|NCT00755586|Fibrosis|fibrosis
569749|NCT00755573|Pain|pain
569750|NCT00755573|Neuropathic pain|neuropathic pain
569751|NCT00755560|Toxocara|toxocara
569752|NCT00755560|Pediatrics|pediatrics
569753|NCT00755560|Albendazole|albendazole
569754|NCT00755560|eosinophilia|eosinophilia
569755|NCT00755560|parasitology|parasitology
569756|NCT00755560|pediatric clinical pharmacology|pediatric clinical pharmacology
569757|NCT00755547|Childhood|childhood
569758|NCT00755547|insulin sensitivity|insulin sensitivity
569759|NCT00755547|steatosis, spectroscopy|steatosis, spectroscopy
569760|NCT00755534|Metastatic colorectal cancer|metastatic colorectal cancer
569761|NCT00755534|Second line|second line
569762|NCT00755534|Irinotecan|irinotecan
569763|NCT00755534|Cetuximab (Erbitux)|cetuximab (erbitux)
569764|NCT00755534|Capecitabine (Xeloda)|capecitabine (xeloda)
569765|NCT00755521|Fibromyalgia|fibromyalgia
569766|NCT00755521|tenderness|tenderness
569767|NCT00755521|widespread pain|widespread pain
569768|NCT00755521|comrbidity|comrbidity
569769|NCT00755508|Chronic Insomnia|chronic insomnia
569770|NCT00755508|DIMS (Disorders of Initiating and Maintaining Sleep)|dims (disorders of initiating and maintaining sleep)
569771|NCT00755508|Disorders of Initiating and Maintaining Sleep|disorders of initiating and maintaining sleep
569772|NCT00755508|Insomnia Disorder Sleep Initiation Dysfunction|insomnia disorder sleep initiation dysfunction
569773|NCT00755508|Transient Insomnia|transient insomnia
569774|NCT00755508|Drug Therapy|drug therapy
569775|NCT00755508|Sleep Disorders, Intrinsic|sleep disorders, intrinsic
569776|NCT00755495|Chronic Insomnia|chronic insomnia
569777|NCT00755495|DIMS (Disorders of Initiating and Maintaining Sleep)|dims (disorders of initiating and maintaining sleep)
569778|NCT00755495|Disorders of Initiating and Maintaining Sleep|disorders of initiating and maintaining sleep
569779|NCT00755495|Insomnia Disorder Sleep Initiation Dysfunction|insomnia disorder sleep initiation dysfunction
569780|NCT00755495|Transient Insomnia|transient insomnia
569781|NCT00755495|Drug Therapy|drug therapy
569782|NCT00755495|Sleep Disorders, Intrinsic|sleep disorders, intrinsic
569783|NCT00755482|Osteoarthritis|osteoarthritis
569784|NCT00755482|Clinical trial|clinical trial
569785|NCT00755482|Aquamin F|aquamin f
569786|NCT00755482|NSAID|nsaid
569787|NCT00755469|Reperfusion injury|reperfusion injury
569788|NCT00755469|Post-Conditioning|post-conditioning
569789|NCT00755469|Infarct size|infarct size
569790|NCT00755456|Peritoneal dialysis|peritoneal dialysis
569791|NCT00755456|L-carnitine|l-carnitine
569792|NCT00755456|Insulin resistance|insulin resistance
569793|NCT00755456|Glucose homeostasis|glucose homeostasis
569794|NCT00755456|Dyslipidemia|dyslipidemia
569795|NCT00755430|autism spectrum disorders (ASD)|autism spectrum disorders (asd)
570031|NCT00754754|retraction|retraction
569796|NCT00755430|structural and functional connectivity|structural and functional connectivity
569797|NCT00755430|diffusion spectrum imaging (DSI)|diffusion spectrum imaging (dsi)
569798|NCT00755430|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
569799|NCT00755430|siblings|siblings
569800|NCT00755430|repeated follow-up measurement|repeated follow-up measurement
569801|NCT00755417|Hot flashes|hot flashes
569802|NCT00755417|Hot flushes|hot flushes
569803|NCT00755417|Postmenopausal symptoms|postmenopausal symptoms
569804|NCT00755417|Vasomotor symptoms|vasomotor symptoms
569805|NCT00755404|Peritoneal dialysis|peritoneal dialysis
569806|NCT00755404|L-carnitine|l-carnitine
569807|NCT00755404|Diabetes|diabetes
569808|NCT00755404|Glucose homeostasis|glucose homeostasis
569809|NCT00755404|Dyslipidemia|dyslipidemia
569810|NCT00755391|BN and subthreshold BN|bn and subthreshold bn
569811|NCT00755378|Phase I|phase i
569812|NCT00755365|pelvic fractures|pelvic fractures
569813|NCT00755365|angioembolism|angioembolism
569814|NCT00755365|Treatment at Hershey Medical Center|treatment at hershey medical center
569815|NCT00755365|Angioembolization in Operating Room|angioembolization in operating room
569816|NCT00755339|Repetitive TMS (rTMS)|repetitive tms (rtms)
569817|NCT00755339|Magnetoencephalogram|magnetoencephalogram
569818|NCT00755339|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
569819|NCT00755339|Tourette Syndrome|tourette syndrome
569820|NCT00755339|Tic Disorder|tic disorder
569821|NCT00755339|Tourete Syndrome|tourete syndrome
569822|NCT00755326|OA|oa
569823|NCT00755313|cognitive/functional effects|cognitive/functional effects
569824|NCT00755313|fatigue|fatigue
569825|NCT00755313|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
569826|NCT00755313|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
569827|NCT00755313|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
569828|NCT00755313|neurotoxicity|neurotoxicity
569829|NCT00755313|stage IA breast cancer|stage ia breast cancer
569830|NCT00755313|stage IB breast cancer|stage ib breast cancer
569831|NCT00755313|stage II breast cancer|stage ii breast cancer
569832|NCT00755313|stage IIIA breast cancer|stage iiia breast cancer
569833|NCT00755313|stage IIIB breast cancer|stage iiib breast cancer
569834|NCT00755313|stage IIIC breast cancer|stage iiic breast cancer
569835|NCT00755313|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
569836|NCT00755313|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
569837|NCT00755313|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
569838|NCT00755313|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
569839|NCT00755300|Total knee replacement|total knee replacement
569840|NCT00755300|esophageal echocardiography|esophageal echocardiography
569841|NCT00755274|Influenza|influenza
569842|NCT00755274|Orthomyxoviruses|orthomyxoviruses
569843|NCT00755274|Orthomyxoviridae Infections|orthomyxoviridae infections
569844|NCT00755274|Influenza vaccine|influenza vaccine
569845|NCT00755261|STS|sts
569846|NCT00755248|Coronary Artery Bypass Grafting (CABG)|coronary artery bypass grafting (cabg)
569847|NCT00755248|outcome|outcome
569848|NCT00755248|saphenous graft patency|saphenous graft patency
569849|NCT00755248|biochemical factors|biochemical factors
569850|NCT00755248|genomics|genomics
569851|NCT00755235|Depression|depression
569852|NCT00755235|Primary care|primary care
569853|NCT00755235|Effectiveness|effectiveness
569854|NCT00755235|Care management|care management
569855|NCT00755222|Peyronie's disease|peyronie's disease
569856|NCT00755222|penile plaque|penile plaque
569857|NCT00755222|penile curvature|penile curvature
569858|NCT00755209|Traumatic brain injury (TBI)|traumatic brain injury (tbi)
569859|NCT00755209|Adults|adults
569860|NCT00755209|Moderately severe TBI|moderately severe tbi
569861|NCT00755209|Delayed traumatic intracranial haemorrhage|delayed traumatic intracranial haemorrhage
569862|NCT00755209|Expanding traumatic intracranial haemorrhage|expanding traumatic intracranial haemorrhage
569863|NCT00755209|Progressive intracranial haemorrhage (PIH)|progressive intracranial haemorrhage (pih)
569864|NCT00755209|Antifibrinolytic agent|antifibrinolytic agent
569865|NCT00755209|Tranexamic acid (TXA)|tranexamic acid (txa)
569866|NCT00755209|Randomised, placebo-controlled trial|randomised, placebo-controlled trial
569867|NCT00755209|Human|human
569868|NCT00755196|Plaque Type Psoriasis|plaque type psoriasis
569869|NCT00755196|Topical|topical
569870|NCT00755183|Meibomian Gland Dysfunction|meibomian gland dysfunction
569871|NCT00755183|Dry Eye Syndrome|dry eye syndrome
569872|NCT00755170|Vinorelbine|vinorelbine
569873|NCT00755170|Bevacizumab|bevacizumab
569874|NCT00755170|Chemotherapy|chemotherapy
569875|NCT00755157|Cancer|cancer
569876|NCT00755157|SCLC|sclc
569877|NCT00755157|Docetaxel|docetaxel
569878|NCT00755157|Bevacizumab|bevacizumab
569879|NCT00755157|Chemotherapy|chemotherapy
569880|NCT00755131|Cardiac Rehabilitation|cardiac rehabilitation
569881|NCT00755131|High Mobility Group Box proteins|high mobility group box proteins
569882|NCT00755131|Inflammatory markers|inflammatory markers
569883|NCT00755131|Cardiopulmonary Functional Capacity|cardiopulmonary functional capacity
569884|NCT00755131|Maximal Oxygen Consumption|maximal oxygen consumption
569885|NCT00755131|Echocardiography|echocardiography
569886|NCT00755131|Left Ventricular Ejection Fraction|left ventricular ejection fraction
569887|NCT00755131|Left Ventricular Chambers Dilation|left ventricular chambers dilation
569888|NCT00755131|Left Ventricular Remodeling|left ventricular remodeling
569889|NCT00755131|Left Atrium Remodeling|left atrium remodeling
569890|NCT00755131|Cardiac Remodeling|cardiac remodeling
569891|NCT00755131|Exercise Training|exercise training
569892|NCT00755118|Metastatic colorectal cancer|metastatic colorectal cancer
569893|NCT00755118|Second line|second line
569894|NCT00755118|Irinotecan|irinotecan
569895|NCT00755118|Cetuximab|cetuximab
569896|NCT00755118|Bevacizumab|bevacizumab
569897|NCT00755105|body iron excretion|body iron excretion
569898|NCT00755105|Iron isotopes|iron isotopes
569899|NCT00755092|Doula|doula
569900|NCT00755092|Psychological care|psychological care
569901|NCT00755092|Labor analgesia|labor analgesia
569902|NCT00755079|spinal cord injury|spinal cord injury
569903|NCT00755079|beta-2 agonist|beta-2 agonist
569904|NCT00755079|respiratory muscle strength|respiratory muscle strength
569905|NCT00755079|pulmonary function test|pulmonary function test
569906|NCT00755053|Clotrimazole|clotrimazole
569907|NCT00755053|Ovule|ovule
569908|NCT00755053|Tablet|tablet
569909|NCT00755053|Vulvovaginal candidiasis|vulvovaginal candidiasis
569910|NCT00755053|Non-inferiority|non-inferiority
569911|NCT00755040|graft versus host disease|graft versus host disease
569912|NCT00755040|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
569913|NCT00755040|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
569914|NCT00755040|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
569915|NCT00755040|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
569916|NCT00755040|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
569917|NCT00755040|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
569918|NCT00755040|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
569919|NCT00755040|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
569920|NCT00755040|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
569921|NCT00755040|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
569922|NCT00755040|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
569923|NCT00755040|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
569924|NCT00755040|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
569925|NCT00755040|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
569926|NCT00755040|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
569927|NCT00755040|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
569928|NCT00755040|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
569929|NCT00755040|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
569930|NCT00755040|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
569931|NCT00755040|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
569932|NCT00755040|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
569933|NCT00755040|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
569934|NCT00755040|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
569935|NCT00755040|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
569936|NCT00755040|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
569937|NCT00755040|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
569938|NCT00755040|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
569939|NCT00755040|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
569940|NCT00755040|splenic marginal zone lymphoma|splenic marginal zone lymphoma
569941|NCT00755040|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
569942|NCT00755040|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
569943|NCT00755040|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
569944|NCT00755040|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
569945|NCT00755040|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
569946|NCT00755040|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
569947|NCT00755040|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
569948|NCT00755040|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
569949|NCT00755040|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
569950|NCT00755040|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
569951|NCT00755040|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
569952|NCT00755040|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
569953|NCT00755040|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
569954|NCT00755040|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
570032|NCT00754754|injury|injury
570033|NCT00754754|monitoring|monitoring
569955|NCT00755040|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
569956|NCT00755040|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
569957|NCT00755040|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
569958|NCT00755040|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
569959|NCT00755040|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
569960|NCT00755040|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
569961|NCT00755040|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
569962|NCT00755040|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
569963|NCT00755040|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
569964|NCT00755040|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
569965|NCT00755040|secondary acute myeloid leukemia|secondary acute myeloid leukemia
569966|NCT00755040|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
569967|NCT00755040|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
569968|NCT00755040|chronic eosinophilic leukemia|chronic eosinophilic leukemia
569969|NCT00755040|primary myelofibrosis|primary myelofibrosis
569970|NCT00755040|chronic neutrophilic leukemia|chronic neutrophilic leukemia
569971|NCT00755040|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
569972|NCT00755040|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
569973|NCT00755040|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
569974|NCT00755040|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
569975|NCT00755040|stage I multiple myeloma|stage i multiple myeloma
569976|NCT00755040|stage II multiple myeloma|stage ii multiple myeloma
569977|NCT00755040|stage III multiple myeloma|stage iii multiple myeloma
569978|NCT00755027|Parkinson's disease|parkinson's disease
569979|NCT00755027|Apathy|apathy
569980|NCT00755027|Rasagiline|rasagiline
569981|NCT00755001|Total Hip Replacement|total hip replacement
569982|NCT00754949|Blepharoconjunctivitis,|blepharoconjunctivitis,
569983|NCT00754949|Ophthalmology|ophthalmology
569984|NCT00754936|Depression|depression
569985|NCT00754923|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
569986|NCT00754923|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
569987|NCT00754923|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
569988|NCT00754923|adenocarcinoma of the lung|adenocarcinoma of the lung
569989|NCT00754923|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
569990|NCT00754923|large cell lung cancer|large cell lung cancer
569991|NCT00754910|stage I non-small cell lung cancer|stage i non-small cell lung cancer
569992|NCT00754910|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
569993|NCT00754910|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
569994|NCT00754910|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
569995|NCT00754910|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
569996|NCT00754910|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
569997|NCT00754897|Phone Interview|phone interview
569998|NCT00754897|Anesthesia|anesthesia
569999|NCT00754897|Siblings|siblings
570000|NCT00754897|Inguinal Hernia|inguinal hernia
570001|NCT00754897|Neurologic Examination|neurologic examination
570002|NCT00754897|Developmental Delay Disorders|developmental delay disorders
570003|NCT00754884|salmon calcitonin|salmon calcitonin
570004|NCT00754884|endorphins|endorphins
570005|NCT00754884|treatment|treatment
570006|NCT00754884|fibromyalgia|fibromyalgia
570007|NCT00754858|extensive stage small cell lung cancer|extensive stage small cell lung cancer
570008|NCT00754845|stage I breast cancer|stage i breast cancer
570009|NCT00754845|stage II breast cancer|stage ii breast cancer
570010|NCT00754845|stage IIIA breast cancer|stage iiia breast cancer
570011|NCT00754845|stage IIIB breast cancer|stage iiib breast cancer
570012|NCT00754845|stage IIIC breast cancer|stage iiic breast cancer
570013|NCT00754832|Multiple sclerosis|multiple sclerosis
570014|NCT00754832|fatigue|fatigue
570015|NCT00754832|ginseng|ginseng
570016|NCT00754806|HALS|hals
570017|NCT00754806|open splenectomy|open splenectomy
570018|NCT00754806|splenomegaly|splenomegaly
570019|NCT00754806|HALS as a hybrid approach of pure laparoscopy and open surgery has some definite advantages over open surgery|hals as a hybrid approach of pure laparoscopy and open surgery has some definite advantages over open surgery
570020|NCT00754806|In the HALS group, incision length is significantly shorter|in the hals group, incision length is significantly shorter
570021|NCT00754806|In the HALS group, postoperative pain is less than with open surgery|in the hals group, postoperative pain is less than with open surgery
570022|NCT00754806|In the HALS group, postoperative hospital stay is shorter than with open surgery|in the hals group, postoperative hospital stay is shorter than with open surgery
570023|NCT00754780|NF1|nf1
570024|NCT00754780|plexiform neurofibroma|plexiform neurofibroma
570025|NCT00754767|neurotoxicity|neurotoxicity
570026|NCT00754767|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
570027|NCT00754767|stage IV breast cancer|stage iv breast cancer
570028|NCT00754767|recurrent breast cancer|recurrent breast cancer
570029|NCT00754754|brain|brain
570030|NCT00754754|surgery|surgery
570034|NCT00754741|medication adherence|medication adherence
570035|NCT00754741|motivational interviewing|motivational interviewing
570036|NCT00754715|Multiple dosing study,|multiple dosing study,
570037|NCT00754715|safety|safety
570038|NCT00754702|Vinorelbine metronomic-lapatinib|vinorelbine metronomic-lapatinib
570039|NCT00754702|Chemotherapy|chemotherapy
570040|NCT00754702|Targeted therapy|targeted therapy
570041|NCT00754689|Rimonabant/metformin combination|rimonabant/metformin combination
570042|NCT00754663|exercise|exercise
570043|NCT00754663|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
570044|NCT00754663|arrhythmia|arrhythmia
570045|NCT00754637|Joint|joint
570046|NCT00754637|Osteoarthritis|osteoarthritis
570047|NCT00754637|Avascular Necrosis|avascular necrosis
570048|NCT00754546|exercise;|exercise;
570049|NCT00754546|treadmill;|treadmill;
570050|NCT00754546|cycle ergometer;|cycle ergometer;
570051|NCT00754546|breathlessness;|breathlessness;
570052|NCT00754546|leg discomfort|leg discomfort
570053|NCT00754533|cardiac rehabilitation|cardiac rehabilitation
570054|NCT00754533|coronary heart disease|coronary heart disease
570055|NCT00754533|interval training|interval training
570056|NCT00754533|continuous training|continuous training
570057|NCT00754533|ventilatory threshold|ventilatory threshold
570058|NCT00754481|Paediatrics|paediatrics
570059|NCT00754468|Barrett's Esophagus|barrett's esophagus
570060|NCT00754468|Esophageal Cancer|esophageal cancer
570061|NCT00754468|Esophageal Dysplasia|esophageal dysplasia
570062|NCT00754468|Low Grade Dysplasia|low grade dysplasia
570063|NCT00754468|High Grade Dysplasia|high grade dysplasia
570064|NCT00754442|hyperparathyroidism|hyperparathyroidism
570065|NCT00754442|parathyroid|parathyroid
570066|NCT00754442|vitamin D|vitamin d
570067|NCT00754442|vitamin D deficiency|vitamin d deficiency
570068|NCT00754416|Shoulder Replacement|shoulder replacement
570069|NCT00754403|Glucose Metabolism Disorder|glucose metabolism disorder
570070|NCT00754403|Dysmetabolic Syndrome|dysmetabolic syndrome
570071|NCT00754403|Type II Diabetes|type ii diabetes
570072|NCT00754403|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
570073|NCT00754403|Dyslipidemia|dyslipidemia
570074|NCT00754403|Drug Therapy|drug therapy
570075|NCT00754390|dietary zinc absorption|dietary zinc absorption
570076|NCT00754390|dietary phytic acid|dietary phytic acid
570077|NCT00754390|dietary calcium|dietary calcium
570078|NCT00754377|Education|education
570079|NCT00754377|Program Evaluation|program evaluation
570080|NCT00754377|Quality of Health Care|quality of health care
570081|NCT00754377|Medical Residents|medical residents
570082|NCT00754351|docetaxel|docetaxel
570083|NCT00754351|gemcitabine|gemcitabine
570084|NCT00754351|bevacizumab|bevacizumab
570085|NCT00754351|chemotherapy|chemotherapy
570086|NCT00754338|comfort|comfort
570087|NCT00754338|wetability|wetability
570088|NCT00754338|protein deposit|protein deposit
570089|NCT00754338|lipid deposit|lipid deposit
570090|NCT00754312|breast cancer|breast cancer
570091|NCT00754299|nonunion/malunion osseous fractures|nonunion/malunion osseous fractures
570092|NCT00754299|nicotine dependent|nicotine dependent
570093|NCT00754299|chronic osseous infection|chronic osseous infection
570094|NCT00754299|infected osseous nonunions|infected osseous nonunions
570095|NCT00754299|Fracture nonunion or infection|fracture nonunion or infection
570096|NCT00754286|Aromatherapy|aromatherapy
570097|NCT00754247|Keloid|keloid
570098|NCT00754247|Hypertrophic scar|hypertrophic scar
570099|NCT00754247|Hydrocortisone, silicone, vitamin E lotion|hydrocortisone, silicone, vitamin e lotion
570100|NCT00754247|HSE|hse
570101|NCT00754247|Onion extract gel|onion extract gel
570102|NCT00754247|OE|oe
570103|NCT00754247|Cetearyl alcohol lotion|cetearyl alcohol lotion
570104|NCT00754247|CEA|cea
570105|NCT00754234|iron absorption|iron absorption
570106|NCT00754234|iron requirements|iron requirements
570107|NCT00754234|dietary guidelines|dietary guidelines
570108|NCT00754234|MyPyramid|mypyramid
570109|NCT00754221|Phase 3, safety study, [S,S]-Reboxetine, Fibromyalgia|phase 3, safety study, [s,s]-reboxetine, fibromyalgia
570110|NCT00754208|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
570111|NCT00754208|Stimulant Treatment|stimulant treatment
570112|NCT00754208|Young Children|young children
570113|NCT00754195|Thoracotomy|thoracotomy
570114|NCT00754182|thyroidectomy|thyroidectomy
570115|NCT00754182|surgery|surgery
570116|NCT00754182|synthetic glue|synthetic glue
570117|NCT00754182|subcuticular suture|subcuticular suture
570118|NCT00754169|Traumatic Brain Injury|traumatic brain injury
570119|NCT00754169|Brain Imaging|brain imaging
570120|NCT00754169|Brain Plasticity|brain plasticity
570121|NCT00754169|Neuroplasticity|neuroplasticity
570122|NCT00754169|Neuropsychological Testing|neuropsychological testing
570123|NCT00754169|Head Injury|head injury
570124|NCT00754169|Healthy Volunteer|healthy volunteer
570125|NCT00754156|Closure, Wounds|closure, wounds
570126|NCT00754143|Type 1 or Type 2 diabetes|type 1 or type 2 diabetes
570127|NCT00754143|proteinuria|proteinuria
570128|NCT00754117|diffuse large b cell lymphoma|diffuse large b cell lymphoma
570129|NCT00754117|newly diagnosed|newly diagnosed
570130|NCT00754078|tomotherapy|tomotherapy
570131|NCT00754065|Oral contraceptive|oral contraceptive
570132|NCT00754065|Estradiol valerate and dienogest|estradiol valerate and dienogest
570133|NCT00754065|EV/DNG|ev/dng
570134|NCT00754065|comparative tolerability|comparative tolerability
570135|NCT00754052|Pediatric|pediatric
570136|NCT00754052|Down syndrome|down syndrome
570137|NCT00754052|Downs|downs
570138|NCT00754052|Cognitive Dysfunction of Down syndrome|cognitive dysfunction of down syndrome
570139|NCT00754039|Mixed hyperlipidemia|mixed hyperlipidemia
570140|NCT00754026|Shoulder surgery|shoulder surgery
570141|NCT00754013|pediatric|pediatric
570142|NCT00754013|Down syndrome|down syndrome
570143|NCT00754013|cognitive dysfunction|cognitive dysfunction
570144|NCT00754013|Downs|downs
570145|NCT00754013|Aricept|aricept
570146|NCT00754013|children with Down syndrome|children with down syndrome
570147|NCT00753987|Cystic Fibrosis|cystic fibrosis
570148|NCT00753987|Hypertonic Saline|hypertonic saline
570149|NCT00753987|Infants|infants
570150|NCT00753961|Shiftworkers|shiftworkers
570151|NCT00753961|volunteers|volunteers
570152|NCT00753948|Tetraplegia|tetraplegia
570153|NCT00753948|Mild asthma|mild asthma
570154|NCT00753948|Exhaled Nitric Oxide|exhaled nitric oxide
570155|NCT00753948|NOS inhibitor|nos inhibitor
570156|NCT00753948|Spinal cord injury|spinal cord injury
570157|NCT00753948|Pulmonary Function|pulmonary function
570158|NCT00753935|aspirin|aspirin
570159|NCT00753935|aspirin resistance|aspirin resistance
570160|NCT00753935|aspirin nonresponse|aspirin nonresponse
570161|NCT00753935|cyclooxygenase|cyclooxygenase
570162|NCT00753935|thromboxane|thromboxane
570163|NCT00753935|oxidative stress|oxidative stress
570164|NCT00753922|Breast Reconstruction|breast reconstruction
570165|NCT00753922|Breast Augmentation|breast augmentation
570166|NCT00753922|Revision|revision
570167|NCT00753922|Silicone breast implants|silicone breast implants
570168|NCT00753922|Round low-bleed|round low-bleed
570169|NCT00753909|Non Small Cell Lung Cancer|non small cell lung cancer
570170|NCT00753909|Paclitaxel|paclitaxel
570171|NCT00753909|Carboplatin|carboplatin
570172|NCT00753909|Bevacizumab|bevacizumab
570173|NCT00753896|Amylin|amylin
570174|NCT00753896|Lilly|lilly
570175|NCT00753896|exenatide once weekly|exenatide once weekly
570176|NCT00753896|thiazolidinedione|thiazolidinedione
570177|NCT00753896|metformin|metformin
570178|NCT00753870|current|current
570179|NCT00753870|no health problems|no health problems
570180|NCT00753870|no daily cough from smoking|no daily cough from smoking
570181|NCT00753857|risk communication|risk communication
570182|NCT00753857|probability sample by random digit dialing|probability sample by random digit dialing
570183|NCT00753844|peptide vaccine|peptide vaccine
570184|NCT00753844|URLC10|urlc10
570185|NCT00753831|Blepharoptosis|blepharoptosis
570186|NCT00753831|Ophthalmoplegia|ophthalmoplegia
570187|NCT00753831|Blepharospasm|blepharospasm
570188|NCT00753818|infant formula|infant formula
570189|NCT00753818|visual development|visual development
570190|NCT00753805|mare's milk|mare's milk
570191|NCT00753805|atopic dermatitis|atopic dermatitis
570192|NCT00753805|endogenous eczema|endogenous eczema
570193|NCT00753805|SCORAD|scorad
570194|NCT00753805|Bifidobacteria|bifidobacteria
570195|NCT00753792|multiple sclerosis|multiple sclerosis
570196|NCT00753792|relapse|relapse
570197|NCT00753792|methylprednisolone|methylprednisolone
570198|NCT00753766|A1c|a1c
570199|NCT00753766|Blood Glucose Management|blood glucose management
570200|NCT00753766|Blood Pressure|blood pressure
570201|NCT00753766|Case Management|case management
570202|NCT00753766|Diabetes Mellitus|diabetes mellitus
570203|NCT00753766|Intervention study|intervention study
570204|NCT00753766|Multifactorial|multifactorial
570205|NCT00753766|Peri-operative complications|peri-operative complications
570206|NCT00753766|Pre-operative|pre-operative
570207|NCT00753753|stent thrombosis|stent thrombosis
570208|NCT00753753|clopidogrel|clopidogrel
570209|NCT00753753|aspirin|aspirin
570210|NCT00753753|bleeding|bleeding
570211|NCT00753753|coronary|coronary
570212|NCT00753753|angioplasty|angioplasty
570213|NCT00753740|Cancer|cancer
570214|NCT00753740|Neoplasms|neoplasms
570215|NCT00753740|Solid Tumor|solid tumor
570216|NCT00753740|Ovarian Cancer|ovarian cancer
570217|NCT00753740|Solid Malignancies|solid malignancies
570218|NCT00753727|soft tissue|soft tissue
570219|NCT00753727|Sarcoma|sarcoma
570220|NCT00753727|Sunitinib|sunitinib
570221|NCT00753727|neoadjuvant|neoadjuvant
570222|NCT00753727|radiotherapy|radiotherapy
570223|NCT00753714|ZD6474|zd6474
570224|NCT00753714|VANDETANIB|vandetanib
570225|NCT00753714|ZACTIMA|zactima
570226|NCT00753714|ADVANCED|advanced
570227|NCT00753714|NSCLC|nsclc
570228|NCT00753714|LUNG CANCER|lung cancer
570229|NCT00753714|ELDERLY PATIENTS|elderly patients
570230|NCT00753714|GEMCITABINE|gemcitabine
570231|NCT00753714|PHASE II|phase ii
570232|NCT00753714|RANDOMIZED|randomized
570233|NCT00753714|DOUBLE-BLIND|double-blind
570234|NCT00753714|histologically or cytologically-confirmed advanced (stage IIIB with supraclavicular lymph node metastases or pleural effusion or stage IV) NSCLC|histologically or cytologically-confirmed advanced (stage iiib with supraclavicular lymph node metastases or pleural effusion or stage iv) nsclc
570235|NCT00753688|metastatic soft-tissue sarcoma|metastatic soft-tissue sarcoma
570236|NCT00753688|pazopanib|pazopanib
570237|NCT00753688|Soft Tissue Sarcoma|soft tissue sarcoma
570238|NCT00753688|placebo|placebo
570239|NCT00753675|Intrahepatic|intrahepatic
570240|NCT00753675|Cholangiocarcinoma|cholangiocarcinoma
570241|NCT00753675|Vandetanib|vandetanib
570242|NCT00753675|Zactima|zactima
570243|NCT00753675|Advanced|advanced
570244|NCT00753675|Biliary|biliary
570245|NCT00753675|Tract|tract
570246|NCT00753675|Gallbladder|gallbladder
570247|NCT00753675|Extrahepatic Bile Duct|extrahepatic bile duct
570248|NCT00753675|Intrahepatic Cholangiocarcinoma|intrahepatic cholangiocarcinoma
570249|NCT00753675|Ampullary Carcinoma|ampullary carcinoma
570250|NCT00753662|TMS AD H2 coil|tms ad h2 coil
570251|NCT00753649|Infant|infant
570252|NCT00753649|First nation|first nation
570253|NCT00753649|Aboriginal|aboriginal
570254|NCT00753649|Canada|canada
570255|NCT00753636|Parkinson's disease|parkinson's disease
570256|NCT00753636|Isradipine|isradipine
570257|NCT00753636|Neuroprotection|neuroprotection
570258|NCT00753623|Pain|pain
570259|NCT00753623|Neuropathic pain|neuropathic pain
570260|NCT00753623|Pain scores|pain scores
570261|NCT00753610|EPC|epc
570262|NCT00753610|CCRT|ccrt
570263|NCT00753610|Cervical cancer|cervical cancer
570264|NCT00753597|B cell depletion|b cell depletion
570265|NCT00753597|steroidogenesis|steroidogenesis
570266|NCT00753571|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
570267|NCT00753571|Cistanche Total Glycosides|cistanche total glycosides
570268|NCT00753571|Randomized Control Trial Study|randomized control trial study
570269|NCT00753545|Serous,|serous,
570270|NCT00753545|Ovarian cancer,|ovarian cancer,
570271|NCT00753545|PARP,|parp,
570272|NCT00753545|BRCA1,|brca1,
570273|NCT00753545|BRCA2,|brca2,
570274|NCT00753545|Poly(ADP ribose) polymerases,|poly(adp ribose) polymerases,
570275|NCT00753545|Platinum sensitive,|platinum sensitive,
570276|NCT00753545|Homologous Recombination Deficiency (HRD)|homologous recombination deficiency (hrd)
570277|NCT00753532|Carotid artery stenoses|carotid artery stenoses
570278|NCT00753532|Brain ischaemia|brain ischaemia
570279|NCT00753532|stroke|stroke
570280|NCT00753532|Lipid abnormalities|lipid abnormalities
570281|NCT00753532|Fatty Liver|fatty liver
570282|NCT00753519|Parkinson's Disease|parkinson's disease
570283|NCT00753519|Brain Stimulation|brain stimulation
570284|NCT00753519|Motor Cortex|motor cortex
570285|NCT00753519|Bradykinesia|bradykinesia
570286|NCT00753519|Parkinson Disease|parkinson disease
570287|NCT00753519|PD|pd
570288|NCT00753480|EOC|eoc
570289|NCT00753480|PPC|ppc
570290|NCT00753480|FTC|ftc
570291|NCT00753467|HBV|hbv
570292|NCT00753467|Treatment|treatment
570293|NCT00753467|Interferon-gamma|interferon-gamma
570294|NCT00753467|combination|combination
570295|NCT00753467|Hepsera|hepsera
570296|NCT00753467|Actimmune|actimmune
570297|NCT00753467|HBV DNA|hbv dna
570298|NCT00753454|Rheumatoid Arthritis|rheumatoid arthritis
570299|NCT00753454|Joint Disease|joint disease
570300|NCT00753454|Arthritis|arthritis
570301|NCT00753454|Certolizumab pegol|certolizumab pegol
570302|NCT00753454|Cimzia|cimzia
570303|NCT00753441|Pancreatic cancer|pancreatic cancer
570304|NCT00753441|Bile duct obstruction|bile duct obstruction
570305|NCT00753441|Stent|stent
570306|NCT00753441|Bypass|bypass
570307|NCT00753428|HIV-free survival|hiv-free survival
570308|NCT00753428|Community based evaluation|community based evaluation
570309|NCT00753428|Pregnancy|pregnancy
570310|NCT00753428|Under 2 child survival|under 2 child survival
570311|NCT00753428|PMTCT|pmtct
570312|NCT00753428|Pediatric HIV infection|pediatric hiv infection
570313|NCT00753428|HAART|haart
570314|NCT00753428|Routine ART|routine art
570315|NCT00753428|HIV Seronegativity|hiv seronegativity
570316|NCT00753415|Urinary Bladder Neoplasms|urinary bladder neoplasms
570317|NCT00753415|Breast Neoplasms|breast neoplasms
570318|NCT00753415|Renal Cell carcinoma|renal cell carcinoma
570319|NCT00753415|Melanoma|melanoma
570320|NCT00753415|Prostatic Neoplasms|prostatic neoplasms
570321|NCT00753415|Colonic Neoplasms|colonic neoplasms
570322|NCT00753415|Urologic Neoplasms|urologic neoplasms
570323|NCT00753415|Urogenital Neoplasms|urogenital neoplasms
570324|NCT00753415|Urinary Bladder Diseases|urinary bladder diseases
570325|NCT00753415|Urologic Diseases|urologic diseases
570326|NCT00753415|Breast Diseases|breast diseases
570327|NCT00753415|Skin Diseases|skin diseases
570328|NCT00753415|Neoplasms|neoplasms
570329|NCT00753415|Glandular and Epithelial Neoplasms by Histologic Type|glandular and epithelial neoplasms by histologic type
570330|NCT00753415|Adenocarcinoma|adenocarcinoma
570331|NCT00753415|Kidney Neoplasms|kidney neoplasms
570332|NCT00753415|Kidney Diseases|kidney diseases
570333|NCT00753415|Neuroendocrine Tumors|neuroendocrine tumors
570334|NCT00753415|Neuroectodermal Tumors|neuroectodermal tumors
570335|NCT00753415|Neoplasms, Germ Cell and Embryonal|neoplasms, germ cell and embryonal
570336|NCT00753415|Neoplasms, Nerve Tissue|neoplasms, nerve tissue
570337|NCT00753415|Nevi and Melanomas|nevi and melanomas
570338|NCT00753415|Genital Neoplasms|genital neoplasms
570339|NCT00753415|Male Genital Diseases|male genital diseases
570340|NCT00753415|Male, Prostatic Diseases|male, prostatic diseases
570341|NCT00753415|Colorectal Neoplasms|colorectal neoplasms
570342|NCT00753415|Intestinal Neoplasms|intestinal neoplasms
570343|NCT00753389|Postoperative residual curarization,|postoperative residual curarization,
570344|NCT00753389|muscle relaxants,|muscle relaxants,
570345|NCT00753389|morbidity mortality|morbidity mortality
570346|NCT00753363|Glucose Metabolism|glucose metabolism
570347|NCT00753350|obesity|obesity
570348|NCT00753324|PMTCT|pmtct
570349|NCT00753324|HAART|haart
570350|NCT00753324|Pregnancy|pregnancy
570351|NCT00753324|HIV Infection|hiv infection
570352|NCT00753324|HIV Transmission|hiv transmission
570353|NCT00753324|HIV Seronegativity|hiv seronegativity
570354|NCT00753311|migraine|migraine
570355|NCT00753311|rizatriptan|rizatriptan
570356|NCT00753311|unilateral trigeminal autonomic symptoms|unilateral trigeminal autonomic symptoms
570357|NCT00753311|Migraine with or without aura|migraine with or without aura
570358|NCT00753272|Efficacy|efficacy
570359|NCT00753272|Influenza Vaccines|influenza vaccines
570360|NCT00753272|Influenza|influenza
570361|NCT00753272|Vaccine|vaccine
570362|NCT00753272|Elderly|elderly
570363|NCT00753259|atrial fibrillation|atrial fibrillation
570364|NCT00753259|disease management program|disease management program
570365|NCT00753259|integrated chronic care program|integrated chronic care program
570366|NCT00753259|guideline|guideline
570367|NCT00753259|stroke|stroke
570368|NCT00753259|heart failure|heart failure
570369|NCT00753259|quality of life|quality of life
570370|NCT00753259|costs|costs
570371|NCT00753246|glioblastoma multiforma|glioblastoma multiforma
570372|NCT00753233|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
570373|NCT00753233|Children|children
570374|NCT00753233|Sudden Death|sudden death
570375|NCT00753233|Arrhythmias|arrhythmias
570376|NCT00753233|Electrophysiology Study|electrophysiology study
570377|NCT00753220|Metastatic|metastatic
570378|NCT00753220|Androgen|androgen
570379|NCT00753220|Independent|independent
570380|NCT00753220|Prostate Cancer|prostate cancer
570381|NCT00753220|(AIPC),|(aipc),
570382|NCT00753220|Hormone-refractory|hormone-refractory
570383|NCT00753220|(HRPC),|(hrpc),
570384|NCT00753220|cryotherapy,|cryotherapy,
570385|NCT00753220|dendritic cell,|dendritic cell,
570386|NCT00753220|immunotherapy|immunotherapy
570387|NCT00753220|Chemo-naïve|chemo-naïve
570388|NCT00753220|lymph nodes|lymph nodes
570389|NCT00753220|bone|bone
570390|NCT00753207|stage IV breast cancer|stage iv breast cancer
570391|NCT00753207|recurrent breast cancer|recurrent breast cancer
570392|NCT00753194|hearing|hearing
570393|NCT00753194|newborn|newborn
570394|NCT00753194|otoacoustic emissions|otoacoustic emissions
570395|NCT00753168|glaucoma, open angle, ocular hypertension, beta blocker, beta adrenergic, intraocular pressure|glaucoma, open angle, ocular hypertension, beta blocker, beta adrenergic, intraocular pressure
570396|NCT00753155|HRQoL;|hrqol;
570397|NCT00753155|exercise|exercise
570398|NCT00753155|capacity|capacity
570399|NCT00753142|Hyperglycemia|hyperglycemia
570400|NCT00753129|Prone position|prone position
570401|NCT00753129|ALI/ARDS|ali/ards
570402|NCT00753129|Head elevation|head elevation
570403|NCT00753103|Infliximab|infliximab
570404|NCT00753103|Vasculitis|vasculitis
570405|NCT00753103|antitnf monoclonal antibody|antitnf monoclonal antibody
570406|NCT00753064|Red Scorpion envenomation|red scorpion envenomation
570407|NCT00753064|Composite clinical scoring system|composite clinical scoring system
570408|NCT00753064|AScVS|ascvs
570409|NCT00753064|Prazosin|prazosin
570410|NCT00753064|Superiority|superiority
570411|NCT00753051|clozapine-resistant schizophrenics|clozapine-resistant schizophrenics
570412|NCT00753051|haloperidol augmenting clozapine|haloperidol augmenting clozapine
570413|NCT00753051|electroconvulsive therapy augmenting clozapine|electroconvulsive therapy augmenting clozapine
570414|NCT00753038|carcinoma|carcinoma
570415|NCT00753038|squamous cell|squamous cell
570416|NCT00753038|head|head
570417|NCT00753038|neck|neck
570418|NCT00753038|REOLYSIN|reolysin
570419|NCT00753038|chemotherapy|chemotherapy
570420|NCT00753038|Carboplatin|carboplatin
570421|NCT00753038|Paclitaxel|paclitaxel
570422|NCT00753025|lower extremity ischemia|lower extremity ischemia
570423|NCT00753025|Bone marrow|bone marrow
570424|NCT00753025|Progenitor cells|progenitor cells
570425|NCT00753025|Neoangiogenesis|neoangiogenesis
570426|NCT00753012|cardiovascular testing|cardiovascular testing
570427|NCT00753012|home blood pressure monitoring|home blood pressure monitoring
570428|NCT00753012|office home blood pressure monitoring|office home blood pressure monitoring
570429|NCT00753012|cardiopulmonary exercise testing|cardiopulmonary exercise testing
570430|NCT00753012|transthoracic echocardiography|transthoracic echocardiography
570431|NCT00753012|Lisdexamfetamine|lisdexamfetamine
570432|NCT00753012|Vyvanse|vyvanse
570433|NCT00753012|normotensive and hypertensive adults with ADHD|normotensive and hypertensive adults with adhd
570434|NCT00753012|ADHD medication.|adhd medication.
570435|NCT00752999|SLE|sle
570436|NCT00752999|Lupus|lupus
570437|NCT00752986|ZD6474|zd6474
570438|NCT00752986|Vandetanib|vandetanib
570439|NCT00752986|Zactima|zactima
570440|NCT00752986|Fulvestrant|fulvestrant
570441|NCT00752986|Faslodex|faslodex
570442|NCT00752986|Breast Cancer|breast cancer
570443|NCT00752986|Advanced, Metastatic|advanced, metastatic
570444|NCT00752986|Hormone Receptor Positive|hormone receptor positive
570445|NCT00752986|Post-Menopausal Patients|post-menopausal patients
570446|NCT00752986|post-menopausal women with hormone receptor positive advanced breast cancer|post-menopausal women with hormone receptor positive advanced breast cancer
570447|NCT00752973|Head Lice|head lice
570448|NCT00752960|single nucleotide polymorphism, SNP, aripiprazole, olanzapine, quetiapine, risperidone, ziprasidone, metabolic syndrome|single nucleotide polymorphism, snp, aripiprazole, olanzapine, quetiapine, risperidone, ziprasidone, metabolic syndrome
570449|NCT00752934|nursing homes|nursing homes
570450|NCT00752934|children|children
570451|NCT00752934|ages 1-18 years|ages 1-18 years
570452|NCT00752934|spastic quadriplegia|spastic quadriplegia
570453|NCT00752921|Etoricoxib, Fasting Headache, Headache, Yom Kippur|etoricoxib, fasting headache, headache, yom kippur
570454|NCT00752895|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
570455|NCT00752895|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
570456|NCT00752895|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
570457|NCT00752895|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
570458|NCT00752882|Ceftazidime|ceftazidime
570459|NCT00752882|Pharmacokinetics|pharmacokinetics
570460|NCT00752882|Pseudomonas|pseudomonas
570461|NCT00752882|aeruginosa|aeruginosa
570462|NCT00752882|Meningitis|meningitis
570463|NCT00752882|Patients|patients
570464|NCT00752882|hospitalised|hospitalised
570465|NCT00752882|cerebrolesion|cerebrolesion
570466|NCT00752882|acquired|acquired
570467|NCT00752882|pneumopathy|pneumopathy
570468|NCT00752882|mechanic|mechanic
570469|NCT00752882|ventilation|ventilation
570470|NCT00752869|low testosterone|low testosterone
570471|NCT00752856|HIV treatment|hiv treatment
570472|NCT00752856|Treatment-naive|treatment-naive
570473|NCT00752856|Adult|adult
570474|NCT00752843|mifepristone|mifepristone
570475|NCT00752843|CORLUX|corlux
570476|NCT00752843|fluvastatin|fluvastatin
570477|NCT00752843|Lescol|lescol
570478|NCT00752843|drug-drug interaction|drug-drug interaction
570479|NCT00752843|DDI|ddi
570480|NCT00752843|pharmacokinetics|pharmacokinetics
570481|NCT00752830|AZD0328|azd0328
570482|NCT00752830|Food Effect|food effect
570483|NCT00752817|Virtual Reality|virtual reality
570484|NCT00752817|Simulator|simulator
570485|NCT00752817|Proficiency|proficiency
570486|NCT00752817|Laparoscopic|laparoscopic
570487|NCT00752817|Colectomy|colectomy
570488|NCT00752817|Education|education
570489|NCT00752817|Surgical Training|surgical training
570490|NCT00752804|ICU patients with acute renal failure after cardiac surgery|icu patients with acute renal failure after cardiac surgery
570491|NCT00752791|Anemia|anemia
570492|NCT00752791|Drug Therapy|drug therapy
570493|NCT00752791|Peritoneal Dialysis.|peritoneal dialysis.
570494|NCT00752778|MRI, PET scan|mri, pet scan
570495|NCT00752765|knee osteoarthritis|knee osteoarthritis
570496|NCT00752765|bariatric surgery|bariatric surgery
570497|NCT00752765|weight loss|weight loss
570498|NCT00752765|knee pain|knee pain
570499|NCT00752752|Marathon Running|marathon running
570500|NCT00752752|Cardiac Ischemia|cardiac ischemia
570501|NCT00752752|Magnetic Resonance Imaging|magnetic resonance imaging
570502|NCT00752739|adenocarcinoma of the prostate|adenocarcinoma of the prostate
570503|NCT00752739|stage I prostate cancer|stage i prostate cancer
570504|NCT00752739|stage II prostate cancer|stage ii prostate cancer
570505|NCT00752739|stage III prostate cancer|stage iii prostate cancer
570506|NCT00752739|stage IV prostate cancer|stage iv prostate cancer
570507|NCT00752726|overweight, orlistat, body composition|overweight, orlistat, body composition
570508|NCT00752713|AMI,|ami,
570509|NCT00752713|Reperfusion|reperfusion
570510|NCT00752713|successful|successful
570511|NCT00752700|Patients|patients
570512|NCT00752700|radically|radically
570513|NCT00752700|treated|treated
570514|NCT00752687|Phase 1|phase 1
570515|NCT00752674|Low back pain|low back pain
570516|NCT00752674|physical therapy|physical therapy
570517|NCT00752674|pain|pain
570518|NCT00752661|osteoarthritis|osteoarthritis
570519|NCT00752661|low back pain|low back pain
570520|NCT00752661|oral drug|oral drug
570521|NCT00752661|tramadol|tramadol
570522|NCT00752648|TMC435350-TiDP16-C106|tmc435350-tidp16-c106
570523|NCT00752648|TMC435350-C106|tmc435350-c106
570524|NCT00752648|Bioavailability|bioavailability
570525|NCT00752648|Pharmacokinetics|pharmacokinetics
570526|NCT00752635|TriCilest|tricilest
570527|NCT00752635|acne vulgaris|acne vulgaris
570528|NCT00752609|Anemia|anemia
570529|NCT00752609|Drug Therapy|drug therapy
570530|NCT00752609|Hemodialysis|hemodialysis
570531|NCT00752609|Kidney Failure|kidney failure
570532|NCT00752596|patients|patients
570533|NCT00752596|with ICD|with icd
570534|NCT00752583|Chronic renal insufficiency (patients under dialysis)|chronic renal insufficiency (patients under dialysis)
570639|NCT00752258|Forehead|forehead
570535|NCT00752570|Metastatic Colorectal Cancer|metastatic colorectal cancer
570536|NCT00752570|colorectal cancer|colorectal cancer
570537|NCT00752570|colon cancer|colon cancer
570538|NCT00752557|Bone mineral density|bone mineral density
570539|NCT00752557|bone morphogenetic protein|bone morphogenetic protein
570540|NCT00752557|osteoporosis|osteoporosis
570541|NCT00752544|TMC435350|tmc435350
570542|NCT00752544|HCV|hcv
570543|NCT00752544|Hepatitis C|hepatitis c
570544|NCT00752544|TMC435350-TiDP16-C109|tmc435350-tidp16-c109
570545|NCT00752544|TMC435350-C109|tmc435350-c109
570546|NCT00752531|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
570547|NCT00752531|COPD|copd
570548|NCT00752518|bolus|bolus
570549|NCT00752518|intravenous|intravenous
570550|NCT00752518|proteasome inhibitor|proteasome inhibitor
570551|NCT00752518|multiple myeloma|multiple myeloma
570552|NCT00752518|refractory|refractory
570553|NCT00752518|relapse|relapse
570554|NCT00752505|Fibromyalgia|fibromyalgia
570555|NCT00752492|Isocapnic hyperpnoea|isocapnic hyperpnoea
570556|NCT00752492|obesity|obesity
570557|NCT00752492|isoflurane|isoflurane
570558|NCT00752492|Recovery of obese patient from isoflurane anesthesia|recovery of obese patient from isoflurane anesthesia
570559|NCT00752479|living|living
570560|NCT00752479|related|related
570561|NCT00752466|Healthy volunteers|healthy volunteers
570562|NCT00752466|drug interaction|drug interaction
570563|NCT00752466|Flunarizine|flunarizine
570564|NCT00752466|Topiramate|topiramate
570565|NCT00752466|Migraine|migraine
570566|NCT00752453|ICU|icu
570567|NCT00752453|patients|patients
570568|NCT00752453|lactate|lactate
570569|NCT00752453|acidosis|acidosis
570570|NCT00752440|Diabetes Mellitus|diabetes mellitus
570571|NCT00752440|Autonomic Neuropathy|autonomic neuropathy
570572|NCT00752440|Inspiratory Muscle training|inspiratory muscle training
570573|NCT00752427|Schizophrenia: paliperidone|schizophrenia: paliperidone
570574|NCT00752414|COPD|copd
570575|NCT00752414|Patients|patients
570576|NCT00752401|Vitamin D|vitamin d
570577|NCT00752401|Cholecalciferol|cholecalciferol
570578|NCT00752401|Vitamin D3|vitamin d3
570579|NCT00752401|25-hydroxyvitamin D3|25-hydroxyvitamin d3
570580|NCT00752401|Immunomodulation|immunomodulation
570581|NCT00752401|Vitamin D deficiency|vitamin d deficiency
570582|NCT00752401|Kidney transplantation|kidney transplantation
570583|NCT00752401|Renal transplantation|renal transplantation
570584|NCT00752401|Graft function|graft function
570585|NCT00752401|Acute rejection|acute rejection
570586|NCT00752401|Renal osteodystrophy|renal osteodystrophy
570587|NCT00752401|Posttransplant bone loss|posttransplant bone loss
570588|NCT00752375|pyelonephritis|pyelonephritis
570589|NCT00752375|pediatric pyelonephritis|pediatric pyelonephritis
570590|NCT00752375|vesicoureteral reflux|vesicoureteral reflux
570591|NCT00752375|DMSA scan|dmsa scan
570592|NCT00752362|Supralimus®,|supralimus®,
570593|NCT00752362|Infinnium®,|infinnium®,
570594|NCT00752362|Matrix®,|matrix®,
570595|NCT00752362|Restenosis|restenosis
570596|NCT00752362|Percutaneous|percutaneous
570597|NCT00752362|Revascularization|revascularization
570598|NCT00752362|Techniques|techniques
570599|NCT00752362|Metallic|metallic
570600|NCT00752362|Platform|platform
570601|NCT00752362|Agents|agents
570602|NCT00752362|Antiproliferative|antiproliferative
570603|NCT00752362|Properties|properties
570604|NCT00752349|Videofluoroscopic|videofluoroscopic
570605|NCT00752349|swallowing|swallowing
570606|NCT00752349|study|study
570607|NCT00752349|(VFSS)|(vfss)
570608|NCT00752349|ultrasound|ultrasound
570609|NCT00752336|HRQoL|hrqol
570610|NCT00752336|exercise capacity|exercise capacity
570611|NCT00752323|adult giant cell glioblastoma|adult giant cell glioblastoma
570612|NCT00752323|adult glioblastoma|adult glioblastoma
570613|NCT00752323|adult gliosarcoma|adult gliosarcoma
570614|NCT00752323|recurrent adult brain tumor|recurrent adult brain tumor
570615|NCT00752310|TMC114-TiDP29-C169|tmc114-tidp29-c169
570616|NCT00752310|TMC114-C169|tmc114-c169
570617|NCT00752310|Darunavir (suspension formulation)|darunavir (suspension formulation)
570618|NCT00752297|Botulinum Toxin Type A|botulinum toxin type a
570619|NCT00752297|Botulinum Toxin|botulinum toxin
570620|NCT00752297|Glabellar Rhytides|glabellar rhytides
570621|NCT00752297|Rhytides|rhytides
570622|NCT00752297|Frown Lines|frown lines
570623|NCT00752297|Neuromuscular Agents|neuromuscular agents
570624|NCT00752297|Neurotoxin|neurotoxin
570625|NCT00752297|Forehead|forehead
570626|NCT00752297|Eyebrow|eyebrow
570627|NCT00752297|Wrinkle|wrinkle
570628|NCT00752284|coronectomy|coronectomy
570629|NCT00752284|neurosensory deficit|neurosensory deficit
570630|NCT00752284|third molar surgery|third molar surgery
570631|NCT00752271|Arthroscopic|arthroscopic
570632|NCT00752258|Botulinum Toxin Type A|botulinum toxin type a
570633|NCT00752258|Botulinum Toxin|botulinum toxin
570634|NCT00752258|Glabellar Rhytides|glabellar rhytides
570635|NCT00752258|Rhytides|rhytides
570636|NCT00752258|Frown Lines|frown lines
570637|NCT00752258|Neuromuscular Agents|neuromuscular agents
570638|NCT00752258|Neurotoxin|neurotoxin
570640|NCT00752258|Eyebrow|eyebrow
570641|NCT00752258|Wrinkle|wrinkle
570642|NCT00752258|Frown Lines Between the Eyebrows|frown lines between the eyebrows
570643|NCT00752245|ICU patients with acute renal failure with sepsis/multi-organ failure|icu patients with acute renal failure with sepsis/multi-organ failure
570644|NCT00752232|Phase IIa|phase iia
570645|NCT00752232|multiple ascending dose study of ACC-001|multiple ascending dose study of acc-001
570646|NCT00752206|AZD0530|azd0530
570647|NCT00752206|Saracatinib|saracatinib
570648|NCT00752206|Osteosarcoma|osteosarcoma
570649|NCT00752206|Recurrent|recurrent
570650|NCT00752206|Localized|localized
570651|NCT00752206|to the Lung|to the lung
570652|NCT00752180|pharmacokinetics|pharmacokinetics
570653|NCT00752180|pharmacodynamics|pharmacodynamics
570654|NCT00752180|type 1 diabetics|type 1 diabetics
570655|NCT00752180|recombinant human insulin|recombinant human insulin
570656|NCT00752167|exercise induced bronchospasm|exercise induced bronchospasm
570657|NCT00752167|asthma|asthma
570658|NCT00752167|athlete|athlete
570659|NCT00752167|sports|sports
570660|NCT00752167|eucapnic voluntary hyperventilation|eucapnic voluntary hyperventilation
570661|NCT00752167|albuterol|albuterol
570662|NCT00752154|Subjects|subjects
570663|NCT00752154|active|active
570664|NCT00752154|Rheumatoid|rheumatoid
570665|NCT00752154|Arthritis|arthritis
570666|NCT00752154|revised|revised
570667|NCT00752154|American|american
570668|NCT00752154|College|college
570669|NCT00752154|Rheumatology|rheumatology
570670|NCT00752154|Criteria|criteria
570671|NCT00752128|Drug Eluting Stent|drug eluting stent
570672|NCT00752128|Interventional Cardiology|interventional cardiology
570673|NCT00752128|Percutaneous Coronary Intervention|percutaneous coronary intervention
570674|NCT00752115|non-small cell lung cancer|non-small cell lung cancer
570675|NCT00752115|previously untreated|previously untreated
570676|NCT00752102|Secondary Hyperparathryoidism|secondary hyperparathryoidism
570677|NCT00752102|Chronic Kidney Disease|chronic kidney disease
570678|NCT00752102|Vitamin D|vitamin d
570679|NCT00752102|Coronary Calcification|coronary calcification
570680|NCT00752102|Bone metabolism|bone metabolism
570681|NCT00752089|enamel fluoride uptake|enamel fluoride uptake
570682|NCT00752089|erosion|erosion
570683|NCT00752089|enamel remineralization|enamel remineralization
570684|NCT00752076|EGFR mutation|egfr mutation
570685|NCT00752076|NSCLC cell line|nsclc cell line
570686|NCT00752076|Malignant pleural effusion|malignant pleural effusion
570687|NCT00752063|Sorafenib|sorafenib
570688|NCT00752063|Capecitabine|capecitabine
570689|NCT00752063|Oxaliplatin|oxaliplatin
570690|NCT00752063|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
570691|NCT00752063|Metastatic Hepatocellular Carcinoma|metastatic hepatocellular carcinoma
570692|NCT00752050|Botulinum Toxin Type A|botulinum toxin type a
570693|NCT00752050|Botulinum Toxin|botulinum toxin
570694|NCT00752050|Glabellar Rhytides|glabellar rhytides
570695|NCT00752050|Rhytides|rhytides
570696|NCT00752050|Frown Lines|frown lines
570697|NCT00752050|Neuromuscular Agents|neuromuscular agents
570698|NCT00752050|Neurotoxin|neurotoxin
570699|NCT00752050|Forehead|forehead
570700|NCT00752050|Eyebrow|eyebrow
570701|NCT00752050|Wrinkle|wrinkle
570702|NCT00752037|HIV|hiv
570703|NCT00752037|Protease Inhibitor|protease inhibitor
570704|NCT00752037|Integrase Inhibitor|integrase inhibitor
570705|NCT00752037|Treatment Experienced|treatment experienced
570706|NCT00752037|Naive|naive
570707|NCT00752024|HICH|hich
570708|NCT00752024|Suction drainages|suction drainages
570709|NCT00752024|TTAC|ttac
570710|NCT00752011|Cancer|cancer
570711|NCT00752011|Solid Tumors|solid tumors
570712|NCT00752011|Advanced Cancer|advanced cancer
570713|NCT00752011|Carboplatin|carboplatin
570714|NCT00752011|Paraplatin|paraplatin
570715|NCT00752011|TAS-106|tas-106
570716|NCT00752011|Antitumor Activity|antitumor activity
570717|NCT00752011|Biomarkers|biomarkers
570718|NCT00751998|biliary|biliary
570719|NCT00751998|ERCP|ercp
570720|NCT00751998|cholangioscopy|cholangioscopy
570721|NCT00751998|pancreatic|pancreatic
570722|NCT00751985|Heavy drinking|heavy drinking
570723|NCT00751985|Ultra-brief intervention|ultra-brief intervention
570724|NCT00751985|Brief intervention|brief intervention
570725|NCT00751985|Alcohol prevention|alcohol prevention
570726|NCT00751985|Randomized trial|randomized trial
570727|NCT00751985|Personal normative feedback|personal normative feedback
570728|NCT00751985|Self-help material|self-help material
570729|NCT00751985|Web-based|web-based
570730|NCT00751985|Intervention Studies|intervention studies
570731|NCT00751985|prevention & control|prevention & control
570932|NCT00751348|varicella|varicella
570732|NCT00751959|Continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
570733|NCT00751959|extremely preterm infant|extremely preterm infant
570734|NCT00751959|Idiopathic respiratory distress syndrome (IRDS)|idiopathic respiratory distress syndrome (irds)
570735|NCT00751959|Surfactant|surfactant
570736|NCT00751946|Posttraumatic Stress Disorder|posttraumatic stress disorder
570738|NCT00751946|psychotherapy|psychotherapy
570739|NCT00751946|adolescents|adolescents
570740|NCT00751946|clinical trial|clinical trial
570741|NCT00751933|Ulcerative colitis|ulcerative colitis
570742|NCT00751933|Vaccines|vaccines
570743|NCT00751933|Oats|oats
570744|NCT00751920|Magnetic Resonance Imaging|magnetic resonance imaging
570745|NCT00751920|Pediatrics|pediatrics
570746|NCT00751920|Multi-Detector Computed Tomography|multi-detector computed tomography
570747|NCT00751920|Computed Tomography|computed tomography
570748|NCT00751920|Detection|detection
570749|NCT00751907|Cerebral blood flow|cerebral blood flow
570750|NCT00751894|Children|children
570751|NCT00751894|cancer|cancer
570752|NCT00751894|Bone marrow transplantation|bone marrow transplantation
570753|NCT00751894|Stem cell mobilization|stem cell mobilization
570754|NCT00751894|G-CSF|g-csf
570755|NCT00751894|Children with solid malignancies|children with solid malignancies
570756|NCT00751881|relapsing multiple sclerosis|relapsing multiple sclerosis
570757|NCT00751868|breast cancer|breast cancer
570758|NCT00751842|Diabetes|diabetes
570759|NCT00751842|Juvenile Diabetes|juvenile diabetes
570760|NCT00751842|Diabetes type 1|diabetes type 1
570761|NCT00751842|Autoimmune Diabetes|autoimmune diabetes
570762|NCT00751842|Insulin dependent Diabetes|insulin dependent diabetes
570763|NCT00751842|Type 1 diabetes|type 1 diabetes
570764|NCT00751842|Type 1 diabetes mellitus|type 1 diabetes mellitus
570765|NCT00751842|Diamyd|diamyd
570766|NCT00751842|rhGAD65|rhgad65
570767|NCT00751842|GAD|gad
570768|NCT00751842|GAD-alum|gad-alum
570769|NCT00751816|musculoskeletal complications|musculoskeletal complications
570770|NCT00751816|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
570771|NCT00751816|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
570772|NCT00751816|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
570773|NCT00751816|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
570774|NCT00751816|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
570775|NCT00751816|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
570776|NCT00751816|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
570777|NCT00751816|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
570778|NCT00751816|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
570779|NCT00751816|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
570780|NCT00751816|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
570781|NCT00751816|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
570782|NCT00751816|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
570783|NCT00751816|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
570784|NCT00751816|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
570785|NCT00751816|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
570786|NCT00751816|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
570787|NCT00751816|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
570788|NCT00751816|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
570789|NCT00751816|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
570790|NCT00751816|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
570791|NCT00751816|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
570792|NCT00751816|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
570793|NCT00751816|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
570794|NCT00751816|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
570795|NCT00751816|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
570796|NCT00751816|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
570797|NCT00751816|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
570798|NCT00751816|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
570799|NCT00751816|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
570800|NCT00751816|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
570801|NCT00751816|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
570802|NCT00751816|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
570803|NCT00751816|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
570804|NCT00751816|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
570805|NCT00751816|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
570806|NCT00751816|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
570807|NCT00751816|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
570808|NCT00751816|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
570871|NCT00751595|HAART|haart
573039|NCT00743730|analgesic|analgesic
570809|NCT00751816|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
570810|NCT00751816|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
570811|NCT00751816|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
570812|NCT00751816|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
570813|NCT00751816|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
570814|NCT00751816|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
570815|NCT00751816|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
570816|NCT00751816|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
570817|NCT00751816|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
570818|NCT00751816|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
570819|NCT00751816|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
570820|NCT00751816|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
570821|NCT00751816|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
570822|NCT00751816|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
570823|NCT00751816|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
570824|NCT00751816|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
570825|NCT00751816|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
570826|NCT00751816|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
570827|NCT00751816|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
570828|NCT00751816|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
570829|NCT00751816|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
570830|NCT00751816|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
570831|NCT00751816|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
570832|NCT00751816|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
570833|NCT00751816|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
570834|NCT00751816|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
570835|NCT00751816|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
570836|NCT00751816|salivary gland acinic cell tumor|salivary gland acinic cell tumor
570837|NCT00751816|salivary gland adenocarcinoma|salivary gland adenocarcinoma
570838|NCT00751816|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
570839|NCT00751816|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
570840|NCT00751816|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
570841|NCT00751816|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
570842|NCT00751816|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
570843|NCT00751816|stage I salivary gland cancer|stage i salivary gland cancer
570844|NCT00751816|stage II salivary gland cancer|stage ii salivary gland cancer
570845|NCT00751816|stage III salivary gland cancer|stage iii salivary gland cancer
570846|NCT00751816|stage IV salivary gland cancer|stage iv salivary gland cancer
570847|NCT00751790|triptorelin, 6-month formulation, advanced prostate cancer|triptorelin, 6-month formulation, advanced prostate cancer
570848|NCT00751712|Aortic Arch|aortic arch
570849|NCT00751699|Pharmacokinetics|pharmacokinetics
570850|NCT00751686|Gastroenteritis|gastroenteritis
570851|NCT00751686|Burden|burden
570852|NCT00751686|Rotavirus|rotavirus
570853|NCT00751686|< 5 years|< 5 years
570854|NCT00751686|Greece|greece
570855|NCT00751686|Children|children
570856|NCT00751660|small cell lung cancer|small cell lung cancer
570857|NCT00751660|non-small cell lung cancer|non-small cell lung cancer
570858|NCT00751660|tobacco use disorder|tobacco use disorder
570859|NCT00751647|CF|cf
570860|NCT00751634|subarachnoid hemorrhage|subarachnoid hemorrhage
570861|NCT00751634|intracerebral hemorrhage|intracerebral hemorrhage
570862|NCT00751634|fever|fever
570863|NCT00751621|Immune globulin subcutaneous|immune globulin subcutaneous
570864|NCT00751621|SCIG|scig
570865|NCT00751621|primary immunodeficiency|primary immunodeficiency
570866|NCT00751621|PID|pid
570867|NCT00751608|Familial hypercholesterolemia, endothelial function, venous occlusion plethysmography, forearm blood flow, ApoAI-mimetic, endothelial dependent vasodilation|familial hypercholesterolemia, endothelial function, venous occlusion plethysmography, forearm blood flow, apoai-mimetic, endothelial dependent vasodilation
570868|NCT00751595|HIV|hiv
570869|NCT00751595|Tat protein|tat protein
570870|NCT00751595|Therapeutic vaccine|therapeutic vaccine
570872|NCT00751595|HIV Therapeutic Vaccine|hiv therapeutic vaccine
570873|NCT00751595|Treatment Experienced|treatment experienced
570874|NCT00751582|nutrition|nutrition
570875|NCT00751582|education|education
570876|NCT00751582|supplementation|supplementation
570877|NCT00751569|umbilical cord blood|umbilical cord blood
570878|NCT00751556|Naproxen Sodium|naproxen sodium
570879|NCT00751556|Bioavailability|bioavailability
570880|NCT00751543|To evaluate the longitudinal change of tumor perfusion in the course of radiation therapy in adenocarcinoma and squamous cell carcinoma using perfusion MDCT|to evaluate the longitudinal change of tumor perfusion in the course of radiation therapy in adenocarcinoma and squamous cell carcinoma using perfusion mdct
570881|NCT00751543|Comparison between adenocarcinoma and squamous cell carcinoma will be evaluated according to the derived perfusion parameter obtained from perfusion MDCT|comparison between adenocarcinoma and squamous cell carcinoma will be evaluated according to the derived perfusion parameter obtained from perfusion mdct
570882|NCT00751530|HIV|hiv
570883|NCT00751530|AIDS|aids
570884|NCT00751530|raltegravir|raltegravir
570885|NCT00751530|BRAVO|bravo
570886|NCT00751530|protease inhibitor|protease inhibitor
570887|NCT00751530|treatment Experienced|treatment experienced
570888|NCT00751517|Vasculitis|vasculitis
570889|NCT00751517|Cyclophosphamide|cyclophosphamide
570890|NCT00751517|Methotrexate|methotrexate
570891|NCT00751517|Systemic Necrotizing Vasculitides|systemic necrotizing vasculitides
570892|NCT00751504|Quetiapine|quetiapine
570893|NCT00751504|Psychotic depression|psychotic depression
570894|NCT00751491|Stable angina|stable angina
570895|NCT00751491|Percutaneous Coronary Intervention|percutaneous coronary intervention
570896|NCT00751491|Myonecrosis|myonecrosis
570897|NCT00751478|ALO-01|alo-01
570898|NCT00751478|morphine|morphine
570899|NCT00751478|Determination of the relative pharmacodynamic effects|determination of the relative pharmacodynamic effects
570900|NCT00751478|(including drug-liking), pharmacokinetics, and safety of|(including drug-liking), pharmacokinetics, and safety of
570901|NCT00751478|ALO-01 when administered whole or crushed and compared to|alo-01 when administered whole or crushed and compared to
570902|NCT00751478|equivalent doses of immediate release morphine and placebo|equivalent doses of immediate release morphine and placebo
570903|NCT00751465|Social Anxiety Disorder|social anxiety disorder
570904|NCT00751465|Social Phobia|social phobia
570905|NCT00751465|Fear of blushing|fear of blushing
570906|NCT00751465|attention|attention
570907|NCT00751465|attention training|attention training
570908|NCT00751465|cognitive behavior therapy|cognitive behavior therapy
570909|NCT00751452|Children|children
570910|NCT00751452|Allogeneic bone marrow transplantation|allogeneic bone marrow transplantation
570911|NCT00751452|Intestinal damage|intestinal damage
570912|NCT00751452|Citrulline|citrulline
570913|NCT00751452|Graft versus Host Disease|graft versus host disease
570914|NCT00751452|0 to 18 years old|0 to 18 years old
570915|NCT00751439|Oximeter|oximeter
570916|NCT00751439|Arterial blood gas|arterial blood gas
570917|NCT00751439|comparison|comparison
570918|NCT00751426|Interferon-alpha|interferon-alpha
570919|NCT00751426|hepatitis c|hepatitis c
570920|NCT00751426|Drug addiction|drug addiction
570921|NCT00751426|methadone|methadone
570922|NCT00751426|psychiatric disorder|psychiatric disorder
570923|NCT00751426|Safety and efficacy of Interferon-alpha i patients with a psychiatric disorder.|safety and efficacy of interferon-alpha i patients with a psychiatric disorder.
570924|NCT00751400|Non-prescription|non-prescription
570925|NCT00751361|Rheopheresis|rheopheresis
570926|NCT00751361|Dry Age Related Macular Degeneration|dry age related macular degeneration
570927|NCT00751361|AMD|amd
570928|NCT00751361|apheresis|apheresis
570929|NCT00751361|microcirculation|microcirculation
570930|NCT00751348|second year of life|second year of life
570931|NCT00751348|one-dose schedule|one-dose schedule
570933|NCT00751348|rubella|rubella
570934|NCT00751348|measles|measles
570935|NCT00751348|mumps|mumps
570936|NCT00751335|Obstructive Sleep Apnea|obstructive sleep apnea
570937|NCT00751335|Humidification|humidification
570938|NCT00751335|Continuous Positive Airway Pressure|continuous positive airway pressure
570939|NCT00751322|Pulmonary|pulmonary
570940|NCT00751322|Protein|protein
570941|NCT00751309|allograft|allograft
570942|NCT00751309|rejection|rejection
570943|NCT00751309|biopsy|biopsy
570944|NCT00751309|gene|gene
570945|NCT00751309|expression|expression
570946|NCT00751309|pulmonary|pulmonary
570947|NCT00751309|lung|lung
570948|NCT00751309|transplant|transplant
570949|NCT00751296|Lenalidomide|lenalidomide
570950|NCT00751296|immunomodulatory drug (IMiD®)|immunomodulatory drug (imid®)
570951|NCT00751296|Thalidomide analogues|thalidomide analogues
570952|NCT00751270|Immunotherapy|immunotherapy
570953|NCT00751270|Gene therapy|gene therapy
570954|NCT00751270|Tumor Vaccine|tumor vaccine
570955|NCT00751270|Cytotoxicity|cytotoxicity
570956|NCT00751270|Radiation|radiation
570957|NCT00751257|Nicotine|nicotine
570958|NCT00751257|N-acetylcysteine|n-acetylcysteine
570959|NCT00751257|smoking reduction|smoking reduction
570960|NCT00751244|women|women
570961|NCT00751244|posttraumatic stress disorder|posttraumatic stress disorder
570962|NCT00751244|PTSD|ptsd
570963|NCT00751244|psychotherapy|psychotherapy
570964|NCT00751244|clinical trial|clinical trial
570965|NCT00751244|emotion regulation|emotion regulation
570966|NCT00751231|PCI|pci
570967|NCT00751231|percutaneous coronary intervention|percutaneous coronary intervention
570968|NCT00751205|Peripheral Neuropathy|peripheral neuropathy
570969|NCT00751205|Prostate Carcinoma|prostate carcinoma
570970|NCT00751205|Ovarian Carcinoma|ovarian carcinoma
570971|NCT00751192|Men who have sex with men|men who have sex with men
570972|NCT00751192|Peru|peru
570973|NCT00751192|HIV testing|hiv testing
570974|NCT00751192|video|video
570975|NCT00751192|online|online
570976|NCT00751192|Internet|internet
570977|NCT00751192|HIV Seronegativity|hiv seronegativity
570978|NCT00751153|drug substitution|drug substitution
570979|NCT00751153|Raltegravir|raltegravir
570980|NCT00751153|Atazanavir|atazanavir
570981|NCT00751153|treatment Experienced|treatment experienced
570982|NCT00751140|surgical candidates|surgical candidates
570983|NCT00751140|upper urinary tract|upper urinary tract
570984|NCT00751140|urothelial carcinoma|urothelial carcinoma
570985|NCT00751140|lymph node dissection|lymph node dissection
570986|NCT00751127|open angle glaucoma|open angle glaucoma
570987|NCT00751127|ocular hypertension|ocular hypertension
570988|NCT00751101|palmar-plantar erythrodysesthesia|palmar-plantar erythrodysesthesia
570989|NCT00751101|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
570990|NCT00751101|stage IV breast cancer|stage iv breast cancer
570991|NCT00751101|recurrent breast cancer|recurrent breast cancer
570992|NCT00751088|single-incision|single-incision
570993|NCT00751088|sling|sling
570994|NCT00751088|stress incontinence|stress incontinence
570995|NCT00751088|surgery|surgery
570996|NCT00751088|treatment|treatment
570997|NCT00751088|Female urinary stress incontinence|female urinary stress incontinence
570998|NCT00751062|open angle glaucoma ocular hypertension|open angle glaucoma ocular hypertension
570999|NCT00751049|open angle glaucoma ocular hypertension|open angle glaucoma ocular hypertension
571000|NCT00751036|GIST|gist
571001|NCT00751023|Methamphetamine|methamphetamine
571002|NCT00751023|Modafinil|modafinil
571003|NCT00751023|Addiction|addiction
571004|NCT00751023|Craving|craving
571005|NCT00751023|Cognitive|cognitive
571006|NCT00751010|Vulvar pain|vulvar pain
571007|NCT00751010|Vulvodynia|vulvodynia
571008|NCT00751010|Interstitial cystitis|interstitial cystitis
571009|NCT00750971|ASSIST|assist
571010|NCT00750971|SLE|sle
571011|NCT00750971|Stem Cell Transplantation|stem cell transplantation
571012|NCT00750971|Tolerance|tolerance
571013|NCT00750958|cardiac rhythm changes|cardiac rhythm changes
571014|NCT00750945|Parkinson's disease|parkinson's disease
571015|NCT00750945|Cueing training|cueing training
571016|NCT00750945|Treadmill training|treadmill training
571017|NCT00750945|Music|music
571018|NCT00750893|Gastroenteritis|gastroenteritis
571019|NCT00750867|multiple system atrophy, MSA,|multiple system atrophy, msa,
571020|NCT00750867|intravenous immunoglobulin, IVIg|intravenous immunoglobulin, ivig
571021|NCT00750854|arthritis|arthritis
571022|NCT00750854|osteoarthritis|osteoarthritis
571023|NCT00750854|fibromyalgia|fibromyalgia
571024|NCT00750854|connective tissue disorder|connective tissue disorder
571025|NCT00750841|advanced cancer|advanced cancer
571026|NCT00750841|metastatic|metastatic
571027|NCT00750841|rifampicin|rifampicin
571028|NCT00750841|pharmacokinetics|pharmacokinetics
571029|NCT00750841|Phase I|phase i
571030|NCT00750841|Advanced solid tumours|advanced solid tumours
571031|NCT00750828|Saliva|saliva
571032|NCT00750828|Sjögren's Syndrome|sjögren's syndrome
571033|NCT00750828|GCF|gcf
571034|NCT00750828|Oral Mucosal Wetness|oral mucosal wetness
571035|NCT00750815|B Cell|b cell
571036|NCT00750815|hematologic malignancy|hematologic malignancy
571037|NCT00750815|plasma|plasma
571038|NCT00750815|bone marrow|bone marrow
571039|NCT00750802|Phase I|phase i
571040|NCT00750776|Quality assurance|quality assurance
571041|NCT00750776|medical treatment|medical treatment
571042|NCT00750776|Patient satisfaction|patient satisfaction
571043|NCT00750763|Mucosal inflammation|mucosal inflammation
571044|NCT00750763|Fleet|fleet
571045|NCT00750763|Picoprep|picoprep
571046|NCT00750763|Colonlytely|colonlytely
571047|NCT00750763|Colonoscopy|colonoscopy
571048|NCT00750763|tolerability|tolerability
571049|NCT00750763|efficacy|efficacy
571050|NCT00750737|Hematologic Malignancies|hematologic malignancies
571051|NCT00750737|Blood Cancer|blood cancer
571052|NCT00750737|Lymphatic Cancer|lymphatic cancer
571053|NCT00750737|Amphotericin B Lipid Complex|amphotericin b lipid complex
571054|NCT00750737|Amphotericin B|amphotericin b
571055|NCT00750737|ABLC|ablc
571056|NCT00750737|Fungizone|fungizone
571057|NCT00750737|Noxafil|noxafil
571058|NCT00750737|SCH56592|sch56592
571059|NCT00750737|Posaconazole|posaconazole
571060|NCT00750737|Invasive fungal infections|invasive fungal infections
571061|NCT00750737|IFI|ifi
571487|NCT00749775|Drug use Investigation|drug use investigation
571062|NCT00750737|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
571063|NCT00750737|HSCT|hsct
571064|NCT00750737|Bone Marrow Transplant|bone marrow transplant
572232|NCT00746863|SPARC sling|sparc sling
571065|NCT00750737|Allogeneic hematopoietic stem cell transplant|allogeneic hematopoietic stem cell transplant
571066|NCT00750724|Hyaluronic acid,|hyaluronic acid,
571067|NCT00750724|OA knee,|oa knee,
571068|NCT00750724|MRI|mri
571069|NCT00750698|lung cancer|lung cancer
571070|NCT00750698|non small cell lung cancer|non small cell lung cancer
571071|NCT00750685|Primary Breast Reconstruction|primary breast reconstruction
571072|NCT00750672|Endometrial neoplasia|endometrial neoplasia
571073|NCT00750672|Follow-up care|follow-up care
571074|NCT00750672|survivorship|survivorship
571075|NCT00750672|Primary care provider|primary care provider
571076|NCT00750659|Chronic myeloid leukemia|chronic myeloid leukemia
571077|NCT00750659|Ph+ acute lymphoblastic leukemia|ph+ acute lymphoblastic leukemia
571078|NCT00750659|stem cell transplantation|stem cell transplantation
571079|NCT00750659|nilotinib|nilotinib
571080|NCT00750646|compliance|compliance
571081|NCT00750646|eye drop administration|eye drop administration
571082|NCT00750646|MEMS|mems
571083|NCT00750646|adherence|adherence
571084|NCT00750633|swimmer's ear|swimmer's ear
571085|NCT00750633|ear drops|ear drops
571086|NCT00750633|ear infection|ear infection
571087|NCT00750633|ear pain|ear pain
571088|NCT00750633|ear inflammation|ear inflammation
571089|NCT00750620|mild, moderate, and severe renal impaired subjects|mild, moderate, and severe renal impaired subjects
571090|NCT00750620|normal renal function subjects|normal renal function subjects
571091|NCT00750620|Glomerular filtration rate (GFR)|glomerular filtration rate (gfr)
571092|NCT00750620|Modification of Diet in Renal Disease (MDRD) formula|modification of diet in renal disease (mdrd) formula
571093|NCT00750620|YM178|ym178
571094|NCT00750620|pharmacokinetics|pharmacokinetics
571095|NCT00750594|Children|children
571096|NCT00750594|Migraine headaches|migraine headaches
571097|NCT00750581|Patent Ductus Arteriosus|patent ductus arteriosus
571098|NCT00750568|Bronchial asthma|bronchial asthma
571099|NCT00750568|Asthma, bronchial|asthma, bronchial
571100|NCT00750568|Status Asthmaticus|status asthmaticus
571101|NCT00750568|Terbutaline sulfate|terbutaline sulfate
571102|NCT00750555|squamous cell cancer of head and neck|squamous cell cancer of head and neck
571103|NCT00750555|SCCHN|scchn
571104|NCT00750529|sleep|sleep
571105|NCT00750529|Alzheimer|alzheimer
571106|NCT00750529|old patients|old patients
571107|NCT00750516|Lactic acid|lactic acid
571108|NCT00750516|hypotension|hypotension
571109|NCT00750516|sepsis|sepsis
571110|NCT00750503|tobacco cessation|tobacco cessation
571111|NCT00750503|behavioral therapy|behavioral therapy
571112|NCT00750503|pharmacotherapy|pharmacotherapy
571113|NCT00750503|workplace|workplace
571114|NCT00750503|oral cancer screening|oral cancer screening
571115|NCT00750503|Tobacco Quit rates|tobacco quit rates
571116|NCT00750477|osteoarthritis|osteoarthritis
571117|NCT00750477|arthritis|arthritis
571118|NCT00750477|knee|knee
571119|NCT00750477|eggshell|eggshell
571120|NCT00750477|membrane|membrane
571121|NCT00750477|OPTION|option
571122|NCT00750451|fertilization in vitro|fertilization in vitro
571123|NCT00750451|assisted reproduction|assisted reproduction
571124|NCT00750451|recurrent implantation failure|recurrent implantation failure
571125|NCT00750451|low molecular weight heparin|low molecular weight heparin
571126|NCT00750451|heparin|heparin
571127|NCT00750451|luteal phase|luteal phase
571128|NCT00750438|Obesity|obesity
571129|NCT00750438|Short chain fatty acids|short chain fatty acids
571130|NCT00750438|Appetite|appetite
571131|NCT00750438|Body weight|body weight
571132|NCT00750438|Insulin sensitivity|insulin sensitivity
571133|NCT00750438|Propionate|propionate
571134|NCT00750438|Propionate ester|propionate ester
571135|NCT00750425|advanced cancer,|advanced cancer,
571136|NCT00750425|metastatic|metastatic
571137|NCT00750425|ketoconazole|ketoconazole
571138|NCT00750425|pharmacokinetics|pharmacokinetics
571139|NCT00750425|Phase I|phase i
571140|NCT00750412|TeenScreen|teenscreen
571141|NCT00750412|Mental Health|mental health
571142|NCT00750412|Adolescent Mental Health|adolescent mental health
571143|NCT00750412|Social Work|social work
571144|NCT00750399|radiation|radiation
571145|NCT00750399|retinopathy|retinopathy
571146|NCT00750399|ranibizumab|ranibizumab
571147|NCT00750399|melanoma|melanoma
571148|NCT00750399|choroid|choroid
571149|NCT00750386|Cancer|cancer
571150|NCT00750386|Ovarian cancer|ovarian cancer
571151|NCT00750386|Dose-dense chemotherapy|dose-dense chemotherapy
571152|NCT00750373|Endocarditis|endocarditis
571153|NCT00750360|Influenza|influenza
571154|NCT00750360|Korea|korea
571155|NCT00750360|FluarixTM|fluarixtm
571156|NCT00750347|pain,|pain,
571157|NCT00750347|analgesia|analgesia
571158|NCT00750347|Healthy volunteers|healthy volunteers
571159|NCT00750334|Oral Clofarabine,|oral clofarabine,
571160|NCT00750334|relapsed/refractory MDS,|relapsed/refractory mds,
571161|NCT00750334|Myelodysplastic|myelodysplastic
571162|NCT00750295|Chronic kidney disease,|chronic kidney disease,
571163|NCT00750295|hemodialysis,|hemodialysis,
571164|NCT00750295|serum phosphorus,|serum phosphorus,
571165|NCT00750295|phosphate binders|phosphate binders
571166|NCT00750282|Alzheimer Disease|alzheimer disease
571167|NCT00750282|Amyloid beta-Protein|amyloid beta-protein
571168|NCT00750269|stage I non-small cell lung cancer|stage i non-small cell lung cancer
571169|NCT00750256|tolerability|tolerability
571170|NCT00750256|Safety|safety
571171|NCT00750256|pharmacokinetics|pharmacokinetics
571172|NCT00750230|arthritis|arthritis
571173|NCT00750230|osteoarthritis|osteoarthritis
571174|NCT00750230|fibromyalgia|fibromyalgia
571175|NCT00750230|connective tissue disorder|connective tissue disorder
571176|NCT00750217|transfer methadone buprenorphine patch heroin addiction|transfer methadone buprenorphine patch heroin addiction
571177|NCT00750204|Acute Lung Injury|acute lung injury
571178|NCT00750204|ALI|ali
571179|NCT00750204|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
571180|NCT00750204|Mechanical Ventilation|mechanical ventilation
571181|NCT00750204|Sedation|sedation
571182|NCT00750204|Critical Illness|critical illness
571183|NCT00750204|Ventilator Induced Lung Injury|ventilator induced lung injury
571184|NCT00750204|VILI|vili
571185|NCT00750204|Cytokines|cytokines
571186|NCT00750204|Protective Ventilation|protective ventilation
571187|NCT00750204|Airway Pressure Release Ventilation|airway pressure release ventilation
571188|NCT00750204|APRV|aprv
571189|NCT00750204|Breathing Comfort|breathing comfort
571190|NCT00750204|Dyssynchrony|dyssynchrony
571191|NCT00750204|Asynchrony|asynchrony
571192|NCT00750191|Lower Back Pain|lower back pain
571193|NCT00750165|Obstructive Sleep Apnea|obstructive sleep apnea
571194|NCT00750165|Humidification|humidification
571195|NCT00750165|Continuous Positive Airway Pressure|continuous positive airway pressure
571196|NCT00750152|tinea cruris|tinea cruris
571197|NCT00750152|jock itch|jock itch
571198|NCT00750139|Tinea Pedis|tinea pedis
571199|NCT00750139|Athlete's foot|athlete's foot
571200|NCT00750126|Allograft|allograft
571201|NCT00750126|Children|children
571202|NCT00750126|malignancy|malignancy
571203|NCT00750126|Reduced Intensity Conditioning|reduced intensity conditioning
571204|NCT00750126|Fludarabin|fludarabin
571205|NCT00750126|Busulfex|busulfex
571206|NCT00750126|Thymoglobulin|thymoglobulin
571207|NCT00750100|infertility|infertility
571208|NCT00750100|IVF|ivf
571209|NCT00750100|hCG|hcg
571210|NCT00750100|primary infertility|primary infertility
571211|NCT00750100|secondary infertility|secondary infertility
571212|NCT00750100|patients requiring in-vitro fertilisation|patients requiring in-vitro fertilisation
571213|NCT00750087|Schizophrenia|schizophrenia
571214|NCT00750074|mechanical ventilation|mechanical ventilation
571215|NCT00750061|Spinal Cord Injury|spinal cord injury
571216|NCT00750048|pain,|pain,
571217|NCT00750048|sensitization,|sensitization,
571218|NCT00750048|analgesia|analgesia
571219|NCT00750035|Total hysterectomy|total hysterectomy
571220|NCT00750035|subtotal hysterectomy|subtotal hysterectomy
571221|NCT00750035|urinary function|urinary function
571222|NCT00750035|bowel function|bowel function
571223|NCT00750035|sexual function|sexual function
571224|NCT00750035|Quality of life|quality of life
571225|NCT00750035|Psychological function|psychological function
571226|NCT00750009|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
571227|NCT00750009|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
571228|NCT00750009|acute undifferentiated leukemia|acute undifferentiated leukemia
571229|NCT00750009|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
571230|NCT00750009|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
571231|NCT00750009|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
571232|NCT00750009|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
571233|NCT00750009|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
571234|NCT00750009|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
571235|NCT00750009|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
571236|NCT00750009|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
571237|NCT00750009|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
571238|NCT00750009|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
571239|NCT00750009|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
571240|NCT00750009|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
571241|NCT00750009|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
571242|NCT00750009|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
571243|NCT00750009|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
571244|NCT00750009|mast cell leukemia|mast cell leukemia
571245|NCT00750009|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
571246|NCT00750009|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
571247|NCT00750009|prolymphocytic leukemia|prolymphocytic leukemia
571248|NCT00750009|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
571249|NCT00750009|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
572441|NCT00746018|uterus|uterus
571250|NCT00750009|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
571251|NCT00750009|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
571252|NCT00750009|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
571253|NCT00750009|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
571254|NCT00750009|refractory hairy cell leukemia|refractory hairy cell leukemia
571255|NCT00750009|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
571256|NCT00750009|secondary acute myeloid leukemia|secondary acute myeloid leukemia
571257|NCT00750009|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
571258|NCT00750009|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
571259|NCT00750009|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
571260|NCT00750009|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
571261|NCT00750009|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
571262|NCT00750009|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
571263|NCT00750009|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
571264|NCT00750009|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
571265|NCT00750009|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
571266|NCT00750009|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
571267|NCT00750009|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
571268|NCT00750009|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
571269|NCT00750009|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
571270|NCT00750009|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
571271|NCT00750009|untreated hairy cell leukemia|untreated hairy cell leukemia
571272|NCT00750009|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
571273|NCT00750009|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
571274|NCT00750009|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
571275|NCT00750009|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
571276|NCT00750009|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
571277|NCT00750009|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
571278|NCT00750009|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
571279|NCT00750009|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
571280|NCT00750009|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
571281|NCT00750009|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
571282|NCT00750009|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
571283|NCT00750009|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
571284|NCT00750009|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
571285|NCT00750009|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
571286|NCT00750009|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
571287|NCT00750009|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
571288|NCT00750009|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
571289|NCT00750009|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
571290|NCT00750009|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
571291|NCT00750009|anaplastic large cell lymphoma|anaplastic large cell lymphoma
571292|NCT00750009|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
571293|NCT00750009|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
571294|NCT00750009|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
571295|NCT00750009|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
571296|NCT00750009|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
571297|NCT00750009|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
571298|NCT00750009|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
571299|NCT00750009|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
571300|NCT00750009|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
571301|NCT00750009|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
571302|NCT00750009|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
571303|NCT00750009|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
571304|NCT00750009|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
571305|NCT00750009|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
571306|NCT00750009|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
571307|NCT00750009|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
571308|NCT00750009|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
571309|NCT00750009|splenic marginal zone lymphoma|splenic marginal zone lymphoma
571310|NCT00750009|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
571311|NCT00750009|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
571312|NCT00750009|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
571313|NCT00750009|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
571314|NCT00750009|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
571315|NCT00750009|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
571316|NCT00750009|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
571317|NCT00750009|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
571318|NCT00750009|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
571319|NCT00750009|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
571320|NCT00750009|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
571321|NCT00750009|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
571322|NCT00750009|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
571323|NCT00750009|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
571324|NCT00750009|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
571325|NCT00750009|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
571326|NCT00750009|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
571327|NCT00750009|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
571328|NCT00750009|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
571329|NCT00750009|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
571330|NCT00750009|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
571331|NCT00750009|stage I mantle cell lymphoma|stage i mantle cell lymphoma
571332|NCT00750009|stage I marginal zone lymphoma|stage i marginal zone lymphoma
571333|NCT00750009|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
571334|NCT00750009|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
571335|NCT00750009|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
571336|NCT00750009|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
571337|NCT00750009|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
571338|NCT00750009|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
571339|NCT00750009|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
571340|NCT00750009|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
571341|NCT00750009|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
571342|NCT00750009|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
571343|NCT00750009|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
571344|NCT00750009|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
571345|NCT00750009|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
571346|NCT00750009|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
571347|NCT00750009|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
571348|NCT00750009|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
571349|NCT00750009|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
571350|NCT00750009|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
571351|NCT00750009|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
571352|NCT00750009|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
571353|NCT00750009|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
571354|NCT00750009|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
571355|NCT00750009|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
571356|NCT00750009|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
571357|NCT00750009|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
571358|NCT00750009|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
571359|NCT00750009|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
571360|NCT00750009|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
571361|NCT00750009|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
571362|NCT00750009|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
571363|NCT00750009|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
571364|NCT00750009|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
571365|NCT00750009|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
571366|NCT00750009|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
571367|NCT00750009|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
571368|NCT00750009|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
571369|NCT00750009|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
571370|NCT00750009|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
571371|NCT00750009|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
571372|NCT00750009|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
571373|NCT00750009|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
571374|NCT00750009|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
571375|NCT00750009|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
571376|NCT00750009|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
571377|NCT00750009|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
571378|NCT00750009|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
571379|NCT00750009|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
571380|NCT00750009|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
571381|NCT00750009|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
571382|NCT00750009|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
571383|NCT00750009|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
571384|NCT00750009|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
571385|NCT00750009|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
571386|NCT00750009|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
571387|NCT00750009|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
571388|NCT00750009|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
571389|NCT00750009|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
571390|NCT00750009|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
571391|NCT00750009|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
571392|NCT00750009|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
571393|NCT00750009|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
571394|NCT00750009|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
571395|NCT00750009|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
571396|NCT00750009|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
571397|NCT00750009|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
571398|NCT00750009|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
571399|NCT00750009|Burkitt lymphoma|burkitt lymphoma
571400|NCT00750009|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
571401|NCT00750009|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
571402|NCT00750009|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
571403|NCT00750009|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
571404|NCT00750009|intraocular lymphoma|intraocular lymphoma
571405|NCT00750009|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
571406|NCT00750009|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
571407|NCT00750009|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
571408|NCT00750009|chronic eosinophilic leukemia|chronic eosinophilic leukemia
571409|NCT00750009|chronic neutrophilic leukemia|chronic neutrophilic leukemia
571410|NCT00750009|primary myelofibrosis|primary myelofibrosis
571411|NCT00750009|essential thrombocythemia|essential thrombocythemia
571412|NCT00750009|polycythemia vera|polycythemia vera
571413|NCT00750009|extramedullary plasmacytoma|extramedullary plasmacytoma
571414|NCT00750009|isolated plasmacytoma of bone|isolated plasmacytoma of bone
571415|NCT00750009|stage I multiple myeloma|stage i multiple myeloma
571416|NCT00750009|stage II multiple myeloma|stage ii multiple myeloma
571417|NCT00750009|stage III multiple myeloma|stage iii multiple myeloma
571418|NCT00750009|primary systemic amyloidosis|primary systemic amyloidosis
571419|NCT00750009|refractory multiple myeloma|refractory multiple myeloma
571420|NCT00750009|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
571421|NCT00750009|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
571422|NCT00750009|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
571423|NCT00750009|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
571424|NCT00750009|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
571425|NCT00750009|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
571426|NCT00750009|stage I childhood anaplastic large cell lymphoma|stage i childhood anaplastic large cell lymphoma
571427|NCT00750009|stage II childhood anaplastic large cell lymphoma|stage ii childhood anaplastic large cell lymphoma
571428|NCT00750009|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
571429|NCT00750009|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
571430|NCT00749970|schizophrenia|schizophrenia
571431|NCT00749970|subjective well-being|subjective well-being
571432|NCT00749970|psychometric validation|psychometric validation
571433|NCT00749957|AAV|aav
571434|NCT00749957|adeno-associated virus|adeno-associated virus
571435|NCT00749957|RPE65|rpe65
571436|NCT00749957|Leber congenital amaurosis|leber congenital amaurosis
571437|NCT00749957|LCA|lca
571438|NCT00749957|gene therapy|gene therapy
571439|NCT00749957|human gene transfer|human gene transfer
571440|NCT00749944|nicotine withdrawal, smoking cessation, varenicline|nicotine withdrawal, smoking cessation, varenicline
571441|NCT00749931|IDC, DCIS, ILC|idc, dcis, ilc
571442|NCT00749918|vitamin D|vitamin d
571443|NCT00749918|Cholecalciferol|cholecalciferol
571444|NCT00749918|Insulin sensitivity|insulin sensitivity
571445|NCT00749918|MinMod Millennium|minmod millennium
571446|NCT00749918|FSIGT|fsigt
571447|NCT00749918|modified frequently sampled IV glucose tolerance test|modified frequently sampled iv glucose tolerance test
571448|NCT00749892|Transitional Cell Carcinoma|transitional cell carcinoma
571449|NCT00749892|Bladder Cancer|bladder cancer
571450|NCT00749892|Urothelial Cancer|urothelial cancer
571451|NCT00749892|Erlotinib Hydrochloride|erlotinib hydrochloride
571452|NCT00749892|Tarceva|tarceva
571453|NCT00749892|OSI-774|osi-774
571454|NCT00749892|TCC|tcc
571455|NCT00749879|PK|pk
571456|NCT00749879|Pharmacokinetics|pharmacokinetics
571457|NCT00749866|Nebulised antibiotics|nebulised antibiotics
571458|NCT00749866|Non cystic fibrosis bronchiectasis|non cystic fibrosis bronchiectasis
571459|NCT00749866|Bacterial Load|bacterial load
571460|NCT00749866|Inflammation|inflammation
571461|NCT00749866|Quality of Life|quality of life
571462|NCT00749866|Side Effects|side effects
571463|NCT00749853|ovarian stimulation|ovarian stimulation
571464|NCT00749853|FSH|fsh
571465|NCT00749853|genotyping|genotyping
571466|NCT00749853|polymorphism|polymorphism
571467|NCT00749840|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
571468|NCT00749840|Human Immunodeficiency Virus|human immunodeficiency virus
571469|NCT00749840|Questionnaire|questionnaire
571470|NCT00749840|AIDS|aids
571471|NCT00749840|HIV|hiv
571472|NCT00749840|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
571473|NCT00749840|HAART|haart
571474|NCT00749840|Steps of HIV Care|steps of hiv care
571475|NCT00749840|CDC|cdc
571476|NCT00749827|Contrast Induced Nephropathy, fluid prophylaxis|contrast induced nephropathy, fluid prophylaxis
571477|NCT00749814|sleep patterns in children in the night prior to surgery and post surgery.|sleep patterns in children in the night prior to surgery and post surgery.
571478|NCT00749814|the influence of melatonin on sleep patterns|the influence of melatonin on sleep patterns
571479|NCT00749801|drug naive|drug naive
571480|NCT00749801|Dyslipidemic|dyslipidemic
571481|NCT00749801|nattokinase|nattokinase
571482|NCT00749801|fibrinolytic|fibrinolytic
571483|NCT00749775|Eplerenone|eplerenone
571484|NCT00749775|Selara|selara
571485|NCT00749775|Hypertension|hypertension
571486|NCT00749775|Good post-marketing study Practice|good post-marketing study practice
571488|NCT00749775|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
571489|NCT00749775|ESSENCE|essence
571490|NCT00749762|DURING|during
571491|NCT00749762|PRONE|prone
571492|NCT00749762|SUPINE|supine
571493|NCT00749762|POSITIONING|positioning
571494|NCT00749749|Abdominal Hysterectomy|abdominal hysterectomy
571495|NCT00749749|Postoperative pain|postoperative pain
571496|NCT00749736|vitamin D|vitamin d
571497|NCT00749736|determine|determine
571498|NCT00749736|normal|normal
571499|NCT00749736|intrapatient|intrapatient
571500|NCT00749736|interpatient|interpatient
571501|NCT00749736|variability|variability
571502|NCT00749736|measures|measures
571503|NCT00749736|immune system|immune system
571504|NCT00749723|brain tumor|brain tumor
571505|NCT00749723|relapse|relapse
571506|NCT00749723|children|children
571507|NCT00749723|etoposide|etoposide
571508|NCT00749723|intraventricular|intraventricular
571509|NCT00749723|temozolomide|temozolomide
571510|NCT00749710|femoral neck fractures|femoral neck fractures
571511|NCT00749710|pertrochanteric fractures|pertrochanteric fractures
571512|NCT00749710|antiaggregant therapy|antiaggregant therapy
571513|NCT00749710|clopidogrel|clopidogrel
571514|NCT00749710|plavix|plavix
571515|NCT00749697|radioiodine|radioiodine
571516|NCT00749697|differentiated thyroid cancers|differentiated thyroid cancers
571517|NCT00749697|dosimetry|dosimetry
571518|NCT00749697|metastases|metastases
571519|NCT00749684|interferon-alpha|interferon-alpha
571520|NCT00749658|Tobacco|tobacco
571521|NCT00749658|Nicotine|nicotine
571522|NCT00749658|Smoking|smoking
571523|NCT00749658|Varenicline|varenicline
571524|NCT00749658|Bupropion|bupropion
571525|NCT00749658|Human laboratory study|human laboratory study
571526|NCT00749658|Stress tolerance|stress tolerance
571527|NCT00749658|Startle response|startle response
571528|NCT00749658|Cognitive assessment|cognitive assessment
571529|NCT00749658|Progressive ratio|progressive ratio
571530|NCT00749658|Motivation|motivation
571531|NCT00749645|Arthritis, Rheumatoid, Andrographolides treatment, Efficacy.|arthritis, rheumatoid, andrographolides treatment, efficacy.
571532|NCT00749632|urinary incontinence, urge|urinary incontinence, urge
571533|NCT00749632|urinary urge incontinence|urinary urge incontinence
571534|NCT00749632|urge incontinence|urge incontinence
571535|NCT00749632|over active bladder|over active bladder
571536|NCT00749619|Tunneled Cuffed Catheter|tunneled cuffed catheter
571537|NCT00749619|Catheter Lock Solution|catheter lock solution
571538|NCT00749619|Catheter Related Bacteremia|catheter related bacteremia
571539|NCT00749606|Obesity|obesity
571540|NCT00749606|Metabolic syndrome|metabolic syndrome
571541|NCT00749606|Weight loss|weight loss
571542|NCT00749606|Diabetes prevention|diabetes prevention
572442|NCT00746018|cervix|cervix
571543|NCT00749593|Congenital Adrenal Hyperplasia|congenital adrenal hyperplasia
571544|NCT00749593|Quality of Life|quality of life
571545|NCT00749593|Genotype|genotype
571546|NCT00749593|Metabolic outcomes|metabolic outcomes
571547|NCT00749580|Safety|safety
571548|NCT00749567|NSCLC|nsclc
571549|NCT00749567|TKI's|tki's
571550|NCT00749567|Anti-VEGF|anti-vegf
571551|NCT00749554|Cooled Radiofrequency|cooled radiofrequency
571552|NCT00749554|Disc biacuplasty|disc biacuplasty
571553|NCT00749554|TransDiscal system|transdiscal system
571554|NCT00749554|Discogenic pain|discogenic pain
571555|NCT00749541|vitamin d coronary catheterization|vitamin d coronary catheterization
571556|NCT00749528|Wheezing|wheezing
571557|NCT00749528|Hair trace elements|hair trace elements
571558|NCT00749528|Hair toxic metals|hair toxic metals
571559|NCT00749528|Oxidative stress|oxidative stress
571560|NCT00749515|Thalassemia|thalassemia
571561|NCT00749515|Iron|iron
571562|NCT00749515|Chelation|chelation
571563|NCT00749502|Neoplasms|neoplasms
571564|NCT00749502|Ovarian neoplasms|ovarian neoplasms
571565|NCT00749502|Prostatic neoplasms|prostatic neoplasms
571566|NCT00749502|Endocrine gland neoplasms|endocrine gland neoplasms
571567|NCT00749502|Ovarian diseases|ovarian diseases
571568|NCT00749502|Adnexal diseases|adnexal diseases
571569|NCT00749502|Genital diseases, female|genital diseases, female
571570|NCT00749502|Genital diseases, male|genital diseases, male
571571|NCT00749502|Genital neoplasms, female|genital neoplasms, female
571572|NCT00749502|Urogenital neoplasms|urogenital neoplasms
571573|NCT00749502|Endocrine system diseases|endocrine system diseases
571574|NCT00749502|Gonadal disorders|gonadal disorders
571575|NCT00749502|Genital neoplasms, male|genital neoplasms, male
571576|NCT00749502|Prostatic diseases|prostatic diseases
571577|NCT00749489|Pain|pain
571578|NCT00749489|Hip Fractures|hip fractures
571579|NCT00749489|Femoral Fractures|femoral fractures
571580|NCT00749489|Analgesics|analgesics
571581|NCT00749489|Opioid|opioid
571582|NCT00749489|Nerve Block|nerve block
571583|NCT00749489|Geriatric|geriatric
571584|NCT00749489|Nerve Stimulation|nerve stimulation
571585|NCT00749463|nicotine dependence, smoking cessation, NRT|nicotine dependence, smoking cessation, nrt
571586|NCT00749450|stage II colon cancer|stage ii colon cancer
571587|NCT00749450|stage III colon cancer|stage iii colon cancer
571588|NCT00749450|stage II rectal cancer|stage ii rectal cancer
571589|NCT00749450|stage III rectal cancer|stage iii rectal cancer
571590|NCT00749437|stage I breast cancer|stage i breast cancer
571591|NCT00749437|stage II breast cancer|stage ii breast cancer
571592|NCT00749437|ductal breast carcinoma in situ|ductal breast carcinoma in situ
571593|NCT00749437|invasive ductal breast carcinoma|invasive ductal breast carcinoma
571594|NCT00749437|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
571595|NCT00749437|papillary ductal breast carcinoma|papillary ductal breast carcinoma
571596|NCT00749437|tubular ductal breast carcinoma|tubular ductal breast carcinoma
571597|NCT00749437|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
571598|NCT00749437|breast cancer in situ|breast cancer in situ
571599|NCT00749411|COPD|copd
571600|NCT00749411|long-acting beta agonist|long-acting beta agonist
571601|NCT00749411|Emphysema|emphysema
571602|NCT00749411|Chronic Bronchitis|chronic bronchitis
571603|NCT00749411|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
571604|NCT00749411|bronchodilator|bronchodilator
571605|NCT00749411|long acting muscarinic antagonist|long acting muscarinic antagonist
571606|NCT00749359|healthy volunteers|healthy volunteers
571607|NCT00749359|paroxetine|paroxetine
571608|NCT00749346|TTFields|ttfields
571609|NCT00749346|NSCLC|nsclc
571610|NCT00749346|Alimta|alimta
571611|NCT00749346|Pemetrexed|pemetrexed
571612|NCT00749333|Healthy Volunteer|healthy volunteer
571613|NCT00749333|Safety|safety
571614|NCT00749333|Tolerability|tolerability
571615|NCT00749333|AZD8566|azd8566
571616|NCT00749333|study|study
571617|NCT00749320|MRI|mri
571618|NCT00749320|Sunitinib|sunitinib
571619|NCT00749320|Pazopanib|pazopanib
571620|NCT00749307|Heart rate variability|heart rate variability
571621|NCT00749307|Docosahexaenoic acid|docosahexaenoic acid
571622|NCT00749307|DHA|dha
571623|NCT00749307|Long chain fatty acids|long chain fatty acids
571624|NCT00749307|Long chain polyunsaturated fatty acids|long chain polyunsaturated fatty acids
571625|NCT00749307|Algal fatty acids|algal fatty acids
571626|NCT00749307|Schizochytrium|schizochytrium
571627|NCT00749307|Omega 3|omega 3
571628|NCT00749307|Death, Sudden, Cardiac|death, sudden, cardiac
571629|NCT00749307|Arrhythmias, Cardiac|arrhythmias, cardiac
571630|NCT00749281|atherosclerosis|atherosclerosis
571631|NCT00749281|ngal|ngal
571632|NCT00749281|coronary artery disease|coronary artery disease
571633|NCT00749268|hernia|hernia
571634|NCT00749255|Breast Cancer|breast cancer
571635|NCT00749255|Digital archiver software|digital archiver software
571636|NCT00749242|Traumatic vertebral fracture|traumatic vertebral fracture
571637|NCT00749242|Vertebroplasty|vertebroplasty
571638|NCT00749242|Balloon kyphoplasty|balloon kyphoplasty
571639|NCT00749242|Bohler bracing|bohler bracing
571640|NCT00749229|Traumatic vertebral fracture|traumatic vertebral fracture
571641|NCT00749229|Balloon Kyphoplasty|balloon kyphoplasty
571642|NCT00749229|type A3.2, or A3.3 or B1 or C1 in the MAGERL CLASSIFICATION|type a3.2, or a3.3 or b1 or c1 in the magerl classification
571643|NCT00749203|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
571644|NCT00749203|PTSD|ptsd
571645|NCT00749203|anxiety disorder|anxiety disorder
571646|NCT00749203|ketamine|ketamine
571647|NCT00749203|depression|depression
571648|NCT00749203|depressed mood|depressed mood
571649|NCT00749177|traditional healing|traditional healing
571650|NCT00749177|anxiety|anxiety
571651|NCT00749177|depression|depression
571652|NCT00749177|aboriginal|aboriginal
571653|NCT00749177|children|children
571654|NCT00749177|youth|youth
571655|NCT00749164|Mesenchymal stem cells|mesenchymal stem cells
571656|NCT00749164|Umbilical cord|umbilical cord
571657|NCT00749164|graft-vs-host disease|graft-vs-host disease
571658|NCT00749164|Steroid resistant|steroid resistant
571659|NCT00749151|smoking cessation|smoking cessation
571660|NCT00749151|telephone help line|telephone help line
571661|NCT00749138|hepatitis C, tamoxifen|hepatitis c, tamoxifen
571662|NCT00749125|Emotional Circuitry|emotional circuitry
571663|NCT00749125|fMRI|fmri
571664|NCT00749112|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
571665|NCT00749112|Anemia|anemia
571666|NCT00749112|Hemolytic|hemolytic
571667|NCT00749112|Autoimmune|autoimmune
571668|NCT00749112|Alemtuzumab|alemtuzumab
571669|NCT00749112|Rituximab|rituximab
571670|NCT00749086|Osteoporosis|osteoporosis
571671|NCT00749086|Non-traumatic vertebral fracture|non-traumatic vertebral fracture
571672|NCT00749086|Vertebral compression|vertebral compression
571673|NCT00749086|Balloon kyphoplasty|balloon kyphoplasty
571674|NCT00749086|Vertebroplasty|vertebroplasty
571675|NCT00749073|Spinal Stenosis|spinal stenosis
571676|NCT00749073|Lumbar Spinal Stenosis|lumbar spinal stenosis
571677|NCT00749073|Laminotomy|laminotomy
571678|NCT00749073|Laminectomy|laminectomy
571679|NCT00749073|Spine Surgery|spine surgery
571680|NCT00749060|osteoporosis|osteoporosis
571681|NCT00749060|non-traumatic vertebral fracture|non-traumatic vertebral fracture
571682|NCT00749060|vertebral compression|vertebral compression
571683|NCT00749060|Balloon kyphoplasty|balloon kyphoplasty
571684|NCT00749060|vertebroplasty|vertebroplasty
571685|NCT00749047|Pioglitazone|pioglitazone
571686|NCT00749047|Open study|open study
571687|NCT00749047|Proteinuria|proteinuria
571688|NCT00749047|Glomerular selectivity indices|glomerular selectivity indices
571689|NCT00749034|Safety|safety
571690|NCT00749034|Immunogenicity|immunogenicity
571691|NCT00749034|Tuberculosis|tuberculosis
571692|NCT00749034|Vaccination|vaccination
571693|NCT00749034|Vaccination against tuberculosis|vaccination against tuberculosis
571694|NCT00749034|Safety and immunogenicity of VPM1002 in comparison with BCG|safety and immunogenicity of vpm1002 in comparison with bcg
571695|NCT00749021|choroidal neovascularization|choroidal neovascularization
571696|NCT00749021|vascularized|vascularized
571697|NCT00749008|Cerebral palsy|cerebral palsy
571698|NCT00749008|Generalized movements|generalized movements
571699|NCT00749008|Fidgety movements|fidgety movements
571700|NCT00749008|Prechtl|prechtl
571701|NCT00748982|AZD1305|azd1305
571702|NCT00748982|anti-arrhythmics|anti-arrhythmics
571703|NCT00748982|safety|safety
571704|NCT00748969|MPS I|mps i
571705|NCT00748969|MPS II|mps ii
571706|NCT00748969|MPS VI|mps vi
571707|NCT00748969|growth hormone|growth hormone
571708|NCT00748969|short stature|short stature
571709|NCT00748956|Mood Disorder|mood disorder
571710|NCT00748956|Anxiety Disorders|anxiety disorders
571711|NCT00748943|chlorine|chlorine
571712|NCT00748943|dioxide|dioxide
571713|NCT00748943|mouthwash|mouthwash
571714|NCT00748943|halitosis|halitosis
571715|NCT00748943|bacteria|bacteria
571716|NCT00748943|saliva|saliva
571717|NCT00748904|cirrhosis of liver and progressive renal failure|cirrhosis of liver and progressive renal failure
571718|NCT00748891|Cancer|cancer
571719|NCT00748891|tumour|tumour
571720|NCT00748891|advanced sold tumour|advanced sold tumour
571721|NCT00748891|imaging|imaging
571722|NCT00748891|DCE-CT Scan|dce-ct scan
571723|NCT00748891|DCE-MRI scan|dce-mri scan
571724|NCT00748891|Cediranib|cediranib
571725|NCT00748891|Recentin|recentin
571726|NCT00748878|To better understand platelet function during ECMO|to better understand platelet function during ecmo
571727|NCT00748865|Dry Eye|dry eye
571728|NCT00748865|Artificial Tears|artificial tears
571729|NCT00748839|HIT|hit
571730|NCT00748839|Heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
571731|NCT00748839|heparin treatment|heparin treatment
571732|NCT00748839|venous thrombosis|venous thrombosis
571733|NCT00748839|arterial thrombosis|arterial thrombosis
571734|NCT00748839|predictive clinical score|predictive clinical score
571735|NCT00748839|biological test|biological test
571736|NCT00748839|anti-H-PF4 antibodies|anti-h-pf4 antibodies
571737|NCT00748813|Influenza vaccine|influenza vaccine
571738|NCT00748800|HIV prevention|hiv prevention
571739|NCT00748800|HIV seronegativity|hiv seronegativity
572443|NCT00746018|08-092|08-092
571740|NCT00748774|Primary Brain Tumor|primary brain tumor
571741|NCT00748774|Caregivers|caregivers
571742|NCT00748774|Symptom Severity|symptom severity
571743|NCT00748774|Questionnaire|questionnaire
571744|NCT00748774|M.D. Anderson Symptom Inventory-Brain Tumor|m.d. anderson symptom inventory-brain tumor
571745|NCT00748774|MDASI-BT|mdasi-bt
571746|NCT00748761|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
571747|NCT00748761|OCD|ocd
571748|NCT00748761|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
571749|NCT00748761|CBT|cbt
571750|NCT00748761|MRSI|mrsi
571751|NCT00748761|Glutamate|glutamate
571752|NCT00748735|cardiac resynchronization therapy|cardiac resynchronization therapy
571753|NCT00748735|echocardiography|echocardiography
571754|NCT00748735|heart failure|heart failure
571755|NCT00748735|left ventricular function|left ventricular function
571756|NCT00748735|pacing|pacing
571757|NCT00748735|myocardial deformation imaging|myocardial deformation imaging
571758|NCT00748735|Optimal Definition of Left Ventricular Lead Position in Cardiac Resynchronization Therapy|optimal definition of left ventricular lead position in cardiac resynchronization therapy
571759|NCT00748722|Breast reconstruction|breast reconstruction
571760|NCT00748722|Perforator flaps|perforator flaps
571761|NCT00748722|CT Angiography|ct angiography
571762|NCT00748696|sarcopenia|sarcopenia
571763|NCT00748696|elderly|elderly
571764|NCT00748696|resistance training|resistance training
571765|NCT00748696|oral nutritional supplement|oral nutritional supplement
571766|NCT00748683|elderly|elderly
571767|NCT00748683|longterm care|longterm care
571768|NCT00748644|Wegener's granulomatosis,|wegener's granulomatosis,
571769|NCT00748644|microscopic polyangiitis,|microscopic polyangiitis,
571770|NCT00748644|ANCA-associated vasculitis,|anca-associated vasculitis,
571771|NCT00748644|rituximab,|rituximab,
571772|NCT00748644|azathioprine|azathioprine
571773|NCT00748631|Vertebral fracture|vertebral fracture
571774|NCT00748631|Vertebral compression fracture|vertebral compression fracture
571775|NCT00748631|Multiple Myeloma Bone marrow diseases|multiple myeloma bone marrow diseases
571776|NCT00748631|Vertebral metastases|vertebral metastases
571777|NCT00748631|Balloon Kyphoplasty|balloon kyphoplasty
571778|NCT00748618|Kidney transplantation (KTX)|kidney transplantation (ktx)
571779|NCT00748618|Vitamin D deficiency|vitamin d deficiency
571780|NCT00748618|Cardiovascular Disease (CVD)|cardiovascular disease (cvd)
571781|NCT00748618|Vascular risk|vascular risk
571782|NCT00748618|Parathyroid hormone (PTH)|parathyroid hormone (pth)
571783|NCT00748618|Carotid intima media thickness (CIMT)|carotid intima media thickness (cimt)
571784|NCT00748618|Insulin resistance (IR)|insulin resistance (ir)
571785|NCT00748605|Obesity|obesity
571786|NCT00748592|Insomnia, Primary Insomnia, Chronic Insomnia, DIMS (Disorders of Initiating and Maintaining Sleep), Disorders of Initiating and Maintaining Sleep|insomnia, primary insomnia, chronic insomnia, dims (disorders of initiating and maintaining sleep), disorders of initiating and maintaining sleep
571787|NCT00748566|Ziprasidone|ziprasidone
571788|NCT00748566|metabolic syndrome|metabolic syndrome
571789|NCT00748566|risk factors|risk factors
571790|NCT00748566|schizophrenia|schizophrenia
571791|NCT00748566|psychotic disorders.|psychotic disorders.
571792|NCT00748540|sensorineural hearing loss|sensorineural hearing loss
571793|NCT00748540|conductive hearing loss|conductive hearing loss
571794|NCT00748540|mixed hearing loss|mixed hearing loss
571795|NCT00748527|fallopian tube cancer|fallopian tube cancer
571796|NCT00748527|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
571797|NCT00748527|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
571798|NCT00748527|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
571799|NCT00748527|peritoneal cavity cancer|peritoneal cavity cancer
571800|NCT00748514|capsular incision|capsular incision
571801|NCT00748514|biochemical recurrence|biochemical recurrence
571802|NCT00748514|radical perineal prostatectomy|radical perineal prostatectomy
571803|NCT00748501|Amyotrophic Lateral Sclerosis,|amyotrophic lateral sclerosis,
571804|NCT00748501|ALS,|als,
571805|NCT00748501|Lou Gehrig's Disease|lou gehrig's disease
571806|NCT00748488|Parkinson|parkinson
571807|NCT00748488|Physical Therapy|physical therapy
571808|NCT00748488|Physical Activity|physical activity
571809|NCT00748462|Acne scar, Wrinkle, Pigmentation, Fractional CO2 laser|acne scar, wrinkle, pigmentation, fractional co2 laser
571810|NCT00748449|Colorectal advanced adenoma|colorectal advanced adenoma
571811|NCT00748449|Colorectal cancer polypectomy (endoscopic)|colorectal cancer polypectomy (endoscopic)
571812|NCT00748449|Colectomy|colectomy
571813|NCT00748449|Colonoscopy with anaesthesia|colonoscopy with anaesthesia
571814|NCT00748449|CT-colonography|ct-colonography
571815|NCT00748436|Obese females|obese females
571816|NCT00748436|Weight loss|weight loss
571817|NCT00748436|Betahistine|betahistine
571818|NCT00748423|Inhaled drug|inhaled drug
571819|NCT00748423|Acute lung injury|acute lung injury
571820|NCT00748423|Nitric oxide|nitric oxide
571821|NCT00748423|Sickle cell|sickle cell
571822|NCT00748410|CD11b|cd11b
571823|NCT00748410|Ulcerative colitis|ulcerative colitis
571824|NCT00748410|99mTc-HMPAO-labelled leukocyte scintigraphy|99mtc-hmpao-labelled leukocyte scintigraphy
571825|NCT00748384|HMP, CNV, AMD, PHP, HPHP, foresee|hmp, cnv, amd, php, hphp, foresee
571826|NCT00748371|platelet aggregation|platelet aggregation
571827|NCT00748371|granule secretion|granule secretion
571828|NCT00748371|thromboxane production|thromboxane production
571829|NCT00748371|prostacyclin production|prostacyclin production
571830|NCT00748358|metastatic prostate carcinoma|metastatic prostate carcinoma
571831|NCT00748358|sunitinib [Substance Name]|sunitinib [substance name]
571832|NCT00748358|Clinical Trial, Phase II [Publication Type]|clinical trial, phase ii [publication type]
571833|NCT00748345|Caspofungin,|caspofungin,
571834|NCT00748345|burn patients,|burn patients,
571835|NCT00748345|pharmacokinetics,|pharmacokinetics,
571836|NCT00748345|optimal dose,|optimal dose,
571837|NCT00748345|antifungal treatment|antifungal treatment
571838|NCT00748319|Receptors KIR|receptors kir
571839|NCT00748319|Polymerase chain reaction|polymerase chain reaction
571840|NCT00748319|Diagnosis|diagnosis
571841|NCT00748319|Lymphoma T-cell cutaneous|lymphoma t-cell cutaneous
571842|NCT00748319|Mycosis fungicides|mycosis fungicides
571843|NCT00748319|Sezary syndrome|sezary syndrome
571844|NCT00748319|Differential diagnosis from dermatitis|differential diagnosis from dermatitis
571845|NCT00748306|challenge|challenge
571846|NCT00748306|early asthmatic response|early asthmatic response
571847|NCT00748306|mild asthmatics|mild asthmatics
571848|NCT00748306|Allergen|allergen
571849|NCT00748306|methacholine|methacholine
571850|NCT00748293|Colonoscopy|colonoscopy
571851|NCT00748293|Colon cleansing|colon cleansing
571852|NCT00748293|Low-reside diet|low-reside diet
571853|NCT00748293|Compliance|compliance
571854|NCT00748293|PEG-ELS|peg-els
571855|NCT00748280|Endodontics|endodontics
571856|NCT00748280|CEM cement|cem cement
571857|NCT00748280|Calcium enriched mixture|calcium enriched mixture
571858|NCT00748280|MTA|mta
571859|NCT00748280|Root Canal Therapy|root canal therapy
571860|NCT00748280|Pain|pain
571861|NCT00748280|Pulpotomy|pulpotomy
571862|NCT00748280|Human|human
571863|NCT00748280|Permanent|permanent
571864|NCT00748280|Molar teeth|molar teeth
571865|NCT00748267|anxiety disorder|anxiety disorder
571866|NCT00748267|pain|pain
571867|NCT00748267|nausea and vomiting|nausea and vomiting
571868|NCT00748267|breast cancer|breast cancer
571869|NCT00748254|Rheumatoid arthritis|rheumatoid arthritis
571870|NCT00748215|diarrhea|diarrhea
571871|NCT00748215|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
571872|NCT00748215|recurrent colon cancer|recurrent colon cancer
571873|NCT00748215|recurrent rectal cancer|recurrent rectal cancer
571874|NCT00748215|stage IV colon cancer|stage iv colon cancer
571875|NCT00748215|stage IV rectal cancer|stage iv rectal cancer
571876|NCT00748202|Hereditary angioedema|hereditary angioedema
571877|NCT00748202|C1-Esterase inhibitor|c1-esterase inhibitor
571878|NCT00748202|intravenous|intravenous
571879|NCT00748202|subcutaneous|subcutaneous
571880|NCT00748202|pharmacokinetic|pharmacokinetic
571881|NCT00748189|Safety|safety
571882|NCT00748189|Untreated|untreated
571883|NCT00748189|Efficacy|efficacy
571884|NCT00748189|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
571885|NCT00748189|Chronic Lymphocytic Leukemia (CLL), untreated|chronic lymphocytic leukemia (cll), untreated
571886|NCT00748189|Ofatumumab|ofatumumab
571887|NCT00748189|Oncology|oncology
571888|NCT00748163|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
571889|NCT00748150|flu|flu
571890|NCT00748150|influenza|influenza
571891|NCT00748150|influenza vaccine antigen|influenza vaccine antigen
571892|NCT00748150|immunogenicity|immunogenicity
571893|NCT00748150|antibody response|antibody response
571894|NCT00748150|intra muscular|intra muscular
571895|NCT00748150|elderly|elderly
571896|NCT00748150|non-elderly|non-elderly
571897|NCT00748137|Type 1 Diabetes|type 1 diabetes
571898|NCT00748137|Youth|youth
571899|NCT00748137|Insulin dose|insulin dose
571900|NCT00748111|Sudden death|sudden death
571901|NCT00748111|Out of hospital cardiac arrest|out of hospital cardiac arrest
571902|NCT00748111|Acute myocardial infarction|acute myocardial infarction
571903|NCT00748111|Acute coronary syndrome|acute coronary syndrome
571904|NCT00748098|PSG|psg
571905|NCT00748098|Restless Legs Syndrome|restless legs syndrome
571906|NCT00748098|gabapentin enacarbil|gabapentin enacarbil
571907|NCT00748098|XP13512|xp13512
571908|NCT00748098|GSK1838262|gsk1838262
571909|NCT00748098|sleep disturbance|sleep disturbance
571910|NCT00748098|RLS|rls
571911|NCT00748098|polysomnography|polysomnography
571912|NCT00748085|Malignant Airway Disease|malignant airway disease
571913|NCT00748085|Lung Cancer|lung cancer
571914|NCT00748085|Inoperable Lung Cancer|inoperable lung cancer
571915|NCT00748085|Mesothelioma|mesothelioma
571916|NCT00748085|Endoluminal Tumor|endoluminal tumor
571917|NCT00748072|Vasopressin|vasopressin
571918|NCT00748072|bleeding|bleeding
571919|NCT00748072|biopsy|biopsy
571920|NCT00748072|ultrasonography|ultrasonography
571921|NCT00748059|autonomic nervous system diseases|autonomic nervous system diseases
571922|NCT00748059|blood pressure|blood pressure
571923|NCT00748059|congenital|congenital
571924|NCT00748059|orthostasis|orthostasis
571925|NCT00748059|catecholamines|catecholamines
571926|NCT00748046|Biodistribution|biodistribution
571927|NCT00748046|Radiation dosimetry|radiation dosimetry
571928|NCT00748046|Pharmacokinetics|pharmacokinetics
571929|NCT00748046|Safety|safety
571930|NCT00748007|Down syndrome, cholinesterase inhibitor, Rivastigmine|down syndrome, cholinesterase inhibitor, rivastigmine
571931|NCT00747994|Paget's disease of bone|paget's disease of bone
571932|NCT00747994|Relatives|relatives
571933|NCT00747994|Mutations screening|mutations screening
571934|NCT00747994|Haplotypes analysis|haplotypes analysis
571935|NCT00747994|Linkage analysis|linkage analysis
571936|NCT00747994|< 55 years|< 55 years
571937|NCT00747994|4 > or = WAFFECTED Bones|4 > or = waffected bones
571938|NCT00747994|bone deformity|bone deformity
571939|NCT00747981|CT Scan|ct scan
571940|NCT00747981|Endoscopy|endoscopy
571941|NCT00747981|Aspiration|aspiration
571942|NCT00747981|Foreign Bodies|foreign bodies
571943|NCT00747955|Human Performance|human performance
571944|NCT00747955|Physical Disability|physical disability
571945|NCT00747955|Functional Outcome Measures|functional outcome measures
571946|NCT00747955|Health Volunteer|health volunteer
571947|NCT00747955|HV|hv
571948|NCT00747942|overweight|overweight
571949|NCT00747942|physical inactivity|physical inactivity
571950|NCT00747942|physical fitness|physical fitness
571951|NCT00747942|lifestyle change|lifestyle change
571952|NCT00747929|Obesity|obesity
571953|NCT00747916|Parietal pleura|parietal pleura
571954|NCT00747916|Neoplasms|neoplasms
571955|NCT00747916|Pleural Surface|pleural surface
571956|NCT00747916|Pleural Neoplasms|pleural neoplasms
571957|NCT00747916|Lung Cancer|lung cancer
571958|NCT00747903|basal cell carcinoma of the skin|basal cell carcinoma of the skin
571959|NCT00747903|recurrent skin cancer|recurrent skin cancer
571960|NCT00747877|stage II multiple myeloma|stage ii multiple myeloma
571961|NCT00747877|stage III multiple myeloma|stage iii multiple myeloma
571962|NCT00747877|refractory multiple myeloma|refractory multiple myeloma
571963|NCT00747877|stage I multiple myeloma|stage i multiple myeloma
571964|NCT00747864|Gestational Age|gestational age
571965|NCT00747864|Urine|urine
571966|NCT00747864|Concentration|concentration
571967|NCT00747864|of S100B|of s100b
571968|NCT00747851|protein|protein
571969|NCT00747851|synthesis|synthesis
571970|NCT00747851|response|response
571971|NCT00747851|PAF-stimulated|paf-stimulated
571972|NCT00747851|PMNs|pmns
571973|NCT00747851|collected|collected
571974|NCT00747838|Afib|afib
571975|NCT00747838|Atrial Fibrillation|atrial fibrillation
571976|NCT00747838|Maze|maze
571977|NCT00747838|Mini-Maze|mini-maze
571978|NCT00747825|cancer|cancer
571979|NCT00747825|oncology|oncology
571980|NCT00747825|melanoma|melanoma
571981|NCT00747825|tumor|tumor
571982|NCT00747812|Headache|headache
571983|NCT00747812|Migraine|migraine
571984|NCT00747812|Refractory|refractory
571985|NCT00747812|Chronic|chronic
571986|NCT00747812|Pain|pain
571987|NCT00747799|recurrent or metastatic Nasopharyngeal Neoplasms|recurrent or metastatic nasopharyngeal neoplasms
571988|NCT00747773|Lung Cancer|lung cancer
571989|NCT00747773|CryoPsray Ablation|cryopsray ablation
571990|NCT00747773|CSA therapy|csa therapy
571991|NCT00747773|CSA treatment|csa treatment
571992|NCT00747773|Lobectomy|lobectomy
571993|NCT00747773|lung resection|lung resection
571994|NCT00747760|TSH Receptor, resistance TSH, Hyperthyrortropinemia|tsh receptor, resistance tsh, hyperthyrortropinemia
571995|NCT00747747|Sinusitis|sinusitis
571996|NCT00747734|Neuropilin-1|neuropilin-1
571997|NCT00747734|NRP1|nrp1
571998|NCT00747734|anti-NRP1|anti-nrp1
571999|NCT00747734|anti-angiogenic|anti-angiogenic
572000|NCT00747708|heart failure|heart failure
572001|NCT00747708|coronary heart disease|coronary heart disease
572002|NCT00747708|adult stem cells|adult stem cells
572003|NCT00747708|bone marrow progenitor cells|bone marrow progenitor cells
572004|NCT00747708|bone marrow stem cells|bone marrow stem cells
572005|NCT00747708|autologous|autologous
572006|NCT00747708|granulocyte-colony stimulating factor|granulocyte-colony stimulating factor
572007|NCT00747708|left ventricular function|left ventricular function
572008|NCT00747708|intracoronary injection|intracoronary injection
572009|NCT00747708|intramyocardial injection|intramyocardial injection
572010|NCT00747695|Pediatric Pharmacokinetics|pediatric pharmacokinetics
572011|NCT00747695|Pediatric Pharmacodynamics|pediatric pharmacodynamics
572012|NCT00747695|Rabeprazole|rabeprazole
572013|NCT00747695|Pediatric GERD|pediatric gerd
572014|NCT00747695|Aciphex|aciphex
572015|NCT00747682|Cerebral Perfusion,|cerebral perfusion,
572016|NCT00747682|Oxygenation,|oxygenation,
572017|NCT00747682|Electrical|electrical
572018|NCT00747682|Activity|activity
572019|NCT00747656|Electrocardiography|electrocardiography
572020|NCT00747656|Emergency medical services|emergency medical services
572021|NCT00747656|Emergency medicine|emergency medicine
572022|NCT00747656|Health services|health services
572023|NCT00747656|Cost effectiveness|cost effectiveness
572024|NCT00747643|tobacco|tobacco
572025|NCT00747643|nicotine|nicotine
572026|NCT00747643|smoking|smoking
572027|NCT00747643|reward|reward
572028|NCT00747643|reinforcement|reinforcement
572029|NCT00747643|craving|craving
572030|NCT00747643|cues|cues
572031|NCT00747643|conditioned stimuli|conditioned stimuli
572032|NCT00747643|cue reactivity|cue reactivity
572033|NCT00747630|Fetal Alcohol Syndrome|fetal alcohol syndrome
572034|NCT00747630|Teen pregnancy|teen pregnancy
572035|NCT00747617|polycystic ovary syndrome|polycystic ovary syndrome
572036|NCT00747617|androgens|androgens
572037|NCT00747617|ovary|ovary
572038|NCT00747617|LH|lh
572039|NCT00747604|Growth Hormone (GH) Insensitivity Syndrome|growth hormone (gh) insensitivity syndrome
572040|NCT00747604|Insulin-like Growth Factor Deficiency (IGFD)|insulin-like growth factor deficiency (igfd)
572041|NCT00747604|Short Stature|short stature
572042|NCT00747604|Insulin-like Growth Factor (IGF-1)|insulin-like growth factor (igf-1)
572043|NCT00747604|Growth|growth
572044|NCT00747591|urine|urine
572045|NCT00747591|concentration|concentration
572046|NCT00747591|of S100B|of s100b
572047|NCT00747578|ankylosing spondylitis (AS), costs,|ankylosing spondylitis (as), costs,
572048|NCT00747578|rheumatoid arthritis (RA),|rheumatoid arthritis (ra),
572049|NCT00747578|systemic lupus erythematosus (SLE),|systemic lupus erythematosus (sle),
572050|NCT00747578|health-related|health-related
572051|NCT00747578|quality of life (HRQOL)|quality of life (hrqol)
572052|NCT00747578|compare|compare
572053|NCT00747578|utility|utility
572054|NCT00747578|patients|patients
572055|NCT00747565|cataract, tecnis, multifocal, intraocular lens|cataract, tecnis, multifocal, intraocular lens
572056|NCT00747552|IAP measurements|iap measurements
572057|NCT00747552|Abdominal compartment syndrome|abdominal compartment syndrome
572058|NCT00747552|NICU patients|nicu patients
572059|NCT00747552|Intra-abdominal Hypertension|intra-abdominal hypertension
572060|NCT00747539|Hepatitis C Virus|hepatitis c virus
572061|NCT00747539|HCV|hcv
572062|NCT00747539|Human Immunodeficiency Virus|human immunodeficiency virus
572063|NCT00747539|Coinfection|coinfection
572064|NCT00747526|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
572065|NCT00747526|Pediatrics|pediatrics
572066|NCT00747526|Pharmacokinetics|pharmacokinetics
572067|NCT00747526|Pharmacodynamics|pharmacodynamics
572068|NCT00747526|Rabeprazole|rabeprazole
572069|NCT00747526|GERD|gerd
572070|NCT00747526|Aciphex|aciphex
572071|NCT00747513|school|school
572072|NCT00747513|prevention|prevention
572073|NCT00747513|overweight|overweight
572074|NCT00747513|children|children
572075|NCT00747513|diet|diet
572076|NCT00747513|physical activity|physical activity
572077|NCT00747513|fitness|fitness
572078|NCT00747487|Leber|leber
572079|NCT00747487|LHON|lhon
572080|NCT00747487|Leber's Hereditary Optic Neuropathy|leber's hereditary optic neuropathy
572081|NCT00747487|Idebenone|idebenone
572082|NCT00747461|Benign Airway Disease|benign airway disease
572083|NCT00747461|Airway Injury|airway injury
572084|NCT00747461|Sarcoidosis|sarcoidosis
572085|NCT00747461|Wegener's Granulomatosis|wegener's granulomatosis
572086|NCT00747461|Rhinoscleroma|rhinoscleroma
572087|NCT00747461|Recurrent Respiratory Papillomatosis(RRP)|recurrent respiratory papillomatosis(rrp)
572088|NCT00747448|Barrett's Esophagus|barrett's esophagus
572089|NCT00747448|High Grade Dysplasia|high grade dysplasia
572090|NCT00747448|Low Grade Dysplasia|low grade dysplasia
572091|NCT00747448|Squamous Dysplasia|squamous dysplasia
572092|NCT00747448|Esophageal Cancer|esophageal cancer
572093|NCT00747448|CryoSpray Ablation|cryospray ablation
572094|NCT00747448|Cryotherapy|cryotherapy
572095|NCT00747448|Cryospray|cryospray
572096|NCT00747435|sensorineural hearing loss|sensorineural hearing loss
572097|NCT00747435|ski slope audiogram|ski slope audiogram
572098|NCT00747435|electric acoustic stimulation|electric acoustic stimulation
572099|NCT00747409|postprandial glucose, diastolic function, analogue insulins|postprandial glucose, diastolic function, analogue insulins
572100|NCT00747396|Romania,|romania,
572101|NCT00747396|children,|children,
572102|NCT00747396|foster care,|foster care,
572103|NCT00747396|institutionalization,|institutionalization,
572104|NCT00747396|brain function,|brain function,
572105|NCT00747396|MRI,|mri,
572106|NCT00747396|attachment,|attachment,
572107|NCT00747396|language,|language,
572108|NCT00747396|growth,|growth,
572109|NCT00747396|IQ,|iq,
572110|NCT00747396|psychiatric symptomatology|psychiatric symptomatology
572111|NCT00747396|early intervention|early intervention
572112|NCT00747383|Diabetes Mellitus|diabetes mellitus
572113|NCT00747383|GLP1|glp1
572114|NCT00747383|DPP4|dpp4
572115|NCT00747370|stress urinary incontinence|stress urinary incontinence
572116|NCT00747370|Tension free vaginal tape|tension free vaginal tape
572117|NCT00747370|tension free vaginal tape obturator|tension free vaginal tape obturator
572118|NCT00747370|genital prolapse|genital prolapse
572119|NCT00747344|Psoriasis|psoriasis
572120|NCT00747344|Psoriatic Arthritis|psoriatic arthritis
572121|NCT00747344|Ustekinumab|ustekinumab
572122|NCT00747344|CNTO 1275|cnto 1275
572123|NCT00747331|Cardiopulmonary bypass|cardiopulmonary bypass
572124|NCT00747331|Lactic acidosis|lactic acidosis
572125|NCT00747331|Oxygen delivery|oxygen delivery
572126|NCT00747331|Acute renal failure|acute renal failure
572127|NCT00747331|outcome|outcome
572128|NCT00747331|cardiac|cardiac
572129|NCT00747331|surgery|surgery
572541|NCT00745550|SB1518|sb1518
572130|NCT00747318|Moderate to Severe|moderate to severe
572131|NCT00747305|stage IV renal cell cancer|stage iv renal cell cancer
572132|NCT00747305|clear cell renal cell carcinoma|clear cell renal cell carcinoma
572133|NCT00747305|recurrent renal cell cancer|recurrent renal cell cancer
572134|NCT00747292|laparoscopic|laparoscopic
572135|NCT00747292|colon|colon
572136|NCT00747292|analgesia|analgesia
572137|NCT00747292|fluid optimised|fluid optimised
572138|NCT00747253|laser interstitial thermal therapy|laser interstitial thermal therapy
572139|NCT00747253|laser therapy|laser therapy
572140|NCT00747253|thermal therapy|thermal therapy
572141|NCT00747253|brain tumors|brain tumors
572142|NCT00747253|recurrent brain tumor|recurrent brain tumor
572143|NCT00747253|progressive brain tumor|progressive brain tumor
572144|NCT00747253|glioblastoma multiforme tumor|glioblastoma multiforme tumor
572145|NCT00747240|Ile198Thr|ile198thr
572146|NCT00747240|Ala379Val|ala379val
572147|NCT00747240|variants|variants
572148|NCT00747240|PAF-AH|paf-ah
572149|NCT00747227|cataract|cataract
572150|NCT00747227|monofocal|monofocal
572151|NCT00747227|intraocular lens|intraocular lens
572152|NCT00747227|acrylic|acrylic
572153|NCT00747214|Rheumatoid Arthritis|rheumatoid arthritis
572154|NCT00747214|RA|ra
572155|NCT00747214|DMARD|dmard
572156|NCT00747214|CRP|crp
572157|NCT00747201|Replicating Effective Programs|replicating effective programs
572158|NCT00747201|Care Management|care management
572159|NCT00747201|Implementation|implementation
572160|NCT00747201|Intervention|intervention
572161|NCT00747188|Problem-based learning (PBL)|problem-based learning (pbl)
572162|NCT00747188|lecture|lecture
572163|NCT00747188|nursing|nursing
572164|NCT00747188|education|education
572165|NCT00747188|none of students had any prior exposure to PBL|none of students had any prior exposure to pbl
572166|NCT00747175|Type 2 diabetes|type 2 diabetes
572167|NCT00747162|Compartment Syndrome|compartment syndrome
572168|NCT00747162|Muscle Oxygenation|muscle oxygenation
572169|NCT00747162|Skin Pigmentation|skin pigmentation
572170|NCT00747149|diabetes|diabetes
572171|NCT00747149|type 2|type 2
572172|NCT00747136|Barrett's|barrett's
572173|NCT00747136|Dysplasia|dysplasia
572174|NCT00747136|esophageal cancer|esophageal cancer
572175|NCT00747136|Patients|patients
572176|NCT00747110|5-ASA|5-asa
572177|NCT00747110|mesalamine|mesalamine
572178|NCT00747110|mesalazine|mesalazine
572179|NCT00747110|budesonide|budesonide
572180|NCT00747110|ulcerative colitis|ulcerative colitis
572181|NCT00747084|unsedated colonoscopy|unsedated colonoscopy
572182|NCT00747071|Clostridium difficile|clostridium difficile
572183|NCT00747071|diarrhea|diarrhea
572184|NCT00747071|colostrum|colostrum
572185|NCT00747058|phase 1, human study, healthy volunteers|phase 1, human study, healthy volunteers
572186|NCT00747045|Chronic Thromboembolic Pulmonary Hypertension|chronic thromboembolic pulmonary hypertension
572187|NCT00747045|Lung Injury|lung injury
572188|NCT00747045|Ventilation Strategies|ventilation strategies
572189|NCT00746993|Contraception|contraception
572190|NCT00746993|Counseling|counseling
572191|NCT00746980|alopecia|alopecia
572192|NCT00746980|areata|areata
572193|NCT00746980|universalis|universalis
572194|NCT00746980|severe|severe
572195|NCT00746980|ophiasis|ophiasis
572196|NCT00746980|variants|variants
572197|NCT00746954|buspirone|buspirone
572198|NCT00746954|acetazolamide|acetazolamide
572199|NCT00746941|PML|pml
572200|NCT00746941|Human Polyomavirus JC|human polyomavirus jc
572201|NCT00746941|HIV|hiv
572202|NCT00746941|Central Nervous System Disease|central nervous system disease
572203|NCT00746941|Mefloquine|mefloquine
572204|NCT00746941|JC Virus|jc virus
572205|NCT00746928|Blood pressure|blood pressure
572206|NCT00746928|Hypertension|hypertension
572207|NCT00746928|sympathetic control|sympathetic control
572208|NCT00746928|chemosensitivity|chemosensitivity
572209|NCT00746928|baroreflex|baroreflex
572210|NCT00746915|Patients undergoing elective pain relief treatment of lumbar epidural steroid injection under fluoroscopy|patients undergoing elective pain relief treatment of lumbar epidural steroid injection under fluoroscopy
572211|NCT00746902|Refractory hypertension|refractory hypertension
572212|NCT00746902|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
572213|NCT00746902|Obesity|obesity
572214|NCT00746902|Leptinemia|leptinemia
572215|NCT00746902|RHOOSAS study|rhoosas study
572216|NCT00746889|osteoarthritis|osteoarthritis
572217|NCT00746889|knee|knee
572218|NCT00746889|corticosteroids|corticosteroids
572219|NCT00746889|ultrasound|ultrasound
572220|NCT00746876|Hip|hip
572221|NCT00746876|Fracture|fracture
572222|NCT00746876|Femoral neck|femoral neck
572223|NCT00746876|Hemiarthroplasty|hemiarthroplasty
572224|NCT00746876|Bipolar|bipolar
572225|NCT00746876|Unipolar|unipolar
572226|NCT00746876|Displaced femoral neck fractures|displaced femoral neck fractures
572227|NCT00746863|mid-urethral sling|mid-urethral sling
572228|NCT00746863|pubovaginal sling|pubovaginal sling
572229|NCT00746863|postoperative pain|postoperative pain
572230|NCT00746863|visual analog scale|visual analog scale
572231|NCT00746863|suprapubic approach|suprapubic approach
572233|NCT00746850|acute cholecystitis|acute cholecystitis
572234|NCT00746850|laparoscopic cholecystectomy|laparoscopic cholecystectomy
572235|NCT00746850|conversion rate|conversion rate
572236|NCT00746850|morbidity|morbidity
572237|NCT00746850|mortality|mortality
572238|NCT00746850|postoperative pain|postoperative pain
572239|NCT00746850|hospital stay|hospital stay
572240|NCT00746837|AZD5672|azd5672
572241|NCT00746824|Obesity|obesity
572242|NCT00746824|weight loss|weight loss
572243|NCT00746824|7TM Pharma|7tm pharma
572244|NCT00746824|TM30339|tm30339
572245|NCT00746824|Y4 receptor antagonist|y4 receptor antagonist
572246|NCT00746811|cholesterol|cholesterol
572247|NCT00746811|hypercholesterolemia|hypercholesterolemia
572248|NCT00746811|omega 3|omega 3
572249|NCT00746798|West Nile Fever|west nile fever
572250|NCT00746798|ChimeriVax|chimerivax
572251|NCT00746798|West Nile Virus Vaccine|west nile virus vaccine
572252|NCT00746785|Olanzapine|olanzapine
572253|NCT00746772|antioxidant|antioxidant
572254|NCT00746772|oral lichen planus|oral lichen planus
572255|NCT00746772|treatment|treatment
572256|NCT00746772|purslane|purslane
572257|NCT00746759|Lung Cancer|lung cancer
572258|NCT00746759|Smoker|smoker
572259|NCT00746759|Former Smoker|former smoker
572260|NCT00746759|Gene Expression|gene expression
572261|NCT00746759|Bronchoscopy|bronchoscopy
572262|NCT00746746|Advanced Melanoma|advanced melanoma
572263|NCT00746733|Drug|drug
572264|NCT00746733|Interaction|interaction
572265|NCT00746733|Study|study
572266|NCT00746720|hip replacement|hip replacement
572267|NCT00746720|osteoarthritis|osteoarthritis
572268|NCT00746720|etoricoxib|etoricoxib
572269|NCT00746720|pain|pain
572270|NCT00746720|cerebrospinal fluid|cerebrospinal fluid
572271|NCT00746720|pharmacokinetics|pharmacokinetics
572272|NCT00746707|adhesive glue, perineal tear, suture|adhesive glue, perineal tear, suture
572273|NCT00746668|Reading|reading
572274|NCT00746668|Macular Degeneration|macular degeneration
572275|NCT00746668|Rehabilitation|rehabilitation
572276|NCT00746668|Vision, Low|vision, low
572277|NCT00746655|Hepatocellular|hepatocellular
572278|NCT00746642|glucose measurements|glucose measurements
572279|NCT00746616|Total Hip Arthroplasty,|total hip arthroplasty,
572280|NCT00746616|Acetabular Cup,|acetabular cup,
572281|NCT00746616|Hip Resurfacing|hip resurfacing
572282|NCT00746616|Young,|young,
572283|NCT00746616|active|active
572284|NCT00746616|patients|patients
572285|NCT00746590|hepatocellular carcinoma|hepatocellular carcinoma
572286|NCT00746590|liver cancer|liver cancer
572287|NCT00746590|Prolarix|prolarix
572288|NCT00746590|tretazicar|tretazicar
572289|NCT00746590|caricotamide|caricotamide
572290|NCT00746590|Phase 2|phase 2
572291|NCT00746590|tumor|tumor
572292|NCT00746590|chemotherapy|chemotherapy
572293|NCT00746564|Implantable Cardiac Monitor|implantable cardiac monitor
572294|NCT00746564|Arrhythmias|arrhythmias
572295|NCT00746564|Atrial Fibrillation|atrial fibrillation
572296|NCT00746551|iron deficiency anemia|iron deficiency anemia
572297|NCT00746551|pregnancy|pregnancy
572298|NCT00746551|third trimester|third trimester
572299|NCT00746551|intravenous iron|intravenous iron
572300|NCT00746551|efficacy|efficacy
572301|NCT00746551|a randomized trial|a randomized trial
572302|NCT00746551|Female|female
572303|NCT00746551|Ferric Compounds/therapeutic use*|ferric compounds/therapeutic use*
572304|NCT00746551|Infusions, Intravenous|infusions, intravenous
572305|NCT00746551|Hematologic/therapy*|hematologic/therapy*
572306|NCT00746538|Hilar cholangiocarcinoma|hilar cholangiocarcinoma
572307|NCT00746538|biliary stent|biliary stent
572308|NCT00746538|plastic stent|plastic stent
572309|NCT00746538|metallic stent|metallic stent
572310|NCT00746538|quality of life|quality of life
572311|NCT00746525|stroke|stroke
572312|NCT00746525|motor learning|motor learning
572313|NCT00746525|rehabilitation of upper extremity|rehabilitation of upper extremity
572314|NCT00746525|functional electrical stimulation|functional electrical stimulation
572315|NCT00746525|FES|fes
572316|NCT00746525|brain computer interface|brain computer interface
572317|NCT00746525|BCI|bci
572318|NCT00746525|coordination|coordination
572319|NCT00746525|motor control|motor control
572320|NCT00746460|primary prevention|primary prevention
572321|NCT00746460|patient knowledge|patient knowledge
572322|NCT00746460|nurse|nurse
572323|NCT00746460|exercise|exercise
572324|NCT00746460|smoking cessation|smoking cessation
572325|NCT00746460|weight loss|weight loss
572326|NCT00746447|maintenance|maintenance
572327|NCT00746447|5-ASA|5-asa
572328|NCT00746447|mesalamine|mesalamine
572329|NCT00746447|mesalazine|mesalazine
572330|NCT00746447|ulcerative colitis|ulcerative colitis
572331|NCT00746434|Mild plaque psoriasis,|mild plaque psoriasis,
572332|NCT00746434|Moderate plaque psoriasis,|moderate plaque psoriasis,
572333|NCT00746434|0.5% Roflumilast cream|0.5% roflumilast cream
572334|NCT00746421|Cognition|cognition
572335|NCT00746421|attention|attention
572336|NCT00746421|bipolar|bipolar
572337|NCT00746421|disability|disability
572338|NCT00746408|Internet|internet
572937|NCT00744120|cancer|cancer
572339|NCT00746408|Information supply|information supply
572340|NCT00746408|Tailoring|tailoring
572341|NCT00746408|Patient empowerment|patient empowerment
572342|NCT00746408|Headaches|headaches
572343|NCT00746408|Consumer Health Information|consumer health information
572344|NCT00746408|Information Services|information services
572345|NCT00746408|Information Storage and Retrieval|information storage and retrieval
572346|NCT00746408|Information Systems|information systems
572347|NCT00746395|capsule|capsule
572348|NCT00746395|endoscopy|endoscopy
572349|NCT00746395|prokinetic|prokinetic
572350|NCT00746395|lubiprostone|lubiprostone
572351|NCT00746395|Normal|normal
572352|NCT00746395|volunteers|volunteers
572353|NCT00746382|Mild atopic dermatitis, Roflumilast cream 0.5%|mild atopic dermatitis, roflumilast cream 0.5%
572354|NCT00746369|HIV|hiv
572355|NCT00746369|Prevention|prevention
572356|NCT00746369|Adolescents|adolescents
572357|NCT00746369|HIV Seronegativity|hiv seronegativity
572358|NCT00746356|heart failure|heart failure
572359|NCT00746356|cardiac resynchronization therapy|cardiac resynchronization therapy
572360|NCT00746356|autocapture|autocapture
572361|NCT00746356|Current RF|current rf
572362|NCT00746356|Promote RF|promote rf
572363|NCT00746343|Bipolar I Disorder|bipolar i disorder
572364|NCT00746343|Medical Risks|medical risks
572365|NCT00746343|Integrated Risk Reduction Intervention|integrated risk reduction intervention
572366|NCT00746343|Currently in Remission|currently in remission
572367|NCT00746343|BMI|bmi
572368|NCT00746330|Asthma|asthma
572369|NCT00746330|Children|children
572370|NCT00746330|Persistent asthma|persistent asthma
572371|NCT00746304|botulinum|botulinum
572372|NCT00746304|esotropia|esotropia
572373|NCT00746278|Ovarian Cysts|ovarian cysts
572374|NCT00746278|Electrocoagulation|electrocoagulation
572375|NCT00746278|Ovarian Function Tests|ovarian function tests
572376|NCT00746278|Laparoscopy|laparoscopy
572377|NCT00746265|behavioral interventions for weight loss|behavioral interventions for weight loss
572378|NCT00746252|bipolar|bipolar
572379|NCT00746252|children|children
572380|NCT00746252|antipsychotic|antipsychotic
572381|NCT00746252|side effect|side effect
572382|NCT00746239|insomnia|insomnia
572383|NCT00746239|sleep difficulty|sleep difficulty
572384|NCT00746239|panic disorder|panic disorder
572385|NCT00746239|nocturnal panic attacks|nocturnal panic attacks
572386|NCT00746239|anxiety|anxiety
572387|NCT00746226|birch pollen|birch pollen
572388|NCT00746213|Thoracotomy|thoracotomy
572389|NCT00746213|Chronic Pain|chronic pain
572390|NCT00746200|chronic constipation|chronic constipation
572391|NCT00746200|electroacupuncture|electroacupuncture
572392|NCT00746200|randomized controlled trial|randomized controlled trial
572393|NCT00746174|insulin sensitivity|insulin sensitivity
572394|NCT00746174|magnetic resonance spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
572395|NCT00746174|lipotoxicity|lipotoxicity
572396|NCT00746174|lipid oxidation|lipid oxidation
572397|NCT00746174|thiazolidinediones|thiazolidinediones
572398|NCT00746174|intracellular|intracellular
572399|NCT00746174|triglyceride|triglyceride
572400|NCT00746174|content|content
572401|NCT00746161|total gastrectomy|total gastrectomy
572402|NCT00746161|double tract reconstruction|double tract reconstruction
572403|NCT00746161|gastric cancer|gastric cancer
572404|NCT00746161|Total gastrectomy in patients with gastric cancer|total gastrectomy in patients with gastric cancer
572405|NCT00746148|Polycystic Ovary Syndrome|polycystic ovary syndrome
572406|NCT00746148|Reflexology|reflexology
572407|NCT00746148|Complementary and Alternative Medicine|complementary and alternative medicine
572408|NCT00746148|Endocrinopathy|endocrinopathy
572409|NCT00746148|Oligo|oligo
572410|NCT00746148|Amenorrhoea|amenorrhoea
572411|NCT00746135|Heart failure (NYHA class III and IV)|heart failure (nyha class iii and iv)
572412|NCT00746135|Ventricular Dyssynchrony|ventricular dyssynchrony
572413|NCT00746109|randomized|randomized
572414|NCT00746109|clinical trial|clinical trial
572415|NCT00746109|ultrasound|ultrasound
572416|NCT00746109|prospective|prospective
572417|NCT00746109|abscess|abscess
572418|NCT00746109|packing|packing
572419|NCT00746109|incision and drainage|incision and drainage
572420|NCT00746109|superficial soft tissue infection|superficial soft tissue infection
572421|NCT00746083|pediatric|pediatric
572422|NCT00746083|obesity|obesity
572423|NCT00746083|African American|african american
572424|NCT00746083|adolescents|adolescents
572425|NCT00746083|intervention|intervention
572426|NCT00746083|home-based|home-based
572427|NCT00746083|community-based|community-based
572428|NCT00746070|cardiovascular disease, endothelium function, aldosterone|cardiovascular disease, endothelium function, aldosterone
572429|NCT00746057|Renal graft|renal graft
572430|NCT00746057|chronic rejection|chronic rejection
572431|NCT00746057|tolerance|tolerance
572432|NCT00746057|DNA chip|dna chip
572433|NCT00746057|biopsy|biopsy
572434|NCT00746044|Healthy|healthy
572435|NCT00746031|MTI|mti
572436|NCT00746031|Fibroids|fibroids
572437|NCT00746031|Novel|novel
572438|NCT00746031|MR imaging|mr imaging
572439|NCT00746031|techniques|techniques
572440|NCT00746018|ovary|ovary
572444|NCT00746005|mild cognitive impairment|mild cognitive impairment
572445|NCT00745992|Voriconazole|voriconazole
572446|NCT00745992|Antifungal Agents|antifungal agents
572447|NCT00745992|Invasive fungal infections|invasive fungal infections
572448|NCT00745992|Therapeutic drug monitoring|therapeutic drug monitoring
572449|NCT00745992|CYP Genetic polymorphism|cyp genetic polymorphism
572450|NCT00745966|Bipolar|bipolar
572451|NCT00745966|atypical antipsychotics|atypical antipsychotics
572452|NCT00745966|quality of life|quality of life
572453|NCT00745966|observational|observational
572454|NCT00745953|Metabolic syndrome|metabolic syndrome
572455|NCT00745953|Lipotoxicity|lipotoxicity
572456|NCT00745953|Insulin sensitivity|insulin sensitivity
572457|NCT00745953|Myocardial triglyceride levels|myocardial triglyceride levels
572458|NCT00745953|Hepatic triglyceride levels|hepatic triglyceride levels
572459|NCT00745953|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
572460|NCT00745940|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
572461|NCT00745940|MBCT|mbct
572462|NCT00745940|Depression|depression
572463|NCT00745940|Traumatic Brain Injury|traumatic brain injury
572464|NCT00745940|TBI|tbi
572465|NCT00745927|Colorectal neoplasm|colorectal neoplasm
572466|NCT00745927|Colorectal cancer|colorectal cancer
572467|NCT00745927|Screening colonoscopy|screening colonoscopy
572468|NCT00745927|CO2 insufflations|co2 insufflations
572469|NCT00745927|Colonoscopy|colonoscopy
572470|NCT00745914|PPAR-gamma, diabetic, kidney disease, atherosclerosis|ppar-gamma, diabetic, kidney disease, atherosclerosis
572471|NCT00745901|contraception|contraception
572472|NCT00745901|bleeding|bleeding
572473|NCT00745901|cycle control|cycle control
572474|NCT00745888|oxidative stress|oxidative stress
572475|NCT00745888|intensive care|intensive care
572476|NCT00745888|Postoperative intensive care|postoperative intensive care
572477|NCT00745875|NSCLC|nsclc
572478|NCT00745875|Phase II|phase ii
572479|NCT00745875|ZD4054|zd4054
572480|NCT00745875|Pemetrexed|pemetrexed
572481|NCT00745875|Lung Cancer|lung cancer
572482|NCT00745862|Skin|skin
572483|NCT00745849|non-allergic rhinitis, laryngopharyngeal reflux|non-allergic rhinitis, laryngopharyngeal reflux
572484|NCT00745836|insulin sensitivity|insulin sensitivity
572485|NCT00745823|HIV Infections|hiv infections
572486|NCT00745823|Treatment Naïve|treatment naïve
572487|NCT00745810|cardiopulmonary bypass|cardiopulmonary bypass
572488|NCT00745810|oxidative injuries|oxidative injuries
572489|NCT00745797|nonsmall cell lung cancer|nonsmall cell lung cancer
572490|NCT00745797|brain metastasis|brain metastasis
572491|NCT00745797|prophylactic cranial irradiation|prophylactic cranial irradiation
572492|NCT00745784|Young Bereaved Spouses|young bereaved spouses
572493|NCT00745771|pharmacokinetics|pharmacokinetics
572494|NCT00745771|of Diractin®|of diractin®
572495|NCT00745771|safety|safety
572496|NCT00745771|efficacy|efficacy
572497|NCT00745771|exercise|exercise
572498|NCT00745758|SAH, vasospasm, ADMA|sah, vasospasm, adma
572499|NCT00745732|Non-Small Cell Lung Cancer|non-small cell lung cancer
572500|NCT00745732|Lung Cancer|lung cancer
572501|NCT00745732|NSCLC|nsclc
572502|NCT00745732|ZD6474|zd6474
572503|NCT00745732|ZACTIMA|zactima
572504|NCT00745732|Vandetanib|vandetanib
572505|NCT00745732|Inoperable NSCLC|inoperable nsclc
572506|NCT00745732|Unresectable NSCLC|unresectable nsclc
572507|NCT00745732|Radiation Therapy|radiation therapy
572508|NCT00745732|Palliative radiation therapy|palliative radiation therapy
572509|NCT00745732|Angiogenesis|angiogenesis
572510|NCT00745719|parathyroidectomy|parathyroidectomy
572511|NCT00745719|cardiovascular|cardiovascular
572512|NCT00745719|bone|bone
572513|NCT00745719|endstage renal disease|endstage renal disease
572514|NCT00745693|Endothelin|endothelin
572515|NCT00745693|Air pollution|air pollution
572516|NCT00745693|Diesel exhaust|diesel exhaust
572517|NCT00745693|Vascular function|vascular function
572518|NCT00745693|exposure|exposure
572519|NCT00745680|Left ventricular remodeling, acute myocardial infarction|left ventricular remodeling, acute myocardial infarction
572520|NCT00745667|laparoscopic|laparoscopic
572521|NCT00745667|peptic ulcer|peptic ulcer
572522|NCT00745654|Lung Transplantation|lung transplantation
572523|NCT00745654|Chronic pain|chronic pain
572524|NCT00745654|Thoracotomy|thoracotomy
572525|NCT00745641|radiation injury|radiation injury
572526|NCT00745641|computed tomography|computed tomography
572527|NCT00745641|reactive oxygen species|reactive oxygen species
572528|NCT00745641|free radicals|free radicals
572529|NCT00745628|coronary heart disease|coronary heart disease
572530|NCT00745628|secondary prevention|secondary prevention
572531|NCT00745602|direct current cardioversion, cerebral blood flow|direct current cardioversion, cerebral blood flow
572532|NCT00745589|vascular,|vascular,
572533|NCT00745589|valvular calcification,|valvular calcification,
572534|NCT00745589|phosphate binder,|phosphate binder,
572535|NCT00745589|sevelamer,|sevelamer,
572536|NCT00745589|endstage renal disease|endstage renal disease
572537|NCT00745589|peritoneal dialysis|peritoneal dialysis
572538|NCT00745563|infertility|infertility
572539|NCT00745563|insemination|insemination
572540|NCT00745563|slow release|slow release
572542|NCT00745550|Chronic Idiopathic Myelofibrosis|chronic idiopathic myelofibrosis
572543|NCT00745550|Myeloproliferative disorders|myeloproliferative disorders
572544|NCT00745550|Polycythemia Vera|polycythemia vera
572545|NCT00745550|Essential Thrombocythemia|essential thrombocythemia
572546|NCT00745550|JAK2 inhibitor|jak2 inhibitor
572547|NCT00745537|postpartum major depression|postpartum major depression
572548|NCT00745537|adolescent mothers|adolescent mothers
572549|NCT00745537|telephone depression care management|telephone depression care management
572550|NCT00745537|barriers to depression care|barriers to depression care
572551|NCT00745524|Attention-deficit hyperactivity disorder|attention-deficit hyperactivity disorder
572552|NCT00745524|adolescent|adolescent
572553|NCT00745524|adult|adult
572554|NCT00745524|high risk population|high risk population
572555|NCT00745524|functional impairment|functional impairment
572556|NCT00745524|quality of life|quality of life
572557|NCT00745511|AMD|amd
572558|NCT00745511|Avastin|avastin
572559|NCT00745511|ORA102|ora102
572560|NCT00745511|macular degeneration|macular degeneration
572561|NCT00745511|neo-vascular age related macular degeneration (AMD)|neo-vascular age related macular degeneration (amd)
572562|NCT00745498|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
572563|NCT00745498|vitrectomy|vitrectomy
572564|NCT00745498|bevacizumab|bevacizumab
572565|NCT00745498|vitreous hemorrhage|vitreous hemorrhage
572566|NCT00745485|Osteoporosis|osteoporosis
572567|NCT00745485|zoledronic acid|zoledronic acid
572568|NCT00745485|postmenopausal women|postmenopausal women
572569|NCT00745472|AEP|aep
572570|NCT00745472|experimental pain|experimental pain
572571|NCT00745472|healthy volunteers|healthy volunteers
572572|NCT00745459|Patients|patients
572573|NCT00745459|undergoing|undergoing
572574|NCT00745459|gastric|gastric
572575|NCT00745459|endoscopy|endoscopy
572576|NCT00745446|Air pollution|air pollution
572577|NCT00745446|Diesel exhaust|diesel exhaust
572578|NCT00745446|Endothelial function|endothelial function
572579|NCT00745446|Vascular function|vascular function
572580|NCT00745446|Particle trap|particle trap
572581|NCT00745446|Thrombosis|thrombosis
572582|NCT00745446|effects|effects
572583|NCT00745446|inhalation|inhalation
572584|NCT00745420|Sickle Cell Disease|sickle cell disease
572585|NCT00745420|Sickle Cell Anemia|sickle cell anemia
572586|NCT00745407|adipocytokines|adipocytokines
572587|NCT00745407|insulin sensitivity|insulin sensitivity
572588|NCT00745407|hypertriglyceridemic patients|hypertriglyceridemic patients
572589|NCT00745394|NIRS|nirs
572590|NCT00745394|bypass|bypass
572591|NCT00745394|cardiopulmonary|cardiopulmonary
572592|NCT00745394|CPB|cpb
572593|NCT00745394|monitoring|monitoring
572594|NCT00745394|system|system
572595|NCT00745381|PANCREAS|pancreas
572596|NCT00745381|STOMACH|stomach
572597|NCT00745381|Questionnaire|questionnaire
572598|NCT00745381|08-105|08-105
572599|NCT00745368|HIV|hiv
572600|NCT00745368|Raltegravir|raltegravir
572601|NCT00745368|pharmacokinetics|pharmacokinetics
572602|NCT00745368|Treatment Experienced|treatment experienced
572603|NCT00745355|Quality of Life|quality of life
572604|NCT00745355|Questionnaires|questionnaires
572605|NCT00745355|08-076|08-076
572606|NCT00745342|type 1 diabetes|type 1 diabetes
572607|NCT00745342|glycemic control|glycemic control
572608|NCT00745342|family conflict|family conflict
572609|NCT00745342|quality of life|quality of life
572610|NCT00745342|parental involvement|parental involvement
572611|NCT00745316|Heart Failure|heart failure
572612|NCT00745316|Renal Insufficiency|renal insufficiency
572613|NCT00745316|Congestive Heart Failure|congestive heart failure
572614|NCT00745303|Tai Chi Chuan; Lipid; Cytokine|tai chi chuan; lipid; cytokine
572615|NCT00745290|Total knee arthroplasty|total knee arthroplasty
572616|NCT00745290|Pain|pain
572617|NCT00745290|Analgesia|analgesia
572618|NCT00745277|carbidopa|carbidopa
572619|NCT00745277|levodopa|levodopa
572620|NCT00745277|Parkinson's disease|parkinson's disease
572621|NCT00745264|heat|heat
572622|NCT00745264|exercise|exercise
572623|NCT00745251|Sleep apnea; obesity|sleep apnea; obesity
572624|NCT00745238|endothelial function|endothelial function
572625|NCT00745238|peripheral arterial tone|peripheral arterial tone
572626|NCT00745238|systemic inflammation|systemic inflammation
572627|NCT00745238|oxidative stress|oxidative stress
572628|NCT00745238|respiratory and peripheral muscular function|respiratory and peripheral muscular function
572629|NCT00745225|peritoneal dialysis, cardiovascular, PPAR-gamma|peritoneal dialysis, cardiovascular, ppar-gamma
572630|NCT00745212|venous thromboembolism diseases|venous thromboembolism diseases
572631|NCT00745212|placental vascular pathologies|placental vascular pathologies
572632|NCT00745212|antithrombotic treatment|antithrombotic treatment
572633|NCT00745212|symptomatic thromboembolic events|symptomatic thromboembolic events
572634|NCT00745212|pregnant women|pregnant women
572635|NCT00745212|score|score
572636|NCT00745212|therapeutic strategies|therapeutic strategies
572637|NCT00745212|heparin|heparin
572638|NCT00745212|aspirin|aspirin
572639|NCT00745212|pregnancy pathology|pregnancy pathology
572640|NCT00745199|End Stage Renal Disease|end stage renal disease
572641|NCT00745199|Cromolyn Sodium|cromolyn sodium
572642|NCT00745199|Pruritus|pruritus
572643|NCT00745199|Tryptase|tryptase
572644|NCT00745160|Questionaires|questionaires
572645|NCT00745147|constipation|constipation
572646|NCT00745147|traditional Chinese medicine|traditional chinese medicine
572647|NCT00745147|Chinese herbal formula|chinese herbal formula
572648|NCT00745147|lactulose|lactulose
572649|NCT00745147|cost-effective|cost-effective
572650|NCT00745147|long-term care|long-term care
572651|NCT00745134|Rectum|rectum
572652|NCT00745134|Rectal Cancer|rectal cancer
572653|NCT00745134|Colon Cancer|colon cancer
572654|NCT00745134|Curcumin|curcumin
572655|NCT00745134|Diferuloylmethane|diferuloylmethane
572656|NCT00745134|Capecitabine|capecitabine
572657|NCT00745134|Radiation Therapy|radiation therapy
572659|NCT00745134|XRT|xrt
572660|NCT00745134|Surgery for Rectal Cancer|surgery for rectal cancer
572661|NCT00745095|Safety|safety
572662|NCT00745095|Efficacy|efficacy
572663|NCT00745095|Colonoscopy|colonoscopy
572664|NCT00745095|PIEE|piee
572665|NCT00745095|MoviPrep|moviprep
572666|NCT00745095|Neostigmine|neostigmine
572667|NCT00745095|Glycopyrrolate|glycopyrrolate
572668|NCT00745069|Tapentadol|tapentadol
572669|NCT00745069|Osteoarthritis|osteoarthritis
572670|NCT00745069|Analgesia|analgesia
572671|NCT00745069|Chronic pain|chronic pain
572672|NCT00745056|Cognition|cognition
572673|NCT00745056|Memory|memory
572674|NCT00745056|Hormone Therapy|hormone therapy
572675|NCT00745056|HT|ht
572676|NCT00745043|COPD|copd
572677|NCT00745043|Betablockers|betablockers
572678|NCT00745043|bronchodilator|bronchodilator
572679|NCT00745043|exercise capacity|exercise capacity
572680|NCT00745043|methacholine challenge|methacholine challenge
572681|NCT00745030|Parkinson's disease|parkinson's disease
572682|NCT00745030|Multiple Systems Atrophy|multiple systems atrophy
572683|NCT00745030|Lewy Body Dementia|lewy body dementia
572684|NCT00745017|recurrent depression|recurrent depression
572685|NCT00745017|major depressive disorder|major depressive disorder
572686|NCT00745017|interpersonal therapy|interpersonal therapy
572687|NCT00745017|cognitive behavioral therapy|cognitive behavioral therapy
572688|NCT00745017|antidepressant therapies|antidepressant therapies
572689|NCT00745017|outome predictors|outome predictors
572690|NCT00745017|personality dimensions|personality dimensions
572691|NCT00745004|IBS D|ibs d
572692|NCT00744978|Efficacy|efficacy
572693|NCT00744978|Safety|safety
572694|NCT00744978|Pharmacokinetics|pharmacokinetics
572695|NCT00744978|Alzheimer's disease|alzheimer's disease
572696|NCT00744952|Large-vessel vasculitis|large-vessel vasculitis
572697|NCT00744939|Gadolinium|gadolinium
572698|NCT00744939|NSF|nsf
572699|NCT00744939|Renal Impairment|renal impairment
572700|NCT00744939|chemically induced|chemically induced
572701|NCT00744939|adverse effects|adverse effects
572702|NCT00744939|Contrast Media|contrast media
572703|NCT00744939|complications|complications
572704|NCT00744913|Pregnancy|pregnancy
572705|NCT00744913|Women|women
572706|NCT00744913|Nicotine replacement therapy|nicotine replacement therapy
572707|NCT00744913|Smoking cessation|smoking cessation
572708|NCT00744900|Pemetrexed, Non-Small Cell Lung Cancer, brain metastasis|pemetrexed, non-small cell lung cancer, brain metastasis
572709|NCT00744887|TMC114-TiDP3-C181|tmc114-tidp3-c181
572710|NCT00744887|TMC114-C181, health volunteers, Darunavir, ritonavir oral solution|tmc114-c181, health volunteers, darunavir, ritonavir oral solution
572711|NCT00744874|atrial fibrillation|atrial fibrillation
572712|NCT00744861|Lumbar Fusion|lumbar fusion
572713|NCT00744861|exospine|exospine
572714|NCT00744861|Exo-Spine|exo-spine
572715|NCT00744848|hemorrhoids|hemorrhoids
572716|NCT00744835|atrial fibrillation|atrial fibrillation
572717|NCT00744822|Lung Transplantation|lung transplantation
572718|NCT00744822|Infections|infections
572719|NCT00744822|Graft Rejection|graft rejection
572720|NCT00744809|TMC278-C152|tmc278-c152
572721|NCT00744809|TMC278-TiDP6-C152|tmc278-tidp6-c152
572722|NCT00744809|Healthy Volunteers|healthy volunteers
572723|NCT00744809|QT/QTc interval|qt/qtc interval
572724|NCT00744796|Endothelial Dystrophy|endothelial dystrophy
572725|NCT00744796|Fuchs' Endothelial Corneal Dystrophy|fuchs' endothelial corneal dystrophy
572726|NCT00744770|TMC278-TiDP6-C121|tmc278-tidp6-c121
572727|NCT00744770|TMC278-C121|tmc278-c121
572728|NCT00744770|open-label|open-label
572729|NCT00744770|drug-drug interaction|drug-drug interaction
572730|NCT00744770|methadone|methadone
572731|NCT00744770|TMC278|tmc278
572732|NCT00744757|5-aza-2'-deoxycytidine|5-aza-2'-deoxycytidine
572733|NCT00744757|decitabine|decitabine
572734|NCT00744757|dacogen|dacogen
572735|NCT00744757|Myelodysplastic Syndrome|myelodysplastic syndrome
572736|NCT00744744|stage 0 bladder cancer|stage 0 bladder cancer
572737|NCT00744731|Partial-onset Seizures|partial-onset seizures
572738|NCT00744731|Simple Partial Seizures|simple partial seizures
572739|NCT00744731|Complex Partial Seizures|complex partial seizures
572740|NCT00744705|Retinal nerve fiber layer|retinal nerve fiber layer
572741|NCT00744705|Glaucoma|glaucoma
572742|NCT00744705|Myopia|myopia
572743|NCT00744692|Immunodeficiencies|immunodeficiencies
572744|NCT00744692|Congenital Marrow Failures|congenital marrow failures
572745|NCT00744692|Hemoglobinopathies|hemoglobinopathies
572746|NCT00744692|Inborn Errors of Metabolism|inborn errors of metabolism
572747|NCT00744692|SCIDS|scids
572748|NCT00744692|Wiskott Aldrich|wiskott aldrich
572749|NCT00744692|FEL|fel
572750|NCT00744692|HLH|hlh
572751|NCT00744692|IPEX|ipex
572752|NCT00744692|LAD|lad
572753|NCT00744692|Sickle Cell|sickle cell
572754|NCT00744692|Thalassemia|thalassemia
572755|NCT00744692|Omenn's Syndrome|omenn's syndrome
572756|NCT00744692|Hurler's Syndrome|hurler's syndrome
572757|NCT00744692|MLD|mld
572758|NCT00744692|ALD|ald
572759|NCT00744692|Sanfilippo|sanfilippo
572760|NCT00744692|Krabbe|krabbe
572761|NCT00744692|Hunter's syndrome|hunter's syndrome
572762|NCT00744692|TaySachs|taysachs
572763|NCT00744692|Diamond Blackfan Anemia|diamond blackfan anemia
572764|NCT00744692|transplant|transplant
572765|NCT00744692|MPS|mps
572766|NCT00744692|Gaucher|gaucher
572767|NCT00744679|MS|ms
572768|NCT00744679|Multiple Sclerosis|multiple sclerosis
572769|NCT00744666|Intravitreal triamcinolone acetonide|intravitreal triamcinolone acetonide
572770|NCT00744666|Side-effects|side-effects
572771|NCT00744666|Ocular hypertension|ocular hypertension
572772|NCT00744666|Glaucoma|glaucoma
572773|NCT00744666|Prevention|prevention
572774|NCT00744666|Vitreoretinal diseases requiring IVTA for treatment|vitreoretinal diseases requiring ivta for treatment
572775|NCT00744653|Breast Cancer|breast cancer
572776|NCT00744653|Recurrence|recurrence
572777|NCT00744640|advanced pancreatic cancer|advanced pancreatic cancer
572778|NCT00744640|palliative chemotherapy|palliative chemotherapy
572779|NCT00744640|first-line therapy|first-line therapy
572780|NCT00744640|capecitabine|capecitabine
572781|NCT00744640|oxaliplatin|oxaliplatin
572782|NCT00744640|gemcitabine|gemcitabine
572783|NCT00744640|dose-finding study|dose-finding study
572784|NCT00744640|Phase II|phase ii
572785|NCT00744627|Generalized Anxiety Disorder|generalized anxiety disorder
572786|NCT00744627|Anxiety Disorders|anxiety disorders
572787|NCT00744627|Drug Therapy|drug therapy
572788|NCT00744614|PC02|pc02
572789|NCT00744614|Respiratory Rate|respiratory rate
572790|NCT00744614|Arterial blood gas|arterial blood gas
572791|NCT00744614|Intubation|intubation
572792|NCT00744614|Capnography|capnography
572793|NCT00744601|impulsivity|impulsivity
572794|NCT00744601|cocaine dependence|cocaine dependence
572795|NCT00744601|relapse|relapse
572796|NCT00744601|neuroimaging|neuroimaging
572797|NCT00744601|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
572798|NCT00744601|single photon emission computed tomography (SPECT)|single photon emission computed tomography (spect)
572799|NCT00744588|substance abuse|substance abuse
572800|NCT00744588|alcohol dependence|alcohol dependence
572801|NCT00744588|hypothalamic-pituitary-adrenal (HPA) system|hypothalamic-pituitary-adrenal (hpa) system
572802|NCT00744588|cosyntropin|cosyntropin
572803|NCT00744588|corticotropin-releasing Hormone (CRH)|corticotropin-releasing hormone (crh)
572804|NCT00744588|pituitary-adrenal system|pituitary-adrenal system
572805|NCT00744588|stress|stress
572806|NCT00744588|trauma|trauma
572807|NCT00744588|neurosteroids|neurosteroids
572808|NCT00744588|cortisol|cortisol
572809|NCT00744588|relapse|relapse
572810|NCT00744575|back pain|back pain
572811|NCT00744575|eeg|eeg
572812|NCT00744575|chronic pain|chronic pain
572813|NCT00744562|Phase 1,|phase 1,
572814|NCT00744562|dose escalation,|dose escalation,
572815|NCT00744562|histologically|histologically
572816|NCT00744562|confirmed|confirmed
572817|NCT00744562|malignancy|malignancy
572818|NCT00744562|metastatic|metastatic
572819|NCT00744549|Male Urogenital Diseases|male urogenital diseases
572820|NCT00744549|Antioxidants|antioxidants
572821|NCT00744549|Vitamin E|vitamin e
572822|NCT00744549|Vitamin D|vitamin d
572823|NCT00744549|Lycopene|lycopene
572824|NCT00744549|Selenium|selenium
572825|NCT00744536|Myelodysplastic syndrome|myelodysplastic syndrome
572826|NCT00744536|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
572827|NCT00744536|High intermediate risk and high risk IPSS score|high intermediate risk and high risk ipss score
572828|NCT00744536|Angiogenesis|angiogenesis
572829|NCT00744536|Metronomic chemotherapy|metronomic chemotherapy
572830|NCT00744536|Myelodysplastic Myeloproliferative Diseases|myelodysplastic myeloproliferative diseases
572831|NCT00744523|carotid artery stenting|carotid artery stenting
572832|NCT00744523|stroke|stroke
572833|NCT00744523|cerebral protection|cerebral protection
572834|NCT00744523|high surgical risk|high surgical risk
572835|NCT00744510|Polycystic Ovary Syndrome|polycystic ovary syndrome
572836|NCT00744510|Reflexology|reflexology
572837|NCT00744510|Complementary and Alternative Medicine|complementary and alternative medicine
572838|NCT00744510|Endocrinopathy|endocrinopathy
572839|NCT00744510|Oligo|oligo
572840|NCT00744510|Amenorrhoea|amenorrhoea
572841|NCT00744484|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
572842|NCT00744484|COPD|copd
572843|NCT00744484|Physical group training|physical group training
572844|NCT00744484|Water exercise|water exercise
573038|NCT00743730|pain|pain
572845|NCT00744484|Cardiorespiratory fitness|cardiorespiratory fitness
572846|NCT00744484|Functional exercise capacity|functional exercise capacity
572847|NCT00744484|Health related quality of life|health related quality of life
572848|NCT00744471|monoclonal antibody RN624 PF-04383119 nerve growth factor anti-nerve growth OA|monoclonal antibody rn624 pf-04383119 nerve growth factor anti-nerve growth oa
572849|NCT00744458|Primary Health care in rural Africa|primary health care in rural africa
572850|NCT00744458|Chronic non-communicable diseases|chronic non-communicable diseases
572851|NCT00744458|Patient Compliance|patient compliance
572852|NCT00744458|Treatment adherence|treatment adherence
572853|NCT00744445|hemodialysis|hemodialysis
572854|NCT00744445|erythropoietin|erythropoietin
572855|NCT00744419|GERD|gerd
572856|NCT00744419|pharmacokinetics|pharmacokinetics
572857|NCT00744419|pantoprazole|pantoprazole
572858|NCT00744419|neonates|neonates
572859|NCT00744419|infants|infants
572860|NCT00744406|recurrent depression|recurrent depression
572861|NCT00744406|major depressive disorder|major depressive disorder
572862|NCT00744406|interpersonal therapy|interpersonal therapy
572863|NCT00744406|cognitive behavioral therapy|cognitive behavioral therapy
572864|NCT00744406|antidepressant treatment|antidepressant treatment
572865|NCT00744406|outcome predictors|outcome predictors
572866|NCT00744406|personality dimensions|personality dimensions
572867|NCT00744393|sleep|sleep
572868|NCT00744393|critically ill|critically ill
572869|NCT00744393|mechanical ventilation|mechanical ventilation
572870|NCT00744380|Analgesia|analgesia
572871|NCT00744380|Mechanical ventilation|mechanical ventilation
572872|NCT00744354|refractory multiple myeloma|refractory multiple myeloma
572873|NCT00744354|stage I multiple myeloma|stage i multiple myeloma
572874|NCT00744354|stage II multiple myeloma|stage ii multiple myeloma
572875|NCT00744354|stage III multiple myeloma|stage iii multiple myeloma
572876|NCT00744341|SLV320; Acute Decompensated Heart Failure (ADHF); chronic heart failure; renal failure; I.V. doses; hospitalization|slv320; acute decompensated heart failure (adhf); chronic heart failure; renal failure; i.v. doses; hospitalization
572877|NCT00744328|Postpartum depression|postpartum depression
572878|NCT00744328|estradiol|estradiol
572879|NCT00744328|Postpartum major depressive disorder|postpartum major depressive disorder
572880|NCT00744315|myocardial revascularization|myocardial revascularization
572881|NCT00744315|myocardial ischemia|myocardial ischemia
572882|NCT00744315|genetics, medical|genetics, medical
572883|NCT00744315|Angiogenesis Inducing Agents|angiogenesis inducing agents
572884|NCT00744302|Dialysate calcium|dialysate calcium
572885|NCT00744302|Mineral metabolism|mineral metabolism
572886|NCT00744302|Parathyroid hormone|parathyroid hormone
572887|NCT00744302|Calcification|calcification
572888|NCT00744302|Cardiovascular disease|cardiovascular disease
572889|NCT00744302|Haemodialysis|haemodialysis
572890|NCT00744289|Hepatitis B|hepatitis b
572891|NCT00744289|People who inject drugs|people who inject drugs
572892|NCT00744289|Financial incentive|financial incentive
572893|NCT00744289|Vaccine completion|vaccine completion
572894|NCT00744276|fibrocystic breast disease|fibrocystic breast disease
572895|NCT00744276|fibrocystic disease of breast|fibrocystic disease of breast
572896|NCT00744276|breast pain|breast pain
572897|NCT00744276|mastalgia|mastalgia
572898|NCT00744276|cyclic mastalgia|cyclic mastalgia
572899|NCT00744276|cystic breast disease|cystic breast disease
572900|NCT00744250|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
572901|NCT00744250|Chronic Pancreatitis|chronic pancreatitis
572902|NCT00744250|Cystic fibrosis|cystic fibrosis
572903|NCT00744250|Pancrelipase|pancrelipase
572904|NCT00744250|Pancrecarb|pancrecarb
572905|NCT00744250|Intraduodenal aspiration|intraduodenal aspiration
572906|NCT00744250|Bioavailability|bioavailability
572907|NCT00744237|nebivolol|nebivolol
572908|NCT00744237|Bystolic ™|bystolic ™
572909|NCT00744237|Hypertension|hypertension
572910|NCT00744237|Diabetes|diabetes
572911|NCT00744198|Autologous|autologous
572912|NCT00744198|Biological|biological
572913|NCT00744198|Mesh|mesh
572914|NCT00744198|Polypropylene|polypropylene
572915|NCT00744198|Sling|sling
572916|NCT00744198|Synthetic|synthetic
572917|NCT00744198|Stress incontinence|stress incontinence
572918|NCT00744198|Surgery|surgery
572919|NCT00744198|TOT|tot
572920|NCT00744198|Treatment|treatment
572921|NCT00744185|infantile capillary hemangiomas|infantile capillary hemangiomas
572922|NCT00744185|propranolol|propranolol
572923|NCT00744185|ultrasonography|ultrasonography
572924|NCT00744172|hysterectomy|hysterectomy
572925|NCT00744172|vaginal|vaginal
572926|NCT00744172|laparoscopy|laparoscopy
572927|NCT00744172|abdominal|abdominal
572928|NCT00744172|complication|complication
572929|NCT00744172|quality of life|quality of life
572930|NCT00744172|cost-effectiveness|cost-effectiveness
572931|NCT00744172|Morbidity of three types of hysterectomy|morbidity of three types of hysterectomy
572932|NCT00744159|colon cancer|colon cancer
572933|NCT00744159|laparoscopic colorectal surgery|laparoscopic colorectal surgery
572934|NCT00744159|cellular immunity|cellular immunity
572935|NCT00744159|HLA-DR expression on monocyte|hla-dr expression on monocyte
572936|NCT00744133|Plasmodium falciparum, NF54, Anopheles stephensi, mosquito, malaria|plasmodium falciparum, nf54, anopheles stephensi, mosquito, malaria
572938|NCT00744107|Ischemic coronary artery disease in native coronary arteries|ischemic coronary artery disease in native coronary arteries
572939|NCT00744107|Single stent|single stent
572940|NCT00744107|RVD 2.5- 4.0mm|rvd 2.5- 4.0mm
572941|NCT00744107|Lesion length up to 26mm|lesion length up to 26mm
572942|NCT00744107|de novo or previously unstented lesions|de novo or previously unstented lesions
572943|NCT00744094|resistance training|resistance training
572944|NCT00744094|protein supplementation|protein supplementation
572945|NCT00744094|hypertrophy|hypertrophy
572946|NCT00744068|Stimulant|stimulant
572947|NCT00744068|Drug treatment|drug treatment
572948|NCT00744068|Continuing care|continuing care
572949|NCT00744068|Telephone support|telephone support
572950|NCT00744068|Aftercare|aftercare
572951|NCT00744055|alcohol dependence|alcohol dependence
572952|NCT00744055|post traumatic stress disorder|post traumatic stress disorder
572953|NCT00744055|treatment|treatment
572954|NCT00744055|prazosin|prazosin
572955|NCT00744042|Hypophosphatasia|hypophosphatasia
572956|NCT00744042|HPP|hpp
572957|NCT00744042|Bone Disease|bone disease
572958|NCT00744042|Soft Bones|soft bones
572959|NCT00744042|Low Alkaline Phosphatase|low alkaline phosphatase
572960|NCT00744042|genetic metabolic disorder|genetic metabolic disorder
572961|NCT00744042|alkaline phosphatase|alkaline phosphatase
572962|NCT00744042|tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
572963|NCT00744042|rickets|rickets
572964|NCT00744042|osteomalacia|osteomalacia
572965|NCT00744029|prehospital delays|prehospital delays
572966|NCT00744029|intervention|intervention
572967|NCT00744029|population-based|population-based
572968|NCT00744029|stroke|stroke
572969|NCT00744016|UC|uc
572970|NCT00744016|Ulcerative colitis|ulcerative colitis
572971|NCT00744016|IBD|ibd
572972|NCT00744016|Inflammatory bowel disease|inflammatory bowel disease
572973|NCT00743990|Cough symptoms|cough symptoms
572974|NCT00743990|Cold symptoms|cold symptoms
572975|NCT00743990|Congestion|congestion
572976|NCT00743990|Children|children
572977|NCT00743990|URI|uri
572978|NCT00743990|Alternative cough symptom treatment|alternative cough symptom treatment
572979|NCT00743951|patient decision aids|patient decision aids
572980|NCT00743951|patient preferences|patient preferences
572981|NCT00743951|osteoarthritis|osteoarthritis
572982|NCT00743951|joint replacement|joint replacement
572983|NCT00743951|waiting times|waiting times
572984|NCT00743925|Unstable Angina|unstable angina
572985|NCT00743925|STEMI|stemi
572986|NCT00743925|NSTEMI|nstemi
572987|NCT00743925|ACS|acs
572988|NCT00743925|Acute Coronary Syndrome|acute coronary syndrome
572989|NCT00743925|C14.280.647.124|c14.280.647.124
572990|NCT00743925|C14.280.647.500|c14.280.647.500
572991|NCT00743912|rifaximin|rifaximin
572992|NCT00743912|midazolam|midazolam
572993|NCT00743912|pharmacokinetics|pharmacokinetics
572994|NCT00743899|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
572995|NCT00743899|Everolimus-eluting stent|everolimus-eluting stent
572996|NCT00743873|medial retinaculum tear s/p patella dislocation|medial retinaculum tear s/p patella dislocation
572997|NCT00743860|darapladib|darapladib
572998|NCT00743860|pharmacokinetics|pharmacokinetics
572999|NCT00743860|metabolite|metabolite
573000|NCT00743860|SB-480848|sb-480848
573001|NCT00743847|schizophrenia, treatment, cognition|schizophrenia, treatment, cognition
573002|NCT00743808|hypertension|hypertension
573003|NCT00743808|diabetes|diabetes
573004|NCT00743808|quality improvement|quality improvement
573005|NCT00743808|blood pressure|blood pressure
573006|NCT00743795|Hepatitis C|hepatitis c
573007|NCT00743795|HCV|hcv
573008|NCT00743795|Rapid Virologic Response|rapid virologic response
573009|NCT00743795|Sustained Virologic Response|sustained virologic response
573010|NCT00743795|HCV RNA|hcv rna
573011|NCT00743795|Polymerase inhibitor|polymerase inhibitor
573012|NCT00743795|GS-9190|gs-9190
573013|NCT00743782|Hypoparathyroidism|hypoparathyroidism
573014|NCT00743782|Parathyroid Hormone 1-34|parathyroid hormone 1-34
573015|NCT00743769|Myocardial Infarction|myocardial infarction
573016|NCT00743769|Myocardial Ischemia|myocardial ischemia
573017|NCT00743769|Myocardial Diseases|myocardial diseases
573018|NCT00743769|Infarction|infarction
573019|NCT00743756|obesity|obesity
573020|NCT00743756|diabetes|diabetes
573021|NCT00743756|endothelial function|endothelial function
573022|NCT00743756|insulin sensitivity|insulin sensitivity
573023|NCT00743743|dementia|dementia
573024|NCT00743743|Alzheimer disease|alzheimer disease
573025|NCT00743743|cognition|cognition
573026|NCT00743743|function|function
573027|NCT00743743|behavior|behavior
573028|NCT00743743|treatment|treatment
573029|NCT00743730|developmental delay|developmental delay
573030|NCT00743730|cognitive impairment|cognitive impairment
573031|NCT00743730|pain control|pain control
573032|NCT00743730|post operative pain|post operative pain
573033|NCT00743730|opioid|opioid
573034|NCT00743730|pain assessment|pain assessment
573035|NCT00743730|Parent Nurse controlled Analgesic|parent nurse controlled analgesic
573036|NCT00743730|patient controlled analgesic|patient controlled analgesic
573037|NCT00743730|children|children
573040|NCT00743730|safety|safety
573041|NCT00743730|parent satisfaction|parent satisfaction
573042|NCT00743730|nurse satisfaction|nurse satisfaction
573043|NCT00743730|Pediatric|pediatric
573044|NCT00743717|total knee arthroplasty|total knee arthroplasty
573045|NCT00743717|osteoarthritis|osteoarthritis
573046|NCT00743717|ceramic bearing|ceramic bearing
573047|NCT00743717|zirconia|zirconia
573048|NCT00743691|Ethiopia|ethiopia
573049|NCT00743691|Community|community
573050|NCT00743691|Community based|community based
573051|NCT00743691|Health extension Worker|health extension worker
573052|NCT00743691|Health Extension Program|health extension program
573053|NCT00743678|Colorectal Cancer|colorectal cancer
573054|NCT00743678|Unresectable liver metastasis|unresectable liver metastasis
573055|NCT00743678|FOLFOX6|folfox6
573056|NCT00743678|Cetuximab|cetuximab
573057|NCT00743678|Neoadjuvant therapy|neoadjuvant therapy
573058|NCT00743665|Youth|youth
573059|NCT00743665|consensus|consensus
573060|NCT00743665|criteria|criteria
573061|NCT00743665|CVS|cvs
573062|NCT00743652|13 valent Pneumococcal Conjugate Vaccine|13 valent pneumococcal conjugate vaccine
573063|NCT00743652|Antibody Response|antibody response
573064|NCT00743652|safety|safety
573065|NCT00743652|Alaskan Native Children|alaskan native children
573066|NCT00743639|Cardiomyopathy|cardiomyopathy
573067|NCT00743639|stem cell|stem cell
573068|NCT00743639|cardiac failure|cardiac failure
573069|NCT00743626|Pap test|pap test
573070|NCT00743626|HPV|hpv
573071|NCT00743626|Healthy patients screened for cervical cancer tests.|healthy patients screened for cervical cancer tests.
573072|NCT00743613|Erectile Dysfunction|erectile dysfunction
573073|NCT00743613|ED|ed
573074|NCT00743613|Peripheral Arterial Disease|peripheral arterial disease
573075|NCT00743613|PAD|pad
573076|NCT00743613|Ankle-Brachial Index|ankle-brachial index
573077|NCT00743613|ABI|abi
573078|NCT00743600|ultrasound|ultrasound
573079|NCT00743600|rotator cuff|rotator cuff
573080|NCT00743561|MSA|msa
573081|NCT00743561|sleep apnea|sleep apnea
573082|NCT00743561|ambulatory polygraphy|ambulatory polygraphy
573083|NCT00743561|polysomnography|polysomnography
573084|NCT00743548|interdental self-care aids|interdental self-care aids
573085|NCT00743548|plaque|plaque
573086|NCT00743548|bleeding gums|bleeding gums
573087|NCT00743535|Cystocele|cystocele
573088|NCT00743535|Mesh|mesh
573089|NCT00743535|Prolapse|prolapse
573090|NCT00743535|Sling|sling
573091|NCT00743535|Stress incontinence|stress incontinence
573092|NCT00743535|Surgery|surgery
573093|NCT00743535|TOT|tot
573094|NCT00743535|TVT|tvt
573095|NCT00743535|Treatment|treatment
573096|NCT00743522|Reducing shocks|reducing shocks
573097|NCT00743509|sarcoma|sarcoma
573098|NCT00743509|Cyclophosphamide|cyclophosphamide
573099|NCT00743509|Sirolimus|sirolimus
573100|NCT00743509|Progressive or recurrent, advanced (unresectable or metastatic) high-grade osteosarcoma, Ewing's or soft tissue sarcoma previously treated with chemotherapy.|progressive or recurrent, advanced (unresectable or metastatic) high-grade osteosarcoma, ewing's or soft tissue sarcoma previously treated with chemotherapy.
573101|NCT00743483|cystic fibrosis|cystic fibrosis
573102|NCT00743483|pancreatic insufficiency|pancreatic insufficiency
573103|NCT00743483|bucelipase alfa|bucelipase alfa
573104|NCT00743483|bile salt stimulating lipase|bile salt stimulating lipase
573105|NCT00743483|BSSL|bssl
573106|NCT00743483|coefficient of fat absorption|coefficient of fat absorption
573107|NCT00743470|HIV co-infected with tuberculosis|hiv co-infected with tuberculosis
573108|NCT00743457|Possible VPS failure with symptom such as headache|possible vps failure with symptom such as headache
573109|NCT00743457|vomiting|vomiting
573110|NCT00743457|lethargy|lethargy
573111|NCT00743457|VPS failure|vps failure
573112|NCT00743444|GERD|gerd
573113|NCT00743444|transient lower esophageal sphincter relaxations (TLESRs)|transient lower esophageal sphincter relaxations (tlesrs)
573114|NCT00743444|reflux|reflux
573115|NCT00743405|schizophrenia|schizophrenia
573116|NCT00743405|M1 receptor agonist|m1 receptor agonist
573117|NCT00743405|safety|safety
573118|NCT00743405|pharmacokinetics|pharmacokinetics
573119|NCT00743405|GSK1034702|gsk1034702
573120|NCT00743379|Phase 1/2|phase 1/2
573121|NCT00743379|Advanced Solid Tumors|advanced solid tumors
573122|NCT00743379|Hypoxia|hypoxia
573123|NCT00743379|Prodrug|prodrug
573124|NCT00743379|Dose-Escalation|dose-escalation
573125|NCT00743379|Evofosfamide|evofosfamide
573126|NCT00743366|quetiapine|quetiapine
573127|NCT00743366|smoked marijuana|smoked marijuana
573128|NCT00743366|marijuana use|marijuana use
573129|NCT00743353|laryngeal|laryngeal
573130|NCT00743353|squamous cell|squamous cell
573131|NCT00743353|anaplastic astrocytoma|anaplastic astrocytoma
573132|NCT00743353|oligodendroglioma|oligodendroglioma
573133|NCT00743353|glioblastoma multiforme|glioblastoma multiforme
573134|NCT00743340|HIV-1 infection|hiv-1 infection
573135|NCT00743340|emtricitabine|emtricitabine
573136|NCT00743340|pediatrics|pediatrics
573137|NCT00743340|pediatric patients|pediatric patients
573138|NCT00743327|hormone therapy|hormone therapy
573139|NCT00743314|lymphedema|lymphedema
573140|NCT00743314|stage I breast cancer|stage i breast cancer
573141|NCT00743314|stage II breast cancer|stage ii breast cancer
573142|NCT00743301|CVD|cvd
573143|NCT00743301|Palm olein|palm olein
573144|NCT00743301|Olive oil|olive oil
573145|NCT00743301|Lard|lard
573146|NCT00743301|healthy men|healthy men
573147|NCT00743301|metabolic syndrome|metabolic syndrome
573148|NCT00743301|Risk of cardiovascular disease and metabolic syndrome|risk of cardiovascular disease and metabolic syndrome
573149|NCT00743288|stage I multiple myeloma|stage i multiple myeloma
573150|NCT00743288|stage II multiple myeloma|stage ii multiple myeloma
573151|NCT00743288|stage III multiple myeloma|stage iii multiple myeloma
573152|NCT00743288|refractory multiple myeloma|refractory multiple myeloma
573153|NCT00743275|Influenza|influenza
573154|NCT00743262|laryngectomy|laryngectomy
573155|NCT00743262|larynx cancer|larynx cancer
573156|NCT00743249|Dry eye|dry eye
573157|NCT00743249|Tear duct|tear duct
573158|NCT00743249|Punctal plug|punctal plug
573159|NCT00743236|perioperative/postoperative complications|perioperative/postoperative complications
573160|NCT00743236|urinary complications|urinary complications
573161|NCT00743236|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
573162|NCT00743236|stage I renal cell cancer|stage i renal cell cancer
573163|NCT00743223|temporomandibular disorder|temporomandibular disorder
573164|NCT00743223|orofacial pain|orofacial pain
573165|NCT00743223|posture of the head|posture of the head
573166|NCT00743210|pregnancy|pregnancy
573167|NCT00743210|obesity|obesity
573168|NCT00743210|asymmetric dimethylarginine|asymmetric dimethylarginine
573169|NCT00743210|L-arginine|l-arginine
573170|NCT00743210|L-citrulline|l-citrulline
573171|NCT00743197|coronary artery disease (CAD)|coronary artery disease (cad)
573172|NCT00743197|chest pain|chest pain
573173|NCT00743197|myocardial ischemia|myocardial ischemia
573174|NCT00743197|endothelial function|endothelial function
573175|NCT00743184|BPH|bph
573176|NCT00743184|LUTS|luts
573177|NCT00743184|Lower urinary tract symptoms (LUTS)|lower urinary tract symptoms (luts)
573178|NCT00743171|Lung transplantation|lung transplantation
573179|NCT00743171|Home spirometry|home spirometry
573180|NCT00743171|non-adherence|non-adherence
573181|NCT00743171|outcomes|outcomes
573182|NCT00743171|bronchiolitis obliterans|bronchiolitis obliterans
573183|NCT00743158|ztr|ztr
573184|NCT00743158|transfer impedance|transfer impedance
573185|NCT00743158|cystic fibrosis|cystic fibrosis
573186|NCT00743158|pulmonary function test|pulmonary function test
573187|NCT00743158|pft|pft
573188|NCT00743145|naltrexone|naltrexone
573189|NCT00743145|smoked marijuana|smoked marijuana
573190|NCT00743145|marijuana use|marijuana use
573191|NCT00743132|evaluation|evaluation
573192|NCT00743132|incidence|incidence
573193|NCT00743132|liver surgery|liver surgery
573194|NCT00743132|resection|resection
573195|NCT00743132|impact|impact
573196|NCT00743132|postoperative|postoperative
573197|NCT00743132|mortality|mortality
573198|NCT00743119|oral thc|oral thc
573199|NCT00743119|cannabis|cannabis
573200|NCT00743119|pain|pain
573201|NCT00743119|analgesic effects|analgesic effects
573202|NCT00743119|dronabinol|dronabinol
573203|NCT00743106|nephrectomy|nephrectomy
573204|NCT00743106|fenoldopam|fenoldopam
573205|NCT00743106|atrophic minimally functioning kidney|atrophic minimally functioning kidney
573206|NCT00743093|acetaminophen|acetaminophen
573207|NCT00743093|protein adducts|protein adducts
573208|NCT00743093|drug safety|drug safety
573209|NCT00743093|alanine aminotransferase|alanine aminotransferase
573210|NCT00743093|Alanine Amino Transferase|alanine amino transferase
573211|NCT00743080|laparoscopy|laparoscopy
573212|NCT00743080|myomectomy|myomectomy
573213|NCT00743080|myomas|myomas
573214|NCT00743080|morcellator|morcellator
573215|NCT00743080|supracervical hysterectomy|supracervical hysterectomy
573216|NCT00743080|surgery|surgery
573217|NCT00743080|symptomatic uterine myomas|symptomatic uterine myomas
573218|NCT00743067|XL880|xl880
573219|NCT00743067|MET inhibitor|met inhibitor
573220|NCT00743067|GSK1363089|gsk1363089
573221|NCT00743067|Solid Tumors|solid tumors
573222|NCT00743067|c-Met|c-met
573223|NCT00743054|Carcinoma, Renal Cell|carcinoma, renal cell
573224|NCT00743054|MicroRNAs|micrornas
573225|NCT00743041|PTSD, EFT, depression, anxiety, telephone|ptsd, eft, depression, anxiety, telephone
573226|NCT00743028|Other hematological and non-hematological malignancies|other hematological and non-hematological malignancies
573227|NCT00743002|TT223|tt223
573228|NCT00742989|osteopathic|osteopathic
573229|NCT00742989|lymphatic|lymphatic
573230|NCT00742989|treatment|treatment
573231|NCT00742989|OLT|olt
573232|NCT00742989|normal|normal
573233|NCT00742976|Weight gain in insulin treated type 2 diabetes|weight gain in insulin treated type 2 diabetes
573234|NCT00742976|extracellular volume|extracellular volume
573235|NCT00742976|insulin treatment|insulin treatment
573236|NCT00742976|sodium retention|sodium retention
573237|NCT00742963|TH-302|th-302
573238|NCT00742963|Advanced Soft Tissue Sarcoma|advanced soft tissue sarcoma
573239|NCT00742963|Doxorubicin|doxorubicin
573240|NCT00742963|Phase 1/2|phase 1/2
573241|NCT00742950|Corneal incision|corneal incision
573242|NCT00742950|Cataract surgery|cataract surgery
573243|NCT00742950|Phacoemulsification|phacoemulsification
573244|NCT00742950|Surgically induced astigmatism|surgically induced astigmatism
573245|NCT00742950|Corneal Topography|corneal topography
573246|NCT00742937|Hypovitaminosis A|hypovitaminosis a
573247|NCT00742924|metastatic osteosarcoma|metastatic osteosarcoma
573248|NCT00742911|Solid Tumors, Liver|solid tumors, liver
573249|NCT00742898|Quasi-experimental design|quasi-experimental design
573250|NCT00742898|Non-targeted opt-out rapid HIV screening|non-targeted opt-out rapid hiv screening
573251|NCT00742898|Diagnostic rapid HIV testing|diagnostic rapid hiv testing
573252|NCT00742898|Emergency department|emergency department
573253|NCT00742898|Effectiveness|effectiveness
573254|NCT00742898|Efficiency|efficiency
573255|NCT00742898|Health services research|health services research
573256|NCT00742898|Program evaluation|program evaluation
573257|NCT00742898|Effectiveness and efficiency of non-targeted rapid HIV screening in the ED|effectiveness and efficiency of non-targeted rapid hiv screening in the ed
573258|NCT00742885|Immunogenicity|immunogenicity
573259|NCT00742885|Safety|safety
573260|NCT00742885|Pandemic Influenza|pandemic influenza
573261|NCT00742872|Mosapride|mosapride
573262|NCT00742872|Irritable Bowel Syndrome|irritable bowel syndrome
573263|NCT00742872|Constipation|constipation
573264|NCT00742859|Atrial Fibrillation|atrial fibrillation
573265|NCT00742859|Betrixaban|betrixaban
573266|NCT00742859|Factor Xa inhibitor|factor xa inhibitor
573267|NCT00742859|Warfarin|warfarin
573268|NCT00742846|Adhesive Capsulitis|adhesive capsulitis
573269|NCT00742846|Subacromial injection|subacromial injection
573270|NCT00742846|Intraarticular injection|intraarticular injection
573271|NCT00742833|Overactive bladder|overactive bladder
573272|NCT00742833|Frequency|frequency
573273|NCT00742833|Micturition|micturition
573274|NCT00742833|Urgency|urgency
573275|NCT00742833|Urge urinary incontinence|urge urinary incontinence
573276|NCT00742833|β3-agonist|β3-agonist
573277|NCT00742820|bioequivalence|bioequivalence
573278|NCT00742807|sensation|sensation
573279|NCT00742807|relief|relief
573280|NCT00742807|during|during
573281|NCT00742807|surgery|surgery
573282|NCT00742781|Crohn's|crohn's
573283|NCT00742781|vitamin D|vitamin d
573284|NCT00742768|absorption|absorption
573285|NCT00742768|encapsulation|encapsulation
573286|NCT00742768|menaquinone|menaquinone
573287|NCT00742768|Bio-availability|bio-availability
573288|NCT00742755|Follow-up of breast abnormalities|follow-up of breast abnormalities
573289|NCT00742755|Korean American immigrants|korean american immigrants
573290|NCT00742742|Walnut|walnut
573291|NCT00742742|Lipids|lipids
573292|NCT00742742|Blood Glucose|blood glucose
573293|NCT00742729|Colorectal cancer screening|colorectal cancer screening
573294|NCT00742729|Fecal occult blood test|fecal occult blood test
573295|NCT00742729|Endoscopies|endoscopies
573296|NCT00742729|Filipino American immigrants|filipino american immigrants
573297|NCT00742729|Community based organizations and churches|community based organizations and churches
573298|NCT00742716|Parathyroid Diseases|parathyroid diseases
573299|NCT00742716|Renal Insufficiency|renal insufficiency
573300|NCT00742716|Kidney Failure, Chronic|kidney failure, chronic
573301|NCT00742716|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
573302|NCT00742716|Vitamin D|vitamin d
573303|NCT00742716|Hyperparathyroidism|hyperparathyroidism
573304|NCT00742716|Renal Insufficiency, Chronic|renal insufficiency, chronic
573305|NCT00742716|Kidney Diseases|kidney diseases
573306|NCT00742716|Kidney Failure|kidney failure
573307|NCT00742690|cirrhosis|cirrhosis
573308|NCT00742690|type 1 hepatorenal syndrome|type 1 hepatorenal syndrome
573309|NCT00742690|terlipressin|terlipressin
573310|NCT00742690|albumin|albumin
573311|NCT00742690|effective circulating volume|effective circulating volume
573312|NCT00742690|Patients|patients
573313|NCT00742690|with|with
573314|NCT00742677|female reproductive cancer|female reproductive cancer
573315|NCT00742664|Prader-Willi Syndrome|prader-willi syndrome
573316|NCT00742664|Compulsive behavior|compulsive behavior
573317|NCT00742664|Hoarding|hoarding
573318|NCT00742664|Obsessive-compulsive disorder|obsessive-compulsive disorder
573319|NCT00742664|Children|children
573320|NCT00742664|Treatment|treatment
573321|NCT00742664|genetically|genetically
573322|NCT00742664|confirmed|confirmed
573323|NCT00742664|diagnosis|diagnosis
573324|NCT00742638|CCMD-3,|ccmd-3,
573325|NCT00742638|CRF,|crf,
573326|NCT00742638|EPS,|eps,
573327|NCT00742638|GCP,|gcp,
573328|NCT00742638|ICH,|ich,
573329|NCT00742638|ITT,|itt,
573330|NCT00742638|LOCF,|locf,
573331|NCT00742638|MADRS,|madrs,
573332|NCT00742638|PANSS,|panss,
573333|NCT00742638|YMRS.|ymrs.
573334|NCT00742638|Acute|acute
573335|NCT00742638|manic|manic
573336|NCT00742638|patients|patients
573337|NCT00742638|with|with
573338|NCT00742638|bipolar|bipolar
573339|NCT00742638|disorder|disorder
573340|NCT00742612|Carotid Endarterectomy|carotid endarterectomy
573341|NCT00742612|von Willebrand Factor|von willebrand factor
573342|NCT00742612|Microembolic Signal|microembolic signal
573441|NCT00742287|polyphenols|polyphenols
573343|NCT00742599|Stomach Diseases|stomach diseases
573344|NCT00742586|Gene Expression Changes in Blood Cells|gene expression changes in blood cells
573345|NCT00742586|RNA|rna
573346|NCT00742586|Pure Autonomic Failure|pure autonomic failure
573347|NCT00742586|Multiply System Atrophy|multiply system atrophy
573348|NCT00742586|Parkinson's Plus|parkinson's plus
573349|NCT00742573|Major Depressive Disorder|major depressive disorder
573350|NCT00742573|Mood Disorders|mood disorders
573351|NCT00742573|Hispanic|hispanic
573352|NCT00742560|Multiple Myeloma|multiple myeloma
573353|NCT00742547|prevention|prevention
573354|NCT00742547|health services research|health services research
573355|NCT00742534|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
573356|NCT00742534|Prematurity|prematurity
573357|NCT00742534|Lung Disease|lung disease
573358|NCT00742534|preterm infants|preterm infants
573359|NCT00742521|cortisol|cortisol
573360|NCT00742521|catecholamines|catecholamines
573361|NCT00742521|Type 1 DM|type 1 dm
573362|NCT00742508|carvedilol phosphate|carvedilol phosphate
573363|NCT00742508|ß-blocker|ß-blocker
573364|NCT00742508|SK&F-105517-D|sk&f-105517-d
573365|NCT00742508|Chronic heart failure(CHF)|chronic heart failure(chf)
573366|NCT00742469|TD|td
573367|NCT00742469|traveller's diarrhea|traveller's diarrhea
573368|NCT00742469|campylobacter|campylobacter
573369|NCT00742469|shigella|shigella
573370|NCT00742469|salmonella|salmonella
573371|NCT00742469|E. coli|e. coli
573372|NCT00742469|diarrhea|diarrhea
573373|NCT00742456|Microcirculation|microcirculation
573374|NCT00742456|Insulin|insulin
573375|NCT00742456|Hypertension|hypertension
573376|NCT00742456|Obesity|obesity
573377|NCT00742443|Scar Revision|scar revision
573378|NCT00742430|aspirin resistance|aspirin resistance
573379|NCT00742430|coronary artery disease|coronary artery disease
573380|NCT00742430|clopidogrel resistance|clopidogrel resistance
573381|NCT00742430|major adverse cardiac events|major adverse cardiac events
573382|NCT00742430|multiplate platelet function analyser|multiplate platelet function analyser
573383|NCT00742430|percutaneous coronary intervention|percutaneous coronary intervention
573384|NCT00742417|Alzheimer's|alzheimer's
573385|NCT00742417|Dementia|dementia
573386|NCT00742417|Senile|senile
573387|NCT00742417|Loss of cognitive abilities|loss of cognitive abilities
573388|NCT00742417|Old age|old age
573389|NCT00742417|Elderly|elderly
573390|NCT00742417|Aging|aging
573391|NCT00742417|Albumin|albumin
573392|NCT00742417|Caregiver|caregiver
573393|NCT00742417|amyloid|amyloid
573394|NCT00742417|beta amyloid|beta amyloid
573395|NCT00742417|Central Nervous System Diseases|central nervous system diseases
573396|NCT00742417|Brain Disease|brain disease
573397|NCT00742417|Mental Disorders|mental disorders
573398|NCT00742417|Plasma Exchange|plasma exchange
573399|NCT00742404|stage I multiple myeloma|stage i multiple myeloma
573400|NCT00742404|stage II multiple myeloma|stage ii multiple myeloma
573401|NCT00742404|stage III multiple myeloma|stage iii multiple myeloma
573402|NCT00742391|Peplin|peplin
573403|NCT00742391|Actinic keratosis|actinic keratosis
573404|NCT00742391|PEP005|pep005
573405|NCT00742378|Glaucoma|glaucoma
573406|NCT00742378|Retinal nerve fiber layer|retinal nerve fiber layer
573407|NCT00742378|Cirrus OCT|cirrus oct
573408|NCT00742365|Seasonal Affective Disorder|seasonal affective disorder
573409|NCT00742365|Light Therapy|light therapy
573410|NCT00742365|Seasonal Depression|seasonal depression
573411|NCT00742365|Psychiatric Disorder|psychiatric disorder
573412|NCT00742365|Bright Light|bright light
573413|NCT00742365|Major Depressive Disorder|major depressive disorder
573414|NCT00742365|Bipolar Disorder|bipolar disorder
573415|NCT00742339|cirrhosis|cirrhosis
573416|NCT00742339|hepatorenal syndrome|hepatorenal syndrome
573417|NCT00742339|terlipressin|terlipressin
573418|NCT00742339|midodrine|midodrine
573419|NCT00742339|octreotide|octreotide
573420|NCT00742339|human albumin|human albumin
573421|NCT00742339|effective circulating volume|effective circulating volume
573422|NCT00742339|The criteria which will be used for the diagnosis of HRS will be the criteria which were recently published by the International Ascites Club|the criteria which will be used for the diagnosis of hrs will be the criteria which were recently published by the international ascites club
573423|NCT00742339|Patients with cirrhosis and type 2 HRS only with serum creatinine value > 2.5 mg/dl|patients with cirrhosis and type 2 hrs only with serum creatinine value > 2.5 mg/dl
573424|NCT00742339|All patients with cirrhosis and type 1 HRS|all patients with cirrhosis and type 1 hrs
573425|NCT00742326|HIV|hiv
573426|NCT00742326|Hepatitis C|hepatitis c
573427|NCT00742326|Liver Disease|liver disease
573428|NCT00742326|Fatty Liver|fatty liver
573429|NCT00742326|Steatosis|steatosis
573430|NCT00742313|Endoscopic|endoscopic
573431|NCT00742313|saphenous|saphenous
573432|NCT00742313|vein|vein
573433|NCT00742313|harvest|harvest
573434|NCT00742300|ASCT|asct
573435|NCT00742300|Tolerance induction|tolerance induction
573436|NCT00742300|SLE|sle
573437|NCT00742300|Transplantation|transplantation
573438|NCT00742300|Autoimmune diseases|autoimmune diseases
573439|NCT00742287|smoking|smoking
573440|NCT00742287|oligomeric proanthocyanidins|oligomeric proanthocyanidins
573442|NCT00742287|supplementation|supplementation
573443|NCT00742287|vascular function|vascular function
573444|NCT00742287|oxidative stress|oxidative stress
573445|NCT00742287|inflammation|inflammation
573446|NCT00742261|Pharmacokinetics|pharmacokinetics
573447|NCT00742261|Safety|safety
573448|NCT00742261|MET|met
573449|NCT00742261|Bioavailability|bioavailability
573450|NCT00742261|Patients|patients
573451|NCT00742261|GSK1363089A|gsk1363089a
573452|NCT00742261|GSK1363089G|gsk1363089g
573453|NCT00742261|GSK1363089|gsk1363089
573454|NCT00742261|Relative|relative
573455|NCT00742248|COPD|copd
573456|NCT00742222|Electronic brachytherapy registry|electronic brachytherapy registry
573457|NCT00742222|Multi-society registry|multi-society registry
573458|NCT00742222|Breast cancer registry|breast cancer registry
573459|NCT00742209|migraine|migraine
573460|NCT00742209|prophylaxis|prophylaxis
573461|NCT00742209|prevention|prevention
573462|NCT00742196|Parapapillary atrophy|parapapillary atrophy
573463|NCT00742196|Retinal nerve fiber layer thickness|retinal nerve fiber layer thickness
573464|NCT00742196|Glaucoma|glaucoma
573465|NCT00742196|Cirrus OCT|cirrus oct
573466|NCT00742170|opioid dependence|opioid dependence
573467|NCT00742170|opioid detoxification|opioid detoxification
573468|NCT00742170|electroacupuncture|electroacupuncture
573469|NCT00742170|adjunctive treatment|adjunctive treatment
573470|NCT00742170|alternative/complementary medicine|alternative/complementary medicine
573471|NCT00742157|Growth Hormone|growth hormone
573472|NCT00742157|TPN|tpn
573473|NCT00742157|Total Parenteral Nutrition|total parenteral nutrition
573474|NCT00742157|Glutamine|glutamine
573475|NCT00742157|Short Bowel Syndrome|short bowel syndrome
573476|NCT00742157|Increase in absorption of small bowel.|increase in absorption of small bowel.
573477|NCT00742144|CD20 positive|cd20 positive
573478|NCT00742144|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
573479|NCT00742144|Follicular lymphoma|follicular lymphoma
573480|NCT00742144|GSK1841157|gsk1841157
573481|NCT00742144|Japanese patient|japanese patient
573482|NCT00742144|Ofatumumab|ofatumumab
573483|NCT00742131|MET inhibitor|met inhibitor
573484|NCT00742131|c-Met|c-met
573485|NCT00742131|XL880|xl880
573486|NCT00742131|GSK1363089|gsk1363089
573487|NCT00742131|Solid Tumors|solid tumors
573488|NCT00742105|PI3K|pi3k
573489|NCT00742105|mTOR|mtor
573490|NCT00742105|Advanced solid tumor|advanced solid tumor
573491|NCT00742105|Adult|adult
573492|NCT00742079|Paranoid Schizophrenia|paranoid schizophrenia
573493|NCT00742079|Paranoid Delusions|paranoid delusions
573494|NCT00742079|CBT|cbt
573495|NCT00742079|D-Cycloserine|d-cycloserine
573496|NCT00742066|Hypertension|hypertension
573497|NCT00742066|Insulin resistance|insulin resistance
573498|NCT00742066|Microcirculation|microcirculation
573499|NCT00742066|Angiotensin II receptor blocker|angiotensin ii receptor blocker
573500|NCT00742053|ECG PICC|ecg picc
573501|NCT00742053|Patients undergoing PICC placement|patients undergoing picc placement
573502|NCT00742040|up-titration|up-titration
573503|NCT00742040|captopril|captopril
573504|NCT00742040|pediatric|pediatric
573505|NCT00742040|cardiac patients|cardiac patients
573506|NCT00742027|Classical Hodgkin Lymphoma|classical hodgkin lymphoma
573507|NCT00742027|Classical Hodgkin's Lymphoma|classical hodgkin's lymphoma
573508|NCT00742027|Hodgkin Lymphoma|hodgkin lymphoma
573509|NCT00742027|Hodgkin's Lymphoma|hodgkin's lymphoma
573510|NCT00742027|Nodular sclerosing|nodular sclerosing
573511|NCT00742027|Mixed-cellularity|mixed-cellularity
573512|NCT00742027|Lymphocyte-rich|lymphocyte-rich
573513|NCT00742027|Lymphocyte depleted|lymphocyte depleted
573514|NCT00742027|HL|hl
573515|NCT00742027|Classical HL|classical hl
573516|NCT00742027|Refractory Hodgkin's Lymphoma|refractory hodgkin's lymphoma
573517|NCT00742027|Refractory Hodgkin Lymphoma|refractory hodgkin lymphoma
573518|NCT00742027|Refractory HL|refractory hl
573519|NCT00742014|Pulmonary arterial hypertension|pulmonary arterial hypertension
573520|NCT00742014|Pediatrics|pediatrics
573521|NCT00742014|Sildenafil|sildenafil
573522|NCT00742014|Catheterization|catheterization
573523|NCT00742014|Right ventricular contractility|right ventricular contractility
573524|NCT00742001|red blood cells|red blood cells
573525|NCT00742001|transfusion|transfusion
573526|NCT00742001|recovery|recovery
573527|NCT00742001|feasibility|feasibility
573528|NCT00742001|white blood cell inactivation|white blood cell inactivation
573529|NCT00741988|Non-Small Cell Lung Cancer|non-small cell lung cancer
573530|NCT00741988|Advanced Disease|advanced disease
573531|NCT00741988|Untreated|untreated
573532|NCT00741988|Ixabepilone|ixabepilone
573533|NCT00741988|Carboplatin|carboplatin
573534|NCT00741988|Bevacizumab|bevacizumab
573535|NCT00741975|HIV prevention|hiv prevention
573536|NCT00741949|Respiratory failure|respiratory failure
573537|NCT00741949|Target Controlled Infusion|target controlled infusion
573538|NCT00741949|TCI|tci
573539|NCT00741949|Propofol|propofol
573540|NCT00741949|Noninvasive ventilation|noninvasive ventilation
573541|NCT00741949|Broncho-alveolar lavage|broncho-alveolar lavage
573542|NCT00741936|Functional Constipation|functional constipation
573749|NCT00741260|Neratinib|neratinib
573543|NCT00741936|Chinese Herbal Medicine|chinese herbal medicine
573544|NCT00741936|MaZiRenWan|mazirenwan
573545|NCT00741936|Hemp Seed Pill|hemp seed pill
573546|NCT00741936|Traditional Chinese Medicine|traditional chinese medicine
573547|NCT00741936|Herbal Medicine|herbal medicine
573548|NCT00741923|beans|beans
573549|NCT00741923|pulses|pulses
573550|NCT00741923|satiety|satiety
573551|NCT00741923|appetite|appetite
573552|NCT00741923|obesity|obesity
573553|NCT00741923|overweight|overweight
573554|NCT00741923|diabetes|diabetes
573555|NCT00741923|metabolic syndrome|metabolic syndrome
573556|NCT00741923|hypertension|hypertension
573557|NCT00741923|blood glucose|blood glucose
573558|NCT00741923|insulin|insulin
573559|NCT00741923|cholesterol|cholesterol
573560|NCT00741923|HDL|hdl
573561|NCT00741923|LDL|ldl
573562|NCT00741923|leptin|leptin
573563|NCT00741923|GLP-1|glp-1
573564|NCT00741923|adiponectin|adiponectin
573565|NCT00741923|Peptide YY|peptide yy
573566|NCT00741923|diet|diet
573567|NCT00741910|Crohn's Disease|crohn's disease
573568|NCT00741910|TNF-alpha inhibitor|tnf-alpha inhibitor
573569|NCT00741910|MAP Kinase inhibitor|map kinase inhibitor
573570|NCT00741910|CNI-1493|cni-1493
573571|NCT00741871|Lymphoid malignancies|lymphoid malignancies
573572|NCT00741871|Hodgkin's Lymphoma|hodgkin's lymphoma
573573|NCT00741871|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
573574|NCT00741858|Chiari malformation;|chiari malformation;
573575|NCT00741858|Duraplasty;|duraplasty;
573576|NCT00741858|Posterior fossa decompression;|posterior fossa decompression;
573577|NCT00741858|Duragen;|duragen;
573578|NCT00741858|Duraguard|duraguard
573579|NCT00741832|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
573580|NCT00741832|dynamic hyperinflation|dynamic hyperinflation
573581|NCT00741832|dyspnea|dyspnea
573582|NCT00741832|recovery|recovery
573583|NCT00741832|positive expiratory pressure|positive expiratory pressure
573584|NCT00741832|exercise|exercise
573585|NCT00741819|pulmonary arterial hypertension|pulmonary arterial hypertension
573586|NCT00741819|PAH|pah
573587|NCT00741819|treprostinil sodium|treprostinil sodium
573588|NCT00741819|inhalation|inhalation
573589|NCT00741819|ventavis|ventavis
573590|NCT00741819|iloprost|iloprost
573591|NCT00741806|vaccination|vaccination
573592|NCT00741806|avian|avian
573593|NCT00741793|Rheumatoid arthritis; psoriatic arthritis; axial spondyloarthritis|rheumatoid arthritis; psoriatic arthritis; axial spondyloarthritis
573594|NCT00741793|Remicade®|remicade®
573595|NCT00741793|Simponi®|simponi®
573596|NCT00741793|Simponi® I.V|simponi® i.v
573597|NCT00741793|Stelara®|stelara®
573598|NCT00741793|Registry|registry
573599|NCT00741793|BioTRAC|biotrac
573600|NCT00741767|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
573601|NCT00741767|COPD|copd
573602|NCT00741767|Sleep|sleep
573603|NCT00741767|Sleep quality|sleep quality
573604|NCT00741767|Lung hyperinflation|lung hyperinflation
573605|NCT00741754|salivary flow|salivary flow
573606|NCT00741754|oral neoplasm|oral neoplasm
573607|NCT00741754|calcium hydroxide|calcium hydroxide
573608|NCT00741754|sodium dodecylsulphate|sodium dodecylsulphate
573609|NCT00741754|radiotherapy.|radiotherapy.
573610|NCT00741741|TMC278-C150|tmc278-c150
573611|NCT00741741|TMC278-TiDP15-C150|tmc278-tidp15-c150
573612|NCT00741741|HIV-1 infected patients|hiv-1 infected patients
573613|NCT00741741|Intramuscular or subcutaneous injection|intramuscular or subcutaneous injection
573614|NCT00741741|Nanosuspension|nanosuspension
573615|NCT00741741|Therapy|therapy
573616|NCT00741741|Prevention|prevention
573617|NCT00741741|Healthy volunteers|healthy volunteers
573618|NCT00741741|HIV Infections|hiv infections
573619|NCT00741728|epidemiology|epidemiology
573620|NCT00741728|risk factors|risk factors
573621|NCT00741728|heart rate|heart rate
573622|NCT00741728|baroreflex sensitivity|baroreflex sensitivity
573623|NCT00741728|sudden death|sudden death
573624|NCT00741715|primary hypercholesterolemia|primary hypercholesterolemia
573625|NCT00741702|Hypertension|hypertension
573626|NCT00741702|Type 2 diabetes|type 2 diabetes
573627|NCT00741702|First Nations populations|first nations populations
573628|NCT00741689|Japanese|japanese
573629|NCT00741689|healthy|healthy
573630|NCT00741689|volunteers|volunteers
573631|NCT00741663|cirrhosis|cirrhosis
573632|NCT00741663|ascites|ascites
573633|NCT00741663|diuretic therapy|diuretic therapy
573634|NCT00741663|potassium canrenoate|potassium canrenoate
573635|NCT00741663|furosemide|furosemide
573636|NCT00741663|hyperkalemia|hyperkalemia
573637|NCT00741663|plasma renin activity|plasma renin activity
573638|NCT00741663|nitric oxide|nitric oxide
573639|NCT00741663|serum sodium concentration|serum sodium concentration
573640|NCT00741663|refractory ascites|refractory ascites
573641|NCT00741663|Nonazotemic patients with cirrhosis and moderate ascites|nonazotemic patients with cirrhosis and moderate ascites
573642|NCT00741650|Musculoskeletal pain|musculoskeletal pain
573643|NCT00741650|Brief cognitive intervention|brief cognitive intervention
573644|NCT00741650|Cognitive behavior therapy|cognitive behavior therapy
573750|NCT00741260|HKI-272|hki-272
573645|NCT00741650|Intervention Study|intervention study
573646|NCT00741650|Health prevention|health prevention
573647|NCT00741650|workplace intervention|workplace intervention
573648|NCT00741637|Vibrio Cholerae|vibrio cholerae
573649|NCT00741637|Diarrhea|diarrhea
573650|NCT00741637|Live oral Vaccines|live oral vaccines
573651|NCT00741637|Immunogenicity|immunogenicity
573652|NCT00741637|Safety|safety
573653|NCT00741637|HIV|hiv
573654|NCT00741624|refractive surgery|refractive surgery
573655|NCT00741585|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
573656|NCT00741585|Chronotherapy|chronotherapy
573657|NCT00741585|Circadian|circadian
573658|NCT00741585|Non-dipper|non-dipper
573659|NCT00741585|Type 2 diabetes|type 2 diabetes
573660|NCT00741585|Resistant hypertension|resistant hypertension
573661|NCT00741585|Total mortality|total mortality
573662|NCT00741572|sarcoidosis|sarcoidosis
573663|NCT00741572|fibrosis|fibrosis
573664|NCT00741572|oxidative stress|oxidative stress
573665|NCT00741572|inflammation|inflammation
573666|NCT00741572|triggers|triggers
573667|NCT00741572|individual sensitivity|individual sensitivity
573668|NCT00741559|epilepsy|epilepsy
573669|NCT00741559|pediatrics|pediatrics
573670|NCT00741559|magnetoencephalography|magnetoencephalography
573671|NCT00741559|electroencephalography|electroencephalography
573672|NCT00741559|positron emission tomography|positron emission tomography
573673|NCT00741546|Vitamin D|vitamin d
573674|NCT00741546|malnutrition|malnutrition
573675|NCT00741546|cardiac surgery|cardiac surgery
573676|NCT00741546|study|study
573677|NCT00741546|emphasize|emphasize
573678|NCT00741546|importance|importance
573679|NCT00741546|significant|significant
573680|NCT00741546|high risk patient|high risk patient
573681|NCT00741520|Obstructive Sleep Apnea|obstructive sleep apnea
573682|NCT00741520|Blood Pressure|blood pressure
573683|NCT00741520|PreHypertension|prehypertension
573684|NCT00741520|Masked Hypertension|masked hypertension
573685|NCT00741507|Anesthetics|anesthetics
573686|NCT00741507|Sedatives|sedatives
573687|NCT00741507|Analgesics|analgesics
573688|NCT00741494|infertility|infertility
573689|NCT00741494|ICSI|icsi
573690|NCT00741494|hyaluronan binding|hyaluronan binding
573691|NCT00741494|sperm|sperm
573692|NCT00741494|sperm selection|sperm selection
573693|NCT00741494|male factor|male factor
573694|NCT00741494|hyaluronan|hyaluronan
573695|NCT00741494|sperm maturity|sperm maturity
573696|NCT00741494|clinical pregnancy rates|clinical pregnancy rates
573697|NCT00741494|hyaluronan binding assay|hyaluronan binding assay
573698|NCT00741494|HBA|hba
573699|NCT00741494|PICSI|picsi
573700|NCT00741481|metastatic colorectal cancer|metastatic colorectal cancer
573701|NCT00741481|fdg pet|fdg pet
573702|NCT00741481|response evaluation|response evaluation
573703|NCT00741468|Drug-drug interactions|drug-drug interactions
573704|NCT00741468|DDI|ddi
573705|NCT00741455|Non-myeloablative transplant|non-myeloablative transplant
573706|NCT00741455|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
573707|NCT00741455|Acute Myelogenous Leukemia|acute myelogenous leukemia
573708|NCT00741455|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
573709|NCT00741455|Multiple Myeloma|multiple myeloma
573710|NCT00741455|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
573711|NCT00741455|Myelodysplastic syndrome|myelodysplastic syndrome
573712|NCT00741455|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
573713|NCT00741455|Hodgkin's Disease|hodgkin's disease
573714|NCT00741416|Heart Disease|heart disease
573715|NCT00741416|Biorepository|biorepository
573716|NCT00741416|Biobank|biobank
573717|NCT00741403|Phase I|phase i
573718|NCT00741403|malignancies|malignancies
573719|NCT00741403|refractory|refractory
573720|NCT00741403|relapsed|relapsed
573721|NCT00741390|Diabetes|diabetes
573722|NCT00741390|Lancets|lancets
573723|NCT00741390|Pain|pain
573724|NCT00741377|Multiple myeloma|multiple myeloma
573725|NCT00741377|bone disease|bone disease
573726|NCT00741377|antibody|antibody
573727|NCT00741364|vitamin D|vitamin d
573728|NCT00741364|prostate cancer|prostate cancer
573729|NCT00741364|prostatectomy|prostatectomy
573730|NCT00741364|pathology|pathology
573731|NCT00741364|immunohistochemistry|immunohistochemistry
573732|NCT00741351|Anesthesia|anesthesia
573733|NCT00741351|Craniotomy|craniotomy
573734|NCT00741351|Neurosurgery|neurosurgery
573735|NCT00741338|MPS I, Mucopolysaccharidosis, Hurler syndrome|mps i, mucopolysaccharidosis, hurler syndrome
573736|NCT00741312|pregnancy|pregnancy
573737|NCT00741312|preeclampsia|preeclampsia
573738|NCT00741312|exercise|exercise
573739|NCT00741299|bipolar affective disorder, Smoking|bipolar affective disorder, smoking
573740|NCT00741286|Cerebral infarction|cerebral infarction
573741|NCT00741286|Cilostazol|cilostazol
573742|NCT00741286|Aspirin|aspirin
573743|NCT00741286|Transcranial Doppler|transcranial doppler
573744|NCT00741286|Pulsatile Index|pulsatile index
573745|NCT00741260|Solid Tumor|solid tumor
573746|NCT00741260|erbB2+ Breast Cancer|erbb2+ breast cancer
573747|NCT00741260|Prior trastuzumab|prior trastuzumab
573748|NCT00741260|Metastatic|metastatic
573751|NCT00741260|Nerlynx|nerlynx
573752|NCT00741260|HER2|her2
573753|NCT00741260|PB-272|pb-272
573754|NCT00741247|staging|staging
573755|NCT00741247|Endobronchial ultrasound|endobronchial ultrasound
573756|NCT00741247|Endoscopic ultrasound|endoscopic ultrasound
573757|NCT00741234|SB939|sb939
573758|NCT00741234|Myelodysplastic Syndrome|myelodysplastic syndrome
573759|NCT00741234|Combination with azacitidine|combination with azacitidine
573760|NCT00741234|Solid malignancies|solid malignancies
573761|NCT00741234|Hematologic malignancies|hematologic malignancies
573762|NCT00741234|HDAC inhibitor|hdac inhibitor
573763|NCT00741234|Refractory to standard therapy|refractory to standard therapy
573764|NCT00741221|Cancer|cancer
573765|NCT00741221|NSCLC|nsclc
573766|NCT00741221|Docetaxel|docetaxel
573767|NCT00741221|Bevacizumab|bevacizumab
573768|NCT00741208|asthma|asthma
573769|NCT00741208|soy isoflavone|soy isoflavone
573770|NCT00741208|genistein|genistein
573772|NCT00741195|Cancer|cancer
573773|NCT00741195|NSCLC|nsclc
573774|NCT00741195|Docetaxel|docetaxel
573775|NCT00741195|Bevacizumab|bevacizumab
573776|NCT00741182|Fracture|fracture
573777|NCT00741182|Osteoporosis|osteoporosis
573778|NCT00741182|Forsteo|forsteo
573779|NCT00741182|Teriparatide|teriparatide
573780|NCT00741182|Fracture healing|fracture healing
573781|NCT00741169|TMC435350-TiDP16-C105|tmc435350-tidp16-c105
573782|NCT00741169|TMC435350-C105|tmc435350-c105
573783|NCT00741169|Hepatitis C|hepatitis c
573784|NCT00741169|HCV|hcv
573785|NCT00741169|Rifampin|rifampin
573786|NCT00741156|pediatric|pediatric
573787|NCT00741156|hypertension|hypertension
573788|NCT00741156|congestive cardiomyopathy|congestive cardiomyopathy
573789|NCT00741156|angiotensin-converting enzyme inhibitor|angiotensin-converting enzyme inhibitor
573790|NCT00741156|cardiac catheterization|cardiac catheterization
573791|NCT00741143|Food Fortification|food fortification
573792|NCT00741143|Iron deficiency|iron deficiency
573793|NCT00741143|NaFeEdta|nafeedta
573794|NCT00741143|Iron deficiency anemia|iron deficiency anemia
573795|NCT00741143|Cognition|cognition
573796|NCT00741130|retinal nerve fiber layer|retinal nerve fiber layer
573797|NCT00741130|optic nerve head|optic nerve head
573798|NCT00741130|Cirrus OCT|cirrus oct
573799|NCT00741117|Pulse Oximetry|pulse oximetry
573800|NCT00741117|Blood Gas Analysis|blood gas analysis
573801|NCT00741117|Liver Disease|liver disease
573802|NCT00741117|Hyperbilirubinemia|hyperbilirubinemia
573803|NCT00741091|Cerebrovascular Disease|cerebrovascular disease
573804|NCT00741091|Carotid Stent|carotid stent
573805|NCT00741091|Stent|stent
573806|NCT00741091|Carotid Endarterectomy (CEA)|carotid endarterectomy (cea)
573807|NCT00741078|endothelial|endothelial
573808|NCT00741078|function|function
573809|NCT00741078|insulin|insulin
573810|NCT00741078|sensitivity|sensitivity
573811|NCT00741065|Coronary Artery Bypass Grafting|coronary artery bypass grafting
573812|NCT00741065|Myocardial Regeneration|myocardial regeneration
573813|NCT00741052|V. cholerae,|v. cholerae,
573814|NCT00741052|ciprofloxacin,|ciprofloxacin,
573815|NCT00741052|azithromycin,|azithromycin,
573816|NCT00741052|randomized|randomized
573817|NCT00741039|Breast|breast
573818|NCT00741039|Lung|lung
573819|NCT00741039|Prostate|prostate
573820|NCT00741039|Vaccine|vaccine
573821|NCT00741026|Insulin Resistance|insulin resistance
573822|NCT00741026|Diabetes mellitus|diabetes mellitus
573823|NCT00741026|Antipsychotic|antipsychotic
573824|NCT00741013|randomized|randomized
573825|NCT00741013|positron emission tomography|positron emission tomography
573826|NCT00741013|lung inflammation|lung inflammation
573827|NCT00741013|lovastatin|lovastatin
573828|NCT00741013|recombinant human activated protein C|recombinant human activated protein c
573829|NCT00741013|endotoxin|endotoxin
573830|NCT00741013|fluorodeoxyglucose|fluorodeoxyglucose
573831|NCT00740987|Mechanical device|mechanical device
573832|NCT00740987|Intermittent pneumatic compression|intermittent pneumatic compression
573833|NCT00740987|Venous thromboembolism prophylaxis|venous thromboembolism prophylaxis
573834|NCT00740987|Intensive care unit|intensive care unit
573835|NCT00740987|Hospitalization|hospitalization
573836|NCT00740987|Intensive|intensive
573837|NCT00740987|Care|care
573838|NCT00740987|Unit|unit
573839|NCT00740961|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
573840|NCT00740961|cognitive/functional effects|cognitive/functional effects
573841|NCT00740961|breast cancer|breast cancer
573842|NCT00740961|colon cancer|colon cancer
573843|NCT00740948|Sjogren's disease|sjogren's disease
573844|NCT00740948|Rituximab|rituximab
573845|NCT00740948|Treatment|treatment
573846|NCT00740948|anti CD20|anti cd20
573847|NCT00740935|prevention|prevention
573848|NCT00740935|rotavirus vaccine|rotavirus vaccine
573849|NCT00740935|gastroenteritis|gastroenteritis
573850|NCT00740935|systematic vaccination|systematic vaccination
573851|NCT00740935|infants|infants
573852|NCT00740935|aged 6 to 12 weeks|aged 6 to 12 weeks
573853|NCT00740922|Becaplermin gel|becaplermin gel
573854|NCT00740922|Target Ulcer|target ulcer
573953|NCT00740480|Staple|staple
573855|NCT00740922|Retrospective Studies|retrospective studies
573856|NCT00740922|Diabetic Foot|diabetic foot
573857|NCT00740922|Neoplasms|neoplasms
573858|NCT00740922|Long-Term Safety|long-term safety
573859|NCT00740922|Topical Administration|topical administration
573860|NCT00740909|Trich|trich
573861|NCT00740909|Hair Pulling|hair pulling
573862|NCT00740909|Cognitive Behavioral Therapy|cognitive behavioral therapy
573863|NCT00740909|Behavioral Therapy|behavioral therapy
573864|NCT00740896|Cigarette Smoking|cigarette smoking
573865|NCT00740896|Airway dendritic cells|airway dendritic cells
573866|NCT00740883|venous thromboembolism|venous thromboembolism
573867|NCT00740883|warfarin|warfarin
573868|NCT00740883|duration of anticoagulation|duration of anticoagulation
573869|NCT00740883|recurrent venous thromboembolism|recurrent venous thromboembolism
573870|NCT00740883|anticoagulant-related bleeding|anticoagulant-related bleeding
573871|NCT00740857|Dental pain analgesia|dental pain analgesia
573872|NCT00740844|Intermittent pneumatic compression|intermittent pneumatic compression
573873|NCT00740844|Hospitalization|hospitalization
573874|NCT00740844|Intensive care unit|intensive care unit
573875|NCT00740844|High bleeding risk|high bleeding risk
573876|NCT00740844|Venous thromboembolism prophylaxis|venous thromboembolism prophylaxis
573877|NCT00740831|Uterine Myomas|uterine myomas
573878|NCT00740779|prostatitis, chronic pelvic pain|prostatitis, chronic pelvic pain
573879|NCT00740766|Perinatal Outcomes|perinatal outcomes
573880|NCT00740766|Obesity|obesity
573881|NCT00740766|Pregnant women|pregnant women
573882|NCT00740753|liver tumor|liver tumor
573883|NCT00740753|cancer|cancer
573884|NCT00740753|hepatoma|hepatoma
573885|NCT00740753|yttrium|yttrium
573886|NCT00740740|Aneurysm|aneurysm
573887|NCT00740740|Rupture|rupture
573888|NCT00740727|Disaster|disaster
573889|NCT00740727|Mass casualty incident|mass casualty incident
573890|NCT00740727|Prehospital|prehospital
573891|NCT00740727|Rehydration|rehydration
573892|NCT00740727|Intravascular access|intravascular access
573893|NCT00740714|Parkinson disease|parkinson disease
573894|NCT00740714|PD|pd
573895|NCT00740714|Coenzyme Q10|coenzyme q10
573896|NCT00740714|CoQ|coq
573897|NCT00740701|TMS|tms
573898|NCT00740701|fMRI|fmri
573899|NCT00740701|verbal working memory|verbal working memory
573900|NCT00740701|classical conditioning|classical conditioning
573901|NCT00740701|eyeblink|eyeblink
573902|NCT00740701|classical eyeblink conditioning|classical eyeblink conditioning
573903|NCT00740701|Healthy subjects|healthy subjects
573904|NCT00740701|Memory|memory
573905|NCT00740675|adverse drug events|adverse drug events
573906|NCT00740675|outpatient|outpatient
573907|NCT00740662|morbid obesity|morbid obesity
573908|NCT00740662|small bowel|small bowel
573909|NCT00740662|gastric bypass|gastric bypass
573910|NCT00740662|weight loss|weight loss
573911|NCT00740636|TEMOZOLOMIDE|temozolomide
573912|NCT00740636|Lung|lung
573913|NCT00740623|Partial Onset Seizures|partial onset seizures
573914|NCT00740623|Simple Partial Seizures|simple partial seizures
573915|NCT00740623|Complex Partial Seizures|complex partial seizures
573916|NCT00740597|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
573917|NCT00740597|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
573918|NCT00740597|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
573919|NCT00740597|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
573920|NCT00740597|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
573921|NCT00740597|adult epithelioid sarcoma|adult epithelioid sarcoma
573922|NCT00740597|adult extraskeletal chondrosarcoma|adult extraskeletal chondrosarcoma
573923|NCT00740597|adult extraskeletal osteosarcoma|adult extraskeletal osteosarcoma
573924|NCT00740597|adult fibrosarcoma|adult fibrosarcoma
573925|NCT00740597|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
573926|NCT00740597|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
573927|NCT00740597|adult malignant mesenchymoma|adult malignant mesenchymoma
573928|NCT00740597|adult neurofibrosarcoma|adult neurofibrosarcoma
573929|NCT00740597|adult rhabdomyosarcoma|adult rhabdomyosarcoma
573930|NCT00740597|dermatofibrosarcoma protuberans|dermatofibrosarcoma protuberans
573931|NCT00740584|Prevention|prevention
573932|NCT00740571|neuralgia|neuralgia
573933|NCT00740571|off-label|off-label
573934|NCT00740571|cancer|cancer
573935|NCT00740558|HRV|hrv
573936|NCT00740558|Activator|activator
573937|NCT00740558|Chiropractic|chiropractic
573938|NCT00740558|VLF|vlf
573939|NCT00740558|HF|hf
573940|NCT00740558|LF|lf
573941|NCT00740558|LF/HF|lf/hf
573942|NCT00740532|EGFR, HER-2, HER-3, MET, KRAS|egfr, her-2, her-3, met, kras
573943|NCT00740506|Behavioral|behavioral
573944|NCT00740506|Environmental|environmental
573945|NCT00740506|Delivery|delivery
573946|NCT00740506|Pregnancy|pregnancy
573947|NCT00740493|recurrent venous thromboembolism|recurrent venous thromboembolism
573948|NCT00740493|idiopathic deep vein thrombosis|idiopathic deep vein thrombosis
573949|NCT00740493|optimal duration of anticoagulation|optimal duration of anticoagulation
573950|NCT00740480|Evaluation|evaluation
573951|NCT00740480|ENTact™|entact™
573952|NCT00740480|Septal|septal
573954|NCT00740480|System|system
573955|NCT00740480|tissue|tissue
573956|NCT00740480|approximation|approximation
573957|NCT00740480|during|during
573958|NCT00740480|septoplasties|septoplasties
573959|NCT00740467|graft versus host disease|graft versus host disease
573960|NCT00740467|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
573961|NCT00740467|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
573962|NCT00740467|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
573963|NCT00740467|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
573964|NCT00740467|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
573965|NCT00740467|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
573966|NCT00740467|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
573967|NCT00740467|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
573968|NCT00740467|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
573969|NCT00740467|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
573970|NCT00740467|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
573971|NCT00740467|refractory multiple myeloma|refractory multiple myeloma
573972|NCT00740467|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
573973|NCT00740467|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
573974|NCT00740467|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
573975|NCT00740467|anaplastic large cell lymphoma|anaplastic large cell lymphoma
573976|NCT00740467|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
573977|NCT00740467|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
573978|NCT00740467|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
573979|NCT00740467|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
573980|NCT00740467|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
573981|NCT00740467|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
573982|NCT00740467|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
573983|NCT00740467|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
573984|NCT00740467|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
573985|NCT00740467|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
573986|NCT00740467|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
573987|NCT00740467|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
573988|NCT00740467|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
573989|NCT00740467|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
573990|NCT00740467|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
573991|NCT00740467|recurrent grade I lymphomatoid granulomatosis|recurrent grade i lymphomatoid granulomatosis
573992|NCT00740467|recurrent grade II lymphomatoid granulomatosis|recurrent grade ii lymphomatoid granulomatosis
573993|NCT00740467|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
573994|NCT00740467|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
573995|NCT00740467|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
573996|NCT00740467|splenic marginal zone lymphoma|splenic marginal zone lymphoma
573997|NCT00740467|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
573998|NCT00740454|pregnancy|pregnancy
573999|NCT00740454|postpartum|postpartum
574000|NCT00740454|deep vein thrombosis|deep vein thrombosis
574001|NCT00740454|venous thromboembolism|venous thromboembolism
574002|NCT00740454|diagnosis|diagnosis
574003|NCT00740454|compression ultrasonography|compression ultrasonography
574004|NCT00740441|renal cell carcinoma|renal cell carcinoma
574005|NCT00740441|rcc|rcc
574006|NCT00740441|kidney cancer|kidney cancer
574007|NCT00740428|Pelvic floor,|pelvic floor,
574008|NCT00740428|muscular dysfunction,|muscular dysfunction,
574009|NCT00740428|urinary incontinence|urinary incontinence
574010|NCT00740415|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
574011|NCT00740415|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
574012|NCT00740415|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
574013|NCT00740415|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
574014|NCT00740389|TMC125-C187|tmc125-c187
574015|NCT00740389|TMC125-TiDP2-C187|tmc125-tidp2-c187
574016|NCT00740389|HIV|hiv
574017|NCT00740389|AIDS|aids
574018|NCT00740389|Fungal Infection|fungal infection
574019|NCT00740389|Pharmacokinetics|pharmacokinetics
574020|NCT00740376|osteoarthritis|osteoarthritis
574021|NCT00740363|renal transplantation|renal transplantation
574022|NCT00740363|diabetes|diabetes
574023|NCT00740363|glucose intolerance|glucose intolerance
574024|NCT00740363|impaired glucose tolerance|impaired glucose tolerance
574025|NCT00740337|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
574026|NCT00740337|COPD|copd
574027|NCT00740337|Emphysema|emphysema
574028|NCT00740337|Natural Killer T-cell|natural killer t-cell
574029|NCT00740337|Interleukin-13|interleukin-13
574030|NCT00740337|Innate Immune Signaling|innate immune signaling
574031|NCT00740324|During|during
574032|NCT00740324|Endoscopy|endoscopy
574033|NCT00740324|Gastric|gastric
574034|NCT00740324|Peristalsis|peristalsis
574035|NCT00740311|Prevention of the reduction of the alveolar crest|prevention of the reduction of the alveolar crest
574036|NCT00740298|infants|infants
574037|NCT00740298|undergoing|undergoing
574038|NCT00740298|vaccinations|vaccinations
574039|NCT00740285|scleroderma|scleroderma
574040|NCT00740285|scleroderma - limited or diffuse types|scleroderma - limited or diffuse types
574041|NCT00740285|lidocaine|lidocaine
574042|NCT00740285|effectiveness|effectiveness
574043|NCT00740272|brady-tachy syndrome|brady-tachy syndrome
574044|NCT00740272|AF ablation|af ablation
574045|NCT00740259|flunarizine|flunarizine
574046|NCT00740259|schizophrenia|schizophrenia
574047|NCT00740259|antipsychotic|antipsychotic
574048|NCT00740233|fibromyalgia|fibromyalgia
574049|NCT00740233|irritable bowel syndrome|irritable bowel syndrome
574050|NCT00740233|interstitial cystitis|interstitial cystitis
574051|NCT00740233|chronic fatigue syndrome|chronic fatigue syndrome
574052|NCT00740233|vulvodynia|vulvodynia
574053|NCT00740233|chronic stress|chronic stress
574054|NCT00740233|chronic pain|chronic pain
574055|NCT00740233|stress-related conditions|stress-related conditions
574056|NCT00740233|functional GI disorders|functional gi disorders
574057|NCT00740220|hypoxemia|hypoxemia
574058|NCT00740220|anoxia|anoxia
574059|NCT00740220|oxygen|oxygen
574060|NCT00740220|dyspnea|dyspnea
574061|NCT00740220|pulmonary disease|pulmonary disease
574062|NCT00740220|chronic obstructive|chronic obstructive
574063|NCT00740194|Physiology|physiology
574064|NCT00740194|males|males
574065|NCT00740181|myelodysplasia|myelodysplasia
574066|NCT00740181|refractory leukemia|refractory leukemia
574067|NCT00740181|acute leukemia|acute leukemia
574068|NCT00740168|bevacizumab|bevacizumab
574069|NCT00740168|cancer|cancer
574070|NCT00740155|Dengue virus|dengue virus
574071|NCT00740155|Dengue fever|dengue fever
574072|NCT00740155|Dengue hemorrhagic fever|dengue hemorrhagic fever
574073|NCT00740155|Dengue diseases|dengue diseases
574074|NCT00740142|L ornithine L aspartate|l ornithine l aspartate
574075|NCT00740142|Lactulose|lactulose
574076|NCT00740142|Hepatic encephalopathy|hepatic encephalopathy
574077|NCT00740142|LOLA|lola
574078|NCT00740129|Paget's Disease|paget's disease
574079|NCT00740129|Zoledronic acid|zoledronic acid
574080|NCT00740129|Reclast®/Aclasta®|reclast®/aclasta®
574081|NCT00740129|infusion|infusion
574082|NCT00740129|re-treatment|re-treatment
574083|NCT00740129|re-lapse|re-lapse
574084|NCT00740116|Tumor of ovary|tumor of ovary
574085|NCT00740116|Surgical blood loss|surgical blood loss
574086|NCT00740116|Postoperative blood loss|postoperative blood loss
574087|NCT00740116|Preventive therapy|preventive therapy
574088|NCT00740116|Thromboembolism|thromboembolism
574089|NCT00740103|Semapimod|semapimod
574090|NCT00740103|Crohn's Disease|crohn's disease
574091|NCT00740103|TNF-alpha inhibitor|tnf-alpha inhibitor
574092|NCT00740103|MAP Kinase inhibitor|map kinase inhibitor
574093|NCT00740103|CNI-1493|cni-1493
574094|NCT00740090|Malaria|malaria
574095|NCT00740090|Reactogenicity, Safety, Immunogenicity|reactogenicity, safety, immunogenicity
574096|NCT00740090|Maleria Endemic|maleria endemic
574097|NCT00740090|Plasmodium Falciparum|plasmodium falciparum
574098|NCT00740090|Dose Escalating|dose escalating
574099|NCT00740077|cranberry|cranberry
574100|NCT00740077|flavonoid|flavonoid
574101|NCT00740077|phenolic acid|phenolic acid
574102|NCT00740077|phytochemical|phytochemical
574103|NCT00740077|bioavailability|bioavailability
574104|NCT00740064|HIV infections|hiv infections
574105|NCT00740038|Stress Management|stress management
574106|NCT00740038|Quality of Life|quality of life
574107|NCT00740038|Exercise|exercise
574108|NCT00740038|Cancer|cancer
574109|NCT00740038|Chemotherapy|chemotherapy
574110|NCT00740025|QD dose|qd dose
574111|NCT00740025|BID dosing|bid dosing
574112|NCT00740025|peak estradiol|peak estradiol
574113|NCT00740025|oocytes|oocytes
574114|NCT00740025|implantation rate|implantation rate
574115|NCT00740025|pregnancy rate|pregnancy rate
574116|NCT00740012|Nocturnal glucose profiles|nocturnal glucose profiles
574117|NCT00740012|continuous glucose profiles|continuous glucose profiles
574118|NCT00739999|heterozygous familial hypercholesterolemia (HeFH); atorvastatin; pediatric|heterozygous familial hypercholesterolemia (hefh); atorvastatin; pediatric
574119|NCT00739986|Crohn's Disease|crohn's disease
574120|NCT00739986|TNF-alpha|tnf-alpha
574121|NCT00739986|IL-6|il-6
574122|NCT00739986|MAP Kinase|map kinase
574123|NCT00739986|CNI-1493|cni-1493
574124|NCT00739973|Hypertension, Aliskiren, Amlodipine|hypertension, aliskiren, amlodipine
574125|NCT00739947|Observational|observational
574126|NCT00739947|rotator cuff tear|rotator cuff tear
574127|NCT00739947|arthroscopic|arthroscopic
574128|NCT00739947|surgical|surgical
574129|NCT00739947|outcome study|outcome study
574130|NCT00739934|Open-Label|open-label
574131|NCT00739934|Pharmacokinetics|pharmacokinetics
574132|NCT00739934|Intravenous to oral switch|intravenous to oral switch
574133|NCT00739934|Safety|safety
574134|NCT00739934|Voriconazole|voriconazole
574135|NCT00739934|Immunocompromise|immunocompromise
574136|NCT00739934|Children|children
574137|NCT00739934|High Risk For Systemic Fungal Infection.|high risk for systemic fungal infection.
574138|NCT00739921|PCR Analysis|pcr analysis
574139|NCT00739921|Allergic fungal sinusitis|allergic fungal sinusitis
574140|NCT00739921|Chronic rhinosinusitis|chronic rhinosinusitis
574141|NCT00739921|Nasal Polyps|nasal polyps
574142|NCT00739908|MDD|mdd
574143|NCT00739895|athletes|athletes
574144|NCT00739882|Efalizumab,|efalizumab,
574145|NCT00739882|Chronic plaque psoriasis|chronic plaque psoriasis
574146|NCT00739882|moderate to severe|moderate to severe
574147|NCT00739882|involving|involving
574148|NCT00739882|hands|hands
574149|NCT00739882|feet|feet
574150|NCT00739869|Silent Infarcts|silent infarcts
574151|NCT00739869|Magnetic Resonance Imaging|magnetic resonance imaging
574152|NCT00739869|MRI|mri
574153|NCT00739869|Subclinical Cerebrovascular Disease|subclinical cerebrovascular disease
574154|NCT00739869|White Matter Grade Abnormalities|white matter grade abnormalities
574155|NCT00739869|Total Brain Volume|total brain volume
574156|NCT00739869|Ventricular and Hippocampal Volume|ventricular and hippocampal volume
574157|NCT00739869|Subclinical Vascular Abnormalities|subclinical vascular abnormalities
574158|NCT00739869|Cerebrovascular Disease|cerebrovascular disease
574159|NCT00739869|CVD|cvd
574160|NCT00739869|Subclinical CVD|subclinical cvd
574161|NCT00739856|posttraumatic stress disorder|posttraumatic stress disorder
574162|NCT00739856|electroconvulsive therapy|electroconvulsive therapy
574163|NCT00739856|medication refractoriness|medication refractoriness
574164|NCT00739843|Dementia,|dementia,
574165|NCT00739843|Cognitive Disorders,|cognitive disorders,
574166|NCT00739843|Hemodialysis|hemodialysis
574167|NCT00739791|adenocarcinoma of the prostate|adenocarcinoma of the prostate
574168|NCT00739791|stage I prostate cancer|stage i prostate cancer
574169|NCT00739791|stage IIB prostate cancer|stage iib prostate cancer
574170|NCT00739791|stage IIA prostate cancer|stage iia prostate cancer
574171|NCT00739765|Trauma|trauma
574172|NCT00739765|Psychotherapy|psychotherapy
574173|NCT00739765|Anxiety|anxiety
574174|NCT00739752|Attitude to Health|attitude to health
574175|NCT00739752|Communication|communication
574176|NCT00739752|Intervention Studies|intervention studies
574177|NCT00739752|Health Promotion|health promotion
574178|NCT00739752|Psychology, Medical|psychology, medical
574179|NCT00739752|Sexual Behavior|sexual behavior
574180|NCT00739752|Behavioral Research|behavioral research
574181|NCT00739752|Vaccination|vaccination
574182|NCT00739713|dry eye|dry eye
574183|NCT00739713|sea buckthorn|sea buckthorn
574184|NCT00739713|Hippophaë|hippophaë
574185|NCT00739700|hemodynamics|hemodynamics
574186|NCT00739700|blood pressure|blood pressure
574187|NCT00739700|blood pressure monitors|blood pressure monitors
574188|NCT00739687|Chronic Heart Failure|chronic heart failure
574189|NCT00739661|Systemic Hedgehog|systemic hedgehog
574190|NCT00739661|Hedgehog Pathway Inhibitor|hedgehog pathway inhibitor
574191|NCT00739648|COPD|copd
574192|NCT00739648|Patients|patients
574193|NCT00739622|TMC278-TiDP6-C136|tmc278-tidp6-c136
574194|NCT00739622|TMC278-C136|tmc278-c136
574195|NCT00739622|Healthy Volunteer|healthy volunteer
574196|NCT00739596|Hypertension|hypertension
574197|NCT00739596|African American|african american
574198|NCT00739596|aliskiren|aliskiren
574199|NCT00739596|hydrochlorothiazide|hydrochlorothiazide
574200|NCT00739596|systolic blood pressure|systolic blood pressure
574201|NCT00739596|diastolic blood pressure|diastolic blood pressure
574202|NCT00739596|amlodipine|amlodipine
574203|NCT00739596|stage 2|stage 2
574204|NCT00739583|Skin preparation|skin preparation
574205|NCT00739583|Skin marking|skin marking
574206|NCT00739583|site marking|site marking
574207|NCT00739583|Site identification|site identification
574208|NCT00739570|Activator|activator
574209|NCT00739570|EMG|emg
574210|NCT00739570|Thermography|thermography
574211|NCT00739570|Diagnostic|diagnostic
574212|NCT00739570|X-Rays|x-rays
574213|NCT00739557|elective TAAA repair|elective taaa repair
574214|NCT00739544|Reference Values|reference values
574215|NCT00739544|Sensory Thresholds|sensory thresholds
574216|NCT00739544|Pain Threshold|pain threshold
574217|NCT00739544|Breast Neoplasms|breast neoplasms
574218|NCT00739531|Asthma|asthma
574219|NCT00739531|nitric oxide|nitric oxide
574220|NCT00739531|eNO|eno
574221|NCT00739531|FENO|feno
574222|NCT00739531|Apieron INSIGHT|apieron insight
574223|NCT00739531|Aerocrine NIOX|aerocrine niox
574224|NCT00739518|Neurological|neurological
574225|NCT00739518|MRI|mri
574226|NCT00739505|Hypophosphatasia|hypophosphatasia
574227|NCT00739505|Bone Disease|bone disease
574228|NCT00739505|Soft Bones|soft bones
574229|NCT00739505|Low Alkaline Phosphatase|low alkaline phosphatase
574230|NCT00739505|genetic metabolic disorder|genetic metabolic disorder
574231|NCT00739505|alkaline phosphatase|alkaline phosphatase
574327|NCT00739219|eNO|eno
574328|NCT00739219|FENO|feno
574232|NCT00739505|tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
574233|NCT00739505|rickets|rickets
574234|NCT00739505|osteomalacia|osteomalacia
574235|NCT00739492|weight loss, obesity, financial incentives|weight loss, obesity, financial incentives
574236|NCT00739479|Metabolic Syndrome|metabolic syndrome
574237|NCT00739479|METS|mets
574238|NCT00739479|Obesity|obesity
574239|NCT00739479|Partially Hydrolyzed Whey Protein|partially hydrolyzed whey protein
574240|NCT00739479|Partially Hydrolyzed Gelatin|partially hydrolyzed gelatin
574241|NCT00739479|PHWP|phwp
574242|NCT00739479|PHG|phg
574243|NCT00739479|Weight Loss|weight loss
574244|NCT00739466|Liposomal Alendronate|liposomal alendronate
574245|NCT00739466|Percutaneous coronary intervention|percutaneous coronary intervention
574246|NCT00739466|Coronary stenting|coronary stenting
574247|NCT00739466|de novo stenotic lesions|de novo stenotic lesions
574248|NCT00739466|Native coronary arteries|native coronary arteries
574249|NCT00739466|Restenosis|restenosis
574250|NCT00739466|Bare metal stent|bare metal stent
574251|NCT00739466|Presillion CoCr coronary stent|presillion cocr coronary stent
574252|NCT00739453|Advanced cancer|advanced cancer
574253|NCT00739453|Non-small cell lung cancer|non-small cell lung cancer
574254|NCT00739453|Pancreatic cancer|pancreatic cancer
574255|NCT00739453|Colorectal cancer|colorectal cancer
574256|NCT00739453|Prostate cancer|prostate cancer
574257|NCT00739414|Histone Deacetylases|histone deacetylases
574258|NCT00739414|HDAC inhibitor|hdac inhibitor
574259|NCT00739414|LBH589|lbh589
574260|NCT00739414|Advanced solid tumor|advanced solid tumor
574261|NCT00739414|Adult|adult
574263|NCT00739401|Aneurysm|aneurysm
574264|NCT00739401|Suprarenal|suprarenal
574265|NCT00739401|Proximal|proximal
574266|NCT00739401|Cuff|cuff
574267|NCT00739401|Extension|extension
574268|NCT00739401|Endograft|endograft
574269|NCT00739401|Endovascular repair|endovascular repair
574270|NCT00739401|EVAR|evar
574271|NCT00739401|Endoleak|endoleak
574272|NCT00739401|Type I|type i
574273|NCT00739388|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
574274|NCT00739388|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
574275|NCT00739388|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
574276|NCT00739388|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
574277|NCT00739388|secondary acute myeloid leukemia|secondary acute myeloid leukemia
574278|NCT00739388|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
574279|NCT00739388|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
574280|NCT00739388|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
574281|NCT00739388|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
574282|NCT00739388|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
574283|NCT00739388|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
574284|NCT00739388|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
574285|NCT00739388|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
574286|NCT00739388|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
574287|NCT00739375|Influence|influence
574288|NCT00739375|of av access|of av access
574289|NCT00739375|flow|flow
574290|NCT00739375|development|development
574291|NCT00739362|Behavioral Weight Loss Treatment|behavioral weight loss treatment
574292|NCT00739362|Obesity|obesity
574293|NCT00739362|Appetite Control|appetite control
574294|NCT00739362|Weight Loss|weight loss
574295|NCT00739362|Transcranial Direct Current Stimulation (TDCS)|transcranial direct current stimulation (tdcs)
574296|NCT00739349|Dry Eye|dry eye
574297|NCT00739349|Cyclosporine|cyclosporine
574298|NCT00739336|diabetes mellitus|diabetes mellitus
574299|NCT00739336|obesity|obesity
574300|NCT00739336|prevention|prevention
574301|NCT00739310|High Frequency Chest Wall Oscillation|high frequency chest wall oscillation
574302|NCT00739310|Cerebral Palsy|cerebral palsy
574303|NCT00739310|Restrictive lung disease|restrictive lung disease
574304|NCT00739297|Chronic asthma|chronic asthma
574305|NCT00739284|preferred|preferred
574306|NCT00739284|procedure|procedure
574307|NCT00739284|drainage|drainage
574308|NCT00739284|obstructed|obstructed
574309|NCT00739284|kidney|kidney
574310|NCT00739284|stone|stone
574311|NCT00739258|HIV-infected person|hiv-infected person
574312|NCT00739258|Entamoeba|entamoeba
574313|NCT00739258|Cryptosporidium|cryptosporidium
574314|NCT00739258|Giardia|giardia
574315|NCT00739258|ELISA|elisa
574316|NCT00739258|PCR|pcr
574317|NCT00739258|IDU|idu
574318|NCT00739258|Gonorrhea|gonorrhea
574319|NCT00739258|Chlamydial trachomatis|chlamydial trachomatis
574320|NCT00739258|Syphilis|syphilis
574321|NCT00739258|Genital warts|genital warts
574322|NCT00739258|Herpes simplex virus|herpes simplex virus
574323|NCT00739232|Safety and tolerability of HSD-016|safety and tolerability of hsd-016
574324|NCT00739219|Asthma|asthma
574325|NCT00739219|inflammation|inflammation
574326|NCT00739219|nitric oxide|nitric oxide
574329|NCT00739206|uncomplicated|uncomplicated
574330|NCT00739206|severe|severe
574331|NCT00739206|treatment|treatment
574332|NCT00739206|Plasmodium Falciparum|plasmodium falciparum
574333|NCT00739193|Blood Pressure|blood pressure
574334|NCT00739180|Childhood obesity|childhood obesity
574335|NCT00739180|Abdominal obesity|abdominal obesity
574336|NCT00739180|Visceral fat|visceral fat
574337|NCT00739180|Insulin resistance|insulin resistance
574338|NCT00739180|Liver fat|liver fat
574339|NCT00739180|Skeletal muscle lipid|skeletal muscle lipid
574340|NCT00739180|Fitness|fitness
574341|NCT00739167|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
574342|NCT00739167|advanced adult primary liver cancer|advanced adult primary liver cancer
574343|NCT00739167|liver metastases|liver metastases
574344|NCT00739167|recurrent adult primary liver cancer|recurrent adult primary liver cancer
574345|NCT00739154|glaucoma|glaucoma
574346|NCT00739154|Phenytoin|phenytoin
574347|NCT00739154|retinal nerve fiber layer|retinal nerve fiber layer
574348|NCT00739154|corrected pattern standard deviation|corrected pattern standard deviation
574349|NCT00739154|visual acuity|visual acuity
574350|NCT00739154|optic disc cupping|optic disc cupping
574351|NCT00739141|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
574352|NCT00739141|CYCLOSPORINE A|cyclosporine a
574353|NCT00739141|FLUDARABINE|fludarabine
574354|NCT00739141|G-CSF|g-csf
574355|NCT00739141|MYCOPHENOLATE MOFETIL (MMF)|mycophenolate mofetil (mmf)
574356|NCT00739141|THI0TEPA|thi0tepa
574357|NCT00739141|UMBILICAL CORD BLOOD (UCB)|umbilical cord blood (ucb)
574358|NCT00739141|08-087|08-087
574359|NCT00739128|celiac disease|celiac disease
574360|NCT00739128|hepatitis B vaccine|hepatitis b vaccine
574361|NCT00739115|Respiratory|respiratory
574362|NCT00739115|Distress|distress
574363|NCT00739115|Prematurity|prematurity
574364|NCT00739115|Heliox|heliox
574365|NCT00739115|CPAP|cpap
574366|NCT00739102|Superficial Femoral Artery|superficial femoral artery
574367|NCT00739102|Nitinol Self-Expandable Stent System|nitinol self-expandable stent system
574368|NCT00739089|hemodynamics|hemodynamics
574369|NCT00739089|oxygen|oxygen
574370|NCT00739089|renal dialysis|renal dialysis
574371|NCT00739089|shock|shock
574372|NCT00739089|sepsis|sepsis
574373|NCT00739089|hypotension|hypotension
574374|NCT00739089|lactic acidosis|lactic acidosis
574375|NCT00739063|Breast cancer|breast cancer
574376|NCT00739063|Carcinoma of the breast|carcinoma of the breast
574377|NCT00739063|Stage IV|stage iv
574378|NCT00739063|Triple receptor-negative|triple receptor-negative
574379|NCT00739063|Triple receptor-negative breast cancer|triple receptor-negative breast cancer
574380|NCT00739063|Metastatic triple receptor-negative breast cancer|metastatic triple receptor-negative breast cancer
574381|NCT00739063|Epidermal growth factor receptor|epidermal growth factor receptor
574382|NCT00739063|EGFR|egfr
574383|NCT00739063|EGFR-overexpressing|egfr-overexpressing
574384|NCT00739063|GFR inhibitor erlotinib|gfr inhibitor erlotinib
574385|NCT00739063|Erlotinib hydrochloride|erlotinib hydrochloride
574386|NCT00739063|Erlotinib|erlotinib
574387|NCT00739063|Tarceva|tarceva
574388|NCT00739063|OSI-774|osi-774
574389|NCT00739024|Migraine|migraine
574390|NCT00739024|Headache|headache
574391|NCT00738998|Breast Cancer|breast cancer
574392|NCT00738998|Aromatase Inhibitors|aromatase inhibitors
574393|NCT00738998|Symptom Assessment|symptom assessment
574394|NCT00738998|Questionnaire|questionnaire
574395|NCT00738998|Survey|survey
574396|NCT00738998|Phone Call|phone call
574397|NCT00738998|Arimidex|arimidex
574398|NCT00738998|Anastrozole|anastrozole
574399|NCT00738959|AZD0328|azd0328
574400|NCT00738959|Japanese|japanese
574401|NCT00738959|Caucasian|caucasian
574402|NCT00738959|pharmacokinetics|pharmacokinetics
574403|NCT00738959|safety|safety
574404|NCT00738959|tolerability|tolerability
574405|NCT00738946|Intermittent Preventive treatment|intermittent preventive treatment
574406|NCT00738946|insecticide treated bednets|insecticide treated bednets
574407|NCT00738946|malaria|malaria
574408|NCT00738933|Atherosclerosis|atherosclerosis
574409|NCT00738933|Plant sterols|plant sterols
574410|NCT00738933|Plant stanols|plant stanols
574411|NCT00738933|Aortic valve|aortic valve
574412|NCT00738907|Type 1 diabetes|type 1 diabetes
574413|NCT00738894|cryptogenic|cryptogenic
574414|NCT00738894|stroke|stroke
574415|NCT00738894|transient ischemic attack|transient ischemic attack
574416|NCT00738894|TIA|tia
574417|NCT00738894|PFO|pfo
574418|NCT00738894|Patent foramen ovale|patent foramen ovale
574419|NCT00738894|HELEX|helex
574420|NCT00738894|Septal Occluder|septal occluder
574421|NCT00738894|PFO Occluder|pfo occluder
574422|NCT00738868|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
574423|NCT00738868|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
574424|NCT00738868|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
574425|NCT00738868|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
574426|NCT00738868|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
574427|NCT00738868|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
574428|NCT00738868|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
574429|NCT00738868|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
574430|NCT00738868|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
574431|NCT00738868|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
574432|NCT00738868|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
574433|NCT00738868|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
574434|NCT00738868|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
574435|NCT00738868|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
574436|NCT00738868|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
574437|NCT00738868|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
574438|NCT00738868|recurrent salivary gland cancer|recurrent salivary gland cancer
574439|NCT00738868|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
574440|NCT00738868|stage III salivary gland cancer|stage iii salivary gland cancer
574441|NCT00738855|Adhesions|adhesions
574442|NCT00738855|Oral contrast|oral contrast
574443|NCT00738855|Exploration|exploration
574444|NCT00738842|Uric|uric
574445|NCT00738842|Acid|acid
574446|NCT00738842|Level|level
574447|NCT00738829|CLL|cll
574448|NCT00738829|untreated|untreated
574449|NCT00738829|immune therapy|immune therapy
574450|NCT00738829|dose escalation|dose escalation
574451|NCT00738829|maximum tolerated dose|maximum tolerated dose
574452|NCT00738829|maintenance therapy|maintenance therapy
574453|NCT00738829|Lenalidomide|lenalidomide
574454|NCT00738829|Rituximab|rituximab
574455|NCT00738829|Fludarabine|fludarabine
574456|NCT00738816|Medication review|medication review
574457|NCT00738816|Patient|patient
574458|NCT00738816|Safety|safety
574459|NCT00738816|Drug|drug
574460|NCT00738816|Prescriptions|prescriptions
574461|NCT00738816|Drug-use|drug-use
574462|NCT00738803|leg length|leg length
574463|NCT00738803|hip arthroplasty|hip arthroplasty
574464|NCT00738803|offset|offset
574465|NCT00738790|rectal cancer|rectal cancer
574466|NCT00738790|preoperative radiotherapy and local excision|preoperative radiotherapy and local excision
574467|NCT00738777|pre-operative|pre-operative
574468|NCT00738777|endocrine treatment|endocrine treatment
574469|NCT00738777|drug resistance|drug resistance
574470|NCT00738764|cancer|cancer
574471|NCT00738764|antibody|antibody
574472|NCT00738764|Phase 1 Clinical Trial|phase 1 clinical trial
574473|NCT00738751|NSCLC|nsclc
574474|NCT00738751|Metastatic|metastatic
574475|NCT00738751|erlotinib|erlotinib
574476|NCT00738751|aerodigestive tract cancers|aerodigestive tract cancers
574477|NCT00738751|non-small cell lung cancer|non-small cell lung cancer
574478|NCT00738751|H&N cancer|h&n cancer
574479|NCT00738738|Generalized Anxiety Disorder Elderly|generalized anxiety disorder elderly
574480|NCT00738725|High risk plaque|high risk plaque
574481|NCT00738725|High-risk plaque|high-risk plaque
574482|NCT00738725|Vulnerable plaque|vulnerable plaque
574483|NCT00738725|Atherosclerotic Disease|atherosclerotic disease
574484|NCT00738725|Heart Disease|heart disease
574485|NCT00738725|Stroke|stroke
574486|NCT00738712|Vascular MRI|vascular mri
574487|NCT00738712|Abdominal MRI|abdominal mri
574488|NCT00738712|Pelvic MRI|pelvic mri
574489|NCT00738712|Breast MRI|breast mri
574490|NCT00738712|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
574491|NCT00738699|ovarian cancer|ovarian cancer
574492|NCT00738699|relapsed ovarian cancer|relapsed ovarian cancer
574493|NCT00738699|refractory ovarian cancer|refractory ovarian cancer
574494|NCT00738686|coronary artery disease|coronary artery disease
574495|NCT00738686|drug-eluting stent|drug-eluting stent
574496|NCT00738686|percutaneous coronary intervention|percutaneous coronary intervention
574497|NCT00738686|major adverse cardiac event|major adverse cardiac event
574498|NCT00738686|in-stent restenosis|in-stent restenosis
574499|NCT00738686|stent thrombosis|stent thrombosis
574500|NCT00738673|Hormone refractory prostate cancer|hormone refractory prostate cancer
574501|NCT00738673|Agonist treatment failure|agonist treatment failure
574502|NCT00738660|type1 DM|type1 dm
574503|NCT00738660|microalbuminuria|microalbuminuria
574504|NCT00738660|nephropathy|nephropathy
574505|NCT00738660|albumin excretion rate|albumin excretion rate
574506|NCT00738660|dual blockade|dual blockade
574507|NCT00738660|ACEI|acei
574508|NCT00738660|ARB|arb
574509|NCT00738647|Filling materials|filling materials
574510|NCT00738647|Restorative materials|restorative materials
574511|NCT00738647|clinical trial|clinical trial
574512|NCT00738647|Resin based composite|resin based composite
574513|NCT00738634|Depression|depression
574514|NCT00738634|Motor Activity|motor activity
574515|NCT00738634|Adolescent|adolescent
574516|NCT00738621|PONV|ponv
574517|NCT00738621|breast surgery|breast surgery
574518|NCT00738621|prevention|prevention
574519|NCT00738621|antiemetics|antiemetics
574520|NCT00738608|morphine|morphine
574521|NCT00738608|consumption|consumption
574522|NCT00738608|postoperative|postoperative
574523|NCT00738608|pain|pain
574524|NCT00738608|Pain during 24h postoperative|pain during 24h postoperative
574525|NCT00738608|Morphine consumption in 24h postoperative|morphine consumption in 24h postoperative
574526|NCT00738595|Smoking Cessation|smoking cessation
574527|NCT00738569|Chronic inflammation|chronic inflammation
574528|NCT00738569|memory cells|memory cells
574529|NCT00738569|activated t-lymphocytes|activated t-lymphocytes
574530|NCT00738543|Antiseptics|antiseptics
574531|NCT00738543|Administration, cutaneous|administration, cutaneous
574532|NCT00738543|Iodophors|iodophors
574533|NCT00738543|Chlorine compounds|chlorine compounds
574534|NCT00738543|Anti-infecting agents, local|anti-infecting agents, local
574535|NCT00738517|heart failure|heart failure
574536|NCT00738517|coronary heart disease|coronary heart disease
574537|NCT00738517|autoantibodies|autoantibodies
574538|NCT00738517|immunoadsorption|immunoadsorption
574539|NCT00738517|immunoglobulin substitution|immunoglobulin substitution
574540|NCT00738504|Intensive insulin therapy|intensive insulin therapy
574541|NCT00738504|Carbohydrate restrictive strategy|carbohydrate restrictive strategy
574542|NCT00738504|RIFLE Criteria|rifle criteria
574543|NCT00738504|Acute Kidney Injury|acute kidney injury
574544|NCT00738504|Critically ill patients|critically ill patients
574545|NCT00738504|Acute|acute
574546|NCT00738491|Angina pectoris|angina pectoris
574547|NCT00738491|Exercise capacity|exercise capacity
574548|NCT00738491|Myocardial ischaemia|myocardial ischaemia
574549|NCT00738491|Air pollution|air pollution
574550|NCT00738478|distal gastrectomy|distal gastrectomy
574551|NCT00738478|quality of life|quality of life
574552|NCT00738452|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
574553|NCT00738452|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
574554|NCT00738452|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
574555|NCT00738452|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
574556|NCT00738439|scoliosis|scoliosis
574557|NCT00738439|kyphosis|kyphosis
574558|NCT00738439|treatment outcomes|treatment outcomes
574559|NCT00738439|spinal deformity|spinal deformity
574560|NCT00738426|non-invasive body contouring of waists hips and thighs|non-invasive body contouring of waists hips and thighs
574561|NCT00738413|Iron chelation|iron chelation
574562|NCT00738413|Iron balance|iron balance
574563|NCT00738413|Secondary iron overload|secondary iron overload
574564|NCT00738413|deferoxamine|deferoxamine
574565|NCT00738413|deferasirox|deferasirox
574566|NCT00738400|Vardenafil|vardenafil
574567|NCT00738400|Erectile Dysfunction|erectile dysfunction
574568|NCT00738400|Double-blind study|double-blind study
574569|NCT00738387|Tumor vascular disrupting agent|tumor vascular disrupting agent
574570|NCT00738387|VDA|vda
574571|NCT00738387|ASA404|asa404
574572|NCT00738387|non-small cell lung cancer|non-small cell lung cancer
574573|NCT00738387|NSCLC|nsclc
574574|NCT00738361|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
574575|NCT00738361|iris melanoma|iris melanoma
574576|NCT00738361|metastatic intraocular melanoma|metastatic intraocular melanoma
574577|NCT00738361|recurrent intraocular melanoma|recurrent intraocular melanoma
574578|NCT00738361|extraocular extension melanoma|extraocular extension melanoma
574579|NCT00738348|surgery|surgery
574580|NCT00738335|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
574581|NCT00738335|tumors metastatic to brain|tumors metastatic to brain
574582|NCT00738335|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
574583|NCT00738322|AZD1305|azd1305
574584|NCT00738322|safety|safety
574585|NCT00738322|pharmacokinetics|pharmacokinetics
574586|NCT00738322|single ascending doses|single ascending doses
574587|NCT00738322|Japanese|japanese
574588|NCT00738322|male|male
574589|NCT00738309|Treatment Outcomes|treatment outcomes
574590|NCT00738309|Spinal Deformity|spinal deformity
574591|NCT00738309|Scheuermann's Kyphosis|scheuermann's kyphosis
574592|NCT00738283|Zinc|zinc
574593|NCT00738283|Copper|copper
574594|NCT00738283|Neonate|neonate
574595|NCT00738257|Renal|renal
574596|NCT00738257|transplant,|transplant,
574597|NCT00738257|pamidronate,|pamidronate,
574598|NCT00738257|ciclosporin,|ciclosporin,
574599|NCT00738257|Ciclosporin A,|ciclosporin a,
574600|NCT00738257|steroids,|steroids,
574601|NCT00738257|bone mineral density,|bone mineral density,
574602|NCT00738257|fracture rates|fracture rates
574603|NCT00738257|immunosuppressive|immunosuppressive
574604|NCT00738257|regimen|regimen
574605|NCT00738244|hearing aid algorithm|hearing aid algorithm
574606|NCT00738244|wind-noise suppression|wind-noise suppression
574607|NCT00738231|risk factors; coronary arterial hearth disease|risk factors; coronary arterial hearth disease
574608|NCT00738218|Coronary Artery Disease|coronary artery disease
574609|NCT00738218|Computed Tomography|computed tomography
574610|NCT00738218|Angiography|angiography
574611|NCT00738205|Electronic device|electronic device
574612|NCT00738205|Growth hormone treatment|growth hormone treatment
574613|NCT00738192|Postoperative analgesia|postoperative analgesia
574614|NCT00738192|Opioids|opioids
574615|NCT00738192|Laparoscopic surgery|laparoscopic surgery
574616|NCT00738179|Continuous Positive Airway Pressure (CPAP)|continuous positive airway pressure (cpap)
574617|NCT00738179|Obstructive Sleep Apnea (OSA)|obstructive sleep apnea (osa)
574618|NCT00738179|Cardiovascular (CV)|cardiovascular (cv)
574619|NCT00738179|Cardiovascular Disease|cardiovascular disease
574620|NCT00738179|Clinical Trial|clinical trial
574621|NCT00738166|diet, organic, health|diet, organic, health
574622|NCT00738166|healthy people|healthy people
574623|NCT00738140|insulin sensitivity|insulin sensitivity
574624|NCT00738140|Diabetes Prevention Program|diabetes prevention program
574625|NCT00738140|lifestyle intervention|lifestyle intervention
574626|NCT00738127|Acute trans-scaphoid perilunate dislocations|acute trans-scaphoid perilunate dislocations
574627|NCT00738127|Open reduction and internal fixation|open reduction and internal fixation
574628|NCT00738127|Kirschner-wire|kirschner-wire
574629|NCT00738127|Range of motion|range of motion
574630|NCT00738114|non-cardiac|non-cardiac
574631|NCT00738114|surgery|surgery
574632|NCT00738114|mortality|mortality
574633|NCT00738114|morbidity|morbidity
574634|NCT00738114|perioperative|perioperative
574635|NCT00738114|period|period
574636|NCT00738101|Omega-3|omega-3
574637|NCT00738101|Omegaven|omegaven
574638|NCT00738101|Cholestasis|cholestasis
574639|NCT00738101|Liver damage|liver damage
574640|NCT00738088|Sulphonylurea|sulphonylurea
574641|NCT00738088|Pharmacogenetics|pharmacogenetics
574642|NCT00738062|NOH|noh
574643|NCT00738062|Neurogenic Orthostatic Hypotension|neurogenic orthostatic hypotension
574644|NCT00738062|Orthostatic hypotension|orthostatic hypotension
574645|NCT00738062|PAF|paf
574646|NCT00738062|Pure Autonomic Failure|pure autonomic failure
574647|NCT00738062|MSA|msa
574648|NCT00738062|Multiple System Atrophy|multiple system atrophy
574649|NCT00738062|Neuropathy|neuropathy
574650|NCT00738062|Autonomic Failure|autonomic failure
574651|NCT00738062|Parkinson|parkinson
574652|NCT00738062|Dopamine Deficiency|dopamine deficiency
574653|NCT00738062|Dopamine|dopamine
574654|NCT00738062|Droxidopa|droxidopa
574655|NCT00738049|atherosclerosis|atherosclerosis
574656|NCT00738049|coronary artery disease|coronary artery disease
574657|NCT00738049|myocardial perfusion defect|myocardial perfusion defect
574658|NCT00738049|endothelial dysfunction|endothelial dysfunction
574659|NCT00738049|endothelin receptor blockade|endothelin receptor blockade
574660|NCT00738036|Analgesics|analgesics
574661|NCT00738036|Opioid|opioid
574662|NCT00738036|Opioid maintenance therapy|opioid maintenance therapy
574663|NCT00738036|Acute pain|acute pain
574664|NCT00738023|diabetes,|diabetes,
574665|NCT00738023|hypertension,|hypertension,
574666|NCT00738023|free-fatty acids|free-fatty acids
574667|NCT00738010|NMES|nmes
574668|NCT00738010|ACL|acl
574669|NCT00738010|Atrophy Prevention|atrophy prevention
574670|NCT00738010|Accelerated Recovery|accelerated recovery
574671|NCT00738010|Knee Surgery|knee surgery
574672|NCT00737997|Pediatrics|pediatrics
574673|NCT00737997|Scoliosis|scoliosis
574674|NCT00737997|Morphine|morphine
574675|NCT00737997|Surgery|surgery
574676|NCT00737997|Analgesia|analgesia
574677|NCT00737984|Infertility|infertility
574678|NCT00737984|Clinical pregnancy rate|clinical pregnancy rate
574679|NCT00737971|avastin|avastin
574680|NCT00737971|bevacizumab|bevacizumab
574681|NCT00737971|triamcinolone|triamcinolone
574682|NCT00737971|diabetic macular edema|diabetic macular edema
574683|NCT00737971|macular edema|macular edema
574684|NCT00737971|intravitreal injection|intravitreal injection
574685|NCT00737958|Angina pectoris|angina pectoris
574686|NCT00737958|Air pollution|air pollution
574687|NCT00737958|Diesel exhaust|diesel exhaust
574688|NCT00737958|Myocardial ischaemia|myocardial ischaemia
574689|NCT00737958|Exercise capacity|exercise capacity
574690|NCT00737919|Cholesterol|cholesterol
574691|NCT00737919|Plant sterols|plant sterols
574692|NCT00737919|Atherosclerotic carotid plaques|atherosclerotic carotid plaques
574693|NCT00737906|Chronic rhinitis|chronic rhinitis
574694|NCT00737906|Nasal Obstruction|nasal obstruction
574695|NCT00737906|Nasal Obstruction Symptoms|nasal obstruction symptoms
574696|NCT00737906|Failed Medical Management for Nasal Obstruction|failed medical management for nasal obstruction
574697|NCT00737906|Inflammation of the nasal mucosa|inflammation of the nasal mucosa
574698|NCT00737906|Pediatric Turbinate reduction|pediatric turbinate reduction
574699|NCT00737906|Coblation|coblation
574700|NCT00737906|Arthrocare|arthrocare
574701|NCT00737906|ENT|ent
574702|NCT00737906|Failed Medical Management for Chronic Sinusitis|failed medical management for chronic sinusitis
574703|NCT00737906|Turbinate|turbinate
574704|NCT00737906|Inferior Turbinate Hypertrophy|inferior turbinate hypertrophy
574705|NCT00737906|Bilateral Inferior Turbinate Hypertrophy|bilateral inferior turbinate hypertrophy
574706|NCT00737906|Turbinate Hypertrophy|turbinate hypertrophy
574707|NCT00737906|Inferior Turbinate|inferior turbinate
574708|NCT00737906|Bilateral Inferior Turbinate|bilateral inferior turbinate
574709|NCT00737893|Erythropoietin|erythropoietin
574710|NCT00737893|Radical Prostatectomy|radical prostatectomy
574711|NCT00737893|Erectile Dysfunction|erectile dysfunction
574712|NCT00737893|Prostate Cancer|prostate cancer
574713|NCT00737880|Pancreas Clinical, Donor|pancreas clinical, donor
574714|NCT00737880|Pancreas Clinical, Preservation Solutions|pancreas clinical, preservation solutions
574715|NCT00737880|Organ Preservation and Procurement, Surgery|organ preservation and procurement, surgery
574716|NCT00737880|Organ Procurement, Ischemia reperfusion Injury|organ procurement, ischemia reperfusion injury
574717|NCT00737880|Organ Preservation and Procurement|organ preservation and procurement
574718|NCT00737867|lung cancer|lung cancer
574719|NCT00737867|chemotherapy|chemotherapy
574720|NCT00737867|vinorelbine|vinorelbine
574721|NCT00737867|gemcitabine|gemcitabine
574722|NCT00737867|carboplatin|carboplatin
574723|NCT00737867|advanced lung cancer|advanced lung cancer
574724|NCT00737867|non-small cell lung cancer|non-small cell lung cancer
574725|NCT00737854|OLP|olp
574726|NCT00737854|Free Soft Tissue Graft|free soft tissue graft
574727|NCT00737854|Treatment|treatment
574728|NCT00737841|stress|stress
574729|NCT00737841|brain-gut interactions|brain-gut interactions
574730|NCT00737841|visceral perception|visceral perception
574731|NCT00737841|gastrointestinal motility|gastrointestinal motility
574732|NCT00737841|emotion|emotion
574733|NCT00737828|Cardiopulmonary exercise test|cardiopulmonary exercise test
574734|NCT00737828|CPX|cpx
574735|NCT00737828|CPEX|cpex
574736|NCT00737828|surgical outcome|surgical outcome
574737|NCT00737828|colorectal surgery|colorectal surgery
574738|NCT00737828|risk stratification|risk stratification
574739|NCT00737815|Randomized Controlled Trial|randomized controlled trial
574740|NCT00737815|Magnesium|magnesium
574741|NCT00737815|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
574742|NCT00737815|Inflammation|inflammation
574743|NCT00737802|GERD|gerd
574744|NCT00737802|Heartburn|heartburn
574745|NCT00737802|Esophageal reflux|esophageal reflux
574746|NCT00737802|Barretts esophagus|barretts esophagus
574747|NCT00737802|Normal subjects|normal subjects
574748|NCT00737763|efalizumab|efalizumab
574749|NCT00737763|Raptiva|raptiva
574750|NCT00737763|Diabetes|diabetes
574751|NCT00737763|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
574752|NCT00737750|Neuromuscular electrical stimulation (NMES)|neuromuscular electrical stimulation (nmes)
574753|NCT00737750|Knee Surgery|knee surgery
574754|NCT00737750|Anterior cruciate ligament|anterior cruciate ligament
574755|NCT00737750|Atrophy Prevention|atrophy prevention
574756|NCT00737750|Accelerated Recovery|accelerated recovery
574757|NCT00737737|Analgesia|analgesia
574758|NCT00737737|Chronic Pain|chronic pain
574759|NCT00737737|Neuroendocrine Axis|neuroendocrine axis
574760|NCT00737737|Degenerative Diseases|degenerative diseases
574761|NCT00737724|Enzyme-Linked ImmunoSpot|enzyme-linked immunospot
574762|NCT00737724|Deferred treatment|deferred treatment
574763|NCT00737724|Immune Recovery Inflammatory Syndrome|immune recovery inflammatory syndrome
574764|NCT00737698|COPD|copd
574765|NCT00737698|exercise|exercise
574766|NCT00737698|repetitive magnetic stimulation|repetitive magnetic stimulation
574767|NCT00737698|quadriceps strength|quadriceps strength
574768|NCT00737685|Pediatric|pediatric
574769|NCT00737685|UBMT|ubmt
574770|NCT00737685|Severe|severe
574771|NCT00737672|Hemodialysis|hemodialysis
574772|NCT00737672|Stent Graft|stent graft
574773|NCT00737672|Venous Anastomosis|venous anastomosis
574774|NCT00737672|Arteriovenous Grafts|arteriovenous grafts
574775|NCT00737659|Renal Transplant|renal transplant
574776|NCT00737659|Renal|renal
574777|NCT00737659|Transplant|transplant
574778|NCT00737659|MMF|mmf
574779|NCT00737659|MPA|mpa
574780|NCT00737659|Recipients|recipients
574781|NCT00737646|Cancer|cancer
574782|NCT00737646|Colorectal cancer|colorectal cancer
574783|NCT00737646|Patient education|patient education
574784|NCT00737646|Physician education|physician education
574785|NCT00737633|Diabetes|diabetes
574786|NCT00737633|Type 2 Diabetes|type 2 diabetes
574787|NCT00737633|Diabetes Mellitus|diabetes mellitus
574788|NCT00737633|Metabolic Diseases|metabolic diseases
574789|NCT00737633|Glucose Metabolism Disorders|glucose metabolism disorders
574790|NCT00737633|Glycemic Control|glycemic control
574791|NCT00737620|Renal Failure, End Stage|renal failure, end stage
574792|NCT00737620|Blood Vessel Grafting|blood vessel grafting
574793|NCT00737620|Hemodialysis|hemodialysis
574794|NCT00737620|Surgical Arteriovenous Shunt|surgical arteriovenous shunt
574795|NCT00737607|outcome|outcome
574796|NCT00737607|surgery|surgery
574797|NCT00737607|lumbar spinal stenosis|lumbar spinal stenosis
574798|NCT00737607|minimally invasive|minimally invasive
574799|NCT00737581|Subject's|subject's
574800|NCT00737581|response|response
574801|NCT00737581|changes|changes
574802|NCT00737581|in spinal|in spinal
574803|NCT00737581|cord|cord
574804|NCT00737581|stimulation|stimulation
574805|NCT00737581|during|during
574806|NCT00737581|postural|postural
574807|NCT00737568|Tenofovir DF|tenofovir df
574808|NCT00737568|Emtricitabine|emtricitabine
574809|NCT00737568|Chronic hepatitis B|chronic hepatitis b
574810|NCT00737568|Combination therapy|combination therapy
574811|NCT00737555|Solid tumour|solid tumour
574812|NCT00737555|Solid tumor|solid tumor
574813|NCT00737555|Pharmacokinetic|pharmacokinetic
574814|NCT00737555|Interaction|interaction
574815|NCT00737555|dose escalation|dose escalation
574816|NCT00737555|cancer|cancer
574817|NCT00737555|paclitaxel|paclitaxel
574818|NCT00737542|management|management
574819|NCT00737542|post|post
574820|NCT00737529|Mantle Cell Lymphoma|mantle cell lymphoma
574821|NCT00737529|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
574822|NCT00737529|CC-5013|cc-5013
574823|NCT00737529|Revlimid|revlimid
574824|NCT00737529|Lenalidomide|lenalidomide
574825|NCT00737516|Registry|registry
574826|NCT00737516|Unrelated Umbilical Cord Blood donor|unrelated umbilical cord blood donor
574827|NCT00737516|Hematopoietic Reconstitution|hematopoietic reconstitution
574828|NCT00737516|Center for Cord Blood|center for cord blood
574829|NCT00737516|Bone Marrow Transplantation|bone marrow transplantation
574830|NCT00737503|vaccine effectiveness, rotavirus, diarrhoea, Bangladesh|vaccine effectiveness, rotavirus, diarrhoea, bangladesh
574831|NCT00737451|urticaria|urticaria
574832|NCT00737451|goiter|goiter
574833|NCT00737438|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
574834|NCT00737438|CAPECITABINE (ORAL)|capecitabine (oral)
574835|NCT00737438|CISPLATIN|cisplatin
574836|NCT00737438|EPIRUBICIN|epirubicin
574837|NCT00737438|IRINOTECAN (CPT-11) CAMPTOSAR|irinotecan (cpt-11) camptosar
574838|NCT00737438|TAXOTERE (DOCETAXEL)|taxotere (docetaxel)
574839|NCT00737438|ESOPHAGUS|esophagus
574840|NCT00737438|STOMACH|stomach
574841|NCT00737438|08-081|08-081
574842|NCT00737425|laparoscopic-assisted surgery|laparoscopic-assisted surgery
574843|NCT00737425|abdominal|abdominal
574844|NCT00737425|pain relief|pain relief
574845|NCT00737425|wound healing|wound healing
574846|NCT00737425|low intensity ultrasound|low intensity ultrasound
574847|NCT00737412|Bio-K+CL1285|bio-k+cl1285
574848|NCT00737412|Probiotics|probiotics
574849|NCT00737412|Traveler's Diarrhea|traveler's diarrhea
574850|NCT00737412|Lactobacillus Acidophilus|lactobacillus acidophilus
574851|NCT00737412|Lactobacillus Casei|lactobacillus casei
574852|NCT00737399|depression|depression
574853|NCT00737399|anxiety|anxiety
574854|NCT00737399|pain|pain
574855|NCT00737399|insomnia|insomnia
574856|NCT00737399|cancer|cancer
574857|NCT00737399|cholangiocarcinoma|cholangiocarcinoma
574858|NCT00737399|EFT (Emotional Freedom Techniques)|eft (emotional freedom techniques)
574859|NCT00737386|Leishmania tropica|leishmania tropica
574860|NCT00737386|Hyrax|hyrax
574861|NCT00737386|Sandfly|sandfly
574862|NCT00737347|type 2 diabetes|type 2 diabetes
574863|NCT00737347|obesity|obesity
574864|NCT00737347|weight gain|weight gain
574865|NCT00737347|thiazolidinediones|thiazolidinediones
574866|NCT00737334|Carotid stenosis|carotid stenosis
574867|NCT00737334|EEGo|eego
574868|NCT00737334|nonlinear EEG|nonlinear eeg
574869|NCT00737334|BIS|bis
574870|NCT00737334|cerebral oximetry|cerebral oximetry
574871|NCT00737334|FORE-SIGHT cerebral oximeter|fore-sight cerebral oximeter
574872|NCT00737334|cerebral monitoring|cerebral monitoring
574873|NCT00737334|arterial jugular venous lactate difference|arterial jugular venous lactate difference
574874|NCT00737334|cerebral ischemia|cerebral ischemia
574875|NCT00737334|carotid endarterectomy|carotid endarterectomy
574876|NCT00737321|Impact of ischemia|impact of ischemia
574877|NCT00737321|Impact of stress and|impact of stress and
574878|NCT00737321|Identify patterns of gene expression|identify patterns of gene expression
574879|NCT00737308|crowns|crowns
574880|NCT00737308|ceramics|ceramics
574881|NCT00737295|Biliary|biliary
574882|NCT00737295|Dyskinesia|dyskinesia
574883|NCT00737295|Gallbladder|gallbladder
574884|NCT00737295|Cholecystitis|cholecystitis
574885|NCT00737282|Uterine Fibroids|uterine fibroids
574886|NCT00737269|Complicated Skin and Soft-Tissue Infection|complicated skin and soft-tissue infection
574887|NCT00737269|Skin Infection|skin infection
574888|NCT00737269|Skin Infection Registry|skin infection registry
574889|NCT00737269|cSSTI Registry|cssti registry
574890|NCT00737243|Carcinoma of Unknown Primary Site|carcinoma of unknown primary site
574891|NCT00737243|Molecular profiling assay|molecular profiling assay
574892|NCT00737243|Bevacizumab|bevacizumab
574893|NCT00737243|Erlotinib|erlotinib
574894|NCT00737243|Paclitaxel|paclitaxel
574895|NCT00737243|Carboplatin|carboplatin
574896|NCT00737230|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
574897|NCT00737230|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
574898|NCT00737230|gastrointestinal complications|gastrointestinal complications
574899|NCT00737230|radiation toxicity|radiation toxicity
574900|NCT00737230|prostate cancer|prostate cancer
574901|NCT00737230|bladder cancer|bladder cancer
574902|NCT00737230|vulvar cancer|vulvar cancer
574903|NCT00737230|vaginal cancer|vaginal cancer
574904|NCT00737230|cervical cancer|cervical cancer
574905|NCT00737230|endometrial cancer|endometrial cancer
574906|NCT00737230|anal cancer|anal cancer
574907|NCT00737230|rectal cancer|rectal cancer
574908|NCT00737230|malignant testicular germ cell tumor|malignant testicular germ cell tumor
574909|NCT00737204|HIV|hiv
574910|NCT00737204|AIDS|aids
574911|NCT00737204|Armodafinil|armodafinil
574912|NCT00737204|Depression|depression
574913|NCT00737191|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
574914|NCT00737191|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
574915|NCT00737191|pain|pain
574916|NCT00737178|IUD|iud
574917|NCT00737178|Intrauterine device|intrauterine device
574918|NCT00737178|Intrauterine contraception|intrauterine contraception
574919|NCT00737178|Medication abortion|medication abortion
574920|NCT00737178|Medical abortion|medical abortion
574921|NCT00737165|Suicide, Prevention|suicide, prevention
574922|NCT00737165|Community|community
574923|NCT00737152|RAS 130|ras 130
574924|NCT00737152|Exercise|exercise
574925|NCT00737152|Diabetes Mellitus|diabetes mellitus
574926|NCT00737152|Type II Diabetes|type ii diabetes
574927|NCT00737152|Diabetes|diabetes
574928|NCT00737152|Aerobic|aerobic
574929|NCT00737139|Hip|hip
574930|NCT00737139|Knee|knee
574931|NCT00737139|Arthroplasty|arthroplasty
574932|NCT00737139|Epinephrine|epinephrine
574933|NCT00737139|Hemostasis|hemostasis
574934|NCT00737126|Diabetic nephropathies|diabetic nephropathies
574935|NCT00737126|Hyperhomocysteinemia|hyperhomocysteinemia
574936|NCT00737126|Folic acid|folic acid
574937|NCT00737126|Endothelial dysfunction|endothelial dysfunction
574938|NCT00737113|allogeneic stem cell transplantation|allogeneic stem cell transplantation
574939|NCT00737113|Engrafted|engrafted
574940|NCT00737113|subjects|subjects
574941|NCT00737087|total shoulder replacement|total shoulder replacement
574942|NCT00737087|rotator cuff|rotator cuff
574943|NCT00737087|osteoarthritis|osteoarthritis
574944|NCT00737087|rheumatoid arthritis|rheumatoid arthritis
574945|NCT00737087|Delta Extend|delta extend
574946|NCT00737074|Fibrovascular proliferation|fibrovascular proliferation
574947|NCT00737074|Internal limiting membrane peeling|internal limiting membrane peeling
574948|NCT00737074|Macular detachment|macular detachment
574949|NCT00737074|Macular hole|macular hole
574950|NCT00737074|Proliferative diabetic retinopathy.|proliferative diabetic retinopathy.
574951|NCT00737061|Female|female
574952|NCT00737061|Sterilization|sterilization
574953|NCT00737048|Pain|pain
574954|NCT00737048|Tooth extraction|tooth extraction
574955|NCT00737048|Oral surgery|oral surgery
574956|NCT00737048|Postoperative pain|postoperative pain
574957|NCT00737048|JNS013|jns013
574958|NCT00737048|Tramadol hydrochloride|tramadol hydrochloride
574959|NCT00737048|Acetaminophen|acetaminophen
574960|NCT00737035|Intimate Partner Homicide|intimate partner homicide
574961|NCT00737035|Parental Homicide|parental homicide
574962|NCT00737035|Guardians of Child Survivors of Parental Homicide|guardians of child survivors of parental homicide
574963|NCT00737035|Post-Traumatic Stress Disorder|post-traumatic stress disorder
574964|NCT00737035|Uxoricide Project|uxoricide project
574965|NCT00737022|Diabetic vitrectomy|diabetic vitrectomy
574966|NCT00737022|Epiretinal membrane (ERM)|epiretinal membrane (erm)
574967|NCT00737022|Macular appearance|macular appearance
574968|NCT00737022|Optical coherence tomography (OCT)|optical coherence tomography (oct)
574969|NCT00737022|Visual function|visual function
574970|NCT00737009|Breast cancer|breast cancer
574971|NCT00737009|adherence|adherence
574972|NCT00737009|anastrozole|anastrozole
574973|NCT00737009|post-menopausal women|post-menopausal women
574974|NCT00736996|Metabolic Syndrome|metabolic syndrome
574975|NCT00736996|Mild Cognitive Impairment|mild cognitive impairment
574976|NCT00736996|Insulin Resistance|insulin resistance
574977|NCT00736996|Endurance Exercise|endurance exercise
574978|NCT00736983|Perianal fistulas|perianal fistulas
574979|NCT00736983|Crohn's disease|crohn's disease
574980|NCT00736970|ridaforolimus|ridaforolimus
574981|NCT00736970|deforolimus|deforolimus
574982|NCT00736970|AP23573|ap23573
574983|NCT00736970|breast cancer|breast cancer
574984|NCT00736957|Chronic Pain|chronic pain
574985|NCT00736957|Acetaminophen|acetaminophen
574986|NCT00736957|Tramadol|tramadol
574987|NCT00736957|JNS013|jns013
574988|NCT00736931|Brivaracetam|brivaracetam
574989|NCT00736931|Cognitive neurophysiological tests (CNT)|cognitive neurophysiological tests (cnt)
574990|NCT00736931|Neuropsychological assessments|neuropsychological assessments
574991|NCT00736918|Suicide Attempt|suicide attempt
574992|NCT00736905|TMC278-TiDP6-C130|tmc278-tidp6-c130
574993|NCT00736905|TMC278-C130|tmc278-c130
574994|NCT00736905|healthy volunteer|healthy volunteer
574995|NCT00736905|hepatic impairment|hepatic impairment
574996|NCT00736905|HIV Infections|hiv infections
574997|NCT00736892|Acute lung injury|acute lung injury
574998|NCT00736892|Acute respiratory distress syndrome|acute respiratory distress syndrome
574999|NCT00736892|Mechanical ventilation|mechanical ventilation
575000|NCT00736892|Prognosis|prognosis
575001|NCT00736892|Definitions|definitions
575002|NCT00736879|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
575003|NCT00736879|Diabetes Mellitus|diabetes mellitus
575004|NCT00736879|Endocrine System Diseases|endocrine system diseases
575005|NCT00736879|Glucose Metabolism Disorders|glucose metabolism disorders
575006|NCT00736879|Metabolic Diseases|metabolic diseases
575007|NCT00736866|acetylcysteine|acetylcysteine
575110|NCT00736684|complications|complications
575008|NCT00736866|contrast-induced nephropathy|contrast-induced nephropathy
575009|NCT00736866|angiography|angiography
575010|NCT00736866|angioplasty with or without Stent|angioplasty with or without stent
575011|NCT00736853|Chronic pain|chronic pain
575012|NCT00736853|Acetoaminophen|acetoaminophen
575013|NCT00736853|Tramadol|tramadol
575014|NCT00736853|Osteoarthritis of the knee|osteoarthritis of the knee
575015|NCT00736853|Low back pain|low back pain
575016|NCT00736840|Methacetin|methacetin
575017|NCT00736840|Breath|breath
575018|NCT00736840|Test|test
575019|NCT00736840|Cirrhosis|cirrhosis
575020|NCT00736827|BK virus|bk virus
575021|NCT00736827|acute renal failure|acute renal failure
575022|NCT00736827|hemodiafiltration|hemodiafiltration
575023|NCT00736827|humans|humans
575024|NCT00736827|patients|patients
575025|NCT00736827|polytrauma|polytrauma
575026|NCT00736827|surgery|surgery
575027|NCT00736827|complement|complement
575028|NCT00736827|inflammation|inflammation
575029|NCT00736827|inflammatory response|inflammatory response
575030|NCT00736827|biomarkers|biomarkers
575031|NCT00736827|cytokines|cytokines
575032|NCT00736827|cell surface markers|cell surface markers
575033|NCT00736827|functional polymorphisms|functional polymorphisms
575034|NCT00736827|infections|infections
575035|NCT00736827|systemic inflammatory response syndrome|systemic inflammatory response syndrome
575036|NCT00736827|SIRS|sirs
575037|NCT00736827|sepsis|sepsis
575038|NCT00736827|severe sepsis|severe sepsis
575039|NCT00736827|shock|shock
575040|NCT00736827|organ dysfunctions|organ dysfunctions
575041|NCT00736827|SOFA|sofa
575042|NCT00736827|severity of disease|severity of disease
575043|NCT00736827|APACHEII|apacheii
575044|NCT00736827|SAPSII|sapsii
575045|NCT00736827|SPAPS3|spaps3
575046|NCT00736827|length of stay|length of stay
575047|NCT00736827|outcome|outcome
575048|NCT00736827|mortality|mortality
575049|NCT00736814|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
575050|NCT00736814|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
575051|NCT00736801|Airway hyperresponsiveness|airway hyperresponsiveness
575052|NCT00736788|AZD1704,|azd1704,
575053|NCT00736788|Japanese|japanese
575054|NCT00736788|Healthy|healthy
575055|NCT00736788|Volunteers,|volunteers,
575056|NCT00736788|Phase I study,|phase i study,
575057|NCT00736788|Single Ascending Dose|single ascending dose
575058|NCT00736788|Safety,|safety,
575059|NCT00736788|Tolerability|tolerability
575060|NCT00736788|Pharmacokinetics|pharmacokinetics
575061|NCT00736775|AD|ad
575062|NCT00736775|Alzheimer's|alzheimer's
575063|NCT00736775|Alzheimers|alzheimers
575064|NCT00736762|Global postural re-education|global postural re-education
575065|NCT00736762|Balance|balance
575066|NCT00736762|Physical therapy|physical therapy
575067|NCT00736762|older people|older people
575068|NCT00736723|NT-proBNP|nt-probnp
575069|NCT00736723|myocardial dysfunction|myocardial dysfunction
575070|NCT00736723|humans|humans
575071|NCT00736723|patients|patients
575072|NCT00736723|polytrauma|polytrauma
575073|NCT00736723|complement|complement
575074|NCT00736723|inflammation|inflammation
575075|NCT00736723|inflammatory response|inflammatory response
575076|NCT00736723|biomarkers|biomarkers
575077|NCT00736723|cytokines|cytokines
575078|NCT00736723|cell surface markers|cell surface markers
575079|NCT00736723|functional polymorphisms|functional polymorphisms
575080|NCT00736723|infections|infections
575081|NCT00736723|systemic inflammatory response syndrome|systemic inflammatory response syndrome
575082|NCT00736723|SIRS|sirs
575083|NCT00736723|sepsis|sepsis
575084|NCT00736723|severe sepsis|severe sepsis
575085|NCT00736723|shock|shock
575086|NCT00736723|organ dysfunctions|organ dysfunctions
575087|NCT00736723|SOFA|sofa
575088|NCT00736723|severity of disease|severity of disease
575089|NCT00736723|APACHEII|apacheii
575090|NCT00736723|SAPSII|sapsii
575091|NCT00736723|SPAPS3|spaps3
575092|NCT00736723|length of stay|length of stay
575093|NCT00736723|outcome|outcome
575094|NCT00736723|mortality|mortality
575095|NCT00736710|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
575096|NCT00736710|Cigarette smoking|cigarette smoking
575097|NCT00736710|Schizophrenia|schizophrenia
575098|NCT00736710|Randomized|randomized
575099|NCT00736710|Double-blind|double-blind
575100|NCT00736710|Placebo-controlled|placebo-controlled
575101|NCT00736710|longitudinal|longitudinal
575102|NCT00736710|nicotine patch|nicotine patch
575103|NCT00736684|Femoral fractures [MeSH]|femoral fractures [mesh]
575104|NCT00736684|hip fractures [MeSH]|hip fractures [mesh]
575105|NCT00736684|trochanteric fractures (femoral neck fractures [MeSH])|trochanteric fractures (femoral neck fractures [mesh])
575106|NCT00736684|intramedullary nailing (fracture fixation, intramedullary [MeSH])|intramedullary nailing (fracture fixation, intramedullary [mesh])
575107|NCT00736684|complex femoral fractures|complex femoral fractures
575108|NCT00736684|femoral nail|femoral nail
575109|NCT00736684|surgical treatment (surgical procedures, operative [MeSH])|surgical treatment (surgical procedures, operative [mesh])
575111|NCT00736658|Japanese|japanese
575112|NCT00736658|MAD|mad
575113|NCT00736658|Multiple ascending dose|multiple ascending dose
575114|NCT00736658|Chronic pain|chronic pain
575115|NCT00736645|adenocarcinoma of the prostate|adenocarcinoma of the prostate
575116|NCT00736645|stage I prostate cancer|stage i prostate cancer
575117|NCT00736645|stage II prostate cancer|stage ii prostate cancer
575118|NCT00736632|Vitamin D|vitamin d
575119|NCT00736632|Insulin Resistance|insulin resistance
575120|NCT00736632|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
575121|NCT00736632|Cardiovascular Disease|cardiovascular disease
575122|NCT00736619|MAB C225(CETUXIMAB)(ANTI-EGFR)|mab c225(cetuximab)(anti-egfr)
575123|NCT00736619|TAXOL (PACLITAXEL)|taxol (paclitaxel)
575124|NCT00736619|Radiation Therapy|radiation therapy
575125|NCT00736619|08-084|08-084
575126|NCT00736606|simvastatin|simvastatin
575127|NCT00736606|AZD5672|azd5672
575128|NCT00736593|Wound|wound
575129|NCT00736593|Healing|healing
575130|NCT00736580|Cesarean delivery|cesarean delivery
575131|NCT00736580|Surgical Needles|surgical needles
575132|NCT00736580|blunt-tip needles|blunt-tip needles
575133|NCT00736580|surgical glove perforation|surgical glove perforation
575134|NCT00736567|Diarrhea|diarrhea
575135|NCT00736567|Diagnostic|diagnostic
575136|NCT00736567|Pediatric|pediatric
575137|NCT00736554|Staphylococcus aureus|staphylococcus aureus
575138|NCT00736554|CA-MRSA|ca-mrsa
575139|NCT00736554|skin and soft tissue infections|skin and soft tissue infections
575140|NCT00736554|resistance|resistance
575141|NCT00736554|emergency department|emergency department
575142|NCT00736541|ARF|arf
575143|NCT00736541|OLT|olt
575144|NCT00736541|NAC|nac
575145|NCT00736541|I/R injury|i/r injury
575146|NCT00736528|safety, tolerability, pharmacokinetics, cognition|safety, tolerability, pharmacokinetics, cognition
575147|NCT00736515|combination therapy,monotherapy,gliclazide MR,insulin,CGMS|combination therapy,monotherapy,gliclazide mr,insulin,cgms
575148|NCT00736489|Asthma|asthma
575149|NCT00736489|airway obstruction|airway obstruction
575150|NCT00736489|beta2-agonist|beta2-agonist
575151|NCT00736489|efficacy|efficacy
575152|NCT00736489|inhalation|inhalation
575153|NCT00736476|helicobacter pylori infection|helicobacter pylori infection
575154|NCT00736476|vaccination|vaccination
575155|NCT00736476|adults|adults
575156|NCT00736463|HDL cholesterol|hdl cholesterol
575157|NCT00736463|statin|statin
575158|NCT00736463|inflammation|inflammation
575159|NCT00736463|atherosclerosis|atherosclerosis
575160|NCT00736463|prevention|prevention
575161|NCT00736463|patients with low baseline HDL cholesterol|patients with low baseline hdl cholesterol
575162|NCT00736437|UV-induced|uv-induced
575163|NCT00736437|Herpes labialis|herpes labialis
575164|NCT00736437|time to healing|time to healing
575165|NCT00736424|Epilepsy|epilepsy
575166|NCT00736424|SUDEP|sudep
575167|NCT00736424|DBS|dbs
575168|NCT00736411|infertility|infertility
575169|NCT00736411|IVF|ivf
575170|NCT00736411|acupuncture|acupuncture
575171|NCT00736385|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
575172|NCT00736372|cancer|cancer
575173|NCT00736372|metastatic cancer|metastatic cancer
575174|NCT00736372|advanced or metastatic cancer|advanced or metastatic cancer
575175|NCT00736346|Panic Disorder|panic disorder
575176|NCT00736346|anxiety|anxiety
575177|NCT00736346|chest pain|chest pain
575178|NCT00736346|emergency department|emergency department
575179|NCT00736346|cognitive-behavioral treatment|cognitive-behavioral treatment
575180|NCT00736320|Hodgkin Lymphoma|hodgkin lymphoma
575181|NCT00736320|early stage|early stage
575182|NCT00736320|PET|pet
575183|NCT00736307|limbal stem cell deficiency|limbal stem cell deficiency
575184|NCT00736294|Catheter Ablation, Radiofrequency|catheter ablation, radiofrequency
575185|NCT00736294|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors
575186|NCT00736281|Sublingual Immunotherapy for Food Allergy|sublingual immunotherapy for food allergy
575187|NCT00736281|Food Drops for Food Allergy|food drops for food allergy
575188|NCT00736268|Lung Disease|lung disease
575189|NCT00736268|Chronic Bronchitis|chronic bronchitis
575190|NCT00736268|Emphysema|emphysema
575191|NCT00736268|Caregiver stress|caregiver stress
575192|NCT00736268|COPD|copd
575193|NCT00736268|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
575194|NCT00736255|ADHD|adhd
575195|NCT00736255|Smoking|smoking
575196|NCT00736242|HIV|hiv
575197|NCT00736229|hyperglycemia|hyperglycemia
575198|NCT00736229|acute coronary syndromes|acute coronary syndromes
575199|NCT00736229|myocardial infarction|myocardial infarction
575200|NCT00736216|cervical cancer|cervical cancer
575201|NCT00736216|human papilloma virus infection|human papilloma virus infection
575202|NCT00736203|fMRI|fmri
575203|NCT00736203|non-smokers|non-smokers
575204|NCT00736190|Hepatitis B|hepatitis b
575205|NCT00736190|Hepatitis|hepatitis
575206|NCT00736190|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
575207|NCT00736190|Tenofovir DF|tenofovir df
575208|NCT00736190|Asian-American|asian-american
575209|NCT00736177|IVF|ivf
575210|NCT00736177|blastocyst transfer|blastocyst transfer
575211|NCT00736177|endometrium|endometrium
575970|NCT00733603|PBS|pbs
575212|NCT00736177|embryo cryopreservation|embryo cryopreservation
575213|NCT00736164|stage I prostate cancer|stage i prostate cancer
575214|NCT00736164|stage II prostate cancer|stage ii prostate cancer
575215|NCT00736164|adenocarcinoma of the prostate|adenocarcinoma of the prostate
575216|NCT00736125|postoperative cognitive dysfunction|postoperative cognitive dysfunction
575217|NCT00736125|total knee arthroplasty|total knee arthroplasty
575218|NCT00736125|cerebral emboli|cerebral emboli
575219|NCT00736125|carbon dioxide lavage|carbon dioxide lavage
575220|NCT00736125|pulsatile saline lavage|pulsatile saline lavage
575221|NCT00736112|Food Allergy in Children|food allergy in children
575222|NCT00736112|Otitis Media with Effusion (OME)|otitis media with effusion (ome)
575223|NCT00736112|Recurrent Middle Ear Infections|recurrent middle ear infections
575224|NCT00736112|Middle Ear Fluid|middle ear fluid
575225|NCT00736112|Food Allergy and Otitis Media with Effusion|food allergy and otitis media with effusion
575226|NCT00736112|Recurrent middle ear fluid in children <4 years old|recurrent middle ear fluid in children <4 years old
575227|NCT00736112|Chronic ear infections in children <4 years old|chronic ear infections in children <4 years old
575228|NCT00736086|femoral artery|femoral artery
575229|NCT00736086|post-percutaneous cardiac catheterization|post-percutaneous cardiac catheterization
575230|NCT00736086|post-percutaneous peripheral vascular catheterization|post-percutaneous peripheral vascular catheterization
575231|NCT00736086|post-percutaneous diagnostic catheterization|post-percutaneous diagnostic catheterization
575232|NCT00736086|early ambulation|early ambulation
575233|NCT00736086|vascular closure|vascular closure
575234|NCT00736073|pancreatitis|pancreatitis
575235|NCT00736060|Fever|fever
575236|NCT00736060|Blood cultures|blood cultures
575237|NCT00736047|Smokers|smokers
575238|NCT00736047|smoking cessation|smoking cessation
575239|NCT00736047|vaccine|vaccine
575240|NCT00736047|antibodies|antibodies
575241|NCT00736047|anti-nicotine|anti-nicotine
575242|NCT00736034|Age Associated Memory Impairment|age associated memory impairment
575243|NCT00736021|PTSD|ptsd
575244|NCT00736021|Pharmacological Treatment|pharmacological treatment
575245|NCT00736021|SSRI|ssri
575246|NCT00736021|Escitalopram|escitalopram
575247|NCT00736021|Anxiety Disorders|anxiety disorders
575248|NCT00736008|Factor V Leiden|factor v leiden
575249|NCT00736008|Prothrombin Mutation|prothrombin mutation
575250|NCT00736008|Hypercoagulability|hypercoagulability
575251|NCT00736008|Pediatrics|pediatrics
575252|NCT00735969|Non-Responder|non-responder
575253|NCT00735969|Relapser|relapser
575254|NCT00735969|High Dose Ribavirin|high dose ribavirin
575255|NCT00735969|Peginterferon|peginterferon
575256|NCT00735969|Chronic Hepatitis C|chronic hepatitis c
575257|NCT00735956|Screening|screening
575258|NCT00735956|Brief Intervention|brief intervention
575259|NCT00735943|Pegaptanib|pegaptanib
575260|NCT00735943|macular degeneration|macular degeneration
575261|NCT00735943|vascular endothelial growth factor|vascular endothelial growth factor
575262|NCT00735904|AG-013736|ag-013736
575263|NCT00735904|axitinib|axitinib
575264|NCT00735904|cisplatin|cisplatin
575265|NCT00735904|gemcitabine|gemcitabine
575266|NCT00735904|NSCLC|nsclc
575267|NCT00735904|squamous cell|squamous cell
575268|NCT00735904|lung cancer|lung cancer
575269|NCT00735878|Lung Cancer|lung cancer
575270|NCT00735878|Advanced Lung Cancer|advanced lung cancer
575271|NCT00735878|NSCLC|nsclc
575272|NCT00735865|Dry Eye Syndrome|dry eye syndrome
575273|NCT00735865|Punctal Occlusion|punctal occlusion
575274|NCT00735865|Punctal Plugs|punctal plugs
575275|NCT00735865|Tear Drainage duct blockage|tear drainage duct blockage
575276|NCT00735852|endometriosis|endometriosis
575277|NCT00735852|chronic cyclical pelvic pain|chronic cyclical pelvic pain
575278|NCT00735826|resectable|resectable
575279|NCT00735826|stage I-III|stage i-iii
575280|NCT00735826|NSCLC|nsclc
575281|NCT00735826|non-small cell lung cancer|non-small cell lung cancer
575282|NCT00735826|vorinostat|vorinostat
575283|NCT00735826|proof of principle|proof of principle
575284|NCT00735826|resectable stage I to III NSCLC|resectable stage i to iii nsclc
575285|NCT00735813|Catheterization, Central|catheterization, central
575286|NCT00735813|Catheterization, Peripheral|catheterization, peripheral
575287|NCT00735813|Infection|infection
575288|NCT00735813|Methods|methods
575289|NCT00735813|Sepsis|sepsis
575290|NCT00735813|Microscopy, Electron, Scanning|microscopy, electron, scanning
575291|NCT00735813|Sonication|sonication
575292|NCT00735813|Taurolidine|taurolidine
575293|NCT00735813|Catheters, Indwelling|catheters, indwelling
575294|NCT00735813|Pediatrics|pediatrics
575295|NCT00735800|Dementia|dementia
575296|NCT00735800|Caregivers|caregivers
575297|NCT00735800|Alzheimer's disease|alzheimer's disease
575298|NCT00735774|Healthy volunteer study|healthy volunteer study
575299|NCT00735748|Patients who will undergo a general anesthesia for a procedure in short stay|patients who will undergo a general anesthesia for a procedure in short stay
575300|NCT00735735|low back pain|low back pain
575301|NCT00735735|chronic|chronic
575302|NCT00735735|Substance P|substance p
575303|NCT00735722|AF|af
575304|NCT00735722|CAD|cad
575305|NCT00735709|Depression|depression
575306|NCT00735709|Depressive Disorder|depressive disorder
576174|NCT00732836|Abraxane|abraxane
575307|NCT00735709|Mood Disorder|mood disorder
575308|NCT00735709|Mental Disorder|mental disorder
575309|NCT00735709|Melancholia, Involutional|melancholia, involutional
575310|NCT00735709|Paraphrenia, Involutional|paraphrenia, involutional
575311|NCT00735709|Drug Therapy|drug therapy
575312|NCT00735696|Non Small Cell Lung Cancer|non small cell lung cancer
575313|NCT00735696|Lung|lung
575314|NCT00735696|NSCLC|nsclc
575315|NCT00735683|Weight loss|weight loss
575316|NCT00735683|Weight-loss drugs|weight-loss drugs
575317|NCT00735683|Obesity|obesity
575318|NCT00735683|Overweight|overweight
575319|NCT00735683|Body weight|body weight
575320|NCT00735683|Diet|diet
575321|NCT00735683|Metabolic Disorder|metabolic disorder
575322|NCT00735683|Nutrition Disorder|nutrition disorder
575323|NCT00735670|SCI|sci
575324|NCT00735657|Efficiency|efficiency
575325|NCT00735657|Pars|pars
575326|NCT00735657|Plana|plana
575327|NCT00735657|Vitrectomy|vitrectomy
575328|NCT00735644|Japanese encephalitis, Hepatitis A, Inactivated Mouse-Brain|japanese encephalitis, hepatitis a, inactivated mouse-brain
575329|NCT00735631|Patients entering the post-operative cardiac intensive care unit following coronary artery reconstruction surgery.|patients entering the post-operative cardiac intensive care unit following coronary artery reconstruction surgery.
575330|NCT00735618|Advanced Cancer|advanced cancer
575331|NCT00735618|Cancer Patients|cancer patients
575332|NCT00735618|Relaxation Therapy|relaxation therapy
575333|NCT00735618|Relaxation and Heart Rate Variability|relaxation and heart rate variability
575334|NCT00735618|Guided Relaxation|guided relaxation
575335|NCT00735618|HRV|hrv
575336|NCT00735618|Stress, Anxiety, and Panic Disorder|stress, anxiety, and panic disorder
575337|NCT00735605|obstructed defecation|obstructed defecation
575338|NCT00735605|constipation|constipation
575339|NCT00735605|puborectalis|puborectalis
575340|NCT00735592|X rays findings|x rays findings
575341|NCT00735579|major abdominal surgery|major abdominal surgery
575342|NCT00735579|coagulation|coagulation
575343|NCT00735579|extracellular matrix proteins|extracellular matrix proteins
575344|NCT00735579|wound healing after major abdominal surgery|wound healing after major abdominal surgery
575345|NCT00735566|gastric cancer|gastric cancer
575346|NCT00735566|antiangiogenic factors|antiangiogenic factors
575347|NCT00735566|TNM stage|tnm stage
575348|NCT00735553|Uterine Fibroids|uterine fibroids
575349|NCT00735527|seizures|seizures
575350|NCT00735527|status epilepticus|status epilepticus
575351|NCT00735527|lorazepam|lorazepam
575352|NCT00735527|intra-nasal|intra-nasal
575353|NCT00735514|radiation toxicity|radiation toxicity
575354|NCT00735514|sexuality and reproductive issues|sexuality and reproductive issues
575355|NCT00735514|stage I endometrial carcinoma|stage i endometrial carcinoma
575356|NCT00735514|stage II endometrial carcinoma|stage ii endometrial carcinoma
575357|NCT00735514|stage IB cervical cancer|stage ib cervical cancer
575487|NCT00735111|KPS|kps
575358|NCT00735514|stage IIA cervical cancer|stage iia cervical cancer
575359|NCT00735514|stage IIB cervical cancer|stage iib cervical cancer
575360|NCT00735514|stage III cervical cancer|stage iii cervical cancer
575361|NCT00735488|Thalassemia|thalassemia
575362|NCT00735488|Sickle cell anemia|sickle cell anemia
575363|NCT00735488|Carrier detection|carrier detection
575364|NCT00735488|Prenatal Diagnosis|prenatal diagnosis
575365|NCT00735488|Genetic counseling|genetic counseling
575366|NCT00735462|external genital warts|external genital warts
575367|NCT00735462|perianal warts|perianal warts
575368|NCT00735462|condylomata acuminata|condylomata acuminata
575369|NCT00735462|human papilloma virus|human papilloma virus
575370|NCT00735462|HPV types 6 and 11|hpv types 6 and 11
575371|NCT00735436|Malignant glioma|malignant glioma
575372|NCT00735436|Glioblastoma multiforme|glioblastoma multiforme
575373|NCT00735436|GBM|gbm
575374|NCT00735436|Gliosarcoma|gliosarcoma
575375|NCT00735436|Gliadel|gliadel
575376|NCT00735436|Carmustine|carmustine
575377|NCT00735436|Irinotecan|irinotecan
575378|NCT00735436|CPT-11|cpt-11
575379|NCT00735436|Camptosar|camptosar
575380|NCT00735436|Avastin|avastin
575381|NCT00735436|Bevacizumab|bevacizumab
575382|NCT00735423|Healthy children|healthy children
575383|NCT00735423|Brain Function|brain function
575384|NCT00735423|Diet|diet
575385|NCT00735423|Nutrition|nutrition
575386|NCT00735423|Language|language
575387|NCT00735423|fMRI|fmri
575388|NCT00735423|ERP|erp
575389|NCT00735423|Behavior|behavior
575390|NCT00735410|Influenza vaccine|influenza vaccine
575391|NCT00735410|Seasonal|seasonal
575392|NCT00735410|Split|split
575393|NCT00735397|Partial onset seizures|partial onset seizures
575394|NCT00735384|sepsis|sepsis
575395|NCT00735384|critical illness|critical illness
575396|NCT00735384|muscle, skeletal|muscle, skeletal
575397|NCT00735384|myopathy|myopathy
575398|NCT00735384|isometric contraction|isometric contraction
575399|NCT00735384|intensive care units|intensive care units
575400|NCT00735384|torque|torque
575401|NCT00735384|muscular atrophy|muscular atrophy
575402|NCT00735384|malignant hyperthermia|malignant hyperthermia
575403|NCT00735384|skin resistance|skin resistance
575404|NCT00735358|gastric variceal bleeding|gastric variceal bleeding
576457|NCT00731640|Multifocal|multifocal
575405|NCT00735358|cyanoacrylate|cyanoacrylate
575406|NCT00735358|rebleeding|rebleeding
575407|NCT00735358|complication|complication
575408|NCT00735358|survival|survival
575409|NCT00735358|acute gastric variceal bleeding|acute gastric variceal bleeding
575410|NCT00735345|Esophageal cancer|esophageal cancer
575411|NCT00735345|Pre-operative|pre-operative
575412|NCT00735345|Chemo-immunotherapy|chemo-immunotherapy
575413|NCT00735345|Radiochemo-immunotherapy|radiochemo-immunotherapy
575414|NCT00735345|EGFR|egfr
575415|NCT00735345|Radiosensitivity|radiosensitivity
575416|NCT00735345|Resection|resection
575417|NCT00735332|Melanoma|melanoma
575418|NCT00735332|Metastatic Melanoma|metastatic melanoma
575419|NCT00735332|Phase II|phase ii
575420|NCT00735332|Skin Cancer|skin cancer
575421|NCT00735319|Neonatal Jaundice|neonatal jaundice
575422|NCT00735319|Physiological Neonatal Jaundice|physiological neonatal jaundice
575423|NCT00735319|Neonatal Hyperbilirubinemia|neonatal hyperbilirubinemia
575424|NCT00735319|Transcutaneous Bilirubinometer|transcutaneous bilirubinometer
575425|NCT00735306|Locally advanced|locally advanced
575426|NCT00735306|Unresectable|unresectable
575427|NCT00735293|hyperhidrosis|hyperhidrosis
575428|NCT00735293|bromidrosis|bromidrosis
575429|NCT00735293|bromhidrosis|bromhidrosis
575430|NCT00735293|osmidrosis|osmidrosis
575431|NCT00735293|hircismus|hircismus
575432|NCT00735293|excessive|excessive
575433|NCT00735293|underarm|underarm
575434|NCT00735293|sweat|sweat
575435|NCT00735293|perspiration|perspiration
575436|NCT00735293|Body Odor|body odor
575437|NCT00735280|Coronary artery disease, stent, heparin|coronary artery disease, stent, heparin
575438|NCT00735267|Generalized Anxiety Disorder|generalized anxiety disorder
575439|NCT00735254|post|post
575440|NCT00735254|surgical|surgical
575441|NCT00735241|colon cancer|colon cancer
575442|NCT00735241|colorectal cancer|colorectal cancer
575443|NCT00735241|liver metastases|liver metastases
575444|NCT00735241|SIR-Spheres Microspheres|sir-spheres microspheres
575445|NCT00735241|yttrium-90|yttrium-90
575446|NCT00735241|FOLFOX|folfox
575447|NCT00735241|Bevacizumab|bevacizumab
575448|NCT00735241|chemo-radiation|chemo-radiation
575449|NCT00735228|surgery|surgery
575450|NCT00735228|artificial pancreas|artificial pancreas
575451|NCT00735228|tight glycemic control|tight glycemic control
575452|NCT00735228|Liver|liver
575453|NCT00735215|Breast cancer,|breast cancer,
575454|NCT00735215|fulvestrant,|fulvestrant,
575455|NCT00735215|postmenopausal,|postmenopausal,
575456|NCT00735215|women|women
575457|NCT00735215|locally advanced,|locally advanced,
575458|NCT00735215|hormone receptor-positive.|hormone receptor-positive.
575459|NCT00735189|warfarin|warfarin
575460|NCT00735189|anticoagulation|anticoagulation
575461|NCT00735189|anticoagulation clinics|anticoagulation clinics
575462|NCT00735176|Radiculopathy, cervical|radiculopathy, cervical
575463|NCT00735176|Nerve Root Compression|nerve root compression
575464|NCT00735176|Disc, intervertebral|disc, intervertebral
575465|NCT00735176|Intervertebral Disk Displacement|intervertebral disk displacement
575466|NCT00735176|Spondylosis|spondylosis
575467|NCT00735176|Spinal Osteophytosis|spinal osteophytosis
575468|NCT00735176|Arthroplasty, replacement|arthroplasty, replacement
575469|NCT00735176|Diskectomy|diskectomy
575470|NCT00735176|Spinal Fusion|spinal fusion
575471|NCT00735163|algorithm|algorithm
575472|NCT00735163|tight glycemic control|tight glycemic control
575473|NCT00735163|glucose control|glucose control
575474|NCT00735163|intensive care|intensive care
575475|NCT00735163|insulin|insulin
575476|NCT00735163|ICU|icu
575477|NCT00735150|Breast|breast
575478|NCT00735150|Ovary|ovary
575479|NCT00735150|Mutation carrier|mutation carrier
575480|NCT00735137|Twins|twins
575481|NCT00735137|Short cervix|short cervix
575482|NCT00735137|Preterm birth|preterm birth
575483|NCT00735137|Vaginal pessary|vaginal pessary
575484|NCT00735124|analgesia requirement and post operative pain|analgesia requirement and post operative pain
575485|NCT00735111|QOL|qol
575486|NCT00735111|Quality of Life|quality of life
575488|NCT00735111|Karnofsky Performance Status|karnofsky performance status
575489|NCT00735111|Cancer|cancer
575490|NCT00735098|Knee Osteoarthritis|knee osteoarthritis
575491|NCT00735098|arthritis|arthritis
575492|NCT00735085|Brain Injury|brain injury
575493|NCT00735072|HIV infection|hiv infection
575494|NCT00735072|T cell activation|t cell activation
575495|NCT00735072|Antiretroviral Therapy|antiretroviral therapy
575496|NCT00735072|CCR5|ccr5
575497|NCT00735072|Maraviroc|maraviroc
575498|NCT00735059|dialysis membrane|dialysis membrane
575499|NCT00735059|Polynephron|polynephron
575500|NCT00735059|Elisio H|elisio h
575501|NCT00735059|Polyethersulfone|polyethersulfone
575502|NCT00735059|Diapes|diapes
575503|NCT00735059|PES-DS|pes-ds
575504|NCT00735059|online post-dilution hemodiafiltration|online post-dilution hemodiafiltration
575505|NCT00735059|hemodialysis|hemodialysis
575506|NCT00735059|protein-bound toxins|protein-bound toxins
575507|NCT00735059|beta-2-microglobulin|beta-2-microglobulin
575508|NCT00735059|hemodialysis patients|hemodialysis patients
575509|NCT00735046|Early dementia in Alzheimer's disease (MMSE ≥ 21)|early dementia in alzheimer's disease (mmse ≥ 21)
575510|NCT00735033|Physical therapy|physical therapy
575511|NCT00735033|Physical therapy modalities|physical therapy modalities
575512|NCT00735033|Cerebral Vascular Accident (CVA)|cerebral vascular accident (cva)
575513|NCT00735020|influenza|influenza
575514|NCT00735020|vaccine|vaccine
575515|NCT00735020|adjuvants|adjuvants
575517|NCT00735007|Multiple Sclerosis|multiple sclerosis
575518|NCT00734968|Urinary tract infection (UTI)|urinary tract infection (uti)
575519|NCT00734968|suburethral sling|suburethral sling
575520|NCT00734968|Prevention|prevention
575521|NCT00734968|Nitrofurantoin|nitrofurantoin
575522|NCT00734968|Prophylaxis|prophylaxis
575523|NCT00734955|Partial Mastectomy|partial mastectomy
575524|NCT00734955|Lumpectomy|lumpectomy
575525|NCT00734955|Mastectomy|mastectomy
575526|NCT00734942|young carers|young carers
575527|NCT00734942|family support|family support
575528|NCT00734942|children (up to the age of 18) of chronically ill parents|children (up to the age of 18) of chronically ill parents
575529|NCT00734929|PONV|ponv
575530|NCT00734929|nausea|nausea
575531|NCT00734929|emesis|emesis
575532|NCT00734929|antiemetics|antiemetics
575533|NCT00734929|aprepitant|aprepitant
575534|NCT00734929|ondansetron|ondansetron
575535|NCT00734929|dexamethasone|dexamethasone
575536|NCT00734916|total parenteral nutrition|total parenteral nutrition
575537|NCT00734916|infections|infections
575538|NCT00734916|Infectious complications related to parenteral nutrition|infectious complications related to parenteral nutrition
575539|NCT00734903|Women|women
575540|NCT00734903|Substance Use Disorders|substance use disorders
575541|NCT00734903|Treatment Efficacy|treatment efficacy
575542|NCT00734903|Women's Health|women's health
575543|NCT00734903|Outcome Assessment (Health Care)|outcome assessment (health care)
575544|NCT00734890|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
575545|NCT00734890|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
575546|NCT00734890|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
575547|NCT00734890|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
575548|NCT00734890|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
575549|NCT00734890|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
575550|NCT00734890|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
575551|NCT00734890|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
575552|NCT00734890|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
575553|NCT00734890|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
575554|NCT00734890|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
575555|NCT00734890|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
575556|NCT00734890|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
575557|NCT00734890|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
575558|NCT00734890|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
575559|NCT00734890|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
575560|NCT00734890|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
575561|NCT00734890|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
575562|NCT00734890|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
575563|NCT00734890|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
575564|NCT00734890|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
575565|NCT00734890|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
575566|NCT00734890|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
575567|NCT00734890|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
575568|NCT00734890|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
575569|NCT00734890|anaplastic large cell lymphoma|anaplastic large cell lymphoma
575570|NCT00734890|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
575571|NCT00734890|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
575572|NCT00734890|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
575573|NCT00734890|Waldenström macroglobulinemia|waldenström macroglobulinemia
575574|NCT00734890|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
575575|NCT00734890|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
575576|NCT00734890|splenic marginal zone lymphoma|splenic marginal zone lymphoma
575577|NCT00734890|intraocular lymphoma|intraocular lymphoma
575578|NCT00734890|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
575579|NCT00734890|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
575580|NCT00734890|small intestine lymphoma|small intestine lymphoma
575581|NCT00734890|adenocarcinoma of the lung|adenocarcinoma of the lung
575582|NCT00734890|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
575583|NCT00734890|large cell lung cancer|large cell lung cancer
575584|NCT00734890|adenosquamous cell lung cancer|adenosquamous cell lung cancer
575585|NCT00734890|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
575586|NCT00734890|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
575587|NCT00734890|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
575588|NCT00734890|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
575589|NCT00734890|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
575590|NCT00734890|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
575591|NCT00734890|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
575592|NCT00734890|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
575593|NCT00734890|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
575594|NCT00734890|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
575595|NCT00734890|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
575596|NCT00734890|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
575597|NCT00734890|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
575598|NCT00734890|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
575599|NCT00734890|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
575600|NCT00734890|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
575601|NCT00734890|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
575602|NCT00734890|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
575603|NCT00734890|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
575604|NCT00734890|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
575605|NCT00734890|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
575606|NCT00734890|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
575607|NCT00734890|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
575608|NCT00734890|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
575609|NCT00734890|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
575610|NCT00734890|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
575611|NCT00734890|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
575612|NCT00734890|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
575613|NCT00734890|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
575614|NCT00734890|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
575615|NCT00734890|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
575616|NCT00734890|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
575617|NCT00734890|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
575618|NCT00734890|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
575619|NCT00734890|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
575620|NCT00734890|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
575621|NCT00734864|Dasatinib|dasatinib
575622|NCT00734864|Sprycel|sprycel
575623|NCT00734864|Temozolomide|temozolomide
575624|NCT00734864|Temodar|temodar
575625|NCT00734864|Recurrent Malignant Glioma|recurrent malignant glioma
575626|NCT00734864|Malignant Glioma|malignant glioma
575627|NCT00734864|glioblastoma multiforme|glioblastoma multiforme
575628|NCT00734864|gliosarcoma|gliosarcoma
575629|NCT00734864|anaplastic astrocytoma|anaplastic astrocytoma
575630|NCT00734864|anaplastic oligodendroglioma|anaplastic oligodendroglioma
575631|NCT00734864|anaplastic mixed glioma|anaplastic mixed glioma
575632|NCT00734864|glioma|glioma
575633|NCT00734851|prostate cancer|prostate cancer
575634|NCT00734851|sunitinib|sunitinib
575635|NCT00734851|docetaxel|docetaxel
575636|NCT00734851|PSA|psa
575637|NCT00734851|radiation|radiation
575638|NCT00734851|PSA recurrence|psa recurrence
575639|NCT00734851|No metastatic disease|no metastatic disease
575640|NCT00734838|Breast Cancer|breast cancer
575641|NCT00734838|Breast Biopsy|breast biopsy
575642|NCT00734838|Reduction mammoplasty|reduction mammoplasty
575643|NCT00734825|Appendicitis|appendicitis
575644|NCT00734825|IV Contrast|iv contrast
575645|NCT00734825|Oral Contrast|oral contrast
575646|NCT00734825|CT scan|ct scan
575647|NCT00734812|Hysterectomy|hysterectomy
575648|NCT00734812|Laparoscopic|laparoscopic
575649|NCT00734799|Posttraumatic Stress Disorder|posttraumatic stress disorder
575650|NCT00734799|Insomnia,|insomnia,
575651|NCT00734799|Imagery Rehearsal Therapy,|imagery rehearsal therapy,
575652|NCT00734799|IRT,|irt,
575653|NCT00734799|Cognitive Behavioral Therapy for Insomnia,|cognitive behavioral therapy for insomnia,
575654|NCT00734799|CBTI.|cbti.
575655|NCT00734786|gonyautoxin|gonyautoxin
575656|NCT00734773|neurotoxicity|neurotoxicity
575657|NCT00734773|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
575658|NCT00734773|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
575659|NCT00734760|patient education|patient education
575660|NCT00734760|acute coronary syndrome|acute coronary syndrome
575661|NCT00734760|prehospital delay to treatment|prehospital delay to treatment
575662|NCT00734747|GERD|gerd
575663|NCT00734747|Gastroesophageal Reflux|gastroesophageal reflux
575664|NCT00734747|Fundoplication|fundoplication
575665|NCT00734747|Endoluminal|endoluminal
578805|NCT00722709|Metabolic|metabolic
575666|NCT00734747|Gastroesophageal Flap Valve|gastroesophageal flap valve
575667|NCT00734734|Prophylaxis of Influenza|prophylaxis of influenza
575668|NCT00734734|Influenza Vaccines|influenza vaccines
575669|NCT00734734|MF59C.1|mf59c.1
575670|NCT00734721|intravitreal injection|intravitreal injection
575671|NCT00734695|BURN|burn
575672|NCT00734695|EYE|eye
575673|NCT00734695|VITAMIN C|vitamin c
575674|NCT00734695|ASCORBIC ACID|ascorbic acid
575675|NCT00734682|Glioblastoma|glioblastoma
575676|NCT00734682|Gliosarcoma|gliosarcoma
575677|NCT00734682|Anaplastic Astrocytoma|anaplastic astrocytoma
575678|NCT00734682|Anaplastic Oligodendroglioma|anaplastic oligodendroglioma
575679|NCT00734682|Anaplastic Mixed Oligoastrocytoma|anaplastic mixed oligoastrocytoma
575680|NCT00734682|Malignant Astrocytoma NOS|malignant astrocytoma nos
575681|NCT00734682|Nanoliposomal CPT-11|nanoliposomal cpt-11
575682|NCT00734682|liposomal irinotecan|liposomal irinotecan
575683|NCT00734669|Diabetes|diabetes
575684|NCT00734669|Hypoglycemia|hypoglycemia
575685|NCT00734656|steroid 5Alpha Reductase|steroid 5alpha reductase
575686|NCT00734656|dutasteride|dutasteride
575687|NCT00734656|neuroactive steroid|neuroactive steroid
575688|NCT00734643|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
575689|NCT00734643|Family coping|family coping
575690|NCT00734643|Complex Congenital Heart Disease|complex congenital heart disease
575691|NCT00734630|nebivolol|nebivolol
575692|NCT00734630|Bystolic ™|bystolic ™
575693|NCT00734630|lisinopril|lisinopril
575694|NCT00734630|losartan|losartan
575695|NCT00734630|Hypertension|hypertension
575696|NCT00734617|Cigarette|cigarette
575697|NCT00734617|Nicotine|nicotine
575698|NCT00734591|Observational Study Exubera|observational study exubera
575699|NCT00734565|vaccine|vaccine
575700|NCT00734565|prevention|prevention
575701|NCT00734565|haemophilus influenzae type b|haemophilus influenzae type b
575702|NCT00734565|children|children
575703|NCT00734552|Continuous Ambulatory Peritoneal Dialysis|continuous ambulatory peritoneal dialysis
575704|NCT00734552|α-Keto Acid|α-keto acid
575705|NCT00734552|Low Protein Diet|low protein diet
575706|NCT00734552|Residual Renal Function|residual renal function
575707|NCT00734539|Candida|candida
575708|NCT00734539|Neonate|neonate
575709|NCT00734539|Fluconazole|fluconazole
575710|NCT00734539|Prophylaxis|prophylaxis
575711|NCT00734539|Colonization|colonization
575712|NCT00734539|Resistance|resistance
575713|NCT00734526|Glioblastoma|glioblastoma
575714|NCT00734526|Gliosarcoma|gliosarcoma
575715|NCT00734526|Brain Cancer|brain cancer
575716|NCT00734526|Sorafenib|sorafenib
575717|NCT00734526|Temozolomide|temozolomide
575718|NCT00734526|Radiation|radiation
575719|NCT00734526|Radiotherapy|radiotherapy
575720|NCT00734526|XRT|xrt
575721|NCT00734513|GI Cancer|gi cancer
575722|NCT00734513|Emotional Disclosure|emotional disclosure
575723|NCT00734513|Behavioral Intervention|behavioral intervention
575724|NCT00734513|Partner|partner
575725|NCT00734513|Couples|couples
575726|NCT00734487|Spectral Domain Optical Coherence Tomography|spectral domain optical coherence tomography
575727|NCT00734487|Optical Coherence Tomography|optical coherence tomography
575728|NCT00734487|AREDS2|areds2
575729|NCT00734487|AMD|amd
575730|NCT00734487|Age-related macular degeneration|age-related macular degeneration
575731|NCT00734487|Drusen|drusen
575732|NCT00734474|Diabetes, type 2 diabetes|diabetes, type 2 diabetes
575733|NCT00734461|Non-physically dependent subjects|non-physically dependent subjects
575734|NCT00734461|history of opioid abuse|history of opioid abuse
575735|NCT00734448|gestational diabetes mellitus|gestational diabetes mellitus
575736|NCT00734448|carbohydrate intolerance|carbohydrate intolerance
575737|NCT00734448|myo-inositol|myo-inositol
575738|NCT00734448|insulin resistance|insulin resistance
575739|NCT00734435|schizophrenia|schizophrenia
575740|NCT00734435|schizophreniform|schizophreniform
575741|NCT00734435|schizoaffective disorder|schizoaffective disorder
575742|NCT00734435|Zyprexa|zyprexa
575743|NCT00734435|olanzapine|olanzapine
575744|NCT00734422|Phobic Disorders (Fear of Flying)|phobic disorders (fear of flying)
575745|NCT00734422|Virtual Reality Exposure Therapy|virtual reality exposure therapy
575746|NCT00734422|Fear extinction|fear extinction
575747|NCT00734422|Yohimbine|yohimbine
575748|NCT00734409|Mechanical ventilation|mechanical ventilation
575749|NCT00734409|Human|human
575750|NCT00734409|conscious sedation|conscious sedation
575751|NCT00734409|bispectral index|bispectral index
575752|NCT00734409|monitoring|monitoring
575753|NCT00734409|critical care|critical care
575754|NCT00734409|propofol|propofol
575755|NCT00734396|Mesenchymal stem cells|mesenchymal stem cells
575756|NCT00734396|Allograft rejection|allograft rejection
575757|NCT00734396|Subclinical rejection|subclinical rejection
575758|NCT00734383|coronary artery bypass surgery|coronary artery bypass surgery
575759|NCT00734383|coronary artery bypass grafting|coronary artery bypass grafting
575760|NCT00734383|cardiopulmonary bypass|cardiopulmonary bypass
575761|NCT00734383|diabetes|diabetes
575762|NCT00734383|myocardial injury markers,|myocardial injury markers,
575763|NCT00734383|sex differences|sex differences
575764|NCT00734383|cardiac anesthesia|cardiac anesthesia
575765|NCT00734383|inhalational anesthetics|inhalational anesthetics
575766|NCT00734370|Panic Disorder and Agoraphobia|panic disorder and agoraphobia
575767|NCT00734370|Virtual Reality Exposure Therapy|virtual reality exposure therapy
575768|NCT00734357|contrast|contrast
575769|NCT00734357|ct|ct
575770|NCT00734357|cat scan|cat scan
575771|NCT00734357|kidney|kidney
575772|NCT00734357|nephrotoxicity|nephrotoxicity
575773|NCT00734357|Computerized Emission Tomography|computerized emission tomography
575774|NCT00734331|inflammatory bowel disease|inflammatory bowel disease
575775|NCT00734331|micro RNA|micro rna
575776|NCT00734331|cholinergic tone|cholinergic tone
575777|NCT00734331|inflammation|inflammation
575778|NCT00734318|Severe asthma|severe asthma
575779|NCT00734318|Fluticasone|fluticasone
575780|NCT00734318|Formoterol|formoterol
575781|NCT00734305|cancer, solid tumors, oncology, Phase I, ErbB3, HER3|cancer, solid tumors, oncology, phase i, erbb3, her3
575782|NCT00734305|(erbB-3, HER-3)|(erbb-3, her-3)
575783|NCT00734292|Asthma|asthma
575784|NCT00734292|Asthma Mild to Moderate|asthma mild to moderate
575785|NCT00734279|Puberty|puberty
575786|NCT00734279|Delayed|delayed
575787|NCT00734279|Early|early
575788|NCT00734279|Precocious|precocious
575789|NCT00734279|Peripubertal|peripubertal
575790|NCT00734279|Gonadotropin|gonadotropin
575791|NCT00734279|FSH|fsh
575792|NCT00734279|LH|lh
575793|NCT00734266|COPD|copd
575794|NCT00734266|CPB|cpb
575795|NCT00734266|Leukotrienes|leukotrienes
575796|NCT00734253|Nephropathy|nephropathy
575797|NCT00734253|Kidney Disease|kidney disease
575798|NCT00734253|Diabetes|diabetes
575799|NCT00734253|Pyridoxamine|pyridoxamine
575800|NCT00734253|Pyridorin|pyridorin
575801|NCT00734253|NephroGenex|nephrogenex
575802|NCT00734253|PYR-210|pyr-210
575803|NCT00734227|Survival and control of hemorrhage|survival and control of hemorrhage
575804|NCT00734214|Parenteral Fluids|parenteral fluids
575805|NCT00734214|Isotonic|isotonic
575806|NCT00734214|Hypotonic|hypotonic
575807|NCT00734214|Pediatric|pediatric
575808|NCT00734214|Fluid overload|fluid overload
575809|NCT00734201|Study effects on blood pressure and weight in obese subjects|study effects on blood pressure and weight in obese subjects
575810|NCT00734175|Vaccine|vaccine
575811|NCT00734175|Influenza|influenza
575812|NCT00734162|tenofovir|tenofovir
575813|NCT00734162|adolescents|adolescents
575814|NCT00734162|chronic hepatitis B|chronic hepatitis b
575815|NCT00734149|Multiple myeloma|multiple myeloma
575816|NCT00734136|Angiogenic Factors|angiogenic factors
575817|NCT00734136|Hepatorenal Syndrome|hepatorenal syndrome
575818|NCT00734136|Liver Disease|liver disease
575819|NCT00734136|Renal Failure|renal failure
575820|NCT00734136|Liver Cirrhosis|liver cirrhosis
575821|NCT00734136|Ascites|ascites
575822|NCT00734123|Atherosclerosis|atherosclerosis
575823|NCT00734123|Cardiovascular Prevention|cardiovascular prevention
575824|NCT00734123|Carotid Intima-Media Thickness|carotid intima-media thickness
575825|NCT00734123|Ankle-Brachial Index|ankle-brachial index
575826|NCT00734110|Arthroplasty, Replacement, Knee, P.F.C. Sigma RPF, Sigma RP|arthroplasty, replacement, knee, p.f.c. sigma rpf, sigma rp
575827|NCT00734097|heartburn|heartburn
575828|NCT00734097|reflux|reflux
575829|NCT00734097|proton|proton
575830|NCT00734097|pump|pump
575831|NCT00734097|inhibitor|inhibitor
575832|NCT00734084|Arthroplasty|arthroplasty
575833|NCT00734084|Knee|knee
575834|NCT00734084|UKA|uka
575835|NCT00734084|Partial|partial
575836|NCT00734084|Preservation|preservation
575837|NCT00734071|Generalized Anxiety Disorder|generalized anxiety disorder
575838|NCT00734071|Mood Disorder|mood disorder
575839|NCT00734071|Affective Disorder|affective disorder
575840|NCT00734071|Anxiety Disorder|anxiety disorder
575841|NCT00734071|Drug Therapy|drug therapy
575842|NCT00734058|Ablation|ablation
575843|NCT00734058|AF|af
575844|NCT00734058|Atrial Fibrillation|atrial fibrillation
575845|NCT00734058|Cardiac|cardiac
575846|NCT00734058|Endocardial|endocardial
575847|NCT00734058|Endocardium|endocardium
575848|NCT00734058|EP|ep
575849|NCT00734058|Electrophysiology|electrophysiology
575850|NCT00734058|Epicardial|epicardial
575851|NCT00734058|Epicardium|epicardium
575852|NCT00734058|Heart|heart
575853|NCT00734058|Interventional|interventional
575854|NCT00734058|Lesion|lesion
575855|NCT00734058|PVI|pvi
575856|NCT00734058|Pulmonary Vein|pulmonary vein
575857|NCT00734058|MAZE|maze
575858|NCT00734058|Surgery|surgery
575859|NCT00734058|Surgical|surgical
575860|NCT00734058|Treatment|treatment
575861|NCT00734058|Patients with persistent AF with 3 months duration|patients with persistent af with 3 months duration
575862|NCT00734058|Requiring concomitant open heart surgery|requiring concomitant open heart surgery
575863|NCT00734045|Congestive Heart Failure (CHF)|congestive heart failure (chf)
575864|NCT00734045|NT-proBNP|nt-probnp
575865|NCT00734032|SB-480848|sb-480848
575866|NCT00734032|Dyslipidaemia|dyslipidaemia
575867|NCT00734019|Arthroplasty, Replacement, Knee, TKR, PFC Sigma|arthroplasty, replacement, knee, tkr, pfc sigma
575868|NCT00734006|Cortico-cortical|cortico-cortical
578806|NCT00722709|Endocrine|endocrine
575869|NCT00734006|connectivity|connectivity
575870|NCT00734006|Transcranial|transcranial
575871|NCT00734006|Magnetic|magnetic
575872|NCT00734006|Stimulation|stimulation
575873|NCT00733993|substance abuse|substance abuse
575874|NCT00733993|cocaine|cocaine
575875|NCT00733993|caffeine|caffeine
575876|NCT00733993|impulsivity|impulsivity
575877|NCT00733980|Depressive Disorder, Major|depressive disorder, major
575878|NCT00733967|Methamphetamine|methamphetamine
575879|NCT00733967|Chantix|chantix
575880|NCT00733967|Varenicline|varenicline
575881|NCT00733941|Exercise test|exercise test
575882|NCT00733941|Running|running
575883|NCT00733941|Arterial diameter|arterial diameter
575884|NCT00733941|Monitoring, physiologic|monitoring, physiologic
575885|NCT00733941|Oxygen Consumption|oxygen consumption
575886|NCT00733928|Arthroplasty,|arthroplasty,
575887|NCT00733928|Replacement,|replacement,
575888|NCT00733928|Knee,|knee,
575889|NCT00733928|P.F.C.|p.f.c.
575890|NCT00733928|Sigma|sigma
575891|NCT00733928|all-polyethylene|all-polyethylene
575892|NCT00733915|Arthroplasty, knee, TKA, TKR, Duofix, Porocoat, LCS|arthroplasty, knee, tka, tkr, duofix, porocoat, lcs
575893|NCT00733902|monoclonal antibody|monoclonal antibody
575894|NCT00733902|RN624|rn624
575895|NCT00733902|PF-04383119|pf-04383119
575896|NCT00733902|nerve growth factor|nerve growth factor
575897|NCT00733902|anti-nerve growth factor|anti-nerve growth factor
575898|NCT00733902|OA|oa
575899|NCT00733902|pain|pain
575900|NCT00733889|esophageal carcinoma|esophageal carcinoma
575901|NCT00733889|cetuximab|cetuximab
575902|NCT00733889|docetaxel|docetaxel
575903|NCT00733889|cisplatin|cisplatin
575904|NCT00733889|5-fluorouracil|5-fluorouracil
575905|NCT00733876|Acute Renal Failure Cardiac Surgery Stem Cell|acute renal failure cardiac surgery stem cell
575906|NCT00733863|Active immunization|active immunization
575907|NCT00733863|Alzheimer disease|alzheimer disease
575908|NCT00733863|Antibody|antibody
575909|NCT00733863|Central Nervous System Diseases|central nervous system diseases
575910|NCT00733863|Neurodegenerative diseases|neurodegenerative diseases
575911|NCT00733863|Vaccine|vaccine
575912|NCT00733824|Plerixafor|plerixafor
575913|NCT00733824|Lymphoma|lymphoma
575914|NCT00733824|Hematopoietic Stem Cell Mobilization|hematopoietic stem cell mobilization
575915|NCT00733824|Transplantation, Autologous|transplantation, autologous
575916|NCT00733824|Receptors, CXCR4|receptors, cxcr4
575917|NCT00733811|thalassemia major|thalassemia major
575918|NCT00733811|chelation treatment|chelation treatment
575919|NCT00733811|secondary hemochromatosis|secondary hemochromatosis
575920|NCT00733798|Melanoma|melanoma
575921|NCT00733798|Malignant melanoma|malignant melanoma
575922|NCT00733798|metastatic melanoma|metastatic melanoma
575923|NCT00733798|Phase 1|phase 1
575924|NCT00733798|Phase 2|phase 2
575925|NCT00733785|Rosiglitazone XR|rosiglitazone xr
575926|NCT00733785|Pharmacokinetics|pharmacokinetics
575927|NCT00733785|Strength Equivalence.|strength equivalence.
575928|NCT00733785|Alzheimers Disease|alzheimers disease
575929|NCT00733785|Repeat dose|repeat dose
575930|NCT00733785|Dose proportionality|dose proportionality
575931|NCT00733772|flaxseed|flaxseed
575932|NCT00733772|lignans|lignans
575933|NCT00733772|alpha-Linolenic Acid|alpha-linolenic acid
575934|NCT00733772|LDL Cholesterol|ldl cholesterol
575935|NCT00733746|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
575936|NCT00733746|stage I pancreatic cancer|stage i pancreatic cancer
575937|NCT00733746|stage II pancreatic cancer|stage ii pancreatic cancer
575938|NCT00733733|kidney|kidney
575939|NCT00733733|transplantation|transplantation
575940|NCT00733733|non-heart-beating donor|non-heart-beating donor
575941|NCT00733733|delayed graft function|delayed graft function
575942|NCT00733733|Antithymocyte globulin|antithymocyte globulin
575943|NCT00733733|ischemia-reperfusion damage|ischemia-reperfusion damage
575944|NCT00733707|adherence|adherence
575945|NCT00733707|oral contraceptive pills|oral contraceptive pills
575946|NCT00733707|contraception|contraception
575947|NCT00733707|text messaging|text messaging
575948|NCT00733694|Arthroplasty, Replacement, Knee,LCS|arthroplasty, replacement, knee,lcs
575949|NCT00733681|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
575950|NCT00733681|Prosthesis Failure|prosthesis failure
575951|NCT00733681|Revision surgery|revision surgery
575952|NCT00733668|considered|considered
575953|NCT00733668|entry|entry
575954|NCT00733668|into|into
575955|NCT00733668|the study|the study
575956|NCT00733668|SSRI|ssri
575957|NCT00733668|Seroquel|seroquel
575958|NCT00733668|Quetiapine|quetiapine
575959|NCT00733668|fumarate|fumarate
575960|NCT00733668|antipsychotic|antipsychotic
575961|NCT00733642|antibody amyloid Alzheimer's Disease AD|antibody amyloid alzheimer's disease ad
575962|NCT00733616|advanced gastric adenocarcinoma|advanced gastric adenocarcinoma
575963|NCT00733616|docetaxel|docetaxel
575964|NCT00733616|oxaliplatin|oxaliplatin
575965|NCT00733616|capecitabine|capecitabine
575966|NCT00733616|intermediate general status|intermediate general status
575967|NCT00733603|Interstitial Cystitis|interstitial cystitis
575968|NCT00733603|IC|ic
575969|NCT00733603|Painful Bladder Syndrome|painful bladder syndrome
575971|NCT00733603|Bladder Pain|bladder pain
575972|NCT00733603|Pelvic Pain|pelvic pain
575973|NCT00733590|defibrillator, implanted|defibrillator, implanted
575974|NCT00733590|genomics|genomics
575975|NCT00733590|electrocardiography|electrocardiography
575976|NCT00733590|electrophysiological study|electrophysiological study
575977|NCT00733590|proteomics|proteomics
575978|NCT00733577|diabetes|diabetes
575979|NCT00733577|pharmacodynamics|pharmacodynamics
575980|NCT00733577|safety|safety
575981|NCT00733577|pharmacokinetics|pharmacokinetics
575982|NCT00733564|Local anesthetic|local anesthetic
575983|NCT00733564|Propofol|propofol
575984|NCT00733564|Sevoflurane|sevoflurane
575985|NCT00733551|motilin|motilin
575986|NCT00733551|gastric emptying|gastric emptying
575987|NCT00733551|GSK962040|gsk962040
575988|NCT00733551|oral dose|oral dose
575989|NCT00733538|stage I multiple myeloma|stage i multiple myeloma
575990|NCT00733525|Bulimia Nervosa|bulimia nervosa
575991|NCT00733512|ReSTOR Aspheric +4 IOL|restor aspheric +4 iol
575992|NCT00733499|Arthroplasty, replacement, Knee, LCS Duofix, Porocoat|arthroplasty, replacement, knee, lcs duofix, porocoat
575993|NCT00733486|Arthroplasty, Replacement, Knee, LCS Complete APG (MeSH);|arthroplasty, replacement, knee, lcs complete apg (mesh);
575994|NCT00733473|Wheezing|wheezing
575995|NCT00733473|Acute asthma|acute asthma
575996|NCT00733473|Children|children
575997|NCT00733460|BFPET|bfpet
575998|NCT00733460|Coronary Artery Disease|coronary artery disease
575999|NCT00733460|Myocardial Perfusion Imaging|myocardial perfusion imaging
576000|NCT00733460|Radiation Dosimetry|radiation dosimetry
576001|NCT00733447|Biventricular failure|biventricular failure
576002|NCT00733434|Microsurgery|microsurgery
576003|NCT00733434|Head and neck|head and neck
576004|NCT00733434|Prostaglandin E1|prostaglandin e1
576005|NCT00733434|Thrombosis|thrombosis
576006|NCT00733434|Complication|complication
576007|NCT00733421|Day surgery|day surgery
576008|NCT00733421|Hallux Valgus|hallux valgus
576009|NCT00733421|Pain|pain
576010|NCT00733421|Analgesics|analgesics
576011|NCT00733395|Muscle pain|muscle pain
576012|NCT00733382|migraine|migraine
576013|NCT00733382|dexamethasone|dexamethasone
576014|NCT00733382|dihydroergotamine|dihydroergotamine
576015|NCT00733369|Arthroplasty|arthroplasty
576016|NCT00733369|Replacement|replacement
576017|NCT00733369|Knee|knee
576018|NCT00733369|PFC Sigma RPF|pfc sigma rpf
576019|NCT00733369|PFC Sigma RP|pfc sigma rp
576020|NCT00733356|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
576021|NCT00733356|ADHD|adhd
576022|NCT00733356|ADD|add
576023|NCT00733356|reading|reading
576024|NCT00733356|brain hemodynamics|brain hemodynamics
576025|NCT00733356|brain imaging|brain imaging
576026|NCT00733356|attention|attention
576027|NCT00733356|Near-Infrared Spectroscopy|near-infrared spectroscopy
576028|NCT00733356|NIRS|nirs
576029|NCT00733356|MSIT|msit
576030|NCT00733343|heart failure|heart failure
576031|NCT00733343|sleep disordered breathing|sleep disordered breathing
576032|NCT00733343|sleep apnea|sleep apnea
576033|NCT00733343|left ventricular systolic dysfunction|left ventricular systolic dysfunction
576034|NCT00733343|SBAS|sbas
576035|NCT00733343|HF|hf
576036|NCT00733330|Arthroplasty, Knee, TKA, TKR, CAS, minimally invasive|arthroplasty, knee, tka, tkr, cas, minimally invasive
576037|NCT00733317|Wheezing|wheezing
576038|NCT00733317|Acute asthma|acute asthma
576039|NCT00733317|Children|children
576040|NCT00733317|Budesonide|budesonide
576041|NCT00733317|Emergency room|emergency room
576042|NCT00733304|age-related macular degeneration (AMD)|age-related macular degeneration (amd)
576043|NCT00733304|choroidal neovascularization (CNV)|choroidal neovascularization (cnv)
576044|NCT00733304|vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
576045|NCT00733304|pazopanib|pazopanib
576046|NCT00733304|angiogenesis|angiogenesis
576047|NCT00733291|Daily disposable contact lenses|daily disposable contact lenses
576048|NCT00733291|Multi-purpose disinfecting solutions|multi-purpose disinfecting solutions
576049|NCT00733278|Postpartum contraception|postpartum contraception
576050|NCT00733278|Copper IUD|copper iud
576051|NCT00733265|Renal Impairment|renal impairment
576052|NCT00733252|non-small cell lung cancer|non-small cell lung cancer
576053|NCT00733252|small cell lung cancer|small cell lung cancer
576054|NCT00733252|benign respiratory tract neoplasm|benign respiratory tract neoplasm
576055|NCT00733252|lung papilloma|lung papilloma
576056|NCT00733252|recurrent respiratory papillomatosis|recurrent respiratory papillomatosis
576057|NCT00733252|squamous lung dysplasia|squamous lung dysplasia
576058|NCT00733252|malignant mesothelioma|malignant mesothelioma
576059|NCT00733252|pulmonary carcinoid tumor|pulmonary carcinoid tumor
576060|NCT00733252|lung metastases|lung metastases
576061|NCT00733239|methadone|methadone
576062|NCT00733239|opioid dependence|opioid dependence
576063|NCT00733239|opioid|opioid
576064|NCT00733226|wheezing|wheezing
576065|NCT00733226|asthma|asthma
576066|NCT00733226|childhood|childhood
576067|NCT00733226|OM-85 BV|om-85 bv
576068|NCT00733226|Broncho-Vaxom|broncho-vaxom
576175|NCT00732836|nab paclitaxel|nab paclitaxel
576069|NCT00733213|Prostate Cancer, Treatment alternatives, Metastasis|prostate cancer, treatment alternatives, metastasis
576070|NCT00733200|Minor Liver Resection|minor liver resection
576071|NCT00733200|Major Liver Resection|major liver resection
576072|NCT00733200|Hilar|hilar
576073|NCT00733174|IGT|igt
576074|NCT00733161|passive leg exercise|passive leg exercise
576075|NCT00733161|congestive heart failure|congestive heart failure
576076|NCT00733161|endothelium-derived factors|endothelium-derived factors
576077|NCT00733161|elderly|elderly
576078|NCT00733148|glucose, interstitial, intensive care|glucose, interstitial, intensive care
576079|NCT00733135|peripheral vascular disease|peripheral vascular disease
576080|NCT00733135|atherectomy|atherectomy
576081|NCT00733135|atherosclerosis|atherosclerosis
576082|NCT00733135|calcified lesions|calcified lesions
576083|NCT00733109|CIN2|cin2
576084|NCT00733109|management|management
576085|NCT00733096|radiculopathy|radiculopathy
576086|NCT00733096|sciatica|sciatica
576087|NCT00733096|low back pain|low back pain
576088|NCT00733083|tonsillectomy|tonsillectomy
576089|NCT00733083|paediatric|paediatric
576090|NCT00733083|pain|pain
576091|NCT00733083|child|child
576092|NCT00733083|opiates|opiates
576093|NCT00733083|pre-emptive|pre-emptive
576094|NCT00733083|oxycodone|oxycodone
576095|NCT00733083|morphine|morphine
576096|NCT00733083|dexamethasone|dexamethasone
576097|NCT00733070|CTO|cto
576098|NCT00733070|Chronic Total Occlusion|chronic total occlusion
576099|NCT00733070|Revascularization|revascularization
576100|NCT00733057|Minocycline|minocycline
576101|NCT00733057|Schizophrenia|schizophrenia
576102|NCT00733057|Negative symptoms|negative symptoms
576103|NCT00733057|Cognitive|cognitive
576104|NCT00733044|Objective tinnitus|objective tinnitus
576105|NCT00733044|Tinnitus|tinnitus
576106|NCT00733044|RCT|rct
576107|NCT00733044|Specialised treatment|specialised treatment
576108|NCT00733044|Usual care|usual care
576109|NCT00733044|Cost-effectiveness|cost-effectiveness
576110|NCT00733031|Phase I,|phase i,
576111|NCT00733031|cancer,|cancer,
576112|NCT00733031|solid tumors,|solid tumors,
576113|NCT00733031|advanced solid malignancies,|advanced solid malignancies,
576114|NCT00733031|dose escalation,|dose escalation,
576115|NCT00733031|combination treatment,|combination treatment,
576116|NCT00733031|TRK inhibitor|trk inhibitor
576117|NCT00733018|Nutrigenomics|nutrigenomics
576118|NCT00733018|Gene Expression|gene expression
576119|NCT00733018|Diet, Carbohydrate-Restricted|diet, carbohydrate-restricted
576120|NCT00733018|Life Style|life style
576121|NCT00733018|Health Behavior|health behavior
576122|NCT00732992|Solid tumor|solid tumor
576123|NCT00732992|malignancy|malignancy
576124|NCT00732992|sunitinib|sunitinib
576125|NCT00732992|pemetrexed|pemetrexed
576126|NCT00732992|phase 1|phase 1
576127|NCT00732992|neoplasms|neoplasms
576128|NCT00732979|Elective|elective
576129|NCT00732979|hepatic|hepatic
576130|NCT00732979|resection|resection
576131|NCT00732979|due to any|due to any
576132|NCT00732979|reason.|reason.
576133|NCT00732966|cyp2c9|cyp2c9
576134|NCT00732966|losartan|losartan
576135|NCT00732966|pharmacogenetics|pharmacogenetics
576136|NCT00732966|pharmacokinetics|pharmacokinetics
576137|NCT00732966|pharmacodynamics|pharmacodynamics
576138|NCT00732953|patients with coronary artery disease|patients with coronary artery disease
576139|NCT00732953|percutaneous coronary intervention|percutaneous coronary intervention
576140|NCT00732953|stent implantation|stent implantation
576141|NCT00732953|paclitaxel eluting balloon|paclitaxel eluting balloon
576142|NCT00732953|angiographic follow-up|angiographic follow-up
576143|NCT00732953|clinical follow-up|clinical follow-up
576144|NCT00732940|SLE|sle
576145|NCT00732940|Lupus|lupus
576146|NCT00732940|Systemic Lupus Erythematosus|systemic lupus erythematosus
576147|NCT00732940|Antibodies|antibodies
576148|NCT00732940|Autoimmune Diseases|autoimmune diseases
576149|NCT00732940|Belimumab|belimumab
576150|NCT00732927|thrombosis, vein, retina|thrombosis, vein, retina
576151|NCT00732914|Renal Cell Carcinoma|renal cell carcinoma
576152|NCT00732914|Sunitinib|sunitinib
576153|NCT00732914|Sorafenib|sorafenib
576154|NCT00732914|Sequential|sequential
576155|NCT00732901|substance abuse|substance abuse
576156|NCT00732901|cocaine|cocaine
576157|NCT00732901|impulsivity|impulsivity
576158|NCT00732901|serotonin|serotonin
576159|NCT00732901|Remeron|remeron
576160|NCT00732901|Mirtzapine|mirtzapine
576161|NCT00732901|Lexapro|lexapro
576162|NCT00732901|Escatilopram|escatilopram
576163|NCT00732888|Pharmacokinetics|pharmacokinetics
576164|NCT00732888|Healthy volunteers|healthy volunteers
576165|NCT00732888|No condition|no condition
576166|NCT00732888|Pharmacokinetics study|pharmacokinetics study
576167|NCT00732862|Type 2 diabetes|type 2 diabetes
576168|NCT00732862|intensive therapy|intensive therapy
576169|NCT00732849|immunonutrition|immunonutrition
576170|NCT00732849|surgical patients|surgical patients
576171|NCT00732849|postoperative period|postoperative period
576172|NCT00732836|Liver Cancer|liver cancer
576173|NCT00732836|Solid Cancer|solid cancer
576176|NCT00732836|HAI abraxane|hai abraxane
576177|NCT00732836|HAI|hai
576178|NCT00732836|hepatic arterial infusion|hepatic arterial infusion
576179|NCT00732836|hepatic metastases|hepatic metastases
576180|NCT00732797|Dizziness|dizziness
576181|NCT00732797|Self-management|self-management
576182|NCT00732797|booklet-based|booklet-based
576183|NCT00732797|vestibular rehabilitation|vestibular rehabilitation
576184|NCT00732784|Pharmacokinetics|pharmacokinetics
576185|NCT00732784|Healthy volunteers|healthy volunteers
576186|NCT00732784|No condition|no condition
576187|NCT00732784|Pharmacokinetics study|pharmacokinetics study
576188|NCT00732771|primary hyperaldosteronism|primary hyperaldosteronism
576189|NCT00732771|hypokalemia|hypokalemia
576190|NCT00732771|hypertension|hypertension
576191|NCT00732771|aldosterone synthase inhibitor|aldosterone synthase inhibitor
576192|NCT00732758|Vitamin D Deficiency|vitamin d deficiency
576193|NCT00732758|Vitamin D Insufficiency|vitamin d insufficiency
576194|NCT00732758|Child|child
576195|NCT00732758|Adolescent|adolescent
576196|NCT00732758|African American|african american
576197|NCT00732758|Caucasian|caucasian
576198|NCT00732758|Definition|definition
576199|NCT00732758|Preadolescent|preadolescent
576200|NCT00732745|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
576201|NCT00732745|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
576202|NCT00732745|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
576203|NCT00732745|stage III esophageal cancer|stage iii esophageal cancer
576204|NCT00732745|stage IV esophageal cancer|stage iv esophageal cancer
576205|NCT00732745|recurrent esophageal cancer|recurrent esophageal cancer
576206|NCT00732732|diarrhea|diarrhea
576207|NCT00732732|Plantain|plantain
576208|NCT00732732|Green banana|green banana
576209|NCT00732732|Infants|infants
576210|NCT00732732|Children|children
576211|NCT00732706|FNB|fnb
576212|NCT00732706|Femoral Nerve|femoral nerve
576213|NCT00732706|Sartorius Twitch|sartorius twitch
576214|NCT00732706|Quadriceps Twitch|quadriceps twitch
576215|NCT00732706|Analgesia|analgesia
576216|NCT00732706|Anesthesia|anesthesia
576217|NCT00732693|Premature ovarian failure|premature ovarian failure
576218|NCT00732693|Sex hormone replacement|sex hormone replacement
576219|NCT00732693|HRT|hrt
576220|NCT00732693|Blood pressure|blood pressure
576221|NCT00732693|Bone mineral density|bone mineral density
576222|NCT00732693|Bone metabolism|bone metabolism
576223|NCT00732693|Uterine function|uterine function
576224|NCT00732680|Empty nose syndrome|empty nose syndrome
576225|NCT00732680|Over resection of turbinate|over resection of turbinate
576226|NCT00732680|Atrophic rhinitis|atrophic rhinitis
576227|NCT00732654|Food Allergy|food allergy
576228|NCT00732654|Oral Immunotherapy|oral immunotherapy
576229|NCT00732654|Immunoglobulin E|immunoglobulin e
576230|NCT00732615|Hypoparathyroidism|hypoparathyroidism
576231|NCT00732602|Glucagon|glucagon
576232|NCT00732602|Glucose-dependent Insulinotropic Polypeptide|glucose-dependent insulinotropic polypeptide
576233|NCT00732602|Glucagon-Like peptide 2|glucagon-like peptide 2
576234|NCT00732589|suprascapular nerve block|suprascapular nerve block
576235|NCT00732589|shoulder pain|shoulder pain
576236|NCT00732589|hemiplegia|hemiplegia
576237|NCT00732576|Cardiovascular|cardiovascular
576238|NCT00732576|Calcification|calcification
576239|NCT00732563|stage I non-small cell lung cancer|stage i non-small cell lung cancer
576240|NCT00732563|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
576241|NCT00732550|cholelithiasis|cholelithiasis
576242|NCT00732550|cholecystitis|cholecystitis
576243|NCT00732537|Hypoxia|hypoxia
576244|NCT00732537|Respiratory failure|respiratory failure
576245|NCT00732537|Infant, term|infant, term
576246|NCT00732537|Nitric oxide|nitric oxide
576247|NCT00732524|Hyperglycemia|hyperglycemia
576248|NCT00732524|Glucose toxicity|glucose toxicity
576249|NCT00732524|Glargine|glargine
576250|NCT00732524|Glipizide|glipizide
576251|NCT00732511|Endothelial dysfunction|endothelial dysfunction
576252|NCT00732511|Blood vessel stiffness|blood vessel stiffness
576253|NCT00732511|Nitric oxide|nitric oxide
576254|NCT00732511|Oxidative stress|oxidative stress
576255|NCT00732498|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
576256|NCT00732498|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
576257|NCT00732498|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
576258|NCT00732498|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
576259|NCT00732498|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
576260|NCT00732498|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
576261|NCT00732498|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
576262|NCT00732498|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
576263|NCT00732498|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
576264|NCT00732498|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
576265|NCT00732498|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
576353|NCT00732199|ventilation|ventilation
576266|NCT00732498|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
576267|NCT00732498|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
576268|NCT00732498|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
576269|NCT00732498|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
576270|NCT00732485|Burn injury|burn injury
576271|NCT00732485|Fenofibrate|fenofibrate
576272|NCT00732485|Insulin resistance|insulin resistance
576273|NCT00732485|Mitochondrial function|mitochondrial function
576274|NCT00732485|Fat oxidation|fat oxidation
576275|NCT00732485|PPAR|ppar
576276|NCT00732485|Protein|protein
576277|NCT00732485|Glucose|glucose
576278|NCT00732485|Wound|wound
576279|NCT00732472|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
576280|NCT00732472|Magnesium stearate|magnesium stearate
576281|NCT00732472|GSK573719|gsk573719
576282|NCT00732459|myocardial protection|myocardial protection
576283|NCT00732459|cardiac surgery|cardiac surgery
576284|NCT00732459|heart valve replacement|heart valve replacement
576285|NCT00732446|moxifloxacin|moxifloxacin
576286|NCT00732446|dexamethasone|dexamethasone
576287|NCT00732446|ocular inflammation|ocular inflammation
576288|NCT00732446|ocular infection|ocular infection
576289|NCT00732420|pazopanib|pazopanib
576290|NCT00732420|Phase I|phase i
576291|NCT00732420|topotecan|topotecan
576292|NCT00732420|Advanced Solid Tumors|advanced solid tumors
576293|NCT00732407|aliskiren|aliskiren
576294|NCT00732407|arteial stiffness|arteial stiffness
576295|NCT00732407|platelet function|platelet function
576296|NCT00732407|diabetes mellitus|diabetes mellitus
576297|NCT00732355|syphilis|syphilis
576298|NCT00732342|Alcohol Abuse|alcohol abuse
576299|NCT00732342|Contingency Management|contingency management
576300|NCT00732342|Treatment Duration|treatment duration
576301|NCT00732316|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
576302|NCT00732316|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
576303|NCT00732316|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
576304|NCT00732316|acute undifferentiated leukemia|acute undifferentiated leukemia
576305|NCT00732316|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
576306|NCT00732316|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
576307|NCT00732316|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
576308|NCT00732316|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
576309|NCT00732316|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
576310|NCT00732316|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
576311|NCT00732316|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
576312|NCT00732316|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
576313|NCT00732316|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
576314|NCT00732316|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
576315|NCT00732316|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
576316|NCT00732316|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
576317|NCT00732316|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
576318|NCT00732316|refractory anemia with excess blasts|refractory anemia with excess blasts
576319|NCT00732316|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
576320|NCT00732316|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
576321|NCT00732316|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
576322|NCT00732290|Healthy volunteer|healthy volunteer
576323|NCT00732290|Pharmacokinetic|pharmacokinetic
576324|NCT00732290|pharmacodynamic|pharmacodynamic
576325|NCT00732290|Polymorphism, Genetic|polymorphism, genetic
576326|NCT00732277|sepsis|sepsis
576327|NCT00732277|septicaemia|septicaemia
576328|NCT00732277|septicemia|septicemia
576329|NCT00732277|paediatric|paediatric
576330|NCT00732277|pediatric|pediatric
576331|NCT00732277|children|children
576332|NCT00732251|Bipolar Disorder|bipolar disorder
576333|NCT00732251|Stable Bipolar Disorder|stable bipolar disorder
576334|NCT00732251|Mania|mania
576335|NCT00732251|Mixed mania|mixed mania
576336|NCT00732251|Allopurinol|allopurinol
576337|NCT00732238|Spinal Cord Injury|spinal cord injury
576338|NCT00732238|Urinary Tract Infection|urinary tract infection
576339|NCT00732238|Catheter Dependent|catheter dependent
576340|NCT00732225|DisCoVisc OVD|discovisc ovd
576341|NCT00732225|Ophthalmic Viscosurgical Device|ophthalmic viscosurgical device
576342|NCT00732212|UGI Bleeding|ugi bleeding
576343|NCT00732212|Ulcer or variceal hemorrhage|ulcer or variceal hemorrhage
576344|NCT00732212|Stigmata of recent hemorrhage|stigmata of recent hemorrhage
576345|NCT00732212|Endoscopy|endoscopy
576346|NCT00732212|Randomized Controlled Trial|randomized controlled trial
576347|NCT00732212|Non-variceal UGI hemorrhage|non-variceal ugi hemorrhage
576348|NCT00732212|Variceal hemorrhage|variceal hemorrhage
576349|NCT00732199|apneic threshold|apneic threshold
576350|NCT00732199|central apnea|central apnea
576351|NCT00732199|intermittent hypoxia|intermittent hypoxia
576352|NCT00732199|aging|aging
576354|NCT00732199|chemoresponsiveness|chemoresponsiveness
576355|NCT00732199|carbon-dioxide reserve|carbon-dioxide reserve
576356|NCT00732173|stage I endometrial carcinoma|stage i endometrial carcinoma
576357|NCT00732173|stage II endometrial carcinoma|stage ii endometrial carcinoma
576358|NCT00732160|Glucose|glucose
576359|NCT00732160|Insulin|insulin
576360|NCT00732147|triglycerides|triglycerides
576361|NCT00732147|endogenous|endogenous
576362|NCT00732147|glucose|glucose
576363|NCT00732147|production|production
576364|NCT00732121|Type 2 Diabetes|type 2 diabetes
576365|NCT00732108|migraine|migraine
576366|NCT00732108|headache|headache
576367|NCT00732108|dizziness|dizziness
576368|NCT00732108|vertigo|vertigo
576369|NCT00732108|topiramate|topiramate
576370|NCT00732108|Topamax|topamax
576371|NCT00732095|Self-change|self-change
576372|NCT00732095|Natural recovery|natural recovery
576373|NCT00732095|Alcohol Drinking|alcohol drinking
576374|NCT00732095|Mechanisms of Change|mechanisms of change
576375|NCT00732095|Advertisements|advertisements
576376|NCT00732082|LAG-3 and gemcitabine treatment for advanced pancreas cancer|lag-3 and gemcitabine treatment for advanced pancreas cancer
576377|NCT00732069|hemodialysis|hemodialysis
576378|NCT00732069|oxidative stress|oxidative stress
576379|NCT00732069|inflammation|inflammation
576380|NCT00732069|kallikrein-kinin|kallikrein-kinin
576381|NCT00732069|angiotensin receptor blockade|angiotensin receptor blockade
576382|NCT00732069|angiotensin converting enzyme inhibition|angiotensin converting enzyme inhibition
576383|NCT00732069|RAAS|raas
576384|NCT00732069|fibrinolysis|fibrinolysis
576385|NCT00732069|endothelial dysfunction|endothelial dysfunction
576386|NCT00732056|Metastatic Breast Cancer|metastatic breast cancer
576387|NCT00732056|Recurrent Breast Cancer|recurrent breast cancer
576388|NCT00732043|prostate cancer|prostate cancer
576389|NCT00732043|prostate-specific antigen|prostate-specific antigen
576390|NCT00732043|PSA|psa
576391|NCT00732043|pomegranate|pomegranate
576392|NCT00732030|Toric IOL|toric iol
576393|NCT00732017|Sprain|sprain
576394|NCT00732017|Electric stimulation|electric stimulation
576395|NCT00732017|Physical trauma|physical trauma
576396|NCT00732017|Inflammation|inflammation
576397|NCT00731991|Muscle|muscle
576398|NCT00731978|Near-Infrared Spectroscopy|near-infrared spectroscopy
576399|NCT00731978|Intraoperative Care|intraoperative care
576400|NCT00731965|Arthritis, Juvenile Rheumatoid|arthritis, juvenile rheumatoid
576401|NCT00731965|Measles-Mumps-Rubella Vaccine|measles-mumps-rubella vaccine
576402|NCT00731965|Serology|serology
576403|NCT00731965|Lymphocytes|lymphocytes
576404|NCT00731952|surgically resectable|surgically resectable
576405|NCT00731939|Erectile Dysfunction|erectile dysfunction
576406|NCT00731939|Penile implant|penile implant
576407|NCT00731939|Titan|titan
576408|NCT00731913|Surgical wounds|surgical wounds
576409|NCT00731913|Sutures|sutures
576410|NCT00731900|pharmacogenetic|pharmacogenetic
576411|NCT00731900|study|study
576412|NCT00731900|Topirmate|topirmate
576413|NCT00731900|induced|induced
576414|NCT00731887|Burn injury|burn injury
576415|NCT00731887|Burn recovery|burn recovery
576416|NCT00731874|Kidney transplantation|kidney transplantation
576417|NCT00731874|Immunosuppression|immunosuppression
576418|NCT00731874|Minimization|minimization
576419|NCT00731874|Tacrolimus|tacrolimus
576420|NCT00731874|Prograf|prograf
576421|NCT00731874|Thymoglobulin|thymoglobulin
576422|NCT00731848|prostate cancer|prostate cancer
576423|NCT00731848|prostate-specific antigens|prostate-specific antigens
576424|NCT00731848|PSA|psa
576425|NCT00731835|Vascular|vascular
576426|NCT00731822|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
576427|NCT00731822|Novel Dry Powder Inhaler|novel dry powder inhaler
576428|NCT00731822|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
576429|NCT00731822|GW685698/GW642444|gw685698/gw642444
576430|NCT00731809|Crohn's disease|crohn's disease
576431|NCT00731796|Stroke|stroke
576432|NCT00731796|Retrochiasmatic|retrochiasmatic
576433|NCT00731796|Vision|vision
576434|NCT00731796|VFD|vfd
576435|NCT00731783|Abscesses|abscesses
576436|NCT00731783|Furunculosis|furunculosis
576437|NCT00731783|Staphylococcus aureus colonization|staphylococcus aureus colonization
576438|NCT00731783|Staphylococcal Skin Infections|staphylococcal skin infections
576439|NCT00731783|MRSA|mrsa
576440|NCT00731770|COPD|copd
576441|NCT00731770|sleep|sleep
576442|NCT00731770|daytime somnolence|daytime somnolence
576443|NCT00731718|Head Lice|head lice
576444|NCT00731692|FTY720, primary progressive multiple sclerosis,PPMS|fty720, primary progressive multiple sclerosis,ppms
576445|NCT00731679|IBS|ibs
576446|NCT00731679|Abdominal pain|abdominal pain
576447|NCT00731679|Bloating|bloating
576448|NCT00731679|Diarrhea|diarrhea
576449|NCT00731679|Rifaximin|rifaximin
576450|NCT00731666|penile length|penile length
576451|NCT00731666|IPP|ipp
576452|NCT00731666|Erectile dysfunction|erectile dysfunction
576453|NCT00731653|depression|depression
576454|NCT00731653|combination|combination
576455|NCT00731640|AcrySof|acrysof
576456|NCT00731640|ReSTOR|restor
576458|NCT00731640|Intraocular Lens|intraocular lens
576459|NCT00731627|intracranial aneurysm|intracranial aneurysm
576460|NCT00731614|cognitive therapy|cognitive therapy
576461|NCT00731614|mirror training|mirror training
576462|NCT00731614|nondirective therapy|nondirective therapy
576463|NCT00731614|veterans|veterans
576464|NCT00731614|amputees|amputees
576465|NCT00731601|shock|shock
576466|NCT00731601|peptic ulcer bleeding|peptic ulcer bleeding
576467|NCT00731601|rebleeding|rebleeding
576468|NCT00731575|asthma|asthma
576469|NCT00731575|child|child
576470|NCT00731575|pathogenesis|pathogenesis
576471|NCT00731575|rhinovirus|rhinovirus
576472|NCT00731575|prednisolone|prednisolone
576473|NCT00731575|Prevention|prevention
576474|NCT00731575|pediatric|pediatric
576475|NCT00731562|food, varenicline, pharmacokinetics, bioavailability|food, varenicline, pharmacokinetics, bioavailability
576476|NCT00731549|Aripiprazole|aripiprazole
576477|NCT00731549|IM Depot|im depot
576478|NCT00731549|Schizophrenia|schizophrenia
576479|NCT00731549|Intramuscular|intramuscular
576480|NCT00731536|Hepatosplenic T-cell Lymphoma|hepatosplenic t-cell lymphoma
576481|NCT00731536|Remicade|remicade
576482|NCT00731536|Infliximab|infliximab
576483|NCT00731536|Dutch national database of pathology|dutch national database of pathology
576484|NCT00731536|PALGA|palga
576485|NCT00731536|Autoimmune disease|autoimmune disease
576486|NCT00731536|Non-Hodgkin lymphoma|non-hodgkin lymphoma
576487|NCT00731523|FTY720, Pharmacokinetics, Renal insufficiency|fty720, pharmacokinetics, renal insufficiency
576488|NCT00731510|Acute mountain sickness|acute mountain sickness
576489|NCT00731510|Body composition,Hypoxia|body composition,hypoxia
576490|NCT00731510|Carbohydrate supplementation|carbohydrate supplementation
576491|NCT00731510|Expedition,|expedition,
576492|NCT00731510|Hydration,|hydration,
576493|NCT00731510|Hypoxia|hypoxia
576494|NCT00731510|Performance|performance
576495|NCT00731497|SODIS|sodis
576496|NCT00731497|Drinking Water|drinking water
576497|NCT00731497|Disinfection|disinfection
576498|NCT00731497|Intervention Trial|intervention trial
576499|NCT00731484|Dry Eye Disease|dry eye disease
576500|NCT00731484|Tear Osmolarity|tear osmolarity
576501|NCT00731484|Tear Osmolality|tear osmolality
576502|NCT00731458|OCT;|oct;
576503|NCT00731458|Cirrus;|cirrus;
576504|NCT00731458|Stratus;|stratus;
576505|NCT00731458|macular thickness|macular thickness
576506|NCT00731445|Z-208|z-208
576507|NCT00731432|gingivitis, diabetes mellitus, herbal, oral inflammation|gingivitis, diabetes mellitus, herbal, oral inflammation
576508|NCT00731419|biliary|biliary
576509|NCT00731419|obstruction|obstruction
576510|NCT00731419|malignant|malignant
576511|NCT00731419|stent|stent
576512|NCT00731419|palliation|palliation
576513|NCT00731393|Thiomersal-free influenza split vaccine 2003/2004|thiomersal-free influenza split vaccine 2003/2004
576514|NCT00731393|Influsplit SSW®/Fluarix™ 2003/2004|influsplit ssw®/fluarix™ 2003/2004
576515|NCT00731393|Influenza|influenza
576516|NCT00731380|Abraxane|abraxane
576517|NCT00731380|Head and Neck Cancer|head and neck cancer
576518|NCT00731380|Determine|determine
576519|NCT00731380|Maximum|maximum
576520|NCT00731380|Tolerated dose|tolerated dose
576521|NCT00731380|ABI-007|abi-007
576522|NCT00731380|Combination|combination
576523|NCT00731380|Cisplatin|cisplatin
576524|NCT00731380|5-Fluorouracil|5-fluorouracil
576525|NCT00731380|Patients|patients
576526|NCT00731354|lipoplasty|lipoplasty
576527|NCT00731354|liposuction|liposuction
576528|NCT00731354|VASER|vaser
576529|NCT00731354|body contouring|body contouring
576530|NCT00731354|body sculpting|body sculpting
576531|NCT00731354|Any patient|any patient
576532|NCT00731354|expressing|expressing
576533|NCT00731354|interest|interest
576534|NCT00731354|in elective surgery|in elective surgery
576535|NCT00731341|Uterine fibroids|uterine fibroids
576536|NCT00731341|Leiomyoma|leiomyoma
576537|NCT00731341|Menorrhagia|menorrhagia
576538|NCT00731341|Hysteroscopic cryoablation|hysteroscopic cryoablation
576539|NCT00731341|Minimally invasive|minimally invasive
576540|NCT00731328|refractory anemia|refractory anemia
576541|NCT00731328|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
576542|NCT00731328|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
576543|NCT00731328|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
576544|NCT00731328|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
576545|NCT00731328|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
576546|NCT00731328|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
576547|NCT00731328|aplastic anemia|aplastic anemia
576548|NCT00731328|paroxysmal nocturnal hemoglobinuria|paroxysmal nocturnal hemoglobinuria
576549|NCT00731315|UTI|uti
576550|NCT00731315|Kiosk|kiosk
576551|NCT00731315|Computer Assisted Care|computer assisted care
576552|NCT00731315|cystitis|cystitis
576553|NCT00731289|Osteoarthritis|osteoarthritis
576554|NCT00731289|Knee|knee
576555|NCT00731289|Hyaluronan|hyaluronan
576556|NCT00731289|Gait Analysis|gait analysis
576649|NCT00730795|Tuberculosis vaccine|tuberculosis vaccine
576557|NCT00731276|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
576558|NCT00731263|Cancer|cancer
576559|NCT00731263|Advance solid tumours|advance solid tumours
576560|NCT00731263|Dose Escalation|dose escalation
576561|NCT00731263|Preliminary efficacy|preliminary efficacy
576562|NCT00731263|AZD8055|azd8055
576563|NCT00731263|Tor kinase inhibitor|tor kinase inhibitor
576564|NCT00731263|Oral administration|oral administration
576565|NCT00731250|Capsaicin challenge|capsaicin challenge
576566|NCT00731237|Drug Eluting Stent|drug eluting stent
576567|NCT00731237|Percutaneous Coronary Intervention|percutaneous coronary intervention
576568|NCT00731237|Everolimus|everolimus
576569|NCT00731224|Alzheimer's disease, rivastigmine, patch|alzheimer's disease, rivastigmine, patch
576570|NCT00731211|Renal Cell Carcinoma|renal cell carcinoma
576571|NCT00731211|Metastatic|metastatic
576572|NCT00731211|Pazopanib|pazopanib
576573|NCT00731211|Previously-treated|previously-treated
576574|NCT00731198|ERCP|ercp
576575|NCT00731198|Drotaverine hydrochloride|drotaverine hydrochloride
576576|NCT00731198|Hyoscine-N-butylbromide|hyoscine-n-butylbromide
576577|NCT00731185|functional|functional
576578|NCT00731185|endoscopic|endoscopic
576579|NCT00731185|sinus|sinus
576580|NCT00731185|surgery|surgery
576581|NCT00731172|crohns disease|crohns disease
576582|NCT00731146|Interscalene Brachial Plexus Block|interscalene brachial plexus block
576583|NCT00731146|Regional Anesthesia|regional anesthesia
576584|NCT00731146|Ultrasound guided peripheral nerve block|ultrasound guided peripheral nerve block
576948|NCT00729521|Fall injury death|fall injury death
576585|NCT00731146|Minimum Effective Anesthetic Volume|minimum effective anesthetic volume
576586|NCT00731146|Nerve Stimulator guided peripheral nerve block|nerve stimulator guided peripheral nerve block
576587|NCT00731133|disulfiram|disulfiram
576588|NCT00731133|methamphetamine dependence|methamphetamine dependence
576589|NCT00731133|open label|open label
576590|NCT00731120|Generalized Anxiety Disorder|generalized anxiety disorder
576591|NCT00731120|Mood Disorder|mood disorder
576592|NCT00731120|Affective Disorder|affective disorder
576593|NCT00731120|Anxiety Disorder|anxiety disorder
576594|NCT00731120|Drug Therapy|drug therapy
576595|NCT00731107|Veress Needle|veress needle
576596|NCT00731107|XCEL bladeless trocar|xcel bladeless trocar
576597|NCT00731107|Laparoscopic entry techniques|laparoscopic entry techniques
576598|NCT00731094|overweight|overweight
576599|NCT00731094|sedentary lifestyle|sedentary lifestyle
576600|NCT00731094|exercise|exercise
576601|NCT00731094|primary health care|primary health care
576602|NCT00731094|controlled clinical trials, randomized|controlled clinical trials, randomized
576603|NCT00731068|Achilles tendon|achilles tendon
576604|NCT00731042|Skin health|skin health
576605|NCT00731029|Influenza|influenza
576606|NCT00731029|Thiomersal-free influenza split vaccine 2002/2003|thiomersal-free influenza split vaccine 2002/2003
576607|NCT00731029|Influsplit SSW®/Fluarix™ 2002/2003|influsplit ssw®/fluarix™ 2002/2003
576608|NCT00731003|serotonin|serotonin
576609|NCT00731003|gut permeability|gut permeability
576610|NCT00731003|visceral sensitivity|visceral sensitivity
576611|NCT00731003|irritable bowel syndrome|irritable bowel syndrome
576612|NCT00730990|Positron Emission Tomography study in healthy volunteers for ligand qualification and receptor occupancy determination.|positron emission tomography study in healthy volunteers for ligand qualification and receptor occupancy determination.
576613|NCT00730964|Surveillance|surveillance
576614|NCT00730964|Optison|optison
576615|NCT00730964|Perflutren|perflutren
576616|NCT00730964|Echocardiography|echocardiography
576617|NCT00730964|Subjects receive Optison during enhanced echocardiography|subjects receive optison during enhanced echocardiography
576618|NCT00730938|fibrin|fibrin
576619|NCT00730938|endophthalmitis|endophthalmitis
576620|NCT00730938|cataract extraction|cataract extraction
576621|NCT00730938|Lens|lens
576622|NCT00730938|implantation,|implantation,
576623|NCT00730938|intraocular|intraocular
576624|NCT00730886|Uterine Fibroids|uterine fibroids
576625|NCT00730886|Unexplained Infertility|unexplained infertility
576626|NCT00730886|MRgFUS|mrgfus
576627|NCT00730886|ExAblate|exablate
576628|NCT00730886|Focused Ultrasound|focused ultrasound
576629|NCT00730886|Myomectomy|myomectomy
576630|NCT00730860|radiofrequency ablation|radiofrequency ablation
576631|NCT00730860|Cancer of Liver|cancer of liver
576632|NCT00730860|postoperative|postoperative
576633|NCT00730860|transhepatic arterial chemoembolization|transhepatic arterial chemoembolization
576634|NCT00730860|prospective|prospective
576635|NCT00730847|Cervarix|cervarix
576636|NCT00730847|Filipinos|filipinos
576637|NCT00730847|Safety and reactogenicity|safety and reactogenicity
576638|NCT00730847|Human papillomavirus|human papillomavirus
576639|NCT00730834|tinnitus|tinnitus
576640|NCT00730834|ringing in the ears|ringing in the ears
576641|NCT00730834|buzzing|buzzing
576642|NCT00730834|static|static
576643|NCT00730834|hyperacusis|hyperacusis
576644|NCT00730834|loudness discomfort|loudness discomfort
576645|NCT00730834|Clinically|clinically
576646|NCT00730834|significant|significant
576647|NCT00730834|discomfort|discomfort
576648|NCT00730808|Enteral nutritional regimen prior to surgery|enteral nutritional regimen prior to surgery
579011|NCT00721825|Neuroaid|neuroaid
576650|NCT00730769|Valganciclovir|valganciclovir
576651|NCT00730769|Ganciclovir|ganciclovir
576652|NCT00730769|Pharmacokinetics|pharmacokinetics
576653|NCT00730769|Solid organ transplantation|solid organ transplantation
576654|NCT00730769|Transplant|transplant
576655|NCT00730756|Adolescents|adolescents
576656|NCT00730756|Irritant(non-allergic)rhinitis|irritant(non-allergic)rhinitis
576657|NCT00730756|Adults|adults
576658|NCT00730756|GW685698|gw685698
576659|NCT00730756|Air Pollution|air pollution
576660|NCT00730730|Iliac Artery, Peripheral Vascular Disease (PVD)|iliac artery, peripheral vascular disease (pvd)
576661|NCT00730704|Human Papilloma Virus vaccines|human papilloma virus vaccines
576662|NCT00730704|HPV|hpv
576663|NCT00730704|Gardasil|gardasil
576664|NCT00730704|Post partum|post partum
576665|NCT00730691|Generalized Anxiety Disorder|generalized anxiety disorder
576666|NCT00730691|Mood Disorder|mood disorder
576667|NCT00730691|Affective Disorder|affective disorder
576668|NCT00730691|Anxiety Disorder|anxiety disorder
576669|NCT00730691|Drug Therapy|drug therapy
576670|NCT00730678|Metabolism|metabolism
576671|NCT00730678|Pharmacogenetic testing|pharmacogenetic testing
576672|NCT00730665|PPI partial responders with non-erosive GERD.|ppi partial responders with non-erosive gerd.
576673|NCT00730652|Medarex Inc.|medarex inc.
576674|NCT00730626|Probiotics|probiotics
576675|NCT00730626|Immunity|immunity
576676|NCT00730626|Immune response|immune response
576677|NCT00730626|Intestinal microflora|intestinal microflora
576678|NCT00730626|Blood lipids|blood lipids
576679|NCT00730626|Phagocytosis activity|phagocytosis activity
576680|NCT00730613|adult anaplastic astrocytoma|adult anaplastic astrocytoma
576681|NCT00730613|adult diffuse astrocytoma|adult diffuse astrocytoma
576682|NCT00730613|adult pilocytic astrocytoma|adult pilocytic astrocytoma
576683|NCT00730613|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
576684|NCT00730613|adult anaplastic ependymoma|adult anaplastic ependymoma
576685|NCT00730613|adult ependymoma|adult ependymoma
576686|NCT00730613|adult myxopapillary ependymoma|adult myxopapillary ependymoma
576687|NCT00730613|adult subependymoma|adult subependymoma
576688|NCT00730613|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
576689|NCT00730613|adult oligodendroglioma|adult oligodendroglioma
576690|NCT00730613|adult brain stem glioma|adult brain stem glioma
576691|NCT00730613|adult giant cell glioblastoma|adult giant cell glioblastoma
576692|NCT00730613|adult glioblastoma|adult glioblastoma
576693|NCT00730613|recurrent adult brain tumor|recurrent adult brain tumor
576694|NCT00730613|adult gliosarcoma|adult gliosarcoma
576695|NCT00730613|adult mixed glioma|adult mixed glioma
576696|NCT00730613|adult pineal gland astrocytoma|adult pineal gland astrocytoma
576697|NCT00730600|Thai Traditional massage|thai traditional massage
576698|NCT00730600|Bone Formation|bone formation
576699|NCT00730600|Bone Resorption|bone resorption
576700|NCT00730587|Nutrition|nutrition
576701|NCT00730587|Body Fat|body fat
576702|NCT00730587|Infant|infant
576703|NCT00730587|Healthy Babies|healthy babies
576704|NCT00730561|nerve conduction velocity|nerve conduction velocity
576705|NCT00730561|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
576706|NCT00730535|Overactive bladder, Tolterodine,Symptoms Relapse, Predictor|overactive bladder, tolterodine,symptoms relapse, predictor
576707|NCT00730522|Methamphetamine|methamphetamine
576708|NCT00730522|Dependency|dependency
576709|NCT00730522|Addiction|addiction
576710|NCT00730522|vigabatrin|vigabatrin
576711|NCT00730509|cystic fibrosis|cystic fibrosis
576712|NCT00730509|folate|folate
576713|NCT00730509|vitamin B12|vitamin b12
576714|NCT00730496|Embryo culture supernatant|embryo culture supernatant
576715|NCT00730496|injection|injection
576716|NCT00730496|embryo transfer|embryo transfer
576717|NCT00730496|embryo implantation rate|embryo implantation rate
576718|NCT00730483|liver metastases|liver metastases
576719|NCT00730483|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
576720|NCT00730483|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
576721|NCT00730483|islet cell carcinoma|islet cell carcinoma
576722|NCT00730483|gastrinoma|gastrinoma
576723|NCT00730483|insulinoma|insulinoma
576724|NCT00730483|glucagonoma|glucagonoma
576725|NCT00730483|pancreatic polypeptide tumor|pancreatic polypeptide tumor
576726|NCT00730483|somatostatinoma|somatostatinoma
576727|NCT00730470|Human Epidermal Growth Factor Receptor 3|human epidermal growth factor receptor 3
576728|NCT00730470|HER3|her3
576729|NCT00730470|Heregulin|heregulin
576730|NCT00730470|erb B3|erb b3
576731|NCT00730470|Solid Tumors|solid tumors
576732|NCT00730470|Phase I Clinical Study|phase i clinical study
576733|NCT00730457|influenza|influenza
576734|NCT00730457|recombinant|recombinant
576735|NCT00730457|hemagglutinin|hemagglutinin
576736|NCT00730457|vaccine|vaccine
576737|NCT00730444|Neuroblastoma|neuroblastoma
576738|NCT00730444|Nuclear medicine|nuclear medicine
576739|NCT00730444|Diagnostic scintigraphy|diagnostic scintigraphy
576740|NCT00730444|Known and suspected neuroblastoma|known and suspected neuroblastoma
576741|NCT00730431|Hepatitis C, healthy volunteers|hepatitis c, healthy volunteers
576742|NCT00730418|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
580794|NCT00715858|doxycycline|doxycycline
576743|NCT00730418|alpha Adrenergic Blockers|alpha adrenergic blockers
576744|NCT00730418|alpha-1 Adrenergic Receptor|alpha-1 adrenergic receptor
576745|NCT00730405|Distal, Subungual onychomycosis|distal, subungual onychomycosis
576746|NCT00730405|onychomycosis|onychomycosis
576747|NCT00730405|nail fungus|nail fungus
576748|NCT00730405|Toenail fungus|toenail fungus
576749|NCT00730392|Type 1 diabetes, Etanercept, honeymoon period|type 1 diabetes, etanercept, honeymoon period
576750|NCT00730366|Malaria|malaria
576751|NCT00730366|Pregnancy|pregnancy
576752|NCT00730366|Intermittent Preventive Treatment|intermittent preventive treatment
576753|NCT00730340|Tonsillectomy, tonsillar fossa, wound closure|tonsillectomy, tonsillar fossa, wound closure
576754|NCT00730314|unrelated|unrelated
576755|NCT00730314|BMT|bmt
576756|NCT00730314|HSCT|hsct
576757|NCT00730314|bone marrow transplantation|bone marrow transplantation
576758|NCT00730314|sickle cell disease|sickle cell disease
576759|NCT00730314|thalassemia|thalassemia
576760|NCT00730314|CGD|cgd
576761|NCT00730314|HLH|hlh
576762|NCT00730314|Blackfan-Diamond anemia|blackfan-diamond anemia
576763|NCT00730314|Hurler|hurler
576764|NCT00730314|leukodystrophy|leukodystrophy
576765|NCT00730314|LAD I|lad i
576766|NCT00730314|Genetic diseases|genetic diseases
576767|NCT00730314|Red blood cell defects|red blood cell defects
576768|NCT00730314|Leukocyte defects and immune deficiencies|leukocyte defects and immune deficiencies
576769|NCT00730314|Hereditary Lymphohistiocytosis|hereditary lymphohistiocytosis
576770|NCT00730314|chronic granulomatous disease|chronic granulomatous disease
576771|NCT00730314|Wiskott-Aldrich syndrome|wiskott-aldrich syndrome
576772|NCT00730314|Chediak Higashi syndrome|chediak higashi syndrome
576773|NCT00730314|CD40 ligand deficiency|cd40 ligand deficiency
576774|NCT00730314|Hyper IgM syndrome|hyper igm syndrome
576775|NCT00730314|leucocytes adhesion defect type 1|leucocytes adhesion defect type 1
576776|NCT00730314|Osteopetrosis|osteopetrosis
576777|NCT00730314|congenital neutropenia|congenital neutropenia
576778|NCT00730314|X-linked lymphoproliferative disease|x-linked lymphoproliferative disease
576779|NCT00730314|Platelets defects|platelets defects
576780|NCT00730314|Congenital amegakaryocytic thrombocytopenia|congenital amegakaryocytic thrombocytopenia
576781|NCT00730314|Metabolic and storage disorders|metabolic and storage disorders
576782|NCT00730314|Hurler disease|hurler disease
576783|NCT00730314|leukodystrophies|leukodystrophies
576784|NCT00730314|Niemann-Pick disease|niemann-pick disease
576785|NCT00730314|Fucosidosis|fucosidosis
576786|NCT00730314|Stem cell defects|stem cell defects
576787|NCT00730314|reticular agenesis|reticular agenesis
576788|NCT00730301|Emphysema|emphysema
576789|NCT00730301|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
576790|NCT00730301|Lung volume reduction|lung volume reduction
576791|NCT00730301|Lung function|lung function
576792|NCT00730288|Dengue|dengue
576793|NCT00730288|Dengue fever|dengue fever
576794|NCT00730288|Dengue hemorrhagic fever|dengue hemorrhagic fever
576795|NCT00730288|Dengue virus|dengue virus
576796|NCT00730262|Glioblastoma Multiforme (GBM)|glioblastoma multiforme (gbm)
576797|NCT00730262|Phase II|phase ii
576798|NCT00730262|Brain Cancer|brain cancer
576799|NCT00730249|ADHD|adhd
576800|NCT00730249|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
576801|NCT00730249|adult|adult
576802|NCT00730249|methylphenidate hydrochloride|methylphenidate hydrochloride
576803|NCT00730249|Medikinet retard|medikinet retard
576804|NCT00730249|controlled clinical trial|controlled clinical trial
576805|NCT00730249|safety|safety
576806|NCT00730249|randomized, double-blind, placebo-controlled trial|randomized, double-blind, placebo-controlled trial
576807|NCT00730249|treatment|treatment
576808|NCT00730249|central nervous system stimulants|central nervous system stimulants
576809|NCT00730249|therapeutic uses|therapeutic uses
576810|NCT00730223|Nevirapine|nevirapine
576811|NCT00730223|Efavirenz|efavirenz
576812|NCT00730223|pharmacokinetics|pharmacokinetics
576813|NCT00730223|healthy|healthy
576814|NCT00730223|CYP2B6|cyp2b6
576815|NCT00730223|HIV/AIDS|hiv/aids
576816|NCT00730210|Hypoparathyroidism|hypoparathyroidism
576817|NCT00730210|HypoPTH|hypopth
576818|NCT00730210|PTH|pth
576819|NCT00730184|acid-base|acid-base
576820|NCT00730184|potassium|potassium
576821|NCT00730184|acidosis|acidosis
576822|NCT00730184|osteoporosis|osteoporosis
576823|NCT00730184|sarcopenia|sarcopenia
576824|NCT00730184|calcium absorption|calcium absorption
576825|NCT00730184|dietary protein|dietary protein
576949|NCT00729508|Cat allergy|cat allergy
576826|NCT00730145|pharmacokinetics, PD-0332334, hemodialysis, renal dialysis|pharmacokinetics, pd-0332334, hemodialysis, renal dialysis
576827|NCT00730119|Non-invasive Blood Pressure (NIBP)|non-invasive blood pressure (nibp)
576828|NCT00730119|GE Monitor|ge monitor
576829|NCT00730119|Temperature|temperature
576830|NCT00730119|SpO2|spo2
576831|NCT00730119|Respiration, ECG|respiration, ecg
576832|NCT00730106|Gastroesophageal reflux disease|gastroesophageal reflux disease
576833|NCT00730106|Alarm symptoms|alarm symptoms
576834|NCT00730106|Gastrointestinal endoscopy|gastrointestinal endoscopy
576835|NCT00730093|Vitamin B12 absorption|vitamin b12 absorption
576836|NCT00730093|Pregnancy|pregnancy
576837|NCT00730080|phenylketonuria|phenylketonuria
576838|NCT00730080|sapropterin|sapropterin
576839|NCT00730080|Kuvan|kuvan
576840|NCT00730080|cognition|cognition
576841|NCT00730080|executive abilities|executive abilities
576842|NCT00730080|brain|brain
576843|NCT00730067|COPD|copd
576844|NCT00730067|Pulmonary hypertension|pulmonary hypertension
576845|NCT00730067|Sildenafil|sildenafil
576846|NCT00730067|NT-pro BNP|nt-pro bnp
576847|NCT00730067|apelin|apelin
576848|NCT00730054|Remifentanil|remifentanil
576849|NCT00730054|clonidine|clonidine
576850|NCT00730054|acute pain|acute pain
576851|NCT00730054|respiration|respiration
576852|NCT00730054|sedation|sedation
576853|NCT00730054|cognitive function|cognitive function
576854|NCT00730041|obstructive sleep apnea|obstructive sleep apnea
576855|NCT00730041|continuous positive air pressure|continuous positive air pressure
576856|NCT00730028|Methicillin-resistant Staphylococcus aureus (MRSA), cellulitis, abscess, children, elderly|methicillin-resistant staphylococcus aureus (mrsa), cellulitis, abscess, children, elderly
576857|NCT00730002|Lupus|lupus
576858|NCT00729989|Meconium Aspiration|meconium aspiration
576859|NCT00729989|Respiratory Distress|respiratory distress
576860|NCT00729989|Meconium Stained Amniotic Fluid|meconium stained amniotic fluid
576861|NCT00729976|Ibuprofen|ibuprofen
576862|NCT00729976|Suppository|suppository
576863|NCT00729976|febrile children|febrile children
576864|NCT00729937|Methicillin, Staphylococcus aureus, MRSA|methicillin, staphylococcus aureus, mrsa
576865|NCT00729924|Raltegravir|raltegravir
576866|NCT00729924|CSF|csf
576867|NCT00729924|ABCB1 SNP|abcb1 snp
576868|NCT00729924|HIV/AIDS|hiv/aids
576869|NCT00729911|Atrial fibrillation Ablation|atrial fibrillation ablation
576870|NCT00729885|Vertigo|vertigo
576871|NCT00729885|Benign Paroxysmal Positional Vertigo|benign paroxysmal positional vertigo
576872|NCT00729885|BPPV|bppv
576873|NCT00729885|Positional Vertigo|positional vertigo
576874|NCT00729872|AG011|ag011
576875|NCT00729872|Ulcerative Colitis|ulcerative colitis
576876|NCT00729872|human Interleukin-10|human interleukin-10
576877|NCT00729859|HDL|hdl
576878|NCT00729859|Insulin sensitivity|insulin sensitivity
576879|NCT00729859|testosterone|testosterone
576880|NCT00729859|estradiol|estradiol
576881|NCT00729859|cholesterol|cholesterol
576882|NCT00729846|choroidal neovascularization|choroidal neovascularization
576883|NCT00729846|macular degeneration|macular degeneration
576884|NCT00729846|macular edema|macular edema
576885|NCT00729846|intravitreal bevacizumab|intravitreal bevacizumab
576886|NCT00729846|vegf|vegf
576887|NCT00729846|verteporfin PDT|verteporfin pdt
576888|NCT00729820|PERSONALITY|personality
576889|NCT00729820|COGNITIVE PERFORMANCE|cognitive performance
576890|NCT00729820|the practical usefulness (validity) of processing speed, accuracy of performance and personality measures in predicting impulsive behavior|the practical usefulness (validity) of processing speed, accuracy of performance and personality measures in predicting impulsive behavior
576891|NCT00729807|recurrent melanoma|recurrent melanoma
576892|NCT00729794|Vasopressin|vasopressin
576893|NCT00729794|Epinephrine|epinephrine
576894|NCT00729794|Adrenal Cortex Hormones|adrenal cortex hormones
576895|NCT00729794|Heart Arrest|heart arrest
576896|NCT00729781|nasal obstruction|nasal obstruction
576897|NCT00729781|airway resistance|airway resistance
576898|NCT00729781|soft tissue collapse|soft tissue collapse
576899|NCT00729781|cosmetic contour deformity|cosmetic contour deformity
576900|NCT00729768|Renal transplant|renal transplant
576901|NCT00729768|Raptiva|raptiva
576902|NCT00729755|Creatine|creatine
576903|NCT00729755|Augmentation|augmentation
576904|NCT00729755|Major Depressive Disorder|major depressive disorder
576905|NCT00729755|Efficacy|efficacy
576906|NCT00729755|Brain Energy Metabolism|brain energy metabolism
576907|NCT00729729|Comparative|comparative
576908|NCT00729729|bioavailability|bioavailability
576909|NCT00729729|of PCA|of pca
576910|NCT00729729|formulations|formulations
576911|NCT00729716|Microfracture|microfracture
576912|NCT00729716|Cartilage repair|cartilage repair
576913|NCT00729716|Autologous chondrocyte implantation|autologous chondrocyte implantation
576914|NCT00729703|ICD|icd
576915|NCT00729703|Minimized|minimized
576916|NCT00729703|ventricular|ventricular
576917|NCT00729703|pacing|pacing
576918|NCT00729703|indication|indication
576919|NCT00729703|Clinical outcome|clinical outcome
576920|NCT00729703|Inappropriate shock|inappropriate shock
576921|NCT00729690|Pregabalin|pregabalin
576922|NCT00729690|CSF|csf
576923|NCT00729690|Neurotransmitter|neurotransmitter
576924|NCT00729677|nausea and vomiting|nausea and vomiting
576925|NCT00729677|colon cancer|colon cancer
576926|NCT00729677|rectal cancer|rectal cancer
576927|NCT00729638|relapsed multiple myeloma|relapsed multiple myeloma
576928|NCT00729638|refractory multiple myeloma|refractory multiple myeloma
576929|NCT00729638|RAD001|rad001
576930|NCT00729638|lenalidomide|lenalidomide
576931|NCT00729625|stroke, rehabilitation, robotics|stroke, rehabilitation, robotics
576932|NCT00729612|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
576933|NCT00729612|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
580795|NCT00715858|rifampin|rifampin
576934|NCT00729612|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
576935|NCT00729612|squamous cell lung cancer|squamous cell lung cancer
576936|NCT00729573|Microbicide|microbicide
576937|NCT00729573|HIV Seronegativity|hiv seronegativity
576938|NCT00729573|Bone Mineral Density|bone mineral density
576939|NCT00729560|PCOS|pcos
576940|NCT00729547|Depression|depression
576941|NCT00729547|Biofeedback|biofeedback
576942|NCT00729547|Psychophysiology|psychophysiology
576943|NCT00729534|Perception|perception
576944|NCT00729534|Focus Group|focus group
576945|NCT00729534|Perception of Clinical Research Participation|perception of clinical research participation
576946|NCT00729521|Fall injury hospitalization|fall injury hospitalization
576947|NCT00729521|Fall injury emergency department visit|fall injury emergency department visit
576950|NCT00729508|Immunotherapy|immunotherapy
576951|NCT00729508|Cat-PAD|cat-pad
576952|NCT00729508|Environmental Exposure Chamber|environmental exposure chamber
576953|NCT00729495|Phase I,|phase i,
576954|NCT00729495|Healthy|healthy
576955|NCT00729495|Volunteer|volunteer
576956|NCT00729495|Study|study
576957|NCT00729482|RAD001 (everolimus)|rad001 (everolimus)
576958|NCT00729482|second-line treatment|second-line treatment
576959|NCT00729482|advanced gastric cancer|advanced gastric cancer
576960|NCT00729469|Vulvar and vaginal atrophy in postmenopausal women|vulvar and vaginal atrophy in postmenopausal women
576961|NCT00729469|Menopausal symptoms|menopausal symptoms
576962|NCT00729469|Vaginal atrophy|vaginal atrophy
576963|NCT00729469|Urogenital atrophy|urogenital atrophy
576964|NCT00729456|Diabetes|diabetes
576965|NCT00729456|Education|education
576966|NCT00729456|Ulcer|ulcer
576967|NCT00729456|Foot|foot
576968|NCT00729456|Behaviour|behaviour
576969|NCT00729443|Single dose|single dose
576970|NCT00729443|Phase 1|phase 1
576971|NCT00729443|Safety of AZD3241|safety of azd3241
576972|NCT00729443|tolerability of AZD3241|tolerability of azd3241
576973|NCT00729430|Heart Attack|heart attack
576974|NCT00729430|Sudden Cardiac Death|sudden cardiac death
576975|NCT00729430|Peri-infarct Zone|peri-infarct zone
576976|NCT00729430|Omega-3 Fatty Acids|omega-3 fatty acids
576977|NCT00729430|Biological Markers|biological markers
576978|NCT00729430|Cytogenetic Analysis|cytogenetic analysis
576979|NCT00729430|Cardiac Arrest|cardiac arrest
576980|NCT00729417|incontinence|incontinence
576981|NCT00729417|obstetric risk factors|obstetric risk factors
576982|NCT00729417|women|women
576983|NCT00729417|of age 18|of age 18
576984|NCT00729417|above|above
576985|NCT00729404|Female Contraception|female contraception
576986|NCT00729404|Ovulation Inhibition|ovulation inhibition
576987|NCT00729391|HIV|hiv
576988|NCT00729391|Sexual Risk|sexual risk
576989|NCT00729391|Substance Abuse|substance abuse
576990|NCT00729391|Victimization|victimization
576991|NCT00729391|Violence|violence
576992|NCT00729391|Voluntary Counseling and Testing (VCT)|voluntary counseling and testing (vct)
576993|NCT00729365|Urine albumin excretion rates|urine albumin excretion rates
576994|NCT00729365|Nighttime and daytime blood pressure|nighttime and daytime blood pressure
576995|NCT00729365|Endothelial Dysfunction|endothelial dysfunction
576996|NCT00729352|NQO1, ozone, airway mucociliary clearance.|nqo1, ozone, airway mucociliary clearance.
576997|NCT00729339|Gastroesophageal reflux disease|gastroesophageal reflux disease
576998|NCT00729339|Mosapride|mosapride
576999|NCT00729339|Lansoprazole|lansoprazole
577000|NCT00729326|diabetes|diabetes
577001|NCT00729326|exenatide|exenatide
577002|NCT00729326|sitagliptin|sitagliptin
577003|NCT00729326|Amylin|amylin
577004|NCT00729326|Lilly|lilly
577005|NCT00729326|metformin|metformin
577006|NCT00729326|thiazolidinedione|thiazolidinedione
577007|NCT00729313|Treatment|treatment
577008|NCT00729300|cocaine|cocaine
577009|NCT00729300|disulfiram|disulfiram
577010|NCT00729300|antabuse|antabuse
577011|NCT00729300|addiction|addiction
577012|NCT00729300|stimulant|stimulant
577013|NCT00729287|stage 0 bladder cancer|stage 0 bladder cancer
577014|NCT00729287|stage I bladder cancer|stage i bladder cancer
577015|NCT00729287|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
577016|NCT00729261|mechanical ventilation|mechanical ventilation
577017|NCT00729261|extubation|extubation
577018|NCT00729261|outcomes|outcomes
577019|NCT00729261|brain injury|brain injury
577020|NCT00729248|Transplants|transplants
577021|NCT00729248|Kidney Transplantation|kidney transplantation
577022|NCT00729248|Immunosuppression|immunosuppression
577023|NCT00729248|Assay|assay
577024|NCT00729248|Graft Rejection|graft rejection
577025|NCT00729235|Slow VT, CRT-D, ATP therapy|slow vt, crt-d, atp therapy
577026|NCT00729235|Incidence|incidence
577027|NCT00729235|of slow VTs|of slow vts
577028|NCT00729235|in CRT-D patients|in crt-d patients
577029|NCT00729235|Clinical|clinical
577030|NCT00729235|relevance|relevance
577031|NCT00729235|treatment|treatment
577032|NCT00729235|VTs|vts
577033|NCT00729235|during|during
577034|NCT00729235|2-years|2-years
577035|NCT00729235|follow-up|follow-up
577036|NCT00729196|Obesity|obesity
577037|NCT00729196|Type 2 Diabetes|type 2 diabetes
577038|NCT00729196|Glycemic Load|glycemic load
577039|NCT00729196|Weight Loss|weight loss
577040|NCT00729196|Glycated Hemoglobin|glycated hemoglobin
577041|NCT00729170|Milk|milk
577042|NCT00729170|Calcium|calcium
577043|NCT00729170|Weight loss|weight loss
577044|NCT00729170|Bone density|bone density
577045|NCT00729170|Appetite|appetite
577046|NCT00729144|fecal incontinence|fecal incontinence
577047|NCT00729144|bowel incontinence|bowel incontinence
577048|NCT00729144|pelvic floor disorder|pelvic floor disorder
577049|NCT00729131|Ozone, TNF, TNF promoter polymorphism, airway hyperresponsiveness.|ozone, tnf, tnf promoter polymorphism, airway hyperresponsiveness.
577050|NCT00729118|stage I multiple myeloma|stage i multiple myeloma
577051|NCT00729118|stage II multiple myeloma|stage ii multiple myeloma
577052|NCT00729118|stage III multiple myeloma|stage iii multiple myeloma
577053|NCT00729118|refractory multiple myeloma|refractory multiple myeloma
577054|NCT00729092|PET SCAN|pet scan
577055|NCT00729092|PAIN LEVELS|pain levels
577056|NCT00729079|Diabetes Prevention|diabetes prevention
577057|NCT00729079|Pre-Diabetes|pre-diabetes
577058|NCT00729079|Exercise|exercise
577059|NCT00729079|Fat Intake|fat intake
577060|NCT00729079|Fasting blood sugar|fasting blood sugar
577061|NCT00729079|tobacco cessation|tobacco cessation
577062|NCT00729053|renal|renal
577063|NCT00729053|cell|cell
577064|NCT00729053|renal carcinoma|renal carcinoma
577065|NCT00729053|metastatic|metastatic
577066|NCT00729053|recurrent|recurrent
577067|NCT00729053|treatment naive|treatment naive
577068|NCT00729040|heart|heart
577069|NCT00729040|weight|weight
577070|NCT00729040|Overweight|overweight
577071|NCT00729040|bmi|bmi
577072|NCT00729040|diabetes|diabetes
577073|NCT00729040|type 2|type 2
577074|NCT00729040|diabetic|diabetic
577075|NCT00729040|walk|walk
577076|NCT00729040|walk*|walk*
577077|NCT00729040|diab*|diab*
577078|NCT00729040|obese|obese
577079|NCT00729040|exercise|exercise
577080|NCT00729040|activity|activity
577081|NCT00729040|coronary|coronary
577082|NCT00729040|pedometer|pedometer
577083|NCT00729027|hypercholesterolemia|hypercholesterolemia
577084|NCT00729014|herbal nephropathy|herbal nephropathy
577085|NCT00729014|Chinese herbal nephropathy|chinese herbal nephropathy
577086|NCT00729014|nephrotoxicity|nephrotoxicity
577087|NCT00729014|renal disease|renal disease
577088|NCT00729014|adverse drug reaction|adverse drug reaction
577089|NCT00729014|Chinese herbal medicine|chinese herbal medicine
577090|NCT00729001|Rotavirus Gastroenteritis|rotavirus gastroenteritis
577091|NCT00729001|Human rotavirus vaccine|human rotavirus vaccine
577092|NCT00728988|Asia Lipitor Pre-treatment in Acute Coronary Syndrome|asia lipitor pre-treatment in acute coronary syndrome
577093|NCT00728975|constipation|constipation
577094|NCT00728975|cancer|cancer
577095|NCT00728975|palliative care|palliative care
577096|NCT00728975|terminal|terminal
577097|NCT00728975|bowel|bowel
577098|NCT00728962|dental implants|dental implants
577099|NCT00728962|Osseotite Certain Prevail|osseotite certain prevail
577100|NCT00728962|multicenter|multicenter
577101|NCT00728962|observational|observational
577102|NCT00728962|clinical study|clinical study
577103|NCT00728962|partial edentulism|partial edentulism
577104|NCT00728962|single stage|single stage
577105|NCT00728962|immediate occlusal loading|immediate occlusal loading
577106|NCT00728962|crestal bone level|crestal bone level
577107|NCT00728962|short fixed bridge|short fixed bridge
577108|NCT00728949|breast cancer|breast cancer
577109|NCT00728949|Postmenopausal|postmenopausal
577110|NCT00728949|Hormones|hormones
577111|NCT00728949|Antiestrogen|antiestrogen
577112|NCT00728936|Hepatitis C|hepatitis c
577113|NCT00728936|unresponsive to pegylated interferon and ribavirin therapy|unresponsive to pegylated interferon and ribavirin therapy
577114|NCT00728936|HCV|hcv
577115|NCT00728923|OCD|ocd
577116|NCT00728910|Low HDL cholesterol|low hdl cholesterol
577117|NCT00728910|High triglycerides|high triglycerides
577118|NCT00728910|niacin|niacin
577119|NCT00728910|fibrate|fibrate
577120|NCT00728897|Healthy volunteer|healthy volunteer
577121|NCT00728897|relative bioavailability.|relative bioavailability.
577122|NCT00728884|dental implants|dental implants
577123|NCT00728884|Certain Prevail|certain prevail
577124|NCT00728884|multicenter|multicenter
577125|NCT00728884|clinical study|clinical study
577126|NCT00728884|partial edentulism|partial edentulism
577127|NCT00728884|total edentulism|total edentulism
577128|NCT00728884|platform switching|platform switching
577129|NCT00728884|single stage|single stage
577130|NCT00728884|early loading|early loading
577131|NCT00728884|crestal bone level|crestal bone level
577132|NCT00728884|single tooth replacements|single tooth replacements
577133|NCT00728884|short or long fixed bridges|short or long fixed bridges
577134|NCT00728884|overdenture|overdenture
577135|NCT00728884|fixed denture|fixed denture
577136|NCT00728871|cervical cancer, HPV, immunity|cervical cancer, hpv, immunity
577137|NCT00728858|Hypertension|hypertension
577138|NCT00728858|SNP|snp
577139|NCT00728858|Nifedipine|nifedipine
577140|NCT00728858|Barnidipine|barnidipine
581197|NCT00714493|humira|humira
577141|NCT00728845|adenocarcinoma of the lung|adenocarcinoma of the lung
577142|NCT00728845|large cell lung cancer|large cell lung cancer
577143|NCT00728845|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
577144|NCT00728845|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
577145|NCT00728845|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
577146|NCT00728832|extended release epidural morphine|extended release epidural morphine
577147|NCT00728832|morphine|morphine
577148|NCT00728832|thoracic epidural|thoracic epidural
577149|NCT00728832|pharmacokinetics|pharmacokinetics
577150|NCT00728832|pharmacodynamics|pharmacodynamics
577151|NCT00728832|postoperative pain|postoperative pain
577152|NCT00728832|upper abdominal surgery|upper abdominal surgery
577153|NCT00728819|Inpatients|inpatients
577154|NCT00728819|Requiring|requiring
577155|NCT00728819|DL PICC|dl picc
577156|NCT00728819|Access|access
577157|NCT00728819|Medications|medications
577158|NCT00728819|Blood|blood
577159|NCT00728806|Continuous Ambulatory Peritoneal Dialysis|continuous ambulatory peritoneal dialysis
577160|NCT00728806|Ultrafiltration failure|ultrafiltration failure
577161|NCT00728806|Biomarker|biomarker
577162|NCT00728806|Proteomics|proteomics
577163|NCT00728793|Advanced Solid Tumors|advanced solid tumors
577164|NCT00728793|EGFR|egfr
577165|NCT00728793|HDAC|hdac
577166|NCT00728793|Her2|her2
577167|NCT00728793|Open-Label|open-label
577168|NCT00728793|Dose-Escalation|dose-escalation
577169|NCT00728780|Adverse events|adverse events
577170|NCT00728780|Pharmacokinetic variables|pharmacokinetic variables
577171|NCT00728767|Heavy drinking|heavy drinking
577172|NCT00728767|Brief intervention|brief intervention
577173|NCT00728767|Alcohol prevention|alcohol prevention
577174|NCT00728767|Randomized trial|randomized trial
577175|NCT00728767|Motivational interviewing|motivational interviewing
577176|NCT00728767|Intervention Studies|intervention studies
577177|NCT00728767|prevention & control|prevention & control
577178|NCT00728754|dental implants|dental implants
577179|NCT00728754|Osseotite Certain Prevail|osseotite certain prevail
577180|NCT00728754|Lateralized|lateralized
577181|NCT00728754|non-lateralized|non-lateralized
577182|NCT00728754|Osseotite Certain|osseotite certain
577183|NCT00728754|multicenter|multicenter
577184|NCT00728754|randomized|randomized
577185|NCT00728754|clinical study|clinical study
577186|NCT00728754|partial edentulism|partial edentulism
577187|NCT00728754|single stage|single stage
577188|NCT00728754|early loading|early loading
577189|NCT00728754|crestal bone level|crestal bone level
577190|NCT00728754|short fixed bridge|short fixed bridge
577191|NCT00728741|Neural Networks|neural networks
577192|NCT00728741|Cortical Activation|cortical activation
577193|NCT00728741|Strategy|strategy
577194|NCT00728741|fMRI|fmri
577195|NCT00728741|Healthy Volunteer|healthy volunteer
577196|NCT00728741|HV|hv
577197|NCT00728728|pregnenolone|pregnenolone
577198|NCT00728728|schizophrenia|schizophrenia
577199|NCT00728728|cognitive|cognitive
577200|NCT00728728|positive symptom|positive symptom
577201|NCT00728728|negative symptom|negative symptom
577202|NCT00728728|placebo control|placebo control
577203|NCT00728715|Budesonide|budesonide
577204|NCT00728715|Formoterol|formoterol
577205|NCT00728715|Non cystic fibrosis bronchiectasis|non cystic fibrosis bronchiectasis
577206|NCT00728689|Orthopoxviral|orthopoxviral
577207|NCT00728689|Smallpox|smallpox
577208|NCT00728689|Monkey pox|monkey pox
577209|NCT00728676|PKU,|pku,
577210|NCT00728676|Phe,|phe,
577211|NCT00728676|PAH,|pah,
577212|NCT00728676|Kuvan,|kuvan,
577213|NCT00728676|Trp,|trp,
577214|NCT00728676|Tyr|tyr
577215|NCT00728663|adenocarcinoma of the prostate|adenocarcinoma of the prostate
577216|NCT00728663|recurrent prostate cancer|recurrent prostate cancer
577217|NCT00728663|stage IV prostate cancer|stage iv prostate cancer
577218|NCT00728650|hepatocellular carcinoma|hepatocellular carcinoma
577219|NCT00728650|colorectal carcinoma metastatic to liver|colorectal carcinoma metastatic to liver
577220|NCT00728650|primary liver cancer|primary liver cancer
577221|NCT00728637|Prevention|prevention
577222|NCT00728624|Antibiotic susceptibility; beta lactamase; ESBLs|antibiotic susceptibility; beta lactamase; esbls
577223|NCT00728598|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
577224|NCT00728598|Angiogenesis|angiogenesis
577225|NCT00728598|Vitreous levels|vitreous levels
577226|NCT00728598|Vascular endothelial growth factor|vascular endothelial growth factor
577227|NCT00728598|Fractalkine|fractalkine
577228|NCT00728598|Growth factor|growth factor
577229|NCT00728585|mucositis|mucositis
577230|NCT00728585|graft versus host disease|graft versus host disease
577231|NCT00728585|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
577232|NCT00728585|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
577233|NCT00728585|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
577234|NCT00728585|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
577235|NCT00728585|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
577318|NCT00728325|Vocational Rehabilitation|vocational rehabilitation
577236|NCT00728585|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
577237|NCT00728585|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
577238|NCT00728585|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
577239|NCT00728585|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
577240|NCT00728585|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
577241|NCT00728585|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
577242|NCT00728585|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
577243|NCT00728585|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
577244|NCT00728585|secondary acute myeloid leukemia|secondary acute myeloid leukemia
577245|NCT00728585|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
577246|NCT00728585|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
577247|NCT00728585|disseminated neuroblastoma|disseminated neuroblastoma
577248|NCT00728585|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
577249|NCT00728585|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
577250|NCT00728585|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
577251|NCT00728585|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
577252|NCT00728585|recurrent neuroblastoma|recurrent neuroblastoma
577253|NCT00728585|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
577254|NCT00728585|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
577255|NCT00728585|stage I multiple myeloma|stage i multiple myeloma
577256|NCT00728585|stage II multiple myeloma|stage ii multiple myeloma
577257|NCT00728585|stage III multiple myeloma|stage iii multiple myeloma
577258|NCT00728585|refractory multiple myeloma|refractory multiple myeloma
577259|NCT00728585|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
577260|NCT00728585|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
577261|NCT00728585|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
577262|NCT00728585|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
577263|NCT00728585|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
577264|NCT00728585|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
577265|NCT00728585|stage IIIA breast cancer|stage iiia breast cancer
577266|NCT00728585|stage IIIB breast cancer|stage iiib breast cancer
577267|NCT00728585|stage IIIC breast cancer|stage iiic breast cancer
577268|NCT00728585|stage IV breast cancer|stage iv breast cancer
577269|NCT00728585|recurrent breast cancer|recurrent breast cancer
577270|NCT00728559|laparoscopy|laparoscopy
577271|NCT00728559|preemptive|preemptive
577272|NCT00728559|postoperative|postoperative
577273|NCT00728559|pain|pain
577274|NCT00728559|trocar|trocar
577275|NCT00728559|site|site
577276|NCT00728546|tuberculosis|tuberculosis
577277|NCT00728546|isoniazid|isoniazid
577278|NCT00728546|Arylamine N-acetyl transferase|arylamine n-acetyl transferase
577279|NCT00728546|genotyping|genotyping
577280|NCT00728546|hepatotoxicity|hepatotoxicity
577281|NCT00728546|pharmacogenetics|pharmacogenetics
577282|NCT00728533|Prostate Cancer requiring Androgen Ablation Therapy|prostate cancer requiring androgen ablation therapy
577283|NCT00728520|Leukemia|leukemia
577284|NCT00728520|Azacitidine|azacitidine
577285|NCT00728520|Untreated|untreated
577286|NCT00728520|Elderly|elderly
577287|NCT00728507|Tuberculosis|tuberculosis
577288|NCT00728507|Moxifloxacin|moxifloxacin
577289|NCT00728507|Rifapentine|rifapentine
577290|NCT00728468|Phase 1|phase 1
577291|NCT00728468|PF-00299804|pf-00299804
577292|NCT00728468|Dextromethorphan|dextromethorphan
577293|NCT00728468|CYP2D6 Inhibition|cyp2d6 inhibition
577294|NCT00728468|Cancer Patients|cancer patients
577295|NCT00728442|Clinical practice guidelines|clinical practice guidelines
577296|NCT00728442|Guideline adherence|guideline adherence
577297|NCT00728442|Clinical decision support systems|clinical decision support systems
577298|NCT00728442|Randomized controlled trial|randomized controlled trial
577299|NCT00728442|Intervention study|intervention study
577300|NCT00728429|cardiac toxicity|cardiac toxicity
577301|NCT00728429|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
577302|NCT00728429|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
577303|NCT00728390|advanced cancer refractory advanced non-small cell lung cancer|advanced cancer refractory advanced non-small cell lung cancer
577304|NCT00728377|gestational diabetes|gestational diabetes
577305|NCT00728377|physical activity|physical activity
577306|NCT00728377|behavior change|behavior change
577307|NCT00728377|glucose tolerance|glucose tolerance
577308|NCT00728377|pregnancy|pregnancy
577309|NCT00728364|Anderson Fabry disease|anderson fabry disease
577310|NCT00728364|chronic kidney disease|chronic kidney disease
577311|NCT00728364|prevalence|prevalence
577312|NCT00728351|Type 2 diabetes, vildagliptin|type 2 diabetes, vildagliptin
577313|NCT00728338|docosahexenoic acid (DHA)|docosahexenoic acid (dha)
577314|NCT00728338|dietary supplement|dietary supplement
577315|NCT00728338|n-3 polyunsaturated fatty acid|n-3 polyunsaturated fatty acid
577316|NCT00728338|cardiovascular disease|cardiovascular disease
577317|NCT00728325|PTSD|ptsd
581198|NCT00714493|restart|restart
577319|NCT00728325|Supported Employment|supported employment
577320|NCT00728312|Methamphetamine|methamphetamine
577321|NCT00728312|Therapeutics|therapeutics
577322|NCT00728312|Psychopharmacology|psychopharmacology
577323|NCT00728312|Amphetamine|amphetamine
577324|NCT00728299|Coronary artery disease, carotid intima-media thickness|coronary artery disease, carotid intima-media thickness
577325|NCT00728286|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
577326|NCT00728286|Acute Coronary Syndrome|acute coronary syndrome
577327|NCT00728286|Platelet dependent thrombogenicity|platelet dependent thrombogenicity
577328|NCT00728273|Efficacy|efficacy
577329|NCT00728273|Vietnam|vietnam
577330|NCT00728273|school children|school children
577331|NCT00728273|anemia|anemia
577332|NCT00728273|fortification|fortification
577333|NCT00728273|micronutrient|micronutrient
577334|NCT00728260|Meningitis|meningitis
577335|NCT00728260|Meningococcal disease|meningococcal disease
577336|NCT00728260|Menactra vaccine|menactra vaccine
577337|NCT00728247|Cervical Spine|cervical spine
577338|NCT00728247|Kinematics|kinematics
577339|NCT00728247|Manipulation|manipulation
577340|NCT00728247|Biomechanics|biomechanics
577341|NCT00728234|aEEG|aeeg
577342|NCT00728234|preterm infants|preterm infants
577343|NCT00728234|predictive value|predictive value
577344|NCT00728234|outcome|outcome
577345|NCT00728221|Ginseng|ginseng
577346|NCT00728221|Korean Red Ginseng|korean red ginseng
577347|NCT00728221|Ginsenoside|ginsenoside
577348|NCT00728221|Flow Mediated Dilation|flow mediated dilation
577349|NCT00728221|Endothelial Function|endothelial function
577350|NCT00728221|Hypertension|hypertension
577351|NCT00728208|Young|young
577352|NCT00728208|Elderly|elderly
577353|NCT00728208|Randomised|randomised
577354|NCT00728208|GSK372475|gsk372475
577355|NCT00728195|Schizophrenia|schizophrenia
577356|NCT00728195|Central Nervous System|central nervous system
577357|NCT00728195|JNJ-37822681|jnj-37822681
577358|NCT00728182|Stroke|stroke
577359|NCT00728182|Vascular cognitive impairment|vascular cognitive impairment
577360|NCT00728182|Coiling|coiling
577361|NCT00728182|Endovascular repair|endovascular repair
577362|NCT00728182|Brain aneurysm|brain aneurysm
577363|NCT00728182|NA-1|na-1
577364|NCT00728169|Asthma|asthma
577365|NCT00728169|Focus Group|focus group
577366|NCT00728169|Community Based Participatory Research|community based participatory research
577367|NCT00728156|Type 2 Diabetes mellitus|type 2 diabetes mellitus
577368|NCT00728156|Coronary artery disease|coronary artery disease
577369|NCT00728156|Platelet dependent thrombogenicity|platelet dependent thrombogenicity
577370|NCT00728156|Aspirin|aspirin
577371|NCT00728156|Clopidogrel|clopidogrel
577372|NCT00728156|Badimon Chamber|badimon chamber
577373|NCT00728130|carcinoma|carcinoma
577374|NCT00728130|upper|upper
577375|NCT00728130|aerodigestive|aerodigestive
577376|NCT00728130|tract|tract
577377|NCT00728130|submandibular|submandibular
577378|NCT00728130|gland|gland
577379|NCT00728117|indomethacin|indomethacin
577380|NCT00728117|ibuprofen|ibuprofen
577381|NCT00728117|preterm infant|preterm infant
577382|NCT00728104|Learn|learn
577383|NCT00728104|L-Carnitine|l-carnitine
577384|NCT00728104|Co-enzyme Q10|co-enzyme q10
577385|NCT00728104|Effective|effective
577386|NCT00728104|These supplements|these supplements
577387|NCT00728104|Compared|compared
577388|NCT00728104|Standard|standard
577389|NCT00728091|aquaretic|aquaretic
577390|NCT00728091|SIADH|siadh
577391|NCT00728078|hepatocellular carcinoma|hepatocellular carcinoma
577392|NCT00728078|liver cancer|liver cancer
577393|NCT00728078|radiofrequency ablation|radiofrequency ablation
577394|NCT00728078|thalidomide|thalidomide
577395|NCT00728052|Tolerability|tolerability
577396|NCT00728052|dose escalation|dose escalation
577397|NCT00728052|GSK598809|gsk598809
577398|NCT00728052|Pharmacodynamics|pharmacodynamics
577399|NCT00728052|Safety|safety
577400|NCT00728052|single|single
577401|NCT00728052|placebo|placebo
577402|NCT00728052|Smokers|smokers
577403|NCT00728052|Pharmacokinetics|pharmacokinetics
577404|NCT00728039|Youth|youth
577405|NCT00728039|Consensus|consensus
577406|NCT00728039|Criteria|criteria
577407|NCT00728039|CVS|cvs
577408|NCT00728026|Chart must reveal the following procedures:|chart must reveal the following procedures:
577409|NCT00728026|Heart rate variability,|heart rate variability,
577410|NCT00728026|Deep Breathing Test,|deep breathing test,
577411|NCT00728026|Valsalva maneuver,|valsalva maneuver,
577412|NCT00728026|Table test,|table test,
577413|NCT00728026|Thermoregulatory Sweat Testing,|thermoregulatory sweat testing,
577414|NCT00728026|Quantitative Sudomotor Axon Reflex Test (QSART),|quantitative sudomotor axon reflex test (qsart),
577415|NCT00728026|Vital signs,|vital signs,
577416|NCT00728026|postural changes in heart rate and blood pressure,|postural changes in heart rate and blood pressure,
577417|NCT00728026|composite autonomic score|composite autonomic score
577418|NCT00728013|Acute coronary syndrome|acute coronary syndrome
577419|NCT00728013|intensive lipid-lowering|intensive lipid-lowering
577420|NCT00728013|statins|statins
577421|NCT00728000|Pancreatic Cancer|pancreatic cancer
577422|NCT00727987|Rheumatoid arthritis|rheumatoid arthritis
577423|NCT00727987|Fully Human anti-TNFa monoclonal antibody|fully human anti-tnfa monoclonal antibody
577424|NCT00727987|CNTO148|cnto148
577425|NCT00727987|Golimumab|golimumab
577426|NCT00727974|Genome Wide Scan (GWS)|genome wide scan (gws)
577427|NCT00727974|Mitochondrial scan|mitochondrial scan
577428|NCT00727974|Family trios|family trios
577429|NCT00727948|Breast cancer|breast cancer
577430|NCT00727948|Angiogenesis|angiogenesis
577431|NCT00727948|Aspirin|aspirin
577432|NCT00727948|Tamoxifen|tamoxifen
577433|NCT00727935|Women|women
577434|NCT00727935|parturients|parturients
577435|NCT00727935|with|with
577436|NCT00727935|realization|realization
577437|NCT00727935|episiotomy|episiotomy
577438|NCT00727922|Neuropathy|neuropathy
577439|NCT00727922|Oxaliplatin|oxaliplatin
577440|NCT00727922|Mangafodipir|mangafodipir
577441|NCT00727909|Hearing loss|hearing loss
577442|NCT00727909|Hearing Aids|hearing aids
577443|NCT00727909|Speech Perception|speech perception
577444|NCT00727909|Persons with Hearing Impairment|persons with hearing impairment
577445|NCT00727896|Life style modification,|life style modification,
577446|NCT00727896|Type 2 diabetes,|type 2 diabetes,
577447|NCT00727896|SMS,|sms,
577448|NCT00727896|Patient adherence|patient adherence
577449|NCT00727883|Breast Cancer|breast cancer
577450|NCT00727883|Adjuvant TAM|adjuvant tam
577451|NCT00727883|post-menopausal|post-menopausal
577452|NCT00727883|women|women
577453|NCT00727870|Shave Biopsy management|shave biopsy management
577454|NCT00727870|"Biopsy/adverse effects[Mesh]"|"biopsy/adverse effects[mesh]"
577455|NCT00727870|"Biopsy/complications[Mesh])"|"biopsy/complications[mesh])"
577456|NCT00727857|Glucose Metabolism Disorder|glucose metabolism disorder
577457|NCT00727857|Dysmetabolic Syndrome|dysmetabolic syndrome
577458|NCT00727857|Type II Diabetes|type ii diabetes
577459|NCT00727857|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
577460|NCT00727857|Dyslipidemia|dyslipidemia
577461|NCT00727857|Drug Therapy|drug therapy
577462|NCT00727844|XDR-TB|xdr-tb
577463|NCT00727844|Linezolid|linezolid
577464|NCT00727844|Drug Resistance|drug resistance
577465|NCT00727844|Computed Tomography|computed tomography
577466|NCT00727844|Pharmacokinetics|pharmacokinetics
577467|NCT00727844|Tuberculosis|tuberculosis
577468|NCT00727844|Drug Resistance Tuberculosis|drug resistance tuberculosis
577469|NCT00727844|MDR-TB|mdr-tb
577470|NCT00727831|neurotoxicity|neurotoxicity
577471|NCT00727831|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
577472|NCT00727831|mucositis|mucositis
577473|NCT00727831|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
577474|NCT00727831|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
577475|NCT00727831|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
577476|NCT00727831|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
577477|NCT00727831|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
577478|NCT00727831|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
577479|NCT00727792|participants|participants
577480|NCT00727792|scheduled|scheduled
577481|NCT00727792|clinically|clinically
577482|NCT00727792|ordered|ordered
577483|NCT00727792|MRI|mri
577484|NCT00727779|diabetes, metabolic syndrome, type 2 diabetes|diabetes, metabolic syndrome, type 2 diabetes
577485|NCT00727766|Clofarabine|clofarabine
577486|NCT00727766|Clolar|clolar
577487|NCT00727766|AML|aml
577488|NCT00727766|Consolidation|consolidation
577489|NCT00727753|Macular Degeneration|macular degeneration
577490|NCT00727753|Age-Related Maculopathies|age-related maculopathies
577491|NCT00727740|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
577492|NCT00727740|Pancreatitis|pancreatitis
577493|NCT00727740|Indomethacin|indomethacin
577494|NCT00727727|Piribedil (trade name: Clarium)|piribedil (trade name: clarium)
577495|NCT00727727|non-ergot dopamine agonist|non-ergot dopamine agonist
577496|NCT00727727|Morbus Parkinson|morbus parkinson
577497|NCT00727727|Tolerability|tolerability
577498|NCT00727727|Efficacy|efficacy
577499|NCT00727727|Post Marketing Surveillance|post marketing surveillance
577500|NCT00727714|Cement dust exposure|cement dust exposure
577501|NCT00727714|Cross-shift study|cross-shift study
577502|NCT00727714|Lung function indices|lung function indices
577503|NCT00727714|Exhaled nitric oxide|exhaled nitric oxide
577504|NCT00727714|Serum inflammatory markers|serum inflammatory markers
577505|NCT00727701|varicose ulcer|varicose ulcer
577506|NCT00727701|veteran|veteran
577507|NCT00727701|recurrence|recurrence
577508|NCT00727701|aftercare|aftercare
577509|NCT00727675|chronic pain|chronic pain
577510|NCT00727675|opioid dependence|opioid dependence
577511|NCT00727675|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
577512|NCT00727662|Breast Cancer|breast cancer
577513|NCT00727662|Fatigue|fatigue
577514|NCT00727662|Proinflammatory Cytokines|proinflammatory cytokines
577515|NCT00727662|Physical functioning|physical functioning
577516|NCT00727662|Quality of life|quality of life
577517|NCT00727649|fecal incontinence|fecal incontinence
577518|NCT00727649|adults|adults
577519|NCT00727649|diarrhea|diarrhea
577520|NCT00727636|inflammatory bowel disease (IBD)|inflammatory bowel disease (ibd)
577521|NCT00727636|immunogenicity|immunogenicity
577522|NCT00727636|safety|safety
577523|NCT00727636|HPV|hpv
577524|NCT00727636|Gardasil|gardasil
577525|NCT00727636|vaccine|vaccine
577526|NCT00727623|acute coronary syndrome|acute coronary syndrome
577527|NCT00727623|myocardial infarction|myocardial infarction
577528|NCT00727623|predictors of mortality|predictors of mortality
577529|NCT00727623|reperfusion therapy|reperfusion therapy
577530|NCT00727610|Adverse drug event|adverse drug event
577531|NCT00727610|harm|harm
577532|NCT00727610|patient safety|patient safety
577533|NCT00727610|clinical decision support|clinical decision support
577534|NCT00727610|Adverse drug related event|adverse drug related event
577535|NCT00727584|spinal cord compression|spinal cord compression
577536|NCT00727584|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
577537|NCT00727571|Anemia|anemia
577538|NCT00727571|Chronic Kidney Disease|chronic kidney disease
577539|NCT00727571|Quality of Life|quality of life
577540|NCT00727571|CKD|ckd
577541|NCT00727571|Chronic Renal Insufficiency|chronic renal insufficiency
577542|NCT00727558|refractive error|refractive error
577543|NCT00727532|clear cell renal cell carcinoma|clear cell renal cell carcinoma
577544|NCT00727532|hereditary clear cell renal cell carcinoma|hereditary clear cell renal cell carcinoma
577545|NCT00727532|recurrent renal cell cancer|recurrent renal cell cancer
577546|NCT00727532|stage I renal cell cancer|stage i renal cell cancer
577547|NCT00727532|stage II renal cell cancer|stage ii renal cell cancer
577548|NCT00727532|stage III renal cell cancer|stage iii renal cell cancer
577549|NCT00727532|stage IV renal cell cancer|stage iv renal cell cancer
577550|NCT00727519|Hemodialysis|hemodialysis
577551|NCT00727519|Nephrology|nephrology
577552|NCT00727519|Pomegranate Juice|pomegranate juice
577553|NCT00727519|Israel|israel
577554|NCT00727493|osteoporosis,|osteoporosis,
577555|NCT00727493|bisphosphonate|bisphosphonate
577556|NCT00727493|therapy|therapy
577557|NCT00727493|dental implant|dental implant
577558|NCT00727480|vascularity|vascularity
577559|NCT00727480|fingertips|fingertips
577560|NCT00727467|auditory cueing device|auditory cueing device
577561|NCT00727467|Parkinson's disease|parkinson's disease
577562|NCT00727467|freezing|freezing
577563|NCT00727467|gait|gait
577564|NCT00727467|mobility|mobility
577565|NCT00727454|Obstructive sleep apnea|obstructive sleep apnea
577566|NCT00727454|CPAP|cpap
577567|NCT00727454|Heart remodeling|heart remodeling
577568|NCT00727454|Cardiovascular disease|cardiovascular disease
577569|NCT00727454|MRI|mri
577570|NCT00727441|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
577571|NCT00727441|stage I pancreatic cancer|stage i pancreatic cancer
577572|NCT00727441|stage II pancreatic cancer|stage ii pancreatic cancer
577573|NCT00727428|FluLaval® TF|flulaval® tf
577574|NCT00727428|Safety|safety
577575|NCT00727428|Immunogenicity|immunogenicity
577576|NCT00727428|Influenza|influenza
577577|NCT00727415|advanced or progressive chronic lymphocytic leukemia|advanced or progressive chronic lymphocytic leukemia
577578|NCT00727415|Lenalidomide|lenalidomide
577579|NCT00727415|Fludarabine|fludarabine
577580|NCT00727389|Prevention|prevention
577581|NCT00727389|Quality of Health Care|quality of health care
577582|NCT00727389|Health Care Evaluation Mechanisms|health care evaluation mechanisms
577583|NCT00727376|esophageal|esophageal
577584|NCT00727376|stenting|stenting
577585|NCT00727363|probiotics|probiotics
577586|NCT00727363|lactobacillus reuteri|lactobacillus reuteri
577587|NCT00727363|preterm infants|preterm infants
577588|NCT00727363|nosocomial infection|nosocomial infection
577589|NCT00727363|necrotizing enterocolitis|necrotizing enterocolitis
577590|NCT00727350|NSCLC|nsclc
577591|NCT00727350|Novalis|novalis
577592|NCT00727350|Stereotactic|stereotactic
577593|NCT00727350|SBRT|sbrt
577594|NCT00727350|T1, T2 or T3NO NSCLC|t1, t2 or t3no nsclc
577595|NCT00727337|auditory perception|auditory perception
577596|NCT00727337|rehabilitation of hearing impaired|rehabilitation of hearing impaired
577597|NCT00727324|Ulcerative Colitis|ulcerative colitis
577598|NCT00727324|UC|uc
577599|NCT00727324|moderate|moderate
577600|NCT00727324|severe|severe
577601|NCT00727324|LPS|lps
577602|NCT00727324|Alkaline Phosphatase|alkaline phosphatase
577603|NCT00727324|AP|ap
577604|NCT00727324|BIAP|biap
577605|NCT00727324|Mucositis|mucositis
577606|NCT00727285|Cystic Fibrosis|cystic fibrosis
577607|NCT00727285|pulmonary exacerbation|pulmonary exacerbation
577608|NCT00727285|gene expression|gene expression
577609|NCT00727285|biomarker|biomarker
577610|NCT00727285|inflammation|inflammation
577611|NCT00727285|CF pulmonary exacerbation|cf pulmonary exacerbation
577612|NCT00727272|Bioavailability|bioavailability
577613|NCT00727246|Traumatic Brain Injury|traumatic brain injury
577614|NCT00727246|FMRI|fmri
577615|NCT00727246|Memory|memory
577616|NCT00727246|Cognition|cognition
577617|NCT00727246|Neuropsychology|neuropsychology
577618|NCT00727233|Neuroblastosis Type I|neuroblastosis type i
577619|NCT00727233|Plexiform Neurofibromas|plexiform neurofibromas
577620|NCT00727233|Angiogenesis Inhibitor|angiogenesis inhibitor
577621|NCT00727233|Kinase Inhibitor|kinase inhibitor
577622|NCT00727233|Neurofibromatosis Type 1|neurofibromatosis type 1
577623|NCT00727233|NF1|nf1
577624|NCT00727233|Plexiform Neurofibroma|plexiform neurofibroma
577625|NCT00727220|type 1 diabetes|type 1 diabetes
577626|NCT00727220|continuous glucose sensor monitoring|continuous glucose sensor monitoring
577627|NCT00727207|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
577628|NCT00727207|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
577629|NCT00727207|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
577630|NCT00727207|stage I mantle cell lymphoma|stage i mantle cell lymphoma
577631|NCT00727207|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
577632|NCT00727207|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
577633|NCT00727181|aortic valve|aortic valve
577634|NCT00727181|heart valve|heart valve
577635|NCT00727181|tissue valve|tissue valve
577636|NCT00727181|bioprosthesis|bioprosthesis
577637|NCT00727181|valve disorder|valve disorder
577638|NCT00727181|valve disease|valve disease
577639|NCT00727181|cardiac surgery|cardiac surgery
577640|NCT00727181|aortic valve stenosis|aortic valve stenosis
577641|NCT00727181|aortic valve regurgitation|aortic valve regurgitation
577642|NCT00727168|prevalence study|prevalence study
577643|NCT00727168|glaucoma|glaucoma
577644|NCT00727142|NPH|nph
577645|NCT00727142|Hydrocephalus|hydrocephalus
577646|NCT00727142|Shunt|shunt
577647|NCT00727129|vasomotor symptoms|vasomotor symptoms
577648|NCT00727129|estrogen|estrogen
577649|NCT00727129|estradiol|estradiol
577650|NCT00727129|hot flashes|hot flashes
577651|NCT00727103|Varenicline|varenicline
577652|NCT00727103|Smoking cessation|smoking cessation
577653|NCT00727103|Schizophrenia|schizophrenia
577654|NCT00727103|Schizoaffective disorder|schizoaffective disorder
577655|NCT00727103|Alcohol dependence|alcohol dependence
577656|NCT00727103|Nicotine dependence|nicotine dependence
577657|NCT00727064|Healthy Subjects|healthy subjects
577658|NCT00727051|invasive coronary angiography|invasive coronary angiography
577659|NCT00727051|multidetector coronary CTA|multidetector coronary cta
577660|NCT00727051|coronary artery disease|coronary artery disease
577661|NCT00727051|detecting coronary artery disease|detecting coronary artery disease
577662|NCT00727038|glaucoma|glaucoma
577663|NCT00727038|neovascular glaucoma|neovascular glaucoma
577664|NCT00727038|new onset glaucoma|new onset glaucoma
577665|NCT00727038|retinal ischemia|retinal ischemia
577666|NCT00727038|central retinal vein occlusion|central retinal vein occlusion
577667|NCT00727038|proliferative diabetic retinopathy|proliferative diabetic retinopathy
577668|NCT00727038|ocular ischemic syndrome|ocular ischemic syndrome
577669|NCT00727038|carotid stenosis|carotid stenosis
577670|NCT00727038|vascular endothelial growth factor|vascular endothelial growth factor
577671|NCT00727038|neovascular|neovascular
577672|NCT00727025|skin closure devices|skin closure devices
577673|NCT00727025|linear scars|linear scars
577674|NCT00727012|mitral valve|mitral valve
577675|NCT00727012|heart valve|heart valve
577676|NCT00727012|valve repair|valve repair
577677|NCT00727012|valve disorder|valve disorder
577678|NCT00727012|valve disease|valve disease
577679|NCT00727012|cardiac surgery|cardiac surgery
577680|NCT00726999|Gabapentin|gabapentin
577681|NCT00726999|Pediatric Spinal Fusion|pediatric spinal fusion
577682|NCT00726999|Narcotic Use|narcotic use
577683|NCT00726986|extensive stage small cell lung cancer|extensive stage small cell lung cancer
577684|NCT00726973|Macular edema|macular edema
577685|NCT00726960|Heroin abuse|heroin abuse
577686|NCT00726960|Opioids|opioids
577687|NCT00726960|Opiates|opiates
577688|NCT00726960|Substance abuse|substance abuse
577689|NCT00726960|Addiction|addiction
577690|NCT00726934|Neutropenic Diet|neutropenic diet
577691|NCT00726934|Food Safety Guidelines|food safety guidelines
577692|NCT00726934|child|child
577693|NCT00726934|cancer|cancer
577694|NCT00726908|Obesity|obesity
577695|NCT00726908|diet|diet
577696|NCT00726908|carbohydrate|carbohydrate
577697|NCT00726908|insulin|insulin
577698|NCT00726895|Bioavailability|bioavailability
577699|NCT00726882|HCV Infection|hcv infection
577700|NCT00726869|Patients After One to three Prior Therapies|patients after one to three prior therapies
577701|NCT00726843|Headache|headache
577702|NCT00726843|Complementary and Alternative Medicine|complementary and alternative medicine
577703|NCT00726843|Pediatric|pediatric
577704|NCT00726843|Yoga|yoga
577705|NCT00726830|pain|pain
577706|NCT00726830|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
577707|NCT00726830|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
577708|NCT00726830|acute undifferentiated leukemia|acute undifferentiated leukemia
577709|NCT00726830|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
577710|NCT00726830|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
581295|NCT00714025|RAD001|rad001
577711|NCT00726830|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
577712|NCT00726830|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
577713|NCT00726830|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
577714|NCT00726830|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
577715|NCT00726830|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
577716|NCT00726830|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
577717|NCT00726830|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
577718|NCT00726830|mast cell leukemia|mast cell leukemia
577719|NCT00726830|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
577720|NCT00726830|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
577721|NCT00726830|prolymphocytic leukemia|prolymphocytic leukemia
577722|NCT00726830|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
577723|NCT00726830|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
577724|NCT00726830|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
577725|NCT00726830|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
577726|NCT00726830|refractory hairy cell leukemia|refractory hairy cell leukemia
577727|NCT00726830|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
577728|NCT00726830|secondary acute myeloid leukemia|secondary acute myeloid leukemia
577729|NCT00726830|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
577730|NCT00726830|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
577731|NCT00726830|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
577732|NCT00726830|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
577733|NCT00726830|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
577734|NCT00726830|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
577735|NCT00726830|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
577736|NCT00726830|untreated hairy cell leukemia|untreated hairy cell leukemia
577737|NCT00726830|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
577738|NCT00726830|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
577739|NCT00726830|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
577740|NCT00726830|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
577741|NCT00726830|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
577742|NCT00726830|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
577743|NCT00726830|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
577744|NCT00726830|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
577745|NCT00726830|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
577746|NCT00726830|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
577747|NCT00726830|anaplastic large cell lymphoma|anaplastic large cell lymphoma
577748|NCT00726830|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
577749|NCT00726830|splenic marginal zone lymphoma|splenic marginal zone lymphoma
577750|NCT00726830|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
577751|NCT00726830|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
577752|NCT00726830|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
577753|NCT00726830|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
577754|NCT00726830|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
577755|NCT00726830|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
577756|NCT00726830|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
577757|NCT00726830|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
577758|NCT00726830|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
577759|NCT00726830|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
577760|NCT00726830|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
577761|NCT00726830|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
577762|NCT00726830|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
577763|NCT00726830|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
577764|NCT00726830|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
577765|NCT00726830|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
577766|NCT00726830|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
577767|NCT00726830|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
577768|NCT00726830|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
577769|NCT00726830|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
577770|NCT00726830|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
577771|NCT00726830|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
577772|NCT00726830|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
577773|NCT00726830|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
581296|NCT00714025|TCC|tcc
577774|NCT00726830|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
577775|NCT00726830|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
577776|NCT00726830|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
577777|NCT00726830|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
577778|NCT00726830|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
577779|NCT00726830|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
577780|NCT00726830|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
577781|NCT00726830|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
577782|NCT00726830|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
577783|NCT00726830|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
577784|NCT00726830|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
577785|NCT00726830|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
577786|NCT00726830|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
577787|NCT00726830|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
577788|NCT00726830|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
577789|NCT00726830|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
577790|NCT00726830|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
577791|NCT00726830|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
577792|NCT00726830|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
577793|NCT00726830|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
577794|NCT00726830|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
577795|NCT00726830|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
577796|NCT00726830|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
577797|NCT00726830|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
577798|NCT00726830|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
577799|NCT00726830|intraocular lymphoma|intraocular lymphoma
577800|NCT00726830|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
577801|NCT00726830|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
577802|NCT00726830|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
577803|NCT00726830|chronic eosinophilic leukemia|chronic eosinophilic leukemia
577804|NCT00726830|chronic neutrophilic leukemia|chronic neutrophilic leukemia
577805|NCT00726830|primary myelofibrosis|primary myelofibrosis
577806|NCT00726830|essential thrombocythemia|essential thrombocythemia
577807|NCT00726830|polycythemia vera|polycythemia vera
577808|NCT00726830|extramedullary plasmacytoma|extramedullary plasmacytoma
577809|NCT00726830|isolated plasmacytoma of bone|isolated plasmacytoma of bone
577810|NCT00726830|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
577811|NCT00726830|stage II multiple myeloma|stage ii multiple myeloma
577812|NCT00726830|stage III multiple myeloma|stage iii multiple myeloma
577813|NCT00726830|primary systemic amyloidosis|primary systemic amyloidosis
577814|NCT00726830|refractory multiple myeloma|refractory multiple myeloma
577815|NCT00726830|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
577816|NCT00726830|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
577817|NCT00726830|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
577818|NCT00726830|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
577819|NCT00726830|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
577820|NCT00726830|Waldenström macroglobulinemia|waldenström macroglobulinemia
577821|NCT00726817|butyrate, visceral perception, compliance|butyrate, visceral perception, compliance
577822|NCT00726791|chronic pain|chronic pain
577823|NCT00726791|pain disorder|pain disorder
577824|NCT00726778|race/ethnicity|race/ethnicity
577825|NCT00726778|insulin senistivity|insulin senistivity
577826|NCT00726778|genetic admixture|genetic admixture
577827|NCT00726778|type 2 diabetes|type 2 diabetes
577828|NCT00726778|obesity|obesity
577829|NCT00726778|body composition|body composition
577830|NCT00726778|Insulin dynamics|insulin dynamics
577831|NCT00726778|Racial/ethnic differences|racial/ethnic differences
577832|NCT00726752|solid tumor|solid tumor
577833|NCT00726752|Axitinib|axitinib
577834|NCT00726752|Pharmacokinetics|pharmacokinetics
577835|NCT00726752|Phase 1|phase 1
577836|NCT00726739|recurrent melanoma|recurrent melanoma
577837|NCT00726713|Metanx|metanx
577838|NCT00726713|diabetes|diabetes
577839|NCT00726713|neuropathy|neuropathy
577840|NCT00726713|folic acid|folic acid
577841|NCT00726713|folate|folate
577842|NCT00726713|L-methylfolate|l-methylfolate
577843|NCT00726713|vitamin B6|vitamin b6
577844|NCT00726713|Pyridoxal 5'-phosphate|pyridoxal 5'-phosphate
577845|NCT00726713|vitamin B12|vitamin b12
577846|NCT00726713|methylcobalamin|methylcobalamin
577847|NCT00726700|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
577848|NCT00726700|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
577849|NCT00726700|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
577931|NCT00726427|Healthy Volunteers|healthy volunteers
577850|NCT00726700|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
577851|NCT00726700|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
577852|NCT00726700|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
577853|NCT00726700|anaplastic large cell lymphoma|anaplastic large cell lymphoma
577854|NCT00726700|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
577855|NCT00726700|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
577856|NCT00726700|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
577857|NCT00726700|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
577858|NCT00726700|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
577859|NCT00726700|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
577860|NCT00726700|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
577861|NCT00726700|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
577862|NCT00726700|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
577863|NCT00726700|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
577864|NCT00726700|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
577865|NCT00726700|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
577866|NCT00726700|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
577867|NCT00726700|stage I mantle cell lymphoma|stage i mantle cell lymphoma
577868|NCT00726700|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
577869|NCT00726700|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
577870|NCT00726700|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
577871|NCT00726700|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
577872|NCT00726700|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
577873|NCT00726700|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
577874|NCT00726700|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
577875|NCT00726700|stage I marginal zone lymphoma|stage i marginal zone lymphoma
577876|NCT00726700|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
577877|NCT00726700|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
577878|NCT00726687|Cancer|cancer
577879|NCT00726687|Indibulin|indibulin
577880|NCT00726687|Capecitabine|capecitabine
577881|NCT00726687|Xeloda|xeloda
577882|NCT00726674|Diabetes HbA1C|diabetes hba1c
577883|NCT00726661|Metastatic Breast Cancer|metastatic breast cancer
577884|NCT00726661|Locally Recurrent Breast Cancer|locally recurrent breast cancer
577885|NCT00726661|Avastin|avastin
577886|NCT00726648|CDP323|cdp323
577887|NCT00726648|Relapsing multiple sclerosis|relapsing multiple sclerosis
577888|NCT00726648|Blood biomarkers|blood biomarkers
577889|NCT00726622|rectal cancer|rectal cancer
577890|NCT00726622|adenocarcinoma of the rectum|adenocarcinoma of the rectum
577891|NCT00726596|recurrent prostate cancer|recurrent prostate cancer
577892|NCT00726596|stage IV prostate cancer|stage iv prostate cancer
577893|NCT00726596|Prostate-Specific Antigen|prostate-specific antigen
577894|NCT00726583|Cancer|cancer
577895|NCT00726583|Solid Tumors|solid tumors
577896|NCT00726583|Carcinoma|carcinoma
577898|NCT00726583|PI3 kinase|pi3 kinase
577899|NCT00726583|PI3K|pi3k
577900|NCT00726570|Disorders, Blood coagulation|disorders, blood coagulation
577901|NCT00726570|Deep Vein Thrombosis|deep vein thrombosis
577902|NCT00726570|Perioperative Care|perioperative care
577903|NCT00726570|Digestive System Surgical Procedures|digestive system surgical procedures
577904|NCT00726544|thrombocytopenia|thrombocytopenia
577905|NCT00726544|microangiopathic hemolytic anemia|microangiopathic hemolytic anemia
577906|NCT00726544|von Willebrand Factor|von willebrand factor
577907|NCT00726544|ADAMTS13|adamts13
577908|NCT00726531|Falls prevention|falls prevention
577909|NCT00726531|Exercise promotion|exercise promotion
577910|NCT00726531|Older people|older people
577911|NCT00726466|Age Related Macular Degeneration|age related macular degeneration
577912|NCT00726466|AMD|amd
577913|NCT00726466|CNV|cnv
577914|NCT00726453|TARGET VESSEL REVASCULARIZATION (TVR)|target vessel revascularization (tvr)
577915|NCT00726453|MYOCARDIAL INFARCTION (MI)|myocardial infarction (mi)
577916|NCT00726453|TARGET VESSEL FAILURE (TVF)|target vessel failure (tvf)
577917|NCT00726453|TARGET LESION REVASCULARIZATION (TLR)|target lesion revascularization (tlr)
577918|NCT00726453|TARGET LESION FAILURE (TLF)|target lesion failure (tlf)
577919|NCT00726453|STENT THROMBOSIS|stent thrombosis
577920|NCT00726453|RESTENOTIC LESION|restenotic lesion
577921|NCT00726453|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
577922|NCT00726440|Type 1 Diabetes|type 1 diabetes
577923|NCT00726440|Real Time Continuous Glucose Monitoring System|real time continuous glucose monitoring system
577924|NCT00726440|HbA1c|hba1c
577925|NCT00726440|Navigator®|navigator®
577926|NCT00726427|pharmacokinetics|pharmacokinetics
577927|NCT00726427|pharmacodynamics|pharmacodynamics
577928|NCT00726427|AZD1656|azd1656
577929|NCT00726427|safety|safety
577930|NCT00726427|tolerability|tolerability
577932|NCT00726414|Bioavailability|bioavailability
577933|NCT00726401|Allergies|allergies
577934|NCT00726401|Nasal|nasal
577935|NCT00726401|Congestion|congestion
577936|NCT00726401|Sneezing|sneezing
577937|NCT00726401|Pruritus|pruritus
577938|NCT00726401|Teary|teary
577939|NCT00726401|Eyes|eyes
577940|NCT00726388|safety|safety
577941|NCT00726388|diclofenac|diclofenac
577942|NCT00726388|pain, postoperative|pain, postoperative
577943|NCT00726375|(GVHD)|(gvhd)
577944|NCT00726362|Statin|statin
577945|NCT00726362|LDL-C|ldl-c
577946|NCT00726336|healthy volunteer|healthy volunteer
577947|NCT00726336|pharmacokinetics|pharmacokinetics
577948|NCT00726336|GSK1349572|gsk1349572
577949|NCT00726336|integrase|integrase
577950|NCT00726323|c-Met|c-met
577951|NCT00726323|Papillary Renal Cell Carcinoma(PRC)|papillary renal cell carcinoma(prc)
577952|NCT00726323|Sporadic papillary renal cell carcinoma,|sporadic papillary renal cell carcinoma,
577953|NCT00726323|Clear cell renal carcinoma|clear cell renal carcinoma
577954|NCT00726323|Hereditary papillary renal cell carcinoma,|hereditary papillary renal cell carcinoma,
577955|NCT00726310|Spondylolisthesis|spondylolisthesis
577956|NCT00726310|Instability|instability
577957|NCT00726284|HNP|hnp
577958|NCT00726271|obesity|obesity
577959|NCT00726271|appetite set point|appetite set point
577960|NCT00726219|Major|major
577961|NCT00726219|knee|knee
577962|NCT00726219|surgery|surgery
577963|NCT00726180|Breast cancer|breast cancer
577964|NCT00726180|Women|women
577965|NCT00726180|w/Her2|w/her2
577966|NCT00726180|positive|positive
577967|NCT00726180|ERnegative|ernegative
577968|NCT00726180|not metastasized|not metastasized
577969|NCT00726167|Ventilator associated Pneumonia|ventilator associated pneumonia
577970|NCT00726167|mechanically ventilated|mechanically ventilated
577971|NCT00726167|procalcitonin|procalcitonin
577972|NCT00726167|pneumonia scores|pneumonia scores
577973|NCT00726154|Bipolar Disorder|bipolar disorder
577974|NCT00726154|Circadian Rhythm|circadian rhythm
577975|NCT00726154|Moderators|moderators
577976|NCT00726154|Lithium|lithium
577977|NCT00726154|Quetiapine|quetiapine
577978|NCT00726141|Brief Intervention|brief intervention
577979|NCT00726141|Smoking Cessation|smoking cessation
577980|NCT00726141|Motivational Interviewing|motivational interviewing
577981|NCT00726141|Expert System|expert system
577982|NCT00726141|Readiness to Change|readiness to change
577983|NCT00726141|Hormonal Contraceptive|hormonal contraceptive
577984|NCT00726141|Adolescents|adolescents
577985|NCT00726128|DDD|ddd
577986|NCT00726102|Zinc nutrition|zinc nutrition
577987|NCT00726102|Growth|growth
577988|NCT00726102|Development|development
577989|NCT00726102|China|china
577990|NCT00726102|Infants|infants
577991|NCT00726102|Toddlers|toddlers
577992|NCT00726076|Epilepsy|epilepsy
577993|NCT00726076|Medication|medication
577994|NCT00726076|Stress|stress
577995|NCT00726076|Sleep|sleep
577996|NCT00726076|Lifestyle Management|lifestyle management
577997|NCT00726063|dental implants|dental implants
577998|NCT00726063|Nanotite implant|nanotite implant
577999|NCT00726063|Osseotite implants|osseotite implants
578000|NCT00726063|multicenter|multicenter
578001|NCT00726063|randomized|randomized
578002|NCT00726063|clinical study|clinical study
578003|NCT00726063|partial edentulism|partial edentulism
578004|NCT00726063|prosthesis|prosthesis
578005|NCT00726050|Theta Burst Stimulation|theta burst stimulation
578006|NCT00726050|Somatosensory Stimulation|somatosensory stimulation
578007|NCT00726050|Somatosensory Cortex|somatosensory cortex
578008|NCT00726050|Tactile Discrimination|tactile discrimination
578009|NCT00726050|Healthy Volunteer|healthy volunteer
578010|NCT00726050|HV|hv
578011|NCT00726037|Denileukin diftitox|denileukin diftitox
578012|NCT00726037|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
578013|NCT00726037|Ontak|ontak
578014|NCT00726037|Regulatory T-cell|regulatory t-cell
578015|NCT00726011|due|due
578016|NCT00726011|cancer treatment|cancer treatment
578017|NCT00725998|Cochlear Implantation.|cochlear implantation.
578018|NCT00725998|Cochlear nerve.|cochlear nerve.
578019|NCT00725998|Child.|child.
578020|NCT00725998|study|study
578021|NCT00725998|ECAP|ecap
578022|NCT00725998|During|during
578023|NCT00725998|First year|first year
578024|NCT00725985|Clinically Isolated Syndrome (CIS)|clinically isolated syndrome (cis)
578025|NCT00725985|Early MS|early ms
578026|NCT00725985|Multiple Sclerosis|multiple sclerosis
578027|NCT00725972|Improve|improve
578028|NCT00725972|Patient care|patient care
578029|NCT00725972|Applying|applying
578030|NCT00725972|Systematic|systematic
578031|NCT00725972|Fashion|fashion
578032|NCT00725972|Proven|proven
578033|NCT00725972|Resuscitation|resuscitation
578034|NCT00725972|Algorithms|algorithms
578035|NCT00725972|High risk|high risk
578036|NCT00725972|Surgical|surgical
578037|NCT00725959|HIV Prevention|hiv prevention
578038|NCT00725959|Social Networking|social networking
578039|NCT00725959|Technology Based Intervention|technology based intervention
578040|NCT00725920|PTSD,|ptsd,
578041|NCT00725920|posttraumatic|posttraumatic
578042|NCT00725920|stress|stress
578043|NCT00725920|disorder,|disorder,
578044|NCT00725920|randomization,|randomization,
578045|NCT00725920|placebo,|placebo,
578046|NCT00725920|controlled|controlled
578047|NCT00725907|PRP|prp
578048|NCT00725907|ATFL|atfl
578049|NCT00725881|PAD|pad
578050|NCT00725881|Peripheral arterial disease|peripheral arterial disease
578051|NCT00725881|Peripheral artery disease|peripheral artery disease
578052|NCT00725881|Intermittent claudication|intermittent claudication
578053|NCT00725881|IC|ic
578054|NCT00725881|atherosclerosis|atherosclerosis
578055|NCT00725881|leg pain|leg pain
578056|NCT00725881|walking pain|walking pain
578057|NCT00725868|Major adverse|major adverse
578058|NCT00725855|Schizophrenia|schizophrenia
578059|NCT00725855|P50 Sensory Gating|p50 sensory gating
578060|NCT00725855|Mismatched Negativity|mismatched negativity
578061|NCT00725829|coagulation|coagulation
578062|NCT00725829|cholesterol|cholesterol
578063|NCT00725829|acute ischemia|acute ischemia
578064|NCT00725829|fibrin clot|fibrin clot
578065|NCT00725803|Hepatitis C|hepatitis c
578066|NCT00725803|HCV|hcv
578067|NCT00725803|Fibrosis|fibrosis
578068|NCT00725803|Apoptosis|apoptosis
578069|NCT00725803|GS-9450|gs-9450
578070|NCT00725790|Erectile Dysfunction|erectile dysfunction
578071|NCT00725790|Spinal Cord Injury|spinal cord injury
578072|NCT00725764|VEGFR2|vegfr2
578073|NCT00725764|XL880|xl880
578074|NCT00725764|foretinib|foretinib
578075|NCT00725764|Squamous Cell Cancer of the Head and Neck|squamous cell cancer of the head and neck
578076|NCT00725764|MET|met
578077|NCT00725764|GSK1363089|gsk1363089
578078|NCT00725738|Myocardial|myocardial
578079|NCT00725738|Infarction,|infarction,
578080|NCT00725738|Stem|stem
578081|NCT00725738|Cell|cell
578082|NCT00725738|Therapy|therapy
578083|NCT00725712|c-Met|c-met
578084|NCT00725712|Metastatic Gastric Carcinoma|metastatic gastric carcinoma
578085|NCT00725712|adenocarcinoma|adenocarcinoma
578086|NCT00725712|Gastric cancer|gastric cancer
578087|NCT00725712|GSK1363089|gsk1363089
578088|NCT00725712|XL880|xl880
578089|NCT00725712|MET inhibitor|met inhibitor
578090|NCT00725686|"Choroidal Neovascularization (CNV) WET AMD"|"choroidal neovascularization (cnv) wet amd"
578091|NCT00725673|COPD|copd
578092|NCT00725673|Osteoporosis|osteoporosis
578093|NCT00725673|BMD|bmd
578094|NCT00725673|DEXA-scan|dexa-scan
578095|NCT00725660|pre eclampsia|pre eclampsia
578096|NCT00725660|doppler|doppler
578097|NCT00725660|uterine|uterine
578098|NCT00725660|arteries|arteries
578099|NCT00725660|angiogenic|angiogenic
578100|NCT00725660|factors|factors
578101|NCT00725647|N terminal B type natriuretic peptide|n terminal b type natriuretic peptide
578102|NCT00725647|echocardiography|echocardiography
578103|NCT00725647|diagnosis|diagnosis
578104|NCT00725647|atrial natriuretic peptides|atrial natriuretic peptides
578105|NCT00725647|preterm infant|preterm infant
578106|NCT00725634|Neoplasms,|neoplasms,
578107|NCT00725634|Lymphoma,|lymphoma,
578108|NCT00725634|Multiple Myeloma,|multiple myeloma,
578109|NCT00725634|Neoplasms, Plasma Cell,|neoplasms, plasma cell,
578110|NCT00725634|Neoplasms by Histologic Type,|neoplasms by histologic type,
578111|NCT00725634|Lymphoproliferative Disorders,|lymphoproliferative disorders,
578112|NCT00725634|Lymphatic Diseases, Immunoproliferative Disorders|lymphatic diseases, immunoproliferative disorders
578113|NCT00725634|Immune System Diseases Hemostatic Disorders|immune system diseases hemostatic disorders
578114|NCT00725634|Vascular Diseases|vascular diseases
578115|NCT00725634|Cardiovascular Diseases|cardiovascular diseases
578116|NCT00725634|Paraproteinemias|paraproteinemias
578117|NCT00725634|Blood Protein Disorders|blood protein disorders
578118|NCT00725634|Hematologic Diseases|hematologic diseases
578119|NCT00725634|Hemorrhagic Disorders|hemorrhagic disorders
578120|NCT00725634|Erlotinib|erlotinib
578121|NCT00725634|Protein Kinase Inhibitors|protein kinase inhibitors
578122|NCT00725634|Enzyme Inhibitors,|enzyme inhibitors,
578123|NCT00725634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
578124|NCT00725634|Pharmacologic Actions|pharmacologic actions
578125|NCT00725608|Suboxone|suboxone
578126|NCT00725608|Subutex|subutex
578127|NCT00725608|Buprenorphine|buprenorphine
578128|NCT00725608|Naloxone|naloxone
578129|NCT00725595|Cheyne Stocks respiration|cheyne stocks respiration
578130|NCT00725595|heart failure|heart failure
578131|NCT00725595|sleep apnea|sleep apnea
578132|NCT00725595|ventilator|ventilator
578133|NCT00725569|Caesarian Section|caesarian section
578134|NCT00725569|Homeopathy|homeopathy
578135|NCT00725569|Pain|pain
578136|NCT00725569|Analgesia|analgesia
578137|NCT00725556|Autism|autism
578138|NCT00725556|Asperger Syndrome|asperger syndrome
578139|NCT00725530|Lens deposits|lens deposits
578140|NCT00725530|Soft contact lens wearers|soft contact lens wearers
578141|NCT00725517|Icodextrin|icodextrin
578142|NCT00725517|ultrafiltration|ultrafiltration
578143|NCT00725517|creatinine clearance|creatinine clearance
578144|NCT00725517|urea nitrogen clearance|urea nitrogen clearance
578145|NCT00725491|Reproductive|reproductive
578146|NCT00725491|techniques|techniques
578147|NCT00725491|assisted|assisted
578148|NCT00725478|Piribedil (trade name: CLARIUM)|piribedil (trade name: clarium)
578149|NCT00725478|non-ergot dopamine agonist|non-ergot dopamine agonist
578150|NCT00725478|Morbus Parkinson|morbus parkinson
578151|NCT00725478|Tolerability|tolerability
578152|NCT00725478|Efficacy|efficacy
578153|NCT00725478|Post Marketing Surveillance|post marketing surveillance
578154|NCT00725465|laparoscopy|laparoscopy
578155|NCT00725465|CO2 colonoscopy|co2 colonoscopy
578156|NCT00725465|intraoperative CO2 colonoscopy|intraoperative co2 colonoscopy
578157|NCT00725465|combined Lap-CO2 procedure|combined lap-co2 procedure
578158|NCT00725465|to evaluate simultaneous CO2 laparoscopy and colonoscopy safety and physiologic effects on patients from the additional CO2 insufflation|to evaluate simultaneous co2 laparoscopy and colonoscopy safety and physiologic effects on patients from the additional co2 insufflation
578159|NCT00725426|healthy subjects|healthy subjects
578160|NCT00725400|Colorectal Cancer|colorectal cancer
578162|NCT00725400|Cetuximab|cetuximab
578163|NCT00725400|Surgery|surgery
578164|NCT00725400|Radiation|radiation
578165|NCT00725348|Psoriasis|psoriasis
578166|NCT00725335|ischemia|ischemia
578167|NCT00725335|liver cancer|liver cancer
578168|NCT00725335|radical excision|radical excision
578169|NCT00725335|prognosis|prognosis
578170|NCT00725309|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
578171|NCT00725309|COPD|copd
578172|NCT00725309|Elastin|elastin
578173|NCT00725309|ELN|eln
578174|NCT00725283|Leukemia|leukemia
578175|NCT00725283|ASCI|asci
578176|NCT00725283|Complete remission|complete remission
578177|NCT00725283|Immunotherapy|immunotherapy
578178|NCT00725283|adult|adult
578179|NCT00725283|Acute Myeloid Leukemia|acute myeloid leukemia
578180|NCT00725283|Tumor antigen|tumor antigen
578181|NCT00725283|WT1|wt1
578182|NCT00725244|Radiation Injuries|radiation injuries
578183|NCT00725244|Telangiectasis|telangiectasis
578184|NCT00725244|Bipolar Eletrocoagulation|bipolar eletrocoagulation
578185|NCT00725244|Argon Plasma Coagulation|argon plasma coagulation
578186|NCT00725231|T cell lymphoma|t cell lymphoma
578187|NCT00725218|NSAIDs|nsaids
578188|NCT00725218|Postoperative pain|postoperative pain
578189|NCT00725218|Analgesia|analgesia
578190|NCT00725218|Abortion|abortion
578191|NCT00725192|PTSD|ptsd
578192|NCT00725192|Posttraumatic Stress Disorder|posttraumatic stress disorder
578193|NCT00725192|Physical Assault|physical assault
578194|NCT00725192|Physical Abuse|physical abuse
578195|NCT00725192|Sexual Assault|sexual assault
578196|NCT00725192|Sexual Abuse|sexual abuse
578197|NCT00725192|Interpersonal Assault|interpersonal assault
578198|NCT00725192|Cognitive Processing Therapy|cognitive processing therapy
578199|NCT00725192|Sleep Impairment|sleep impairment
578200|NCT00725192|Insomnia|insomnia
578201|NCT00725192|Hypnosis|hypnosis
578202|NCT00725179|acetaminophen toxicity|acetaminophen toxicity
578203|NCT00725179|n-acetylcysteine|n-acetylcysteine
578204|NCT00725179|liver toxicity|liver toxicity
578205|NCT00725166|Aging|aging
578206|NCT00725166|Biopsy|biopsy
578207|NCT00725166|Skeletal muscle|skeletal muscle
578208|NCT00725166|Molecular biology|molecular biology
578209|NCT00725166|Genetic markers|genetic markers
578210|NCT00725166|Gene expression regulation|gene expression regulation
578211|NCT00725166|Young and old men|young and old men
578212|NCT00725166|Healthy volunteers|healthy volunteers
578213|NCT00725153|Contact lens deposits|contact lens deposits
578214|NCT00725153|Soft contact lenses|soft contact lenses
578215|NCT00725153|Myopia|myopia
578216|NCT00725140|Migraine|migraine
578217|NCT00725140|Early intervention|early intervention
578218|NCT00725140|Primary Care|primary care
578219|NCT00725140|Almotriptan|almotriptan
578220|NCT00725127|Aspirin|aspirin
578221|NCT00725127|Chronotherapy|chronotherapy
578222|NCT00725127|Primary prevention|primary prevention
578223|NCT00725127|Impaired fasting glucose|impaired fasting glucose
578224|NCT00725127|Type 2 diabetes|type 2 diabetes
578225|NCT00725127|Total mortality|total mortality
578226|NCT00725127|Myocardial infarction|myocardial infarction
578227|NCT00725127|Stroke|stroke
578228|NCT00725127|Angina pectoris|angina pectoris
578229|NCT00725127|Chronic kidney disease|chronic kidney disease
578230|NCT00725114|due|due
578231|NCT00725114|cancer|cancer
578232|NCT00725114|treatment|treatment
578233|NCT00725088|ST-Elevated Myocardial Infarction|st-elevated myocardial infarction
578234|NCT00725088|Exercise Training|exercise training
578235|NCT00725088|Rehabilitation|rehabilitation
578236|NCT00725075|Negative symptoms|negative symptoms
578237|NCT00725075|Glycine Uptake inhibitor|glycine uptake inhibitor
578238|NCT00725075|Add-on treatment|add-on treatment
578239|NCT00725075|Second Generation Antipsychotic|second generation antipsychotic
578240|NCT00725062|graft versus host disease|graft versus host disease
578241|NCT00725062|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
578242|NCT00725062|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
578310|NCT00724997|live attenuated flu vaccines|live attenuated flu vaccines
578243|NCT00725062|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
578244|NCT00725062|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
578245|NCT00725062|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
578246|NCT00725062|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
578247|NCT00725062|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
578248|NCT00725062|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
578249|NCT00725062|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
578250|NCT00725062|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
578251|NCT00725062|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
578252|NCT00725062|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
578253|NCT00725062|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
578254|NCT00725062|stage I multiple myeloma|stage i multiple myeloma
578255|NCT00725062|stage II multiple myeloma|stage ii multiple myeloma
578256|NCT00725062|stage III multiple myeloma|stage iii multiple myeloma
578257|NCT00725062|refractory multiple myeloma|refractory multiple myeloma
578258|NCT00725062|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
578259|NCT00725062|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
578260|NCT00725062|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
578261|NCT00725062|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
578262|NCT00725062|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
578263|NCT00725062|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
578264|NCT00725062|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
578265|NCT00725062|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
578266|NCT00725062|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
578267|NCT00725062|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
578268|NCT00725062|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
578269|NCT00725062|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
578270|NCT00725062|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
578271|NCT00725062|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
578272|NCT00725062|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
578273|NCT00725062|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
578274|NCT00725062|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
578275|NCT00725062|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
578276|NCT00725062|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
578277|NCT00725062|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
578278|NCT00725062|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
578279|NCT00725062|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
578280|NCT00725062|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
578281|NCT00725062|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
578282|NCT00725062|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
578283|NCT00725062|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
578284|NCT00725062|splenic marginal zone lymphoma|splenic marginal zone lymphoma
578285|NCT00725062|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
578286|NCT00725062|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
578287|NCT00725062|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
578288|NCT00725062|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
578289|NCT00725062|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
578290|NCT00725062|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
578291|NCT00725062|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
578292|NCT00725062|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
578293|NCT00725062|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
578294|NCT00725062|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
578295|NCT00725062|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
578296|NCT00725062|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
578297|NCT00725062|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
578298|NCT00725062|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
578299|NCT00725049|dental implants|dental implants
578300|NCT00725049|Nanotite Certain implant|nanotite certain implant
578301|NCT00725049|Osseotite|osseotite
578302|NCT00725049|multicenter|multicenter
578303|NCT00725049|randomized|randomized
578304|NCT00725049|clinical study|clinical study
578305|NCT00725049|partial edentulism|partial edentulism
578306|NCT00725049|crestal bone level|crestal bone level
578307|NCT00725049|short fixed bridge|short fixed bridge
578308|NCT00725049|cost analysis|cost analysis
578309|NCT00725023|Pain, chronic pain, tennis elbow, lateral epicondylitis|pain, chronic pain, tennis elbow, lateral epicondylitis
578804|NCT00722709|Peritoneum|peritoneum
578311|NCT00724997|Influenza A (H1N1)|influenza a (h1n1)
578312|NCT00724997|intranasally application|intranasally application
578313|NCT00724997|replication-deficient influenza virus|replication-deficient influenza virus
578314|NCT00724984|PCI-24781|pci-24781
578315|NCT00724984|Lymphoma|lymphoma
578316|NCT00724984|Hodgkin Disease|hodgkin disease
578317|NCT00724984|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
578318|NCT00724984|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
578319|NCT00724984|Lymphoma, Follicular|lymphoma, follicular
578320|NCT00724984|Lymphoma, B-Cell, Marginal Zone|lymphoma, b-cell, marginal zone
578321|NCT00724984|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
578322|NCT00724984|Lymphoma, Mantle Cell|lymphoma, mantle cell
578323|NCT00724984|Lymphoma, T-Cell, Cutaneous|lymphoma, t-cell, cutaneous
578324|NCT00724984|Lymphoma, T-Cell, Peripheral|lymphoma, t-cell, peripheral
578325|NCT00724971|B-cell Non-Hodgkin's Lymphoma|b-cell non-hodgkin's lymphoma
578326|NCT00724971|NHL|nhl
578327|NCT00724919|ESBL|esbl
578328|NCT00724906|Essential Tremor|essential tremor
578329|NCT00724906|Parkinsonian Tremor|parkinsonian tremor
578330|NCT00724906|Parkinson Disease|parkinson disease
578331|NCT00724906|Upper Extremity Tremor with duration of less than 2 years|upper extremity tremor with duration of less than 2 years
578332|NCT00724906|Diagnosis|diagnosis
578333|NCT00724906|Subjects|subjects
578334|NCT00724906|Upper|upper
578335|NCT00724906|Extremity|extremity
578336|NCT00724906|Tremor|tremor
578337|NCT00724906|Less|less
578338|NCT00724906|Than 2 years|than 2 years
578339|NCT00724880|coronary artery bypass grafting|coronary artery bypass grafting
578340|NCT00724880|clopidogrel|clopidogrel
578341|NCT00724880|post-operative bleeding|post-operative bleeding
578342|NCT00724867|Systemic Lupus Erythematosus|systemic lupus erythematosus
578343|NCT00724867|Belimumab|belimumab
578344|NCT00724867|SLE|sle
578345|NCT00724867|Antibodies|antibodies
578346|NCT00724867|Lupus|lupus
578347|NCT00724867|Autoimmune Diseases|autoimmune diseases
578348|NCT00724828|Bacterial otitis media|bacterial otitis media
578349|NCT00724828|pneumoniae|pneumoniae
578350|NCT00724828|sepsis|sepsis
578351|NCT00724828|bacteremia|bacteremia
578352|NCT00724828|meningitis|meningitis
578353|NCT00724828|Streptococcus pneumoniae carriage rate|streptococcus pneumoniae carriage rate
578354|NCT00724802|babies with canavan disease|babies with canavan disease
578355|NCT00724789|Neonatal outcome|neonatal outcome
578356|NCT00724789|Congenital malformations|congenital malformations
578357|NCT00724789|In-Vitro fertilization|in-vitro fertilization
578358|NCT00724789|Controlled ovarian stimulation|controlled ovarian stimulation
578359|NCT00724789|Follow-up|follow-up
578360|NCT00724776|Chronic hepatitis C, Albinterferon alfa 2b, phase I, Japan|chronic hepatitis c, albinterferon alfa 2b, phase i, japan
578361|NCT00724763|acupuncture, high blood pressure, HRV|acupuncture, high blood pressure, hrv
578362|NCT00724724|Stroke|stroke
578363|NCT00724724|Transient Ischemic Attack|transient ischemic attack
578364|NCT00724711|HIV|hiv
578365|NCT00724711|HIV 1|hiv 1
578366|NCT00724685|Ropivacaine|ropivacaine
578367|NCT00724685|elastomeric pump|elastomeric pump
578368|NCT00724685|patient controlled analgesia|patient controlled analgesia
578369|NCT00724685|morphine consumption|morphine consumption
578370|NCT00724659|Arthrogram|arthrogram
578371|NCT00724659|Contrast|contrast
578372|NCT00724659|Joint|joint
578373|NCT00724659|Ultrasound|ultrasound
578374|NCT00724646|parents|parents
578375|NCT00724646|medically fragile|medically fragile
578376|NCT00724646|death|death
578377|NCT00724646|end-of-life care|end-of-life care
578378|NCT00724646|surveys|surveys
578379|NCT00724633|dialysate|dialysate
578380|NCT00724633|sodium|sodium
578381|NCT00724633|hemodialysis|hemodialysis
578382|NCT00724633|blood pressure|blood pressure
578383|NCT00724633|thirst|thirst
578384|NCT00724633|intradialytic symptoms|intradialytic symptoms
578385|NCT00724633|interdialytic weight gain|interdialytic weight gain
578386|NCT00724633|extracellular fluid balance|extracellular fluid balance
578387|NCT00724633|mechanisms|mechanisms
578388|NCT00724607|Concussion, traumatic brain injury|concussion, traumatic brain injury
578389|NCT00724607|Screening|screening
578390|NCT00724607|neuroimaging|neuroimaging
578391|NCT00724607|Posttraumatic stress disorder|posttraumatic stress disorder
578392|NCT00724594|chorioamnionitis|chorioamnionitis
578393|NCT00724594|maternal chorioamnionitis|maternal chorioamnionitis
578394|NCT00724594|neonatal white matter injury|neonatal white matter injury
578395|NCT00724594|N-acetylcysteine|n-acetylcysteine
578396|NCT00724594|NAC|nac
578397|NCT00724594|anti-oxidant treatment|anti-oxidant treatment
578398|NCT00724581|Atrial fibrillation, amiodarone|atrial fibrillation, amiodarone
578399|NCT00724568|Newly Diagnosed Multiple Myeloma|newly diagnosed multiple myeloma
578400|NCT00724555|stroke|stroke
578401|NCT00724555|tissue plasminogen activator|tissue plasminogen activator
578402|NCT00724555|tPA|tpa
578403|NCT00724529|Crohn's Disease|crohn's disease
578404|NCT00724529|Ankylosing Spondylitis|ankylosing spondylitis
578405|NCT00724516|Mammogram|mammogram
578406|NCT00724516|Biopsy|biopsy
578407|NCT00724516|Needle|needle
578408|NCT00724516|Wire|wire
578409|NCT00724516|Localization|localization
578410|NCT00724516|Compression|compression
578411|NCT00724516|Paddle|paddle
578412|NCT00724503|colon cancer|colon cancer
578413|NCT00724503|Colorectal carcinoma|colorectal carcinoma
578414|NCT00724503|liver metastases|liver metastases
578415|NCT00724503|SIR-Spheres microspheres|sir-spheres microspheres
578416|NCT00724503|yttrium-90|yttrium-90
578417|NCT00724503|FOLFOX|folfox
578418|NCT00724503|bevacizumab|bevacizumab
578419|NCT00724503|metastatic colorectal cancer|metastatic colorectal cancer
578420|NCT00724490|Deep Brain Stimulation|deep brain stimulation
578421|NCT00724490|Obsessive Compulsive Disorder|obsessive compulsive disorder
578422|NCT00724490|Nucleus Accumbens|nucleus accumbens
578423|NCT00724438|Contraception|contraception
578424|NCT00724438|Implanon|implanon
578425|NCT00724438|Obesity|obesity
578426|NCT00724438|Blood spots|blood spots
578427|NCT00724438|Implant|implant
578428|NCT00724438|Pharmacokinetics|pharmacokinetics
578429|NCT00724412|Dry Eye|dry eye
578430|NCT00724412|Corneal Staining|corneal staining
578431|NCT00724360|relapsed/refractory|relapsed/refractory
578432|NCT00724360|HER2|her2
578433|NCT00724360|positive|positive
578434|NCT00724360|B-ALL|b-all
578435|NCT00724360|trastuzumab|trastuzumab
578436|NCT00724347|Auditory Perception|auditory perception
578437|NCT00724347|Hearing Loss|hearing loss
578438|NCT00724347|Presbycusis|presbycusis
578439|NCT00724347|Perceptual Learning|perceptual learning
578440|NCT00724347|Hearing Prosthesis|hearing prosthesis
578441|NCT00724347|Speech Discrimination|speech discrimination
578442|NCT00724347|Delayed Treatment|delayed treatment
578443|NCT00724334|myelofibrosis|myelofibrosis
578444|NCT00724321|iloprost|iloprost
578445|NCT00724321|hypoxic|hypoxic
578446|NCT00724321|pulmonary|pulmonary
578447|NCT00724321|vasoconstriction|vasoconstriction
578448|NCT00724321|altitude|altitude
578449|NCT00724308|Smoking|smoking
578450|NCT00724308|Smoking Cessation|smoking cessation
578451|NCT00724308|Tobacco|tobacco
578452|NCT00724308|Mental Health|mental health
578453|NCT00724282|sleep|sleep
578454|NCT00724282|eszopiclone|eszopiclone
578455|NCT00724282|insulin secretion|insulin secretion
578456|NCT00724282|insulin action|insulin action
578457|NCT00724282|glucose tolerance|glucose tolerance
578458|NCT00724269|Contact lens wear|contact lens wear
578459|NCT00724269|multi-purpose solution|multi-purpose solution
578460|NCT00724269|corneal staining|corneal staining
578461|NCT00724256|Pyelonephritis.|pyelonephritis.
578462|NCT00724256|Urinary Tract Infections.|urinary tract infections.
578463|NCT00724256|Children.|children.
578464|NCT00724256|Randomised controlled trial.|randomised controlled trial.
578465|NCT00724256|Therapy.|therapy.
578466|NCT00724256|Ceftibuten.|ceftibuten.
578467|NCT00724204|probiotics|probiotics
578468|NCT00724204|safety|safety
578469|NCT00724204|fecal microbiota|fecal microbiota
578470|NCT00724204|infections|infections
578471|NCT00724178|Pediatric HIV infection, bone mineral content, bone mineral density, Vitamin D, calcium Dual x-ray absorptiometry|pediatric hiv infection, bone mineral content, bone mineral density, vitamin d, calcium dual x-ray absorptiometry
578472|NCT00724165|physical activity|physical activity
578473|NCT00724165|Latinas|latinas
578474|NCT00724152|coping skills|coping skills
578475|NCT00724152|psychology|psychology
578476|NCT00724152|audiology|audiology
578477|NCT00724152|veterans|veterans
578478|NCT00724152|tinnitus|tinnitus
578479|NCT00724152|adult|adult
578480|NCT00724152|intervention studies|intervention studies
578481|NCT00724152|tinnitus, noise induced|tinnitus, noise induced
578482|NCT00724152|noise|noise
578483|NCT00724152|auditory perception|auditory perception
578484|NCT00724126|Diarrhea|diarrhea
578485|NCT00724126|Rifaximin|rifaximin
578486|NCT00724126|IBS|ibs
578487|NCT00724126|Abdominal pain|abdominal pain
578488|NCT00724126|Bloating|bloating
578489|NCT00724113|Shoulder capsulitis|shoulder capsulitis
578490|NCT00724113|ARTHRO distension|arthro distension
578491|NCT00724113|Mobilisation|mobilisation
578492|NCT00724113|Randomised clinical trial|randomised clinical trial
578493|NCT00724100|Malignancy|malignancy
578494|NCT00724100|Solid tumor|solid tumor
578495|NCT00724100|Tubulin inhibitor|tubulin inhibitor
578496|NCT00724087|short sleep duration|short sleep duration
578497|NCT00724087|energy expenditure|energy expenditure
578498|NCT00724087|insulin secretion|insulin secretion
578499|NCT00724087|insulin action|insulin action
578500|NCT00724087|lipid turnover|lipid turnover
578501|NCT00724087|free fatty acids|free fatty acids
578502|NCT00724074|Arthritis of the knee|arthritis of the knee
578503|NCT00724074|Knee replacement|knee replacement
578504|NCT00724074|Osteoarthritis, knee|osteoarthritis, knee
578505|NCT00724074|Arthroplasty, knee|arthroplasty, knee
578506|NCT00724061|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
578629|NCT00723476|Advance Care Planning|advance care planning
578507|NCT00724061|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
578508|NCT00724061|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
578509|NCT00724061|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
578510|NCT00724061|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
578511|NCT00724061|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
578512|NCT00724061|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
578513|NCT00724061|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
578514|NCT00724061|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
578515|NCT00724061|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
578516|NCT00724048|Huntington Disease|huntington disease
578517|NCT00724035|Anesthesia|anesthesia
578518|NCT00724035|Upper extremity|upper extremity
578519|NCT00724035|Nerve block|nerve block
578520|NCT00724035|Ultrasound|ultrasound
578521|NCT00724035|Brachial plexus|brachial plexus
578522|NCT00724022|Kidney transplant status|kidney transplant status
578523|NCT00724022|Steroid free|steroid free
578525|NCT00724022|Calcineurin|calcineurin
578526|NCT00724022|Inhibitor|inhibitor
578527|NCT00724022|Immunosuppression|immunosuppression
578528|NCT00723970|Major Depressive Disorder|major depressive disorder
578529|NCT00723970|Insomnia|insomnia
578530|NCT00723970|Hot Flashes|hot flashes
578531|NCT00723970|Menopause|menopause
578532|NCT00723970|Quetiapine|quetiapine
578533|NCT00723944|dental implants|dental implants
578534|NCT00723944|Osseotite Certain Prevail|osseotite certain prevail
578535|NCT00723944|Lateralized|lateralized
578536|NCT00723944|non-lateralized|non-lateralized
578537|NCT00723944|Osseotite Certain|osseotite certain
578538|NCT00723944|multicenter|multicenter
578539|NCT00723944|randomized|randomized
578540|NCT00723944|clinical study|clinical study
578541|NCT00723944|partial edentulism|partial edentulism
578542|NCT00723944|single stage|single stage
578543|NCT00723944|early loading|early loading
578544|NCT00723944|crestal bone level|crestal bone level
578545|NCT00723944|short fixed bridge|short fixed bridge
578546|NCT00723918|HIV-associated neuropathy|hiv-associated neuropathy
578547|NCT00723918|HIV|hiv
578548|NCT00723918|AIDS|aids
578549|NCT00723918|cannabinoid|cannabinoid
578550|NCT00723918|Cannabis|cannabis
578551|NCT00723918|methadone|methadone
578552|NCT00723918|distal sensory polyneuropathy|distal sensory polyneuropathy
578553|NCT00723918|polyneuropathy|polyneuropathy
578554|NCT00723905|Crohn's Disease, Rheumatoid Arthritis|crohn's disease, rheumatoid arthritis
578555|NCT00723866|Botulinum toxin, Spasticity, Stroke, Rehabilitation.|botulinum toxin, spasticity, stroke, rehabilitation.
578556|NCT00723853|Obesity|obesity
578557|NCT00723853|Type 2 diabetes|type 2 diabetes
578558|NCT00723853|African American children|african american children
578559|NCT00723853|African American youth|african american youth
578560|NCT00723853|Community based|community based
578561|NCT00723853|Family oriented|family oriented
578562|NCT00723853|Obesity & Risk of type 2 diabetes|obesity & risk of type 2 diabetes
578563|NCT00723840|EuroQOL (EQ-5D)|euroqol (eq-5d)
578564|NCT00723814|normal|normal
578565|NCT00723801|Marfan syndrome|marfan syndrome
578566|NCT00723801|Losartan|losartan
578567|NCT00723801|Atenolol|atenolol
578568|NCT00723801|Diastolic Function|diastolic function
578569|NCT00723801|Aortic Stiffness|aortic stiffness
578570|NCT00723788|Appendicitis|appendicitis
578571|NCT00723788|Children|children
578572|NCT00723788|Magnetic Resonance Imaging|magnetic resonance imaging
578573|NCT00723775|KALETRA|kaletra
578574|NCT00723775|GSK706769|gsk706769
578575|NCT00723775|HIV|hiv
578576|NCT00723775|healthy volunteers|healthy volunteers
578577|NCT00723762|Valproic acid|valproic acid
578578|NCT00723762|Urea cycle|urea cycle
578579|NCT00723762|Ornithine|ornithine
578580|NCT00723762|Valproate|valproate
578581|NCT00723762|Side effect|side effect
578582|NCT00723749|Suboxone|suboxone
578583|NCT00723749|Subutex|subutex
578584|NCT00723749|Buprenorphine|buprenorphine
578585|NCT00723749|Naloxone|naloxone
578586|NCT00723697|Subutex|subutex
578587|NCT00723684|ADHD|adhd
578588|NCT00723684|Children|children
578589|NCT00723684|EEG-Neurofeedback|eeg-neurofeedback
578590|NCT00723658|Waldenström macroglobulinemia|waldenström macroglobulinemia
578591|NCT00723619|asthma|asthma
578592|NCT00723619|spirometry|spirometry
578593|NCT00723619|FENO|feno
578594|NCT00723619|normal values for spirometry in childhood|normal values for spirometry in childhood
578595|NCT00723619|normal values for FENO in childhood|normal values for feno in childhood
578596|NCT00723606|Intramuscular ziprasidone, agitation, efficacy and safety|intramuscular ziprasidone, agitation, efficacy and safety
578597|NCT00723593|Graft-Versus-Host Disease|graft-versus-host disease
578598|NCT00723593|Gastrointestinal|gastrointestinal
578599|NCT00723593|Apoptotic Assay|apoptotic assay
578600|NCT00723593|Serum Proteomic Pattern Analysis|serum proteomic pattern analysis
578601|NCT00723593|Mucosal Biopsy|mucosal biopsy
578602|NCT00723593|Graft Versus Host Disease|graft versus host disease
578603|NCT00723593|GVHD|gvhd
578604|NCT00723580|Kabuki Syndrome|kabuki syndrome
578605|NCT00723580|Actigraphy|actigraphy
578606|NCT00723580|Treatment Response Measurement|treatment response measurement
578607|NCT00723567|Spectrin Gene|spectrin gene
578608|NCT00723567|Hereditary Elliptocytosis (HE)|hereditary elliptocytosis (he)
578609|NCT00723567|Hereditary Pyropoikilocytosis (HPP)|hereditary pyropoikilocytosis (hpp)
578610|NCT00723567|Genetics|genetics
578611|NCT00723554|pulmonary arterial hypertension|pulmonary arterial hypertension
578612|NCT00723554|inhaled therapy|inhaled therapy
578613|NCT00723554|power disc-15|power disc-15
578614|NCT00723528|Psoriasis|psoriasis
578615|NCT00723528|Ustekinumab|ustekinumab
578616|NCT00723528|CNTO 1275|cnto 1275
578617|NCT00723515|White spot lesion|white spot lesion
578618|NCT00723515|Tooth remineralization|tooth remineralization
578619|NCT00723515|Fluoride varnishes|fluoride varnishes
578620|NCT00723502|Helicobacter pylori|helicobacter pylori
578621|NCT00723502|Eradication|eradication
578622|NCT00723502|Dyspepsia|dyspepsia
578623|NCT00723489|Yellow Fever Vaccine|yellow fever vaccine
578624|NCT00723489|Scarification Method|scarification method
578625|NCT00723489|Atopic Dermatitis|atopic dermatitis
578626|NCT00723489|IgG antibodies|igg antibodies
578627|NCT00723476|Quality of Life|quality of life
578628|NCT00723476|Adolescent|adolescent
578630|NCT00723476|Palliative Care|palliative care
578631|NCT00723476|End-of-Life Care|end-of-life care
578632|NCT00723476|HIV/AIDS|hiv/aids
578633|NCT00723476|Psychological Adjustment|psychological adjustment
578634|NCT00723450|Bipolar I pediatric lamictal adolescent|bipolar i pediatric lamictal adolescent
578635|NCT00723437|nail, psoriasis, NAPSI,acitretin|nail, psoriasis, napsi,acitretin
578636|NCT00723424|AZD5672|azd5672
578637|NCT00723424|digoxin|digoxin
578638|NCT00723411|Diabetes|diabetes
578639|NCT00723411|Juvenile Diabetes|juvenile diabetes
578640|NCT00723411|Diabetes type 1|diabetes type 1
578641|NCT00723411|Autoimmune Diabetes|autoimmune diabetes
578642|NCT00723411|Insulin dependent Diabetes|insulin dependent diabetes
578643|NCT00723411|Type 1 diabetes|type 1 diabetes
578644|NCT00723411|Type 1 diabetes mellitus|type 1 diabetes mellitus
578645|NCT00723411|Diamyd|diamyd
578646|NCT00723411|rhGAD65|rhgad65
578647|NCT00723411|GAD|gad
578648|NCT00723411|GAD-alum|gad-alum
578649|NCT00723398|omega-3 fatty acids|omega-3 fatty acids
578650|NCT00723398|antiestrogens|antiestrogens
578651|NCT00723398|breast cancer prevention|breast cancer prevention
578652|NCT00723398|breast density|breast density
578653|NCT00723398|biomarkers of mammary carcinogenesis|biomarkers of mammary carcinogenesis
578654|NCT00723385|cholesterol|cholesterol
578655|NCT00723385|LDL-cholesterol|ldl-cholesterol
578656|NCT00723385|cholecalciferol|cholecalciferol
578657|NCT00723385|lipids|lipids
578658|NCT00723385|C-reactive protein|c-reactive protein
578659|NCT00723359|Multiple Myeloma|multiple myeloma
578660|NCT00723359|Refractory|refractory
578661|NCT00723359|Relapsed|relapsed
578662|NCT00723346|Relapse|relapse
578663|NCT00723346|Lymphoma lymphoblastic|lymphoma lymphoblastic
578664|NCT00723333|Bone Marrow Transplant|bone marrow transplant
578665|NCT00723333|Myelofibrosis|myelofibrosis
578666|NCT00723333|Stem Cell Transplant|stem cell transplant
578667|NCT00723333|Allogenic Transplant|allogenic transplant
578668|NCT00723320|Atherosclerosis|atherosclerosis
578669|NCT00723320|Atorvastatin|atorvastatin
578670|NCT00723320|Therapeutic lifestyle change|therapeutic lifestyle change
578671|NCT00723320|CIMT|cimt
578672|NCT00723320|ABI|abi
578673|NCT00723320|PWV|pwv
578674|NCT00723307|No diabetes mellitus|no diabetes mellitus
578675|NCT00723307|Elevated waist circumference|elevated waist circumference
578676|NCT00723294|invasive ductal breast carcinoma|invasive ductal breast carcinoma
578677|NCT00723294|male breast cancer|male breast cancer
578678|NCT00723294|stage IA breast cancer|stage ia breast cancer
578679|NCT00723294|stage IB breast cancer|stage ib breast cancer
578680|NCT00723294|stage II breast cancer|stage ii breast cancer
578681|NCT00723281|transplant coronary artery disease|transplant coronary artery disease
578682|NCT00723281|CT angiography|ct angiography
578683|NCT00723281|conventional angiography|conventional angiography
578684|NCT00723281|intravascular ultrasound|intravascular ultrasound
578685|NCT00723281|Heart transplant patients with known transplant coronary artery disease|heart transplant patients with known transplant coronary artery disease
578686|NCT00723268|Oral ulcers|oral ulcers
578687|NCT00723216|Prevention|prevention
578688|NCT00723216|venous thromboembolism|venous thromboembolism
578689|NCT00723216|curative surgery|curative surgery
578690|NCT00723203|Philadelphia chromosome positive adult precursor acute lymphoblastic leukemia|philadelphia chromosome positive adult precursor acute lymphoblastic leukemia
578691|NCT00723203|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
578692|NCT00723203|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
578693|NCT00723190|CLONICEL|clonicel
578694|NCT00723190|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
578695|NCT00723190|clonidine HCl sustained release|clonidine hcl sustained release
578696|NCT00723177|opioid withdrawal, analgesia|opioid withdrawal, analgesia
578697|NCT00723164|Sevoflurane induction|sevoflurane induction
578698|NCT00723164|Premedication|premedication
578699|NCT00723164|laryngeal mask airway|laryngeal mask airway
578700|NCT00723164|Anesthesia, inhalation [E03.155.197.197]|anesthesia, inhalation [e03.155.197.197]
578701|NCT00723125|Breast Cancer|breast cancer
578702|NCT00723112|Myelodysplastic Syndrome|myelodysplastic syndrome
578703|NCT00723112|Erythropoiesis|erythropoiesis
578704|NCT00723112|Ineffective Hematopoiesis|ineffective hematopoiesis
578705|NCT00723112|Erythroid Progenitors|erythroid progenitors
578706|NCT00723112|Dyserythropoiesis|dyserythropoiesis
578707|NCT00723086|docetaxel, prednisolone, drug combination|docetaxel, prednisolone, drug combination
578708|NCT00723073|micafungin, caspofungin, febrile neutropenia|micafungin, caspofungin, febrile neutropenia
578709|NCT00723047|Patients|patients
578710|NCT00723047|CD complicated|cd complicated
578711|NCT00723047|least|least
578712|NCT00723047|One perianal fistula|one perianal fistula
578713|NCT00723047|Draining|draining
578714|NCT00723047|2 months duration|2 months duration
578715|NCT00723021|Bronchodilator|bronchodilator
578716|NCT00723008|anxiety|anxiety
578717|NCT00723008|insomnia|insomnia
578718|NCT00723008|pain|pain
578719|NCT00723008|Alpha Stim|alpha stim
578720|NCT00723008|Cranial electrotherapy stimulation|cranial electrotherapy stimulation
578721|NCT00722995|Morbid obesity|morbid obesity
578722|NCT00722995|Sleeve gastrectomy|sleeve gastrectomy
578723|NCT00722995|Gastric bypass|gastric bypass
578724|NCT00722995|Complications|complications
578725|NCT00722995|Efficacity|efficacity
578726|NCT00722995|Safety|safety
578727|NCT00722995|Compare|compare
578728|NCT00722982|coxarthrosis|coxarthrosis
578729|NCT00722982|hip|hip
578730|NCT00722982|RSA|rsa
578731|NCT00722982|DXA|dxa
578732|NCT00722982|C-stem AMT|c-stem amt
578733|NCT00722982|Marathon|marathon
578734|NCT00722969|non-small cell lung cancer|non-small cell lung cancer
578735|NCT00722969|erlotinib|erlotinib
578736|NCT00722969|sorafenib|sorafenib
578737|NCT00722956|atorvastatin|atorvastatin
578738|NCT00722956|AZD5672|azd5672
578739|NCT00722943|infant|infant
578740|NCT00722943|premature|premature
578741|NCT00722943|message|message
578742|NCT00722943|therapy|therapy
578743|NCT00722943|NICU|nicu
578744|NCT00722943|neonatal intensive care unit|neonatal intensive care unit
578745|NCT00722943|cortisol level|cortisol level
578746|NCT00722943|stress|stress
578747|NCT00722943|postnatal|postnatal
578748|NCT00722943|weight gain|weight gain
578749|NCT00722943|DMT|dmt
578750|NCT00722943|Development Message Therapy|development message therapy
578751|NCT00722943|growth|growth
578752|NCT00722930|Follicular Lymphoma|follicular lymphoma
578753|NCT00722930|High-risk FLIPI|high-risk flipi
578754|NCT00722930|R-CHOP|r-chop
578755|NCT00722930|GOTEL|gotel
578756|NCT00722930|Partial|partial
578757|NCT00722930|Complete|complete
578758|NCT00722930|Response|response
578759|NCT00722930|Induction|induction
578760|NCT00722930|Chemotherapy|chemotherapy
578761|NCT00722917|Glucose Metabolism Disorder|glucose metabolism disorder
578762|NCT00722917|Dysmetabolic Syndrome|dysmetabolic syndrome
578763|NCT00722917|Type II Diabetes|type ii diabetes
578764|NCT00722917|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
578765|NCT00722917|Dyslipidemia|dyslipidemia
578766|NCT00722917|Drug Therapy|drug therapy
578767|NCT00722904|post-intervention surveillance of aortic coarctation|post-intervention surveillance of aortic coarctation
578768|NCT00722904|MRA and 2D phase contrast imaging|mra and 2d phase contrast imaging
578769|NCT00722904|4D Flow velocity mapping|4d flow velocity mapping
578770|NCT00722904|Patients undergoing routine post-intervention surveillance of aortic coarctation|patients undergoing routine post-intervention surveillance of aortic coarctation
578771|NCT00722904|Healthy volunteers|healthy volunteers
578772|NCT00722891|Eye Diseases|eye diseases
578773|NCT00722878|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
578774|NCT00722865|Avastin|avastin
578775|NCT00722865|bevacizumab|bevacizumab
578776|NCT00722865|ABVD|abvd
578777|NCT00722865|angiogenesis|angiogenesis
578778|NCT00722865|antiangiogenic|antiangiogenic
578779|NCT00722865|Hodgkin|hodgkin
578780|NCT00722839|cytomegalovirus infection|cytomegalovirus infection
578781|NCT00722826|Pulmonary Regurgitation|pulmonary regurgitation
578782|NCT00722826|Tetralogy of Fallot|tetralogy of fallot
578783|NCT00722800|YAZ|yaz
578784|NCT00722800|oral contraceptive|oral contraceptive
578785|NCT00722800|hidradenitis suppurativa|hidradenitis suppurativa
578786|NCT00722774|Vaccine|vaccine
578787|NCT00722774|Influenza|influenza
578788|NCT00722761|YAZ|yaz
578789|NCT00722761|oral contraceptive|oral contraceptive
578790|NCT00722761|Acne vulgaris|acne vulgaris
578791|NCT00722748|Genebank|genebank
578792|NCT00722748|Gene registry|gene registry
578793|NCT00722748|Cardiac Arrythmia Disease|cardiac arrythmia disease
578794|NCT00722735|uncomplicated Urinary Tract Infection in Women|uncomplicated urinary tract infection in women
578795|NCT00722735|Antibacterial Chemotherapy|antibacterial chemotherapy
578796|NCT00722735|Proof-of-Concept|proof-of-concept
578797|NCT00722709|Pain|pain
578798|NCT00722709|Fatigue|fatigue
578799|NCT00722709|Colon|colon
578800|NCT00722709|Surgery|surgery
578801|NCT00722709|ERAS|eras
578802|NCT00722709|Fastrack|fastrack
578803|NCT00722709|Local anaesthetic|local anaesthetic
578807|NCT00722709|Post surgical metabolic response|post surgical metabolic response
578808|NCT00722709|Complications|complications
578809|NCT00722709|Time to passage of flatus|time to passage of flatus
578810|NCT00722709|Time to passage of stool|time to passage of stool
578811|NCT00722709|Time to discharge from facility|time to discharge from facility
578812|NCT00722709|Re-admission rate|re-admission rate
578813|NCT00722696|Metabolism|metabolism
578814|NCT00722696|Muscles|muscles
578815|NCT00722696|Exercise|exercise
578816|NCT00722670|risk reduction|risk reduction
578817|NCT00722670|prevention|prevention
578818|NCT00722670|HIV prevention|hiv prevention
578819|NCT00722657|asthma|asthma
578820|NCT00722657|epidemiology|epidemiology
578821|NCT00722644|HIV|hiv
578822|NCT00722644|Medication Adherence|medication adherence
578823|NCT00722644|Stress Management|stress management
578824|NCT00722644|CD4/Viral Loads|cd4/viral loads
578825|NCT00722644|Cognitive Behavioral Treatment|cognitive behavioral treatment
578826|NCT00722618|Infertility|infertility
578827|NCT00722605|lung|lung
578828|NCT00722605|esophageal|esophageal
578829|NCT00722605|cone beam ct scan|cone beam ct scan
578830|NCT00722592|cancer|cancer
578831|NCT00722592|ovarian|ovarian
578832|NCT00722592|platinum-resistant|platinum-resistant
578833|NCT00722592|Phase II|phase ii
578834|NCT00722592|EC145|ec145
578835|NCT00722592|EC20|ec20
578836|NCT00722579|Coronary Artery Disease|coronary artery disease
578837|NCT00722553|Transitional Cell Carcinoma of the Urinary Bladder|transitional cell carcinoma of the urinary bladder
578838|NCT00722553|Transitional Cell Carcinoma|transitional cell carcinoma
578839|NCT00722553|Bladder Cancer|bladder cancer
578840|NCT00722553|Urinary Bladder Cancer|urinary bladder cancer
578841|NCT00722553|Bladder|bladder
578842|NCT00722553|Carcinoma|carcinoma
578843|NCT00722553|Urinary|urinary
578844|NCT00722553|Metastatic|metastatic
578845|NCT00722553|Relapsed|relapsed
578846|NCT00722527|Primary Familial and Congenital Polycythemia|primary familial and congenital polycythemia
578847|NCT00722527|Polycythemia|polycythemia
578848|NCT00722527|Molecular Biology|molecular biology
578849|NCT00722527|Genetics|genetics
578850|NCT00722527|Erythropoiesis|erythropoiesis
578851|NCT00722527|EPOR mutation|epor mutation
578852|NCT00722527|Thrombocytosis|thrombocytosis
578853|NCT00722527|Hypoxia|hypoxia
578854|NCT00722475|recurrent miscarriage|recurrent miscarriage
578855|NCT00722475|immunology|immunology
578856|NCT00722475|intravenous immunoglobulin|intravenous immunoglobulin
578857|NCT00722475|miscarriage|miscarriage
578858|NCT00722462|Infertility|infertility
578859|NCT00722462|IVF|ivf
578860|NCT00722462|Acupuncture|acupuncture
578861|NCT00722436|antifibrinolytic, tranexamic acid|antifibrinolytic, tranexamic acid
578862|NCT00722423|Hepatitis C|hepatitis c
578863|NCT00722423|integrated care|integrated care
578864|NCT00722423|alpha interferon|alpha interferon
578865|NCT00722423|mental health|mental health
578866|NCT00722410|Carbapenem|carbapenem
578867|NCT00722410|resistant|resistant
578868|NCT00722410|Klebsiella pneumoniae|klebsiella pneumoniae
578869|NCT00722410|Carpapenemases|carpapenemases
578870|NCT00722410|Probiotics|probiotics
578871|NCT00722410|VSL3|vsl3
578872|NCT00722397|genetics, pediatrics|genetics, pediatrics
578873|NCT00722384|AMD|amd
578874|NCT00722384|Macular Degeneration|macular degeneration
578875|NCT00722384|Opko Health|opko health
578876|NCT00722384|Acuity Pharmaceuticals|acuity pharmaceuticals
578877|NCT00722384|bevasiranib|bevasiranib
578878|NCT00722384|Cand5|cand5
578879|NCT00722384|Age-Related|age-related
578880|NCT00722345|Obesity|obesity
578881|NCT00722345|Physical activity|physical activity
578882|NCT00722345|Adolescents|adolescents
578883|NCT00722345|Exercise counseling intervention|exercise counseling intervention
578884|NCT00722332|HBIG (Hepatitis B Immune Globulin)|hbig (hepatitis b immune globulin)
578885|NCT00722332|Chronic Hepatitis B Recurrence|chronic hepatitis b recurrence
578886|NCT00722332|Liver Transplant|liver transplant
578887|NCT00722319|oral anticoagulation|oral anticoagulation
578888|NCT00722319|warfarin|warfarin
578889|NCT00722319|percutaneous coronary intervention|percutaneous coronary intervention
578890|NCT00722319|stent|stent
578891|NCT00722319|antiplatelet agents|antiplatelet agents
578892|NCT00722306|non-restorative|non-restorative
578893|NCT00722306|sleep|sleep
578894|NCT00722293|Solid tumors|solid tumors
578895|NCT00722293|Cancer|cancer
578896|NCT00722293|Neoplasms, Ovarian|neoplasms, ovarian
578897|NCT00722293|doxorubicin|doxorubicin
578898|NCT00722293|epirubicin|epirubicin
578899|NCT00722293|anti-angiogenesis|anti-angiogenesis
578900|NCT00722293|pharmacodynamics|pharmacodynamics
578901|NCT00722293|pazopanib (GW786034)|pazopanib (gw786034)
578902|NCT00722293|pharmacokinetics|pharmacokinetics
578903|NCT00722293|Soft Tissue|soft tissue
578904|NCT00722293|Sarcoma|sarcoma
578905|NCT00722280|Amputation, upper limb, composite tissue, immunosuppression|amputation, upper limb, composite tissue, immunosuppression
578906|NCT00722267|severe COPD|severe copd
578907|NCT00722267|COPD symptoms|copd symptoms
578908|NCT00722267|variability of symptoms|variability of symptoms
582063|NCT00711230|HIV|hiv
578909|NCT00722267|patient's perception|patient's perception
578910|NCT00722254|Myeloproliferative Disorder|myeloproliferative disorder
578911|NCT00722254|Primary Myelofibrosis|primary myelofibrosis
578912|NCT00722254|Primary Pulmonary Hypertension|primary pulmonary hypertension
578913|NCT00722254|Secondary Myelofibrosis|secondary myelofibrosis
578914|NCT00722254|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
578915|NCT00722254|Flolan|flolan
578916|NCT00722254|Clonality|clonality
578917|NCT00722254|CD34+ cells|cd34+ cells
578918|NCT00722254|Hematologic abnormalities|hematologic abnormalities
578919|NCT00722241|Continuous Glucose Monitoring|continuous glucose monitoring
578920|NCT00722241|Interstitial Fluid|interstitial fluid
578921|NCT00722241|Diabetes Mellitus|diabetes mellitus
578922|NCT00722215|Endothelin antagonist|endothelin antagonist
578923|NCT00722215|Chronic kidney disease|chronic kidney disease
578924|NCT00722215|Proteinuria|proteinuria
578925|NCT00722215|Cardiovascular disease|cardiovascular disease
578926|NCT00722215|Blood pressure|blood pressure
578927|NCT00722215|Arterial stiffness|arterial stiffness
578928|NCT00722215|Endothelial function|endothelial function
578929|NCT00722189|Mycoses|mycoses
578930|NCT00722176|Schizophrenia|schizophrenia
578931|NCT00722163|Cognitive Behavioural therapy|cognitive behavioural therapy
578932|NCT00722163|Psychosis|psychosis
578933|NCT00722150|Artesunate|artesunate
578934|NCT00722150|Plasmodium Falciparum|plasmodium falciparum
578935|NCT00722150|Cambodia|cambodia
578936|NCT00722124|tobacco use|tobacco use
578937|NCT00722124|cigarettes|cigarettes
578938|NCT00722124|smokers|smokers
578939|NCT00722111|tongue|tongue
578940|NCT00722111|pressure|pressure
578941|NCT00722098|Melanoma|melanoma
578942|NCT00722098|Dendritic Cell|dendritic cell
578943|NCT00722098|Vaccine|vaccine
578944|NCT00722098|Immunotherapy|immunotherapy
578945|NCT00722098|Cyclophosphamide|cyclophosphamide
578946|NCT00722085|Amniotic Fluid Sludge|amniotic fluid sludge
578947|NCT00722085|Cerclage|cerclage
578948|NCT00722085|Ultrasound|ultrasound
578949|NCT00722085|Preterm Delivery|preterm delivery
578950|NCT00722085|Neonatal|neonatal
578951|NCT00722072|male breast cancer|male breast cancer
578952|NCT00722072|stage IIIA breast cancer|stage iiia breast cancer
578953|NCT00722072|stage IIIB breast cancer|stage iiib breast cancer
578954|NCT00722072|stage IIIC breast cancer|stage iiic breast cancer
578955|NCT00722072|stage IV breast cancer|stage iv breast cancer
578956|NCT00722072|recurrent breast cancer|recurrent breast cancer
578957|NCT00722046|Alzheimer's disease|alzheimer's disease
578958|NCT00722046|antibody|antibody
578959|NCT00722046|amyloid|amyloid
578960|NCT00722033|preterm|preterm
578961|NCT00722033|aEEG|aeeg
578962|NCT00722033|apneas|apneas
578963|NCT00722033|surfactant|surfactant
578964|NCT00722033|indomethacin|indomethacin
578965|NCT00722033|aminophyline|aminophyline
578966|NCT00722020|Asthma|asthma
578967|NCT00722020|Bronchial Disease|bronchial disease
578968|NCT00722020|Status Asthmaticus|status asthmaticus
578969|NCT00722020|High Frequency Chest Wall Oscillation|high frequency chest wall oscillation
578970|NCT00722020|the Vest|the vest
578971|NCT00722020|HFCWO|hfcwo
578972|NCT00722007|hip resurfacing|hip resurfacing
578973|NCT00722007|osteoarthritis|osteoarthritis
578974|NCT00722007|avascular necrosis|avascular necrosis
578975|NCT00722007|rheumatoid arthritis|rheumatoid arthritis
578976|NCT00721994|hip resurfacing|hip resurfacing
578977|NCT00721994|osteoarthritis|osteoarthritis
578978|NCT00721994|avascular necrosis|avascular necrosis
578979|NCT00721994|rheumatoid arthritis|rheumatoid arthritis
578980|NCT00721981|patient preference|patient preference
578981|NCT00721981|oncology|oncology
578982|NCT00721981|chemotherapy|chemotherapy
578983|NCT00721981|NSCLC|nsclc
578984|NCT00721968|Open angle|open angle
578985|NCT00721968|Glaucoma|glaucoma
578986|NCT00721968|Cataract|cataract
578987|NCT00721968|Surgery|surgery
578988|NCT00721955|Bipolar 1 disorder,|bipolar 1 disorder,
578989|NCT00721955|agitation,|agitation,
578990|NCT00721955|acute,|acute,
578991|NCT00721955|treatment|treatment
578992|NCT00721929|adrenal glands, adrenal masses|adrenal glands, adrenal masses
578993|NCT00721890|chemoprevention|chemoprevention
578994|NCT00721890|green tea|green tea
578995|NCT00721890|relapse free-survival|relapse free-survival
578996|NCT00721890|proteases|proteases
578997|NCT00721864|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
578998|NCT00721864|PIG-A Mutation|pig-a mutation
578999|NCT00721864|Prion Protein|prion protein
579000|NCT00721864|Hematopoietic stem cells|hematopoietic stem cells
579001|NCT00721864|Clonal disorder|clonal disorder
579002|NCT00721838|adolescent obesity|adolescent obesity
579003|NCT00721838|eating behavior|eating behavior
579004|NCT00721838|dietary intake|dietary intake
579005|NCT00721825|Stroke|stroke
579006|NCT00721825|Cerebral infarct|cerebral infarct
579007|NCT00721825|Rehabilitation|rehabilitation
579008|NCT00721825|Double blind Randomized|double blind randomized
579009|NCT00721825|Placebo controlled|placebo controlled
579010|NCT00721825|Traditional Chinese Medicine|traditional chinese medicine
579012|NCT00721812|pharmacokinetics|pharmacokinetics
579013|NCT00721812|Phase 1|phase 1
579014|NCT00721812|first time in humans|first time in humans
579015|NCT00721812|IBD|ibd
579016|NCT00721812|safety|safety
579017|NCT00721812|human volunteers|human volunteers
579018|NCT00721799|Positron-Emission Tomography|positron-emission tomography
579019|NCT00721799|radiation therapy|radiation therapy
579020|NCT00721799|cisplatin|cisplatin
579021|NCT00721799|chemotherapy|chemotherapy
579022|NCT00721799|FLT|flt
579023|NCT00721786|Smoking cessation|smoking cessation
579024|NCT00721786|Cigarette smoking|cigarette smoking
579025|NCT00721786|Tobacco smoking|tobacco smoking
579026|NCT00721786|Internet interventions|internet interventions
579027|NCT00721786|Spanish-speaking|spanish-speaking
579028|NCT00721773|Continuous Ambulatory Peritoneal Dialysis|continuous ambulatory peritoneal dialysis
579029|NCT00721773|Angiotensin-converting Enzyme Inhibitor|angiotensin-converting enzyme inhibitor
579030|NCT00721773|Angiotensin II Receptor Blocker|angiotensin ii receptor blocker
579031|NCT00721773|Renin angiotensin system inhibitor|renin angiotensin system inhibitor
579032|NCT00721773|Residual Renal Function|residual renal function
579033|NCT00721760|Hip fractures|hip fractures
579034|NCT00721760|Heparin Low-Molecular-Weight|heparin low-molecular-weight
579035|NCT00721760|Randomized Controlled Trial|randomized controlled trial
579036|NCT00721747|breast cancer patients her2 negative pathological responses|breast cancer patients her2 negative pathological responses
579037|NCT00721734|Myeloma|myeloma
579038|NCT00721734|Renal Insufficiency|renal insufficiency
579039|NCT00721734|Proteasome|proteasome
579040|NCT00721734|Hematological|hematological
579041|NCT00721734|carfilzomib|carfilzomib
579042|NCT00721734|PR-171|pr-171
579043|NCT00721721|Dietary Sodium|dietary sodium
579044|NCT00721721|Dietary Potassium|dietary potassium
579045|NCT00721721|Genes|genes
579046|NCT00721721|Genomics|genomics
579047|NCT00721708|histidine dipeptides|histidine dipeptides
579048|NCT00721708|carnosine|carnosine
579049|NCT00721708|anserine|anserine
579050|NCT00721695|Cataract|cataract
579051|NCT00721695|Cataract Extraction|cataract extraction
579052|NCT00721695|Lens Implantation|lens implantation
579053|NCT00721695|Phacoemulsification|phacoemulsification
579054|NCT00721682|Pediatry|pediatry
579055|NCT00721682|Ill-treatment|ill-treatment
579056|NCT00721682|Pain|pain
579057|NCT00721682|maltreated children|maltreated children
579058|NCT00721669|solid tumor|solid tumor
579059|NCT00721656|Dry eye syndromes|dry eye syndromes
579060|NCT00721656|Corneal diseases|corneal diseases
579061|NCT00721656|Conjunctival Diseases|conjunctival diseases
579062|NCT00721643|Angelica keiskei|angelica keiskei
579063|NCT00721643|absorption kinetics|absorption kinetics
579064|NCT00721643|quercetin|quercetin
579065|NCT00721630|CAPECITABINE|capecitabine
579066|NCT00721630|LAPATINIB|lapatinib
579067|NCT00721604|shock|shock
579068|NCT00721604|fluid responsiveness|fluid responsiveness
579069|NCT00721604|volume expansion|volume expansion
579070|NCT00721591|Recurrent Pregnancy Loss|recurrent pregnancy loss
579071|NCT00721591|Habitual abortion|habitual abortion
579072|NCT00721591|Fetal demise|fetal demise
579073|NCT00721591|Antiphospholipid antibodies|antiphospholipid antibodies
579074|NCT00721591|Inherited thrombophilia|inherited thrombophilia
579075|NCT00721578|Observational study|observational study
579076|NCT00721578|Effectiveness|effectiveness
579077|NCT00721578|Safety|safety
579078|NCT00721578|Tolerability|tolerability
579079|NCT00721578|Systemic Fungal Infection|systemic fungal infection
579080|NCT00721565|Breast Cancer|breast cancer
579081|NCT00721565|Exercise|exercise
579082|NCT00721565|Social Cognitive Theory|social cognitive theory
579083|NCT00721565|Adherence|adherence
579084|NCT00721565|Symptoms|symptoms
579085|NCT00721565|Body Composition|body composition
579086|NCT00721552|beta-cell function|beta-cell function
579087|NCT00721552|glucocorticoid-induced diabetes|glucocorticoid-induced diabetes
579088|NCT00721552|glucocorticoid|glucocorticoid
579089|NCT00721552|DPP-4 inhibitors|dpp-4 inhibitors
579090|NCT00721552|sitagliptin|sitagliptin
579091|NCT00721552|diabetes mellitus|diabetes mellitus
579092|NCT00721552|steroid diabetes|steroid diabetes
579093|NCT00721552|insulin resistance|insulin resistance
579094|NCT00721552|insulin sensitivity|insulin sensitivity
579095|NCT00721526|alcohol dependence|alcohol dependence
579096|NCT00721526|alcoholism|alcoholism
579097|NCT00721526|anxiety disorder|anxiety disorder
579098|NCT00721526|pharmacotherapy|pharmacotherapy
579099|NCT00721526|disulfiram|disulfiram
579100|NCT00721526|lorazepam|lorazepam
579101|NCT00721513|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
579102|NCT00721513|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
579103|NCT00721513|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
579104|NCT00721513|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
579105|NCT00721513|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
579106|NCT00721513|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
579107|NCT00721513|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
579108|NCT00721513|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
579109|NCT00721487|C. albicans|c. albicans
579110|NCT00721487|fluconazole|fluconazole
579111|NCT00721461|Assess|assess
579112|NCT00721461|Tolerability|tolerability
579113|NCT00721461|MedPulser DDS device|medpulser dds device
579114|NCT00721448|Pharmacokinetics|pharmacokinetics
579115|NCT00721422|Pharmacokinetics of PD 0332334 in subjects with renal insufficiency|pharmacokinetics of pd 0332334 in subjects with renal insufficiency
579116|NCT00721409|hormone-receptor positive advanced breast cancer|hormone-receptor positive advanced breast cancer
579117|NCT00721396|Meningococcal disease,|meningococcal disease,
579118|NCT00721396|Neisseria meningitidis serogroup B,|neisseria meningitidis serogroup b,
579119|NCT00721396|Prevention,|prevention,
579120|NCT00721396|Vaccination,|vaccination,
579121|NCT00721396|Infants|infants
579122|NCT00721383|caregiving, Alzheimer's disease, physical activity|caregiving, alzheimer's disease, physical activity
579123|NCT00721370|sentinel lymph node mapping|sentinel lymph node mapping
579124|NCT00721370|breast cancer|breast cancer
579125|NCT00721370|near infrared imaging|near infrared imaging
579126|NCT00721357|muscles|muscles
579127|NCT00721357|work|work
579128|NCT00721357|Magnetic Resonance Imaging|magnetic resonance imaging
579129|NCT00721357|control groups|control groups
579130|NCT00721344|Healthy males and females|healthy males and females
579131|NCT00721331|CombinatoRx|combinatorx
579132|NCT00721331|Atopic|atopic
579133|NCT00721331|Dermatitis|dermatitis
579134|NCT00721331|Topical|topical
579135|NCT00721331|CRx-197|crx-197
579136|NCT00721331|Normal Healthy Volunteers|normal healthy volunteers
579137|NCT00721318|chronic widespread pain|chronic widespread pain
579138|NCT00721318|fibromyalgia|fibromyalgia
579139|NCT00721318|rheumatoid arthritis|rheumatoid arthritis
579140|NCT00721318|Estonia|estonia
579141|NCT00721305|Type 1 human immunodeficiency virus infection|type 1 human immunodeficiency virus infection
579142|NCT00721305|Lovastatin|lovastatin
579143|NCT00721305|Adaptive Immunity|adaptive immunity
579144|NCT00721305|Cellular cholesterol|cellular cholesterol
579145|NCT00721305|Rho GTPases|rho gtpases
579146|NCT00721305|Lymphocyte function-associated antigen-1|lymphocyte function-associated antigen-1
579147|NCT00721253|ReSTOR|restor
579148|NCT00721240|responder|responder
579149|NCT00721240|leucotriene antagonist|leucotriene antagonist
579150|NCT00721214|Myelodysplastic Syndrome|myelodysplastic syndrome
579151|NCT00721214|5-azacytidine|5-azacytidine
579152|NCT00721214|allogeneic stem cell transplantation|allogeneic stem cell transplantation
579153|NCT00721201|subclinical Cushing's|subclinical cushing's
579154|NCT00721175|biliary stent|biliary stent
579155|NCT00721175|plastic stent|plastic stent
579156|NCT00721175|metallic stent|metallic stent
579157|NCT00721175|Complex hilar cholangiocarcinoma (Bismuth type II,III,IV)|complex hilar cholangiocarcinoma (bismuth type ii,iii,iv)
579158|NCT00721162|Ovarian Cancer,|ovarian cancer,
579159|NCT00721162|Fallopian Tube Cancer|fallopian tube cancer
579160|NCT00721162|Primary Peritoneal Carcinoma|primary peritoneal carcinoma
579161|NCT00721149|Atrial Fibrillation|atrial fibrillation
579162|NCT00721149|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
579163|NCT00721149|Ablation|ablation
579164|NCT00721149|Non-randomized|non-randomized
579165|NCT00721136|bleeding|bleeding
579166|NCT00721136|anticoagulation|anticoagulation
579167|NCT00721136|pacemaker|pacemaker
579168|NCT00721136|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
579169|NCT00721136|"patients undergoing implantation of a pacemaker or defibrillator (ICD)"|"patients undergoing implantation of a pacemaker or defibrillator (icd)"
579170|NCT00721110|pain control|pain control
579171|NCT00721110|nausea|nausea
579172|NCT00721110|surgery recovery|surgery recovery
579173|NCT00721097|Severe asthma|severe asthma
579174|NCT00721097|exacerbation|exacerbation
579175|NCT00721097|predictive factors|predictive factors
579176|NCT00721097|Severe|severe
579177|NCT00721084|short sleep duration|short sleep duration
579178|NCT00721084|maximal aerobic capacity|maximal aerobic capacity
579179|NCT00721084|body fat|body fat
579180|NCT00721084|visceral adiposity|visceral adiposity
579181|NCT00721084|activity-related energy expenditure|activity-related energy expenditure
579182|NCT00721084|energy metabolism|energy metabolism
579183|NCT00721071|Pediatrics|pediatrics
579184|NCT00721071|Cystic Fibrosis|cystic fibrosis
579185|NCT00721071|Hypertonic Saline|hypertonic saline
579186|NCT00721071|Induced Sputum|induced sputum
579187|NCT00721071|Expectorated Sputum|expectorated sputum
579188|NCT00721058|Eligible|eligible
579189|NCT00721058|Operable|operable
579190|NCT00721058|Disease|disease
579191|NCT00721058|Conserving|conserving
579192|NCT00721058|Therapy|therapy
579193|NCT00721058|Visible mass on mammography|visible mass on mammography
579194|NCT00721058|Ultrasound > 0.5 cm|ultrasound > 0.5 cm
579195|NCT00721058|Histologically|histologically
579196|NCT00721058|Proven|proven
579197|NCT00721045|Heart Failure|heart failure
579198|NCT00721045|Congestive Heart Failure|congestive heart failure
579199|NCT00721032|Ventricular tachycardia (VT)|ventricular tachycardia (vt)
579200|NCT00721032|Implantable cardioverter-defibrillator (ICD)|implantable cardioverter-defibrillator (icd)
579201|NCT00721032|Ablation|ablation
579202|NCT00721032|Cardiomyopathy|cardiomyopathy
579203|NCT00721032|Electrophysiology study|electrophysiology study
579204|NCT00721019|short sleep duration|short sleep duration
579205|NCT00721019|glucose clamp technique|glucose clamp technique
579206|NCT00721019|insulin secretion|insulin secretion
579207|NCT00721019|insulin action|insulin action
579208|NCT00721019|lipid turnover|lipid turnover
579209|NCT00721019|free fatty acids|free fatty acids
579210|NCT00721006|peripheral artery disease|peripheral artery disease
579211|NCT00721006|peripheral vascular disease|peripheral vascular disease
579212|NCT00721006|PAD|pad
579213|NCT00721006|PVD|pvd
579214|NCT00720993|Colorectal cancer screening|colorectal cancer screening
579215|NCT00720993|Gene expression|gene expression
579216|NCT00720993|RTPCR|rtpcr
579217|NCT00720980|granuloma annulare, ROM|granuloma annulare, rom
579218|NCT00720967|Renal dysfunction|renal dysfunction
579219|NCT00720967|Hemodialysis|hemodialysis
579220|NCT00720967|Modified ultrafiltration|modified ultrafiltration
579221|NCT00720967|Open heart surgery|open heart surgery
579222|NCT00720954|Thoracoscopy|thoracoscopy
579223|NCT00720954|Pleural needle biopsy|pleural needle biopsy
579224|NCT00720954|Malignant pleural diseases|malignant pleural diseases
579225|NCT00720954|Mesothelioma|mesothelioma
579226|NCT00720954|Diagnosis|diagnosis
579227|NCT00720954|Pleurisy tuberculosis|pleurisy tuberculosis
579228|NCT00720954|Patients with pleural diseases and pleural effusion should have been included in the study.|patients with pleural diseases and pleural effusion should have been included in the study.
579229|NCT00720941|SUTENT|sutent
579230|NCT00720941|Locally advanced and/or metastatic renal cell carcinoma|locally advanced and/or metastatic renal cell carcinoma
579231|NCT00720941|Pazopanib|pazopanib
579232|NCT00720941|Sunitinib|sunitinib
579233|NCT00720941|GW786034|gw786034
579234|NCT00720941|Renal cell carcinoma|renal cell carcinoma
579235|NCT00720928|Behcet's disease|behcet's disease
579236|NCT00720928|posterior uveitis|posterior uveitis
579237|NCT00720928|flucinolone acetonide|flucinolone acetonide
579238|NCT00720928|RETISERT|retisert
579239|NCT00720915|unprovoked deep vein thrombosis|unprovoked deep vein thrombosis
579240|NCT00720915|unprovoked pulmonary embolism|unprovoked pulmonary embolism
579241|NCT00720915|anticoagulant therapy|anticoagulant therapy
579242|NCT00720889|short sleep duration|short sleep duration
579243|NCT00720889|glucose clamp technique|glucose clamp technique
579244|NCT00720889|insulin secretion|insulin secretion
579245|NCT00720889|insulin action|insulin action
579246|NCT00720889|lipid turnover|lipid turnover
579247|NCT00720889|free fatty acids|free fatty acids
579248|NCT00720876|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
579249|NCT00720876|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
579250|NCT00720876|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
579251|NCT00720876|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
579252|NCT00720876|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
579253|NCT00720876|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
579254|NCT00720876|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
579255|NCT00720876|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
579256|NCT00720876|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
579257|NCT00720876|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
579258|NCT00720876|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
579259|NCT00720876|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
579260|NCT00720876|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
579261|NCT00720876|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
579262|NCT00720876|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
579263|NCT00720876|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
579264|NCT00720876|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
579265|NCT00720876|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
579266|NCT00720876|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
579267|NCT00720876|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
579268|NCT00720876|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
579269|NCT00720876|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
579270|NCT00720876|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
579271|NCT00720876|splenic marginal zone lymphoma|splenic marginal zone lymphoma
579272|NCT00720876|stage I marginal zone lymphoma|stage i marginal zone lymphoma
579273|NCT00720876|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
579274|NCT00720876|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
579275|NCT00720876|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
579276|NCT00720876|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
579277|NCT00720876|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
582064|NCT00711230|Vaccine|vaccine
579278|NCT00720876|stage I mantle cell lymphoma|stage i mantle cell lymphoma
579279|NCT00720876|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
579280|NCT00720876|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
579281|NCT00720850|MDS|mds
579282|NCT00720850|AML|aml
579283|NCT00720850|Lenalidomide|lenalidomide
579284|NCT00720850|monosomy 5|monosomy 5
579285|NCT00720850|monosomy del5q|monosomy del5q
579286|NCT00720837|Brain Tumor|brain tumor
579287|NCT00720837|Brain Cancer|brain cancer
579288|NCT00720837|MR-guided laser thermal ablation of brain tumors|mr-guided laser thermal ablation of brain tumors
579289|NCT00720837|Visualase® Thermal Therapy System|visualase® thermal therapy system
579290|NCT00720837|Magnetic Resonance Thermal Imaging|magnetic resonance thermal imaging
579291|NCT00720837|MRTI|mrti
579292|NCT00720837|Visualase Cooled Laser Application System|visualase cooled laser application system
579293|NCT00720837|Laser Interstitial Thermal Therapy|laser interstitial thermal therapy
579294|NCT00720837|LITT|litt
579295|NCT00720824|Immunizations|immunizations
579296|NCT00720824|Children|children
579297|NCT00720824|Injections|injections
579298|NCT00720824|aged 4-6 Years|aged 4-6 years
579299|NCT00720824|Hypnosis|hypnosis
579300|NCT00720811|Malaria ACT|malaria act
579301|NCT00720811|Rapid|rapid
579302|NCT00720811|Diagnosis|diagnosis
579303|NCT00720811|Community|community
579304|NCT00720811|health|health
579305|NCT00720811|worker|worker
579306|NCT00720811|Artemesinin|artemesinin
579307|NCT00720811|based|based
579308|NCT00720811|Combination|combination
579309|NCT00720811|Therapy|therapy
579310|NCT00720811|Anti Malarial|anti malarial
579311|NCT00720811|Treatment|treatment
579312|NCT00720811|antibiotics|antibiotics
579313|NCT00720785|Metastatic Solid Tumor|metastatic solid tumor
579314|NCT00720785|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
579315|NCT00720785|Small Lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
579316|NCT00720785|Tumor Cytotoxicity|tumor cytotoxicity
579317|NCT00720785|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
579318|NCT00720785|Multiple Myeloma|multiple myeloma
579319|NCT00720785|Lung Cancer|lung cancer
579320|NCT00720785|Prostate Cancer|prostate cancer
579321|NCT00720785|Colon Cancer|colon cancer
579322|NCT00720785|Kidney Cancer|kidney cancer
579323|NCT00720785|Pancreatic Cancer|pancreatic cancer
579324|NCT00720785|Leukemia|leukemia
579325|NCT00720785|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
579326|NCT00720785|CML|cml
579327|NCT00720785|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
579328|NCT00720785|SLL|sll
579329|NCT00720785|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
579330|NCT00720785|CLL|cll
579331|NCT00720772|coronary calcification|coronary calcification
579332|NCT00720772|vascular calcification|vascular calcification
579333|NCT00720772|sodium thiosulfate|sodium thiosulfate
579334|NCT00720759|stroke|stroke
579335|NCT00720759|hemiparesis|hemiparesis
579336|NCT00720759|randomized controlled trial|randomized controlled trial
579337|NCT00720759|d-cycloserine|d-cycloserine
579338|NCT00720759|distributed practice|distributed practice
579339|NCT00720759|constraint induced movement therapy|constraint induced movement therapy
579340|NCT00720733|HIV|hiv
579341|NCT00720733|Mood|mood
579342|NCT00720733|Emotion|emotion
579343|NCT00720733|Coping|coping
579344|NCT00720733|Aids|aids
579345|NCT00720733|Affect|affect
579346|NCT00720733|Adults|adults
579347|NCT00720733|Diagnosed|diagnosed
579348|NCT00720707|Coronally advanced flap|coronally advanced flap
579349|NCT00720707|gingival recession|gingival recession
579350|NCT00720707|enamel matrix protein|enamel matrix protein
579351|NCT00720707|acellular dermal matrix|acellular dermal matrix
579352|NCT00720707|root coverage|root coverage
579353|NCT00720668|hepatitis B|hepatitis b
579354|NCT00720668|hepatocellular carcinoma|hepatocellular carcinoma
579355|NCT00720668|radiofrequency ablation|radiofrequency ablation
579356|NCT00720668|reactivation|reactivation
579357|NCT00720655|coronary heart disease|coronary heart disease
579358|NCT00720629|graft versus host disease|graft versus host disease
579359|NCT00720629|GVHD|gvhd
579360|NCT00720629|allogeneic transplant|allogeneic transplant
579361|NCT00720629|GVHD prevention|gvhd prevention
579362|NCT00720629|unrelated donors|unrelated donors
579363|NCT00720629|mismatched unrelated donors|mismatched unrelated donors
579364|NCT00720629|hematological malignancies|hematological malignancies
579365|NCT00720629|Leukemia|leukemia
579366|NCT00720629|Lymphoma|lymphoma
579367|NCT00720629|Myelodysplastic Syndrome|myelodysplastic syndrome
579368|NCT00720629|Myelofibrosis|myelofibrosis
579369|NCT00720629|Aplastic Anemia|aplastic anemia
579370|NCT00720629|Multiple Myeloma|multiple myeloma
579371|NCT00720616|Growth hormone|growth hormone
579372|NCT00720616|Metabolic syndrome|metabolic syndrome
579373|NCT00720616|Insulin sensitivity|insulin sensitivity
579374|NCT00720603|Autologous Stem Cell Transplant|autologous stem cell transplant
579375|NCT00720577|Peripheral Arterial Disease|peripheral arterial disease
579377|NCT00720577|Lower extremity peripheral arterial atherosclerotic plaque|lower extremity peripheral arterial atherosclerotic plaque
582260|NCT00710450|IL4|il4
579378|NCT00720577|RNA Expression|rna expression
579379|NCT00720577|Lipid Biomarkers|lipid biomarkers
579380|NCT00720564|adult glioblastoma|adult glioblastoma
579381|NCT00720564|adult anaplastic astrocytoma|adult anaplastic astrocytoma
579382|NCT00720564|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
579383|NCT00720564|adult gliosarcoma|adult gliosarcoma
579384|NCT00720564|adult mixed glioma|adult mixed glioma
579385|NCT00720551|STISIM|stisim
579386|NCT00720551|Alcohol|alcohol
579387|NCT00720538|Inflammatory bowel diseases.|inflammatory bowel diseases.
579388|NCT00720538|Crohn disease.|crohn disease.
579389|NCT00720538|Ulcerative, colitis.|ulcerative, colitis.
579390|NCT00720538|Randomised controlled trial.|randomised controlled trial.
579391|NCT00720538|Therapy.|therapy.
579392|NCT00720538|Thalidomide.|thalidomide.
579393|NCT00720538|Children.|children.
579394|NCT00720525|arterial stiffness|arterial stiffness
579395|NCT00720525|arterial wave reflections|arterial wave reflections
579396|NCT00720525|diastolic heart failure|diastolic heart failure
579397|NCT00720512|adenocarcinoma of the colon|adenocarcinoma of the colon
579398|NCT00720512|adenocarcinoma of the rectum|adenocarcinoma of the rectum
579399|NCT00720512|recurrent colon cancer|recurrent colon cancer
579400|NCT00720512|recurrent rectal cancer|recurrent rectal cancer
579401|NCT00720512|stage IV colon cancer|stage iv colon cancer
579402|NCT00720512|stage IV rectal cancer|stage iv rectal cancer
579403|NCT00720512|stage III rectal cancer|stage iii rectal cancer
579404|NCT00720512|stage III colon cancer|stage iii colon cancer
579405|NCT00720473|Bipolar depression|bipolar depression
579406|NCT00720473|Elderly|elderly
579407|NCT00720473|Lamotrigine|lamotrigine
579408|NCT00720473|Brain energy metabolism|brain energy metabolism
579409|NCT00720460|Magnetic Resonance Imaging|magnetic resonance imaging
579410|NCT00720460|Minimally Invasive Therapy|minimally invasive therapy
579411|NCT00720460|Transcatheter Therapeutics|transcatheter therapeutics
579412|NCT00720460|Healthy Volunteers|healthy volunteers
579413|NCT00720460|Gadolinium Contrast|gadolinium contrast
579414|NCT00720460|Healthy Volunteer|healthy volunteer
579415|NCT00720460|HV|hv
579416|NCT00720447|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
579417|NCT00720447|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
579418|NCT00720421|Phase I|phase i
579419|NCT00720421|pharmacodynamic study|pharmacodynamic study
579420|NCT00720408|Immunosuppressant|immunosuppressant
579421|NCT00720408|Graft loss|graft loss
579422|NCT00720408|Combination drug therapy|combination drug therapy
579423|NCT00720408|Randomized controlled trial|randomized controlled trial
579424|NCT00720408|Open level method|open level method
579425|NCT00720395|Psychiatry|psychiatry
579426|NCT00720395|Pregnancy|pregnancy
579427|NCT00720369|Bipolar depression|bipolar depression
579428|NCT00720369|elderly|elderly
579429|NCT00720369|Coenzyme Q10|coenzyme q10
579430|NCT00720369|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
579431|NCT00720356|adult glioblastoma|adult glioblastoma
579432|NCT00720356|adult gliosarcoma|adult gliosarcoma
579433|NCT00720330|Inguinal Herniorrhaphy|inguinal herniorrhaphy
579434|NCT00720330|Pain assessment|pain assessment
579435|NCT00720330|Outcomes|outcomes
579436|NCT00720317|Diabetic Retinopathy|diabetic retinopathy
579437|NCT00720317|Sickle Cell Trait|sickle cell trait
579438|NCT00720317|Vision Loss|vision loss
579439|NCT00720317|Eye disease|eye disease
579440|NCT00720304|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
579441|NCT00720304|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
579442|NCT00720304|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
579443|NCT00720304|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
579444|NCT00720304|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
579445|NCT00720304|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
579446|NCT00720304|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
579447|NCT00720304|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
579448|NCT00720304|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
579449|NCT00720304|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
579450|NCT00720304|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
579451|NCT00720304|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
579452|NCT00720304|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
579453|NCT00720304|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
579454|NCT00720304|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
579455|NCT00720291|Metronidazole|metronidazole
579456|NCT00720291|BV|bv
579457|NCT00720291|Pregnancy|pregnancy
579458|NCT00720265|Organ Transplantation|organ transplantation
579459|NCT00720265|Tacrolimus|tacrolimus
579460|NCT00720265|Prograf|prograf
579461|NCT00720265|FK506MR|fk506mr
579462|NCT00720226|COPD|copd
579463|NCT00720226|emphysema|emphysema
579464|NCT00720226|angiotensin receptor blocker|angiotensin receptor blocker
579465|NCT00720200|Communication|communication
579466|NCT00720200|Intensive Care Units|intensive care units
579467|NCT00720200|Palliative Care|palliative care
579468|NCT00720200|End-of-Life Issues|end-of-life issues
579469|NCT00720200|Talking with Your Doctor|talking with your doctor
579470|NCT00720200|Coping with Chronic Illness|coping with chronic illness
579471|NCT00720161|metformin, spina bifida, duchenne, insulin resistance|metformin, spina bifida, duchenne, insulin resistance
579472|NCT00720148|Solid tumors|solid tumors
579473|NCT00720122|Bone density|bone density
579474|NCT00720122|Bone turnover markers|bone turnover markers
579475|NCT00720122|rhIGF-1|rhigf-1
579476|NCT00720122|Bone structure|bone structure
579477|NCT00720122|Anorexia nervosa|anorexia nervosa
579478|NCT00720096|Persistent Ovarian Cancer|persistent ovarian cancer
579479|NCT00720096|Genomic directed salvage chemotherapy|genomic directed salvage chemotherapy
579480|NCT00720096|Genomic Microarray|genomic microarray
579481|NCT00720083|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
579482|NCT00720083|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
579483|NCT00720083|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
579484|NCT00720083|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
579485|NCT00720083|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
579486|NCT00720083|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
579487|NCT00720083|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
579488|NCT00720083|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
579489|NCT00720070|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
579490|NCT00720070|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
579491|NCT00720070|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
579492|NCT00720070|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
579493|NCT00720070|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
579494|NCT00720070|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
579495|NCT00720070|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
579496|NCT00720070|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
579497|NCT00720070|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
579498|NCT00720070|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
579499|NCT00720070|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
579500|NCT00720070|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
579501|NCT00720070|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
579502|NCT00720070|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
579503|NCT00720070|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
579504|NCT00720070|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
579505|NCT00720070|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
579506|NCT00720070|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
579507|NCT00720070|tongue cancer|tongue cancer
579508|NCT00720057|Dental Pain|dental pain
579509|NCT00720057|Analgesia|analgesia
579510|NCT00720031|Melanoma,|melanoma,
579511|NCT00720031|Melan-A tumor reactive T cell clones,|melan-a tumor reactive t cell clones,
579512|NCT00720031|immunotherapy|immunotherapy
579513|NCT00720031|HLA-A2 melanoma patients with|hla-a2 melanoma patients with
579514|NCT00720031|either loco-regional or lymphnode metastasis|either loco-regional or lymphnode metastasis
579515|NCT00720031|transit nodules not surgically resectable|transit nodules not surgically resectable
579516|NCT00720031|-measurable cutaneous or visceral metastasis .|-measurable cutaneous or visceral metastasis .
579517|NCT00720031|Patients' tumor express Melan-A/MART-1 antigen.|patients' tumor express melan-a/mart-1 antigen.
579518|NCT00720005|Cataract|cataract
579519|NCT00720005|cataract extraction|cataract extraction
579520|NCT00720005|intraocular lens|intraocular lens
579521|NCT00720005|age related|age related
579522|NCT00719992|Exercise tolerance test|exercise tolerance test
579523|NCT00719992|HS-CRP|hs-crp
579524|NCT00719992|Coronary angiography|coronary angiography
579525|NCT00719992|Patients|patients
579526|NCT00719979|Major Depressive Disorder|major depressive disorder
579527|NCT00719979|Cognitive Behavior Therapy|cognitive behavior therapy
579528|NCT00719979|Technology Assisted|technology assisted
579529|NCT00719979|Internet|internet
579530|NCT00719979|Primary Care|primary care
579531|NCT00719966|stage IA breast cancer|stage ia breast cancer
579532|NCT00719966|stage IB breast cancer|stage ib breast cancer
579533|NCT00719966|stage II breast cancer|stage ii breast cancer
579534|NCT00719966|stage IIIA breast cancer|stage iiia breast cancer
579535|NCT00719966|stage IIIB breast cancer|stage iiib breast cancer
579536|NCT00719966|stage IIIC breast cancer|stage iiic breast cancer
579537|NCT00719966|stage IV breast cancer|stage iv breast cancer
579538|NCT00719966|ductal breast carcinoma in situ|ductal breast carcinoma in situ
579539|NCT00719953|Cognitex|cognitex
579540|NCT00719953|subjects|subjects
579541|NCT00719940|tinnitus, cognitive behavioral therapy, CBT|tinnitus, cognitive behavioral therapy, cbt
579542|NCT00719927|Social Support|social support
579543|NCT00719914|eptifibatide|eptifibatide
579544|NCT00719914|Integrilin|integrilin
579545|NCT00719914|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
579546|NCT00719914|Acute Myocardial Infarction|acute myocardial infarction
579547|NCT00719849|chronic myelogenous leukemia|chronic myelogenous leukemia
579548|NCT00719849|acute lymphoblastic leukemia|acute lymphoblastic leukemia
579549|NCT00719849|acute myeloid leukemia|acute myeloid leukemia
579550|NCT00719849|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
579551|NCT00719849|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
579552|NCT00719849|anaplastic large cell lymphoma|anaplastic large cell lymphoma
579553|NCT00719849|splenic marginal zone lymphoma|splenic marginal zone lymphoma
579554|NCT00719849|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
579555|NCT00719849|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
579556|NCT00719849|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
579557|NCT00719849|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
579558|NCT00719849|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
579559|NCT00719849|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
579560|NCT00719849|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
579561|NCT00719849|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
579562|NCT00719849|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
579563|NCT00719849|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
579564|NCT00719849|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
579565|NCT00719849|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
579566|NCT00719849|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
579567|NCT00719849|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
579568|NCT00719849|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
579569|NCT00719849|refractory multiple myeloma|refractory multiple myeloma
579570|NCT00719849|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
579571|NCT00719849|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
579572|NCT00719849|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
579573|NCT00719849|myelodysplastic/myeloproliferative disease|myelodysplastic/myeloproliferative disease
579574|NCT00719849|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
579575|NCT00719849|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
579576|NCT00719849|refractory anemia|refractory anemia
579577|NCT00719849|refractory anemia with excess blasts|refractory anemia with excess blasts
579578|NCT00719849|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
579579|NCT00719849|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
579580|NCT00719849|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
579581|NCT00719849|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
579582|NCT00719849|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
579583|NCT00719849|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
579584|NCT00719849|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
579585|NCT00719849|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
579586|NCT00719849|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
579587|NCT00719849|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
579588|NCT00719849|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
579589|NCT00719849|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
579590|NCT00719849|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
579591|NCT00719849|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
579592|NCT00719849|stage II multiple myeloma|stage ii multiple myeloma
579593|NCT00719849|stage III multiple myeloma|stage iii multiple myeloma
579594|NCT00719849|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
579595|NCT00719849|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
579596|NCT00719849|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
579597|NCT00719849|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
579598|NCT00719849|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
579599|NCT00719849|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
579600|NCT00719849|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
579601|NCT00719849|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
579602|NCT00719849|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
579603|NCT00719849|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
579604|NCT00719849|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
579605|NCT00719849|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
579606|NCT00719849|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
579607|NCT00719849|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
579608|NCT00719849|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
579609|NCT00719849|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
579610|NCT00719849|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
579611|NCT00719849|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
579612|NCT00719849|chronic eosinophilic leukemia|chronic eosinophilic leukemia
579613|NCT00719849|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
579614|NCT00719849|chronic neutrophilic leukemia|chronic neutrophilic leukemia
579615|NCT00719849|essential thrombocythemia|essential thrombocythemia
579616|NCT00719849|polycythemia vera|polycythemia vera
579617|NCT00719836|SB1518|sb1518
579618|NCT00719836|Chronic Idiopathic Myelofibrosis|chronic idiopathic myelofibrosis
579619|NCT00719836|JAK2 Inhibitor|jak2 inhibitor
579620|NCT00719823|Maraviroc Compassionate Use|maraviroc compassionate use
579621|NCT00719810|complicated|complicated
579622|NCT00719810|skin|skin
579623|NCT00719797|stage IV rectal cancer|stage iv rectal cancer
579624|NCT00719797|stage IV colon cancer|stage iv colon cancer
579625|NCT00719797|stage III rectal cancer|stage iii rectal cancer
579626|NCT00719797|stage III colon cancer|stage iii colon cancer
579627|NCT00719784|Respiratory|respiratory
579628|NCT00719784|Pulmonary|pulmonary
579629|NCT00719784|Thoracic|thoracic
579630|NCT00719784|Chest|chest
579631|NCT00719784|Lung|lung
579632|NCT00719771|Osteoarthritis|osteoarthritis
579633|NCT00719771|Glenohumeral joint|glenohumeral joint
579634|NCT00719771|Glenoid|glenoid
579635|NCT00719771|Shoulder arthroplasty|shoulder arthroplasty
579636|NCT00719758|TRK-100STP,|trk-100stp,
579637|NCT00719758|beraprost sodium,|beraprost sodium,
579638|NCT00719758|Careload LA|careload la
579639|NCT00719758|AST-120|ast-120
579640|NCT00719758|Spherical carbon adsorbent|spherical carbon adsorbent
579641|NCT00719758|Drug-drug interaction|drug-drug interaction
579642|NCT00719745|Organ transplantation|organ transplantation
579643|NCT00719745|Tacrolimus|tacrolimus
579644|NCT00719745|Prograf|prograf
579645|NCT00719745|MR4|mr4
579646|NCT00719732|ReSTOR Aspheric +3 IOL|restor aspheric +3 iol
579647|NCT00719719|Mast Cell|mast cell
579648|NCT00719719|Tryptase|tryptase
579649|NCT00719719|Bone Marrow|bone marrow
579650|NCT00719719|Hives|hives
579651|NCT00719719|Adult|adult
579652|NCT00719719|Anaphylaxis|anaphylaxis
579653|NCT00719706|Bipolar disorder|bipolar disorder
579654|NCT00719706|Bipolar depression|bipolar depression
579655|NCT00719706|Natural substances|natural substances
579656|NCT00719706|Depression|depression
579657|NCT00719693|Food effect, phase I|food effect, phase i
579658|NCT00719693|adverse events|adverse events
579659|NCT00719680|CVID|cvid
579660|NCT00719680|XLA|xla
579661|NCT00719667|OPCAB|opcab
579662|NCT00719667|coronary|coronary
579663|NCT00719667|bypass|bypass
579664|NCT00719667|grafting|grafting
579665|NCT00719667|off pump|off pump
579666|NCT00719654|Preeclampsia|preeclampsia
579667|NCT00719654|Proteome|proteome
579668|NCT00719654|Pregnancy|pregnancy
579669|NCT00719641|Colonoscopy|colonoscopy
579670|NCT00719641|Looping|looping
579671|NCT00719641|Prevent Looping|prevent looping
579672|NCT00719641|Colon Cancer Screening|colon cancer screening
579673|NCT00719641|Segmental Stiffening Wire|segmental stiffening wire
579674|NCT00719628|Postoperative|postoperative
579675|NCT00719628|Cognitive|cognitive
579676|NCT00719628|Dysfunction|dysfunction
579677|NCT00719615|Thyroid Cancer|thyroid cancer
579678|NCT00719615|Thyroid Nodules|thyroid nodules
579679|NCT00719615|Vitamin D|vitamin d
579680|NCT00719602|Coinfection|coinfection
579681|NCT00719589|Voiding Dysfunction|voiding dysfunction
579682|NCT00719589|Interstim|interstim
579683|NCT00719576|Cartilage legions|cartilage legions
579684|NCT00719576|symptomatic focal cartilage defects|symptomatic focal cartilage defects
579685|NCT00719576|microfracture|microfracture
579686|NCT00719576|MACI|maci
579687|NCT00719576|autologous chondrocyte|autologous chondrocyte
579688|NCT00719563|fatigue|fatigue
579689|NCT00719563|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
579690|NCT00719563|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
579691|NCT00719563|acute undifferentiated leukemia|acute undifferentiated leukemia
579692|NCT00719563|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
579693|NCT00719563|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
579694|NCT00719563|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
579894|NCT00719316|Chronic Kidney Disease|chronic kidney disease
579695|NCT00719563|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
579696|NCT00719563|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
579697|NCT00719563|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
579698|NCT00719563|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
579699|NCT00719563|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
579700|NCT00719563|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
579701|NCT00719563|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
579702|NCT00719563|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
579703|NCT00719563|mast cell leukemia|mast cell leukemia
579704|NCT00719563|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
579705|NCT00719563|prolymphocytic leukemia|prolymphocytic leukemia
579706|NCT00719563|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
579707|NCT00719563|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
579708|NCT00719563|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
579709|NCT00719563|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
579710|NCT00719563|refractory hairy cell leukemia|refractory hairy cell leukemia
579711|NCT00719563|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
579712|NCT00719563|secondary acute myeloid leukemia|secondary acute myeloid leukemia
579713|NCT00719563|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
579714|NCT00719563|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
579715|NCT00719563|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
579716|NCT00719563|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
579717|NCT00719563|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
579718|NCT00719563|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
579719|NCT00719563|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
579720|NCT00719563|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
579721|NCT00719563|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
579722|NCT00719563|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
579723|NCT00719563|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
579724|NCT00719563|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
579725|NCT00719563|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
579726|NCT00719563|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
579727|NCT00719563|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
579728|NCT00719563|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
579729|NCT00719563|anaplastic large cell lymphoma|anaplastic large cell lymphoma
579730|NCT00719563|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
579731|NCT00719563|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
579732|NCT00719563|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
579733|NCT00719563|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
579734|NCT00719563|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
579735|NCT00719563|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
579736|NCT00719563|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
579737|NCT00719563|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
579738|NCT00719563|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
579739|NCT00719563|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
579740|NCT00719563|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
579741|NCT00719563|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
579742|NCT00719563|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
579743|NCT00719563|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
579744|NCT00719563|Waldenström macroglobulinemia|waldenström macroglobulinemia
579745|NCT00719563|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
579746|NCT00719563|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
579747|NCT00719563|splenic marginal zone lymphoma|splenic marginal zone lymphoma
579748|NCT00719563|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
579749|NCT00719563|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
579750|NCT00719563|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
579751|NCT00719563|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
579752|NCT00719563|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
579753|NCT00719563|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
579754|NCT00719563|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
579755|NCT00719563|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
579756|NCT00719563|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
579757|NCT00719563|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
579758|NCT00719563|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
579759|NCT00719563|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
579760|NCT00719563|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
579920|NCT00719199|metastatic cancer|metastatic cancer
579761|NCT00719563|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
579762|NCT00719563|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
579763|NCT00719563|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
579764|NCT00719563|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
579765|NCT00719563|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
579766|NCT00719563|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
579767|NCT00719563|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
579768|NCT00719563|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
579769|NCT00719563|stage I mantle cell lymphoma|stage i mantle cell lymphoma
579770|NCT00719563|stage I marginal zone lymphoma|stage i marginal zone lymphoma
579771|NCT00719563|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
579772|NCT00719563|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
579773|NCT00719563|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
579774|NCT00719563|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
579775|NCT00719563|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
579776|NCT00719563|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
579777|NCT00719563|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
579778|NCT00719563|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
579779|NCT00719563|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
579780|NCT00719563|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
579781|NCT00719563|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
579782|NCT00719563|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
579783|NCT00719563|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
579784|NCT00719563|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
579785|NCT00719563|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
579786|NCT00719563|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
579787|NCT00719563|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
579788|NCT00719563|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
579789|NCT00719563|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
579790|NCT00719563|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
579791|NCT00719563|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
579792|NCT00719563|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
579793|NCT00719563|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
579794|NCT00719563|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
579795|NCT00719563|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
579796|NCT00719563|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
579797|NCT00719563|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
579798|NCT00719563|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
579799|NCT00719563|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
579800|NCT00719563|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
579801|NCT00719563|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
579802|NCT00719563|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
579803|NCT00719563|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
579804|NCT00719563|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
579805|NCT00719563|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
579806|NCT00719563|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
579807|NCT00719563|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
579808|NCT00719563|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
579809|NCT00719563|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
579810|NCT00719563|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
579811|NCT00719563|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
579812|NCT00719563|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
579813|NCT00719563|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
579814|NCT00719563|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
579815|NCT00719563|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
579816|NCT00719563|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
579817|NCT00719563|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
579818|NCT00719563|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
579819|NCT00719563|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
579820|NCT00719563|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
579821|NCT00719563|intraocular lymphoma|intraocular lymphoma
579822|NCT00719563|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
579823|NCT00719563|chronic eosinophilic leukemia|chronic eosinophilic leukemia
579824|NCT00719563|chronic neutrophilic leukemia|chronic neutrophilic leukemia
579825|NCT00719563|primary myelofibrosis|primary myelofibrosis
579826|NCT00719563|essential thrombocythemia|essential thrombocythemia
579827|NCT00719563|polycythemia vera|polycythemia vera
579828|NCT00719563|extramedullary plasmacytoma|extramedullary plasmacytoma
579829|NCT00719563|isolated plasmacytoma of bone|isolated plasmacytoma of bone
579830|NCT00719563|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
579831|NCT00719563|stage I multiple myeloma|stage i multiple myeloma
579832|NCT00719563|stage II multiple myeloma|stage ii multiple myeloma
579833|NCT00719563|stage III multiple myeloma|stage iii multiple myeloma
579834|NCT00719563|primary systemic amyloidosis|primary systemic amyloidosis
579835|NCT00719563|refractory multiple myeloma|refractory multiple myeloma
579836|NCT00719563|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
579837|NCT00719563|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
579838|NCT00719563|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
579839|NCT00719563|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
579840|NCT00719550|Locally Advanced|locally advanced
579841|NCT00719550|Metastatic|metastatic
579842|NCT00719537|preeclampsia|preeclampsia
579843|NCT00719537|progesterone|progesterone
579844|NCT00719537|aspirin|aspirin
579845|NCT00719537|prevent|prevent
579846|NCT00719537|soluble fms-like tyrosine kinase (sFlt-1)|soluble fms-like tyrosine kinase (sflt-1)
579847|NCT00719537|Placental Growth Factor (PlGF)|placental growth factor (plgf)
579848|NCT00719537|risk|risk
579849|NCT00719524|Neoplasms|neoplasms
579850|NCT00719524|Antineoplastic Combined Chemotherapy Protocol|antineoplastic combined chemotherapy protocol
579851|NCT00719511|Rhinoconjunctivitis|rhinoconjunctivitis
579852|NCT00719511|Allergic|allergic
579853|NCT00719498|Epo-alpha|epo-alpha
579854|NCT00719498|Cardiac arrest|cardiac arrest
579855|NCT00719498|Mild hypothermia|mild hypothermia
579856|NCT00719485|lumbar decompression|lumbar decompression
579857|NCT00719472|Follicular NHL|follicular nhl
579858|NCT00719472|NHL|nhl
579859|NCT00719472|Large B-Cell NHL|large b-cell nhl
579860|NCT00719446|Acute Lung Injury|acute lung injury
579861|NCT00719433|stroke|stroke
579862|NCT00719433|chronic|chronic
579863|NCT00719433|rehabilitation|rehabilitation
579864|NCT00719433|robot therapy|robot therapy
579865|NCT00719433|arm therapy|arm therapy
579866|NCT00719420|Randomized clinical trial|randomized clinical trial
579867|NCT00719420|Helicobacter pylori|helicobacter pylori
579868|NCT00719420|clarithromycin|clarithromycin
579869|NCT00719420|metronidazole|metronidazole
579870|NCT00719420|amoxicillin|amoxicillin
579871|NCT00719420|proton pump inhibitor|proton pump inhibitor
579872|NCT00719420|Colombia|colombia
579873|NCT00719407|birth asphyxia|birth asphyxia
579874|NCT00719407|neonatal encephalopathy|neonatal encephalopathy
579875|NCT00719407|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
579876|NCT00719407|neuroprotection|neuroprotection
579877|NCT00719407|neonate|neonate
579878|NCT00719394|alzheimer Disease|alzheimer disease
579879|NCT00719368|Groin hernia|groin hernia
579880|NCT00719368|pain|pain
579881|NCT00719368|chronic|chronic
579882|NCT00719368|quantitative sensory testing|quantitative sensory testing
579883|NCT00719368|Persistent postoperative pain|persistent postoperative pain
579884|NCT00719342|Retinal vessel diameter|retinal vessel diameter
579885|NCT00719342|Flicker-induced vasodilatation|flicker-induced vasodilatation
579886|NCT00719342|Optic nerve head blood flow|optic nerve head blood flow
579887|NCT00719342|Ocular Physiology|ocular physiology
579888|NCT00719342|Regional Blood Flow|regional blood flow
579889|NCT00719329|chlorhexidine|chlorhexidine
579890|NCT00719329|umbilical cord|umbilical cord
579891|NCT00719316|Renin inhibitor|renin inhibitor
579892|NCT00719316|Patients|patients
579893|NCT00719316|ACE inhibitor or ARB|ace inhibitor or arb
579895|NCT00719316|Hypertension|hypertension
579896|NCT00719290|Primary Angle Closure Glaucoma|primary angle closure glaucoma
579897|NCT00719290|Phacoemulsification|phacoemulsification
579898|NCT00719290|Goniosynechialysis|goniosynechialysis
579899|NCT00719290|Outflow facility|outflow facility
579900|NCT00719277|cardiac arrhythmia|cardiac arrhythmia
579901|NCT00719277|syncope|syncope
579902|NCT00719277|ECG|ecg
579903|NCT00719277|implantable ECG monitor|implantable ecg monitor
579904|NCT00719277|ILR|ilr
579905|NCT00719264|Renal cell carcinoma|renal cell carcinoma
579906|NCT00719264|Adults|adults
579907|NCT00719264|Bevacizumab|bevacizumab
579908|NCT00719264|RAD001|rad001
579909|NCT00719264|Everolimus|everolimus
579910|NCT00719264|Interferon|interferon
579911|NCT00719264|Clear|clear
579912|NCT00719264|Roferon|roferon
579913|NCT00719264|Avastin|avastin
579914|NCT00719264|Nephrectomy|nephrectomy
579915|NCT00719264|newly diagnosed|newly diagnosed
579916|NCT00719251|Complications of Diabetes Mellitus|complications of diabetes mellitus
579917|NCT00719251|Electric stimulation|electric stimulation
579918|NCT00719251|Low-Level Laser Therapy|low-level laser therapy
579919|NCT00719199|Colorectal cancer|colorectal cancer
579921|NCT00719199|prior therapy|prior therapy
579922|NCT00719199|1b|1b
579923|NCT00719186|Polycystic Ovary Syndrome|polycystic ovary syndrome
579924|NCT00719186|Infertility|infertility
579925|NCT00719186|Pregnancy|pregnancy
579926|NCT00719186|Women|women
579927|NCT00719173|nausea and vomiting|nausea and vomiting
579928|NCT00719173|breast cancer|breast cancer
579929|NCT00719160|Gastric acid|gastric acid
579930|NCT00719160|Dietary protein|dietary protein
579931|NCT00719160|Calcium|calcium
579932|NCT00719160|Intestinal absorption|intestinal absorption
579933|NCT00719160|Calcium sensing receptor|calcium sensing receptor
579934|NCT00719108|Diabetes, Healthy Volunteers|diabetes, healthy volunteers
579935|NCT00719095|prescription opioid|prescription opioid
579936|NCT00719095|opioid detoxification|opioid detoxification
579937|NCT00719095|buprenorphine|buprenorphine
579938|NCT00719095|naltrexone|naltrexone
579939|NCT00719095|community reinforcement approach|community reinforcement approach
579940|NCT00719095|prescription opioid abuse|prescription opioid abuse
579941|NCT00719082|Human Stability|human stability
579942|NCT00719082|Geriatric|geriatric
579943|NCT00719082|Posturography|posturography
579944|NCT00719069|healthy subjects who smoke|healthy subjects who smoke
579945|NCT00719069|healthy subjects|healthy subjects
579946|NCT00719056|teicoplanin|teicoplanin
579947|NCT00719056|prophylaxis|prophylaxis
579948|NCT00719056|arthroplasty|arthroplasty
579949|NCT00719056|surgical site infections|surgical site infections
579950|NCT00719043|Influenza|influenza
579951|NCT00719043|H5N1|h5n1
579952|NCT00719043|Avian|avian
579953|NCT00719043|Vaccines|vaccines
579954|NCT00719043|Safety|safety
579955|NCT00719043|Immunogenicity|immunogenicity
579956|NCT00719043|Pandemic|pandemic
579957|NCT00719043|Human|human
579958|NCT00719017|Brachytherapy|brachytherapy
579959|NCT00719017|Early stage edometrial cancer|early stage edometrial cancer
579960|NCT00719017|Quality of life|quality of life
579961|NCT00719017|Recurrence|recurrence
579962|NCT00719017|Treatment|treatment
579963|NCT00719017|Vaginectomy|vaginectomy
579964|NCT00719004|Anatomy|anatomy
579965|NCT00719004|Foot|foot
579966|NCT00719004|Sonography|sonography
579967|NCT00719004|Medical|medical
579968|NCT00718991|CLI|cli
579969|NCT00718991|excimer laser|excimer laser
579970|NCT00718991|debulking|debulking
579971|NCT00718978|bioengineered|bioengineered
579972|NCT00718978|ski|ski
579973|NCT00718978|keratinocytes|keratinocytes
579974|NCT00718978|fibroblasts|fibroblasts
579975|NCT00718978|skin|skin
579976|NCT00718978|culture|culture
579977|NCT00718978|autologous|autologous
579978|NCT00718978|CSS|css
579979|NCT00718978|full-thickness loss of substance from:|full-thickness loss of substance from:
579980|NCT00718978|burns|burns
579981|NCT00718978|ulcers|ulcers
579982|NCT00718978|giant nevi|giant nevi
579983|NCT00718978|cicatricial outcomes|cicatricial outcomes
579984|NCT00718965|Primary hypercholesterolemia|primary hypercholesterolemia
579985|NCT00718952|Pulmonary Hypertension|pulmonary hypertension
579986|NCT00718939|Diastolic Heart Failure|diastolic heart failure
579987|NCT00718939|Cardiac dysfunction|cardiac dysfunction
579988|NCT00718939|Heart Failure|heart failure
579989|NCT00718926|dry eye|dry eye
579990|NCT00718926|Thiol redox|thiol redox
579991|NCT00718926|Oxidative stress|oxidative stress
579992|NCT00718913|Adjuvant Gastric Cancer|adjuvant gastric cancer
579993|NCT00718913|Adjuvant chemotherapy|adjuvant chemotherapy
579994|NCT00718913|Adjuvant chemo-radiation|adjuvant chemo-radiation
579995|NCT00718913|Capecitabine|capecitabine
579996|NCT00718874|obesity, puberty, diabetes,insulin dynamics|obesity, puberty, diabetes,insulin dynamics
579997|NCT00718861|Osteoporosis|osteoporosis
579998|NCT00718861|zoledronic acid|zoledronic acid
579999|NCT00718861|post-menopausal|post-menopausal
580000|NCT00718848|hemodialysis|hemodialysis
580001|NCT00718848|left ventricular hypertrophy|left ventricular hypertrophy
580002|NCT00718848|left ventricular systolic function|left ventricular systolic function
580003|NCT00718835|smoking cessation|smoking cessation
580004|NCT00718835|behavioral treatment|behavioral treatment
580005|NCT00718835|contingency management|contingency management
580006|NCT00718835|opioid maintenance|opioid maintenance
580007|NCT00718835|methadone|methadone
580008|NCT00718835|buprenorphine|buprenorphine
580009|NCT00718822|clinical outcome|clinical outcome
580010|NCT00718822|ICSI cycles|icsi cycles
580011|NCT00718822|low oxygen|low oxygen
580012|NCT00718822|poor responders|poor responders
580013|NCT00718822|pregnancy rate|pregnancy rate
580014|NCT00718822|prospective randomized study|prospective randomized study
580015|NCT00718796|cardiovascular disease|cardiovascular disease
580016|NCT00718796|naturopathic medicine|naturopathic medicine
580017|NCT00718796|natural health products|natural health products
580018|NCT00718796|lifestyle intervention|lifestyle intervention
580019|NCT00718796|dietary advice|dietary advice
580020|NCT00718796|coronary heart disease|coronary heart disease
580021|NCT00718770|Not respond|not respond
580022|NCT00718770|Radioactive iodine|radioactive iodine
580023|NCT00718770|Therapy|therapy
580024|NCT00718770|Shows signs|shows signs
580025|NCT00718770|Aggressive behavior|aggressive behavior
580026|NCT00718744|Allergen-extract|allergen-extract
580027|NCT00718744|Standardization|standardization
580028|NCT00718731|Alzheimer Disease|alzheimer disease
580029|NCT00718718|Arthritis, Rheumatoid|arthritis, rheumatoid
580030|NCT00718718|Rheumatoid Arthritis|rheumatoid arthritis
580031|NCT00718718|Active Rheumatoid Arthritis|active rheumatoid arthritis
580032|NCT00718718|CNTO 136|cnto 136
580033|NCT00718718|Interleukin-6|interleukin-6
580034|NCT00718718|Anti-interleukin-6 monoclonal antibody|anti-interleukin-6 monoclonal antibody
580035|NCT00718718|Methotrexate|methotrexate
580036|NCT00718718|Placebo|placebo
580037|NCT00718705|Prematurity|prematurity
580038|NCT00718705|Ureaplasma spp|ureaplasma spp
580039|NCT00718705|Mycoplasma Hominis|mycoplasma hominis
580040|NCT00718705|Amniotic fluid|amniotic fluid
580041|NCT00718705|Josamycine|josamycine
580042|NCT00718692|Idiopathic|idiopathic
580043|NCT00718692|ITP|itp
580044|NCT00718666|Safety|safety
580045|NCT00718666|Vaccines, conjugate|vaccines, conjugate
580046|NCT00718666|Immunogenicity|immunogenicity
580047|NCT00718666|Meningococcal vaccine|meningococcal vaccine
580048|NCT00718666|Booster vaccination|booster vaccination
580049|NCT00718666|Primary vaccination|primary vaccination
580050|NCT00718666|Neisseria meningitides|neisseria meningitides
580051|NCT00718666|Toddlers|toddlers
580052|NCT00718666|Humans|humans
580053|NCT00718666|Meningococcal disease|meningococcal disease
580054|NCT00718653|Macular pigment, lutein, green tea extract, antioxidant|macular pigment, lutein, green tea extract, antioxidant
580055|NCT00718640|Multiple Myeloma|multiple myeloma
580056|NCT00718640|Velcade|velcade
580057|NCT00718640|Bortezomib|bortezomib
580058|NCT00718640|Dexamethasone|dexamethasone
580059|NCT00718627|Urea cycle Disorders|urea cycle disorders
580060|NCT00718627|Carbamoylphosphate synthetase I deficiency|carbamoylphosphate synthetase i deficiency
580061|NCT00718627|Ornithine transcarbamoylase deficiency|ornithine transcarbamoylase deficiency
580062|NCT00718627|Argininosuccinate synthase deficiency|argininosuccinate synthase deficiency
580063|NCT00718627|Citrullinemia|citrullinemia
580064|NCT00718627|newborns|newborns
580065|NCT00718627|infants|infants
580066|NCT00718627|liver cell transplantation|liver cell transplantation
580067|NCT00718627|liver cell infusion|liver cell infusion
580068|NCT00718614|Choroidal blood flow|choroidal blood flow
580069|NCT00718614|Laser Doppler flowmetry|laser doppler flowmetry
580070|NCT00718614|Diabetic Retinopathy|diabetic retinopathy
580071|NCT00718614|Diabetic Neuropathy|diabetic neuropathy
580072|NCT00718601|Myeloma|myeloma
580073|NCT00718601|Multiple Myeloma|multiple myeloma
580074|NCT00718601|Relapsed Multiple Myeloma|relapsed multiple myeloma
580075|NCT00718601|Refractory Multiple Myeloma|refractory multiple myeloma
580076|NCT00718601|Relapsed or Refractory Multiple Myeloma|relapsed or refractory multiple myeloma
580077|NCT00718588|RA|ra
580078|NCT00718575|Liver Disease|liver disease
580079|NCT00718575|Transplantation|transplantation
580080|NCT00718562|nilotinib|nilotinib
580081|NCT00718562|AMN107|amn107
580082|NCT00718562|Sunitinib|sunitinib
580083|NCT00718562|Sunitinib malate|sunitinib malate
580084|NCT00718562|Imatinib|imatinib
580085|NCT00718562|Imatinib mesylate|imatinib mesylate
580086|NCT00718562|Tyrosine|tyrosine
580087|NCT00718536|Atazanavir|atazanavir
580088|NCT00718536|Raltegravir|raltegravir
580089|NCT00718536|once-daily|once-daily
580090|NCT00718536|pharmacokinetics|pharmacokinetics
580091|NCT00718536|HIV|hiv
580092|NCT00718497|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
580093|NCT00718497|Cerebrospinal Fluid|cerebrospinal fluid
580094|NCT00718497|Neurodegenerative Disease|neurodegenerative disease
580095|NCT00718497|Motor Neuron Disease|motor neuron disease
580096|NCT00718497|Autonomic Nervous System|autonomic nervous system
580097|NCT00718497|Neurodegenerative Diseases|neurodegenerative diseases
580098|NCT00718497|Movement Disorders|movement disorders
580099|NCT00718484|Sarcoma|sarcoma
580100|NCT00718484|Soft Tissue Sarcoma|soft tissue sarcoma
580101|NCT00718484|Doxorubicin|doxorubicin
580102|NCT00718484|anthracyclin|anthracyclin
580103|NCT00718484|Palifosfamide|palifosfamide
580104|NCT00718484|IFOS|ifos
580105|NCT00718471|STEMI|stemi
580106|NCT00718471|Primary PCI|primary pci
580107|NCT00718471|Anticoagulation|anticoagulation
580108|NCT00718458|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
580109|NCT00718458|Cerebrospinal Fluid|cerebrospinal fluid
580110|NCT00718458|Neurodegenerative Disease|neurodegenerative disease
580111|NCT00718458|Motor Neuron Disease|motor neuron disease
580112|NCT00718458|Autonomic Nervous System|autonomic nervous system
580113|NCT00718458|Neurodegenerative Diseases|neurodegenerative diseases
580114|NCT00718458|Movement Disorders|movement disorders
580115|NCT00718445|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
580116|NCT00718445|Cerebrospinal Fluid|cerebrospinal fluid
580117|NCT00718445|Neurodegenerative Disease|neurodegenerative disease
580118|NCT00718445|Motor Neuron Disease|motor neuron disease
580119|NCT00718445|Autonomic Nervous System|autonomic nervous system
580120|NCT00718445|Neurodegenerative Diseases|neurodegenerative diseases
580121|NCT00718445|Movement Disorders|movement disorders
580122|NCT00718432|Frailty|frailty
580123|NCT00718432|Osteoporosis|osteoporosis
580124|NCT00718432|Depression|depression
580125|NCT00718419|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
580126|NCT00718419|Multiple Myeloma|multiple myeloma
580127|NCT00718406|Acute coronary syndrome|acute coronary syndrome
580128|NCT00718406|Chest pain|chest pain
580129|NCT00718406|Betablockers|betablockers
580130|NCT00718406|Morphine|morphine
580131|NCT00718406|Prehospital phase|prehospital phase
580132|NCT00718393|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
580133|NCT00718393|Cerebrospinal Fluid|cerebrospinal fluid
580134|NCT00718393|Neurodegenerative Disease|neurodegenerative disease
580135|NCT00718393|Motor Neuron Disease|motor neuron disease
580136|NCT00718393|Autonomic Nervous System|autonomic nervous system
580137|NCT00718393|Neurodegenerative Diseases|neurodegenerative diseases
580138|NCT00718393|Movement Disorders|movement disorders
580139|NCT00718354|Bleeding events|bleeding events
580140|NCT00718341|Fragile X Syndrome, adults, efficacy|fragile x syndrome, adults, efficacy
580141|NCT00718328|Intracerebral|intracerebral
580142|NCT00718328|Hemorrhage|hemorrhage
580143|NCT00718328|Edema|edema
580144|NCT00718328|Statins|statins
580145|NCT00718302|Ankle Fractures|ankle fractures
580146|NCT00718302|Displaced Lateral Malleolus Fractures|displaced lateral malleolus fractures
580147|NCT00718302|Antiglide Plating|antiglide plating
580148|NCT00718302|Lateral Plating|lateral plating
580149|NCT00718289|Citric acid|citric acid
580150|NCT00718289|citrate|citrate
580151|NCT00718289|acetic acid|acetic acid
580152|NCT00718289|acetate|acetate
580153|NCT00718289|haemodialysis|haemodialysis
580154|NCT00718289|calcium|calcium
580155|NCT00718289|hypotension|hypotension
580156|NCT00718289|haemodynamics|haemodynamics
580157|NCT00718289|Dialysate for Haemodialysis|dialysate for haemodialysis
580158|NCT00718276|Healthy postmenopausal women|healthy postmenopausal women
580159|NCT00718250|Acute myeloid leukaemia|acute myeloid leukaemia
580160|NCT00718250|Cancer vaccines|cancer vaccines
580161|NCT00718250|Immunotherapy|immunotherapy
580162|NCT00718237|Gastroenteritis|gastroenteritis
580163|NCT00718237|Rotavirus|rotavirus
580164|NCT00718224|Knee surgery|knee surgery
580165|NCT00718224|VTE prevention|vte prevention
580166|NCT00718198|Inpatient|inpatient
580167|NCT00718198|Computer Physician Order Entry|computer physician order entry
580168|NCT00718198|Diabetes Mellitus|diabetes mellitus
580169|NCT00718185|Sildenafil|sildenafil
580170|NCT00718185|Pediatrics|pediatrics
580171|NCT00718172|Ribavirin Pretreatment|ribavirin pretreatment
580172|NCT00718172|Gene Expression|gene expression
580173|NCT00718172|Peginterferon|peginterferon
580174|NCT00718172|Hepatitis C|hepatitis c
580175|NCT00718172|Liver Biopsy|liver biopsy
580176|NCT00718172|HCV|hcv
580177|NCT00718159|Acute Myeloid Leukemia|acute myeloid leukemia
580178|NCT00718159|Myeloid Leukemia|myeloid leukemia
580179|NCT00718159|Relapsed|relapsed
580180|NCT00718159|Refractory|refractory
580181|NCT00718146|Influenza|influenza
580182|NCT00718146|Orthomyxoviridae Infections|orthomyxoviridae infections
580183|NCT00718146|Orthomyxoviruses|orthomyxoviruses
580184|NCT00718146|Split-virion influenza vaccine|split-virion influenza vaccine
580185|NCT00718133|Asthma|asthma
580186|NCT00718133|Allergy|allergy
580187|NCT00718133|Respiratory|respiratory
580188|NCT00718133|Pollution|pollution
580189|NCT00718133|Children|children
580190|NCT00718133|Air pollution|air pollution
580191|NCT00718120|Fluviral|fluviral
580192|NCT00718120|Influenza|influenza
580193|NCT00718107|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
580194|NCT00718107|Cerebrospinal Fluid|cerebrospinal fluid
580195|NCT00718107|Neurodegenerative Disease|neurodegenerative disease
580196|NCT00718107|Motor Neuron Disease|motor neuron disease
580197|NCT00718107|Autonomic Nervous System|autonomic nervous system
580198|NCT00718107|Neurodegenerative Diseases|neurodegenerative diseases
580199|NCT00718107|Movement Disorders|movement disorders
580200|NCT00718107|Quality of Life|quality of life
580201|NCT00718094|Ulcerative colitis|ulcerative colitis
580202|NCT00718094|EGCG|egcg
580203|NCT00718094|Green tea polyphenols|green tea polyphenols
580204|NCT00718094|Inflammatory bowel disease|inflammatory bowel disease
580205|NCT00718094|Colitis|colitis
580206|NCT00718094|IBD|ibd
580207|NCT00718094|Green tea|green tea
580208|NCT00718068|Potassium chloride|potassium chloride
580209|NCT00718068|Preparations, Pharmaceutical|preparations, pharmaceutical
580210|NCT00718068|Hypokalemia|hypokalemia
580211|NCT00718068|Critical Care|critical care
580212|NCT00718068|Adult|adult
580213|NCT00718068|Randomized Controlled Trial|randomized controlled trial
580214|NCT00718055|MRI|mri
580215|NCT00718055|liverspecific|liverspecific
580216|NCT00718055|contrast|contrast
580217|NCT00718055|colorectal|colorectal
580218|NCT00718055|metastases|metastases
580219|NCT00718042|healthy donors|healthy donors
580220|NCT00718029|Human Immunodeficiency Virus|human immunodeficiency virus
580221|NCT00718029|Cerebrospinal Fluid|cerebrospinal fluid
580222|NCT00718029|Raltegravir|raltegravir
580223|NCT00718029|Drug Concentrations|drug concentrations
580224|NCT00718016|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
580225|NCT00718016|Cerebrospinal Fluid|cerebrospinal fluid
580226|NCT00718016|Neurodegenerative Disease|neurodegenerative disease
580227|NCT00718016|Motor Neuron Disease|motor neuron disease
580228|NCT00718016|Autonomic Nervous System|autonomic nervous system
580229|NCT00718016|Neurodegenerative Diseases|neurodegenerative diseases
580230|NCT00718016|Movement Disorders|movement disorders
580231|NCT00718003|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
580232|NCT00718003|Cerebrospinal Fluid|cerebrospinal fluid
580233|NCT00718003|Neurodegenerative Disease|neurodegenerative disease
580234|NCT00718003|Motor Neuron Disease|motor neuron disease
580235|NCT00718003|Autonomic Nervous System|autonomic nervous system
580236|NCT00718003|Neurodegenerative Diseases|neurodegenerative diseases
580237|NCT00718003|Movement Disorders|movement disorders
580238|NCT00717990|Colorectal cancer|colorectal cancer
580239|NCT00717990|Bevacizumab|bevacizumab
580240|NCT00717990|XELIRI|xeliri
580241|NCT00717951|advanced breast cancer|advanced breast cancer
580242|NCT00717951|docetaxol|docetaxol
580243|NCT00717951|capecitabine|capecitabine
580244|NCT00717951|cisplatin|cisplatin
580245|NCT00717925|B-cell Non-Hodgkin's Lymphoma|b-cell non-hodgkin's lymphoma
580246|NCT00717925|NHL|nhl
580247|NCT00717912|BLOOD GLUCOSE|blood glucose
580248|NCT00717912|glycemic index|glycemic index
580249|NCT00717912|rates of digestion and absorption of food|rates of digestion and absorption of food
580250|NCT00717899|Asthma|asthma
580251|NCT00717899|Allergy|allergy
580252|NCT00717899|Respiratory|respiratory
580253|NCT00717899|Pollution|pollution
580254|NCT00717899|Children|children
580255|NCT00717899|Air pollution|air pollution
580256|NCT00717886|Breast|breast
580257|NCT00717886|Lymph Nodes|lymph nodes
580258|NCT00717873|Mucus Clearance|mucus clearance
580259|NCT00717873|Secretion Clearance|secretion clearance
580260|NCT00717873|HFCWO|hfcwo
580261|NCT00717808|Tranilast|tranilast
580262|NCT00717808|Rheumatoid Arthritis|rheumatoid arthritis
580263|NCT00717808|Pharmacokinetics|pharmacokinetics
580264|NCT00717808|Methotrexate|methotrexate
580265|NCT00717795|Survivor|survivor
580266|NCT00717795|Physical Activity|physical activity
580267|NCT00717795|NED|ned
580268|NCT00717795|08-067|08-067
580269|NCT00717782|botulinum toxin|botulinum toxin
580270|NCT00717782|thrombosed external haemorrhoids|thrombosed external haemorrhoids
580271|NCT00717782|pain|pain
580272|NCT00717769|Atopic Dermatitis|atopic dermatitis
580273|NCT00717756|liver cancer, second line|liver cancer, second line
580274|NCT00717743|RCC|rcc
580275|NCT00717743|patients|patients
580276|NCT00717743|scheduled|scheduled
580277|NCT00717743|nephrectomy|nephrectomy
580278|NCT00717730|Nutrition|nutrition
580279|NCT00717730|Children|children
580280|NCT00717730|Folate|folate
580281|NCT00717730|Vitamin B12|vitamin b12
580282|NCT00717730|India|india
580283|NCT00717730|Homocysteine|homocysteine
580284|NCT00717730|Methyl Malonic Acid|methyl malonic acid
580285|NCT00717717|Cancer Survivor|cancer survivor
580286|NCT00717717|Physical Activity|physical activity
580287|NCT00717717|Health Behavior|health behavior
580288|NCT00717717|Psychosocial Well-being|psychosocial well-being
580289|NCT00717717|Coaching|coaching
580290|NCT00717717|Long Term|long term
580291|NCT00717717|Consequences|consequences
580292|NCT00717717|Chemotherapy|chemotherapy
580293|NCT00717717|Motivation|motivation
580294|NCT00717704|Malignant solid tumor|malignant solid tumor
580295|NCT00717704|Phase 1|phase 1
580296|NCT00717704|Dose escalation|dose escalation
580297|NCT00717704|Metastatic or locally advanced/unresectable|metastatic or locally advanced/unresectable
580298|NCT00717704|Disease progression through standard therapy|disease progression through standard therapy
580299|NCT00717691|Hallux Limitus|hallux limitus
580300|NCT00717691|Dynamic Splinting|dynamic splinting
580301|NCT00717691|Dynasplint|dynasplint
580302|NCT00717678|Immunosuppressant|immunosuppressant
580303|NCT00717678|Combination drug therapy|combination drug therapy
580304|NCT00717678|Graft loss|graft loss
580305|NCT00717678|Randomized controlled trial|randomized controlled trial
580306|NCT00717678|Open level method|open level method
580307|NCT00717665|Hypertension|hypertension
580308|NCT00717665|Telemanagement|telemanagement
580309|NCT00717665|Home blood pressure monitoring|home blood pressure monitoring
580310|NCT00717665|Self care|self care
580311|NCT00717639|diagnostic accuracy|diagnostic accuracy
580312|NCT00717639|magnetic resonance angiography|magnetic resonance angiography
580313|NCT00717639|steady state|steady state
580314|NCT00717639|digital subtraction angiography|digital subtraction angiography
580315|NCT00717639|peripheral arteries|peripheral arteries
580316|NCT00717626|Hemophilia|hemophilia
580317|NCT00717626|Prophylaxis|prophylaxis
580318|NCT00717626|Youth|youth
580319|NCT00717626|Young Adults|young adults
580320|NCT00717626|Feasibility|feasibility
580321|NCT00717600|bacteriuria|bacteriuria
580322|NCT00717600|urinary tract infection|urinary tract infection
580323|NCT00717600|probiotics|probiotics
580324|NCT00717600|lactobacillus|lactobacillus
580325|NCT00717600|vagina|vagina
580326|NCT00717600|bladder|bladder
580435|NCT00717106|ILR|ilr
580327|NCT00717600|neurogenic bladder|neurogenic bladder
580328|NCT00717600|spina bifida|spina bifida
580329|NCT00717600|myelomeningocele|myelomeningocele
580330|NCT00717600|neuropathic bladder|neuropathic bladder
580331|NCT00717587|stage IV renal cell cancer|stage iv renal cell cancer
580332|NCT00717587|recurrent renal cell cancer|recurrent renal cell cancer
580333|NCT00717574|depth of sedation|depth of sedation
580334|NCT00717574|nitrous oxide|nitrous oxide
580335|NCT00717574|general anesthesia|general anesthesia
580336|NCT00717574|anesthesia indices|anesthesia indices
580337|NCT00717561|CAP|cap
580338|NCT00717561|Community-acquired pneumonia|community-acquired pneumonia
580339|NCT00717548|Somatic Complaints|somatic complaints
580340|NCT00717535|health status unknown|health status unknown
580341|NCT00717522|Soft Tissue Sarcoma|soft tissue sarcoma
580342|NCT00717522|CC-4047|cc-4047
580343|NCT00717522|Pomalidomide|pomalidomide
580344|NCT00717509|schizophrenia|schizophrenia
580345|NCT00717509|metabolic side effect|metabolic side effect
580346|NCT00717509|clozapine|clozapine
580347|NCT00717509|genetic polymorphism|genetic polymorphism
580348|NCT00717496|Breastfeeding|breastfeeding
580349|NCT00717496|Telephone Support|telephone support
580350|NCT00717496|Latino|latino
580351|NCT00717470|Kidney|kidney
580352|NCT00717470|Prograf|prograf
580353|NCT00717470|Transplant|transplant
580354|NCT00717470|Advagraf|advagraf
580355|NCT00717470|Immunosuppression|immunosuppression
580356|NCT00717470|FK506|fk506
580357|NCT00717444|Substance Abuse|substance abuse
580358|NCT00717444|HIV|hiv
580359|NCT00717444|Contingency Management|contingency management
580360|NCT00717444|Physical Activity|physical activity
580361|NCT00717431|Deep Brain Stimulation|deep brain stimulation
580362|NCT00717431|Seizures|seizures
580363|NCT00717431|Epilepsy|epilepsy
580364|NCT00717392|ADHD|adhd
580365|NCT00717392|ASD|asd
580366|NCT00717379|Organ Transplantation|organ transplantation
580367|NCT00717379|Tacrolimus|tacrolimus
580368|NCT00717379|Prograf|prograf
580369|NCT00717379|Kidney|kidney
580370|NCT00717379|Immunosuppression|immunosuppression
580371|NCT00717340|tivozanib|tivozanib
580372|NCT00717340|AV-951|av-951
580373|NCT00717327|MRL|mrl
580374|NCT00717327|Adolescents|adolescents
580375|NCT00717327|Health Literacy|health literacy
580376|NCT00717301|TBI, traumatic brain injury, S100B, head CT scan|tbi, traumatic brain injury, s100b, head ct scan
580377|NCT00717288|diabetes|diabetes
580378|NCT00717288|hyperglycemia|hyperglycemia
580379|NCT00717288|open heart surgery|open heart surgery
580380|NCT00717288|cardiothoracic surgery|cardiothoracic surgery
580381|NCT00717288|detemir|detemir
580382|NCT00717288|insulin infusion|insulin infusion
580383|NCT00717288|intravenous insulin|intravenous insulin
580384|NCT00717275|Brain Metastases|brain metastases
580385|NCT00717275|Temozolomide|temozolomide
580386|NCT00717275|Temodar|temodar
580387|NCT00717275|TMZ|tmz
580388|NCT00717275|Stereotactic Radiosurgery|stereotactic radiosurgery
580389|NCT00717275|SRS|srs
580390|NCT00717236|Certolizumab pegol|certolizumab pegol
580391|NCT00717236|Cimzia|cimzia
580392|NCT00717236|Rheumatoid Arthritis|rheumatoid arthritis
580393|NCT00717236|Joint Disease|joint disease
580394|NCT00717236|Chronic Arthritis|chronic arthritis
580395|NCT00717223|Diabetes|diabetes
580396|NCT00717223|Type 1 diabetes mellitus|type 1 diabetes mellitus
580397|NCT00717223|Type 2 diabetes mellitus|type 2 diabetes mellitus
580398|NCT00717223|Literacy|literacy
580399|NCT00717223|Glycemic control|glycemic control
580400|NCT00717210|1p/19q loss|1p/19q loss
580401|NCT00717210|MGMT|mgmt
580402|NCT00717210|prognostic factors|prognostic factors
580403|NCT00717210|PCV|pcv
580404|NCT00717210|temozolomide|temozolomide
580405|NCT00717197|HGG|hgg
580406|NCT00717197|anaplastic astrocytoma|anaplastic astrocytoma
580407|NCT00717197|anaplastic oligodendroglioma|anaplastic oligodendroglioma
580408|NCT00717197|anaplastic mixed glioma|anaplastic mixed glioma
580409|NCT00717197|glioblastoma multiforme|glioblastoma multiforme
580411|NCT00717197|Xeloda|xeloda
580412|NCT00717197|capecitabine|capecitabine
580413|NCT00717171|electrical stimulation|electrical stimulation
580414|NCT00717171|pain|pain
580415|NCT00717171|medication|medication
580416|NCT00717171|edema|edema
580417|NCT00717171|interferential|interferential
580418|NCT00717171|neuromuscular|neuromuscular
580419|NCT00717171|high voltage pulsed current|high voltage pulsed current
580420|NCT00717171|knee|knee
580421|NCT00717158|Health Behavior|health behavior
580422|NCT00717158|Lifestyle|lifestyle
580423|NCT00717158|health care costs|health care costs
580424|NCT00717158|quality of life|quality of life
580425|NCT00717145|bioequivalence|bioequivalence
580426|NCT00717132|weight|weight
580427|NCT00717132|cost effectiveness|cost effectiveness
580428|NCT00717132|obesity|obesity
580429|NCT00717132|family based behavioral treatment|family based behavioral treatment
580430|NCT00717119|GI|gi
580431|NCT00717119|NSAID|nsaid
580432|NCT00717119|Complications|complications
580433|NCT00717119|Treated|treated
580434|NCT00717119|Patients|patients
580436|NCT00717106|ECG monitoring|ecg monitoring
580437|NCT00717106|cardiac arrhythmia|cardiac arrhythmia
580438|NCT00717106|syncope|syncope
580439|NCT00717106|presyncope|presyncope
580440|NCT00717106|fainting|fainting
580441|NCT00717080|Retinitis Pigmentosa|retinitis pigmentosa
580442|NCT00717080|Cataract|cataract
580443|NCT00717067|maraviroc, pharmacokinetics, renal impairment|maraviroc, pharmacokinetics, renal impairment
580444|NCT00717054|postoperative nausea and vomiting|postoperative nausea and vomiting
580445|NCT00717041|Depression|depression
580446|NCT00717041|Anxiety|anxiety
580447|NCT00717041|Cognitive Impairment|cognitive impairment
580448|NCT00717041|Emergency medicine|emergency medicine
580449|NCT00717041|prehospital care|prehospital care
580450|NCT00717028|Cerebral palsy|cerebral palsy
580451|NCT00717028|Dysphagia|dysphagia
580452|NCT00717028|Deglutition|deglutition
580453|NCT00717028|Endoscopy|endoscopy
580454|NCT00717015|Hormone Receptor Positive Breast Cancer|hormone receptor positive breast cancer
580455|NCT00716989|Cutaneous immune system|cutaneous immune system
580456|NCT00716989|innate immunity|innate immunity
580457|NCT00716989|tuberculin skin tests|tuberculin skin tests
580458|NCT00716989|intradermal vaccination|intradermal vaccination
580459|NCT00716989|pathophysiology|pathophysiology
580460|NCT00716989|Healthy subjects|healthy subjects
580461|NCT00716989|Immunosuppressed patients|immunosuppressed patients
580462|NCT00716976|ototoxicity|ototoxicity
580463|NCT00716976|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
580464|NCT00716976|childhood extracranial germ cell tumor|childhood extracranial germ cell tumor
580465|NCT00716976|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
580466|NCT00716976|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
580467|NCT00716976|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
580468|NCT00716976|childhood teratoma|childhood teratoma
580469|NCT00716976|childhood medulloblastoma|childhood medulloblastoma
580470|NCT00716976|disseminated neuroblastoma|disseminated neuroblastoma
580471|NCT00716976|regional neuroblastoma|regional neuroblastoma
580472|NCT00716976|localized resectable neuroblastoma|localized resectable neuroblastoma
580473|NCT00716976|localized unresectable neuroblastoma|localized unresectable neuroblastoma
580474|NCT00716976|stage 4S neuroblastoma|stage 4s neuroblastoma
580475|NCT00716976|localized osteosarcoma|localized osteosarcoma
580476|NCT00716976|metastatic osteosarcoma|metastatic osteosarcoma
580477|NCT00716976|childhood hepatoblastoma|childhood hepatoblastoma
580478|NCT00716976|stage I childhood liver cancer|stage i childhood liver cancer
580479|NCT00716976|stage II childhood liver cancer|stage ii childhood liver cancer
580480|NCT00716976|stage III childhood liver cancer|stage iii childhood liver cancer
580481|NCT00716976|stage IV childhood liver cancer|stage iv childhood liver cancer
580482|NCT00716963|late allergic response|late allergic response
580483|NCT00716963|fluticasone propionate|fluticasone propionate
580484|NCT00716937|pilonidal sinus|pilonidal sinus
580485|NCT00716937|karydakis|karydakis
580486|NCT00716937|laying open|laying open
580487|NCT00716911|cytomegalovirus infection|cytomegalovirus infection
580488|NCT00716911|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
580489|NCT00716911|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
580490|NCT00716911|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
580491|NCT00716911|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
580492|NCT00716911|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
580493|NCT00716911|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
580494|NCT00716911|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
580495|NCT00716911|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
580496|NCT00716911|refractory hairy cell leukemia|refractory hairy cell leukemia
580497|NCT00716911|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
580498|NCT00716911|secondary acute myeloid leukemia|secondary acute myeloid leukemia
580499|NCT00716911|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
580500|NCT00716911|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
580501|NCT00716911|splenic marginal zone lymphoma|splenic marginal zone lymphoma
580502|NCT00716911|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
580503|NCT00716911|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
580504|NCT00716911|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
580505|NCT00716911|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
580506|NCT00716911|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
580507|NCT00716911|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
580508|NCT00716911|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
580509|NCT00716911|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
580510|NCT00716911|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
580511|NCT00716911|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
580512|NCT00716911|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
580793|NCT00715858|serum|serum
580513|NCT00716911|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
580514|NCT00716911|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
580515|NCT00716911|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
580516|NCT00716911|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
580517|NCT00716911|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
580518|NCT00716911|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
580519|NCT00716911|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
580520|NCT00716911|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
580521|NCT00716911|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
580522|NCT00716911|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
580523|NCT00716911|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
580524|NCT00716911|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
580525|NCT00716911|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
580526|NCT00716911|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
580527|NCT00716911|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
580528|NCT00716911|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
580529|NCT00716911|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
580530|NCT00716911|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
580531|NCT00716911|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
580532|NCT00716911|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
580533|NCT00716911|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
580534|NCT00716911|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
580535|NCT00716911|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
580536|NCT00716911|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
580537|NCT00716911|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
580538|NCT00716911|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
580539|NCT00716911|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
580540|NCT00716911|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
580541|NCT00716911|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
580542|NCT00716911|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
580543|NCT00716911|chronic eosinophilic leukemia|chronic eosinophilic leukemia
580544|NCT00716911|chronic neutrophilic leukemia|chronic neutrophilic leukemia
580545|NCT00716911|primary myelofibrosis|primary myelofibrosis
580546|NCT00716911|stage II multiple myeloma|stage ii multiple myeloma
580547|NCT00716911|stage III multiple myeloma|stage iii multiple myeloma
580548|NCT00716911|refractory multiple myeloma|refractory multiple myeloma
580549|NCT00716911|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
580550|NCT00716911|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
580551|NCT00716911|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
580552|NCT00716911|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
580553|NCT00716911|stage I multiple myeloma|stage i multiple myeloma
580554|NCT00716898|Condition|condition
580555|NCT00716898|Cancer|cancer
580556|NCT00716898|Patients|patients
580557|NCT00716898|Thrombosis|thrombosis
580558|NCT00716898|Unstable|unstable
580559|NCT00716898|Angina|angina
580560|NCT00716898|Pectoris|pectoris
580561|NCT00716885|Heart failure|heart failure
580562|NCT00716885|Oxidative stress|oxidative stress
580563|NCT00716885|Endothelial Progenitor Cells|endothelial progenitor cells
580564|NCT00716885|White blood cells|white blood cells
580565|NCT00716872|cancer|cancer
580566|NCT00716872|sleep|sleep
580567|NCT00716872|insomnia|insomnia
580568|NCT00716872|Internet|internet
580569|NCT00716872|SHUTi|shuti
580570|NCT00716833|pain|pain
580571|NCT00716833|coxibe|coxibe
580572|NCT00716833|preemptive|preemptive
580573|NCT00716833|abdominothoracic|abdominothoracic
580574|NCT00716833|sensibilisation|sensibilisation
580575|NCT00716833|Analgesia|analgesia
580576|NCT00716807|BMS|bms
580577|NCT00716807|TMD|tmd
580578|NCT00716794|Prostate cancer|prostate cancer
580579|NCT00716794|HE3235|he3235
580580|NCT00716794|Apoptone|apoptone
580581|NCT00716781|Group B streptococcus|group b streptococcus
580582|NCT00716781|Sepsis|sepsis
580583|NCT00716781|Infants|infants
580584|NCT00716781|Diagnosis|diagnosis
580585|NCT00716781|Physical examination|physical examination
580586|NCT00716781|Laboratory tests|laboratory tests
580587|NCT00716768|Laparoscopic|laparoscopic
580588|NCT00716768|Inguinal Hernia|inguinal hernia
580589|NCT00716768|Infants|infants
580590|NCT00716755|Positron emission tomography|positron emission tomography
580591|NCT00716755|antipsychotics|antipsychotics
580592|NCT00716755|risperidone|risperidone
580593|NCT00716755|olanzapine|olanzapine
580594|NCT00716755|Dopamine|dopamine
580595|NCT00716755|D2 receptor|d2 receptor
580596|NCT00716755|elderly|elderly
580597|NCT00716755|schizophrenia|schizophrenia
580598|NCT00716755|schizoaffective disorder|schizoaffective disorder
580599|NCT00716755|schizophreniform disorder|schizophreniform disorder
580600|NCT00716755|delusional disorder|delusional disorder
580601|NCT00716755|psychotic disorder NOS|psychotic disorder nos
580602|NCT00716729|Questionnaire|questionnaire
580603|NCT00716729|Hip|hip
580604|NCT00716729|Groin|groin
580605|NCT00716729|Disability|disability
580606|NCT00716729|Strength|strength
580607|NCT00716729|To develop two new outcome measures for patients with hip and groin disability|to develop two new outcome measures for patients with hip and groin disability
580608|NCT00716716|Hemophilia B severe, previously treated patients|hemophilia b severe, previously treated patients
580609|NCT00716703|Appendicitis|appendicitis
580610|NCT00716703|Computed tomography|computed tomography
580611|NCT00716703|pediatric|pediatric
580612|NCT00716703|child|child
580613|NCT00716703|sensitivity|sensitivity
580614|NCT00716703|specificity|specificity
580615|NCT00716703|contrast administration route|contrast administration route
580616|NCT00716703|time factors|time factors
580617|NCT00716690|Stem cell transplantation|stem cell transplantation
580618|NCT00716690|GVHD|gvhd
580619|NCT00716677|difficult asthma|difficult asthma
580620|NCT00716677|respiratory inductance plethysmography|respiratory inductance plethysmography
580621|NCT00716664|cystic fibrosis|cystic fibrosis
580622|NCT00716664|musculoskeletal|musculoskeletal
580623|NCT00716664|exercise capacity|exercise capacity
580624|NCT00716664|posture|posture
580625|NCT00716664|lung function|lung function
580626|NCT00716664|physical functioning|physical functioning
580627|NCT00716612|Coenzyme Q 10|coenzyme q 10
580628|NCT00716612|Statin|statin
580629|NCT00716612|Myalgia|myalgia
580630|NCT00716599|malaria|malaria
580631|NCT00716599|diagnosis|diagnosis
580632|NCT00716599|rapid diagnostic test|rapid diagnostic test
580633|NCT00716599|rapid diagnostic tests|rapid diagnostic tests
580634|NCT00716599|fever case management|fever case management
580635|NCT00716599|training|training
580636|NCT00716599|fever case management in malaria-endemic areas|fever case management in malaria-endemic areas
580637|NCT00716573|Cardiac transplantation|cardiac transplantation
580638|NCT00716573|Chronic renal insufficiency|chronic renal insufficiency
580639|NCT00716573|Everolimus|everolimus
580640|NCT00716521|mobile actigraphy inpatient polysomnography actigraphy ambien|mobile actigraphy inpatient polysomnography actigraphy ambien
580641|NCT00716508|Patella tendon rupute, suture anchors, repair patella tendon|patella tendon rupute, suture anchors, repair patella tendon
580642|NCT00716482|breast|breast
580643|NCT00716482|lesion|lesion
580644|NCT00716482|ultrasound|ultrasound
580645|NCT00716482|BI-RADS|bi-rads
580646|NCT00716482|malignancy|malignancy
580647|NCT00716482|women|women
580648|NCT00716469|Neurofibroma|neurofibroma
580649|NCT00716469|Plexiform|plexiform
580650|NCT00716469|NF1|nf1
580651|NCT00716469|Photo dynamic therapy|photo dynamic therapy
580652|NCT00716456|MAB C225(CETUXIMAB)(ANTI-EGFR)|mab c225(cetuximab)(anti-egfr)
580653|NCT00716456|OSI-774, TARCEVA (ERLOTINIB)|osi-774, tarceva (erlotinib)
580654|NCT00716456|Lung|lung
580655|NCT00716456|Adenocarcinoma|adenocarcinoma
580656|NCT00716456|Lung cancer|lung cancer
580657|NCT00716443|Nasolabial folds|nasolabial folds
580658|NCT00716443|wrinkles|wrinkles
580659|NCT00716443|topical anesthetic|topical anesthetic
580660|NCT00716430|acute coronary syndromes|acute coronary syndromes
580661|NCT00716430|quality improvement|quality improvement
580662|NCT00716404|FlowMedica|flowmedica
580663|NCT00716404|Benephit|benephit
580664|NCT00716404|TRT|trt
580665|NCT00716404|Patients|patients
580666|NCT00716404|Components|components
580667|NCT00716404|Benephit Infusion System|benephit infusion system
580668|NCT00716404|Planned|planned
580669|NCT00716404|To be used|to be used
580670|NCT00716391|Head and Neck Cancer|head and neck cancer
580671|NCT00716378|Simulated Driving|simulated driving
580672|NCT00716378|Risky Driving Behavior|risky driving behavior
580673|NCT00716378|Social Influences|social influences
580674|NCT00716365|angiography|angiography
580675|NCT00716365|hemostasis|hemostasis
580676|NCT00716365|femoral artery|femoral artery
580677|NCT00716365|duplex|duplex
580678|NCT00716352|non-ST elevation acute coronary syndrome|non-st elevation acute coronary syndrome
580679|NCT00716352|educational intervention|educational intervention
580680|NCT00716352|evidence based practice|evidence based practice
580681|NCT00716352|guidelines|guidelines
580682|NCT00716339|pseudophakic accommodation|pseudophakic accommodation
580683|NCT00716326|Transcutaneous Electrical Nerve Stimulation|transcutaneous electrical nerve stimulation
580684|NCT00716326|Chronic pain|chronic pain
580685|NCT00716326|Neuropathic pain|neuropathic pain
580686|NCT00716326|Short-term efficacy|short-term efficacy
580687|NCT00716326|Long-term efficacy|long-term efficacy
580688|NCT00716300|obesity|obesity
580689|NCT00716300|CVD|cvd
580690|NCT00716300|HDL kinetics|hdl kinetics
580691|NCT00716300|Anti-inflammatory and anti-oxidation studies|anti-inflammatory and anti-oxidation studies
580692|NCT00716300|30 subjects recruited (15 MetS and 15 lean controls)|30 subjects recruited (15 mets and 15 lean controls)
580693|NCT00716261|Parkinson's disease|parkinson's disease
580694|NCT00716261|Audio feedback|audio feedback
580695|NCT00716261|postural control|postural control
580696|NCT00716235|ADHD|adhd
580697|NCT00716235|ASD|asd
580698|NCT00716235|PDD|pdd
580699|NCT00716235|DCD|dcd
580700|NCT00716235|Executive Functions|executive functions
580701|NCT00716196|thin prep|thin prep
580702|NCT00716196|EUS|eus
580703|NCT00716183|mastitis|mastitis
580704|NCT00716183|Staphylococcus|staphylococcus
580705|NCT00716183|Streptococcus|streptococcus
580706|NCT00716183|lactation|lactation
580707|NCT00716183|breastfeeding|breastfeeding
580708|NCT00716170|Diabetes Mellitus|diabetes mellitus
580709|NCT00716170|Glucagon|glucagon
580710|NCT00716170|Insulin|insulin
580711|NCT00716170|Incretin hormones|incretin hormones
580712|NCT00716170|Glucose-dependent insulinotropic polypeptide|glucose-dependent insulinotropic polypeptide
580713|NCT00716170|Glucagon-like peptide-1|glucagon-like peptide-1
580714|NCT00716170|Glucagon-like peptide-2|glucagon-like peptide-2
580715|NCT00716144|Psoriasis|psoriasis
580716|NCT00716131|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
580717|NCT00716131|Cerebrospinal Fluid|cerebrospinal fluid
580718|NCT00716131|Neurodegenerative Disease|neurodegenerative disease
580719|NCT00716131|Motor Neuron Disease|motor neuron disease
580720|NCT00716131|Autonomic Nervous System|autonomic nervous system
580721|NCT00716131|Neurodegenerative Diseases|neurodegenerative diseases
580722|NCT00716131|Movement Disorders|movement disorders
580723|NCT00716118|Oocyte Cryopreservation|oocyte cryopreservation
580724|NCT00716118|Slow-Freeze|slow-freeze
580725|NCT00716118|Egg Freezing|egg freezing
580726|NCT00716118|Meiotic Spindle|meiotic spindle
580727|NCT00716118|Mitochondria|mitochondria
580728|NCT00716118|Human Oocytes Freezing.|human oocytes freezing.
580729|NCT00716105|Infant formula|infant formula
580730|NCT00716105|Protein metabolism|protein metabolism
580731|NCT00716079|Cerebral Hemorrhage|cerebral hemorrhage
580732|NCT00716079|Stroke|stroke
580733|NCT00716079|antihypertensive drugs|antihypertensive drugs
580734|NCT00716079|blood pressure|blood pressure
580735|NCT00716079|disability|disability
580736|NCT00716079|clinical trial|clinical trial
580737|NCT00716079|outcomes|outcomes
580738|NCT00716053|emphysema|emphysema
580739|NCT00716053|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
580740|NCT00716053|COPD|copd
580741|NCT00716053|lung volume reduction|lung volume reduction
580742|NCT00716053|LVRS|lvrs
580743|NCT00716053|BLVR|blvr
580744|NCT00716053|Aeris|aeris
580745|NCT00716040|AIDS treatment|aids treatment
580746|NCT00716040|HAART adherence|haart adherence
580747|NCT00716040|intervention|intervention
580748|NCT00716014|Pachyonychia Congenita|pachyonychia congenita
580749|NCT00716014|siRNA|sirna
580750|NCT00716001|patients with chronic renal failure undergoing elective percutaneous coronary intervention|patients with chronic renal failure undergoing elective percutaneous coronary intervention
580751|NCT00715988|Methadone|methadone
580752|NCT00715988|analgesia|analgesia
580753|NCT00715988|newborns|newborns
580754|NCT00715988|QT prolongation|qt prolongation
580755|NCT00715988|Young Infants|young infants
580756|NCT00715975|clobetasol|clobetasol
580757|NCT00715975|halobetasol|halobetasol
580758|NCT00715975|psoriasis|psoriasis
580759|NCT00715975|evaluating the efficacy and tolerability of the drug Halobetasol propionate|evaluating the efficacy and tolerability of the drug halobetasol propionate
580760|NCT00715962|Hospitalization|hospitalization
580761|NCT00715962|Aged|aged
580762|NCT00715949|traumatic brain injury|traumatic brain injury
580763|NCT00715949|pediatric|pediatric
580764|NCT00715949|neurocognitive|neurocognitive
580765|NCT00715949|concussion|concussion
580766|NCT00715936|Integrated early child development, growth and health|integrated early child development, growth and health
580767|NCT00715936|Psychosocial stimulation|psychosocial stimulation
580768|NCT00715936|Care for child development|care for child development
580769|NCT00715923|informed consent document|informed consent document
580770|NCT00715923|ethics|ethics
580771|NCT00715910|Meningococcal vaccine|meningococcal vaccine
580772|NCT00715910|Booster vaccination|booster vaccination
580773|NCT00715910|Immunogenicity|immunogenicity
580774|NCT00715910|Meningococcal disease|meningococcal disease
580775|NCT00715910|Safety|safety
580776|NCT00715897|chronic neurological deficient due to stroke|chronic neurological deficient due to stroke
580777|NCT00715884|Atherosclerosis|atherosclerosis
580778|NCT00715884|de novo native coronary lesion|de novo native coronary lesion
580779|NCT00715871|smoking|smoking
580780|NCT00715871|smoke cessation|smoke cessation
580781|NCT00715871|stop smoking|stop smoking
580782|NCT00715871|quit smoking|quit smoking
580783|NCT00715871|nicotine replacement therapy|nicotine replacement therapy
580784|NCT00715871|Smoke Break|smoke break
580785|NCT00715871|liquid cigarette|liquid cigarette
580786|NCT00715871|liquid nicotine cigarette|liquid nicotine cigarette
580787|NCT00715858|Alzheimer's disease|alzheimer's disease
580788|NCT00715858|dementia|dementia
580789|NCT00715858|inflammation|inflammation
580790|NCT00715858|cytokine|cytokine
580791|NCT00715858|biomarker|biomarker
580792|NCT00715858|cerebrospinal fluid|cerebrospinal fluid
580796|NCT00715845|cardiovascular disease|cardiovascular disease
580797|NCT00715845|embolism|embolism
580798|NCT00715845|microemboli|microemboli
580799|NCT00715845|cognitive decline|cognitive decline
580800|NCT00715845|mitral valve repair|mitral valve repair
580801|NCT00715845|cerebral microemboli|cerebral microemboli
580802|NCT00715845|coronary artery bypass graft|coronary artery bypass graft
580803|NCT00715845|CABG|cabg
580804|NCT00715845|transcranial doppler|transcranial doppler
580805|NCT00715845|transesophageal echocardiogram|transesophageal echocardiogram
580806|NCT00715845|magnetic resonance imaging|magnetic resonance imaging
580807|NCT00715845|carbon dioxide|carbon dioxide
580808|NCT00715832|Breast cancer|breast cancer
580809|NCT00715832|Dendritic cell vaccine|dendritic cell vaccine
580810|NCT00715832|OFA/iLRP|ofa/ilrp
580811|NCT00715832|Patients|patients
580812|NCT00715832|Line|line
580813|NCT00715832|Chemotherapy|chemotherapy
580814|NCT00715832|Setting|setting
580815|NCT00715832|Four different lines|four different lines
580816|NCT00715806|claustrophobia|claustrophobia
580817|NCT00715806|magnetic resonance imaging|magnetic resonance imaging
580818|NCT00715806|MRI|mri
580819|NCT00715806|anxiety|anxiety
580820|NCT00715806|open design|open design
580821|NCT00715806|severely anxious patients|severely anxious patients
580822|NCT00715793|Decitabine|decitabine
580823|NCT00715793|Temozolomide|temozolomide
580824|NCT00715793|Metastatic|metastatic
580825|NCT00715793|Melanoma|melanoma
580826|NCT00715793|Non-resectable|non-resectable
580827|NCT00715793|Stage IIIB melanoma|stage iiib melanoma
580828|NCT00715793|stage IV melanoma|stage iv melanoma
580829|NCT00715793|TMZ|tmz
580830|NCT00715793|DTIC|dtic
580831|NCT00715793|promoter methylation|promoter methylation
580832|NCT00715793|skin cancer|skin cancer
580833|NCT00715793|chemotherapy|chemotherapy
580834|NCT00715767|BLS training|bls training
580835|NCT00715767|CPR|cpr
580836|NCT00715767|post graduate education|post graduate education
580837|NCT00715767|resource-limited settings|resource-limited settings
580838|NCT00715767|medical education|medical education
580839|NCT00715767|CPR retention|cpr retention
580840|NCT00715767|cultural barriers|cultural barriers
580841|NCT00715741|atelectasis|atelectasis
580842|NCT00715741|oxygen|oxygen
580843|NCT00715741|saturation|saturation
580844|NCT00715728|Plastic surgery|plastic surgery
580845|NCT00715728|Warming|warming
580846|NCT00715728|Core temperature|core temperature
580847|NCT00715728|Bair Hugger|bair hugger
580848|NCT00715728|Hot Dog heating system|hot dog heating system
580849|NCT00715715|Hepatitis B e Antigen|hepatitis b e antigen
580850|NCT00715715|HBeAg-positive chronic hepatitis B|hbeag-positive chronic hepatitis b
580851|NCT00715702|AZD5672|azd5672
580852|NCT00715676|Osteoporosis|osteoporosis
580853|NCT00715676|2-methylene-19-nor-(20S)-1a, 25-dihydroxyvitamin D3|2-methylene-19-nor-(20s)-1a, 25-dihydroxyvitamin d3
580854|NCT00715676|Vitamin D|vitamin d
580855|NCT00715676|Bone Density Conservation Agents|bone density conservation agents
580856|NCT00715676|Bone Regeneration|bone regeneration
580857|NCT00715650|Rehabilitation, Vocational|rehabilitation, vocational
580858|NCT00715650|Compensation and Redress|compensation and redress
580859|NCT00715650|disability evaluation|disability evaluation
580860|NCT00715637|AML|aml
580861|NCT00715637|Leukemia|leukemia
580862|NCT00715637|MDS|mds
580863|NCT00715637|Amonafide|amonafide
580864|NCT00715637|Cytarabine|cytarabine
580865|NCT00715637|Daunorubicin|daunorubicin
580866|NCT00715637|Lymphatic disorders|lymphatic disorders
580867|NCT00715624|hyperglycemia, GLP-1, metformin, insulin|hyperglycemia, glp-1, metformin, insulin
580868|NCT00715611|pemetrexed|pemetrexed
580869|NCT00715611|cisplatin|cisplatin
580870|NCT00715611|IMRT|imrt
580871|NCT00715611|PLEURA|pleura
580872|NCT00715611|Malignant|malignant
580873|NCT00715611|08-053|08-053
580874|NCT00715598|Pain Assessment|pain assessment
580875|NCT00715598|Measurement|measurement
580876|NCT00715585|diabetes|diabetes
580877|NCT00715585|education|education
580878|NCT00715585|health literacy|health literacy
580879|NCT00715572|hypothyroidism, treatment, thyroxine, triiodothyronine|hypothyroidism, treatment, thyroxine, triiodothyronine
580880|NCT00715559|Major depressive disorder, depression|major depressive disorder, depression
580881|NCT00715559|neurotrophic|neurotrophic
580882|NCT00715559|brain-derived neurotrophic factor|brain-derived neurotrophic factor
580883|NCT00715559|antidepressant|antidepressant
580884|NCT00715559|cysteamine|cysteamine
580885|NCT00715546|Adipose-derived stem cell|adipose-derived stem cell
580886|NCT00715546|Lipodystrophy|lipodystrophy
580887|NCT00715533|acute (< 24 hours) stroke|acute (< 24 hours) stroke
580888|NCT00715533|stroke|stroke
580890|NCT00715533|MRI|mri
580891|NCT00715533|imaging|imaging
580892|NCT00715533|acute|acute
580893|NCT00715520|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
580894|NCT00715520|Rehabilitation|rehabilitation
580895|NCT00715520|Stroke|stroke
580896|NCT00715520|Plasticity|plasticity
580897|NCT00715507|decision making|decision making
580898|NCT00715507|graphic display|graphic display
582460|NCT00709748|Empi|empi
580899|NCT00715494|brain injuries, dementia, myopathies, muscle disorders|brain injuries, dementia, myopathies, muscle disorders
580900|NCT00715481|Type 2 diabetes|type 2 diabetes
580901|NCT00715481|Cardiovascular disease|cardiovascular disease
580902|NCT00715481|Diabetic Nephropathy|diabetic nephropathy
580903|NCT00715481|Glomerular filtration rate|glomerular filtration rate
580904|NCT00715481|Albuminuria|albuminuria
580905|NCT00715455|CAD|cad
580906|NCT00715455|PCI|pci
580907|NCT00715455|ANTICOAGULANT|anticoagulant
580908|NCT00715442|Kidney|kidney
580909|NCT00715442|Renal Cell Carcinoma|renal cell carcinoma
580910|NCT00715442|RCC|rcc
580911|NCT00715442|Sutent|sutent
580912|NCT00715442|Sunitinib malate|sunitinib malate
580913|NCT00715442|Clear cell|clear cell
580914|NCT00715442|SU011248|su011248
580915|NCT00715442|Nephrectomy|nephrectomy
580916|NCT00715442|Surgical removal of kidney|surgical removal of kidney
580917|NCT00715442|Cytoreductive nephrectomy|cytoreductive nephrectomy
580918|NCT00715429|leg cramps|leg cramps
580919|NCT00715429|vitamin D deficiency|vitamin d deficiency
580920|NCT00715416|peripheral vascular diseases|peripheral vascular diseases
580921|NCT00715416|Intermittent Claudication|intermittent claudication
580922|NCT00715416|Angioplasty|angioplasty
580923|NCT00715390|Children|children
580924|NCT00715390|Cardiac Arrhythmia|cardiac arrhythmia
580925|NCT00715390|General Anesthesia|general anesthesia
580926|NCT00715377|benztropine|benztropine
580927|NCT00715377|Anticholinergic antiparkinsonian agents|anticholinergic antiparkinsonian agents
580928|NCT00715377|antipsychotics|antipsychotics
580929|NCT00715377|elderly population|elderly population
580930|NCT00715377|side-effects|side-effects
580931|NCT00715338|Exhaled Breath Condensate|exhaled breath condensate
580932|NCT00715338|elective surgery|elective surgery
580933|NCT00715338|mechanical ventilation|mechanical ventilation
580934|NCT00715338|Isofurans|isofurans
580935|NCT00715338|thrombomodulin|thrombomodulin
580936|NCT00715338|requiring|requiring
580937|NCT00715338|mechanical|mechanical
580938|NCT00715338|ventilation|ventilation
580939|NCT00715325|colonoscopy|colonoscopy
580940|NCT00715325|disposable|disposable
580941|NCT00715325|single use|single use
580942|NCT00715312|Inflammation|inflammation
580943|NCT00715312|LDL|ldl
580944|NCT00715312|Oleic acid|oleic acid
580945|NCT00715312|Palmitic acid|palmitic acid
580946|NCT00715312|trans fatty acid|trans fatty acid
580947|NCT00715312|C-reactive protein|c-reactive protein
580948|NCT00715286|epithelial ovarian cancer|epithelial ovarian cancer
580949|NCT00715286|neoadjuvant chemotherapy|neoadjuvant chemotherapy
580950|NCT00715286|randomized study|randomized study
580951|NCT00715273|Magnetic Resonance Imaging|magnetic resonance imaging
580952|NCT00715273|Atherosclerotic Plaque|atherosclerotic plaque
580953|NCT00715273|Lipid Lowering Therapy|lipid lowering therapy
580954|NCT00715247|Myeloproliferative Disorders|myeloproliferative disorders
580955|NCT00715247|Hematological Malignancies|hematological malignancies
580956|NCT00715247|Polycythemia Vera|polycythemia vera
580957|NCT00715247|Essential Thrombocythemia|essential thrombocythemia
580958|NCT00715247|Myelofibrosis|myelofibrosis
580959|NCT00715247|Genetics|genetics
580960|NCT00715247|Chronic Leukemia|chronic leukemia
580961|NCT00715234|adolescent reminder/recall|adolescent reminder/recall
580962|NCT00715234|adolescent vaccines|adolescent vaccines
580963|NCT00715234|Tdap|tdap
580964|NCT00715234|Meningococcal|meningococcal
580965|NCT00715234|HPV|hpv
580966|NCT00715234|Reminder cards|reminder cards
580967|NCT00715234|Recall messages|recall messages
580968|NCT00715234|vaccine|vaccine
580969|NCT00715234|conjugate|conjugate
580970|NCT00715221|Diabetes|diabetes
580971|NCT00715195|Cognitive behavioral|cognitive behavioral
580972|NCT00715195|Long-term study|long-term study
580973|NCT00715195|Education|education
580974|NCT00715182|Renal Cell Cancer|renal cell cancer
580975|NCT00715156|allergy, peach, birch|allergy, peach, birch
580976|NCT00715156|recombinants allergens diagnosis|recombinants allergens diagnosis
580977|NCT00715156|OAS|oas
580978|NCT00715156|LTP|ltp
580979|NCT00715156|systemic reactions|systemic reactions
580980|NCT00715156|subjects with severe reaction to other fruits|subjects with severe reaction to other fruits
580981|NCT00715143|hip|hip
580982|NCT00715143|replacement|replacement
580983|NCT00715143|ceramic|ceramic
580984|NCT00715143|orthopaedic|orthopaedic
580985|NCT00715143|joint|joint
580986|NCT00715143|degenerative|degenerative
580987|NCT00715143|non-inflammatory|non-inflammatory
580988|NCT00715143|osteoarthritis|osteoarthritis
580989|NCT00715143|avascular necrosis|avascular necrosis
580990|NCT00715143|congenital hip dysplasia|congenital hip dysplasia
580991|NCT00715143|traumatic arthritis|traumatic arthritis
580992|NCT00715130|Energy|energy
580993|NCT00715130|Obesity|obesity
580994|NCT00715130|Energy Balance|energy balance
580995|NCT00715130|Physical Activity|physical activity
580996|NCT00715130|Dietary Intake|dietary intake
580997|NCT00715130|Overweight|overweight
580998|NCT00715130|Sedentary|sedentary
580999|NCT00715130|Worksite|worksite
581000|NCT00715130|Body Mass Index|body mass index
582566|NCT00709397|raltegravir|raltegravir
581001|NCT00715130|Weight Maintenance|weight maintenance
581002|NCT00715117|children|children
581003|NCT00715117|pediatric|pediatric
581004|NCT00715117|Crohn's Disease|crohn's disease
581005|NCT00715117|naltrexone|naltrexone
581006|NCT00715117|LDN|ldn
581007|NCT00715117|IBD|ibd
581008|NCT00715117|Inflammatory bowel disease|inflammatory bowel disease
581009|NCT00715091|NSAIDS|nsaids
581010|NCT00715091|ankylosing spondylitis|ankylosing spondylitis
581011|NCT00715091|SpA|spa
581012|NCT00715091|Spondyloarthritis|spondyloarthritis
581013|NCT00715091|radiographic changes|radiographic changes
581014|NCT00715078|prostate cancer|prostate cancer
581015|NCT00715078|prostate|prostate
581016|NCT00715078|immune therapy|immune therapy
581017|NCT00715078|immunotherapy|immunotherapy
581018|NCT00715078|vaccine|vaccine
581019|NCT00715078|dendritic cells|dendritic cells
581020|NCT00715078|antigen-presenting cells|antigen-presenting cells
581021|NCT00715078|antigen presenting cells|antigen presenting cells
581022|NCT00715078|cancer vaccine|cancer vaccine
581023|NCT00715078|prostate specific antigen (PSA)|prostate specific antigen (psa)
581024|NCT00715078|prostatic adenocarcinoma|prostatic adenocarcinoma
581025|NCT00715065|syncope|syncope
581026|NCT00715065|faint|faint
581027|NCT00715065|blood|blood
581028|NCT00715065|blood injury phobia|blood injury phobia
581029|NCT00715065|phobia|phobia
581030|NCT00715052|neurologic deficiency due traumatic brain injury|neurologic deficiency due traumatic brain injury
581031|NCT00715039|generalized anxiety disorder|generalized anxiety disorder
581032|NCT00715039|onset of efficacy|onset of efficacy
581033|NCT00715039|Daily Assessment of Symptoms-Anxiety (DAS-A)|daily assessment of symptoms-anxiety (das-a)
581034|NCT00715039|Methods|methods
581035|NCT00715026|Arthritis|arthritis
581036|NCT00715026|Total Hip|total hip
581037|NCT00715026|Ceramic|ceramic
581038|NCT00715026|Hip Replacement|hip replacement
581039|NCT00715026|Total Hip Arthroplasty (THA)|total hip arthroplasty (tha)
581040|NCT00715026|Joint Disease|joint disease
581041|NCT00715013|recurrent Glioblastoma|recurrent glioblastoma
581042|NCT00715000|Preterm babies hydration|preterm babies hydration
581043|NCT00715000|Oral rehydration solution|oral rehydration solution
581044|NCT00715000|Continuous gastric drip|continuous gastric drip
581045|NCT00715000|Fluid therapy|fluid therapy
581046|NCT00715000|Premature babies comfort|premature babies comfort
581047|NCT00715000|Infant care|infant care
581048|NCT00715000|Technical challenge for the nurses/doctors in charge|technical challenge for the nurses/doctors in charge
581049|NCT00714987|ARDS|ards
581050|NCT00714987|Mechanical ventilation|mechanical ventilation
581051|NCT00714987|PEEP with low level|peep with low level
581052|NCT00714987|PEEP with high level|peep with high level
581053|NCT00714987|EVLW|evlw
581054|NCT00714987|Picco® system|picco® system
581055|NCT00714987|PaO2/FiO2 ratio|pao2/fio2 ratio
581056|NCT00714974|Neuromuscular blocking agents|neuromuscular blocking agents
581057|NCT00714974|Bispectral analysis|bispectral analysis
581058|NCT00714948|Bladder|bladder
581059|NCT00714948|Urinary|urinary
581060|NCT00714948|SORAFENIB|sorafenib
581061|NCT00714948|CISPLATIN|cisplatin
581062|NCT00714948|GEMCITABINE|gemcitabine
581063|NCT00714935|Risk Factors|risk factors
581064|NCT00714935|Risk Reduction Behavior|risk reduction behavior
581065|NCT00714935|Counseling|counseling
581066|NCT00714909|Breast cancer|breast cancer
581067|NCT00714909|Catheter related thrombosis|catheter related thrombosis
581068|NCT00714909|Diagnosis|diagnosis
581069|NCT00714909|Echography doppler|echography doppler
581070|NCT00714909|Risk factors|risk factors
581071|NCT00714896|smoking cessation|smoking cessation
581072|NCT00714896|nicotine dependence|nicotine dependence
581073|NCT00714896|stage-based intervention|stage-based intervention
581074|NCT00714896|nicotine replacement medications|nicotine replacement medications
581075|NCT00714896|counseling|counseling
581076|NCT00714896|substance abuse treatment|substance abuse treatment
581077|NCT00714883|drug-eluting stents|drug-eluting stents
581078|NCT00714883|Percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
581079|NCT00714870|BMI|bmi
581080|NCT00714870|Quality of life|quality of life
581081|NCT00714857|ICU patients|icu patients
581082|NCT00714857|Dexmedetomidine|dexmedetomidine
581083|NCT00714857|Sedation|sedation
581084|NCT00714857|Judged|judged
581085|NCT00714857|Attending|attending
581086|NCT00714857|Physician|physician
581087|NCT00714844|insulin therapy|insulin therapy
581088|NCT00714844|insulin detemir|insulin detemir
581089|NCT00714844|waist circumference|waist circumference
581090|NCT00714831|Physical activity promotion|physical activity promotion
581091|NCT00714831|Primary health care|primary health care
581092|NCT00714831|Adherence|adherence
581093|NCT00714818|Schizophrenia|schizophrenia
581094|NCT00714818|Bipolar Disorder|bipolar disorder
581095|NCT00714818|Schizoaffective disorder|schizoaffective disorder
581096|NCT00714818|Genetic Counseling|genetic counseling
581097|NCT00714818|Risk perception|risk perception
581098|NCT00714818|Stigma|stigma
581099|NCT00714818|Control|control
581100|NCT00714818|Knowledge|knowledge
581101|NCT00714818|family members|family members
581102|NCT00714818|Sibling parent or child with schizophrenia|sibling parent or child with schizophrenia
581103|NCT00714818|Sibling parent or child with bipolar disorder|sibling parent or child with bipolar disorder
581104|NCT00714818|Sibling parent or child with schizoaffective disorder|sibling parent or child with schizoaffective disorder
581105|NCT00714805|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
581106|NCT00714805|Gastric Motility|gastric motility
581107|NCT00714805|Autonomic Nervous System|autonomic nervous system
581108|NCT00714805|Neurodegenerative Diseases|neurodegenerative diseases
581109|NCT00714805|Movement Disorders|movement disorders
581110|NCT00714805|Gastrointestinal Motility|gastrointestinal motility
581111|NCT00714779|Major depressive Disorder|major depressive disorder
581112|NCT00714779|fluoxetine|fluoxetine
581113|NCT00714779|short-term psychodynamic psychotherapy|short-term psychodynamic psychotherapy
581114|NCT00714779|PET|pet
581115|NCT00714753|stage I prostate cancer|stage i prostate cancer
581116|NCT00714753|stage II prostate cancer|stage ii prostate cancer
581117|NCT00714753|adenocarcinoma of the prostate|adenocarcinoma of the prostate
581118|NCT00714740|apnea, sleep, altitude, hypoxia|apnea, sleep, altitude, hypoxia
581119|NCT00714727|migraine|migraine
581120|NCT00714727|headache|headache
581121|NCT00714727|acupuncture|acupuncture
581122|NCT00714714|acne|acne
581123|NCT00714714|irritation|irritation
581124|NCT00714714|objective sensory methods|objective sensory methods
581125|NCT00714688|Adult|adult
581126|NCT00714688|ADHD|adhd
581127|NCT00714688|Concerta|concerta
581128|NCT00714675|citrulline|citrulline
581129|NCT00714675|protein-energy malnutrition|protein-energy malnutrition
581130|NCT00714675|aged|aged
581131|NCT00714675|protein biosynthesis|protein biosynthesis
581132|NCT00714675|amino acid|amino acid
581133|NCT00714662|high flux hemodialysis|high flux hemodialysis
581134|NCT00714649|Head and Neck Squamous Cell Carcinoma treated with surgery|head and neck squamous cell carcinoma treated with surgery
581135|NCT00714649|and/or radiotherapy|and/or radiotherapy
581136|NCT00714636|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
581137|NCT00714636|Cerebrospinal Fluid|cerebrospinal fluid
581138|NCT00714636|Neurodegenerative Disease|neurodegenerative disease
581139|NCT00714636|Motor Neuron Disease|motor neuron disease
581140|NCT00714636|Autonomic Nervous System|autonomic nervous system
581141|NCT00714636|Neurodegenerative Diseases|neurodegenerative diseases
581142|NCT00714636|Movement Disorders|movement disorders
581143|NCT00714623|Coronary Artery Disease|coronary artery disease
581144|NCT00714623|Coronary Restenosis|coronary restenosis
581145|NCT00714623|Coronary Thrombosis|coronary thrombosis
581146|NCT00714623|Drug-Eluting Stents|drug-eluting stents
581147|NCT00714623|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
581148|NCT00714610|Serum metal ion concentration|serum metal ion concentration
581149|NCT00714597|Venous thrombosis|venous thrombosis
581150|NCT00714597|Primary prevention|primary prevention
581151|NCT00714584|Infusions, Intravenous|infusions, intravenous
581152|NCT00714584|Safety|safety
581153|NCT00714584|Pharmacokinetics|pharmacokinetics
581154|NCT00714584|Naltrexone|naltrexone
581155|NCT00714584|Administration, Oral|administration, oral
581156|NCT00714571|cognitive rehabilitation|cognitive rehabilitation
581157|NCT00714571|explicit memory training|explicit memory training
581158|NCT00714571|mild cognitive impairment|mild cognitive impairment
581159|NCT00714571|Alzheimer's disease|alzheimer's disease
581160|NCT00714571|traumatic brain injury|traumatic brain injury
581161|NCT00714571|veterans|veterans
581162|NCT00714558|Pharmacokinetics|pharmacokinetics
581163|NCT00714558|Administration, Oral|administration, oral
581164|NCT00714558|Naltrexone|naltrexone
581165|NCT00714558|Biological Availability|biological availability
581166|NCT00714558|Infusions, Intravenous|infusions, intravenous
581167|NCT00714558|Fentanyl|fentanyl
581168|NCT00714558|Safety|safety
581169|NCT00714558|Naloxone|naloxone
581170|NCT00714545|Coronary Artery Disease|coronary artery disease
581171|NCT00714545|Coronary Restenosis|coronary restenosis
581172|NCT00714545|Brachytherapy|brachytherapy
581173|NCT00714532|smoking cessation|smoking cessation
581174|NCT00714532|Asian American|asian american
581175|NCT00714532|Chinese American|chinese american
581176|NCT00714532|smoking reduction|smoking reduction
581177|NCT00714532|stage-based intervention|stage-based intervention
581178|NCT00714532|expert system|expert system
581179|NCT00714532|nicotine replacement|nicotine replacement
581180|NCT00714532|counseling|counseling
581181|NCT00714519|Xenaderm|xenaderm
581182|NCT00714519|partial|partial
581183|NCT00714519|thickness|thickness
581184|NCT00714519|wounds|wounds
581185|NCT00714519|Nursing Homes|nursing homes
581186|NCT00714506|obesity|obesity
581187|NCT00714506|physical activity|physical activity
581188|NCT00714506|older adults|older adults
581189|NCT00714506|functional disability|functional disability
581190|NCT00714493|rheumatoid arthritis|rheumatoid arthritis
581191|NCT00714493|remicade|remicade
581192|NCT00714493|infliximab|infliximab
581193|NCT00714493|Centocor|centocor
581194|NCT00714493|etanercept|etanercept
581195|NCT00714493|enbrel|enbrel
581196|NCT00714493|adalimumab|adalimumab
581199|NCT00714493|swollen joints|swollen joints
581200|NCT00714493|tender joints.|tender joints.
581201|NCT00714480|Thymoglobulin|thymoglobulin
581202|NCT00714480|Renal Transplant|renal transplant
581203|NCT00714480|Kidney Transplant|kidney transplant
581204|NCT00714480|Immunosuppression|immunosuppression
581205|NCT00714480|Induction therapy|induction therapy
581206|NCT00714467|smoking cessation|smoking cessation
581207|NCT00714467|Asian|asian
581208|NCT00714467|Chinese American|chinese american
581209|NCT00714467|family support|family support
581210|NCT00714467|social support|social support
581211|NCT00714467|stage-based intervention|stage-based intervention
581212|NCT00714441|Diabetes Type 2|diabetes type 2
581213|NCT00714441|Distress|distress
581214|NCT00714441|Problem Solving Therapy|problem solving therapy
581215|NCT00714441|Computer Automated Self-Management (CASM)|computer automated self-management (casm)
581216|NCT00714428|Traumatic Brain Injury|traumatic brain injury
581217|NCT00714428|Quality of Life|quality of life
581218|NCT00714402|UTI|uti
581219|NCT00714389|Urogynecology|urogynecology
581220|NCT00714376|Prostate cancer|prostate cancer
581221|NCT00714376|High-risk prostate cancer|high-risk prostate cancer
581222|NCT00714376|Radical prostatectomy|radical prostatectomy
581223|NCT00714376|Early rising PSA|early rising psa
581224|NCT00714376|Taxotere|taxotere
581225|NCT00714376|Docetaxel|docetaxel
581226|NCT00714350|Information Display|information display
581227|NCT00714350|situational awareness|situational awareness
581228|NCT00714350|Create intuitive visualization|create intuitive visualization
581229|NCT00714337|Formulation|formulation
581230|NCT00714337|pharmacokinetics|pharmacokinetics
581231|NCT00714324|Nutrition|nutrition
581232|NCT00714324|Screening|screening
581233|NCT00714311|borderline personality disorder|borderline personality disorder
581234|NCT00714311|randomized controlled trial|randomized controlled trial
581235|NCT00714311|Transference-Focused Psychotherapy|transference-focused psychotherapy
581236|NCT00714311|treatment by experienced community psychotherapists|treatment by experienced community psychotherapists
581237|NCT00714298|biological markers|biological markers
581238|NCT00714298|emergency service hospital|emergency service hospital
581239|NCT00714298|heart fatty acid binding protein|heart fatty acid binding protein
581240|NCT00714298|ischemia modified albumin|ischemia modified albumin
581241|NCT00714285|Primary study|primary study
581242|NCT00714285|immunogenicity|immunogenicity
581243|NCT00714285|safety|safety
581244|NCT00714259|Low Grade B Cell Malignancies|low grade b cell malignancies
581245|NCT00714259|nonmyeloablative transplant|nonmyeloablative transplant
581246|NCT00714259|allogeneic|allogeneic
581247|NCT00714246|advanced non small cell lung cancer|advanced non small cell lung cancer
581248|NCT00714233|Polycystic Ovary Syndrome|polycystic ovary syndrome
581249|NCT00714233|Overweight Adolescent Girls|overweight adolescent girls
581250|NCT00714233|Irregular Menstrual Cycles|irregular menstrual cycles
581251|NCT00714220|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
581252|NCT00714220|Gastric Motility|gastric motility
581253|NCT00714220|Autonomic Nervous System|autonomic nervous system
581254|NCT00714220|Neurodegenerative Diseases|neurodegenerative diseases
581255|NCT00714220|Movement Disorders|movement disorders
581256|NCT00714220|Substrate Utilization|substrate utilization
581257|NCT00714207|adolescents|adolescents
581258|NCT00714207|smoking|smoking
581259|NCT00714207|smoking cessation|smoking cessation
581260|NCT00714207|tobacco use|tobacco use
581261|NCT00714194|sedation|sedation
581262|NCT00714194|delirium|delirium
581263|NCT00714194|sleep|sleep
581264|NCT00714194|sedation withdrawal|sedation withdrawal
581265|NCT00714194|ICU patients|icu patients
581266|NCT00714181|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
581267|NCT00714168|Weight Loss|weight loss
581268|NCT00714168|Weight Control|weight control
581269|NCT00714155|Colpocleisis|colpocleisis
581270|NCT00714142|Renal blood flow|renal blood flow
581271|NCT00714142|PET imaging|pet imaging
581272|NCT00714129|Steatosis|steatosis
581273|NCT00714129|Diabetes|diabetes
581274|NCT00714116|safety|safety
581275|NCT00714116|pharmacokinetics|pharmacokinetics
581276|NCT00714103|Leukemia|leukemia
581277|NCT00714103|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
581278|NCT00714103|CLL|cll
581279|NCT00714103|8-Chloro-Adenosine|8-chloro-adenosine
581280|NCT00714103|purine analogues|purine analogues
581281|NCT00714103|Cancer|cancer
581282|NCT00714090|repetitive Transcranial Magnetic Stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
581283|NCT00714090|Major depressive disorders|major depressive disorders
581284|NCT00714090|Depression|depression
581285|NCT00714090|Venlafaxine|venlafaxine
581286|NCT00714077|rectal cancer|rectal cancer
581287|NCT00714077|concurrent chemoradiotherapy|concurrent chemoradiotherapy
581288|NCT00714077|adjuvant therapy|adjuvant therapy
581289|NCT00714077|phase III study|phase iii study
581290|NCT00714038|Quality development project|quality development project
581291|NCT00714038|primary care nurses|primary care nurses
581292|NCT00714038|asthma|asthma
581293|NCT00714038|patient compliance|patient compliance
581294|NCT00714038|follow-up|follow-up
581297|NCT00714025|Palliative treatment|palliative treatment
581298|NCT00714025|advance or metastatic TCC|advance or metastatic tcc
581299|NCT00714025|Failure after Platinum-based chemotherapy|failure after platinum-based chemotherapy
581300|NCT00714012|Display development|display development
581301|NCT00714012|Intuitive display use|intuitive display use
581302|NCT00714012|visualizations are intuitive|visualizations are intuitive
581303|NCT00713999|Sexually transmitted infections|sexually transmitted infections
581304|NCT00713999|Urogenital schistosomiasis|urogenital schistosomiasis
581305|NCT00713999|Schistosoma haematobium|schistosoma haematobium
581306|NCT00713999|Reproductive health|reproductive health
581307|NCT00713999|Pelvic examination|pelvic examination
581308|NCT00713999|Ultrasonography|ultrasonography
581309|NCT00713999|Questionnaire|questionnaire
581310|NCT00713999|Madagascar|madagascar
581311|NCT00713986|Pain|pain
581312|NCT00713986|Newborn Infant|newborn infant
581313|NCT00713986|Analgesia|analgesia
581314|NCT00713960|Quality development project|quality development project
581315|NCT00713960|primary care nurses|primary care nurses
581316|NCT00713960|cardiovascular disease|cardiovascular disease
581317|NCT00713960|secondary prevention|secondary prevention
581318|NCT00713960|follow-up|follow-up
581319|NCT00713947|Gastric lesions induced by low dose of aspirin|gastric lesions induced by low dose of aspirin
581320|NCT00713947|Helicobacter pylori|helicobacter pylori
581321|NCT00713934|Autologous Bone marrow stem cells|autologous bone marrow stem cells
581322|NCT00713934|Cirrhosis|cirrhosis
581323|NCT00713921|Female|female
581324|NCT00713921|Diabetics|diabetics
581325|NCT00713921|Stroke|stroke
581326|NCT00713908|Voiding dysfunction following TVT placement|voiding dysfunction following tvt placement
581327|NCT00713895|smoking cessation|smoking cessation
581328|NCT00713895|randomized trial|randomized trial
581329|NCT00713895|Asian|asian
581330|NCT00713895|Chinese American|chinese american
581331|NCT00713895|stages of change|stages of change
581332|NCT00713882|Survivors|survivors
581333|NCT00713882|Quality of Life|quality of life
581334|NCT00713869|Oocyte cryopreservation|oocyte cryopreservation
581335|NCT00713869|Slow freeze|slow freeze
581336|NCT00713843|Neck Pain|neck pain
581337|NCT00713843|Manuel Therapy Utrecht|manuel therapy utrecht
581338|NCT00713843|Physiotherapy|physiotherapy
581339|NCT00713830|hyperglycemia, GLP-1|hyperglycemia, glp-1
581340|NCT00713817|Pain|pain
581341|NCT00713817|Peripheral Neuropathy|peripheral neuropathy
581342|NCT00713804|Schizophrenia|schizophrenia
581343|NCT00713804|Bipolar Disorder|bipolar disorder
581344|NCT00713804|Schizoaffective disorder|schizoaffective disorder
581345|NCT00713804|Genetic Counseling|genetic counseling
581346|NCT00713804|Risk perception|risk perception
581347|NCT00713804|Stigma|stigma
581348|NCT00713804|Control|control
581349|NCT00713804|Knowledge|knowledge
581350|NCT00713791|Healthy Volunteers|healthy volunteers
581351|NCT00713791|ZD4054|zd4054
581352|NCT00713778|Ovarian Cysts|ovarian cysts
581353|NCT00713778|Electrocoagulation|electrocoagulation
581354|NCT00713778|Ovarian Function Tests|ovarian function tests
581355|NCT00713778|Laparoscopy|laparoscopy
581356|NCT00713765|Healthy volunteers|healthy volunteers
581357|NCT00713752|HIV-negative|hiv-negative
581358|NCT00713739|kidney stones|kidney stones
581359|NCT00713739|ureteral stones|ureteral stones
581360|NCT00713739|medical expulsion therapy|medical expulsion therapy
581361|NCT00713726|Pain|pain
581362|NCT00713726|Analgesia|analgesia
581363|NCT00713726|Newborn Infant|newborn infant
581364|NCT00713726|Opioids|opioids
581365|NCT00713726|Side-effects|side-effects
581366|NCT00713726|Intensive care|intensive care
581367|NCT00713726|Postoperative|postoperative
581368|NCT00713713|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
581369|NCT00713713|Tidal volume|tidal volume
581370|NCT00713713|cardiac output|cardiac output
581371|NCT00713713|Respiration, Artificial|respiration, artificial
581372|NCT00713713|Protective ventilation|protective ventilation
581373|NCT00713700|patent ductus arteriosus|patent ductus arteriosus
581374|NCT00713700|PDA|pda
581375|NCT00713687|photodynamic therapy|photodynamic therapy
581376|NCT00713687|PDT|pdt
581377|NCT00713687|gemcitabine|gemcitabine
581378|NCT00713687|oxaliplatin|oxaliplatin
581379|NCT00713687|cholangiocarcinoma|cholangiocarcinoma
581380|NCT00713674|Methicillin resistance|methicillin resistance
581381|NCT00713661|Colorectal Anastomosis|colorectal anastomosis
581382|NCT00713661|Colorectal Resection|colorectal resection
581383|NCT00713661|Tachosil|tachosil
581384|NCT00713635|Congenital Heart Disease|congenital heart disease
581385|NCT00713622|Partial|partial
581386|NCT00713622|onset|onset
581387|NCT00713622|seizures|seizures
581388|NCT00713609|Acne|acne
581389|NCT00713609|Acne Vulgaris|acne vulgaris
581390|NCT00713609|Pimples|pimples
581391|NCT00713596|Nasal Surgery|nasal surgery
581392|NCT00713596|Septorhinoplasty|septorhinoplasty
581393|NCT00713596|fibrin glue|fibrin glue
581394|NCT00713596|fibrinogen|fibrinogen
581395|NCT00713596|Swelling|swelling
581396|NCT00713596|fibrin|fibrin
581397|NCT00713596|tisseel|tisseel
581398|NCT00713583|Cocaine, levodopa, contingency management|cocaine, levodopa, contingency management
581399|NCT00713570|intellectual functioning|intellectual functioning
581400|NCT00713570|memory,visual-spatial and perceptual functions|memory,visual-spatial and perceptual functions
581401|NCT00713570|cognitive abilities|cognitive abilities
581402|NCT00713570|COMT|comt
581403|NCT00713570|BDNF|bdnf
581404|NCT00713570|neuron biological systemic pathway candidate genes|neuron biological systemic pathway candidate genes
581405|NCT00713570|Chinese|chinese
581406|NCT00713570|Taiwan|taiwan
581407|NCT00713570|Healthy subjects|healthy subjects
581408|NCT00713557|coronary angioplasty|coronary angioplasty
581409|NCT00713544|Rheumatoid Arthritis|rheumatoid arthritis
581410|NCT00713544|RA|ra
581411|NCT00713544|AZD5672|azd5672
581412|NCT00713531|HIV-negative|hiv-negative
581413|NCT00713531|male and female clients|male and female clients
581414|NCT00713531|ages 18-50 years|ages 18-50 years
581415|NCT00713531|seeking HIV counseling|seeking hiv counseling
581416|NCT00713531|testing at TRCARC|testing at trcarc
581417|NCT00713518|AMD Age Related Macular Degeneration Choroidal Neovascularization Monet|amd age related macular degeneration choroidal neovascularization monet
581418|NCT00713505|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
581419|NCT00713505|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
581420|NCT00713505|cancer survivor|cancer survivor
581421|NCT00713505|cognitive/functional effects|cognitive/functional effects
581422|NCT00713505|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
581423|NCT00713505|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
581424|NCT00713505|childhood anaplastic large cell lymphoma|childhood anaplastic large cell lymphoma
581425|NCT00713505|childhood large cell lymphoma|childhood large cell lymphoma
581426|NCT00713505|childhood lymphoblastic lymphoma|childhood lymphoblastic lymphoma
581427|NCT00713505|childhood small noncleaved cell lymphoma|childhood small noncleaved cell lymphoma
581428|NCT00713505|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
581429|NCT00713505|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
581430|NCT00713505|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
581431|NCT00713492|Alcohol|alcohol
581432|NCT00713492|Self -Administration|self -administration
581433|NCT00713492|Intoxication|intoxication
581434|NCT00713492|Healthy Volunteer|healthy volunteer
581435|NCT00713492|HV|hv
581436|NCT00713479|methamphetamine|methamphetamine
581437|NCT00713479|varenicline|varenicline
581438|NCT00713479|Chantix|chantix
581439|NCT00713479|stimulant|stimulant
581440|NCT00713479|crystal meth|crystal meth
581441|NCT00713466|CLIPP cases|clipp cases
581442|NCT00713466|Pediatric clerkship|pediatric clerkship
581443|NCT00713466|Standardizing|standardizing
581444|NCT00713466|Students' exposure|students' exposure
581445|NCT00713466|Essential|essential
581446|NCT00713466|Enhancing|enhancing
581447|NCT00713466|Experience|experience
581448|NCT00713453|Pompe disease|pompe disease
581449|NCT00713453|muscle|muscle
581450|NCT00713453|enzyme replacement therapy|enzyme replacement therapy
581451|NCT00713440|Incretin Effect|incretin effect
581452|NCT00713440|Steroids|steroids
581453|NCT00713440|Glucagon-Like Peptide 1|glucagon-like peptide 1
581454|NCT00713440|Gastric Inhibitory Peptide|gastric inhibitory peptide
581455|NCT00713440|Glucose-dependent Insulinotropic Polypeptide|glucose-dependent insulinotropic polypeptide
581456|NCT00713440|Insulin|insulin
581457|NCT00713440|C-peptide|c-peptide
581458|NCT00713440|Glucagon|glucagon
581459|NCT00713427|Biliary|biliary
581460|NCT00713427|Strictures|strictures
581461|NCT00713427|Malignant|malignant
581462|NCT00713427|Neoplasm|neoplasm
581463|NCT00713427|Palliation|palliation
581464|NCT00713414|Spasmodic Dysphonia|spasmodic dysphonia
581465|NCT00713414|Dystonia|dystonia
581466|NCT00713414|Basal Ganglia|basal ganglia
581467|NCT00713414|PET Imaging|pet imaging
581468|NCT00713414|fMRI|fmri
581469|NCT00713414|Voice Disorder|voice disorder
581470|NCT00713414|Healthy Volunteer|healthy volunteer
581471|NCT00713414|HV|hv
581472|NCT00713375|Autonomic Nervous System|autonomic nervous system
581473|NCT00713375|Subarachnoid Hemorrhage|subarachnoid hemorrhage
581474|NCT00713375|Intracranial Hemorrhages|intracranial hemorrhages
581475|NCT00713375|Cerebral Hemorrhage|cerebral hemorrhage
581476|NCT00713362|Aspiration, chest tube, pneumothorax, thoracoscopic surgery|aspiration, chest tube, pneumothorax, thoracoscopic surgery
581477|NCT00713349|White|white
581478|NCT00713349|Petrolatum|petrolatum
581479|NCT00713349|Xenaderm|xenaderm
581480|NCT00713349|Vehicle|vehicle
581481|NCT00713349|Partial thickness wounds|partial thickness wounds
581482|NCT00713349|Healing|healing
581483|NCT00713349|Cryo-surgery|cryo-surgery
581484|NCT00713336|ZD4054|zd4054
581485|NCT00713336|Healthy Volunteers|healthy volunteers
581486|NCT00713336|QT interval|qt interval
581487|NCT00713323|Pain|pain
581488|NCT00713323|Peripheral Neuropathy|peripheral neuropathy
581489|NCT00713297|medication errors|medication errors
581490|NCT00713297|computerized physician order entry|computerized physician order entry
581491|NCT00713297|pharmaceutical care|pharmaceutical care
581492|NCT00713297|chemotherapeutic agents|chemotherapeutic agents
581493|NCT00713297|reengineering|reengineering
581494|NCT00713284|Kidney transplantation|kidney transplantation
581495|NCT00713284|Sirolimus|sirolimus
581496|NCT00713284|Immunosuppression|immunosuppression
581497|NCT00713284|Tacrolimus|tacrolimus
581498|NCT00713271|Healthy male|healthy male
581499|NCT00713271|tolerability|tolerability
581500|NCT00713271|safety|safety
581501|NCT00713271|inhalation|inhalation
581502|NCT00713258|Postmenopausal women|postmenopausal women
581503|NCT00713258|Back pain|back pain
581504|NCT00713258|Osteoporosis related fracture|osteoporosis related fracture
581505|NCT00713245|Pompe disease|pompe disease
581506|NCT00713245|late onset|late onset
581507|NCT00713232|naming test|naming test
581508|NCT00713219|IMRT|imrt
581509|NCT00713219|cetuximab|cetuximab
581510|NCT00713219|docetaxel|docetaxel
581511|NCT00713206|Dental implants, maxilla, sinus lift, augmentation|dental implants, maxilla, sinus lift, augmentation
581512|NCT00713193|Idiopathic TTP|idiopathic ttp
581513|NCT00713193|Treatment|treatment
581514|NCT00713193|Exacerbation|exacerbation
581515|NCT00713193|Relapse|relapse
581516|NCT00713193|Plasma Exchange|plasma exchange
581517|NCT00713167|Grape Seed Extract|grape seed extract
581518|NCT00713167|Hyperlipidemia|hyperlipidemia
581519|NCT00713154|Radiotherapy|radiotherapy
581520|NCT00713154|induced|induced
581521|NCT00713128|nausea vomiting colorectal cancer|nausea vomiting colorectal cancer
581522|NCT00713115|laparoscopy, needlescopy, adrenalectomy|laparoscopy, needlescopy, adrenalectomy
581523|NCT00713102|in-flight emergency|in-flight emergency
581524|NCT00713089|Eczema|eczema
581525|NCT00713089|Asthma|asthma
581526|NCT00713089|Allergic rhinitis|allergic rhinitis
581527|NCT00713089|Singapore|singapore
581528|NCT00713089|Indonesia|indonesia
581529|NCT00713089|Gastrointestinal Flora|gastrointestinal flora
581530|NCT00713076|multi-purpose solution|multi-purpose solution
581531|NCT00713076|contact lens wearers|contact lens wearers
581532|NCT00713076|Contact lense wearers|contact lense wearers
581533|NCT00713063|smoking cessation|smoking cessation
581534|NCT00713063|exercise|exercise
581535|NCT00713063|physical activity|physical activity
581536|NCT00713063|health education|health education
581537|NCT00713050|stroke|stroke
581538|NCT00713050|aphasia|aphasia
581539|NCT00713050|imitation|imitation
581540|NCT00713050|mirror neuron|mirror neuron
581541|NCT00713037|fluoromisonidazole|fluoromisonidazole
581542|NCT00713037|PET scan|pet scan
581543|NCT00713037|Hypoxia-PET|hypoxia-pet
581544|NCT00713037|IMPT|impt
581545|NCT00713024|Pain; Functional neuroimaging; Neuropathy; Thermal sensation|pain; functional neuroimaging; neuropathy; thermal sensation
581546|NCT00713011|Adalat XL|adalat xl
581547|NCT00713011|Diltiazem|diltiazem
581548|NCT00713011|Tiazac XC|tiazac xc
581549|NCT00713011|Proteinuria|proteinuria
581550|NCT00712998|radiation injuries|radiation injuries
581551|NCT00712998|free radicals|free radicals
581552|NCT00712998|reactive oxygen species|reactive oxygen species
581553|NCT00712998|radiation injury from X-ray computed tomography|radiation injury from x-ray computed tomography
581554|NCT00712998|free radical production|free radical production
581555|NCT00712998|blood reactive oxygen species level|blood reactive oxygen species level
581556|NCT00712985|Breast cancer|breast cancer
581557|NCT00712985|aromatase inhibitors|aromatase inhibitors
581558|NCT00712972|knee injection|knee injection
581559|NCT00712972|parapatellar|parapatellar
581560|NCT00712959|Pertussis|pertussis
581561|NCT00712959|Tetanus|tetanus
581562|NCT00712959|Diphtheria|diphtheria
581563|NCT00712959|Acellular pertussis|acellular pertussis
581564|NCT00712959|ADACEL®,|adacel®,
581565|NCT00712959|Tdap vaccine|tdap vaccine
581566|NCT00712933|SLE|sle
581567|NCT00712933|Belimumab|belimumab
581568|NCT00712933|Antibodies|antibodies
581569|NCT00712933|Systemic Lupus Erythematosus|systemic lupus erythematosus
581570|NCT00712933|Lupus|lupus
581571|NCT00712933|Autoimmune Diseases|autoimmune diseases
581572|NCT00712907|vitamin C|vitamin c
581573|NCT00712907|retinal blood flow|retinal blood flow
581574|NCT00712907|intraocular pressure|intraocular pressure
581575|NCT00712907|retinal vessel diameter|retinal vessel diameter
581576|NCT00712894|Acute myocardial infarction|acute myocardial infarction
581577|NCT00712894|Percutaneous coronary intervention|percutaneous coronary intervention
581578|NCT00712894|No-reflow phenomenon|no-reflow phenomenon
581579|NCT00712894|Vasodilator agents|vasodilator agents
581580|NCT00712855|Liver Cancer|liver cancer
581581|NCT00712842|Diabetes|diabetes
581582|NCT00712842|ocular blood flow|ocular blood flow
581583|NCT00712829|Prostate cancer|prostate cancer
581584|NCT00712829|Imaging|imaging
581585|NCT00712816|osteoarthritis|osteoarthritis
581586|NCT00712816|total knee arthroplasty|total knee arthroplasty
581587|NCT00712816|cryotherapy|cryotherapy
581588|NCT00712790|First line treatment for Hepatocellular Carcinoma|first line treatment for hepatocellular carcinoma
581589|NCT00712777|Brimonidine|brimonidine
581590|NCT00712777|alpha 2 receptor polymorphism|alpha 2 receptor polymorphism
583460|NCT00705549|BCRA1|bcra1
581591|NCT00712777|Intraocular Pressure|intraocular pressure
581592|NCT00712764|Adenosine|adenosine
581593|NCT00712764|Choroidal blood flow|choroidal blood flow
581594|NCT00712764|Suction cup|suction cup
581595|NCT00712751|Rectum|rectum
581596|NCT00712751|Quality of Life|quality of life
581597|NCT00712751|Sexual Health|sexual health
581598|NCT00712751|08-073|08-073
581599|NCT00712738|Nifedipine|nifedipine
581600|NCT00712738|Thalassemia|thalassemia
581601|NCT00712738|Hemochromatosis|hemochromatosis
581602|NCT00712738|Iron Overload|iron overload
581603|NCT00712738|Iron Excretion|iron excretion
581604|NCT00712712|bone metastases|bone metastases
581605|NCT00712712|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
581606|NCT00712712|pain|pain
581607|NCT00712699|Preschool|preschool
581608|NCT00712699|Children|children
581609|NCT00712699|ADHD|adhd
581610|NCT00712699|Medication|medication
581611|NCT00712699|Controlled Study|controlled study
581612|NCT00712699|Placebo|placebo
581613|NCT00712699|Mixed Amphetamine Salts|mixed amphetamine salts
581614|NCT00712673|hyperglycemia, GLP-1, metformin|hyperglycemia, glp-1, metformin
581615|NCT00712660|prevention|prevention
581616|NCT00712660|relapse|relapse
581617|NCT00712660|schizophrenia|schizophrenia
581618|NCT00712634|cytomegalovirus infection|cytomegalovirus infection
581619|NCT00712621|Genetics Home Reference related topics|genetics home reference related topics
581620|NCT00712621|breast cancer|breast cancer
581621|NCT00712621|breast cancer related to depression|breast cancer related to depression
581622|NCT00712621|Condition|condition
581623|NCT00712621|Stage I-IV Carcinoma of Breast|stage i-iv carcinoma of breast
581624|NCT00712608|Term|term
581625|NCT00712608|Infant|infant
581626|NCT00712608|Formula|formula
581627|NCT00712595|Uterine fibroids|uterine fibroids
581628|NCT00712595|mifepristone|mifepristone
581629|NCT00712595|antiprogestins|antiprogestins
581630|NCT00712582|Non-Hodgkin|non-hodgkin
581631|NCT00712582|Lymphoma|lymphoma
581632|NCT00712582|Rituximab|rituximab
581633|NCT00712582|Cyclophosphamide|cyclophosphamide
581634|NCT00712582|Doxorubicin|doxorubicin
581635|NCT00712582|Vincristine|vincristine
581636|NCT00712582|ifosfamide|ifosfamide
581637|NCT00712582|etoposide|etoposide
581638|NCT00712582|carboplatin|carboplatin
581639|NCT00712582|stem cell transplant|stem cell transplant
581640|NCT00712582|08-026|08-026
581641|NCT00712569|Communication|communication
581642|NCT00712569|Internet|internet
581643|NCT00712569|Physician|physician
581644|NCT00712569|Patient|patient
581645|NCT00712569|08-079|08-079
581646|NCT00712556|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
581647|NCT00712556|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
581648|NCT00712556|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
581649|NCT00712556|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
581650|NCT00712556|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
581651|NCT00712556|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
581652|NCT00712556|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
581653|NCT00712556|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
581654|NCT00712556|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
581655|NCT00712556|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
581656|NCT00712556|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
581657|NCT00712556|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
581658|NCT00712556|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
581659|NCT00712556|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
581660|NCT00712556|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
581661|NCT00712556|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
581662|NCT00712556|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
581663|NCT00712556|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
581664|NCT00712556|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
581665|NCT00712556|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
581666|NCT00712556|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
581667|NCT00712556|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
581668|NCT00712556|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
581669|NCT00712556|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
581670|NCT00712556|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
581671|NCT00712556|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
581672|NCT00712556|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
581673|NCT00712556|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
581674|NCT00712556|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
581675|NCT00712556|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
581676|NCT00712556|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
581677|NCT00712556|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
581678|NCT00712556|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
581679|NCT00712556|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
581680|NCT00712556|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
581681|NCT00712556|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
581682|NCT00712556|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
581683|NCT00712556|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
581684|NCT00712556|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
581685|NCT00712556|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
581686|NCT00712556|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
581687|NCT00712556|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
581688|NCT00712556|splenic marginal zone lymphoma|splenic marginal zone lymphoma
581689|NCT00712556|NC stage II adult immunoblastic large cell lymphoma|nc stage ii adult immunoblastic large cell lymphoma
581690|NCT00712556|NC stage II adult lymphoblastic lymphoma|nc stage ii adult lymphoblastic lymphoma
581691|NCT00712556|NC stage II grade 1 follicular lymphoma|nc stage ii grade 1 follicular lymphoma
581692|NCT00712556|NC stage II grade 2 follicular lymphoma|nc stage ii grade 2 follicular lymphoma
581693|NCT00712556|NC stage II grade 3 follicular lymphoma|nc stage ii grade 3 follicular lymphoma
581694|NCT00712556|NC stage II mantle cell lymphoma|nc stage ii mantle cell lymphoma
581695|NCT00712556|NC stage II marginal zone lymphoma|nc stage ii marginal zone lymphoma
581696|NCT00712556|NC stage II small lymphocytic lymphoma|nc stage ii small lymphocytic lymphoma
581697|NCT00712543|constipation|constipation
581698|NCT00712543|laxative|laxative
581699|NCT00712543|lactulose|lactulose
581700|NCT00712543|Kristalose®|kristalose®
581701|NCT00712530|HIV|hiv
581702|NCT00712530|Vaccine|vaccine
581703|NCT00712530|Immune Therapy|immune therapy
581704|NCT00712530|DermaVir|dermavir
581705|NCT00712517|postoperative pain|postoperative pain
581706|NCT00712517|Piritramid|piritramid
581707|NCT00712517|propofol|propofol
581708|NCT00712517|sevoflurane|sevoflurane
581709|NCT00712517|varicose vein|varicose vein
581710|NCT00712517|Anesthesia|anesthesia
581711|NCT00712504|advanced solid tumors, non small cell lung cancer, pulmonary neoplasms, sunitinib (SUTENT), docetaxel (Taxotere), Angiogenesis Inhibitors|advanced solid tumors, non small cell lung cancer, pulmonary neoplasms, sunitinib (sutent), docetaxel (taxotere), angiogenesis inhibitors
581712|NCT00712491|wet AMD|wet amd
581713|NCT00712491|CNV|cnv
581714|NCT00712465|Atrial fibrillation|atrial fibrillation
581715|NCT00712465|interaction|interaction
581716|NCT00712465|pharmacokinetic|pharmacokinetic
581717|NCT00712452|fertility|fertility
581718|NCT00712452|chemotherapy|chemotherapy
581719|NCT00712439|DPN,|dpn,
581720|NCT00712439|Diabetic|diabetic
581721|NCT00712439|Peripheral|peripheral
581722|NCT00712439|Neuropathy|neuropathy
581723|NCT00712439|Painful|painful
581724|NCT00712426|Huntington's disease|huntington's disease
581725|NCT00712426|Creatine|creatine
581726|NCT00712426|Mitochondrial Dysfunction|mitochondrial dysfunction
581727|NCT00712426|Total Functional Capacity|total functional capacity
581728|NCT00712426|UHDRS|uhdrs
581729|NCT00712413|Helicobacter pylori infection|helicobacter pylori infection
581730|NCT00712413|Quadruple therapy|quadruple therapy
581731|NCT00712413|Safety|safety
581732|NCT00712413|Efficacy|efficacy
581733|NCT00712413|Tolerability|tolerability
581734|NCT00712413|BID dosing|bid dosing
581735|NCT00712400|Latanoprost|latanoprost
581736|NCT00712400|Choroidal Blood Flow|choroidal blood flow
581737|NCT00712400|Intraocular Pressure|intraocular pressure
581738|NCT00712374|Malaria|malaria
581739|NCT00712374|All causes mortality|all causes mortality
581740|NCT00712374|Cost effectiveness|cost effectiveness
581741|NCT00712361|Invasive|invasive
581742|NCT00712361|Non-Invasive|non-invasive
581743|NCT00712361|Peripheral blood parameters|peripheral blood parameters
581744|NCT00712361|Finger mounted device|finger mounted device
581745|NCT00712361|Blood tissue|blood tissue
581746|NCT00712361|Tissue color distribution|tissue color distribution
581747|NCT00712361|Accuracy|accuracy
581748|NCT00712361|Tissue pigmentation|tissue pigmentation
581749|NCT00712361|pH|ph
581750|NCT00712361|Hemoglobin|hemoglobin
581751|NCT00712361|Hematocrit|hematocrit
581752|NCT00712361|SpO2|spo2
581753|NCT00712361|Blood pressure|blood pressure
581754|NCT00712361|Pulse|pulse
581755|NCT00712361|CO2|co2
581756|NCT00712348|Gaucher disease|gaucher disease
581757|NCT00712348|imiglucerase|imiglucerase
581758|NCT00712348|glucocerebrosidase|glucocerebrosidase
581759|NCT00712348|enzyme replacement therapy|enzyme replacement therapy
581760|NCT00712348|lysosomal storage disorder|lysosomal storage disorder
581761|NCT00712335|asthmatics|asthmatics
581762|NCT00712335|smokers|smokers
581763|NCT00712335|inhaled corticosteroids|inhaled corticosteroids
581764|NCT00712335|leukotriene receptor antagonists|leukotriene receptor antagonists
581861|NCT00712036|Interim Methadone Treatment|interim methadone treatment
581862|NCT00712036|Counseling|counseling
581863|NCT00712023|Hypothermia|hypothermia
583461|NCT00705549|Alimta|alimta
581765|NCT00712322|Pediatric, Children, Urodynamics, Oral Suspension, Overactive bladder, Dose-finding, Neurogenic Detrusor Overactivity, Meningomyelocele, Spinal cord injury|pediatric, children, urodynamics, oral suspension, overactive bladder, dose-finding, neurogenic detrusor overactivity, meningomyelocele, spinal cord injury
581766|NCT00712309|atherosclerotic|atherosclerotic
581767|NCT00712309|lesions|lesions
581768|NCT00712296|Asthma|asthma
581769|NCT00712296|alternative medicine|alternative medicine
581770|NCT00712296|complementary medicine|complementary medicine
581771|NCT00712296|herbal therapy|herbal therapy
581772|NCT00712283|fitness to drive|fitness to drive
581773|NCT00712283|operate machines|operate machines
581774|NCT00712283|To determine the fitness to drive and operate machines.|to determine the fitness to drive and operate machines.
581775|NCT00712270|Schizophrenia|schizophrenia
581776|NCT00712270|Antipsychotic drug treatment response|antipsychotic drug treatment response
581777|NCT00712270|Risperidone|risperidone
581778|NCT00712270|Aripiprazole|aripiprazole
581779|NCT00712270|Fallypride|fallypride
581780|NCT00712270|Positron emission tomography|positron emission tomography
581781|NCT00712270|Magnetic Resonance Imaging|magnetic resonance imaging
581782|NCT00712270|Dopamine D2 Receptors|dopamine d2 receptors
581783|NCT00712257|treatment of superficial femoral artery instent restenosis|treatment of superficial femoral artery instent restenosis
581784|NCT00712244|Discovisc|discovisc
581785|NCT00712244|Ophthalmic Viscosurgical Device|ophthalmic viscosurgical device
581786|NCT00712231|pseudophakic|pseudophakic
581787|NCT00712231|anterior chamber depth|anterior chamber depth
581788|NCT00712231|Pentacam|pentacam
581789|NCT00712218|Ovarian cancer, FIGO stage IIB-IV|ovarian cancer, figo stage iib-iv
581790|NCT00712205|Asthma|asthma
581791|NCT00712205|Vitamin D|vitamin d
581792|NCT00712192|coronary artery bypass grafting|coronary artery bypass grafting
581793|NCT00712192|endoscopic vein harvest|endoscopic vein harvest
581794|NCT00712192|saphenous vein|saphenous vein
581795|NCT00712192|endothelial cells|endothelial cells
581796|NCT00712192|eNOS|enos
581797|NCT00712192|ET-1|et-1
581798|NCT00712179|Stroke|stroke
581799|NCT00712179|walking|walking
581800|NCT00712179|Treadmill|treadmill
581801|NCT00712179|body weight support system|body weight support system
581802|NCT00712166|cystic fibrosis|cystic fibrosis
581803|NCT00712166|pseudomonas aeruginosa|pseudomonas aeruginosa
581804|NCT00712166|lung infection|lung infection
581805|NCT00712166|CFQ-R|cfq-r
581806|NCT00712166|inhaled antibiotic|inhaled antibiotic
581807|NCT00712166|aztreonam lysine|aztreonam lysine
581808|NCT00712153|multislice computed tomography|multislice computed tomography
581809|NCT00712153|coronary artery bypass grafting|coronary artery bypass grafting
581810|NCT00712153|Patients|patients
581811|NCT00712153|underwent|underwent
581812|NCT00712153|surgeries|surgeries
581813|NCT00712140|stage IA breast cancer|stage ia breast cancer
581814|NCT00712140|stage IB breast cancer|stage ib breast cancer
581815|NCT00712140|stage II breast cancer|stage ii breast cancer
581816|NCT00712140|stage IIIA breast cancer|stage iiia breast cancer
581817|NCT00712140|HER2-positive breast cancer|her2-positive breast cancer
581818|NCT00712127|Body Fat|body fat
581819|NCT00712127|Exercise|exercise
581820|NCT00712127|Metabolic syndrome|metabolic syndrome
581821|NCT00712127|Obesity|obesity
581822|NCT00712127|Nutrition|nutrition
581823|NCT00712127|Physical Activity|physical activity
581824|NCT00712127|Weight Loss|weight loss
581825|NCT00712114|phase I|phase i
581826|NCT00712114|safety|safety
581827|NCT00712114|tolerance|tolerance
581828|NCT00712114|rheumatoid arthritis|rheumatoid arthritis
581829|NCT00712114|pharmacokinetics|pharmacokinetics
581830|NCT00712114|methotrexate|methotrexate
581831|NCT00712114|anti-inflammatory|anti-inflammatory
581832|NCT00712101|infarction|infarction
581833|NCT00712101|intervention|intervention
581834|NCT00712101|stent|stent
581835|NCT00712101|abciximab|abciximab
581836|NCT00712101|platelets|platelets
581837|NCT00712088|HIV|hiv
581838|NCT00712088|Unsafe Sex|unsafe sex
581839|NCT00712088|High Risk Sex|high risk sex
581840|NCT00712088|HIV Prevention|hiv prevention
581841|NCT00712088|African-American|african-american
581842|NCT00712088|gay|gay
581843|NCT00712088|bisexual|bisexual
581844|NCT00712088|intervention trial|intervention trial
581845|NCT00712075|Cognitive Behavioral Therapy|cognitive behavioral therapy
581846|NCT00712075|Social Skills Training|social skills training
581847|NCT00712075|Experience Sampling Method|experience sampling method
581848|NCT00712075|Computer-assisted therapy|computer-assisted therapy
581849|NCT00712075|schizophrenia|schizophrenia
581850|NCT00712062|PCNSL|pcnsl
581851|NCT00712062|Pemetrexed|pemetrexed
581852|NCT00712062|Alimta|alimta
581853|NCT00712062|Recurrent|recurrent
581854|NCT00712062|Progressive|progressive
581855|NCT00712049|intima-media-thickness|intima-media-thickness
581856|NCT00712049|dyslipidemia|dyslipidemia
581857|NCT00712049|progression of atherosclerosis|progression of atherosclerosis
581858|NCT00712049|peripheral artery disease|peripheral artery disease
581859|NCT00712049|major cardiovascular events|major cardiovascular events
581860|NCT00712036|Heroin dependence|heroin dependence
581966|NCT00711607|NOMAC-E2|nomac-e2
581864|NCT00712023|Vascular surgery|vascular surgery
581865|NCT00712023|Forced-air warming mattress|forced-air warming mattress
581866|NCT00712023|Circulating-water mattress|circulating-water mattress
581867|NCT00712010|Glucose|glucose
581868|NCT00712010|Insulin|insulin
581869|NCT00711997|H19 gene, plasmid, diphtheria toxin, pancreatic cancer|h19 gene, plasmid, diphtheria toxin, pancreatic cancer
581870|NCT00711984|renal artery stenosis|renal artery stenosis
581871|NCT00711984|stent|stent
581872|NCT00711984|comparison of treatments|comparison of treatments
581873|NCT00711984|progression|progression
581874|NCT00711984|atherosclerosis|atherosclerosis
581875|NCT00711984|peripheral artery disease|peripheral artery disease
581876|NCT00711984|major cardiovascular events|major cardiovascular events
581877|NCT00711958|Chemotherapy associated anemia in cancer patients|chemotherapy associated anemia in cancer patients
581878|NCT00711945|Crohn's disease|crohn's disease
581879|NCT00711945|Relapse|relapse
581880|NCT00711945|outcomes|outcomes
581881|NCT00711945|growth|growth
581882|NCT00711932|Ovarian Cancer|ovarian cancer
581883|NCT00711932|TRA-8|tra-8
581884|NCT00711932|Monoclonal Antibody|monoclonal antibody
581885|NCT00711932|Tissue Slice Technology|tissue slice technology
581886|NCT00711906|Malaria|malaria
581887|NCT00711906|Pregnancy|pregnancy
581888|NCT00711906|HIV|hiv
581889|NCT00711906|Intermittent Preventive Treatment|intermittent preventive treatment
581890|NCT00711906|Safety|safety
581891|NCT00711906|Efficacy|efficacy
581892|NCT00711880|Pain|pain
581893|NCT00711880|Peripheral Neuropathy|peripheral neuropathy
581894|NCT00711854|Staphylococcal infection|staphylococcal infection
581895|NCT00711841|HELLP syndrome|hellp syndrome
581896|NCT00711841|dexamethasone|dexamethasone
581897|NCT00711841|postpartum period|postpartum period
581898|NCT00711841|class I HELLP syndrome|class i hellp syndrome
581899|NCT00711815|Women of the state of Alabama|women of the state of alabama
581900|NCT00711815|CIN 1|cin 1
581901|NCT00711815|negative biopsy|negative biopsy
581902|NCT00711815|normal colposcopy|normal colposcopy
581903|NCT00711815|HPV|hpv
581904|NCT00711802|Complicated|complicated
581905|NCT00711802|Skin|skin
581906|NCT00711802|Structure|structure
581907|NCT00711789|Acute renal failure|acute renal failure
581908|NCT00711789|Septic shock|septic shock
581909|NCT00711789|angiotensin II|angiotensin ii
581910|NCT00711789|neutrophil gelatinase associated lipocalin (NGAL)|neutrophil gelatinase associated lipocalin (ngal)
581911|NCT00711789|cystatin C|cystatin c
581912|NCT00711776|Aciclovir cream 5%|aciclovir cream 5%
581913|NCT00711776|Volunteer|volunteer
581914|NCT00711776|Japanese|japanese
581915|NCT00711776|Male|male
581916|NCT00711776|Bioequivalence|bioequivalence
581917|NCT00711763|Preterm Infant|preterm infant
581918|NCT00711763|Parenteral nutrition cycling|parenteral nutrition cycling
581919|NCT00711763|TPN cycling|tpn cycling
581920|NCT00711763|Hypercalcuria|hypercalcuria
581921|NCT00711750|underwent|underwent
581922|NCT00711750|specific|specific
581923|NCT00711750|creation|creation
581924|NCT00711750|hospital|hospital
581925|NCT00711750|November 2003|november 2003
581926|NCT00711750|October 2005|october 2005
581927|NCT00711737|metabolic parameters|metabolic parameters
581928|NCT00711737|escitalopram|escitalopram
581929|NCT00711737|metabolic syndrome|metabolic syndrome
581930|NCT00711737|antidepressant|antidepressant
581931|NCT00711724|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
581932|NCT00711724|Adolescent|adolescent
581933|NCT00711711|Physical Therapy - Therapeutics - Edema|physical therapy - therapeutics - edema
581934|NCT00711711|Arthroplasty replacement knee|arthroplasty replacement knee
581935|NCT00711711|Treatment outcome|treatment outcome
581936|NCT00711685|Topical vancomycin|topical vancomycin
581937|NCT00711685|mediastinitis|mediastinitis
581938|NCT00711685|coronary|coronary
581939|NCT00711685|artery|artery
581940|NCT00711685|bypass|bypass
581941|NCT00711685|graft|graft
581942|NCT00711685|Patients|patients
581943|NCT00711672|Personal Communication|personal communication
581944|NCT00711672|Doctor Patient Relations|doctor patient relations
581945|NCT00711672|Narrative Medicine|narrative medicine
581946|NCT00711659|Physical exam|physical exam
581947|NCT00711659|Pediatric clerkship|pediatric clerkship
581948|NCT00711659|Medical students|medical students
581949|NCT00711646|Spasticity|spasticity
581950|NCT00711646|Multiple Sclerosis|multiple sclerosis
581951|NCT00711633|Premature birth,|premature birth,
581952|NCT00711633|infant,|infant,
581953|NCT00711633|infant formula,|infant formula,
581954|NCT00711633|bacterial colonization,|bacterial colonization,
581955|NCT00711633|Bifidobacterium,|bifidobacterium,
581956|NCT00711633|calprotectin|calprotectin
581957|NCT00711620|sepsis|sepsis
581958|NCT00711620|Immunotherapy|immunotherapy
581959|NCT00711620|Thymosin|thymosin
581960|NCT00711607|pharmacokinetics (PK)|pharmacokinetics (pk)
581961|NCT00711607|combined oral contraceptive|combined oral contraceptive
581962|NCT00711607|nomegestrol acetate|nomegestrol acetate
581963|NCT00711607|estradiol|estradiol
581964|NCT00711607|NOMAC|nomac
581965|NCT00711607|E2|e2
581967|NCT00711607|pharmacokinetics|pharmacokinetics
581968|NCT00711581|Cholecystectomy|cholecystectomy
581969|NCT00711581|Cholecystectomy, Laparoscopic|cholecystectomy, laparoscopic
581970|NCT00711581|Laparoscopy|laparoscopy
581971|NCT00711568|depression|depression
581972|NCT00711568|magnetic stimulation|magnetic stimulation
581973|NCT00711555|nausea|nausea
581974|NCT00711555|vomiting|vomiting
581975|NCT00711555|multiple days|multiple days
581976|NCT00711555|chemotherapy|chemotherapy
581977|NCT00711555|serotonin receptor antagonist|serotonin receptor antagonist
581978|NCT00711555|quality of life|quality of life
581979|NCT00711555|therapy|therapy
581980|NCT00711555|corticosteroids|corticosteroids
581981|NCT00711555|aprepitant|aprepitant
581982|NCT00711555|rescue therapy|rescue therapy
581983|NCT00711542|intracoronary progenitor cell therapy|intracoronary progenitor cell therapy
581984|NCT00711542|NSTEMI|nstemi
581985|NCT00711542|coronary flow reserve|coronary flow reserve
581986|NCT00711542|randomized doubleblind Placebo-controlled trial|randomized doubleblind placebo-controlled trial
581987|NCT00711529|hot flashes|hot flashes
581988|NCT00711529|breast cancer|breast cancer
581989|NCT00711529|Hypnotherapy|hypnotherapy
581990|NCT00711529|Quality of Life|quality of life
581991|NCT00711529|Gabapentin|gabapentin
581992|NCT00711503|endogenous insulin production|endogenous insulin production
581993|NCT00711503|C-peptide level|c-peptide level
581994|NCT00711503|insulin requirement|insulin requirement
581995|NCT00711490|Diabetic Macular Edema|diabetic macular edema
581996|NCT00711490|Diabetic Retinopathy|diabetic retinopathy
581997|NCT00711490|Rapamycin|rapamycin
581998|NCT00711490|Sirolimus|sirolimus
581999|NCT00711490|Diabetes|diabetes
582000|NCT00711477|obesity|obesity
582001|NCT00711477|overweight|overweight
582002|NCT00711477|magnetic resonance imaging|magnetic resonance imaging
582003|NCT00711477|naltrexone|naltrexone
582004|NCT00711477|bupropion|bupropion
582005|NCT00711464|cognition, pharmacology, memory, attention|cognition, pharmacology, memory, attention
582006|NCT00711451|systemic vascular resistance|systemic vascular resistance
582007|NCT00711451|pregnancy|pregnancy
582008|NCT00711451|scheduled cesarean delivery|scheduled cesarean delivery
582009|NCT00711451|syncytiotrophoblast apoptosis|syncytiotrophoblast apoptosis
582010|NCT00711451|continuous wave Doppler|continuous wave doppler
582011|NCT00711438|Breathlessness|breathlessness
582012|NCT00711438|Dyspnoea|dyspnoea
582013|NCT00711438|Dyspnea|dyspnea
582014|NCT00711438|Palliative care|palliative care
582015|NCT00711438|RCT|rct
582016|NCT00711438|Randomised controlled trial|randomised controlled trial
582017|NCT00711438|COPD|copd
582018|NCT00711438|Chronic respiratory disease|chronic respiratory disease
582019|NCT00711425|Jaw, Edentulous, Partially (posterior mandible)|jaw, edentulous, partially (posterior mandible)
582020|NCT00711412|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
582021|NCT00711412|stage I esophageal cancer|stage i esophageal cancer
582022|NCT00711412|stage II esophageal cancer|stage ii esophageal cancer
582023|NCT00711412|stage III esophageal cancer|stage iii esophageal cancer
582024|NCT00711412|stage IV esophageal cancer|stage iv esophageal cancer
582025|NCT00711399|Respiratory sounds|respiratory sounds
582026|NCT00711399|Wheeze|wheeze
582027|NCT00711399|Cough|cough
582028|NCT00711386|pharmacokinetics|pharmacokinetics
582029|NCT00711386|CCR5|ccr5
582030|NCT00711386|Healthy volunteers|healthy volunteers
582031|NCT00711386|GSK706769|gsk706769
582032|NCT00711373|VCA|vca
582033|NCT00711373|composite tissue allotransplantation|composite tissue allotransplantation
582034|NCT00711373|amputation|amputation
582035|NCT00711373|Hand|hand
582036|NCT00711360|heart failure|heart failure
582037|NCT00711360|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
582038|NCT00711360|intrathoracic impedance|intrathoracic impedance
582039|NCT00711360|cardiac resynchronization therapy|cardiac resynchronization therapy
582040|NCT00711360|home monitoring|home monitoring
582041|NCT00711347|Discovisc|discovisc
582042|NCT00711347|Ophthalmic Visco Surgical Device|ophthalmic visco surgical device
582043|NCT00711321|Alzheimer|alzheimer
582044|NCT00711321|Morbus Alzheimer|morbus alzheimer
582045|NCT00711321|Vaccine|vaccine
582046|NCT00711321|Alzheimer Vaccine|alzheimer vaccine
582047|NCT00711321|A-beta immunotherapy|a-beta immunotherapy
582048|NCT00711308|pulmonary embolism|pulmonary embolism
582049|NCT00711308|low molecular weight heparin|low molecular weight heparin
582050|NCT00711308|vitamin K antagonist|vitamin k antagonist
582051|NCT00711308|Longterm|longterm
582052|NCT00711295|Influenza (Pandemic)|influenza (pandemic)
582053|NCT00711282|Replacement of non-restorable single tooth/teeth|replacement of non-restorable single tooth/teeth
582054|NCT00711256|Sunscreen|sunscreen
582055|NCT00711256|Application|application
582056|NCT00711256|Vitamin D|vitamin d
582057|NCT00711256|Sun protection factor|sun protection factor
582058|NCT00711256|Clothing|clothing
582059|NCT00711243|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
582060|NCT00711243|adenocarcinoma of the stomach|adenocarcinoma of the stomach
582061|NCT00711243|stage III gastric cancer|stage iii gastric cancer
582062|NCT00711243|stage IV gastric cancer|stage iv gastric cancer
582065|NCT00711230|Immune Therapy|immune therapy
582066|NCT00711230|DermaVir|dermavir
582067|NCT00711204|Severe|severe
582068|NCT00711204|Alzheimer's Disease|alzheimer's disease
582069|NCT00711191|pancreas cancer; cancer of the pancreas; gemcitabine; chemotherapy; monoclonal antibody; immunotherapy; CD40|pancreas cancer; cancer of the pancreas; gemcitabine; chemotherapy; monoclonal antibody; immunotherapy; cd40
582070|NCT00711165|Asthma|asthma
582071|NCT00711165|Nitric Oxide|nitric oxide
582072|NCT00711165|Exhaled Breath Condensate|exhaled breath condensate
582073|NCT00711165|Methacholine Challenge|methacholine challenge
582074|NCT00711152|diabetes|diabetes
582075|NCT00711152|protocol-driven structured care|protocol-driven structured care
582076|NCT00711152|web-based|web-based
582077|NCT00711152|joint asia diabetes evaluation|joint asia diabetes evaluation
582078|NCT00711139|Alzheimer|alzheimer
582079|NCT00711139|Morbus Alzheimer|morbus alzheimer
582080|NCT00711139|Alzheimer Vaccine|alzheimer vaccine
582081|NCT00711139|Vaccine|vaccine
582082|NCT00711139|AD|ad
582083|NCT00711139|A-beta immunotherapy|a-beta immunotherapy
582084|NCT00711126|intravenous,|intravenous,
582085|NCT00711126|tolerability|tolerability
582086|NCT00711126|pharmacokinetics,|pharmacokinetics,
582087|NCT00711126|oral,|oral,
582088|NCT00711126|pharmacodynamics,|pharmacodynamics,
582089|NCT00711126|safety,|safety,
582090|NCT00711126|GW642444,|gw642444,
582091|NCT00711126|inhaled,|inhaled,
582092|NCT00711113|Jaw, Edentulous, Partially (posterior maxilla)|jaw, edentulous, partially (posterior maxilla)
582093|NCT00711100|Substitution for cigarettes|substitution for cigarettes
582094|NCT00711100|Oral tobacco products|oral tobacco products
582095|NCT00711087|Spinal Cord Injury|spinal cord injury
582096|NCT00711087|Bladder|bladder
582097|NCT00711087|Botulinum toxin (BOTOX-A|botulinum toxin (botox-a
582098|NCT00711087|Detrusor External Sphincter Dyssynergia|detrusor external sphincter dyssynergia
582099|NCT00711074|pharmacokinetics|pharmacokinetics
582100|NCT00711074|mass balance|mass balance
582101|NCT00711074|radiolabel|radiolabel
582102|NCT00711074|AZD5672|azd5672
582103|NCT00711048|GERD|gerd
582104|NCT00711048|healthy volunteer|healthy volunteer
582105|NCT00711048|esophagus|esophagus
582106|NCT00711048|pain|pain
582107|NCT00711035|CMV|cmv
582108|NCT00711035|Adenovirus|adenovirus
582109|NCT00711035|EBV|ebv
582110|NCT00711035|non-myeloablative transplants|non-myeloablative transplants
582111|NCT00711035|Prior allogeneic hematopoietic stem cell transplant|prior allogeneic hematopoietic stem cell transplant
582112|NCT00711022|Jaw, Edentulous (maxilla, with poor bone quality and quantity)|jaw, edentulous (maxilla, with poor bone quality and quantity)
582113|NCT00711009|Human Immunodeficiency Virus infection|human immunodeficiency virus infection
582114|NCT00710996|AcrySof IQ IOL|acrysof iq iol
582115|NCT00710983|Mortality|mortality
582116|NCT00710983|Morbidity|morbidity
582117|NCT00710983|Growth|growth
582118|NCT00710983|Immunology|immunology
582119|NCT00710970|Urinary Bladder Neoplasms|urinary bladder neoplasms
582120|NCT00710970|Previous Chemotherapy|previous chemotherapy
582121|NCT00710970|Tamoxifen|tamoxifen
582122|NCT00710970|Anti-tumor activity|anti-tumor activity
582123|NCT00710957|Vitamin D|vitamin d
582124|NCT00710957|Physical Function|physical function
582125|NCT00710957|Falls|falls
582126|NCT00710957|Aging|aging
582127|NCT00710957|CHS|chs
582128|NCT00710944|Jaw, Edentulous, Partially (missing/extracted/avulsed teeth in the maxilla within zone 15(4)-25(13))|jaw, edentulous, partially (missing/extracted/avulsed teeth in the maxilla within zone 15(4)-25(13))
582129|NCT00710931|Bilateral Cataract|bilateral cataract
582130|NCT00710931|IOL|iol
582131|NCT00710931|ReSTOR|restor
582132|NCT00710931|Aspheric|aspheric
582133|NCT00710905|Cataract IOL ReSTOR Aspheric|cataract iol restor aspheric
582134|NCT00710905|Bilateral cataract|bilateral cataract
582135|NCT00710892|suicide gene-modified allodepleted donor lymphocytes|suicide gene-modified allodepleted donor lymphocytes
582136|NCT00710892|given to recipients of haploidentical stem cell transplants|given to recipients of haploidentical stem cell transplants
582137|NCT00710892|Stage III|stage iii
582138|NCT00710892|Stage IV|stage iv
582139|NCT00710892|Myelodysplastic syndrome|myelodysplastic syndrome
582140|NCT00710892|AML after first relapse|aml after first relapse
582141|NCT00710892|primary refractory disease|primary refractory disease
582142|NCT00710892|CML|cml
582143|NCT00710892|Hemophagocytic lymphohistiocytosis (HLH)|hemophagocytic lymphohistiocytosis (hlh)
582144|NCT00710892|familial hemophagocytic lymphohistiocytosis (FLH)|familial hemophagocytic lymphohistiocytosis (flh)
582145|NCT00710892|viral-associated hemophagocytic syndrome (VAHS)|viral-associated hemophagocytic syndrome (vahs)
582146|NCT00710892|Severe chronic active Epstein Barr virus infection (SCAEBV)|severe chronic active epstein barr virus infection (scaebv)
582147|NCT00710892|T or NK cell malignancy|t or nk cell malignancy
582148|NCT00710892|X-linked lymphoproliferative disease (XLP)|x-linked lymphoproliferative disease (xlp)
582149|NCT00710879|Efficacy|efficacy
582150|NCT00710866|Influenza Vaccines|influenza vaccines
582151|NCT00710866|Infant|infant
582152|NCT00710866|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
582153|NCT00710853|Geriatric|geriatric
582154|NCT00710853|Qi gong|qi gong
582155|NCT00710853|Yoga|yoga
582156|NCT00710853|Tai chi|tai chi
582157|NCT00710853|Geriatric Assessment|geriatric assessment
582158|NCT00710840|Knee Replacement|knee replacement
582159|NCT00710840|Knee OA|knee oa
582160|NCT00710840|OA|oa
582161|NCT00710827|NEBIDO,|nebido,
582162|NCT00710827|Hypogonadism,|hypogonadism,
582163|NCT00710827|Symptomatic late onset,|symptomatic late onset,
582164|NCT00710827|Testosterone deficiency|testosterone deficiency
582165|NCT00710814|Roux-en-Y gastric bypass|roux-en-y gastric bypass
582166|NCT00710814|Leptin|leptin
582167|NCT00710814|Bariatric surgery|bariatric surgery
582168|NCT00710814|Overweight after Roux-en-Y gastric bypass surgery|overweight after roux-en-y gastric bypass surgery
582169|NCT00710801|Hepatitis C Virus|hepatitis c virus
582170|NCT00710801|HCV|hcv
582171|NCT00710801|Liver Transplant|liver transplant
582172|NCT00710801|Cyclosporine|cyclosporine
582173|NCT00710801|Tacrolimus|tacrolimus
582174|NCT00710801|Myfortic|myfortic
582175|NCT00710788|QT interval|qt interval
582176|NCT00710788|QT dispersion|qt dispersion
582177|NCT00710788|arrhythmias|arrhythmias
582178|NCT00710788|death|death
582179|NCT00710788|TC score|tc score
582180|NCT00710775|Aortic valve stenosis|aortic valve stenosis
582181|NCT00710775|Heart surgery|heart surgery
582182|NCT00710775|Endovascular techniques|endovascular techniques
582183|NCT00710749|Lower urinary tract symptoms leading to lower flow rates|lower urinary tract symptoms leading to lower flow rates
582184|NCT00710697|Bladder Cancer|bladder cancer
582185|NCT00710697|Breast Cancer|breast cancer
582186|NCT00710697|Colorectal Cancer|colorectal cancer
582187|NCT00710697|Gastrointestinal Neoplasm|gastrointestinal neoplasm
582188|NCT00710697|Head and Neck Cancer|head and neck cancer
582189|NCT00710697|Lung Cancer|lung cancer
582190|NCT00710697|Ovarian Cancer|ovarian cancer
582191|NCT00710697|Pancreatic Cancer|pancreatic cancer
582192|NCT00710697|Prostrate Cancer|prostrate cancer
582193|NCT00710684|Alzheimer's disease cognition SB-742457|alzheimer's disease cognition sb-742457
582194|NCT00710671|HIV positive|hiv positive
582195|NCT00710671|YMSM|ymsm
582196|NCT00710671|risk factors|risk factors
582197|NCT00710671|coping|coping
582198|NCT00710671|identity development|identity development
582199|NCT00710671|psychosocial needs|psychosocial needs
582200|NCT00710658|Internet support|internet support
582201|NCT00710658|Tailored information|tailored information
582202|NCT00710658|Self-management|self-management
582203|NCT00710658|Quality of life|quality of life
582204|NCT00710658|Online messaging|online messaging
582205|NCT00710658|Online discussion groups|online discussion groups
582206|NCT00710645|Multiple Sclerosis|multiple sclerosis
582207|NCT00710645|Spasticity|spasticity
582208|NCT00710632|cachexia|cachexia
582209|NCT00710632|lung cancer|lung cancer
582210|NCT00710632|gastrointestinal cancer|gastrointestinal cancer
582211|NCT00710632|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
582212|NCT00710632|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
582213|NCT00710606|contraceptive ring|contraceptive ring
582214|NCT00710606|obesity|obesity
582215|NCT00710606|pharmacokinetics|pharmacokinetics
582216|NCT00710606|pharmacodynamics|pharmacodynamics
582217|NCT00710606|Pharmacokinetics of the contraceptive ring in obese women.|pharmacokinetics of the contraceptive ring in obese women.
582218|NCT00710593|Highly-active antiretroviral therapy|highly-active antiretroviral therapy
582219|NCT00710593|Human papillomavirus|human papillomavirus
582220|NCT00710593|HPV vaccine|hpv vaccine
582221|NCT00710567|Heart Failure|heart failure
582222|NCT00710567|LVAS|lvas
582223|NCT00710567|LVAD|lvad
582224|NCT00710567|Rotary Pump|rotary pump
582225|NCT00710554|Pain|pain
582226|NCT00710554|Peripheral Neuropathy|peripheral neuropathy
582227|NCT00710554|Allodynia|allodynia
582228|NCT00710541|non invasive ventilation|non invasive ventilation
582229|NCT00710541|COPD|copd
582230|NCT00710541|hypercapnia|hypercapnia
582231|NCT00710541|GOLD stage IV|gold stage iv
582232|NCT00710528|CLL|cll
582233|NCT00710528|NHL|nhl
582234|NCT00710528|AML|aml
582235|NCT00710528|MM|mm
582236|NCT00710528|Phosphatidylinositol 3-kinase|phosphatidylinositol 3-kinase
582237|NCT00710515|Melanoma|melanoma
582238|NCT00710515|Phase I|phase i
582239|NCT00710515|AZD6244|azd6244
582240|NCT00710502|Transvaginal|transvaginal
582241|NCT00710502|NOTES|notes
582242|NCT00710502|Cholecystectomy|cholecystectomy
582243|NCT00710502|Laparoscopic|laparoscopic
582244|NCT00710489|Acne|acne
582245|NCT00710489|Actinic Keratosis|actinic keratosis
582246|NCT00710489|Dysplastic Nevi|dysplastic nevi
582247|NCT00710489|Eczema|eczema
582248|NCT00710489|Psoriasis|psoriasis
582249|NCT00710489|Vitiligo|vitiligo
582250|NCT00710489|Skin Cancer|skin cancer
582251|NCT00710489|Rosacea|rosacea
582252|NCT00710489|Leg or Foot Ulcers|leg or foot ulcers
582253|NCT00710489|Atopic Dermatosis|atopic dermatosis
582254|NCT00710463|COPD|copd
582255|NCT00710463|non invasive ventilation|non invasive ventilation
582256|NCT00710463|pulmonary rehabilitation|pulmonary rehabilitation
582257|NCT00710450|IL13|il13
582258|NCT00710450|leukotriene|leukotriene
582259|NCT00710450|histamine|histamine
582261|NCT00710450|Must be allergic asthma or allergic rhinitis|must be allergic asthma or allergic rhinitis
582262|NCT00710437|Dexmedetomidine|dexmedetomidine
582263|NCT00710437|Carotid Endarterectomy|carotid endarterectomy
582264|NCT00710437|Electroencephalogram|electroencephalogram
582265|NCT00710424|Pain|pain
582266|NCT00710424|diabetic neuropathy|diabetic neuropathy
582267|NCT00710411|humans|humans
582268|NCT00710411|patients|patients
582269|NCT00710411|polytrauma|polytrauma
582270|NCT00710411|complement|complement
582271|NCT00710411|inflammation|inflammation
582272|NCT00710411|inflammatory response|inflammatory response
582273|NCT00710411|biomarkers|biomarkers
582274|NCT00710411|cytokines|cytokines
582275|NCT00710411|cell surface markers|cell surface markers
582276|NCT00710411|apoptosis|apoptosis
582277|NCT00710411|NF-kappaB|nf-kappab
582278|NCT00710411|functional polymorphisms|functional polymorphisms
582279|NCT00710411|mesenchymal stem cell|mesenchymal stem cell
582280|NCT00710411|severity of injury|severity of injury
582281|NCT00710411|ISS|iss
582282|NCT00710411|infections|infections
582283|NCT00710411|systemic inflammatory response syndrome|systemic inflammatory response syndrome
582284|NCT00710411|SIRS|sirs
582285|NCT00710411|sepsis|sepsis
582286|NCT00710411|severe sepsis|severe sepsis
582287|NCT00710411|shock|shock
582288|NCT00710411|organ dysfunctions|organ dysfunctions
582289|NCT00710411|SOFA|sofa
582290|NCT00710411|severity of disease|severity of disease
582291|NCT00710411|APACHEII|apacheii
582292|NCT00710411|SAPSII|sapsii
582293|NCT00710411|SPAPS3|spaps3
582294|NCT00710411|length of stay|length of stay
582295|NCT00710411|wound healing|wound healing
582296|NCT00710411|outcome|outcome
582297|NCT00710411|mortality|mortality
582298|NCT00710398|Dairy Products|dairy products
582299|NCT00710398|Dietary Protein|dietary protein
582300|NCT00710398|Body Composition|body composition
582301|NCT00710398|Fat mass loss|fat mass loss
582302|NCT00710398|Lean mass gain|lean mass gain
582303|NCT00710398|Pre-menopausal Women|pre-menopausal women
582304|NCT00710359|Cobalamin deficiency|cobalamin deficiency
582305|NCT00710359|Infant|infant
582306|NCT00710359|Nutrition|nutrition
582307|NCT00710359|Cobalamin supplementation|cobalamin supplementation
582308|NCT00710359|Feeding problems|feeding problems
582309|NCT00710359|Gastrointestinal symptoms|gastrointestinal symptoms
582310|NCT00710346|Leiomyoma|leiomyoma
582311|NCT00710346|Uterus|uterus
582312|NCT00710346|Fibroids|fibroids
582313|NCT00710346|Surgical|surgical
582314|NCT00710320|Children core temperature,|children core temperature,
582315|NCT00710320|Pediatric surgery,|pediatric surgery,
582316|NCT00710320|Anesthesia induction|anesthesia induction
582317|NCT00710294|Refractory Hypertension|refractory hypertension
582318|NCT00710294|High Blood Pressure|high blood pressure
582319|NCT00710294|Uncontrolled Blood Pressure|uncontrolled blood pressure
582320|NCT00710281|Intracranial Aneurysm|intracranial aneurysm
582321|NCT00710281|Subarachnoid arterial aneurysm|subarachnoid arterial aneurysm
582322|NCT00710281|Aneurysm|aneurysm
582323|NCT00710281|Brain Aneurysm|brain aneurysm
582324|NCT00710281|Cerebral Aneurysm|cerebral aneurysm
582325|NCT00710281|Wall Shear Stress(WSS)|wall shear stress(wss)
582326|NCT00710281|Hemodynamic Stress|hemodynamic stress
582327|NCT00710281|Subarachnoid Hemorrhage(SAH)|subarachnoid hemorrhage(sah)
582328|NCT00710268|Bevacizumab|bevacizumab
582329|NCT00710268|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
582330|NCT00710268|Metastatic Solid Tumours|metastatic solid tumours
582331|NCT00710268|PARP inhibitor|parp inhibitor
582332|NCT00710255|Asthma|asthma
582333|NCT00710255|Exercise induced bronchospasm|exercise induced bronchospasm
582334|NCT00710255|Hyperpnea induced bronchospasm|hyperpnea induced bronchospasm
582335|NCT00710255|leukotrienes|leukotrienes
582336|NCT00710255|adenosine|adenosine
582337|NCT00710255|exhaled breath condensate|exhaled breath condensate
582338|NCT00710242|prolonged labor|prolonged labor
582339|NCT00710229|age related macular degeneration|age related macular degeneration
582340|NCT00710229|Ranibizumab-Lucentis|ranibizumab-lucentis
582341|NCT00710229|Bevacizumab-Avastin|bevacizumab-avastin
582342|NCT00710216|Viral kinetics|viral kinetics
582343|NCT00710216|Viral dynamics|viral dynamics
582344|NCT00710216|Telbivudine|telbivudine
582345|NCT00710216|Lamivudine|lamivudine
582346|NCT00710203|Dermatosis Papulosa Nigra|dermatosis papulosa nigra
582347|NCT00710203|seborrheic keratoses|seborrheic keratoses
582348|NCT00710190|Drug Resistant Hypertension|drug resistant hypertension
582349|NCT00710190|Refractory Hypertension|refractory hypertension
582350|NCT00710190|High Blood Pressure|high blood pressure
582351|NCT00710190|Baroreflex Hypertension Therapy|baroreflex hypertension therapy
582352|NCT00710177|PPHN|pphn
582353|NCT00710177|PTGS1|ptgs1
582354|NCT00710177|NSAID|nsaid
582355|NCT00710151|neurotoxicity|neurotoxicity
582356|NCT00710151|cognition in survivors|cognition in survivors
582357|NCT00710151|diagnostic imaging|diagnostic imaging
582358|NCT00710138|Cobalamin deficiency|cobalamin deficiency
582359|NCT00710138|Infant|infant
582360|NCT00710138|Nutrition|nutrition
583462|NCT00705549|Gemcitabine|gemcitabine
582361|NCT00710138|Cobalamin supplementation|cobalamin supplementation
582362|NCT00710138|Neurodevelopment|neurodevelopment
582363|NCT00710138|Neurological symptoms|neurological symptoms
582364|NCT00710112|CLD|cld
582365|NCT00710112|VLBW infants|vlbw infants
582366|NCT00710112|Toll like Receptors|toll like receptors
582367|NCT00710112|Biomarkers|biomarkers
582368|NCT00710099|iontophoresis|iontophoresis
582369|NCT00710099|cutaneous microcirculation|cutaneous microcirculation
582370|NCT00710099|sildenafil|sildenafil
582371|NCT00710099|Healthy volunteers|healthy volunteers
582372|NCT00710086|Remifentanil|remifentanil
582373|NCT00710086|Patient-controlled analgesia|patient-controlled analgesia
582374|NCT00710086|Intravenous analgesia|intravenous analgesia
582375|NCT00710073|Chronic pelvic pain syndrome|chronic pelvic pain syndrome
582376|NCT00710073|Neuromodulation|neuromodulation
582378|NCT00710060|Popular Opinion Leader|popular opinion leader
582379|NCT00710060|POL|pol
582380|NCT00710060|Behavioral Intervention|behavioral intervention
582381|NCT00710060|STD|std
582382|NCT00710060|STI|sti
582383|NCT00710060|Community|community
582384|NCT00710060|Prevention|prevention
582385|NCT00710060|International|international
582386|NCT00710060|Global|global
582387|NCT00710047|ZD4054|zd4054
582388|NCT00710047|Zibotentan|zibotentan
582389|NCT00710047|Healthy Volunteers|healthy volunteers
582390|NCT00710034|Oral Tobacco Products|oral tobacco products
582391|NCT00710034|Snus|snus
582392|NCT00710034|Smoking Substitution|smoking substitution
582393|NCT00710034|Harm Reduction|harm reduction
582394|NCT00710034|Biomarkers of Tobacco Exposure|biomarkers of tobacco exposure
582395|NCT00710021|Systemic lupus erythematosus|systemic lupus erythematosus
582396|NCT00710021|SLE|sle
582397|NCT00710021|Vitamin D3|vitamin d3
582398|NCT00710021|Vitamin D deficiency|vitamin d deficiency
582399|NCT00710021|IFN alpha expression|ifn alpha expression
582400|NCT00710008|type 2 diabetes,|type 2 diabetes,
582401|NCT00710008|exercise training,|exercise training,
582402|NCT00710008|ATP-synthesis,|atp-synthesis,
582403|NCT00710008|intramyocellular lipids,|intramyocellular lipids,
582404|NCT00710008|hepatocellular lipids|hepatocellular lipids
582405|NCT00710008|first degree relatives of|first degree relatives of
582406|NCT00710008|patients|patients
582407|NCT00709982|Norgestimate|norgestimate
582408|NCT00709982|Contraceptives, Oral|contraceptives, oral
582409|NCT00709982|Ortho-Cyclen|ortho-cyclen
582410|NCT00709982|Folic Acid|folic acid
582411|NCT00709982|Ethinyl Estradiol|ethinyl estradiol
582412|NCT00709969|Malaria|malaria
582413|NCT00709969|co-artemether|co-artemether
582414|NCT00709969|auditory|auditory
582415|NCT00709969|Plasmodium falciparum|plasmodium falciparum
582416|NCT00709969|marsh fever|marsh fever
582417|NCT00709969|remittent fever|remittent fever
582418|NCT00709969|artemether|artemether
582419|NCT00709969|artemisinins|artemisinins
582420|NCT00709969|lumefantrine|lumefantrine
582421|NCT00709969|child|child
582422|NCT00709969|infant|infant
582423|NCT00709969|Africa|africa
582424|NCT00709956|Ventavis|ventavis
582425|NCT00709956|iloprost|iloprost
582426|NCT00709956|inhaled treatment|inhaled treatment
582427|NCT00709956|pulmonary arterial hypertension|pulmonary arterial hypertension
582428|NCT00709904|venous thromboprophylaxis|venous thromboprophylaxis
582429|NCT00709904|primary prevention|primary prevention
582430|NCT00709904|orthopedic surgery|orthopedic surgery
582431|NCT00709878|skin rash, lapatinib, cetuximab, erlotinib, panitumumab|skin rash, lapatinib, cetuximab, erlotinib, panitumumab
582432|NCT00709865|renal insufficiency|renal insufficiency
582433|NCT00709865|diuretic|diuretic
582434|NCT00709865|congestive heart failure|congestive heart failure
582435|NCT00709865|acute decompensated heart failure|acute decompensated heart failure
582436|NCT00709852|Patients referred for a contrast-enhanced MRI of the CNS|patients referred for a contrast-enhanced mri of the cns
582437|NCT00709852|CNS Imaging|cns imaging
582438|NCT00709839|glucocorticoid|glucocorticoid
582439|NCT00709839|hydrocortisone|hydrocortisone
582440|NCT00709839|carbohydrate metabolism|carbohydrate metabolism
582441|NCT00709839|appetite-regulatory hormones|appetite-regulatory hormones
582442|NCT00709813|Symptom management|symptom management
582443|NCT00709813|Cancer|cancer
582444|NCT00709813|Patient-centered care|patient-centered care
582445|NCT00709800|Pandemic Influenza|pandemic influenza
582446|NCT00709800|Avian Influenza|avian influenza
582447|NCT00709800|DNA Vaccines|dna vaccines
582448|NCT00709800|Antibody|antibody
582449|NCT00709800|T Cells|t cells
582450|NCT00709800|HA/NP/M2|ha/np/m2
582451|NCT00709787|Epidemiology, hypertension, risk factors, coronary heart disease, patient management, compliance with medication|epidemiology, hypertension, risk factors, coronary heart disease, patient management, compliance with medication
582452|NCT00709761|Erbb2|erbb2
582453|NCT00709761|ABRAXANE|abraxane
582454|NCT00709761|MBC|mbc
582455|NCT00709761|first or second line therapy|first or second line therapy
582456|NCT00709761|Metastatic Breast Cancer|metastatic breast cancer
582457|NCT00709761|TYKERB|tykerb
582458|NCT00709748|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
582459|NCT00709748|TENS|tens
582461|NCT00709748|Electrotherapy|electrotherapy
582462|NCT00709748|Back pain|back pain
582463|NCT00709748|Lower back pain|lower back pain
582464|NCT00709748|Chronic lower back pain|chronic lower back pain
582465|NCT00709735|stress disorders|stress disorders
582466|NCT00709735|post-traumatic|post-traumatic
582467|NCT00709735|memory|memory
582468|NCT00709735|propranolol|propranolol
582469|NCT00709735|psychophysiology|psychophysiology
582470|NCT00709722|Lupus nephritis|lupus nephritis
582471|NCT00709722|Deoxyspergualin|deoxyspergualin
582472|NCT00709722|Immunosuppression|immunosuppression
582473|NCT00709709|stenosis|stenosis
582474|NCT00709709|coronaropathy|coronaropathy
582475|NCT00709709|stent|stent
582476|NCT00709709|bypass surgery|bypass surgery
582477|NCT00709709|suspect|suspect
582478|NCT00709709|known|known
582479|NCT00709696|Tobacco|tobacco
582480|NCT00709696|nicotine|nicotine
582481|NCT00709696|smoking|smoking
582482|NCT00709696|varenicline|varenicline
582483|NCT00709696|human laboratory study|human laboratory study
582484|NCT00709696|stress tolerance|stress tolerance
582485|NCT00709696|startle response|startle response
582486|NCT00709696|cognitive assessment|cognitive assessment
582487|NCT00709696|progressive ratio|progressive ratio
582488|NCT00709670|MSCT|msct
582489|NCT00709670|Echocardiography|echocardiography
582490|NCT00709670|Coronarography|coronarography
582491|NCT00709670|Acute coronary syndrome without ST segment elevation|acute coronary syndrome without st segment elevation
582492|NCT00709670|normal ECG|normal ecg
582493|NCT00709670|normal troponin|normal troponin
582494|NCT00709670|Acute|acute
582495|NCT00709657|Age-related macular degeneration|age-related macular degeneration
582496|NCT00709657|anti-VEGF|anti-vegf
582497|NCT00709644|Ortho Tri-Cyclen Lo|ortho tri-cyclen lo
582498|NCT00709644|Contraceptives, Oral|contraceptives, oral
582499|NCT00709644|Norgestimate|norgestimate
582500|NCT00709644|Ethinyl Estradiol|ethinyl estradiol
582501|NCT00709644|Folic Acid|folic acid
582502|NCT00709644|Female Contraception|female contraception
582503|NCT00709631|Malignant transformation of leg ulcer|malignant transformation of leg ulcer
582504|NCT00709631|MARJOLIN's ulcer|marjolin's ulcer
582505|NCT00709631|Biopsy|biopsy
582506|NCT00709631|Leg ulcer|leg ulcer
582507|NCT00709631|Chronic wound|chronic wound
582508|NCT00709631|Squamous cell carcinoma|squamous cell carcinoma
582509|NCT00709631|Basal cell carcinoma|basal cell carcinoma
582510|NCT00709618|Erbb2|erbb2
582511|NCT00709618|MBC|mbc
582512|NCT00709618|First or Second line therapy|first or second line therapy
582513|NCT00709618|Metastatic Breast Cancer|metastatic breast cancer
582514|NCT00709618|Vinorelbine|vinorelbine
582515|NCT00709618|Tykerb|tykerb
582516|NCT00709605|HIV Negative|hiv negative
582517|NCT00709605|Healthy|healthy
582518|NCT00709605|Immunity|immunity
582519|NCT00709605|Preventive|preventive
582520|NCT00709605|Virus|virus
582521|NCT00709605|Healthy Volunteer|healthy volunteer
582522|NCT00709605|HV|hv
582523|NCT00709592|total body irradiation|total body irradiation
582524|NCT00709592|Allogeneic Peripheral Blood Stem Cell Transplantation|allogeneic peripheral blood stem cell transplantation
582525|NCT00709592|thymoglobulin|thymoglobulin
582526|NCT00709579|Patients needing an oral corticotherapy|patients needing an oral corticotherapy
582527|NCT00709579|Patients needing a topical corticotherapy|patients needing a topical corticotherapy
582528|NCT00709579|Corticotherapy|corticotherapy
582529|NCT00709566|Hip|hip
582530|NCT00709566|osteoarthritis|osteoarthritis
582531|NCT00709566|exercise|exercise
582532|NCT00709566|manual therapy|manual therapy
582533|NCT00709553|ZD4054|zd4054
582534|NCT00709553|Healthy Volunteers|healthy volunteers
582535|NCT00709527|AMD|amd
582536|NCT00709514|Oneness|oneness
582537|NCT00709514|DCB-WH1|dcb-wh1
582538|NCT00709514|DCB-WH1-CP001|dcb-wh1-cp001
582539|NCT00709514|chronic|chronic
582540|NCT00709514|diabetic|diabetic
582541|NCT00709514|foot ulcers|foot ulcers
582542|NCT00709514|topical ointment|topical ointment
582543|NCT00709501|weight loss|weight loss
582544|NCT00709501|obesity|obesity
582545|NCT00709501|overweight|overweight
582546|NCT00709488|Litx™ BPH System|litx™ bph system
582547|NCT00709488|LS11|ls11
582548|NCT00709488|Talaporfin sodium|talaporfin sodium
582549|NCT00709462|Breast cancer|breast cancer
582550|NCT00709462|Colorectal cancer|colorectal cancer
582551|NCT00709462|Pancreatic cancer|pancreatic cancer
582552|NCT00709462|Bladder cancer|bladder cancer
582553|NCT00709462|Ovarian cancer|ovarian cancer
582554|NCT00709462|Metastatic cancer|metastatic cancer
582555|NCT00709462|Locally advanced cancer|locally advanced cancer
582556|NCT00709462|Cancer Vaccine|cancer vaccine
582557|NCT00709462|Vaccine|vaccine
582558|NCT00709449|Age-related macular degeneration|age-related macular degeneration
582559|NCT00709449|Glaucoma|glaucoma
582560|NCT00709436|orthopedic|orthopedic
582561|NCT00709436|ketamine|ketamine
582562|NCT00709436|pain|pain
582563|NCT00709410|Cholera, Diarrhea, Vaccination, Vaccines|cholera, diarrhea, vaccination, vaccines
582564|NCT00709397|HIV-1|hiv-1
582565|NCT00709397|drug resistance|drug resistance
582567|NCT00709397|integrase inhibitor|integrase inhibitor
582568|NCT00709371|obesity|obesity
582569|NCT00709371|zonisamide|zonisamide
582570|NCT00709371|bupropion|bupropion
582571|NCT00709358|bacteria|bacteria
582572|NCT00709358|fungi|fungi
582573|NCT00709358|real time PCR|real time pcr
582574|NCT00709358|adequate antimicrobial therapy|adequate antimicrobial therapy
582575|NCT00709358|microbial DNA|microbial dna
582576|NCT00709358|microbial diagnosis|microbial diagnosis
582577|NCT00709345|Antipsychotic Medications|antipsychotic medications
582578|NCT00709345|Behavioral Interventions|behavioral interventions
582579|NCT00709332|Norgestimate|norgestimate
582580|NCT00709332|Folic Acid|folic acid
582581|NCT00709332|Ortho-Cyclen|ortho-cyclen
582582|NCT00709332|Female contraception|female contraception
582583|NCT00709332|Ethinyl Estradiol|ethinyl estradiol
582584|NCT00709332|Drug Interactions|drug interactions
582585|NCT00709332|Pharmacokinetics|pharmacokinetics
582586|NCT00709332|Contraceptives, Oral|contraceptives, oral
582587|NCT00709319|Diabetic retinopathy|diabetic retinopathy
582588|NCT00709319|Diabetic macular edema|diabetic macular edema
582589|NCT00709319|dme|dme
582590|NCT00709319|vitrectomy|vitrectomy
582591|NCT00709293|Ischemia Reperfusion Injury|ischemia reperfusion injury
582592|NCT00709293|Pediatric Heart Transplant|pediatric heart transplant
582593|NCT00709293|ATG|atg
582594|NCT00709293|Induction Therapy|induction therapy
582595|NCT00709280|Cystic Fibrosis|cystic fibrosis
582596|NCT00709280|hypertonic saline|hypertonic saline
582597|NCT00709280|inhaled saline|inhaled saline
582598|NCT00709267|Folic Acid|folic acid
582599|NCT00709267|Chemistry, Analytical|chemistry, analytical
582600|NCT00709267|Administration, Oral|administration, oral
582601|NCT00709267|Infusions, Intravenous|infusions, intravenous
582602|NCT00709267|Biological Availability|biological availability
582603|NCT00709267|Safety|safety
582604|NCT00709254|AeroLEF|aerolef
582605|NCT00709254|fentanyl|fentanyl
582606|NCT00709254|pharmacokinetics|pharmacokinetics
582607|NCT00709254|liposome|liposome
582608|NCT00709254|encapsulated|encapsulated
582609|NCT00709241|Heart failure|heart failure
582610|NCT00709241|Psychosocial factors|psychosocial factors
582611|NCT00709241|Depression|depression
582612|NCT00709241|Patient compliance|patient compliance
582613|NCT00709215|refractory TdT-positive leukemia|refractory tdt-positive leukemia
582614|NCT00709215|ALL|all
582615|NCT00709215|AML|aml
582616|NCT00709215|blastic CML|blastic cml
582617|NCT00709189|Pharmacokinetics|pharmacokinetics
582618|NCT00709189|Ethinyl Estradiol|ethinyl estradiol
582619|NCT00709189|Drug Interactions|drug interactions
582620|NCT00709189|Norgestimate|norgestimate
582621|NCT00709189|Contraceptives, Oral|contraceptives, oral
582622|NCT00709189|Ortho-Cyclen|ortho-cyclen
582623|NCT00709189|Folic Acid|folic acid
582624|NCT00709176|Quality of Life|quality of life
582752|NCT00708617|Liver fibrosis|liver fibrosis
582625|NCT00709176|Randomized Clinical Trial|randomized clinical trial
582626|NCT00709176|Advanced Cancer|advanced cancer
582627|NCT00709176|Breast Cancer|breast cancer
582628|NCT00709176|Colorectal Cancer|colorectal cancer
582629|NCT00709176|Lung Cancer|lung cancer
582630|NCT00709176|Prostate Cancer|prostate cancer
582631|NCT00709176|Family caregiver|family caregiver
582632|NCT00709176|cancer survivorship|cancer survivorship
582633|NCT00709176|coping|coping
582634|NCT00709176|communication|communication
582635|NCT00709176|uncertainty|uncertainty
582636|NCT00709176|support|support
582637|NCT00709176|depression|depression
582638|NCT00709176|self-efficacy|self-efficacy
582639|NCT00709176|benefits of illness|benefits of illness
582640|NCT00709176|Caregivers|caregivers
582641|NCT00709163|Pediatric|pediatric
582642|NCT00709163|Dilated Cardiomyopathy|dilated cardiomyopathy
582643|NCT00709163|Nesiritide|nesiritide
582644|NCT00709150|Major Depression|major depression
582645|NCT00709150|Diabetes|diabetes
582646|NCT00709150|Hispanics|hispanics
582647|NCT00709150|Collaborative Depression Care Management|collaborative depression care management
582648|NCT00709137|resistant hypertensions|resistant hypertensions
582649|NCT00709137|spironolactone|spironolactone
582650|NCT00709137|amiloride|amiloride
582651|NCT00709137|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
582652|NCT00709124|Respiration, Artificial|respiration, artificial
582653|NCT00709124|Critical Illness|critical illness
582654|NCT00709124|Intensive Care Units|intensive care units
582655|NCT00709124|Electric Stimulation Therapy|electric stimulation therapy
582656|NCT00709124|Muscle Weakness|muscle weakness
582657|NCT00709124|Paresis|paresis
582658|NCT00709124|Mechanically|mechanically
582659|NCT00709124|Ventilated|ventilated
582660|NCT00709124|Patients|patients
582661|NCT00709124|Admitted|admitted
582662|NCT00709124|Medical|medical
582663|NCT00709111|CCR5 antagonist|ccr5 antagonist
582664|NCT00709111|CD4 T-cell count|cd4 t-cell count
582665|NCT00709111|immune activation|immune activation
582666|NCT00709111|treatment experienced|treatment experienced
582667|NCT00709098|pulmonary arterial hypertension|pulmonary arterial hypertension
582668|NCT00709098|inhaled treatment|inhaled treatment
582669|NCT00709098|inhalation solution|inhalation solution
582670|NCT00709098|iloprost|iloprost
582671|NCT00709098|Ventavis|ventavis
582672|NCT00709085|single nucleotide polymorphism|single nucleotide polymorphism
582673|NCT00709072|stuttering|stuttering
582674|NCT00709072|relapse|relapse
582675|NCT00709072|Lidcombe Program|lidcombe program
582676|NCT00709072|Preschool children|preschool children
582677|NCT00709059|hepatitis C|hepatitis c
582678|NCT00709046|Endoscopic treatment|endoscopic treatment
582679|NCT00709046|Peptic ulcer|peptic ulcer
582680|NCT00709046|Bleeding|bleeding
582681|NCT00709046|Thermocoagulation|thermocoagulation
582682|NCT00709046|Proton pump inhibitors|proton pump inhibitors
582683|NCT00709033|refractory|refractory
582684|NCT00709033|relapsed|relapsed
582685|NCT00709033|low|low
582686|NCT00709033|intermediate-grade|intermediate-grade
582687|NCT00709033|Non-Hodgkin lymphoma|non-hodgkin lymphoma
582688|NCT00709033|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
582689|NCT00709020|cancer survivor|cancer survivor
582690|NCT00709020|breast cancer|breast cancer
582691|NCT00708981|Diabetic Nephropathy|diabetic nephropathy
582692|NCT00708968|randomized clinical trial|randomized clinical trial
582693|NCT00708968|coping|coping
582694|NCT00708968|quality of life|quality of life
582695|NCT00708968|family|family
582696|NCT00708968|family caregiver|family caregiver
582697|NCT00708968|cancer survivorship|cancer survivorship
582698|NCT00708968|communication|communication
582699|NCT00708968|uncertainty|uncertainty
582700|NCT00708968|support|support
582701|NCT00708968|family education|family education
582702|NCT00708968|Caregivers|caregivers
582703|NCT00708955|Evaluation and Treatment|evaluation and treatment
582704|NCT00708955|Eye Diseases|eye diseases
582705|NCT00708942|Cervical intraepithelial neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
582706|NCT00708929|Age-related macular degeneration|age-related macular degeneration
582707|NCT00708929|Complement factor H|complement factor h
582708|NCT00708929|Choroidal blood flow|choroidal blood flow
582709|NCT00708916|Cutaneous lupus|cutaneous lupus
582710|NCT00708916|Intervention|intervention
582711|NCT00708916|Discoid lupus|discoid lupus
582712|NCT00708916|Phosphodiesterase 5 inhibitor|phosphodiesterase 5 inhibitor
582713|NCT00708903|Thorough QTc study|thorough qtc study
582714|NCT00708890|Substance use disorders|substance use disorders
582715|NCT00708890|Self-help groups|self-help groups
582716|NCT00708890|Twelve Step groups|twelve step groups
582717|NCT00708877|cancer|cancer
582718|NCT00708877|cholangiocarcinoma|cholangiocarcinoma
582719|NCT00708851|psoriasis|psoriasis
582720|NCT00708812|Non-small Cell Lung Cancer|non-small cell lung cancer
582721|NCT00708812|Endostar|endostar
582722|NCT00708812|Paclitaxel|paclitaxel
582723|NCT00708812|Carboplatin|carboplatin
582724|NCT00708760|web based learning|web based learning
582725|NCT00708760|moderate sedation|moderate sedation
582726|NCT00708747|Immunoglobulins|immunoglobulins
582727|NCT00708747|inhibitor proteins|inhibitor proteins
582728|NCT00708747|human albumin|human albumin
582729|NCT00708747|systemic inflammatory response syndrome|systemic inflammatory response syndrome
582730|NCT00708747|interleukins|interleukins
582731|NCT00708747|standardized serum-protein solution|standardized serum-protein solution
582732|NCT00708734|exercise|exercise
582733|NCT00708721|hypomethylating therapy|hypomethylating therapy
582734|NCT00708721|CML|cml
582735|NCT00708721|myelodysplastic syndromes|myelodysplastic syndromes
582736|NCT00708708|Plaque-type psoriasis|plaque-type psoriasis
582737|NCT00708695|nurse|nurse
582738|NCT00708695|home visits|home visits
582739|NCT00708695|pregnancy|pregnancy
582740|NCT00708695|welfare|welfare
582741|NCT00708695|child development|child development
582742|NCT00708695|Child Rearing|child rearing
582743|NCT00708695|Reproductive Behavior|reproductive behavior
582744|NCT00708695|Risk Reduction Behavior|risk reduction behavior
582745|NCT00708656|IBD|ibd
582746|NCT00708656|Colitis|colitis
582747|NCT00708656|UC|uc
582748|NCT00708630|yellow fever vaccine|yellow fever vaccine
582749|NCT00708630|patient information|patient information
582750|NCT00708630|symptom reports|symptom reports
582751|NCT00708630|patient satisfaction|patient satisfaction
582753|NCT00708617|Alcoholic liver disease|alcoholic liver disease
582754|NCT00708617|Non invasive diagnostic methods|non invasive diagnostic methods
582755|NCT00708617|Transient elastography|transient elastography
582756|NCT00708617|Fibrotest|fibrotest
582757|NCT00708604|Diabetes Mellitus|diabetes mellitus
582758|NCT00708604|Kidney Transplantation|kidney transplantation
582759|NCT00708604|Islet Transplantation|islet transplantation
582760|NCT00708604|Sirolimus/Tacrolimus/MMF-based Immunosuppressive Regimen|sirolimus/tacrolimus/mmf-based immunosuppressive regimen
582761|NCT00708565|To study the effects of iloprost on hypoxic pulmonary vasoconstriction at high altitude|to study the effects of iloprost on hypoxic pulmonary vasoconstriction at high altitude
582762|NCT00708552|Alzheimer's disease|alzheimer's disease
582763|NCT00708552|Cognition|cognition
582764|NCT00708552|SB-742457|sb-742457
582765|NCT00708526|hypercapnia|hypercapnia
582766|NCT00708526|hyperpnoea|hyperpnoea
582767|NCT00708526|accelerated recovery|accelerated recovery
582768|NCT00708513|Cell Saver|cell saver
582769|NCT00708513|Liver Tumors|liver tumors
582770|NCT00708513|Liver Cancer|liver cancer
582771|NCT00708513|Surgical Oncology|surgical oncology
582772|NCT00708513|Whipple|whipple
582773|NCT00708513|Blood Transfusion|blood transfusion
582774|NCT00708513|Blood salvage|blood salvage
582775|NCT00708513|cancer surgery|cancer surgery
582776|NCT00708513|blood loss|blood loss
582777|NCT00708500|Treatment failure|treatment failure
582778|NCT00708487|in vitro fertilization|in vitro fertilization
582779|NCT00708487|oxygen concentration|oxygen concentration
582780|NCT00708487|blastocyst|blastocyst
582781|NCT00708487|live birth|live birth
582782|NCT00708487|embryo|embryo
582783|NCT00708474|Bone graft|bone graft
582784|NCT00708474|Bone void filler|bone void filler
582785|NCT00708474|Bone plug|bone plug
582786|NCT00708474|OsseoFit™|osseofit™
582787|NCT00708474|knee|knee
582788|NCT00708474|bone graft sites in the knee|bone graft sites in the knee
582789|NCT00708461|obesity|obesity
582790|NCT00708461|obesity prevention|obesity prevention
582791|NCT00708461|worksite|worksite
582792|NCT00708461|environment|environment
582793|NCT00708461|intervention|intervention
582794|NCT00708448|NSCLC|nsclc
582795|NCT00708435|Anticoagulant reversal|anticoagulant reversal
582796|NCT00708435|Prothrombin|prothrombin
582797|NCT00708435|Complex|complex
582798|NCT00708435|Concentrate|concentrate
582799|NCT00708435|Coagulopathy|coagulopathy
582800|NCT00708435|induced by|induced by
582801|NCT00708435|coumarin|coumarin
582802|NCT00708435|derivatives|derivatives
582803|NCT00708435|Kcentra|kcentra
582804|NCT00708422|Ocular surface health|ocular surface health
582805|NCT00708422|OSDI|osdi
582806|NCT00708422|TFBUT|tfbut
582807|NCT00708422|Glaucoma|glaucoma
582808|NCT00708422|Ocular hypertension|ocular hypertension
582809|NCT00708422|Corneal staining|corneal staining
582810|NCT00708409|Ross operation|ross operation
582811|NCT00708409|autograft procedure|autograft procedure
582812|NCT00708409|pulmonary homograft|pulmonary homograft
582813|NCT00708409|root replacement technique|root replacement technique
582814|NCT00708409|subcoronary implantation technique|subcoronary implantation technique
582815|NCT00708396|Patients|patients
582816|NCT00708396|suffer|suffer
582817|NCT00708396|from|from
582818|NCT00708383|embryo development|embryo development
582819|NCT00708383|embryo quality|embryo quality
582820|NCT00708383|implantation|implantation
582821|NCT00708383|IVF/ICSI outcome|ivf/icsi outcome
582822|NCT00708383|multiple pregnancy|multiple pregnancy
582823|NCT00708370|Interventional|interventional
582824|NCT00708370|Non-drug|non-drug
582825|NCT00708370|Disease Management Program|disease management program
582826|NCT00708370|Cardiovascular Risk Control|cardiovascular risk control
582827|NCT00708370|Dyslipidemias|dyslipidemias
582828|NCT00708370|Primary Care Centers|primary care centers
582829|NCT00708357|eNOS Gene Polymorphism|enos gene polymorphism
582830|NCT00708357|ocular blood flow|ocular blood flow
582831|NCT00708331|Cataract|cataract
582832|NCT00708331|Extraction|extraction
582833|NCT00708331|Intraocular Lens|intraocular lens
582834|NCT00708331|Hydrophilic Acrylic|hydrophilic acrylic
582835|NCT00708318|AeroLEF|aerolef
582836|NCT00708318|fentanyl|fentanyl
582837|NCT00708318|pharmacokinetic|pharmacokinetic
582838|NCT00708318|liposome|liposome
582839|NCT00708318|encapsulated|encapsulated
582840|NCT00708305|toothpaste|toothpaste
582841|NCT00708305|plaque fluid|plaque fluid
582842|NCT00708305|fluoride|fluoride
582843|NCT00708292|AUY922|auy922
582844|NCT00708292|Multiple Myeloma|multiple myeloma
582845|NCT00708292|HSP90 inhibitors|hsp90 inhibitors
582846|NCT00708292|Phase I/II|phase i/ii
582847|NCT00708279|angina pectoris, osteopathic manipulation|angina pectoris, osteopathic manipulation
582848|NCT00708266|Obesity|obesity
582849|NCT00708266|Diabetes|diabetes
582850|NCT00708266|Non-esterified fatty acids|non-esterified fatty acids
582851|NCT00708266|Cytokines|cytokines
582852|NCT00708266|Inflammation|inflammation
582853|NCT00708266|Subcutaneous fat|subcutaneous fat
582854|NCT00708266|Adipose tissue|adipose tissue
582855|NCT00708253|balloon assisted enteroscopy|balloon assisted enteroscopy
582856|NCT00708253|single balloon enteroscopy|single balloon enteroscopy
582857|NCT00708253|double balloon enteroscopy|double balloon enteroscopy
582858|NCT00708253|insertion depth|insertion depth
582859|NCT00708227|Asthma|asthma
582860|NCT00708227|Pharmacogenetics|pharmacogenetics
582861|NCT00708227|Salmeterol|salmeterol
582862|NCT00708227|African American|african american
582863|NCT00708227|White|white
582864|NCT00708201|ileus|ileus
582865|NCT00708201|POI|poi
582866|NCT00708188|Stroke, ischemic, etiology, TOAST, CT, multidetector|stroke, ischemic, etiology, toast, ct, multidetector
582867|NCT00708175|Glucose Metabolism Disorder|glucose metabolism disorder
582868|NCT00708175|Dysmetabolic Syndrome|dysmetabolic syndrome
582869|NCT00708175|Type II Diabetes|type ii diabetes
582870|NCT00708175|Diabetes Mellitus|diabetes mellitus
582871|NCT00708175|Lipoatrophic|lipoatrophic
582872|NCT00708175|Postmenopausal|postmenopausal
582873|NCT00708162|HIV|hiv
582874|NCT00708162|HIV I|hiv i
582875|NCT00708162|Treatment Experienced|treatment experienced
582876|NCT00708149|lansoprazole, weaning,stress ulcer prophylaxis|lansoprazole, weaning,stress ulcer prophylaxis
582877|NCT00708136|Falls|falls
582878|NCT00708136|elderly|elderly
582879|NCT00708136|Balance|balance
582880|NCT00708136|speed of stepping|speed of stepping
582881|NCT00708136|Stability|stability
582882|NCT00708136|ELDERLY FALLERS|elderly fallers
582883|NCT00708123|remineralization|remineralization
582884|NCT00708123|enamel|enamel
582885|NCT00708123|fluoride|fluoride
582886|NCT00708123|caries|caries
582887|NCT00708123|in situ|in situ
582888|NCT00708110|dose-ranging study|dose-ranging study
582889|NCT00708110|phase IIa|phase iia
582890|NCT00708110|integrase inhibitor|integrase inhibitor
582891|NCT00708110|HIV-1 infection|hiv-1 infection
582892|NCT00708097|fluoride|fluoride
582893|NCT00708097|in situ|in situ
582894|NCT00708097|remineralization|remineralization
582895|NCT00708097|enamel|enamel
582896|NCT00708097|caries|caries
582897|NCT00708084|Rabies post-exposure prophylaxis|rabies post-exposure prophylaxis
582898|NCT00708084|Monoclonal antibody|monoclonal antibody
582899|NCT00708058|Implanted cardiac defibrillators|implanted cardiac defibrillators
582900|NCT00708058|Congestive Heart Failure|congestive heart failure
582901|NCT00708058|Emergency Department|emergency department
582902|NCT00708045|Breast Cancer|breast cancer
582903|NCT00708019|cancer pain|cancer pain
582904|NCT00708019|bone metastasis|bone metastasis
582905|NCT00708019|psychoeducational intervention|psychoeducational intervention
582906|NCT00708019|nurse coaching|nurse coaching
582907|NCT00708019|patient education|patient education
582908|NCT00708019|breast cancer|breast cancer
582909|NCT00707993|Glucose Metabolism Disorder|glucose metabolism disorder
582910|NCT00707993|Dysmetabolic Syndrome|dysmetabolic syndrome
582911|NCT00707993|Type II Diabetes|type ii diabetes
582912|NCT00707993|Diabetes Mellitus|diabetes mellitus
582913|NCT00707993|Lipoatrophic|lipoatrophic
582914|NCT00707993|Dyslipidemia|dyslipidemia
582915|NCT00707993|Drug Therapy|drug therapy
582916|NCT00707980|Major Depressive Disorder|major depressive disorder
582917|NCT00707980|Depression|depression
582918|NCT00707980|Melancholia|melancholia
582919|NCT00707980|Mood Disorder|mood disorder
582920|NCT00707980|Dysthymic Disorder|dysthymic disorder
582921|NCT00707980|Drug Therapy|drug therapy
582922|NCT00707967|Tuberculosis vaccine|tuberculosis vaccine
582923|NCT00707954|Diabetes|diabetes
582924|NCT00707954|TA-7284|ta-7284
582925|NCT00707941|Influenza like illness|influenza like illness
582926|NCT00707941|Pneumonia|pneumonia
582927|NCT00707941|Bronchiolitis|bronchiolitis
582928|NCT00707941|Upper respiratory tract illness|upper respiratory tract illness
582929|NCT00707941|Otitis media|otitis media
582930|NCT00707941|Viral shedding|viral shedding
582931|NCT00707941|Nasopharyngeal wash|nasopharyngeal wash
582932|NCT00707941|Viral culture|viral culture
582934|NCT00707928|retained placenta|retained placenta
582935|NCT00707915|aged|aged
582936|NCT00707915|benzodiazepines|benzodiazepines
582937|NCT00707915|hypnotics|hypnotics
582938|NCT00707915|cognition|cognition
582939|NCT00707915|posture|posture
582940|NCT00707902|Sore throats,|sore throats,
582941|NCT00707902|Pharyngitis|pharyngitis
582942|NCT00707902|Acute|acute
582943|NCT00707876|Peripheral arterial disease (PAD); Magnetic Resonance Angiography (MRA); Magnetic Resonance Imaging (MRI), imaging agent or biomarker|peripheral arterial disease (pad); magnetic resonance angiography (mra); magnetic resonance imaging (mri), imaging agent or biomarker
582944|NCT00707863|Escitalopram|escitalopram
582945|NCT00707863|Lexapro|lexapro
582946|NCT00707863|fMRI|fmri
582947|NCT00707863|pictures|pictures
582948|NCT00707850|Hepatitis C|hepatitis c
582949|NCT00707850|Thalassemia|thalassemia
582950|NCT00707850|Pegasys|pegasys
582951|NCT00707850|Ribavirin|ribavirin
582952|NCT00707824|pruritus|pruritus
582953|NCT00707824|epidural morphine|epidural morphine
582954|NCT00707811|Dyspnea|dyspnea
582955|NCT00707811|Shortness of Breath|shortness of breath
582956|NCT00707811|Trouble Breathing|trouble breathing
582957|NCT00707811|ST2|st2
582958|NCT00707811|IL-33|il-33
582959|NCT00707798|Young adults|young adults
582960|NCT00707798|Pneumococcal vaccine,|pneumococcal vaccine,
582961|NCT00707798|Streptococcus pneumoniae,|streptococcus pneumoniae,
582962|NCT00707785|vitamin A|vitamin a
582963|NCT00707785|Treatment|treatment
582964|NCT00707785|neonates|neonates
582965|NCT00707785|newborn|newborn
582966|NCT00707785|sepsis|sepsis
582967|NCT00707785|necrotizing enterocolitis|necrotizing enterocolitis
582968|NCT00707785|meningitis|meningitis
582969|NCT00707785|pneumonia|pneumonia
582970|NCT00707772|Hepatitis C|hepatitis c
582971|NCT00707772|Hemophilia|hemophilia
582972|NCT00707772|Pegasys|pegasys
582973|NCT00707772|Ribavirin|ribavirin
582974|NCT00707759|Pediatric renal transplantation,Bone metabolism (DXA-pQCT)|pediatric renal transplantation,bone metabolism (dxa-pqct)
582975|NCT00707759|mRNAFOXP3/IL-17,Steroid withdrawal|mrnafoxp3/il-17,steroid withdrawal
582976|NCT00707746|statin intolerant|statin intolerant
582977|NCT00707746|hypercholesterolemia|hypercholesterolemia
582978|NCT00707707|breast cancer|breast cancer
582979|NCT00707707|triple negative|triple negative
582980|NCT00707707|metastatic|metastatic
582981|NCT00707694|95 years of age and older|95 years of age and older
582982|NCT00707681|microbio, MS-20, Hepatoma, Advanced Hepatocellular Carcinoma|microbio, ms-20, hepatoma, advanced hepatocellular carcinoma
582983|NCT00707668|Diabetes|diabetes
582984|NCT00707668|metabolic syndrome|metabolic syndrome
582985|NCT00707668|dyslipidemia|dyslipidemia
582986|NCT00707668|osteoporosis|osteoporosis
582987|NCT00707642|West Nile Virus|west nile virus
582988|NCT00707642|West Nile Vaccine|west nile vaccine
582989|NCT00707642|West Nile virus disease|west nile virus disease
582990|NCT00707642|Hawaii Biotech|hawaii biotech
582991|NCT00707629|type 1 diabetes|type 1 diabetes
582992|NCT00707629|neurocognitive measures|neurocognitive measures
582993|NCT00707629|behavioral measures|behavioral measures
582994|NCT00707603|Insulin resistance|insulin resistance
582995|NCT00707603|Liver fat|liver fat
582996|NCT00707603|Muscle fat|muscle fat
582997|NCT00707603|Abdominal fat|abdominal fat
582998|NCT00707603|Cytokines|cytokines
582999|NCT00707577|Worksite Wellness|worksite wellness
583000|NCT00707577|Weight loss and maintenance|weight loss and maintenance
583001|NCT00707577|Physical Activity|physical activity
583002|NCT00707577|Health and Fitness interventions|health and fitness interventions
583003|NCT00707577|Healthy eating|healthy eating
583004|NCT00707577|Weight loss|weight loss
583005|NCT00707577|Maintenance programs|maintenance programs
583006|NCT00707564|hemostasis|hemostasis
583007|NCT00707564|tooth extractions|tooth extractions
583008|NCT00707551|AZD1305|azd1305
583009|NCT00707551|Verapamil|verapamil
583010|NCT00707551|Ketoconazole|ketoconazole
583011|NCT00707551|pharmacokinetics|pharmacokinetics
583012|NCT00707525|aneuploidies, natural cycle, stimulated cycle, preimplantation genetic diagnosis|aneuploidies, natural cycle, stimulated cycle, preimplantation genetic diagnosis
583013|NCT00707486|Hemostasis, tooth extractions, third molar|hemostasis, tooth extractions, third molar
583014|NCT00707473|Carcinoma of Paranasal Sinuses|carcinoma of paranasal sinuses
583015|NCT00707473|Paranasal Sinuses|paranasal sinuses
583016|NCT00707473|Nasal Sinuses|nasal sinuses
583017|NCT00707473|Nasal Cavity|nasal cavity
583018|NCT00707473|Squamous Cell Carcinoma|squamous cell carcinoma
583019|NCT00707473|Undifferentiated Carcinoma|undifferentiated carcinoma
583020|NCT00707473|Poorly Differentiated Carcinoma|poorly differentiated carcinoma
583021|NCT00707473|Docetaxel|docetaxel
583022|NCT00707473|5-Fluorouracil|5-fluorouracil
583023|NCT00707473|Cisplatin|cisplatin
583024|NCT00707473|Platinol®|platinol®
583025|NCT00707473|Platinol®-AQ|platinol®-aq
583026|NCT00707460|Diabetes|diabetes
583027|NCT00707460|Cardiovascular|cardiovascular
583028|NCT00707460|Obesity|obesity
583029|NCT00707460|First.Nation|first.nation
583030|NCT00707460|Aboriginal (Health)|aboriginal (health)
583031|NCT00707460|Dietary|dietary
583032|NCT00707460|Intervention|intervention
583033|NCT00707460|Nutrition|nutrition
583034|NCT00707460|Traditional (Diet)|traditional (diet)
583035|NCT00707460|Sandy Lake (Health & Diabetes Project)|sandy lake (health & diabetes project)
583036|NCT00707460|(High) protein|(high) protein
583037|NCT00707460|(High) fibre (er)|(high) fibre (er)
583038|NCT00707460|(Low) carbohydrate|(low) carbohydrate
583039|NCT00707447|diabetes-prevention|diabetes-prevention
583040|NCT00707447|lifestyle modification|lifestyle modification
583041|NCT00707447|behavior therapy|behavior therapy
583042|NCT00707447|self-management|self-management
583043|NCT00707434|Continuous Glucose Monitor|continuous glucose monitor
583044|NCT00707434|Medtronic Guardian|medtronic guardian
583045|NCT00707434|Guardian® blood-sugar monitoring device|guardian® blood-sugar monitoring device
583046|NCT00707434|Glucose Monitoring|glucose monitoring
583047|NCT00707434|Critically Ill|critically ill
583048|NCT00707434|ICU|icu
583049|NCT00707434|Intensive Care Unit|intensive care unit
583050|NCT00707434|Glycemic Excursions|glycemic excursions
583051|NCT00707434|Glucose Control|glucose control
583052|NCT00707434|Glucose Testing|glucose testing
583053|NCT00707434|Hyperglycemia|hyperglycemia
583054|NCT00707434|Hypoglycemia|hypoglycemia
583055|NCT00707434|Insulin Infusion|insulin infusion
583056|NCT00707382|Pharmacogenetics|pharmacogenetics
583057|NCT00707382|Compliance|compliance
583058|NCT00707382|Antipsychotic drugs|antipsychotic drugs
583059|NCT00707382|Schizophrenia|schizophrenia
583060|NCT00707369|Periodontitis|periodontitis
583061|NCT00707369|Mechanical Debridement|mechanical debridement
583062|NCT00707369|Antibiotics|antibiotics
583063|NCT00707369|Attachment loss|attachment loss
583064|NCT00707369|Randomized controlled trial|randomized controlled trial
583065|NCT00707356|Prostatic disease|prostatic disease
583066|NCT00707356|genital neoplasm, male|genital neoplasm, male
583067|NCT00707356|Urogenital neoplasm|urogenital neoplasm
583068|NCT00707356|Genital disease|genital disease
583069|NCT00707356|male|male
583070|NCT00707356|Male urogenital disease|male urogenital disease
583071|NCT00707356|Neoplasms|neoplasms
583072|NCT00707356|Neoplasm by site|neoplasm by site
583073|NCT00707356|prostatic neoplasm|prostatic neoplasm
583074|NCT00707356|Carcinoma|carcinoma
583075|NCT00707330|oxidative stress|oxidative stress
583076|NCT00707330|8-oxo-deoxyguanine|8-oxo-deoxyguanine
583077|NCT00707330|8-oxodG|8-oxodg
583078|NCT00707330|clarithromycin|clarithromycin
583079|NCT00707330|malondialdehyde|malondialdehyde
583080|NCT00707330|mda|mda
583081|NCT00707330|vitamine C|vitamine c
583082|NCT00707330|ascorbic acid|ascorbic acid
583083|NCT00707317|M. tuberculosis|m. tuberculosis
583084|NCT00707317|latent tuberculosis infection|latent tuberculosis infection
583085|NCT00707317|Quantiferon assay|quantiferon assay
583086|NCT00707317|ELISPOT assay|elispot assay
583087|NCT00707317|tuberculin skin test|tuberculin skin test
583088|NCT00707317|immunocompromised patients|immunocompromised patients
583089|NCT00707304|Non Small Cell Lung Cancer|non small cell lung cancer
583090|NCT00707304|Talactoferrin|talactoferrin
583091|NCT00707304|Dendritic Cell Recruiter and Activator|dendritic cell recruiter and activator
583092|NCT00707304|Immunomodulatory agent|immunomodulatory agent
583093|NCT00707291|contact lens|contact lens
583094|NCT00707291|normal|normal
583095|NCT00707252|Non-small cell lung cancer|non-small cell lung cancer
583096|NCT00707252|Erlotinib|erlotinib
583097|NCT00707252|Polyphenon E|polyphenon e
583098|NCT00707252|Tarceva|tarceva
583099|NCT00707252|Advanced Non-small Cell Lung Cancer Stage IIIb or IV|advanced non-small cell lung cancer stage iiib or iv
583100|NCT00707239|Hospital-acquired pneumonia|hospital-acquired pneumonia
583101|NCT00707239|Ventilator-associated pneumonia|ventilator-associated pneumonia
583102|NCT00707226|Laser Doppler flowmetry|laser doppler flowmetry
583103|NCT00707226|Choroidal blood flow|choroidal blood flow
583104|NCT00707226|Fundus pulsation amplitude|fundus pulsation amplitude
583105|NCT00707226|Intraocular Pressure|intraocular pressure
583106|NCT00707200|severe malarial anemia (SMA)|severe malarial anemia (sma)
583107|NCT00707200|cerebral malarial (CM)|cerebral malarial (cm)
583108|NCT00707200|lactic acidosis|lactic acidosis
583109|NCT00707200|hyperparasitemia|hyperparasitemia
583110|NCT00707200|respiratory distress|respiratory distress
583111|NCT00707200|hypoxia|hypoxia
583112|NCT00707200|death|death
583113|NCT00707200|transfusion|transfusion
583114|NCT00707187|systemic sclerosis|systemic sclerosis
583115|NCT00707187|scleroderma|scleroderma
583116|NCT00707187|raynaud phenomenon|raynaud phenomenon
583117|NCT00707174|Lentigo Maligna|lentigo maligna
583118|NCT00707148|pertussis, diptheria, tetanus, vaccine, Tdap|pertussis, diptheria, tetanus, vaccine, tdap
583119|NCT00707122|serum albumin, severe sepsis, septic shock, fluid therapy, hypoalbuminemia, critically ill|serum albumin, severe sepsis, septic shock, fluid therapy, hypoalbuminemia, critically ill
583120|NCT00707083|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
583121|NCT00707083|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
583122|NCT00707083|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
583123|NCT00707083|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
583124|NCT00707070|psoriasis|psoriasis
583125|NCT00707070|acitretin|acitretin
583126|NCT00707070|efalizumab|efalizumab
583127|NCT00707031|hyperglycemia, GLP-1, metformin|hyperglycemia, glp-1, metformin
583128|NCT00707005|antibiotic susceptibility|antibiotic susceptibility
583129|NCT00707005|bacterial flora|bacterial flora
583130|NCT00707005|fluoroquinolone|fluoroquinolone
583131|NCT00707005|LASIK|lasik
583132|NCT00707005|refractive surgery|refractive surgery
583133|NCT00706992|MART-1 Peptide|mart-1 peptide
583134|NCT00706992|Melanoma|melanoma
583135|NCT00706992|Adjuvant Therapy|adjuvant therapy
583136|NCT00706992|Gene Therapy|gene therapy
583137|NCT00706992|T Cell Persistence|t cell persistence
583138|NCT00706979|smoking|smoking
583139|NCT00706979|smoking cessation|smoking cessation
583140|NCT00706979|nicotine replacement therapy|nicotine replacement therapy
583141|NCT00706966|adenocarcinoma of the prostate|adenocarcinoma of the prostate
583142|NCT00706966|stage IIB prostate cancer|stage iib prostate cancer
583143|NCT00706966|stage IIA prostate cancer|stage iia prostate cancer
583144|NCT00706966|benign prostatic hyperplasia|benign prostatic hyperplasia
583145|NCT00706953|pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
583146|NCT00706953|VELCADE|velcade
583147|NCT00706953|DOXIL|doxil
583148|NCT00706953|relapsed|relapsed
583149|NCT00706953|Multiple Myeloma|multiple myeloma
583150|NCT00706940|dry eye|dry eye
583151|NCT00706940|Optical coherence tomography|optical coherence tomography
583152|NCT00706927|xalacom|xalacom
583153|NCT00706927|combigan|combigan
583154|NCT00706927|ocular blood flow|ocular blood flow
583155|NCT00706914|Airflow Obstruction, Chronic|airflow obstruction, chronic
583156|NCT00706914|Chronic Airflow Obstruction|chronic airflow obstruction
583157|NCT00706914|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
583158|NCT00706914|Chronic Obstructive Airway Disease|chronic obstructive airway disease
583159|NCT00706914|Chronic Obstructive Lung Disease|chronic obstructive lung disease
583160|NCT00706914|COPD|copd
583161|NCT00706914|COAD|coad
583163|NCT00706901|IHMD|ihmd
583463|NCT00705536|rHuPH20|rhuph20
583164|NCT00706888|Reduction of cardiovascular factor of risk|reduction of cardiovascular factor of risk
583165|NCT00706875|GTD survivors|gtd survivors
583166|NCT00706875|questionnaires|questionnaires
583167|NCT00706875|GTD|gtd
583168|NCT00706862|Non small cell lung cancer|non small cell lung cancer
583169|NCT00706862|Talactoferrin|talactoferrin
583170|NCT00706862|Dendritic cell recruiter and activator|dendritic cell recruiter and activator
583171|NCT00706862|DCRA|dcra
583172|NCT00706862|Immunomodulatory agent|immunomodulatory agent
583173|NCT00706862|Lactoferrin|lactoferrin
583174|NCT00706849|familial hypercholesterolemia|familial hypercholesterolemia
583175|NCT00706836|anxiety|anxiety
583176|NCT00706836|functional magnetic resonance imaging|functional magnetic resonance imaging
583177|NCT00706836|fMRI|fmri
583178|NCT00706836|pregabalin|pregabalin
583179|NCT00706836|Lyrica|lyrica
583180|NCT00706823|Endotracheal Intubation|endotracheal intubation
583181|NCT00706823|Supraglottic Airway|supraglottic airway
583182|NCT00706810|Cancer|cancer
583183|NCT00706810|Brain cancer|brain cancer
583184|NCT00706810|Meningioma|meningioma
583185|NCT00706797|Moderate Rheumatoid Arthritis|moderate rheumatoid arthritis
583186|NCT00706784|Healthy women 18-40 years of age|healthy women 18-40 years of age
583187|NCT00706771|sodium bicarbonate|sodium bicarbonate
583188|NCT00706771|serum neutrophil gelatinase associated lipocalin|serum neutrophil gelatinase associated lipocalin
583189|NCT00706771|renal impairment|renal impairment
583190|NCT00706771|renal failure|renal failure
583191|NCT00706771|systemic inflammatory response syndrome|systemic inflammatory response syndrome
583192|NCT00706771|defined|defined
583193|NCT00706771|by serum NGAL ≥ 100 ng/ml.|by serum ngal ≥ 100 ng/ml.
583194|NCT00706758|Irritable bowel syndrome|irritable bowel syndrome
583195|NCT00706758|Patient education|patient education
583196|NCT00706745|atherosclerosis|atherosclerosis
583197|NCT00706745|dietary supplements|dietary supplements
583198|NCT00706745|randomised controlled trial|randomised controlled trial
583199|NCT00706745|arterial stiffness|arterial stiffness
583200|NCT00706745|linoleic acid|linoleic acid
583201|NCT00706732|Influenza|influenza
583202|NCT00706732|Flu|flu
583203|NCT00706732|A/Wyoming/03/2003|a/wyoming/03/2003
583204|NCT00706732|Alphavirus|alphavirus
583205|NCT00706719|Adult Onset Idiopathic Hypothalamic Hypogonadism (AIHH)|adult onset idiopathic hypothalamic hypogonadism (aihh)
583206|NCT00706719|Secondary hypogonadism|secondary hypogonadism
583207|NCT00706719|Semen volume|semen volume
583208|NCT00706719|Sperm count|sperm count
583209|NCT00706719|Sperm motility|sperm motility
583210|NCT00706706|sunitinib Phase IV metastatic renal cell carcinoma Chinese|sunitinib phase iv metastatic renal cell carcinoma chinese
583211|NCT00706693|hypoglycemia|hypoglycemia
583212|NCT00706693|treatment|treatment
583213|NCT00706693|glucose|glucose
583214|NCT00706693|sucrose|sucrose
583215|NCT00706693|fructose|fructose
583216|NCT00706654|Aripiprazole|aripiprazole
583217|NCT00706654|Intramuscular (IM) depot|intramuscular (im) depot
583218|NCT00706654|Schizophrenia|schizophrenia
583219|NCT00706615|stage IV breast cancer|stage iv breast cancer
583220|NCT00706615|recurrent breast cancer|recurrent breast cancer
583221|NCT00706602|COPD|copd
583222|NCT00706602|prognosis|prognosis
583223|NCT00706602|prediction rule|prediction rule
583224|NCT00706602|health-related quality of life|health-related quality of life
583225|NCT00706602|risk factors|risk factors
583226|NCT00706602|derivation|derivation
583227|NCT00706602|validation|validation
583228|NCT00706602|exacerbation|exacerbation
583229|NCT00706602|mortality|mortality
583230|NCT00706602|primary care|primary care
583231|NCT00706602|treatment|treatment
583232|NCT00706602|decision making|decision making
583233|NCT00706589|Chronic Motor Tic disorder|chronic motor tic disorder
583234|NCT00706589|Chronic Phonic Tic disorder|chronic phonic tic disorder
583235|NCT00706589|Tourette's disorder|tourette's disorder
583236|NCT00706589|Aripiprazole|aripiprazole
583237|NCT00706589|Abilify|abilify
583238|NCT00706589|Children|children
583239|NCT00706589|Adolescent|adolescent
583240|NCT00706576|Hepatocellular cancer|hepatocellular cancer
583241|NCT00706576|HCC|hcc
583242|NCT00706576|Opioid growth factor|opioid growth factor
583243|NCT00706576|OGF|ogf
583244|NCT00706576|Cirrhosis|cirrhosis
583245|NCT00706550|pneumococcal polysaccharide vaccine|pneumococcal polysaccharide vaccine
583246|NCT00706537|Pharmacokinetic safety NASH patients|pharmacokinetic safety nash patients
583247|NCT00706511|OSA|osa
583248|NCT00706511|Diabetes|diabetes
583249|NCT00706511|Metabolism|metabolism
583250|NCT00706511|Gender|gender
583251|NCT00706485|Y-90 plaque applicator|y-90 plaque applicator
583252|NCT00706485|dural brachytherapy|dural brachytherapy
583253|NCT00706446|Asthma|asthma
583254|NCT00706446|Pharmacogenetics|pharmacogenetics
583255|NCT00706446|Beta agonists|beta agonists
583256|NCT00706446|salmeterol|salmeterol
583257|NCT00706446|formoterol|formoterol
583258|NCT00706446|tiotropium|tiotropium
583259|NCT00706446|beta adrenergic receptor|beta adrenergic receptor
583260|NCT00706446|single nucleotide polymorphism|single nucleotide polymorphism
583261|NCT00706433|Photodynamic Therapy|photodynamic therapy
583655|NCT00704314|Statins|statins
583262|NCT00706420|Diabetes Mellitus|diabetes mellitus
583263|NCT00706420|Islet Transplantation Alone|islet transplantation alone
583264|NCT00706420|Glucocorticoid-free Immunosuppressive Regimen|glucocorticoid-free immunosuppressive regimen
583265|NCT00706394|Powerlink|powerlink
583266|NCT00706394|34mm|34mm
583267|NCT00706394|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
583268|NCT00706394|EVAR|evar
583269|NCT00706381|Deiodinase|deiodinase
583270|NCT00706381|Bile Acids|bile acids
583271|NCT00706381|Cholecystokinin|cholecystokinin
583272|NCT00706381|Thyroid Hormones|thyroid hormones
583273|NCT00706381|Energy Expenditure|energy expenditure
583274|NCT00706381|Health Volunteer|health volunteer
583276|NCT00706368|Sexually transmitted infections|sexually transmitted infections
583277|NCT00706368|Acceptability|acceptability
583278|NCT00706368|Adolescent vaginitis|adolescent vaginitis
583279|NCT00706342|Adult Refractory Immune Thrombocytopenic Purpura (ITP)|adult refractory immune thrombocytopenic purpura (itp)
583280|NCT00706329|Minimally invasive surgery|minimally invasive surgery
583281|NCT00706329|Umbilical hernia|umbilical hernia
583282|NCT00706329|Infant|infant
583283|NCT00706316|Nasopharygneal Cancer|nasopharygneal cancer
583284|NCT00706316|Epstein Barr Virus|epstein barr virus
583285|NCT00706316|(EBV)-Specific Cytotoxic T-Lymphocytes|(ebv)-specific cytotoxic t-lymphocytes
583286|NCT00706316|Recurrent|recurrent
583287|NCT00706316|Metastatic|metastatic
583288|NCT00706316|EBV-Positive Nasopharygneal Cancer|ebv-positive nasopharygneal cancer
583289|NCT00706303|COPD|copd
583290|NCT00706303|self management|self management
583291|NCT00706290|anxiety|anxiety
583292|NCT00706290|depression|depression
583293|NCT00706290|quality of life|quality of life
583294|NCT00706290|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
583295|NCT00706290|advanced cancer|advanced cancer
583296|NCT00706290|metastatic cancer|metastatic cancer
583297|NCT00706290|stage IV cancer|stage iv cancer
583298|NCT00706290|cognitive behavioral therapy|cognitive behavioral therapy
583299|NCT00706277|forced vital capacity|forced vital capacity
583300|NCT00706277|forced expired volume in 1 s|forced expired volume in 1 s
583301|NCT00706264|Short cervix|short cervix
583302|NCT00706264|preterm birth|preterm birth
583303|NCT00706264|arabin pessary|arabin pessary
583304|NCT00706238|metastatic,|metastatic,
583305|NCT00706238|Melanoma,|melanoma,
583306|NCT00706238|Antigen-Specific Cancer Immunotherapeutic,|antigen-specific cancer immunotherapeutic,
583307|NCT00706238|ASCI|asci
583308|NCT00706238|MAGE-A3|mage-a3
583309|NCT00706238|tumor antigen,|tumor antigen,
583310|NCT00706199|bone marrow|bone marrow
583311|NCT00706199|antigen expression|antigen expression
583312|NCT00706199|volunteers|volunteers
583313|NCT00706186|Mild Alzheimer's|mild alzheimer's
583314|NCT00706186|Disease|disease
583315|NCT00706173|Post-traumatic stress disorder|post-traumatic stress disorder
583316|NCT00706173|PTSD|ptsd
583317|NCT00706173|Cortisol|cortisol
583318|NCT00706173|hydrocortisone|hydrocortisone
583319|NCT00706173|pharmacological treatment|pharmacological treatment
583320|NCT00706160|Epilepsy|epilepsy
583321|NCT00706160|Language|language
583322|NCT00706160|fMRI|fmri
583323|NCT00706160|Magnetoencephalogram|magnetoencephalogram
583324|NCT00706160|Temporal Lobe Epilepsy|temporal lobe epilepsy
583325|NCT00706160|Partial Epilepsy|partial epilepsy
583326|NCT00706160|Healthy Volunteer|healthy volunteer
583327|NCT00706160|HV|hv
583328|NCT00706147|Hereditary ALS|hereditary als
583329|NCT00706147|Hereditary neurological disease|hereditary neurological disease
583330|NCT00706147|Lou Gehrig's Disease|lou gehrig's disease
583331|NCT00706147|Motor Neuron Disease|motor neuron disease
583332|NCT00706147|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
583333|NCT00706147|Familial ALS|familial als
583334|NCT00706147|Neuromuscular disease|neuromuscular disease
583335|NCT00706147|SOD1 mutation|sod1 mutation
583336|NCT00706147|Superoxide dismutase|superoxide dismutase
583337|NCT00706147|SOD1 positive ALS|sod1 positive als
583338|NCT00706147|inherited ALS|inherited als
583339|NCT00706134|Hypertension|hypertension
583340|NCT00706134|≥ 65 years|≥ 65 years
583341|NCT00706134|aliskiren|aliskiren
583342|NCT00706134|placebo|placebo
583343|NCT00706134|light meal|light meal
583344|NCT00706121|colon cancer|colon cancer
583345|NCT00706121|rectal cancer|rectal cancer
583346|NCT00706121|adenomatous polyp|adenomatous polyp
583347|NCT00706095|Cancer|cancer
583348|NCT00706095|advanced solid tumors|advanced solid tumors
583349|NCT00706069|Metastatic Breast Cancer|metastatic breast cancer
583350|NCT00706069|Vinorelbine oral|vinorelbine oral
583351|NCT00706069|Capecitabine|capecitabine
583352|NCT00706043|Low back pain|low back pain
583353|NCT00706030|Metastatic breast cancer|metastatic breast cancer
583354|NCT00706030|HKI-272|hki-272
583355|NCT00706030|Neratinib|neratinib
583356|NCT00706030|Nerlynx|nerlynx
583357|NCT00706030|PB-272|pb-272
583358|NCT00706004|constipation|constipation
583359|NCT00706004|cystic fibrosis|cystic fibrosis
583360|NCT00706004|lubiprostone|lubiprostone
583361|NCT00706004|Constipation in adults with cystic fibrosis|constipation in adults with cystic fibrosis
583362|NCT00705978|Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis|pancreatic exocrine insufficiency due to chronic pancreatitis
583363|NCT00705965|Coronary artery disease|coronary artery disease
583364|NCT00705965|depression|depression
583365|NCT00705965|psychotherapy|psychotherapy
583366|NCT00705965|randomized controlled trial|randomized controlled trial
583367|NCT00705952|No diabetes medications|no diabetes medications
583368|NCT00705952|New onset|new onset
583369|NCT00705939|Gaucher Disease|gaucher disease
583370|NCT00705939|Enzyme replacement therapy|enzyme replacement therapy
583371|NCT00705926|Acute Infection|acute infection
583372|NCT00705926|HIV|hiv
583373|NCT00705926|HAART|haart
583374|NCT00705926|Treatment Naive|treatment naive
583375|NCT00705913|aortic valve|aortic valve
583376|NCT00705913|heart valve|heart valve
583377|NCT00705913|valve replacement|valve replacement
583378|NCT00705913|valve disease|valve disease
583379|NCT00705900|psoriasis|psoriasis
583380|NCT00705887|Ultraviolet Rays|ultraviolet rays
583381|NCT00705887|Motivation|motivation
583382|NCT00705887|Health Education|health education
583383|NCT00705887|Randomized Controlled Trial|randomized controlled trial
583384|NCT00705887|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
583385|NCT00705874|cancer|cancer
583386|NCT00705874|advanced cancer|advanced cancer
583387|NCT00705874|solid tumors|solid tumors
583388|NCT00705874|lymphoma|lymphoma
583389|NCT00705874|CGC-11047|cgc-11047
583390|NCT00705861|Erectile dysfunction|erectile dysfunction
583391|NCT00705861|Diabetes Mellitus|diabetes mellitus
583392|NCT00705861|SK3530|sk3530
583393|NCT00705848|trachea|trachea
583394|NCT00705848|malacia|malacia
583395|NCT00705848|stenosis|stenosis
583396|NCT00705835|Prostate|prostate
583397|NCT00705835|ALHYDROGEL|alhydrogel
583398|NCT00705835|RS-PSMA|rs-psma
583399|NCT00705809|Epidemiology|epidemiology
583400|NCT00705809|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
583401|NCT00705796|Hypogonadism|hypogonadism
583402|NCT00705796|Spermatogenesis|spermatogenesis
583403|NCT00705796|Quality of Life|quality of life
583404|NCT00705783|Aripiprazole|aripiprazole
583405|NCT00705783|Intramuscular (IM) depot|intramuscular (im) depot
583406|NCT00705783|Schizophrenia|schizophrenia
583407|NCT00705770|Open-Angle Glaucoma|open-angle glaucoma
583408|NCT00705770|Intraocular Pressure|intraocular pressure
583409|NCT00705770|Anecortave Acetate|anecortave acetate
583410|NCT00705757|periocular skin pigmentation|periocular skin pigmentation
583411|NCT00705757|Lumigan|lumigan
583412|NCT00705757|Travatan|travatan
583413|NCT00705757|Xalatan|xalatan
583414|NCT00705757|latanoprost|latanoprost
583415|NCT00705757|bimatoprost|bimatoprost
583416|NCT00705757|travoprost|travoprost
583417|NCT00705731|Colorectal cancer (CRC)|colorectal cancer (crc)
583418|NCT00705731|Colorectal cancer screening|colorectal cancer screening
583419|NCT00705731|Colonoscopy|colonoscopy
583420|NCT00705731|Fecal occult blood test (FOBT)|fecal occult blood test (fobt)
583421|NCT00705731|Cost-effectiveness|cost-effectiveness
583422|NCT00705718|Endurant Stent Graft System|endurant stent graft system
583423|NCT00705718|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
583424|NCT00705718|Endovascular Treatment|endovascular treatment
583425|NCT00705705|High-Risk Behavior|high-risk behavior
583426|NCT00705705|Men Who Have Sex With Men|men who have sex with men
583427|NCT00705705|HIV Seronegativity|hiv seronegativity
583428|NCT00705692|Tetanus|tetanus
583429|NCT00705692|Vaccines|vaccines
583430|NCT00705692|Renal Dialysis|renal dialysis
583431|NCT00705692|Levamisole|levamisole
583432|NCT00705679|Microbicide|microbicide
583433|NCT00705679|HIV Seronegativity|hiv seronegativity
583434|NCT00705653|cancer|cancer
583435|NCT00705653|advanced cancer|advanced cancer
583436|NCT00705653|solid tumors|solid tumors
583437|NCT00705653|CGC-11047|cgc-11047
583438|NCT00705653|PG-11047|pg-11047
583439|NCT00705640|stage II melanoma|stage ii melanoma
583440|NCT00705640|stage III melanoma|stage iii melanoma
583441|NCT00705640|stage IV melanoma|stage iv melanoma
583442|NCT00705640|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
583443|NCT00705640|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
583444|NCT00705640|conjunctival melanoma|conjunctival melanoma
583445|NCT00705640|extraocular extension melanoma|extraocular extension melanoma
583446|NCT00705640|iris melanoma|iris melanoma
583447|NCT00705640|metastatic intraocular melanoma|metastatic intraocular melanoma
583448|NCT00705640|recurrent intraocular melanoma|recurrent intraocular melanoma
583449|NCT00705627|nasopharyngeal carcinoma|nasopharyngeal carcinoma
583450|NCT00705627|neoadjuvant chemotherapy|neoadjuvant chemotherapy
583451|NCT00705627|concurrent chemotherapy|concurrent chemotherapy
583452|NCT00705627|randomized controlled clinical trials|randomized controlled clinical trials
583453|NCT00705601|Nonrestorative Sleep, Restorative Sleep Questionnaire Refinement|nonrestorative sleep, restorative sleep questionnaire refinement
583454|NCT00705575|Essential Hypertension|essential hypertension
583455|NCT00705575|Stage II|stage ii
583456|NCT00705549|Advanced|advanced
583457|NCT00705549|NSCLC|nsclc
583458|NCT00705549|ERCC1|ercc1
583459|NCT00705549|RRM1|rrm1
583464|NCT00705536|Hyaluronidase|hyaluronidase
583465|NCT00705536|Insulin|insulin
583466|NCT00705523|alcohol|alcohol
583467|NCT00705523|treatment|treatment
583468|NCT00705523|nicotinic acetylcholine receptors|nicotinic acetylcholine receptors
583469|NCT00705523|pharmacotherapy|pharmacotherapy
583470|NCT00705523|outpatient|outpatient
583471|NCT00705510|Cyclosporine|cyclosporine
583472|NCT00705510|Unstable tear film|unstable tear film
583473|NCT00705510|Meibomian gland|meibomian gland
583474|NCT00705510|Meibomian gland dysfunction|meibomian gland dysfunction
583475|NCT00705497|Radiofrequency tumor ablation|radiofrequency tumor ablation
583476|NCT00705497|RFA|rfa
583477|NCT00705458|stress myocardial perfusion imaging|stress myocardial perfusion imaging
583478|NCT00705458|coronary computed tomography angiography|coronary computed tomography angiography
583479|NCT00705445|Malnutrition|malnutrition
583480|NCT00705445|Diarrhea|diarrhea
583481|NCT00705445|Pneumonia|pneumonia
583482|NCT00705445|Growth|growth
583483|NCT00705445|Zinc Supplements|zinc supplements
583484|NCT00705445|Microbiome|microbiome
583485|NCT00705419|Treatment Experienced|treatment experienced
583486|NCT00705354|Sinusitis|sinusitis
583487|NCT00705354|Chronic Sinusitis|chronic sinusitis
583488|NCT00705354|Nasal Surgery|nasal surgery
583489|NCT00705354|Functional Endoscopic Sinus Surgery (FESS)|functional endoscopic sinus surgery (fess)
583490|NCT00705354|Enoscopic Sinus Surgery (ESS)|enoscopic sinus surgery (ess)
583491|NCT00705341|Normal Controls|normal controls
583492|NCT00705328|low-income families|low-income families
583493|NCT00705328|children|children
583494|NCT00705328|recreation|recreation
583495|NCT00705328|family healthy lifestyle|family healthy lifestyle
583496|NCT00705328|linkages to community resources|linkages to community resources
583497|NCT00705328|Families with low incomes|families with low incomes
583498|NCT00705328|working poor|working poor
583499|NCT00705328|welfare recipients|welfare recipients
583500|NCT00705315|breast cancer|breast cancer
583501|NCT00705315|chemotherapy|chemotherapy
583502|NCT00705315|biological therapy|biological therapy
583503|NCT00705302|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
583504|NCT00705302|Outpatient|outpatient
583505|NCT00705302|Patient education|patient education
583506|NCT00705302|Pulmonary rehabilitation|pulmonary rehabilitation
583507|NCT00705302|Self-management|self-management
583508|NCT00705250|Bendamustine HCL|bendamustine hcl
583509|NCT00705237|sinusitis|sinusitis
583510|NCT00705185|Major Depressive Disorder|major depressive disorder
583511|NCT00705185|Blood Test|blood test
583512|NCT00705159|Blepharokeratoconjunctivitis|blepharokeratoconjunctivitis
583513|NCT00705146|Osteoarthritis, carpometacarpal joint|osteoarthritis, carpometacarpal joint
583514|NCT00705146|Thumb splints|thumb splints
583515|NCT00705146|AUSCAN-HI 3.1|auscan-hi 3.1
583516|NCT00705146|Grip and pinch strength|grip and pinch strength
583517|NCT00705133|pulmonary hypertension|pulmonary hypertension
583518|NCT00705133|pulmonary fibrosis|pulmonary fibrosis
583519|NCT00705133|interstitial lung disease|interstitial lung disease
583520|NCT00705120|Osteogenesis Imperfecta|osteogenesis imperfecta
583521|NCT00705120|Bone Marrow Cell Transplantation|bone marrow cell transplantation
583522|NCT00705120|Mesenchymal Stem Cells|mesenchymal stem cells
583523|NCT00705120|Stem Cell Transplantation, Mesenchymal|stem cell transplantation, mesenchymal
583524|NCT00705094|cardiovascular risk factors|cardiovascular risk factors
583525|NCT00705094|cardiac function|cardiac function
583526|NCT00705094|VO2peak|vo2peak
583527|NCT00705094|Chemotherapy|chemotherapy
583528|NCT00705055|Anthropometry|anthropometry
583529|NCT00705055|face recognition|face recognition
583530|NCT00705055|genetic disease|genetic disease
583531|NCT00705055|newborn infant|newborn infant
583532|NCT00705016|Randomized treatment|randomized treatment
583533|NCT00705016|open-label|open-label
583534|NCT00705016|controlled|controlled
583535|NCT00705016|recurrent|recurrent
583536|NCT00705016|metastatic|metastatic
583537|NCT00705016|SCCHN|scchn
583538|NCT00705016|suitable|suitable
583539|NCT00705016|for local therapy|for local therapy
583540|NCT00705003|depression|depression
583541|NCT00704990|Attention Deficit Disorder|attention deficit disorder
583542|NCT00704990|Pediatrics|pediatrics
583543|NCT00704990|Attention|attention
583544|NCT00704990|Impulsivity|impulsivity
583545|NCT00704990|Complementary Therapies|complementary therapies
583546|NCT00704938|recurrent renal cell cancer|recurrent renal cell cancer
583547|NCT00704938|stage IV renal cell cancer|stage iv renal cell cancer
583548|NCT00704938|recurrent melanoma|recurrent melanoma
583549|NCT00704938|stage IV melanoma|stage iv melanoma
583550|NCT00704938|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
583551|NCT00704925|Lambert Eaton Myasthenic Syndrome|lambert eaton myasthenic syndrome
583552|NCT00704925|3,4 DAP|3,4 dap
583553|NCT00704925|3,4 Diaminopyridine|3,4 diaminopyridine
583554|NCT00704912|Polycystic Ovary Syndrome|polycystic ovary syndrome
583555|NCT00704886|dementia|dementia
583556|NCT00704860|healthy volunteers treatment resistant major depression hippocampus atrophy MRI serotonin genotyping|healthy volunteers treatment resistant major depression hippocampus atrophy mri serotonin genotyping
583846|NCT00703352|Mustard.|mustard.
583557|NCT00704847|Osteoarthritis, oral salmon calcitonin, treatment, efficacy,|osteoarthritis, oral salmon calcitonin, treatment, efficacy,
583558|NCT00704847|tolerability|tolerability
583559|NCT00704834|Multiple Sclerosis|multiple sclerosis
583560|NCT00704834|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
583561|NCT00704834|Chronic Progressive Multiple Sclerosis|chronic progressive multiple sclerosis
583562|NCT00704834|Clinically Isolated Syndrome|clinically isolated syndrome
583563|NCT00704834|Normal Controls|normal controls
583564|NCT00704834|Blood Draw|blood draw
583565|NCT00704821|Cancer|cancer
583566|NCT00704821|PTC299|ptc299
583567|NCT00704821|VEGF|vegf
583568|NCT00704821|Angiogenesis|angiogenesis
583569|NCT00704821|Post-transcriptional control|post-transcriptional control
583570|NCT00704821|Docetaxel|docetaxel
583571|NCT00704743|Colles fracture treatment|colles fracture treatment
583572|NCT00704743|Displaced fracture of distal radius|displaced fracture of distal radius
583573|NCT00704743|distal radius fracture treatment|distal radius fracture treatment
583574|NCT00704743|RCT|rct
583575|NCT00704743|Emergency Department|emergency department
583576|NCT00704743|cast|cast
583577|NCT00704743|splint|splint
583578|NCT00704743|treatment|treatment
583579|NCT00704730|Medullary Thyroid Cancer|medullary thyroid cancer
583580|NCT00704730|MTC|mtc
583581|NCT00704704|high risk MDS|high risk mds
583582|NCT00704704|IPSS|ipss
583583|NCT00704704|5-AZA-Cytidine|5-aza-cytidine
583584|NCT00704704|Thalidomide|thalidomide
583585|NCT00704704|response rate|response rate
583586|NCT00704704|cytogenetic response|cytogenetic response
583587|NCT00704704|QOL questionaries|qol questionaries
583588|NCT00704704|INT-2 or High risk MDS|int-2 or high risk mds
583589|NCT00704678|Chronic Kidney Disease|chronic kidney disease
583590|NCT00704678|hemodialysis|hemodialysis
583591|NCT00704678|hyperphosphatemia|hyperphosphatemia
583592|NCT00704678|Asian|asian
583593|NCT00704678|patients|patients
583594|NCT00704665|Diffuse Scleroderma|diffuse scleroderma
583595|NCT00704665|Skin score|skin score
583596|NCT00704639|Head and Neck|head and neck
583597|NCT00704639|Cetuximab|cetuximab
583598|NCT00704639|Carboplatin|carboplatin
583599|NCT00704639|Radiotherapy|radiotherapy
583600|NCT00704626|Multiple Sclerosis|multiple sclerosis
583601|NCT00704626|Autoimmune disease|autoimmune disease
583602|NCT00704626|Inflammatory disease|inflammatory disease
583603|NCT00704626|Myasthenia Gravis|myasthenia gravis
583604|NCT00704626|Transverse Myelitis|transverse myelitis
583605|NCT00704600|Locally advanced rectal cancer|locally advanced rectal cancer
583606|NCT00704600|nelfinavir|nelfinavir
583607|NCT00704600|radiosensitivity|radiosensitivity
583608|NCT00704600|chemoradiation|chemoradiation
583609|NCT00704587|cancer occurence|cancer occurence
583610|NCT00704587|cancer recurrence|cancer recurrence
583611|NCT00704587|neo-adjuvant treatment response measurement|neo-adjuvant treatment response measurement
583612|NCT00704561|Acute Myocardial Infarction|acute myocardial infarction
583613|NCT00704561|Percutaneous Coronary Interventions|percutaneous coronary interventions
583614|NCT00704561|Optical Coherence Tomography|optical coherence tomography
583615|NCT00704561|Thrombus|thrombus
583616|NCT00704509|Schizophrenia|schizophrenia
583617|NCT00704509|Antipsychotic|antipsychotic
583618|NCT00704509|Bifeprunox|bifeprunox
583619|NCT00704496|Sleep, Pseudoephedrine|sleep, pseudoephedrine
583620|NCT00704483|Chronic Kidney Disease|chronic kidney disease
583621|NCT00704483|hemodialysis|hemodialysis
583622|NCT00704483|hyperphosphatemia|hyperphosphatemia
583623|NCT00704483|hemodiafiltration|hemodiafiltration
583624|NCT00704470|Patient Simulation|patient simulation
583625|NCT00704470|Education, Medical, Continuing|education, medical, continuing
583626|NCT00704470|Education, Medical, Graduate|education, medical, graduate
583627|NCT00704470|Stress|stress
583628|NCT00704457|Interstitial Cystitis|interstitial cystitis
583629|NCT00704457|IC|ic
583630|NCT00704457|Sacral Nerve Stimulation|sacral nerve stimulation
583631|NCT00704431|SB-480848|sb-480848
583632|NCT00704431|darapladib|darapladib
583633|NCT00704431|tolerability|tolerability
583634|NCT00704418|Cataract extraction|cataract extraction
583635|NCT00704418|intraocular lens implantation|intraocular lens implantation
583636|NCT00704405|hepatitis C|hepatitis c
583637|NCT00704392|Solid tumors|solid tumors
583638|NCT00704392|NSCLC|nsclc
583639|NCT00704379|traumatic brain injury|traumatic brain injury
583640|NCT00704379|TBI|tbi
583641|NCT00704379|mood disorders|mood disorders
583642|NCT00704379|anxiety disorders|anxiety disorders
583643|NCT00704379|community reintegration|community reintegration
583644|NCT00704379|executive function|executive function
583645|NCT00704379|sertraline|sertraline
583646|NCT00704379|diffusion tensor imaging|diffusion tensor imaging
583647|NCT00704366|Advanced carcinoma|advanced carcinoma
583648|NCT00704327|Cognitive Functions|cognitive functions
583649|NCT00704327|Brain Ischemia|brain ischemia
583650|NCT00704327|Cerebral Atrophy|cerebral atrophy
583651|NCT00704327|Dementia|dementia
583652|NCT00704327|Intracranial atherosclerosis|intracranial atherosclerosis
583653|NCT00704327|Memory impairment|memory impairment
583654|NCT00704314|Insulin resistance|insulin resistance
583656|NCT00704314|Muscle and liver triglycerides|muscle and liver triglycerides
583657|NCT00704301|Delirium|delirium
583658|NCT00704301|Confusion|confusion
583659|NCT00704288|GBM|gbm
583660|NCT00704288|Malignant gliomas|malignant gliomas
583661|NCT00704275|dry eye|dry eye
583662|NCT00704249|HIV infection|hiv infection
583663|NCT00704249|nevirapine|nevirapine
583664|NCT00704249|Treatment Experienced|treatment experienced
583665|NCT00704236|Traditional Chinese Treatment|traditional chinese treatment
583666|NCT00704210|Low Back Pain|low back pain
583667|NCT00704171|Elective pulmonary resection via open thoracotomy.|elective pulmonary resection via open thoracotomy.
583668|NCT00704158|CR011-vcMMAE|cr011-vcmmae
583669|NCT00704158|locally advanced breast cancer|locally advanced breast cancer
583670|NCT00704158|metastatic breast cancer|metastatic breast cancer
583671|NCT00704158|breast cancer|breast cancer
583672|NCT00704158|CuraGen|curagen
583673|NCT00704145|Drug Eluting Stents|drug eluting stents
583674|NCT00704145|Percutaneous Coronary Interventions|percutaneous coronary interventions
583675|NCT00704145|Optical Coherence Tomography|optical coherence tomography
583676|NCT00704119|Rhudex|rhudex
583677|NCT00704119|pharmacokinetic study|pharmacokinetic study
583678|NCT00704106|Hepatitis B|hepatitis b
583679|NCT00704106|HBV|hbv
583680|NCT00704106|Treatment|treatment
583681|NCT00704093|pacing|pacing
583682|NCT00704093|perfusion|perfusion
583683|NCT00704093|oxidative metabolism|oxidative metabolism
583684|NCT00704093|efficiency|efficiency
583685|NCT00704080|GBM|gbm
583686|NCT00704080|Anaplastic glioma|anaplastic glioma
583687|NCT00704067|vocational rehabilitation|vocational rehabilitation
583688|NCT00704067|supported employment|supported employment
583689|NCT00704067|cognitive training|cognitive training
583690|NCT00704067|cognitive remediation|cognitive remediation
583691|NCT00704067|cognitive rehabilitation|cognitive rehabilitation
583692|NCT00704067|veterans|veterans
583693|NCT00704054|Pediatric|pediatric
583694|NCT00704054|Solid Tumor|solid tumor
583695|NCT00704054|CNS Tumor|cns tumor
583696|NCT00704054|Lymphoma|lymphoma
583697|NCT00704015|Smoking cessation|smoking cessation
583698|NCT00704015|Acute injury|acute injury
583699|NCT00704015|Musculoskeletal|musculoskeletal
583700|NCT00704015|Postoperative complications|postoperative complications
583701|NCT00704002|neck fracture of the fifth metacarpal|neck fracture of the fifth metacarpal
583702|NCT00704002|displacement|displacement
583703|NCT00704002|antegrade intramedullary splinting|antegrade intramedullary splinting
583704|NCT00704002|conservative treatment|conservative treatment
583705|NCT00703989|hyperglycemia|hyperglycemia
583706|NCT00703989|diabetic complications|diabetic complications
583707|NCT00703989|advanced glycation endproducts|advanced glycation endproducts
583708|NCT00703989|hexosamine pathway|hexosamine pathway
583709|NCT00703989|prostacyclin synthase|prostacyclin synthase
583710|NCT00703989|reactive oxygen species|reactive oxygen species
583711|NCT00703976|head and neck cancers|head and neck cancers
583712|NCT00703963|International normalized ratio (INR)|international normalized ratio (inr)
583713|NCT00703950|Sucking patterns|sucking patterns
583714|NCT00703950|preterm infants|preterm infants
583715|NCT00703950|breastfeeding|breastfeeding
583716|NCT00703924|cutaneous leishmaniasis topical treatment safety efficacy|cutaneous leishmaniasis topical treatment safety efficacy
583717|NCT00703898|HIV|hiv
583718|NCT00703898|nevirapine|nevirapine
583719|NCT00703898|durability|durability
583720|NCT00703898|AIDS|aids
583721|NCT00703898|Treatment Naïve|treatment naïve
583722|NCT00703885|functional magnetic resonance imaging|functional magnetic resonance imaging
583723|NCT00703885|fMRI|fmri
583724|NCT00703885|alprazolam|alprazolam
583725|NCT00703885|anxiety disorders|anxiety disorders
583726|NCT00703872|Chronic Hepatitis C|chronic hepatitis c
583727|NCT00703872|Naive|naive
583728|NCT00703872|Nonresponders|nonresponders
583729|NCT00703872|Interferon|interferon
583730|NCT00703872|Patients with Chronic Hepatitis C|patients with chronic hepatitis c
583731|NCT00703859|Radiotherapy plus temozolomide plus DCA|radiotherapy plus temozolomide plus dca
583732|NCT00703859|PK profile of DCA|pk profile of dca
583733|NCT00703859|MGMT promoter methylation status|mgmt promoter methylation status
583734|NCT00703859|Newly diagnosed Glioblastoma multiform tumours|newly diagnosed glioblastoma multiform tumours
583735|NCT00703846|Phase 4|phase 4
583736|NCT00703846|Seborrheic|seborrheic
583737|NCT00703846|Ketoconazole|ketoconazole
583738|NCT00703846|Dermatitis|dermatitis
583739|NCT00703794|ev3 Neurovascular|ev3 neurovascular
583740|NCT00703794|aneurysms|aneurysms
583741|NCT00703794|cerebrovascular|cerebrovascular
583742|NCT00703794|endovascular|endovascular
583743|NCT00703794|neurovascular therapies|neurovascular therapies
583744|NCT00703794|RACER|racer
583745|NCT00703794|AXIUM|axium
583746|NCT00703794|The AXIUM Progressive Coil System|the axium progressive coil system
583747|NCT00703794|ev3|ev3
583748|NCT00703794|MTI|mti
583749|NCT00703794|Micro Therapeutics|micro therapeutics
583750|NCT00703794|FX detachable coil system|fx detachable coil system
583751|NCT00703794|K060747|k060747
583752|NCT00703794|brain diseases|brain diseases
583847|NCT00703352|Senning.|senning.
583753|NCT00703781|Cataract extraction with intraocular lens implantation|cataract extraction with intraocular lens implantation
583754|NCT00703768|Quality of Life|quality of life
583755|NCT00703768|Androgen Deprivation Therapy|androgen deprivation therapy
583756|NCT00703768|Goserelin|goserelin
583757|NCT00703755|Diabetes|diabetes
583758|NCT00703755|Hypertriglyceridaemia|hypertriglyceridaemia
583759|NCT00703755|Metabolic Syndrome|metabolic syndrome
583760|NCT00703716|mini-invasive|mini-invasive
583761|NCT00703716|dynamic screw-plate|dynamic screw-plate
583762|NCT00703716|Surfix|surfix
583763|NCT00703716|Lock-screw|lock-screw
583764|NCT00703703|Heart rate, overactive bladder|heart rate, overactive bladder
583765|NCT00703677|progressive supranuclear palsy|progressive supranuclear palsy
583766|NCT00703677|corticobasal degeneration|corticobasal degeneration
583767|NCT00703677|PSP|psp
583768|NCT00703677|CBD|cbd
583769|NCT00703677|lithium|lithium
583770|NCT00703677|tau|tau
583771|NCT00703651|Influenza|influenza
583772|NCT00703651|Orthomyxoviridae Infection|orthomyxoviridae infection
583773|NCT00703651|Inactivated, Split-virion influenza vaccine|inactivated, split-virion influenza vaccine
583774|NCT00703651|Intradermal injection|intradermal injection
583775|NCT00703651|Adults.|adults.
583776|NCT00703612|Diabetes Mellitus|diabetes mellitus
583777|NCT00703612|Adipose-derived stem cells|adipose-derived stem cells
583778|NCT00703612|Adipose stromal vascular fraction|adipose stromal vascular fraction
583779|NCT00703612|Autologous|autologous
583780|NCT00703612|Hyperglycemia|hyperglycemia
583781|NCT00703599|Diabetes Mellitus|diabetes mellitus
583782|NCT00703599|Adipose-derived stem cells|adipose-derived stem cells
583783|NCT00703599|Adipose stromal vascular fraction|adipose stromal vascular fraction
583784|NCT00703599|Autologous|autologous
583785|NCT00703599|Insulin-dependence|insulin-dependence
583786|NCT00703586|Maraviroc|maraviroc
583787|NCT00703586|Treatment Experienced|treatment experienced
583788|NCT00703573|Atopic Dermatitis|atopic dermatitis
583789|NCT00703560|HCV|hcv
583790|NCT00703560|Genotype 1|genotype 1
583791|NCT00703560|HIV co-infection|hiv co-infection
583792|NCT00703560|viral kinetics|viral kinetics
583793|NCT00703560|HCV quasi-species|hcv quasi-species
583794|NCT00703560|Hepatitis C genotype 1|hepatitis c genotype 1
583795|NCT00703560|HIV Infections|hiv infections
583796|NCT00703547|Depression|depression
583797|NCT00703534|GERD|gerd
583798|NCT00703534|Acid Reflux|acid reflux
583799|NCT00703534|Heartburn|heartburn
583800|NCT00703534|Regurgitation|regurgitation
583801|NCT00703534|non-acid reflux|non-acid reflux
583802|NCT00703534|PRO measures|pro measures
583803|NCT00703521|rabies vaccination|rabies vaccination
583804|NCT00703521|pre-exposure prophylaxis|pre-exposure prophylaxis
583805|NCT00703521|rabies virus neutralizing antibody|rabies virus neutralizing antibody
583806|NCT00703521|Antibody response|antibody response
583807|NCT00703521|immunologic memory of rabies vaccination|immunologic memory of rabies vaccination
583808|NCT00703521|Safety of rabies vaccination administered in pre-exposure regimens both intramuscular and intradermal routes|safety of rabies vaccination administered in pre-exposure regimens both intramuscular and intradermal routes
583809|NCT00703508|PCOS|pcos
583810|NCT00703495|traumatic|traumatic
583811|NCT00703495|brain injury|brain injury
583812|NCT00703495|brain regional oxygen saturation (rSO2)|brain regional oxygen saturation (rso2)
583813|NCT00703495|brain tissue oxygenation (PbtO2)|brain tissue oxygenation (pbto2)
583814|NCT00703495|cerebral perfusion pressure (CPP)|cerebral perfusion pressure (cpp)
583815|NCT00703482|Ventricular diastolic Function|ventricular diastolic function
583816|NCT00703482|Diabetes|diabetes
583817|NCT00703469|Hep C|hep c
583818|NCT00703456|Functional ankle instability|functional ankle instability
583819|NCT00703456|Balance training|balance training
583820|NCT00703443|Genetics|genetics
583821|NCT00703443|Dilated Cardiomyopathy|dilated cardiomyopathy
583822|NCT00703443|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
583823|NCT00703443|Mitochondrial Cardiomyopathy|mitochondrial cardiomyopathy
583824|NCT00703443|Noncompaction Cardiomyopathy|noncompaction cardiomyopathy
583825|NCT00703443|Restrictive Cardiomyopathy|restrictive cardiomyopathy
583826|NCT00703443|Heart Failure|heart failure
583827|NCT00703430|Alzheimer's disease, agitation, aggression, dementia|alzheimer's disease, agitation, aggression, dementia
583828|NCT00703417|osteoporosis|osteoporosis
583829|NCT00703417|diabetes|diabetes
583830|NCT00703404|Anti-Retroviral Therapy|anti-retroviral therapy
583831|NCT00703404|HIV|hiv
583832|NCT00703404|Virologic Response|virologic response
583833|NCT00703404|Treatment Naïve|treatment naïve
583834|NCT00703391|Chronic|chronic
583835|NCT00703391|obstructive|obstructive
583836|NCT00703391|pulmonary|pulmonary
583837|NCT00703391|lung|lung
583838|NCT00703391|respiratory disease|respiratory disease
583839|NCT00703391|tolerability|tolerability
583840|NCT00703391|placebo-controlled|placebo-controlled
583841|NCT00703391|pharmacokinetics|pharmacokinetics
583842|NCT00703391|COPD|copd
583843|NCT00703365|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
583844|NCT00703352|Transposition of the great arteries.|transposition of the great arteries.
583845|NCT00703352|Transposition of the great vessels.|transposition of the great vessels.
583848|NCT00703339|fibrosis, pulmonary|fibrosis, pulmonary
583849|NCT00703339|hypertension, pulmonary|hypertension, pulmonary
583850|NCT00703339|exercise, aerobic|exercise, aerobic
583851|NCT00703326|Metastatic breast cancer|metastatic breast cancer
583852|NCT00703326|HER2 negative breast cancer|her2 negative breast cancer
583853|NCT00703326|locally recurrent breast cancer|locally recurrent breast cancer
583854|NCT00703313|Study drug concentration in human tears|study drug concentration in human tears
583855|NCT00703274|ischemic stroke|ischemic stroke
583856|NCT00703274|stroke|stroke
583857|NCT00703274|cerebrovascular stroke|cerebrovascular stroke
583858|NCT00703274|cerebrovascular accident|cerebrovascular accident
583859|NCT00703274|CVA|cva
583860|NCT00703274|community health services|community health services
583861|NCT00703274|community health workers|community health workers
583862|NCT00703274|navigators|navigators
583863|NCT00703274|health education|health education
583864|NCT00703274|barriers to care|barriers to care
583865|NCT00703274|healthcare access|healthcare access
583866|NCT00703274|healthcare disparities|healthcare disparities
583867|NCT00703248|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
583868|NCT00703248|complementary therapies|complementary therapies
583869|NCT00703222|high-risk neuroblastoma|high-risk neuroblastoma
583870|NCT00703222|single autologous stem cell rescue|single autologous stem cell rescue
583871|NCT00703209|symptomatic diabetic neuropathy|symptomatic diabetic neuropathy
583872|NCT00703209|diabetes|diabetes
583873|NCT00703209|burning feet|burning feet
583874|NCT00703209|Diabetic Neuropathy|diabetic neuropathy
583875|NCT00703209|Loss of sensation in the foot|loss of sensation in the foot
583876|NCT00703209|Neuropathy|neuropathy
583877|NCT00703209|Painful Diabetic Neuropathy|painful diabetic neuropathy
583878|NCT00703196|cervical cancer|cervical cancer
583879|NCT00703196|human papilloma virus infection|human papilloma virus infection
583880|NCT00703196|low-grade squamous intraepithelial lesion|low-grade squamous intraepithelial lesion
583881|NCT00703196|high-grade squamous intraepithelial lesion|high-grade squamous intraepithelial lesion
583882|NCT00703196|atypical squamous cells of undetermined significance|atypical squamous cells of undetermined significance
583883|NCT00703196|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
583884|NCT00703196|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
583885|NCT00703196|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
583886|NCT00703144|Pharmacokinetics|pharmacokinetics
583887|NCT00703144|piperacillin/tazobactam.|piperacillin/tazobactam.
583888|NCT00703144|Septic patients|septic patients
583889|NCT00703144|oliguric renal failure|oliguric renal failure
583890|NCT00703144|continuous veno-venous hemodiafiltration.|continuous veno-venous hemodiafiltration.
583891|NCT00703131|fistula|fistula
583892|NCT00703131|anal fistula|anal fistula
583893|NCT00703118|Hepatitis C, Chronic|hepatitis c, chronic
583894|NCT00703118|Telaprevir|telaprevir
583895|NCT00703118|Peg-IFN-alfa-2a|peg-ifn-alfa-2a
583896|NCT00703118|Ribavirin|ribavirin
583897|NCT00703105|ovarian cancer|ovarian cancer
583898|NCT00703105|Tregs|tregs
583899|NCT00703105|vaccine|vaccine
583900|NCT00703105|Recurrent Ovarian Cancer|recurrent ovarian cancer
583901|NCT00703079|Acromegaly|acromegaly
583903|NCT00703079|IGF-I|igf-i
583904|NCT00703079|Octreotide-LAR|octreotide-lar
583905|NCT00703079|Lanreotide|lanreotide
583906|NCT00703079|Transsphenoidal surgery|transsphenoidal surgery
583907|NCT00703066|Malaria|malaria
583908|NCT00703066|Vaccine|vaccine
583909|NCT00703066|GMZ2|gmz2
583910|NCT00703066|Safety|safety
583911|NCT00703066|African|african
583912|NCT00703066|immunogenicity|immunogenicity
583913|NCT00703053|influenza, H5N1, vaccine, avian influenza, parent protocol|influenza, h5n1, vaccine, avian influenza, parent protocol
583914|NCT00703040|Care engagement|care engagement
583915|NCT00703040|Linkage to care|linkage to care
583916|NCT00703040|HIV Infections|hiv infections
583917|NCT00703027|diabetes mellitus|diabetes mellitus
583918|NCT00703027|care decision|care decision
583919|NCT00703027|data mining|data mining
583920|NCT00703014|Neonatal outcome|neonatal outcome
583921|NCT00703014|Congenital malformations|congenital malformations
583922|NCT00703014|In-Vitro fertilization|in-vitro fertilization
583923|NCT00703014|Controlled ovarian stimulation|controlled ovarian stimulation
583924|NCT00703014|Follow-up|follow-up
583925|NCT00702988|Neonatal outcome|neonatal outcome
583926|NCT00702988|Congenital malformations|congenital malformations
583927|NCT00702988|In-Vitro Fertilization|in-vitro fertilization
583928|NCT00702988|Controlled ovarian stimulation|controlled ovarian stimulation
583929|NCT00702988|Follow-up|follow-up
583930|NCT00702975|phase II|phase ii
583931|NCT00702975|NSCLC|nsclc
583932|NCT00702975|bevacizumab|bevacizumab
583933|NCT00702975|erlotinib|erlotinib
583934|NCT00702975|metastatic NSCLC|metastatic nsclc
583935|NCT00702962|lung cancer|lung cancer
583936|NCT00702962|small cell lung cancer|small cell lung cancer
583937|NCT00702949|breast cancer|breast cancer
583938|NCT00702949|hot flashes|hot flashes
583939|NCT00702923|Stage D0 Prostate Cancer|stage d0 prostate cancer
583940|NCT00702923|Rising PSA|rising psa
583941|NCT00702923|Casodex|casodex
583942|NCT00702923|Tremelimumab|tremelimumab
583943|NCT00702910|Asthma patients|asthma patients
583944|NCT00702910|Magnesium stearate|magnesium stearate
583945|NCT00702910|Tolerability|tolerability
583946|NCT00702910|Safety|safety
583947|NCT00702910|Lactose|lactose
583948|NCT00702910|GW642444M|gw642444m
583949|NCT00702910|Pharmacodynamics|pharmacodynamics
583950|NCT00702910|Efficacy|efficacy
583951|NCT00702910|Pharmacokinetics|pharmacokinetics
583952|NCT00702884|recurrent esophageal cancer|recurrent esophageal cancer
583953|NCT00702884|stage IIIA esophageal cancer|stage iiia esophageal cancer
583954|NCT00702884|stage IIIB esophageal cancer|stage iiib esophageal cancer
583955|NCT00702884|stage IIIC esophageal cancer|stage iiic esophageal cancer
583956|NCT00702884|stage IV esophageal cancer|stage iv esophageal cancer
583957|NCT00702871|Ventilator Associated Pneumonia|ventilator associated pneumonia
583958|NCT00702871|antimicrobial susceptibility pattern|antimicrobial susceptibility pattern
583959|NCT00702871|stress ulcer prophylaxis|stress ulcer prophylaxis
583960|NCT00702858|Breast Cancer|breast cancer
583961|NCT00702858|Joint Pain|joint pain
583962|NCT00702858|Aromatase Inhibitors|aromatase inhibitors
583963|NCT00702845|In vitro fertilization|in vitro fertilization
583964|NCT00702845|Pharmacological effects of drugs|pharmacological effects of drugs
583965|NCT00702845|Hormones|hormones
583966|NCT00702845|Hormone Substitutes and Hormone Antagonists|hormone substitutes and hormone antagonists
583967|NCT00702845|Pharmacological Actions|pharmacological actions
583968|NCT00702845|Randomized|randomized
583969|NCT00702845|Multi-center|multi-center
583970|NCT00702845|Multi-national|multi-national
583971|NCT00702845|Double-blind|double-blind
583972|NCT00702845|Active-controlled|active-controlled
583973|NCT00702845|Equivalence|equivalence
583974|NCT00702832|Vestibular rehabilitation|vestibular rehabilitation
583975|NCT00702832|acute vestibular injury|acute vestibular injury
583976|NCT00702832|Dizziness|dizziness
583977|NCT00702832|Nausea|nausea
583978|NCT00702832|Nystagmus|nystagmus
583979|NCT00702832|Daily life activities|daily life activities
583980|NCT00702832|Balance|balance
583981|NCT00702832|physiotherapy|physiotherapy
583982|NCT00702819|Pan-Vascular Endothelial Growth Factor Blockade|pan-vascular endothelial growth factor blockade
583983|NCT00702819|Safety|safety
583984|NCT00702806|Pharmacological effects of drugs|pharmacological effects of drugs
583985|NCT00702806|Hormones|hormones
583986|NCT00702806|Hormone substitutes and Hormone Antagonists|hormone substitutes and hormone antagonists
583987|NCT00702806|Pharmacological Actions|pharmacological actions
583988|NCT00702806|Randomized|randomized
583989|NCT00702806|Multi-center|multi-center
583990|NCT00702806|Multi-national|multi-national
583991|NCT00702793|Smoking cessation|smoking cessation
583992|NCT00702793|schizophrenia|schizophrenia
583993|NCT00702793|schizoaffective|schizoaffective
583994|NCT00702793|psychosis|psychosis
583995|NCT00702793|varenicline|varenicline
583997|NCT00702793|chantix|chantix
583998|NCT00702793|nicotine dependence|nicotine dependence
583999|NCT00702780|Alzheimer's disease|alzheimer's disease
584000|NCT00702780|escitalopram|escitalopram
584001|NCT00702780|MRI|mri
584002|NCT00702767|This study was completed in October 2006|this study was completed in october 2006
584003|NCT00702741|Knee|knee
584004|NCT00702741|Meniscus|meniscus
584005|NCT00702741|Meniscectomy|meniscectomy
584006|NCT00702741|Mesenchymal Stem Cells|mesenchymal stem cells
584007|NCT00702741|MSCs|mscs
584008|NCT00702741|Adult Human Stem Cells|adult human stem cells
584009|NCT00702741|Osiris|osiris
584010|NCT00702741|Chondrogen|chondrogen
584011|NCT00702728|Contrast induced nephropathy|contrast induced nephropathy
584012|NCT00702728|Furosemide|furosemide
584013|NCT00702728|Percutaneous coronary interventions|percutaneous coronary interventions
584014|NCT00702728|Saline hydration|saline hydration
584015|NCT00702702|Uterine fibroids|uterine fibroids
584016|NCT00702702|Anemia|anemia
584017|NCT00702689|Skin Sclerosis|skin sclerosis
584018|NCT00702689|Graft Versus Host Disease|graft versus host disease
584019|NCT00702676|Healthy Volunteers|healthy volunteers
584020|NCT00702663|Hepatitis B|hepatitis b
584021|NCT00702663|Hepatitis B vaccination|hepatitis b vaccination
584022|NCT00702663|booster effect|booster effect
584023|NCT00702663|Taiwan|taiwan
584024|NCT00702663|young adults|young adults
584025|NCT00702637|Traumatic Brain Injury|traumatic brain injury
584026|NCT00702637|Fatigue|fatigue
584027|NCT00702637|Modafinil|modafinil
584028|NCT00702637|Somnolence|somnolence
584029|NCT00702624|Neonatal outcome|neonatal outcome
584030|NCT00702624|Congenital malformations|congenital malformations
584031|NCT00702624|In-Vitro fertilization|in-vitro fertilization
584032|NCT00702624|Controlled ovarian stimulation|controlled ovarian stimulation
584033|NCT00702624|Follow-up|follow-up
584034|NCT00702611|Ulcerative Colitis|ulcerative colitis
584035|NCT00702611|Inflammatory Bowel disease|inflammatory bowel disease
584036|NCT00702611|Steroid dependent|steroid dependent
584037|NCT00702611|Adacolumn|adacolumn
584038|NCT00702611|Apheresis|apheresis
584039|NCT00702611|Granulocyte Monocyte apheresis|granulocyte monocyte apheresis
584040|NCT00702611|GMA apheresis|gma apheresis
584041|NCT00702611|Granulocytapheresis|granulocytapheresis
584042|NCT00702598|Depression|depression
584043|NCT00702598|occupational function|occupational function
584044|NCT00702598|rating scales|rating scales
584045|NCT00702598|RCT|rct
584046|NCT00702598|cognitive behaviour therapy|cognitive behaviour therapy
584047|NCT00702598|CBT|cbt
584048|NCT00702598|escitalopram|escitalopram
584049|NCT00702598|antidepressants|antidepressants
584050|NCT00702585|Ovulation Induction|ovulation induction
584051|NCT00702585|Pharmacological effects of drugs|pharmacological effects of drugs
584052|NCT00702585|Hormones|hormones
584053|NCT00702585|Hormone substitutes and Hormone Antagonists|hormone substitutes and hormone antagonists
584054|NCT00702585|Pharmacological Actions|pharmacological actions
584055|NCT00702585|Randomized|randomized
584056|NCT00702585|Multi-center|multi-center
584057|NCT00702585|Multi-national|multi-national
584058|NCT00702572|Phase I|phase i
584059|NCT00702572|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
584060|NCT00702546|In-vitro fertilization|in-vitro fertilization
584061|NCT00702546|Controlled Ovarian Stimulation|controlled ovarian stimulation
584062|NCT00702546|Cumulative pregnancy data|cumulative pregnancy data
584063|NCT00702546|Follow-up|follow-up
584064|NCT00702533|Hyper/Hyposecretion|hyper/hyposecretion
584065|NCT00702533|Gastric Analysis|gastric analysis
584066|NCT00702533|Gastric pH|gastric ph
584067|NCT00702533|SmartPill|smartpill
584068|NCT00702533|ph Monitoring|ph monitoring
584069|NCT00702533|Gastric Secretion|gastric secretion
584070|NCT00702533|Gastric Acid Output|gastric acid output
584071|NCT00702533|Healthy Volunteer|healthy volunteer
584072|NCT00702533|HV|hv
584073|NCT00702520|Neonatal outcome|neonatal outcome
584074|NCT00702520|Congenital malformations|congenital malformations
584075|NCT00702520|In-Vitro fertilization|in-vitro fertilization
584076|NCT00702520|Controlled ovarian stimulation|controlled ovarian stimulation
584077|NCT00702520|Follow-up|follow-up
584078|NCT00702507|Diaper dermatitis complicated by candidiasis|diaper dermatitis complicated by candidiasis
584079|NCT00702494|placental growth factor|placental growth factor
584080|NCT00702494|monoclonal antibody|monoclonal antibody
584081|NCT00702494|Phase I|phase i
584082|NCT00702494|solid tumors|solid tumors
584083|NCT00702494|Patients with solid tumors|patients with solid tumors
584084|NCT00702481|Head and Neck Squamous Cell Cancer|head and neck squamous cell cancer
584085|NCT00702481|Chemoradiation|chemoradiation
584086|NCT00702481|EGFR monoclonal antibody|egfr monoclonal antibody
584087|NCT00702468|Spasticity|spasticity
584088|NCT00702468|Multiple Sclerosis|multiple sclerosis
584089|NCT00702455|Weight loss maintenance.|weight loss maintenance.
584090|NCT00702455|Interactive phone and mail-based intervention.|interactive phone and mail-based intervention.
584091|NCT00702442|Nausea, Vomiting|nausea, vomiting
584092|NCT00702442|Vomiting episodes|vomiting episodes
584093|NCT00702416|Analgesia, Patient-controlled|analgesia, patient-controlled
584094|NCT00702416|Anesthesia, Regional|anesthesia, regional
584095|NCT00702416|Ultrasound|ultrasound
584096|NCT00702416|Postoperative Pain|postoperative pain
584097|NCT00702416|Brachial Plexus|brachial plexus
584098|NCT00702364|Attention|attention
584099|NCT00702364|Traumatic Brain INjury|traumatic brain injury
584100|NCT00702364|Atomoxetine|atomoxetine
584101|NCT00702364|Strattera|strattera
584102|NCT00702351|Infertility|infertility
584103|NCT00702351|Pharmacological effects of drugs|pharmacological effects of drugs
584104|NCT00702351|Drug therapy|drug therapy
584105|NCT00702351|Hormones|hormones
584106|NCT00702351|GnRH agonist|gnrh agonist
584107|NCT00702351|RecFSH|recfsh
584108|NCT00702351|Corifollitropin alfa|corifollitropin alfa
584109|NCT00702351|Open-label|open-label
584110|NCT00702338|Neonatal outcome|neonatal outcome
584111|NCT00702338|Congenital malformations|congenital malformations
584112|NCT00702338|Ovulation Induction|ovulation induction
584113|NCT00702338|Follow-up|follow-up
584114|NCT00702325|Asthma|asthma
584115|NCT00702312|Blood pressure|blood pressure
584116|NCT00702299|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
584117|NCT00702299|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
584118|NCT00702299|peritoneal cavity cancer|peritoneal cavity cancer
584119|NCT00702299|fallopian tube cancer|fallopian tube cancer
584120|NCT00702286|Surface acoustic ultrasound|surface acoustic ultrasound
584121|NCT00702286|biofilm formation|biofilm formation
584122|NCT00702286|percoutaneous nephrostomy tube|percoutaneous nephrostomy tube
584123|NCT00702286|Patients requiring per coetaneous drainage due to urinary|patients requiring per coetaneous drainage due to urinary
584124|NCT00702286|tract obstruction|tract obstruction
584125|NCT00702286|To evaluate the efficacy of surface acoustic wave in|to evaluate the efficacy of surface acoustic wave in
584126|NCT00702286|reducing pain and improving drainage|reducing pain and improving drainage
584127|NCT00702273|In-vitro fertilization|in-vitro fertilization
584128|NCT00702273|Controlled Ovarian Stimulation|controlled ovarian stimulation
584129|NCT00702273|Cumulative pregnancy data|cumulative pregnancy data
584130|NCT00702273|Follow-up|follow-up
584131|NCT00702247|Multiple Myeloma - Nonmyeloablative transplantation - Autologous Transplant - Graft versus myeloma|multiple myeloma - nonmyeloablative transplantation - autologous transplant - graft versus myeloma
584225|NCT00701909|Level of drowsiness|level of drowsiness
584132|NCT00702247|Newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
584133|NCT00702247|Tandem Auto-Allo Transplant|tandem auto-allo transplant
584134|NCT00702247|Overall survival|overall survival
584135|NCT00702247|Event free survival|event free survival
584136|NCT00702247|Disease response|disease response
584137|NCT00702234|Neonatal outcome|neonatal outcome
584138|NCT00702234|Congenital malformations|congenital malformations
584139|NCT00702234|In-Vitro fertilization|in-vitro fertilization
584140|NCT00702234|Controlled ovarian stimulation|controlled ovarian stimulation
584141|NCT00702234|Follow-up|follow-up
584142|NCT00702221|high blood pressure|high blood pressure
584143|NCT00702221|vaccines|vaccines
584144|NCT00702208|cervical cytology|cervical cytology
584145|NCT00702208|Pap smear|pap smear
584146|NCT00702208|self-sampling|self-sampling
584147|NCT00702208|abnormal|abnormal
584148|NCT00702208|normal|normal
584149|NCT00702195|Neonatal outcome|neonatal outcome
584150|NCT00702195|Congenital malformations|congenital malformations
584151|NCT00702195|In-Vitro Fertilization|in-vitro fertilization
584152|NCT00702195|Controlled ovarian stimulation|controlled ovarian stimulation
584153|NCT00702195|Follow-up|follow-up
584154|NCT00702195|Ovulation Induction|ovulation induction
584155|NCT00702195|Neonates|neonates
584156|NCT00702182|Lung Cancer|lung cancer
584157|NCT00702182|Vinorelbine|vinorelbine
584158|NCT00702182|Erlotinib|erlotinib
584159|NCT00702182|Phase 1|phase 1
584160|NCT00702169|high frequency ventilation monitoring|high frequency ventilation monitoring
584161|NCT00702169|lung disease|lung disease
584162|NCT00702169|Respiratory distress syndrome|respiratory distress syndrome
584163|NCT00702169|lung barotrauma|lung barotrauma
584164|NCT00702169|mechanical ventilation|mechanical ventilation
584165|NCT00702169|endotracheal tube displacement|endotracheal tube displacement
584166|NCT00702169|endotracheal tube occlusion|endotracheal tube occlusion
584167|NCT00702169|one lung intubation|one lung intubation
584168|NCT00702156|Heart Failure|heart failure
584169|NCT00702156|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
584170|NCT00702156|Beta-blockers|beta-blockers
584171|NCT00702156|Pulmonary Function|pulmonary function
584172|NCT00702130|Ventilator Associated Pneumonia|ventilator associated pneumonia
584173|NCT00702104|prostate cancer|prostate cancer
584174|NCT00702078|COPD|copd
584175|NCT00702078|home-based treatment|home-based treatment
584176|NCT00702078|early intervention|early intervention
584177|NCT00702065|Multiple Sclerosis Quality of life|multiple sclerosis quality of life
584178|NCT00702052|Mantle Cell Lymphoma|mantle cell lymphoma
584179|NCT00702052|Lymphoma|lymphoma
584180|NCT00702052|B-Cell Lymphoma|b-cell lymphoma
584181|NCT00702052|Mantle Zone Lymphoma|mantle zone lymphoma
584182|NCT00702052|Refractory Lymphoma|refractory lymphoma
584183|NCT00702052|Aggressive Lymphoma|aggressive lymphoma
584184|NCT00702052|PILLAR-1|pillar-1
584185|NCT00702026|Irritable Bowel Syndrome|irritable bowel syndrome
584186|NCT00702026|Hypersensitivity|hypersensitivity
584187|NCT00702026|Probiotics|probiotics
584188|NCT00702026|Multispecies|multispecies
584189|NCT00702013|P-glycoprotein|p-glycoprotein
584190|NCT00702013|lymphocyte|lymphocyte
584191|NCT00702013|HIV|hiv
584192|NCT00702013|children|children
584193|NCT00702013|ontogenesis|ontogenesis
584194|NCT00702013|Ontogenesis P-gp in human lymphocytes|ontogenesis p-gp in human lymphocytes
584195|NCT00702013|Study of the influence of HIV infection|study of the influence of hiv infection
584196|NCT00702013|Antiretroviral treatments on P-gp activity|antiretroviral treatments on p-gp activity
584197|NCT00702013|Expression in human lymphocytes|expression in human lymphocytes
584198|NCT00702000|ICU acquired paresis|icu acquired paresis
584199|NCT00701987|Cutaneous Metastatic Melanoma|cutaneous metastatic melanoma
584200|NCT00701974|Non-inferiority based on efficiency|non-inferiority based on efficiency
584201|NCT00701961|Mefloquine-artesunate|mefloquine-artesunate
584202|NCT00701961|Malaria|malaria
584203|NCT00701961|Pregnancy|pregnancy
584204|NCT00701961|Pharmacokinetics|pharmacokinetics
584205|NCT00701961|Sub-Saharan Africa|sub-saharan africa
584206|NCT00701961|P falciparum malaria infection in pregnancy|p falciparum malaria infection in pregnancy
584207|NCT00701948|Late onset neonatal sepsis|late onset neonatal sepsis
584208|NCT00701948|Nosocomial bacterial infection|nosocomial bacterial infection
584209|NCT00701948|Inflammatory markers|inflammatory markers
584210|NCT00701948|multiplex dosage|multiplex dosage
584211|NCT00701935|diabetes mellitus|diabetes mellitus
584212|NCT00701935|Amylin|amylin
584213|NCT00701935|Lilly|lilly
584214|NCT00701922|lung transplantation|lung transplantation
584215|NCT00701922|Bronchiolitis Obliterans|bronchiolitis obliterans
584216|NCT00701922|Epstein-Barr Virus Infections|epstein-barr virus infections
584217|NCT00701922|Paramyxoviridae Infections|paramyxoviridae infections
584218|NCT00701922|Herpesviridae|herpesviridae
584219|NCT00701909|wound care|wound care
584220|NCT00701909|procedural pain intensity|procedural pain intensity
584221|NCT00701909|procedural hyperalgesia|procedural hyperalgesia
584222|NCT00701909|wound care pain intensity|wound care pain intensity
584223|NCT00701909|wound care hyperalgesia|wound care hyperalgesia
584224|NCT00701909|Wound care pain quality|wound care pain quality
584226|NCT00701909|level of nausea|level of nausea
584227|NCT00701909|Level of vomiting|level of vomiting
584228|NCT00701909|Level of hallucinations|level of hallucinations
584229|NCT00701909|Level of dysphoria|level of dysphoria
584230|NCT00701896|HIV|hiv
584231|NCT00701896|Positive|positive
584232|NCT00701896|Smokers|smokers
584233|NCT00701896|Varenicline|varenicline
584234|NCT00701883|Cholesterol|cholesterol
584235|NCT00701883|Hyperlipidemia|hyperlipidemia
584236|NCT00701883|HDL|hdl
584237|NCT00701883|LDL|ldl
584238|NCT00701883|Triglycerides|triglycerides
584239|NCT00701883|Dyslipidemia|dyslipidemia
584240|NCT00701870|NSCLC|nsclc
584241|NCT00701870|Chemotherapy induced neutropenia|chemotherapy induced neutropenia
584242|NCT00701870|CIN|cin
584243|NCT00701857|stage III esophageal cancer|stage iii esophageal cancer
584244|NCT00701857|stage IV esophageal cancer|stage iv esophageal cancer
584245|NCT00701844|Aplastic Anemia|aplastic anemia
584246|NCT00701844|Lymphatic Diseases|lymphatic diseases
584247|NCT00701844|Leukemia|leukemia
584248|NCT00701844|Leukemia, Lymphoid|leukemia, lymphoid
584249|NCT00701844|Immunoproliferative Disorders|immunoproliferative disorders
584250|NCT00701844|Precursor Cell Lymphoblastic Leukemia-Lymphoma|precursor cell lymphoblastic leukemia-lymphoma
584251|NCT00701844|Anemia|anemia
584252|NCT00701844|Quality of Life|quality of life
584253|NCT00701844|Lymphoproliferative Disorders|lymphoproliferative disorders
584254|NCT00701844|Lymphoma|lymphoma
584255|NCT00701844|Multiple Myeloma|multiple myeloma
584256|NCT00701805|Secondary hyperparathyroidism|secondary hyperparathyroidism
584257|NCT00701805|Hemodialysis|hemodialysis
584258|NCT00701805|paricalcitol|paricalcitol
584259|NCT00701792|cirrhosis transplantation|cirrhosis transplantation
584260|NCT00701779|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
584261|NCT00701779|Dutasteride|dutasteride
584262|NCT00701779|Tamsulosin|tamsulosin
584263|NCT00701753|Pharmacogenetic|pharmacogenetic
584264|NCT00701753|DNA|dna
584265|NCT00701753|RNA|rna
584266|NCT00701753|Antipsychotic|antipsychotic
584267|NCT00701753|Olanzapine|olanzapine
584268|NCT00701753|Risperidone|risperidone
584269|NCT00701753|Quetiapine|quetiapine
584270|NCT00701753|Personalized medicine|personalized medicine
584271|NCT00701740|photoaging|photoaging
584272|NCT00701740|isotretinoin|isotretinoin
584273|NCT00701740|profilometry|profilometry
584274|NCT00701740|digital analysis|digital analysis
584275|NCT00701727|metabolic diseases|metabolic diseases
584276|NCT00701727|metabolic disorder|metabolic disorder
584277|NCT00701727|dyslipidemias|dyslipidemias
584278|NCT00701727|lipid metabolism disorders|lipid metabolism disorders
584279|NCT00701714|Treatment|treatment
584280|NCT00701714|associated|associated
584281|NCT00701714|with CRI|with cri
584282|NCT00701688|Mucositis, Oral|mucositis, oral
584283|NCT00701688|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
584284|NCT00701688|Allogeneic Transplantation|allogeneic transplantation
584285|NCT00701688|Pharmacokinetics|pharmacokinetics
584286|NCT00701688|Maximum Tolerated Dose|maximum tolerated dose
584287|NCT00701675|sertraline|sertraline
584288|NCT00701675|pharmacotherapy|pharmacotherapy
584289|NCT00701675|geriatric|geriatric
584290|NCT00701649|mild essential hypertension|mild essential hypertension
584291|NCT00701649|moderate essential hypertension|moderate essential hypertension
584292|NCT00701636|Daptomycin|daptomycin
584293|NCT00701636|Antibiotic Prophylaxis|antibiotic prophylaxis
584294|NCT00701636|Pharmacokinetics|pharmacokinetics
584295|NCT00701636|Surgical Wound Infection|surgical wound infection
584296|NCT00701636|Staphylococcus aureus|staphylococcus aureus
584297|NCT00701636|Cardiopulmonary Bypass Surgery|cardiopulmonary bypass surgery
584298|NCT00701623|The intention of this work is to verify the effectiveness and safety of sodium heparin in the treatment of burns of the skin.|the intention of this work is to verify the effectiveness and safety of sodium heparin in the treatment of burns of the skin.
584299|NCT00701610|Von Willebramd Factor (VWF)|von willebramd factor (vwf)
584300|NCT00701610|All infants born in our hospital since August 2007 ill august 2009 will enter.|all infants born in our hospital since august 2007 ill august 2009 will enter.
584301|NCT00701610|Therombocytopenia, maternal aspirin will be excluded|therombocytopenia, maternal aspirin will be excluded
584302|NCT00701597|ocular blood flow dysregulation, glaucoma, endothelin-1|ocular blood flow dysregulation, glaucoma, endothelin-1
584303|NCT00701584|Phytoestrogens|phytoestrogens
584304|NCT00701584|Isoflavones|isoflavones
584305|NCT00701584|Lignans|lignans
584306|NCT00701584|Breast cancer survival|breast cancer survival
584307|NCT00701584|breast cancer recurrence|breast cancer recurrence
584308|NCT00701571|Virtual Reality|virtual reality
584309|NCT00701571|Oncology|oncology
584310|NCT00701571|Lumbar puncture|lumbar puncture
584311|NCT00701545|von Willebrand disease|von willebrand disease
584312|NCT00701545|VWD, Humate-P®|vwd, humate-p®
584313|NCT00701545|Infusion volume reduced|infusion volume reduced
584314|NCT00701545|ivr|ivr
584315|NCT00701532|Cocaine|cocaine
584316|NCT00701532|Substance abuse|substance abuse
584317|NCT00701532|Addiction|addiction
584318|NCT00701532|Dependence|dependence
584319|NCT00701532|Modafinil|modafinil
584320|NCT00701532|Brain imaging|brain imaging
584321|NCT00701519|CHF,|chf,
584322|NCT00701519|Sleep apnea,|sleep apnea,
584323|NCT00701519|Obstructive sleep apnea,|obstructive sleep apnea,
584324|NCT00701519|Heart failure|heart failure
584325|NCT00701506|Knee|knee
584326|NCT00701506|Osteoarthritis|osteoarthritis
584327|NCT00701506|Treatment|treatment
584328|NCT00701506|Electrostimulation|electrostimulation
584329|NCT00701493|Topiramate|topiramate
584330|NCT00701493|Topiramate oral liquid|topiramate oral liquid
584331|NCT00701493|TOPAMAX Sprinkle capsule|topamax sprinkle capsule
584332|NCT00701493|topiramate capsules|topiramate capsules
584333|NCT00701480|acne|acne
584334|NCT00701480|skin cleanser|skin cleanser
584335|NCT00701480|Hibiscus sabdariffa|hibiscus sabdariffa
584336|NCT00701480|Roselle|roselle
584337|NCT00701480|safety|safety
584338|NCT00701480|efficacy|efficacy
584339|NCT00701467|ICD|icd
584340|NCT00701467|ICD implanted patients|icd implanted patients
584341|NCT00701454|Thai-muslim|thai-muslim
584342|NCT00701454|Thai-HALAL|thai-halal
584343|NCT00701454|Diabetes|diabetes
584344|NCT00701454|Hypertension|hypertension
584345|NCT00701454|Hyperlipidemia|hyperlipidemia
584346|NCT00701454|Metabolic syndrome|metabolic syndrome
584347|NCT00701441|sleep apnea,|sleep apnea,
584348|NCT00701441|oxidative stress|oxidative stress
584349|NCT00701428|Hypertension|hypertension
584350|NCT00701428|Sleep Apnea|sleep apnea
584351|NCT00701428|Angiotensin II antagonist|angiotensin ii antagonist
584352|NCT00701428|CPAP|cpap
584353|NCT00701415|α-GAL, α-Galactosidase-A, r-hαGAL|α-gal, α-galactosidase-a, r-hαgal
584354|NCT00701402|time to lipid-lowering drug implementation|time to lipid-lowering drug implementation
584355|NCT00701402|dyslipidemic patients|dyslipidemic patients
584356|NCT00701376|Gastric Bypass surgery|gastric bypass surgery
584357|NCT00701376|Hepatic disease|hepatic disease
584358|NCT00701376|Hepatic function|hepatic function
584359|NCT00701350|Pregnancy|pregnancy
584360|NCT00701350|Intra-amniotic Infection|intra-amniotic infection
584361|NCT00701350|Preterm Birth|preterm birth
584362|NCT00701350|Preterm Premature Rupture of Membranes|preterm premature rupture of membranes
584363|NCT00701337|Estrogen Replacement Therapy|estrogen replacement therapy
584364|NCT00701337|menopausal women|menopausal women
584365|NCT00701311|Prostatitis|prostatitis
584366|NCT00701311|Pelvic pain|pelvic pain
584367|NCT00701285|heart failure|heart failure
584368|NCT00701285|pitavastatin|pitavastatin
584369|NCT00701285|pravastatin|pravastatin
584370|NCT00701285|statin|statin
584371|NCT00701259|Frequent heartburn, proton pump inhibitor, lansoprazole|frequent heartburn, proton pump inhibitor, lansoprazole
584372|NCT00701259|Treatment of|treatment of
584373|NCT00701259|over 14 days|over 14 days
584374|NCT00701246|Anemia|anemia
584375|NCT00701246|Iron deficiency anemia|iron deficiency anemia
584376|NCT00701246|Infants|infants
584377|NCT00701246|Children|children
584378|NCT00701246|Clinical trials|clinical trials
584379|NCT00701246|Ferrous sulfate|ferrous sulfate
584380|NCT00701246|Folic acid|folic acid
584381|NCT00701246|Daycare centers|daycare centers
584382|NCT00701246|Anaemia in children|anaemia in children
584383|NCT00701246|born at term|born at term
584384|NCT00701246|non-twins|non-twins
584385|NCT00701246|with parental approval for participation in the study|with parental approval for participation in the study
584386|NCT00701246|growth|growth
584387|NCT00701220|Cardiovascular Disease|cardiovascular disease
584388|NCT00701220|Cardiomyopathy|cardiomyopathy
584389|NCT00701220|Heart Disease|heart disease
584390|NCT00701220|Myocardial Disease|myocardial disease
584391|NCT00701220|Myocardial Ischemia|myocardial ischemia
584392|NCT00701207|To determine if nicotine treatment reduces lung inflammation|to determine if nicotine treatment reduces lung inflammation
584393|NCT00701194|placement instability|placement instability
584394|NCT00701194|disruptive behavior disorders|disruptive behavior disorders
584395|NCT00701194|school readiness|school readiness
584396|NCT00701194|developmental delays|developmental delays
584397|NCT00701194|cortisol|cortisol
584398|NCT00701194|executive functioning|executive functioning
584399|NCT00701194|therapeutic foster care|therapeutic foster care
584400|NCT00701194|prevention|prevention
584401|NCT00701194|early intervention|early intervention
584402|NCT00701181|Phase II|phase ii
584403|NCT00701181|Prospective|prospective
584404|NCT00701181|Randomized|randomized
584405|NCT00701181|Diabetic Macular Edema|diabetic macular edema
584406|NCT00701181|PF-04523655|pf-04523655
584407|NCT00701181|Laser|laser
584408|NCT00701129|Glycogenesis 2|glycogenesis 2
584409|NCT00701129|Acid|acid
584410|NCT00701129|Maltase|maltase
584411|NCT00701129|Deficiency|deficiency
584412|NCT00701090|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
584413|NCT00701090|Non Insulin Dependent|non insulin dependent
584414|NCT00701077|Brugada syndrome|brugada syndrome
584415|NCT00701077|Electrophysiological study|electrophysiological study
584416|NCT00701077|Ion channel blockade|ion channel blockade
584417|NCT00701064|posttraumatic stress disorder|posttraumatic stress disorder
584418|NCT00701064|phototherapy|phototherapy
584419|NCT00701064|anxiety|anxiety
584420|NCT00701064|depression|depression
584421|NCT00701064|sleep|sleep
584422|NCT00701064|negative ion generator|negative ion generator
584423|NCT00701038|Sleep apnea,|sleep apnea,
584424|NCT00701038|obstructive sleep apnea,|obstructive sleep apnea,
584425|NCT00701038|heart failure,|heart failure,
584426|NCT00701038|CHF|chf
584427|NCT00701025|inflammation in asthmatic and non-asthmatic participants|inflammation in asthmatic and non-asthmatic participants
584428|NCT00701012|low or high ligation|low or high ligation
584429|NCT00700986|Electroretinography|electroretinography
584430|NCT00700986|Rheumatoid Arthritis|rheumatoid arthritis
584431|NCT00700986|Anti-TNF|anti-tnf
584432|NCT00700986|Disease Modifying Anti-Rheumatic Drugs (DMARD)|disease modifying anti-rheumatic drugs (dmard)
584433|NCT00700973|anger|anger
584434|NCT00700973|psychotherapy, brief|psychotherapy, brief
584435|NCT00700973|diagnosis, dual|diagnosis, dual
584436|NCT00700947|Heart Disease|heart disease
584437|NCT00700947|Mitral Regurgitation|mitral regurgitation
584438|NCT00700947|Heart Valve Disease|heart valve disease
584439|NCT00700947|Mitral Valve Insufficiency|mitral valve insufficiency
584440|NCT00700947|Heart Surgery|heart surgery
584441|NCT00700947|Heart Valve Surgery|heart valve surgery
584442|NCT00700934|FEV1|fev1
584443|NCT00700934|mortality|mortality
584444|NCT00700934|Quality of life|quality of life
584445|NCT00700908|type 2 diabetes|type 2 diabetes
584446|NCT00700908|telephone intervention|telephone intervention
584447|NCT00700908|automated|automated
584448|NCT00700882|stage IV melanoma|stage iv melanoma
584449|NCT00700882|acral lentiginous malignant melanoma|acral lentiginous malignant melanoma
584450|NCT00700882|mucosal melanoma|mucosal melanoma
584451|NCT00700882|recurrent melanoma|recurrent melanoma
584452|NCT00700882|stage IIIA melanoma|stage iiia melanoma
584453|NCT00700882|stage IIIB melanoma|stage iiib melanoma
584454|NCT00700882|stage IIIC melanoma|stage iiic melanoma
584455|NCT00700869|Altered level of consciousness|altered level of consciousness
584456|NCT00700869|Tracheal tube withdrawal|tracheal tube withdrawal
584457|NCT00700869|Respiration|respiration
584458|NCT00700869|Artificial Respiration|artificial respiration
584459|NCT00700869|Physiology|physiology
584460|NCT00700856|diabetes|diabetes
584461|NCT00700856|cardiovascular disease|cardiovascular disease
584462|NCT00700856|pioglitazone|pioglitazone
584463|NCT00700856|sulphonylurea|sulphonylurea
584464|NCT00700856|metformin monotherapy|metformin monotherapy
584465|NCT00700856|hypoglycemic therapy|hypoglycemic therapy
584466|NCT00700843|bariatric surgery|bariatric surgery
584467|NCT00700843|long term follow up|long term follow up
584468|NCT00700843|gastric partitioning surgery|gastric partitioning surgery
584469|NCT00700843|Roux-en-Y gastric bypass surgery|roux-en-y gastric bypass surgery
584470|NCT00700843|obesity|obesity
584471|NCT00700804|Calcium retention|calcium retention
584472|NCT00700804|dietary protein|dietary protein
584473|NCT00700804|dietary calcium|dietary calcium
584474|NCT00700791|Single and bilateral body contouring surgical sites.|single and bilateral body contouring surgical sites.
584475|NCT00700778|breast cancer|breast cancer
584476|NCT00700778|BRCA1 mutation carrier|brca1 mutation carrier
584477|NCT00700739|Cervical|cervical
584478|NCT00700739|Disc|disc
584479|NCT00700739|Arthroplasty|arthroplasty
584480|NCT00700739|Spinal|spinal
584481|NCT00700726|blood test|blood test
584482|NCT00700726|asthma|asthma
584483|NCT00700726|skin test|skin test
584484|NCT00700713|Meningitis|meningitis
584485|NCT00700713|Meningococcemia|meningococcemia
584486|NCT00700713|Neisseria meningitidis|neisseria meningitidis
584487|NCT00700713|Menactra®|menactra®
584488|NCT00700700|Congestive Heart Failure|congestive heart failure
584489|NCT00700700|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
584490|NCT00700700|Dyspnea|dyspnea
584491|NCT00700700|Exercise Tolerance|exercise tolerance
584492|NCT00700687|cardiovascular prophylactic therapy|cardiovascular prophylactic therapy
584493|NCT00700674|EEG entropy|eeg entropy
584494|NCT00700674|Elderly|elderly
584495|NCT00700674|Decreases|decreases
584496|NCT00700674|POCD|pocd
584497|NCT00700674|Use of EEG entropy|use of eeg entropy
584498|NCT00700674|Geriatric|geriatric
584499|NCT00700635|Meningitis; Meningococcal infection, Neisseria meningitidis|meningitis; meningococcal infection, neisseria meningitidis
584500|NCT00700609|Depression|depression
584501|NCT00700609|Family Therapy|family therapy
584502|NCT00700609|Adolescents|adolescents
584503|NCT00700596|Salvia|salvia
584504|NCT00700596|SA|sa
584505|NCT00700596|Salvinorin|salvinorin
584506|NCT00700596|Psychotomimetic Effects|psychotomimetic effects
584507|NCT00700583|nocturia|nocturia
584508|NCT00700583|bladder|bladder
584509|NCT00700583|urination disorders|urination disorders
584510|NCT00700583|hydrochlorothiazide|hydrochlorothiazide
584511|NCT00700583|terazosin|terazosin
584512|NCT00700557|Antibiotic Associated Diarrhea|antibiotic associated diarrhea
584513|NCT00700557|probiotics|probiotics
584514|NCT00700557|treatment|treatment
584515|NCT00700544|AML|aml
584516|NCT00700544|elderly patients|elderly patients
584517|NCT00700544|Treatment outcome|treatment outcome
584518|NCT00700531|Hemodialysis|hemodialysis
584519|NCT00700531|Multiple myeloma|multiple myeloma
584520|NCT00700531|Cast nephropathy|cast nephropathy
584521|NCT00700531|Kidney failure|kidney failure
584522|NCT00700518|Raynaud's Syndrome|raynaud's syndrome
584523|NCT00700518|Raynaud's Disease|raynaud's disease
584524|NCT00700518|RP|rp
584525|NCT00700505|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
584526|NCT00700505|BPH|bph
584527|NCT00700505|Benign Prostatic Hypertrophy|benign prostatic hypertrophy
584528|NCT00700505|Urinary Retention|urinary retention
584529|NCT00700505|Shy Bladder|shy bladder
584530|NCT00700505|Urinary Hesitancy|urinary hesitancy
584531|NCT00700505|Bashful Bladder|bashful bladder
584532|NCT00700505|Paruresis|paruresis
584533|NCT00700492|subfertility|subfertility
584534|NCT00700492|pregnancy rate|pregnancy rate
584535|NCT00700492|miscarriage|miscarriage
584536|NCT00700479|vascular endothelium|vascular endothelium
584537|NCT00700479|nitric oxide|nitric oxide
584538|NCT00700479|aldosterone|aldosterone
584539|NCT00700479|vascular biology|vascular biology
584540|NCT00700466|Outcome assessment, patients;|outcome assessment, patients;
584541|NCT00700466|autonomic nervous system;|autonomic nervous system;
584542|NCT00700466|perioperative care;|perioperative care;
584543|NCT00700466|adrenergic beta antagonist|adrenergic beta antagonist
584544|NCT00700466|Autonomic regulation|autonomic regulation
584545|NCT00700466|Perioperative beta-blockade|perioperative beta-blockade
584546|NCT00700466|outcome|outcome
584547|NCT00700440|Radiotherapy|radiotherapy
584548|NCT00700440|chemotherapy|chemotherapy
584549|NCT00700440|Drug Targeting|drug targeting
584550|NCT00700440|loco-regionally advanced nasopharyngeal carcinoma|loco-regionally advanced nasopharyngeal carcinoma
584551|NCT00700440|Safety.|safety.
584552|NCT00700440|efficacy|efficacy
584553|NCT00700427|ADHD|adhd
584554|NCT00700427|Adult|adult
584555|NCT00700427|long term|long term
584556|NCT00700427|maintenance of response|maintenance of response
584557|NCT00700427|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
584558|NCT00700388|Chronic bronchitis|chronic bronchitis
584559|NCT00700388|COPD|copd
584560|NCT00700388|Bronchiectasis|bronchiectasis
584561|NCT00700375|Patients undergoing an emergent coronary procedure|patients undergoing an emergent coronary procedure
584562|NCT00700362|Complications|complications
584563|NCT00700362|Hyperglycemia|hyperglycemia
584564|NCT00700362|Insulin infusion|insulin infusion
584565|NCT00700349|depression|depression
584566|NCT00700349|stress|stress
584567|NCT00700349|microcredit|microcredit
584568|NCT00700349|poverty|poverty
584569|NCT00700349|South Africa|south africa
584570|NCT00700336|malignant pleural mesothelioma|malignant pleural mesothelioma
584571|NCT00700336|solid tumors|solid tumors
584572|NCT00700323|ADHD|adhd
584573|NCT00700323|ADHD diagnosed children|adhd diagnosed children
584574|NCT00700310|Partial onset seizures|partial onset seizures
584575|NCT00700310|E2007|e2007
584576|NCT00700310|perampanel|perampanel
584577|NCT00700310|refractory partial seizures|refractory partial seizures
584578|NCT00700310|adjunctive therapy|adjunctive therapy
584579|NCT00700310|seizure frequency|seizure frequency
584580|NCT00700310|reduction in seizure frequency|reduction in seizure frequency
584581|NCT00700310|safety|safety
584582|NCT00700310|concomitant AED(s)|concomitant aed(s)
584583|NCT00700297|Oral aphthosis|oral aphthosis
584584|NCT00700297|Genital aphthosis|genital aphthosis
584585|NCT00700297|Psuedofolliculitis|psuedofolliculitis
584586|NCT00700297|Erythem nodusom|erythem nodusom
584587|NCT00700297|Joint manifestations|joint manifestations
584588|NCT00700297|Colchicine|colchicine
584589|NCT00700284|HIV-I|hiv-i
584590|NCT00700284|Reverse transcriptase inhibitors|reverse transcriptase inhibitors
584591|NCT00700284|HIV Seronegativity|hiv seronegativity
584592|NCT00700271|Hypertension|hypertension
584593|NCT00700271|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
584594|NCT00700245|Obese|obese
584595|NCT00700245|Adults|adults
584596|NCT00700232|genetics|genetics
584597|NCT00700232|gene expression|gene expression
584598|NCT00700232|MDR3|mdr3
584599|NCT00700232|estrogens|estrogens
584600|NCT00700232|cholestasis|cholestasis
584601|NCT00700232|pregnancy|pregnancy
584602|NCT00700232|controls|controls
584603|NCT00700219|Preterm Labor|preterm labor
584604|NCT00700219|Preterm Birth|preterm birth
584605|NCT00700219|Intra-amniotic Infection|intra-amniotic infection
584606|NCT00700219|Pregnancy|pregnancy
584607|NCT00700219|Women|women
584608|NCT00700206|Hematology|hematology
584609|NCT00700206|MDS|mds
584610|NCT00700206|Myelodysplastic Syndrome|myelodysplastic syndrome
584611|NCT00700206|Low Risk MDS|low risk mds
584612|NCT00700206|Intermediate-1 risk MDS|intermediate-1 risk mds
584613|NCT00700206|Int-1 risk MDS|int-1 risk mds
584614|NCT00700206|Telintra|telintra
584615|NCT00700206|ezatiostat hydrochloride|ezatiostat hydrochloride
584616|NCT00700206|ezatiostat|ezatiostat
584617|NCT00700206|TLK199|tlk199
584618|NCT00700206|Glutathione|glutathione
584619|NCT00700206|Glutathione analog|glutathione analog
584620|NCT00700206|Glutathione Transferase|glutathione transferase
584621|NCT00700206|Glutathione Transferase inhibitor|glutathione transferase inhibitor
584816|NCT00699322|sitagliptin|sitagliptin
584622|NCT00700206|Glutathione Transferase P1-1 inhibitor|glutathione transferase p1-1 inhibitor
584623|NCT00700206|GSTp1-1 inhibitor|gstp1-1 inhibitor
584624|NCT00700206|Apoptosis|apoptosis
584625|NCT00700206|Differentiation|differentiation
584626|NCT00700206|Enzyme inhibitor|enzyme inhibitor
584627|NCT00700167|ANTIGENBEARING DENDRITIC CELLS|antigenbearing dendritic cells
584628|NCT00700167|98-098|98-098
584629|NCT00700154|Vascular Surgery|vascular surgery
584630|NCT00700154|Complications|complications
584631|NCT00700154|Hyperglycemia|hyperglycemia
584632|NCT00700154|Insulin infusion|insulin infusion
584633|NCT00700154|Diabetic ulcers|diabetic ulcers
584634|NCT00700154|Infection|infection
584635|NCT00700141|Tachosil|tachosil
584636|NCT00700141|thyroid|thyroid
584637|NCT00700141|parathyroid|parathyroid
584638|NCT00700141|fleece-bound hemostasispathologic processes|fleece-bound hemostasispathologic processes
584639|NCT00700141|hemorrhage|hemorrhage
584640|NCT00700141|thyroid surgery|thyroid surgery
584641|NCT00700128|headaches|headaches
584642|NCT00700128|migraines|migraines
584643|NCT00700128|breakthrough bleeding|breakthrough bleeding
584644|NCT00700128|breakthrough spotting|breakthrough spotting
584645|NCT00700128|menstrually associated migraines|menstrually associated migraines
584646|NCT00700128|breakthrough bleeding or breakthrough spotting|breakthrough bleeding or breakthrough spotting
584647|NCT00700115|HAART|haart
584648|NCT00700115|lopinavir/ritonavir|lopinavir/ritonavir
584649|NCT00700115|raltegravir|raltegravir
584650|NCT00700115|HIV/AIDS patients on HAART|hiv/aids patients on haart
584651|NCT00700115|Treatment Experienced|treatment experienced
584652|NCT00700089|Attempted suicide|attempted suicide
584653|NCT00700089|Assertive intervention|assertive intervention
584654|NCT00700089|Prevention|prevention
584655|NCT00700089|Treatment|treatment
584656|NCT00700076|ORG 25935|org 25935
584657|NCT00700076|Ketamine|ketamine
584658|NCT00700076|healthy subjects|healthy subjects
584659|NCT00700063|Peplin|peplin
584660|NCT00700063|Actinic keratosis|actinic keratosis
584661|NCT00700063|PEP005|pep005
584662|NCT00700050|Cystic Fibrosis|cystic fibrosis
584663|NCT00700050|Sex hormones|sex hormones
584664|NCT00700050|Pseudomonas aeruginosa|pseudomonas aeruginosa
584665|NCT00700050|Paediatrics|paediatrics
584666|NCT00700024|Body composition|body composition
584667|NCT00700024|Physical activity|physical activity
584668|NCT00700024|Metabolic syndrome|metabolic syndrome
584669|NCT00700011|Myelodysplastic Syndromes|myelodysplastic syndromes
584670|NCT00699998|ACS|acs
584671|NCT00699985|Psychological Symptoms|psychological symptoms
584672|NCT00699985|Behcet's Disease|behcet's disease
584673|NCT00699972|E2007|e2007
584674|NCT00699972|perampanel|perampanel
584675|NCT00699972|refractory partial seizures|refractory partial seizures
584676|NCT00699972|adjunctive therapy|adjunctive therapy
584677|NCT00699972|seizure frequency|seizure frequency
584678|NCT00699972|partial onset seizures|partial onset seizures
584679|NCT00699972|reduction in seizure frequency|reduction in seizure frequency
584680|NCT00699972|safety|safety
584681|NCT00699972|concomitant AED(s)|concomitant aed(s)
584682|NCT00699959|Coronary patients|coronary patients
584683|NCT00699959|heart failure|heart failure
584684|NCT00699959|dyslipidemia|dyslipidemia
584685|NCT00699946|delirium, atypical antipsychotics, olanzapine, orthopedic|delirium, atypical antipsychotics, olanzapine, orthopedic
584686|NCT00699933|acute pancreatitis|acute pancreatitis
584687|NCT00699933|interventional therapy|interventional therapy
584688|NCT00699933|CT-guided drainage therapy|ct-guided drainage therapy
584689|NCT00699933|percutaneous necrosectomy|percutaneous necrosectomy
584690|NCT00699933|Comparison of different diagnostic procedures: MRI, CT, Ultrasound|comparison of different diagnostic procedures: mri, ct, ultrasound
584691|NCT00699933|Evaluation of interventional therapy including percutaneous drainage techniques und necrosectomies|evaluation of interventional therapy including percutaneous drainage techniques und necrosectomies
584692|NCT00699907|Ovarian epithelial cancer|ovarian epithelial cancer
584693|NCT00699907|High risk|high risk
584694|NCT00699907|Biomarkers|biomarkers
584695|NCT00699894|PONV|ponv
584696|NCT00699894|prevention of postoperative nausea and vomiting|prevention of postoperative nausea and vomiting
584697|NCT00699894|aprepitant|aprepitant
584698|NCT00699894|ondansetron|ondansetron
584699|NCT00699894|orthognathic surgery|orthognathic surgery
584700|NCT00699881|Time to Progression|time to progression
584701|NCT00699881|Toxicity|toxicity
584702|NCT00699881|Overall survival|overall survival
584703|NCT00699881|Response rate|response rate
584704|NCT00699881|Quality of live|quality of live
584705|NCT00699855|Growth Hormon Deficiency and|growth hormon deficiency and
584706|NCT00699855|Turner Syndrome in pre-pubertal children|turner syndrome in pre-pubertal children
584707|NCT00699855|Long term follow-up of predictive markers|long term follow-up of predictive markers
584708|NCT00699842|Myelodysplastic Syndrome|myelodysplastic syndrome
584709|NCT00699842|MDS|mds
584710|NCT00699842|Low to Intermediate-1 MDS|low to intermediate-1 mds
584711|NCT00699842|Non-deletion 5q|non-deletion 5q
584712|NCT00699842|Lenalidomide|lenalidomide
584713|NCT00699790|Diabetes|diabetes
584714|NCT00699790|NOS|nos
584715|NCT00699764|Herpes simplex candidate vaccine|herpes simplex candidate vaccine
584716|NCT00699764|Herpes simplex|herpes simplex
584717|NCT00699751|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
584718|NCT00699751|Bone Metastases|bone metastases
584719|NCT00699751|Radium-223|radium-223
584720|NCT00699738|Healthy women during pregnancy and in the postpartum period|healthy women during pregnancy and in the postpartum period
584721|NCT00699725|Compliance|compliance
584722|NCT00699725|gastroprotector therapy|gastroprotector therapy
584723|NCT00699725|NSAID|nsaid
584724|NCT00699725|risk factors|risk factors
584725|NCT00699712|ADHF|adhf
584726|NCT00699712|AHF|ahf
584727|NCT00699712|HF|hf
584728|NCT00699699|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
584729|NCT00699686|Diabetes|diabetes
584730|NCT00699686|Insulin|insulin
584731|NCT00699686|Endothelium|endothelium
584732|NCT00699686|Cardiovascular disease|cardiovascular disease
584733|NCT00699686|Stem cells|stem cells
584734|NCT00699673|Brain natriuretic peptide|brain natriuretic peptide
584735|NCT00699673|EuroScore|euroscore
584736|NCT00699673|Cardiac surgery|cardiac surgery
584737|NCT00699673|Cardiopulmonary bypass|cardiopulmonary bypass
584738|NCT00699673|Coronary artery disease|coronary artery disease
584739|NCT00699673|Valvular disease|valvular disease
584740|NCT00699673|Risk stratification in cardiac surgery|risk stratification in cardiac surgery
584741|NCT00699660|Disability Examination|disability examination
584742|NCT00699660|Clinician Administered PTSD Scale|clinician administered ptsd scale
584743|NCT00699660|Quality of Care|quality of care
584744|NCT00699634|Neuropathic|neuropathic
584745|NCT00699634|Pain|pain
584746|NCT00699634|Phantom|phantom
584747|NCT00699634|Limb|limb
584748|NCT00699621|Intracerebral hemorrhage|intracerebral hemorrhage
584749|NCT00699621|Hematoma enlargement|hematoma enlargement
584750|NCT00699621|Antiplatelet agent|antiplatelet agent
584751|NCT00699621|Platelet transfusion|platelet transfusion
584752|NCT00699621|Outcome|outcome
584753|NCT00699608|Zopiclone|zopiclone
584754|NCT00699608|Hypnotic|hypnotic
584755|NCT00699608|Residual effects|residual effects
584756|NCT00699608|Eszopiclone|eszopiclone
584757|NCT00699582|E2007 (perampanel)|e2007 (perampanel)
584758|NCT00699582|refractory partial seizures|refractory partial seizures
584759|NCT00699582|adjunctive therapy|adjunctive therapy
584760|NCT00699582|seizure frequency|seizure frequency
584761|NCT00699582|reduction in seizure frequency|reduction in seizure frequency
584762|NCT00699582|partial onset seizures|partial onset seizures
584763|NCT00699582|safety|safety
584764|NCT00699582|concomitant AED(s)|concomitant aed(s)
584765|NCT00699569|hyperimmune colostrum|hyperimmune colostrum
584766|NCT00699569|mucositis|mucositis
584767|NCT00699556|alcohol|alcohol
584768|NCT00699556|nicotine|nicotine
584769|NCT00699556|smoking cessation|smoking cessation
584770|NCT00699556|smoking cessation medications|smoking cessation medications
584771|NCT00699530|Prolactin|prolactin
584772|NCT00699530|Insulin resistance|insulin resistance
584773|NCT00699530|Glucose tolerance|glucose tolerance
584774|NCT00699530|Body Composition|body composition
584775|NCT00699530|Substrate metabolism|substrate metabolism
584776|NCT00699517|tubulin modulator|tubulin modulator
584777|NCT00699517|endothelium|endothelium
584778|NCT00699517|combretastatin|combretastatin
584779|NCT00699517|cisplatin|cisplatin
584780|NCT00699504|ECG|ecg
584781|NCT00699504|QT|qt
584782|NCT00699504|Effect of study drug on healthy volunteers|effect of study drug on healthy volunteers
584783|NCT00699478|vitamin B12 deficiency|vitamin b12 deficiency
584784|NCT00699478|post total gastrectomy|post total gastrectomy
584785|NCT00699478|stomach cancer|stomach cancer
584786|NCT00699465|Thromboprophylaxis|thromboprophylaxis
584787|NCT00699465|Prevention of venous thromboembolism after ICH|prevention of venous thromboembolism after ich
584788|NCT00699465|Enoxaparin|enoxaparin
584789|NCT00699465|Intermittent pneumatic compression|intermittent pneumatic compression
584790|NCT00699452|aortic stenosis|aortic stenosis
584791|NCT00699452|valve|valve
584792|NCT00699452|candesartan|candesartan
584793|NCT00699439|Medical Informatics|medical informatics
584794|NCT00699439|Asthma|asthma
584795|NCT00699439|Emergency Service, Hospital|emergency service, hospital
584796|NCT00699439|Bayesian Method|bayesian method
584797|NCT00699387|Chagas disease|chagas disease
584798|NCT00699387|Pediatrics|pediatrics
584799|NCT00699387|benznidazole|benznidazole
584800|NCT00699387|population pharmacokinetics|population pharmacokinetics
584801|NCT00699387|neglected diseases|neglected diseases
584802|NCT00699387|parasitology|parasitology
584803|NCT00699387|pediatric clinical pharmacology|pediatric clinical pharmacology
584804|NCT00699374|sunitinib|sunitinib
584805|NCT00699374|phase 3|phase 3
584806|NCT00699374|randomized|randomized
584807|NCT00699374|hepatocellular|hepatocellular
584808|NCT00699374|liver|liver
584809|NCT00699361|Pantoprazole|pantoprazole
584810|NCT00699361|congestive heart failure|congestive heart failure
584811|NCT00699335|pain|pain
584812|NCT00699335|fentanyl|fentanyl
584813|NCT00699335|transdermal patch|transdermal patch
584814|NCT00699322|glucose variability|glucose variability
584815|NCT00699322|oxidative stress|oxidative stress
584817|NCT00699322|glimepiride|glimepiride
584818|NCT00699309|Total Hip Replacement|total hip replacement
584819|NCT00699309|Total Hip Arthroplasty|total hip arthroplasty
584820|NCT00699309|Minimally Invasive|minimally invasive
584821|NCT00699309|Microplasty|microplasty
584822|NCT00699309|Hip Arthritis|hip arthritis
584823|NCT00699296|LBH589|lbh589
584824|NCT00699296|HDAC inhibitor|hdac inhibitor
584825|NCT00699296|cutaneous T-ceII lymphoma|cutaneous t-ceii lymphoma
584826|NCT00699296|adult T-cell leukemia|adult t-cell leukemia
584827|NCT00699283|Epilepsy; Monotherapy|epilepsy; monotherapy
584828|NCT00699283|Partial Onset Seizures|partial onset seizures
584829|NCT00699283|Adults and Adolescents|adults and adolescents
584830|NCT00699270|Total Shoulder Arthroplasty|total shoulder arthroplasty
584831|NCT00699270|Total Shoulder Replacement|total shoulder replacement
584832|NCT00699270|Shoulder Arthritis|shoulder arthritis
584833|NCT00699257|Partial Knee Arthroplasty|partial knee arthroplasty
584834|NCT00699257|Partial Knee Replacement|partial knee replacement
584835|NCT00699257|Arthritis of Medial Compartment of the Knee|arthritis of medial compartment of the knee
584836|NCT00699257|Oxford Knee|oxford knee
584837|NCT00699244|forearm|forearm
584838|NCT00699244|hand|hand
584839|NCT00699244|elbow|elbow
584840|NCT00699244|wrist|wrist
584841|NCT00699244|brachial plexus|brachial plexus
584842|NCT00699244|infraclavicular block|infraclavicular block
584843|NCT00699231|Hepatitis B|hepatitis b
584844|NCT00699231|Engerix™-B|engerix™-b
584845|NCT00699231|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
584846|NCT00699231|Adjuvant|adjuvant
584847|NCT00699218|Bipolar|bipolar
584848|NCT00699218|Depression|depression
584849|NCT00699218|TMS|tms
584850|NCT00699218|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
584851|NCT00699218|treatment|treatment
584852|NCT00699218|Efficacy|efficacy
584853|NCT00699218|Safety|safety
584854|NCT00699192|Blood pressure|blood pressure
584855|NCT00699192|hypertension|hypertension
584856|NCT00699192|elderly|elderly
584858|NCT00699166|Diarrhea|diarrhea
584859|NCT00699166|gastrointestinal functional disorder|gastrointestinal functional disorder
584860|NCT00699166|IBS-D|ibs-d
584861|NCT00699127|anxiety|anxiety
584862|NCT00699127|parents|parents
584863|NCT00699127|NICU|nicu
584864|NCT00699127|prematurity|prematurity
584865|NCT00699127|Anxiety of parents to NICU infants|anxiety of parents to nicu infants
584866|NCT00699114|Pain|pain
584867|NCT00699114|Analgesics|analgesics
584868|NCT00699114|Molar|molar
584869|NCT00699114|Third|third
584870|NCT00699114|Acetaminophen|acetaminophen
584871|NCT00699114|Paracetamol|paracetamol
584872|NCT00699114|Ibuprofen|ibuprofen
584873|NCT00699114|Codeine|codeine
584874|NCT00699114|Placebo|placebo
584875|NCT00699101|Breast Cancer|breast cancer
584876|NCT00699101|Conture®|conture®
584877|NCT00699101|Brachytherapy|brachytherapy
584878|NCT00699088|Total Hip Arthroplasty|total hip arthroplasty
584879|NCT00699088|Total Hip Replacement|total hip replacement
584880|NCT00699088|Minimally Invasive|minimally invasive
584881|NCT00699088|Microplasty|microplasty
584882|NCT00699062|antileukotriene|antileukotriene
584883|NCT00699062|small airway|small airway
584884|NCT00699062|airway remodeling|airway remodeling
584885|NCT00699062|HRCT|hrct
584886|NCT00699049|Alpha blocker|alpha blocker
584887|NCT00699049|Tamsulosin|tamsulosin
584888|NCT00699049|Solifenacin|solifenacin
584889|NCT00699049|Overactive Bladder|overactive bladder
584890|NCT00699049|Urgency incontinence|urgency incontinence
584891|NCT00699036|nonalcoholic steatohepatitis (NASH)|nonalcoholic steatohepatitis (nash)
584892|NCT00699036|fatty liver|fatty liver
584893|NCT00699036|insulin resistance|insulin resistance
584894|NCT00699023|postprandial lipemia|postprandial lipemia
584895|NCT00699023|type 2 diabetes|type 2 diabetes
584896|NCT00699023|ezetimibe|ezetimibe
584897|NCT00699023|hypercholesterolemia|hypercholesterolemia
584898|NCT00699010|Abuse Liability|abuse liability
584899|NCT00699010|Abuse Prevention|abuse prevention
584900|NCT00699010|Abuse Resistance|abuse resistance
584901|NCT00699010|Abuse Deterrence|abuse deterrence
584902|NCT00698997|autism|autism
584903|NCT00698997|autism spectrum disorder|autism spectrum disorder
584904|NCT00698997|intensive intervention for toddlers with autism|intensive intervention for toddlers with autism
584905|NCT00698997|PDD NOS|pdd nos
584906|NCT00698997|early steps study|early steps study
584907|NCT00698997|early start denver model|early start denver model
584908|NCT00698997|early intervention for infants and toddlers with autism|early intervention for infants and toddlers with autism
584909|NCT00698997|toddler treatment|toddler treatment
584910|NCT00698997|Sally Rogers|sally rogers
584911|NCT00698997|University of California, Davis|university of california, davis
584912|NCT00698997|University of Michigan|university of michigan
584913|NCT00698997|MIND Institute|mind institute
584914|NCT00698984|Soy Isoflavones, Bone Mineral Density, Bone Mineral Content, postmenopausal Women, Bone Markers, Bone Health, Phytoestrogens|soy isoflavones, bone mineral density, bone mineral content, postmenopausal women, bone markers, bone health, phytoestrogens
584915|NCT00698958|Respiratory insufficiency|respiratory insufficiency
584916|NCT00698958|Hypercapnic chronic respiratory failure secondary to neuromuscular diseases or alterations of thoracic cage|hypercapnic chronic respiratory failure secondary to neuromuscular diseases or alterations of thoracic cage
584917|NCT00698932|DPP-4 inhibitors|dpp-4 inhibitors
584918|NCT00698932|HBA1c|hba1c
584919|NCT00698932|Incretins|incretins
584920|NCT00698919|Bacterial DNA|bacterial dna
584921|NCT00698919|Systemic inflammatory response syndrome|systemic inflammatory response syndrome
584922|NCT00698919|Infection|infection
584923|NCT00698919|Intensive Care Unit|intensive care unit
584924|NCT00698906|Hepatitis B|hepatitis b
584925|NCT00698906|HBV-MPL|hbv-mpl
584926|NCT00698906|Recombinant Hepatitis B vaccine|recombinant hepatitis b vaccine
584927|NCT00698893|Herpes simplex|herpes simplex
584928|NCT00698893|Herpes simplex candidate (gD) vaccine|herpes simplex candidate (gd) vaccine
584929|NCT00698880|Portal vein embolization|portal vein embolization
584930|NCT00698880|Hepatic vein embolization|hepatic vein embolization
584931|NCT00698880|Liver regeneration|liver regeneration
584932|NCT00698867|Total Elbow Arthroplasty|total elbow arthroplasty
584933|NCT00698867|Total Elbow Replacement|total elbow replacement
584934|NCT00698867|Osteoarthritis|osteoarthritis
584935|NCT00698867|Elbow arthritis|elbow arthritis
584936|NCT00698854|Total Knee Arthroplasty|total knee arthroplasty
584937|NCT00698854|Total Knee Replacement|total knee replacement
584938|NCT00698854|Knee Arthritis|knee arthritis
584939|NCT00698828|Cachexia, COPD, Chronic Obstructive Pulmonary Disease|cachexia, copd, chronic obstructive pulmonary disease
584940|NCT00698763|An ischaemic cerebrovascular event (stroke or TIA)|an ischaemic cerebrovascular event (stroke or tia)
584941|NCT00698750|Fractured Humeral Head|fractured humeral head
584942|NCT00698750|Traumatic Arthritis|traumatic arthritis
584943|NCT00698750|Resurfacing Shoulder|resurfacing shoulder
584944|NCT00698750|Shoulder Replacement|shoulder replacement
584945|NCT00698750|Shoulder Arthritis|shoulder arthritis
584946|NCT00698737|Opioid|opioid
584947|NCT00698737|Cocaine|cocaine
584948|NCT00698711|Prostate cancer|prostate cancer
584949|NCT00698711|MUC-2-KLH|muc-2-klh
584950|NCT00698711|QS 21|qs 21
584951|NCT00698698|tear proteins|tear proteins
584952|NCT00698698|diabetic retinopathy|diabetic retinopathy
584953|NCT00698698|HPLC|hplc
584954|NCT00698698|Mass spectroscopy|mass spectroscopy
584955|NCT00698685|Allogeneic Hematopoietic Cell Transplantation|allogeneic hematopoietic cell transplantation
584956|NCT00698685|Preparative Regimen|preparative regimen
584957|NCT00698685|Pentostatin|pentostatin
584958|NCT00698685|Alemtuzumab|alemtuzumab
584959|NCT00698685|Hodgkin Disease and Lymphoma, non-Hodgkin|hodgkin disease and lymphoma, non-hodgkin
584960|NCT00698685|leukemia, myeloid, acute|leukemia, myeloid, acute
584961|NCT00698685|leukemia, lymphocytic, acute|leukemia, lymphocytic, acute
584962|NCT00698685|leukemia, myeloid, chronic|leukemia, myeloid, chronic
584963|NCT00698685|leukemia, lymphocytic, chronic|leukemia, lymphocytic, chronic
584964|NCT00698685|Multiple Myeloma|multiple myeloma
584965|NCT00698685|Myelodysplastic Syndromes|myelodysplastic syndromes
584966|NCT00698685|Carcinoma, Renal Cell|carcinoma, renal cell
584967|NCT00698672|RSA|rsa
584968|NCT00698646|Systolic blood pressure|systolic blood pressure
584969|NCT00698646|Diastolic blood pressure|diastolic blood pressure
584970|NCT00698646|Valsartan|valsartan
584971|NCT00698646|Hydrochlorothiazide|hydrochlorothiazide
584972|NCT00698633|Hip arthroplasty|hip arthroplasty
584973|NCT00698607|Everolimus|everolimus
584974|NCT00698607|Sirolimus|sirolimus
584975|NCT00698607|drug eluting stent|drug eluting stent
584976|NCT00698607|Clopidogrel|clopidogrel
584977|NCT00698581|Epilepsy; Monotherapy|epilepsy; monotherapy
584978|NCT00698581|Partial Onset Seizures|partial onset seizures
584979|NCT00698581|Adults and Adolescents|adults and adolescents
584980|NCT00698568|Herpes simplex, Herpes simplex candidate vaccine|herpes simplex, herpes simplex candidate vaccine
584981|NCT00698555|Hepatitis B|hepatitis b
584982|NCT00698555|HBV-MPL|hbv-mpl
584983|NCT00698555|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
584984|NCT00698542|PSST|psst
584985|NCT00698542|sepsis|sepsis
584986|NCT00698542|Neuro Care Unit|neuro care unit
584987|NCT00698542|Surviving Sepsis Campaign|surviving sepsis campaign
584988|NCT00698542|SSC|ssc
584989|NCT00698529|Technology Transfer|technology transfer
584990|NCT00698529|HIV Seronegativity|hiv seronegativity
584991|NCT00698516|Bevacizumab|bevacizumab
584992|NCT00698516|Small Cell Lung Cancer (SCLC)|small cell lung cancer (sclc)
584993|NCT00698516|Topotecan|topotecan
584994|NCT00698503|Metal on Metal|metal on metal
584995|NCT00698503|Total Hip Arthroplasty|total hip arthroplasty
584996|NCT00698503|Total Hip Replacement|total hip replacement
584997|NCT00698490|Herpes simplex|herpes simplex
584998|NCT00698490|Herpes simplex candidate vaccine|herpes simplex candidate vaccine
584999|NCT00698464|Pasireotide|pasireotide
585000|NCT00698464|PK profile,|pk profile,
585001|NCT00698464|Single dose|single dose
585002|NCT00698464|Pasireotide subcutaneous injection|pasireotide subcutaneous injection
585003|NCT00698464|Safety|safety
585004|NCT00698464|Mild hepatic impaired patients|mild hepatic impaired patients
585005|NCT00698464|Moderate hepatic impaired patients|moderate hepatic impaired patients
585006|NCT00698464|Severe hepatic impaired patients|severe hepatic impaired patients
585007|NCT00698451|Ovarian cancer|ovarian cancer
585008|NCT00698451|fallopian tube cancer|fallopian tube cancer
585009|NCT00698451|primary peritoneal cancer|primary peritoneal cancer
585010|NCT00698451|DOXIL|doxil
585011|NCT00698451|carboplatin|carboplatin
585012|NCT00698451|bevacizumab|bevacizumab
585013|NCT00698438|At least 18 years of age|at least 18 years of age
585014|NCT00698438|Open-angle glaucoma|open-angle glaucoma
585015|NCT00698425|Iontophoresis|iontophoresis
585016|NCT00698425|Ophthalmology|ophthalmology
585017|NCT00698412|Knee osteoarthritis|knee osteoarthritis
585018|NCT00698412|Daily cane use|daily cane use
585019|NCT00698412|Pain|pain
585020|NCT00698412|Function|function
585021|NCT00698412|Quality of life|quality of life
585022|NCT00698412|Energy consumption during the gait|energy consumption during the gait
585023|NCT00698399|liver|liver
585024|NCT00698399|transplant|transplant
585025|NCT00698399|TMAO|tmao
585026|NCT00698399|NGAL|ngal
585027|NCT00698399|cystatin-C|cystatin-c
585028|NCT00698399|Ischemia Reperfusion Injury|ischemia reperfusion injury
585029|NCT00698399|Liver Transplant|liver transplant
585030|NCT00698399|LTx|ltx
585031|NCT00698399|allantion|allantion
585032|NCT00698386|Micronutrient Zinc|micronutrient zinc
585033|NCT00698386|Category I PTB|category i ptb
585034|NCT00698386|RNTCP|rntcp
585035|NCT00698386|DOTS|dots
585036|NCT00698386|Sputum smear conversion|sputum smear conversion
585037|NCT00698386|Reduced relapse|reduced relapse
585038|NCT00698386|Immunopathogenesis|immunopathogenesis
585039|NCT00698386|Category-I|category-i
585040|NCT00698373|Fluorine-18-α-methyltyrosine,|fluorine-18-α-methyltyrosine,
585041|NCT00698373|Positron emission tomography,|positron emission tomography,
585042|NCT00698373|Fluorine-18-fluorodeoxyglucose,|fluorine-18-fluorodeoxyglucose,
585043|NCT00698373|Lung cancer,|lung cancer,
585044|NCT00698360|chronic kidney disease|chronic kidney disease
585045|NCT00698360|melatonin|melatonin
585046|NCT00698360|erythropoietin|erythropoietin
585047|NCT00698360|circadian rhythm|circadian rhythm
585048|NCT00698347|Total Knee Replacement|total knee replacement
585049|NCT00698347|Total Knee Arthroplasty|total knee arthroplasty
585050|NCT00698347|Hip Arthritis|hip arthritis
585051|NCT00698334|HIV infection|hiv infection
585052|NCT00698334|Acquired immunodeficiency syndrome|acquired immunodeficiency syndrome
585053|NCT00698334|Tuberculosis|tuberculosis
585054|NCT00698321|HIV/STD Prevention|hiv/std prevention
585055|NCT00698321|HIV Seronegativity|hiv seronegativity
585056|NCT00698295|schizophrenia|schizophrenia
585057|NCT00698295|atypical antipsychotics|atypical antipsychotics
585058|NCT00698295|EEG|eeg
585059|NCT00698243|OSI-027|osi-027
585060|NCT00698243|Solid tumor|solid tumor
585061|NCT00698243|Lymphoma|lymphoma
585062|NCT00698204|Mucositis|mucositis
585063|NCT00698204|Head and Neck Cancer|head and neck cancer
585064|NCT00698204|Head and Neck Neoplasms|head and neck neoplasms
585065|NCT00698204|Stomatitis|stomatitis
585066|NCT00698191|Lupus Erythematosus,Systemic|lupus erythematosus,systemic
585067|NCT00698191|Lupus Nephritis|lupus nephritis
585068|NCT00698191|Mesenchymal Stem Cells|mesenchymal stem cells
585069|NCT00698191|Transplantation|transplantation
585070|NCT00698178|Gastroesophageal reflux disease|gastroesophageal reflux disease
585071|NCT00698178|Waist circumference|waist circumference
585072|NCT00698178|Body mass index|body mass index
585073|NCT00698178|Obesity|obesity
585074|NCT00698152|Total Hip Arthroplasty|total hip arthroplasty
585075|NCT00698152|Total Hip Replacement|total hip replacement
585076|NCT00698152|Hip Arthritis|hip arthritis
585077|NCT00698152|Polyethylene|polyethylene
585078|NCT00698139|heart failure|heart failure
585079|NCT00698139|chronotropic incompetence|chronotropic incompetence
585080|NCT00698113|anxiety|anxiety
585081|NCT00698113|depression|depression
585082|NCT00698113|stress|stress
585083|NCT00698113|cancer symptoms|cancer symptoms
585084|NCT00698113|pediatric cancer|pediatric cancer
585085|NCT00698113|massage|massage
585086|NCT00698113|parent delivered massage|parent delivered massage
585087|NCT00698100|DNA|dna
585088|NCT00698100|HU & MOUSE|hu & mouse
585089|NCT00698100|TYROSINASE|tyrosinase
585090|NCT00698087|Hepatitis B|hepatitis b
585091|NCT00698087|Engerix™-B|engerix™-b
585092|NCT00698087|Adjuvanted recombinant hepatitis B vaccine|adjuvanted recombinant hepatitis b vaccine
585093|NCT00698061|Hepatitis B|hepatitis b
585094|NCT00698061|Adjuvanted vaccine|adjuvanted vaccine
585095|NCT00698048|Sepsis|sepsis
585096|NCT00698048|Septic Shock|septic shock
585097|NCT00698048|Vasopressin|vasopressin
585098|NCT00698048|Copeptin|copeptin
585099|NCT00698048|Paediatrics|paediatrics
585100|NCT00698035|Vaginal Testosterone Cream|vaginal testosterone cream
585101|NCT00698035|ESTRING|estring
585102|NCT00698022|healthy|healthy
585103|NCT00698022|weight gain|weight gain
585104|NCT00698022|anti-psychotic|anti-psychotic
585105|NCT00698022|risperidone|risperidone
585106|NCT00698022|mifepristone|mifepristone
585107|NCT00698022|mitigation|mitigation
585108|NCT00698022|weight loss|weight loss
585109|NCT00698009|Neuroblastoma|neuroblastoma
585110|NCT00698009|Natural Killer Cell|natural killer cell
585111|NCT00698009|NK Cell Infusion|nk cell infusion
585112|NCT00698009|Haploidentical Natural Killer (NK) Cells|haploidentical natural killer (nk) cells
585113|NCT00698009|Fludarabine|fludarabine
585114|NCT00698009|Fludarabine Phosphate|fludarabine phosphate
585115|NCT00698009|Fludara|fludara
585116|NCT00698009|Cyclophosphamide|cyclophosphamide
585117|NCT00698009|Cytoxan|cytoxan
585118|NCT00698009|Neosar|neosar
585119|NCT00698009|Interleukin-2|interleukin-2
585120|NCT00698009|IL-2|il-2
585121|NCT00698009|Proleukin|proleukin
585122|NCT00698009|Mesna|mesna
585123|NCT00698009|Mesnex|mesnex
585124|NCT00698009|Infusion of NK cells|infusion of nk cells
585125|NCT00698009|Pediatric NK Cell Infusion|pediatric nk cell infusion
585126|NCT00698009|Pediatric Neuroblastoma|pediatric neuroblastoma
585127|NCT00698009|Pediatric NK|pediatric nk
585128|NCT00698009|Pediatric|pediatric
585129|NCT00697983|Osteoporosis|osteoporosis
585130|NCT00697983|ATP|atp
585131|NCT00697983|Purinergic receptors|purinergic receptors
585132|NCT00697983|Bone mineral density|bone mineral density
585133|NCT00697983|Single nucleotide polymorphism|single nucleotide polymorphism
585134|NCT00697970|Hepatitis B|hepatitis b
585135|NCT00697970|Engerix™-B|engerix™-b
585136|NCT00697970|Recombinant Hepatitis B vaccine|recombinant hepatitis b vaccine
585137|NCT00697970|Adjuvant|adjuvant
585138|NCT00697957|acceleration|acceleration
585139|NCT00697957|bone density|bone density
585140|NCT00697957|cardiovascular diseases|cardiovascular diseases
585141|NCT00697957|exercise|exercise
585142|NCT00697957|female|female
585143|NCT00697957|fragility fractures|fragility fractures
585144|NCT00697957|impact intensity|impact intensity
585145|NCT00697957|intervention studies|intervention studies
585146|NCT00697957|osteoporosis|osteoporosis
585147|NCT00697957|premenopause|premenopause
585148|NCT00697944|FUNGAL INFECTION|fungal infection
585149|NCT00697944|SEPSIS|sepsis
585150|NCT00697944|INTENSIVE CARE|intensive care
585151|NCT00697944|AMBISOME|ambisome
585152|NCT00697944|PREEMPTIVE TREATMENT|preemptive treatment
585153|NCT00697944|Sepsis with candida colonisation|sepsis with candida colonisation
585154|NCT00697931|Hepatitis B|hepatitis b
585155|NCT00697931|Engerix™-B|engerix™-b
585156|NCT00697931|Recombinant Hepatitis B vaccine|recombinant hepatitis b vaccine
585157|NCT00697931|Adjuvant|adjuvant
585158|NCT00697918|Partial onset seizure|partial onset seizure
585159|NCT00697918|Adjunctive therapy|adjunctive therapy
585160|NCT00697905|nasopharyngeal carcinoma|nasopharyngeal carcinoma
585161|NCT00697905|Gemcitabine-Carboplatin|gemcitabine-carboplatin
585162|NCT00697892|Human Immunodeficiency Virus|human immunodeficiency virus
585163|NCT00697892|Drug Interactions|drug interactions
585164|NCT00697879|tumour|tumour
585165|NCT00697879|Solid tumour|solid tumour
585166|NCT00697879|histone deacetylase inhibitor|histone deacetylase inhibitor
585167|NCT00697879|dose escalation|dose escalation
585168|NCT00697879|cancer|cancer
585169|NCT00697866|Adjuvanted hepatitis B vaccine|adjuvanted hepatitis b vaccine
585170|NCT00697866|Hepatitis B|hepatitis b
585171|NCT00697866|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
585172|NCT00697853|Hepatitis B|hepatitis b
585173|NCT00697853|Adjuvanted hepatitis B vaccine|adjuvanted hepatitis b vaccine
585174|NCT00697853|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
585175|NCT00697840|Hepatitis B|hepatitis b
585176|NCT00697840|Engerix™-B|engerix™-b
585177|NCT00697840|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
585178|NCT00697840|Adjuvant|adjuvant
585179|NCT00697814|Hypogonadotropic hypogonadism|hypogonadotropic hypogonadism
585180|NCT00697814|Prolactinoma|prolactinoma
585181|NCT00697788|pediatric|pediatric
585182|NCT00697788|burn|burn
585183|NCT00697788|sedation|sedation
585184|NCT00697775|Hepatitis B|hepatitis b
585185|NCT00697775|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
585186|NCT00697775|Adjuvant|adjuvant
585187|NCT00697762|Partial onset seizure|partial onset seizure
585188|NCT00697762|Adjunctive therapy|adjunctive therapy
585189|NCT00697749|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
585190|NCT00697749|Adjuvanted hepatitis B vaccine|adjuvanted hepatitis b vaccine
585191|NCT00697749|Hepatitis B|hepatitis b
585192|NCT00697736|Systemic Scleroderma|systemic scleroderma
585193|NCT00697736|Echocardiography|echocardiography
585194|NCT00697723|Coronary artery bypass graft|coronary artery bypass graft
585195|NCT00697723|Intra-aortic balloon pump|intra-aortic balloon pump
585196|NCT00697723|transit-time flowmetry|transit-time flowmetry
585197|NCT00697710|Atopic Dermatitis|atopic dermatitis
585198|NCT00697697|asthmatic children|asthmatic children
585199|NCT00697684|Reduced Intensity Allogeneic Stem Cell Transplant|reduced intensity allogeneic stem cell transplant
585200|NCT00697684|Clofarabine|clofarabine
585201|NCT00697684|Rabbit Antithymocyte Globulin|rabbit antithymocyte globulin
585202|NCT00697684|Total Lymphoid Radiation|total lymphoid radiation
585203|NCT00697671|NK cell infusion|nk cell infusion
585204|NCT00697671|Immunotherapy|immunotherapy
585205|NCT00697671|hematologic malignancy|hematologic malignancy
585206|NCT00697671|Miltenyi Biotec device|miltenyi biotec device
585207|NCT00697671|haploidentical donor|haploidentical donor
585208|NCT00697658|Paliperidone ER|paliperidone er
585209|NCT00697658|Schizophrenia|schizophrenia
585210|NCT00697645|Stroke,|stroke,
585211|NCT00697645|Cerebrovascular disease,|cerebrovascular disease,
585212|NCT00697645|Transcranial magnetic stimulation,|transcranial magnetic stimulation,
585213|NCT00697645|rehabilitation|rehabilitation
585214|NCT00697632|MET|met
585215|NCT00697632|AXL|axl
585216|NCT00697632|VEGFR|vegfr
585217|NCT00697632|NSCLC|nsclc
585218|NCT00697632|HNSCC (Head and neck squamous cell carcinoma)|hnscc (head and neck squamous cell carcinoma)
585219|NCT00697632|Tumor|tumor
585220|NCT00697632|Safety|safety
585221|NCT00697632|Phase 1|phase 1
585222|NCT00697632|Solid tumor|solid tumor
585223|NCT00697606|Seprafilm®|seprafilm®
585224|NCT00697606|cesarean|cesarean
585225|NCT00697606|adhesions|adhesions
585226|NCT00697606|primary|primary
585227|NCT00697606|repeat|repeat
585228|NCT00697593|Efalizumab|efalizumab
585229|NCT00697593|Chronic Plaque Psoriasis|chronic plaque psoriasis
585230|NCT00697593|Transition from systemic therapies on to Efalizumab|transition from systemic therapies on to efalizumab
585231|NCT00697580|Obesity|obesity
585232|NCT00697580|Type 2 Diabetes|type 2 diabetes
585233|NCT00697580|Cardiovascular risk|cardiovascular risk
585234|NCT00697580|Cancer|cancer
585235|NCT00697580|Latino|latino
585236|NCT00697580|Adolescents|adolescents
585237|NCT00697580|Strength Training|strength training
585238|NCT00697580|Circuit Training|circuit training
585239|NCT00697580|Nutrition|nutrition
585240|NCT00697567|Herpes simplex|herpes simplex
585241|NCT00697567|Herpes simplex vaccine|herpes simplex vaccine
585242|NCT00697554|Hepatitis B|hepatitis b
585243|NCT00697554|Adjuvanted hepatitis B vaccine|adjuvanted hepatitis b vaccine
585244|NCT00697541|erythematous rosacea|erythematous rosacea
585245|NCT00697541|facial gel|facial gel
585246|NCT00697541|brimonidine|brimonidine
585247|NCT00697541|ophthalmic solution|ophthalmic solution
585248|NCT00697528|Graves|graves
585249|NCT00697528|Color Doppler Imaging|color doppler imaging
585250|NCT00697528|Graves' Ophthalmopathy|graves' ophthalmopathy
585251|NCT00697528|Orbital Venous Flow|orbital venous flow
585252|NCT00697489|Pelvic organ prolapse|pelvic organ prolapse
585253|NCT00697489|Urinary incontinence|urinary incontinence
585254|NCT00697489|Mesh|mesh
585255|NCT00697476|second line chemotherapy|second line chemotherapy
585256|NCT00697463|Teriparatide|teriparatide
585257|NCT00697463|Forteo|forteo
585258|NCT00697463|Osteopenia|osteopenia
585259|NCT00697463|Osteoporosis|osteoporosis
585260|NCT00697463|Fracture|fracture
585261|NCT00697463|Low Bone Density|low bone density
585262|NCT00697463|Premenopausal women|premenopausal women
585263|NCT00697411|Aicardi syndrome|aicardi syndrome
585264|NCT00697411|Microphthalmia with linear skin defects (MLS) syndrome|microphthalmia with linear skin defects (mls) syndrome
585265|NCT00697411|X-linked disorders|x-linked disorders
585266|NCT00697372|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
585267|NCT00697372|Drug-Eluting Stents|drug-eluting stents
585268|NCT00697359|Atrial fibrillation|atrial fibrillation
585269|NCT00697359|Monitoring|monitoring
585270|NCT00697359|Pulmonary vein isolation|pulmonary vein isolation
585271|NCT00697359|Implantable loop recorder|implantable loop recorder
585272|NCT00697346|Drug therapy|drug therapy
585273|NCT00697333|NSCLC|nsclc
585274|NCT00697333|FDG-PET|fdg-pet
585275|NCT00697333|Radiotherapy|radiotherapy
585276|NCT00697333|planning|planning
585277|NCT00697333|target volumes|target volumes
585278|NCT00697307|bioequivalence|bioequivalence
585279|NCT00697307|contraception|contraception
585280|NCT00697307|contraceptive patch|contraceptive patch
585281|NCT00697307|ORTHO EVRA|ortho evra
585282|NCT00697307|norelgestromin|norelgestromin
585283|NCT00697307|NGMN|ngmn
585284|NCT00697307|ethinyl estradiol|ethinyl estradiol
585285|NCT00697307|EE|ee
585286|NCT00697294|Vitamin D deficiency|vitamin d deficiency
585287|NCT00697294|Infants|infants
585288|NCT00697294|Breast feeding|breast feeding
585289|NCT00697281|allergic rhinitis|allergic rhinitis
585290|NCT00697281|human|human
585291|NCT00697281|clinical trial|clinical trial
585292|NCT00697281|efficacy|efficacy
585293|NCT00697281|safety|safety
585294|NCT00697281|challenge test|challenge test
585295|NCT00697268|Depression|depression
585296|NCT00697268|Depression Treatment|depression treatment
585297|NCT00697268|Unipolar Depression|unipolar depression
585298|NCT00697268|Citalopram|citalopram
585299|NCT00697268|Serotonin|serotonin
585300|NCT00697268|Major Depression|major depression
585301|NCT00697268|Healthy Volunteer|healthy volunteer
585302|NCT00697268|HV|hv
585303|NCT00697255|Pharmacological effects of drugs|pharmacological effects of drugs
585304|NCT00697255|Hormones|hormones
585305|NCT00697255|Hormone Substitutes and Hormone Antagonists|hormone substitutes and hormone antagonists
585306|NCT00697255|Pharmacological Actions|pharmacological actions
585307|NCT00697255|Monofollicular growth|monofollicular growth
585308|NCT00697255|Randomized|randomized
585309|NCT00697255|Open-label|open-label
585310|NCT00697255|Active-controlled|active-controlled
585311|NCT00697242|Hepatitis B|hepatitis b
585312|NCT00697242|Engerix™-B|engerix™-b
585313|NCT00697242|Recombinant Hepatitis B vaccine|recombinant hepatitis b vaccine
585314|NCT00697229|Hepatitis B|hepatitis b
585315|NCT00697229|Engerix™-B|engerix™-b
585316|NCT00697229|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
585317|NCT00697216|Hepatitis B|hepatitis b
585318|NCT00697216|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
585319|NCT00697216|Adjuvanted hepatitis B vaccine|adjuvanted hepatitis b vaccine
585320|NCT00697177|Gastro-oesophageal reflux|gastro-oesophageal reflux
585321|NCT00697177|24 hour oesophageal pH monitoring|24 hour oesophageal ph monitoring
585322|NCT00697177|Physiotherapy Airway clearance techniques|physiotherapy airway clearance techniques
585323|NCT00697177|Exercise|exercise
585324|NCT00697164|Malaria|malaria
585325|NCT00697164|Treatment|treatment
585326|NCT00697164|Adjunctive|adjunctive
585327|NCT00697164|Erythropoietin|erythropoietin
585328|NCT00697164|Survival|survival
585329|NCT00697151|cerebrovascular diseases|cerebrovascular diseases
585330|NCT00697151|ischemic stroke|ischemic stroke
585331|NCT00697151|patent foramen ovale|patent foramen ovale
585332|NCT00697151|warfarin|warfarin
585333|NCT00697151|aspirin|aspirin
585334|NCT00697151|transesophageal echocardiography|transesophageal echocardiography
585335|NCT00697138|Cocaine|cocaine
585336|NCT00697138|Dependence|dependence
585337|NCT00697138|Pharmacotherapies|pharmacotherapies
585338|NCT00697125|Hepatitis B|hepatitis b
585339|NCT00697125|Engerix™-B|engerix™-b
585340|NCT00697125|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
585341|NCT00697099|VTE prevention|vte prevention
585342|NCT00697099|Total Hip Replacement|total hip replacement
585343|NCT00697099|Heparin Low-Molecular-Weight|heparin low-molecular-weight
585344|NCT00697086|Heart disease|heart disease
585345|NCT00697073|Friedreich's Ataxia|friedreich's ataxia
585346|NCT00697073|Idebenone|idebenone
585347|NCT00697073|ICARS|icars
585348|NCT00697060|Metastatic|metastatic
585349|NCT00697060|Previously treated|previously treated
585350|NCT00697047|Colorectal Neoplasms|colorectal neoplasms
585351|NCT00697047|Mass Screening|mass screening
585352|NCT00697047|Population Surveillance|population surveillance
585353|NCT00697047|Randomized controlled trial|randomized controlled trial
585354|NCT00697047|Occult Blood|occult blood
585355|NCT00697047|Colonoscopy|colonoscopy
585356|NCT00697047|Sigmoidoscopy|sigmoidoscopy
585357|NCT00697047|Health Behavior|health behavior
585358|NCT00697047|Colorectal Screening|colorectal screening
585359|NCT00697021|Thromboelastography|thromboelastography
585360|NCT00697021|Aspirin|aspirin
585361|NCT00697021|Clopidogrel|clopidogrel
585362|NCT00697021|Plavix|plavix
585363|NCT00697021|Resistance|resistance
585364|NCT00697021|Platelet|platelet
585365|NCT00697021|Coronary Stenting|coronary stenting
585366|NCT00697021|Bare Metal Stent|bare metal stent
585367|NCT00697021|Dual antiplatelet therapy|dual antiplatelet therapy
585368|NCT00697021|Overreactivity|overreactivity
585369|NCT00697021|Primary Coronary Intervention|primary coronary intervention
585370|NCT00697008|GERD|gerd
585371|NCT00697008|CLINICAL GUIDELINE|clinical guideline
585372|NCT00697008|Symptoms|symptoms
585373|NCT00697008|clinical outcome|clinical outcome
585374|NCT00696982|Arterial stiffness|arterial stiffness
585375|NCT00696982|Augmentation index|augmentation index
585376|NCT00696982|diabetes mellitus|diabetes mellitus
585377|NCT00696956|local drug delivery|local drug delivery
585378|NCT00696956|balloon angioplasty|balloon angioplasty
585379|NCT00696956|safety and tolerance of paclitaxel coated PTA balloons|safety and tolerance of paclitaxel coated pta balloons
585380|NCT00696956|in inhibiting restenosis of below the knee arteries|in inhibiting restenosis of below the knee arteries
585381|NCT00696956|Efficacy of paclitaxel coated PTA balloons|efficacy of paclitaxel coated pta balloons
585382|NCT00696956|in inhibiting restenosis of below the knee arteries (late lumen loss)|in inhibiting restenosis of below the knee arteries (late lumen loss)
585383|NCT00696943|cell death|cell death
585384|NCT00696943|PET imaging|pet imaging
585385|NCT00696943|brain metastases|brain metastases
585386|NCT00696943|stereotactic radiosurgery|stereotactic radiosurgery
585387|NCT00696930|Malignant Carcinoid Tumors|malignant carcinoid tumors
585388|NCT00696917|Hepatitis B|hepatitis b
585389|NCT00696917|Adjuvanted Hepatitis B vaccine|adjuvanted hepatitis b vaccine
585390|NCT00696917|Recombinant Hepatitis B vaccine|recombinant hepatitis b vaccine
585391|NCT00696891|Adjuvanted hepatitis B vaccine, hepatitis B, Engerix™-B|adjuvanted hepatitis b vaccine, hepatitis b, engerix™-b
585392|NCT00696878|Infertility|infertility
585393|NCT00696878|Pharmacological effects of drugs|pharmacological effects of drugs
585394|NCT00696878|Hormones, Hormone Substitutes and Hormone Antagonists|hormones, hormone substitutes and hormone antagonists
585395|NCT00696878|Pharmacological Actions|pharmacological actions
585396|NCT00696878|Multi-center|multi-center
585397|NCT00696865|Safety|safety
585398|NCT00696865|Tolerability|tolerability
585399|NCT00696865|Phase I|phase i
585400|NCT00696852|Mindfulness|mindfulness
585401|NCT00696852|Meditation|meditation
585402|NCT00696852|Yoga|yoga
585403|NCT00696852|Inflammatory Markers|inflammatory markers
585404|NCT00696839|Behavior Therapy|behavior therapy
585405|NCT00696839|Anti-Retroviral Agents|anti-retroviral agents
585406|NCT00696839|Relaxation|relaxation
585407|NCT00696839|Clinical Nursing Research|clinical nursing research
585408|NCT00696839|Complementary Therapies|complementary therapies
585409|NCT00696813|Registry|registry
585410|NCT00696813|Healthcare Utilization|healthcare utilization
585411|NCT00696813|Outcome|outcome
585412|NCT00696813|Safety|safety
585413|NCT00696813|Efficacy|efficacy
585414|NCT00696813|Cost-effectiveness|cost-effectiveness
585415|NCT00696813|Paliperidone ER|paliperidone er
585416|NCT00696813|Invega®|invega®
585417|NCT00696813|Oral antipsychotics|oral antipsychotics
585418|NCT00696800|Infertility|infertility
585419|NCT00696800|Pharmacological effect of drugs|pharmacological effect of drugs
585420|NCT00696800|Hormones|hormones
585421|NCT00696800|Hormone substitutes and hormone antagonists|hormone substitutes and hormone antagonists
585422|NCT00696800|Pharmacological actions|pharmacological actions
585423|NCT00696800|Randomized|randomized
585424|NCT00696800|Multi-center|multi-center
585425|NCT00696800|Multi-national|multi-national
585426|NCT00696800|Double-blind|double-blind
585427|NCT00696800|Active-controlled|active-controlled
585428|NCT00696800|Non-inferiority|non-inferiority
585429|NCT00696761|LUTS|luts
585430|NCT00696761|BPH|bph
585431|NCT00696761|bladder outlet obstruction|bladder outlet obstruction
585432|NCT00696761|bladder contractility|bladder contractility
585433|NCT00696748|metabolic syndrome|metabolic syndrome
585434|NCT00696748|hypogonadism|hypogonadism
585435|NCT00696748|testosterone undecanoate|testosterone undecanoate
585436|NCT00696735|Phase III study patients with follicular lymphoma|phase iii study patients with follicular lymphoma
585437|NCT00696709|Herpes Zoster (Shingles)|herpes zoster (shingles)
585438|NCT00696696|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
585439|NCT00696696|metastatic|metastatic
585440|NCT00696696|EGRF inhibitor|egrf inhibitor
585441|NCT00696696|targeted therapy|targeted therapy
585442|NCT00696696|combined cancer therapy|combined cancer therapy
585443|NCT00696696|kinase inhibitor|kinase inhibitor
585444|NCT00696696|VEGF-R inhibitor|vegf-r inhibitor
585445|NCT00696683|scorpion|scorpion
585446|NCT00696683|sting|sting
585447|NCT00696683|envenomation|envenomation
585448|NCT00696683|antivenom|antivenom
585449|NCT00696631|Heart disease|heart disease
585450|NCT00696631|morbidity|morbidity
585451|NCT00696618|HIV prevention|hiv prevention
585452|NCT00696618|MSM|msm
585453|NCT00696618|Enema|enema
585454|NCT00696618|HIV Seronegativity|hiv seronegativity
585455|NCT00696605|Hypoosmolality|hypoosmolality
585456|NCT00696605|Hyperosmolality|hyperosmolality
585457|NCT00696605|Copeptin|copeptin
585458|NCT00696605|Vasopressin|vasopressin
585459|NCT00696592|Age-Related Macular Degeneration|age-related macular degeneration
585460|NCT00696592|Choroidal Neovascularization|choroidal neovascularization
585461|NCT00696592|Bevacizumab|bevacizumab
585462|NCT00696592|Photodynamic Therapy|photodynamic therapy
585463|NCT00696579|BCG|bcg
585464|NCT00696579|Gemcitabine|gemcitabine
585465|NCT00696579|Intravesical|intravesical
585466|NCT00696579|Therapy|therapy
585467|NCT00696579|Superficial|superficial
585468|NCT00696579|Transitional|transitional
585469|NCT00696579|Cell carcinoma|cell carcinoma
585470|NCT00696566|Thrombosis|thrombosis
585471|NCT00696566|Platelet aggregation inhibitor|platelet aggregation inhibitor
585472|NCT00696566|Blood platelets|blood platelets
585473|NCT00696566|P2 receptor|p2 receptor
585474|NCT00696566|Cytochrome P450|cytochrome p450
585475|NCT00696540|Bronchiolitis, respiratory distress, hypertonic saline|bronchiolitis, respiratory distress, hypertonic saline
585476|NCT00696527|Infiltrative breast cancer-Clinical practice|infiltrative breast cancer-clinical practice
585477|NCT00696527|Women with infiltrative breast cancer|women with infiltrative breast cancer
585478|NCT00696514|fracture|fracture
585479|NCT00696514|cognition|cognition
585480|NCT00696501|Neuromuscular mapping|neuromuscular mapping
585481|NCT00696501|Spinal surgery|spinal surgery
585482|NCT00696501|Neurodiagnostics|neurodiagnostics
585483|NCT00696501|Segmental root innervation|segmental root innervation
585484|NCT00696501|Dermatomal innervation|dermatomal innervation
585485|NCT00696501|Myotomal innervation|myotomal innervation
585486|NCT00696501|Nerve roots|nerve roots
585487|NCT00696501|Sensory|sensory
585488|NCT00696501|Signs and Symptoms|signs and symptoms
585489|NCT00696462|forced-air warming|forced-air warming
585490|NCT00696462|Bair Hugger|bair hugger
585491|NCT00696462|cesarean section|cesarean section
585492|NCT00696462|postoperative infection|postoperative infection
585493|NCT00696462|surgical site infections|surgical site infections
585494|NCT00696436|Essential Hypertension|essential hypertension
585495|NCT00696436|Cardiovascular Disease|cardiovascular disease
585496|NCT00696436|High Blood Pressure|high blood pressure
585497|NCT00696436|Drug Therapy|drug therapy
585498|NCT00696423|Infanrix/Hib|infanrix/hib
585499|NCT00696423|Chinese children|chinese children
585500|NCT00696410|Heart Failure|heart failure
585501|NCT00696410|Cardiomyopathy|cardiomyopathy
585502|NCT00696410|Remodeling|remodeling
585503|NCT00696410|Antioxidant|antioxidant
585504|NCT00696410|Zinc|zinc
585505|NCT00696410|Copper|copper
585506|NCT00696384|Essential Hypertension|essential hypertension
585507|NCT00696384|Cardiovascular Disease|cardiovascular disease
585508|NCT00696384|High Blood Pressure|high blood pressure
585509|NCT00696384|Drug Therapy|drug therapy
585510|NCT00696371|Neuroinflammation|neuroinflammation
585511|NCT00696371|PBR28|pbr28
585512|NCT00696371|PET Imaging|pet imaging
585513|NCT00696371|Health Volunteer|health volunteer
585514|NCT00696371|HV|hv
585515|NCT00696358|Vitiligo|vitiligo
585516|NCT00696345|colorectal cancer|colorectal cancer
585517|NCT00696345|screening|screening
585518|NCT00696345|biomarker|biomarker
585519|NCT00696345|plasma|plasma
585520|NCT00696345|blood|blood
585521|NCT00696332|ALS|als
585522|NCT00696319|Rupture of the anterior cruciate ligament of the knee|rupture of the anterior cruciate ligament of the knee
585523|NCT00696306|Acute Ischemic Stroke|acute ischemic stroke
585524|NCT00696306|Stroke|stroke
585525|NCT00696306|MRI|mri
585526|NCT00696306|DTI|dti
585527|NCT00696306|Diffusion Tensor Imaging|diffusion tensor imaging
585528|NCT00696306|SWI|swi
585529|NCT00696306|Susceptibility Weighted Imaging|susceptibility weighted imaging
585530|NCT00696306|Outcome|outcome
585531|NCT00696306|Axonal Injury|axonal injury
585532|NCT00696280|nausea|nausea
585533|NCT00696280|vomiting|vomiting
585534|NCT00696280|Carboplatin|carboplatin
585535|NCT00696280|cancer|cancer
585536|NCT00696280|delayed emesis following treatment with carboplatin|delayed emesis following treatment with carboplatin
585537|NCT00696241|Essential Hypertension|essential hypertension
585538|NCT00696241|Cardiovascular Disease|cardiovascular disease
585539|NCT00696241|High Blood Pressure|high blood pressure
585540|NCT00696241|Drug Therapy|drug therapy
585541|NCT00696215|Parkinson's disease|parkinson's disease
585542|NCT00696215|rasagiline|rasagiline
585543|NCT00696215|cognition|cognition
585544|NCT00696215|MAO-B|mao-b
585545|NCT00696202|Mirena|mirena
585546|NCT00696202|Levonorgestrel|levonorgestrel
585547|NCT00696202|Intrauterine device|intrauterine device
585548|NCT00696202|Efficacy|efficacy
585549|NCT00696202|Tolerability|tolerability
585550|NCT00696202|First year of use|first year of use
585551|NCT00696189|Post operative visual loss (POVL)|post operative visual loss (povl)
585552|NCT00696189|Intraocular pressure (IOP)|intraocular pressure (iop)
585553|NCT00696189|Nitrous oxide|nitrous oxide
585554|NCT00696176|STAT 3 DECOY|stat 3 decoy
585555|NCT00696150|ultrasound|ultrasound
585556|NCT00696150|hip|hip
585557|NCT00696150|pain|pain
585558|NCT00696124|lower leg ischemia|lower leg ischemia
585559|NCT00696124|peripheral artery disease|peripheral artery disease
585560|NCT00696111|PCOS|pcos
585561|NCT00696111|OSA|osa
585562|NCT00696111|Metabolism|metabolism
585563|NCT00696111|Diabetes|diabetes
585564|NCT00696085|fetal alcohol exposure|fetal alcohol exposure
585565|NCT00696085|blood markers of alcohol use|blood markers of alcohol use
585566|NCT00696085|brief intervention|brief intervention
585567|NCT00696059|Rheumatoid arthritis|rheumatoid arthritis
585568|NCT00696059|Computed tomography|computed tomography
585569|NCT00696059|Magnetic resonance imaging|magnetic resonance imaging
585570|NCT00696059|Radiography|radiography
585571|NCT00696059|Tumor necrosis factor alpha antagonists|tumor necrosis factor alpha antagonists
585572|NCT00696046|CORD BLOOD CELLS|cord blood cells
585573|NCT00696046|INTRA BONE MARROW INJECTION|intra bone marrow injection
585574|NCT00696046|ENGRAFTMENT|engraftment
585575|NCT00696046|transplants|transplants
585576|NCT00696033|Benzodiazepines|benzodiazepines
585577|NCT00696033|Lorazepam|lorazepam
585578|NCT00696033|Diazepam|diazepam
585579|NCT00696033|Memory|memory
585580|NCT00696033|Perceptual priming|perceptual priming
585581|NCT00696033|Functional brain imaging|functional brain imaging
585582|NCT00696033|FMRI|fmri
585583|NCT00696007|Upper GU Tract Transitional Cell Carinoma|upper gu tract transitional cell carinoma
585584|NCT00696007|Nephroureterectomy|nephroureterectomy
585585|NCT00696007|Chemotherapy|chemotherapy
585586|NCT00696007|Gemcitabine|gemcitabine
585587|NCT00696007|Cisplatin|cisplatin
585588|NCT00695981|Rotator cuff|rotator cuff
585589|NCT00695981|Arthroscopic surgery|arthroscopic surgery
585590|NCT00695981|Open surgery|open surgery
585591|NCT00695981|Physiotherapy|physiotherapy
585592|NCT00695981|Physical therapy|physical therapy
585593|NCT00695981|Effectiveness|effectiveness
585594|NCT00695981|RCT|rct
585595|NCT00695981|cost-effectiveness|cost-effectiveness
585596|NCT00695955|Essential Hypertension|essential hypertension
585597|NCT00695955|Cardiovascular Disease|cardiovascular disease
585598|NCT00695955|High Blood Pressure|high blood pressure
585599|NCT00695955|Drug Therapy|drug therapy
585600|NCT00695942|preeclampsia|preeclampsia
585601|NCT00695942|eclampsia|eclampsia
585602|NCT00695942|retroplacental hematoma|retroplacental hematoma
585603|NCT00695942|vascular IUGR|vascular iugr
585604|NCT00695942|IUFD|iufd
585605|NCT00695942|VTE|vte
585606|NCT00695929|cardiac surgery with cardiopulmonary bypass|cardiac surgery with cardiopulmonary bypass
585607|NCT00695903|Gram-positive bacterial infections|gram-positive bacterial infections
585608|NCT00695903|Staph Aureus|staph aureus
585609|NCT00695903|Bacteremia|bacteremia
585610|NCT00695903|MRSA|mrsa
585611|NCT00695903|Infective Endocarditis|infective endocarditis
585612|NCT00695903|Right-sided Infective endocarditis|right-sided infective endocarditis
585613|NCT00695903|SABIE|sabie
585614|NCT00695903|SAIE|saie
585615|NCT00695903|RIE|rie
585616|NCT00695890|Pupillometry|pupillometry
585617|NCT00695890|Sevoflorane|sevoflorane
585618|NCT00695890|Propofol|propofol
585619|NCT00695877|HIV Seronegativity|hiv seronegativity
585620|NCT00695877|HIV Preventive Vaccine|hiv preventive vaccine
585621|NCT00695851|PCK3145|pck3145
585622|NCT00695851|Prostate|prostate
585623|NCT00695838|GERD symptoms- Waist circumference|gerd symptoms- waist circumference
585624|NCT00695838|Patients with symptomatic GERD|patients with symptomatic gerd
585625|NCT00695812|Neurodevelopmental disorders|neurodevelopmental disorders
585626|NCT00695812|Autism Spectrum Disorders|autism spectrum disorders
585627|NCT00695812|Broader autism phenotype|broader autism phenotype
585628|NCT00695812|Siblings|siblings
585629|NCT00695812|Cognitive language and social emotional development|cognitive language and social emotional development
585630|NCT00695812|to identify siblings who manifest any autism or broader autism phenotype characteristics|to identify siblings who manifest any autism or broader autism phenotype characteristics
585631|NCT00695799|Propofol|propofol
585632|NCT00695799|Anesthesia care provider|anesthesia care provider
585633|NCT00695799|Pollution|pollution
585634|NCT00695799|Operating room|operating room
585635|NCT00695799|Environment|environment
585636|NCT00695786|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
585637|NCT00695786|Lymphoma|lymphoma
585638|NCT00695786|Lenalidomide|lenalidomide
585639|NCT00695786|Revlimid|revlimid
585640|NCT00695786|Rituximab|rituximab
585641|NCT00695786|Rituxan|rituxan
585642|NCT00695773|Prostate Cancer Surgery|prostate cancer surgery
585643|NCT00695773|Laparoscopic surgery for Prostate Cancer|laparoscopic surgery for prostate cancer
585644|NCT00695773|Prostatectomy|prostatectomy
585645|NCT00695773|Urologic Surgical Procedures|urologic surgical procedures
585646|NCT00695747|Glaucoma|glaucoma
585647|NCT00695747|Cataracts|cataracts
585648|NCT00695747|Phacoemulsification(IOL)|phacoemulsification(iol)
585649|NCT00695747|Trabeculectomy|trabeculectomy
585650|NCT00695734|hemodialysis|hemodialysis
585651|NCT00695734|end stage renal failure|end stage renal failure
585652|NCT00695734|tuberculosis|tuberculosis
585653|NCT00695734|latent tuberculosis infection|latent tuberculosis infection
585654|NCT00695734|Patients under hemodialysis for end stage renal failure|patients under hemodialysis for end stage renal failure
585655|NCT00695708|schizophrenia|schizophrenia
585656|NCT00695708|neuroplasticity|neuroplasticity
585657|NCT00695708|sensory gating|sensory gating
585658|NCT00695708|cognitive impairment|cognitive impairment
585659|NCT00695708|MEG|meg
585660|NCT00695708|Disorders with Psychotic Features|disorders with psychotic features
585661|NCT00695695|Parents|parents
585662|NCT00695695|Down Syndrome|down syndrome
585663|NCT00695695|Hope|hope
585664|NCT00695695|Uncertainty|uncertainty
585665|NCT00695695|Adaptation|adaptation
585666|NCT00695695|DS|ds
585667|NCT00695695|Survey|survey
585668|NCT00695682|Remicade|remicade
585669|NCT00695682|Infliximab|infliximab
585670|NCT00695682|CSME|csme
585671|NCT00695682|BDR|bdr
585672|NCT00695682|CNV|cnv
585673|NCT00695682|AMD|amd
585674|NCT00695669|H5N1|h5n1
585675|NCT00695669|immunogenicity|immunogenicity
585676|NCT00695669|influenza|influenza
585677|NCT00695669|Avian|avian
585678|NCT00695669|pandemic|pandemic
585679|NCT00695669|vaccines|vaccines
585680|NCT00695669|human|human
585681|NCT00695669|safety|safety
585682|NCT00695656|Hypertension|hypertension
585683|NCT00695656|general practitioner consultation|general practitioner consultation
585684|NCT00695656|Patients with hypertension|patients with hypertension
585685|NCT00695630|conscious sedation|conscious sedation
585686|NCT00695630|dental anxiety/drug therapy|dental anxiety/drug therapy
585687|NCT00695630|behavior/drug effects|behavior/drug effects
585688|NCT00695617|MARS treatment|mars treatment
585689|NCT00695617|Citrate anticoagulation|citrate anticoagulation
585690|NCT00695604|Acute asthma|acute asthma
585691|NCT00695604|fluticasone|fluticasone
585692|NCT00695604|inhaled corticosteroids|inhaled corticosteroids
585693|NCT00695591|Home sleep testing neuromuscular disease|home sleep testing neuromuscular disease
585694|NCT00695591|Neuromuscular disease patients with FEV1<50% of predicted|neuromuscular disease patients with fev1<50% of predicted
585695|NCT00695552|Major depression, exercise|major depression, exercise
585696|NCT00695539|Rosuvastatin|rosuvastatin
585697|NCT00695539|hypercholesterolaemia|hypercholesterolaemia
585698|NCT00695526|cranberry|cranberry
585699|NCT00695526|total to HDL cholesterol ratio|total to hdl cholesterol ratio
585700|NCT00695526|type 2 diabetes|type 2 diabetes
585701|NCT00695513|Food supplement|food supplement
585702|NCT00695513|Haemodialysis|haemodialysis
585703|NCT00695500|Varenicline|varenicline
585704|NCT00695500|Alcohol|alcohol
585705|NCT00695500|Alcohol Use|alcohol use
585706|NCT00695487|Anesthesia|anesthesia
585707|NCT00695487|THC|thc
586087|NCT00694018|walking|walking
585708|NCT00695487|Postoperative Nausea|postoperative nausea
585709|NCT00695474|Hypovitaminosis D|hypovitaminosis d
585710|NCT00695474|Type 2 diabetes|type 2 diabetes
585711|NCT00695474|Glycemic control|glycemic control
585712|NCT00695474|Inflammation|inflammation
585713|NCT00695474|Blood pressure|blood pressure
585714|NCT00695461|Colorectal surgery|colorectal surgery
585715|NCT00695461|Probiotics|probiotics
585716|NCT00695461|Lactobacillus|lactobacillus
585717|NCT00695461|Bacterial translocation|bacterial translocation
585718|NCT00695461|Postoperative complications|postoperative complications
585719|NCT00695461|Inflammatory reaction|inflammatory reaction
585720|NCT00695448|Phosphoinositide 3-kinase inhibitor|phosphoinositide 3-kinase inhibitor
585721|NCT00695448|solid tumors|solid tumors
585722|NCT00695435|normal volunteers|normal volunteers
585723|NCT00695435|anti-infective|anti-infective
585724|NCT00695435|tobramycin|tobramycin
585725|NCT00695422|high-grade squamous intraepithelial lesion|high-grade squamous intraepithelial lesion
585726|NCT00695422|low-grade squamous intraepithelial lesion|low-grade squamous intraepithelial lesion
585727|NCT00695422|human papilloma virus infection|human papilloma virus infection
585728|NCT00695422|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
585729|NCT00695422|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
585730|NCT00695422|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
585731|NCT00695422|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
585732|NCT00695422|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
585733|NCT00695422|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
585734|NCT00695422|AIDS-related malignancies|aids-related malignancies
585735|NCT00695422|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
585736|NCT00695422|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
585737|NCT00695422|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
585738|NCT00695422|multicentric Castleman disease|multicentric castleman disease
585739|NCT00695422|HIV Infections|hiv infections
585740|NCT00695409|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
585741|NCT00695409|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
585742|NCT00695409|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
585743|NCT00695409|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
585744|NCT00695409|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
585745|NCT00695409|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
585746|NCT00695409|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
585747|NCT00695409|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
585748|NCT00695409|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
585749|NCT00695409|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
585750|NCT00695409|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
585751|NCT00695409|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
585752|NCT00695409|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
585753|NCT00695409|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
585754|NCT00695409|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
585755|NCT00695409|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
585756|NCT00695409|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
585757|NCT00695409|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
585758|NCT00695396|MDS|mds
585759|NCT00695396|Myelodysplastic syndromes|myelodysplastic syndromes
585760|NCT00695396|Anemia|anemia
585761|NCT00695396|Epoetin alfa|epoetin alfa
585762|NCT00695396|EPO|epo
585763|NCT00695383|Exercise therapy|exercise therapy
585764|NCT00695383|Physiotherapy|physiotherapy
585765|NCT00695383|Critical illness|critical illness
585766|NCT00695383|Intensive care|intensive care
585767|NCT00695383|Muscle weakness|muscle weakness
585768|NCT00695383|Mechanical ventilation|mechanical ventilation
585769|NCT00695370|Children|children
585770|NCT00695370|cancer|cancer
585771|NCT00695370|Bone marrow transplantation|bone marrow transplantation
585772|NCT00695370|Mobilization|mobilization
585773|NCT00695370|G-CSF|g-csf
585774|NCT00695370|Children with solid malignancies|children with solid malignancies
585775|NCT00695357|Asthma treatment|asthma treatment
585776|NCT00695357|GINA 2006|gina 2006
585777|NCT00695357|patient perception|patient perception
585778|NCT00695344|Effect of everolimus in graft vascular cardiac illness|effect of everolimus in graft vascular cardiac illness
585779|NCT00695331|Labor Augmentation|labor augmentation
585780|NCT00695331|Misoprostol|misoprostol
585781|NCT00695331|Oxytocin|oxytocin
585782|NCT00695318|AMD|amd
585783|NCT00695318|Age-Related Macular Degeneration|age-related macular degeneration
585784|NCT00695318|Geographic Atrophy|geographic atrophy
585785|NCT00695318|GA|ga
585786|NCT00695305|rilapladib,|rilapladib,
585787|NCT00695305|Lp-PLA2,|lp-pla2,
585788|NCT00695305|atherosclerosis|atherosclerosis
585789|NCT00695305|SB-659032,|sb-659032,
585790|NCT00695305|FDG-PET,|fdg-pet,
585791|NCT00695292|Small Cell Lung Cancer|small cell lung cancer
585792|NCT00695292|Extensive Stage|extensive stage
585793|NCT00695292|irinotecan|irinotecan
585794|NCT00695292|carboplatin|carboplatin
585795|NCT00695292|sunitinib|sunitinib
585796|NCT00695279|Gene therapy|gene therapy
585797|NCT00695253|AAA|aaa
585798|NCT00695240|Continuous bupivacaine infusion|continuous bupivacaine infusion
585799|NCT00695240|Analgesia|analgesia
585800|NCT00695227|laryngopharyngeal reflux|laryngopharyngeal reflux
585801|NCT00695227|extraesophageal reflux symptoms|extraesophageal reflux symptoms
585802|NCT00695214|Obstructive Sleep Apnea|obstructive sleep apnea
585803|NCT00695214|Propofol|propofol
585804|NCT00695214|Sleep Endoscopy|sleep endoscopy
585805|NCT00695201|DEXAMETHASONE|dexamethasone
585806|NCT00695201|FLOXURIDINE|floxuridine
585807|NCT00695201|IRINOTECAN (CPT-11) CAMPTOSAR|irinotecan (cpt-11) camptosar
585808|NCT00695201|OXALIPLATIN|oxaliplatin
585809|NCT00695188|rheumatoid arthritis|rheumatoid arthritis
585810|NCT00695188|MTX polyglutamates|mtx polyglutamates
585811|NCT00695188|clinical outcome|clinical outcome
585812|NCT00695175|Hypertension|hypertension
585813|NCT00695175|Private cardiology consultation|private cardiology consultation
585814|NCT00695175|Patients with hypertension|patients with hypertension
585815|NCT00695162|noise|noise
585816|NCT00695162|speech intelligibility|speech intelligibility
585817|NCT00695162|cognition|cognition
585818|NCT00695149|Spinal cord Injury|spinal cord injury
585819|NCT00695149|Central nervous system|central nervous system
585820|NCT00695149|Regeneration|regeneration
585821|NCT00695149|Bone marrow stromal cells|bone marrow stromal cells
585822|NCT00695149|Transplantation|transplantation
585823|NCT00695136|Autism|autism
585824|NCT00695136|Cognitive Disorder|cognitive disorder
585825|NCT00695136|Sleep|sleep
585826|NCT00695136|Autism Spectrum Disorder|autism spectrum disorder
585827|NCT00695136|ASD|asd
585828|NCT00695123|Bone Marrow Transplant|bone marrow transplant
585829|NCT00695123|Sickle Cell Disease|sickle cell disease
585830|NCT00695123|G-CSF|g-csf
585831|NCT00695123|Apheresis|apheresis
585832|NCT00695123|SD|sd
585833|NCT00695123|Healthy Volunteer|healthy volunteer
585834|NCT00695123|HV|hv
585835|NCT00695110|testosterone|testosterone
585836|NCT00695110|male hypogonadism|male hypogonadism
585837|NCT00695110|low testosterone|low testosterone
585838|NCT00695097|Rituximab|rituximab
585839|NCT00695097|Renal Transplant Rejection|renal transplant rejection
585840|NCT00695097|B cells|b cells
585841|NCT00695097|Patients with biopsy proven acute rejection cellular infiltrate, B cells|patients with biopsy proven acute rejection cellular infiltrate, b cells
585842|NCT00695084|multiple sclerosis|multiple sclerosis
585843|NCT00695071|Healthy Volunteers|healthy volunteers
585844|NCT00695058|Stress incontinence|stress incontinence
585845|NCT00695058|urge incontinence|urge incontinence
585846|NCT00695058|overactive bladder syndrome|overactive bladder syndrome
585847|NCT00695058|vibration|vibration
585848|NCT00695058|nerve stimulation|nerve stimulation
585849|NCT00695045|Pain, Postoperative|pain, postoperative
585850|NCT00695045|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
585851|NCT00695045|Morphine|morphine
585852|NCT00695045|Injections, Intrathecal|injections, intrathecal
585853|NCT00695032|renal toxicity|renal toxicity
585854|NCT00695032|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
585855|NCT00695032|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
585856|NCT00695019|Prevention of Relapse|prevention of relapse
585857|NCT00695019|HCV genotype 1b|hcv genotype 1b
585858|NCT00695019|Recurrence|recurrence
585859|NCT00695006|manual therapy, cervical traction, cervical radiculopathy|manual therapy, cervical traction, cervical radiculopathy
585860|NCT00694993|first time in human|first time in human
585861|NCT00694993|Allergic rhinitis,|allergic rhinitis,
585862|NCT00694980|UC|uc
585863|NCT00694980|Ulcerative Colitis|ulcerative colitis
585864|NCT00694967|short cervix, cervical funneling, spontaneous preterm birth, cerclage, progesterone|short cervix, cervical funneling, spontaneous preterm birth, cerclage, progesterone
585865|NCT00694954|Iron deficiency anemia|iron deficiency anemia
585866|NCT00694954|Wireless capsule endoscopy|wireless capsule endoscopy
585867|NCT00694954|Obscure-occult gastrointestinal bleeding|obscure-occult gastrointestinal bleeding
585868|NCT00694941|ONO-2506PO|ono-2506po
585869|NCT00694941|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
585870|NCT00694941|ALS|als
585871|NCT00694915|STCC (Superficial Transitional Cell Carcinoma)|stcc (superficial transitional cell carcinoma)
585872|NCT00694902|Healthy Volunteers|healthy volunteers
585873|NCT00694889|Psychosis|psychosis
585874|NCT00694889|First Episode|first episode
585875|NCT00694889|Schizophrenia|schizophrenia
585876|NCT00694889|Cognitive Remediation|cognitive remediation
585877|NCT00694876|Health Literacy|health literacy
585878|NCT00694876|Patient Nonadherence|patient nonadherence
585879|NCT00694876|Patient Noncompliance|patient noncompliance
585880|NCT00694876|Follow Up|follow up
585881|NCT00694876|India|india
585882|NCT00694876|Glaucoma|glaucoma
585883|NCT00694863|high risk for ESRD|high risk for esrd
585884|NCT00694863|immunosuppressive treatment|immunosuppressive treatment
585885|NCT00694863|membranous nephropathy|membranous nephropathy
585886|NCT00694863|ACTH|acth
585887|NCT00694850|Interstitial lung disease associated pulmonary hypertension|interstitial lung disease associated pulmonary hypertension
585888|NCT00694837|glioblastoma|glioblastoma
585889|NCT00694837|nelfinavir|nelfinavir
585890|NCT00694837|functional imaging|functional imaging
585891|NCT00694837|AKT pathway|akt pathway
585892|NCT00694824|Coronary artery calcification|coronary artery calcification
585893|NCT00694824|calcium score|calcium score
585894|NCT00694824|(TGF) b1,|(tgf) b1,
585895|NCT00694824|fetuin A|fetuin a
585896|NCT00694824|osteoprotegerin (OPG)|osteoprotegerin (opg)
585897|NCT00694824|fibroblast growth factor (FGF) 23,|fibroblast growth factor (fgf) 23,
585898|NCT00694824|matrix gla protein (MGP)|matrix gla protein (mgp)
585899|NCT00694824|hemodialysis patients|hemodialysis patients
585900|NCT00694811|Obesity|obesity
585901|NCT00694811|Weight loss|weight loss
585902|NCT00694811|Diet|diet
585903|NCT00694811|Very-low-energy diet|very-low-energy diet
585904|NCT00694811|Predictive factors|predictive factors
585905|NCT00694811|Re-feeding|re-feeding
585906|NCT00694798|STCC|stcc
585907|NCT00694798|Superficial Transitional Cell Carcinoma- BCG refractor|superficial transitional cell carcinoma- bcg refractor
585908|NCT00694772|Obstructive sleep apnea|obstructive sleep apnea
585909|NCT00694772|OSA|osa
585910|NCT00694772|Apnea hypopnea index|apnea hypopnea index
585911|NCT00694772|AHI|ahi
585912|NCT00694772|Coblation|coblation
585913|NCT00694772|Electrocautery|electrocautery
585914|NCT00694772|Tonsillectomy|tonsillectomy
585915|NCT00694772|Tonsillotomy|tonsillotomy
585916|NCT00694759|Polycystic ovary syndrome|polycystic ovary syndrome
585917|NCT00694759|insulin|insulin
585918|NCT00694759|PCOS|pcos
585919|NCT00694759|cortisol regulation|cortisol regulation
585920|NCT00694759|regulation|regulation
585921|NCT00694746|ALT|alt
585922|NCT00694746|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
585923|NCT00694746|Adolescents|adolescents
585924|NCT00694746|Overweight|overweight
585925|NCT00694746|Treatment|treatment
585926|NCT00694733|Obesity|obesity
585927|NCT00694733|Menopausal Syndrome|menopausal syndrome
585928|NCT00694733|Cortisol|cortisol
585929|NCT00694720|Cheyne-stokes breathing|cheyne-stokes breathing
585930|NCT00694694|Malaria|malaria
585931|NCT00694694|Africa|africa
585932|NCT00694694|Child|child
585933|NCT00694681|Telephonic care management|telephonic care management
585934|NCT00694668|Deliberate Self-Harm|deliberate self-harm
585935|NCT00694668|Self-Injurious Behaviour|self-injurious behaviour
585936|NCT00694668|Suicidal Behaviour|suicidal behaviour
585937|NCT00694668|Cognitive behavioural therapy|cognitive behavioural therapy
585938|NCT00694668|Mindfulness Based cognitive therapy|mindfulness based cognitive therapy
585939|NCT00694655|Yellow Fever|yellow fever
585940|NCT00694655|Vaccine|vaccine
585941|NCT00694655|Immunity|immunity
585942|NCT00694655|yellow fever vaccine|yellow fever vaccine
585943|NCT00694655|CD8 T cell responses|cd8 t cell responses
585944|NCT00694642|Refractory angina|refractory angina
585945|NCT00694629|pulmonary tuberculosis|pulmonary tuberculosis
585946|NCT00694629|treatment|treatment
585947|NCT00694616|Obstructive sleep apnea|obstructive sleep apnea
585948|NCT00694616|Metabolic syndrome|metabolic syndrome
585949|NCT00694616|Insulin resistance|insulin resistance
585950|NCT00694616|Hypertension|hypertension
585951|NCT00694616|Dyslipidemia|dyslipidemia
585952|NCT00694616|Continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
585953|NCT00694603|cetuximab|cetuximab
585954|NCT00694603|tyrosine kinase inhibitor|tyrosine kinase inhibitor
585955|NCT00694590|AMD3100|amd3100
585956|NCT00694590|Rituximab|rituximab
585957|NCT00694590|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
585958|NCT00694590|CLL|cll
585959|NCT00694590|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
585960|NCT00694590|SLL|sll
585961|NCT00694577|non-invasive breast cancer|non-invasive breast cancer
585962|NCT00694577|early invasive breast cancer|early invasive breast cancer
585963|NCT00694577|radiation|radiation
585964|NCT00694577|PBI|pbi
585965|NCT00694564|abdominal pain|abdominal pain
585966|NCT00694564|children|children
585967|NCT00694551|vaccine|vaccine
585968|NCT00694551|PSMA|psma
585969|NCT00694551|TARP|tarp
585970|NCT00694551|immunology|immunology
585971|NCT00694551|PSA|psa
585972|NCT00694538|Interferential laser therapy|interferential laser therapy
585973|NCT00694525|21OHD|21ohd
585974|NCT00694525|21-hydroxylase deficiency|21-hydroxylase deficiency
585975|NCT00694525|CAH|cah
585976|NCT00694499|Morbidity|morbidity
585977|NCT00694499|Mortality|mortality
585978|NCT00694486|otitis|otitis
585979|NCT00694486|Eustachian tube function|eustachian tube function
585980|NCT00694486|Normal middle ear status|normal middle ear status
585981|NCT00694473|hyperglycemia|hyperglycemia
585982|NCT00694473|hypoglycemia|hypoglycemia
585983|NCT00694473|insulin|insulin
585984|NCT00694473|critical illness|critical illness
585985|NCT00694473|intensive insulin therapy|intensive insulin therapy
585986|NCT00694473|continuous glucose monitoring|continuous glucose monitoring
585987|NCT00694473|CGM|cgm
585988|NCT00694473|interstitial fluid glucose|interstitial fluid glucose
585989|NCT00694473|intensive care unit|intensive care unit
585990|NCT00694473|Blood glucose|blood glucose
585991|NCT00694460|rabies vaccination|rabies vaccination
585992|NCT00694460|pre-exposure prophylaxis|pre-exposure prophylaxis
585993|NCT00694460|rabies virus neutralizing antibody|rabies virus neutralizing antibody
585994|NCT00694434|Cryopreservation|cryopreservation
585995|NCT00694434|Frozen embryo transfer|frozen embryo transfer
585996|NCT00694434|Graduated Embryo Score|graduated embryo score
585997|NCT00694421|otitis|otitis
585998|NCT00694421|Eustachian tube|eustachian tube
585999|NCT00694421|virus|virus
586000|NCT00694421|Middle ear disease|middle ear disease
586001|NCT00694408|End stage liver disease|end stage liver disease
586002|NCT00694408|Paediatric liver transplantation|paediatric liver transplantation
586003|NCT00694408|Steroid free immunosuppression|steroid free immunosuppression
586004|NCT00694395|Qualitative study|qualitative study
586005|NCT00694395|stroke|stroke
586006|NCT00694395|20 patients, Family or caregivers|20 patients, family or caregivers
586007|NCT00694395|acute ischemic stroke|acute ischemic stroke
586008|NCT00694395|delayed to receive thrombolytic therapy.|delayed to receive thrombolytic therapy.
586009|NCT00694382|chemotherapy|chemotherapy
586010|NCT00694369|Postoperative Dental Pain|postoperative dental pain
586011|NCT00694343|Cesarean section|cesarean section
586012|NCT00694343|spinal anesthesia|spinal anesthesia
586013|NCT00694343|hypotension|hypotension
586014|NCT00694330|vaccine|vaccine
586015|NCT00694330|GM-K562|gm-k562
586016|NCT00694330|malignant glioma|malignant glioma
586017|NCT00694304|Major Depressive Disorder|major depressive disorder
586018|NCT00694304|Long-term|long-term
586019|NCT00694304|Safety|safety
586020|NCT00694304|Open-label|open-label
586021|NCT00694291|Rising PSA|rising psa
586022|NCT00694265|Carpal Tunnel Syndrome|carpal tunnel syndrome
586023|NCT00694265|Median Nerve|median nerve
586024|NCT00694265|Ultrasonography|ultrasonography
586025|NCT00694265|Prospective cohort study|prospective cohort study
586026|NCT00694252|Breast cancer|breast cancer
586027|NCT00694252|Tykerb|tykerb
586028|NCT00694252|CTCs|ctcs
586029|NCT00694239|hypertension|hypertension
586030|NCT00694239|compliance|compliance
586031|NCT00694226|Adolescent|adolescent
586032|NCT00694226|Substance use|substance use
586033|NCT00694226|Brief intervention|brief intervention
586034|NCT00694226|Child psychiatry|child psychiatry
586035|NCT00694213|Pandemic Influenza|pandemic influenza
586036|NCT00694213|Avian Influenza|avian influenza
586037|NCT00694213|DNA Vaccines|dna vaccines
586038|NCT00694213|Antibody|antibody
586039|NCT00694213|T Cells|t cells
586040|NCT00694213|HA/NP/M2|ha/np/m2
586041|NCT00694213|Biojector|biojector
586042|NCT00694200|breast cancer|breast cancer
586043|NCT00694200|chemotherapy|chemotherapy
586044|NCT00694200|anti-angiogenesis therapy|anti-angiogenesis therapy
586045|NCT00694174|Procedural Pain in Newborn Infants|procedural pain in newborn infants
586046|NCT00694174|newborn infant|newborn infant
586047|NCT00694174|acute procedural pain|acute procedural pain
586048|NCT00694174|skin blood flow changes|skin blood flow changes
586049|NCT00694174|sucrose analgesia|sucrose analgesia
586050|NCT00694174|laser doppler imager|laser doppler imager
586051|NCT00694174|neonatal infant pain scale|neonatal infant pain scale
586052|NCT00694161|Transthyretin|transthyretin
586053|NCT00694161|TTR|ttr
586054|NCT00694161|ATTR|attr
586055|NCT00694161|TTR amyloidosis|ttr amyloidosis
586056|NCT00694161|cardiomyopathy|cardiomyopathy
586057|NCT00694161|V122I|v122i
586058|NCT00694161|wild-type TTR|wild-type ttr
586059|NCT00694161|SSA|ssa
586060|NCT00694161|Patients with V122I or wild-type TTR amyloid cardiomyopathy|patients with v122i or wild-type ttr amyloid cardiomyopathy
586061|NCT00694148|Treatment of glabellar frown lines|treatment of glabellar frown lines
586062|NCT00694135|Iontophoresis|iontophoresis
586063|NCT00694135|Non-Infectious Acute Anterior Segment Uveitis|non-infectious acute anterior segment uveitis
586064|NCT00694135|Ophthalmology|ophthalmology
586065|NCT00694122|glucose|glucose
586066|NCT00694122|cortisol|cortisol
586067|NCT00694122|growth hormone|growth hormone
586068|NCT00694122|glucagon|glucagon
586069|NCT00694122|insulin|insulin
586070|NCT00694109|Familial Hypercholesterolemia|familial hypercholesterolemia
586071|NCT00694109|FH|fh
586072|NCT00694109|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
586073|NCT00694109|HeFH|hefh
586074|NCT00694109|Homozygous Familial Hypercholesterolemia|homozygous familial hypercholesterolemia
586075|NCT00694109|HoFH|hofh
586076|NCT00694057|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
586077|NCT00694057|Metformin|metformin
586078|NCT00694057|HbA1c|hba1c
586079|NCT00694044|Safety, Tolerability, Pharmacokinetics, Cognition|safety, tolerability, pharmacokinetics, cognition
586080|NCT00694031|Mortality|mortality
586081|NCT00694031|Convective therapies|convective therapies
586082|NCT00694031|On-line Hemodiafiltration|on-line hemodiafiltration
586083|NCT00694031|Dialysis Adequacy|dialysis adequacy
586084|NCT00694031|Age 18 or older|age 18 or older
586085|NCT00694031|Undergoing hemodialysis|undergoing hemodialysis
586086|NCT00694018|randomized trial|randomized trial
586088|NCT00694005|stent|stent
586089|NCT00694005|bifurcation|bifurcation
586090|NCT00694005|balloon angioplasty|balloon angioplasty
586091|NCT00693966|HPV, Vaccine|hpv, vaccine
586092|NCT00693953|Evoked Potentials|evoked potentials
586093|NCT00693953|Evoked Potentials, Auditory|evoked potentials, auditory
586094|NCT00693953|Evoked Potentials, Visual|evoked potentials, visual
586095|NCT00693953|Electroencephalography|electroencephalography
586096|NCT00693953|Brain Mapping|brain mapping
586097|NCT00693940|Peripheral Arterial Disease|peripheral arterial disease
586098|NCT00693940|PAD|pad
586099|NCT00693927|Hematopoietic cell transplantation|hematopoietic cell transplantation
586100|NCT00693927|Allogeneic|allogeneic
586101|NCT00693927|Nonmyeloablative|nonmyeloablative
586102|NCT00693927|CD8-depletion|cd8-depletion
586103|NCT00693927|PBSC|pbsc
586104|NCT00693927|GVHD|gvhd
586105|NCT00693927|Hematological malignancies and renal cell carcinoma|hematological malignancies and renal cell carcinoma
586106|NCT00693914|Brain Tumor|brain tumor
586107|NCT00693914|Cognitive Late Effects|cognitive late effects
586108|NCT00693914|Radiation Therapy|radiation therapy
586109|NCT00693914|Working Memory|working memory
586110|NCT00693888|dementia|dementia
586111|NCT00693888|system of care|system of care
586112|NCT00693888|level of care|level of care
586113|NCT00693888|interventional study|interventional study
586114|NCT00693888|evaluation|evaluation
586115|NCT00693888|dementia diagnostic|dementia diagnostic
586116|NCT00693888|Evaluation of the care study|evaluation of the care study
586117|NCT00693875|incidence|incidence
586118|NCT00693875|awareness|awareness
586119|NCT00693875|general anesthesia|general anesthesia
586120|NCT00693875|relevant factor|relevant factor
586121|NCT00693875|the incidence of intra-operative awareness in China|the incidence of intra-operative awareness in china
586122|NCT00693875|the relevant factors|the relevant factors
586123|NCT00693862|Focus of the study is pharmacokinetics of the study drug|focus of the study is pharmacokinetics of the study drug
586124|NCT00693849|depression|depression
586125|NCT00693849|CNS|cns
586126|NCT00693849|iSPOT|ispot
586127|NCT00693849|MDD|mdd
586128|NCT00693836|stage I non-small cell lung cancer|stage i non-small cell lung cancer
586129|NCT00693836|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
586130|NCT00693836|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
586131|NCT00693836|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
586132|NCT00693836|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
586133|NCT00693836|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
586134|NCT00693836|extensive stage small cell lung cancer|extensive stage small cell lung cancer
586135|NCT00693836|limited stage small cell lung cancer|limited stage small cell lung cancer
586136|NCT00693836|recurrent small cell lung cancer|recurrent small cell lung cancer
586137|NCT00693823|atherosclerosis|atherosclerosis
586138|NCT00693823|stent|stent
586139|NCT00693823|angioplasty|angioplasty
586140|NCT00693823|covered stent|covered stent
586141|NCT00693797|ventricular hypertrophy|ventricular hypertrophy
586142|NCT00693797|collagen|collagen
586143|NCT00693797|aortic stenosis|aortic stenosis
586144|NCT00693784|Intervertebral Disk|intervertebral disk
586145|NCT00693784|chronic low back pain|chronic low back pain
586146|NCT00693784|internal disc disruption|internal disc disruption
586147|NCT00693784|degenerative disc disease|degenerative disc disease
586148|NCT00693758|MRI|mri
586149|NCT00693758|coronary reactivity|coronary reactivity
586150|NCT00693758|coronary physiology|coronary physiology
586151|NCT00693745|Acutely|acutely
586152|NCT00693719|recurrent breast cancer|recurrent breast cancer
586153|NCT00693719|stage IIIA breast cancer|stage iiia breast cancer
586154|NCT00693719|stage IIIB breast cancer|stage iiib breast cancer
586155|NCT00693719|stage IIIC breast cancer|stage iiic breast cancer
586156|NCT00693719|stage IV breast cancer|stage iv breast cancer
586157|NCT00693706|cell culture|cell culture
586158|NCT00693706|Safety|safety
586159|NCT00693706|Influenza|influenza
586160|NCT00693706|Humans|humans
586161|NCT00693706|Adults|adults
586162|NCT00693706|Immunogenicity|immunogenicity
586163|NCT00693706|Influenza vaccine|influenza vaccine
586164|NCT00693706|Vaccine|vaccine
586165|NCT00693680|depression|depression
586166|NCT00693680|antidepressant treatment|antidepressant treatment
586167|NCT00693680|zinc|zinc
586168|NCT00693680|placebo|placebo
586169|NCT00693667|osteoporosis|osteoporosis
586170|NCT00693667|postmenopausal women|postmenopausal women
586171|NCT00693667|botanical drug|botanical drug
586172|NCT00693654|Uremic Pruritis|uremic pruritis
586173|NCT00693641|Jellyfish|jellyfish
586174|NCT00693641|Cyanea sp|cyanea sp
586175|NCT00693641|Safe Sea|safe sea
586176|NCT00693641|Prevention|prevention
586177|NCT00693641|treatment|treatment
586178|NCT00693641|Pain relief|pain relief
586179|NCT00693641|Prevention of pain|prevention of pain
586180|NCT00693628|volume|volume
586181|NCT00693628|healing|healing
586182|NCT00693628|shrinker|shrinker
586183|NCT00693628|transtibial amputation|transtibial amputation
586184|NCT00693628|individuals who have undergone transtibial amputation|individuals who have undergone transtibial amputation
586185|NCT00693615|HPV, Vaccine|hpv, vaccine
586186|NCT00693589|endothelial function|endothelial function
586187|NCT00693589|flow mediated dilatation|flow mediated dilatation
586188|NCT00693589|rosuvastatin|rosuvastatin
586189|NCT00693589|folic acid|folic acid
586190|NCT00693589|B vitamins|b vitamins
586191|NCT00693576|renal transplant|renal transplant
586192|NCT00693576|panel reactive antibody|panel reactive antibody
586193|NCT00693576|sensitization|sensitization
586194|NCT00693576|simvastatin|simvastatin
586195|NCT00693576|immunological|immunological
586196|NCT00693563|Spinal Cord Injury|spinal cord injury
586197|NCT00693550|lip and oral cavity squamous cell carcinoma|lip and oral cavity squamous cell carcinoma
586198|NCT00693550|oropharyngeal squamous cell carcinoma|oropharyngeal squamous cell carcinoma
586199|NCT00693524|liver allograft transplantation|liver allograft transplantation
586200|NCT00693524|sequential therapy|sequential therapy
586201|NCT00693524|tacrolimus|tacrolimus
586202|NCT00693511|obesity|obesity
586203|NCT00693511|adolescents|adolescents
586204|NCT00693511|adiposity|adiposity
586205|NCT00693511|insulin sensitivity|insulin sensitivity
586206|NCT00693511|type 2 diabetes|type 2 diabetes
586207|NCT00693511|Latino|latino
586208|NCT00693511|circuit training|circuit training
586209|NCT00693511|physical activity|physical activity
586210|NCT00693511|motivational interviewing|motivational interviewing
586211|NCT00693498|pediatrics|pediatrics
586212|NCT00693498|congenital heart disease|congenital heart disease
586213|NCT00693472|Antipsychotic Agents|antipsychotic agents
586214|NCT00693459|Hemorrhoids|hemorrhoids
586215|NCT00693446|Pancreas-kidney allograft|pancreas-kidney allograft
586216|NCT00693446|tacrolimus|tacrolimus
586217|NCT00693446|sirolimus|sirolimus
586218|NCT00693446|Pancreas-kidney allograft recipients|pancreas-kidney allograft recipients
586219|NCT00693381|Transplantation|transplantation
586220|NCT00693381|Graft Rejection|graft rejection
586221|NCT00693381|Renal Transplantation|renal transplantation
586222|NCT00693355|gut health|gut health
586223|NCT00693342|stage IA primary peritoneal cavity cancer|stage ia primary peritoneal cavity cancer
586224|NCT00693342|stage IB primary peritoneal cavity cancer|stage ib primary peritoneal cavity cancer
586225|NCT00693342|stage IC primary peritoneal cavity cancer|stage ic primary peritoneal cavity cancer
586226|NCT00693342|stage IIA primary peritoneal cavity cancer|stage iia primary peritoneal cavity cancer
586227|NCT00693342|stage IIB primary peritoneal cavity cancer|stage iib primary peritoneal cavity cancer
586228|NCT00693342|stage IIC primary peritoneal cavity cancer|stage iic primary peritoneal cavity cancer
586229|NCT00693342|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
586230|NCT00693342|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
586231|NCT00693342|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
586232|NCT00693342|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
586233|NCT00693342|stage IA fallopian tube cancer|stage ia fallopian tube cancer
586234|NCT00693342|stage IB fallopian tube cancer|stage ib fallopian tube cancer
586235|NCT00693342|stage IC fallopian tube cancer|stage ic fallopian tube cancer
586236|NCT00693342|stage IIA fallopian tube cancer|stage iia fallopian tube cancer
586237|NCT00693342|stage IIB fallopian tube cancer|stage iib fallopian tube cancer
586238|NCT00693342|stage IIC fallopian tube cancer|stage iic fallopian tube cancer
586239|NCT00693342|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
586240|NCT00693342|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
586241|NCT00693342|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
586242|NCT00693342|stage IV fallopian tube cancer|stage iv fallopian tube cancer
586243|NCT00693342|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
586244|NCT00693342|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
586245|NCT00693342|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
586246|NCT00693342|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
586247|NCT00693342|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
586248|NCT00693342|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
586249|NCT00693342|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
586250|NCT00693342|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
586251|NCT00693342|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
586252|NCT00693342|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
586253|NCT00693329|Contrast Induced Nephrophathy (CIN)|contrast induced nephrophathy (cin)
586254|NCT00693329|Kidney|kidney
586255|NCT00693329|NGAL|ngal
586256|NCT00693316|Healthy volunteer study|healthy volunteer study
586257|NCT00693303|single subject|single subject
586258|NCT00693303|quantitative|quantitative
586259|NCT00693290|Colonoscopy|colonoscopy
586260|NCT00693290|Colorectal screening|colorectal screening
586261|NCT00693290|Colon preparation|colon preparation
586262|NCT00693277|none - entry made in error|none - entry made in error
586263|NCT00693264|Human Volunteers|human volunteers
586264|NCT00693264|Hoodia|hoodia
586265|NCT00693264|Safety|safety
586266|NCT00693251|stent|stent
586267|NCT00693251|bifurcation|bifurcation
586268|NCT00693251|coronary artery stenosis|coronary artery stenosis
586269|NCT00693251|balloon angioplasty|balloon angioplasty
586270|NCT00693238|Prostate Cancer|prostate cancer
586271|NCT00693238|Proton Radiation|proton radiation
586272|NCT00693225|Erosive Esophagitis|erosive esophagitis
586273|NCT00693225|Reflux Esophagitis|reflux esophagitis
586274|NCT00693225|Gastroesophageal reflux disease|gastroesophageal reflux disease
586275|NCT00693225|GERD|gerd
586276|NCT00693225|proton pump inhibitor|proton pump inhibitor
586277|NCT00693225|omeprazole/sodium bicarbonate|omeprazole/sodium bicarbonate
586278|NCT00693212|ADHD|adhd
586279|NCT00693212|Adult|adult
586280|NCT00693212|crossover|crossover
586281|NCT00693212|randomized|randomized
586282|NCT00693212|Long-term|long-term
586283|NCT00693212|Open-label|open-label
586284|NCT00693212|methylphenidate|methylphenidate
586285|NCT00693212|Social adjustment|social adjustment
586286|NCT00693199|Amlodipine|amlodipine
586287|NCT00693199|Terazosin|terazosin
586288|NCT00693199|Lower Urinary Tract Symptoms (LUTS)|lower urinary tract symptoms (luts)
586289|NCT00693199|Essential hypertension|essential hypertension
586290|NCT00693199|International Prostate Symptom Score (IPSS)|international prostate symptom score (ipss)
586291|NCT00693199|Quality Of Life (QOL)|quality of life (qol)
586292|NCT00693173|anal|anal
586293|NCT00693173|cancer|cancer
586294|NCT00693173|rectal|rectal
586295|NCT00693173|IMRT|imrt
586296|NCT00693173|genital|genital
586297|NCT00693173|sparing|sparing
586298|NCT00693173|drop|drop
586299|NCT00693173|technique|technique
586300|NCT00693160|healthy volunteers|healthy volunteers
586301|NCT00693160|analgesia|analgesia
586302|NCT00693160|pain|pain
586303|NCT00693160|Healthy subjects|healthy subjects
586304|NCT00693147|Goiter [C19.874.283]|goiter [c19.874.283]
586305|NCT00693147|Thyroid Neoplasms [C19.874.788]|thyroid neoplasms [c19.874.788]
586306|NCT00693121|Traumatic Brain Injury|traumatic brain injury
586307|NCT00693121|Posttraumatic Confusional State|posttraumatic confusional state
586308|NCT00693121|Delirium|delirium
586309|NCT00693121|Amantadine|amantadine
586310|NCT00693121|Clinical trial|clinical trial
586311|NCT00693108|Poor|poor
586312|NCT00693108|Response|response
586313|NCT00693108|Ovarian|ovarian
586314|NCT00693108|Stimulation|stimulation
586315|NCT00693108|IVF|ivf
586316|NCT00693108|Patients|patients
586317|NCT00693095|Grade IV Glioblastoma Multiforme|grade iv glioblastoma multiforme
586318|NCT00693095|Newly-diagnosed|newly-diagnosed
586319|NCT00693095|CMV positive|cmv positive
586320|NCT00693082|PCOS|pcos
586321|NCT00693082|flaxseed|flaxseed
586322|NCT00693069|angioplasty|angioplasty
586323|NCT00693069|clopidogrel|clopidogrel
586324|NCT00693069|coronary artery disease|coronary artery disease
586325|NCT00693069|platelets|platelets
586326|NCT00693069|Percutaneous coronary intervention|percutaneous coronary intervention
586327|NCT00693056|Erectile Dysfunctions|erectile dysfunctions
586328|NCT00693056|ED|ed
586329|NCT00693043|Pain control|pain control
586330|NCT00693030|Coronary Artery Disease|coronary artery disease
586457|NCT00692588|Rifampicin|rifampicin
586331|NCT00693030|Percutaneous Coronary Interventions|percutaneous coronary interventions
586332|NCT00693030|Drug-Eluting stents|drug-eluting stents
586333|NCT00693030|Optical Coherence Tomography|optical coherence tomography
586334|NCT00693030|Thrombosis|thrombosis
586335|NCT00693030|Long lesions in native vessel requiring stents in overlap|long lesions in native vessel requiring stents in overlap
586336|NCT00692991|Microvascular Obstruction|microvascular obstruction
586337|NCT00692991|Cardiac MRI|cardiac mri
586338|NCT00692991|Alcohol Ablation|alcohol ablation
586339|NCT00692991|Diagnostic PCI|diagnostic pci
586340|NCT00692978|Monodisperse aerosols|monodisperse aerosols
586341|NCT00692978|Healthy Volunteers|healthy volunteers
586342|NCT00692978|Asthmatics|asthmatics
586343|NCT00692978|Pharmacokinetics|pharmacokinetics
586344|NCT00692978|Randomized|randomized
586345|NCT00692965|HIV|hiv
586346|NCT00692965|Sleep Quality|sleep quality
586347|NCT00692965|Sleep apnea|sleep apnea
586348|NCT00692965|Berlin Questionnaire|berlin questionnaire
586349|NCT00692965|Pittsburgh Sleep Quality Index|pittsburgh sleep quality index
586350|NCT00692952|contraceptive efficacy|contraceptive efficacy
586351|NCT00692939|Stem cell transplantation|stem cell transplantation
586352|NCT00692939|Crohn's Disease|crohn's disease
586353|NCT00692926|ALDHbr|aldhbr
586354|NCT00692926|Umbilical Cord Blood|umbilical cord blood
586355|NCT00692926|Transplantation|transplantation
586356|NCT00692926|Hematological malignancy|hematological malignancy
586357|NCT00692926|MDS|mds
586358|NCT00692926|severe aplastic anemia|severe aplastic anemia
586359|NCT00692926|inborn error of metabolism|inborn error of metabolism
586360|NCT00692926|congenital marrow failure or congenital immunodeficiency syndrome|congenital marrow failure or congenital immunodeficiency syndrome
586361|NCT00692926|Hurler's Disease|hurler's disease
586362|NCT00692926|Tay Sach's|tay sach's
586363|NCT00692926|PMD|pmd
586364|NCT00692926|Hunter's Syndrome|hunter's syndrome
586365|NCT00692926|Krabbe|krabbe
586366|NCT00692926|MLD|mld
586367|NCT00692926|ALD|ald
586368|NCT00692926|ALL|all
586369|NCT00692926|AML|aml
586370|NCT00692887|AMD|amd
586371|NCT00692874|Quality of Life|quality of life
586372|NCT00692861|Celiac Disease|celiac disease
586373|NCT00692861|Ataxia|ataxia
586374|NCT00692861|Adults|adults
586375|NCT00692861|Health Volunteer|health volunteer
586376|NCT00692861|HV|hv
586377|NCT00692848|Procalcitonin|procalcitonin
586378|NCT00692848|Antibiotic|antibiotic
586379|NCT00692848|Fever without source|fever without source
586380|NCT00692848|Fever without focus|fever without focus
586381|NCT00692848|bacteremia|bacteremia
586382|NCT00692848|Urinary tract infection|urinary tract infection
586383|NCT00692835|Goiter [C19.874.283]|goiter [c19.874.283]
586384|NCT00692835|Thyroid Neoplasms [C19.874.788]|thyroid neoplasms [c19.874.788]
586385|NCT00692822|Neisseria gonorrheae|neisseria gonorrheae
586386|NCT00692822|Antimicrobial Susceptibility|antimicrobial susceptibility
586387|NCT00692822|Quinolone Resistance|quinolone resistance
586388|NCT00692822|Sexually transmitted diseases|sexually transmitted diseases
586389|NCT00692809|Latent tuberculosis infection|latent tuberculosis infection
586390|NCT00692809|Human immunodeficiency virus|human immunodeficiency virus
586391|NCT00692809|Tuberculosis|tuberculosis
586392|NCT00692809|Natural Killer T Cells|natural killer t cells
586393|NCT00692809|Invariant Natural Killer T Cells|invariant natural killer t cells
586394|NCT00692809|Regulatory T cells|regulatory t cells
586395|NCT00692809|Interferon-gamma|interferon-gamma
586396|NCT00692796|Pulmonary fibrosis|pulmonary fibrosis
586397|NCT00692796|Pulmonary rehabilitation|pulmonary rehabilitation
586398|NCT00692796|Dyspnea|dyspnea
586399|NCT00692796|Quality of life|quality of life
586400|NCT00692783|candida|candida
586401|NCT00692783|dubliniensis|dubliniensis
586402|NCT00692783|candidiasis|candidiasis
586403|NCT00692783|HIV|hiv
586404|NCT00692783|AIDS|aids
586405|NCT00692783|azole resistance.|azole resistance.
586406|NCT00692770|Hepatocellular carcinoma|hepatocellular carcinoma
586407|NCT00692770|Sorafenib|sorafenib
586408|NCT00692770|Adjuvant|adjuvant
586409|NCT00692770|Surgical resection|surgical resection
586410|NCT00692770|Ablation|ablation
586411|NCT00692770|Nexavar|nexavar
586412|NCT00692770|Adjuvant therapy|adjuvant therapy
586413|NCT00692770|Liver cancer|liver cancer
586414|NCT00692770|HCC|hcc
586415|NCT00692770|STORM|storm
586416|NCT00692757|Hypochlorous Acid|hypochlorous acid
586417|NCT00692757|Colony forming units|colony forming units
586418|NCT00692757|surgical site infection|surgical site infection
586419|NCT00692757|nosocomial infection|nosocomial infection
586420|NCT00692757|bacterial bioburden|bacterial bioburden
586421|NCT00692757|wound healing|wound healing
586422|NCT00692744|Subarachnoid hemorrhage|subarachnoid hemorrhage
586423|NCT00692744|Cerebral aneurysm|cerebral aneurysm
586424|NCT00692744|Elderly|elderly
586425|NCT00692731|green tea,|green tea,
586426|NCT00692731|polyphenols,|polyphenols,
586427|NCT00692731|weight loss,|weight loss,
586428|NCT00692731|body fat|body fat
586429|NCT00692705|Alzheimer´s Disease|alzheimer´s disease
586430|NCT00692705|amyloid deposits|amyloid deposits
586431|NCT00692705|Positron Emission Tomography|positron emission tomography
586432|NCT00692705|phase I|phase i
586433|NCT00692653|Localized prostate cancer|localized prostate cancer
586434|NCT00692653|Treatment decision making|treatment decision making
586435|NCT00692653|Tailored decision aid|tailored decision aid
586436|NCT00692640|Cancer|cancer
586437|NCT00692640|Solid Tumors|solid tumors
586438|NCT00692640|NSCLC|nsclc
586439|NCT00692627|Falciparum|falciparum
586440|NCT00692627|malaria|malaria
586441|NCT00692627|volume|volume
586442|NCT00692627|haemodynamics|haemodynamics
586443|NCT00692601|Acute Exercise protocol|acute exercise protocol
586444|NCT00692601|Crossover design|crossover design
586445|NCT00692601|Oxygen consumption (VO2)|oxygen consumption (vo2)
586446|NCT00692601|Respiratory Exchange Ratio (RER)|respiratory exchange ratio (rer)
586447|NCT00692601|Adrenergic System Agonism|adrenergic system agonism
586448|NCT00692601|Capsiate Natura|capsiate natura
586449|NCT00692601|Young|young
586450|NCT00692601|Male|male
586451|NCT00692588|Alzheimer's Disease|alzheimer's disease
586452|NCT00692588|Magnetic Resonance Imaging|magnetic resonance imaging
586453|NCT00692588|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
586454|NCT00692588|Diffusion Tensor Imaging|diffusion tensor imaging
586455|NCT00692588|Susceptibility Weighted Imaging|susceptibility weighted imaging
586456|NCT00692588|Doxycycline|doxycycline
586458|NCT00692575|Brain Injuries, Traumatic|brain injuries, traumatic
586459|NCT00692575|Caregivers|caregivers
586460|NCT00692562|Islets of Langerhans Transplantation|islets of langerhans transplantation
586461|NCT00692562|Kidney Transplantation|kidney transplantation
586462|NCT00692562|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
586463|NCT00692562|alemtuzumab|alemtuzumab
586464|NCT00692549|ultrasound|ultrasound
586465|NCT00692549|iv access|iv access
586466|NCT00692549|Patients with difficult iv access in emergency departments.|patients with difficult iv access in emergency departments.
586467|NCT00692536|Obesity|obesity
586468|NCT00692536|Postmenopausal|postmenopausal
586469|NCT00692536|Diet intervention|diet intervention
586470|NCT00692523|Stroke|stroke
586471|NCT00692523|rehabilitation|rehabilitation
586472|NCT00692523|Nintendo Wii|nintendo wii
586473|NCT00692510|AZD3480|azd3480
586474|NCT00692510|Cocktail|cocktail
586475|NCT00692510|caffeine|caffeine
586476|NCT00692510|bupropion|bupropion
586477|NCT00692510|omeprazole|omeprazole
586478|NCT00692510|midazolam|midazolam
586479|NCT00692510|rosiglitazone|rosiglitazone
586480|NCT00692510|metabolism|metabolism
586481|NCT00692510|Drug Drug Interaction|drug drug interaction
586482|NCT00692497|One-Stop|one-stop
586483|NCT00692497|Public Health Research|public health research
586484|NCT00692497|Delivery of Health Care/*standards|delivery of health care/*standards
586485|NCT00692497|Evaluation Studies|evaluation studies
586486|NCT00692497|Referral|referral
586487|NCT00692497|Surgery, Outpatient|surgery, outpatient
586488|NCT00692497|Surgery, Day|surgery, day
586489|NCT00692497|Telemedicine|telemedicine
586490|NCT00692484|Antimicrobial|antimicrobial
586491|NCT00692484|Antisepsis|antisepsis
586492|NCT00692484|Topical antisepsis|topical antisepsis
586493|NCT00692471|Sleep|sleep
586494|NCT00692471|Orthostatic tachycardia|orthostatic tachycardia
586495|NCT00692471|POTS|pots
586496|NCT00692445|depression|depression
586497|NCT00692432|Macrophage Migration Inhibitory Factor|macrophage migration inhibitory factor
586498|NCT00692432|MIF|mif
586499|NCT00692432|Cardiopulmonary bypass|cardiopulmonary bypass
586500|NCT00692432|CPB|cpb
586501|NCT00692432|inflammation|inflammation
586502|NCT00692432|inflammatory marker|inflammatory marker
586503|NCT00692432|myocardial depression|myocardial depression
586504|NCT00692432|myocardial depressant factor|myocardial depressant factor
586505|NCT00692419|pain|pain
586506|NCT00692419|sexual dysfunction|sexual dysfunction
586507|NCT00692419|depression|depression
586508|NCT00692419|symptoms|symptoms
586509|NCT00692380|gated IMRT|gated imrt
586510|NCT00692367|Body fat|body fat
586511|NCT00692367|Exercise|exercise
586512|NCT00692367|Fatty acids|fatty acids
586513|NCT00692367|Impaired glucose tolerance|impaired glucose tolerance
586514|NCT00692367|Insulin resistance|insulin resistance
586515|NCT00692367|Insulin Sensitivity|insulin sensitivity
586516|NCT00692367|Metabolic syndrome|metabolic syndrome
586517|NCT00692367|Obesity|obesity
586518|NCT00692367|Physical activity|physical activity
586519|NCT00692367|Weight Loss|weight loss
586520|NCT00692354|Advanced|advanced
586521|NCT00692354|Solid|solid
586522|NCT00692354|Tumour|tumour
586523|NCT00692354|Tumor|tumor
586524|NCT00692354|Oral|oral
586525|NCT00692341|hepatic impairment|hepatic impairment
586526|NCT00692328|fatigue; TMS; MEP|fatigue; tms; mep
586527|NCT00692315|glutathione|glutathione
586528|NCT00692315|methionine|methionine
586529|NCT00692315|folinic acid|folinic acid
586530|NCT00692315|redox|redox
586531|NCT00692315|oxidative stress|oxidative stress
586532|NCT00692315|behavior|behavior
586533|NCT00692302|Suicide Attempts|suicide attempts
586534|NCT00692302|Adolescents|adolescents
586535|NCT00692302|Suicidal|suicidal
586536|NCT00692302|Adolescent Suicide Attempters|adolescent suicide attempters
586537|NCT00692289|Quality of Life|quality of life
586538|NCT00692263|Healthy subjects|healthy subjects
586539|NCT00692250|Familial Hypercholesterolemia|familial hypercholesterolemia
586540|NCT00692237|Type 2 diabetes mellitus|type 2 diabetes mellitus
586541|NCT00692237|Endothelial dysfunction|endothelial dysfunction
586542|NCT00692237|Sildenafil|sildenafil
586543|NCT00692224|neonatal jaundice|neonatal jaundice
586544|NCT00692224|zinc|zinc
586545|NCT00692224|hyperbilirubinemia|hyperbilirubinemia
586546|NCT00692224|enterohepatic circulation|enterohepatic circulation
586547|NCT00692224|bilirubin|bilirubin
586548|NCT00692211|screening|screening
586549|NCT00692198|COPD|copd
586550|NCT00692185|Anorexia Nervosa|anorexia nervosa
586551|NCT00692172|psoriasis|psoriasis
586552|NCT00692172|alefacept|alefacept
586553|NCT00692172|intramuscular|intramuscular
586554|NCT00692159|TRC102|trc102
586555|NCT00692159|Methoxyamine HCL|methoxyamine hcl
586556|NCT00692159|Pemetrexed|pemetrexed
586557|NCT00692159|Alimta|alimta
586558|NCT00692159|Tracon|tracon
586559|NCT00692159|Phase 1|phase 1
586560|NCT00692159|Cancer|cancer
586561|NCT00692159|BER|ber
586562|NCT00692159|Base Excision Repair|base excision repair
586563|NCT00692159|Small Molecule|small molecule
586564|NCT00692159|Anti-folate|anti-folate
586565|NCT00692159|Solid Tumor|solid tumor
586566|NCT00692159|Neoplastic Processes|neoplastic processes
586567|NCT00692159|Pathologic Processes|pathologic processes
586568|NCT00692159|Pathological Conditions, Signs and Symptoms|pathological conditions, signs and symptoms
586569|NCT00692146|Proof of Mechanism|proof of mechanism
586570|NCT00692146|Capsaicin evoked pain|capsaicin evoked pain
586571|NCT00692133|schizophrenia|schizophrenia
586572|NCT00692133|bipolar disorder|bipolar disorder
586573|NCT00692133|antipsychotic treatment|antipsychotic treatment
586574|NCT00692133|patients´preferences|patients´preferences
586575|NCT00692107|Radiotherapy|radiotherapy
586576|NCT00692107|Dose|dose
586577|NCT00692094|melatonin|melatonin
586578|NCT00692094|circadian rhythms|circadian rhythms
586579|NCT00692094|sleep|sleep
586580|NCT00692081|adolescents|adolescents
586581|NCT00692081|borderline intellectual functioning|borderline intellectual functioning
586582|NCT00692081|social competence training|social competence training
586583|NCT00692081|vocational training|vocational training
586584|NCT00692081|group intervention|group intervention
586585|NCT00692081|cognitive behavioral therapy|cognitive behavioral therapy
586586|NCT00692081|Adolescents with borderline intellectual functioning|adolescents with borderline intellectual functioning
586587|NCT00692068|residual renal function|residual renal function
586588|NCT00692068|oxidative stress|oxidative stress
586589|NCT00692068|carbonyl stress|carbonyl stress
586590|NCT00692068|peritoneal dialysis|peritoneal dialysis
586591|NCT00692042|Safety|safety
586592|NCT00692042|tolerability|tolerability
586593|NCT00692029|Normal|normal
586594|NCT00692029|Healthy Volunteers|healthy volunteers
586595|NCT00692016|Naproxen Sodium|naproxen sodium
586596|NCT00691990|Goiter [C19.874.283]|goiter [c19.874.283]
586597|NCT00691990|Thyroid Neoplasms [C19.874.788]|thyroid neoplasms [c19.874.788]
586598|NCT00691977|Radiation Therapy|radiation therapy
586599|NCT00691938|LBH589|lbh589
586600|NCT00691938|Decitabine|decitabine
586601|NCT00691938|panobinostat|panobinostat
586602|NCT00691938|histone deacetylase|histone deacetylase
586603|NCT00691938|methylation|methylation
586604|NCT00691938|hypomethylation|hypomethylation
586605|NCT00691925|refractive surgery|refractive surgery
586606|NCT00691886|sedation|sedation
586607|NCT00691873|Allergic|allergic
586608|NCT00691873|Asthma|asthma
586609|NCT00691873|Immunotherapy|immunotherapy
586610|NCT00691860|Parastomal hernias|parastomal hernias
586611|NCT00691860|Tolerance of lightweight meshes|tolerance of lightweight meshes
586612|NCT00691860|Paracolostomy hernias|paracolostomy hernias
586613|NCT00691860|Peristomal hernias|peristomal hernias
586614|NCT00691847|Refractive surgery|refractive surgery
586615|NCT00691834|Magnetic resonance Imaging|magnetic resonance imaging
586616|NCT00691821|Negative-Pressure Wound Therapy|negative-pressure wound therapy
586617|NCT00691821|Bandages|bandages
586618|NCT00691821|Community Health Services|community health services
586619|NCT00691795|Analgesia|analgesia
586620|NCT00691795|Epidural|epidural
586621|NCT00691795|Pregnancy|pregnancy
586622|NCT00691795|Labor|labor
586623|NCT00691795|Clonidine|clonidine
586624|NCT00691795|Fentanyl|fentanyl
586625|NCT00691795|Bupivacaine|bupivacaine
586626|NCT00691795|Childbirth|childbirth
586627|NCT00691782|African American females between the ages of 21 and 60|african american females between the ages of 21 and 60
586628|NCT00691769|alopecia|alopecia
586629|NCT00691769|lupus|lupus
586630|NCT00691756|renal failure|renal failure
586631|NCT00691756|thoracoabdominal aortic aneurysm repair|thoracoabdominal aortic aneurysm repair
586632|NCT00691756|cold crystalloid|cold crystalloid
586633|NCT00691756|cold blood|cold blood
586634|NCT00691756|renal perfusion|renal perfusion
586635|NCT00691743|Upper GI Symptoms|upper gi symptoms
586636|NCT00691743|GERD|gerd
586637|NCT00691743|NSAIDs|nsaids
586638|NCT00691717|Anecortave acetate|anecortave acetate
586639|NCT00691717|Open-angle glaucoma|open-angle glaucoma
586641|NCT00691717|OHT|oht
586642|NCT00691704|Multiple Myeloma|multiple myeloma
586643|NCT00691691|Liver malignancy|liver malignancy
586644|NCT00691691|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
586645|NCT00691691|Efficacy of SBRT in liver tumors|efficacy of sbrt in liver tumors
586646|NCT00691691|Hepatic toxicity with SBRT|hepatic toxicity with sbrt
586647|NCT00691678|breast cancer|breast cancer
586648|NCT00691678|aromatase inhibitor|aromatase inhibitor
586649|NCT00691678|supportive care|supportive care
586650|NCT00691665|Rhinitis|rhinitis
586651|NCT00691665|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
586652|NCT00691665|allergies|allergies
586653|NCT00691652|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
586654|NCT00691652|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
586655|NCT00691652|splenic marginal zone lymphoma|splenic marginal zone lymphoma
586656|NCT00691652|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
586657|NCT00691652|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
586658|NCT00691652|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
586659|NCT00691652|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
586660|NCT00691652|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
586661|NCT00691652|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
586662|NCT00691652|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
586663|NCT00691652|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
586664|NCT00691652|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
586665|NCT00691652|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
586666|NCT00691652|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
586667|NCT00691652|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
587012|NCT00690586|AVP|avp
586668|NCT00691652|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
586669|NCT00691652|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
586670|NCT00691639|Open-angle glaucoma|open-angle glaucoma
586671|NCT00691639|IOP|iop
586672|NCT00691626|posttraumatic stress|posttraumatic stress
586673|NCT00691626|nightmares|nightmares
586674|NCT00691626|sleep|sleep
586675|NCT00691626|psychotherapy|psychotherapy
586676|NCT00691626|imagery rehearsal|imagery rehearsal
586677|NCT00691626|insomnia|insomnia
586678|NCT00691626|behavioral treatment|behavioral treatment
586679|NCT00691626|veterans|veterans
586680|NCT00691626|Operation Iraqi Freedom|operation iraqi freedom
586681|NCT00691626|Operation Enduring Freedom|operation enduring freedom
586682|NCT00691613|Apoptosis|apoptosis
586683|NCT00691613|Annexin|annexin
586684|NCT00691613|Hypoxia|hypoxia
586685|NCT00691613|Ischemia-Reperfusion Injury|ischemia-reperfusion injury
586686|NCT00691600|abscess|abscess
586687|NCT00691600|Abscesses in the pediatric emergency population|abscesses in the pediatric emergency population
586688|NCT00691587|mechanical ventilation|mechanical ventilation
586689|NCT00691587|mechanically ventilated|mechanically ventilated
586690|NCT00691587|Pseudomonas aeruginosa|pseudomonas aeruginosa
586691|NCT00691587|ventilator associated pneumonia|ventilator associated pneumonia
586692|NCT00691574|Smith-Magenis Syndrome|smith-magenis syndrome
586693|NCT00691574|melatonin|melatonin
586694|NCT00691574|circadian rhythm|circadian rhythm
586695|NCT00691574|sleep|sleep
586696|NCT00691561|HIV Prevention|hiv prevention
586697|NCT00691561|African American|african american
586698|NCT00691561|Black|black
586699|NCT00691561|gay|gay
586700|NCT00691561|Men who have sex men|men who have sex men
586701|NCT00691561|HIV Seronegativity|hiv seronegativity
586702|NCT00691548|Stage IV cancer|stage iv cancer
586703|NCT00691522|PERITUMORAL BRAIN EDEMA|peritumoral brain edema
586704|NCT00691522|PRIMARY MALIGNANT BRAIN TUMORS|primary malignant brain tumors
586705|NCT00691522|METASTATIC BRAIN TUMORS|metastatic brain tumors
586706|NCT00691509|breast cancer|breast cancer
586707|NCT00691496|HIV Prevention|hiv prevention
586708|NCT00691496|African-American|african-american
586709|NCT00691496|gay|gay
586710|NCT00691496|bisexual|bisexual
586711|NCT00691496|intervention trial|intervention trial
586712|NCT00691496|HIV Seronegativity|hiv seronegativity
586713|NCT00691483|smoking cessation|smoking cessation
586714|NCT00691483|smoking treatment|smoking treatment
586715|NCT00691483|patient self-selected quit date|patient self-selected quit date
586716|NCT00691470|Anticoagulation|anticoagulation
586717|NCT00691470|Vitamin K-dependent clotting factor inhibitor|vitamin k-dependent clotting factor inhibitor
586718|NCT00691470|Coumadin|coumadin
586719|NCT00691470|Warfarin|warfarin
586720|NCT00691470|Atrial fibrillation|atrial fibrillation
586721|NCT00691470|Prosthetic heart valve|prosthetic heart valve
586722|NCT00691470|Venous thromboembolic disease|venous thromboembolic disease
586723|NCT00691470|Myocardial infarction or cardiomyopathy|myocardial infarction or cardiomyopathy
586724|NCT00691470|Patients with one or more of the following indications for chronic warfarin anticoagulation:|patients with one or more of the following indications for chronic warfarin anticoagulation:
586725|NCT00691470|Atrial fibrillation (paroxysmal, persistent or permanent, not due to a reversible cause, documented by ECG) or atrial flutter;|atrial fibrillation (paroxysmal, persistent or permanent, not due to a reversible cause, documented by ecg) or atrial flutter;
586726|NCT00691470|A prosthetic heart valve in the aortic or mitral position that requires chronic anticoagulation;|a prosthetic heart valve in the aortic or mitral position that requires chronic anticoagulation;
586727|NCT00691470|A history of venous thromboembolic disease (DVT and/or PE) requiring long term anticoagulation (> 6 months);|a history of venous thromboembolic disease (dvt and/or pe) requiring long term anticoagulation (> 6 months);
586728|NCT00691470|A history of myocardial infarction or cardiomyopathy requiring anticoagulation.|a history of myocardial infarction or cardiomyopathy requiring anticoagulation.
586729|NCT00691470|Currently receiving chronic warfarin therapy for another indication not listed, with Sponsor approval.|currently receiving chronic warfarin therapy for another indication not listed, with sponsor approval.
586730|NCT00691457|Contact lens|contact lens
586731|NCT00691457|solution|solution
586732|NCT00691457|confocal microscope|confocal microscope
586733|NCT00691444|melatonin|melatonin
586734|NCT00691444|circadian rhythms|circadian rhythms
586735|NCT00691444|sleep|sleep
586736|NCT00691418|perinatal|perinatal
586737|NCT00691418|premature|premature
586738|NCT00691418|pregnancy|pregnancy
586739|NCT00691418|gestation|gestation
586740|NCT00691405|Arformoterol|arformoterol
586741|NCT00691405|(R,R)-formoterol|(r,r)-formoterol
586742|NCT00691392|Multi-Drug Resistant Tuberculosis|multi-drug resistant tuberculosis
586743|NCT00691392|Extensively Drug Resistant Tuberculosis|extensively drug resistant tuberculosis
586744|NCT00691392|MDR TB|mdr tb
586745|NCT00691392|XDR TB|xdr tb
586746|NCT00691392|MDR|mdr
586747|NCT00691392|XDR|xdr
586748|NCT00691379|Breast cancer|breast cancer
586749|NCT00691379|Triple negative|triple negative
586750|NCT00691379|Chemotherapy|chemotherapy
586751|NCT00691379|Anti-angiogenesis therapy|anti-angiogenesis therapy
586752|NCT00691353|Bipolar Disorder|bipolar disorder
586753|NCT00691353|antipsychotics|antipsychotics
586754|NCT00691353|social functioning|social functioning
586755|NCT00691353|mood stabilizers|mood stabilizers
586756|NCT00691353|Bipolar Disorder Type I|bipolar disorder type i
586757|NCT00691353|atypical antipsychotics|atypical antipsychotics
586758|NCT00691353|monotherapy|monotherapy
586759|NCT00691353|cotherapy|cotherapy
586760|NCT00691340|POAG|poag
586761|NCT00691340|Alzheimer's disease|alzheimer's disease
586762|NCT00691340|cellular proteome|cellular proteome
586763|NCT00691340|human leucocytes|human leucocytes
586764|NCT00691340|vasospasm|vasospasm
586765|NCT00691340|Healthy subjects|healthy subjects
586766|NCT00691327|Revision of augmentation or reconstruction|revision of augmentation or reconstruction
586767|NCT00691314|Stroke|stroke
586768|NCT00691314|Transietn Ischemic Attack|transietn ischemic attack
586769|NCT00691314|Stents|stents
586770|NCT00691314|Stenosis|stenosis
586771|NCT00691301|cervical squamous cell carcinoma|cervical squamous cell carcinoma
586772|NCT00691301|recurrent cervical cancer|recurrent cervical cancer
586773|NCT00691301|stage III cervical cancer|stage iii cervical cancer
586774|NCT00691301|stage IVA cervical cancer|stage iva cervical cancer
586775|NCT00691301|stage IVB cervical cancer|stage ivb cervical cancer
586776|NCT00691288|omega-3 fatty acid|omega-3 fatty acid
586777|NCT00691288|hypertriglyceridemia|hypertriglyceridemia
586778|NCT00691288|HIV|hiv
586779|NCT00691288|pediatric|pediatric
586780|NCT00691288|HAART|haart
586781|NCT00691275|dehydration|dehydration
586782|NCT00691275|acute gastroenteritis|acute gastroenteritis
586783|NCT00691275|ondansetron|ondansetron
586784|NCT00691275|rehydration|rehydration
586785|NCT00691262|Atopic dermatitis|atopic dermatitis
586786|NCT00691262|Prograf|prograf
586787|NCT00691262|Tacrolimus|tacrolimus
586788|NCT00691262|FK506|fk506
586789|NCT00691262|Tacrolimus ointment|tacrolimus ointment
586790|NCT00691249|Diabetes|diabetes
586791|NCT00691249|Diet|diet
586792|NCT00691249|Fiber|fiber
586793|NCT00691236|osteosarcoma|osteosarcoma
586794|NCT00691236|zoledronic acid|zoledronic acid
586795|NCT00691236|bisphosphonates|bisphosphonates
586796|NCT00691236|adjuvant to chemotherapy|adjuvant to chemotherapy
586797|NCT00691223|Focal dermal hypoplasia|focal dermal hypoplasia
586798|NCT00691223|Goltz syndrome|goltz syndrome
586799|NCT00691223|X linked disorders|x linked disorders
586800|NCT00691223|PORCN|porcn
586801|NCT00691223|Wnt signaling|wnt signaling
586802|NCT00691210|Hodgkin's Disease|hodgkin's disease
586803|NCT00691210|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
586804|NCT00691184|Onychomycosis, Toenail fungal infection, Terbinafine HCl, Pharmacokinetics|onychomycosis, toenail fungal infection, terbinafine hcl, pharmacokinetics
586805|NCT00691171|gastroesophageal reflux disease|gastroesophageal reflux disease
586806|NCT00691171|GERD|gerd
586807|NCT00691171|nonsteroidal anti-inflammatory drugs|nonsteroidal anti-inflammatory drugs
586808|NCT00691171|peptic ulcer|peptic ulcer
586809|NCT00691171|Diagnosed GERD|diagnosed gerd
586810|NCT00691171|Atypical GERD symptoms|atypical gerd symptoms
586811|NCT00691171|chronic NSAID therapy|chronic nsaid therapy
586812|NCT00691171|Risk for ulcer|risk for ulcer
586813|NCT00691145|Atopic dermatitis|atopic dermatitis
586814|NCT00691145|Tacrolimus ointment|tacrolimus ointment
586815|NCT00691132|non-small cell lung cancer|non-small cell lung cancer
586816|NCT00691132|small cell lung cancer|small cell lung cancer
586817|NCT00691132|tobacco use disorder|tobacco use disorder
586818|NCT00691119|breast cancer|breast cancer
586819|NCT00691119|radiation|radiation
586820|NCT00691119|Relaxation and Visualization Therapy|relaxation and visualization therapy
586821|NCT00691119|relaxation|relaxation
586822|NCT00691119|visualization|visualization
586823|NCT00691119|RVT|rvt
586824|NCT00691119|complementary and alternative medicine|complementary and alternative medicine
586825|NCT00691119|CAM|cam
586826|NCT00691119|alternative medicine|alternative medicine
586827|NCT00691093|observational|observational
586828|NCT00691080|Melatonin|melatonin
586829|NCT00691080|Sleep|sleep
586830|NCT00691080|Autism|autism
586831|NCT00691080|ASD|asd
586832|NCT00691080|Sleep problems in children with autism spectrum disorder|sleep problems in children with autism spectrum disorder
586833|NCT00691054|recurrent pancreatic cancer|recurrent pancreatic cancer
586834|NCT00691054|stage III pancreatic cancer|stage iii pancreatic cancer
586835|NCT00691054|stage IV pancreatic cancer|stage iv pancreatic cancer
586836|NCT00691041|HIV Prevention|hiv prevention
586837|NCT00691041|Men who have sex with men|men who have sex with men
586838|NCT00691041|African American|african american
586839|NCT00691041|Unprotected sex|unprotected sex
586840|NCT00691041|HIV Seronegativity|hiv seronegativity
586841|NCT00691028|Rheumatoid Arthritis|rheumatoid arthritis
586842|NCT00691028|RA|ra
586843|NCT00691028|Infliximab|infliximab
586844|NCT00691028|TA-650|ta-650
586845|NCT00691028|Remicade|remicade
586846|NCT00691015|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
586847|NCT00691015|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
586848|NCT00691015|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
586849|NCT00691015|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
586850|NCT00691015|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
586851|NCT00691015|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
586852|NCT00691015|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
586853|NCT00691015|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
586854|NCT00691015|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
586855|NCT00691015|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
586856|NCT00691015|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
586857|NCT00691015|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
586858|NCT00691015|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
586859|NCT00691015|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
586860|NCT00691015|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
586861|NCT00691015|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
586862|NCT00691015|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
586863|NCT00691015|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
586864|NCT00691015|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
586865|NCT00691015|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
586866|NCT00691015|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
586867|NCT00691015|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
586868|NCT00691015|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
586869|NCT00691015|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
586870|NCT00691015|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
586871|NCT00691015|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
586872|NCT00691015|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
586873|NCT00691015|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
586874|NCT00691015|splenic marginal zone lymphoma|splenic marginal zone lymphoma
586875|NCT00691015|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
586876|NCT00691015|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
586877|NCT00691015|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
586878|NCT00691015|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
586879|NCT00691015|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
586880|NCT00691015|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
586881|NCT00691015|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
586882|NCT00691015|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
586883|NCT00691015|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
586884|NCT00691015|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
586885|NCT00691015|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
586886|NCT00691015|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
586887|NCT00691015|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
586888|NCT00691015|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
586889|NCT00691015|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
586890|NCT00691015|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
586891|NCT00691015|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
586892|NCT00691015|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
586893|NCT00691015|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
586894|NCT00691015|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
586895|NCT00691015|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
586896|NCT00691015|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
586897|NCT00691015|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
586898|NCT00691015|secondary acute myeloid leukemia|secondary acute myeloid leukemia
586899|NCT00691015|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
586900|NCT00691015|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
586901|NCT00691015|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
586902|NCT00691015|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
586903|NCT00691015|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
586904|NCT00691015|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
586905|NCT00691015|stage I multiple myeloma|stage i multiple myeloma
586906|NCT00691015|stage II multiple myeloma|stage ii multiple myeloma
586907|NCT00691015|stage III multiple myeloma|stage iii multiple myeloma
586908|NCT00691015|primary myelofibrosis|primary myelofibrosis
586909|NCT00691015|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
586910|NCT00691015|chronic eosinophilic leukemia|chronic eosinophilic leukemia
586911|NCT00691015|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
587013|NCT00690586|ANP|anp
586912|NCT00691015|chronic neutrophilic leukemia|chronic neutrophilic leukemia
586913|NCT00690989|Headache|headache
586914|NCT00690989|Adherence|adherence
586915|NCT00690989|Followup|followup
586916|NCT00690976|HIV Seronegativity|hiv seronegativity
586917|NCT00690976|HIV risk behavior|hiv risk behavior
586918|NCT00690976|Unprotected sex|unprotected sex
586919|NCT00690976|men who have sex with men|men who have sex with men
586920|NCT00690976|gay|gay
586921|NCT00690976|Latino|latino
586922|NCT00690976|Unsafe Sex|unsafe sex
586923|NCT00690963|Radiotherapy|radiotherapy
586924|NCT00690963|Intensity-Modulated|intensity-modulated
586925|NCT00690963|Dose Fractionation|dose fractionation
586926|NCT00690950|BPH|bph
586927|NCT00690937|hypercholesterolemia, bile acid sequestrant, LDL-cholesterol|hypercholesterolemia, bile acid sequestrant, ldl-cholesterol
586928|NCT00690924|lung cancer|lung cancer
586929|NCT00690924|tobacco use disorder|tobacco use disorder
586930|NCT00690924|squamous lung dysplasia|squamous lung dysplasia
586931|NCT00690885|chronic cough|chronic cough
586932|NCT00690885|COPD|copd
586933|NCT00690885|IPF|ipf
586934|NCT00690885|interferon alpha|interferon alpha
586935|NCT00690872|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
586936|NCT00690872|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
586937|NCT00690872|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
586938|NCT00690872|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
586939|NCT00690859|Bipolar disorders|bipolar disorders
586940|NCT00690859|Predictors of recurrence|predictors of recurrence
586941|NCT00690820|Cystic Fibrosis|cystic fibrosis
586942|NCT00690820|Pancreatic Exocrine Insufficiency|pancreatic exocrine insufficiency
586943|NCT00690807|eczema|eczema
586944|NCT00690781|casein|casein
586945|NCT00690781|milk soluble proteins|milk soluble proteins
586946|NCT00690781|protein feeding pattern|protein feeding pattern
586947|NCT00690781|overweight|overweight
586948|NCT00690781|obesity|obesity
586949|NCT00690781|energy restriction|energy restriction
586950|NCT00690781|protein metabolism|protein metabolism
586951|NCT00690781|lean body mass|lean body mass
586952|NCT00690781|body composition|body composition
586953|NCT00690781|nitrogen balance|nitrogen balance
586954|NCT00690781|protein synthesis|protein synthesis
586955|NCT00690781|proteolysis|proteolysis
586956|NCT00690781|spread|spread
586957|NCT00690781|pulse|pulse
586958|NCT00690768|Diabetic Retinopathy|diabetic retinopathy
586959|NCT00690768|Retinal detachment|retinal detachment
586960|NCT00690768|Vitreous Hemorrhage|vitreous hemorrhage
586961|NCT00690768|Bevacizumab|bevacizumab
586962|NCT00690768|preoperative|preoperative
586963|NCT00690768|pars plana vitrectomy|pars plana vitrectomy
586964|NCT00690755|Diabetic|diabetic
586965|NCT00690716|Nasal CO2|nasal co2
586966|NCT00690716|Phase II|phase ii
586967|NCT00690716|Adaptive|adaptive
586968|NCT00690716|Randomized|randomized
586969|NCT00690716|Double-Blind|double-blind
586970|NCT00690716|Placebo-Controlled|placebo-controlled
586971|NCT00690716|Multiple-Dose|multiple-dose
586972|NCT00690716|Multi-center|multi-center
586973|NCT00690716|Safety|safety
586974|NCT00690716|Efficacy|efficacy
586975|NCT00690716|Mild Headache|mild headache
586976|NCT00690716|Migraineur|migraineur
586977|NCT00690703|non small cell lung cancer|non small cell lung cancer
586978|NCT00690703|pulmonary metastases|pulmonary metastases
586979|NCT00690703|radiofrequency ablation|radiofrequency ablation
586980|NCT00690690|HIV Seronegativity|hiv seronegativity
586981|NCT00690690|HIV risk behavior|hiv risk behavior
586982|NCT00690690|Unprotected sex|unprotected sex
586983|NCT00690690|men who have sex with men|men who have sex with men
586984|NCT00690690|gay|gay
586985|NCT00690690|Latino|latino
586986|NCT00690690|unsafe sex|unsafe sex
586987|NCT00690690|high risk sex|high risk sex
586988|NCT00690677|LBH589|lbh589
586989|NCT00690677|Metastatic Colorectal Cancer|metastatic colorectal cancer
586990|NCT00690677|Refractory Colorectal Cancer|refractory colorectal cancer
586991|NCT00690664|Hair characteristics|hair characteristics
586992|NCT00690651|ankle|ankle
586993|NCT00690651|fracture|fracture
586994|NCT00690651|mobilisation|mobilisation
586995|NCT00690651|bed rest|bed rest
586996|NCT00690651|internal fixation|internal fixation
586997|NCT00690638|dutogliptin|dutogliptin
586998|NCT00690638|PHX1149|phx1149
586999|NCT00690638|DPP4 inhibitor|dpp4 inhibitor
587000|NCT00690625|Myofacial pain|myofacial pain
587001|NCT00690625|Omega 3 fatty acids|omega 3 fatty acids
587002|NCT00690612|pediatric|pediatric
587003|NCT00690612|renal disease|renal disease
587004|NCT00690612|high blood pressure|high blood pressure
587005|NCT00690599|Patient satisfaction|patient satisfaction
587006|NCT00690599|Dentist-Patient relations|dentist-patient relations
587007|NCT00690599|Answering services|answering services
587008|NCT00690586|Nephrotic syndrome|nephrotic syndrome
587009|NCT00690586|Underfill and overfill theory|underfill and overfill theory
587010|NCT00690586|Steroid resistance|steroid resistance
587011|NCT00690586|Urine proteomics|urine proteomics
587014|NCT00690586|Angiotensin II|angiotensin ii
587015|NCT00690586|Renin and Aldosterone|renin and aldosterone
587016|NCT00690573|Juvenile Rheumatoid Arthritis|juvenile rheumatoid arthritis
587017|NCT00690560|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
587018|NCT00690560|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
587019|NCT00690560|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
587020|NCT00690560|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
587021|NCT00690560|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
587022|NCT00690547|Functionality|functionality
587023|NCT00690547|Deliberately|deliberately
587024|NCT00690547|Activated|activated
587025|NCT00690547|Quadriceps|quadriceps
587026|NCT00690547|Femoris|femoris
587027|NCT00690547|During|during
587028|NCT00690547|After|after
587029|NCT00690547|Active|active
587030|NCT00690547|Extension|extension
587031|NCT00690534|sarcopenia|sarcopenia
587032|NCT00690534|aging|aging
587033|NCT00690534|muscle metabolism|muscle metabolism
587034|NCT00690521|congestive heart failure|congestive heart failure
587035|NCT00690521|diuretics|diuretics
587036|NCT00690521|combination|combination
587037|NCT00690508|Intubation, Trachea, Sternum,|intubation, trachea, sternum,
587038|NCT00690508|Tube tip, Tube placement, Tube tip palpation,|tube tip, tube placement, tube tip palpation,
587039|NCT00690508|Validate|validate
587040|NCT00690508|use|use
587041|NCT00690508|SSTTP|ssttp
587042|NCT00690508|corrrect|corrrect
587043|NCT00690508|placement|placement
587044|NCT00690495|Anesthesia|anesthesia
587045|NCT00690495|Induction|induction
587046|NCT00690495|Pain|pain
587047|NCT00690482|COPD|copd
587048|NCT00690456|Randomized Controlled Trial|randomized controlled trial
587049|NCT00690456|Metformin|metformin
587050|NCT00690443|Hyperlipidemia|hyperlipidemia
587051|NCT00690430|Carcinoid|carcinoid
587052|NCT00690430|neuroendocrine|neuroendocrine
587053|NCT00690430|gastroenteropancreatic|gastroenteropancreatic
587054|NCT00690430|somatostatin analogue|somatostatin analogue
587055|NCT00690430|Symptomatic Refractory Resistant Carcinoid Disease|symptomatic refractory resistant carcinoid disease
587056|NCT00690404|formulation|formulation
587057|NCT00690404|pharmacokinetic|pharmacokinetic
587058|NCT00690404|crossover formulation|crossover formulation
587059|NCT00690404|food effect|food effect
587060|NCT00690404|oral solution|oral solution
587061|NCT00690404|healthy volunteers|healthy volunteers
587062|NCT00690391|surgery|surgery
587063|NCT00690391|prognostic|prognostic
587064|NCT00690391|palliation|palliation
587065|NCT00690365|Switching|switching
587066|NCT00690365|Quetiapine|quetiapine
587067|NCT00690365|schizophrenia|schizophrenia
587068|NCT00690365|unsuccessfully treated|unsuccessfully treated
587069|NCT00690365|antipsychotics|antipsychotics
587070|NCT00690352|Specialized Substance Abuse Supervision|specialized substance abuse supervision
587071|NCT00690352|SSAS|ssas
587072|NCT00690352|substance use disorder|substance use disorder
587073|NCT00690352|felony drug offender|felony drug offender
587074|NCT00690352|probation|probation
587075|NCT00690352|parole|parole
587076|NCT00690352|cognitive behavioral therapy|cognitive behavioral therapy
587077|NCT00690352|CBT|cbt
587078|NCT00690326|physical activity|physical activity
587079|NCT00690326|Diabetes mellitus|diabetes mellitus
587080|NCT00690326|Behavioral change communication|behavioral change communication
587081|NCT00690326|Household physical activity|household physical activity
587082|NCT00690313|Vigamox, topical antibiotics, Intravitreal injections, macular degeneration, endophthalmitis|vigamox, topical antibiotics, intravitreal injections, macular degeneration, endophthalmitis
587083|NCT00690300|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
587084|NCT00690300|pancreatic cancer|pancreatic cancer
587085|NCT00690300|pancreas carcinoma|pancreas carcinoma
587086|NCT00690300|advanced pancreatic cancer|advanced pancreatic cancer
587087|NCT00690300|metastatic pancreatic cancer|metastatic pancreatic cancer
587088|NCT00690300|second line|second line
587089|NCT00690300|palliative|palliative
587090|NCT00690300|Oxaliplatin|oxaliplatin
587091|NCT00690300|Docetaxel|docetaxel
587092|NCT00690300|Taxotere|taxotere
587093|NCT00690300|Eloxatin|eloxatin
587094|NCT00690300|Cancer of pancreas|cancer of pancreas
587095|NCT00690300|Pancreas cancer|pancreas cancer
587096|NCT00690287|Type 2 diabetes|type 2 diabetes
587097|NCT00690274|schizophrenia|schizophrenia
587098|NCT00690274|cognitive deficients|cognitive deficients
587099|NCT00690274|cognitive enhancing|cognitive enhancing
587100|NCT00690274|antipsychotics|antipsychotics
587101|NCT00690261|tumor associated macrophage|tumor associated macrophage
587102|NCT00690261|lung cancer|lung cancer
587103|NCT00690261|outcome|outcome
587104|NCT00690248|Acute mania|acute mania
587105|NCT00690248|Bipolar disorder|bipolar disorder
587106|NCT00690248|depressive symptoms|depressive symptoms
587107|NCT00690248|mixed mania|mixed mania
587108|NCT00690235|Schizophrenia|schizophrenia
587109|NCT00690235|Schizoaffective|schizoaffective
587110|NCT00690235|Olanzapine|olanzapine
587111|NCT00690235|Zyprexa|zyprexa
587112|NCT00690235|Clozapine|clozapine
587113|NCT00690235|Clozaril|clozaril
587114|NCT00690235|Pramlintide|pramlintide
587115|NCT00690235|Diabetes|diabetes
587116|NCT00690235|Weight Gain|weight gain
587117|NCT00690235|Obesity|obesity
587118|NCT00690235|Metabolic Syndrome|metabolic syndrome
587119|NCT00690222|cataract surgery|cataract surgery
587120|NCT00690222|phacoemulsification|phacoemulsification
587121|NCT00690222|pupil|pupil
587122|NCT00690222|dilation|dilation
587123|NCT00690222|mydriasis|mydriasis
587124|NCT00690222|intracameral|intracameral
587125|NCT00690222|topical|topical
587126|NCT00690222|pseudoexfoliation syndrome|pseudoexfoliation syndrome
587127|NCT00690209|Chronic ischemic cardiomyopathy with residual viability|chronic ischemic cardiomyopathy with residual viability
587128|NCT00690209|surgical coronary revascularization|surgical coronary revascularization
587129|NCT00690209|stem cell therapy|stem cell therapy
587130|NCT00690209|Chronic ischemic heart disease|chronic ischemic heart disease
587131|NCT00690209|severe impairment of global contractility left ventricular dilation|severe impairment of global contractility left ventricular dilation
587132|NCT00690209|residual viability|residual viability
587133|NCT00690183|physical activity|physical activity
587134|NCT00690183|stem cells|stem cells
587135|NCT00690183|lifestyle|lifestyle
587136|NCT00690170|ketamine|ketamine
587137|NCT00690170|nicotine|nicotine
587138|NCT00690170|schizophrenia|schizophrenia
587139|NCT00690170|cognitive deficits|cognitive deficits
587140|NCT00690170|P300 oddball paradigm|p300 oddball paradigm
587141|NCT00690170|Mismatch Negativity|mismatch negativity
587142|NCT00690170|P50 gating|p50 gating
587143|NCT00690157|heart failure, prognosis, markers,heart transplantation|heart failure, prognosis, markers,heart transplantation
587144|NCT00690144|simulation|simulation
587145|NCT00690144|medical education|medical education
587146|NCT00690144|performance of clinical reasoning and skills|performance of clinical reasoning and skills
587147|NCT00690131|Smoking cessation, severe mental illness, behavioral treatment|smoking cessation, severe mental illness, behavioral treatment
587148|NCT00690118|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
587149|NCT00690118|survival time|survival time
587150|NCT00690118|ALS functioning Rating Scale|als functioning rating scale
587151|NCT00690118|quality of life|quality of life
587152|NCT00690118|non-invasive ventilation|non-invasive ventilation
587153|NCT00690118|clinical tolerability|clinical tolerability
587154|NCT00690118|survival|survival
587155|NCT00690105|Dermatitis, Atopic|dermatitis, atopic
587156|NCT00690105|Dermatologic Agents|dermatologic agents
587157|NCT00690105|Topical Drug Administration|topical drug administration
587158|NCT00690105|Tacrolimus|tacrolimus
587159|NCT00690105|Calcineurin|calcineurin
587160|NCT00690105|Corticosteroid|corticosteroid
587161|NCT00690105|Fluticasone propionate|fluticasone propionate
587162|NCT00690105|Face|face
587163|NCT00690092|Coccidioidin|coccidioidin
587164|NCT00690092|Coccidioidin SD|coccidioidin sd
587165|NCT00690092|Spherule-derived coccidioidin|spherule-derived coccidioidin
587166|NCT00690092|Coccidioidomycosis|coccidioidomycosis
587167|NCT00690092|Valley Fever|valley fever
587168|NCT00690092|Coccidioides immitis|coccidioides immitis
587169|NCT00690079|MAD|mad
587170|NCT00690079|Multiple ascending dose|multiple ascending dose
587171|NCT00690079|Chronic pain|chronic pain
587173|NCT00690066|T1DM|t1dm
587174|NCT00690066|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
587175|NCT00690066|Type 1 Diabetes|type 1 diabetes
587176|NCT00690066|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
587177|NCT00690066|Juvenile Diabetes|juvenile diabetes
587178|NCT00690066|Adult Human Stem Cells|adult human stem cells
587179|NCT00690066|Mesenchymal Stem Cells|mesenchymal stem cells
587180|NCT00690066|MSCs|mscs
587181|NCT00690066|Insulin|insulin
587182|NCT00690066|Osiris|osiris
587183|NCT00690066|Prochymal|prochymal
587184|NCT00690053|Toxicity|toxicity
587185|NCT00690053|PET|pet
587186|NCT00690053|HX-4|hx-4
587187|NCT00690053|cancer|cancer
587188|NCT00690040|Induction of labor|induction of labor
587189|NCT00690040|Ripening|ripening
587190|NCT00690040|Single balloon catheter|single balloon catheter
587191|NCT00690040|Double balloon catheter|double balloon catheter
587192|NCT00690014|OAT|oat
587193|NCT00690014|GFR|gfr
587194|NCT00690014|renal function|renal function
587195|NCT00690014|PAH|pah
587196|NCT00690001|HIV-1 infection|hiv-1 infection
587197|NCT00690001|Treatment Experienced|treatment experienced
587198|NCT00689988|Down syndrome|down syndrome
587199|NCT00689988|communication AIDS for disabled|communication aids for disabled
587200|NCT00689988|language development disorders|language development disorders
587201|NCT00689988|vocabulary|vocabulary
587202|NCT00689988|gestures|gestures
587203|NCT00689988|language tests|language tests
587204|NCT00689988|child|child
587205|NCT00689975|stage IA breast cancer|stage ia breast cancer
587206|NCT00689975|stage IB breast cancer|stage ib breast cancer
587207|NCT00689975|stage II breast cancer|stage ii breast cancer
587208|NCT00689975|stage IIIA breast cancer|stage iiia breast cancer
587209|NCT00689975|stage IIIB breast cancer|stage iiib breast cancer
587311|NCT00689572|crack|crack
587210|NCT00689975|stage IIIC breast cancer|stage iiic breast cancer
587211|NCT00689962|Lisfranc|lisfranc
587212|NCT00689962|fracture|fracture
587213|NCT00689962|dislocation|dislocation
587214|NCT00689962|bioabsorbable|bioabsorbable
587215|NCT00689949|folic acid|folic acid
587216|NCT00689949|folate|folate
587217|NCT00689949|p-aminobenzoylglutamate|p-aminobenzoylglutamate
587218|NCT00689949|formiminoglutamate|formiminoglutamate
587219|NCT00689949|homocysteine|homocysteine
587220|NCT00689949|experimental validation of a new biomarker|experimental validation of a new biomarker
587221|NCT00689936|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
587222|NCT00689936|Lenalidomide|lenalidomide
587223|NCT00689936|Revlimid|revlimid
587224|NCT00689936|phase III|phase iii
587225|NCT00689910|pharmacokinetics|pharmacokinetics
587226|NCT00689910|pregnancy|pregnancy
587227|NCT00689910|Raltegravir|raltegravir
587228|NCT00689910|HIV|hiv
587229|NCT00689910|antiretroviral|antiretroviral
587230|NCT00689910|Treatment of HIV in pregnant women with Raltegravir|treatment of hiv in pregnant women with raltegravir
587231|NCT00689897|Primary Dysmenorrhea|primary dysmenorrhea
587232|NCT00689897|Deqi|deqi
587233|NCT00689897|acupuncture|acupuncture
587234|NCT00689897|psychology|psychology
587235|NCT00689858|Healthy volunteers|healthy volunteers
587236|NCT00689845|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
587237|NCT00689845|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
587238|NCT00689845|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
587239|NCT00689845|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
587240|NCT00689845|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
587241|NCT00689832|Dermatitis, Atopic|dermatitis, atopic
587242|NCT00689832|Dermatologic Agents|dermatologic agents
587243|NCT00689832|Topical Drug Administration|topical drug administration
587244|NCT00689832|Tacrolimus|tacrolimus
587245|NCT00689832|Calcineurin|calcineurin
587246|NCT00689832|Corticosteroid|corticosteroid
587247|NCT00689832|Fluticasone propionate|fluticasone propionate
587248|NCT00689832|Child|child
587249|NCT00689819|Hypertension|hypertension
587250|NCT00689819|High blood pressure|high blood pressure
587251|NCT00689819|Pre-clinical cardiac dysfunction|pre-clinical cardiac dysfunction
587252|NCT00689806|Asthma|asthma
587253|NCT00689793|Fatigue|fatigue
587254|NCT00689793|Blood donation|blood donation
587255|NCT00689793|Iron deficiency|iron deficiency
587256|NCT00689793|Ferrous sulphate|ferrous sulphate
587257|NCT00689793|Donation|donation
587258|NCT00689793|Donors|donors
587259|NCT00689793|Iron|iron
587260|NCT00689793|Ferritin|ferritin
587261|NCT00689793|Hemoglobin|hemoglobin
587262|NCT00689793|Anemia|anemia
587263|NCT00689793|Anaemia|anaemia
587264|NCT00689793|Haemoglobin|haemoglobin
587265|NCT00689793|Don|don
587266|NCT00689793|Women blood donors|women blood donors
587267|NCT00689780|Pain|pain
587268|NCT00689780|safety|safety
587269|NCT00689780|chronic low back pain|chronic low back pain
587270|NCT00689767|drug eluting stent|drug eluting stent
587271|NCT00689754|gastrointestinal hemorrhage|gastrointestinal hemorrhage
587272|NCT00689754|gastrointestinal intubation|gastrointestinal intubation
587273|NCT00689754|endoscopy|endoscopy
587274|NCT00689741|HPV|hpv
587275|NCT00689741|vaccine|vaccine
587276|NCT00689715|Cystic tumor|cystic tumor
587277|NCT00689715|Pancreas|pancreas
587278|NCT00689715|EUS|eus
587279|NCT00689702|cetuximab|cetuximab
587280|NCT00689702|capecitabine|capecitabine
587281|NCT00689702|radiotherapy|radiotherapy
587282|NCT00689702|rectal cancer|rectal cancer
587283|NCT00689676|expressive language|expressive language
587284|NCT00689676|cognition|cognition
587285|NCT00689676|early development|early development
587286|NCT00689676|very low birt weight|very low birt weight
587287|NCT00689676|prematurity|prematurity
587288|NCT00689663|cholecystectomy|cholecystectomy
587289|NCT00689637|AZD3480|azd3480
587290|NCT00689637|Warfarin|warfarin
587291|NCT00689637|Drug interaction|drug interaction
587292|NCT00689624|Colorectal Cancer|colorectal cancer
587293|NCT00689624|Cetuximab|cetuximab
587294|NCT00689624|FOLFOXIRI|folfoxiri
587295|NCT00689611|Acute coronary syndrome|acute coronary syndrome
587296|NCT00689611|Myocardial infarction|myocardial infarction
587297|NCT00689611|Smoking cessation|smoking cessation
587298|NCT00689611|Zyban|zyban
587299|NCT00689611|Secondary intervention post-ACS|secondary intervention post-acs
587300|NCT00689598|Atrial fibrillation, spironolactone|atrial fibrillation, spironolactone
587301|NCT00689585|Complex Regional Pain Syndrome|complex regional pain syndrome
587302|NCT00689585|Reflex Sympathetic Dystrophy|reflex sympathetic dystrophy
587303|NCT00689585|RSD|rsd
587304|NCT00689585|Chronic Pain|chronic pain
587305|NCT00689585|Ethosuximide|ethosuximide
587306|NCT00689585|Zarontin|zarontin
587307|NCT00689585|Anticonvulsant|anticonvulsant
587308|NCT00689572|cocaine dependence|cocaine dependence
587309|NCT00689572|cocaine abuse|cocaine abuse
587310|NCT00689572|cocaine|cocaine
587312|NCT00689559|Alzheimer's disease|alzheimer's disease
587313|NCT00689559|AZD3480|azd3480
587314|NCT00689559|Aripiprazole|aripiprazole
587315|NCT00689533|VEPTR|veptr
587316|NCT00689533|TIS|tis
587317|NCT00689533|scoliosis|scoliosis
587318|NCT00689533|juvenile|juvenile
587319|NCT00689520|Venous thromboembolism|venous thromboembolism
587320|NCT00689520|low molecular weight heparin|low molecular weight heparin
587321|NCT00689520|Vitamin K antagonist|vitamin k antagonist
587322|NCT00689520|Longterm|longterm
587323|NCT00689507|Multiple Myeloma|multiple myeloma
587324|NCT00689507|Relapsed|relapsed
587325|NCT00689507|Refractory|refractory
587326|NCT00689507|Bortezomib|bortezomib
587327|NCT00689507|Velcade|velcade
587328|NCT00689494|Nanopaz device|nanopaz device
587329|NCT00689494|Blood progesterone measure in using the device|blood progesterone measure in using the device
587330|NCT00689494|Delivery progesterone|delivery progesterone
587331|NCT00689494|Progesterone levonorgestrel|progesterone levonorgestrel
587332|NCT00689481|Plaque-type Psoriasis|plaque-type psoriasis
587333|NCT00689481|psoriasis|psoriasis
587334|NCT00689468|Otitis media|otitis media
587335|NCT00689468|Echinacea|echinacea
587336|NCT00689468|Osteopathic Medicine|osteopathic medicine
587337|NCT00689455|Metabolic Syndrome|metabolic syndrome
587338|NCT00689455|Lipids|lipids
587339|NCT00689455|Waist Circumference|waist circumference
587340|NCT00689429|Pilon Fractures|pilon fractures
587341|NCT00689416|imaging biomarkers|imaging biomarkers
587342|NCT00689416|MRI|mri
587343|NCT00689416|FDG-PET/CT scanning|fdg-pet/ct scanning
587344|NCT00689416|Crestor|crestor
587345|NCT00689403|AZD1305|azd1305
587346|NCT00689403|pharmacokinetics|pharmacokinetics
587347|NCT00689403|Properties of different ER formulations|properties of different er formulations
587348|NCT00689377|Peripheral Arterial Disease (PAD)|peripheral arterial disease (pad)
587349|NCT00689377|Cardiovascular Disease (CVD)|cardiovascular disease (cvd)
587350|NCT00689377|Atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease
587351|NCT00689377|Atherosclerosis|atherosclerosis
587352|NCT00689377|Primary CVD prevention|primary cvd prevention
587353|NCT00689364|Cohort Study|cohort study
587354|NCT00689364|Colorectal Cancer|colorectal cancer
587355|NCT00689364|Traditional Chinese Medicine|traditional chinese medicine
587356|NCT00689364|Risk of recurrence and metastasis|risk of recurrence and metastasis
587357|NCT00689351|Prevention|prevention
587358|NCT00689351|against|against
587359|NCT00689351|pneumococcal|pneumococcal
587360|NCT00689351|disease|disease
587361|NCT00689351|Vaccine|vaccine
587362|NCT00689338|Candida|candida
587363|NCT00689338|Candidemia|candidemia
587364|NCT00689338|Systemic Candidiasis|systemic candidiasis
587365|NCT00689338|ICU|icu
587366|NCT00689338|Intensive Care Unit|intensive care unit
587367|NCT00689338|Critical Care Unit|critical care unit
587368|NCT00689338|Anidulafungin|anidulafungin
587369|NCT00689338|Ecalta|ecalta
587370|NCT00689338|Eraxis|eraxis
587371|NCT00689338|Fluconazole|fluconazole
587372|NCT00689338|Voriconazole|voriconazole
587373|NCT00689325|Schizophrenia|schizophrenia
587374|NCT00689325|remission|remission
587375|NCT00689325|subjective well-being and effectiveness|subjective well-being and effectiveness
587376|NCT00689325|Quality of Life|quality of life
587377|NCT00689312|Gastroenteritis|gastroenteritis
587378|NCT00689312|Pediatrics|pediatrics
587379|NCT00689312|Rehydration therapy|rehydration therapy
587380|NCT00689299|Sublingual Immunotherapy (SLIT)|sublingual immunotherapy (slit)
587381|NCT00689299|Non-seasonal allergic rhinitis|non-seasonal allergic rhinitis
587382|NCT00689299|Immunotherapy|immunotherapy
587383|NCT00689299|Allergic rhinitis|allergic rhinitis
587384|NCT00689299|Cat|cat
587385|NCT00689299|Perennial allergy|perennial allergy
587386|NCT00689299|Non-seasonal allergy|non-seasonal allergy
587387|NCT00689286|Knee Osteoarthritis|knee osteoarthritis
587388|NCT00689286|Neuromuscular stimulator|neuromuscular stimulator
587389|NCT00689273|PF-04136309 CCR2 osteoarthritic pain knee, phase 2 placebo multicenter double-blind placebo-controlled|pf-04136309 ccr2 osteoarthritic pain knee, phase 2 placebo multicenter double-blind placebo-controlled
587390|NCT00689247|AZD1305|azd1305
587391|NCT00689247|ADME|adme
587392|NCT00689247|pharmacokinetic|pharmacokinetic
587393|NCT00689247|Absorption|absorption
587394|NCT00689247|distribution|distribution
587395|NCT00689247|metabolism|metabolism
587396|NCT00689247|excretion|excretion
587397|NCT00689221|newly diagnosed Glioblastoma (WHO Grade IV)|newly diagnosed glioblastoma (who grade iv)
587398|NCT00689221|Cilengitide|cilengitide
587399|NCT00689221|Temozolomide|temozolomide
587400|NCT00689221|Radiotherapy|radiotherapy
587401|NCT00689208|Clamp|clamp
587402|NCT00689195|Curcumin|curcumin
587403|NCT00689195|Ashwagandha|ashwagandha
587404|NCT00689195|osteosarcoma|osteosarcoma
587405|NCT00689195|Pharmacokinetics of curcumin and ashwagandha formulation|pharmacokinetics of curcumin and ashwagandha formulation
587406|NCT00689195|response|response
587407|NCT00689182|iron reduction|iron reduction
587408|NCT00689182|iron overload|iron overload
587409|NCT00689182|phlebotomy|phlebotomy
587410|NCT00689182|hematopoietic stem cell transplant|hematopoietic stem cell transplant
587411|NCT00689169|Lymphoma|lymphoma
587412|NCT00689169|Lymphoma Diffuse|lymphoma diffuse
587413|NCT00689169|B-Cell lymphoma|b-cell lymphoma
587414|NCT00689169|Aggressive lymphoma|aggressive lymphoma
587415|NCT00689156|Epirubicin|epirubicin
587416|NCT00689156|docetaxel|docetaxel
587417|NCT00689156|Adjuvant chemotherapy|adjuvant chemotherapy
587418|NCT00689156|DNA Topoisomerases, Type II|dna topoisomerases, type ii
587419|NCT00689130|Analgesia|analgesia
587420|NCT00689130|Bispectral Index|bispectral index
587421|NCT00689130|BIS Variability|bis variability
587422|NCT00689130|Electroencephalography|electroencephalography
587423|NCT00689130|Electromyography|electromyography
587424|NCT00689130|Monitoring, Intraoperative|monitoring, intraoperative
587425|NCT00689130|Movement|movement
587426|NCT00689130|Pain, Postoperative|pain, postoperative
587427|NCT00689130|Somatic Events|somatic events
587428|NCT00689130|Patients under general anesthesia undergoing a moderately painful procedure.|patients under general anesthesia undergoing a moderately painful procedure.
587429|NCT00689117|Acne Vulgaris|acne vulgaris
587430|NCT00689117|Acne|acne
587431|NCT00689104|Micturition|micturition
587432|NCT00689104|Urinary incontinence|urinary incontinence
587433|NCT00689104|Urinary urge incontinence|urinary urge incontinence
587434|NCT00689104|Overactive bladder (OAB)|overactive bladder (oab)
587435|NCT00689104|Urgency|urgency
587436|NCT00689104|YM178|ym178
587437|NCT00689104|Frequency|frequency
587438|NCT00689091|Awareness|awareness
587439|NCT00689091|BIS Monitor|bis monitor
587440|NCT00689091|electronic alerts|electronic alerts
587441|NCT00689091|minimum|minimum
587442|NCT00689091|alveolar|alveolar
587443|NCT00689091|concentration|concentration
587444|NCT00689078|Allergic conjunctivitis|allergic conjunctivitis
587445|NCT00689065|siRNA|sirna
587446|NCT00689065|RNA interference (RNAi)|rna interference (rnai)
587447|NCT00689065|Cyclodextrin|cyclodextrin
587448|NCT00689065|Cancer|cancer
587449|NCT00689065|Neoplasms|neoplasms
587450|NCT00689065|Solid Tumor|solid tumor
587451|NCT00689065|Ovarian Cancer|ovarian cancer
587452|NCT00689065|Lung Cancer|lung cancer
587453|NCT00689065|Non Small Cell Lung Cancer|non small cell lung cancer
587454|NCT00689065|Pancreatic Cancer|pancreatic cancer
587455|NCT00689065|Breast Cancer|breast cancer
587456|NCT00689065|Colon Cancer|colon cancer
587457|NCT00689065|Endometrial Cancer|endometrial cancer
587458|NCT00689065|Kidney (Renal Cell) Cancer|kidney (renal cell) cancer
587459|NCT00689065|Melanoma|melanoma
587460|NCT00689065|Prostate Cancer|prostate cancer
587461|NCT00689065|Skin Cancer|skin cancer
587462|NCT00689065|Thyroid Cancer|thyroid cancer
587463|NCT00689065|Solid Malignancies|solid malignancies
587464|NCT00689039|AZD1305|azd1305
587465|NCT00689039|safety|safety
587466|NCT00689039|pharmacokinetics|pharmacokinetics
587467|NCT00689039|multiple ascending doses|multiple ascending doses
587468|NCT00689039|Safety and pharmacokinetics|safety and pharmacokinetics
587469|NCT00689026|Colonoscopy|colonoscopy
587470|NCT00689026|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
587471|NCT00689026|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
587472|NCT00689026|Cleansing|cleansing
587473|NCT00689026|Preparation|preparation
587474|NCT00689026|PEG|peg
587475|NCT00689026|Quality|quality
587476|NCT00689013|Herpes Zoster|herpes zoster
587477|NCT00689013|Prevention & control|prevention & control
587478|NCT00689013|Pharmacists|pharmacists
587479|NCT00689013|Pharmacy|pharmacy
587480|NCT00689013|Pharmacies|pharmacies
587481|NCT00689013|Aged|aged
587482|NCT00689013|Immunization|immunization
587483|NCT00689013|Vaccination|vaccination
587484|NCT00689000|Leukemia|leukemia
587485|NCT00689000|AML|aml
587486|NCT00689000|MDS|mds
587487|NCT00689000|MM|mm
587488|NCT00689000|Acute Myeloid Leukemia|acute myeloid leukemia
587489|NCT00689000|Myelodysplastic Syndrome|myelodysplastic syndrome
587490|NCT00689000|Multiple Myeloma|multiple myeloma
587491|NCT00689000|Cancer|cancer
587492|NCT00689000|Hematological malignancies|hematological malignancies
587493|NCT00689000|Elderly|elderly
587494|NCT00689000|Refractory|refractory
587495|NCT00689000|Blood|blood
587496|NCT00688974|type 2 diabetes|type 2 diabetes
587497|NCT00688974|obesity|obesity
587498|NCT00688974|gastric bypass|gastric bypass
587499|NCT00688974|adjustable gastric banding|adjustable gastric banding
587500|NCT00688974|BMI > 35.|bmi > 35.
587501|NCT00688974|obesity for more than 5 years|obesity for more than 5 years
587502|NCT00688961|omega-3 fatty acids|omega-3 fatty acids
587503|NCT00688961|aspirin|aspirin
587504|NCT00688961|platelet aggregation|platelet aggregation
587505|NCT00688961|Healthy volunteers; no disease|healthy volunteers; no disease
587506|NCT00688948|pilot clinical trial|pilot clinical trial
587507|NCT00688935|melatonin|melatonin
587508|NCT00688935|circadian rhythms|circadian rhythms
587509|NCT00688935|sleep|sleep
587510|NCT00688935|sleep disorders|sleep disorders
587511|NCT00688909|breast cancer|breast cancer
587512|NCT00688909|adjuvant treatment in post menopausal women|adjuvant treatment in post menopausal women
587513|NCT00688909|letrozole|letrozole
587514|NCT00688909|arthralgia-myalgia|arthralgia-myalgia
587515|NCT00688883|Fludarabine|fludarabine
587516|NCT00688883|Purine analog|purine analog
587517|NCT00688883|Indolent lymphoma|indolent lymphoma
587518|NCT00688870|Prevention against pneumococcal disease|prevention against pneumococcal disease
587519|NCT00688844|PKU|pku
587520|NCT00688844|Phenylketonuria|phenylketonuria
587521|NCT00688844|BH4|bh4
587522|NCT00688844|Kuvan|kuvan
587523|NCT00688844|Tetrahydrobiopterin|tetrahydrobiopterin
587524|NCT00688844|Sapropterin Dihydrochloride|sapropterin dihydrochloride
587525|NCT00688844|Nutrition|nutrition
587526|NCT00688844|PHE|phe
587527|NCT00688844|Phenylalanine|phenylalanine
587528|NCT00688844|PAH|pah
587529|NCT00688844|Phenylalanine hydroxylase|phenylalanine hydroxylase
587530|NCT00688844|Neurotransmitters|neurotransmitters
587531|NCT00688844|Serotonin|serotonin
587532|NCT00688844|Catecholamines|catecholamines
587533|NCT00688844|Diet|diet
587534|NCT00688844|Body Fat|body fat
587535|NCT00688844|Bone Density|bone density
587536|NCT00688831|AZD1305|azd1305
587537|NCT00688831|SAD|sad
587538|NCT00688831|safety|safety
587539|NCT00688831|pharmcokinetics|pharmcokinetics
587540|NCT00688831|Safety and tolerability|safety and tolerability
587541|NCT00688818|Co-morbid depressive and anxiety disorders|co-morbid depressive and anxiety disorders
587542|NCT00688818|Quetiapine|quetiapine
587543|NCT00688818|Randomized|randomized
587544|NCT00688818|Placebo-controlled|placebo-controlled
587545|NCT00688818|Double-blind|double-blind
587546|NCT00688818|Major depressive disorder|major depressive disorder
587547|NCT00688818|Dysthymic disorder|dysthymic disorder
587548|NCT00688818|Anxiety disorders|anxiety disorders
587549|NCT00688818|Generalized anxiety disorder|generalized anxiety disorder
587550|NCT00688818|Social anxiety disorder|social anxiety disorder
587551|NCT00688818|Panic disorder|panic disorder
587552|NCT00688818|Post-traumatic stress disorder|post-traumatic stress disorder
587553|NCT00688805|Propanolol|propanolol
587554|NCT00688805|Substance Abuse|substance abuse
587555|NCT00688805|Craving|craving
587556|NCT00688805|Imagery|imagery
587557|NCT00688805|Drug Cues|drug cues
587558|NCT00688805|Cocaine|cocaine
587559|NCT00688792|Asthma|asthma
587560|NCT00688792|Children|children
587561|NCT00688792|Adherence|adherence
587562|NCT00688792|Maternal factors|maternal factors
587563|NCT00688779|Healthy male|healthy male
587564|NCT00688779|allergic rhinitis|allergic rhinitis
587565|NCT00688779|tolerability|tolerability
587566|NCT00688779|safety|safety
587567|NCT00688779|intranasally|intranasally
587568|NCT00688779|Healthy subjects|healthy subjects
587569|NCT00688766|GIST|gist
587570|NCT00688766|Metastatic and/or Unresectable Gastrointestinal Stromal|metastatic and/or unresectable gastrointestinal stromal
587571|NCT00688753|renal cell carcinoma|renal cell carcinoma
587572|NCT00688753|non clear cell carcinoma|non clear cell carcinoma
587573|NCT00688753|papillary cell renal carcinoma|papillary cell renal carcinoma
587574|NCT00688753|adults|adults
587575|NCT00688753|everolimus|everolimus
587576|NCT00688740|adjuvant treatment|adjuvant treatment
587577|NCT00688727|non epileptic seizures|non epileptic seizures
587578|NCT00688727|cognitive behavioural therapy|cognitive behavioural therapy
587579|NCT00688727|dissociative disorders|dissociative disorders
587580|NCT00688727|Seizure disorders|seizure disorders
587581|NCT00688727|randomised controlled trial|randomised controlled trial
587582|NCT00688714|Antiplatelet|antiplatelet
587583|NCT00688701|hyperglycemia, GLP-1|hyperglycemia, glp-1
587584|NCT00688688|Frequency|frequency
587585|NCT00688688|Overactive Bladder|overactive bladder
587586|NCT00688688|Urgency|urgency
587587|NCT00688688|Urinary urge incontinence|urinary urge incontinence
587588|NCT00688688|Urinary incontinence|urinary incontinence
587589|NCT00688688|Micturition|micturition
587590|NCT00688675|GERD|gerd
587591|NCT00688675|Pharmacoepidemiology|pharmacoepidemiology
587592|NCT00688662|Sphincter of Oddi Dysfunction|sphincter of oddi dysfunction
587593|NCT00688662|Pancreatitis|pancreatitis
587594|NCT00688662|Sphincterotomy|sphincterotomy
587595|NCT00688623|Neuroendocrine tumors|neuroendocrine tumors
587596|NCT00688623|non-functioning neuroendocrine tumors carcinoids|non-functioning neuroendocrine tumors carcinoids
587597|NCT00688623|non-functioning carcinoids|non-functioning carcinoids
587598|NCT00688623|adults|adults
587599|NCT00688623|everolimus|everolimus
587600|NCT00688610|primary care|primary care
587601|NCT00688610|procalcitonin|procalcitonin
587602|NCT00688610|antibiotic prescription|antibiotic prescription
587603|NCT00688597|Pompe Disease|pompe disease
587604|NCT00688584|problem drinking|problem drinking
587605|NCT00688584|randomized control trial|randomized control trial
587606|NCT00688584|Pamphlet-based personalized alcohol feedback (PAF)|pamphlet-based personalized alcohol feedback (paf)
587607|NCT00688571|Pulmonary Valve|pulmonary valve
587608|NCT00688571|Congenital Heart Disease|congenital heart disease
587609|NCT00688545|Celecoxib|celecoxib
587610|NCT00688545|COX-2|cox-2
587611|NCT00688545|NSAIDs|nsaids
587612|NCT00688545|observational study|observational study
587613|NCT00688545|noninterventional study|noninterventional study
587614|NCT00688545|cohort study|cohort study
587615|NCT00688545|registry|registry
587616|NCT00688545|epidemiologic study|epidemiologic study
587617|NCT00688545|pediatrics|pediatrics
587618|NCT00688545|rheumatology|rheumatology
587619|NCT00688545|phase iv study|phase iv study
587620|NCT00688532|Prostate cancer|prostate cancer
587621|NCT00688532|pharmacoepidemiology study|pharmacoepidemiology study
587622|NCT00688519|Plaque-type Psoriasis|plaque-type psoriasis
587623|NCT00688519|Psoriasis|psoriasis
587624|NCT00688506|Chronic pelvic pain syndrome|chronic pelvic pain syndrome
587625|NCT00688506|Neuromodulation|neuromodulation
587626|NCT00688506|Brain effects|brain effects
587627|NCT00688506|Neuroimaging|neuroimaging
587629|NCT00688493|Healthy volunteers|healthy volunteers
587630|NCT00688480|CKD|ckd
587631|NCT00688480|LVH|lvh
587632|NCT00688480|Echo LVH|echo lvh
587633|NCT00688480|Chronic Stage 3|chronic stage 3
587634|NCT00688467|Neutrophilic Asthma|neutrophilic asthma
587635|NCT00688454|Hyperlipidemia|hyperlipidemia
587636|NCT00688454|Rosuvastatin|rosuvastatin
587637|NCT00688454|Efficacy|efficacy
587638|NCT00688454|tolerability|tolerability
587639|NCT00688454|CRESTOR therapy|crestor therapy
587640|NCT00688441|Randomized|randomized
587641|NCT00688441|Double-Blind|double-blind
587642|NCT00688441|Multi-Center|multi-center
587643|NCT00688441|Placebo-Controlled|placebo-controlled
587644|NCT00688441|Phase II|phase ii
587645|NCT00688441|Nasal Carbon Dioxide|nasal carbon dioxide
587646|NCT00688441|Carbon Dioxide|carbon dioxide
587647|NCT00688441|Efficacy|efficacy
587648|NCT00688441|Safety|safety
587649|NCT00688441|Total Nasal Symptom Score|total nasal symptom score
587650|NCT00688441|RQLQ|rqlq
587651|NCT00688428|esomeprazole|esomeprazole
587652|NCT00688428|upper gi symptoms|upper gi symptoms
587653|NCT00688428|low dose Aspirin treatment|low dose aspirin treatment
587654|NCT00688402|Reflux Inhibitor|reflux inhibitor
587655|NCT00688402|GERD|gerd
587656|NCT00688402|formulations|formulations
587657|NCT00688389|Dengue fever, CLEC5A, Mannose receptor, DC-SIGN, NALP,|dengue fever, clec5a, mannose receptor, dc-sign, nalp,
587658|NCT00688389|decoy receptor 3 (DcR3), Toll-like receptors(TLRs),|decoy receptor 3 (dcr3), toll-like receptors(tlrs),
587659|NCT00688389|(Nod)-like receptors (NLRs)|(nod)-like receptors (nlrs)
587660|NCT00688376|Attention|attention
587661|NCT00688376|cancer|cancer
587662|NCT00688376|chemotherapy|chemotherapy
587663|NCT00688376|donepezil|donepezil
587664|NCT00688376|acetylcholinesterase|acetylcholinesterase
587665|NCT00688376|inhibitor|inhibitor
587666|NCT00688363|Diabetes control|diabetes control
587667|NCT00688363|glycated haemoglobin|glycated haemoglobin
587668|NCT00688363|blood-glucose-self-monitoring|blood-glucose-self-monitoring
587669|NCT00688363|type 2-diabetes|type 2-diabetes
587670|NCT00688363|conventional insulin therapy|conventional insulin therapy
587671|NCT00688350|Hypertension|hypertension
587672|NCT00688350|Aging|aging
587673|NCT00688350|Medication adherence|medication adherence
587674|NCT00688350|Medication compliance|medication compliance
587675|NCT00688337|Breast cancer|breast cancer
587676|NCT00688337|lymph nodes|lymph nodes
587677|NCT00688337|gene-expression|gene-expression
587678|NCT00688337|oncotype|oncotype
587679|NCT00688337|Age over 18|age over 18
587680|NCT00688337|Newly diagnosed breast cancer prior to surgery or treatment.|newly diagnosed breast cancer prior to surgery or treatment.
587681|NCT00688337|No evidence of clinical nodal disease|no evidence of clinical nodal disease
587682|NCT00688324|schizophrenia|schizophrenia
587683|NCT00688324|schizoaffective disorder|schizoaffective disorder
587684|NCT00688324|glutamate|glutamate
587685|NCT00688324|NMDA receptor|nmda receptor
587686|NCT00688324|magnetic resonance spectroscopy|magnetic resonance spectroscopy
587687|NCT00688324|acamprosate|acamprosate
587688|NCT00688311|HIV|hiv
587689|NCT00688311|synbiotic|synbiotic
587690|NCT00688311|probiotic|probiotic
587691|NCT00688311|immune activation|immune activation
587692|NCT00688311|blood CD4 count|blood cd4 count
587693|NCT00688311|bacterial translocation|bacterial translocation
587694|NCT00688311|Human Immunodeficiency Virus|human immunodeficiency virus
587695|NCT00688285|chronic kidney disease|chronic kidney disease
587696|NCT00688285|clinical alerts|clinical alerts
587697|NCT00688285|late referral|late referral
587698|NCT00688285|electronic medical record|electronic medical record
587699|NCT00688285|Computerized clinical decision support systems (CDSS)|computerized clinical decision support systems (cdss)
587700|NCT00688272|Safety|safety
587701|NCT00688272|Photoirritant|photoirritant
587702|NCT00688272|Photosensitivity|photosensitivity
587703|NCT00688272|Placebo control|placebo control
587704|NCT00688272|Ciprofloxacin|ciprofloxacin
587705|NCT00688272|Eltrombopag|eltrombopag
587706|NCT00688259|clinical trials|clinical trials
587707|NCT00688259|psychotherapy|psychotherapy
587708|NCT00688246|osteoporosis|osteoporosis
587709|NCT00688246|breast cancer|breast cancer
587710|NCT00688233|Seifi's Functional, Class II/1, Mandibular Retrognathism|seifi's functional, class ii/1, mandibular retrognathism
587711|NCT00688220|Arthritis|arthritis
587712|NCT00688220|Carpel tunnel syndrome|carpel tunnel syndrome
587713|NCT00688220|Epicondylitis|epicondylitis
587714|NCT00688207|PPAR agonist,|ppar agonist,
587715|NCT00688207|Rosiglitazone XR,|rosiglitazone xr,
587716|NCT00688207|BRL-049653.|brl-049653.
587717|NCT00688207|Alzheimer's disease,|alzheimer's disease,
587718|NCT00688194|stage IV breast cancer|stage iv breast cancer
587719|NCT00688194|recurrent breast cancer|recurrent breast cancer
587720|NCT00688168|Multiple Myeloma|multiple myeloma
587721|NCT00688168|Phone Call|phone call
587722|NCT00688168|Treatment Naive|treatment naive
587723|NCT00688168|Inflammatory Cytokines|inflammatory cytokines
587724|NCT00688168|Questionnaire|questionnaire
587725|NCT00688168|Survey|survey
587726|NCT00688168|Interactive Voice Response|interactive voice response
587727|NCT00688168|Symptom Production|symptom production
587728|NCT00688168|Pain|pain
587729|NCT00688168|IVR|ivr
587730|NCT00688168|MM|mm
587731|NCT00688129|school readiness|school readiness
587732|NCT00688129|foster care|foster care
587733|NCT00688129|maltreatment|maltreatment
587734|NCT00688129|literacy|literacy
587735|NCT00688129|social emotional skills|social emotional skills
587736|NCT00688129|self regulation|self regulation
587737|NCT00688129|caregiver involvement|caregiver involvement
587738|NCT00688116|metastatic cancer|metastatic cancer
587739|NCT00688116|solid tumor|solid tumor
587740|NCT00688116|histologically or cytologically confirmed non-hematological malignancy that is metastatic or unresectable|histologically or cytologically confirmed non-hematological malignancy that is metastatic or unresectable
587741|NCT00688116|STA-9090|sta-9090
587742|NCT00688116|ganetespib|ganetespib
587743|NCT00688090|Immunotherapy, Melanoma, Cancer Vaccine|immunotherapy, melanoma, cancer vaccine
587744|NCT00688077|Fibroblast growth factor - 23|fibroblast growth factor - 23
587745|NCT00688077|Calcitonin|calcitonin
587746|NCT00688064|Acne|acne
587747|NCT00688051|Cystic Fibrosis|cystic fibrosis
587748|NCT00688051|Adherence to treatment|adherence to treatment
587749|NCT00688038|Advanced Cancer|advanced cancer
587750|NCT00688038|Bone Metastases|bone metastases
587751|NCT00688038|Laser Ablation|laser ablation
587752|NCT00688038|Magnetic Resonance Thermal Imaging|magnetic resonance thermal imaging
587753|NCT00688038|Laser Induced Thermal Therapy|laser induced thermal therapy
587754|NCT00688038|MRTI|mrti
587755|NCT00688038|LITT|litt
587756|NCT00688012|antisense|antisense
587757|NCT00688012|microRna antagonist|microrna antagonist
587758|NCT00688012|anti-miR-122|anti-mir-122
587759|NCT00688012|Safety in healthy volunteers|safety in healthy volunteers
587760|NCT00688012|Hepatitis C|hepatitis c
587761|NCT00687999|Chronic hepatitis C|chronic hepatitis c
587762|NCT00687999|diabetes|diabetes
587763|NCT00687999|Insulin resistance|insulin resistance
587764|NCT00687999|combination therapy|combination therapy
587765|NCT00687986|surgery|surgery
587766|NCT00687986|stereotactic radiotherapy|stereotactic radiotherapy
587767|NCT00687986|tumor control|tumor control
587768|NCT00687986|quality of life|quality of life
587769|NCT00687960|Diabetes|diabetes
587770|NCT00687960|Diet|diet
587771|NCT00687960|Fiber|fiber
587772|NCT00687960|Age|age
587773|NCT00687947|FHM|fhm
587774|NCT00687947|MA|ma
587775|NCT00687947|healthy controls|healthy controls
587776|NCT00687947|CGRP|cgrp
587777|NCT00687934|metastatic cancer|metastatic cancer
587778|NCT00687934|solid tumor|solid tumor
587779|NCT00687934|histologically or cytologically confirmed non-hematological|histologically or cytologically confirmed non-hematological
587780|NCT00687934|malignancy that is metastatic or unresectable for which no|malignancy that is metastatic or unresectable for which no
587781|NCT00687934|standard therapy exists|standard therapy exists
587782|NCT00687934|STA-9090|sta-9090
587783|NCT00687934|ganetespib|ganetespib
587784|NCT00687921|Knee trauma|knee trauma
587785|NCT00687921|MRI|mri
587786|NCT00687921|arthroscopy|arthroscopy
587787|NCT00687921|Patients over the age of 18 who had knee trauma intent to or had MRI assessment scheduled for arthroscopy|patients over the age of 18 who had knee trauma intent to or had mri assessment scheduled for arthroscopy
587788|NCT00687908|Acne|acne
587789|NCT00687895|malaria microscopy primary health care children|malaria microscopy primary health care children
587790|NCT00687882|Venous Thromboembolism|venous thromboembolism
587791|NCT00687882|Postthrombotic Syndrome|postthrombotic syndrome
587792|NCT00687882|Antithrombotic Therapy|antithrombotic therapy
587793|NCT00687882|Duration of Therapy|duration of therapy
587794|NCT00687882|Children|children
587795|NCT00687869|stroke|stroke
587796|NCT00687869|rehabilitation|rehabilitation
587797|NCT00687869|patient care management|patient care management
587798|NCT00687869|patient participation|patient participation
587799|NCT00687856|Left Ventricular Assist Device|left ventricular assist device
587800|NCT00687843|Gastric Cancer|gastric cancer
587801|NCT00687843|TS-1|ts-1
587802|NCT00687843|PSK|psk
587803|NCT00687843|Relapse-free survival|relapse-free survival
587804|NCT00687830|Afternoon colonoscopy|afternoon colonoscopy
587805|NCT00687830|Morning|morning
587806|NCT00687830|Evening|evening
587807|NCT00687830|Bowel Preparation|bowel preparation
587808|NCT00687830|Efficacy|efficacy
587809|NCT00687830|Satisfaction|satisfaction
587810|NCT00687817|NSCLC|nsclc
587811|NCT00687804|DME|dme
587812|NCT00687804|Diabetic|diabetic
587813|NCT00687804|macula|macula
587814|NCT00687804|edema|edema
587815|NCT00687804|ranibizumab|ranibizumab
587816|NCT00687804|RESTORE|restore
587817|NCT00687791|patients with cataract and glaucoma|patients with cataract and glaucoma
587818|NCT00687791|ologen|ologen
587819|NCT00687791|oculusgen|oculusgen
587820|NCT00687791|collagen matrix|collagen matrix
587821|NCT00687791|Phacotrabeculectomy|phacotrabeculectomy
587822|NCT00687791|Aeon Astron|aeon astron
587823|NCT00687791|trabeculectomy|trabeculectomy
587824|NCT00687791|tissue engineering|tissue engineering
587825|NCT00687791|mitomycin-C|mitomycin-c
587826|NCT00687778|C11-Acetate|c11-acetate
587827|NCT00687778|FDG|fdg
587828|NCT00687778|sarcoma|sarcoma
587829|NCT00687778|Measurement of C11-Acetate uptake in tumors which are often non-FDG avid.|measurement of c11-acetate uptake in tumors which are often non-fdg avid.
587830|NCT00687778|Soft tissue sarcomas|soft tissue sarcomas
587831|NCT00687778|well-differentiated thyroid cancer|well-differentiated thyroid cancer
587832|NCT00687778|well-differentiated and bronchoalveolar lung cancer|well-differentiated and bronchoalveolar lung cancer
587833|NCT00687778|indolent lymphomas, neuroendocrine tumors|indolent lymphomas, neuroendocrine tumors
587834|NCT00687778|GIST|gist
587835|NCT00687778|uterine malignancies|uterine malignancies
587836|NCT00687778|mucin-producing cancer|mucin-producing cancer
587837|NCT00687778|teratoma, hepatoma|teratoma, hepatoma
587838|NCT00687778|HCC|hcc
587839|NCT00687778|lobular breast carcinoma|lobular breast carcinoma
587840|NCT00687765|patients with newly diagnosed glioblastoma|patients with newly diagnosed glioblastoma
587841|NCT00687752|fetal deglutition|fetal deglutition
587842|NCT00687752|larynx|larynx
587843|NCT00687752|fetal CNS pathology|fetal cns pathology
587844|NCT00687752|sonography|sonography
587845|NCT00687752|hydramnios|hydramnios
587846|NCT00687739|hormone therapy|hormone therapy
587847|NCT00687739|obesity|obesity
587848|NCT00687739|postmenopause|postmenopause
587849|NCT00687739|disease /disorder proneness /risk|disease /disorder proneness /risk
587850|NCT00687739|insulin sensitivity /resistance|insulin sensitivity /resistance
587851|NCT00687739|metabolic syndrome|metabolic syndrome
587852|NCT00687739|women's health|women's health
587853|NCT00687726|osteoarthritis|osteoarthritis
587854|NCT00687726|knee|knee
587855|NCT00687726|exercise|exercise
587856|NCT00687726|balance|balance
587857|NCT00687700|propranolol|propranolol
587858|NCT00687700|B2-agonist,|b2-agonist,
587859|NCT00687700|B-antagonist,|b-antagonist,
587860|NCT00687687|Patients must have advanced (stage III or IV), persistent or recurrent uterine carcinosarcoma with documented disease progression.|patients must have advanced (stage iii or iv), persistent or recurrent uterine carcinosarcoma with documented disease progression.
587861|NCT00687674|refractory multiple myeloma|refractory multiple myeloma
587862|NCT00687661|Chronic Kidney Failure|chronic kidney failure
587863|NCT00687661|Vascular Calcification|vascular calcification
587864|NCT00687661|Bisphosphonates|bisphosphonates
587865|NCT00687648|stage IV breast cancer|stage iv breast cancer
587866|NCT00687648|recurrent breast cancer|recurrent breast cancer
587867|NCT00687648|HER2-negative breast cancer|her2-negative breast cancer
587868|NCT00687648|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
587869|NCT00687648|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
587870|NCT00687622|MEK inhibitor|mek inhibitor
587871|NCT00687622|solid tumors|solid tumors
587872|NCT00687622|First Time in Human|first time in human
587873|NCT00687622|GSK1120212|gsk1120212
587874|NCT00687622|Oncology|oncology
587875|NCT00687622|melanoma|melanoma
587876|NCT00687609|Attention Deficit Hyperactivity Disorder with Cannabis Abuse|attention deficit hyperactivity disorder with cannabis abuse
587877|NCT00687609|Marihuana Abuse|marihuana abuse
587878|NCT00687609|Comorbid Cannabis Abuse|comorbid cannabis abuse
587879|NCT00687583|pediatrics|pediatrics
587880|NCT00687583|anesthesia|anesthesia
587881|NCT00687583|head movements|head movements
587882|NCT00687583|endotracheal tube|endotracheal tube
587883|NCT00687570|patients with rectal cancer undergoing surgery|patients with rectal cancer undergoing surgery
587884|NCT00687570|Bowel purity degree|bowel purity degree
587885|NCT00687570|Bowel preparation|bowel preparation
587886|NCT00687570|Rectal cancer|rectal cancer
587887|NCT00687570|Nutritional status|nutritional status
587888|NCT00687570|complications with traditional bowel preparation|complications with traditional bowel preparation
587889|NCT00687570|Complications|complications
587890|NCT00687570|Physiological status|physiological status
587891|NCT00687544|HIV|hiv
587892|NCT00687492|hypercholesterolemia|hypercholesterolemia
587893|NCT00687492|NCEP ATP III guidelines|ncep atp iii guidelines
587894|NCT00687492|survey|survey
587895|NCT00687479|insulin sensitivity|insulin sensitivity
587896|NCT00687479|insulin secretion|insulin secretion
587897|NCT00687479|infant outcome|infant outcome
587898|NCT00687466|Cystic Fibrosis|cystic fibrosis
587899|NCT00687466|Glucose Intolerance|glucose intolerance
587900|NCT00687453|Glargine|glargine
587901|NCT00687453|Type 2 diabetes|type 2 diabetes
587902|NCT00687453|Basal insulin|basal insulin
587903|NCT00687414|gene expression|gene expression
587904|NCT00687414|gene sequencing|gene sequencing
587905|NCT00687414|gene encoding|gene encoding
587906|NCT00687414|MPD|mpd
587907|NCT00687414|MDS|mds
587908|NCT00687414|AML|aml
587909|NCT00687414|mDia|mdia
587910|NCT00687388|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors
587911|NCT00687388|Alpha Blockers|alpha blockers
587912|NCT00687388|Treatment Outcome|treatment outcome
587913|NCT00687375|Inguinal|inguinal
587914|NCT00687375|Groin hernia|groin hernia
587915|NCT00687375|TAPP|tapp
587916|NCT00687375|TEP|tep
587917|NCT00687375|Comparing|comparing
587918|NCT00687375|Two|two
587919|NCT00687375|Techniques|techniques
587920|NCT00687349|End-of-Life issues|end-of-life issues
587921|NCT00687349|Talking with your doctor|talking with your doctor
587922|NCT00687349|Coping with chronic illness|coping with chronic illness
587923|NCT00687336|Helicobacter pylori|helicobacter pylori
587924|NCT00687336|Treatment|treatment
587925|NCT00687336|Upper gastrointestinal bleeding|upper gastrointestinal bleeding
587926|NCT00687310|Asthma education|asthma education
587927|NCT00687310|satisfaction adherence|satisfaction adherence
587928|NCT00687310|Quality of Life|quality of life
587929|NCT00687310|PIKO meter cluster|piko meter cluster
587930|NCT00687310|Symbicort® Turbuhaler®|symbicort® turbuhaler®
587931|NCT00687297|Stage IIIB Non Small Cell Lung Cancer|stage iiib non small cell lung cancer
587932|NCT00687297|Stage IV Non Small Cell Lung Cancer|stage iv non small cell lung cancer
587933|NCT00687297|Vandetanib|vandetanib
587934|NCT00687297|Docetaxel plus carboplatin|docetaxel plus carboplatin
587935|NCT00687258|Anemia|anemia
587936|NCT00687258|Oxidative Stress|oxidative stress
587937|NCT00687258|Erythropoietin|erythropoietin
587938|NCT00687258|dialyser membrane|dialyser membrane
587939|NCT00687258|Vitamin E|vitamin e
587940|NCT00687258|Erythropoietin responsiveness|erythropoietin responsiveness
587941|NCT00687258|Erythropoietin resistance|erythropoietin resistance
587942|NCT00687258|hemodialysis|hemodialysis
587943|NCT00687245|children|children
587944|NCT00687245|reflux|reflux
587945|NCT00687245|GERD|gerd
587946|NCT00687245|pediatric|pediatric
587947|NCT00687232|Phase I|phase i
587948|NCT00687232|Japan|japan
587949|NCT00687232|Japanese|japanese
587950|NCT00687232|inhalation|inhalation
587951|NCT00687219|hepatitis C|hepatitis c
587952|NCT00687193|Phase 2 monotherapy in Japan|phase 2 monotherapy in japan
587953|NCT00687180|Prednisolone dosage|prednisolone dosage
587954|NCT00687167|Therapeutic Equivalency|therapeutic equivalency
587955|NCT00687154|DME|dme
587956|NCT00687154|Laser|laser
587957|NCT00687154|macular edema|macular edema
587958|NCT00687154|retinopathy|retinopathy
587959|NCT00687154|scatter photocoagulation|scatter photocoagulation
587960|NCT00687141|Safety|safety
587961|NCT00687141|tolerability|tolerability
587962|NCT00687141|AZD0328|azd0328
587963|NCT00687128|Insulin resistance|insulin resistance
587964|NCT00687128|Metabolic syndrome|metabolic syndrome
587965|NCT00687128|Aerobic exercise|aerobic exercise
587966|NCT00687128|Exercise behavior|exercise behavior
587967|NCT00687115|24 Hour Energy Expenditure|24 hour energy expenditure
587968|NCT00687115|Respiratory Chamber|respiratory chamber
587969|NCT00687115|Obesity|obesity
587970|NCT00687115|Weight Loss|weight loss
587971|NCT00687115|Overfeeding|overfeeding
587972|NCT00687102|breast cancer|breast cancer
587973|NCT00687102|Tamoxifen|tamoxifen
587974|NCT00687102|Raloxifene|raloxifene
587975|NCT00687102|hormone therapy|hormone therapy
587976|NCT00687089|Opiates|opiates
587977|NCT00687089|Subutex|subutex
587978|NCT00687089|Buprenorphine|buprenorphine
587979|NCT00687089|Patients who addicted to opiates|patients who addicted to opiates
587980|NCT00687076|Endovascular Intervention|endovascular intervention
587981|NCT00687076|MRI|mri
587982|NCT00687076|Ultrasound|ultrasound
587983|NCT00687076|Cholesterol Medications|cholesterol medications
587984|NCT00687076|High Cholesterol|high cholesterol
587985|NCT00687076|Peripheral Arterial disease|peripheral arterial disease
587986|NCT00687076|Claudication|claudication
587987|NCT00687076|Leg Pain|leg pain
587988|NCT00687076|Niaspan|niaspan
587989|NCT00687076|Extended Release Niacin|extended release niacin
587990|NCT00687076|Zetia|zetia
587991|NCT00687076|Ezetimibe|ezetimibe
587992|NCT00687076|Simvastatin|simvastatin
587993|NCT00687076|Zocor|zocor
587994|NCT00687076|Atorvastatin|atorvastatin
587995|NCT00687076|Lipitor|lipitor
587996|NCT00687050|end-stage renal disease|end-stage renal disease
587997|NCT00687050|chronic kidney disease|chronic kidney disease
587998|NCT00687037|oral hygiene|oral hygiene
587999|NCT00687024|Epilepsy|epilepsy
588000|NCT00687024|Magnetic Resonance Imaging|magnetic resonance imaging
588001|NCT00687024|Magnetoencephalography|magnetoencephalography
588002|NCT00687011|Antiemetic|antiemetic
588003|NCT00686998|Schizophrenia|schizophrenia
588004|NCT00686985|Docetaxel|docetaxel
588005|NCT00686985|Carboplatin|carboplatin
588006|NCT00686985|chemotherapy|chemotherapy
588007|NCT00686985|relapse SCLC|relapse sclc
588008|NCT00686972|Bariatric Surgery|bariatric surgery
588009|NCT00686972|Glucose Regulation|glucose regulation
588010|NCT00686972|Cardiac Function|cardiac function
588011|NCT00686972|Body Composition|body composition
588012|NCT00686946|Severe mental illness|severe mental illness
588013|NCT00686946|Antipsychotic medications|antipsychotic medications
588014|NCT00686946|Pregnancy|pregnancy
588015|NCT00686946|Evidence-based guidelines|evidence-based guidelines
588016|NCT00686946|Maternal and infant health and wellbeing|maternal and infant health and wellbeing
588017|NCT00686933|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
588018|NCT00686907|melatonin, circadian rhythms, sleep|melatonin, circadian rhythms, sleep
588019|NCT00686881|hepatitis C|hepatitis c
588020|NCT00686868|GSK1841157;|gsk1841157;
588021|NCT00686868|rheumatoid arthritis,|rheumatoid arthritis,
588022|NCT00686868|B-cell depletion|b-cell depletion
588023|NCT00686868|anti-CD20 monoclonal antibody,|anti-cd20 monoclonal antibody,
588024|NCT00686855|tacrolimus|tacrolimus
588025|NCT00686855|dexamethasone|dexamethasone
588026|NCT00686855|oral rinse|oral rinse
588027|NCT00686842|HIV infection|hiv infection
588028|NCT00686842|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
588029|NCT00686842|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
588030|NCT00686842|Treatment Experienced|treatment experienced
588031|NCT00686829|HIV|hiv
588032|NCT00686829|Treatment Experienced|treatment experienced
588033|NCT00686816|pre-diabetic|pre-diabetic
588034|NCT00686816|obese|obese
588035|NCT00686803|hypertension|hypertension
588036|NCT00686803|controlled hypertension|controlled hypertension
588037|NCT00686803|hypertensives|hypertensives
588038|NCT00686790|Hepatitis D|hepatitis d
588039|NCT00686790|Hepatitis B|hepatitis b
588040|NCT00686777|hepatitis C|hepatitis c
588041|NCT00686764|trans-femoral amputation|trans-femoral amputation
588042|NCT00686738|osteosarcoma|osteosarcoma
588043|NCT00686738|transforming growth factor-beta 1|transforming growth factor-beta 1
588044|NCT00686738|nuclear factor-kappa B|nuclear factor-kappa b
588045|NCT00686738|positron emission tomography/computed tomography|positron emission tomography/computed tomography
588046|NCT00686738|magnetic resonance spectroscopy|magnetic resonance spectroscopy
588047|NCT00686738|predicting response to neoadjuvant chemotherapy|predicting response to neoadjuvant chemotherapy
588048|NCT00686712|Glargine|glargine
588049|NCT00686712|Type 2 diabetes|type 2 diabetes
588050|NCT00686712|Basal insulin|basal insulin
588051|NCT00686699|Anti-Dyskinesia Agents|anti-dyskinesia agents
588052|NCT00686699|Antipsychotic Agents|antipsychotic agents
588053|NCT00686673|DECISION AIDS|decision aids
588054|NCT00686660|copd|copd
588055|NCT00686660|rehabilitation|rehabilitation
588056|NCT00686660|quality of life|quality of life
588057|NCT00686660|inflammation|inflammation
588058|NCT00686647|Coronary Angioplasty|coronary angioplasty
588059|NCT00686647|Coronary Stents|coronary stents
588060|NCT00686647|Scoring Balloons|scoring balloons
588061|NCT00686647|Coronary Artery Bifurcation Lesions|coronary artery bifurcation lesions
588062|NCT00686634|sitagliptin|sitagliptin
588063|NCT00686634|type 2 diabetes|type 2 diabetes
588064|NCT00686634|combination therapy|combination therapy
588065|NCT00686608|Obesity|obesity
588066|NCT00686556|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
588067|NCT00686556|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
588068|NCT00686556|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
588069|NCT00686556|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
588070|NCT00686556|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
588071|NCT00686556|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
588072|NCT00686556|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
588073|NCT00686556|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
588074|NCT00686556|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
588075|NCT00686556|ALL|all
588076|NCT00686556|MDS|mds
588077|NCT00686543|Antifungal Agents|antifungal agents
588078|NCT00686543|Anti-Infective Agents|anti-infective agents
588079|NCT00686530|Fetal Death|fetal death
588080|NCT00686530|Magnetic Resonance Imaging|magnetic resonance imaging
588081|NCT00686530|Autopsy|autopsy
588082|NCT00686530|Telencephalon|telencephalon
588083|NCT00686530|Pyramidal Tracts|pyramidal tracts
588084|NCT00686504|Pain|pain
588085|NCT00686504|PET|pet
588086|NCT00686504|Phase 1|phase 1
588087|NCT00686504|Analgesia|analgesia
588088|NCT00686504|Positron Emission Tomography|positron emission tomography
588089|NCT00686504|mGlu5 receptor|mglu5 receptor
588090|NCT00686504|Dose finding|dose finding
588091|NCT00686504|Analgesia/Pain|analgesia/pain
588092|NCT00686491|Asthma|asthma
588093|NCT00686491|Environment|environment
588094|NCT00686491|Type of sport|type of sport
588095|NCT00686491|Cardiovascular disease|cardiovascular disease
588096|NCT00686491|Athletes|athletes
588097|NCT00686478|burn|burn
588098|NCT00686478|hypertrophic scar|hypertrophic scar
588099|NCT00686478|fibroproliferative disorder|fibroproliferative disorder
588100|NCT00686465|recurrent cancer|recurrent cancer
588101|NCT00686465|PET/CT|pet/ct
588102|NCT00686465|FDG|fdg
588103|NCT00686465|planned management|planned management
588104|NCT00686465|actual treatment|actual treatment
588105|NCT00686452|Asthma|asthma
588106|NCT00686452|Airway hyperresponsiveness|airway hyperresponsiveness
588107|NCT00686452|Swimmers|swimmers
588108|NCT00686452|Airway inflammation|airway inflammation
588109|NCT00686452|Airway remodelling|airway remodelling
588110|NCT00686439|osteoarthritis|osteoarthritis
588111|NCT00686439|adalimumab|adalimumab
588112|NCT00686439|mri|mri
588113|NCT00686426|Obesity|obesity
588114|NCT00686426|Weight gain|weight gain
588115|NCT00686426|regain|regain
588116|NCT00686426|dairy|dairy
588117|NCT00686426|calcium|calcium
588118|NCT00686413|PET|pet
588119|NCT00686413|AZD3480|azd3480
588120|NCT00686413|PET examination|pet examination
588121|NCT00686400|schizophrenia|schizophrenia
588122|NCT00686400|first-episode|first-episode
588123|NCT00686400|infection|infection
588124|NCT00686400|Toxoplasma gondii|toxoplasma gondii
588125|NCT00686400|levels of IgG antibodies to TG|levels of igg antibodies to tg
588126|NCT00686387|Tissue Bank|tissue bank
588127|NCT00686387|Glioblastoma Multiforme|glioblastoma multiforme
588128|NCT00686387|NAT2|nat2
588129|NCT00686387|EGFR|egfr
588130|NCT00686387|MGMT|mgmt
588131|NCT00686387|Brain and Spinal TumorGliomas|brain and spinal tumorgliomas
588132|NCT00686374|Crohn's Disease|crohn's disease
588133|NCT00686374|adalimumab|adalimumab
588134|NCT00686361|Cystic Fibrosis|cystic fibrosis
588135|NCT00686361|choline nutrition|choline nutrition
588136|NCT00686361|choline and methyl metabolism|choline and methyl metabolism
588137|NCT00686361|CF and oxidative stress|cf and oxidative stress
588138|NCT00686348|acromegaly|acromegaly
588139|NCT00686335|asthma|asthma
588140|NCT00686335|nocturnal asthma|nocturnal asthma
588141|NCT00686335|glucocorticoid dependent persistent asthma|glucocorticoid dependent persistent asthma
588142|NCT00686335|signs and symptoms|signs and symptoms
588143|NCT00686335|lung function|lung function
588144|NCT00686335|prednisone|prednisone
588145|NCT00686322|chemotherapy|chemotherapy
588146|NCT00686322|radiotherapy|radiotherapy
588147|NCT00686322|lung cancer|lung cancer
588148|NCT00686309|exhaled NO|exhaled no
588149|NCT00686309|off line|off line
588150|NCT00686309|on line|on line
588151|NCT00686309|comparison|comparison
588152|NCT00686309|Bland altman method|bland altman method
588153|NCT00686296|soft tissue abscess requiring incision and drainage|soft tissue abscess requiring incision and drainage
588154|NCT00686283|Adolescents|adolescents
588155|NCT00686283|Diabetes|diabetes
588156|NCT00686283|Exercise|exercise
588157|NCT00686270|HIV-1 infection|hiv-1 infection
588158|NCT00686270|NRTI resistance|nrti resistance
588159|NCT00686270|M184V mutation|m184v mutation
588160|NCT00686270|reverse transcriptase|reverse transcriptase
588161|NCT00686270|apricitabine|apricitabine
588162|NCT00686270|drug resistance|drug resistance
588163|NCT00686270|safety and tolerability|safety and tolerability
588164|NCT00686270|therapy failure|therapy failure
588165|NCT00686270|Treatment Experienced|treatment experienced
588166|NCT00686257|acute respiratory insufficiency|acute respiratory insufficiency
588167|NCT00686257|noninvasive ventilation|noninvasive ventilation
588168|NCT00686257|oronasal face mask|oronasal face mask
588169|NCT00686257|total face mask|total face mask
588170|NCT00686244|metabolic syndrome|metabolic syndrome
588171|NCT00686244|physical activity|physical activity
588172|NCT00686244|overweight|overweight
588173|NCT00686244|malnutrition|malnutrition
588174|NCT00686244|prevention|prevention
588659|NCT00684229|Anesthesia; regional|anesthesia; regional
588175|NCT00686231|To determine if topical nitroglycerin acts to vasodilate the radial artery by a direct local action, or by systemic vasodilation|to determine if topical nitroglycerin acts to vasodilate the radial artery by a direct local action, or by systemic vasodilation
588176|NCT00686231|To determine if topical nitroglycerin dilates the radial artery in the presence of local anesthetic agents used in cardiac catheterization|to determine if topical nitroglycerin dilates the radial artery in the presence of local anesthetic agents used in cardiac catheterization
588177|NCT00686218|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
588178|NCT00686205|healthy donors|healthy donors
588179|NCT00686205|HIV positives|hiv positives
588180|NCT00686192|Obesity|obesity
588181|NCT00686192|Calcium carbonate|calcium carbonate
588182|NCT00686192|Dietary Supplements|dietary supplements
588183|NCT00686192|Lipolysis|lipolysis
588184|NCT00686179|TQT|tqt
588185|NCT00686179|ECG|ecg
588186|NCT00686179|QT|qt
588187|NCT00686179|QTc|qtc
588188|NCT00686179|AZD3480|azd3480
588189|NCT00686179|ECG(QTc effects)|ecg(qtc effects)
588190|NCT00686166|adenocarcinoma of the rectum|adenocarcinoma of the rectum
588191|NCT00686166|stage IIA rectal cancer|stage iia rectal cancer
588192|NCT00686166|stage IIB rectal cancer|stage iib rectal cancer
588193|NCT00686166|stage IIC rectal cancer|stage iic rectal cancer
588194|NCT00686166|stage IIIA rectal cancer|stage iiia rectal cancer
588195|NCT00686166|stage IIIB rectal cancer|stage iiib rectal cancer
588196|NCT00686166|stage IIIC rectal cancer|stage iiic rectal cancer
588197|NCT00686140|Schizophrenia|schizophrenia
588198|NCT00686140|clinical trial|clinical trial
588199|NCT00686140|risperidone|risperidone
588200|NCT00686140|immune|immune
588201|NCT00686140|celecoxib|celecoxib
588202|NCT00686127|breast cancer|breast cancer
588203|NCT00686127|neuropathic pain|neuropathic pain
588204|NCT00686127|topical lidocaine|topical lidocaine
588205|NCT00686127|postmastectomy pain|postmastectomy pain
588206|NCT00686127|breast symptoms|breast symptoms
588207|NCT00686127|breast pain|breast pain
588208|NCT00686114|Esophageal cancer|esophageal cancer
588209|NCT00686114|chemoradiation|chemoradiation
588210|NCT00686114|radiosensitivity|radiosensitivity
588211|NCT00686114|EGFR inhibition|egfr inhibition
588212|NCT00686101|Perception of risk|perception of risk
588213|NCT00686101|Smoking risks|smoking risks
588214|NCT00686101|Smoking consequences|smoking consequences
588215|NCT00686101|Quitting smoking|quitting smoking
588216|NCT00686101|Motivation to quit smoking|motivation to quit smoking
588217|NCT00686101|Schizophrenia|schizophrenia
588218|NCT00686088|prostate cancer|prostate cancer
588219|NCT00686088|locally recurrent|locally recurrent
588220|NCT00686088|PRX302|prx302
588221|NCT00686075|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
588222|NCT00686075|Parainfluenza Virus Type 3 (PIV3)|parainfluenza virus type 3 (piv3)
588223|NCT00686075|MEDI-534|medi-534
588224|NCT00686062|Prenatal testing|prenatal testing
588225|NCT00686062|Amniocentesis|amniocentesis
588226|NCT00686062|Decision making|decision making
588227|NCT00686062|Down syndrome|down syndrome
588228|NCT00686049|HIV Treatment Readiness Measure (HTRM)|hiv treatment readiness measure (htrm)
588229|NCT00686049|Highly Active Antiretroviral Treatment (HAART)|highly active antiretroviral treatment (haart)
588230|NCT00686049|Adherence|adherence
588231|NCT00686049|Treatment readiness|treatment readiness
588232|NCT00686049|HIV|hiv
588233|NCT00686036|prostate cancer|prostate cancer
588234|NCT00686036|hormone treatment|hormone treatment
588235|NCT00686023|pertrochanteric femur fracture|pertrochanteric femur fracture
588236|NCT00686023|DHS|dhs
588237|NCT00686023|IMN|imn
588238|NCT00686010|CETP Inhibitor|cetp inhibitor
588239|NCT00686010|HDL-C|hdl-c
588240|NCT00686010|LDL-C|ldl-c
588241|NCT00686010|Apolipoprotein|apolipoprotein
588242|NCT00685997|Malignant lymphoma|malignant lymphoma
588243|NCT00685997|Hodgkin's disease|hodgkin's disease
588244|NCT00685997|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
588245|NCT00685997|Imaging|imaging
588246|NCT00685997|Whole-Body MRI|whole-body mri
588247|NCT00685997|CT|ct
588248|NCT00685997|Radiation|radiation
588249|NCT00685984|Type 2 diabetes|type 2 diabetes
588250|NCT00685984|silent myocardial ischemia|silent myocardial ischemia
588251|NCT00685984|endothelial function|endothelial function
588252|NCT00685971|Cystic Fibrosis|cystic fibrosis
588253|NCT00685971|Vitamin D deficiency|vitamin d deficiency
588254|NCT00685958|Blood thinner|blood thinner
588255|NCT00685958|enoxaparin|enoxaparin
588256|NCT00685958|hip fracture surgery|hip fracture surgery
588257|NCT00685958|bleeding|bleeding
588258|NCT00685958|thromboembolism|thromboembolism
588259|NCT00685945|Bradykinin|bradykinin
588260|NCT00685945|Obesity|obesity
588261|NCT00685945|Nitric Oxide Donor|nitric oxide donor
588262|NCT00685945|tissue type plasminogen activator|tissue type plasminogen activator
588263|NCT00685945|isosorbide dinitrate|isosorbide dinitrate
588264|NCT00685945|phosphodiesterase inhibitor|phosphodiesterase inhibitor
588265|NCT00685945|Renin-Angiotensin Aldosterone System|renin-angiotensin aldosterone system
588266|NCT00685945|Fibrinolysis|fibrinolysis
588267|NCT00685945|Angiotensin converting enzyme|angiotensin converting enzyme
588268|NCT00685932|Postpartum pain|postpartum pain
588269|NCT00685932|Post-cesarean pain|post-cesarean pain
588270|NCT00685932|Surgical retractor|surgical retractor
588271|NCT00685932|Elastic retractor|elastic retractor
588272|NCT00685919|Dopamine|dopamine
588273|NCT00685919|Natriuresis|natriuresis
588274|NCT00685919|Catecholamines|catecholamines
588275|NCT00685906|oral contraceptive|oral contraceptive
588276|NCT00685906|birth control|birth control
588277|NCT00685906|Healthy volunteers|healthy volunteers
588278|NCT00685893|End-of-life issues|end-of-life issues
588279|NCT00685893|Talking with your doctor|talking with your doctor
588280|NCT00685893|Coping with chronic illness|coping with chronic illness
588281|NCT00685880|thumb carpo metacarpal joint osteoarthritis|thumb carpo metacarpal joint osteoarthritis
588282|NCT00685880|prolotherapy|prolotherapy
588283|NCT00685880|intra articular steroid|intra articular steroid
588284|NCT00685880|hand therapy|hand therapy
588285|NCT00685867|Staphylococcus aureus|staphylococcus aureus
588286|NCT00685867|Resistance|resistance
588287|NCT00685867|Prevention|prevention
588288|NCT00685854|Macular Telangiectasia|macular telangiectasia
588289|NCT00685854|Vascular Endothelial Growth Factor|vascular endothelial growth factor
588290|NCT00685854|Ranibizumab|ranibizumab
588291|NCT00685841|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
588292|NCT00685828|gastrointestinal stromal tumor|gastrointestinal stromal tumor
588293|NCT00685815|IV Iron|iv iron
588294|NCT00685815|Restless Legs Syndrome|restless legs syndrome
588295|NCT00685815|RLS|rls
588296|NCT00685815|Iron|iron
588297|NCT00685789|Bell's palsy，deqi，acupuncture, neuropsychology|bell's palsy，deqi，acupuncture, neuropsychology
588298|NCT00685776|CHD/CHD risk-equivalent disease|chd/chd risk-equivalent disease
588299|NCT00685776|Coronary Heart Disease (CHD)|coronary heart disease (chd)
588300|NCT00685763|Pancreatic cancer|pancreatic cancer
588301|NCT00685763|Unresectable|unresectable
588302|NCT00685763|Proton radiation|proton radiation
588303|NCT00685763|Chemotherapy|chemotherapy
588304|NCT00685750|tumor antigen|tumor antigen
588305|NCT00685750|biomarkers|biomarkers
588306|NCT00685737|Hyperlipidemia|hyperlipidemia
588307|NCT00685724|pathological gambling|pathological gambling
588308|NCT00685724|cognitive-behavioral therapy|cognitive-behavioral therapy
588309|NCT00685724|motivational enhancement therapy|motivational enhancement therapy
588310|NCT00685711|Cat allergy|cat allergy
588311|NCT00685711|Immunotherapy|immunotherapy
588312|NCT00685711|Cat-PAD|cat-pad
588313|NCT00685698|Diabetic Foot Infections, DFI, Nemonoxacin|diabetic foot infections, dfi, nemonoxacin
588314|NCT00685685|Therapeutic Equivalency|therapeutic equivalency
588315|NCT00685672|labor analgesia|labor analgesia
588316|NCT00685672|fentanyl|fentanyl
588317|NCT00685672|epinephrine|epinephrine
588318|NCT00685659|cocaine dependence|cocaine dependence
588319|NCT00685659|treatment|treatment
588320|NCT00685659|continuing care|continuing care
588321|NCT00685659|outcomes|outcomes
588322|NCT00685659|incentives|incentives
588323|NCT00685659|adaptive|adaptive
588324|NCT00685646|bone metastases|bone metastases
588325|NCT00685646|stage IV prostate cancer|stage iv prostate cancer
588326|NCT00685633|stage I prostate cancer|stage i prostate cancer
588327|NCT00685633|stage II prostate cancer|stage ii prostate cancer
588328|NCT00685633|stage III prostate cancer|stage iii prostate cancer
588329|NCT00685633|recurrent prostate cancer|recurrent prostate cancer
588330|NCT00685607|Pilot Study|pilot study
588331|NCT00685607|Outcome Measures|outcome measures
588332|NCT00685594|diabetes|diabetes
588333|NCT00685594|vitamin D|vitamin d
588334|NCT00685594|cholecalciferol|cholecalciferol
588335|NCT00685594|glucose tolerance|glucose tolerance
588336|NCT00685581|TFA|tfa
588337|NCT00685581|SFA|sfa
588338|NCT00685581|Clinical trial|clinical trial
588339|NCT00685581|fat milk|fat milk
588340|NCT00685568|colon cancer|colon cancer
588341|NCT00685568|rectal cancer|rectal cancer
588342|NCT00685568|familial adenomatous polyposis|familial adenomatous polyposis
588343|NCT00685555|Screen time|screen time
588344|NCT00685555|Fruits and Vegetable Consumption|fruits and vegetable consumption
588345|NCT00685555|Physical Activity|physical activity
588346|NCT00685555|Obesity|obesity
588347|NCT00685555|Overweight|overweight
588348|NCT00685542|diacerein|diacerein
588349|NCT00685542|osteoarthritis|osteoarthritis
588350|NCT00685542|hand|hand
588351|NCT00685529|COPD|copd
588352|NCT00685529|Arformoterol|arformoterol
588353|NCT00685529|formoterol|formoterol
588354|NCT00685516|adenocarcinoma of the prostate|adenocarcinoma of the prostate
588355|NCT00685516|recurrent prostate cancer|recurrent prostate cancer
588356|NCT00685516|stage I prostate cancer|stage i prostate cancer
588357|NCT00685516|stage II prostate cancer|stage ii prostate cancer
588358|NCT00685516|stage III prostate cancer|stage iii prostate cancer
588359|NCT00685516|stage IV prostate cancer|stage iv prostate cancer
588360|NCT00685503|Macular Telangiectasia|macular telangiectasia
588361|NCT00685503|Vascular Endothelial Growth Factor|vascular endothelial growth factor
588362|NCT00685503|Ranibizumab|ranibizumab
588363|NCT00685503|Neovascularization|neovascularization
588364|NCT00685490|branch retinal vein occlusion|branch retinal vein occlusion
588365|NCT00685490|internal limiting membrane|internal limiting membrane
588366|NCT00685490|macular edema|macular edema
588367|NCT00685490|vitrectomy|vitrectomy
588368|NCT00685477|CCK infusion|cck infusion
588369|NCT00685477|Gallbladder ejection fraction|gallbladder ejection fraction
588370|NCT00685477|Normal volunteers|normal volunteers
588371|NCT00685464|Abciximab|abciximab
588372|NCT00685464|Reo-Pro|reo-pro
588373|NCT00685464|Intracoronary|intracoronary
588374|NCT00685464|PCI|pci
588375|NCT00685451|cognitive behavior therapy|cognitive behavior therapy
588376|NCT00685451|addiction|addiction
588377|NCT00685451|PTSD|ptsd
588378|NCT00685438|Environmental Medicine|environmental medicine
588379|NCT00685438|Altitude|altitude
588380|NCT00685438|Ultraviolet Rays|ultraviolet rays
588381|NCT00685438|Antioxidants|antioxidants
588382|NCT00685438|Oxidative Stress|oxidative stress
588383|NCT00685438|Erythema|erythema
588384|NCT00685425|Asthma|asthma
588385|NCT00685425|Exercised induced bronchoconstriction|exercised induced bronchoconstriction
588386|NCT00685412|CIN 2 or 3|cin 2 or 3
588387|NCT00685412|cervical cancer|cervical cancer
588388|NCT00685399|Uveitis|uveitis
588389|NCT00685399|eye|eye
588390|NCT00685399|IL-17|il-17
588391|NCT00685399|IL-17A|il-17a
588392|NCT00685399|IL17|il17
588393|NCT00685399|AIN457|ain457
588394|NCT00685399|Vogt-Koyanagi-Harada|vogt-koyanagi-harada
588395|NCT00685399|Behcet's|behcet's
588396|NCT00685399|Behcet|behcet
588397|NCT00685399|Sympathetic ophthalmia|sympathetic ophthalmia
588398|NCT00685399|Multifocal choroiditis|multifocal choroiditis
588399|NCT00685399|Birdshot|birdshot
588400|NCT00685399|HLA-B27|hla-b27
588401|NCT00685399|Birdshot retinochoroiditis|birdshot retinochoroiditis
588402|NCT00685399|Retinal vasculitis|retinal vasculitis
588403|NCT00685399|Sarcoidosis|sarcoidosis
588404|NCT00685399|Intermediate uveitis|intermediate uveitis
588405|NCT00685399|Panuveitis|panuveitis
588406|NCT00685399|Posterior uveitis|posterior uveitis
588407|NCT00685386|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
588408|NCT00685386|carbon dioxide|carbon dioxide
588409|NCT00685386|randomized controlled clinical trial|randomized controlled clinical trial
588410|NCT00685373|Cryopyrin-associated periodic syndromes (CAPS):|cryopyrin-associated periodic syndromes (caps):
588411|NCT00685373|Familial Cold Autoinflammatory Syndrome (FCAS),|familial cold autoinflammatory syndrome (fcas),
588412|NCT00685373|Muckle-Wells Syndrome (MWS),|muckle-wells syndrome (mws),
588413|NCT00685373|MWS with overlapping symptoms of Neonatal Onset Multisystem Inflammatory Disease (NOMID) or Neonatal Onset Multisystem Inflammatory Disease (NOMID),|mws with overlapping symptoms of neonatal onset multisystem inflammatory disease (nomid) or neonatal onset multisystem inflammatory disease (nomid),
588414|NCT00685373|children,|children,
588415|NCT00685373|systemic autoinflammatory disease,|systemic autoinflammatory disease,
588416|NCT00685373|CIAS-1 gene,|cias-1 gene,
588417|NCT00685373|NALP-3,|nalp-3,
588418|NCT00685373|ACZ885,|acz885,
588660|NCT00684229|Cancer recurrence|cancer recurrence
588419|NCT00685373|human monoclonal anti-human interleukin-1beta (IL-1beta),|human monoclonal anti-human interleukin-1beta (il-1beta),
588420|NCT00685373|antibody,|antibody,
588421|NCT00685373|autosomal dominant,|autosomal dominant,
588422|NCT00685373|familial autoinflammatory syndrome|familial autoinflammatory syndrome
588423|NCT00685360|Tuberculosis|tuberculosis
588424|NCT00685360|Pulmonary|pulmonary
588425|NCT00685360|Multidrug resistant|multidrug resistant
588426|NCT00685360|Antitubercular Agents|antitubercular agents
588427|NCT00685360|OPC 67683|opc 67683
588428|NCT00685347|Asthma|asthma
588429|NCT00685347|Exercised induced bronchoconstriction|exercised induced bronchoconstriction
588430|NCT00685334|Atypical Antipsychotics|atypical antipsychotics
588431|NCT00685334|Anorexia Nervosa|anorexia nervosa
588432|NCT00685321|schizophrenia|schizophrenia
588433|NCT00685321|TMS|tms
588434|NCT00685321|brain stimulation|brain stimulation
588435|NCT00685321|negative symptoms|negative symptoms
588436|NCT00685321|clinical improvement|clinical improvement
588437|NCT00685321|cognitive improvement|cognitive improvement
588438|NCT00685308|Atherosclerosis|atherosclerosis
588439|NCT00685308|Intracranial artery|intracranial artery
588440|NCT00685308|Angioplasty|angioplasty
588441|NCT00685308|Stent|stent
588442|NCT00685295|Emergency Department|emergency department
588443|NCT00685295|acute|acute
588444|NCT00685269|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
588445|NCT00685269|OSAS|osas
588446|NCT00685256|breast cancer|breast cancer
588447|NCT00685256|hereditary breast/ovarian cancer (BRCA1, BRCA2)|hereditary breast/ovarian cancer (brca1, brca2)
588448|NCT00685243|Fraxel|fraxel
588449|NCT00685243|Pulsed dye laser|pulsed dye laser
588450|NCT00685243|Surgical scars|surgical scars
588451|NCT00685230|scorpion sting|scorpion sting
588452|NCT00685230|envenomation|envenomation
588453|NCT00685230|alacramyn|alacramyn
588454|NCT00685191|Raltegravir|raltegravir
588455|NCT00685191|HIV|hiv
588456|NCT00685191|dynamics|dynamics
588457|NCT00685191|viral load|viral load
588458|NCT00685191|Treatment Experienced|treatment experienced
588459|NCT00685178|addiction|addiction
588460|NCT00685178|drug dependence|drug dependence
588461|NCT00685178|stimulant|stimulant
588462|NCT00685139|Therapeutic Equivalency|therapeutic equivalency
588463|NCT00685126|RAD|rad
588464|NCT00685126|Reactive Airways Disease|reactive airways disease
588465|NCT00685126|Levalbuterol|levalbuterol
588466|NCT00685126|Racemic albuterol|racemic albuterol
588467|NCT00685100|IVTA; CNV; age-related macular degeneration; PDT|ivta; cnv; age-related macular degeneration; pdt
588468|NCT00685087|To define the natural history and the clinical, laboratory and histomorphometric features of chronic pancreatitis (CP).|to define the natural history and the clinical, laboratory and histomorphometric features of chronic pancreatitis (cp).
588469|NCT00685087|To identify clinical and laboratory parameters that correlate with the pathophysiologic state in patients with CP.|to identify clinical and laboratory parameters that correlate with the pathophysiologic state in patients with cp.
588470|NCT00685087|To quantify the behavioral abnormalities associated with CP.|to quantify the behavioral abnormalities associated with cp.
588471|NCT00685087|To determine psychological and behavioral correlates of CP disease progression and outcomes.|to determine psychological and behavioral correlates of cp disease progression and outcomes.
588472|NCT00685074|Motivational Interview|motivational interview
588473|NCT00685074|Computer based intervention|computer based intervention
588474|NCT00685074|Substance abuse|substance abuse
588475|NCT00685074|post-partum|post-partum
588476|NCT00685061|Adult, primary deceased donor kidney transplant recipients|adult, primary deceased donor kidney transplant recipients
588477|NCT00685048|Gambling|gambling
588478|NCT00685048|Brief Therapies|brief therapies
588479|NCT00685048|Substance Abuse|substance abuse
588480|NCT00685035|high frequency chest wall oscillation, cystic fibrosis|high frequency chest wall oscillation, cystic fibrosis
588481|NCT00685022|Asthma|asthma
588482|NCT00685022|Racemic albuterol|racemic albuterol
588483|NCT00685009|Cognition|cognition
588484|NCT00685009|Memory|memory
588778|NCT00683761|astrocytoma|astrocytoma
588485|NCT00685009|Hormone Therapy|hormone therapy
588486|NCT00684983|IGF-1R|igf-1r
588487|NCT00684983|IMC-A12|imc-a12
588488|NCT00684970|CRPC|crpc
588489|NCT00684970|HRPC|hrpc
588490|NCT00684970|metastatic prostate cancer|metastatic prostate cancer
588491|NCT00684931|Attention|attention
588492|NCT00684931|Deficit|deficit
588493|NCT00684931|Disorder|disorder
588494|NCT00684931|Hyperactivity|hyperactivity
588495|NCT00684931|cerebellum|cerebellum
588496|NCT00684931|alteration|alteration
588497|NCT00684931|fronto-cerebello-frontal loops|fronto-cerebello-frontal loops
588498|NCT00684918|AML, obatoclax|aml, obatoclax
588499|NCT00684905|adenocarcinoma of the prostate|adenocarcinoma of the prostate
588500|NCT00684905|recurrent prostate cancer|recurrent prostate cancer
588501|NCT00684905|stage I prostate cancer|stage i prostate cancer
588502|NCT00684905|stage II prostate cancer|stage ii prostate cancer
588503|NCT00684905|stage III prostate cancer|stage iii prostate cancer
588504|NCT00684892|Emphysema|emphysema
588505|NCT00684892|Endobronchial Lung Volume Reduction|endobronchial lung volume reduction
588506|NCT00684879|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
588507|NCT00684879|Health Belief Model|health belief model
588508|NCT00684879|Illness Perceptions|illness perceptions
588509|NCT00684879|Screening|screening
588510|NCT00684879|HHT|hht
588511|NCT00684866|Asthma|asthma
588512|NCT00684866|Levalbuterol|levalbuterol
588513|NCT00684866|Racemic Albuterol|racemic albuterol
588514|NCT00684853|AMD|amd
588515|NCT00684853|PDT|pdt
588516|NCT00684853|Avastin|avastin
588517|NCT00684853|Bevacizumab|bevacizumab
588518|NCT00684853|Full fluence|full fluence
588519|NCT00684853|exudative|exudative
588520|NCT00684853|CNV|cnv
588521|NCT00684853|Drusen|drusen
588522|NCT00684853|ARMD|armd
588523|NCT00684853|Vetaporfin|vetaporfin
588524|NCT00684853|efficacy|efficacy
588525|NCT00684853|treatment|treatment
588526|NCT00684840|Behavioral Economics|behavioral economics
588527|NCT00684840|Drug self administration|drug self administration
588528|NCT00684840|Opioid|opioid
588529|NCT00684827|Asthma|asthma
588530|NCT00684827|Racemic albuterol|racemic albuterol
588531|NCT00684814|equivalency|equivalency
588532|NCT00684814|Therapeutic equivalency|therapeutic equivalency
588533|NCT00684801|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
588534|NCT00684801|recurrent small cell lung cancer|recurrent small cell lung cancer
588535|NCT00684801|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
588536|NCT00684801|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
588537|NCT00684801|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
588538|NCT00684801|extensive stage small cell lung cancer|extensive stage small cell lung cancer
588539|NCT00684801|recurrent pancreatic cancer|recurrent pancreatic cancer
588540|NCT00684801|stage III pancreatic cancer|stage iii pancreatic cancer
588541|NCT00684801|stage IV pancreatic cancer|stage iv pancreatic cancer
588542|NCT00684801|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
588543|NCT00684801|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
588544|NCT00684801|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
588545|NCT00684801|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
588546|NCT00684801|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
588547|NCT00684801|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
588548|NCT00684801|recurrent colon cancer|recurrent colon cancer
588549|NCT00684801|stage III colon cancer|stage iii colon cancer
588550|NCT00684801|stage IV colon cancer|stage iv colon cancer
588551|NCT00684801|recurrent rectal cancer|recurrent rectal cancer
588552|NCT00684801|stage III rectal cancer|stage iii rectal cancer
588553|NCT00684801|stage IV rectal cancer|stage iv rectal cancer
588554|NCT00684788|opiate dependence|opiate dependence
588555|NCT00684788|naltrexone|naltrexone
588556|NCT00684788|reinforcement|reinforcement
588557|NCT00684788|behavior therapy|behavior therapy
588558|NCT00684788|cocaine dependence|cocaine dependence
588559|NCT00684788|risk reduction behavior|risk reduction behavior
588560|NCT00684749|Mentor BodyLogic TM System|mentor bodylogic tm system
588561|NCT00684749|Breast augmentation|breast augmentation
588562|NCT00684749|Breast implant choice|breast implant choice
588563|NCT00684749|Reoperation rates|reoperation rates
588564|NCT00684736|septic shock|septic shock
588565|NCT00684736|shock|shock
588566|NCT00684736|serotonin|serotonin
588567|NCT00684736|kynurenine|kynurenine
588568|NCT00684736|tryptophan|tryptophan
588569|NCT00684723|Therapeutic Equivalency|therapeutic equivalency
588570|NCT00684710|Alzheimer Disease|alzheimer disease
588571|NCT00684697|premature infants iron neurodevelopment|premature infants iron neurodevelopment
588572|NCT00684684|Bronchoscopy|bronchoscopy
588573|NCT00684684|Clinically indicated for routine diagnostic bronchoscopy|clinically indicated for routine diagnostic bronchoscopy
588574|NCT00684671|Immune memory|immune memory
588575|NCT00684671|Combined hepatitis A and B vaccine|combined hepatitis a and b vaccine
588576|NCT00684671|> 41 years old|> 41 years old
588577|NCT00684658|Type 1 Diabetes|type 1 diabetes
588578|NCT00684658|Children and Teenagers|children and teenagers
588874|NCT00683371|Microarray|microarray
588579|NCT00684658|Coping with Chronic Illness|coping with chronic illness
588580|NCT00684658|Adolescence|adolescence
588581|NCT00684658|Internet psychosocial program|internet psychosocial program
588582|NCT00684658|Coping Skills Training|coping skills training
588583|NCT00684645|Safety and tolerability of SUTENT® in patients with metastatic or advanced renal cell carcinoma after failure of cytokines in real-life setting.|safety and tolerability of sutent® in patients with metastatic or advanced renal cell carcinoma after failure of cytokines in real-life setting.
588584|NCT00684632|Pain, cancer|pain, cancer
588585|NCT00684606|Induction of Labor|induction of labor
588586|NCT00684606|Low Bishop Score|low bishop score
588587|NCT00684606|Transcervical Foley Catheter.|transcervical foley catheter.
588588|NCT00684606|IV Oxytocin|iv oxytocin
588589|NCT00684580|St. Jude Alumni|st. jude alumni
588590|NCT00684580|St. Jude Life Participants|st. jude life participants
588591|NCT00684554|Heroin Dependence|heroin dependence
588592|NCT00684554|Opioid Dependence|opioid dependence
588593|NCT00684554|Primary Care|primary care
588594|NCT00684554|Buprenorphine|buprenorphine
588595|NCT00684541|Social Anxiety|social anxiety
588596|NCT00684541|Information Processing|information processing
588597|NCT00684541|Interpretation|interpretation
588598|NCT00684528|DM 2|dm 2
588599|NCT00684528|Metformin|metformin
588600|NCT00684528|Januvia|januvia
588601|NCT00684528|Community setting|community setting
588602|NCT00684528|newly diagnosed diadetics, or diabetes patients not treated during the last year|newly diagnosed diadetics, or diabetes patients not treated during the last year
588603|NCT00684502|Safety|safety
588604|NCT00684502|tolerability|tolerability
588605|NCT00684502|AZD2066|azd2066
588606|NCT00684502|Pain conditions|pain conditions
588607|NCT00684489|hypertension|hypertension
588608|NCT00684489|renin-guided therapeutics|renin-guided therapeutics
588609|NCT00684463|Antiemetic|antiemetic
588610|NCT00684450|titration of protamine|titration of protamine
588611|NCT00684450|exact dose|exact dose
588612|NCT00684450|protamine|protamine
588613|NCT00684450|neutralize heparin|neutralize heparin
588614|NCT00684437|Health Literacy|health literacy
588615|NCT00684437|Smoking Risk|smoking risk
588616|NCT00684437|Focus Group|focus group
588617|NCT00684437|Questionnaire|questionnaire
588618|NCT00684437|Survey|survey
588619|NCT00684411|T NHL|t nhl
588620|NCT00684411|Gleevec|gleevec
588621|NCT00684411|imatinib mesylate|imatinib mesylate
588622|NCT00684398|Neurofibromatosis Type 1|neurofibromatosis type 1
588623|NCT00684398|Quality of Life|quality of life
588624|NCT00684398|Adaptation|adaptation
588625|NCT00684398|Stress and Coping Model|stress and coping model
588627|NCT00684398|Survey|survey
588628|NCT00684359|Patients having PCI with a drug eluting stent|patients having pci with a drug eluting stent
588629|NCT00684346|18FDG-PET imaging|18fdg-pet imaging
588630|NCT00684346|airway inflammation|airway inflammation
588631|NCT00684346|cystic fibrosis|cystic fibrosis
588632|NCT00684346|pediatric|pediatric
588633|NCT00684346|pulmonary exacerbation|pulmonary exacerbation
588634|NCT00684333|painless Injections|painless injections
588635|NCT00684333|Subcutaneous Injections|subcutaneous injections
588636|NCT00684333|Subcutaneous Injections to healthy volunteers|subcutaneous injections to healthy volunteers
588637|NCT00684320|Social Anxiety Disorder|social anxiety disorder
588638|NCT00684320|Information Processing|information processing
588639|NCT00684320|Attention Bias|attention bias
588640|NCT00684307|Anticoagulant Treatment|anticoagulant treatment
588641|NCT00684307|Risk Factors For Stroke|risk factors for stroke
588642|NCT00684294|cancer|cancer
588643|NCT00684294|oncology|oncology
588644|NCT00684294|solid tumor|solid tumor
588645|NCT00684268|silibinin|silibinin
588646|NCT00684268|chronic hepatitis C|chronic hepatitis c
588647|NCT00684268|peginterferon|peginterferon
588648|NCT00684268|ribavirin|ribavirin
588649|NCT00684268|nonresponders|nonresponders
588650|NCT00684268|efficacy of iv. silibinin|efficacy of iv. silibinin
588651|NCT00684268|safety|safety
588652|NCT00684255|Autoimmune Disease|autoimmune disease
588653|NCT00684255|Reduced Intensity Transplant|reduced intensity transplant
588654|NCT00684242|Advanced Cancer|advanced cancer
588655|NCT00684242|Refractory Cancer Pain|refractory cancer pain
588656|NCT00684242|Lenalidomide|lenalidomide
588657|NCT00684242|Revlimid|revlimid
588658|NCT00684242|CC-5103|cc-5103
588661|NCT00684229|Anesthesia; inhalational|anesthesia; inhalational
588662|NCT00684229|Analgesia; opioid|analgesia; opioid
588663|NCT00684216|metastatic|metastatic
588664|NCT00684216|ER positive|er positive
588665|NCT00684216|PD during/after first line hormonal treatment|pd during/after first line hormonal treatment
588666|NCT00684190|Reflux Inhibitor|reflux inhibitor
588667|NCT00684190|GERD|gerd
588668|NCT00684190|PPI Interaction|ppi interaction
588669|NCT00684177|infection|infection
588670|NCT00684177|retapamulin|retapamulin
588671|NCT00684177|secondarily-infected traumatic lesions|secondarily-infected traumatic lesions
588672|NCT00684177|placebo|placebo
588673|NCT00684164|Euvolemic Hyponatremia|euvolemic hyponatremia
588674|NCT00684164|Hypervolemic Hyponatremia|hypervolemic hyponatremia
588675|NCT00684164|Neurological injury|neurological injury
588676|NCT00684151|Lipid-lowering|lipid-lowering
588677|NCT00684138|cataract|cataract
588678|NCT00684138|cataract surgery|cataract surgery
588679|NCT00684138|IOL|iol
588680|NCT00684138|intraocular lens|intraocular lens
588681|NCT00684138|ReSTOR|restor
588682|NCT00684138|Replacement of cataract|replacement of cataract
588683|NCT00684125|late cardiac tamponade|late cardiac tamponade
588684|NCT00684112|pediatrics|pediatrics
588685|NCT00684112|Scoliosis|scoliosis
588686|NCT00684112|Gabapentin|gabapentin
588687|NCT00684099|NSCLC|nsclc
588688|NCT00684099|Pemetrexed|pemetrexed
588689|NCT00684099|Docetaxel|docetaxel
588690|NCT00684073|Suboxone|suboxone
588691|NCT00684073|Subutex|subutex
588692|NCT00684073|Buprenorphine|buprenorphine
588693|NCT00684073|Naloxone|naloxone
588694|NCT00684060|Acute Myocardial Infarction|acute myocardial infarction
588695|NCT00684060|Global Left Ventricular Ejection Fraction|global left ventricular ejection fraction
588696|NCT00684060|Regional Left Ventricular Ejection Fraction|regional left ventricular ejection fraction
588697|NCT00684060|Left Ventricular Mass|left ventricular mass
588698|NCT00684060|Infarct Size|infarct size
588699|NCT00684060|End Systolic Volume|end systolic volume
588700|NCT00684060|End Diastolic Volume|end diastolic volume
588701|NCT00684047|Fibrin Sealant|fibrin sealant
588702|NCT00684047|Hemostasis|hemostasis
588703|NCT00684047|Peripheral Vascular Surgery|peripheral vascular surgery
588704|NCT00684034|Redox state in the course of chronic renal insufficiency and hemodialysis.|redox state in the course of chronic renal insufficiency and hemodialysis.
588705|NCT00684021|Acute Myocardial Infarction|acute myocardial infarction
588706|NCT00684021|Global Left Ventricular Ejection Fraction|global left ventricular ejection fraction
588707|NCT00684021|Regional Left Ventricular Ejection Fraction|regional left ventricular ejection fraction
588708|NCT00684021|Left Ventricular Mass|left ventricular mass
588709|NCT00684021|Infarct Size|infarct size
588710|NCT00684021|End Systolic Volume|end systolic volume
588711|NCT00684021|End Diastolic Volume|end diastolic volume
588712|NCT00684008|interleukin-7|interleukin-7
588713|NCT00684008|immune based therapies|immune based therapies
588714|NCT00684008|graft vs host disease|graft vs host disease
588715|NCT00684008|immune reconstitution|immune reconstitution
588716|NCT00684008|infection|infection
588717|NCT00684008|lymphopenia|lymphopenia
588718|NCT00684008|hematopoetic stem cell transplantation|hematopoetic stem cell transplantation
588719|NCT00684008|bone marrow transplantation|bone marrow transplantation
588720|NCT00684008|peripheral blood stem cell transplant|peripheral blood stem cell transplant
588721|NCT00684008|immunosuppression|immunosuppression
588722|NCT00683995|Pain, Cancer|pain, cancer
588723|NCT00683982|nitazoxanide|nitazoxanide
588724|NCT00683982|Probiotics|probiotics
588725|NCT00683982|Diarrhea|diarrhea
588726|NCT00683982|Rotavirus|rotavirus
588727|NCT00683982|Children|children
588728|NCT00683943|Spinocerebellar Ataxia|spinocerebellar ataxia
588729|NCT00683943|Lithium|lithium
588730|NCT00683917|Uterine fibroids|uterine fibroids
588731|NCT00683917|Fibroids|fibroids
588732|NCT00683891|FOCUS|focus
588733|NCT00683891|Weight gain|weight gain
588734|NCT00683891|Sialorrhea|sialorrhea
588735|NCT00683891|Treatment refractory schizophrenia|treatment refractory schizophrenia
588736|NCT00683891|FazaClo|fazaclo
588737|NCT00683891|Treatment resistant schizophrenia|treatment resistant schizophrenia
588738|NCT00683891|clozapine|clozapine
588739|NCT00683891|Hypersalivation|hypersalivation
588740|NCT00683865|Antibiotic treatment|antibiotic treatment
588741|NCT00683865|Pelvic infection|pelvic infection
588742|NCT00683865|Interventional study|interventional study
588743|NCT00683865|Female|female
588744|NCT00683852|Depression|depression
588745|NCT00683839|Tobacco|tobacco
588746|NCT00683839|Smoking|smoking
588747|NCT00683839|Smokeless|smokeless
588748|NCT00683839|Cessation|cessation
588749|NCT00683839|Public health clinic|public health clinic
588750|NCT00683839|Dental patients|dental patients
588751|NCT00683839|5 As|5 as
588752|NCT00683839|NRT|nrt
588753|NCT00683839|Tobacco Quit Line|tobacco quit line
588754|NCT00683839|Smokeless tobacco|smokeless tobacco
588755|NCT00683826|Leucine|leucine
588756|NCT00683826|Weight Loss|weight loss
588757|NCT00683813|cardiac rehabilitation|cardiac rehabilitation
588758|NCT00683813|telehealth|telehealth
588759|NCT00683813|Internet|internet
588760|NCT00683800|Menopause|menopause
588761|NCT00683800|Hot Flush|hot flush
588762|NCT00683800|Hot Flash|hot flash
588763|NCT00683800|Desvenlafaxine succinate Sustained Release|desvenlafaxine succinate sustained release
588764|NCT00683787|recurrent gastric cancer|recurrent gastric cancer
588765|NCT00683787|stage IV gastric cancer|stage iv gastric cancer
588766|NCT00683787|adenocarcinoma of the stomach|adenocarcinoma of the stomach
588767|NCT00683761|High grade recurrent glioma|high grade recurrent glioma
588768|NCT00683761|Phase 2|phase 2
588769|NCT00683761|Phase 1|phase 1
588770|NCT00683761|Multi-center|multi-center
588771|NCT00683761|Open label|open label
588772|NCT00683761|Multiple dose|multiple dose
588773|NCT00683761|Brain Cancer|brain cancer
588774|NCT00683761|Brain Tumor|brain tumor
588775|NCT00683761|GBM|gbm
588776|NCT00683761|glioma|glioma
588777|NCT00683761|glioblastoma|glioblastoma
588779|NCT00683761|oligodendroglioma|oligodendroglioma
588780|NCT00683761|131I-TM601|131i-tm601
588781|NCT00683761|TM601|tm601
588782|NCT00683748|Transplantation|transplantation
588783|NCT00683748|Immunological monitoring|immunological monitoring
588784|NCT00683748|Immunological risk|immunological risk
588785|NCT00683748|T cell reactivity|t cell reactivity
588786|NCT00683748|Cellular immunity|cellular immunity
588787|NCT00683735|Incretin, DPP-4, metformin, sitagliptin, insulin secretion|incretin, dpp-4, metformin, sitagliptin, insulin secretion
588788|NCT00683722|COPD|copd
588789|NCT00683722|Airflow Obstruction, Chronic|airflow obstruction, chronic
588790|NCT00683722|Chronic Airflow Obstruction|chronic airflow obstruction
588791|NCT00683722|Chronic Obstructive Airway Disease|chronic obstructive airway disease
588792|NCT00683722|Chronic Obstructive Lung Disease|chronic obstructive lung disease
588793|NCT00683722|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
588794|NCT00683722|Pulmonary Emphysema|pulmonary emphysema
588795|NCT00683722|Chronic Bronchitis|chronic bronchitis
588796|NCT00683722|Mesenchymal Stem Cells|mesenchymal stem cells
588797|NCT00683722|MSCs|mscs
588798|NCT00683722|Adult Human Stem Cells|adult human stem cells
588799|NCT00683722|Osiris|osiris
588800|NCT00683722|Prochymal|prochymal
588801|NCT00683709|Bipolar and Schizoaffective Disorder|bipolar and schizoaffective disorder
588802|NCT00683709|Clozapine|clozapine
588803|NCT00683709|Metabolic Side Effects|metabolic side effects
588804|NCT00683709|Diet & Exercise|diet & exercise
588805|NCT00683709|BMI|bmi
588806|NCT00683696|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
588807|NCT00683696|Heart Failure|heart failure
588808|NCT00683696|Ventricular Dyssynchrony|ventricular dyssynchrony
588809|NCT00683696|Mechanical Dyssynchrony|mechanical dyssynchrony
588810|NCT00683696|Intraventricular Dyssynchrony|intraventricular dyssynchrony
588811|NCT00683696|Echocardiography|echocardiography
588812|NCT00683696|Normal QRS|normal qrs
588813|NCT00683696|Heart Disease|heart disease
588814|NCT00683696|EchoCRT|echocrt
588815|NCT00683683|cardiac arrest, hypothermia, knowledge translation|cardiac arrest, hypothermia, knowledge translation
588816|NCT00683644|tinnitus, zinc|tinnitus, zinc
588817|NCT00683631|liver cancer|liver cancer
588818|NCT00683631|liver tumor|liver tumor
588819|NCT00683631|HCC|hcc
588820|NCT00683631|hepatocellular carcinoma|hepatocellular carcinoma
588821|NCT00683631|hepatoma|hepatoma
588822|NCT00683618|HMG-CoA|hmg-coa
588823|NCT00683618|LDL-C|ldl-c
588824|NCT00683618|CHD|chd
588825|NCT00683579|HAART|haart
588826|NCT00683579|DHHS guidelines|dhhs guidelines
588827|NCT00683579|Treatment Naive|treatment naive
588828|NCT00683566|parkinson|parkinson
588829|NCT00683553|Acute Renal Failure|acute renal failure
588830|NCT00683553|Acute Kidney Injury|acute kidney injury
588831|NCT00683540|implementation|implementation
588832|NCT00683540|evaluation|evaluation
588833|NCT00683540|research methodology|research methodology
588834|NCT00683540|intervention|intervention
588835|NCT00683527|Iron supplementation|iron supplementation
588836|NCT00683527|Timing|timing
588837|NCT00683527|Serum ferritin|serum ferritin
588838|NCT00683527|Very low birth weight infants|very low birth weight infants
588839|NCT00683514|Untreated locally advanced inoperable stage IIIA or stage IIIB NSCLC amenable to radical radiotherapy to a dose of 66 Gy|untreated locally advanced inoperable stage iiia or stage iiib nsclc amenable to radical radiotherapy to a dose of 66 gy
588840|NCT00683501|ocular hypertension|ocular hypertension
588841|NCT00683501|elevated IOP|elevated iop
588842|NCT00683501|glaucoma|glaucoma
588843|NCT00683501|neuroprotection|neuroprotection
588844|NCT00683488|Substance Abuse|substance abuse
588845|NCT00683488|Adolescent community reinforcement approach|adolescent community reinforcement approach
588846|NCT00683488|Adolescent Risk Behavior Assessment|adolescent risk behavior assessment
588847|NCT00683488|Child and Adolescent Services Assessment|child and adolescent services assessment
588848|NCT00683488|Cognitive behavioral therapy|cognitive behavioral therapy
588849|NCT00683488|Cognitive Therapy Rating Scale|cognitive therapy rating scale
588850|NCT00683488|Individual behavior therapy|individual behavior therapy
588851|NCT00683488|Individual cognitive problem solving|individual cognitive problem solving
588852|NCT00683488|Motivational enhancement therapy|motivational enhancement therapy
588853|NCT00683488|HIV-Positive Youth With Substance Abuse|hiv-positive youth with substance abuse
588854|NCT00683488|Complementary Therapies|complementary therapies
588855|NCT00683475|Prostate Cancer|prostate cancer
588856|NCT00683449|Asthma|asthma
588857|NCT00683449|Dose-Escalation|dose-escalation
588858|NCT00683449|Controlled|controlled
588859|NCT00683449|MN-221|mn-221
588860|NCT00683436|insomnia|insomnia
588861|NCT00683397|assess|assess
588862|NCT00683397|prevalence|prevalence
588863|NCT00683397|thrombophilia|thrombophilia
588864|NCT00683397|common|common
588865|NCT00683397|VTE|vte
588866|NCT00683397|risk factors|risk factors
588867|NCT00683397|patients|patients
588868|NCT00683384|Arthritis|arthritis
588869|NCT00683384|psoriatic|psoriatic
588870|NCT00683371|Chronic Rhinosinusitis|chronic rhinosinusitis
588871|NCT00683371|Sinus Disease|sinus disease
588872|NCT00683371|Allergy|allergy
588873|NCT00683371|Maxillary Sinus|maxillary sinus
588875|NCT00683358|cancer|cancer
588876|NCT00683358|pancreas|pancreas
588877|NCT00683358|advanced|advanced
588878|NCT00683358|peptide|peptide
588879|NCT00683358|vaccination|vaccination
588880|NCT00683358|VEGFR1|vegfr1
588881|NCT00683358|HLA|hla
588882|NCT00683358|gemcitabine|gemcitabine
588883|NCT00683358|IFA|ifa
588884|NCT00683358|Cancer of Pancreas|cancer of pancreas
588885|NCT00683358|Neoplasms, Pancreatic|neoplasms, pancreatic
588886|NCT00683358|Pancreas Cancer|pancreas cancer
588887|NCT00683332|Observational study|observational study
588888|NCT00683332|Tigecycline|tigecycline
588889|NCT00683332|infection|infection
588890|NCT00683332|skin|skin
588891|NCT00683332|abdominal|abdominal
588892|NCT00683319|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
588893|NCT00683319|cognitive/functional effects|cognitive/functional effects
588894|NCT00683319|ototoxicity|ototoxicity
588895|NCT00683319|childhood infratentorial ependymoma|childhood infratentorial ependymoma
588896|NCT00683319|childhood supratentorial ependymoma|childhood supratentorial ependymoma
588897|NCT00683293|Laparoscopic Hysterectomy|laparoscopic hysterectomy
588898|NCT00683293|Robot-assisted Laparoscopic Hysterectomy|robot-assisted laparoscopic hysterectomy
588899|NCT00683293|Robot-assisted Surgery|robot-assisted surgery
588900|NCT00683280|Contingency Management|contingency management
588901|NCT00683280|Cigarette Smoking Cessation|cigarette smoking cessation
588902|NCT00683280|varenicline|varenicline
588903|NCT00683267|THA, Total hip arthroplasty, total hip replacement|tha, total hip arthroplasty, total hip replacement
588904|NCT00683254|nasal obstruction|nasal obstruction
588905|NCT00683254|nasal stent|nasal stent
588906|NCT00683241|Vaccine|vaccine
588907|NCT00683241|Ovarian|ovarian
588908|NCT00683241|Peritoneal|peritoneal
588909|NCT00683228|Second hand Smoke|second hand smoke
588910|NCT00683202|Assisted reproduction|assisted reproduction
588911|NCT00683202|Ovarian response|ovarian response
588912|NCT00683202|Uteroplacental hemodynamics|uteroplacental hemodynamics
588913|NCT00683202|Doppler ultrasonography|doppler ultrasonography
588914|NCT00683202|Implantation rate|implantation rate
588915|NCT00683202|Pregnancy rate|pregnancy rate
588916|NCT00683202|Live birth rate|live birth rate
588917|NCT00683189|MLD|mld
588918|NCT00683176|Diabetic Macular Edema|diabetic macular edema
588919|NCT00683176|OCT|oct
588920|NCT00683163|Combination of PTH and ibandronate|combination of pth and ibandronate
588921|NCT00683163|Bone marker formation|bone marker formation
588922|NCT00683163|Postmenopausal|postmenopausal
588923|NCT00683163|Trabecular spine BMD|trabecular spine bmd
588924|NCT00683150|Endothelial Function|endothelial function
588925|NCT00683150|Abdominal Surgery|abdominal surgery
588926|NCT00683150|Thoracic Surgery|thoracic surgery
588927|NCT00683150|Vendy's-DTM Machine|vendy's-dtm machine
588928|NCT00683150|Digital Thermal Monitoring|digital thermal monitoring
588929|NCT00683150|DTM|dtm
588930|NCT00683124|Marfan Syndrome|marfan syndrome
588931|NCT00683124|Losartan|losartan
588932|NCT00683124|Nebivolol|nebivolol
588933|NCT00683124|Transforming Growth Factor Beta|transforming growth factor beta
588934|NCT00683124|Aortic Root Dilation|aortic root dilation
588935|NCT00683111|acute coronary syndrome|acute coronary syndrome
588936|NCT00683111|acute myocardial infarction|acute myocardial infarction
588937|NCT00683111|aspirin|aspirin
588938|NCT00683111|clopidogrel|clopidogrel
588939|NCT00683111|heparin|heparin
588940|NCT00683111|thrombolytic|thrombolytic
588941|NCT00683111|famotidine|famotidine
588942|NCT00683111|esomeprazole|esomeprazole
588943|NCT00683098|recurrent hernia|recurrent hernia
588944|NCT00683098|endoscopic total extraperitoneal repair|endoscopic total extraperitoneal repair
588945|NCT00683098|inguinal pain|inguinal pain
588946|NCT00683098|questionnaire|questionnaire
588947|NCT00683085|cancer|cancer
588948|NCT00683085|pancreas|pancreas
588949|NCT00683085|advanced|advanced
588950|NCT00683085|peptide|peptide
588951|NCT00683085|vaccination|vaccination
588952|NCT00683085|VEGFR1|vegfr1
588953|NCT00683085|HLA|hla
588954|NCT00683085|gemcitabine|gemcitabine
588955|NCT00683085|IFA|ifa
588956|NCT00683085|Cancer of Pancreas|cancer of pancreas
588957|NCT00683085|Neoplasms, Pancreas|neoplasms, pancreas
588958|NCT00683085|Pancreas Cancer|pancreas cancer
588959|NCT00683072|Ventilator|ventilator
588960|NCT00683072|patient-ventilator asynchrony|patient-ventilator asynchrony
588961|NCT00683046|Relapsed or refractory acute myelogenous or lymphoid leukemia.|relapsed or refractory acute myelogenous or lymphoid leukemia.
588962|NCT00683046|Acute myeloid or lymphocytic leukemia in first remission at high-risk for recurrence.Chronic myelogenous leukemia in accelerated phase or blast-crisis.|acute myeloid or lymphocytic leukemia in first remission at high-risk for recurrence.chronic myelogenous leukemia in accelerated phase or blast-crisis.
588963|NCT00683046|Chronic myelogenous leukemia in chronic phase|chronic myelogenous leukemia in chronic phase
588964|NCT00683046|Chronic myelogenous leukemia in accelerated phase or blast-crisis|chronic myelogenous leukemia in accelerated phase or blast-crisis
588965|NCT00683046|Recurrent or refractory malignant lymphoma or Hodgkin's disease.|recurrent or refractory malignant lymphoma or hodgkin's disease.
588966|NCT00683046|Chronic lymphocytic leukemia, relapsed or with poor prognostic features.|chronic lymphocytic leukemia, relapsed or with poor prognostic features.
588967|NCT00683046|Myeloproliferative disorder (polycythemia vera, myelofibrosis) with poor prognostic features.|myeloproliferative disorder (polycythemia vera, myelofibrosis) with poor prognostic features.
588968|NCT00683046|Severe aplastic anemia after failure of immunosuppressive therapy.|severe aplastic anemia after failure of immunosuppressive therapy.
588969|NCT00683046|Myelodysplastic syndromes (including PNH)|myelodysplastic syndromes (including pnh)
588970|NCT00683046|Multiple myeloma at high risk for disease recurrence.|multiple myeloma at high risk for disease recurrence.
588971|NCT00683033|Contingency Management|contingency management
588972|NCT00683033|Cigarette Smoking Cessation|cigarette smoking cessation
588973|NCT00683033|Substance Abusers|substance abusers
588974|NCT00683020|Chronic Diseases|chronic diseases
588975|NCT00683020|Diabetes|diabetes
588976|NCT00683020|Vulnerable population|vulnerable population
588977|NCT00683020|Urban populations|urban populations
588978|NCT00683020|Disease Management|disease management
588979|NCT00683020|Health Information Technology|health information technology
588980|NCT00683020|Safety|safety
588981|NCT00683020|Health Literacy|health literacy
588982|NCT00683020|Level of English Proficiency|level of english proficiency
588983|NCT00683007|TE echo|te echo
588984|NCT00683007|hemodilution|hemodilution
588985|NCT00683007|hypertonic|hypertonic
588986|NCT00683007|saline|saline
588987|NCT00683007|Arterial Pressure Cardiac Output|arterial pressure cardiac output
588988|NCT00682994|Advanced Cancer|advanced cancer
588989|NCT00682994|Family Member|family member
588990|NCT00682994|Palliative Care|palliative care
588991|NCT00682994|Decision Making|decision making
588992|NCT00682994|Information Disclosure|information disclosure
588993|NCT00682994|Interview|interview
588994|NCT00682994|Survey|survey
588995|NCT00682994|Questionnaire|questionnaire
588996|NCT00682981|ES-SCLC|es-sclc
588997|NCT00682981|Obatoclax|obatoclax
588998|NCT00682968|patient non-adherence|patient non-adherence
588999|NCT00682968|antihypertensive agents|antihypertensive agents
589000|NCT00682968|hypertension|hypertension
589001|NCT00682955|Diarrhea|diarrhea
589002|NCT00682955|Zinc Sulphate|zinc sulphate
589003|NCT00682955|Efficacy|efficacy
589004|NCT00682929|cannabis|cannabis
589005|NCT00682929|marijuana|marijuana
589006|NCT00682929|Multiple Sclerosis|multiple sclerosis
589007|NCT00682929|spasticity|spasticity
589008|NCT00682916|Obesity|obesity
589009|NCT00682916|Diabetes|diabetes
589010|NCT00682916|Soluble Fiber|soluble fiber
589011|NCT00682916|Overweight|overweight
589012|NCT00682903|glucose|glucose
589013|NCT00682903|diabetes|diabetes
589014|NCT00682903|glycemia|glycemia
589015|NCT00682877|gastroparesis|gastroparesis
589016|NCT00682877|Digestive|digestive
589017|NCT00682877|Gastrointestinal|gastrointestinal
589018|NCT00682877|Stomach|stomach
589019|NCT00682877|Motility|motility
589020|NCT00682877|Non-Invasive|non-invasive
589021|NCT00682877|Capsule|capsule
589022|NCT00682877|GI|gi
589023|NCT00682877|Device|device
589024|NCT00682877|Digestive System Diseases|digestive system diseases
589025|NCT00682838|Treatment compliance|treatment compliance
589026|NCT00682838|Self-management|self-management
589027|NCT00682838|Telemedicine|telemedicine
589028|NCT00682825|Anesthesia|anesthesia
589029|NCT00682825|Awareness|awareness
589030|NCT00682825|Bispectral|bispectral
589032|NCT00682825|Recall|recall
589033|NCT00682799|RC|rc
589034|NCT00682799|RIC|ric
589035|NCT00682799|MDS|mds
589036|NCT00682799|SCT|sct
589037|NCT00682786|rectal|rectal
589038|NCT00682786|rectum|rectum
589039|NCT00682786|cancer|cancer
589040|NCT00682786|carcinoma|carcinoma
589041|NCT00682760|Botulinum Toxin Type A|botulinum toxin type a
589042|NCT00682760|Blepharospasm|blepharospasm
589043|NCT00682747|xerostomia|xerostomia
589044|NCT00682747|hyperbaric oxygenation|hyperbaric oxygenation
589045|NCT00682747|radiotherapy|radiotherapy
589046|NCT00682721|Bacterial Vaginosis|bacterial vaginosis
589047|NCT00682721|Herpes Simplex Virus Type II|herpes simplex virus type ii
589048|NCT00682708|malnutrition|malnutrition
589049|NCT00682708|ready to use food|ready to use food
589050|NCT00682708|Niger|niger
589051|NCT00682695|stroke|stroke
589052|NCT00682695|brain attack|brain attack
589053|NCT00682695|hemorrhagic stroke|hemorrhagic stroke
589054|NCT00682695|risk factors|risk factors
589055|NCT00682682|Pain distraction|pain distraction
589056|NCT00682682|Analgesic interventions|analgesic interventions
589057|NCT00682682|Burn patients|burn patients
589058|NCT00682669|Asthma|asthma
589059|NCT00682669|Mindfulness-based stress reduction|mindfulness-based stress reduction
589060|NCT00682669|Peak expiratory flow rate|peak expiratory flow rate
589061|NCT00682669|Spirometry|spirometry
589062|NCT00682669|Quality of life|quality of life
589063|NCT00682656|cutaneous leishmaniasis|cutaneous leishmaniasis
589064|NCT00682656|azithromycin|azithromycin
589065|NCT00682656|N- methyl glucamine|n- methyl glucamine
589066|NCT00682643|Perennial Allergic Rhinitis|perennial allergic rhinitis
589067|NCT00682643|fluticasone furoate|fluticasone furoate
589068|NCT00682643|ocular safety|ocular safety
589069|NCT00682630|Malaria|malaria
589070|NCT00682630|anti-malarial|anti-malarial
589071|NCT00682630|pyronaridine|pyronaridine
589072|NCT00682630|ACT|act
589073|NCT00682617|hip|hip
589074|NCT00682617|osteoarthritis|osteoarthritis
589075|NCT00682617|exercise|exercise
589076|NCT00682617|disability|disability
589077|NCT00682617|physical function|physical function
589078|NCT00682604|Family Health Program; Food consumption; Nutritional status|family health program; food consumption; nutritional status
589079|NCT00682591|hepatitis C|hepatitis c
589080|NCT00682591|drug substitution|drug substitution
589081|NCT00682591|neurocognitive|neurocognitive
589082|NCT00682591|patients with stable drug substitution therapy|patients with stable drug substitution therapy
589083|NCT00682591|patients with interferon-based antiviral therapy|patients with interferon-based antiviral therapy
589084|NCT00682578|falciparum malaria|falciparum malaria
589085|NCT00682578|vivax malaria|vivax malaria
589086|NCT00682578|dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
589087|NCT00682539|diabetic retinopathy|diabetic retinopathy
589088|NCT00682539|macular edema|macular edema
589089|NCT00682539|intravitreal Avastin/ Triamcinolone / Lucentis|intravitreal avastin/ triamcinolone / lucentis
589090|NCT00682526|EMS patients with intention to treat with coronary reperfusion therapy (PCI or thrombolytics) based on their initial presentation|ems patients with intention to treat with coronary reperfusion therapy (pci or thrombolytics) based on their initial presentation
589091|NCT00682513|dystonia|dystonia
589092|NCT00682513|parkinsonism|parkinsonism
589093|NCT00682513|rapid-onset dystonia-parkinsonism|rapid-onset dystonia-parkinsonism
589094|NCT00682513|RDP|rdp
589095|NCT00682513|Alternating Hemiplegia of Childhood|alternating hemiplegia of childhood
589096|NCT00682513|AHC|ahc
589097|NCT00682500|Pneumonia|pneumonia
589098|NCT00682500|Aspiration|aspiration
589099|NCT00682500|Drowning|drowning
589100|NCT00682500|inhalation|inhalation
589101|NCT00682487|Myocardial infarction|myocardial infarction
589102|NCT00682487|Stress|stress
589103|NCT00682487|Hair Cortisol|hair cortisol
589104|NCT00682474|Cigarette smoking|cigarette smoking
589105|NCT00682474|Nicotine dependence|nicotine dependence
589106|NCT00682474|Adolescents|adolescents
589107|NCT00682474|Youth|youth
589108|NCT00682474|School health|school health
589109|NCT00682474|Randomized controlled trial|randomized controlled trial
589110|NCT00682461|Nicotine Tolerability NRT|nicotine tolerability nrt
589111|NCT00682448|Olanzapine|olanzapine
589112|NCT00682448|Zyprexa|zyprexa
589113|NCT00682448|Weight Gain|weight gain
589114|NCT00682448|Antipsychotics|antipsychotics
589115|NCT00682448|Metformin|metformin
589116|NCT00682448|Glucophage|glucophage
589117|NCT00682448|Bipolar Disorder|bipolar disorder
589118|NCT00682448|Schizophrenia|schizophrenia
589119|NCT00682448|Depression|depression
589120|NCT00682448|Diabetes|diabetes
589121|NCT00682448|Side effects|side effects
589122|NCT00682448|Metabolic complications|metabolic complications
589123|NCT00682448|Prevention|prevention
589124|NCT00682448|Treatment|treatment
589125|NCT00682448|Metabolic side effects of olanzapine|metabolic side effects of olanzapine
589126|NCT00682435|Nonedlerly patients with acute moderate to severe pain|nonedlerly patients with acute moderate to severe pain
589127|NCT00682422|pediatrics, overweight, obese, behavioral intervention|pediatrics, overweight, obese, behavioral intervention
589128|NCT00682383|Advanced NSCLC|advanced nsclc
589129|NCT00682383|Lung Cancer|lung cancer
589130|NCT00682383|Mount Sinai Medical Center CCOP|mount sinai medical center ccop
589131|NCT00682357|Osteoarthritis, intra articular steroids|osteoarthritis, intra articular steroids
589132|NCT00682318|Fish oil|fish oil
589133|NCT00682318|red wine|red wine
589134|NCT00682318|alcohol|alcohol
589135|NCT00682318|oxidative stress|oxidative stress
589136|NCT00682318|Healthy volunteers|healthy volunteers
589137|NCT00682305|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
589138|NCT00682305|Hematopoeitic Stem Cell Transplantation|hematopoeitic stem cell transplantation
589139|NCT00682292|Renal transplantation|renal transplantation
589140|NCT00682292|Immunisation|immunisation
589141|NCT00682292|Acute rejection|acute rejection
589142|NCT00682292|Induction therapy|induction therapy
589143|NCT00682292|Thymoglobulin|thymoglobulin
589144|NCT00682292|Daclizumab|daclizumab
589145|NCT00682292|Rejection in sensitized renal transplant recipients|rejection in sensitized renal transplant recipients
589146|NCT00682279|lapatinib|lapatinib
589147|NCT00682279|GW572016|gw572016
589148|NCT00682279|topotecan|topotecan
589149|NCT00682279|oral topotecan|oral topotecan
589150|NCT00682279|SK&F-104864|sk&f-104864
589151|NCT00682279|EGFR|egfr
589152|NCT00682279|ErbB1|erbb1
589153|NCT00682279|HER-2/neu|her-2/neu
589154|NCT00682279|ErbB2|erbb2
589155|NCT00682279|BCRP|bcrp
589156|NCT00682266|Adolescent|adolescent
589157|NCT00682266|Overweight|overweight
589158|NCT00682266|Exercise|exercise
589159|NCT00682266|multidisciplinary approach|multidisciplinary approach
589160|NCT00682266|Oxygen uptake|oxygen uptake
589161|NCT00682266|Flow mediated dilatation|flow mediated dilatation
589162|NCT00682266|Cardiovascular Risk Factors|cardiovascular risk factors
589163|NCT00682253|SPECT/CT|spect/ct
589164|NCT00682253|MRI|mri
589165|NCT00682253|Breast neoplasms|breast neoplasms
589166|NCT00682240|retinal morphology|retinal morphology
589167|NCT00682240|laser treatment|laser treatment
589168|NCT00682240|pascal laser|pascal laser
589169|NCT00682240|HD-OCT|hd-oct
589170|NCT00682227|Epitope peptide, CTL, Esophageal cancer, Vaccination|epitope peptide, ctl, esophageal cancer, vaccination
589171|NCT00682214|25(OH)D, muscle strength|25(oh)d, muscle strength
589172|NCT00682201|Pregnancy|pregnancy
589173|NCT00682201|Blood pressure|blood pressure
589174|NCT00682201|Cardiac output|cardiac output
589175|NCT00682188|Overweight|overweight
589176|NCT00682188|Obesity|obesity
589177|NCT00682188|Adolescents|adolescents
589178|NCT00682188|Youth|youth
589179|NCT00682188|School health|school health
589180|NCT00682188|Randomized controlled trial|randomized controlled trial
589181|NCT00682188|Intervention study|intervention study
589182|NCT00682175|Congestive Heart Failure|congestive heart failure
589183|NCT00682162|acupuncture|acupuncture
589184|NCT00682162|randomised controlled trial|randomised controlled trial
589185|NCT00682162|placebo|placebo
589186|NCT00682162|sham laser|sham laser
589187|NCT00682162|vasomotor rhinitis|vasomotor rhinitis
589188|NCT00682149|Oxidative stress|oxidative stress
589189|NCT00682149|malondialdehyde|malondialdehyde
589190|NCT00682149|glutathione|glutathione
589191|NCT00682149|diabetes|diabetes
589192|NCT00682149|polyphenol containing antioxidants|polyphenol containing antioxidants
589193|NCT00682149|diet rich in vegetables|diet rich in vegetables
589194|NCT00682149|weekly aerobic exercise|weekly aerobic exercise
589195|NCT00682136|postoperative analgesia|postoperative analgesia
589196|NCT00682136|abdominal surgery|abdominal surgery
589197|NCT00682136|ropivacaine|ropivacaine
589198|NCT00682136|local anaesthesia|local anaesthesia
589199|NCT00682136|tap block|tap block
589200|NCT00682136|pain management|pain management
589201|NCT00682123|19-norandrostenedione|19-norandrostenedione
589202|NCT00682123|steroids|steroids
589203|NCT00682123|drugs in sport|drugs in sport
589204|NCT00682123|World Anti-Doping Agency|world anti-doping agency
589205|NCT00682110|End-stage liver disease|end-stage liver disease
589206|NCT00682110|Hemodynamic measurements|hemodynamic measurements
589207|NCT00682110|Hyperdynamic circulation|hyperdynamic circulation
589208|NCT00682110|Pulmonary artery catheter|pulmonary artery catheter
589209|NCT00682110|Cardiac output|cardiac output
589210|NCT00682084|Cushing's syndrome|cushing's syndrome
589211|NCT00682084|Glucose tolerance|glucose tolerance
589212|NCT00682084|Insulin sensitivity|insulin sensitivity
589213|NCT00682084|Substrate metabolism|substrate metabolism
589214|NCT00682084|Body composition|body composition
589215|NCT00682071|Ultrasound-guided|ultrasound-guided
589216|NCT00682071|embryo transfer|embryo transfer
589217|NCT00682071|in-vitro fertilization|in-vitro fertilization
589218|NCT00682058|body composition|body composition
589219|NCT00682058|weight loss|weight loss
589220|NCT00682058|fat|fat
589221|NCT00682058|fat distribution|fat distribution
589222|NCT00682058|fat free mass|fat free mass
589223|NCT00682058|organ|organ
589224|NCT00682058|resting energy expenditure|resting energy expenditure
589225|NCT00682045|tuberculosis|tuberculosis
589226|NCT00682045|transplantation|transplantation
589227|NCT00682032|NSCLC|nsclc
589228|NCT00682019|Erectile Dysfunction|erectile dysfunction
589229|NCT00682019|Vardenafil|vardenafil
589230|NCT00682006|Omphalitis|omphalitis
589231|NCT00682006|4% Chlorhexidine|4% chlorhexidine
589232|NCT00682006|Newborns|newborns
589233|NCT00681993|cosmetic|cosmetic
589234|NCT00681993|effect|effect
589235|NCT00681993|breast|breast
589236|NCT00681993|irradiation|irradiation
589237|NCT00681993|concurrent|concurrent
589238|NCT00681993|chemotherapy|chemotherapy
589239|NCT00681993|potential acute|potential acute
589240|NCT00681993|late skin|late skin
589241|NCT00681993|subcutaneous toxicities|subcutaneous toxicities
589242|NCT00681980|TSP/HAM, HTLV-1, treatment|tsp/ham, htlv-1, treatment
589243|NCT00681967|squamous cell cancer of the head & neck|squamous cell cancer of the head & neck
589244|NCT00681967|Gefitinib|gefitinib
589245|NCT00681967|IRESSA|iressa
589246|NCT00681967|EGFR Inhibitor|egfr inhibitor
589247|NCT00681967|EGFR-tyrosine kinase inhibitor|egfr-tyrosine kinase inhibitor
589248|NCT00681967|Subjects with histologically proven squamous cell cancer of the head & neck|subjects with histologically proven squamous cell cancer of the head & neck
589249|NCT00681967|Cohort 1:qualifying for postoperative radiotherapy|cohort 1:qualifying for postoperative radiotherapy
589250|NCT00681967|(pT3, pT4, pN2b, pN2c, pN3).|(pt3, pt4, pn2b, pn2c, pn3).
589251|NCT00681967|Cohort 2:qualifying for definite chemoradiotherapy|cohort 2:qualifying for definite chemoradiotherapy
589252|NCT00681967|(Lateral oropharynx, tonsils: T1N2b-3, T2N1-3, T3any N;|(lateral oropharynx, tonsils: t1n2b-3, t2n1-3, t3any n;
589253|NCT00681967|Base of tongue, vallecula: T1N1-3, T2-4 any N; Oral cavity,|base of tongue, vallecula: t1n1-3, t2-4 any n; oral cavity,
589254|NCT00681967|glottic and supraglottic larynx; Any TN1-3, T3-4 any N;|glottic and supraglottic larynx; any tn1-3, t3-4 any n;
589255|NCT00681967|Hypopharynx: T1N1-3, T2-4 and N)|hypopharynx: t1n1-3, t2-4 and n)
589256|NCT00681954|TRALI|trali
589257|NCT00681954|Randomized Autologous Transfusion|randomized autologous transfusion
589258|NCT00681954|Intra-Operative Testing of Pulmonary Function|intra-operative testing of pulmonary function
589259|NCT00681928|stage I breast cancer|stage i breast cancer
589260|NCT00681928|stage II breast cancer|stage ii breast cancer
589261|NCT00681928|stage IIIA breast cancer|stage iiia breast cancer
589262|NCT00681928|stage IIIB breast cancer|stage iiib breast cancer
589263|NCT00681928|stage IIIC breast cancer|stage iiic breast cancer
589264|NCT00681915|Phase I|phase i
589265|NCT00681915|Pharmacokinetics|pharmacokinetics
589266|NCT00681902|Pediatric|pediatric
589267|NCT00681902|Pain|pain
589268|NCT00681902|Needle|needle
589269|NCT00681902|Emergency|emergency
589270|NCT00681902|Phlebotomy|phlebotomy
589271|NCT00681902|Intravenous|intravenous
589272|NCT00681902|Lidocaine|lidocaine
589273|NCT00681902|Local|local
589274|NCT00681902|Anesthesia|anesthesia
589275|NCT00681876|Metastatic colorectal cancer|metastatic colorectal cancer
589276|NCT00681876|Second line|second line
589277|NCT00681876|Irinotecan|irinotecan
589278|NCT00681876|Erbitux (Cetuximab)|erbitux (cetuximab)
589279|NCT00681876|Avastin (Bevacizumab)|avastin (bevacizumab)
589280|NCT00681850|Diabetes|diabetes
589281|NCT00681850|Benchmarking|benchmarking
589282|NCT00681850|quality of patient care|quality of patient care
589283|NCT00681850|Diabetic Population|diabetic population
589284|NCT00681837|gastroesophageal reflux|gastroesophageal reflux
589285|NCT00681837|prevalence|prevalence
589286|NCT00681837|childhood|childhood
589287|NCT00681837|France|france
589288|NCT00681811|Metazyme|metazyme
589289|NCT00681811|Late Infantile Metachromatic Leukodystrophy|late infantile metachromatic leukodystrophy
589290|NCT00681798|pancreatic cancer|pancreatic cancer
589291|NCT00681798|pancreatic adenocarcinoma|pancreatic adenocarcinoma
589292|NCT00681798|pancreas cancer|pancreas cancer
589293|NCT00681798|dose escalation study|dose escalation study
589294|NCT00681798|locally advanced unresectable pancreatic adenocarcinoma|locally advanced unresectable pancreatic adenocarcinoma
589295|NCT00681798|Zactima|zactima
589296|NCT00681798|Vandetanib|vandetanib
589297|NCT00681798|ZD6474|zd6474
589298|NCT00681785|thrombophylaxis and transurethral surgery|thrombophylaxis and transurethral surgery
589299|NCT00681772|Erectile Dysfunction|erectile dysfunction
589300|NCT00681772|Vardenafil|vardenafil
589301|NCT00681759|Low Dose Aspirin (LDA)|low dose aspirin (lda)
589302|NCT00681759|Cardiovascular disease|cardiovascular disease
589303|NCT00681759|Low Dose Aspirin (LDA) use in in subjects with cardiovascular risk or disease|low dose aspirin (lda) use in in subjects with cardiovascular risk or disease
589304|NCT00681746|Anxiety|anxiety
589305|NCT00681746|GABA receptors|gaba receptors
589306|NCT00681746|Positron Emission Tomography|positron emission tomography
589307|NCT00681746|PET|pet
589308|NCT00681746|phase I|phase i
589309|NCT00681733|NASH Pentoxifylline Pioglitazone|nash pentoxifylline pioglitazone
589310|NCT00681720|Anxiety|anxiety
589311|NCT00681720|GABA receptors|gaba receptors
589312|NCT00681720|Positron Emission Tomography|positron emission tomography
589313|NCT00681720|PET|pet
589314|NCT00681720|phase I|phase i
589315|NCT00681707|Hypertension|hypertension
589316|NCT00681707|Post stroke|post stroke
589317|NCT00681707|JNC7|jnc7
589318|NCT00681707|2007 ESH-ESC guidelines|2007 esh-esc guidelines
589319|NCT00681707|survey|survey
589320|NCT00681694|brachytherapy|brachytherapy
589321|NCT00681694|radioactive seed implants|radioactive seed implants
589322|NCT00681681|stroke|stroke
589323|NCT00681681|vascular marker|vascular marker
589324|NCT00681681|stroke risk|stroke risk
589325|NCT00681681|risk factors|risk factors
589326|NCT00681681|sex differences|sex differences
589327|NCT00681668|Postpartum Depression|postpartum depression
589328|NCT00681668|Quetiapine|quetiapine
589329|NCT00681668|Psychotic Symptoms|psychotic symptoms
589330|NCT00681642|Corneal epithelial wound|corneal epithelial wound
589331|NCT00681642|Human autoserum|human autoserum
589332|NCT00681642|Cord blood|cord blood
589333|NCT00681629|Schizophrenia|schizophrenia
589334|NCT00681629|Integrated Care|integrated care
589335|NCT00681629|Quetiapine|quetiapine
589336|NCT00681616|Anterior compartment syndrome|anterior compartment syndrome
589337|NCT00681616|Tibia|tibia
589338|NCT00681616|Trauma|trauma
589339|NCT00681616|Blood circulation|blood circulation
589340|NCT00681616|Nerve compression syndromes|nerve compression syndromes
589341|NCT00681603|corneal neovascularization|corneal neovascularization
589342|NCT00681603|lipid keratopathy|lipid keratopathy
589343|NCT00681603|penetrating keratopathy|penetrating keratopathy
589344|NCT00681603|bevacizumab|bevacizumab
589345|NCT00681603|Avastin|avastin
589346|NCT00681603|subconjunctival injection|subconjunctival injection
589347|NCT00681590|vitamin D|vitamin d
589348|NCT00681590|deficiency|deficiency
589349|NCT00681590|elderly|elderly
589350|NCT00681577|Peptide Vaccine|peptide vaccine
589351|NCT00681577|URLC10|urlc10
589352|NCT00681577|KOC1|koc1
589353|NCT00681577|VEGFR1|vegfr1
589354|NCT00681577|VEGFR2|vegfr2
589355|NCT00681564|Periodontitis|periodontitis
589356|NCT00681564|Oral health|oral health
589357|NCT00681564|Cardiovascular disease|cardiovascular disease
589358|NCT00681551|Detection of brain metastasis by MRI|detection of brain metastasis by mri
589359|NCT00681551|Magnevist|magnevist
589569|NCT00680732|Prevention|prevention
589360|NCT00681551|Brain metastasis|brain metastasis
589361|NCT00681551|Meglumine gadopentetate|meglumine gadopentetate
589362|NCT00681538|Spasticity|spasticity
589363|NCT00681538|Multiple Sclerosis|multiple sclerosis
589364|NCT00681512|NSCLC|nsclc
589365|NCT00681512|lung cancer|lung cancer
589366|NCT00681512|non small cell lung cancer|non small cell lung cancer
589367|NCT00681512|lung carcinoma|lung carcinoma
589368|NCT00681499|Quality of Life|quality of life
589369|NCT00681499|Liver Neoplasms|liver neoplasms
589370|NCT00681499|Surgical procedures, Operative|surgical procedures, operative
589371|NCT00681486|Ghrelin|ghrelin
589372|NCT00681486|Nutrition|nutrition
589373|NCT00681486|Cancer patients|cancer patients
589374|NCT00681486|Survival|survival
589375|NCT00681473|proton radiation therapy|proton radiation therapy
589376|NCT00681473|photon radiation therapy|photon radiation therapy
589377|NCT00681460|gestational diabetes|gestational diabetes
589378|NCT00681460|birth weight|birth weight
589379|NCT00681460|fetal growth|fetal growth
589380|NCT00681460|insulin resistance|insulin resistance
589381|NCT00681460|oxidative stress|oxidative stress
589382|NCT00681460|inflammatory reaction|inflammatory reaction
589383|NCT00681460|Fetal Development|fetal development
589384|NCT00681447|lumbar disc herniation|lumbar disc herniation
589385|NCT00681447|discogenic pain|discogenic pain
589386|NCT00681447|lumbar interlaminar epidural|lumbar interlaminar epidural
589387|NCT00681447|injections|injections
589388|NCT00681434|stroke|stroke
589389|NCT00681434|upper extremity|upper extremity
589390|NCT00681434|hemiparesis|hemiparesis
589391|NCT00681421|Peptide Vaccine|peptide vaccine
589392|NCT00681421|URLC10|urlc10
589393|NCT00681421|VEGFR1|vegfr1
589394|NCT00681421|VEGFR2|vegfr2
589395|NCT00681408|Steatohepatitis|steatohepatitis
589396|NCT00681408|NASH|nash
589397|NCT00681408|NAFLD|nafld
589398|NCT00681408|omega 3 fatty acids|omega 3 fatty acids
589399|NCT00681408|Exercise conditioning|exercise conditioning
589400|NCT00681382|Asthma|asthma
589401|NCT00681382|use of asthma medication|use of asthma medication
589402|NCT00681382|asthma control|asthma control
589403|NCT00681382|telephone survey|telephone survey
589404|NCT00681382|patient's perception|patient's perception
589405|NCT00681369|breast cancer|breast cancer
589406|NCT00681369|fulvestrant|fulvestrant
589407|NCT00681369|longitudinal study|longitudinal study
589408|NCT00681369|France|france
589409|NCT00681356|TKA|tka
589410|NCT00681356|Total knee arthroplasty|total knee arthroplasty
589411|NCT00681356|Total knee replacement|total knee replacement
589412|NCT00681356|Knee surgery|knee surgery
589413|NCT00681343|Randomized|randomized
589414|NCT00681343|study|study
589415|NCT00681343|effectiveness/toxicity|effectiveness/toxicity
589416|NCT00681343|induction therapy|induction therapy
589417|NCT00681343|recipients|recipients
589418|NCT00681330|Peptide Vaccine|peptide vaccine
589419|NCT00681330|URLC10|urlc10
589420|NCT00681330|TTK|ttk
589421|NCT00681330|KOC1|koc1
589422|NCT00681317|Phase I|phase i
589423|NCT00681317|Pharmacokinetics|pharmacokinetics
589424|NCT00681304|Resected Breast Cancer|resected breast cancer
589425|NCT00681304|Breast Cancer|breast cancer
589426|NCT00681291|surgical mesh|surgical mesh
589427|NCT00681291|inguinal hernia repair|inguinal hernia repair
589428|NCT00681291|chronic groin pain|chronic groin pain
589429|NCT00681278|Hypertension|hypertension
589430|NCT00681278|Type II DM|type ii dm
589431|NCT00681278|JNC7|jnc7
589432|NCT00681278|2007 ESH-ESC guidelines|2007 esh-esc guidelines
589433|NCT00681278|survey|survey
589434|NCT00681265|ocular lubricants|ocular lubricants
589435|NCT00681252|Peptide Vaccine|peptide vaccine
589436|NCT00681252|URLC10|urlc10
589437|NCT00681252|VEGFR1|vegfr1
589438|NCT00681252|VEGFR2|vegfr2
589439|NCT00681239|childhood|childhood
589440|NCT00681239|epilepsy|epilepsy
589441|NCT00681239|intractable|intractable
589442|NCT00681239|seizures|seizures
589443|NCT00681239|Atkins|atkins
589444|NCT00681239|ketogenic|ketogenic
589445|NCT00681226|peripheral arterial disease|peripheral arterial disease
589446|NCT00681226|angiotensin converting enzyme inhibitors|angiotensin converting enzyme inhibitors
589447|NCT00681226|exercise|exercise
589448|NCT00681200|Blood Pressure Reduction|blood pressure reduction
589449|NCT00681200|Stress Reactivity and Recovery|stress reactivity and recovery
589450|NCT00681200|Meditation|meditation
589451|NCT00681200|Transcendental Meditation|transcendental meditation
589452|NCT00681200|Stress Reduction|stress reduction
589453|NCT00681200|Stress Management|stress management
589454|NCT00681174|Care, Postoperative|care, postoperative
589455|NCT00681174|Analgesia|analgesia
589456|NCT00681174|Analgesics, Opioid|analgesics, opioid
589457|NCT00681174|Morphine|morphine
589458|NCT00681174|Remifentanil|remifentanil
589459|NCT00681174|Oxycodone|oxycodone
589460|NCT00681174|Anesthesia, Regional|anesthesia, regional
589461|NCT00681174|Anesthesia, Intravenous|anesthesia, intravenous
589462|NCT00681174|Preanesthetic Medication|preanesthetic medication
589463|NCT00681174|Analgesia, Patient-Controlled|analgesia, patient-controlled
589464|NCT00681161|obstructive sleep apnea|obstructive sleep apnea
589465|NCT00681161|OSA|osa
589466|NCT00681161|diabetes|diabetes
589467|NCT00681161|pre-diabetic condition|pre-diabetic condition
589468|NCT00681161|obesity|obesity
589469|NCT00681161|blood glucose|blood glucose
589470|NCT00681161|continuous positive airway pressure|continuous positive airway pressure
589471|NCT00681161|CPAP|cpap
589472|NCT00681148|Prostate specific antigen (PSA)|prostate specific antigen (psa)
589473|NCT00681148|Prostate cancer|prostate cancer
589474|NCT00681148|Lower urinary tract symptoms|lower urinary tract symptoms
589475|NCT00681148|Radioactive seed implantation|radioactive seed implantation
589476|NCT00681135|orthodontics|orthodontics
589477|NCT00681135|toothbrush|toothbrush
589478|NCT00681135|interdental brush|interdental brush
589479|NCT00681135|oral hygiene|oral hygiene
589480|NCT00681122|Breast Cancer|breast cancer
589481|NCT00681122|hormone therapy|hormone therapy
589482|NCT00681122|aromatase inhibitor|aromatase inhibitor
589483|NCT00681096|Low back pain in nurses|low back pain in nurses
589484|NCT00681083|Obstructive Sleep Apnea|obstructive sleep apnea
589485|NCT00681083|Humidification|humidification
589486|NCT00681083|Continuous Positive Airway Pressure|continuous positive airway pressure
589487|NCT00681070|laceration|laceration
589488|NCT00681070|wound management|wound management
589489|NCT00681070|absorbable sutures|absorbable sutures
589490|NCT00681070|cosmetic outcomes|cosmetic outcomes
589491|NCT00681044|monoclonal immunoglobulin deposition disease|monoclonal immunoglobulin deposition disease
589492|NCT00681044|light chain deposition disease|light chain deposition disease
589493|NCT00681018|premature|premature
589494|NCT00681018|infants|infants
589495|NCT00681005|PPI test|ppi test
589496|NCT00681005|gastroesophageal reflux disease|gastroesophageal reflux disease
589497|NCT00681005|CYP2C19|cyp2c19
589498|NCT00681005|rabeprazole|rabeprazole
589499|NCT00681005|pantoprazole|pantoprazole
589500|NCT00680992|Giant Cell Tumor of Bone|giant cell tumor of bone
589501|NCT00680979|Prevention|prevention
589502|NCT00680979|Obesity|obesity
589503|NCT00680979|Binge Eating|binge eating
589504|NCT00680979|Adolescents|adolescents
589505|NCT00680979|Overweight|overweight
589506|NCT00680979|Weight Gain|weight gain
589507|NCT00680966|Treatment efficacy|treatment efficacy
589508|NCT00680966|Family therapy|family therapy
589509|NCT00680966|Teens|teens
589510|NCT00680966|Substance abuse|substance abuse
589511|NCT00680966|Substance dependence|substance dependence
589512|NCT00680940|NSCLC|nsclc
589513|NCT00680927|Atrial Fibrillation|atrial fibrillation
589514|NCT00680927|Risk of cardiac arrhythmias|risk of cardiac arrhythmias
589515|NCT00680927|Loop recorder|loop recorder
589516|NCT00680914|Streptococcus pneumoniae|streptococcus pneumoniae
589517|NCT00680914|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
589518|NCT00680901|unresectable|unresectable
589519|NCT00680901|HER2|her2
589520|NCT00680901|TYVERB|tyverb
589521|NCT00680901|ErbB2|erbb2
589522|NCT00680901|TYKERB|tykerb
589523|NCT00680901|capecitabine|capecitabine
589524|NCT00680901|CapeOx|capeox
589525|NCT00680901|gastric/esophageal cancer|gastric/esophageal cancer
589526|NCT00680901|GE junction|ge junction
589527|NCT00680901|metastatic|metastatic
589528|NCT00680901|lapatinib|lapatinib
589529|NCT00680901|oxaliplatin|oxaliplatin
589530|NCT00680888|Psychosis|psychosis
589531|NCT00680888|adolescents|adolescents
589532|NCT00680888|adherence|adherence
589533|NCT00680888|quetiapine|quetiapine
589534|NCT00680875|School Based Services|school based services
589535|NCT00680875|Prevention|prevention
589536|NCT00680875|Children|children
589537|NCT00680862|HIV|hiv
589538|NCT00680862|screening|screening
589539|NCT00680849|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
589540|NCT00680849|Coronary Disease|coronary disease
589541|NCT00680836|Irritable Bowel Syndrome|irritable bowel syndrome
589542|NCT00680836|Diarrhea|diarrhea
589543|NCT00680836|Gulf War|gulf war
589544|NCT00680836|Veterans|veterans
589545|NCT00680836|Small intestinal bacterial overgrowth (SIBO)|small intestinal bacterial overgrowth (sibo)
589546|NCT00680823|Headache|headache
589547|NCT00680823|Migraine|migraine
589548|NCT00680823|Ropivacaine|ropivacaine
589549|NCT00680797|Aging|aging
589550|NCT00680797|Hormones|hormones
589551|NCT00680797|Insulin resistance|insulin resistance
589552|NCT00680784|sprain|sprain
589553|NCT00680784|ankle|ankle
589554|NCT00680784|pain|pain
589555|NCT00680771|Primary Insomnia|primary insomnia
589556|NCT00680771|Insomnia|insomnia
589557|NCT00680771|Good Sleepers|good sleepers
589558|NCT00680771|Hep B|hep b
589559|NCT00680771|Vaccine|vaccine
589560|NCT00680758|male breast cancer|male breast cancer
589561|NCT00680758|stage IV breast cancer|stage iv breast cancer
589562|NCT00680745|Dapagliflozin|dapagliflozin
589563|NCT00680745|efficacy|efficacy
589564|NCT00680745|safety|safety
589565|NCT00680745|sulphonylurea|sulphonylurea
589566|NCT00680745|Type 2 diabetes|type 2 diabetes
589567|NCT00680732|Malaria|malaria
589568|NCT00680732|Pregnancy|pregnancy
589570|NCT00680732|Chloroquine|chloroquine
589571|NCT00680732|Sulphadoxine pyrimethamine|sulphadoxine pyrimethamine
589572|NCT00680732|Maternal anaemia|maternal anaemia
589573|NCT00680732|Birth weight|birth weight
589574|NCT00680732|Foetal anaemia|foetal anaemia
589575|NCT00680719|substance abuse|substance abuse
589576|NCT00680719|HIV risk|hiv risk
589577|NCT00680719|Behavior and Mental Disorders|behavior and mental disorders
589578|NCT00680719|HIV Seronegativity|hiv seronegativity
589579|NCT00680693|IBS, functional gastrointestinal disease|ibs, functional gastrointestinal disease
589580|NCT00680680|Urinary retention secondary to benign prostatic hyperplasia|urinary retention secondary to benign prostatic hyperplasia
589581|NCT00680667|ductal breast carcinoma|ductal breast carcinoma
589582|NCT00680667|stage I breast cancer|stage i breast cancer
589583|NCT00680667|stage II breast cancer|stage ii breast cancer
589584|NCT00680667|stage IIIA breast cancer|stage iiia breast cancer
589585|NCT00680667|stage IIIB breast cancer|stage iiib breast cancer
589586|NCT00680667|stage IIIC breast cancer|stage iiic breast cancer
589587|NCT00680667|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
589588|NCT00680667|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
589589|NCT00680654|Pulmonary hypertension|pulmonary hypertension
589590|NCT00680641|COPD|copd
589591|NCT00680641|Emphysema|emphysema
589592|NCT00680641|Simvastatin|simvastatin
589593|NCT00680628|Pulmonary Embolism|pulmonary embolism
589594|NCT00680628|Tenecteplase|tenecteplase
589595|NCT00680628|Enoxaparin|enoxaparin
589596|NCT00680628|Thrombosis|thrombosis
589597|NCT00680628|Fibrinolytics|fibrinolytics
589598|NCT00680615|Smokeless tobacco|smokeless tobacco
589599|NCT00680602|behavior therapy|behavior therapy
589600|NCT00680602|group therapy|group therapy
589601|NCT00680602|psychopharmacology|psychopharmacology
589602|NCT00680589|TYRP2 DNA Vaccine|tyrp2 dna vaccine
589603|NCT00680576|adolescent substance abuse|adolescent substance abuse
589604|NCT00680550|Atrial Fibrillation|atrial fibrillation
589605|NCT00680550|Risk of cardiac Arrhythmias|risk of cardiac arrhythmias
589606|NCT00680550|Loop recorder|loop recorder
589607|NCT00680537|physical therapy program|physical therapy program
589608|NCT00680524|telephone-based intervention for PTSD|telephone-based intervention for ptsd
589609|NCT00680511|methamphetamine abuse|methamphetamine abuse
589610|NCT00680498|Age-Related Macular Degeneration|age-related macular degeneration
589611|NCT00680498|Ranibizumab|ranibizumab
589612|NCT00680498|Lucentis|lucentis
589613|NCT00680498|Photodynamic Therapy|photodynamic therapy
589614|NCT00680498|Verteporfin|verteporfin
589615|NCT00680498|Visudyne|visudyne
589616|NCT00680485|GSK580416|gsk580416
589617|NCT00680485|ketoconazole interaction|ketoconazole interaction
589618|NCT00680485|pleuromutilin|pleuromutilin
589619|NCT00680485|oral dose|oral dose
589620|NCT00680472|Shoulder pain|shoulder pain
589621|NCT00680472|Pain|pain
589622|NCT00680472|Ketoprofen|ketoprofen
589623|NCT00680472|Topical Patch|topical patch
589624|NCT00680459|central line infection|central line infection
589625|NCT00680459|70% ethanol|70% ethanol
589626|NCT00680459|Sepsis|sepsis
589627|NCT00680446|Primary Immune Deficiency|primary immune deficiency
589628|NCT00680446|Subcutaneous|subcutaneous
589629|NCT00680446|Immunoglobulin G|immunoglobulin g
589630|NCT00680420|pancreas cancer|pancreas cancer
589631|NCT00680420|pancreas cyst|pancreas cyst
589632|NCT00680420|DNA microarray|dna microarray
589633|NCT00680407|NASH|nash
589634|NCT00680407|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
589635|NCT00680394|abortion|abortion
589636|NCT00680394|medical abortion|medical abortion
589637|NCT00680394|mifepristone|mifepristone
589638|NCT00680394|misoprostol|misoprostol
589639|NCT00680381|adolescent substance abuse|adolescent substance abuse
589640|NCT00680368|Feasibility|feasibility
589641|NCT00680368|Supervision|supervision
589642|NCT00680368|Assessing|assessing
589643|NCT00680355|golden rice carotenoids|golden rice carotenoids
589644|NCT00680355|healthy volunteers|healthy volunteers
589645|NCT00680355|retinol equivalence|retinol equivalence
589646|NCT00680342|hepatitis C|hepatitis c
589647|NCT00680329|Adherence|adherence
589648|NCT00680329|Compliance|compliance
589649|NCT00680329|Glaucoma|glaucoma
589650|NCT00680329|Ocular Hypertension|ocular hypertension
589651|NCT00680316|Pulmozyme|pulmozyme
589652|NCT00680316|CF|cf
589653|NCT00680303|Early Stuttering|early stuttering
589654|NCT00680303|Lidcombe Program|lidcombe program
589655|NCT00680303|Stuttering Treatment|stuttering treatment
589656|NCT00680303|Efficiency|efficiency
589657|NCT00680303|Efficacy|efficacy
589658|NCT00680303|Service Delivery|service delivery
589659|NCT00680303|Models of intervention|models of intervention
589660|NCT00680290|exercise, quality of life, cpx|exercise, quality of life, cpx
589661|NCT00680277|spirulina|spirulina
589662|NCT00680277|carotenoids|carotenoids
589663|NCT00680264|Treatment Outcomes|treatment outcomes
589664|NCT00680264|Scoliosis|scoliosis
589665|NCT00680264|Cerebral Palsy|cerebral palsy
589666|NCT00680238|Pregnancy|pregnancy
589667|NCT00680238|implantation|implantation
589668|NCT00680238|miscarriage|miscarriage
589669|NCT00680238|sHLA-G|shla-g
589670|NCT00680225|Choroidal melanoma|choroidal melanoma
589671|NCT00680225|Lucentis|lucentis
589672|NCT00680225|TTT-ICG|ttt-icg
589673|NCT00680212|dietary beta-carotene|dietary beta-carotene
589674|NCT00680212|vitamin A status|vitamin a status
589675|NCT00680212|intrinsically labeled plant foods|intrinsically labeled plant foods
589676|NCT00680199|Insomnia|insomnia
589677|NCT00680199|Primary Insomnia|primary insomnia
589678|NCT00680199|Good Sleepers|good sleepers
589679|NCT00680199|ERP|erp
589680|NCT00680173|Chronic Hepatitis C|chronic hepatitis c
589681|NCT00680173|Single nucleotide polymorphisms|single nucleotide polymorphisms
589682|NCT00680173|Sustained virological response|sustained virological response
589683|NCT00680173|Peginterferon|peginterferon
589684|NCT00680173|Ribavirin|ribavirin
589685|NCT00680160|Onychomycosis|onychomycosis
589686|NCT00680160|Fungal Nail|fungal nail
589687|NCT00680147|HPV|hpv
589688|NCT00680147|Gardasil|gardasil
589689|NCT00680147|African-American|african-american
589690|NCT00680147|adolescent|adolescent
589691|NCT00680147|health behavior|health behavior
589692|NCT00680147|sexually transmitted infections|sexually transmitted infections
589693|NCT00680147|This will enroll 300 mothers of teenage girls and boys to identify barriers to HPV vaccination among low-income, African-American teens.|this will enroll 300 mothers of teenage girls and boys to identify barriers to hpv vaccination among low-income, african-american teens.
589694|NCT00680134|Onychomycosis|onychomycosis
589695|NCT00680134|Fungal Nail|fungal nail
589696|NCT00680121|Alcoholism|alcoholism
589697|NCT00680121|Benfotiamine|benfotiamine
589698|NCT00680121|Thiamine|thiamine
589699|NCT00680095|Onychomycosis|onychomycosis
589700|NCT00680095|Fungal Nail|fungal nail
589701|NCT00680082|statins|statins
589702|NCT00680082|rosuvastatin|rosuvastatin
589703|NCT00680082|cross sectional study|cross sectional study
589704|NCT00680082|France|france
589705|NCT00680082|CV risk factors|cv risk factors
589706|NCT00680069|avian influenza,H5N1,Influenza,parent protocol|avian influenza,h5n1,influenza,parent protocol
589707|NCT00680056|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
589708|NCT00680056|Tiotropium|tiotropium
589709|NCT00680056|Formoterol|formoterol
589710|NCT00680056|Bronchodilator Agents|bronchodilator agents
589711|NCT00680056|Exercise Tolerance|exercise tolerance
589712|NCT00680056|Randomized Controlled Trial [Publication Type]|randomized controlled trial [publication type]
589713|NCT00680056|COPD|copd
589714|NCT00680043|anemia|anemia
589715|NCT00680043|chronic kidney disease|chronic kidney disease
589716|NCT00680043|CKD|ckd
589717|NCT00680043|chronic renal failure|chronic renal failure
589718|NCT00680043|CRF|crf
589719|NCT00680043|erythropoietin|erythropoietin
589720|NCT00680043|EPO|epo
589721|NCT00680043|erythropoiesis stimulating agent|erythropoiesis stimulating agent
589722|NCT00680043|ESA|esa
589723|NCT00680043|Hematide™|hematide™
589724|NCT00680043|hemoglobin|hemoglobin
589725|NCT00680043|Hb|hb
589726|NCT00680043|Hgb|hgb
589727|NCT00680043|Omontys|omontys
589728|NCT00680043|peginesatide|peginesatide
589729|NCT00680043|red blood cell|red blood cell
589730|NCT00680043|red blood cell production|red blood cell production
589731|NCT00680030|impedance|impedance
589732|NCT00680030|manometry|manometry
589733|NCT00680030|motility disorders|motility disorders
589734|NCT00680030|ineffective motility|ineffective motility
589735|NCT00680030|diffuse esophageal spasms|diffuse esophageal spasms
589736|NCT00680030|achlasia-like dysmotility|achlasia-like dysmotility
589737|NCT00680017|Dyslipidemia|dyslipidemia
589738|NCT00680017|Kidney Disease|kidney disease
589739|NCT00680004|Dynamic CTA|dynamic cta
589740|NCT00680004|follow-up|follow-up
589741|NCT00680004|EVAR|evar
589742|NCT00679991|arteriovenous fistula|arteriovenous fistula
589743|NCT00679991|AVF|avf
589744|NCT00679991|hemodialysis|hemodialysis
589745|NCT00679991|vascular access|vascular access
589746|NCT00679991|PRT 201|prt 201
589747|NCT00679991|dose escalation|dose escalation
589748|NCT00679991|dialysis|dialysis
589749|NCT00679991|fistula|fistula
589750|NCT00679991|access|access
589751|NCT00679991|vonapanitase|vonapanitase
589752|NCT00679991|kidney|kidney
589753|NCT00679991|renal|renal
589754|NCT00679978|osteoporosis|osteoporosis
589755|NCT00679978|glucocorticoid|glucocorticoid
589756|NCT00679978|bone mineral density|bone mineral density
589757|NCT00679978|osteonecrosis of the femoral head|osteonecrosis of the femoral head
589758|NCT00679965|Onychomycosis|onychomycosis
589759|NCT00679965|Fungal Nail|fungal nail
589760|NCT00679952|Pancreatic fistula|pancreatic fistula
589761|NCT00679952|Pancreatic duct stent|pancreatic duct stent
589762|NCT00679952|Closed suction drainage|closed suction drainage
589763|NCT00679939|Type 2 diabetes mellitus|type 2 diabetes mellitus
589764|NCT00679939|bone|bone
589765|NCT00679939|x-ray absorptiometry|x-ray absorptiometry
589766|NCT00679939|bone biomarkers|bone biomarkers
589767|NCT00679939|dual-energy|dual-energy
589768|NCT00679939|bone mineral density|bone mineral density
589769|NCT00679926|HIV|hiv
589770|NCT00679926|AIDS|aids
589771|NCT00679926|HIV/AIDS|hiv/aids
589772|NCT00679926|Treatment Naive|treatment naive
589773|NCT00679913|Pancreatic cancer|pancreatic cancer
589774|NCT00679913|Pancreaticoduodenectomy|pancreaticoduodenectomy
589775|NCT00679913|Extended lymphadenectomy|extended lymphadenectomy
589776|NCT00679900|Primary Insomnia|primary insomnia
589777|NCT00679900|Sleep Maintenance Difficulties|sleep maintenance difficulties
589778|NCT00679887|chiropractic|chiropractic
589779|NCT00679887|myofascial trigger points|myofascial trigger points
589780|NCT00679887|ischemic compression|ischemic compression
589781|NCT00679887|shoulder pain|shoulder pain
589782|NCT00679874|Cardiovascular Magnetic Resonance Imaging|cardiovascular magnetic resonance imaging
589783|NCT00679874|Cardiotoxicity|cardiotoxicity
589784|NCT00679874|Anthracyclines|anthracyclines
589785|NCT00679874|Trastuzumab|trastuzumab
589786|NCT00679874|Breast cancer|breast cancer
589787|NCT00679874|Toxicity|toxicity
589788|NCT00679861|primary medical care|primary medical care
589789|NCT00679861|computer expert system|computer expert system
589790|NCT00679861|motivational interviewing|motivational interviewing
589791|NCT00679861|health behavior change counselling|health behavior change counselling
589792|NCT00679861|stages of change|stages of change
589793|NCT00679848|Weight Loss|weight loss
589794|NCT00679848|Transoral Suturing|transoral suturing
589795|NCT00679848|Experimental|experimental
589796|NCT00679822|OSA|osa
589797|NCT00679822|sleep apnea|sleep apnea
589798|NCT00679822|heart failure|heart failure
589799|NCT00679822|CHF|chf
589800|NCT00679822|heart clinic|heart clinic
589801|NCT00679822|clinic|clinic
589802|NCT00679822|obstructive sleep apnea|obstructive sleep apnea
589803|NCT00679809|Resident|resident
589804|NCT00679809|Safety|safety
589805|NCT00679809|Fatigue|fatigue
589806|NCT00679809|Continuity|continuity
589807|NCT00679809|ICU|icu
589808|NCT00679796|varicella|varicella
589809|NCT00679796|case-control|case-control
589810|NCT00679783|Breast cancer|breast cancer
589811|NCT00679783|Ovarian cancer|ovarian cancer
589812|NCT00679783|BRCA|brca
589813|NCT00679783|Triple negative|triple negative
589814|NCT00679783|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
589815|NCT00679783|Known BRCA or Recurrent High Grade Serious/ Undifferentiated Tubo- Ovarian Carcinoma|known brca or recurrent high grade serious/ undifferentiated tubo- ovarian carcinoma
589816|NCT00679783|Known BRCA or Triple Negative Breast Cancer|known brca or triple negative breast cancer
589817|NCT00679770|Onychomycosis|onychomycosis
589818|NCT00679770|Fungal Nail|fungal nail
589819|NCT00679757|Sleep apnea|sleep apnea
589820|NCT00679757|Obstructive sleep apnea|obstructive sleep apnea
589821|NCT00679757|Wound healing|wound healing
589822|NCT00679757|Non-healing wounds|non-healing wounds
589823|NCT00679744|Tay-Sachs disease.|tay-sachs disease.
589824|NCT00679744|Sandhoff disease.|sandhoff disease.
589825|NCT00679744|GM2 Gangliosidosis.|gm2 gangliosidosis.
589826|NCT00679744|β-hexosaminidase deficiency.|β-hexosaminidase deficiency.
589827|NCT00679744|Hexosaminidase|hexosaminidase
589828|NCT00679744|Phase I clinical trial.|phase i clinical trial.
589829|NCT00679731|Psoriasis|psoriasis
589830|NCT00679705|Hemodynamics and arterial function of healthy females|hemodynamics and arterial function of healthy females
589831|NCT00679692|GH,IGF-1, IGFBP-3|gh,igf-1, igfbp-3
589832|NCT00679679|Polycystic ovary syndrome|polycystic ovary syndrome
589833|NCT00679679|Treatment|treatment
589834|NCT00679679|Metformin|metformin
589835|NCT00679666|keratoconus|keratoconus
589836|NCT00679666|ectasia|ectasia
589837|NCT00679666|cross-linking|cross-linking
589838|NCT00679666|riboflavin|riboflavin
589839|NCT00679666|UVA light|uva light
589840|NCT00679666|cornea|cornea
589841|NCT00679640|candesartan|candesartan
589842|NCT00679640|heart failure|heart failure
589843|NCT00679640|cohort study|cohort study
589844|NCT00679640|France|france
589845|NCT00679627|Alzheimer's Disease|alzheimer's disease
589846|NCT00679627|Galantamine|galantamine
589847|NCT00679627|Dementia, Alzheimer type|dementia, alzheimer type
589848|NCT00679627|Memory loss|memory loss
589849|NCT00679614|Tramacet|tramacet
589850|NCT00679614|naloxone|naloxone
589851|NCT00679614|morphine|morphine
589852|NCT00679614|analgesia|analgesia
589853|NCT00679614|elderly|elderly
589854|NCT00679614|elderly patients|elderly patients
589855|NCT00679601|Onychomycosis|onychomycosis
589856|NCT00679601|Fungal Nail|fungal nail
589857|NCT00679588|Digestive System Surgical Procedure|digestive system surgical procedure
589858|NCT00679588|Urologic Surgical Procedure|urologic surgical procedure
589859|NCT00679588|Prevention of venous thromboembolism|prevention of venous thromboembolism
589860|NCT00679588|Abdominal surgery|abdominal surgery
589861|NCT00679575|statins|statins
589862|NCT00679575|myocardial infarction|myocardial infarction
589863|NCT00679575|case-referent study|case-referent study
589864|NCT00679575|France|france
589865|NCT00679549|Heart Failure|heart failure
589866|NCT00679549|Obstructive Sleep Apnea|obstructive sleep apnea
589867|NCT00679549|OSA|osa
589868|NCT00679549|CHF|chf
589869|NCT00679549|Sleep apnea|sleep apnea
589870|NCT00679549|CHD|chd
589871|NCT00679536|Reduced Toxicity|reduced toxicity
589872|NCT00679536|Toxicity|toxicity
589873|NCT00679536|Event Free Survival|event free survival
589874|NCT00679536|Graft vs Host Disease|graft vs host disease
589875|NCT00679523|Onychomycosis|onychomycosis
589876|NCT00679523|Fungal Nail|fungal nail
589877|NCT00679510|Rheumatoid Arthritis|rheumatoid arthritis
589878|NCT00679510|Rosuvastatin|rosuvastatin
589879|NCT00679510|Cardiovascular|cardiovascular
589880|NCT00679510|Intima media thickness|intima media thickness
589881|NCT00679497|Low risk HIV infection|low risk hiv infection
589882|NCT00679497|HIV Seronegativity|hiv seronegativity
589883|NCT00679497|HIV Preventive Vaccine|hiv preventive vaccine
589884|NCT00679471|pre-term infants|pre-term infants
589885|NCT00679471|full-term infants|full-term infants
589886|NCT00679471|MRI|mri
589887|NCT00679471|brain structure development|brain structure development
589888|NCT00679471|pre term|pre term
589889|NCT00679471|full term|full term
589890|NCT00679458|analgesia|analgesia
589891|NCT00679458|pain|pain
589892|NCT00679458|buprenorphine|buprenorphine
589893|NCT00679458|opioid|opioid
589894|NCT00679458|naloxone|naloxone
589895|NCT00679445|Macular|macular
589896|NCT00679445|Degeneration|degeneration
589897|NCT00679445|AMD|amd
589898|NCT00679445|Wet Age-related macular degeneration|wet age-related macular degeneration
589899|NCT00679432|Ulcerative colitis|ulcerative colitis
589900|NCT00679406|Chronic Insomnia lasting more than 1 month|chronic insomnia lasting more than 1 month
589901|NCT00679393|Calcaneus|calcaneus
589902|NCT00679393|Intra-articular fracture|intra-articular fracture
589903|NCT00679393|open reduction internal fixation|open reduction internal fixation
589904|NCT00679393|primary subtalar fusion|primary subtalar fusion
589905|NCT00679380|Ulcerative colitis|ulcerative colitis
589906|NCT00679367|primary systemic amyloidosis|primary systemic amyloidosis
589907|NCT00679341|HER2-positive breast cancer|her2-positive breast cancer
589908|NCT00679341|HER2|her2
589909|NCT00679341|Herceptin|herceptin
589910|NCT00679341|Taxotere|taxotere
589911|NCT00679341|MBC|mbc
589912|NCT00679341|Breast cancer|breast cancer
589913|NCT00679341|TDM1|tdm1
589914|NCT00679341|TDM-1|tdm-1
589915|NCT00679341|HER2-positive|her2-positive
589916|NCT00679341|HER2+|her2+
589917|NCT00679341|HER2 positive breast cancer|her2 positive breast cancer
589918|NCT00679341|HER2+ breast cancer|her2+ breast cancer
589919|NCT00679341|Armed Herceptin|armed herceptin
589920|NCT00679341|Trastuzumab emtansine|trastuzumab emtansine
589921|NCT00679341|Trastuzumab DM1|trastuzumab dm1
589922|NCT00679315|female voiding dysfunction|female voiding dysfunction
589923|NCT00679315|alpha adrenoreceptor antagonists|alpha adrenoreceptor antagonists
589924|NCT00679315|IPSS or American Urological Association symptom index|ipss or american urological association symptom index
589925|NCT00679302|skin abscess|skin abscess
589926|NCT00679302|CA-MRSA|ca-mrsa
589927|NCT00679289|KW2871|kw2871
589928|NCT00679289|Ecromeximab|ecromeximab
589929|NCT00679289|Anti-ganglioside|anti-ganglioside
589930|NCT00679289|Antibody|antibody
589931|NCT00679289|Interferon alpha|interferon alpha
589932|NCT00679289|Metastatic melanoma|metastatic melanoma
589933|NCT00679276|vaginal prolapse|vaginal prolapse
589934|NCT00679263|asthma|asthma
589935|NCT00679263|randomized|randomized
589936|NCT00679263|placebo controlled|placebo controlled
589937|NCT00679263|dose escalation|dose escalation
589938|NCT00679263|safety|safety
589939|NCT00679263|efficacy|efficacy
589940|NCT00679263|single blind|single blind
589941|NCT00679263|MN-221|mn-221
589942|NCT00679250|allergic rhinitis|allergic rhinitis
589943|NCT00679250|levocetirizine|levocetirizine
589944|NCT00679250|nasal provocation testing|nasal provocation testing
589945|NCT00679250|nasal allergen challenge|nasal allergen challenge
589946|NCT00679250|nasal adenosine monophosphate challenge|nasal adenosine monophosphate challenge
589947|NCT00679224|Pulmonary Arterial Hypertesion|pulmonary arterial hypertesion
589948|NCT00679224|observational safety|observational safety
589949|NCT00679211|HER2-positive breast cancer|her2-positive breast cancer
589950|NCT00679211|HER2|her2
589951|NCT00679211|MBC|mbc
589952|NCT00679211|Trastuzumab emtansine|trastuzumab emtansine
589953|NCT00679198|osteoporosis|osteoporosis
589954|NCT00679198|fracture|fracture
589955|NCT00679198|communication|communication
589956|NCT00679198|prescription medication|prescription medication
589957|NCT00679185|fatigue|fatigue
589958|NCT00679185|stage I breast cancer|stage i breast cancer
589959|NCT00679185|stage II breast cancer|stage ii breast cancer
589960|NCT00679185|stage IIIA breast cancer|stage iiia breast cancer
589961|NCT00679185|stage IIIB breast cancer|stage iiib breast cancer
589962|NCT00679185|stage IIIC breast cancer|stage iiic breast cancer
589963|NCT00679185|lymphedema|lymphedema
589964|NCT00679133|c-Met|c-met
589965|NCT00679133|VEGFR|vegfr
589966|NCT00679133|Ron|ron
589967|NCT00679133|Cancer|cancer
589968|NCT00679133|Tumor|tumor
589969|NCT00679133|Safety|safety
589970|NCT00679133|Phase 1|phase 1
589971|NCT00679120|Unicompartmental osteoarthrosis|unicompartmental osteoarthrosis
589972|NCT00679120|RSA|rsa
589973|NCT00679120|Bone-remodelling|bone-remodelling
589974|NCT00679107|Degenerative Disc Disease|degenerative disc disease
589975|NCT00679068|respiratory mechanics|respiratory mechanics
589976|NCT00679068|bosentan|bosentan
589977|NCT00679068|exercise capacity|exercise capacity
589978|NCT00679042|Diabetes Mellitus Type 1|diabetes mellitus type 1
589979|NCT00679042|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
589980|NCT00679042|Islets of Langerhans Transplantation|islets of langerhans transplantation
589981|NCT00679042|Allogeneic Islet transplantation|allogeneic islet transplantation
589982|NCT00679003|Crohn's disease|crohn's disease
589983|NCT00679003|Ulcerative colitis|ulcerative colitis
589984|NCT00679003|Inflammatory bowel disease|inflammatory bowel disease
589985|NCT00679003|Illness behavior|illness behavior
589986|NCT00679003|Cognitive behavioral therapy|cognitive behavioral therapy
589987|NCT00678990|Islets of Langerhans|islets of langerhans
589988|NCT00678990|islets|islets
589989|NCT00678990|heparin|heparin
589990|NCT00678977|pharmacokinetics|pharmacokinetics
589991|NCT00678977|cisplatin|cisplatin
589992|NCT00678977|pazopanib (GW786034)|pazopanib (gw786034)
589993|NCT00678977|Solid tumors|solid tumors
589994|NCT00678977|anti-angiogenesis|anti-angiogenesis
589995|NCT00678977|gemcitabine|gemcitabine
589996|NCT00678964|NSCLC|nsclc
589997|NCT00678964|Elderly patients|elderly patients
589998|NCT00678938|smoking reduction|smoking reduction
589999|NCT00678938|smoking cessation|smoking cessation
590000|NCT00678938|stages of change|stages of change
590001|NCT00678938|expert system interventions|expert system interventions
590002|NCT00678912|mechanical ventilation|mechanical ventilation
590003|NCT00678912|automated weaning|automated weaning
590004|NCT00678912|children|children
590005|NCT00678899|High frequency severe to profound|high frequency severe to profound
590006|NCT00678886|Type 1 diabetes|type 1 diabetes
590007|NCT00678886|new onset type 1 diabetes|new onset type 1 diabetes
590008|NCT00678886|T1DM|t1dm
590009|NCT00678886|Type l diabetes|type l diabetes
590010|NCT00678886|juvenile diabetes|juvenile diabetes
590011|NCT00678873|Single Incision|single incision
590012|NCT00678873|Single Access|single access
590013|NCT00678873|Surgery|surgery
590014|NCT00678873|Cholecystectomy|cholecystectomy
590015|NCT00678860|Questionnaire|questionnaire
590016|NCT00678860|Computer Assisted Interface|computer assisted interface
590017|NCT00678860|Quality of Life|quality of life
590018|NCT00678860|Dry Eye|dry eye
590019|NCT00678860|Ocular Surface Disease|ocular surface disease
590020|NCT00678860|Healthy Volunteer|healthy volunteer
590021|NCT00678860|HV|hv
590022|NCT00678847|bio-electrical stimulation therapy|bio-electrical stimulation therapy
590023|NCT00678847|chronic venous ulcers|chronic venous ulcers
590024|NCT00678847|microcurrent|microcurrent
590025|NCT00678847|chronic wounds|chronic wounds
590026|NCT00678847|complete healing|complete healing
590027|NCT00678821|Exercise|exercise
590028|NCT00678821|Pulmonary Hypertension|pulmonary hypertension
590029|NCT00678821|Pulmonary Rehabilitation|pulmonary rehabilitation
590030|NCT00678821|Interstitial Lung Disease|interstitial lung disease
590031|NCT00678795|Detrusor overactivity|detrusor overactivity
590032|NCT00678795|Multiple Sclerosis|multiple sclerosis
590033|NCT00678782|knee|knee
590034|NCT00678782|synovitis|synovitis
590035|NCT00678782|arthritis|arthritis
590036|NCT00678782|rheumatoid arthritis|rheumatoid arthritis
590037|NCT00678782|psoriatic arthritis|psoriatic arthritis
590038|NCT00678782|spondyloarthropathies|spondyloarthropathies
590039|NCT00678782|intraarticular|intraarticular
590040|NCT00678782|etanercept|etanercept
590041|NCT00678756|Psoriasis vulgaris,|psoriasis vulgaris,
590042|NCT00678756|vitamin D, UVB-phototherapy, ketokonazol,|vitamin d, uvb-phototherapy, ketokonazol,
590043|NCT00678756|Optical Coherence Tomography,|optical coherence tomography,
590044|NCT00678756|local PASI, Nizoral|local pasi, nizoral
590045|NCT00678743|cholesterol|cholesterol
590046|NCT00678743|dyslipidemia|dyslipidemia
590047|NCT00678743|omega 3|omega 3
590049|NCT00678730|COMT gene polymorphism|comt gene polymorphism
590050|NCT00678730|schizophrenia|schizophrenia
590051|NCT00678730|cannabis use|cannabis use
590052|NCT00678717|abdominal|abdominal
590053|NCT00678717|Pelvic|pelvic
590054|NCT00678717|Pain|pain
590055|NCT00678717|SCS|scs
590056|NCT00678717|Healthy and Chronic Visceral Pain patients|healthy and chronic visceral pain patients
590057|NCT00678717|Chronic Visceral Pain and spinal cord stimulator|chronic visceral pain and spinal cord stimulator
590058|NCT00678704|Vardenafil|vardenafil
590059|NCT00678704|PDE5 inhibitor|pde5 inhibitor
590060|NCT00678704|Erectile Dysfunction|erectile dysfunction
590061|NCT00678704|Diabetes Mellitus|diabetes mellitus
590062|NCT00678704|Sexual Dysfunction|sexual dysfunction
590063|NCT00678691|fibromyalgia|fibromyalgia
590064|NCT00678691|fatigue|fatigue
590065|NCT00678678|Physiotherapy|physiotherapy
590066|NCT00678678|Breathing exercises|breathing exercises
590067|NCT00678678|Bariatric Surgery|bariatric surgery
590068|NCT00678678|Laparoscopy|laparoscopy
590069|NCT00678665|ecg|ecg
590070|NCT00678665|TSA2000|tsa2000
590071|NCT00678665|Heart rate variability|heart rate variability
590072|NCT00678665|wavelets|wavelets
590271|NCT00677937|prevention|prevention
590073|NCT00678652|Meningococcal vaccine|meningococcal vaccine
590074|NCT00678652|Neisseria meningitidis|neisseria meningitidis
590075|NCT00678639|ACS|acs
590076|NCT00678639|Acute Coronary Syndrome|acute coronary syndrome
590077|NCT00678639|Chest pain|chest pain
590078|NCT00678639|Cardiac MRI|cardiac mri
590079|NCT00678639|CMR|cmr
590080|NCT00678639|Risk Stratification|risk stratification
590081|NCT00678639|Emergency Department|emergency department
590082|NCT00678626|Key words: Docetaxel; breast cancer; breast diseases; breast neoplasms; antineoplastic agents; neoplasms;HER-2 negative; Stage IIIB or IV breast cancer.|key words: docetaxel; breast cancer; breast diseases; breast neoplasms; antineoplastic agents; neoplasms;her-2 negative; stage iiib or iv breast cancer.
590083|NCT00678613|probiotics|probiotics
590084|NCT00678613|cirrhosis|cirrhosis
590085|NCT00678613|prophylaxis|prophylaxis
590086|NCT00678613|cirrhotic|cirrhotic
590087|NCT00678613|patients|patients
590088|NCT00678613|with|with
590089|NCT00678613|ascites|ascites
590090|NCT00678613|using|using
590091|NCT00678600|Informatics|informatics
590092|NCT00678600|Alerts|alerts
590093|NCT00678600|Toxicity|toxicity
590094|NCT00678600|Virologic failure|virologic failure
590095|NCT00678600|Suboptimal follow up|suboptimal follow up
590096|NCT00678587|elective invasive procedure.|elective invasive procedure.
590097|NCT00678587|platelet transfusion|platelet transfusion
590098|NCT00678587|chronic liver disease-related thrombocytopenia|chronic liver disease-related thrombocytopenia
590099|NCT00678587|platelets|platelets
590100|NCT00678587|thrombopoietin|thrombopoietin
590101|NCT00678574|hormones|hormones
590102|NCT00678574|menses|menses
590103|NCT00678574|PMS|pms
590104|NCT00678574|PMDD|pmdd
590105|NCT00678561|chronic plaque psoriasis, topical treatment|chronic plaque psoriasis, topical treatment
590106|NCT00678535|1st line treatment for Gastric Cancer|1st line treatment for gastric cancer
590107|NCT00678535|Cetuximab|cetuximab
590108|NCT00678535|Capecitabine|capecitabine
590109|NCT00678535|Xeloda|xeloda
590110|NCT00678535|Cisplatin|cisplatin
590111|NCT00678535|Progression-free survival|progression-free survival
590112|NCT00678522|Atorvastatin|atorvastatin
590113|NCT00678522|Renal function|renal function
590114|NCT00678522|Hemodynamics|hemodynamics
590115|NCT00678522|Diabetes type II|diabetes type ii
590116|NCT00678522|sodium excretion|sodium excretion
590117|NCT00678509|HLA-A*2402|hla-a*2402
590118|NCT00678509|Peptide Vaccine|peptide vaccine
590119|NCT00678509|TTK|ttk
590120|NCT00678496|CBT-software|cbt-software
590121|NCT00678496|Computerised Cognitive Behavioural Therapy|computerised cognitive behavioural therapy
590122|NCT00678496|CCBT|ccbt
590123|NCT00678496|Cognitive Therapy|cognitive therapy
590124|NCT00678496|Therapy, Computer-Assisted|therapy, computer-assisted
590125|NCT00678496|Depression|depression
590126|NCT00678496|Multiple Sclerosis|multiple sclerosis
590127|NCT00678483|Cholesterol|cholesterol
590128|NCT00678483|HDL|hdl
590129|NCT00678483|triglycerides|triglycerides
590130|NCT00678483|insulin|insulin
590131|NCT00678483|blood glucose|blood glucose
590132|NCT00678457|alcohol dependence|alcohol dependence
590133|NCT00678457|alcohol abuse|alcohol abuse
590134|NCT00678457|drinking|drinking
590135|NCT00678457|alcohol|alcohol
590136|NCT00678444|Anxiety|anxiety
590137|NCT00678444|Satisfaction|satisfaction
590138|NCT00678444|Incomplete bladder emptying|incomplete bladder emptying
590139|NCT00678444|Clean Intermittent Self-catheterization|clean intermittent self-catheterization
590140|NCT00678444|Prolapse/incontinence surgery|prolapse/incontinence surgery
590141|NCT00678431|Alzheimer's Disease|alzheimer's disease
590142|NCT00678431|Dementia|dementia
590143|NCT00678431|Nutritional Supplement|nutritional supplement
590144|NCT00678431|Resveratrol|resveratrol
590145|NCT00678418|Addiction|addiction
590146|NCT00678418|Opiate dependence|opiate dependence
590147|NCT00678418|Inpatient detoxification|inpatient detoxification
590148|NCT00678418|opioid dependence|opioid dependence
590149|NCT00678418|heroin dependence|heroin dependence
590150|NCT00678405|Breathlessness|breathlessness
590151|NCT00678405|Dyspnoea|dyspnoea
590152|NCT00678405|Dyspnea|dyspnea
590153|NCT00678405|Palliative care|palliative care
590154|NCT00678405|RCT|rct
590155|NCT00678405|Randomised controlled trial|randomised controlled trial
590156|NCT00678405|Lung cancer|lung cancer
590157|NCT00678405|COPD|copd
590158|NCT00678405|Heart failure|heart failure
590159|NCT00678405|Chronic respiratory disease|chronic respiratory disease
590160|NCT00678392|Axitinib in Second Line Treatment of Patients With Metastatic Renal Cell Cancer|axitinib in second line treatment of patients with metastatic renal cell cancer
590161|NCT00678379|Tonsillectomy|tonsillectomy
590162|NCT00678379|Postoperative Pain|postoperative pain
590163|NCT00678379|Clonidine|clonidine
590164|NCT00678379|Anesthetics, Local|anesthetics, local
590165|NCT00678366|laparoscopy|laparoscopy
590166|NCT00678366|carbon dioxide|carbon dioxide
590167|NCT00678366|oxygen|oxygen
590168|NCT00678366|pain|pain
590169|NCT00678366|inflammation|inflammation
590170|NCT00678353|Degenerative disc disease|degenerative disc disease
590171|NCT00678340|Randomized Controlled Trial|randomized controlled trial
590272|NCT00677937|education|education
590172|NCT00678340|Single-Blind Study|single-blind study
590173|NCT00678340|Catheter Ablation|catheter ablation
590174|NCT00678327|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
590175|NCT00678327|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
590176|NCT00678327|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
590177|NCT00678327|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
590178|NCT00678327|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
590179|NCT00678327|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
590180|NCT00678327|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
590181|NCT00678314|Anesthetics|anesthetics
590182|NCT00678314|Local|local
590183|NCT00678314|ropivacaine|ropivacaine
590184|NCT00678314|Surgery|surgery
590185|NCT00678314|Hand|hand
590186|NCT00678314|carpel tunnel|carpel tunnel
590187|NCT00678314|Carpal tunnel surgery|carpal tunnel surgery
590188|NCT00678301|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
590189|NCT00678301|Streptococcus pneumoniae|streptococcus pneumoniae
590190|NCT00678288|Renal Cell Cancer|renal cell cancer
590191|NCT00678288|Interferon|interferon
590192|NCT00678275|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
590193|NCT00678262|pain|pain
590195|NCT00678262|Heart rate variability|heart rate variability
590196|NCT00678262|wavelets|wavelets
590197|NCT00678249|Hemodialysis|hemodialysis
590198|NCT00678249|Vascular Prosthesis|vascular prosthesis
590199|NCT00678249|stenoses|stenoses
590200|NCT00678249|grafts|grafts
590201|NCT00678236|RSA|rsa
590202|NCT00678236|Gonarthritis|gonarthritis
590203|NCT00678236|Bone Cement|bone cement
590204|NCT00678210|dose response; PASI 75 response endpoint; subjects with moderate to severe chronic plaque psoriasis|dose response; pasi 75 response endpoint; subjects with moderate to severe chronic plaque psoriasis
590205|NCT00678197|Quality of care|quality of care
590206|NCT00678197|Access to care|access to care
590207|NCT00678197|Health Outcomes|health outcomes
590208|NCT00678184|Atorvastatin|atorvastatin
590209|NCT00678184|healthy|healthy
590210|NCT00678184|sodium excretion|sodium excretion
590211|NCT00678184|hemodynamics|hemodynamics
590212|NCT00678184|tubular function|tubular function
590213|NCT00678171|Degenerative Disc Disease|degenerative disc disease
590214|NCT00678158|High Does Single Fraction IGRT|high does single fraction igrt
590215|NCT00678158|Bone|bone
590216|NCT00678158|Lymph Nodes|lymph nodes
590217|NCT00678158|Soft Tissue|soft tissue
590218|NCT00678145|Diabetes|diabetes
590219|NCT00678145|Hypoglycemia|hypoglycemia
590220|NCT00678145|HAAF|haaf
590221|NCT00678145|Counterregulation|counterregulation
590222|NCT00678132|PARP Inhibitor|parp inhibitor
590223|NCT00678132|Combination Study|combination study
590224|NCT00678132|Chemotherapy|chemotherapy
590225|NCT00678132|Advanced Cancer|advanced cancer
590226|NCT00678132|Neoplasms|neoplasms
590227|NCT00678132|Cancer|cancer
590228|NCT00678132|Solid Tumor|solid tumor
590229|NCT00678119|Kidney cancer|kidney cancer
590230|NCT00678119|Renal cancer|renal cancer
590231|NCT00678119|Renal Cell Carcinoma|renal cell carcinoma
590232|NCT00678106|dalbavancin adolescent subjects|dalbavancin adolescent subjects
590233|NCT00678093|Low back pain|low back pain
590234|NCT00678093|Manual therapy|manual therapy
590235|NCT00678093|Mulligan snag|mulligan snag
590236|NCT00678080|Type 2 diabetes mellitus|type 2 diabetes mellitus
590237|NCT00678080|Pregnancy|pregnancy
590238|NCT00678080|Metformin|metformin
590239|NCT00678080|Insulin|insulin
590240|NCT00678080|Pregnant women|pregnant women
590241|NCT00678067|Hypercholesterolemic children|hypercholesterolemic children
590242|NCT00678067|Docosahexaenoic acid|docosahexaenoic acid
590243|NCT00678067|Eicosapentaenoic acid|eicosapentaenoic acid
590244|NCT00678067|Blood lipid profile|blood lipid profile
590245|NCT00678041|urinary catheterization|urinary catheterization
590246|NCT00678041|urinary tract infection|urinary tract infection
590247|NCT00678041|urinary incontinence|urinary incontinence
590248|NCT00678041|pelvic floor prolapse|pelvic floor prolapse
590249|NCT00678041|antibiotics|antibiotics
590250|NCT00678028|MBL, UTI|mbl, uti
590251|NCT00678015|NDGA|ndga
590252|NCT00678015|Prostate Cancer|prostate cancer
590253|NCT00678002|solid organ transplant|solid organ transplant
590254|NCT00677989|perforated appendicitis|perforated appendicitis
590255|NCT00677989|laparoscopic appendectomy|laparoscopic appendectomy
590256|NCT00677989|open appendectomy|open appendectomy
590257|NCT00677989|cytokines|cytokines
590258|NCT00677989|free radicals|free radicals
590259|NCT00677989|oxidized proteins|oxidized proteins
590260|NCT00677976|fMRI|fmri
590261|NCT00677976|IBS|ibs
590262|NCT00677976|Brain Activation|brain activation
590263|NCT00677963|carotid|carotid
590264|NCT00677963|atherosclerosis|atherosclerosis
590265|NCT00677963|arteriosclerosis|arteriosclerosis
590266|NCT00677963|plaque|plaque
590267|NCT00677963|neovascularization|neovascularization
590268|NCT00677963|carotid endarterectomy|carotid endarterectomy
590269|NCT00677950|Degenerative Disc Disease|degenerative disc disease
590270|NCT00677937|diabetes mellitus|diabetes mellitus
590273|NCT00677937|impaired glucose tolerance|impaired glucose tolerance
590274|NCT00677937|multi-ethnic|multi-ethnic
590275|NCT00677924|Colorectal Neoplasms|colorectal neoplasms
590276|NCT00677924|Colorectal Tumors|colorectal tumors
590277|NCT00677924|Colorectal Carcinoma|colorectal carcinoma
590278|NCT00677911|Chronic pain|chronic pain
590279|NCT00677911|Interleukin-6|interleukin-6
590280|NCT00677911|pain catastrophizing|pain catastrophizing
590281|NCT00677911|cytokines|cytokines
590282|NCT00677911|cortisol|cortisol
590283|NCT00677898|Patient-Centered Care|patient-centered care
590284|NCT00677898|Adverse effects|adverse effects
590285|NCT00677898|Antipsychotics|antipsychotics
590286|NCT00677885|Alzheimer Disease|alzheimer disease
590287|NCT00677885|Parkinson's Disease|parkinson's disease
590288|NCT00677885|Frontotemporal Dementia|frontotemporal dementia
590289|NCT00677885|PET Imaging|pet imaging
590290|NCT00677885|AD|ad
590291|NCT00677885|Parkinson Disease|parkinson disease
590292|NCT00677885|PD|pd
590293|NCT00677872|Moderate to severe COPD and coincident pulmonary hypertension|moderate to severe copd and coincident pulmonary hypertension
590294|NCT00677859|Leukemia|leukemia
590295|NCT00677859|Graft vs. Host Disease|graft vs. host disease
590296|NCT00677859|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
590297|NCT00677859|Bone Marrow Transplant|bone marrow transplant
590298|NCT00677859|Myelodysplasia|myelodysplasia
590299|NCT00677846|contrast agent ultrasound, vein thrombosis, vascularization|contrast agent ultrasound, vein thrombosis, vascularization
590300|NCT00677833|P. Falciparum Malaria|p. falciparum malaria
590301|NCT00677833|drug treatment|drug treatment
590302|NCT00677833|clinical trial|clinical trial
590303|NCT00677820|Influenza|influenza
590304|NCT00677820|FluMist|flumist
590305|NCT00677820|vaccine|vaccine
590306|NCT00677820|prevention|prevention
590307|NCT00677820|trivalent|trivalent
590308|NCT00677807|COPD|copd
590309|NCT00677807|adults|adults
590310|NCT00677807|β2-agonist|β2-agonist
590311|NCT00677807|indacaterol|indacaterol
590312|NCT00677794|Video Capsule Endoscopy|video capsule endoscopy
590313|NCT00677794|Small Bowel|small bowel
590314|NCT00677768|Biomarkers|biomarkers
590315|NCT00677768|Plasma|plasma
590316|NCT00677768|Cerebrospinal Fluid|cerebrospinal fluid
590317|NCT00677768|DNA|dna
590318|NCT00677768|Serum|serum
590319|NCT00677755|Medical abortion|medical abortion
590320|NCT00677755|emergency contraception|emergency contraception
590321|NCT00677755|mifepristone|mifepristone
590322|NCT00677742|oral contraception|oral contraception
590323|NCT00677742|hormonal contraception|hormonal contraception
590324|NCT00677742|contraceptive behavior|contraceptive behavior
590325|NCT00677742|patient compliance|patient compliance
590326|NCT00677729|bronchiolitis|bronchiolitis
590327|NCT00677729|hypertonic saline|hypertonic saline
590328|NCT00677729|infants|infants
590329|NCT00677716|glioblastoma multiforme|glioblastoma multiforme
590330|NCT00677716|GBM|gbm
590331|NCT00677716|brain cancer|brain cancer
590332|NCT00677716|Cotara|cotara
590333|NCT00677716|radioactive isotope|radioactive isotope
590334|NCT00677716|monoclonal antibody|monoclonal antibody
590335|NCT00677716|Glioblastoma multiforme at first relapse|glioblastoma multiforme at first relapse
590336|NCT00677703|birth control pills|birth control pills
590337|NCT00677703|contraception|contraception
590338|NCT00677703|continuation|continuation
590339|NCT00677703|text messaging|text messaging
590340|NCT00677703|contraceptive continuation|contraceptive continuation
590341|NCT00677703|contraceptive knowledge|contraceptive knowledge
590342|NCT00677690|COPD|copd
590343|NCT00677677|Lung transplant|lung transplant
590344|NCT00677677|Liver transplant|liver transplant
590345|NCT00677677|Kidney transplant|kidney transplant
590346|NCT00677677|Pancreas transplant|pancreas transplant
590347|NCT00677677|HPV|hpv
590348|NCT00677677|Human Papillomavirus Quadrivalent Vaccine|human papillomavirus quadrivalent vaccine
590349|NCT00677664|diabetic retinopathy|diabetic retinopathy
590350|NCT00677664|panretinal photocoagulation|panretinal photocoagulation
590351|NCT00677664|copaxone|copaxone
590352|NCT00677664|nerve fiber layer thickness|nerve fiber layer thickness
590353|NCT00677664|retinal function|retinal function
590354|NCT00677651|adipose|adipose
590355|NCT00677651|lean|lean
590356|NCT00677651|obese|obese
590357|NCT00677651|overweight|overweight
590358|NCT00677651|healthy|healthy
590359|NCT00677625|Liver|liver
590360|NCT00677625|Transplant|transplant
590361|NCT00677612|HLA-A*0201|hla-a*0201
590362|NCT00677612|Peptide Vaccine|peptide vaccine
590363|NCT00677612|VEGFR1|vegfr1
590364|NCT00677612|VEGFR2|vegfr2
590365|NCT00677599|Cardiovascular disease|cardiovascular disease
590366|NCT00677599|type 2 diabetes|type 2 diabetes
590367|NCT00677599|flavonoids|flavonoids
590368|NCT00677599|cocoa|cocoa
590369|NCT00677599|soy|soy
590370|NCT00677599|epicatechin|epicatechin
590371|NCT00677599|postmenopausal|postmenopausal
590372|NCT00677599|carotid intima media thickness|carotid intima media thickness
590373|NCT00677599|plaque volume|plaque volume
590374|NCT00677586|colorectal neoplasms|colorectal neoplasms
590375|NCT00677586|liver metastasis|liver metastasis
590376|NCT00677586|surgery|surgery
590377|NCT00677573|ART|art
590378|NCT00677573|poor responder|poor responder
590379|NCT00677573|GnRH antagonist|gnrh antagonist
590380|NCT00677573|Gonadotropins|gonadotropins
590381|NCT00677560|resistance|resistance
590382|NCT00677560|reactance|reactance
590383|NCT00677560|inflammation|inflammation
590384|NCT00677547|Kidney|kidney
590385|NCT00677547|Influenza vaccine|influenza vaccine
590386|NCT00677547|CMI|cmi
590387|NCT00677534|Endstage renal disease|endstage renal disease
590388|NCT00677534|Vitamin D|vitamin d
590389|NCT00677534|Monocyte function|monocyte function
590390|NCT00677508|Constipation|constipation
590391|NCT00677508|Fecal incontinence|fecal incontinence
590392|NCT00677508|Quality of life|quality of life
590393|NCT00677508|Health related quality of life|health related quality of life
590394|NCT00677495|Gluten-free diet|gluten-free diet
590395|NCT00677495|Celiac Disease|celiac disease
590396|NCT00677495|Genetic predisposition|genetic predisposition
590397|NCT00677495|Phage display library|phage display library
590398|NCT00677495|Autoimmune diseases|autoimmune diseases
590399|NCT00677482|liver transplant|liver transplant
590400|NCT00677482|lung transplant|lung transplant
590401|NCT00677482|kidney transplant|kidney transplant
590402|NCT00677482|heart transplant|heart transplant
590403|NCT00677482|CMV microRNA|cmv microrna
590404|NCT00677469|Hyperthyroidism|hyperthyroidism
590405|NCT00677469|Cholestyramine|cholestyramine
590406|NCT00677456|Gastric Cancer|gastric cancer
590407|NCT00677456|total gastrectomy|total gastrectomy
590408|NCT00677456|reconstruction|reconstruction
590409|NCT00677456|life quality|life quality
590410|NCT00677443|metastatic colorectal cancer|metastatic colorectal cancer
590411|NCT00677443|S-1|s-1
590412|NCT00677443|Capecitabine|capecitabine
590413|NCT00677443|Oxaliplatin|oxaliplatin
590414|NCT00677443|non-inferiority study|non-inferiority study
590415|NCT00677430|Breast Cancer|breast cancer
590416|NCT00677430|Breast Reconstruction|breast reconstruction
590417|NCT00677430|Digital Imaging|digital imaging
590418|NCT00677430|Questionnaire|questionnaire
590419|NCT00677430|Survey|survey
590420|NCT00677404|Peripheral vascular diseases|peripheral vascular diseases
590421|NCT00677404|chronic lower limb ischemia|chronic lower limb ischemia
590422|NCT00677391|Obesity|obesity
590423|NCT00677378|TRPV1|trpv1
590424|NCT00677378|Nerve growth factor|nerve growth factor
590425|NCT00677378|Capsaicin|capsaicin
590426|NCT00677378|TrkA|trka
590427|NCT00677378|Retrosternal pain|retrosternal pain
590428|NCT00677378|Epigastric pain|epigastric pain
590429|NCT00677378|Esophagitis|esophagitis
590430|NCT00677378|Gastrointestinal symptoms|gastrointestinal symptoms
590431|NCT00677352|Panic Disorder|panic disorder
590432|NCT00677339|Tuberculosis|tuberculosis
590433|NCT00677339|Adjunctive therapy|adjunctive therapy
590434|NCT00677339|L-arginine|l-arginine
590435|NCT00677339|Nitric oxide|nitric oxide
590436|NCT00677339|Vitamin D|vitamin d
590437|NCT00677326|HLA-A*0201|hla-a*0201
590438|NCT00677326|Peptide Vaccine|peptide vaccine
590439|NCT00677326|VEGFR1|vegfr1
590440|NCT00677326|VEGFR2|vegfr2
590441|NCT00677313|metreleptin|metreleptin
590442|NCT00677313|leptin|leptin
590443|NCT00677313|Amylin|amylin
590444|NCT00677313|diabetes mellitus|diabetes mellitus
590445|NCT00677313|hypertriglyceridemia|hypertriglyceridemia
590446|NCT00677313|lipodystrophy|lipodystrophy
590447|NCT00677300|HIV|hiv
590448|NCT00677300|Treatment Naive|treatment naive
590449|NCT00677287|HLA-A*2402|hla-a*2402
590450|NCT00677287|Peptide Vaccine|peptide vaccine
590451|NCT00677287|RNF43|rnf43
590452|NCT00677287|TOMM34|tomm34
590453|NCT00677287|VEGFR1|vegfr1
590454|NCT00677287|VEGFR2|vegfr2
590455|NCT00677274|Epidural analgesia|epidural analgesia
590456|NCT00677274|Patient-controlled analgesia|patient-controlled analgesia
590457|NCT00677261|Knee|knee
590458|NCT00677261|Arthroplasty|arthroplasty
590459|NCT00677261|Sciatic|sciatic
590460|NCT00677261|Nerve|nerve
590461|NCT00677261|Block|block
590462|NCT00677261|Regional|regional
590463|NCT00677261|Anesthesia|anesthesia
590464|NCT00677261|Infiltration|infiltration
590465|NCT00677261|Local Anesthetic|local anesthetic
590466|NCT00677261|Analgesia|analgesia
590467|NCT00677248|Eprotirome|eprotirome
590468|NCT00677248|KB2115|kb2115
590469|NCT00677248|dyslipidemia|dyslipidemia
590470|NCT00677248|hypercholesterolemia|hypercholesterolemia
590471|NCT00677248|hypertriglyceridemia|hypertriglyceridemia
590472|NCT00677235|Hemodialysis|hemodialysis
590473|NCT00677235|Vascular Prosthesis|vascular prosthesis
590474|NCT00677235|Stenosis|stenosis
590475|NCT00677235|End-stage Renal Disease (ESRD)|end-stage renal disease (esrd)
590476|NCT00677222|Acute Myocardial Infarction, Heart Attack|acute myocardial infarction, heart attack
590477|NCT00677209|house dust mite|house dust mite
590478|NCT00677209|asthma|asthma
590479|NCT00677209|autovaccine|autovaccine
590480|NCT00677209|allergy|allergy
590481|NCT00677196|PNL|pnl
590482|NCT00677196|Lithoclast|lithoclast
590483|NCT00677196|Stonebreaker|stonebreaker
590484|NCT00677196|efficiency stone fragmentation|efficiency stone fragmentation
590485|NCT00677183|NASH|nash
590486|NCT00677183|Biomarker|biomarker
590487|NCT00677157|Fatigue|fatigue
590488|NCT00677157|Fibromyalgia|fibromyalgia
590489|NCT00677157|Pain|pain
590490|NCT00677157|Complex Regional Pain Syndrome|complex regional pain syndrome
590491|NCT00677157|Reflex Sympathetic Dystrophy|reflex sympathetic dystrophy
590492|NCT00677157|CPRS|cprs
590493|NCT00677157|RSD|rsd
590494|NCT00677144|Colorectal Neoplasm|colorectal neoplasm
590495|NCT00677144|S-1|s-1
590496|NCT00677144|Capecitabine|capecitabine
590497|NCT00677144|Oxaliplatin|oxaliplatin
590498|NCT00677131|pediatrics|pediatrics
590499|NCT00677131|antibiotics|antibiotics
590500|NCT00677131|patient education|patient education
590501|NCT00677118|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
590502|NCT00677118|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
590503|NCT00677118|Adjuvant chemotherapy|adjuvant chemotherapy
590504|NCT00677118|Clinical trial|clinical trial
590505|NCT00677105|Lymphoma|lymphoma
590506|NCT00677105|Neoplasms|neoplasms
590507|NCT00677105|Solid Tumors|solid tumors
590508|NCT00677105|Advanced Cancer|advanced cancer
590509|NCT00677092|Treatment|treatment
590510|NCT00677092|Chronic kidney disease|chronic kidney disease
590511|NCT00677092|Fibrosing disorders|fibrosing disorders
590512|NCT00677092|Imatinib mesylate|imatinib mesylate
590513|NCT00677079|BRCA-1 or BRCA-2 associated advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer|brca-1 or brca-2 associated advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer
590514|NCT00677079|BRCA-1|brca-1
590515|NCT00677079|BRCA-2|brca-2
590516|NCT00677066|bronchiolitis|bronchiolitis
590517|NCT00677066|oxygen|oxygen
590518|NCT00677066|children|children
590519|NCT00677053|Unstable Angina|unstable angina
590520|NCT00677053|Myocardial Infarction|myocardial infarction
590521|NCT00677053|Thrombolysis|thrombolysis
590522|NCT00677053|Anticoagulant|anticoagulant
590523|NCT00677053|Acute Coronary Syndrome|acute coronary syndrome
590524|NCT00677027|Beta-glucan|beta-glucan
590525|NCT00677027|immune system|immune system
590526|NCT00677027|Healthy subjects|healthy subjects
590527|NCT00677014|Heart Failure|heart failure
590528|NCT00677014|HF|hf
590529|NCT00677014|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
590530|NCT00677014|CRT|crt
590531|NCT00677014|Optimization|optimization
590532|NCT00677014|SmartDelay|smartdelay
590533|NCT00677014|Echocardiography|echocardiography
590534|NCT00677014|AV Delay|av delay
590535|NCT00677001|Solid tumors|solid tumors
590536|NCT00677001|solid malignancies|solid malignancies
590537|NCT00677001|neoplasms|neoplasms
590538|NCT00677001|refractory solid tumors|refractory solid tumors
590539|NCT00677001|advanced solid tumors|advanced solid tumors
590540|NCT00676988|Luminal Crohn's Disease|luminal crohn's disease
590541|NCT00676988|Infliximab|infliximab
590542|NCT00676975|Irritable Bowel disease|irritable bowel disease
590543|NCT00676975|Traditional Chinese Medicine|traditional chinese medicine
590544|NCT00676962|Implementation|implementation
590545|NCT00676962|facilitation|facilitation
590546|NCT00676962|psychotherapy|psychotherapy
590547|NCT00676962|training|training
590548|NCT00676949|epitope peptide|epitope peptide
590549|NCT00676949|cyclophosphamide|cyclophosphamide
590550|NCT00676949|interleukin-2|interleukin-2
590551|NCT00676936|Cancer|cancer
590552|NCT00676936|pain|pain
590553|NCT00676936|corticosteroids|corticosteroids
590554|NCT00676936|palliative|palliative
590555|NCT00676936|supportive care|supportive care
590556|NCT00676936|Cancer patients with pain|cancer patients with pain
590557|NCT00676910|Advanced Cancer|advanced cancer
590558|NCT00676910|Malignancies|malignancies
590559|NCT00676910|Neoplasms|neoplasms
590560|NCT00676910|Incurable Solid Cancers|incurable solid cancers
590561|NCT00676897|statin, sepsis, septic shock, simvastatin|statin, sepsis, septic shock, simvastatin
590562|NCT00676884|atopic eczema|atopic eczema
590563|NCT00676884|atopic dermatitis|atopic dermatitis
590564|NCT00676884|allergy|allergy
590565|NCT00676858|Embolism|embolism
590566|NCT00676858|Argon|argon
590567|NCT00676845|Arterial stiffness|arterial stiffness
590568|NCT00676845|Vascular protection|vascular protection
590569|NCT00676832|colitis|colitis
590570|NCT00676832|ulcerative|ulcerative
590571|NCT00676832|moderate|moderate
590572|NCT00676832|severe|severe
590573|NCT00676806|Umbilical cord blood transplantation|umbilical cord blood transplantation
590574|NCT00676806|full ablation conditioning|full ablation conditioning
590575|NCT00676806|reduced intensity conditioning|reduced intensity conditioning
590576|NCT00676793|breast cancer|breast cancer
590577|NCT00676793|EGCG|egcg
590578|NCT00676793|Polyphenon E|polyphenon e
590579|NCT00676793|c-Met|c-met
590580|NCT00676793|VEGF|vegf
590581|NCT00676793|HGF|hgf
590582|NCT00676780|EGCG|egcg
590583|NCT00676780|polyphenols|polyphenols
590584|NCT00676780|biomarkers|biomarkers
590585|NCT00676780|prostate specific antigen|prostate specific antigen
590586|NCT00676767|Aging|aging
590587|NCT00676767|Diabetes|diabetes
590588|NCT00676767|Diet|diet
590589|NCT00676767|Fiber|fiber
590590|NCT00676754|Multidrug-Resistant Tuberculosis, tuberculosis, Peru|multidrug-resistant tuberculosis, tuberculosis, peru
590591|NCT00676728|Advanced or Refractory Leukemia|advanced or refractory leukemia
590592|NCT00676728|Myelodysplastic Syndromes|myelodysplastic syndromes
590593|NCT00676728|JNJ 26481585|jnj 26481585
590594|NCT00676728|Histone-Deacetylase Inhibitor|histone-deacetylase inhibitor
590595|NCT00676728|Advanced Leukemia|advanced leukemia
590596|NCT00676728|Refractory Leukemia|refractory leukemia
590597|NCT00676702|Pancrelipase|pancrelipase
590598|NCT00676702|PANCREASE MT|pancrease mt
590599|NCT00676702|Cross-Over Studies|cross-over studies
590600|NCT00676702|Duodenum|duodenum
590601|NCT00676702|Intestine, Small|intestine, small
590602|NCT00676702|Lipase|lipase
590603|NCT00676702|Amylases|amylases
590604|NCT00676702|Peptide Hydrolases|peptide hydrolases
590605|NCT00676702|Intubation|intubation
590606|NCT00676702|Safety|safety
590607|NCT00676702|Capsules|capsules
590608|NCT00676689|Pulmonic|pulmonic
590609|NCT00676689|Regurgitation|regurgitation
590610|NCT00676689|Pulmonary Valve Conduit|pulmonary valve conduit
590611|NCT00676689|Stenosis|stenosis
590612|NCT00676689|Congenital Heart Defect|congenital heart defect
590613|NCT00676676|Depression|depression
590614|NCT00676676|Major Depressive Disorder|major depressive disorder
590615|NCT00676663|Breast Neoplasms|breast neoplasms
590616|NCT00676663|Breast Tumor|breast tumor
590617|NCT00676663|Mammary Neoplasms|mammary neoplasms
590618|NCT00676650|Docetaxel-refractory mCRPC|docetaxel-refractory mcrpc
590619|NCT00676650|Second-line treatment with sunitinib and prednisone|second-line treatment with sunitinib and prednisone
590620|NCT00676637|Adherence|adherence
590621|NCT00676637|Compliance|compliance
590622|NCT00676637|Glaucoma|glaucoma
590623|NCT00676637|Ocular Hypertension|ocular hypertension
590624|NCT00676624|uveitis|uveitis
590625|NCT00676624|vitrectomy|vitrectomy
590626|NCT00676624|infection|infection
590627|NCT00676624|severe|severe
590628|NCT00676611|Acetabular Fractures|acetabular fractures
590629|NCT00676598|therapeutic hypothermia|therapeutic hypothermia
590630|NCT00676585|Cardiac Arrest, Shock, Steroids|cardiac arrest, shock, steroids
590631|NCT00676572|severe asthma|severe asthma
590632|NCT00676572|corticosteroid insensitivity|corticosteroid insensitivity
590633|NCT00676559|Diabetic|diabetic
590634|NCT00676559|Macular|macular
590635|NCT00676559|Edema|edema
590636|NCT00676559|DME|dme
590637|NCT00676559|Clinically Significant Macular Edema (CSME)|clinically significant macular edema (csme)
590638|NCT00676533|Cipro|cipro
590639|NCT00676533|Urinary Tract Infection|urinary tract infection
590640|NCT00676520|Angioplasty|angioplasty
590641|NCT00676520|Coronary Restenosis|coronary restenosis
590642|NCT00676520|Coronary Artery Disease|coronary artery disease
590643|NCT00676520|Coronary Artery Restenosis|coronary artery restenosis
590644|NCT00676520|Coronary Artery Stenosis|coronary artery stenosis
590645|NCT00676520|Total Artery Occlusion|total artery occlusion
590646|NCT00676520|Stents|stents
590647|NCT00676520|Stent Thrombosis|stent thrombosis
590648|NCT00676520|Total Coronary Occlusion|total coronary occlusion
590649|NCT00676520|Vascular Disease|vascular disease
590650|NCT00676520|Myocardial Ischemia|myocardial ischemia
590651|NCT00676507|Gene therapy|gene therapy
590652|NCT00676507|Flow cytometry|flow cytometry
590653|NCT00676507|Immunoenzyme technique|immunoenzyme technique
590654|NCT00676507|Laboratory biomarker analysis|laboratory biomarker analysis
590655|NCT00676507|Quality-of-life-assessment|quality-of-life-assessment
590656|NCT00676507|Tumor cell-derivative vaccine therapy|tumor cell-derivative vaccine therapy
590657|NCT00676481|Patient Education|patient education
590658|NCT00676481|Emergency Medicine|emergency medicine
590659|NCT00676481|HIV Prevention|hiv prevention
590660|NCT00676481|HIV Seronegativity|hiv seronegativity
590661|NCT00676468|Asthma|asthma
590662|NCT00676468|Inflammation|inflammation
590663|NCT00676468|Airway|airway
590664|NCT00676468|Fish Oil|fish oil
590665|NCT00676468|Singulair|singulair
590666|NCT00676455|CT Software|ct software
590667|NCT00676455|MeVis™|mevis™
590668|NCT00676455|Metastatic pulmonary and hepatic lesion growth|metastatic pulmonary and hepatic lesion growth
590669|NCT00676416|General anesthesia|general anesthesia
590670|NCT00676416|Propofol|propofol
590671|NCT00676416|Immunity|immunity
590672|NCT00676416|Alveolar Macrophages|alveolar macrophages
590673|NCT00676403|pregabalin, RLS, efficacy, safety|pregabalin, rls, efficacy, safety
590674|NCT00676390|Heart Failure|heart failure
590675|NCT00676377|Neostigmine, Post Operative, Ileus|neostigmine, post operative, ileus
590676|NCT00676364|pediatric patients|pediatric patients
590677|NCT00676364|pain|pain
590678|NCT00676364|anxiety|anxiety
590679|NCT00676364|topical anesthetic|topical anesthetic
590680|NCT00676364|randomized control trial|randomized control trial
590681|NCT00676338|Amylin|amylin
590682|NCT00676338|Lilly|lilly
590683|NCT00676338|exenatide once weekly|exenatide once weekly
590684|NCT00676338|Byetta|byetta
590685|NCT00676338|Januvia|januvia
590686|NCT00676338|sitagliptin|sitagliptin
591460|NCT00673504|gemcitabine|gemcitabine
590687|NCT00676338|thiazolidinedione|thiazolidinedione
590688|NCT00676325|anterior vaginal prolapse|anterior vaginal prolapse
590689|NCT00676325|traditional treatment|traditional treatment
590690|NCT00676325|mesh, graft|mesh, graft
590691|NCT00676325|NAZCA TC™ POP REPAIR SYSTEM|nazca tc™ pop repair system
590692|NCT00676325|colporrhaphy|colporrhaphy
590693|NCT00676312|Osteoporosis|osteoporosis
590694|NCT00676312|parathyroid hormone|parathyroid hormone
590695|NCT00676312|pharmacodynamic|pharmacodynamic
590696|NCT00676312|pharmacokinetic|pharmacokinetic
590697|NCT00676299|Advanced Solid Cancers|advanced solid cancers
590698|NCT00676299|Refractory Solid Cancers|refractory solid cancers
590699|NCT00676299|Protein Kinase Inhibitors|protein kinase inhibitors
590700|NCT00676299|Phase 1 Study|phase 1 study
590701|NCT00676299|Oral Chemotherapy|oral chemotherapy
590702|NCT00676286|Prostate cancer active surveillance|prostate cancer active surveillance
590703|NCT00676286|3 Tesla MR biological imaging in prostate cancer|3 tesla mr biological imaging in prostate cancer
590704|NCT00676286|tumor gene re-arrangements in prostate cancer|tumor gene re-arrangements in prostate cancer
590705|NCT00676260|Glucose Metabolism Disorder|glucose metabolism disorder
590706|NCT00676260|Dysmetabolic Syndrome|dysmetabolic syndrome
590707|NCT00676260|Type II Diabetes|type ii diabetes
590708|NCT00676260|Diabetes Mellitus|diabetes mellitus
590709|NCT00676260|Lipoatrophic|lipoatrophic
590710|NCT00676260|Dyslipidemia|dyslipidemia
590711|NCT00676260|Drug Therapy|drug therapy
590712|NCT00676247|Ultrasonography|ultrasonography
590713|NCT00676247|Doppler|doppler
590714|NCT00676247|Hemodynamics|hemodynamics
590715|NCT00676247|Neurobehavioral development|neurobehavioral development
590716|NCT00676234|erythropoietin|erythropoietin
590717|NCT00676221|Renal transplant recipient|renal transplant recipient
590718|NCT00676221|Immunosuppression|immunosuppression
590719|NCT00676221|Gastro-intestinal symptoms|gastro-intestinal symptoms
590720|NCT00676221|Quality of life|quality of life
590721|NCT00676221|Cellcept|cellcept
590722|NCT00676221|Myfortic|myfortic
590723|NCT00676221|Kidney transplant patients.|kidney transplant patients.
590724|NCT00676208|Shared Medical Appointments|shared medical appointments
590725|NCT00676208|Diabetes|diabetes
590726|NCT00676208|Education|education
590727|NCT00676195|N-Acetyl Cysteine|n-acetyl cysteine
590728|NCT00676169|Pseudomonas aeruginosa|pseudomonas aeruginosa
590729|NCT00676169|EPIC|epic
590730|NCT00676156|multiple sclerosis|multiple sclerosis
590731|NCT00676156|lipoic acid|lipoic acid
590732|NCT00676156|LA|la
590733|NCT00676156|pharmacokinetics|pharmacokinetics
590734|NCT00676156|immunological effects|immunological effects
590735|NCT00676143|antibody|antibody
590736|NCT00676143|immunotherapy|immunotherapy
590737|NCT00676130|Cellulitis|cellulitis
590738|NCT00676130|Bactrim|bactrim
590739|NCT00676130|Trimethoprim Sulfamethoxazole|trimethoprim sulfamethoxazole
590740|NCT00676130|MRSA|mrsa
590741|NCT00676130|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
590742|NCT00676117|male|male
590743|NCT00676117|Japan|japan
590744|NCT00676117|Japanese|japanese
590745|NCT00676117|Healthy volunteers|healthy volunteers
590746|NCT00676104|Traumatic Brain Injury|traumatic brain injury
590747|NCT00676104|Trauma|trauma
590748|NCT00676104|Hypothermia|hypothermia
590749|NCT00676091|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
590750|NCT00676065|Contraception|contraception
590751|NCT00676065|Thromboembolism|thromboembolism
590752|NCT00676065|Breast Cancer|breast cancer
590753|NCT00676052|COPD|copd
590754|NCT00676052|Multicenter|multicenter
590755|NCT00676052|GSK233705B|gsk233705b
590756|NCT00676052|double-blind|double-blind
590757|NCT00676052|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
590758|NCT00676052|randomized|randomized
590759|NCT00676039|Therapeutic Equivalency|therapeutic equivalency
590760|NCT00676039|Human Experimentation|human experimentation
590761|NCT00676039|Bioequivalence|bioequivalence
590762|NCT00676039|Brand name|brand name
590763|NCT00676039|Generic|generic
590764|NCT00676039|Antidepressant|antidepressant
590765|NCT00676039|Healthy volunteers|healthy volunteers
590766|NCT00676026|menses|menses
590767|NCT00676026|women|women
590768|NCT00676026|healthy controls|healthy controls
590769|NCT00676026|Healthy females with regular menstrual cycles|healthy females with regular menstrual cycles
590770|NCT00676013|Burns|burns
590771|NCT00676013|Skin grafting|skin grafting
590772|NCT00676013|AlloDerm|alloderm
590773|NCT00676013|Integra|integra
590774|NCT00676013|Homograft|homograft
590775|NCT00676013|Autograft|autograft
590776|NCT00676013|Burn Scar|burn scar
590777|NCT00675987|Impaired Fasting Glucose FPG >100-<126 mg/dL|impaired fasting glucose fpg >100-<126 mg/dl
590778|NCT00675974|Burn|burn
590779|NCT00675974|Scar|scar
590780|NCT00675974|Pressure garments|pressure garments
590781|NCT00675974|Wound healing|wound healing
590782|NCT00675974|Burn Injury|burn injury
590783|NCT00675961|Tomsk|tomsk
590784|NCT00675961|TB-Alcohol|tb-alcohol
590785|NCT00675961|Alcohol and co-occurring disease|alcohol and co-occurring disease
591461|NCT00673504|sunitinib|sunitinib
590786|NCT00675961|Brief counseling intervention|brief counseling intervention
590787|NCT00675961|Naltrexone|naltrexone
590788|NCT00675948|Palliative Care|palliative care
590789|NCT00675948|Pain|pain
590790|NCT00675948|Cancer|cancer
590791|NCT00675935|Patient falls|patient falls
590792|NCT00675935|fall risk|fall risk
590793|NCT00675935|fall prevention|fall prevention
590794|NCT00675922|Burn|burn
590795|NCT00675922|Wounds|wounds
590796|NCT00675922|Wound infection|wound infection
590797|NCT00675922|Topical antimicrobials|topical antimicrobials
590798|NCT00675922|Cerium|cerium
590799|NCT00675922|Dakins|dakins
590800|NCT00675922|Sulfamylon Soaks|sulfamylon soaks
590801|NCT00675922|Silver Nitrate|silver nitrate
590802|NCT00675909|Sedation|sedation
590803|NCT00675909|Anxiety|anxiety
590804|NCT00675909|Minor procedures|minor procedures
590805|NCT00675909|Emergency Department|emergency department
590806|NCT00675896|major depression with comorbid fibromyalgia.|major depression with comorbid fibromyalgia.
590807|NCT00675870|Acute Promyelocytic Leukemia|acute promyelocytic leukemia
590808|NCT00675870|Cancer|cancer
590809|NCT00675870|Leukemia|leukemia
590811|NCT00675870|ATRA|atra
590812|NCT00675870|Tretinoid|tretinoid
590813|NCT00675870|Vesanoid|vesanoid
590814|NCT00675870|Retinoic Acid Receptor Alpha|retinoic acid receptor alpha
590815|NCT00675870|All Trans Retinoic Acid|all trans retinoic acid
590816|NCT00675870|Arsenic Trioxide|arsenic trioxide
590817|NCT00675870|Trisenox|trisenox
590818|NCT00675870|Retinoid|retinoid
590819|NCT00675870|Relapsed or Refractory Acute Promyelocytic Leukemia|relapsed or refractory acute promyelocytic leukemia
590820|NCT00675857|Type II diabetes|type ii diabetes
590821|NCT00675857|Metabolic syndrome|metabolic syndrome
590822|NCT00675844|Extension study|extension study
590823|NCT00675844|HIV-1 infection|hiv-1 infection
590824|NCT00675844|Treatment Naive|treatment naive
590825|NCT00675831|CD25+|cd25+
590826|NCT00675831|Tregs|tregs
590827|NCT00675831|DLI|dli
590828|NCT00675831|Donor lymphocyte infusion|donor lymphocyte infusion
590829|NCT00675818|acute kidney injury|acute kidney injury
590830|NCT00675818|renal replacement therapy|renal replacement therapy
590831|NCT00675818|critical care unit|critical care unit
590832|NCT00675818|hemodialysis|hemodialysis
590833|NCT00675818|hemofiltration|hemofiltration
590834|NCT00675805|intravenous immunoglobulin|intravenous immunoglobulin
590835|NCT00675805|IVIG|ivig
590836|NCT00675805|adverse reactions|adverse reactions
590837|NCT00675779|endometriosis|endometriosis
590838|NCT00675779|atorvastatin|atorvastatin
590839|NCT00675779|oral|oral
590840|NCT00675779|contraception|contraception
590841|NCT00675779|pain|pain
590842|NCT00675779|relief|relief
590843|NCT00675779|pelvic pain in women with endometriosis|pelvic pain in women with endometriosis
590844|NCT00675753|Genes|genes
590845|NCT00675753|Ethnology|ethnology
590846|NCT00675753|Cytokines|cytokines
590847|NCT00675753|prematurity|prematurity
590848|NCT00675727|Melanoma|melanoma
590849|NCT00675727|Mycobacterium w|mycobacterium w
590850|NCT00675714|anabolic agents|anabolic agents
590851|NCT00675714|exercise|exercise
590852|NCT00675701|To determine whether lixivaptan administration at supratherapeutic or therapeutic doses results in the prolongation of the QTc interval.|to determine whether lixivaptan administration at supratherapeutic or therapeutic doses results in the prolongation of the qtc interval.
590853|NCT00675688|Menopause|menopause
590854|NCT00675675|Tourette Syndrome|tourette syndrome
590855|NCT00675675|Chronic Tic Disorder|chronic tic disorder
590856|NCT00675675|Tics|tics
590857|NCT00675675|Behavior Therapy|behavior therapy
590858|NCT00675675|Habit Reversal Training|habit reversal training
590859|NCT00675675|Child|child
590860|NCT00675675|Adolescent|adolescent
590861|NCT00675675|Neuroimaging|neuroimaging
590862|NCT00675662|Obesity|obesity
590863|NCT00675662|overweight|overweight
590864|NCT00675662|BMI|bmi
590865|NCT00675662|ifestyle|ifestyle
590866|NCT00675662|diet|diet
590867|NCT00675662|nutrition|nutrition
590868|NCT00675662|physical activity|physical activity
590869|NCT00675662|pre-school|pre-school
590870|NCT00675662|toddlers|toddlers
590871|NCT00675662|children|children
590872|NCT00675662|Prevention of overweight and obesity in pre-school children|prevention of overweight and obesity in pre-school children
590873|NCT00675649|Injections|injections
590874|NCT00675649|Severe, persistent asthma|severe, persistent asthma
590875|NCT00675636|colon cancer|colon cancer
590876|NCT00675636|hereditary non-polyposis colon cancer|hereditary non-polyposis colon cancer
590877|NCT00675636|rectal cancer|rectal cancer
590878|NCT00675636|familial adenomatous polyposis|familial adenomatous polyposis
590879|NCT00675623|Alzheimer's disease, clinical trial, memory loss, mitochondria,|alzheimer's disease, clinical trial, memory loss, mitochondria,
590880|NCT00675623|investigational drug, neurodegenerative disease, dementia|investigational drug, neurodegenerative disease, dementia
590881|NCT00675610|communication|communication
590882|NCT00675610|HIV/AIDS|hiv/aids
590883|NCT00675610|Treatment Experienced|treatment experienced
590884|NCT00675597|Bevacizumab (Avastin)|bevacizumab (avastin)
590885|NCT00675597|Taxotere (Docetaxel)|taxotere (docetaxel)
590886|NCT00675597|Vinorelbine Tartrate (Navelbine)|vinorelbine tartrate (navelbine)
590887|NCT00675597|07-178|07-178
590888|NCT00675558|Obesity|obesity
590889|NCT00675558|morbid obesity|morbid obesity
590890|NCT00675558|bariatric surgery|bariatric surgery
590891|NCT00675532|Opioids, vivitrol, naltrexone, primary care|opioids, vivitrol, naltrexone, primary care
590892|NCT00675519|problem drinkers|problem drinkers
590893|NCT00675506|Growth Hormone Releasing Hormone|growth hormone releasing hormone
590894|NCT00675506|Growth Hormone Pulse|growth hormone pulse
590895|NCT00675506|Visceral Adipose Tissue|visceral adipose tissue
590896|NCT00675506|Carotid Intima-Media Thickness|carotid intima-media thickness
590897|NCT00675480|myocardial infarction, thrombectomy, salvage index|myocardial infarction, thrombectomy, salvage index
590898|NCT00675467|Pediatric Cancer|pediatric cancer
590899|NCT00675467|Focus Group|focus group
590900|NCT00675467|Pediatric cancer patients|pediatric cancer patients
590901|NCT00675467|Parents of Pediatric cancer patients|parents of pediatric cancer patients
590902|NCT00675467|Pediatric Palliative Care Program|pediatric palliative care program
590903|NCT00675454|COPD|copd
590904|NCT00675454|Lung Volume Reduction Surgery|lung volume reduction surgery
590905|NCT00675454|Lung Transplant|lung transplant
590906|NCT00675454|Quality of Life|quality of life
590907|NCT00675441|Chronic Graft-versus-Host Disease|chronic graft-versus-host disease
590908|NCT00675441|cGVHD|cgvhd
590909|NCT00675441|GVHD|gvhd
590910|NCT00675441|Lenalidomide|lenalidomide
590911|NCT00675441|Revlimid|revlimid
590912|NCT00675441|CC-5013|cc-5013
590913|NCT00675441|Stem Cell Transplant|stem cell transplant
590914|NCT00675441|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
590915|NCT00675441|Allogeneic HSCT|allogeneic hsct
590916|NCT00675441|HSCT|hsct
590917|NCT00675441|Post-Transplant Prophylactic Immunosuppressive Therapy|post-transplant prophylactic immunosuppressive therapy
590918|NCT00675441|Steroids|steroids
590919|NCT00675441|Standard-of-care steroid treatment|standard-of-care steroid treatment
590920|NCT00675441|Corticosteroids|corticosteroids
590921|NCT00675441|Prednisone|prednisone
590922|NCT00675441|Medrol|medrol
590923|NCT00675428|Relapsed or refractory Multiple Myeloma|relapsed or refractory multiple myeloma
590924|NCT00675415|Hypoxemia|hypoxemia
590925|NCT00675415|Capnography|capnography
590926|NCT00675415|Apnea|apnea
590927|NCT00675415|Sedation|sedation
590928|NCT00675415|ERCP|ercp
590929|NCT00675415|EUS|eus
590930|NCT00675389|HIV|hiv
590931|NCT00675389|AIDS|aids
590932|NCT00675389|Community Health Workers|community health workers
590933|NCT00675389|Mobile Phones|mobile phones
590934|NCT00675389|Adherence|adherence
590935|NCT00675389|Antiretroviral Therapy|antiretroviral therapy
590936|NCT00675376|COPD|copd
590937|NCT00675376|Lung Transplant|lung transplant
590938|NCT00675376|Quality of Life|quality of life
590939|NCT00675376|End Stage Lung Disease|end stage lung disease
590940|NCT00675363|ICU|icu
590941|NCT00675363|Sedation strategies|sedation strategies
590942|NCT00675363|Daily sedative interruption|daily sedative interruption
590943|NCT00675363|Sedation protocols|sedation protocols
590944|NCT00675363|Mechanical Ventilation|mechanical ventilation
590945|NCT00675363|Sedation|sedation
590946|NCT00675350|Omacetaxine|omacetaxine
590947|NCT00675350|Homoharringtonine|homoharringtonine
590948|NCT00675350|HHT|hht
590949|NCT00675350|Solid and hematologic malignant tumors|solid and hematologic malignant tumors
590950|NCT00675337|iron stores|iron stores
590951|NCT00675337|anemia|anemia
590952|NCT00675337|iron deficiency|iron deficiency
590953|NCT00675337|infancy|infancy
590954|NCT00675337|placental transfusion|placental transfusion
590955|NCT00675337|iron deficiency in infancy|iron deficiency in infancy
590956|NCT00675337|anemia in infancy|anemia in infancy
590957|NCT00675337|placement of neonate|placement of neonate
590958|NCT00675324|Colonoscopy|colonoscopy
590959|NCT00675324|Bowel preparation|bowel preparation
590960|NCT00675324|Salt and electrolyte balance|salt and electrolyte balance
590961|NCT00675324|Patients undergoing colonoscopy|patients undergoing colonoscopy
590962|NCT00675324|Complication with traditional bowel preparation|complication with traditional bowel preparation
590963|NCT00675324|Bowel purity degree without traditional bowel preparation|bowel purity degree without traditional bowel preparation
590964|NCT00675311|Remote monitoring|remote monitoring
590965|NCT00675311|Type 1 Diabetes|type 1 diabetes
590966|NCT00675311|Type 2 diabetes|type 2 diabetes
590967|NCT00675298|Prostatitis|prostatitis
590968|NCT00675298|Cystitis, Interstitial|cystitis, interstitial
590969|NCT00675298|Urinary Bladder, Overactive|urinary bladder, overactive
590970|NCT00675298|Chronic pelvic pain syndrome|chronic pelvic pain syndrome
590971|NCT00675298|Painful bladder syndrome|painful bladder syndrome
590972|NCT00675298|Urgency|urgency
590973|NCT00675298|Frequency|frequency
590974|NCT00675285|airway inflammation|airway inflammation
590975|NCT00675285|childhood asthma|childhood asthma
590976|NCT00675285|fractional exhaled nitric oxide|fractional exhaled nitric oxide
590977|NCT00675285|leukotriene receptor antagonists|leukotriene receptor antagonists
590978|NCT00675285|lung function|lung function
590979|NCT00675272|brain death|brain death
590980|NCT00675272|subarachnoid hemorrhage|subarachnoid hemorrhage
590981|NCT00675272|traumatic brain injury|traumatic brain injury
590982|NCT00675272|brain injury|brain injury
590983|NCT00675272|intracerebral hemorrhage|intracerebral hemorrhage
590984|NCT00675272|organ donation|organ donation
590985|NCT00675259|stage II breast cancer|stage ii breast cancer
590986|NCT00675259|stage IIIA breast cancer|stage iiia breast cancer
590987|NCT00675259|stage IIIB breast cancer|stage iiib breast cancer
590988|NCT00675259|stage IIIC breast cancer|stage iiic breast cancer
590989|NCT00675246|corticoid therapy|corticoid therapy
590990|NCT00675246|fetal lung maturation|fetal lung maturation
590991|NCT00675246|late preterm|late preterm
590992|NCT00675246|respiratory distress syndrome|respiratory distress syndrome
590993|NCT00675246|neonatal death|neonatal death
590994|NCT00675233|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
590995|NCT00675233|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
590996|NCT00675233|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
590997|NCT00675233|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
590998|NCT00675233|stage 0 laryngeal cancer|stage 0 laryngeal cancer
590999|NCT00675207|glaucoma|glaucoma
591000|NCT00675207|ocular hypertension|ocular hypertension
591001|NCT00675207|adjunctive treatment|adjunctive treatment
591002|NCT00675207|prostaglandin|prostaglandin
591003|NCT00675207|prostaglandin analog|prostaglandin analog
591004|NCT00675207|brimonidine|brimonidine
591005|NCT00675207|dorzolamide|dorzolamide
591006|NCT00675207|brinzolamide|brinzolamide
591007|NCT00675207|alpha agonist|alpha agonist
591008|NCT00675207|carbonic anhydrase inhibitor|carbonic anhydrase inhibitor
591009|NCT00675207|intraocular pressure|intraocular pressure
591010|NCT00675194|cisplatin|cisplatin
591011|NCT00675194|capecitabine|capecitabine
591012|NCT00675194|gastric|gastric
591013|NCT00675194|irinotecan|irinotecan
591014|NCT00675194|metastatic|metastatic
591015|NCT00675194|chemotherapy|chemotherapy
591016|NCT00675181|melatonin|melatonin
591017|NCT00675181|skin blood flow|skin blood flow
591018|NCT00675181|choroidal blood flow|choroidal blood flow
591019|NCT00675181|vasospastic subjects|vasospastic subjects
591020|NCT00675181|normal subjects|normal subjects
591021|NCT00675168|Lung Cancer|lung cancer
591022|NCT00675168|PET/CT|pet/ct
591023|NCT00675168|Diagnosis|diagnosis
591024|NCT00675155|Apoplexy|apoplexy
591025|NCT00675155|Cerebral Stroke|cerebral stroke
591026|NCT00675155|Cerebrovascular Accident|cerebrovascular accident
591027|NCT00675155|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
591028|NCT00675155|Cerebrovascular Apoplexy|cerebrovascular apoplexy
591029|NCT00675155|Cerebrovascular Stroke|cerebrovascular stroke
591030|NCT00675142|Infertility|infertility
591031|NCT00675142|Intra-uterine insemination|intra-uterine insemination
591032|NCT00675142|ovarian stimulation|ovarian stimulation
591033|NCT00675116|safety,|safety,
591034|NCT00675116|healthy volunteers,|healthy volunteers,
591035|NCT00675116|GW823296,|gw823296,
591036|NCT00675116|pharmacokinetics|pharmacokinetics
591037|NCT00675103|Gout|gout
591038|NCT00675103|Gouty Arthritis|gouty arthritis
591039|NCT00675103|Anti-Gout preparations|anti-gout preparations
591040|NCT00675090|Alzheimers Disease|alzheimers disease
591041|NCT00675077|Akinetic-Rigid Variant of Huntington Disease|akinetic-rigid variant of huntington disease
591042|NCT00675077|Chorea, Chronic Progressive Hereditary (Huntington)|chorea, chronic progressive hereditary (huntington)
591043|NCT00675077|Chronic Progressive Hereditary Chorea (Huntington)|chronic progressive hereditary chorea (huntington)
591044|NCT00675077|Huntington Chorea|huntington chorea
591162|NCT00674622|Lateral epicondylitis|lateral epicondylitis
591045|NCT00675077|Huntington Chronic Progressive Hereditary Chorea|huntington chronic progressive hereditary chorea
591046|NCT00675077|Huntington Disease, Akinetic-Rigid Variant|huntington disease, akinetic-rigid variant
591047|NCT00675077|Huntington Disease, Juvenile|huntington disease, juvenile
591048|NCT00675077|Huntington Disease, Juvenile-Onset|huntington disease, juvenile-onset
591049|NCT00675064|pharmacokinetics,|pharmacokinetics,
591051|NCT00675064|single ascending dose,|single ascending dose,
591052|NCT00675064|Healthy volunteers,|healthy volunteers,
591053|NCT00675051|To determine if there is a trans-pulmonary gradient in the levels of EMPs in patients with PH|to determine if there is a trans-pulmonary gradient in the levels of emps in patients with ph
591054|NCT00675051|To determine if the EMPs measured at the pulmonary capillary wedge position correlates even more strongly with the severity of PH than the circulating levels|to determine if the emps measured at the pulmonary capillary wedge position correlates even more strongly with the severity of ph than the circulating levels
591055|NCT00675051|To determine if PH therapy with ET-1 receptor blocker will modify EMPs levels|to determine if ph therapy with et-1 receptor blocker will modify emps levels
591056|NCT00675012|NGR-hTNF|ngr-htnf
591057|NCT00675012|Capecitabine|capecitabine
591058|NCT00675012|Oxaliplatin|oxaliplatin
591059|NCT00675012|Colon cancer|colon cancer
591060|NCT00674999|Burn|burn
591061|NCT00674999|Partial thickness burn|partial thickness burn
591062|NCT00674960|Brain Atrophy, Circumscribed Lobar|brain atrophy, circumscribed lobar
591063|NCT00674960|Circumscribed Lobar Atrophy of the Brain|circumscribed lobar atrophy of the brain
591064|NCT00674960|Lobar Atrophy (Brain)|lobar atrophy (brain)
591065|NCT00674960|Pick Disease|pick disease
591066|NCT00674960|Pick's Disease|pick's disease
591067|NCT00674960|Picks Disease of Brain|picks disease of brain
591068|NCT00674947|Relapsed|relapsed
591069|NCT00674947|Refractory|refractory
591070|NCT00674934|MS (Multiple Sclerosis)|ms (multiple sclerosis)
591071|NCT00674934|Multiple Sclerosis, Acute Fulminating|multiple sclerosis, acute fulminating
591072|NCT00674934|Sclerosis, Disseminated|sclerosis, disseminated
591073|NCT00674921|Opportunistic Infections|opportunistic infections
591074|NCT00674921|AIDS|aids
591075|NCT00674921|HIV|hiv
591076|NCT00674921|Treatment Experienced|treatment experienced
591077|NCT00674908|Vaccine|vaccine
591078|NCT00674908|Prevention|prevention
591079|NCT00674908|Diphtheria|diphtheria
591080|NCT00674908|Tetanus|tetanus
591081|NCT00674908|Pertussis|pertussis
591082|NCT00674908|Hepatitis B|hepatitis b
591083|NCT00674908|Haemophilus influenzae type b|haemophilus influenzae type b
591084|NCT00674908|Vaccine interchangeability|vaccine interchangeability
591085|NCT00674908|Single vs mixed sequence|single vs mixed sequence
591086|NCT00674908|Healthy infants|healthy infants
591087|NCT00674895|Idiopathic Parkinson's Disease|idiopathic parkinson's disease
591088|NCT00674895|Lewy Body Parkinson's Disease|lewy body parkinson's disease
591089|NCT00674895|Paralysis Agitans|paralysis agitans
591090|NCT00674895|Parkinson's Disease, Idiopathic|parkinson's disease, idiopathic
591091|NCT00674895|Parkinson's Disease, Lewy Body|parkinson's disease, lewy body
591092|NCT00674895|Primary Parkinsonism|primary parkinsonism
591093|NCT00674882|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
591094|NCT00674882|Follow-up studies|follow-up studies
591095|NCT00674882|Outcomes research|outcomes research
591096|NCT00674882|Data collection|data collection
591097|NCT00674869|sealant|sealant
591098|NCT00674869|pit|pit
591099|NCT00674869|child|child
591100|NCT00674869|over|over
591101|NCT00674869|6 years old|6 years old
591102|NCT00674869|least|least
591103|NCT00674843|MYOTONIC DYSTROPHY|myotonic dystrophy
591104|NCT00674843|MYOPATHIES|myopathies
591105|NCT00674843|Distal Myopathies|distal myopathies
591106|NCT00674843|Muscular Dystrophy, Duchenne|muscular dystrophy, duchenne
591107|NCT00674843|Phosphorylase Deficiency (McArdle Disease)|phosphorylase deficiency (mcardle disease)
591108|NCT00674817|salbutamol,|salbutamol,
591109|NCT00674817|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
591110|NCT00674817|GSK961081 muscarinic receptor antagonist,|gsk961081 muscarinic receptor antagonist,
591111|NCT00674817|COPD|copd
591112|NCT00674817|ipratropium bromide,|ipratropium bromide,
591113|NCT00674817|Asthma|asthma
591114|NCT00674817|ß2-adrenergic agonist,|ß2-adrenergic agonist,
591115|NCT00674804|Communicating a Diagnosis|communicating a diagnosis
591116|NCT00674804|Cancer Diagnosis|cancer diagnosis
591117|NCT00674804|Recurrence of Cancer|recurrence of cancer
591118|NCT00674804|Initial Cancer Diagnosis|initial cancer diagnosis
591119|NCT00674791|Immunotherapeutic vaccine|immunotherapeutic vaccine
591120|NCT00674791|breast cancer|breast cancer
591121|NCT00674791|TxN2-3M0 breast cancer|txn2-3m0 breast cancer
591122|NCT00674791|metastatic breast cancer|metastatic breast cancer
591123|NCT00674791|immunotherapy|immunotherapy
591124|NCT00674791|antigen|antigen
591125|NCT00674791|Histologically confirmed, TxN2-3M0 or metastatic breast cancer|histologically confirmed, txn2-3m0 or metastatic breast cancer
591126|NCT00674778|Radial|radial
591127|NCT00674778|Femoral|femoral
591128|NCT00674778|artery|artery
591129|NCT00674778|Invasive cardiology safety|invasive cardiology safety
591130|NCT00674739|external genital warts|external genital warts
591131|NCT00674739|perianal warts|perianal warts
591132|NCT00674739|condylomata acuminata|condylomata acuminata
591133|NCT00674739|venereal warts|venereal warts
591134|NCT00674739|HPV types 6 and 11|hpv types 6 and 11
591135|NCT00674726|appendicitis|appendicitis
591136|NCT00674726|gastroenteritis|gastroenteritis
591137|NCT00674726|temperature|temperature
591138|NCT00674726|fever|fever
591139|NCT00674726|acute abdomen|acute abdomen
591140|NCT00674726|Axilo-rectal temperature in appendicitis|axilo-rectal temperature in appendicitis
591141|NCT00674726|Axilo-rectal temperature in gastroenteritis|axilo-rectal temperature in gastroenteritis
591142|NCT00674713|Patients undergoing laparoscopic cholecystectomy for cholelithiasis|patients undergoing laparoscopic cholecystectomy for cholelithiasis
591143|NCT00674700|House dust mites allergy|house dust mites allergy
591144|NCT00674674|topotecan|topotecan
591145|NCT00674674|pharmacokinetics|pharmacokinetics
591146|NCT00674674|neoplastic|neoplastic
591147|NCT00674674|meningitis|meningitis
591148|NCT00674661|ectasia|ectasia
591149|NCT00674661|cross-linking|cross-linking
591150|NCT00674661|crosslinking|crosslinking
591151|NCT00674661|cornea|cornea
591152|NCT00674661|riboflavin|riboflavin
591153|NCT00674661|UVA|uva
591154|NCT00674648|Multiple Diseases|multiple diseases
591155|NCT00674648|Hematopoietic System|hematopoietic system
591156|NCT00674648|CMV-PP65 PROTEIN SPECIFIC T CELLS|cmv-pp65 protein specific t cells
591157|NCT00674635|adaptive study,|adaptive study,
591158|NCT00674635|DAS28,|das28,
591159|NCT00674635|monoclonal antibody|monoclonal antibody
591160|NCT00674635|GSK315234A;|gsk315234a;
591161|NCT00674635|rheumatoid arthritis,|rheumatoid arthritis,
591163|NCT00674622|Tennis elbow|tennis elbow
591164|NCT00674622|Prolotherapy|prolotherapy
591165|NCT00674609|Palliative Care|palliative care
591166|NCT00674609|Pain|pain
591167|NCT00674609|Cancer|cancer
591168|NCT00674596|PTX3, ramipril, endothelial dysfunction|ptx3, ramipril, endothelial dysfunction
591169|NCT00674596|1- Diabetic proteinuria|1- diabetic proteinuria
591170|NCT00674596|2- The aim of this study was to find out whether the|2- the aim of this study was to find out whether the
591171|NCT00674596|beneficial effects of RAS blockage in diabetic|beneficial effects of ras blockage in diabetic
591172|NCT00674596|proteinuria has any relation with the alteration|proteinuria has any relation with the alteration
591173|NCT00674596|of PTX3 levels.|of ptx3 levels.
591174|NCT00674583|Conjugate vaccine|conjugate vaccine
591175|NCT00674583|Meningococcal disease|meningococcal disease
591176|NCT00674583|Immunogenicity|immunogenicity
591177|NCT00674583|Meningococcal vaccine|meningococcal vaccine
591178|NCT00674583|Safety|safety
591179|NCT00674570|Stress Disorders, Posttraumatic|stress disorders, posttraumatic
591180|NCT00674570|Hydrocortisone|hydrocortisone
591181|NCT00674570|Cycloserine|cycloserine
591182|NCT00674570|Extinction, Psychological|extinction, psychological
591183|NCT00674570|PTSD|ptsd
591184|NCT00674570|San Francisco|san francisco
591185|NCT00674557|recurrent breast cancer|recurrent breast cancer
591186|NCT00674557|stage IIIA breast cancer|stage iiia breast cancer
591187|NCT00674557|stage IIIB breast cancer|stage iiib breast cancer
591188|NCT00674557|stage IIIC breast cancer|stage iiic breast cancer
591189|NCT00674557|stage IV breast cancer|stage iv breast cancer
591190|NCT00674557|HER2-negative breast cancer|her2-negative breast cancer
591191|NCT00674557|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
591192|NCT00674557|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
591193|NCT00674544|childhood|childhood
591194|NCT00674544|children|children
591195|NCT00674544|obesity|obesity
591196|NCT00674544|physical activity|physical activity
591197|NCT00674544|nutrition|nutrition
591198|NCT00674544|fitness|fitness
591199|NCT00674544|family|family
591200|NCT00674531|Arteriosclerosis|arteriosclerosis
591201|NCT00674531|Arterial Occlusive Diseases|arterial occlusive diseases
591202|NCT00674531|Enterovirus|enterovirus
591203|NCT00674531|Artery resection|artery resection
591204|NCT00674518|Health Promotion|health promotion
591205|NCT00674518|Health Behavior Change|health behavior change
591206|NCT00674518|Physical Activity|physical activity
591207|NCT00674518|Dietary Change|dietary change
591208|NCT00674518|Weight Loss|weight loss
591209|NCT00674518|Obesity|obesity
591210|NCT00674479|Advanced Hematologic Malignancies|advanced hematologic malignancies
591211|NCT00674479|Cancer|cancer
591212|NCT00674479|Blood|blood
591213|NCT00674479|Bone marrow|bone marrow
591214|NCT00674479|Lymph nodes|lymph nodes
591215|NCT00674479|JAK kinase inhibitor INCB018424 phosphate|jak kinase inhibitor incb018424 phosphate
591216|NCT00674479|Acute Myeloid Leukemia|acute myeloid leukemia
591217|NCT00674479|AML|aml
591218|NCT00674479|Acute Lymphocytic leukemia|acute lymphocytic leukemia
591219|NCT00674479|ALL|all
591220|NCT00674479|Myelodysplastic Syndrome|myelodysplastic syndrome
591221|NCT00674479|MDS|mds
591222|NCT00674479|Chronic myelogenous leukemia - Blast Crisis|chronic myelogenous leukemia - blast crisis
591223|NCT00674479|CML|cml
591224|NCT00674479|INCB018424|incb018424
591225|NCT00674466|GLP-1, incretin, type 2 diabetes|glp-1, incretin, type 2 diabetes
591226|NCT00674453|Osteoporosis|osteoporosis
591227|NCT00674453|lasofoxifene|lasofoxifene
591228|NCT00674453|bone density|bone density
591229|NCT00674453|bone markers|bone markers
591230|NCT00674440|Congenital Hyperinsulinism|congenital hyperinsulinism
591231|NCT00674440|Hyperinsulinism|hyperinsulinism
591232|NCT00674440|Persistent Hyperinsulinemic Hypoglycemia of Infancy|persistent hyperinsulinemic hypoglycemia of infancy
591233|NCT00674440|CHI|chi
591234|NCT00674440|PHHI|phhi
591235|NCT00674440|F-DOPA|f-dopa
591236|NCT00674440|L-fluoro-dihydroxyphenylalanine|l-fluoro-dihydroxyphenylalanine
591237|NCT00674427|AML|aml
591238|NCT00674427|ALL|all
591239|NCT00674427|MDS|mds
591240|NCT00674427|CLL|cll
591241|NCT00674427|Multiple Myeloma|multiple myeloma
591242|NCT00674414|stage IA breast cancer|stage ia breast cancer
591243|NCT00674414|stage IB breast cancer|stage ib breast cancer
591244|NCT00674414|stage II breast cancer|stage ii breast cancer
591245|NCT00674414|stage IIIA breast cancer|stage iiia breast cancer
591246|NCT00674414|HER2-positive breast cancer|her2-positive breast cancer
591247|NCT00674388|Children|children
591248|NCT00674388|Anesthesia|anesthesia
591249|NCT00674388|Surgery|surgery
591250|NCT00674388|Complication|complication
591251|NCT00674375|Chest Pain|chest pain
591252|NCT00674375|Acute Myocardial Infarction|acute myocardial infarction
591253|NCT00674375|Patient Safety|patient safety
591254|NCT00674375|Misdiagnosis|misdiagnosis
591255|NCT00674362|Rheumatoid Arthritis|rheumatoid arthritis
591256|NCT00674362|Moderate to Low Disease activity|moderate to low disease activity
591257|NCT00674362|Certolizumab pegol|certolizumab pegol
591258|NCT00674336|Norovirus|norovirus
591259|NCT00674336|Gastroenteritis|gastroenteritis
591260|NCT00674336|Clinical Trial|clinical trial
591261|NCT00674336|Stomach flu|stomach flu
591262|NCT00674336|Oysters|oysters
591263|NCT00674336|Shellfish|shellfish
591264|NCT00674336|high hydrostatic pressures|high hydrostatic pressures
591265|NCT00674323|Polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
591266|NCT00674323|PCV|pcv
591267|NCT00674323|Age-related macular degeneration (AMD) variant|age-related macular degeneration (amd) variant
591268|NCT00674323|vision|vision
591269|NCT00674323|polyps|polyps
591270|NCT00674323|indocyanine green angiography|indocyanine green angiography
591271|NCT00674323|verteporfin|verteporfin
591272|NCT00674323|ranibizumab|ranibizumab
591273|NCT00674323|photodynamic therapy|photodynamic therapy
591274|NCT00674297|Persistently Antiphospholipid Antibody Positive Patients|persistently antiphospholipid antibody positive patients
591275|NCT00674271|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
591276|NCT00674271|Mannose-Binding lectin|mannose-binding lectin
591277|NCT00674271|Toll-Like Receptors|toll-like receptors
591278|NCT00674271|Atherosclerosis|atherosclerosis
591279|NCT00674271|Carotid Arteries|carotid arteries
591280|NCT00674271|Diabetes Complications|diabetes complications
591281|NCT00674271|Diabetic Angiopathies|diabetic angiopathies
591282|NCT00674258|HLA-A*2402|hla-a*2402
591283|NCT00674258|Peptide Vaccine|peptide vaccine
591284|NCT00674258|URLC10|urlc10
591285|NCT00674258|TTK|ttk
591286|NCT00674258|KOC1|koc1
591287|NCT00674245|heartburn|heartburn
591288|NCT00674245|acid reflux|acid reflux
591289|NCT00674245|GERD|gerd
591290|NCT00674245|spectrum analysis|spectrum analysis
591291|NCT00674245|electroencephalogram|electroencephalogram
591292|NCT00674245|esophagitis|esophagitis
591293|NCT00674245|peptic|peptic
591294|NCT00674232|incomplete abortion|incomplete abortion
591295|NCT00674232|spontaneous miscarriage|spontaneous miscarriage
591296|NCT00674219|GAD|gad
591297|NCT00674206|Metastatic breast cancer|metastatic breast cancer
591298|NCT00674154|Vitamin D|vitamin d
591299|NCT00674154|Primary hyperparathyroidism|primary hyperparathyroidism
591300|NCT00674154|hypercalcemia|hypercalcemia
591301|NCT00674141|Multiple Sclerosis, relapsing remitting, Dexamethasone|multiple sclerosis, relapsing remitting, dexamethasone
591302|NCT00674128|pacemaker|pacemaker
591303|NCT00674128|cardioverter-defibrillator|cardioverter-defibrillator
591304|NCT00674128|ICD|icd
591305|NCT00674128|cardiac resynchronization device|cardiac resynchronization device
591306|NCT00674128|cyanoacrylate|cyanoacrylate
591307|NCT00674128|suture|suture
591308|NCT00674128|Dermabond|dermabond
591309|NCT00674128|Vicryl|vicryl
591310|NCT00674102|Vascular disrupting agent|vascular disrupting agent
591311|NCT00674102|Non-small cell lung cancer|non-small cell lung cancer
591312|NCT00674089|IMR|imr
591313|NCT00674089|Newborn Mortality|newborn mortality
591314|NCT00674089|Vitamin A Effectiveness|vitamin a effectiveness
591315|NCT00674089|Premature Mortality|premature mortality
591316|NCT00674089|Mortality|mortality
591317|NCT00674063|Chronic Plaque Psoriasis|chronic plaque psoriasis
591318|NCT00674063|Alefacept|alefacept
591319|NCT00674050|Healthy Males or Females subjects|healthy males or females subjects
591320|NCT00674037|recruitment|recruitment
591321|NCT00674037|physicians participating in the recruitment of patients|physicians participating in the recruitment of patients
591322|NCT00674024|Pazopanib|pazopanib
591323|NCT00674024|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
591324|NCT00674024|Advanced Cancer|advanced cancer
591325|NCT00674024|Pharmacokinetics|pharmacokinetics
591326|NCT00674024|Cancer|cancer
591327|NCT00674024|Solid Tumor|solid tumor
591328|NCT00674024|Lymphoma|lymphoma
591329|NCT00674011|hypertension|hypertension
591330|NCT00674011|bevacizumab|bevacizumab
591331|NCT00674011|metastatic breast cancer|metastatic breast cancer
591332|NCT00673998|Isokinetic|isokinetic
591333|NCT00673998|Fatigue|fatigue
591334|NCT00673998|Strength|strength
591335|NCT00673998|Older|older
591336|NCT00673985|SFA, Edwards, Popliteal, LifeStent, PTA, Nitinol|sfa, edwards, popliteal, lifestent, pta, nitinol
591337|NCT00673972|Functional dyspepsia|functional dyspepsia
591338|NCT00673972|Gastric emptying|gastric emptying
591339|NCT00673972|Helicobacter pylori|helicobacter pylori
591340|NCT00673972|Lansoprazole|lansoprazole
591341|NCT00673972|Epigastric pain syndrome|epigastric pain syndrome
591342|NCT00673972|Postprandial distress syndrome|postprandial distress syndrome
591343|NCT00673959|Dry eye|dry eye
591344|NCT00673959|artificial tears|artificial tears
591345|NCT00673946|bronchiolitis|bronchiolitis
591346|NCT00673946|hospitalization|hospitalization
591347|NCT00673946|oximetry|oximetry
591348|NCT00673946|pediatrics|pediatrics
591349|NCT00673920|RA|ra
591350|NCT00673907|Wood smoke|wood smoke
591351|NCT00673907|Health effects|health effects
591352|NCT00673907|Human|human
591353|NCT00673907|Airway inflammation|airway inflammation
591354|NCT00673907|Cardiovascular effects|cardiovascular effects
591355|NCT00673855|Dry eye|dry eye
591356|NCT00673855|Artificial tear|artificial tear
591357|NCT00673842|Noninvasive assessment|noninvasive assessment
591358|NCT00673842|Holter|holter
591462|NCT00673504|Phase 2|phase 2
591359|NCT00673829|Breast Cancer|breast cancer
591360|NCT00673829|T cells|t cells
591361|NCT00673829|Gene Transfer|gene transfer
591362|NCT00673816|Von Hippel Lindau|von hippel lindau
591363|NCT00673816|Sunitinib Malate|sunitinib malate
591364|NCT00673816|Sutent|sutent
591365|NCT00673816|Von Hippel-Lindau Syndrome|von hippel-lindau syndrome
591366|NCT00673816|VHL|vhl
591367|NCT00673803|posterior capsule opacification|posterior capsule opacification
591368|NCT00673803|micro incision|micro incision
591369|NCT00673803|sharp optic edge|sharp optic edge
591370|NCT00673790|nebivolol|nebivolol
591371|NCT00673790|BYSTOLIC ™|bystolic ™
591372|NCT00673790|hydrochlorothiazide|hydrochlorothiazide
591373|NCT00673790|lisinopril|lisinopril
591374|NCT00673790|Prinivil (TM)|prinivil (tm)
591375|NCT00673790|Zestril (TM)|zestril (tm)
591376|NCT00673790|losartan|losartan
591377|NCT00673790|Cozaar (TM)|cozaar (tm)
591378|NCT00673790|Impaired Fasting Glucose|impaired fasting glucose
591379|NCT00673790|Impaired Glucose Tolerance|impaired glucose tolerance
591380|NCT00673790|hypertension|hypertension
591381|NCT00673777|HLA-A*0201|hla-a*0201
591382|NCT00673777|Peptide Vaccine|peptide vaccine
591383|NCT00673777|URLC10|urlc10
591384|NCT00673777|VEGFR1|vegfr1
591385|NCT00673777|VEGFR2|vegfr2
591386|NCT00673751|mesenteric blood flow|mesenteric blood flow
591387|NCT00673751|GLP-2|glp-2
591388|NCT00673751|short bowel syndrome|short bowel syndrome
591389|NCT00673751|Glucagon-Like Peptide 2|glucagon-like peptide 2
591390|NCT00673738|Lung|lung
591391|NCT00673738|Thoracic|thoracic
591392|NCT00673738|Immunotherapy|immunotherapy
591393|NCT00673738|Radiotherapy|radiotherapy
591394|NCT00673738|LA - NSCLC|la - nsclc
591395|NCT00673738|Non-Small Cell Lung Cancer|non-small cell lung cancer
591396|NCT00673725|Atopic Dermatitis|atopic dermatitis
591397|NCT00673712|Coronary Artery Bypass Graft Surgery|coronary artery bypass graft surgery
591398|NCT00673712|Pneumonia|pneumonia
591399|NCT00673712|Surgical Site Infection|surgical site infection
591400|NCT00673699|NBI|nbi
591401|NCT00673699|gastroscopy|gastroscopy
591402|NCT00673699|biopsy|biopsy
591403|NCT00673699|intestinal metaplasia|intestinal metaplasia
591404|NCT00673686|Oral contraceptive|oral contraceptive
591405|NCT00673686|Ovulation|ovulation
591406|NCT00673686|Missing pills|missing pills
591407|NCT00673686|Intake compliance|intake compliance
591408|NCT00673686|Cycle control|cycle control
591409|NCT00673660|Statins|statins
591410|NCT00673660|Compliance|compliance
591411|NCT00673660|Dyslipidemia|dyslipidemia
591412|NCT00673647|cannabis|cannabis
591413|NCT00673647|dependence|dependence
591414|NCT00673647|marijuana|marijuana
591415|NCT00673647|CBT|cbt
591416|NCT00673647|efficacy of CBT for cannabis use disorders|efficacy of cbt for cannabis use disorders
591417|NCT00673634|preoxygenation|preoxygenation
591418|NCT00673634|method|method
591419|NCT00673634|efficiency|efficiency
591420|NCT00673634|obesity|obesity
591421|NCT00673634|BiPAP|bipap
591422|NCT00673634|FeO2|feo2
591423|NCT00673621|Asthmatics and non-asthmatic male and female subjects|asthmatics and non-asthmatic male and female subjects
591424|NCT00673608|Haemoglobinopathies,|haemoglobinopathies,
591425|NCT00673608|Myelodysplastic Syndromes,|myelodysplastic syndromes,
591426|NCT00673608|Transfusional iron overload,|transfusional iron overload,
591427|NCT00673608|cardiac iron load|cardiac iron load
591428|NCT00673595|smoking|smoking
591429|NCT00673595|varenicline|varenicline
591430|NCT00673595|flow-mediated dilation|flow-mediated dilation
591431|NCT00673595|blood pressure|blood pressure
591432|NCT00673595|baroreflex|baroreflex
591433|NCT00673582|Statins|statins
591434|NCT00673582|Intima Media Thickness|intima media thickness
591435|NCT00673582|Plaque Area|plaque area
591436|NCT00673569|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
591437|NCT00673569|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
591438|NCT00673569|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
591439|NCT00673569|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
591440|NCT00673556|Chronic Plaque Psoriasis|chronic plaque psoriasis
591441|NCT00673556|Alefacept|alefacept
591442|NCT00673543|Corticosteroids|corticosteroids
591443|NCT00673543|Pregnancy|pregnancy
591444|NCT00673543|Glucose control|glucose control
591445|NCT00673530|Hospital malnutrition|hospital malnutrition
591446|NCT00673530|Nutritional Status|nutritional status
591447|NCT00673530|Nutrition Assessment|nutrition assessment
591448|NCT00673530|Enteral Nutrition|enteral nutrition
591449|NCT00673530|Parenteral Nutrition|parenteral nutrition
591450|NCT00673530|Severity of illness index|severity of illness index
591451|NCT00673530|cost analysis|cost analysis
591452|NCT00673517|Acute respiratory distress syndrome|acute respiratory distress syndrome
591453|NCT00673517|Ventilator induced lung injury|ventilator induced lung injury
591454|NCT00673517|High frequency oscillation|high frequency oscillation
591455|NCT00673517|Lung protective ventilation|lung protective ventilation
591456|NCT00673517|Biomarkers|biomarkers
591457|NCT00673517|Biotrauma|biotrauma
591458|NCT00673504|cancer|cancer
591459|NCT00673504|pancreatic cancer|pancreatic cancer
591463|NCT00673491|Critical Pathways|critical pathways
591464|NCT00673491|Stroke|stroke
591465|NCT00673491|Randomized Controlled Trial|randomized controlled trial
591466|NCT00673491|Effectiveness|effectiveness
591467|NCT00673439|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
591468|NCT00673439|thrombocytopenia|thrombocytopenia
591469|NCT00673439|HIT|hit
591470|NCT00673439|thrombosis|thrombosis
591471|NCT00673439|blood clot|blood clot
591472|NCT00673439|blood thinner|blood thinner
591473|NCT00673439|anticoagulant|anticoagulant
591474|NCT00673439|heparin|heparin
591475|NCT00673439|warfarin|warfarin
591476|NCT00673439|fondaparinux|fondaparinux
591477|NCT00673439|Arixtra|arixtra
591478|NCT00673426|enoxaparin|enoxaparin
591479|NCT00673426|chronic renal disease|chronic renal disease
591480|NCT00673426|Anticoagulant activity of enoxaparin sodic|anticoagulant activity of enoxaparin sodic
591481|NCT00673413|Perception|perception
591482|NCT00673413|Emotions|emotions
591483|NCT00673413|Adaptation|adaptation
591484|NCT00673413|Estomia|estomia
591485|NCT00673400|Obstructed defecation syndrome|obstructed defecation syndrome
591486|NCT00673400|ODS|ods
591487|NCT00673400|Rectocele|rectocele
591488|NCT00673400|Intussusception|intussusception
591489|NCT00673400|STARR|starr
591490|NCT00673387|overweight|overweight
591491|NCT00673387|obesity|obesity
591492|NCT00673387|pramlintide|pramlintide
591493|NCT00673387|metreleptin|metreleptin
591494|NCT00673387|Amylin|amylin
591495|NCT00673374|emergency|emergency
591496|NCT00673374|acute|acute
591497|NCT00673374|nontraumatic|nontraumatic
591498|NCT00673374|abdominal pain|abdominal pain
591499|NCT00673374|tenderness|tenderness
591500|NCT00673374|CT scan|ct scan
591501|NCT00673374|radiation|radiation
591502|NCT00673374|diagnosis|diagnosis
591503|NCT00673348|Mycoses|mycoses
591504|NCT00673348|Voriconazole|voriconazole
591505|NCT00673335|breast cancer|breast cancer
591506|NCT00673335|hereditary breast/ovarian cancer (BRCA1, BRCA2)|hereditary breast/ovarian cancer (brca1, brca2)
591507|NCT00673335|BRCA1 mutation carrier|brca1 mutation carrier
591508|NCT00673335|BRCA2 mutation carrier|brca2 mutation carrier
591509|NCT00673322|Colorectal Cancer|colorectal cancer
591510|NCT00673322|T cells|t cells
591511|NCT00673322|Gene Transfer|gene transfer
591512|NCT00673309|burns|burns
591513|NCT00673296|Bevacizumab|bevacizumab
591514|NCT00673296|Diabetic premacular hemorrhage|diabetic premacular hemorrhage
591515|NCT00673296|Intravitreal gas|intravitreal gas
591516|NCT00673283|lung cancer|lung cancer
591517|NCT00673283|nodules|nodules
591518|NCT00673283|radiography|radiography
591519|NCT00673283|CT|ct
591520|NCT00673283|Stereoscopy|stereoscopy
591521|NCT00673257|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
591522|NCT00673244|Renal Replacement Therapy|renal replacement therapy
591523|NCT00673244|Dialysis|dialysis
591524|NCT00673231|Dapagliflozin|dapagliflozin
591525|NCT00673231|efficacy|efficacy
591526|NCT00673231|safety|safety
591527|NCT00673231|add on to insulin|add on to insulin
591528|NCT00673231|Oral AntiDiabetic|oral antidiabetic
591529|NCT00673231|Type 2 diabetes|type 2 diabetes
591530|NCT00673218|IL13|il13
591531|NCT00673218|Cytokines|cytokines
591532|NCT00673218|Basophil stimulation|basophil stimulation
591533|NCT00673205|androgen antagonists|androgen antagonists
591534|NCT00673205|prostate neoplasms|prostate neoplasms
591535|NCT00673179|Doxorubicin|doxorubicin
591536|NCT00673179|AD|ad
591537|NCT00673179|Hydroxydaunomycin hydrochloride|hydroxydaunomycin hydrochloride
591538|NCT00673179|Cisplatin|cisplatin
591539|NCT00673179|Paraplatin®|paraplatin®
591540|NCT00673179|Methotrexate|methotrexate
591541|NCT00673179|Ifosfamide|ifosfamide
591542|NCT00673179|Osteosarcoma|osteosarcoma
591543|NCT00673179|Sargramostim|sargramostim
591544|NCT00673179|Leukine™|leukine™
591545|NCT00673179|Leucovorin|leucovorin
591546|NCT00673179|Gemcitabine|gemcitabine
591547|NCT00673179|Gemzar|gemzar
591548|NCT00673179|Gemcitabine Hydrochloride|gemcitabine hydrochloride
591549|NCT00673179|GM-CSF|gm-csf
591550|NCT00673179|Questionnaire|questionnaire
591551|NCT00673179|Survey|survey
591552|NCT00673166|Staff motivation|staff motivation
591553|NCT00673166|Hospital mortality|hospital mortality
591554|NCT00673166|Perception of quality of care|perception of quality of care
591555|NCT00673140|ALS (Amyotrophic Lateral Sclerosis)|als (amyotrophic lateral sclerosis)
591556|NCT00673140|Amyotrophic Lateral Sclerosis With Dementia|amyotrophic lateral sclerosis with dementia
591557|NCT00673140|Amyotrophic Lateral Sclerosis, Guam Form|amyotrophic lateral sclerosis, guam form
591558|NCT00673140|Dementia With Amyotrophic Lateral Sclerosis|dementia with amyotrophic lateral sclerosis
591559|NCT00673140|Gehrig's Disease|gehrig's disease
591560|NCT00673140|Guam Form of Amyotrophic Lateral Sclerosis|guam form of amyotrophic lateral sclerosis
591561|NCT00673140|Lou Gehrig Disease|lou gehrig disease
591562|NCT00673127|hormone refractory|hormone refractory
591563|NCT00673127|KHAD|khad
591564|NCT00673127|ketoconazole|ketoconazole
591565|NCT00673127|dutasteride|dutasteride
591566|NCT00673127|hydrocortisone|hydrocortisone
591567|NCT00673114|Haplo/cord|haplo/cord
591568|NCT00673114|hematologic malignancy|hematologic malignancy
591569|NCT00673114|MDS|mds
591570|NCT00673114|Aplastic Anemia|aplastic anemia
591571|NCT00673114|AML|aml
591572|NCT00673114|ALL|all
591573|NCT00673114|CML|cml
591574|NCT00673101|liver fibrosis, cirrhosis|liver fibrosis, cirrhosis
591575|NCT00673101|FibroScan|fibroscan
591576|NCT00673101|transient elastography|transient elastography
591577|NCT00673101|elastometry|elastometry
591578|NCT00673101|methotrexate|methotrexate
591579|NCT00673101|non invasive blood markers|non invasive blood markers
591580|NCT00673101|FibroTest|fibrotest
591581|NCT00673101|treatment|treatment
591582|NCT00673075|carvedilol|carvedilol
591583|NCT00673075|Coreg (TM)|coreg (tm)
591584|NCT00673075|hypertension|hypertension
591585|NCT00673075|blood pressure|blood pressure
591586|NCT00673075|coronary artery disease|coronary artery disease
591587|NCT00673075|Nebivolol|nebivolol
591588|NCT00673075|BYSTOLIC (TM)|bystolic (tm)
591589|NCT00673049|IGR-1R|igr-1r
591590|NCT00673049|Non small cell lung cancer|non small cell lung cancer
591591|NCT00673049|CP-751|cp-751
591592|NCT00673049|871|871
591593|NCT00673049|Figitumumab|figitumumab
591594|NCT00673036|Coronary syndrome|coronary syndrome
591595|NCT00673036|Myocardial infarction|myocardial infarction
591596|NCT00673036|French registry|french registry
591597|NCT00673010|124-IODINE|124-iodine
591598|NCT00673010|I-131 METAIODOBENZ SULF (MIBG)|i-131 metaiodobenz sulf (mibg)
591599|NCT00673010|Thyroid|thyroid
591600|NCT00673010|Parathyroid|parathyroid
591601|NCT00672997|Glaucoma|glaucoma
591602|NCT00672997|Hypertension|hypertension
591603|NCT00672984|QT/QTc|qt/qtc
591604|NCT00672958|Major Depressive Disorder|major depressive disorder
591605|NCT00672958|Depression|depression
591606|NCT00672958|Drug Therapy|drug therapy
591607|NCT00672958|Major Depressive Episode|major depressive episode
591608|NCT00672932|raltegravir|raltegravir
591609|NCT00672932|central nervous system (CNS)|central nervous system (cns)
591610|NCT00672932|HIV-1|hiv-1
591611|NCT00672932|AIDS|aids
591612|NCT00672932|cerebrospinal fluid (CSF)|cerebrospinal fluid (csf)
591613|NCT00672932|immunoactivation|immunoactivation
591614|NCT00672932|antiretroviral therapy|antiretroviral therapy
591615|NCT00672932|suppression|suppression
591616|NCT00672919|Glucose Metabolism Disorder|glucose metabolism disorder
591617|NCT00672919|Dysmetabolic Syndrome|dysmetabolic syndrome
591618|NCT00672919|Type II Diabetes|type ii diabetes
591619|NCT00672919|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
591620|NCT00672919|Dyslipidemia|dyslipidemia
591621|NCT00672919|Drug Therapy|drug therapy
591622|NCT00672906|anorexia nervosa|anorexia nervosa
591623|NCT00672906|group parent training|group parent training
591624|NCT00672906|caregiver burden|caregiver burden
591625|NCT00672906|eating disorders|eating disorders
591626|NCT00672906|treatment|treatment
591627|NCT00672893|central airway stenosis, lung sounds, airway obstruction, bronchial obstruction, bronchoscopic treatment|central airway stenosis, lung sounds, airway obstruction, bronchial obstruction, bronchoscopic treatment
591628|NCT00672880|Chronic low back pain accompanied by depression|chronic low back pain accompanied by depression
591629|NCT00672854|parenteral nutrition|parenteral nutrition
591630|NCT00672854|lipid emulsion|lipid emulsion
591631|NCT00672854|nosocomial infection|nosocomial infection
591632|NCT00672854|mortality|mortality
591633|NCT00672854|endothelial function|endothelial function
591634|NCT00672854|inflammatory markers|inflammatory markers
591635|NCT00672854|oxidative stress|oxidative stress
591636|NCT00672854|immune function|immune function
591637|NCT00672854|autonomic nervous system|autonomic nervous system
591638|NCT00672854|insulin sensitivity|insulin sensitivity
591639|NCT00672854|carbohydrate metabolism|carbohydrate metabolism
591640|NCT00672841|candidemia|candidemia
591641|NCT00672841|invasive candidiasis|invasive candidiasis
591642|NCT00672841|preemptive antifungal therapy|preemptive antifungal therapy
591643|NCT00672841|surveillance|surveillance
591644|NCT00672841|β-D-Glucan (BDG)|β-d-glucan (bdg)
591645|NCT00672828|colon cancer|colon cancer
591646|NCT00672828|rectal cancer|rectal cancer
591647|NCT00672815|coordinated school health|coordinated school health
591648|NCT00672815|school health policy evaluation|school health policy evaluation
591649|NCT00672815|physical activity|physical activity
591650|NCT00672802|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
591651|NCT00672802|COPD|copd
591652|NCT00672802|Insomnia|insomnia
591653|NCT00672802|Drug Therapy|drug therapy
591654|NCT00672789|Sickle cell anemia|sickle cell anemia
591655|NCT00672789|Children|children
591656|NCT00672789|Hydroxyurea|hydroxyurea
591657|NCT00672789|Treatment Adherence|treatment adherence
591658|NCT00672776|hippocampus|hippocampus
591659|NCT00672776|paroxetine|paroxetine
591660|NCT00672776|stress|stress
591661|NCT00672776|PTSD|ptsd
591662|NCT00672763|Crohn's Disease|crohn's disease
591663|NCT00672763|Inflammatory Bowel Disease|inflammatory bowel disease
591664|NCT00672763|Vitamin D|vitamin d
591665|NCT00672763|Randomised|randomised
591666|NCT00672763|Placebo|placebo
591667|NCT00672750|laparoscopic|laparoscopic
591668|NCT00672750|myomectomy|myomectomy
591669|NCT00672750|menorrhagia|menorrhagia
591670|NCT00672750|pelvic pain|pelvic pain
591671|NCT00672724|Insomnia|insomnia
591672|NCT00672724|Sleep Disorder|sleep disorder
591673|NCT00672724|Drug Therapy|drug therapy
591674|NCT00672711|Complex Regional Pain Syndrome|complex regional pain syndrome
591675|NCT00672711|Chronic Post-surgical Pain|chronic post-surgical pain
591676|NCT00672711|Genetic susceptibility|genetic susceptibility
591677|NCT00672711|COMT|comt
591678|NCT00672698|SURGICAL RISK|surgical risk
591679|NCT00672698|ELDERLY|elderly
591680|NCT00672698|MAJOR SURGERY|major surgery
591681|NCT00672698|P-POSSUM|p-possum
591682|NCT00672698|SAPS II|saps ii
591683|NCT00672685|Cognitive decline|cognitive decline
591684|NCT00672685|omega-3 fatty acids|omega-3 fatty acids
591685|NCT00672685|nutrition|nutrition
591686|NCT00672685|physical exercise|physical exercise
591687|NCT00672685|cognitive training|cognitive training
591688|NCT00672685|social activities|social activities
591689|NCT00672685|frailty|frailty
591690|NCT00672672|Wound healing of surgical site treated with autologous platlet gel|wound healing of surgical site treated with autologous platlet gel
591691|NCT00672659|Lost of interest, Depressed Mood|lost of interest, depressed mood
591692|NCT00672646|Analgesic effect|analgesic effect
591693|NCT00672633|Omega 3 Fatty Acids|omega 3 fatty acids
591694|NCT00672633|Triglycerides|triglycerides
591695|NCT00672633|Lovaza|lovaza
591696|NCT00672633|Trial|trial
591697|NCT00672620|Major Depressive Disorder|major depressive disorder
591698|NCT00672620|Depression|depression
591699|NCT00672620|Drug Therapy|drug therapy
591700|NCT00672620|Major Depressive Episode|major depressive episode
591701|NCT00672607|premenstual syndrome, PMS, clinical trial|premenstual syndrome, pms, clinical trial
591702|NCT00672581|Hepatic Impairment|hepatic impairment
591703|NCT00672568|Rotator cuff, Shoulder, Arthroscopic shoulder surgery|rotator cuff, shoulder, arthroscopic shoulder surgery
591704|NCT00672555|pilonidal sinus|pilonidal sinus
591705|NCT00672555|recurrence|recurrence
591706|NCT00672555|Limberg flap|limberg flap
591707|NCT00672542|melanoma|melanoma
591708|NCT00672542|dendritic cell|dendritic cell
591709|NCT00672542|immunoproteasome|immunoproteasome
591710|NCT00672542|vaccine|vaccine
591711|NCT00672529|Childhood Asthma|childhood asthma
591712|NCT00672529|Inhaled Corticosteroids|inhaled corticosteroids
591713|NCT00672529|Alternative Medicine|alternative medicine
591714|NCT00672529|Vitamins, minerals, and fish oil as Add-on Treatment|vitamins, minerals, and fish oil as add-on treatment
591715|NCT00672516|hemorrhage|hemorrhage
591716|NCT00672516|cardiopulmonary bypass|cardiopulmonary bypass
591717|NCT00672516|blood component transfusion|blood component transfusion
591718|NCT00672516|hemostasis, surgical|hemostasis, surgical
591719|NCT00672503|indwelling urinary catheters|indwelling urinary catheters
591720|NCT00672503|urinary tract infections|urinary tract infections
591721|NCT00672503|foley-catheter related infections|foley-catheter related infections
591722|NCT00672503|hospital acquired CA-UTI|hospital acquired ca-uti
591723|NCT00672490|Acute Mania|acute mania
591724|NCT00672490|Bipolar Disorder|bipolar disorder
591725|NCT00672490|Quetiapine Fumarate|quetiapine fumarate
591726|NCT00672490|Lithium|lithium
591727|NCT00672477|opioid-induced constipation|opioid-induced constipation
591728|NCT00672464|Schizophrenia|schizophrenia
591729|NCT00672464|Schizoaffective|schizoaffective
591730|NCT00672464|Cardiovascular|cardiovascular
591731|NCT00672464|Olanzapine|olanzapine
591732|NCT00672464|Metformin|metformin
591733|NCT00672464|Simvastatin|simvastatin
591734|NCT00672451|diabetic kidney disease|diabetic kidney disease
591735|NCT00672451|albuminuria|albuminuria
591736|NCT00672412|Treatment Experienced|treatment experienced
591737|NCT00672399|Amylin|amylin
591738|NCT00672399|Eli Lilly|eli lilly
591739|NCT00672399|exenatide|exenatide
591740|NCT00672399|moxifloxacin|moxifloxacin
591741|NCT00672386|Diabetes|diabetes
591742|NCT00672386|Type 2 Diabetes|type 2 diabetes
591743|NCT00672386|Adult-Onset Diabetes Mellitus|adult-onset diabetes mellitus
591744|NCT00672386|Metabolic Syndrome|metabolic syndrome
591745|NCT00672386|HbA1c|hba1c
591746|NCT00672386|Body Weight|body weight
591747|NCT00672386|Metformin|metformin
591748|NCT00672373|Tardive Dyskinesia|tardive dyskinesia
591749|NCT00672373|Schizophrenia|schizophrenia
591750|NCT00672373|Extract of Gingko Biloba|extract of gingko biloba
591751|NCT00672360|Autism Spectrum Disorder|autism spectrum disorder
591752|NCT00672347|caudal anesthesia, clonidine, morphine, bupivacaine|caudal anesthesia, clonidine, morphine, bupivacaine
591753|NCT00672334|Cardiac surgery|cardiac surgery
591754|NCT00672334|Cardiopulmonary bypass|cardiopulmonary bypass
591755|NCT00672334|Oxidative stress|oxidative stress
591756|NCT00672334|Acute renal dysfunction|acute renal dysfunction
591757|NCT00672334|Sodium bicarbonate|sodium bicarbonate
591758|NCT00672321|recurrent melanoma|recurrent melanoma
591759|NCT00672321|stage IB melanoma|stage ib melanoma
591760|NCT00672321|stage II melanoma|stage ii melanoma
591761|NCT00672321|stage IIIA melanoma|stage iiia melanoma
591762|NCT00672308|Cholera, benefiber, ORS|cholera, benefiber, ors
591763|NCT00672295|Ovarian Cancer|ovarian cancer
591764|NCT00672295|Peritoneal Cancer|peritoneal cancer
591765|NCT00672295|Tubal Cancer|tubal cancer
591766|NCT00672295|Fallopian Tube Cancer|fallopian tube cancer
591767|NCT00672295|Dasatinib|dasatinib
591768|NCT00672295|Sprycel|sprycel
591769|NCT00672295|Paclitaxel|paclitaxel
591770|NCT00672295|Taxol|taxol
591771|NCT00672295|Carboplatin|carboplatin
591772|NCT00672295|Paraplatin|paraplatin
591773|NCT00672282|androgen antagonists|androgen antagonists
591774|NCT00672282|prostate neoplasms|prostate neoplasms
591775|NCT00672269|carcinoid|carcinoid
591776|NCT00672269|family members|family members
591777|NCT00672269|familial|familial
591778|NCT00672269|tumors|tumors
591779|NCT00672269|cancer|cancer
591780|NCT00672256|Smoking|smoking
591781|NCT00672256|fMRI|fmri
591782|NCT00672243|GBM|gbm
591783|NCT00672243|Brain tumor|brain tumor
591784|NCT00672243|Erlotinib|erlotinib
591785|NCT00672243|Sirolimus|sirolimus
591786|NCT00672243|Glioblastoma multiforme|glioblastoma multiforme
591787|NCT00672243|Glioblastoma|glioblastoma
591788|NCT00672243|Gliosarcoma3|gliosarcoma3
591789|NCT00672243|Tarceva|tarceva
591790|NCT00672243|Rapamune|rapamune
591791|NCT00672230|Lactation|lactation
591792|NCT00672230|Breast milk|breast milk
591793|NCT00672230|Lutein|lutein
591794|NCT00672230|Lutein supplement|lutein supplement
591795|NCT00672217|Breast cancer survivors, insomnia, quality of life|breast cancer survivors, insomnia, quality of life
591796|NCT00672204|Islet transplant|islet transplant
591797|NCT00672204|Diabetes Mellitus|diabetes mellitus
591798|NCT00672204|Hypoglycemia|hypoglycemia
591799|NCT00672191|HIV|hiv
591800|NCT00672191|Human immunodeficiency virus|human immunodeficiency virus
591801|NCT00672191|Immunodeficiency Virus, Human|immunodeficiency virus, human
591802|NCT00672191|HIV-1|hiv-1
591803|NCT00672191|ART|art
591804|NCT00672191|antiretroviral therapy|antiretroviral therapy
591805|NCT00672191|HAART|haart
591806|NCT00672191|highly active retroviral therapy|highly active retroviral therapy
591807|NCT00672191|cluster of differentiation CD 4+ T cell counts|cluster of differentiation cd 4+ t cell counts
591808|NCT00672191|HIV-1 Subjects successfully ART treated|hiv-1 subjects successfully art treated
591809|NCT00672191|Treatment Experienced|treatment experienced
591810|NCT00672178|RCC|rcc
591811|NCT00672178|metastatic|metastatic
591812|NCT00672178|sorafenib|sorafenib
591813|NCT00672165|MAB HUM 195 ACTINIUM-225 LABELED|mab hum 195 actinium-225 labeled
591814|NCT00672165|HEMATOPOIETIC SYSTEM|hematopoietic system
591815|NCT00672165|02-017|02-017
591816|NCT00672152|Autologous transplantation|autologous transplantation
591817|NCT00672152|Allogeneic transplantation|allogeneic transplantation
591818|NCT00672139|Opioid-Induced Constipation|opioid-induced constipation
591819|NCT00672100|Peripheral Nerve Infusion,|peripheral nerve infusion,
591820|NCT00672100|continuous brachial plexus block,|continuous brachial plexus block,
591821|NCT00672100|post-operative pain|post-operative pain
591822|NCT00672100|diaphragmatic paresis|diaphragmatic paresis
591823|NCT00672087|Chronic Prostatitis with Chronic Pelvic Pain Syndrome|chronic prostatitis with chronic pelvic pain syndrome
591824|NCT00672087|Chronic Bacterial Prostatitis|chronic bacterial prostatitis
591825|NCT00672087|Asymptomatic Inflammatory Prostatitis|asymptomatic inflammatory prostatitis
591826|NCT00672087|Painful Bladder Syndrome|painful bladder syndrome
591827|NCT00672087|Cystitis, Interstitial|cystitis, interstitial
591828|NCT00672074|Postoperative Ileus|postoperative ileus
591829|NCT00672061|Sleep Apnea, Obstructive|sleep apnea, obstructive
591830|NCT00672061|Insomnia|insomnia
591831|NCT00672061|Drug Therapy|drug therapy
591832|NCT00672048|glaucoma|glaucoma
591833|NCT00672048|optometrists|optometrists
591834|NCT00672035|LT|lt
591835|NCT00672035|Healthy Adults|healthy adults
591836|NCT00672035|Dose Ranging|dose ranging
591837|NCT00672035|Patch|patch
591838|NCT00672035|Vaccine|vaccine
591839|NCT00672009|prostate cancer|prostate cancer
591840|NCT00672009|radical prostatectomy|radical prostatectomy
591841|NCT00672009|ixabepilone|ixabepilone
591842|NCT00671970|Glioblastoma|glioblastoma
591843|NCT00671970|Gliosarcoma|gliosarcoma
591844|NCT00671970|Recurrent MG|recurrent mg
591845|NCT00671970|Malignant glioma|malignant glioma
591846|NCT00671970|Glioma|glioma
591847|NCT00671970|Glioblastoma multiforme (GBM)|glioblastoma multiforme (gbm)
591848|NCT00671970|GBM|gbm
591849|NCT00671970|Brain tumor|brain tumor
591850|NCT00671970|Anaplastic astrocytoma|anaplastic astrocytoma
591851|NCT00671970|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
591852|NCT00671970|Anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
591853|NCT00671970|Bevacizumab|bevacizumab
591854|NCT00671970|Avastin|avastin
591855|NCT00671970|Erlotinib|erlotinib
591856|NCT00671970|Tarceva|tarceva
591857|NCT00671957|Obesity|obesity
591858|NCT00671957|Bariatric|bariatric
591859|NCT00671957|Surgery|surgery
591860|NCT00671957|Activity|activity
591861|NCT00671944|protein|protein
591862|NCT00671944|calcium|calcium
591863|NCT00671944|parathyroid hormone|parathyroid hormone
591864|NCT00671944|bone markers|bone markers
591865|NCT00671944|calcium kinetics|calcium kinetics
591866|NCT00671944|absorption|absorption
591867|NCT00671931|dexmedetomidine|dexmedetomidine
591868|NCT00671931|neuromonitoring|neuromonitoring
591869|NCT00671931|spine procedures|spine procedures
591870|NCT00671931|safe dose|safe dose
591871|NCT00671931|1- safe dose of dexmedetomidine when used in total intravenous anesthesia for procedures require neuromonitoring|1- safe dose of dexmedetomidine when used in total intravenous anesthesia for procedures require neuromonitoring
591872|NCT00671931|2- safe dose of propofol when uses in comination with dexmedetomidine in neuromontoring|2- safe dose of propofol when uses in comination with dexmedetomidine in neuromontoring
591873|NCT00671931|3effect of dexmedetomidine on somatosensory evoked potential and motor evoked potentials|3effect of dexmedetomidine on somatosensory evoked potential and motor evoked potentials
591874|NCT00671918|breast cancer|breast cancer
591875|NCT00671918|lymph nodes|lymph nodes
591876|NCT00671918|melanoma|melanoma
591877|NCT00671918|surgery|surgery
591878|NCT00671905|atrial fibrillation|atrial fibrillation
591879|NCT00671905|PV isolation|pv isolation
591880|NCT00671905|ablation|ablation
591881|NCT00671905|ganglionic plexi|ganglionic plexi
591882|NCT00671905|parasympathetic denervation|parasympathetic denervation
591883|NCT00671892|LPS endotoxin|lps endotoxin
591884|NCT00671892|asthma|asthma
591885|NCT00671866|OP|op
591886|NCT00671866|Pesticides|pesticides
591887|NCT00671866|Long-Term Low Level Exposure|long-term low level exposure
591888|NCT00671866|Occupational Health|occupational health
591889|NCT00671866|Neurobehavioral Effects|neurobehavioral effects
591890|NCT00671853|Bipolar Disorder|bipolar disorder
591891|NCT00671853|Anxiety|anxiety
591892|NCT00671853|Anxiety Disorders|anxiety disorders
591893|NCT00671853|Substance Use Disorders|substance use disorders
591894|NCT00671827|Gynecologic Cancer|gynecologic cancer
591895|NCT00671827|Cervical Cancer|cervical cancer
591896|NCT00671827|Endometrial Cancer|endometrial cancer
591897|NCT00671827|Fallopian Tube Cancer|fallopian tube cancer
591898|NCT00671827|Ovarian Cancer|ovarian cancer
591899|NCT00671827|Uterine Cancer|uterine cancer
591900|NCT00671827|Vaginal Cancer|vaginal cancer
591901|NCT00671827|Vulvar Cancer|vulvar cancer
591902|NCT00671827|Questionnaire|questionnaire
591903|NCT00671827|Survey|survey
591904|NCT00671827|Robot-Assisted Surgery|robot-assisted surgery
591905|NCT00671814|antibiotic|antibiotic
591906|NCT00671801|Malignant Gliomas|malignant gliomas
591907|NCT00671801|Glioblastoma Multiforme|glioblastoma multiforme
591908|NCT00671801|Gliosarcoma|gliosarcoma
591909|NCT00671801|Anaplastic Astrocytoma|anaplastic astrocytoma
591910|NCT00671801|Anaplastic Oligodendroglioma|anaplastic oligodendroglioma
591911|NCT00671801|Anaplastic Oligoastrocytoma|anaplastic oligoastrocytoma
591912|NCT00671801|Camptosar|camptosar
591913|NCT00671801|Irinotecan|irinotecan
591914|NCT00671801|CPT-11|cpt-11
591915|NCT00671801|Lenalidomide|lenalidomide
591916|NCT00671801|Revlimid|revlimid
591917|NCT00671801|CC-5013|cc-5013
591918|NCT00671775|Bariatric Surgery|bariatric surgery
591919|NCT00671775|Obesity|obesity
591920|NCT00671775|Cognitive Function|cognitive function
591921|NCT00671736|cystic fibrosis|cystic fibrosis
591922|NCT00671736|Moli1901|moli1901
591923|NCT00671736|Lancovutide|lancovutide
591924|NCT00671736|2622U90|2622u90
591925|NCT00671736|duramycin|duramycin
591926|NCT00671736|lung|lung
591927|NCT00671723|Atelectasis|atelectasis
591928|NCT00671710|malignant glial brain tumors|malignant glial brain tumors
591929|NCT00671697|MDS|mds
591930|NCT00671697|hypomethylating agent|hypomethylating agent
591931|NCT00671697|oxidative stress|oxidative stress
591932|NCT00671684|Hirschsprung's disease|hirschsprung's disease
591933|NCT00671684|Constipation|constipation
591934|NCT00671684|Endoscopy, digestive system|endoscopy, digestive system
591935|NCT00671684|Diagnosis|diagnosis
591936|NCT00671684|Colonoscopy|colonoscopy
591937|NCT00671658|Lymphoma|lymphoma
591938|NCT00671658|HYPER-CVAD|hyper-cvad
591939|NCT00671658|Leukemia|leukemia
591940|NCT00671658|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
591941|NCT00671658|ALL|all
591942|NCT00671658|Remission Duration|remission duration
591943|NCT00671658|Chemotherapy|chemotherapy
591944|NCT00671658|Asparaginase|asparaginase
591945|NCT00671658|Cyclophosphamide|cyclophosphamide
591946|NCT00671658|Cytarabine|cytarabine
591947|NCT00671658|Dexamethasone|dexamethasone
591948|NCT00671658|Doxorubicin|doxorubicin
591949|NCT00671658|Leukine|leukine
591950|NCT00671658|Methotrexate|methotrexate
591951|NCT00671658|Rituximab|rituximab
591952|NCT00671658|Vincristine|vincristine
591953|NCT00671645|pilot study|pilot study
591954|NCT00671645|rectal|rectal
591955|NCT00671645|carcinoma|carcinoma
591956|NCT00671645|phase II|phase ii
591957|NCT00671645|preoperative|preoperative
591958|NCT00671645|RadioChemo|radiochemo
591959|NCT00671645|molecular|molecular
591960|NCT00671645|target|target
591961|NCT00671645|therapy|therapy
591962|NCT00671645|T3|t3
591963|NCT00671645|ABCSG|abcsg
591964|NCT00671645|TAKO|tako
591965|NCT00671645|R04|r04
591966|NCT00671645|08|08
591967|NCT00671632|Addiction|addiction
591968|NCT00671619|opthalmology|opthalmology
591969|NCT00671619|antibody fragment|antibody fragment
591970|NCT00671619|TNF alpha|tnf alpha
591971|NCT00671606|Endometrial Cancer|endometrial cancer
591972|NCT00671606|Lymphatic Mapping|lymphatic mapping
591973|NCT00671606|Sentinel Node Identification|sentinel node identification
591974|NCT00671606|Lymph Node|lymph node
591975|NCT00671606|Intraoperative lymphatic mapping|intraoperative lymphatic mapping
591976|NCT00671606|Total hysterectomy|total hysterectomy
591977|NCT00671606|Bilateral salpingooophorectomy|bilateral salpingooophorectomy
591978|NCT00671606|Lymph node staging|lymph node staging
591979|NCT00671606|Laparotomy|laparotomy
591980|NCT00671606|Laparoscopy|laparoscopy
591981|NCT00671593|Allergy|allergy
591982|NCT00671593|Asthma|asthma
591983|NCT00671593|healthy|healthy
591984|NCT00671593|Normal|normal
591985|NCT00671580|Skin Infections|skin infections
591986|NCT00671580|Complicated Skin and Skin Structure Infections|complicated skin and skin structure infections
591987|NCT00671567|Sleep Disorder|sleep disorder
591988|NCT00671567|Insomnia|insomnia
591989|NCT00671554|Melanoma|melanoma
591990|NCT00671554|Dendritic cells|dendritic cells
591991|NCT00671554|Cell therapy|cell therapy
591992|NCT00671554|BCG vaccine|bcg vaccine
591993|NCT00671528|Impetiginous|impetiginous
591994|NCT00671515|Depressive Disorder, Major|depressive disorder, major
591995|NCT00671515|Metabolic Syndrome X|metabolic syndrome x
591996|NCT00671515|pioglitazone|pioglitazone
591997|NCT00671489|Patients|patients
591998|NCT00671489|high-energy|high-energy
591999|NCT00671489|admitted|admitted
592000|NCT00671489|intensive care unit|intensive care unit
592001|NCT00671489|motor vehicle accident|motor vehicle accident
592002|NCT00671489|falling from height|falling from height
592003|NCT00671489|other accident|other accident
592004|NCT00671476|ductal breast carcinoma in situ|ductal breast carcinoma in situ
592005|NCT00671463|Pancreas surgery|pancreas surgery
592006|NCT00671463|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
592007|NCT00671463|Pancreatic neuroendocrine tumor|pancreatic neuroendocrine tumor
592008|NCT00671463|Pancreatic duct stenting|pancreatic duct stenting
592009|NCT00671437|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
592010|NCT00671424|Interaction,|interaction,
592011|NCT00671424|Diabetes,|diabetes,
592012|NCT00671424|healthy male subjects|healthy male subjects
592013|NCT00671424|GSK189075,|gsk189075,
592014|NCT00671424|Diuretics,|diuretics,
592015|NCT00671411|Ultrasound|ultrasound
592016|NCT00671411|07-165|07-165
592017|NCT00671398|Insomnia|insomnia
592018|NCT00671398|Sleep Disorder|sleep disorder
592019|NCT00671398|Drug Therapy|drug therapy
592020|NCT00671385|screening|screening
592021|NCT00671385|compositional analysis|compositional analysis
592022|NCT00671385|metabolism|metabolism
592023|NCT00671385|breast|breast
592024|NCT00671385|breast cyst|breast cyst
592025|NCT00671385|breast infection|breast infection
592026|NCT00671385|breast inflammation|breast inflammation
592027|NCT00671385|lipoma|lipoma
592028|NCT00671385|benign growth|benign growth
592029|NCT00671385|Women without a diagnosis for a region of interest in the breast|women without a diagnosis for a region of interest in the breast
592030|NCT00671372|CRC|crc
592031|NCT00671372|Metastatic CRC|metastatic crc
592032|NCT00671372|APO2L/TRAIL|apo2l/trail
592033|NCT00671359|Food effects|food effects
592034|NCT00671346|Cancer|cancer
592035|NCT00671346|Coronary artery disease|coronary artery disease
592036|NCT00671346|Myocardial infarction|myocardial infarction
592037|NCT00671346|Cerebrovascular stroke|cerebrovascular stroke
592038|NCT00671346|Homocysteine|homocysteine
592039|NCT00671346|Vitamin B Complex|vitamin b complex
592040|NCT00671346|Folic acid|folic acid
592041|NCT00671346|Vitamin B12|vitamin b12
592042|NCT00671346|Vitamin B6|vitamin b6
592043|NCT00671346|Pyridoxal phosphate|pyridoxal phosphate
592044|NCT00671346|Osteoporotic fractures|osteoporotic fractures
592045|NCT00671346|Diabetes|diabetes
592046|NCT00671333|Randomized|randomized
592047|NCT00671333|Prospective|prospective
592048|NCT00671333|Procedure / Surgery|procedure / surgery
592049|NCT00671320|acute ankle sprain, acute pain, South America|acute ankle sprain, acute pain, south america
592050|NCT00671307|Gelsolin|gelsolin
592051|NCT00671307|Trauma|trauma
592052|NCT00671307|Pneumonia|pneumonia
592053|NCT00671307|Peritonitis|peritonitis
592054|NCT00671307|Burn|burn
592055|NCT00671307|Infection|infection
592056|NCT00671307|Sepsis|sepsis
592057|NCT00671307|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
592058|NCT00671294|Insomnia|insomnia
592059|NCT00671281|FESS|fess
592060|NCT00671281|Tranexamic acid|tranexamic acid
592061|NCT00671281|Hemostasis|hemostasis
592062|NCT00671281|Visualization|visualization
592063|NCT00671268|Grass pollen allergy|grass pollen allergy
592064|NCT00671268|specific immunotherapy|specific immunotherapy
592065|NCT00671255|Chronic Insomnia|chronic insomnia
592066|NCT00671255|Drug Therapy|drug therapy
592067|NCT00671255|Elderly|elderly
592068|NCT00671242|Fluorine-18-α-methyltyrosine,|fluorine-18-α-methyltyrosine,
592069|NCT00671242|Positron emission tomography,|positron emission tomography,
592070|NCT00671242|Fluorine-18-fluorodeoxyglucose,|fluorine-18-fluorodeoxyglucose,
592071|NCT00671242|Lung cancer,|lung cancer,
592072|NCT00671242|Angiogenesis|angiogenesis
592073|NCT00671242|The median VEGF rate was 45% (range, 10-78%).|the median vegf rate was 45% (range, 10-78%).
592074|NCT00671242|High expression was seen in 30 patients (81%, 30/37).|high expression was seen in 30 patients (81%, 30/37).
592075|NCT00671242|VEGF expression was statistically associated with progressively growing microvessel count.|vegf expression was statistically associated with progressively growing microvessel count.
592076|NCT00671229|Healthy|healthy
592077|NCT00671229|Asthma|asthma
592078|NCT00671229|Nitric Oxide|nitric oxide
592079|NCT00671216|safety|safety
592080|NCT00671216|pharmacodynamics|pharmacodynamics
592081|NCT00671216|Muscarinic Receptor Antagonist|muscarinic receptor antagonist
592082|NCT00671216|tolerability|tolerability
592083|NCT00671216|healthy subjects|healthy subjects
592084|NCT00671216|GS642444|gs642444
592085|NCT00671216|GSK233705|gsk233705
592086|NCT00671216|Anticholinergic|anticholinergic
592087|NCT00671216|ß2 agonist|ß2 agonist
592088|NCT00671216|pharmacokinetics|pharmacokinetics
592089|NCT00671203|Tissue oximetry|tissue oximetry
592090|NCT00671203|Ischemia|ischemia
592091|NCT00671203|Aortic Aneurysm Repair|aortic aneurysm repair
592092|NCT00671203|Aortic Stent|aortic stent
592093|NCT00671203|Vascular Stent|vascular stent
592094|NCT00671203|Aortic graft|aortic graft
592095|NCT00671203|Vascular graft|vascular graft
592096|NCT00671190|Sleep Disorder|sleep disorder
592097|NCT00671190|Circadian Rhythm Sleep Disorder|circadian rhythm sleep disorder
592098|NCT00671190|Drug Therapy|drug therapy
592099|NCT00671177|colonoscopy|colonoscopy
592100|NCT00671177|diagnostic techniques|diagnostic techniques
592101|NCT00671177|digestive system|digestive system
592102|NCT00671177|endoscopy|endoscopy
592103|NCT00671177|gastrointestinal|gastrointestinal
592104|NCT00671151|COPD exacerbation|copd exacerbation
592105|NCT00671151|histone|histone
592106|NCT00671151|steroid resistance|steroid resistance
592107|NCT00671151|inflammation|inflammation
592108|NCT00671151|theophylline|theophylline
592109|NCT00671138|Celiac disease|celiac disease
592110|NCT00671138|Parasitic infections|parasitic infections
592111|NCT00671138|necator americanus|necator americanus
592112|NCT00671138|Immunity|immunity
592113|NCT00671125|Sleep Disorder|sleep disorder
592114|NCT00671125|Insomnia|insomnia
592115|NCT00671125|Drug Therapy|drug therapy
592116|NCT00671112|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
592117|NCT00671112|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
592118|NCT00671112|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
592119|NCT00671112|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
592120|NCT00671112|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
592121|NCT00671112|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
592122|NCT00671112|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
592123|NCT00671112|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
592124|NCT00671112|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
592125|NCT00671112|splenic marginal zone lymphoma|splenic marginal zone lymphoma
592126|NCT00671112|refractory hairy cell leukemia|refractory hairy cell leukemia
592127|NCT00671112|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
592128|NCT00671112|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
592129|NCT00671112|hairy cell leukemia|hairy cell leukemia
592130|NCT00671112|cutaneous B and T cell lymphoma|cutaneous b and t cell lymphoma
592131|NCT00671112|transformed lymphoma|transformed lymphoma
592132|NCT00671112|transformed B and T cell cutaneous lymphoma|transformed b and t cell cutaneous lymphoma
592133|NCT00671112|relapsed or refractory diffuse large B cell lymphoma|relapsed or refractory diffuse large b cell lymphoma
592134|NCT00671112|extranodal T cell lymphomas|extranodal t cell lymphomas
592135|NCT00671112|anaplastic large cell lymphoma|anaplastic large cell lymphoma
592136|NCT00671112|angioimmunoblastic T cell lymphoma|angioimmunoblastic t cell lymphoma
592137|NCT00671112|PTCL-NOS|ptcl-nos
592138|NCT00671112|nasal or disseminated extranodal T/NK lymphoma|nasal or disseminated extranodal t/nk lymphoma
592139|NCT00671112|enteropathy-associated T cell lymphoma|enteropathy-associated t cell lymphoma
592140|NCT00671112|hepatosplenic gamma/delta T cell lymphoma|hepatosplenic gamma/delta t cell lymphoma
592141|NCT00671112|subcutaneous panniculitis-like T cell lymphoma|subcutaneous panniculitis-like t cell lymphoma
592142|NCT00671112|T-prolymphocytic leukemia|t-prolymphocytic leukemia
592143|NCT00671112|adult T-cell leukemia/lymphoma|adult t-cell leukemia/lymphoma
592144|NCT00671112|large granular lymphocytic leukemia|large granular lymphocytic leukemia
592145|NCT00671112|aggressive NK leukemia|aggressive nk leukemia
592146|NCT00671099|Patients|patients
592147|NCT00671099|with high-energy|with high-energy
592148|NCT00671099|admitted|admitted
592149|NCT00671099|intensive care unit|intensive care unit
592150|NCT00671099|motor vehicle accident|motor vehicle accident
592151|NCT00671099|falling from height|falling from height
592152|NCT00671099|other accident|other accident
592153|NCT00671086|Chronic Insomnia|chronic insomnia
592223|NCT00670917|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
592154|NCT00671086|DIMS (Disorders of Initiating and Maintaining Sleep)|dims (disorders of initiating and maintaining sleep)
592155|NCT00671086|Disorders of Initiating and Maintaining Sleep|disorders of initiating and maintaining sleep
592156|NCT00671086|Insomnia Disorder Sleep Initiation Dysfunction|insomnia disorder sleep initiation dysfunction
592157|NCT00671086|Transient Insomnia|transient insomnia
592158|NCT00671086|Drug Therapy|drug therapy
592159|NCT00671086|Sleep Disorders, Intrinsic|sleep disorders, intrinsic
592160|NCT00671073|Airflow Obstruction, Chronic|airflow obstruction, chronic
592161|NCT00671073|Chronic Airflow Obstruction|chronic airflow obstruction
592162|NCT00671073|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
592163|NCT00671073|Chronic Obstructive Airway Disease|chronic obstructive airway disease
592164|NCT00671073|Chronic Obstructive Lung Disease|chronic obstructive lung disease
592165|NCT00671073|COPD|copd
592166|NCT00671073|COAD|coad
592167|NCT00671060|intrauterine fetal death|intrauterine fetal death
592168|NCT00671060|misoprostol|misoprostol
592169|NCT00671047|Autoimmune Diseases|autoimmune diseases
592170|NCT00671047|Lupus|lupus
592171|NCT00671021|platelet aggregation|platelet aggregation
592172|NCT00671021|aspirin|aspirin
592173|NCT00670995|Tobacco use among middle and junior high school students remains a concern among health educators.|tobacco use among middle and junior high school students remains a concern among health educators.
592174|NCT00670995|The use of tobacco prevention programs and their integration into school-based curricula has been lacking due to a number of factors.|the use of tobacco prevention programs and their integration into school-based curricula has been lacking due to a number of factors.
592175|NCT00670982|HER2 positive|her2 positive
592176|NCT00670982|bevacizumab|bevacizumab
592177|NCT00670982|vinorelbine|vinorelbine
592178|NCT00670982|trastuzumab|trastuzumab
592179|NCT00670969|Obesity|obesity
592180|NCT00670956|prenatal steroids|prenatal steroids
592181|NCT00670956|hydrops|hydrops
592182|NCT00670956|congenital cystic adenomatoid malformation of the lung|congenital cystic adenomatoid malformation of the lung
592183|NCT00670956|prenatal intervention|prenatal intervention
592184|NCT00670956|betamethasone|betamethasone
592185|NCT00670956|prenatal diagnosis|prenatal diagnosis
592186|NCT00670943|Clopidogrel discontinuation|clopidogrel discontinuation
592187|NCT00670943|Platelet aggregation|platelet aggregation
592188|NCT00670930|Asthma, adults, anti-immunoglobulin E ( IgE), omalizumab, airway inflammation, airway remodeling, allergy|asthma, adults, anti-immunoglobulin e ( ige), omalizumab, airway inflammation, airway remodeling, allergy
592189|NCT00670917|pain|pain
592190|NCT00670917|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
592191|NCT00670917|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
592192|NCT00670917|acute undifferentiated leukemia|acute undifferentiated leukemia
592193|NCT00670917|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
592194|NCT00670917|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
592195|NCT00670917|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
592196|NCT00670917|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
592197|NCT00670917|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
592198|NCT00670917|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
592199|NCT00670917|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
592200|NCT00670917|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
592201|NCT00670917|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
592202|NCT00670917|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
592203|NCT00670917|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
592204|NCT00670917|mast cell leukemia|mast cell leukemia
592205|NCT00670917|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
592206|NCT00670917|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
592207|NCT00670917|prolymphocytic leukemia|prolymphocytic leukemia
592208|NCT00670917|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
592209|NCT00670917|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
592210|NCT00670917|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
592211|NCT00670917|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
592212|NCT00670917|refractory hairy cell leukemia|refractory hairy cell leukemia
592213|NCT00670917|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
592214|NCT00670917|secondary acute myeloid leukemia|secondary acute myeloid leukemia
592215|NCT00670917|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
592216|NCT00670917|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
592217|NCT00670917|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
592218|NCT00670917|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
592219|NCT00670917|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
592220|NCT00670917|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
592221|NCT00670917|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
592222|NCT00670917|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
592636|NCT00669526|CBT|cbt
592224|NCT00670917|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
592225|NCT00670917|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
592226|NCT00670917|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
592227|NCT00670917|untreated hairy cell leukemia|untreated hairy cell leukemia
592228|NCT00670917|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
592229|NCT00670917|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
592230|NCT00670917|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
592231|NCT00670917|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
592232|NCT00670917|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
592233|NCT00670917|anaplastic large cell lymphoma|anaplastic large cell lymphoma
592234|NCT00670917|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
592235|NCT00670917|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
592236|NCT00670917|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
592237|NCT00670917|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
592238|NCT00670917|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
592239|NCT00670917|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
592240|NCT00670917|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
592241|NCT00670917|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
592242|NCT00670917|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
592243|NCT00670917|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
592244|NCT00670917|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
592245|NCT00670917|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
592246|NCT00670917|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
592247|NCT00670917|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
592248|NCT00670917|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
592249|NCT00670917|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
592250|NCT00670917|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
592251|NCT00670917|splenic marginal zone lymphoma|splenic marginal zone lymphoma
592252|NCT00670917|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
592253|NCT00670917|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
592254|NCT00670917|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
592255|NCT00670917|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
592256|NCT00670917|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
592351|NCT00670865|Medical records systems|medical records systems
592257|NCT00670917|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
592258|NCT00670917|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
592259|NCT00670917|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
592260|NCT00670917|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
592261|NCT00670917|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
592262|NCT00670917|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
592263|NCT00670917|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
592264|NCT00670917|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
592265|NCT00670917|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
592266|NCT00670917|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
592267|NCT00670917|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
592268|NCT00670917|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
592269|NCT00670917|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
592270|NCT00670917|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
592271|NCT00670917|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
592272|NCT00670917|stage I mantle cell lymphoma|stage i mantle cell lymphoma
592273|NCT00670917|stage I marginal zone lymphoma|stage i marginal zone lymphoma
592274|NCT00670917|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
592275|NCT00670917|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
592276|NCT00670917|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
592277|NCT00670917|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
592278|NCT00670917|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
592279|NCT00670917|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
592280|NCT00670917|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
592281|NCT00670917|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
592282|NCT00670917|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
592283|NCT00670917|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
592284|NCT00670917|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
592285|NCT00670917|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
592286|NCT00670917|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
592287|NCT00670917|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
592288|NCT00670917|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
592289|NCT00670917|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
592290|NCT00670917|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
592291|NCT00670917|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
592292|NCT00670917|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
592293|NCT00670917|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
592294|NCT00670917|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
592295|NCT00670917|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
592296|NCT00670917|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
592297|NCT00670917|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
592298|NCT00670917|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
592299|NCT00670917|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
592300|NCT00670917|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
592301|NCT00670917|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
592302|NCT00670917|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
592303|NCT00670917|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
592304|NCT00670917|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
592305|NCT00670917|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
592306|NCT00670917|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
592307|NCT00670917|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
592308|NCT00670917|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
592309|NCT00670917|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
592310|NCT00670917|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
592311|NCT00670917|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
592312|NCT00670917|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
592313|NCT00670917|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
592314|NCT00670917|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
592315|NCT00670917|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
592316|NCT00670917|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
592317|NCT00670917|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
592318|NCT00670917|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
592319|NCT00670917|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
592320|NCT00670917|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
592321|NCT00670917|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
592322|NCT00670917|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
592323|NCT00670917|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
592324|NCT00670917|intraocular lymphoma|intraocular lymphoma
592325|NCT00670917|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
592326|NCT00670917|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
592327|NCT00670917|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
592328|NCT00670917|chronic eosinophilic leukemia|chronic eosinophilic leukemia
592329|NCT00670917|chronic neutrophilic leukemia|chronic neutrophilic leukemia
592330|NCT00670917|primary myelofibrosis|primary myelofibrosis
592331|NCT00670917|essential thrombocythemia|essential thrombocythemia
592332|NCT00670917|polycythemia vera|polycythemia vera
592333|NCT00670917|extramedullary plasmacytoma|extramedullary plasmacytoma
592334|NCT00670917|isolated plasmacytoma of bone|isolated plasmacytoma of bone
592335|NCT00670917|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
592336|NCT00670917|stage I multiple myeloma|stage i multiple myeloma
592337|NCT00670917|stage II multiple myeloma|stage ii multiple myeloma
592338|NCT00670917|stage III multiple myeloma|stage iii multiple myeloma
592339|NCT00670917|primary systemic amyloidosis|primary systemic amyloidosis
592340|NCT00670917|refractory multiple myeloma|refractory multiple myeloma
592341|NCT00670917|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
592342|NCT00670917|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
592343|NCT00670917|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
592344|NCT00670917|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
592345|NCT00670904|Smoking cessation|smoking cessation
592346|NCT00670904|Pharmacist-delivered|pharmacist-delivered
592347|NCT00670865|Hospitalization|hospitalization
592348|NCT00670865|Continuity of care|continuity of care
592349|NCT00670865|Discharge summary|discharge summary
592350|NCT00670865|Quality improvement|quality improvement
592352|NCT00670865|Hospital information systems|hospital information systems
592353|NCT00670852|Glenoid component|glenoid component
592354|NCT00670852|radiolucent lines|radiolucent lines
592355|NCT00670852|Glenoid loosening|glenoid loosening
592356|NCT00670852|glenohumeral arthritis|glenohumeral arthritis
592357|NCT00670852|autologous bone graft|autologous bone graft
592358|NCT00670839|Hepatitis B vaccination|hepatitis b vaccination
592359|NCT00670839|GenHevac-B Pasteur|genhevac-b pasteur
592360|NCT00670839|HIV infection|hiv infection
592361|NCT00670826|Patient warming|patient warming
592362|NCT00670813|Depression|depression
592363|NCT00670813|(total) sleep deprivation|(total) sleep deprivation
592364|NCT00670813|Modafinil|modafinil
592365|NCT00670813|polysomnography sleep|polysomnography sleep
592366|NCT00670800|Polycystic Ovary Syndrome|polycystic ovary syndrome
592367|NCT00670800|Insulin resistance|insulin resistance
592368|NCT00670800|Metformin|metformin
592369|NCT00670800|Brain function|brain function
592370|NCT00670787|Hypertension|hypertension
592371|NCT00670787|combination pill|combination pill
592372|NCT00670787|compliance|compliance
592373|NCT00670774|Kidney|kidney
592374|NCT00670774|Transplant|transplant
592375|NCT00670774|donor|donor
592376|NCT00670761|misoprostol|misoprostol
592377|NCT00670761|incomplete abortion|incomplete abortion
592378|NCT00670761|sublingual|sublingual
592379|NCT00670761|postabortion care|postabortion care
592380|NCT00670761|MVA|mva
592381|NCT00670748|Metastatic Cancer|metastatic cancer
592382|NCT00670748|Gene Therapy|gene therapy
592383|NCT00670748|Immunotherapy|immunotherapy
592384|NCT00670748|Tumor Regression|tumor regression
592385|NCT00670748|Metastatic Melanoma|metastatic melanoma
592386|NCT00670748|Metastatic Renal Cell Cancer|metastatic renal cell cancer
592387|NCT00670735|Pediatric Hydrocephalus|pediatric hydrocephalus
592388|NCT00670709|encephalography|encephalography
592389|NCT00670709|quantitative|quantitative
592390|NCT00670709|biomarkers|biomarkers
592391|NCT00670696|Topical anesthesia|topical anesthesia
592392|NCT00670696|Rapydan|rapydan
592393|NCT00670696|Topical anaesthesia for venous cannulation|topical anaesthesia for venous cannulation
592394|NCT00670657|candidemia|candidemia
592395|NCT00670657|invasive candidiasis|invasive candidiasis
592396|NCT00670657|Ambisome|ambisome
592397|NCT00670657|liposomal amphotericin B|liposomal amphotericin b
592398|NCT00670644|male breast cancer|male breast cancer
592399|NCT00670644|recurrent breast cancer|recurrent breast cancer
592400|NCT00670644|stage I breast cancer|stage i breast cancer
592401|NCT00670644|stage II breast cancer|stage ii breast cancer
592402|NCT00670644|stage IIIA breast cancer|stage iiia breast cancer
592403|NCT00670644|stage IIIB breast cancer|stage iiib breast cancer
592404|NCT00670644|stage IIIC breast cancer|stage iiic breast cancer
592405|NCT00670644|stage IV breast cancer|stage iv breast cancer
592406|NCT00670631|Multiple Myeloma|multiple myeloma
592407|NCT00670631|myeloma|myeloma
592408|NCT00670605|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
592409|NCT00670605|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
592410|NCT00670592|HCD122|hcd122
592411|NCT00670592|CD40|cd40
592412|NCT00670592|NHL|nhl
592413|NCT00670592|HL|hl
592414|NCT00670579|TIVAD|tivad
592415|NCT00670579|complications|complications
592416|NCT00670579|nursing|nursing
592417|NCT00670579|cystic fibrosis|cystic fibrosis
592418|NCT00670579|implanted|implanted
592419|NCT00670553|Prostate,|prostate,
592420|NCT00670553|Head & Neck,|head & neck,
592421|NCT00670553|Esophageal|esophageal
592422|NCT00670540|pulmonary embolism|pulmonary embolism
592423|NCT00670540|duplex ultrasound examination|duplex ultrasound examination
592424|NCT00670540|recurrence|recurrence
592425|NCT00670527|Prostate cancer|prostate cancer
592426|NCT00670527|[18F] Fluorocholine PET/CT|[18f] fluorocholine pet/ct
592427|NCT00670527|FCH|fch
592428|NCT00670527|lymph node metastasis|lymph node metastasis
592429|NCT00670527|staging|staging
592430|NCT00670527|sensitivity|sensitivity
592431|NCT00670527|specificity|specificity
592432|NCT00670527|PROPET|propet
592433|NCT00670514|RCT|rct
592434|NCT00670514|tobacco|tobacco
592435|NCT00670514|treatment intensity|treatment intensity
592436|NCT00670514|dentistry|dentistry
592437|NCT00670514|follow-up|follow-up
592438|NCT00670514|Smoking cessation|smoking cessation
592439|NCT00670514|Cost effectiveness|cost effectiveness
592440|NCT00670475|osteoarthritis|osteoarthritis
592441|NCT00670475|Knee|knee
592442|NCT00670475|virgin olive oil|virgin olive oil
592443|NCT00670475|piroxicam|piroxicam
592444|NCT00670475|Topical|topical
592445|NCT00670462|obesity, weight loss, treatment|obesity, weight loss, treatment
592446|NCT00670449|FTY720|fty720
592447|NCT00670449|multiple sclerosis|multiple sclerosis
592448|NCT00670449|MS|ms
592449|NCT00670423|Tacrolimus|tacrolimus
592450|NCT00670423|Sirolimus|sirolimus
592451|NCT00670423|Bortezomib|bortezomib
592452|NCT00670423|Acute Graft Versus Host Disease|acute graft versus host disease
592453|NCT00670423|Allogeneic Peripheral Blood Stem Cell Transplantation|allogeneic peripheral blood stem cell transplantation
592454|NCT00670410|Neuroblastoma|neuroblastoma
592455|NCT00670410|Autologous Transplant|autologous transplant
592456|NCT00670410|Allogeneic Transplant|allogeneic transplant
592457|NCT00670410|Immunotherapy|immunotherapy
592458|NCT00670397|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
592459|NCT00670397|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
592460|NCT00670397|stage 0 lip and oral cavity cancer|stage 0 lip and oral cavity cancer
592461|NCT00670384|SLIT|slit
592462|NCT00670384|Immunotherapy|immunotherapy
592463|NCT00670384|Short ragweed|short ragweed
592464|NCT00670384|SAR|sar
592465|NCT00670384|Seasonal allergic rhinitis|seasonal allergic rhinitis
592466|NCT00670371|Caregiver burden|caregiver burden
592467|NCT00670358|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
592468|NCT00670358|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
592469|NCT00670358|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
592470|NCT00670358|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
592471|NCT00670358|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
592472|NCT00670358|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
592473|NCT00670358|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
592474|NCT00670358|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
592475|NCT00670345|tranexamic acid|tranexamic acid
592476|NCT00670345|prostatectomy|prostatectomy
592477|NCT00670345|surgery|surgery
592478|NCT00670332|coronary artery disease|coronary artery disease
592479|NCT00670332|echocardiography|echocardiography
592480|NCT00670332|cardiac imaging|cardiac imaging
592481|NCT00670332|heart disease|heart disease
592482|NCT00670332|ultrasound contrast agent|ultrasound contrast agent
592483|NCT00670332|prognosis|prognosis
592484|NCT00670306|Cetrorelix|cetrorelix
592485|NCT00670306|BPH|bph
592486|NCT00670293|Anorexia Nervosa|anorexia nervosa
592487|NCT00670293|PET Imaging|pet imaging
592488|NCT00670293|Dopamine|dopamine
592489|NCT00670280|Neonatal Intensive Care Units|neonatal intensive care units
592490|NCT00670280|Infant Morbidity|infant morbidity
592491|NCT00670280|Low Birth Weight|low birth weight
592492|NCT00670280|Low Income Populations|low income populations
592493|NCT00670280|MCH Research|mch research
592494|NCT00670280|Respiratory Illnesses|respiratory illnesses
592495|NCT00670280|Substance Exposed Infants|substance exposed infants
592496|NCT00670280|Counseling|counseling
592497|NCT00670267|Asthma|asthma
592498|NCT00670267|hyperresponsiveness|hyperresponsiveness
592499|NCT00670254|Sepsis|sepsis
592500|NCT00670254|Septic|septic
592501|NCT00670254|Shock|shock
592502|NCT00670254|Glucocorticoids|glucocorticoids
592503|NCT00670254|Hydrocortisone|hydrocortisone
592504|NCT00670215|Prevention of infectious complications|prevention of infectious complications
592505|NCT00670215|transrectal needle biopsies of the prostate|transrectal needle biopsies of the prostate
592506|NCT00670215|TRNBP|trnbp
592507|NCT00670202|Patients scheduled for elective carotid endarterectomy|patients scheduled for elective carotid endarterectomy
592508|NCT00670163|Men Who Have Sex With Men|men who have sex with men
592509|NCT00670111|Heart failure|heart failure
592510|NCT00670111|exercise capacity|exercise capacity
592511|NCT00670111|ejection fraction|ejection fraction
592512|NCT00670111|Heart failure normal ejection fraction|heart failure normal ejection fraction
592513|NCT00670059|Single embryo transfer/ aneuploidy screening|single embryo transfer/ aneuploidy screening
592514|NCT00670046|recurrent prostate cancer|recurrent prostate cancer
592515|NCT00670046|stage I prostate cancer|stage i prostate cancer
592516|NCT00670046|stage IIB prostate cancer|stage iib prostate cancer
592517|NCT00670046|stage IIA prostate cancer|stage iia prostate cancer
592518|NCT00670046|stage III prostate cancer|stage iii prostate cancer
592519|NCT00670046|stage IV prostate cancer|stage iv prostate cancer
592520|NCT00670033|IOP|iop
592521|NCT00670033|Open-angle glaucoma|open-angle glaucoma
592522|NCT00670033|Ocular Hypertension|ocular hypertension
592523|NCT00670020|Women undergoing Cesarean section after the onset of labor|women undergoing cesarean section after the onset of labor
592524|NCT00670007|Alpha1-proteinase inhibitor deficiency|alpha1-proteinase inhibitor deficiency
592525|NCT00670007|Chronic augmentation and maintenance therapy|chronic augmentation and maintenance therapy
592526|NCT00670007|Emphysema|emphysema
592527|NCT00670007|Emphysema due to Alpha 1-proteinase inhibitor deficiency|emphysema due to alpha 1-proteinase inhibitor deficiency
592528|NCT00669994|UTI|uti
592529|NCT00669994|Urinary Tract Infection|urinary tract infection
592530|NCT00669981|PTSD|ptsd
592531|NCT00669981|Relationship Distress|relationship distress
592532|NCT00669981|Couple Therapy|couple therapy
592533|NCT00669968|PET myocardial perfusion imaging|pet myocardial perfusion imaging
592534|NCT00669968|Cardiac PET|cardiac pet
592535|NCT00669968|Rubidium|rubidium
592536|NCT00669968|Coronary Artery CT Angiogram|coronary artery ct angiogram
592537|NCT00669968|Coronary Flow Reserve|coronary flow reserve
592538|NCT00669968|Adenosine stress test|adenosine stress test
592539|NCT00669955|H. Pylori|h. pylori
592540|NCT00669955|Quadruple therapy|quadruple therapy
592541|NCT00669955|Eradication rate|eradication rate
592542|NCT00669955|Multinational trial|multinational trial
592543|NCT00669955|Resistance to antibiotics|resistance to antibiotics
592544|NCT00669955|Subjects with confirmed Helicobacter Pylori infection|subjects with confirmed helicobacter pylori infection
592545|NCT00669942|Rheumatoid Arthritis|rheumatoid arthritis
592546|NCT00669929|Cost effectiveness analysis of rotavirus vaccination|cost effectiveness analysis of rotavirus vaccination
592547|NCT00669916|Plaque psoriasis|plaque psoriasis
592548|NCT00669890|AML|aml
592549|NCT00669890|JMML|jmml
592550|NCT00669890|MDS|mds
592551|NCT00669890|Allogenic Atem Cell Transplant|allogenic atem cell transplant
592552|NCT00669890|Gemtuzumab Ozogamicin|gemtuzumab ozogamicin
592553|NCT00669877|Burkitt's Lymphoma|burkitt's lymphoma
592554|NCT00669877|Burkitt's Like Lymphoma|burkitt's like lymphoma
592555|NCT00669877|Leukemia|leukemia
592556|NCT00669877|Hyper-CVAD|hyper-cvad
592557|NCT00669877|Rituximab|rituximab
592558|NCT00669877|Methotrexate|methotrexate
592559|NCT00669877|Cytarabine|cytarabine
592560|NCT00669851|coronary artery disease|coronary artery disease
592561|NCT00669851|echocardiography|echocardiography
592562|NCT00669851|cardiac imaging|cardiac imaging
592563|NCT00669851|heart disease|heart disease
592564|NCT00669851|ultrasound contrast agent|ultrasound contrast agent
592565|NCT00669851|myocardial contrast enhancement|myocardial contrast enhancement
592566|NCT00669851|myocardial perfusion|myocardial perfusion
592567|NCT00669838|Anesthesia, Local|anesthesia, local
592568|NCT00669838|Lidocaine|lidocaine
592569|NCT00669838|Dental care|dental care
592570|NCT00669838|Arrhythmias, Cardiac|arrhythmias, cardiac
592571|NCT00669838|Anxiety|anxiety
592572|NCT00669825|Celiac Disease|celiac disease
592573|NCT00669812|small intestine lymphoma|small intestine lymphoma
592574|NCT00669812|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
592575|NCT00669812|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
592576|NCT00669812|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
592577|NCT00669812|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
592578|NCT00669786|Ongoing Pregnancy Rate|ongoing pregnancy rate
592579|NCT00669760|cystic fibrosis|cystic fibrosis
592580|NCT00669760|Staphylococcus aureus|staphylococcus aureus
592581|NCT00669760|persistent colonization-infection|persistent colonization-infection
592582|NCT00669760|clinical status|clinical status
592583|NCT00669760|lung function|lung function
592584|NCT00669747|Ductal Carcinoma In Situ|ductal carcinoma in situ
592585|NCT00669747|DCIS|dcis
592586|NCT00669747|Breast Cancer|breast cancer
592587|NCT00669747|Carboplatin|carboplatin
592588|NCT00669747|Intraductal|intraductal
592589|NCT00669721|osteoprotegerin|osteoprotegerin
592590|NCT00669721|RANKL|rankl
592591|NCT00669721|heparin|heparin
592592|NCT00669721|hemodialysis|hemodialysis
592593|NCT00669721|anticoagulation|anticoagulation
592594|NCT00669721|vascular calcification|vascular calcification
592595|NCT00669708|dry skin|dry skin
592596|NCT00669708|cooling|cooling
592597|NCT00669708|itch|itch
592598|NCT00669695|statins|statins
592599|NCT00669695|cardiovascular risk|cardiovascular risk
592600|NCT00669695|Obstructive sleep apnea syndrome (OSAS) patients|obstructive sleep apnea syndrome (osas) patients
592601|NCT00669643|Leprosy|leprosy
592602|NCT00669643|Communicable Diseases|communicable diseases
592603|NCT00669643|Skin Diseases|skin diseases
592604|NCT00669643|Multidrug Therapy|multidrug therapy
592605|NCT00669643|MDT|mdt
592606|NCT00669643|Uniform Multidrug Therapy|uniform multidrug therapy
592607|NCT00669643|U-MDT|u-mdt
592608|NCT00669630|Community-based Participatory Research (CBPR)|community-based participatory research (cbpr)
592609|NCT00669630|Vulnerable population|vulnerable population
592610|NCT00669630|High-risk population|high-risk population
592611|NCT00669630|African-Americans|african-americans
592612|NCT00669630|Health Disparities|health disparities
592613|NCT00669630|Clinical Trial|clinical trial
592614|NCT00669617|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
592615|NCT00669617|COPD|copd
592616|NCT00669617|indacaterol|indacaterol
592617|NCT00669617|adults|adults
592618|NCT00669604|Mother to child transmission of HIV|mother to child transmission of hiv
592619|NCT00669604|HIV infected children|hiv infected children
592620|NCT00669591|breast cancer|breast cancer
592621|NCT00669591|docetaxel chemotherapy|docetaxel chemotherapy
592622|NCT00669591|bavituximab|bavituximab
592623|NCT00669591|monoclonal antibody|monoclonal antibody
592624|NCT00669578|secondary myelofibrosis|secondary myelofibrosis
592625|NCT00669578|polycythemia vera|polycythemia vera
592626|NCT00669578|essential thrombocythemia|essential thrombocythemia
592627|NCT00669578|primary myelofibrosis|primary myelofibrosis
592628|NCT00669565|Locally Advanced or Metastatic Breast Cancer|locally advanced or metastatic breast cancer
592629|NCT00669539|Amblyopia associated with strabismus|amblyopia associated with strabismus
592630|NCT00669539|Refractive error|refractive error
592631|NCT00669526|anxiety|anxiety
592632|NCT00669526|depression|depression
592633|NCT00669526|Major Depressive Disorder|major depressive disorder
592634|NCT00669526|child|child
592635|NCT00669526|adolescent|adolescent
592637|NCT00669526|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
592638|NCT00669526|primary care|primary care
592639|NCT00669513|partial sleep deprivation|partial sleep deprivation
592640|NCT00669513|endothelial dysfunction|endothelial dysfunction
592641|NCT00669513|sympathetic activity|sympathetic activity
592642|NCT00669513|inflammation|inflammation
592643|NCT00669500|dietary intake|dietary intake
592644|NCT00669500|genetic predisposition|genetic predisposition
592645|NCT00669500|body composition|body composition
592646|NCT00669487|HIV/AIDS patients|hiv/aids patients
592647|NCT00669461|Constipation|constipation
592648|NCT00669461|Parkinson's Disease|parkinson's disease
592649|NCT00669448|Multiple chemical sensitivities|multiple chemical sensitivities
592650|NCT00669448|MCS|mcs
592651|NCT00669448|Mindfulness-based cognitive therapy|mindfulness-based cognitive therapy
592652|NCT00669448|MBCT|mbct
592653|NCT00669448|Behavioural intervention|behavioural intervention
592654|NCT00669448|Stress|stress
592655|NCT00669448|Illness perceptions|illness perceptions
592656|NCT00669448|Pilot trial|pilot trial
592657|NCT00669435|Essential hypertension|essential hypertension
592658|NCT00669435|Liver steatosis|liver steatosis
592659|NCT00669422|Ovarian Cancer|ovarian cancer
592660|NCT00669422|Fallopian Tube Cancer|fallopian tube cancer
592661|NCT00669422|Peritoneal Cancer|peritoneal cancer
592662|NCT00669422|Uterine Neoplasms|uterine neoplasms
592663|NCT00669422|Vulvar Cancer|vulvar cancer
592664|NCT00669422|Endometrial Cancer|endometrial cancer
592665|NCT00669422|Cervical Cancer|cervical cancer
592666|NCT00669422|Assay|assay
592667|NCT00669422|Chemotherapy|chemotherapy
592668|NCT00669422|Recurrent|recurrent
592669|NCT00669422|Refractory|refractory
592670|NCT00669422|Persistent|persistent
592671|NCT00669422|Chemoresponse|chemoresponse
592672|NCT00669422|Sensitivity|sensitivity
592673|NCT00669422|Precision Therapeutics|precision therapeutics
592674|NCT00669422|ChemoFx|chemofx
592675|NCT00669409|monoclonal antibody|monoclonal antibody
592676|NCT00669396|contraception|contraception
592677|NCT00669396|emergency contraception|emergency contraception
592678|NCT00669396|pregnancy prevention after unprotected intercourse|pregnancy prevention after unprotected intercourse
592679|NCT00669383|premature delivery|premature delivery
592680|NCT00669383|respiratory distress syndrome|respiratory distress syndrome
592681|NCT00669370|advanced gastric cancer|advanced gastric cancer
592682|NCT00669370|adenocarcinoma|adenocarcinoma
592683|NCT00669357|End stage heart disease|end stage heart disease
592684|NCT00669344|cognition|cognition
592685|NCT00669344|stroke|stroke
592686|NCT00669344|VCI|vci
592687|NCT00669344|VCIND|vcind
592688|NCT00669344|Cognitive Impairment, No Dementia|cognitive impairment, no dementia
592689|NCT00669331|randomized clinical trial|randomized clinical trial
592690|NCT00669331|mannitol|mannitol
592691|NCT00669331|mucoactive|mucoactive
592692|NCT00669318|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
592693|NCT00669318|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
592694|NCT00669318|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
592695|NCT00669305|Genetics|genetics
592696|NCT00669305|Blood cells|blood cells
592697|NCT00669305|Vector-mediated gene transfer|vector-mediated gene transfer
592698|NCT00669305|Bone marrow|bone marrow
592699|NCT00669305|CD34 cells|cd34 cells
592700|NCT00669292|esophageal cancer|esophageal cancer
592701|NCT00669292|peptide|peptide
592702|NCT00669292|URLC10|urlc10
592703|NCT00669292|TTK|ttk
592704|NCT00669292|CpG7909|cpg7909
592705|NCT00669214|Raptiva|raptiva
592706|NCT00669214|Moderate plaque psoriasis|moderate plaque psoriasis
592707|NCT00669214|Severe plaque psoriasis|severe plaque psoriasis
592708|NCT00669214|Scalp|scalp
592709|NCT00669201|cartilage|cartilage
592710|NCT00669201|osteoarthritis|osteoarthritis
592711|NCT00669201|T2 mapping|t2 mapping
592712|NCT00669201|MRI|mri
592713|NCT00669201|Wrist|wrist
592714|NCT00669188|Patient Provider Interaction|patient provider interaction
592715|NCT00669188|Physician Training|physician training
592716|NCT00669188|Patient Provider Training|patient provider training
592717|NCT00669175|Naloxone|naloxone
592718|NCT00669175|Neonate|neonate
592719|NCT00669175|Pain|pain
592720|NCT00669149|ptca|ptca
592721|NCT00669149|antiaggregant therapy|antiaggregant therapy
592722|NCT00669149|anticoagulant therapy|anticoagulant therapy
592723|NCT00669136|AFP + GM-CSF Plasmid Prime and AFP Adenoviral Vector Boost|afp + gm-csf plasmid prime and afp adenoviral vector boost
592724|NCT00669136|AFP Immunization|afp immunization
592725|NCT00669123|Chondroitin sulphate|chondroitin sulphate
592726|NCT00669123|Knee osteoarthritis|knee osteoarthritis
592727|NCT00669123|Psoriasis|psoriasis
592728|NCT00669110|MDD|mdd
592729|NCT00669110|Depression|depression
592730|NCT00669110|Pediatrics|pediatrics
592731|NCT00669110|Major Depressive Disorder|major depressive disorder
592732|NCT00669097|ADME|adme
592733|NCT00669097|TKI258|tki258
592734|NCT00669097|RTKs inhibitor|rtks inhibitor
592735|NCT00669097|PDGRF inhibitor|pdgrf inhibitor
592736|NCT00669097|VEGFER inhibitor|vegfer inhibitor
592737|NCT00669084|Innate Immunity|innate immunity
592738|NCT00669084|Malaria|malaria
592739|NCT00669084|Plasmodium|plasmodium
592740|NCT00669084|Hemoglobinopathy|hemoglobinopathy
592741|NCT00669084|G6PD Deficiency|g6pd deficiency
592742|NCT00669058|hygiene|hygiene
592743|NCT00669045|TNKase|tnkase
592744|NCT00669045|AMI|ami
592745|NCT00669006|neuropathic pain|neuropathic pain
592746|NCT00669006|database|database
592747|NCT00669006|prospective|prospective
592748|NCT00669006|national|national
592749|NCT00668980|Down syndrome|down syndrome
592750|NCT00668980|symbolic representation|symbolic representation
592751|NCT00668980|gestures|gestures
592752|NCT00668980|expressive language development|expressive language development
592753|NCT00668967|Cardiovascular Diseases|cardiovascular diseases
592754|NCT00668967|Hypertension|hypertension
592755|NCT00668954|Diabetes|diabetes
592756|NCT00668954|Pomegranate|pomegranate
592757|NCT00668954|Biomarkers|biomarkers
592758|NCT00668954|Antioxidant|antioxidant
592759|NCT00668941|Bone Density|bone density
592760|NCT00668941|Bone Turnover|bone turnover
592761|NCT00668941|Histomorphometry|histomorphometry
592762|NCT00668902|CYP2C19|cyp2c19
592763|NCT00668902|Pantoprazole|pantoprazole
592764|NCT00668902|Genotype|genotype
592765|NCT00668902|Pharmacokinetics|pharmacokinetics
592766|NCT00668902|Metabolism|metabolism
592767|NCT00668889|Hygiene|hygiene
592768|NCT00668876|immunonutrition|immunonutrition
592769|NCT00668876|pancreaticoduodenectomy|pancreaticoduodenectomy
592770|NCT00668876|Th1|th1
592771|NCT00668876|Th2|th2
592772|NCT00668876|Th17|th17
592773|NCT00668837|Paliperidone|paliperidone
592774|NCT00668837|schizophrenia|schizophrenia
592775|NCT00668824|Congenital Heart Disease (CHD)|congenital heart disease (chd)
592776|NCT00668811|thyroid cancer|thyroid cancer
592777|NCT00668811|metastatic thyroid cancer|metastatic thyroid cancer
592778|NCT00668811|differentiated thyroid cancer|differentiated thyroid cancer
592779|NCT00668811|papillary thyroid cancer|papillary thyroid cancer
592780|NCT00668811|follicular thyroid cancer|follicular thyroid cancer
592781|NCT00668811|Histologically confirmed|histologically confirmed
592782|NCT00668811|metastatic stage 2,stage 3, or stage 4 differentiated thyroid cancer|metastatic stage 2,stage 3, or stage 4 differentiated thyroid cancer
592783|NCT00668798|cytomegalovirus breast milk preterm infants transmission|cytomegalovirus breast milk preterm infants transmission
592784|NCT00668798|transmission of CMV via thawed frozen breast milk|transmission of cmv via thawed frozen breast milk
592785|NCT00668785|Ranibizumab|ranibizumab
592786|NCT00668785|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
592787|NCT00668785|Macular Edema following Panretinal Photocoagulation|macular edema following panretinal photocoagulation
592788|NCT00668785|Safety and Efficacy|safety and efficacy
592789|NCT00668785|Intravitreal Injection|intravitreal injection
592790|NCT00668759|atrial fibrillation|atrial fibrillation
592791|NCT00668759|atrial fib|atrial fib
592792|NCT00668759|AF|af
592793|NCT00668746|chronic periodontitis, antibiotic resistance|chronic periodontitis, antibiotic resistance
592794|NCT00668733|Actinic keratoses|actinic keratoses
592795|NCT00668733|Dermatologic disease|dermatologic disease
592796|NCT00668720|tinnitus|tinnitus
592797|NCT00668720|transcranial magnetic stimulation|transcranial magnetic stimulation
592798|NCT00668707|melatonin|melatonin
592799|NCT00668707|natural health product (NHP)|natural health product (nhp)
592800|NCT00668707|lung cancer|lung cancer
592801|NCT00668707|complementary and alternative medicine (CAM)|complementary and alternative medicine (cam)
592802|NCT00668707|randomized clinical trial|randomized clinical trial
592803|NCT00668694|Psychosocial stimulation in addition to iron supplementation will improve mental and psychomotor development, language, behavior and growth of IDA infants.|psychosocial stimulation in addition to iron supplementation will improve mental and psychomotor development, language, behavior and growth of ida infants.
592804|NCT00668694|With the addition of stimulation IDA infants will catch up to the non-anemic infants.|with the addition of stimulation ida infants will catch up to the non-anemic infants.
592805|NCT00668681|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
592806|NCT00668655|Rosacea, metronidazole|rosacea, metronidazole
592807|NCT00668629|Hygiene|hygiene
592808|NCT00668616|breast cancer with 1-3 afflicted axillary lymph nodes|breast cancer with 1-3 afflicted axillary lymph nodes
592809|NCT00668603|Postmenopausal vasomotor symptoms|postmenopausal vasomotor symptoms
592810|NCT00668603|Hot flush|hot flush
592811|NCT00668603|Vascular function|vascular function
592812|NCT00668603|Cardiac function|cardiac function
592813|NCT00668603|Cardiovascular risk factor|cardiovascular risk factor
592814|NCT00668590|Diabetes|diabetes
592815|NCT00668577|Hygiene|hygiene
592816|NCT00668564|Inborn errors of metabolism|inborn errors of metabolism
592817|NCT00668564|Sphingolipidoses|sphingolipidoses
592818|NCT00668564|Recessive Leukodystrophies- GLD, Krabbe disease, MLD|recessive leukodystrophies- gld, krabbe disease, mld
592819|NCT00668564|Peroxisomal Disorders|peroxisomal disorders
592820|NCT00668564|Wolman syndrome|wolman syndrome
592821|NCT00668564|Niemann-Pick B patients|niemann-pick b patients
592822|NCT00668564|Niemann-Pick C subtype 2|niemann-pick c subtype 2
592823|NCT00668551|Parkinson disease|parkinson disease
592824|NCT00668551|Telemedicine|telemedicine
592825|NCT00668538|Miconazole|miconazole
592826|NCT00668538|CYP1A2|cyp1a2
592827|NCT00668538|CYP3A4|cyp3a4
592828|NCT00668538|Women|women
592829|NCT00668538|Healthy Subjects|healthy subjects
592830|NCT00668525|Depression|depression
592831|NCT00668525|Major Depressive Disorder|major depressive disorder
592832|NCT00668525|Escitalopram|escitalopram
592833|NCT00668512|metastatic cutaneous melanoma|metastatic cutaneous melanoma
592834|NCT00668512|alpha-gal glycolipids|alpha-gal glycolipids
592835|NCT00668486|Hygiene|hygiene
592836|NCT00668473|systemic sclerosis angiogenesis|systemic sclerosis angiogenesis
592837|NCT00668460|hygiene|hygiene
592838|NCT00668447|bone density|bone density
592839|NCT00668447|bone loss|bone loss
592840|NCT00668447|postmenopausal|postmenopausal
592841|NCT00668434|Back Pain|back pain
592842|NCT00668434|Leg Pain|leg pain
592843|NCT00668421|Myelofibrosis|myelofibrosis
592844|NCT00668421|Essential Thrombocythemia|essential thrombocythemia
592845|NCT00668421|Polycythemia Vera|polycythemia vera
592846|NCT00668421|JAK2 V617F Mutation|jak2 v617f mutation
592847|NCT00668421|Lestaurtinib|lestaurtinib
592848|NCT00668408|OTLT|otlt
592849|NCT00668408|COPD|copd
592850|NCT00668408|CHRONIC HYPOXEMIA|chronic hypoxemia
592851|NCT00668408|CHF|chf
592852|NCT00668395|CYP2B6|cyp2b6
592853|NCT00668395|Efavirenz|efavirenz
592854|NCT00668395|Pharmacokinetics|pharmacokinetics
592855|NCT00668395|Pharmacogenetics|pharmacogenetics
592856|NCT00668395|Drug-Interactions|drug-interactions
592857|NCT00668382|Cancerous solid tumors|cancerous solid tumors
592858|NCT00668382|Alpha-Gal Glycosphingolipids|alpha-gal glycosphingolipids
592859|NCT00668369|Liver Transplantation|liver transplantation
592860|NCT00668369|Tolerance|tolerance
592861|NCT00668369|Hepatitis C virus infection|hepatitis c virus infection
592862|NCT00668369|Immune responses|immune responses
592863|NCT00668369|Allograft tolerance|allograft tolerance
592864|NCT00668369|Immunosuppression weaning|immunosuppression weaning
592865|NCT00668369|Immunosuppression minimization|immunosuppression minimization
592866|NCT00668356|HIV disease in children|hiv disease in children
592867|NCT00668356|HIV|hiv
592868|NCT00668356|children|children
592869|NCT00668356|didanosine|didanosine
592870|NCT00668356|bioequivalence|bioequivalence
592871|NCT00668356|pharmacokinetics|pharmacokinetics
592872|NCT00668356|treatment experienced|treatment experienced
592873|NCT00668343|edss attack|edss attack
592874|NCT00668330|Bone mineral density|bone mineral density
592875|NCT00668330|ibandronate|ibandronate
592876|NCT00668330|alfacalcidol|alfacalcidol
592877|NCT00668317|Hyper-responsiveness, reflux cough|hyper-responsiveness, reflux cough
592878|NCT00668304|Sinusitis|sinusitis
592879|NCT00668291|Endocrinology, CARNEY Complex,|endocrinology, carney complex,
592880|NCT00668291|primary pigmented nodular adrenocortical disease (PPNAD),|primary pigmented nodular adrenocortical disease (ppnad),
592881|NCT00668291|PRKAR1A|prkar1a
592882|NCT00668278|Supraglottic airway|supraglottic airway
592883|NCT00668278|I-gel|i-gel
592884|NCT00668278|Laryngeal mask|laryngeal mask
592885|NCT00668278|Controlled ventilation|controlled ventilation
592886|NCT00668278|Peak airway pressure|peak airway pressure
592887|NCT00668278|Seal pressure|seal pressure
592888|NCT00668278|Anaesthesia|anaesthesia
592889|NCT00668278|Surgery|surgery
592890|NCT00668265|Generalized Anxiety Disorder|generalized anxiety disorder
592891|NCT00668265|Opiate Dependence|opiate dependence
592892|NCT00668265|Methadone-Maintenance|methadone-maintenance
592893|NCT00668265|Drug Addiction Treatment|drug addiction treatment
592894|NCT00668252|endothelial progenitor cells|endothelial progenitor cells
592895|NCT00668252|estrogen|estrogen
592896|NCT00668252|menopause|menopause
592897|NCT00668252|cardiovascular risk|cardiovascular risk
592898|NCT00668239|diffuse macular oedema|diffuse macular oedema
592899|NCT00668239|type 2 diabetes mellitus|type 2 diabetes mellitus
592900|NCT00668239|laser therapy|laser therapy
592901|NCT00668226|Hygiene|hygiene
592902|NCT00668213|Macular Degeneration|macular degeneration
592903|NCT00668200|Paget's|paget's
592904|NCT00668200|hypocalcemia|hypocalcemia
592905|NCT00668200|zoledronic acid|zoledronic acid
592906|NCT00668200|serum calcium|serum calcium
592907|NCT00668187|Tay-Sachs disease|tay-sachs disease
592908|NCT00668187|Sandhoff disease|sandhoff disease
592909|NCT00668187|Late Onset Tay-Sachs disease|late onset tay-sachs disease
592910|NCT00668187|LOTS|lots
592911|NCT00668187|hexosaminidase A deficiency|hexosaminidase a deficiency
592912|NCT00668187|hexosaminidase A and B deficiency|hexosaminidase a and b deficiency
592913|NCT00668187|infantile Tay-Sachs disease|infantile tay-sachs disease
592914|NCT00668187|adult-onset Tay-Sachs disease|adult-onset tay-sachs disease
592915|NCT00668187|prospective|prospective
592916|NCT00668187|natural history|natural history
592917|NCT00668187|GM1 gangliosidosis|gm1 gangliosidosis
592918|NCT00668187|gangliosidoses|gangliosidoses
592919|NCT00668187|β-galactosidase|β-galactosidase
592920|NCT00668187|β-galactosidase deficiency|β-galactosidase deficiency
592921|NCT00668187|hexosaminidase|hexosaminidase
592922|NCT00668187|hexosaminidase deficiency|hexosaminidase deficiency
592923|NCT00668187|Tay-Sachs|tay-sachs
592924|NCT00668187|Sandhoff|sandhoff
592925|NCT00668187|juvenile Tay-Sachs|juvenile tay-sachs
592926|NCT00668187|juvenile Tay-Sachs disease|juvenile tay-sachs disease
592927|NCT00668187|late onset Tay-Sachs|late onset tay-sachs
592928|NCT00668187|juvenile Sandhoff|juvenile sandhoff
592929|NCT00668187|juvenile Sandhoff disease|juvenile sandhoff disease
592930|NCT00668187|GM2 gangliosidosis|gm2 gangliosidosis
592931|NCT00668148|Sarcoma|sarcoma
592932|NCT00668148|Ewing's sarcoma / peripheral neuroectodermal tumor (PNET);|ewing's sarcoma / peripheral neuroectodermal tumor (pnet);
592933|NCT00668148|rhabdomyosarcoma;|rhabdomyosarcoma;
592934|NCT00668148|leiomyosarcoma;|leiomyosarcoma;
592935|NCT00668148|adipocytic sarcoma|adipocytic sarcoma
592936|NCT00668148|synovial sarcoma|synovial sarcoma
592937|NCT00668135|Erectile Dysfunction|erectile dysfunction
592938|NCT00668135|Vardenafil|vardenafil
592939|NCT00668109|Erectile Dysfunction|erectile dysfunction
592940|NCT00668109|Diabetes mellitus|diabetes mellitus
592941|NCT00668109|Hypertension|hypertension
592942|NCT00668109|Hyperlipidemia|hyperlipidemia
592943|NCT00668109|Vardenafil|vardenafil
592944|NCT00668096|Erectile Dysfunction|erectile dysfunction
592945|NCT00668096|PDE5 inhibitors|pde5 inhibitors
592946|NCT00668083|second line|second line
592947|NCT00668083|Prostate Cancer|prostate cancer
592948|NCT00668083|bicalutamide|bicalutamide
592949|NCT00668083|biochemical relapse/progression in patients with Prostate Cancer treated with bicalutamide 150mg|biochemical relapse/progression in patients with prostate cancer treated with bicalutamide 150mg
592950|NCT00668070|NASH|nash
592951|NCT00668070|Chronic liver disease|chronic liver disease
592952|NCT00668057|Male Erectile Dysfunction|male erectile dysfunction
592953|NCT00668044|Ciprofloxacin regimen in compromised patients|ciprofloxacin regimen in compromised patients
592954|NCT00668044|Ciprofloxacin|ciprofloxacin
592955|NCT00668044|Burned patients|burned patients
592956|NCT00668031|Transfusion requirements|transfusion requirements
592957|NCT00668031|Hip replacement surgery|hip replacement surgery
592958|NCT00668031|Prevention of blood loss|prevention of blood loss
592959|NCT00668031|Bloodloss|bloodloss
592960|NCT00668018|Male Erectile Dysfunction|male erectile dysfunction
592961|NCT00668018|Vardenafil|vardenafil
592962|NCT00668005|Erectile Dysfunction|erectile dysfunction
592963|NCT00668005|Arterial hypertension|arterial hypertension
592964|NCT00668005|Vardenafil|vardenafil
592965|NCT00667992|Asthma hyperreactivity|asthma hyperreactivity
592966|NCT00667979|Erectile Dysfunction|erectile dysfunction
592967|NCT00667979|Vardenafil|vardenafil
592968|NCT00667966|Spinal cord injury|spinal cord injury
592969|NCT00667966|Urodynamic|urodynamic
592970|NCT00667966|Erectile dysfunction|erectile dysfunction
592971|NCT00667966|Vardenafil|vardenafil
592972|NCT00667953|Temzolomide|temzolomide
592973|NCT00667953|Gleevec|gleevec
592974|NCT00667953|Melanoma|melanoma
592975|NCT00667953|Advanced melanoma|advanced melanoma
592976|NCT00667953|Phase II|phase ii
592977|NCT00667940|Medical education|medical education
592978|NCT00667940|faculty development|faculty development
592979|NCT00667940|rater training|rater training
592980|NCT00667940|clinical competence|clinical competence
592981|NCT00667940|assessment|assessment
592982|NCT00667927|Autologous bone marrow transplant|autologous bone marrow transplant
592983|NCT00667927|gene marking|gene marking
592984|NCT00667914|Hip-unit|hip-unit
592985|NCT00667914|Geriatric care|geriatric care
592986|NCT00667914|Mobility|mobility
592987|NCT00667914|Site of residence|site of residence
592988|NCT00667901|stage III melanoma|stage iii melanoma
592989|NCT00667901|stage IV melanoma|stage iv melanoma
592990|NCT00667888|Prostate Cancer|prostate cancer
592991|NCT00667888|Radiation|radiation
592992|NCT00667888|Radiotherapy|radiotherapy
592993|NCT00667888|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
592994|NCT00667888|IMRT|imrt
592995|NCT00667888|Hypofractionated Intensity Modulated Radiotherapy|hypofractionated intensity modulated radiotherapy
592996|NCT00667888|HIMRT|himrt
592997|NCT00667875|Alcohol Dependence|alcohol dependence
592998|NCT00667875|Alcoholism|alcoholism
592999|NCT00667875|Naltrexone|naltrexone
593000|NCT00667875|Aripiprazole|aripiprazole
593001|NCT00667875|Substance Abuse|substance abuse
593002|NCT00667862|Prostate|prostate
593003|NCT00667862|Cancer|cancer
593004|NCT00667862|Adenocarcinoma|adenocarcinoma
593005|NCT00667862|Prostate-Specific Antigen|prostate-specific antigen
593006|NCT00667862|metastatic|metastatic
593007|NCT00667862|male|male
593008|NCT00667862|HRPC|hrpc
593009|NCT00667862|DACi|daci
593010|NCT00667849|Tibia|tibia
593011|NCT00667836|Neurofibromatosis Type 1|neurofibromatosis type 1
593012|NCT00667836|NF1|nf1
593013|NCT00667836|Spinal Anomalies|spinal anomalies
593014|NCT00667823|SERAPHIN|seraphin
593015|NCT00667823|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
593016|NCT00667823|ACT-064992|act-064992
593017|NCT00667810|antibody|antibody
593018|NCT00667810|immunotherapy|immunotherapy
593019|NCT00667797|Asthma|asthma
593020|NCT00667797|COPD|copd
593021|NCT00667797|chronic emphysema|chronic emphysema
593022|NCT00667797|chronic bronchitis|chronic bronchitis
593023|NCT00667784|pediatric stem cell donor|pediatric stem cell donor
593223|NCT00667095|OAB|oab
593024|NCT00667784|emotional sequelae|emotional sequelae
593025|NCT00667784|physical sequelae|physical sequelae
593026|NCT00667784|psychological consequences of minor donation|psychological consequences of minor donation
593027|NCT00667784|Bone Marrow Transplantation|bone marrow transplantation
593028|NCT00667784|Questionnaire|questionnaire
593029|NCT00667784|Survey|survey
593030|NCT00667784|Sibling Donor|sibling donor
593031|NCT00667784|Stem Cell Transplant|stem cell transplant
593032|NCT00667784|Well-Being|well-being
593033|NCT00667771|Alcohol|alcohol
593034|NCT00667771|Naltrexone|naltrexone
593035|NCT00667771|fMRI|fmri
593036|NCT00667771|Alcoholism|alcoholism
593037|NCT00667771|Alcoholics|alcoholics
593038|NCT00667771|Alcohol Dependence|alcohol dependence
593039|NCT00667745|Lithium|lithium
593040|NCT00667745|Symptoms|symptoms
593041|NCT00667745|Medication Changes|medication changes
593042|NCT00667732|diabetes|diabetes
593043|NCT00667732|insulin|insulin
593044|NCT00667732|byetta|byetta
593045|NCT00667732|glucose|glucose
593046|NCT00667732|blood sugar|blood sugar
593047|NCT00667732|metformin|metformin
593048|NCT00667732|A1c|a1c
593049|NCT00667719|essential hypertension|essential hypertension
593050|NCT00667719|high blood pressure|high blood pressure
593051|NCT00667693|intubation|intubation
593052|NCT00667693|obese|obese
593053|NCT00667680|tDCS, major depression|tdcs, major depression
593054|NCT00667667|whole body vibration|whole body vibration
593055|NCT00667667|exercise|exercise
593056|NCT00667667|postmenopausal|postmenopausal
593057|NCT00667667|BMD|bmd
593058|NCT00667667|bone|bone
593059|NCT00667667|elderly females|elderly females
593060|NCT00667667|Caucasian race|caucasian race
593061|NCT00667654|Osteoarthritis, Knee|osteoarthritis, knee
593062|NCT00667641|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
593063|NCT00667641|recurrent breast cancer|recurrent breast cancer
593064|NCT00667641|stage IV breast cancer|stage iv breast cancer
593065|NCT00667641|recurrent prostate cancer|recurrent prostate cancer
593066|NCT00667641|stage IV prostate cancer|stage iv prostate cancer
593067|NCT00667641|recurrent colon cancer|recurrent colon cancer
593068|NCT00667641|stage IV colon cancer|stage iv colon cancer
593069|NCT00667641|recurrent pancreatic cancer|recurrent pancreatic cancer
593070|NCT00667641|stage IV pancreatic cancer|stage iv pancreatic cancer
593071|NCT00667641|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
593072|NCT00667641|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
593073|NCT00667641|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
593074|NCT00667641|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
593075|NCT00667641|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
593076|NCT00667641|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
593077|NCT00667641|recurrent melanoma|recurrent melanoma
593078|NCT00667641|stage IV melanoma|stage iv melanoma
593079|NCT00667641|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
593080|NCT00667641|recurrent thyroid cancer|recurrent thyroid cancer
593081|NCT00667615|vorinostat|vorinostat
593082|NCT00667615|rituximab|rituximab
593083|NCT00667615|cyclophosphamide|cyclophosphamide
593084|NCT00667615|etoposide|etoposide
593085|NCT00667615|prednisone|prednisone
593086|NCT00667615|Quality of life|quality of life
593087|NCT00667615|08-045|08-045
593088|NCT00667602|Meningococcal|meningococcal
593089|NCT00667602|ACWY|acwy
593090|NCT00667602|Conjugate Vaccine|conjugate vaccine
593091|NCT00667602|Meningitis|meningitis
593092|NCT00667602|Toddlers|toddlers
593093|NCT00667602|Infants|infants
593094|NCT00667602|Concomitant Vaccination|concomitant vaccination
593095|NCT00667589|sorafenib|sorafenib
593096|NCT00667589|rash|rash
593097|NCT00667589|hand foot skin reaction|hand foot skin reaction
593098|NCT00667576|chronic kidney disease|chronic kidney disease
593099|NCT00667576|secondary hyperparathyroidism|secondary hyperparathyroidism
593100|NCT00667576|hemodialysis|hemodialysis
593101|NCT00667576|paricalcitol|paricalcitol
593102|NCT00667576|maxacalcitol|maxacalcitol
593103|NCT00667563|human papilloma virus infection|human papilloma virus infection
593104|NCT00667563|cervical cancer|cervical cancer
593105|NCT00667563|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
593106|NCT00667563|HIV infection|hiv infection
593107|NCT00667550|Lower urinary tract symptoms|lower urinary tract symptoms
593108|NCT00667550|Colorectal disorders|colorectal disorders
593109|NCT00667550|Urinary incontinence|urinary incontinence
593110|NCT00667550|Fecal incontinence|fecal incontinence
593111|NCT00667550|Voiding dysfunction|voiding dysfunction
593112|NCT00667550|Urgency frequency|urgency frequency
593113|NCT00667550|Sexual dysfunction|sexual dysfunction
593114|NCT00667550|Colorectal malignancies|colorectal malignancies
593115|NCT00667550|Inflammatory bowel disease|inflammatory bowel disease
593116|NCT00667524|Eosinophilic Esophagitis|eosinophilic esophagitis
593117|NCT00667524|Dysphagia|dysphagia
593118|NCT00667524|Esophageal bougienage|esophageal bougienage
593119|NCT00667524|Esophageal Dilation|esophageal dilation
593120|NCT00667511|ESRD|esrd
593121|NCT00667511|End Stage Renal Disease|end stage renal disease
593122|NCT00667511|Daily Hemodialysis|daily hemodialysis
593123|NCT00667511|Nocturnal Hemodialysis|nocturnal hemodialysis
593124|NCT00667511|Hemodialysis|hemodialysis
593125|NCT00667511|Kidney Failure|kidney failure
593126|NCT00667511|Kidney Disease|kidney disease
593127|NCT00667498|Pediatric Obesity|pediatric obesity
593128|NCT00667498|Insulin Resistance|insulin resistance
593129|NCT00667498|Hyperinsulinemia|hyperinsulinemia
593130|NCT00667498|Metformin|metformin
593131|NCT00667498|Glucose Tolerance|glucose tolerance
593132|NCT00667498|Microalbuminuria|microalbuminuria
593133|NCT00667498|Adolescents|adolescents
593134|NCT00667498|Visceral Fat|visceral fat
593135|NCT00667472|port wine stain birthmarks|port wine stain birthmarks
593136|NCT00667459|Cervical Disc|cervical disc
593137|NCT00667446|GnRH analog|gnrh analog
593138|NCT00667446|Luteinizing hormone (LH)|luteinizing hormone (lh)
593139|NCT00667446|Gonadotrophin-releasing hormone agonist(GnRHa)|gonadotrophin-releasing hormone agonist(gnrha)
593140|NCT00667446|Suppression of LH|suppression of lh
593141|NCT00667446|Gonadotrophin-releasing hormone (GnRH)|gonadotrophin-releasing hormone (gnrh)
593142|NCT00667446|CPP|cpp
593143|NCT00667446|Leuprolide acetate|leuprolide acetate
593144|NCT00667446|Central Precocious Puberty|central precocious puberty
593145|NCT00667446|Depot formulation|depot formulation
593146|NCT00667446|Lupron|lupron
593147|NCT00667446|Tanner staging|tanner staging
593148|NCT00667446|Pediatrics|pediatrics
593149|NCT00667433|HIV|hiv
593150|NCT00667433|African American|african american
593151|NCT00667433|treatment naïve|treatment naïve
593152|NCT00667420|gastric|gastric
593153|NCT00667420|esophageal|esophageal
593154|NCT00667420|panitumumab|panitumumab
593155|NCT00667407|Asthma|asthma
593156|NCT00667394|Brain Tumor|brain tumor
593157|NCT00667394|Chemotherapy|chemotherapy
593158|NCT00667394|Radiation|radiation
593159|NCT00667394|Anti-Angiogenesis|anti-angiogenesis
593160|NCT00667394|Glioblastoma|glioblastoma
593161|NCT00667394|Glioma|glioma
593162|NCT00667381|Ultrasound guidance|ultrasound guidance
593163|NCT00667381|Vascular access|vascular access
593164|NCT00667381|Vascular complications|vascular complications
593165|NCT00667368|bacterial vaginosis, women, chlamydia, gonorrhea, mentronidazole, vaginal, children|bacterial vaginosis, women, chlamydia, gonorrhea, mentronidazole, vaginal, children
593166|NCT00667355|Ankylosing Spondylitis|ankylosing spondylitis
593167|NCT00667329|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
593168|NCT00667329|Lymphoma|lymphoma
593169|NCT00667329|2CdA|2cda
593170|NCT00667329|Cladribine|cladribine
593171|NCT00667329|Leustatin|leustatin
593172|NCT00667329|Cyclophosphamide|cyclophosphamide
593173|NCT00667329|Cytoxan|cytoxan
593174|NCT00667329|Neosar|neosar
593175|NCT00667329|Rituxan|rituxan
593176|NCT00667329|Rituximab|rituximab
593177|NCT00667316|low back pain|low back pain
593178|NCT00667316|workers|workers
593179|NCT00667316|disability|disability
593180|NCT00667316|sick leave|sick leave
593181|NCT00667303|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
593182|NCT00667290|functional ability|functional ability
593183|NCT00667290|gait|gait
593184|NCT00667290|musculoskeletal disorder therapy|musculoskeletal disorder therapy
593185|NCT00667290|peripheral blood vessel disorder|peripheral blood vessel disorder
593186|NCT00667277|Myelofibrosis|myelofibrosis
593187|NCT00667277|Idiopathic|idiopathic
593188|NCT00667277|Bevacizumab|bevacizumab
593189|NCT00667277|Avastin|avastin
593190|NCT00667277|bone marrow fibrosis|bone marrow fibrosis
593191|NCT00667277|bone marrow angiogenesis|bone marrow angiogenesis
593192|NCT00667277|JAK2|jak2
593193|NCT00667264|pain|pain
593194|NCT00667264|phantom limb|phantom limb
593195|NCT00667264|stump pain|stump pain
593196|NCT00667264|catheter|catheter
593197|NCT00667264|nerve block|nerve block
593198|NCT00667264|peripheral nerve block|peripheral nerve block
593199|NCT00667264|ucsd|ucsd
593200|NCT00667264|Post-amputation phantom limb or stump pain|post-amputation phantom limb or stump pain
593201|NCT00667251|recurrent breast cancer|recurrent breast cancer
593202|NCT00667251|HER2-positive breast cancer|her2-positive breast cancer
593203|NCT00667251|stage IV breast cancer|stage iv breast cancer
593204|NCT00667212|anger|anger
593205|NCT00667212|intermittent|intermittent
593206|NCT00667212|explosive|explosive
593207|NCT00667199|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
593208|NCT00667199|Bone Metastases|bone metastases
593209|NCT00667199|Radium-223|radium-223
593210|NCT00667199|Palliation of bone pain|palliation of bone pain
593211|NCT00667186|HIV|hiv
593212|NCT00667186|Prevention|prevention
593213|NCT00667186|Public Health|public health
593214|NCT00667186|Screening|screening
593215|NCT00667160|Mild Atopic Dermatitis|mild atopic dermatitis
593216|NCT00667160|Protopic|protopic
593217|NCT00667160|Pediatric|pediatric
593218|NCT00667134|systemic sclerosis autoantibodies|systemic sclerosis autoantibodies
593219|NCT00667121|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
593220|NCT00667121|breast cancer|breast cancer
593221|NCT00667121|hot flashes|hot flashes
593222|NCT00667121|depression|depression
593224|NCT00667095|Over Active Bladder|over active bladder
593225|NCT00667095|overactive bladder|overactive bladder
593226|NCT00667095|Urinary Urge Incontinence|urinary urge incontinence
593227|NCT00667095|Urinary Incontinence|urinary incontinence
593228|NCT00667095|Botox|botox
593229|NCT00667095|DMSO|dmso
593230|NCT00667095|bladder instillation|bladder instillation
593231|NCT00667095|instillation|instillation
593232|NCT00667095|detrusor hyperreflexia|detrusor hyperreflexia
593233|NCT00667095|urge incontinence|urge incontinence
593234|NCT00667082|Non small Cell Lung Cancer|non small cell lung cancer
593235|NCT00667082|Pancreatic Cancer|pancreatic cancer
593236|NCT00667082|Melanoma|melanoma
593237|NCT00667082|Lymphoma|lymphoma
593238|NCT00667082|Multiple Myeloma|multiple myeloma
593239|NCT00667069|adenocarcinoma of the prostate|adenocarcinoma of the prostate
593240|NCT00667069|stage III prostate cancer|stage iii prostate cancer
593241|NCT00667069|stage IV prostate cancer|stage iv prostate cancer
593242|NCT00667056|Chronic Allergic Contact Dermatitis|chronic allergic contact dermatitis
593243|NCT00667056|Protopic|protopic
593244|NCT00667043|therapeutic hypothermia|therapeutic hypothermia
593245|NCT00667043|cardiac arrest|cardiac arrest
593246|NCT00667043|sedation|sedation
593247|NCT00667043|remifentanil|remifentanil
593248|NCT00667043|propofol|propofol
593249|NCT00667043|fentanyl|fentanyl
593250|NCT00667043|midazolam|midazolam
593251|NCT00667030|Inflammation|inflammation
593252|NCT00667030|Aging|aging
593253|NCT00667030|Metabolism|metabolism
593254|NCT00667030|Exercise|exercise
593255|NCT00667017|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
593256|NCT00667017|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
593257|NCT00666991|ovarian cancer|ovarian cancer
593258|NCT00666991|Mullerian tumors|mullerian tumors
593259|NCT00666991|peritoneal cavity carcinoma|peritoneal cavity carcinoma
593260|NCT00666991|gastrointestinal tract tumor|gastrointestinal tract tumor
593261|NCT00666991|GI tract tumor|gi tract tumor
593262|NCT00666991|pancreatic cancer|pancreatic cancer
593263|NCT00666991|colon cancer|colon cancer
593264|NCT00666978|bladder cancer|bladder cancer
593265|NCT00666978|cervical cancer|cervical cancer
593266|NCT00666978|esophageal cancer|esophageal cancer
593267|NCT00666978|gastric cancer|gastric cancer
593268|NCT00666978|renal cell carcinoma|renal cell carcinoma
593269|NCT00666978|adult primary liver cancer|adult primary liver cancer
593270|NCT00666978|non-small cell lung cancer|non-small cell lung cancer
593271|NCT00666978|small cell lung cancer|small cell lung cancer
593272|NCT00666978|pancreatic cancer|pancreatic cancer
593273|NCT00666978|hypopharyngeal cancer|hypopharyngeal cancer
593274|NCT00666978|laryngeal cancer|laryngeal cancer
593275|NCT00666978|lip and oral cavity cancer|lip and oral cavity cancer
593276|NCT00666978|nasopharyngeal cancer|nasopharyngeal cancer
593277|NCT00666978|oropharyngeal cancer|oropharyngeal cancer
593278|NCT00666978|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
593279|NCT00666978|adult acute myeloid leukemia|adult acute myeloid leukemia
593280|NCT00666978|tobacco use disorder|tobacco use disorder
593281|NCT00666965|SPM 962|spm 962
593282|NCT00666965|rotigotine|rotigotine
593283|NCT00666965|Idiopathic Restless Legs Syndrome|idiopathic restless legs syndrome
593284|NCT00666965|RLS|rls
593285|NCT00666926|Pancreatic Neoplasm|pancreatic neoplasm
593286|NCT00666926|Head and Neck neoplasm|head and neck neoplasm
593287|NCT00666926|Prostatic neoplasms; Focal Adhesion Kinase|prostatic neoplasms; focal adhesion kinase
593288|NCT00666926|Phase 1|phase 1
593289|NCT00666926|Pharmacodynamics|pharmacodynamics
593290|NCT00666926|FDG-PET|fdg-pet
593291|NCT00666913|breast cancer in situ|breast cancer in situ
593292|NCT00666913|stage I breast cancer|stage i breast cancer
593293|NCT00666913|stage II breast cancer|stage ii breast cancer
593294|NCT00666913|stage IIIA breast cancer|stage iiia breast cancer
593295|NCT00666913|stage IIIB breast cancer|stage iiib breast cancer
593296|NCT00666913|stage IIIC breast cancer|stage iiic breast cancer
593297|NCT00666913|hot flashes|hot flashes
593298|NCT00666887|Multiple Sclerosis|multiple sclerosis
593299|NCT00666887|Clinically Isolated Syndrome|clinically isolated syndrome
593300|NCT00666887|Minocycline|minocycline
593301|NCT00666887|Placebo|placebo
593302|NCT00666874|Obesity, lifestyle, vascular inflammation|obesity, lifestyle, vascular inflammation
593303|NCT00666848|Metabolic syndrome|metabolic syndrome
593304|NCT00666848|Hypertension|hypertension
593305|NCT00666848|Sitagliptin|sitagliptin
593306|NCT00666848|Enalapril|enalapril
593307|NCT00666835|Treatment of anemia in hemodialysis patients|treatment of anemia in hemodialysis patients
593308|NCT00666822|stage I breast cancer|stage i breast cancer
593309|NCT00666822|stage II breast cancer|stage ii breast cancer
593310|NCT00666822|stage IIIA breast cancer|stage iiia breast cancer
593311|NCT00666809|Vardenafil,|vardenafil,
593312|NCT00666809|Tinnitus|tinnitus
593313|NCT00666757|Severe Depressive Episode|severe depressive episode
593314|NCT00666744|exercise|exercise
593315|NCT00666744|frequency|frequency
593316|NCT00666744|duration|duration
593317|NCT00666731|male breast cancer|male breast cancer
593412|NCT00666380|Malaria|malaria
593318|NCT00666731|breast cancer|breast cancer
593319|NCT00666731|ductal breast carcinoma in situ|ductal breast carcinoma in situ
593320|NCT00666731|lobular breast carcinoma in situ|lobular breast carcinoma in situ
593321|NCT00666731|atypical ductal breast hyperplasia|atypical ductal breast hyperplasia
593322|NCT00666705|maraviroc|maraviroc
593323|NCT00666705|raltegravir|raltegravir
593324|NCT00666705|drug interaction study|drug interaction study
593325|NCT00666705|healthy volunteers|healthy volunteers
593326|NCT00666692|cancer|cancer
593327|NCT00666692|carcinoma|carcinoma
593328|NCT00666692|monoclonal antibody therapy|monoclonal antibody therapy
593329|NCT00666692|anti-angiogenesis|anti-angiogenesis
593330|NCT00666666|prostate Cancer|prostate cancer
593331|NCT00666666|adenocarcinoma of the prostate|adenocarcinoma of the prostate
593332|NCT00666666|stage IV prostate cancer|stage iv prostate cancer
593774|NCT00665379|interface pressure|interface pressure
593333|NCT00666666|newly diagnosed stage IV prostate cancer|newly diagnosed stage iv prostate cancer
593334|NCT00666653|Parkinson's disease|parkinson's disease
593335|NCT00666653|Dopamine Agonist|dopamine agonist
593336|NCT00666653|Levodopa|levodopa
593337|NCT00666653|Pharmacokinetics|pharmacokinetics
593338|NCT00666653|Dyskinesia|dyskinesia
593339|NCT00666640|Osteoporosis|osteoporosis
593340|NCT00666640|Fracture|fracture
593341|NCT00666640|DXA|dxa
593342|NCT00666640|Dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
593343|NCT00666640|Computed tomography|computed tomography
593344|NCT00666640|3D DXA|3d dxa
593345|NCT00666627|Osteoporosis|osteoporosis
593346|NCT00666627|Post-menopausal osteoporosis|post-menopausal osteoporosis
593347|NCT00666627|Bisphosphonates|bisphosphonates
593348|NCT00666627|Alendronate|alendronate
593349|NCT00666627|Ibandronate|ibandronate
593350|NCT00666627|Risedronate|risedronate
593351|NCT00666614|Sleep|sleep
593352|NCT00666614|Fatigue|fatigue
593353|NCT00666614|High Dose Chemotherapy|high dose chemotherapy
593354|NCT00666601|Microdialysis|microdialysis
593355|NCT00666601|Antibiotic|antibiotic
593356|NCT00666601|Healthy subjects|healthy subjects
593357|NCT00666549|Myeloproliferative Disease|myeloproliferative disease
593358|NCT00666549|Myelofibrosis|myelofibrosis
593359|NCT00666549|Idiopathic Myelofibrosis|idiopathic myelofibrosis
593360|NCT00666549|Essential Thrombocythemia|essential thrombocythemia
593361|NCT00666549|Polycythemia Vera|polycythemia vera
593362|NCT00666536|Hypertension|hypertension
593363|NCT00666536|adults|adults
593364|NCT00666536|Valsartan + Amlodipine|valsartan + amlodipine
593365|NCT00666536|Angiotensin Receptor Blockers|angiotensin receptor blockers
593366|NCT00666523|osteoarthritis, knee or hip|osteoarthritis, knee or hip
593367|NCT00666510|nitric oxide|nitric oxide
593368|NCT00666510|bronchospasm|bronchospasm
593369|NCT00666510|anesthesia|anesthesia
593370|NCT00666510|induced sputum|induced sputum
593371|NCT00666510|asthma|asthma
593372|NCT00666497|Acute Myeloid Leukemia|acute myeloid leukemia
593373|NCT00666497|Myelodysplastic Syndrome|myelodysplastic syndrome
593374|NCT00666497|Azacitidine|azacitidine
593375|NCT00666497|Vidaza|vidaza
593376|NCT00666497|MGCD0103|mgcd0103
593377|NCT00666497|Histone deacetylase inhibitor|histone deacetylase inhibitor
593378|NCT00666497|DNA methyltransferase inhibitor|dna methyltransferase inhibitor
593379|NCT00666497|Epigenetic Therapy|epigenetic therapy
593380|NCT00666484|neurotoxicity|neurotoxicity
593381|NCT00666484|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
593382|NCT00666484|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
593383|NCT00666484|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
593384|NCT00666484|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
593385|NCT00666484|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
593386|NCT00666484|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
593387|NCT00666484|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
593388|NCT00666484|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
593389|NCT00666471|epistaxis|epistaxis
593390|NCT00666471|Epistaxis refractory to emergency physician treatment|epistaxis refractory to emergency physician treatment
593391|NCT00666458|Type 2 diabetes|type 2 diabetes
593392|NCT00666458|metformin|metformin
593393|NCT00666445|Alzheimer's Disease|alzheimer's disease
593394|NCT00666445|Diagnosis|diagnosis
593395|NCT00666445|Neuronal function|neuronal function
593396|NCT00666445|Cognitive Impairment|cognitive impairment
593397|NCT00666445|Magnetoencephalography|magnetoencephalography
593398|NCT00666432|schizophrenia|schizophrenia
593399|NCT00666432|bipolar|bipolar
593400|NCT00666432|eye movements|eye movements
593401|NCT00666432|phenotype|phenotype
593402|NCT00666432|biochemical|biochemical
593403|NCT00666432|relatives|relatives
593404|NCT00666419|nonspecific low back pain|nonspecific low back pain
593405|NCT00666419|schoolchildren|schoolchildren
593406|NCT00666419|prevalence|prevalence
593407|NCT00666393|IONSYS™|ionsys™
593408|NCT00666393|Pain, Postoperative|pain, postoperative
593409|NCT00666393|Analgesia, Patient-Controlled|analgesia, patient-controlled
593410|NCT00666393|Opioids|opioids
593411|NCT00666393|Pediatrics|pediatrics
593413|NCT00666380|Vaccine|vaccine
593414|NCT00666380|MSP-1 (merozoite surface protein-1)|msp-1 (merozoite surface protein-1)
593415|NCT00666380|Phase 1|phase 1
593416|NCT00666367|COPD|copd
593417|NCT00666354|Nail Psoriasis|nail psoriasis
593418|NCT00666354|Psoriasis|psoriasis
593419|NCT00666354|Fingernail Psoriasis|fingernail psoriasis
593420|NCT00666354|Methotrexate|methotrexate
593421|NCT00666328|Hypertension|hypertension
593422|NCT00666328|Hemorrhage|hemorrhage
593423|NCT00666328|Intracranial Pressure|intracranial pressure
593424|NCT00666328|Antihypertensive Agent|antihypertensive agent
593425|NCT00666328|Calcium Channel Blocker|calcium channel blocker
593426|NCT00666315|Consecutive euthyroid patients with multinodular goiter for whom a total Thyroidectomy under general anesthesia is indicated|consecutive euthyroid patients with multinodular goiter for whom a total thyroidectomy under general anesthesia is indicated
593427|NCT00666302|Atopic Dermatitis|atopic dermatitis
593428|NCT00666302|Protopic|protopic
593429|NCT00666302|Elidel|elidel
593430|NCT00666289|polycythemia vera|polycythemia vera
593431|NCT00666289|essential thrombocythemia|essential thrombocythemia
593432|NCT00666289|idiopathic myelofibrosis|idiopathic myelofibrosis
593433|NCT00666289|family clusters|family clusters
593434|NCT00666250|blood pressure|blood pressure
593435|NCT00666250|dyslipidemia|dyslipidemia
593436|NCT00666250|hyperglycemia|hyperglycemia
593437|NCT00666237|Glaucoma|glaucoma
593438|NCT00666237|Tube shunt surgery|tube shunt surgery
593439|NCT00666237|Trabeculectomy|trabeculectomy
593440|NCT00666224|Clinically Definite Multiple Sclerosis|clinically definite multiple sclerosis
593441|NCT00666224|Clinically Isolated Syndrome|clinically isolated syndrome
593442|NCT00666224|Multiple Sclerosis|multiple sclerosis
593443|NCT00666211|pain|pain
593444|NCT00666211|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
593445|NCT00666211|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
593446|NCT00666211|acute undifferentiated leukemia|acute undifferentiated leukemia
593447|NCT00666211|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
593448|NCT00666211|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
593449|NCT00666211|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
593450|NCT00666211|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
593451|NCT00666211|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
593452|NCT00666211|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
593453|NCT00666211|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
593454|NCT00666211|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
593455|NCT00666211|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
593456|NCT00666211|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
593457|NCT00666211|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
593458|NCT00666211|mast cell leukemia|mast cell leukemia
593459|NCT00666211|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
593460|NCT00666211|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
593461|NCT00666211|prolymphocytic leukemia|prolymphocytic leukemia
593462|NCT00666211|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
593463|NCT00666211|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
593464|NCT00666211|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
593465|NCT00666211|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
593466|NCT00666211|refractory hairy cell leukemia|refractory hairy cell leukemia
593467|NCT00666211|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
593468|NCT00666211|secondary acute myeloid leukemia|secondary acute myeloid leukemia
593469|NCT00666211|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
593470|NCT00666211|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
593471|NCT00666211|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
593472|NCT00666211|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
593473|NCT00666211|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
593474|NCT00666211|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
593475|NCT00666211|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
593476|NCT00666211|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
593477|NCT00666211|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
593478|NCT00666211|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
593479|NCT00666211|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
593480|NCT00666211|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
593481|NCT00666211|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
593482|NCT00666211|anaplastic large cell lymphoma|anaplastic large cell lymphoma
593483|NCT00666211|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
593484|NCT00666211|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
593485|NCT00666211|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
593624|NCT00666055|Aging|aging
593486|NCT00666211|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
593487|NCT00666211|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
593488|NCT00666211|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
593489|NCT00666211|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
593490|NCT00666211|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
593491|NCT00666211|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
593492|NCT00666211|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
593493|NCT00666211|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
593494|NCT00666211|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
593495|NCT00666211|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
593496|NCT00666211|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
593497|NCT00666211|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
593498|NCT00666211|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
593499|NCT00666211|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
593500|NCT00666211|splenic marginal zone lymphoma|splenic marginal zone lymphoma
593501|NCT00666211|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
593502|NCT00666211|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
593503|NCT00666211|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
593504|NCT00666211|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
593505|NCT00666211|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
593506|NCT00666211|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
593507|NCT00666211|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
593508|NCT00666211|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
593509|NCT00666211|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
593510|NCT00666211|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
593511|NCT00666211|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
593512|NCT00666211|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
593513|NCT00666211|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
593514|NCT00666211|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
593515|NCT00666211|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
593516|NCT00666211|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
593517|NCT00666211|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
593518|NCT00666211|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
593519|NCT00666211|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
593520|NCT00666211|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
593521|NCT00666211|stage I mantle cell lymphoma|stage i mantle cell lymphoma
593522|NCT00666211|stage I marginal zone lymphoma|stage i marginal zone lymphoma
593523|NCT00666211|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
593524|NCT00666211|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
593525|NCT00666211|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
593526|NCT00666211|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
593527|NCT00666211|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
593528|NCT00666211|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
593529|NCT00666211|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
593530|NCT00666211|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
593531|NCT00666211|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
593532|NCT00666211|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
593533|NCT00666211|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
593534|NCT00666211|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
593535|NCT00666211|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
593536|NCT00666211|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
593537|NCT00666211|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
593538|NCT00666211|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
593539|NCT00666211|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
593540|NCT00666211|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
593541|NCT00666211|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
593542|NCT00666211|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
593543|NCT00666211|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
593544|NCT00666211|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
593545|NCT00666211|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
593546|NCT00666211|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
593547|NCT00666211|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
593548|NCT00666211|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
593549|NCT00666211|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
593550|NCT00666211|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
593551|NCT00666211|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
593552|NCT00666211|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
593553|NCT00666211|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
593554|NCT00666211|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
593555|NCT00666211|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
593556|NCT00666211|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
593557|NCT00666211|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
593558|NCT00666211|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
593559|NCT00666211|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
593560|NCT00666211|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
593561|NCT00666211|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
593562|NCT00666211|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
593563|NCT00666211|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
593564|NCT00666211|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
593565|NCT00666211|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
593566|NCT00666211|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
593567|NCT00666211|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
593568|NCT00666211|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
593569|NCT00666211|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
593570|NCT00666211|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
593571|NCT00666211|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
593572|NCT00666211|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
593573|NCT00666211|intraocular lymphoma|intraocular lymphoma
593574|NCT00666211|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
593575|NCT00666211|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
593576|NCT00666211|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
593577|NCT00666211|chronic eosinophilic leukemia|chronic eosinophilic leukemia
593578|NCT00666211|chronic neutrophilic leukemia|chronic neutrophilic leukemia
593579|NCT00666211|primary myelofibrosis|primary myelofibrosis
593580|NCT00666211|essential thrombocythemia|essential thrombocythemia
593581|NCT00666211|polycythemia vera|polycythemia vera
593582|NCT00666211|extramedullary plasmacytoma|extramedullary plasmacytoma
593583|NCT00666211|isolated plasmacytoma of bone|isolated plasmacytoma of bone
593584|NCT00666211|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
593585|NCT00666211|stage I multiple myeloma|stage i multiple myeloma
593586|NCT00666211|stage II multiple myeloma|stage ii multiple myeloma
593587|NCT00666211|stage III multiple myeloma|stage iii multiple myeloma
593588|NCT00666211|primary systemic amyloidosis|primary systemic amyloidosis
593589|NCT00666211|refractory multiple myeloma|refractory multiple myeloma
593590|NCT00666211|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
593591|NCT00666211|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
593592|NCT00666211|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
593593|NCT00666211|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
593594|NCT00666211|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
593595|NCT00666185|Micafungin|micafungin
593596|NCT00666185|Esophageal Candidiasis|esophageal candidiasis
593597|NCT00666185|Fluconazole|fluconazole
593598|NCT00666172|Women's Health|women's health
593599|NCT00666172|Obesity|obesity
593600|NCT00666172|Metabolic Syndrome|metabolic syndrome
593601|NCT00666172|Arterial Function|arterial function
593602|NCT00666172|Lipoproteins|lipoproteins
593603|NCT00666172|Overweight|overweight
593604|NCT00666159|Atopic Dermatitis|atopic dermatitis
593605|NCT00666159|Protopic|protopic
593606|NCT00666159|Pediatric|pediatric
593607|NCT00666146|Schizophrenia|schizophrenia
593608|NCT00666146|Genetics|genetics
593609|NCT00666146|Eyetracking|eyetracking
593610|NCT00666133|Preeclampsia|preeclampsia
593611|NCT00666133|Eclampsia|eclampsia
593612|NCT00666133|Magnesium Sulfate|magnesium sulfate
593613|NCT00666107|HPV|hpv
593614|NCT00666107|HIV|hiv
593615|NCT00666107|Gardasil|gardasil
593616|NCT00666107|Vaccine|vaccine
593617|NCT00666094|Type 2-diabetes|type 2-diabetes
593618|NCT00666094|exercise therapy|exercise therapy
593619|NCT00666094|RCT|rct
593620|NCT00666094|Norway|norway
593621|NCT00666081|Pazopanib, paclitaxel, carboplatin|pazopanib, paclitaxel, carboplatin
593622|NCT00666068|Patients with hypopituitarism|patients with hypopituitarism
593623|NCT00666055|Sex|sex
593625|NCT00666055|Antiretroviral|antiretroviral
593626|NCT00666055|Pharmacokinetics|pharmacokinetics
593627|NCT00666055|post-menopausal women with HIV infection|post-menopausal women with hiv infection
593628|NCT00666055|pre-menopausal women with HIV infection|pre-menopausal women with hiv infection
593629|NCT00666029|metabolic syndrome|metabolic syndrome
593630|NCT00666029|Volunteers recruited from the community|volunteers recruited from the community
593631|NCT00666016|non alcoholic steatohepatitis nash hepatoprotective hepatoprotection ALT AST new drug candidate interventional study TRO19622 Trophos cholest-4-en-3-one oxime|non alcoholic steatohepatitis nash hepatoprotective hepatoprotection alt ast new drug candidate interventional study tro19622 trophos cholest-4-en-3-one oxime
593632|NCT00666003|Hemodynamics|hemodynamics
593633|NCT00665977|Obstructive Sleep Apnea|obstructive sleep apnea
593634|NCT00665977|Nasal Congestion|nasal congestion
593635|NCT00665977|Sinus congestion|sinus congestion
593636|NCT00665964|osteoarthritis|osteoarthritis
593637|NCT00665964|knee|knee
593638|NCT00665964|total knee arthroplasty|total knee arthroplasty
593639|NCT00665964|gonarthrrsis|gonarthrrsis
593640|NCT00665964|polyethylene|polyethylene
593641|NCT00665964|posterior stabilized|posterior stabilized
593642|NCT00665951|pediatric|pediatric
593643|NCT00665951|pharmacokinetics|pharmacokinetics
593644|NCT00665951|HIV infection|hiv infection
593645|NCT00665938|Physical development|physical development
593646|NCT00665899|breast cancer|breast cancer
593647|NCT00665899|couples|couples
593648|NCT00665899|cognitive behavioral therapy|cognitive behavioral therapy
593649|NCT00665899|Women with early stage breast cancer and their partners.|women with early stage breast cancer and their partners.
593650|NCT00665886|Peripheral venous catheter|peripheral venous catheter
593651|NCT00665886|Catheter-related complication|catheter-related complication
593652|NCT00665886|Bacterial Colonization|bacterial colonization
593653|NCT00665886|Dwell time|dwell time
593654|NCT00665886|Closed system|closed system
593655|NCT00665886|Costs|costs
593656|NCT00665886|Polyurethane|polyurethane
593657|NCT00665886|Teflon|teflon
593658|NCT00665873|Totally Implantable Venous Access Devices|totally implantable venous access devices
593659|NCT00665873|Infections|infections
593660|NCT00665873|Chemotherapy|chemotherapy
593661|NCT00665873|Valuated infections TIVAD|valuated infections tivad
593662|NCT00665860|Osteoporosis|osteoporosis
593663|NCT00665860|Soy isoflavones|soy isoflavones
593664|NCT00665860|Postmenopausal women|postmenopausal women
593665|NCT00665860|Safety|safety
593666|NCT00665860|Efficacy|efficacy
593667|NCT00665860|Effective dosage|effective dosage
593668|NCT00665847|HIV-1|hiv-1
593669|NCT00665847|TMC125-TiDP35-C213|tmc125-tidp35-c213
593670|NCT00665847|TMC125-C213|tmc125-c213
593671|NCT00665821|nonspecific low back pain|nonspecific low back pain
593672|NCT00665821|disability|disability
593673|NCT00665821|sick leave|sick leave
593674|NCT00665821|catastrophizing|catastrophizing
593675|NCT00665821|workers|workers
593676|NCT00665795|Dysthyroid Optic Neuropathy|dysthyroid optic neuropathy
593677|NCT00665795|multidetector computed tomography|multidetector computed tomography
593678|NCT00665795|color doppler|color doppler
593679|NCT00665795|Grave´s Orbitopathy|grave´s orbitopathy
593680|NCT00665795|Grave´s Disease|grave´s disease
593681|NCT00665795|morphometric analysis|morphometric analysis
593682|NCT00665782|anxiety disorder|anxiety disorder
593683|NCT00665782|depression|depression
593684|NCT00665782|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
593685|NCT00665782|ductal breast carcinoma in situ|ductal breast carcinoma in situ
593686|NCT00665782|breast cancer in situ|breast cancer in situ
593687|NCT00665782|stage I breast cancer|stage i breast cancer
593688|NCT00665782|stage II breast cancer|stage ii breast cancer
593689|NCT00665782|stage IIIA breast cancer|stage iiia breast cancer
593690|NCT00665782|stage IIIB breast cancer|stage iiib breast cancer
593691|NCT00665782|stage IIIC breast cancer|stage iiic breast cancer
593692|NCT00665769|hypercapnia|hypercapnia
593693|NCT00665769|normocapnia|normocapnia
593694|NCT00665769|chronic lung disease|chronic lung disease
593695|NCT00665769|periventricular leukomalacia|periventricular leukomalacia
593696|NCT00665769|intraventricular hemorrhage|intraventricular hemorrhage
593697|NCT00665769|hypotension|hypotension
593698|NCT00665769|cerebral autoregulation|cerebral autoregulation
593699|NCT00665769|heart rate variability|heart rate variability
593700|NCT00665769|autonomic nervous system|autonomic nervous system
593701|NCT00665769|detrended fluctuation analysis|detrended fluctuation analysis
593702|NCT00665756|Glaucoma|glaucoma
593703|NCT00665756|Drainage implant|drainage implant
593704|NCT00665756|Ahmed valve|ahmed valve
593705|NCT00665756|Second trabeculectomy|second trabeculectomy
593706|NCT00665717|interaction|interaction
593707|NCT00665717|statins|statins
593708|NCT00665717|pharmacokinetics|pharmacokinetics
593709|NCT00665704|Smoking Cessation|smoking cessation
593710|NCT00665704|Internet|internet
593711|NCT00665704|Intervention Studies|intervention studies
593712|NCT00665704|Health Services Accessibility|health services accessibility
593713|NCT00665691|All Malignancies|all malignancies
593714|NCT00665652|Neuropathy|neuropathy
593815|NCT00665184|Hypokinesia|hypokinesia
593715|NCT00665652|Nonmalignant Monoclonal Gammopathy of Undetermined Significance (MGUS)|nonmalignant monoclonal gammopathy of undetermined significance (mgus)
593716|NCT00665652|MGUS|mgus
593717|NCT00665639|Micafungin|micafungin
593718|NCT00665639|Esophageal Candidiasis|esophageal candidiasis
593719|NCT00665639|caspofungin|caspofungin
593720|NCT00665613|warfarin use|warfarin use
593721|NCT00665600|COPD|copd
593722|NCT00665600|Chronic Bronchitis|chronic bronchitis
593723|NCT00665600|Chronic Emphysema|chronic emphysema
593724|NCT00665587|Atrial fibrillation|atrial fibrillation
593725|NCT00665587|Maze procedure|maze procedure
593726|NCT00665587|Mid-term results|mid-term results
593727|NCT00665587|Long-term results|long-term results
593728|NCT00665587|Surgical ablation|surgical ablation
593729|NCT00665561|Maraviroc|maraviroc
593730|NCT00665561|HIV-1|hiv-1
593731|NCT00665561|Safety|safety
593732|NCT00665561|Non-interventional|non-interventional
593733|NCT00665548|Knee Osteoarthritis|knee osteoarthritis
593734|NCT00665548|magnetic resonance imaging|magnetic resonance imaging
593735|NCT00665548|x rays|x rays
593736|NCT00665535|Pressure ulcers|pressure ulcers
593737|NCT00665535|Nursing facilities|nursing facilities
593738|NCT00665535|Elderly|elderly
593739|NCT00665535|At risk for pressure ulcers|at risk for pressure ulcers
593740|NCT00665522|Pain|pain
593741|NCT00665522|Postoperative Analgesia|postoperative analgesia
593742|NCT00665522|Patient-Controlled Opioids|patient-controlled opioids
593743|NCT00665509|Influenza|influenza
593744|NCT00665509|Vaccine|vaccine
593745|NCT00665509|CHMP criteria|chmp criteria
593746|NCT00665496|Erectile Dysfunction|erectile dysfunction
593747|NCT00665496|Vardenafil|vardenafil
593748|NCT00665496|Onset of action|onset of action
593749|NCT00665470|Malignant Melanoma|malignant melanoma
593750|NCT00665470|HLA-A2|hla-a2
593751|NCT00665470|Immunotherapy|immunotherapy
593752|NCT00665470|Clinical Response|clinical response
593753|NCT00665470|Skin Cancer|skin cancer
593754|NCT00665457|stage II breast cancer|stage ii breast cancer
593755|NCT00665457|stage IIIA breast cancer|stage iiia breast cancer
593756|NCT00665457|stage IIIB breast cancer|stage iiib breast cancer
593757|NCT00665457|stage IIIC breast cancer|stage iiic breast cancer
593758|NCT00665444|bipolar disorder|bipolar disorder
593759|NCT00665444|sedation|sedation
593760|NCT00665444|overweight|overweight
593761|NCT00665444|Abilify|abilify
593762|NCT00665444|medication|medication
593763|NCT00665418|Anesthesia|anesthesia
593764|NCT00665418|children|children
593765|NCT00665418|Larynx|larynx
593766|NCT00665405|Delivery, obstetric|delivery, obstetric
593767|NCT00665405|Atelectasis|atelectasis
593768|NCT00665392|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
593769|NCT00665392|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
593770|NCT00665392|tongue cancer|tongue cancer
593771|NCT00665379|leg lymphedema|leg lymphedema
593772|NCT00665379|volume measurement|volume measurement
593773|NCT00665379|compression therapy|compression therapy
593775|NCT00665379|static stiffness index (SSI)|static stiffness index (ssi)
593776|NCT00665379|volume change|volume change
593777|NCT00665353|HIV|hiv
593778|NCT00665353|HCV|hcv
593779|NCT00665340|Erectile Dysfunction|erectile dysfunction
593780|NCT00665340|Vardenafil|vardenafil
593781|NCT00665327|Community Acquired Pneumonia|community acquired pneumonia
593782|NCT00665327|Pneumonia,|pneumonia,
593783|NCT00665327|CAP|cap
593784|NCT00665314|Mobilisation stem cells|mobilisation stem cells
593785|NCT00665314|G-CSF Mobilisation Regimen|g-csf mobilisation regimen
593786|NCT00665314|Lymphoma|lymphoma
593787|NCT00665314|Multiple Myeloma|multiple myeloma
593788|NCT00665314|Adult patients with lymphoma (Non Hodgkin's Lymphoma, Hodgkin's Disease) or Multiple Myeloma who previously failed Stem Cell Collections or Collection attempts.|adult patients with lymphoma (non hodgkin's lymphoma, hodgkin's disease) or multiple myeloma who previously failed stem cell collections or collection attempts.
593789|NCT00665301|Non-invasive Cardiac Output|non-invasive cardiac output
593790|NCT00665288|cardiac arrest|cardiac arrest
593791|NCT00665288|heart arrest|heart arrest
593792|NCT00665288|CPR|cpr
593793|NCT00665288|resuscitation|resuscitation
593794|NCT00665288|bystander CPR|bystander cpr
593795|NCT00665275|complementary|complementary
593796|NCT00665275|alternative|alternative
593797|NCT00665275|medicine|medicine
593798|NCT00665262|analgesia|analgesia
593799|NCT00665262|hip arthroplasty|hip arthroplasty
593800|NCT00665262|knee arthroplasty|knee arthroplasty
593801|NCT00665249|problem drinking|problem drinking
593802|NCT00665249|heavy drinking|heavy drinking
593803|NCT00665249|Alcohol|alcohol
593804|NCT00665249|moderation|moderation
593805|NCT00665249|motivational interviewing|motivational interviewing
593806|NCT00665236|Migraine|migraine
593807|NCT00665223|Huntington's Disease|huntington's disease
593808|NCT00665210|hip arthritis|hip arthritis
593809|NCT00665210|implant sizing|implant sizing
593810|NCT00665197|Esophageal cancer|esophageal cancer
593811|NCT00665197|Brachytherapy|brachytherapy
593812|NCT00665197|Radiotherapy|radiotherapy
593813|NCT00665197|Palliation|palliation
593814|NCT00665197|Dysphagia|dysphagia
593816|NCT00665184|Gait|gait
593817|NCT00665184|Quality of life|quality of life
593818|NCT00665184|Dopamine replacement|dopamine replacement
593819|NCT00665184|Resistance training|resistance training
593820|NCT00665171|Polycystic ovary syndrome|polycystic ovary syndrome
593821|NCT00665171|Single nucleotide polymorphism|single nucleotide polymorphism
593822|NCT00665171|Whole genome analysis|whole genome analysis
593823|NCT00665171|Multigenerational family study|multigenerational family study
593824|NCT00665158|Abdominal obesity, exercise, behaviour modification|abdominal obesity, exercise, behaviour modification
593825|NCT00665145|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
593826|NCT00665145|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
593827|NCT00665145|Diabetic Polyneuropathy|diabetic polyneuropathy
593828|NCT00665145|Stem Cells|stem cells
593829|NCT00665132|wrist|wrist
593830|NCT00665132|hand|hand
593831|NCT00665132|pain|pain
593832|NCT00665132|failed CTR|failed ctr
593833|NCT00665132|carpal tunnel syndrome|carpal tunnel syndrome
593834|NCT00665132|CTS|cts
593835|NCT00665132|CTR|ctr
593836|NCT00665132|carpel tunnel release|carpel tunnel release
593837|NCT00665132|Peripheral nerve|peripheral nerve
593838|NCT00665132|Median nerve|median nerve
593839|NCT00665119|Respiratory Insufficiency|respiratory insufficiency
593840|NCT00665119|Respiration, Artificial|respiration, artificial
593841|NCT00665119|Remifentanil|remifentanil
593842|NCT00665119|Respiratory Mechanics|respiratory mechanics
593843|NCT00665119|Work of Breathing|work of breathing
593844|NCT00665106|Diabetic macular edema|diabetic macular edema
593845|NCT00665106|Diabetes|diabetes
593846|NCT00665106|Diabetic retinopathy|diabetic retinopathy
593847|NCT00665067|Myeloproliferative Disease|myeloproliferative disease
593848|NCT00665067|Myelofibrosis|myelofibrosis
593849|NCT00665067|Idiopathic Myelofibrosis|idiopathic myelofibrosis
593850|NCT00665067|Essential Thrombocythemia|essential thrombocythemia
593851|NCT00665067|Polycythemia Vera|polycythemia vera
593852|NCT00665067|Biomarkers|biomarkers
593853|NCT00665067|Philadelphia Chromosome Negative|philadelphia chromosome negative
593854|NCT00665067|Clonal Hematopoietic malignancies|clonal hematopoietic malignancies
593855|NCT00665054|Vardenafil|vardenafil
593856|NCT00665054|Erectile dysfunction|erectile dysfunction
593857|NCT00665054|SSES-E (sexual self-efficacy scale - erectile function)|sses-e (sexual self-efficacy scale - erectile function)
593858|NCT00665028|Anesthesia|anesthesia
593859|NCT00665028|Postoperative myocardial ischemia|postoperative myocardial ischemia
593860|NCT00665028|ST monitoring|st monitoring
593861|NCT00665015|pleural effusion|pleural effusion
593862|NCT00665015|coronary artery bypass|coronary artery bypass
593863|NCT00665015|heart valve replacement|heart valve replacement
593864|NCT00665002|Myeloid|myeloid
593865|NCT00665002|Monocytic|monocytic
593866|NCT00665002|Hematopoietic|hematopoietic
593867|NCT00665002|Neoplasms|neoplasms
593868|NCT00665002|Acute Myelogenous Leukemia|acute myelogenous leukemia
593869|NCT00665002|AML|aml
593870|NCT00665002|Myelodysplastic Syndrome|myelodysplastic syndrome
593871|NCT00665002|MDS|mds
593872|NCT00664989|Hemiarthroplasty Stemmed Resurfacing Conventional Shoulder|hemiarthroplasty stemmed resurfacing conventional shoulder
593873|NCT00664976|bipolar depression|bipolar depression
593874|NCT00664976|Electroconvulsive therapy|electroconvulsive therapy
593875|NCT00664963|Arterial Occlusive Diseases|arterial occlusive diseases
593876|NCT00664963|Peripheral Vascular Diseases|peripheral vascular diseases
593877|NCT00664963|Drug eluting stent|drug eluting stent
593878|NCT00664963|Restenosis|restenosis
593879|NCT00664963|Below the knee|below the knee
593880|NCT00664963|Intervention|intervention
593881|NCT00664950|intertrochanteric hip fracture fixation|intertrochanteric hip fracture fixation
593882|NCT00664950|interTAN IM Nail|intertan im nail
593883|NCT00664950|sliding hip screw|sliding hip screw
593884|NCT00664924|ICU|icu
593885|NCT00664898|anti-CD40|anti-cd40
593886|NCT00664898|Myeloma|myeloma
593887|NCT00664885|non-psychiatric|non-psychiatric
593888|NCT00664885|clinics|clinics
593889|NCT00664872|case manager|case manager
593890|NCT00664872|suicide|suicide
593891|NCT00664872|attempt|attempt
593892|NCT00664872|effectiveness|effectiveness
593893|NCT00664859|LCP-AtorFen|lcp-atorfen
593894|NCT00664859|Non-HDL cholesterol|non-hdl cholesterol
593895|NCT00664859|Triglycerides|triglycerides
593896|NCT00664859|HDL cholesterol|hdl cholesterol
593897|NCT00664859|LDL cholesterol|ldl cholesterol
593898|NCT00664859|Atorvastatin|atorvastatin
593899|NCT00664859|Fenofibrate|fenofibrate
593900|NCT00664846|Stroke|stroke
593901|NCT00664846|Prevention Therapy|prevention therapy
593902|NCT00664833|Erectile dysfunction|erectile dysfunction
593903|NCT00664833|Phosphodiesterase Type 5 Inhibitors|phosphodiesterase type 5 inhibitors
593904|NCT00664833|Patient education|patient education
593905|NCT00664833|Impotence|impotence
593906|NCT00664833|Vardenafil|vardenafil
593907|NCT00664820|Rheumatoid Arthritics|rheumatoid arthritics
593908|NCT00664820|probiotics|probiotics
593909|NCT00664820|Lactobacillus|lactobacillus
593910|NCT00664781|stage IIIA breast cancer|stage iiia breast cancer
593911|NCT00664781|stage IIIB breast cancer|stage iiib breast cancer
594007|NCT00664430|Dialysis|dialysis
593912|NCT00664781|stage IIIC breast cancer|stage iiic breast cancer
593913|NCT00664781|stage IV breast cancer|stage iv breast cancer
593914|NCT00664781|recurrent breast cancer|recurrent breast cancer
593915|NCT00664781|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
593916|NCT00664781|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
593917|NCT00664781|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
593918|NCT00664781|ovarian stromal cancer|ovarian stromal cancer
593919|NCT00664781|ovarian sarcoma|ovarian sarcoma
593920|NCT00664781|BRCA1 mutation carrier|brca1 mutation carrier
593921|NCT00664781|BRCA2 mutation carrier|brca2 mutation carrier
593922|NCT00664781|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
593923|NCT00664781|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
593924|NCT00664781|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
593925|NCT00664781|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
593926|NCT00664781|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
593927|NCT00664781|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
593928|NCT00664781|ovarian papillary serous carcinoma|ovarian papillary serous carcinoma
593929|NCT00664768|hypoallergenicity|hypoallergenicity
593930|NCT00664768|Cow Milk Allergy|cow milk allergy
593931|NCT00664768|DBPCFC|dbpcfc
593932|NCT00664768|Stool microflora|stool microflora
593933|NCT00664768|Stool characteristics|stool characteristics
593934|NCT00664755|Menstrual Cycle effects|menstrual cycle effects
593935|NCT00664755|Cue Reactivity|cue reactivity
593936|NCT00664755|Smoking Cessation|smoking cessation
593937|NCT00664755|Impulsivity|impulsivity
593938|NCT00664742|Metabolic syndrome,dyslipidemia,fluvastatin extended release|metabolic syndrome,dyslipidemia,fluvastatin extended release
593939|NCT00664729|Abdominal|abdominal
593940|NCT00664729|obesity|obesity
593941|NCT00664729|exercise|exercise
593942|NCT00664729|intensity|intensity
593943|NCT00664729|weight loss|weight loss
593944|NCT00664729|women|women
593945|NCT00664716|Rheumatoid Arthritis|rheumatoid arthritis
593946|NCT00664716|RA|ra
593947|NCT00664716|DMARD inadequate response|dmard inadequate response
593948|NCT00664716|Methotrexate|methotrexate
593949|NCT00664703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors
593950|NCT00664703|Dopamine|dopamine
593951|NCT00664703|Methylphenidate|methylphenidate
593952|NCT00664703|Mental Disorders Diagnosed in Childhood|mental disorders diagnosed in childhood
593953|NCT00664703|Neurologic Manifestations|neurologic manifestations
593954|NCT00664703|Attention Deficit and Disruptive Behavior Disorders|attention deficit and disruptive behavior disorders
593955|NCT00664703|Hyperkinesis|hyperkinesis
593956|NCT00664703|Dyskinesias|dyskinesias
593957|NCT00664690|shoulder surgery|shoulder surgery
593958|NCT00664690|analgesia|analgesia
593959|NCT00664677|Adult|adult
593960|NCT00664677|Leukemia|leukemia
593961|NCT00664677|Terameprocol|terameprocol
593962|NCT00664677|Survivin|survivin
593963|NCT00664677|AML|aml
593964|NCT00664677|ALL|all
593965|NCT00664677|ATL|atl
593966|NCT00664677|CML|cml
593967|NCT00664677|CLL|cll
593968|NCT00664677|CMML|cmml
593969|NCT00664677|MDS|mds
593970|NCT00664664|insomnia|insomnia
593971|NCT00664664|sleep maintenance insomnia|sleep maintenance insomnia
593972|NCT00664664|sleep quality|sleep quality
593973|NCT00664664|non-restorative sleep|non-restorative sleep
593974|NCT00664664|multiple awakenings|multiple awakenings
593975|NCT00664651|joint contracture|joint contracture
593976|NCT00664651|total knee arthroplasty|total knee arthroplasty
593977|NCT00664612|Cervical Spine|cervical spine
593978|NCT00664599|Ocular lesions, Visual Acuity, Retinal Vasculitis|ocular lesions, visual acuity, retinal vasculitis
593979|NCT00664586|Terameprocol (EM-1421)|terameprocol (em-1421)
593980|NCT00664586|Phase 1|phase 1
593981|NCT00664586|Infusion|infusion
593982|NCT00664586|Refractory Solid Tumors|refractory solid tumors
593983|NCT00664586|Lymphoma|lymphoma
593984|NCT00664586|Maximum Tolerated Dose|maximum tolerated dose
593985|NCT00664586|Tumor Response|tumor response
593986|NCT00664586|Tumor Markers|tumor markers
593987|NCT00664586|Pharmacokinetics|pharmacokinetics
593988|NCT00664573|Safety|safety
593989|NCT00664573|Rheumatoid Arthritis|rheumatoid arthritis
593990|NCT00664573|Baminercept alfa|baminercept alfa
593991|NCT00664573|Methotrexate|methotrexate
593992|NCT00664573|BG9924|bg9924
593993|NCT00664573|Efficacy|efficacy
593994|NCT00664547|obesity, exercise, diet, insulin resistance|obesity, exercise, diet, insulin resistance
593995|NCT00664508|Arthroplasty|arthroplasty
593996|NCT00664508|Hip Replacement|hip replacement
593997|NCT00664508|motion analysis|motion analysis
593998|NCT00664495|Obesity, exercise, diet, insulin resistance|obesity, exercise, diet, insulin resistance
593999|NCT00664456|stage IIB prostate cancer|stage iib prostate cancer
594000|NCT00664456|stage IIA prostate cancer|stage iia prostate cancer
594001|NCT00664456|stage I prostate cancer|stage i prostate cancer
594002|NCT00664443|cardiac arrest|cardiac arrest
594003|NCT00664443|CPR|cpr
594004|NCT00664443|resuscitation|resuscitation
594005|NCT00664443|bystander CPR|bystander cpr
594006|NCT00664443|dispatch-assisted CPR|dispatch-assisted cpr
594008|NCT00664430|Calcitriol Resistant|calcitriol resistant
594009|NCT00664430|Secondary Hyperparathyroidism|secondary hyperparathyroidism
594010|NCT00664417|Influenza|influenza
594011|NCT00664417|A/H5N1|a/h5n1
594012|NCT00664417|Orthomyxoviridae Infections|orthomyxoviridae infections
594013|NCT00664417|Influenza Pandemics|influenza pandemics
594014|NCT00664404|Smoking|smoking
594015|NCT00664404|Smoking Cessation|smoking cessation
594016|NCT00664404|Nicotine Withdrawal|nicotine withdrawal
594017|NCT00664404|Nicotine Dependence|nicotine dependence
594018|NCT00664404|Neuroregulatory Effects|neuroregulatory effects
594019|NCT00664404|Magnetic Resonance Imaging|magnetic resonance imaging
594020|NCT00664404|MRI|mri
594021|NCT00664378|Multiple myeloma, relapsed, refractory|multiple myeloma, relapsed, refractory
594022|NCT00664365|Premature ejaculation.|premature ejaculation.
594023|NCT00664365|FTIH,|ftih,
594024|NCT00664365|GSK958108,|gsk958108,
594025|NCT00664365|5HT1a antagonist,|5ht1a antagonist,
594026|NCT00664352|Double blind|double blind
594027|NCT00664352|Placebo controlled|placebo controlled
594028|NCT00664352|wound healing|wound healing
594029|NCT00664339|Heart failure,|heart failure,
594030|NCT00664339|infection,|infection,
594031|NCT00664339|immune system,|immune system,
594032|NCT00664339|atherosclerosis|atherosclerosis
594033|NCT00664326|Renal Cell Carcinoma|renal cell carcinoma
594034|NCT00664313|Linezolid|linezolid
594035|NCT00664313|Zyvox|zyvox
594036|NCT00664313|Peripheral Neuropathy|peripheral neuropathy
594037|NCT00664313|Optic Neuropathy|optic neuropathy
594038|NCT00664313|Anemia|anemia
594039|NCT00664313|Thrombocytopenia|thrombocytopenia
594040|NCT00664300|Gilles de la Tourette's syndrome|gilles de la tourette's syndrome
594041|NCT00664300|Facial expression recognition of emotion|facial expression recognition of emotion
594042|NCT00664300|Frequency levels|frequency levels
594043|NCT00664300|Automatic and voluntary information treatment|automatic and voluntary information treatment
594044|NCT00664300|Patient with Gilles de la Tourette's syndrome|patient with gilles de la tourette's syndrome
594045|NCT00664261|tobacco use disorder|tobacco use disorder
594046|NCT00664235|Pressure Ulcers|pressure ulcers
594047|NCT00664235|Tissue Injury|tissue injury
594048|NCT00664222|heart failure|heart failure
594049|NCT00664222|insulin resistance|insulin resistance
594050|NCT00664222|inflammatory cytokine|inflammatory cytokine
594051|NCT00664222|spironolactone|spironolactone
594052|NCT00664222|furosemide|furosemide
594053|NCT00664209|Parkinson's disease|parkinson's disease
594054|NCT00664209|levodopa|levodopa
594055|NCT00664209|Helicobacter pylori|helicobacter pylori
594056|NCT00664196|Prostate Cancer|prostate cancer
594057|NCT00664196|T cells|t cells
594058|NCT00664196|Gene Transfer|gene transfer
594059|NCT00664183|diabetic retinopathy|diabetic retinopathy
594060|NCT00664157|Idiopathic Parkinson's disease|idiopathic parkinson's disease
594061|NCT00664157|L-Dopa|l-dopa
594062|NCT00664157|Deep Brain stimulation|deep brain stimulation
594063|NCT00664157|Facial expression recognition of emotion|facial expression recognition of emotion
594064|NCT00664157|Frequency levels|frequency levels
594065|NCT00664157|Automatic and voluntary information treatment|automatic and voluntary information treatment
594066|NCT00664157|Patient with an Idiopathic Parkinson's disease|patient with an idiopathic parkinson's disease
594067|NCT00664131|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
594068|NCT00664131|ALL survivors|all survivors
594069|NCT00664131|ALL neurologic symptoms|all neurologic symptoms
594070|NCT00664131|ALL neurologic disability|all neurologic disability
594071|NCT00664131|ALL late effects|all late effects
594072|NCT00664118|Doula|doula
594073|NCT00664118|Patient-controlled epidural analgesia|patient-controlled epidural analgesia
594074|NCT00664118|Neuraxial analgesia|neuraxial analgesia
594075|NCT00664118|Labor analgesia|labor analgesia
594076|NCT00664105|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
594077|NCT00664105|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
594078|NCT00664092|Substance Abuse|substance abuse
594079|NCT00664092|Ex-Offenders|ex-offenders
594080|NCT00664092|Substance Abuse Recovery|substance abuse recovery
594081|NCT00664079|Thyroid Deficiency|thyroid deficiency
594082|NCT00664079|Thyroid Stimulating Hormone|thyroid stimulating hormone
594083|NCT00664053|bone mineral density|bone mineral density
594084|NCT00664053|bone turnover markers|bone turnover markers
594085|NCT00664053|strength|strength
594086|NCT00664053|balance|balance
594087|NCT00664014|hyponatremia|hyponatremia
594088|NCT00664014|Non-acute and non hypovolemic hyponatremia|non-acute and non hypovolemic hyponatremia
594089|NCT00663988|face transplantation|face transplantation
594090|NCT00663975|cystic fibrosis|cystic fibrosis
594091|NCT00663975|pancreatic insufficiency|pancreatic insufficiency
594092|NCT00663975|pancreatic enzymes|pancreatic enzymes
594093|NCT00663975|pediatrics|pediatrics
594094|NCT00663962|Thoracotomy|thoracotomy
594095|NCT00663962|Post-surgical|post-surgical
594096|NCT00663962|Pregabalin|pregabalin
594097|NCT00663949|diabetes|diabetes
594098|NCT00663949|proteinuria|proteinuria
594099|NCT00663949|pentoxifylline|pentoxifylline
594100|NCT00663936|Alzheimer's Disease|alzheimer's disease
594101|NCT00663936|Alzheimer's|alzheimer's
594102|NCT00663923|Excimer Laser|excimer laser
594103|NCT00663923|photorefractive keratectomy|photorefractive keratectomy
594104|NCT00663923|astigmatism|astigmatism
594105|NCT00663910|basal cell carcinoma of the skin|basal cell carcinoma of the skin
594106|NCT00663910|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
594107|NCT00663910|recurrent skin cancer|recurrent skin cancer
594108|NCT00663897|functional dyspepsia|functional dyspepsia
594109|NCT00663897|epigastric pain syndrome|epigastric pain syndrome
594110|NCT00663897|postprandial distress syndrome|postprandial distress syndrome
594111|NCT00663897|proton pump inhibitor|proton pump inhibitor
594112|NCT00663897|5 HT-4 receptor agonist|5 ht-4 receptor agonist
594113|NCT00663884|diabetes mellitus, Type 2|diabetes mellitus, type 2
594114|NCT00663884|mitiglinide|mitiglinide
594115|NCT00663871|Fish Oil|fish oil
594116|NCT00663871|Omega-3 fatty acids|omega-3 fatty acids
594117|NCT00663871|Affect|affect
594118|NCT00663871|Depression|depression
594119|NCT00663871|Anger|anger
594120|NCT00663871|Nutrition|nutrition
594121|NCT00663871|Impulsivity|impulsivity
594122|NCT00663871|Aggression|aggression
594123|NCT00663871|Cognition|cognition
594124|NCT00663871|Behavior|behavior
594125|NCT00663845|Male Erectile Dysfunction|male erectile dysfunction
594126|NCT00663845|Dyslipidemia|dyslipidemia
594127|NCT00663845|Vardenafil|vardenafil
594128|NCT00663832|Male|male
594129|NCT00663832|Prostate|prostate
594130|NCT00663832|Cancer|cancer
594131|NCT00663832|HRPC|hrpc
594132|NCT00663832|DACi|daci
594133|NCT00663819|Low anterior colon resection|low anterior colon resection
594134|NCT00663819|Proctectomy|proctectomy
594135|NCT00663819|Proctocolectomy|proctocolectomy
594136|NCT00663819|Anastomosis|anastomosis
594137|NCT00663819|Rectal Cancer|rectal cancer
594138|NCT00663819|Ileostomy|ileostomy
594139|NCT00663806|UTI|uti
594140|NCT00663793|Male Contraception|male contraception
594141|NCT00663793|Hypogonadism|hypogonadism
594142|NCT00663793|Testosterone|testosterone
594143|NCT00663780|pharmacogenomics|pharmacogenomics
594144|NCT00663780|polymorphisms|polymorphisms
594145|NCT00663780|wound healing|wound healing
594146|NCT00663754|Body Image|body image
594147|NCT00663741|Unresectable / recurrent gastric cancer|unresectable / recurrent gastric cancer
594148|NCT00663741|Sorafenib|sorafenib
594149|NCT00663741|S-1|s-1
594150|NCT00663741|Gastric|gastric
594151|NCT00663741|Cisplatin|cisplatin
594152|NCT00663741|CDDP|cddp
594153|NCT00663728|Erectile Dysfunction|erectile dysfunction
594154|NCT00663728|Vardenafil|vardenafil
594155|NCT00663715|Sciatic Nerve|sciatic nerve
594156|NCT00663715|Peripheral Nerve Block|peripheral nerve block
594157|NCT00663715|Lower extremity surgery|lower extremity surgery
594158|NCT00663715|Local Anesthesia|local anesthesia
594159|NCT00663715|Ultrasound guided nerve blocks|ultrasound guided nerve blocks
594160|NCT00663689|erlotinib|erlotinib
594161|NCT00663650|Basal Cell Carcinoma|basal cell carcinoma
594162|NCT00663650|BCC|bcc
594163|NCT00663650|Periocular BCC|periocular bcc
594164|NCT00663650|Frozen Section Control|frozen section control
594165|NCT00663650|Permanent Section Control|permanent section control
594166|NCT00663650|Recurrence Rates|recurrence rates
594167|NCT00663637|endotracheal tube obstruction, occlusion|endotracheal tube obstruction, occlusion
594168|NCT00663637|mechanical ventilation, complication|mechanical ventilation, complication
594169|NCT00663637|work of breathing|work of breathing
594170|NCT00663637|airway resistance|airway resistance
594171|NCT00663637|secretions|secretions
594172|NCT00663637|pneumonia, ventilator associated|pneumonia, ventilator associated
594173|NCT00663637|biofilms|biofilms
594174|NCT00663637|endotracheal tube|endotracheal tube
594175|NCT00663611|Immune Function|immune function
594176|NCT00663611|Metabolism|metabolism
594177|NCT00663611|Pulsatile Growth Hormone|pulsatile growth hormone
594178|NCT00663598|Erectile Dysfunction|erectile dysfunction
594179|NCT00663598|Vardenafil|vardenafil
594180|NCT00663585|Migraine|migraine
594181|NCT00663585|Headache|headache
594182|NCT00663585|Vipassana|vipassana
594183|NCT00663585|Meditation|meditation
594184|NCT00663585|Intensive|intensive
594185|NCT00663572|Newborn|newborn
594186|NCT00663572|nutrition|nutrition
594187|NCT00663572|genetic|genetic
594188|NCT00663572|feeding behaviour|feeding behaviour
594189|NCT00663572|psychomotor development|psychomotor development
594190|NCT00663572|long-term effects|long-term effects
594191|NCT00663572|nutritional imprinting.|nutritional imprinting.
594192|NCT00663559|renal|renal
594193|NCT00663559|Sunitinib|sunitinib
594194|NCT00663559|Unresectable and/or metastatic renal cell cancer|unresectable and/or metastatic renal cell cancer
594195|NCT00663546|Malaria|malaria
594196|NCT00663546|Plasmodium|plasmodium
594197|NCT00663546|Hemoglobin E|hemoglobin e
594198|NCT00663546|Alpha-thalssemia|alpha-thalssemia
594199|NCT00663546|G6PD Deficiency|g6pd deficiency
594200|NCT00663533|Vasectomy|vasectomy
594201|NCT00663533|Contraception|contraception
594202|NCT00663520|Cardiac disease|cardiac disease
594203|NCT00663520|vascular dysfunction|vascular dysfunction
594204|NCT00663520|women|women
594205|NCT00663520|chest pain|chest pain
594206|NCT00663520|echocardiography|echocardiography
594207|NCT00663507|Sickle Cell Disease|sickle cell disease
594208|NCT00663507|Immunosuppression|immunosuppression
594209|NCT00663507|Organ & Tissue Transplantation|organ & tissue transplantation
594210|NCT00663507|Transplantation Immunology|transplantation immunology
594211|NCT00663494|heart failure|heart failure
594212|NCT00663494|MMP|mmp
594213|NCT00663494|coronary sinus|coronary sinus
594214|NCT00663481|CoFactor|cofactor
594215|NCT00663481|ANX-510|anx-510
594216|NCT00663468|determine changes in patient pain level|determine changes in patient pain level
594217|NCT00663468|determine changes in patient functionality|determine changes in patient functionality
594218|NCT00663468|determine changes in patient life quality|determine changes in patient life quality
594219|NCT00663455|kidney transplant recipients|kidney transplant recipients
594220|NCT00663455|children and adolescents with kidney transplants|children and adolescents with kidney transplants
594221|NCT00663442|ADHD|adhd
594222|NCT00663442|side effects|side effects
594223|NCT00663442|sleep|sleep
594224|NCT00663442|dopamine|dopamine
594225|NCT00663442|pharmacogenetics|pharmacogenetics
594226|NCT00663403|daptomycin|daptomycin
594227|NCT00663403|pharmacokinetics|pharmacokinetics
594228|NCT00663403|renal replacement therapy|renal replacement therapy
594229|NCT00663403|critical illness|critical illness
594230|NCT00663403|intensive care units|intensive care units
594231|NCT00663377|Heart Failure|heart failure
594232|NCT00663377|Insulin Resistance|insulin resistance
594233|NCT00663377|Losartan|losartan
594234|NCT00663377|ACE inhibitor|ace inhibitor
594235|NCT00663377|Inflammatory cytokine|inflammatory cytokine
594236|NCT00663364|dry skin|dry skin
594237|NCT00663351|Arthritis|arthritis
594238|NCT00663351|Osteoarthritis|osteoarthritis
594239|NCT00663351|Traumatic Arthritis|traumatic arthritis
594240|NCT00663351|Degenerative Joint Disease|degenerative joint disease
594241|NCT00663351|Avascular Necrosis|avascular necrosis
594242|NCT00663338|Stroke|stroke
594243|NCT00663338|Hemispatial neglect|hemispatial neglect
594244|NCT00663338|Unilateral neglect|unilateral neglect
594245|NCT00663338|Spatial neglect|spatial neglect
594246|NCT00663338|Motor|motor
594247|NCT00663338|Weakness|weakness
594248|NCT00663312|Idiopathic Parkinson's disease|idiopathic parkinson's disease
594249|NCT00663312|Deep Brain stimulation|deep brain stimulation
594250|NCT00663312|Hepatic glucose production|hepatic glucose production
594251|NCT00663312|Insulin|insulin
594252|NCT00663312|Weight gain|weight gain
594253|NCT00663312|Patient with an Idiopathic Parkinson's disease|patient with an idiopathic parkinson's disease
594254|NCT00663299|Intracranial aneurysm|intracranial aneurysm
594255|NCT00663247|Diverticular disease|diverticular disease
594256|NCT00663247|Inflammation|inflammation
594257|NCT00663247|Mesalazine|mesalazine
594258|NCT00663234|Treatment Experienced|treatment experienced
594259|NCT00663221|Osteoporosis prevention|osteoporosis prevention
594260|NCT00663195|heart failure|heart failure
594261|NCT00663195|fibrosis|fibrosis
594262|NCT00663195|MMP|mmp
594263|NCT00663195|spironolactone|spironolactone
594264|NCT00663195|furosemide|furosemide
594265|NCT00663182|Entecavir|entecavir
594266|NCT00663182|cirrhosis|cirrhosis
594267|NCT00663182|anti-viral|anti-viral
594268|NCT00663182|therapy|therapy
594269|NCT00663169|Arthritis Gouty|arthritis gouty
594270|NCT00663169|ACZ885|acz885
594271|NCT00663169|IL1B protein|il1b protein
594272|NCT00663169|Pain|pain
594273|NCT00663156|lipoaugmentation|lipoaugmentation
594274|NCT00663156|breast augmentation|breast augmentation
594275|NCT00663156|fat grafting|fat grafting
594276|NCT00663156|liposuction|liposuction
594277|NCT00663156|lipoinfiltration|lipoinfiltration
594278|NCT00663156|Spear|spear
594279|NCT00663156|breast implants|breast implants
594280|NCT00663156|ASERF|aserf
594281|NCT00663156|Lipivage|lipivage
594282|NCT00663156|Baker|baker
594283|NCT00663156|harvest|harvest
594284|NCT00663156|autologous|autologous
594285|NCT00663156|Georgetown|georgetown
594286|NCT00663143|investigate|investigate
594287|NCT00663143|TZD exposure|tzd exposure
594288|NCT00663143|in vitro|in vitro
594289|NCT00663143|alters|alters
594290|NCT00663143|bone|bone
594291|NCT00663143|formation|formation
594292|NCT00663143|differentiation|differentiation
594293|NCT00663143|capacity|capacity
594294|NCT00663143|bone marrow|bone marrow
594295|NCT00663143|stromal cells|stromal cells
594296|NCT00663130|Erectile Dysfunction|erectile dysfunction
594297|NCT00663130|Vardenafil|vardenafil
594298|NCT00663117|naltrexone|naltrexone
594299|NCT00663117|LDN|ldn
594300|NCT00663117|IBD|ibd
594301|NCT00663117|Inflammatory bowel disease|inflammatory bowel disease
594302|NCT00663104|early menopause|early menopause
594303|NCT00663104|exercise|exercise
594304|NCT00663104|phytoestrogen|phytoestrogen
594305|NCT00663104|bone|bone
594306|NCT00663104|CHD-risk factors|chd-risk factors
594307|NCT00663091|WPP-201|wpp-201
594408|NCT00662662|Squamous Cell Carcinoma|squamous cell carcinoma
594308|NCT00663078|Cognitive Behavioral Therapy|cognitive behavioral therapy
594309|NCT00663078|expert patient programme|expert patient programme
594310|NCT00663078|deprived population|deprived population
594311|NCT00663078|women|women
594312|NCT00663065|Healthy subjects over 65|healthy subjects over 65
594313|NCT00663065|healthy subjects|healthy subjects
594314|NCT00663052|Enbrel|enbrel
594315|NCT00663052|Psoriasis|psoriasis
594316|NCT00663052|Topical Psoriasis|topical psoriasis
594317|NCT00663052|Wyeth Psoriasis|wyeth psoriasis
594318|NCT00663052|Active Psoriasis|active psoriasis
594319|NCT00663039|Schizophrenia|schizophrenia
594320|NCT00663039|Eye movements|eye movements
594321|NCT00663039|phenotype|phenotype
594322|NCT00663039|biochemical|biochemical
594323|NCT00663039|relatives|relatives
594324|NCT00663026|antibody|antibody
594325|NCT00663026|immunotherapy|immunotherapy
594326|NCT00663013|burn|burn
594327|NCT00663013|pain|pain
594328|NCT00663013|anxiety|anxiety
594329|NCT00663000|acromegaly|acromegaly
594330|NCT00663000|diabetes|diabetes
594331|NCT00663000|insulin resistance|insulin resistance
594332|NCT00663000|impaired glucose tolerance|impaired glucose tolerance
594333|NCT00662987|tonsillectomy|tonsillectomy
594334|NCT00662987|antibiotics|antibiotics
594335|NCT00662961|Plastic Surgery|plastic surgery
594336|NCT00662948|Folicular Lymphoma|folicular lymphoma
594337|NCT00662948|Consolidation|consolidation
594338|NCT00662948|Maintenance|maintenance
594339|NCT00662935|deep brain stimulation|deep brain stimulation
594340|NCT00662935|cluster headache|cluster headache
594341|NCT00662935|hypothalamus|hypothalamus
594342|NCT00662922|critical illness|critical illness
594343|NCT00662922|hypoglycemia|hypoglycemia
594344|NCT00662922|neurocognitive dysfunction|neurocognitive dysfunction
594345|NCT00662922|intensive insulin therapy|intensive insulin therapy
594346|NCT00662909|Frequency|frequency
594347|NCT00662909|YM178|ym178
594348|NCT00662909|Overactive bladder (OAB)|overactive bladder (oab)
594349|NCT00662909|Micturition|micturition
594350|NCT00662909|Urgency|urgency
594351|NCT00662909|Urinary urge incontinence|urinary urge incontinence
594352|NCT00662909|Urinary incontinence|urinary incontinence
594353|NCT00662883|ketamine|ketamine
594354|NCT00662883|corticosteroid|corticosteroid
594355|NCT00662883|intranasal|intranasal
594356|NCT00662883|phase I|phase i
594357|NCT00662883|Healthy volunteers|healthy volunteers
594358|NCT00662870|DAPTACEL|daptacel
594359|NCT00662870|Diphtheria|diphtheria
594360|NCT00662870|Tetanus|tetanus
594361|NCT00662870|Whooping Cough|whooping cough
594362|NCT00662870|Polio|polio
594363|NCT00662870|Haemophilus influenzae type b|haemophilus influenzae type b
594364|NCT00662870|Pertussis|pertussis
594365|NCT00662857|Diabetic adult male, diabetic adult female|diabetic adult male, diabetic adult female
594366|NCT00662844|Vitamin D insufficiency,vitamin D3 treatment,young women|vitamin d insufficiency,vitamin d3 treatment,young women
594367|NCT00662831|Diabetic Foot Ulcers Neuroischaemic|diabetic foot ulcers neuroischaemic
594368|NCT00662805|pharmacovigilance|pharmacovigilance
594369|NCT00662805|COPD|copd
594370|NCT00662779|asthma|asthma
594371|NCT00662779|exercise induced bronchospasm|exercise induced bronchospasm
594372|NCT00662779|prevention|prevention
594373|NCT00662779|EIB|eib
594374|NCT00662779|children|children
594375|NCT00662766|Black currant|black currant
594376|NCT00662766|Berry seed|berry seed
594377|NCT00662766|Press residue|press residue
594378|NCT00662766|Tocopherol|tocopherol
594379|NCT00662766|Fatty acids|fatty acids
594380|NCT00662766|Fiber|fiber
594381|NCT00662766|Total phenols|total phenols
594382|NCT00662766|TEAC|teac
594383|NCT00662766|Comet assay|comet assay
594384|NCT00662766|Dihydroxybenzoic acid|dihydroxybenzoic acid
594385|NCT00662753|hypertension|hypertension
594386|NCT00662753|home blood pressure monitoring|home blood pressure monitoring
594387|NCT00662753|nurse telephone follow up|nurse telephone follow up
594388|NCT00662753|medically underserved populations|medically underserved populations
594389|NCT00662727|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
594390|NCT00662727|Myocardial Ischemia|myocardial ischemia
594391|NCT00662727|Refractory Angina|refractory angina
594392|NCT00662701|Atrial Fibrillation|atrial fibrillation
594393|NCT00662688|thromboembolism|thromboembolism
594394|NCT00662688|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
594395|NCT00662688|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
594396|NCT00662688|stage IV pancreatic cancer|stage iv pancreatic cancer
594397|NCT00662688|recurrent pancreatic cancer|recurrent pancreatic cancer
594398|NCT00662675|Exocrine pancreatic insufficiency|exocrine pancreatic insufficiency
594399|NCT00662675|Steatorrhea|steatorrhea
594400|NCT00662675|Malabsorption syndromes|malabsorption syndromes
594401|NCT00662675|Cystic fibrosis|cystic fibrosis
594402|NCT00662675|Pediatrics|pediatrics
594403|NCT00662675|Adult|adult
594404|NCT00662675|Pancrelipase|pancrelipase
594405|NCT00662662|Oropharyngeal Cancer|oropharyngeal cancer
594406|NCT00662662|Non-Oropharyngeal Cancer|non-oropharyngeal cancer
594407|NCT00662662|Head and Neck Cancer|head and neck cancer
594409|NCT00662662|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
594410|NCT00662662|SCCHN|scchn
594411|NCT00662662|HPV-16|hpv-16
594412|NCT00662662|Questionnaire|questionnaire
594413|NCT00662662|Sexual Behavior|sexual behavior
594414|NCT00662662|Survey|survey
594415|NCT00662649|Multiple sclerosis.|multiple sclerosis.
594416|NCT00662649|Relapse-remitting|relapse-remitting
594417|NCT00662649|Fingolimod|fingolimod
594418|NCT00662623|Chronic Obstructive Sleep Apnea|chronic obstructive sleep apnea
594419|NCT00662623|Sleep Apnea|sleep apnea
594420|NCT00662623|Sleep Apnea Treatment|sleep apnea treatment
594421|NCT00662597|Tumor vascular disrupting agent|tumor vascular disrupting agent
594422|NCT00662597|VDA|vda
594423|NCT00662597|ASA404|asa404
594424|NCT00662597|non-small cell lung cancer|non-small cell lung cancer
594425|NCT00662597|NSCLC|nsclc
594426|NCT00662584|repetitive magnetic transcranial stimulation (rTMS)|repetitive magnetic transcranial stimulation (rtms)
594427|NCT00662584|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
594428|NCT00662571|nucleotide polymorphisms|nucleotide polymorphisms
594429|NCT00662571|disequilibrium haplotype|disequilibrium haplotype
594430|NCT00662571|acamprosate|acamprosate
594431|NCT00662571|differentiate|differentiate
594432|NCT00662571|pharmacogenomic|pharmacogenomic
594433|NCT00662571|effective individualized treatment|effective individualized treatment
594434|NCT00662571|alcohol dependent|alcohol dependent
594435|NCT00662571|N-methyl-D-aspartate receptor (NMDA)|n-methyl-d-aspartate receptor (nmda)
594436|NCT00662571|metabotropic glutamate receptor|metabotropic glutamate receptor
594437|NCT00662571|decreasing craving|decreasing craving
594438|NCT00662571|abstinence maintenance|abstinence maintenance
594439|NCT00662558|Chronic low back pain|chronic low back pain
594440|NCT00662545|HIV|hiv
594441|NCT00662545|Hepatitis B|hepatitis b
594442|NCT00662545|treatment experienced|treatment experienced
594443|NCT00662532|Peri-implantitis; antibiotic|peri-implantitis; antibiotic
594444|NCT00662493|knee pain|knee pain
594445|NCT00662493|exercise|exercise
594446|NCT00662493|rehabilitation|rehabilitation
594447|NCT00662480|population|population
594448|NCT00662480|screening|screening
594449|NCT00662480|abdominal aortic aneurysms|abdominal aortic aneurysms
594450|NCT00662480|peripheral arterial disease|peripheral arterial disease
594451|NCT00662480|hypertension|hypertension
594452|NCT00662480|Prevention|prevention
594453|NCT00662467|Myocardial Infarction|myocardial infarction
594454|NCT00662467|Hemorrhage|hemorrhage
594455|NCT00662467|Thromboembolism|thromboembolism
594456|NCT00662467|Clopidogrel|clopidogrel
594457|NCT00662467|Aspirin|aspirin
594458|NCT00662467|Warfarin|warfarin
594459|NCT00662454|contraceptive|contraceptive
594460|NCT00662454|efficacy|efficacy
594461|NCT00662454|body weight|body weight
594462|NCT00662441|Erectile Dysfunction|erectile dysfunction
594463|NCT00662441|Vardenafil|vardenafil
594464|NCT00662428|cost-benefit analysis|cost-benefit analysis
594465|NCT00662428|practice guideline|practice guideline
594466|NCT00662428|inpatients|inpatients
594467|NCT00662415|phantom limb pain|phantom limb pain
594468|NCT00662415|fMRI|fmri
594469|NCT00662415|mirror therapy|mirror therapy
594470|NCT00662402|K Grant|k grant
594471|NCT00662402|Career Advancement|career advancement
594472|NCT00662402|Award|award
594473|NCT00662402|Consultation|consultation
594474|NCT00662402|Application|application
594475|NCT00662402|K|k
594476|NCT00662402|The NIH priority score of the reviewed proposal.|the nih priority score of the reviewed proposal.
594477|NCT00662402|Percent of subjects who obtain funding for proposal.|percent of subjects who obtain funding for proposal.
594478|NCT00662402|Percent of subjects who submit proposals for funding.|percent of subjects who submit proposals for funding.
594479|NCT00662389|skin laxity, wrinkles, rhytids|skin laxity, wrinkles, rhytids
594480|NCT00662363|constipation|constipation
594481|NCT00662363|opioid|opioid
594482|NCT00662363|rehabilitation|rehabilitation
594483|NCT00662363|post-operative|post-operative
594484|NCT00662363|orthopedic|orthopedic
594485|NCT00662350|BPH|bph
594486|NCT00662337|Bioequivalence, diphenhydramine hydrochloride|bioequivalence, diphenhydramine hydrochloride
594487|NCT00662298|severe asthma|severe asthma
594488|NCT00662298|prednisolone pharmacokinetics|prednisolone pharmacokinetics
594489|NCT00662298|anti-inflammatory effects|anti-inflammatory effects
594490|NCT00662285|iron status|iron status
594491|NCT00662285|blood donors|blood donors
594492|NCT00662272|Flu|flu
594493|NCT00662272|Influenza vaccine|influenza vaccine
594494|NCT00662272|Adjuvant|adjuvant
594495|NCT00662272|Safety of an adjuvanted vaccine|safety of an adjuvanted vaccine
594496|NCT00662272|Immune response to an adjuvanted vaccine|immune response to an adjuvanted vaccine
594497|NCT00662259|Anxiety disorders|anxiety disorders
594498|NCT00662259|Generalized anxiety|generalized anxiety
594499|NCT00662233|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
594500|NCT00662233|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
594501|NCT00662233|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
594502|NCT00662233|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
594503|NCT00662233|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
594504|NCT00662233|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
594505|NCT00662233|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
594506|NCT00662233|ovarian sarcoma|ovarian sarcoma
594507|NCT00662233|stage II uterine sarcoma|stage ii uterine sarcoma
594508|NCT00662233|stage III uterine sarcoma|stage iii uterine sarcoma
594509|NCT00662233|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
594510|NCT00662220|chronic|chronic
594511|NCT00662220|hepatitis C|hepatitis c
594512|NCT00662220|ribavirin|ribavirin
594513|NCT00662220|SVR|svr
594514|NCT00662220|genotype one|genotype one
594515|NCT00662220|genotype four|genotype four
594516|NCT00662207|electric stimulation|electric stimulation
594517|NCT00662207|urethral obstruction|urethral obstruction
594518|NCT00662207|urodynamics|urodynamics
594519|NCT00662207|urology|urology
594520|NCT00662194|HIV|hiv
594521|NCT00662194|HBV|hbv
594522|NCT00662194|HCV|hcv
594523|NCT00662194|co-infection|co-infection
594524|NCT00662194|innate immunity|innate immunity
594525|NCT00662181|growth hormone|growth hormone
594526|NCT00662181|quality of life|quality of life
594527|NCT00662181|fat redistribution|fat redistribution
594528|NCT00662181|sugar metabolism|sugar metabolism
594529|NCT00662181|fat metabolism|fat metabolism
594530|NCT00662181|cytokines|cytokines
594531|NCT00662168|carcinoid|carcinoid
594532|NCT00662168|familial|familial
594533|NCT00662168|Collect and describe information about the medical and environmental factors associated with each cases of carcinoid carcinoma|collect and describe information about the medical and environmental factors associated with each cases of carcinoid carcinoma
594534|NCT00662168|Develop a genogram representing the family cancer history of cases of Carcinoid.|develop a genogram representing the family cancer history of cases of carcinoid.
594535|NCT00662155|Primary Insomnia|primary insomnia
594536|NCT00662155|Cognitive Behavioral Therapy|cognitive behavioral therapy
594537|NCT00662155|Insomnia|insomnia
594538|NCT00662155|Sleep|sleep
594539|NCT00662155|Zolpidem|zolpidem
594540|NCT00662155|Ambien|ambien
594541|NCT00662155|CBT|cbt
594542|NCT00662155|CBT-I|cbt-i
594543|NCT00662142|DHA|dha
594544|NCT00662142|fMRI|fmri
594545|NCT00662129|stage IV breast cancer|stage iv breast cancer
594546|NCT00662129|male breast cancer|male breast cancer
594547|NCT00662129|recurrent breast cancer|recurrent breast cancer
594548|NCT00662116|diastolic heart failure|diastolic heart failure
594549|NCT00662103|fatigue|fatigue
594550|NCT00662103|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
594551|NCT00662103|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
594552|NCT00662103|cancer survivor|cancer survivor
594553|NCT00662103|stage IA breast cancer|stage ia breast cancer
594554|NCT00662103|stage IB breast cancer|stage ib breast cancer
594555|NCT00662103|stage II breast cancer|stage ii breast cancer
594556|NCT00662103|stage IIIA breast cancer|stage iiia breast cancer
594557|NCT00662103|stage IIIB breast cancer|stage iiib breast cancer
594558|NCT00662103|stage IIIC breast cancer|stage iiic breast cancer
594559|NCT00662103|breast cancer in situ|breast cancer in situ
594560|NCT00662090|MDS|mds
594561|NCT00662090|JMML|jmml
594562|NCT00662090|EWOG-MDS|ewog-mds
594563|NCT00662090|Myelodysplastic Syndromes (MDS)|myelodysplastic syndromes (mds)
594564|NCT00662090|Juvenile Myelomonocytic Leukemia (JMML)|juvenile myelomonocytic leukemia (jmml)
594565|NCT00662077|osteoporosis|osteoporosis
594566|NCT00662077|bifosfonates|bifosfonates
594567|NCT00662077|ibandronate|ibandronate
594568|NCT00662064|Lower urinary tract|lower urinary tract
594569|NCT00662064|Physiology|physiology
594570|NCT00662064|Pathology|pathology
594571|NCT00662064|Immunohistochemistry|immunohistochemistry
594572|NCT00662064|Urinary bladder|urinary bladder
594573|NCT00662051|Asthma|asthma
594574|NCT00662051|Exhaled Nitric Oxide|exhaled nitric oxide
594575|NCT00662051|Asthma Control Test|asthma control test
594576|NCT00662038|idiopathic|idiopathic
594577|NCT00662038|pulmonary|pulmonary
594578|NCT00662038|fibrosis|fibrosis
594579|NCT00662012|Leishmaniasis|leishmaniasis
594580|NCT00662012|Sodium stibogluconate|sodium stibogluconate
594581|NCT00662012|Pentostam|pentostam
594582|NCT00662012|sand fly|sand fly
594583|NCT00661999|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
594584|NCT00661999|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
594585|NCT00661999|extramedullary plasmacytoma|extramedullary plasmacytoma
594586|NCT00661999|isolated plasmacytoma of bone|isolated plasmacytoma of bone
594587|NCT00661999|refractory multiple myeloma|refractory multiple myeloma
594588|NCT00661999|stage I multiple myeloma|stage i multiple myeloma
594589|NCT00661999|stage II multiple myeloma|stage ii multiple myeloma
594590|NCT00661999|stage III multiple myeloma|stage iii multiple myeloma
594591|NCT00661999|primary systemic amyloidosis|primary systemic amyloidosis
594592|NCT00661999|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
594593|NCT00661999|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
595015|NCT00660595|Risperidone|risperidone
594594|NCT00661999|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
594595|NCT00661999|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
594596|NCT00661999|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
594597|NCT00661999|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
594598|NCT00661999|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
594599|NCT00661999|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
594600|NCT00661999|anaplastic large cell lymphoma|anaplastic large cell lymphoma
594601|NCT00661999|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
594602|NCT00661999|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
594603|NCT00661999|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
594604|NCT00661999|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
594605|NCT00661999|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
594606|NCT00661999|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
594607|NCT00661999|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
594608|NCT00661999|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
594609|NCT00661999|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
594610|NCT00661999|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
594611|NCT00661999|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
594612|NCT00661999|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
594613|NCT00661999|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
594614|NCT00661999|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
594615|NCT00661999|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
594616|NCT00661999|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
594617|NCT00661999|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
594618|NCT00661999|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
594619|NCT00661999|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
594620|NCT00661999|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
594621|NCT00661999|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
594622|NCT00661999|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
594623|NCT00661999|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
594624|NCT00661999|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
594625|NCT00661999|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
594626|NCT00661999|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
594627|NCT00661999|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
594850|NCT00661310|medicines|medicines
594628|NCT00661999|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
594629|NCT00661999|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
594630|NCT00661999|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
594631|NCT00661999|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
594632|NCT00661999|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
594633|NCT00661999|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
594634|NCT00661999|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
594635|NCT00661999|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
594636|NCT00661999|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
594637|NCT00661999|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
594638|NCT00661999|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
594639|NCT00661999|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
594640|NCT00661999|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
594641|NCT00661999|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
594642|NCT00661999|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
594643|NCT00661999|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
594644|NCT00661999|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
594645|NCT00661999|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
594646|NCT00661999|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
594647|NCT00661999|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
594648|NCT00661999|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
594649|NCT00661999|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
594650|NCT00661999|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
594651|NCT00661999|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
594652|NCT00661999|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
594653|NCT00661999|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
594654|NCT00661999|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
594655|NCT00661999|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
594656|NCT00661999|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
594657|NCT00661999|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
594658|NCT00661999|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
594659|NCT00661999|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
594660|NCT00661999|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
594661|NCT00661999|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
594662|NCT00661999|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
594663|NCT00661999|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
594664|NCT00661999|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
594665|NCT00661999|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
594666|NCT00661999|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
594667|NCT00661999|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
594668|NCT00661999|stage I mantle cell lymphoma|stage i mantle cell lymphoma
594669|NCT00661999|stage I marginal zone lymphoma|stage i marginal zone lymphoma
594670|NCT00661999|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
594671|NCT00661999|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
594672|NCT00661999|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
594673|NCT00661999|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
594674|NCT00661999|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
594675|NCT00661999|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
594676|NCT00661999|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
594677|NCT00661999|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
594678|NCT00661999|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
594679|NCT00661999|splenic marginal zone lymphoma|splenic marginal zone lymphoma
594680|NCT00661999|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
594681|NCT00661999|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
594682|NCT00661999|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
594683|NCT00661999|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
594684|NCT00661999|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
594685|NCT00661999|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
594686|NCT00661999|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
594687|NCT00661999|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
594688|NCT00661999|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
594689|NCT00661999|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
594690|NCT00661999|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
594691|NCT00661999|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
594692|NCT00661999|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
594693|NCT00661999|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
594694|NCT00661999|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
594695|NCT00661999|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
594696|NCT00661999|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
594697|NCT00661999|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
594698|NCT00661999|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
594699|NCT00661999|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
594700|NCT00661999|refractory hairy cell leukemia|refractory hairy cell leukemia
594701|NCT00661999|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
594702|NCT00661999|prolymphocytic leukemia|prolymphocytic leukemia
594703|NCT00661999|anemia|anemia
594704|NCT00661999|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
594705|NCT00661999|acute undifferentiated leukemia|acute undifferentiated leukemia
594706|NCT00661999|mast cell leukemia|mast cell leukemia
594707|NCT00661999|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
594708|NCT00661999|untreated hairy cell leukemia|untreated hairy cell leukemia
594709|NCT00661973|asthma|asthma
594710|NCT00661973|airway smooth muscle|airway smooth muscle
594711|NCT00661973|inhaled corticosteroids|inhaled corticosteroids
594712|NCT00661960|HIV Positive|hiv positive
594713|NCT00661960|AIDS|aids
594714|NCT00661960|Antiretroviral Therapy|antiretroviral therapy
594715|NCT00661960|Gastrointestinal-Associated Lymphoid Tissue|gastrointestinal-associated lymphoid tissue
594716|NCT00661960|Immune Reconstitution|immune reconstitution
594717|NCT00661960|treatment experienced|treatment experienced
594718|NCT00661947|fructose|fructose
594719|NCT00661947|sucrose|sucrose
594720|NCT00661947|high fructose corn syrup|high fructose corn syrup
594721|NCT00661947|serum uric acid|serum uric acid
594722|NCT00661947|lactate|lactate
594723|NCT00661947|glucose|glucose
594724|NCT00661947|triglycerides|triglycerides
594725|NCT00661947|Bioavailability of fructose from two formulations|bioavailability of fructose from two formulations
594726|NCT00661934|Subject undergoing Dialysis and Subject suffering from Cardiac Malfunction|subject undergoing dialysis and subject suffering from cardiac malfunction
594727|NCT00661921|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
594728|NCT00661921|AMG 108|amg 108
594729|NCT00661921|HbA1C|hba1c
594730|NCT00661921|glucose|glucose
594731|NCT00661921|metformin|metformin
594732|NCT00661921|sulfonylurea|sulfonylurea
594733|NCT00661921|IL-1 Inhibitor|il-1 inhibitor
594734|NCT00661921|biologic|biologic
594735|NCT00661921|subcutaneous injection|subcutaneous injection
594736|NCT00661895|African American|african american
594737|NCT00661882|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
594738|NCT00661882|recurrent pancreatic cancer|recurrent pancreatic cancer
594739|NCT00661882|stage I pancreatic cancer|stage i pancreatic cancer
594740|NCT00661882|stage II pancreatic cancer|stage ii pancreatic cancer
594741|NCT00661882|stage III pancreatic cancer|stage iii pancreatic cancer
594742|NCT00661856|Soy Isoflavones, Bone Mineral Density, Post menopausal women|soy isoflavones, bone mineral density, post menopausal women
594743|NCT00661843|insomnia|insomnia
594744|NCT00661843|geriatric|geriatric
594745|NCT00661843|yoga|yoga
594746|NCT00661843|sleep|sleep
594747|NCT00661843|electrocardiogram|electrocardiogram
594748|NCT00661830|advanced|advanced
594749|NCT00661830|metastatic|metastatic
594750|NCT00661830|biliary|biliary
594751|NCT00661830|tract|tract
594752|NCT00661817|Exercise|exercise
594753|NCT00661817|Physical Fitness|physical fitness
594754|NCT00661817|Patient Compliance|patient compliance
594755|NCT00661817|Health Behavior|health behavior
594756|NCT00661791|preterm infants|preterm infants
594757|NCT00661791|massage|massage
594758|NCT00661791|physical activity|physical activity
594759|NCT00661791|weight gain|weight gain
594760|NCT00661791|length of hospital stay|length of hospital stay
594761|NCT00661791|NICU|nicu
594762|NCT00661765|varenicline bioavailability transdermal smoking cessation|varenicline bioavailability transdermal smoking cessation
594763|NCT00661739|palliative|palliative
594764|NCT00661739|Breast cancer|breast cancer
594765|NCT00661739|metastatic|metastatic
594766|NCT00661739|Bendamustine|bendamustine
594767|NCT00661739|phase I|phase i
594768|NCT00661726|Thalassemia Intermedia|thalassemia intermedia
594769|NCT00661713|Meningococcal disease|meningococcal disease
594770|NCT00661713|Neisseria meningitidis serogroup B|neisseria meningitidis serogroup b
594771|NCT00661713|prevention|prevention
594772|NCT00661713|vaccination|vaccination
594773|NCT00661713|adolescents|adolescents
594774|NCT00661700|Erectile Dysfunction|erectile dysfunction
594775|NCT00661700|Quality of Life|quality of life
594776|NCT00661674|Palonosetron|palonosetron
594777|NCT00661674|Hydroxyzine|hydroxyzine
594778|NCT00661674|Acute opioid withdrawal|acute opioid withdrawal
594779|NCT00661661|Long term open label study in Japan|long term open label study in japan
594780|NCT00661661|CP-690|cp-690
594781|NCT00661661|550|550
594782|NCT00661661|tofacitinib|tofacitinib
594783|NCT00661648|surgery|surgery
594784|NCT00661635|Laparoscopic Cholecystectomy Surgery, Acute Pain, Perioperative Pain|laparoscopic cholecystectomy surgery, acute pain, perioperative pain
594785|NCT00661609|Anti-mitotic|anti-mitotic
594786|NCT00661609|Eg5 Inhibitor|eg5 inhibitor
594787|NCT00661609|Kinesin Spindle Protein Inhibitor|kinesin spindle protein inhibitor
594788|NCT00661609|Urothelial Cancer|urothelial cancer
594789|NCT00661609|Bladder Cancer|bladder cancer
594790|NCT00661609|Renal Pelvis Cancer|renal pelvis cancer
594791|NCT00661609|Urethra Cancer|urethra cancer
594792|NCT00661609|Ureter Cancer|ureter cancer
594793|NCT00661609|Recurrent|recurrent
594794|NCT00661609|Advanced|advanced
594795|NCT00661609|Stage IV|stage iv
594796|NCT00661596|Erectile Dysfunction|erectile dysfunction
594797|NCT00661596|Vardenafil|vardenafil
594798|NCT00661583|trabeculectomy|trabeculectomy
594799|NCT00661583|glaucoma|glaucoma
594800|NCT00661583|ranibizumab|ranibizumab
594801|NCT00661570|laryngectomy|laryngectomy
594802|NCT00661570|larynx cancer|larynx cancer
594803|NCT00661557|Booster vaccination|booster vaccination
594804|NCT00661557|Meningococcal vaccine|meningococcal vaccine
594805|NCT00661557|Meningococcal disease|meningococcal disease
594806|NCT00661557|Safety|safety
594807|NCT00661557|immunogenicity|immunogenicity
594808|NCT00661544|Multiple Myeloma|multiple myeloma
594809|NCT00661544|Ascorbic Acid|ascorbic acid
594810|NCT00661544|Vitamin C|vitamin c
594811|NCT00661544|Arsenic Trioxide|arsenic trioxide
594812|NCT00661544|Trisenox|trisenox
594813|NCT00661544|Melphalan|melphalan
594814|NCT00661544|Autologous Stem Cell Transplant|autologous stem cell transplant
594815|NCT00661544|Stem Cell Transplantation|stem cell transplantation
594816|NCT00661531|Breast cancer|breast cancer
594817|NCT00661531|Metastatic breast cancer|metastatic breast cancer
594818|NCT00661531|ER positive breast cancer|er positive breast cancer
594819|NCT00661531|Hormonal therapy|hormonal therapy
594820|NCT00661492|Androgen-independent prostate cancer(AIPC)|androgen-independent prostate cancer(aipc)
594821|NCT00661466|Gastrointestinal surgery|gastrointestinal surgery
594822|NCT00661466|Post operative pain|post operative pain
594823|NCT00661453|Spinal Muscular Atrophy|spinal muscular atrophy
594824|NCT00661453|SMA|sma
594825|NCT00661453|Valproic Acid|valproic acid
594826|NCT00661427|Head and Neck cancer|head and neck cancer
594827|NCT00661427|Cetuximab|cetuximab
594828|NCT00661414|Cancer|cancer
594829|NCT00661414|Solid tumors|solid tumors
594830|NCT00661401|gammaglobulin|gammaglobulin
594831|NCT00661401|subcutaneous infusion|subcutaneous infusion
594832|NCT00661401|specific antibodies|specific antibodies
594833|NCT00661401|primary antibody deficiency|primary antibody deficiency
594834|NCT00661375|BAY 43-9006|bay 43-9006
594835|NCT00661375|Phase II|phase ii
594836|NCT00661375|Renal cell carcinoma|renal cell carcinoma
594837|NCT00661375|Response rate|response rate
594838|NCT00661362|DPP-4 inhibitors|dpp-4 inhibitors
594839|NCT00661362|HbA1c|hba1c
594840|NCT00661362|Incretins|incretins
594841|NCT00661349|Kaletra|kaletra
594842|NCT00661349|Nevirapina|nevirapina
594843|NCT00661349|HCV chronic infection|hcv chronic infection
594844|NCT00661349|Fibroscan|fibroscan
594845|NCT00661349|hepatic fibrosis|hepatic fibrosis
594846|NCT00661349|treatment experienced|treatment experienced
594847|NCT00661336|stage III melanoma|stage iii melanoma
594848|NCT00661336|recurrent melanoma|recurrent melanoma
594849|NCT00661310|re-admissions|re-admissions
594851|NCT00661310|management|management
594852|NCT00661310|patients|patients
594853|NCT00661310|80 years and older|80 years and older
594854|NCT00661310|acute|acute
594855|NCT00661310|admissions|admissions
594856|NCT00661310|hospital|hospital
594857|NCT00661297|Erectile Dysfunction|erectile dysfunction
594858|NCT00661297|Vardenafil|vardenafil
594859|NCT00661271|mindfulness|mindfulness
594860|NCT00661271|meditation|meditation
594861|NCT00661271|urban youth|urban youth
594862|NCT00661271|stress reduction|stress reduction
594863|NCT00661271|adolescent|adolescent
594864|NCT00661271|Stress reduction for urban youth|stress reduction for urban youth
594865|NCT00661258|HIV antiretroviral treatment adherence intervention China|hiv antiretroviral treatment adherence intervention china
594866|NCT00661258|adherence to antiretroviral treatment|adherence to antiretroviral treatment
594867|NCT00661258|treatment experienced|treatment experienced
594868|NCT00661232|Myocardial Viability|myocardial viability
594869|NCT00661232|Delayed Enhancement Magnetic Resonance Imaging|delayed enhancement magnetic resonance imaging
594870|NCT00661232|Functional Recovery|functional recovery
594871|NCT00661206|Clopidogrel|clopidogrel
594872|NCT00661206|Drug-eluting stent|drug-eluting stent
594873|NCT00661193|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
594874|NCT00661193|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
594875|NCT00661193|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
594876|NCT00661193|adenocarcinoma of the lung|adenocarcinoma of the lung
594877|NCT00661193|large cell lung cancer|large cell lung cancer
594878|NCT00661193|squamous cell lung cancer|squamous cell lung cancer
594879|NCT00661141|acetaldehyde|acetaldehyde
594880|NCT00661141|ethanol|ethanol
594881|NCT00661141|ALDH2|aldh2
594882|NCT00661128|Sudden Cardiac Arrest|sudden cardiac arrest
594883|NCT00661115|Erectile dysfunction|erectile dysfunction
594884|NCT00661115|Sexual Dysfunction|sexual dysfunction
594885|NCT00661089|stroke|stroke
594886|NCT00661089|shoulder pain|shoulder pain
594887|NCT00661089|spasticity|spasticity
594888|NCT00661063|neuropathic pain|neuropathic pain
594889|NCT00661063|ketamine|ketamine
594890|NCT00661063|clonidine|clonidine
594891|NCT00661063|association|association
594892|NCT00661024|thyroid surgery|thyroid surgery
594893|NCT00661024|recurrent laryngeal nerves visualization|recurrent laryngeal nerves visualization
594894|NCT00661024|intraoperative neuromonitoring|intraoperative neuromonitoring
594895|NCT00661024|predictive values|predictive values
594896|NCT00661011|Non-small cell lung carcinoma|non-small cell lung carcinoma
594897|NCT00661011|Concomitant radiochemotherapy|concomitant radiochemotherapy
594898|NCT00661011|Cisplatin|cisplatin
594899|NCT00661011|Vinorelbine|vinorelbine
594900|NCT00661011|Radiotherapy|radiotherapy
594901|NCT00661011|Chemotherapy|chemotherapy
594902|NCT00661011|Unresectable stage III non-small cell lung carcinoma|unresectable stage iii non-small cell lung carcinoma
594903|NCT00661011|Surgery|surgery
594904|NCT00661011|Unresectable stage III non-small cell lung carcinoma not suitable for radical radiotherapy after objective response to induction chemotherapy|unresectable stage iii non-small cell lung carcinoma not suitable for radical radiotherapy after objective response to induction chemotherapy
594905|NCT00660998|Erectile dysfunction|erectile dysfunction
594906|NCT00660998|Diabetes mellitus type 1|diabetes mellitus type 1
594907|NCT00660998|Vardenafil|vardenafil
594908|NCT00660985|Acne vulgaris|acne vulgaris
594909|NCT00660985|Differin|differin
594910|NCT00660985|Adapalene|adapalene
594911|NCT00660972|HIV Integrase Inhibitors|hiv integrase inhibitors
594912|NCT00660972|HIV Nucleoside Reverse Transcriptase Inhibitors|hiv nucleoside reverse transcriptase inhibitors
594913|NCT00660972|Treatment Naive|treatment naive
594914|NCT00660972|Viral Load|viral load
594915|NCT00660959|Euvolemic|euvolemic
594916|NCT00660959|Hyponatremia|hyponatremia
594917|NCT00660959|Serum Sodium|serum sodium
594918|NCT00660959|Fluid Overload|fluid overload
594919|NCT00660959|Vasopressin Antagonist|vasopressin antagonist
594920|NCT00660946|anticoagulation in dialysis patients|anticoagulation in dialysis patients
594921|NCT00660946|chronic anticoagulation|chronic anticoagulation
594922|NCT00660946|warfarin|warfarin
594923|NCT00660946|hemodialysis|hemodialysis
594924|NCT00660946|INR|inr
594925|NCT00660946|Point of Care|point of care
594926|NCT00660933|postpartum anemia|postpartum anemia
594927|NCT00660933|intravenous iron|intravenous iron
594928|NCT00660907|Dapagliflozin|dapagliflozin
594929|NCT00660907|efficacy|efficacy
594930|NCT00660907|safety|safety
594931|NCT00660907|metformin|metformin
594932|NCT00660907|Type 2 diabetes|type 2 diabetes
594933|NCT00660894|adenocarcinoma of the colon|adenocarcinoma of the colon
594934|NCT00660894|stage III colon cancer|stage iii colon cancer
594935|NCT00660881|Lupus|lupus
594936|NCT00660881|Monoclonal antibody|monoclonal antibody
594937|NCT00660881|B-Cell immunotherapy|b-cell immunotherapy
594938|NCT00660868|smell|smell
594939|NCT00660868|olfaction|olfaction
594940|NCT00660868|olfactory sensitivity|olfactory sensitivity
594941|NCT00660868|smell loss|smell loss
594942|NCT00660868|chemoreception|chemoreception
594943|NCT00660855|laparoscopy|laparoscopy
594944|NCT00660842|quality of life|quality of life
594945|NCT00660842|weekly therapy|weekly therapy
594946|NCT00660842|neurotoxicity|neurotoxicity
594947|NCT00660816|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
594948|NCT00660816|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
594949|NCT00660816|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
594950|NCT00660803|Advanced Breast Cancer|advanced breast cancer
594951|NCT00660803|Hormone Therapy|hormone therapy
594952|NCT00660790|diabetes mellitus type II, therapy non-responders|diabetes mellitus type ii, therapy non-responders
594953|NCT00660777|oropharyngeal exercises|oropharyngeal exercises
594954|NCT00660777|obstructive sleep apnea|obstructive sleep apnea
594955|NCT00660777|speech therapy|speech therapy
594956|NCT00660764|cholesterol|cholesterol
594957|NCT00660764|coronary heart disease|coronary heart disease
594958|NCT00660764|rosuvastatin|rosuvastatin
594959|NCT00660764|LDL-C goal|ldl-c goal
594960|NCT00660764|hypercholesterolemia|hypercholesterolemia
594961|NCT00660764|secondary prevention|secondary prevention
594962|NCT00660764|primary prevention|primary prevention
594963|NCT00660764|CVA|cva
594964|NCT00660751|Physiology of Serotonergic and Adrenergic systems|physiology of serotonergic and adrenergic systems
594965|NCT00660738|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
594966|NCT00660738|walking|walking
594967|NCT00660738|exercise test|exercise test
594968|NCT00660738|quality of life|quality of life
594969|NCT00660738|dyspnea|dyspnea
594970|NCT00660738|desaturation|desaturation
594971|NCT00660725|Gemcitabine|gemcitabine
594972|NCT00660725|Oxaliplatin|oxaliplatin
594973|NCT00660725|Vandetanib|vandetanib
594974|NCT00660725|Phase I|phase i
594975|NCT00660712|Bipolar disorder|bipolar disorder
594976|NCT00660712|patient characteristics|patient characteristics
594977|NCT00660712|treatment characteristics|treatment characteristics
594978|NCT00660699|Cholangiocarcinoma|cholangiocarcinoma
594979|NCT00660699|Gallbladder|gallbladder
594980|NCT00660699|Pancreatic|pancreatic
594981|NCT00660699|Ampullary|ampullary
594982|NCT00660699|Cancer|cancer
594983|NCT00660686|randomized clinical trial|randomized clinical trial
594984|NCT00660686|elderly|elderly
594985|NCT00660686|cancer survivor|cancer survivor
594986|NCT00660686|bone health|bone health
594987|NCT00660686|body composition|body composition
594988|NCT00660686|signs and symptoms|signs and symptoms
594989|NCT00660686|Androgen Deprivation Therapy|androgen deprivation therapy
594990|NCT00660673|levodopa/carbidopa intestinal gel|levodopa/carbidopa intestinal gel
594991|NCT00660673|Severe Motor Fluctuations|severe motor fluctuations
594992|NCT00660673|Levodopa|levodopa
594993|NCT00660673|Carbidopa|carbidopa
594994|NCT00660673|Parkinson's Disease|parkinson's disease
594995|NCT00660673|Dyskinesia|dyskinesia
594996|NCT00660660|GERD|gerd
594997|NCT00660660|Esophageal Reflux|esophageal reflux
594998|NCT00660660|Gastro-Esophageal Reflux|gastro-esophageal reflux
594999|NCT00660660|Regurgitation|regurgitation
595000|NCT00660660|Gastric|gastric
595001|NCT00660647|Rheumatoid arthritis, adalimumab, efficacy, adverse events|rheumatoid arthritis, adalimumab, efficacy, adverse events
595002|NCT00660634|Peripheral arterial obstructive disease|peripheral arterial obstructive disease
595003|NCT00660634|Intermittent Claudication|intermittent claudication
595004|NCT00660634|Endovascular treatment|endovascular treatment
595005|NCT00660634|Flow-mediated dilation|flow-mediated dilation
595006|NCT00660621|High Grade|high grade
595007|NCT00660621|Malignant|malignant
595008|NCT00660621|GBM|gbm
595009|NCT00660608|Transfusion regulation|transfusion regulation
595010|NCT00660595|Schizophrenia|schizophrenia
595011|NCT00660595|Schizoaffective psychosis|schizoaffective psychosis
595012|NCT00660595|Schizophreniformic psychosis|schizophreniformic psychosis
595013|NCT00660595|Pilot study|pilot study
595014|NCT00660595|Quetiapine Prolong|quetiapine prolong
595016|NCT00660582|Erbitux|erbitux
595017|NCT00660582|Colorectal cancer|colorectal cancer
595018|NCT00660582|Oxaliplatin|oxaliplatin
595019|NCT00660582|Flox|flox
595020|NCT00660582|Fluorouracil + folinic acid|fluorouracil + folinic acid
595021|NCT00660582|K-RAS|k-ras
595022|NCT00660569|asthma treatment|asthma treatment
595023|NCT00660569|utilization|utilization
595024|NCT00660569|real life practice|real life practice
595025|NCT00660530|stage 5|stage 5
595026|NCT00660530|chronic|chronic
595027|NCT00660530|hemodialysis|hemodialysis
595028|NCT00660504|Extensive Disease-Small Cell Lung Cancer|extensive disease-small cell lung cancer
595029|NCT00660491|flow mediated dilatation|flow mediated dilatation
595030|NCT00660491|maximal oxygen uptake|maximal oxygen uptake
595031|NCT00660491|blood lipid|blood lipid
595032|NCT00660465|Regional BOLD signal dependency on arterial PaCO2.|regional bold signal dependency on arterial paco2.
595033|NCT00660465|Effect of breathing exercises on brain regional O2 level.|effect of breathing exercises on brain regional o2 level.
595034|NCT00660465|Healthy subjects|healthy subjects
595035|NCT00660452|Allergy|allergy
595036|NCT00660452|SLIT|slit
595037|NCT00660452|Asthma|asthma
595038|NCT00660452|House Dust Mites|house dust mites
595039|NCT00660439|PTSD|ptsd
595040|NCT00660426|cancer|cancer
595041|NCT00660426|gastrointestinal|gastrointestinal
595042|NCT00660426|tumor|tumor
595043|NCT00660413|Acceleromyography|acceleromyography
595044|NCT00660413|Mechanomyography|mechanomyography
595045|NCT00660413|Neuromuscular block|neuromuscular block
595046|NCT00660413|Neuromuscular monitoring|neuromuscular monitoring
595047|NCT00660413|Dose-response|dose-response
595048|NCT00660413|Potency|potency
595049|NCT00660413|Rocuronium|rocuronium
595050|NCT00660400|Myeloid|myeloid
595051|NCT00660400|Monocytic|monocytic
595052|NCT00660387|levodopa-carbidopa|levodopa-carbidopa
595053|NCT00660387|Carbidopa|carbidopa
595054|NCT00660387|levodopa|levodopa
595055|NCT00660387|dyskinesia|dyskinesia
595056|NCT00660387|Duodopa|duodopa
595057|NCT00660387|levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
595058|NCT00660387|Severe Motor Fluctuations|severe motor fluctuations
595059|NCT00660387|levodopa/carbidopa suspension|levodopa/carbidopa suspension
595060|NCT00660387|DUOPA|duopa
595061|NCT00660361|HIV|hiv
595062|NCT00660361|HBV|hbv
595063|NCT00660361|co-infection|co-infection
595064|NCT00660361|drug resistance|drug resistance
595065|NCT00660361|tenofovir|tenofovir
595066|NCT00660361|HIV-HBV co-infection|hiv-hbv co-infection
595067|NCT00660348|recurrent pancreatic cancer|recurrent pancreatic cancer
595068|NCT00660348|stage III pancreatic cancer|stage iii pancreatic cancer
595069|NCT00660348|stage IV pancreatic cancer|stage iv pancreatic cancer
595070|NCT00660348|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
595071|NCT00660348|pain|pain
595072|NCT00660348|stage II pancreatic cancer|stage ii pancreatic cancer
595073|NCT00660335|secretin, RG1068, MRCP, pancreas|secretin, rg1068, mrcp, pancreas
595074|NCT00660322|Asthma|asthma
595075|NCT00660322|Telemedicine|telemedicine
595076|NCT00660322|Randomized controlled trial|randomized controlled trial
595077|NCT00660309|Type 2 diabetes mellitus|type 2 diabetes mellitus
595078|NCT00660309|renal disease|renal disease
595079|NCT00660309|hypertension|hypertension
595080|NCT00660309|renal blood flow|renal blood flow
595081|NCT00660309|retinal blood flow|retinal blood flow
595082|NCT00660309|aliskiren|aliskiren
595083|NCT00660309|irbesartan|irbesartan
595084|NCT00660309|captopril|captopril
595085|NCT00660296|CO2|co2
595086|NCT00660296|pain|pain
595087|NCT00660296|colonoscopy|colonoscopy
595088|NCT00660296|cancer|cancer
595089|NCT00660296|screening|screening
595090|NCT00660283|GBM|gbm
595091|NCT00660283|Newly|newly
595092|NCT00660283|diagnosed|diagnosed
595093|NCT00660283|malignant|malignant
595094|NCT00660283|high grade|high grade
595095|NCT00660270|Chemotherapy|chemotherapy
595096|NCT00660270|Radiation|radiation
595097|NCT00660244|Arimidex|arimidex
595098|NCT00660244|Post menopausal|post menopausal
595099|NCT00660244|arthralgia|arthralgia
595100|NCT00660231|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
595101|NCT00660231|stage IB mycosis fungoides/Sezary syndrome|stage ib mycosis fungoides/sezary syndrome
595102|NCT00660231|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
595103|NCT00660231|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
595104|NCT00660231|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
595105|NCT00660231|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
595106|NCT00660231|stage IB cutaneous T-cell non-Hodgkin lymphoma|stage ib cutaneous t-cell non-hodgkin lymphoma
595107|NCT00660231|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
595108|NCT00660231|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
595109|NCT00660231|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
595110|NCT00660218|Stage III and IV head and neck cancer|stage iii and iv head and neck cancer
595112|NCT00660205|PE|pe
595113|NCT00660205|D-dimer|d-dimer
595114|NCT00660205|cancer|cancer
595115|NCT00660205|VTE|vte
595116|NCT00660192|Migraine, refractory migraine, Pain, Botulinum Toxin , Botox|migraine, refractory migraine, pain, botulinum toxin , botox
595117|NCT00660179|pulmonary arterial hypertension SERAPHIN|pulmonary arterial hypertension seraphin
595118|NCT00660166|Natural killer cells|natural killer cells
595119|NCT00660166|autologous stem cell transplant|autologous stem cell transplant
595120|NCT00660166|immunotherapy|immunotherapy
595121|NCT00660153|Advanced Colorectal Cancer and Other Gastrointestinal Cancers|advanced colorectal cancer and other gastrointestinal cancers
595122|NCT00660153|tivozanib|tivozanib
595123|NCT00660153|AV-951|av-951
595124|NCT00660140|Cholangiocarcinoma|cholangiocarcinoma
595125|NCT00660140|Gallbladder|gallbladder
595126|NCT00660140|Cancer|cancer
595127|NCT00660114|Cough variant asthma|cough variant asthma
595128|NCT00660114|Pulmicort® Respules®|pulmicort® respules®
595129|NCT00660114|Chinese patient Eligibility|chinese patient eligibility
595130|NCT00660101|ovarian cancer|ovarian cancer
595131|NCT00660101|vaccine|vaccine
595132|NCT00660101|immunotherapy|immunotherapy
595133|NCT00660101|autologous|autologous
595134|NCT00660075|Diabetes mellitus|diabetes mellitus
595135|NCT00660075|Postprandial|postprandial
595136|NCT00660075|Hyperlipidemia|hyperlipidemia
595137|NCT00660075|Atherosclerosis|atherosclerosis
595138|NCT00660062|Major depression|major depression
595139|NCT00660062|relapse prevention|relapse prevention
595140|NCT00660062|ECT|ect
595141|NCT00660062|escitalopram|escitalopram
595142|NCT00660062|nortriptyline|nortriptyline
595143|NCT00660036|Acute myeloid leukemia|acute myeloid leukemia
595144|NCT00660036|Refractory|refractory
595145|NCT00660036|Relapsed|relapsed
595146|NCT00660036|Second line|second line
595147|NCT00660036|Gemtuzumab ozogamicin|gemtuzumab ozogamicin
595148|NCT00660036|Mitoxantrone|mitoxantrone
595149|NCT00660036|Etoposide|etoposide
595150|NCT00660036|Phase I|phase i
595151|NCT00660036|Phase II|phase ii
595152|NCT00660010|CPP|cpp
595153|NCT00660010|central precocious puberty|central precocious puberty
595154|NCT00660010|pediatrics|pediatrics
595155|NCT00660010|suppression of LH|suppression of lh
595156|NCT00660010|Lupron|lupron
595157|NCT00660010|leuprolide acetate|leuprolide acetate
595158|NCT00660010|depot formulation|depot formulation
595159|NCT00660010|GnRHa|gnrha
595160|NCT00660010|GnRH agonist|gnrh agonist
595161|NCT00660010|GNRH analog|gnrh analog
595162|NCT00660010|LH|lh
595163|NCT00660010|Tanner staging|tanner staging
595164|NCT00659997|Ascariasis|ascariasis
595165|NCT00659997|Trichuriasis|trichuriasis
595166|NCT00659997|Drug resistance|drug resistance
595167|NCT00659984|recurrent neuroblastoma|recurrent neuroblastoma
595168|NCT00659971|oral candidiasis|oral candidiasis
595169|NCT00659958|zonisamide|zonisamide
595170|NCT00659958|partial onset seizures|partial onset seizures
595171|NCT00659958|effectiveness|effectiveness
595172|NCT00659958|tolerability|tolerability
595173|NCT00659945|Postoperation, nausea, vomiting, anesthesia, plastic surgery|postoperation, nausea, vomiting, anesthesia, plastic surgery
595174|NCT00659932|diabetes|diabetes
595175|NCT00659932|cognitive behavioural therapy|cognitive behavioural therapy
595176|NCT00659906|randomized clinical trial|randomized clinical trial
595177|NCT00659906|cancer survivor|cancer survivor
595178|NCT00659906|bone health|bone health
595179|NCT00659906|body composition|body composition
595180|NCT00659906|signs and symptoms|signs and symptoms
595181|NCT00659893|Peplin|peplin
595182|NCT00659893|PEP005|pep005
595183|NCT00659893|Actinic Keratosis|actinic keratosis
595184|NCT00659880|Meniscus transplant|meniscus transplant
595185|NCT00659880|Meniscal allograft|meniscal allograft
595186|NCT00659880|MAT|mat
595187|NCT00659880|Knee|knee
595188|NCT00659867|Ulcerative Colitis|ulcerative colitis
595189|NCT00659867|Endomicroscopy|endomicroscopy
595190|NCT00659867|Chromoendoscopy|chromoendoscopy
595191|NCT00659867|Confocal colonoscope|confocal colonoscope
595192|NCT00659867|Surveillance colonoscopy|surveillance colonoscopy
595193|NCT00659854|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
595194|NCT00659854|The study examines the response of infants diagnosed with obstructive sleep apnea syndrome to diet changes|the study examines the response of infants diagnosed with obstructive sleep apnea syndrome to diet changes
595195|NCT00659841|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
595196|NCT00659841|Ciclesonide|ciclesonide
595197|NCT00659841|Hay Fever|hay fever
595198|NCT00659841|SAR|sar
595199|NCT00659828|Congenital leptin deficiency|congenital leptin deficiency
595200|NCT00659828|Obesity|obesity
595201|NCT00659828|Metabolic Syndrome|metabolic syndrome
595202|NCT00659828|Diabetes|diabetes
595203|NCT00659776|ferumoxytol|ferumoxytol
595204|NCT00659763|IBS|ibs
595205|NCT00659763|Diagnosis|diagnosis
595206|NCT00659750|Perennial Allergic Rhinitis|perennial allergic rhinitis
595207|NCT00659750|Ciclesonide|ciclesonide
595208|NCT00659750|PAR|par
595209|NCT00659737|Post-operative Nausea and Vomiting (PONV)|post-operative nausea and vomiting (ponv)
595210|NCT00659724|Dialyzer|dialyzer
595211|NCT00659698|surgical|surgical
595212|NCT00659698|site|site
595213|NCT00659698|infection|infection
595214|NCT00659685|Bioequivalence|bioequivalence
595215|NCT00659685|Ondansetron ODT|ondansetron odt
595216|NCT00659685|Fasting|fasting
595217|NCT00659685|To Determine Bioequivalence Under Fasting conditions|to determine bioequivalence under fasting conditions
595218|NCT00659672|hypertension|hypertension
595219|NCT00659672|prehypertension|prehypertension
595220|NCT00659672|high blood pressure|high blood pressure
595221|NCT00659672|blood pressure|blood pressure
595222|NCT00659672|heart disease|heart disease
595223|NCT00659646|Diabetes|diabetes
595224|NCT00659646|ulcers|ulcers
595225|NCT00659646|ulcerations|ulcerations
595226|NCT00659646|infection|infection
595227|NCT00659633|lidocaine|lidocaine
595228|NCT00659633|allodynia|allodynia
595229|NCT00659633|chronic regional pain syndrome|chronic regional pain syndrome
595230|NCT00659633|pain|pain
595231|NCT00659620|Kidney Transplant|kidney transplant
595232|NCT00659620|Chronic Allograft Nephropathy|chronic allograft nephropathy
595233|NCT00659620|Mesenchymal Stem Cell infusion|mesenchymal stem cell infusion
595234|NCT00659594|Seasonal Allergic rhinitis|seasonal allergic rhinitis
595235|NCT00659594|Ciclesonide|ciclesonide
595236|NCT00659594|Hay Fever|hay fever
595237|NCT00659594|SAR|sar
595238|NCT00659568|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
595239|NCT00659568|stage III renal cell cancer|stage iii renal cell cancer
595240|NCT00659568|stage IV renal cell cancer|stage iv renal cell cancer
595241|NCT00659568|recurrent renal cell cancer|recurrent renal cell cancer
595242|NCT00659568|recurrent endometrial carcinoma|recurrent endometrial carcinoma
595243|NCT00659568|stage III endometrial carcinoma|stage iii endometrial carcinoma
595244|NCT00659568|stage IV endometrial carcinoma|stage iv endometrial carcinoma
595245|NCT00659568|recurrent breast cancer|recurrent breast cancer
595246|NCT00659568|stage IIIA breast cancer|stage iiia breast cancer
595247|NCT00659568|stage IIIB breast cancer|stage iiib breast cancer
595248|NCT00659568|stage IIIC breast cancer|stage iiic breast cancer
595249|NCT00659568|stage IV breast cancer|stage iv breast cancer
595250|NCT00659568|recurrent small cell lung cancer|recurrent small cell lung cancer
595251|NCT00659568|extensive stage small cell lung cancer|extensive stage small cell lung cancer
595252|NCT00659568|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
595253|NCT00659568|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
595254|NCT00659568|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
595255|NCT00659568|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
595256|NCT00659568|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
595257|NCT00659568|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
595258|NCT00659568|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
595259|NCT00659568|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
595260|NCT00659568|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
595261|NCT00659568|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
595262|NCT00659568|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
595263|NCT00659568|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
595264|NCT00659568|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
595265|NCT00659568|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
595266|NCT00659568|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
595267|NCT00659568|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
595268|NCT00659568|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
595269|NCT00659568|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
595270|NCT00659568|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
595271|NCT00659568|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
595272|NCT00659568|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
595273|NCT00659568|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
595274|NCT00659568|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
595275|NCT00659568|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
595276|NCT00659568|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
595277|NCT00659568|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
595278|NCT00659568|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
595279|NCT00659568|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
595280|NCT00659568|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
595281|NCT00659568|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
595282|NCT00659568|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
595283|NCT00659568|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
595284|NCT00659568|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
595285|NCT00659568|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
595286|NCT00659568|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
595287|NCT00659568|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
595288|NCT00659568|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
595289|NCT00659568|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
595290|NCT00659568|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
595291|NCT00659568|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
595292|NCT00659568|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
595293|NCT00659568|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
595294|NCT00659568|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
595295|NCT00659568|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
595296|NCT00659568|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
595297|NCT00659568|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
595298|NCT00659568|anaplastic large cell lymphoma|anaplastic large cell lymphoma
595299|NCT00659568|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
595300|NCT00659568|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
595301|NCT00659568|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
595302|NCT00659568|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
595303|NCT00659568|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
595304|NCT00659568|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
595305|NCT00659568|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
595306|NCT00659568|splenic marginal zone lymphoma|splenic marginal zone lymphoma
595307|NCT00659568|Waldenström macroglobulinemia|waldenström macroglobulinemia
595308|NCT00659555|vascular endothelial growth factor,|vascular endothelial growth factor,
595309|NCT00659555|drug interaction,|drug interaction,
595310|NCT00659555|pharmacokinetics,|pharmacokinetics,
595311|NCT00659555|age-related macular degeneration,|age-related macular degeneration,
595312|NCT00659555|pazopanib,|pazopanib,
595313|NCT00659555|angiogenesis,|angiogenesis,
595314|NCT00659555|ketoconazole|ketoconazole
595315|NCT00659542|inguinal hernia|inguinal hernia
595316|NCT00659542|inguinal hernioplasty|inguinal hernioplasty
595317|NCT00659542|mesh fixation|mesh fixation
595318|NCT00659542|Lichtenstein hernioplasty|lichtenstein hernioplasty
595319|NCT00659529|cystic fibrosis|cystic fibrosis
595320|NCT00659529|inflammation|inflammation
595321|NCT00659529|pH|ph
595322|NCT00659529|EBC|ebc
595323|NCT00659529|sputum biomarkers|sputum biomarkers
595324|NCT00659529|phosphodiesterase inhibitors|phosphodiesterase inhibitors
595325|NCT00659503|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
595326|NCT00659503|Ciclesonide|ciclesonide
595327|NCT00659503|Hay Fever|hay fever
595328|NCT00659503|SAR|sar
595329|NCT00659490|Analgesic effect|analgesic effect
595330|NCT00659490|Molar extraction|molar extraction
595331|NCT00659464|Infrared Spectroscopy|infrared spectroscopy
595332|NCT00659464|Syncope|syncope
595333|NCT00659464|Tilt Table Testing|tilt table testing
595334|NCT00659451|Hypertension|hypertension
595335|NCT00659451|Diabetes mellitus|diabetes mellitus
595336|NCT00659451|Heart|heart
595337|NCT00659425|Moxetumomab pasudotox|moxetumomab pasudotox
595338|NCT00659412|Psoriatic arthritis|psoriatic arthritis
595339|NCT00659412|psoriasis|psoriasis
595340|NCT00659412|Alefacept|alefacept
595341|NCT00659399|Pretreated Ovarian Carcinoma|pretreated ovarian carcinoma
595342|NCT00659386|Heart failure|heart failure
595343|NCT00659386|Parvovirus B19|parvovirus b19
595344|NCT00659386|Intravenous immuneglobulin|intravenous immuneglobulin
595345|NCT00659373|cognitive/functional effects|cognitive/functional effects
595346|NCT00659373|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
595347|NCT00659373|fatigue|fatigue
595348|NCT00659373|sleep disorders|sleep disorders
595349|NCT00659373|stage IA breast cancer|stage ia breast cancer
595350|NCT00659373|stage IB breast cancer|stage ib breast cancer
595351|NCT00659373|stage II breast cancer|stage ii breast cancer
595352|NCT00659373|stage IIIA breast cancer|stage iiia breast cancer
595353|NCT00659334|Combidex|combidex
595354|NCT00659334|Diagnostic imaging|diagnostic imaging
595355|NCT00659308|pain|pain
595356|NCT00659308|bullous keratopathy|bullous keratopathy
595357|NCT00659308|amniotic membrane|amniotic membrane
595358|NCT00659308|anterior stromal puncture|anterior stromal puncture
595359|NCT00659269|Vitamin B-12|vitamin b-12
595360|NCT00659269|Vitamin B-6|vitamin b-6
595361|NCT00659269|Chemotherapy-Induced Neuropathy|chemotherapy-induced neuropathy
595362|NCT00659269|Taxanes|taxanes
595363|NCT00659269|Vinca alkaloid|vinca alkaloid
595364|NCT00659269|Heavy metals|heavy metals
595365|NCT00659269|Neuropathy|neuropathy
595366|NCT00659269|Nerve pain|nerve pain
595367|NCT00659256|Hepatitis C Virus|hepatitis c virus
595368|NCT00659256|Atherosclerosis|atherosclerosis
595369|NCT00659256|Intima-Media Thickness|intima-media thickness
595370|NCT00659256|Coronary Artery Calcium Score|coronary artery calcium score
595371|NCT00659256|Hepatitis C|hepatitis c
595372|NCT00659243|Replacement therapy|replacement therapy
595373|NCT00659243|Pasteurized breast milk|pasteurized breast milk
595374|NCT00659243|Preterm infants|preterm infants
595375|NCT00659243|BSSL|bssl
595376|NCT00659230|PTSD|ptsd
595377|NCT00659230|Veterans|veterans
595378|NCT00659230|Nepicastat|nepicastat
595379|NCT00659230|OIF/OEF|oif/oef
595380|NCT00659217|Mesenchymal Stem Cells|mesenchymal stem cells
595381|NCT00659217|lupus Nephritis|lupus nephritis
595382|NCT00659191|Healthy volunteer,|healthy volunteer,
595383|NCT00659191|HIV infected subjects|hiv infected subjects
595384|NCT00659178|Doxil,|doxil,
595385|NCT00659178|pegylated liposomal doxorubicin,|pegylated liposomal doxorubicin,
595386|NCT00659178|ovarian cancer|ovarian cancer
595387|NCT00659178|IL-18,|il-18,
595388|NCT00659178|combination study,|combination study,
595389|NCT00659178|immunotherapy,|immunotherapy,
595390|NCT00659178|cytokine,|cytokine,
595391|NCT00659165|diabetes|diabetes
595392|NCT00659165|insulin dependent diabetes|insulin dependent diabetes
595393|NCT00659165|diabetes mellitus|diabetes mellitus
595394|NCT00659165|detemir|detemir
595395|NCT00659165|levemir|levemir
595396|NCT00659165|glargine|glargine
595397|NCT00659165|lantus|lantus
595398|NCT00659165|insulin|insulin
595399|NCT00659165|appetite|appetite
595400|NCT00659165|satiety|satiety
595401|NCT00659165|centrally acting mediators of satiety|centrally acting mediators of satiety
595402|NCT00659165|three factor eating questionnaire|three factor eating questionnaire
595403|NCT00659165|PYY|pyy
595404|NCT00659165|ghrelin|ghrelin
595405|NCT00659165|leptin|leptin
595406|NCT00659152|ALI/ARDS|ali/ards
595407|NCT00659113|stage IIA esophageal cancer|stage iia esophageal cancer
595408|NCT00659113|stage IIB esophageal cancer|stage iib esophageal cancer
595409|NCT00659113|stage IIIA esophageal cancer|stage iiia esophageal cancer
595410|NCT00659113|stage IIIB esophageal cancer|stage iiib esophageal cancer
595411|NCT00659113|stage IIIC esophageal cancer|stage iiic esophageal cancer
595412|NCT00659113|stage IV esophageal cancer|stage iv esophageal cancer
595413|NCT00659087|Total Knee|total knee
595414|NCT00659087|Range of Motion|range of motion
595415|NCT00659087|Pain|pain
595416|NCT00659074|bioequivalence|bioequivalence
595417|NCT00659074|Ondansetron ODT|ondansetron odt
595418|NCT00659074|Fasting|fasting
595419|NCT00659074|To Determine Bioequivalence Under Fasting Conditions|to determine bioequivalence under fasting conditions
595420|NCT00659061|micronutrients|micronutrients
595421|NCT00659048|Perennial Allergic Rhinitis|perennial allergic rhinitis
595422|NCT00659048|Ciclesonide|ciclesonide
595423|NCT00659048|PAR|par
595424|NCT00659035|driving|driving
595425|NCT00659035|opioids|opioids
595426|NCT00659035|impairment|impairment
595427|NCT00659035|ability|ability
595428|NCT00659035|patients|patients
595429|NCT00659035|receiving|receiving
595430|NCT00659035|oral morphine|oral morphine
595431|NCT00659035|severe|severe
595432|NCT00659022|colorectal cancer|colorectal cancer
595433|NCT00659022|liver metastases|liver metastases
595434|NCT00659022|angiogenesis|angiogenesis
595435|NCT00659022|metabolism|metabolism
595436|NCT00659009|environmental|environmental
595437|NCT00659009|hypobaric hypoxia|hypobaric hypoxia
595438|NCT00659009|sleep|sleep
595439|NCT00659009|respiratory-disturbance|respiratory-disturbance
595440|NCT00659009|neurobehavioral performance|neurobehavioral performance
595441|NCT00659009|Effect of altitude on sleep-related respiratory disturbance|effect of altitude on sleep-related respiratory disturbance
595442|NCT00658970|Open label|open label
595443|NCT00658970|Dose escalation|dose escalation
595444|NCT00658957|Diabetes|diabetes
595445|NCT00658957|Foot Ulcer|foot ulcer
595446|NCT00658944|Stress urinary incontinence|stress urinary incontinence
595447|NCT00658944|Mixed urinary incontinence|mixed urinary incontinence
595448|NCT00658944|surgery|surgery
595449|NCT00658944|trans obturator tape|trans obturator tape
595450|NCT00658944|Maximum urethral closure pressure|maximum urethral closure pressure
595451|NCT00658944|Valsalva leak point pressure|valsalva leak point pressure
595452|NCT00658944|outcome|outcome
595453|NCT00658931|Depression|depression
595454|NCT00658931|Bereavement|bereavement
595455|NCT00658931|Pilot Projects|pilot projects
595456|NCT00658931|Antidepressant Drugs|antidepressant drugs
595457|NCT00658918|Perennial Allergic Rhinitis|perennial allergic rhinitis
595458|NCT00658918|Ciclesonide|ciclesonide
595459|NCT00658918|Hay Fever|hay fever
595460|NCT00658918|PAR|par
595461|NCT00658905|Preterm infants|preterm infants
595462|NCT00658905|Replacement therapy|replacement therapy
595463|NCT00658905|Infant formula|infant formula
595464|NCT00658905|BSSL|bssl
595465|NCT00658905|BSSL is present in fresh mother's milk but not in infant formula.|bssl is present in fresh mother's milk but not in infant formula.
595466|NCT00658892|recurrent melanoma|recurrent melanoma
595467|NCT00658892|stage IV melanoma|stage iv melanoma
595468|NCT00658866|ertapenem tissue PK|ertapenem tissue pk
595469|NCT00658853|COPD|copd
595470|NCT00658853|training|training
595471|NCT00658853|VO2peak|vo2peak
595472|NCT00658853|performance|performance
595473|NCT00658853|ventilation|ventilation
595474|NCT00658853|high aerobic intensity treadmill walking|high aerobic intensity treadmill walking
595475|NCT00658853|one leg training by cycling|one leg training by cycling
595476|NCT00658827|Inflammatory Bowel Disease|inflammatory bowel disease
595477|NCT00658827|Rheumatoid Arthritis|rheumatoid arthritis
595478|NCT00658827|Psoriatic Arthritis|psoriatic arthritis
595479|NCT00658827|Ankylosing Spondylitis|ankylosing spondylitis
595480|NCT00658827|Psoriasis|psoriasis
595481|NCT00658827|Pregnant women exposed to infliximab|pregnant women exposed to infliximab
595482|NCT00658775|GERD|gerd
595483|NCT00658775|erosive GERD|erosive gerd
595484|NCT00658775|erosive esophagitis|erosive esophagitis
595485|NCT00658749|AIR645|air645
595486|NCT00658749|Altair Therapeutics|altair therapeutics
595487|NCT00658749|IL4|il4
595488|NCT00658749|IL13|il13
595489|NCT00658749|IL-4|il-4
595490|NCT00658749|IL-13|il-13
595491|NCT00658710|hemiplegia|hemiplegia
595492|NCT00658710|stroke|stroke
595493|NCT00658710|TRIDENT|trident
595494|NCT00658697|Rising PSA|rising psa
595495|NCT00658697|androgen deprivation|androgen deprivation
595496|NCT00658697|bevacizumab (avastin)|bevacizumab (avastin)
595497|NCT00658697|docetaxel|docetaxel
595498|NCT00658697|lupron|lupron
595499|NCT00658697|zoladex|zoladex
595500|NCT00658697|bicalutamide|bicalutamide
595501|NCT00658658|Epidermal Growth Factor|epidermal growth factor
595502|NCT00658658|Pediatric|pediatric
595503|NCT00658658|Solid Tumors|solid tumors
595504|NCT00658658|Panitumumab|panitumumab
595505|NCT00658658|Dose Limiting Toxicity|dose limiting toxicity
595506|NCT00658645|Schizophrenia|schizophrenia
595507|NCT00658645|Antipsychotic|antipsychotic
595508|NCT00658645|Bifeprunox|bifeprunox
595509|NCT00658632|GERD|gerd
595510|NCT00658632|erosive GERD|erosive gerd
595511|NCT00658632|erosive esophagitis|erosive esophagitis
595512|NCT00658606|plaque psoriasis|plaque psoriasis
595513|NCT00658606|alefacept|alefacept
595514|NCT00658606|Amevive|amevive
595515|NCT00658606|narrow band ultraviolet B|narrow band ultraviolet b
595516|NCT00658606|phototherapy|phototherapy
595517|NCT00658593|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
595518|NCT00658593|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
595519|NCT00658593|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
595520|NCT00658593|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
595521|NCT00658593|adenocarcinoma with squamous metaplasia of the gallbladder|adenocarcinoma with squamous metaplasia of the gallbladder
595522|NCT00658593|unresectable gallbladder cancer|unresectable gallbladder cancer
595523|NCT00658593|recurrent gallbladder cancer|recurrent gallbladder cancer
595524|NCT00658593|liver and intrahepatic biliary tract cancer|liver and intrahepatic biliary tract cancer
595525|NCT00658580|Small cell lung carcinoma|small cell lung carcinoma
595526|NCT00658580|Chemotherapy|chemotherapy
595527|NCT00658580|Phase III randomised study|phase iii randomised study
595528|NCT00658528|GERD|gerd
595529|NCT00658528|erosive GERD|erosive gerd
595530|NCT00658528|erosive esophagitis|erosive esophagitis
595531|NCT00658476|Adolescent Depression|adolescent depression
595532|NCT00658476|Depression|depression
595533|NCT00658476|Teenage Depression|teenage depression
595534|NCT00658476|Los Angeles|los angeles
595535|NCT00658463|Diabetes|diabetes
595536|NCT00658463|Triglycerides|triglycerides
595537|NCT00658463|HDL-cholesterol|hdl-cholesterol
595538|NCT00658463|kinetic|kinetic
595539|NCT00658463|rosuvastatin|rosuvastatin
595540|NCT00658450|Malaria, Cerebral|malaria, cerebral
595541|NCT00658437|Melanoma, Stage IV, Phase II|melanoma, stage iv, phase ii
595542|NCT00658411|AML|aml
595543|NCT00658411|ALL|all
595544|NCT00658411|MDS|mds
595545|NCT00658411|iron overload|iron overload
595546|NCT00658411|deferoxamine|deferoxamine
595547|NCT00658398|Alcohol|alcohol
595548|NCT00658398|dependency|dependency
595549|NCT00658385|GCSF|gcsf
595550|NCT00658372|PD 0332334 phase 3 pivotal trial|pd 0332334 phase 3 pivotal trial
595551|NCT00658359|Immunosuppression|immunosuppression
595552|NCT00658359|JAK inhibitor|jak inhibitor
595553|NCT00658359|kidney transplantation|kidney transplantation
595554|NCT00658346|HIV-1 group O|hiv-1 group o
595555|NCT00658346|HIV-1 group M|hiv-1 group m
595556|NCT00658346|Cameroon|cameroon
595557|NCT00658346|HIV-1 infection|hiv-1 infection
595558|NCT00658346|treatment naïve|treatment naïve
595559|NCT00658333|Renal Transplantation|renal transplantation
595560|NCT00658333|Immunosuppression|immunosuppression
595561|NCT00658333|Renal transplant recipients|renal transplant recipients
595562|NCT00658333|Gastrointestinal symptoms associated with MMF therapy|gastrointestinal symptoms associated with mmf therapy
595563|NCT00658320|Renal transplantation|renal transplantation
595564|NCT00658320|everolimus|everolimus
595565|NCT00658320|mycophenolate mofetil|mycophenolate mofetil
595566|NCT00658320|cyclosporine|cyclosporine
595567|NCT00658320|corticosteroid|corticosteroid
595568|NCT00658320|basiliximab|basiliximab
595569|NCT00658320|Banff diagnosis|banff diagnosis
595570|NCT00658320|Acute rejection|acute rejection
595571|NCT00658320|Therapeutic drug monitoring (TDM)|therapeutic drug monitoring (tdm)
595572|NCT00658320|de novo renal transplant recipient|de novo renal transplant recipient
595573|NCT00658307|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
595574|NCT00658307|double-blind|double-blind
595575|NCT00658307|sham-controlled|sham-controlled
595576|NCT00658307|randomized|randomized
595577|NCT00658281|Breast Cancer|breast cancer
595578|NCT00658281|On Board Imager Kilovoltage|on board imager kilovoltage
595579|NCT00658281|Cone Beam Computed Tomography|cone beam computed tomography
595580|NCT00658281|Electronic Portal Imaging Device|electronic portal imaging device
595581|NCT00658281|Lymph Nodes|lymph nodes
595582|NCT00658281|CBCT|cbct
595583|NCT00658281|OBI KV|obi kv
595584|NCT00658268|Surgical procedures operative|surgical procedures operative
595585|NCT00658268|Prosthesis implantation|prosthesis implantation
595586|NCT00658268|Arthroplasty replacement|arthroplasty replacement
595587|NCT00658255|stable asthma|stable asthma
595588|NCT00658255|adults|adults
595589|NCT00658255|formoterol|formoterol
595590|NCT00658255|Symbicort|symbicort
595591|NCT00658255|Oxis Turbuhaler|oxis turbuhaler
595592|NCT00658255|bronchodilation|bronchodilation
595593|NCT00658242|craniofacial|craniofacial
595594|NCT00658242|maxillofacial|maxillofacial
595595|NCT00658242|osteotomy|osteotomy
595596|NCT00658242|craniectomy|craniectomy
595597|NCT00658242|craniotomy|craniotomy
595598|NCT00658229|Exercise|exercise
595599|NCT00658229|Prostatic|prostatic
595600|NCT00658229|Neoplasm|neoplasm
595601|NCT00658229|Androgen|androgen
595602|NCT00658229|Deprivation|deprivation
595603|NCT00658216|Diagnosis and prognosis|diagnosis and prognosis
595604|NCT00658216|Very elderly population|very elderly population
595605|NCT00658216|Heart failure|heart failure
595606|NCT00658216|Brain natriuretic peptide|brain natriuretic peptide
595607|NCT00658216|Observational prospective study|observational prospective study
595608|NCT00658216|Older|older
595609|NCT00658216|Dyspneic patients aged 80|dyspneic patients aged 80
595610|NCT00658203|CRT-P|crt-p
595611|NCT00658203|PEA|pea
595612|NCT00658203|Severe Heart Failure (NYHA Class III or IV)|severe heart failure (nyha class iii or iv)
595613|NCT00658203|Cardiomyopathy of any etiology|cardiomyopathy of any etiology
595614|NCT00658203|Sinus rhythm|sinus rhythm
595615|NCT00658203|Reduced Left-Ventricular Ejection Fraction|reduced left-ventricular ejection fraction
595616|NCT00658203|LVEDD>30 mm/m2|lvedd>30 mm/m2
595617|NCT00658203|QRS Duration: > 150 ms or > 120 ms|qrs duration: > 150 ms or > 120 ms
595618|NCT00658203|Aortic Pre-Ejection Delay > 140 ms|aortic pre-ejection delay > 140 ms
595619|NCT00658203|Interventricular Mechanical Delay > 40 ms|interventricular mechanical delay > 40 ms
595620|NCT00658203|Delayed activation of postero-lateral Left Ventricular wall|delayed activation of postero-lateral left ventricular wall
595621|NCT00658203|Optimal and stable pharmacological treatment|optimal and stable pharmacological treatment
595622|NCT00658190|Cervical cancer, automation, Internet, telecytology|cervical cancer, automation, internet, telecytology
595623|NCT00658177|Erectile dysfunction|erectile dysfunction
595624|NCT00658177|Vardenafil|vardenafil
595625|NCT00658164|Nonalcoholic fatty liver disease associated with increased iron stores|nonalcoholic fatty liver disease associated with increased iron stores
595626|NCT00658151|focus|focus
595627|NCT00658151|study|study
595628|NCT00658151|evaluate|evaluate
595629|NCT00658151|sonographic|sonographic
595630|NCT00658151|findings|findings
595631|NCT00658151|colon|colon
595632|NCT00658151|patients|patients
595633|NCT00658151|developed|developed
595634|NCT00658086|ALN-RSV01|aln-rsv01
595635|NCT00658086|Respiratory Syncytial Virus|respiratory syncytial virus
595636|NCT00658073|Kidney transplant|kidney transplant
595637|NCT00658073|Mesenchymal stem cell (MSC)|mesenchymal stem cell (msc)
595638|NCT00658060|FMF, Exertional leg pain|fmf, exertional leg pain
595639|NCT00658047|Arthritis, Rheumatoid|arthritis, rheumatoid
595640|NCT00658047|Phase II|phase ii
595641|NCT00658047|Rheumatoid Arthritis|rheumatoid arthritis
595642|NCT00658034|Cancer|cancer
595643|NCT00658034|Fatigue|fatigue
595644|NCT00658034|Acupuncture|acupuncture
595645|NCT00658021|diabetes|diabetes
595646|NCT00658021|adolescents|adolescents
595647|NCT00658021|exenatide|exenatide
595648|NCT00658021|Astra Zeneca|astra zeneca
595649|NCT00658008|PD 0332334 phase 3 pivotal trial|pd 0332334 phase 3 pivotal trial
595650|NCT00657995|pancreatogenic|pancreatogenic
595651|NCT00657995|diabetes|diabetes
595652|NCT00657995|artificial|artificial
595653|NCT00657995|pancreas|pancreas
595654|NCT00657969|Polymorphism, genetic|polymorphism, genetic
595655|NCT00657969|Risk factors|risk factors
595656|NCT00657969|Carotid Artery, Internal, Dissection|carotid artery, internal, dissection
595657|NCT00657969|Vertebral Artery Dissection|vertebral artery dissection
595658|NCT00657969|Genetic predisposition|genetic predisposition
595659|NCT00657969|Outcome|outcome
595660|NCT00657969|Therapy|therapy
595661|NCT00657956|osteoarthritis|osteoarthritis
595662|NCT00657956|arthroplasty|arthroplasty
595663|NCT00657956|knee joint|knee joint
595664|NCT00657956|radiography|radiography
595665|NCT00657956|surgery|surgery
595666|NCT00657956|Bone Density|bone density
595667|NCT00657956|Outcome Assessment (Health Care)|outcome assessment (health care)
595668|NCT00657943|carotid|carotid
595669|NCT00657943|intima|intima
595670|NCT00657943|media|media
595671|NCT00657943|thickness|thickness
595672|NCT00657943|insulin|insulin
595673|NCT00657943|metformin|metformin
595674|NCT00657917|leishmaniasis|leishmaniasis
595675|NCT00657917|cutaneous|cutaneous
595676|NCT00657917|Old World|old world
595677|NCT00657917|Leishmania major|leishmania major
595678|NCT00657917|Treatment|treatment
595679|NCT00657904|androgen antagonists|androgen antagonists
595680|NCT00657904|prostate neoplasms|prostate neoplasms
595681|NCT00657891|Allergic Asthma|allergic asthma
595682|NCT00657891|Anti IgE|anti ige
595683|NCT00657891|Xolair|xolair
595684|NCT00657891|Basophil|basophil
595685|NCT00657891|IL-13|il-13
595686|NCT00657891|IL-4|il-4
595687|NCT00657891|Histamine|histamine
595688|NCT00657878|platinum free interval|platinum free interval
595689|NCT00657878|chemotherapy|chemotherapy
595690|NCT00657852|pamidronate,bone loss, liver transplantation|pamidronate,bone loss, liver transplantation
595691|NCT00657839|Benign Prostate Hyperplasia|benign prostate hyperplasia
595692|NCT00657839|Vardenafil|vardenafil
595693|NCT00657839|Genital Disease|genital disease
595694|NCT00657839|Male: Signs and symptoms of Benign Prostate Hyperplasia|male: signs and symptoms of benign prostate hyperplasia
595695|NCT00657826|Diseased Heart Valve, Replacement|diseased heart valve, replacement
595696|NCT00657813|Alzheimer|alzheimer
595697|NCT00657813|SPECT|spect
595698|NCT00657800|diabetes, inpatient, education,|diabetes, inpatient, education,
595699|NCT00657787|Posttraumatic Stress Disorder|posttraumatic stress disorder
595700|NCT00657787|Veterans|veterans
595701|NCT00657787|Health Services|health services
595702|NCT00657774|Asthma|asthma
595703|NCT00657774|Mild to Moderate|mild to moderate
595704|NCT00657748|Leukodystrophy|leukodystrophy
595705|NCT00657748|Canavan disease,|canavan disease,
595706|NCT00657748|Aspartoacylase,|aspartoacylase,
595707|NCT00657748|Lithium,|lithium,
595708|NCT00657748|Glyceryl Triacetate|glyceryl triacetate
595709|NCT00657735|bipolar|bipolar
595710|NCT00657735|depression|depression
595711|NCT00657735|prefrontal|prefrontal
595712|NCT00657735|cortex|cortex
595713|NCT00657735|antidepressant|antidepressant
595714|NCT00657735|response|response
595715|NCT00657722|Pulmonary hypertension|pulmonary hypertension
595716|NCT00657722|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
595717|NCT00657722|Operability|operability
595718|NCT00657722|Thromboendarteriectomy|thromboendarteriectomy
595719|NCT00657722|Operative mortality rate|operative mortality rate
595720|NCT00657722|Technical failure|technical failure
595721|NCT00657722|Pulmonary angiography|pulmonary angiography
595722|NCT00657722|Computed tomography|computed tomography
595723|NCT00657709|infant|infant
595724|NCT00657709|Meningococcal disease|meningococcal disease
595725|NCT00657709|prevention|prevention
595726|NCT00657709|vaccination|vaccination
595727|NCT00657696|primary health care|primary health care
595728|NCT00657696|organizations|organizations
595729|NCT00657696|learning|learning
595730|NCT00657696|quality of health care|quality of health care
595731|NCT00657683|GBS|gbs
595732|NCT00657683|GBS prevention|gbs prevention
595733|NCT00657670|refractive error|refractive error
595734|NCT00657670|spectacles|spectacles
595735|NCT00657670|ready made spectacles|ready made spectacles
595736|NCT00657670|vision|vision
595737|NCT00657670|cost effectiveness|cost effectiveness
595738|NCT00657657|Hepatitis|hepatitis
595739|NCT00657657|vaccine|vaccine
595740|NCT00657644|Erectile Dysfunction|erectile dysfunction
595741|NCT00657631|Acceptance and Commitment Therapy|acceptance and commitment therapy
595742|NCT00657631|Delusions|delusions
595743|NCT00657618|Leishmaniasis, Sodium stibogluconate, Pentostam, sand fly|leishmaniasis, sodium stibogluconate, pentostam, sand fly
595744|NCT00657605|Congenital leptin deficiency|congenital leptin deficiency
595745|NCT00657605|Obesity|obesity
595746|NCT00657605|Metabolic syndrome|metabolic syndrome
595747|NCT00657605|Diabetes|diabetes
595748|NCT00657566|intraabdominal|intraabdominal
595749|NCT00657566|peritonitis|peritonitis
595750|NCT00657566|sepsis|sepsis
595751|NCT00657566|duration|duration
595752|NCT00657566|antibiotics|antibiotics
595753|NCT00657540|black widow spider|black widow spider
595754|NCT00657540|antivenom|antivenom
595755|NCT00657540|latrodectism|latrodectism
595756|NCT00657527|Crestor|crestor
595757|NCT00657527|Rosuvastatin|rosuvastatin
595758|NCT00657527|Cholesterol|cholesterol
595759|NCT00657527|Coronary artery disease|coronary artery disease
595760|NCT00657527|Myocardial ischaemia.|myocardial ischaemia.
595761|NCT00657514|hemoglobin desaturation kinetics|hemoglobin desaturation kinetics
595762|NCT00657514|peripheral arterial disease|peripheral arterial disease
595763|NCT00657514|chronic angina|chronic angina
595764|NCT00657514|exercise tolerance|exercise tolerance
595765|NCT00657501|testosterone|testosterone
595766|NCT00657501|hypoactive sexual desire disorder|hypoactive sexual desire disorder
595767|NCT00657501|menopause|menopause
595768|NCT00657488|Multiple Myeloma, Thalidomide, dose, dexamethasone|multiple myeloma, thalidomide, dose, dexamethasone
595769|NCT00657475|Heparin low dose|heparin low dose
595770|NCT00657475|Inflammation|inflammation
595771|NCT00657475|Blood loss|blood loss
595772|NCT00657462|Medical Informatics Applications|medical informatics applications
595773|NCT00657462|Software|software
595774|NCT00657462|Utilization|utilization
595775|NCT00657449|sprains and strains|sprains and strains
595776|NCT00657436|Acute Coronary Syndrome|acute coronary syndrome
595777|NCT00657436|Myocardial Infarction|myocardial infarction
595778|NCT00657436|Coronary Artery Disease|coronary artery disease
595779|NCT00657423|Lung Neoplasms|lung neoplasms
595780|NCT00657423|Endostatins|endostatins
595781|NCT00657423|Vascular Endothelial Growth Factors|vascular endothelial growth factors
595782|NCT00657423|Fibroblast Growth Factors|fibroblast growth factors
595783|NCT00657423|Survival Rate|survival rate
595784|NCT00657410|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
595785|NCT00657397|Methadone|methadone
595786|NCT00657397|Substance Dependence|substance dependence
595787|NCT00657384|Specify the primary condition or disease being studied Major Hepatectomy|specify the primary condition or disease being studied major hepatectomy
595788|NCT00657371|Colorectal Cancer|colorectal cancer
595789|NCT00657371|Colonoscopy|colonoscopy
595790|NCT00657371|Third Eye Retroscope|third eye retroscope
595791|NCT00657371|Third Eye Retroscope Auxiliary Imaging System|third eye retroscope auxiliary imaging system
595792|NCT00657371|Polypectomy|polypectomy
595793|NCT00657358|lidocaine|lidocaine
595794|NCT00657358|allodynia|allodynia
595795|NCT00657358|chronic regional pain syndrome|chronic regional pain syndrome
595796|NCT00657358|pain|pain
595797|NCT00657345|trastuzumab|trastuzumab
595798|NCT00657345|breast cancer|breast cancer
595799|NCT00657345|her2 positive breast cancer|her2 positive breast cancer
595800|NCT00657306|Cirrhosis|cirrhosis
595801|NCT00657306|Ascites|ascites
595802|NCT00657306|Adrenal insufficiency|adrenal insufficiency
595803|NCT00657306|Hepatorenal syndrome|hepatorenal syndrome
595804|NCT00657306|Portal hypertension|portal hypertension
595805|NCT00657293|COPD|copd
595806|NCT00657293|arm training|arm training
595807|NCT00657293|dyspnoea|dyspnoea
595808|NCT00657293|quality of life|quality of life
595809|NCT00657267|recurrent glioblastoma|recurrent glioblastoma
595810|NCT00657267|temodar|temodar
595811|NCT00657267|temozolomide|temozolomide
595812|NCT00657254|Extension|extension
595813|NCT00657254|Sorafenib|sorafenib
595814|NCT00657254|Survival|survival
595815|NCT00657241|cardiac work|cardiac work
595816|NCT00657241|coreg cr|coreg cr
595817|NCT00657241|valsartan|valsartan
595818|NCT00657241|tonometry|tonometry
595819|NCT00657228|Anaphylaxis|anaphylaxis
595820|NCT00657228|Anaphylactoid reactions|anaphylactoid reactions
595821|NCT00657202|NF1|nf1
595822|NCT00657202|neurofibroma|neurofibroma
595823|NCT00657202|ranibizumab|ranibizumab
595824|NCT00657202|Lucentis|lucentis
595825|NCT00657189|Sifalimumab|sifalimumab
595826|NCT00657189|MEDI-545|medi-545
595827|NCT00657189|Lupus erythematosus, systemic|lupus erythematosus, systemic
595828|NCT00657163|Stroke recovery|stroke recovery
595829|NCT00657163|Pharmacological modulation|pharmacological modulation
595830|NCT00657163|Selective Serotonin Reuptake Inhibitor (SSRI)|selective serotonin reuptake inhibitor (ssri)
595831|NCT00657163|Fluoxetine|fluoxetine
595832|NCT00657163|Brain plasticity|brain plasticity
595833|NCT00657163|Ischemic Stroke and Motor impairment|ischemic stroke and motor impairment
595834|NCT00657163|Modulation of recovery and cerebral plasticity by Fluoxetine|modulation of recovery and cerebral plasticity by fluoxetine
595835|NCT00657137|HER2/neu positive|her2/neu positive
595836|NCT00657137|locally advanced or metastatic|locally advanced or metastatic
595837|NCT00657124|AEN|aen
595838|NCT00657111|influenza, elderly, United Kingdom|influenza, elderly, united kingdom
595839|NCT00657098|Side effects|side effects
595840|NCT00657098|Angiogenesis inhibitors|angiogenesis inhibitors
595841|NCT00657098|Epidermal growth factor receptor inhibitors|epidermal growth factor receptor inhibitors
595842|NCT00657098|Tyrosinekinase inhibitors|tyrosinekinase inhibitors
595843|NCT00657085|Laser hair removal|laser hair removal
595844|NCT00657072|scapholunate instability|scapholunate instability
595845|NCT00657072|neural networks|neural networks
595846|NCT00657072|scaphoid|scaphoid
595847|NCT00657072|lunate|lunate
595848|NCT00657072|Suspected torn scapholunate interosseous ligament|suspected torn scapholunate interosseous ligament
595849|NCT00657072|Suspected other torn wrist ligaments|suspected other torn wrist ligaments
595850|NCT00657059|IgA nephropathy|iga nephropathy
595851|NCT00657059|mycophenolate mofetil|mycophenolate mofetil
595852|NCT00657033|Erectile Dysfunction|erectile dysfunction
595853|NCT00657020|nicotine|nicotine
595854|NCT00657020|therapy|therapy
595855|NCT00657020|fMRI/EEG|fmri/eeg
595856|NCT00657020|replacement|replacement
595857|NCT00657007|lupus|lupus
595858|NCT00657007|SLE|sle
595859|NCT00656994|Sleep Disorder|sleep disorder
595860|NCT00656994|Insomnia|insomnia
595861|NCT00656981|Moderate Acne Vulgaris|moderate acne vulgaris
595862|NCT00656981|Acne|acne
595863|NCT00656968|peptic ulcer disease|peptic ulcer disease
595864|NCT00656968|gastric cancer|gastric cancer
595865|NCT00656968|therapeutics|therapeutics
595866|NCT00656955|Kidney Cancer|kidney cancer
595867|NCT00656955|Renal Cell Cancer|renal cell cancer
595868|NCT00656955|Heterogeneity|heterogeneity
595869|NCT00656955|Molecular Epidemiology|molecular epidemiology
595870|NCT00656955|Survival|survival
595871|NCT00656955|Occupational Exposure|occupational exposure
595872|NCT00656955|Renal Cancer|renal cancer
595873|NCT00656955|Survival Study|survival study
595874|NCT00656942|Pain|pain
595875|NCT00656929|Vitamin D|vitamin d
595876|NCT00656929|Viral URI|viral uri
595877|NCT00656929|Influenza|influenza
595878|NCT00656929|Colds|colds
595879|NCT00656916|Post-Transplant Constrictive Bronchiolitis|post-transplant constrictive bronchiolitis
595880|NCT00656916|Bronchiolitis|bronchiolitis
595881|NCT00656916|Fluticasone Propionate|fluticasone propionate
595882|NCT00656916|Inhaled Corticosteroids|inhaled corticosteroids
595883|NCT00656916|Lung Condition|lung condition
595884|NCT00656916|PTCB|ptcb
595885|NCT00656903|Lucentis|lucentis
595886|NCT00656903|Indocyanine Green Angiography|indocyanine green angiography
595887|NCT00656903|Choroidal Neovascularization|choroidal neovascularization
595888|NCT00656903|Macular Degeneration|macular degeneration
595889|NCT00656903|Ranibizumab|ranibizumab
595890|NCT00656903|Age-Related Macular Degeneration|age-related macular degeneration
595891|NCT00656903|AMD|amd
595892|NCT00656890|ulcerative colitis, rectal bleeding|ulcerative colitis, rectal bleeding
595893|NCT00656877|Fat Embolism Total Knee Arthroplasty|fat embolism total knee arthroplasty
595894|NCT00656864|Diabetes|diabetes
595895|NCT00656864|pioglitazone|pioglitazone
595896|NCT00656864|GIP|gip
595897|NCT00656851|HIV/AIDS|hiv/aids
595898|NCT00656851|Heart disease|heart disease
595899|NCT00656851|Diabetes|diabetes
595900|NCT00656851|Cardiovascular disease risk|cardiovascular disease risk
595901|NCT00656851|Dyslipidemia|dyslipidemia
595902|NCT00656851|Visceral adiposity|visceral adiposity
595903|NCT00656851|treatment experienced|treatment experienced
595904|NCT00656838|colon|colon
595905|NCT00656838|rectal|rectal
595906|NCT00656838|cancer|cancer
595907|NCT00656838|screening|screening
595908|NCT00656825|P144|p144
595909|NCT00656825|TGF-β1|tgf-β1
595910|NCT00656825|Healthy volunteers|healthy volunteers
595911|NCT00656825|Cutaneous tolerability|cutaneous tolerability
595912|NCT00656825|Skin fibrosis|skin fibrosis
595913|NCT00656825|systemic scleroderma|systemic scleroderma
595914|NCT00656825|systemic sclerosis|systemic sclerosis
595915|NCT00656825|Safety|safety
595916|NCT00656812|advanced MALT lymphoma|advanced malt lymphoma
595917|NCT00656812|Rituximab|rituximab
595918|NCT00656812|2CdA|2cda
595919|NCT00656812|chemotherapy|chemotherapy
595920|NCT00656812|immunotherapy|immunotherapy
595921|NCT00656773|morphine, sufentanil, acute pain, opioid, Prehospital Emergency Care|morphine, sufentanil, acute pain, opioid, prehospital emergency care
595922|NCT00656760|unknown primary, head and neck cancer, squamous cell carcinoma|unknown primary, head and neck cancer, squamous cell carcinoma
595923|NCT00656760|Unknown primary head and neck cancer|unknown primary head and neck cancer
595924|NCT00656747|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
595925|NCT00656747|Acute exacerbation of COPD (AECOPD)|acute exacerbation of copd (aecopd)
595926|NCT00656747|chronic bronchitis|chronic bronchitis
595927|NCT00656747|bronchitis|bronchitis
595928|NCT00656747|chest infection|chest infection
595929|NCT00656747|smoking|smoking
595930|NCT00656747|lung disease|lung disease
595931|NCT00656747|lung|lung
595932|NCT00656747|lungs|lungs
595933|NCT00656734|Medarex Inc.|medarex inc.
595934|NCT00656721|bronchiectasis|bronchiectasis
595935|NCT00656721|physiotherapy|physiotherapy
595936|NCT00656721|flutter valve|flutter valve
595937|NCT00656721|impulse oscillation technique|impulse oscillation technique
595938|NCT00656708|Burns|burns
595939|NCT00656708|Wounds|wounds
595940|NCT00656708|Healthcare associated infections|healthcare associated infections
595941|NCT00656708|MRSA|mrsa
595942|NCT00656708|VRE|vre
595943|NCT00656695|Iminoral|iminoral
595944|NCT00656695|Neoral|neoral
595945|NCT00656695|Acute renal transplant rejection|acute renal transplant rejection
595946|NCT00656682|Prevention & Control|prevention & control
595947|NCT00656682|Hyperglycemia|hyperglycemia
595948|NCT00656682|Obesity|obesity
595949|NCT00656682|Diabetes Mellitus|diabetes mellitus
595950|NCT00656682|Cost Benefit Analysis|cost benefit analysis
595951|NCT00656669|newly diagnosed breast cancer|newly diagnosed breast cancer
595952|NCT00656669|neoadjuvant therapy|neoadjuvant therapy
595953|NCT00656656|pemphigus|pemphigus
595954|NCT00656656|rituximab|rituximab
595955|NCT00656656|immunoadsorption|immunoadsorption
595956|NCT00656656|dexamethasone|dexamethasone
595957|NCT00656656|treatment|treatment
595958|NCT00656656|management|management
595959|NCT00656617|Acute Myeloid Leukemia|acute myeloid leukemia
595960|NCT00656617|(AML)|(aml)
595961|NCT00656617|Myelodysplastic syndrome|myelodysplastic syndrome
595962|NCT00656617|(MDS)|(mds)
595963|NCT00656617|Leukemia|leukemia
595964|NCT00656617|Idarubicin|idarubicin
595965|NCT00656617|Cytarabine|cytarabine
595966|NCT00656617|Vorinostat|vorinostat
595967|NCT00656617|Ara-C|ara-c
595968|NCT00656604|recurrent breast cancer|recurrent breast cancer
595969|NCT00656604|stage I breast cancer|stage i breast cancer
595970|NCT00656604|stage II breast cancer|stage ii breast cancer
595971|NCT00656604|stage IIIA breast cancer|stage iiia breast cancer
595972|NCT00656604|stage IIIB breast cancer|stage iiib breast cancer
595973|NCT00656604|stage IIIC breast cancer|stage iiic breast cancer
595974|NCT00656591|Child mortality, Nepal, Community, care practices|child mortality, nepal, community, care practices
595975|NCT00656578|Foot|foot
595976|NCT00656578|Bunion|bunion
595977|NCT00656578|Bunionectomy|bunionectomy
595978|NCT00656578|Hallux Valgus Deformity|hallux valgus deformity
595979|NCT00656578|Surgery for Transpositional first metatarsal osteotomy - Bunionectomy|surgery for transpositional first metatarsal osteotomy - bunionectomy
595980|NCT00656565|measure inspiratory spirometry with dry powder inhaler device in series with the spirometer|measure inspiratory spirometry with dry powder inhaler device in series with the spirometer
595981|NCT00656526|analgesia, postlaminectomy , lidocaine, dorsal root|analgesia, postlaminectomy , lidocaine, dorsal root
595982|NCT00656513|hypopharyngeal cancer|hypopharyngeal cancer
595983|NCT00656513|laryngeal cancer|laryngeal cancer
595984|NCT00656513|lip and oral cavity cancer|lip and oral cavity cancer
595985|NCT00656513|nasopharyngeal cancer|nasopharyngeal cancer
595986|NCT00656513|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
595987|NCT00656513|oropharyngeal cancer|oropharyngeal cancer
595988|NCT00656513|salivary gland cancer|salivary gland cancer
595989|NCT00656513|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
595990|NCT00656513|xerostomia|xerostomia
595991|NCT00656513|tongue cancer|tongue cancer
595992|NCT00656500|surgical patients|surgical patients
595993|NCT00656500|cigarette smoking|cigarette smoking
595994|NCT00656500|postoperative complications|postoperative complications
595995|NCT00656500|telephone counseling|telephone counseling
595996|NCT00656500|quitlines|quitlines
595997|NCT00656487|Cannabis Dependence|cannabis dependence
595998|NCT00656487|Marijuana Dependence|marijuana dependence
595999|NCT00656487|Cannabis Withdrawal|cannabis withdrawal
596000|NCT00656487|Rimonabant|rimonabant
596001|NCT00656487|cannabinoid receptor type 1 (CB1) inverse agonist|cannabinoid receptor type 1 (cb1) inverse agonist
596002|NCT00656487|Neuropsychology|neuropsychology
596003|NCT00656487|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
596004|NCT00656487|Endocannabinoids|endocannabinoids
596005|NCT00656487|Cortisol|cortisol
596006|NCT00656474|burn wounds|burn wounds
596007|NCT00656474|wound healing|wound healing
596008|NCT00656461|Advanced cancer|advanced cancer
596009|NCT00656448|Acute Myelogenous Leukemia|acute myelogenous leukemia
596010|NCT00656448|AML|aml
596011|NCT00656448|Myelodysplastic Syndrome|myelodysplastic syndrome
596012|NCT00656448|MDS|mds
596013|NCT00656448|Leukemia|leukemia
596014|NCT00656448|Procrit|procrit
596015|NCT00656448|Epoetin Alfa|epoetin alfa
596016|NCT00656448|Epogen|epogen
596017|NCT00656435|proliferative diabetic retinopathy|proliferative diabetic retinopathy
596018|NCT00656435|bevacizumab (Avastin)|bevacizumab (avastin)
596019|NCT00656435|vitreous hemorrhage|vitreous hemorrhage
596020|NCT00656435|long acting gas|long acting gas
596021|NCT00656422|insulin therapy|insulin therapy
596022|NCT00656422|hepatic fat|hepatic fat
596023|NCT00656422|type 2 diabetes|type 2 diabetes
596024|NCT00656422|body composition|body composition
596025|NCT00656422|comparison of insulin detemir and insulin glargine|comparison of insulin detemir and insulin glargine
596026|NCT00656422|Changes in Hepatic Fat|changes in hepatic fat
596027|NCT00656422|Obesity|obesity
596028|NCT00656409|Ataxia telangiectasia,|ataxia telangiectasia,
596029|NCT00656409|Conjugated pneumococcal,|conjugated pneumococcal,
596030|NCT00656409|Prevenar,|prevenar,
596031|NCT00656409|Immunogenicity ,|immunogenicity ,
596032|NCT00656409|Vaccine|vaccine
596033|NCT00656396|Blood loss|blood loss
596034|NCT00656396|Point of care monitoring|point of care monitoring
596035|NCT00656396|FFP|ffp
596036|NCT00656396|Major surgery|major surgery
596037|NCT00656396|Prothrombin Time|prothrombin time
596038|NCT00656396|Blood coagulation tests|blood coagulation tests
596039|NCT00656383|venous ulcer, leg ulcer, stasis ulcer|venous ulcer, leg ulcer, stasis ulcer
596040|NCT00656370|Hylenex|hylenex
596041|NCT00656370|subcutaneous infusion|subcutaneous infusion
596042|NCT00656370|hyaluronidase|hyaluronidase
596043|NCT00656370|rHuPH20|rhuph20
596044|NCT00656370|recombinant human hyaluronidase|recombinant human hyaluronidase
596045|NCT00656344|PTSD|ptsd
596046|NCT00656344|Substance Abuse|substance abuse
596047|NCT00656344|WTC attacks|wtc attacks
596048|NCT00656344|Iraq War|iraq war
596049|NCT00656318|women|women
596050|NCT00656318|menses|menses
596051|NCT00656318|oral contraceptives|oral contraceptives
596052|NCT00656318|Healthy menstruating females|healthy menstruating females
596053|NCT00656305|Bone Cancer|bone cancer
596054|NCT00656305|Pain Palliation|pain palliation
596055|NCT00656305|Metastasis|metastasis
596056|NCT00656305|Multiple Myeloma|multiple myeloma
596057|NCT00656305|Breast Cancer|breast cancer
596058|NCT00656305|Lung Cancer|lung cancer
596059|NCT00656305|Prostate Cancer|prostate cancer
596060|NCT00656305|cancer related Pain|cancer related pain
596061|NCT00656305|Tumors|tumors
596062|NCT00656292|Plasma concentrations of inflammatory markers|plasma concentrations of inflammatory markers
596063|NCT00656292|C-Reactive Protein (CRP)|c-reactive protein (crp)
596064|NCT00656292|Interleukin-6 (IL-6)|interleukin-6 (il-6)
596752|NCT00653874|jaundice|jaundice
596065|NCT00656292|Tumor Necrosis Factor-Alpha (TNF)|tumor necrosis factor-alpha (tnf)
596066|NCT00656292|Aspartate Aminotransferase (AST)|aspartate aminotransferase (ast)
596067|NCT00656292|Alanine Aminotransferase (ALT)|alanine aminotransferase (alt)
596068|NCT00656292|Creatine Kinase (CK)|creatine kinase (ck)
596069|NCT00656279|chronic kidney disease|chronic kidney disease
596070|NCT00656279|predialysis|predialysis
596071|NCT00656279|hyperphosphatemia|hyperphosphatemia
596072|NCT00656279|dietary intervention|dietary intervention
596073|NCT00656279|intensive dietary education|intensive dietary education
596074|NCT00656279|low phosphorus diet|low phosphorus diet
596075|NCT00656266|renal insufficiency and/or renal failure after liver transplantation|renal insufficiency and/or renal failure after liver transplantation
596076|NCT00656214|Lichen Planus|lichen planus
596077|NCT00656201|Infertility|infertility
596078|NCT00656201|In vitro fertilization|in vitro fertilization
596079|NCT00656201|Embryo transfer|embryo transfer
596080|NCT00656201|Crinone|crinone
596081|NCT00656201|Intramuscular Progesterone|intramuscular progesterone
596082|NCT00656201|Progesterone support|progesterone support
596083|NCT00656188|Erectile Dysfunction|erectile dysfunction
596084|NCT00656188|Vardenafil|vardenafil
596085|NCT00656175|lipodystrophy|lipodystrophy
596087|NCT00656175|visceral fat|visceral fat
596088|NCT00656175|HIV|hiv
596089|NCT00656175|women|women
596090|NCT00656175|raltegravir|raltegravir
596091|NCT00656175|ART|art
596092|NCT00656175|anti HIV therapy|anti hiv therapy
596093|NCT00656175|NNRTI|nnrti
596094|NCT00656175|Protease inhibitor|protease inhibitor
596095|NCT00656175|integrase inhibitor|integrase inhibitor
596096|NCT00656175|treatment experienced|treatment experienced
596097|NCT00656149|telerehabilitation|telerehabilitation
596098|NCT00656149|functional electrical stimulation|functional electrical stimulation
596099|NCT00656149|spinal cord injury|spinal cord injury
596100|NCT00656149|hand function rehabilitation|hand function rehabilitation
596101|NCT00656123|adenocarcinoma of the colon|adenocarcinoma of the colon
596102|NCT00656123|adenocarcinoma of the rectum|adenocarcinoma of the rectum
596103|NCT00656123|stage IV colon cancer|stage iv colon cancer
596104|NCT00656123|stage IV rectal cancer|stage iv rectal cancer
596105|NCT00656123|liver metastases|liver metastases
596106|NCT00656110|Restless legs syndrome|restless legs syndrome
596107|NCT00656110|Morton's neuroma|morton's neuroma
596108|NCT00656110|Randomized controlled trial|randomized controlled trial
596109|NCT00656097|Rabies post-exposure prophylaxis|rabies post-exposure prophylaxis
596110|NCT00656071|ARDS|ards
596111|NCT00656071|Acute respiratory distress syndrome|acute respiratory distress syndrome
596112|NCT00656071|Adult respiratory distress syndrome|adult respiratory distress syndrome
596113|NCT00656071|respiratory distress|respiratory distress
596114|NCT00656058|Leukotriene|leukotriene
596115|NCT00656058|Chronic Graft-Versus-Host Disease|chronic graft-versus-host disease
596116|NCT00656058|Montelukast|montelukast
596117|NCT00656058|Stem Cell Transplant|stem cell transplant
596118|NCT00656058|Bronchiolitis Obliterans|bronchiolitis obliterans
596119|NCT00656045|Obesity|obesity
596120|NCT00656045|Physical Activity|physical activity
596121|NCT00656045|Weight Loss|weight loss
596122|NCT00656045|Exercise|exercise
596123|NCT00656045|Dietary Intake|dietary intake
596124|NCT00656045|Energy|energy
596125|NCT00656045|Behavioral|behavioral
596126|NCT00656045|Healthy Eating|healthy eating
596127|NCT00656032|insulin resistance|insulin resistance
596128|NCT00656032|end stage renal disease|end stage renal disease
596129|NCT00656006|Hepatitis C|hepatitis c
596130|NCT00656006|Chronic|chronic
596131|NCT00656006|Genotype 2 or 3|genotype 2 or 3
596132|NCT00656006|Treatment naive|treatment naive
596133|NCT00655993|COPD|copd
596134|NCT00655993|Inflammation|inflammation
596135|NCT00655993|CRP levels|crp levels
596136|NCT00655993|simvastatin|simvastatin
596137|NCT00655954|COPD|copd
596138|NCT00655954|asthma|asthma
596139|NCT00655954|smokers|smokers
596140|NCT00655954|healthy volunteers|healthy volunteers
596141|NCT00655954|bronchiectasis|bronchiectasis
596142|NCT00655954|cystic fibrosis|cystic fibrosis
596143|NCT00655941|Osteoarthritis|osteoarthritis
596144|NCT00655941|Obesity|obesity
596145|NCT00655941|Weight loss|weight loss
596146|NCT00655941|Dietary instruction|dietary instruction
596147|NCT00655941|Exercise|exercise
596148|NCT00655941|Attention|attention
596149|NCT00655928|Acute lung injury|acute lung injury
596150|NCT00655928|Lung resection|lung resection
596151|NCT00655902|Trans fat|trans fat
596152|NCT00655902|Obesity|obesity
596153|NCT00655902|Insulin sensitivity|insulin sensitivity
596154|NCT00655876|stage IIA esophageal cancer|stage iia esophageal cancer
596155|NCT00655876|stage IIB esophageal cancer|stage iib esophageal cancer
596156|NCT00655876|stage IIIA esophageal cancer|stage iiia esophageal cancer
596157|NCT00655876|stage IIIB esophageal cancer|stage iiib esophageal cancer
596158|NCT00655876|stage IIIC esophageal cancer|stage iiic esophageal cancer
596159|NCT00655876|stage IV esophageal cancer|stage iv esophageal cancer
596160|NCT00655876|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
596161|NCT00655863|Glucose Metabolism Disorder|glucose metabolism disorder
596753|NCT00653874|neonates|neonates
596162|NCT00655863|Dysmetabolic Syndrome|dysmetabolic syndrome
596163|NCT00655863|Type II Diabetes|type ii diabetes
596164|NCT00655863|Diabetes Mellitus|diabetes mellitus
596165|NCT00655863|Lipoatrophic; Dyslipidemia|lipoatrophic; dyslipidemia
596166|NCT00655863|Drug Therapy|drug therapy
596167|NCT00655850|Lung Cancer|lung cancer
596168|NCT00655850|Non-Small Cell Lung Cancer|non-small cell lung cancer
596169|NCT00655850|Metronomic Chemotherapy|metronomic chemotherapy
596170|NCT00655837|Antigens, CD40|antigens, cd40
596171|NCT00655837|Antibodies, Monoclonal|antibodies, monoclonal
596172|NCT00655837|Combined Modality Therapy|combined modality therapy
596173|NCT00655837|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
596174|NCT00655837|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
596175|NCT00655837|Hematologic Diseases|hematologic diseases
596176|NCT00655837|Immunoproliferative Disorders|immunoproliferative disorders
596177|NCT00655837|Lymphatic Diseases|lymphatic diseases
596178|NCT00655837|Lymphoproliferative Disorders|lymphoproliferative disorders
596179|NCT00655837|Lymphoma|lymphoma
596180|NCT00655811|Healthy volunteers|healthy volunteers
596181|NCT00655785|Epitope peptide|epitope peptide
596182|NCT00655785|CTL|ctl
596183|NCT00655785|Pancreatic cancer|pancreatic cancer
596184|NCT00655785|Vaccination VEGFR1|vaccination vegfr1
596185|NCT00655785|VEGFR2|vegfr2
596186|NCT00655772|chlorine|chlorine
596187|NCT00655772|dioxide|dioxide
596188|NCT00655772|mouthwash|mouthwash
596189|NCT00655772|organoleptic|organoleptic
596190|NCT00655772|measurements|measurements
596191|NCT00655772|volatile|volatile
596192|NCT00655772|sulfur|sulfur
596193|NCT00655772|compounds|compounds
596194|NCT00655746|Healthy Subjects|healthy subjects
596195|NCT00655720|infant formula|infant formula
596196|NCT00655707|Adult stem cell therapy|adult stem cell therapy
596197|NCT00655694|COPD|copd
596198|NCT00655694|smokers|smokers
596199|NCT00655694|healthy volunteers|healthy volunteers
596200|NCT00655681|pediatric osteoporosis|pediatric osteoporosis
596201|NCT00655681|pediatric osteopenia|pediatric osteopenia
596202|NCT00655681|pamidronate|pamidronate
596203|NCT00655681|post operative osteopenia|post operative osteopenia
596204|NCT00655668|NHL, Non-Hodgkin's Lymphoma, T-cell Lymphoma|nhl, non-hodgkin's lymphoma, t-cell lymphoma
596205|NCT00655629|Erectile Dysfunction|erectile dysfunction
596206|NCT00655603|GLP-1|glp-1
596207|NCT00655603|Glucagon secretion|glucagon secretion
596208|NCT00655603|Glucose turn-over|glucose turn-over
596209|NCT00655590|Erectile Dysfunction|erectile dysfunction
596210|NCT00655590|Sildenafil|sildenafil
596211|NCT00655590|Vardenafil|vardenafil
596212|NCT00655590|Spermatogenesis|spermatogenesis
596213|NCT00655590|Sperm concentration|sperm concentration
596214|NCT00655590|Sperm count|sperm count
596215|NCT00655590|Morphology|morphology
596216|NCT00655590|Motility|motility
596217|NCT00655590|Reproductive hormonal|reproductive hormonal
596218|NCT00655577|Aging|aging
596219|NCT00655577|Osteoporosis|osteoporosis
596220|NCT00655577|Exercise|exercise
596221|NCT00655577|Population based|population based
596222|NCT00655577|Randomized trial|randomized trial
596223|NCT00655577|Falls|falls
596224|NCT00655577|Fractures|fractures
596225|NCT00655551|epilepsy|epilepsy
596226|NCT00655551|seizures|seizures
596227|NCT00655551|Lacosamide|lacosamide
596228|NCT00655551|Vimpat|vimpat
596229|NCT00655551|intravenous|intravenous
596230|NCT00655525|inflammation|inflammation
596231|NCT00655525|end stage renal disease|end stage renal disease
596232|NCT00655512|pimecrolimus|pimecrolimus
596233|NCT00655512|hydrocortison|hydrocortison
596234|NCT00655512|betamethasone|betamethasone
596235|NCT00655512|clobetasol-17-Propionat|clobetasol-17-propionat
596236|NCT00655512|Optical Coherence Tomography|optical coherence tomography
596237|NCT00655512|skin healthy probands|skin healthy probands
596238|NCT00655499|adenocarcinoma of the colon|adenocarcinoma of the colon
596239|NCT00655499|adenocarcinoma of the rectum|adenocarcinoma of the rectum
596240|NCT00655499|stage IV colon cancer|stage iv colon cancer
596241|NCT00655499|recurrent rectal cancer|recurrent rectal cancer
596242|NCT00655499|stage IV rectal cancer|stage iv rectal cancer
596243|NCT00655499|recurrent colon cancer|recurrent colon cancer
596244|NCT00655486|Epilepsy|epilepsy
596245|NCT00655486|seizures|seizures
596246|NCT00655486|antiepileptic|antiepileptic
596247|NCT00655486|Lacosamide|lacosamide
596248|NCT00655486|Vimpat|vimpat
596249|NCT00655486|safety|safety
596250|NCT00655486|adjunctive|adjunctive
596251|NCT00655460|Glucose|glucose
596252|NCT00655460|Insulin|insulin
596253|NCT00655460|computer|computer
596254|NCT00655460|critical care|critical care
596255|NCT00655447|oophorectomy|oophorectomy
596256|NCT00655447|ovarian conservation|ovarian conservation
596257|NCT00655447|stroke|stroke
596258|NCT00655447|breast cancer|breast cancer
596259|NCT00655447|ovarian cancer|ovarian cancer
596260|NCT00655447|other cancer|other cancer
596261|NCT00655447|hip fracture|hip fracture
596262|NCT00655434|Herpes simplex virus 2|herpes simplex virus 2
596263|NCT00655434|HSV 2|hsv 2
596856|NCT00653471|capnography|capnography
596264|NCT00655434|Antibody status to Herpesvirus 2, Human|antibody status to herpesvirus 2, human
596265|NCT00655421|screening|screening
596266|NCT00655421|oral precancers|oral precancers
596267|NCT00655421|tobacco users|tobacco users
596268|NCT00655421|VELScope|velscope
596269|NCT00655421|Visual Inspection|visual inspection
596270|NCT00655421|Toluidine Blue|toluidine blue
596271|NCT00655408|Infants|infants
596272|NCT00655408|Prevalence|prevalence
596273|NCT00655408|Iron|iron
596274|NCT00655408|Deficiency|deficiency
596275|NCT00655408|Treatment|treatment
596276|NCT00655395|Leukemia|leukemia
596277|NCT00655395|MDS|mds
596278|NCT00655382|dynamic pelvic mri|dynamic pelvic mri
596279|NCT00655382|dynamic mri|dynamic mri
596280|NCT00655382|STARR procedure|starr procedure
596281|NCT00655382|STARR|starr
596282|NCT00655382|ODS|ods
596283|NCT00655382|obstructive defecation syndrome|obstructive defecation syndrome
596284|NCT00655382|outlet obstruction|outlet obstruction
596285|NCT00655382|obstructed defecation|obstructed defecation
596286|NCT00655382|stapled trans anal rectal resection|stapled trans anal rectal resection
596287|NCT00655356|Treatment of moderate to severe bilateral nasolabial fold wrinkles|treatment of moderate to severe bilateral nasolabial fold wrinkles
596288|NCT00655343|GvHD|gvhd
596289|NCT00655343|aGvHD prophylaxis|agvhd prophylaxis
596290|NCT00655343|Matched unrelated donor|matched unrelated donor
596291|NCT00655343|ATG|atg
596292|NCT00655343|SCT|sct
596293|NCT00655343|BMT|bmt
596294|NCT00655343|polyclonal antibody|polyclonal antibody
596295|NCT00655343|GvHD prophylaxis for patients with ALL, AML, CML, MDS, OMF|gvhd prophylaxis for patients with all, aml, cml, mds, omf
596296|NCT00655343|Patients with allogeneic BM or PBSC transplantation|patients with allogeneic bm or pbsc transplantation
596297|NCT00655343|Patients with a matched unrelated donor|patients with a matched unrelated donor
596298|NCT00655330|Type 2 diabetes mellitus|type 2 diabetes mellitus
596299|NCT00655330|Nephropathy|nephropathy
596300|NCT00655330|valsartan|valsartan
596301|NCT00655330|probucol|probucol
596302|NCT00655330|Proteinuria|proteinuria
596303|NCT00655317|acupuncture|acupuncture
596304|NCT00655317|colon surgery|colon surgery
596305|NCT00655317|post operative ileus|post operative ileus
596306|NCT00655317|post ileus|post ileus
596307|NCT00655317|ileus|ileus
596308|NCT00655317|colectomy|colectomy
596309|NCT00655317|colorectal pathology|colorectal pathology
596310|NCT00655291|pain|pain
596311|NCT00655278|Movement Disorder|movement disorder
596312|NCT00655252|Expanded access|expanded access
596313|NCT00655252|metastatic renal cell cancer|metastatic renal cell cancer
596314|NCT00655252|progression despite VEGF receptors|progression despite vegf receptors
596315|NCT00655239|Ultra High Risk of Schizophrenia|ultra high risk of schizophrenia
596316|NCT00655239|Prodrome|prodrome
596317|NCT00655239|Psychosis|psychosis
596318|NCT00655239|Schizophrenia|schizophrenia
596319|NCT00655239|Cognitive Remediation|cognitive remediation
596320|NCT00655226|Cognitive Behavior Therapy|cognitive behavior therapy
596321|NCT00655226|Interferon-alpha|interferon-alpha
596322|NCT00655226|Communicable Diseases|communicable diseases
596323|NCT00655226|Liver Diseases|liver diseases
596324|NCT00655226|Depression|depression
596325|NCT00655226|Hepatitis, Chronic|hepatitis, chronic
596326|NCT00655226|Interferons|interferons
596327|NCT00655226|Ribavirin|ribavirin
596328|NCT00655226|Hepatitis, Viral, Human|hepatitis, viral, human
596329|NCT00655226|Infection|infection
596330|NCT00655226|Hepatitis|hepatitis
596331|NCT00655226|Mood Disorders|mood disorders
596332|NCT00655226|Peginterferon alfa-2a|peginterferon alfa-2a
596333|NCT00655226|Hepatitis C|hepatitis c
596334|NCT00655226|Interferon Alfa-2a|interferon alfa-2a
596335|NCT00655226|Interferon Alfa-2b|interferon alfa-2b
596336|NCT00655226|Depressive Disorder, Major|depressive disorder, major
596337|NCT00655226|Depressive Disorder|depressive disorder
596338|NCT00655213|Pacing, AV conduction disorders, minimized ventricular pacing, AF|pacing, av conduction disorders, minimized ventricular pacing, af
596339|NCT00655174|autism|autism
596340|NCT00655174|fluvoxamine|fluvoxamine
596341|NCT00655174|sertraline|sertraline
596342|NCT00655174|selective seratonin reuptake inhibitors|selective seratonin reuptake inhibitors
596343|NCT00655174|paediatrics|paediatrics
596344|NCT00655161|NSCLC|nsclc
596345|NCT00655161|Cancer Immunotherapy|cancer immunotherapy
596346|NCT00655148|DTaP-IPV|dtap-ipv
596347|NCT00655148|Clinical Trial|clinical trial
596348|NCT00655148|Safety|safety
596349|NCT00655148|Immunogenicity|immunogenicity
596350|NCT00655109|Allergic conjunctivitis|allergic conjunctivitis
596351|NCT00655109|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
596352|NCT00655096|Screening Protocol|screening protocol
596353|NCT00655096|Eye Diseases|eye diseases
596354|NCT00655083|Infantile colic|infantile colic
596355|NCT00655083|Abdominal Cramps|abdominal cramps
596356|NCT00655083|Colicky Pain|colicky pain
596357|NCT00655083|Functional gastrointestinal disorders|functional gastrointestinal disorders
596358|NCT00655070|Hibernating Myocardium|hibernating myocardium
596359|NCT00655070|Blood Flow|blood flow
596360|NCT00655070|Ultrasound|ultrasound
596361|NCT00655070|PET imaging|pet imaging
597045|NCT00652613|HNSCC|hnscc
596362|NCT00655057|Dopamine Transporter|dopamine transporter
596363|NCT00655057|Biomarker|biomarker
596364|NCT00655057|SPECT Brain Imaging|spect brain imaging
596365|NCT00655057|Antidepressant Therapy|antidepressant therapy
596366|NCT00655031|Punicaceae|punicaceae
596367|NCT00655031|Pomegranate|pomegranate
596368|NCT00655018|Non-Alcoholic Fatty Liver Disease (NAFLD)|non-alcoholic fatty liver disease (nafld)
596369|NCT00655018|Non-Alcoholic Steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
596370|NCT00655018|Liver histology|liver histology
596371|NCT00655018|Insulin Resistance|insulin resistance
596372|NCT00655018|Weight loss|weight loss
596373|NCT00655018|Alpha-tocopherol|alpha-tocopherol
596374|NCT00655018|ascorbic acid|ascorbic acid
596375|NCT00655005|head and neck cancer|head and neck cancer
596376|NCT00654966|Urotensin II|urotensin ii
596377|NCT00654966|Soluble epoxide hydrolase|soluble epoxide hydrolase
596378|NCT00654966|Iontophoresis|iontophoresis
596379|NCT00654966|Healthy volunteers|healthy volunteers
596380|NCT00654953|cocaine dependence|cocaine dependence
596381|NCT00654953|depressive symptoms|depressive symptoms
596382|NCT00654953|relapse|relapse
596383|NCT00654953|sertraline|sertraline
596384|NCT00654953|gabapentin|gabapentin
596385|NCT00654927|multiple sclerosis|multiple sclerosis
596386|NCT00654927|MS|ms
596387|NCT00654927|walking|walking
596388|NCT00654927|leg strength|leg strength
596389|NCT00654927|demyelination|demyelination
596390|NCT00654914|Sexual Dysfunction|sexual dysfunction
596391|NCT00654901|Diphtheria|diphtheria
596392|NCT00654901|Tetanus|tetanus
596393|NCT00654901|Pertussis|pertussis
596394|NCT00654901|Hepatitis B|hepatitis b
596395|NCT00654901|Poliomyelitis|poliomyelitis
596396|NCT00654901|Invasive Haemophilus influenzae type b.|invasive haemophilus influenzae type b.
596397|NCT00654901|Haemophilus Influenzae Type B Infection|haemophilus influenzae type b infection
596398|NCT00654888|cataract extraction|cataract extraction
596399|NCT00654888|surgery|surgery
596400|NCT00654888|corneal disease|corneal disease
596401|NCT00654875|Essential Hypertension|essential hypertension
596402|NCT00654849|Electrosurgery|electrosurgery
596403|NCT00654849|Gyrus Pk|gyrus pk
596404|NCT00654849|abdominal hysterectomy|abdominal hysterectomy
596405|NCT00654849|Blood Loss, Surgical|blood loss, surgical
596406|NCT00654849|Length of stay|length of stay
596407|NCT00654849|Overall cost|overall cost
596408|NCT00654836|recurrent breast cancer|recurrent breast cancer
596409|NCT00654836|stage III breast cancer|stage iii breast cancer
596410|NCT00654836|stage IV breast cancer|stage iv breast cancer
596411|NCT00654810|functional ability|functional ability
596412|NCT00654810|gait|gait
596413|NCT00654810|musculoskeletal disorder therapy|musculoskeletal disorder therapy
596414|NCT00654810|peripheral blood vessel disorder|peripheral blood vessel disorder
596415|NCT00654797|Glucose|glucose
596416|NCT00654797|Insulin|insulin
596417|NCT00654797|computer|computer
596418|NCT00654797|critical care|critical care
596419|NCT00654784|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
596420|NCT00654784|DMD|dmd
596421|NCT00654784|Duchenne|duchenne
596422|NCT00654771|protein/creatinine ratio|protein/creatinine ratio
596423|NCT00654771|clean catch urine|clean catch urine
596424|NCT00654771|catheterized urine|catheterized urine
596425|NCT00654758|cancer|cancer
596426|NCT00654758|carcinoma|carcinoma
596427|NCT00654758|chemotherapy|chemotherapy
596428|NCT00654758|monoclonal antibody therapy|monoclonal antibody therapy
596429|NCT00654758|anti-angiogenesis|anti-angiogenesis
596430|NCT00654745|blood pressure reduction|blood pressure reduction
596431|NCT00654732|Hodgkin Lymphoma|hodgkin lymphoma
596432|NCT00654732|Lymphoma|lymphoma
596433|NCT00654732|Adriamycin|adriamycin
596434|NCT00654732|Doxorubicin Hydrochloride|doxorubicin hydrochloride
596435|NCT00654732|Adriamycin PFS®|adriamycin pfs®
596436|NCT00654732|Adriamycin RDF™|adriamycin rdf™
596437|NCT00654732|Rituxan|rituxan
596438|NCT00654732|Rituximab|rituximab
596439|NCT00654732|Bleomycin|bleomycin
596440|NCT00654732|Bleomycin sulfate|bleomycin sulfate
596441|NCT00654732|Blenoxane®|blenoxane®
596442|NCT00654732|BLM|blm
596443|NCT00654732|Vinblastine|vinblastine
596444|NCT00654732|Velban|velban
596445|NCT00654732|Dacarbazine|dacarbazine
596446|NCT00654732|DTIC|dtic
596447|NCT00654732|DTIC-Dome®|dtic-dome®
596448|NCT00654732|R-ABVD|r-abvd
596449|NCT00654732|ABVD|abvd
596450|NCT00654719|Heart failure|heart failure
596451|NCT00654719|cachexia|cachexia
596452|NCT00654706|Schizophrenia|schizophrenia
596453|NCT00654706|Cognition|cognition
596454|NCT00654706|MATRICS Consensus Cognitive Battery|matrics consensus cognitive battery
596455|NCT00654693|NTX|ntx
596456|NCT00654693|Nihon Kohden|nihon kohden
596457|NCT00654693|mobile monitoring|mobile monitoring
596458|NCT00654693|monitoring|monitoring
596459|NCT00654693|nihon|nihon
596460|NCT00654693|kohden|kohden
596461|NCT00654693|monitoring device|monitoring device
596462|NCT00654693|remote monitoring|remote monitoring
596463|NCT00654693|wireless|wireless
596464|NCT00654680|Erectile Dysfunction|erectile dysfunction
597249|NCT00651755|Emend|emend
596465|NCT00654680|Traumatic spinal cord injury|traumatic spinal cord injury
596466|NCT00654680|Vardenafil|vardenafil
596467|NCT00654667|Resveratrol|resveratrol
596468|NCT00654667|Insulin Resistance|insulin resistance
596469|NCT00654667|Metabolic Syndrome|metabolic syndrome
596470|NCT00654667|Sirtuin 1|sirtuin 1
596471|NCT00654667|IGF-1|igf-1
596472|NCT00654667|Satiety|satiety
596473|NCT00654667|Leptin|leptin
596474|NCT00654667|Adiponectin|adiponectin
596475|NCT00654641|Surgical Wound Dehiscence|surgical wound dehiscence
596476|NCT00654641|Wound Infection|wound infection
596477|NCT00654641|Obesity|obesity
596478|NCT00654641|Cesarean Delivery|cesarean delivery
596479|NCT00654641|Wound Closure|wound closure
596480|NCT00654641|Negative Pressure wound closure|negative pressure wound closure
596481|NCT00654615|unstable metaphyseal distal radius fractures|unstable metaphyseal distal radius fractures
596482|NCT00654615|randomized controlled trial|randomized controlled trial
596483|NCT00654615|surgical fixation|surgical fixation
596484|NCT00654615|volar plate|volar plate
596485|NCT00654615|intramedullary distal radius fixation system|intramedullary distal radius fixation system
596486|NCT00654602|cholesterol|cholesterol
596487|NCT00654602|low density lipoproteins|low density lipoproteins
596488|NCT00654602|dyslipidaemia|dyslipidaemia
596489|NCT00654602|Rosuvastatin|rosuvastatin
596490|NCT00654602|Crestor|crestor
596491|NCT00654589|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
596492|NCT00654589|HCT|hct
596493|NCT00654589|iron overload|iron overload
596494|NCT00654589|chelators|chelators
596495|NCT00654589|ICL670|icl670
596496|NCT00654589|deferasirox|deferasirox
596497|NCT00654589|serum ferritin|serum ferritin
596498|NCT00654589|LIC|lic
596499|NCT00654589|transfusional hemosiderosis|transfusional hemosiderosis
596500|NCT00654589|blood transfusions|blood transfusions
596501|NCT00654589|adults|adults
596502|NCT00654589|iron chelation|iron chelation
596503|NCT00654589|3-6 months|3-6 months
596504|NCT00654589|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
596505|NCT00654576|schizophrenia|schizophrenia
596506|NCT00654576|antipsychotic|antipsychotic
596507|NCT00654576|outcome|outcome
596508|NCT00654576|psychosocial intervention|psychosocial intervention
596509|NCT00654563|Memory Disorders|memory disorders
596510|NCT00654563|Memory loss|memory loss
596511|NCT00654563|Age Associated Memory Impairment|age associated memory impairment
596512|NCT00654550|Photorefractive keratectomy|photorefractive keratectomy
596513|NCT00654550|Re-epithelialization|re-epithelialization
596514|NCT00654550|Nexagon|nexagon
596515|NCT00654550|PRK|prk
596516|NCT00654550|Coda|coda
596517|NCT00654537|Cholesterol|cholesterol
596518|NCT00654537|hypercholesterolemia|hypercholesterolemia
596519|NCT00654537|low density lipoproteins|low density lipoproteins
596520|NCT00654524|Endometriosis|endometriosis
596521|NCT00654524|Recurrence|recurrence
596522|NCT00654524|Pregnancy Rate|pregnancy rate
596523|NCT00654524|Laparoscopy|laparoscopy
596524|NCT00654524|Gonadotropin-Releasing Hormone|gonadotropin-releasing hormone
596525|NCT00654511|Dexmedetomidine,|dexmedetomidine,
596526|NCT00654511|fentanyl,|fentanyl,
596527|NCT00654511|tonsillectomy|tonsillectomy
596528|NCT00654511|and adenoidectomy,|and adenoidectomy,
596529|NCT00654485|Cholesterol|cholesterol
596530|NCT00654485|hypercholesterolemia|hypercholesterolemia
596531|NCT00654485|low density lipoproteins|low density lipoproteins
596532|NCT00654485|metabolic syndrome|metabolic syndrome
596533|NCT00654485|Rosuvastatin|rosuvastatin
596534|NCT00654472|magnetic resonance imaging, mitral valve area|magnetic resonance imaging, mitral valve area
596535|NCT00654446|Cholesterol|cholesterol
596536|NCT00654446|low density lipoproteins|low density lipoproteins
596537|NCT00654446|dyslipidaemia|dyslipidaemia
596538|NCT00654446|Rosuvastatin|rosuvastatin
596539|NCT00654446|Crestor|crestor
596540|NCT00654446|Simvastatin|simvastatin
596541|NCT00654446|Zocor|zocor
596542|NCT00654446|Renal|renal
596543|NCT00654446|kidney|kidney
596544|NCT00654433|Hurler Syndrome|hurler syndrome
596545|NCT00654433|MPS I|mps i
596546|NCT00654433|Hurler-Scheie Syndrome|hurler-scheie syndrome
596547|NCT00654433|Hunter Syndrome|hunter syndrome
596548|NCT00654433|MPS II|mps ii
596549|NCT00654433|Sanfilippo Syndrome|sanfilippo syndrome
596550|NCT00654433|MPS III|mps iii
596551|NCT00654433|Maroteaux-Lamy Syndrome|maroteaux-lamy syndrome
596552|NCT00654433|MPS VI|mps vi
596553|NCT00654433|Krabbe Disease|krabbe disease
596554|NCT00654433|Globoid Leukodystrophy|globoid leukodystrophy
596555|NCT00654433|Metachromatic Leukodystrophy|metachromatic leukodystrophy
596556|NCT00654433|MLD|mld
596557|NCT00654433|Adrenoleukodystrophy|adrenoleukodystrophy
596558|NCT00654433|ALD|ald
596559|NCT00654433|Adrenomyeloneuropathy|adrenomyeloneuropathy
596560|NCT00654433|AMN|amn
596561|NCT00654433|Sandhoff Disease|sandhoff disease
596562|NCT00654433|Tay Sachs Disease|tay sachs disease
596563|NCT00654433|Pelizaeus Merzbacher|pelizaeus merzbacher
596564|NCT00654433|PMD|pmd
596565|NCT00654433|Niemann-Pick Disease A|niemann-pick disease a
596566|NCT00654433|Niemann-Pick Disease B|niemann-pick disease b
596567|NCT00654433|Alpha-mannosidosis|alpha-mannosidosis
596568|NCT00654433|Inherited metabolic diseases|inherited metabolic diseases
596569|NCT00654433|Inborn errors of metabolism|inborn errors of metabolism
596570|NCT00654433|Lysosomal storage diseases|lysosomal storage diseases
596571|NCT00654433|Peroxisomal storage diseases|peroxisomal storage diseases
596572|NCT00654433|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
596573|NCT00654433|Umbilical cord blood transplantation|umbilical cord blood transplantation
596574|NCT00654433|Mucopolysaccharidosis|mucopolysaccharidosis
596575|NCT00654433|Mucopolysaccharidosis I|mucopolysaccharidosis i
596576|NCT00654433|Mucopolysaccharidosis II|mucopolysaccharidosis ii
596577|NCT00654433|Mucopolysaccharidosis III|mucopolysaccharidosis iii
596578|NCT00654433|Mucopolysaccharidosis VI|mucopolysaccharidosis vi
596579|NCT00654433|I Cell disease|i cell disease
596580|NCT00654433|Fucosidosis|fucosidosis
596581|NCT00654433|GM1 Gangliosidosis|gm1 gangliosidosis
596582|NCT00654433|Canavan Disease|canavan disease
596583|NCT00654407|Cholesterol|cholesterol
596584|NCT00654407|hypercholesterolemia|hypercholesterolemia
596585|NCT00654407|Coronary Heart disease|coronary heart disease
596586|NCT00654407|low density lipoproteins|low density lipoproteins
596587|NCT00654407|Rosuvastatin|rosuvastatin
596588|NCT00654407|Atorvastatin|atorvastatin
596589|NCT00654407|simvastatin|simvastatin
596590|NCT00654394|Cholesterol|cholesterol
596591|NCT00654394|Carotid Artery Stenosis|carotid artery stenosis
596592|NCT00654394|Hypercholesterolemia|hypercholesterolemia
596593|NCT00654394|Rosuvastatin|rosuvastatin
596594|NCT00654394|Crestor|crestor
596595|NCT00654368|Amgen|amgen
596596|NCT00654355|atopic dermatitis|atopic dermatitis
596597|NCT00654355|eczema|eczema
596598|NCT00654342|Sentinel lymph node-colon cancer|sentinel lymph node-colon cancer
596599|NCT00654329|Dexmedetomidine, transmucosal, myringotomy,|dexmedetomidine, transmucosal, myringotomy,
596600|NCT00654316|TB|tb
596601|NCT00654316|Tuberculosis|tuberculosis
596602|NCT00654316|MVA85A|mva85a
596603|NCT00654316|Vaccine|vaccine
596604|NCT00654316|BCG|bcg
596605|NCT00654303|Cholesterol|cholesterol
596606|NCT00654303|Hypercholesterolaemia|hypercholesterolaemia
596607|NCT00654303|Statins|statins
596608|NCT00654290|Atrial fibrillation|atrial fibrillation
596609|NCT00654290|coronary bypass|coronary bypass
596610|NCT00654290|Amiodarone|amiodarone
596611|NCT00654290|Propranolol|propranolol
596612|NCT00654290|Coronary Artery Bypass Graft (CABG)|coronary artery bypass graft (cabg)
596613|NCT00654277|bioequivalence|bioequivalence
596614|NCT00654277|Ondansetron ODT|ondansetron odt
596615|NCT00654277|Fasting|fasting
596616|NCT00654277|To determine bioequivalence under fasting conditions|to determine bioequivalence under fasting conditions
596617|NCT00654251|Spinocerebellar ataxia|spinocerebellar ataxia
596618|NCT00654251|Machado-Joseph disease|machado-joseph disease
596619|NCT00654251|Gait monitoring|gait monitoring
596620|NCT00654251|Functional vision assessment|functional vision assessment
596621|NCT00654238|Thyroid Cancer|thyroid cancer
596622|NCT00654238|Anaplastic|anaplastic
596623|NCT00654238|Medullary|medullary
596624|NCT00654238|sorafenib|sorafenib
596625|NCT00654225|Cholesterol|cholesterol
596626|NCT00654225|low density lipoproteins|low density lipoproteins
596627|NCT00654225|dyslipidaemia|dyslipidaemia
596628|NCT00654225|Rosuvastatin|rosuvastatin
596629|NCT00654225|Crestor|crestor
596630|NCT00654225|Atorvastatin|atorvastatin
596631|NCT00654225|Lipitor|lipitor
596632|NCT00654225|South Asian|south asian
596633|NCT00654212|stenting, laparoscopic surgery, colon cancer|stenting, laparoscopic surgery, colon cancer
596634|NCT00654199|CABG|cabg
596635|NCT00654199|Ventricular Asynchrony|ventricular asynchrony
596636|NCT00654199|Normal Sinus Rhythm|normal sinus rhythm
596637|NCT00654186|Androgen Independent Prostate Cancer (AIPC)|androgen independent prostate cancer (aipc)
596638|NCT00654186|Chemo naive|chemo naive
596639|NCT00654173|Cholesterol|cholesterol
596640|NCT00654173|low density lipoproteins|low density lipoproteins
596641|NCT00654173|dyslipidaemia|dyslipidaemia
596642|NCT00654173|Rosuvastatin|rosuvastatin
596643|NCT00654173|Crestor|crestor
596644|NCT00654173|Atorvastatin|atorvastatin
596645|NCT00654173|Lipitor|lipitor
596646|NCT00654173|Zocor|zocor
596647|NCT00654173|simvastatin|simvastatin
596648|NCT00654160|stage IIIB anal cancer|stage iiib anal cancer
596649|NCT00654160|stage IV anal cancer|stage iv anal cancer
596650|NCT00654160|recurrent anal cancer|recurrent anal cancer
596651|NCT00654160|carcinoma of the appendix|carcinoma of the appendix
596652|NCT00654160|stage III colon cancer|stage iii colon cancer
596653|NCT00654160|stage IV colon cancer|stage iv colon cancer
596654|NCT00654160|recurrent colon cancer|recurrent colon cancer
596655|NCT00654160|stage III rectal cancer|stage iii rectal cancer
596656|NCT00654160|stage IV rectal cancer|stage iv rectal cancer
596657|NCT00654160|recurrent rectal cancer|recurrent rectal cancer
596658|NCT00654160|stage III esophageal cancer|stage iii esophageal cancer
596659|NCT00654160|stage IV esophageal cancer|stage iv esophageal cancer
596660|NCT00654160|recurrent esophageal cancer|recurrent esophageal cancer
596661|NCT00654160|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
596751|NCT00653887|constipation|constipation
596662|NCT00654160|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
596663|NCT00654160|unresectable gallbladder cancer|unresectable gallbladder cancer
596664|NCT00654160|recurrent gallbladder cancer|recurrent gallbladder cancer
596665|NCT00654160|stage III gastric cancer|stage iii gastric cancer
596666|NCT00654160|stage IV gastric cancer|stage iv gastric cancer
596667|NCT00654160|recurrent gastric cancer|recurrent gastric cancer
596668|NCT00654160|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
596669|NCT00654160|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
596670|NCT00654160|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
596671|NCT00654160|gastrointestinal stromal tumor|gastrointestinal stromal tumor
596672|NCT00654160|advanced adult primary liver cancer|advanced adult primary liver cancer
596673|NCT00654160|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
596674|NCT00654160|recurrent adult primary liver cancer|recurrent adult primary liver cancer
596675|NCT00654160|stage II pancreatic cancer|stage ii pancreatic cancer
596676|NCT00654160|stage III pancreatic cancer|stage iii pancreatic cancer
596677|NCT00654160|stage IV pancreatic cancer|stage iv pancreatic cancer
596678|NCT00654160|recurrent pancreatic cancer|recurrent pancreatic cancer
596679|NCT00654160|recurrent small intestine cancer|recurrent small intestine cancer
596680|NCT00654160|small intestine adenocarcinoma|small intestine adenocarcinoma
596681|NCT00654160|small intestine leiomyosarcoma|small intestine leiomyosarcoma
596682|NCT00654160|small intestine lymphoma|small intestine lymphoma
596683|NCT00654147|HIV|hiv
596684|NCT00654147|antiretroviral therapy naive|antiretroviral therapy naive
596685|NCT00654147|Integrase inhibitor|integrase inhibitor
596686|NCT00654147|HIV/AIDS|hiv/aids
596687|NCT00654147|treatment naïve|treatment naïve
596688|NCT00654121|prevention|prevention
596689|NCT00654108|Escherichia coli, cholera, diarrhea, vaccine|escherichia coli, cholera, diarrhea, vaccine
596690|NCT00654069|Pain|pain
596691|NCT00654056|Type 2 diabetes|type 2 diabetes
596692|NCT00654056|Severe insulin resistance|severe insulin resistance
596693|NCT00654043|Bioequivalence|bioequivalence
596694|NCT00654043|Torsemide Tablets|torsemide tablets
596695|NCT00654043|fed|fed
596696|NCT00654043|To determine bioequivalence under fed conditions.|to determine bioequivalence under fed conditions.
596697|NCT00654030|Lung Cancer Vaccine|lung cancer vaccine
596698|NCT00654030|Early Stage Lung Cancer|early stage lung cancer
596699|NCT00654030|Lung Cancer|lung cancer
596700|NCT00654004|trifunctional|trifunctional
596701|NCT00654004|protein|protein
596702|NCT00654004|deficiency|deficiency
596703|NCT00654004|TFP|tfp
596704|NCT00654004|weight|weight
596705|NCT00654004|regulation|regulation
596706|NCT00653991|HIV/AIDS Prevention|hiv/aids prevention
596707|NCT00653991|Men Who Have Sex With Men (MSM)|men who have sex with men (msm)
596708|NCT00653991|Risky Sexual Behavior|risky sexual behavior
596709|NCT00653991|Socially Optimized Learning in a Virtual Environment (SOLVE)|socially optimized learning in a virtual environment (solve)
596710|NCT00653991|HIV Seronegativity|hiv seronegativity
596711|NCT00653978|ERCP|ercp
596712|NCT00653978|cholangiocarcinoma|cholangiocarcinoma
596713|NCT00653978|hilar stricture|hilar stricture
596714|NCT00653965|Cholesterol|cholesterol
596715|NCT00653965|low density lipoproteins|low density lipoproteins
596716|NCT00653965|dyslipidaemia|dyslipidaemia
596717|NCT00653965|Rosuvastatin|rosuvastatin
596718|NCT00653965|Crestor|crestor
596719|NCT00653965|Atorvastatin|atorvastatin
596720|NCT00653965|Lipitor|lipitor
596721|NCT00653965|Hispanic|hispanic
596722|NCT00653952|Paclitaxel HCl|paclitaxel hcl
596723|NCT00653952|CAELYX|caelyx
596724|NCT00653952|DOXIL|doxil
596725|NCT00653952|Ovarian Carcinoma|ovarian carcinoma
596726|NCT00653952|Doxorubicin HCl|doxorubicin hcl
596727|NCT00653939|non-small cell lung cancer|non-small cell lung cancer
596728|NCT00653939|non-small cell lung carcinoma|non-small cell lung carcinoma
596729|NCT00653939|neoplasms, lung|neoplasms, lung
596730|NCT00653939|lung cancer|lung cancer
596731|NCT00653939|tumors|tumors
596732|NCT00653939|NSCLC|nsclc
596733|NCT00653926|Postoperative pain|postoperative pain
596734|NCT00653926|Local infiltration analgesia|local infiltration analgesia
596735|NCT00653926|Knee arthroplasty|knee arthroplasty
596736|NCT00653926|Postoperative pain management following unicompartmental knee arthroplasty|postoperative pain management following unicompartmental knee arthroplasty
596737|NCT00653900|Verify now|verify now
596738|NCT00653900|platelet function|platelet function
596739|NCT00653900|platelet function testing|platelet function testing
596740|NCT00653900|bleeding risk|bleeding risk
596741|NCT00653900|periprocedural bleeding|periprocedural bleeding
596742|NCT00653900|clopidogrel|clopidogrel
596743|NCT00653900|Our initial goal is to establish if a certain degree of|our initial goal is to establish if a certain degree of
596744|NCT00653900|platelet function abnormality can predict a higher bleeding|platelet function abnormality can predict a higher bleeding
596745|NCT00653900|or higher transfusions.|or higher transfusions.
596746|NCT00653887|Biofeedback|biofeedback
596747|NCT00653887|anal sphincter|anal sphincter
596748|NCT00653887|cortical excitability|cortical excitability
596749|NCT00653887|magnetic stimulation|magnetic stimulation
596750|NCT00653887|incontinence|incontinence
596754|NCT00653874|transcutaneous bilirubinometry|transcutaneous bilirubinometry
596755|NCT00653874|clinical assessment of bilirubin|clinical assessment of bilirubin
596756|NCT00653861|Aesthetic correction|aesthetic correction
596757|NCT00653848|Adjuvant treatment, high risk, radical radiotherapy|adjuvant treatment, high risk, radical radiotherapy
596758|NCT00653822|Amevive|amevive
596759|NCT00653822|alefacept|alefacept
596760|NCT00653822|pharmacokinetics|pharmacokinetics
596761|NCT00653822|Japanese|japanese
596762|NCT00653783|Parkinson disease|parkinson disease
596763|NCT00653783|Multiple System Atrophy|multiple system atrophy
596764|NCT00653783|MSA|msa
596765|NCT00653783|Progressive Supranuclear Palsy|progressive supranuclear palsy
596766|NCT00653783|PSP|psp
596767|NCT00653783|observational|observational
596768|NCT00653783|biomarker|biomarker
596769|NCT00653757|stage I prostate cancer|stage i prostate cancer
596770|NCT00653757|stage II prostate cancer|stage ii prostate cancer
596771|NCT00653757|stage III prostate cancer|stage iii prostate cancer
596772|NCT00653757|stage IV prostate cancer|stage iv prostate cancer
596773|NCT00653744|Cholesterol|cholesterol
596774|NCT00653744|low density lipoproteins|low density lipoproteins
596775|NCT00653744|dyslipidaemia|dyslipidaemia
596776|NCT00653744|Rosuvastatin|rosuvastatin
596777|NCT00653744|Crestor|crestor
596778|NCT00653744|Atorvastatin|atorvastatin
596779|NCT00653744|Lipitor|lipitor
596780|NCT00653744|African American|african american
596781|NCT00653731|dementia|dementia
596782|NCT00653731|snoezelen|snoezelen
596783|NCT00653731|structured reminiscence therapy|structured reminiscence therapy
596784|NCT00653731|10-minutes activation|10-minutes activation
596785|NCT00653731|apathy|apathy
596786|NCT00653718|Pain|pain
596787|NCT00653718|Characterize musculoskeletal pain|characterize musculoskeletal pain
596788|NCT00653718|Breast cancer patients treated with aromatase inhibitors|breast cancer patients treated with aromatase inhibitors
596789|NCT00653705|Probiotics|probiotics
596790|NCT00653705|Children|children
596791|NCT00653705|Child Care Center|child care center
596792|NCT00653705|Nutrition|nutrition
596793|NCT00653705|Health promotion|health promotion
596794|NCT00653692|Substance abuse|substance abuse
596795|NCT00653692|fetal development|fetal development
596796|NCT00653692|vagal tone|vagal tone
596797|NCT00653679|exercise|exercise
596798|NCT00653679|muscle protein signalling|muscle protein signalling
596799|NCT00653679|protein synthesis|protein synthesis
596800|NCT00653666|CPT1A|cpt1a
596801|NCT00653666|steatosis|steatosis
596802|NCT00653666|deficiency|deficiency
596803|NCT00653666|metabolic|metabolic
596804|NCT00653666|response|response
596805|NCT00653666|fasting|fasting
596806|NCT00653653|pharmacogenetics|pharmacogenetics
596807|NCT00653653|pharmacoeconomics|pharmacoeconomics
596808|NCT00653653|adverse events|adverse events
596809|NCT00653653|drug metabolism|drug metabolism
596810|NCT00653640|rehabilitation|rehabilitation
596811|NCT00653640|head injury|head injury
596812|NCT00653640|3 months post injury|3 months post injury
596813|NCT00653640|require manual assistance or walking aids to walk|require manual assistance or walking aids to walk
596814|NCT00653640|very slow walking speed|very slow walking speed
596815|NCT00653640|able to follow two step commands|able to follow two step commands
596816|NCT00653614|Oral contraception|oral contraception
596817|NCT00653601|GPI|gpi
596818|NCT00653601|glycoprotein IIb/IIIa inhibitor|glycoprotein iib/iiia inhibitor
596819|NCT00653601|Aggrastat|aggrastat
596820|NCT00653601|Tirofiban|tirofiban
596821|NCT00653601|Verify now|verify now
596822|NCT00653601|platelet function testing|platelet function testing
596823|NCT00653601|bridge therapy|bridge therapy
596824|NCT00653588|Cholesterol|cholesterol
596825|NCT00653588|low density lipoproteins|low density lipoproteins
596826|NCT00653588|Hypercholesterolemia|hypercholesterolemia
596827|NCT00653588|Coronary Heart Disease|coronary heart disease
596828|NCT00653588|Rosuvastatin|rosuvastatin
596829|NCT00653588|Crestor|crestor
596830|NCT00653588|Atorvastatin|atorvastatin
596831|NCT00653588|Lipitor|lipitor
596832|NCT00653575|Sexual Behavior|sexual behavior
596833|NCT00653575|HIV|hiv
596834|NCT00653575|Sexually Transmitted Diseases|sexually transmitted diseases
596835|NCT00653562|polysomnography|polysomnography
596836|NCT00653562|zolpidem|zolpidem
596837|NCT00653562|Sleep disorders|sleep disorders
596838|NCT00653562|adolescent|adolescent
596839|NCT00653549|Bioequivalence|bioequivalence
596840|NCT00653549|Torsemide Tablets|torsemide tablets
596841|NCT00653549|fasting|fasting
596842|NCT00653536|stroke|stroke
596843|NCT00653536|neuroflo|neuroflo
596844|NCT00653536|device|device
596845|NCT00653536|failure to recanalize|failure to recanalize
596846|NCT00653510|Type 2 diabetes|type 2 diabetes
596847|NCT00653510|Dysregulation|dysregulation
596848|NCT00653510|Metabolism|metabolism
596849|NCT00653510|Cardiac output|cardiac output
596850|NCT00653497|Osteoarthritis|osteoarthritis
596851|NCT00653484|colon cancer|colon cancer
596852|NCT00653484|rectal cancer|rectal cancer
596853|NCT00653484|obesity|obesity
596854|NCT00653471|obesity|obesity
596855|NCT00653471|osa|osa
596857|NCT00653471|general anesthesia|general anesthesia
596858|NCT00653458|bioequivalence|bioequivalence
596859|NCT00653458|Ondansetron ODT|ondansetron odt
596860|NCT00653458|fed|fed
596861|NCT00653458|To determine bioequivalence under fed conditions|to determine bioequivalence under fed conditions
596862|NCT00653445|Low density lipoproteins|low density lipoproteins
596863|NCT00653445|Hypercholesterolemia|hypercholesterolemia
596864|NCT00653445|Coronary Heart Disease|coronary heart disease
596865|NCT00653445|Rosuvastatin|rosuvastatin
596866|NCT00653445|Crestor|crestor
596867|NCT00653445|Ezetimibe|ezetimibe
596868|NCT00653432|Treatment|treatment
596869|NCT00653432|Osteoarthritis|osteoarthritis
596870|NCT00653419|bioequivalence|bioequivalence
596871|NCT00653419|buspirone HCl|buspirone hcl
596872|NCT00653419|fasting|fasting
596873|NCT00653406|Schizophrenia|schizophrenia
596874|NCT00653406|Risperidone|risperidone
596875|NCT00653406|Intramuscular injection|intramuscular injection
596876|NCT00653406|Pharmacokinetics|pharmacokinetics
596877|NCT00653393|bioequivalence, single- dose, fasting|bioequivalence, single- dose, fasting
596878|NCT00653380|bioequivalence|bioequivalence
596879|NCT00653380|doxycycline monohydrate|doxycycline monohydrate
596880|NCT00653380|fasting|fasting
596881|NCT00653367|Thoracotomy|thoracotomy
596882|NCT00653367|Nerve section|nerve section
596883|NCT00653367|QST|qst
596884|NCT00653367|Quantitative Sensory Test|quantitative sensory test
596885|NCT00653367|Muscle sparing Posterolateral thoracotomy|muscle sparing posterolateral thoracotomy
596886|NCT00653367|Chest|chest
596887|NCT00653367|Wall|wall
596888|NCT00653367|Surgical|surgical
596889|NCT00653367|Incision|incision
596890|NCT00653367|Tumors or cancer of the lung|tumors or cancer of the lung
596891|NCT00653354|hallux valgus|hallux valgus
596892|NCT00653341|insulin naive|insulin naive
596893|NCT00653328|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
596894|NCT00653328|fallopian tube cancer|fallopian tube cancer
596895|NCT00653328|peritoneal cavity cancer|peritoneal cavity cancer
596896|NCT00653315|Bioequivalence, Tramadol APAP, fasting|bioequivalence, tramadol apap, fasting
596897|NCT00653263|methamphetamine|methamphetamine
596898|NCT00653263|drug abuse|drug abuse
596899|NCT00653263|withdrawal|withdrawal
596900|NCT00653250|stage I non-small cell lung cancer|stage i non-small cell lung cancer
596901|NCT00653250|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
596902|NCT00653250|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
596903|NCT00653224|levocetirizine|levocetirizine
596904|NCT00653224|Xyzal|xyzal
596905|NCT00653224|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
596906|NCT00653224|total symptom score|total symptom score
596907|NCT00653224|quality of life|quality of life
596908|NCT00653198|Rotavirus severe gastroenteritis (RV SGE)|rotavirus severe gastroenteritis (rv sge)
596909|NCT00653185|Glucose Metabolism Disorder|glucose metabolism disorder
596910|NCT00653185|Dysmetabolic Syndrome|dysmetabolic syndrome
596911|NCT00653185|Type II Diabetes|type ii diabetes
596912|NCT00653185|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
596913|NCT00653185|Dyslipidemia|dyslipidemia
596914|NCT00653185|Hyperglycemia|hyperglycemia
596915|NCT00653172|CAP|cap
596916|NCT00653172|community acquired pneumonia|community acquired pneumonia
596917|NCT00653159|Intrauterine device, contraception, unplanned pregnancy|intrauterine device, contraception, unplanned pregnancy
596918|NCT00653146|cervical cancer|cervical cancer
596919|NCT00653146|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
596920|NCT00653146|human papilloma virus infection|human papilloma virus infection
596921|NCT00653146|atypical squamous cells of undetermined significance|atypical squamous cells of undetermined significance
596922|NCT00653146|low-grade squamous intraepithelial lesion|low-grade squamous intraepithelial lesion
596923|NCT00653133|ultrasonography|ultrasonography
596924|NCT00653133|peripheral nerve block|peripheral nerve block
596925|NCT00653133|peripheral nerve stimulation|peripheral nerve stimulation
596926|NCT00653120|Bioequivalence, Propranolol ER capsules, fasting|bioequivalence, propranolol er capsules, fasting
596927|NCT00653107|Palliation|palliation
596928|NCT00653107|Cancer oesophagus|cancer oesophagus
596929|NCT00653107|Stent|stent
596930|NCT00653107|Brachytherapy|brachytherapy
596931|NCT00653107|Randomized|randomized
596932|NCT00653094|crohn|crohn
596933|NCT00653094|fistula|fistula
596934|NCT00653094|surgery|surgery
596935|NCT00653094|fibrin glue|fibrin glue
596936|NCT00653094|seton drainage|seton drainage
596937|NCT00653081|Shoulder pain|shoulder pain
596938|NCT00653081|Supervised Exercises|supervised exercises
596939|NCT00653081|Radial Shock Wave Therapy|radial shock wave therapy
596940|NCT00653055|Bioequivalence|bioequivalence
596941|NCT00653055|Cabergoline|cabergoline
596942|NCT00653055|Fasting|fasting
596943|NCT00653042|Myocardial Ischemia|myocardial ischemia
596944|NCT00653042|kidney failure|kidney failure
596945|NCT00653042|CABG|cabg
596946|NCT00653042|cardiopulmonary bypass (CPB) pump|cardiopulmonary bypass (cpb) pump
596947|NCT00653042|Coronary Artery Bypass Surgery|coronary artery bypass surgery
596948|NCT00653042|heart surgery|heart surgery
596949|NCT00653042|nesiritide|nesiritide
596950|NCT00653042|Coronary Heart Disease|coronary heart disease
596951|NCT00653029|Post concussion syndrome|post concussion syndrome
596952|NCT00653029|Mild traumatic brain injury|mild traumatic brain injury
596953|NCT00653029|Effort|effort
596954|NCT00653029|fmri|fmri
596955|NCT00653016|Contraception|contraception
596956|NCT00653016|norelgestromin|norelgestromin
596957|NCT00653016|ethinyl estradiol|ethinyl estradiol
596958|NCT00653016|transdermal contraceptive patch|transdermal contraceptive patch
596959|NCT00653016|EVRA|evra
596960|NCT00653016|ORTHO EVRA|ortho evra
596961|NCT00653003|Bioequivalence, Leflunomide, fed|bioequivalence, leflunomide, fed
596962|NCT00652977|sphincter tears|sphincter tears
596963|NCT00652977|Ritgen maneuver|ritgen maneuver
596964|NCT00652977|perineal tears|perineal tears
596965|NCT00652977|prevention|prevention
596966|NCT00652977|delivery|delivery
596967|NCT00652964|sleep apnea, PHOX2B, hypoventilation, polysomnography|sleep apnea, phox2b, hypoventilation, polysomnography
596968|NCT00652938|Co-administration|co-administration
596969|NCT00652938|HPV vaccine|hpv vaccine
596970|NCT00652938|Cervical cancer|cervical cancer
596971|NCT00652925|arthritis|arthritis
596972|NCT00652925|juvenile|juvenile
596973|NCT00652912|bioequivalence, Clonazepam ODT , fasting|bioequivalence, clonazepam odt , fasting
596974|NCT00652899|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
596975|NCT00652899|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
596976|NCT00652899|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
596977|NCT00652899|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
596978|NCT00652899|fallopian tube cancer|fallopian tube cancer
596979|NCT00652899|peritoneal cavity cancer|peritoneal cavity cancer
596980|NCT00652886|Bioequivalence, Oxandrolone,fasting|bioequivalence, oxandrolone,fasting
596981|NCT00652873|Bioequivalence|bioequivalence
596982|NCT00652873|Cabergoline|cabergoline
596983|NCT00652873|Fed|fed
596984|NCT00652860|lung metastases|lung metastases
596985|NCT00652860|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
596986|NCT00652834|Renal transplant recipients|renal transplant recipients
596987|NCT00652834|Gastrointestinal findings in small bowel capsule endoscopy|gastrointestinal findings in small bowel capsule endoscopy
596988|NCT00652834|Mycophenolic acid|mycophenolic acid
596989|NCT00652834|Mycophenolate Mofetil|mycophenolate mofetil
596990|NCT00652834|Mycophenolate Sodium|mycophenolate sodium
596991|NCT00652821|bioequivalence, single-dose, fed|bioequivalence, single-dose, fed
596992|NCT00652808|knee, OA patients|knee, oa patients
596993|NCT00652795|bioequivalence|bioequivalence
596994|NCT00652795|doxycycline monohydrate|doxycycline monohydrate
596995|NCT00652795|fasting|fasting
596996|NCT00652769|Lung|lung
596997|NCT00652769|Cancer|cancer
596998|NCT00652769|Staging|staging
596999|NCT00652769|Endobronchial|endobronchial
597000|NCT00652769|Ultrasound|ultrasound
597001|NCT00652769|Endoscopic|endoscopic
597002|NCT00652756|Respiration, Artificial|respiration, artificial
597003|NCT00652756|Transportation of Patients|transportation of patients
597004|NCT00652756|Intubation, Intratracheal|intubation, intratracheal
597005|NCT00652756|Tracheostomy|tracheostomy
597006|NCT00652743|immunogenicity|immunogenicity
597007|NCT00652743|safety|safety
597008|NCT00652743|GSK pandemic candidate vaccine|gsk pandemic candidate vaccine
597009|NCT00652730|bioequivalence|bioequivalence
597010|NCT00652730|buspirone HCl|buspirone hcl
597011|NCT00652730|fed|fed
597012|NCT00652704|Bioequivalence|bioequivalence
597013|NCT00652704|Doxycycline Monohydrate|doxycycline monohydrate
597014|NCT00652704|Fed|fed
597015|NCT00652691|peritoneal cavity cancer|peritoneal cavity cancer
597016|NCT00652691|ovarian clear cell tumor with proliferating activity|ovarian clear cell tumor with proliferating activity
597017|NCT00652691|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
597018|NCT00652691|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
597019|NCT00652691|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
597020|NCT00652691|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
597021|NCT00652691|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
597022|NCT00652691|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
597023|NCT00652678|Breast cancer|breast cancer
597024|NCT00652678|Radiation effects|radiation effects
597025|NCT00652665|Bioequivalence, single-dose, fasting|bioequivalence, single-dose, fasting
597026|NCT00652652|Congestive Heart Failure (CHF)|congestive heart failure (chf)
597027|NCT00652652|Heart Failure|heart failure
597028|NCT00652652|Chronic Heart Failure|chronic heart failure
597029|NCT00652652|Dyspnea|dyspnea
597030|NCT00652652|nesiritide|nesiritide
597031|NCT00652652|Natrecor|natrecor
597032|NCT00652639|bioequivalence, Clonazepam tablets, fasting|bioequivalence, clonazepam tablets, fasting
597033|NCT00652626|MDS|mds
597034|NCT00652626|AML|aml
597035|NCT00652626|Solid Tumors|solid tumors
597036|NCT00652626|Azacitidine|azacitidine
597037|NCT00652626|PK|pk
597038|NCT00652626|Pharmacokinetics|pharmacokinetics
597039|NCT00652626|Renal Impairment|renal impairment
597040|NCT00652626|Multiple Myeloma|multiple myeloma
597041|NCT00652626|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
597042|NCT00652626|Hodgkin's Disease|hodgkin's disease
597043|NCT00652613|3DCRT|3dcrt
597044|NCT00652613|IMRT|imrt
597046|NCT00652613|Quality of life|quality of life
597047|NCT00652613|Major salivary gland sparing|major salivary gland sparing
597048|NCT00652613|Pattern of local and loco-regional recurrence|pattern of local and loco-regional recurrence
597049|NCT00652613|Disease Free Survival (DFS) & Overall Survival (OAS)|disease free survival (dfs) & overall survival (oas)
597050|NCT00652613|Dose reduction to normal structures with IMRT|dose reduction to normal structures with imrt
597051|NCT00652600|Bioequivalence, Propranolol ER capsules, fed|bioequivalence, propranolol er capsules, fed
597052|NCT00652587|hepatocellular carcinoma|hepatocellular carcinoma
597053|NCT00652587|hepatectomy|hepatectomy
597054|NCT00652587|chemoembolization|chemoembolization
597055|NCT00652587|randomized controlled trial|randomized controlled trial
597056|NCT00652587|prognosis|prognosis
597057|NCT00652574|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
597058|NCT00652574|Dasatinib|dasatinib
597059|NCT00652574|BMS-354825|bms-354825
597060|NCT00652574|Sprycel|sprycel
597061|NCT00652574|MPM|mpm
597062|NCT00652548|Clavicle|clavicle
597063|NCT00652548|Fracture|fracture
597064|NCT00652548|Ultrasound|ultrasound
597065|NCT00652548|Radiation|radiation
597066|NCT00652522|AF ablation|af ablation
597067|NCT00652522|Pulmonary vein isolation(PVI)|pulmonary vein isolation(pvi)
597068|NCT00652522|reduced LV ejection fraction|reduced lv ejection fraction
597069|NCT00652522|symptomatic atrial fibrillation|symptomatic atrial fibrillation
597070|NCT00652522|persistent AF|persistent af
597071|NCT00652470|infants|infants
597072|NCT00652470|Hydrocephalus|hydrocephalus
597073|NCT00652470|Cerebrospinal Fluid Shunt|cerebrospinal fluid shunt
597074|NCT00652470|Ventriculostomy|ventriculostomy
597075|NCT00652470|neurosurgery|neurosurgery
597076|NCT00652418|Magnevist|magnevist
597077|NCT00652418|Magnetic Resonance Angiography|magnetic resonance angiography
597078|NCT00652418|Meglumine gadopentetate|meglumine gadopentetate
597079|NCT00652418|Determination of effective dose in MRA|determination of effective dose in mra
597080|NCT00652405|cephalic phase reflex|cephalic phase reflex
597081|NCT00652405|gene expression|gene expression
597082|NCT00652405|inflammation|inflammation
597083|NCT00652405|adiponectin|adiponectin
597084|NCT00652405|pancreatic polypeptide|pancreatic polypeptide
597085|NCT00652392|asthma|asthma
597086|NCT00652392|adolescents|adolescents
597087|NCT00652392|adults|adults
597088|NCT00652392|Symbicort|symbicort
597089|NCT00652392|budesonide/formoterol|budesonide/formoterol
597090|NCT00652392|budesonide|budesonide
597091|NCT00652379|Acromegaly|acromegaly
597092|NCT00652379|Insulin sensitivity|insulin sensitivity
597093|NCT00652379|Glucose tolerance|glucose tolerance
597094|NCT00652379|Body composition|body composition
597095|NCT00652379|Growth Hormone|growth hormone
597096|NCT00652353|Clinical decision rule|clinical decision rule
597097|NCT00652353|Ottawa Ankle Rule|ottawa ankle rule
597098|NCT00652353|Ottawa Foot Rule|ottawa foot rule
597099|NCT00652353|Ankle|ankle
597100|NCT00652353|Trauma|trauma
597101|NCT00652353|Education|education
597102|NCT00652353|Foot Trauma|foot trauma
597103|NCT00652314|Hemostatic products|hemostatic products
597104|NCT00652314|Surgical hemostasis|surgical hemostasis
597105|NCT00652314|Thrombi-gel|thrombi-gel
597106|NCT00652314|Gelatin Sponge|gelatin sponge
597107|NCT00652314|Time to hemostasis|time to hemostasis
597108|NCT00652288|Type I Diabetes Mellitus|type i diabetes mellitus
597109|NCT00652275|Malaria|malaria
597110|NCT00652275|vaccine|vaccine
597111|NCT00652275|Merozoite surface Antigene|merozoite surface antigene
597112|NCT00652275|Mali|mali
597113|NCT00652275|Children|children
597114|NCT00652262|Vardenafil|vardenafil
597115|NCT00652262|PDE5 inhibitor|pde5 inhibitor
597116|NCT00652262|Erectile dysfunction|erectile dysfunction
597117|NCT00652262|Spinal cord injury|spinal cord injury
597118|NCT00652249|Hydrocephalus|hydrocephalus
597119|NCT00652249|shunt dysfunction|shunt dysfunction
597120|NCT00652249|shunt flow|shunt flow
597121|NCT00652236|Low back pain|low back pain
597122|NCT00652236|Economics|economics
597123|NCT00652236|Cost-effectiveness|cost-effectiveness
597124|NCT00652210|Bladder cancer|bladder cancer
597125|NCT00652210|prostate cancer|prostate cancer
597126|NCT00652210|multiphoton microscopy|multiphoton microscopy
597127|NCT00652197|Hydrocephalus|hydrocephalus
597128|NCT00652197|shunt dysfunction|shunt dysfunction
597129|NCT00652197|shunt flow|shunt flow
597130|NCT00652184|antiviral|antiviral
597131|NCT00652184|herpes zoster|herpes zoster
597132|NCT00652184|postherpetic neuralgia|postherpetic neuralgia
597133|NCT00652184|varicella zoster virus|varicella zoster virus
597134|NCT00652184|shingles|shingles
597135|NCT00652171|Treatment|treatment
597136|NCT00652171|Augmentation|augmentation
597137|NCT00652171|Resistant depression|resistant depression
597138|NCT00652171|Lamotrigine|lamotrigine
597139|NCT00652145|ulcerative colitis|ulcerative colitis
597140|NCT00652145|inflammatory bowel disease|inflammatory bowel disease
597141|NCT00652132|ototoxicity|ototoxicity
597142|NCT00652132|childhood hepatoblastoma|childhood hepatoblastoma
597143|NCT00652132|stage I childhood liver cancer|stage i childhood liver cancer
597144|NCT00652132|stage II childhood liver cancer|stage ii childhood liver cancer
597145|NCT00652132|stage III childhood liver cancer|stage iii childhood liver cancer
597146|NCT00652119|Ovarian Cancer|ovarian cancer
597147|NCT00652119|Peritoneal Cancer|peritoneal cancer
597148|NCT00652119|Fallopian Tube Cancer|fallopian tube cancer
597149|NCT00652119|Carcinoma of Mullerian Origin|carcinoma of mullerian origin
597150|NCT00652119|Paclitaxel|paclitaxel
597151|NCT00652119|Taxol|taxol
597152|NCT00652119|Carboplatin|carboplatin
597153|NCT00652119|Paraplatin®|paraplatin®
597154|NCT00652119|Avastin|avastin
597155|NCT00652119|Bevacizumab|bevacizumab
597156|NCT00652119|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
597157|NCT00652119|rhuMAb-VEGF|rhumab-vegf
597158|NCT00652067|Mycobacterium avium-intracellulare|mycobacterium avium-intracellulare
597159|NCT00652041|Multiple Myeloma|multiple myeloma
597160|NCT00652041|Relapsed|relapsed
597161|NCT00652041|Refractary|refractary
597162|NCT00652028|Pharmacokinetics|pharmacokinetics
597163|NCT00652028|Pharmacodynamics|pharmacodynamics
597164|NCT00652028|Escalating dose|escalating dose
597165|NCT00652028|Dexmedotimidine|dexmedotimidine
597166|NCT00652028|Intubated|intubated
597167|NCT00652028|Mechanically ventilated|mechanically ventilated
597168|NCT00652028|Pediatrics|pediatrics
597169|NCT00652015|in-stent-thrombosis|in-stent-thrombosis
597170|NCT00652015|CD39|cd39
597171|NCT00652015|CD73|cd73
597172|NCT00652015|EPC|epc
597173|NCT00652002|Asthma|asthma
597174|NCT00652002|Symbicort|symbicort
597175|NCT00652002|budesonide/formoterol|budesonide/formoterol
597176|NCT00652002|budesonide|budesonide
597177|NCT00652002|formoterol|formoterol
597178|NCT00651989|optical coherence tomography|optical coherence tomography
597179|NCT00651989|spectral domain|spectral domain
597180|NCT00651989|time domain|time domain
597181|NCT00651976|stage IA breast cancer|stage ia breast cancer
597182|NCT00651976|stage IB breast cancer|stage ib breast cancer
597183|NCT00651976|stage II breast cancer|stage ii breast cancer
597184|NCT00651976|stage III breast cancer|stage iii breast cancer
597185|NCT00651976|HER2-negative breast cancer|her2-negative breast cancer
597186|NCT00651976|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
597187|NCT00651950|Hydrocephalus|hydrocephalus
597188|NCT00651950|shunt dysfunction|shunt dysfunction
597189|NCT00651950|shunt flow|shunt flow
597190|NCT00651937|Multiple Myeloma|multiple myeloma
597191|NCT00651937|Primary Amyloidosis|primary amyloidosis
597192|NCT00651937|Cytokine Modulation|cytokine modulation
597193|NCT00651937|Melphalan|melphalan
597194|NCT00651937|Alkeran|alkeran
597195|NCT00651937|Transplant Induced Symptoms|transplant induced symptoms
597196|NCT00651937|Stem Cell Infusion|stem cell infusion
597197|NCT00651937|Autologous stem cell transplant|autologous stem cell transplant
597198|NCT00651937|ASCT|asct
597199|NCT00651937|Granulocyte-colony stimulating factor|granulocyte-colony stimulating factor
597200|NCT00651937|G-CSF|g-csf
597201|NCT00651937|Apheresis|apheresis
597202|NCT00651924|chronic pain|chronic pain
597203|NCT00651924|IVR|ivr
597204|NCT00651924|cognitive-behavior therapy|cognitive-behavior therapy
597205|NCT00651898|abdominal surgery|abdominal surgery
597206|NCT00651898|hypothermia|hypothermia
597207|NCT00651898|circulating water mattress|circulating water mattress
597208|NCT00651885|UT-15C|ut-15c
597209|NCT00651885|Peripheral Vascular Disease|peripheral vascular disease
597210|NCT00651885|Treprostinil|treprostinil
597211|NCT00651872|Posttraumatic Stress Disorder|posttraumatic stress disorder
597212|NCT00651872|Functional Impairment|functional impairment
597213|NCT00651872|Veterans|veterans
597214|NCT00651872|Military Personnel|military personnel
597215|NCT00651846|Contraception|contraception
597216|NCT00651846|Hemostasis|hemostasis
597217|NCT00651846|Blood Coagulation|blood coagulation
597218|NCT00651820|wound healing|wound healing
597219|NCT00651820|scarring|scarring
597220|NCT00651820|collagenase|collagenase
597221|NCT00651820|Santyl|santyl
597222|NCT00651794|Neonatal Resuscitation|neonatal resuscitation
597223|NCT00651794|Patient Care Team|patient care team
597224|NCT00651794|Medical Errors|medical errors
597225|NCT00651781|Acute Myeloid Leukemia|acute myeloid leukemia
597226|NCT00651781|Relapsed|relapsed
597227|NCT00651781|Refractory|refractory
597228|NCT00651768|asthma|asthma
597229|NCT00651768|adults|adults
597230|NCT00651768|adolescents|adolescents
597231|NCT00651768|safety|safety
597232|NCT00651768|Symbicort|symbicort
597233|NCT00651768|budesonide/formoterol|budesonide/formoterol
597234|NCT00651768|budesonide|budesonide
597235|NCT00651755|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
597236|NCT00651755|Lymphoma|lymphoma
597237|NCT00651755|Nausea|nausea
597238|NCT00651755|Cyclophosphamide|cyclophosphamide
597239|NCT00651755|Cytoxan|cytoxan
597240|NCT00651755|Neosar|neosar
597241|NCT00651755|Doxorubicin|doxorubicin
597242|NCT00651755|AD|ad
597243|NCT00651755|Hydroxydaunomycin hydrochloride|hydroxydaunomycin hydrochloride
597244|NCT00651755|Vincristine|vincristine
597245|NCT00651755|Prednisone|prednisone
597246|NCT00651755|Rituximab|rituximab
597247|NCT00651755|Rituxan|rituxan
597248|NCT00651755|Aprepitant|aprepitant
597250|NCT00651755|L754030|l754030
597251|NCT00651755|MK869|mk869
597252|NCT00651755|Drug Metabolism|drug metabolism
597253|NCT00651755|CHOP|chop
597254|NCT00651755|R-CHOP|r-chop
597255|NCT00651755|NHL|nhl
597256|NCT00651716|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
597257|NCT00651716|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
597258|NCT00651716|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
597259|NCT00651716|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
597260|NCT00651716|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
597261|NCT00651716|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
597262|NCT00651716|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
597263|NCT00651716|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
597264|NCT00651716|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
597265|NCT00651716|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
597266|NCT00651716|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
597267|NCT00651716|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
597268|NCT00651716|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
597269|NCT00651716|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
597270|NCT00651716|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
597271|NCT00651716|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
597272|NCT00651716|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
597273|NCT00651716|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
597274|NCT00651716|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
597275|NCT00651716|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
597276|NCT00651716|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
597277|NCT00651716|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
597278|NCT00651716|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
597279|NCT00651716|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
597280|NCT00651716|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
597281|NCT00651716|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
597282|NCT00651716|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
597283|NCT00651716|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
597284|NCT00651716|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
597285|NCT00651716|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
597286|NCT00651716|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
597287|NCT00651716|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
597288|NCT00651716|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
597289|NCT00651716|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
597290|NCT00651716|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
597291|NCT00651716|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
597292|NCT00651716|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
597293|NCT00651716|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
597294|NCT00651716|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
597295|NCT00651716|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
597296|NCT00651716|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
597297|NCT00651716|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
597298|NCT00651716|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
597299|NCT00651716|splenic marginal zone lymphoma|splenic marginal zone lymphoma
597300|NCT00651716|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
597301|NCT00651716|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
597302|NCT00651716|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
597303|NCT00651716|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
597304|NCT00651716|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
597305|NCT00651716|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
597306|NCT00651716|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
597307|NCT00651716|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
597308|NCT00651716|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
597309|NCT00651716|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
597310|NCT00651716|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
597311|NCT00651716|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
597312|NCT00651716|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
597313|NCT00651716|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
597394|NCT00651521|Cardiovascular mortality|cardiovascular mortality
597314|NCT00651716|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
597315|NCT00651716|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
597316|NCT00651716|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
597317|NCT00651716|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
597318|NCT00651716|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
597319|NCT00651716|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
597320|NCT00651716|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
597321|NCT00651716|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
597322|NCT00651716|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
597323|NCT00651716|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
597324|NCT00651716|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
597325|NCT00651716|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
597326|NCT00651716|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
597327|NCT00651716|refractory hairy cell leukemia|refractory hairy cell leukemia
597328|NCT00651716|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
597329|NCT00651716|secondary acute myeloid leukemia|secondary acute myeloid leukemia
597330|NCT00651716|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
597331|NCT00651716|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
597332|NCT00651716|chronic eosinophilic leukemia|chronic eosinophilic leukemia
597333|NCT00651716|primary myelofibrosis|primary myelofibrosis
597334|NCT00651716|chronic neutrophilic leukemia|chronic neutrophilic leukemia
597335|NCT00651716|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
597336|NCT00651716|disseminated neuroblastoma|disseminated neuroblastoma
597337|NCT00651716|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
597338|NCT00651716|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
597339|NCT00651716|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
597340|NCT00651716|recurrent neuroblastoma|recurrent neuroblastoma
597341|NCT00651716|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
597342|NCT00651716|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
597343|NCT00651716|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
597344|NCT00651716|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
597345|NCT00651716|stage I multiple myeloma|stage i multiple myeloma
597346|NCT00651716|stage II multiple myeloma|stage ii multiple myeloma
597347|NCT00651716|stage III multiple myeloma|stage iii multiple myeloma
597348|NCT00651716|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
597349|NCT00651716|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
597350|NCT00651716|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
597351|NCT00651716|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
597352|NCT00651716|stage IIIA breast cancer|stage iiia breast cancer
597353|NCT00651716|stage IIIB breast cancer|stage iiib breast cancer
597354|NCT00651716|stage IIIC breast cancer|stage iiic breast cancer
597355|NCT00651716|stage IV breast cancer|stage iv breast cancer
597356|NCT00651716|refractory multiple myeloma|refractory multiple myeloma
597357|NCT00651677|hand assisted laparoscopy|hand assisted laparoscopy
597358|NCT00651677|rectal cancer|rectal cancer
597359|NCT00651677|short term outcomes|short term outcomes
597360|NCT00651677|straight laparoscopy|straight laparoscopy
597361|NCT00651651|Asthma|asthma
597362|NCT00651651|Symbicort|symbicort
597363|NCT00651651|budesonide/formoterol|budesonide/formoterol
597364|NCT00651651|budesonide|budesonide
597365|NCT00651651|formoterol|formoterol
597366|NCT00651638|PK and safety profile of ARQ 197|pk and safety profile of arq 197
597367|NCT00651625|arthrocentesis|arthrocentesis
597368|NCT00651625|injections|injections
597369|NCT00651625|anesthesia|anesthesia
597370|NCT00651625|biopsy|biopsy
597371|NCT00651625|aspiration|aspiration
597372|NCT00651625|syringe|syringe
597373|NCT00651625|safety|safety
597374|NCT00651625|pain|pain
597375|NCT00651599|Vasomotor symptoms|vasomotor symptoms
597376|NCT00651599|Vasomotor System|vasomotor system
597377|NCT00651573|Surgery|surgery
597378|NCT00651573|Cardiopulmonary bypass|cardiopulmonary bypass
597379|NCT00651573|Coronary artery bypass graft|coronary artery bypass graft
597380|NCT00651573|Valve procedure|valve procedure
597381|NCT00651573|Hematocrit level|hematocrit level
597382|NCT00651573|Outcomes|outcomes
597383|NCT00651547|Asthma|asthma
597384|NCT00651547|Symbicort|symbicort
597385|NCT00651547|budesonide/formoterol|budesonide/formoterol
597386|NCT00651547|budesonide|budesonide
597387|NCT00651547|formoterol|formoterol
597388|NCT00651547|children|children
597389|NCT00651534|Formulation Drug Study, healthy postmenopausal|formulation drug study, healthy postmenopausal
597390|NCT00651521|Angiographic CAD|angiographic cad
597391|NCT00651521|Chronic kidney disease|chronic kidney disease
597392|NCT00651521|Left ventricular dysfunction|left ventricular dysfunction
597393|NCT00651521|Body mass index|body mass index
597395|NCT00651521|Coronary angiography|coronary angiography
597396|NCT00651508|Patients with Advanced or Metastatic stage IIIB/IV Non-Small Cell Lung Cancer|patients with advanced or metastatic stage iiib/iv non-small cell lung cancer
597397|NCT00651495|Decision aids|decision aids
597398|NCT00651495|Seniors|seniors
597399|NCT00651495|Chronic disease management|chronic disease management
597400|NCT00651495|Advance directives|advance directives
597401|NCT00651469|Moderate Acne Vulgaris|moderate acne vulgaris
597402|NCT00651469|Acne|acne
597403|NCT00651443|galiximab|galiximab
597404|NCT00651443|Untreated NHL|untreated nhl
597405|NCT00651443|antibody|antibody
597406|NCT00651443|open-label|open-label
597407|NCT00651430|Balance|balance
597408|NCT00651430|Voluntary stepping|voluntary stepping
597409|NCT00651430|function|function
597410|NCT00651430|disability|disability
597411|NCT00651430|fear of falls|fear of falls
597412|NCT00651430|Total Hip Arthroplasty|total hip arthroplasty
597413|NCT00651417|Organic germanium|organic germanium
597414|NCT00651417|fatigue|fatigue
597415|NCT00651417|radiation therapy|radiation therapy
597416|NCT00651417|breast cancer|breast cancer
597417|NCT00651417|prostate cancer|prostate cancer
597418|NCT00651365|Advanced solid tumors|advanced solid tumors
597419|NCT00651365|Refractory solid tumor|refractory solid tumor
597420|NCT00651365|Antineoplastic protocol|antineoplastic protocol
597421|NCT00651365|Drug therapy|drug therapy
597422|NCT00651365|Pharmacokinetics|pharmacokinetics
597423|NCT00651365|Met inhibitor|met inhibitor
597424|NCT00651352|NRT|nrt
597425|NCT00651352|Bioequivalence|bioequivalence
597426|NCT00651352|Nicotine|nicotine
597427|NCT00651339|Cerebral Palsy|cerebral palsy
597428|NCT00651339|Balance|balance
597429|NCT00651339|Gait|gait
597430|NCT00651326|adenocarcinoma of the prostate|adenocarcinoma of the prostate
597431|NCT00651326|stage I prostate cancer|stage i prostate cancer
597432|NCT00651326|stage II prostate cancer|stage ii prostate cancer
597433|NCT00651326|stage III prostate cancer|stage iii prostate cancer
597434|NCT00651326|stage IV prostate cancer|stage iv prostate cancer
597435|NCT00651313|Dysmenorrhea|dysmenorrhea
597436|NCT00651313|Periods|periods
597437|NCT00651313|Menstrual|menstrual
597438|NCT00651313|Primary dysmenorrhea in women with recurrent dysmenorrhea|primary dysmenorrhea in women with recurrent dysmenorrhea
597439|NCT00651261|adult acute basophilic leukemia|adult acute basophilic leukemia
597440|NCT00651261|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
597441|NCT00651261|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
597442|NCT00651261|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
597443|NCT00651261|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
597444|NCT00651261|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
597445|NCT00651261|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
597446|NCT00651261|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
597447|NCT00651261|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
597448|NCT00651261|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
597449|NCT00651261|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
597450|NCT00651261|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
597451|NCT00651261|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
597452|NCT00651261|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
597453|NCT00651261|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
597454|NCT00651261|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
597455|NCT00651261|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
597456|NCT00651248|Saliva|saliva
597457|NCT00651248|Oral health|oral health
597458|NCT00651248|Aged|aged
597459|NCT00651209|Hepatitis B, chronic|hepatitis b, chronic
597460|NCT00651209|Telbivudine|telbivudine
597461|NCT00651209|Tenofovir|tenofovir
597462|NCT00651209|Roadmap Concept|roadmap concept
597463|NCT00651196|Type 1 diabetes|type 1 diabetes
597464|NCT00651196|bone|bone
597465|NCT00651170|Median block nerve|median block nerve
597466|NCT00651170|Ultrasound|ultrasound
597467|NCT00651131|post-surgical|post-surgical
597468|NCT00651131|wound infection|wound infection
597469|NCT00651131|superficial|superficial
597470|NCT00651131|deep|deep
597471|NCT00651131|surgical|surgical
597472|NCT00651105|Diabetes|diabetes
597473|NCT00651105|Hyperglycemia|hyperglycemia
597474|NCT00651105|Healthy|healthy
597475|NCT00651105|Vildagliptin|vildagliptin
597476|NCT00651105|Adults|adults
597477|NCT00651092|turbinectomy|turbinectomy
597478|NCT00651079|GSK1247303,|gsk1247303,
597479|NCT00651079|Integrase,|integrase,
597480|NCT00651079|First Time in Human|first time in human
597481|NCT00651066|HIV|hiv
597482|NCT00651066|Tuberculosis|tuberculosis
597483|NCT00651066|Rifabutin|rifabutin
597484|NCT00651066|Pharmacokinetics|pharmacokinetics
597485|NCT00651066|Vietnam|vietnam
597486|NCT00651040|Polymyositis|polymyositis
597487|NCT00651040|Dermatomyositis|dermatomyositis
597488|NCT00651040|Glucocorticoids|glucocorticoids
597489|NCT00651040|Methotrexate|methotrexate
597490|NCT00651001|fructose|fructose
597491|NCT00651001|leptin|leptin
597492|NCT00651001|metabolic syndrome|metabolic syndrome
597493|NCT00651001|blood pressure|blood pressure
597494|NCT00651001|inflammation|inflammation
597495|NCT00651001|Relationship of fructose intake to leptin levels|relationship of fructose intake to leptin levels
597496|NCT00651001|Relationship of fructose to metabolic syndrome|relationship of fructose to metabolic syndrome
597497|NCT00651001|Relationship of fructose to inflammation parameters|relationship of fructose to inflammation parameters
597498|NCT00651001|Relationship of fructose to blood pressure|relationship of fructose to blood pressure
597499|NCT00650988|Barrett's Esophagus|barrett's esophagus
597500|NCT00650988|Cryospray ablation|cryospray ablation
597501|NCT00650988|High Grade Dysplasia|high grade dysplasia
597502|NCT00650988|Early Esophageal Cancers|early esophageal cancers
597503|NCT00650988|Esophageal Neoplasms|esophageal neoplasms
597504|NCT00650988|Esophageal Intramucosal Cancer (IMCA)|esophageal intramucosal cancer (imca)
597505|NCT00650988|Esophageal Cancer limited to esophageal wall|esophageal cancer limited to esophageal wall
597506|NCT00650988|Barretts esophagus High Grade Dysplasia (HGD)|barretts esophagus high grade dysplasia (hgd)
597507|NCT00650975|STEMI|stemi
597508|NCT00650975|Laser|laser
597509|NCT00650975|Thrombus|thrombus
597510|NCT00650975|Thrombectomy|thrombectomy
597511|NCT00650962|CPR|cpr
597512|NCT00650962|Preshock CPR|preshock cpr
597513|NCT00650962|OHCA|ohca
597514|NCT00650962|EMS|ems
597515|NCT00650949|Glioblastoma multiforme|glioblastoma multiforme
597516|NCT00650949|Glioma|glioma
597517|NCT00650949|Phase Ib/II|phase ib/ii
597518|NCT00650949|CYT997|cyt997
597519|NCT00650936|Atrial|atrial
597520|NCT00650936|Septal|septal
597521|NCT00650936|Defect|defect
597522|NCT00650910|lapatinib|lapatinib
597523|NCT00650910|Metastatic ErbB2 positive breast cancer|metastatic erbb2 positive breast cancer
597524|NCT00650910|digoxin|digoxin
597525|NCT00650897|Efficacy|efficacy
597526|NCT00650897|Antidepressant|antidepressant
597527|NCT00650897|Escitalopram|escitalopram
597528|NCT00650897|Major Depression|major depression
597529|NCT00650897|Diabetes Mellitus|diabetes mellitus
597530|NCT00650897|Self Care|self care
597531|NCT00650884|Dynamic Splinting for low-load, prolonged-duration stretch|dynamic splinting for low-load, prolonged-duration stretch
597532|NCT00650871|sleep,|sleep,
597533|NCT00650871|polysomnography.|polysomnography.
597534|NCT00650871|GW679769,|gw679769,
597535|NCT00650871|primary insomnia,|primary insomnia,
597536|NCT00650871|cognitive function,|cognitive function,
597537|NCT00650858|Intraventricular hemorrhage (IVH)|intraventricular hemorrhage (ivh)
597538|NCT00650858|rt-PA|rt-pa
597539|NCT00650845|contrast-induced nephropathy, creatinemia|contrast-induced nephropathy, creatinemia
597540|NCT00650832|HIV, anti-infectives|hiv, anti-infectives
597541|NCT00650806|Obesity|obesity
597542|NCT00650806|Overweight|overweight
597543|NCT00650806|Weight loss|weight loss
597544|NCT00650806|Anti-Obesity Agents|anti-obesity agents
597545|NCT00650806|Human|human
597546|NCT00650793|Schizophrenia|schizophrenia
597547|NCT00650793|paliperidone|paliperidone
597548|NCT00650780|Viatmin D, 25-hydroxyvitamin D, Vitamin D binding protein|viatmin d, 25-hydroxyvitamin d, vitamin d binding protein
597549|NCT00650754|DHEA|dhea
597550|NCT00650754|Pregnancy|pregnancy
597551|NCT00650741|Endothelial Dysfunction|endothelial dysfunction
597552|NCT00650741|FMD|fmd
597553|NCT00650728|radiofrequency ablation|radiofrequency ablation
597554|NCT00650715|Fibromyalgia|fibromyalgia
597555|NCT00650715|Whole-Body vibration|whole-body vibration
597556|NCT00650715|Exercise|exercise
597557|NCT00650715|IGF-1|igf-1
597558|NCT00650702|glaucoma, ocular hypertension, IOP|glaucoma, ocular hypertension, iop
597559|NCT00650624|knee osteoarthritis; Japan|knee osteoarthritis; japan
597560|NCT00650598|anterior cruciate ligament, arthroscopy, knee, post-surgical pain|anterior cruciate ligament, arthroscopy, knee, post-surgical pain
597561|NCT00650585|smoking|smoking
597562|NCT00650585|alcohol|alcohol
597563|NCT00650585|prevention|prevention
597564|NCT00650585|prevention & control|prevention & control
597565|NCT00650572|human epidermal growth factor receptor 2|human epidermal growth factor receptor 2
597566|NCT00650572|epidermal growth factor receptor|epidermal growth factor receptor
597567|NCT00650572|EGFR|egfr
597568|NCT00650572|type I receptor tyrosine kinase|type i receptor tyrosine kinase
597569|NCT00650559|COPD|copd
597570|NCT00650559|Emphysema|emphysema
597571|NCT00650559|thorax enlargement|thorax enlargement
597572|NCT00650559|LVRS|lvrs
597573|NCT00650546|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
597574|NCT00650546|NASH|nash
597575|NCT00650507|children|children
597576|NCT00650507|cardiac surgery|cardiac surgery
597577|NCT00650507|remote ischemic preconditioning|remote ischemic preconditioning
597578|NCT00650507|SHAM|sham
597579|NCT00650507|ischemia-reperfusion|ischemia-reperfusion
597580|NCT00650468|Renal Transplantation|renal transplantation
597581|NCT00650468|Prograf|prograf
597582|NCT00650455|valdecoxib, severe rheumatoid arthritis|valdecoxib, severe rheumatoid arthritis
597583|NCT00650260|intraoperative warming|intraoperative warming
597584|NCT00650260|anesthesia|anesthesia
597585|NCT00650260|hypothermia|hypothermia
597586|NCT00650260|body temperature|body temperature
597587|NCT00650182|patch|patch
597588|NCT00650182|fentanyl|fentanyl
597589|NCT00650182|chronic pain|chronic pain
597590|NCT00650143|Stem cell|stem cell
597591|NCT00650143|Myocardial infarction|myocardial infarction
597592|NCT00650143|G-CSF|g-csf
597593|NCT00650143|CD26-inhibition|cd26-inhibition
597594|NCT00650130|driving under the influence|driving under the influence
597595|NCT00650130|psychoactive substances|psychoactive substances
597596|NCT00650130|oral fluid|oral fluid
597597|NCT00650130|whole blood|whole blood
597598|NCT00650130|plasma|plasma
597599|NCT00650130|Ratio of psychoactive substances in whole blood-plasma-oral fluid|ratio of psychoactive substances in whole blood-plasma-oral fluid
597600|NCT00650130|Prevalence of psychoactive substances in road traffic|prevalence of psychoactive substances in road traffic
597601|NCT00650104|ropinirole IR|ropinirole ir
597602|NCT00650104|efficacy|efficacy
597603|NCT00650104|safety|safety
597604|NCT00650104|open-label|open-label
597605|NCT00650104|long term safety; REQUIP|long term safety; requip
597606|NCT00650104|ropinirole XL|ropinirole xl
597607|NCT00650104|ropinirole CR|ropinirole cr
597608|NCT00650104|Parkinson's disease|parkinson's disease
597609|NCT00650091|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
597610|NCT00650091|Prednisone|prednisone
597611|NCT00650091|Azathioprine|azathioprine
597612|NCT00650091|NAC|nac
597613|NCT00650091|N-acetylcysteine|n-acetylcysteine
597614|NCT00650078|Signs and Symptoms|signs and symptoms
597615|NCT00650078|Autoimmune Diseases|autoimmune diseases
597616|NCT00650078|Joint Diseases|joint diseases
597617|NCT00650078|Arthritis|arthritis
597618|NCT00650078|Connective Tissue Diseases|connective tissue diseases
597619|NCT00650078|Arthritis, Rheumatoid|arthritis, rheumatoid
597620|NCT00650078|Rheumatic Diseases|rheumatic diseases
597621|NCT00650078|Predniso(lo)ne|predniso(lo)ne
597622|NCT00650039|Post surgical pain|post surgical pain
597623|NCT00650039|Anterior Cruciate ligament reconstruction|anterior cruciate ligament reconstruction
597624|NCT00650039|Arthroscopy|arthroscopy
597625|NCT00650039|Perioperative pain|perioperative pain
597626|NCT00649961|Premature Birth|premature birth
597627|NCT00649961|Brain injury|brain injury
597628|NCT00649961|Neuroprotection|neuroprotection
597629|NCT00649961|Melatonin|melatonin
597630|NCT00649961|Pharmacokinetics|pharmacokinetics
597631|NCT00649922|Vaccines with adalimumab dosing|vaccines with adalimumab dosing
597632|NCT00649909|Diabetes Mellitus|diabetes mellitus
597633|NCT00649909|Type II|type ii
597634|NCT00649909|Aspirin|aspirin
597635|NCT00649909|Resistance|resistance
597636|NCT00649883|Influenza|influenza
597637|NCT00649883|vaccine|vaccine
597638|NCT00649883|children|children
597639|NCT00649792|multiple sclerosis|multiple sclerosis
597640|NCT00649792|MS|ms
597641|NCT00649792|walking|walking
597642|NCT00649792|leg strength|leg strength
597643|NCT00649792|demyelination|demyelination
597644|NCT00649766|tailored health messages|tailored health messages
597645|NCT00649766|glaucoma|glaucoma
597646|NCT00649766|diabetic retinopathy|diabetic retinopathy
597647|NCT00649766|dilated fundus exams|dilated fundus exams
597648|NCT00649766|health behavior|health behavior
597649|NCT00649753|sacroiliac joint dysfunction|sacroiliac joint dysfunction
597650|NCT00649753|algometer|algometer
597651|NCT00649753|Chiropractic|chiropractic
597652|NCT00649753|Manual Therapy|manual therapy
597653|NCT00649753|indicator points associated with sacroiliac joint dysfunction|indicator points associated with sacroiliac joint dysfunction
597655|NCT00649701|Internet|internet
597656|NCT00649701|MSM|msm
597657|NCT00649701|Condom Use|condom use
597658|NCT00649701|Disclosure|disclosure
597659|NCT00649610|acute low back pain|acute low back pain
597660|NCT00649584|Antigens, CD30|antigens, cd30
597661|NCT00649584|Antibody-Drug Conjugate|antibody-drug conjugate
597662|NCT00649584|Antibodies, Monoclonal|antibodies, monoclonal
597663|NCT00649584|monomethyl auristatin E|monomethyl auristatin e
597664|NCT00649584|Combined Modality Therapy|combined modality therapy
597665|NCT00649584|Drug Therapy|drug therapy
597666|NCT00649584|Immunotherapy|immunotherapy
597667|NCT00649584|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
597668|NCT00649584|Disease, Hodgkin|disease, hodgkin
597669|NCT00649584|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
597670|NCT00649584|Hematologic Diseases|hematologic diseases
597671|NCT00649584|Lymphoma|lymphoma
597672|NCT00649428|Treatment of moderate to severe bilateral nasolabial fold wrinkles|treatment of moderate to severe bilateral nasolabial fold wrinkles
597673|NCT00649337|mammography|mammography
597674|NCT00649337|ultrasound|ultrasound
597675|NCT00649337|breast cancer|breast cancer
597676|NCT00649337|screening|screening
597677|NCT00649298|Randomized Controlled Trial|randomized controlled trial
597678|NCT00649298|Clinical Trial|clinical trial
597679|NCT00649298|Controlled Clinical Trial|controlled clinical trial
597680|NCT00649298|Clinical Trial, Phase IV|clinical trial, phase iv
597681|NCT00649298|Multicenter Study|multicenter study
597682|NCT00649298|End Stage Kidney Disease|end stage kidney disease
597683|NCT00649298|Hemodialysis|hemodialysis
597684|NCT00649298|Renal Dialysis|renal dialysis
597685|NCT00649298|Renal Replacement Therapy|renal replacement therapy
597686|NCT00649298|Nocturnal Dialysis|nocturnal dialysis
597687|NCT00649298|Extended dialysis|extended dialysis
597688|NCT00649298|Quality of Life|quality of life
597689|NCT00649298|Quality Adjusted Life Year|quality adjusted life year
597690|NCT00649298|Hypertrophy, Left Ventricular|hypertrophy, left ventricular
597691|NCT00649298|Blood Pressure|blood pressure
597692|NCT00649298|Hypertension|hypertension
597693|NCT00649298|Anemia|anemia
597694|NCT00649298|Hematinics|hematinics
597695|NCT00649298|Erythropoiesis Stimulating Agents|erythropoiesis stimulating agents
597696|NCT00649298|Cost-utility Analysis|cost-utility analysis
597697|NCT00649298|Economic Evaluation|economic evaluation
597698|NCT00649298|Health Care Utilisation|health care utilisation
597699|NCT00649298|Health Care Costs|health care costs
597700|NCT00649298|Health Expenditures|health expenditures
597701|NCT00649298|Hospitalization|hospitalization
597702|NCT00649298|Cost Analysis|cost analysis
597703|NCT00649298|Cardiovascular Diseases|cardiovascular diseases
597704|NCT00649298|Acute Coronary Syndrome|acute coronary syndrome
597705|NCT00649298|Myocardial Infarction|myocardial infarction
597706|NCT00649298|Stroke|stroke
597707|NCT00649298|Cerebrovascular Disorders|cerebrovascular disorders
597708|NCT00649298|Mortality|mortality
597709|NCT00649298|Arteriovenous Fistula|arteriovenous fistula
597710|NCT00649298|Arteriovenous Shunt, Surgical|arteriovenous shunt, surgical
597711|NCT00649298|Thrombosis|thrombosis
597712|NCT00649298|Infection|infection
597713|NCT00649246|genetics|genetics
597714|NCT00649246|type 1 diabetes|type 1 diabetes
597715|NCT00649246|biomarkers|biomarkers
597716|NCT00649246|autoimmunity|autoimmunity
597717|NCT00649207|WBRT|wbrt
597718|NCT00649207|Brain Metastases|brain metastases
597719|NCT00649207|Radiation|radiation
597720|NCT00649207|ABT-888|abt-888
597721|NCT00649207|PARP|parp
597722|NCT00649142|Groin hernia|groin hernia
597723|NCT00649142|Chronic postsurgical pain|chronic postsurgical pain
597724|NCT00649142|open mesh repair|open mesh repair
597725|NCT00649142|laparoscopic mesh glue fixation|laparoscopic mesh glue fixation
597726|NCT00649142|Sensory changes after groin hernia repair|sensory changes after groin hernia repair
597727|NCT00649025|Asthma|asthma
597728|NCT00649025|Asthma Moderate to Severe|asthma moderate to severe
597729|NCT00648999|Kaletra|kaletra
597730|NCT00648986|brittle nails|brittle nails
597731|NCT00648986|Tazarotene|tazarotene
597732|NCT00648986|Tazorac|tazorac
597733|NCT00648973|Seasonal Allergic Rhinitis, nasal congestion|seasonal allergic rhinitis, nasal congestion
597734|NCT00648908|multiple sclerosis|multiple sclerosis
597735|NCT00648908|MS|ms
597736|NCT00648908|walking|walking
597737|NCT00648908|leg strength|leg strength
597738|NCT00648908|demyelination|demyelination
597739|NCT00648895|Hypertension|hypertension
597740|NCT00648895|Blood pressure|blood pressure
597741|NCT00648895|Nebivolol|nebivolol
597742|NCT00648895|Bystolic (TM)|bystolic (tm)
597743|NCT00648895|Metoprolol ER (TM)|metoprolol er (tm)
597744|NCT00648869|pharmaceutical preparations|pharmaceutical preparations
597745|NCT00648817|HIV-1|hiv-1
597746|NCT00648817|tenofovir DF|tenofovir df
597747|NCT00648739|B-cell Chronic Lymphocytic Leukemia|b-cell chronic lymphocytic leukemia
597748|NCT00648739|Leukemia|leukemia
597749|NCT00648739|Multiple Myeloma|multiple myeloma
597750|NCT00648739|CD200|cd200
597751|NCT00648739|Anti-CD200|anti-cd200
597752|NCT00648687|prematurity|prematurity
597753|NCT00648687|retinopathy of prematurity|retinopathy of prematurity
597754|NCT00648687|pain|pain
597755|NCT00648687|very low birth weight infants|very low birth weight infants
597756|NCT00648635|Rectal Cancer|rectal cancer
597757|NCT00648635|Recurrent Rectal Adenocarcinoma|recurrent rectal adenocarcinoma
597758|NCT00648635|Quality of Life|quality of life
597759|NCT00648635|QOL|qol
597760|NCT00648635|Questionnaire|questionnaire
597761|NCT00648635|Survey|survey
597762|NCT00648609|Community based self management of COPD with palliative care|community based self management of copd with palliative care
597763|NCT00648479|Fracture Fixation|fracture fixation
597764|NCT00648453|Fontain II-III stage|fontain ii-iii stage
597765|NCT00648375|Propanolol|propanolol
597766|NCT00648375|Beta Blockers|beta blockers
597767|NCT00648375|Reconsolidation|reconsolidation
597768|NCT00648375|Cognitive Therapy|cognitive therapy
597769|NCT00648375|PTSD|ptsd
597770|NCT00648323|Benign Prostate Hyperplasia|benign prostate hyperplasia
597771|NCT00648284|Type 2 diabetes|type 2 diabetes
597772|NCT00648284|CV risk|cv risk
597773|NCT00648284|rosiglitazone|rosiglitazone
597774|NCT00648284|AVANDIA|avandia
597775|NCT00648258|osteoarthritis, knee|osteoarthritis, knee
597776|NCT00648258|osteoarthritis, hip|osteoarthritis, hip
597777|NCT00648245|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
597778|NCT00648245|COPD|copd
597779|NCT00648245|Chronic bronchitis|chronic bronchitis
597780|NCT00648232|HIV|hiv
597781|NCT00648232|AIDS|aids
597782|NCT00648232|Prevention|prevention
597783|NCT00648232|VCT|vct
597784|NCT00648232|Voluntary Counseling and Testing|voluntary counseling and testing
597785|NCT00648206|driving under the influence|driving under the influence
597786|NCT00648206|psychoactive substances|psychoactive substances
597787|NCT00648206|blood samples|blood samples
597788|NCT00648206|Prevalence of psychoactive substances in road traffic|prevalence of psychoactive substances in road traffic
597789|NCT00648167|ESRD|esrd
597790|NCT00648167|end-stage renal disease|end-stage renal disease
597791|NCT00648167|end stage renal disease|end stage renal disease
597792|NCT00648167|hemodialysis|hemodialysis
597793|NCT00648167|dialysis|dialysis
597794|NCT00648167|kidney failure|kidney failure
597795|NCT00648167|renal failure|renal failure
597796|NCT00648167|kidney|kidney
597797|NCT00648167|renal|renal
597798|NCT00648167|phosphate binder|phosphate binder
597799|NCT00648167|phosphorus|phosphorus
597800|NCT00648115|Veterans|veterans
597801|NCT00648115|Substance-Related Disorders|substance-related disorders
597802|NCT00648115|Mental Health|mental health
597803|NCT00648102|Breast cancer|breast cancer
597804|NCT00648102|Colorectal cancer|colorectal cancer
597805|NCT00648102|Pancreatic cancer|pancreatic cancer
597806|NCT00648102|Bladder cancer|bladder cancer
597807|NCT00648102|Ovarian cancer|ovarian cancer
597808|NCT00648102|Metastatic cancer|metastatic cancer
597809|NCT00648102|Locally advanced cancer|locally advanced cancer
597810|NCT00648102|Cancer Vaccine|cancer vaccine
597811|NCT00648102|Vaccine|vaccine
597812|NCT00648089|Acute ST Elevation Myocardial Infarction|acute st elevation myocardial infarction
597813|NCT00648037|RITUXIMAB|rituximab
597814|NCT00648037|Lymphoma|lymphoma
597815|NCT00647998|Surgical complications|surgical complications
597816|NCT00647998|Spinal ischemia|spinal ischemia
597817|NCT00647998|Stroke|stroke
597818|NCT00647998|Neuroprotection|neuroprotection
597819|NCT00647946|lipodystrophy|lipodystrophy
597820|NCT00647933|Females|females
597821|NCT00647933|Corifollitropin alfa|corifollitropin alfa
597822|NCT00647933|Antibodies|antibodies
597823|NCT00647933|Pharmacokinetics|pharmacokinetics
597824|NCT00647933|Pharmacodynamics|pharmacodynamics
597825|NCT00647868|pharmacokinetics|pharmacokinetics
597826|NCT00647868|testosterone|testosterone
597827|NCT00647868|hypogonadism|hypogonadism
597828|NCT00647829|pharyngitis, sore throat|pharyngitis, sore throat
597829|NCT00647790|PET imaging|pet imaging
597830|NCT00647790|invasive breast cancer|invasive breast cancer
597831|NCT00647725|Epidural analgesia|epidural analgesia
597832|NCT00647725|Latent analgesia|latent analgesia
597833|NCT00647725|Active analgesia|active analgesia
597834|NCT00647725|Labor delivery|labor delivery
597835|NCT00647699|keratoconus|keratoconus
597836|NCT00647699|cross-linking|cross-linking
597837|NCT00647699|riboflavin|riboflavin
597838|NCT00647699|UVA light|uva light
597839|NCT00647699|cornea|cornea
597840|NCT00647595|Obesity|obesity
597841|NCT00647595|Physical activity|physical activity
597842|NCT00647595|Pregnancy|pregnancy
597843|NCT00647595|Diabetes mellitus|diabetes mellitus
597844|NCT00647582|stage I breast cancer|stage i breast cancer
597845|NCT00647582|stage II breast cancer|stage ii breast cancer
597846|NCT00647569|vertical rectus abdominis musculocutaneus flap|vertical rectus abdominis musculocutaneus flap
597847|NCT00647569|mesh repair|mesh repair
597848|NCT00647569|salvage surgery|salvage surgery
597849|NCT00647530|adenocarcinoma of the colon|adenocarcinoma of the colon
597850|NCT00647530|stage I colon cancer|stage i colon cancer
597851|NCT00647530|stage II colon cancer|stage ii colon cancer
597852|NCT00647530|stage III colon cancer|stage iii colon cancer
597853|NCT00647504|stent thrombosis|stent thrombosis
597854|NCT00647504|stent restenosis|stent restenosis
597855|NCT00647504|intravascular ultrasound|intravascular ultrasound
597856|NCT00647478|Insulin-like Growth Factor|insulin-like growth factor
597857|NCT00647478|Insulin-like Growth Factor binding protein 3|insulin-like growth factor binding protein 3
597858|NCT00647478|Insulin-like Growth Factor-I system component levels|insulin-like growth factor-i system component levels
597859|NCT00647478|Insulin-like Growth Factor-I polymorphism|insulin-like growth factor-i polymorphism
597860|NCT00647478|Alzheimer's disease|alzheimer's disease
597861|NCT00647478|Mild Cognitive Impairment|mild cognitive impairment
597862|NCT00647478|Normal cognitive function|normal cognitive function
597863|NCT00647478|Observational cross sectional study|observational cross sectional study
597864|NCT00647465|Influenza vaccine|influenza vaccine
597865|NCT00647465|interferon|interferon
597866|NCT00647465|adjuvant|adjuvant
597867|NCT00647465|the elderly|the elderly
597868|NCT00647452|Lipid metabolism|lipid metabolism
597869|NCT00647452|VLDL|vldl
597870|NCT00647452|Exercise|exercise
597871|NCT00647452|Lipid metabolism in exercise|lipid metabolism in exercise
597872|NCT00647439|OCULAR INFLAMMATORY DISEASE|ocular inflammatory disease
597873|NCT00647439|Immune Mediated|immune mediated
597874|NCT00647439|Gene Expression Patterns|gene expression patterns
597875|NCT00647439|Diabetic Retinopathy|diabetic retinopathy
597876|NCT00647439|Age-Related Macular Degeneration|age-related macular degeneration
597877|NCT00647439|AMD|amd
597878|NCT00647439|Uveitis|uveitis
598620|NCT00644072|Neoplasms|neoplasms
597879|NCT00647426|Stage IIIB/IV|stage iiib/iv
597880|NCT00647413|smoking|smoking
597881|NCT00647413|passive smoking|passive smoking
597882|NCT00647413|exposure to environmental smoke|exposure to environmental smoke
597883|NCT00647413|home smoking ban|home smoking ban
597884|NCT00647413|urinary cotinine|urinary cotinine
597885|NCT00647400|Psoriasis|psoriasis
597886|NCT00647387|muscular|muscular
597887|NCT00647387|ventricular|ventricular
597888|NCT00647387|septal|septal
597889|NCT00647387|defects|defects
597890|NCT00647387|VSD|vsd
597891|NCT00647361|respiratory insufficiency|respiratory insufficiency
597892|NCT00647361|respiration|respiration
597893|NCT00647361|ventilators|ventilators
597894|NCT00647361|diaphragm|diaphragm
597895|NCT00647361|electromyography|electromyography
597896|NCT00647361|mechanical ventilation|mechanical ventilation
597897|NCT00647348|Secondary progressive Multiple Sclerosis|secondary progressive multiple sclerosis
597898|NCT00647348|Simvastatin|simvastatin
597899|NCT00647348|MRI|mri
597900|NCT00647322|Intractable epilepsy, Drug Reduction, Antiepileptic medication|intractable epilepsy, drug reduction, antiepileptic medication
597901|NCT00647296|ALS|als
597902|NCT00647296|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
597903|NCT00647296|Lou Gehrig|lou gehrig
597904|NCT00647296|Lou Gehrig's|lou gehrig's
597905|NCT00647296|Lou Gehrig's disease|lou gehrig's disease
597906|NCT00647296|Motor Neuron Disease|motor neuron disease
597907|NCT00647296|Nervous System Diseases|nervous system diseases
597908|NCT00647296|KNS-760704|kns-760704
597909|NCT00647283|Liver Transplantation|liver transplantation
597910|NCT00647283|Tolerance|tolerance
597911|NCT00647283|Allograft tolerance|allograft tolerance
597912|NCT00647283|Immunosuppression minimization|immunosuppression minimization
597913|NCT00647283|Immunosuppression weaning|immunosuppression weaning
597914|NCT00647283|Immunological tolerance|immunological tolerance
597915|NCT00647257|Sick Sinus Syndrome; Atrial Fibrillation; Pacemaker|sick sinus syndrome; atrial fibrillation; pacemaker
597916|NCT00647244|Tenofovir|tenofovir
597917|NCT00647244|Abacavir|abacavir
597918|NCT00647244|Antiretroviral therapy|antiretroviral therapy
597919|NCT00647244|HIV|hiv
597920|NCT00647244|Nucleoside analogue reverse transcriptase inhibitor|nucleoside analogue reverse transcriptase inhibitor
597921|NCT00647231|Osteoarthritis,Knee,Ketoprofen,Pain,Patch,Analgesic|osteoarthritis,knee,ketoprofen,pain,patch,analgesic
597922|NCT00647218|stage II breast cancer|stage ii breast cancer
597923|NCT00647218|stage IIIA breast cancer|stage iiia breast cancer
597924|NCT00647218|stage IIIB breast cancer|stage iiib breast cancer
597925|NCT00647218|stage IIIC breast cancer|stage iiic breast cancer
597926|NCT00647205|Interferon, gamma|interferon, gamma
597927|NCT00647205|HIV Infections|hiv infections
597928|NCT00647205|Tuberculosis|tuberculosis
597929|NCT00647192|atrial fibrillation|atrial fibrillation
597930|NCT00647192|electrical cardioversion|electrical cardioversion
597931|NCT00647192|prevention of atrial fibrillation recurrence|prevention of atrial fibrillation recurrence
597932|NCT00647192|mineralocorticoid receptor blocker|mineralocorticoid receptor blocker
597933|NCT00647192|eplerenone|eplerenone
597934|NCT00647192|Recurrence of atrial fibrillation after cardioversion|recurrence of atrial fibrillation after cardioversion
597935|NCT00647179|Acromegaly|acromegaly
597936|NCT00647179|Growth Hormone|growth hormone
597937|NCT00647179|Insulin resistance|insulin resistance
597938|NCT00647179|Glucose tolerance|glucose tolerance
597939|NCT00647179|Body Composition|body composition
597940|NCT00647179|Substrate metabolism|substrate metabolism
597941|NCT00647166|Vasculitis|vasculitis
597942|NCT00647166|Polyarteritis nodosa (PAN)|polyarteritis nodosa (pan)
597943|NCT00647166|Microscopic polyangiitis (MPA)|microscopic polyangiitis (mpa)
597944|NCT00647166|Eosinophilic granulomatosis with polyangiitis (EGPA)|eosinophilic granulomatosis with polyangiitis (egpa)
597945|NCT00647166|Churg Strauss syndrome (CSS)|churg strauss syndrome (css)
597946|NCT00647166|Azathioprine|azathioprine
597947|NCT00647153|stage I colon cancer|stage i colon cancer
597948|NCT00647153|stage II colon cancer|stage ii colon cancer
597949|NCT00647153|stage III colon cancer|stage iii colon cancer
597950|NCT00647153|stage IV colon cancer|stage iv colon cancer
597951|NCT00647153|stage I rectal cancer|stage i rectal cancer
597952|NCT00647153|stage II rectal cancer|stage ii rectal cancer
597953|NCT00647153|stage III rectal cancer|stage iii rectal cancer
597954|NCT00647153|stage IV rectal cancer|stage iv rectal cancer
597955|NCT00647140|Thyroid neoplasm|thyroid neoplasm
597956|NCT00647140|Thyroid carcinoma|thyroid carcinoma
597957|NCT00647140|Medullary carcinoma|medullary carcinoma
597958|NCT00647140|Positron Emission Tomography (PET)|positron emission tomography (pet)
597959|NCT00647140|18F-L DOPA|18f-l dopa
597960|NCT00647140|Calcitonin|calcitonin
597961|NCT00647140|Carcinoembryonic Antibodies|carcinoembryonic antibodies
597962|NCT00647140|Cervical ultrasonography|cervical ultrasonography
597963|NCT00647140|Cervical-chest-abdomen tomography|cervical-chest-abdomen tomography
597964|NCT00647140|Cervical-chest-abdomen magnetic resonance imaging|cervical-chest-abdomen magnetic resonance imaging
597965|NCT00647140|Osseous radionuclide imaging|osseous radionuclide imaging
597966|NCT00647140|Post-PET surgery|post-pet surgery
597967|NCT00647140|Post-PET biopsy|post-pet biopsy
597968|NCT00647140|Post-PET histology|post-pet histology
597969|NCT00647127|Buprenorphine|buprenorphine
597970|NCT00647127|Fentanyl|fentanyl
597971|NCT00647127|Analgesic effect|analgesic effect
597972|NCT00647127|Anti-hyperalgesic effect|anti-hyperalgesic effect
597973|NCT00647127|Experimental pain|experimental pain
597974|NCT00647114|Cancers expressing HER-2 and/or CEA|cancers expressing her-2 and/or cea
597975|NCT00647088|Aortic Valve stenosis|aortic valve stenosis
597976|NCT00647088|Genetic|genetic
597977|NCT00647088|Mineralisation inhibitors|mineralisation inhibitors
597978|NCT00647075|Breast cancer|breast cancer
597979|NCT00647075|undergoing|undergoing
597980|NCT00647075|adjuvant/neoadjuvant chemotherapy|adjuvant/neoadjuvant chemotherapy
597981|NCT00647075|symptomatic therapy|symptomatic therapy
597982|NCT00647036|Parenteral nutrition, Infants, Dipeotiven, Microbial invasion|parenteral nutrition, infants, dipeotiven, microbial invasion
597983|NCT00646997|atrial fibrillation, left atrium, velocity vector imaging|atrial fibrillation, left atrium, velocity vector imaging
597984|NCT00646984|Lipodystrophy|lipodystrophy
597985|NCT00646984|Treatment interruption|treatment interruption
597986|NCT00646984|HIV|hiv
597987|NCT00646971|Isoprostane|isoprostane
597988|NCT00646971|Alkane|alkane
597989|NCT00646971|Exhaled condensate|exhaled condensate
597990|NCT00646971|Peripheral arterial tonometry|peripheral arterial tonometry
597991|NCT00646971|Polysomnography|polysomnography
597992|NCT00646971|Obstructive Sleep Apnea|obstructive sleep apnea
597993|NCT00646971|Hypoxia|hypoxia
597994|NCT00646945|Patient in a oncology unit who has to undergo a painful or invasive procedure|patient in a oncology unit who has to undergo a painful or invasive procedure
597995|NCT00646906|acetaminophen|acetaminophen
597996|NCT00646906|low dose aspirin|low dose aspirin
597997|NCT00646906|cyclooxygenase|cyclooxygenase
597998|NCT00646906|prostaglandin|prostaglandin
597999|NCT00646906|drug interaction|drug interaction
598000|NCT00646906|platelet inhibition|platelet inhibition
598001|NCT00646906|urinary prostaglandin metabolites|urinary prostaglandin metabolites
598002|NCT00646906|oxidant stress|oxidant stress
598003|NCT00646906|smoking|smoking
598004|NCT00646893|aneuploidy|aneuploidy
598005|NCT00646893|miscarriage|miscarriage
598006|NCT00646893|pregnancy loss|pregnancy loss
598007|NCT00646893|PGD|pgd
598008|NCT00646893|PGS|pgs
598009|NCT00646893|Preimplantation Genetic Diagnosis|preimplantation genetic diagnosis
598010|NCT00646893|chromosome abnormalities|chromosome abnormalities
598011|NCT00646893|IVF|ivf
598012|NCT00646893|ART|art
598013|NCT00646867|Tetrix cream, contact dermatitis, effect on burning and itching|tetrix cream, contact dermatitis, effect on burning and itching
598014|NCT00646854|Lymphoma, T-Cell|lymphoma, t-cell
598015|NCT00646854|Lymphoma, T-Cell, Peripheral|lymphoma, t-cell, peripheral
598016|NCT00646854|MabCampath|mabcampath
598017|NCT00646854|Campath|campath
598018|NCT00646854|CHOP-14|chop-14
598019|NCT00646854|CD52 expression|cd52 expression
598020|NCT00646841|Essential hypertension, doxazosin, ambulatory blood pressure monitoring|essential hypertension, doxazosin, ambulatory blood pressure monitoring
598021|NCT00646828|Pseudohypoaldosteronism type 1|pseudohypoaldosteronism type 1
598022|NCT00646828|Mineralocorticoid receptor|mineralocorticoid receptor
598023|NCT00646828|Aldosterone|aldosterone
598024|NCT00646828|Cardiovascular disease|cardiovascular disease
598025|NCT00646815|insulin sensitivity|insulin sensitivity
598026|NCT00646815|substrate metabolism|substrate metabolism
598027|NCT00646815|fatty liver|fatty liver
598028|NCT00646815|intramyocellular lipids|intramyocellular lipids
598029|NCT00646815|growth hormone deficiency|growth hormone deficiency
598030|NCT00646815|Growth hormone deficiency (Adult)|growth hormone deficiency (adult)
598031|NCT00646750|Z-BEAM|z-beam
598032|NCT00646750|Autologous|autologous
598033|NCT00646750|Lymphoma|lymphoma
598034|NCT00646750|GELTAMO|geltamo
598035|NCT00646737|Kidney transplantation|kidney transplantation
598036|NCT00646737|conversion|conversion
598037|NCT00646737|mycophenolate mofetil|mycophenolate mofetil
598038|NCT00646737|mycophenolate sodium,|mycophenolate sodium,
598039|NCT00646737|tacrolimus|tacrolimus
598040|NCT00646724|Islets of Langerhans Transplantation|islets of langerhans transplantation
598041|NCT00646724|Mesenchymal Stem Cells|mesenchymal stem cells
598042|NCT00646724|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
598043|NCT00646698|VLDL-TG kinetics|vldl-tg kinetics
598044|NCT00646698|Obesity|obesity
598045|NCT00646698|Body composition|body composition
598046|NCT00646698|Tracers|tracers
598047|NCT00646698|Tissue biopsies|tissue biopsies
598048|NCT00646672|ECMO|ecmo
598049|NCT00646672|Cerebral Perfusion|cerebral perfusion
598050|NCT00646672|Carotid Artery|carotid artery
598051|NCT00646672|Aneurysm|aneurysm
598052|NCT00646672|Cerebral Circulation|cerebral circulation
598053|NCT00646672|Common Carotid Artery Occlusion|common carotid artery occlusion
598054|NCT00646659|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
598055|NCT00646659|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
598056|NCT00646659|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
598057|NCT00646659|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
598058|NCT00646659|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
598059|NCT00646659|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
598060|NCT00646659|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
598061|NCT00646659|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
598062|NCT00646659|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
598063|NCT00646646|Sedation|sedation
598064|NCT00646646|Eye Movements|eye movements
598065|NCT00646633|Cancer|cancer
598066|NCT00646633|Acupuncture|acupuncture
598067|NCT00646620|asthma|asthma
598068|NCT00646620|bronchodilatation|bronchodilatation
598069|NCT00646620|Symbicort|symbicort
598070|NCT00646620|budesonide/formoterol|budesonide/formoterol
598071|NCT00646620|Advair Diskus|advair diskus
598072|NCT00646620|Ventolin|ventolin
598073|NCT00646607|colorectal neoplasm|colorectal neoplasm
598074|NCT00646607|high risk|high risk
598075|NCT00646607|stage II/III|stage ii/iii
598076|NCT00646594|Asthma|asthma
598077|NCT00646594|inhaled cortocisteroids|inhaled cortocisteroids
598078|NCT00646594|Symbicort|symbicort
598079|NCT00646594|budesonide/formoterol|budesonide/formoterol
598080|NCT00646594|Advair|advair
598081|NCT00646594|fluticasone/salmeterol|fluticasone/salmeterol
598082|NCT00646581|Schizophrenia|schizophrenia
598083|NCT00646581|Memory|memory
598084|NCT00646581|Concentration|concentration
598085|NCT00646581|Insulin|insulin
598086|NCT00646568|IVF|ivf
598087|NCT00646568|ovarian reserve|ovarian reserve
598088|NCT00646568|androgens|androgens
598089|NCT00646568|thecal cells|thecal cells
598090|NCT00646568|Fertility Agents, Female|fertility agents, female
598091|NCT00646555|Tissue Samples|tissue samples
598092|NCT00646555|VEGF Receptors|vegf receptors
598093|NCT00646555|VEGF|vegf
598094|NCT00646555|Microvessel Density|microvessel density
598095|NCT00646555|Hypoxia Inducible Factor|hypoxia inducible factor
598096|NCT00646555|Inflammatory Breast Cancer|inflammatory breast cancer
598097|NCT00646555|IBC|ibc
598098|NCT00646542|Type 2 diabetes, vildagliptin|type 2 diabetes, vildagliptin
598099|NCT00646529|asthma|asthma
598100|NCT00646529|children|children
598101|NCT00646529|Symbicort|symbicort
598102|NCT00646529|budesonide/formoterol|budesonide/formoterol
598103|NCT00646529|Pulmicort|pulmicort
598104|NCT00646529|budesonide|budesonide
598105|NCT00646516|Asthma|asthma
598106|NCT00646516|inhaled corticosteroids|inhaled corticosteroids
598107|NCT00646516|Symbicort|symbicort
598108|NCT00646516|budesonide/formoterol|budesonide/formoterol
598109|NCT00646516|budesonide|budesonide
598110|NCT00646503|Hepatitis B, Chronic|hepatitis b, chronic
598111|NCT00646503|Telbivudine|telbivudine
598112|NCT00646503|Polymerase Chain reaction|polymerase chain reaction
598113|NCT00646490|serum, pleural effusion, procalcitonin, pneumonia|serum, pleural effusion, procalcitonin, pneumonia
598114|NCT00646464|CPT|cpt
598115|NCT00646464|ADHD|adhd
598116|NCT00646451|Essential tremor|essential tremor
598117|NCT00646451|Activities of Daily Living (ADL's)|activities of daily living (adl's)
598118|NCT00646438|Diabetes|diabetes
598119|NCT00646438|CABG|cabg
598120|NCT00646425|Non-infectious uveitis|non-infectious uveitis
598121|NCT00646412|randomized, controlled, single-blind study|randomized, controlled, single-blind study
598122|NCT00646412|Adhesion Prophylaxis|adhesion prophylaxis
598123|NCT00646412|Abdominal Surgery|abdominal surgery
598124|NCT00646412|Laparotomy, median|laparotomy, median
598125|NCT00646399|Staphylococcal|staphylococcal
598126|NCT00646399|Coagulase Negative Staphylococcus|coagulase negative staphylococcus
598127|NCT00646399|Monoclonal antibodies|monoclonal antibodies
598128|NCT00646399|Very Low Birth Weight Infants|very low birth weight infants
598129|NCT00646399|Prophylaxis|prophylaxis
598130|NCT00646373|Cardiac surgery|cardiac surgery
598131|NCT00646373|Pump prime|pump prime
598132|NCT00646373|Blood transfusions|blood transfusions
598133|NCT00646360|birth size, gestational age, development, child growth,|birth size, gestational age, development, child growth,
598134|NCT00646360|prenatal nutrition, DHA|prenatal nutrition, dha
598135|NCT00646347|stroke|stroke
598136|NCT00646347|upper limb rehabilitation|upper limb rehabilitation
598137|NCT00646347|treatment|treatment
598138|NCT00646347|movement recovery from sever paralytic upper limb|movement recovery from sever paralytic upper limb
598139|NCT00646347|neuro hand orthosis|neuro hand orthosis
598140|NCT00646347|self practice program|self practice program
598141|NCT00646347|subacute|subacute
598142|NCT00646334|Large Pore Size Propylene Mesh|large pore size propylene mesh
598143|NCT00646334|Incisional Hernia|incisional hernia
598144|NCT00646334|Randomized Controlled Double-blind Study|randomized controlled double-blind study
598145|NCT00646321|asthma|asthma
598146|NCT00646321|children|children
598147|NCT00646321|adolescents|adolescents
598148|NCT00646321|Symbicort|symbicort
598149|NCT00646321|budesonide/ formoterol|budesonide/ formoterol
598150|NCT00646321|budesonide|budesonide
598151|NCT00646308|growth hormone deficiency, pituitary tumors|growth hormone deficiency, pituitary tumors
598152|NCT00646295|TRO|tro
598222|NCT00646139|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
598153|NCT00646269|Dementia ; Alzheimer's Disease ; Non pharmacological treatments ; cognitive training ; reminiscence therapy ; efficacy assessment|dementia ; alzheimer's disease ; non pharmacological treatments ; cognitive training ; reminiscence therapy ; efficacy assessment
598154|NCT00646256|schizoaffective|schizoaffective
598155|NCT00646256|schizotypal|schizotypal
598156|NCT00646243|Heart failure|heart failure
598157|NCT00646243|echocardiography|echocardiography
598158|NCT00646243|cardiac resynchronization therapy|cardiac resynchronization therapy
598159|NCT00646243|left ventricular dyssynchrony|left ventricular dyssynchrony
598160|NCT00646230|recurrent neuroblastoma|recurrent neuroblastoma
598161|NCT00646217|SELF Care Talk|self care talk
598162|NCT00646217|stroke|stroke
598163|NCT00646217|caregivers|caregivers
598164|NCT00646217|Caregiving as experienced by older adults caring for a spouse/partner with a first-ever stroke|caregiving as experienced by older adults caring for a spouse/partner with a first-ever stroke
598165|NCT00646204|Parkinson's disease|parkinson's disease
598166|NCT00646204|non-motor symptoms|non-motor symptoms
598167|NCT00646165|Leukemia, CLL|leukemia, cll
598168|NCT00646152|Antiviral|antiviral
598169|NCT00646152|Influenza|influenza
598170|NCT00646152|Interferon|interferon
598171|NCT00646152|Prophylaxis|prophylaxis
598172|NCT00646152|SARS|sars
598173|NCT00646152|Healthy Volunteer|healthy volunteer
598174|NCT00646152|HV|hv
598175|NCT00646139|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
598176|NCT00646139|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
598177|NCT00646139|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
598178|NCT00646139|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
598179|NCT00646139|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
598180|NCT00646139|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
598181|NCT00646139|anaplastic large cell lymphoma|anaplastic large cell lymphoma
598182|NCT00646139|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
598183|NCT00646139|splenic marginal zone lymphoma|splenic marginal zone lymphoma
598184|NCT00646139|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
598185|NCT00646139|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
598186|NCT00646139|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
598187|NCT00646139|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
598188|NCT00646139|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
598189|NCT00646139|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
598190|NCT00646139|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
598191|NCT00646139|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
598192|NCT00646139|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
598193|NCT00646139|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
598194|NCT00646139|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
598195|NCT00646139|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
598196|NCT00646139|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
598197|NCT00646139|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
598198|NCT00646139|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
598199|NCT00646139|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
598200|NCT00646139|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
598201|NCT00646139|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
598202|NCT00646139|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
598203|NCT00646139|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
598204|NCT00646139|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
598205|NCT00646139|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
598206|NCT00646139|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
598207|NCT00646139|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
598208|NCT00646139|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
598209|NCT00646139|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
598210|NCT00646139|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
598211|NCT00646139|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
598212|NCT00646139|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
598213|NCT00646139|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
598214|NCT00646139|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
598215|NCT00646139|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
598216|NCT00646139|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
598217|NCT00646139|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
598218|NCT00646139|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
598219|NCT00646139|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
598220|NCT00646139|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
598221|NCT00646139|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
598223|NCT00646139|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
598224|NCT00646139|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
598225|NCT00646139|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
598226|NCT00646139|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
598227|NCT00646139|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
598228|NCT00646139|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
598229|NCT00646139|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
598230|NCT00646139|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
598231|NCT00646139|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
598232|NCT00646139|intraocular lymphoma|intraocular lymphoma
598233|NCT00646139|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
598234|NCT00646139|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
598235|NCT00646139|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
598236|NCT00646139|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
598237|NCT00646139|small intestine lymphoma|small intestine lymphoma
598238|NCT00646100|hepatocellular carcinoma|hepatocellular carcinoma
598239|NCT00646100|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
598240|NCT00646100|prospective control study|prospective control study
598241|NCT00646100|best support care|best support care
598242|NCT00646100|survival|survival
598243|NCT00646074|Caregiver|caregiver
598244|NCT00646074|Alzheimer's disease|alzheimer's disease
598245|NCT00646074|Caregiving as experienced by older adults caring for a spouse with Alzheimer's disease or dementia|caregiving as experienced by older adults caring for a spouse with alzheimer's disease or dementia
598246|NCT00646061|renal colic|renal colic
598247|NCT00646048|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
598248|NCT00646048|AAA|aaa
598249|NCT00646048|TriVascular Stent-Graft System|trivascular stent-graft system
598250|NCT00646048|Stent-Graft|stent-graft
598251|NCT00646022|Neuroendocrine|neuroendocrine
598252|NCT00646022|PET|pet
598253|NCT00646022|Gastrointestinal|gastrointestinal
598254|NCT00646022|Serotonin|serotonin
598255|NCT00646022|Carcinoid Tumor|carcinoid tumor
598256|NCT00646022|Gastrointestinal Carcinoid Tumor|gastrointestinal carcinoid tumor
598257|NCT00646022|Familial Cancer Tumor|familial cancer tumor
598258|NCT00646009|asthma|asthma
598259|NCT00646009|adults|adults
598260|NCT00646009|Symbicort|symbicort
598261|NCT00646009|budesonide/formoterol|budesonide/formoterol
598262|NCT00646009|Advair Diskus|advair diskus
598263|NCT00646009|Ventolin|ventolin
598264|NCT00645996|Probiotics|probiotics
598265|NCT00645996|vaccines|vaccines
598266|NCT00645996|Measles|measles
598267|NCT00645996|Mumps|mumps
598268|NCT00645996|Rubella|rubella
598269|NCT00645983|Chamomile|chamomile
598270|NCT00645983|Anxiety|anxiety
598271|NCT00645983|Complementary and Alternative Medicine|complementary and alternative medicine
598272|NCT00645970|chronic pain|chronic pain
598273|NCT00645970|combat injuries|combat injuries
598274|NCT00645970|pain assessment|pain assessment
598275|NCT00645970|multiple traumas|multiple traumas
598276|NCT00645970|rehabilitation|rehabilitation
598277|NCT00645957|drainage|drainage
598278|NCT00645957|irrigation|irrigation
598279|NCT00645931|Bone Marrow|bone marrow
598280|NCT00645931|Bone Marrow Transplant|bone marrow transplant
598281|NCT00645931|Pediatric|pediatric
598282|NCT00645931|Psychological Impact|psychological impact
598283|NCT00645931|Psychology|psychology
598284|NCT00645918|Platelets|platelets
598285|NCT00645918|Platelet Function Tests|platelet function tests
598286|NCT00645918|Clopidogrel|clopidogrel
598287|NCT00645918|Drug Eluting Stents|drug eluting stents
598288|NCT00645918|Acute Coronary Syndrome|acute coronary syndrome
598289|NCT00645918|Myocardial Ischemia|myocardial ischemia
598290|NCT00645918|Stent Thrombosis|stent thrombosis
598291|NCT00645918|Heart Diseases|heart diseases
598292|NCT00645918|Coronary Disease|coronary disease
598293|NCT00645918|Arterial Occlusive Disease|arterial occlusive disease
598294|NCT00645879|Propionic Acidemia|propionic acidemia
598295|NCT00645879|hyperammonemia|hyperammonemia
598296|NCT00645879|hypotonia|hypotonia
598297|NCT00645879|glutamine|glutamine
598298|NCT00645879|ornithine alpha ketoglutarate|ornithine alpha ketoglutarate
598299|NCT00645879|citrate|citrate
598300|NCT00645866|stage IIIA breast cancer|stage iiia breast cancer
598301|NCT00645866|stage IIIB breast cancer|stage iiib breast cancer
598302|NCT00645866|stage IIIC breast cancer|stage iiic breast cancer
598303|NCT00645840|Type 1 diabetes mellitus|type 1 diabetes mellitus
598304|NCT00645840|IL1 beta|il1 beta
598305|NCT00645840|Anakinra|anakinra
598306|NCT00645827|Insulin|insulin
598307|NCT00645827|Blood Glucose|blood glucose
598308|NCT00645801|Routine screening colonoscopy|routine screening colonoscopy
598309|NCT00645801|Colonoscopy Preparation|colonoscopy preparation
598310|NCT00645801|Amitiza|amitiza
598311|NCT00645801|GoLYTELY|golytely
598312|NCT00645801|Pegylated Electrolytes|pegylated electrolytes
598313|NCT00645801|Preparation Solution|preparation solution
598314|NCT00645801|Colonoscopy Solution|colonoscopy solution
598315|NCT00645788|Ciprofloxacin|ciprofloxacin
598316|NCT00645788|cystic fibrosis|cystic fibrosis
598317|NCT00645788|sweat test|sweat test
598318|NCT00645788|pulmonary function test|pulmonary function test
598319|NCT00645775|Weight loss|weight loss
598320|NCT00645775|Antiobesity|antiobesity
598321|NCT00645775|Metabolic syndrome|metabolic syndrome
598322|NCT00645775|Leptin|leptin
598323|NCT00645762|Chronic rhinosinusitis|chronic rhinosinusitis
598324|NCT00645762|Chronic sinusitis|chronic sinusitis
598325|NCT00645762|Maxillary sinus|maxillary sinus
598326|NCT00645762|Anterior ethmoid sinus|anterior ethmoid sinus
598327|NCT00645762|Ethmoid infundibulum|ethmoid infundibulum
598328|NCT00645762|Balloon dilation|balloon dilation
598329|NCT00645762|Endoscopic visualization|endoscopic visualization
598330|NCT00645762|Local anesthesia|local anesthesia
598331|NCT00645762|Canine fossa|canine fossa
598332|NCT00645762|Less invasive|less invasive
598333|NCT00645736|Chronic Hepatitis B|chronic hepatitis b
598334|NCT00645723|Acinetobacter baumanii|acinetobacter baumanii
598335|NCT00645723|Ventilator-associated pneumonia|ventilator-associated pneumonia
598336|NCT00645697|tuberculosis|tuberculosis
598337|NCT00645697|Multifocal serpiginous choroiditis|multifocal serpiginous choroiditis
598338|NCT00645697|histoplasmosis|histoplasmosis
598339|NCT00645697|Harada toxoplasmosis|harada toxoplasmosis
598340|NCT00645684|Gastrointestinal Anastomosis|gastrointestinal anastomosis
598341|NCT00645684|Multicentre|multicentre
598342|NCT00645684|Randomized controlled single-blind study|randomized controlled single-blind study
598343|NCT00645684|synthetic, absorbable, braided and coated suture material|synthetic, absorbable, braided and coated suture material
598344|NCT00645684|Laparotomy|laparotomy
598345|NCT00645645|Holoprosencephaly|holoprosencephaly
598346|NCT00645645|Agenesis of Corpus|agenesis of corpus
598347|NCT00645645|Callosum|callosum
598348|NCT00645645|Genetic Tests|genetic tests
598349|NCT00645632|localized osteosarcoma|localized osteosarcoma
598350|NCT00645619|Pneumonia,viral|pneumonia,viral
598351|NCT00645619|Pneumonia,bacterial|pneumonia,bacterial
598352|NCT00645619|TREM-1 protein,human|trem-1 protein,human
598353|NCT00645606|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
598354|NCT00645606|Maintenance in first-line treatment|maintenance in first-line treatment
598355|NCT00645606|Elderly patients|elderly patients
598356|NCT00645593|Bladder Cancer|bladder cancer
598357|NCT00645567|Biomechanics|biomechanics
598358|NCT00645567|Ergonomics|ergonomics
598359|NCT00645567|Spinal Cord Injury|spinal cord injury
598360|NCT00645567|Pain|pain
598361|NCT00645567|Shoulder|shoulder
598362|NCT00645554|Galantamine oral solution|galantamine oral solution
598363|NCT00645554|Galantamine tablet|galantamine tablet
598364|NCT00645554|Bioequivalence|bioequivalence
598365|NCT00645541|Breast Cancer|breast cancer
598366|NCT00645541|Carcinoma of the Breast|carcinoma of the breast
598367|NCT00645541|Lymph Nodes|lymph nodes
598368|NCT00645541|Lymphazurin|lymphazurin
598369|NCT00645541|Axillary Reverse Mapping|axillary reverse mapping
598370|NCT00645528|insulin|insulin
598371|NCT00645528|teaching|teaching
598372|NCT00645502|Schizophrenia|schizophrenia
598373|NCT00645502|Risperidone|risperidone
598374|NCT00645502|Orally-disintegrating tablet|orally-disintegrating tablet
598375|NCT00645502|Bioequivalence|bioequivalence
598376|NCT00645489|heart failure intervention|heart failure intervention
598377|NCT00645450|Stress|stress
598378|NCT00645450|Posttraumatic|posttraumatic
598379|NCT00645450|PTSD|ptsd
598380|NCT00645450|Propranolol|propranolol
598381|NCT00645450|Treatment|treatment
598382|NCT00645437|renal diseases|renal diseases
598383|NCT00645437|levofloxacin|levofloxacin
598384|NCT00645411|Influenza|influenza
598386|NCT00645411|Cell Culture-Derived|cell culture-derived
598387|NCT00645411|Egg-Derived|egg-derived
598388|NCT00645411|Healthy Children|healthy children
598389|NCT00645411|Healthy Adolescents|healthy adolescents
598390|NCT00645411|Safety|safety
598391|NCT00645411|Immunogenicity|immunogenicity
598392|NCT00645411|Trivalent|trivalent
598393|NCT00645411|Inactivated|inactivated
598394|NCT00645411|Vaccination|vaccination
598395|NCT00645385|GBM|gbm
598396|NCT00645385|AA|aa
598397|NCT00645385|AO|ao
598398|NCT00645385|Brain|brain
598399|NCT00645385|Tumors|tumors
598400|NCT00645385|Malignant|malignant
598401|NCT00645385|Glioblastoma|glioblastoma
598402|NCT00645385|Multiforme|multiforme
598403|NCT00645385|Carmustine|carmustine
598404|NCT00645385|implant|implant
598405|NCT00645385|BCNU|bcnu
598406|NCT00645385|Gliadel|gliadel
598407|NCT00645385|Wafers|wafers
598408|NCT00645385|MRS|mrs
598409|NCT00645385|Spectroscopy|spectroscopy
598410|NCT00645359|dMRI|dmri
598411|NCT00645359|diffusion MRI|diffusion mri
598412|NCT00645359|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
598413|NCT00645359|DLBCL|dlbcl
598414|NCT00645346|GBS|gbs
598415|NCT00645333|breast cancer|breast cancer
598416|NCT00645333|Phase I clinical trial|phase i clinical trial
598417|NCT00645333|cancer stem cells|cancer stem cells
598418|NCT00645333|agents with other mechanisms of action|agents with other mechanisms of action
598419|NCT00645333|Notch inhibitors|notch inhibitors
598420|NCT00645307|paliperidone|paliperidone
598421|NCT00645307|Schizophrenia|schizophrenia
598422|NCT00645294|Hepatitis B|hepatitis b
598423|NCT00645294|Adefovir dipivoxil|adefovir dipivoxil
598424|NCT00645294|Children|children
598425|NCT00645294|Adolescents|adolescents
598426|NCT00645294|Pharmacokinetics|pharmacokinetics
598427|NCT00645190|Alzheimer Disease|alzheimer disease
598428|NCT00645190|galantamine|galantamine
598429|NCT00645177|Breast Cancer|breast cancer
598430|NCT00645164|wound healing|wound healing
598431|NCT00645164|photoallergenicity|photoallergenicity
598432|NCT00645164|Healthy subjects|healthy subjects
598433|NCT00645138|breast carcinoma|breast carcinoma
598434|NCT00645138|breast cancer|breast cancer
598435|NCT00645138|paravertebral block|paravertebral block
598436|NCT00645138|comparison of paravertebral block and general anesthesia|comparison of paravertebral block and general anesthesia
598437|NCT00645138|ultrasound|ultrasound
598438|NCT00645125|pediatric taste test|pediatric taste test
598439|NCT00645125|antibiotic taste test|antibiotic taste test
598440|NCT00645125|cefdinir|cefdinir
598441|NCT00645125|amoxicillin|amoxicillin
598442|NCT00645099|Paliperidone ER|paliperidone er
598443|NCT00645099|Olanzapine|olanzapine
598444|NCT00645099|Schizophrenia|schizophrenia
598445|NCT00645073|Acute Bacterial Sinusitis|acute bacterial sinusitis
598446|NCT00645060|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
598447|NCT00645047|PTSD|ptsd
598448|NCT00645047|Telemedicine|telemedicine
598449|NCT00645047|Patient-Centered Care|patient-centered care
598450|NCT00645047|Professional Patient Relationship|professional patient relationship
598451|NCT00645047|Psychotherapy|psychotherapy
598452|NCT00645047|Cognitive Therapy|cognitive therapy
598453|NCT00645008|Stressors|stressors
598454|NCT00645008|Patient Satisfaction|patient satisfaction
598455|NCT00645008|Cardiothoracic-Intensive Care Unit|cardiothoracic-intensive care unit
598456|NCT00645008|Coronary bypass patient|coronary bypass patient
598457|NCT00644995|Depression|depression
598458|NCT00644995|Smoking|smoking
598459|NCT00644995|Physical Activity|physical activity
598460|NCT00644930|ARDS,|ards,
598461|NCT00644930|noninvasive ventilation,|noninvasive ventilation,
598462|NCT00644930|intubation,|intubation,
598463|NCT00644930|mortality,|mortality,
598464|NCT00644930|intensive care|intensive care
598465|NCT00644917|wound healing|wound healing
598466|NCT00644917|phototoxicity|phototoxicity
598467|NCT00644917|Healthy Subjects|healthy subjects
598468|NCT00644904|Multiple Sclerosis|multiple sclerosis
598469|NCT00644904|Vitamin D|vitamin d
598470|NCT00644904|Safety|safety
598471|NCT00644891|Pediatric taste test|pediatric taste test
598472|NCT00644891|Antibiotic taste test|antibiotic taste test
598473|NCT00644891|cefdinir|cefdinir
598474|NCT00644891|amoxicillin|amoxicillin
598475|NCT00644878|leukemia|leukemia
598476|NCT00644878|chronic myelogenous leukemia|chronic myelogenous leukemia
598477|NCT00644878|chronic phase|chronic phase
598478|NCT00644878|molecular response|molecular response
598479|NCT00644878|nilotinib|nilotinib
598480|NCT00644878|ENABL|enabl
598481|NCT00644852|Schizophrenia|schizophrenia
598482|NCT00644852|Schizoaffective disorder|schizoaffective disorder
598483|NCT00644852|Risperidone long-acting injectable, Long-term evaluation|risperidone long-acting injectable, long-term evaluation
598484|NCT00644826|randomized controlled trial|randomized controlled trial
598485|NCT00644826|public health|public health
598486|NCT00644826|Preventive Health Services|preventive health services
598487|NCT00644787|Pain|pain
598488|NCT00644787|Cancer|cancer
598489|NCT00644787|Fentanyl|fentanyl
598490|NCT00644787|JNS020QD|jns020qd
598491|NCT00644787|JNS005|jns005
598492|NCT00644774|pediatric taste test|pediatric taste test
598493|NCT00644774|antibiotic taste test|antibiotic taste test
598494|NCT00644774|cefdinir|cefdinir
598495|NCT00644774|azithromycin|azithromycin
598496|NCT00644761|Hepatitis B|hepatitis b
598497|NCT00644761|Post-Liver Transplantation|post-liver transplantation
598498|NCT00644761|Adefovir Dipivoxil|adefovir dipivoxil
598499|NCT00644761|Tacrolimus|tacrolimus
598500|NCT00644761|Cyclosporine|cyclosporine
598501|NCT00644735|Erosive Esophagitis|erosive esophagitis
598502|NCT00644735|Nexium|nexium
598503|NCT00644735|Esomeprazole|esomeprazole
598504|NCT00644735|Lansoprazole|lansoprazole
598505|NCT00644735|Heartburn|heartburn
598506|NCT00644722|Intubation|intubation
598507|NCT00644722|Out-of-hospital|out-of-hospital
598508|NCT00644722|Laryngoscope|laryngoscope
598509|NCT00644722|Blades|blades
598510|NCT00644722|Emergency|emergency
598511|NCT00644696|Neuroblastoma|neuroblastoma
598512|NCT00644696|Irinotecan|irinotecan
598513|NCT00644696|Bortezomib|bortezomib
598514|NCT00644683|premenopausal women with breast cancer|premenopausal women with breast cancer
598515|NCT00644657|Platelets, platelet aggregation inhibitors|platelets, platelet aggregation inhibitors
598516|NCT00644644|NTX|ntx
598517|NCT00644644|Nihon Kohden|nihon kohden
598518|NCT00644644|mobile monitoring|mobile monitoring
598519|NCT00644618|pancreatic cancer|pancreatic cancer
598520|NCT00644618|locally advanced|locally advanced
598521|NCT00644592|Healthy Volunteers|healthy volunteers
598522|NCT00644579|wart|wart
598523|NCT00644579|cutaneous|cutaneous
598524|NCT00644579|transplant|transplant
598525|NCT00644579|Cutaneous warts in immune suppressed, kidney transplant patients|cutaneous warts in immune suppressed, kidney transplant patients
598526|NCT00644566|ADHD|adhd
598527|NCT00644566|Primary Care|primary care
598528|NCT00644566|Pediatrics|pediatrics
598529|NCT00644566|Health services|health services
598530|NCT00644566|shared care|shared care
598531|NCT00644566|care manager|care manager
598532|NCT00644566|screening|screening
598533|NCT00644540|Influenza|influenza
598534|NCT00644540|vaccines|vaccines
598535|NCT00644540|children|children
598536|NCT00644527|depression|depression
598537|NCT00644527|music|music
598538|NCT00644527|sound|sound
598539|NCT00644527|randomized controlled trial|randomized controlled trial
598540|NCT00644514|LPS endotoxin|lps endotoxin
598541|NCT00644514|Asthma|asthma
598542|NCT00644501|type 1 diabetes|type 1 diabetes
598543|NCT00644501|beta cells|beta cells
598544|NCT00644501|immunomodulation|immunomodulation
598545|NCT00644501|immunointervention|immunointervention
598546|NCT00644475|Hypertension|hypertension
598547|NCT00644475|Insulin sensitivity|insulin sensitivity
598548|NCT00644475|Fibrinolysis|fibrinolysis
598549|NCT00644462|wheeze detection|wheeze detection
598550|NCT00644436|tetrix cream|tetrix cream
598551|NCT00644436|substantivity|substantivity
598552|NCT00644436|resistance to a gentle wash|resistance to a gentle wash
598553|NCT00644436|Tetrix Cream remaining on hands after gentle washing with soap and water.|tetrix cream remaining on hands after gentle washing with soap and water.
598554|NCT00644423|PTSD|ptsd
598555|NCT00644423|Cognition|cognition
598556|NCT00644423|Fish Oil|fish oil
598557|NCT00644423|Omega-3 Fatty Acid|omega-3 fatty acid
598558|NCT00644410|heart failure|heart failure
598559|NCT00644410|stem cell|stem cell
598560|NCT00644410|mesenchymal stromal cell|mesenchymal stromal cell
598561|NCT00644410|mesenchymal stem cell|mesenchymal stem cell
598562|NCT00644397|distal femur fracture|distal femur fracture
598563|NCT00644397|locked plates|locked plates
598564|NCT00644397|functional outcomes|functional outcomes
598565|NCT00644397|cost management|cost management
598566|NCT00644397|femur head|femur head
598567|NCT00644397|femur neck|femur neck
598568|NCT00644384|basal cell carcinoma of the skin|basal cell carcinoma of the skin
598569|NCT00644384|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
598570|NCT00644371|Allogeneic|allogeneic
598571|NCT00644371|Lymphoma|lymphoma
598572|NCT00644371|GELTAMO|geltamo
598573|NCT00644371|Z-RIC|z-ric
598574|NCT00644345|Microvolt T wave alternans|microvolt t wave alternans
598575|NCT00644345|reproducibility|reproducibility
598576|NCT00644319|malignant pleural effusion|malignant pleural effusion
598577|NCT00644306|Multiple Myeloma, very elderly patients, thalidomide|multiple myeloma, very elderly patients, thalidomide
598578|NCT00644280|Glaucoma,Ahmed Valve|glaucoma,ahmed valve
598579|NCT00644267|hypertension|hypertension
598580|NCT00644267|cardiovascular risk|cardiovascular risk
598581|NCT00644267|risk score|risk score
598582|NCT00644254|Prognosis|prognosis
598583|NCT00644254|Extracapsular lymph node involvement|extracapsular lymph node involvement
598584|NCT00644241|stem cell therapy|stem cell therapy
598585|NCT00644241|T2DM|t2dm
598586|NCT00644241|Efficacy Of Autologous Bone Marrow Derived Stem Cell Transplantation In Patients With Type 2 Diabetes Mellitus|efficacy of autologous bone marrow derived stem cell transplantation in patients with type 2 diabetes mellitus
598587|NCT00644215|injected bleb|injected bleb
598588|NCT00644215|mitomycin drop|mitomycin drop
598589|NCT00644215|5-Fu injection|5-fu injection
598590|NCT00644215|early bleb failure|early bleb failure
598591|NCT00644202|weight control|weight control
598592|NCT00644189|clofarabine|clofarabine
598593|NCT00644189|Clolar|clolar
598594|NCT00644189|lymphoma|lymphoma
598595|NCT00644189|NHL|nhl
598596|NCT00644189|oral chemotherapy|oral chemotherapy
598597|NCT00644163|HIV|hiv
598598|NCT00644163|STI|sti
598599|NCT00644163|Risk Reduction|risk reduction
598600|NCT00644163|Couples|couples
598601|NCT00644163|African American|african american
598602|NCT00644163|HIV Seronegativity|hiv seronegativity
598603|NCT00644150|Risk Reduction Counseling|risk reduction counseling
598604|NCT00644150|Anhui, China|anhui, china
598605|NCT00644150|HIV|hiv
598606|NCT00644150|STI|sti
598607|NCT00644137|smoking sensations|smoking sensations
598608|NCT00644137|no cravings|no cravings
598609|NCT00644137|desire to smoke|desire to smoke
598610|NCT00644124|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
598611|NCT00644124|angiogenesis inhibitors|angiogenesis inhibitors
598612|NCT00644124|CHOP protocol|chop protocol
598613|NCT00644111|Minimally Invasive Decompression and Fusion|minimally invasive decompression and fusion
598614|NCT00644111|Postoperative analgesia|postoperative analgesia
598615|NCT00644111|Epidural|epidural
598616|NCT00644111|Lumbar|lumbar
598617|NCT00644085|IVF and ICSI|ivf and icsi
598618|NCT00644072|Hsp90 Inhibitor|hsp90 inhibitor
598619|NCT00644072|Her2|her2
598621|NCT00644072|Advanced Cancer|advanced cancer
598622|NCT00644072|Cancer|cancer
598623|NCT00644072|Solid Tumor|solid tumor
598624|NCT00644072|Lymphoma|lymphoma
598625|NCT00644059|Influenza|influenza
598626|NCT00644059|vaccine|vaccine
598627|NCT00644059|children|children
598628|NCT00644046|Chronic Kidney Disease|chronic kidney disease
598629|NCT00644046|Prevention|prevention
598630|NCT00644046|Cardiovascular disease|cardiovascular disease
598631|NCT00644020|Hepatocellular carcinoma|hepatocellular carcinoma
598632|NCT00644020|recurrence|recurrence
598633|NCT00644007|Erectile dysfunction|erectile dysfunction
598634|NCT00644007|Hypertension|hypertension
598635|NCT00644007|SK3530|sk3530
598636|NCT00643994|Prostate Cancer|prostate cancer
598637|NCT00643994|CyberKnife|cyberknife
598638|NCT00643994|Stereotactic Radiosurgery|stereotactic radiosurgery
598639|NCT00643994|Radiotherapy|radiotherapy
598640|NCT00643994|Radiation|radiation
598641|NCT00643994|Prostate Tumor|prostate tumor
598642|NCT00643994|Prostate Surgery|prostate surgery
598643|NCT00643968|HIV virological control|hiv virological control
598644|NCT00643968|Lipid profile and morphological fat distribution|lipid profile and morphological fat distribution
598645|NCT00643968|Treatment Experienced|treatment experienced
598646|NCT00643955|Evaluation of muscle strength and central activation|evaluation of muscle strength and central activation
598647|NCT00643929|thrombopoietin receptor agonist|thrombopoietin receptor agonist
598648|NCT00643929|ocular safety|ocular safety
598649|NCT00643929|HCV|hcv
598650|NCT00643929|SB-497115-GR|sb-497115-gr
598651|NCT00643929|CIT|cit
598652|NCT00643929|ITP|itp
598653|NCT00643929|cataract|cataract
598654|NCT00643929|eltrombopag olamine|eltrombopag olamine
598655|NCT00643929|lens opacity|lens opacity
598656|NCT00643916|Meningitis; Meningococcal Infection|meningitis; meningococcal infection
598657|NCT00643903|Side Effects|side effects
598658|NCT00643903|Adherence|adherence
598659|NCT00643903|Coping|coping
598660|NCT00643903|HIV|hiv
598661|NCT00643903|AIDS|aids
598662|NCT00643903|Complementary Therapies|complementary therapies
598663|NCT00643890|Keywords:|keywords:
598664|NCT00643890|Parkinson's disease|parkinson's disease
598665|NCT00643890|Gene transfer|gene transfer
598666|NCT00643890|Gene therapy|gene therapy
598667|NCT00643890|Subthalamic nucleus|subthalamic nucleus
598668|NCT00643890|Adeno-associated virus|adeno-associated virus
598669|NCT00643890|Study placed in the following topic categories:|study placed in the following topic categories:
598670|NCT00643890|Ganglion Cysts|ganglion cysts
598671|NCT00643890|Movement Disorders|movement disorders
598672|NCT00643890|Parkinson Disease|parkinson disease
598673|NCT00643890|Basal Ganglia Diseases|basal ganglia diseases
598674|NCT00643890|Central Nervous System Diseases|central nervous system diseases
598675|NCT00643890|Parkinsonian Disorders|parkinsonian disorders
598676|NCT00643890|Neurodegenerative Diseases|neurodegenerative diseases
598677|NCT00643890|Brain Diseases|brain diseases
598678|NCT00643890|Additional relevant MeSH terms:|additional relevant mesh terms:
598679|NCT00643890|Nervous System Diseases|nervous system diseases
598680|NCT00643877|Colorectal Neoplasms|colorectal neoplasms
598681|NCT00643877|Regional|regional
598682|NCT00643877|Liver|liver
598683|NCT00643877|Neoplasm Metastasis|neoplasm metastasis
598684|NCT00643864|mirror training|mirror training
598685|NCT00643864|stroke|stroke
598686|NCT00643864|hemiparesis|hemiparesis
598687|NCT00643864|rehabilitation|rehabilitation
598688|NCT00643825|Temozolomide|temozolomide
598689|NCT00643825|Phase II|phase ii
598690|NCT00643825|Chemotherapy|chemotherapy
598691|NCT00643825|Glioblastoma|glioblastoma
598692|NCT00643825|Progression-free Survival|progression-free survival
598693|NCT00643812|Firearm storage|firearm storage
598694|NCT00643812|Suicide|suicide
598695|NCT00643812|Unintentional injury|unintentional injury
598696|NCT00643812|Alaska Native|alaska native
598697|NCT00643812|Suicide Attempt|suicide attempt
598698|NCT00643773|Elderly|elderly
598699|NCT00643760|Peripheral Diabetic Neuropathy (PDN)|peripheral diabetic neuropathy (pdn)
598700|NCT00643760|Neuropathic Pain|neuropathic pain
598701|NCT00643747|retinal dystrophy|retinal dystrophy
598702|NCT00643747|Leber congenital amaurosis|leber congenital amaurosis
598703|NCT00643747|RPE65|rpe65
598704|NCT00643747|gene therapy|gene therapy
598705|NCT00643721|Young healthy athletes|young healthy athletes
598706|NCT00643708|anovulation|anovulation
598707|NCT00643708|laser|laser
598708|NCT00643708|ovarian interstitial|ovarian interstitial
598709|NCT00643708|polycystic ovary syndrome|polycystic ovary syndrome
598710|NCT00643708|ultrasound-guided|ultrasound-guided
598711|NCT00643695|hepatitis C|hepatitis c
598712|NCT00643695|depression|depression
598713|NCT00643695|exercise|exercise
598714|NCT00643682|colonoscopy|colonoscopy
598715|NCT00643682|bowel preparation|bowel preparation
598716|NCT00643682|patient education|patient education
598717|NCT00643682|polyp detection|polyp detection
598718|NCT00643656|Liver biopsy|liver biopsy
598719|NCT00643643|HIV|hiv
598720|NCT00643643|Treatment Naïve|treatment naïve
598721|NCT00643630|Tetrix crea|tetrix crea
598722|NCT00643630|skin barrier|skin barrier
598723|NCT00643630|antigen reaction|antigen reaction
598724|NCT00643630|prevention|prevention
598725|NCT00643630|The efficacy of Tetrix Cream to prevent an antigen reaction on the skin.|the efficacy of tetrix cream to prevent an antigen reaction on the skin.
598726|NCT00643617|Prostate Cancer|prostate cancer
598727|NCT00643617|CyberKnife|cyberknife
598728|NCT00643617|Stereotactic Radiosurgery|stereotactic radiosurgery
598729|NCT00643617|Radiosurgery|radiosurgery
598730|NCT00643617|Prostate Tumor|prostate tumor
598731|NCT00643617|Prostate Surgery|prostate surgery
598732|NCT00643604|Pulmonary arterial hypertension|pulmonary arterial hypertension
598733|NCT00643604|treatment satisfaction|treatment satisfaction
598734|NCT00643604|rapid switch|rapid switch
598735|NCT00643604|remodulin|remodulin
598736|NCT00643604|Quality of life|quality of life
598737|NCT00643591|high grade glioma|high grade glioma
598738|NCT00643591|FDG-PET-CT|fdg-pet-ct
598739|NCT00643591|blood proteins|blood proteins
598740|NCT00643591|prognosis|prognosis
598741|NCT00643578|formoterol|formoterol
598742|NCT00643578|methacholine challenge|methacholine challenge
598743|NCT00643552|Muscle Strength|muscle strength
598744|NCT00643526|Rheumatoid arthritis|rheumatoid arthritis
598745|NCT00643526|Psoriatic arthritis|psoriatic arthritis
598746|NCT00643526|Ankylosing spondylitis|ankylosing spondylitis
598747|NCT00643526|Psoriasis|psoriasis
598748|NCT00643526|Autoinjector|autoinjector
598749|NCT00643513|QUALITY OF LIFE|quality of life
598750|NCT00643513|POSTMENOPAUSAL WOMEN|postmenopausal women
598751|NCT00643513|HORMONE RECEPTOR POSITIVE DISSEMINATED BREAST CANCER|hormone receptor positive disseminated breast cancer
598752|NCT00643513|FASLODEX|faslodex
598753|NCT00643500|Levetiracetam|levetiracetam
598754|NCT00643500|Keppra|keppra
598755|NCT00643487|Knee physiology|knee physiology
598756|NCT00643487|Anterior compartment knee|anterior compartment knee
598757|NCT00643487|Infrapatellar plica|infrapatellar plica
598758|NCT00643487|Ligamentum mucosum|ligamentum mucosum
598759|NCT00643487|Enthesis organ|enthesis organ
598760|NCT00643487|Fat pad of the knee|fat pad of the knee
598761|NCT00643487|Patellofemoral kinematics|patellofemoral kinematics
598762|NCT00643435|self-efficacy|self-efficacy
598763|NCT00643435|chronic illness|chronic illness
598764|NCT00643435|health behavior|health behavior
598765|NCT00643435|education, medical, residency|education, medical, residency
598766|NCT00643422|normal eyes|normal eyes
598767|NCT00643396|small cell lung cancer|small cell lung cancer
598768|NCT00643396|radiotherapy|radiotherapy
598769|NCT00643370|lung cancer|lung cancer
598770|NCT00643370|tumor motion|tumor motion
598771|NCT00643357|children with burns|children with burns
598772|NCT00643357|Child between 5 and 15 years of age , burned for many days and who has to undergo at least 3 procedures of care|child between 5 and 15 years of age , burned for many days and who has to undergo at least 3 procedures of care
598773|NCT00643344|obesity|obesity
598774|NCT00643344|mindfulness based stress reduction|mindfulness based stress reduction
598775|NCT00643344|diet and exercise|diet and exercise
598776|NCT00643344|mindful eating|mindful eating
598777|NCT00643344|stress|stress
598778|NCT00643331|Osteoporosis|osteoporosis
598779|NCT00643331|Exercise|exercise
598780|NCT00643331|Low bone density|low bone density
598781|NCT00643331|Falls|falls
598782|NCT00643318|lung cancer|lung cancer
598783|NCT00643318|lung tumor|lung tumor
598784|NCT00643318|non-small cell lung cancer|non-small cell lung cancer
598785|NCT00643318|NSCLC|nsclc
598786|NCT00643318|CyberKnife|cyberknife
598787|NCT00643318|radiosurgery|radiosurgery
598788|NCT00643318|lung surgery|lung surgery
598790|NCT00643305|Motivational Interviewing|motivational interviewing
598791|NCT00643305|Skills|skills
598792|NCT00643305|Prevention|prevention
598793|NCT00643305|Mental illness|mental illness
598794|NCT00643305|Risk reduction|risk reduction
598795|NCT00643305|HIV/AIDS|hiv/aids
598796|NCT00643305|HIV Seronegativity|hiv seronegativity
598797|NCT00643279|implantable hemodynamic monitor|implantable hemodynamic monitor
598798|NCT00643279|Intracardiac pressures|intracardiac pressures
598799|NCT00643266|recollection training|recollection training
598800|NCT00643266|aging|aging
598801|NCT00643266|amnestic mild cognitive impairment|amnestic mild cognitive impairment
598802|NCT00643266|fMRI|fmri
598803|NCT00643253|exclusive breastfeeding|exclusive breastfeeding
598804|NCT00643253|breastfeeding promotion|breastfeeding promotion
598805|NCT00643253|health promotion|health promotion
598806|NCT00643240|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
598807|NCT00643240|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
598808|NCT00643240|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
598809|NCT00643214|Tetrix Cream|tetrix cream
598810|NCT00643214|Antigen reaction|antigen reaction
598811|NCT00643214|effect on healing|effect on healing
598812|NCT00643214|To determine if application of Tetrix Cream to lesions of contact dermatitis interferes with their rate of healing|to determine if application of tetrix cream to lesions of contact dermatitis interferes with their rate of healing
598813|NCT00643188|Atrial fibrillation|atrial fibrillation
598814|NCT00643188|Ablation|ablation
598815|NCT00643188|Heart failure|heart failure
598816|NCT00643188|Home Monitoring|home monitoring
598817|NCT00643175|The main objective is to have an endocrinologist treat osteoporosis in patients with fragility hip fractures.|the main objective is to have an endocrinologist treat osteoporosis in patients with fragility hip fractures.
598818|NCT00643162|Depression|depression
598819|NCT00643162|Massage|massage
598820|NCT00643162|Lexapro|lexapro
598821|NCT00643162|Alternative Therapy|alternative therapy
598822|NCT00643162|Anti-depressant|anti-depressant
598823|NCT00643123|Bipolar Disorder|bipolar disorder
598824|NCT00643123|Mania|mania
598825|NCT00643123|Mixed mania|mixed mania
598826|NCT00643123|Allopurinol|allopurinol
598827|NCT00643123|Treatment-Resistant mania|treatment-resistant mania
598828|NCT00643110|Hypoglycemia|hypoglycemia
598829|NCT00643097|adult giant cell glioblastoma|adult giant cell glioblastoma
598830|NCT00643097|adult gliosarcoma|adult gliosarcoma
598831|NCT00643097|adult glioblastoma|adult glioblastoma
598832|NCT00643084|Colorectal|colorectal
598833|NCT00643084|Bowel preparation|bowel preparation
598834|NCT00643084|Laparoscopic surgery|laparoscopic surgery
598835|NCT00643071|Ulcerative colitis|ulcerative colitis
598836|NCT00643071|Tacrolimus|tacrolimus
598837|NCT00643071|FK506|fk506
598838|NCT00643071|Treatment outcome|treatment outcome
598839|NCT00643058|LPS endotoxin|lps endotoxin
598840|NCT00643045|Parkinson Disease|parkinson disease
598841|NCT00643019|Sexually Transmitted Infections|sexually transmitted infections
598842|NCT00643019|Secondary Prevention|secondary prevention
598843|NCT00643019|Cognitive Behavioral Intervention|cognitive behavioral intervention
598844|NCT00643006|Fibromyalgia|fibromyalgia
598845|NCT00643006|Physical activity|physical activity
598846|NCT00643006|Function|function
598847|NCT00643006|Pain|pain
598848|NCT00643006|Exercise|exercise
598849|NCT00643006|Inflammation|inflammation
598850|NCT00642980|Pregnancy|pregnancy
598851|NCT00642980|Preterm delivery|preterm delivery
598852|NCT00642980|Bacterial vaginosis|bacterial vaginosis
598853|NCT00642980|Randomized Clinical Trial|randomized clinical trial
598854|NCT00642980|Clindamycin|clindamycin
598855|NCT00642928|Excessive Daytime Sleepiness|excessive daytime sleepiness
598856|NCT00642928|Parkinson's disease|parkinson's disease
598857|NCT00642902|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
598858|NCT00642902|Atacicept|atacicept
598859|NCT00642889|Parkinson's disease|parkinson's disease
598860|NCT00642863|iron deficiency|iron deficiency
598861|NCT00642863|iron deficiency anemia|iron deficiency anemia
598862|NCT00642863|infant|infant
598863|NCT00642863|development|development
598864|NCT00642863|behavior|behavior
598865|NCT00642837|Health-Related Quality of Life|health-related quality of life
598866|NCT00642837|KEQ-5D|keq-5d
598867|NCT00642837|Sleep disturbance|sleep disturbance
598868|NCT00642837|Sleep quality|sleep quality
598869|NCT00642837|SF-1|sf-1
598870|NCT00642837|Pain intensity|pain intensity
598871|NCT00642837|Pain relief|pain relief
598872|NCT00642837|Tramadol|tramadol
598873|NCT00642837|Acetaminophen|acetaminophen
598874|NCT00642811|coronary artery disease (CAD)|coronary artery disease (cad)
598875|NCT00642811|heart attack|heart attack
598876|NCT00642811|stable angina|stable angina
598877|NCT00642785|herpes|herpes
598878|NCT00642785|HSV|hsv
598879|NCT00642785|zoster|zoster
598880|NCT00642785|HZV|hzv
598881|NCT00642785|shingles|shingles
598882|NCT00642772|Osteoarthritis|osteoarthritis
598883|NCT00642772|Veterans|veterans
598884|NCT00642772|Physical Therapy|physical therapy
598885|NCT00642772|Health Services Research|health services research
598886|NCT00642759|NSCLC|nsclc
598887|NCT00642759|Abraxane|abraxane
598888|NCT00642759|Carboplatin|carboplatin
598889|NCT00642759|Bevacizumab|bevacizumab
598890|NCT00642759|Avastin|avastin
598891|NCT00642746|Colon|colon
598892|NCT00642746|Cancer|cancer
598893|NCT00642746|Metastatic|metastatic
598894|NCT00642746|Colorectal|colorectal
598895|NCT00642707|HIV|hiv
598896|NCT00642707|Treatment Naïve|treatment naïve
598897|NCT00642694|MDD|mdd
598898|NCT00642694|Major Depressive Disorder|major depressive disorder
598899|NCT00642694|Depression|depression
598900|NCT00642694|Initial Insomnia|initial insomnia
598901|NCT00642694|sleep|sleep
598902|NCT00642694|difficulty sleeping|difficulty sleeping
598903|NCT00642694|down|down
598904|NCT00642694|sad|sad
598905|NCT00642694|Major Depressive Disorder(MDD) and initial insomnia|major depressive disorder(mdd) and initial insomnia
598906|NCT00642655|IVIG|ivig
598907|NCT00642655|Rituximab|rituximab
598908|NCT00642655|Highly Sensitized|highly sensitized
598909|NCT00642655|Kidney Transplantation|kidney transplantation
598910|NCT00642642|Acne|acne
598911|NCT00642590|Fertility|fertility
598912|NCT00642590|Pregnancy|pregnancy
598913|NCT00642590|Conception|conception
598914|NCT00642590|Infertility|infertility
598915|NCT00642590|Behavioral|behavioral
598916|NCT00642590|Lifestyle|lifestyle
598917|NCT00642590|Nutrition|nutrition
598918|NCT00642564|Epilepsy|epilepsy
598919|NCT00642564|Headache|headache
598920|NCT00642564|Migraine|migraine
598921|NCT00642551|vitamin K2|vitamin k2
598922|NCT00642551|menaquinone-7|menaquinone-7
598923|NCT00642551|bone health|bone health
598924|NCT00642551|vascular health|vascular health
598925|NCT00642538|Diabetic adult male, diabetic postmenopausal women|diabetic adult male, diabetic postmenopausal women
598926|NCT00642525|detection of anastomotic leakage|detection of anastomotic leakage
598927|NCT00642525|esophageal resection|esophageal resection
598928|NCT00642525|diagnostic safety|diagnostic safety
598929|NCT00642512|CINV|cinv
598930|NCT00642512|chemotherapy|chemotherapy
598931|NCT00642512|nausea|nausea
598932|NCT00642512|vomiting|vomiting
598933|NCT00642512|retching|retching
598934|NCT00642499|HIV|hiv
598935|NCT00642499|AIDS|aids
598936|NCT00642499|nausea|nausea
598937|NCT00642499|vomiting|vomiting
598938|NCT00642499|HAART|haart
598939|NCT00642499|Treatment Experienced|treatment experienced
598940|NCT00642499|HIV Infections|hiv infections
598941|NCT00642486|treatment|treatment
598942|NCT00642486|positive airway pressure|positive airway pressure
598943|NCT00642486|compliance|compliance
598944|NCT00642486|cost effectiveness|cost effectiveness
598945|NCT00642486|clinical trial|clinical trial
598946|NCT00642447|noninvasive ventilation|noninvasive ventilation
598947|NCT00642447|helium|helium
598948|NCT00642447|oxygen|oxygen
598949|NCT00642447|sulfur mustard|sulfur mustard
598950|NCT00642447|chronic bronchitis|chronic bronchitis
598951|NCT00642447|bronchiolitis|bronchiolitis
598952|NCT00642434|diabetes blood pressure oxidative stress|diabetes blood pressure oxidative stress
598953|NCT00642421|Acromegaly|acromegaly
598954|NCT00642395|Multiple Myeloma|multiple myeloma
598955|NCT00642395|Autologous Stem Cells Transplantation|autologous stem cells transplantation
598956|NCT00642395|High Dose Melphalan|high dose melphalan
598957|NCT00642395|Bortezomib|bortezomib
598958|NCT00642382|Osteoarthritis|osteoarthritis
598959|NCT00642382|Hyaluronic Acid|hyaluronic acid
598960|NCT00642369|Polysomnograph|polysomnograph
598961|NCT00642356|Idiopathic Parkinson's disease|idiopathic parkinson's disease
598962|NCT00642356|carbidopa/levodopa/entacapone|carbidopa/levodopa/entacapone
598963|NCT00642356|non-motor symptoms|non-motor symptoms
598964|NCT00642356|motor-symptoms|motor-symptoms
598965|NCT00642343|Balance|balance
598966|NCT00642343|Severe, Profound deafness|severe, profound deafness
598967|NCT00642343|Children|children
598968|NCT00642343|unilateral/bilateral cochlear implants|unilateral/bilateral cochlear implants
598969|NCT00642343|unilateral cochlear implant|unilateral cochlear implant
598970|NCT00642343|bilateral cochlear implants|bilateral cochlear implants
598971|NCT00642330|patent|patent
598972|NCT00642330|ductus|ductus
598973|NCT00642330|arteriosus|arteriosus
598974|NCT00642330|ibuprofen|ibuprofen
598975|NCT00642330|premature|premature
598976|NCT00642330|infant|infant
598977|NCT00642317|Healthy Control|healthy control
598978|NCT00642317|Tobacco Use|tobacco use
598979|NCT00642317|Tobacco Initiation|tobacco initiation
598980|NCT00642317|Smoking|smoking
598981|NCT00642317|Questionnaire|questionnaire
598982|NCT00642317|Survey|survey
598983|NCT00642291|Emtricitabine|emtricitabine
598984|NCT00642291|Pediatric|pediatric
598985|NCT00642291|HIV-1|hiv-1
598986|NCT00642291|Treatment of HIV-1|treatment of hiv-1
598987|NCT00642278|Type 2 diabetes mellitus|type 2 diabetes mellitus
598988|NCT00642278|Metformin|metformin
598989|NCT00642278|Hemoglobin A1c|hemoglobin a1c
598990|NCT00642252|remineraliation|remineraliation
598991|NCT00642252|pre-existing white-spot (non-cavitated) enamel lesions|pre-existing white-spot (non-cavitated) enamel lesions
598992|NCT00642239|Sodium Glycididazole, Radiochemotherapy, Esophageal Carcinoma|sodium glycididazole, radiochemotherapy, esophageal carcinoma
598993|NCT00642226|Branch Retinal Vein Occlusion|branch retinal vein occlusion
598994|NCT00642226|BRVO|brvo
598995|NCT00642226|Macular Edema|macular edema
598996|NCT00642226|Triamcinolone|triamcinolone
598997|NCT00642226|Vitrectomy|vitrectomy
598998|NCT00642213|stroke|stroke
598999|NCT00642213|ischemic|ischemic
599000|NCT00642213|TIA|tia
599001|NCT00642213|hemorrhage|hemorrhage
599002|NCT00642213|incidence|incidence
599003|NCT00642213|case-fatality|case-fatality
599004|NCT00642213|risk factors|risk factors
599005|NCT00642213|genetic|genetic
599006|NCT00642187|Asthma|asthma
599007|NCT00642187|Pulmicort|pulmicort
599008|NCT00642187|Turbuhaler|turbuhaler
599009|NCT00642187|Budesonide|budesonide
599010|NCT00642187|Flexhaler|flexhaler
599011|NCT00642161|Asthma|asthma
599012|NCT00642161|Pulmicort|pulmicort
599013|NCT00642161|Children|children
599014|NCT00642161|Paediatrics|paediatrics
599015|NCT00642161|budesonide|budesonide
599016|NCT00642161|Flexhaler|flexhaler
599017|NCT00642148|GW856553|gw856553
599018|NCT00642148|p38 MAPK|p38 mapk
599019|NCT00642148|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
599020|NCT00642135|premature|premature
599021|NCT00642135|neonates|neonates
599022|NCT00642135|infants|infants
599023|NCT00642135|children|children
599024|NCT00642135|Mydriasert®|mydriasert®
599025|NCT00642135|mydriasis|mydriasis
599026|NCT00642135|fundus|fundus
599027|NCT00642135|Tropicamide|tropicamide
599028|NCT00642135|Phenylephrine|phenylephrine
599029|NCT00642135|clinical trial|clinical trial
599030|NCT00642135|Infant|infant
599031|NCT00642135|premature newborns|premature newborns
599032|NCT00642135|bilateral diagnosis fundus|bilateral diagnosis fundus
599033|NCT00642122|Asthma|asthma
599034|NCT00642122|Pulmicort|pulmicort
599035|NCT00642122|budesonide|budesonide
599036|NCT00642122|respules|respules
599037|NCT00642122|turbuhaler|turbuhaler
599038|NCT00642096|High blood pressure|high blood pressure
599039|NCT00642096|hypertension|hypertension
599040|NCT00642096|(TOPROL-XL)|(toprol-xl)
599041|NCT00642096|metoprolol succinate|metoprolol succinate
599042|NCT00642096|hydrochlorothiazide|hydrochlorothiazide
599043|NCT00642083|outflow stenosis|outflow stenosis
599044|NCT00642083|stentgraft|stentgraft
599045|NCT00642070|Current symptoms of urinary tract infection|current symptoms of urinary tract infection
599046|NCT00642057|chorea|chorea
599047|NCT00642057|dyskinesia|dyskinesia
599048|NCT00642057|hyperkinetic|hyperkinetic
599049|NCT00642044|Keratoconus|keratoconus
599050|NCT00642031|Hematologic Malignancies|hematologic malignancies
599051|NCT00642031|Leukemia|leukemia
599052|NCT00642031|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
599053|NCT00642031|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
599054|NCT00642031|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
599055|NCT00642031|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
599056|NCT00642031|Agnogenic Myeloid Metaplasia|agnogenic myeloid metaplasia
599057|NCT00642031|Triciribine Phosphate Monohydrate|triciribine phosphate monohydrate
599058|NCT00642031|Triciribine|triciribine
599059|NCT00642031|TCN-PM|tcn-pm
599060|NCT00642031|VD-0002|vd-0002
599061|NCT00642018|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
599062|NCT00642005|Humidification|humidification
599063|NCT00642005|Laparoscopy|laparoscopy
599064|NCT00642005|Colon|colon
599065|NCT00642005|Hemicolectomy|hemicolectomy
599066|NCT00642005|Warming|warming
599067|NCT00641992|amebic liver abscess|amebic liver abscess
599068|NCT00641992|failure|failure
599069|NCT00641992|prognosis|prognosis
599070|NCT00641979|Allergic rhinitis|allergic rhinitis
599071|NCT00641979|Nasal symptoms|nasal symptoms
599072|NCT00641979|Congestion|congestion
599073|NCT00641979|Rhinorrhea|rhinorrhea
599074|NCT00641979|Sneeze|sneeze
599075|NCT00641979|budesonide|budesonide
599076|NCT00641979|Rhinocort AQUA|rhinocort aqua
599077|NCT00641953|Foot Pain|foot pain
599078|NCT00641953|Diabetic Neuropathy Pain|diabetic neuropathy pain
599079|NCT00641953|Diabetic Peripheral Neuropathy foot pain|diabetic peripheral neuropathy foot pain
599080|NCT00641940|Prevention|prevention
599081|NCT00641940|Girls|girls
599082|NCT00641940|Resilience|resilience
599083|NCT00641927|bipolar disorder|bipolar disorder
599084|NCT00641927|bipolar type II disorder|bipolar type ii disorder
599085|NCT00641927|antidepressant|antidepressant
599086|NCT00641927|mood stabilizer|mood stabilizer
599087|NCT00641927|venlafaxine|venlafaxine
599088|NCT00641927|lithium carbonate|lithium carbonate
599089|NCT00641914|Asthma|asthma
599090|NCT00641914|Pulmicort|pulmicort
599091|NCT00641914|budesonide|budesonide
599092|NCT00641901|gingivitis|gingivitis
599093|NCT00641901|pregnancy|pregnancy
599094|NCT00641901|pre-term birth|pre-term birth
599095|NCT00641888|Cardiovascular risk|cardiovascular risk
599096|NCT00641888|Inflammatory biomarkers|inflammatory biomarkers
599097|NCT00641888|Human immunodeficiency virus|human immunodeficiency virus
599098|NCT00641875|arterial stiffness|arterial stiffness
599099|NCT00641875|artery|artery
599100|NCT00641875|aortic pulse wave velocity|aortic pulse wave velocity
599101|NCT00641875|pulse wave analysis|pulse wave analysis
599102|NCT00641875|augmentation index|augmentation index
599103|NCT00641875|end stage renal disease|end stage renal disease
599104|NCT00641875|nocturnal hemodialysis|nocturnal hemodialysis
599105|NCT00641875|extended hours of hemodialysis|extended hours of hemodialysis
599106|NCT00641875|cardiovascular|cardiovascular
599107|NCT00641875|hemodialysis|hemodialysis
599108|NCT00641862|Pregnancy|pregnancy
599109|NCT00641862|Maternal Nutritional Status|maternal nutritional status
599110|NCT00641862|Vitamin B12|vitamin b12
599111|NCT00641849|BMI|bmi
599112|NCT00641849|Physical Activity|physical activity
599113|NCT00641849|Food|food
599114|NCT00641849|Nutrition|nutrition
599115|NCT00641849|Dietary behaviors|dietary behaviors
599116|NCT00641849|Diet|diet
599117|NCT00641849|Adult|adult
599118|NCT00641849|Adults|adults
599119|NCT00641849|Fat|fat
599120|NCT00641849|Fats|fats
599121|NCT00641849|Self monitoring|self monitoring
599122|NCT00641849|Automated feedback|automated feedback
599123|NCT00641823|Orthopedic Surgical Procedures|orthopedic surgical procedures
599124|NCT00641810|Caffeine|caffeine
599125|NCT00641810|Snoring|snoring
599126|NCT00641810|Sleep|sleep
599488|NCT00640471|recurrent rectal cancer|recurrent rectal cancer
599127|NCT00641797|Canalith Repositioning Technique|canalith repositioning technique
599128|NCT00641797|Vertigo|vertigo
599318|NCT00641212|Paediatric|paediatric
599129|NCT00641784|Composite Early neonatal Outcome|composite early neonatal outcome
599130|NCT00641784|Late Neurological neonatal outcome|late neurological neonatal outcome
599131|NCT00641758|Coronary Artery Disease|coronary artery disease
599132|NCT00641758|endothelial dysfunction|endothelial dysfunction
599133|NCT00641758|Nitric oxide|nitric oxide
599134|NCT00641745|Lurasidone|lurasidone
599135|NCT00641745|Schizophrenia|schizophrenia
599136|NCT00641745|Latuda|latuda
599137|NCT00641732|venous thromboembolism|venous thromboembolism
599138|NCT00641732|oral anticoagulant|oral anticoagulant
599139|NCT00641732|direct factor Xa inhibitor|direct factor xa inhibitor
599140|NCT00641732|total knee replacement|total knee replacement
599141|NCT00641732|drug therapy|drug therapy
599142|NCT00641693|Allergic rhinitis|allergic rhinitis
599143|NCT00641693|Paediatric|paediatric
599144|NCT00641693|Nasal symptoms|nasal symptoms
599145|NCT00641693|Congestion|congestion
599146|NCT00641693|Rhinorrhea|rhinorrhea
599147|NCT00641693|Sneeze|sneeze
599148|NCT00641693|budesonide|budesonide
599149|NCT00641693|Rhinocort AQUA|rhinocort aqua
599150|NCT00641680|Seasonal allergic rhinitis|seasonal allergic rhinitis
599151|NCT00641680|Nasal symptoms|nasal symptoms
599152|NCT00641680|Congestion|congestion
599153|NCT00641680|Rhinorrhea|rhinorrhea
599154|NCT00641680|Sneeze|sneeze
599155|NCT00641680|budesonide|budesonide
599156|NCT00641680|Rhinocort AQUA|rhinocort aqua
599157|NCT00641680|Fluticasone propionate|fluticasone propionate
599158|NCT00641680|Flonase|flonase
599159|NCT00641667|Pain|pain
599160|NCT00641667|Cancer|cancer
599161|NCT00641667|Fentanyl|fentanyl
599162|NCT00641667|JNS020QD|jns020qd
599163|NCT00641654|Chronic hepatitis C|chronic hepatitis c
599164|NCT00641654|genotype 2 or 3|genotype 2 or 3
599165|NCT00641654|relapse|relapse
599166|NCT00641654|pegylated interferon|pegylated interferon
599167|NCT00641654|ribavirin|ribavirin
599168|NCT00641641|Viral compartments|viral compartments
599169|NCT00641641|integrase inhibitor therapy|integrase inhibitor therapy
599170|NCT00641641|viral species|viral species
599171|NCT00641628|Nipple sparing mastectomy|nipple sparing mastectomy
599172|NCT00641628|NAC conservation|nac conservation
599173|NCT00641602|Erosive Esophagitis|erosive esophagitis
599174|NCT00641602|Nexium|nexium
599175|NCT00641602|Heartburn|heartburn
599176|NCT00641589|Chronic Kidney Disease|chronic kidney disease
599177|NCT00641589|anemia|anemia
599178|NCT00641589|epoetin alfa|epoetin alfa
599179|NCT00641576|Endosseous implants|endosseous implants
599180|NCT00641563|dexmedetomidine|dexmedetomidine
599181|NCT00641563|midazolam|midazolam
599182|NCT00641563|remifentanil|remifentanil
599183|NCT00641563|Electroencephalography|electroencephalography
599184|NCT00641563|Event related potentials|event related potentials
599185|NCT00641563|BIS|bis
599186|NCT00641563|Bispectral Index|bispectral index
599187|NCT00641563|Response Entropy|response entropy
599188|NCT00641563|State Entropy|state entropy
599189|NCT00641550|physical exercise|physical exercise
599190|NCT00641550|maternal complications|maternal complications
599191|NCT00641550|preterm labor|preterm labor
599192|NCT00641550|birthweight|birthweight
599193|NCT00641550|Apgar scores|apgar scores
599194|NCT00641524|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
599195|NCT00641524|liver fibrosis|liver fibrosis
599196|NCT00641524|metabolic syndrome|metabolic syndrome
599197|NCT00641524|iron overload|iron overload
599198|NCT00641524|phlebotomy|phlebotomy
599199|NCT00641511|PTSD|ptsd
599200|NCT00641498|suicide|suicide
599201|NCT00641498|parasuicide|parasuicide
599202|NCT00641498|prevention|prevention
599203|NCT00641498|individual supportive psychotherapy|individual supportive psychotherapy
599204|NCT00641472|Asthma|asthma
599205|NCT00641472|Pulmicort|pulmicort
599206|NCT00641472|Children|children
599207|NCT00641472|paediatrics|paediatrics
599208|NCT00641472|budesonide|budesonide
599209|NCT00641459|Behavioral and Psychological Symptoms of Dementia|behavioral and psychological symptoms of dementia
599210|NCT00641459|BPSD|bpsd
599211|NCT00641459|NPI|npi
599212|NCT00641459|CGI|cgi
599213|NCT00641459|MMSE|mmse
599214|NCT00641446|Children|children
599215|NCT00641446|Asthma|asthma
599216|NCT00641446|Varivax|varivax
599217|NCT00641446|varicella|varicella
599218|NCT00641446|Pulmicort|pulmicort
599219|NCT00641446|budesonide|budesonide
599220|NCT00641433|chemocautery|chemocautery
599221|NCT00641420|Acne scarring|acne scarring
599222|NCT00641420|Post inflammatory hyperpigmentation|post inflammatory hyperpigmentation
599223|NCT00641407|Bedtime insulins|bedtime insulins
599224|NCT00641407|Poorly controlled type 2 diabetes|poorly controlled type 2 diabetes
599225|NCT00641407|Glycemic control|glycemic control
599226|NCT00641407|HbA1c|hba1c
599227|NCT00641394|cortisol|cortisol
599228|NCT00641394|hydrocortisone|hydrocortisone
599229|NCT00641394|psychotherapy|psychotherapy
599230|NCT00641394|Emotional Freedom Techniques (EFT)|emotional freedom techniques (eft)
599231|NCT00641394|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
599232|NCT00641394|depression|depression
599233|NCT00641394|anxiety|anxiety
599234|NCT00641381|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
599235|NCT00641381|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
599236|NCT00641381|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
599237|NCT00641381|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
599238|NCT00641381|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
599239|NCT00641381|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
599240|NCT00641381|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
599241|NCT00641381|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
599242|NCT00641381|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
599243|NCT00641381|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
599244|NCT00641381|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
599245|NCT00641381|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
599246|NCT00641381|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
599247|NCT00641381|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
599248|NCT00641381|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
599249|NCT00641381|Burkitt lymphoma|burkitt lymphoma
599250|NCT00641381|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
599251|NCT00641381|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
599252|NCT00641381|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
599253|NCT00641381|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
599254|NCT00641381|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
599255|NCT00641381|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
599256|NCT00641381|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
599257|NCT00641381|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
599258|NCT00641381|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
599259|NCT00641381|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
599260|NCT00641381|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
599261|NCT00641381|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
599262|NCT00641381|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
599263|NCT00641381|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
599264|NCT00641381|HIV Infections|hiv infections
599265|NCT00641381|Treatment Experienced|treatment experienced
599266|NCT00641368|Adolescent|adolescent
599267|NCT00641368|Child|child
599268|NCT00641368|Computer|computer
599269|NCT00641368|Depression|depression
599270|NCT00641368|Resilience|resilience
599271|NCT00641342|Parastomal hernia|parastomal hernia
599272|NCT00641342|Onlay mesh|onlay mesh
599273|NCT00641342|Sublay mesh|sublay mesh
599274|NCT00641342|Pain|pain
599275|NCT00641342|Health questionnaire|health questionnaire
599276|NCT00641329|ADHD|adhd
599277|NCT00641329|ADD|add
599278|NCT00641329|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
599279|NCT00641329|Attention Deficit|attention deficit
599280|NCT00641329|Clonidine|clonidine
599281|NCT00641329|CLONICEL|clonicel
599282|NCT00641329|Addrenex|addrenex
599283|NCT00641316|Freeze-dried bone allograft|freeze-dried bone allograft
599284|NCT00641316|Platelet-rich plasma|platelet-rich plasma
599285|NCT00641316|Platelet-derived growth factors|platelet-derived growth factors
599286|NCT00641316|Laser-threaded dental implants|laser-threaded dental implants
599287|NCT00641316|Resorbable blast textured dental implants|resorbable blast textured dental implants
599288|NCT00641303|pain|pain
599289|NCT00641303|fatigue|fatigue
599290|NCT00641303|hot flashes|hot flashes
599291|NCT00641303|sleep disorders|sleep disorders
599292|NCT00641303|depression|depression
599293|NCT00641303|anxiety disorder|anxiety disorder
599294|NCT00641303|stage I breast cancer|stage i breast cancer
599295|NCT00641303|stage II breast cancer|stage ii breast cancer
599296|NCT00641303|stage IIIA breast cancer|stage iiia breast cancer
599297|NCT00641303|stage IIIB breast cancer|stage iiib breast cancer
599298|NCT00641303|stage IIIC breast cancer|stage iiic breast cancer
599299|NCT00641290|CABG|cabg
599300|NCT00641290|Valve surgery|valve surgery
599301|NCT00641277|endosseous dental implants|endosseous dental implants
599302|NCT00641277|dental aesthetics|dental aesthetics
599303|NCT00641264|Laryngopharyngeal reflux (LPR)|laryngopharyngeal reflux (lpr)
599304|NCT00641264|Omeprazole|omeprazole
599305|NCT00641264|Losec|losec
599306|NCT00641264|Quality of Life|quality of life
599307|NCT00641264|Laryngitis|laryngitis
599308|NCT00641251|T2 Diabetes|t2 diabetes
599309|NCT00641251|Type 2 diabetes CVD event rates and mortality|type 2 diabetes cvd event rates and mortality
599310|NCT00641238|NSCLC|nsclc
599311|NCT00641238|lung cancer|lung cancer
599312|NCT00641225|Ascending Single Dose|ascending single dose
599313|NCT00641225|Safety|safety
599314|NCT00641225|Pharmacokinetics|pharmacokinetics
599315|NCT00641225|Open-label|open-label
599316|NCT00641212|Allergic rhinitis|allergic rhinitis
599317|NCT00641212|Perennial allergic rhinitis|perennial allergic rhinitis
599319|NCT00641212|Growth|growth
599320|NCT00641212|budesonide|budesonide
599321|NCT00641212|Rhinocort AQUA|rhinocort aqua
599322|NCT00641199|Antibiotic-associated diarrhea|antibiotic-associated diarrhea
599323|NCT00641199|Probiotic|probiotic
599324|NCT00641199|Quality of life|quality of life
599325|NCT00641199|Antibiotics|antibiotics
599326|NCT00641186|excessive daytime somnolence|excessive daytime somnolence
599327|NCT00641186|Parkinson disease|parkinson disease
599328|NCT00641186|sleep disturbance|sleep disturbance
599329|NCT00641173|PTSD|ptsd
599330|NCT00641173|cortisol|cortisol
599331|NCT00641173|hippocampus|hippocampus
599332|NCT00641173|memory|memory
599333|NCT00641160|vinorelbine|vinorelbine
599334|NCT00641160|metronomic dosing|metronomic dosing
599335|NCT00641160|oral administration|oral administration
599336|NCT00641160|nonhematologic malignancies|nonhematologic malignancies
599337|NCT00641160|pharmacokinetics|pharmacokinetics
599338|NCT00641134|Cardiac Rehabilitation|cardiac rehabilitation
599339|NCT00641134|Old age|old age
599340|NCT00641134|Home physical training|home physical training
599341|NCT00641108|SPECT Brain Imaging|spect brain imaging
599342|NCT00641108|Cognitive Therapy|cognitive therapy
599343|NCT00641108|Serotonin Transporter Binding|serotonin transporter binding
599344|NCT00641108|Predictive Biomarker|predictive biomarker
599345|NCT00641095|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
599346|NCT00641095|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
599347|NCT00641095|stage I mantle cell lymphoma|stage i mantle cell lymphoma
599348|NCT00641095|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
599349|NCT00641095|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
599350|NCT00641069|Cardiac arrest|cardiac arrest
599351|NCT00641069|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
599352|NCT00641056|diabetes|diabetes
599353|NCT00641056|exenatide|exenatide
599354|NCT00641056|exenatide once weekly|exenatide once weekly
599355|NCT00641056|metformin|metformin
599356|NCT00641056|sulfonylurea|sulfonylurea
599357|NCT00641056|insulin glargine|insulin glargine
599358|NCT00641056|Amylin|amylin
599359|NCT00641056|Lilly|lilly
599360|NCT00641030|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
599361|NCT00641030|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
599362|NCT00641030|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
599363|NCT00641030|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
599364|NCT00641030|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
599365|NCT00641030|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
599366|NCT00641030|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
599367|NCT00641030|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
599368|NCT00641030|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
599369|NCT00641030|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
599370|NCT00641030|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
599371|NCT00641030|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
599372|NCT00641030|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
599373|NCT00641030|secondary acute myeloid leukemia|secondary acute myeloid leukemia
599374|NCT00641030|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
599375|NCT00641030|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
599376|NCT00641030|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
599377|NCT00641030|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
599378|NCT00640991|Clinical Trial|clinical trial
599379|NCT00640991|Insulin|insulin
599380|NCT00640978|Pancreatic Cancer|pancreatic cancer
599381|NCT00640978|Advanced Pancreatic Cancer|advanced pancreatic cancer
599382|NCT00640978|Unresectable|unresectable
599383|NCT00640978|Metastatic|metastatic
599384|NCT00640978|RAD001|rad001
599385|NCT00640978|Everolimus|everolimus
599386|NCT00640978|Erlotinib|erlotinib
599387|NCT00640978|OSI-774|osi-774
599388|NCT00640978|Erlotinib Hydrochloride|erlotinib hydrochloride
599389|NCT00640978|Tarceva|tarceva
599390|NCT00640952|Parkinson's disease|parkinson's disease
599391|NCT00640952|impulse control behaviors|impulse control behaviors
599392|NCT00640952|dopa-dysregulation|dopa-dysregulation
599393|NCT00640939|Tendonitis|tendonitis
599394|NCT00640939|Bursitis|bursitis
599395|NCT00640913|Defunctioning stoma|defunctioning stoma
599396|NCT00640913|Low anterior resection|low anterior resection
599397|NCT00640913|TME surgery|tme surgery
599398|NCT00640913|Early stoma reversal|early stoma reversal
599399|NCT00640900|overweight|overweight
599400|NCT00640900|obesity|obesity
599401|NCT00640900|weight loss|weight loss
599402|NCT00640900|commercial weight loss program|commercial weight loss program
599403|NCT00640887|HIV|hiv
599404|NCT00640887|Tuberculosis|tuberculosis
599405|NCT00640887|Rifabutin|rifabutin
599406|NCT00640887|Pharmacokinetics|pharmacokinetics
599783|NCT00639171|breast|breast
599407|NCT00640887|South Africa|south africa
599408|NCT00640874|Prophylaxis|prophylaxis
599409|NCT00640874|pandemic influenza|pandemic influenza
599410|NCT00640874|influenza A|influenza a
599411|NCT00640874|H5N1 virus|h5n1 virus
599412|NCT00640861|stage II breast cancer|stage ii breast cancer
599413|NCT00640861|stage IIIA breast cancer|stage iiia breast cancer
599414|NCT00640861|stage IIIB breast cancer|stage iiib breast cancer
599415|NCT00640861|stage IIIC breast cancer|stage iiic breast cancer
599416|NCT00640861|stage IA breast cancer|stage ia breast cancer
599417|NCT00640861|stage IB breast cancer|stage ib breast cancer
599418|NCT00640861|triple-negative breast cancer|triple-negative breast cancer
599419|NCT00640861|HER2-positive breast cancer|her2-positive breast cancer
599420|NCT00640835|Opioid dependence|opioid dependence
599421|NCT00640809|Bowel Disease|bowel disease
599422|NCT00640796|Hematologic malignancies, non-B lineage|hematologic malignancies, non-b lineage
599423|NCT00640796|NK cell expansion|nk cell expansion
599424|NCT00640796|CliniMACS device|clinimacs device
599425|NCT00640796|Immunotherapy|immunotherapy
599426|NCT00640783|Metabolic syndrome|metabolic syndrome
599427|NCT00640783|Mediterranean diet|mediterranean diet
599428|NCT00640783|Inflammatory markers|inflammatory markers
599429|NCT00640783|Endothelial function|endothelial function
599430|NCT00640757|Methionine|methionine
599431|NCT00640757|Metabolic syndrome|metabolic syndrome
599432|NCT00640757|Glucose Metabolism|glucose metabolism
599433|NCT00640757|Amino acid|amino acid
599434|NCT00640757|Insulin clamp|insulin clamp
599435|NCT00640744|Atherogenesis|atherogenesis
599436|NCT00640744|Atheroma|atheroma
599437|NCT00640744|Arteriosclerosis|arteriosclerosis
599438|NCT00640731|DVT|dvt
599439|NCT00640731|Peripheral Vascular Disease|peripheral vascular disease
599440|NCT00640731|Venous Thrombosis|venous thrombosis
599441|NCT00640731|Deep Vein Thrombosis|deep vein thrombosis
599442|NCT00640718|heart and respiratory monitoring|heart and respiratory monitoring
599443|NCT00640692|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
599444|NCT00640692|GIST|gist
599445|NCT00640692|Sunitinib|sunitinib
599446|NCT00640692|Imatinib|imatinib
599447|NCT00640679|Clopidogrel|clopidogrel
599448|NCT00640679|Drug-eluting Stent|drug-eluting stent
599449|NCT00640666|Breast cancer|breast cancer
599450|NCT00640666|Exercise|exercise
599451|NCT00640666|Biomarkers|biomarkers
599452|NCT00640653|Sexual Behavior|sexual behavior
599453|NCT00640653|Abstinence|abstinence
599454|NCT00640653|Intervention Studies|intervention studies
599455|NCT00640653|HIV|hiv
599456|NCT00640653|Sexually Transmitted Infection|sexually transmitted infection
599457|NCT00640653|Theory of Planned Behavior|theory of planned behavior
599458|NCT00640653|HIV Seronegativity|hiv seronegativity
599459|NCT00640640|IOP|iop
599460|NCT00640640|OPA|opa
599461|NCT00640640|AMD|amd
599462|NCT00640640|bevacizumab|bevacizumab
599463|NCT00640640|ranibizumab|ranibizumab
599464|NCT00640640|choroidal blood flow|choroidal blood flow
599465|NCT00640640|DCT|dct
599466|NCT00640640|Ocular Pulse Amplitude change following anti VEGF|ocular pulse amplitude change following anti vegf
599467|NCT00640640|Ocular Pulse Amplitude|ocular pulse amplitude
599468|NCT00640614|Dermatitis, Contact|dermatitis, contact
599469|NCT00640601|Seroquel|seroquel
599470|NCT00640601|schizophrenia|schizophrenia
599471|NCT00640601|Extended Release|extended release
599472|NCT00640588|Hepatitis B, chronic|hepatitis b, chronic
599473|NCT00640588|Viral kinetics|viral kinetics
599474|NCT00640588|Telbivudine|telbivudine
599475|NCT00640588|Adefovir|adefovir
599476|NCT00640588|Compliance|compliance
599477|NCT00640562|Schizophrenia|schizophrenia
599478|NCT00640562|Depression|depression
599479|NCT00640562|Quetiapine|quetiapine
599480|NCT00640549|LDL-subfractions, HDL-subfractions, non insulin dependent diabetes mellitus (NIDDM), hyperlipidemia, atorvastatin|ldl-subfractions, hdl-subfractions, non insulin dependent diabetes mellitus (niddm), hyperlipidemia, atorvastatin
599481|NCT00640497|acute GVHD|acute gvhd
599482|NCT00640497|immunotoxin|immunotoxin
599483|NCT00640497|anti-CD3|anti-cd3
599484|NCT00640497|anti-CD7|anti-cd7
599485|NCT00640497|Ricin A|ricin a
599486|NCT00640471|recurrent colon cancer|recurrent colon cancer
599487|NCT00640471|stage IV colon cancer|stage iv colon cancer
599489|NCT00640471|stage IV rectal cancer|stage iv rectal cancer
599490|NCT00640445|Clinical Trial|clinical trial
599491|NCT00640445|Combat Disorders|combat disorders
599492|NCT00640445|PTSD|ptsd
599493|NCT00640445|Internet-Based Intervention|internet-based intervention
599494|NCT00640445|Mental Health Services|mental health services
599495|NCT00640445|Post-deployment Reintegration|post-deployment reintegration
599496|NCT00640393|Etanercept, UVB, Enbrel, Psoriasis.|etanercept, uvb, enbrel, psoriasis.
599497|NCT00640380|cervical|cervical
599498|NCT00640380|paravertebral|paravertebral
599499|NCT00640380|block|block
599500|NCT00640367|Acute ischemic stroke|acute ischemic stroke
599501|NCT00640367|thrombolysis|thrombolysis
599502|NCT00640367|intra-arterial thrombolysis|intra-arterial thrombolysis
599503|NCT00640354|Automated External Defibrillator|automated external defibrillator
599504|NCT00640354|Resuscitation|resuscitation
599505|NCT00640354|Pediatric|pediatric
599506|NCT00640328|relapsing forms of multiple sclerosis|relapsing forms of multiple sclerosis
599507|NCT00640328|ofatumumab|ofatumumab
599508|NCT00640328|multiple sclerosis|multiple sclerosis
599509|NCT00640315|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
599510|NCT00640315|COPD|copd
599511|NCT00640315|Pulmonary hypertension|pulmonary hypertension
599512|NCT00640302|Index cases|index cases
599513|NCT00640302|pandemic influenza|pandemic influenza
599514|NCT00640302|influenza A|influenza a
599515|NCT00640302|H5N1 virus|h5n1 virus
599516|NCT00640289|Factor XIII Deficiency|factor xiii deficiency
599517|NCT00640289|Rare Bleeding Disorder|rare bleeding disorder
599518|NCT00640289|Hemophilia|hemophilia
599519|NCT00640289|Fibrogammin P|fibrogammin p
599520|NCT00640276|pitavastatin|pitavastatin
599521|NCT00640276|metabolic syndrome|metabolic syndrome
599522|NCT00640276|metabolic syndrome risk score|metabolic syndrome risk score
599523|NCT00640276|hypercholesterolemia|hypercholesterolemia
599524|NCT00640263|HIV-1|hiv-1
599525|NCT00640263|Breastfeeding|breastfeeding
599526|NCT00640263|Prevention|prevention
599527|NCT00640263|lamivudine|lamivudine
599528|NCT00640263|lopinavir/ritonavir|lopinavir/ritonavir
599529|NCT00640250|Dermatitis, Contact, Bronopol, Disperse Blue 106|dermatitis, contact, bronopol, disperse blue 106
599530|NCT00640237|Vitamine D State|vitamine d state
599531|NCT00640211|Prophylaxis|prophylaxis
599532|NCT00640211|pandemic influenza|pandemic influenza
599533|NCT00640211|influenza A|influenza a
599534|NCT00640211|H5N1 virus|h5n1 virus
599535|NCT00640198|Aphasia|aphasia
599536|NCT00640198|Memantine|memantine
599537|NCT00640198|Constraint-induced language therapy|constraint-induced language therapy
599538|NCT00640198|Event-related potentials|event-related potentials
599539|NCT00640159|Parkinson's disease|parkinson's disease
599540|NCT00640159|selegiline to Zelapar switch|selegiline to zelapar switch
599541|NCT00640159|orally disintegrating formulation|orally disintegrating formulation
599542|NCT00640133|Deep Brain Stimulation|deep brain stimulation
599543|NCT00640133|Treatment Refractory|treatment refractory
599544|NCT00640133|Ventral Internal Capsule/Ventral Striatum|ventral internal capsule/ventral striatum
599545|NCT00640133|Neurosurgery|neurosurgery
599546|NCT00640133|Neuroimaging|neuroimaging
599547|NCT00640120|wheeze detection|wheeze detection
599548|NCT00640107|Magnetic Resonance Imaging|magnetic resonance imaging
599549|NCT00640094|Melatonin|melatonin
599550|NCT00640094|Acute myocardial infarction|acute myocardial infarction
599551|NCT00640094|Primary angioplasty|primary angioplasty
599552|NCT00640081|adenocarcinoma of the colon|adenocarcinoma of the colon
599553|NCT00640081|stage IV colon cancer|stage iv colon cancer
599554|NCT00640081|adenocarcinoma of the rectum|adenocarcinoma of the rectum
599555|NCT00640081|stage IV rectal cancer|stage iv rectal cancer
599556|NCT00640081|stage III colon cancer|stage iii colon cancer
599557|NCT00640081|stage III rectal cancer|stage iii rectal cancer
599558|NCT00640081|recurrent colon cancer|recurrent colon cancer
599559|NCT00640081|recurrent rectal cancer|recurrent rectal cancer
599560|NCT00640068|coronary artery disease|coronary artery disease
599561|NCT00640068|chest pain|chest pain
599562|NCT00640068|coronary artery bypass graft|coronary artery bypass graft
599563|NCT00640068|stress test|stress test
599564|NCT00640068|Coronary Angiography|coronary angiography
599565|NCT00640055|verbal autopsy|verbal autopsy
599566|NCT00640055|stillbirth|stillbirth
599567|NCT00640055|neonatal death|neonatal death
599568|NCT00640042|pain|pain
599569|NCT00640042|opioid|opioid
599570|NCT00640042|abuse|abuse
599571|NCT00640042|moderate-severe pain requiring continuous, around-the-clock opioid therapy for an extended period of time|moderate-severe pain requiring continuous, around-the-clock opioid therapy for an extended period of time
599572|NCT00640029|Arthroplasty|arthroplasty
599573|NCT00640029|Arthrodesis|arthrodesis
599574|NCT00640029|Prosthesis|prosthesis
599575|NCT00640029|Disc replacement|disc replacement
599576|NCT00640029|Spine|spine
599577|NCT00640029|Lumbar|lumbar
599578|NCT00640029|Cervical|cervical
599579|NCT00640029|Intervertebral disk|intervertebral disk
599580|NCT00640029|Cervical or lumbar intervertebral disk|cervical or lumbar intervertebral disk
599581|NCT00640029|Degenerative pathology|degenerative pathology
599582|NCT00640016|Asthma|asthma
599583|NCT00640016|CAT-354|cat-354
599584|NCT00640016|Tralokinumab|tralokinumab
599585|NCT00640003|AT|at
599586|NCT00640003|Ataxia|ataxia
599587|NCT00640003|Telangiectasia|telangiectasia
599588|NCT00639990|Intraabdominal pressure|intraabdominal pressure
599589|NCT00639977|Intraocular Pressure|intraocular pressure
599590|NCT00639977|Acupuncture|acupuncture
599591|NCT00639977|Healthy Volunteers|healthy volunteers
599592|NCT00639964|diabetes|diabetes
599593|NCT00639964|pregnancy|pregnancy
599594|NCT00639964|macrosomia|macrosomia
599595|NCT00639964|lipidics markers|lipidics markers
599596|NCT00639964|nutritional factors|nutritional factors
599597|NCT00639964|placenta|placenta
599598|NCT00639964|umbilical blood cord|umbilical blood cord
599599|NCT00639951|Snake Bite|snake bite
599600|NCT00639951|Antivenin Treatment|antivenin treatment
599601|NCT00639938|Pregnancy, High-Risk|pregnancy, high-risk
600424|NCT00636909|ENGRAFTMENT|engraftment
599602|NCT00639938|HIV Seronegativity|hiv seronegativity
599603|NCT00639912|contrast induced nephropathy STEMI PCI|contrast induced nephropathy stemi pci
599604|NCT00639899|Varicocele|varicocele
599605|NCT00639873|Uncomplicated P. falciparum malaria|uncomplicated p. falciparum malaria
599606|NCT00639860|extraction|extraction
599607|NCT00639860|implant|implant
599608|NCT00639860|alveolar ridge preservation|alveolar ridge preservation
599609|NCT00639847|Asthma management|asthma management
599610|NCT00639847|cost|cost
599611|NCT00639847|disease management|disease management
599612|NCT00639847|respiratory care|respiratory care
599614|NCT00639847|health care utilization|health care utilization
599615|NCT00639847|health related quality of life|health related quality of life
599616|NCT00639834|rheumatoid|rheumatoid
599617|NCT00639834|arthritis|arthritis
599618|NCT00639834|RA|ra
599619|NCT00639834|joint inflammation|joint inflammation
599620|NCT00639834|autoimmune|autoimmune
599621|NCT00639834|Medarex|medarex
599622|NCT00639834|Rheumatology|rheumatology
599623|NCT00639821|Gene expression microarray|gene expression microarray
599624|NCT00639821|Inflammatory bowel disease|inflammatory bowel disease
599625|NCT00639821|Infliximab|infliximab
599626|NCT00639808|delayed gastric emptying|delayed gastric emptying
599627|NCT00639808|symptomatic gastroparesis|symptomatic gastroparesis
599628|NCT00639808|diabetes mellitus|diabetes mellitus
599629|NCT00639795|Thoracic paravertebral block|thoracic paravertebral block
599630|NCT00639795|Cytokines|cytokines
599631|NCT00639795|Video assisted thorascopic surgery|video assisted thorascopic surgery
599632|NCT00639795|Pain|pain
599633|NCT00639782|thromboembolism|thromboembolism
599634|NCT00639782|mechanical heart valves|mechanical heart valves
599635|NCT00639782|randomized|randomized
599636|NCT00639769|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
599637|NCT00639769|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
599638|NCT00639769|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
599639|NCT00639769|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
599640|NCT00639769|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
599641|NCT00639769|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
599642|NCT00639769|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
599643|NCT00639769|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
599644|NCT00639769|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
599645|NCT00639769|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
599646|NCT00639769|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
599647|NCT00639769|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
599648|NCT00639769|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
599649|NCT00639769|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
599650|NCT00639769|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
599651|NCT00639769|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
599652|NCT00639769|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
599653|NCT00639769|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
599654|NCT00639769|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
599655|NCT00639769|recurrent salivary gland cancer|recurrent salivary gland cancer
599656|NCT00639769|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
599657|NCT00639769|stage IV salivary gland cancer|stage iv salivary gland cancer
599658|NCT00639756|Uric acid|uric acid
599659|NCT00639756|Fructose|fructose
599660|NCT00639756|Hypertension|hypertension
599661|NCT00639756|Insulin|insulin
599662|NCT00639756|Glucose|glucose
599663|NCT00639756|HOMA|homa
599664|NCT00639743|Pulmonary embolism|pulmonary embolism
599665|NCT00639743|Heparin|heparin
599666|NCT00639743|Thrombolytic therapy|thrombolytic therapy
599667|NCT00639743|Bleeding|bleeding
599668|NCT00639730|Epilepsy|epilepsy
599669|NCT00639717|GVHD|gvhd
599670|NCT00639704|MRI|mri
599671|NCT00639704|SPECT|spect
599672|NCT00639704|Cardiac function|cardiac function
599673|NCT00639691|Asthma, Anti-immunoglobin E, omalizumab|asthma, anti-immunoglobin e, omalizumab
599674|NCT00639678|healthy volunteers|healthy volunteers
599675|NCT00639665|Cocoa, diabetes, polyphenols|cocoa, diabetes, polyphenols
599676|NCT00639652|Carcinoma, Basal Cell|carcinoma, basal cell
599677|NCT00639652|3D-histology|3d-histology
599678|NCT00639652|Micrographic surgery|micrographic surgery
599679|NCT00639652|Mohs surgery|mohs surgery
599680|NCT00639652|Shave excision|shave excision
599681|NCT00639652|Recurrence|recurrence
599682|NCT00639652|Esthetic outcome|esthetic outcome
599683|NCT00639639|adult giant cell glioblastoma|adult giant cell glioblastoma
600425|NCT00636909|CHIMERISM|chimerism
599684|NCT00639639|adult gliosarcoma|adult gliosarcoma
599685|NCT00639587|Cetirizine|cetirizine
599686|NCT00639587|Zyrtec|zyrtec
599687|NCT00639574|Pain, morphine, nefopam, co analgesia, ureteral calculi, emergency|pain, morphine, nefopam, co analgesia, ureteral calculi, emergency
599688|NCT00639561|digestive system|digestive system
599689|NCT00639561|Diet|diet
599690|NCT00639548|Deep Sedation|deep sedation
599691|NCT00639548|EEG|eeg
599692|NCT00639548|Event-Related Potentials|event-related potentials
599693|NCT00639548|Evoked potentials, auditory|evoked potentials, auditory
599694|NCT00639548|BIS-Index|bis-index
599695|NCT00639548|Entropy|entropy
599696|NCT00639548|ICU|icu
599697|NCT00639535|Radiology|radiology
599698|NCT00639535|MRI|mri
599699|NCT00639535|Positron emission tomography|positron emission tomography
599700|NCT00639535|Breast Abnormalities|breast abnormalities
599701|NCT00639535|Dense Breast Tissue|dense breast tissue
599702|NCT00639522|Liposomal paclitaxel|liposomal paclitaxel
599703|NCT00639522|Maximum tolerated dose|maximum tolerated dose
599704|NCT00639522|Pharmacokinetics|pharmacokinetics
599705|NCT00639522|Gastric carcinoma|gastric carcinoma
599706|NCT00639496|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
599707|NCT00639470|Patient Education Handout|patient education handout
599708|NCT00639470|Parents|parents
599709|NCT00639470|Patient Education|patient education
599710|NCT00639457|PPAR-gamma agonist|ppar-gamma agonist
599711|NCT00639457|glucose metabolism|glucose metabolism
599712|NCT00639457|inflammation|inflammation
599713|NCT00639457|adipose tissue distribution|adipose tissue distribution
599714|NCT00639457|cardiac function|cardiac function
599715|NCT00639457|vascular function|vascular function
599716|NCT00639457|mass spectrometry|mass spectrometry
599717|NCT00639457|Treatment Experienced|treatment experienced
599718|NCT00639431|phantom limb pain|phantom limb pain
599719|NCT00639431|limb amputation|limb amputation
599720|NCT00639431|Amputation|amputation
599721|NCT00639431|Phantom Limb|phantom limb
599722|NCT00639431|Pain|pain
599723|NCT00639405|Parathyroid|parathyroid
599724|NCT00639405|MRI|mri
599725|NCT00639405|SPECT|spect
599726|NCT00639392|Sickle cell disease|sickle cell disease
599727|NCT00639379|toric contact lenses|toric contact lenses
599728|NCT00639379|vision|vision
599729|NCT00639379|comfort|comfort
599730|NCT00639379|toric fit characteristics|toric fit characteristics
599731|NCT00639379|slit lamp findings|slit lamp findings
599732|NCT00639366|recurrent breast cancer|recurrent breast cancer
599733|NCT00639366|stage IIIA breast cancer|stage iiia breast cancer
599734|NCT00639366|stage IIIB breast cancer|stage iiib breast cancer
599735|NCT00639366|stage IIIC breast cancer|stage iiic breast cancer
599736|NCT00639366|stage IV breast cancer|stage iv breast cancer
599737|NCT00639327|Stomach Neoplasms|stomach neoplasms
599738|NCT00639327|Second line chemotherapy|second line chemotherapy
599739|NCT00639327|Refractory to S-1|refractory to s-1
599740|NCT00639327|irinotecan|irinotecan
599741|NCT00639327|S-1 and Irinotecan Combination|s-1 and irinotecan combination
599742|NCT00639327|Phase III study|phase iii study
599743|NCT00639314|pylorus-preserving pancreaticoduodenectomy|pylorus-preserving pancreaticoduodenectomy
599744|NCT00639314|pylorus-resecting pancreaticoduodenectomy|pylorus-resecting pancreaticoduodenectomy
599745|NCT00639314|randomized controlled trial|randomized controlled trial
599746|NCT00639314|delayed gastric empty|delayed gastric empty
599747|NCT00639314|quality of life|quality of life
599748|NCT00639301|Survivor|survivor
599749|NCT00639301|Quality of Life|quality of life
599750|NCT00639301|Eye|eye
599751|NCT00639288|Alcohol Dependence|alcohol dependence
599752|NCT00639288|PTSD|ptsd
599753|NCT00639288|CPT-C|cpt-c
599754|NCT00639262|Sorafenib|sorafenib
599755|NCT00639262|Radiation Therapy|radiation therapy
599756|NCT00639262|Radiotherapy|radiotherapy
599757|NCT00639262|Temozolomide|temozolomide
599758|NCT00639262|Brain Metastases|brain metastases
599759|NCT00639262|Brain Tumors|brain tumors
599760|NCT00639236|COPD|copd
599761|NCT00639236|Hypertonic saline|hypertonic saline
599762|NCT00639236|Quality of life|quality of life
599763|NCT00639236|Dyspnoea.|dyspnoea.
599764|NCT00639223|Statin related myalgia|statin related myalgia
599765|NCT00639223|Hyperlipidemia|hyperlipidemia
599766|NCT00639223|Red yeast rice|red yeast rice
599767|NCT00639223|Cardiovascular Diseases|cardiovascular diseases
599768|NCT00639223|Nutritional and Metabolic Diseases|nutritional and metabolic diseases
599769|NCT00639210|breast cancer|breast cancer
599770|NCT00639210|exercise|exercise
599771|NCT00639210|osteoporosis|osteoporosis
599772|NCT00639210|fracture|fracture
599773|NCT00639210|quality of life|quality of life
599774|NCT00639197|Tunneling|tunneling
599775|NCT00639197|Short term|short term
599776|NCT00639197|central venous catheters|central venous catheters
599777|NCT00639197|Ultrasound Guided|ultrasound guided
599778|NCT00639197|Internal jugular|internal jugular
599779|NCT00639197|Assess safety and improve technical difficulty|assess safety and improve technical difficulty
599780|NCT00639184|asphyxia|asphyxia
599781|NCT00639184|neurodevelopmental outcome|neurodevelopmental outcome
599782|NCT00639184|home counseling|home counseling
599784|NCT00639171|diagnostic radiology|diagnostic radiology
599785|NCT00639171|suspicious breast tumors|suspicious breast tumors
599786|NCT00639171|MRI|mri
599787|NCT00639145|HIV|hiv
599788|NCT00639145|Pregnancy|pregnancy
599789|NCT00639145|Antiretrovirals|antiretrovirals
599790|NCT00639145|HIV Seronegativity|hiv seronegativity
599791|NCT00639145|Treatment Experienced|treatment experienced
599792|NCT00639132|Natural History|natural history
599793|NCT00639132|Metachromatic Leukodystrophy|metachromatic leukodystrophy
599794|NCT00639132|Disease Progression|disease progression
599795|NCT00639106|Breast expander|breast expander
599796|NCT00639106|Breast reconstruction|breast reconstruction
599797|NCT00639106|implants|implants
599798|NCT00639106|08-024|08-024
599799|NCT00639093|cigarette smoking|cigarette smoking
599800|NCT00639093|psychoeducational and motivational program|psychoeducational and motivational program
599801|NCT00639093|virtual reality|virtual reality
599802|NCT00639080|Type 2 diabetes|type 2 diabetes
599803|NCT00639080|Dyslipidemia|dyslipidemia
599804|NCT00639067|Cancer of Lung|cancer of lung
599805|NCT00639067|Cancer of the Lung|cancer of the lung
599806|NCT00639067|Lung Cancer|lung cancer
599807|NCT00639067|Neoplasms, Lung|neoplasms, lung
599808|NCT00639067|Neoplasms, Pulmonary|neoplasms, pulmonary
599809|NCT00639067|Pulmonary Cancer|pulmonary cancer
599810|NCT00639067|Pulmonary Neoplasms|pulmonary neoplasms
599811|NCT00639054|classification|classification
599812|NCT00639054|diagnosis|diagnosis
599813|NCT00639054|genetics|genetics
599814|NCT00639054|mortality|mortality
599815|NCT00639054|pathology|pathology
599816|NCT00639041|n-3 LC-PUFA|n-3 lc-pufa
599817|NCT00639041|hypertriglyceridemic|hypertriglyceridemic
599818|NCT00639041|human|human
599819|NCT00639041|TAG|tag
599820|NCT00639028|ankle|ankle
599821|NCT00639028|diagnosis|diagnosis
599822|NCT00639028|sprain|sprain
599823|NCT00639028|care|care
599824|NCT00639028|injury|injury
599825|NCT00639028|stress radiography|stress radiography
599826|NCT00639028|ultrasonography|ultrasonography
599827|NCT00639015|Sepsis|sepsis
599828|NCT00639015|Septic Shock|septic shock
599829|NCT00639015|phenylephrine|phenylephrine
599830|NCT00639015|norepinephrine|norepinephrine
599831|NCT00639015|catecholamine|catecholamine
599832|NCT00638989|Asthma|asthma
599833|NCT00638989|CAT-354|cat-354
599834|NCT00638989|Tralokinumab|tralokinumab
599835|NCT00638989|Healthy|healthy
599836|NCT00638976|Eptifibatide|eptifibatide
599837|NCT00638976|IV eptifibatide|iv eptifibatide
599838|NCT00638976|GP IIB/IIIA inhibitors|gp iib/iiia inhibitors
599839|NCT00638976|DES stent|des stent
599840|NCT00638950|n-3 LC-PUFA|n-3 lc-pufa
599841|NCT00638950|Rheumatoid arthritis|rheumatoid arthritis
599842|NCT00638950|disease activity|disease activity
599843|NCT00638950|inflammation|inflammation
599844|NCT00638950|oxidative stress|oxidative stress
599845|NCT00638950|immune system|immune system
599846|NCT00638924|healthy sedentary women|healthy sedentary women
599847|NCT00638885|PTSD|ptsd
599848|NCT00638885|hippocampus|hippocampus
599849|NCT00638885|twins|twins
599850|NCT00638872|diabetes|diabetes
599851|NCT00638872|foot ulcer|foot ulcer
599852|NCT00638872|polydeoxyribonucleotide|polydeoxyribonucleotide
599853|NCT00638859|Community-Acquired pneumonia|community-acquired pneumonia
599855|NCT00638859|children|children
599856|NCT00638859|Child|child
599857|NCT00638846|toric contact lenses|toric contact lenses
599858|NCT00638846|vision|vision
599859|NCT00638846|comfort|comfort
599860|NCT00638846|toric fit characteristics|toric fit characteristics
599861|NCT00638846|slit lamp findings|slit lamp findings
599862|NCT00638833|Multiple Sclerosis|multiple sclerosis
599863|NCT00638820|osteopetrosis|osteopetrosis
599864|NCT00638794|Myocardial Infarction|myocardial infarction
599865|NCT00638794|Myocardial Ischemia|myocardial ischemia
599866|NCT00638781|Acute ischemic stroke|acute ischemic stroke
599867|NCT00638768|physical therapy|physical therapy
599868|NCT00638768|rehabilitation|rehabilitation
599869|NCT00638768|pain|pain
599870|NCT00638768|osteoporosis|osteoporosis
599871|NCT00638768|vertebral fracture|vertebral fracture
599872|NCT00638755|Allergic Rhinitis|allergic rhinitis
599873|NCT00638755|Perennial Allergic Rhinitis|perennial allergic rhinitis
599874|NCT00638755|Allergies to perennial allergens|allergies to perennial allergens
599875|NCT00638755|Allergies to perennial allergens (e.g. dog, cat, dust mites, etc.)|allergies to perennial allergens (e.g. dog, cat, dust mites, etc.)
599876|NCT00638742|Latanoprost Pediatrics Pharmacokinetics Safety|latanoprost pediatrics pharmacokinetics safety
599877|NCT00638729|bispectral index|bispectral index
599878|NCT00638729|sedation|sedation
599879|NCT00638729|stress hormones|stress hormones
599880|NCT00638729|cognitive function|cognitive function
599881|NCT00638716|Type 2 Diabetes Mellitus, incretins, GLP-1, HbA1c, metformin|type 2 diabetes mellitus, incretins, glp-1, hba1c, metformin
599882|NCT00638703|hyperoxaluria|hyperoxaluria
599883|NCT00638703|PH|ph
599884|NCT00638703|oxalate|oxalate
599885|NCT00638690|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
599886|NCT00638690|CRPC|crpc
599887|NCT00638690|Abiraterone Acetate|abiraterone acetate
599888|NCT00638690|CB7630|cb7630
599889|NCT00638677|Oral microbiology|oral microbiology
599890|NCT00638664|conventional pulse sequences for MR|conventional pulse sequences for mr
599891|NCT00638664|cardiac chambers and walls|cardiac chambers and walls
599892|NCT00638664|cardio-thoracic vasculature|cardio-thoracic vasculature
599893|NCT00638664|the great vessels|the great vessels
599894|NCT00638664|coronary vasculature|coronary vasculature
599895|NCT00638664|cardiac|cardiac
599896|NCT00638664|great vessels|great vessels
599897|NCT00638651|Tattoos|tattoos
599898|NCT00638651|Black/blue tattoos|black/blue tattoos
599899|NCT00638638|Myocardial infarction|myocardial infarction
599900|NCT00638638|Angioplasty|angioplasty
599901|NCT00638638|Coronary stenting|coronary stenting
599902|NCT00638638|Abciximab|abciximab
599903|NCT00638638|Myocardial reperfusion|myocardial reperfusion
599904|NCT00638638|Microcirculation|microcirculation
599905|NCT00638638|EKG|ekg
599906|NCT00638638|ST elevation myocardial infarction within 6 h of symptom onset|st elevation myocardial infarction within 6 h of symptom onset
599907|NCT00638625|Needle biopsy|needle biopsy
599908|NCT00638625|CT Scan|ct scan
599909|NCT00638625|Lung Tumor|lung tumor
599910|NCT00638625|Lung Mass|lung mass
599911|NCT00638612|Immunotherapy|immunotherapy
599912|NCT00638612|Gene Therapy|gene therapy
599913|NCT00638612|Cytotoxicity|cytotoxicity
599914|NCT00638612|Tumor vaccine|tumor vaccine
599915|NCT00638612|Radiation|radiation
599916|NCT00638612|Surgery|surgery
599917|NCT00638612|Chemoradiation|chemoradiation
599918|NCT00638599|Intubation, intratracheal|intubation, intratracheal
599919|NCT00638599|Homeostasis|homeostasis
599920|NCT00638599|Mastectomy, modified radical|mastectomy, modified radical
599921|NCT00638599|Breast Neoplasms|breast neoplasms
599922|NCT00638560|PGC-1alpha|pgc-1alpha
599923|NCT00638560|PPARgamma|ppargamma
599924|NCT00638560|oxidative stress|oxidative stress
599925|NCT00638560|training intervention|training intervention
599926|NCT00638547|Hurler Syndrome|hurler syndrome
599927|NCT00638547|mucopolysaccharidosis type I|mucopolysaccharidosis type i
599928|NCT00638547|Iduronidase deficiency|iduronidase deficiency
599929|NCT00638534|Acute Otitis Media|acute otitis media
599930|NCT00638534|AOM|aom
599931|NCT00638534|children|children
599932|NCT00638534|Child|child
599933|NCT00638521|lipids|lipids
599934|NCT00638521|proteins|proteins
599935|NCT00638521|membrane|membrane
599936|NCT00638521|lipid raft|lipid raft
599937|NCT00638482|Dent's disease|dent's disease
599938|NCT00638482|Nephrolithiasis|nephrolithiasis
599939|NCT00638482|clinical trial|clinical trial
599940|NCT00638482|thiazides|thiazides
599941|NCT00638469|Psoriasis|psoriasis
599942|NCT00638469|Biologic|biologic
599943|NCT00638469|adalimumab|adalimumab
599944|NCT00638469|narrowband UVB|narrowband uvb
599945|NCT00638469|phototherapy|phototherapy
599946|NCT00638469|half-side comparison|half-side comparison
599947|NCT00638456|Eosinophils|eosinophils
599948|NCT00638456|Esophagitis|esophagitis
599949|NCT00638456|Microscopy|microscopy
599950|NCT00638443|Neurogenic claudication, lumbar spinal stenosis, treadmill testing|neurogenic claudication, lumbar spinal stenosis, treadmill testing
599951|NCT00638430|myopia|myopia
599952|NCT00638430|Humphery Matrix 30-2 test|humphery matrix 30-2 test
599953|NCT00638404|Preoperative somatic questions|preoperative somatic questions
599954|NCT00638404|Preoperative audio tone evaluations|preoperative audio tone evaluations
599955|NCT00638404|Preoperative anxiety and previous experience with postop pain|preoperative anxiety and previous experience with postop pain
599956|NCT00638391|Primary early MCa|primary early mca
599957|NCT00638391|Arimidex|arimidex
599958|NCT00638378|Prostate Cancer|prostate cancer
599959|NCT00638365|Cystic Fibrosis, Pseudomonas aeruginosa, Pulmonary CF|cystic fibrosis, pseudomonas aeruginosa, pulmonary cf
599960|NCT00638352|Core Biopsy|core biopsy
599961|NCT00638352|Needle Biopsy|needle biopsy
599962|NCT00638352|Percutaneous Biopsy|percutaneous biopsy
599963|NCT00638339|Respiration, artificial|respiration, artificial
599964|NCT00638339|respiratory insufficiency|respiratory insufficiency
599965|NCT00638339|noninvasive ventilation|noninvasive ventilation
599966|NCT00638339|sleep deprivation|sleep deprivation
599967|NCT00638339|intensive care units|intensive care units
599968|NCT00638326|Clopidogrel, thrombosis, Percutaneous Transluminal Coronary Angioplasty, stents|clopidogrel, thrombosis, percutaneous transluminal coronary angioplasty, stents
599969|NCT00638313|GLP-1|glp-1
599970|NCT00638300|hemodialysis|hemodialysis
599971|NCT00638300|iron|iron
599972|NCT00638300|inflammation|inflammation
599973|NCT00638300|atomic absorption|atomic absorption
599974|NCT00638300|dialysate|dialysate
599975|NCT00638300|advanced oxidation protein products|advanced oxidation protein products
599976|NCT00638300|large pore dialysate|large pore dialysate
599977|NCT00638300|bicarbonate|bicarbonate
599978|NCT00638300|calcium|calcium
599979|NCT00638300|citrate|citrate
599980|NCT00638300|ligand|ligand
599981|NCT00638287|Subjects with pituitary disease undergoing testing for GH|subjects with pituitary disease undergoing testing for gh
599982|NCT00638287|deficiency|deficiency
600223|NCT00637624|Antioxidants|antioxidants
599983|NCT00638287|Subjects with suspicion for (or diagnosis of) acromegaly|subjects with suspicion for (or diagnosis of) acromegaly
599984|NCT00638287|undergoing OGTT testing|undergoing ogtt testing
599985|NCT00638287|Normal controls without evidence of pituitary dysfunction|normal controls without evidence of pituitary dysfunction
599986|NCT00638274|Quality of pain relief with 2 different methods of identifying epidural space|quality of pain relief with 2 different methods of identifying epidural space
599987|NCT00638261|Psoriasis|psoriasis
599988|NCT00638261|Biologic|biologic
599989|NCT00638261|Adalimumab|adalimumab
599990|NCT00638261|Narrow-band UVB|narrow-band uvb
599991|NCT00638261|phototherapy|phototherapy
599992|NCT00638261|half-side comparison|half-side comparison
599993|NCT00638248|Acute ischemic stroke|acute ischemic stroke
599994|NCT00638235|Pelvic floor repair|pelvic floor repair
599995|NCT00638235|prolapse|prolapse
599996|NCT00638235|mesh|mesh
599997|NCT00638222|Carvedilol|carvedilol
599998|NCT00638222|Heart Disease|heart disease
599999|NCT00638222|Vascular Disease|vascular disease
600000|NCT00638222|Kidney|kidney
600001|NCT00638196|relapsing multiple sclerosis|relapsing multiple sclerosis
600002|NCT00638196|polyunsaturated fatty acids|polyunsaturated fatty acids
600003|NCT00638196|omega-6 fatty acids|omega-6 fatty acids
600004|NCT00638170|Urinary Tract Infections|urinary tract infections
600005|NCT00638170|Cranberry|cranberry
600006|NCT00638170|Prevention|prevention
600007|NCT00638157|Gram-positive bacterial infections|gram-positive bacterial infections
600008|NCT00638157|Staph Aureus|staph aureus
600009|NCT00638157|endocarditis|endocarditis
600010|NCT00638157|bacteremia|bacteremia
600011|NCT00638157|methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
600012|NCT00638144|Hepatitis C|hepatitis c
600013|NCT00638144|liver transplantation|liver transplantation
600014|NCT00638144|antibodies mediated neutralization|antibodies mediated neutralization
600015|NCT00638144|monoclonal antibodies|monoclonal antibodies
600016|NCT00638092|hypothyroxinemia|hypothyroxinemia
600017|NCT00638092|preterm infants|preterm infants
600018|NCT00638092|iodine|iodine
600019|NCT00638092|neurodevelopmental outcome|neurodevelopmental outcome
600020|NCT00638092|Iodine supplementation|iodine supplementation
600021|NCT00638092|Randomised controlled trial|randomised controlled trial
600022|NCT00638079|Pharmacokinetics|pharmacokinetics
600023|NCT00638079|Food Effect|food effect
600024|NCT00638079|Bioavailability|bioavailability
600025|NCT00638079|Megace ES|megace es
600026|NCT00638066|vaginismus|vaginismus
600027|NCT00638066|botulinum toxin A|botulinum toxin a
600028|NCT00638066|dyspareunia|dyspareunia
600029|NCT00638066|unconsummated marriage|unconsummated marriage
600030|NCT00638040|hypoxia|hypoxia
600031|NCT00638040|lactate|lactate
600032|NCT00638040|pH|ph
600033|NCT00638040|tumor microenvironments|tumor microenvironments
600034|NCT00638040|survival|survival
600035|NCT00638027|multiple sclerosis|multiple sclerosis
600036|NCT00638014|Sternal wound closure|sternal wound closure
600037|NCT00638014|cardiac surgery|cardiac surgery
600038|NCT00638014|sternal nonunion|sternal nonunion
600039|NCT00638001|patients with haemophilia A moderate or severe|patients with haemophilia a moderate or severe
600040|NCT00638001|patients with haemophilia B moderate or severe|patients with haemophilia b moderate or severe
600041|NCT00637988|Barrett's Esophagus|barrett's esophagus
600042|NCT00637988|Nexium|nexium
600043|NCT00637975|neuropathic pain|neuropathic pain
600044|NCT00637975|oxycodone|oxycodone
600045|NCT00637975|pregabalin|pregabalin
600046|NCT00637975|Patients with cancer and presenting a neuropathic pain|patients with cancer and presenting a neuropathic pain
600047|NCT00637962|HIV|hiv
600048|NCT00637962|AIDS|aids
600049|NCT00637962|Vaccine|vaccine
600050|NCT00637962|intravaginal|intravaginal
600051|NCT00637962|mucosal|mucosal
600052|NCT00637962|HIV Seronegativity|hiv seronegativity
600053|NCT00637949|Osteoarthritis|osteoarthritis
600054|NCT00637949|lumiracoxib|lumiracoxib
600055|NCT00637949|rofecoxib|rofecoxib
600056|NCT00637949|Cox-2|cox-2
600057|NCT00637949|Osteoarthritis (primary osteoarthritis hip, hand, knee or spine (cervical or lumbar)|osteoarthritis (primary osteoarthritis hip, hand, knee or spine (cervical or lumbar)
600058|NCT00637936|perioperative oxygen|perioperative oxygen
600059|NCT00637936|respiratory complications|respiratory complications
600060|NCT00637923|Hepatitis C, Chronic|hepatitis c, chronic
600061|NCT00637910|Advanced NSCLC|advanced nsclc
600062|NCT00637910|EGFR|egfr
600063|NCT00637910|EGFR copy number|egfr copy number
600064|NCT00637910|Kras mutations|kras mutations
600065|NCT00637910|EGRF mutations|egrf mutations
600066|NCT00637910|Docetaxel|docetaxel
600067|NCT00637910|Erlotinib|erlotinib
600068|NCT00637910|Polymorphisms|polymorphisms
600069|NCT00637897|recurrent breast cancer|recurrent breast cancer
600070|NCT00637897|stage IV breast cancer|stage iv breast cancer
600071|NCT00637871|Casodex|casodex
600072|NCT00637871|bicalutamide|bicalutamide
600073|NCT00637871|Tamoxifen|tamoxifen
600074|NCT00637871|Gynaecomastia|gynaecomastia
600075|NCT00637871|Prostate Cancer|prostate cancer
600076|NCT00637845|Nexium|nexium
600077|NCT00637845|Esomeprazole Magnesium|esomeprazole magnesium
600422|NCT00636909|G-CSF|g-csf
600078|NCT00637845|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
600079|NCT00637845|Heartburn|heartburn
600080|NCT00637832|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
600081|NCT00637832|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
600082|NCT00637832|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
600083|NCT00637832|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
600084|NCT00637832|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
600085|NCT00637832|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
600086|NCT00637832|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
600087|NCT00637832|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
600088|NCT00637832|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
600089|NCT00637832|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
600090|NCT00637832|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
600091|NCT00637832|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
600092|NCT00637832|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
600093|NCT00637832|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
600094|NCT00637832|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
600095|NCT00637806|Megestrol acetate|megestrol acetate
600096|NCT00637806|Anorexia|anorexia
600097|NCT00637806|Cachexia|cachexia
600098|NCT00637806|Cancer|cancer
600099|NCT00637806|Unintended weight loss|unintended weight loss
600100|NCT00637806|Body weight|body weight
600101|NCT00637806|Appetite|appetite
600102|NCT00637806|Megace ES|megace es
600103|NCT00637793|Xerostomia|xerostomia
600104|NCT00637793|Sjogren's Syndrome|sjogren's syndrome
600105|NCT00637780|Sulfasalazine delayed release tablets|sulfasalazine delayed release tablets
600106|NCT00637780|azulfidine entabs|azulfidine entabs
600107|NCT00637780|Pharmacokinetics|pharmacokinetics
600108|NCT00637780|Juvenile Idiopathic Arthritis (JIA)|juvenile idiopathic arthritis (jia)
600109|NCT00637767|stage I multiple myeloma|stage i multiple myeloma
600110|NCT00637767|stage II multiple myeloma|stage ii multiple myeloma
600111|NCT00637767|stage III multiple myeloma|stage iii multiple myeloma
600112|NCT00637754|ICD|icd
600113|NCT00637754|Sports|sports
600114|NCT00637741|Peripheral Vascular Disease|peripheral vascular disease
600115|NCT00637741|Intermittent claudication|intermittent claudication
600116|NCT00637741|Critical Limb Ischemia|critical limb ischemia
600117|NCT00637741|TASC|tasc
600118|NCT00637728|Megestrol acetate|megestrol acetate
600119|NCT00637728|Anorexia|anorexia
600120|NCT00637728|Cachexia|cachexia
600121|NCT00637728|Lung cancer|lung cancer
600122|NCT00637728|Pancreatic cancer|pancreatic cancer
600123|NCT00637728|Unintended weight loss|unintended weight loss
600124|NCT00637728|Body weight|body weight
600125|NCT00637728|Appetite|appetite
600126|NCT00637728|Megace ES|megace es
600127|NCT00637689|Chronic graft versus host disease|chronic graft versus host disease
600128|NCT00637689|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
600129|NCT00637689|Biomarkers|biomarkers
600130|NCT00637689|Response criteria|response criteria
600131|NCT00637689|Surrogate endpoints|surrogate endpoints
600132|NCT00637689|Natural history|natural history
600133|NCT00637676|malignant pleural effusion|malignant pleural effusion
600134|NCT00637676|subcutaneous tunneled drainage|subcutaneous tunneled drainage
600135|NCT00637676|talc pleurodesis|talc pleurodesis
600136|NCT00637663|Chronic hepatitis B|chronic hepatitis b
600137|NCT00637663|Lamivudine|lamivudine
600138|NCT00637663|Entecavir|entecavir
600139|NCT00637637|tumors metastatic to brain|tumors metastatic to brain
600140|NCT00637637|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
600141|NCT00637637|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
600142|NCT00637637|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
600143|NCT00637637|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
600144|NCT00637637|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
600145|NCT00637637|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
600146|NCT00637637|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
600147|NCT00637637|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
600148|NCT00637637|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
600149|NCT00637637|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
600150|NCT00637637|stage IV anal cancer|stage iv anal cancer
600151|NCT00637637|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
600152|NCT00637637|stage IV bladder cancer|stage iv bladder cancer
600153|NCT00637637|stage IV borderline ovarian surface epithelial-stromal tumor|stage iv borderline ovarian surface epithelial-stromal tumor
600154|NCT00637637|stage IV breast cancer|stage iv breast cancer
600155|NCT00637637|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
600156|NCT00637637|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
600157|NCT00637637|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
600158|NCT00637637|stage IV childhood liver cancer|stage iv childhood liver cancer
600159|NCT00637637|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
600160|NCT00637637|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
600161|NCT00637637|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
600162|NCT00637637|stage IV colon cancer|stage iv colon cancer
600163|NCT00637637|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
600164|NCT00637637|stage IV esophageal cancer|stage iv esophageal cancer
600165|NCT00637637|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
600166|NCT00637637|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
600167|NCT00637637|stage IV gastric cancer|stage iv gastric cancer
600168|NCT00637637|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
600169|NCT00637637|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
600170|NCT00637637|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
600171|NCT00637637|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
600172|NCT00637637|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
600173|NCT00637637|stage IV laryngeal cancer|stage iv laryngeal cancer
600174|NCT00637637|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
600175|NCT00637637|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
600176|NCT00637637|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
600177|NCT00637637|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
600178|NCT00637637|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
600179|NCT00637637|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
600180|NCT00637637|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
600181|NCT00637637|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
600182|NCT00637637|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
600183|NCT00637637|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
600184|NCT00637637|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
600185|NCT00637637|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
600186|NCT00637637|stage IV pancreatic cancer|stage iv pancreatic cancer
600187|NCT00637637|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
600188|NCT00637637|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
600189|NCT00637637|stage IV penile cancer|stage iv penile cancer
600190|NCT00637637|stage IV prostate cancer|stage iv prostate cancer
600191|NCT00637637|stage IV rectal cancer|stage iv rectal cancer
600192|NCT00637637|stage IV renal cell cancer|stage iv renal cell cancer
600193|NCT00637637|stage IV salivary gland cancer|stage iv salivary gland cancer
600194|NCT00637637|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
600195|NCT00637637|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
600196|NCT00637637|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
600197|NCT00637637|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
600316|NCT00637195|HPV|hpv
600198|NCT00637637|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
600199|NCT00637637|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
600200|NCT00637637|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
600201|NCT00637637|stage IV endometrial carcinoma|stage iv endometrial carcinoma
600202|NCT00637637|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
600203|NCT00637637|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
600204|NCT00637637|stage IVB vulvar cancer|stage ivb vulvar cancer
600205|NCT00637637|stage IV Wilms tumor|stage iv wilms tumor
600206|NCT00637637|stage IVB cervical cancer|stage ivb cervical cancer
600207|NCT00637637|stage IVB vaginal cancer|stage ivb vaginal cancer
600208|NCT00637637|metastatic adult malignant fibrous histiocytoma of bone|metastatic adult malignant fibrous histiocytoma of bone
600209|NCT00637637|metastatic childhood malignant fibrous histiocytoma of bone|metastatic childhood malignant fibrous histiocytoma of bone
600210|NCT00637637|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
600211|NCT00637637|metastatic parathyroid cancer|metastatic parathyroid cancer
600212|NCT00637637|metastatic pheochromocytoma|metastatic pheochromocytoma
600213|NCT00637637|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
600214|NCT00637637|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
600215|NCT00637637|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
600216|NCT00637637|disseminated neuroblastoma|disseminated neuroblastoma
600217|NCT00637637|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
600218|NCT00637637|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
600219|NCT00637637|tongue cancer|tongue cancer
600220|NCT00637624|Acetylcysteine|acetylcysteine
600221|NCT00637624|Cisplatin|cisplatin
600222|NCT00637624|Neuropathy|neuropathy
600224|NCT00637598|Diagnostic Imaging|diagnostic imaging
600225|NCT00637598|Mammography|mammography
600226|NCT00637598|Breast Tomosynthesis|breast tomosynthesis
600227|NCT00637572|Weight loss|weight loss
600228|NCT00637572|Cachexia|cachexia
600229|NCT00637572|Anorexia|anorexia
600230|NCT00637572|Megestrol acetate oral suspension|megestrol acetate oral suspension
600231|NCT00637572|Nanocrystal dispersion|nanocrystal dispersion
600232|NCT00637572|Nanocrystal technology|nanocrystal technology
600233|NCT00637572|Body weight changes|body weight changes
600234|NCT00637572|AIDS wasting|aids wasting
600235|NCT00637572|HIV wasting|hiv wasting
600236|NCT00637572|Emaciation|emaciation
600237|NCT00637572|Megace ES|megace es
600238|NCT00637572|Megace|megace
600239|NCT00637572|Treatment Experienced|treatment experienced
600240|NCT00637559|Nexium|nexium
600241|NCT00637559|Barrett's esophagus|barrett's esophagus
600242|NCT00637546|Treatment|treatment
600243|NCT00637546|Efficacy|efficacy
600244|NCT00637546|Diabetes|diabetes
600245|NCT00637546|Gait|gait
600246|NCT00637546|Balance|balance
600247|NCT00637520|Nonalcoholic Fatty Liver Disease|nonalcoholic fatty liver disease
600248|NCT00637520|Insulin Resistance|insulin resistance
600249|NCT00637520|Lipid Metabolism|lipid metabolism
600250|NCT00637507|High-Frequency Ventilation|high-frequency ventilation
600251|NCT00637507|Tracheal Gas Insufflation|tracheal gas insufflation
600252|NCT00637507|Respiration, Artificial|respiration, artificial
600253|NCT00637507|Respiratory Distress Syndrome|respiratory distress syndrome
600254|NCT00637507|Adult|adult
600255|NCT00637494|psychotic depression|psychotic depression
600256|NCT00637494|major depression with psychotic features|major depression with psychotic features
600257|NCT00637494|psychosis|psychosis
600258|NCT00637416|horseness|horseness
600259|NCT00637403|renal impairment|renal impairment
600260|NCT00637403|end stage renal disease|end stage renal disease
600261|NCT00637403|megestrol acetate|megestrol acetate
600262|NCT00637403|pharmacokinetics|pharmacokinetics
600263|NCT00637403|hemodialysis|hemodialysis
600264|NCT00637403|renal dialysis|renal dialysis
600265|NCT00637403|kidney failure, chronic|kidney failure, chronic
600266|NCT00637403|renal insufficiency|renal insufficiency
600267|NCT00637403|Megace ES|megace es
600268|NCT00637377|Eye diseases|eye diseases
600269|NCT00637377|Vision Impairment and Blindness|vision impairment and blindness
600270|NCT00637377|Eyes and Vision|eyes and vision
600271|NCT00637377|Seniors|seniors
600272|NCT00637377|Neovascular Age-Related Macular Degeneration (AMD)|neovascular age-related macular degeneration (amd)
600273|NCT00637377|Retinal Disease|retinal disease
600274|NCT00637364|pain|pain
600275|NCT00637364|pancreas|pancreas
600276|NCT00637364|pancreatic cancer|pancreatic cancer
600277|NCT00637364|pancreatic adenocarcinoma|pancreatic adenocarcinoma
600278|NCT00637364|ductal adenocarcinoma|ductal adenocarcinoma
600279|NCT00637338|Long-acting GLP-1 Diabetes|long-acting glp-1 diabetes
600280|NCT00637325|trastuzumab optimization in breast cancer|trastuzumab optimization in breast cancer
600281|NCT00637299|COPD|copd
600282|NCT00637286|Zolmitriptan|zolmitriptan
600283|NCT00637286|ZOMIG|zomig
600284|NCT00637286|migraine|migraine
600285|NCT00637286|headache response|headache response
600286|NCT00637286|headache|headache
600287|NCT00637286|headache pain|headache pain
600288|NCT00637286|MIDAS|midas
600289|NCT00637286|HCPC|hcpc
600290|NCT00637273|diabetes|diabetes
600291|NCT00637273|exenatide once weekly|exenatide once weekly
600292|NCT00637273|Byetta|byetta
600293|NCT00637273|sitagliptin|sitagliptin
600294|NCT00637273|Januvia|januvia
600295|NCT00637273|thiazolidinedione|thiazolidinedione
600296|NCT00637273|Amylin|amylin
600297|NCT00637273|Lilly|lilly
600298|NCT00637273|Pioglitazone|pioglitazone
600299|NCT00637260|motorcortex stimulation|motorcortex stimulation
600300|NCT00637260|Parkinson's disease|parkinson's disease
600301|NCT00637260|neuromodulation|neuromodulation
600302|NCT00637247|pancreatic cancer|pancreatic cancer
600303|NCT00637247|metastatic|metastatic
600304|NCT00637247|chemotherapy naive|chemotherapy naive
600305|NCT00637221|Safety|safety
600306|NCT00637221|Tolerability|tolerability
600307|NCT00637208|prostate cancer|prostate cancer
600308|NCT00637208|venography|venography
600309|NCT00637208|male patients|male patients
600310|NCT00637208|Localized microscopic prostate cancer up to Gleason 6 (3+3)|localized microscopic prostate cancer up to gleason 6 (3+3)
600311|NCT00637208|PSA level <14|psa level <14
600312|NCT00637208|presence of varicocele|presence of varicocele
600313|NCT00637195|Human papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
600314|NCT00637195|Hepatitis B|hepatitis b
600315|NCT00637195|Cervical cancer|cervical cancer
600317|NCT00637195|Papillomavirus|papillomavirus
600318|NCT00637182|Gynecomastia|gynecomastia
600319|NCT00637182|Anastrazole|anastrazole
600320|NCT00637182|Arimidex|arimidex
600321|NCT00637182|Pubertal|pubertal
600322|NCT00637182|males|males
600323|NCT00637182|boys|boys
600324|NCT00637169|oxygen therapy|oxygen therapy
600325|NCT00637169|neurodevelopmental impairment|neurodevelopmental impairment
600423|NCT00636909|GVHD|gvhd
600326|NCT00637156|Symptomatic DDD at Two Adjacent Levels of cervical spine|symptomatic ddd at two adjacent levels of cervical spine
600327|NCT00637143|Renal transplant|renal transplant
600328|NCT00637143|Cyclosporine|cyclosporine
600329|NCT00637143|Tacrolimus|tacrolimus
600330|NCT00637143|Intervention|intervention
600331|NCT00637143|Interstitial Fibrosis Tubular Atrophy|interstitial fibrosis tubular atrophy
600332|NCT00637143|Chronic Renal Allograft Failure|chronic renal allograft failure
600333|NCT00637117|Lymphoma, Dendritic, Vaccine, Radiotherapy|lymphoma, dendritic, vaccine, radiotherapy
600334|NCT00637104|percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
600335|NCT00637104|stents|stents
600336|NCT00637104|restenosis|restenosis
600337|NCT00637104|biocompatible materials|biocompatible materials
600338|NCT00637104|ceramics|ceramics
600339|NCT00637078|hypertension|hypertension
600340|NCT00637078|hypercholesterolemia|hypercholesterolemia
600341|NCT00637078|family physicians|family physicians
600342|NCT00637078|fixed dose combination therapy|fixed dose combination therapy
600343|NCT00637078|cluster randomized controlled trial|cluster randomized controlled trial
600344|NCT00637065|Pulmonary hypertension|pulmonary hypertension
600345|NCT00637065|Interstitial lung disease|interstitial lung disease
600346|NCT00637065|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
600347|NCT00637065|Nonspecific interstitial pneumonia|nonspecific interstitial pneumonia
600348|NCT00637065|Bosentan|bosentan
600349|NCT00637065|Endothelin receptor antagonists|endothelin receptor antagonists
600350|NCT00637065|Pulmonary vascular resistance|pulmonary vascular resistance
600351|NCT00637052|preleukemia|preleukemia
600352|NCT00637052|dysplasia of myeloid blood cells|dysplasia of myeloid blood cells
600353|NCT00637039|Advanced cancer|advanced cancer
600354|NCT00637039|Solid tumour|solid tumour
600355|NCT00637039|Solid malignancies|solid malignancies
600356|NCT00637039|Neoplasms|neoplasms
600357|NCT00637026|Iressa, Gefitinib, Breast Cancer, Surgery|iressa, gefitinib, breast cancer, surgery
600358|NCT00637013|Subacromial impingement|subacromial impingement
600359|NCT00637013|Shoulder|shoulder
600360|NCT00637013|RCT|rct
600361|NCT00637013|Effectiveness|effectiveness
600362|NCT00637013|Cost-effectiveness|cost-effectiveness
600363|NCT00637000|Opioid dependence|opioid dependence
600364|NCT00637000|Opioid withdrawal symptoms|opioid withdrawal symptoms
600365|NCT00636987|aortic valve|aortic valve
600366|NCT00636987|mitral valve|mitral valve
600367|NCT00636987|heart valve|heart valve
600368|NCT00636987|tissue valve|tissue valve
600369|NCT00636987|bioprosthesis|bioprosthesis
600370|NCT00636987|valve disorder|valve disorder
600371|NCT00636987|valve disease|valve disease
600372|NCT00636987|cardiac surgery|cardiac surgery
600373|NCT00636987|aortic valve regurgitation|aortic valve regurgitation
600374|NCT00636987|aortic valve stenosis|aortic valve stenosis
600375|NCT00636987|mitral valve regurgitation|mitral valve regurgitation
600376|NCT00636987|mitral valve stenosis|mitral valve stenosis
600377|NCT00636974|Patients who are going to have regional anaesthesia for lower limbs surgery.|patients who are going to have regional anaesthesia for lower limbs surgery.
600378|NCT00636974|Leg Surgery.|leg surgery.
600379|NCT00636961|COPD, Indacaterol Maleate, Exercise testing|copd, indacaterol maleate, exercise testing
600380|NCT00636948|Rectal cancer surgery|rectal cancer surgery
600381|NCT00636948|Symptomatic anastomotic leakage|symptomatic anastomotic leakage
600382|NCT00636948|Defunctioning stoma|defunctioning stoma
600383|NCT00636948|TME surgery|tme surgery
600384|NCT00636935|Pneumocystis jirovecii Pneumonia|pneumocystis jirovecii pneumonia
600385|NCT00636935|Corticosteroid Therapy|corticosteroid therapy
600386|NCT00636935|HIV|hiv
600387|NCT00636935|Pneumonia|pneumonia
600388|NCT00636935|Pulmonary Function Testing|pulmonary function testing
600389|NCT00636935|Antibiotics|antibiotics
600390|NCT00636935|Prednisone|prednisone
600391|NCT00636935|Human Immunodeficiency Virus|human immunodeficiency virus
600392|NCT00636935|CD4|cd4
600393|NCT00636935|CD8|cd8
600394|NCT00636935|Viral Load|viral load
600395|NCT00636935|Bactrim|bactrim
600396|NCT00636935|Pentamidine|pentamidine
600397|NCT00636935|Atovaquone|atovaquone
600398|NCT00636935|Primaquine/Clindamycin|primaquine/clindamycin
600399|NCT00636935|Trimethoprim/Dapsone|trimethoprim/dapsone
600400|NCT00636922|Acute Myeloid Leukemia|acute myeloid leukemia
600401|NCT00636922|Elderly|elderly
600402|NCT00636922|Unfit|unfit
600403|NCT00636922|Everolimus|everolimus
600404|NCT00636922|RAD001|rad001
600405|NCT00636909|AML|aml
600406|NCT00636909|ALL|all
600407|NCT00636909|CML|cml
600408|NCT00636909|CLL|cll
600409|NCT00636909|MDS|mds
600410|NCT00636909|NHL|nhl
600411|NCT00636909|HODGKIN'S LYMPHOMA|hodgkin's lymphoma
600412|NCT00636909|APLASTIC ANEMIA|aplastic anemia
600413|NCT00636909|MULTIPLE MYELOMA|multiple myeloma
600414|NCT00636909|MYELOPROLIFERATIVE DISORDER|myeloproliferative disorder
600415|NCT00636909|ALLOGENEIC|allogeneic
600416|NCT00636909|STEM CELL TRANSPLANT|stem cell transplant
600417|NCT00636909|HEMATOLOGIC DISORDERS|hematologic disorders
600418|NCT00636909|CYCLOPHOSPHAMIDE|cyclophosphamide
600419|NCT00636909|FLUDARABINE|fludarabine
600420|NCT00636909|CYCLOSPORINE|cyclosporine
600421|NCT00636909|METHOTREXATE|methotrexate
600426|NCT00636896|weight gain|weight gain
600427|NCT00636896|olanzapine|olanzapine
600428|NCT00636896|atypical antipsychotic|atypical antipsychotic
600429|NCT00636883|Pancreatic cancer|pancreatic cancer
600430|NCT00636857|Water-Electrolyte Imbalance|water-electrolyte imbalance
600431|NCT00636844|chemotherapy, cardiotoxicity|chemotherapy, cardiotoxicity
600432|NCT00636831|Prophylactic|prophylactic
600433|NCT00636831|Antibiotic|antibiotic
600434|NCT00636831|Infection|infection
600435|NCT00636831|Primary case|primary case
600436|NCT00636805|Aloxi|aloxi
600437|NCT00636805|Brain Neoplasm, Primary|brain neoplasm, primary
600438|NCT00636805|Brain Neoplasms, Malignant|brain neoplasms, malignant
600439|NCT00636766|cardiovascular events|cardiovascular events
600565|NCT00636129|stress management|stress management
600440|NCT00636753|Metabolic and endocrine changes in schizophrenic patients by antipsychotics treatment.|metabolic and endocrine changes in schizophrenic patients by antipsychotics treatment.
600441|NCT00636740|Prostate cancer, hormone resistant, bisphosphonate|prostate cancer, hormone resistant, bisphosphonate
600442|NCT00636727|arthrocentesis|arthrocentesis
600443|NCT00636727|arthroscopy|arthroscopy
600444|NCT00636727|arthroplasty|arthroplasty
600445|NCT00636714|intensive insulin therapy|intensive insulin therapy
600446|NCT00636714|glucose control|glucose control
600447|NCT00636714|nurse directed|nurse directed
600448|NCT00636714|nomogram directed|nomogram directed
600449|NCT00636701|Cerebrovascular Accident|cerebrovascular accident
600450|NCT00636701|rehabilitation|rehabilitation
600451|NCT00636688|Obesity|obesity
600452|NCT00636688|Lifestyle changes|lifestyle changes
600453|NCT00636675|Accidental falls|accidental falls
600454|NCT00636649|Eating disorder|eating disorder
600455|NCT00636636|Postherpetic Neuralgia (PHN), shingles|postherpetic neuralgia (phn), shingles
600456|NCT00636623|Pilates Exercises|pilates exercises
600457|NCT00636623|Connective Tissue Massage|connective tissue massage
600458|NCT00636610|Hedgehog|hedgehog
600459|NCT00636610|CRC|crc
600460|NCT00636610|Colorectal Cancer|colorectal cancer
600461|NCT00636610|Hedgehog Pathway Inhibitor|hedgehog pathway inhibitor
600462|NCT00636584|sodium nitroprusside|sodium nitroprusside
600463|NCT00636584|thyroid hormones|thyroid hormones
600464|NCT00636584|thoracic surgery|thoracic surgery
600465|NCT00636571|Exercise|exercise
600466|NCT00636571|Non-Small Cell Lung Cancer|non-small cell lung cancer
600467|NCT00636571|Cardiopulmonary Fitness|cardiopulmonary fitness
600468|NCT00636558|coxsackie virus|coxsackie virus
600469|NCT00636558|melanoma|melanoma
600470|NCT00636558|breast cancer|breast cancer
600471|NCT00636558|prostate cancer|prostate cancer
600472|NCT00636545|Genasense|genasense
600473|NCT00636545|oblimersen|oblimersen
600474|NCT00636545|antisense|antisense
600475|NCT00636545|Bcl-2 antisense|bcl-2 antisense
600476|NCT00636545|Solid Tumors|solid tumors
600477|NCT00636519|Botulism Antitoxin,Heptavalent,Bivalent,EDB Muscle,Paralysis|botulism antitoxin,heptavalent,bivalent,edb muscle,paralysis
600478|NCT00636506|Erectile dysfunction|erectile dysfunction
600479|NCT00636506|Impotence|impotence
600480|NCT00636493|retinal vein occlusion|retinal vein occlusion
600481|NCT00636493|sustained drug delivery implant|sustained drug delivery implant
600482|NCT00636493|steroid|steroid
600483|NCT00636493|macular edema|macular edema
600484|NCT00636480|Antimicrobial|antimicrobial
600485|NCT00636480|Antisepsis|antisepsis
600486|NCT00636467|Breast cancer (tumors> 2 cm)|breast cancer (tumors> 2 cm)
600487|NCT00636467|Detection|detection
600488|NCT00636467|Axillary sentinel lymph node|axillary sentinel lymph node
600489|NCT00636454|OA|oa
600490|NCT00636454|Pain|pain
600491|NCT00636454|Cognitive Therapy|cognitive therapy
600492|NCT00636454|Behavior Therapy|behavior therapy
600493|NCT00636454|Knee OA|knee oa
600494|NCT00636454|Hip OA|hip oa
600495|NCT00636441|Early-Stage Breast Cancer|early-stage breast cancer
600496|NCT00636441|Preoperative systemic chemotherapy (PST)|preoperative systemic chemotherapy (pst)
600497|NCT00636441|Genomic|genomic
600498|NCT00636441|Genomic Predictor|genomic predictor
600499|NCT00636441|Genomic Expression Profiles|genomic expression profiles
600500|NCT00636441|Randomized|randomized
600501|NCT00636441|Pathologic complete response (pCR)|pathologic complete response (pcr)
600502|NCT00636441|HER2 negative|her2 negative
600503|NCT00636441|Doxorubicin and docetaxel|doxorubicin and docetaxel
600504|NCT00636441|Doxorubicin and cyclophosphamide|doxorubicin and cyclophosphamide
600505|NCT00636428|endoscopy|endoscopy
600506|NCT00636428|Midazolam|midazolam
600507|NCT00636428|pediatric|pediatric
600508|NCT00636428|sedation|sedation
600509|NCT00636428|comfort|comfort
600510|NCT00636415|Analgesia|analgesia
600511|NCT00636415|Morphine|morphine
600512|NCT00636415|Bupivacaine|bupivacaine
600513|NCT00636415|Osteoarthritis|osteoarthritis
600514|NCT00636415|Knee|knee
600515|NCT00636402|Vessel Sealing System|vessel sealing system
600516|NCT00636402|Cold Knife|cold knife
600517|NCT00636402|Tonsillectomy|tonsillectomy
600518|NCT00636402|Pain|pain
600519|NCT00636402|Postoperative|postoperative
600520|NCT00636389|Hemodialysis|hemodialysis
600521|NCT00636389|Dialysis, Renal|dialysis, renal
600522|NCT00636389|Dialysis, Extracorporeal|dialysis, extracorporeal
600523|NCT00636389|Extracorporeal Dialysis|extracorporeal dialysis
600524|NCT00636376|elevated intracranial pressure|elevated intracranial pressure
600525|NCT00636376|inadequate cerebral perfusion|inadequate cerebral perfusion
600526|NCT00636376|secondary brain damage|secondary brain damage
600527|NCT00636350|pepper carotenoids|pepper carotenoids
600528|NCT00636350|xanthophylls|xanthophylls
600529|NCT00636350|healthy volunteers|healthy volunteers
600530|NCT00636337|Pediatric|pediatric
600531|NCT00636337|Brain Tumor|brain tumor
600532|NCT00636337|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
600533|NCT00636337|Inattention|inattention
600534|NCT00636337|Childhood cancer survivors|childhood cancer survivors
600535|NCT00636324|Respiratory distress syndrome|respiratory distress syndrome
600536|NCT00636324|Preterm infants|preterm infants
600537|NCT00636324|Extubation failure|extubation failure
600538|NCT00636324|Pneumothorax|pneumothorax
600539|NCT00636324|Lung injury|lung injury
600540|NCT00636324|Airway pressure|airway pressure
600541|NCT00636311|Hodgkin disease|hodgkin disease
600542|NCT00636311|Salvage therapy|salvage therapy
600543|NCT00636311|Bortezomib|bortezomib
600544|NCT00636311|Transplantation|transplantation
600545|NCT00636298|esophageal carcinoma|esophageal carcinoma
600546|NCT00636298|cancer of the esophagus|cancer of the esophagus
600547|NCT00636298|locally advanced or metastatic esophageal cancer|locally advanced or metastatic esophageal cancer
600548|NCT00636285|A110|a110
600549|NCT00636285|Safety|safety
600550|NCT00636272|ICD|icd
600551|NCT00636272|CRT-D|crt-d
600552|NCT00636259|Prostate cancer|prostate cancer
600553|NCT00636259|Casodex|casodex
600554|NCT00636233|anencephaly|anencephaly
600555|NCT00636233|acrania|acrania
600556|NCT00636220|HIV-1 Infections|hiv-1 infections
600557|NCT00636155|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
600558|NCT00636155|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
600559|NCT00636155|EL625|el625
600560|NCT00636155|cenersen|cenersen
600561|NCT00636129|relaxation|relaxation
600562|NCT00636129|relaxation response|relaxation response
600563|NCT00636129|meditation|meditation
600564|NCT00636129|nitric oxide|nitric oxide
600566|NCT00636129|stress|stress
600567|NCT00636129|Relaxation Techniques|relaxation techniques
600568|NCT00636116|snake bite|snake bite
600569|NCT00636116|antivenin treatment|antivenin treatment
600570|NCT00636103|Traditional Chinese Medicine|traditional chinese medicine
600571|NCT00636103|Asthma|asthma
600572|NCT00636103|Paediatric|paediatric
600573|NCT00636077|Hemodialysis|hemodialysis
600574|NCT00636077|Dialysis, Renal|dialysis, renal
600575|NCT00636051|evidence based practice beliefs|evidence based practice beliefs
600576|NCT00636051|evidence based practice implementation|evidence based practice implementation
600577|NCT00636051|evidence based practice dissemination|evidence based practice dissemination
600578|NCT00636038|beta-carotene|beta-carotene
600579|NCT00636038|yellow maize|yellow maize
600580|NCT00636038|vitamin A|vitamin a
600581|NCT00636012|acupuncture|acupuncture
600582|NCT00636012|Acupuncture points|acupuncture points
600583|NCT00635986|Analgesia|analgesia
600584|NCT00635986|Fentanyl|fentanyl
600585|NCT00635986|Orthopedic|orthopedic
600586|NCT00635986|Mechanism of action|mechanism of action
600587|NCT00635986|Surgery|surgery
600588|NCT00635973|Iressa|iressa
600589|NCT00635973|Gefitinib|gefitinib
600590|NCT00635973|Cancer|cancer
600591|NCT00635973|Patients diagnosed with cancer who have previously received Iressa in an Iressa clinical trial|patients diagnosed with cancer who have previously received iressa in an iressa clinical trial
600592|NCT00635960|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
600593|NCT00635960|ALS|als
600594|NCT00635960|Growth Hormone|growth hormone
600595|NCT00635960|IGF-I|igf-i
600596|NCT00635947|Amniotic fluid index|amniotic fluid index
600597|NCT00635947|maternal hydration|maternal hydration
600598|NCT00635947|isotonic solution|isotonic solution
600599|NCT00635947|Amniotic Fluid|amniotic fluid
600600|NCT00635934|Lumbar Degenerative Disc Disease at One Level from L4-S1|lumbar degenerative disc disease at one level from l4-s1
600601|NCT00635921|Borderline Personality Disorder|borderline personality disorder
600602|NCT00635921|ziprasidone|ziprasidone
600603|NCT00635895|Fibromyalgia|fibromyalgia
600604|NCT00635895|Manual Lymphatic Drainage|manual lymphatic drainage
600605|NCT00635895|Connective Tissue Massage|connective tissue massage
600606|NCT00635895|Pain|pain
600607|NCT00635895|Health Related Quality of Life|health related quality of life
600608|NCT00635895|Randomized Controlled Trial|randomized controlled trial
600609|NCT00635882|mometasone|mometasone
600610|NCT00635882|formoterol|formoterol
600611|NCT00635869|evidence based practice beliefs|evidence based practice beliefs
600612|NCT00635869|evidence based practice implementation|evidence based practice implementation
600613|NCT00635869|evidence based practice knowledge|evidence based practice knowledge
600614|NCT00635869|nurse physician collaboration|nurse physician collaboration
600615|NCT00635856|Iressa|iressa
600616|NCT00635856|Gefitinib|gefitinib
600617|NCT00635856|Prostate Cancer|prostate cancer
600618|NCT00635856|PSA|psa
600619|NCT00635843|Lumbar degenerative disc disease at one level from L4-S1|lumbar degenerative disc disease at one level from l4-s1
600620|NCT00635817|CPP|cpp
600621|NCT00635817|central precocious puberty|central precocious puberty
600622|NCT00635817|pediatrics|pediatrics
600623|NCT00635817|suppression of luteinizing hormone|suppression of luteinizing hormone
600624|NCT00635817|Lupron|lupron
600625|NCT00635817|leuprolide acetate|leuprolide acetate
600626|NCT00635817|depot formulation|depot formulation
600627|NCT00635817|GnRHa|gnrha
600628|NCT00635817|GnRH agonist|gnrh agonist
600629|NCT00635817|GnRH analog|gnrh analog
600630|NCT00635817|luteinizing hormone|luteinizing hormone
600631|NCT00635791|Malignant Solid Tumour|malignant solid tumour
600632|NCT00635791|Renal cell carcinoma|renal cell carcinoma
600633|NCT00635791|Non small cell lung carcinoma|non small cell lung carcinoma
600634|NCT00635765|Acromegaly|acromegaly
600635|NCT00635752|TF-CBT|tf-cbt
600636|NCT00635752|Effectiveness study|effectiveness study
600637|NCT00635752|Trauma|trauma
600638|NCT00635752|Therapy|therapy
600639|NCT00635739|Whey protein|whey protein
600640|NCT00635739|Resistance exercise|resistance exercise
600641|NCT00635739|Physical activity|physical activity
600642|NCT00635739|Mobility disability|mobility disability
600643|NCT00635739|Physical function|physical function
600644|NCT00635739|Muscle mass|muscle mass
600645|NCT00635739|Muscle strength|muscle strength
600646|NCT00635739|Older Adults|older adults
600647|NCT00635739|Mobility-Limited|mobility-limited
600648|NCT00635726|Bladder Cancer|bladder cancer
600649|NCT00635713|Advanced breast cancer, FASLODEX, ARIMIDEX, Fulvestrant, Anastrozole, postmenopausal|advanced breast cancer, faslodex, arimidex, fulvestrant, anastrozole, postmenopausal
600650|NCT00635700|psychosis|psychosis
600651|NCT00635700|schizophrenia|schizophrenia
600652|NCT00635700|prodrome|prodrome
600653|NCT00635700|ziprasidone|ziprasidone
600654|NCT00635700|placebo|placebo
600655|NCT00635687|variceal bleeding|variceal bleeding
600656|NCT00635687|transient elastography|transient elastography
600657|NCT00635674|sleep apnea|sleep apnea
600658|NCT00635674|risk factors|risk factors
600659|NCT00635674|continuous positive airway pressure|continuous positive airway pressure
600660|NCT00635674|insulin resistance|insulin resistance
600661|NCT00635674|metabolic syndrome|metabolic syndrome
600662|NCT00635674|compliance|compliance
600663|NCT00635661|function|function
600664|NCT00635661|disability|disability
600665|NCT00635635|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
600666|NCT00635635|Anxiety,|anxiety,
600667|NCT00635635|Depression,|depression,
600668|NCT00635635|Guided Imagery|guided imagery
600669|NCT00635635|Military Sexual Trauma|military sexual trauma
600670|NCT00635622|Bacterial Vaginosis|bacterial vaginosis
600671|NCT00635622|BV|bv
600672|NCT00635622|UCSF|ucsf
600673|NCT00635622|SFGH|sfgh
600674|NCT00635596|MT110|mt110
600675|NCT00635596|solid tumors|solid tumors
600676|NCT00635596|phase I|phase i
600677|NCT00635596|BiTE|bite
600678|NCT00635596|bispecific T-cell engager|bispecific t-cell engager
600679|NCT00635583|Bone|bone
600680|NCT00635583|Dairy Intervention|dairy intervention
600681|NCT00635583|Girls|girls
600682|NCT00635583|Boys|boys
600683|NCT00635583|Calcium|calcium
600684|NCT00635583|Bone Mineralization|bone mineralization
600685|NCT00635583|Peak Bone Mass|peak bone mass
600686|NCT00635583|Bone and Bones|bone and bones
600687|NCT00635583|Female|female
600688|NCT00635583|Male|male
600689|NCT00635583|Adolescent|adolescent
600690|NCT00635583|Healthy|healthy
600815|NCT00635141|Hypertonic Saline|hypertonic saline
600691|NCT00635570|Contraception, Compliance, Acceptability|contraception, compliance, acceptability
600692|NCT00635557|Recurrent|recurrent
600693|NCT00635557|Relapsed|relapsed
600694|NCT00635557|Glioblastoma|glioblastoma
600695|NCT00635557|Multiforme|multiforme
600696|NCT00635544|Adolescence|adolescence
600697|NCT00635544|Overweight|overweight
600698|NCT00635544|Dietary Fiber|dietary fiber
600699|NCT00635544|Glycemic Index|glycemic index
600700|NCT00635544|Healthy lifestyle|healthy lifestyle
600701|NCT00635518|Health Plan Implementation|health plan implementation
600702|NCT00635518|Feeding and Eating Disorders of Childhood|feeding and eating disorders of childhood
600703|NCT00635518|Breast Feeding|breast feeding
600704|NCT00635518|Overweight|overweight
600705|NCT00635518|Child|child
600706|NCT00635518|Infant Nutrition Physiology|infant nutrition physiology
600707|NCT00635518|Public Health|public health
600708|NCT00635505|Asthma|asthma
600709|NCT00635505|albuterol|albuterol
600710|NCT00635505|HFA|hfa
600711|NCT00635492|diabetes|diabetes
600712|NCT00635492|insulin|insulin
600713|NCT00635492|exenatide|exenatide
600714|NCT00635492|Byetta|byetta
600715|NCT00635492|Amylin|amylin
600716|NCT00635492|Lilly|lilly
600717|NCT00635479|Fractures|fractures
600718|NCT00635479|Pelvic bones|pelvic bones
600719|NCT00635479|Acetabulum|acetabulum
600720|NCT00635479|Hip bones|hip bones
600721|NCT00635466|laparoscopic surgery, rectal carcinoma, phase II trial|laparoscopic surgery, rectal carcinoma, phase ii trial
600722|NCT00635453|Breast Feeding|breast feeding
600723|NCT00635453|Child|child
600724|NCT00635453|Infant Nutrition Physiology|infant nutrition physiology
600725|NCT00635453|Public Health|public health
600726|NCT00635453|Morbidity|morbidity
600727|NCT00635453|Health Plan Implementation|health plan implementation
600728|NCT00635440|skeletal muscle|skeletal muscle
600729|NCT00635440|ubiquitin|ubiquitin
600730|NCT00635440|proteasome|proteasome
600731|NCT00635440|IGF-1|igf-1
600732|NCT00635440|MGF|mgf
600733|NCT00635440|protein catabolism|protein catabolism
600734|NCT00635440|neuromuscular electrical stimulation|neuromuscular electrical stimulation
600735|NCT00635440|Investigate effect of NMES on muscle metabolism of catabolic patients|investigate effect of nmes on muscle metabolism of catabolic patients
600736|NCT00635427|VPRIV|vpriv
600737|NCT00635427|Enzyme Replacement Therapy|enzyme replacement therapy
600738|NCT00635427|Gaucher disease|gaucher disease
600739|NCT00635427|glucocerebrosidase|glucocerebrosidase
600740|NCT00635427|beta-glucocerebrosidase|beta-glucocerebrosidase
600741|NCT00635427|Acid beta-glucocerebrosidase|acid beta-glucocerebrosidase
600742|NCT00635427|glucosylceramidase|glucosylceramidase
600743|NCT00635427|D-glucosyl-N-acylsphingosine glucohydrolase|d-glucosyl-n-acylsphingosine glucohydrolase
600744|NCT00635427|gene activation|gene activation
600745|NCT00635427|human|human
600746|NCT00635414|Gastroesophageal Reflux Disease (GERD), esomeprazole, Nexium|gastroesophageal reflux disease (gerd), esomeprazole, nexium
600747|NCT00635362|Contraception|contraception
600748|NCT00635362|Contraceptive Devices|contraceptive devices
600749|NCT00635362|Intrauterine Devices|intrauterine devices
600750|NCT00635362|Unplanned Pregnancy|unplanned pregnancy
600751|NCT00635362|Postpartum Period|postpartum period
600752|NCT00635349|WOMAC|womac
600753|NCT00635349|Knee osteoarthritis pain|knee osteoarthritis pain
600754|NCT00635349|Pain intensity|pain intensity
600755|NCT00635349|Tramadol|tramadol
600756|NCT00635349|Acetaminophen|acetaminophen
600757|NCT00635349|Meloxicam|meloxicam
600758|NCT00635349|Aceclofenac|aceclofenac
600759|NCT00635336|Epitope peptide|epitope peptide
600760|NCT00635336|CTL|ctl
600761|NCT00635336|Advanced bladder cancer|advanced bladder cancer
600762|NCT00635336|Vaccination|vaccination
600763|NCT00635336|advanced bladder cancer which showed resistance for standard treatments|advanced bladder cancer which showed resistance for standard treatments
600764|NCT00635310|Chronic hepatitis C|chronic hepatitis c
600765|NCT00635310|Chronic hepatitis B|chronic hepatitis b
600766|NCT00635310|Liver biopsy|liver biopsy
600767|NCT00635310|Hemodialysis|hemodialysis
600768|NCT00635310|1-Deamino-8- D-Arginine Vasopressin|1-deamino-8- d-arginine vasopressin
600769|NCT00635297|osteoporosis|osteoporosis
600770|NCT00635297|vertebroplasty|vertebroplasty
600771|NCT00635297|prophylactic|prophylactic
600772|NCT00635297|vertebrae|vertebrae
600773|NCT00635297|fracture|fracture
600774|NCT00635271|Asthma|asthma
600775|NCT00635271|Biomarker|biomarker
600776|NCT00635271|Exhaled Breath Condensate|exhaled breath condensate
600777|NCT00635271|Cytokine|cytokine
600778|NCT00635271|Healthy Volunteer|healthy volunteer
600779|NCT00635271|HV|hv
600780|NCT00635258|GnRH antagonist|gnrh antagonist
600781|NCT00635258|oocyte donation|oocyte donation
600782|NCT00635258|pregnancy|pregnancy
600783|NCT00635258|implantation|implantation
600784|NCT00635245|stage IA breast cancer|stage ia breast cancer
600785|NCT00635245|stage IB breast cancer|stage ib breast cancer
600786|NCT00635245|stage II breast cancer|stage ii breast cancer
600787|NCT00635232|Hypertension|hypertension
600788|NCT00635232|High Blood Pressure|high blood pressure
600789|NCT00635219|Major depressive disorder|major depressive disorder
600790|NCT00635219|Placebo-controlled|placebo-controlled
600791|NCT00635219|Active reference|active reference
600792|NCT00635219|Multicenter study|multicenter study
600793|NCT00635219|Randomised study|randomised study
600794|NCT00635219|Acute treatment|acute treatment
600795|NCT00635206|OSA|osa
600796|NCT00635193|Ovarian neoplasms|ovarian neoplasms
600797|NCT00635193|Angiogenesis inhibitors|angiogenesis inhibitors
600798|NCT00635193|Angiogenesis|angiogenesis
600799|NCT00635193|Volociximab|volociximab
600800|NCT00635193|Ovarian cancer|ovarian cancer
600801|NCT00635193|Antibody|antibody
600802|NCT00635193|Monoclonals|monoclonals
600803|NCT00635180|Isometric exercise|isometric exercise
600804|NCT00635180|intraocular pressure|intraocular pressure
600805|NCT00635180|Physiological changes in intraocular pressure during isometric exercise|physiological changes in intraocular pressure during isometric exercise
600806|NCT00635167|Prostate cancer|prostate cancer
600807|NCT00635167|prostatic vascularity|prostatic vascularity
600808|NCT00635167|External Beam Radiation treatment|external beam radiation treatment
600809|NCT00635167|Contrast Enhanced transrectal Ultrasound|contrast enhanced transrectal ultrasound
600810|NCT00635154|stage I multiple myeloma|stage i multiple myeloma
600811|NCT00635154|stage II multiple myeloma|stage ii multiple myeloma
600812|NCT00635154|stage III multiple myeloma|stage iii multiple myeloma
600813|NCT00635141|Cystic Fibrosis|cystic fibrosis
600814|NCT00635141|Lung Clearance Index|lung clearance index
600816|NCT00635141|Pediatrics|pediatrics
600817|NCT00635128|Diphtheria|diphtheria
600818|NCT00635128|vaccine|vaccine
600819|NCT00635128|DTP|dtp
600820|NCT00635128|Poliomyelitis|poliomyelitis
600821|NCT00635128|Pertussis|pertussis
600822|NCT00635128|Booster|booster
600823|NCT00635128|Tetanus|tetanus
600824|NCT00635102|Alcohol Dependence, Alcoholism, Glycine, D-Cycloserine|alcohol dependence, alcoholism, glycine, d-cycloserine
600825|NCT00635089|Eosinophilic Esophagitis|eosinophilic esophagitis
600826|NCT00635089|Cinquil|cinquil
600827|NCT00635063|Cancer Breakthrough Pain|cancer breakthrough pain
600828|NCT00635050|Breast cancer|breast cancer
600829|NCT00635037|Myofascial pain syndrome|myofascial pain syndrome
600830|NCT00635037|Acupuncture|acupuncture
600831|NCT00635037|Nonsteroidal anti-inflammatory agents|nonsteroidal anti-inflammatory agents
600832|NCT00635037|Muscle relaxants, central|muscle relaxants, central
600833|NCT00635037|Quality of life.|quality of life.
600834|NCT00635037|muscle relaxants, analgesia|muscle relaxants, analgesia
600835|NCT00635024|refractory multiple myeloma|refractory multiple myeloma
600836|NCT00635024|stage I multiple myeloma|stage i multiple myeloma
600837|NCT00635024|stage II multiple myeloma|stage ii multiple myeloma
600838|NCT00635024|stage III multiple myeloma|stage iii multiple myeloma
600839|NCT00635011|comorbidity|comorbidity
600840|NCT00635011|Quality of Life|quality of life
600841|NCT00635011|Body Weight Changes|body weight changes
600842|NCT00634998|Vitamin C|vitamin c
600843|NCT00634998|Ascorbic Acid|ascorbic acid
600844|NCT00634998|Diabetic Neuropathies|diabetic neuropathies
600845|NCT00634972|Retinopathy of Prematurity|retinopathy of prematurity
600846|NCT00634972|Premature Infants|premature infants
600847|NCT00634972|ACULAR|acular
600848|NCT00634972|Refresh Tears|refresh tears
600849|NCT00634959|HIV Infections|hiv infections
600850|NCT00634959|Treatment Naïve|treatment naïve
600851|NCT00634946|Chemonucleolysis|chemonucleolysis
600852|NCT00634946|Lumbar Vertebrae|lumbar vertebrae
600853|NCT00634946|Hernia|hernia
600854|NCT00634933|active|active
600855|NCT00634933|rheumatoid|rheumatoid
600856|NCT00634933|arthritis|arthritis
600857|NCT00634933|anti CD20|anti cd20
600858|NCT00634920|De novo renal transplantation|de novo renal transplantation
600859|NCT00634907|Genotyping|genotyping
600860|NCT00634907|Warfarin dosing|warfarin dosing
600861|NCT00634907|arthroplasty|arthroplasty
600862|NCT00634894|Ovarian Cancer|ovarian cancer
600863|NCT00634894|Fallopian Tube Cancer|fallopian tube cancer
600864|NCT00634894|Peritoneal Cancer|peritoneal cancer
600865|NCT00634894|Femara|femara
600866|NCT00634894|Letrozole|letrozole
600867|NCT00634894|Placebo|placebo
600868|NCT00634881|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
600869|NCT00634881|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
600870|NCT00634881|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
600871|NCT00634881|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
600872|NCT00634881|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
600873|NCT00634868|ulcer wound diabetes|ulcer wound diabetes
600874|NCT00634855|Endothelial progenitor cells|endothelial progenitor cells
600875|NCT00634855|Endothelial dysfunction|endothelial dysfunction
600876|NCT00634777|HNSCC biopsy-proven|hnscc biopsy-proven
600877|NCT00634777|T1-T4 oral cavity oropharynx hypopharynx larynx|t1-t4 oral cavity oropharynx hypopharynx larynx
600878|NCT00634777|N+ scheduled for an organ preservation treatment protocol based on concomitant|n+ scheduled for an organ preservation treatment protocol based on concomitant
600879|NCT00634777|chemoradiation|chemoradiation
600880|NCT00634764|Maternal weight gain|maternal weight gain
600881|NCT00634764|Neonatal birth weight|neonatal birth weight
600882|NCT00634764|Weight gain attitude|weight gain attitude
600883|NCT00634764|Pregnancy|pregnancy
600884|NCT00634764|Body fat|body fat
600885|NCT00634764|Maternal Behavior|maternal behavior
600886|NCT00634764|Birth outcomes|birth outcomes
600887|NCT00634751|advanced pancreatic and biliary tract carcinomas|advanced pancreatic and biliary tract carcinomas
600888|NCT00634738|ischemic compression;carpal tunnel syndrome|ischemic compression;carpal tunnel syndrome
600889|NCT00634725|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
600890|NCT00634725|stage III pancreatic cancer|stage iii pancreatic cancer
600891|NCT00634712|Congestive Heart Failure|congestive heart failure
600892|NCT00634712|Atacand|atacand
600893|NCT00634712|Candesartan|candesartan
600894|NCT00634686|Omega-3 fatty acids|omega-3 fatty acids
600895|NCT00634686|immune response|immune response
600896|NCT00634673|Serum Fatty Acids|serum fatty acids
600897|NCT00634673|FABP2 Gene|fabp2 gene
600898|NCT00634673|Polymorphism Ala54Thr|polymorphism ala54thr
600899|NCT00634647|Chemotherapy|chemotherapy
600900|NCT00634647|Pharmacokinetics|pharmacokinetics
600901|NCT00634647|Gene Polymorphisms|gene polymorphisms
600902|NCT00634647|Prostate Cancer|prostate cancer
600903|NCT00634634|breast cancer|breast cancer
600904|NCT00634634|Postmenopausal Women with Hormone Receptor-Positive Locally Advanced Breast Cancer|postmenopausal women with hormone receptor-positive locally advanced breast cancer
600905|NCT00634621|Bladder|bladder
600906|NCT00634621|Cancer|cancer
600907|NCT00634621|Cystoscopy|cystoscopy
600908|NCT00634621|Hexaminolevulinate|hexaminolevulinate
600909|NCT00634621|Hexvix|hexvix
600910|NCT00634595|clinical trial|clinical trial
600911|NCT00634595|randomized|randomized
600912|NCT00634595|Endostatin|endostatin
600913|NCT00634595|gene therapy|gene therapy
600914|NCT00634595|head and neck cancer|head and neck cancer
600915|NCT00634595|head and neck squamous carcinoma|head and neck squamous carcinoma
600916|NCT00634582|adenocarcinoma of the prostate|adenocarcinoma of the prostate
600917|NCT00634582|stage IV prostate cancer|stage iv prostate cancer
600918|NCT00634582|recurrent prostate cancer|recurrent prostate cancer
600919|NCT00634582|bone metastases|bone metastases
600920|NCT00634569|CVID, XLA, hyper IgM syndrome, Wiskott-Aldrich Syndrome|cvid, xla, hyper igm syndrome, wiskott-aldrich syndrome
600921|NCT00634556|Tourette Syndrome|tourette syndrome
600922|NCT00634556|fMRI|fmri
600923|NCT00634556|levodopa|levodopa
600924|NCT00634556|working memory|working memory
600925|NCT00634556|dopamine|dopamine
600926|NCT00634543|Diabetic neuropathy|diabetic neuropathy
600927|NCT00634543|Ultracet|ultracet
600928|NCT00634543|Tramadol hydrochloride|tramadol hydrochloride
600929|NCT00634543|Acetaminophen|acetaminophen
600930|NCT00634543|Gabapentin|gabapentin
600931|NCT00634530|Pregnancy|pregnancy
600932|NCT00634530|Prenatal Care|prenatal care
600933|NCT00634530|Weight|weight
600934|NCT00634530|Nutritional Status|nutritional status
600935|NCT00634504|high dose methotrexate|high dose methotrexate
600936|NCT00634504|Voraxaze|voraxaze
600937|NCT00634504|leucovorin|leucovorin
600938|NCT00634504|delayed elimination|delayed elimination
600939|NCT00634504|methotrexate toxicity|methotrexate toxicity
600940|NCT00634504|rescue|rescue
600941|NCT00634504|renal insufficiency|renal insufficiency
600942|NCT00634478|essential tremor|essential tremor
600943|NCT00634478|deep brain stimulation|deep brain stimulation
600944|NCT00634452|Hodgkin's|hodgkin's
600945|NCT00634452|Cancer|cancer
600946|NCT00634452|bi-measurable disease|bi-measurable disease
600947|NCT00634452|Lymphoma|lymphoma
600948|NCT00634439|cerebrovascular accident|cerebrovascular accident
600949|NCT00634439|stroke|stroke
600950|NCT00634439|transient ischemic attack|transient ischemic attack
600951|NCT00634439|TIA|tia
600952|NCT00634439|CVA|cva
600953|NCT00634439|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
600954|NCT00634439|ADHD|adhd
600955|NCT00634426|Spine|spine
600956|NCT00634426|Neoplasm metastasis|neoplasm metastasis
600957|NCT00634426|Treatment, surgical|treatment, surgical
600958|NCT00634426|Treatment, nonoperative|treatment, nonoperative
600959|NCT00634426|Quality of life|quality of life
600960|NCT00634413|COPD|copd
600961|NCT00634400|Congestive Heart Failure|congestive heart failure
600962|NCT00634400|Atacand|atacand
600963|NCT00634400|Candesartan|candesartan
600964|NCT00634374|Rx medibottle|rx medibottle
600965|NCT00634374|Oral syringe|oral syringe
600966|NCT00634374|Liquid medication|liquid medication
600967|NCT00634374|Bitter-tasting|bitter-tasting
600968|NCT00634374|Infants|infants
600969|NCT00634322|osteosarcoma|osteosarcoma
600970|NCT00634322|high dose methotrexate|high dose methotrexate
600971|NCT00634322|leucovorin|leucovorin
600972|NCT00634309|Congestive Heart Failure|congestive heart failure
600973|NCT00634309|Atacand|atacand
600974|NCT00634309|Candesartan|candesartan
600975|NCT00634296|Heart failure|heart failure
600976|NCT00634296|Systolic dysfunction|systolic dysfunction
600977|NCT00634296|Inspiratory muscle weakness|inspiratory muscle weakness
600978|NCT00634270|Plexiform, Neurofibromatosis Type 1, Sirolimus, Phase II|plexiform, neurofibromatosis type 1, sirolimus, phase ii
600979|NCT00634257|Advanced Cancer|advanced cancer
600980|NCT00634257|Solid Tumors|solid tumors
600981|NCT00634257|Spirituality|spirituality
600982|NCT00634257|Religiosity|religiosity
600983|NCT00634257|Symptom Distress|symptom distress
600984|NCT00634257|Quality of Life|quality of life
600985|NCT00634257|Caregivers|caregivers
600986|NCT00634257|Questionnaire|questionnaire
600987|NCT00634257|Survey|survey
600988|NCT00634244|Acute Myelogenous Leukemia (AML), Carboplatin, Topotecan, Flavopiridol, Mitoxantrone, Cytosine Arabinoside, Sirolimus, Etoposide|acute myelogenous leukemia (aml), carboplatin, topotecan, flavopiridol, mitoxantrone, cytosine arabinoside, sirolimus, etoposide
600989|NCT00634231|Malignant glioma|malignant glioma
600990|NCT00634231|Glioblastoma multiforme|glioblastoma multiforme
600991|NCT00634231|Anaplastic astrocytoma|anaplastic astrocytoma
600992|NCT00634231|Recurrent ependymoma|recurrent ependymoma
600993|NCT00634231|Gene therapy|gene therapy
600994|NCT00634231|Immunotherapy|immunotherapy
600995|NCT00634218|nicotine|nicotine
600996|NCT00634218|smoking|smoking
600997|NCT00634218|smoking cessation|smoking cessation
600998|NCT00634205|Mesothelioma|mesothelioma
600999|NCT00634205|Valproate|valproate
601000|NCT00634205|Doxorubicin|doxorubicin
601001|NCT00634205|Chemotherapy|chemotherapy
601002|NCT00634205|Phase II|phase ii
601003|NCT00634192|Chronic infection with P. aeruginosa in Cystic Fibrosis subjects|chronic infection with p. aeruginosa in cystic fibrosis subjects
601004|NCT00634179|Lymphoma|lymphoma
601005|NCT00634166|thermal injuries|thermal injuries
601006|NCT00634166|burns|burns
601007|NCT00634166|Burn Patients (Subjects with Thermal Injuries Requiring Meshed Autografts)|burn patients (subjects with thermal injuries requiring meshed autografts)
601008|NCT00634140|gallbladder|gallbladder
601009|NCT00634140|ezetimibe for 4 to 6 weeks prior to gallbladder removal|ezetimibe for 4 to 6 weeks prior to gallbladder removal
601010|NCT00634114|Reflux Esophagitis|reflux esophagitis
601011|NCT00634075|Severe sepsis|severe sepsis
601012|NCT00634075|Proinflammatory cytokines|proinflammatory cytokines
601013|NCT00634075|ICU|icu
601014|NCT00634062|Affective Lability|affective lability
601015|NCT00634062|Borderline Personality Disorder|borderline personality disorder
601016|NCT00634062|Pharmacotherapy|pharmacotherapy
601017|NCT00634049|invasive fungal infections caused by rare molds, rare yeasts|invasive fungal infections caused by rare molds, rare yeasts
601018|NCT00634049|BAL8557|bal8557
601019|NCT00634049|Isavuconazole|isavuconazole
601020|NCT00634049|Aspergillosis|aspergillosis
601021|NCT00634049|or by dimorphic fungi|or by dimorphic fungi
601022|NCT00634049|ASP9766|asp9766
601023|NCT00634036|Asthma|asthma
601024|NCT00634036|obesity|obesity
601025|NCT00634036|exacerbation|exacerbation
601026|NCT00634036|asthmatics|asthmatics
601027|NCT00634036|fat|fat
601028|NCT00634036|overweight|overweight
601029|NCT00634036|adipose tissue|adipose tissue
601030|NCT00634036|leptin|leptin
601031|NCT00634036|adiponectin|adiponectin
601032|NCT00634036|pioglitazone|pioglitazone
601033|NCT00634036|Actos|actos
601034|NCT00634036|wheezing|wheezing
601035|NCT00634036|Pittsburgh|pittsburgh
601036|NCT00634036|Pennsylvania|pennsylvania
601037|NCT00634036|pulmonary|pulmonary
601038|NCT00634036|lung|lung
601039|NCT00634010|Advanced Cancer|advanced cancer
601040|NCT00634010|Solid Tumors|solid tumors
601041|NCT00634010|Cancer Pain|cancer pain
601042|NCT00634010|Opioid Pain Killer|opioid pain killer
601043|NCT00634010|Morphine|morphine
601044|NCT00634010|Methadone|methadone
601045|NCT00633997|Diabetes mellitus|diabetes mellitus
601046|NCT00633997|type 2 diabetes|type 2 diabetes
601047|NCT00633997|vildagliptin|vildagliptin
601048|NCT00633997|pharmacokinetics|pharmacokinetics
601049|NCT00633984|Social Anxiety Disorder|social anxiety disorder
601050|NCT00633984|Cognitive Behavioral Group Therapy|cognitive behavioral group therapy
601051|NCT00633984|D-cycloserine|d-cycloserine
601052|NCT00633971|Post thrombotic syndrome|post thrombotic syndrome
601053|NCT00633971|Thrombosis|thrombosis
601054|NCT00633971|Deep vein thrombosis|deep vein thrombosis
601055|NCT00633971|Venous thrombosis|venous thrombosis
601056|NCT00633971|Edema|edema
601057|NCT00633971|stasis ulcers|stasis ulcers
601058|NCT00633958|18F-FLT|18f-flt
601059|NCT00633958|FLT|flt
601060|NCT00633958|PET|pet
601061|NCT00633958|CNS tumors|cns tumors
601062|NCT00633958|Newly|newly
601063|NCT00633958|diagnosed|diagnosed
601064|NCT00633945|Cutaneous Lupus Erythematosus|cutaneous lupus erythematosus
601065|NCT00633945|CLE|cle
601066|NCT00633945|lenalidomide|lenalidomide
601067|NCT00633945|revlimid|revlimid
601068|NCT00633945|thalidomide derivative|thalidomide derivative
601069|NCT00633945|drug|drug
601070|NCT00633945|lupus|lupus
601071|NCT00633932|Reflux Esophagitis|reflux esophagitis
601072|NCT00633919|House dust mites|house dust mites
601073|NCT00633919|Sublingual immunotherapy|sublingual immunotherapy
601074|NCT00633919|Allergy|allergy
601075|NCT00633919|Allergic asthma|allergic asthma
601076|NCT00633906|HIV|hiv
601077|NCT00633906|Sexually Transmitted diseases|sexually transmitted diseases
601078|NCT00633906|Adolescents|adolescents
601079|NCT00633906|Prevention|prevention
601080|NCT00633906|HIV Seronegativity|hiv seronegativity
601081|NCT00633880|NOH|noh
601082|NCT00633880|Neurogenic Orthostatic Hypotension|neurogenic orthostatic hypotension
601083|NCT00633880|Orthostatic hypotension|orthostatic hypotension
601084|NCT00633880|PAF|paf
601085|NCT00633880|Pure Autonomic Failure|pure autonomic failure
601086|NCT00633880|MSA|msa
601087|NCT00633880|Multiple System Atrophy|multiple system atrophy
601088|NCT00633880|Neuropathy|neuropathy
601089|NCT00633880|Autonomic Failure|autonomic failure
601090|NCT00633880|Parkinson|parkinson
601091|NCT00633880|Dopamine Deficiency|dopamine deficiency
601092|NCT00633880|Dopamine|dopamine
601093|NCT00633880|Droxidopa|droxidopa
601094|NCT00633867|Tracheal intubation|tracheal intubation
601095|NCT00633867|Laryngoscopy|laryngoscopy
601096|NCT00633867|videolaryngoscope|videolaryngoscope
601097|NCT00633867|McGrath|mcgrath
601098|NCT00633867|success|success
601099|NCT00633867|time|time
601100|NCT00633854|annular array ultrasound|annular array ultrasound
601101|NCT00633854|ophthalmic ultrasound|ophthalmic ultrasound
601102|NCT00633854|posterior vitreous detachment (PVD)|posterior vitreous detachment (pvd)
601103|NCT00633841|Alzheimer|alzheimer
601104|NCT00633841|Morbus Alzheimer|morbus alzheimer
601105|NCT00633841|Alzheimer Vaccine|alzheimer vaccine
601106|NCT00633841|Vaccine|vaccine
601107|NCT00633841|AD|ad
601108|NCT00633841|Aβ immunotherapy|aβ immunotherapy
601109|NCT00633828|Bone Density|bone density
601110|NCT00633828|Bone mass|bone mass
601111|NCT00633828|Bone mineral density|bone mineral density
601112|NCT00633828|Bone structure|bone structure
601113|NCT00633828|Cardiovascular risk factors|cardiovascular risk factors
601114|NCT00633828|Fat Mass|fat mass
601115|NCT00633828|Adiposity|adiposity
601116|NCT00633815|Supine|supine
601117|NCT00633815|Upright|upright
601118|NCT00633802|Risperidone|risperidone
601119|NCT00633802|Borderlone Personality Disorder|borderlone personality disorder
601120|NCT00633776|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
601121|NCT00633776|COPD|copd
601122|NCT00633776|Chronic bronchitis|chronic bronchitis
601123|NCT00633776|Emphysema|emphysema
601124|NCT00633776|Perforomist|perforomist
601125|NCT00633776|Foradil|foradil
601126|NCT00633776|CT|ct
601127|NCT00633776|lung function|lung function
601128|NCT00633763|Diagnostic|diagnostic
601129|NCT00633763|PET/CT imaging of pancreas|pet/ct imaging of pancreas
601130|NCT00633763|Detecting pancreatic beta cell loss during diabetes|detecting pancreatic beta cell loss during diabetes
601131|NCT00633750|stage I breast cancer|stage i breast cancer
601132|NCT00633750|stage II breast cancer|stage ii breast cancer
601133|NCT00633750|stage IIIA breast cancer|stage iiia breast cancer
601134|NCT00633750|stage IIIB breast cancer|stage iiib breast cancer
601135|NCT00633737|Psychology|psychology
601136|NCT00633737|Laparoscopy|laparoscopy
601137|NCT00633737|Cholecystectomy|cholecystectomy
601138|NCT00633737|Psychoneuroimmunology|psychoneuroimmunology
601139|NCT00633737|Wound healing|wound healing
601140|NCT00633737|Preparation for surgery|preparation for surgery
601141|NCT00633737|Stress reduction|stress reduction
601142|NCT00633737|Stress|stress
601143|NCT00633737|Relaxation|relaxation
601144|NCT00633711|OSAS|osas
601145|NCT00633711|blood pressure|blood pressure
601146|NCT00633711|sympathetic nervous system|sympathetic nervous system
601147|NCT00633711|treatment|treatment
601148|NCT00633711|CPAP|cpap
601149|NCT00633698|lipoprotein(a)|lipoprotein(a)
601150|NCT00633698|niacin|niacin
601151|NCT00633698|placebo|placebo
601152|NCT00633698|intervention|intervention
601153|NCT00633685|Posttraumatic Stress Disorder|posttraumatic stress disorder
601154|NCT00633685|Fluoxetine|fluoxetine
601155|NCT00633685|Factors predicting response|factors predicting response
601156|NCT00633685|Resilience|resilience
601157|NCT00633685|Pharmacologic augmentation strategies|pharmacologic augmentation strategies
601158|NCT00633672|NSAID|nsaid
601159|NCT00633672|Nexium|nexium
601160|NCT00633672|esomeprazole|esomeprazole
601161|NCT00633672|Gastric Ulcers|gastric ulcers
601162|NCT00633659|Hemospan|hemospan
601163|NCT00633659|Oxygen carriers|oxygen carriers
601164|NCT00633659|Blood substitutes|blood substitutes
601165|NCT00633659|Ischemia|ischemia
601166|NCT00633659|Tissue oxygenation|tissue oxygenation
601167|NCT00633646|nitrogen balance|nitrogen balance
601168|NCT00633646|malnutrition|malnutrition
601169|NCT00633646|chronic kidney disease|chronic kidney disease
601170|NCT00633646|diet|diet
601171|NCT00633646|glomerular filtration rate|glomerular filtration rate
601172|NCT00633633|Heart Failure|heart failure
601173|NCT00633633|Lifestyle Intervention|lifestyle intervention
601174|NCT00633633|Exercise|exercise
601175|NCT00633633|Diet|diet
601176|NCT00633620|colonoscopy|colonoscopy
601177|NCT00633620|narrow band imaging|narrow band imaging
601178|NCT00633620|adenoma|adenoma
601179|NCT00633620|diagnosis|diagnosis
601180|NCT00633620|colonoscopic adenoma detection|colonoscopic adenoma detection
601181|NCT00633594|Mantle Cell Lymphoma|mantle cell lymphoma
601182|NCT00633594|Rituximab|rituximab
601183|NCT00633594|Lenalidomide|lenalidomide
601184|NCT00633594|Bortezomib|bortezomib
601185|NCT00633594|Phase 1/2|phase 1/2
601186|NCT00633581|fatigue|fatigue
601187|NCT00633581|ascorbic acid|ascorbic acid
601188|NCT00633581|oxidative stress|oxidative stress
601189|NCT00633568|Non-small cell lung carcinoma|non-small cell lung carcinoma
601190|NCT00633568|Concomitant radiochemotherapy|concomitant radiochemotherapy
601191|NCT00633568|Cisplatin|cisplatin
601192|NCT00633568|Docetaxel|docetaxel
601193|NCT00633568|Radiotherapy|radiotherapy
601194|NCT00633568|Chemotherapy|chemotherapy
601195|NCT00633568|Unresectable stage III non-small cell lung carcinoma|unresectable stage iii non-small cell lung carcinoma
601196|NCT00633542|thalidomide|thalidomide
601197|NCT00633542|maintenance|maintenance
601198|NCT00633542|interferon|interferon
601199|NCT00633542|dexamethasone|dexamethasone
601200|NCT00633542|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
601201|NCT00633542|relapsed refractory multiple myeloma|relapsed refractory multiple myeloma
601202|NCT00633529|Phase 1b|phase 1b
601203|NCT00633529|Non-Small Cell Lung Cancer|non-small cell lung cancer
601204|NCT00633529|Advanced or Metastatic Disease|advanced or metastatic disease
601205|NCT00633529|Prior chemotherapy|prior chemotherapy
601206|NCT00633516|moles|moles
601207|NCT00633516|melanoma|melanoma
601208|NCT00633503|free tissue transfer|free tissue transfer
601209|NCT00633503|pedicle tissue transfer|pedicle tissue transfer
601210|NCT00633503|complications|complications
601211|NCT00633503|modulated imaging spectroscopy|modulated imaging spectroscopy
601212|NCT00633503|observation|observation
601213|NCT00633503|clinical observation/diagnosis|clinical observation/diagnosis
601214|NCT00633503|tissue defects requiring free tissue transfer|tissue defects requiring free tissue transfer
601215|NCT00633503|tissue defects requiring pedicle tissue transfer|tissue defects requiring pedicle tissue transfer
601216|NCT00633490|Toxicity|toxicity
601217|NCT00633490|Efficacy|efficacy
601218|NCT00633477|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
601219|NCT00633477|Septic Shock|septic shock
601220|NCT00633477|Septicemia|septicemia
601221|NCT00633477|Drug Therapy|drug therapy
601222|NCT00633451|shoulder pain|shoulder pain
601223|NCT00633451|shoulder impingement syndrome|shoulder impingement syndrome
601224|NCT00633451|manual therapy|manual therapy
601225|NCT00633451|rehabilitation|rehabilitation
601226|NCT00633438|Knee Surgery Arthroscopic Surgery|knee surgery arthroscopic surgery
601227|NCT00633412|NSAID|nsaid
601228|NCT00633412|Nexium|nexium
601229|NCT00633412|esomeprazole|esomeprazole
601230|NCT00633412|Gastric Ulcers|gastric ulcers
601231|NCT00633399|Major Depressive Disorder|major depressive disorder
601232|NCT00633399|Major Depression|major depression
601233|NCT00633399|Depression|depression
601234|NCT00633399|Geodon|geodon
601235|NCT00633399|Ziprasidone|ziprasidone
601236|NCT00633399|SSRI Augmentation|ssri augmentation
601237|NCT00633399|Treatment Resistant Depression|treatment resistant depression
601238|NCT00633386|Knee Surgery|knee surgery
601239|NCT00633386|Arthroscopic Surgery|arthroscopic surgery
601240|NCT00633373|lung|lung
601241|NCT00633373|transplant|transplant
601242|NCT00633373|transplant rejection|transplant rejection
601243|NCT00633373|Cyclosporine|cyclosporine
601244|NCT00633373|bronchiolitis obliterans|bronchiolitis obliterans
601245|NCT00633373|aerosol|aerosol
601246|NCT00633360|Women|women
601247|NCT00633360|PMS|pms
601248|NCT00633360|Depression|depression
601249|NCT00633347|oocyte donation|oocyte donation
601250|NCT00633347|endometrial preparation|endometrial preparation
601251|NCT00633334|Cancer|cancer
601252|NCT00633334|GI|gi
601253|NCT00633334|Tumor|tumor
601254|NCT00633334|Gastrointestinal|gastrointestinal
601255|NCT00633334|high risk|high risk
601256|NCT00633321|smoking cessation|smoking cessation
601257|NCT00633321|quit smoking|quit smoking
601258|NCT00633321|smoking vaccine|smoking vaccine
601259|NCT00633321|nicotine vaccine|nicotine vaccine
601260|NCT00633321|TA-NIC|ta-nic
601261|NCT00633321|Aid for smoking cessation in smokers motivated to quit|aid for smoking cessation in smokers motivated to quit
601262|NCT00633308|hemodialysis|hemodialysis
601263|NCT00633295|GIST|gist
601264|NCT00633295|TKI|tki
601265|NCT00633295|IMATINIB|imatinib
601266|NCT00633295|NILOTINIB|nilotinib
601267|NCT00633295|AMN107|amn107
601268|NCT00633282|Nonalcoholic Fatty Liver Disease|nonalcoholic fatty liver disease
601269|NCT00633282|Pioglitazone|pioglitazone
601270|NCT00633282|Berberine|berberine
601271|NCT00633282|Impaired Glucose Metabolism|impaired glucose metabolism
601272|NCT00633269|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
601273|NCT00633269|Metastatic Solid Tumours|metastatic solid tumours
601274|NCT00633230|hepatitis C virus|hepatitis c virus
601275|NCT00633230|complementary and alternative medicine|complementary and alternative medicine
601276|NCT00633230|peginterferon alfa and ribavirin|peginterferon alfa and ribavirin
601277|NCT00633217|DISKUS|diskus
601278|NCT00633217|Salmeterol|salmeterol
601279|NCT00633217|Fluticasone Propionate|fluticasone propionate
601280|NCT00633217|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
601281|NCT00633217|Hydroflouroalkane|hydroflouroalkane
601282|NCT00633217|COPD|copd
601283|NCT00633217|HFA MDI|hfa mdi
601284|NCT00633204|Epitope peptide, CTL, TUR-Bt, Bladder cancer, Vaccination|epitope peptide, ctl, tur-bt, bladder cancer, vaccination
601285|NCT00633204|Bladder cancer after surgery|bladder cancer after surgery
601286|NCT00633191|Cystic fibrosis|cystic fibrosis
601287|NCT00633191|Prevention|prevention
601288|NCT00633191|Infection|infection
601289|NCT00633191|Pseudomonas aeruginosa|pseudomonas aeruginosa
601290|NCT00633191|Gargle|gargle
601291|NCT00633178|Prenatal Depression|prenatal depression
601292|NCT00633178|Postpartum Depression|postpartum depression
601293|NCT00633178|Fetal Development|fetal development
601294|NCT00633178|Interpersonal Therapy|interpersonal therapy
601295|NCT00633165|sarcoma|sarcoma
601296|NCT00633165|myxoid liposarcoma|myxoid liposarcoma
601297|NCT00633152|complicated skin and skin structure infections|complicated skin and skin structure infections
601298|NCT00633152|linezolid|linezolid
601299|NCT00633152|ceftaroline|ceftaroline
601300|NCT00633152|clinical response|clinical response
601301|NCT00633152|microbiological response|microbiological response
601302|NCT00633152|Cellulitis|cellulitis
601303|NCT00633152|Abscess|abscess
601304|NCT00633152|Wound infection|wound infection
601305|NCT00633152|Deeper soft tissue|deeper soft tissue
601306|NCT00633152|Significant surgical intervention|significant surgical intervention
601307|NCT00633152|Gram-positive bacterial infection|gram-positive bacterial infection
601308|NCT00633152|Gram-negative bacterial infection|gram-negative bacterial infection
601309|NCT00633152|bacterial infection|bacterial infection
601310|NCT00633152|cephalosporin|cephalosporin
601311|NCT00633152|broad-spectrum activity|broad-spectrum activity
601312|NCT00633139|Metazym|metazym
601313|NCT00633139|Late infantile|late infantile
601506|NCT00632320|COPD|copd
601314|NCT00633139|Metachromatic leukodystrophy|metachromatic leukodystrophy
601315|NCT00633139|Long-term safety|long-term safety
601316|NCT00633126|PK|pk
601317|NCT00633126|Pharmacokinetics|pharmacokinetics
601318|NCT00633113|Total Knee Arthroplasty|total knee arthroplasty
601319|NCT00633113|Minimally Invasive Knee Replacement|minimally invasive knee replacement
601320|NCT00633113|Knee Osteoarthritis|knee osteoarthritis
601321|NCT00633113|Cost effectiveness minimally invasive knee surgery|cost effectiveness minimally invasive knee surgery
601322|NCT00633074|Influenza|influenza
601323|NCT00633061|Childhood Cancer|childhood cancer
601324|NCT00633061|Central Venous Catheter|central venous catheter
601325|NCT00633061|Deep Vein Thrombosis|deep vein thrombosis
601326|NCT00633061|Catheter-related Infection|catheter-related infection
601327|NCT00633061|Catheter-related Occlusion|catheter-related occlusion
601328|NCT00633048|ascending single-dose study|ascending single-dose study
601329|NCT00633048|healthy subjects|healthy subjects
601330|NCT00633035|ulcer|ulcer
601331|NCT00633035|esomeprazole|esomeprazole
601332|NCT00633035|famotidine|famotidine
601333|NCT00633035|Neurosurgery|neurosurgery
601334|NCT00633022|FDG-PET/CT, atherosclerosis|fdg-pet/ct, atherosclerosis
601335|NCT00633009|Leishmaniasis|leishmaniasis
601336|NCT00633009|Delayed-Type Hypersensitivity (DTH)|delayed-type hypersensitivity (dth)
601337|NCT00633009|Skin Test|skin test
601338|NCT00633009|Conversion|conversion
601339|NCT00633009|Prior exposure to Leishmania major|prior exposure to leishmania major
601340|NCT00632996|shoulder pain|shoulder pain
601341|NCT00632996|shoulder impingement syndrome|shoulder impingement syndrome
601342|NCT00632996|manual therapy|manual therapy
601343|NCT00632996|rehabilitation|rehabilitation
601344|NCT00632970|Raltegravir|raltegravir
601345|NCT00632970|Lopinavir|lopinavir
601346|NCT00632918|Image quality|image quality
601347|NCT00632918|Dual-source CT|dual-source ct
601348|NCT00632918|Coronary angiography|coronary angiography
601349|NCT00632918|Heart rate|heart rate
601350|NCT00632905|Prostate Cancer|prostate cancer
601351|NCT00632905|Prostatic adenoma|prostatic adenoma
601352|NCT00632905|Prostatic neoplasm|prostatic neoplasm
601353|NCT00632892|oxidative stress markers in urine|oxidative stress markers in urine
601354|NCT00632892|urine norepinephrine|urine norepinephrine
601355|NCT00632892|renal tubular enzyme markers|renal tubular enzyme markers
601356|NCT00632866|auto-immune diseases|auto-immune diseases
601357|NCT00632866|hydroxychloroquine|hydroxychloroquine
601358|NCT00632866|primary Sjögren's syndrome|primary sjögren's syndrome
601359|NCT00632866|inflammatory arthritides|inflammatory arthritides
601360|NCT00632866|inflammatory rheumatic diseases|inflammatory rheumatic diseases
601361|NCT00632866|dryness|dryness
601362|NCT00632866|joint diseases|joint diseases
601363|NCT00632853|limited stage small cell lung cancer|limited stage small cell lung cancer
601364|NCT00632814|Kogenate,|kogenate,
601365|NCT00632814|Children,|children,
601366|NCT00632814|Factor VIII,|factor viii,
601367|NCT00632814|Hemophilia A,|hemophilia a,
601368|NCT00632814|Prophylactic|prophylactic
601369|NCT00632801|elective laparoscopic colectomy|elective laparoscopic colectomy
601370|NCT00632801|chewing gum|chewing gum
601371|NCT00632801|ileus|ileus
601372|NCT00632801|post-operative care|post-operative care
601373|NCT00632801|colectomy|colectomy
601374|NCT00632788|myocardial infarction|myocardial infarction
601375|NCT00632788|catheterization|catheterization
601376|NCT00632788|angioplasty|angioplasty
601377|NCT00632788|door-to-balloon time|door-to-balloon time
601378|NCT00632775|pediatrics|pediatrics
601379|NCT00632775|Hyponatremia|hyponatremia
601380|NCT00632775|Sodium Chloride|sodium chloride
601381|NCT00632775|maintenance fluids|maintenance fluids
601382|NCT00632762|Amantadine benefit|amantadine benefit
601383|NCT00632762|Dyskinesia|dyskinesia
601384|NCT00632762|Parkinson's disease|parkinson's disease
601385|NCT00632736|ropinirole XL|ropinirole xl
601386|NCT00632736|REQUIP|requip
601387|NCT00632736|Parkinson's disease|parkinson's disease
601388|NCT00632736|long term safety|long term safety
601389|NCT00632736|efficacy|efficacy
601390|NCT00632736|safety|safety
601391|NCT00632736|ropinirole CR|ropinirole cr
601392|NCT00632736|ropinirole IR|ropinirole ir
601393|NCT00632736|open-label|open-label
601394|NCT00632723|oestrogen receptor|oestrogen receptor
601395|NCT00632723|ER negative tumours|er negative tumours
601396|NCT00632723|epidermal growth factor receptor (EGFR)|epidermal growth factor receptor (egfr)
601397|NCT00632710|rheumatoid arthritis|rheumatoid arthritis
601398|NCT00632710|hands|hands
601399|NCT00632710|randomized controlled|randomized controlled
601400|NCT00632710|low level laser|low level laser
601401|NCT00632697|endometriosis|endometriosis
601402|NCT00632697|immunomodulation|immunomodulation
601403|NCT00632697|infertility|infertility
601404|NCT00632697|laparoscopic surgery|laparoscopic surgery
601405|NCT00632697|pentoxifylline|pentoxifylline
601406|NCT00632684|Family Caregiving|family caregiving
601407|NCT00632684|Dementia|dementia
601408|NCT00632671|Obesity cohort|obesity cohort
601409|NCT00632658|cGVHD|cgvhd
601410|NCT00632645|Huntington|huntington
601411|NCT00632645|Neuroleptic|neuroleptic
601412|NCT00632645|Unified Huntington Disease Rating Scale (UHDRS)|unified huntington disease rating scale (uhdrs)
601413|NCT00632645|Independence Scale|independence scale
601414|NCT00632645|Neuroleptic Prescription required|neuroleptic prescription required
601415|NCT00632632|World Trade Center Victims|world trade center victims
601416|NCT00632632|Iraq War Veterans|iraq war veterans
601417|NCT00632632|PTSD|ptsd
601418|NCT00632619|Subthreshold Manic States in Children|subthreshold manic states in children
601419|NCT00632619|ADHD|adhd
601420|NCT00632606|pregnant women|pregnant women
601421|NCT00632593|Early Complications of both techniques|early complications of both techniques
601422|NCT00632593|Fistula rate|fistula rate
601423|NCT00632593|Dehiscence rate|dehiscence rate
601424|NCT00632593|reoperation rate and cause|reoperation rate and cause
601425|NCT00632580|Pain, Postoperative|pain, postoperative
601426|NCT00632567|Anal incontinence|anal incontinence
601427|NCT00632567|First delivery was traumatic|first delivery was traumatic
601428|NCT00632567|No anal incontinence|no anal incontinence
601429|NCT00632528|MEOPA|meopa
601430|NCT00632528|spasticity|spasticity
601431|NCT00632528|multilevel surgery|multilevel surgery
601432|NCT00632528|cerebral palsy|cerebral palsy
601433|NCT00632528|children|children
601434|NCT00632515|Colorectal Cancer|colorectal cancer
601435|NCT00632515|CRC|crc
601436|NCT00632515|Familial CRC|familial crc
601437|NCT00632515|Cancer Screening|cancer screening
601438|NCT00632515|Questionnaire|questionnaire
601439|NCT00632515|First Degree Relatives|first degree relatives
601440|NCT00632515|FDRs|fdrs
601441|NCT00632515|Risk Communication|risk communication
601442|NCT00632489|Refractory Malignancy|refractory malignancy
601443|NCT00632489|Breast Cancer|breast cancer
601444|NCT00632489|LBH589|lbh589
601445|NCT00632489|Capecitabine|capecitabine
601446|NCT00632489|Lapatinib|lapatinib
601447|NCT00632476|Smoking During Pregnancy|smoking during pregnancy
601448|NCT00632476|Vitamin C|vitamin c
601449|NCT00632476|Newborn Lung Function|newborn lung function
601450|NCT00632476|Ascorbic Acid|ascorbic acid
601451|NCT00632463|Transplant|transplant
601452|NCT00632463|Immunosuppression|immunosuppression
601453|NCT00632437|Brain Tumor|brain tumor
601454|NCT00632437|Craniotomy Surgery|craniotomy surgery
601455|NCT00632437|Brain Function|brain function
601456|NCT00632437|Intraoperative Optical Imaging|intraoperative optical imaging
601457|NCT00632437|Speckle-Contrast Imaging|speckle-contrast imaging
601458|NCT00632437|Cortical Mapping|cortical mapping
601459|NCT00632437|Somatosensory Cortex|somatosensory cortex
601460|NCT00632437|Cerebral blood flow|cerebral blood flow
601461|NCT00632437|CBF|cbf
601462|NCT00632437|Laser Speckle Contrast Imaging|laser speckle contrast imaging
601463|NCT00632437|Multi-Spectral Imaging|multi-spectral imaging
601464|NCT00632398|massage|massage
601465|NCT00632398|oncology massage|oncology massage
601466|NCT00632398|palliative care|palliative care
601467|NCT00632398|supportive care|supportive care
601468|NCT00632398|integrative oncology|integrative oncology
601469|NCT00632398|informal caregiving|informal caregiving
601470|NCT00632398|spouse caregiving|spouse caregiving
601471|NCT00632398|family caregiving|family caregiving
601472|NCT00632398|caregiver education|caregiver education
601473|NCT00632398|psychosocial oncology|psychosocial oncology
601474|NCT00632398|caregiver stress|caregiver stress
601475|NCT00632398|coping with cancer|coping with cancer
601476|NCT00632398|quality of life|quality of life
601477|NCT00632398|end of life care|end of life care
601478|NCT00632359|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
601479|NCT00632359|CLL|cll
601480|NCT00632359|Lenalidomide|lenalidomide
601481|NCT00632359|Revlimid|revlimid
601482|NCT00632346|childhood abuse|childhood abuse
601483|NCT00632346|overweight|overweight
601484|NCT00632346|obesity|obesity
601485|NCT00632346|BMI as a young adult|bmi as a young adult
601486|NCT00632346|childhood physical abuse|childhood physical abuse
601487|NCT00632346|childhood emotional abuse|childhood emotional abuse
601488|NCT00632346|childhood sexual abuse|childhood sexual abuse
601489|NCT00632346|childhood physical neglect|childhood physical neglect
601490|NCT00632346|childhood emotional neglect|childhood emotional neglect
601491|NCT00632346|childhood witnessing of domestic violence|childhood witnessing of domestic violence
601492|NCT00632346|parental marital discord|parental marital discord
601493|NCT00632346|household members with substance abuse|household members with substance abuse
601494|NCT00632346|household members with mental illness|household members with mental illness
601495|NCT00632346|household members with criminal behavior|household members with criminal behavior
601496|NCT00632346|cumulative adverse childhood experiences|cumulative adverse childhood experiences
601497|NCT00632333|Epitope peptide|epitope peptide
601498|NCT00632333|Vaccination|vaccination
601499|NCT00632333|Chemoradiation|chemoradiation
601500|NCT00632333|Esophageal cancer|esophageal cancer
601501|NCT00632320|Ventilator, mechanical|ventilator, mechanical
601502|NCT00632320|Ventilator weaning|ventilator weaning
601503|NCT00632320|Rapid shallow breathing index|rapid shallow breathing index
601504|NCT00632320|Continuous positive airway pressure|continuous positive airway pressure
601505|NCT00632320|Receiver operating characteristic curve|receiver operating characteristic curve
601507|NCT00632307|lung tumor|lung tumor
601508|NCT00632307|pleural tumor|pleural tumor
601509|NCT00632307|interstitial lung disease|interstitial lung disease
601510|NCT00632307|airway infection|airway infection
601511|NCT00632307|COPD|copd
601512|NCT00632307|sleep apnea|sleep apnea
601513|NCT00632307|ion mobility spectrometry|ion mobility spectrometry
601514|NCT00632307|breath analysis|breath analysis
601515|NCT00632294|Bone Cancer|bone cancer
601516|NCT00632294|Allograft Retrieval|allograft retrieval
601517|NCT00632294|Allograft Bone|allograft bone
601518|NCT00632294|Bone Mineral Density|bone mineral density
601519|NCT00632268|mTOR inhibitor|mtor inhibitor
601520|NCT00632268|RAD001|rad001
601521|NCT00632268|everolimus|everolimus
601522|NCT00632268|chemotherapy|chemotherapy
601523|NCT00632268|cisplatin|cisplatin
601524|NCT00632268|high-dose 5-FU|high-dose 5-fu
601525|NCT00632255|Chronic Myeloid Leukemia|chronic myeloid leukemia
601526|NCT00632255|Long term Imatinib therapy compliance|long term imatinib therapy compliance
601527|NCT00632255|Newly diagnosed|newly diagnosed
601528|NCT00632255|Late side effects|late side effects
601529|NCT00632229|Obsessive-Compulsive Disorder; Adults; Medication; Treatment|obsessive-compulsive disorder; adults; medication; treatment
601530|NCT00632190|cervical cancer|cervical cancer
601531|NCT00632190|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
601532|NCT00632190|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
601533|NCT00632190|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
601534|NCT00632138|sexual dysfunction|sexual dysfunction
601535|NCT00632138|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
601536|NCT00632138|prostate cancer|prostate cancer
601537|NCT00632138|benign prostatic hyperplasia|benign prostatic hyperplasia
601538|NCT00632138|urinary incontinence|urinary incontinence
601539|NCT00632125|CKD subjects with or without dialysis treatment|ckd subjects with or without dialysis treatment
601540|NCT00632112|large volume nebulizer|large volume nebulizer
601541|NCT00632099|cocaine|cocaine
601542|NCT00632099|treatment|treatment
601543|NCT00632099|progesterone|progesterone
601544|NCT00632086|PK|pk
601545|NCT00632073|HIV Infections|hiv infections
601546|NCT00632073|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
601547|NCT00632073|treatment experienced|treatment experienced
601548|NCT00632060|Low Back Pain|low back pain
601549|NCT00632060|Manual / Manipulative Therapy|manual / manipulative therapy
601550|NCT00632047|breast cancer|breast cancer
601551|NCT00632047|cervical cancer|cervical cancer
601552|NCT00632034|fracture|fracture
601553|NCT00632034|tibia|tibia
601554|NCT00632034|stem cell|stem cell
601555|NCT00632021|Low Health Literacy|low health literacy
601556|NCT00632021|Medication Errors|medication errors
601557|NCT00632021|Cardiovascular Disease|cardiovascular disease
601558|NCT00632021|Pharmacist|pharmacist
601559|NCT00632021|Care Transition|care transition
601560|NCT00631995|Neisseria meningitidis|neisseria meningitidis
601561|NCT00631982|in vitro maturation oocytes|in vitro maturation oocytes
601562|NCT00631969|Erectile Dysfunction|erectile dysfunction
601563|NCT00631917|Hypertension, aliskiren, ramipril, colonoscopy|hypertension, aliskiren, ramipril, colonoscopy
601564|NCT00631904|Pacemaker|pacemaker
601565|NCT00631878|Staphylococcal|staphylococcal
601566|NCT00631878|Monoclonal antibodies|monoclonal antibodies
601567|NCT00631878|Very Low Birth Weight Infants|very low birth weight infants
601568|NCT00631878|Prophylaxis|prophylaxis
601569|NCT00631865|melanocytes|melanocytes
601570|NCT00631852|Breast Cancer, Biomarkers, Ginseng Root|breast cancer, biomarkers, ginseng root
601571|NCT00631839|Thoracic Neoplasms|thoracic neoplasms
601572|NCT00631839|Platinum-based chemotherapy|platinum-based chemotherapy
601573|NCT00631839|3-D Conformal Radiotherapy|3-d conformal radiotherapy
601574|NCT00631839|Chemo-radiotherapy induced lung injury|chemo-radiotherapy induced lung injury
601575|NCT00631839|Chemo-radiotherapy induced esophagus injury|chemo-radiotherapy induced esophagus injury
601576|NCT00631826|Shoulder|shoulder
601577|NCT00631826|Injuries|injuries
601578|NCT00631826|Flexiblity|flexiblity
601579|NCT00631826|Rotational resistance|rotational resistance
601580|NCT00631800|Staphylococcal|staphylococcal
601581|NCT00631800|Monoclonal antibodies|monoclonal antibodies
601582|NCT00631800|Very Low Birth Weight Infants|very low birth weight infants
601583|NCT00631800|Prophylaxis|prophylaxis
601584|NCT00631787|Nitric Oxide|nitric oxide
601585|NCT00631787|Hemolysis|hemolysis
601586|NCT00631787|Plasma Hemoglobin|plasma hemoglobin
601587|NCT00631787|Dimethyl Sulfoxide|dimethyl sulfoxide
601588|NCT00631787|Organ Dysfuntion|organ dysfuntion
601589|NCT00631787|Healthy Volunteer|healthy volunteer
601590|NCT00631787|HV|hv
601591|NCT00631774|type 2 diabetes|type 2 diabetes
601592|NCT00631774|meal replacement|meal replacement
601593|NCT00631774|postprandial response|postprandial response
601594|NCT00631774|Glucerna SR|glucerna sr
601595|NCT00631761|urethrocystoscopy|urethrocystoscopy
601596|NCT00631761|cystoscopy|cystoscopy
601597|NCT00631761|objective structured assessment of surgical skills (OSATS)|objective structured assessment of surgical skills (osats)
601598|NCT00631748|cocaine|cocaine
601599|NCT00631748|quetiapine fumarate|quetiapine fumarate
601600|NCT00631748|dependence|dependence
601601|NCT00631748|abuse|abuse
601602|NCT00631748|addiction|addiction
601603|NCT00631748|treatment|treatment
601604|NCT00631735|cancer|cancer
601605|NCT00631735|qualitative|qualitative
601606|NCT00631722|PANSS|panss
601607|NCT00631722|Acute Episode of Schizophrenia|acute episode of schizophrenia
601608|NCT00631696|Healthy males Human volunteers pregabalin or placebo sperm quality and quantity|healthy males human volunteers pregabalin or placebo sperm quality and quantity
601609|NCT00631657|placebo controlled|placebo controlled
601610|NCT00631657|randomized|randomized
601611|NCT00631657|double blind|double blind
601612|NCT00631644|Adolescents|adolescents
601613|NCT00631644|Eating Behavior|eating behavior
601614|NCT00631644|Eating in the Absence of Hunger|eating in the absence of hunger
601615|NCT00631644|Disordered Eating|disordered eating
601616|NCT00631644|Food Intake|food intake
601617|NCT00631644|Macronutrient Composition|macronutrient composition
601618|NCT00631644|Obesity|obesity
601619|NCT00631644|Adolescent|adolescent
601620|NCT00631644|Healthy Volunteer|healthy volunteer
601621|NCT00631644|HV|hv
601622|NCT00631631|Drug Therapy|drug therapy
601623|NCT00631605|eating disorders|eating disorders
601624|NCT00631605|ghrelin|ghrelin
601625|NCT00631605|leptin|leptin
601626|NCT00631605|BIA|bia
601627|NCT00631592|GSK1349572,|gsk1349572,
601628|NCT00631592|healthy volunteers,|healthy volunteers,
601629|NCT00631592|repeat dose,|repeat dose,
601630|NCT00631592|relative bioavailability|relative bioavailability
601631|NCT00631592|Healthy subjects|healthy subjects
601632|NCT00631566|HIV|hiv
601633|NCT00631566|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
601634|NCT00631566|HIV and Staphylococcus aureus infection|hiv and staphylococcus aureus infection
601635|NCT00631540|renal artery stenosis|renal artery stenosis
601636|NCT00631540|hypertension|hypertension
601637|NCT00631540|renovascular|renovascular
601638|NCT00631540|renal artery blockage|renal artery blockage
601639|NCT00631540|renal artery disease|renal artery disease
601640|NCT00631540|renal arteries|renal arteries
601641|NCT00631540|angioplasty renal artery|angioplasty renal artery
601642|NCT00631540|renal artery stent|renal artery stent
601643|NCT00631540|renal artery doppler|renal artery doppler
601644|NCT00631540|renovascular hypertension|renovascular hypertension
601645|NCT00631540|kidney stenosis|kidney stenosis
601646|NCT00631540|renal artery|renal artery
601647|NCT00631540|stent|stent
601648|NCT00631540|stenting|stenting
601649|NCT00631540|kidney disease|kidney disease
601650|NCT00631540|renal failure|renal failure
601651|NCT00631540|atherosclerosis|atherosclerosis
601652|NCT00631540|arterial hypertension|arterial hypertension
601653|NCT00631540|stenosis|stenosis
601654|NCT00631527|Prostate Cancer|prostate cancer
601655|NCT00631527|Radiation Therapy|radiation therapy
601656|NCT00631527|RT|rt
601657|NCT00631527|Radiotherapy|radiotherapy
601658|NCT00631527|Hormone Ablation|hormone ablation
601659|NCT00631527|Sunitinib Malate|sunitinib malate
601660|NCT00631527|Leuprolide|leuprolide
601661|NCT00631527|Lupron|lupron
601662|NCT00631527|Zoladex|zoladex
601663|NCT00631527|Goserelin|goserelin
601664|NCT00631527|Casodex|casodex
601665|NCT00631527|Bicalutamide|bicalutamide
601666|NCT00631527|SU011248|su011248
601667|NCT00631527|Sutent|sutent
601668|NCT00631527|Angiogenesis inhibitor|angiogenesis inhibitor
601669|NCT00631514|antihypertensive drugs|antihypertensive drugs
601670|NCT00631514|non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
601671|NCT00631514|interaction|interaction
601672|NCT00631514|family practice|family practice
601673|NCT00631514|arterial blood pressure|arterial blood pressure
601674|NCT00631501|tendinopathy|tendinopathy
601675|NCT00631501|tennis elbow|tennis elbow
601676|NCT00631501|lateral epicondylitis|lateral epicondylitis
601677|NCT00631501|lateral epicondylalgia|lateral epicondylalgia
601678|NCT00631501|MMP-inhibitor|mmp-inhibitor
601679|NCT00631475|Actelion|actelion
601680|NCT00631475|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
601681|NCT00631475|bosentan|bosentan
601682|NCT00631475|Tracleer|tracleer
601683|NCT00631475|Interstitial Lung Disease|interstitial lung disease
601684|NCT00631475|BUILD 3 (NCT00391443)|build 3 (nct00391443)
601685|NCT00631462|primary myelofibrosis|primary myelofibrosis
601686|NCT00631462|post-polycythemia vera myelofibrosis|post-polycythemia vera myelofibrosis
601687|NCT00631462|post-essential thrombocythemia myelofibrosis|post-essential thrombocythemia myelofibrosis
601688|NCT00631449|HIV|hiv
601689|NCT00631449|Treatment intensification|treatment intensification
601690|NCT00631449|Low level viremia|low level viremia
601691|NCT00631449|Suboptimal CD4+ T cell response|suboptimal cd4+ t cell response
601692|NCT00631449|treatment experienced|treatment experienced
601693|NCT00631436|Diffusion Tensor Imaging|diffusion tensor imaging
601694|NCT00631436|Electroencephalography|electroencephalography
601695|NCT00631436|Blast Injury|blast injury
601696|NCT00631436|Traumatic Brain Injury|traumatic brain injury
601697|NCT00631410|Phase 1|phase 1
601698|NCT00631410|CRC|crc
601699|NCT00631410|SU011248|su011248
601700|NCT00631410|Sunitinib|sunitinib
601701|NCT00631410|FOLFOX|folfox
601702|NCT00631410|Colorectal cancer|colorectal cancer
601703|NCT00631410|metastatic carcinoma of the colon or rectum|metastatic carcinoma of the colon or rectum
601704|NCT00631397|weakening of the bones|weakening of the bones
601705|NCT00631384|Voluntary Counseling and Testing|voluntary counseling and testing
601706|NCT00631384|HIV|hiv
601707|NCT00631384|HIV seronegativity|hiv seronegativity
601708|NCT00631371|temsirolimus|temsirolimus
601709|NCT00631371|renal cell carcinoma|renal cell carcinoma
601710|NCT00631371|kidney cancer|kidney cancer
601711|NCT00631371|urogenital cancer|urogenital cancer
601712|NCT00631358|Ocular inflammation|ocular inflammation
601713|NCT00631345|prediabetes|prediabetes
601714|NCT00631345|overweight|overweight
601715|NCT00631345|obesity|obesity
601716|NCT00631345|metabolic syndrome|metabolic syndrome
601717|NCT00631345|community health worker|community health worker
601718|NCT00631332|women, dementia, cognition.|women, dementia, cognition.
601719|NCT00631332|non-demented women at least age 65|non-demented women at least age 65
601720|NCT00631319|OA|oa
601721|NCT00631319|Chronic Pain|chronic pain
601722|NCT00631319|Osteoarthritis|osteoarthritis
601723|NCT00631319|OA Pain|oa pain
601724|NCT00631319|Osteoarthritis Pain|osteoarthritis pain
601725|NCT00631319|Pain|pain
601726|NCT00631319|Hip Pain|hip pain
601727|NCT00631319|Knee Pain|knee pain
601728|NCT00631319|Joint Pain|joint pain
601729|NCT00631293|Healthy volunteers|healthy volunteers
601730|NCT00631280|Decision Aid|decision aid
601731|NCT00631280|Informed Choice|informed choice
601732|NCT00631280|Adherence|adherence
601733|NCT00631267|reduction|reduction
601734|NCT00631267|satisfaction|satisfaction
601735|NCT00631267|visual-analog scale|visual-analog scale
601736|NCT00631267|complications|complications
601737|NCT00631267|functional outcome|functional outcome
601738|NCT00631267|radiological outcome|radiological outcome
601739|NCT00631241|Cervical Cancer|cervical cancer
601740|NCT00631241|Parametrial Lymph Nodes|parametrial lymph nodes
601741|NCT00631241|Sentinel Nodes|sentinel nodes
601742|NCT00631241|Intraoperative Lymphatic Mapping|intraoperative lymphatic mapping
601743|NCT00631241|Single Photon Emission Computed Tomography|single photon emission computed tomography
601744|NCT00631241|SPECT/CT|spect/ct
601745|NCT00631228|drug eluting stents|drug eluting stents
601746|NCT00631228|stents|stents
601747|NCT00631228|Angioplasty|angioplasty
601748|NCT00631228|coronary artery disease|coronary artery disease
601749|NCT00631228|total coronary occlusion|total coronary occlusion
601750|NCT00631228|coronary artery restenosis|coronary artery restenosis
601751|NCT00631228|stent thrombosis|stent thrombosis
601752|NCT00631228|vascular disease|vascular disease
601753|NCT00631228|myocardial ischemia|myocardial ischemia
601754|NCT00631228|coronary artery stenosis|coronary artery stenosis
601755|NCT00631215|Hyperbaric|hyperbaric
601756|NCT00631215|Oxygen|oxygen
601757|NCT00631215|autism|autism
601758|NCT00631202|FRDA|frda
601759|NCT00631202|Erythropoietin|erythropoietin
601760|NCT00631202|Epoetin alfa|epoetin alfa
601761|NCT00631189|dyslipidemia|dyslipidemia
601762|NCT00631176|oral intubation|oral intubation
601763|NCT00631176|just in time|just in time
601764|NCT00631176|simulation education|simulation education
601765|NCT00631176|high fidelity training|high fidelity training
601766|NCT00631176|intubation training|intubation training
601767|NCT00631176|intubation success|intubation success
601768|NCT00631163|Iron Overload,|iron overload,
601769|NCT00631163|Chelation,|chelation,
601770|NCT00631163|MDS,|mds,
601771|NCT00631163|Chronic Anemia,|chronic anemia,
601772|NCT00631163|Deferasirox,|deferasirox,
601773|NCT00631163|Transfusional hemosiderosis,|transfusional hemosiderosis,
601774|NCT00631150|Levetiracetam|levetiracetam
601775|NCT00631150|Keppra|keppra
601776|NCT00631137|musculoskeletal complications|musculoskeletal complications
601777|NCT00631137|adult anaplastic astrocytoma|adult anaplastic astrocytoma
601778|NCT00631137|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
601779|NCT00631137|adult giant cell glioblastoma|adult giant cell glioblastoma
601780|NCT00631137|adult glioblastoma|adult glioblastoma
601781|NCT00631137|adult gliosarcoma|adult gliosarcoma
601782|NCT00631124|Contraception|contraception
601783|NCT00631111|dental pain|dental pain
601784|NCT00631111|analgesic|analgesic
601785|NCT00631111|NSAID|nsaid
601786|NCT00631111|ibuprofen|ibuprofen
601787|NCT00631111|aspirin|aspirin
601788|NCT00631098|Resuscitation|resuscitation
601789|NCT00631098|venous cannulation|venous cannulation
601790|NCT00631098|external jugular vein|external jugular vein
601791|NCT00631098|cubital vein|cubital vein
601792|NCT00631085|healthy nonsmoking nonasthmatic volunteers|healthy nonsmoking nonasthmatic volunteers
601793|NCT00631072|iNKT|inkt
601794|NCT00631072|in vitro autologous iNKT|in vitro autologous inkt
601795|NCT00631059|Hitachi|hitachi
601796|NCT00631059|Leukemia|leukemia
601797|NCT00631059|Relapse|relapse
601798|NCT00631059|Chemotherapy Resistance|chemotherapy resistance
601799|NCT00631046|n-3 LCPUFA|n-3 lcpufa
601800|NCT00631046|Fish oil|fish oil
601801|NCT00631046|essential fatty acids|essential fatty acids
601802|NCT00631046|infant growth|infant growth
601803|NCT00631046|obesity|obesity
601804|NCT00631046|Intestinal microbiota|intestinal microbiota
601805|NCT00631033|obesity|obesity
601806|NCT00631033|hyperinsulinism|hyperinsulinism
601807|NCT00631033|diazoxide|diazoxide
601808|NCT00631033|metformin|metformin
601809|NCT00631020|Youth|youth
601810|NCT00631020|Smoking|smoking
601811|NCT00631020|Tobacco|tobacco
601812|NCT00631020|Adolescent|adolescent
601813|NCT00631020|Dependence|dependence
601814|NCT00631020|Teen smoking|teen smoking
601815|NCT00631020|Smoking and youth|smoking and youth
601816|NCT00631020|Youth and tobacco|youth and tobacco
601817|NCT00631007|Type 2 diabetes|type 2 diabetes
601818|NCT00631007|diabetes|diabetes
601819|NCT00631007|diabetes mellitus|diabetes mellitus
601820|NCT00631007|diabetes mellitus, type 2|diabetes mellitus, type 2
601821|NCT00631007|non-TZD|non-tzd
601822|NCT00631007|thiazolidinedione|thiazolidinedione
601823|NCT00631007|selective peroxisome proliferator-activated receptor gamma modulator|selective peroxisome proliferator-activated receptor gamma modulator
601824|NCT00631007|SPPARM|spparm
601825|NCT00631007|peroxisome proliferator-activated receptor gamma|peroxisome proliferator-activated receptor gamma
601826|NCT00631007|PPAR gamma|ppar gamma
601827|NCT00631007|insulin sensitizer|insulin sensitizer
601828|NCT00631007|glucose control|glucose control
601829|NCT00631007|endocrinopathy|endocrinopathy
601830|NCT00631007|hypoglycemic agent|hypoglycemic agent
601831|NCT00631007|sulfonylurea|sulfonylurea
601832|NCT00631007|metformin|metformin
601833|NCT00631007|pioglitazone|pioglitazone
601834|NCT00631007|nutritional and metabolic diseases|nutritional and metabolic diseases
601835|NCT00630994|primary myelofibrosis|primary myelofibrosis
601836|NCT00630994|secondary myelofibrosis|secondary myelofibrosis
601837|NCT00630994|essential thrombocythemia|essential thrombocythemia
601838|NCT00630994|polycythemia vera|polycythemia vera
601839|NCT00630981|dissociative disorders|dissociative disorders
601840|NCT00630968|Levetiracetam|levetiracetam
601841|NCT00630968|Keppra|keppra
601842|NCT00630955|Alcohol Drinking|alcohol drinking
601843|NCT00630955|Memantine|memantine
601844|NCT00630942|PSC|psc
601845|NCT00630916|Aortic valve insufficiency|aortic valve insufficiency
601846|NCT00630916|Aortic valve|aortic valve
601847|NCT00630916|Aortic disease|aortic disease
601848|NCT00630916|Aortic incompetence|aortic incompetence
601849|NCT00630890|Hilar Cholangiocarcinoma (Klatskin Tumor)|hilar cholangiocarcinoma (klatskin tumor)
601850|NCT00630890|External Beam Radiation|external beam radiation
601851|NCT00630890|Cyberknife|cyberknife
601852|NCT00630890|Capecitabine|capecitabine
601853|NCT00630864|Transthyretin, TTR, amyloidosis, TTR amyloidosis, polyneuropathy|transthyretin, ttr, amyloidosis, ttr amyloidosis, polyneuropathy
601854|NCT00630838|Hirschsprung disease|hirschsprung disease
601855|NCT00630838|enterocolitis|enterocolitis
601856|NCT00630838|probiotics|probiotics
601857|NCT00630812|cystic fibrosis|cystic fibrosis
601858|NCT00630812|mannitol|mannitol
601859|NCT00630812|mucoactive|mucoactive
601860|NCT00630799|prostate|prostate
601861|NCT00630799|cancer|cancer
601862|NCT00630773|CPR|cpr
601863|NCT00630773|compression sensor|compression sensor
601864|NCT00630773|chest compression adjuncts|chest compression adjuncts
601865|NCT00630747|Hunter syndrome|hunter syndrome
601866|NCT00630747|hunters syndrome|hunters syndrome
601867|NCT00630747|hunter's syndrome|hunter's syndrome
601868|NCT00630747|hunter disease|hunter disease
601869|NCT00630747|hunters disease|hunters disease
601870|NCT00630747|hunter's disease|hunter's disease
601871|NCT00630747|MPS II|mps ii
601872|NCT00630747|MPSII|mpsii
601873|NCT00630747|MPS2|mps2
601874|NCT00630747|MPS 2|mps 2
601875|NCT00630747|mucopolysaccharides|mucopolysaccharides
601876|NCT00630747|lysosomal storage disease|lysosomal storage disease
601877|NCT00630747|lysosomal storage disorder|lysosomal storage disorder
601878|NCT00630747|chronic ear infection|chronic ear infection
601879|NCT00630747|enlarged adenoids|enlarged adenoids
601880|NCT00630747|mps symptoms|mps symptoms
601881|NCT00630747|mps diagnosis|mps diagnosis
601882|NCT00630747|mps ii therapy|mps ii therapy
601883|NCT00630747|MPS II treatment|mps ii treatment
601884|NCT00630747|ert treatment|ert treatment
601885|NCT00630747|elaprase|elaprase
601886|NCT00630747|idursulfase|idursulfase
601887|NCT00630747|iduronate sulfatase|iduronate sulfatase
601888|NCT00630747|iduronate 2 sulfatase|iduronate 2 sulfatase
601889|NCT00630747|enzyme replacement therapy|enzyme replacement therapy
601890|NCT00630747|hunter syndrome treatment|hunter syndrome treatment
601891|NCT00630747|hunter's syndrome treatment|hunter's syndrome treatment
601892|NCT00630747|hunter syndrome therapy|hunter syndrome therapy
601893|NCT00630747|hunter's disease treatment|hunter's disease treatment
601894|NCT00630747|mps society|mps society
601895|NCT00630734|HIV|hiv
601896|NCT00630734|Pravastatin|pravastatin
601897|NCT00630734|Darunavir|darunavir
601898|NCT00630734|Ritonavir|ritonavir
601899|NCT00630734|Genetic|genetic
601900|NCT00630708|Renal insufficiency|renal insufficiency
601901|NCT00630708|Benazepril|benazepril
601902|NCT00630708|Losartan|losartan
601903|NCT00630708|combination treatment|combination treatment
601904|NCT00630708|Safety|safety
601905|NCT00630695|Axillary lymphocele breast cancer|axillary lymphocele breast cancer
601906|NCT00630682|Methamphetamine|methamphetamine
601907|NCT00630682|Drug Abuse|drug abuse
601908|NCT00630682|Drug Treatment|drug treatment
601909|NCT00630682|Addiction|addiction
601910|NCT00630682|Meth|meth
601911|NCT00630682|Treatment for Methamphetamine Dependence|treatment for methamphetamine dependence
601912|NCT00630669|Internal hemorrhoids|internal hemorrhoids
601913|NCT00630669|Rubber band ligation|rubber band ligation
601914|NCT00630669|Bipolar coagulation|bipolar coagulation
601915|NCT00630656|sepsis|sepsis
601916|NCT00630656|talactoferrin|talactoferrin
601917|NCT00630656|lactoferrin|lactoferrin
601918|NCT00630656|recombinant human lactoferrin|recombinant human lactoferrin
601919|NCT00630630|Levetiracetam|levetiracetam
601920|NCT00630630|Keppra|keppra
601921|NCT00630617|Obesity|obesity
601922|NCT00630617|Prevention|prevention
601923|NCT00630617|Childhood|childhood
601924|NCT00630617|Children|children
601925|NCT00630617|Primary care-giver|primary care-giver
601926|NCT00630604|ultrasonography|ultrasonography
601927|NCT00630604|knee|knee
601928|NCT00630604|early degeneration|early degeneration
601929|NCT00630604|cartilage|cartilage
601930|NCT00630591|Daughters And MothErS Against Breast Cancer|daughters and mothers against breast cancer
601931|NCT00630591|DAMES|dames
601932|NCT00630591|Breast Cancer|breast cancer
601933|NCT00630591|Weight Loss|weight loss
601934|NCT00630591|Home-based weight loss|home-based weight loss
601935|NCT00630591|Quality of Life|quality of life
601936|NCT00630591|Diet|diet
601937|NCT00630591|Exercise|exercise
601938|NCT00630591|Daughter|daughter
601939|NCT00630591|Mother|mother
601940|NCT00630591|Cancer Prevention|cancer prevention
601941|NCT00630591|Prevention|prevention
601942|NCT00630578|PTSD|ptsd
601943|NCT00630578|Posttraumatic Stress Disorder|posttraumatic stress disorder
601944|NCT00630578|Physical Assault|physical assault
601945|NCT00630578|Physical Abuse|physical abuse
601946|NCT00630578|Sexual Assault|sexual assault
601947|NCT00630578|Sexual Abuse|sexual abuse
601948|NCT00630578|Interpersonal Assault|interpersonal assault
601949|NCT00630578|Cognitive Processing Therapy|cognitive processing therapy
601950|NCT00630565|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
601951|NCT00630565|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
601952|NCT00630565|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
601953|NCT00630565|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
601954|NCT00630565|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
601955|NCT00630565|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
601956|NCT00630565|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
601957|NCT00630552|AMG 479|amg 479
601958|NCT00630552|Gemcitabine|gemcitabine
601959|NCT00630552|TR-2|tr-2
601960|NCT00630552|IGF-1R|igf-1r
601961|NCT00630552|AMG 655|amg 655
601962|NCT00630552|Pancreatic cancer|pancreatic cancer
601963|NCT00630552|Adenocarcinoma of the Pancreas|adenocarcinoma of the pancreas
601964|NCT00630552|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
601965|NCT00630539|Menopausal symptoms|menopausal symptoms
601966|NCT00630539|Urogenital atrophy|urogenital atrophy
601967|NCT00630539|Vulvar and vaginal atrophy in postmenopausal women|vulvar and vaginal atrophy in postmenopausal women
601968|NCT00630539|Vaginal atrophy|vaginal atrophy
601969|NCT00630513|localized community acquired intra-abdominal infection (IAI)|localized community acquired intra-abdominal infection (iai)
601970|NCT00630513|antibiotics|antibiotics
601971|NCT00630513|localized peritonitis|localized peritonitis
601972|NCT00630513|ertapenem|ertapenem
601973|NCT00630500|Dementia associated with Parkinson's disease|dementia associated with parkinson's disease
601974|NCT00630500|Dementia with Lewy bodies|dementia with lewy bodies
601975|NCT00630500|Memantine|memantine
601976|NCT00630500|Placebo-controlled|placebo-controlled
601977|NCT00630500|Parallel group|parallel group
601978|NCT00630474|sleep apnea, rhinitis|sleep apnea, rhinitis
601979|NCT00630461|mild asthma, mild allergies|mild asthma, mild allergies
601980|NCT00630435|Premarin®|premarin®
601981|NCT00630422|Rett Syndrome|rett syndrome
601982|NCT00630422|Selfcare|selfcare
601983|NCT00630422|Mobility limitation|mobility limitation
601984|NCT00630422|Interpersonal relations|interpersonal relations
601985|NCT00630422|This study avaliated patients with Rett Syndrome|this study avaliated patients with rett syndrome
601986|NCT00630409|Renal cell carcinoma|renal cell carcinoma
601987|NCT00630409|Kidney Cancer|kidney cancer
601988|NCT00630409|Gemcitabine|gemcitabine
601989|NCT00630409|Doxil|doxil
601990|NCT00630409|Chemotherapy|chemotherapy
601991|NCT00630396|stroke|stroke
601992|NCT00630396|ischemic|ischemic
601993|NCT00630396|neuroprotection|neuroprotection
601994|NCT00630396|minocycline|minocycline
601995|NCT00630396|tissue plasminogen activator (tPA)|tissue plasminogen activator (tpa)
601996|NCT00630396|biomarkers|biomarkers
601997|NCT00630396|pharmacokinetics|pharmacokinetics
601998|NCT00630396|antiapoptotic|antiapoptotic
601999|NCT00630396|anti-inflammatory|anti-inflammatory
602000|NCT00630396|treatment|treatment
602001|NCT00630396|matrix metalloproteinase-9 (MMP-9)|matrix metalloproteinase-9 (mmp-9)
602002|NCT00630396|thrombolysis|thrombolysis
602003|NCT00630396|Minocycline to Improve Neurologic Outcome in Stroke (MINOS)|minocycline to improve neurologic outcome in stroke (minos)
602004|NCT00630396|cerebrovascular stroke|cerebrovascular stroke
602005|NCT00630396|cerebrovascular accident|cerebrovascular accident
602006|NCT00630396|cerebral stroke|cerebral stroke
602007|NCT00630396|cerebrovascular accident (CVA)|cerebrovascular accident (cva)
602008|NCT00630383|Parasite|parasite
602009|NCT00630383|Necator|necator
602010|NCT00630383|immune regulation|immune regulation
602011|NCT00630383|regulatory T cells|regulatory t cells
602012|NCT00630383|foxp3|foxp3
602013|NCT00630383|cytokines|cytokines
602014|NCT00630383|multiple sclerosis|multiple sclerosis
602015|NCT00630383|hygiene hypothesis|hygiene hypothesis
602016|NCT00630357|Levetiracetam|levetiracetam
602017|NCT00630357|Keppra|keppra
602018|NCT00630344|RAD001|rad001
602019|NCT00630344|bicalutamide|bicalutamide
602020|NCT00630344|androgen independent prostate cancer|androgen independent prostate cancer
602021|NCT00630331|Influenza|influenza
602022|NCT00630331|Flu|flu
602023|NCT00630331|Cell Culture-Derived|cell culture-derived
602024|NCT00630331|Egg-Derived|egg-derived
602025|NCT00630331|Healthy Adults|healthy adults
602026|NCT00630331|Efficacy|efficacy
602027|NCT00630331|Safety|safety
602028|NCT00630331|Immunogenicity|immunogenicity
602029|NCT00630331|Trivalent|trivalent
602030|NCT00630331|Inactivated|inactivated
602031|NCT00630331|Influenza-Like Illness|influenza-like illness
602032|NCT00630331|Vaccination|vaccination
602033|NCT00630318|MR scanning|mr scanning
602034|NCT00630305|toric|toric
602035|NCT00630305|endothelial bleb|endothelial bleb
602036|NCT00630279|pancreatic exocrine insufficiency|pancreatic exocrine insufficiency
602037|NCT00630279|chronic pancreatitis|chronic pancreatitis
602038|NCT00630266|Heart failure|heart failure
602039|NCT00630266|left ventricular dilation|left ventricular dilation
602040|NCT00630266|mitral valve repair|mitral valve repair
602041|NCT00630266|mitral valve replacement|mitral valve replacement
602042|NCT00630253|Fanconi anemia|fanconi anemia
602043|NCT00630240|epirubicin|epirubicin
602044|NCT00630240|mitomycin C|mitomycin c
602045|NCT00630240|cisplatin|cisplatin
602046|NCT00630240|Hepatocellular carcinoma|hepatocellular carcinoma
602047|NCT00630227|emphysema|emphysema
602048|NCT00630227|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
602049|NCT00630227|lung volume reduction|lung volume reduction
602050|NCT00630214|Total thyroidectomy|total thyroidectomy
602051|NCT00630214|CND|cnd
602052|NCT00630214|hypocalcemia|hypocalcemia
602053|NCT00630214|calcium|calcium
602054|NCT00630214|vitamin D|vitamin d
602055|NCT00630201|opioid dependence|opioid dependence
602056|NCT00630201|opioid addiction|opioid addiction
602057|NCT00630201|buprenorphine|buprenorphine
602058|NCT00630201|methadone|methadone
602059|NCT00630201|heroin|heroin
602060|NCT00630201|implant|implant
602061|NCT00630201|opioid withdrawal|opioid withdrawal
602062|NCT00630201|opioid pain medication|opioid pain medication
602063|NCT00630201|suboxone|suboxone
602064|NCT00630188|prostate cancer screening|prostate cancer screening
602065|NCT00630188|shared decision making|shared decision making
602066|NCT00630188|prostate-specific antigen|prostate-specific antigen
602067|NCT00630188|decision making|decision making
602068|NCT00630188|physician-patient relations|physician-patient relations
602069|NCT00630175|Insomnia|insomnia
602070|NCT00630162|protozoa|protozoa
602071|NCT00630162|Amoeba|amoeba
602072|NCT00630149|Nasopharyngeal Neoplasms|nasopharyngeal neoplasms
602073|NCT00630149|Pemetrexed|pemetrexed
602074|NCT00630110|Non Small Cell Lung|non small cell lung
602075|NCT00630097|methamphetamine addiction, meth dependence|methamphetamine addiction, meth dependence
602076|NCT00630084|chronic hepatitis C|chronic hepatitis c
602077|NCT00630084|sustained virological response|sustained virological response
602078|NCT00630084|peginterferon|peginterferon
602079|NCT00630084|ribavirin|ribavirin
602080|NCT00630084|neoplasms|neoplasms
602081|NCT00630071|Diagnostic Appendicitis|diagnostic appendicitis
602082|NCT00630071|Procalcitonin|procalcitonin
602083|NCT00630058|Chronic Hepatitis C|chronic hepatitis c
602084|NCT00630058|Protease Inhibitor|protease inhibitor
602085|NCT00630058|Telaprevir|telaprevir
602086|NCT00630032|stage II breast cancer|stage ii breast cancer
602087|NCT00630032|stage IIIA breast cancer|stage iiia breast cancer
602088|NCT00630032|stage IIIB breast cancer|stage iiib breast cancer
602089|NCT00630032|stage IIIC breast cancer|stage iiic breast cancer
602090|NCT00630019|Aqueous humor penetration by anti-infectives|aqueous humor penetration by anti-infectives
602091|NCT00629993|cervical cancer screening|cervical cancer screening
602092|NCT00629993|medically underserved women|medically underserved women
602093|NCT00629993|HPV vaccine|hpv vaccine
602094|NCT00629967|chronic hepatitis C|chronic hepatitis c
602095|NCT00629967|genotype 1|genotype 1
602096|NCT00629967|rapid virological response|rapid virological response
602097|NCT00629967|sustained virological response|sustained virological response
602098|NCT00629967|peginterferon|peginterferon
602099|NCT00629967|ribavirin|ribavirin
602100|NCT00629967|treatment duration|treatment duration
602101|NCT00629954|ABUJA HEART STUDY NIGERIA|abuja heart study nigeria
602102|NCT00629954|CARDIOVASCULAR DISEASES|cardiovascular diseases
602103|NCT00629928|NSAID, Nexium, esomeprazole, Gastric Ulcers|nsaid, nexium, esomeprazole, gastric ulcers
602104|NCT00629915|Moyamoya|moyamoya
602105|NCT00629915|stroke|stroke
602106|NCT00629902|Heart valve prosthesis|heart valve prosthesis
602107|NCT00629889|seizure|seizure
602108|NCT00629889|adult anaplastic astrocytoma|adult anaplastic astrocytoma
602109|NCT00629889|adult diffuse astrocytoma|adult diffuse astrocytoma
602110|NCT00629889|adult pineal gland astrocytoma|adult pineal gland astrocytoma
602111|NCT00629889|adult glioblastoma|adult glioblastoma
602112|NCT00629889|adult gliosarcoma|adult gliosarcoma
602113|NCT00629889|adult giant cell glioblastoma|adult giant cell glioblastoma
602114|NCT00629889|adult brain stem glioma|adult brain stem glioma
602115|NCT00629889|adult ependymoblastoma|adult ependymoblastoma
602116|NCT00629889|adult medulloblastoma|adult medulloblastoma
602117|NCT00629889|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
602118|NCT00629889|adult ependymoma|adult ependymoma
602119|NCT00629889|adult anaplastic ependymoma|adult anaplastic ependymoma
602120|NCT00629889|adult anaplastic meningioma|adult anaplastic meningioma
602121|NCT00629889|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
602122|NCT00629889|adult oligodendroglioma|adult oligodendroglioma
602123|NCT00629889|adult pineoblastoma|adult pineoblastoma
602124|NCT00629889|adult pineocytoma|adult pineocytoma
602125|NCT00629889|adult mixed glioma|adult mixed glioma
602126|NCT00629889|adult papillary meningioma|adult papillary meningioma
602127|NCT00629889|recurrent adult brain tumor|recurrent adult brain tumor
602128|NCT00629889|adult grade II meningioma|adult grade ii meningioma
602129|NCT00629876|Chemotherapy|chemotherapy
602130|NCT00629876|Drug Therapy|drug therapy
602131|NCT00629863|stage I gastric cancer|stage i gastric cancer
602132|NCT00629863|stage II gastric cancer|stage ii gastric cancer
602133|NCT00629863|stage III gastric cancer|stage iii gastric cancer
602134|NCT00629863|stage I esophageal cancer|stage i esophageal cancer
602135|NCT00629863|stage II esophageal cancer|stage ii esophageal cancer
602136|NCT00629863|stage III esophageal cancer|stage iii esophageal cancer
602137|NCT00629850|spinal cord injury|spinal cord injury
602138|NCT00629850|respiratory muscle training|respiratory muscle training
602139|NCT00629850|sleep quality|sleep quality
602140|NCT00629837|FVIII|fviii
602141|NCT00629837|Long acting|long acting
602142|NCT00629837|pk|pk
602143|NCT00629824|chronic hepatitis C|chronic hepatitis c
602144|NCT00629824|sustained virological response|sustained virological response
602145|NCT00629824|rapid virological response|rapid virological response
602146|NCT00629824|peginterferon|peginterferon
602147|NCT00629824|ribavirin|ribavirin
602148|NCT00629824|old age|old age
602149|NCT00629811|Cicatrix|cicatrix
602150|NCT00629811|Scar|scar
602151|NCT00629811|TGFβ3|tgfβ3
602152|NCT00629811|Avotermin|avotermin
602153|NCT00629811|Juvista|juvista
602154|NCT00629811|RN1001|rn1001
602155|NCT00629798|Busulfan|busulfan
602156|NCT00629798|Melphalan|melphalan
602157|NCT00629798|Fludarabine|fludarabine
602158|NCT00629798|08-008|08-008
602159|NCT00629785|asthma|asthma
602160|NCT00629785|pulmonary function tests|pulmonary function tests
602161|NCT00629785|obesity|obesity
602162|NCT00629772|Palmoplantar psoriasis|palmoplantar psoriasis
602163|NCT00629772|Infliximab|infliximab
602164|NCT00629759|Jennerex|jennerex
602165|NCT00629759|unresectable liver tumors|unresectable liver tumors
602166|NCT00629759|primary liver cancer|primary liver cancer
602167|NCT00629759|metastatic liver cancer|metastatic liver cancer
602168|NCT00629759|oncolytic virus|oncolytic virus
602169|NCT00629759|vaccinia virus|vaccinia virus
602170|NCT00629759|Pexa-Vec|pexa-vec
602171|NCT00629746|Thyroid|thyroid
602172|NCT00629746|RLN|rln
602173|NCT00629746|EMG|emg
602174|NCT00629733|pharmacokinetics|pharmacokinetics
602175|NCT00629733|ultra low molecular weight heparin|ultra low molecular weight heparin
602176|NCT00629720|elevated detrusor leak point pressure|elevated detrusor leak point pressure
602177|NCT00629707|diabetic ketoacidosis|diabetic ketoacidosis
602178|NCT00629707|DKA|dka
602179|NCT00629707|cerebral edema|cerebral edema
602180|NCT00629707|brain edema|brain edema
602181|NCT00629694|adenoidectomy, myringotomy, tubes insertion, otitis media, adenoid hyperthophy|adenoidectomy, myringotomy, tubes insertion, otitis media, adenoid hyperthophy
602182|NCT00629655|fMRI|fmri
602183|NCT00629655|spinal cord|spinal cord
602184|NCT00629655|human|human
602185|NCT00629655|health|health
602186|NCT00629655|cerebral infarction|cerebral infarction
602187|NCT00629655|healthy|healthy
602188|NCT00629642|Neurogenic bladder|neurogenic bladder
602189|NCT00629642|Vesicare|vesicare
602190|NCT00629629|Health Plan Implementation|health plan implementation
602284|NCT00629239|inhalation|inhalation
602191|NCT00629629|Feeding and Eating Disorders of Childhood|feeding and eating disorders of childhood
602192|NCT00629629|Breastfeeding|breastfeeding
602193|NCT00629629|Complementary feeding|complementary feeding
602194|NCT00629629|Morbidity|morbidity
602195|NCT00629629|Anemia|anemia
602196|NCT00629629|Public policy|public policy
602197|NCT00629616|stage II breast cancer|stage ii breast cancer
602198|NCT00629616|stage IIIA breast cancer|stage iiia breast cancer
602199|NCT00629616|stage IIIB breast cancer|stage iiib breast cancer
602200|NCT00629616|stage IIIC breast cancer|stage iiic breast cancer
602201|NCT00629603|hepatitis C virus infection|hepatitis c virus infection
602202|NCT00629603|chronic liver disease|chronic liver disease
602203|NCT00629603|fibrosis-related cytokine|fibrosis-related cytokine
602204|NCT00629577|cervical cancer|cervical cancer
602205|NCT00629577|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
602206|NCT00629577|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
602207|NCT00629577|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
602208|NCT00629564|Gastroesophageal Reflux Disease (GERD), esomeprazole, Nexium|gastroesophageal reflux disease (gerd), esomeprazole, nexium
602209|NCT00629551|Major Depressive Disorder|major depressive disorder
602210|NCT00629551|Depression|depression
602211|NCT00629551|Major Depressive Episode|major depressive episode
602212|NCT00629551|Antidepressant|antidepressant
602213|NCT00629538|congestive heart failure|congestive heart failure
602214|NCT00629538|thoracentesis|thoracentesis
602215|NCT00629538|transudative pleural effusions|transudative pleural effusions
602216|NCT00629512|NSAID, Nexium, esomeprazole, Gastric Ulcers|nsaid, nexium, esomeprazole, gastric ulcers
602217|NCT00629499|Early Stage Breast Cancer|early stage breast cancer
602218|NCT00629499|Her2-positive|her2-positive
602219|NCT00629499|nab paclitaxel|nab paclitaxel
602220|NCT00629499|cyclophosphamide|cyclophosphamide
602221|NCT00629499|trastuzumab|trastuzumab
602222|NCT00629486|cytokine gene|cytokine gene
602223|NCT00629486|hepatitis B|hepatitis b
602224|NCT00629486|hepatocellular carcinoma|hepatocellular carcinoma
602225|NCT00629486|chronic liver disease|chronic liver disease
602226|NCT00629473|multiple myeloma|multiple myeloma
602227|NCT00629473|leukemias (inc. CLL)|leukemias (inc. cll)
602228|NCT00629473|lymphomas|lymphomas
602229|NCT00629473|cutaneous lymphoma|cutaneous lymphoma
602230|NCT00629473|marginal zone lymphoma|marginal zone lymphoma
602231|NCT00629473|advanced malignancies without standard treatment options|advanced malignancies without standard treatment options
602232|NCT00629460|Pulmonary Nodules|pulmonary nodules
602233|NCT00629447|Primary Brain Tumor|primary brain tumor
602234|NCT00629447|Venous Thromboembolism|venous thromboembolism
602235|NCT00629447|Heparin|heparin
602236|NCT00629434|Diabetes Education|diabetes education
602237|NCT00629434|Telemedicine|telemedicine
602238|NCT00629395|pediatric|pediatric
602239|NCT00629395|brain tumor|brain tumor
602240|NCT00629395|survivors|survivors
602241|NCT00629382|abdominal sepsis|abdominal sepsis
602242|NCT00629382|abdominal surgery|abdominal surgery
602243|NCT00629382|septic shock|septic shock
602244|NCT00629382|polymyxin B|polymyxin b
602245|NCT00629382|hemoperfusion|hemoperfusion
602246|NCT00629382|Endotoxins|endotoxins
602247|NCT00629343|Soft Tissue Sarcoma|soft tissue sarcoma
602248|NCT00629343|Mesothelioma|mesothelioma
602249|NCT00629343|Azacitidine|azacitidine
602250|NCT00629343|Temozolomide|temozolomide
602251|NCT00629343|Temodar|temodar
602252|NCT00629330|prostate cancer|prostate cancer
602253|NCT00629330|prostate cancer screening|prostate cancer screening
602254|NCT00629330|prostate specific antigen|prostate specific antigen
602255|NCT00629330|African American males|african american males
602256|NCT00629317|Skin Aging|skin aging
602257|NCT00629317|Rejuvenation|rejuvenation
602258|NCT00629317|Photodynamic Therapy|photodynamic therapy
602259|NCT00629317|Methyl Aminolevulinate|methyl aminolevulinate
602260|NCT00629304|type 1 diabetes|type 1 diabetes
602261|NCT00629304|PDA phone (Personal Digital Assistant)|pda phone (personal digital assistant)
602262|NCT00629304|HbA1c|hba1c
602263|NCT00629291|iron overload|iron overload
602264|NCT00629291|Thalassemia|thalassemia
602265|NCT00629291|Anemia, Sickle Cell|anemia, sickle cell
602266|NCT00629291|Magnetic Resonance Imaging|magnetic resonance imaging
602267|NCT00629278|stage IA breast cancer|stage ia breast cancer
602268|NCT00629278|stage IB breast cancer|stage ib breast cancer
602269|NCT00629278|stage II breast cancer|stage ii breast cancer
602270|NCT00629278|stage IIIA breast cancer|stage iiia breast cancer
602271|NCT00629278|HER2-positive breast cancer|her2-positive breast cancer
602272|NCT00629265|Dysphagia|dysphagia
602273|NCT00629265|Neuromuscular Electrical Stimulation (NMES)|neuromuscular electrical stimulation (nmes)
602274|NCT00629265|Head & Neck Cancer|head & neck cancer
602275|NCT00629265|Radiation and ChemoTherapy|radiation and chemotherapy
602276|NCT00629252|Schizophrenia|schizophrenia
602277|NCT00629252|PPI|ppi
602278|NCT00629252|P50|p50
602279|NCT00629252|CANTAB|cantab
602280|NCT00629252|sensory gating|sensory gating
602281|NCT00629252|Schizophrenic patients according to DSM-IV|schizophrenic patients according to dsm-iv
602282|NCT00629239|COPD|copd
602283|NCT00629239|tolerability|tolerability
602285|NCT00629226|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
602286|NCT00629226|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
602287|NCT00629226|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
602288|NCT00629226|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
602289|NCT00629226|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
602290|NCT00629226|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
602291|NCT00629226|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
602292|NCT00629226|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
602293|NCT00629226|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
602294|NCT00629226|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
602419|NCT00628784|Ablation|ablation
602295|NCT00629226|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
602296|NCT00629213|prevention,|prevention,
602297|NCT00629213|type 2 diabetes,|type 2 diabetes,
602298|NCT00629213|metabolic syndrome,|metabolic syndrome,
602299|NCT00629213|acarbose treatment|acarbose treatment
602300|NCT00629200|Advanced Malignancies|advanced malignancies
602301|NCT00629200|Solid Tumors|solid tumors
602302|NCT00629200|Melanoma|melanoma
602303|NCT00629200|Renal Cell Carcinoma|renal cell carcinoma
602304|NCT00629200|Phase I Studies|phase i studies
602305|NCT00629200|Sodium Stibogluconate|sodium stibogluconate
602306|NCT00629200|Interferon Alpha-2b|interferon alpha-2b
602307|NCT00629200|Intron A|intron a
602309|NCT00629187|Lung Neoplasm|lung neoplasm
602310|NCT00629187|Breast Neoplasm|breast neoplasm
602311|NCT00629187|Melanoma|melanoma
602312|NCT00629187|Central Nervous System Neoplasms|central nervous system neoplasms
602313|NCT00629187|Neoplasm Metastasis|neoplasm metastasis
602314|NCT00629187|Neoplasm Second Primary|neoplasm second primary
602315|NCT00629187|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
602316|NCT00629174|Cognitive function|cognitive function
602317|NCT00629174|Elderly|elderly
602318|NCT00629174|Exercise|exercise
602319|NCT00629174|Mental activity|mental activity
602320|NCT00629148|metastasis|metastasis
602321|NCT00629148|chemotherapy|chemotherapy
602322|NCT00629148|breast cancer|breast cancer
602323|NCT00629148|Vinorelbine|vinorelbine
602324|NCT00629148|Capecitabine|capecitabine
602325|NCT00629148|sequential chemotherapy|sequential chemotherapy
602326|NCT00629148|TTF|ttf
602327|NCT00629135|abscess|abscess
602328|NCT00629135|intraabdominal abscess|intraabdominal abscess
602329|NCT00629135|Moxifloxacine|moxifloxacine
602330|NCT00629135|Moxifloxacin|moxifloxacin
602331|NCT00629135|Metronidazole|metronidazole
602332|NCT00629135|Tazobactam|tazobactam
602333|NCT00629135|Piperacilline|piperacilline
602334|NCT00629135|Piperacillin|piperacillin
602335|NCT00629135|Tazobac|tazobac
602336|NCT00629122|Kidney Transplantation|kidney transplantation
602337|NCT00629122|Tacrolimus (Prograf)|tacrolimus (prograf)
602338|NCT00629122|Pharmacokinetics|pharmacokinetics
602339|NCT00629122|Sublingual administration|sublingual administration
602340|NCT00629122|Drug interactions (Cytochrome P450 and p-glycoprotein)|drug interactions (cytochrome p450 and p-glycoprotein)
602341|NCT00629096|Dilated Cardiomyopathy|dilated cardiomyopathy
602342|NCT00629096|Marrow stem cells|marrow stem cells
602343|NCT00629096|Myocardial regeneration|myocardial regeneration
602344|NCT00629096|Mesenchymal stem cells|mesenchymal stem cells
602345|NCT00629096|Marrow-derived endothelial progenitor cells|marrow-derived endothelial progenitor cells
602346|NCT00629083|SUI|sui
602347|NCT00629083|Bulkamid|bulkamid
602348|NCT00629083|Urinary Incontinence|urinary incontinence
602349|NCT00629070|cerebral palsy|cerebral palsy
602350|NCT00629070|muscle strength|muscle strength
602351|NCT00629070|muscle architecture|muscle architecture
602352|NCT00629070|ultrasound|ultrasound
602353|NCT00629070|rehabilitation|rehabilitation
602354|NCT00629070|rectus femoris|rectus femoris
602355|NCT00629070|quadriceps muscle|quadriceps muscle
602356|NCT00629057|androgen-insensitive, non-metastatic, prostate, cancer|androgen-insensitive, non-metastatic, prostate, cancer
602357|NCT00629031|Visceral leishmaniasis|visceral leishmaniasis
602358|NCT00629031|Paromomycin|paromomycin
602359|NCT00629018|Stem Cells|stem cells
602360|NCT00629018|Heart Failure|heart failure
602361|NCT00629018|Dilated Cardiomyopathy|dilated cardiomyopathy
602362|NCT00629005|rehabilitation|rehabilitation
602363|NCT00629005|upper extremity|upper extremity
602364|NCT00629005|motor skills|motor skills
602365|NCT00628992|COPD: chronic obstructive pulmonary disease and acute respiratory failure|copd: chronic obstructive pulmonary disease and acute respiratory failure
602366|NCT00628966|Heart Attack|heart attack
602367|NCT00628966|ICD|icd
602368|NCT00628966|Risk Stratification|risk stratification
602369|NCT00628966|Arrhythmia|arrhythmia
602370|NCT00628953|Asthma|asthma
602371|NCT00628953|Acid Reflux|acid reflux
602372|NCT00628953|Nexium|nexium
602373|NCT00628953|Esomeprazole|esomeprazole
602374|NCT00628914|Major Depressive Disorder|major depressive disorder
602375|NCT00628914|Insomnia|insomnia
602376|NCT00628914|Escitalopram|escitalopram
602377|NCT00628914|Lexapro|lexapro
602378|NCT00628914|Eszopiclone|eszopiclone
602379|NCT00628914|Lunesta|lunesta
602380|NCT00628914|Cordance|cordance
602381|NCT00628901|Leiomyoma|leiomyoma
602382|NCT00628901|Uterine Fibroids|uterine fibroids
602383|NCT00628901|Uterine Fibroid Embolization (UFE)|uterine fibroid embolization (ufe)
602384|NCT00628901|Uterine Artery Embolization (UAE)|uterine artery embolization (uae)
602385|NCT00628901|Uterine Neoplasms|uterine neoplasms
602386|NCT00628901|Menorrhagia|menorrhagia
602387|NCT00628888|Unipolar Depression|unipolar depression
602388|NCT00628888|Anxiety|anxiety
602389|NCT00628888|Adolescent|adolescent
602390|NCT00628888|Emotion|emotion
602391|NCT00628888|Cognitive Behavioral|cognitive behavioral
602392|NCT00628875|mechanical ventilation|mechanical ventilation
602393|NCT00628875|thoracic impedence|thoracic impedence
602394|NCT00628875|defibrillator pads|defibrillator pads
602395|NCT00628875|ventilation detection|ventilation detection
602396|NCT00628875|pediatric ventilation|pediatric ventilation
602397|NCT00628862|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
602398|NCT00628862|COPD|copd
602399|NCT00628849|Mandible|mandible
602400|NCT00628849|fracture|fracture
602401|NCT00628849|Champy|champy
602402|NCT00628849|AO technique|ao technique
602403|NCT00628836|Neuromuscular stimulator|neuromuscular stimulator
602404|NCT00628836|Shoulder subluxation|shoulder subluxation
602405|NCT00628823|Celiac Disease|celiac disease
602406|NCT00628823|Endomysial antibodies|endomysial antibodies
602407|NCT00628823|Mild enteropathy|mild enteropathy
602408|NCT00628823|Treatment|treatment
602409|NCT00628823|Gluten-free diet|gluten-free diet
602410|NCT00628810|adenocarcinoma of the colon|adenocarcinoma of the colon
602411|NCT00628810|adenocarcinoma of the rectum|adenocarcinoma of the rectum
602412|NCT00628810|stage IV colon cancer|stage iv colon cancer
602413|NCT00628810|stage IV rectal cancer|stage iv rectal cancer
602414|NCT00628810|recurrent colon cancer|recurrent colon cancer
602415|NCT00628810|recurrent rectal cancer|recurrent rectal cancer
602416|NCT00628797|systemic sclerosis|systemic sclerosis
602417|NCT00628797|skin fibrosis|skin fibrosis
602418|NCT00628784|Dysplasia|dysplasia
602420|NCT00628784|Squamous dysplasia|squamous dysplasia
602421|NCT00628784|Early esophageal adenocarcinoma|early esophageal adenocarcinoma
602422|NCT00628784|Cryotherapy|cryotherapy
602423|NCT00628771|HIV Prevention|hiv prevention
602424|NCT00628771|Teen Pregnancy|teen pregnancy
602425|NCT00628771|Translational Research|translational research
602426|NCT00628771|Group Care|group care
602427|NCT00628771|Prenatal Care|prenatal care
602428|NCT00628771|STD Prevention|std prevention
602429|NCT00628771|Gonorrhea|gonorrhea
602430|NCT00628771|Chlamydia|chlamydia
602431|NCT00628771|Adolescent Health|adolescent health
602432|NCT00628771|Community Health Centers|community health centers
602433|NCT00628771|CenteringPregnancy Plus|centeringpregnancy plus
602434|NCT00628771|HIV seronegativity|hiv seronegativity
602435|NCT00628758|Symbicort|symbicort
602436|NCT00628758|Turbuhaler|turbuhaler
602437|NCT00628758|Persistent Asthma|persistent asthma
602438|NCT00628745|TRANSTHYRETIN|transthyretin
602439|NCT00628745|AMYLOIDOSIS|amyloidosis
602440|NCT00628745|TRANSTHYRETIN AMYLOIDOSIS|transthyretin amyloidosis
602441|NCT00628732|Cyclophosphamide|cyclophosphamide
602442|NCT00628732|Topotecan|topotecan
602443|NCT00628732|Phase II|phase ii
602444|NCT00628732|Children|children
602445|NCT00628732|Relapsed solid tumors|relapsed solid tumors
602446|NCT00628719|Visceral leishmaniasis|visceral leishmaniasis
602447|NCT00628719|India|india
602448|NCT00628719|Liposomal Amphotericin B|liposomal amphotericin b
602449|NCT00628719|Amphotericin B deoxycholate|amphotericin b deoxycholate
602450|NCT00628706|tetrahydrocannabinol|tetrahydrocannabinol
602451|NCT00628706|memory|memory
602452|NCT00628706|reward|reward
602453|NCT00628706|magnetic resonance imaging|magnetic resonance imaging
602454|NCT00628706|endocannabinoids|endocannabinoids
602456|NCT00628680|Renal Disease|renal disease
602457|NCT00628680|Kidney Failure|kidney failure
602458|NCT00628680|End Stage Renal Disease|end stage renal disease
602459|NCT00628667|Chronic Posterior Laryngitis|chronic posterior laryngitis
602460|NCT00628667|CPL|cpl
602461|NCT00628667|Pharyngeal acid reflux|pharyngeal acid reflux
602462|NCT00628667|Esomeprazole|esomeprazole
602463|NCT00628667|Nexium|nexium
602464|NCT00628654|ovarian germ cell tumor|ovarian germ cell tumor
602465|NCT00628654|ovarian epithelial cancer|ovarian epithelial cancer
602466|NCT00628628|Tumor Lysis Syndrome|tumor lysis syndrome
602467|NCT00628628|TLS|tls
602468|NCT00628628|hyperuricemia|hyperuricemia
602469|NCT00628628|Leukemia|leukemia
602470|NCT00628628|Lymphoma|lymphoma
602471|NCT00628628|Acute myeloid leukemia|acute myeloid leukemia
602472|NCT00628628|Chronic myelocytic leukemia|chronic myelocytic leukemia
602473|NCT00628628|CML|cml
602474|NCT00628628|lactate dehydrogenase|lactate dehydrogenase
602475|NCT00628628|LDH|ldh
602476|NCT00628628|Myelodysplastic Syndrome|myelodysplastic syndrome
602477|NCT00628628|Rasburicase|rasburicase
602478|NCT00628628|Elitek™|elitek™
602479|NCT00628615|Urodynamics|urodynamics
602480|NCT00628615|Overactive bladder syndrome|overactive bladder syndrome
602481|NCT00628615|Lower urinary tract symptoms LUTS|lower urinary tract symptoms luts
602482|NCT00628602|Neuromuscular stimulator|neuromuscular stimulator
602483|NCT00628602|Pressure ulcer prevention|pressure ulcer prevention
602484|NCT00628589|schizophrenia, agitation, inhaled loxapine, ADASUVE|schizophrenia, agitation, inhaled loxapine, adasuve
602485|NCT00628576|Deep Venous Thrombosis|deep venous thrombosis
602486|NCT00628576|lower extremities|lower extremities
602487|NCT00628576|Chronic Venous Insufficiency|chronic venous insufficiency
602488|NCT00628576|Postthrombotic Syndrome|postthrombotic syndrome
602489|NCT00628576|Heparins|heparins
602490|NCT00628576|Low-molecular- weight heparin|low-molecular- weight heparin
602491|NCT00628576|Tinzaparin|tinzaparin
602492|NCT00628550|cardiac arrest|cardiac arrest
602493|NCT00628550|cardiopulmonary arrest|cardiopulmonary arrest
602494|NCT00628550|vasopressin|vasopressin
602495|NCT00628550|epinephrine|epinephrine
602496|NCT00628550|pediatrics|pediatrics
602497|NCT00628550|in hospital cardiopulmonary resuscitation|in hospital cardiopulmonary resuscitation
602498|NCT00628537|Neuromuscular stimulator|neuromuscular stimulator
602499|NCT00628537|Flexor deformities of wrist and fingers|flexor deformities of wrist and fingers
602500|NCT00628498|VOD|vod
602501|NCT00628485|swallowing function|swallowing function
602502|NCT00628485|neuromuscular stimulator|neuromuscular stimulator
602503|NCT00628472|botulinum toxin a|botulinum toxin a
602504|NCT00628472|botox|botox
602505|NCT00628472|Decreasing botox injection pain|decreasing botox injection pain
602506|NCT00628472|injections|injections
602507|NCT00628459|iron|iron
602508|NCT00628459|multiple micronutrient|multiple micronutrient
602509|NCT00628459|malaria|malaria
602510|NCT00628459|anemia|anemia
602511|NCT00628459|preschool children|preschool children
602512|NCT00628446|spinal cord injury|spinal cord injury
602513|NCT00628446|Coronary artery calcium|coronary artery calcium
602514|NCT00628446|Dyslipidemia|dyslipidemia
602515|NCT00628433|phase I/II|phase i/ii
602516|NCT00628433|ulcerative colitis|ulcerative colitis
602517|NCT00628433|safety|safety
602518|NCT00628433|tolerance|tolerance
602519|NCT00628433|pharmacokinetics|pharmacokinetics
602520|NCT00628420|Schizophrenia|schizophrenia
602521|NCT00628420|N-desmethylclozapine|n-desmethylclozapine
602522|NCT00628420|clozapine|clozapine
602523|NCT00628420|psychosis|psychosis
602524|NCT00628420|randomized|randomized
602525|NCT00628420|placebo studies|placebo studies
602526|NCT00628407|leaning|leaning
602527|NCT00628407|CPR|cpr
602528|NCT00628407|sternal pressure|sternal pressure
602529|NCT00628407|incomplete release|incomplete release
602530|NCT00628407|chest compressions|chest compressions
602531|NCT00628407|pediatric|pediatric
602532|NCT00628394|Cognition|cognition
602533|NCT00628394|schizophrenia|schizophrenia
602534|NCT00628394|Atomoxetine|atomoxetine
602535|NCT00628394|Strattera|strattera
602536|NCT00628394|cognitive remediation|cognitive remediation
602537|NCT00628381|sepsis|sepsis
602538|NCT00628381|microcirculation|microcirculation
602539|NCT00628381|nitric oxide|nitric oxide
602540|NCT00628381|citrulline|citrulline
602541|NCT00628368|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
602542|NCT00628368|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
602543|NCT00628368|adenocarcinoma of the rectum|adenocarcinoma of the rectum
602544|NCT00628368|recurrent rectal cancer|recurrent rectal cancer
602545|NCT00628368|stage I rectal cancer|stage i rectal cancer
602546|NCT00628368|stage II rectal cancer|stage ii rectal cancer
602547|NCT00628368|stage III rectal cancer|stage iii rectal cancer
602548|NCT00628368|stage IV rectal cancer|stage iv rectal cancer
602549|NCT00628368|recurrent esophageal cancer|recurrent esophageal cancer
602550|NCT00628368|stage I esophageal cancer|stage i esophageal cancer
602551|NCT00628368|stage II esophageal cancer|stage ii esophageal cancer
602552|NCT00628368|stage III esophageal cancer|stage iii esophageal cancer
602553|NCT00628368|stage IV esophageal cancer|stage iv esophageal cancer
602554|NCT00628355|lidocaine|lidocaine
602555|NCT00628355|ischemic compression|ischemic compression
602556|NCT00628355|chronic pelvic pain|chronic pelvic pain
602557|NCT00628355|myofascial pain syndrome|myofascial pain syndrome
602558|NCT00628342|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
602559|NCT00628342|GERD|gerd
602560|NCT00628342|Esomeprazole|esomeprazole
602561|NCT00628342|Heartburn|heartburn
602562|NCT00628342|Nexium|nexium
602563|NCT00628329|asthma, retinol, cis-retinoic acid|asthma, retinol, cis-retinoic acid
602564|NCT00628316|tinnitus|tinnitus
602565|NCT00628316|caffeine|caffeine
602566|NCT00628303|Good health|good health
602567|NCT00628277|Obesity|obesity
602568|NCT00628277|coronary heart disease|coronary heart disease
602569|NCT00628277|coronary risk factors|coronary risk factors
602570|NCT00628277|weight loss|weight loss
602571|NCT00628277|exercise|exercise
602572|NCT00628264|cardiac surgery|cardiac surgery
603028|NCT00626366|Nasal Spray|nasal spray
602573|NCT00628264|coronary artery bypass grafting|coronary artery bypass grafting
602574|NCT00628264|valve surgery|valve surgery
602575|NCT00628264|acute kidney injury|acute kidney injury
602576|NCT00628251|Advanced ovarian cancer|advanced ovarian cancer
602577|NCT00628251|BRCA1 protein|brca1 protein
602578|NCT00628251|BRCA2 protein|brca2 protein
602579|NCT00628251|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
602580|NCT00628238|Chronic Lymphocytic Leukemia Research Consortium|chronic lymphocytic leukemia research consortium
602581|NCT00628238|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
602582|NCT00628238|CLL|cll
602583|NCT00628238|CLL Research Consortium|cll research consortium
602584|NCT00628238|CRC|crc
602585|NCT00628238|Revlimid|revlimid
602586|NCT00628238|lenalidomide|lenalidomide
602587|NCT00628238|Rituximab|rituximab
602588|NCT00628238|Rituxan|rituxan
602589|NCT00628238|First-line|first-line
602590|NCT00628238|therapy|therapy
602591|NCT00628238|untreated|untreated
602592|NCT00628238|Frontline|frontline
602593|NCT00628225|Smoking cessation|smoking cessation
602594|NCT00628212|insulin resistance|insulin resistance
602595|NCT00628186|pancreaticoduodenectomy|pancreaticoduodenectomy
602596|NCT00628186|stent|stent
602597|NCT00628186|pancreaticojejunostomy|pancreaticojejunostomy
602598|NCT00628186|hospital stay|hospital stay
602599|NCT00628186|complication|complication
602600|NCT00628186|pancreatic fistula|pancreatic fistula
602601|NCT00628160|Septic shock|septic shock
602602|NCT00628160|Cirrhosis|cirrhosis
602603|NCT00628160|Survival|survival
602604|NCT00628147|colonic neoplasms|colonic neoplasms
602605|NCT00628147|colonoscopy|colonoscopy
602606|NCT00628147|narrow band imaging|narrow band imaging
602607|NCT00628147|diagnostic techniques|diagnostic techniques
602608|NCT00628134|cystic fibrosis|cystic fibrosis
602609|NCT00628134|surfactant|surfactant
602610|NCT00628134|aerosol|aerosol
602611|NCT00628134|inhaled drug|inhaled drug
602612|NCT00628134|inhaled antibiotic|inhaled antibiotic
602613|NCT00628121|infertility, menstrual cycle, LH surge|infertility, menstrual cycle, lh surge
602614|NCT00628108|Xyzal|xyzal
602615|NCT00628108|Levocetirizine|levocetirizine
602616|NCT00628108|Allergy|allergy
602617|NCT00628108|Children|children
602618|NCT00628108|Seasonal Allergies|seasonal allergies
602619|NCT00628095|rheumatoid arthritis DMARD methotrexate|rheumatoid arthritis dmard methotrexate
602620|NCT00628082|Cardiac Energetics|cardiac energetics
602621|NCT00628082|Dynamic Diastolic filling Assessment|dynamic diastolic filling assessment
602622|NCT00628082|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
602623|NCT00628082|Arterial and Ventricular Stiffening|arterial and ventricular stiffening
602624|NCT00628069|Orthopedics|orthopedics
602625|NCT00628069|bone fixation|bone fixation
602626|NCT00628056|Perhexiline|perhexiline
602627|NCT00628056|diabetes|diabetes
602628|NCT00628056|diabetic cardiomyopathy|diabetic cardiomyopathy
602629|NCT00628056|high energy phosphate kinetics|high energy phosphate kinetics
602630|NCT00628056|magnetic resonance spectroscopy|magnetic resonance spectroscopy
602631|NCT00628043|Cancer|cancer
602632|NCT00628043|patients|patients
602633|NCT00628043|with|with
602634|NCT00628043|chemotherapy|chemotherapy
602635|NCT00628043|induced|induced
602636|NCT00628043|anemia|anemia
602637|NCT00628030|Behavioral intervention|behavioral intervention
602638|NCT00628030|Obesity prevention|obesity prevention
602639|NCT00628017|polyunsaturated fatty acids|polyunsaturated fatty acids
602640|NCT00628017|Alzheimer's disease|alzheimer's disease
602641|NCT00628017|mild cognitive impairment|mild cognitive impairment
602642|NCT00628017|fish oil|fish oil
602643|NCT00628017|cognition|cognition
602644|NCT00627978|breast|breast
602645|NCT00627965|Sildenafil citrate|sildenafil citrate
602646|NCT00627965|Prevention|prevention
602647|NCT00627965|High Altitude Pulmonary Edema|high altitude pulmonary edema
602648|NCT00627965|Acute Mountain Sickness|acute mountain sickness
602649|NCT00627965|Healthy Lowland Subjects|healthy lowland subjects
602650|NCT00627965|Pulmonary Artery Systolic Pressure|pulmonary artery systolic pressure
602651|NCT00627952|hypertension|hypertension
602652|NCT00627952|intraglomerular pressure|intraglomerular pressure
602653|NCT00627926|Genotype 1|genotype 1
602654|NCT00627913|Floppy Iris Syndrome|floppy iris syndrome
602655|NCT00627900|drug-eluting stents|drug-eluting stents
602656|NCT00627887|Depressive Disorder, Major|depressive disorder, major
602657|NCT00627887|Electroconvulsive Therapy|electroconvulsive therapy
602658|NCT00627887|Lithium Carbonate|lithium carbonate
602659|NCT00627887|venlafaxine|venlafaxine
602660|NCT00627848|Alzheimer's disease|alzheimer's disease
602661|NCT00627848|fmri|fmri
602662|NCT00627848|face recognition|face recognition
602663|NCT00627848|rivastigmine|rivastigmine
602664|NCT00627835|squamous cell carcinoma|squamous cell carcinoma
602665|NCT00627835|head and neck|head and neck
602666|NCT00627835|Neoadjuvant Sorafenib and Concurrent Sorafenib, Cisplatin and Radiation|neoadjuvant sorafenib and concurrent sorafenib, cisplatin and radiation
602667|NCT00627822|Medical students|medical students
602668|NCT00627822|Medical education|medical education
602669|NCT00627822|Private hospital|private hospital
603029|NCT00626366|Nasal Drop|nasal drop
602670|NCT00627822|Patient satisfaction|patient satisfaction
602671|NCT00627822|Questionnaires|questionnaires
602672|NCT00627809|coronary microcirculation|coronary microcirculation
602673|NCT00627809|acut myocardial infarction|acut myocardial infarction
602674|NCT00627809|infarct size|infarct size
602675|NCT00627809|streptokinase|streptokinase
602676|NCT00627809|reperfusion|reperfusion
602677|NCT00627796|GH|gh
602678|NCT00627796|IGF-I|igf-i
602679|NCT00627796|tumor|tumor
602680|NCT00627796|lanreotide|lanreotide
602681|NCT00627770|Physical Therapy - Therapeutics - Edema|physical therapy - therapeutics - edema
602682|NCT00627770|Arthroplasty replacement knee|arthroplasty replacement knee
602683|NCT00627770|Treatment outcome|treatment outcome
602684|NCT00627757|metabolic syndrome|metabolic syndrome
602685|NCT00627757|weight gain|weight gain
602686|NCT00627757|antipsychotic drugs|antipsychotic drugs
602687|NCT00627757|Metabolic syndrome and treatment with antipsychotic drugs|metabolic syndrome and treatment with antipsychotic drugs
602688|NCT00627744|Type 2 diabetes, IGT, Myocardial infarction, Incretins|type 2 diabetes, igt, myocardial infarction, incretins
602689|NCT00627731|Asthma Patients|asthma patients
602690|NCT00627718|Age-related macular degeneration|age-related macular degeneration
602691|NCT00627718|HRT|hrt
602692|NCT00627718|Macular edema|macular edema
602693|NCT00627718|Screening for disease|screening for disease
602694|NCT00627692|Constipation in elderly patients|constipation in elderly patients
602695|NCT00627679|Pediatric asthma|pediatric asthma
602696|NCT00627666|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
602697|NCT00627666|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
602698|NCT00627666|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
602699|NCT00627666|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
602700|NCT00627666|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
602701|NCT00627666|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
602702|NCT00627666|acute lymphocytic leukemia|acute lymphocytic leukemia
602703|NCT00627666|secondary acute myeloid leukemia|secondary acute myeloid leukemia
602704|NCT00627666|acute undifferentiated leukemia|acute undifferentiated leukemia
602705|NCT00627666|mast cell leukemia|mast cell leukemia
602706|NCT00627666|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
602707|NCT00627666|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
602708|NCT00627666|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
602709|NCT00627666|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
602710|NCT00627666|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
602711|NCT00627666|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
602712|NCT00627666|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
602713|NCT00627666|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
602714|NCT00627666|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
602715|NCT00627666|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
602716|NCT00627666|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
602717|NCT00627666|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
602718|NCT00627666|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
602719|NCT00627666|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
602720|NCT00627666|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
602721|NCT00627666|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
602722|NCT00627666|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
602723|NCT00627666|refractory anemia with excess blasts|refractory anemia with excess blasts
602724|NCT00627653|PPAR|ppar
602725|NCT00627653|PET study|pet study
602726|NCT00627653|heart metabolism|heart metabolism
602727|NCT00627614|stage I breast cancer|stage i breast cancer
602728|NCT00627614|stage II breast cancer|stage ii breast cancer
602729|NCT00627614|stage IIIA breast cancer|stage iiia breast cancer
602730|NCT00627614|stage IIIB breast cancer|stage iiib breast cancer
602731|NCT00627614|stage IIIC breast cancer|stage iiic breast cancer
602732|NCT00627614|stage IV breast cancer|stage iv breast cancer
602733|NCT00627588|ProSavin|prosavin
602734|NCT00627588|Parkinson's Disease|parkinson's disease
602735|NCT00627588|Gene Therapy|gene therapy
602736|NCT00627575|drug interaction|drug interaction
602737|NCT00627575|pharmacokinetics|pharmacokinetics
602738|NCT00627575|healthy volunteers|healthy volunteers
602739|NCT00627562|robotic|robotic
602740|NCT00627562|robot assisted|robot assisted
602741|NCT00627562|minimally invasive|minimally invasive
602742|NCT00627562|tumors of head and neck|tumors of head and neck
602743|NCT00627549|cystocele, anterior repair, mesh|cystocele, anterior repair, mesh
602744|NCT00627536|scarring, Juvista, avotermin, transforming growth factor beta 3, TGFB3|scarring, juvista, avotermin, transforming growth factor beta 3, tgfb3
602745|NCT00627510|Therapeutic Drug Monitoring (TDM)|therapeutic drug monitoring (tdm)
602746|NCT00627510|Antidepressant|antidepressant
602747|NCT00627510|Antipsychotic|antipsychotic
602748|NCT00627510|Treatment adherence|treatment adherence
602749|NCT00627510|Compliance|compliance
602750|NCT00627510|Metabolism|metabolism
602751|NCT00627510|Do patients take their psychiatric medication as prescribed?|do patients take their psychiatric medication as prescribed?
602752|NCT00627510|Do psychiatric patients metabolize their medication faster than expected?|do psychiatric patients metabolize their medication faster than expected?
602753|NCT00627510|What are the exact odds that the patient of a physician prescribing antidepressants or antipsychotics has plasma levels that are BELOW those intended?|what are the exact odds that the patient of a physician prescribing antidepressants or antipsychotics has plasma levels that are below those intended?
602754|NCT00627484|Insulin resistance|insulin resistance
602755|NCT00627484|Insulin sensitivity|insulin sensitivity
602756|NCT00627484|bariatric surgery|bariatric surgery
602757|NCT00627484|diabetes|diabetes
602758|NCT00627484|calorie restriction|calorie restriction
602759|NCT00627484|body composition|body composition
602760|NCT00627458|Hexavalent vaccine|hexavalent vaccine
602761|NCT00627458|Booster|booster
602762|NCT00627432|stage III bladder cancer|stage iii bladder cancer
602763|NCT00627432|stage IV bladder cancer|stage iv bladder cancer
602764|NCT00627432|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
602765|NCT00627406|GnRH antagonist|gnrh antagonist
602766|NCT00627406|GnRH agonist|gnrh agonist
602767|NCT00627406|hCG|hcg
602768|NCT00627406|OHSS|ohss
602769|NCT00627406|In vitro fertilization|in vitro fertilization
602770|NCT00627406|ovulation induction|ovulation induction
602771|NCT00627406|Clinical pregnancy rate|clinical pregnancy rate
602772|NCT00627393|Granulocyte Transfusions|granulocyte transfusions
602773|NCT00627380|HIV|hiv
602774|NCT00627380|AIDS|aids
602775|NCT00627380|insulin resistance|insulin resistance
602776|NCT00627380|diabetes|diabetes
602777|NCT00627380|dyslipidemia|dyslipidemia
602778|NCT00627380|visceral adiposity|visceral adiposity
602779|NCT00627380|subcutaneous adipose wasting|subcutaneous adipose wasting
602780|NCT00627380|cardiovascular disease|cardiovascular disease
602781|NCT00627380|hypertension|hypertension
602782|NCT00627380|endothelial function|endothelial function
602783|NCT00627380|quality of life|quality of life
602784|NCT00627380|Complementary Therapies|complementary therapies
602785|NCT00627367|Acute Pain, Emergency Department, ED, Hydromorphone, Dilaudid Protocolized Nonprotocolized Usual Care|acute pain, emergency department, ed, hydromorphone, dilaudid protocolized nonprotocolized usual care
602786|NCT00627354|stage IV prostate cancer|stage iv prostate cancer
602787|NCT00627354|recurrent prostate cancer|recurrent prostate cancer
602788|NCT00627354|adenocarcinoma of the prostate|adenocarcinoma of the prostate
602789|NCT00627341|Exposure Therapy|exposure therapy
602790|NCT00627341|Relapse Prevention|relapse prevention
602791|NCT00627341|Anorexia Nervosa|anorexia nervosa
602792|NCT00627328|Physiologic Pacing|physiologic pacing
602793|NCT00627328|Dual Chamber Pacing|dual chamber pacing
602794|NCT00627328|Atrioventricular Block|atrioventricular block
602795|NCT00627328|Bradycardia|bradycardia
602796|NCT00627328|Sick Sinus Syndrome|sick sinus syndrome
602797|NCT00627315|Obesity|obesity
602798|NCT00627315|Insulin Resistance|insulin resistance
602799|NCT00627315|Bariatric Surgery|bariatric surgery
602800|NCT00627315|Gastric Banding|gastric banding
602801|NCT00627315|Gastric Bypass|gastric bypass
602802|NCT00627302|Quality of Vision|quality of vision
602803|NCT00627289|Chronic pain|chronic pain
602804|NCT00627289|groin hernia|groin hernia
602805|NCT00627289|neuropathic pain|neuropathic pain
602806|NCT00627289|chronic postoperative pain|chronic postoperative pain
602807|NCT00627289|Postherniotomy pain|postherniotomy pain
602808|NCT00627289|Neuroplastic changes|neuroplastic changes
602809|NCT00627276|ductal breast carcinoma in situ|ductal breast carcinoma in situ
602810|NCT00627276|atypical ductal breast hyperplasia|atypical ductal breast hyperplasia
602811|NCT00627263|ICD|icd
602812|NCT00627263|Cardiac Arrhythmia|cardiac arrhythmia
602813|NCT00627263|Arrhythmia|arrhythmia
602814|NCT00627263|Stress|stress
602815|NCT00627263|Anger|anger
602816|NCT00627250|Irritability|irritability
602817|NCT00627250|Aggression|aggression
602818|NCT00627250|Brain Injury|brain injury
602819|NCT00627250|Amantadine|amantadine
602820|NCT00627250|Irritability and Aggression Due to Traumatic Brain Injury|irritability and aggression due to traumatic brain injury
602821|NCT00627237|Brain Injuries|brain injuries
602822|NCT00627237|Cognitive Rehabilitation|cognitive rehabilitation
602823|NCT00627237|Executive Functioning|executive functioning
602824|NCT00627211|quality assessment|quality assessment
602825|NCT00627211|pain reduction|pain reduction
602826|NCT00627211|gastroscopy|gastroscopy
602827|NCT00627211|carbondioxide insufflation|carbondioxide insufflation
602828|NCT00627211|Patient satisfaction|patient satisfaction
602829|NCT00627185|Tobacco control|tobacco control
602830|NCT00627185|Tobacco cessation|tobacco cessation
602831|NCT00627185|Tobacco use|tobacco use
602832|NCT00627172|Coronary artery disease|coronary artery disease
602833|NCT00627172|MDCT|mdct
602834|NCT00627172|Positron emission tomography|positron emission tomography
602835|NCT00627172|Ultrasound|ultrasound
602836|NCT00627159|community-based|community-based
602837|NCT00627159|culturally-sensitive|culturally-sensitive
602838|NCT00627159|high risk assessment|high risk assessment
602839|NCT00627159|education classes|education classes
602840|NCT00627159|cardiovascular risk profile|cardiovascular risk profile
602841|NCT00627159|Indo-Asian population|indo-asian population
602842|NCT00627146|Diabetes Mellitus, type 1|diabetes mellitus, type 1
602843|NCT00627146|ChAgly CD3|chagly cd3
602844|NCT00627133|Alcohol seizure|alcohol seizure
602845|NCT00627120|healthy volunteers|healthy volunteers
602846|NCT00627107|ReWalk, Paraplegia, SCI|rewalk, paraplegia, sci
602847|NCT00627068|cardiovascular|cardiovascular
602848|NCT00627068|vasodilation|vasodilation
602849|NCT00627068|endothelium|endothelium
602850|NCT00627068|Subjects with high cardiovascular risk|subjects with high cardiovascular risk
602851|NCT00627055|Second line antiretroviral therapy|second line antiretroviral therapy
602852|NCT00627055|HIV genotypic resistance|hiv genotypic resistance
602853|NCT00627055|Kaletra monotherapy|kaletra monotherapy
602854|NCT00627055|Thailand|thailand
602855|NCT00627055|48-week efficacy and safety between 2 NRTIs plus lopinavir/ritonavir (LPV/r) and LPV/r monotherapy in patients failing a standard NNRTI-based treatment regimen|48-week efficacy and safety between 2 nrtis plus lopinavir/ritonavir (lpv/r) and lpv/r monotherapy in patients failing a standard nnrti-based treatment regimen
602856|NCT00627055|treatment experienced|treatment experienced
602857|NCT00627042|Liver disease|liver disease
602858|NCT00627042|Neoplasms|neoplasms
602859|NCT00627042|Liver neoplasms|liver neoplasms
602860|NCT00627042|Carcinoma, Hepatocellular|carcinoma, hepatocellular
602861|NCT00627029|Care coordination|care coordination
602862|NCT00627029|Disease management|disease management
602863|NCT00627029|Medicare|medicare
602864|NCT00627029|Fee-for-service|fee-for-service
602865|NCT00627029|Random assignment|random assignment
602866|NCT00627029|Elderly|elderly
602867|NCT00627016|Non-Erosive Gastroesophageal Reflux Disease|non-erosive gastroesophageal reflux disease
602868|NCT00627016|GERD|gerd
602869|NCT00627016|heartburn|heartburn
602870|NCT00627016|sleep disturbance|sleep disturbance
602871|NCT00627016|nocturnal Reflux|nocturnal reflux
602872|NCT00626990|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
602873|NCT00626990|adult anaplastic astrocytoma|adult anaplastic astrocytoma
602874|NCT00626977|Analgesia|analgesia
602875|NCT00626977|Obstetrical|obstetrical
602876|NCT00626977|Anesthesia|anesthesia
602877|NCT00626977|Epidural|epidural
602878|NCT00626977|Newborn|newborn
602879|NCT00626977|Anesthetics, local|anesthetics, local
602880|NCT00626977|Clonidine|clonidine
602881|NCT00626977|Pregnant women|pregnant women
602882|NCT00626977|Infant, newborn|infant, newborn
602883|NCT00626964|Arterial stiffness|arterial stiffness
602884|NCT00626964|PulseWave velocity|pulsewave velocity
602885|NCT00626964|Body composition|body composition
602886|NCT00626964|Bioimpedance|bioimpedance
602887|NCT00626964|Morbid Obesity|morbid obesity
602888|NCT00626964|APO A|apo a
602889|NCT00626964|APO B|apo b
602890|NCT00626964|Framingham risk score|framingham risk score
602891|NCT00626964|Prevention of Coronary Heart Disease|prevention of coronary heart disease
602892|NCT00626964|Lifestyle Intervention|lifestyle intervention
602893|NCT00626964|Bariatric Surgery|bariatric surgery
602894|NCT00626964|Low Energy Diet|low energy diet
602895|NCT00626951|LMA Supreme|lma supreme
602896|NCT00626951|LMA ProSeal|lma proseal
602897|NCT00626951|Laryngeal mask airway|laryngeal mask airway
602898|NCT00626951|Ventilation|ventilation
602899|NCT00626938|sarcoidosis|sarcoidosis
602900|NCT00626938|protein profile|protein profile
602901|NCT00626938|CYP-450|cyp-450
602902|NCT00626938|TNF-alpha polymorphisms|tnf-alpha polymorphisms
602903|NCT00626938|HLA|hla
602904|NCT00626925|Randomized Trial|randomized trial
602905|NCT00626925|Medication for Heavy Drinking|medication for heavy drinking
602906|NCT00626925|Topiramate Treatment|topiramate treatment
602907|NCT00626912|large aneurysm|large aneurysm
602908|NCT00626912|recurrence|recurrence
602909|NCT00626912|hydrocoil|hydrocoil
602910|NCT00626899|Validation of Cardiac Output measurement in hypothermic patients|validation of cardiac output measurement in hypothermic patients
602911|NCT00626886|Herniorrhaphy|herniorrhaphy
602912|NCT00626886|Inguinal Hernia Repair|inguinal hernia repair
602913|NCT00626886|Postoperative pain|postoperative pain
602914|NCT00626873|ovarian germ cell tumor|ovarian germ cell tumor
602915|NCT00626873|ovarian epithelial cancer|ovarian epithelial cancer
602916|NCT00626860|melanoma|melanoma
602917|NCT00626847|primary open angle glaucoma|primary open angle glaucoma
602918|NCT00626847|Nuclear Genetics|nuclear genetics
602919|NCT00626847|Mitochondrial DNA|mitochondrial dna
602920|NCT00626847|POAG|poag
602921|NCT00626834|cocaine addiction|cocaine addiction
602922|NCT00626834|vigabatrin|vigabatrin
602923|NCT00626834|ovation pharmaceuticals|ovation pharmaceuticals
602924|NCT00626834|cocaine|cocaine
602925|NCT00626834|cocaine related disorders|cocaine related disorders
602926|NCT00626834|behavior addictive|behavior addictive
602927|NCT00626834|mental disorders|mental disorders
602928|NCT00626834|therapeutic uses|therapeutic uses
602929|NCT00626834|physiologic effects of drugs|physiologic effects of drugs
602930|NCT00626834|disorder of environmental origin|disorder of environmental origin
603030|NCT00626366|Intranasal Medication|intranasal medication
602931|NCT00626834|central nervous system stimulants|central nervous system stimulants
602932|NCT00626834|central nervous system agents|central nervous system agents
602933|NCT00626834|pharmacological actions|pharmacological actions
602934|NCT00626834|substance related disorders|substance related disorders
602935|NCT00626821|Stoma|stoma
602936|NCT00626821|Ostomy|ostomy
602937|NCT00626782|glaucoma|glaucoma
602938|NCT00626782|glucoma filtering surgery|glucoma filtering surgery
602939|NCT00626782|ranibizumab|ranibizumab
602940|NCT00626782|mitomycin C|mitomycin c
602941|NCT00626782|patients requiring first time glaucoma filtering surgery|patients requiring first time glaucoma filtering surgery
602942|NCT00626769|Genistein|genistein
602943|NCT00626769|Bone mineral density|bone mineral density
602944|NCT00626769|digital mammography|digital mammography
602945|NCT00626769|safety|safety
602946|NCT00626756|fluid|fluid
602947|NCT00626756|Lidco technology|lidco technology
602948|NCT00626756|guided therapy|guided therapy
602949|NCT00626756|fluid management guided by Lidco technology|fluid management guided by lidco technology
602950|NCT00626730|adult grade II meningioma|adult grade ii meningioma
602951|NCT00626730|adult grade III meningioma|adult grade iii meningioma
602952|NCT00626717|Keratoconus|keratoconus
602953|NCT00626717|Cross linking|cross linking
602954|NCT00626717|Riboflavin|riboflavin
602955|NCT00626704|Sarcoma|sarcoma
602956|NCT00626704|Soft Tissue Sarcoma|soft tissue sarcoma
602957|NCT00626704|Locally Advanced or Metastatic, Unresectable Soft Tissue Sarcoma|locally advanced or metastatic, unresectable soft tissue sarcoma
602958|NCT00626704|AMG 655|amg 655
602959|NCT00626704|STS|sts
602960|NCT00626704|Doxorubicin|doxorubicin
602961|NCT00626704|Death receptor|death receptor
602962|NCT00626704|TRAIL receptor|trail receptor
602963|NCT00626704|Apoptosis|apoptosis
602964|NCT00626691|antioxidant|antioxidant
602965|NCT00626691|walnut|walnut
602966|NCT00626691|nutritional status|nutritional status
602967|NCT00626691|Antioxidant capacity|antioxidant capacity
602968|NCT00626678|Pemphigus Vulgaris|pemphigus vulgaris
602969|NCT00626678|Azathioprine|azathioprine
602970|NCT00626678|Prednisone|prednisone
602971|NCT00626665|Raynaud disease|raynaud disease
602972|NCT00626665|Scleroderma|scleroderma
602973|NCT00626639|palifermin|palifermin
602974|NCT00626639|Clinical Trial|clinical trial
602975|NCT00626639|Oncology|oncology
602976|NCT00626639|Head & Neck|head & neck
602977|NCT00626626|leukemia|leukemia
602978|NCT00626626|myelodysplastic syndrome|myelodysplastic syndrome
602979|NCT00626626|chronic myelogenous leukemia|chronic myelogenous leukemia
602980|NCT00626626|lymphoma|lymphoma
602981|NCT00626626|mantle cell lymphoma|mantle cell lymphoma
602982|NCT00626600|Oxycodone Hydrochloride 50mg/mL|oxycodone hydrochloride 50mg/ml
602983|NCT00626600|Observational|observational
602984|NCT00626600|Infusion|infusion
602985|NCT00626600|Severe cancer pain|severe cancer pain
602986|NCT00626587|Endobronchial ultrasonography|endobronchial ultrasonography
602987|NCT00626587|Peripheral pulmonary lesions|peripheral pulmonary lesions
602988|NCT00626587|Transbronchial needle aspiration|transbronchial needle aspiration
602989|NCT00626587|Probe location|probe location
602990|NCT00626587|Diagnostic yield|diagnostic yield
602991|NCT00626587|EBUS guided TBNA for peripheral pulmonary lesions|ebus guided tbna for peripheral pulmonary lesions
602992|NCT00626574|Epoetin alfa|epoetin alfa
602993|NCT00626574|aneurysm|aneurysm
602994|NCT00626574|subarachnoid hemorrhage|subarachnoid hemorrhage
602995|NCT00626561|Cervical Cancer|cervical cancer
602996|NCT00626561|Uterine Cancer|uterine cancer
602997|NCT00626561|Bevacizumab|bevacizumab
602998|NCT00626561|Avastin|avastin
602999|NCT00626561|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
603000|NCT00626561|rhuMAb-VEGF|rhumab-vegf
603001|NCT00626561|Paclitaxel|paclitaxel
603002|NCT00626561|Taxol|taxol
603003|NCT00626548|Hormone Resistant Prostate Cancer|hormone resistant prostate cancer
603004|NCT00626548|Endothelin A Receptor Antagonist|endothelin a receptor antagonist
603005|NCT00626548|Endothelin A|endothelin a
603006|NCT00626548|Endothelin A antagonist|endothelin a antagonist
603007|NCT00626535|Symptomatic Gastroesophageal Reflux Disease (sGERD)|symptomatic gastroesophageal reflux disease (sgerd)
603008|NCT00626535|Nexium|nexium
603009|NCT00626535|Esomeprazole|esomeprazole
603010|NCT00626522|Bronchitis|bronchitis
603011|NCT00626522|Chronic|chronic
603012|NCT00626522|Emphysema|emphysema
603013|NCT00626522|Smokers or ex-Smokers|smokers or ex-smokers
603014|NCT00626509|stage IV renal cell cancer|stage iv renal cell cancer
603015|NCT00626483|adult giant cell glioblastoma|adult giant cell glioblastoma
603016|NCT00626483|adult gliosarcoma|adult gliosarcoma
603017|NCT00626470|Trochanter|trochanter
603018|NCT00626470|Femur|femur
603019|NCT00626470|Fracture|fracture
603020|NCT00626431|Lupron Depot|lupron depot
603021|NCT00626431|prostate cancer|prostate cancer
603022|NCT00626431|leuprolide acetate|leuprolide acetate
603023|NCT00626405|stage IV melanoma|stage iv melanoma
603024|NCT00626379|Coronary Heart Disease|coronary heart disease
603025|NCT00626379|Subclinical Atherosclerosis|subclinical atherosclerosis
603026|NCT00626379|CVD-Related Markers of Inflammation|cvd-related markers of inflammation
603027|NCT00626379|Mortality|mortality
603031|NCT00626353|Stroke|stroke
603032|NCT00626353|rehabilitation|rehabilitation
603033|NCT00626353|motor recovery|motor recovery
603034|NCT00626353|cognition|cognition
603035|NCT00626353|quality of life|quality of life
603036|NCT00626340|menopause|menopause
603037|NCT00626340|women|women
603038|NCT00626340|major depressive disorder|major depressive disorder
603039|NCT00626340|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
603040|NCT00626327|vaccine|vaccine
603041|NCT00626327|toddlers|toddlers
603042|NCT00626327|healthy|healthy
603043|NCT00626327|meningitis|meningitis
603044|NCT00626327|meningococcal|meningococcal
603045|NCT00626327|measles|measles
603046|NCT00626327|mumps|mumps
603047|NCT00626327|rubella|rubella
603048|NCT00626327|varicella|varicella
603049|NCT00626327|Prevention of Meningococcal disease types ACWY|prevention of meningococcal disease types acwy
603050|NCT00626301|efficacy|efficacy
603051|NCT00626301|safety|safety
603052|NCT00626301|pharmacokinetics|pharmacokinetics
603053|NCT00626301|LPV/r monotherapy|lpv/r monotherapy
603054|NCT00626301|Thai children|thai children
603055|NCT00626301|efficacy safety LPV/r monotherapy maintenance|efficacy safety lpv/r monotherapy maintenance
603056|NCT00626301|treatment experienced|treatment experienced
603057|NCT00626288|Mesalazine in Irritable Bowel Syndrome|mesalazine in irritable bowel syndrome
603058|NCT00626275|Rheumatoid arthritis|rheumatoid arthritis
603059|NCT00626275|arthritis|arthritis
603060|NCT00626262|Gastroesophageal reflux disease|gastroesophageal reflux disease
603061|NCT00626262|Nexium|nexium
603062|NCT00626262|Esomeprazole|esomeprazole
603063|NCT00626262|Administration methods.|administration methods.
603064|NCT00626249|Nephropathy|nephropathy
603065|NCT00626249|Kidney Disease|kidney disease
603066|NCT00626249|Diabetic|diabetic
603067|NCT00626249|Renal|renal
603068|NCT00626249|Diabetics|diabetics
603069|NCT00626236|ADHD and conduct problems|adhd and conduct problems
603070|NCT00626223|ESRD patients|esrd patients
603071|NCT00626223|C-reactive protein|c-reactive protein
603072|NCT00626223|homocysteine|homocysteine
603073|NCT00626223|5-MTHF|5-mthf
603074|NCT00626223|survival|survival
603075|NCT00626223|Hemodialysis patients|hemodialysis patients
603076|NCT00626210|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
603077|NCT00626210|Sleep|sleep
603078|NCT00626210|Fatigue|fatigue
603079|NCT00626210|Memory|memory
603080|NCT00626197|SLE|sle
603081|NCT00626197|Lupus|lupus
603082|NCT00626197|BELONG|belong
603083|NCT00626184|Celiac Disease|celiac disease
603084|NCT00626171|smoking|smoking
603085|NCT00626171|asthma|asthma
603086|NCT00626171|sputum|sputum
603087|NCT00626158|pancreatic cancer|pancreatic cancer
603088|NCT00626158|biliary cancer|biliary cancer
603089|NCT00626158|gemcitabine|gemcitabine
603090|NCT00626158|capecitabine|capecitabine
603091|NCT00626145|BMMNC|bmmnc
603092|NCT00626145|STEMI|stemi
603093|NCT00626145|stem cell|stem cell
603094|NCT00626145|intracoronary delivery|intracoronary delivery
603095|NCT00626132|Blood pressure|blood pressure
603096|NCT00626132|Herbs|herbs
603097|NCT00626132|Food|food
603098|NCT00626119|breast cancer|breast cancer
603099|NCT00626106|postmenopausal|postmenopausal
603100|NCT00626106|hormone receptor positive|hormone receptor positive
603101|NCT00626106|locally advanced|locally advanced
603102|NCT00626106|metastatic|metastatic
603103|NCT00626080|Insulin|insulin
603104|NCT00626080|Detemir|detemir
603105|NCT00626080|Brain|brain
603106|NCT00626080|Glucose metabolism|glucose metabolism
603107|NCT00626067|Travatan Dosing Aid|travatan dosing aid
603108|NCT00626067|compliance monitoring dispenser|compliance monitoring dispenser
603109|NCT00626054|Colonoscopy|colonoscopy
603110|NCT00626054|PEG Solution|peg solution
603111|NCT00626041|Community pharmacies|community pharmacies
603112|NCT00626041|Primary care networks|primary care networks
603113|NCT00626041|Global risk assessment|global risk assessment
603114|NCT00626041|Blood pressure screening|blood pressure screening
603115|NCT00626028|Pulmonary Vasculature|pulmonary vasculature
603116|NCT00626028|Nitric Oxide|nitric oxide
603117|NCT00626028|INOmax®|inomax®
603118|NCT00626028|Acute Lung Injury|acute lung injury
603119|NCT00626028|Pulmonary Vasodilator Testing|pulmonary vasodilator testing
603120|NCT00626028|Idiopathic Pulmonary Arterial Hypertension|idiopathic pulmonary arterial hypertension
603121|NCT00626028|Congenital Heart Disease|congenital heart disease
603122|NCT00626028|reversible pulmonary hypertension|reversible pulmonary hypertension
603123|NCT00626028|vasoreactivity|vasoreactivity
603124|NCT00626015|adult glioblastoma|adult glioblastoma
603125|NCT00626015|adult giant cell glioblastoma|adult giant cell glioblastoma
603126|NCT00626015|adult gliosarcoma|adult gliosarcoma
603127|NCT00626015|adult high grade glioma|adult high grade glioma
603128|NCT00626002|Open label|open label
603129|NCT00625989|asthma|asthma
603130|NCT00625989|atopy|atopy
603131|NCT00625989|allergen challenge|allergen challenge
603132|NCT00625989|sputum myeloid and plasmacytoid dendritic cells|sputum myeloid and plasmacytoid dendritic cells
603133|NCT00625976|Complex regional pain syndrome type I|complex regional pain syndrome type i
603134|NCT00625976|Graded exposure in vivo|graded exposure in vivo
603135|NCT00625976|Physiotherapy|physiotherapy
603136|NCT00625976|Pain-related fear|pain-related fear
603137|NCT00625963|Pulmonary Hypertension;|pulmonary hypertension;
603138|NCT00625963|ILD;|ild;
603139|NCT00625963|CT Imaging;|ct imaging;
603140|NCT00625963|Echocardiogram;|echocardiogram;
603141|NCT00625963|Hemodynamic measurements of RHC.|hemodynamic measurements of rhc.
603142|NCT00625963|Pulmonary Function Tests|pulmonary function tests
603143|NCT00625950|Hyperprolactinemia|hyperprolactinemia
603144|NCT00625950|Endometriosis|endometriosis
603145|NCT00625950|laparoscopy|laparoscopy
603146|NCT00625950|angiogenesis, VEGF|angiogenesis, vegf
603260|NCT00625625|stage I rectal cancer|stage i rectal cancer
603147|NCT00625937|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
603148|NCT00625937|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
603149|NCT00625937|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
603150|NCT00625937|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
603151|NCT00625937|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
603152|NCT00625937|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
603153|NCT00625937|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
603154|NCT00625937|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
603155|NCT00625937|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
603156|NCT00625937|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
603157|NCT00625937|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
603158|NCT00625937|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
603159|NCT00625937|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
603160|NCT00625937|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
603161|NCT00625937|tongue cancer|tongue cancer
603162|NCT00625924|Plastic surgery|plastic surgery
603163|NCT00625924|reconstruction|reconstruction
603164|NCT00625911|thoracotomy|thoracotomy
603165|NCT00625911|minimally invasive direct coronary artery bypass|minimally invasive direct coronary artery bypass
603166|NCT00625911|ketamine|ketamine
603167|NCT00625911|pain|pain
603168|NCT00625898|HER2 positive breast cancer|her2 positive breast cancer
603169|NCT00625898|invasive breast cancer|invasive breast cancer
603170|NCT00625898|bevacizumab|bevacizumab
603171|NCT00625898|NSABP|nsabp
603172|NCT00625898|Roche|roche
603173|NCT00625898|CIRG|cirg
603174|NCT00625898|trastuzumab|trastuzumab
603175|NCT00625898|cyclophosphamide|cyclophosphamide
603176|NCT00625898|docetaxel|docetaxel
603177|NCT00625898|carboplatin|carboplatin
603178|NCT00625898|5-fluorouracil|5-fluorouracil
603179|NCT00625898|epirubicin|epirubicin
603180|NCT00625885|Anterior Cruciate Ligament/injuries|anterior cruciate ligament/injuries
603181|NCT00625885|Anterior Cruciate Ligament/surgery|anterior cruciate ligament/surgery
603182|NCT00625885|Knee injuries/surgery|knee injuries/surgery
603183|NCT00625885|Outcomes research|outcomes research
603184|NCT00625885|Prospective Studies|prospective studies
603185|NCT00625859|pharmacodynamics|pharmacodynamics
603186|NCT00625859|Healthy adult male volunteers,|healthy adult male volunteers,
603187|NCT00625859|pharmacokinetics,|pharmacokinetics,
603188|NCT00625820|Kidney Disease|kidney disease
603189|NCT00625820|Albuminuria|albuminuria
603190|NCT00625820|Glomerular filtration rate|glomerular filtration rate
603191|NCT00625807|Stress|stress
603192|NCT00625807|meditation|meditation
603193|NCT00625807|stress reduction|stress reduction
603194|NCT00625807|fMRI|fmri
603195|NCT00625807|behavioral|behavioral
603196|NCT00625781|Gestational diabetes mellitus|gestational diabetes mellitus
603197|NCT00625781|Impaired glucose Tolerance|impaired glucose tolerance
603198|NCT00625781|Pregnancy|pregnancy
603199|NCT00625781|Fetal macrosomia|fetal macrosomia
603200|NCT00625781|Treatment|treatment
603201|NCT00625781|Perinatal morbidity|perinatal morbidity
603202|NCT00625768|Antibody|antibody
603203|NCT00625768|safety|safety
603204|NCT00625768|tolerability|tolerability
603205|NCT00625768|efficacy|efficacy
603206|NCT00625768|metastatic renal cell carcinoma|metastatic renal cell carcinoma
603207|NCT00625768|metastatic malignant melanoma|metastatic malignant melanoma
603208|NCT00625755|renal cell carcinoma|renal cell carcinoma
603209|NCT00625755|AJCC Stage IV (primary or relasped) renal cell carcinoma|ajcc stage iv (primary or relasped) renal cell carcinoma
603210|NCT00625742|Advanced Cancer|advanced cancer
603211|NCT00625742|Cancer Cachexia|cancer cachexia
603212|NCT00625742|Cachexia|cachexia
603213|NCT00625742|Melatonin|melatonin
603214|NCT00625742|Juven|juven
603215|NCT00625742|Exercise Training|exercise training
603216|NCT00625742|Weight Loss|weight loss
603217|NCT00625729|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
603218|NCT00625729|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
603219|NCT00625729|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
603220|NCT00625729|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
603221|NCT00625729|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
603222|NCT00625729|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
603223|NCT00625729|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
603224|NCT00625729|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
603225|NCT00625729|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
603226|NCT00625729|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
603227|NCT00625729|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
603228|NCT00625729|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
603229|NCT00625729|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
603230|NCT00625729|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
603231|NCT00625729|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
603232|NCT00625729|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
603233|NCT00625703|Pharmacokinetic|pharmacokinetic
603234|NCT00625690|lung cancer|lung cancer
603235|NCT00625677|meningococcal serogroup C vaccine|meningococcal serogroup c vaccine
603236|NCT00625677|reduced dose|reduced dose
603237|NCT00625677|meningococcal serogroup C conjugate vaccine|meningococcal serogroup c conjugate vaccine
603238|NCT00625677|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
603239|NCT00625664|Cancer|cancer
603240|NCT00625664|Neoplasms|neoplasms
603241|NCT00625664|Bladder|bladder
603242|NCT00625664|Urothelial Tract|urothelial tract
603243|NCT00625651|Colon Cancer|colon cancer
603244|NCT00625651|Colorectal Cancer|colorectal cancer
603245|NCT00625651|Rectal Cancer|rectal cancer
603246|NCT00625651|AMG 655|amg 655
603247|NCT00625651|Bevacizumab|bevacizumab
603248|NCT00625651|Modified FOLFOX6|modified folfox6
603249|NCT00625651|mFOLFOX6|mfolfox6
603250|NCT00625651|FOLFOX|folfox
603251|NCT00625638|Advanced Cancer|advanced cancer
603252|NCT00625638|Caregiver|caregiver
603253|NCT00625638|Interactive Voice Response|interactive voice response
603254|NCT00625638|Symptom Control|symptom control
603255|NCT00625638|IVR System|ivr system
603256|NCT00625638|Questionnaire|questionnaire
603257|NCT00625625|stage I colon cancer|stage i colon cancer
603258|NCT00625625|stage II colon cancer|stage ii colon cancer
603259|NCT00625625|stage III colon cancer|stage iii colon cancer
603261|NCT00625625|stage II rectal cancer|stage ii rectal cancer
603262|NCT00625625|stage III rectal cancer|stage iii rectal cancer
603263|NCT00625586|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
603264|NCT00625586|stage IV pancreatic cancer|stage iv pancreatic cancer
603265|NCT00625586|recurrent pancreatic cancer|recurrent pancreatic cancer
603266|NCT00625573|Colon Cancer|colon cancer
603267|NCT00625573|Abraxis Oncology|abraxis oncology
603268|NCT00625573|Abraxane|abraxane
603269|NCT00625573|Phase II|phase ii
603270|NCT00625573|Colorectal|colorectal
603271|NCT00625573|Mt. Sinai Medical Center|mt. sinai medical center
603272|NCT00625573|CCOP|ccop
603273|NCT00625560|Chronic hepatitis B|chronic hepatitis b
603274|NCT00625560|Lamivudine|lamivudine
603275|NCT00625560|Entecavir|entecavir
603276|NCT00625534|Hernia|hernia
603277|NCT00625534|Laparoscopy|laparoscopy
603278|NCT00625534|Pain|pain
603279|NCT00625534|Sexual|sexual
603280|NCT00625534|Quality|quality
603281|NCT00625521|Discoid lupus erythematosus|discoid lupus erythematosus
603282|NCT00625495|Gastroesophageal reflux disease|gastroesophageal reflux disease
603283|NCT00625495|Nexium|nexium
603284|NCT00625495|Esomeprazole|esomeprazole
603285|NCT00625495|Administration methods.|administration methods.
603286|NCT00625482|BCG vaccine|bcg vaccine
603287|NCT00625482|Oral polio vaccine|oral polio vaccine
603288|NCT00625482|Vitamin A supplementation|vitamin a supplementation
603289|NCT00625482|Low-birth-weigth|low-birth-weigth
603290|NCT00625482|Sex-differential|sex-differential
603291|NCT00625482|Prevention|prevention
603292|NCT00625482|Immunological parameters|immunological parameters
603293|NCT00625469|pulmonary arterial hypertension|pulmonary arterial hypertension
603294|NCT00625469|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
603295|NCT00625469|bosentan|bosentan
603296|NCT00625456|phase I|phase i
603297|NCT00625456|advanced metastatic solid tumors|advanced metastatic solid tumors
603298|NCT00625456|oncolytic virus|oncolytic virus
603299|NCT00625456|vaccinia virus|vaccinia virus
603300|NCT00625456|melanoma|melanoma
603301|NCT00625456|lung cancer|lung cancer
603302|NCT00625456|renal cell carcinoma|renal cell carcinoma
603303|NCT00625456|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
603304|NCT00625456|Pexa-Vec|pexa-vec
603305|NCT00625443|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
603306|NCT00625443|ITP|itp
603307|NCT00625443|Chronic Idiopathic Thrombocytopenic Purpura|chronic idiopathic thrombocytopenic purpura
603308|NCT00625430|Prostate Cancer|prostate cancer
603309|NCT00625430|Gene Therapy|gene therapy
603310|NCT00625430|Fludarabine|fludarabine
603311|NCT00625430|Adenovirus|adenovirus
603312|NCT00625430|phase I|phase i
603313|NCT00625417|male breast cancer|male breast cancer
603314|NCT00625417|stage IA breast cancer|stage ia breast cancer
603315|NCT00625417|stage IB breast cancer|stage ib breast cancer
603316|NCT00625417|stage II breast cancer|stage ii breast cancer
603317|NCT00625417|stage IIIA breast cancer|stage iiia breast cancer
603318|NCT00625417|stage IIIB breast cancer|stage iiib breast cancer
603319|NCT00625417|stage IIIC breast cancer|stage iiic breast cancer
603320|NCT00625417|stage IV breast cancer|stage iv breast cancer
603321|NCT00625404|Aspartate Aminotransferase (AST)|aspartate aminotransferase (ast)
603322|NCT00625404|Alanine Aminotransferase (ALT)|alanine aminotransferase (alt)
603323|NCT00625404|HIV|hiv
603324|NCT00625404|HIV Prevention|hiv prevention
603325|NCT00625404|Oral PrEP|oral prep
603326|NCT00625404|Truvada|truvada
603327|NCT00625404|women|women
603328|NCT00625404|Tenofovir|tenofovir
603329|NCT00625404|TDF|tdf
603330|NCT00625404|FTC|ftc
603331|NCT00625404|emtricitabine|emtricitabine
603332|NCT00625404|hepatitis|hepatitis
603333|NCT00625404|Pre-exposure Prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
603334|NCT00625404|HIV Seronegativity|hiv seronegativity
603335|NCT00625391|postmenopausal, bone, dietary supplement, mind-body exercise|postmenopausal, bone, dietary supplement, mind-body exercise
603336|NCT00625378|Cancer|cancer
603337|NCT00625378|Sorafenib|sorafenib
603338|NCT00625378|Extension program|extension program
603339|NCT00625365|DEFINITY|definity
603340|NCT00625365|Safety|safety
603341|NCT00625365|Survelliance|survelliance
603342|NCT00625352|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
603343|NCT00625352|Aged|aged
603344|NCT00625352|Gemcitabine|gemcitabine
603345|NCT00625352|UFT|uft
603346|NCT00625339|Chronic hepatitis B|chronic hepatitis b
603347|NCT00625339|Lamivudine|lamivudine
603348|NCT00625339|Entecavir|entecavir
603349|NCT00625326|psoriasis|psoriasis
603350|NCT00625313|Cataract|cataract
603351|NCT00625313|aphakia|aphakia
603352|NCT00625313|intraocular lens|intraocular lens
603353|NCT00625313|IOL|iol
603354|NCT00625313|Optical correction of aphakia|optical correction of aphakia
603355|NCT00625300|repetitive transcranial stimulation|repetitive transcranial stimulation
603356|NCT00625300|Parkinson's Disease|parkinson's disease
603357|NCT00625274|Nexium|nexium
603358|NCT00625274|esomeprazole|esomeprazole
603359|NCT00625274|lansoprazole|lansoprazole
603360|NCT00625274|pantoprazole|pantoprazole
603361|NCT00625274|Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)|nonsteroidal anti-inflammatory drugs (nsaids)
603362|NCT00625261|Language delay|language delay
603363|NCT00625261|Speech and language disorders|speech and language disorders
603364|NCT00625261|Early language intervention|early language intervention
603365|NCT00625261|Parent-based language intervention|parent-based language intervention
603366|NCT00625235|Obesity|obesity
603367|NCT00625235|Weight loss|weight loss
603368|NCT00625235|Weight maintenance|weight maintenance
603369|NCT00625235|VLED|vled
603370|NCT00625222|Electroencephalography|electroencephalography
603371|NCT00625222|Seizure frequency|seizure frequency
603372|NCT00625222|Seizure severity|seizure severity
603373|NCT00625209|septic shock|septic shock
603374|NCT00625209|coagulation|coagulation
603375|NCT00625209|immunomodulation|immunomodulation
603376|NCT00625209|survival|survival
603377|NCT00625196|Healthy Japanese volunteers|healthy japanese volunteers
603378|NCT00625183|adenocarcinoma of the rectum|adenocarcinoma of the rectum
603379|NCT00625183|stage II rectal cancer|stage ii rectal cancer
603380|NCT00625183|stage III rectal cancer|stage iii rectal cancer
603381|NCT00625170|Antipsychotics|antipsychotics
603382|NCT00625170|Olanzapine|olanzapine
603383|NCT00625170|Haloperidol|haloperidol
603384|NCT00625170|Insulin resistance|insulin resistance
603385|NCT00625170|Dyslipidemia|dyslipidemia
603386|NCT00625131|Stress Disorders, Posttraumatic|stress disorders, posttraumatic
603387|NCT00625131|Tobacco Use Disorder|tobacco use disorder
603388|NCT00625118|Hib conjugate vaccine|hib conjugate vaccine
603389|NCT00625118|reactogenicity|reactogenicity
603390|NCT00625118|local reactions|local reactions
603391|NCT00625118|systemic symptoms|systemic symptoms
603392|NCT00625092|peritoneal cavity cancer|peritoneal cavity cancer
603393|NCT00625079|pulmonary hypertension|pulmonary hypertension
603394|NCT00625079|pulmonary arterial hypertension|pulmonary arterial hypertension
603395|NCT00625079|interstitial lung disease|interstitial lung disease
603396|NCT00625079|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
603397|NCT00625066|precancerous condition|precancerous condition
603398|NCT00625066|colon cancer|colon cancer
603399|NCT00625066|rectal cancer|rectal cancer
603400|NCT00625053|Neuroticism|neuroticism
603401|NCT00625053|Hernia, ventral|hernia, ventral
603402|NCT00625053|Laparoscopy|laparoscopy
603403|NCT00625053|Quality of life|quality of life
603404|NCT00625040|Incretin effect|incretin effect
603405|NCT00625040|Gastric banding|gastric banding
603406|NCT00625040|Glucagon|glucagon
603407|NCT00625040|Glucagon-Like Peptide 1|glucagon-like peptide 1
603408|NCT00625040|Gastric Inhibitory Peptide|gastric inhibitory peptide
603409|NCT00625040|Glucose Intestinal Peptide|glucose intestinal peptide
603410|NCT00625040|Insulin|insulin
603411|NCT00625040|C-peptide|c-peptide
603412|NCT00625027|Emergency Department Visit|emergency department visit
603413|NCT00625027|Telehealth Ontario|telehealth ontario
603414|NCT00625027|Triage Levels|triage levels
603415|NCT00625014|Insulin resistance|insulin resistance
603416|NCT00625014|Dyslipidemia|dyslipidemia
603417|NCT00625014|Haloperidol|haloperidol
603418|NCT00625001|Turner Syndrome|turner syndrome
603419|NCT00625001|bone mineral density|bone mineral density
603420|NCT00625001|estrogen replacement therapy|estrogen replacement therapy
603421|NCT00625001|dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
603422|NCT00624988|Spinal cord injury|spinal cord injury
603423|NCT00624988|vibration therapy|vibration therapy
603424|NCT00624988|bone density|bone density
603425|NCT00624962|childhood soft tissue sarcoma|childhood soft tissue sarcoma
603426|NCT00624962|neuroblastoma|neuroblastoma
603427|NCT00624962|childhood hepatoblastoma|childhood hepatoblastoma
603428|NCT00624962|childhood cerebellar astrocytoma|childhood cerebellar astrocytoma
603429|NCT00624962|childhood ependymoma|childhood ependymoma
603430|NCT00624962|childhood brain stem glioma|childhood brain stem glioma
603431|NCT00624962|childhood meningioma|childhood meningioma
603432|NCT00624962|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
603433|NCT00624962|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
603434|NCT00624962|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
603435|NCT00624962|central nervous system neoplasm|central nervous system neoplasm
603436|NCT00624962|Wilms tumor and other childhood kidney tumors|wilms tumor and other childhood kidney tumors
603437|NCT00624962|childhood brain tumor|childhood brain tumor
603438|NCT00624962|childhood medulloblastoma|childhood medulloblastoma
603439|NCT00624949|Turner syndrome|turner syndrome
603440|NCT00624949|aortic dimensions|aortic dimensions
603441|NCT00624949|blood pressure|blood pressure
603442|NCT00624949|aortic dilatation|aortic dilatation
603443|NCT00624949|aortic rupture|aortic rupture
603444|NCT00624936|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
603445|NCT00624936|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
603446|NCT00624936|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
603447|NCT00624936|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
603448|NCT00624936|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
603449|NCT00624936|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
603450|NCT00624936|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
603451|NCT00624936|myelodysplastic syndromes|myelodysplastic syndromes
603452|NCT00624936|secondary acute myeloid leukemia|secondary acute myeloid leukemia
603453|NCT00624923|Coronary Artery Disease|coronary artery disease
603454|NCT00624923|Inflammation|inflammation
603455|NCT00624923|Overweight|overweight
603456|NCT00624923|Metabolic Syndrome|metabolic syndrome
603457|NCT00624923|Salsalate|salsalate
603458|NCT00624910|Post Operative Pain|post operative pain
603459|NCT00624910|Hysterectomy|hysterectomy
603460|NCT00624884|Aortic regurgitation,velocity vector imaging|aortic regurgitation,velocity vector imaging
603461|NCT00624871|Interleukin 1-beta|interleukin 1-beta
603462|NCT00624871|Interleukin 6|interleukin 6
603463|NCT00624871|Vitamin C|vitamin c
603464|NCT00624871|HIE|hie
603465|NCT00624871|neonates|neonates
603466|NCT00624858|Depression|depression
603467|NCT00624858|depressed|depressed
603468|NCT00624858|overweight|overweight
603469|NCT00624858|obese|obese
603470|NCT00624845|Meniscectomy|meniscectomy
603471|NCT00624832|Asthma|asthma
603472|NCT00624832|allergen challenge|allergen challenge
603473|NCT00624832|bronchoprovocation|bronchoprovocation
603474|NCT00624832|Methacholine challenge|methacholine challenge
603475|NCT00624832|serum Immunoglobulin E|serum immunoglobulin e
603476|NCT00624832|Nitric Oxide|nitric oxide
603477|NCT00624832|skin prick test|skin prick test
603478|NCT00624819|Streptococcus pneumoniae|streptococcus pneumoniae
603479|NCT00624819|Haemophilus influenzae|haemophilus influenzae
603480|NCT00624819|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
603481|NCT00624819|Antibody persistence|antibody persistence
603482|NCT00624806|Pressure ulcer|pressure ulcer
603483|NCT00624806|Telemedicine|telemedicine
603484|NCT00624793|Nausea|nausea
603485|NCT00624793|Vomiting|vomiting
603486|NCT00624793|Retching|retching
603487|NCT00624793|HIV/AIDS|hiv/aids
603488|NCT00624793|Symptom Management|symptom management
603489|NCT00624793|Complementary Therapies|complementary therapies
603490|NCT00624767|insulin|insulin
603491|NCT00624767|insulin aspart|insulin aspart
603492|NCT00624767|Type 2 Diabetes|type 2 diabetes
603493|NCT00624767|diabetes mellitus|diabetes mellitus
603494|NCT00624754|Obstructive airway disease|obstructive airway disease
603495|NCT00624754|bronchiolitis obliterans|bronchiolitis obliterans
603496|NCT00624754|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
603497|NCT00624754|bone marrow transplantation|bone marrow transplantation
603498|NCT00624754|inhaled treatment|inhaled treatment
603499|NCT00624754|Budesonide Formoterol|budesonide formoterol
603500|NCT00624741|Parkinson's disease|parkinson's disease
603501|NCT00624741|Antiparkinsonian|antiparkinsonian
603502|NCT00624741|Compassionate use|compassionate use
603503|NCT00624728|Positron-Emission Tomography|positron-emission tomography
603504|NCT00624728|Alovudine [Substance Name]|alovudine [substance name]
603505|NCT00624728|18F-FLT|18f-flt
603506|NCT00624728|Magnetic Resonance Imaging|magnetic resonance imaging
603507|NCT00624728|Astrocytoma|astrocytoma
603508|NCT00624728|Glioblastoma|glioblastoma
603509|NCT00624702|Asthma, cough, spirometry, maleate, xinafoate, acetate, SDDPI (single dose dry powder inhaler)|asthma, cough, spirometry, maleate, xinafoate, acetate, sddpi (single dose dry powder inhaler)
603510|NCT00624689|Body composition|body composition
603511|NCT00624689|Glucose tolerance|glucose tolerance
603512|NCT00624689|Intima-media thickness|intima-media thickness
603513|NCT00624689|Visual acuity|visual acuity
603514|NCT00624689|Neurological development|neurological development
603515|NCT00624676|Acne|acne
603516|NCT00624676|lipophilic hydroxy acid|lipophilic hydroxy acid
603517|NCT00624676|benzoyl peroxide|benzoyl peroxide
603518|NCT00624663|Rivastigmine, Repeated administration, Healthy Volunteers, organophosphate poisoning, protection, pharmacokinetics, behavioral effects|rivastigmine, repeated administration, healthy volunteers, organophosphate poisoning, protection, pharmacokinetics, behavioral effects
603519|NCT00624650|Acute Lung Injury|acute lung injury
603520|NCT00624650|Extravascular Lung Water|extravascular lung water
603521|NCT00624650|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
603522|NCT00624637|aromatherapy|aromatherapy
603523|NCT00624637|massage|massage
603524|NCT00624637|comfort|comfort
603525|NCT00624637|postoperative|postoperative
603526|NCT00624637|infants|infants
603527|NCT00624637|craniofacial surgery|craniofacial surgery
603528|NCT00624624|hypogonadotropic hypogonadism|hypogonadotropic hypogonadism
603529|NCT00624624|bariatric surgery|bariatric surgery
603530|NCT00624624|serum androgen levels|serum androgen levels
603531|NCT00624624|bone density|bone density
603532|NCT00624611|CPB|cpb
603533|NCT00624611|red blood cell washing|red blood cell washing
603534|NCT00624585|MDS|mds
603535|NCT00624585|MDS/MPD|mds/mpd
603536|NCT00624585|MDS/AML|mds/aml
603537|NCT00624585|CMML|cmml
603538|NCT00624585|Excess Marrow Blasts|excess marrow blasts
603539|NCT00624572|primary teeth|primary teeth
603540|NCT00624572|chlorexidine|chlorexidine
603541|NCT00624572|root canal therapy|root canal therapy
603542|NCT00624572|Pulpectomy|pulpectomy
603543|NCT00624559|Salt sensitivity of Blood Pressure|salt sensitivity of blood pressure
603544|NCT00624546|GERD|gerd
603545|NCT00624546|gastroesophageal reflux|gastroesophageal reflux
603546|NCT00624546|antireflux surgery|antireflux surgery
603547|NCT00624546|Barrett's|barrett's
603548|NCT00624546|Esophagus|esophagus
603549|NCT00624546|Esophagitis|esophagitis
603550|NCT00624533|Low back Pain|low back pain
603551|NCT00624533|Physical Therapy Modalities|physical therapy modalities
603552|NCT00624533|Exercise Movement Techniques|exercise movement techniques
603553|NCT00624533|Primary Health Care|primary health care
603554|NCT00624520|Stress, Psychological|stress, psychological
603555|NCT00624520|Tachycardia, Ventricular|tachycardia, ventricular
603556|NCT00624520|Defibrillators, Implantable|defibrillators, implantable
603557|NCT00624520|Death, Sudden Cardiac|death, sudden cardiac
603558|NCT00624520|Cognitive Therapy|cognitive therapy
603559|NCT00624520|Anger|anger
603560|NCT00624494|venous oxygen saturation|venous oxygen saturation
603561|NCT00624494|transpulmonary thermodilution|transpulmonary thermodilution
603562|NCT00624481|osteoporosis|osteoporosis
603563|NCT00624481|osteopenia|osteopenia
603564|NCT00624481|bone mineral density|bone mineral density
603565|NCT00624481|teriparatide|teriparatide
603566|NCT00624468|atacicept|atacicept
603567|NCT00624468|neuritis|neuritis
603568|NCT00624455|Gabapentin|gabapentin
603569|NCT00624455|tonsillectomy|tonsillectomy
603570|NCT00624455|post-operative pain|post-operative pain
603571|NCT00624455|morphine requirements|morphine requirements
603572|NCT00624455|randomized double blind|randomized double blind
603573|NCT00624455|adenotonsillectomy|adenotonsillectomy
603574|NCT00624429|Asthma|asthma
603575|NCT00624429|Children|children
603576|NCT00624416|Obesity therapy|obesity therapy
603577|NCT00624416|fat|fat
603578|NCT00624416|drug mechanism|drug mechanism
603579|NCT00624416|adipose tissue|adipose tissue
603580|NCT00624416|cellular pharmacology|cellular pharmacology
603581|NCT00624403|Anesthesia|anesthesia
603582|NCT00624403|Laryngeal mask airway|laryngeal mask airway
603583|NCT00624351|Lupus|lupus
603584|NCT00624351|Monoclonal antibody|monoclonal antibody
603585|NCT00624351|B-Cell immunotherapy|b-cell immunotherapy
603586|NCT00624338|Atacicept 75 and 150 mg|atacicept 75 and 150 mg
603587|NCT00624338|Placebo|placebo
603588|NCT00624325|genotype 1 nonresponders|genotype 1 nonresponders
603589|NCT00624312|Procrit|procrit
603590|NCT00624312|Erythropoietin|erythropoietin
603591|NCT00624312|Patients undergoing major surgical oncology operations|patients undergoing major surgical oncology operations
603592|NCT00624299|botox|botox
603593|NCT00624299|limb reconstructions|limb reconstructions
603594|NCT00624299|limb reconstruction surgery|limb reconstruction surgery
603595|NCT00624286|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
603596|NCT00624286|COPD|copd
603597|NCT00624286|indacaterol|indacaterol
603598|NCT00624273|digital ulcers,|digital ulcers,
603599|NCT00624273|systemic sclerosis,|systemic sclerosis,
603600|NCT00624273|sildenafil,|sildenafil,
603601|NCT00624273|vasoactive therapies|vasoactive therapies
603602|NCT00624260|Colorectal cancer|colorectal cancer
603603|NCT00624260|Recurrence|recurrence
603604|NCT00624260|Positron Emission Tomography|positron emission tomography
603605|NCT00624260|Colorectal Cancer with high risk of recurrence stage III|colorectal cancer with high risk of recurrence stage iii
603606|NCT00624260|Colorectal Cancer with high risk of recurrence stage IV|colorectal cancer with high risk of recurrence stage iv
603607|NCT00624260|T4N0M0 operated in emergency( because of perforation)|t4n0m0 operated in emergency( because of perforation)
603608|NCT00624247|routine HIV testing|routine hiv testing
603609|NCT00624247|jails|jails
603610|NCT00624247|criminal justice system|criminal justice system
603611|NCT00624247|substance abuse|substance abuse
603612|NCT00624247|mental illness|mental illness
603613|NCT00624247|HIV|hiv
603614|NCT00624234|neurofibromatosis type 1|neurofibromatosis type 1
603615|NCT00624234|reading disabilities|reading disabilities
603616|NCT00624234|NF-1|nf-1
603617|NCT00624234|learning disabilities|learning disabilities
603618|NCT00624234|tutoring intervention|tutoring intervention
603619|NCT00624208|Randomized|randomized
603620|NCT00624208|double-blind|double-blind
603621|NCT00624208|4-group clinical interventional study|4-group clinical interventional study
603622|NCT00624195|HIV Dementia|hiv dementia
603623|NCT00624195|HAART|haart
603624|NCT00624195|Cognitive Impairment|cognitive impairment
603625|NCT00624195|Antiretroviral Regimen|antiretroviral regimen
603626|NCT00624195|Viral Load|viral load
603627|NCT00624195|CNS Drug Penetration|cns drug penetration
603628|NCT00624169|Perforated peptic ulcer|perforated peptic ulcer
603629|NCT00624169|Mortality|mortality
603630|NCT00624156|Breast Cancer|breast cancer
603631|NCT00624143|Antifungal prophylaxis, acute leukemia induction,|antifungal prophylaxis, acute leukemia induction,
603632|NCT00624130|Contraception,|contraception,
603633|NCT00624130|Cycle control,|cycle control,
603634|NCT00624130|Bleeding pattern|bleeding pattern
603635|NCT00624117|shoulder joint|shoulder joint
603636|NCT00624117|recovery of function|recovery of function
603637|NCT00624117|effectiveness of rehabilitation|effectiveness of rehabilitation
603638|NCT00624117|rehabilitation|rehabilitation
603639|NCT00624104|VLDL|vldl
603640|NCT00624104|Kinetics|kinetics
603641|NCT00624104|Hyperinsulinaemia|hyperinsulinaemia
603642|NCT00624104|Obesity|obesity
603643|NCT00624091|Early-surgery, infective endocarditis, in-hospital mortality|early-surgery, infective endocarditis, in-hospital mortality
603644|NCT00624078|faboterapics|faboterapics
603645|NCT00624078|treatment|treatment
603646|NCT00624078|scorpion sting|scorpion sting
603647|NCT00624078|envenomation|envenomation
603648|NCT00624065|target blood pressure|target blood pressure
603649|NCT00624065|hypertension|hypertension
603650|NCT00624065|COREG CR|coreg cr
603651|NCT00624065|carvedilol CR|carvedilol cr
603652|NCT00624065|Stage 1 or 2 essential hypertension|stage 1 or 2 essential hypertension
603653|NCT00624065|lisinopril|lisinopril
603654|NCT00624039|presbyopia|presbyopia
603655|NCT00624013|Diabetes|diabetes
603656|NCT00624013|Depression|depression
603657|NCT00624013|diabetes outcomes|diabetes outcomes
603658|NCT00624013|quality of life|quality of life
603659|NCT00624000|Ischemic Stroke|ischemic stroke
603660|NCT00623987|Residual vein thrombosis|residual vein thrombosis
603661|NCT00623987|Optimal duration|optimal duration
603662|NCT00623987|Oral anticoagulants|oral anticoagulants
603663|NCT00623974|Hypocalcemia|hypocalcemia
603664|NCT00623974|Teriparatide|teriparatide
603665|NCT00623974|Forteo|forteo
603666|NCT00623974|Calcium|calcium
603667|NCT00623974|Calcitriol|calcitriol
603668|NCT00623974|Rocaltrol|rocaltrol
603669|NCT00623961|Neuropathic Pain|neuropathic pain
603670|NCT00623948|Pressure ulcers|pressure ulcers
603671|NCT00623948|Electrical Stimulation|electrical stimulation
603672|NCT00623948|Spinal Cord Injury|spinal cord injury
603673|NCT00623935|AML|aml
603674|NCT00623922|Patient education|patient education
603675|NCT00623922|Nurse consultation|nurse consultation
603676|NCT00623922|Arthritis|arthritis
603677|NCT00623922|Wellbeing|wellbeing
603678|NCT00623922|Coping|coping
603679|NCT00623922|Health related quality of life|health related quality of life
603680|NCT00623909|Laser Therapy|laser therapy
603681|NCT00623909|Post Thoracotomy Pain|post thoracotomy pain
603682|NCT00623909|AvicennaTM laser|avicennatm laser
603683|NCT00623896|Nehb|nehb
603684|NCT00623896|ST Elevation Myocardial Infarcton|st elevation myocardial infarcton
603685|NCT00623896|STEMI|stemi
603686|NCT00623896|ECG|ecg
603687|NCT00623883|Human Colonic Aberrant Crypt Foci|human colonic aberrant crypt foci
603688|NCT00623857|Micronutrients|micronutrients
603689|NCT00623857|Zinc|zinc
603690|NCT00623857|Vitamins|vitamins
603691|NCT00623857|Trace elements|trace elements
603692|NCT00623857|Minerals|minerals
603693|NCT00623857|Vitamin A|vitamin a
603694|NCT00623857|Vitamin B1|vitamin b1
603695|NCT00623857|Vitamin B2|vitamin b2
603696|NCT00623857|Niacin|niacin
603697|NCT00623857|Vitamin B6|vitamin b6
603698|NCT00623857|Folic acid|folic acid
603699|NCT00623857|Vitamin B12|vitamin b12
603700|NCT00623857|Vitamin C|vitamin c
603701|NCT00623857|Vitamin D|vitamin d
603702|NCT00623857|Vitamin E|vitamin e
603703|NCT00623857|Vitamin K|vitamin k
603704|NCT00623857|Iron|iron
603705|NCT00623857|Iodine|iodine
603706|NCT00623857|Copper|copper
603707|NCT00623857|Selenium|selenium
603708|NCT00623857|Magnesium|magnesium
603709|NCT00623857|Calcium|calcium
603710|NCT00623857|Malaria|malaria
603711|NCT00623857|Immunity|immunity
603712|NCT00623857|Anthropometry|anthropometry
603713|NCT00623844|Prevention|prevention
603714|NCT00623844|Physical activity|physical activity
603715|NCT00623844|Obesity|obesity
603716|NCT00623844|Motor skills|motor skills
603717|NCT00623844|Kindergarten|kindergarten
603718|NCT00623831|MBV|mbv
603719|NCT00623831|Mixed Bacterial Vaccine|mixed bacterial vaccine
603720|NCT00623831|NY-ESO-1|ny-eso-1
603721|NCT00623818|Mirror Therapy|mirror therapy
603722|NCT00623818|Phantom Limb Pain|phantom limb pain
603723|NCT00623818|Amputee|amputee
603724|NCT00623818|Healthy Volunteer|healthy volunteer
603725|NCT00623818|HV|hv
603726|NCT00623792|Morbid obesity|morbid obesity
603727|NCT00623792|Diet therapy|diet therapy
603728|NCT00623792|Bariatric Surgery|bariatric surgery
603729|NCT00623792|Gastric bypass|gastric bypass
603730|NCT00623792|Behavior therapy|behavior therapy
603731|NCT00623792|Randomized controlled trial|randomized controlled trial
603732|NCT00623792|Weight loss|weight loss
603733|NCT00623753|Vaccine|vaccine
603734|NCT00623753|Prevention|prevention
603735|NCT00623753|HIV|hiv
603736|NCT00623753|AIDS|aids
603737|NCT00623753|Human Immunodeficiency Virus|human immunodeficiency virus
603738|NCT00623753|HIV Seronegativity, HIV Preventive Vaccine|hiv seronegativity, hiv preventive vaccine
603739|NCT00623740|Hydrocortisone|hydrocortisone
603740|NCT00623740|Very low birth weight|very low birth weight
603741|NCT00623740|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
603742|NCT00623740|Prevention Cerebral palsy|prevention cerebral palsy
603743|NCT00623727|Hemophilia A|hemophilia a
603744|NCT00623727|FVIII disease|fviii disease
603745|NCT00623727|rFVIII|rfviii
603746|NCT00623701|sublingual grass pollen preparation|sublingual grass pollen preparation
603747|NCT00623701|IgE-mediated Allergic Disease attributed to grass pollen|ige-mediated allergic disease attributed to grass pollen
603748|NCT00623688|Metered Dose Inhalers|metered dose inhalers
603749|NCT00623688|Nebulizers|nebulizers
603750|NCT00623688|Randomized Controlled Trial|randomized controlled trial
603751|NCT00623675|zeolites|zeolites
603752|NCT00623675|nutraceuticals|nutraceuticals
603753|NCT00623675|natural supplements|natural supplements
603754|NCT00623675|Healthy volunteers|healthy volunteers
603755|NCT00623662|Glucose infusion|glucose infusion
603756|NCT00623662|Liver function|liver function
603757|NCT00623662|Liver resection|liver resection
603758|NCT00623662|Albumin synthesis|albumin synthesis
603759|NCT00623662|Stable isotopes|stable isotopes
603760|NCT00623636|Migraine|migraine
603761|NCT00623610|Diabetes mellitus, type 1|diabetes mellitus, type 1
603762|NCT00623610|pancreatic beta cell|pancreatic beta cell
603763|NCT00623610|transplantation|transplantation
603764|NCT00623584|penetrating keratoplasty|penetrating keratoplasty
603765|NCT00623584|corneal transplantation|corneal transplantation
603766|NCT00623584|corneal grafting|corneal grafting
603767|NCT00623584|corneal grafts|corneal grafts
603768|NCT00623584|culture media|culture media
603769|NCT00623584|corneal culturing|corneal culturing
603770|NCT00623584|in vitro culturing|in vitro culturing
603771|NCT00623571|frail elderly|frail elderly
603772|NCT00623571|hospital at home|hospital at home
603773|NCT00623571|heart failure|heart failure
603774|NCT00623571|Acute exacerbation of chronic heart failure|acute exacerbation of chronic heart failure
603775|NCT00623558|head and neck neoplasm|head and neck neoplasm
603776|NCT00623558|cetuximab|cetuximab
603777|NCT00623558|docetaxel|docetaxel
603778|NCT00623558|cisplatin|cisplatin
603779|NCT00623558|radiotherapy|radiotherapy
603780|NCT00623545|Exenatide|exenatide
603781|NCT00623545|Byetta|byetta
603782|NCT00623545|weight loss|weight loss
603783|NCT00623545|energy expenditure|energy expenditure
603784|NCT00623545|normal volunteers|normal volunteers
603785|NCT00623532|Tertiary prevention of disability|tertiary prevention of disability
603786|NCT00623519|Adjuvant postmenopausal breast cancer women|adjuvant postmenopausal breast cancer women
603787|NCT00623506|TBI|tbi
603788|NCT00623506|Pregnenolone|pregnenolone
603789|NCT00623506|Cognition|cognition
603790|NCT00623493|Screening|screening
603791|NCT00623493|Suicide|suicide
603792|NCT00623493|Emergency Department|emergency department
603793|NCT00623493|Children and Adolescents|children and adolescents
603794|NCT00623493|Suicide Risk|suicide risk
603795|NCT00623480|Hemophilia A|hemophilia a
603796|NCT00623467|Central Nervous System Imaging|central nervous system imaging
603797|NCT00623467|Diagnostic Imaging|diagnostic imaging
603798|NCT00623454|anxiety|anxiety
603799|NCT00623454|panic disorder|panic disorder
603800|NCT00623454|chest pain|chest pain
603801|NCT00623454|palpitations|palpitations
603802|NCT00623441|Coronary Artery Disease|coronary artery disease
603803|NCT00623441|Drug-eluting stent|drug-eluting stent
603804|NCT00623402|Metastatic melanoma|metastatic melanoma
603805|NCT00623402|Pegylated interferon|pegylated interferon
603806|NCT00623402|Protein Kinase Inhibitors|protein kinase inhibitors
603807|NCT00623402|Sorafenib|sorafenib
603808|NCT00623402|PegIntron|pegintron
603809|NCT00623402|Therapeutic Uses|therapeutic uses
603810|NCT00623402|melanoma (skin)|melanoma (skin)
603811|NCT00623389|Neurologic disorders|neurologic disorders
603812|NCT00623389|Rare disease|rare disease
603813|NCT00623389|Spinal cord injuries|spinal cord injuries
603814|NCT00623389|Stroke|stroke
603815|NCT00623389|Paraplegia|paraplegia
603816|NCT00623389|Tetraplegia|tetraplegia
603817|NCT00623363|Parkinson's Disease|parkinson's disease
603818|NCT00623363|motor complications|motor complications
603819|NCT00623363|dyskinesia|dyskinesia
603820|NCT00623363|Motor complications associated with Parkinson's|motor complications associated with parkinson's
603821|NCT00623350|Telemedicine|telemedicine
603822|NCT00623350|Stroke, Acute|stroke, acute
603823|NCT00623350|Rural|rural
603824|NCT00623350|Thrombolysis|thrombolysis
603825|NCT00623350|Consultation|consultation
603826|NCT00623337|care seeking|care seeking
603827|NCT00623337|pregnancy and childbirth|pregnancy and childbirth
603828|NCT00623337|newborn care practices|newborn care practices
603829|NCT00623337|low birth weight babies|low birth weight babies
603830|NCT00623298|Posttraumatic stress disorder|posttraumatic stress disorder
603831|NCT00623298|depression|depression
603832|NCT00623298|Narrative Exposure Therapy|narrative exposure therapy
603833|NCT00623298|Interpersonal Psychotherapy|interpersonal psychotherapy
603834|NCT00623285|Pain.|pain.
603835|NCT00623285|Postoperative.|postoperative.
603836|NCT00623285|CABG.|cabg.
603837|NCT00623272|The assessment of left ventricular ejection fraction (LVEF)|the assessment of left ventricular ejection fraction (lvef)
603838|NCT00623246|Obstructive Sleep Apnea|obstructive sleep apnea
603839|NCT00623246|OSA|osa
603840|NCT00623246|Adherence|adherence
603841|NCT00623246|CPAP|cpap
603842|NCT00623246|Cognition|cognition
603843|NCT00623233|Breast Neoplasm|breast neoplasm
603844|NCT00623220|pain, retinopathy of prematurity, infant, premature, eye exam, nitrous oxide|pain, retinopathy of prematurity, infant, premature, eye exam, nitrous oxide
603845|NCT00623207|Chest Pain Low work Capacity Rate Incompetence|chest pain low work capacity rate incompetence
603846|NCT00623181|Influenza|influenza
603847|NCT00623181|Influenza virus|influenza virus
603848|NCT00623168|Ribavirin|ribavirin
603849|NCT00623168|Hemorrhagic Fever with Renal Syndrome|hemorrhagic fever with renal syndrome
603850|NCT00623155|malaria|malaria
603851|NCT00623155|intermittent preventive treatment|intermittent preventive treatment
603852|NCT00623155|season|season
603853|NCT00623155|children|children
603854|NCT00623142|Myocardial protection|myocardial protection
603855|NCT00623142|Ischemic Reperfusion Injury|ischemic reperfusion injury
603856|NCT00623142|Hyperbaric Oxygen|hyperbaric oxygen
603857|NCT00623142|Preconditioning|preconditioning
603858|NCT00623129|hypopharyngeal cancer|hypopharyngeal cancer
603859|NCT00623129|lip and oral cavity cancer|lip and oral cavity cancer
603860|NCT00623129|laryngeal cancer|laryngeal cancer
603861|NCT00623129|nasopharyngeal cancer|nasopharyngeal cancer
603862|NCT00623129|oropharyngeal cancer|oropharyngeal cancer
603863|NCT00623129|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
603864|NCT00623129|salivary gland cancer|salivary gland cancer
603865|NCT00623129|xerostomia|xerostomia
603866|NCT00623129|radiation toxicity|radiation toxicity
603867|NCT00623116|Kallmann Syndrome|kallmann syndrome
603868|NCT00623116|hypogonadotropic hypogonadism|hypogonadotropic hypogonadism
603869|NCT00623103|Parkinson's disease dementia|parkinson's disease dementia
603870|NCT00623103|cholinesterase inhibitor|cholinesterase inhibitor
603871|NCT00623103|rivastigmine|rivastigmine
603872|NCT00623090|prostate cancer screening education|prostate cancer screening education
603873|NCT00623090|behavioral oncology|behavioral oncology
603874|NCT00623090|randomized trial|randomized trial
603875|NCT00623077|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
603876|NCT00623077|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
603877|NCT00623077|childhood hepatoblastoma|childhood hepatoblastoma
603878|NCT00623077|recurrent childhood liver cancer|recurrent childhood liver cancer
603879|NCT00623077|stage IV childhood liver cancer|stage iv childhood liver cancer
603880|NCT00623077|adult primary liver cancer|adult primary liver cancer
603881|NCT00623077|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
603882|NCT00623077|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
603883|NCT00623077|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
603963|NCT00622921|alcohol dependence|alcohol dependence
603884|NCT00623077|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
603885|NCT00623077|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
603886|NCT00623077|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
603887|NCT00623077|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
603888|NCT00623077|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
603889|NCT00623077|stage IV Wilms tumor|stage iv wilms tumor
603890|NCT00623077|stage V Wilms tumor|stage v wilms tumor
603891|NCT00623077|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
603892|NCT00623077|stage IV renal cell cancer|stage iv renal cell cancer
603893|NCT00623077|childhood mixed glioma|childhood mixed glioma
603894|NCT00623077|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
603895|NCT00623077|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
603896|NCT00623077|recurrent childhood ependymoma|recurrent childhood ependymoma
603897|NCT00623077|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
603898|NCT00623077|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
603899|NCT00623077|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
603900|NCT00623077|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
603901|NCT00623077|untreated childhood brain stem glioma|untreated childhood brain stem glioma
603902|NCT00623077|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
603903|NCT00623077|childhood infratentorial ependymoma|childhood infratentorial ependymoma
603904|NCT00623077|childhood supratentorial ependymoma|childhood supratentorial ependymoma
603905|NCT00623077|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
603906|NCT00623077|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
603907|NCT00623077|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
603908|NCT00623077|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
603909|NCT00623077|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
603910|NCT00623077|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
603911|NCT00623077|recurrent retinoblastoma|recurrent retinoblastoma
603912|NCT00623077|extraocular retinoblastoma|extraocular retinoblastoma
603913|NCT00623077|intraocular retinoblastoma|intraocular retinoblastoma
603914|NCT00623077|childhood renal cell carcinoma|childhood renal cell carcinoma
603915|NCT00623077|clear cell renal cell carcinoma|clear cell renal cell carcinoma
603916|NCT00623077|recurrent renal cell cancer|recurrent renal cell cancer
603917|NCT00623077|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
603918|NCT00623077|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
603919|NCT00623077|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
603920|NCT00623064|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
603921|NCT00623064|stage IV bladder cancer|stage iv bladder cancer
603922|NCT00623064|stage III bladder cancer|stage iii bladder cancer
603923|NCT00623064|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
603924|NCT00623064|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
603925|NCT00623051|male circumcision|male circumcision
603926|NCT00623051|HIV|hiv
603927|NCT00623051|sexual behavior|sexual behavior
603928|NCT00623051|HIV prevention|hiv prevention
603929|NCT00623051|HIV Seronegativity|hiv seronegativity
603930|NCT00623038|Apgar score|apgar score
603931|NCT00623038|neonatal assessment|neonatal assessment
603932|NCT00623038|preterm infants|preterm infants
603933|NCT00623038|resuscitation|resuscitation
603934|NCT00623025|HIV|hiv
603935|NCT00623025|Steatorrhea|steatorrhea
603936|NCT00622999|Malnutrition|malnutrition
603937|NCT00622999|Colon cancer|colon cancer
603938|NCT00622999|Colon surgery|colon surgery
603939|NCT00622999|Outcome|outcome
603940|NCT00622999|Complication rate|complication rate
603941|NCT00622973|Prostate cancer|prostate cancer
603942|NCT00622973|Bladder cancer|bladder cancer
603943|NCT00622973|Pelvic lymph node metastases|pelvic lymph node metastases
603944|NCT00622973|Diffusion-weighted MRI|diffusion-weighted mri
603945|NCT00622973|Sinerem (USPIO)-enhanced MRI|sinerem (uspio)-enhanced mri
603946|NCT00622973|Imaging influence on surgery|imaging influence on surgery
603947|NCT00622973|Noninvasive detection of pelvic lymph node metastases|noninvasive detection of pelvic lymph node metastases
603948|NCT00622973|Influence of imaging protocol on surgical outcome|influence of imaging protocol on surgical outcome
603949|NCT00622960|obesity|obesity
603950|NCT00622960|type 2 diabetes|type 2 diabetes
603951|NCT00622960|weight loss|weight loss
603952|NCT00622960|monounsaturated fat|monounsaturated fat
603953|NCT00622960|diet|diet
603954|NCT00622947|Depression|depression
603955|NCT00622947|antidepressant effect|antidepressant effect
603956|NCT00622947|rTMS|rtms
603957|NCT00622947|sham|sham
603958|NCT00622947|cognition|cognition
603959|NCT00622947|saliva cortisol|saliva cortisol
603960|NCT00622947|brain derived neurotropic factor|brain derived neurotropic factor
603961|NCT00622934|multiple trauma|multiple trauma
603962|NCT00622921|PTSD|ptsd
603964|NCT00622895|scleroderma|scleroderma
603965|NCT00622895|systemic sclerosis|systemic sclerosis
603966|NCT00622882|Staphylococcus aureus|staphylococcus aureus
603967|NCT00622882|Bacteremia|bacteremia
603968|NCT00622882|Outcome|outcome
603969|NCT00622882|Mortality|mortality
603970|NCT00622882|Recurrence|recurrence
603971|NCT00622882|Infectious Diseases specialists|infectious diseases specialists
603972|NCT00622869|Liver transplantation|liver transplantation
603973|NCT00622869|everolimus|everolimus
603974|NCT00622869|calcineurin inhibitors|calcineurin inhibitors
603975|NCT00622869|tacrolimus|tacrolimus
603976|NCT00622869|renal function|renal function
603977|NCT00622869|MDRD formula|mdrd formula
603978|NCT00622869|progression of fibrosis|progression of fibrosis
603979|NCT00622856|diabetes|diabetes
603980|NCT00622856|adolescents|adolescents
603981|NCT00622856|psychological therapy|psychological therapy
603982|NCT00622843|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
603983|NCT00622843|polysaccharide vaccine|polysaccharide vaccine
603984|NCT00622843|PPV|ppv
603985|NCT00622843|PCV|pcv
603986|NCT00622843|Streptococcus pneumoniae|streptococcus pneumoniae
603987|NCT00622843|Prevnar|prevnar
603988|NCT00622843|Pneumovax|pneumovax
603989|NCT00622843|HIV|hiv
603990|NCT00622830|darapladib,|darapladib,
603991|NCT00622830|SB480848,|sb480848,
603992|NCT00622830|Japanese healthy volunteers|japanese healthy volunteers
603993|NCT00622817|Epinephrine|epinephrine
603994|NCT00622817|Nasal decongestant|nasal decongestant
603995|NCT00622817|RSV|rsv
603996|NCT00622817|xylometazoline|xylometazoline
603997|NCT00622817|Bronchiolitis|bronchiolitis
603998|NCT00622804|Stomach cancer|stomach cancer
603999|NCT00622804|Gastrectomy|gastrectomy
604000|NCT00622804|Postgastrectomy syndrome|postgastrectomy syndrome
604001|NCT00622791|Cardiopulmonary bypass|cardiopulmonary bypass
604002|NCT00622791|coronary artery bypass graft|coronary artery bypass graft
604003|NCT00622791|coronary artery disease|coronary artery disease
604004|NCT00622791|propofol|propofol
604005|NCT00622791|pharmacokinetics|pharmacokinetics
604006|NCT00622791|pharmacodynamics|pharmacodynamics
604007|NCT00622778|intracranial bleeding|intracranial bleeding
604008|NCT00622778|computed tomography scan|computed tomography scan
604009|NCT00622765|Obesity, Overweight, Body Weight, Body Size, Nutritional and Metabolic Diseases|obesity, overweight, body weight, body size, nutritional and metabolic diseases
604010|NCT00622752|Smoking cessation|smoking cessation
604011|NCT00622752|Craving|craving
604012|NCT00622752|Smokers|smokers
604013|NCT00622739|Bipolar Disorder|bipolar disorder
604014|NCT00622739|Children|children
604015|NCT00622739|Adolescents|adolescents
604016|NCT00622739|Treatment|treatment
604017|NCT00622726|Vascular Endothelial Growth Factor|vascular endothelial growth factor
604018|NCT00622726|Angiogenesis Inhibitor|angiogenesis inhibitor
604019|NCT00622726|Premature infants|premature infants
604020|NCT00622726|Bevacizumab|bevacizumab
604021|NCT00622726|Zone I or Posterior Zone II ROP|zone i or posterior zone ii rop
604022|NCT00622726|Aggressive Posterior ROP|aggressive posterior rop
604023|NCT00622726|Stage 3 ROP|stage 3 rop
604024|NCT00622726|Neonatal Intensive Care Unit|neonatal intensive care unit
604025|NCT00622713|Alzheimer's disease|alzheimer's disease
604026|NCT00622713|cholinesterase inhibitor|cholinesterase inhibitor
604027|NCT00622713|rivastigmine|rivastigmine
604028|NCT00622700|MS|ms
604029|NCT00622700|Clinically Isolated Syndrome|clinically isolated syndrome
604030|NCT00622700|CIS|cis
604031|NCT00622700|CDMS|cdms
604032|NCT00622700|relapses|relapses
604033|NCT00622687|iloprost|iloprost
604034|NCT00622687|systemic sclerosis|systemic sclerosis
604035|NCT00622687|digital ulcers|digital ulcers
604036|NCT00622687|observational study|observational study
604037|NCT00622687|randomized|randomized
604038|NCT00622674|recurrent breast cancer|recurrent breast cancer
604039|NCT00622674|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
604040|NCT00622674|recurrent small cell lung cancer|recurrent small cell lung cancer
604041|NCT00622674|recurrent colon cancer|recurrent colon cancer
604042|NCT00622674|recurrent pancreatic cancer|recurrent pancreatic cancer
604043|NCT00622674|recurrent head and neck cancer|recurrent head and neck cancer
604044|NCT00622674|recurrent sarcoma|recurrent sarcoma
604045|NCT00622674|recurrent kidney cancer|recurrent kidney cancer
604046|NCT00622674|recurrent renal cell cancer|recurrent renal cell cancer
604047|NCT00622661|Glycemic response|glycemic response
604048|NCT00622661|Glycemic index|glycemic index
604049|NCT00622661|Obesity|obesity
604050|NCT00622661|Carbohydrates|carbohydrates
604051|NCT00622661|Insulin|insulin
604052|NCT00622661|Blood glucose|blood glucose
604053|NCT00622648|Medical prevention therapy|medical prevention therapy
604054|NCT00622635|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
604055|NCT00622635|COPD|copd
604056|NCT00622635|indacaterol|indacaterol
604057|NCT00622609|first time in human,|first time in human,
604058|NCT00622609|MAG|mag
604059|NCT00622609|monoclonal antibody,|monoclonal antibody,
604060|NCT00622609|healthy subjects,|healthy subjects,
604061|NCT00622609|GSK249320,|gsk249320,
604062|NCT00622596|opiate dependence|opiate dependence
604063|NCT00622596|buprenorphine|buprenorphine
604064|NCT00622583|Herniorrhaphy|herniorrhaphy
604065|NCT00622570|Traumatic brain injury, barbiturate coma|traumatic brain injury, barbiturate coma
604066|NCT00622544|Microalbuminuria|microalbuminuria
604067|NCT00622544|Proteinuria|proteinuria
604068|NCT00622531|heart failure|heart failure
604069|NCT00622531|BNP|bnp
604070|NCT00622531|natriuretic peptide|natriuretic peptide
604071|NCT00622518|otitis media|otitis media
604072|NCT00622518|children|children
604073|NCT00622505|Multiple myeloma|multiple myeloma
604074|NCT00622505|zoledronic acid|zoledronic acid
604075|NCT00622505|skeletal complications|skeletal complications
604076|NCT00622505|bone|bone
604077|NCT00622492|VV-ECMO|vv-ecmo
604078|NCT00622492|VA-ECMO|va-ecmo
604079|NCT00622492|PPHN|pphn
604080|NCT00622492|organ circulation|organ circulation
604081|NCT00622479|Sorafenib|sorafenib
604082|NCT00622479|Hypophosphatemia|hypophosphatemia
604083|NCT00622479|Left ventricular ejection fraction (LVEF)|left ventricular ejection fraction (lvef)
604084|NCT00622479|Beta-type Natriuretic Peptide (BNP)|beta-type natriuretic peptide (bnp)
604085|NCT00622466|stage IV breast cancer|stage iv breast cancer
604086|NCT00622466|male breast cancer|male breast cancer
604087|NCT00622466|recurrent breast cancer|recurrent breast cancer
604088|NCT00622466|HER2-negative breast cancer|her2-negative breast cancer
604089|NCT00622440|HSIL|hsil
604090|NCT00622440|HGAIN|hgain
604091|NCT00622440|AIN|ain
604092|NCT00622440|neoplasia|neoplasia
604093|NCT00622440|dysplasia|dysplasia
604094|NCT00622440|TCM|tcm
604095|NCT00622440|Traditional Chinese Medicine|traditional chinese medicine
604096|NCT00622401|stage IV breast cancer|stage iv breast cancer
604097|NCT00622401|dendritic cell vaccine|dendritic cell vaccine
604098|NCT00622401|tumor fusion vaccine|tumor fusion vaccine
604099|NCT00622401|IL-12|il-12
604100|NCT00622375|Pharmacokinetic study|pharmacokinetic study
604101|NCT00622375|Healthy subjects|healthy subjects
604102|NCT00622362|Immunotherapy|immunotherapy
604103|NCT00622362|Allergy|allergy
604104|NCT00622362|Allergoid|allergoid
604105|NCT00622362|Depigmented|depigmented
604106|NCT00622362|Polymerized|polymerized
604107|NCT00622362|Allergen-extract|allergen-extract
604108|NCT00622362|mites|mites
604109|NCT00622362|Asthma|asthma
604110|NCT00622349|Randomised phase III|randomised phase iii
604111|NCT00622349|Chemotherapy|chemotherapy
604112|NCT00622349|Advanced non-small cell lung carcinoma|advanced non-small cell lung carcinoma
604113|NCT00622336|Multiple Myeloma|multiple myeloma
604114|NCT00622336|Revlimid|revlimid
604115|NCT00622323|diabetes|diabetes
604116|NCT00622323|exenatide|exenatide
604117|NCT00622323|metformin|metformin
604118|NCT00622323|sulfonylurea|sulfonylurea
604119|NCT00622323|Byetta|byetta
604120|NCT00622323|Amylin|amylin
604121|NCT00622323|Lilly|lilly
604122|NCT00622271|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
604123|NCT00622271|Adolescents and Families|adolescents and families
604124|NCT00622271|Group Therapy Intervention|group therapy intervention
604125|NCT00622258|everolimus|everolimus
604126|NCT00622258|mTOR inhibitor|mtor inhibitor
604127|NCT00622258|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
604128|NCT00622245|Depression|depression
604129|NCT00622245|Bipolar disorder|bipolar disorder
604130|NCT00622245|Placebo-controlled|placebo-controlled
604131|NCT00622245|Double-blind|double-blind
604132|NCT00622245|Multicenter|multicenter
604133|NCT00622245|Clinical study|clinical study
604134|NCT00622245|Mania|mania
604135|NCT00622232|HIV-1|hiv-1
604136|NCT00622232|treatment experienced, complementary therapies|treatment experienced, complementary therapies
604137|NCT00622219|Alcohol abuse|alcohol abuse
604138|NCT00622219|Drug abuse|drug abuse
604139|NCT00622206|Pharmacokinetics|pharmacokinetics
604140|NCT00622206|ritonavir|ritonavir
604141|NCT00622206|saquinavir|saquinavir
604142|NCT00622206|safety and toxicity|safety and toxicity
604143|NCT00622206|treatment experienced|treatment experienced
604144|NCT00622193|NSCLC|nsclc
604145|NCT00622180|Vitiligo|vitiligo
604146|NCT00622180|Light treatment for vitiligo|light treatment for vitiligo
604147|NCT00622180|Excilite|excilite
604148|NCT00622167|Plaque characteristics|plaque characteristics
604149|NCT00622167|DSCT|dsct
604150|NCT00622167|IVUS|ivus
604151|NCT00622141|bioequivalence|bioequivalence
604152|NCT00622141|ritonavir boosted generic GPO saquinavir|ritonavir boosted generic gpo saquinavir
604153|NCT00622141|saftey|saftey
604154|NCT00622141|pharmacokinetics|pharmacokinetics
604155|NCT00622128|Behavioral Research|behavioral research
604156|NCT00622128|Dementia|dementia
604157|NCT00622128|Aggression|aggression
604158|NCT00622102|warfarin|warfarin
604159|NCT00622102|adherence|adherence
604160|NCT00622102|Mechanical heart valves|mechanical heart valves
604161|NCT00622089|diabetes|diabetes
604162|NCT00622089|type 2 diabetes|type 2 diabetes
604163|NCT00622089|cholesterol|cholesterol
604164|NCT00622076|postoperative|postoperative
604165|NCT00622076|Catheterization|catheterization
604166|NCT00622076|colporrhaphy|colporrhaphy
604167|NCT00622076|cystocele|cystocele
604168|NCT00622076|cystitis|cystitis
604169|NCT00622063|cancer, solid tumor|cancer, solid tumor
604170|NCT00622024|Arrhythmia|arrhythmia
604171|NCT00622024|Depression|depression
604172|NCT00622024|Coronary Artery Disease|coronary artery disease
604173|NCT00621998|Risperidone|risperidone
604174|NCT00621998|Olanzapine|olanzapine
604175|NCT00621998|Tardive dyskinesia|tardive dyskinesia
604176|NCT00621972|acute renal failure|acute renal failure
604177|NCT00621972|arteriovenous fistula|arteriovenous fistula
604178|NCT00621972|KIM-1|kim-1
604179|NCT00621972|chronic kidney disease|chronic kidney disease
604180|NCT00621959|levocetirizine|levocetirizine
604181|NCT00621959|Xyzal|xyzal
604182|NCT00621959|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
604183|NCT00621959|total symptom score|total symptom score
604184|NCT00621959|quality of life|quality of life
604185|NCT00621946|Asthma|asthma
604186|NCT00621946|Depression|depression
604187|NCT00621946|Escitalopram|escitalopram
604188|NCT00621907|randomized|randomized
604189|NCT00621907|analgesic|analgesic
604190|NCT00621907|caesarean scars|caesarean scars
604191|NCT00621907|locoregional anaesthesia|locoregional anaesthesia
604192|NCT00621907|infiltration|infiltration
604193|NCT00621907|levobupivacaïne|levobupivacaïne
604194|NCT00621907|Chirocaïne|chirocaïne
604195|NCT00621907|caesarian|caesarian
604196|NCT00621907|unique administration|unique administration
604197|NCT00621907|post-caesarian analgesic|post-caesarian analgesic
604198|NCT00621894|Immune thrombocytopenic purpura|immune thrombocytopenic purpura
604199|NCT00621894|thrombopoietin mimetic|thrombopoietin mimetic
604200|NCT00621894|ITP|itp
604201|NCT00621881|hepatic impairment|hepatic impairment
604202|NCT00621868|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
604203|NCT00621868|ASP1941|asp1941
604204|NCT00621842|Geriatric Psychiatry|geriatric psychiatry
604205|NCT00621842|Aged|aged
604206|NCT00621842|lamotrigine|lamotrigine
604207|NCT00621816|nitroprusside|nitroprusside
604208|NCT00621816|intensive care unit|intensive care unit
604209|NCT00621816|hypertension|hypertension
604210|NCT00621816|blood pressure reduction|blood pressure reduction
604211|NCT00621803|Probiotic|probiotic
604212|NCT00621803|Pseudomonas aeruginosa|pseudomonas aeruginosa
604213|NCT00621803|Gastric colonization|gastric colonization
604214|NCT00621803|Respiratory tract colonization|respiratory tract colonization
604215|NCT00621803|Ventilator aquired pneumoniae|ventilator aquired pneumoniae
604216|NCT00621803|determine the effect of oral administration of this probiotic on gastric and respiratory tract colonisation/infection by P. aeruginosa|determine the effect of oral administration of this probiotic on gastric and respiratory tract colonisation/infection by p. aeruginosa
604217|NCT00621790|fenoldopam|fenoldopam
604218|NCT00621790|acute renal failure|acute renal failure
604219|NCT00621790|renal replacement therapy|renal replacement therapy
604220|NCT00621790|mortality|mortality
604221|NCT00621790|cardiac surgery|cardiac surgery
604222|NCT00621790|cardiac anesthesia|cardiac anesthesia
604223|NCT00621790|intensive care unit|intensive care unit
604224|NCT00621777|schizophrenia|schizophrenia
604225|NCT00621777|bipolar disorder|bipolar disorder
604226|NCT00621777|varenicline|varenicline
604227|NCT00621777|smoking cessation|smoking cessation
604228|NCT00621777|relapse prevention|relapse prevention
604229|NCT00621777|cognitive behavioral therapy|cognitive behavioral therapy
604230|NCT00621764|Japanese encephalitis (JE)|japanese encephalitis (je)
604231|NCT00621764|Hepatitis A|hepatitis a
604232|NCT00621764|Inactivated Mouse-Brain|inactivated mouse-brain
604233|NCT00621751|Brain Injury|brain injury
604234|NCT00621751|Irritability|irritability
604235|NCT00621751|Aggression|aggression
604236|NCT00621738|mental stress|mental stress
604362|NCT00621309|drug interactions|drug interactions
604237|NCT00621738|cardiovascular risk factor|cardiovascular risk factor
604238|NCT00621738|platelet adhesion|platelet adhesion
604239|NCT00621725|Advanced cancer|advanced cancer
604240|NCT00621725|metastatic|metastatic
604241|NCT00621725|hepatic impairment|hepatic impairment
604242|NCT00621712|Renal Dialysis|renal dialysis
604243|NCT00621712|Dialysis, Extracorporeal|dialysis, extracorporeal
604244|NCT00621712|Dialysis, Renal|dialysis, renal
604245|NCT00621712|Extracorporeal Dialysis|extracorporeal dialysis
604246|NCT00621699|pharmacokinetics|pharmacokinetics
604247|NCT00621699|drug interactions|drug interactions
604248|NCT00621699|ezetimibe|ezetimibe
604249|NCT00621699|tacrolimus|tacrolimus
604250|NCT00621699|human experimentation|human experimentation
604251|NCT00621686|adult glioblastoma|adult glioblastoma
604252|NCT00621686|adult giant cell glioblastoma|adult giant cell glioblastoma
604253|NCT00621686|adult gliosarcoma|adult gliosarcoma
604254|NCT00621686|recurrent adult brain tumor|recurrent adult brain tumor
604255|NCT00621673|Hemophilia A,|hemophilia a,
604256|NCT00621673|Inhibitor formation,|inhibitor formation,
604257|NCT00621673|rFVIII|rfviii
604258|NCT00621660|Acupuncture therapy|acupuncture therapy
604259|NCT00621660|Cancer|cancer
604260|NCT00621660|Emesis|emesis
604261|NCT00621660|Expectations|expectations
604262|NCT00621660|Placebo|placebo
604263|NCT00621647|Seroquel|seroquel
604264|NCT00621647|dementia|dementia
604265|NCT00621647|agitation symptoms|agitation symptoms
604266|NCT00621647|Alzheimer's disease|alzheimer's disease
604267|NCT00621647|vascular dementia|vascular dementia
604268|NCT00621647|quetiapine fumarate|quetiapine fumarate
604269|NCT00621634|Tardive dyskinesia|tardive dyskinesia
604270|NCT00621634|Schizophrenia|schizophrenia
604271|NCT00621634|Essential fatty acids|essential fatty acids
604272|NCT00621621|atrioventricular nodal reentrant tachycardia|atrioventricular nodal reentrant tachycardia
604273|NCT00621621|AVNRT|avnrt
604274|NCT00621608|Chronic ulcers|chronic ulcers
604275|NCT00621608|Diabetes|diabetes
604276|NCT00621608|Hyperbaric Oxygen Therapy|hyperbaric oxygen therapy
604277|NCT00621595|School Breakfast|school breakfast
604278|NCT00621595|Diet|diet
604279|NCT00621595|Nutrition|nutrition
604280|NCT00621595|Brain Function|brain function
604281|NCT00621595|Cognition|cognition
604282|NCT00621595|USDA|usda
604283|NCT00621595|Healthy Children|healthy children
604284|NCT00621569|Blood Pressure|blood pressure
604285|NCT00621569|Dash Diet|dash diet
604286|NCT00621543|Intrauterine Device|intrauterine device
604287|NCT00621543|Induced Abortion|induced abortion
604288|NCT00621543|Medical Abortion|medical abortion
604289|NCT00621530|Total hip arthroplasty|total hip arthroplasty
604290|NCT00621530|Total hip replacement|total hip replacement
604291|NCT00621530|Pain, postoperative|pain, postoperative
604292|NCT00621530|Ketorolac|ketorolac
604293|NCT00621530|Patients undergoing unilateral total hip arthroplasty|patients undergoing unilateral total hip arthroplasty
604294|NCT00621517|Restless Legs Syndrome|restless legs syndrome
604295|NCT00621517|Bupropion|bupropion
604296|NCT00621504|ceftaroline|ceftaroline
604297|NCT00621504|Community-acquired pneumonia|community-acquired pneumonia
604298|NCT00621504|CAP|cap
604299|NCT00621504|IV (intravenous)|iv (intravenous)
604300|NCT00621504|Streptococcus pneumoniae|streptococcus pneumoniae
604301|NCT00621504|Haemophilus influenzae|haemophilus influenzae
604302|NCT00621504|Mycoplasma pneumoniae|mycoplasma pneumoniae
604303|NCT00621504|Chlamydophila spp|chlamydophila spp
604304|NCT00621504|Legionella spp|legionella spp
604305|NCT00621504|Multi-drug resistant Streptococcus pneumoniae (MDRSP)|multi-drug resistant streptococcus pneumoniae (mdrsp)
604306|NCT00621504|antimicrobial resistance|antimicrobial resistance
604307|NCT00621504|pneumococci|pneumococci
604308|NCT00621504|Ceftriaxone|ceftriaxone
604309|NCT00621504|bacteria|bacteria
604310|NCT00621504|ß-lactam|ß-lactam
604311|NCT00621504|beta-lactam|beta-lactam
604312|NCT00621504|antibiotic|antibiotic
604313|NCT00621491|cardiac pacing|cardiac pacing
604314|NCT00621491|pacing complication|pacing complication
604315|NCT00621491|venous thrombosis|venous thrombosis
604316|NCT00621491|warfarin|warfarin
604317|NCT00621491|anticoagulation|anticoagulation
604318|NCT00621491|randomized trial|randomized trial
604319|NCT00621465|Psychosis|psychosis
604320|NCT00621465|Homelessness|homelessness
604321|NCT00621465|Case Management|case management
604322|NCT00621465|Severe Mental Illness|severe mental illness
604323|NCT00621439|ocular melanoma|ocular melanoma
604324|NCT00621426|T wave alternans (TWA)|t wave alternans (twa)
604325|NCT00621426|dialysis|dialysis
604326|NCT00621426|end stage renal disease|end stage renal disease
604327|NCT00621426|sudden cardiac death|sudden cardiac death
604328|NCT00621426|T-wave alternans|t-wave alternans
604329|NCT00621426|Cardiac electrical instability|cardiac electrical instability
604330|NCT00621426|Sympathetic and electrolyte-induced alterations|sympathetic and electrolyte-induced alterations
604331|NCT00621426|Ventricular repolarization|ventricular repolarization
604332|NCT00621413|prostate|prostate
604333|NCT00621413|cancer|cancer
604334|NCT00621413|intermediate risk|intermediate risk
604335|NCT00621413|high risk|high risk
604336|NCT00621413|brachytherapy|brachytherapy
604337|NCT00621413|Cesium-131|cesium-131
604338|NCT00621413|seed brachytherapy|seed brachytherapy
604339|NCT00621413|intermediate and high risk cancer of the prostate|intermediate and high risk cancer of the prostate
604340|NCT00621400|newly-diagnosed light-chain (AL)-amyloidosis|newly-diagnosed light-chain (al)-amyloidosis
604341|NCT00621387|reactive arthritis|reactive arthritis
604342|NCT00621387|antibiotics|antibiotics
604343|NCT00621374|Pain Management|pain management
604344|NCT00621374|Cognitive Behavior Therapy|cognitive behavior therapy
604345|NCT00621374|Hypnosis|hypnosis
604346|NCT00621361|Lung Cancer|lung cancer
604347|NCT00621361|AZD2171|azd2171
604348|NCT00621361|cediranib|cediranib
604349|NCT00621361|RECENTIN|recentin
604350|NCT00621361|etoposide|etoposide
604351|NCT00621361|cisplatin|cisplatin
604352|NCT00621348|maintenance fluids|maintenance fluids
604353|NCT00621348|hyponatremia|hyponatremia
604354|NCT00621348|vasopressin|vasopressin
604355|NCT00621348|children|children
604356|NCT00621335|Open angle glaucoma|open angle glaucoma
604357|NCT00621335|Ocular hypertension|ocular hypertension
604358|NCT00621335|Parallel comparison|parallel comparison
604359|NCT00621335|Combigan|combigan
604360|NCT00621335|Cosopt|cosopt
604361|NCT00621322|Tuberculosis vaccine|tuberculosis vaccine
604363|NCT00621309|cytochrome P4503A4|cytochrome p4503a4
604364|NCT00621309|Pregnane X-receptor|pregnane x-receptor
604365|NCT00621309|induction|induction
604366|NCT00621309|drug metabolism|drug metabolism
604367|NCT00621296|Chronic Hepatitis C|chronic hepatitis c
604368|NCT00621296|Protease Inhibitor|protease inhibitor
604369|NCT00621270|Major Depression Neurogenesis|major depression neurogenesis
604370|NCT00621270|Major Depressive Disorder with Concomitant Anxiety|major depressive disorder with concomitant anxiety
604371|NCT00621257|IBD|ibd
604372|NCT00621257|Inflammatory Bowel Disease|inflammatory bowel disease
604373|NCT00621257|Crohn's Disease|crohn's disease
604374|NCT00621257|Ulcerative Colitis|ulcerative colitis
604375|NCT00621257|Vitamin D|vitamin d
604376|NCT00621244|HDAC inhibitor|hdac inhibitor
604377|NCT00621244|Oral|oral
604378|NCT00621244|LBH589|lbh589
604379|NCT00621244|Lymphoma|lymphoma
604380|NCT00621244|Leukemia|leukemia
604381|NCT00621244|Multiple myeloma|multiple myeloma
604382|NCT00621231|Protein Function|protein function
604383|NCT00621231|normal versus high protein intake|normal versus high protein intake
604384|NCT00621218|tretinoin, efficacy, safety, rosacea|tretinoin, efficacy, safety, rosacea
604385|NCT00621205|Insulin resistance, weight reduction, adipose tissue, peripheral|insulin resistance, weight reduction, adipose tissue, peripheral
604386|NCT00621205|mononuclear cells, gene expression profile, transcriptomics|mononuclear cells, gene expression profile, transcriptomics
604387|NCT00621192|meropenem|meropenem
604388|NCT00621192|infants|infants
604389|NCT00621192|intra-abdominal infection|intra-abdominal infection
604390|NCT00621192|pharmacokinetics|pharmacokinetics
604391|NCT00621192|safety|safety
604392|NCT00621179|Endometriosis,infertility,in vitro fertilization|endometriosis,infertility,in vitro fertilization
604393|NCT00621166|Generic lopinavir/ritonavir|generic lopinavir/ritonavir
604394|NCT00621166|Pharmacokinetics|pharmacokinetics
604395|NCT00621166|Pregnancy|pregnancy
604396|NCT00621166|Antiviral activity|antiviral activity
604397|NCT00621166|Safety|safety
604398|NCT00621153|Candesartan Cilexetil|candesartan cilexetil
604399|NCT00621153|hydrochlorothiazide|hydrochlorothiazide
604400|NCT00621153|severe hypertension|severe hypertension
604401|NCT00621114|Dialysis, Extracorporeal|dialysis, extracorporeal
604402|NCT00621114|Dialysis, Renal|dialysis, renal
604403|NCT00621114|Extracorporeal Dialysis|extracorporeal dialysis
604404|NCT00621114|Hemodialysis|hemodialysis
604405|NCT00621101|pharmacokinetics|pharmacokinetics
604406|NCT00621101|drug interactions|drug interactions
604407|NCT00621101|ezetimibe|ezetimibe
604408|NCT00621101|sirolimus|sirolimus
604409|NCT00621101|human experimentation|human experimentation
604410|NCT00621075|PAH; V/Q SCAN;RHC;Echo;CT Scans; Angiography;PFTs|pah; v/q scan;rhc;echo;ct scans; angiography;pfts
604411|NCT00621062|varicose|varicose
604412|NCT00621062|vein|vein
604413|NCT00621062|ligation|ligation
604414|NCT00621062|laser|laser
604415|NCT00621062|foam|foam
604416|NCT00621062|sclerotherapy|sclerotherapy
604417|NCT00621062|radiofrequency|radiofrequency
604418|NCT00621062|duplex|duplex
604419|NCT00621062|sf36|sf36
604420|NCT00621062|Aberdeen|aberdeen
604421|NCT00621062|VCSS|vcss
604422|NCT00621062|quality|quality
604423|NCT00621062|recurrence|recurrence
604424|NCT00621049|Non-Small Cell Lung Cancer|non-small cell lung cancer
604425|NCT00621049|Resected|resected
604426|NCT00621049|Carboplatin|carboplatin
604427|NCT00621049|Docetaxel|docetaxel
604428|NCT00621049|Bevacizumab|bevacizumab
604429|NCT00621049|Erlotinib|erlotinib
604430|NCT00621036|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
604431|NCT00621036|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
604432|NCT00621036|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
604433|NCT00621036|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
604434|NCT00621036|anaplastic large cell lymphoma|anaplastic large cell lymphoma
604435|NCT00621036|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
604436|NCT00621036|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
604437|NCT00621036|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
604438|NCT00621036|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
604439|NCT00621036|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
604440|NCT00621036|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
604441|NCT00621036|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
604442|NCT00621036|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
604443|NCT00621036|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
604444|NCT00621036|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
604445|NCT00621036|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
604446|NCT00621036|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
604447|NCT00621036|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
604448|NCT00621036|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
604449|NCT00621036|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
604450|NCT00621036|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
604451|NCT00621036|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
604452|NCT00621036|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
604453|NCT00621036|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
604454|NCT00621036|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
604455|NCT00621036|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
604456|NCT00621036|intraocular lymphoma|intraocular lymphoma
604457|NCT00621036|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
604458|NCT00621036|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
604459|NCT00621036|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
604460|NCT00621036|small intestine lymphoma|small intestine lymphoma
604461|NCT00621036|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
604462|NCT00621023|Myelodysplastic syndrome|myelodysplastic syndrome
604463|NCT00621023|MDS|mds
604464|NCT00620997|cornea|cornea
604465|NCT00620997|analgesia|analgesia
604466|NCT00620997|topical|topical
604467|NCT00620997|anesthetic|anesthetic
604468|NCT00620984|Staphylococcus aureus|staphylococcus aureus
604469|NCT00620984|Breastfeeding|breastfeeding
604470|NCT00620984|Lactational Mastitis|lactational mastitis
604471|NCT00620984|Polymerase Chain Reaction (PCR) amplification analysis|polymerase chain reaction (pcr) amplification analysis
604472|NCT00620984|staphylococcal infections|staphylococcal infections
604473|NCT00620984|staphylococcal Carrier State|staphylococcal carrier state
604474|NCT00620971|Non Small Cell Lung Cancer|non small cell lung cancer
604475|NCT00620971|Cisplatin|cisplatin
604476|NCT00620971|VInorelbine|vinorelbine
604477|NCT00620971|Docetaxel|docetaxel
604478|NCT00620971|Gemcitabine|gemcitabine
604479|NCT00620971|Bevacizumab|bevacizumab
604480|NCT00620958|Mediation|mediation
604481|NCT00620958|Outcome|outcome
604482|NCT00620958|CBT|cbt
604483|NCT00620958|Child Anxiety Intervention|child anxiety intervention
604484|NCT00620945|Congenital heart surgery|congenital heart surgery
604485|NCT00620945|Cardiopulmonary bypass|cardiopulmonary bypass
604486|NCT00620945|Phenoxybenzamine|phenoxybenzamine
604487|NCT00620906|manipulation|manipulation
604488|NCT00620906|manual therapy|manual therapy
604489|NCT00620906|Sacroiliac joint|sacroiliac joint
604490|NCT00620906|effects on manipulation on sacroiliac joint|effects on manipulation on sacroiliac joint
604491|NCT00620893|Dry eye signs and symptoms|dry eye signs and symptoms
604492|NCT00620893|refractive regression|refractive regression
604493|NCT00620841|Tacrolimus|tacrolimus
604494|NCT00620841|Renal Transplantation|renal transplantation
604495|NCT00620841|genetic polymorphisms|genetic polymorphisms
604496|NCT00620841|Drug drug interactions|drug drug interactions
604497|NCT00620815|avian flu|avian flu
604498|NCT00620815|seasonal influenza vaccine|seasonal influenza vaccine
604499|NCT00620815|influenza vaccine|influenza vaccine
604500|NCT00620815|prepandemic vaccine|prepandemic vaccine
604501|NCT00620815|virus strain with the potential to cause pandemic|virus strain with the potential to cause pandemic
604502|NCT00620815|tetravalent vaccine|tetravalent vaccine
604503|NCT00620815|Prophylaxis of influenza|prophylaxis of influenza
604504|NCT00620802|Platelet function testing|platelet function testing
604505|NCT00620802|Healthy volunteers|healthy volunteers
604506|NCT00620789|Insomnia|insomnia
604507|NCT00620789|Depression|depression
604508|NCT00620776|Generalized Anxiety Disorder|generalized anxiety disorder
604509|NCT00620776|Cognitive Behavioral Therapy|cognitive behavioral therapy
604510|NCT00620776|Psychotherapy plus medication|psychotherapy plus medication
604511|NCT00620776|Combined treatment|combined treatment
604512|NCT00620763|Meat protein|meat protein
604513|NCT00620763|acid load|acid load
604514|NCT00620763|calcium retention|calcium retention
604515|NCT00620763|postmenopausal women|postmenopausal women
604516|NCT00620750|Alcohol dependence|alcohol dependence
604517|NCT00620711|Hypoxic ischemic encephalopathy|hypoxic ischemic encephalopathy
604518|NCT00620711|HIE|hie
604519|NCT00620711|Neonatal encephalopathy|neonatal encephalopathy
604520|NCT00620711|Cooling|cooling
604521|NCT00620711|hypothermia|hypothermia
604522|NCT00620698|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
604523|NCT00620698|motor neuron disease|motor neuron disease
604524|NCT00620698|outcome measure|outcome measure
604525|NCT00620698|biomarker|biomarker
604526|NCT00620698|impedance|impedance
604527|NCT00620685|Arthritis, rheumatoid|arthritis, rheumatoid
604528|NCT00620672|n-3 supplementation during pregnancy|n-3 supplementation during pregnancy
604529|NCT00620672|DHA and pregnancy, infant development|dha and pregnancy, infant development
604530|NCT00620672|n-3 status and gestation|n-3 status and gestation
604531|NCT00620672|DHA and visual acuity and cognition during infancy|dha and visual acuity and cognition during infancy
604532|NCT00620646|clopidogrel|clopidogrel
604533|NCT00620646|platelets|platelets
604534|NCT00620646|percutaneous coronary intervention|percutaneous coronary intervention
604535|NCT00620633|Bone Marrow|bone marrow
604536|NCT00620620|Healthy adult volunteers|healthy adult volunteers
604537|NCT00620607|gastric|gastric
604538|NCT00620594|Neoplasms|neoplasms
604539|NCT00620594|breast neoplasms|breast neoplasms
604540|NCT00620594|breast diseases|breast diseases
604541|NCT00620594|solid tumors|solid tumors
604542|NCT00620594|BEZ235|bez235
604543|NCT00620594|breast cancer|breast cancer
604544|NCT00620594|PI3K Inhibitor|pi3k inhibitor
604545|NCT00620594|Phosphatidylinositol 3|phosphatidylinositol 3
604546|NCT00620594|kinase|kinase
604547|NCT00620594|advanced|advanced
604548|NCT00620568|Safety|safety
604549|NCT00620568|Tolerability|tolerability
604550|NCT00620568|Schizophrenia|schizophrenia
604551|NCT00620542|Coronary artery disease|coronary artery disease
604552|NCT00620529|polycystic ovary syndrome|polycystic ovary syndrome
604553|NCT00620529|cardiovascular risk|cardiovascular risk
604554|NCT00620529|metabolism|metabolism
604555|NCT00620529|blood pressure|blood pressure
604556|NCT00620529|liver fat|liver fat
604557|NCT00620529|heart rate variability|heart rate variability
604558|NCT00620503|PK|pk
604559|NCT00620503|Pharmacokinetics|pharmacokinetics
604560|NCT00620490|Epidural analgesia|epidural analgesia
604561|NCT00620490|Contraindications|contraindications
604562|NCT00620490|Paravertebral nerve block analgesia|paravertebral nerve block analgesia
604563|NCT00620490|ropivacaine|ropivacaine
604564|NCT00620490|Visual analogical scale|visual analogical scale
604565|NCT00620490|Morphine|morphine
604566|NCT00620490|Side effects|side effects
604567|NCT00620490|Pain and thoracotomy|pain and thoracotomy
604568|NCT00620451|Treatment|treatment
604569|NCT00620451|Active|active
604570|NCT00620451|Celiac|celiac
604571|NCT00620451|Remission|remission
604572|NCT00620451|Induction|induction
604573|NCT00620438|Lumefantrine|lumefantrine
604574|NCT00620438|Efavirenz|efavirenz
604575|NCT00620438|Nevirapine|nevirapine
604576|NCT00620438|Rifampicin|rifampicin
604577|NCT00620438|HIV|hiv
604578|NCT00620425|sumatriptan|sumatriptan
604579|NCT00620425|Intraject|intraject
604580|NCT00620425|Local Site Reactions|local site reactions
604581|NCT00620412|influenza|influenza
604582|NCT00620412|vaccines|vaccines
604583|NCT00620412|probiotics|probiotics
604584|NCT00620412|LGG|lgg
604585|NCT00620399|lumbar fusion|lumbar fusion
604586|NCT00620386|Intubating conditions|intubating conditions
604587|NCT00620386|Bonfils intubation fiberscope|bonfils intubation fiberscope
604588|NCT00620386|Macintosh laryngoscope|macintosh laryngoscope
604589|NCT00620386|neuromuscular blockade|neuromuscular blockade
604590|NCT00620373|Dense breast tissue|dense breast tissue
604591|NCT00620373|Breast Cancer Screening|breast cancer screening
604592|NCT00620373|Molecular Breast Imaging|molecular breast imaging
604593|NCT00620373|Breast Cancer|breast cancer
604594|NCT00620373|Breast|breast
604595|NCT00620360|dietary fructose|dietary fructose
604596|NCT00620360|plasma lipids|plasma lipids
604597|NCT00620360|healthy humans|healthy humans
604598|NCT00620360|gender differences|gender differences
604599|NCT00620360|hepatic de novo lipogenesis|hepatic de novo lipogenesis
604953|NCT00619281|Morbidity|morbidity
604600|NCT00620347|SCLC (small cell lung cancer)|sclc (small cell lung cancer)
604601|NCT00620347|ED (extensive disease)|ed (extensive disease)
604602|NCT00620347|RR (response rate)|rr (response rate)
604603|NCT00620334|ASTHMA|asthma
604604|NCT00620295|recurrent pancreatic cancer|recurrent pancreatic cancer
604605|NCT00620295|recurrent breast cancer|recurrent breast cancer
604606|NCT00620295|recurrent small cell lung cancer|recurrent small cell lung cancer
604607|NCT00620295|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
604608|NCT00620295|recurrent colon cancer|recurrent colon cancer
604609|NCT00620295|recurrent prostate cancer|recurrent prostate cancer
604610|NCT00620295|recurrent head and neck cancer|recurrent head and neck cancer
604611|NCT00620295|ovarian cancer|ovarian cancer
604612|NCT00620295|recurrent uterine cancer|recurrent uterine cancer
604613|NCT00620295|recurrent kidney cancer|recurrent kidney cancer
604614|NCT00620295|recurrent osteosarcoma|recurrent osteosarcoma
604615|NCT00620269|NSCLC|nsclc
604616|NCT00620269|EGFR mutation|egfr mutation
604617|NCT00620269|Erlotinib|erlotinib
604618|NCT00620269|IP chemotherapy|ip chemotherapy
604619|NCT00620269|CCRT|ccrt
604620|NCT00620256|Glaucoma|glaucoma
604621|NCT00620256|Hypertension|hypertension
604622|NCT00620243|Ovarian cancer|ovarian cancer
604623|NCT00620243|PET|pet
604624|NCT00620243|CT|ct
604625|NCT00620243|04-064|04-064
604626|NCT00620230|Allergic rhinitis, anti-interleukin 4|allergic rhinitis, anti-interleukin 4
604627|NCT00620217|heart ischemia|heart ischemia
604628|NCT00620217|coronary artery disease|coronary artery disease
604629|NCT00620217|plasmid|plasmid
604630|NCT00620217|VEGF|vegf
604631|NCT00620217|FGF|fgf
604632|NCT00620217|percutaneous|percutaneous
604633|NCT00620217|gene therapy|gene therapy
604634|NCT00620217|SPECT|spect
604635|NCT00620217|nuclear magnetic resonance|nuclear magnetic resonance
604636|NCT00620204|atorvastatin|atorvastatin
604637|NCT00620204|Angina Pectoris, Variant|angina pectoris, variant
604638|NCT00620204|endothelial dysfunction|endothelial dysfunction
604639|NCT00620191|metformin|metformin
604640|NCT00620191|mild cognitive impairment|mild cognitive impairment
604641|NCT00620191|alzheimer's disease|alzheimer's disease
604642|NCT00620191|overweight|overweight
604643|NCT00620191|insulin|insulin
604644|NCT00620178|candesartan|candesartan
604645|NCT00620178|losartan|losartan
604646|NCT00620178|blood pressure|blood pressure
604647|NCT00620178|cardiovascular disease|cardiovascular disease
604648|NCT00620178|health care consumption|health care consumption
604649|NCT00620165|tremor|tremor
604650|NCT00620165|writing|writing
604651|NCT00620165|feeding|feeding
604652|NCT00620165|pouring|pouring
604653|NCT00620139|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
604654|NCT00620139|chemoradiotherapy|chemoradiotherapy
604655|NCT00620139|molecular effects|molecular effects
604656|NCT00620139|05-016|05-016
604657|NCT00620126|Inflammatory bowel disease|inflammatory bowel disease
604658|NCT00620126|Ulcerative colitis|ulcerative colitis
604659|NCT00620126|Telemedicine|telemedicine
604660|NCT00620126|Telemanagement|telemanagement
604661|NCT00620126|Chronic disease|chronic disease
604662|NCT00620087|Atypical lobular hyperplasia|atypical lobular hyperplasia
604663|NCT00620087|Atypical ductal hyperplasia|atypical ductal hyperplasia
604664|NCT00620087|Lobular carcinoma in situ|lobular carcinoma in situ
604665|NCT00620087|Molecular Breast Imaging|molecular breast imaging
604666|NCT00620074|invasive aspergillosis, opportunistic mold infection|invasive aspergillosis, opportunistic mold infection
604667|NCT00620048|heart|heart
604668|NCT00620048|stem Cells|stem cells
604669|NCT00620048|low EF|low ef
604670|NCT00620048|heart attack|heart attack
604671|NCT00620048|cardiomyopathy|cardiomyopathy
604672|NCT00620048|congestive heart failure|congestive heart failure
604673|NCT00620048|cardiovascular disease|cardiovascular disease
604674|NCT00620048|Heart Failure|heart failure
604675|NCT00620048|Low Ejection Fraction|low ejection fraction
604676|NCT00620022|indacaterol|indacaterol
604677|NCT00620022|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
604678|NCT00620022|exercise endurance|exercise endurance
604679|NCT00620022|moderate to severe chronic obstructive pulmonary disease|moderate to severe chronic obstructive pulmonary disease
604680|NCT00620022|COPD|copd
604681|NCT00620009|Empathy|empathy
604682|NCT00620009|Feedback|feedback
604683|NCT00620009|Psychotherapy|psychotherapy
604684|NCT00619996|Prostate Cancer|prostate cancer
604685|NCT00619996|Sorafenib|sorafenib
604686|NCT00619996|Nexavar|nexavar
604687|NCT00619996|Docetaxel|docetaxel
604688|NCT00619996|Pisa|pisa
604689|NCT00619996|Ricci|ricci
604690|NCT00619983|Asymmetric Diabetic Proximal Motor Neuropathy|asymmetric diabetic proximal motor neuropathy
604691|NCT00619983|Diabetic Autonomic Neuropathy|diabetic autonomic neuropathy
604692|NCT00619983|Diabetic Neuralgia|diabetic neuralgia
604693|NCT00619983|Diabetic Neuropathy, Painful|diabetic neuropathy, painful
604694|NCT00619983|Neuralgia, Diabetic|neuralgia, diabetic
604695|NCT00619983|Low back pain, chronic|low back pain, chronic
604696|NCT00619944|HIV|hiv
604697|NCT00619944|lumefantrine|lumefantrine
604698|NCT00619944|lopinavir|lopinavir
604699|NCT00619944|Africa|africa
604700|NCT00619944|Antimalarials|antimalarials
604701|NCT00619944|treatment naïve|treatment naïve
604702|NCT00619931|Healthy adult volunteers|healthy adult volunteers
604703|NCT00619918|bronchiolitis|bronchiolitis
604704|NCT00619918|hypertonic saline|hypertonic saline
604705|NCT00619905|Rheumatoid Arthritis|rheumatoid arthritis
604706|NCT00619905|Anti-interleukin-1 beta|anti-interleukin-1 beta
604707|NCT00619905|ACZ885|acz885
604708|NCT00619892|SSRI Resistant|ssri resistant
604709|NCT00619892|Seroquel SR|seroquel sr
604710|NCT00619892|Seroquel XR|seroquel xr
604711|NCT00619892|Panic Disorder|panic disorder
604712|NCT00619892|Comorbid Panic Disorder|comorbid panic disorder
604713|NCT00619892|Quetiapine SR|quetiapine sr
604714|NCT00619892|Quetiapine XR|quetiapine xr
604715|NCT00619879|Leukemia, Myelogenous, Chronic|leukemia, myelogenous, chronic
604716|NCT00619879|Leukemia, Lymphoblastic, Acute|leukemia, lymphoblastic, acute
604717|NCT00619879|Leukemia, Myelogenous, Acute|leukemia, myelogenous, acute
604718|NCT00619879|Myeloproliferative-Myelodysplastic Diseases|myeloproliferative-myelodysplastic diseases
604719|NCT00619879|Juvenile Myelomonocytic Leukemia|juvenile myelomonocytic leukemia
604720|NCT00619879|Dysmyelopoietic Syndromes|dysmyelopoietic syndromes
604721|NCT00619879|Lymphoma, Malignant|lymphoma, malignant
604722|NCT00619879|Stem Cell Transplantation, Hematopoietic|stem cell transplantation, hematopoietic
604723|NCT00619879|Allogeneic Transplantation|allogeneic transplantation
604724|NCT00619879|Human Leukocyte Antigens|human leukocyte antigens
604725|NCT00619879|Busulfan|busulfan
604726|NCT00619879|Total Body Irradiation|total body irradiation
604727|NCT00619879|VP-16|vp-16
604728|NCT00619879|Etoposide|etoposide
604729|NCT00619879|Cyclophosphamide|cyclophosphamide
604730|NCT00619879|Graft-Versus-Host Disease|graft-versus-host disease
604731|NCT00619866|bone mineral density|bone mineral density
604732|NCT00619866|NBI-56418|nbi-56418
604733|NCT00619866|estradiol|estradiol
604734|NCT00619866|Endometriosis|endometriosis
604735|NCT00619866|Pelvic Pain|pelvic pain
604736|NCT00619853|Improving the assisting hand function in children with Hemiplegic Cerebral palsy|improving the assisting hand function in children with hemiplegic cerebral palsy
604737|NCT00619840|ADHD|adhd
604738|NCT00619840|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
604739|NCT00619840|adult|adult
604740|NCT00619840|methylphenidate hydrochloride|methylphenidate hydrochloride
604741|NCT00619840|Medikinet retard|medikinet retard
604742|NCT00619840|long-term observation|long-term observation
604743|NCT00619840|controlled clinical trial|controlled clinical trial
604744|NCT00619840|safety|safety
604745|NCT00619840|randomized, double-blind, placebo-controlled trial|randomized, double-blind, placebo-controlled trial
604746|NCT00619840|treatment|treatment
604747|NCT00619840|central nervous system stimulants|central nervous system stimulants
604748|NCT00619840|therapeutic uses|therapeutic uses
604749|NCT00619827|Sublingual immunotherapy|sublingual immunotherapy
604750|NCT00619827|Rhinitis|rhinitis
604751|NCT00619827|Conjunctivitis|conjunctivitis
604752|NCT00619827|Allergen challenge|allergen challenge
604753|NCT00619827|Allergen exposition chamber|allergen exposition chamber
604754|NCT00619827|Grass pollen tablet|grass pollen tablet
604755|NCT00619827|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
604756|NCT00619814|Colon polyps|colon polyps
604757|NCT00619814|Fecal occult blood test|fecal occult blood test
604758|NCT00619814|Double contrast barium enema|double contrast barium enema
604759|NCT00619814|Colonoscopy|colonoscopy
604760|NCT00619801|Xyzal|xyzal
604761|NCT00619801|Levocetirizine|levocetirizine
604762|NCT00619801|Allergy|allergy
604763|NCT00619801|Children|children
604764|NCT00619801|Seasonal Allergies|seasonal allergies
604765|NCT00619775|Carotid Artery Disease|carotid artery disease
604766|NCT00619775|Embolic Protection|embolic protection
604767|NCT00619762|Breast reconstruction|breast reconstruction
604768|NCT00619736|Healthy|healthy
604769|NCT00619710|skin infections|skin infections
604770|NCT00619710|MERREM|merrem
604771|NCT00619710|PRIMAXIN IV|primaxin iv
604772|NCT00619710|complex abscess|complex abscess
604773|NCT00619710|perirectal abscess|perirectal abscess
604774|NCT00619710|wound infections|wound infections
604775|NCT00619710|infected ischemic/diabetic ulcers|infected ischemic/diabetic ulcers
604776|NCT00619710|cellulitis|cellulitis
604777|NCT00619710|Meropenem|meropenem
604778|NCT00619710|Imipenem-cilastatin|imipenem-cilastatin
604779|NCT00619671|Rituxan|rituxan
604780|NCT00619671|Rituximab|rituximab
604781|NCT00619671|Myasthenia Gravis|myasthenia gravis
604783|NCT00619658|telephone follow-up|telephone follow-up
604784|NCT00619658|medical abortion|medical abortion
604785|NCT00619658|induced abortion|induced abortion
604786|NCT00619645|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
604787|NCT00619645|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
604788|NCT00619645|refractory anemia with excess blasts|refractory anemia with excess blasts
604789|NCT00619645|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
604790|NCT00619645|refractory anemia|refractory anemia
604791|NCT00619645|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
604792|NCT00619645|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
604793|NCT00619645|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
604794|NCT00619645|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
604795|NCT00619645|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
604796|NCT00619645|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
604797|NCT00619645|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
604798|NCT00619645|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
604799|NCT00619645|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
604800|NCT00619645|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
604801|NCT00619645|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
604802|NCT00619645|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
604803|NCT00619645|refractory multiple myeloma|refractory multiple myeloma
604804|NCT00619645|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
604805|NCT00619645|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
604806|NCT00619645|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
604807|NCT00619645|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
604808|NCT00619645|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
604809|NCT00619645|secondary acute myeloid leukemia|secondary acute myeloid leukemia
604810|NCT00619645|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
604811|NCT00619645|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
604812|NCT00619645|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
604813|NCT00619645|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
604814|NCT00619645|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
604815|NCT00619645|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
604816|NCT00619645|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
604817|NCT00619645|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
604818|NCT00619645|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
604819|NCT00619645|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
604820|NCT00619645|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
604821|NCT00619645|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
604822|NCT00619645|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
604823|NCT00619645|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
604824|NCT00619645|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
604825|NCT00619645|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
604826|NCT00619645|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
604827|NCT00619645|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
604828|NCT00619645|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
604829|NCT00619645|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
604830|NCT00619645|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
604831|NCT00619645|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
604832|NCT00619645|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
604833|NCT00619645|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
604834|NCT00619645|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
604835|NCT00619645|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
604836|NCT00619645|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
604837|NCT00619645|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
604838|NCT00619645|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
604839|NCT00619645|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
604840|NCT00619645|stage I multiple myeloma|stage i multiple myeloma
604841|NCT00619645|stage II multiple myeloma|stage ii multiple myeloma
604842|NCT00619645|stage III multiple myeloma|stage iii multiple myeloma
604843|NCT00619645|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
604844|NCT00619645|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
604846|NCT00619619|Child|child
604847|NCT00619619|Adolescent|adolescent
604848|NCT00619619|Pharmacokinetic|pharmacokinetic
604849|NCT00619619|Outpatient|outpatient
604850|NCT00619619|Pediatrics|pediatrics
604851|NCT00619619|Depressive Disorder|depressive disorder
604852|NCT00619619|Major|major
604853|NCT00619606|prevention of hypoxia|prevention of hypoxia
604854|NCT00619606|prevention of hypercapnia|prevention of hypercapnia
604855|NCT00619593|Heart failure|heart failure
604856|NCT00619593|Ventricular Fibrillation|ventricular fibrillation
604857|NCT00619593|Sudden cardiac death|sudden cardiac death
604858|NCT00619593|Hospitalization due to heart failure|hospitalization due to heart failure
604859|NCT00619593|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
604860|NCT00619593|Risk of 1st heart failure hospitalization|risk of 1st heart failure hospitalization
604861|NCT00619580|E coli|e coli
604862|NCT00619567|Cognition|cognition
604863|NCT00619567|Rehabilitation|rehabilitation
604864|NCT00619567|Cognitive Stimulation|cognitive stimulation
604865|NCT00619567|Human Immunodeficiency Virus|human immunodeficiency virus
604866|NCT00619567|AIDS|aids
604867|NCT00619554|Healthy volunteers|healthy volunteers
604868|NCT00619541|HCC|hcc
604869|NCT00619541|Sorafenib|sorafenib
604870|NCT00619541|Pisa|pisa
604871|NCT00619541|Ricci|ricci
604872|NCT00619541|5-FU|5-fu
604873|NCT00619541|5FU|5fu
604874|NCT00619541|5 FU|5 fu
604875|NCT00619541|Advanced HCC|advanced hcc
604876|NCT00619528|Transplants|transplants
604877|NCT00619528|Kidney Transplantation|kidney transplantation
604878|NCT00619528|Immunosuppression|immunosuppression
604879|NCT00619528|HLA Antigens|hla antigens
604880|NCT00619528|Stem Cells|stem cells
604881|NCT00619528|Bone Marrow|bone marrow
604882|NCT00619515|adenocarcinoma of the prostate|adenocarcinoma of the prostate
604883|NCT00619515|stage I prostate cancer|stage i prostate cancer
604884|NCT00619515|stage II prostate cancer|stage ii prostate cancer
604885|NCT00619502|Hepatitis B|hepatitis b
604886|NCT00619502|Polio|polio
604887|NCT00619502|Diphtheria|diphtheria
604888|NCT00619502|Pertussis|pertussis
604889|NCT00619502|H.influenzae type b|h.influenzae type b
604890|NCT00619476|Neuropathic Pain|neuropathic pain
604891|NCT00619476|Post-herpetic neuralgia|post-herpetic neuralgia
604892|NCT00619476|PHN|phn
604893|NCT00619463|Traumatic Brain Injury|traumatic brain injury
604894|NCT00619463|Exercise|exercise
604895|NCT00619463|Cognition|cognition
604896|NCT00619463|Brain Derived Neurotrophic Factor (BDNF)|brain derived neurotrophic factor (bdnf)
604897|NCT00619463|peripheral vascular endothelial growth factor (VEGF)|peripheral vascular endothelial growth factor (vegf)
604898|NCT00619450|atrial fibrillation|atrial fibrillation
604899|NCT00619450|cardiac pacing|cardiac pacing
604900|NCT00619450|CAT scanner|cat scanner
604901|NCT00619437|schizophrenia|schizophrenia
604902|NCT00619437|genetics|genetics
604903|NCT00619437|family|family
604904|NCT00619437|multiplex|multiplex
604905|NCT00619437|haplotypes|haplotypes
604906|NCT00619424|erlotinib|erlotinib
604907|NCT00619424|pharmacokinetics|pharmacokinetics
604908|NCT00619424|Solid tumors|solid tumors
604909|NCT00619424|pemetrexed|pemetrexed
604910|NCT00619424|anti-angiogenesis|anti-angiogenesis
604911|NCT00619424|pazopanib (GW786034)|pazopanib (gw786034)
604912|NCT00619424|cytokine and angiogenic factors|cytokine and angiogenic factors
604913|NCT00619411|Major Depression|major depression
604914|NCT00619411|Dysthymic Disorder|dysthymic disorder
604915|NCT00619411|Adjustment Disorder|adjustment disorder
604916|NCT00619411|With Depressed Mood|with depressed mood
604917|NCT00619411|Depressive|depressive
604918|NCT00619411|Disorder Not|disorder not
604919|NCT00619411|Otherwise|otherwise
604920|NCT00619411|Specified|specified
604921|NCT00619411|Adolescent|adolescent
604922|NCT00619411|Psychotherapy|psychotherapy
604923|NCT00619398|FK506|fk506
604924|NCT00619398|tacrolimus|tacrolimus
604925|NCT00619398|prograf|prograf
604926|NCT00619398|Liver transplantation|liver transplantation
604927|NCT00619385|Pharmacokinetics|pharmacokinetics
604928|NCT00619372|OKT3|okt3
604929|NCT00619372|beta-glucosylceramide|beta-glucosylceramide
604930|NCT00619372|oral tolerance|oral tolerance
604931|NCT00619372|anti-CD3|anti-cd3
604932|NCT00619372|Safety assessment and healthy volunteers|safety assessment and healthy volunteers
604933|NCT00619346|Safety|safety
604934|NCT00619346|Tolerability|tolerability
604935|NCT00619346|Assessment of potential adverse events and/or laboratory abnormalities|assessment of potential adverse events and/or laboratory abnormalities
604936|NCT00619320|HIV primary prevention|hiv primary prevention
604937|NCT00619320|Health promotion|health promotion
604938|NCT00619320|Health behavior|health behavior
604939|NCT00619320|Risk reduction behavior|risk reduction behavior
604940|NCT00619320|Sexual behavior|sexual behavior
604941|NCT00619320|Safe sex|safe sex
604942|NCT00619320|Women's health|women's health
604943|NCT00619320|Minority health|minority health
604944|NCT00619320|Pregnant Women|pregnant women
604945|NCT00619320|HIV seronegativity|hiv seronegativity
604946|NCT00619294|Coronary Vasospasm|coronary vasospasm
604947|NCT00619294|Endothelium, Vascular|endothelium, vascular
604948|NCT00619294|Vasodilation|vasodilation
604949|NCT00619294|Hyperemia|hyperemia
604950|NCT00619281|Cardiac surgery|cardiac surgery
604951|NCT00619281|Low cardiac output syndrome|low cardiac output syndrome
604952|NCT00619281|Mortality|mortality
604954|NCT00619268|Temsirolimus|temsirolimus
604955|NCT00619268|Bevacizumab|bevacizumab
604956|NCT00619268|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
604957|NCT00619268|Non-progression|non-progression
604958|NCT00619255|Adolescents|adolescents
604959|NCT00619255|Quality Assurance and Improvement|quality assurance and improvement
604960|NCT00619255|Substance Abuse|substance abuse
604961|NCT00619255|Posttraumatic Stress|posttraumatic stress
604962|NCT00619255|Family Centered Care|family centered care
604963|NCT00619255|Trauma Systems|trauma systems
604964|NCT00619242|Esophageal cancer|esophageal cancer
604965|NCT00619229|Alprostadil|alprostadil
604966|NCT00619229|prostaglandin E1|prostaglandin e1
604967|NCT00619229|Prostavasin®|prostavasin®
604968|NCT00619229|macular degeneration|macular degeneration
604969|NCT00619216|Orthotopic Liver Transplant Recipients with GI disturbance|orthotopic liver transplant recipients with gi disturbance
604970|NCT00619203|Bacterial meningitis|bacterial meningitis
604971|NCT00619203|glycerol|glycerol
604972|NCT00619203|high dose paracetamol|high dose paracetamol
604973|NCT00619203|children|children
604974|NCT00619190|open label|open label
604975|NCT00619190|aripiprazole|aripiprazole
604976|NCT00619190|children|children
604977|NCT00619190|adolescents|adolescents
604978|NCT00619190|autism spectrum disorders|autism spectrum disorders
604979|NCT00619164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
604980|NCT00619164|Coronary Stenosis|coronary stenosis
604981|NCT00619164|Coronary Thrombosis|coronary thrombosis
604982|NCT00619151|aortic valve|aortic valve
604983|NCT00619151|heart valve|heart valve
604984|NCT00619151|valve replacement|valve replacement
604985|NCT00619151|Valve disease|valve disease
604986|NCT00619138|Cognitive therapy|cognitive therapy
604987|NCT00619138|Stepped care|stepped care
604988|NCT00619138|Self-help|self-help
604989|NCT00619138|Internet|internet
604990|NCT00619138|Anxiety|anxiety
604991|NCT00619112|adult glioblastoma|adult glioblastoma
604992|NCT00619112|adult gliosarcoma|adult gliosarcoma
604993|NCT00619112|adult anaplastic astrocytoma|adult anaplastic astrocytoma
604994|NCT00619112|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
604995|NCT00619112|adult mixed glioma|adult mixed glioma
604996|NCT00619112|recurrent adult brain tumor|recurrent adult brain tumor
604997|NCT00619099|Myelodysplastic Syndrome|myelodysplastic syndrome
604998|NCT00619099|Decitabine|decitabine
604999|NCT00619099|Dacogen|dacogen
605000|NCT00619099|MGI PHARMA, Inc.|mgi pharma, inc.
605001|NCT00619086|thyroidectomy|thyroidectomy
605002|NCT00619086|dexamethasone|dexamethasone
605003|NCT00619086|steroid|steroid
605004|NCT00619086|nausea|nausea
605005|NCT00619073|blood platelets|blood platelets
605006|NCT00619073|platelet aggregation inhibitors|platelet aggregation inhibitors
605007|NCT00619073|antiplatelet drugs|antiplatelet drugs
605008|NCT00619073|clopidogrel|clopidogrel
605009|NCT00619060|skin cancer|skin cancer
605010|NCT00619060|healthy, no evidence of disease|healthy, no evidence of disease
605011|NCT00619021|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
605012|NCT00619021|stage I non-small cell lung cancer|stage i non-small cell lung cancer
605013|NCT00619021|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
605014|NCT00619008|obesity|obesity
605015|NCT00619008|low carbohydrate diet|low carbohydrate diet
605016|NCT00619008|high complex carbohydrate diet|high complex carbohydrate diet
605017|NCT00619008|weight regulation hormones|weight regulation hormones
605018|NCT00619008|hunger|hunger
605019|NCT00619008|satiety|satiety
605020|NCT00619008|energy expenditure|energy expenditure
605021|NCT00619008|body composition|body composition
605022|NCT00619008|weight loss|weight loss
605023|NCT00618982|Kidney cancer,|kidney cancer,
605024|NCT00618982|Sorafenib,|sorafenib,
605025|NCT00618982|Dose escalation,|dose escalation,
605026|NCT00618982|No previous treatment|no previous treatment
605027|NCT00618969|Haploidentical|haploidentical
605028|NCT00618969|peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
605029|NCT00618969|leukemia|leukemia
605030|NCT00618969|myeloma|myeloma
605031|NCT00618969|Hodgkin's disease|hodgkin's disease
605032|NCT00618969|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
605033|NCT00618956|NSRI|nsri
605034|NCT00618956|milnacipran|milnacipran
605035|NCT00618956|fibromyalgia|fibromyalgia
605036|NCT00618956|blood pressure|blood pressure
605037|NCT00618956|hypertension|hypertension
605038|NCT00618917|NSCLC|nsclc
605039|NCT00618917|lung cancer|lung cancer
605040|NCT00618917|chemotherapy|chemotherapy
605041|NCT00618917|radiation therapy|radiation therapy
605042|NCT00618917|radiation toxicity|radiation toxicity
605043|NCT00618904|Probiotics|probiotics
605044|NCT00618904|Functional Gastrointestinal Symptoms|functional gastrointestinal symptoms
605045|NCT00618865|Omega-3 Fatty Acids|omega-3 fatty acids
605046|NCT00618865|Major Depressive Disorder|major depressive disorder
605047|NCT00618865|Pregnancy|pregnancy
605048|NCT00618865|Women during pregnancy and after childbirth are more vulnerable to psychiatric disorders|women during pregnancy and after childbirth are more vulnerable to psychiatric disorders
605049|NCT00618865|Pharmacotherapy for depression during pregnancy is a clinical dilemma.|pharmacotherapy for depression during pregnancy is a clinical dilemma.
605050|NCT00618865|Omega-3 polyunsaturated fatty acids (PUFAs) might be a promising alternative of treatment for pregnant women with depression.|omega-3 polyunsaturated fatty acids (pufas) might be a promising alternative of treatment for pregnant women with depression.
605051|NCT00618852|Pediatrics|pediatrics
605052|NCT00618852|Erythrocyte Transfusion|erythrocyte transfusion
605053|NCT00618852|Furosemide|furosemide
605054|NCT00618852|Fluid Overload|fluid overload
605055|NCT00618839|Complex skin defects|complex skin defects
605056|NCT00618839|Burns|burns
605057|NCT00618839|Wound infection|wound infection
605058|NCT00618839|Skin trauma|skin trauma
605059|NCT00618826|Breast cancer|breast cancer
605060|NCT00618800|Falls|falls
605061|NCT00618800|Elderly|elderly
605062|NCT00618800|Injury|injury
605063|NCT00618800|Medication|medication
605064|NCT00618800|Pharmacy|pharmacy
605065|NCT00618800|Pharmacist|pharmacist
605066|NCT00618761|glucose clamp|glucose clamp
605067|NCT00618761|beta-cell|beta-cell
605068|NCT00618748|Bipolar|bipolar
605069|NCT00618709|Healthy volunteers|healthy volunteers
605070|NCT00618696|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
605071|NCT00618696|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
605072|NCT00618696|secondary acute myeloid leukemia|secondary acute myeloid leukemia
605073|NCT00618696|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
605074|NCT00618696|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
605075|NCT00618696|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
605076|NCT00618696|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
605077|NCT00618696|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
605078|NCT00618696|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
605079|NCT00618696|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
605080|NCT00618696|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
605081|NCT00618683|AVNRT|avnrt
605082|NCT00618683|Atrioventricular|atrioventricular
605083|NCT00618683|nodal reentrant circuit|nodal reentrant circuit
605084|NCT00618683|nodal reentrant tachycardia|nodal reentrant tachycardia
605085|NCT00618683|Paroxysmal supraventricular tachycardia|paroxysmal supraventricular tachycardia
605086|NCT00618670|aging|aging
605087|NCT00618670|gait|gait
605088|NCT00618670|musculoskeletal disorder therapy|musculoskeletal disorder therapy
605089|NCT00618670|peripheral blood vessel disorder|peripheral blood vessel disorder
605090|NCT00618670|muscle function|muscle function
605091|NCT00618670|muscle strength|muscle strength
605092|NCT00618670|quality of life|quality of life
605093|NCT00618657|pre-operative|pre-operative
605094|NCT00618657|neo-adjuvant|neo-adjuvant
605095|NCT00618657|triple negative|triple negative
605096|NCT00618657|HER2 positive|her2 positive
605097|NCT00618657|hormone receptor positive|hormone receptor positive
605098|NCT00618657|breast|breast
605099|NCT00618657|Carboplatin|carboplatin
605100|NCT00618657|Nab-paclitaxel|nab-paclitaxel
605101|NCT00618657|Trastuzumab|trastuzumab
605102|NCT00618657|Bevacizumab|bevacizumab
605103|NCT00618657|Inflammatory|inflammatory
605104|NCT00618631|Smoking|smoking
605105|NCT00618631|Nicotine|nicotine
605106|NCT00618631|Endogenous Opioids|endogenous opioids
605107|NCT00618631|PET Study|pet study
605108|NCT00618631|Carfentanil|carfentanil
605109|NCT00618605|HIV Seronegativity|hiv seronegativity
605110|NCT00618605|HIV Preventative Vaccine|hiv preventative vaccine
605111|NCT00618592|carbohydrate supplementation|carbohydrate supplementation
605112|NCT00618592|cardiac surgery|cardiac surgery
605113|NCT00618592|spine surgery|spine surgery
605114|NCT00618592|insulin resistance|insulin resistance
605115|NCT00618592|insulin sensitivity|insulin sensitivity
605116|NCT00618592|short insulin tolerance test|short insulin tolerance test
605117|NCT00618592|HOMA|homa
605118|NCT00618592|outcomes|outcomes
605119|NCT00618579|Interaction with LMWH or warfarin|interaction with lmwh or warfarin
605120|NCT00618566|Women with physical Disabilities|women with physical disabilities
605121|NCT00618566|Secondary Conditions|secondary conditions
605122|NCT00618566|Depression|depression
605123|NCT00618566|Cognitive Behavioral Therapy|cognitive behavioral therapy
605124|NCT00618566|Consumer Control|consumer control
605125|NCT00618553|Lung Cancer|lung cancer
605126|NCT00618553|Pulmonary Rehabilitation|pulmonary rehabilitation
605127|NCT00618553|Questionnaire|questionnaire
605128|NCT00618553|Survey|survey
605129|NCT00618553|Lung Function|lung function
605130|NCT00618553|Quality of Life|quality of life
605131|NCT00618540|childhood Langerhans cell histiocytosis|childhood langerhans cell histiocytosis
605132|NCT00618527|relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
605133|NCT00618527|multiple sclerosis|multiple sclerosis
605134|NCT00618514|Varicose Veins|varicose veins
605135|NCT00618514|Laser Ablation|laser ablation
605136|NCT00618514|Laser Wire Fibers|laser wire fibers
605137|NCT00618501|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
605138|NCT00618488|Probiotics|probiotics
605139|NCT00618488|BB12|bb12
605140|NCT00618488|Gastrointestinal Symptoms|gastrointestinal symptoms
605141|NCT00618475|Depression|depression
605142|NCT00618475|End Stage Renal Disease|end stage renal disease
605143|NCT00618475|Kidney Disease|kidney disease
605144|NCT00618475|Mental Health|mental health
605145|NCT00618462|Cognitive Behavioral Therapy|cognitive behavioral therapy
605146|NCT00618462|Pathological Gambling|pathological gambling
605147|NCT00618449|Trachoma|trachoma
605148|NCT00618449|Chlamydia trachomatis|chlamydia trachomatis
605149|NCT00618436|Seizures|seizures
605150|NCT00618436|Traumatic Brain Injury|traumatic brain injury
605151|NCT00618436|Subarachnoid Hemorrhage|subarachnoid hemorrhage
605152|NCT00618423|Neuropathic pain|neuropathic pain
605153|NCT00618423|Chronic pain|chronic pain
605154|NCT00618423|Acute postoperative pain|acute postoperative pain
605155|NCT00618423|Ketamine|ketamine
605156|NCT00618423|Back surgery|back surgery
605157|NCT00618423|Anesthesia|anesthesia
605158|NCT00618423|Perioperative|perioperative
605159|NCT00618397|ketamine|ketamine
605160|NCT00618397|pharmacokinetics|pharmacokinetics
605161|NCT00618397|sedation|sedation
605162|NCT00618397|critical care|critical care
605163|NCT00618397|opioid tolerance|opioid tolerance
605164|NCT00618397|NMDA Antagonist|nmda antagonist
605165|NCT00618384|TACE|tace
605166|NCT00618384|hepatocellular carcinoma|hepatocellular carcinoma
605167|NCT00618371|Intensification|intensification
605168|NCT00618371|HIV viremia|hiv viremia
605169|NCT00618371|Human Immunodeficiency Virus|human immunodeficiency virus
605170|NCT00618345|refractory multiple myeloma|refractory multiple myeloma
605171|NCT00618293|intraoperative bleeding|intraoperative bleeding
605172|NCT00618293|aortic-valve replacement|aortic-valve replacement
605173|NCT00618293|aortic stenosis|aortic stenosis
605174|NCT00618293|Von Willebrand|von willebrand
605175|NCT00618293|HEAMATE|heamate
605176|NCT00618254|Prevention of nausea and vomiting associated with radiation or chemotherapy|prevention of nausea and vomiting associated with radiation or chemotherapy
605177|NCT00618241|interactions|interactions
605178|NCT00618241|neuropathic pain|neuropathic pain
605179|NCT00618241|pharmacokinetics|pharmacokinetics
605180|NCT00618215|cluster-randomised trial|cluster-randomised trial
605181|NCT00618215|routine oral examination|routine oral examination
605182|NCT00618215|implementation research|implementation research
605183|NCT00618215|practice based research|practice based research
605184|NCT00618215|CPG|cpg
605185|NCT00618215|recall interval assignment for routine oral examination|recall interval assignment for routine oral examination
605186|NCT00618215|prescription bitewing radiographs|prescription bitewing radiographs
605187|NCT00618215|preventive advice and feed back oral disease|preventive advice and feed back oral disease
605188|NCT00618176|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
605189|NCT00618176|adverse effects|adverse effects
605190|NCT00618176|Treatment Outcome|treatment outcome
605191|NCT00618176|Drug Resistance, Viral|drug resistance, viral
605192|NCT00618176|treatment naïve|treatment naïve
605193|NCT00618163|Anti-inflammatory|anti-inflammatory
605194|NCT00618150|GERD|gerd
605195|NCT00618150|Dyspepsia|dyspepsia
605196|NCT00618150|Education|education
605197|NCT00618150|Information|information
605198|NCT00618137|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
605199|NCT00618137|Gene expression profiling|gene expression profiling
605200|NCT00618137|Inert dusts|inert dusts
605201|NCT00618137|Natural course|natural course
605202|NCT00618137|Prospective assessment|prospective assessment
605203|NCT00618124|solid tumor malignancy, SU011248, sunitinib, capecitabine, Phase 1|solid tumor malignancy, su011248, sunitinib, capecitabine, phase 1
605204|NCT00618111|Prevention of nausea and vomiting associated with radiation or chemotherapy|prevention of nausea and vomiting associated with radiation or chemotherapy
605205|NCT00618098|anticoagulant reversal|anticoagulant reversal
605206|NCT00618098|urgent surgery|urgent surgery
605207|NCT00618098|invasive procedures|invasive procedures
605208|NCT00618098|vitamin K|vitamin k
605209|NCT00618098|prothrombin complex concentrate|prothrombin complex concentrate
605210|NCT00618072|hyperinsulinemia|hyperinsulinemia
605211|NCT00618072|insulin resistance|insulin resistance
605212|NCT00618072|perimenopause|perimenopause
605213|NCT00618072|obesity|obesity
605214|NCT00618072|overweight|overweight
605215|NCT00618072|women|women
605216|NCT00618033|Hemodialysis|hemodialysis
605217|NCT00618033|ESRD|esrd
605218|NCT00618020|CTO|cto
605219|NCT00618020|Chronic Total Occlusion|chronic total occlusion
605220|NCT00618020|Revascularization|revascularization
605221|NCT00617994|psoriasis|psoriasis
605222|NCT00617981|hepatocellular carcinoma|hepatocellular carcinoma
605223|NCT00617981|liver cancer|liver cancer
605224|NCT00617942|Breast Cancer|breast cancer
605225|NCT00617929|chronic myelogenous leukemia|chronic myelogenous leukemia
605226|NCT00617929|acute lymphoblastic leukemia|acute lymphoblastic leukemia
605227|NCT00617929|chronic myeloid leukemia|chronic myeloid leukemia
605228|NCT00617929|lymphoblastic leukemia|lymphoblastic leukemia
605229|NCT00617929|acute myeloid leukemia|acute myeloid leukemia
605230|NCT00617929|chronic eosinophilic leukemia|chronic eosinophilic leukemia
605231|NCT00617929|primary myelofibrosis|primary myelofibrosis
605232|NCT00617929|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
605233|NCT00617929|chronic neutrophilic leukemia|chronic neutrophilic leukemia
605234|NCT00617929|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
605235|NCT00617929|disseminated neuroblastoma|disseminated neuroblastoma
605236|NCT00617929|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
605237|NCT00617929|Burkitt lymphoma|burkitt lymphoma
605238|NCT00617929|rhabdomyosarcoma|rhabdomyosarcoma
605239|NCT00617929|myelodysplastic syndromes|myelodysplastic syndromes
605240|NCT00617929|Hodgkin lymphoma|hodgkin lymphoma
605241|NCT00617929|lymphoblastic lymphoma|lymphoblastic lymphoma
605242|NCT00617929|breast cancer|breast cancer
605243|NCT00617929|follicular lymphoma|follicular lymphoma
605244|NCT00617929|mantle cell lymphoma|mantle cell lymphoma
605245|NCT00617929|marginal zone lymphoma|marginal zone lymphoma
605246|NCT00617929|recurrent neuroblastoma|recurrent neuroblastoma
605247|NCT00617929|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
605248|NCT00617929|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
605249|NCT00617929|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
605250|NCT00617929|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
605251|NCT00617929|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
605252|NCT00617929|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
605253|NCT00617929|refractory hairy cell leukemia|refractory hairy cell leukemia
605254|NCT00617929|refractory multiple myeloma|refractory multiple myeloma
605255|NCT00617929|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
605256|NCT00617929|secondary acute myeloid leukemia|secondary acute myeloid leukemia
605257|NCT00617929|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
605258|NCT00617929|splenic marginal zone lymphoma|splenic marginal zone lymphoma
605259|NCT00617929|stage I multiple myeloma|stage i multiple myeloma
605260|NCT00617929|stage II multiple myeloma|stage ii multiple myeloma
605261|NCT00617929|stage III multiple myeloma|stage iii multiple myeloma
605262|NCT00617929|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
605263|NCT00617929|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
605264|NCT00617929|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
605265|NCT00617929|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
605266|NCT00617929|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
605267|NCT00617929|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
605268|NCT00617929|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
605269|NCT00617929|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
605270|NCT00617929|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
605271|NCT00617929|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
605272|NCT00617929|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
605273|NCT00617929|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
605274|NCT00617929|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
605275|NCT00617929|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
605276|NCT00617929|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
605277|NCT00617929|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
605278|NCT00617929|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
605279|NCT00617929|stage IIIA breast cancer|stage iiia breast cancer
605280|NCT00617929|stage IIIB breast cancer|stage iiib breast cancer
605281|NCT00617929|stage IIIC breast cancer|stage iiic breast cancer
605282|NCT00617929|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
605283|NCT00617929|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
605284|NCT00617929|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
605285|NCT00617929|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
605286|NCT00617929|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
605287|NCT00617929|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
605288|NCT00617929|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
605289|NCT00617929|stage IV breast cancer|stage iv breast cancer
605290|NCT00617929|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
605291|NCT00617929|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
605292|NCT00617929|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
605293|NCT00617929|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
605294|NCT00617929|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
605295|NCT00617929|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
605296|NCT00617929|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
605297|NCT00617929|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
605298|NCT00617929|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
605299|NCT00617916|hyperspectral imaging|hyperspectral imaging
605300|NCT00617916|tissue oxygenation|tissue oxygenation
605301|NCT00617916|diabetic foot ulcers|diabetic foot ulcers
605302|NCT00617916|wound healing|wound healing
605303|NCT00617916|prevention|prevention
605304|NCT00617903|rosacea|rosacea
605305|NCT00617903|papulopustular|papulopustular
605306|NCT00617903|azelaic acid|azelaic acid
605307|NCT00617903|foam|foam
605308|NCT00617890|anti-IGF-1R|anti-igf-1r
605309|NCT00617851|Influenza|influenza
605310|NCT00617851|adults|adults
605311|NCT00617851|different lots|different lots
605312|NCT00617851|trivalent subunit influenza virus vaccine (IVV)|trivalent subunit influenza virus vaccine (ivv)
605313|NCT00617851|trivalent subunit influenza vaccine|trivalent subunit influenza vaccine
605314|NCT00617838|Celiac disease|celiac disease
605315|NCT00617838|genetic risk|genetic risk
605316|NCT00617838|gluten introduction|gluten introduction
605317|NCT00617838|predicting antibodies|predicting antibodies
605318|NCT00617825|chronic venous disorders|chronic venous disorders
605319|NCT00617825|cryotherapy|cryotherapy
605320|NCT00617825|skin microcirculation|skin microcirculation
605321|NCT00617825|skin temperature|skin temperature
605322|NCT00617812|Vaccine|vaccine
605323|NCT00617812|Prevention|prevention
605324|NCT00617812|Diphtheria|diphtheria
605325|NCT00617812|Tetanus|tetanus
605326|NCT00617812|Pertussis|pertussis
605327|NCT00617812|Hepatitis B|hepatitis b
605328|NCT00617812|Haemophilus influenzae type b|haemophilus influenzae type b
605329|NCT00617812|Healthy infants|healthy infants
605330|NCT00617799|stage IV renal cell cancer|stage iv renal cell cancer
605331|NCT00617799|stage IV melanoma|stage iv melanoma
605332|NCT00617786|urinary urgency|urinary urgency
605333|NCT00617786|urinary frequency|urinary frequency
605334|NCT00617786|urge incontinence|urge incontinence
605335|NCT00617786|sacral neuromodulation therapy|sacral neuromodulation therapy
605336|NCT00617786|urgency|urgency
605337|NCT00617786|frequency|frequency
605338|NCT00617773|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
605339|NCT00617773|recurrent fallopian tube cancer|recurrent fallopian tube cancer
605340|NCT00617773|recurrent primary peritoneal cancer|recurrent primary peritoneal cancer
605341|NCT00617747|Zolmitriptan|zolmitriptan
605342|NCT00617747|ZOMIG|zomig
605343|NCT00617747|migraine|migraine
605344|NCT00617747|headache response|headache response
605345|NCT00617747|headache|headache
605346|NCT00617747|headache pain|headache pain
605347|NCT00617734|Squamous Cell Carcinoma in Head and Neck|squamous cell carcinoma in head and neck
605348|NCT00617734|Prior Platinum-based chemotherapy|prior platinum-based chemotherapy
605349|NCT00617734|Cetuximab|cetuximab
605350|NCT00617734|Erbitux|erbitux
605351|NCT00617734|IMC-A12|imc-a12
605352|NCT00617721|Defective gene(s) in plasma membrane remodelling.|defective gene(s) in plasma membrane remodelling.
605353|NCT00617721|Scott syndrome,|scott syndrome,
605354|NCT00617721|Reduced prothrombin consumption,|reduced prothrombin consumption,
605355|NCT00617721|Circulating biomakers of scott syndrome|circulating biomakers of scott syndrome
605356|NCT00617695|Zolmitriptan|zolmitriptan
605357|NCT00617695|ZOMIG|zomig
605358|NCT00617695|migraine|migraine
605359|NCT00617695|headache response|headache response
605360|NCT00617695|headache|headache
605361|NCT00617695|headache pain|headache pain
605362|NCT00617682|Maternal immunization|maternal immunization
605363|NCT00617682|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
605364|NCT00617682|Otitis media|otitis media
605365|NCT00617669|Hormone Resistant Prostate Cancer|hormone resistant prostate cancer
605366|NCT00617669|Endothelin A Receptor Antagonist|endothelin a receptor antagonist
605367|NCT00617669|Endothelin A|endothelin a
605368|NCT00617669|Endothelin A antagonist|endothelin a antagonist
605369|NCT00617656|LUNG CANCER|lung cancer
605370|NCT00617643|Nevirapine|nevirapine
605371|NCT00617643|Rifampicin|rifampicin
605372|NCT00617643|Pharmacokinetics|pharmacokinetics
605373|NCT00617617|isoflavones|isoflavones
605374|NCT00617617|soy|soy
605375|NCT00617604|kidney transplant|kidney transplant
605376|NCT00617604|alefacept|alefacept
605377|NCT00617591|Lenalidomide|lenalidomide
605378|NCT00617591|Revlimid|revlimid
605379|NCT00617591|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
605380|NCT00617591|Doxil|doxil
605381|NCT00617591|Dexamethasone|dexamethasone
605382|NCT00617591|Decadron|decadron
605383|NCT00617578|Antitachy pacing|antitachy pacing
605384|NCT00617578|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
605385|NCT00617552|postoperative ileus|postoperative ileus
605386|NCT00617552|POI|poi
605387|NCT00617552|major open abdominal surgery|major open abdominal surgery
605388|NCT00617539|recurrent breast cancer|recurrent breast cancer
605389|NCT00617539|stage IV breast cancer|stage iv breast cancer
605390|NCT00617539|male breast cancer|male breast cancer
605391|NCT00617539|tumors metastatic to brain|tumors metastatic to brain
605392|NCT00617526|HIV|hiv
605393|NCT00617526|treatment naïve|treatment naïve
605394|NCT00617500|climacteric|climacteric
605395|NCT00617500|complementary therapy|complementary therapy
605396|NCT00617500|hormonal replacement therapy|hormonal replacement therapy
605397|NCT00617474|erythropoietin|erythropoietin
605398|NCT00617474|kidney allograft survival|kidney allograft survival
605399|NCT00617474|Recombinant Erythropoietin|recombinant erythropoietin
605400|NCT00617474|erythropoietin (Epo)-induced protein 29, human|erythropoietin (epo)-induced protein 29, human
605401|NCT00617461|Post-herpetic neuralgia(PHN)|post-herpetic neuralgia(phn)
605402|NCT00617461|Neuropathic pain|neuropathic pain
605403|NCT00617448|diathermy hemorrhoids|diathermy hemorrhoids
605404|NCT00617448|Ligasure|ligasure
605405|NCT00617448|randomized controlled trial|randomized controlled trial
605406|NCT00617448|Postoperative pain|postoperative pain
605407|NCT00617448|Surgical Procedure, Ambulatory|surgical procedure, ambulatory
605408|NCT00617448|Local Anesthesia|local anesthesia
605409|NCT00617448|Safety procedure long term|safety procedure long term
605410|NCT00617448|Day Surgery|day surgery
605411|NCT00617435|Trans fatty acid|trans fatty acid
605412|NCT00617435|Insulin resistance|insulin resistance
605413|NCT00617435|Skeletal muscle|skeletal muscle
605414|NCT00617435|Adipose tissue|adipose tissue
605415|NCT00617409|SCLC|sclc
605416|NCT00617409|vaccine|vaccine
605417|NCT00617409|immunize|immunize
605418|NCT00617396|Irritable Bowel Syndrome|irritable bowel syndrome
605419|NCT00617396|Seroquel|seroquel
605420|NCT00617396|Abdominal Pain|abdominal pain
605421|NCT00617383|demyelinating disease|demyelinating disease
605422|NCT00617383|multiple sclerosis|multiple sclerosis
605423|NCT00617383|female monozygotic identical twins|female monozygotic identical twins
605425|NCT00617383|non-concordant|non-concordant
605426|NCT00617383|clinically isolated syndrome - CIS|clinically isolated syndrome - cis
605427|NCT00617383|brain MRI|brain mri
605428|NCT00617383|proteomics|proteomics
605429|NCT00617370|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
605430|NCT00617370|EPIRUBICIN|epirubicin
605431|NCT00617370|PEGFILGRASTIM|pegfilgrastim
605432|NCT00617370|TAXOL (PACLITAXEL)|taxol (paclitaxel)
605433|NCT00617357|incisional hernia|incisional hernia
605434|NCT00617357|abdominal hernia repair|abdominal hernia repair
605435|NCT00617357|Ventral incisional hernia repair|ventral incisional hernia repair
605436|NCT00617344|Dengue fever|dengue fever
605437|NCT00617344|Dengue hemorrhagic fever|dengue hemorrhagic fever
605438|NCT00617344|Dengue virus|dengue virus
605439|NCT00617331|vaccine, priming, influenza, flu, A/H9N2|vaccine, priming, influenza, flu, a/h9n2
605440|NCT00617318|Pomegranate|pomegranate
605441|NCT00617318|Influenza|influenza
605442|NCT00617318|Common Cold|common cold
605443|NCT00617318|Cough|cough
605444|NCT00617318|Severity|severity
605445|NCT00617318|Efficacy|efficacy
605446|NCT00617305|ambrisentan|ambrisentan
605447|NCT00617305|PAH|pah
605448|NCT00617305|combination therapy|combination therapy
605449|NCT00617305|phosphodiesterase type-5 inhibitor (PDE-5i)|phosphodiesterase type-5 inhibitor (pde-5i)
605450|NCT00617305|cardiovascular|cardiovascular
605451|NCT00617305|endothelin receptor antagonist|endothelin receptor antagonist
605452|NCT00617305|ERA|era
605453|NCT00617292|21-hydroxylase deficiency|21-hydroxylase deficiency
605454|NCT00617292|21OHD|21ohd
605455|NCT00617292|CAH|cah
605456|NCT00617266|tobacco, cessation, BPO, RCT, KAP|tobacco, cessation, bpo, rct, kap
605457|NCT00617240|antipsychotic|antipsychotic
605458|NCT00617240|metformin|metformin
605459|NCT00617240|children|children
605460|NCT00617240|adolescents|adolescents
605461|NCT00617227|Enteral vancomycin therapy, serum vancomycin levels, renal failure|enteral vancomycin therapy, serum vancomycin levels, renal failure
605462|NCT00617214|Schizophrenia|schizophrenia
605463|NCT00617214|Integrated care program|integrated care program
605464|NCT00617214|Seroquel|seroquel
605465|NCT00617201|cocaine|cocaine
605466|NCT00617201|dependence|dependence
605467|NCT00617201|stimulants|stimulants
605468|NCT00617188|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
605469|NCT00617175|Implantable Cardiac Defibrillator|implantable cardiac defibrillator
605470|NCT00617175|therapies reduction|therapies reduction
605471|NCT00617175|Shocks|shocks
605472|NCT00617175|Quality of Life|quality of life
605473|NCT00617149|exercise,|exercise,
605474|NCT00617149|excessive weight gain during pregnancy|excessive weight gain during pregnancy
605475|NCT00617136|Surgery|surgery
605476|NCT00617136|Anesthesia|anesthesia
605477|NCT00617136|Hypothermia|hypothermia
605478|NCT00617136|Temperature|temperature
605479|NCT00617136|Perioperative|perioperative
605480|NCT00617136|Temperature Management|temperature management
605481|NCT00617110|diesel exhaust particles|diesel exhaust particles
605482|NCT00617110|live attenuated influenza virus vaccine|live attenuated influenza virus vaccine
605483|NCT00617110|flu vaccine|flu vaccine
605484|NCT00617097|Pain associated with first trimester surgical abortion|pain associated with first trimester surgical abortion
605485|NCT00617084|Drug Eluting Stents|drug eluting stents
605486|NCT00617084|Interventional Cardiology|interventional cardiology
605487|NCT00617071|colon cancer|colon cancer
605488|NCT00617071|rectal cancer|rectal cancer
605489|NCT00617058|antipsychotic|antipsychotic
605490|NCT00617058|metformin|metformin
605491|NCT00617058|children|children
605492|NCT00617058|adolescents|adolescents
605493|NCT00617045|Post Partum Depression|post partum depression
605494|NCT00617006|Anesthesia Workspace|anesthesia workspace
605495|NCT00617006|Hospital Acquired Infections|hospital acquired infections
605496|NCT00617006|Hand Hygiene|hand hygiene
605497|NCT00617006|Alcohol Based Cleanser|alcohol based cleanser
605498|NCT00617006|Bacterial Contamination|bacterial contamination
605499|NCT00616980|PAD|pad
605500|NCT00616980|PVD|pvd
605501|NCT00616980|CLI|cli
605502|NCT00616980|Stem Cells|stem cells
605503|NCT00616967|stage II breast cancer|stage ii breast cancer
605504|NCT00616967|stage IIIA breast cancer|stage iiia breast cancer
605505|NCT00616967|stage IIIB breast cancer|stage iiib breast cancer
605506|NCT00616967|stage IIIC breast cancer|stage iiic breast cancer
605507|NCT00616967|ductal breast carcinoma|ductal breast carcinoma
605508|NCT00616967|lobular breast carcinoma|lobular breast carcinoma
605509|NCT00616954|mismatched|mismatched
605510|NCT00616954|Stem cell transplatation|stem cell transplatation
605511|NCT00616954|Bone marrow transplantation|bone marrow transplantation
605512|NCT00616954|T cell depletion|t cell depletion
605513|NCT00616954|engraftment|engraftment
605514|NCT00616954|Patients undergoing allogeneic haplo-SCT|patients undergoing allogeneic haplo-sct
605515|NCT00616941|NY-ESO-1 OLP4|ny-eso-1 olp4
605516|NCT00616941|Ovarian Cancer|ovarian cancer
605517|NCT00616941|Cancer Vaccine|cancer vaccine
605518|NCT00616928|vaccines|vaccines
605519|NCT00616928|immunogenicity|immunogenicity
605520|NCT00616928|human|human
605521|NCT00616928|safety|safety
605522|NCT00616928|influenza|influenza
605523|NCT00616915|Wellbutrin SR|wellbutrin sr
605524|NCT00616902|Zemplar, paricalcitol, PRIMO II|zemplar, paricalcitol, primo ii
605525|NCT00616876|lactulose|lactulose
605526|NCT00616876|prebiotic|prebiotic
605527|NCT00616876|premature infant|premature infant
605528|NCT00616876|enteral feeding|enteral feeding
605529|NCT00616876|stools|stools
605530|NCT00616876|lactobacillus|lactobacillus
605531|NCT00616876|nutrition|nutrition
605532|NCT00616876|growth|growth
605533|NCT00616850|Total Knee Arthroplasty|total knee arthroplasty
605534|NCT00616850|Intravenous Lidocaine Infusion|intravenous lidocaine infusion
605535|NCT00616850|Femoral Block Catheter|femoral block catheter
605536|NCT00616837|Remote consultation/*methods|remote consultation/*methods
605537|NCT00616837|Orthopaedics methods|orthopaedics methods
605538|NCT00616837|Telemedicine|telemedicine
605539|NCT00616837|Follow-up study|follow-up study
605540|NCT00616837|Ambulatory care|ambulatory care
605541|NCT00616824|Acellular dermal matrix|acellular dermal matrix
605542|NCT00616824|breast reconstruction|breast reconstruction
605543|NCT00616824|tissue expander|tissue expander
605544|NCT00616824|postoperative pain|postoperative pain
605545|NCT00616824|complication|complication
605546|NCT00616824|pain|pain
605547|NCT00616824|patient satisfaction|patient satisfaction
605548|NCT00616811|Type 2 diabetes, vildagliptin|type 2 diabetes, vildagliptin
605549|NCT00616785|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
605550|NCT00616785|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
605551|NCT00616759|Depression|depression
605552|NCT00616759|Electroconvulsive therapy|electroconvulsive therapy
605553|NCT00616746|Alcohol, nicotine|alcohol, nicotine
605554|NCT00616733|Multiple sclerosis, relapsing, secondary progressive, clinically isolated syndrome, MRI|multiple sclerosis, relapsing, secondary progressive, clinically isolated syndrome, mri
605555|NCT00616720|stage I multiple myeloma|stage i multiple myeloma
605556|NCT00616720|stage II multiple myeloma|stage ii multiple myeloma
605557|NCT00616720|stage III multiple myeloma|stage iii multiple myeloma
605558|NCT00616720|refractory multiple myeloma|refractory multiple myeloma
605559|NCT00616707|Inflammation|inflammation
605560|NCT00616707|Oxidative Stress|oxidative stress
605561|NCT00616707|Microalbuminuria|microalbuminuria
605562|NCT00616668|Transtibial amputees due to vascular diseases.|transtibial amputees due to vascular diseases.
605563|NCT00616655|Anxiety|anxiety
605564|NCT00616642|recurrent pituitary tumor|recurrent pituitary tumor
605565|NCT00616642|ACTH-producing pituitary tumor|acth-producing pituitary tumor
605566|NCT00616642|nonfunctioning pituitary tumor|nonfunctioning pituitary tumor
605567|NCT00616616|appendectomy|appendectomy
605568|NCT00616616|cholecystectomy|cholecystectomy
605569|NCT00616616|gastric banding|gastric banding
605570|NCT00616616|adrenalectomy|adrenalectomy
605571|NCT00616616|Gastric lap-band placement|gastric lap-band placement
605572|NCT00616603|Total Knee Arthroplasty.|total knee arthroplasty.
605573|NCT00616603|Sciatic nerve Blocks.|sciatic nerve blocks.
605574|NCT00616603|Dexamethasone.|dexamethasone.
605575|NCT00616590|sleep disorders|sleep disorders
605576|NCT00616590|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
605577|NCT00616590|fatigue|fatigue
605578|NCT00616590|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
605579|NCT00616590|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
605580|NCT00616590|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
605581|NCT00616590|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
605582|NCT00616590|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
605583|NCT00616590|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
605584|NCT00616590|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
605585|NCT00616590|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
605586|NCT00616590|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
605587|NCT00616590|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
605588|NCT00616590|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
605589|NCT00616590|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
605590|NCT00616590|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
605591|NCT00616590|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
605592|NCT00616590|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
605593|NCT00616590|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
605594|NCT00616590|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
605595|NCT00616590|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
605596|NCT00616590|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
605597|NCT00616590|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
605598|NCT00616590|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
605599|NCT00616590|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
605600|NCT00616590|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
605601|NCT00616590|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
605602|NCT00616590|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
605603|NCT00616590|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
605604|NCT00616590|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
605605|NCT00616590|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
605606|NCT00616590|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
605607|NCT00616590|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
605608|NCT00616590|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
605609|NCT00616590|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
605610|NCT00616590|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
605611|NCT00616590|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
605612|NCT00616590|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
605613|NCT00616590|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
605614|NCT00616590|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
605615|NCT00616590|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
605616|NCT00616590|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
605617|NCT00616590|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
605618|NCT00616590|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
605619|NCT00616590|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
605620|NCT00616590|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
605621|NCT00616590|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
605622|NCT00616590|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
605623|NCT00616590|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
605624|NCT00616590|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
605625|NCT00616590|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
605626|NCT00616590|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
605627|NCT00616590|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
605628|NCT00616590|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
605629|NCT00616590|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
605630|NCT00616590|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
605631|NCT00616590|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
605632|NCT00616590|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
605633|NCT00616590|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
605634|NCT00616590|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
605635|NCT00616590|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
605636|NCT00616590|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
605637|NCT00616590|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
605638|NCT00616590|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
605639|NCT00616590|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
605640|NCT00616590|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
605641|NCT00616590|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
605642|NCT00616590|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
605643|NCT00616590|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
605644|NCT00616590|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
605645|NCT00616590|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
605646|NCT00616590|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
605647|NCT00616590|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
605648|NCT00616590|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
605649|NCT00616590|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
605650|NCT00616590|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
605651|NCT00616590|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
605652|NCT00616590|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
605653|NCT00616590|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
605654|NCT00616590|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
605655|NCT00616590|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
605656|NCT00616590|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
605657|NCT00616590|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
605658|NCT00616590|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
605659|NCT00616590|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
605660|NCT00616590|recurrent salivary gland cancer|recurrent salivary gland cancer
605661|NCT00616590|stage I salivary gland cancer|stage i salivary gland cancer
605662|NCT00616590|stage II salivary gland cancer|stage ii salivary gland cancer
605663|NCT00616590|stage III salivary gland cancer|stage iii salivary gland cancer
605664|NCT00616590|stage IV salivary gland cancer|stage iv salivary gland cancer
605665|NCT00616577|Caudal Epidural Ropivacaine|caudal epidural ropivacaine
605666|NCT00616564|GM-CSF|gm-csf
605667|NCT00616564|Interleukin|interleukin
605668|NCT00616564|IL-2|il-2
605669|NCT00616564|Sargrostim|sargrostim
605670|NCT00616551|Acromegaly|acromegaly
605671|NCT00616538|Atopic|atopic
605672|NCT00616538|Dermatitis|dermatitis
605673|NCT00616538|eczema|eczema
605674|NCT00616538|skin barrier|skin barrier
605675|NCT00616538|ceramide|ceramide
605676|NCT00616538|topical|topical
605677|NCT00616538|inflamation|inflamation
605678|NCT00616538|steroid|steroid
605679|NCT00616538|SCORAD|scorad
605680|NCT00616538|glucocorticoids|glucocorticoids
605681|NCT00616538|EpiCeram|epiceram
605682|NCT00616538|Cutivate|cutivate
605683|NCT00616538|fluticasone|fluticasone
605684|NCT00616512|Water|water
605685|NCT00616512|oral care|oral care
605686|NCT00616512|oral hygiene|oral hygiene
605687|NCT00616512|dysphagia|dysphagia
605688|NCT00616512|thin liquid dysphagia|thin liquid dysphagia
605689|NCT00616512|thickened liquids|thickened liquids
605690|NCT00616499|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
605691|NCT00616499|adenocarcinoma of the lung|adenocarcinoma of the lung
605692|NCT00616499|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
605693|NCT00616499|large cell lung cancer|large cell lung cancer
605694|NCT00616460|safety|safety
605695|NCT00616460|efficacy|efficacy
605696|NCT00616421|vaccine|vaccine
605697|NCT00616421|children|children
605698|NCT00616421|healthy|healthy
605699|NCT00616421|meningitis|meningitis
605700|NCT00616421|meningococcal|meningococcal
605701|NCT00616421|prevention of meningococcal disease serogroups ACWY|prevention of meningococcal disease serogroups acwy
605702|NCT00616421|Menveo|menveo
605703|NCT00616408|GH|gh
605704|NCT00616408|IGF-I|igf-i
605705|NCT00616408|GH-secreting tumors|gh-secreting tumors
605706|NCT00616408|Octreotide|octreotide
605707|NCT00616395|Infant Nutrition|infant nutrition
605708|NCT00616395|Soy Phytochemicals|soy phytochemicals
605709|NCT00616395|Infant Body Composition|infant body composition
605710|NCT00616395|Brain Function|brain function
605711|NCT00616395|Cognition and Development|cognition and development
605712|NCT00616395|Healthy Infants|healthy infants
605713|NCT00616382|PDA|pda
605714|NCT00616382|indomethacin|indomethacin
605715|NCT00616382|pentoxifylline|pentoxifylline
605716|NCT00616382|Patent Ductus Arteriosus [PDA] resistant to therapy|patent ductus arteriosus [pda] resistant to therapy
605717|NCT00616369|pulmonary hypertension|pulmonary hypertension
605718|NCT00616369|hypertension|hypertension
605719|NCT00616369|cardiomyopathy|cardiomyopathy
605720|NCT00616369|arrhythmias|arrhythmias
605721|NCT00616356|Yellow Fever|yellow fever
605722|NCT00616343|ET|et
605723|NCT00616317|Antiphospholipid Syndrome|antiphospholipid syndrome
605724|NCT00616304|severe falciparum malaria|severe falciparum malaria
605725|NCT00616291|recurrent prostate cancer|recurrent prostate cancer
605726|NCT00616291|stage IV prostate cancer|stage iv prostate cancer
605727|NCT00616278|Growth Failure AND|growth failure and
605728|NCT00616278|Chronic Renal Insufficiency OR|chronic renal insufficiency or
605729|NCT00616278|End Stage Renal Disease|end stage renal disease
605730|NCT00616265|Sleep apnea|sleep apnea
605731|NCT00616265|Refractory Hypertension|refractory hypertension
605732|NCT00616265|Difficult-to-treat hypertension|difficult-to-treat hypertension
605733|NCT00616265|CPAP|cpap
605734|NCT00616252|Antiretroviral|antiretroviral
605735|NCT00616252|Pharmacokinetics|pharmacokinetics
605736|NCT00616252|Pregnancy|pregnancy
605737|NCT00616239|Melasma|melasma
605738|NCT00616239|Dark spots on the face|dark spots on the face
605739|NCT00616213|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
605740|NCT00616200|D-IBS (diarrhea predominant irritable bowel syndrome)|d-ibs (diarrhea predominant irritable bowel syndrome)
605741|NCT00616174|Cesarean delivery|cesarean delivery
605742|NCT00616174|Active Warming|active warming
605743|NCT00616174|Neonatal Temperature|neonatal temperature
605744|NCT00616161|Acute Heart Failure|acute heart failure
605745|NCT00616161|Inotropes|inotropes
605746|NCT00616161|Lusitropic agents|lusitropic agents
605747|NCT00616161|Istaroxime|istaroxime
605748|NCT00616161|PST2744|pst2744
605749|NCT00616148|Epilepsy|epilepsy
605750|NCT00616148|Seizures|seizures
605751|NCT00616135|Breast|breast
605752|NCT00616135|Stem Cell|stem cell
605753|NCT00616135|Adipose Derived Stem Cells|adipose derived stem cells
605754|NCT00616135|Adipose Derived Regenerative Cells|adipose derived regenerative cells
605755|NCT00616135|ADRC|adrc
605756|NCT00616135|Reconstructive Breast Surgery|reconstructive breast surgery
605757|NCT00616135|Breast Reconstruction|breast reconstruction
605758|NCT00616135|Cancer|cancer
605759|NCT00616135|Carcinoma|carcinoma
605760|NCT00616135|Autologous fat transplantation|autologous fat transplantation
605761|NCT00616135|Autologous fat|autologous fat
605762|NCT00616135|Cosmetic breast deformities|cosmetic breast deformities
605763|NCT00616135|Functional breast deformity|functional breast deformity
605764|NCT00616135|Lumpectomy|lumpectomy
605765|NCT00616135|Segmental mastectomy|segmental mastectomy
605766|NCT00616135|Quadrantectomy|quadrantectomy
605767|NCT00616135|breast conservation therapy|breast conservation therapy
605768|NCT00616122|recurrent breast cancer|recurrent breast cancer
605769|NCT00616122|stage IV breast cancer|stage iv breast cancer
605770|NCT00616122|male breast cancer|male breast cancer
605771|NCT00616096|Serum Immunoglobulin E above 5000 kU/l|serum immunoglobulin e above 5000 ku/l
605772|NCT00616083|Breast Feeding|breast feeding
605773|NCT00616083|Body Composition|body composition
605774|NCT00616083|Body Fat|body fat
605775|NCT00616083|Infant|infant
605776|NCT00616083|Diet|diet
605777|NCT00616083|Healthy Infants|healthy infants
605778|NCT00616057|fructans supplementation|fructans supplementation
605779|NCT00616044|Spinal Anesthesia|spinal anesthesia
605780|NCT00616044|Epidural Anesthesia|epidural anesthesia
605781|NCT00616044|Orthopedic procedures|orthopedic procedures
605782|NCT00616031|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
605783|NCT00616031|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
605784|NCT00616018|acetaminophen|acetaminophen
605785|NCT00616018|protein adducts|protein adducts
605786|NCT00616018|hepatic function|hepatic function
605787|NCT00616018|drug safety|drug safety
605788|NCT00616018|non drinkers|non drinkers
605789|NCT00616005|Glioblastoma|glioblastoma
605790|NCT00616005|GBM|gbm
605791|NCT00616005|Brain tumor|brain tumor
605792|NCT00616005|Temodar|temodar
605793|NCT00616005|Temozolomide|temozolomide
605794|NCT00616005|Irinotecan|irinotecan
605795|NCT00616005|CPT-11|cpt-11
605796|NCT00616005|Camptosar|camptosar
605797|NCT00616005|Malignant glioma|malignant glioma
605798|NCT00616005|Anaplastic astrocytoma|anaplastic astrocytoma
605799|NCT00616005|Glioblastoma multiforme|glioblastoma multiforme
605800|NCT00615979|trauma|trauma
605801|NCT00615979|portable ultrasound|portable ultrasound
605802|NCT00615979|telemedicine|telemedicine
605803|NCT00615979|Department of Defense|department of defense
605804|NCT00615966|kidney transplantation|kidney transplantation
605805|NCT00615966|ischemia-reperfusion injury|ischemia-reperfusion injury
605806|NCT00615966|phosphatidylserine binding|phosphatidylserine binding
605807|NCT00615940|HER2negative|her2negative
605808|NCT00615927|Glioblastoma|glioblastoma
605809|NCT00615927|Gliosarcoma|gliosarcoma
605810|NCT00615927|glioblastoma multiforme (GBM)|glioblastoma multiforme (gbm)
605811|NCT00615927|GBM|gbm
605812|NCT00615927|Imatinib Mesylate|imatinib mesylate
605813|NCT00615927|Gleevec|gleevec
605814|NCT00615927|Hydroxyurea|hydroxyurea
605815|NCT00615927|Droxia|droxia
605816|NCT00615927|Hydrea|hydrea
605817|NCT00615927|Hydroxycarbamide|hydroxycarbamide
605818|NCT00615927|Imatinib|imatinib
605819|NCT00615927|Brain tumor|brain tumor
605820|NCT00615927|Malignant brain tumor|malignant brain tumor
605821|NCT00615927|Recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
605822|NCT00615927|Progressive glioblastoma multiforme|progressive glioblastoma multiforme
605823|NCT00615901|cyclophosphamide|cyclophosphamide
605824|NCT00615901|methotrexate|methotrexate
605825|NCT00615901|fluorouracil|fluorouracil
605826|NCT00615901|PEG-filgrastim|peg-filgrastim
605827|NCT00615888|elective open repair|elective open repair
605828|NCT00615888|complications|complications
605829|NCT00615888|morbidity and mortality|morbidity and mortality
605830|NCT00615888|fast track patient management|fast track patient management
605831|NCT00615875|naproxen|naproxen
605832|NCT00615875|acute pain|acute pain
605833|NCT00615875|postoperative pain|postoperative pain
605834|NCT00615875|thoracic surgery|thoracic surgery
605835|NCT00615875|head and neck surgery|head and neck surgery
605836|NCT00615875|opiate sparing|opiate sparing
605837|NCT00615862|Sepsis, alcoholism, cortisol, delirium, critical care|sepsis, alcoholism, cortisol, delirium, critical care
605838|NCT00615849|pneumothorax, thoracoscopy, pleurodesis|pneumothorax, thoracoscopy, pleurodesis
605839|NCT00615823|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
605840|NCT00615810|LDL|ldl
605841|NCT00615810|HDL|hdl
605842|NCT00615810|triglycerides|triglycerides
605843|NCT00615810|non HDL cholesterol|non hdl cholesterol
605844|NCT00615810|cholesterol|cholesterol
605845|NCT00615810|HIV 1|hiv 1
605846|NCT00615810|Metabolic parameters|metabolic parameters
605847|NCT00615810|treatment experienced|treatment experienced
605848|NCT00615784|Acute Myeloid Leukemia|acute myeloid leukemia
605849|NCT00615784|AML|aml
605850|NCT00615784|Bexarotene|bexarotene
605851|NCT00615758|Erlotinib|erlotinib
605852|NCT00615758|Biological therapy|biological therapy
605853|NCT00615758|Tyrosin Kinase Inhibitor therapy|tyrosin kinase inhibitor therapy
605854|NCT00615745|Human Immunodeficiency Virus|human immunodeficiency virus
605855|NCT00615745|treatment experienced|treatment experienced
605856|NCT00615732|qigong|qigong
605857|NCT00615732|traditional chinese medicine|traditional chinese medicine
605858|NCT00615732|exercise therapy|exercise therapy
605859|NCT00615732|neck pain|neck pain
605860|NCT00615719|Chest Pain|chest pain
605861|NCT00615719|Coronary Angiography|coronary angiography
605862|NCT00615719|Acute Coronary Syndromes|acute coronary syndromes
605863|NCT00615719|Computed Tomography|computed tomography
605864|NCT00615706|asthma, inhaled corticosteroids|asthma, inhaled corticosteroids
605865|NCT00615693|Uveitis|uveitis
605866|NCT00615693|Macular Edema|macular edema
606060|NCT00614718|Defibrillators|defibrillators
605867|NCT00615667|Refractory Nephrotic syndrome|refractory nephrotic syndrome
605868|NCT00615667|Tacrolimus|tacrolimus
605869|NCT00615654|Hydrotherapy,|hydrotherapy,
605870|NCT00615654|RCT,|rct,
605871|NCT00615641|Children|children
605872|NCT00615641|Nutrition|nutrition
605873|NCT00615641|Body Fat|body fat
605874|NCT00615641|Physical Activity|physical activity
605875|NCT00615641|Diet|diet
605876|NCT00615641|Childhood Obesity|childhood obesity
605877|NCT00615641|Healthy Children|healthy children
605878|NCT00615628|Inheritance of Osteosarcoma & Paget's Disease through Chromosome 18|inheritance of osteosarcoma & paget's disease through chromosome 18
605879|NCT00615615|Levetiracetam|levetiracetam
605880|NCT00615615|Keppra|keppra
605881|NCT00615602|Early breast cancer|early breast cancer
605882|NCT00615602|Axillary node positive|axillary node positive
605883|NCT00615602|HER2 overexpression|her2 overexpression
605884|NCT00615602|Adjuvant chemotherapy|adjuvant chemotherapy
605885|NCT00615602|Dose dense|dose dense
605886|NCT00615602|Docetaxel|docetaxel
605887|NCT00615602|Trastuzumab|trastuzumab
605888|NCT00615602|FEC|fec
605889|NCT00615589|Stage II/III Multiple Myeloma(within 10 months from diagnosis)|stage ii/iii multiple myeloma(within 10 months from diagnosis)
605890|NCT00615589|high risk|high risk
605891|NCT00615589|relapse|relapse
605892|NCT00615589|persistent|persistent
605893|NCT00615576|Smoker,|smoker,
605894|NCT00615576|Male,|male,
605895|NCT00615576|Chronic Obstructive Lung Disease|chronic obstructive lung disease
605896|NCT00615576|Cystic Fibrosis,|cystic fibrosis,
605897|NCT00615576|Healthy Volunteer,|healthy volunteer,
605898|NCT00615550|Preterm|preterm
605899|NCT00615550|Cervix|cervix
605900|NCT00615537|Thyroid Nodule|thyroid nodule
605901|NCT00615537|Thyroid Cancer|thyroid cancer
605902|NCT00615537|Laser Ablation|laser ablation
605903|NCT00615537|LITT|litt
605904|NCT00615537|Nodular Goiter|nodular goiter
605905|NCT00615537|Thyroid Mass|thyroid mass
605906|NCT00615524|Breast cancer|breast cancer
605907|NCT00615524|Advanced|advanced
605908|NCT00615524|Metastatic|metastatic
605909|NCT00615524|Pazopanib|pazopanib
605910|NCT00615524|GW786034|gw786034
605911|NCT00615524|Exemestane|exemestane
605912|NCT00615524|Efficacy|efficacy
605913|NCT00615524|Tolerability|tolerability
605914|NCT00615524|Health-Related Quality of Life|health-related quality of life
605915|NCT00615511|schizophrenia|schizophrenia
605916|NCT00615511|schizoaffective disorder|schizoaffective disorder
605917|NCT00615511|negative symptoms|negative symptoms
605918|NCT00615511|cognition|cognition
605919|NCT00615498|Asthma, obesity, bariatric|asthma, obesity, bariatric
605920|NCT00615485|Examine the risk of osteoporosis in survivors of solid pediatric cancers|examine the risk of osteoporosis in survivors of solid pediatric cancers
605921|NCT00615472|Parkinson's Disease|parkinson's disease
605922|NCT00615472|Deep brain stimulation (DBS)|deep brain stimulation (dbs)
605923|NCT00615472|Subthalamic Nucleus|subthalamic nucleus
605924|NCT00615472|Total Intravenous Anesthesia|total intravenous anesthesia
605925|NCT00615472|Inhalational Anesthesia|inhalational anesthesia
605926|NCT00615459|Chronic obstructive pulmonary disease, indacaterol, tiotropium, placebo controlled|chronic obstructive pulmonary disease, indacaterol, tiotropium, placebo controlled
605927|NCT00615446|solid tumor malignancy, SU011248, sunitinib, neoplasms|solid tumor malignancy, su011248, sunitinib, neoplasms
605928|NCT00615433|Schizophrenia|schizophrenia
605929|NCT00615433|Latuda|latuda
605930|NCT00615433|Lurasidone|lurasidone
605931|NCT00615420|Mucositis|mucositis
605932|NCT00615420|Radiation|radiation
605933|NCT00615420|Honey|honey
605934|NCT00615407|Asthma, alcohol|asthma, alcohol
605935|NCT00615394|cardiomyopathy, stem cell, cardiac failure|cardiomyopathy, stem cell, cardiac failure
605936|NCT00615381|Intracranial Aneurysm, Unruptured|intracranial aneurysm, unruptured
605937|NCT00615381|Craniotomy|craniotomy
605938|NCT00615381|Insulin|insulin
605939|NCT00615381|Neuropsychology|neuropsychology
605940|NCT00615368|Type 1 diabetes|type 1 diabetes
605941|NCT00615368|Hypoglycaemia|hypoglycaemia
605942|NCT00615368|Cognitive function|cognitive function
605943|NCT00615368|Erythropoietin|erythropoietin
605944|NCT00615355|vitiligo|vitiligo
605945|NCT00615355|narrow-band UVB|narrow-band uvb
605946|NCT00615355|ReCell|recell
605947|NCT00615355|transplantation|transplantation
605948|NCT00615355|laser|laser
605949|NCT00615329|Create tumor specific gene profiles to improve diagnostic accuracy|create tumor specific gene profiles to improve diagnostic accuracy
605950|NCT00615329|Perform gene set validation for diagnostic predictive power|perform gene set validation for diagnostic predictive power
605951|NCT00615329|Define deviant gene list implicated in pathogenesis|define deviant gene list implicated in pathogenesis
605952|NCT00615303|Bowel preparation, colonoscopy, simethicone, air bubble|bowel preparation, colonoscopy, simethicone, air bubble
605953|NCT00615277|Young adults|young adults
605954|NCT00615277|Long-chain polyunsaturated fatty acids|long-chain polyunsaturated fatty acids
605955|NCT00615277|Cognitive function|cognitive function
605956|NCT00615277|Mood|mood
605957|NCT00615277|Supply with omega-3 fatty acids|supply with omega-3 fatty acids
605958|NCT00615251|In vitro fertilization|in vitro fertilization
606061|NCT00614679|biofilm|biofilm
606062|NCT00614679|catheter lock solution|catheter lock solution
605959|NCT00615238|overweight, physical activity, body composition, metabolic syndrome|overweight, physical activity, body composition, metabolic syndrome
605960|NCT00615225|brain death|brain death
605961|NCT00615225|inflammation|inflammation
605962|NCT00615225|endotoxin|endotoxin
605963|NCT00615225|transplantation|transplantation
605964|NCT00615225|graft|graft
605965|NCT00615225|apoptosis|apoptosis
605966|NCT00615225|Systemic inflammatory response|systemic inflammatory response
605967|NCT00615225|Apoptosis activation|apoptosis activation
605968|NCT00615225|Graft outcome|graft outcome
605969|NCT00615212|Healthy Subjects,|healthy subjects,
605970|NCT00615212|Cytochrome P450 isoenzymes,|cytochrome p450 isoenzymes,
605971|NCT00615212|Repeat Dose|repeat dose
605972|NCT00615212|GSK376501,|gsk376501,
605973|NCT00615186|Neuradiab|neuradiab
605974|NCT00615186|Locoregional glioblastoma multiforme disease|locoregional glioblastoma multiforme disease
605975|NCT00615186|Anti-tenascin|anti-tenascin
605976|NCT00615186|Radiolabeled antibody therapy|radiolabeled antibody therapy
605977|NCT00615186|Survival|survival
605978|NCT00615173|Tacrolimus|tacrolimus
605979|NCT00615173|lupus nephritis|lupus nephritis
605980|NCT00615160|Metastatic melanoma|metastatic melanoma
605981|NCT00615160|anti angiogenetic treatment|anti angiogenetic treatment
605982|NCT00615147|Any cancer|any cancer
605983|NCT00615147|suspected pulmonary embolism|suspected pulmonary embolism
605984|NCT00615134|treatment experienced|treatment experienced
605985|NCT00615121|Smoking|smoking
605986|NCT00615121|Hypertension|hypertension
605987|NCT00615121|Diabetes|diabetes
605988|NCT00615121|Cardiovascular disease|cardiovascular disease
605989|NCT00615121|Renal Failure|renal failure
605990|NCT00615043|Transurethral resection of bladder tumor|transurethral resection of bladder tumor
605991|NCT00615043|TURBT|turbt
605992|NCT00615030|COPD, bronchodilator, long acting beta agonist, LABA|copd, bronchodilator, long acting beta agonist, laba
605993|NCT00615017|Sepsis|sepsis
605994|NCT00615017|septic shock|septic shock
605995|NCT00615017|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
605996|NCT00615004|Acromegaly|acromegaly
605997|NCT00615004|GH|gh
605998|NCT00615004|IGF-I|igf-i
605999|NCT00615004|Octreotide-LAR|octreotide-lar
606000|NCT00615004|Lanreotide|lanreotide
606001|NCT00615004|Transsphenoidal surgery|transsphenoidal surgery
606002|NCT00614991|Healthy Subjects|healthy subjects
606003|NCT00614991|Pharmacokinetics study|pharmacokinetics study
606004|NCT00614991|Pharmacokinetics of medications|pharmacokinetics of medications
606005|NCT00614978|HER-2 positive; brain metastases|her-2 positive; brain metastases
606006|NCT00614965|Cancer|cancer
606007|NCT00614965|NSCLC|nsclc
606008|NCT00614965|second-line chemotherapy|second-line chemotherapy
606009|NCT00614965|irinotecan|irinotecan
606010|NCT00614965|pemetrexed|pemetrexed
606011|NCT00614939|DPP-4 inhibitors|dpp-4 inhibitors
606012|NCT00614939|HbA1c|hba1c
606013|NCT00614939|incretins|incretins
606014|NCT00614939|Renal Impairment|renal impairment
606015|NCT00614926|Fatigue|fatigue
606016|NCT00614926|low energy|low energy
606017|NCT00614926|ALS|als
606018|NCT00614926|treatment|treatment
606019|NCT00614913|Proton|proton
606020|NCT00614913|Radiotherapy|radiotherapy
606021|NCT00614913|Hepatocellular carcinoma|hepatocellular carcinoma
606022|NCT00614913|Liver Cancer|liver cancer
606023|NCT00614900|COPD|copd
606024|NCT00614900|pulmonary hypertension|pulmonary hypertension
606025|NCT00614900|NT-proBNP|nt-probnp
606026|NCT00614900|6 minutes walk test|6 minutes walk test
606027|NCT00614887|Subarachnoid hemorrhage|subarachnoid hemorrhage
606028|NCT00614887|Pituitary gland|pituitary gland
606029|NCT00614887|Adrenal gland|adrenal gland
606030|NCT00614874|Asthma|asthma
606031|NCT00614874|Avandia|avandia
606032|NCT00614861|Non-cancer pain|non-cancer pain
606033|NCT00614861|Pain|pain
606034|NCT00614848|restenosis|restenosis
606035|NCT00614835|Gemcitabine|gemcitabine
606036|NCT00614835|Docetaxel|docetaxel
606037|NCT00614835|uterine sarcoma|uterine sarcoma
606038|NCT00614809|gefitinib|gefitinib
606039|NCT00614809|brain metastasis|brain metastasis
606040|NCT00614796|COPD|copd
606041|NCT00614796|Lifestyle|lifestyle
606042|NCT00614796|Pedometer|pedometer
606043|NCT00614783|Screening|screening
606044|NCT00614770|colonoscopy|colonoscopy
606045|NCT00614744|NICHD Neonatal Research Network|nichd neonatal research network
606046|NCT00614744|Hypoxic-ischemic encephalopathy (HIE)|hypoxic-ischemic encephalopathy (hie)
606047|NCT00614744|Hypothermia|hypothermia
606048|NCT00614744|Neonatal depression|neonatal depression
606049|NCT00614744|Perinatal asphyxia|perinatal asphyxia
606050|NCT00614731|Keyhole Limpet Hemocyanin|keyhole limpet hemocyanin
606051|NCT00614731|KLH|klh
606052|NCT00614731|atopic dermatitis|atopic dermatitis
606053|NCT00614731|IgG antibodies|igg antibodies
606054|NCT00614731|scarification|scarification
606055|NCT00614718|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
606056|NCT00614718|lead failure|lead failure
606057|NCT00614718|pace/sense lead|pace/sense lead
606058|NCT00614718|ICD complication|icd complication
606059|NCT00614718|inappropriate therapy|inappropriate therapy
606063|NCT00614679|catheter salvage|catheter salvage
606064|NCT00614666|coccidioidomycosis|coccidioidomycosis
606065|NCT00614666|Valley Fever|valley fever
606066|NCT00614666|nikkomycin Z|nikkomycin z
606067|NCT00614653|Pancreatic Cancer|pancreatic cancer
606068|NCT00614653|Bevacizumab|bevacizumab
606069|NCT00614653|Avastin™|avastin™
606070|NCT00614653|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
606071|NCT00614653|rhuMAb-VEGF|rhumab-vegf
606072|NCT00614653|Erlotinib|erlotinib
606073|NCT00614653|Erlotinib Hydrochloride|erlotinib hydrochloride
606074|NCT00614653|Tarceva|tarceva
606075|NCT00614653|OSI-774|osi-774
606076|NCT00614653|Capecitabine|capecitabine
606077|NCT00614653|Xeloda|xeloda
606078|NCT00614640|HAART|haart
606079|NCT00614640|Therapeutic vaccine|therapeutic vaccine
606080|NCT00614614|Meningococcal disease|meningococcal disease
606081|NCT00614614|Toddlers|toddlers
606082|NCT00614614|Neisseria meningitidis|neisseria meningitidis
606083|NCT00614614|Meningococcal vaccines|meningococcal vaccines
606084|NCT00614614|Immunogenicity|immunogenicity
606085|NCT00614614|Human serum bactericidal assay|human serum bactericidal assay
606086|NCT00614614|Safety|safety
606087|NCT00614614|Vaccines, conjugate|vaccines, conjugate
606088|NCT00614614|Booster vaccination|booster vaccination
606089|NCT00614601|pancreatic cancer|pancreatic cancer
606090|NCT00614601|vaccine therapy|vaccine therapy
606091|NCT00614588|temperature|temperature
606092|NCT00614588|monitor|monitor
606093|NCT00614588|surgery|surgery
606094|NCT00614562|critical associated illness polyneuropathy or polymyopathy (CIP/M)|critical associated illness polyneuropathy or polymyopathy (cip/m)
606095|NCT00614549|Levetiracetam|levetiracetam
606096|NCT00614549|Keppra|keppra
606097|NCT00614549|Epilepsy|epilepsy
606098|NCT00614549|Efficacy|efficacy
606099|NCT00614549|Safety|safety
606100|NCT00614536|Reflux Symptom Index|reflux symptom index
606101|NCT00614536|Reflux Finding Score|reflux finding score
606102|NCT00614536|Rabeprazole|rabeprazole
606103|NCT00614536|LaryngoPharyngeal Reflux Disease|laryngopharyngeal reflux disease
606104|NCT00614536|GastroEsophageal Reflux Disease|gastroesophageal reflux disease
606105|NCT00614523|MDS|mds
606106|NCT00614523|Low Risk MDS|low risk mds
606107|NCT00614523|Intermediate-1 Risk MDS|intermediate-1 risk mds
606108|NCT00614523|Thrombocytopenia|thrombocytopenia
606109|NCT00614484|Proton|proton
606110|NCT00614484|Radiation|radiation
606111|NCT00614458|latent HIV|latent hiv
606112|NCT00614458|resting CD4+ T cell|resting cd4+ t cell
606113|NCT00614458|valproic acid (VPA)|valproic acid (vpa)
606114|NCT00614458|Raltegravir (MK-0518) intensification|raltegravir (mk-0518) intensification
606115|NCT00614458|HIV replication|hiv replication
606116|NCT00614458|treatment experienced|treatment experienced
606117|NCT00614445|Nausea|nausea
606118|NCT00614445|Vomiting|vomiting
606119|NCT00614445|Pregnancy|pregnancy
606120|NCT00614445|Hyperemesis gravidarum|hyperemesis gravidarum
606121|NCT00614445|Pregnancy complications|pregnancy complications
606122|NCT00614432|anticoagulation|anticoagulation
606123|NCT00614432|surgical abortion|surgical abortion
606124|NCT00614419|Hernioplasty|hernioplasty
606125|NCT00614419|polypropylene|polypropylene
606126|NCT00614419|extracellular matrix|extracellular matrix
606127|NCT00614419|xenograft|xenograft
606128|NCT00614406|Celebrex|celebrex
606129|NCT00614406|prostaglandin inhibitor|prostaglandin inhibitor
606130|NCT00614406|ovulation|ovulation
606131|NCT00614406|menstrual cycles|menstrual cycles
606132|NCT00614367|chromosomal abnormalities in single cells|chromosomal abnormalities in single cells
606133|NCT00614354|99mTc-glucarate imaging to detect acute coronary syndrome|99mtc-glucarate imaging to detect acute coronary syndrome
606134|NCT00614341|diabetes mellitus|diabetes mellitus
606135|NCT00614341|neuropathy|neuropathy
606136|NCT00614341|distal symmetric polyneuropathy|distal symmetric polyneuropathy
606137|NCT00614341|pulsed electric fild|pulsed electric fild
606138|NCT00614328|Alcohol|alcohol
606139|NCT00614328|Alcohol Abuse|alcohol abuse
606140|NCT00614328|Alcohol Drinking|alcohol drinking
606141|NCT00614289|Mild to Moderate Hand Dermatitis|mild to moderate hand dermatitis
606142|NCT00614289|Hand Eczema|hand eczema
606143|NCT00614276|Sexual Dysfunction|sexual dysfunction
606144|NCT00614276|Cancer-related Sexual Dysfunction|cancer-related sexual dysfunction
606145|NCT00614276|Female Cancer Survivors|female cancer survivors
606146|NCT00614276|Tendrils|tendrils
606147|NCT00614276|Website program|website program
606148|NCT00614276|Self-help tool|self-help tool
606149|NCT00614276|Sexual counseling|sexual counseling
606150|NCT00614276|Questionnaires|questionnaires
606151|NCT00614263|Colonoscopy|colonoscopy
606152|NCT00614263|Sedation levels|sedation levels
606153|NCT00614250|Obstructive sleep apnea|obstructive sleep apnea
606154|NCT00614211|Cervix|cervix
606155|NCT00614211|Cervical|cervical
606156|NCT00614211|Cancer|cancer
606157|NCT00614211|Carcinoma|carcinoma
606158|NCT00614211|Radical hysterectomy|radical hysterectomy
606159|NCT00614211|Hysterectomy|hysterectomy
606160|NCT00614211|Laparoscopy|laparoscopy
606161|NCT00614211|Laparoscopic|laparoscopic
606162|NCT00614211|Robotic|robotic
606163|NCT00614211|Squamous Cell|squamous cell
606164|NCT00614211|Adenosquamous|adenosquamous
606165|NCT00614211|Adenocarcinoma|adenocarcinoma
606166|NCT00614211|Lymphatic Mapping|lymphatic mapping
606167|NCT00614211|IOLM|iolm
606168|NCT00614211|SPECT|spect
606169|NCT00614211|Sentinel Node|sentinel node
606170|NCT00614211|Uterine cervix|uterine cervix
606171|NCT00614198|autism|autism
606172|NCT00614198|autism spectrum disorder|autism spectrum disorder
606173|NCT00614198|diet|diet
606174|NCT00614198|gluten|gluten
606175|NCT00614198|casein|casein
606176|NCT00614198|intervention|intervention
606177|NCT00614198|peptide|peptide
606178|NCT00614198|randomised|randomised
606179|NCT00614198|controlled|controlled
606180|NCT00614198|adaptive design|adaptive design
606181|NCT00614198|Autism Diagnostic Observation Schedule (ADOS)|autism diagnostic observation schedule (ados)
606182|NCT00614198|Gilliam Autism Rating Scale (GARS)|gilliam autism rating scale (gars)
606183|NCT00614198|Vineland Adaptive Behaviour Scale (VABS)|vineland adaptive behaviour scale (vabs)
606184|NCT00614198|Attention-Deficit Hyperactivity Disorder (ADHD)-IV Scale|attention-deficit hyperactivity disorder (adhd)-iv scale
606185|NCT00614172|Proton|proton
606186|NCT00614172|Radiation|radiation
606187|NCT00614172|Breast cancer|breast cancer
606188|NCT00614159|Child age 1-10 years having a GI Endoscopy with sedation|child age 1-10 years having a gi endoscopy with sedation
606189|NCT00614146|liver failure, albumin dialysis, liver support|liver failure, albumin dialysis, liver support
606190|NCT00614133|protein metabolism|protein metabolism
606191|NCT00614133|surgery|surgery
606192|NCT00614133|parenteral nutrition|parenteral nutrition
606193|NCT00614107|Atrial Fibrillation post open heart surgery|atrial fibrillation post open heart surgery
606194|NCT00614094|placenta, hypoglycemia|placenta, hypoglycemia
606195|NCT00614081|Glomerular filtration rate measurement|glomerular filtration rate measurement
606196|NCT00614081|Contrast-enhanced dynamic MR imaging|contrast-enhanced dynamic mr imaging
606197|NCT00614081|Renal transplant recipients|renal transplant recipients
606198|NCT00614068|Treatment|treatment
606199|NCT00614068|PTSD|ptsd
606200|NCT00614042|CLL|cll
606201|NCT00614042|NHL|nhl
606202|NCT00614042|TRU-016|tru-016
606203|NCT00614042|chronic lymphocytic leukemia|chronic lymphocytic leukemia
606204|NCT00614042|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
606205|NCT00614029|sumatriptan|sumatriptan
606206|NCT00614029|Injections|injections
606207|NCT00614029|Subcutaneous|subcutaneous
606208|NCT00614016|healthy volunteers|healthy volunteers
606209|NCT00614003|decisional conflict;|decisional conflict;
606210|NCT00614003|decision quality;|decision quality;
606211|NCT00614003|place of end of life care;|place of end of life care;
606212|NCT00614003|provider education|provider education
606213|NCT00613977|fetal lung maturity|fetal lung maturity
606214|NCT00613977|lamellar body count|lamellar body count
606215|NCT00613964|Natriuretic Peptides|natriuretic peptides
606216|NCT00613964|Heart Failure|heart failure
606217|NCT00613964|Renal Failure|renal failure
606218|NCT00613938|Acute pain|acute pain
606219|NCT00613938|bunionectomy|bunionectomy
606220|NCT00613938|tapentadol|tapentadol
606221|NCT00613925|endometrial biopsy|endometrial biopsy
606222|NCT00613925|pain management|pain management
606223|NCT00613912|Magnetic Resonance Imaging, Magnetic Resonance Spectroscopy, Perfusion, brain|magnetic resonance imaging, magnetic resonance spectroscopy, perfusion, brain
606224|NCT00613899|home care|home care
606225|NCT00613899|home rehabilitation|home rehabilitation
606226|NCT00613899|telemedicine|telemedicine
606227|NCT00613899|ALS|als
606228|NCT00613886|NPH|nph
606229|NCT00613886|Normal Pressure Hydrocephalus|normal pressure hydrocephalus
606230|NCT00613873|colonoscopy|colonoscopy
606231|NCT00613860|Endoscopic lung volume reduction, heterogeneous emphysema, interventional bronchoscopy|endoscopic lung volume reduction, heterogeneous emphysema, interventional bronchoscopy
606232|NCT00613847|PET Scan|pet scan
606233|NCT00613847|Invasive Solid Tumors|invasive solid tumors
606234|NCT00613834|Essure sterilization|essure sterilization
606235|NCT00613834|pain management|pain management
606236|NCT00613834|intrauterine lidocaine infusion|intrauterine lidocaine infusion
606237|NCT00613821|surgical abortion|surgical abortion
606238|NCT00613821|pain management|pain management
606239|NCT00613808|venous|venous
606240|NCT00613808|leg|leg
606241|NCT00613808|ulcer|ulcer
606242|NCT00613795|pneumonia|pneumonia
606243|NCT00613795|ventilator associated pneumonia|ventilator associated pneumonia
606244|NCT00613795|probiotics|probiotics
606245|NCT00613795|Lactobacillus GG|lactobacillus gg
606246|NCT00613769|Surgical site infections|surgical site infections
606247|NCT00613717|iron deficiency anemia|iron deficiency anemia
606248|NCT00613717|iron deficiency|iron deficiency
606249|NCT00613717|infant|infant
606250|NCT00613717|development|development
606251|NCT00613717|behavior|behavior
606252|NCT00613691|Refractory|refractory
606253|NCT00613691|Progressive|progressive
606254|NCT00613678|pain|pain
606255|NCT00613678|activities of daily living|activities of daily living
606256|NCT00613678|symptoms|symptoms
606257|NCT00613678|self-management|self-management
606258|NCT00613652|solid tumors|solid tumors
606259|NCT00613652|solid malignancies|solid malignancies
606260|NCT00613626|Extensive Stage|extensive stage
606261|NCT00613626|Untreated|untreated
606262|NCT00613600|Safety|safety
606263|NCT00613600|Efficacy|efficacy
606264|NCT00613600|Glucomannan|glucomannan
606265|NCT00613600|Dietary fiber|dietary fiber
606266|NCT00613600|Weight loss|weight loss
606267|NCT00613587|Interleukin 13|interleukin 13
606268|NCT00613587|Interleukin 4|interleukin 4
606269|NCT00613587|Leukotrienes|leukotrienes
606270|NCT00613587|Basophil Histamine Release|basophil histamine release
606271|NCT00613561|Patients with the Severe Immunodeficiency diseases|patients with the severe immunodeficiency diseases
606272|NCT00613561|Severe Immunodeficiency diseases|severe immunodeficiency diseases
606273|NCT00613548|Moderate|moderate
606274|NCT00613548|Mitral|mitral
606275|NCT00613548|Regurgitation|regurgitation
606276|NCT00613548|CABG|cabg
606277|NCT00613535|Partial Meniscectomy|partial meniscectomy
606278|NCT00613535|Partial Thickness Knee Tear|partial thickness knee tear
606279|NCT00613535|MR Imaging|mr imaging
606280|NCT00613535|Mechanical Debridement|mechanical debridement
606281|NCT00613535|Crepitus|crepitus
606282|NCT00613535|Stability|stability
606283|NCT00613535|Coblation|coblation
606284|NCT00613535|Bipolar Radiofrequency|bipolar radiofrequency
606285|NCT00613535|Debridement|debridement
606286|NCT00613535|Recurrent Knee Pain|recurrent knee pain
606287|NCT00613535|meniscectomy|meniscectomy
606288|NCT00613535|meniscus|meniscus
606289|NCT00613535|cartilage lesion|cartilage lesion
606290|NCT00613535|articular cartilage lesion|articular cartilage lesion
606291|NCT00613535|articular cartilage|articular cartilage
606292|NCT00613535|knee|knee
606293|NCT00613522|Sleep apnea, Berlin, Stroke|sleep apnea, berlin, stroke
606294|NCT00613509|Melanoma, Cancer|melanoma, cancer
606295|NCT00613496|Atrial Fibrillation|atrial fibrillation
606296|NCT00613496|irbesartan|irbesartan
606297|NCT00613496|AT-II-antagonist|at-ii-antagonist
606298|NCT00613496|Adhesion Molecules|adhesion molecules
606299|NCT00613496|oxidative stress markers|oxidative stress markers
606300|NCT00613496|hsCRP|hscrp
606301|NCT00613496|ICAM|icam
606302|NCT00613496|VCAM|vcam
606303|NCT00613496|MCP-1|mcp-1
606304|NCT00613496|vWF|vwf
606305|NCT00613496|TGFβ1|tgfβ1
606306|NCT00613496|TNF-α|tnf-α
606307|NCT00613496|Interleukin-6|interleukin-6
606308|NCT00613496|8isoProstaglandinF2α|8isoprostaglandinf2α
606309|NCT00613470|Depression|depression
606310|NCT00613470|Antidepressants|antidepressants
606311|NCT00613444|Acne|acne
606312|NCT00613444|laser|laser
606313|NCT00613431|pharmacodynamics|pharmacodynamics
606314|NCT00613405|substance-related disorders|substance-related disorders
606315|NCT00613392|antioxidant|antioxidant
606316|NCT00613392|oxidant stress|oxidant stress
606317|NCT00613392|trauma|trauma
606318|NCT00613392|free radical|free radical
606319|NCT00613379|HIV|hiv
606320|NCT00613379|treatment naïve|treatment naïve
606321|NCT00613366|intrauterine device|intrauterine device
606322|NCT00613366|cervical dilation|cervical dilation
606323|NCT00613366|nulliparous women|nulliparous women
606324|NCT00613366|pain management|pain management
606325|NCT00613353|Female|female
606326|NCT00613340|Cervical pain|cervical pain
606327|NCT00613340|Zygapophysial joint|zygapophysial joint
606328|NCT00613340|Specificity|specificity
606329|NCT00613327|Overactive bladder|overactive bladder
606330|NCT00613327|Oxybutynin chloride|oxybutynin chloride
606331|NCT00613327|OROS|oros
606332|NCT00613288|acute|acute
606333|NCT00613288|testosterone|testosterone
606334|NCT00613288|experimental|experimental
606335|NCT00613288|hypogonadism|hypogonadism
606336|NCT00613288|lipolysis|lipolysis
606337|NCT00613288|insulin sensitivity|insulin sensitivity
606338|NCT00613288|protein|protein
606339|NCT00613288|metabolism|metabolism
606340|NCT00613288|Experimental hypogonadism|experimental hypogonadism
606341|NCT00613288|Testosterone substitution|testosterone substitution
606342|NCT00613275|PNRP|pnrp
606343|NCT00613275|Navigation|navigation
606344|NCT00613275|Navigator|navigator
606345|NCT00613275|Activation|activation
606346|NCT00613275|Disparities|disparities
606347|NCT00613275|Primary Care|primary care
606348|NCT00613275|Racial and Ethnic Minorities|racial and ethnic minorities
606349|NCT00613262|Narrow Band Imaging|narrow band imaging
606350|NCT00613249|HIV-1 Infection|hiv-1 infection
606351|NCT00613249|HIV Seronegativity|hiv seronegativity
606352|NCT00613223|Malignant Gliomas|malignant gliomas
606353|NCT00613223|Etopophos|etopophos
606354|NCT00613223|Toposar|toposar
606355|NCT00613223|VePesid|vepesid
606356|NCT00613223|Etoposide|etoposide
606357|NCT00613223|Vandetanib|vandetanib
606358|NCT00613223|Zactima|zactima
606359|NCT00613223|ZD6474|zd6474
606360|NCT00613223|VP-16|vp-16
606361|NCT00613223|Brain Tumor|brain tumor
606362|NCT00613223|Recurring Malignant Brain Tumor|recurring malignant brain tumor
606363|NCT00613223|Gliosarcoma|gliosarcoma
606364|NCT00613223|Glioblastoma|glioblastoma
606365|NCT00613223|Glioma|glioma
606366|NCT00613223|Malignant Glioma|malignant glioma
606367|NCT00613223|GBM|gbm
606368|NCT00613210|preterm delivery|preterm delivery
606369|NCT00613210|shory cervix|shory cervix
606370|NCT00613210|amniotic fluid sludge|amniotic fluid sludge
606371|NCT00613210|uterine artery doppler|uterine artery doppler
606372|NCT00613210|singeltone|singeltone
606373|NCT00613210|normal amniotic fluid index|normal amniotic fluid index
606374|NCT00613210|without rupter of membranes|without rupter of membranes
606609|NCT00612638|CPT-11|cpt-11
606375|NCT00613210|24-34 weeks of gestation|24-34 weeks of gestation
606376|NCT00613197|Crohn's Disease|crohn's disease
606377|NCT00613184|Respiratory Syncytial virus|respiratory syncytial virus
606378|NCT00613184|Bronchiolitis|bronchiolitis
606379|NCT00613184|Pediatric|pediatric
606380|NCT00613171|Systemic sclerosis, scleroderma, fibrosis, STI571, imatinib|systemic sclerosis, scleroderma, fibrosis, sti571, imatinib
606381|NCT00613158|Subclincal Atherosclerosis|subclincal atherosclerosis
606382|NCT00613145|Refractory Malignancy|refractory malignancy
606383|NCT00613145|Phase I|phase i
606384|NCT00613145|Sorafenib|sorafenib
606385|NCT00613145|Capecitabine|capecitabine
606386|NCT00613132|Glioblastoma|glioblastoma
606387|NCT00613132|Gliosarcoma|gliosarcoma
606388|NCT00613132|GBM|gbm
606389|NCT00613132|Brain tumor|brain tumor
606390|NCT00613132|RAD0001|rad0001
606391|NCT00613132|Hydroxyurea|hydroxyurea
606392|NCT00613132|Gleevec|gleevec
606393|NCT00613132|Imatinib|imatinib
606394|NCT00613132|Droxia|droxia
606395|NCT00613132|Everolimus|everolimus
606396|NCT00613132|Hydrea|hydrea
606397|NCT00613132|Hydroxycarbamide|hydroxycarbamide
606398|NCT00613132|Recurrent GBM|recurrent gbm
606399|NCT00613132|Imatinib mesylate|imatinib mesylate
606400|NCT00613132|Glioblastoma multiforme|glioblastoma multiforme
606401|NCT00613119|Inflammation|inflammation
606402|NCT00613119|Frontotemporal Dementia|frontotemporal dementia
606403|NCT00613119|Dementia|dementia
606404|NCT00613119|PBR28|pbr28
606405|NCT00613119|PET Imaging|pet imaging
606406|NCT00613093|Temodar|temodar
606407|NCT00613093|Temozolomide|temozolomide
606408|NCT00613093|O6-BG|o6-bg
606409|NCT00613093|O6-Benzylguanine|o6-benzylguanine
606410|NCT00613093|NSC 637037|nsc 637037
606411|NCT00613093|Temodar-Resistant Malignant Glioma|temodar-resistant malignant glioma
606412|NCT00613093|Brain tumor|brain tumor
606413|NCT00613093|CNS tumor|cns tumor
606414|NCT00613093|Cerebral glioblastoma|cerebral glioblastoma
606415|NCT00613093|Anaplastic astrocytomas|anaplastic astrocytomas
606416|NCT00613093|Glioma|glioma
606417|NCT00613080|stage III rectal cancer|stage iii rectal cancer
606418|NCT00613080|adenocarcinoma of the rectum|adenocarcinoma of the rectum
606419|NCT00613067|Generalized anxiety disorder|generalized anxiety disorder
606420|NCT00613067|N100|n100
606421|NCT00613067|Central serotonergic activity|central serotonergic activity
606422|NCT00613054|GBM|gbm
606423|NCT00613054|Brain tumor|brain tumor
606424|NCT00613054|Zactima|zactima
606425|NCT00613054|Gleevec|gleevec
606426|NCT00613054|Hydroxyurea|hydroxyurea
606427|NCT00613054|Glioblastoma|glioblastoma
606428|NCT00613054|Gliosarcoma|gliosarcoma
606429|NCT00613054|Recurrent malignant glioma|recurrent malignant glioma
606430|NCT00613054|ZD6474|zd6474
606431|NCT00613054|Malignant glioma|malignant glioma
606432|NCT00613054|Imatinib|imatinib
606433|NCT00613054|Droxia|droxia
606434|NCT00613054|Hydrea|hydrea
606435|NCT00613054|Hydroxycarbamide|hydroxycarbamide
606436|NCT00613054|Vandetanib|vandetanib
606437|NCT00613028|Glioblastoma|glioblastoma
606438|NCT00613028|Gliosarcoma|gliosarcoma
606439|NCT00613028|GBM|gbm
606440|NCT00613028|Bevacizumab|bevacizumab
606441|NCT00613028|Avastin|avastin
606442|NCT00613028|Etoposide|etoposide
606443|NCT00613028|Brain tumor|brain tumor
606444|NCT00613028|Irinotecan|irinotecan
606445|NCT00613028|Glioblastoma multiforme|glioblastoma multiforme
606446|NCT00613028|Temodar|temodar
606447|NCT00613028|Temozolomide|temozolomide
606448|NCT00613028|Etopophos|etopophos
606449|NCT00613028|Toposar|toposar
606450|NCT00613028|VePesid|vepesid
606451|NCT00613028|VP-16|vp-16
606452|NCT00613028|Camptosar|camptosar
606453|NCT00613015|Cocaine Addiction|cocaine addiction
606454|NCT00613015|Cocaine Dependence|cocaine dependence
606455|NCT00613002|hypoactive sexual desire disorder|hypoactive sexual desire disorder
606456|NCT00613002|testosterone|testosterone
606457|NCT00613002|menopause|menopause
606458|NCT00612989|Glioblastoma|glioblastoma
606459|NCT00612989|Gliosarcoma|gliosarcoma
606460|NCT00612989|GBM|gbm
606461|NCT00612989|Temodar|temodar
606462|NCT00612989|Temozolomide|temozolomide
606463|NCT00612989|O6-BG|o6-bg
606464|NCT00612989|O6-Benzylguanine|o6-benzylguanine
606465|NCT00612989|Recurrent GBM|recurrent gbm
606466|NCT00612989|Progressive GBM|progressive gbm
606467|NCT00612989|Brain tumor|brain tumor
606468|NCT00612989|Malignant glioma|malignant glioma
606469|NCT00612989|Neulasta|neulasta
606470|NCT00612989|Pegfilgrastim|pegfilgrastim
606471|NCT00612976|treatment of COPD|treatment of copd
606472|NCT00612976|documentation of relevant data|documentation of relevant data
606473|NCT00612976|related to the budesonide/formoterole therapy in patients with COPD.|related to the budesonide/formoterole therapy in patients with copd.
606474|NCT00612963|Candidiasis, Oral|candidiasis, oral
606475|NCT00612963|Thrush|thrush
606476|NCT00612963|Candidiasis|candidiasis
606477|NCT00612937|Group B Streptococci|group b streptococci
606478|NCT00612937|Respiratory Disease|respiratory disease
606479|NCT00612937|Beta Lactam|beta lactam
606480|NCT00612937|Newborn|newborn
606481|NCT00612937|Respiratory Distress|respiratory distress
606482|NCT00612898|HIV infection|hiv infection
606483|NCT00612898|Drug resistance|drug resistance
606484|NCT00612898|Reverse transcriptase inhibitor|reverse transcriptase inhibitor
606485|NCT00612898|Nucleoside analogue|nucleoside analogue
606486|NCT00612898|treatment experienced|treatment experienced
606487|NCT00612859|Levetiracetam|levetiracetam
606488|NCT00612859|Keppra|keppra
606489|NCT00612846|Common Bile Duct Calculi|common bile duct calculi
606490|NCT00612846|Choledocholithiasis|choledocholithiasis
606491|NCT00612846|Endoscopic sphincterotomy|endoscopic sphincterotomy
606492|NCT00612846|Cholecystectomy, laparoscopic|cholecystectomy, laparoscopic
606493|NCT00612846|Laparoscopic bile duct exploration|laparoscopic bile duct exploration
606494|NCT00612833|Vasectomy|vasectomy
606495|NCT00612833|Male contraception|male contraception
606496|NCT00612833|Contraceptive effectiveness|contraceptive effectiveness
606497|NCT00612833|Semen analysis|semen analysis
606498|NCT00612833|Surgical techniques|surgical techniques
606499|NCT00612833|Fascial interposition|fascial interposition
606500|NCT00612833|Cautery|cautery
606501|NCT00612833|The relative contraceptive effectiveness of three methods of occluding the vas, in the context of a no-scalpel vasectomy procedure.|the relative contraceptive effectiveness of three methods of occluding the vas, in the context of a no-scalpel vasectomy procedure.
607076|NCT00610974|walking|walking
606502|NCT00612820|Vienna Challenge Chamber|vienna challenge chamber
606503|NCT00612820|Seasonal Allergic Rhinitis,|seasonal allergic rhinitis,
606504|NCT00612807|Older Adults|older adults
606505|NCT00612794|exenatide|exenatide
606506|NCT00612794|Byetta|byetta
606507|NCT00612794|diabetes|diabetes
606508|NCT00612794|Amylin|amylin
606509|NCT00612794|Lilly|lilly
606510|NCT00612781|intraocular lens|intraocular lens
606511|NCT00612781|blue-light filtering intraocular lens|blue-light filtering intraocular lens
606512|NCT00612781|contrast acuity|contrast acuity
606513|NCT00612781|color vision|color vision
606514|NCT00612768|Bioequivalence|bioequivalence
606515|NCT00612768|Thimerosal|thimerosal
606516|NCT00612768|Fragrance Mix|fragrance mix
606517|NCT00612768|PVP formulation|pvp formulation
606518|NCT00612768|Contact dermatitis|contact dermatitis
606519|NCT00612755|chronic hepatitis C|chronic hepatitis c
606520|NCT00612755|co-infection|co-infection
606521|NCT00612755|extend treatment|extend treatment
606522|NCT00612755|co-infected HIV-HCV|co-infected hiv-hcv
606523|NCT00612742|Cardiovascular event|cardiovascular event
606524|NCT00612742|Breast Cancer|breast cancer
606525|NCT00612742|Testosterone|testosterone
606526|NCT00612742|Menopause|menopause
606527|NCT00612742|Hypoactive Sexual Desire Disorder|hypoactive sexual desire disorder
606528|NCT00612729|intraocular lens|intraocular lens
606529|NCT00612729|light filtering intraocular lens|light filtering intraocular lens
606530|NCT00612729|contrast acuity|contrast acuity
606531|NCT00612729|color vision|color vision
606532|NCT00612716|stage I multiple myeloma|stage i multiple myeloma
606533|NCT00612716|stage II multiple myeloma|stage ii multiple myeloma
606534|NCT00612716|stage III multiple myeloma|stage iii multiple myeloma
606535|NCT00612716|refractory multiple myeloma|refractory multiple myeloma
606536|NCT00612716|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
606537|NCT00612716|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
606538|NCT00612716|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
606539|NCT00612716|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
606540|NCT00612716|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
606541|NCT00612716|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
606542|NCT00612716|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
606543|NCT00612716|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
606544|NCT00612716|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
606545|NCT00612716|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
606546|NCT00612716|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
606547|NCT00612716|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
606548|NCT00612716|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
606549|NCT00612716|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
606550|NCT00612716|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
606551|NCT00612716|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
606552|NCT00612716|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
606553|NCT00612716|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
606554|NCT00612716|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
606555|NCT00612716|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
606639|NCT00612469|mutans streptococci|mutans streptococci
606556|NCT00612716|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
606557|NCT00612716|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
606558|NCT00612716|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
606559|NCT00612716|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
606560|NCT00612716|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
606561|NCT00612716|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
606562|NCT00612716|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
606563|NCT00612716|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
606564|NCT00612716|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
606565|NCT00612716|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
606566|NCT00612716|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
606567|NCT00612716|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
606568|NCT00612716|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
606569|NCT00612716|splenic marginal zone lymphoma|splenic marginal zone lymphoma
606570|NCT00612716|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
606571|NCT00612716|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
606572|NCT00612716|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
606573|NCT00612716|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
606574|NCT00612716|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
606575|NCT00612716|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
606576|NCT00612716|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
606577|NCT00612716|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
606578|NCT00612716|Burkitt lymphoma|burkitt lymphoma
606579|NCT00612716|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
606580|NCT00612716|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
606581|NCT00612716|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
606582|NCT00612716|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
606583|NCT00612716|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
606584|NCT00612703|Cancer, oral, erlotinib, tarceva, solid tumor, advanced tumor, phase 1|cancer, oral, erlotinib, tarceva, solid tumor, advanced tumor, phase 1
606585|NCT00612703|Tumor|tumor
606586|NCT00612690|Children|children
606587|NCT00612690|School-Based Mental Health Services|school-based mental health services
606588|NCT00612690|Urban Poverty|urban poverty
606589|NCT00612677|recurrent|recurrent
606590|NCT00612677|non-small cell|non-small cell
606591|NCT00612651|GBM|gbm
606592|NCT00612651|Malignant glioma|malignant glioma
606593|NCT00612651|Brain tumor|brain tumor
606594|NCT00612651|Temodar|temodar
606595|NCT00612651|Temozolomide|temozolomide
606596|NCT00612651|SCH 66336|sch 66336
606597|NCT00612651|Farnesyl transferase inhibitor|farnesyl transferase inhibitor
606598|NCT00612651|Glioblastoma multiforme|glioblastoma multiforme
606599|NCT00612651|Gliosarcoma|gliosarcoma
606600|NCT00612651|Anaplastic astrocytoma|anaplastic astrocytoma
606601|NCT00612651|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
606602|NCT00612651|Anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
606603|NCT00612638|Temodar|temodar
606604|NCT00612638|Temozolomide|temozolomide
606605|NCT00612638|O6-Benzylguanine|o6-benzylguanine
606606|NCT00612638|O6-BG|o6-bg
606607|NCT00612638|NSC 637037|nsc 637037
606608|NCT00612638|Irinotecan|irinotecan
606610|NCT00612638|Recurrent cerebral anaplastic glioma|recurrent cerebral anaplastic glioma
606611|NCT00612638|Progressive cerebral anaplastic glioma|progressive cerebral anaplastic glioma
606612|NCT00612638|Malignant glioma|malignant glioma
606613|NCT00612560|breast neoplasms|breast neoplasms
606614|NCT00612560|phytoestrogens|phytoestrogens
606615|NCT00612560|tumor characteristics|tumor characteristics
606616|NCT00612560|proliferation|proliferation
606617|NCT00612560|apoptosis|apoptosis
606618|NCT00612560|estrogen receptor|estrogen receptor
606619|NCT00612560|HER2|her2
606620|NCT00612547|Protozoan Infections|protozoan infections
606621|NCT00612547|Communicable Diseases|communicable diseases
606622|NCT00612547|Malaria Infection|malaria infection
606623|NCT00612547|Malaria, falciparum|malaria, falciparum
606624|NCT00612547|Malaria, vivax|malaria, vivax
606625|NCT00612547|Artesunate Amodiaquine|artesunate amodiaquine
606626|NCT00612521|Coronary artery disease|coronary artery disease
606627|NCT00612521|Coronary artery stenting|coronary artery stenting
606628|NCT00612521|peri-procedural myonecrosis|peri-procedural myonecrosis
606629|NCT00612521|Adenosine|adenosine
606630|NCT00612508|contraception|contraception
606631|NCT00612508|NuvaRing|nuvaring
606632|NCT00612508|Desogen|desogen
606633|NCT00612508|vaginal biopsy|vaginal biopsy
606634|NCT00612482|Substance abuse|substance abuse
606635|NCT00612469|dental caries|dental caries
606636|NCT00612469|vancomycin|vancomycin
606637|NCT00612469|chlorhexidine|chlorhexidine
606638|NCT00612469|sodium fluoride|sodium fluoride
606640|NCT00612456|angiogenesis|angiogenesis
606641|NCT00612456|pazopanib,|pazopanib,
606642|NCT00612456|age-related macular degeneration (AMD),|age-related macular degeneration (amd),
606643|NCT00612456|vascular endothelial growth factor (VEGF),|vascular endothelial growth factor (vegf),
606644|NCT00612456|choroidal neovascularization (CNV),|choroidal neovascularization (cnv),
606645|NCT00612443|breast cancer|breast cancer
606646|NCT00612430|Glioblastoma|glioblastoma
606647|NCT00612430|Gliosarcoma|gliosarcoma
606648|NCT00612430|GBM|gbm
606649|NCT00612430|MG|mg
606650|NCT00612430|Brain tumor|brain tumor
606651|NCT00612430|Bevacizumab|bevacizumab
606652|NCT00612430|Avastin|avastin
606653|NCT00612430|Etoposide|etoposide
606654|NCT00612430|VP-16|vp-16
606655|NCT00612430|Etopophos|etopophos
606656|NCT00612430|Toposar|toposar
606657|NCT00612430|VePesid|vepesid
606658|NCT00612430|Glioblastoma multiforme|glioblastoma multiforme
606659|NCT00612430|Recurrent GBM|recurrent gbm
606660|NCT00612430|Anaplastic astrocytoma|anaplastic astrocytoma
606661|NCT00612430|Malignant glioma|malignant glioma
606662|NCT00612417|Interaction with recombinant FVIII|interaction with recombinant fviii
606663|NCT00612404|gastrointestinal disorder|gastrointestinal disorder
606664|NCT00612404|endoscopy|endoscopy
606665|NCT00612404|patient with gastrointestinal disorders for whom an endoscopy is performed and who is treated with esomeprazole afterwards.|patient with gastrointestinal disorders for whom an endoscopy is performed and who is treated with esomeprazole afterwards.
606666|NCT00612391|humerus fracture|humerus fracture
606667|NCT00612378|Glabellar Furrowing|glabellar furrowing
606668|NCT00612365|Body Composition|body composition
606669|NCT00612365|Abdomen|abdomen
606670|NCT00612365|Atherosclerosis|atherosclerosis
606671|NCT00612339|Glioma|glioma
606672|NCT00612339|Temozolomide|temozolomide
606673|NCT00612339|Temodar|temodar
606674|NCT00612339|Avastin|avastin
606675|NCT00612339|Bevacizumab|bevacizumab
606676|NCT00612339|GBM|gbm
606677|NCT00612339|Gliosarcoma|gliosarcoma
606678|NCT00612339|Multifocal GBM|multifocal gbm
606679|NCT00612339|Brain tumor|brain tumor
606680|NCT00612339|Unresectable GBM|unresectable gbm
606681|NCT00612339|Glioblastoma multiforme|glioblastoma multiforme
606682|NCT00612313|Major Depressive Disorder|major depressive disorder
606683|NCT00612313|MDD|mdd
606684|NCT00612313|Children|children
606685|NCT00612313|Adolescents|adolescents
606686|NCT00612313|Antidepressant|antidepressant
606687|NCT00612313|CBT|cbt
606688|NCT00612300|Ambulatory stroke patients|ambulatory stroke patients
606689|NCT00612300|Gait training|gait training
606690|NCT00612300|Lokomat|lokomat
606691|NCT00612300|Physical therapy|physical therapy
606692|NCT00612287|Pain|pain
606693|NCT00612287|Chronic pain|chronic pain
606694|NCT00612287|Buprenorphine|buprenorphine
606695|NCT00612287|Drug addiction|drug addiction
606696|NCT00612274|allogeneic|allogeneic
606697|NCT00612261|Branch retinal vein occlusion; treatment|branch retinal vein occlusion; treatment
606698|NCT00612248|Osteoarthritis|osteoarthritis
606699|NCT00612248|Thumb|thumb
606700|NCT00612248|Splint|splint
606701|NCT00612248|Pain|pain
606702|NCT00612248|Function|function
606703|NCT00612248|Osteoarthritis of the trapeziometacarpal (TMC) joint|osteoarthritis of the trapeziometacarpal (tmc) joint
606704|NCT00612235|epilepsy|epilepsy
606705|NCT00612235|lamotrigine|lamotrigine
606706|NCT00612235|levetiracetam|levetiracetam
606707|NCT00612235|carbamazepine|carbamazepine
606708|NCT00612235|phenytoin|phenytoin
606709|NCT00612235|lamictal|lamictal
606710|NCT00612235|keppra|keppra
606711|NCT00612235|tegretol|tegretol
606712|NCT00612235|carbatrol|carbatrol
606713|NCT00612235|dilantin|dilantin
606714|NCT00612222|Immunotherapy|immunotherapy
606715|NCT00612222|Metastatic Melanoma|metastatic melanoma
606716|NCT00612222|Vaccination|vaccination
606717|NCT00612222|Tumor Regression|tumor regression
606718|NCT00612222|Skin Cancer|skin cancer
606719|NCT00612209|ARQ 197, advanced solid tumors, phase 1, dose escalation, pharmacodynamics, safety|arq 197, advanced solid tumors, phase 1, dose escalation, pharmacodynamics, safety
606720|NCT00612196|Safety and tolerability|safety and tolerability
606721|NCT00612183|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
606722|NCT00612183|mantle cell lymphoma|mantle cell lymphoma
606723|NCT00612170|Phase 3, safety and efficacy study, [S,S[-Reboxetine, Fibromyalgia|phase 3, safety and efficacy study, [s,s[-reboxetine, fibromyalgia
606724|NCT00612157|Obstructive Sleep Apnea|obstructive sleep apnea
606725|NCT00612157|Continuous Positive Airway Pressure|continuous positive airway pressure
606726|NCT00612157|CPAP Compliance|cpap compliance
606727|NCT00612157|Non-benzodiazepine hypnotics|non-benzodiazepine hypnotics
606728|NCT00612144|Type 2 DM|type 2 dm
606729|NCT00612131|medical residents PGY 2 and 3|medical residents pgy 2 and 3
606730|NCT00612118|Allergic rhinitis,|allergic rhinitis,
606731|NCT00612118|Vienna Challenge Chamber|vienna challenge chamber
606732|NCT00612105|Postherpetic Neuralgia, PHN, Shingles,|postherpetic neuralgia, phn, shingles,
606733|NCT00612092|Coronary CT angiography|coronary ct angiography
606734|NCT00612092|Radiation dose estimates|radiation dose estimates
606735|NCT00612079|Sertindole|sertindole
606736|NCT00612079|sensory gating|sensory gating
606737|NCT00612079|PPI|ppi
606738|NCT00612079|P50 suppression|p50 suppression
606739|NCT00612079|CANTAB|cantab
606740|NCT00612079|Effect of Sertindole on sensory gating (P50 suppression)|effect of sertindole on sensory gating (p50 suppression)
606741|NCT00612079|on sensorimotor gating (PPI)|on sensorimotor gating (ppi)
606742|NCT00612079|and cognition (CANTAB)|and cognition (cantab)
606743|NCT00612066|ACTH-producing pituitary tumor|acth-producing pituitary tumor
606744|NCT00612053|cardiovascular disease|cardiovascular disease
606745|NCT00612053|coronary artery bypass grafting (CABG)|coronary artery bypass grafting (cabg)
606746|NCT00612053|coronary artery disease (CAD)|coronary artery disease (cad)
606747|NCT00612053|percutaneous transluminal coronary angioplasty (PCI)|percutaneous transluminal coronary angioplasty (pci)
606748|NCT00612053|unprotected left main disease|unprotected left main disease
606749|NCT00612027|gastrointestinal disorder|gastrointestinal disorder
606750|NCT00612027|acid associated gastrointestinal symptoms.|acid associated gastrointestinal symptoms.
606751|NCT00612027|esomeprazole therapy in patients with gastrointestinal disorders|esomeprazole therapy in patients with gastrointestinal disorders
606752|NCT00612027|patients with acid associated gastrointestinal symptoms|patients with acid associated gastrointestinal symptoms
606753|NCT00612014|delayed gastric emptying|delayed gastric emptying
606754|NCT00612014|symptomatic gastroparesis|symptomatic gastroparesis
606755|NCT00612014|diabetes mellitus|diabetes mellitus
606756|NCT00612001|adult anaplastic astrocytoma|adult anaplastic astrocytoma
606757|NCT00612001|adult glioblastoma|adult glioblastoma
606758|NCT00612001|adult giant cell glioblastoma|adult giant cell glioblastoma
606759|NCT00612001|adult gliosarcoma|adult gliosarcoma
606760|NCT00612001|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
606761|NCT00612001|recurrent adult brain tumor|recurrent adult brain tumor
606762|NCT00612001|adult mixed glioma|adult mixed glioma
606763|NCT00611988|Walking therapy|walking therapy
606764|NCT00611988|Diabetes mellitus|diabetes mellitus
606765|NCT00611988|Peripheral arterial disease|peripheral arterial disease
606766|NCT00611975|Gonadal Steroid Hormones|gonadal steroid hormones
606767|NCT00611975|Healthy Volunteers|healthy volunteers
606768|NCT00611975|Antidepressant Side Effects|antidepressant side effects
606769|NCT00611975|Fluoxetine|fluoxetine
606770|NCT00611975|Bupropion|bupropion
606771|NCT00611975|Prolactin|prolactin
606772|NCT00611975|Testosterone|testosterone
606773|NCT00611975|Estradiol|estradiol
606774|NCT00611975|Progesterone|progesterone
606775|NCT00611975|Sexual Function|sexual function
606776|NCT00611975|Serotonin Reuptake Inhibitors|serotonin reuptake inhibitors
606777|NCT00611975|17-OH Pregnenolone|17-oh pregnenolone
606778|NCT00611949|Geranium oil|geranium oil
606779|NCT00611949|Neuropathy|neuropathy
606780|NCT00611949|Shingles|shingles
606781|NCT00611949|Herpes zoster|herpes zoster
606782|NCT00611936|Atomoxetine|atomoxetine
606783|NCT00611936|Stress|stress
606784|NCT00611936|d-amphetamine|d-amphetamine
606785|NCT00611923|Premenstrual Dysphoric Disorder|premenstrual dysphoric disorder
606786|NCT00611923|PMDD|pmdd
606787|NCT00611923|PMS|pms
606788|NCT00611897|NMDA|nmda
606789|NCT00611897|glutamate|glutamate
606790|NCT00611897|N-acetylcysteine|n-acetylcysteine
606791|NCT00611897|P3|p3
606792|NCT00611858|5-FU|5-fu
606793|NCT00611858|cetuximab|cetuximab
606794|NCT00611858|radiation|radiation
606795|NCT00611858|adenocarcinoma of the rectum|adenocarcinoma of the rectum
606796|NCT00611858|neoadjuvant therapy|neoadjuvant therapy
606797|NCT00611845|CABG surgery requiring CPB and at increased risk of bleeding and blood transfusion|cabg surgery requiring cpb and at increased risk of bleeding and blood transfusion
606798|NCT00611832|behavior problems|behavior problems
606799|NCT00611832|children|children
606800|NCT00611832|prevention|prevention
606801|NCT00611832|television|television
606802|NCT00611832|media|media
606803|NCT00611832|parenting|parenting
606804|NCT00611819|hepatitis|hepatitis
606805|NCT00611819|co-infection|co-infection
606806|NCT00611806|Cognition|cognition
606807|NCT00611806|Folic Acid|folic acid
606808|NCT00611806|B12|b12
606809|NCT00611793|Refractory Malignancy|refractory malignancy
606810|NCT00611793|Advanced Malignancies|advanced malignancies
606811|NCT00611793|PTK787/ZK222584|ptk787/zk222584
606812|NCT00611793|Bevacizumab|bevacizumab
606813|NCT00611780|Coronary CT angiography|coronary ct angiography
606814|NCT00611780|Radiation dose estimates|radiation dose estimates
606815|NCT00611767|Thiopental|thiopental
606816|NCT00611767|Alcohol|alcohol
606817|NCT00611767|Family History|family history
606818|NCT00611767|Vulnerability|vulnerability
606819|NCT00611767|GABA|gaba
606820|NCT00611741|MRS, glutamate, osmolality|mrs, glutamate, osmolality
606821|NCT00611728|Glioblastoma|glioblastoma
606822|NCT00611728|CPT 11|cpt 11
606823|NCT00611728|Sutent|sutent
606824|NCT00611728|Sunitinib|sunitinib
606825|NCT00611728|Sunitinib malate|sunitinib malate
606826|NCT00611728|Malignant Glioma|malignant glioma
606827|NCT00611728|GBM|gbm
606828|NCT00611728|Irinotecan|irinotecan
606829|NCT00611728|Camptosar|camptosar
606830|NCT00611728|Anaplastic astrocytoma|anaplastic astrocytoma
606831|NCT00611728|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
607285|NCT00610038|KIR6.2|kir6.2
606832|NCT00611728|Anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
606833|NCT00611728|SU011248|su011248
606834|NCT00611728|Brain tumor|brain tumor
606835|NCT00611728|Recurrent malignant glioma|recurrent malignant glioma
606836|NCT00611715|recurrent breast cancer|recurrent breast cancer
606837|NCT00611715|stage IV breast cancer|stage iv breast cancer
606838|NCT00611702|ELISPOT|elispot
606839|NCT00611702|RT-PCR|rt-pcr
606840|NCT00611702|Luminex|luminex
606841|NCT00611702|Genomics|genomics
606842|NCT00611689|Refractory Malignancy|refractory malignancy
606843|NCT00611689|Solid Tumors|solid tumors
606844|NCT00611689|PTK787|ptk787
606845|NCT00611689|ZK222584|zk222584
606846|NCT00611676|osteoarthritis pain|osteoarthritis pain
606847|NCT00611676|activity limitation|activity limitation
606848|NCT00611676|antidepressant|antidepressant
606849|NCT00611676|depression|depression
606850|NCT00611676|single-blind|single-blind
606851|NCT00611663|Pneumococcal vaccine|pneumococcal vaccine
606852|NCT00611663|SLE|sle
606853|NCT00611663|Vaccination|vaccination
606854|NCT00611663|Immunosuppression|immunosuppression
606855|NCT00611663|SLE as defined by the ACR classification|sle as defined by the acr classification
606856|NCT00611663|Stable SLE|stable sle
606857|NCT00611663|SLE treated by systemic corticosteroids|sle treated by systemic corticosteroids
606858|NCT00611650|non-small cell lung cancer|non-small cell lung cancer
606859|NCT00611650|squamous lung dysplasia|squamous lung dysplasia
606860|NCT00611650|tobacco use disorder|tobacco use disorder
606861|NCT00611637|Immunotherapy|immunotherapy
606862|NCT00611624|MammoSite|mammosite
606863|NCT00611624|brachytherapy|brachytherapy
606864|NCT00611572|GABA|gaba
606865|NCT00611572|glutamate|glutamate
606866|NCT00611572|NMDA|nmda
606867|NCT00611572|P300|p300
606868|NCT00611572|MMN|mmn
606869|NCT00611559|Infanrix hexa|infanrix hexa
606870|NCT00611559|combined vaccine|combined vaccine
606871|NCT00611546|preterm|preterm
606872|NCT00611546|parenteral nutrition|parenteral nutrition
606873|NCT00611546|TPN|tpn
606874|NCT00611546|lipid emulsions|lipid emulsions
606875|NCT00611546|photo-protection|photo-protection
606876|NCT00611546|oxidative stress|oxidative stress
606877|NCT00611533|Menopause|menopause
606878|NCT00611533|Cognition|cognition
606879|NCT00611520|treatment of COPD|treatment of copd
606880|NCT00611520|related to the budesonide/formoterole therapy in patients with COPD.|related to the budesonide/formoterole therapy in patients with copd.
606881|NCT00611494|Drug tolerance|drug tolerance
606882|NCT00611494|Quality of Life|quality of life
606883|NCT00611429|Treatment|treatment
606884|NCT00611429|Adherence|adherence
606885|NCT00611429|Intervention|intervention
606886|NCT00611429|Quality of Life|quality of life
606887|NCT00611416|catechins|catechins
606888|NCT00611416|caffeine|caffeine
606889|NCT00611416|energy expenditure|energy expenditure
606890|NCT00611416|fat oxidation|fat oxidation
606891|NCT00611416|appetite|appetite
606892|NCT00611403|LASIK|lasik
606893|NCT00611390|Viral laryngitis;|viral laryngitis;
606894|NCT00611390|Viral tracheitis;|viral tracheitis;
606895|NCT00611390|Herbal medicine;|herbal medicine;
606896|NCT00611390|Traditional medicine;|traditional medicine;
606897|NCT00611390|Aromatic essential oils;|aromatic essential oils;
606898|NCT00611377|delirium|delirium
606899|NCT00611377|mechanical ventilation|mechanical ventilation
606900|NCT00611377|age|age
606901|NCT00611377|severity score|severity score
606902|NCT00611364|Physical therapy|physical therapy
606903|NCT00611364|hypertension|hypertension
606904|NCT00611364|aged|aged
606905|NCT00611364|exercise|exercise
606906|NCT00611364|Physical exercise|physical exercise
606907|NCT00611364|Physical activity|physical activity
606908|NCT00611351|graft versus host disease|graft versus host disease
606909|NCT00611351|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
606910|NCT00611351|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
606911|NCT00611351|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
606912|NCT00611351|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
606913|NCT00611351|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
606914|NCT00611351|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
606915|NCT00611351|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
606916|NCT00611351|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
606917|NCT00611351|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
606918|NCT00611351|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
606919|NCT00611351|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
606920|NCT00611351|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
606921|NCT00611351|stage III multiple myeloma|stage iii multiple myeloma
606922|NCT00611351|refractory multiple myeloma|refractory multiple myeloma
606923|NCT00611351|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
607082|NCT00610961|Transplantation, Pancreas|transplantation, pancreas
606924|NCT00611351|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
606925|NCT00611351|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
606926|NCT00611351|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
606927|NCT00611351|secondary myelofibrosis|secondary myelofibrosis
606928|NCT00611351|secondary acute myeloid leukemia|secondary acute myeloid leukemia
606929|NCT00611351|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
606930|NCT00611351|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
606931|NCT00611351|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
606932|NCT00611351|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
606933|NCT00611351|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
606934|NCT00611351|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
606935|NCT00611351|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
606936|NCT00611351|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
606937|NCT00611351|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
606938|NCT00611351|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
606939|NCT00611351|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
606940|NCT00611351|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
606941|NCT00611351|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
606942|NCT00611351|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
606943|NCT00611351|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
606944|NCT00611351|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
606945|NCT00611351|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
606946|NCT00611351|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
606947|NCT00611351|splenic marginal zone lymphoma|splenic marginal zone lymphoma
606948|NCT00611351|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
606949|NCT00611351|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
606950|NCT00611351|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
606951|NCT00611351|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
606952|NCT00611351|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
606953|NCT00611351|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
606954|NCT00611351|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
606955|NCT00611351|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
606956|NCT00611351|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
606957|NCT00611351|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
606958|NCT00611351|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
606959|NCT00611351|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
606960|NCT00611351|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
606961|NCT00611351|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
606962|NCT00611351|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
606963|NCT00611351|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
606964|NCT00611351|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
606965|NCT00611351|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
606966|NCT00611351|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
606967|NCT00611351|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
606968|NCT00611351|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
606969|NCT00611351|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
606970|NCT00611351|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
606971|NCT00611351|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
606972|NCT00611351|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
606973|NCT00611351|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
606974|NCT00611351|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
606975|NCT00611351|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
606976|NCT00611351|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
606977|NCT00611351|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
606978|NCT00611351|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
606979|NCT00611351|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
606980|NCT00611351|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
606981|NCT00611351|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
606982|NCT00611351|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
606983|NCT00611351|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
606984|NCT00611351|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
606985|NCT00611351|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
607284|NCT00610038|mutation|mutation
606986|NCT00611351|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
606987|NCT00611351|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
606988|NCT00611351|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
606989|NCT00611351|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
606990|NCT00611351|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
606991|NCT00611351|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
606992|NCT00611351|refractory hairy cell leukemia|refractory hairy cell leukemia
606993|NCT00611351|stage I multiple myeloma|stage i multiple myeloma
606994|NCT00611351|stage II multiple myeloma|stage ii multiple myeloma
606995|NCT00611338|Complementary Therapies|complementary therapies
606996|NCT00611325|Glioblastoma|glioblastoma
606997|NCT00611325|Gliosarcoma|gliosarcoma
606998|NCT00611325|Glioblastoma multiforme|glioblastoma multiforme
606999|NCT00611325|Recurrent malignant glioma|recurrent malignant glioma
607000|NCT00611325|GBM|gbm
607001|NCT00611325|Recurrent GBM|recurrent gbm
607002|NCT00611325|Malignant glioma|malignant glioma
607003|NCT00611325|Brain tumor|brain tumor
607004|NCT00611325|Avastin|avastin
607005|NCT00611325|Bevacizumab|bevacizumab
607006|NCT00611325|Bortezomib|bortezomib
607007|NCT00611325|Velcade|velcade
607008|NCT00611312|Alzheimer's disease|alzheimer's disease
607009|NCT00611312|Cognitive training|cognitive training
607010|NCT00611299|Probiotics|probiotics
607011|NCT00611299|Immune response|immune response
607012|NCT00611299|Blood lipids|blood lipids
607013|NCT00611299|Intestinal microflora|intestinal microflora
607014|NCT00611299|Tolerance|tolerance
607015|NCT00611286|Drug-eluting stent|drug-eluting stent
607016|NCT00611286|clopidogrel|clopidogrel
607017|NCT00611286|bare metal stent|bare metal stent
607018|NCT00611286|landmark analysis|landmark analysis
607019|NCT00611286|Patients with coronary artery disease|patients with coronary artery disease
607020|NCT00611273|Glabellar Furrowing|glabellar furrowing
607021|NCT00611260|Meditation|meditation
607022|NCT00611260|Congestive Heart Failure|congestive heart failure
607023|NCT00611260|ICD|icd
607024|NCT00611260|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
607025|NCT00611221|massage|massage
607026|NCT00611221|labour|labour
607027|NCT00611195|Anesthesia|anesthesia
607028|NCT00611195|Children|children
607029|NCT00611195|Larynx|larynx
607030|NCT00611182|dyspnea|dyspnea
607031|NCT00611182|pulmonary fibrosis|pulmonary fibrosis
607032|NCT00611182|interstitial lung disease|interstitial lung disease
607033|NCT00611182|shortness of breath|shortness of breath
607034|NCT00611169|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
607035|NCT00611169|tirofiban|tirofiban
607036|NCT00611169|Magnetic Resonance Imaging|magnetic resonance imaging
607037|NCT00611169|Myocardial Infarction|myocardial infarction
607038|NCT00611156|Thermogenesis|thermogenesis
607039|NCT00611156|Meal-induced thermogenesis|meal-induced thermogenesis
607040|NCT00611156|energy expenditure|energy expenditure
607041|NCT00611156|fat oxidation|fat oxidation
607042|NCT00611156|bioactive ingredients|bioactive ingredients
607043|NCT00611156|spices|spices
607044|NCT00611156|ginger|ginger
607045|NCT00611156|horseradish|horseradish
607046|NCT00611156|black pepper|black pepper
607047|NCT00611156|mustard|mustard
607048|NCT00611143|Off-pump coronary artery bypass graft|off-pump coronary artery bypass graft
607049|NCT00611143|Atorvastatin|atorvastatin
607050|NCT00611143|Postoperative atrial fibrillation|postoperative atrial fibrillation
607051|NCT00611130|Cocaine|cocaine
607052|NCT00611130|Addiction|addiction
607053|NCT00611130|Dependence|dependence
607054|NCT00611130|Treatment|treatment
607055|NCT00611117|adaptation to high fat diet|adaptation to high fat diet
607056|NCT00611117|activity|activity
607057|NCT00611117|exercise|exercise
607058|NCT00611104|breast cancer|breast cancer
607059|NCT00611078|Soft Tissue Sarcoma|soft tissue sarcoma
607060|NCT00611078|environment|environment
607061|NCT00611078|pollutants|pollutants
607062|NCT00611078|04-088|04-088
607063|NCT00611052|Depressive Disorder|depressive disorder
607064|NCT00611052|Depressive Disorder, Major|depressive disorder, major
607065|NCT00611052|Mental Health|mental health
607066|NCT00611052|Prevention|prevention
607067|NCT00611039|Darunavir/ritonavir|darunavir/ritonavir
607068|NCT00611039|virtual inhibitory quotient|virtual inhibitory quotient
607069|NCT00611039|dose reduction|dose reduction
607070|NCT00611026|Treatment of overactive bladder|treatment of overactive bladder
607071|NCT00611013|Development of multi-purpose novel imaging protocols|development of multi-purpose novel imaging protocols
607072|NCT00611000|colon cancer|colon cancer
607073|NCT00611000|rectal cancer|rectal cancer
607074|NCT00610987|Antibiotic Prophylaxis|antibiotic prophylaxis
607075|NCT00610974|Spinal cord injury|spinal cord injury
607077|NCT00610974|gait training|gait training
607078|NCT00610974|body-weight supported treadmill training|body-weight supported treadmill training
607079|NCT00610974|rehabilitation|rehabilitation
607080|NCT00610961|BK Polyomavirus|bk polyomavirus
607081|NCT00610961|Transplantation, Kidney|transplantation, kidney
607083|NCT00610948|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
607084|NCT00610935|Influenza|influenza
607085|NCT00610935|Subjects with uncomplicated acute influenza|subjects with uncomplicated acute influenza
607086|NCT00610922|Performance of motor skills|performance of motor skills
607088|NCT00610870|Myocardial infarct size|myocardial infarct size
607089|NCT00610870|Atorvastatin|atorvastatin
607090|NCT00610870|SPECT|spect
607091|NCT00610870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
607092|NCT00610844|lung cancer|lung cancer
607093|NCT00610844|lung metastasis|lung metastasis
607094|NCT00610844|radiofrequency ablation|radiofrequency ablation
607095|NCT00610805|SLE|sle
607096|NCT00610805|lupus|lupus
607097|NCT00610805|cardiovascular|cardiovascular
607098|NCT00610805|IMT|imt
607099|NCT00610805|Systemic Lupus Erythematosus|systemic lupus erythematosus
607100|NCT00610779|Rhino-sinusitis;|rhino-sinusitis;
607101|NCT00610779|Herbal medicine;|herbal medicine;
607102|NCT00610779|Traditional medicine;|traditional medicine;
607103|NCT00610779|Aromatic essential oils;|aromatic essential oils;
607104|NCT00610766|coronary CT angiography|coronary ct angiography
607105|NCT00610766|radiation dose estimates|radiation dose estimates
607106|NCT00610753|Anorexia nervosa|anorexia nervosa
607107|NCT00610753|Adolescents|adolescents
607108|NCT00610753|Family therapy|family therapy
607109|NCT00610740|recurrent cervical cancer|recurrent cervical cancer
607110|NCT00610740|cervical cancer|cervical cancer
607111|NCT00610740|endometrial carcinoma|endometrial carcinoma
607112|NCT00610740|ovarian epithelial cancer|ovarian epithelial cancer
607113|NCT00610740|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
607114|NCT00610740|recurrent endometrial carcinoma|recurrent endometrial carcinoma
607115|NCT00610727|Migraine, Prochlorperazine aerosol|migraine, prochlorperazine aerosol
607116|NCT00610714|Cancer|cancer
607117|NCT00610714|Tumour|tumour
607118|NCT00610714|Ovarian Neoplasms|ovarian neoplasms
607119|NCT00610714|Ovarian Cancer|ovarian cancer
607120|NCT00610675|Fifty two weeks|fifty two weeks
607121|NCT00610675|Open label|open label
607122|NCT00610675|extension|extension
607123|NCT00610662|cervical cancer|cervical cancer
607124|NCT00610662|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
607125|NCT00610662|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
607126|NCT00610662|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
607127|NCT00610649|randomized|randomized
607128|NCT00610649|placebo controlled|placebo controlled
607129|NCT00610649|maximum tolerated dose|maximum tolerated dose
607130|NCT00610636|FOLFOX-4|folfox-4
607131|NCT00610636|neoadjuvant chemotherapy|neoadjuvant chemotherapy
607132|NCT00610636|colorectal cancer|colorectal cancer
607133|NCT00610636|liver metastasis|liver metastasis
607134|NCT00610636|resectability|resectability
607135|NCT00610623|Pseudomonas aeruginosa|pseudomonas aeruginosa
607136|NCT00610623|Pneumonia|pneumonia
607137|NCT00610623|Ventilator-Associated|ventilator-associated
607138|NCT00610623|Quorum Sensing|quorum sensing
607139|NCT00610610|Fibromyalgia|fibromyalgia
607140|NCT00610610|Paroxetine|paroxetine
607141|NCT00610597|liver|liver
607142|NCT00610597|alcohol|alcohol
607143|NCT00610597|lymphocyte|lymphocyte
607144|NCT00610584|seasonal allergic rhinitis|seasonal allergic rhinitis
607145|NCT00610584|acupuncture|acupuncture
607146|NCT00610584|RCT|rct
607147|NCT00610584|CAM|cam
607148|NCT00610571|Temodar|temodar
607149|NCT00610571|Temozolomide|temozolomide
607150|NCT00610571|Topotecan|topotecan
607151|NCT00610571|Hycamtin|hycamtin
607152|NCT00610571|Malignant Gliomas|malignant gliomas
607153|NCT00610571|Brain tumor|brain tumor
607154|NCT00610571|Anaplastic astrocytoma|anaplastic astrocytoma
607155|NCT00610571|AA|aa
607156|NCT00610571|GBM|gbm
607157|NCT00610571|Glioblastoma Multiform|glioblastoma multiform
607158|NCT00610571|Gliosarcoma|gliosarcoma
607159|NCT00610545|ATORVASTATIN|atorvastatin
607160|NCT00610545|VASCULAR SURGERY|vascular surgery
607161|NCT00610545|CARDIOVASCULAR OUTCOMES|cardiovascular outcomes
607162|NCT00610532|pharmacoresistance|pharmacoresistance
607163|NCT00610532|healthy volunteers|healthy volunteers
607164|NCT00610519|Viral pharyngo-tonsillitis;|viral pharyngo-tonsillitis;
607165|NCT00610519|Herbal medicine;|herbal medicine;
607166|NCT00610519|Traditional medicine;|traditional medicine;
607167|NCT00610519|Aromatic essential oils;|aromatic essential oils;
607168|NCT00610506|Atypical Depression|atypical depression
607169|NCT00610493|Advanced Cancer|advanced cancer
607170|NCT00610493|Bevacizumab|bevacizumab
607171|NCT00610493|Temsirolimus|temsirolimus
607172|NCT00610493|Avastin|avastin
607173|NCT00610493|Torisel|torisel
607174|NCT00610493|CCI-779|cci-779
607175|NCT00610493|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
607176|NCT00610493|rhuMAb-VEGF|rhumab-vegf
607177|NCT00610493|dynamic contrast-enhanced magnetic resonance imaging|dynamic contrast-enhanced magnetic resonance imaging
607178|NCT00610493|DCE|dce
607179|NCT00610493|magnetic resonance imaging|magnetic resonance imaging
607180|NCT00610493|MRI|mri
607181|NCT00610480|Dry Eyes|dry eyes
607182|NCT00610480|Tear Film Stability|tear film stability
607183|NCT00610454|Levetiracetam|levetiracetam
607184|NCT00610454|Keppra|keppra
607185|NCT00610441|randomized|randomized
607186|NCT00610441|double blind|double blind
607187|NCT00610441|placebo controlled|placebo controlled
607188|NCT00610428|Migraine, Staccato Prochlorperazine|migraine, staccato prochlorperazine
607189|NCT00610428|Migraine headache with or without aura.|migraine headache with or without aura.
607190|NCT00610376|Handwashing|handwashing
607191|NCT00610376|Randomized controlled trial|randomized controlled trial
607192|NCT00610376|Cluster randomization|cluster randomization
607193|NCT00610376|Community intervention trial|community intervention trial
607194|NCT00610376|Disease prevention|disease prevention
607195|NCT00610376|Pediatric communicable disease|pediatric communicable disease
607196|NCT00610376|Preschool|preschool
607197|NCT00610376|Illness absenteeism|illness absenteeism
607198|NCT00610350|Levosimendan|levosimendan
607199|NCT00610350|pre-conditioning|pre-conditioning
607200|NCT00610350|cardiac surgery|cardiac surgery
607201|NCT00610350|myocardial function|myocardial function
607202|NCT00610350|contractility|contractility
607203|NCT00610350|heart|heart
607204|NCT00610350|ischaemia|ischaemia
607205|NCT00610324|oropharyngeal cleansing|oropharyngeal cleansing
607206|NCT00610324|oral decontamination|oral decontamination
607207|NCT00610324|oropharyngeal bacterial flora|oropharyngeal bacterial flora
607208|NCT00610324|oropharyngeal colonization|oropharyngeal colonization
607209|NCT00610324|critical illness|critical illness
607210|NCT00610324|mechanical ventilation|mechanical ventilation
607211|NCT00610324|tracheal intubation|tracheal intubation
607212|NCT00610324|prophylaxis|prophylaxis
607213|NCT00610311|Metastatic Melanoma|metastatic melanoma
607214|NCT00610311|Immunotherapy|immunotherapy
607215|NCT00610311|Vaccination|vaccination
607216|NCT00610311|Tumor Regression|tumor regression
607217|NCT00610311|Skin Cancer|skin cancer
607218|NCT00610298|disability affecting strength, balance and coordination|disability affecting strength, balance and coordination
607219|NCT00610272|single bone metastasis|single bone metastasis
607220|NCT00610272|multiple bone metastasis|multiple bone metastasis
607221|NCT00610272|pain relief|pain relief
607222|NCT00610272|radiotherapy|radiotherapy
607223|NCT00610259|Depressive disorder|depressive disorder
607224|NCT00610259|Sleep initiation and maintenance disorder|sleep initiation and maintenance disorder
607225|NCT00610259|Behavior therapy|behavior therapy
607226|NCT00610246|Thorax|thorax
607227|NCT00610246|Abdomen|abdomen
607228|NCT00610246|Pelvis|pelvis
607229|NCT00610246|Lesion|lesion
607230|NCT00610246|Cancer|cancer
607231|NCT00610246|Radiation|radiation
607232|NCT00610246|Chemotherapy|chemotherapy
607233|NCT00610246|Phase 1|phase 1
607234|NCT00610246|Advanced Cancer|advanced cancer
607235|NCT00610246|Sorafenib|sorafenib
607236|NCT00610246|Nexavar|nexavar
607237|NCT00610246|BAY43-9006|bay43-9006
607238|NCT00610233|deep brain stimulation|deep brain stimulation
607239|NCT00610233|urodynamics|urodynamics
607240|NCT00610220|pediatrics|pediatrics
607241|NCT00610220|wrist fractures|wrist fractures
607242|NCT00610220|casting|casting
607243|NCT00610220|wrist splint|wrist splint
607244|NCT00610207|Anal fistula|anal fistula
607245|NCT00610207|fistula in ano|fistula in ano
607246|NCT00610207|anorectal fistula|anorectal fistula
607247|NCT00610207|Crohn's Disease|crohn's disease
607248|NCT00610181|Breast Cancer|breast cancer
607249|NCT00610181|Breast Carcinoma|breast carcinoma
607250|NCT00610181|Invasive Lobular Cancer|invasive lobular cancer
607251|NCT00610181|Mixed Invasive Ductal-lobular Carcinoma|mixed invasive ductal-lobular carcinoma
607252|NCT00610181|Magnetic Resonance Imaging|magnetic resonance imaging
607253|NCT00610181|MRI|mri
607254|NCT00610168|dTpa vaccine|dtpa vaccine
607255|NCT00610168|pertussis|pertussis
607256|NCT00610168|Tdap|tdap
607257|NCT00610168|Boostrix|boostrix
607258|NCT00610168|booster|booster
607259|NCT00610168|tetanus|tetanus
607260|NCT00610168|diphtheria|diphtheria
607261|NCT00610142|atopic dermatitis|atopic dermatitis
607262|NCT00610142|pimecrolimus|pimecrolimus
607263|NCT00610142|hydrocortison|hydrocortison
607264|NCT00610142|Optical Coherence Tomography|optical coherence tomography
607265|NCT00610129|MK-0646|mk-0646
607266|NCT00610090|UNITE|unite
607267|NCT00610090|AAA|aaa
607268|NCT00610090|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
607269|NCT00610090|Stent|stent
607270|NCT00610090|Graft|graft
607271|NCT00610077|Letrozole|letrozole
607272|NCT00610077|Clomiphene citrate|clomiphene citrate
607273|NCT00610077|Anovulatory infertility|anovulatory infertility
607274|NCT00610077|Ovulation induction|ovulation induction
607275|NCT00610064|Refractory lower urinary tract dysfunction|refractory lower urinary tract dysfunction
607276|NCT00610064|Sacral neuromodulation|sacral neuromodulation
607277|NCT00610064|Brain effects|brain effects
607278|NCT00610064|Neuroimaging|neuroimaging
607279|NCT00610064|Neuromodulation|neuromodulation
607280|NCT00610051|severe heart failure|severe heart failure
607281|NCT00610051|transplants|transplants
607282|NCT00610038|neonatal|neonatal
607283|NCT00610038|diabetes mellitus|diabetes mellitus
607286|NCT00610038|SUR1|sur1
607287|NCT00610038|Neonatal diabetes mellitus with KIR6.2 or SUR1 mutations|neonatal diabetes mellitus with kir6.2 or sur1 mutations
607288|NCT00610025|NOTES|notes
607289|NCT00610025|transgastric endoscopy|transgastric endoscopy
607290|NCT00610025|obesity surgery|obesity surgery
607291|NCT00610025|Roux-en-Y surgery|roux-en-y surgery
607292|NCT00610012|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
607293|NCT00610012|MRCC|mrcc
607294|NCT00610012|Therapy-reality|therapy-reality
607295|NCT00610012|Observation|observation
607296|NCT00610012|Registry|registry
607297|NCT00610012|RCC|rcc
607298|NCT00610012|ARCC|arcc
607299|NCT00610012|Germany|germany
607300|NCT00610012|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
607301|NCT00610012|Renal Cell Carcinoma|renal cell carcinoma
607302|NCT00610012|Renal Cell Cancer|renal cell cancer
607303|NCT00610012|Sorafenib|sorafenib
607304|NCT00610012|Sunitinib|sunitinib
607305|NCT00610012|Interferon|interferon
607306|NCT00610012|Interleukin|interleukin
607307|NCT00610012|Temsirolimus|temsirolimus
607308|NCT00610012|Pazopanib|pazopanib
607309|NCT00610012|Cytokines|cytokines
607310|NCT00610012|VEGF|vegf
607311|NCT00609999|Glioblastoma|glioblastoma
607312|NCT00609999|Gliosarcoma|gliosarcoma
607313|NCT00609999|GBM|gbm
607314|NCT00609999|Recurrent MG|recurrent mg
607315|NCT00609999|Erlotinib|erlotinib
607316|NCT00609999|Dasatinib|dasatinib
607317|NCT00609999|Brain tumor|brain tumor
607318|NCT00609999|Malignant glioma|malignant glioma
607319|NCT00609999|Tarceva|tarceva
607320|NCT00609999|Sprycel|sprycel
607321|NCT00609986|Kidney|kidney
607322|NCT00609986|Transplantation|transplantation
607323|NCT00609986|Diabetes|diabetes
607324|NCT00609986|Hyperglycemia|hyperglycemia
607325|NCT00609973|Postoperative recurrence, inflammatory bowel disease|postoperative recurrence, inflammatory bowel disease
607326|NCT00609960|children anesthesia anxiety clowns|children anesthesia anxiety clowns
607327|NCT00609934|renal cell carcinoma|renal cell carcinoma
607328|NCT00609934|kidney cancer|kidney cancer
607329|NCT00609934|bone metastases|bone metastases
607330|NCT00609934|RCC|rcc
607331|NCT00609934|bone pain|bone pain
607332|NCT00609934|palliative radiotherapy|palliative radiotherapy
607333|NCT00609934|sorafenib|sorafenib
607334|NCT00609934|radiation|radiation
607335|NCT00609934|renal cell|renal cell
607336|NCT00609882|Nasal CPAP|nasal cpap
607337|NCT00609882|High flow nasal cannula|high flow nasal cannula
607338|NCT00609882|Neonate|neonate
607339|NCT00609843|Bladder cancer|bladder cancer
607340|NCT00609843|Radiotherapy|radiotherapy
607341|NCT00609843|Tumour delineation|tumour delineation
607342|NCT00609843|Markers|markers
607343|NCT00609830|Glucocorticoids|glucocorticoids
607344|NCT00609830|Osteoporosis|osteoporosis
607345|NCT00609830|Rheumatoid Arthritis|rheumatoid arthritis
607346|NCT00609830|Prevention|prevention
607347|NCT00609830|GIOP|giop
607348|NCT00609830|Patient Education|patient education
607349|NCT00609817|Relapsed Multiple Myeloma|relapsed multiple myeloma
607350|NCT00609817|Refractory Multiple Myeloma|refractory multiple myeloma
607351|NCT00609817|GCS 100|gcs 100
607352|NCT00609804|Non-Small Cell Lung Cancer|non-small cell lung cancer
607353|NCT00609804|Advanced|advanced
607354|NCT00609804|Erlotinib|erlotinib
607355|NCT00609804|Sorafenib|sorafenib
607356|NCT00609804|Progressing on erlotinib|progressing on erlotinib
607357|NCT00609791|recurrent breast cancer|recurrent breast cancer
607358|NCT00609791|stage IV breast cancer|stage iv breast cancer
607359|NCT00609791|male breast cancer|male breast cancer
607360|NCT00609778|CPR|cpr
607361|NCT00609778|Mechanical|mechanical
607362|NCT00609778|Manual|manual
607363|NCT00609778|Survival|survival
607364|NCT00609778|ROSC|rosc
607365|NCT00609765|advanced|advanced
607366|NCT00609765|unresectable|unresectable
607367|NCT00609765|metastatic|metastatic
607368|NCT00609765|endocrine|endocrine
607369|NCT00609765|tumors|tumors
607370|NCT00609752|Crohn Disease|crohn disease
607371|NCT00609752|Children|children
607372|NCT00609752|Bone Density|bone density
607373|NCT00609752|Prednisolone|prednisolone
607374|NCT00609752|Liquid Diet Therapy|liquid diet therapy
607375|NCT00609752|Quality of Life|quality of life
607376|NCT00609752|Metabolic Bone Disease|metabolic bone disease
607377|NCT00609739|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
607378|NCT00609726|Endoscopic Ultrasonography|endoscopic ultrasonography
607379|NCT00609726|Pancreatitis|pancreatitis
607380|NCT00609726|EUS|eus
607381|NCT00609713|Child|child
607382|NCT00609713|Obesity|obesity
607383|NCT00609700|burn injury|burn injury
607384|NCT00609700|volume replacement|volume replacement
607385|NCT00609700|Ringer's Lactate solution|ringer's lactate solution
607386|NCT00609700|Ringer's Acetate solution|ringer's acetate solution
607387|NCT00609700|volume replacement with crystalloids|volume replacement with crystalloids
607388|NCT00609687|sarcoidosis|sarcoidosis
607389|NCT00609687|diagnostic vitrectomy|diagnostic vitrectomy
607390|NCT00609687|vitreous biopsy|vitreous biopsy
608307|NCT00605904|Craving|craving
607391|NCT00609687|sarcoidosis-associated ocular inflammation|sarcoidosis-associated ocular inflammation
607392|NCT00609674|Perennial allergic rhinitis; fluticasone furoate nasal spray|perennial allergic rhinitis; fluticasone furoate nasal spray
607393|NCT00609661|Mesenchymal Stem Cells, Burn|mesenchymal stem cells, burn
607394|NCT00609648|Dental Anxiety|dental anxiety
607395|NCT00609648|Dental Phobia|dental phobia
607396|NCT00609648|Odontophobia|odontophobia
607397|NCT00609635|Respiratory|respiratory
607398|NCT00609635|RSV-induced respiratory illness|rsv-induced respiratory illness
607399|NCT00609622|metastatic colorectal cancer sunitinib (Sutent) bevacizumab (Avastin) randomized study|metastatic colorectal cancer sunitinib (sutent) bevacizumab (avastin) randomized study
607400|NCT00609609|Allogeneic stem cell grafts|allogeneic stem cell grafts
607401|NCT00609609|Allogeneic bone marrow graft|allogeneic bone marrow graft
607402|NCT00609609|Blood and Marrow Transplantation|blood and marrow transplantation
607403|NCT00609609|Stem cell graft|stem cell graft
607404|NCT00609609|Graft Versus Host Disease|graft versus host disease
607405|NCT00609609|GVHD|gvhd
607406|NCT00609609|Extracorporeal Photopheresis|extracorporeal photopheresis
607407|NCT00609609|ECP|ecp
607408|NCT00609609|Photopheresis|photopheresis
607409|NCT00609609|Methylprednisolone|methylprednisolone
607410|NCT00609609|Medrol|medrol
607411|NCT00609609|Depo-Medrol|depo-medrol
607412|NCT00609609|Solu-Medrol|solu-medrol
607413|NCT00609596|dutasteride|dutasteride
607414|NCT00609596|tamsulosin|tamsulosin
607415|NCT00609596|benign prostatic hyperplasia|benign prostatic hyperplasia
607416|NCT00609570|hypertension|hypertension
607417|NCT00609570|supplement|supplement
607418|NCT00609570|HRV|hrv
607419|NCT00609557|osteoarthritis pain|osteoarthritis pain
607420|NCT00609557|activity limitation|activity limitation
607421|NCT00609557|antidepressant|antidepressant
607422|NCT00609557|depression|depression
607423|NCT00609557|single-blind|single-blind
607424|NCT00609544|Non Dialysis-dependent chronic kidney disease and anemia|non dialysis-dependent chronic kidney disease and anemia
607425|NCT00609531|Restricted repetitive behaviors|restricted repetitive behaviors
607426|NCT00609531|restricted interests|restricted interests
607427|NCT00609531|Aspergers|aspergers
607428|NCT00609531|Autism|autism
607429|NCT00609505|Hereditary Breast and Ovarian Cancer syndrome|hereditary breast and ovarian cancer syndrome
607430|NCT00609505|genetic counseling|genetic counseling
607431|NCT00609505|breast cancer|breast cancer
607432|NCT00609505|ovarian cancer|ovarian cancer
607433|NCT00609505|telemedicine|telemedicine
607434|NCT00609505|Cancer genetic counseling|cancer genetic counseling
607435|NCT00609479|Distal radius fracture|distal radius fracture
607436|NCT00609479|Colle´s fracture|colle´s fracture
607437|NCT00609479|Internal fixation|internal fixation
607438|NCT00609479|External fixation|external fixation
607439|NCT00609479|DASH|dash
607440|NCT00609479|PRWE|prwe
607441|NCT00609466|Opioid|opioid
607442|NCT00609466|Central acting analgesic|central acting analgesic
607443|NCT00609466|CG5503 IR|cg5503 ir
607444|NCT00609466|Postoperative pain|postoperative pain
607445|NCT00609466|Bunionectomy|bunionectomy
607446|NCT00609466|Morphine|morphine
607447|NCT00609466|Placebo|placebo
607448|NCT00609453|Control participants|control participants
607449|NCT00609440|Morquio's disease; physiotherapy; results|morquio's disease; physiotherapy; results
607450|NCT00609427|cognitive training|cognitive training
607451|NCT00609427|cognitive rehabilitation|cognitive rehabilitation
607452|NCT00609414|Burns|burns
607453|NCT00609414|Albumin|albumin
607454|NCT00609414|Fluid Resuscitation|fluid resuscitation
607455|NCT00609401|Sorafenib|sorafenib
607457|NCT00609401|Metastatic disease|metastatic disease
607458|NCT00609375|Sepsis|sepsis
607459|NCT00609375|Bacteremia|bacteremia
607460|NCT00609375|Intravenous infusions|intravenous infusions
607461|NCT00609375|cefepime|cefepime
607462|NCT00609362|BMD|bmd
607463|NCT00609362|Rosiglitazone|rosiglitazone
607464|NCT00609362|Bone marrow fat|bone marrow fat
607465|NCT00609349|risk factors for pulmonary arterial hypertension|risk factors for pulmonary arterial hypertension
607466|NCT00609323|Pain|pain
607467|NCT00609323|postherpetic neuralgia|postherpetic neuralgia
607468|NCT00609310|clinical trial|clinical trial
607469|NCT00609310|flavonoid treatment|flavonoid treatment
607470|NCT00609310|neoplasia recurrence|neoplasia recurrence
607471|NCT00609310|colorectal cancer|colorectal cancer
607472|NCT00609310|polypectomy|polypectomy
607473|NCT00609310|adenoma in Colon|adenoma in colon
607474|NCT00609310|Neoplasia Recurrence Rates|neoplasia recurrence rates
607475|NCT00609310|postpolypectomy patients|postpolypectomy patients
607476|NCT00609297|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
607477|NCT00609297|pain|pain
607478|NCT00609284|Stage III|stage iii
607479|NCT00609284|Stage IV|stage iv
607480|NCT00609284|locally advanced|locally advanced
607481|NCT00609245|epilepsy|epilepsy
607482|NCT00609245|photosensitive|photosensitive
607483|NCT00609245|valproic acid|valproic acid
607484|NCT00609219|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
607485|NCT00609219|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
608716|NCT00603837|Hypothermia|hypothermia
607486|NCT00609219|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
607487|NCT00609219|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
607488|NCT00609180|Acute Lung Injury|acute lung injury
607489|NCT00609180|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
607490|NCT00609180|Feeding|feeding
607491|NCT00609180|Critical Care|critical care
607492|NCT00609180|Ventilator|ventilator
607493|NCT00609180|Omega-3 Fatty Acid|omega-3 fatty acid
607494|NCT00609180|Antioxidant|antioxidant
607495|NCT00609167|stage II multiple myeloma|stage ii multiple myeloma
607496|NCT00609167|stage III multiple myeloma|stage iii multiple myeloma
607497|NCT00609154|Type 2 diabetes|type 2 diabetes
607498|NCT00609154|Insulin|insulin
607499|NCT00609154|biosynthesis|biosynthesis
607500|NCT00609154|Non diabetic control|non diabetic control
607501|NCT00609128|tears|tears
607502|NCT00609128|conjunctival epithelial cells|conjunctival epithelial cells
607503|NCT00609128|olopatadine|olopatadine
607504|NCT00609128|impression cytology|impression cytology
607505|NCT00609115|Sub-acute care|sub-acute care
607506|NCT00609115|Robotics|robotics
607507|NCT00609102|Type 2 diabetes|type 2 diabetes
607508|NCT00609089|Family|family
607509|NCT00609089|treatment|treatment
607510|NCT00609089|reinforcement|reinforcement
607511|NCT00609089|substance|substance
607512|NCT00609089|trial|trial
607513|NCT00609089|drug|drug
607514|NCT00609089|abuse|abuse
607515|NCT00609089|HIV|hiv
607516|NCT00609089|risk|risk
607517|NCT00609063|Statins|statins
607518|NCT00609063|Myalgia|myalgia
607519|NCT00609063|Muscle Cramp|muscle cramp
607520|NCT00609050|cystic fibrosis|cystic fibrosis
607521|NCT00609050|exercise|exercise
607522|NCT00609050|perceived exertion|perceived exertion
607523|NCT00609050|aerobic fitness|aerobic fitness
607524|NCT00609050|lung function|lung function
607525|NCT00609050|health related quality of life|health related quality of life
607526|NCT00609050|self-regulated exercise|self-regulated exercise
607527|NCT00609037|Gastric Bypass|gastric bypass
607528|NCT00609037|Body contouring|body contouring
607529|NCT00609037|Excessive weight loss|excessive weight loss
607530|NCT00609011|Melanoma|melanoma
607531|NCT00609011|Metastatic|metastatic
607532|NCT00608998|Chronic renal failure|chronic renal failure
607533|NCT00608998|Vasculopathy|vasculopathy
607534|NCT00608998|Cardiovascular risk|cardiovascular risk
607535|NCT00608998|Chronic renal failure patients|chronic renal failure patients
607536|NCT00608985|sleeplessness|sleeplessness
607537|NCT00608985|orexin receptor antagonist|orexin receptor antagonist
607538|NCT00608985|almorexant|almorexant
607539|NCT00608985|insomnia|insomnia
607540|NCT00608972|negative for a protein called HER2/neu|negative for a protein called her2/neu
607541|NCT00608972|negative for estrogen receptors (ER) and progesterone receptors (PR).|negative for estrogen receptors (er) and progesterone receptors (pr).
607542|NCT00608972|breast cancer|breast cancer
607543|NCT00608959|Skin colonization|skin colonization
607544|NCT00608959|Catheter colonization|catheter colonization
607545|NCT00608959|Catheter site infection|catheter site infection
607546|NCT00608946|efficacy of treatment with copper in patients with mild Alzheimer´s disease|efficacy of treatment with copper in patients with mild alzheimer´s disease
607547|NCT00608946|cognitive status over time|cognitive status over time
607548|NCT00608946|CSF and volumetric data over time (1 year)|csf and volumetric data over time (1 year)
607549|NCT00608933|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
607550|NCT00608933|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
607551|NCT00608920|SPECT|spect
607552|NCT00608894|Autoimmune hepatitis|autoimmune hepatitis
607553|NCT00608894|Chronic active hepatitis|chronic active hepatitis
607554|NCT00608881|Huntington's disease|huntington's disease
607555|NCT00608881|Huntington disease|huntington disease
607556|NCT00608881|HD|hd
607557|NCT00608881|coenzyme Q10|coenzyme q10
607558|NCT00608881|CoQ|coq
607559|NCT00608868|Carcinoma|carcinoma
607560|NCT00608868|Non Small Cell Lung|non small cell lung
607561|NCT00608868|EGFR mutation|egfr mutation
607562|NCT00608868|Gefitinib|gefitinib
607563|NCT00608855|bone metastases|bone metastases
607564|NCT00608855|pain|pain
607565|NCT00608855|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
607566|NCT00608816|epinephrine|epinephrine
607567|NCT00608790|Tuberculosis, TB, Mycobacterium tuberculosis, children, South Africa|tuberculosis, tb, mycobacterium tuberculosis, children, south africa
607568|NCT00608777|Localized mild breakthrough|localized mild breakthrough
607569|NCT00608764|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
607570|NCT00608764|COPD|copd
607571|NCT00608764|Emphysema|emphysema
607572|NCT00608764|Chronic Bronchitis|chronic bronchitis
607573|NCT00608764|Genetics|genetics
607574|NCT00608764|Association Studies|association studies
607575|NCT00608764|Computed Tomography|computed tomography
607576|NCT00608751|Newly Diagnosed head and neck cancer|newly diagnosed head and neck cancer
607577|NCT00608738|neutropenia|neutropenia
607578|NCT00608738|infection|infection
607579|NCT00608738|radiation toxicity|radiation toxicity
607814|NCT00608062|endothelial function|endothelial function
607580|NCT00608738|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
607581|NCT00608738|malnutrition|malnutrition
607582|NCT00608738|musculoskeletal complications|musculoskeletal complications
607583|NCT00608738|thrombocytopenia|thrombocytopenia
607584|NCT00608738|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
607585|NCT00608725|heart rate|heart rate
607586|NCT00608725|blood pressure|blood pressure
607587|NCT00608725|blood volume|blood volume
607588|NCT00608725|sympathetic nervous system|sympathetic nervous system
607589|NCT00608725|orthostatic tachycardia|orthostatic tachycardia
607590|NCT00608725|orthostatic intolerance|orthostatic intolerance
607591|NCT00608725|POTS|pots
607592|NCT00608712|bariatric surgery|bariatric surgery
607593|NCT00608712|ulcer prevention|ulcer prevention
607594|NCT00608699|Flushing|flushing
607595|NCT00608699|GSK256073A,|gsk256073a,
607596|NCT00608699|Dose Escalation,|dose escalation,
607597|NCT00608699|Immediate Release Niacin,|immediate release niacin,
607598|NCT00608686|NIAAA|niaaa
607599|NCT00608686|Alcohol|alcohol
607600|NCT00608686|Neurosteroids|neurosteroids
607601|NCT00608686|Intoxication|intoxication
607602|NCT00608673|discoid lupus erythematosus|discoid lupus erythematosus
607603|NCT00608673|pimecrolimus 1% cream|pimecrolimus 1% cream
607604|NCT00608673|betamethasone valerate 0.1% cream|betamethasone valerate 0.1% cream
607605|NCT00608660|Peripheral Facial Paralysis|peripheral facial paralysis
607606|NCT00608660|Acupuncture|acupuncture
607607|NCT00608660|RCT|rct
607608|NCT00608634|actinic keratosis|actinic keratosis
607609|NCT00608621|physostigmine|physostigmine
607610|NCT00608621|postoperative analgesia|postoperative analgesia
607611|NCT00608621|pain|pain
607612|NCT00608621|patient-controlled analgesia|patient-controlled analgesia
607613|NCT00608621|Opioid consumption|opioid consumption
607614|NCT00608621|Pain quality (VAS Score)|pain quality (vas score)
607615|NCT00608621|Hemodynamics|hemodynamics
607616|NCT00608621|Mobilisation|mobilisation
607617|NCT00608621|Side effects|side effects
607618|NCT00608595|adenocarcinoma of the rectum|adenocarcinoma of the rectum
607619|NCT00608595|recurrent rectal cancer|recurrent rectal cancer
607620|NCT00608595|stage I rectal cancer|stage i rectal cancer
607621|NCT00608595|stage II rectal cancer|stage ii rectal cancer
607622|NCT00608595|stage III rectal cancer|stage iii rectal cancer
607623|NCT00608582|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
607624|NCT00608582|TMS|tms
607625|NCT00608582|Treat Naming|treat naming
607626|NCT00608582|Aphasia|aphasia
607627|NCT00608582|Chronic Stroke|chronic stroke
607628|NCT00608582|Randomized, Controlled Trial|randomized, controlled trial
607629|NCT00608569|Drug Therapy, Combination|drug therapy, combination
607630|NCT00608569|HIV Non-Nucleoside Reverse Transcriptase Inhibitors|hiv non-nucleoside reverse transcriptase inhibitors
607631|NCT00608569|HIV Protease Inhibitors|hiv protease inhibitors
607632|NCT00608569|Viral Load|viral load
607633|NCT00608569|Virologic Failure|virologic failure
607634|NCT00608556|Heterotaxy|heterotaxy
607635|NCT00608556|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
607636|NCT00608556|Congenital Heart Disease|congenital heart disease
607637|NCT00608556|Genetic Study|genetic study
607638|NCT00608556|Situs Inversus|situs inversus
607639|NCT00608543|cognitive function|cognitive function
607640|NCT00608543|psychosocial function|psychosocial function
607641|NCT00608543|augmentation|augmentation
607642|NCT00608543|treatment refractory depression|treatment refractory depression
607643|NCT00608530|pain|pain
607644|NCT00608530|chronic pain|chronic pain
607645|NCT00608530|chronic back pain|chronic back pain
607646|NCT00608530|randomized clinical trial|randomized clinical trial
607647|NCT00608517|graft versus host disease|graft versus host disease
607648|NCT00608517|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
607649|NCT00608517|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
607650|NCT00608517|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
607651|NCT00608517|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
607652|NCT00608517|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
607653|NCT00608517|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
607654|NCT00608517|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
607655|NCT00608517|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
607656|NCT00608517|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
607657|NCT00608517|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
607658|NCT00608517|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
607659|NCT00608517|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
607660|NCT00608517|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
607661|NCT00608517|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
607662|NCT00608517|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
607815|NCT00608062|women|women
607663|NCT00608517|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
607664|NCT00608517|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
607665|NCT00608517|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
607666|NCT00608517|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
607667|NCT00608517|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
607668|NCT00608517|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
607669|NCT00608517|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
607670|NCT00608517|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
607671|NCT00608517|noncontiguous stage II adult non-Hodgkin lymphoma|noncontiguous stage ii adult non-hodgkin lymphoma
607672|NCT00608517|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
607673|NCT00608517|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
607674|NCT00608517|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
607675|NCT00608517|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
607676|NCT00608517|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
607677|NCT00608517|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
607678|NCT00608517|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
607679|NCT00608517|secondary acute myeloid leukemia|secondary acute myeloid leukemia
607680|NCT00608517|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
607681|NCT00608517|splenic marginal zone lymphoma|splenic marginal zone lymphoma
607682|NCT00608517|stage I multiple myeloma|stage i multiple myeloma
607683|NCT00608517|stage II multiple myeloma|stage ii multiple myeloma
607684|NCT00608517|refractory multiple myeloma|refractory multiple myeloma
607685|NCT00608517|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
607686|NCT00608517|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
607687|NCT00608517|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
607688|NCT00608517|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
607689|NCT00608517|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
607690|NCT00608517|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
607691|NCT00608517|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
607692|NCT00608517|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
607693|NCT00608517|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
607694|NCT00608517|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
607695|NCT00608517|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
607696|NCT00608517|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
607697|NCT00608517|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
607698|NCT00608517|stage III multiple myeloma|stage iii multiple myeloma
607699|NCT00608517|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
607700|NCT00608517|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
607701|NCT00608517|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
607702|NCT00608517|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
607703|NCT00608517|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
607704|NCT00608517|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
607705|NCT00608517|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
607706|NCT00608517|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
607707|NCT00608517|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
607708|NCT00608517|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
607709|NCT00608517|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
607710|NCT00608517|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
607711|NCT00608517|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
607712|NCT00608517|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
607713|NCT00608517|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
607714|NCT00608517|Philadelphia chromosome positive adult precursor acute lymphoblastic leukemia|philadelphia chromosome positive adult precursor acute lymphoblastic leukemia
607715|NCT00608517|Philadelphia chromosome positive childhood precursor acute lymphoblastic leukemia|philadelphia chromosome positive childhood precursor acute lymphoblastic leukemia
607716|NCT00608517|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
607717|NCT00608517|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
607718|NCT00608517|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
607719|NCT00608517|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
607720|NCT00608517|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
607721|NCT00608517|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
607722|NCT00608517|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
607723|NCT00608517|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
607724|NCT00608517|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
607725|NCT00608517|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
607726|NCT00608504|Behavioral Economics|behavioral economics
607727|NCT00608504|Drug self administration|drug self administration
607728|NCT00608504|Opioid|opioid
607729|NCT00608491|Acute Decompensated Heart Failure|acute decompensated heart failure
607730|NCT00608491|Acute Decompensated Heart Failure With Cardiorenal Syndrome|acute decompensated heart failure with cardiorenal syndrome
607731|NCT00608491|Cardiorenal Syndrome|cardiorenal syndrome
607732|NCT00608491|Persistent Congestion|persistent congestion
607733|NCT00608491|Ultra Filtration|ultra filtration
607734|NCT00608465|Fibrolytic Dysfunction|fibrolytic dysfunction
607735|NCT00608465|Obesity|obesity
607736|NCT00608465|PAI-1|pai-1
607737|NCT00608452|Lung|lung
607738|NCT00608452|Ovarian|ovarian
607739|NCT00608452|Breast|breast
607740|NCT00608452|Hodgkin's|hodgkin's
607741|NCT00608439|CAST|cast
607742|NCT00608439|Centella asiatica|centella asiatica
607743|NCT00608439|Diabetes|diabetes
607744|NCT00608439|Diabetic neuropathy|diabetic neuropathy
607745|NCT00608426|African Americans|african americans
607746|NCT00608426|telephone counseling|telephone counseling
607747|NCT00608426|community health planning|community health planning
607748|NCT00608426|ethnic groups|ethnic groups
607749|NCT00608400|CLA|cla
607750|NCT00608400|PTH|pth
607751|NCT00608400|nutritional supplement|nutritional supplement
607752|NCT00608374|Waldenström macroglobulinemia|waldenström macroglobulinemia
607753|NCT00608374|splenic marginal zone lymphoma|splenic marginal zone lymphoma
607754|NCT00608374|stage I marginal zone lymphoma|stage i marginal zone lymphoma
607755|NCT00608374|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
607756|NCT00608374|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
607757|NCT00608374|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
607758|NCT00608374|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
607759|NCT00608348|exercise|exercise
607760|NCT00608348|hypoglycemia|hypoglycemia
607761|NCT00608348|sympathetic nerve activity|sympathetic nerve activity
607762|NCT00608335|Antifungal|antifungal
607763|NCT00608335|Echinocandin|echinocandin
607764|NCT00608335|Candidiasis|candidiasis
607765|NCT00608335|Micafungin|micafungin
607766|NCT00608322|Sepsis|sepsis
607767|NCT00608322|Severe sepsis|severe sepsis
607768|NCT00608322|Septic shock|septic shock
607769|NCT00608283|Kidney transplant|kidney transplant
607770|NCT00608283|Live donor transplant|live donor transplant
607771|NCT00608244|Tacrolimus|tacrolimus
607772|NCT00608244|Pharmacokinetics|pharmacokinetics
607773|NCT00608244|Liver Transplantation|liver transplantation
607774|NCT00608218|Asthma|asthma
607775|NCT00608218|ciclesonide|ciclesonide
607776|NCT00608218|inhaled steroids|inhaled steroids
607777|NCT00608218|Alvesco|alvesco
607778|NCT00608205|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
607779|NCT00608205|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
607780|NCT00608205|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
607781|NCT00608205|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
607782|NCT00608205|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
607783|NCT00608205|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
607784|NCT00608205|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
607785|NCT00608205|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
607786|NCT00608192|HIV|hiv
607787|NCT00608192|viral hepatitis|viral hepatitis
607788|NCT00608192|methadone maintenance|methadone maintenance
607789|NCT00608192|case management|case management
607790|NCT00608192|costs|costs
607791|NCT00608192|vaccination|vaccination
607792|NCT00608192|risk reduction education|risk reduction education
607793|NCT00608179|epinephrine|epinephrine
607794|NCT00608179|glucose clamp|glucose clamp
607795|NCT00608153|essential hypertension|essential hypertension
607796|NCT00608153|ARB|arb
607797|NCT00608153|compliance|compliance
607798|NCT00608153|candesartan|candesartan
607799|NCT00608140|Advanced Heart Failure|advanced heart failure
607800|NCT00608140|Non-Ischemic Heart Failure|non-ischemic heart failure
607801|NCT00608140|Mitral Regurgitation|mitral regurgitation
607802|NCT00608140|Mitral Valve Replacement|mitral valve replacement
607803|NCT00608140|Congestive Heart Failure|congestive heart failure
607804|NCT00608140|Surgical Mitral Valvuloplasty|surgical mitral valvuloplasty
607805|NCT00608140|Dilated Cardiomyopathy|dilated cardiomyopathy
607806|NCT00608140|Annular Ring|annular ring
607807|NCT00608101|hypoglycemia|hypoglycemia
607808|NCT00608101|exercise|exercise
607809|NCT00608101|corticosteroids|corticosteroids
607810|NCT00608088|Breast feeding|breast feeding
607811|NCT00608088|breastfeeding|breastfeeding
607812|NCT00608088|randomized clinical trial|randomized clinical trial
607813|NCT00608088|poverty|poverty
607816|NCT00608062|female|female
607817|NCT00608062|estrogen deficiency|estrogen deficiency
607818|NCT00608062|sex hormones|sex hormones
607819|NCT00608062|adiposity|adiposity
607820|NCT00608062|oxidative stress|oxidative stress
607821|NCT00608062|antioxidants|antioxidants
607822|NCT00608049|Blood Pressure|blood pressure
607823|NCT00608049|Diabetes|diabetes
607824|NCT00608049|Nutrition|nutrition
607825|NCT00608049|Dietary Carbohydrate|dietary carbohydrate
607826|NCT00608049|Lipoproteins|lipoproteins
607827|NCT00608049|Insulin Resistance|insulin resistance
607828|NCT00608036|Adolescents|adolescents
607829|NCT00608036|Neighborhood|neighborhood
607830|NCT00608036|Walkability|walkability
607831|NCT00608036|Physical Activity|physical activity
607832|NCT00608036|Quality of Life|quality of life
607833|NCT00608036|Ecological Analysis|ecological analysis
607834|NCT00608036|Dietary Patterns|dietary patterns
607835|NCT00608036|Weight Status|weight status
607836|NCT00608036|Neighborhood Environment|neighborhood environment
607837|NCT00608036|Food Environment|food environment
607838|NCT00608036|Recreation Environment|recreation environment
607839|NCT00608023|HIV|hiv
607840|NCT00608023|Lipodystrophy|lipodystrophy
607841|NCT00608023|Abdominal fat accumulation|abdominal fat accumulation
607842|NCT00608023|Growth hormone releasing hormone|growth hormone releasing hormone
607843|NCT00608023|HIV-associated lipodystrophy|hiv-associated lipodystrophy
607844|NCT00608023|Treatment experienced|treatment experienced
607845|NCT00608010|Preservation of supernumerary embryos in an IVF program|preservation of supernumerary embryos in an ivf program
607846|NCT00607997|Leukemia|leukemia
607847|NCT00607997|Myeloid|myeloid
607848|NCT00607997|Elderly|elderly
607849|NCT00607997|Hematologic|hematologic
607850|NCT00607997|Blood|blood
607851|NCT00607997|Cancer|cancer
607852|NCT00607997|Malignancy|malignancy
607853|NCT00607997|SNS-595|sns-595
607854|NCT00607997|Sunesis|sunesis
607855|NCT00607997|Hematologic Diseases|hematologic diseases
607856|NCT00607997|Myelodysplastic Syndromes|myelodysplastic syndromes
607857|NCT00607997|Older|older
607858|NCT00607997|voreloxin|voreloxin
607859|NCT00607997|reveal-1|reveal-1
607860|NCT00607984|thiotepa|thiotepa
607861|NCT00607984|melphalan|melphalan
607862|NCT00607984|brain tumor|brain tumor
607863|NCT00607984|tumors of central nervous system and other solid tumors|tumors of central nervous system and other solid tumors
607864|NCT00607971|Constipation predominant irritable bowel syndrome|constipation predominant irritable bowel syndrome
607865|NCT00607958|Tipranavir|tipranavir
607866|NCT00607958|ritonavir|ritonavir
607867|NCT00607958|dose reduction|dose reduction
607868|NCT00607958|inhibitory quotient|inhibitory quotient
607869|NCT00607945|Type 2 diabetes mellitus|type 2 diabetes mellitus
607870|NCT00607945|conjugated linoleic acid|conjugated linoleic acid
607871|NCT00607945|weight loss|weight loss
607872|NCT00607945|rosiglitazone|rosiglitazone
607873|NCT00607945|glucose control|glucose control
607874|NCT00607945|insulin sensitivity|insulin sensitivity
607875|NCT00607932|recurrent prostate cancer|recurrent prostate cancer
607876|NCT00607906|safety|safety
607877|NCT00607906|pharmacodynamics|pharmacodynamics
607878|NCT00607906|diabetes|diabetes
607879|NCT00607906|pharmacokinetics|pharmacokinetics
607880|NCT00607893|Sleep-Disordered Breathing|sleep-disordered breathing
607881|NCT00607880|vascular access device complications|vascular access device complications
607882|NCT00607880|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
607883|NCT00607867|Diabetes Mellitus (type 2)|diabetes mellitus (type 2)
607884|NCT00607867|Diet|diet
607885|NCT00607867|Glycohemoglobin|glycohemoglobin
607886|NCT00607867|Lipids|lipids
607887|NCT00607867|Kidney Function|kidney function
607888|NCT00607867|Glycemic Index|glycemic index
607889|NCT00607867|Dietary Protein|dietary protein
607890|NCT00607867|Dietary Carbohydrate|dietary carbohydrate
607891|NCT00607854|Zevalin|zevalin
607892|NCT00607854|Reduced intensity conditioning|reduced intensity conditioning
607893|NCT00607854|Allogenic stem cell transplantation|allogenic stem cell transplantation
607894|NCT00607828|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
607895|NCT00607828|advanced adult primary liver cancer|advanced adult primary liver cancer
607896|NCT00607828|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
607897|NCT00607828|recurrent adult primary liver cancer|recurrent adult primary liver cancer
607898|NCT00607815|PTSD|ptsd
607899|NCT00607815|OEF/OIF|oef/oif
607900|NCT00607815|Combat|combat
607901|NCT00607815|Treatment|treatment
607902|NCT00607815|CPT|cpt
607903|NCT00607815|PCT|pct
607904|NCT00607815|Cognitive|cognitive
607905|NCT00607802|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
607906|NCT00607802|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
607907|NCT00607776|dry, eyes|dry, eyes
607908|NCT00607776|Amelioration of dry eye symptoms|amelioration of dry eye symptoms
607909|NCT00607763|Antifungal|antifungal
607910|NCT00607763|Echinocandin|echinocandin
607911|NCT00607763|Candidiasis|candidiasis
607912|NCT00607763|Micafungin|micafungin
608305|NCT00605904|Yohimbine|yohimbine
607913|NCT00607750|Wet AMD, Comentis, ATG003, mecamylamine|wet amd, comentis, atg003, mecamylamine
607914|NCT00607724|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
607915|NCT00607685|Trabeculectomy|trabeculectomy
607916|NCT00607685|Wound healing|wound healing
607917|NCT00607685|5 Fluorouracil|5 fluorouracil
607918|NCT00607685|Hyaluronic acid|hyaluronic acid
607919|NCT00607685|post-operative scarring|post-operative scarring
607920|NCT00607672|Angiotensin Converting Enzyme|angiotensin converting enzyme
607921|NCT00607672|Angiotensin Receptor Blockers|angiotensin receptor blockers
607922|NCT00607672|Cardiopulmonary Bypass|cardiopulmonary bypass
607923|NCT00607672|Fibrinolysis|fibrinolysis
607924|NCT00607672|Inflammation|inflammation
607925|NCT00607659|Chlamydia|chlamydia
607926|NCT00607659|Chlamydia trachomatis|chlamydia trachomatis
607927|NCT00607659|Adolescent Health|adolescent health
607928|NCT00607659|Female Health|female health
607929|NCT00607659|Sexually Transmitted Infections|sexually transmitted infections
607930|NCT00607659|Infertility|infertility
607931|NCT00607659|Pelvic Inflammatory Disease|pelvic inflammatory disease
607932|NCT00607646|hypoglycemia|hypoglycemia
607933|NCT00607646|dehydroepiandrosterone|dehydroepiandrosterone
607934|NCT00607633|essential hypertension|essential hypertension
607936|NCT00607633|left ventricular hypertrophy|left ventricular hypertrophy
607937|NCT00607633|candesartan|candesartan
607938|NCT00607620|Alcohol Abuse|alcohol abuse
607939|NCT00607620|Alcohol Dependence|alcohol dependence
607940|NCT00607620|Alcohol Use Disorder|alcohol use disorder
607941|NCT00607620|Screening|screening
607942|NCT00607620|Brief Intervention|brief intervention
607943|NCT00607620|Motivational Interviewing|motivational interviewing
607944|NCT00607607|ovarian cancer|ovarian cancer
607945|NCT00607607|endometrial cancer|endometrial cancer
607946|NCT00607581|amyloidosis|amyloidosis
607947|NCT00607581|lenalidomide|lenalidomide
607948|NCT00607581|cyclophosphamide|cyclophosphamide
607949|NCT00607581|dexamethasone|dexamethasone
607950|NCT00607568|physical stress|physical stress
607951|NCT00607568|psychological stress|psychological stress
607952|NCT00607555|Infant, premature|infant, premature
607953|NCT00607555|Infant, very low birth weight|infant, very low birth weight
607954|NCT00607555|Apnea|apnea
607955|NCT00607555|Feeding methods|feeding methods
607956|NCT00607555|Diaphragm|diaphragm
607957|NCT00607542|spasticity|spasticity
607958|NCT00607542|cerebral palsy|cerebral palsy
607959|NCT00607542|baclofen|baclofen
607960|NCT00607542|pharmacokinetics|pharmacokinetics
607961|NCT00607542|pharmacodynamics|pharmacodynamics
607962|NCT00607542|dosing|dosing
607963|NCT00607542|safety|safety
607964|NCT00607542|efficacy|efficacy
607965|NCT00607529|Multiple Diseases|multiple diseases
607966|NCT00607516|fracture|fracture
607967|NCT00607516|arthroplasty|arthroplasty
607968|NCT00607516|wear|wear
607969|NCT00607516|osteoporosis|osteoporosis
607970|NCT00607516|bone|bone
607971|NCT00607490|Vulvodynia|vulvodynia
607972|NCT00607490|Vulvar pain|vulvar pain
607973|NCT00607490|Dyspareunia|dyspareunia
607974|NCT00607490|Sexual dysfunction|sexual dysfunction
607975|NCT00607490|Vestibulitis|vestibulitis
607976|NCT00607464|Hypothermia, premature infants, Polyethylene occlusive wrap|hypothermia, premature infants, polyethylene occlusive wrap
607977|NCT00607438|Locally Advanced or Metastatic|locally advanced or metastatic
607978|NCT00607425|non-small cell lung cancer|non-small cell lung cancer
607979|NCT00607425|screening|screening
607980|NCT00607425|saliva|saliva
607981|NCT00607425|gene expression|gene expression
607982|NCT00607425|healthy control subject|healthy control subject
607983|NCT00607412|PTSD|ptsd
607984|NCT00607412|substance use disorders|substance use disorders
607985|NCT00607412|psychotherapy|psychotherapy
607986|NCT00607399|Solid tumor|solid tumor
607987|NCT00607399|Advanced Cancer|advanced cancer
607988|NCT00607399|MET Inhibitor|met inhibitor
607989|NCT00607399|Receptor Tyrosine Kinase Inhibitor (RTKI)|receptor tyrosine kinase inhibitor (rtki)
607990|NCT00607386|Hunter syndrome|hunter syndrome
607991|NCT00607386|hunters syndrome|hunters syndrome
607992|NCT00607386|hunter's syndrome|hunter's syndrome
607993|NCT00607386|hunter disease|hunter disease
607994|NCT00607386|hunters disease|hunters disease
607995|NCT00607386|hunter's disease|hunter's disease
607996|NCT00607386|MPS II|mps ii
607997|NCT00607386|MPSII|mpsii
607998|NCT00607386|MPS2|mps2
607999|NCT00607386|MPS 2|mps 2
608000|NCT00607386|mucopolysaccharides|mucopolysaccharides
608001|NCT00607386|lysosomal storage disease|lysosomal storage disease
608002|NCT00607386|lysosomal storage disorder|lysosomal storage disorder
608003|NCT00607386|chronic ear infection|chronic ear infection
608004|NCT00607386|enlarged adenoids|enlarged adenoids
608005|NCT00607386|mps symptoms|mps symptoms
608006|NCT00607386|mps diagnosis|mps diagnosis
608007|NCT00607386|mps ii therapy|mps ii therapy
608008|NCT00607386|MPS II treatment|mps ii treatment
608009|NCT00607386|ert treatment|ert treatment
608010|NCT00607386|elaprase|elaprase
608011|NCT00607386|idursulfase|idursulfase
608012|NCT00607386|iduronate sulfatase|iduronate sulfatase
608306|NCT00605904|Acamprosate|acamprosate
608013|NCT00607386|iduronate 2 sulfatase|iduronate 2 sulfatase
608014|NCT00607386|enzyme replacement therapy|enzyme replacement therapy
608015|NCT00607386|hunter syndrome treatment|hunter syndrome treatment
608016|NCT00607386|hunter's syndrome treatment|hunter's syndrome treatment
608017|NCT00607386|hunter syndrome therapy|hunter syndrome therapy
608018|NCT00607386|hunter's disease treatment|hunter's disease treatment
608019|NCT00607386|mps society|mps society
608020|NCT00607373|Apolipoprotein B|apolipoprotein b
608021|NCT00607373|Homozygous Familial Hypercholesterolemia|homozygous familial hypercholesterolemia
608022|NCT00607373|LDL-receptor gene|ldl-receptor gene
608023|NCT00607360|cocaine addiction, treatment, contingency management, employment intervention|cocaine addiction, treatment, contingency management, employment intervention
608024|NCT00607347|Keywords by National Institute of General Medical Sciences|keywords by national institute of general medical sciences
608025|NCT00607347|Hypertension|hypertension
608026|NCT00607347|Adverse metabolic effects|adverse metabolic effects
608027|NCT00607347|Beta blockers|beta blockers
608028|NCT00607347|Dyslipidemia|dyslipidemia
608029|NCT00607347|Atenolol|atenolol
608030|NCT00607347|New onset diabetes|new onset diabetes
608031|NCT00607347|Pharmacokinetic study|pharmacokinetic study
608032|NCT00607347|Oral glucose tolerance test|oral glucose tolerance test
608033|NCT00607334|Child Language|child language
608034|NCT00607334|Language Therapy|language therapy
608035|NCT00607334|Vocabulary|vocabulary
608036|NCT00607321|restenosis|restenosis
608037|NCT00607321|Coronary Disease|coronary disease
608038|NCT00607321|Coronary Arteriosclerosis|coronary arteriosclerosis
608039|NCT00607321|Arterial Occlusive Diseases|arterial occlusive diseases
608040|NCT00607295|chemotherapy|chemotherapy
608041|NCT00607295|hormonal therapy|hormonal therapy
608042|NCT00607295|urogenital atrophy|urogenital atrophy
608043|NCT00607269|Drug Abuse|drug abuse
608044|NCT00607269|Contingency management|contingency management
608045|NCT00607269|Voucher-based Reinforcement Therapy|voucher-based reinforcement therapy
608046|NCT00607269|Homosexuality|homosexuality
608047|NCT00607269|Homeless Persons|homeless persons
608048|NCT00607243|Smallpox vaccine efficacy|smallpox vaccine efficacy
608049|NCT00607230|type 1 diabetes mellitus|type 1 diabetes mellitus
608050|NCT00607230|immune modulation|immune modulation
608051|NCT00607230|cure|cure
608052|NCT00607230|autoimmunity|autoimmunity
608053|NCT00607217|Coronary artery diseases|coronary artery diseases
608054|NCT00607217|Myocardial infarction|myocardial infarction
608055|NCT00607217|Stable angina|stable angina
608056|NCT00607217|Influenza|influenza
608057|NCT00607217|Vaccine|vaccine
608058|NCT00607204|Basic Research|basic research
608059|NCT00607204|Individual Sleep Duration|individual sleep duration
608060|NCT00607204|Melatonin|melatonin
608061|NCT00607204|Electroencephalogram|electroencephalogram
608062|NCT00607204|Alertness|alertness
608063|NCT00607204|Mood|mood
608064|NCT00607191|Idiopathic talipes equinovarus (ITEV)|idiopathic talipes equinovarus (itev)
608065|NCT00607178|Influenza|influenza
608066|NCT00607178|Vaccine|vaccine
608067|NCT00607126|impaired ambulation|impaired ambulation
608068|NCT00607113|Neuroendocrine Carcinoma|neuroendocrine carcinoma
608069|NCT00607113|Avastin|avastin
608070|NCT00607113|Bevacizumab|bevacizumab
608071|NCT00607113|RAD001|rad001
608072|NCT00607113|Everolimus|everolimus
608073|NCT00607100|High-Resolution Optical Coherence Tomography|high-resolution optical coherence tomography
608074|NCT00607100|Retinal Nerve Fiber Layer|retinal nerve fiber layer
608075|NCT00607100|Band Atrophy|band atrophy
608076|NCT00607061|Glutathione|glutathione
608077|NCT00607061|Cysteine|cysteine
608078|NCT00607061|Synthesis rate|synthesis rate
608079|NCT00607061|Newborns|newborns
608080|NCT00607061|Low birth weight newborn babies|low birth weight newborn babies
608081|NCT00607022|dental implant|dental implant
608082|NCT00607022|early loading|early loading
608083|NCT00607022|traditional loading|traditional loading
608084|NCT00607022|anterior|anterior
608085|NCT00607022|implant stability|implant stability
608086|NCT00607022|Subjects presenting with one tooth missing in the anterior|subjects presenting with one tooth missing in the anterior
608087|NCT00607022|incisor/canine) or pre-molar regions of the mandible|incisor/canine) or pre-molar regions of the mandible
608088|NCT00607022|or maxilla with existing teeth that were healthy|or maxilla with existing teeth that were healthy
608089|NCT00607022|or adequately restored shall be screened.|or adequately restored shall be screened.
608090|NCT00606996|Drug Abuse|drug abuse
608091|NCT00606996|Drug Dependence|drug dependence
608092|NCT00606996|Alcohol Abuse|alcohol abuse
608093|NCT00606996|Alcohol Dependence|alcohol dependence
608094|NCT00606996|Major Depressive Disorder|major depressive disorder
608095|NCT00606996|Dysthymic Disorder|dysthymic disorder
608096|NCT00606996|Prisoners|prisoners
608097|NCT00606996|Women|women
608098|NCT00606970|Chemotherapy|chemotherapy
608099|NCT00606970|Breast Cancer|breast cancer
608100|NCT00606970|Colon Cancer|colon cancer
608101|NCT00606970|Lung Cancer|lung cancer
608102|NCT00606957|Obesity|obesity
608103|NCT00606957|Metabolism|metabolism
608104|NCT00606944|enhanced recovery program|enhanced recovery program
608105|NCT00606931|biopsy|biopsy
608107|NCT00606931|image-guidance|image-guidance
608108|NCT00606931|breast cancer|breast cancer
608109|NCT00606931|FDG|fdg
608110|NCT00606931|PEM|pem
608111|NCT00606918|Strength testing|strength testing
608112|NCT00606918|Disease progression|disease progression
608113|NCT00606918|ALS|als
608114|NCT00606918|Healthy Adults|healthy adults
608115|NCT00606905|Recurrent miscarriage|recurrent miscarriage
608116|NCT00606905|Recurrent spontaneous abortion|recurrent spontaneous abortion
608117|NCT00606905|Habitual abortion|habitual abortion
608118|NCT00606905|IVIG|ivig
608119|NCT00606905|Randomized Controlled Trial|randomized controlled trial
608120|NCT00606892|therapeutic effects|therapeutic effects
608121|NCT00606879|Solid tumor|solid tumor
608122|NCT00606879|Advanced Cancer|advanced cancer
608123|NCT00606879|MET inhibitor|met inhibitor
608124|NCT00606879|Receptor Tyrosine Kinase Inhibitor (RTKI)|receptor tyrosine kinase inhibitor (rtki)
608125|NCT00606866|renal, metastatic, carcinoma|renal, metastatic, carcinoma
608126|NCT00606853|Substance abuse|substance abuse
608127|NCT00606853|Contingency Management|contingency management
608128|NCT00606840|overweight|overweight
608129|NCT00606840|prevention of weight gain|prevention of weight gain
608130|NCT00606840|young adults|young adults
608131|NCT00606840|self-regulation|self-regulation
608132|NCT00606840|daily weighing|daily weighing
608133|NCT00606840|weight gain prevention|weight gain prevention
608134|NCT00606827|Contrast-induced nephrophaty|contrast-induced nephrophaty
608135|NCT00606827|Contrast media|contrast media
608136|NCT00606827|Angiography|angiography
608137|NCT00606827|Coronary percutaneous intervention|coronary percutaneous intervention
608138|NCT00606814|Solid Tumors, IPI-504, docetaxel,cancer|solid tumors, ipi-504, docetaxel,cancer
608139|NCT00606801|cognitive enhancers|cognitive enhancers
608140|NCT00606801|Nootropic Agents|nootropic agents
608141|NCT00606788|randomized clinical trials|randomized clinical trials
608142|NCT00606788|intensive care|intensive care
608143|NCT00606788|mechanical ventilation|mechanical ventilation
608144|NCT00606788|ventilator weaning|ventilator weaning
608145|NCT00606788|clinical protocols|clinical protocols
608146|NCT00606788|therapy, computer-assisted|therapy, computer-assisted
608147|NCT00606788|humans|humans
608148|NCT00606788|various surgical diseases requiring mechanical ventilation over 24 hours|various surgical diseases requiring mechanical ventilation over 24 hours
608149|NCT00606775|Adrenergic beta-Antagonists|adrenergic beta-antagonists
608150|NCT00606775|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
608151|NCT00606775|Cardiomyopathies|cardiomyopathies
608152|NCT00606775|Troponin I|troponin i
608153|NCT00606762|laparoscopic cholecystectomy|laparoscopic cholecystectomy
608154|NCT00606762|low pressure pneumoperitoneum|low pressure pneumoperitoneum
608155|NCT00606736|right ventricular outflow tract arrhythmia|right ventricular outflow tract arrhythmia
608156|NCT00606736|sex hormone level|sex hormone level
608157|NCT00606736|menstrual cycle|menstrual cycle
608158|NCT00606736|Gonadal Hormones|gonadal hormones
608159|NCT00606723|relapsed or refractory AML|relapsed or refractory aml
608160|NCT00606723|in children, adolescents and young adults|in children, adolescents and young adults
608161|NCT00606697|Primary Insomnia Adults|primary insomnia adults
608162|NCT00606684|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
608163|NCT00606684|COPD|copd
608164|NCT00606684|GW642444|gw642444
608165|NCT00606671|polycystic ovary syndrome (PCOS)|polycystic ovary syndrome (pcos)
608166|NCT00606658|Insomnia|insomnia
608167|NCT00606658|Ayurveda|ayurveda
608168|NCT00606658|Shirodhara|shirodhara
608169|NCT00606658|Quality of Life|quality of life
608170|NCT00606632|Renal Mass|renal mass
608171|NCT00606632|Clear Cell Renal Cell Carcinoma|clear cell renal cell carcinoma
608172|NCT00606632|Cancer of Kidney|cancer of kidney
608173|NCT00606632|Kidney Cancer|kidney cancer
608174|NCT00606632|Neoplasms|neoplasms
608175|NCT00606632|cG250|cg250
608176|NCT00606632|antibody, monoclonal|antibody, monoclonal
608177|NCT00606632|Iodine 124|iodine 124
608178|NCT00606632|Positron-Emission Tomography|positron-emission tomography
608179|NCT00606632|Kidney|kidney
608180|NCT00606632|Renal Cancer|renal cancer
608181|NCT00606632|Renal Neoplasms|renal neoplasms
608182|NCT00606619|Gastrectomy|gastrectomy
608183|NCT00606619|Oral feeding|oral feeding
608184|NCT00606619|Nutrition|nutrition
608185|NCT00606619|Gastric cancer|gastric cancer
608186|NCT00606593|insomnia|insomnia
608187|NCT00606593|elderly|elderly
608188|NCT00606593|sleeplessness|sleeplessness
608189|NCT00606580|cutaneous leishmaniasis, topical treatment, Tunisia|cutaneous leishmaniasis, topical treatment, tunisia
608190|NCT00606567|Defibrillators, Implantable|defibrillators, implantable
608191|NCT00606554|Respiratory Insufficiency|respiratory insufficiency
608192|NCT00606554|Ventilators, Mechanical|ventilators, mechanical
608193|NCT00606554|Ventilator Weaning|ventilator weaning
608194|NCT00606554|Therapy, Computer-Assisted|therapy, computer-assisted
608195|NCT00606541|Social Anxiety Disorder|social anxiety disorder
608196|NCT00606541|Quetiapine XR|quetiapine xr
608197|NCT00606541|Prevention|prevention
608198|NCT00606541|tolerability|tolerability
608199|NCT00606528|Antiviral therapy|antiviral therapy
608200|NCT00606515|Pharmacokinetics|pharmacokinetics
608201|NCT00606515|Liposomal paclitaxel|liposomal paclitaxel
608202|NCT00606502|Stage IIIB/IV non-small cell lung cancer|stage iiib/iv non-small cell lung cancer
608203|NCT00606502|Non-small cell lung cancer|non-small cell lung cancer
608204|NCT00606502|NSCLC|nsclc
608205|NCT00606502|Lung Cancer|lung cancer
608206|NCT00606502|Pralatrexate|pralatrexate
608207|NCT00606502|Erlotinib|erlotinib
608208|NCT00606502|Tarceva|tarceva
608209|NCT00606502|PDX|pdx
608210|NCT00606502|Smoking|smoking
608211|NCT00606502|Smoker|smoker
608212|NCT00606450|plaque psoriasis|plaque psoriasis
608213|NCT00606437|Umbilical Cord Blood Graft|umbilical cord blood graft
608214|NCT00606437|Stem Cell Transplantation|stem cell transplantation
608215|NCT00606424|head and neck cancer|head and neck cancer
608216|NCT00606411|Sleep-Related Eating Disorder|sleep-related eating disorder
608217|NCT00606411|Topiramate|topiramate
608218|NCT00606411|Parasomnia|parasomnia
608219|NCT00606398|colorectal metastases|colorectal metastases
608220|NCT00606385|Recurrence|recurrence
608221|NCT00606385|Survival|survival
608222|NCT00606385|Immunology|immunology
608223|NCT00606385|Laparoscopy|laparoscopy
608224|NCT00606372|Off-pump|off-pump
608225|NCT00606372|OPCAB|opcab
608226|NCT00606372|EuroSCORE|euroscore
608227|NCT00606372|high-risk patients|high-risk patients
608228|NCT00606372|Quality of life|quality of life
608229|NCT00606372|Validity of EuroSCORE|validity of euroscore
608230|NCT00606359|Influenza|influenza
608231|NCT00606359|Orthomyxoviridae Infections|orthomyxoviridae infections
608232|NCT00606359|Renal Transplant|renal transplant
608233|NCT00606346|Crohn's Disease|crohn's disease
608234|NCT00606346|Ulcerative Colitis|ulcerative colitis
608235|NCT00606346|Indeterminate Colitis|indeterminate colitis
608236|NCT00606346|Inflammatory Bowel Diseases|inflammatory bowel diseases
608237|NCT00606346|Immunomodulators|immunomodulators
608238|NCT00606346|infliximab|infliximab
608239|NCT00606346|TNF-alpha|tnf-alpha
608240|NCT00606333|Coronary artery disease|coronary artery disease
608241|NCT00606333|drug-eluting stents|drug-eluting stents
608242|NCT00606333|sirolimus-eluting coronary stents|sirolimus-eluting coronary stents
608243|NCT00606294|Head|head
608244|NCT00606294|Neck|neck
608245|NCT00606294|04-070|04-070
608246|NCT00606268|Antifungal Prophylaxis|antifungal prophylaxis
608247|NCT00606268|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
608248|NCT00606268|HSCT|hsct
608249|NCT00606268|Micafungin|micafungin
608250|NCT00606255|blood pressure|blood pressure
608251|NCT00606255|compliance|compliance
608252|NCT00606255|treatment|treatment
608253|NCT00606216|MRI|mri
608254|NCT00606164|Alzheimer's Disease|alzheimer's disease
608255|NCT00606164|bryostatin 1|bryostatin 1
608256|NCT00606164|bryostatin|bryostatin
608257|NCT00606164|safety|safety
608258|NCT00606164|efficacy|efficacy
608259|NCT00606164|pharmacokinetics|pharmacokinetics
608260|NCT00606164|pharmacodynamics|pharmacodynamics
608261|NCT00606164|protein kinase C|protein kinase c
608262|NCT00606151|drug eluding stents|drug eluding stents
608263|NCT00606151|perioperative bridging|perioperative bridging
608264|NCT00606151|Stents|stents
608265|NCT00606125|Chemotherapy|chemotherapy
608266|NCT00606125|Solid Tumors|solid tumors
608267|NCT00606125|Sorafenib|sorafenib
608268|NCT00606125|Carboplatin|carboplatin
608269|NCT00606125|Paclitaxel|paclitaxel
608270|NCT00606099|Adults|adults
608271|NCT00606099|compensated chronic hepatitis B|compensated chronic hepatitis b
608272|NCT00606099|telbivudin|telbivudin
608273|NCT00606099|aedevofir dipivoxil|aedevofir dipivoxil
608274|NCT00606086|Hepatitis, HCV, Liver disease, HepC|hepatitis, hcv, liver disease, hepc
608275|NCT00606060|Hemophilia,|hemophilia,
608276|NCT00606060|Continuous Infusion|continuous infusion
608277|NCT00606047|femoroacetabular impingement|femoroacetabular impingement
608278|NCT00606034|Type 2 diabetes|type 2 diabetes
608279|NCT00606034|Insulin Resistance|insulin resistance
608280|NCT00606034|Continuous Subcutaneous Insulin Infusion|continuous subcutaneous insulin infusion
608281|NCT00606034|U-500 Insulin|u-500 insulin
608282|NCT00606034|Omnipod|omnipod
608283|NCT00606008|Sutent|sutent
608284|NCT00605995|Schizophrenia|schizophrenia
608285|NCT00605995|Randomized trial|randomized trial
608286|NCT00605995|Statin|statin
608287|NCT00605995|Placebo|placebo
608289|NCT00605969|femoroacetabular, impingement|femoroacetabular, impingement
608290|NCT00605956|head lice|head lice
608291|NCT00605956|NatrOVA Creme Rinse - 1% is intended for the treatment of head lice|natrova creme rinse - 1% is intended for the treatment of head lice
608292|NCT00605943|Retinal Disease|retinal disease
608293|NCT00605943|Bevacizumab|bevacizumab
608294|NCT00605943|Ranibizumab|ranibizumab
608295|NCT00605943|Retinal Eye Disease|retinal eye disease
608296|NCT00605943|Macular Degeneration|macular degeneration
608297|NCT00605930|Progressive Supranuclear Palsy|progressive supranuclear palsy
608298|NCT00605930|PSP|psp
608299|NCT00605930|Nutriceutical|nutriceutical
608300|NCT00605930|Pyruvate|pyruvate
608301|NCT00605930|Creatine|creatine
608302|NCT00605930|Niacinamide|niacinamide
608303|NCT00605904|Chemical Stressor|chemical stressor
608304|NCT00605904|Alcoholism|alcoholism
608308|NCT00605878|Atopic Dermatitis (Eczema)|atopic dermatitis (eczema)
608309|NCT00605878|Bacteria|bacteria
608310|NCT00605878|Filaggrin|filaggrin
608311|NCT00605878|Skin|skin
608312|NCT00605878|Microbiome|microbiome
608313|NCT00605878|Atopic Dermatitis|atopic dermatitis
608314|NCT00605878|Eczema|eczema
608315|NCT00605878|Health Volunteer|health volunteer
608316|NCT00605878|HG|hg
608317|NCT00605852|Allergic rhinitis|allergic rhinitis
608318|NCT00605852|first time in human|first time in human
608319|NCT00605839|mobile technology|mobile technology
608320|NCT00605839|cell phones|cell phones
608321|NCT00605839|type 1 diabetes|type 1 diabetes
608322|NCT00605800|Liver resection|liver resection
608323|NCT00605774|catecholamines|catecholamines
608324|NCT00605774|diabetes|diabetes
608325|NCT00605774|exercise|exercise
608326|NCT00605761|Cystic Fibrosis|cystic fibrosis
608327|NCT00605761|Lung function|lung function
608328|NCT00605761|Anti-Inflammatory|anti-inflammatory
608329|NCT00605748|catheter ablation|catheter ablation
608330|NCT00605748|atrial fibrillation|atrial fibrillation
608331|NCT00605748|pulmonary vein|pulmonary vein
608332|NCT00605696|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
608333|NCT00605696|Acute Lung Injury|acute lung injury
608334|NCT00605657|ALPS|alps
608335|NCT00605657|Valproic Acid|valproic acid
608336|NCT00605657|Lymphadenopathy|lymphadenopathy
608337|NCT00605657|Splenomegaly|splenomegaly
608338|NCT00605657|Histone Deacytelase (HDAC) Inhibitor|histone deacytelase (hdac) inhibitor
608339|NCT00605657|Autoimmune Lymphoproliferative Syndrome|autoimmune lymphoproliferative syndrome
608340|NCT00605631|Pacing|pacing
608341|NCT00605605|endothelial function|endothelial function
608342|NCT00605605|atherosclerosis|atherosclerosis
608343|NCT00605605|smoking|smoking
608344|NCT00605605|inflammation|inflammation
608345|NCT00605605|antioxidant|antioxidant
608346|NCT00605592|Type 1 Diabetes|type 1 diabetes
608347|NCT00605592|Kidney Transplant|kidney transplant
608348|NCT00605592|Hypoglycemic Unawareness|hypoglycemic unawareness
608349|NCT00605592|Islet Transplant|islet transplant
608350|NCT00605592|Pancreatic Islet Cell Transplantation|pancreatic islet cell transplantation
608351|NCT00605592|University of Virginia|university of virginia
608352|NCT00605592|Islet Transplantation|islet transplantation
608353|NCT00605592|Kidney Transplantation|kidney transplantation
608354|NCT00605566|Neuroendocrine|neuroendocrine
608355|NCT00605566|sorafenib|sorafenib
608356|NCT00605566|cyclophosphamide|cyclophosphamide
608357|NCT00605566|pharmacodynamic|pharmacodynamic
608358|NCT00605540|COPD|copd
608359|NCT00605540|Survival|survival
608360|NCT00605540|Exacerbation|exacerbation
608361|NCT00605540|Disease markers|disease markers
608362|NCT00605527|Acute Lung Injury|acute lung injury
608363|NCT00605527|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
608364|NCT00605514|Hemorrhagic Fever|hemorrhagic fever
608365|NCT00605514|Healthy|healthy
608366|NCT00605514|Immunity|immunity
608367|NCT00605514|T-Cells|t-cells
608368|NCT00605514|Filovirus|filovirus
608369|NCT00605514|Healthy Volunteer|healthy volunteer
608370|NCT00605514|HV|hv
608371|NCT00605488|Pet Scan|pet scan
608372|NCT00605475|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
608373|NCT00605475|Canakinumab|canakinumab
608374|NCT00605475|ACZ885|acz885
608375|NCT00605475|IL-1B antagonist|il-1b antagonist
608376|NCT00605475|metformin|metformin
608377|NCT00605475|glycemic control|glycemic control
608378|NCT00605475|insulin sensitivity|insulin sensitivity
608379|NCT00605449|GSK376501|gsk376501
608380|NCT00605449|Simvastatin|simvastatin
608381|NCT00605449|Healthy Subjects|healthy subjects
608382|NCT00605449|Repeat Dose|repeat dose
608383|NCT00605449|Drug Interaction|drug interaction
608384|NCT00605449|Randomized|randomized
608385|NCT00605449|Pharmacokinetics|pharmacokinetics
608386|NCT00605436|overweight|overweight
608387|NCT00605436|sedentary|sedentary
608388|NCT00605436|metabolic syndrome|metabolic syndrome
608389|NCT00605423|AMD|amd
608390|NCT00605423|Almera|almera
608391|NCT00605423|Steroid|steroid
608392|NCT00605423|Macular|macular
608393|NCT00605423|ARMD|armd
608394|NCT00605410|Methacholine bronchoprovocation|methacholine bronchoprovocation
608395|NCT00605410|Antimuscarinic|antimuscarinic
608396|NCT00605397|Cu-64 LABELED TRASTUZUMAB|cu-64 labeled trastuzumab
608397|NCT00605371|Healthy volunteers|healthy volunteers
608398|NCT00605371|Bioequivalence|bioequivalence
608399|NCT00605371|Food Effects|food effects
608400|NCT00605358|geriatric depression|geriatric depression
608401|NCT00605319|BPH|bph
608402|NCT00605319|BOO|boo
608403|NCT00605306|Asthma|asthma
608404|NCT00605306|spirometry|spirometry
608405|NCT00605306|lung function|lung function
608406|NCT00605306|serum cortisol|serum cortisol
608407|NCT00605306|serum potassium|serum potassium
608408|NCT00605306|plasma glucose|plasma glucose
608409|NCT00605280|randomized sham-controlled multicenter macular edema|randomized sham-controlled multicenter macular edema
608410|NCT00605267|Breast Cancer|breast cancer
608411|NCT00605267|Breast Neoplasms|breast neoplasms
608717|NCT00603837|Prevention|prevention
608412|NCT00605267|Tumors or cancer of the human BREAST|tumors or cancer of the human breast
608413|NCT00605267|Tumor or cancer of the human MAMMARY GLAND|tumor or cancer of the human mammary gland
608414|NCT00605254|P-Glycoprotein|p-glycoprotein
608415|NCT00605254|Positron Emission Tomography|positron emission tomography
608416|NCT00605254|Blood Brain Barrier|blood brain barrier
608417|NCT00605254|Quantitative Imaging|quantitative imaging
608418|NCT00605254|Multi-Drug Transporter|multi-drug transporter
608419|NCT00605254|Healthy Volunteer|healthy volunteer
608420|NCT00605254|HV|hv
608421|NCT00605241|pharmacodynamics,|pharmacodynamics,
608422|NCT00605241|pharmacokinetics,|pharmacokinetics,
608423|NCT00605241|tolerability,|tolerability,
608424|NCT00605241|Safety,|safety,
608425|NCT00605241|single dose,|single dose,
608426|NCT00605241|placebo,|placebo,
608427|NCT00605241|Nicotine reward|nicotine reward
608428|NCT00605241|GSK598809|gsk598809
608429|NCT00605176|Actinic keratosis|actinic keratosis
608430|NCT00605176|Skin disease|skin disease
608431|NCT00605163|Parkinson disease, observational, longitudinal|parkinson disease, observational, longitudinal
608432|NCT00605150|Unresectable HCC|unresectable hcc
608433|NCT00605124|osteoarthritis|osteoarthritis
608434|NCT00605124|knee|knee
608435|NCT00605124|total knee arthroplasty|total knee arthroplasty
608436|NCT00605124|exercise|exercise
608437|NCT00605098|HIV|hiv
608438|NCT00605098|Pregnancy|pregnancy
608439|NCT00605098|Vertical disease transmission|vertical disease transmission
608440|NCT00605098|Pharmacokinetics|pharmacokinetics
608441|NCT00605098|HIV seronegativity|hiv seronegativity
608442|NCT00605072|cognitive disorders|cognitive disorders
608443|NCT00605072|angiotensin receptor blockers|angiotensin receptor blockers
608444|NCT00605059|Alzheimer|alzheimer
608445|NCT00605059|SPECT|spect
608446|NCT00605046|Alzheimer|alzheimer
608447|NCT00605046|SPECT|spect
608448|NCT00605007|COPD|copd
608449|NCT00605007|Diabetes|diabetes
608450|NCT00605007|Respiratory Disorders|respiratory disorders
608451|NCT00604994|Lymphoedema|lymphoedema
608452|NCT00604994|Gynaecology|gynaecology
608453|NCT00604994|Oncology|oncology
608454|NCT00604994|Malignant|malignant
608455|NCT00604994|Benign|benign
608456|NCT00604994|Incidence|incidence
608457|NCT00604955|visceral leishmaniasis|visceral leishmaniasis
608458|NCT00604955|kala-azar|kala-azar
608459|NCT00604955|Bihar, India|bihar, india
608460|NCT00604942|Oesophagus|oesophagus
608461|NCT00604942|Dysphagia|dysphagia
608462|NCT00604942|Impedance|impedance
608463|NCT00604942|High Resolution Manometry|high resolution manometry
608464|NCT00604942|Peristalsis|peristalsis
608465|NCT00604942|Contractile Pressure|contractile pressure
608466|NCT00604942|Coordination of contraction|coordination of contraction
608467|NCT00604942|Bolus transport|bolus transport
608468|NCT00604929|muscle protein synthesis|muscle protein synthesis
608469|NCT00604929|whole-body protein breakdown|whole-body protein breakdown
608470|NCT00604929|nutrition|nutrition
608471|NCT00604916|oral hygiene|oral hygiene
608472|NCT00604890|Double-Blind|double-blind
608473|NCT00604890|Placebo|placebo
608474|NCT00604890|Topical|topical
608475|NCT00604890|Treatment|treatment
608476|NCT00604890|Dose-Ranging|dose-ranging
608477|NCT00604890|sBCC|sbcc
608478|NCT00604877|exercise|exercise
608479|NCT00604877|glucose metabolism|glucose metabolism
608480|NCT00604877|insulin sensitivity|insulin sensitivity
608481|NCT00604877|Vascular Function|vascular function
608482|NCT00604864|deep endometriosis|deep endometriosis
608483|NCT00604864|pelvic pain|pelvic pain
608484|NCT00604864|infliximab|infliximab
608485|NCT00604864|anti TNFa|anti tnfa
608486|NCT00604838|amniotic fluid leakage|amniotic fluid leakage
608487|NCT00604838|urinary incontinence|urinary incontinence
608488|NCT00604838|pregnancy|pregnancy
608489|NCT00604838|home test|home test
608490|NCT00604838|vaginal wetness|vaginal wetness
608491|NCT00604825|menopause|menopause
608492|NCT00604825|hormone therapy|hormone therapy
608493|NCT00604825|hot flashes|hot flashes
608494|NCT00604825|vasomotor symptoms|vasomotor symptoms
608495|NCT00604786|Basophils|basophils
608496|NCT00604786|Mast Cells|mast cells
608497|NCT00604786|IgE|ige
608498|NCT00604786|IgE receptors|ige receptors
608499|NCT00604786|omalizumab|omalizumab
608500|NCT00604773|delirium|delirium
608501|NCT00604773|critical care|critical care
608502|NCT00604773|risk factors|risk factors
608503|NCT00604773|prediction|prediction
608504|NCT00604747|motor learning|motor learning
608505|NCT00604747|hemiplegia|hemiplegia
608506|NCT00604747|stroke|stroke
608507|NCT00604747|practice|practice
608508|NCT00604747|physiotherapy|physiotherapy
608509|NCT00604695|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
608510|NCT00604695|Acute Myocardial Infarction|acute myocardial infarction
608511|NCT00604695|No Reflow|no reflow
608512|NCT00604682|psoriasis|psoriasis
608513|NCT00604669|Diabetes|diabetes
608514|NCT00604669|Nutrition/Dietics|nutrition/dietics
608515|NCT00604669|clinical outcomes|clinical outcomes
608516|NCT00604669|total parenteral nutrition|total parenteral nutrition
608517|NCT00604643|Abdominal Aneurysm|abdominal aneurysm
608518|NCT00604643|Endovascular Aortic Repair (EVAR)|endovascular aortic repair (evar)
608519|NCT00604643|Endovascular Stent Graft|endovascular stent graft
608520|NCT00604643|Endograft|endograft
608521|NCT00604630|stroke|stroke
608522|NCT00604630|EPO|epo
608523|NCT00604630|erythropoietin|erythropoietin
608524|NCT00604630|ischemia|ischemia
608525|NCT00604630|hypoxia|hypoxia
608526|NCT00604630|antiapoptosis|antiapoptosis
608527|NCT00604630|neuroprotection|neuroprotection
608528|NCT00604630|rtPA|rtpa
608529|NCT00604630|thrombolysis|thrombolysis
608530|NCT00604630|stroke, middle cerebral artery|stroke, middle cerebral artery
608531|NCT00604630|Ischemic stroke in the middle cerebral artery territory|ischemic stroke in the middle cerebral artery territory
608532|NCT00604617|Mycobacterium tuberculosis|mycobacterium tuberculosis
608533|NCT00604617|Tuberculin Test|tuberculin test
608534|NCT00604617|South Africa|south africa
608535|NCT00604591|Dementia Treatment|dementia treatment
608536|NCT00604591|Frontotemporal Dementia|frontotemporal dementia
608537|NCT00604591|Dopamine|dopamine
608538|NCT00604591|Frontotemporal Lobar Degeneration|frontotemporal lobar degeneration
608539|NCT00604578|Pioglitazone|pioglitazone
608540|NCT00604578|Asthma|asthma
608541|NCT00604578|Peroxisome Proliferator-Advanced Receptor Gamma|peroxisome proliferator-advanced receptor gamma
608542|NCT00604578|Airflow Obstruction|airflow obstruction
608543|NCT00604578|Airway Inflammation|airway inflammation
608544|NCT00604565|Hemodialysis|hemodialysis
608545|NCT00604552|Abdominal Aneurysm|abdominal aneurysm
608546|NCT00604552|Endovascular Aortic Repair (EVAR)|endovascular aortic repair (evar)
608547|NCT00604552|Endovascular Stent Graft|endovascular stent graft
608548|NCT00604552|Endograft|endograft
608549|NCT00604539|Chondroitin sulphate|chondroitin sulphate
608550|NCT00604539|Synovitis|synovitis
608551|NCT00604539|Knee osteoarthritis|knee osteoarthritis
608552|NCT00604539|Magnetic Resonance Imaging|magnetic resonance imaging
608553|NCT00604526|recurrent|recurrent
608554|NCT00604487|induction|induction
608555|NCT00604487|cervix|cervix
608556|NCT00604487|balloon|balloon
608557|NCT00604487|Bishop|bishop
608558|NCT00604474|Deafness|deafness
608559|NCT00604474|Hearing Loss|hearing loss
608560|NCT00604474|Cochlear Implants|cochlear implants
608561|NCT00604474|Advanced Bionics|advanced bionics
608562|NCT00604474|HiResolution Bionic Ear System|hiresolution bionic ear system
608563|NCT00604461|Carboplatin|carboplatin
608564|NCT00604461|Bevacizumab|bevacizumab
608565|NCT00604461|Avastin|avastin
608566|NCT00604461|Pemetrexed|pemetrexed
608567|NCT00604461|Alimta|alimta
608568|NCT00604448|pulses|pulses
608569|NCT00604448|beans|beans
608570|NCT00604448|obesity|obesity
608571|NCT00604448|overweight|overweight
608572|NCT00604448|metabolic syndrome|metabolic syndrome
608573|NCT00604435|breast cancer|breast cancer
608574|NCT00604435|neoadjuvant chemotherapy|neoadjuvant chemotherapy
608575|NCT00604435|docetaxel|docetaxel
608576|NCT00604435|epirubicin|epirubicin
608577|NCT00604435|recombinant human endostatin (endostar)|recombinant human endostatin (endostar)
608578|NCT00604435|chemotherapy|chemotherapy
608579|NCT00604435|endostatin|endostatin
608580|NCT00604422|Colonic disease|colonic disease
608581|NCT00604422|Ulcerative colitis|ulcerative colitis
608582|NCT00604422|suspected or known colonic disease|suspected or known colonic disease
608583|NCT00604357|CNI free|cni free
608584|NCT00604357|mTOR inhibition|mtor inhibition
608585|NCT00604357|induction|induction
608586|NCT00604357|IL2 receptor antibodies|il2 receptor antibodies
608587|NCT00604357|renal function|renal function
608588|NCT00604357|liver transplantation|liver transplantation
608589|NCT00604331|Pyruvic Acid|pyruvic acid
608590|NCT00604331|Shock, Cardiogenic|shock, cardiogenic
608591|NCT00604331|Catecholamines|catecholamines
608592|NCT00604331|Intra-Aortic Balloon Pumping|intra-aortic balloon pumping
608593|NCT00604331|Cardiac Output|cardiac output
608594|NCT00604331|Cardiac Index|cardiac index
608595|NCT00604331|Cardiac Function|cardiac function
608596|NCT00604318|quality of life|quality of life
608597|NCT00604292|Colonic Diseases|colonic diseases
608598|NCT00604279|Schizophrenia|schizophrenia
608599|NCT00604279|Paliperidone|paliperidone
608600|NCT00604279|Paliperidone palmitate|paliperidone palmitate
608601|NCT00604279|Risperidone|risperidone
608602|NCT00604279|Risperidone long acting injection|risperidone long acting injection
608603|NCT00604279|R092670|r092670
608604|NCT00604266|Potentially resectable hilar cholangiocarcinoma as per initial imaging studies.|potentially resectable hilar cholangiocarcinoma as per initial imaging studies.
608605|NCT00604266|Able to undergo PET/CT and MRI with Gadolinium|able to undergo pet/ct and mri with gadolinium
608606|NCT00604240|NICU|nicu
608607|NCT00604240|caregivers|caregivers
608608|NCT00604240|discharge instructions|discharge instructions
608609|NCT00604227|high altitude pulmonary edema|high altitude pulmonary edema
608610|NCT00604227|pulmonary interstitial fluid|pulmonary interstitial fluid
608611|NCT00604227|pulmonary function testing|pulmonary function testing
608612|NCT00604227|hypoxia|hypoxia
608613|NCT00604227|pulmonary endothelial function|pulmonary endothelial function
609107|NCT00602082|insulinoma|insulinoma
608614|NCT00604227|high altitude exposure without prior acclimatization|high altitude exposure without prior acclimatization
608615|NCT00604214|Sepsis|sepsis
608616|NCT00604214|Septic shock|septic shock
608617|NCT00604201|Myelodyplastic Syndrome (MDS)|myelodyplastic syndrome (mds)
608618|NCT00604201|Severe Aplastic Anemia (SAA)|severe aplastic anemia (saa)
608619|NCT00604201|Stem Cell Transplant|stem cell transplant
608620|NCT00604201|Haploidentical Stem Cells|haploidentical stem cells
608621|NCT00604201|Umbilical Cord Blood|umbilical cord blood
608622|NCT00604201|Severe Aplastic Anemia|severe aplastic anemia
608623|NCT00604201|Myelodysplastic Syndrome|myelodysplastic syndrome
608624|NCT00604201|MDS|mds
608625|NCT00604175|HIV|hiv
608626|NCT00604175|HPV 6|hpv 6
608627|NCT00604175|HPV 11|hpv 11
608628|NCT00604175|HPV 16|hpv 16
608629|NCT00604175|HPV 18|hpv 18
608630|NCT00604175|Vaccine|vaccine
608631|NCT00604162|Suspected colonic disease|suspected colonic disease
608632|NCT00604162|Known colonic disease|known colonic disease
608633|NCT00604136|melanoma|melanoma
608634|NCT00604136|tumor infiltrating lymphocytes|tumor infiltrating lymphocytes
608635|NCT00604136|interleukin-2|interleukin-2
608636|NCT00604123|JNJ-17166864|jnj-17166864
608637|NCT00604123|allergic rhinitis|allergic rhinitis
608638|NCT00604123|pharmacokinetics|pharmacokinetics
608639|NCT00604123|biomarkers|biomarkers
608640|NCT00604123|rhinitis symptoms|rhinitis symptoms
608641|NCT00604123|mountain cedar pollen|mountain cedar pollen
608642|NCT00604110|Biventricular pacing|biventricular pacing
608643|NCT00604110|resynchronisation therapy|resynchronisation therapy
608644|NCT00604110|cardiac surgery|cardiac surgery
608645|NCT00604110|ejection fraction of less 45%|ejection fraction of less 45%
608646|NCT00604097|youth suicide|youth suicide
608647|NCT00604097|family therapy|family therapy
608648|NCT00604097|primary care|primary care
608649|NCT00604097|intervention|intervention
608650|NCT00604084|Scabies|scabies
608651|NCT00604084|Ivermectin|ivermectin
608652|NCT00604084|Lindane|lindane
608653|NCT00604084|Mass Eradication|mass eradication
608654|NCT00604071|HMP, CNV, PHP, HPHP, AMD|hmp, cnv, php, hphp, amd
608655|NCT00604058|Poliomyelitis|poliomyelitis
608656|NCT00604058|intradermal|intradermal
608657|NCT00604045|post traumatic stress disorder|post traumatic stress disorder
608658|NCT00604045|cognitive bias|cognitive bias
608659|NCT00604045|attention|attention
608660|NCT00604045|combat|combat
608661|NCT00604045|neuroimaging|neuroimaging
608662|NCT00604032|Safety when exposed to sunlight|safety when exposed to sunlight
608663|NCT00604019|sepsis|sepsis
608664|NCT00604019|septic shock|septic shock
608665|NCT00604006|Prevention of heart failure in individuals at high risk|prevention of heart failure in individuals at high risk
608666|NCT00603993|Rheumatoid arthritis|rheumatoid arthritis
608667|NCT00603967|Breast Cancer|breast cancer
608668|NCT00603967|Postmenopausal|postmenopausal
608669|NCT00603967|Aromatase|aromatase
608670|NCT00603954|Nonmyeloablative conditioning.|nonmyeloablative conditioning.
608671|NCT00603954|Hematological malignancies.|hematological malignancies.
608672|NCT00603954|GVHD.|gvhd.
608673|NCT00603941|Anaplastic Thyroid Cancer|anaplastic thyroid cancer
608674|NCT00603941|Neoplasm|neoplasm
608675|NCT00603941|Tumor|tumor
608676|NCT00603941|Anti-neoplastic Agent|anti-neoplastic agent
608677|NCT00603941|First-line treatment of advanced Anaplastic thyroid cancer|first-line treatment of advanced anaplastic thyroid cancer
608678|NCT00603928|attitude|attitude
608679|NCT00603928|attitude of health personnel|attitude of health personnel
608680|NCT00603928|ethics|ethics
608681|NCT00603928|bioethics|bioethics
608682|NCT00603928|biomedical ethics|biomedical ethics
608683|NCT00603928|patient care|patient care
608684|NCT00603928|physicians|physicians
608685|NCT00603928|placebo effect|placebo effect
608686|NCT00603928|placebos|placebos
608687|NCT00603928|questionnaires|questionnaires
608688|NCT00603928|therapy|therapy
608689|NCT00603928|general practice|general practice
608690|NCT00603915|gemcitabine|gemcitabine
608691|NCT00603915|carboplatin|carboplatin
608692|NCT00603915|cisplatin|cisplatin
608693|NCT00603915|erlotinib|erlotinib
608694|NCT00603915|tarceva|tarceva
608695|NCT00603915|nasopharyngeal|nasopharyngeal
608696|NCT00603902|Obesity|obesity
608697|NCT00603902|Weight loss|weight loss
608698|NCT00603902|lorcaserin|lorcaserin
608699|NCT00603902|APD356|apd356
608700|NCT00603902|BLOSSOM|blossom
608701|NCT00603902|Hypertension|hypertension
608702|NCT00603902|Dyslipidemia|dyslipidemia
608703|NCT00603902|Sleep apnea|sleep apnea
608704|NCT00603902|glucose tolerance|glucose tolerance
608705|NCT00603902|cardiovascular disease|cardiovascular disease
608706|NCT00603902|Arena|arena
608707|NCT00603889|Hookworm|hookworm
608708|NCT00603889|Allergy|allergy
608709|NCT00603889|Vaccine|vaccine
608710|NCT00603889|Skin test|skin test
608711|NCT00603863|pancreatic cancer|pancreatic cancer
608712|NCT00603863|hPAM4|hpam4
608713|NCT00603863|MUC1 antibody|muc1 antibody
608714|NCT00603863|cancer of the pancreas|cancer of the pancreas
608715|NCT00603850|HMP, PHP, AMD, CNV, HPHP|hmp, php, amd, cnv, hphp
608718|NCT00603837|ELGANs(Extremely low gestational age neonates)|elgans(extremely low gestational age neonates)
608719|NCT00603837|Polyethylene Wrap|polyethylene wrap
608720|NCT00603837|Sodium Acetate Transport Mattress|sodium acetate transport mattress
608721|NCT00603824|heparin-Induced thrombocytopenia|heparin-induced thrombocytopenia
608722|NCT00603824|fondaparinux|fondaparinux
608723|NCT00603811|Influenza vaccines|influenza vaccines
608724|NCT00603811|M2e|m2e
608725|NCT00603798|Actinic keratosis|actinic keratosis
608726|NCT00603798|Dermatologic disease|dermatologic disease
608727|NCT00603785|Chronic sinusitis|chronic sinusitis
608728|NCT00603785|Xolair|xolair
608729|NCT00603785|Nasal Discharge|nasal discharge
608730|NCT00603785|Nasal Obstruction|nasal obstruction
608731|NCT00603785|Facial Pain|facial pain
608732|NCT00603785|Hyposmia|hyposmia
608733|NCT00603772|Tretinoin|tretinoin
608734|NCT00603772|exposure to UV light|exposure to uv light
608735|NCT00603772|phototoxicity|phototoxicity
608736|NCT00603772|Safety when exposed to sunlight|safety when exposed to sunlight
608737|NCT00603759|COX2 inhibitor|cox2 inhibitor
608738|NCT00603759|head and neck cancer|head and neck cancer
608739|NCT00603759|chemoradiation|chemoradiation
608740|NCT00603746|Adolescents|adolescents
608741|NCT00603746|Adults|adults
608742|NCT00603746|Asthma|asthma
608743|NCT00603746|Pharmacokinetics|pharmacokinetics
608744|NCT00603746|Pharmacogenetics|pharmacogenetics
608745|NCT00603746|GW685698X|gw685698x
608746|NCT00603733|Ulcerative Colitis|ulcerative colitis
608747|NCT00603733|5-Aminosalicylate|5-aminosalicylate
608748|NCT00603720|PET|pet
608749|NCT00603720|Heart metabolism|heart metabolism
608750|NCT00603720|Nitric oxide|nitric oxide
608751|NCT00603720|Myocardial remodeling|myocardial remodeling
608752|NCT00603707|capsule|capsule
608753|NCT00603707|constipation|constipation
608754|NCT00603707|whole gut transit|whole gut transit
608755|NCT00603707|colonic transit|colonic transit
608756|NCT00603707|gastric emptying|gastric emptying
608757|NCT00603707|small bowel transit|small bowel transit
608758|NCT00603694|Hippocampus|hippocampus
608759|NCT00603694|Memory|memory
608760|NCT00603694|Radiation|radiation
608761|NCT00603681|constipation|constipation
608762|NCT00603681|aged|aged
608763|NCT00603681|polyethylene glycol|polyethylene glycol
608764|NCT00603668|CLL|cll
608765|NCT00603655|Diet|diet
608766|NCT00603655|glycemic load|glycemic load
608767|NCT00603655|overweight|overweight
608768|NCT00603655|obesity|obesity
608769|NCT00603655|hyperlipidemia|hyperlipidemia
608770|NCT00603642|AMG 531|amg 531
608771|NCT00603642|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
608772|NCT00603642|ITP|itp
608773|NCT00603642|Thrombocytopenia|thrombocytopenia
608774|NCT00603642|Japan|japan
608775|NCT00603642|Placebo controlled|placebo controlled
608776|NCT00603642|Phase 3|phase 3
608777|NCT00603629|Acute Asthma|acute asthma
608778|NCT00603616|Inflammatory Bowel Disease|inflammatory bowel disease
608779|NCT00603616|Crohn disease|crohn disease
608780|NCT00603616|Crohn's disease|crohn's disease
608781|NCT00603616|Rifaximin|rifaximin
608782|NCT00603603|C-section|c-section
608783|NCT00603603|Surg Wound Infect|surg wound infect
608784|NCT00603590|Cardiovascular disease|cardiovascular disease
608785|NCT00603590|primary prevention|primary prevention
608786|NCT00603590|Polypill|polypill
608787|NCT00603590|efficacy|efficacy
608788|NCT00603590|safety|safety
608789|NCT00603590|ADR|adr
608790|NCT00603590|Diabetes|diabetes
608791|NCT00603590|Adherence|adherence
608792|NCT00603590|Compliance|compliance
608793|NCT00603564|CPAP|cpap
608794|NCT00603564|community-acquired pneumonia|community-acquired pneumonia
608795|NCT00603564|acute respiratory failure|acute respiratory failure
608796|NCT00603564|hypoxemia|hypoxemia
608797|NCT00603564|Continuous Positive Airway Pressure|continuous positive airway pressure
608798|NCT00603551|Osteoporosis|osteoporosis
608799|NCT00603551|Cancer|cancer
608800|NCT00603551|Chemotherapy|chemotherapy
608801|NCT00603551|Bone Density|bone density
608802|NCT00603551|DXA Scan|dxa scan
608803|NCT00603551|Heel Scan|heel scan
608804|NCT00603538|CP-751,871, Non-small cell lung cancer, Phase 1|cp-751,871, non-small cell lung cancer, phase 1
608805|NCT00603512|Phase II MTX add-on study in Japan|phase ii mtx add-on study in japan
608806|NCT00603499|Diabetes|diabetes
608807|NCT00603499|Hypertension|hypertension
608808|NCT00603499|Hypomagnesemia|hypomagnesemia
608809|NCT00603486|Non-invasive Blood Pressure (NIBP)|non-invasive blood pressure (nibp)
608810|NCT00603486|GE Dinamap|ge dinamap
608811|NCT00603486|SuperSTAT|superstat
608812|NCT00603460|Ovarian Cancer|ovarian cancer
608813|NCT00603460|Peritoneal Cancer|peritoneal cancer
608814|NCT00603434|Methamphetamine|methamphetamine
608815|NCT00603421|borderline personality disorder|borderline personality disorder
608816|NCT00603421|suicide|suicide
608817|NCT00603421|suicidality|suicidality
608818|NCT00603421|suicide attempt|suicide attempt
608819|NCT00603421|suicidal behavior|suicidal behavior
608820|NCT00603421|self-injurious behavior|self-injurious behavior
608821|NCT00603421|self-harm behavior|self-harm behavior
608822|NCT00603421|suicide prevention center|suicide prevention center
608823|NCT00603421|telephone intervention|telephone intervention
608824|NCT00603408|Breast Cancer|breast cancer
608825|NCT00603408|Locally Advanced|locally advanced
608826|NCT00603408|Neoadjuvant|neoadjuvant
608827|NCT00603382|Adults|adults
608828|NCT00603382|Pharmacokinetics|pharmacokinetics
608829|NCT00603382|Pharmacogenetics|pharmacogenetics
608830|NCT00603382|Asthma|asthma
608831|NCT00603382|Adolescents|adolescents
608832|NCT00603382|GW685698X|gw685698x
608833|NCT00603369|HIV prevention|hiv prevention
608834|NCT00603369|HIV seronegativity|hiv seronegativity
608835|NCT00603356|GIST|gist
608836|NCT00603356|Ovarian Cancer|ovarian cancer
608837|NCT00603356|Mesothelioma|mesothelioma
608838|NCT00603356|Renal|renal
608839|NCT00603356|Colorectal Cancer|colorectal cancer
608840|NCT00603356|Sarcoma|sarcoma
608841|NCT00603356|NSCLC|nsclc
608842|NCT00603356|Cancer|cancer
608843|NCT00603343|antimuscarinics|antimuscarinics
608844|NCT00603343|children|children
608845|NCT00603343|overactive bladder|overactive bladder
608846|NCT00603343|propiverine|propiverine
608847|NCT00603343|urinary incontinence|urinary incontinence
608848|NCT00603343|urotherapy|urotherapy
608849|NCT00603330|Mesenchymal stem cells|mesenchymal stem cells
608850|NCT00603330|Graft-versus-host disease|graft-versus-host disease
608851|NCT00603330|Poor graft function|poor graft function
608852|NCT00603330|Chimerism|chimerism
608853|NCT00603330|Hematopoietic cell transplantation recipients|hematopoietic cell transplantation recipients
608854|NCT00603330|Low donor T-cell chimerism|low donor t-cell chimerism
608855|NCT00603317|Warfarin|warfarin
608856|NCT00603317|Drug interaction|drug interaction
608857|NCT00603317|Pharmacogenetics|pharmacogenetics
608858|NCT00603317|Amoxicillin|amoxicillin
608859|NCT00603317|Clavulanic acid|clavulanic acid
608860|NCT00603304|Serenoa repens|serenoa repens
608861|NCT00603304|Urological symptoms|urological symptoms
608862|NCT00603304|hyperplasia|hyperplasia
608864|NCT00603291|obesity|obesity
608865|NCT00603291|weight loss|weight loss
608866|NCT00603291|lorcaserin|lorcaserin
608867|NCT00603291|APD356|apd356
608868|NCT00603291|BLOOM-DM|bloom-dm
608869|NCT00603291|hypertension|hypertension
608870|NCT00603291|dyslipidemia|dyslipidemia
608871|NCT00603291|sleep apnea|sleep apnea
608872|NCT00603291|glucose tolerance|glucose tolerance
608873|NCT00603291|cardiovascular disease|cardiovascular disease
608874|NCT00603291|Arena|arena
608875|NCT00603278|Adolescents|adolescents
608876|NCT00603278|Adults|adults
608877|NCT00603278|Pharmacokinetics|pharmacokinetics
608878|NCT00603278|Asthma|asthma
608879|NCT00603278|GW685698X|gw685698x
608880|NCT00603278|Pharmacogenetics|pharmacogenetics
608881|NCT00603265|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
608882|NCT00603265|Neuropathic Pain|neuropathic pain
608883|NCT00603252|combined hepatitis A and B vaccine|combined hepatitis a and b vaccine
608884|NCT00603252|risk factors|risk factors
608885|NCT00603239|diabetes|diabetes
608886|NCT00603239|exenatide|exenatide
608887|NCT00603239|metformin|metformin
608888|NCT00603239|thiazolidinedione|thiazolidinedione
608889|NCT00603239|Byetta|byetta
608890|NCT00603239|Amylin|amylin
608891|NCT00603239|Lilly|lilly
608892|NCT00603226|Coronary slow flow phenomenon|coronary slow flow phenomenon
608893|NCT00603226|Coronary angiography|coronary angiography
608894|NCT00603226|Acute coronary syndrome|acute coronary syndrome
608895|NCT00603226|Chest pain|chest pain
608896|NCT00603226|Unstable angina|unstable angina
608897|NCT00603213|Congestive Heart Failure|congestive heart failure
608898|NCT00603213|Impedance|impedance
608899|NCT00603213|Optivol Thoracid Fluid Status monitoring system|optivol thoracid fluid status monitoring system
608900|NCT00603200|Quality of Life|quality of life
608901|NCT00603187|Male Contraception|male contraception
608902|NCT00603187|Acyline|acyline
608903|NCT00603174|NAVA|nava
608904|NCT00603174|mechanical ventilation|mechanical ventilation
608905|NCT00603174|infants|infants
608906|NCT00603174|pediatric intensive care|pediatric intensive care
608907|NCT00603174|infant|infant
608908|NCT00603148|Genetic Polymorphism|genetic polymorphism
608909|NCT00603148|Integrin alpha2beta1|integrin alpha2beta1
608910|NCT00603148|Phenotype|phenotype
608911|NCT00603122|altitude illness|altitude illness
608912|NCT00603122|hypoxia|hypoxia
608913|NCT00603109|Body weight, fat mass, growth hormone, ghrelin|body weight, fat mass, growth hormone, ghrelin
608914|NCT00603083|Hip Arthroplasty|hip arthroplasty
608915|NCT00603083|Treatment Outcome|treatment outcome
608916|NCT00603083|Local Anesthesia|local anesthesia
608917|NCT00603070|Medication Errors|medication errors
608918|NCT00603070|Adverse Drug Events|adverse drug events
608919|NCT00603070|Patient Safety|patient safety
608920|NCT00603070|Electronic Prescribing Systems|electronic prescribing systems
608921|NCT00603070|Medication Reconciliation|medication reconciliation
608922|NCT00603057|Non Small Cell Lung Cancer|non small cell lung cancer
608923|NCT00603018|eating disorders|eating disorders
608924|NCT00603018|anorexia nervosa|anorexia nervosa
608925|NCT00603018|anorexia|anorexia
608927|NCT00603018|brain imaging|brain imaging
608928|NCT00603018|serotonin|serotonin
608929|NCT00603018|fMRI|fmri
608930|NCT00603018|Prozac|prozac
608931|NCT00603018|fluoxetine|fluoxetine
608932|NCT00603005|Glaucoma|glaucoma
608933|NCT00603005|Adherence|adherence
608934|NCT00602992|3T MRI|3t mri
608935|NCT00602992|Gamma Knife Radiosurgery|gamma knife radiosurgery
608936|NCT00602979|endotracheal intubation|endotracheal intubation
608937|NCT00602979|intubation|intubation
608938|NCT00602979|laryngoscopy|laryngoscopy
608939|NCT00602979|laryngoscope|laryngoscope
608940|NCT00602979|surgery|surgery
608941|NCT00602966|Oocyte cryopreservation|oocyte cryopreservation
608942|NCT00602966|slow freeze|slow freeze
608943|NCT00602966|vitrification|vitrification
608944|NCT00602940|PCOS|pcos
608945|NCT00602940|ovulation|ovulation
608946|NCT00602940|hormones|hormones
608947|NCT00602940|women|women
608948|NCT00602927|Varenicline, Imaging, fMRI|varenicline, imaging, fmri
608949|NCT00602914|MicronJet (microneedles)|micronjet (microneedles)
608950|NCT00602914|Intradermal|intradermal
608951|NCT00602862|Angiogenesis inhibitors|angiogenesis inhibitors
608952|NCT00602836|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
608953|NCT00602836|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
608954|NCT00602836|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
608955|NCT00602836|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
608956|NCT00602836|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
608957|NCT00602836|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
608958|NCT00602836|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
608959|NCT00602836|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
608960|NCT00602836|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
608961|NCT00602836|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
608962|NCT00602758|AIDS|aids
608963|NCT00602758|Adherence|adherence
608964|NCT00602758|Antiretroviral Therapy|antiretroviral therapy
608965|NCT00602758|HIV|hiv
608966|NCT00602745|pancreatic cancer|pancreatic cancer
608967|NCT00602732|Partner Abuse|partner abuse
608968|NCT00602732|Preventive Intervention|preventive intervention
608969|NCT00602732|Postpartum Depression|postpartum depression
608970|NCT00602732|Postpartum PTSD|postpartum ptsd
608971|NCT00602706|refractory multiple myeloma|refractory multiple myeloma
608972|NCT00602706|stage I multiple myeloma|stage i multiple myeloma
608973|NCT00602706|stage II multiple myeloma|stage ii multiple myeloma
608974|NCT00602706|stage III multiple myeloma|stage iii multiple myeloma
608975|NCT00602693|chronic myelogenous leukemia|chronic myelogenous leukemia
608976|NCT00602693|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
608977|NCT00602693|prolymphocytic leukemia|prolymphocytic leukemia
608978|NCT00602693|advanced chronic lymphocytic leukemia|advanced chronic lymphocytic leukemia
608979|NCT00602693|small lymphocytic lymphoma|small lymphocytic lymphoma
608980|NCT00602693|B-cell lymphoma|b-cell lymphoma
608981|NCT00602693|follicular lymphoma|follicular lymphoma
608982|NCT00602693|diffuse large cell lymphoma|diffuse large cell lymphoma
608983|NCT00602693|anaplastic large cell lymphoma|anaplastic large cell lymphoma
608984|NCT00602693|Hodgkin lymphoma|hodgkin lymphoma
608985|NCT00602693|multiple myeloma|multiple myeloma
608986|NCT00602680|Alzheimer|alzheimer
608987|NCT00602680|cognitive|cognitive
608988|NCT00602667|untreated childhood medulloblastoma|untreated childhood medulloblastoma
608989|NCT00602667|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
608990|NCT00602667|untreated childhood pineoblastoma|untreated childhood pineoblastoma
608991|NCT00602667|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
608992|NCT00602667|childhood choroid plexus tumor|childhood choroid plexus tumor
608993|NCT00602667|childhood high grade glioma|childhood high grade glioma
608994|NCT00602667|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
608995|NCT00602628|ductal breast carcinoma in situ|ductal breast carcinoma in situ
608996|NCT00602628|invasive ductal breast carcinoma|invasive ductal breast carcinoma
608997|NCT00602628|breast cancer in situ|breast cancer in situ
608998|NCT00602628|stage I breast cancer|stage i breast cancer
608999|NCT00602628|stage II breast cancer|stage ii breast cancer
609000|NCT00602628|stage IIIA breast cancer|stage iiia breast cancer
609001|NCT00602602|stage IV pancreatic cancer|stage iv pancreatic cancer
609002|NCT00602602|recurrent pancreatic cancer|recurrent pancreatic cancer
609003|NCT00602589|open-label|open-label
609004|NCT00602589|randomized|randomized
609005|NCT00602589|crossover|crossover
609006|NCT00602589|bioequivalence|bioequivalence
609007|NCT00602576|recurrent melanoma|recurrent melanoma
609008|NCT00602576|stage III melanoma|stage iii melanoma
609009|NCT00602576|stage IV melanoma|stage iv melanoma
609010|NCT00602563|Generalized Anxiety Disorder|generalized anxiety disorder
609011|NCT00602563|Information Processing|information processing
609012|NCT00602550|HIV|hiv
609013|NCT00602537|Bipolar Type II Disorder|bipolar type ii disorder
609014|NCT00602537|Hypomania|hypomania
609015|NCT00602537|Antidepressant|antidepressant
609016|NCT00602537|Mood Stabilizer|mood stabilizer
609017|NCT00602537|Venlafaxine|venlafaxine
609018|NCT00602537|Lithium Carbonate|lithium carbonate
609019|NCT00602537|Major Depressive Episode|major depressive episode
609020|NCT00602537|Hypomanic Episodes|hypomanic episodes
609021|NCT00602537|Prevention of Depression Relapse|prevention of depression relapse
609022|NCT00602511|Melfalan refractory multiple myeloma|melfalan refractory multiple myeloma
609023|NCT00602511|Multiple myeloma|multiple myeloma
609024|NCT00602511|Relapsing|relapsing
609025|NCT00602511|Refractory|refractory
609026|NCT00602511|Thalidomide|thalidomide
609027|NCT00602511|Bortezomib|bortezomib
609028|NCT00602511|Randomized clinical trial|randomized clinical trial
609029|NCT00602485|adherence, cardiac rehabilitation|adherence, cardiac rehabilitation
609030|NCT00602446|iron overload|iron overload
609031|NCT00602433|advanced nonsmall cell lung cancer|advanced nonsmall cell lung cancer
609032|NCT00602420|pain|pain
609033|NCT00602420|musculoskeletal complications|musculoskeletal complications
609034|NCT00602420|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
609035|NCT00602368|cervical cancer|cervical cancer
609036|NCT00602368|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
609037|NCT00602368|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
609038|NCT00602368|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
609039|NCT00602355|Postpartum|postpartum
609040|NCT00602355|Depression|depression
609041|NCT00602355|Medication Therapy|medication therapy
609042|NCT00602355|Zoloft|zoloft
609043|NCT00602355|Sertraline|sertraline
609044|NCT00602355|Interpersonal Psychotherapy|interpersonal psychotherapy
609045|NCT00602329|recurrent colon cancer|recurrent colon cancer
609046|NCT00602329|recurrent rectal cancer|recurrent rectal cancer
609047|NCT00602329|stage III colon cancer|stage iii colon cancer
609048|NCT00602329|stage III rectal cancer|stage iii rectal cancer
609049|NCT00602329|stage IV colon cancer|stage iv colon cancer
609050|NCT00602329|stage IV rectal cancer|stage iv rectal cancer
609051|NCT00602329|adenocarcinoma of the colon|adenocarcinoma of the colon
609052|NCT00602329|adenocarcinoma of the rectum|adenocarcinoma of the rectum
609053|NCT00602316|invasive ductal breast carcinoma|invasive ductal breast carcinoma
609054|NCT00602316|stage IA breast cancer|stage ia breast cancer
609055|NCT00602316|stage IB breast cancer|stage ib breast cancer
609056|NCT00602316|stage II breast cancer|stage ii breast cancer
609057|NCT00602316|stage IIIA breast cancer|stage iiia breast cancer
609058|NCT00602290|Major Depression|major depression
609059|NCT00602290|Geriatric Major Unipolar Depression|geriatric major unipolar depression
609060|NCT00602290|Executive Cognitive Dysfunction|executive cognitive dysfunction
609061|NCT00602290|Elderly|elderly
609062|NCT00602290|Geriatric|geriatric
609063|NCT00602290|Executive Cognitive Impairment|executive cognitive impairment
609064|NCT00602290|Quality of Life|quality of life
609065|NCT00602290|Disability|disability
609066|NCT00602290|Comorbidity|comorbidity
609067|NCT00602290|Medical Burden|medical burden
609068|NCT00602290|Safety|safety
609069|NCT00602290|Candidate Genes|candidate genes
609070|NCT00602264|Anorexia nervosa|anorexia nervosa
609071|NCT00602264|Adipokines|adipokines
609072|NCT00602264|Ghrelin|ghrelin
609073|NCT00602264|Fat mass|fat mass
609074|NCT00602212|generalized anxiety disorder (GAD)|generalized anxiety disorder (gad)
609075|NCT00602199|stage IV melanoma|stage iv melanoma
609076|NCT00602186|female voiding dysfunction|female voiding dysfunction
609077|NCT00602186|Tamsolusin|tamsolusin
609078|NCT00602186|prazosin|prazosin
609079|NCT00602160|Food allergy|food allergy
609080|NCT00602160|Chinese Herbs|chinese herbs
609081|NCT00602160|Investigational new drug|investigational new drug
609082|NCT00602160|Herbs|herbs
609083|NCT00602160|Therapeutic medicine|therapeutic medicine
609084|NCT00602160|Traditional Chinese medicine|traditional chinese medicine
609085|NCT00602147|mucositis|mucositis
609086|NCT00602147|stage I multiple myeloma|stage i multiple myeloma
609087|NCT00602147|stage II multiple myeloma|stage ii multiple myeloma
609088|NCT00602147|stage III multiple myeloma|stage iii multiple myeloma
609089|NCT00602147|refractory multiple myeloma|refractory multiple myeloma
609090|NCT00602108|stage I breast cancer|stage i breast cancer
609091|NCT00602108|stage II breast cancer|stage ii breast cancer
609092|NCT00602095|Labor induction|labor induction
609093|NCT00602095|cervical ripening|cervical ripening
609094|NCT00602095|misoprostol|misoprostol
609095|NCT00602095|dinoprostone|dinoprostone
609096|NCT00602095|balloon catheter|balloon catheter
609097|NCT00602095|prostaglandin|prostaglandin
609098|NCT00602082|pancreatic alpha cell adenoma|pancreatic alpha cell adenoma
609099|NCT00602082|pancreatic alpha cell carcinoma|pancreatic alpha cell carcinoma
609100|NCT00602082|pancreatic beta islet cell adenoma|pancreatic beta islet cell adenoma
609101|NCT00602082|pancreatic beta islet cell carcinoma|pancreatic beta islet cell carcinoma
609102|NCT00602082|pancreatic delta cell adenoma|pancreatic delta cell adenoma
609103|NCT00602082|pancreatic delta cell carcinoma|pancreatic delta cell carcinoma
609104|NCT00602082|pancreatic G-cell adenoma|pancreatic g-cell adenoma
609105|NCT00602082|pancreatic G-cell carcinoma|pancreatic g-cell carcinoma
609106|NCT00602082|gastrinoma|gastrinoma
609108|NCT00602082|glucagonoma|glucagonoma
609109|NCT00602082|pancreatic polypeptide tumor|pancreatic polypeptide tumor
609110|NCT00602082|somatostatinoma|somatostatinoma
609111|NCT00602082|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
609112|NCT00602082|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
609113|NCT00602082|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
609114|NCT00602082|islet cell carcinoma|islet cell carcinoma
609115|NCT00602082|recurrent islet cell carcinoma|recurrent islet cell carcinoma
609116|NCT00602069|PTSD|ptsd
609117|NCT00602069|Intimate Partner Violence|intimate partner violence
609118|NCT00602069|Cognitive Behavioral Therapy|cognitive behavioral therapy
609119|NCT00602069|Empowerment|empowerment
609120|NCT00602056|Immunization dropout|immunization dropout
609121|NCT00602056|Immunization card|immunization card
609122|NCT00602056|Center based education|center based education
609123|NCT00602030|lung cancer|lung cancer
609124|NCT00602030|NSCLC|nsclc
609125|NCT00602030|lung neoplasms|lung neoplasms
609126|NCT00602030|respiratory|respiratory
609127|NCT00602004|Arteriovenous fistula|arteriovenous fistula
609128|NCT00602004|hypertrophy|hypertrophy
609129|NCT00602004|losartan|losartan
609130|NCT00601991|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
609131|NCT00601991|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
609132|NCT00601978|Parkinson's disease|parkinson's disease
609133|NCT00601978|carbidopa/levodopa/entacapone|carbidopa/levodopa/entacapone
609134|NCT00601978|carbidopa/levodopa|carbidopa/levodopa
609135|NCT00601978|non-motor symptoms|non-motor symptoms
609136|NCT00601978|event-related potential|event-related potential
609137|NCT00601978|ERP|erp
609138|NCT00601978|EEG|eeg
609139|NCT00601978|electroencephalogram|electroencephalogram
609140|NCT00601952|post traumatic stress disorder|post traumatic stress disorder
609141|NCT00601952|cognitive bias|cognitive bias
609142|NCT00601952|attention|attention
609143|NCT00601952|combat|combat
609144|NCT00601939|Abused|abused
609145|NCT00601939|Female|female
609146|NCT00601939|African American|african american
609147|NCT00601939|Group Empowerment Psychoeducational Intervention|group empowerment psychoeducational intervention
609148|NCT00601939|Enhanced Treatment as Usual|enhanced treatment as usual
609149|NCT00601926|papillary renal cell carcinoma|papillary renal cell carcinoma
609150|NCT00601926|stage III renal cell cancer|stage iii renal cell cancer
609151|NCT00601926|stage IV renal cell cancer|stage iv renal cell cancer
609152|NCT00601913|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
609153|NCT00601913|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
609154|NCT00601913|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
609155|NCT00601913|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
609156|NCT00601913|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
609157|NCT00601913|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
609158|NCT00601913|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
609159|NCT00601913|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
609160|NCT00601913|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
609161|NCT00601913|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
609162|NCT00601913|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
609163|NCT00601887|Anti-inflammatory|anti-inflammatory
609164|NCT00601848|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
609165|NCT00601848|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
609166|NCT00601848|malignant pleural effusion|malignant pleural effusion
609167|NCT00601835|Diphtheria|diphtheria
609168|NCT00601835|Tetanus|tetanus
609169|NCT00601809|Gastrointestinal|gastrointestinal
609170|NCT00601809|Adhesive Small Intestine Obstruction|adhesive small intestine obstruction
609171|NCT00601809|Oral water soluble contrast|oral water soluble contrast
609172|NCT00601809|Non-operative Conservative Management|non-operative conservative management
609173|NCT00601809|Operative rate|operative rate
609174|NCT00601809|Hospital stay|hospital stay
609175|NCT00601796|adenocarcinoma of the lung|adenocarcinoma of the lung
609176|NCT00601796|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
609177|NCT00601757|Preventive Intervention|preventive intervention
609178|NCT00601757|Postpartum Depression|postpartum depression
609179|NCT00601757|Women on Public Assistance|women on public assistance
609180|NCT00601744|Orbital Exenteration|orbital exenteration
609181|NCT00601744|Eye Cancer|eye cancer
609182|NCT00601744|Social-Psychological Aspects|social-psychological aspects
609183|NCT00601744|Quality of Life|quality of life
609184|NCT00601744|Questionnaire|questionnaire
609185|NCT00601744|Facial Appearance|facial appearance
609186|NCT00601744|Survey|survey
609187|NCT00601744|Interview|interview
609188|NCT00601731|Prevention of Meningococcal disease|prevention of meningococcal disease
609189|NCT00601705|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
609190|NCT00601705|adenocarcinoma of the stomach|adenocarcinoma of the stomach
609191|NCT00601705|stage III esophageal cancer|stage iii esophageal cancer
609192|NCT00601705|stage IV esophageal cancer|stage iv esophageal cancer
609193|NCT00601705|stage III gastric cancer|stage iii gastric cancer
609194|NCT00601705|stage IV gastric cancer|stage iv gastric cancer
609195|NCT00601705|stage II esophageal cancer|stage ii esophageal cancer
609196|NCT00601705|stage II gastric cancer|stage ii gastric cancer
609197|NCT00601692|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
609198|NCT00601692|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
609199|NCT00601692|stage II esophageal cancer|stage ii esophageal cancer
609200|NCT00601692|stage III esophageal cancer|stage iii esophageal cancer
609201|NCT00601692|stage IV esophageal cancer|stage iv esophageal cancer
609202|NCT00601679|CHF treatment&prognosis,NT-proBNP testing.|chf treatment&prognosis,nt-probnp testing.
609203|NCT00601653|Binge Eating Disorder|binge eating disorder
609204|NCT00601653|BED|bed
609205|NCT00601653|Nutrition|nutrition
609206|NCT00601653|Energy Density|energy density
609207|NCT00601653|Cognitive Behavioral Therapy|cognitive behavioral therapy
609208|NCT00601653|CBT|cbt
609209|NCT00601640|skin cancer|skin cancer
609210|NCT00601627|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
609211|NCT00601627|stage II pancreatic cancer|stage ii pancreatic cancer
609212|NCT00601627|stage III pancreatic cancer|stage iii pancreatic cancer
609213|NCT00601614|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
609214|NCT00601601|stage 0 cervical cancer|stage 0 cervical cancer
609215|NCT00601601|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
609216|NCT00601601|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
609217|NCT00601601|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
609218|NCT00601562|HIV|hiv
609219|NCT00601549|Rectal cancer|rectal cancer
609220|NCT00601549|CCRT|ccrt
609221|NCT00601549|Laparoscopic Surgery|laparoscopic surgery
609222|NCT00601549|rectal cancer can be resected by curative and elective surgery|rectal cancer can be resected by curative and elective surgery
609223|NCT00601549|rectal adenocarcinoma below peritoneal reflection|rectal adenocarcinoma below peritoneal reflection
609224|NCT00601549|American Society of Anesthesiology（ASA） classⅠ to Ⅲ lesions|american society of anesthesiology（asa） classⅰ to ⅲ lesions
609225|NCT00601510|stage III gastric cancer|stage iii gastric cancer
609226|NCT00601510|stage IV gastric cancer|stage iv gastric cancer
609227|NCT00601484|Painful Bladder Syndrome, monoclonal antibody|painful bladder syndrome, monoclonal antibody
609228|NCT00601471|ankle sprain|ankle sprain
609229|NCT00601471|ankle injuries|ankle injuries
609230|NCT00601471|sprains and strains|sprains and strains
609231|NCT00601458|Primary, unilateral, first metatarsal bunionectomy with osteotomy|primary, unilateral, first metatarsal bunionectomy with osteotomy
609232|NCT00601445|Changes in sleep with aging|changes in sleep with aging
609233|NCT00601432|open-label|open-label
609234|NCT00601432|randomized|randomized
609235|NCT00601432|crossover|crossover
609236|NCT00601432|food effect|food effect
609237|NCT00601406|male breast cancer|male breast cancer
609238|NCT00601406|stage IA breast cancer|stage ia breast cancer
609239|NCT00601406|stage IB breast cancer|stage ib breast cancer
609240|NCT00601406|stage II breast cancer|stage ii breast cancer
609241|NCT00601406|stage I prostate cancer|stage i prostate cancer
609242|NCT00601406|stage IIB prostate cancer|stage iib prostate cancer
609243|NCT00601406|stage IIA prostate cancer|stage iia prostate cancer
609244|NCT00601406|stage III prostate cancer|stage iii prostate cancer
609245|NCT00601406|stage IA cervical cancer|stage ia cervical cancer
609246|NCT00601406|stage IB cervical cancer|stage ib cervical cancer
609247|NCT00601406|stage IIA cervical cancer|stage iia cervical cancer
609248|NCT00601406|stage IIB cervical cancer|stage iib cervical cancer
609249|NCT00601406|stage III cervical cancer|stage iii cervical cancer
609250|NCT00601406|stage IVA cervical cancer|stage iva cervical cancer
609251|NCT00601406|stage IVB cervical cancer|stage ivb cervical cancer
609252|NCT00601406|stage I vaginal cancer|stage i vaginal cancer
609253|NCT00601406|stage II vaginal cancer|stage ii vaginal cancer
609254|NCT00601406|stage III vaginal cancer|stage iii vaginal cancer
609255|NCT00601406|stage IVA vaginal cancer|stage iva vaginal cancer
609256|NCT00601406|stage IVB vaginal cancer|stage ivb vaginal cancer
609257|NCT00601406|stage IA vulvar cancer|stage ia vulvar cancer
609258|NCT00601406|stage IB vulvar cancer|stage ib vulvar cancer
609259|NCT00601406|stage II vulvar cancer|stage ii vulvar cancer
609260|NCT00601406|stage IIIC vulvar cancer|stage iiic vulvar cancer
609261|NCT00601406|stage IIIA vulvar cancer|stage iiia vulvar cancer
609262|NCT00601406|stage IIIB vulvar cancer|stage iiib vulvar cancer
609263|NCT00601406|stage IVB vulvar cancer|stage ivb vulvar cancer
609264|NCT00601406|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
609265|NCT00601406|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
609266|NCT00601406|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
609267|NCT00601406|stage IA ovarian germ cell tumor|stage ia ovarian germ cell tumor
609268|NCT00601406|stage IB ovarian germ cell tumor|stage ib ovarian germ cell tumor
609269|NCT00601406|stage IC ovarian germ cell tumor|stage ic ovarian germ cell tumor
609270|NCT00601406|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
609271|NCT00601406|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
609272|NCT00601406|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
609273|NCT00601406|stage IIA ovarian germ cell tumor|stage iia ovarian germ cell tumor
609274|NCT00601406|stage IIB ovarian germ cell tumor|stage iib ovarian germ cell tumor
609275|NCT00601406|stage IIC ovarian germ cell tumor|stage iic ovarian germ cell tumor
609276|NCT00601406|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
609277|NCT00601406|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
609278|NCT00601406|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
609279|NCT00601406|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
609280|NCT00601406|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
609281|NCT00601406|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
609282|NCT00601406|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
609283|NCT00601406|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
609284|NCT00601406|stage II endometrial carcinoma|stage ii endometrial carcinoma
609285|NCT00601406|ovarian stromal cancer|ovarian stromal cancer
609286|NCT00601406|ovarian sarcoma|ovarian sarcoma
609287|NCT00601406|stage IA fallopian tube cancer|stage ia fallopian tube cancer
609288|NCT00601406|stage IB fallopian tube cancer|stage ib fallopian tube cancer
609289|NCT00601406|stage IC fallopian tube cancer|stage ic fallopian tube cancer
609290|NCT00601406|stage IIA fallopian tube cancer|stage iia fallopian tube cancer
609291|NCT00601406|stage IIB fallopian tube cancer|stage iib fallopian tube cancer
609292|NCT00601406|stage IIC fallopian tube cancer|stage iic fallopian tube cancer
609293|NCT00601406|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
609294|NCT00601406|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
609295|NCT00601406|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
609296|NCT00601406|stage IV fallopian tube cancer|stage iv fallopian tube cancer
609297|NCT00601406|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
609298|NCT00601406|stage IA primary peritoneal cavity cancer|stage ia primary peritoneal cavity cancer
609299|NCT00601406|stage IB primary peritoneal cavity cancer|stage ib primary peritoneal cavity cancer
609300|NCT00601406|stage IC primary peritoneal cavity cancer|stage ic primary peritoneal cavity cancer
609301|NCT00601406|stage IIA primary peritoneal cavity cancer|stage iia primary peritoneal cavity cancer
609302|NCT00601406|stage IIB primary peritoneal cavity cancer|stage iib primary peritoneal cavity cancer
609303|NCT00601406|stage IIC primary peritoneal cavity cancer|stage iic primary peritoneal cavity cancer
609304|NCT00601406|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
609305|NCT00601406|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
609306|NCT00601406|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
609307|NCT00601406|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
609308|NCT00601406|stage IA endometrial carcinoma|stage ia endometrial carcinoma
609309|NCT00601406|stage IB endometrial carcinoma|stage ib endometrial carcinoma
609310|NCT00601406|stage IIIA endometrial carcinoma|stage iiia endometrial carcinoma
609311|NCT00601406|stage IIIB endometrial carcinoma|stage iiib endometrial carcinoma
609312|NCT00601406|stage IIIC endometrial carcinoma|stage iiic endometrial carcinoma
609313|NCT00601406|stage IVA endometrial carcinoma|stage iva endometrial carcinoma
609314|NCT00601406|stage IVB endometrial carcinoma|stage ivb endometrial carcinoma
609315|NCT00601406|stage IA uterine sarcoma|stage ia uterine sarcoma
609316|NCT00601406|stage IB uterine sarcoma|stage ib uterine sarcoma
609317|NCT00601406|stage IC uterine sarcoma|stage ic uterine sarcoma
609318|NCT00601406|stage IIA uterine sarcoma|stage iia uterine sarcoma
609319|NCT00601406|stage IIB uterine sarcoma|stage iib uterine sarcoma
609320|NCT00601406|stage IIIA uterine sarcoma|stage iiia uterine sarcoma
609321|NCT00601406|stage IIIB uterine sarcoma|stage iiib uterine sarcoma
609322|NCT00601406|stage IIIC uterine sarcoma|stage iiic uterine sarcoma
609323|NCT00601406|stage IVA uterine sarcoma|stage iva uterine sarcoma
609324|NCT00601406|stage IVB uterine sarcoma|stage ivb uterine sarcoma
609325|NCT00601354|Binge Eating|binge eating
609326|NCT00601354|Orlistat|orlistat
609327|NCT00601354|Alli|alli
609328|NCT00601354|Guided Self-Help|guided self-help
609329|NCT00601341|arthralgia|arthralgia
609330|NCT00601341|joint pain|joint pain
609331|NCT00601341|knee injuries|knee injuries
609332|NCT00601341|knee joint|knee joint
609333|NCT00601341|low back pain|low back pain
609334|NCT00601289|pituitary chromophobe adenoma|pituitary chromophobe adenoma
609335|NCT00601289|recurrent pituitary tumor|recurrent pituitary tumor
609336|NCT00601289|ACTH-producing pituitary tumor|acth-producing pituitary tumor
609337|NCT00601289|growth hormone-producing pituitary tumor|growth hormone-producing pituitary tumor
609338|NCT00601289|prolactin-producing pituitary tumor|prolactin-producing pituitary tumor
609339|NCT00601289|pituitary basophilic adenoma|pituitary basophilic adenoma
609340|NCT00601289|pituitary eosinophilic adenoma|pituitary eosinophilic adenoma
609341|NCT00601289|prolactin secreting adenoma|prolactin secreting adenoma
609342|NCT00601289|nonfunctioning pituitary tumor|nonfunctioning pituitary tumor
609343|NCT00601276|pedophilia|pedophilia
609344|NCT00601276|antiandrogens|antiandrogens
609345|NCT00601276|gonadotropin releasing hormone agonists|gonadotropin releasing hormone agonists
609346|NCT00601263|Chinese Herbal Therapy|chinese herbal therapy
609347|NCT00601263|Asthma|asthma
609444|NCT00600886|Acromegaly,|acromegaly,
609348|NCT00601263|Investigational new drug (IND)|investigational new drug (ind)
609349|NCT00601263|Complementary and Alternative Medicine|complementary and alternative medicine
609350|NCT00601237|HIV Prevention|hiv prevention
609351|NCT00601237|Mobile Phone|mobile phone
609352|NCT00601237|Technology-Based Intervention|technology-based intervention
609353|NCT00601237|HIV|hiv
609354|NCT00601237|HIV Seronegativity|hiv seronegativity
609355|NCT00601224|Social Cognition|social cognition
609356|NCT00601224|Group Therapy|group therapy
609357|NCT00601224|Psychosocial Intervention|psychosocial intervention
609358|NCT00601198|Oxaliplatin-induced Neuropathy|oxaliplatin-induced neuropathy
609359|NCT00601198|Colon and rectum|colon and rectum
609360|NCT00601185|06-009|06-009
609361|NCT00601185|Confocal reflectance microscopy|confocal reflectance microscopy
609362|NCT00601185|shave-biopsy|shave-biopsy
609363|NCT00601172|vomiting|vomiting
609364|NCT00601172|colorectal cancer|colorectal cancer
609365|NCT00601172|nausea|nausea
609366|NCT00601172|oxaliplatin|oxaliplatin
609367|NCT00601159|Metastatic Breast Cancer|metastatic breast cancer
609368|NCT00601159|triple-negative Breast Cancer|triple-negative breast cancer
609369|NCT00601159|cisplatin|cisplatin
609370|NCT00601159|chemotherapy|chemotherapy
609371|NCT00601146|Hodgkin's disease|hodgkin's disease
609372|NCT00601146|CT scan|ct scan
609373|NCT00601133|Solid Tumors|solid tumors
609374|NCT00601133|Acute Inpatient Rehabilitation|acute inpatient rehabilitation
609375|NCT00601133|Postural Instability|postural instability
609376|NCT00601133|Balance|balance
609377|NCT00601133|Function|function
609378|NCT00601133|Walking|walking
609379|NCT00601133|Questionnaire|questionnaire
609380|NCT00601133|Survey|survey
609381|NCT00601120|antiangiogenic therapy|antiangiogenic therapy
609382|NCT00601120|RF ablation|rf ablation
609383|NCT00601107|psoriasis|psoriasis
609384|NCT00601107|psoriasis vulgaris|psoriasis vulgaris
609385|NCT00601107|plaque psoriasis|plaque psoriasis
609386|NCT00601107|chronic plaque psoriasis|chronic plaque psoriasis
609387|NCT00601094|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
609388|NCT00601094|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
609389|NCT00601094|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
609390|NCT00601081|Very low birth weight infants|very low birth weight infants
609391|NCT00601081|HMF|hmf
609392|NCT00601081|immune system function|immune system function
609393|NCT00601068|osteonecrosis, jaws, bisphosphonate, fosamax, alendronate|osteonecrosis, jaws, bisphosphonate, fosamax, alendronate
609394|NCT00601055|COPD|copd
609395|NCT00601055|Geriatric Depression|geriatric depression
609396|NCT00601055|Problem-Solving Therapy|problem-solving therapy
609397|NCT00601055|Treatment Adherence|treatment adherence
609398|NCT00601042|smoking reduction|smoking reduction
609399|NCT00601042|smoking cessation|smoking cessation
609400|NCT00601042|randomized trial|randomized trial
609401|NCT00601042|Swedish snus|swedish snus
609402|NCT00601042|smokeless tobacco|smokeless tobacco
609403|NCT00601029|Exertional Rhabdomyolysis|exertional rhabdomyolysis
609404|NCT00601016|Infantile hemangioma|infantile hemangioma
609405|NCT00601016|Hemangioma|hemangioma
609406|NCT00601016|Hemangioma of Infancy|hemangioma of infancy
609407|NCT00601016|benign tumors of infancy|benign tumors of infancy
609408|NCT00601016|Congenital hemangioma|congenital hemangioma
609409|NCT00601016|Capillary|capillary
609410|NCT00600990|post-operative nausea and vomiting|post-operative nausea and vomiting
609411|NCT00600990|PONV|ponv
609412|NCT00600977|ALL|all
609413|NCT00600977|Chemotherapy|chemotherapy
609414|NCT00600977|Pharmacokinetics of doxorubicin (pegylated or not)|pharmacokinetics of doxorubicin (pegylated or not)
609415|NCT00600977|elderly ALL|elderly all
609416|NCT00600964|CLL|cll
609417|NCT00600964|obatoclax|obatoclax
609418|NCT00600938|iron overload|iron overload
609419|NCT00600938|cardiac iron|cardiac iron
609420|NCT00600938|haemosiderosis|haemosiderosis
609421|NCT00600938|myocardial T2*|myocardial t2*
609422|NCT00600938|left ventricular ejection fraction|left ventricular ejection fraction
609423|NCT00600938|LVEF|lvef
609424|NCT00600938|cardiac dysfunction|cardiac dysfunction
609425|NCT00600938|thalassaemia|thalassaemia
609426|NCT00600938|Diamond Blackfan anemia|diamond blackfan anemia
609427|NCT00600938|DBA|dba
609428|NCT00600938|sideroblastic anemia|sideroblastic anemia
609429|NCT00600938|myelodysplastic syndromes|myelodysplastic syndromes
609430|NCT00600938|MDS (low and INT-1 risk as per the IPSS for MDS)|mds (low and int-1 risk as per the ipss for mds)
609431|NCT00600938|liver MRI|liver mri
609432|NCT00600938|deferasirox|deferasirox
609433|NCT00600938|deferoxamine|deferoxamine
609434|NCT00600938|ICL670|icl670
609435|NCT00600938|DFO|dfo
609436|NCT00600938|cardiovascular magnetic resonance imaging|cardiovascular magnetic resonance imaging
609437|NCT00600925|Colorectal surgery|colorectal surgery
609438|NCT00600912|lipid emulsion|lipid emulsion
609439|NCT00600912|fish oil|fish oil
609440|NCT00600912|parenteral nutrition|parenteral nutrition
609441|NCT00600912|leucotriene LTB5|leucotriene ltb5
609442|NCT00600912|hepatic function|hepatic function
609443|NCT00600899|Postoperative pain treatment|postoperative pain treatment
609445|NCT00600886|adult,|adult,
609446|NCT00600886|growth hormone,|growth hormone,
609447|NCT00600886|insulin-like growth factor I,|insulin-like growth factor i,
609448|NCT00600886|somatostatin analogue|somatostatin analogue
609449|NCT00600873|neuroprotection|neuroprotection
609450|NCT00600873|oxidative stress|oxidative stress
609451|NCT00600860|MDS (all IPSS subtypes)|mds (all ipss subtypes)
609452|NCT00600860|Newly diagnosed|newly diagnosed
609453|NCT00600847|urticaria|urticaria
609454|NCT00600847|cold urticaria|cold urticaria
609455|NCT00600847|acquired cold urticaria|acquired cold urticaria
609456|NCT00600808|SR-hGH, Pharmacokinetics, Pharmacodynamics|sr-hgh, pharmacokinetics, pharmacodynamics
609457|NCT00600795|NPH|nph
609458|NCT00600795|TGF-beta|tgf-beta
609459|NCT00600782|Tuberculosis vaccine|tuberculosis vaccine
609460|NCT00600769|MAC|mac
609461|NCT00600769|NTM|ntm
609462|NCT00600756|schizophrenia|schizophrenia
609463|NCT00600756|SWNK|swnk
609464|NCT00600743|Eating|eating
609465|NCT00600743|Food Intake|food intake
609466|NCT00600743|Appetite|appetite
609467|NCT00600730|fMRi|fmri
609468|NCT00600730|hypoglycemia|hypoglycemia
609469|NCT00600717|Magnetoencephalography(MEG)|magnetoencephalography(meg)
609470|NCT00600717|Electroencephalography (EEG)|electroencephalography (eeg)
609471|NCT00600717|Intracranial recordings (iEEG/ECoG/SEEG)|intracranial recordings (ieeg/ecog/seeg)
609472|NCT00600717|Functional Mapping|functional mapping
609473|NCT00600717|Epilepsy|epilepsy
609474|NCT00600717|Migraine|migraine
609475|NCT00600717|HFOs|hfos
609476|NCT00600717|ripples|ripples
609477|NCT00600717|fast ripples|fast ripples
609478|NCT00600717|high-gamma|high-gamma
609479|NCT00600704|Allogenic Blood Use|allogenic blood use
609480|NCT00600704|Total Blood Loss|total blood loss
609481|NCT00600704|Reinfusion of Washed Shed Blood|reinfusion of washed shed blood
609482|NCT00600691|Finasteride|finasteride
609483|NCT00600691|hematuria|hematuria
609484|NCT00600691|hematospermia|hematospermia
609485|NCT00600691|prostate biopsy|prostate biopsy
609486|NCT00600678|food for special medical purposes|food for special medical purposes
609487|NCT00600665|Sickle Cell Anemia|sickle cell anemia
609488|NCT00600665|Sickle Cell Disease|sickle cell disease
609489|NCT00600652|glucocorticoid-receptor|glucocorticoid-receptor
609490|NCT00600652|flow cytometry|flow cytometry
609491|NCT00600652|glucocorticoid-resistant|glucocorticoid-resistant
609492|NCT00600652|prediction|prediction
609493|NCT00600639|old patients|old patients
609494|NCT00600639|NIV|niv
609495|NCT00600639|Intubation|intubation
609496|NCT00600639|COPD|copd
609497|NCT00600613|Radiation Therapy|radiation therapy
609498|NCT00600587|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
609499|NCT00600587|Genes, erbB-1|genes, erbb-1
609500|NCT00600587|tyrosine kinase inhibitor|tyrosine kinase inhibitor
609501|NCT00600587|Neoadjuvant Therapy|neoadjuvant therapy
609502|NCT00600574|fibromyalgia|fibromyalgia
609503|NCT00600574|physical therapies|physical therapies
609504|NCT00600574|stretching|stretching
609505|NCT00600574|Ai Chi|ai chi
609506|NCT00600561|meditation|meditation
609507|NCT00600561|mindfulness|mindfulness
609508|NCT00600561|HIV|hiv
609509|NCT00600561|CD4|cd4
609510|NCT00600561|Complementary Therapies|complementary therapies
609511|NCT00600548|Cutaneous leishmaniasis|cutaneous leishmaniasis
609512|NCT00600548|Miltefosine|miltefosine
609513|NCT00600548|Meglumine antimoniate|meglumine antimoniate
609514|NCT00600548|L. braziliensis, L. guyanensis|l. braziliensis, l. guyanensis
609515|NCT00600535|Prostate neoplasms|prostate neoplasms
609516|NCT00600535|Abiraterone acetate|abiraterone acetate
609517|NCT00600535|CB7630|cb7630
609518|NCT00600535|Prostate cancer|prostate cancer
609519|NCT00600535|Pharmacokinetics|pharmacokinetics
609520|NCT00600522|intraoperative ultrasonography|intraoperative ultrasonography
609521|NCT00600522|hepatectomy|hepatectomy
609522|NCT00600522|colorectal liver metastases|colorectal liver metastases
609523|NCT00600522|hepatocellular carcinoma|hepatocellular carcinoma
609524|NCT00600522|contrast enhanced intraoperative ultrasonography.|contrast enhanced intraoperative ultrasonography.
609525|NCT00600509|Levetiracetam|levetiracetam
609526|NCT00600509|Keppra|keppra
609527|NCT00600496|ARRY-142886|arry-142886
609528|NCT00600496|AZD6244|azd6244
609529|NCT00600496|Cancer|cancer
609530|NCT00600496|Colon Cancer|colon cancer
609531|NCT00600496|Breast Cancer|breast cancer
609532|NCT00600496|Lung Cancer|lung cancer
609533|NCT00600496|Melanoma|melanoma
609534|NCT00600496|Kidney Cancer|kidney cancer
609535|NCT00600483|obesity|obesity
609536|NCT00600483|diabetes|diabetes
609537|NCT00600470|Behavior Problems|behavior problems
609538|NCT00600470|Behavior Disorders|behavior disorders
609539|NCT00600457|healing time|healing time
609540|NCT00600457|pain|pain
609541|NCT00600457|infection|infection
609542|NCT00600444|permanent venous access|permanent venous access
609543|NCT00600444|chemotherapy|chemotherapy
609544|NCT00600444|parenteral nutrition|parenteral nutrition
609630|NCT00599989|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
609631|NCT00599989|skin reactions secondary to radiation therapy|skin reactions secondary to radiation therapy
609545|NCT00600444|Patients with a benign and/or malignant diseases which demand a safe and permanent venous access, e.g. for chemotherapy and/or parenteral nutrition|patients with a benign and/or malignant diseases which demand a safe and permanent venous access, e.g. for chemotherapy and/or parenteral nutrition
609546|NCT00600444|benign diseases|benign diseases
609547|NCT00600444|malignant diseases|malignant diseases
609548|NCT00600431|nevus count|nevus count
609549|NCT00600431|children|children
609550|NCT00600431|chemotherapy|chemotherapy
609551|NCT00600418|PTSD|ptsd
609552|NCT00600418|DYADIC TREATMENT|dyadic treatment
609553|NCT00600418|WAR AND TERROR|war and terror
609554|NCT00600418|Posttraumatic symptoms among toddlers|posttraumatic symptoms among toddlers
609555|NCT00600405|Nephrolithiasis|nephrolithiasis
609556|NCT00600405|Ureteral Calculi|ureteral calculi
609557|NCT00600379|stroke chronic gait deficits virtual reality training|stroke chronic gait deficits virtual reality training
609558|NCT00600353|nausea|nausea
609559|NCT00600353|cancer|cancer
609560|NCT00600353|CINV|cinv
609561|NCT00600327|Stroke|stroke
609562|NCT00600327|thrombosis|thrombosis
609563|NCT00600327|thromboembolic|thromboembolic
609564|NCT00600327|Transient Ischemic Attack|transient ischemic attack
609565|NCT00600327|TIA|tia
609566|NCT00600314|Graft-Versus-Host Disease|graft-versus-host disease
609567|NCT00600314|Transplantation, Allogeneic|transplantation, allogeneic
609568|NCT00600314|Transplantation, Hematopoietic Stem Cell|transplantation, hematopoietic stem cell
609569|NCT00600314|Calorimetry, Respiration|calorimetry, respiration
609570|NCT00600301|Macula|macula
609571|NCT00600301|Edema|edema
609572|NCT00600275|BGT226|bgt226
609573|NCT00600275|Solid tumors|solid tumors
609574|NCT00600275|Breast cancer|breast cancer
609575|NCT00600275|Cowden Syndrome|cowden syndrome
609576|NCT00600275|Phosphatidylinositol 3'-kinase (PI3K) inhibitor|phosphatidylinositol 3'-kinase (pi3k) inhibitor
609577|NCT00600275|Advanced solid tumors (including sporadic and Cowden Syndrome) (Phase I part)|advanced solid tumors (including sporadic and cowden syndrome) (phase i part)
609578|NCT00600275|Advanced breast cancer (including sporadic and Cowden Syndrome) (Phase II part)|advanced breast cancer (including sporadic and cowden syndrome) (phase ii part)
609579|NCT00600262|severe nonproliferative|severe nonproliferative
609580|NCT00600262|proliferative diabetic retinopathy|proliferative diabetic retinopathy
609581|NCT00600262|active photocoagulated diabetic retinopathy|active photocoagulated diabetic retinopathy
609582|NCT00600262|intravitreal bevacizumab|intravitreal bevacizumab
609583|NCT00600249|Breast cancer.|breast cancer.
609584|NCT00600249|Triple negative.|triple negative.
609585|NCT00600249|Neoadjuvant chemotherapy.|neoadjuvant chemotherapy.
609586|NCT00600249|Targeted therapy.|targeted therapy.
609587|NCT00600236|Diabetes mellitus type 2 with 10 years of diagnosis and no diabetic retinopathy|diabetes mellitus type 2 with 10 years of diagnosis and no diabetic retinopathy
609588|NCT00600236|Diabetes mellitus type 2 with 10 years of diagnosis and proliferative diabetic retinopathy|diabetes mellitus type 2 with 10 years of diagnosis and proliferative diabetic retinopathy
609589|NCT00600184|Stroke|stroke
609590|NCT00600184|Rehabilitation|rehabilitation
609591|NCT00600184|Robotics|robotics
609592|NCT00600171|dose ranging|dose ranging
609593|NCT00600171|placebo|placebo
609594|NCT00600171|asthma|asthma
609595|NCT00600171|safety|safety
609596|NCT00600171|efficacy|efficacy
609597|NCT00600171|pharmacokinetics|pharmacokinetics
609598|NCT00600158|colectomy|colectomy
609599|NCT00600145|Human volunteers|human volunteers
609600|NCT00600145|amphetamine dependence|amphetamine dependence
609601|NCT00600119|NKTR, constipation, opioid, induced, bowel, dysfunction, Naloxol, Naloxone, Narcan, PEG naloxol, OIC, OBD, Nektar|nktr, constipation, opioid, induced, bowel, dysfunction, naloxol, naloxone, narcan, peg naloxol, oic, obd, nektar
609602|NCT00600093|Amantadine|amantadine
609603|NCT00600067|Diabetes|diabetes
609604|NCT00600067|Type 2 Diabetes|type 2 diabetes
609605|NCT00600067|Diabetes Mellitus|diabetes mellitus
609606|NCT00600067|Metabolic Diseases|metabolic diseases
609607|NCT00600067|Glucose Metabolism Disorders|glucose metabolism disorders
609608|NCT00600067|Glycemic Control|glycemic control
609609|NCT00600054|Diffuse intrinsic pontine glioma|diffuse intrinsic pontine glioma
609610|NCT00600054|Common Terminology Criteria|common terminology criteria
609611|NCT00600054|Epidermal Growth factor receptor|epidermal growth factor receptor
609612|NCT00600054|Human antihuman antibody|human antihuman antibody
609613|NCT00600054|pharmacokinetics|pharmacokinetics
609614|NCT00600054|monoclonal antibody|monoclonal antibody
609615|NCT00600054|Informed Consent Form|informed consent form
609616|NCT00600041|Proton Pump Inhibitors|proton pump inhibitors
609617|NCT00600041|pantoprazole|pantoprazole
609618|NCT00600041|Cardiac Output|cardiac output
609619|NCT00600041|Echocardiography|echocardiography
609620|NCT00600041|adverse effects|adverse effects
609621|NCT00600028|idiopathic pulmonary fibrosis cough|idiopathic pulmonary fibrosis cough
609622|NCT00600015|Non-Small Cell Lung Cancer|non-small cell lung cancer
609623|NCT00600015|Advanced|advanced
609624|NCT00600015|Sorafenib|sorafenib
609625|NCT00600015|Erlotinib|erlotinib
609626|NCT00600015|Double-blind|double-blind
609627|NCT00600015|Placebo-controlled|placebo-controlled
609628|NCT00600002|GM-CSF|gm-csf
609629|NCT00600002|Leukine|leukine
609632|NCT00599989|stage I breast cancer|stage i breast cancer
609633|NCT00599989|stage II breast cancer|stage ii breast cancer
609634|NCT00599989|invasive lobular breast carcinoma with predominant in situ component|invasive lobular breast carcinoma with predominant in situ component
609635|NCT00599989|invasive lobular breast carcinoma|invasive lobular breast carcinoma
609636|NCT00599989|comedo ductal breast carcinoma|comedo ductal breast carcinoma
609637|NCT00599989|ductal breast carcinoma in situ|ductal breast carcinoma in situ
609638|NCT00599989|invasive ductal breast carcinoma|invasive ductal breast carcinoma
609639|NCT00599989|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
609640|NCT00599989|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
609641|NCT00599989|papillary ductal breast carcinoma|papillary ductal breast carcinoma
609642|NCT00599989|tubular ductal breast carcinoma|tubular ductal breast carcinoma
609643|NCT00599989|Paget disease of the breast with intraductal carcinoma|paget disease of the breast with intraductal carcinoma
609644|NCT00599989|Paget disease of the breast with invasive ductal carcinoma|paget disease of the breast with invasive ductal carcinoma
609645|NCT00599989|breast cancer in situ|breast cancer in situ
609646|NCT00599950|Mitomycin C|mitomycin c
609647|NCT00599950|Corneal epithelium|corneal epithelium
609648|NCT00599950|Photorefractive keratectomy (PRK)|photorefractive keratectomy (prk)
609649|NCT00599950|Confocal microscope|confocal microscope
609651|NCT00599924|advanced solid tumors,|advanced solid tumors,
609652|NCT00599924|colorectal cancer,|colorectal cancer,
609653|NCT00599924|sunitinib (SUTENT),|sunitinib (sutent),
609654|NCT00599924|FOLFOX|folfox
609655|NCT00599911|Drug therapy|drug therapy
609656|NCT00599911|Depressive disorder|depressive disorder
609657|NCT00599911|Antidepressive agents|antidepressive agents
609658|NCT00599911|Depressive symptoms|depressive symptoms
609659|NCT00599911|Affective disorders|affective disorders
609660|NCT00599911|Randomized controlled trial|randomized controlled trial
609661|NCT00599911|Placebo-controlled|placebo-controlled
609662|NCT00599911|Double-blind|double-blind
609663|NCT00599911|Active reference|active reference
609664|NCT00599911|Multicenter study|multicenter study
609665|NCT00599898|Preterm labor|preterm labor
609666|NCT00599898|Atosiban|atosiban
609667|NCT00599898|Nifedipine|nifedipine
609668|NCT00599872|Allergy|allergy
609669|NCT00599872|Sublingual Immunotherapy|sublingual immunotherapy
609670|NCT00599872|Allergic Rhinitis|allergic rhinitis
609671|NCT00599859|lactase|lactase
609672|NCT00599859|lactose|lactose
609673|NCT00599859|microflora|microflora
609674|NCT00599846|age-related macular degeneration|age-related macular degeneration
609675|NCT00599846|geographic atrophy|geographic atrophy
609676|NCT00599833|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
609677|NCT00599833|stage III pancreatic cancer|stage iii pancreatic cancer
609678|NCT00599820|Angioid Streaks|angioid streaks
609679|NCT00599820|Choroidal Neovascularization|choroidal neovascularization
609680|NCT00599820|Bevacizumab|bevacizumab
609681|NCT00599794|Sepsis|sepsis
609682|NCT00599794|Intravascular volume|intravascular volume
609683|NCT00599794|Ultrasound|ultrasound
609684|NCT00599794|Noninvasive measurement|noninvasive measurement
609685|NCT00599781|adenosine deaminase|adenosine deaminase
609686|NCT00599781|SCID|scid
609687|NCT00599781|gene therapy|gene therapy
609688|NCT00599781|retroviral vector|retroviral vector
609689|NCT00599742|Balance disorder|balance disorder
609690|NCT00599742|Vestibular disorder|vestibular disorder
609691|NCT00599742|Generalized anxiety disorder|generalized anxiety disorder
609692|NCT00599742|Separation anxiety disorder|separation anxiety disorder
609693|NCT00599742|Children|children
609694|NCT00599742|Balance training|balance training
609695|NCT00599716|dry eye syndrome|dry eye syndrome
609696|NCT00599716|dry eye disease|dry eye disease
609697|NCT00599716|Vismed|vismed
609698|NCT00599716|dry eye|dry eye
609699|NCT00599716|sodium hyaluronate|sodium hyaluronate
609700|NCT00599716|hyaluronic acid|hyaluronic acid
609701|NCT00599690|Epi-LASIK-LASIK microkeratome|epi-lasik-lasik microkeratome
609702|NCT00599690|Corneal thickness|corneal thickness
609703|NCT00599690|Confocal microscope|confocal microscope
609704|NCT00599677|acupuncture|acupuncture
609705|NCT00599677|meridian|meridian
609706|NCT00599677|acupoint|acupoint
609707|NCT00599664|Urinary Calculi|urinary calculi
609708|NCT00599664|Urinary Stones|urinary stones
609709|NCT00599664|Urinary Tract Stones|urinary tract stones
609710|NCT00599664|Calculi|calculi
609711|NCT00599651|Respiratory Distress Syndrome|respiratory distress syndrome
609712|NCT00599651|Newborn RDS|newborn rds
609713|NCT00599625|Crohn's Disease|crohn's disease
609714|NCT00599612|GW856553,|gw856553,
609715|NCT00599612|radiolabel|radiolabel
609716|NCT00599612|ADME,|adme,
609717|NCT00599599|Prolonged Exposure Therapy|prolonged exposure therapy
609718|NCT00599599|Adherence to HIV Medications|adherence to hiv medications
609719|NCT00599599|Complementary Therapies|complementary therapies
609720|NCT00599586|migraine|migraine
609721|NCT00599586|acupuncture|acupuncture
609722|NCT00599586|efficacy|efficacy
609723|NCT00599586|safety|safety
609724|NCT00599586|meridian|meridian
609725|NCT00599586|acupoint|acupoint
609726|NCT00599573|HIV|hiv
609727|NCT00599573|cocaine dependence|cocaine dependence
609728|NCT00599573|cocaine abuse|cocaine abuse
609729|NCT00599573|cocaine addiction|cocaine addiction
609730|NCT00599573|cocaine users|cocaine users
609731|NCT00599573|cocaine-related disorders|cocaine-related disorders
609732|NCT00599573|HIV Infection|hiv infection
609733|NCT00599560|Meniere's disease|meniere's disease
609734|NCT00599560|stress|stress
609735|NCT00599560|vasopressin|vasopressin
609736|NCT00599560|endolymphatic sac|endolymphatic sac
609737|NCT00599560|V2 receptor|v2 receptor
609738|NCT00599560|cyclic AMP|cyclic amp
609739|NCT00599560|Plasma vasopressin level and V2R mRNA expression level in the endolymphatic sac both were significantly higher in patients with Meniere's disease.|plasma vasopressin level and v2r mrna expression level in the endolymphatic sac both were significantly higher in patients with meniere's disease.
609740|NCT00599560|In Meniere's disease, there were significant negative co-relationships between vasopressin and V2R.|in meniere's disease, there were significant negative co-relationships between vasopressin and v2r.
609741|NCT00599560|The cyclic AMP activity was basically up-regulated in the endolymphatic sac in Meniere's disease..|the cyclic amp activity was basically up-regulated in the endolymphatic sac in meniere's disease..
609742|NCT00599560|The cyclic AMP sensitivity for vasopressin was significantly elevated in the endolymphatic sac in Meniere's disease.|the cyclic amp sensitivity for vasopressin was significantly elevated in the endolymphatic sac in meniere's disease.
609743|NCT00599547|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
609744|NCT00599521|Acne Vulgaris|acne vulgaris
609745|NCT00599521|Adapalene|adapalene
609746|NCT00599508|memory|memory
609747|NCT00599508|aging|aging
609748|NCT00599495|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
609749|NCT00599495|Multiple Myeloma|multiple myeloma
609750|NCT00599482|HEMOGLOBIN SC DISEASE|hemoglobin sc disease
609751|NCT00599482|HEMOGLOBIN C DISEASE|hemoglobin c disease
609752|NCT00599482|SICKLE CELL TRAIT|sickle cell trait
609753|NCT00599482|THALASSEMIA|thalassemia
609754|NCT00599469|Acute Confusional Senile Dementia|acute confusional senile dementia
609755|NCT00599469|Alzheimer Type Senile Dementia|alzheimer type senile dementia
609756|NCT00599469|SENILE PLAQUES|senile plaques
609757|NCT00599469|NEUROFIBRILLARY TANGLES|neurofibrillary tangles
609758|NCT00599469|NEUROPIL THREADS|neuropil threads
609759|NCT00599456|Hot flashes|hot flashes
609760|NCT00599456|Menopause|menopause
609761|NCT00599456|Omega 3 fatty Acids|omega 3 fatty acids
609762|NCT00599443|Cell-derived subunit influenza vaccine|cell-derived subunit influenza vaccine
609763|NCT00599443|Safety|safety
609764|NCT00599443|Reactogenicity|reactogenicity
609765|NCT00599430|Probiotic|probiotic
609766|NCT00599430|Lactobacillus|lactobacillus
609767|NCT00599430|NCFM|ncfm
609768|NCT00599430|Bifidobacterium|bifidobacterium
609769|NCT00599430|Healthy children|healthy children
609770|NCT00599404|Pharmacokinetics study|pharmacokinetics study
609771|NCT00599391|KIDNEY FAILURE, ACUTE|kidney failure, acute
609772|NCT00599391|KIDNEY FAILURE, CHRONIC|kidney failure, chronic
609773|NCT00599391|RENAL INSUFFICIENCY|renal insufficiency
609774|NCT00599365|adherence|adherence
609775|NCT00599365|pharmacist intervention|pharmacist intervention
609776|NCT00599365|persistence|persistence
609777|NCT00599365|renal clinic|renal clinic
609778|NCT00599365|pill count|pill count
609779|NCT00599352|Hypovitaminosis|hypovitaminosis
609780|NCT00599352|Chronic liver disease|chronic liver disease
609781|NCT00599339|Rotigotine|rotigotine
609782|NCT00599339|Neupro|neupro
609783|NCT00599326|Exjade PCT Study|exjade pct study
609784|NCT00599326|PCT Study|pct study
609785|NCT00599326|Porphyria Cutanea Tarda|porphyria cutanea tarda
609786|NCT00599287|ICU delirium|icu delirium
609787|NCT00599287|Hypoactive delirium|hypoactive delirium
609788|NCT00599287|Haloperidol|haloperidol
609789|NCT00599287|Methylphenidate|methylphenidate
609790|NCT00599287|Rivastigmine|rivastigmine
609791|NCT00599287|Hypoactive ICU delirium|hypoactive icu delirium
609792|NCT00599274|Multiple Sclerosis|multiple sclerosis
609793|NCT00599274|Interferon beta 1a|interferon beta 1a
609794|NCT00599274|Avonex|avonex
609795|NCT00599261|Cardiac Pacemaker, Artificial|cardiac pacemaker, artificial
609796|NCT00599248|osteoarthritis, knee|osteoarthritis, knee
609797|NCT00599235|Hypertension|hypertension
609798|NCT00599235|Exercise capacity|exercise capacity
609799|NCT00599235|PDE5 inhibitors|pde5 inhibitors
609800|NCT00599222|AMD|amd
609801|NCT00599222|macular degeneration|macular degeneration
609802|NCT00599222|anti-VEGF|anti-vegf
609803|NCT00599222|laser treatment|laser treatment
609804|NCT00599196|Rotigotine|rotigotine
609805|NCT00599196|Neupro®|neupro®
609806|NCT00599183|Cervical spine herniation|cervical spine herniation
609807|NCT00599183|MRI cervical spine|mri cervical spine
609808|NCT00599183|Diffusion tensor imaging cervical spine|diffusion tensor imaging cervical spine
609809|NCT00599170|This is a standard phase II trial, in which patients with newly diagnosed diffuse large B cell lymphoma will receive R-CHOP with GM-CSF|this is a standard phase ii trial, in which patients with newly diagnosed diffuse large b cell lymphoma will receive r-chop with gm-csf
609810|NCT00599144|Cholecystectomy|cholecystectomy
609811|NCT00599131|Cancer of Larynx|cancer of larynx
609812|NCT00599118|Atrial Fibrillation|atrial fibrillation
609813|NCT00599118|Genetics|genetics
609814|NCT00599092|pituitary tumor|pituitary tumor
609815|NCT00599092|recurrence|recurrence
609816|NCT00599079|MAC|mac
609817|NCT00599066|M-Entropy|m-entropy
609818|NCT00599053|Ureaplasma|ureaplasma
609819|NCT00599053|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
609820|NCT00599053|very low birthweight|very low birthweight
609821|NCT00599014|Cardiomyopathy, heart failure, DNA,|cardiomyopathy, heart failure, dna,
609822|NCT00599014|echocardiography, messenger RNA, natural history|echocardiography, messenger rna, natural history
609823|NCT00599001|healthy volunteer|healthy volunteer
609824|NCT00599001|research subjects|research subjects
609825|NCT00599001|Immunostimulatory sequence (ISS)|immunostimulatory sequence (iss)
609826|NCT00599001|phase 1|phase 1
609827|NCT00598988|infectious mononucleosis, mono, acupuncture|infectious mononucleosis, mono, acupuncture
609828|NCT00598975|Phase 2a: Multiple solid tumor types|phase 2a: multiple solid tumor types
609829|NCT00598975|Phase 2b: Second-Line Colorectal Cancer (CRC)|phase 2b: second-line colorectal cancer (crc)
609830|NCT00598962|MAC|mac
609831|NCT00598949|Pituitary|pituitary
609832|NCT00598949|Adenoma|adenoma
609833|NCT00598949|Tumor|tumor
609834|NCT00598949|Acromegaly|acromegaly
609835|NCT00598949|Prolactinoma|prolactinoma
609836|NCT00598949|Cushing's|cushing's
609837|NCT00598936|Hypoxia|hypoxia
609838|NCT00598936|Cerebral Hypoxia|cerebral hypoxia
609839|NCT00598923|tbi|tbi
609840|NCT00598923|traumatic brain injury|traumatic brain injury
609841|NCT00598923|epilepsy|epilepsy
609842|NCT00598910|HIV infection|hiv infection
609843|NCT00598897|MAC|mac
609844|NCT00598884|Clinical Protocols|clinical protocols
609845|NCT00598884|Behavioral Research|behavioral research
609846|NCT00598884|Prevention|prevention
609847|NCT00598871|Thymosin beta 4|thymosin beta 4
609848|NCT00598871|Corneal wound healing|corneal wound healing
609849|NCT00598871|Vitrectomy|vitrectomy
609850|NCT00598871|Diabetes|diabetes
609851|NCT00598858|prostate cancer|prostate cancer
609852|NCT00598858|Prostatectomy|prostatectomy
609853|NCT00598845|Endometrial cancer|endometrial cancer
609854|NCT00598845|Molecular markers|molecular markers
609855|NCT00598845|Lymph node metastasis|lymph node metastasis
609856|NCT00598845|Prospective study|prospective study
609857|NCT00598845|Prognosis|prognosis
609858|NCT00598845|Cancer of Endometrium|cancer of endometrium
609859|NCT00598845|Tumor Markers, Biological|tumor markers, biological
609860|NCT00598832|Acne Vulgaris|acne vulgaris
609861|NCT00598832|Adapalene|adapalene
609862|NCT00598819|Cerebral Oxygenation|cerebral oxygenation
609863|NCT00598819|Oxygen Monitoring|oxygen monitoring
609864|NCT00598806|Noninvasive Bladder Cancer|noninvasive bladder cancer
609865|NCT00598780|Levocetirizine|levocetirizine
609866|NCT00598780|Xyzal|xyzal
609867|NCT00598780|Rhinitis allergic persistent|rhinitis allergic persistent
609868|NCT00598780|Rhinitis nonseasonal|rhinitis nonseasonal
609869|NCT00598767|Aortic valve insufficiency|aortic valve insufficiency
609870|NCT00598767|Aortic valve stenosis|aortic valve stenosis
609871|NCT00598767|3D echocardiogram|3d echocardiogram
609872|NCT00598767|3D computed tomography|3d computed tomography
609873|NCT00598754|Aortic valve stenosis|aortic valve stenosis
609874|NCT00598754|Aortic valve insufficiency|aortic valve insufficiency
609875|NCT00598754|Two dimensional echocardiography|two dimensional echocardiography
609876|NCT00598754|Three dimensional echocardiography|three dimensional echocardiography
609877|NCT00598741|Bone|bone
609878|NCT00598741|Sarcoma|sarcoma
609879|NCT00598741|04-083|04-083
609880|NCT00598728|Survivors|survivors
609881|NCT00598728|Quality of Life|quality of life
609882|NCT00598715|In-stent restenosis|in-stent restenosis
609883|NCT00598715|In-DES-restenosis|in-des-restenosis
609884|NCT00598715|paclitaxel|paclitaxel
609885|NCT00598715|sirolimus|sirolimus
609886|NCT00598689|LASIK|lasik
609887|NCT00598689|Ocular Lubricants|ocular lubricants
609888|NCT00598689|Corneal Epithelium|corneal epithelium
609889|NCT00598689|Wound Healing|wound healing
609890|NCT00598663|Type 1 diabetes|type 1 diabetes
609891|NCT00598650|Lewy Body Disease|lewy body disease
609892|NCT00598650|Dementia|dementia
609893|NCT00598650|Clinical Trial|clinical trial
609894|NCT00598650|Phase II|phase ii
609895|NCT00598650|E2020|e2020
609896|NCT00598650|donepezil hydrochloride|donepezil hydrochloride
609897|NCT00598637|drug eluting stent|drug eluting stent
609898|NCT00598637|left main disease|left main disease
609899|NCT00598611|urticaria|urticaria
609900|NCT00598598|Aortic valve insufficiency|aortic valve insufficiency
609901|NCT00598598|Aortic valve stenosis|aortic valve stenosis
609902|NCT00598598|3D echocardiogram|3d echocardiogram
609903|NCT00598572|Deferoxamine|deferoxamine
609904|NCT00598572|Safety|safety
609905|NCT00598572|Intracerebral hemorrhage|intracerebral hemorrhage
609906|NCT00598559|Acute pain|acute pain
609907|NCT00598559|Fever|fever
609908|NCT00598559|IV Acetaminophen|iv acetaminophen
609909|NCT00598559|Analgesic|analgesic
609910|NCT00598546|Stomach|stomach
609911|NCT00598546|Gastric|gastric
609912|NCT00598546|Stomach Tumor|stomach tumor
609913|NCT00598546|Stomach Cancer|stomach cancer
609914|NCT00598507|ZK-EPO|zk-epo
609915|NCT00598507|ZK219477|zk219477
609916|NCT00598507|EpothiloneZK|epothilonezk
609917|NCT00598494|effect of bedrest|effect of bedrest
609918|NCT00598494|cardiac atrophy|cardiac atrophy
609919|NCT00598481|SCID|scid
609920|NCT00598481|gene therapy|gene therapy
609921|NCT00598481|Adenosine deaminase|adenosine deaminase
609922|NCT00598481|retroviral vector|retroviral vector
609923|NCT00598455|angiomyolipomata|angiomyolipomata
609924|NCT00598455|tuberous sclerosis complex|tuberous sclerosis complex
609925|NCT00598442|anemia|anemia
609926|NCT00598442|chronic kidney disease|chronic kidney disease
609927|NCT00598442|CKD|ckd
609928|NCT00598442|chronic renal failure|chronic renal failure
609929|NCT00598442|CRF|crf
609930|NCT00598442|erythropoietin|erythropoietin
609931|NCT00598442|EPO|epo
609932|NCT00598442|erythropoiesis stimulating agent|erythropoiesis stimulating agent
609933|NCT00598442|ESA|esa
609934|NCT00598442|Hematide™|hematide™
609935|NCT00598442|hemoglobin|hemoglobin
609936|NCT00598442|Hb|hb
609937|NCT00598442|Hgb|hgb
609938|NCT00598442|Omontys|omontys
609939|NCT00598442|peginesatide|peginesatide
609940|NCT00598442|red blood cell|red blood cell
609941|NCT00598442|red blood cell production|red blood cell production
609942|NCT00598429|NICHD Neonatal Research Network|nichd neonatal research network
609943|NCT00598429|Hypoxemic respiratory failure (HRF)|hypoxemic respiratory failure (hrf)
609944|NCT00598429|Persistent pulmonary hypertension of the newborn (PPHN)|persistent pulmonary hypertension of the newborn (pphn)
609945|NCT00598429|Prostaglandin E1 (PGE1)|prostaglandin e1 (pge1)
609946|NCT00598429|Mechanical ventilation|mechanical ventilation
609947|NCT00598429|Meconium, aspiration|meconium, aspiration
609948|NCT00598416|Hepatitis C|hepatitis c
609949|NCT00598416|Substance Abuse|substance abuse
609950|NCT00598416|Psychoeducation|psychoeducation
609951|NCT00598416|Psychiatric functioning|psychiatric functioning
609952|NCT00598416|Physical Functioning|physical functioning
609953|NCT00598416|Quality of Life|quality of life
609954|NCT00598416|NIAAA|niaaa
609955|NCT00598416|Alcohol|alcohol
609956|NCT00598403|Cystitis|cystitis
609957|NCT00598390|Cannabinoid|cannabinoid
609958|NCT00598390|CB1 Receptor|cb1 receptor
609959|NCT00598390|Brain Imaging|brain imaging
609960|NCT00598390|PET Imaging|pet imaging
609961|NCT00598390|[11C]MePPEP|[11c]meppep
609962|NCT00598390|Healthy Volunteer|healthy volunteer
609963|NCT00598390|HV|hv
609964|NCT00598377|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
609965|NCT00598377|Adrenal functions|adrenal functions
609966|NCT00598377|Renal volume|renal volume
609967|NCT00598377|Glomerular filtration rate|glomerular filtration rate
609968|NCT00598377|Adrenal Cortex Function Tests|adrenal cortex function tests
609969|NCT00598364|thyroid|thyroid
609970|NCT00598364|nodule|nodule
609971|NCT00598364|genetic|genetic
609972|NCT00598364|mutation|mutation
609973|NCT00598364|malignancy|malignancy
609974|NCT00598351|Meningioma|meningioma
609975|NCT00598351|Ependymoma|ependymoma
609976|NCT00598351|Schwannoma|schwannoma
609977|NCT00598351|Acoustic Neuroma|acoustic neuroma
609978|NCT00598351|Vestibular Schwannoma|vestibular schwannoma
609979|NCT00598351|Neurofibromatosis Type 2|neurofibromatosis type 2
609980|NCT00598351|NF2|nf2
609981|NCT00598325|Nicotine|nicotine
609982|NCT00598325|Vaccine|vaccine
609983|NCT00598325|Immunogenicity|immunogenicity
609984|NCT00598325|Tobacco|tobacco
609985|NCT00598325|Habits|habits
609986|NCT00598299|corneal epithelium|corneal epithelium
609987|NCT00598286|CB1 Receptor|cb1 receptor
609989|NCT00598286|Cannabinoid|cannabinoid
609990|NCT00598286|[18F]FMPEP-d2|[18f]fmpep-d2
609991|NCT00598286|Brain Imaging|brain imaging
609992|NCT00598286|Healthy Volunteer|healthy volunteer
609993|NCT00598286|HV|hv
609994|NCT00598273|anemia|anemia
609995|NCT00598273|chronic kidney disease|chronic kidney disease
609996|NCT00598273|CKD|ckd
609997|NCT00598273|chronic renal failure|chronic renal failure
609998|NCT00598273|CRF|crf
609999|NCT00598273|erythropoietin|erythropoietin
610000|NCT00598273|EPO|epo
610001|NCT00598273|erythropoiesis stimulating agent|erythropoiesis stimulating agent
610002|NCT00598273|ESA|esa
610003|NCT00598273|Hematide™|hematide™
610004|NCT00598273|hemoglobin|hemoglobin
610005|NCT00598273|Hb|hb
610006|NCT00598273|Hgb|hgb
610007|NCT00598273|Omontys|omontys
610008|NCT00598273|peginesatide|peginesatide
610009|NCT00598273|red blood cell|red blood cell
610010|NCT00598273|red blood cell production|red blood cell production
610011|NCT00598260|active management|active management
610012|NCT00598260|induction of labor|induction of labor
610013|NCT00598260|cesarean delivery|cesarean delivery
610014|NCT00598260|Cesarean|cesarean
610015|NCT00598247|Colon Cancer Rectal Colorectal Women|colon cancer rectal colorectal women
610016|NCT00598208|In-vitro fertilization|in-vitro fertilization
610017|NCT00598195|Ketamine|ketamine
610018|NCT00598195|Phamacokinetics|phamacokinetics
610019|NCT00598195|Cardiopulmonary bypass (CPB)|cardiopulmonary bypass (cpb)
610020|NCT00598195|ketamine/norketamine pharmacokinetic parameters|ketamine/norketamine pharmacokinetic parameters
610021|NCT00598182|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
610022|NCT00598182|OROS methylphenidate|oros methylphenidate
610023|NCT00598169|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
610024|NCT00598169|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
610025|NCT00598169|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
610026|NCT00598169|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
610027|NCT00598169|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
610028|NCT00598169|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
610029|NCT00598169|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
610030|NCT00598169|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
610031|NCT00598130|Patients undergoing elective open partial nephrectomy surgery|patients undergoing elective open partial nephrectomy surgery
610032|NCT00598130|Excision of a kidney|excision of a kidney
610033|NCT00598117|Esophageal|esophageal
610034|NCT00598117|CancerEsophagus|canceresophagus
610035|NCT00598104|Asthma, interleukin-13|asthma, interleukin-13
610036|NCT00598091|Solid Tumors|solid tumors
610037|NCT00598091|Phase I|phase i
610038|NCT00598091|Expanded Cohort|expanded cohort
610039|NCT00598091|Pancreatic Cancer|pancreatic cancer
610040|NCT00598091|Dasatinib|dasatinib
610041|NCT00598091|Gemcitabine|gemcitabine
610042|NCT00598065|lung|lung
610043|NCT00598052|Marijuana dependence withdrawal Escitalopram|marijuana dependence withdrawal escitalopram
610044|NCT00598026|Tele medicine|tele medicine
610045|NCT00598026|ICD follow-up|icd follow-up
610046|NCT00598026|Cost / benefit study|cost / benefit study
610047|NCT00598013|Kidney Transplantation|kidney transplantation
610048|NCT00598013|Thiazolidinediones|thiazolidinediones
610049|NCT00598013|Insulin Resistance|insulin resistance
610050|NCT00598013|Atherosclerosis|atherosclerosis
610051|NCT00598000|Lung cancer|lung cancer
610052|NCT00598000|Quality of Life|quality of life
610053|NCT00598000|VATS|vats
610054|NCT00598000|thoracotomy|thoracotomy
610055|NCT00598000|05-006|05-006
610056|NCT00597987|BRCA1|brca1
610057|NCT00597974|carotid artery stenosis|carotid artery stenosis
610058|NCT00597974|Neuropsychological tests|neuropsychological tests
610059|NCT00597974|Stroke|stroke
610060|NCT00597974|Transient ischemia|transient ischemia
610061|NCT00597974|Stenting|stenting
610062|NCT00597961|Lung|lung
610063|NCT00597961|skin|skin
610064|NCT00597961|melanoma|melanoma
610065|NCT00597948|mental retardation|mental retardation
610066|NCT00597948|downs syndrome|downs syndrome
610067|NCT00597948|autism|autism
610068|NCT00597948|autism spectrum disorder|autism spectrum disorder
610069|NCT00597948|cerebral palsy|cerebral palsy
610070|NCT00597948|developmental disability|developmental disability
610071|NCT00597948|developmental disabilities|developmental disabilities
610072|NCT00597948|intellectual disability|intellectual disability
610073|NCT00597948|intellectual disabilities|intellectual disabilities
610074|NCT00597948|health promotion|health promotion
610075|NCT00597948|disease prevention|disease prevention
610076|NCT00597948|physical health|physical health
610077|NCT00597948|emotional health|emotional health
610078|NCT00597948|behavioral health|behavioral health
610079|NCT00597948|mental health|mental health
610080|NCT00597948|spiritual health|spiritual health
610081|NCT00597948|prevention|prevention
610082|NCT00597935|prolapse|prolapse
610083|NCT00597935|urinary incontinence|urinary incontinence
610084|NCT00597935|uterosacral vaginal vault ligament suspension|uterosacral vaginal vault ligament suspension
610085|NCT00597935|sacrospinous ligament fixation|sacrospinous ligament fixation
610086|NCT00597935|behavioral therapy|behavioral therapy
610087|NCT00597935|pelvic muscle training|pelvic muscle training
610088|NCT00597922|Acute Myocardial Infarction|acute myocardial infarction
610089|NCT00597922|Heart Attack|heart attack
610090|NCT00597922|Gender Differences|gender differences
610091|NCT00597922|Risk Factors|risk factors
610092|NCT00597922|Quality of Care|quality of care
610093|NCT00597909|Ammonul®|ammonul®
610094|NCT00597909|sodium phenylacetate and sodium benzoate|sodium phenylacetate and sodium benzoate
610095|NCT00597909|hepatic encephalopathy|hepatic encephalopathy
610096|NCT00597909|Grade 3 or 4 Hepatic Encephalopathy|grade 3 or 4 hepatic encephalopathy
610097|NCT00597883|carotid endarterectomy|carotid endarterectomy
610098|NCT00597883|Neuropsychological tests|neuropsychological tests
610099|NCT00597883|Stroke|stroke
610100|NCT00597883|Transient ischemia|transient ischemia
610101|NCT00597870|TAA|taa
610102|NCT00597844|type I thyroplasty|type i thyroplasty
610103|NCT00597844|unilateral vocal fold augmentation|unilateral vocal fold augmentation
610104|NCT00597831|depression|depression
610105|NCT00597831|electroconvulsive therapy|electroconvulsive therapy
610106|NCT00597831|Ultrasonography Doppler Transcranial|ultrasonography doppler transcranial
610107|NCT00597831|intracranial pressure|intracranial pressure
610108|NCT00597792|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
610109|NCT00597792|Plicator|plicator
610110|NCT00597792|Full-thickness Plication|full-thickness plication
610111|NCT00597779|intertrochanteric fractures|intertrochanteric fractures
610112|NCT00597766|CVA|cva
610113|NCT00597766|Hemiplegia|hemiplegia
610114|NCT00597766|Hemiplegic shoulder pain|hemiplegic shoulder pain
610115|NCT00597766|Subacromial steroid injection|subacromial steroid injection
610116|NCT00597753|anemia|anemia
610117|NCT00597753|chronic kidney disease|chronic kidney disease
610118|NCT00597753|CKD|ckd
610119|NCT00597753|chronic renal failure|chronic renal failure
610120|NCT00597753|CRF|crf
610121|NCT00597753|dialysis|dialysis
610122|NCT00597753|erythropoietin|erythropoietin
610123|NCT00597753|EPO|epo
610124|NCT00597753|erythropoiesis stimulating agent|erythropoiesis stimulating agent
610125|NCT00597753|ESA|esa
610126|NCT00597753|Hematide™|hematide™
610127|NCT00597753|hemodialysis|hemodialysis
610128|NCT00597753|hemoglobin|hemoglobin
610129|NCT00597753|Hb|hb
610130|NCT00597753|Hgb|hgb
610131|NCT00597753|Omontys|omontys
610132|NCT00597753|peginesatide|peginesatide
610133|NCT00597753|red blood cell|red blood cell
610134|NCT00597753|red blood cell production|red blood cell production
610135|NCT00597727|Peanut Allergy|peanut allergy
610136|NCT00597727|Sublingual immunotherapy|sublingual immunotherapy
610137|NCT00597714|Stem Cell Transplantation, Non-myeloablative|stem cell transplantation, non-myeloablative
610138|NCT00597701|Alcohol withdrawal|alcohol withdrawal
610139|NCT00597701|Delirium tremors|delirium tremors
610140|NCT00597675|Peanut allergy|peanut allergy
610141|NCT00597636|smokers|smokers
610142|NCT00597623|Osteoarthritis|osteoarthritis
610143|NCT00597623|Hand|hand
610144|NCT00597623|Tumor Necrosis Factor-alpha inhibitors|tumor necrosis factor-alpha inhibitors
610145|NCT00597623|Biological Therapy|biological therapy
610146|NCT00597610|Rectum|rectum
610147|NCT00597610|Rectal|rectal
610148|NCT00597597|Metastatic breast cancer|metastatic breast cancer
610149|NCT00597597|ER and PR hormone receptor negative|er and pr hormone receptor negative
610150|NCT00597597|HER2/neu negative|her2/neu negative
610151|NCT00597597|EGFR positive|egfr positive
610152|NCT00597584|anemia|anemia
610153|NCT00597584|chronic kidney disease|chronic kidney disease
610154|NCT00597584|CKD|ckd
610155|NCT00597584|chronic renal failure|chronic renal failure
610156|NCT00597584|CRF|crf
610157|NCT00597584|dialysis|dialysis
610158|NCT00597584|erythropoietin|erythropoietin
610159|NCT00597584|EPO|epo
610160|NCT00597584|erythropoiesis stimulating agent|erythropoiesis stimulating agent
610161|NCT00597584|ESA|esa
610162|NCT00597584|Hematide™|hematide™
610163|NCT00597584|hemodialysis|hemodialysis
610164|NCT00597584|hemoglobin|hemoglobin
610165|NCT00597584|Hb|hb
610166|NCT00597584|Hgb|hgb
610167|NCT00597584|Omontys|omontys
610168|NCT00597584|peginesatide|peginesatide
610169|NCT00597584|red blood cell|red blood cell
610170|NCT00597584|red blood cell production|red blood cell production
610171|NCT00597558|Egg allergy|egg allergy
610172|NCT00597545|Carotid Endarterectomy|carotid endarterectomy
610173|NCT00597545|Neuropsychological tests|neuropsychological tests
610174|NCT00597545|Stroke|stroke
610175|NCT00597545|Transient ischemia|transient ischemia
610176|NCT00597545|Hypoperfusion|hypoperfusion
610177|NCT00597545|Ischemia|ischemia
610178|NCT00597532|Breast Cancer|breast cancer
610179|NCT00597532|Soy|soy
610180|NCT00597532|Milk|milk
610181|NCT00597532|Supplementation|supplementation
610182|NCT00597532|02-062|02-062
610183|NCT00597519|Cancer|cancer
610184|NCT00597519|Leukemia|leukemia
610185|NCT00597519|Myelodysplastic Syndrome|myelodysplastic syndrome
610186|NCT00597519|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
610187|NCT00597519|Total Body Irradiation|total body irradiation
610188|NCT00597519|Umbilical Cord Blood Grafts|umbilical cord blood grafts
610189|NCT00597519|06-014|06-014
610190|NCT00597506|colorectal|colorectal
610191|NCT00597506|refractory|refractory
610192|NCT00597506|adenocarcinoma|adenocarcinoma
610193|NCT00597506|bevacizumab|bevacizumab
610194|NCT00597506|everolimus|everolimus
610195|NCT00597493|Recurrent Glioblastoma Multiforme|recurrent glioblastoma multiforme
610196|NCT00597493|GBM|gbm
610197|NCT00597493|Glioblastoma|glioblastoma
610198|NCT00597493|Sorafenib|sorafenib
610199|NCT00597493|Temozolomide|temozolomide
610200|NCT00597493|Brain Tumor|brain tumor
610201|NCT00597493|Recurrent GBM|recurrent gbm
610202|NCT00597493|Temodar|temodar
610203|NCT00597493|Gliosarcoma|gliosarcoma
610204|NCT00597493|Glioma|glioma
610205|NCT00597493|Nexavar|nexavar
610206|NCT00597480|Growth hormone|growth hormone
610207|NCT00597480|Child|child
610208|NCT00597480|insulin resistance|insulin resistance
610209|NCT00597480|metabolic syndrome X|metabolic syndrome x
610210|NCT00597480|children born small for gestational age|children born small for gestational age
610211|NCT00597467|myopia|myopia
610212|NCT00597467|hyperopia|hyperopia
610213|NCT00597467|extended wear|extended wear
610214|NCT00597467|ametropia|ametropia
610215|NCT00597454|Breast|breast
610216|NCT00597441|unrelated|unrelated
610217|NCT00597441|umbilical cord blood transplantation|umbilical cord blood transplantation
610218|NCT00597441|thymus transplantation|thymus transplantation
610219|NCT00597415|Osteoarthritis|osteoarthritis
610220|NCT00597415|Knee pain|knee pain
610221|NCT00597402|Avastin|avastin
610222|NCT00597402|Bevacizumab|bevacizumab
610223|NCT00597402|Temozolomide|temozolomide
610224|NCT00597402|Temodar|temodar
610225|NCT00597402|Irinotecan|irinotecan
610226|NCT00597402|Camptosar|camptosar
610227|NCT00597402|GBM|gbm
610228|NCT00597402|Glioblastoma Multiforme|glioblastoma multiforme
610229|NCT00597402|Gliosarcoma|gliosarcoma
610230|NCT00597402|Brain tumor|brain tumor
610231|NCT00597402|Glioma|glioma
610232|NCT00597402|New GBM|new gbm
610233|NCT00597402|Newly diagnosed GBM or gliosarcoma malignant brain tumor|newly diagnosed gbm or gliosarcoma malignant brain tumor
610234|NCT00597389|posttraumatic stress disorder|posttraumatic stress disorder
610235|NCT00597389|propranolol|propranolol
610236|NCT00597389|inderol|inderol
610237|NCT00597389|child|child
610238|NCT00597389|trauma|trauma
610239|NCT00597389|Posttraumatic stress disorders (PTSD)|posttraumatic stress disorders (ptsd)
610240|NCT00597376|memory loss|memory loss
610241|NCT00597363|vascular access site|vascular access site
610242|NCT00597363|arterial puncture|arterial puncture
610243|NCT00597363|femoral pseudoaneurysm|femoral pseudoaneurysm
610244|NCT00597350|Fenugreek|fenugreek
610245|NCT00597350|Trigonella foenum-graecum|trigonella foenum-graecum
610246|NCT00597350|Diabetes mellitus|diabetes mellitus
610247|NCT00597350|Blood sugar|blood sugar
610248|NCT00597350|Insulin|insulin
610249|NCT00597350|Glucose|glucose
610250|NCT00597337|bullying|bullying
610251|NCT00597337|victimisation|victimisation
610252|NCT00597337|aggressive behavior|aggressive behavior
610253|NCT00597324|Allen's test|allen's test
610254|NCT00597324|lactate|lactate
610255|NCT00597324|safety|safety
610256|NCT00597324|radial intervention|radial intervention
610257|NCT00597324|Patients with coronary artery disease|patients with coronary artery disease
610258|NCT00597311|rectal cancer|rectal cancer
610259|NCT00597311|radiotherapy|radiotherapy
610260|NCT00597311|radiochemotherapy|radiochemotherapy
610261|NCT00597298|diaphragmatic paralysis|diaphragmatic paralysis
610262|NCT00597298|cardiac surgery|cardiac surgery
610263|NCT00597298|respiratory muscle training|respiratory muscle training
610264|NCT00597285|18-F-Fluoro-2-Deoxy-D-Glucose (FDG)|18-f-fluoro-2-deoxy-d-glucose (fdg)
610265|NCT00597285|Magnetic Resonance|magnetic resonance
610266|NCT00597285|Epilepsy|epilepsy
610267|NCT00597285|HHV-6B|hhv-6b
610268|NCT00597285|Healthy Volunteer|healthy volunteer
610269|NCT00597285|HV|hv
610270|NCT00597272|melanoma|melanoma
610271|NCT00597272|resected local|resected local
610272|NCT00597272|systemic metastasis|systemic metastasis
610273|NCT00597259|hepatitis B, entecavir, pegylated interferon alfa-2a|hepatitis b, entecavir, pegylated interferon alfa-2a
610274|NCT00597246|Brain|brain
610275|NCT00597246|CNS|cns
610276|NCT00597246|Central Nervous System|central nervous system
610277|NCT00597207|CPR|cpr
610278|NCT00597207|mechanical|mechanical
610279|NCT00597207|manual|manual
610280|NCT00597207|outcome|outcome
610281|NCT00597207|survival|survival
610282|NCT00597207|quality|quality
610283|NCT00597194|inguinal hernia|inguinal hernia
610284|NCT00597194|laparoscopic repair|laparoscopic repair
610285|NCT00597194|open repair|open repair
610286|NCT00597194|randomized|randomized
610287|NCT00597181|Inflammatory response|inflammatory response
610288|NCT00597168|Schizophrenia|schizophrenia
610289|NCT00597168|atypical antipsychotic|atypical antipsychotic
610290|NCT00597168|quality of life|quality of life
610291|NCT00597168|ambulatory setting|ambulatory setting
610292|NCT00597142|renal stent|renal stent
610293|NCT00597142|stent|stent
610294|NCT00597142|atherosclerosis|atherosclerosis
610295|NCT00597142|aortorenal ostium|aortorenal ostium
610296|NCT00597142|renal|renal
610297|NCT00597142|renal artery|renal artery
610298|NCT00597142|PTRA|ptra
610299|NCT00597129|pancreatic cancer|pancreatic cancer
610300|NCT00597129|cancer of the pancreas|cancer of the pancreas
610301|NCT00597129|pancreas cancer|pancreas cancer
610302|NCT00597116|Mesothelioma|mesothelioma
610303|NCT00597116|inoperable|inoperable
610304|NCT00597116|relapsed|relapsed
610305|NCT00597103|Hemodialysis|hemodialysis
610306|NCT00597103|Frequent Hemodialysis|frequent hemodialysis
610307|NCT00597103|Sleep Apnea|sleep apnea
610308|NCT00597103|Restless Leg Syndrome|restless leg syndrome
610309|NCT00597103|Cognitive Function|cognitive function
610310|NCT00597090|Infections|infections
610311|NCT00597090|lymphoma|lymphoma
610312|NCT00597064|asthma|asthma
610313|NCT00597064|asthma control questionnaire|asthma control questionnaire
610314|NCT00597064|oral corticosteroid|oral corticosteroid
610315|NCT00597064|air trapping|air trapping
610316|NCT00597064|AQLQ|aqlq
610317|NCT00597064|control|control
610318|NCT00597064|quality of life|quality of life
610319|NCT00597038|Dasatinib|dasatinib
610320|NCT00597038|Dacarbazine|dacarbazine
610321|NCT00597025|Malnutrition|malnutrition
610322|NCT00597025|Hypoalbuminemia|hypoalbuminemia
610323|NCT00597025|Dietary Supplements|dietary supplements
610324|NCT00597025|Hemodialysis|hemodialysis
610325|NCT00597025|Peritoneal Dialysis|peritoneal dialysis
610326|NCT00597012|Meniscal Tear|meniscal tear
610327|NCT00597012|Osteoarthritis|osteoarthritis
610328|NCT00597012|Arthroscopic Partial Meniscectomy|arthroscopic partial meniscectomy
610329|NCT00597012|Physical Therapy|physical therapy
610330|NCT00596999|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
610331|NCT00596999|Acute myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
610332|NCT00596999|Acute Lymphocytic Leukemia (ALL)|acute lymphocytic leukemia (all)
610333|NCT00596999|Sickle Cell Disease (SCD)|sickle cell disease (scd)
610334|NCT00596999|Beta Thalassemia|beta thalassemia
610335|NCT00596999|Inborn Errors of Metabolism|inborn errors of metabolism
610336|NCT00596999|Severe Combined Immunodeficiency Disease (SCID)|severe combined immunodeficiency disease (scid)
610337|NCT00596986|Depression|depression
610338|NCT00596986|Duloxetine|duloxetine
610339|NCT00596986|Psychotherapy|psychotherapy
610340|NCT00596986|Magnetic Resonance Imaging|magnetic resonance imaging
610341|NCT00596960|Alcohol Abuse|alcohol abuse
610342|NCT00596960|Alcohol Dependence|alcohol dependence
610343|NCT00596960|Carbohydrate Deficient Transferrin|carbohydrate deficient transferrin
610344|NCT00596960|Drug Dependence|drug dependence
610345|NCT00596960|Hepatitis C|hepatitis c
610346|NCT00596960|Motivation|motivation
610347|NCT00596947|kidney transplantation|kidney transplantation
610348|NCT00596947|tacrolimus|tacrolimus
610349|NCT00596947|Prograf|prograf
610350|NCT00596947|mycophenolate mofetil|mycophenolate mofetil
610351|NCT00596947|CellCept|cellcept
610352|NCT00596947|corticosteroid withdrawal|corticosteroid withdrawal
610353|NCT00596947|prednisone withdrawal|prednisone withdrawal
610354|NCT00596947|prednisone maintenance|prednisone maintenance
610355|NCT00596947|rabbit antithymocyte globulin|rabbit antithymocyte globulin
610356|NCT00596947|Thymoglobulin|thymoglobulin
610357|NCT00596934|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
610358|NCT00596934|Insulin resistance|insulin resistance
610359|NCT00596934|Obesity|obesity
610360|NCT00596934|Leptin therapy|leptin therapy
610361|NCT00596934|NASH|nash
610362|NCT00596921|Ultrasonography|ultrasonography
610363|NCT00596921|Central Venous Pressure|central venous pressure
610364|NCT00596921|Noninvasive monitoring|noninvasive monitoring
610365|NCT00596921|Shock|shock
610366|NCT00596921|Resuscitation|resuscitation
610367|NCT00596908|Essential Tremor|essential tremor
610368|NCT00596908|Parkinsonian Tremor|parkinsonian tremor
610369|NCT00596908|Parkinson Disease|parkinson disease
610370|NCT00596908|Upper Extremity Tremor with duration of less than 2 years|upper extremity tremor with duration of less than 2 years
610371|NCT00596895|Isoflavone, PSA, prostate cancer, recurrent, quality of life|isoflavone, psa, prostate cancer, recurrent, quality of life
610372|NCT00596882|smoking cessation|smoking cessation
610373|NCT00596882|nicotine dependence|nicotine dependence
610374|NCT00596882|message prime|message prime
610375|NCT00596882|recruitment|recruitment
610376|NCT00596856|Early childhood caries - ECC|early childhood caries - ecc
610377|NCT00596856|Referral behavior|referral behavior
610378|NCT00596856|Oral health risk assessment|oral health risk assessment
610379|NCT00596856|Guideline development and dissemination|guideline development and dissemination
610380|NCT00596830|IGF-1R inhibitor|igf-1r inhibitor
610381|NCT00596830|Non-small-cell lung carcinoma|non-small-cell lung carcinoma
610382|NCT00596830|CP-751|cp-751
610383|NCT00596830|871|871
610384|NCT00596817|Relapse prevention|relapse prevention
610385|NCT00596817|Antidepressants|antidepressants
610386|NCT00596817|Placebo-controlled|placebo-controlled
610387|NCT00596817|Double-blind|double-blind
610388|NCT00596817|Multicentre study|multicentre study
610389|NCT00596804|NHL|nhl
610390|NCT00596804|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
610391|NCT00596804|follicular lymphoma|follicular lymphoma
610392|NCT00596804|B-cell lymphoma|b-cell lymphoma
610393|NCT00596804|diffuse large cell lymphoma|diffuse large cell lymphoma
610394|NCT00596804|small lymphoctytic lymphoma|small lymphoctytic lymphoma
610395|NCT00596804|Mantle cell lymphoma|mantle cell lymphoma
610396|NCT00596804|MALT|malt
610397|NCT00596804|marginal zone lymphoma|marginal zone lymphoma
610398|NCT00596804|High-Grade|high-grade
610399|NCT00596804|Intermediate-Grade|intermediate-grade
610400|NCT00596804|Low-Grade|low-grade
610401|NCT00596804|Mixed|mixed
610402|NCT00596778|Physical therapy specialty|physical therapy specialty
610403|NCT00596778|Postoperative period. Abdominal surgery|postoperative period. abdominal surgery
610404|NCT00596778|Anesthesia recovery period|anesthesia recovery period
610405|NCT00596778|Spirometry|spirometry
610406|NCT00596765|Brain Injury|brain injury
610407|NCT00596765|Neuropsychology|neuropsychology
610408|NCT00596765|Cognitive Behavioral Therapy|cognitive behavioral therapy
610409|NCT00596765|Neuropsychological Rehabilitation|neuropsychological rehabilitation
610410|NCT00596752|Alprostadil|alprostadil
610411|NCT00596752|Prostavasin|prostavasin
610412|NCT00596752|PAOD|paod
610413|NCT00596752|Fontaine Stage IV|fontaine stage iv
610414|NCT00596739|Bariatric surgery, weight loss surgery, male infertility, Roux-En-Y, gastric banding|bariatric surgery, weight loss surgery, male infertility, roux-en-y, gastric banding
610415|NCT00596726|All patients presenting for high-risk cardiac surgery and who might post-operatively meet the study inclusion criteria are potential study candidates.|all patients presenting for high-risk cardiac surgery and who might post-operatively meet the study inclusion criteria are potential study candidates.
610416|NCT00596713|general population|general population
610417|NCT00596700|Capsule endoscopy|capsule endoscopy
610418|NCT00596700|Crohn's disease|crohn's disease
610419|NCT00596700|IBD|ibd
610420|NCT00596700|Activity score|activity score
610421|NCT00596700|Small bowel|small bowel
610422|NCT00596700|Crohn's disease of the small bowel in any stage|crohn's disease of the small bowel in any stage
610423|NCT00596700|Recruiting|recruiting
610424|NCT00596687|diabetes|diabetes
610425|NCT00596687|post-op complications|post-op complications
610426|NCT00596687|inpatient hyperglycemia|inpatient hyperglycemia
610427|NCT00596674|Women|women
610428|NCT00596674|Fibromyalgia Syndrome|fibromyalgia syndrome
610429|NCT00596674|Health Behaviors|health behaviors
610430|NCT00596674|Quality of Life|quality of life
610431|NCT00596661|coronary stent|coronary stent
610432|NCT00596648|Lung Cancer|lung cancer
610433|NCT00596648|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
610434|NCT00596648|NSCLC|nsclc
610435|NCT00596635|UTI|uti
610436|NCT00596635|elderly|elderly
610437|NCT00596635|prevention|prevention
610438|NCT00596635|cranberry|cranberry
610439|NCT00596635|E.Coli|e.coli
610440|NCT00596622|Major Depressive or Manic Episodes|major depressive or manic episodes
610441|NCT00596622|Bipolar|bipolar
610442|NCT00596622|Mania|mania
610443|NCT00596622|Depression|depression
610444|NCT00596622|Lithium|lithium
610445|NCT00596622|fMRI|fmri
610446|NCT00596622|Pictures|pictures
610447|NCT00596622|Brain Scan|brain scan
610448|NCT00596609|Injections, intrathecal|injections, intrathecal
610449|NCT00596609|Transcranial|transcranial
610450|NCT00596609|Spinal Fusion|spinal fusion
610451|NCT00596609|Evoked Potentials, Motor|evoked potentials, motor
610452|NCT00596596|Constipation|constipation
610453|NCT00596596|prucalopride|prucalopride
610454|NCT00596570|Atrial fibrillation|atrial fibrillation
610455|NCT00596570|Oral Anticoagulation|oral anticoagulation
610456|NCT00596570|Percutaneous coronary intervention|percutaneous coronary intervention
610457|NCT00596557|Renal function, heart transplant, everolimus|renal function, heart transplant, everolimus
610458|NCT00596544|sexual dysfunction|sexual dysfunction
610459|NCT00596531|Tinnitus|tinnitus
610460|NCT00596531|acamprosate|acamprosate
610461|NCT00596531|clinical trial|clinical trial
610462|NCT00596505|proliferative diabetic retinopathy|proliferative diabetic retinopathy
610463|NCT00596505|bevacizumab (Avastin)|bevacizumab (avastin)
610464|NCT00596505|vitreous hemorrhage|vitreous hemorrhage
610465|NCT00596505|silicone oil|silicone oil
610466|NCT00596479|CAD|cad
610467|NCT00596479|G-CSF|g-csf
610468|NCT00596479|Collaterals|collaterals
610469|NCT00596479|CFI|cfi
610470|NCT00596479|perfusion|perfusion
610471|NCT00596466|open-label|open-label
610472|NCT00596466|extension study|extension study
610473|NCT00596466|pregabalin|pregabalin
610474|NCT00596466|partial epilepsy|partial epilepsy
610475|NCT00596453|Prostate Specific Antigen (PSA)|prostate specific antigen (psa)
610476|NCT00596453|Elevated Prostate Specific Antigen (PSA)|elevated prostate specific antigen (psa)
610477|NCT00596440|smoking|smoking
610478|NCT00596440|teachable moment|teachable moment
610479|NCT00596440|cancer|cancer
610480|NCT00596427|type two diabetes|type two diabetes
610481|NCT00596427|gluconeogenesis|gluconeogenesis
610482|NCT00596427|glucose|glucose
610483|NCT00596427|lipid synthesis|lipid synthesis
610484|NCT00596427|hepatic insulin sensitivity|hepatic insulin sensitivity
610485|NCT00596427|colesevelam HCl|colesevelam hcl
610486|NCT00596414|liver|liver
610487|NCT00596414|biopsy|biopsy
610488|NCT00596388|HMP, AMD, CNV, PHP, HPHP|hmp, amd, cnv, php, hphp
610489|NCT00596375|Lidocaine|lidocaine
610490|NCT00596375|Infant|infant
610491|NCT00596375|Urinary Catheterization|urinary catheterization
610492|NCT00596375|Emergency Medicine|emergency medicine
610493|NCT00596375|Analgesia|analgesia
610494|NCT00596362|Melanoma|melanoma
610495|NCT00596362|Eye|eye
610496|NCT00596362|Avastin|avastin
610497|NCT00596349|epithelial Ovarian Cancer|epithelial ovarian cancer
610498|NCT00596349|Quality of Life|quality of life
610499|NCT00596349|Survivorship|survivorship
610500|NCT00596323|antenna|antenna
610501|NCT00596323|continuous glucose monitoring|continuous glucose monitoring
610502|NCT00596323|electromagnetic|electromagnetic
610503|NCT00596310|Lung cancer|lung cancer
610504|NCT00596310|screening|screening
610505|NCT00596297|Diabetic Retinopathy|diabetic retinopathy
610506|NCT00596297|Vitreous Hemorrhage|vitreous hemorrhage
610507|NCT00596297|Bevacizumab|bevacizumab
610508|NCT00596297|pars plana vitrectomy|pars plana vitrectomy
610509|NCT00596297|preoperative|preoperative
610510|NCT00596284|Cognitive Behavior Therapy|cognitive behavior therapy
610511|NCT00596284|Alzheimer's Disease|alzheimer's disease
610512|NCT00596258|Cervical Intraepithelial Neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
610513|NCT00596258|High-grade Cervical Intraepithelial Neoplasia|high-grade cervical intraepithelial neoplasia
610514|NCT00596258|High-grade Squamous Intraepithelial Lesions (HSIL)|high-grade squamous intraepithelial lesions (hsil)
610515|NCT00596258|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
610516|NCT00596258|High-Grade Cervical Intraepithelial Lesions (CIN 2/3)|high-grade cervical intraepithelial lesions (cin 2/3)
610517|NCT00596245|non-smoking healthy volunteers aged 18 - 35|non-smoking healthy volunteers aged 18 - 35
610518|NCT00596219|HEAD|head
610519|NCT00596219|NECK|neck
610520|NCT00596219|SQUAMOUS|squamous
610521|NCT00596219|CARCINOMA|carcinoma
610522|NCT00596193|Hyperalgesia|hyperalgesia
610523|NCT00596193|nociceptors|nociceptors
610524|NCT00596193|Neurons|neurons
610525|NCT00596180|carbon monoxide poisoning|carbon monoxide poisoning
610526|NCT00596180|brain injury|brain injury
610527|NCT00596167|Short-daily hemodialysis|short-daily hemodialysis
610528|NCT00596167|pharmacokinetics|pharmacokinetics
610529|NCT00596167|levofloxacin|levofloxacin
610530|NCT00596167|gentamicin|gentamicin
610531|NCT00596167|vancomycin|vancomycin
610532|NCT00596141|oral periodontal gingival intraoral mucosal mucoperiosteal|oral periodontal gingival intraoral mucosal mucoperiosteal
610533|NCT00596141|Surgery, Oral|surgery, oral
610534|NCT00596128|Blood glucose|blood glucose
610535|NCT00596128|Clinical pathways|clinical pathways
610536|NCT00596076|Low back pain|low back pain
610537|NCT00596063|pharmacokinetics|pharmacokinetics
610538|NCT00596063|pharmacodynamics|pharmacodynamics
610539|NCT00596063|recombinant human insulin|recombinant human insulin
610540|NCT00596063|healthy volunteers|healthy volunteers
610541|NCT00596050|procedural sedation|procedural sedation
610542|NCT00596050|fracture reduction|fracture reduction
610543|NCT00596050|pediatric emergency medicine|pediatric emergency medicine
610544|NCT00596050|etomidate|etomidate
610545|NCT00596050|ketamine|ketamine
610546|NCT00596050|analgesia|analgesia
610547|NCT00596037|Growth hormone Deficiency|growth hormone deficiency
610548|NCT00596011|prostate cancer|prostate cancer
610549|NCT00596011|PIN|pin
610550|NCT00596011|polyphenon E|polyphenon e
610551|NCT00596011|EGCG|egcg
610552|NCT00595998|AMD, HMP, PHP|amd, hmp, php
610553|NCT00595985|Time to Progression|time to progression
610554|NCT00595985|Toxicity|toxicity
610555|NCT00595985|Overall survival|overall survival
610556|NCT00595985|Response rate|response rate
610557|NCT00595985|Quality of live|quality of live
610558|NCT00595985|Toxicities|toxicities
610559|NCT00595972|Time to Progression|time to progression
610560|NCT00595972|Overall survival|overall survival
610561|NCT00595972|Response rate|response rate
610562|NCT00595972|Quality of Live|quality of live
610563|NCT00595972|Toxicities|toxicities
610564|NCT00595933|Head and Neck cancer|head and neck cancer
610565|NCT00595933|Radiation therapy|radiation therapy
610566|NCT00595933|Dry mouth remedies|dry mouth remedies
610567|NCT00595933|Dry Mouth|dry mouth
610568|NCT00595933|Xerostomia|xerostomia
610569|NCT00595920|Tovaxin|tovaxin
610570|NCT00595920|Autologous|autologous
610571|NCT00595920|T-cell vaccine (TCV)|t-cell vaccine (tcv)
610572|NCT00595907|tuberculosis|tuberculosis
610573|NCT00595907|interferon gamma release assays|interferon gamma release assays
610574|NCT00595907|treatment|treatment
610575|NCT00595894|rheumatoid arthritis|rheumatoid arthritis
610576|NCT00595894|African Americans|african americans
610577|NCT00595894|osteopenia|osteopenia
610578|NCT00595894|osteoporosis|osteoporosis
610579|NCT00595894|bone mineral density|bone mineral density
610580|NCT00595881|Bedside emergency ultrasound|bedside emergency ultrasound
610581|NCT00595881|Abscess|abscess
610582|NCT00595881|Cellulitis|cellulitis
610583|NCT00595881|Soft tissue infection|soft tissue infection
610584|NCT00595881|Methicillin resistant staphylococcus aureus (MRSA)|methicillin resistant staphylococcus aureus (mrsa)
610585|NCT00595868|Nicotine|nicotine
610586|NCT00595868|Smoking|smoking
610587|NCT00595868|Smoking Cessation|smoking cessation
610588|NCT00595855|glaucoma|glaucoma
610589|NCT00595855|surgery|surgery
610590|NCT00595855|non penetrating procedures|non penetrating procedures
610591|NCT00595855|cataract|cataract
610592|NCT00595842|Mineral trioxide aggregate|mineral trioxide aggregate
610593|NCT00595829|Polycythemia Vera|polycythemia vera
610594|NCT00595829|PV|pv
610595|NCT00595816|low back pain|low back pain
610596|NCT00595816|physical fitness|physical fitness
610597|NCT00595816|injury|injury
610598|NCT00595816|prevention|prevention
610599|NCT00595816|conscripts|conscripts
610600|NCT00595777|Institutional change|institutional change
610601|NCT00595777|Improved pain management|improved pain management
610602|NCT00595764|Buprenorphine|buprenorphine
610603|NCT00595764|Buprenorphine/naloxone|buprenorphine/naloxone
610604|NCT00595764|Counseling|counseling
610605|NCT00595764|Primary care|primary care
610606|NCT00595751|ADHD, Attention Deficit Hyperactivity Disorder|adhd, attention deficit hyperactivity disorder
610607|NCT00595738|Congestive heart failure|congestive heart failure
610608|NCT00595738|Cardiac biomarkers|cardiac biomarkers
610609|NCT00595738|Hemodynamics|hemodynamics
610610|NCT00595738|Tailored therapy|tailored therapy
610611|NCT00595725|Cervix|cervix
610612|NCT00595725|Endometrium|endometrium
610613|NCT00595725|Cervical Carcinoma|cervical carcinoma
610614|NCT00595725|Lymphatic Mapping|lymphatic mapping
610615|NCT00595712|Genovarum|genovarum
610616|NCT00595712|Medial opening-wedge high tibial osteotomy|medial opening-wedge high tibial osteotomy
610617|NCT00595712|allograft|allograft
610618|NCT00595686|Hematologic Malignancies Hsp90 Hematologic Malignancy|hematologic malignancies hsp90 hematologic malignancy
610619|NCT00595673|Perfusion|perfusion
610620|NCT00595673|Echocardiograpy|echocardiograpy
610621|NCT00595673|SPECT|spect
610622|NCT00595673|angiography|angiography
610623|NCT00595673|Chest pain|chest pain
610624|NCT00595660|Palpable Breast Mass|palpable breast mass
610625|NCT00595660|FNA|fna
610626|NCT00595660|Cytology|cytology
610627|NCT00595660|Fine needle aspiration|fine needle aspiration
610628|NCT00595660|Specimen Adequacy|specimen adequacy
610629|NCT00595634|Hip|hip
610630|NCT00595634|Fracture|fracture
610631|NCT00595634|Intertrochanteric|intertrochanteric
610632|NCT00595634|intramedullary|intramedullary
610633|NCT00595608|aftercare|aftercare
610634|NCT00595608|nasal septum|nasal septum
610635|NCT00595608|turbinates|turbinates
610636|NCT00595595|Dental Pulp|dental pulp
610637|NCT00595595|Regenerative Medicine|regenerative medicine
610638|NCT00595595|Odontoblasts|odontoblasts
610639|NCT00595595|Stem Cells|stem cells
610640|NCT00595595|Growth factor differentiation of stem/progenitor cells|growth factor differentiation of stem/progenitor cells
610641|NCT00595595|Odontoblast-specific cell phenotypes|odontoblast-specific cell phenotypes
610642|NCT00595569|flexible insulin therapy|flexible insulin therapy
610643|NCT00595569|diabetes education|diabetes education
610644|NCT00595569|diabetes|diabetes
610645|NCT00595569|insulin|insulin
610646|NCT00595569|Weekly ambulatory sessions|weekly ambulatory sessions
610647|NCT00595556|Zonisamide|zonisamide
610648|NCT00595556|Pharmacotherapy|pharmacotherapy
610649|NCT00595556|Alcohol dependence|alcohol dependence
610650|NCT00595556|anticonvulsant|anticonvulsant
610651|NCT00595530|ketamine|ketamine
610652|NCT00595530|vasoocclusive pain|vasoocclusive pain
610653|NCT00595517|gastrointestinal|gastrointestinal
610654|NCT00595517|GI|gi
610655|NCT00595517|NSAID|nsaid
610656|NCT00595517|Japan|japan
610657|NCT00595517|Japanese|japanese
610658|NCT00595517|Gastric ulcer|gastric ulcer
610659|NCT00595517|duodenal ulcer|duodenal ulcer
610660|NCT00595504|schizophrenia|schizophrenia
610661|NCT00595504|metabolism|metabolism
610662|NCT00595504|antipsychotics|antipsychotics
610663|NCT00595504|diabetes|diabetes
610664|NCT00595504|rozerem|rozerem
610665|NCT00595491|Asthma|asthma
610666|NCT00595491|Inflammation|inflammation
610667|NCT00595491|Allergic|allergic
610668|NCT00595491|Airway|airway
610669|NCT00595491|Challenge|challenge
610670|NCT00595491|Chemokines|chemokines
610671|NCT00595439|Sensory Evoked Potentials (SEPs)|sensory evoked potentials (seps)
610672|NCT00595439|Electromyogram|electromyogram
610673|NCT00595439|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
610674|NCT00595439|Complex Regional Pain Syndrome|complex regional pain syndrome
610675|NCT00595439|Focal Hand Dystonia|focal hand dystonia
610676|NCT00595439|Focal Dystonia|focal dystonia
610677|NCT00595439|Chronic Regional Pain Syndrome|chronic regional pain syndrome
610678|NCT00595439|CRPS|crps
610679|NCT00595426|Knee Arthroplasty|knee arthroplasty
610680|NCT00595426|Factor Xa|factor xa
610681|NCT00595426|VTE|vte
610682|NCT00595426|Thrombosis|thrombosis
610683|NCT00595426|Anticoagulants|anticoagulants
610684|NCT00595413|Rheumatoid arthritis|rheumatoid arthritis
610685|NCT00595413|Atacicept|atacicept
610686|NCT00595413|Adalimumab|adalimumab
610687|NCT00595413|Humira®|humira®
610688|NCT00595387|Cognitive Behavioral Therapy|cognitive behavioral therapy
610689|NCT00595361|asthma|asthma
610690|NCT00595361|exercise induced asthma|exercise induced asthma
610691|NCT00595361|exercise induced bronchoconstriction|exercise induced bronchoconstriction
610692|NCT00595361|long acting beta agonist|long acting beta agonist
610693|NCT00595361|salmeterol|salmeterol
610694|NCT00595361|exercise challenge|exercise challenge
610695|NCT00595361|bronchoprotection|bronchoprotection
610696|NCT00595361|beta 2 adrenergic receptor polymorphisms|beta 2 adrenergic receptor polymorphisms
610697|NCT00595361|pharmacogenetics|pharmacogenetics
610698|NCT00595335|Thyroid-associated ophthalmopathy|thyroid-associated ophthalmopathy
610699|NCT00595335|Rituximab|rituximab
610700|NCT00595335|Proptosis|proptosis
610701|NCT00595322|Bevacizumab|bevacizumab
610702|NCT00595322|Radiation Treatment|radiation treatment
610703|NCT00595322|Brain Cancer|brain cancer
610704|NCT00595296|BreastCancer|breastcancer
610705|NCT00595296|Sentinel Lymph Nodes|sentinel lymph nodes
610706|NCT00595296|Metastasis|metastasis
610707|NCT00595283|Preschool Onset Major Depressive Disorder|preschool onset major depressive disorder
610708|NCT00595283|Preschool Depression|preschool depression
610709|NCT00595283|Emotion Development|emotion development
610710|NCT00595283|Parent Child Interaction|parent child interaction
610711|NCT00595257|PAD, CLI, Critical Limb Ischemia, bone marrow, stem cell, injection, infusion|pad, cli, critical limb ischemia, bone marrow, stem cell, injection, infusion
610712|NCT00595244|Perfusion|perfusion
610713|NCT00595244|Echocardiograpy|echocardiograpy
610714|NCT00595244|SPECT|spect
610715|NCT00595244|angiography|angiography
610716|NCT00595244|Chest pain|chest pain
610717|NCT00595231|GAD|gad
610718|NCT00595218|Patient Preferences|patient preferences
610719|NCT00595218|Patient Satisfaction|patient satisfaction
610720|NCT00595218|Patient-Doctor Relationship|patient-doctor relationship
610721|NCT00595205|vaccination|vaccination
610722|NCT00595205|intussusception|intussusception
610723|NCT00595205|Rotavirus|rotavirus
610724|NCT00595205|vaccine|vaccine
610725|NCT00595179|Infrared|infrared
610726|NCT00595179|Imaging Techniques|imaging techniques
610727|NCT00595179|Kidney Reperfusion|kidney reperfusion
610728|NCT00595179|Pneumoperitoneum|pneumoperitoneum
610729|NCT00595179|Nephrectomy|nephrectomy
610730|NCT00595166|Women with excessive vaginal tissue that obstruct the examiner's view of the cervix during a vaginal speculum examination|women with excessive vaginal tissue that obstruct the examiner's view of the cervix during a vaginal speculum examination
610731|NCT00595140|Acromegaly,|acromegaly,
610732|NCT00595140|growth hormone receptor antagonist,|growth hormone receptor antagonist,
610733|NCT00595140|somatostatin analogue,|somatostatin analogue,
610734|NCT00595140|combined medical treatment,|combined medical treatment,
610735|NCT00595140|acute effect,|acute effect,
610736|NCT00595140|endogenous GH|endogenous gh
610737|NCT00595127|Fanconi|fanconi
610738|NCT00595127|Anemia|anemia
610739|NCT00595127|Stem Cell|stem cell
610740|NCT00595127|Transplant|transplant
610741|NCT00595114|COPD|copd
610742|NCT00595114|Airway|airway
610743|NCT00595114|Inflammation|inflammation
610744|NCT00595114|Infection|infection
610745|NCT00595114|Lipid Mediators|lipid mediators
610746|NCT00595114|Oxidative Stress|oxidative stress
610747|NCT00595088|Bladder Cancer|bladder cancer
610748|NCT00595088|Refractory|refractory
610749|NCT00595075|sleep|sleep
610750|NCT00595075|performance|performance
610751|NCT00595075|night shift|night shift
610752|NCT00595075|Ramelteon|ramelteon
610753|NCT00595075|Healthy Individuals|healthy individuals
610754|NCT00595062|Breast|breast
610755|NCT00595062|Cancer|cancer
610756|NCT00595049|pulmonary|pulmonary
610757|NCT00595049|arterial|arterial
610758|NCT00595049|artery|artery
610759|NCT00595049|hypertension|hypertension
610760|NCT00595049|systemic|systemic
610761|NCT00595049|sclerosis|sclerosis
610762|NCT00595049|scleroderma|scleroderma
610763|NCT00595049|remodelling|remodelling
610764|NCT00595049|bosentan|bosentan
610765|NCT00595049|tracleer|tracleer
610766|NCT00595049|intravascular|intravascular
610767|NCT00595023|Sentinel lymph node|sentinel lymph node
610768|NCT00595023|Metastasis|metastasis
610769|NCT00595010|Child Maltreatment|child maltreatment
610770|NCT00595010|Child Neglect|child neglect
610771|NCT00595010|Child Physical Abuse|child physical abuse
610772|NCT00595010|Evidence-Based Practice|evidence-based practice
610773|NCT00594997|Lyme disease|lyme disease
610774|NCT00594997|educational intervention for children|educational intervention for children
610775|NCT00594997|tick borne illness|tick borne illness
610776|NCT00594997|prophylactic therapy in children|prophylactic therapy in children
610777|NCT00594997|Self-efficacy|self-efficacy
610778|NCT00594997|tick prevention|tick prevention
610779|NCT00594997|tick avoidance|tick avoidance
610780|NCT00594997|health behavior modification|health behavior modification
610781|NCT00594971|Health Services Research|health services research
610782|NCT00594971|Family practice|family practice
610783|NCT00594932|lupus, arthritis, mycophenolate, biomarkers|lupus, arthritis, mycophenolate, biomarkers
610784|NCT00594919|acute kidney injury|acute kidney injury
610785|NCT00594919|ngal|ngal
610786|NCT00594919|cardiac surgery|cardiac surgery
610787|NCT00594906|Fracture Healing|fracture healing
610788|NCT00594906|Teriparatide|teriparatide
610789|NCT00594906|Forteo|forteo
610790|NCT00594906|Pelvic Fractures|pelvic fractures
610791|NCT00594893|Hip|hip
610792|NCT00594893|Arthroplasty|arthroplasty
610793|NCT00594893|Minimally Invasive|minimally invasive
610794|NCT00594880|HIV|hiv
610795|NCT00594880|HIV-1|hiv-1
610796|NCT00594880|Pegasys|pegasys
610797|NCT00594880|Peg-IFN-Alpha-2A|peg-ifn-alpha-2a
610798|NCT00594880|Viral Suppression|viral suppression
610799|NCT00594880|ART cessation|art cessation
610800|NCT00594880|Immune function|immune function
610801|NCT00594880|Innate Immunity|innate immunity
610802|NCT00594880|Toxicity|toxicity
610803|NCT00594880|Immune-based therapy|immune-based therapy
610804|NCT00594880|Treatment interruption|treatment interruption
610805|NCT00594867|Healthy|healthy
610806|NCT00594867|Volunteer|volunteer
610807|NCT00594854|NSAID|nsaid
610808|NCT00594854|Gastric Ulcer|gastric ulcer
610809|NCT00594854|High risk|high risk
610810|NCT00594854|Arthrotec|arthrotec
610811|NCT00594854|Vimovo|vimovo
610812|NCT00594841|Acromioclavicular Joint|acromioclavicular joint
610813|NCT00594841|Shoulder dislocation|shoulder dislocation
610814|NCT00594841|AC dislocation|ac dislocation
610815|NCT00594828|Patient self-testing|patient self-testing
610816|NCT00594828|Oral anticoagulation therapy|oral anticoagulation therapy
610817|NCT00594828|Expert Systems|expert systems
610818|NCT00594828|Point-of-Care Systems|point-of-care systems
610819|NCT00594828|International Normalized Ratio|international normalized ratio
610820|NCT00594815|Lymphoma|lymphoma
610821|NCT00594815|Central Nervous System|central nervous system
610822|NCT00594802|ALLERGIC REACTION|allergic reaction
610823|NCT00594789|Osteoporosis|osteoporosis
610824|NCT00594789|Fractures|fractures
610825|NCT00594789|Bone densitometry|bone densitometry
610826|NCT00594789|Dual-energy x-ray absorptiometry|dual-energy x-ray absorptiometry
610827|NCT00594776|Cone Beam CT|cone beam ct
610828|NCT00594776|CBCT|cbct
610829|NCT00594776|Bone Tumors|bone tumors
610830|NCT00594776|Autographs|autographs
610831|NCT00594776|Allographs|allographs
610832|NCT00594763|Turner syndrome|turner syndrome
610833|NCT00594763|Thromboembolic disease|thromboembolic disease
610834|NCT00594737|PET|pet
610835|NCT00594737|frontotemporal dementia|frontotemporal dementia
610836|NCT00594737|memantine|memantine
610837|NCT00594737|Pick's disease|pick's disease
610838|NCT00594724|Tongue|tongue
610839|NCT00594724|Carcinoma|carcinoma
610840|NCT00594724|Cancer|cancer
610841|NCT00594724|02-093|02-093
610842|NCT00594711|Psychotherapy|psychotherapy
610843|NCT00594711|depression|depression
610844|NCT00594698|Perfusion|perfusion
610845|NCT00594698|Echocardiography|echocardiography
610846|NCT00594698|Cardiac angiography|cardiac angiography
610847|NCT00594698|SPECT|spect
610848|NCT00594685|Heparin|heparin
610849|NCT00594685|Thromboembolism|thromboembolism
610850|NCT00594685|Thrombosis|thrombosis
610851|NCT00594672|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
610852|NCT00594672|Cataracts|cataracts
610853|NCT00594672|Age Related Macular Degeneration|age related macular degeneration
610854|NCT00594672|AMD|amd
610855|NCT00594672|Cataract|cataract
610856|NCT00594659|Marijuana|marijuana
610857|NCT00594659|Treatment|treatment
610858|NCT00594659|Behavioral|behavioral
610859|NCT00594659|Computer|computer
610860|NCT00594659|Internet|internet
610861|NCT00594646|HIV Prevention|hiv prevention
610862|NCT00594646|Non-occupational post-exposure prophylaxis|non-occupational post-exposure prophylaxis
610863|NCT00594646|HIV seronegativity|hiv seronegativity
610864|NCT00594633|Cognitive dysfunction|cognitive dysfunction
610865|NCT00594607|clotting|clotting
610866|NCT00594607|hemodialysis|hemodialysis
610867|NCT00594607|anticoagulation|anticoagulation
610868|NCT00594607|bleeding risk|bleeding risk
610869|NCT00594594|spinal cord injury|spinal cord injury
610870|NCT00594594|urinary tract infection|urinary tract infection
610871|NCT00594594|probiotics|probiotics
610872|NCT00594594|Lactobacilli|lactobacilli
610873|NCT00594581|cicatrix, scarring, TGF-beta3, avotermin, Juvista|cicatrix, scarring, tgf-beta3, avotermin, juvista
610874|NCT00594555|Blood disease, bone marrow|blood disease, bone marrow
610875|NCT00594555|AML|aml
610876|NCT00594555|CML,Blast Crisis|cml,blast crisis
610877|NCT00594542|lidocaine|lidocaine
610878|NCT00594542|local anesthesia|local anesthesia
610879|NCT00594542|Mohs micrographic surgery|mohs micrographic surgery
610880|NCT00594529|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
610881|NCT00594529|Metastatic liver lesions from colorectal cancers|metastatic liver lesions from colorectal cancers
610882|NCT00594516|Low Back Pain|low back pain
610883|NCT00594516|Dose Equivalence|dose equivalence
610884|NCT00594516|Tapentadol (CG5503)|tapentadol (cg5503)
610885|NCT00594516|Tapentadol-IR|tapentadol-ir
610886|NCT00594516|Tapentadol-ER|tapentadol-er
610887|NCT00594503|traumatic brain injury|traumatic brain injury
610888|NCT00594490|Breast, reconstruction, silicone|breast, reconstruction, silicone
610889|NCT00594477|IMRT|imrt
610890|NCT00594477|breast cancer with regional nodal metastasis|breast cancer with regional nodal metastasis
610891|NCT00594464|Rotigotine|rotigotine
610892|NCT00594464|NEUPRO®|neupro®
610893|NCT00594464|Parkinson's Disease (PD)|parkinson's disease (pd)
610894|NCT00594464|perioperative use|perioperative use
610895|NCT00594464|anaesthesia,|anaesthesia,
610896|NCT00594451|rheumatoid arthritis|rheumatoid arthritis
610897|NCT00594451|cigarette smoking|cigarette smoking
610898|NCT00594451|gene-environmental interactions|gene-environmental interactions
610899|NCT00594451|autoimmunity|autoimmunity
610900|NCT00594451|disease severity|disease severity
610901|NCT00594438|Synthes Reamer-Irrigator-Aspirator (RIA)|synthes reamer-irrigator-aspirator (ria)
610902|NCT00594438|Zimmer Sentinal Reamer|zimmer sentinal reamer
610903|NCT00594438|Transesophageal Echocardiogram (TEE)|transesophageal echocardiogram (tee)
610904|NCT00594412|1H-Magnetic Resonance Spectroscopy|1h-magnetic resonance spectroscopy
610905|NCT00594412|Hepatic Steatosis|hepatic steatosis
610906|NCT00594412|Liver Fat|liver fat
610907|NCT00594412|Liver Biopsy|liver biopsy
610908|NCT00594412|Liver|liver
610909|NCT00594412|Hepatitis|hepatitis
610910|NCT00594412|Fatty Liver|fatty liver
610911|NCT00594399|Aging|aging
610912|NCT00594399|Exercise|exercise
610913|NCT00594399|Impaired Glucose Tolerance|impaired glucose tolerance
610914|NCT00594399|Obesity|obesity
610915|NCT00594399|Functional Status|functional status
610916|NCT00594399|Disability|disability
610917|NCT00594399|Health Services Research|health services research
610918|NCT00594399|Randomized Controlled Trial|randomized controlled trial
610919|NCT00594399|Diabetes|diabetes
611111|NCT00593411|MD Analyze|md analyze
610920|NCT00594399|Adaptive Randomization Design|adaptive randomization design
610921|NCT00594386|Rotigotine|rotigotine
610922|NCT00594386|Neupro|neupro
610923|NCT00594373|Microbicide|microbicide
610924|NCT00594373|HIV Seronegativity|hiv seronegativity
610925|NCT00594360|Exercise Prescription|exercise prescription
610926|NCT00594360|Self-efficacy|self-efficacy
610927|NCT00594360|Decisional Balance|decisional balance
610928|NCT00594360|Readiness to Change|readiness to change
610929|NCT00594360|Physical Activity|physical activity
610930|NCT00594347|Streptococcus pneumoniae|streptococcus pneumoniae
610931|NCT00594334|osteopenia|osteopenia
610932|NCT00594334|periodontitis|periodontitis
610933|NCT00594321|spinal fractures|spinal fractures
610934|NCT00594269|Antidepressants|antidepressants
610935|NCT00594269|Antipsychotics|antipsychotics
610936|NCT00594269|Dementia|dementia
610937|NCT00594269|Discontinuation study|discontinuation study
610938|NCT00594269|Behavioural- and Psychological Symptoms in Dementia|behavioural- and psychological symptoms in dementia
610939|NCT00594256|Schizophrenia|schizophrenia
610940|NCT00594256|Sleep Architecture|sleep architecture
610941|NCT00594256|Sodium Oxybate|sodium oxybate
610942|NCT00594256|Insomnia|insomnia
610943|NCT00594256|Cognition|cognition
610944|NCT00594230|Myelodysplastic Syndromes (MDS)|myelodysplastic syndromes (mds)
610945|NCT00594230|Refractory|refractory
610946|NCT00594230|LBH589|lbh589
610947|NCT00594217|PCOS|pcos
610948|NCT00594191|Statins|statins
610949|NCT00594191|HMG-CoA reductase inhibitors|hmg-coa reductase inhibitors
610950|NCT00594191|Cirrhosis|cirrhosis
610951|NCT00594191|Portal hypertension|portal hypertension
610952|NCT00594191|Variceal bleeding|variceal bleeding
610953|NCT00594178|spinal cord injury|spinal cord injury
610954|NCT00594165|Rotigotine|rotigotine
610955|NCT00594152|Diabetic autonomic neuropathy|diabetic autonomic neuropathy
610956|NCT00594139|non-neurogenic over active bladder|non-neurogenic over active bladder
610957|NCT00594139|urge predominant incontinence|urge predominant incontinence
610958|NCT00594126|Myeloma|myeloma
610959|NCT00594126|Multiple Myeloma|multiple myeloma
610960|NCT00594126|Relapsed Multiple Myeloma|relapsed multiple myeloma
610961|NCT00594126|Refractory Multiple Myeloma|refractory multiple myeloma
610962|NCT00594126|Relapsed or Refractory Multiple Myeloma|relapsed or refractory multiple myeloma
610963|NCT00594100|carotid artery stenosis|carotid artery stenosis
610964|NCT00594100|embolic protection device|embolic protection device
610965|NCT00594100|GORE Neuro Protection System|gore neuro protection system
610966|NCT00594100|GORE Flow Reversal System|gore flow reversal system
610967|NCT00594100|reverse flow|reverse flow
610968|NCT00594100|proximal occlusion device|proximal occlusion device
610969|NCT00594100|GNPS|gnps
610970|NCT00594100|Parodi|parodi
610971|NCT00594100|EMPiRE|empire
610972|NCT00594100|distal embolization|distal embolization
610973|NCT00594100|minimizing risks of CAS|minimizing risks of cas
610974|NCT00594100|PAES|paes
610975|NCT00594048|high blood pressure|high blood pressure
610976|NCT00594035|Spinal procedure|spinal procedure
610977|NCT00594035|Dura incision|dura incision
610978|NCT00594022|Electric Stimulation|electric stimulation
610979|NCT00594022|Latency to Persistent Sleep (LPS)|latency to persistent sleep (lps)
610980|NCT00594022|Transient Insomnia|transient insomnia
610981|NCT00594022|Insomnia|insomnia
610982|NCT00593970|influenza|influenza
610983|NCT00593970|vaccine|vaccine
610984|NCT00593970|pregnancy|pregnancy
610985|NCT00593957|Rett Syndrome|rett syndrome
610986|NCT00593957|Dextromethorphan|dextromethorphan
610987|NCT00593944|CLL|cll
610988|NCT00593944|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
610989|NCT00593944|B cell|b cell
610990|NCT00593944|leukemia|leukemia
610991|NCT00593944|lymphocyte|lymphocyte
610992|NCT00593944|antibody|antibody
610993|NCT00593944|monoclonal|monoclonal
610994|NCT00593944|cancer|cancer
610995|NCT00593944|blood|blood
610996|NCT00593931|Brain functional MRI|brain functional mri
610997|NCT00593918|RSV, asthma, innate immunity, gene, cytokines|rsv, asthma, innate immunity, gene, cytokines
610998|NCT00593905|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
610999|NCT00593905|Pulmonary Hypertension|pulmonary hypertension
611000|NCT00593905|Pharmacogenomics|pharmacogenomics
611001|NCT00593905|DNA Testing|dna testing
611002|NCT00593905|sitaxsentan|sitaxsentan
611003|NCT00593905|bosentan|bosentan
611004|NCT00593905|ambrisentan|ambrisentan
611005|NCT00593905|elevated pulmonary artery pressures|elevated pulmonary artery pressures
611006|NCT00593905|Letairis|letairis
611007|NCT00593905|Tracleer|tracleer
611008|NCT00593905|Thelin|thelin
611009|NCT00593905|Primary Pulmonary Hypertension|primary pulmonary hypertension
611010|NCT00593905|Pulmonary Artery|pulmonary artery
611011|NCT00593892|Cytokine Levels|cytokine levels
611012|NCT00593892|Traumatic Injury|traumatic injury
611013|NCT00593892|Multisystem Organ Failure|multisystem organ failure
611014|NCT00593879|MDD|mdd
611015|NCT00593879|Depression|depression
611016|NCT00593879|Mecamylamine|mecamylamine
611017|NCT00593879|Add-on Therapy|add-on therapy
611018|NCT00593879|Major Depressive Disorder|major depressive disorder
611019|NCT00593866|Patients who have confirmed cancer arising from the pancreas|patients who have confirmed cancer arising from the pancreas
611020|NCT00593853|LHRH-agonist related fatigue|lhrh-agonist related fatigue
611021|NCT00593801|extremely low birth weight infants|extremely low birth weight infants
611022|NCT00593801|transfusion need|transfusion need
611023|NCT00593801|erythropoietin|erythropoietin
611024|NCT00593801|trace elements|trace elements
611025|NCT00593801|antioxidant enzymes|antioxidant enzymes
611026|NCT00593801|reduction of the transfusion need by EPO treatment|reduction of the transfusion need by epo treatment
611027|NCT00593801|trace elements and antioxidant enzymes in blood|trace elements and antioxidant enzymes in blood
611028|NCT00593788|GIN test|gin test
611029|NCT00593788|gap detection|gap detection
611030|NCT00593788|temporal resolution|temporal resolution
611031|NCT00593788|auditory perception|auditory perception
611032|NCT00593788|psychoacoustics|psychoacoustics
611033|NCT00593775|implantation rate|implantation rate
611034|NCT00593762|Peripheral arterial occlusive disease|peripheral arterial occlusive disease
611035|NCT00593762|Aspirin|aspirin
611036|NCT00593762|Clopidogrel|clopidogrel
611037|NCT00593762|Resistance|resistance
611038|NCT00593762|Catheter interventional procedure|catheter interventional procedure
611039|NCT00593762|ASA and clopidogrel resistance|asa and clopidogrel resistance
611040|NCT00593749|obesity prevention|obesity prevention
611041|NCT00593749|corner stores|corner stores
611042|NCT00593749|schools|schools
611043|NCT00593736|Delayed sleep phase syndrome; drug therapy|delayed sleep phase syndrome; drug therapy
611044|NCT00593723|IMRT|imrt
611045|NCT00593710|Randomized|randomized
611046|NCT00593710|double-blind superiority trial|double-blind superiority trial
611047|NCT00593697|breast cancer|breast cancer
611048|NCT00593697|adjuvant therapy|adjuvant therapy
611049|NCT00593697|trastuzumab|trastuzumab
611050|NCT00593697|chemotherapy|chemotherapy
611051|NCT00593684|neonate|neonate
611052|NCT00593684|central lines|central lines
611053|NCT00593684|very low birth weight|very low birth weight
611054|NCT00593684|silver alginate|silver alginate
611055|NCT00593671|aneuploidies in 7 chromosomes increased with advanced maternal age|aneuploidies in 7 chromosomes increased with advanced maternal age
611056|NCT00593658|hypoxemia|hypoxemia
611057|NCT00593658|liver transplantation evaluation|liver transplantation evaluation
611058|NCT00593658|cirrhosis|cirrhosis
611059|NCT00593645|Conditioning regimens|conditioning regimens
611060|NCT00593645|Stem Cell Transplantation|stem cell transplantation
611061|NCT00593645|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
611062|NCT00593645|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
611063|NCT00593645|Nonmyeloablative conditioning|nonmyeloablative conditioning
611064|NCT00593645|Clofarabine|clofarabine
611065|NCT00593645|Cytarabine|cytarabine
611066|NCT00593645|Anti-thymocyte globulin|anti-thymocyte globulin
611067|NCT00593632|low HDL|low hdl
611068|NCT00593619|Intravenous Iron|intravenous iron
611069|NCT00593619|Safety|safety
611070|NCT00593619|Perioperative|perioperative
611071|NCT00593619|Iron deficiency|iron deficiency
611072|NCT00593619|Non hemodialysis population|non hemodialysis population
611073|NCT00593619|Perioperative blood conservation|perioperative blood conservation
611074|NCT00593606|Rotigotine|rotigotine
611075|NCT00593606|NEUPRO|neupro
611076|NCT00593606|Switching trial from ropinirole to rotigotine,|switching trial from ropinirole to rotigotine,
611077|NCT00593606|safety and tolerability|safety and tolerability
611078|NCT00593606|Parkinson disease|parkinson disease
611079|NCT00593593|benign prostate hyperplasia|benign prostate hyperplasia
611080|NCT00593593|Dutasteride|dutasteride
611081|NCT00593593|pharmacovigilance|pharmacovigilance
611082|NCT00593580|Ovarian cancer|ovarian cancer
611083|NCT00593580|bone mineral density|bone mineral density
611084|NCT00593580|bisphosphonates|bisphosphonates
611085|NCT00593580|chemotherapy|chemotherapy
611086|NCT00593567|Diabetic Foot Ulcer|diabetic foot ulcer
611087|NCT00593541|MRI|mri
611088|NCT00593528|Cirrhosis, STIC TIPS, Portal Hypertension, Transjugular Intrahepatic Portosystemic Shunt , Stents, PTFE|cirrhosis, stic tips, portal hypertension, transjugular intrahepatic portosystemic shunt , stents, ptfe
611089|NCT00593528|cirrhotic HTP|cirrhotic htp
611090|NCT00593502|influenza|influenza
611091|NCT00593502|children|children
611092|NCT00593502|acute otitis media|acute otitis media
611093|NCT00593502|oseltamivir|oseltamivir
611094|NCT00593489|Insulin|insulin
611095|NCT00593489|Diabetes Mellitus|diabetes mellitus
611096|NCT00593489|Practice Behaviour|practice behaviour
611097|NCT00593489|Preceptor|preceptor
611098|NCT00593489|Pharmacy|pharmacy
611099|NCT00593476|Type 2 Diabetes|type 2 diabetes
611100|NCT00593476|Glycemic Control|glycemic control
611101|NCT00593476|Diabetes Support and Education|diabetes support and education
611102|NCT00593476|Portion Control|portion control
611103|NCT00593476|Prepackaged meals|prepackaged meals
611104|NCT00593463|opioid dependence|opioid dependence
611105|NCT00593463|methadone|methadone
611106|NCT00593463|opioid|opioid
611107|NCT00593450|bevacizumab|bevacizumab
611108|NCT00593450|ranibizumab|ranibizumab
611109|NCT00593450|choroidal neovascularization|choroidal neovascularization
611110|NCT00593437|bone density diagnostic equipment discrepancies|bone density diagnostic equipment discrepancies
611112|NCT00593411|Central Nervous System|central nervous system
611113|NCT00593411|Spine Disease|spine disease
611114|NCT00593411|Peripheral Nerve|peripheral nerve
611116|NCT00593398|pregnant women|pregnant women
611117|NCT00593398|infants|infants
611118|NCT00593398|Cameroon|cameroon
611119|NCT00593385|Symptomatic claudication or rest pain and angiographic confirmation of either de novo or restenotic lesions in the common and/or external iliac artery.|symptomatic claudication or rest pain and angiographic confirmation of either de novo or restenotic lesions in the common and/or external iliac artery.
611120|NCT00593372|Alzheimer's Disease|alzheimer's disease
611121|NCT00593372|Memory|memory
611122|NCT00593372|Treatment|treatment
611123|NCT00593359|Spinal surgery|spinal surgery
611124|NCT00593359|Prone spinal surgery|prone spinal surgery
611125|NCT00593333|Femur Fracture|femur fracture
611126|NCT00593333|Intramedullary Nailing|intramedullary nailing
611127|NCT00593333|Trochanteric Nailing|trochanteric nailing
611128|NCT00593333|Piriformis Starting Portal|piriformis starting portal
611129|NCT00593333|Trochanteric Insertion Portal|trochanteric insertion portal
611130|NCT00593320|SRS|srs
611131|NCT00593307|glycemic response|glycemic response
611132|NCT00593307|hunger|hunger
611133|NCT00593294|PCOS|pcos
611134|NCT00593294|oral contraceptives|oral contraceptives
611135|NCT00593294|physical exercise|physical exercise
611136|NCT00593294|CVR|cvr
611137|NCT00593281|Hyaluronidase|hyaluronidase
611138|NCT00593281|Hylenex|hylenex
611139|NCT00593281|subcutaneous|subcutaneous
611140|NCT00593281|morphine|morphine
611141|NCT00593281|absorption|absorption
611142|NCT00593281|bioavailability|bioavailability
611143|NCT00593281|PK study of morphine in patients with pain|pk study of morphine in patients with pain
611144|NCT00593242|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
611145|NCT00593242|autologous cord blood cells|autologous cord blood cells
611146|NCT00593242|newborn infants|newborn infants
611147|NCT00593229|Thrombotic microangiopathy (TMA)|thrombotic microangiopathy (tma)
611148|NCT00593229|Hemolytic uremic syndrome (HUS)|hemolytic uremic syndrome (hus)
611149|NCT00593229|Thrombotic thrombocytopenic purpura (TTP)|thrombotic thrombocytopenic purpura (ttp)
611150|NCT00593216|functional magnetic Resonance Imaging|functional magnetic resonance imaging
611151|NCT00593216|vertigo|vertigo
611152|NCT00593216|vestibular|vestibular
611153|NCT00593177|Plaque psoriasis|plaque psoriasis
611154|NCT00593177|Psoriasis|psoriasis
611155|NCT00593164|Hypothermia, Induced|hypothermia, induced
611156|NCT00593164|Death, Sudden, Cardiac|death, sudden, cardiac
611157|NCT00593164|Resuscitation|resuscitation
611158|NCT00593164|Coma|coma
611159|NCT00593151|Antimetabolites|antimetabolites
611160|NCT00593151|Virus Diseases|virus diseases
611161|NCT00593151|Anti-Infective Agents|anti-infective agents
611162|NCT00593151|RNA Virus Infections|rna virus infections
611163|NCT00593151|Digestive System Diseases|digestive system diseases
611164|NCT00593151|Flaviviridae Infections|flaviviridae infections
611165|NCT00593151|Antineoplastic Agents|antineoplastic agents
611166|NCT00593151|Therapeutic Uses|therapeutic uses
611167|NCT00593151|Antiviral Agents|antiviral agents
611168|NCT00593151|Molecular Mechanisms of Action|molecular mechanisms of action
611169|NCT00593151|Pharmacologic Actions|pharmacologic actions
611170|NCT00593138|Focalin XR|focalin xr
611171|NCT00593138|Adult|adult
611172|NCT00593138|PET scan|pet scan
611173|NCT00593125|cocaine|cocaine
611174|NCT00593125|opioids|opioids
611175|NCT00593125|heroin|heroin
611176|NCT00593125|levetiracetam|levetiracetam
611177|NCT00593112|HMRS Scanning|hmrs scanning
611178|NCT00593112|ADHD|adhd
611179|NCT00593112|Child|child
611180|NCT00593112|Adolescent|adolescent
611181|NCT00593112|HMRS Scans|hmrs scans
611182|NCT00593099|Bipolar Disorder|bipolar disorder
611183|NCT00593099|Nicotine Dependence|nicotine dependence
611184|NCT00593099|Smoking Cessation|smoking cessation
611185|NCT00593099|Bupropion, sustained-release|bupropion, sustained-release
611186|NCT00593086|wound care|wound care
611187|NCT00593060|Temsirolimus|temsirolimus
611188|NCT00593060|cetuximab|cetuximab
611189|NCT00593060|metastatic disease|metastatic disease
611190|NCT00593047|hypercholesterolemia|hypercholesterolemia
611191|NCT00593034|Alcohol abuse|alcohol abuse
611192|NCT00593034|Drug abuse|drug abuse
611193|NCT00593021|Obscure Gastrointestinal Bleeding|obscure gastrointestinal bleeding
611194|NCT00593021|Occult Gastrointestinal Bleeding|occult gastrointestinal bleeding
611195|NCT00593021|Overt Gastrointestinal Bleeding|overt gastrointestinal bleeding
611196|NCT00593021|Capsule Endoscopy|capsule endoscopy
611197|NCT00593021|CT Enterography|ct enterography
611198|NCT00593008|metastatic pancreatic cancer|metastatic pancreatic cancer
611199|NCT00592943|Adults|adults
611200|NCT00592943|Healthy Volunteers|healthy volunteers
611201|NCT00592943|Nuvigil|nuvigil
611202|NCT00592943|Armodafinil|armodafinil
611203|NCT00592943|DAT occupancy in healthy volunteers|dat occupancy in healthy volunteers
611204|NCT00592930|anorexia nervosa, treatment, adolescents, olanzapine|anorexia nervosa, treatment, adolescents, olanzapine
611205|NCT00592917|osteoporosis|osteoporosis
611206|NCT00592917|fractures|fractures
611207|NCT00592917|risk of fracture|risk of fracture
611208|NCT00592917|vitamin-D|vitamin-d
611209|NCT00592917|calcium|calcium
611210|NCT00592917|falls|falls
611211|NCT00592917|bone mineral density|bone mineral density
611212|NCT00592917|bone metabolism|bone metabolism
611213|NCT00592904|Neuralgia|neuralgia
611214|NCT00592904|neuropathy|neuropathy
611215|NCT00592891|brain injury|brain injury
611216|NCT00592891|brain disorders|brain disorders
611217|NCT00592852|bipolar disorder|bipolar disorder
611218|NCT00592852|obsessive compulsive disorder|obsessive compulsive disorder
611219|NCT00592852|Prozac|prozac
611220|NCT00592839|Nocturnal vasomotor symptoms in postmenopausal women|nocturnal vasomotor symptoms in postmenopausal women
611221|NCT00592826|PHP|php
611222|NCT00592826|HMP|hmp
611223|NCT00592826|HPHP|hphp
611224|NCT00592826|AMD|amd
611225|NCT00592826|CNV|cnv
611226|NCT00592813|rehabilitation|rehabilitation
611227|NCT00592813|function|function
611228|NCT00592800|statistics|statistics
611229|NCT00592800|probability|probability
611230|NCT00592774|Post-Herpetic Neuralgia|post-herpetic neuralgia
611231|NCT00592774|PHN)|phn)
611232|NCT00592761|Deglutition Disorders|deglutition disorders
611233|NCT00592761|Mendelsohn Maneuver|mendelsohn maneuver
611234|NCT00592761|SEMG|semg
611235|NCT00592748|charged particle radiation therapy|charged particle radiation therapy
611236|NCT00592696|Adolescent depression|adolescent depression
611237|NCT00592696|Adolescent smoking|adolescent smoking
611238|NCT00592683|bipolar disorder|bipolar disorder
611239|NCT00592683|fish oil|fish oil
611240|NCT00592683|aripiprazole|aripiprazole
611241|NCT00592683|children|children
611242|NCT00592657|retrospective chart review|retrospective chart review
611243|NCT00592657|Jimsonweed ingestion|jimsonweed ingestion
611244|NCT00592644|ectasia|ectasia
611245|NCT00592644|vascular lesions|vascular lesions
611246|NCT00592644|vocal cords|vocal cords
611247|NCT00592644|voice|voice
611248|NCT00592644|pulsed dye laser|pulsed dye laser
611249|NCT00592631|asthma|asthma
611250|NCT00592631|sleep apnea|sleep apnea
611251|NCT00592618|ESRD|esrd
611252|NCT00592618|Hemodialysis|hemodialysis
611253|NCT00592618|Sleep Apnea|sleep apnea
611254|NCT00592592|pediatric rhabdomyosarcoma|pediatric rhabdomyosarcoma
611255|NCT00592592|proton radiation therapy|proton radiation therapy
611256|NCT00592566|Severe leptospirosis|severe leptospirosis
611257|NCT00592566|Pulmonary hemorrhage|pulmonary hemorrhage
611258|NCT00592553|Duchenne muscular dystrophy|duchenne muscular dystrophy
611259|NCT00592553|Becker muscular dystrophy|becker muscular dystrophy
611260|NCT00592553|Nonsense mutation|nonsense mutation
611261|NCT00592553|Premature stop codon|premature stop codon
611262|NCT00592553|DMD/BMD|dmd/bmd
611263|NCT00592553|PTC124|ptc124
611264|NCT00592514|Patients undergoing head and neck surgery that involves the upper aerodigestive tract|patients undergoing head and neck surgery that involves the upper aerodigestive tract
611265|NCT00592501|proton radiation|proton radiation
611266|NCT00592501|photon radiation|photon radiation
611267|NCT00592501|5-FU|5-fu
611268|NCT00592501|cisplatin|cisplatin
611269|NCT00592488|Septic shock|septic shock
611270|NCT00592488|Acetyl-L-carnitine|acetyl-l-carnitine
611271|NCT00592475|conivaptan|conivaptan
611272|NCT00592475|Liver Cirrhosis|liver cirrhosis
611273|NCT00592475|Hypertension, Portal|hypertension, portal
611274|NCT00592462|Breast Cancer|breast cancer
611275|NCT00592462|Whole Body MRI|whole body mri
611276|NCT00592462|Magnetic Resonance Imaging|magnetic resonance imaging
611277|NCT00592462|Metastases|metastases
611278|NCT00592449|Insomnia|insomnia
611279|NCT00592449|Knee pain|knee pain
611280|NCT00592449|Osteoarthritis|osteoarthritis
611281|NCT00592449|Arthritis|arthritis
611282|NCT00592449|Sleep|sleep
611283|NCT00592436|ADHD|adhd
611284|NCT00592436|pediatric|pediatric
611285|NCT00592436|children|children
611286|NCT00592423|Lateral neck rotation|lateral neck rotation
611287|NCT00592423|Continuous Positive Airway Pressure|continuous positive airway pressure
611288|NCT00592397|Dietary Intervention|dietary intervention
611289|NCT00592397|Nutrigenomics|nutrigenomics
611290|NCT00592397|Diet, Carbohydrate-Restricted|diet, carbohydrate-restricted
611291|NCT00592397|Gene Expression|gene expression
611292|NCT00592397|Gene Expression Profiling|gene expression profiling
611293|NCT00592397|Oligonucleotide Array Sequence Analysis|oligonucleotide array sequence analysis
611294|NCT00592397|Biological Markers|biological markers
611295|NCT00592397|Food|food
611296|NCT00592397|Obesity|obesity
611297|NCT00592397|Blood|blood
611298|NCT00592397|Subcutaneous Fat, Abdominal|subcutaneous fat, abdominal
611299|NCT00592384|spinal cord injuries|spinal cord injuries
611300|NCT00592384|major depressive disorder|major depressive disorder
611301|NCT00592384|dysthymia|dysthymia
611302|NCT00592384|antidepressant agents|antidepressant agents
611303|NCT00592384|pain|pain
611304|NCT00592384|quality of life|quality of life
611305|NCT00592384|muscle spasticity|muscle spasticity
611306|NCT00592384|community participation|community participation
611307|NCT00592384|anxiety|anxiety
611308|NCT00592358|bipolar disorder|bipolar disorder
611309|NCT00592358|children|children
611310|NCT00592358|adolescents|adolescents
611311|NCT00592358|Invega|invega
611312|NCT00592345|sarcoma of the thoracic/lumbar/spine/sacrum|sarcoma of the thoracic/lumbar/spine/sacrum
611313|NCT00592345|paraspinal soft tissues|paraspinal soft tissues
611314|NCT00592345|proton radiation therapy|proton radiation therapy
611315|NCT00592345|photon radiation therapy|photon radiation therapy
611316|NCT00592345|radiation applicator plaque|radiation applicator plaque
611317|NCT00592319|Papilloma|papilloma
611318|NCT00592319|pulsed dye laser|pulsed dye laser
611319|NCT00592319|Celebrex|celebrex
611320|NCT00592319|voice|voice
611321|NCT00592306|ATG|atg
611322|NCT00592306|rabbit thymoglobulin|rabbit thymoglobulin
611323|NCT00592306|reperfusion lung injury|reperfusion lung injury
611324|NCT00592306|primary graft dysfunction|primary graft dysfunction
611325|NCT00592306|lung transplantation|lung transplantation
611326|NCT00592293|proton beam radiation|proton beam radiation
611327|NCT00592280|Pancreas transplantation|pancreas transplantation
611328|NCT00592280|graft pancreatitis|graft pancreatitis
611329|NCT00592280|Two-layer method|two-layer method
611330|NCT00592280|organ preservation|organ preservation
611331|NCT00592267|pediatric|pediatric
611332|NCT00592267|bipolar disorder|bipolar disorder
611333|NCT00592254|ADHD|adhd
611334|NCT00592254|Adults|adults
611335|NCT00592241|Insulin Pump|insulin pump
611336|NCT00592228|intermediate lesion|intermediate lesion
611337|NCT00592228|drug-eluting stent|drug-eluting stent
611338|NCT00592228|fractional flow reserve|fractional flow reserve
611339|NCT00592215|Second trimester labor induction|second trimester labor induction
611340|NCT00592202|Morbid obesity|morbid obesity
611341|NCT00592202|Adolescents|adolescents
611342|NCT00592202|Gastric restrictive procedure|gastric restrictive procedure
611343|NCT00592202|Adjustable gastric band|adjustable gastric band
611344|NCT00592202|Treatment|treatment
611345|NCT00592189|Burns|burns
611346|NCT00592189|Wound healing|wound healing
611347|NCT00592189|Amnion|amnion
611348|NCT00592163|Cancer|cancer
611349|NCT00592163|Arsenic|arsenic
611350|NCT00592150|Essential Hypertension|essential hypertension
611351|NCT00592137|calcium carbonate|calcium carbonate
611352|NCT00592137|obesity|obesity
611353|NCT00592137|dairy|dairy
611354|NCT00592137|energy expenditure|energy expenditure
611355|NCT00592124|Microbicide|microbicide
611356|NCT00592124|HIV Seronegativity|hiv seronegativity
611357|NCT00592111|Pediatric|pediatric
611358|NCT00592111|Hodgkin's Disease|hodgkin's disease
611359|NCT00592111|96-016|96-016
611360|NCT00592098|Lower limb amputation at least 6 months prior to inclusion|lower limb amputation at least 6 months prior to inclusion
611361|NCT00592098|Presenting with moderate-to-severe pain intensity|presenting with moderate-to-severe pain intensity
611362|NCT00592098|Outpatients, aged 18 years and above|outpatients, aged 18 years and above
611363|NCT00592085|Tobacco Use|tobacco use
611364|NCT00592085|Smoking|smoking
611365|NCT00592085|Alcohol Use|alcohol use
611366|NCT00592085|Smoking Cessation|smoking cessation
611367|NCT00592072|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
611368|NCT00592072|Medium Chain Fatty Acid|medium chain fatty acid
611369|NCT00592072|Hypoglycemia|hypoglycemia
611370|NCT00592046|Phase I|phase i
611371|NCT00592046|Hematologic Cancers|hematologic cancers
611372|NCT00592046|Blood Cancers|blood cancers
611373|NCT00592046|Leukemia|leukemia
611374|NCT00592046|multiple myeloma|multiple myeloma
611375|NCT00592046|myelodysplasia (MDS)|myelodysplasia (mds)
611376|NCT00592046|Relapsed/refractory leukemia or lymphoma|relapsed/refractory leukemia or lymphoma
611377|NCT00592033|COPD oxygen|copd oxygen
611378|NCT00592033|COPD rehabilitation|copd rehabilitation
611379|NCT00592033|exercise|exercise
611380|NCT00592020|kidney|kidney
611381|NCT00592020|transplantation|transplantation
611382|NCT00592020|minimal invasive|minimal invasive
611383|NCT00592020|short transverse|short transverse
611384|NCT00592020|hockey stick|hockey stick
611385|NCT00592020|incision|incision
611386|NCT00592020|quality of life|quality of life
611387|NCT00592020|planned kidney transplantation|planned kidney transplantation
611388|NCT00592007|Non Small Cell Lung Cancer|non small cell lung cancer
611389|NCT00592007|Stage IIIB|stage iiib
611390|NCT00592007|Stage IV|stage iv
611391|NCT00592007|Stable on Erlotinib|stable on erlotinib
611392|NCT00592007|Exhibit Positivity for Estrogen or Progesterone Receptor|exhibit positivity for estrogen or progesterone receptor
611393|NCT00591994|tinnitus|tinnitus
611394|NCT00591994|piribedil|piribedil
611395|NCT00591994|acoustic otoemissions|acoustic otoemissions
611396|NCT00591994|ECoG|ecog
611397|NCT00591981|Geriatric|geriatric
611398|NCT00591981|Thoracic|thoracic
611399|NCT00591981|neoplasm|neoplasm
611400|NCT00591981|(Patients over 70 years of age) Geriatric oncology patients with thoracic neoplasms of the lung, esophagus, pleura and thymus.|(patients over 70 years of age) geriatric oncology patients with thoracic neoplasms of the lung, esophagus, pleura and thymus.
611401|NCT00591968|ultrasound|ultrasound
611402|NCT00591968|telediagnosis|telediagnosis
611403|NCT00591968|teleultrasound|teleultrasound
611404|NCT00591968|telesonography|telesonography
611405|NCT00591968|teleultrasonography|teleultrasonography
611406|NCT00591968|teleradiology|teleradiology
611508|NCT00591604|burn|burn
611407|NCT00591968|telemedicine|telemedicine
611408|NCT00591968|dominican republic|dominican republic
611409|NCT00591968|puntacana|puntacana
611410|NCT00591968|veron|veron
611411|NCT00591968|store-and-forward|store-and-forward
611412|NCT00591968|asynchronous|asynchronous
611413|NCT00591955|geriatric|geriatric
611414|NCT00591955|sepsis|sepsis
611415|NCT00591955|outcome assessment(healthcare)|outcome assessment(healthcare)
611416|NCT00591942|dental cement|dental cement
611417|NCT00591942|ceramic crowns|ceramic crowns
611418|NCT00591942|three-unit bridges|three-unit bridges
611419|NCT00591942|sensitivity|sensitivity
611420|NCT00591916|burn|burn
611421|NCT00591916|donor site|donor site
611422|NCT00591916|grafting|grafting
611423|NCT00591916|scar|scar
611424|NCT00591903|Diabetes and Cardiac Proteomics|diabetes and cardiac proteomics
611425|NCT00591903|Atrial Appendage and Proteomics|atrial appendage and proteomics
611426|NCT00591903|Diabetic Cardiomyopathy|diabetic cardiomyopathy
611427|NCT00591903|Tissue Sample|tissue sample
611428|NCT00591877|GERDCAM: Complementary and alternative medicine|gerdcam: complementary and alternative medicine
611429|NCT00591877|NERD: non-erosive reflux disease|nerd: non-erosive reflux disease
611430|NCT00591877|GERD: gastroesophageal reflux disease|gerd: gastroesophageal reflux disease
611431|NCT00591877|AC: acupuncture|ac: acupuncture
611432|NCT00591877|SAC: sham acupuncture|sac: sham acupuncture
611433|NCT00591877|LES: lower esophageal sphincter pressure|les: lower esophageal sphincter pressure
611434|NCT00591877|TLESR: transient lower esophageal sphincter relaxation|tlesr: transient lower esophageal sphincter relaxation
611435|NCT00591877|Acupuncture|acupuncture
611436|NCT00591877|Yoga|yoga
611437|NCT00591864|Benign breast disease|benign breast disease
611438|NCT00591864|Breast|breast
611439|NCT00591864|MRI|mri
611440|NCT00591864|Mammography|mammography
611441|NCT00591864|Ultrasound|ultrasound
611442|NCT00591864|Molecular Breast Imaging|molecular breast imaging
611443|NCT00591864|Breast Cancer|breast cancer
611444|NCT00591851|breast cancer|breast cancer
611445|NCT00591851|adenocarcinoma of the breast|adenocarcinoma of the breast
611446|NCT00591851|cardiac safety|cardiac safety
611447|NCT00591851|Breast cancer patients seen at the Memorial Sloan-Kettering Cancer Center|breast cancer patients seen at the memorial sloan-kettering cancer center
611448|NCT00591838|SBRT|sbrt
611449|NCT00591773|Blood pressure|blood pressure
611450|NCT00591773|Blood pressure monitoring, ambulatory|blood pressure monitoring, ambulatory
611451|NCT00591760|Heart Failure|heart failure
611452|NCT00591760|Growth Hormone|growth hormone
611453|NCT00591760|Anabolism|anabolism
611454|NCT00591760|Anabolic Deficiency|anabolic deficiency
611455|NCT00591760|Hormone replacement|hormone replacement
611456|NCT00591747|randomized clinical trial|randomized clinical trial
611457|NCT00591747|elderly|elderly
611458|NCT00591747|cancer survivor|cancer survivor
611459|NCT00591747|bone health|bone health
611460|NCT00591747|body composition|body composition
611461|NCT00591747|signs and symptoms|signs and symptoms
611462|NCT00591734|Metastatic Melanoma|metastatic melanoma
611463|NCT00591734|Everolimus|everolimus
611464|NCT00591734|RAD001|rad001
611465|NCT00591734|Bevacizumab|bevacizumab
611466|NCT00591721|energy conservation education|energy conservation education
611467|NCT00591721|occupational therapy intervention|occupational therapy intervention
611468|NCT00591721|fatigue management|fatigue management
611469|NCT00591721|psychoeducation|psychoeducation
611470|NCT00591708|calcium|calcium
611471|NCT00591708|bone|bone
611472|NCT00591708|bone density|bone density
611473|NCT00591708|adolescence|adolescence
611474|NCT00591695|Malignant Colorectal Obstruction|malignant colorectal obstruction
611475|NCT00591695|Stent Bridge to Surgery|stent bridge to surgery
611476|NCT00591669|Inflammatory bowel disease|inflammatory bowel disease
611477|NCT00591669|Crohn's disease|crohn's disease
611478|NCT00591643|Adrenal tumors|adrenal tumors
611479|NCT00591643|Adrenal malignancies|adrenal malignancies
611480|NCT00591643|abnormal hormonal secretions|abnormal hormonal secretions
611481|NCT00591643|electrolytes abnormalities|electrolytes abnormalities
611482|NCT00591643|Imaging|imaging
611483|NCT00591643|Scanning|scanning
611484|NCT00591643|tumor localization|tumor localization
611485|NCT00591630|Diffuse Large Cell Lymphoma|diffuse large cell lymphoma
611486|NCT00591630|Lymphoma|lymphoma
611487|NCT00591630|Zevalin|zevalin
611488|NCT00591630|Ibritumomab|ibritumomab
611489|NCT00591630|IDEC-Y2B8|idec-y2b8
611490|NCT00591630|Carmustine|carmustine
611491|NCT00591630|BCNU|bcnu
611492|NCT00591630|BiCNU|bicnu
611493|NCT00591630|Etoposide|etoposide
611494|NCT00591630|VePesid|vepesid
611495|NCT00591630|Cytarabine|cytarabine
611496|NCT00591630|Ara-C|ara-c
611497|NCT00591630|Cytosar|cytosar
611498|NCT00591630|DepoCyt|depocyt
611499|NCT00591630|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
611500|NCT00591630|Melphalan|melphalan
611501|NCT00591630|Rituximab|rituximab
611502|NCT00591630|Rituxan|rituxan
611503|NCT00591630|BEAM|beam
611504|NCT00591617|Opioids|opioids
611505|NCT00591617|drug dependence|drug dependence
611506|NCT00591617|drug abuse|drug abuse
611507|NCT00591617|treatment|treatment
611509|NCT00591604|vitamin D|vitamin d
611510|NCT00591604|nutrition|nutrition
611511|NCT00591604|burn recovery|burn recovery
611512|NCT00591591|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
611513|NCT00591591|sleep disordered breathing|sleep disordered breathing
611514|NCT00591591|polysomnography (psg)|polysomnography (psg)
611515|NCT00591591|continuous positive airway pressure (cpap)|continuous positive airway pressure (cpap)
611516|NCT00591591|brain vascular autoregulation|brain vascular autoregulation
611517|NCT00591591|brain tissue oxygenation|brain tissue oxygenation
611518|NCT00591591|near-infrared spectroscopy|near-infrared spectroscopy
611519|NCT00591591|Obstructive Sleep Apnea|obstructive sleep apnea
611520|NCT00591578|Blood pressure|blood pressure
611521|NCT00591578|blood pressure monitoring, ambulatory|blood pressure monitoring, ambulatory
611522|NCT00591565|Anxiety|anxiety
611523|NCT00591565|SSRI|ssri
611524|NCT00591565|SNRI|snri
611525|NCT00591565|Acamprosate|acamprosate
611526|NCT00591552|Lung cancer|lung cancer
611527|NCT00591552|Lymph node dissection|lymph node dissection
611528|NCT00591539|Carotid Artery Disease|carotid artery disease
611529|NCT00591539|Intima-Media Thickening|intima-media thickening
611530|NCT00591539|Carotid Ultrasound|carotid ultrasound
611531|NCT00591539|Pediatric Cancer Survivors|pediatric cancer survivors
611532|NCT00591539|Cancer Survivors|cancer survivors
611533|NCT00591539|Head or Neck Cancer|head or neck cancer
611534|NCT00591539|Radiation Therapy|radiation therapy
611536|NCT00591513|burns|burns
611537|NCT00591513|burn scars|burn scars
611538|NCT00591513|congenital giant nevi|congenital giant nevi
611539|NCT00591500|Melanoma|melanoma
611540|NCT00591500|Skin cancer|skin cancer
611541|NCT00591500|Genetic Susceptibility|genetic susceptibility
611542|NCT00591500|polymorphisms|polymorphisms
611543|NCT00591487|suction|suction
611544|NCT00591487|assisted|assisted
611545|NCT00591487|lipectomy|lipectomy
611546|NCT00591487|liposuction|liposuction
611547|NCT00591487|contour|contour
611548|NCT00591487|cosmetic|cosmetic
611549|NCT00591487|plastic|plastic
611550|NCT00591487|surgery|surgery
611551|NCT00591487|Klein|klein
611552|NCT00591487|tumescent|tumescent
611553|NCT00591487|technique|technique
611554|NCT00591487|Healthy women wanting Suction Assisted Lipectomy|healthy women wanting suction assisted lipectomy
611555|NCT00591474|VRE|vre
611556|NCT00591474|Probiotics|probiotics
611557|NCT00591474|colonization|colonization
611558|NCT00591474|gut health|gut health
611559|NCT00591461|Barrett's Esophagus|barrett's esophagus
611560|NCT00591461|Upper Endoscopy|upper endoscopy
611561|NCT00591461|Esophageal biopsies|esophageal biopsies
611562|NCT00591461|Accuracy|accuracy
611563|NCT00591461|Interobserver Agreement|interobserver agreement
611564|NCT00591448|Thermal injury|thermal injury
611565|NCT00591435|Anesthesia|anesthesia
611566|NCT00591435|Surgery|surgery
611567|NCT00591435|Education|education
611568|NCT00591435|Economics|economics
611569|NCT00591422|Arsenic|arsenic
611570|NCT00591422|Cancer|cancer
611571|NCT00591383|Cancer|cancer
611572|NCT00591383|Indibulin|indibulin
611573|NCT00591383|Erlotinib|erlotinib
611574|NCT00591370|Memorial Sloan-Kettering Cancer Center patients with measurable, unresectable stage|memorial sloan-kettering cancer center patients with measurable, unresectable stage
611575|NCT00591370|III or IV melanoma|iii or iv melanoma
611576|NCT00591357|Antibiotic associated diarrhea|antibiotic associated diarrhea
611577|NCT00591357|Clostridium difficile|clostridium difficile
611578|NCT00591357|loperamide|loperamide
611579|NCT00591344|Parkinson's disease|parkinson's disease
611580|NCT00591344|exercise|exercise
611581|NCT00591331|Head Lice|head lice
611582|NCT00591318|Ceftriaxone|ceftriaxone
611583|NCT00591318|Psychosis|psychosis
611584|NCT00591318|Schizophrenia|schizophrenia
611585|NCT00591318|Schizoaffective Disorder|schizoaffective disorder
611586|NCT00591305|papilloma|papilloma
611587|NCT00591305|PDL|pdl
611588|NCT00591305|diindolylmethane|diindolylmethane
611589|NCT00591305|recurrence|recurrence
611590|NCT00591292|cancer|cancer
611591|NCT00591292|tumor|tumor
611592|NCT00591292|solid tumor|solid tumor
611593|NCT00591292|advanced tumor|advanced tumor
611594|NCT00591279|large bowel cancer|large bowel cancer
611595|NCT00591279|polyps|polyps
611596|NCT00591279|colorectal cancer|colorectal cancer
611597|NCT00591266|Blood pressure|blood pressure
611598|NCT00591266|blood pressure monitoring ambulatory|blood pressure monitoring ambulatory
611599|NCT00591266|Drug Therapy|drug therapy
611600|NCT00591253|Blood pressure|blood pressure
611601|NCT00591253|blood pressure monitoring ambulatory|blood pressure monitoring ambulatory
611602|NCT00591253|Drug Therapy|drug therapy
611603|NCT00591240|RNA, ribosomal, 16S|rna, ribosomal, 16s
611604|NCT00591240|Biosensing techniques|biosensing techniques
611605|NCT00591240|Microchip analytical procedures|microchip analytical procedures
611606|NCT00591214|Chronic Hepatitis C|chronic hepatitis c
611607|NCT00591214|Protease Inhibitor|protease inhibitor
611608|NCT00591201|Spondylarthritis|spondylarthritis
611609|NCT00591201|TNF|tnf
611610|NCT00591201|Infliximab|infliximab
611611|NCT00591201|Ankylosing spondylitis|ankylosing spondylitis
611612|NCT00591201|Juvenile SpA|juvenile spa
611613|NCT00591201|Juvenile arthritis|juvenile arthritis
611614|NCT00591188|kidney cancer, capecitabine, interferon|kidney cancer, capecitabine, interferon
611615|NCT00591162|Bone, Dexa, Parathyroid, Diuretic, Tetracycline|bone, dexa, parathyroid, diuretic, tetracycline
611616|NCT00591149|cancer|cancer
611617|NCT00591149|head and neck cancer|head and neck cancer
611618|NCT00591149|squamous cell cancer|squamous cell cancer
611619|NCT00591123|Unresectable|unresectable
611620|NCT00591123|Metastatic|metastatic
611621|NCT00591123|Esophagus|esophagus
611622|NCT00591123|Gastric Cardia|gastric cardia
611623|NCT00591097|urine|urine
611624|NCT00591097|pediatric|pediatric
611625|NCT00591097|Normal urine from healthy pediatric population|normal urine from healthy pediatric population
611626|NCT00591084|randomized trial|randomized trial
611627|NCT00591084|ischemic stroke|ischemic stroke
611628|NCT00591084|Ginsenoside-Rd|ginsenoside-rd
611629|NCT00591071|hyperglycemia|hyperglycemia
611630|NCT00591071|insulin treatment|insulin treatment
611631|NCT00591071|intensive care|intensive care
611632|NCT00591071|hypoglycemia|hypoglycemia
611633|NCT00591071|mechanical ventilation|mechanical ventilation
611634|NCT00591071|critically ill patients|critically ill patients
611635|NCT00591058|recurrent glioma|recurrent glioma
611636|NCT00591058|Phase I|phase i
611637|NCT00591058|Multi-Center|multi-center
611638|NCT00591058|Open label|open label
611639|NCT00591058|Brain Cancer|brain cancer
611640|NCT00591058|Brain tumor|brain tumor
611641|NCT00591058|GBM|gbm
611642|NCT00591058|Glioma|glioma
611643|NCT00591058|Glioblastoma multiforme|glioblastoma multiforme
611644|NCT00591045|gastric adenocarcinoma|gastric adenocarcinoma
611645|NCT00591045|neoadjuvant chemotherapy|neoadjuvant chemotherapy
611646|NCT00591045|efficacy|efficacy
611647|NCT00591045|safety|safety
611648|NCT00591045|chemotherapy|chemotherapy
611649|NCT00591032|Critical illness|critical illness
611650|NCT00591032|Euthyroid sick syndromes|euthyroid sick syndromes
611651|NCT00591032|Intensive care|intensive care
611652|NCT00591032|Non-thyroidal illness syndrome|non-thyroidal illness syndrome
611653|NCT00591032|Low-T3 syndrome|low-t3 syndrome
611654|NCT00591019|P50, Psychomotor Vigilance Test (PVT), Arousal, Reaction Time|p50, psychomotor vigilance test (pvt), arousal, reaction time
611655|NCT00591006|Phenytoin|phenytoin
611656|NCT00591006|Dilantin|dilantin
611657|NCT00591006|Corticosteroid|corticosteroid
611658|NCT00591006|Neuroprotection|neuroprotection
611659|NCT00591006|Mania|mania
611660|NCT00591006|Cognition|cognition
611661|NCT00591006|Mood|mood
611662|NCT00591006|Memory|memory
611663|NCT00591006|Hydrocortisone|hydrocortisone
611664|NCT00591006|Healthy Controls|healthy controls
611665|NCT00591006|MRI|mri
611666|NCT00591006|hippocampal activation|hippocampal activation
611667|NCT00590993|MRSI|mrsi
611668|NCT00590993|MRI|mri
611669|NCT00590993|Prostate Cancer|prostate cancer
611670|NCT00590980|Stroke|stroke
611671|NCT00590980|TIA (transient ischemic attack)|tia (transient ischemic attack)
611672|NCT00590980|Brain|brain
611673|NCT00590980|Blood Flow|blood flow
611674|NCT00590980|Quantitative magnetic resonance angiography (QMRA)|quantitative magnetic resonance angiography (qmra)
611675|NCT00590967|para-aortic lymph nodes|para-aortic lymph nodes
611676|NCT00590954|Malignant Gliomas|malignant gliomas
611677|NCT00590954|CNS|cns
611678|NCT00590954|Brain Cancer|brain cancer
611679|NCT00590954|Cancer|cancer
611680|NCT00590954|Perifosine|perifosine
611681|NCT00590941|Lymphoma|lymphoma
611682|NCT00590941|Rituximab|rituximab
611683|NCT00590941|CHOP|chop
611684|NCT00590915|ALL|all
611685|NCT00590902|non small cell lung cancer|non small cell lung cancer
611686|NCT00590889|artificial heart valve|artificial heart valve
611687|NCT00590889|mitral heart valve|mitral heart valve
611688|NCT00590889|aortic heart valve|aortic heart valve
611689|NCT00590889|endocarditis|endocarditis
611690|NCT00590889|Aortic valve disease requiring replacement|aortic valve disease requiring replacement
611691|NCT00590889|Mitral valve disease requiring replacement|mitral valve disease requiring replacement
611692|NCT00590876|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
611693|NCT00590876|Hypoglycemia|hypoglycemia
611694|NCT00590876|Pancreatic Islet Cell Allotransplantation|pancreatic islet cell allotransplantation
611695|NCT00590863|depression, medication, antidepressant, chronic, recurrent|depression, medication, antidepressant, chronic, recurrent
611696|NCT00590837|AML|aml
611697|NCT00590837|Chemotherapy|chemotherapy
611698|NCT00590837|older|older
611699|NCT00590837|De novo AML|de novo aml
611700|NCT00590824|Melanoma|melanoma
611701|NCT00590824|hu14.18-IL2|hu14.18-il2
611702|NCT00590811|adolescents|adolescents
611703|NCT00590811|young adults|young adults
611704|NCT00590811|dysmenorrhea|dysmenorrhea
611705|NCT00590811|pelvic pain|pelvic pain
611706|NCT00590798|Cardiac Catheterization|cardiac catheterization
611707|NCT00590798|Walk|walk
611708|NCT00590798|Heart Catheterization|heart catheterization
611709|NCT00590798|Coronary Disease|coronary disease
611710|NCT00590798|Heart Disease|heart disease
611711|NCT00590798|Coronary Artery Disease|coronary artery disease
611712|NCT00590785|High Risk|high risk
611713|NCT00590785|Breast Cancer|breast cancer
611714|NCT00590785|Positive Nodes|positive nodes
611715|NCT00590785|Cyclophosphamide|cyclophosphamide
611716|NCT00590785|Doxorubicin|doxorubicin
611717|NCT00590785|96-041|96-041
611718|NCT00590772|sleep|sleep
611719|NCT00590772|somnolence|somnolence
611720|NCT00590772|allergies|allergies
611721|NCT00590772|rhinitis|rhinitis
611722|NCT00590772|fatigue|fatigue
611723|NCT00590720|Asthma|asthma
611724|NCT00590720|Bronchitis|bronchitis
611725|NCT00590707|Hip fractures|hip fractures
611726|NCT00590707|Femoral neck fractures|femoral neck fractures
611727|NCT00590707|Trochanteric fractures|trochanteric fractures
611728|NCT00590707|Intertrochanteric fractures|intertrochanteric fractures
611729|NCT00590707|Subtrochanteric fractures|subtrochanteric fractures
611730|NCT00590707|Delirium|delirium
611731|NCT00590707|Confusion|confusion
611732|NCT00590694|ranibizumab|ranibizumab
611733|NCT00590694|Lucentis|lucentis
611734|NCT00590694|Pigment Epithelial Detachment|pigment epithelial detachment
611735|NCT00590694|Macular Degeneration|macular degeneration
611736|NCT00590694|PrONTO|pronto
611737|NCT00590668|atrial fibrillation|atrial fibrillation
611738|NCT00590668|pulmonary vein ablation|pulmonary vein ablation
611739|NCT00590668|pulmonary vein stenosis|pulmonary vein stenosis
611740|NCT00590655|maintenance therapy|maintenance therapy
611741|NCT00590642|obsessive compulsive disorder|obsessive compulsive disorder
611742|NCT00590642|OCD|ocd
611743|NCT00590642|treatment-resistant|treatment-resistant
611744|NCT00590642|SSRI|ssri
611745|NCT00590629|Women with and without CAD|women with and without cad
611746|NCT00590616|Aortic atheroma|aortic atheroma
611747|NCT00590603|Multiple myeloma|multiple myeloma
611748|NCT00590577|Schizophrenia|schizophrenia
611749|NCT00590577|Long-acting injectable antipsychotic medication|long-acting injectable antipsychotic medication
611750|NCT00590564|Hepatitis C|hepatitis c
611751|NCT00590564|Sho-saiko-to|sho-saiko-to
611752|NCT00590564|SST|sst
611753|NCT00590564|Interferon Therapy|interferon therapy
611754|NCT00590551|Skin Breakdown|skin breakdown
611755|NCT00590551|Skin Damage|skin damage
611756|NCT00590551|Skin Integrity|skin integrity
611757|NCT00590551|Pressure|pressure
611758|NCT00590551|Slings|slings
611759|NCT00590525|hsCRP|hscrp
611760|NCT00590512|dietary salt|dietary salt
611761|NCT00590512|sodium|sodium
611762|NCT00590512|blood vessels|blood vessels
611763|NCT00590512|vascular function|vascular function
611764|NCT00590512|endothelial function|endothelial function
611765|NCT00590512|heart disease risk|heart disease risk
611766|NCT00590512|cardiovascular disease risk|cardiovascular disease risk
611767|NCT00590499|agitation|agitation
611768|NCT00590499|craniotomy|craniotomy
611769|NCT00590499|incidence|incidence
611770|NCT00590499|risk factor|risk factor
611771|NCT00590499|outcome|outcome
611772|NCT00590473|Interstitial Cystitis|interstitial cystitis
611773|NCT00590473|IC|ic
611774|NCT00590473|Neuromodulation|neuromodulation
611775|NCT00590473|Interstim Therapy|interstim therapy
611776|NCT00590460|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
611777|NCT00590460|Fanconi Anemia|fanconi anemia
611778|NCT00590460|Severe Aplastic Anemia|severe aplastic anemia
611779|NCT00590460|fludarabine|fludarabine
611780|NCT00590460|campath|campath
611781|NCT00590460|anti-CD45|anti-cd45
611782|NCT00590447|1st-line therapy|1st-line therapy
611783|NCT00590447|single agent rituximab|single agent rituximab
611784|NCT00590447|CHOP|chop
611785|NCT00590447|risk stratification|risk stratification
611786|NCT00590434|CRC - Colorectal cancer|crc - colorectal cancer
611787|NCT00590434|CVA - Cerebral Vascular Accident|cva - cerebral vascular accident
611788|NCT00590434|MI - Myocardial Infarction|mi - myocardial infarction
611789|NCT00590434|CAD - Coronary Artery Disease|cad - coronary artery disease
611790|NCT00590434|DM - Diabetes Mellitus|dm - diabetes mellitus
611791|NCT00590434|PVD - Peripheral Vascular Disease|pvd - peripheral vascular disease
611792|NCT00590434|NSAIDS - Non-Steroidal Anti inflammatory Drugs|nsaids - non-steroidal anti inflammatory drugs
611793|NCT00590434|screening|screening
611794|NCT00590434|colonoscopy|colonoscopy
611795|NCT00590408|coenzyme Q10|coenzyme q10
611796|NCT00590408|statin|statin
611797|NCT00590408|myalgia|myalgia
611798|NCT00590395|Cholecystitis|cholecystitis
611799|NCT00590395|FDG PET/CT|fdg pet/ct
611800|NCT00590395|HIDA scan|hida scan
611801|NCT00590356|Device closure|device closure
611802|NCT00590304|Asthma, Children, Rural Population, Morbidity, Endotoxin|asthma, children, rural population, morbidity, endotoxin
611803|NCT00590291|Coronary Artery Disease|coronary artery disease
611804|NCT00590291|Arteriovenous Malformations|arteriovenous malformations
611805|NCT00590291|Myocardial Infarction|myocardial infarction
611806|NCT00590291|CAD|cad
611807|NCT00590291|MI|mi
611808|NCT00590291|Heart Attack|heart attack
611809|NCT00590291|AVM|avm
611810|NCT00590291|genetic|genetic
611811|NCT00590291|familial|familial
611812|NCT00590278|Tomudex|tomudex
611813|NCT00590278|inoperable rectal cancer|inoperable rectal cancer
611814|NCT00590278|recurrent rectal cancer|recurrent rectal cancer
611815|NCT00590265|bipolar type II disorder|bipolar type ii disorder
611816|NCT00590265|depression|depression
611817|NCT00590265|remission|remission
611818|NCT00590265|light-therapy|light-therapy
611819|NCT00590265|efficacy|efficacy
611820|NCT00590265|safety|safety
611821|NCT00590252|Magnetic Resonance|magnetic resonance
611822|NCT00590252|Imaging|imaging
611823|NCT00590252|Spectroscopy|spectroscopy
611824|NCT00590239|Barrett's Esophagus|barrett's esophagus
611825|NCT00590239|Neoplasia|neoplasia
611826|NCT00590239|Endoscopic mucosal resection|endoscopic mucosal resection
611827|NCT00590239|High resolution endoscopy|high resolution endoscopy
611828|NCT00590239|Chromoendoscopy|chromoendoscopy
611829|NCT00590226|type 2 diabetes|type 2 diabetes
611830|NCT00590226|inpatient hyperglycemia|inpatient hyperglycemia
611831|NCT00590226|SQ insulin|sq insulin
611832|NCT00590226|Hospitalized patients with type 2 diabetes|hospitalized patients with type 2 diabetes
611833|NCT00590213|Casodex|casodex
611834|NCT00590213|Prostate Cancer|prostate cancer
611835|NCT00590200|CAD|cad
611836|NCT00590200|Cardiovascular Disease|cardiovascular disease
611837|NCT00590200|CVD|cvd
611838|NCT00590200|MI|mi
611839|NCT00590200|Myocardial Infarction|myocardial infarction
611840|NCT00590200|Heart Attack|heart attack
611841|NCT00590200|CABG|cabg
611842|NCT00590200|Revascularization|revascularization
611843|NCT00590200|genetic|genetic
611844|NCT00590174|stent|stent
611845|NCT00590174|antiplatelet therapy|antiplatelet therapy
611846|NCT00590161|Fatty Liver|fatty liver
611847|NCT00590161|Nonalcoholic fatty liver disease (NALFD)|nonalcoholic fatty liver disease (nalfd)
611848|NCT00590161|NAFLD|nafld
611849|NCT00590161|Nonalcoholic steatohepatitis (NASH)|nonalcoholic steatohepatitis (nash)
611850|NCT00590161|NASH|nash
611851|NCT00590161|pentoxifylline|pentoxifylline
611852|NCT00590135|calcific aortic valve stenosis|calcific aortic valve stenosis
611853|NCT00590135|echocardiography, transthoracic|echocardiography, transthoracic
611854|NCT00590122|Parkinson's disease|parkinson's disease
611855|NCT00590122|"time to on"|"time to on"
611856|NCT00590122|delayed on|delayed on
611857|NCT00590109|Breast Cancer|breast cancer
611858|NCT00590109|Jewish|jewish
611859|NCT00590109|BRCA1|brca1
611860|NCT00590109|BRCA2|brca2
611861|NCT00590109|97-029|97-029
611862|NCT00590096|Neuroblastoma|neuroblastoma
611863|NCT00590096|Pheochromocytoma|pheochromocytoma
611864|NCT00590096|MIBG|mibg
611865|NCT00590083|stem cell transplantation|stem cell transplantation
611866|NCT00590083|adenovirus|adenovirus
611867|NCT00590083|Cytotoxic T-Lymphocytes|cytotoxic t-lymphocytes
611868|NCT00590083|prophylaxis|prophylaxis
611869|NCT00590070|myocardial infarction|myocardial infarction
611870|NCT00590070|no reflow|no reflow
611871|NCT00590070|primary PCI|primary pci
611872|NCT00590070|Coronary no-reflow phenomenon|coronary no-reflow phenomenon
611873|NCT00590070|primary percutaneous coronary intervention (primary PCI)|primary percutaneous coronary intervention (primary pci)
611874|NCT00590044|Diabetic ketoacidosis|diabetic ketoacidosis
611875|NCT00590044|insulin therapy|insulin therapy
611876|NCT00590044|DKA|dka
611877|NCT00590031|Esophageal Carcinoma|esophageal carcinoma
611878|NCT00590031|Cisplatin|cisplatin
611879|NCT00590031|Irinotecan|irinotecan
611880|NCT00590031|Radiation Therapy|radiation therapy
611881|NCT00590031|02-045|02-045
611882|NCT00590018|Congenital heart disease.|congenital heart disease.
611883|NCT00590018|Low cardiac output syndrome.|low cardiac output syndrome.
611884|NCT00590018|Corticosteroids.|corticosteroids.
611885|NCT00590018|Hydrocortisone.|hydrocortisone.
611886|NCT00590018|Blood pressure.|blood pressure.
611887|NCT00590018|Inotropes.|inotropes.
611888|NCT00590005|severe asthma|severe asthma
611889|NCT00590005|poorly controlled asthma|poorly controlled asthma
611890|NCT00589979|Osteoarthritis|osteoarthritis
611891|NCT00589979|Knee|knee
611892|NCT00589979|Lidoderm|lidoderm
611893|NCT00589979|Lidocaine|lidocaine
611894|NCT00589979|Topical patch|topical patch
611895|NCT00589979|Adjunct therapy|adjunct therapy
611896|NCT00589966|prostate cancer treatment|prostate cancer treatment
611897|NCT00589966|treatment side-effects|treatment side-effects
611898|NCT00589966|early diagnosis|early diagnosis
611899|NCT00589966|African American Men|african american men
611900|NCT00589966|coping skills training|coping skills training
611901|NCT00589966|quality of life|quality of life
611902|NCT00589966|Prostate cancer treatment side-effects|prostate cancer treatment side-effects
611903|NCT00589953|Extreme Prematurity|extreme prematurity
611904|NCT00589953|Erythropoietin|erythropoietin
611905|NCT00589953|Perinatal Brain Injury|perinatal brain injury
611906|NCT00589953|Intraventricular Hemorrhage|intraventricular hemorrhage
611907|NCT00589953|Periventricular Leukomalacia|periventricular leukomalacia
611908|NCT00589953|Neurodevelopmental Outcomes|neurodevelopmental outcomes
611909|NCT00589953|Randomized Clinical Trial|randomized clinical trial
611910|NCT00589927|stents|stents
611911|NCT00589927|cilostazol|cilostazol
611912|NCT00589914|Schizophrenia|schizophrenia
611913|NCT00589914|long-acting injectable antipsychotic medication|long-acting injectable antipsychotic medication
611914|NCT00589901|metastatic breast cancer|metastatic breast cancer
611915|NCT00589901|capecitabine|capecitabine
611916|NCT00589901|synergistic effect|synergistic effect
611917|NCT00589901|chemotherapy|chemotherapy
611918|NCT00589888|hypertension|hypertension
611919|NCT00589888|metabolic syndrome|metabolic syndrome
611920|NCT00589888|vascular reactivity|vascular reactivity
611921|NCT00589888|Elevated blood pressure|elevated blood pressure
611922|NCT00589888|lipid toxicity|lipid toxicity
611923|NCT00589875|Immunotherapy|immunotherapy
611924|NCT00589875|Cytotoxicity|cytotoxicity
611925|NCT00589875|Tumor vaccine|tumor vaccine
611926|NCT00589862|Drug Eluting Stents|drug eluting stents
611927|NCT00589862|Clopidogrel Resistance|clopidogrel resistance
611928|NCT00589862|Aspirin Resistance|aspirin resistance
611929|NCT00589849|Myocardial Infarction|myocardial infarction
611930|NCT00589849|Arrhythmia|arrhythmia
611931|NCT00589849|T-wave alternans|t-wave alternans
611932|NCT00589836|HCM|hcm
611933|NCT00589836|HOCM|hocm
611934|NCT00589836|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
611935|NCT00589836|tissue doppler echocardiography|tissue doppler echocardiography
611936|NCT00589836|myocardial torsion|myocardial torsion
611937|NCT00589823|Pain|pain
611938|NCT00589823|Cancer|cancer
611939|NCT00589823|Breakthrough|breakthrough
611940|NCT00589810|ISR|isr
611941|NCT00589810|in-stent restenosis|in-stent restenosis
611942|NCT00589810|restenosis|restenosis
611943|NCT00589810|BMS|bms
611944|NCT00589810|bare metal stent|bare metal stent
611945|NCT00589810|revascularization|revascularization
611946|NCT00589810|genetic|genetic
611947|NCT00589810|cardiac catheterization|cardiac catheterization
611948|NCT00589797|Degenerative|degenerative
611949|NCT00589797|Disc|disc
611950|NCT00589784|Sunitinib|sunitinib
611951|NCT00589784|Brain Cancer|brain cancer
611952|NCT00589784|CNS Cancer|cns cancer
611953|NCT00589784|meningioma|meningioma
611954|NCT00589784|intracranial hemangiopericytoma|intracranial hemangiopericytoma
611955|NCT00589784|hemangioblastoma|hemangioblastoma
611956|NCT00589784|malignant meningioma|malignant meningioma
611957|NCT00589784|neurofibromatosis|neurofibromatosis
611958|NCT00589784|neurofibromatosis type 1|neurofibromatosis type 1
611959|NCT00589784|neurofibromatosis type 2|neurofibromatosis type 2
611960|NCT00589784|07-135|07-135
611961|NCT00589771|IBS|ibs
611962|NCT00589771|Saccharomyces boulardii|saccharomyces boulardii
611963|NCT00589771|probiotics|probiotics
611964|NCT00589771|cytokine|cytokine
611965|NCT00589771|histology|histology
611966|NCT00589771|Efficacy|efficacy
611967|NCT00589758|Right Ventricle|right ventricle
611968|NCT00589758|Echocardiogram|echocardiogram
611969|NCT00589758|Evaluation of Heart Failure|evaluation of heart failure
611970|NCT00589745|Diagnosis|diagnosis
611971|NCT00589732|stents|stents
611972|NCT00589732|angiotensin-converting enzyme|angiotensin-converting enzyme
611973|NCT00589719|Asthma; minority; low-income; African American; Arkansas|asthma; minority; low-income; african american; arkansas
611974|NCT00589706|high grade gliomas of the brain|high grade gliomas of the brain
611975|NCT00589706|anti-body treatment|anti-body treatment
611976|NCT00589706|survival|survival
611977|NCT00589693|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
611978|NCT00589693|Pneumonia, hospital-acquired|pneumonia, hospital-acquired
611979|NCT00589693|Doripenem|doripenem
611980|NCT00589693|Imipenem-cilastatin|imipenem-cilastatin
611981|NCT00589680|Acidosis, Diabetic|acidosis, diabetic
611982|NCT00589680|Diabetic Acidosis|diabetic acidosis
611983|NCT00589680|Diabetic Ketosis|diabetic ketosis
611984|NCT00589680|Ketoacidosis, Diabetic|ketoacidosis, diabetic
611985|NCT00589680|Ketosis, Diabetic|ketosis, diabetic
611986|NCT00589667|Head and Neck Cancer|head and neck cancer
611987|NCT00589667|GEMCITABINE|gemcitabine
611988|NCT00589667|PEMETREXED|pemetrexed
611989|NCT00589667|ALTIMA|altima
611990|NCT00589667|epidermoid/squamous cell|epidermoid/squamous cell
611991|NCT00589667|carcinoma|carcinoma
611993|NCT00589667|larynx|larynx
611994|NCT00589667|paranasal sinus|paranasal sinus
611995|NCT00589667|head/neck squamous cell carcinoma|head/neck squamous cell carcinoma
611996|NCT00589654|amenorrhea|amenorrhea
611997|NCT00589654|menstrual cycle|menstrual cycle
611998|NCT00589654|Breast cancer|breast cancer
611999|NCT00589654|questionnaire|questionnaire
612000|NCT00589654|97-127|97-127
612001|NCT00589641|adolescents|adolescents
612002|NCT00589641|suicidal ideation and behavior|suicidal ideation and behavior
612003|NCT00589641|depression|depression
612004|NCT00589641|substance abuse|substance abuse
612005|NCT00589628|Childhood|childhood
612006|NCT00589628|Uveitis|uveitis
612007|NCT00589615|vitamin D|vitamin d
612008|NCT00589615|bone density|bone density
612009|NCT00589602|Adult leukemia|adult leukemia
612010|NCT00589602|lymphoma|lymphoma
612011|NCT00589602|myelodysplastic syndromes|myelodysplastic syndromes
612012|NCT00589602|plasma cell disorders|plasma cell disorders
612013|NCT00589589|burns|burns
612014|NCT00589589|hypoglycemia|hypoglycemia
612015|NCT00589589|hyperglycemia|hyperglycemia
612016|NCT00589589|glucose monitoring|glucose monitoring
612017|NCT00589563|graft versus host disease|graft versus host disease
612018|NCT00589563|infection|infection
612019|NCT00589563|adult favorable prognosis Hodgkin lymphoma|adult favorable prognosis hodgkin lymphoma
612020|NCT00589563|adult unfavorable prognosis Hodgkin lymphoma|adult unfavorable prognosis hodgkin lymphoma
612021|NCT00589563|childhood favorable prognosis Hodgkin lymphoma|childhood favorable prognosis hodgkin lymphoma
612022|NCT00589563|childhood unfavorable prognosis Hodgkin lymphoma|childhood unfavorable prognosis hodgkin lymphoma
612023|NCT00589563|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
612024|NCT00589563|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
612025|NCT00589563|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
612026|NCT00589563|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
612027|NCT00589563|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
612028|NCT00589563|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
612029|NCT00589563|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
612030|NCT00589563|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
612031|NCT00589563|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
612032|NCT00589563|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
612033|NCT00589563|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
612034|NCT00589563|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
612035|NCT00589563|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
612036|NCT00589563|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
612037|NCT00589563|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
612038|NCT00589563|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
612039|NCT00589563|anaplastic large cell lymphoma|anaplastic large cell lymphoma
612040|NCT00589563|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
612041|NCT00589563|Burkitt lymphoma|burkitt lymphoma
612042|NCT00589563|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
612043|NCT00589563|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
612044|NCT00589563|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
612045|NCT00589563|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
612046|NCT00589563|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
612047|NCT00589563|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
612048|NCT00589563|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
612049|NCT00589563|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
612050|NCT00589563|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
612051|NCT00589563|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
612052|NCT00589563|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
612053|NCT00589563|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
612054|NCT00589563|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
612055|NCT00589563|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
612056|NCT00589563|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
612057|NCT00589563|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
612058|NCT00589563|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
612059|NCT00589563|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
612060|NCT00589563|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
612061|NCT00589563|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
612062|NCT00589563|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
612063|NCT00589563|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
612064|NCT00589563|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
612065|NCT00589563|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
612066|NCT00589563|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
612067|NCT00589563|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
612068|NCT00589563|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
612069|NCT00589563|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
612070|NCT00589563|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
612071|NCT00589563|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
612072|NCT00589563|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
612073|NCT00589563|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
612074|NCT00589563|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
612075|NCT00589563|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
612076|NCT00589563|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
612399|NCT00588536|6-Thioguanine|6-thioguanine
612077|NCT00589563|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
612078|NCT00589563|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
612079|NCT00589563|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
612080|NCT00589563|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
612081|NCT00589563|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
612082|NCT00589563|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
612083|NCT00589563|recurrent grade I lymphomatoid granulomatosis|recurrent grade i lymphomatoid granulomatosis
612084|NCT00589563|recurrent grade II lymphomatoid granulomatosis|recurrent grade ii lymphomatoid granulomatosis
612085|NCT00589563|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
612086|NCT00589563|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
612087|NCT00589563|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
612088|NCT00589563|small intestine lymphoma|small intestine lymphoma
612089|NCT00589563|splenic marginal zone lymphoma|splenic marginal zone lymphoma
612090|NCT00589563|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
612091|NCT00589563|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
612092|NCT00589563|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
612093|NCT00589563|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
612094|NCT00589563|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
612095|NCT00589563|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
612096|NCT00589563|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
612097|NCT00589563|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
612098|NCT00589563|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
612099|NCT00589563|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
612100|NCT00589563|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
612101|NCT00589563|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
612102|NCT00589563|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
612103|NCT00589563|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
612104|NCT00589563|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
612105|NCT00589563|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
612106|NCT00589563|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
612107|NCT00589563|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
612108|NCT00589563|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
612109|NCT00589563|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
612110|NCT00589563|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
612111|NCT00589563|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
612112|NCT00589563|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
612113|NCT00589563|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
612114|NCT00589563|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
612115|NCT00589563|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
612116|NCT00589563|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
612117|NCT00589563|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
612118|NCT00589563|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
612119|NCT00589563|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
612120|NCT00589563|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
612121|NCT00589563|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
612122|NCT00589563|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
612123|NCT00589563|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
612124|NCT00589563|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
612125|NCT00589563|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
612126|NCT00589563|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
612127|NCT00589563|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
612128|NCT00589563|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
612129|NCT00589563|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
612130|NCT00589563|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
612131|NCT00589563|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
612132|NCT00589563|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
612133|NCT00589563|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
612134|NCT00589563|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
612135|NCT00589563|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
612136|NCT00589563|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
612137|NCT00589563|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
612138|NCT00589563|secondary acute myeloid leukemia|secondary acute myeloid leukemia
612400|NCT00588536|6-TG|6-tg
612139|NCT00589563|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
612140|NCT00589563|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
612141|NCT00589563|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
612142|NCT00589563|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
612143|NCT00589563|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
612144|NCT00589563|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
612145|NCT00589563|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
612146|NCT00589563|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
612147|NCT00589563|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
612148|NCT00589563|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
612149|NCT00589563|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
612150|NCT00589563|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
612151|NCT00589563|stage I multiple myeloma|stage i multiple myeloma
612152|NCT00589563|stage II multiple myeloma|stage ii multiple myeloma
612153|NCT00589563|stage III multiple myeloma|stage iii multiple myeloma
612154|NCT00589563|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
612155|NCT00589563|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
612156|NCT00589563|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
612157|NCT00589563|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
612158|NCT00589563|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
612159|NCT00589563|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
612160|NCT00589563|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
612161|NCT00589563|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
612162|NCT00589563|primary myelofibrosis|primary myelofibrosis
612163|NCT00589563|secondary myelofibrosis|secondary myelofibrosis
612164|NCT00589550|clear cell renal cell carcinoma|clear cell renal cell carcinoma
612165|NCT00589550|stage III renal cell cancer|stage iii renal cell cancer
612166|NCT00589550|stage IV renal cell cancer|stage iv renal cell cancer
612167|NCT00589537|testicular seminoma|testicular seminoma
612168|NCT00589537|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
612169|NCT00589524|blocked arteries|blocked arteries
612170|NCT00589524|narrowing arteries|narrowing arteries
612171|NCT00589524|IVUS|ivus
612172|NCT00589524|CT|ct
612173|NCT00589511|Bilateral severe to profound sensorineural hearing loss|bilateral severe to profound sensorineural hearing loss
612174|NCT00589459|undiagnosed diabetes|undiagnosed diabetes
612175|NCT00589459|undiagnosed pre-diabetes|undiagnosed pre-diabetes
612176|NCT00589459|acute coronary syndrome|acute coronary syndrome
612177|NCT00589459|undiagnosed pre-diabetes and undiagnosed diabetes|undiagnosed pre-diabetes and undiagnosed diabetes
612178|NCT00589446|Embryoscopy|embryoscopy
612179|NCT00589446|recurrent miscarriage|recurrent miscarriage
612180|NCT00589446|missed abortion|missed abortion
612181|NCT00589446|Structural anomalies in recurrent miscarriage|structural anomalies in recurrent miscarriage
612182|NCT00589446|Embryoscopically directed biopsy for karyotyping|embryoscopically directed biopsy for karyotyping
612183|NCT00589420|adenocarcinoma of the prostate|adenocarcinoma of the prostate
612184|NCT00589420|recurrent prostate cancer|recurrent prostate cancer
612185|NCT00589420|stage IV prostate cancer|stage iv prostate cancer
612186|NCT00589394|pneumococcal vaccine|pneumococcal vaccine
612187|NCT00589394|normal response|normal response
612188|NCT00589394|immunodeficiency|immunodeficiency
612189|NCT00589394|Healthy patients|healthy patients
612190|NCT00589394|Healthy Volunteers|healthy volunteers
612191|NCT00589381|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
612192|NCT00589381|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
612193|NCT00589381|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
612194|NCT00589381|anaplastic large cell lymphoma|anaplastic large cell lymphoma
612195|NCT00589381|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
612196|NCT00589381|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
612197|NCT00589381|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
612198|NCT00589381|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
612199|NCT00589381|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
612200|NCT00589381|Waldenström macroglobulinemia|waldenström macroglobulinemia
612201|NCT00589381|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
612202|NCT00589381|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
612203|NCT00589381|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
612204|NCT00589381|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
612205|NCT00589381|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
612206|NCT00589381|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
612207|NCT00589381|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
612208|NCT00589381|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
612610|NCT00587639|Depression|depression
612209|NCT00589381|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
612210|NCT00589381|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
612211|NCT00589381|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
612212|NCT00589381|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
612213|NCT00589381|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
612214|NCT00589381|splenic marginal zone lymphoma|splenic marginal zone lymphoma
612215|NCT00589381|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
612216|NCT00589368|Brain Infarction|brain infarction
612217|NCT00589368|pathology|pathology
612218|NCT00589368|physiopathology|physiopathology
612219|NCT00589368|psychology|psychology
612220|NCT00589368|rehabilitation|rehabilitation
612221|NCT00589368|Fingers|fingers
612222|NCT00589368|Grasp|grasp
612223|NCT00589368|Functional Laterality|functional laterality
612224|NCT00589368|Hand|hand
612225|NCT00589368|Strength|strength
612226|NCT00589368|Neuronal Plasticity|neuronal plasticity
612227|NCT00589368|Psychomotor Performance|psychomotor performance
612228|NCT00589368|Biomechanis|biomechanis
612229|NCT00589368|Touch|touch
612230|NCT00589368|Weight-Bearing|weight-bearing
612231|NCT00589355|c-reactive protein|c-reactive protein
612232|NCT00589355|endothelial dysfunction|endothelial dysfunction
612233|NCT00589355|glucose intolerance|glucose intolerance
612234|NCT00589329|Preterm birth|preterm birth
612235|NCT00589329|antibiotics|antibiotics
612236|NCT00589329|preterm labor|preterm labor
612237|NCT00589329|respiratory distress|respiratory distress
612238|NCT00589329|pergnancy|pergnancy
612239|NCT00589303|Atrial Fibrillation|atrial fibrillation
612240|NCT00589303|Heart Failure|heart failure
612241|NCT00589303|AV Node ablation|av node ablation
612242|NCT00589303|Cardiac pacemaker|cardiac pacemaker
612243|NCT00589303|Antiarrhythmic drug|antiarrhythmic drug
612244|NCT00589290|Histone deacetylase (HDAC) Inhibitors|histone deacetylase (hdac) inhibitors
612245|NCT00589290|Mediastinal Neoplasm|mediastinal neoplasm
612246|NCT00589290|Thymic Carcinoma|thymic carcinoma
612247|NCT00589290|Thymoma|thymoma
612248|NCT00589277|Smoking|smoking
612249|NCT00589277|Tobacco|tobacco
612250|NCT00589277|Message Framing|message framing
612251|NCT00589264|zinc|zinc
612252|NCT00589264|iron|iron
612253|NCT00589264|child development|child development
612254|NCT00589264|visual attention|visual attention
612255|NCT00589264|Peru|peru
612256|NCT00589251|penicillin allergy, penicillin skin test|penicillin allergy, penicillin skin test
612257|NCT00589238|stage II breast cancer|stage ii breast cancer
612258|NCT00589238|stage IIIA breast cancer|stage iiia breast cancer
612259|NCT00589238|stage IIIB breast cancer|stage iiib breast cancer
612260|NCT00589238|stage IIIC breast cancer|stage iiic breast cancer
612261|NCT00589225|PH|ph
612262|NCT00589225|PH type I|ph type i
612263|NCT00589225|Primary Hyperoxaluria|primary hyperoxaluria
612264|NCT00589225|Hyperoxaluria|hyperoxaluria
612265|NCT00589225|Primary Oxalosis|primary oxalosis
612266|NCT00589225|PH type II|ph type ii
612267|NCT00589225|PH type III|ph type iii
612268|NCT00589225|Genetic testing for PH|genetic testing for ph
612269|NCT00589225|Genetic testing for Primary Hyperoxaluria|genetic testing for primary hyperoxaluria
612270|NCT00589225|Hereditary study for PH|hereditary study for ph
612271|NCT00589225|Hereditary study for Primary Hyperoxaluria|hereditary study for primary hyperoxaluria
612272|NCT00589212|GliaSite|gliasite
612273|NCT00589212|Brain metastases|brain metastases
612274|NCT00589212|1-3 METS|1-3 mets
612275|NCT00589186|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
612276|NCT00589186|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
612277|NCT00589186|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
612278|NCT00589186|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
612279|NCT00589173|Preventive Care|preventive care
612280|NCT00589173|Health information technology|health information technology
612281|NCT00589173|Personal health record|personal health record
612282|NCT00589121|radiation fibrosis|radiation fibrosis
612283|NCT00589121|radiation toxicity|radiation toxicity
612284|NCT00589121|lymphedema|lymphedema
612285|NCT00589121|musculoskeletal complications|musculoskeletal complications
612286|NCT00589121|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
612287|NCT00589121|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
612288|NCT00589121|adult extraskeletal chondrosarcoma|adult extraskeletal chondrosarcoma
612289|NCT00589121|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
612290|NCT00589108|knee arthroplasty|knee arthroplasty
612291|NCT00589082|AML|aml
612292|NCT00589082|elderly|elderly
612293|NCT00589082|DaunoXome|daunoxome
612294|NCT00589056|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
612422|NCT00588445|Gefitnib|gefitnib
612295|NCT00589056|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
612296|NCT00589056|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
612297|NCT00589030|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
612298|NCT00589030|advanced adult primary liver cancer|advanced adult primary liver cancer
612299|NCT00589030|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
612300|NCT00589030|recurrent adult primary liver cancer|recurrent adult primary liver cancer
612301|NCT00588978|c-reactive protein|c-reactive protein
612302|NCT00588978|obesity|obesity
612303|NCT00588978|women's cardiovascular health|women's cardiovascular health
612304|NCT00588965|QT interval|qt interval
612305|NCT00588965|beta-blocker|beta-blocker
612306|NCT00588965|exercise|exercise
612307|NCT00588965|electrocardiogram|electrocardiogram
612308|NCT00588965|repolarizaton|repolarizaton
612309|NCT00588939|reflux|reflux
612310|NCT00588939|heartburn|heartburn
612311|NCT00588926|Deep Brain Stimulation|deep brain stimulation
612312|NCT00588926|Movement Disorders|movement disorders
612313|NCT00588926|Remifentanil|remifentanil
612314|NCT00588926|Sedation|sedation
612315|NCT00588926|Basal Ganglia electrical activity|basal ganglia electrical activity
612316|NCT00588913|recurrent renal cell cancer|recurrent renal cell cancer
612317|NCT00588913|stage IV renal cell cancer|stage iv renal cell cancer
612318|NCT00588913|clear cell renal cell carcinoma|clear cell renal cell carcinoma
612319|NCT00588913|lung metastases|lung metastases
612320|NCT00588900|stage IV colon cancer|stage iv colon cancer
612321|NCT00588900|stage IV rectal cancer|stage iv rectal cancer
612322|NCT00588900|recurrent colon cancer|recurrent colon cancer
612323|NCT00588900|recurrent rectal cancer|recurrent rectal cancer
612324|NCT00588874|male osteoporosis|male osteoporosis
612325|NCT00588874|male osteopenia|male osteopenia
612326|NCT00588874|calciotropic hormones|calciotropic hormones
612327|NCT00588848|Obstructive Sleep Apnea Hypopnea Syndrome|obstructive sleep apnea hypopnea syndrome
612328|NCT00588848|OSA|osa
612329|NCT00588848|Postoperative|postoperative
612330|NCT00588848|CPAP|cpap
612331|NCT00588835|pharmacokinetics|pharmacokinetics
612332|NCT00588835|nausea and vomiting post chemotherapy|nausea and vomiting post chemotherapy
612333|NCT00588822|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
612334|NCT00588796|fibrinogen|fibrinogen
612335|NCT00588796|burns|burns
612336|NCT00588796|trauma|trauma
612337|NCT00588796|metabolism|metabolism
612338|NCT00588757|IVC filters|ivc filters
612339|NCT00588757|Trauma|trauma
612340|NCT00588757|Dwell time|dwell time
612341|NCT00588718|Necrotizing enterocolitis|necrotizing enterocolitis
612342|NCT00588718|Progressive necrotizing enterocolitis|progressive necrotizing enterocolitis
612343|NCT00588718|Proteomics in blood|proteomics in blood
612344|NCT00588718|Genomics in blood|genomics in blood
612345|NCT00588718|Multi-center|multi-center
612346|NCT00588705|Daughters|daughters
612347|NCT00588705|Communication|communication
612348|NCT00588705|genetic risk|genetic risk
612349|NCT00588705|Genetic Counseling|genetic counseling
612350|NCT00588692|Heart Failure|heart failure
612351|NCT00588692|Afterload Reduction|afterload reduction
612352|NCT00588692|Sphygmocor|sphygmocor
612353|NCT00588679|Prostate Cancer|prostate cancer
612354|NCT00588679|Cancer|cancer
612355|NCT00588679|MRI|mri
612356|NCT00588679|Magnetic Resonance Imaging|magnetic resonance imaging
612357|NCT00588679|06-035|06-035
612358|NCT00588666|Myeloproliferative Disorder|myeloproliferative disorder
612359|NCT00588666|urinary bladder|urinary bladder
612360|NCT00588666|Cancer|cancer
612361|NCT00588666|ureter|ureter
612362|NCT00588666|renal pelvis|renal pelvis
612363|NCT00588666|chemotherapy|chemotherapy
612364|NCT00588653|Crohn's disease|crohn's disease
612365|NCT00588653|capsule endoscopy|capsule endoscopy
612366|NCT00588653|computed tomography enterography|computed tomography enterography
612367|NCT00588653|colonoscopy|colonoscopy
612368|NCT00588653|small bowel follow-through|small bowel follow-through
612369|NCT00588640|Pain|pain
612370|NCT00588640|HEENT cancer|heent cancer
612371|NCT00588627|Chronic cough|chronic cough
612372|NCT00588627|Post nasal drip|post nasal drip
612373|NCT00588588|Ventilator associated pneumonia|ventilator associated pneumonia
612374|NCT00588588|Intensive Care|intensive care
612375|NCT00588588|Antibiotics|antibiotics
612376|NCT00588588|Mortality|mortality
612377|NCT00588588|Length of stay|length of stay
612378|NCT00588575|Barrett's Esophagus|barrett's esophagus
612379|NCT00588562|PH|ph
612380|NCT00588562|PH1|ph1
612381|NCT00588562|PH2|ph2
612382|NCT00588562|PH3|ph3
612383|NCT00588562|PHI|phi
612384|NCT00588562|PHII|phii
612385|NCT00588562|PHIII|phiii
612386|NCT00588562|PH NonI-NonII|ph noni-nonii
612387|NCT00588562|Primary Hyperoxaluria|primary hyperoxaluria
612388|NCT00588562|Primary Oxalosis|primary oxalosis
612389|NCT00588562|Hyperoxaluria|hyperoxaluria
612390|NCT00588562|Oxalate|oxalate
612391|NCT00588562|Cystinuria|cystinuria
612392|NCT00588562|Cystine|cystine
612393|NCT00588562|APRT|aprt
612394|NCT00588562|Adenine phosphoribosyl transferase deficiency|adenine phosphoribosyl transferase deficiency
612395|NCT00588562|Dent disease|dent disease
612396|NCT00588562|Dent|dent
612397|NCT00588536|Langerhans Cell Histiocytosis|langerhans cell histiocytosis
612398|NCT00588536|LCH|lch
612401|NCT00588536|Methotrexate|methotrexate
612402|NCT00588536|MTX|mtx
612403|NCT00588536|94-132|94-132
612404|NCT00588523|Brain|brain
612405|NCT00588523|CNS|cns
612406|NCT00588523|TEMOZOLOMIDE|temozolomide
612407|NCT00588523|Busulfan|busulfan
612408|NCT00588523|Thiotepa|thiotepa
612409|NCT00588510|Sarcoma|sarcoma
612410|NCT00588510|Bone|bone
612411|NCT00588497|female sterilization, micro-insert, hysteroscopy|female sterilization, micro-insert, hysteroscopy
612412|NCT00588484|Carotid artery|carotid artery
612413|NCT00588484|Common carotid artery|common carotid artery
612414|NCT00588484|Measurement|measurement
612415|NCT00588484|Ultrasound|ultrasound
612416|NCT00588458|Primary sclerosing cholangitis|primary sclerosing cholangitis
612417|NCT00588458|Computed tomographic cholangiography|computed tomographic cholangiography
612418|NCT00588458|MELD score|meld score
612419|NCT00588458|Mayo risk score for PSC|mayo risk score for psc
612420|NCT00588445|Lung Cancer|lung cancer
612421|NCT00588445|Non-small cell lung cancer|non-small cell lung cancer
612423|NCT00588445|Cancer|cancer
612424|NCT00588445|NSCLC|nsclc
612425|NCT00588445|bronchioloalveolar cancer|bronchioloalveolar cancer
612426|NCT00588445|smoker|smoker
612427|NCT00588432|Stroke|stroke
612428|NCT00588432|Immobilization|immobilization
612429|NCT00588432|Myofacial Pain|myofacial pain
612430|NCT00588432|Hyperthyroid Myopathy|hyperthyroid myopathy
612431|NCT00588419|Breast Cancer|breast cancer
612432|NCT00588419|Cancer|cancer
612433|NCT00588419|Breast Sensation|breast sensation
612434|NCT00588419|Postmastectomy Breast Reconstruction|postmastectomy breast reconstruction
612435|NCT00588406|acute, emergency department|acute, emergency department
612436|NCT00588380|GLP-1|glp-1
612437|NCT00588380|Insulin Secretion|insulin secretion
612438|NCT00588367|Inflammation|inflammation
612439|NCT00588367|Pancreas|pancreas
612440|NCT00588367|Chronic pancreatitis|chronic pancreatitis
612441|NCT00588367|Alcoholic pancreatitis|alcoholic pancreatitis
612442|NCT00588367|Carcinoma, pancreatic ductal|carcinoma, pancreatic ductal
612443|NCT00588367|Pancreatic neoplasms|pancreatic neoplasms
612444|NCT00588354|herniated disk|herniated disk
612445|NCT00588354|radiculopathy|radiculopathy
612446|NCT00588354|clonidine|clonidine
612447|NCT00588354|epidural|epidural
612448|NCT00588354|steroid|steroid
612449|NCT00588354|corticosteroid|corticosteroid
612450|NCT00588354|nucleus pulposus|nucleus pulposus
612451|NCT00588354|transforaminal|transforaminal
612452|NCT00588341|Melanoma|melanoma
612453|NCT00588341|Skin Cancer|skin cancer
612454|NCT00588341|Cancer|cancer
612455|NCT00588341|Temozolamide|temozolamide
612457|NCT00588302|primary biliary cirrhosis|primary biliary cirrhosis
612458|NCT00588302|ursodeoxycholic acid|ursodeoxycholic acid
612459|NCT00588289|Pediatric Cancers|pediatric cancers
612460|NCT00588289|Oncology|oncology
612461|NCT00588276|measurable disease|measurable disease
612462|NCT00588276|locally advanced disease|locally advanced disease
612463|NCT00588263|Ashkenazi Jewish|ashkenazi jewish
612464|NCT00588263|Cancer|cancer
612465|NCT00588263|00-087|00-087
612466|NCT00588237|ovary|ovary
612467|NCT00588237|BEVACIZUMAB|bevacizumab
612468|NCT00588237|CISPLATIN|cisplatin
612469|NCT00588237|TAXOL|taxol
612470|NCT00588224|stomach|stomach
612471|NCT00588224|accommodation|accommodation
612472|NCT00588224|volume|volume
612473|NCT00588224|SPECT|spect
612474|NCT00588224|3 dimensional ultrasonography|3 dimensional ultrasonography
612475|NCT00588224|healthy volunteers|healthy volunteers
612476|NCT00588211|Cancer related-Risks|cancer related-risks
612477|NCT00588211|Risk Perception|risk perception
612478|NCT00588211|Survey|survey
612479|NCT00588211|Focus Group|focus group
612480|NCT00588211|Smoking cessation|smoking cessation
612481|NCT00588211|tobacco|tobacco
612482|NCT00588198|histologically confirmed melanoma of any site|histologically confirmed melanoma of any site
612483|NCT00588185|Progressive Prostate Cancer|progressive prostate cancer
612484|NCT00588185|[18F]-Fluoro-2-Deoxy-D-Glucose|[18f]-fluoro-2-deoxy-d-glucose
612485|NCT00588185|[18F] Dihydro-Testosterone|[18f] dihydro-testosterone
612486|NCT00588185|Pet Imaging|pet imaging
612487|NCT00588185|Pet scan|pet scan
612488|NCT00588185|00-095|00-095
612489|NCT00588172|Metformin|metformin
612490|NCT00588172|Type 2 diabetes|type 2 diabetes
612491|NCT00588172|Oct1|oct1
612492|NCT00588159|Preoperative gabapentin|preoperative gabapentin
612493|NCT00588159|Acute pain|acute pain
612494|NCT00588159|Post-thoracotomy pain|post-thoracotomy pain
612495|NCT00588159|Epidural analgesia|epidural analgesia
612496|NCT00588146|anemia|anemia
612497|NCT00588146|HHT|hht
612498|NCT00588146|Liver disease|liver disease
612499|NCT00588146|Hypoxemia|hypoxemia
612500|NCT00588146|Iron deficiency anemia|iron deficiency anemia
612501|NCT00588146|Liver disease with high cardiac output|liver disease with high cardiac output
612502|NCT00588146|Diffuse pulmonary AVMs with hypoxemia|diffuse pulmonary avms with hypoxemia
612503|NCT00588133|antifibrinolytic, bleeding, heart|antifibrinolytic, bleeding, heart
612504|NCT00588120|Hyperoxaluria|hyperoxaluria
612505|NCT00588120|Unknown Hyperoxaluria|unknown hyperoxaluria
612506|NCT00588120|Enteric Hyperoxaluria|enteric hyperoxaluria
612507|NCT00588120|Oxaluric|oxaluric
612508|NCT00588120|High Oxalate|high oxalate
612509|NCT00588120|Oxalate|oxalate
612510|NCT00588120|C13|c13
612511|NCT00588120|Oxalate Diet|oxalate diet
612512|NCT00588107|Cancer|cancer
612513|NCT00588107|Smoker|smoker
612514|NCT00588107|Web based intervention|web based intervention
612515|NCT00588107|Partnership for Health|partnership for health
612516|NCT00588107|Cancer Survivors|cancer survivors
612517|NCT00588094|Lymphoma|lymphoma
612518|NCT00588094|ASCT|asct
612519|NCT00588094|B-cell non-Hodgkin's lymphoma|b-cell non-hodgkin's lymphoma
612520|NCT00588094|Cancer|cancer
612521|NCT00588094|Second line therapy|second line therapy
612522|NCT00588094|ICE|ice
612523|NCT00588094|Stem cell transplant|stem cell transplant
612524|NCT00588081|Vaginal Reconstruction|vaginal reconstruction
612525|NCT00588068|Adrenal Gland|adrenal gland
612526|NCT00588068|No stage requirement|no stage requirement
612527|NCT00588042|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
612528|NCT00588042|Coronary Artery Disease|coronary artery disease
612529|NCT00588042|Coronary Occlusion|coronary occlusion
612530|NCT00588029|Family members|family members
612531|NCT00588016|Itraconazole|itraconazole
612532|NCT00588003|Breast|breast
612533|NCT00588003|ANASTROZOLE|anastrozole
612534|NCT00587990|Chronic Ischemic Left Ventricular Dysfunction|chronic ischemic left ventricular dysfunction
612535|NCT00587977|Abdominal aortic aneurysm|abdominal aortic aneurysm
612536|NCT00587964|Cancer|cancer
612537|NCT00587964|Brain Metastasis|brain metastasis
612538|NCT00587964|Radiosurgery|radiosurgery
612539|NCT00587964|Bladder cancer|bladder cancer
612540|NCT00587964|Breast cancer|breast cancer
612541|NCT00587964|Cervical cancer|cervical cancer
612542|NCT00587964|Colon cancer|colon cancer
612543|NCT00587964|HEENT cancer|heent cancer
612544|NCT00587964|Lung cancer|lung cancer
612545|NCT00587964|Melanoma|melanoma
612546|NCT00587964|Pancreatic cancer|pancreatic cancer
612547|NCT00587964|Prostate cancer|prostate cancer
612548|NCT00587964|Rectal cancer|rectal cancer
612549|NCT00587964|Sarcoma|sarcoma
612550|NCT00587964|Testicular cancer|testicular cancer
612551|NCT00587964|Radiation|radiation
612552|NCT00587951|Clinical decision-making|clinical decision-making
612553|NCT00587951|Ictal SPECT|ictal spect
612554|NCT00587951|Epilepsy surgery|epilepsy surgery
612555|NCT00587938|congestive heart failure|congestive heart failure
612556|NCT00587938|Brain naturietic peptide|brain naturietic peptide
612557|NCT00587938|hospital utilization cost|hospital utilization cost
612558|NCT00587925|osteoporosis|osteoporosis
612559|NCT00587912|Kaposi's Sarcoma AIDS Related|kaposi's sarcoma aids related
612560|NCT00587912|Kaposi's Sarcoma Classical|kaposi's sarcoma classical
612561|NCT00587912|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
612562|NCT00587912|HEMATOPOIETIC SYSTEM|hematopoietic system
612563|NCT00587912|Cancer|cancer
612564|NCT00587912|AIDS|aids
612565|NCT00587899|Atrial Fibrillation|atrial fibrillation
612566|NCT00587899|AF|af
612567|NCT00587899|A fib|a fib
612568|NCT00587899|cardiac ablation|cardiac ablation
612569|NCT00587899|modified maze procedure|modified maze procedure
612570|NCT00587886|Cancer|cancer
612571|NCT00587886|Endometrial cancer|endometrial cancer
612572|NCT00587886|Ovarian cancer|ovarian cancer
612573|NCT00587886|Corpus Uteri|corpus uteri
612574|NCT00587886|Endometrium|endometrium
612575|NCT00587873|Relapsed|relapsed
612576|NCT00587873|Hodgkin's Disease|hodgkin's disease
612577|NCT00587873|Methotrexate|methotrexate
612578|NCT00587873|6-Thioguanine|6-thioguanine
612579|NCT00587873|94-030|94-030
612580|NCT00587847|leukemia|leukemia
612581|NCT00587821|Breast Cancer|breast cancer
612582|NCT00587821|Breast biopsy|breast biopsy
612583|NCT00587808|Heart Failure|heart failure
612584|NCT00587808|Heart Failure, Diastolic|heart failure, diastolic
612585|NCT00587808|Stroke Volume|stroke volume
612586|NCT00587769|Smoking|smoking
612587|NCT00587769|Smoking cessation|smoking cessation
612588|NCT00587769|Bupropion|bupropion
612589|NCT00587769|Varenicline|varenicline
612590|NCT00587769|Tobacco use disorder|tobacco use disorder
612591|NCT00587756|intraoperative ultrasonography|intraoperative ultrasonography
612592|NCT00587756|colorectal liver metastases|colorectal liver metastases
612593|NCT00587756|hepatectomy|hepatectomy
612594|NCT00587756|portal vein embolization|portal vein embolization
612595|NCT00587756|Liver|liver
612596|NCT00587730|heart disease|heart disease
612597|NCT00587730|cardiac disease|cardiac disease
612598|NCT00587730|chest pain|chest pain
612599|NCT00587730|myocardial infarction|myocardial infarction
612600|NCT00587730|heart attack|heart attack
612601|NCT00587691|Tovaxin|tovaxin
612602|NCT00587691|TCV|tcv
612603|NCT00587691|Autologous|autologous
612604|NCT00587678|PAD|pad
612605|NCT00587665|Pain|pain
612606|NCT00587652|Barrett Esophagus|barrett esophagus
612607|NCT00587652|Methylene blue|methylene blue
612608|NCT00587652|Chromoendoscopy|chromoendoscopy
612609|NCT00587639|Adolescent|adolescent
612611|NCT00587639|rTMS|rtms
612612|NCT00587626|neck pain|neck pain
612613|NCT00587626|shoulder pain|shoulder pain
612614|NCT00587626|cervical pain|cervical pain
612615|NCT00587626|chronic|chronic
612616|NCT00587626|recurrent|recurrent
612617|NCT00587600|Barrett's Esophagus|barrett's esophagus
612618|NCT00587600|High Grade Dysplasia|high grade dysplasia
612619|NCT00587600|Photodynamic Therapy|photodynamic therapy
612620|NCT00587574|chronic graft-versus-host disease|chronic graft-versus-host disease
612621|NCT00587561|schizophrenia|schizophrenia
612622|NCT00587561|social cognition|social cognition
612623|NCT00587561|cognition|cognition
612624|NCT00587561|treatment|treatment
612625|NCT00587561|outcome|outcome
612626|NCT00587548|locate the ureters during abdominal surgery|locate the ureters during abdominal surgery
612627|NCT00587535|hemochromatosis|hemochromatosis
612628|NCT00587535|liver cirrhosis|liver cirrhosis
612629|NCT00587535|liver diseases|liver diseases
612630|NCT00587522|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
612631|NCT00587522|NDO Full-thickness Plicator|ndo full-thickness plicator
612632|NCT00587522|Plicator|plicator
612633|NCT00587522|Endoluminal GERD Therapy|endoluminal gerd therapy
612634|NCT00587496|HSV DNA|hsv dna
612635|NCT00587496|volunteers|volunteers
612636|NCT00587483|cardiopulmonary bypass|cardiopulmonary bypass
612637|NCT00587483|reperfusion ventricular fibrillation|reperfusion ventricular fibrillation
612638|NCT00587483|ventricular fibrillation|ventricular fibrillation
612639|NCT00587483|amiodarone|amiodarone
612640|NCT00587483|lidocaine|lidocaine
612641|NCT00587483|cardiac surgery|cardiac surgery
612642|NCT00587470|valve, mitral, regurgitation|valve, mitral, regurgitation
612643|NCT00587457|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
612644|NCT00587457|Prolymphocytic Leukemia|prolymphocytic leukemia
612645|NCT00587457|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
612646|NCT00587457|Moxetumomab pasudotox|moxetumomab pasudotox
612647|NCT00587444|heparin management|heparin management
612648|NCT00587431|Prostate|prostate
612649|NCT00587431|Cancer|cancer
612650|NCT00587431|Docetaxel|docetaxel
612651|NCT00587431|03-076|03-076
612652|NCT00587405|Watermelon Stomach|watermelon stomach
612653|NCT00587405|Cryotherapy|cryotherapy
612654|NCT00587405|Argon Plasma Coagulation|argon plasma coagulation
612655|NCT00587392|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
612656|NCT00587392|Long-term follow-up (LTFU)|long-term follow-up (ltfu)
612657|NCT00587392|Endoscopic Full-thickness Plication|endoscopic full-thickness plication
612658|NCT00587392|Plicator|plicator
612659|NCT00587379|testing for Endothelial Dysfunction and coronary angiography|testing for endothelial dysfunction and coronary angiography
612660|NCT00587353|tobacco use cessation|tobacco use cessation
612661|NCT00587353|radiation oncology|radiation oncology
612662|NCT00587353|smoking|smoking
612663|NCT00587314|Photodynamic Therapy|photodynamic therapy
612664|NCT00587314|Barrett's Esophagus|barrett's esophagus
612665|NCT00587314|Early Esophageal Adenocarcinoma|early esophageal adenocarcinoma
612666|NCT00587301|Child Obesity|child obesity
612667|NCT00587288|Cinquil™|cinquil™
612668|NCT00587288|Reslizumab|reslizumab
612669|NCT00587275|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
612670|NCT00587275|GERD|gerd
612671|NCT00587262|Cochlear|cochlear
612672|NCT00587262|Hearing|hearing
612673|NCT00587262|High frequency hearing loss|high frequency hearing loss
612674|NCT00587249|Malaria, Plasmodium falciparium, Hepatitis B Core Antigen, Circumsporozoite Epitopes|malaria, plasmodium falciparium, hepatitis b core antigen, circumsporozoite epitopes
612675|NCT00587236|Autofluorescence|autofluorescence
612676|NCT00587236|Narrow Band|narrow band
612677|NCT00587236|High definition white light|high definition white light
612678|NCT00587210|Crohn Disease|crohn disease
612679|NCT00587210|Inflammatory Bowel Disease|inflammatory bowel disease
612680|NCT00587197|esophageal varices|esophageal varices
612681|NCT00587197|portal hypertension|portal hypertension
612682|NCT00587197|gastric varices|gastric varices
612683|NCT00587197|cost effectiveness|cost effectiveness
612684|NCT00587184|Barrett's Esophagus|barrett's esophagus
612685|NCT00587184|Confocal Microscopy|confocal microscopy
612686|NCT00587171|Amblyopia|amblyopia
612687|NCT00587171|Vision Therapy|vision therapy
612688|NCT00587171|Patching|patching
612689|NCT00587158|Paricalcitol|paricalcitol
612690|NCT00587158|Parathyroid Hormone|parathyroid hormone
612691|NCT00587158|Bone Alkaline Phosphatase|bone alkaline phosphatase
612692|NCT00587158|Chronic Kidney Disease|chronic kidney disease
612693|NCT00587158|Glomerular Filtration Rate|glomerular filtration rate
612694|NCT00587158|Vitamin D Receptor|vitamin d receptor
612695|NCT00587158|Interstitial Fibrosis and Tubular Atrophy|interstitial fibrosis and tubular atrophy
612696|NCT00587158|Zemplar®|zemplar®
612697|NCT00587145|Stomach Neoplasms|stomach neoplasms
612698|NCT00587145|Secondary|secondary
612699|NCT00587145|Combination chemotherapy|combination chemotherapy
612700|NCT00587145|S-1|s-1
612701|NCT00587145|Docetaxel|docetaxel
612702|NCT00587145|oxaliplatin|oxaliplatin
612703|NCT00587132|Diabetes mellitus|diabetes mellitus
612704|NCT00587132|Peutz-Jeghers syndrome|peutz-jeghers syndrome
612705|NCT00587119|Urso|urso
612706|NCT00587119|Budesonide|budesonide
612707|NCT00587119|PBC|pbc
612708|NCT00587119|overlap AIH|overlap aih
612709|NCT00587119|PBC with overlap features of autoimmune hepatitis|pbc with overlap features of autoimmune hepatitis
612710|NCT00587093|Newly diagnosed|newly diagnosed
612711|NCT00587093|CA 125|ca 125
612712|NCT00587093|CT scan|ct scan
612713|NCT00587093|01-048|01-048
612714|NCT00587067|FUDR|fudr
612715|NCT00587067|FLOXORUIDINE|floxoruidine
612716|NCT00587067|DEXAMETHASONE|dexamethasone
612717|NCT00587067|Hepatic|hepatic
612718|NCT00587067|Cancer|cancer
612719|NCT00587067|02-120|02-120
612720|NCT00587054|leukemia|leukemia
612721|NCT00587054|non-Hodgkins|non-hodgkins
612722|NCT00587054|lymphoblastic lymphoma|lymphoblastic lymphoma
612723|NCT00587054|myelodysplastic syndrome|myelodysplastic syndrome
612724|NCT00587054|paroxysmal nocturnal hemoglobinuria (PNH)|paroxysmal nocturnal hemoglobinuria (pnh)
612725|NCT00587054|cytoreductive regimen|cytoreductive regimen
612726|NCT00587054|allogeneic stem cell transplant|allogeneic stem cell transplant
612727|NCT00587041|Synbiotic|synbiotic
612728|NCT00587041|Urine Oxalate|urine oxalate
612729|NCT00587041|Probiotic|probiotic
612730|NCT00587041|Kidney Stone|kidney stone
612731|NCT00587041|Gastric Bypass|gastric bypass
612732|NCT00587041|Crohn's|crohn's
612733|NCT00587041|Stone|stone
612734|NCT00587041|Hyperoxaluria|hyperoxaluria
612735|NCT00587041|Enteric Hyperoxaluria|enteric hyperoxaluria
612736|NCT00587028|Colonography|colonography
612737|NCT00587028|Colonoscopy|colonoscopy
612738|NCT00587028|Virtual|virtual
612739|NCT00587028|Computed Tomographic Colonography|computed tomographic colonography
612740|NCT00587028|Large intestine|large intestine
612741|NCT00587028|colon|colon
612742|NCT00587002|Acute Coronary Syndrome|acute coronary syndrome
612743|NCT00587002|Women|women
612744|NCT00586989|Barrett's Esophagus|barrett's esophagus
612745|NCT00586989|Esophageal Cancer|esophageal cancer
612746|NCT00586989|High Grade Dysplasia|high grade dysplasia
612747|NCT00586976|pain, ropivacaine, infusion, sternotomy|pain, ropivacaine, infusion, sternotomy
612748|NCT00586963|Erosive Esophagitis|erosive esophagitis
612749|NCT00586963|Reflux Esophagitis|reflux esophagitis
612750|NCT00586963|GERD|gerd
612751|NCT00586950|Myocardial Free Fatty Acid metabolism|myocardial free fatty acid metabolism
612752|NCT00586950|High risk patients|high risk patients
612753|NCT00586950|End-stage renal failure|end-stage renal failure
612754|NCT00586950|Cardiovascular events|cardiovascular events
612755|NCT00586950|prognosis|prognosis
612756|NCT00586937|Lung Cancer Survivors|lung cancer survivors
612757|NCT00586911|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
612758|NCT00586911|NASH|nash
612759|NCT00586911|Betaine|betaine
612760|NCT00586898|Prostate|prostate
612761|NCT00586898|Cancer|cancer
612762|NCT00586898|Hormones|hormones
612763|NCT00586898|01-085|01-085
612764|NCT00586898|ANTIFUNGAL ANTIBIOTICS|antifungal antibiotics
612765|NCT00586898|ESTROGENS|estrogens
612766|NCT00586898|LUPRON|lupron
612767|NCT00586898|TESTOSTERONE|testosterone
612768|NCT00586898|ZOLADEX|zoladex
612769|NCT00586885|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
612770|NCT00586885|NASH|nash
612771|NCT00586885|L-Alanine|l-alanine
612772|NCT00586872|Barrett's Esophagus|barrett's esophagus
612773|NCT00586872|Early Esophageal Adenocarcinoma|early esophageal adenocarcinoma
612774|NCT00586872|Endoscopic Mucosal Resection|endoscopic mucosal resection
612775|NCT00586859|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
612776|NCT00586859|NDO Full-thickness Plicator|ndo full-thickness plicator
612777|NCT00586859|Plicator|plicator
612778|NCT00586859|Endoluminal GERD Therapy|endoluminal gerd therapy
612779|NCT00586846|Cisplatin|cisplatin
612780|NCT00586846|Doxorubicin|doxorubicin
612781|NCT00586846|Methotrexate|methotrexate
612782|NCT00586846|Osteosarcoma|osteosarcoma
612783|NCT00586846|03-074|03-074
612784|NCT00586833|Heart Failure|heart failure
612785|NCT00586833|Heart Failure, Diastolic|heart failure, diastolic
612786|NCT00586833|Dyspnea, Paroxysmal|dyspnea, paroxysmal
612787|NCT00586833|Edema, Cardiac|edema, cardiac
612788|NCT00586820|Coronary Atherosclerosis|coronary atherosclerosis
612789|NCT00586820|Microvascular Dysfunction|microvascular dysfunction
612790|NCT00586820|Non-ST Elevation Myocardial Infarction|non-st elevation myocardial infarction
612791|NCT00586807|Ulcerative colitis|ulcerative colitis
612792|NCT00586807|pediatrics|pediatrics
612793|NCT00586807|UC|uc
612794|NCT00586807|protein metabolism|protein metabolism
612795|NCT00586807|energy expenditure|energy expenditure
612796|NCT00586794|Hypertension|hypertension
612797|NCT00586794|Eisenmenger|eisenmenger
612798|NCT00586781|ankle replacement|ankle replacement
612799|NCT00586781|end-stage arthritis of the ankle|end-stage arthritis of the ankle
612800|NCT00586781|degenerative ankle disease|degenerative ankle disease
612801|NCT00586755|Intensive Induction|intensive induction
612802|NCT00586755|High Dose Chemotherapy|high dose chemotherapy
612803|NCT00586755|Bone Marrow Transplantation|bone marrow transplantation
612804|NCT00586755|Mantle Cell Lymphoma|mantle cell lymphoma
612805|NCT00586742|SLAP lesions|slap lesions
612806|NCT00586742|labral repair|labral repair
612807|NCT00586742|bicepstenodesis|bicepstenodesis
612808|NCT00586742|conservative treatment|conservative treatment
612809|NCT00586729|Burn|burn
612810|NCT00586729|Burn wound management|burn wound management
612811|NCT00586729|Burn graft|burn graft
612812|NCT00586703|Stem cell transplant|stem cell transplant
612813|NCT00586703|mismatched donor|mismatched donor
612814|NCT00586703|NK infusion|nk infusion
612815|NCT00586690|Stem cell transplant|stem cell transplant
612816|NCT00586690|matched donor|matched donor
612817|NCT00586690|NK infusion|nk infusion
612818|NCT00586677|child abuse|child abuse
612819|NCT00586677|child neglect|child neglect
612820|NCT00586677|PCIT|pcit
612821|NCT00586677|Lutzker|lutzker
612822|NCT00586677|attachment|attachment
612823|NCT00586677|parenting|parenting
612824|NCT00586638|cognition|cognition
612825|NCT00586638|cognition disorders|cognition disorders
612826|NCT00586638|executive function|executive function
612827|NCT00586638|cognitive control|cognitive control
612828|NCT00586638|attentional control|attentional control
612829|NCT00586638|biomedical enhancement|biomedical enhancement
612830|NCT00586638|cognitive enhancement|cognitive enhancement
612831|NCT00586638|computerized|computerized
612832|NCT00586638|computer-based|computer-based
612833|NCT00586638|video game|video game
612834|NCT00586612|Conjugate vaccine|conjugate vaccine
612835|NCT00586612|Persistence|persistence
612836|NCT00586612|Hib vaccine|hib vaccine
612837|NCT00586612|Combination vaccine|combination vaccine
612838|NCT00586612|Meningococcal vaccine|meningococcal vaccine
612839|NCT00586612|Safety|safety
612840|NCT00586612|Preterm/full-term infants|preterm/full-term infants
612841|NCT00586612|Immunogenicity|immunogenicity
612842|NCT00586599|IBD|ibd
612843|NCT00586599|CD|cd
612844|NCT00586599|UC|uc
612845|NCT00586599|Crohn's Disease|crohn's disease
612846|NCT00586599|Ulcerative Colitis|ulcerative colitis
612847|NCT00586599|Pediatric|pediatric
612848|NCT00586599|inflammatory markers|inflammatory markers
612849|NCT00586573|ADHD|adhd
612850|NCT00586573|Namenda|namenda
612851|NCT00586560|solid tumors|solid tumors
612852|NCT00586547|Haploidentical|haploidentical
612853|NCT00586547|Stem Cell Transplant|stem cell transplant
612854|NCT00586547|Graft-Versus-Host disease|graft-versus-host disease
612855|NCT00586534|crack, cocaine, addiction treatment, virtual reality|crack, cocaine, addiction treatment, virtual reality
612856|NCT00586521|Coagulation Disorders|coagulation disorders
612857|NCT00586495|Sorafenib|sorafenib
612858|NCT00586495|Nexavar|nexavar
612859|NCT00586495|Metastatic RCC|metastatic rcc
612860|NCT00586495|Renal Cell Carcinoma|renal cell carcinoma
612861|NCT00586495|Unresectable RCC|unresectable rcc
612862|NCT00586482|cigarettes, surgery|cigarettes, surgery
612863|NCT00586482|Smokers scheduled for elective surgery|smokers scheduled for elective surgery
612864|NCT00586469|Influenza|influenza
612865|NCT00586443|solid tumors|solid tumors
612866|NCT00586443|avastin|avastin
612867|NCT00586443|Phase I|phase i
612868|NCT00586443|Phase 1|phase 1
612869|NCT00586443|combination therapy|combination therapy
612870|NCT00586443|bevacizumab|bevacizumab
612871|NCT00586443|RAD001|rad001
612872|NCT00586443|everolimus|everolimus
612873|NCT00586443|pantitumumab|pantitumumab
612874|NCT00586430|apolipoprotein E e4|apolipoprotein e e4
612875|NCT00586430|Alzheimer's disease|alzheimer's disease
612876|NCT00586430|somnolence|somnolence
612877|NCT00586430|Early detection|early detection
612878|NCT00586417|angiogenesis|angiogenesis
612879|NCT00586417|tumor angiogenesis|tumor angiogenesis
612880|NCT00586417|biomarkers|biomarkers
612881|NCT00586417|healthy volunteers|healthy volunteers
612882|NCT00586404|Barrett's Esophagus|barrett's esophagus
612883|NCT00586404|Esophageal neoplasms|esophageal neoplasms
612884|NCT00586404|gastroesophageal reflux|gastroesophageal reflux
612885|NCT00586404|gastrointestinal neoplasms|gastrointestinal neoplasms
612886|NCT00586391|B cell Lymphoma|b cell lymphoma
612887|NCT00586391|Cancer|cancer
612888|NCT00586391|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
612889|NCT00586391|CD19 CHIMERIC RECEPTOR EXPRESSING T LYMPHOCYTES|cd19 chimeric receptor expressing t lymphocytes
612890|NCT00586391|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
612891|NCT00586365|complex elbow trauma|complex elbow trauma
612892|NCT00586365|prevention|prevention
612893|NCT00586365|complication|complication
612894|NCT00586365|naproxen|naproxen
612895|NCT00586365|NSAIDS|nsaids
612896|NCT00586352|Pediatric|pediatric
612897|NCT00586352|Crohn's disease|crohn's disease
612898|NCT00586352|Ulcerative colitis|ulcerative colitis
612899|NCT00586339|HPV|hpv
612900|NCT00586339|Human papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
612901|NCT00586339|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
612902|NCT00586339|Cervical cancer|cervical cancer
612903|NCT00586339|Papillomavirus|papillomavirus
612904|NCT00586326|MammoSite|mammosite
612905|NCT00586326|DCIS|dcis
612906|NCT00586313|EUS Biopsy for Non-alcoholic Fatty Liver Disease|eus biopsy for non-alcoholic fatty liver disease
612907|NCT00586300|Knee pain|knee pain
612908|NCT00586287|Phenprocoumon|phenprocoumon
612909|NCT00586287|Dosing algorithm|dosing algorithm
612910|NCT00586287|loading dose|loading dose
612911|NCT00586274|Stem Cell Transplant|stem cell transplant
612912|NCT00586274|Anemia|anemia
612913|NCT00586274|Fanconi|fanconi
612914|NCT00586261|Kidney Failure, Chronic|kidney failure, chronic
612915|NCT00586261|Renal Insufficiency, Chronic|renal insufficiency, chronic
612916|NCT00586261|Proteinuria|proteinuria
612917|NCT00586261|Albuminuria|albuminuria
612918|NCT00586248|Peripheral nerve stimulator, cardiac pacemaker|peripheral nerve stimulator, cardiac pacemaker
612919|NCT00586235|Fusion|fusion
612920|NCT00586235|Ultrasound|ultrasound
612921|NCT00586235|Computed tomography|computed tomography
612922|NCT00586222|Omega-3 Fatty Acids|omega-3 fatty acids
612923|NCT00586222|Pediatric Bipolar Disorder|pediatric bipolar disorder
612924|NCT00586222|Adolescent Bipolar Disorder|adolescent bipolar disorder
612925|NCT00586222|MRS|mrs
612926|NCT00586209|sickle cell disease|sickle cell disease
612927|NCT00586209|sickle cell anemia|sickle cell anemia
612928|NCT00586209|L-glutamine|l-glutamine
612929|NCT00586209|Sickle Cell Anemia (homozygous and heterozygous)|sickle cell anemia (homozygous and heterozygous)
612930|NCT00586209|Sickle ß0-Thalassemia|sickle ß0-thalassemia
612931|NCT00586196|Delirium|delirium
612932|NCT00586196|Postoperative confusion|postoperative confusion
612933|NCT00586196|Hip fracture|hip fracture
612934|NCT00586196|Long bone fracture|long bone fracture
612935|NCT00586183|Ventricular Remodeling|ventricular remodeling
612936|NCT00586170|nonunion|nonunion
612937|NCT00586170|fracture|fracture
612938|NCT00586157|ADHD|adhd
612939|NCT00586157|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
612940|NCT00586157|Daytrana|daytrana
612941|NCT00586157|MTS Patch|mts patch
612942|NCT00586157|Methylphenidate Transdermal System|methylphenidate transdermal system
612943|NCT00586131|end-stage renal disease|end-stage renal disease
612944|NCT00586131|automated peritoneal dialysis|automated peritoneal dialysis
612945|NCT00586131|metabolic acidosis|metabolic acidosis
612946|NCT00586131|nitrogen balances|nitrogen balances
612947|NCT00586118|Sedation|sedation
612948|NCT00586118|Volatile anaesthetic|volatile anaesthetic
612949|NCT00586118|Sevoflurane|sevoflurane
612950|NCT00586118|Propofol|propofol
612951|NCT00586118|Recovery|recovery
612952|NCT00586105|Sorafenib|sorafenib
612953|NCT00586105|Nexavar|nexavar
612954|NCT00586105|Metastatic RCC|metastatic rcc
612955|NCT00586105|Renal Cell Carcinoma|renal cell carcinoma
612956|NCT00586105|Unresectable RCC|unresectable rcc
612957|NCT00586092|Phase I|phase i
612958|NCT00586092|Phase 1|phase 1
612959|NCT00586092|avastin|avastin
612960|NCT00586092|bevacizumab|bevacizumab
612961|NCT00586092|ABT-510|abt-510
612962|NCT00586092|solid tumors|solid tumors
612963|NCT00586092|angiogenesis|angiogenesis
612964|NCT00586066|Bipolar disorder|bipolar disorder
612965|NCT00586066|Cognitive dysfunction|cognitive dysfunction
612966|NCT00586066|Memantine|memantine
612967|NCT00586066|NMDA antagonist|nmda antagonist
612968|NCT00586053|Colonic Polyps|colonic polyps
612969|NCT00586053|Colon|colon
612970|NCT00586053|Large Intestine|large intestine
612971|NCT00586053|Cecum|cecum
612972|NCT00586053|Sigmoid|sigmoid
612973|NCT00586053|Rectum|rectum
612974|NCT00586053|Colonoscopy|colonoscopy
612975|NCT00586053|Virtual Colonoscopy|virtual colonoscopy
612976|NCT00586053|CT Colonography|ct colonography
612977|NCT00586053|Computed Tomographic Colonography|computed tomographic colonography
612978|NCT00586053|Colonography|colonography
612979|NCT00586040|skin cancer|skin cancer
612980|NCT00586040|skin excision|skin excision
612981|NCT00586040|laser|laser
612982|NCT00586040|superficial sutures|superficial sutures
612983|NCT00586040|wound healing|wound healing
612984|NCT00586027|cardiac surgery|cardiac surgery
612985|NCT00586027|low cardiac output|low cardiac output
612986|NCT00586027|natriuretic peptide B|natriuretic peptide b
612987|NCT00586027|mortality|mortality
612988|NCT00586027|morbidity|morbidity
612989|NCT00586014|Multiple myeloma|multiple myeloma
612990|NCT00586014|Autologous Stem Cell Transplant|autologous stem cell transplant
612991|NCT00586001|Anxiety|anxiety
612992|NCT00586001|Emotional Disorders|emotional disorders
612993|NCT00586001|Unified|unified
612994|NCT00586001|Depression|depression
612995|NCT00585962|proton beam radiation|proton beam radiation
612996|NCT00585910|ADHD|adhd
612997|NCT00585910|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
612998|NCT00585910|Strattera|strattera
612999|NCT00585910|Concerta|concerta
613000|NCT00585910|Atomoxetine|atomoxetine
613001|NCT00585910|OROS Methylphenidate|oros methylphenidate
613002|NCT00585897|Diabetes|diabetes
613003|NCT00585897|Obesity|obesity
613004|NCT00585884|Reconstruction, Silicone prostheses|reconstruction, silicone prostheses
613005|NCT00585871|ICD patients with 5 VTs per 3 month period|icd patients with 5 vts per 3 month period
613006|NCT00585845|Cancer|cancer
613007|NCT00585845|Ovarian cancer|ovarian cancer
613008|NCT00585845|Pancreatic cancer|pancreatic cancer
613009|NCT00585845|Non-small cell lung cancer|non-small cell lung cancer
613010|NCT00585845|Mesothelioma|mesothelioma
613011|NCT00585845|Mesothelin|mesothelin
613012|NCT00585845|Immunotherapy|immunotherapy
613013|NCT00585832|hypertension|hypertension
613014|NCT00585832|pre-hypertension|pre-hypertension
613015|NCT00585832|adolescents|adolescents
613016|NCT00585832|diet|diet
613017|NCT00585832|vascular function|vascular function
613018|NCT00585806|Heart Failure with preserved ejection fraction|heart failure with preserved ejection fraction
613019|NCT00585793|HIV/AIDS|hiv/aids
613020|NCT00585767|Hydronephrosis|hydronephrosis
613021|NCT00585715|Cellulite|cellulite
613022|NCT00585715|Nd:YAG Laser|nd:yag laser
613023|NCT00585702|Bipolar Disorder|bipolar disorder
613024|NCT00585702|Pregnancy|pregnancy
613025|NCT00585702|Infant Development|infant development
613026|NCT00585689|Locally advanced urothelial carcinoma of the bladder|locally advanced urothelial carcinoma of the bladder
613027|NCT00585650|palmoplantar psoriasis|palmoplantar psoriasis
613028|NCT00585650|etanercept|etanercept
613029|NCT00585650|Enbrel|enbrel
613030|NCT00585637|Vitamin D|vitamin d
613031|NCT00585637|Blacks|blacks
613032|NCT00585637|cancer|cancer
613033|NCT00585637|hypertension|hypertension
613034|NCT00585624|Esophagectomy|esophagectomy
613035|NCT00585624|Pancreaticoduodenectomy|pancreaticoduodenectomy
613036|NCT00585624|Whipple|whipple
613037|NCT00585611|Heart Failure, Congestive|heart failure, congestive
613038|NCT00585585|Depression|depression
613039|NCT00585585|Betahistine Dihydrochloride|betahistine dihydrochloride
613040|NCT00585572|Normal Tissues/Brains|normal tissues/brains
613041|NCT00585572|Alzheimer|alzheimer
613042|NCT00585572|Motor Neuron Disease|motor neuron disease
613043|NCT00585572|Dementia|dementia
613044|NCT00585572|Healthy Control Volunteers|healthy control volunteers
613045|NCT00585572|Populations At Risk|populations at risk
613046|NCT00585572|MCI|mci
613047|NCT00585559|Lipid|lipid
613048|NCT00585559|Peroxidation|peroxidation
613049|NCT00585559|N-Acetylcysteine|n-acetylcysteine
613050|NCT00585559|Acetaminophen|acetaminophen
613051|NCT00585559|Vasospasm|vasospasm
613052|NCT00585546|heart failure|heart failure
613053|NCT00585546|dilated cardiomyopathy|dilated cardiomyopathy
613054|NCT00585546|heart assist device|heart assist device
613055|NCT00585546|clenbuterol|clenbuterol
613056|NCT00585546|adrenergic beta agonists|adrenergic beta agonists
613057|NCT00585546|heart transplantation|heart transplantation
613058|NCT00585507|hormone receptor positive breast cancer|hormone receptor positive breast cancer
613059|NCT00585507|Fulvestrant|fulvestrant
613060|NCT00585481|Epidemiological Study|epidemiological study
613061|NCT00585481|Incidence of severe Respiratory Syncytial Virus|incidence of severe respiratory syncytial virus
613062|NCT00585481|Preterm Brazilian children|preterm brazilian children
613063|NCT00585455|vascular endothelium|vascular endothelium
613064|NCT00585455|nitric oxide|nitric oxide
613065|NCT00585455|depression|depression
613066|NCT00585455|heart failure|heart failure
613067|NCT00585455|vascular biology|vascular biology
613068|NCT00585416|Prostate Cancer|prostate cancer
613069|NCT00585416|Hormone Refractory|hormone refractory
613070|NCT00585416|Metastatic|metastatic
613071|NCT00585364|Allergic Bronchopulmonary Aspergillosis|allergic bronchopulmonary aspergillosis
613072|NCT00585364|Aspergillus fumigatus|aspergillus fumigatus
613073|NCT00585364|cytokine expression|cytokine expression
613074|NCT00585338|facial telangiectasia,|facial telangiectasia,
613075|NCT00585338|leg vein telangiectasia|leg vein telangiectasia
613076|NCT00585338|Port Wine Stain birthmarks|port wine stain birthmarks
613077|NCT00585312|FAP|fap
613078|NCT00585299|steatosis|steatosis
613079|NCT00585299|fatty liver|fatty liver
613080|NCT00585299|insulin sensitivity|insulin sensitivity
613081|NCT00585299|fatty liver (steatosis)|fatty liver (steatosis)
613082|NCT00585286|acne vulgaris|acne vulgaris
613083|NCT00585286|scarring|scarring
613084|NCT00585286|laser|laser
613085|NCT00585260|asthma|asthma
613086|NCT00585260|bronchoprovocation challenge test|bronchoprovocation challenge test
613087|NCT00585260|mannitol|mannitol
613088|NCT00585260|methacholine|methacholine
613089|NCT00585247|birthmarks|birthmarks
613090|NCT00585221|Gastrointestinal stromal tumors|gastrointestinal stromal tumors
613091|NCT00585221|Imatinib|imatinib
613092|NCT00585221|Peginterferon α-2b|peginterferon α-2b
613093|NCT00585221|Immunotherapy|immunotherapy
613094|NCT00585221|Targeted therapy|targeted therapy
613095|NCT00585208|insomnia|insomnia
613096|NCT00585208|sleep disturbance|sleep disturbance
613097|NCT00585208|bipolar disorder|bipolar disorder
613098|NCT00585195|Crizotinib|crizotinib
613099|NCT00585195|dose-finding|dose-finding
613100|NCT00585195|drug-drug interaction|drug-drug interaction
613101|NCT00585195|ALK rearrangements|alk rearrangements
613102|NCT00585195|c-Met mutations or amplifications|c-met mutations or amplifications
613103|NCT00585195|c-Met dependent tumors|c-met dependent tumors
613104|NCT00585195|ROS1 rearrangements|ros1 rearrangements
613105|NCT00585195|c-Met exon 14 deletion|c-met exon 14 deletion
613106|NCT00585195|c-Met exon 14 skipping|c-met exon 14 skipping
613107|NCT00585195|c-Met exon 14 alterations|c-met exon 14 alterations
613108|NCT00585182|Obesity|obesity
613109|NCT00585182|venous thrombosis|venous thrombosis
613110|NCT00585182|Anticoagulants|anticoagulants
613111|NCT00585169|Pathological Gambling|pathological gambling
613112|NCT00585169|Compulsive Gambling|compulsive gambling
613113|NCT00585169|Gambling Addiction|gambling addiction
613114|NCT00585169|Gambling|gambling
613115|NCT00585169|Treatment|treatment
613116|NCT00585169|Memantine|memantine
613117|NCT00585169|Pharmacology|pharmacology
613118|NCT00585156|Celebrex, Bone Ingrowth, Pain relief|celebrex, bone ingrowth, pain relief
613119|NCT00585143|Dyslipidemia|dyslipidemia
613120|NCT00585078|capecitabine|capecitabine
613121|NCT00585078|oxaliplatin|oxaliplatin
613122|NCT00585052|Ovarian Cancer|ovarian cancer
613123|NCT00585052|Epithelial Ovarian Cancer|epithelial ovarian cancer
613124|NCT00585052|Lovastatin|lovastatin
613125|NCT00585052|Paclitaxel|paclitaxel
613126|NCT00585039|child|child
613127|NCT00585039|emergency department|emergency department
613128|NCT00585026|Refractive error|refractive error
613129|NCT00585026|Asthenopia|asthenopia
613130|NCT00585026|Presbyopia|presbyopia
613131|NCT00585026|Eyeglasses|eyeglasses
613132|NCT00585026|Productivity|productivity
613133|NCT00585026|Visual comfort|visual comfort
613134|NCT00585026|Ergonomics|ergonomics
613135|NCT00585013|Inhaled Nitric Oxide (NO)|inhaled nitric oxide (no)
613136|NCT00585013|Anti-inflammatory|anti-inflammatory
613137|NCT00585013|Anti-reperfusion agent|anti-reperfusion agent
613138|NCT00584974|Depression|depression
613139|NCT00584974|Mental Disorders|mental disorders
613140|NCT00584974|Mood Disorders|mood disorders
613141|NCT00584974|Depressive Disorder, Major|depressive disorder, major
613142|NCT00584974|Dysthymic Disorder|dysthymic disorder
613143|NCT00584961|Metabolic Syndrome, Bipolar Disorder and Cardiovascular Risk Factors|metabolic syndrome, bipolar disorder and cardiovascular risk factors
613144|NCT00584948|FXTAS, Fragile X Premutation|fxtas, fragile x premutation
613145|NCT00584935|Pemphigoid|pemphigoid
613146|NCT00584935|Blistering Diseases|blistering diseases
613147|NCT00584935|Blindness|blindness
613148|NCT00584935|Autoimmune|autoimmune
613149|NCT00584935|Rituximab|rituximab
613150|NCT00584922|Esophageal injury|esophageal injury
613151|NCT00584922|Catheter Ablation|catheter ablation
613152|NCT00584922|Atrial Fibrillation|atrial fibrillation
613153|NCT00584896|heart disease|heart disease
613154|NCT00584896|coronary artery disease|coronary artery disease
613155|NCT00584896|echocardiogram|echocardiogram
613156|NCT00584896|ultrasound|ultrasound
613157|NCT00584896|angiogram|angiogram
613158|NCT00584896|SPECT|spect
613159|NCT00584896|chest pain|chest pain
613160|NCT00584896|perfusion|perfusion
613161|NCT00584883|Patients who have newly diagnosed brain tumors|patients who have newly diagnosed brain tumors
613162|NCT00584844|Live Vaccine Strain (LVS), Bacterial Infections, Ulceroglandular, Oculoglandular|live vaccine strain (lvs), bacterial infections, ulceroglandular, oculoglandular
613163|NCT00584831|astigmatism|astigmatism
613164|NCT00584831|visual acuity|visual acuity
613165|NCT00584831|orientation|orientation
613166|NCT00584831|contact lenses|contact lenses
613167|NCT00584818|coronary artery disease|coronary artery disease
613168|NCT00584818|chest pain|chest pain
613169|NCT00584818|healthy volunteers|healthy volunteers
613170|NCT00584818|SPECT|spect
613171|NCT00584818|angiogram|angiogram
613172|NCT00584818|ultrasound|ultrasound
613173|NCT00584818|echocardiogram|echocardiogram
613174|NCT00584818|perfusion|perfusion
613175|NCT00584805|EEE|eee
613176|NCT00584792|Prostate Cancer|prostate cancer
613177|NCT00584779|Gabapentin Pharmacokinetics, renal impairment|gabapentin pharmacokinetics, renal impairment
613178|NCT00584753|Breast cancer|breast cancer
613179|NCT00584740|Crohn's disease, moderate, severe, active, AIN457|crohn's disease, moderate, severe, active, ain457
613180|NCT00584727|astigmatism|astigmatism
613181|NCT00584727|visual acuity|visual acuity
613182|NCT00584727|fit|fit
613183|NCT00584727|comfort|comfort
613184|NCT00584727|satisfaction|satisfaction
613185|NCT00584727|contact lens|contact lens
613186|NCT00584714|ultrasound|ultrasound
613187|NCT00584714|perfusion|perfusion
613188|NCT00584714|SPECT|spect
613189|NCT00584714|coronary artery disease|coronary artery disease
613190|NCT00584714|chest pain|chest pain
613191|NCT00584714|low probability|low probability
613192|NCT00584714|angiography|angiography
613193|NCT00584714|clinical outcomes|clinical outcomes
613194|NCT00584688|anorexia|anorexia
613195|NCT00584688|nervosa|nervosa
613196|NCT00584688|eating|eating
613197|NCT00584688|disorder|disorder
613198|NCT00584688|study|study
613199|NCT00584688|research|research
613200|NCT00584688|clinical|clinical
613201|NCT00584688|trial|trial
613202|NCT00584688|psychiatry|psychiatry
613203|NCT00584688|psychiatric|psychiatric
613204|NCT00584675|GERD|gerd
613205|NCT00584675|laryngopharyngeal reflux disease|laryngopharyngeal reflux disease
613206|NCT00584662|Rhinitis|rhinitis
613207|NCT00584649|Inappropriate Sinus Tachycardia|inappropriate sinus tachycardia
613208|NCT00584649|Inappropiate Tachycardia|inappropiate tachycardia
613209|NCT00584649|Sinus Tachycardia|sinus tachycardia
613210|NCT00584649|Palpitations|palpitations
613211|NCT00584649|Fast Heart rate|fast heart rate
613212|NCT00584636|child|child
613213|NCT00584636|emergency department|emergency department
613214|NCT00584623|dysphagia|dysphagia
613215|NCT00584623|videofluoroscopy|videofluoroscopy
613216|NCT00584623|flexible endoscopic evaluation|flexible endoscopic evaluation
613217|NCT00584610|Women's health|women's health
613218|NCT00584597|Radiation-Induced Mucositis|radiation-induced mucositis
613219|NCT00584597|Head and neck cancer|head and neck cancer
613220|NCT00584597|TRAUMEEL|traumeel
613221|NCT00584597|Mucositis|mucositis
613222|NCT00584597|Radiation|radiation
613223|NCT00584597|Oral cancer|oral cancer
613224|NCT00584597|Inflammation of the mouth|inflammation of the mouth
613225|NCT00584597|Homeopathic Medication|homeopathic medication
613226|NCT00584584|Allergic rhinitis, adults, monoclonal antibody, interleukin-13.|allergic rhinitis, adults, monoclonal antibody, interleukin-13.
613227|NCT00584558|Arrhythmia|arrhythmia
613228|NCT00584558|Catheter Ablation|catheter ablation
613229|NCT00584545|pharyngeal manometry|pharyngeal manometry
613230|NCT00584545|videofluoroscopy|videofluoroscopy
613231|NCT00584532|Localized|localized
613232|NCT00584532|Prostate|prostate
613233|NCT00584532|Cancer|cancer
613234|NCT00584519|Schizophrenia, Overweight, Cardiovascular Risk, Obesity|schizophrenia, overweight, cardiovascular risk, obesity
613235|NCT00584506|orbital fractures|orbital fractures
613236|NCT00584467|GEM|gem
613237|NCT00584467|Arteriosclerosis|arteriosclerosis
613238|NCT00584467|biomarkers|biomarkers
613239|NCT00584467|Atherosclerosis|atherosclerosis
613240|NCT00584454|Coxiella burnetti, Bacterial Infections, Rickettsia, Hepatits, Endocarditis|coxiella burnetti, bacterial infections, rickettsia, hepatits, endocarditis
613241|NCT00584428|Breast Cancer|breast cancer
613242|NCT00584428|Cancer Treatment|cancer treatment
613243|NCT00584428|Breast Cancer Treatment|breast cancer treatment
613244|NCT00584415|Catheter Ablation|catheter ablation
613245|NCT00584415|Atrial Fibrillation|atrial fibrillation
613246|NCT00584402|liver cancer|liver cancer
613247|NCT00584389|Obesity|obesity
613248|NCT00584389|Energy expenditure|energy expenditure
613249|NCT00584389|Fatty acid|fatty acid
613250|NCT00584389|Triglyceride|triglyceride
613251|NCT00584376|Essential tremor|essential tremor
613252|NCT00584376|tremor|tremor
613253|NCT00584376|pregabalin|pregabalin
613254|NCT00584376|lyrica|lyrica
613255|NCT00584350|coronary angiogram|coronary angiogram
613256|NCT00584350|percutaneous coronary intervention|percutaneous coronary intervention
613257|NCT00584337|tomography|tomography
613258|NCT00584337|coronary artery disease|coronary artery disease
613259|NCT00584337|Stress Test|stress test
613260|NCT00584337|Coronary CT Angiography|coronary ct angiography
613261|NCT00584337|Diagnostic Accuracy|diagnostic accuracy
613262|NCT00584337|Non invasive testing|non invasive testing
613263|NCT00584324|elective surgery|elective surgery
613264|NCT00584324|general anesthesia|general anesthesia
613265|NCT00584324|implicit memory|implicit memory
613266|NCT00584298|Barostat|barostat
613267|NCT00584298|distention|distention
613268|NCT00584298|IBS|ibs
613269|NCT00584298|irritable|irritable
613270|NCT00584298|bowel|bowel
613271|NCT00584298|syndrome|syndrome
613272|NCT00584298|colorectal|colorectal
613273|NCT00584298|sensation|sensation
613274|NCT00584298|modulation|modulation
613275|NCT00584298|reproducibility|reproducibility
613276|NCT00584272|cleft palate|cleft palate
613277|NCT00584272|suture materials|suture materials
613278|NCT00584259|GERD|gerd
613279|NCT00584259|Gastro-Esophageal Disease|gastro-esophageal disease
613280|NCT00584246|Restless legs syndrome|restless legs syndrome
613281|NCT00584246|RLS|rls
613282|NCT00584246|Pregabalin|pregabalin
613283|NCT00584246|Lyrica|lyrica
613284|NCT00584233|breast cancer|breast cancer
613285|NCT00584220|Astigmatism|astigmatism
613286|NCT00584220|vision|vision
613287|NCT00584220|comfort|comfort
613288|NCT00584220|satisfaction|satisfaction
613289|NCT00584220|contact lenses|contact lenses
613290|NCT00584207|uterine fibroids|uterine fibroids
613291|NCT00584194|Hemorrhagic Fever, Viral Infections, Neurologic diseases, Arbovirus Infections, RVF|hemorrhagic fever, viral infections, neurologic diseases, arbovirus infections, rvf
613292|NCT00584168|UPPP|uppp
613293|NCT00584168|Dexamethasone|dexamethasone
613294|NCT00584168|Uvulopalatopharyngoplasty|uvulopalatopharyngoplasty
613295|NCT00584168|Pain Management|pain management
613296|NCT00584168|Increasing pain management in patients that have undergone UPPP surgery|increasing pain management in patients that have undergone uppp surgery
613297|NCT00584155|Cisplatin Ototoxicity|cisplatin ototoxicity
613298|NCT00584155|Lactated Ringer's|lactated ringer's
613299|NCT00584155|Ear Cancer|ear cancer
613300|NCT00584155|Hearing loss|hearing loss
613301|NCT00584155|Hearing loss due to Cisplatin Ototoxicity|hearing loss due to cisplatin ototoxicity
613302|NCT00584142|breast cancer|breast cancer
613303|NCT00584142|survivors|survivors
613304|NCT00584129|Cancer|cancer
613305|NCT00584129|Dysphagia|dysphagia
613306|NCT00584129|Radiation|radiation
613436|NCT00583622|Gemcitabine|gemcitabine
613307|NCT00584129|Patients with H&N cancer who will be receiving chemoradiation|patients with h&n cancer who will be receiving chemoradiation
613308|NCT00584116|Aortic Valve Replacement|aortic valve replacement
613309|NCT00584116|AVR|avr
613310|NCT00584103|transradial amputation|transradial amputation
613311|NCT00584103|prosthesis|prosthesis
613312|NCT00584103|prefabricated prosthesis|prefabricated prosthesis
613313|NCT00584103|inexpensive|inexpensive
613314|NCT00584103|custom prosthesis|custom prosthesis
613315|NCT00584103|adult transradial amputation|adult transradial amputation
613316|NCT00584090|urinary incontinence|urinary incontinence
613317|NCT00584090|parkinson's disease|parkinson's disease
613318|NCT00584090|vesicare|vesicare
613319|NCT00584090|solifenacin succinate|solifenacin succinate
613320|NCT00584064|patent|patent
613321|NCT00584064|foramen|foramen
613322|NCT00584064|ovale|ovale
613323|NCT00584064|PFO|pfo
613324|NCT00584051|Control group|control group
613325|NCT00584038|contraceptive compliance|contraceptive compliance
613326|NCT00584038|educational intervention|educational intervention
613327|NCT00584038|oral contraception|oral contraception
613328|NCT00584025|Parkinson's disease|parkinson's disease
613329|NCT00584025|dyskinesia|dyskinesia
613330|NCT00584025|levetiracetam|levetiracetam
613331|NCT00584025|keppra|keppra
613332|NCT00584012|Any cancer|any cancer
613333|NCT00584012|Breast cancer|breast cancer
613334|NCT00584012|Lovastatin|lovastatin
613335|NCT00584012|Docetaxel|docetaxel
613336|NCT00583999|leptin, leptin receptors, adiponectin|leptin, leptin receptors, adiponectin
613337|NCT00583986|top mounted|top mounted
613338|NCT00583986|actuation indicator|actuation indicator
613339|NCT00583986|Asthma|asthma
613340|NCT00583986|COPD|copd
613341|NCT00583986|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
613342|NCT00583960|swallowing problems|swallowing problems
613343|NCT00583960|tracheal stenosis|tracheal stenosis
613344|NCT00583947|Asthma|asthma
613345|NCT00583947|Respiratory Tract Diseases|respiratory tract diseases
613346|NCT00583934|esophageal cancer, head and neck cancer, dysplasia|esophageal cancer, head and neck cancer, dysplasia
613347|NCT00583921|Atrial Fibrillation|atrial fibrillation
613348|NCT00583921|ICD|icd
613349|NCT00583921|BiV ICD|biv icd
613350|NCT00583921|CHF|chf
613351|NCT00583921|Congestive Heart Failure|congestive heart failure
613352|NCT00583921|AF|af
613353|NCT00583908|astigmatism|astigmatism
613354|NCT00583908|orientation|orientation
613355|NCT00583908|visual acuity|visual acuity
613356|NCT00583908|contact lenses|contact lenses
613357|NCT00583895|dermatitis|dermatitis
613358|NCT00583895|atopic|atopic
613359|NCT00583895|ImCOOH|imcooh
613360|NCT00583895|safety|safety
613361|NCT00583895|tolerability|tolerability
613362|NCT00583895|efficacy|efficacy
613363|NCT00583895|pharmacokinetics|pharmacokinetics
613364|NCT00583882|Central Venous Catheter|central venous catheter
613365|NCT00583882|Guidewire|guidewire
613366|NCT00583882|Burn|burn
613367|NCT00583869|Post-operative Pain|post-operative pain
613368|NCT00583869|Fracture Patients|fracture patients
613369|NCT00583869|Pregabalin|pregabalin
613370|NCT00583869|LYRICA|lyrica
613371|NCT00583856|computer aided design|computer aided design
613372|NCT00583856|maxillofacial fracture|maxillofacial fracture
613373|NCT00583856|orbital design|orbital design
613374|NCT00583843|Lumpectomy|lumpectomy
613375|NCT00583843|Ultrasonography|ultrasonography
613376|NCT00583843|Radiotherapy|radiotherapy
613377|NCT00583830|Lung Cancer|lung cancer
613378|NCT00583804|Spinal Cord Injury|spinal cord injury
613379|NCT00583804|Tetraplegia|tetraplegia
613380|NCT00583804|Functional Electrical Stimulation|functional electrical stimulation
613381|NCT00583804|Neuroprosthesis|neuroprosthesis
613382|NCT00583791|muscular|muscular
613383|NCT00583791|ventricular|ventricular
613384|NCT00583791|septal|septal
613385|NCT00583791|defects|defects
613386|NCT00583791|VSD|vsd
613387|NCT00583778|Asthma|asthma
613388|NCT00583778|Bronchodilators|bronchodilators
613389|NCT00583778|Levalbuterol|levalbuterol
613390|NCT00583778|Ipratropium|ipratropium
613391|NCT00583765|Kidney Failure, Acute|kidney failure, acute
613392|NCT00583765|Hemodialysis|hemodialysis
613393|NCT00583765|Hemofiltration|hemofiltration
613394|NCT00583765|Anticoagulation|anticoagulation
613395|NCT00583765|Citrate|citrate
613396|NCT00583752|prostate cancer|prostate cancer
613397|NCT00583752|vaccine|vaccine
613398|NCT00583752|immunotherapy|immunotherapy
613399|NCT00583739|Fatigue|fatigue
613400|NCT00583739|Yoga|yoga
613401|NCT00583739|Anxiety|anxiety
613402|NCT00583739|Quality of Life|quality of life
613403|NCT00583726|chemotherapy|chemotherapy
613404|NCT00583726|exercise|exercise
613405|NCT00583726|diet|diet
613406|NCT00583726|fruit|fruit
613407|NCT00583726|vegetables|vegetables
613408|NCT00583726|low-fat|low-fat
613409|NCT00583700|Breast Neoplasms|breast neoplasms
613410|NCT00583700|Radiotherapy|radiotherapy
613411|NCT00583687|Arterial pulse contour cardiac output|arterial pulse contour cardiac output
613412|NCT00583687|Changing vascular tone|changing vascular tone
613413|NCT00583687|Tissue Oxymetry|tissue oxymetry
613414|NCT00583687|Prediction of Fluid Responsiveness|prediction of fluid responsiveness
613415|NCT00583674|Gastric Cancer|gastric cancer
613416|NCT00583674|Metastatic Gastric, Gastroesophageal Junction, or Distal Esophageal Adenocarcinoma|metastatic gastric, gastroesophageal junction, or distal esophageal adenocarcinoma
613417|NCT00583674|AMG 386|amg 386
613418|NCT00583674|Cisplatin|cisplatin
613419|NCT00583674|Capecitabine|capecitabine
613420|NCT00583661|Ventricular Assist Device|ventricular assist device
613421|NCT00583661|Pediatric Ventricular Assist Device|pediatric ventricular assist device
613422|NCT00583648|urinary tract infections|urinary tract infections
613423|NCT00583648|urine|urine
613424|NCT00583648|urinalysis|urinalysis
613425|NCT00583648|urine protocols|urine protocols
613426|NCT00583648|urinalysis protocols|urinalysis protocols
613427|NCT00583648|nursing protocols|nursing protocols
613428|NCT00583648|Emergency Department|emergency department
613429|NCT00583635|Preeclampsia|preeclampsia
613430|NCT00583635|Prevention|prevention
613431|NCT00583635|Food Supplement|food supplement
613432|NCT00583622|Ovarian Cancer|ovarian cancer
613433|NCT00583622|Epithelial Ovarian Cancer|epithelial ovarian cancer
613434|NCT00583622|Bevacizumab|bevacizumab
613435|NCT00583622|Carboplatin|carboplatin
613437|NCT00583622|Docetaxel|docetaxel
613438|NCT00583622|Melphalan|melphalan
613439|NCT00583596|patent ductus arteriosus (PDA)|patent ductus arteriosus (pda)
613440|NCT00583557|Rheumatoid Arthritis|rheumatoid arthritis
613442|NCT00583544|Healthy|healthy
613443|NCT00583544|Healthy Volunteers|healthy volunteers
613444|NCT00583531|Antibiotic-refractory Pouchitis|antibiotic-refractory pouchitis
613445|NCT00583531|Pouchitis|pouchitis
613446|NCT00583531|Ulcerative Colitis|ulcerative colitis
613447|NCT00583505|membranous|membranous
613448|NCT00583505|ventricular|ventricular
613449|NCT00583505|septal|septal
613450|NCT00583505|defects|defects
613451|NCT00583505|VSD|vsd
613452|NCT00583492|Prostatic Neoplasms|prostatic neoplasms
613453|NCT00583492|Prostate Cancer|prostate cancer
613454|NCT00583492|Adenocarinomas|adenocarinomas
613455|NCT00583492|Tumors of the Prostate|tumors of the prostate
613456|NCT00583492|Gene Therapy|gene therapy
613457|NCT00583492|IMRT|imrt
613458|NCT00583466|submucosal cushion|submucosal cushion
613459|NCT00583466|polypectomy|polypectomy
613460|NCT00583466|endoscopic mucosal resection|endoscopic mucosal resection
613461|NCT00583453|Tonsillectomy|tonsillectomy
613462|NCT00583453|Analgesia|analgesia
613463|NCT00583453|Pain measurement|pain measurement
613464|NCT00583453|Celecoxib|celecoxib
613465|NCT00583440|12-step|12-step
613466|NCT00583440|mutual help|mutual help
613467|NCT00583440|dual diagnosis|dual diagnosis
613468|NCT00583440|serious mental illness|serious mental illness
613469|NCT00583401|PFO|pfo
613470|NCT00583401|stroke|stroke
613471|NCT00583388|cardiology|cardiology
613472|NCT00583388|preventive medicine|preventive medicine
613473|NCT00583388|cardiovascular physiology|cardiovascular physiology
613474|NCT00583388|healthy subjects|healthy subjects
613475|NCT00583375|arthritis|arthritis
613476|NCT00583375|ankle pain|ankle pain
613477|NCT00583375|foot pain|foot pain
613478|NCT00583375|hindfoot fracture|hindfoot fracture
613479|NCT00583375|ankle fracture|ankle fracture
613480|NCT00583362|SLE|sle
613481|NCT00583362|Lupus|lupus
613482|NCT00583349|Bladder Cancer|bladder cancer
613483|NCT00583349|Chemotherapy|chemotherapy
613484|NCT00583349|Bladder Neoplasms|bladder neoplasms
613485|NCT00583310|Prehypertension|prehypertension
613486|NCT00583297|Arrhythmia|arrhythmia
613487|NCT00583297|Heart Failure|heart failure
613488|NCT00583297|T-wave Alternans|t-wave alternans
613489|NCT00583297|Implanted Cardioverter Defibrillator|implanted cardioverter defibrillator
613490|NCT00583297|Biological Markers|biological markers
613491|NCT00583297|Molecular Genetics|molecular genetics
613492|NCT00583297|Corus CAD|corus cad
613493|NCT00583297|ASGES|asges
613494|NCT00583297|Age/Sex/Gene Expression Score|age/sex/gene expression score
613495|NCT00583297|Gene Expression|gene expression
613496|NCT00583297|GES|ges
613497|NCT00583297|CVD|cvd
613498|NCT00583297|Precision Medicine|precision medicine
613499|NCT00583297|Sudden Cardiac Death|sudden cardiac death
613500|NCT00583297|Electrophysiology Study|electrophysiology study
613501|NCT00583297|Cardiovascular Disease|cardiovascular disease
613502|NCT00583297|ICD|icd
613503|NCT00583297|EPS|eps
613504|NCT00583297|SCD|scd
613505|NCT00583297|TWA|twa
613506|NCT00583284|delayed enhancement computed tomography|delayed enhancement computed tomography
613507|NCT00583284|ventricular tachycardia ablation|ventricular tachycardia ablation
613508|NCT00583284|ventricular tachycardia|ventricular tachycardia
613509|NCT00583245|Osteoarthritis|osteoarthritis
613510|NCT00583245|Gait training|gait training
613511|NCT00583245|Knee pain|knee pain
613512|NCT00583245|Rehabilitation|rehabilitation
613513|NCT00583245|Physical Therapy|physical therapy
613514|NCT00583232|Pediatric|pediatric
613515|NCT00583232|Crohn's disease|crohn's disease
613516|NCT00583232|protein metabolism|protein metabolism
613517|NCT00583232|energy metabolism|energy metabolism
613518|NCT00583206|sepsis|sepsis
613519|NCT00583206|atrophy|atrophy
613520|NCT00583206|muscle|muscle
613521|NCT00583206|weakness|weakness
613522|NCT00583193|Post Traumatic Stress Disorder|post traumatic stress disorder
613523|NCT00583193|Duloxetine|duloxetine
613524|NCT00583193|Antidepressants|antidepressants
613525|NCT00583180|Primary and/or secondary hyperalgesia|primary and/or secondary hyperalgesia
613526|NCT00583180|hypoesthesia|hypoesthesia
613527|NCT00583167|HIV|hiv
613528|NCT00583167|AIDS|aids
613529|NCT00583167|CNS|cns
613530|NCT00583167|brain|brain
613531|NCT00583167|affects|affects
613532|NCT00583154|constipation|constipation
613533|NCT00583154|laxative|laxative
613534|NCT00583128|IBS|ibs
613535|NCT00583128|Irritable Bowel Syndrome|irritable bowel syndrome
613536|NCT00583102|Acute Myeloid Leukemia|acute myeloid leukemia
613537|NCT00583102|AML|aml
613538|NCT00583102|Lovastatin|lovastatin
613539|NCT00583102|Cytarabine|cytarabine
613540|NCT00583076|Pouchitis|pouchitis
613541|NCT00583076|Active Pouchitis|active pouchitis
613542|NCT00583076|Safety and Efficacy of AST120|safety and efficacy of ast120
613543|NCT00583037|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
613544|NCT00583037|Sleep quality|sleep quality
613545|NCT00583037|Adult|adult
613546|NCT00583037|Critical Care|critical care
613547|NCT00583024|prostate cancer|prostate cancer
613548|NCT00583024|vaccine|vaccine
613549|NCT00583024|immunotherapy|immunotherapy
613550|NCT00583011|Amniocentesis|amniocentesis
613551|NCT00583011|Genetic amniocentesis|genetic amniocentesis
613552|NCT00583011|Fetal lung maturity|fetal lung maturity
613553|NCT00583011|Pain control|pain control
613554|NCT00583011|Pregnancy|pregnancy
613555|NCT00583011|High risk pregnancy|high risk pregnancy
613556|NCT00582998|Vacuum Assisted Closure (VAC)|vacuum assisted closure (vac)
613557|NCT00582998|Calcaneus Fracture|calcaneus fracture
613558|NCT00582998|Pilon Fracture|pilon fracture
613559|NCT00582998|Tibial Plateau Fracture|tibial plateau fracture
613560|NCT00582998|Open Reduction and Internal Fixation|open reduction and internal fixation
613561|NCT00582985|Tracon|tracon
613562|NCT00582985|CD105|cd105
613563|NCT00582985|Anti CD105|anti cd105
613564|NCT00582985|TRC105|trc105
613565|NCT00582985|Phase 1|phase 1
613566|NCT00582985|Cancer|cancer
613567|NCT00582985|Monoclonal antibody|monoclonal antibody
613568|NCT00582985|Solid Tumor|solid tumor
613569|NCT00582972|Calcium Absorption|calcium absorption
613570|NCT00582972|Fractional Calcium Absorption|fractional calcium absorption
613571|NCT00582972|Omeprazole|omeprazole
613572|NCT00582972|Stable Calcium Isotopes|stable calcium isotopes
613573|NCT00582972|Proton Pump Inhibitor|proton pump inhibitor
613574|NCT00582972|Intestinal Absorption of Calcium|intestinal absorption of calcium
613575|NCT00582959|radiology imaging|radiology imaging
613576|NCT00582959|malignancy|malignancy
613577|NCT00582959|undergoing radiation therapy|undergoing radiation therapy
613578|NCT00582946|Hearing Loss, Eardrum, Transducer, Hearing in Noise|hearing loss, eardrum, transducer, hearing in noise
613579|NCT00582933|Cancer|cancer
613580|NCT00582933|Donors|donors
613581|NCT00582933|Leukemia|leukemia
613582|NCT00582933|Myelodysplastic Syndrome|myelodysplastic syndrome
613583|NCT00582933|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
613584|NCT00582933|Lymphoma|lymphoma
613585|NCT00582933|AML|aml
613586|NCT00582933|ALL|all
613587|NCT00582933|CML|cml
613588|NCT00582933|Allogeneic marrow transplant|allogeneic marrow transplant
613589|NCT00582933|Bone marrow transplant|bone marrow transplant
613590|NCT00582920|osseous lesions|osseous lesions
613591|NCT00582920|breast cancer|breast cancer
613592|NCT00582920|metastatic breast cancer|metastatic breast cancer
613593|NCT00582907|FMF|fmf
613594|NCT00582907|IL1 Trap (Rilonacept)|il1 trap (rilonacept)
613595|NCT00582907|Periodic fever syndromes|periodic fever syndromes
613596|NCT00582907|Autoinflammatory syndromes|autoinflammatory syndromes
613597|NCT00582907|Familial Mediterranean Fever|familial mediterranean fever
613598|NCT00582907|colchicine|colchicine
613599|NCT00582894|Allogenic stem cell transplant|allogenic stem cell transplant
613600|NCT00582894|Hematologic diseases|hematologic diseases
613601|NCT00582881|Anti-RNP/Sm Autoantibody-Positive|anti-rnp/sm autoantibody-positive
613602|NCT00582881|MCTD|mctd
613603|NCT00582881|SLE|sle
613604|NCT00582868|Subarachnoid hemorrhage|subarachnoid hemorrhage
613605|NCT00582868|Cerebral Vasospasm|cerebral vasospasm
613606|NCT00582868|Cleaved-tau protein|cleaved-tau protein
613607|NCT00582868|Brain oxygen tension level|brain oxygen tension level
613608|NCT00582855|AQW051|aqw051
613609|NCT00582855|Mild Alzheimer's disease|mild alzheimer's disease
613610|NCT00582855|Amnestic Mild Cognitive Impairment|amnestic mild cognitive impairment
613611|NCT00582842|Early Stage|early stage
613612|NCT00582842|Localized|localized
613613|NCT00582829|Colorectal|colorectal
613614|NCT00582829|Cancer|cancer
613615|NCT00582829|Screening|screening
613616|NCT00582829|Intervention|intervention
613617|NCT00582829|Family|family
613618|NCT00582816|Recurrent or Refractory Leukemia or Solid Tumors in Pediatrics|recurrent or refractory leukemia or solid tumors in pediatrics
613619|NCT00582803|breast cancer|breast cancer
613620|NCT00582803|germline mutation|germline mutation
613621|NCT00582803|BRCA1|brca1
613622|NCT00582803|BRCA2|brca2
613623|NCT00582803|family history|family history
613624|NCT00582803|genetic testing|genetic testing
613625|NCT00582803|unaffected women over age 25 who are at elevated risk for|unaffected women over age 25 who are at elevated risk for
613626|NCT00582803|breast cancer by virtue by a hereditary predisposition|breast cancer by virtue by a hereditary predisposition
613627|NCT00582790|Renal Cell Cancer|renal cell cancer
613628|NCT00582790|Metastatic|metastatic
613629|NCT00582777|nocturnal blood pressure|nocturnal blood pressure
613630|NCT00582777|chronic renal disease|chronic renal disease
613631|NCT00582777|hypertensive renal disease|hypertensive renal disease
613632|NCT00582777|African Americans|african americans
613633|NCT00582777|ABPM|abpm
613634|NCT00582764|Breast Lesion|breast lesion
613635|NCT00582764|Lesion|lesion
613636|NCT00582764|Breast|breast
613637|NCT00582764|Cancer|cancer
613638|NCT00582764|05-091|05-091
613639|NCT00582751|Volumetric Analysis|volumetric analysis
613640|NCT00582751|Multiple Diseases|multiple diseases
613641|NCT00582738|Fibrosis progression|fibrosis progression
613642|NCT00582738|recurrent hepatitis C|recurrent hepatitis c
613643|NCT00582738|viral infection|viral infection
613644|NCT00582738|liver transplant recipients|liver transplant recipients
613645|NCT00582738|everolimus|everolimus
613646|NCT00582738|Hepatitis C recurrence after orthotopic liver transplantation (OLT)|hepatitis c recurrence after orthotopic liver transplantation (olt)
613647|NCT00582725|DLBCL, Elderly|dlbcl, elderly
613648|NCT00582725|previously untreated DLBCL in the elderly|previously untreated dlbcl in the elderly
613649|NCT00582712|medullary thyroid cancer|medullary thyroid cancer
613650|NCT00582712|lithium|lithium
613651|NCT00582699|Pancreatic Cancer|pancreatic cancer
613652|NCT00582699|Pancreatic|pancreatic
613653|NCT00582686|Calcaneus Fractures|calcaneus fractures
613654|NCT00582686|Iliac Crest Bone Grafting|iliac crest bone grafting
613655|NCT00582686|Open Reduction & Internal Fixation|open reduction & internal fixation
613656|NCT00582673|Parkinson's, L-dopa, dyskinesia|parkinson's, l-dopa, dyskinesia
613657|NCT00582634|non small cell lung cancer|non small cell lung cancer
613658|NCT00582634|adjuvant|adjuvant
613659|NCT00582634|cisplatin|cisplatin
613660|NCT00582634|docetaxel|docetaxel
613661|NCT00582621|Genetic Studies|genetic studies
613662|NCT00582621|00-069|00-069
613663|NCT00582621|blood|blood
613664|NCT00582621|saliva|saliva
613665|NCT00582621|buccal cell|buccal cell
613666|NCT00582582|Metastatic|metastatic
613667|NCT00582582|Hormone Refractory|hormone refractory
613668|NCT00582582|Prostate Cancer|prostate cancer
613669|NCT00582569|Breast lesion|breast lesion
613670|NCT00582569|Spectroscopy|spectroscopy
613671|NCT00582569|MRI|mri
613672|NCT00582556|bone mineral density|bone mineral density
613673|NCT00582543|Prostate Cancer|prostate cancer
613674|NCT00582543|Prostate|prostate
613675|NCT00582530|Prostate Cancer|prostate cancer
613676|NCT00582530|Early Prostate Cancer|early prostate cancer
613677|NCT00582530|Radical Prostatectomy|radical prostatectomy
613678|NCT00582517|Orthopaedic Trauma|orthopaedic trauma
613679|NCT00582517|Knee Dislocation|knee dislocation
613680|NCT00582517|Compass Hinge External Fixator|compass hinge external fixator
613681|NCT00582517|External Brace|external brace
613682|NCT00582504|Encephalitis,VEE|encephalitis,vee
613683|NCT00582491|Modafinil|modafinil
613684|NCT00582491|Sleep|sleep
613685|NCT00582491|Cognition|cognition
613686|NCT00582491|Cocaine Dependence|cocaine dependence
613687|NCT00582478|Breast cancer|breast cancer
613688|NCT00582478|Quality of Life|quality of life
613689|NCT00582452|HNPCC|hnpcc
613690|NCT00582452|prophylactic colectomy|prophylactic colectomy
613691|NCT00582439|Orthopaedic Trauma Fractures|orthopaedic trauma fractures
613692|NCT00582439|Orthopaedic Trauma Non-unions|orthopaedic trauma non-unions
613693|NCT00582439|Reamer-Irrigator-Aspirator (RIA)|reamer-irrigator-aspirator (ria)
613694|NCT00582439|Bone Graft|bone graft
613695|NCT00582426|Colorectal cancer|colorectal cancer
613696|NCT00582426|diarrhea|diarrhea
613697|NCT00582426|drug therapy|drug therapy
613698|NCT00582426|octreotide|octreotide
613699|NCT00582426|fluorouracil|fluorouracil
613700|NCT00582426|irinotecan|irinotecan
613701|NCT00582426|capecitabine|capecitabine
613702|NCT00582426|prevention|prevention
613703|NCT00582413|Head and Neck Cancer|head and neck cancer
613704|NCT00582400|livers, hepatocellular carcinoma (HCC)|livers, hepatocellular carcinoma (hcc)
613705|NCT00582374|Periodontal Disease|periodontal disease
613706|NCT00582374|Preterm Birth|preterm birth
613707|NCT00582374|Low Birth Weight|low birth weight
613708|NCT00582374|Pregnancy|pregnancy
613709|NCT00582361|Open Fractures|open fractures
613710|NCT00582361|Vacuum Assisted Closure (VAC) device|vacuum assisted closure (vac) device
613711|NCT00582361|Irrigation and Debridement|irrigation and debridement
613712|NCT00582348|Lung Cancer|lung cancer
613713|NCT00582348|Survivor|survivor
613714|NCT00582348|Lung|lung
613715|NCT00582335|Colorectal cancer|colorectal cancer
613716|NCT00582335|Genetic testing|genetic testing
613717|NCT00582335|Genetic mutations|genetic mutations
613718|NCT00582322|Breast Cancer|breast cancer
613719|NCT00582322|Ovarian Cancer|ovarian cancer
613720|NCT00582322|Family History|family history
613721|NCT00582322|Genetic Studies|genetic studies
613722|NCT00582309|Glycemic Control|glycemic control
613723|NCT00582309|Intravenous Infusion|intravenous infusion
613724|NCT00582309|Standard Insulin infusion algorithm|standard insulin infusion algorithm
613725|NCT00582309|Infusion|infusion
613726|NCT00582309|Critically Ill|critically ill
613727|NCT00582296|Lynch syndrome|lynch syndrome
613728|NCT00582296|04-144|04-144
613729|NCT00582270|non-hodkin's lymphoma|non-hodkin's lymphoma
613730|NCT00582270|follicular|follicular
613731|NCT00582270|non-follicular|non-follicular
613732|NCT00582270|infectious disease|infectious disease
613733|NCT00582257|Gastric Cancer|gastric cancer
613734|NCT00582257|Stomach Cancer|stomach cancer
613735|NCT00582257|05-118|05-118
613736|NCT00582244|Menopausal symptoms|menopausal symptoms
613737|NCT00582244|Quality of Life|quality of life
613738|NCT00582244|Breast cancer|breast cancer
613739|NCT00582244|Multicenter trial|multicenter trial
613740|NCT00582231|Penile injection therapy|penile injection therapy
613741|NCT00582231|Erectile dysfunction|erectile dysfunction
613742|NCT00582231|Radical pelvic surgery|radical pelvic surgery
613743|NCT00582231|Penile Injection Anxiety|penile injection anxiety
613744|NCT00582218|HIV/AIDS|hiv/aids
613745|NCT00582218|Access to care|access to care
613746|NCT00582205|Ovarian Cancer|ovarian cancer
613747|NCT00582205|Fallopian Tube Cancer|fallopian tube cancer
613748|NCT00582205|Primary Peritoneal Carcinoma|primary peritoneal carcinoma
613749|NCT00582205|Uterine Cancer|uterine cancer
613750|NCT00582205|Intraperitoneal Chemotherapy|intraperitoneal chemotherapy
613751|NCT00582205|IP Chemotherapy|ip chemotherapy
613752|NCT00582205|Gynecologic Cancer|gynecologic cancer
613753|NCT00582205|Women's Cancer|women's cancer
613754|NCT00582205|Cisplatin|cisplatin
613755|NCT00582205|Paclitaxel|paclitaxel
613756|NCT00582205|Recurrent Platinum Sensitive Ovarian Cancer|recurrent platinum sensitive ovarian cancer
613757|NCT00582192|Phase I trial|phase i trial
613758|NCT00582192|Oncologists' Communication Styles|oncologists' communication styles
613759|NCT00582179|Draining Hematoma|draining hematoma
613760|NCT00582179|Vacuum Assisted Closure (VAC)|vacuum assisted closure (vac)
613761|NCT00582179|Negative Pressure Wound Therapy (NPWT)|negative pressure wound therapy (npwt)
613762|NCT00582179|Draining Hematoma following orthopaedic surgery|draining hematoma following orthopaedic surgery
613763|NCT00582166|Zevalin, High Tumor Burden Indolent Non-Hodgkin's Lymphoma|zevalin, high tumor burden indolent non-hodgkin's lymphoma
613764|NCT00582140|Prostate|prostate
613765|NCT00582140|Cancer|cancer
613766|NCT00582140|Stage D0|stage d0
613767|NCT00582140|Non-Metastatic|non-metastatic
613768|NCT00582140|Rising PSA|rising psa
613769|NCT00582127|senile|senile
613770|NCT00582127|dementia|dementia
613771|NCT00582114|Hemodialysis|hemodialysis
613772|NCT00582114|Hypertension|hypertension
613773|NCT00582114|Left ventricular hypertrophy|left ventricular hypertrophy
613774|NCT00582101|HIV|hiv
613775|NCT00582101|prevention|prevention
613776|NCT00582101|families|families
613777|NCT00582101|Latinos|latinos
613778|NCT00582101|communication|communication
613779|NCT00582101|sexuality|sexuality
613780|NCT00582101|monitoring|monitoring
613781|NCT00582101|health promotion|health promotion
613782|NCT00582101|HIV Prevention|hiv prevention
613783|NCT00582101|HIV Seronegativity|hiv seronegativity
613784|NCT00582088|Encephalitis, Viral Infections, Neurologic diseases, Alphavirus Infections, VEE|encephalitis, viral infections, neurologic diseases, alphavirus infections, vee
613785|NCT00582075|Cancer|cancer
613786|NCT00582075|Brain metastases|brain metastases
613787|NCT00582075|Gamma Knife Radiosurgery|gamma knife radiosurgery
613788|NCT00582075|Temodar|temodar
613789|NCT00582075|Temozolomide|temozolomide
613790|NCT00582062|Gastric Cancer|gastric cancer
613791|NCT00582062|Pancreatic cancer|pancreatic cancer
613792|NCT00582049|Retinoblastoma|retinoblastoma
613793|NCT00582049|Sporadic heritable retinoblastoma|sporadic heritable retinoblastoma
613794|NCT00582049|Paternal exposures|paternal exposures
613795|NCT00582036|Hyperglycemia|hyperglycemia
613796|NCT00582036|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
613797|NCT00582036|Bone marrow transplant|bone marrow transplant
613798|NCT00582036|High blood sugar|high blood sugar
613799|NCT00582023|HIV|hiv
613800|NCT00582023|coping|coping
613801|NCT00582023|emotion|emotion
613802|NCT00582023|affect|affect
613803|NCT00582023|HIV infection|hiv infection
613804|NCT00582023|Complimentary therapies|complimentary therapies
613805|NCT00582010|ischemia-reperfusion|ischemia-reperfusion
613806|NCT00582010|nitric oxide|nitric oxide
613807|NCT00582010|inflammation|inflammation
613808|NCT00582010|cell-death|cell-death
613809|NCT00582010|Liver-function post transplantation|liver-function post transplantation
613810|NCT00581997|Pulmonary fibrosis, systemic sclerosis|pulmonary fibrosis, systemic sclerosis
613811|NCT00581984|breast cancer|breast cancer
613812|NCT00581984|breast reconstruction|breast reconstruction
613813|NCT00581984|silicone implants|silicone implants
613814|NCT00581971|Radiosensitization|radiosensitization
613815|NCT00581971|COX-2 inhibitor|cox-2 inhibitor
613816|NCT00581971|Celecoxib|celecoxib
613817|NCT00581971|Head and Neck Cancer|head and neck cancer
613818|NCT00581971|Chemoradiation|chemoradiation
613819|NCT00581958|total body irradiation|total body irradiation
613820|NCT00581958|Cancer|cancer
613821|NCT00581958|Hematopoietic System|hematopoietic system
613822|NCT00581932|clozapine, schizophrenia|clozapine, schizophrenia
613823|NCT00581919|previously treated multiple myeloma|previously treated multiple myeloma
613824|NCT00581906|Head and Neck Cancer|head and neck cancer
613825|NCT00581906|Head Cancer|head cancer
613826|NCT00581906|Neck Cancer|neck cancer
613827|NCT00581906|Dynamic Contrast Enhanced MRI|dynamic contrast enhanced mri
613828|NCT00581906|Magnetic Resonance Spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
613829|NCT00581906|Diffusion Weighted MRI (DW-MRI)|diffusion weighted mri (dw-mri)
613830|NCT00581906|06-007|06-007
613831|NCT00581893|epilepsy|epilepsy
613832|NCT00581893|cognitive impairment|cognitive impairment
613833|NCT00581893|driving simulation|driving simulation
613834|NCT00581893|cross-over study|cross-over study
613835|NCT00581880|end stage|end stage
613836|NCT00581880|Terminally Ill|terminally ill
613837|NCT00581854|untreated mantle cell lymphoma|untreated mantle cell lymphoma
613838|NCT00581841|Healthy adult normals|healthy adult normals
613839|NCT00581828|Calcium Absorption|calcium absorption
613840|NCT00581828|Intestinal Absorption of Calcium|intestinal absorption of calcium
613841|NCT00581828|Fractional Calcium Absorption|fractional calcium absorption
613842|NCT00581828|Stable Calcium Isotopes|stable calcium isotopes
613843|NCT00581828|Hypovitaminosis D|hypovitaminosis d
613844|NCT00581828|Vitamin D|vitamin d
613845|NCT00581828|Bone Mineral Density|bone mineral density
613846|NCT00581828|Physical Function|physical function
613847|NCT00581802|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
613848|NCT00581802|Treatment Naive|treatment naive
613849|NCT00581802|Latent HIV Infections|latent hiv infections
613850|NCT00581789|non small cell lung cancer|non small cell lung cancer
613851|NCT00581789|sunitinib|sunitinib
613852|NCT00581789|erlotinib|erlotinib
613853|NCT00581789|phase 1|phase 1
613854|NCT00581776|Untreated Mantle Cell Lymphoma|untreated mantle cell lymphoma
613855|NCT00581750|Biopsy|biopsy
613856|NCT00581750|Breast|breast
613857|NCT00581750|01-135|01-135
613858|NCT00581724|breast cancer|breast cancer
613859|NCT00581724|Colorectal cancer|colorectal cancer
613860|NCT00581724|Prostate cancer|prostate cancer
613861|NCT00581724|Head and Neck cancer|head and neck cancer
613862|NCT00581724|Lung cancer|lung cancer
613863|NCT00581724|cancer survivors|cancer survivors
613864|NCT00581724|07-068|07-068
613865|NCT00581724|quality of life|quality of life
613866|NCT00581724|Pain in cancer survivors|pain in cancer survivors
613867|NCT00581711|Electronic Health Record|electronic health record
613868|NCT00581711|Clinical Decision Support|clinical decision support
613869|NCT00581711|Otitis Media|otitis media
613870|NCT00581698|Melanoma|melanoma
613871|NCT00581698|Negative regional lymph nodes|negative regional lymph nodes
613872|NCT00581698|Primary melanomas Clark III and Breslow thickness > 1 mm, or Clark|primary melanomas clark iii and breslow thickness > 1 mm, or clark
613873|NCT00581698|IV-V and any Breslow thickness, and clinically negative regional nodes|iv-v and any breslow thickness, and clinically negative regional nodes
613874|NCT00581685|Chronic pain|chronic pain
613875|NCT00581685|Preemptive analgesia|preemptive analgesia
613876|NCT00581685|Pregabalin|pregabalin
613877|NCT00581685|Celecoxib|celecoxib
613878|NCT00581685|Hip Arthroplasty|hip arthroplasty
613879|NCT00581685|Osteoarthritis|osteoarthritis
613880|NCT00581672|Anxiety|anxiety
613881|NCT00581672|Black men|black men
613882|NCT00581672|Prostate Cancer|prostate cancer
613883|NCT00581672|07-125|07-125
613884|NCT00581633|saline|saline
613885|NCT00581633|sodium|sodium
613886|NCT00581633|kidney|kidney
613887|NCT00581633|tachycardia|tachycardia
613888|NCT00581620|pneumococcus conjugated vaccine|pneumococcus conjugated vaccine
613889|NCT00581607|Sarcoidosis|sarcoidosis
613890|NCT00581594|Pelvic organ prolapse|pelvic organ prolapse
613891|NCT00581594|Posterior wall defects|posterior wall defects
613892|NCT00581594|Graft-augmented repair|graft-augmented repair
613893|NCT00581594|Posterior colporrhaphy|posterior colporrhaphy
613894|NCT00581581|neonatal encephalopathy|neonatal encephalopathy
613895|NCT00581581|therapeutic hypothermia|therapeutic hypothermia
613896|NCT00581581|head cooling|head cooling
613897|NCT00581581|neonatal asphyxia|neonatal asphyxia
613898|NCT00581568|Skin cooling during laser treatment|skin cooling during laser treatment
613899|NCT00581555|Psoriasis|psoriasis
613900|NCT00581529|breast|breast
613901|NCT00581516|Prostate Cancer|prostate cancer
613902|NCT00581516|PCA3|pca3
613903|NCT00581503|early detection of lung and pleural cancer|early detection of lung and pleural cancer
613904|NCT00581503|early detection of prostate cancer|early detection of prostate cancer
613905|NCT00581490|Premature pubarche|premature pubarche
613906|NCT00581490|Adrenal hyperandrogenism|adrenal hyperandrogenism
613907|NCT00581490|Metabolic syndrome|metabolic syndrome
613908|NCT00581477|autonomic nervous system diseases|autonomic nervous system diseases
613909|NCT00581477|blood pressure|blood pressure
613910|NCT00581477|congenital|congenital
613911|NCT00581477|orthostasis|orthostasis
613912|NCT00581477|catecholamines|catecholamines
613913|NCT00581464|Smoking cessation|smoking cessation
613914|NCT00581464|Tobacco dependence|tobacco dependence
613915|NCT00581464|Mindfulness|mindfulness
613916|NCT00581464|fMRI|fmri
613917|NCT00581464|Craving|craving
613918|NCT00581438|Approach Haemophilia A and B|approach haemophilia a and b
613919|NCT00581425|BCC|bcc
613920|NCT00581425|Basal Cell Carcinoma|basal cell carcinoma
613921|NCT00581425|Intron-A|intron-a
613922|NCT00581425|Aldara|aldara
613923|NCT00581425|Basal Cell Carcinoma excluding scalp and face|basal cell carcinoma excluding scalp and face
613924|NCT00581412|Pelvic organ prolapse|pelvic organ prolapse
613925|NCT00581412|Composite biologic/synthetic graft|composite biologic/synthetic graft
613926|NCT00581412|Abdominal sacrocolpopexy|abdominal sacrocolpopexy
613927|NCT00581399|Open heart surgery|open heart surgery
613928|NCT00581399|Cardiopulmonary Bypass|cardiopulmonary bypass
613929|NCT00581399|Coronary Artery Bypass Grafting|coronary artery bypass grafting
613930|NCT00581399|Chest Tube|chest tube
613931|NCT00581399|Valve Replacement|valve replacement
613932|NCT00581399|Valve Repair|valve repair
613933|NCT00581386|Endotracheal Intubation|endotracheal intubation
613934|NCT00581386|Supraglottic Airway|supraglottic airway
613935|NCT00581373|water|water
613936|NCT00581373|orthostatic hypotension|orthostatic hypotension
613937|NCT00581373|blood pressure|blood pressure
613938|NCT00581360|Adenoid cystic carcinoma|adenoid cystic carcinoma
613939|NCT00581360|bortezomib|bortezomib
613940|NCT00581360|doxorubicin|doxorubicin
613941|NCT00581334|Pelvic organ prolapse|pelvic organ prolapse
613942|NCT00581334|Robotic-assisted laparoscopic sacrocolpopexy|robotic-assisted laparoscopic sacrocolpopexy
613943|NCT00581334|Post hysterectomy prolapse|post hysterectomy prolapse
613944|NCT00581334|Symptomatic post hysterectomy prolapse of stage II or greater|symptomatic post hysterectomy prolapse of stage ii or greater
613945|NCT00581321|water|water
613946|NCT00581321|blood pressure|blood pressure
613947|NCT00581321|vascular resistance|vascular resistance
613948|NCT00581321|cardiac transplantation|cardiac transplantation
613949|NCT00581308|atrial septal defect, septal occluder, HELEX|atrial septal defect, septal occluder, helex
613950|NCT00581295|internal bleeding|internal bleeding
613951|NCT00581295|changes in tissue perfusion|changes in tissue perfusion
613952|NCT00581282|Cocaine abstinence|cocaine abstinence
613953|NCT00581282|PET scan|pet scan
613954|NCT00581256|left sided|left sided
613955|NCT00581243|Safety,Tolerability, Schizophrenia|safety,tolerability, schizophrenia
613956|NCT00581230|Endotracheal Intubation|endotracheal intubation
613957|NCT00581230|Rapid Airway Management Positioner|rapid airway management positioner
613958|NCT00581217|Burn injury|burn injury
613959|NCT00581217|Skin graft|skin graft
613960|NCT00581217|Donor site dressing|donor site dressing
613961|NCT00581217|Outcomes|outcomes
613962|NCT00581217|Infection rate|infection rate
613963|NCT00581217|Healing time|healing time
613964|NCT00581217|Cosmetic Result|cosmetic result
613965|NCT00581217|Pain|pain
613966|NCT00581217|Burn injured patients requiring skin grafting|burn injured patients requiring skin grafting
613967|NCT00581204|trauma situations|trauma situations
613968|NCT00581204|Lower Body Negative Pressure (LBNP)|lower body negative pressure (lbnp)
613969|NCT00581191|SAD|sad
613970|NCT00581191|Healthy|healthy
613971|NCT00581178|Ureteral Stent|ureteral stent
613972|NCT00581178|Kidney Stones|kidney stones
613973|NCT00581152|TBX3|tbx3
613974|NCT00581126|BENEFIX|benefix
613975|NCT00581126|Hemophilia B|hemophilia b
613976|NCT00581113|whole brain radiotherapy|whole brain radiotherapy
613977|NCT00581113|neural stem cell|neural stem cell
613978|NCT00581113|brain metastases|brain metastases
613979|NCT00581113|radiosurgery|radiosurgery
613980|NCT00581100|Nail Psoriasis|nail psoriasis
613981|NCT00581100|Plaque Psoriasis|plaque psoriasis
613982|NCT00581087|Hypertension, pulmonary|hypertension, pulmonary
613983|NCT00581087|DHEA|dhea
613984|NCT00581087|six-minute walk test|six-minute walk test
613985|NCT00581087|pulmonary arterial pressure|pulmonary arterial pressure
613986|NCT00581074|obesity|obesity
613987|NCT00581074|diet|diet
613988|NCT00581074|weight loss|weight loss
613989|NCT00581074|metabolic syndrome|metabolic syndrome
613990|NCT00581061|Incontinence|incontinence
613991|NCT00581061|Robotic Prostatectomy|robotic prostatectomy
613992|NCT00581048|Asthma|asthma
613993|NCT00581048|Allergy|allergy
613994|NCT00581048|Atopy|atopy
613995|NCT00581048|Vitamin E|vitamin e
613996|NCT00581048|GSTP1|gstp1
613997|NCT00581048|Oxidative stress|oxidative stress
613998|NCT00581035|Meningococcal disease|meningococcal disease
613999|NCT00581035|pneumococcal disease|pneumococcal disease
614000|NCT00581035|meningitis|meningitis
614001|NCT00581022|postural tachycardia syndrome|postural tachycardia syndrome
614002|NCT00581022|sleep|sleep
614003|NCT00581022|insomnia|insomnia
614004|NCT00581009|Sleep deprivation|sleep deprivation
614005|NCT00581009|antidepressant|antidepressant
614006|NCT00581009|depression|depression
614007|NCT00581009|chronobiological|chronobiological
614008|NCT00580996|water|water
614009|NCT00580996|orthostatic hypotension|orthostatic hypotension
614010|NCT00580996|blood pressure|blood pressure
614011|NCT00580983|Head and Neck cancer|head and neck cancer
614012|NCT00580970|prostate cancer|prostate cancer
614013|NCT00580970|radiation therapy|radiation therapy
614014|NCT00580970|lovastatin|lovastatin
614015|NCT00580970|rectal injury|rectal injury
614016|NCT00580957|Obesity|obesity
614017|NCT00580957|Hypertension|hypertension
614018|NCT00580957|Autonomic Nervous System|autonomic nervous system
614019|NCT00580944|Port wine stain|port wine stain
614020|NCT00580944|progressive malformation of human skin|progressive malformation of human skin
614021|NCT00580931|nutraceutical, dementia, cognition, HDAC inhibitor|nutraceutical, dementia, cognition, hdac inhibitor
614022|NCT00580918|Mild Traumatic Brain Injury|mild traumatic brain injury
614023|NCT00580918|fMRI|fmri
614024|NCT00580905|Adenosine|adenosine
614025|NCT00580905|Cytokines|cytokines
614026|NCT00580905|Inflammation|inflammation
614027|NCT00580905|VEGF|vegf
614028|NCT00580879|Anorectal sphincter laceration|anorectal sphincter laceration
614029|NCT00580879|Pelvic floor dysfunction|pelvic floor dysfunction
614030|NCT00580879|Sphincter tear|sphincter tear
614031|NCT00580866|Elbow|elbow
614032|NCT00580866|Upper Extremity Fractures|upper extremity fractures
614033|NCT00580866|Distal Humerus|distal humerus
614034|NCT00580866|Elbow Injuries|elbow injuries
614035|NCT00580866|Dislocations|dislocations
614036|NCT00580866|Peri-articular Elbow Injuries|peri-articular elbow injuries
614037|NCT00580853|smoking lapse behavior|smoking lapse behavior
614038|NCT00580853|smoking cessation|smoking cessation
614039|NCT00580853|varenicline|varenicline
614040|NCT00580853|bupropion|bupropion
614041|NCT00580853|medication effect on smoking lapse behavior|medication effect on smoking lapse behavior
614042|NCT00580840|Rheumatoid Arthritis|rheumatoid arthritis
614043|NCT00580840|Joint Disease|joint disease
614044|NCT00580840|Arthritis|arthritis
614045|NCT00580840|Certolizumab pegol|certolizumab pegol
614046|NCT00580840|Cimzia|cimzia
614047|NCT00580814|Brookhaven|brookhaven
614048|NCT00580814|ADHD|adhd
614049|NCT00580814|Dopamine|dopamine
614050|NCT00580814|methylphenidate|methylphenidate
614051|NCT00580814|PET|pet
614052|NCT00580801|Hepatitis C|hepatitis c
614053|NCT00580801|Telaprevir|telaprevir
614054|NCT00580801|Pegylated-interferon-alfa-2a|pegylated-interferon-alfa-2a
614055|NCT00580801|Pegasys|pegasys
614056|NCT00580801|Ribavirin|ribavirin
614057|NCT00580801|Copegus|copegus
614058|NCT00580788|Endocrine System Diseases|endocrine system diseases
614059|NCT00580788|MusculoSkeletal System Diseases|musculoskeletal system diseases
614060|NCT00580788|Hormones|hormones
614061|NCT00580788|Malignancy|malignancy
614062|NCT00580788|Postmenopausal Women|postmenopausal women
614063|NCT00580788|Bone metabolism|bone metabolism
614064|NCT00580775|Menopause|menopause
614065|NCT00580775|Hormone Replacement Therapy|hormone replacement therapy
614066|NCT00580775|Sudden Cardiac Death|sudden cardiac death
614067|NCT00580749|Pancreatitis|pancreatitis
614068|NCT00580749|enteral feeding|enteral feeding
614069|NCT00580749|distal jejunal feeding|distal jejunal feeding
614070|NCT00580749|naso gastric feeding|naso gastric feeding
614071|NCT00580749|pancreatic rest|pancreatic rest
614072|NCT00580736|sebaceous hyperplasia|sebaceous hyperplasia
614073|NCT00580723|acne|acne
614074|NCT00580723|rosacea|rosacea
614075|NCT00580723|acne rosacea|acne rosacea
614076|NCT00580723|papulopustular rosacea|papulopustular rosacea
614077|NCT00580723|erythema|erythema
614078|NCT00580723|telangiectasia|telangiectasia
614079|NCT00580723|flushing|flushing
614080|NCT00580710|type 1 diabetes|type 1 diabetes
614081|NCT00580710|hypoglycemia|hypoglycemia
614082|NCT00580710|magnetic resonance imaging|magnetic resonance imaging
614083|NCT00580697|Lower urinary tract symptoms|lower urinary tract symptoms
614084|NCT00580697|Gynecologic malignancy|gynecologic malignancy
614085|NCT00580697|Urinary incontinence|urinary incontinence
614086|NCT00580697|Fecal incontinence|fecal incontinence
614087|NCT00580697|Frequency|frequency
614088|NCT00580697|Voiding dysfunction|voiding dysfunction
614089|NCT00580697|Sexual dysfunction|sexual dysfunction
614090|NCT00580684|pneumococcus conjugated vaccine 7 valent|pneumococcus conjugated vaccine 7 valent
614091|NCT00580671|Adolescent Marijuana Abuse|adolescent marijuana abuse
614092|NCT00580658|Dystonia|dystonia
614093|NCT00580645|alcohol|alcohol
614094|NCT00580645|smoking cessation|smoking cessation
614095|NCT00580645|varenicline|varenicline
614096|NCT00580645|bupropion|bupropion
614097|NCT00580645|smoking cessation medications|smoking cessation medications
614098|NCT00580619|Chronic fatigue syndrome|chronic fatigue syndrome
614099|NCT00580619|Postural tachycardia syndrome|postural tachycardia syndrome
614100|NCT00580619|Autonomic nervous system|autonomic nervous system
614101|NCT00580606|Food Allergy|food allergy
614102|NCT00580606|Peanut Allergy|peanut allergy
614103|NCT00580606|Sublingual Immunotherapy|sublingual immunotherapy
614104|NCT00580593|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
614105|NCT00580593|ALS|als
614106|NCT00580593|nocturnal noninvasive positive pressure ventilation|nocturnal noninvasive positive pressure ventilation
614107|NCT00580593|NIPPV|nippv
614108|NCT00580593|forced vital capacity|forced vital capacity
614109|NCT00580593|FVC|fvc
614110|NCT00580567|Impulsivity|impulsivity
614111|NCT00580567|Gambling|gambling
614112|NCT00580567|Pathological Gamblers|pathological gamblers
614113|NCT00580567|Problem Gamblers|problem gamblers
614114|NCT00580567|Non-Pathological Gamblers|non-pathological gamblers
614115|NCT00580567|Risk-taking|risk-taking
614116|NCT00580567|Inhibition|inhibition
614117|NCT00580567|Gambling Severity|gambling severity
614118|NCT00580515|Cancer|cancer
614119|NCT00580515|Randomized Controlled Trial|randomized controlled trial
614120|NCT00580515|Family Therapy intervention|family therapy intervention
614121|NCT00580502|Obesity, 50 lbs overweight|obesity, 50 lbs overweight
614122|NCT00580489|helicopter|helicopter
614123|NCT00580489|aeromedical|aeromedical
614124|NCT00580489|pain relief|pain relief
614125|NCT00580489|analgesia|analgesia
614126|NCT00580489|fentanyl|fentanyl
614127|NCT00580489|morphine|morphine
614128|NCT00580489|adverse events|adverse events
614129|NCT00580476|Breast Cancer|breast cancer
614130|NCT00580476|Prostate Cancer|prostate cancer
614131|NCT00580463|central nervous system (CNS) tumor|central nervous system (cns) tumor
614132|NCT00580463|tissue collection|tissue collection
614133|NCT00580385|BONE|bone
614134|NCT00580359|Stomach Neoplasms|stomach neoplasms
614135|NCT00580359|Secondary|secondary
614136|NCT00580359|Combination chemotherapy|combination chemotherapy
614137|NCT00580359|S-1|s-1
614138|NCT00580359|Capecitabine|capecitabine
614139|NCT00580346|Aspiration pneumonia|aspiration pneumonia
614140|NCT00580346|Implanted laryngeal stimulator|implanted laryngeal stimulator
614141|NCT00580346|Vocal cord closure|vocal cord closure
614142|NCT00580346|Modified barium swallow|modified barium swallow
614143|NCT00580333|ER negative|er negative
614144|NCT00580333|PR negative|pr negative
614145|NCT00580333|HER2 negative|her2 negative
614146|NCT00580320|melanoma|melanoma
614147|NCT00580320|soft tissue sarcoma|soft tissue sarcoma
614148|NCT00580320|APUD tumor|apud tumor
614149|NCT00580320|dacarbazine|dacarbazine
614150|NCT00580320|bortezomib|bortezomib
614151|NCT00580320|velcade|velcade
614152|NCT00580307|Headache|headache
614153|NCT00580307|Rhinogenic|rhinogenic
614154|NCT00580307|Nose|nose
614155|NCT00580307|Nasal septum|nasal septum
614156|NCT00580307|Deviated septum|deviated septum
614157|NCT00580307|Surgery|surgery
614158|NCT00580307|Septoplasty|septoplasty
614159|NCT00580307|Turbinoplasty|turbinoplasty
614160|NCT00580307|Contact point|contact point
614161|NCT00580307|HIT-6|hit-6
614162|NCT00580294|Sciatica|sciatica
614163|NCT00580294|Diabetic Neuropathies|diabetic neuropathies
614164|NCT00580294|Complex Regional Pain Syndromes|complex regional pain syndromes
614165|NCT00580294|Low Back Pain|low back pain
614166|NCT00580294|Neck Pain|neck pain
614167|NCT00580294|Headache|headache
614168|NCT00580294|Back Pain|back pain
614169|NCT00580294|Arthritis|arthritis
614170|NCT00580294|Brachial Plexus Injury (stinger/burner)|brachial plexus injury (stinger/burner)
614171|NCT00580294|Chronic Pain|chronic pain
614172|NCT00580294|Contractures|contractures
614173|NCT00580294|Diabetes|diabetes
614174|NCT00580294|Fibromyalgia|fibromyalgia
614175|NCT00580294|Foot Pain|foot pain
614176|NCT00580294|Fracture|fracture
614177|NCT00580294|Hip|hip
614178|NCT00580294|Herpes Zoster (shingles)|herpes zoster (shingles)
614179|NCT00580294|Migraine|migraine
614180|NCT00580294|Neuropathic Pain|neuropathic pain
614181|NCT00580294|Osteoarthritis|osteoarthritis
614182|NCT00580294|Osteoporosis|osteoporosis
614183|NCT00580294|Rheumatoid Arthritis|rheumatoid arthritis
614184|NCT00580294|Scoliosis|scoliosis
614185|NCT00580294|Nerve pain|nerve pain
614186|NCT00580294|Opana|opana
614187|NCT00580294|Opioid|opioid
614188|NCT00580294|Opioid Rotation|opioid rotation
614189|NCT00580294|Oxymorphone|oxymorphone
614190|NCT00580294|Morphine|morphine
614191|NCT00580294|neuropathic|neuropathic
614192|NCT00580294|oxycodone|oxycodone
614193|NCT00580281|Gastric cancer|gastric cancer
614194|NCT00580281|Leukemia|leukemia
614195|NCT00580281|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
614196|NCT00580281|Imatinib|imatinib
614197|NCT00580281|Gleevec|gleevec
614198|NCT00580255|CHF|chf
614199|NCT00580255|CRT|crt
614200|NCT00580255|Atrial Arrhythmias|atrial arrhythmias
614201|NCT00580255|Ventricular Arrhythmias|ventricular arrhythmias
614202|NCT00580255|BioZ|bioz
614203|NCT00580255|Optivol|optivol
614204|NCT00580242|Myelodysplasia|myelodysplasia
614205|NCT00580229|Rituxan|rituxan
614206|NCT00580229|Rituximab|rituximab
614207|NCT00580216|stroke|stroke
614208|NCT00580216|systemic thromboembolic events|systemic thromboembolic events
614209|NCT00580203|HEENT cancers|heent cancers
614210|NCT00580203|larynx|larynx
614211|NCT00580203|thyroid|thyroid
614212|NCT00580203|sarcoma|sarcoma
614213|NCT00580203|specimen analysis|specimen analysis
614214|NCT00580177|Inguinal hernia|inguinal hernia
614215|NCT00580177|Randomized controlled trial|randomized controlled trial
614216|NCT00580177|Surgery|surgery
614217|NCT00580177|Complications|complications
614218|NCT00580177|Surgical mesh|surgical mesh
614219|NCT00580151|Pain not controled by morphine|pain not controled by morphine
614220|NCT00580151|Anxiety not controled by lorazepam|anxiety not controled by lorazepam
614221|NCT00580138|Deglutition Disorders|deglutition disorders
614222|NCT00580138|Evaluation|evaluation
614223|NCT00580138|Real-time internet|real-time internet
614224|NCT00580112|Breast Neoplasms|breast neoplasms
614225|NCT00580112|Trabectedin|trabectedin
614226|NCT00580112|Yondelis|yondelis
614227|NCT00580099|premature infant, body composition, total energy expenditure|premature infant, body composition, total energy expenditure
614228|NCT00580099|inflammatory growth mediators|inflammatory growth mediators
614229|NCT00580086|Breast cancer|breast cancer
614230|NCT00580086|MR spectroscopy|mr spectroscopy
614231|NCT00580086|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
614232|NCT00580060|AJCC|ajcc
614233|NCT00580060|stage|stage
614234|NCT00580060|IIB|iib
614235|NCT00580060|IIC|iic
614236|NCT00580060|III|iii
614237|NCT00580060|IV|iv
614238|NCT00580060|Melanoma|melanoma
614239|NCT00580060|HLA-A2+|hla-a2+
614240|NCT00580060|Vaccine|vaccine
614241|NCT00580047|bone density|bone density
614242|NCT00580047|osteopenia|osteopenia
614243|NCT00580047|transplant|transplant
614244|NCT00580047|zoledronic acid|zoledronic acid
614245|NCT00580047|alendronate|alendronate
614246|NCT00580034|Allogeneic Stem Cell Transplantation, Campath, HLA-Matched|allogeneic stem cell transplantation, campath, hla-matched
614247|NCT00580021|Ashkenazi ancestry|ashkenazi ancestry
614248|NCT00580021|mutations in BRCA1 or BRCA2|mutations in brca1 or brca2
614249|NCT00580021|Breast Cancer|breast cancer
614250|NCT00580021|Pancreatic Cancer|pancreatic cancer
614251|NCT00580008|tomography|tomography
614252|NCT00580008|coronary artery disease|coronary artery disease
614253|NCT00580008|coronary artery bypass grafting|coronary artery bypass grafting
614254|NCT00580008|vein graft|vein graft
614255|NCT00579982|Mood disorder|mood disorder
614256|NCT00579943|very low birth weight infant|very low birth weight infant
614257|NCT00579943|cerebral autoregulation|cerebral autoregulation
614258|NCT00579943|intraventricular hemorrhage|intraventricular hemorrhage
614259|NCT00579943|carbon dioxide|carbon dioxide
614260|NCT00579943|cerebral blood flow velocity|cerebral blood flow velocity
614261|NCT00579943|ultrasonography, Doppler, transcranial|ultrasonography, doppler, transcranial
614262|NCT00579943|cerebrovascular circulation|cerebrovascular circulation
614263|NCT00579930|Bone|bone
614264|NCT00579930|Soft Tissue|soft tissue
614265|NCT00579917|Survivor|survivor
614266|NCT00579917|Behavioral Intervention|behavioral intervention
614267|NCT00579917|Bone Marrow|bone marrow
614268|NCT00579917|Stem Cell Transplantation|stem cell transplantation
614269|NCT00579904|PCOS|pcos
614270|NCT00579904|polycystic ovary syndrome|polycystic ovary syndrome
614271|NCT00579904|insulin resistance|insulin resistance
614272|NCT00579904|fish oil|fish oil
614273|NCT00579904|walnut-oil|walnut-oil
614274|NCT00579904|walnuts|walnuts
614275|NCT00579904|almonds|almonds
614276|NCT00579904|monounsaturated fats|monounsaturated fats
614277|NCT00579904|polyunsaturated fats|polyunsaturated fats
614278|NCT00579904|MUFA|mufa
614279|NCT00579904|PUFA|pufa
614280|NCT00579891|colorectal cancer|colorectal cancer
614281|NCT00579891|tissue collection|tissue collection
614282|NCT00579865|Quality of Life|quality of life
614283|NCT00579852|Lung|lung
614284|NCT00579839|PreTerm Birth|preterm birth
614285|NCT00579839|PreTerm Neonate|preterm neonate
614286|NCT00579839|High risk pregnancy|high risk pregnancy
614287|NCT00579839|Preterm Baby|preterm baby
614288|NCT00579839|Premature Baby|premature baby
614289|NCT00579839|Cord Clamping|cord clamping
614290|NCT00579839|Milking the cord|milking the cord
614291|NCT00579813|obesity|obesity
614292|NCT00579813|inflammation|inflammation
614293|NCT00579813|diabetes|diabetes
614294|NCT00579800|Vibrant-DE|vibrant-de
614295|NCT00579800|IDEAL|ideal
614296|NCT00579800|MRI|mri
614297|NCT00579800|Breast|breast
614298|NCT00579800|07-091|07-091
614299|NCT00579787|cervical cancer|cervical cancer
614300|NCT00579787|quality of life assessment|quality of life assessment
614301|NCT00579787|behavioral|behavioral
614302|NCT00579774|Aging|aging
614303|NCT00579774|oxidative stress|oxidative stress
614304|NCT00579774|glycoxidative stress|glycoxidative stress
614305|NCT00579774|glycation|glycation
614306|NCT00579774|inflammation|inflammation
614307|NCT00579774|nutrition|nutrition
614308|NCT00579774|low AGE intake|low age intake
614309|NCT00579774|dietary AGEs|dietary ages
614310|NCT00579761|Endocarditis|endocarditis
614311|NCT00579761|neurological deficit|neurological deficit
614312|NCT00579748|OCT imaging|oct imaging
614313|NCT00579748|Barrett's esophagus|barrett's esophagus
614314|NCT00579735|Breast cancer|breast cancer
614315|NCT00579709|Thymus Transplantation|thymus transplantation
614316|NCT00579709|DiGeorge Anomaly|digeorge anomaly
614317|NCT00579709|DiGeorge Syndrome|digeorge syndrome
614318|NCT00579709|Athymia|athymia
614319|NCT00579709|Low T cell numbers|low t cell numbers
614320|NCT00579709|Immunoreconstitution|immunoreconstitution
614321|NCT00579709|Immunodeficiency|immunodeficiency
614322|NCT00579709|Complete DiGeorge|complete digeorge
614323|NCT00579709|Typical DiGeorge|typical digeorge
614324|NCT00579709|Atypical DiGeorge|atypical digeorge
614325|NCT00579709|Complete DiGeorge Anomaly|complete digeorge anomaly
614326|NCT00579696|Multiple Diseases|multiple diseases
614327|NCT00579696|Queens|queens
614328|NCT00579683|non-small cell lung cancer|non-small cell lung cancer
614329|NCT00579683|NSCLC|nsclc
614330|NCT00579683|metastatic disease|metastatic disease
614331|NCT00579683|resistent disease|resistent disease
614332|NCT00579683|RNA analysis|rna analysis
614333|NCT00579683|04-103|04-103
614334|NCT00579670|Ziprasidone in patients with schizophrenia|ziprasidone in patients with schizophrenia
614335|NCT00579657|parameters of metabolic syndrome|parameters of metabolic syndrome
614336|NCT00579631|survivors|survivors
614337|NCT00579631|adolescent|adolescent
614338|NCT00579631|pediatric|pediatric
614339|NCT00579618|non-cancer affected volunteers|non-cancer affected volunteers
614340|NCT00579618|aged 60 years or older|aged 60 years or older
614341|NCT00579605|Breastfeeding|breastfeeding
614342|NCT00579605|Self-efficacy|self-efficacy
614343|NCT00579605|Motivational Interviewing|motivational interviewing
614344|NCT00579579|Bowel function|bowel function
614345|NCT00579579|Bladder function|bladder function
614346|NCT00579579|Sexual function|sexual function
614347|NCT00579579|Quality of life|quality of life
614348|NCT00579566|Biochemical Determinants|biochemical determinants
614349|NCT00579566|Molecular Determinants|molecular determinants
614350|NCT00579553|Pre Term|pre term
614351|NCT00579553|Pre Term Birth|pre term birth
614352|NCT00579553|Premature Birth|premature birth
614353|NCT00579553|Premature baby|premature baby
614354|NCT00579553|High risk pregnancy|high risk pregnancy
614355|NCT00579553|Progesterone|progesterone
614356|NCT00579553|IM Progesterone|im progesterone
614357|NCT00579553|Vaginal Progesterone|vaginal progesterone
614358|NCT00579527|DiGeorge Anomaly|digeorge anomaly
614359|NCT00579527|Thymus Transplantation|thymus transplantation
614360|NCT00579527|DiGeorge Syndrome|digeorge syndrome
614361|NCT00579527|Athymia|athymia
614362|NCT00579527|Parathyroid Transplantation|parathyroid transplantation
614363|NCT00579527|Hypocalcemia|hypocalcemia
614364|NCT00579527|Hypoparathyroidism|hypoparathyroidism
614365|NCT00579527|Low T cell numbers|low t cell numbers
614366|NCT00579527|Immunoreconstitution|immunoreconstitution
614367|NCT00579527|Immunodeficiency|immunodeficiency
614368|NCT00579527|Complete DiGeorge Anomaly|complete digeorge anomaly
614369|NCT00579527|Complete Atypical DiGeorge Anomaly|complete atypical digeorge anomaly
614370|NCT00579527|Complete DiGeorge Syndrome|complete digeorge syndrome
614371|NCT00579527|Complete Atypical DiGeorge Syndrome|complete atypical digeorge syndrome
614372|NCT00579501|Myxoid|myxoid
614373|NCT00579501|Liposarcoma|liposarcoma
614374|NCT00579501|Trabectedin|trabectedin
614375|NCT00579501|Dexamethasone|dexamethasone
614376|NCT00579475|mifepristone|mifepristone
614377|NCT00579475|leiomyomas|leiomyomas
614378|NCT00579475|breast epithelial cell proliferation|breast epithelial cell proliferation
614379|NCT00579462|Stage III or IV Lung Cancer|stage iii or iv lung cancer
614380|NCT00579449|child abuse|child abuse
614381|NCT00579449|child neglect|child neglect
614382|NCT00579436|inflammation|inflammation
614383|NCT00579436|obesity|obesity
614384|NCT00579436|diabetes|diabetes
614385|NCT00579423|prostate|prostate
614386|NCT00579423|cancer|cancer
614387|NCT00579423|vaccine|vaccine
614388|NCT00579410|gastric acid|gastric acid
614389|NCT00579410|esophageal reflux|esophageal reflux
614390|NCT00579410|peptic ulcer|peptic ulcer
614391|NCT00579410|heartburn|heartburn
614392|NCT00579397|Markers of Inflammation|markers of inflammation
614393|NCT00579397|acute graft versus host disease|acute graft versus host disease
614394|NCT00579397|predicting aGVHD|predicting agvhd
614395|NCT00579384|Photosensitive epilepsy|photosensitive epilepsy
614396|NCT00579384|Reflex epilepsy|reflex epilepsy
614397|NCT00579384|Epilepsy|epilepsy
614398|NCT00579384|JNJ-26489112|jnj-26489112
614399|NCT00579371|islet transplantation|islet transplantation
614400|NCT00579371|type 1 diabetes mellitus|type 1 diabetes mellitus
614401|NCT00579371|steroid-free immunosuppression|steroid-free immunosuppression
614402|NCT00579371|rabbit anti-thymocyte globulin|rabbit anti-thymocyte globulin
614403|NCT00579358|Congenital heart defects|congenital heart defects
614404|NCT00579332|PSA|psa
614405|NCT00579332|biochemical failure|biochemical failure
614406|NCT00579319|breast cancer|breast cancer
614407|NCT00579306|hypertension|hypertension
614408|NCT00579306|stroke|stroke
614409|NCT00579306|cerebrovascular accident|cerebrovascular accident
614410|NCT00579293|adult survivor of childhood cancer|adult survivor of childhood cancer
614411|NCT00579293|computer assisted screening of survivors (CASS)|computer assisted screening of survivors (cass)
614412|NCT00579280|Randomized|randomized
614413|NCT00579280|Double-Blind|double-blind
614414|NCT00579280|Placebo-Controlled|placebo-controlled
614415|NCT00579280|Quetiapine|quetiapine
614416|NCT00579280|DivalproexSodiumER|divalproexsodiumer
614417|NCT00579280|Bipolar|bipolar
614418|NCT00579280|Anxiety|anxiety
614419|NCT00579280|Panic|panic
614420|NCT00579280|GAD|gad
614421|NCT00579267|MINI-KID|mini-kid
614422|NCT00579267|structured diagnostic interview|structured diagnostic interview
614423|NCT00579267|reliability and validity|reliability and validity
614424|NCT00579267|K-SADS|k-sads
614425|NCT00579267|Sheehan Disability Scale|sheehan disability scale
614426|NCT00579254|Efficacy,safety & tolerability of Caduet In Patients With Cardiovascular Risk Factors|efficacy,safety & tolerability of caduet in patients with cardiovascular risk factors
614427|NCT00579228|Diabetes|diabetes
614428|NCT00579228|Vascular risk|vascular risk
614429|NCT00579228|Inflammation|inflammation
614430|NCT00579215|Cancer|cancer
614431|NCT00579215|Enhanced Care|enhanced care
614432|NCT00579215|Decision-Making|decision-making
614433|NCT00579215|Advance Lung Cancer|advance lung cancer
614434|NCT00579215|Questionaires|questionaires
614435|NCT00579215|Stage III Lung Cancer|stage iii lung cancer
614436|NCT00579215|Stage IV Lung Cancer|stage iv lung cancer
614437|NCT00579202|Dialyzer|dialyzer
614438|NCT00579189|ear tubes|ear tubes
614439|NCT00579189|ear drainage|ear drainage
614440|NCT00579189|ear infection|ear infection
614441|NCT00579189|ear drops|ear drops
614442|NCT00579163|Blood|blood
614443|NCT00579163|Salvia|salvia
614444|NCT00579163|Tissue|tissue
614445|NCT00579150|Birth Defects|birth defects
614446|NCT00579150|High Risk Pregnancy|high risk pregnancy
614447|NCT00579150|Type 2 Diabetes|type 2 diabetes
614448|NCT00579137|Severe Combined Immunodeficiency Disease|severe combined immunodeficiency disease
614449|NCT00579137|Severe Primary Immunodeficiency Disorder|severe primary immunodeficiency disorder
614450|NCT00579137|Undefined T cell Deficiency Disorder|undefined t cell deficiency disorder
614451|NCT00579137|Wiskott-Aldrick Syndrome|wiskott-aldrick syndrome
614452|NCT00579137|Allogeneic stem cell transplant|allogeneic stem cell transplant
614453|NCT00579137|Fludarabine|fludarabine
614454|NCT00579137|monoclonal antibodies|monoclonal antibodies
614455|NCT00579124|Blood and Marrow Transplant|blood and marrow transplant
614456|NCT00579124|T cell Depletion|t cell depletion
614457|NCT00579124|Unrelated|unrelated
614458|NCT00579124|Related|related
614459|NCT00579124|Donor|donor
614460|NCT00579111|Myelodysplastic and Myeloproliferative Disorders|myelodysplastic and myeloproliferative disorders
614461|NCT00579111|Acute Myelogenous Leukemia|acute myelogenous leukemia
614462|NCT00579111|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
614463|NCT00579111|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
614464|NCT00579111|Multiple Myeloma|multiple myeloma
614465|NCT00579111|Plasma Cell dyscrasia|plasma cell dyscrasia
614466|NCT00579111|Lymphoproliferative disorders|lymphoproliferative disorders
614467|NCT00579111|Hematologic Diseases|hematologic diseases
614468|NCT00579111|Fludarabine|fludarabine
614469|NCT00579111|Busulfan|busulfan
614470|NCT00579111|Campath|campath
614471|NCT00579111|Alemtuzumab|alemtuzumab
614472|NCT00579111|allogeneic stem cell transplant|allogeneic stem cell transplant
614473|NCT00579098|Atrial Fibrillation|atrial fibrillation
614474|NCT00579098|Arrhythmia|arrhythmia
614475|NCT00579098|Pulmonary Vein Isolation|pulmonary vein isolation
614476|NCT00579098|Left atrial catheter ablation|left atrial catheter ablation
614477|NCT00579098|Inflammation|inflammation
614478|NCT00579098|Endothelial dysfunction|endothelial dysfunction
614479|NCT00579072|Prostate|prostate
614480|NCT00579072|cognitive effects|cognitive effects
614481|NCT00579072|06-084|06-084
614482|NCT00579046|Anemia|anemia
614483|NCT00579046|Chronic obstructive Pulmonary Disease|chronic obstructive pulmonary disease
614484|NCT00579046|Erythropoietin|erythropoietin
614485|NCT00579046|6-minute walk test|6-minute walk test
614486|NCT00579033|somatosensory|somatosensory
614487|NCT00579033|cortex|cortex
614488|NCT00579033|neuroimaging|neuroimaging
614489|NCT00579033|tactile|tactile
614490|NCT00579033|cortical plasticity|cortical plasticity
614491|NCT00579033|dystonia|dystonia
614492|NCT00579020|cornea|cornea
614493|NCT00579020|inflammation|inflammation
614494|NCT00579020|blepharitis|blepharitis
614495|NCT00579020|lid infection|lid infection
614496|NCT00579007|Prophylactic Mastectomy|prophylactic mastectomy
614497|NCT00579007|Prophylactic Oophorectomy|prophylactic oophorectomy
614498|NCT00578994|Unicompartmental Knee|unicompartmental knee
614499|NCT00578994|Partial Knee|partial knee
614500|NCT00578994|Knee arthroplasty|knee arthroplasty
614501|NCT00578981|Osteoporosis, age-related|osteoporosis, age-related
614502|NCT00578981|Osteoporosis, Postmenopausal|osteoporosis, postmenopausal
614503|NCT00578981|Bone Loss|bone loss
614504|NCT00578981|Low Bone Density|low bone density
614505|NCT00578968|COPD|copd
614506|NCT00578968|Tiotropium|tiotropium
614507|NCT00578968|Spiriva|spiriva
614508|NCT00578955|Blepharoconjunctivitis, Ophthalmology|blepharoconjunctivitis, ophthalmology
614509|NCT00578942|Allogeneic Stem Cell Transplantation, Campath, HLA-Matched|allogeneic stem cell transplantation, campath, hla-matched
614510|NCT00578929|allergic rhinitis|allergic rhinitis
614511|NCT00578929|allergies|allergies
614512|NCT00578929|seasonal allergies|seasonal allergies
614513|NCT00578903|Severe Aplastic Anemia|severe aplastic anemia
614514|NCT00578903|Severe|severe
614515|NCT00578890|diabetic foot|diabetic foot
614516|NCT00578890|osteomyelitis|osteomyelitis
614517|NCT00578877|Contraception|contraception
614518|NCT00578877|SILCS Diaphragm|silcs diaphragm
614519|NCT00578877|Contraceptive Gel|contraceptive gel
614520|NCT00578864|Neuroblastoma|neuroblastoma
614521|NCT00578864|Etoposide|etoposide
614522|NCT00578864|Cisplatin|cisplatin
614523|NCT00578864|Adriamycin|adriamycin
614524|NCT00578864|Cyclophosphamide|cyclophosphamide
614525|NCT00578864|Cytoxan|cytoxan
614526|NCT00578851|Hip Arthroplasty|hip arthroplasty
614527|NCT00578851|Hip Arthritis|hip arthritis
614528|NCT00578825|Severe acute respiratory syndrome|severe acute respiratory syndrome
614529|NCT00578799|ulcerative colitis|ulcerative colitis
614530|NCT00578773|ear tubes|ear tubes
614531|NCT00578773|ear infection|ear infection
614532|NCT00578773|ear drops|ear drops
614533|NCT00578773|ear tube surgery|ear tube surgery
614534|NCT00578773|acute otitis media|acute otitis media
614535|NCT00578760|hearing loss|hearing loss
614536|NCT00578760|ototoxicity|ototoxicity
614537|NCT00578760|cisplatin|cisplatin
614538|NCT00578747|Breast Cancer|breast cancer
614539|NCT00578747|Breast Neoplasms|breast neoplasms
614540|NCT00578747|Targeted Radiotherapy|targeted radiotherapy
614541|NCT00578747|Mastectomy|mastectomy
614542|NCT00578747|Seroma|seroma
614543|NCT00578721|Colorectal cancer|colorectal cancer
614544|NCT00578721|aspirin|aspirin
614545|NCT00578708|membranous|membranous
614546|NCT00578708|ventricular|ventricular
614547|NCT00578708|septal|septal
614548|NCT00578708|defect|defect
614549|NCT00578708|VSD|vsd
614550|NCT00578695|Hyponatremia|hyponatremia
614551|NCT00578695|Serum Sodium|serum sodium
614552|NCT00578695|Fluid Overload|fluid overload
614553|NCT00578695|Heart Failure|heart failure
614554|NCT00578695|Acute Heart Failure|acute heart failure
614555|NCT00578695|Vasopressin Antagonist|vasopressin antagonist
614556|NCT00578669|Smoking Cessation|smoking cessation
614557|NCT00578669|Tobacco Use Cessation|tobacco use cessation
614558|NCT00578669|Antidepressants|antidepressants
614559|NCT00578656|Food Allergy|food allergy
614560|NCT00578656|Milk Allergy|milk allergy
614561|NCT00578643|Stem Cell Transplant|stem cell transplant
614562|NCT00578643|Chronic Granulomatous Disease|chronic granulomatous disease
614563|NCT00578643|Fludarabine|fludarabine
614564|NCT00578643|Busulfan|busulfan
614565|NCT00578643|Cyclophosphamide|cyclophosphamide
614566|NCT00578630|pediatric tumors|pediatric tumors
614567|NCT00578630|genetic test development|genetic test development
614568|NCT00578630|All Pediatric patients with a histologically proven tumor.|all pediatric patients with a histologically proven tumor.
614569|NCT00578617|Atrial fibrillation|atrial fibrillation
614570|NCT00578617|Left Atrial Ablation|left atrial ablation
614571|NCT00578617|Pulmonary Vein Isolation|pulmonary vein isolation
614572|NCT00578617|Catheter Ablation|catheter ablation
614573|NCT00578617|Antiarrhythmic Drug Therapy|antiarrhythmic drug therapy
614574|NCT00578591|Graft Versus Host Disease|graft versus host disease
614575|NCT00578591|GVHD|gvhd
614576|NCT00578591|allogeneic hematopoietic transplant|allogeneic hematopoietic transplant
614577|NCT00578591|AHT|aht
614578|NCT00578591|posttransplant|posttransplant
614579|NCT00578591|Rituximab|rituximab
614580|NCT00578578|Omega3 fatty acids|omega3 fatty acids
614581|NCT00578578|hsCRP|hscrp
614582|NCT00578578|CAD|cad
614583|NCT00578565|Rheumatoid Arthritis|rheumatoid arthritis
614584|NCT00578565|Interstitial Pneumonia|interstitial pneumonia
614585|NCT00578565|Rheumatology|rheumatology
614586|NCT00578565|Rituximab|rituximab
614587|NCT00578552|tobacco|tobacco
614588|NCT00578552|smoking|smoking
614589|NCT00578552|gabapentin|gabapentin
614590|NCT00578552|abstinence|abstinence
614591|NCT00578539|Stem Cell Transplantation|stem cell transplantation
614592|NCT00578526|urothelial cancer|urothelial cancer
614593|NCT00578526|targeted therapy|targeted therapy
614594|NCT00578526|antiangiogenesis therapy|antiangiogenesis therapy
614595|NCT00578526|SU011248|su011248
614596|NCT00578526|clinical trial|clinical trial
614597|NCT00578500|chemotherapy, female, fertility preservation, gonadotoxicity|chemotherapy, female, fertility preservation, gonadotoxicity
614598|NCT00578500|oophorectomy, in vitro maturation, ovarian cryopreservation,|oophorectomy, in vitro maturation, ovarian cryopreservation,
614599|NCT00578500|oocyte cryopreservation, ovarian transplantation|oocyte cryopreservation, ovarian transplantation
614600|NCT00578474|Acute otitis media|acute otitis media
614601|NCT00578474|Tympanostomy tubes|tympanostomy tubes
614602|NCT00578461|Stem Cell Transplant|stem cell transplant
614603|NCT00578461|myeloproliferative disease|myeloproliferative disease
614604|NCT00578461|myelodsyplastic disease|myelodsyplastic disease
614605|NCT00578461|Leukemia|leukemia
614606|NCT00578461|Cancer|cancer
614607|NCT00578461|Lymphoma|lymphoma
614608|NCT00578461|Lymphoma, Hodgkin|lymphoma, hodgkin
614609|NCT00578461|Lymphoma, non-Hodgkin|lymphoma, non-hodgkin
614610|NCT00578435|ERYTHROPOIESIS|erythropoiesis
614611|NCT00578435|Genetic Disorders|genetic disorders
614612|NCT00578435|Sickle Cell Anemia|sickle cell anemia
614613|NCT00578435|Thalassemia|thalassemia
615410|NCT00574873|CML|cml
614614|NCT00578435|Diamond Blackfan Anemia|diamond blackfan anemia
614615|NCT00578422|PAD|pad
614616|NCT00578422|Peripheral Artery Disease|peripheral artery disease
614617|NCT00578422|IVUS|ivus
614618|NCT00578422|Plaque|plaque
614619|NCT00578409|castration resistant prostate cancer|castration resistant prostate cancer
614620|NCT00578409|progressive castrate metastatic prostate cancer|progressive castrate metastatic prostate cancer
614621|NCT00578396|Grapes and colon cancer prevention|grapes and colon cancer prevention
614622|NCT00578383|Depression|depression
614623|NCT00578383|Major depression|major depression
614624|NCT00578383|Bipolar Disorder|bipolar disorder
614625|NCT00578383|Bipolar depression|bipolar depression
614626|NCT00578383|LFMS|lfms
614627|NCT00578383|low field magnetic stimulation|low field magnetic stimulation
614628|NCT00578383|mood disorders|mood disorders
614629|NCT00578383|affective disorders|affective disorders
614630|NCT00578370|Ciclosporin|ciclosporin
614631|NCT00578370|Plaque type psoriasis|plaque type psoriasis
614632|NCT00578370|Psoriasis plaque test|psoriasis plaque test
614633|NCT00578370|Sonography|sonography
614634|NCT00578370|Cyclosporin|cyclosporin
614635|NCT00578370|Psoriasis|psoriasis
614636|NCT00578357|problem gambling|problem gambling
614637|NCT00578357|personalized feedback|personalized feedback
614638|NCT00578357|gambling addiction|gambling addiction
614639|NCT00578344|Sickle Cell Disease|sickle cell disease
614640|NCT00578344|SCD|scd
614641|NCT00578344|Hemoglobin SS|hemoglobin ss
614642|NCT00578344|Hemoglobin SC|hemoglobin sc
614643|NCT00578344|Hemoglobin Sb0/+|hemoglobin sb0/+
614644|NCT00578344|HLA genotype|hla genotype
614645|NCT00578344|Severe anemia|severe anemia
614646|NCT00578344|Transfusion therapy|transfusion therapy
614647|NCT00578331|rhinitis|rhinitis
614648|NCT00578331|perennial allergic rhinitis|perennial allergic rhinitis
614649|NCT00578331|allergic rhinitis|allergic rhinitis
614650|NCT00578292|transfusion-dependent|transfusion-dependent
614651|NCT00578292|homozygous b0/+-thalassemia|homozygous b0/+-thalassemia
614652|NCT00578292|severe variants of b0/+-thalassemia|severe variants of b0/+-thalassemia
614653|NCT00578292|chronic transfusion therapy|chronic transfusion therapy
614654|NCT00578292|iron chelating agents|iron chelating agents
614655|NCT00578292|severe|severe
614656|NCT00578292|transfusion-dependent homozygous b0/+-thalassemia or severe variants of b0/+-thalassemia|transfusion-dependent homozygous b0/+-thalassemia or severe variants of b0/+-thalassemia
614657|NCT00578266|Severe Aplastic Anemia (SAA)|severe aplastic anemia (saa)
614658|NCT00578266|Transplant for Severe Aplastic Anemia (SAA)|transplant for severe aplastic anemia (saa)
614659|NCT00578240|benign|benign
614660|NCT00578240|Rising PSA|rising psa
614661|NCT00578240|Clinical Metastases|clinical metastases
614662|NCT00578240|90-040|90-040
614663|NCT00578227|Human papillomavirus infection,|human papillomavirus infection,
614664|NCT00578227|cervical cancer|cervical cancer
614665|NCT00578227|HPV vaccine,|hpv vaccine,
614666|NCT00578214|mohs micrographic surgery|mohs micrographic surgery
614667|NCT00578214|skin cancer|skin cancer
614668|NCT00578214|anxiety|anxiety
614669|NCT00578214|basal cell carcinoma|basal cell carcinoma
614670|NCT00578214|squamous cell carcinoma|squamous cell carcinoma
614671|NCT00578214|midazolam|midazolam
614672|NCT00578214|versed|versed
614673|NCT00578201|Esophageal neoplasms|esophageal neoplasms
614674|NCT00578201|Cetuximab|cetuximab
614675|NCT00578201|Oxaliplatin|oxaliplatin
614676|NCT00578201|Fluorouracil|fluorouracil
614677|NCT00578201|radiotherapy|radiotherapy
614678|NCT00578188|Adolescent Health|adolescent health
614679|NCT00578188|Sexually transmitted infection|sexually transmitted infection
614680|NCT00578188|Women's Health|women's health
614681|NCT00578175|Vaccines|vaccines
614682|NCT00578175|Rubella|rubella
614683|NCT00578175|Varicella Vaccine|varicella vaccine
614684|NCT00578175|Children|children
614685|NCT00578175|Humans|humans
614686|NCT00578175|Mumps|mumps
614687|NCT00578175|Immunogenicity|immunogenicity
614688|NCT00578175|Safety|safety
614689|NCT00578175|Measles|measles
614690|NCT00578175|Combined Vaccine|combined vaccine
614691|NCT00578162|Cancer|cancer
614692|NCT00578162|Survivors|survivors
614693|NCT00578149|chemoradiotherapy|chemoradiotherapy
614694|NCT00578149|Lung cancer|lung cancer
614695|NCT00578136|Rectus Sheath|rectus sheath
614696|NCT00578136|Local infiltration|local infiltration
614697|NCT00578136|Pain Control|pain control
614698|NCT00578123|Prostate|prostate
614699|NCT00578123|Cancer|cancer
614700|NCT00578123|Quality of Life|quality of life
614701|NCT00578123|Questionaires|questionaires
614702|NCT00578123|04-094|04-094
614703|NCT00578110|glaucoma VEP detection device diagnosis vision|glaucoma vep detection device diagnosis vision
614704|NCT00578071|esophageal cancer|esophageal cancer
614705|NCT00578032|head|head
614706|NCT00578032|neck|neck
614707|NCT00578032|cancer|cancer
614708|NCT00578032|reconstruction|reconstruction
614709|NCT00578032|quality of life|quality of life
614710|NCT00578032|07-150|07-150
614711|NCT00578019|Comparative|comparative
614712|NCT00578019|Supracondylar Femur Fracture|supracondylar femur fracture
614713|NCT00578019|Intramedullary nailing|intramedullary nailing
614714|NCT00578019|Less Invasive Stabilization System (LISS) Plating|less invasive stabilization system (liss) plating
614715|NCT00578006|toxicity related symptoms|toxicity related symptoms
614716|NCT00578006|04-020|04-020
614717|NCT00577993|Lymphoma|lymphoma
614718|NCT00577993|Follicular Lymphoma|follicular lymphoma
614719|NCT00577993|Indolent Lymphoma|indolent lymphoma
614720|NCT00577993|Fludarabine|fludarabine
614721|NCT00577993|Novantrone|novantrone
614722|NCT00577993|Mitoxantrone|mitoxantrone
614723|NCT00577993|Decadron|decadron
614724|NCT00577993|Dexamethasone|dexamethasone
614725|NCT00577993|Rituximab|rituximab
614726|NCT00577993|Anti-CD20|anti-cd20
614727|NCT00577993|IDEC-C2B8|idec-c2b8
614728|NCT00577993|Chimeric Anti-CD20 Antibody|chimeric anti-cd20 antibody
614729|NCT00577993|Interferon|interferon
614730|NCT00577993|Interferon Alpha-2b|interferon alpha-2b
614731|NCT00577993|IFN|ifn
614732|NCT00577993|Doxorubicin|doxorubicin
614733|NCT00577993|Vincristine|vincristine
614734|NCT00577993|Bleomycin|bleomycin
614735|NCT00577993|Cyclophosphamide|cyclophosphamide
614736|NCT00577993|Etoposide|etoposide
614737|NCT00577993|Cisplatin|cisplatin
614738|NCT00577993|Ara-C|ara-c
614739|NCT00577993|Methyl-Prednisolone|methyl-prednisolone
614740|NCT00577993|Procarbazine|procarbazine
614741|NCT00577993|Prednisone|prednisone
614742|NCT00577993|FND|fnd
614743|NCT00577980|Prostate Cancer|prostate cancer
614744|NCT00577980|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
614745|NCT00577980|Testosterone Replacement Therapy|testosterone replacement therapy
614746|NCT00577980|Testosterone|testosterone
614747|NCT00577980|CRPC|crpc
614748|NCT00577980|TRT|trt
614749|NCT00577967|Uremic pruritis|uremic pruritis
614750|NCT00577954|Coma|coma
614751|NCT00577954|TBI|tbi
614752|NCT00577954|Stroke|stroke
614753|NCT00577954|SAH|sah
614754|NCT00577954|Cerebral Anoxia|cerebral anoxia
614755|NCT00577954|Multimodal MRI|multimodal mri
614756|NCT00577915|Breast cancer|breast cancer
614757|NCT00577915|MRI spectroscopy|mri spectroscopy
614758|NCT00577915|Diagnostic radiology|diagnostic radiology
614759|NCT00577902|head and neck cancer|head and neck cancer
614760|NCT00577824|diabetes|diabetes
614761|NCT00577824|exenatide|exenatide
614762|NCT00577824|LY2148568|ly2148568
614763|NCT00577824|Byetta|byetta
614764|NCT00577824|Lilly|lilly
614765|NCT00577824|Amylin|amylin
614766|NCT00577811|Special Need Plans|special need plans
614767|NCT00577811|Fee for Services|fee for services
614768|NCT00577811|Access to Care|access to care
614769|NCT00577811|Medicaid|medicaid
614770|NCT00577798|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
614771|NCT00577798|cardiac toxicity|cardiac toxicity
614772|NCT00577798|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
614773|NCT00577798|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
614774|NCT00577798|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
614775|NCT00577798|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
614776|NCT00577798|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
614777|NCT00577798|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
614778|NCT00577798|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
614779|NCT00577798|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
614780|NCT00577798|anaplastic large cell lymphoma|anaplastic large cell lymphoma
614781|NCT00577798|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
614782|NCT00577798|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
614783|NCT00577798|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
614784|NCT00577798|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
614785|NCT00577798|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
614786|NCT00577798|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
614787|NCT00577798|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
614788|NCT00577798|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
614789|NCT00577798|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
614790|NCT00577798|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
614791|NCT00577798|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
614792|NCT00577798|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
614793|NCT00577798|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
614794|NCT00577798|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
614795|NCT00577798|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
614796|NCT00577798|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
614797|NCT00577798|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
614798|NCT00577798|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
614799|NCT00577798|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
614800|NCT00577798|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
615028|NCT00576927|Sleep hygiene|sleep hygiene
614801|NCT00577798|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
614802|NCT00577798|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
614803|NCT00577798|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
614804|NCT00577798|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
614805|NCT00577798|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
614806|NCT00577798|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
614807|NCT00577798|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
614808|NCT00577798|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
614809|NCT00577798|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
614916|NCT00577382|Sutent|sutent
614810|NCT00577798|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
614811|NCT00577798|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
614812|NCT00577798|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
614813|NCT00577798|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
614814|NCT00577798|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
614815|NCT00577798|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
614816|NCT00577798|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
614817|NCT00577798|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
614818|NCT00577798|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
614819|NCT00577798|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
614820|NCT00577798|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
614821|NCT00577798|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
614822|NCT00577798|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
614823|NCT00577798|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
614824|NCT00577798|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
614825|NCT00577798|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
614826|NCT00577798|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
614827|NCT00577798|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
614828|NCT00577798|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
614829|NCT00577798|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
614830|NCT00577798|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
614831|NCT00577798|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
614832|NCT00577798|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
614833|NCT00577798|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
614834|NCT00577798|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
614835|NCT00577798|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
614836|NCT00577798|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
614837|NCT00577798|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
614838|NCT00577798|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
614839|NCT00577798|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
614840|NCT00577798|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
614841|NCT00577798|stage I mantle cell lymphoma|stage i mantle cell lymphoma
614842|NCT00577798|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
614843|NCT00577798|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
614844|NCT00577798|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
614845|NCT00577798|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
614846|NCT00577798|splenic marginal zone lymphoma|splenic marginal zone lymphoma
614847|NCT00577798|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
614848|NCT00577798|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
614849|NCT00577798|stage I marginal zone lymphoma|stage i marginal zone lymphoma
614850|NCT00577798|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
614851|NCT00577798|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
614852|NCT00577798|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
614853|NCT00577798|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
614854|NCT00577798|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
614855|NCT00577798|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
614856|NCT00577798|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
614857|NCT00577785|cystectomy|cystectomy
614858|NCT00577772|SmartPill Capsule|smartpill capsule
614859|NCT00577772|Digestive System Diseases|digestive system diseases
614860|NCT00577772|Small Bowel Bacterial Overgrowth|small bowel bacterial overgrowth
614861|NCT00577772|Gastrointestinal Device|gastrointestinal device
614862|NCT00577772|Oro-cecal|oro-cecal
614863|NCT00577759|Quality assurance, health care|quality assurance, health care
614864|NCT00577759|primary health care|primary health care
614865|NCT00577759|community health services|community health services
614866|NCT00577759|referral and consultation|referral and consultation
614867|NCT00577759|exercise|exercise
614868|NCT00577759|diet|diet
614869|NCT00577759|tobacco|tobacco
614870|NCT00577746|Non Small Cell Lung|non small cell lung
614871|NCT00577733|Pulmonary function test|pulmonary function test
614872|NCT00577733|Methacholine challenge|methacholine challenge
614873|NCT00577733|Breathing variability|breathing variability
614874|NCT00577733|Polygraphy|polygraphy
614875|NCT00577707|Lung Cancer|lung cancer
614876|NCT00577707|Erlotinib|erlotinib
614877|NCT00577707|clinical stage IB-IIIA|clinical stage ib-iiia
614878|NCT00577694|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
614879|NCT00577681|HIV|hiv
614880|NCT00577681|Lipoproteins|lipoproteins
614881|NCT00577681|Inflammatory Markers|inflammatory markers
614882|NCT00577681|Coagulation Markers|coagulation markers
614883|NCT00577681|Treatment Experienced|treatment experienced
614884|NCT00577655|Pediatric, asthma, albuterol-HFA and Placebo|pediatric, asthma, albuterol-hfa and placebo
614885|NCT00577642|aminobisphosphonates|aminobisphosphonates
614886|NCT00577629|high risk non-hodgkins lymphoma|high risk non-hodgkins lymphoma
614887|NCT00577629|NHL|nhl
614888|NCT00577629|Bexxar|bexxar
614889|NCT00577629|high dose chemotherapy|high dose chemotherapy
614890|NCT00577616|Endovascular repair|endovascular repair
614891|NCT00577616|Ruptured aorta-iliac aneurysms|ruptured aorta-iliac aneurysms
614892|NCT00577616|Mortality at 30 days|mortality at 30 days
614893|NCT00577603|stoma, hernia, mesh|stoma, hernia, mesh
614894|NCT00577590|Type II Diabetes Mellitus|type ii diabetes mellitus
614895|NCT00577590|Diabetes|diabetes
614896|NCT00577590|PET|pet
614897|NCT00577590|Heart Metabolism|heart metabolism
614898|NCT00577590|Lovaza|lovaza
614899|NCT00577525|LATENT VIRAL INFECTION|latent viral infection
614900|NCT00577525|GENOME HYBRIDIZATION|genome hybridization
614901|NCT00577525|HERPES VIRUS|herpes virus
614902|NCT00577525|ADENOVIRUS|adenovirus
614903|NCT00577499|cystic fibrosis|cystic fibrosis
614904|NCT00577499|constipation|constipation
614905|NCT00577499|lubiprostone|lubiprostone
614906|NCT00577499|nutrition|nutrition
614907|NCT00577499|pulmonary function|pulmonary function
614908|NCT00577447|autism|autism
614909|NCT00577447|omega-3 fatty acids|omega-3 fatty acids
614910|NCT00577447|docosahexaenoic acid|docosahexaenoic acid
614911|NCT00577434|Procedural sedation|procedural sedation
614912|NCT00577434|Sedation for diagnostic imaging|sedation for diagnostic imaging
614913|NCT00577408|Opiate Dependence|opiate dependence
614914|NCT00577408|Heroin Dependence|heroin dependence
614915|NCT00577408|Naltrexone|naltrexone
614917|NCT00577382|malignant melanoma|malignant melanoma
614918|NCT00577369|arterial line|arterial line
614919|NCT00577369|end-expiratory desflurane|end-expiratory desflurane
614920|NCT00577304|Raynaud's|raynaud's
614921|NCT00577304|Nitroglycerin|nitroglycerin
614922|NCT00577304|Scleroderma|scleroderma
614923|NCT00577278|graft versus host disease|graft versus host disease
614924|NCT00577278|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
614925|NCT00577278|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
614926|NCT00577278|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
614927|NCT00577278|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
614928|NCT00577278|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
614929|NCT00577278|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
614930|NCT00577278|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
614931|NCT00577278|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
614932|NCT00577278|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
614933|NCT00577278|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
614934|NCT00577278|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
614935|NCT00577278|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
614936|NCT00577278|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
614937|NCT00577278|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
614938|NCT00577278|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
614939|NCT00577278|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
614940|NCT00577278|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
614941|NCT00577278|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
614942|NCT00577278|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
614943|NCT00577278|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
614944|NCT00577278|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
614945|NCT00577278|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
614946|NCT00577278|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
614947|NCT00577278|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
614948|NCT00577278|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
614949|NCT00577278|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
614950|NCT00577278|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
614951|NCT00577278|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
614952|NCT00577278|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
614953|NCT00577278|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
614954|NCT00577278|stage I marginal zone lymphoma|stage i marginal zone lymphoma
614955|NCT00577278|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
614956|NCT00577278|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
614957|NCT00577278|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
614958|NCT00577278|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
614959|NCT00577278|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
614960|NCT00577278|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
614961|NCT00577278|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
614962|NCT00577278|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
614963|NCT00577278|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
614964|NCT00577278|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
614965|NCT00577278|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
614966|NCT00577278|stage I mantle cell lymphoma|stage i mantle cell lymphoma
614967|NCT00577278|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
614968|NCT00577278|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
614969|NCT00577278|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
614970|NCT00577278|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
614971|NCT00577278|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
614972|NCT00577278|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
614973|NCT00577278|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
614974|NCT00577278|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
614975|NCT00577278|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
614976|NCT00577278|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
614977|NCT00577278|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
614978|NCT00577278|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
614979|NCT00577278|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
614980|NCT00577278|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
614981|NCT00577265|Asthma Control|asthma control
614982|NCT00577252|Cystic fibrosis|cystic fibrosis
614983|NCT00577252|Adolescents|adolescents
614984|NCT00577252|Coping Compliance|coping compliance
614985|NCT00577252|Adjustment|adjustment
614986|NCT00577226|scoliosis, immature spine|scoliosis, immature spine
614987|NCT00577213|Diagnosis|diagnosis
614988|NCT00577213|Hemangiomas|hemangiomas
614989|NCT00577213|Vascular Malformations|vascular malformations
614990|NCT00577213|Venular Malformations|venular malformations
614991|NCT00577213|Venous Malformations|venous malformations
614992|NCT00577213|Lymphatic Malformations|lymphatic malformations
614993|NCT00577213|Arteriovenous Malformations|arteriovenous malformations
614994|NCT00577174|Children|children
614995|NCT00577174|Obesity|obesity
614996|NCT00577174|Insulin resistance|insulin resistance
614997|NCT00577174|Diabetes|diabetes
614998|NCT00577174|Mitochondrial Function|mitochondrial function
614999|NCT00577161|pixantrone|pixantrone
615000|NCT00577161|NHL|nhl
615001|NCT00577161|rituximab|rituximab
615002|NCT00577161|fludarabine|fludarabine
615003|NCT00577148|NASH|nash
615004|NCT00577148|chronic liver disease|chronic liver disease
615005|NCT00577135|Loop Diuretics|loop diuretics
615006|NCT00577135|Furosemide|furosemide
615007|NCT00577135|Fluid Overload|fluid overload
615008|NCT00577135|Cardio Renal Failure|cardio renal failure
615009|NCT00577122|Medroxyprogesterone progesterone acetate (MPA)|medroxyprogesterone progesterone acetate (mpa)
615010|NCT00577122|Cyclophosphamide plus Methotrexate|cyclophosphamide plus methotrexate
615011|NCT00577096|multiple myeloma|multiple myeloma
615012|NCT00577096|polysomnography|polysomnography
615013|NCT00577096|quality of life|quality of life
615014|NCT00577096|exercise|exercise
615015|NCT00577083|miss rates|miss rates
615016|NCT00577057|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
615017|NCT00577057|Stage III - IVB|stage iii - ivb
615018|NCT00577044|NAFLD|nafld
615019|NCT00577005|GABAergic|gabaergic
615020|NCT00577005|levetiracetam|levetiracetam
615021|NCT00576992|Barrett's Esophagus|barrett's esophagus
615022|NCT00576992|Demographics|demographics
615023|NCT00576992|Questionnaire|questionnaire
615024|NCT00576992|Heartburn|heartburn
615025|NCT00576979|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
615026|NCT00576979|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
615027|NCT00576940|enteral nutrition, immunomodulating nutrition|enteral nutrition, immunomodulating nutrition
615029|NCT00576927|Sleep latency|sleep latency
615030|NCT00576927|Elderly sleep|elderly sleep
615031|NCT00576927|Nursing Home sleep|nursing home sleep
615032|NCT00576914|adjuvant therapy|adjuvant therapy
615033|NCT00576914|non-small cell lung cancer|non-small cell lung cancer
615034|NCT00576914|vinorelbine|vinorelbine
615035|NCT00576914|cisplatin|cisplatin
615036|NCT00576914|recombinant human endostatin(endostar)|recombinant human endostatin(endostar)
615037|NCT00576888|Multifocal lymphangioendoltheliomatosis with thrombocytopenia|multifocal lymphangioendoltheliomatosis with thrombocytopenia
615038|NCT00576888|Cutaneovisceral angiomatosis with thrombocytopenia|cutaneovisceral angiomatosis with thrombocytopenia
615039|NCT00576888|Thrombocytopenia|thrombocytopenia
615040|NCT00576888|Hemangiomas|hemangiomas
615041|NCT00576888|Hemangiomatosis|hemangiomatosis
615042|NCT00576888|Lymphatic malformation|lymphatic malformation
615043|NCT00576888|Kasabach-Merritt|kasabach-merritt
615044|NCT00576888|Blue-rubber bleb nevus|blue-rubber bleb nevus
615045|NCT00576888|Angiomatosis|angiomatosis
615046|NCT00576875|Depression|depression
615047|NCT00576875|Elderly|elderly
615048|NCT00576875|Neuroimaging|neuroimaging
615049|NCT00576875|Postmortem|postmortem
615050|NCT00576875|Knockout mouse|knockout mouse
615051|NCT00576836|Thymus Transplantation|thymus transplantation
615052|NCT00576836|DiGeorge Syndrome|digeorge syndrome
615053|NCT00576836|DiGeorge Anomaly|digeorge anomaly
615054|NCT00576836|Athymia|athymia
615055|NCT00576836|Parathyroid Transplantation|parathyroid transplantation
615056|NCT00576836|Hypocalcemia|hypocalcemia
615057|NCT00576836|Hypoparathyroidism|hypoparathyroidism
615058|NCT00576836|Low T cell numbers|low t cell numbers
615059|NCT00576836|Immunoreconstitution|immunoreconstitution
615060|NCT00576836|Immunodeficiency|immunodeficiency
615061|NCT00576836|Complete DiGeorge|complete digeorge
615062|NCT00576836|Complete DiGeorge Anomaly|complete digeorge anomaly
615063|NCT00576836|Typical DiGeorge|typical digeorge
615064|NCT00576823|child|child
615065|NCT00576823|bladder|bladder
615066|NCT00576823|neuropathic|neuropathic
615067|NCT00576823|alpha blockers|alpha blockers
615068|NCT00576797|vaginal|vaginal
615069|NCT00576797|bacteria|bacteria
615070|NCT00576797|microflora|microflora
615071|NCT00576797|bacterial DNA|bacterial dna
615072|NCT00576797|To determine the normal bacteria in the vagina|to determine the normal bacteria in the vagina
615073|NCT00576784|type 2 diabetes|type 2 diabetes
615074|NCT00576784|insulin treatment|insulin treatment
615075|NCT00576784|ß-cell function|ß-cell function
615076|NCT00576745|Sutures|sutures
615077|NCT00576732|Irritability|irritability
615078|NCT00576732|Risperidone|risperidone
615079|NCT00576732|Antipsychotic agent|antipsychotic agent
615080|NCT00576732|Autism|autism
615081|NCT00576732|Adolescents|adolescents
615082|NCT00576732|Children|children
615083|NCT00576706|Patients with rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis or any other arthritis-like disease requiring continuous NSAIDs therapy|patients with rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis or any other arthritis-like disease requiring continuous nsaids therapy
615084|NCT00576693|ischemic stroke|ischemic stroke
615085|NCT00576693|intracranial stenting|intracranial stenting
615086|NCT00576693|vascular risk factor management|vascular risk factor management
615087|NCT00576680|RAD001|rad001
615088|NCT00576680|temozolomide|temozolomide
615089|NCT00576667|NASH|nash
615090|NCT00576667|chronic liver disease|chronic liver disease
615091|NCT00576615|healthy volunteers|healthy volunteers
615092|NCT00576615|amnesic effects|amnesic effects
615093|NCT00576589|Safety in patients with Asymptomatic cholelithiasis/gallstones.|safety in patients with asymptomatic cholelithiasis/gallstones.
615094|NCT00576576|Atherosclerosis, vulnerable plaque, IVUS, shear stress|atherosclerosis, vulnerable plaque, ivus, shear stress
615095|NCT00576563|rectal cancer|rectal cancer
615096|NCT00576563|blood proteins|blood proteins
615097|NCT00576563|irradiation|irradiation
615098|NCT00576563|FDG-PET-CT|fdg-pet-ct
615099|NCT00576550|Hand eczema|hand eczema
615100|NCT00576550|Prevention|prevention
615101|NCT00576537|New/Recurrent Glioblastoma|new/recurrent glioblastoma
615102|NCT00576524|Hypotension during dialysis|hypotension during dialysis
615103|NCT00576524|End Stage Renal Disease|end stage renal disease
615104|NCT00576524|Decrease complications during dialysis|decrease complications during dialysis
615105|NCT00576524|Low Blood Pressure|low blood pressure
615106|NCT00576511|Constipation|constipation
615107|NCT00576511|Prucalopride|prucalopride
615108|NCT00576511|Colonic Transit Time|colonic transit time
615109|NCT00576498|GERD|gerd
615110|NCT00576498|NBI|nbi
615111|NCT00576498|AFI|afi
615112|NCT00576498|IM|im
615113|NCT00576498|SSBE|ssbe
615114|NCT00576498|LSBE|lsbe
615115|NCT00576498|LGD|lgd
615116|NCT00576498|HGD|hgd
615117|NCT00576485|Cataract|cataract
615118|NCT00576485|Intraocular lens|intraocular lens
615119|NCT00576485|Spherical aberration|spherical aberration
615120|NCT00576485|Contrast sensitivity|contrast sensitivity
615121|NCT00576472|Brain Tumor, Acute Lymphoblastic Leukemia, Methylphenidate, Cognitive Late Effects|brain tumor, acute lymphoblastic leukemia, methylphenidate, cognitive late effects
615122|NCT00576407|Thymus Transplantation|thymus transplantation
615408|NCT00574873|Bosutinib|bosutinib
615123|NCT00576407|DiGeorge Syndrome|digeorge syndrome
615124|NCT00576407|Athymia|athymia
615125|NCT00576407|Low T cell numbers|low t cell numbers
615126|NCT00576407|Immunoreconstitution|immunoreconstitution
615127|NCT00576407|Primary immunodeficiency|primary immunodeficiency
615128|NCT00576407|DiGeorge Anomaly|digeorge anomaly
615129|NCT00576407|Complete DiGeorge|complete digeorge
615130|NCT00576407|Typical DiGeorge|typical digeorge
615131|NCT00576394|Glucose, Insulin|glucose, insulin
615132|NCT00576381|Precedex|precedex
615133|NCT00576381|Open Heart Surgery|open heart surgery
615134|NCT00576381|Dexmedetomidine|dexmedetomidine
615135|NCT00576381|Sedation|sedation
615136|NCT00576355|Adolescent|adolescent
615137|NCT00576355|Psychopathology|psychopathology
615138|NCT00576355|Interpersonal Therapy|interpersonal therapy
615139|NCT00576355|Interpersonal and Social Rhythm Therapy|interpersonal and social rhythm therapy
615140|NCT00576329|vitreoretinal surgery, ketorolac, Acular, mydriasis|vitreoretinal surgery, ketorolac, acular, mydriasis
615141|NCT00576316|Asthma|asthma
615142|NCT00576264|open abdominal surgery|open abdominal surgery
615143|NCT00576264|abdominal laparoscopic surgery|abdominal laparoscopic surgery
615144|NCT00576264|peritoneal stem cells|peritoneal stem cells
615145|NCT00576264|patients scheduled for any type of elective intra-abdominal surgery at Cedars-Sinai Medical Center with designated surgeons|patients scheduled for any type of elective intra-abdominal surgery at cedars-sinai medical center with designated surgeons
615146|NCT00576251|Ocular inflammation|ocular inflammation
615147|NCT00576251|blepharaconjunctivitis|blepharaconjunctivitis
615148|NCT00576238|Atopic eczema|atopic eczema
615149|NCT00576238|Topical corticosteroid|topical corticosteroid
615150|NCT00576225|NSCLC|nsclc
615151|NCT00576225|women|women
615152|NCT00576225|CT-2103|ct-2103
615153|NCT00576225|paclitaxel|paclitaxel
615154|NCT00576225|carboplatin|carboplatin
615155|NCT00576212|termination fetal anomaly|termination fetal anomaly
615156|NCT00576212|psychological sequelae pregnancy termination for anomalies|psychological sequelae pregnancy termination for anomalies
615157|NCT00576212|supportive follow-up pregnancy termination anomalies|supportive follow-up pregnancy termination anomalies
615158|NCT00576173|Cancer pain|cancer pain
615159|NCT00576173|Breakthrough pain|breakthrough pain
615160|NCT00576173|acetaminophen|acetaminophen
615161|NCT00576173|tramadol hydrochloride|tramadol hydrochloride
615162|NCT00576173|Ultracet|ultracet
615163|NCT00576160|medication adherence|medication adherence
615164|NCT00576147|TBI|tbi
615165|NCT00576147|NIRS|nirs
615166|NCT00576147|Hematoma|hematoma
615167|NCT00576134|Larynx, tracheotomy, titanium beads|larynx, tracheotomy, titanium beads
615168|NCT00576082|Lyme borreliosis|lyme borreliosis
615169|NCT00576082|Erythema migrans|erythema migrans
615170|NCT00576082|Borrelial lymphocytoma|borrelial lymphocytoma
615171|NCT00576082|Acrodermatitis chronica atrophicans|acrodermatitis chronica atrophicans
615172|NCT00576082|Borrelia burgdorferi|borrelia burgdorferi
615173|NCT00576082|Borrelia afzelii|borrelia afzelii
615174|NCT00576082|Borrelia garinii|borrelia garinii
615175|NCT00576069|asthma|asthma
615176|NCT00576069|lung function|lung function
615177|NCT00576069|inflammation|inflammation
615178|NCT00576056|Hepatocellular|hepatocellular
615179|NCT00576056|Carcinoma|carcinoma
615180|NCT00576056|TACE|tace
615181|NCT00576056|Sorafenib|sorafenib
615182|NCT00576056|Transcatheter Arterial Chemoembolization|transcatheter arterial chemoembolization
615183|NCT00576056|Nexavar|nexavar
615184|NCT00576056|Unresectable|unresectable
615185|NCT00576043|training|training
615186|NCT00576043|Patient satisfaction|patient satisfaction
615187|NCT00576043|endoscopy|endoscopy
615188|NCT00576043|simulator|simulator
615189|NCT00576043|Safety|safety
615190|NCT00576017|Cancer pain treatment|cancer pain treatment
615191|NCT00576017|Fentanyl TTS|fentanyl tts
615192|NCT00576017|Dihydrocodeine|dihydrocodeine
615193|NCT00576017|Tramadol|tramadol
615194|NCT00576017|Cancer pain|cancer pain
615195|NCT00576017|Durogesic|durogesic
615196|NCT00576017|Ultram|ultram
615197|NCT00576004|Pelvic organ prolapse, Urinary incontinence, Burch colposuspension, surgery|pelvic organ prolapse, urinary incontinence, burch colposuspension, surgery
615198|NCT00575991|conjugated linoleic acid, body fat, children, overweight|conjugated linoleic acid, body fat, children, overweight
615199|NCT00575978|breast cancer|breast cancer
615200|NCT00575965|simvastatin|simvastatin
615201|NCT00575939|HIV|hiv
615202|NCT00575939|IMT|imt
615203|NCT00575939|coronary|coronary
615204|NCT00575939|Treatment Naive|treatment naive
615205|NCT00575926|Randomized controlled trial|randomized controlled trial
615206|NCT00575926|Lingzhi|lingzhi
615207|NCT00575926|Immune functions|immune functions
615208|NCT00575926|Quality of life|quality of life
615209|NCT00575926|Survival|survival
615210|NCT00575900|Adolescent obesity,|adolescent obesity,
615211|NCT00575900|low carbohydrate diets|low carbohydrate diets
615212|NCT00575900|metabolic risk factors|metabolic risk factors
615213|NCT00575900|BMI|bmi
615214|NCT00575887|Temozolomide|temozolomide
615215|NCT00575887|Brain Tumor, Recurrent|brain tumor, recurrent
615216|NCT00575887|Chemotherapy|chemotherapy
615217|NCT00575874|rivoglitazone HCl|rivoglitazone hcl
615409|NCT00574873|imatinib|imatinib
615218|NCT00575874|pioglitazone HCl|pioglitazone hcl
615219|NCT00575874|thiazolidinedione|thiazolidinedione
615220|NCT00575874|peroxisome proliferator-activated receptor gamma (PPAR gamma)|peroxisome proliferator-activated receptor gamma (ppar gamma)
615221|NCT00575874|type 2 diabetes mellitus|type 2 diabetes mellitus
615222|NCT00575861|asthma|asthma
615223|NCT00575861|nitric oxide gas exchange|nitric oxide gas exchange
615224|NCT00575861|lung function|lung function
615225|NCT00575848|Schizophrenia|schizophrenia
615226|NCT00575848|Glycine|glycine
615227|NCT00575848|Magnetic Resonance Spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
615228|NCT00575835|vitamin D|vitamin d
615229|NCT00575835|seasonal variation|seasonal variation
615230|NCT00575835|PTH|pth
615231|NCT00575835|bone markers|bone markers
615232|NCT00575822|GERD|gerd
615233|NCT00575822|Sham|sham
615234|NCT00575822|Randomized Controlled Study|randomized controlled study
615235|NCT00575822|Endoscopic Full-thickness Plication|endoscopic full-thickness plication
615236|NCT00575822|Plicator|plicator
615237|NCT00575809|Mucositis, hematopoietic stem cell transplantation, chemotherapy|mucositis, hematopoietic stem cell transplantation, chemotherapy
615238|NCT00575796|pediatrics|pediatrics
615239|NCT00575796|Low Grade Glioma|low grade glioma
615240|NCT00575796|Vinblastine|vinblastine
615241|NCT00575783|type 1 diabetes|type 1 diabetes
615242|NCT00575783|hypoglycemia|hypoglycemia
615243|NCT00575783|magnetic resonance imaging|magnetic resonance imaging
615244|NCT00575757|Steatosis|steatosis
615245|NCT00575757|NASH|nash
615246|NCT00575744|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
615247|NCT00575744|Axillary Node Dissection|axillary node dissection
615248|NCT00575744|Intraoperative Injection|intraoperative injection
615249|NCT00575744|Lumpectomy|lumpectomy
615250|NCT00575744|Mastectomy|mastectomy
615251|NCT00575718|Quitting tobacco|quitting tobacco
615252|NCT00575718|tobacco use|tobacco use
615253|NCT00575679|Automobile driving|automobile driving
615254|NCT00575679|Driving under the influence|driving under the influence
615255|NCT00575679|Interview, psychological|interview, psychological
615256|NCT00575679|Brief intervention|brief intervention
615257|NCT00575679|Brief motivational interview|brief motivational interview
615258|NCT00575666|cognition, psychopathology|cognition, psychopathology
615259|NCT00575653|Guillain-Barre Syndrome|guillain-barre syndrome
615260|NCT00575653|Meningococcal vaccines|meningococcal vaccines
615261|NCT00575653|Tetravalent Meningococcal Vaccine|tetravalent meningococcal vaccine
615262|NCT00575653|Vaccination|vaccination
615263|NCT00575653|Vaccines|vaccines
615264|NCT00575653|Vaccines, Conjugate|vaccines, conjugate
615265|NCT00575627|Hepatitis C|hepatitis c
615266|NCT00575627|persistently normal ALT|persistently normal alt
615267|NCT00575627|pNNALT|pnnalt
615268|NCT00575627|Theraphy for Hepatitis C|theraphy for hepatitis c
615269|NCT00575627|Pegylated Interferon|pegylated interferon
615270|NCT00575627|Combined therapy|combined therapy
615271|NCT00575614|Constipation|constipation
615272|NCT00575614|Prucalopride|prucalopride
615273|NCT00575614|Ano-rectal physiology|ano-rectal physiology
615274|NCT00575614|Oro-caecal transit time|oro-caecal transit time
615275|NCT00575614|QOL|qol
615276|NCT00575601|pco|pco
615277|NCT00575601|simvastatin|simvastatin
615278|NCT00575601|ivf|ivf
615279|NCT00575601|embryo transfer|embryo transfer
615280|NCT00575588|DPP-4 Inhibitors|dpp-4 inhibitors
615281|NCT00575588|HbA1c|hba1c
615282|NCT00575588|incretins|incretins
615283|NCT00575575|Suicidal ideation|suicidal ideation
615284|NCT00575575|cognitive behavior therapy|cognitive behavior therapy
615285|NCT00575536|spasticity|spasticity
615286|NCT00575536|rhizotomy|rhizotomy
615287|NCT00575536|surgery|surgery
615288|NCT00575523|atropine|atropine
615289|NCT00575523|percutaneous ethanol instillation|percutaneous ethanol instillation
615290|NCT00575523|hepatoma|hepatoma
615291|NCT00575523|bradycardia|bradycardia
615292|NCT00575523|arrhythmia|arrhythmia
615293|NCT00575510|unified theory of behavior|unified theory of behavior
615294|NCT00575510|Pap test|pap test
615295|NCT00575510|cervical dysplasia|cervical dysplasia
615296|NCT00575510|women's health|women's health
615297|NCT00575497|Hemodialysis|hemodialysis
615298|NCT00575497|Adequacy|adequacy
615299|NCT00575497|Frequency|frequency
615300|NCT00575484|Congestive Heart Failure|congestive heart failure
615301|NCT00575484|Renal Insufficiency|renal insufficiency
615302|NCT00575484|Hypertonic Saline Solution|hypertonic saline solution
615303|NCT00575484|Diuretic Resistance|diuretic resistance
615304|NCT00575484|Cardiorenal Syndrome|cardiorenal syndrome
615305|NCT00575471|rivoglitazone HCl|rivoglitazone hcl
615306|NCT00575471|thiazolidinedione|thiazolidinedione
615307|NCT00575471|peroxisome proliferator-activated receptor gamma (PPARgamma)|peroxisome proliferator-activated receptor gamma (ppargamma)
615308|NCT00575471|diabetes mellitus, type 2|diabetes mellitus, type 2
615309|NCT00575432|magnetic resonance imaging|magnetic resonance imaging
615310|NCT00575432|renal function|renal function
615311|NCT00575432|renal transplant|renal transplant
615312|NCT00575432|urinary calculi|urinary calculi
615313|NCT00575432|healthy controls|healthy controls
615314|NCT00575432|kidney|kidney
615315|NCT00575419|Contrast Induced Nephropathy|contrast induced nephropathy
615316|NCT00575393|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
615317|NCT00575393|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
615318|NCT00575393|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
615319|NCT00575354|Sevoflurane|sevoflurane
615320|NCT00575354|Isoflurane|isoflurane
615321|NCT00575354|Breast tumor|breast tumor
615322|NCT00575354|Anesthesia|anesthesia
615323|NCT00575341|Central Adrenal Insufficiency|central adrenal insufficiency
615324|NCT00575341|DHEA|dhea
615325|NCT00575341|Pubes|pubes
615326|NCT00575328|Sexual Dysfunction|sexual dysfunction
615327|NCT00575328|Bipolar Disorder|bipolar disorder
615328|NCT00575315|HIV-HCV Coinfection|hiv-hcv coinfection
615329|NCT00575315|HIV|hiv
615330|NCT00575315|Histology|histology
615331|NCT00575302|IVF|ivf
615332|NCT00575302|poor responder|poor responder
615333|NCT00575302|recFSH|recfsh
615334|NCT00575302|Fertilization in Vitro|fertilization in vitro
615335|NCT00575302|Poor responders|poor responders
615336|NCT00575276|Pain, Cholecystectomy, Cytokines, Sex Differences|pain, cholecystectomy, cytokines, sex differences
615337|NCT00575263|Pain, Sodium Channel, Dental pulp|pain, sodium channel, dental pulp
615338|NCT00575250|Osteoporosis/prevention & control|osteoporosis/prevention & control
615339|NCT00575250|Osteoporosis Prevention and Self-Management Course|osteoporosis prevention and self-management course
615340|NCT00575250|Patient Education/*trends//Questionnaires|patient education/*trends//questionnaires
615341|NCT00575250|Adult//Aged//Middle Aged|adult//aged//middle aged
615342|NCT00575250|Life Style//|life style//
615343|NCT00575237|Laparoscopic Surgery|laparoscopic surgery
615344|NCT00575237|Shoulder pain|shoulder pain
615345|NCT00575237|PDNV|pdnv
615346|NCT00575237|Anesthesia|anesthesia
615347|NCT00575237|Residual CO2|residual co2
615348|NCT00575237|Postoperative Pain|postoperative pain
615349|NCT00575237|Female ASA 1 and 2 outpatients who were scheduled for elective gynecologic laparoscopic surgery|female asa 1 and 2 outpatients who were scheduled for elective gynecologic laparoscopic surgery
615350|NCT00575224|Hepatitis C|hepatitis c
615351|NCT00575224|Genotype 6|genotype 6
615352|NCT00575224|Novel genoytpe|novel genoytpe
615353|NCT00575224|HCV|hcv
615354|NCT00575224|Treatment|treatment
615355|NCT00575211|New onset cardiomyopathy|new onset cardiomyopathy
615356|NCT00575211|Onset of symptoms less than 6 months|onset of symptoms less than 6 months
615357|NCT00575211|LVEF < 40%|lvef < 40%
615358|NCT00575198|Chest tubes|chest tubes
615359|NCT00575198|Trauma|trauma
615360|NCT00575185|Mono|mono
615361|NCT00575185|Mononucleosis|mononucleosis
615362|NCT00575185|Epstein-Barr virus|epstein-barr virus
615363|NCT00575172|type2 diabetes mellitus|type2 diabetes mellitus
615364|NCT00575172|cardiovascular disease|cardiovascular disease
615365|NCT00575172|macrovascular event|macrovascular event
615366|NCT00575159|type 1 Diabetes mellitus, pharmacokinetics,|type 1 diabetes mellitus, pharmacokinetics,
615367|NCT00575159|pharmacodynamics|pharmacodynamics
615368|NCT00575159|Adult male and females,|adult male and females,
615369|NCT00575146|glioblastoma|glioblastoma
615370|NCT00575146|ketogenic diet|ketogenic diet
615371|NCT00575120|Endothelial Function, MRI, Vascular Biology|endothelial function, mri, vascular biology
615372|NCT00575081|Physiological Brain Atlas, Brain registry, Brain database|physiological brain atlas, brain registry, brain database
615373|NCT00575042|PBC|pbc
615374|NCT00575042|Primary Biliary Cirrhosis|primary biliary cirrhosis
615375|NCT00575042|Fenofibrate|fenofibrate
615376|NCT00575042|Triglide|triglide
615377|NCT00575029|megestrol acetate|megestrol acetate
615378|NCT00575029|adrenal insufficiency|adrenal insufficiency
615379|NCT00575029|adrenal suppression|adrenal suppression
615380|NCT00574990|Interdisciplinary Communication|interdisciplinary communication
615381|NCT00574990|Safety Management|safety management
615382|NCT00574990|Management, Medication Therapy|management, medication therapy
615383|NCT00574990|Cooperative Behavior|cooperative behavior
615384|NCT00574990|Drug Therapy Management|drug therapy management
615385|NCT00574990|Physician Nurse Relationships|physician nurse relationships
615386|NCT00574990|Side Effects|side effects
615387|NCT00574990|Hospital Information Systems|hospital information systems
615388|NCT00574990|Documentation|documentation
615389|NCT00574990|Quality Assurance, Health Care|quality assurance, health care
615390|NCT00574977|vaccinia|vaccinia
615391|NCT00574977|virus|virus
615392|NCT00574977|tumor|tumor
615393|NCT00574977|melanoma|melanoma
615394|NCT00574977|breast cancer|breast cancer
615395|NCT00574977|squamous cell cancer|squamous cell cancer
615396|NCT00574977|colorectal|colorectal
615397|NCT00574977|liver|liver
615398|NCT00574977|pancreatic|pancreatic
615399|NCT00574977|adenocarcinoma|adenocarcinoma
615400|NCT00574951|fallopian tube cancer|fallopian tube cancer
615401|NCT00574951|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
615402|NCT00574951|primary peritoneal cavity cancer|primary peritoneal cavity cancer
615403|NCT00574925|H. pylori|h. pylori
615404|NCT00574912|Type 2 diabetes|type 2 diabetes
615405|NCT00574912|Insulin Glargine|insulin glargine
615406|NCT00574912|Endogenous Glucose Production|endogenous glucose production
615407|NCT00574899|Prostate|prostate
615411|NCT00574860|Oral Mucositis|oral mucositis
615412|NCT00574860|Chemoradiation therapy|chemoradiation therapy
615413|NCT00574860|Head and neck cancer|head and neck cancer
615414|NCT00574847|ischemic heart disease|ischemic heart disease
615415|NCT00574847|mental stress-induced myocardial ischemia|mental stress-induced myocardial ischemia
615416|NCT00574847|escitalopram|escitalopram
615417|NCT00574821|Hypertrophic Cardiomyopathy(HCM)|hypertrophic cardiomyopathy(hcm)
615418|NCT00574821|Magnetocardiography (MCG)|magnetocardiography (mcg)
615419|NCT00574808|Primary care|primary care
615420|NCT00574808|Prevention of Cardiovascular Disease|prevention of cardiovascular disease
615421|NCT00574808|Chronic Disease Management|chronic disease management
615422|NCT00574808|Chronic Disease Prevention|chronic disease prevention
615423|NCT00574808|Chronic Care Model|chronic care model
615424|NCT00574808|Outreach Facilitation|outreach facilitation
615425|NCT00574782|cholesterol, coronary heart disease|cholesterol, coronary heart disease
615426|NCT00574782|rosuvastatin|rosuvastatin
615427|NCT00574782|LDL-C goal|ldl-c goal
615428|NCT00574782|hypercholesterolemia|hypercholesterolemia
615429|NCT00574769|RAD001|rad001
615430|NCT00574769|mTOR inhibition|mtor inhibition
615431|NCT00574769|docetaxel|docetaxel
615432|NCT00574769|bevacizumab|bevacizumab
615433|NCT00574769|adenocarcinoma of the prostate|adenocarcinoma of the prostate
615434|NCT00574769|recurrent prostate cancer|recurrent prostate cancer
615435|NCT00574769|stage IV prostate cancer|stage iv prostate cancer
615436|NCT00574769|prostate cancer|prostate cancer
615437|NCT00574769|Metastatic, androgen independent prostate cancer|metastatic, androgen independent prostate cancer
615438|NCT00574743|ERL080A, Heart Transplantation, Mycophenolate, EC-MPS|erl080a, heart transplantation, mycophenolate, ec-mps
615439|NCT00574717|hyperopia|hyperopia
615440|NCT00574717|ocular refraction|ocular refraction
615441|NCT00574717|infant|infant
615442|NCT00574717|vision|vision
615443|NCT00574691|Closure Device|closure device
615444|NCT00574691|Angiography|angiography
615445|NCT00574691|Angioplasty|angioplasty
615446|NCT00574691|Hemostasis|hemostasis
615447|NCT00574691|Heart Catheterization|heart catheterization
615448|NCT00574691|Coronary Angiography|coronary angiography
615449|NCT00574678|Screening tool for cancer|screening tool for cancer
615450|NCT00574665|Type 2 Diabetes|type 2 diabetes
615451|NCT00574665|Endothelial Function|endothelial function
615452|NCT00574665|Fibrinolytic Balance|fibrinolytic balance
615453|NCT00574652|HCV+|hcv+
615454|NCT00574652|cryoglobulinemia|cryoglobulinemia
615455|NCT00574652|Vasculitis|vasculitis
615456|NCT00574652|IL-2 treatment|il-2 treatment
615457|NCT00574652|safety and efficacy|safety and efficacy
615458|NCT00574639|Type 1 Diabetes|type 1 diabetes
615459|NCT00574639|Alprazolam|alprazolam
615460|NCT00574639|Exercise|exercise
615461|NCT00574626|NHL|nhl
615462|NCT00574626|Non Hodgkins Lymphoma|non hodgkins lymphoma
615463|NCT00574626|BMT|bmt
615464|NCT00574626|Bone Marrow Transplant|bone marrow transplant
615465|NCT00574626|PBSCT|pbsct
615466|NCT00574626|Peripheral Blood Stem Cell Transplant|peripheral blood stem cell transplant
615467|NCT00574626|PSCT|psct
615468|NCT00574613|Skin fibrosis|skin fibrosis
615469|NCT00574613|systemic scleroderma|systemic scleroderma
615470|NCT00574613|systemic sclerosis|systemic sclerosis
615471|NCT00574613|P144|p144
615472|NCT00574613|orphan drug|orphan drug
615473|NCT00574613|soluble collagen|soluble collagen
615474|NCT00574613|durometer|durometer
615475|NCT00574613|skin fibrosis in systemic sclerosis|skin fibrosis in systemic sclerosis
615476|NCT00574600|HIV Seronegativity|hiv seronegativity
615477|NCT00574600|HIV Preventive Vaccine|hiv preventive vaccine
615478|NCT00574587|Vorinostat|vorinostat
615479|NCT00574587|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
615480|NCT00574574|cardiovascular disease|cardiovascular disease
615481|NCT00574574|CVD|cvd
615482|NCT00574574|skin health|skin health
615483|NCT00574574|postmenopausal women|postmenopausal women
615484|NCT00574574|anthocyanin|anthocyanin
615485|NCT00574574|inflammation|inflammation
615486|NCT00574561|CT angiography (CTA)|ct angiography (cta)
615487|NCT00574561|Magnetocardiography (MCG)|magnetocardiography (mcg)
615488|NCT00574561|heart disease|heart disease
615489|NCT00574548|Vaccines, Pneumococcal Conjugate Vaccine|vaccines, pneumococcal conjugate vaccine
615490|NCT00574535|Reproductive Hormones|reproductive hormones
615491|NCT00574522|HIV|hiv
615492|NCT00574522|AIDS|aids
615493|NCT00574522|Radiation|radiation
615494|NCT00574522|Far infrared|far infrared
615495|NCT00574522|Treatment|treatment
615496|NCT00574522|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
615497|NCT00574522|Complimentary therapies|complimentary therapies
615498|NCT00574509|NHL|nhl
615499|NCT00574509|Non Hodgkins Lymphoma|non hodgkins lymphoma
615500|NCT00574509|131Iodine-Anti-B1 Radioimmunotherapy|131iodine-anti-b1 radioimmunotherapy
615501|NCT00574509|Autologous Hematopoietic Stem Cell Transplant|autologous hematopoietic stem cell transplant
615502|NCT00574509|AHSCT|ahsct
615503|NCT00574496|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
615504|NCT00574496|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
615597|NCT00574145|stage IIIA breast cancer|stage iiia breast cancer
615505|NCT00574496|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
615506|NCT00574496|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
615507|NCT00574496|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
615508|NCT00574496|childhood lymphocyte depletion Hodgkin lymphoma|childhood lymphocyte depletion hodgkin lymphoma
615509|NCT00574496|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
615510|NCT00574496|childhood nodular sclerosis Hodgkin lymphoma|childhood nodular sclerosis hodgkin lymphoma
615511|NCT00574496|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
615512|NCT00574496|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
615513|NCT00574496|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
615514|NCT00574496|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
615515|NCT00574483|Renal cell carcinoma|renal cell carcinoma
615516|NCT00574457|Atherosclerosis|atherosclerosis
615517|NCT00574457|Cardiovascular Risk Prevention|cardiovascular risk prevention
615518|NCT00574457|Carotid Ultrasound|carotid ultrasound
615519|NCT00574457|Handheld ultrasound|handheld ultrasound
615520|NCT00574457|Office Practice|office practice
615521|NCT00574457|Carotid Intima Media Thickness|carotid intima media thickness
615522|NCT00574457|Carotid Plaque|carotid plaque
615523|NCT00574444|transvaginal peritoneoscopy|transvaginal peritoneoscopy
615524|NCT00574431|Critical care|critical care
615525|NCT00574431|Intensive care unit|intensive care unit
615526|NCT00574431|Early enteral nutrition|early enteral nutrition
615527|NCT00574431|Nutritional management protocol|nutritional management protocol
615528|NCT00574418|Fibroid Tumor|fibroid tumor
615529|NCT00574418|Fibroid Uterus|fibroid uterus
615530|NCT00574418|Fibroids, Uterine|fibroids, uterine
615531|NCT00574418|Fibromyoma|fibromyoma
615532|NCT00574418|Uterine Neoplasms|uterine neoplasms
615533|NCT00574405|Insulin pump|insulin pump
615534|NCT00574405|Beta cell|beta cell
615535|NCT00574392|skin disorders|skin disorders
615536|NCT00574379|Allergic Rhinitis|allergic rhinitis
615537|NCT00574379|Mountain Cedar Pollen|mountain cedar pollen
615538|NCT00574379|Pollen Allergy|pollen allergy
615539|NCT00574379|Rhinoconjunctivitis|rhinoconjunctivitis
615540|NCT00574366|recurrent breast cancer|recurrent breast cancer
615541|NCT00574366|stage IV breast cancer|stage iv breast cancer
615542|NCT00574366|male breast cancer|male breast cancer
615543|NCT00574353|colorectal cancer|colorectal cancer
615544|NCT00574353|07-151|07-151
615545|NCT00574340|Type 2 Diabetes|type 2 diabetes
615546|NCT00574340|Endothelial Function|endothelial function
615547|NCT00574340|Fibrinolytic Balance|fibrinolytic balance
615548|NCT00574340|Hypoglycemia|hypoglycemia
615549|NCT00574327|Role|role
615550|NCT00574327|Registry|registry
615551|NCT00574327|Barrett's Esophagus|barrett's esophagus
615552|NCT00574314|women|women
615553|NCT00574314|Registry|registry
615554|NCT00574301|Image Guided Vacuum Assisted Biopsy|image guided vacuum assisted biopsy
615555|NCT00574301|Radiofrequency Ablation|radiofrequency ablation
615556|NCT00574301|Breast Conservation Therapy|breast conservation therapy
615557|NCT00574301|Mastectomy|mastectomy
615558|NCT00574301|MRI|mri
615559|NCT00574288|Multiple Myeloma|multiple myeloma
615560|NCT00574288|Daratumumab|daratumumab
615561|NCT00574288|Safety|safety
615562|NCT00574288|HuMax-CD38|humax-cd38
615563|NCT00574288|Dose-escalation|dose-escalation
615564|NCT00574275|metastatic pancreatic cancer|metastatic pancreatic cancer
615565|NCT00574275|angiogenesis inhibitor|angiogenesis inhibitor
615566|NCT00574275|gemcitabine|gemcitabine
615567|NCT00574262|acute ischemic stroke|acute ischemic stroke
615568|NCT00574262|clinical pathway|clinical pathway
615569|NCT00574262|quality of care|quality of care
615570|NCT00574262|secondary prevention|secondary prevention
615571|NCT00574249|Psoriasis|psoriasis
615572|NCT00574249|Moderate Psoriasis|moderate psoriasis
615573|NCT00574249|Severe Psoriasis|severe psoriasis
615574|NCT00574249|Chronic Plaque Psoriasis|chronic plaque psoriasis
615575|NCT00574249|Severe Chronic Plaque Psoriasis|severe chronic plaque psoriasis
615576|NCT00574210|Seasonal Allergic Rhinitis (SAR)|seasonal allergic rhinitis (sar)
615577|NCT00574210|Environmental Exposure Chamber (EEC)|environmental exposure chamber (eec)
615578|NCT00574210|Therapeutic Uses|therapeutic uses
615579|NCT00574210|Antihistamine Drug|antihistamine drug
615580|NCT00574210|Ragweed Pollen|ragweed pollen
615581|NCT00574197|Heart Transplant|heart transplant
615582|NCT00574197|gastrointestinal|gastrointestinal
615583|NCT00574197|Cellcept|cellcept
615584|NCT00574197|Myfortic|myfortic
615585|NCT00574197|GI|gi
615586|NCT00574197|GI symptoms with Mycophenolate Mofetil after heart transplant|gi symptoms with mycophenolate mofetil after heart transplant
615587|NCT00574184|ED|ed
615588|NCT00574184|Erectile Dysfunction|erectile dysfunction
615589|NCT00574158|ozone|ozone
615590|NCT00574158|inflammatory airway disease|inflammatory airway disease
615591|NCT00574158|polymorphisms|polymorphisms
615592|NCT00574145|fatigue|fatigue
615593|NCT00574145|depression|depression
615594|NCT00574145|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
615595|NCT00574145|stage I breast cancer|stage i breast cancer
615596|NCT00574145|stage II breast cancer|stage ii breast cancer
615598|NCT00574145|stage IIIB breast cancer|stage iiib breast cancer
615599|NCT00574145|stage IIIC breast cancer|stage iiic breast cancer
615600|NCT00574145|recurrent breast cancer|recurrent breast cancer
615601|NCT00574119|heart failure|heart failure
615602|NCT00574119|positron emission tomography|positron emission tomography
615603|NCT00574119|magnetic resonance imaging|magnetic resonance imaging
615604|NCT00574119|myocardial energetics|myocardial energetics
615605|NCT00574119|myocardial perfusion|myocardial perfusion
615606|NCT00574106|Cancer|cancer
615607|NCT00574106|Tumors|tumors
615608|NCT00574093|combination therapy|combination therapy
615609|NCT00574093|Lucentis|lucentis
615610|NCT00574093|Visudyne|visudyne
615611|NCT00574054|Familial Dementia|familial dementia
615612|NCT00574054|Semantic Dementia|semantic dementia
615613|NCT00574054|Senile Paranoid Dementia|senile paranoid dementia
615614|NCT00574041|Multiple Sclerosis|multiple sclerosis
615615|NCT00574041|Avonex|avonex
615616|NCT00574041|side effects|side effects
615617|NCT00574041|flu like symptoms|flu like symptoms
615618|NCT00574028|IBD Study|ibd study
615619|NCT00574015|toothache|toothache
615620|NCT00574015|regional anesthesia|regional anesthesia
615621|NCT00574015|emergency department|emergency department
615622|NCT00573989|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
615623|NCT00573989|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
615624|NCT00573989|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
615625|NCT00573989|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
615626|NCT00573989|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
615627|NCT00573989|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
615628|NCT00573989|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
615629|NCT00573989|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
615630|NCT00573976|SCIM|scim
615631|NCT00573976|SCIM III|scim iii
615632|NCT00573976|Multi-Center|multi-center
615633|NCT00573976|United States|united states
615634|NCT00573963|Cesarean section|cesarean section
615635|NCT00573950|cilostazol|cilostazol
615636|NCT00573950|Type 2 Diabetes mellitus|type 2 diabetes mellitus
615637|NCT00573950|Metabolic Syndrome|metabolic syndrome
615638|NCT00573950|adipocytokines|adipocytokines
615639|NCT00573950|arterial stiffness|arterial stiffness
615640|NCT00573950|Pulse wave velocity|pulse wave velocity
615641|NCT00573937|Neoplasms|neoplasms
615642|NCT00573937|Pain|pain
615643|NCT00573937|Methadone|methadone
615644|NCT00573937|Morphine|morphine
615645|NCT00573911|Barrett's esophagus|barrett's esophagus
615646|NCT00573911|GERD|gerd
615647|NCT00573898|daptomycin|daptomycin
615648|NCT00573885|non-small cell lung cancer|non-small cell lung cancer
615649|NCT00573885|small cell lung cancer|small cell lung cancer
615650|NCT00573885|tobacco use disorder|tobacco use disorder
615651|NCT00573872|Radiosurgery|radiosurgery
615652|NCT00573872|Phase II|phase ii
615653|NCT00573872|Cancer|cancer
615654|NCT00573872|Spinal|spinal
615655|NCT00573872|AVM|avm
615656|NCT00573859|Smoking|smoking
615657|NCT00573859|ADHD|adhd
615658|NCT00573859|Stimulant medication|stimulant medication
615659|NCT00573846|IBD|ibd
615660|NCT00573833|adenocarcinoma of the prostate|adenocarcinoma of the prostate
615661|NCT00573833|stage IIB prostate cancer|stage iib prostate cancer
615662|NCT00573833|stage IIA prostate cancer|stage iia prostate cancer
615663|NCT00573820|Tumors or cancer of the prostate|tumors or cancer of the prostate
615664|NCT00573820|Cancer of Prostate|cancer of prostate
615665|NCT00573820|Cancer of the Prostate|cancer of the prostate
615666|NCT00573820|Neoplasms, Prostate|neoplasms, prostate
615667|NCT00573820|Neoplasms, Prostatic|neoplasms, prostatic
615668|NCT00573820|Prostate Cancer|prostate cancer
615669|NCT00573820|Prostate Neoplasms|prostate neoplasms
615670|NCT00573820|Prostatic Cancer|prostatic cancer
615671|NCT00573807|Neuralgia, Sciatic|neuralgia, sciatic
615672|NCT00573807|Sciatic Neuralgia|sciatic neuralgia
615673|NCT00573807|Sciatica, Bilateral|sciatica, bilateral
615674|NCT00573807|Lower back pain|lower back pain
615675|NCT00573794|Ulcerative Colitis|ulcerative colitis
615676|NCT00573781|Systems biology|systems biology
615677|NCT00573781|Nutrigenomics|nutrigenomics
615678|NCT00573781|Metabolomics|metabolomics
615679|NCT00573781|Gene expression|gene expression
615680|NCT00573781|Fat tissue|fat tissue
615681|NCT00573781|Peripheral mononuclear cells|peripheral mononuclear cells
615682|NCT00573781|Gene clusters|gene clusters
615683|NCT00573781|Gene expression profiles|gene expression profiles
615684|NCT00573781|Personal diets|personal diets
615685|NCT00573781|Metabolic syndrome|metabolic syndrome
615686|NCT00573781|Type 2 Diabetes|type 2 diabetes
615687|NCT00573781|Atherosclerosis|atherosclerosis
615688|NCT00573768|Ankle, sprain, diclofenac diethylamine|ankle, sprain, diclofenac diethylamine
615689|NCT00573755|stage IV breast cancer|stage iv breast cancer
615690|NCT00573755|recurrent breast cancer|recurrent breast cancer
615691|NCT00573742|hypertension|hypertension
615692|NCT00573729|vascular malformation|vascular malformation
615693|NCT00573716|bone mineral content|bone mineral content
615694|NCT00573716|aripiprazole monotherapy|aripiprazole monotherapy
615695|NCT00573716|risperidone monotherapy|risperidone monotherapy
615696|NCT00573703|Laparoscopic Burch colposuspension|laparoscopic burch colposuspension
615697|NCT00573703|Stress incontinence|stress incontinence
615698|NCT00573703|Surgery|surgery
615699|NCT00573703|TOT|tot
615700|NCT00573703|Treatment|treatment
615701|NCT00573703|Predominant or genuine stress urinary incontinence|predominant or genuine stress urinary incontinence
615702|NCT00573690|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
615703|NCT00573664|Cesarean section|cesarean section
615704|NCT00573664|Gabapentin|gabapentin
615705|NCT00573651|JIA|jia
615706|NCT00573651|SEA syndrome|sea syndrome
615707|NCT00573651|AS|as
615708|NCT00573651|psoriatic arthritis|psoriatic arthritis
615709|NCT00573651|HPV vaccine|hpv vaccine
615710|NCT00573638|glaucoma|glaucoma
615711|NCT00573638|compliance|compliance
615712|NCT00573638|eye drops|eye drops
615713|NCT00573638|deliver aid|deliver aid
615714|NCT00573638|Patients could range anywhere from 40 to 80 years old|patients could range anywhere from 40 to 80 years old
615715|NCT00573638|Patients must have diagnosis requiring treatment with Xalatan.|patients must have diagnosis requiring treatment with xalatan.
615716|NCT00573638|Patients will be male or female and from any racial/ethnic background.|patients will be male or female and from any racial/ethnic background.
615717|NCT00573612|Fibromyalgia|fibromyalgia
615718|NCT00573612|Fibromyalgia patients|fibromyalgia patients
615719|NCT00573599|Migraine|migraine
615720|NCT00573599|Emergency|emergency
615721|NCT00573599|imitrex|imitrex
615722|NCT00573599|prochlorperazine|prochlorperazine
615723|NCT00573599|Acute Migraine Headache in the Emergency Department|acute migraine headache in the emergency department
615724|NCT00573573|PRIMARY HYPERPARATHYROIDISM|primary hyperparathyroidism
615725|NCT00573573|PARATHYROID NEOPLASMS|parathyroid neoplasms
615726|NCT00573573|SECONDARY HYPERPARATHYROIDISM|secondary hyperparathyroidism
615727|NCT00573573|HYPOCALCEMIA|hypocalcemia
615728|NCT00573560|Heart failure|heart failure
615729|NCT00573560|percutaneous|percutaneous
615730|NCT00573560|interventional cardiology|interventional cardiology
615731|NCT00573560|apical remodeling|apical remodeling
615732|NCT00573560|LV dilatation|lv dilatation
615733|NCT00573560|akinesis|akinesis
615734|NCT00573560|dyskinesis|dyskinesis
615735|NCT00573547|depression|depression
615736|NCT00573547|chronic renal failures|chronic renal failures
615737|NCT00573547|end stage renal disease|end stage renal disease
615738|NCT00573534|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
615739|NCT00573534|ADHD|adhd
615740|NCT00573534|ADD|add
615741|NCT00573534|Prevention|prevention
615742|NCT00573534|Substance use|substance use
615743|NCT00573534|Adolescent|adolescent
615744|NCT00573521|ESBL positive cultures|esbl positive cultures
615745|NCT00573508|Overactive Bladder|overactive bladder
615746|NCT00573495|Advanced breast cancer|advanced breast cancer
615747|NCT00573482|weight gain prevention|weight gain prevention
615748|NCT00573482|obesity|obesity
615749|NCT00573482|overweight|overweight
615750|NCT00573482|food environment|food environment
615751|NCT00573482|The intervention group received the education in REDE techniques|the intervention group received the education in rede techniques
615752|NCT00573482|The control group received no intervention at all.|the control group received no intervention at all.
615753|NCT00573482|Both groups were exposed to the food labels and the new lower ED foods.|both groups were exposed to the food labels and the new lower ed foods.
615754|NCT00573482|Only the intervention group received the education sessions and only they were eligible for the price reductions.|only the intervention group received the education sessions and only they were eligible for the price reductions.
615755|NCT00573469|gastrointestinal|gastrointestinal
615756|NCT00573469|GI|gi
615757|NCT00573469|Crohn's disease|crohn's disease
615758|NCT00573469|Japan|japan
615759|NCT00573469|Japanese|japanese
615760|NCT00573456|Thye 1 Diabetes|thye 1 diabetes
615761|NCT00573456|Type 2 Diabetes|type 2 diabetes
615762|NCT00573443|Amyotrophic Lateral Sclerosis (Lou Gehrig's disease, ALS)|amyotrophic lateral sclerosis (lou gehrig's disease, als)
615763|NCT00573443|Multiple Sclerosis (MS)|multiple sclerosis (ms)
615764|NCT00573430|Candesartan Cilexetil|candesartan cilexetil
615765|NCT00573430|Non-diabetic Nephropathy|non-diabetic nephropathy
615766|NCT00573430|hypertension|hypertension
615767|NCT00573430|urine protein creatinine ratio|urine protein creatinine ratio
615768|NCT00573417|Schizophrenia|schizophrenia
615769|NCT00573417|Clozapine|clozapine
615770|NCT00573417|Cognition|cognition
615771|NCT00573417|Metabolic Syndrome|metabolic syndrome
615772|NCT00573417|Negative Symptoms|negative symptoms
615773|NCT00573417|Wakefulness|wakefulness
615774|NCT00573417|Fatigue|fatigue
615775|NCT00573404|gastrointestinal stromal tumor|gastrointestinal stromal tumor
615776|NCT00573378|CML|cml
615777|NCT00573365|dermatitis|dermatitis
615778|NCT00573365|skin|skin
615779|NCT00573365|radiation|radiation
615780|NCT00573365|light|light
615781|NCT00573365|LED photomodulation|led photomodulation
615782|NCT00573365|Gentlewaves|gentlewaves
615783|NCT00573352|Arthritis, Degenerative|arthritis, degenerative
615784|NCT00573352|Osteoarthrosis|osteoarthrosis
615785|NCT00573352|Osteoarthrosis Deformans|osteoarthrosis deformans
615786|NCT00573339|Cardiac|cardiac
615787|NCT00573339|MRI|mri
615788|NCT00573339|normal controls|normal controls
615789|NCT00573313|Alcoholic Liver Disease (ALD)|alcoholic liver disease (ald)
615790|NCT00573313|S-adenosylmethionine|s-adenosylmethionine
615791|NCT00573313|SAMe|same
615792|NCT00573300|Schizophrenia|schizophrenia
615793|NCT00573300|Immune System|immune system
615794|NCT00573300|Kynurenate|kynurenate
615795|NCT00573300|tryptophan metabolism|tryptophan metabolism
615796|NCT00573300|NMDA receptor|nmda receptor
615797|NCT00573300|indolamine 2,3-deoxygenase (IDO)|indolamine 2,3-deoxygenase (ido)
615798|NCT00573287|Clozapine, risperidone, first episode,|clozapine, risperidone, first episode,
615799|NCT00573274|Cesarean section|cesarean section
615800|NCT00573274|Cardiac Output|cardiac output
615801|NCT00573274|Physioflow|physioflow
615802|NCT00573274|Cardiography, Impedance|cardiography, impedance
615803|NCT00573261|Diabetic neuropathy|diabetic neuropathy
615804|NCT00573261|Pregabalin|pregabalin
615805|NCT00573261|Lyrica|lyrica
615806|NCT00573248|Nicotine|nicotine
615807|NCT00573248|ADHD|adhd
615808|NCT00573248|Gender|gender
615809|NCT00573235|isolates|isolates
615810|NCT00573235|infection|infection
615811|NCT00573235|E coli isolates|e coli isolates
615812|NCT00573222|Asthma|asthma
615813|NCT00573209|Impotence|impotence
615814|NCT00573209|Male Impotence|male impotence
615815|NCT00573209|Male Sexual Impotence|male sexual impotence
615816|NCT00573196|Affective Psychosis, Bipolar|affective psychosis, bipolar
615817|NCT00573196|Depression, Bipolar|depression, bipolar
615818|NCT00573196|Mania|mania
615819|NCT00573196|Manic Disorder|manic disorder
615820|NCT00573196|Manic State|manic state
615821|NCT00573196|Manic-Depressive Psychosis|manic-depressive psychosis
615822|NCT00573196|Psychoses, Manic-Depressive|psychoses, manic-depressive
615823|NCT00573196|Psychosis, Manic-Depressive|psychosis, manic-depressive
615824|NCT00573183|Cocaine, methamphetamine, amphetamine, other stimulant drugs|cocaine, methamphetamine, amphetamine, other stimulant drugs
615825|NCT00573170|Migraine, acute|migraine, acute
615826|NCT00573170|Migraine|migraine
615827|NCT00573170|Butalbital-containing Combination Medication (BCM)|butalbital-containing combination medication (bcm)
615828|NCT00573170|Naproxen sodium|naproxen sodium
615829|NCT00573170|Sumatriptan succinate|sumatriptan succinate
615830|NCT00573170|TREXIMET®|treximet®
615831|NCT00573157|nephritis|nephritis
615832|NCT00573157|atacicept|atacicept
615833|NCT00573131|Esophageal cancer|esophageal cancer
615834|NCT00573131|Localized esophageal cancer|localized esophageal cancer
615835|NCT00573131|Operable esophageal cancer|operable esophageal cancer
615836|NCT00573131|Loco-regional esophageal cancer|loco-regional esophageal cancer
615837|NCT00573131|Esophagectomy|esophagectomy
615838|NCT00573131|Phase 2|phase 2
615839|NCT00573131|Paclitaxel|paclitaxel
615840|NCT00573131|Tumor|tumor
615841|NCT00573131|Local|local
615842|NCT00573131|Chemotherapy|chemotherapy
615843|NCT00573131|radiation therapy|radiation therapy
615844|NCT00573131|surgery|surgery
615845|NCT00573131|OncoGel|oncogel
615846|NCT00573131|Squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
615847|NCT00573118|Pregnancy complications: preeclampsia , severe IUGR , IUFD or placental abruption (n = 5).|pregnancy complications: preeclampsia , severe iugr , iufd or placental abruption (n = 5).
615848|NCT00573092|Cardiovascular Epidemiology|cardiovascular epidemiology
615849|NCT00573092|Genomics|genomics
615850|NCT00573092|Genome-Wide Association Study|genome-wide association study
615851|NCT00573079|Kidney|kidney
615852|NCT00573079|Infants|infants
615853|NCT00573066|Postoperative from cardiac surgery|postoperative from cardiac surgery
615854|NCT00573066|Dexmedetomidine|dexmedetomidine
615855|NCT00573053|hypercapneic response|hypercapneic response
615856|NCT00573053|hyperoxic response|hyperoxic response
615857|NCT00573053|breathing pattern|breathing pattern
615858|NCT00573053|periodic breathing|periodic breathing
615859|NCT00573053|sighs|sighs
615860|NCT00573040|Radiotherapy|radiotherapy
615861|NCT00573040|NSCLC|nsclc
615862|NCT00573040|Stage III non-small cell lung cancer|stage iii non-small cell lung cancer
615863|NCT00573027|microvascular dysfunction|microvascular dysfunction
615864|NCT00573027|Microvascular|microvascular
615865|NCT00573014|Obtunded blunt trauma patients|obtunded blunt trauma patients
615866|NCT00573001|naive|naive
615867|NCT00573001|HIV-1|hiv-1
615868|NCT00573001|simplified treatment|simplified treatment
615869|NCT00573001|Treatment Experienced|treatment experienced
615870|NCT00572988|symptom management|symptom management
615871|NCT00572988|function status|function status
615872|NCT00572988|physical activity|physical activity
615873|NCT00572988|health care utilization|health care utilization
615874|NCT00572975|New diagnostic test for Cystic Fibrosis.|new diagnostic test for cystic fibrosis.
615875|NCT00572949|heart disease|heart disease
615876|NCT00572949|chest pain|chest pain
615877|NCT00572949|coronary artery disease|coronary artery disease
615878|NCT00572949|atherosclerosis|atherosclerosis
615879|NCT00572936|Glaucoma|glaucoma
615880|NCT00572936|Ocular Hypertension|ocular hypertension
615881|NCT00572936|Timolol®, Latanoprost® and Dorzolamide®|timolol®, latanoprost® and dorzolamide®
615882|NCT00572923|radiotherapy|radiotherapy
615883|NCT00572923|LD-SCLC|ld-sclc
615884|NCT00572923|stage I-III small cell lung cancer|stage i-iii small cell lung cancer
615885|NCT00572897|Myelofibrosis|myelofibrosis
615886|NCT00572897|Myeloproliferative disease|myeloproliferative disease
615887|NCT00572897|Stem Cell Transplant|stem cell transplant
615888|NCT00572897|Allogeneic Transplant|allogeneic transplant
615889|NCT00572897|Conditioning Regimen|conditioning regimen
615890|NCT00572897|Reduced Intensity Regimen|reduced intensity regimen
615891|NCT00572897|Fludarabine|fludarabine
615892|NCT00572897|Melphalan|melphalan
615893|NCT00572897|ATG|atg
615894|NCT00572884|permethrin|permethrin
615895|NCT00572884|pyrethroid|pyrethroid
615896|NCT00572884|pharmacokinetics|pharmacokinetics
615897|NCT00572884|metabolism|metabolism
615898|NCT00572884|accelerator mass spectrometry|accelerator mass spectrometry
615899|NCT00572884|human exposure|human exposure
615900|NCT00572858|Hypo E|hypo e
615901|NCT00572845|Basal Energy Expenditure|basal energy expenditure
615902|NCT00572845|Spasticity|spasticity
615903|NCT00572845|Modified Ashworth Scale|modified ashworth scale
615904|NCT00572845|Penn Spasm Frequency Score|penn spasm frequency score
615905|NCT00572832|Human Papillomavirus Vaccine|human papillomavirus vaccine
615906|NCT00572819|Hysteroscopy|hysteroscopy
615907|NCT00572819|Misoprostol|misoprostol
615908|NCT00572819|Postmenopausal women|postmenopausal women
615909|NCT00572819|Cervical ripening|cervical ripening
615910|NCT00572819|Dilatation|dilatation
615911|NCT00572819|Sequential trial|sequential trial
615912|NCT00572819|Estradiol|estradiol
615913|NCT00572780|Crohn's Disease|crohn's disease
615914|NCT00572780|CT Enteroclysis|ct enteroclysis
615915|NCT00572767|randomised-controlled trial|randomised-controlled trial
615916|NCT00572767|ischemic stroke|ischemic stroke
615917|NCT00572767|motor recovery|motor recovery
615918|NCT00572767|amphetamine|amphetamine
615919|NCT00572767|motor recovery of patients after a first-ever ischemic stroke|motor recovery of patients after a first-ever ischemic stroke
615920|NCT00572741|Autism|autism
615921|NCT00572741|vitamin B 12|vitamin b 12
615922|NCT00572741|glutathione|glutathione
615923|NCT00572715|kidney|kidney
615924|NCT00572715|neonates|neonates
615925|NCT00572702|Biocompatible Materials|biocompatible materials
615926|NCT00572702|Female|female
615927|NCT00572702|Humans|humans
615928|NCT00572702|Pelvic Floor|pelvic floor
615929|NCT00572702|Polypropylenes|polypropylenes
615930|NCT00572702|Prostheses and Implants|prostheses and implants
615931|NCT00572702|Surgical Mesh|surgical mesh
615932|NCT00572702|Uterine Prolapse/*therapy|uterine prolapse/*therapy
615933|NCT00572689|Exenatide|exenatide
615934|NCT00572689|TCF7L2 polymorphism|tcf7l2 polymorphism
615935|NCT00572689|Pharmacodynamics|pharmacodynamics
615936|NCT00572689|Pharmacokinetics|pharmacokinetics
615937|NCT00572663|Proteinuria|proteinuria
615938|NCT00572663|Antioxidant|antioxidant
615939|NCT00572663|N-acetylcysteine|n-acetylcysteine
615940|NCT00572650|Type-2 diabetes, DPP-4 inhibitor, vildagliptin|type-2 diabetes, dpp-4 inhibitor, vildagliptin
615941|NCT00572624|Heart Metabolism|heart metabolism
615942|NCT00572624|Obesity|obesity
615943|NCT00572624|Weight loss|weight loss
615944|NCT00572624|Gastric bypass surgery|gastric bypass surgery
615945|NCT00572624|Diet and exercise|diet and exercise
615946|NCT00572611|Mass Balance|mass balance
615947|NCT00572611|Metabolism|metabolism
615948|NCT00572611|Absorption|absorption
615949|NCT00572611|Excretion|excretion
615950|NCT00572611|Pharmacokinetics|pharmacokinetics
615951|NCT00572598|PET|pet
615952|NCT00572598|multidrug resistance|multidrug resistance
615953|NCT00572598|fluoropaclitaxel|fluoropaclitaxel
615954|NCT00572598|paclitaxel|paclitaxel
615955|NCT00572598|breast cancer|breast cancer
615956|NCT00572598|dosimetry|dosimetry
615957|NCT00572598|imaging feasibility|imaging feasibility
615958|NCT00572585|Ulcerative colitis|ulcerative colitis
615959|NCT00572585|immunosuppressive therapy|immunosuppressive therapy
615960|NCT00572585|AEB071|aeb071
615961|NCT00572585|Modified Baron score|modified baron score
615962|NCT00572585|Partial Mayo score|partial mayo score
615963|NCT00572533|End-Stage Renal Disease|end-stage renal disease
615964|NCT00572533|Chronic Hemodialysis|chronic hemodialysis
615965|NCT00572520|Depressive Disorder|depressive disorder
615966|NCT00572520|Weight Loss|weight loss
615967|NCT00572520|Behavioral Treatment|behavioral treatment
615968|NCT00572520|Behavior Therapy|behavior therapy
615969|NCT00572520|Randomized Clinical Trial|randomized clinical trial
615970|NCT00572507|Absorbable Monofilament Suture Material|absorbable monofilament suture material
615971|NCT00572507|Safety and Efficacy|safety and efficacy
615972|NCT00572507|Abdominal Wall/ Fascia|abdominal wall/ fascia
615973|NCT00572507|Laparotomy|laparotomy
615974|NCT00572494|Tibial arteries|tibial arteries
615975|NCT00572494|Absorbable implants|absorbable implants
615976|NCT00572494|Stents|stents
615977|NCT00572494|Limb salvage|limb salvage
616165|NCT00571675|Prednisone|prednisone
615978|NCT00572481|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
615979|NCT00572481|Axillary Node Dissection|axillary node dissection
615980|NCT00572481|Prevention of lymphedema|prevention of lymphedema
615981|NCT00572481|Prevention of neuroma|prevention of neuroma
615982|NCT00572481|Prevention of seroma|prevention of seroma
615983|NCT00572468|cancer|cancer
615984|NCT00572468|pre-operative surgery|pre-operative surgery
615985|NCT00572468|prostate|prostate
615986|NCT00572468|prostatectomy|prostatectomy
615987|NCT00572468|radiation|radiation
615988|NCT00572455|Open-Angle Glaucoma|open-angle glaucoma
615989|NCT00572455|Ocular Hypertension|ocular hypertension
615990|NCT00572442|Non-invasive heart scan|non-invasive heart scan
615991|NCT00572442|MCG|mcg
615992|NCT00572442|Cardiac Risk Factors|cardiac risk factors
615993|NCT00572442|healthy volunteers|healthy volunteers
615994|NCT00572429|HIV/AIDS|hiv/aids
615995|NCT00572429|HAART|haart
615996|NCT00572429|high cholesterol|high cholesterol
615997|NCT00572429|exercise|exercise
615998|NCT00572429|L-carnitine|l-carnitine
615999|NCT00572429|Complimentary therapies|complimentary therapies
616000|NCT00572416|fatigue|fatigue
616001|NCT00572416|activity-rest|activity-rest
616002|NCT00572416|sleep-wake|sleep-wake
616003|NCT00572416|psychological distress|psychological distress
616004|NCT00572416|symptom management|symptom management
616005|NCT00572403|microalbuminuria|microalbuminuria
616006|NCT00572403|risk factors|risk factors
616007|NCT00572377|Sexual|sexual
616008|NCT00572377|Arousal|arousal
616009|NCT00572377|Female|female
616010|NCT00572364|Cancer|cancer
616011|NCT00572364|Advanced solid malignancies|advanced solid malignancies
616012|NCT00572351|Wine|wine
616013|NCT00572325|radiotherapy|radiotherapy
616014|NCT00572325|NSCLC|nsclc
616015|NCT00572325|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
616016|NCT00572312|Proteinuria,|proteinuria,
616017|NCT00572312|atorvastatin|atorvastatin
616018|NCT00572299|glucocorticoids, prednisone, alendronate,osteoclasts|glucocorticoids, prednisone, alendronate,osteoclasts
616019|NCT00572286|heart transplant|heart transplant
616020|NCT00572286|advanced heart failure|advanced heart failure
616021|NCT00572286|orthotropic heart transplantation|orthotropic heart transplantation
616022|NCT00572286|(MCG) magnetocardiograph|(mcg) magnetocardiograph
616023|NCT00572286|echocardiogram|echocardiogram
616024|NCT00572260|MRSA|mrsa
616025|NCT00572260|Increased risk for infection|increased risk for infection
616026|NCT00572234|Methamphetamine|methamphetamine
616027|NCT00572234|Bupropion SR|bupropion sr
616028|NCT00572221|CQI|cqi
616029|NCT00572221|QA|qa
616030|NCT00572221|Best Practice|best practice
616031|NCT00572221|Quality Improvement|quality improvement
616032|NCT00572221|Nursing Facilities|nursing facilities
616033|NCT00572221|Nursing Homes|nursing homes
616034|NCT00572221|Care|care
616035|NCT00572195|Epilepsy|epilepsy
616036|NCT00572195|Responsive neurostimulation|responsive neurostimulation
616037|NCT00572195|RNS System|rns system
616038|NCT00572195|NeuroPace|neuropace
616039|NCT00572195|Brain stimulation|brain stimulation
616040|NCT00572195|Seizures|seizures
616041|NCT00572182|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
616042|NCT00572182|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
616043|NCT00572182|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
616044|NCT00572182|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
616045|NCT00572182|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
616046|NCT00572182|childhood choroid plexus tumor|childhood choroid plexus tumor
616047|NCT00572182|childhood craniopharyngioma|childhood craniopharyngioma
616048|NCT00572182|recurrent childhood ependymoma|recurrent childhood ependymoma
616049|NCT00572182|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
616050|NCT00572182|childhood oligodendroglioma|childhood oligodendroglioma
616051|NCT00572182|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
616052|NCT00572182|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
616053|NCT00572182|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
616054|NCT00572182|childhood spinal cord neoplasm|childhood spinal cord neoplasm
616055|NCT00572182|childhood infratentorial ependymoma|childhood infratentorial ependymoma
616056|NCT00572182|childhood supratentorial ependymoma|childhood supratentorial ependymoma
616057|NCT00572182|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
616058|NCT00572182|childhood grade III meningioma|childhood grade iii meningioma
616059|NCT00572156|IGF-1 Deficiency|igf-1 deficiency
616060|NCT00572156|growth|growth
616061|NCT00572156|ISS|iss
616062|NCT00572156|Constitutional growth delay|constitutional growth delay
616063|NCT00572156|Primary IGFD|primary igfd
616064|NCT00572156|Primary IGF Deficiency|primary igf deficiency
616065|NCT00572143|Colonic Neoplasms/surgery*|colonic neoplasms/surgery*
616066|NCT00572143|Continuity of Patient Care*|continuity of patient care*
616067|NCT00572143|Follow-Up Studies|follow-up studies
616068|NCT00572143|Quality of Life|quality of life
616069|NCT00572143|Patient Satisfaction|patient satisfaction
616070|NCT00572130|Tumor-targeted gene medicine|tumor-targeted gene medicine
616071|NCT00572130|Cyclin G1 gene|cyclin g1 gene
616072|NCT00572130|Osteosarcoma|osteosarcoma
616073|NCT00572117|Bipolar Disorder|bipolar disorder
616074|NCT00572117|Manic Disorder|manic disorder
616075|NCT00572117|Alcoholism|alcoholism
616076|NCT00572117|Alcohol Abuse|alcohol abuse
616077|NCT00572117|Alcohol Dependence|alcohol dependence
616078|NCT00572117|Clinical Trial|clinical trial
616079|NCT00572117|Evaluation Trial|evaluation trial
616080|NCT00572117|Intervention Trial|intervention trial
616081|NCT00572117|Validation Studies|validation studies
616082|NCT00572091|Heart Failure|heart failure
616083|NCT00572091|Mitral Regurgitation|mitral regurgitation
616084|NCT00572078|solid tumor|solid tumor
616085|NCT00572039|Age-Related Macular Degeneration|age-related macular degeneration
616086|NCT00572039|AMD|amd
616087|NCT00572039|Vision Function|vision function
616088|NCT00572039|Problem Solving Treatment|problem solving treatment
616089|NCT00572039|PST|pst
616090|NCT00572026|Attention deficit|attention deficit
616091|NCT00572026|Hyperactivity|hyperactivity
616092|NCT00572026|Attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
616093|NCT00571987|Breast cancer|breast cancer
616094|NCT00571987|Lumpectomy|lumpectomy
616095|NCT00571987|Radiofrequency Ablation|radiofrequency ablation
616096|NCT00571987|Negative margins|negative margins
616097|NCT00571987|Breast Conserving Surgery|breast conserving surgery
616098|NCT00571961|HIV|hiv
616099|NCT00571961|Pharmacokinetics|pharmacokinetics
616100|NCT00571961|Buprenorphine|buprenorphine
616101|NCT00571961|Kaletra|kaletra
616102|NCT00571961|HIV Seronegativity|hiv seronegativity
616103|NCT00571948|infant, complementary food, iron, meat, LC-PUFA, omega-3,|infant, complementary food, iron, meat, lc-pufa, omega-3,
616104|NCT00571948|rapeseed oil, diet|rapeseed oil, diet
616105|NCT00571922|methamphetamine, crystal, treatment|methamphetamine, crystal, treatment
616106|NCT00571909|Polycystic Kidney Disease|polycystic kidney disease
616107|NCT00571909|Chronic Kidney Pain|chronic kidney pain
616108|NCT00571909|Autosomal Dominant Polycystic Kidney|autosomal dominant polycystic kidney
616109|NCT00571909|Kidney Cyst|kidney cyst
616110|NCT00571909|VSPL|vspl
616111|NCT00571909|video thoracoscopic splanchnicectomy|video thoracoscopic splanchnicectomy
616112|NCT00571896|constipation|constipation
616113|NCT00571896|SennaS|sennas
616114|NCT00571883|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
616115|NCT00571883|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
616116|NCT00571883|tongue cancer|tongue cancer
616117|NCT00571844|High Blood Pressure|high blood pressure
616118|NCT00571844|Exercise|exercise
616119|NCT00571844|Diet|diet
616120|NCT00571844|Biomarkers|biomarkers
616121|NCT00571831|macula edema|macula edema
616122|NCT00571831|intraocular lens|intraocular lens
616123|NCT00571831|prospective randomized parallel clinical design|prospective randomized parallel clinical design
616124|NCT00571818|euglycemic|euglycemic
616125|NCT00571818|transplant|transplant
616126|NCT00571818|pancreas|pancreas
616127|NCT00571818|hyperglycemic|hyperglycemic
616128|NCT00571818|kidney|kidney
616129|NCT00571805|cigarette|cigarette
616130|NCT00571805|craving|craving
616131|NCT00571805|reward|reward
616132|NCT00571792|COPD|copd
616133|NCT00571792|The cohort will be comprised of normal non-smoking individuals, those individuals|the cohort will be comprised of normal non-smoking individuals, those individuals
616134|NCT00571792|who smoke who do not exhibit symptoms of COPD and individuals who smoke who do demonstrate|who smoke who do not exhibit symptoms of copd and individuals who smoke who do demonstrate
616135|NCT00571792|symptoms of COPD|symptoms of copd
616136|NCT00571766|chronic hypertension in pregnancy|chronic hypertension in pregnancy
616137|NCT00571766|chronic Hypertension|chronic hypertension
616138|NCT00571753|pulmonary tuberculosis|pulmonary tuberculosis
616139|NCT00571753|NAT2 genotyping|nat2 genotyping
616140|NCT00571753|hepatotoxicity of isoniazid|hepatotoxicity of isoniazid
616141|NCT00571740|stage IV colon cancer|stage iv colon cancer
616142|NCT00571740|stage IV rectal cancer|stage iv rectal cancer
616143|NCT00571740|recurrent colon cancer|recurrent colon cancer
616144|NCT00571740|recurrent rectal cancer|recurrent rectal cancer
616145|NCT00571727|growth|growth
616146|NCT00571727|insulin like growth factor|insulin like growth factor
616147|NCT00571727|Larons syndrome|larons syndrome
616148|NCT00571714|Chronic hepatitis C|chronic hepatitis c
616149|NCT00571714|Pilot Comparison|pilot comparison
616150|NCT00571714|Peginterferon alph-2a|peginterferon alph-2a
616151|NCT00571714|Ribavirin|ribavirin
616152|NCT00571714|Betaine|betaine
616153|NCT00571714|Genotype 1|genotype 1
616154|NCT00571714|Treatment naive|treatment naive
616155|NCT00571701|HPV|hpv
616156|NCT00571701|RRP|rrp
616157|NCT00571688|Bipolar Disorder|bipolar disorder
616158|NCT00571688|Depression, Bipolar|depression, bipolar
616159|NCT00571688|Mania|mania
616160|NCT00571675|Prostate Cancer|prostate cancer
616161|NCT00571675|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
616162|NCT00571675|HRPC|hrpc
616163|NCT00571675|Docetaxel|docetaxel
616164|NCT00571675|Taxotere|taxotere
616166|NCT00571675|Metastatic (Stage IV) Disease|metastatic (stage iv) disease
616167|NCT00571675|Chemotherapy-naïve metastatic Hormone Refractory Prostate Cancer (HRPC)|chemotherapy-naïve metastatic hormone refractory prostate cancer (hrpc)
616168|NCT00571649|Acute medical illnesses with increased risk for VTE.|acute medical illnesses with increased risk for vte.
616169|NCT00571649|Deep vein thrombosis (DVT)|deep vein thrombosis (dvt)
616170|NCT00571649|Pulmonary embolism (PE),|pulmonary embolism (pe),
616171|NCT00571649|Venous Thromboembolic disease (VTE),|venous thromboembolic disease (vte),
616172|NCT00571649|Medical illness|medical illness
616173|NCT00571636|Opioids infusion|opioids infusion
616174|NCT00571636|mechanical ventilation|mechanical ventilation
616175|NCT00571623|Brain Injury|brain injury
616176|NCT00571623|Intracranial hypertension|intracranial hypertension
616177|NCT00571623|Human subjects|human subjects
616178|NCT00571623|Nursing care|nursing care
616179|NCT00571610|Heart Failure|heart failure
616180|NCT00571610|Mitral Regurgitation|mitral regurgitation
616181|NCT00571597|surgery|surgery
616182|NCT00571597|ablation|ablation
616183|NCT00571597|radiofrequency|radiofrequency
616184|NCT00571597|minimaze|minimaze
616185|NCT00571597|transtelephonic monitoring|transtelephonic monitoring
616186|NCT00571571|Identity difussion|identity difussion
616187|NCT00571571|Adolescent psychotherapy|adolescent psychotherapy
616188|NCT00571571|Transference Focused Psychotherapy for Adolescents|transference focused psychotherapy for adolescents
616189|NCT00571571|Identity|identity
616190|NCT00571571|Identity crisis|identity crisis
616191|NCT00571571|Identity pathology|identity pathology
616192|NCT00571545|Traumatic brain injury|traumatic brain injury
616193|NCT00571545|Depression|depression
616194|NCT00571545|Exercise|exercise
616195|NCT00571506|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
616196|NCT00571506|Vascular Diseases|vascular diseases
616197|NCT00571506|Thiazolidinediones|thiazolidinediones
616198|NCT00571506|Platelet Aggregation|platelet aggregation
616199|NCT00571493|non-hodgkin's lymphoma|non-hodgkin's lymphoma
616200|NCT00571493|mantle cell lymphoma|mantle cell lymphoma
616201|NCT00571493|BEAM|beam
616202|NCT00571493|Velcade|velcade
616203|NCT00571480|auricular acupuncture|auricular acupuncture
616204|NCT00571480|pregnancy related low back pain|pregnancy related low back pain
616205|NCT00571480|acupuncture|acupuncture
616206|NCT00571467|Autoimmune Diseases|autoimmune diseases
616207|NCT00571467|Bleeding Disorders|bleeding disorders
616208|NCT00571467|Blood and Blood Disorders|blood and blood disorders
616209|NCT00571454|depression|depression
616210|NCT00571454|primary care|primary care
616211|NCT00571454|Latino|latino
616212|NCT00571454|telephone|telephone
616213|NCT00571454|care management|care management
616214|NCT00571441|stroke|stroke
616215|NCT00571441|Brain injury|brain injury
616216|NCT00571441|nursing|nursing
616217|NCT00571441|Critical care|critical care
616218|NCT00571428|COPD|copd
616219|NCT00571428|Chronic Bronchitis|chronic bronchitis
616220|NCT00571428|Emphysema|emphysema
616221|NCT00571415|Image guided adaptive radiotherapy|image guided adaptive radiotherapy
616222|NCT00571402|Family Treatment|family treatment
616223|NCT00571402|Pharmacotherapy|pharmacotherapy
616224|NCT00571389|Stage IV|stage iv
616225|NCT00571389|Advanced Stage III|advanced stage iii
616226|NCT00571376|Quality of health care|quality of health care
616227|NCT00571376|Health care costs|health care costs
616228|NCT00571350|Cystocele|cystocele
616229|NCT00571350|tension free vaginal tapes|tension free vaginal tapes
616230|NCT00571350|urinary incontinence|urinary incontinence
616231|NCT00571337|Stop infliximab.|stop infliximab.
616232|NCT00571324|hyperinsulinism|hyperinsulinism
616233|NCT00571324|hypoglycemia|hypoglycemia
616234|NCT00571324|KATP channel|katp channel
616235|NCT00571324|Kir6.2|kir6.2
616236|NCT00571311|Assent|assent
616237|NCT00571311|Adolescent|adolescent
616238|NCT00571311|Informed Consent|informed consent
616239|NCT00571298|Extrapleural pneumonectomy|extrapleural pneumonectomy
616240|NCT00571298|Pleurectomy Decortication|pleurectomy decortication
616241|NCT00571298|Mesothelioma|mesothelioma
616242|NCT00571298|cisplatin|cisplatin
616243|NCT00571298|gemcitabine|gemcitabine
616244|NCT00571298|amifostine|amifostine
616245|NCT00571298|sodium thiosulfate|sodium thiosulfate
616246|NCT00571285|Parkinson's disease|parkinson's disease
616247|NCT00571285|Nutrition|nutrition
616248|NCT00571285|Vitamin supplement|vitamin supplement
616249|NCT00571285|Motor function|motor function
616250|NCT00571285|Non-motor function|non-motor function
616251|NCT00571272|Cholestatic Liver Disease|cholestatic liver disease
616252|NCT00571272|Cholestasis|cholestasis
616253|NCT00571272|Childhood Diseases|childhood diseases
616254|NCT00571272|Genetic Diseases|genetic diseases
616255|NCT00571272|Bile Acid Synthesis and Metabolism Defects|bile acid synthesis and metabolism defects
616256|NCT00571272|Progressive Familial Intrahepatic Cholestasis|progressive familial intrahepatic cholestasis
616257|NCT00571259|Sodium citrate|sodium citrate
616258|NCT00571259|Gentamicin|gentamicin
616259|NCT00571259|Prophylaxis|prophylaxis
616260|NCT00571259|Hemodialysis|hemodialysis
616261|NCT00571259|Central venous catheter|central venous catheter
616262|NCT00571246|treatment|treatment
616263|NCT00571246|Lamotrigine|lamotrigine
616264|NCT00571246|Topiramate|topiramate
616265|NCT00571246|alcohol dependence|alcohol dependence
616266|NCT00571246|post traumatic stress disorder|post traumatic stress disorder
616267|NCT00571233|Single Ventricle|single ventricle
616268|NCT00571233|Congenital Heart Disease|congenital heart disease
616269|NCT00571233|Children|children
616270|NCT00571233|Fontan|fontan
616271|NCT00571233|Tricuspid Atresia|tricuspid atresia
616272|NCT00571233|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
616273|NCT00571233|Heart Failure|heart failure
616274|NCT00571233|Biomarkers|biomarkers
616275|NCT00571233|Single ventricle physiology such as:|single ventricle physiology such as:
616276|NCT00571233|unbalanced AV canal|unbalanced av canal
616277|NCT00571233|Interested in patients both before and after Fontan Surgery|interested in patients both before and after fontan surgery
616278|NCT00571220|gastric bypass|gastric bypass
616279|NCT00571220|diabetes|diabetes
616280|NCT00571220|obesity|obesity
616281|NCT00571220|diet-induced weight loss|diet-induced weight loss
616282|NCT00571220|incretin levels (GLP-1,GIP)|incretin levels (glp-1,gip)
616283|NCT00571220|incretin effect|incretin effect
616284|NCT00571207|driving under the influence of drugs|driving under the influence of drugs
616285|NCT00571207|on-site oral fluid screening devices|on-site oral fluid screening devices
616286|NCT00571207|checklist|checklist
616287|NCT00571194|pravastatin, peritoneal dialysis, pediatric patients|pravastatin, peritoneal dialysis, pediatric patients
616288|NCT00571181|Algorithms|algorithms
616289|NCT00571181|Anesthesia, General/*methods|anesthesia, general/*methods
616290|NCT00571181|Anesthetics, Intravenous/*administration & dosage|anesthetics, intravenous/*administration & dosage
616291|NCT00571181|Drug Delivery Systems/*methods/statistics & numerical data|drug delivery systems/*methods/statistics & numerical data
616292|NCT00571181|Electroencephalography/drug effects/*methods/|electroencephalography/drug effects/*methods/
616293|NCT00571181|Feasibility Studies|feasibility studies
616294|NCT00571181|Propofol/*administration & dosage|propofol/*administration & dosage
616295|NCT00571181|Remifentanil/*administration & dosage|remifentanil/*administration & dosage
616296|NCT00571181|Bronchoscopy/*methods|bronchoscopy/*methods
616297|NCT00571181|Prospective Studies|prospective studies
616298|NCT00571181|Software|software
616299|NCT00571168|chemotherapy induced nausea and vomiting|chemotherapy induced nausea and vomiting
616300|NCT00571168|autologous peripheral blood stemcell transplantation|autologous peripheral blood stemcell transplantation
616301|NCT00571168|high dose chemotherapy|high dose chemotherapy
616302|NCT00571142|edema|edema
616303|NCT00571142|retinal thickness|retinal thickness
616304|NCT00571142|diabetic retinopathy|diabetic retinopathy
616305|NCT00571129|Primary,silicone tube,revision,mitomycin C,endoscopic DCR|primary,silicone tube,revision,mitomycin c,endoscopic dcr
616306|NCT00571116|Metastatic Melanoma|metastatic melanoma
616307|NCT00571116|Disulfiram|disulfiram
616308|NCT00571116|Arsenic Trioxide|arsenic trioxide
616309|NCT00571116|Metastatic Melanoma and at Least One Prior Systemic Therapy|metastatic melanoma and at least one prior systemic therapy
616310|NCT00571103|acamprosate, impulse-control disorders|acamprosate, impulse-control disorders
616311|NCT00571090|Thyroid nodule|thyroid nodule
616312|NCT00571090|Biopsy, Fine-Needle|biopsy, fine-needle
616313|NCT00571077|Thyroid neoplasms|thyroid neoplasms
616314|NCT00571077|thyroid nodules|thyroid nodules
616315|NCT00571077|electrical impedance scanning|electrical impedance scanning
616316|NCT00571051|MEG, mindfulness, tactile perception|meg, mindfulness, tactile perception
616317|NCT00571038|Hypertension|hypertension
616318|NCT00571038|Self-help groups|self-help groups
616319|NCT00571038|Community health networks|community health networks
616320|NCT00571038|Health knowledge, attitudes, practice|health knowledge, attitudes, practice
616321|NCT00571038|Patient participation|patient participation
616322|NCT00571038|Randomized clinical trial|randomized clinical trial
616323|NCT00571025|Mild Cognitive Impairment|mild cognitive impairment
616324|NCT00571025|disease/disorder proneness/risk|disease/disorder proneness/risk
616325|NCT00571025|family genetics|family genetics
616326|NCT00571025|genetic counseling|genetic counseling
616327|NCT00571025|genetic marker|genetic marker
616328|NCT00571025|genetic polymorphism|genetic polymorphism
616329|NCT00571025|genetic susceptibility|genetic susceptibility
616330|NCT00571012|glaucoma|glaucoma
616331|NCT00571012|outflow facility|outflow facility
616332|NCT00571012|Healthy eye function|healthy eye function
616333|NCT00570999|Peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
616334|NCT00570999|Palifermin|palifermin
616335|NCT00570999|Kepivance|kepivance
616336|NCT00570999|Prevenar|prevenar
616337|NCT00570999|Placebo|placebo
616338|NCT00570986|Plaque Psoriasis|plaque psoriasis
616339|NCT00570973|Variceal Bleeding|variceal bleeding
616340|NCT00570973|Cirrhosis|cirrhosis
616341|NCT00570973|Encephalopathy|encephalopathy
616342|NCT00570973|Endoscopic band ligation|endoscopic band ligation
616343|NCT00570973|TIPS|tips
616344|NCT00570960|Peritonitis|peritonitis
616345|NCT00570947|CPR Anytime|cpr anytime
616346|NCT00570921|Breast cancer|breast cancer
616347|NCT00570921|Fulvestrant|fulvestrant
616348|NCT00570921|Everolimus|everolimus
616349|NCT00570908|brain metastasis|brain metastasis
616350|NCT00570908|breast cancer|breast cancer
616351|NCT00570908|metastatic breast cancer|metastatic breast cancer
616352|NCT00570895|Iron|iron
616353|NCT00570895|Absorption|absorption
616354|NCT00570895|Ascorbic Acid|ascorbic acid
616355|NCT00570895|Ferrous Fumarate|ferrous fumarate
616356|NCT00570882|Renal cell carcinoma|renal cell carcinoma
616357|NCT00570882|Sunitinib|sunitinib
616358|NCT00570882|phase II study|phase ii study
616359|NCT00570882|Randomized study|randomized study
616360|NCT00570869|Infant CPR|infant cpr
616361|NCT00570856|Folic Acid|folic acid
616362|NCT00570856|Homocysteine|homocysteine
616363|NCT00570856|intima-media thickness|intima-media thickness
616364|NCT00570817|Methotrexate|methotrexate
616365|NCT00570817|Nephrotoxicity|nephrotoxicity
616366|NCT00570817|Hydration|hydration
616367|NCT00570817|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
616368|NCT00570817|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
616369|NCT00570817|Medulloblastoma|medulloblastoma
616370|NCT00570817|Ependymoma|ependymoma
616371|NCT00570817|Prolonged elimination time of methotrexate|prolonged elimination time of methotrexate
616372|NCT00570804|Smoking Cessation|smoking cessation
616373|NCT00570804|Puerto Rico Quitline|puerto rico quitline
616374|NCT00570804|Motivational Relapse Prevention|motivational relapse prevention
616375|NCT00570804|Oral Cancer|oral cancer
616376|NCT00570804|Risk Reduction|risk reduction
616377|NCT00570804|Tobacco Use|tobacco use
616378|NCT00570804|Alcohol Use|alcohol use
616379|NCT00570804|MAPS|maps
616380|NCT00570804|Motivation and Problem-Solving|motivation and problem-solving
616381|NCT00570804|Telephone Interview|telephone interview
616382|NCT00570804|Counseling|counseling
616383|NCT00570791|Cornea|cornea
616384|NCT00570791|Tonometers|tonometers
616385|NCT00570791|Goldmann applanation|goldmann applanation
616386|NCT00570791|Tonopen|tonopen
616387|NCT00570791|Shiotz|shiotz
616388|NCT00570791|Pneumatonometer|pneumatonometer
616389|NCT00570778|QVA, Indacaterol, Glycopyrrolate, Concept1, COPD, cross over study, safety and efficacy, trough FEV1|qva, indacaterol, glycopyrrolate, concept1, copd, cross over study, safety and efficacy, trough fev1
616390|NCT00570739|Colesevelam|colesevelam
616391|NCT00570739|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
616392|NCT00570739|Pre-diabetes|pre-diabetes
616393|NCT00570739|Metformin|metformin
616394|NCT00570700|prostate|prostate
616395|NCT00570687|Inhaled Insulin|inhaled insulin
616396|NCT00570674|SSCHN|sschn
616397|NCT00570674|Abraxane|abraxane
616398|NCT00570674|IMRT|imrt
616399|NCT00570648|Corneal transplantation|corneal transplantation
616400|NCT00570635|GIST|gist
616401|NCT00570635|Gastrointestinal Cancer|gastrointestinal cancer
616402|NCT00570622|Cirrhosis|cirrhosis
616403|NCT00570622|oxidative stress|oxidative stress
616404|NCT00570622|pioglitazone|pioglitazone
616405|NCT00570609|CPR|cpr
616406|NCT00570583|Depression|depression
616407|NCT00570583|Cognitive impairment|cognitive impairment
616408|NCT00570583|Dementia|dementia
616409|NCT00570583|Neuroimaging|neuroimaging
616410|NCT00570583|Genetics|genetics
616411|NCT00570570|stroke|stroke
616412|NCT00570570|hemiplegia|hemiplegia
616413|NCT00570570|gait|gait
616414|NCT00570570|Strengthening|strengthening
616415|NCT00570570|Physiotherapy|physiotherapy
616416|NCT00570557|Skill Maintenance|skill maintenance
616417|NCT00570557|Skill Decay|skill decay
616418|NCT00570557|Screening|screening
616419|NCT00570544|copd|copd
616420|NCT00570544|emphysema|emphysema
616421|NCT00570544|tiotropium|tiotropium
616422|NCT00570544|lung function|lung function
616423|NCT00570544|dynamic hyperinflation|dynamic hyperinflation
616424|NCT00570518|driving under the influence|driving under the influence
616425|NCT00570518|psychoactive substances|psychoactive substances
616426|NCT00570518|roadside surveys|roadside surveys
616427|NCT00570518|hospital surveys|hospital surveys
616428|NCT00570518|accident involvement risk estimation|accident involvement risk estimation
616429|NCT00570492|allergic rhinitis|allergic rhinitis
616430|NCT00570492|fluticasone furoate nasal spray|fluticasone furoate nasal spray
616431|NCT00570492|growth|growth
616432|NCT00570479|Retisert|retisert
616433|NCT00570479|Uveitis|uveitis
616434|NCT00570479|glaucoma|glaucoma
616435|NCT00570466|Type 2 Diabetes|type 2 diabetes
616436|NCT00570466|Prevention|prevention
616437|NCT00570466|Children|children
616438|NCT00570466|Diet|diet
616439|NCT00570466|Physical Activity|physical activity
616440|NCT00570440|AE adverse event|ae adverse event
616441|NCT00570440|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
616442|NCT00570440|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
616443|NCT00570440|ART antiretroviral therapy|art antiretroviral therapy
616444|NCT00570440|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
616445|NCT00570440|DCF data collection forms|dcf data collection forms
616446|NCT00570440|DMC Data Monitoring Committee|dmc data monitoring committee
616447|NCT00570440|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
616448|NCT00570440|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
617634|NCT00565617|DBS|dbs
616449|NCT00570440|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
616450|NCT00570440|ICH International Conference of Harmonisation|ich international conference of harmonisation
616451|NCT00570440|IND Investigational New Drug Application|ind investigational new drug application
616452|NCT00570440|IRB Institutional Review Board|irb institutional review board
616453|NCT00570440|IU international units|iu international units
616454|NCT00570440|mg milligram(s)|mg milligram(s)
616455|NCT00570440|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
616456|NCT00570440|PCR polymerase chain reaction|pcr polymerase chain reaction
616457|NCT00570440|SAE serious adverse event|sae serious adverse event
616458|NCT00570440|µg microgram|µg microgram
616459|NCT00570440|ULN upper limit of the normal range|uln upper limit of the normal range
616460|NCT00570440|WB Western Blot|wb western blot
616461|NCT00570427|psychotherapy|psychotherapy
616462|NCT00570427|behavior therapy|behavior therapy
616463|NCT00570427|counseling|counseling
616464|NCT00570427|aging|aging
616465|NCT00570427|medically underserved population|medically underserved population
616466|NCT00570401|adenocarcinoma of the lung|adenocarcinoma of the lung
616467|NCT00570401|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
616468|NCT00570401|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
616469|NCT00570401|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
616470|NCT00570401|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
616471|NCT00570388|Neurocognitive|neurocognitive
616472|NCT00570388|Alcohol Dependence|alcohol dependence
616473|NCT00570388|Prometa|prometa
616474|NCT00570388|Prometa Protocol|prometa protocol
616475|NCT00570388|Starosta|starosta
616476|NCT00570375|Blood disease, bone marrow|blood disease, bone marrow
616477|NCT00570362|Normal tension glaucoma|normal tension glaucoma
616478|NCT00570362|Glutathione|glutathione
616479|NCT00570362|Antioxidant|antioxidant
616480|NCT00570349|Inhaled Nitric oxide|inhaled nitric oxide
616481|NCT00570349|Cystic Fibrosis|cystic fibrosis
616482|NCT00570336|HCV|hcv
616483|NCT00570336|HCV treatment failure|hcv treatment failure
616484|NCT00570336|Elevated aminotransferases|elevated aminotransferases
616485|NCT00570323|Breast Cancer|breast cancer
616486|NCT00570323|HORMONE RECEPTOR POSITIVE BREAST CANCER|hormone receptor positive breast cancer
616487|NCT00570297|Pediatric|pediatric
616488|NCT00570297|Polymorphism, Genetic|polymorphism, genetic
616489|NCT00570297|Adrenergic beta-Agonists|adrenergic beta-agonists
616490|NCT00570284|Cancer|cancer
616491|NCT00570284|solid tumor|solid tumor
616492|NCT00570284|food effect|food effect
616493|NCT00570284|HDAC inhibitor|hdac inhibitor
616494|NCT00570284|oral|oral
616495|NCT00570284|LBH589|lbh589
616496|NCT00570271|placebo effect|placebo effect
616497|NCT00570271|blood pressure|blood pressure
616498|NCT00570271|autonomic nervous system|autonomic nervous system
616499|NCT00570271|prestige|prestige
616500|NCT00570271|basic research on physiological placebo effects|basic research on physiological placebo effects
616501|NCT00570245|Lung transplantation|lung transplantation
616502|NCT00570232|Resectable, recurrent head and neck cancer|resectable, recurrent head and neck cancer
616503|NCT00570206|Probation|probation
616504|NCT00570206|Motivational|motivational
616505|NCT00570180|newly diagnosed|newly diagnosed
616506|NCT00570167|Osteoarthritis|osteoarthritis
616507|NCT00570167|Hip|hip
616508|NCT00570167|Artroplasty|artroplasty
616509|NCT00570167|Resurfacing|resurfacing
616510|NCT00570154|Mitochondrial Function in Monocytes|mitochondrial function in monocytes
616511|NCT00570154|Macrophages and Diabetes or Insulin Resistance|macrophages and diabetes or insulin resistance
616512|NCT00570154|Peripheral Blood Mononuclear Cells|peripheral blood mononuclear cells
616513|NCT00570154|Diabetes|diabetes
616514|NCT00570154|Monocyte|monocyte
616515|NCT00570154|Macrophages|macrophages
616516|NCT00570154|Proteome|proteome
616517|NCT00570154|Type 2 Diabetes|type 2 diabetes
616518|NCT00570154|Insulin Resistance|insulin resistance
616519|NCT00570154|Insulin Sensitivity|insulin sensitivity
616520|NCT00570154|Pre-Diabetes|pre-diabetes
616521|NCT00570154|Healthy Volunteer|healthy volunteer
616522|NCT00570154|HV|hv
616523|NCT00570128|Down Syndrome|down syndrome
616524|NCT00570128|trisomy 21|trisomy 21
616525|NCT00570115|Sleep Apnea Syndromes diastolic disfunction left atrium|sleep apnea syndromes diastolic disfunction left atrium
616526|NCT00570102|dietary manipulation|dietary manipulation
616527|NCT00570102|infants|infants
616528|NCT00570102|feasibility|feasibility
616529|NCT00570102|Type 1 Diabetes Mellitus, Beta-cell Autoimmunity|type 1 diabetes mellitus, beta-cell autoimmunity
616530|NCT00570089|Ranolazine|ranolazine
616531|NCT00570089|Myocardial ischemia|myocardial ischemia
616532|NCT00570089|Double blinded|double blinded
616533|NCT00570089|Placebo controlled|placebo controlled
616534|NCT00570063|Schizophrenia|schizophrenia
616535|NCT00570063|acute exacerbation|acute exacerbation
616536|NCT00570063|and PF-02545920|and pf-02545920
616537|NCT00570050|Major Depressive Disorder, Memory, Executive function|major depressive disorder, memory, executive function
616538|NCT00570037|Influenza|influenza
616539|NCT00570037|Vaccine|vaccine
616540|NCT00570037|Children|children
616541|NCT00570024|Acupuncture|acupuncture
617635|NCT00565617|ECS|ecs
616542|NCT00570024|Coronary Artery Disease|coronary artery disease
616543|NCT00569985|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
616544|NCT00569985|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
616545|NCT00569985|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
616546|NCT00569985|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
616547|NCT00569985|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
616548|NCT00569985|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
616549|NCT00569985|Treatment Experienced|treatment experienced
616550|NCT00569959|fasting lipid measures|fasting lipid measures
616551|NCT00569959|non-fasting lipid measures|non-fasting lipid measures
616552|NCT00569959|clinical decision-making|clinical decision-making
616553|NCT00569959|LDL-Cholesterol|ldl-cholesterol
616554|NCT00569946|AG-013736|ag-013736
616555|NCT00569946|RCC|rcc
616556|NCT00569946|Phase 2|phase 2
616557|NCT00569933|Hip Surgery|hip surgery
616558|NCT00569933|Perioperative|perioperative
616559|NCT00569933|suggestions/imagery|suggestions/imagery
616560|NCT00569907|type 2 diabetes|type 2 diabetes
616561|NCT00569907|continuous glucose monitoring|continuous glucose monitoring
616562|NCT00569907|exenatide|exenatide
616563|NCT00569907|exenatide use|exenatide use
616564|NCT00569881|Epithelium|epithelium
616565|NCT00569881|Wound Healing|wound healing
616566|NCT00569881|PRK|prk
616567|NCT00569868|PLASMACYTOMA|plasmacytoma
616568|NCT00569829|cognitive behavioral therapy|cognitive behavioral therapy
616569|NCT00569829|anxiety disorders|anxiety disorders
616570|NCT00569829|school-based intervention|school-based intervention
616571|NCT00569829|randomized, controlled trial|randomized, controlled trial
616572|NCT00569816|myocardial protection|myocardial protection
616573|NCT00569816|pharmacological preconditioning|pharmacological preconditioning
616574|NCT00569816|volatile anesthetics|volatile anesthetics
616575|NCT00569816|myocardial injury following CABG surgery|myocardial injury following cabg surgery
616576|NCT00569790|S-1|s-1
616577|NCT00569790|Irinotecan|irinotecan
616578|NCT00569790|Bevacizumab|bevacizumab
616579|NCT00569764|schizophrenia|schizophrenia
616580|NCT00569764|metabolic syndrome|metabolic syndrome
616581|NCT00569764|aripiprazole|aripiprazole
616582|NCT00569751|de novo|de novo
616583|NCT00569751|coronary|coronary
616584|NCT00569751|coronary artery disease|coronary artery disease
616585|NCT00569751|coronary disease|coronary disease
616586|NCT00569738|neuroendocrine tumor|neuroendocrine tumor
616587|NCT00569738|somatostatin analog|somatostatin analog
616588|NCT00569738|Gallium 68|gallium 68
616589|NCT00569738|PET|pet
616590|NCT00569712|non-small cell lung cancer|non-small cell lung cancer
616591|NCT00569712|precancerous condition|precancerous condition
616592|NCT00569699|S-1|s-1
616593|NCT00569699|Bevacizumab|bevacizumab
616594|NCT00569686|PAD|pad
616595|NCT00569686|peripheral artery disease|peripheral artery disease
616596|NCT00569673|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
616597|NCT00569673|fallopian tube cancer|fallopian tube cancer
616598|NCT00569673|primary peritoneal cavity cancer|primary peritoneal cavity cancer
616599|NCT00569660|Myelofibrosis|myelofibrosis
616601|NCT00569660|Leukemia|leukemia
616602|NCT00569660|Azacitidine|azacitidine
616603|NCT00569660|Vidaza|vidaza
616604|NCT00569647|preoperative anxiety|preoperative anxiety
616605|NCT00569647|burn reconstruction|burn reconstruction
616606|NCT00569634|Venous blood gas|venous blood gas
616607|NCT00569634|Arterial blood gas|arterial blood gas
616608|NCT00569634|pH|ph
616609|NCT00569634|pCO2|pco2
616610|NCT00569634|Bicarbonate|bicarbonate
616611|NCT00569608|Parental stress|parental stress
616612|NCT00569608|Early discharge|early discharge
616613|NCT00569608|Anxiety|anxiety
616614|NCT00569608|Depression|depression
616615|NCT00569608|Neonatal Intensive Care Unit|neonatal intensive care unit
616616|NCT00569595|Prevention of Diabetes and other chronic diseases|prevention of diabetes and other chronic diseases
616617|NCT00569582|Cushing's Disease|cushing's disease
616618|NCT00569582|Cushing's Syndrome|cushing's syndrome
616619|NCT00569582|Cushings|cushings
616620|NCT00569582|Pituitary|pituitary
616621|NCT00569582|ACTH|acth
616622|NCT00569582|Adrenocorticotropic hormone|adrenocorticotropic hormone
616623|NCT00569582|Ectopic|ectopic
616624|NCT00569582|Adrenal adenoma|adrenal adenoma
616625|NCT00569582|Adrenal carcinoma|adrenal carcinoma
616626|NCT00569582|Adrenal autonomy|adrenal autonomy
616627|NCT00569582|Cortisol|cortisol
616628|NCT00569582|Hypercortisolemia|hypercortisolemia
616629|NCT00569582|Cushingoid|cushingoid
616630|NCT00569582|Moon facies|moon facies
616631|NCT00569582|Dorsocervical fat|dorsocervical fat
616632|NCT00569582|Plethora|plethora
616633|NCT00569582|Hirsutism|hirsutism
616634|NCT00569582|Violaceous striae|violaceous striae
616635|NCT00569582|Hormone|hormone
616636|NCT00569582|Contraceptive|contraceptive
616637|NCT00569582|Endocrine|endocrine
616638|NCT00569582|Cushing Syndrome|cushing syndrome
616639|NCT00569582|Ectopic ACTH Secretion|ectopic acth secretion
616640|NCT00569556|Diabetes Mellitus|diabetes mellitus
616641|NCT00569556|Chronic Care Model|chronic care model
616642|NCT00569556|Case Management|case management
616643|NCT00569543|breast cancer in situ|breast cancer in situ
616644|NCT00569543|ductal breast carcinoma in situ|ductal breast carcinoma in situ
616645|NCT00569543|stage I breast cancer|stage i breast cancer
616646|NCT00569543|stage II breast cancer|stage ii breast cancer
616647|NCT00569543|stage IIIA breast cancer|stage iiia breast cancer
616648|NCT00569543|stage IIIB breast cancer|stage iiib breast cancer
616649|NCT00569543|stage IIIC breast cancer|stage iiic breast cancer
616650|NCT00569543|stage IV breast cancer|stage iv breast cancer
616651|NCT00569530|nitric oxide|nitric oxide
616652|NCT00569530|surfactant|surfactant
616653|NCT00569530|bronchopulmonary dysplasia|bronchopulmonary dysplasia
616654|NCT00569530|prematurity|prematurity
616655|NCT00569530|neonates|neonates
616656|NCT00569530|iNO|ino
616657|NCT00569530|Infasurf|infasurf
616658|NCT00569530|lung function|lung function
616659|NCT00569530|ventilated infants|ventilated infants
616660|NCT00569517|obesity|obesity
616661|NCT00569517|CBT|cbt
616662|NCT00569517|Atypical antipsychotics|atypical antipsychotics
616663|NCT00569517|metabolic syndrome|metabolic syndrome
616664|NCT00569504|schizophrenia|schizophrenia
616665|NCT00569504|antipsychotics|antipsychotics
616666|NCT00569504|metabolic syndrome|metabolic syndrome
616667|NCT00569504|prevalence|prevalence
616668|NCT00569478|ICD|icd
616669|NCT00569478|Rehabilitation|rehabilitation
616670|NCT00569465|nitric oxide|nitric oxide
616671|NCT00569465|oxidative stress|oxidative stress
616672|NCT00569465|diabetes|diabetes
616673|NCT00569465|hypertension|hypertension
616674|NCT00569465|endothelial dysfunction|endothelial dysfunction
616675|NCT00569439|Labor|labor
616676|NCT00569439|Carbohydrate|carbohydrate
616677|NCT00569439|Dystocia|dystocia
616678|NCT00569413|Sex|sex
616679|NCT00569413|brain imaging|brain imaging
616680|NCT00569413|dopamine|dopamine
616681|NCT00569413|sexual disorder|sexual disorder
616682|NCT00569387|pancreatic cancer|pancreatic cancer
616683|NCT00569387|vaccine|vaccine
616684|NCT00569361|allergic rhinitis to dust mite|allergic rhinitis to dust mite
616685|NCT00569361|allergic rhinitis associated with bronchial hyperreactivity|allergic rhinitis associated with bronchial hyperreactivity
616686|NCT00569361|allergic rhinitis associated with asthma|allergic rhinitis associated with asthma
616687|NCT00569335|S-1, Bevacizumab, Irinotecan|s-1, bevacizumab, irinotecan
616688|NCT00569322|ICU|icu
616689|NCT00569322|Admission|admission
616690|NCT00569322|BG|bg
616691|NCT00569309|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
616692|NCT00569309|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
616693|NCT00569309|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
616694|NCT00569309|stage I mantle cell lymphoma|stage i mantle cell lymphoma
616695|NCT00569309|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
616696|NCT00569309|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
616697|NCT00569309|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
616698|NCT00569309|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
616699|NCT00569309|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
616700|NCT00569309|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
616701|NCT00569309|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
616702|NCT00569309|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
616703|NCT00569309|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
616704|NCT00569309|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
616705|NCT00569309|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
616706|NCT00569309|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
616707|NCT00569309|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
616708|NCT00569309|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
616709|NCT00569309|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
616710|NCT00569309|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
616711|NCT00569309|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
616712|NCT00569309|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
616713|NCT00569309|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
616714|NCT00569309|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
616715|NCT00569309|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
616716|NCT00569309|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
616717|NCT00569309|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
616718|NCT00569309|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
616719|NCT00569309|stage I multiple myeloma|stage i multiple myeloma
616720|NCT00569309|stage II multiple myeloma|stage ii multiple myeloma
616721|NCT00569309|stage III multiple myeloma|stage iii multiple myeloma
616722|NCT00569309|refractory multiple myeloma|refractory multiple myeloma
616723|NCT00569309|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
616724|NCT00569309|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
616725|NCT00569309|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
616726|NCT00569309|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
616727|NCT00569309|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
616728|NCT00569309|anaplastic large cell lymphoma|anaplastic large cell lymphoma
616729|NCT00569309|small intestine lymphoma|small intestine lymphoma
616730|NCT00569296|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
616731|NCT00569296|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
616732|NCT00569283|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
616733|NCT00569283|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
616734|NCT00569283|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
616735|NCT00569283|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
616736|NCT00569283|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
616737|NCT00569283|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
616738|NCT00569283|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
616739|NCT00569283|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
616740|NCT00569283|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
616741|NCT00569283|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
616742|NCT00569283|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
616743|NCT00569283|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
616744|NCT00569283|chronic eosinophilic leukemia|chronic eosinophilic leukemia
616745|NCT00569283|primary myelofibrosis|primary myelofibrosis
616746|NCT00569283|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
616747|NCT00569283|chronic neutrophilic leukemia|chronic neutrophilic leukemia
616748|NCT00569283|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
616749|NCT00569283|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
616750|NCT00569283|disseminated neuroblastoma|disseminated neuroblastoma
616751|NCT00569283|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
616752|NCT00569283|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
616753|NCT00569283|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
616754|NCT00569283|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
616755|NCT00569283|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
616756|NCT00569283|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
616757|NCT00569283|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
616758|NCT00569283|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
616759|NCT00569283|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
616760|NCT00569283|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
616761|NCT00569283|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
616762|NCT00569283|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
616763|NCT00569283|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
616764|NCT00569283|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
616765|NCT00569283|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
616766|NCT00569283|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
616767|NCT00569283|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
616768|NCT00569283|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
616769|NCT00569283|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
616770|NCT00569283|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
616771|NCT00569283|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
616772|NCT00569283|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
616773|NCT00569283|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
616774|NCT00569283|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
616775|NCT00569283|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
616776|NCT00569283|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
616777|NCT00569283|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
616778|NCT00569283|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
616779|NCT00569283|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
616780|NCT00569283|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
616781|NCT00569283|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
616782|NCT00569283|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
618205|NCT00562874|NUTRITION|nutrition
616783|NCT00569283|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
616784|NCT00569283|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
616785|NCT00569283|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
616786|NCT00569283|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
616787|NCT00569283|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
616788|NCT00569283|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
616789|NCT00569283|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
616790|NCT00569283|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
616791|NCT00569283|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
616792|NCT00569283|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
616793|NCT00569283|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
616794|NCT00569283|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
616795|NCT00569283|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
616796|NCT00569283|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
616797|NCT00569283|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
616798|NCT00569283|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
616799|NCT00569283|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
616800|NCT00569283|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
616801|NCT00569283|splenic marginal zone lymphoma|splenic marginal zone lymphoma
616802|NCT00569283|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
616803|NCT00569283|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
616804|NCT00569283|recurrent neuroblastoma|recurrent neuroblastoma
616805|NCT00569283|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
616806|NCT00569283|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
616807|NCT00569283|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
616808|NCT00569283|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
616809|NCT00569283|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
616810|NCT00569283|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
616811|NCT00569283|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
616812|NCT00569283|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
616813|NCT00569283|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
616814|NCT00569283|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
616815|NCT00569283|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
616816|NCT00569283|refractory hairy cell leukemia|refractory hairy cell leukemia
616817|NCT00569283|refractory multiple myeloma|refractory multiple myeloma
616818|NCT00569283|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
616819|NCT00569283|secondary acute myeloid leukemia|secondary acute myeloid leukemia
616820|NCT00569283|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
616821|NCT00569283|stage I multiple myeloma|stage i multiple myeloma
616822|NCT00569283|stage II multiple myeloma|stage ii multiple myeloma
616823|NCT00569283|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
616824|NCT00569283|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
616825|NCT00569283|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
616826|NCT00569283|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
616827|NCT00569283|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
616828|NCT00569283|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
616829|NCT00569283|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
616830|NCT00569283|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
616831|NCT00569283|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
616832|NCT00569283|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
616833|NCT00569283|stage III multiple myeloma|stage iii multiple myeloma
616834|NCT00569283|stage IIIA breast cancer|stage iiia breast cancer
616835|NCT00569283|stage IIIB breast cancer|stage iiib breast cancer
616836|NCT00569283|stage IIIC breast cancer|stage iiic breast cancer
616837|NCT00569283|stage IV breast cancer|stage iv breast cancer
616838|NCT00569283|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
616839|NCT00569283|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
616840|NCT00569283|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
616841|NCT00569283|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
616842|NCT00569283|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
616843|NCT00569283|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
616844|NCT00569283|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
616845|NCT00569283|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
616846|NCT00569283|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
616847|NCT00569257|LHRH receptor|lhrh receptor
616848|NCT00569257|receptor positive tumors|receptor positive tumors
616849|NCT00569257|platinum resistant ovarian cancer|platinum resistant ovarian cancer
616850|NCT00569244|Primary Dysmenorrhea|primary dysmenorrhea
616851|NCT00569244|Menstrual Pain|menstrual pain
616852|NCT00569244|Oral Contraception|oral contraception
616853|NCT00569231|Warts|warts
616854|NCT00569231|Candida|candida
616855|NCT00569231|HPV|hpv
616856|NCT00569231|Injections, Intralesional|injections, intralesional
616857|NCT00569231|Immune System|immune system
616858|NCT00569192|asthmatic children|asthmatic children
616859|NCT00569179|Myeloid Malignancies|myeloid malignancies
616860|NCT00569179|Bone Marrow Transplant|bone marrow transplant
616861|NCT00569179|AML|aml
616862|NCT00569179|ALL|all
616863|NCT00569179|MDS|mds
616864|NCT00569179|CML|cml
616865|NCT00569166|fatigue|fatigue
616866|NCT00569166|sleep disorders|sleep disorders
616867|NCT00569166|ductal breast carcinoma in situ|ductal breast carcinoma in situ
616868|NCT00569166|lobular breast carcinoma in situ|lobular breast carcinoma in situ
616869|NCT00569166|breast cancer|breast cancer
616870|NCT00569166|hot flashes|hot flashes
616871|NCT00569153|Androgen-independent prostate cancer, metastatic|androgen-independent prostate cancer, metastatic
616872|NCT00569088|hemorrhagic stroke|hemorrhagic stroke
616873|NCT00569088|Chinese Medicine|chinese medicine
616874|NCT00569088|pathogenesis|pathogenesis
616875|NCT00569088|YURE|yure
616876|NCT00569075|Apoptic biomarkers|apoptic biomarkers
616877|NCT00569075|Early detection periodontitis|early detection periodontitis
616878|NCT00569075|Gingival crevicular fluid|gingival crevicular fluid
616879|NCT00569075|Healthy subjects|healthy subjects
616880|NCT00569062|Psychomotor retardation|psychomotor retardation
616881|NCT00569062|cytokines|cytokines
616882|NCT00569062|GW856553|gw856553
616883|NCT00569062|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
616884|NCT00569036|Advanced or Metastatic Solid Tumors or Neoplasms|advanced or metastatic solid tumors or neoplasms
616885|NCT00569023|Beta Carotene|beta carotene
616886|NCT00569023|visual functions|visual functions
616887|NCT00569023|Fundus albipunctatus|fundus albipunctatus
616888|NCT00569023|Night Blindness|night blindness
616889|NCT00569010|Acute Myelogenous Leukemia|acute myelogenous leukemia
616890|NCT00569010|AML|aml
616891|NCT00569010|Myelodysplastic Syndrome|myelodysplastic syndrome
616892|NCT00569010|MDS|mds
616893|NCT00569010|Leukemia|leukemia
616894|NCT00568997|Atopic dermatitis eczema pediatric pimecrolimus malignancy|atopic dermatitis eczema pediatric pimecrolimus malignancy
616895|NCT00568971|DCF|dcf
616896|NCT00568971|Advanced gastric cancer|advanced gastric cancer
616897|NCT00568971|Phase II study|phase ii study
616898|NCT00568971|Efficacy|efficacy
616899|NCT00568971|Toxicity|toxicity
616900|NCT00568958|heavy episodic drinking|heavy episodic drinking
616901|NCT00568958|young adults|young adults
616902|NCT00568958|naltrexone|naltrexone
616903|NCT00568958|BASICS counseling|basics counseling
616904|NCT00568958|alcohol-related consequences|alcohol-related consequences
616905|NCT00568958|double-blind trial|double-blind trial
616906|NCT00568958|randomized clinical trial|randomized clinical trial
616907|NCT00568945|Atrial Fibrillation|atrial fibrillation
616908|NCT00568945|Capadenoson|capadenoson
616909|NCT00568880|stage I multiple myeloma|stage i multiple myeloma
616910|NCT00568880|stage II multiple myeloma|stage ii multiple myeloma
616911|NCT00568880|stage III multiple myeloma|stage iii multiple myeloma
616912|NCT00568880|refractory multiple myeloma|refractory multiple myeloma
616913|NCT00568841|advanced Non-Small-Cell Lung Cancer|advanced non-small-cell lung cancer
616914|NCT00568841|erlotinib|erlotinib
616915|NCT00568841|FDG-PET|fdg-pet
616916|NCT00568841|FLT-PET|flt-pet
616917|NCT00568828|Macular Teleangiectasia|macular teleangiectasia
616918|NCT00568828|Macular Pigment|macular pigment
616919|NCT00568815|DLBCL|dlbcl
616920|NCT00568815|Rituximab|rituximab
616921|NCT00568815|ESHAP|eshap
616922|NCT00568815|Efficacy|efficacy
616923|NCT00568815|Toxicity|toxicity
616924|NCT00568789|Insomnia|insomnia
616925|NCT00568789|Aged|aged
616926|NCT00568789|Postural Balance|postural balance
616927|NCT00568789|Drug Therapy|drug therapy
616928|NCT00568763|stage IV melanoma|stage iv melanoma
616929|NCT00568763|recurrent melanoma|recurrent melanoma
616930|NCT00568750|gastrointestinal stromal tumor|gastrointestinal stromal tumor
616931|NCT00568737|Severe Sepsis|severe sepsis
616932|NCT00568724|Hydronephrosis|hydronephrosis
616933|NCT00568724|Ureteral obstruction|ureteral obstruction
616934|NCT00568711|Doxycycline,|doxycycline,
616935|NCT00568711|Rifampin|rifampin
616936|NCT00568711|Scrub typhus.|scrub typhus.
616937|NCT00568672|Major Depression|major depression
616938|NCT00568672|Olanzapine|olanzapine
616939|NCT00568672|add-on therapy|add-on therapy
616940|NCT00568672|antidepressant|antidepressant
616941|NCT00568672|atypical antipsychotic|atypical antipsychotic
616942|NCT00568659|Gas exchange|gas exchange
616943|NCT00568659|Respiratory mechanics|respiratory mechanics
616944|NCT00568659|Ventilator Induced Lung Injury|ventilator induced lung injury
616945|NCT00568607|NK/T cell lymphoma|nk/t cell lymphoma
616946|NCT00568607|Response Rate|response rate
616947|NCT00568607|TTP|ttp
616948|NCT00568607|OS|os
616949|NCT00568607|Toxicities|toxicities
616950|NCT00568594|Apolipoprotein A-I,|apolipoprotein a-i,
618206|NCT00562874|HIV/AIDS|hiv/aids
616951|NCT00568594|Atherosclerosis,|atherosclerosis,
616952|NCT00568594|HDL,|hdl,
616953|NCT00568594|Inflammation,|inflammation,
616954|NCT00568568|Growth Hormone|growth hormone
616955|NCT00568568|GH signaling|gh signaling
616956|NCT00568568|Insulin resistance|insulin resistance
616957|NCT00568568|Insulin Signaling|insulin signaling
616958|NCT00568542|cardiomyopathy|cardiomyopathy
616959|NCT00568542|ischemia|ischemia
616960|NCT00568542|percutaneous coronary intervention|percutaneous coronary intervention
616961|NCT00568542|remodeling|remodeling
616962|NCT00568529|Advanced gastric cancer|advanced gastric cancer
616963|NCT00568529|Response rate|response rate
616964|NCT00568529|Side effects|side effects
616965|NCT00568529|time to progression|time to progression
616966|NCT00568529|overall survival|overall survival
616967|NCT00568516|ASP3550|asp3550
616968|NCT00568516|Degarelix|degarelix
616969|NCT00568516|Prostate cancer|prostate cancer
616970|NCT00568516|Prostatic neoplasms|prostatic neoplasms
616971|NCT00568503|COPD/TIOTROPIUM/QAX028|copd/tiotropium/qax028
616972|NCT00568477|Rituximab, Heemannn|rituximab, heemannn
616973|NCT00568464|ESFT (Ewing's sarcoma family of tumors)|esft (ewing's sarcoma family of tumors)
616974|NCT00568464|Response rate|response rate
616975|NCT00568464|TTP|ttp
616976|NCT00568464|OS|os
616977|NCT00568464|Toxicity|toxicity
616978|NCT00568451|stage IV melanoma|stage iv melanoma
616979|NCT00568451|recurrent melanoma|recurrent melanoma
616980|NCT00568412|atopic dermatitis|atopic dermatitis
616981|NCT00568399|Coronary|coronary
616982|NCT00568399|Calcification|calcification
616983|NCT00568399|Dialysis|dialysis
616984|NCT00568399|Thiosulfate|thiosulfate
616985|NCT00568399|Cardiovascular|cardiovascular
616986|NCT00568386|Dry eye|dry eye
616987|NCT00568373|Gastroparesis|gastroparesis
616988|NCT00568373|Gastric electrical stimulator|gastric electrical stimulator
616989|NCT00568347|chronic airflow obstruction|chronic airflow obstruction
616990|NCT00568334|chickenpox|chickenpox
616991|NCT00568334|varicella|varicella
616992|NCT00568334|two-dose schedule|two-dose schedule
616993|NCT00568334|second year of life|second year of life
616994|NCT00568321|monoclonal antibody|monoclonal antibody
616995|NCT00568308|Hepatocellular Carcinoma|hepatocellular carcinoma
616996|NCT00568308|PI-88|pi-88
616997|NCT00568308|Phase III|phase iii
616998|NCT00568308|Adjuvant Therapy|adjuvant therapy
616999|NCT00568308|Hepatoma|hepatoma
617000|NCT00568308|Liver Cancer|liver cancer
617001|NCT00568269|Recurrence rate after inguinal hernia repair on primary inguinal herina.|recurrence rate after inguinal hernia repair on primary inguinal herina.
617002|NCT00568256|Ulcerative Colitis|ulcerative colitis
617003|NCT00568256|IBD Flare-Up|ibd flare-up
617004|NCT00568256|Stress|stress
617005|NCT00568243|Visuomotor Integration|visuomotor integration
617006|NCT00568243|Visual Attention|visual attention
617007|NCT00568243|Healthy Volunteer|healthy volunteer
617008|NCT00568243|HV|hv
617009|NCT00568230|heart failure|heart failure
617010|NCT00568230|mitral regurgitation|mitral regurgitation
617011|NCT00568204|pruritus, itching, mexyn-a, clearitch, magicool-plus|pruritus, itching, mexyn-a, clearitch, magicool-plus
617012|NCT00568191|Age-related macular degeneration|age-related macular degeneration
617013|NCT00568191|choroidal neovascularization|choroidal neovascularization
617014|NCT00568191|Stratus OCT|stratus oct
617015|NCT00568191|Cirrus OCT|cirrus oct
617016|NCT00568165|Heart failure, congestive|heart failure, congestive
617017|NCT00568165|Echocardiography|echocardiography
617018|NCT00568165|Patient care team|patient care team
617019|NCT00568152|Apples|apples
617020|NCT00568152|Dietary intervention|dietary intervention
617021|NCT00568152|Procyanidins|procyanidins
617022|NCT00568139|adrenal cancer|adrenal cancer
617023|NCT00568139|mitotane (Lysodren)|mitotane (lysodren)
617024|NCT00568139|adverse events|adverse events
617025|NCT00568126|Antidepressant Induced Sexual Dysfunction|antidepressant induced sexual dysfunction
617026|NCT00568126|Depression|depression
617027|NCT00568126|Sexual Dysfunction|sexual dysfunction
617028|NCT00568113|preterm labour|preterm labour
617029|NCT00568113|n acetyl cysteine|n acetyl cysteine
617030|NCT00568113|bacterial vaginosis|bacterial vaginosis
617031|NCT00568100|gas exchange|gas exchange
617032|NCT00568100|pressure support ventilation|pressure support ventilation
617033|NCT00568100|respiratory mechanics|respiratory mechanics
617034|NCT00568100|COPD|copd
617035|NCT00568100|NAVA|nava
617036|NCT00568087|N-acetylcysteine|n-acetylcysteine
617037|NCT00568087|Alcoholism|alcoholism
617038|NCT00568087|Treatment|treatment
617039|NCT00568061|INOT44|inot44
617040|NCT00568061|NOMI|nomi
617041|NCT00568048|stage IV melanoma|stage iv melanoma
617042|NCT00568048|recurrent melanoma|recurrent melanoma
617043|NCT00568035|diabetic|diabetic
617044|NCT00568035|peripheral|peripheral
617045|NCT00568035|neuropathy|neuropathy
617046|NCT00568009|Congestive Heart Failure|congestive heart failure
617047|NCT00568009|Impaired Renal Function|impaired renal function
617048|NCT00567996|Chronic obstructive pulmonary disease, indacaterol, salmeterol, placebo controlled|chronic obstructive pulmonary disease, indacaterol, salmeterol, placebo controlled
618300|NCT00562497|Acute GVHD|acute gvhd
617049|NCT00567970|liver metastases|liver metastases
617050|NCT00567957|pre-eclampsia|pre-eclampsia
617051|NCT00567957|remifentanil|remifentanil
617052|NCT00567957|anesthesia, general|anesthesia, general
617053|NCT00567957|analgesics, opioid|analgesics, opioid
617054|NCT00567957|anesthetics, intravenous|anesthetics, intravenous
617055|NCT00567957|Cesarean section|cesarean section
617056|NCT00567957|newborn|newborn
617057|NCT00567957|maternal haemodynamic|maternal haemodynamic
617058|NCT00567944|Physical Therapy Modalities|physical therapy modalities
617059|NCT00567944|Electric Stimulation|electric stimulation
617060|NCT00567944|Postural Balance|postural balance
617061|NCT00567918|Keratoconjunctivitis|keratoconjunctivitis
617062|NCT00567918|Vernal keratoconjunctivitis|vernal keratoconjunctivitis
617063|NCT00567918|FK506|fk506
617064|NCT00567918|Tacrolimus|tacrolimus
617065|NCT00567905|Type 2 Diabetes|type 2 diabetes
617066|NCT00567905|Green tea extract|green tea extract
617067|NCT00567905|overweight|overweight
617068|NCT00567892|tinnitus|tinnitus
617069|NCT00567892|subjective tinnitus|subjective tinnitus
617070|NCT00567892|therapy|therapy
617071|NCT00567892|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
617072|NCT00567892|clinical trial|clinical trial
617073|NCT00567879|Breast Cancer|breast cancer
617074|NCT00567879|HER2 positive|her2 positive
617075|NCT00567879|adult-female|adult-female
617076|NCT00567879|LBH589|lbh589
617077|NCT00567879|HDAC inhibitor|hdac inhibitor
617078|NCT00567879|panobinostat|panobinostat
617079|NCT00567853|mitral valve regurgitation|mitral valve regurgitation
617080|NCT00567853|mitral valve disease|mitral valve disease
617081|NCT00567853|mitral valve repair|mitral valve repair
617082|NCT00567853|mitral valve dysfunction|mitral valve dysfunction
617083|NCT00567853|heart valve|heart valve
617084|NCT00567853|valve disease|valve disease
617085|NCT00567853|cardiac surgery|cardiac surgery
617086|NCT00567840|Early Bactericidal Activity|early bactericidal activity
617087|NCT00567840|EBA|eba
617088|NCT00567840|pulmonary tuberculosis|pulmonary tuberculosis
617089|NCT00567840|PA-824|pa-824
617090|NCT00567840|Pretomanid|pretomanid
617091|NCT00567840|CL-007|cl-007
617092|NCT00567827|Pneumonia|pneumonia
617093|NCT00567814|Cocaine|cocaine
617094|NCT00567814|Dependence|dependence
617095|NCT00567814|Addiction|addiction
617096|NCT00567814|Cortisol|cortisol
617097|NCT00567814|GABA|gaba
617098|NCT00567801|Lower Extremity|lower extremity
617099|NCT00567801|Ischemia|ischemia
617100|NCT00567788|Glaucoma, angle-closure|glaucoma, angle-closure
617101|NCT00567762|Keratoconjunctivitis|keratoconjunctivitis
617102|NCT00567762|vernal keratoconjunctivitis|vernal keratoconjunctivitis
617103|NCT00567762|FK506|fk506
617104|NCT00567762|Tacrolimus|tacrolimus
617105|NCT00567749|HIV-1 Infections|hiv-1 infections
617106|NCT00567736|low back pain|low back pain
617107|NCT00567736|complementary therapies|complementary therapies
617108|NCT00567697|ranibizumab|ranibizumab
617109|NCT00567697|CRVO|crvo
617110|NCT00567697|macular edema|macular edema
617111|NCT00567697|sham|sham
617112|NCT00567684|Transitional Cell Carcinoma|transitional cell carcinoma
617113|NCT00567684|Urothelial Cancer|urothelial cancer
617114|NCT00567684|Bladder Cancer|bladder cancer
617115|NCT00567684|Computed Tomography Urography|computed tomography urography
617116|NCT00567684|CTU|ctu
617117|NCT00567684|Intravenous Urography|intravenous urography
617118|NCT00567684|IVU|ivu
617119|NCT00567684|TCC|tcc
617120|NCT00567684|transitional cell carcinomas|transitional cell carcinomas
617121|NCT00567671|keratoconus|keratoconus
617122|NCT00567671|ectasia|ectasia
617123|NCT00567671|cross-linking|cross-linking
617124|NCT00567671|riboflavin|riboflavin
617125|NCT00567671|UVA light|uva light
617126|NCT00567671|cornea|cornea
617127|NCT00567632|Pneumococci|pneumococci
617128|NCT00567632|Antibody|antibody
617129|NCT00567632|Standard laboratory values|standard laboratory values
617130|NCT00567619|GERD|gerd
617131|NCT00567619|NIS|nis
617132|NCT00567580|stage IIB prostate cancer|stage iib prostate cancer
617133|NCT00567580|stage IIA prostate cancer|stage iia prostate cancer
617134|NCT00567580|stage III prostate cancer|stage iii prostate cancer
617135|NCT00567580|adenocarcinoma of the prostate|adenocarcinoma of the prostate
617136|NCT00567554|breast cancer|breast cancer
617137|NCT00567554|primary systemic therapy|primary systemic therapy
617138|NCT00567554|pCR Rates|pcr rates
617139|NCT00567554|Bevacizumab|bevacizumab
617140|NCT00567554|Trastuzumab|trastuzumab
617141|NCT00567554|Lapatinib|lapatinib
617142|NCT00567554|Everolimus|everolimus
617143|NCT00567541|shoulder|shoulder
617144|NCT00567541|pain|pain
617145|NCT00567541|stroke|stroke
617146|NCT00567541|subluxation|subluxation
617147|NCT00567528|Soft tissue injuries|soft tissue injuries
617148|NCT00567528|Topical ibuprofen|topical ibuprofen
617149|NCT00567528|Adolescent athletes|adolescent athletes
617150|NCT00567489|ESRD|esrd
617151|NCT00567489|Diabetes|diabetes
617152|NCT00567489|CAPD|capd
617153|NCT00567489|APD|apd
618380|NCT00562211|children|children
617154|NCT00567476|Asthma, anti-immunoglobulin E, omalizumab|asthma, anti-immunoglobulin e, omalizumab
617155|NCT00567463|Asthma|asthma
617156|NCT00567463|Bronchial hyperresponsiveness|bronchial hyperresponsiveness
617157|NCT00567463|Methacholine|methacholine
617158|NCT00567463|Induced sputum|induced sputum
617159|NCT00567463|bronchial biopsies|bronchial biopsies
617160|NCT00567450|sciatic block|sciatic block
617161|NCT00567450|ropivacaine|ropivacaine
617162|NCT00567450|mepivacaine|mepivacaine
617163|NCT00567450|locoregional anesthesia|locoregional anesthesia
617164|NCT00567437|aortic stenosis|aortic stenosis
617165|NCT00567437|prognosis|prognosis
617166|NCT00567437|brain natriuretic peptide|brain natriuretic peptide
617167|NCT00567424|epilepsy|epilepsy
617168|NCT00567424|refractory|refractory
617169|NCT00567424|seizure|seizure
617170|NCT00567424|drug interactions|drug interactions
617171|NCT00567424|pharmacokinetics|pharmacokinetics
617172|NCT00567411|Glaucoma|glaucoma
617174|NCT00567411|laser trabeculoplasty|laser trabeculoplasty
617175|NCT00567411|selective laser trabeculoplasty|selective laser trabeculoplasty
617176|NCT00567411|intraocular pressure|intraocular pressure
617177|NCT00567398|ESRD|esrd
617178|NCT00567398|Diabetes|diabetes
617179|NCT00567398|CAPD|capd
617180|NCT00567398|APD|apd
617181|NCT00567372|Diffuse diabetic macular edema|diffuse diabetic macular edema
617182|NCT00567372|sub-tenon|sub-tenon
617183|NCT00567372|Bevacizumab|bevacizumab
617184|NCT00567359|NSCLC|nsclc
617185|NCT00567359|erlotinib|erlotinib
617186|NCT00567359|epidermal growth factor receptor|epidermal growth factor receptor
617187|NCT00567359|EGFR|egfr
617188|NCT00567346|randomised|randomised
617189|NCT00567346|double-blind|double-blind
617190|NCT00567346|placebo-controlled|placebo-controlled
617191|NCT00567346|efficacy and safety|efficacy and safety
617192|NCT00567346|Oralgen® Grass Pollen|oralgen® grass pollen
617193|NCT00567346|allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
617194|NCT00567346|Allergy|allergy
617195|NCT00567346|Rhinoconjunctivitis|rhinoconjunctivitis
617196|NCT00567346|Immunotherapy|immunotherapy
617197|NCT00567346|Grass pollen extract|grass pollen extract
617198|NCT00567320|varenicline|varenicline
617199|NCT00567294|Osteoporosis|osteoporosis
617200|NCT00567294|Medication adherence|medication adherence
617201|NCT00567294|Telephonic education|telephonic education
617202|NCT00567294|Motivational interviewing|motivational interviewing
617203|NCT00567281|Schizoaffective disorder|schizoaffective disorder
617204|NCT00567281|Auditory Hallucinations|auditory hallucinations
617205|NCT00567281|Voices|voices
617206|NCT00567281|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
617207|NCT00567281|rTMS|rtms
617208|NCT00567281|Wernicke's Area|wernicke's area
617209|NCT00567281|Middle Temporal Cortex|middle temporal cortex
617210|NCT00567281|Persistent Auditory Hallucinations|persistent auditory hallucinations
617211|NCT00567281|"Previously Participated in Parent rTMS Protocol"|"previously participated in parent rtms protocol"
617212|NCT00567268|Post-Marketing surveillance|post-marketing surveillance
617213|NCT00567255|Obesity|obesity
617214|NCT00567242|aphasia|aphasia
617215|NCT00567242|therapies, investigational|therapies, investigational
617216|NCT00567242|rehabilitation of speech and language disorders|rehabilitation of speech and language disorders
617217|NCT00567242|magnetic resonance imaging, functional|magnetic resonance imaging, functional
617218|NCT00567242|language|language
617219|NCT00567229|refractory multiple myeloma|refractory multiple myeloma
617220|NCT00567190|Herceptin|herceptin
617221|NCT00567190|Breast cancer|breast cancer
617222|NCT00567190|MBC|mbc
617223|NCT00567190|Taxotere|taxotere
617224|NCT00567190|HER2|her2
617225|NCT00567190|HER2 positive breast cancer|her2 positive breast cancer
617226|NCT00567190|HER2 + breast cancer|her2 + breast cancer
617227|NCT00567190|HER2-positive|her2-positive
617228|NCT00567190|HER2-positive metastatic breast cancer|her2-positive metastatic breast cancer
617229|NCT00567164|Oral Contraception|oral contraception
617230|NCT00567164|Birth Control pill|birth control pill
617231|NCT00567164|Healthy women requesting oral contraception|healthy women requesting oral contraception
617232|NCT00567164|Contraceptive efficacy|contraceptive efficacy
617233|NCT00567125|low-pressure pneumoperitoneum|low-pressure pneumoperitoneum
617234|NCT00567125|laparoscopy|laparoscopy
617235|NCT00567125|cytokines|cytokines
617236|NCT00567125|VEGF-A|vegf-a
617237|NCT00567125|endostatin|endostatin
617238|NCT00567099|Psychiatry|psychiatry
617239|NCT00567099|Antipsychotic|antipsychotic
617240|NCT00567099|Psychopharmacology|psychopharmacology
617241|NCT00567099|Clinical Trial|clinical trial
617242|NCT00567099|Open Label|open label
617243|NCT00567099|Schizophrenia|schizophrenia
617244|NCT00567099|Sensory Gating|sensory gating
617245|NCT00567099|Attention|attention
617246|NCT00567099|Memory|memory
617247|NCT00567086|Migraine|migraine
617248|NCT00567073|Glycogen Storage Disease Type II (GSD-II)|glycogen storage disease type ii (gsd-ii)
617249|NCT00567073|GSD-II|gsd-ii
617250|NCT00567073|Pompe Disease|pompe disease
617251|NCT00567073|Pompe Disease (Late-Onset)|pompe disease (late-onset)
617252|NCT00567073|Acid Maltase Deficiency Disease|acid maltase deficiency disease
617253|NCT00567073|Glycogenosis II|glycogenosis ii
617254|NCT00567060|Piracetam|piracetam
617255|NCT00567060|Nootropil|nootropil
617256|NCT00567034|Zyprexa|zyprexa
617257|NCT00567034|naltrexone|naltrexone
617258|NCT00567034|schizophrenia|schizophrenia
617259|NCT00567034|Metabolic Syndrome|metabolic syndrome
617260|NCT00567034|pain|pain
617261|NCT00567021|reflux|reflux
617262|NCT00567021|NSAR treatment|nsar treatment
617263|NCT00567021|Patients with reflux symptoms or gastrointestinal symptoms after NSAR Treatment|patients with reflux symptoms or gastrointestinal symptoms after nsar treatment
617264|NCT00567008|cocaine|cocaine
617265|NCT00567008|crack cocaine|crack cocaine
617266|NCT00567008|cocaine-related disorders|cocaine-related disorders
617267|NCT00567008|substance-related disorders|substance-related disorders
617268|NCT00567008|alpha4beta2 nicotinic acetylcholine receptor|alpha4beta2 nicotinic acetylcholine receptor
617269|NCT00566995|Kidney Tumors|kidney tumors
617270|NCT00566995|Clear Cell Renal Cancer|clear cell renal cancer
617271|NCT00566995|VEGFR Inhibitor|vegfr inhibitor
617272|NCT00566995|EGFR Inhibitor|egfr inhibitor
617273|NCT00566995|VHL|vhl
617274|NCT00566995|Von Hippel Lindau|von hippel lindau
617275|NCT00566995|Kidney Tumor|kidney tumor
617276|NCT00566982|Urogenital atrophy|urogenital atrophy
617277|NCT00566982|Menopausal symptoms|menopausal symptoms
617278|NCT00566982|Vulvar and vaginal atrophy in postmenopausal women|vulvar and vaginal atrophy in postmenopausal women
617279|NCT00566982|Vaginal atrophy|vaginal atrophy
617280|NCT00566969|cocaine, opiate, methadone, carvedilol|cocaine, opiate, methadone, carvedilol
617281|NCT00566956|Hydrosalpinx/IVF/Reproductive outcome.|hydrosalpinx/ivf/reproductive outcome.
617282|NCT00566956|Hydrosalpinx|hydrosalpinx
617283|NCT00566943|Staple Line Reinforcement, Buttress|staple line reinforcement, buttress
617284|NCT00566917|Vagina|vagina
617285|NCT00566917|Prolapse|prolapse
617286|NCT00566917|Anterior vaginal wall prolapse|anterior vaginal wall prolapse
617287|NCT00566904|Post-herpetic Neuralgia|post-herpetic neuralgia
617288|NCT00566904|Pain after Shingles|pain after shingles
617289|NCT00566904|Shingles|shingles
617290|NCT00566904|PHN|phn
617291|NCT00566891|percutaneous coronary angioplasty|percutaneous coronary angioplasty
617292|NCT00566891|pci|pci
617293|NCT00566891|tirofiban|tirofiban
617294|NCT00566891|side effects|side effects
617295|NCT00566878|Glycogen Storage Disease|glycogen storage disease
617296|NCT00566878|GSD-II|gsd-ii
617297|NCT00566878|Pompe Disease|pompe disease
617298|NCT00566878|Pompe Disease (Late-Onset)|pompe disease (late-onset)
617299|NCT00566878|Acid Maltase Deficiency Disease|acid maltase deficiency disease
617300|NCT00566878|Glycogenosis II|glycogenosis ii
617301|NCT00566852|cognitive/functional effects|cognitive/functional effects
617302|NCT00566852|neurotoxicity|neurotoxicity
617303|NCT00566852|tumors metastatic to brain|tumors metastatic to brain
617304|NCT00566852|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
617305|NCT00566839|COPD|copd
617306|NCT00566839|LVRS|lvrs
617307|NCT00566839|Awake surgery|awake surgery
617308|NCT00566839|Thoracic epidural anesthesia|thoracic epidural anesthesia
617309|NCT00566839|One-lung ventilation|one-lung ventilation
617310|NCT00566839|Emphysema|emphysema
617311|NCT00566839|VATS|vats
617312|NCT00566839|Lung surgery|lung surgery
617313|NCT00566826|Physical Function|physical function
617314|NCT00566826|Total Knee Replacement|total knee replacement
617315|NCT00566826|Physical Activity|physical activity
617316|NCT00566826|Behavioral Support|behavioral support
617317|NCT00566826|Arthroplasty|arthroplasty
617318|NCT00566826|Function|function
617319|NCT00566826|Self-Care|self-care
617320|NCT00566813|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
617321|NCT00566813|Islets of Langerhans Transplantation|islets of langerhans transplantation
617322|NCT00566813|Exenatide|exenatide
617323|NCT00566813|Soluble tumor necrosis factor receptor|soluble tumor necrosis factor receptor
617324|NCT00566800|esophageal cancer|esophageal cancer
617325|NCT00566800|Barrett esophagus|barrett esophagus
617326|NCT00566787|AF|af
617327|NCT00566787|Atrial Fibrillation|atrial fibrillation
617328|NCT00566787|afib|afib
617329|NCT00566787|racing heart|racing heart
617330|NCT00566787|cabg|cabg
617331|NCT00566787|valve|valve
617332|NCT00566787|ablation|ablation
617333|NCT00566787|bipolar|bipolar
617334|NCT00566787|radiofrequency|radiofrequency
617335|NCT00566787|rf|rf
617336|NCT00566774|myocardial infarction|myocardial infarction
617337|NCT00566774|secondary prevention|secondary prevention
617338|NCT00566774|health insurance|health insurance
617339|NCT00566774|cost-sharing|cost-sharing
617340|NCT00566761|Macular edema|macular edema
617341|NCT00566761|central retinal vein occlusion|central retinal vein occlusion
617342|NCT00566761|bevacizumab|bevacizumab
617343|NCT00566761|triamcinolone|triamcinolone
617344|NCT00566709|transfusion|transfusion
617345|NCT00566709|NIRS|nirs
617346|NCT00566709|cerebral oxygenation|cerebral oxygenation
617347|NCT00566709|red blood cell|red blood cell
617348|NCT00566709|near infrared spectroscopy|near infrared spectroscopy
617349|NCT00566696|Haploidentical stem cell transplant|haploidentical stem cell transplant
617350|NCT00566696|Allogeneic stem cell transplant|allogeneic stem cell transplant
617351|NCT00566696|Mismatched family member stem cell donor transplant|mismatched family member stem cell donor transplant
617352|NCT00566696|Bone marrow transplant|bone marrow transplant
617353|NCT00566696|High risk hematologic malignancies|high risk hematologic malignancies
617354|NCT00566696|T cell depletion methodology|t cell depletion methodology
617355|NCT00566696|Miltenyi Biotec CliniMACS stem cell selection device|miltenyi biotec clinimacs stem cell selection device
617356|NCT00566696|Campath-1H intravenous|campath-1h intravenous
617357|NCT00566683|Propofol|propofol
617358|NCT00566683|colonoscopy|colonoscopy
617359|NCT00566683|sedation|sedation
617360|NCT00566683|pain|pain
617361|NCT00566683|compare NAPS versus diazemuls in outpatient colonoscopy|compare naps versus diazemuls in outpatient colonoscopy
617362|NCT00566670|Hemodialysis|hemodialysis
617363|NCT00566657|Critical Limb Ischemia|critical limb ischemia
617364|NCT00566657|Peripheral Artery Disease|peripheral artery disease
617365|NCT00566657|Plasmid based gene therapy|plasmid based gene therapy
617366|NCT00566644|endometrial cancer|endometrial cancer
617367|NCT00566644|hereditary non-polyposis colon cancer (hMSH2, hMLH1, hPMS1, hPMS2)|hereditary non-polyposis colon cancer (hmsh2, hmlh1, hpms1, hpms2)
617368|NCT00566631|Schizophrenia|schizophrenia
617369|NCT00566631|Paliperidone Extended Release (ER)|paliperidone extended release (er)
617370|NCT00566631|Invega|invega
617371|NCT00566618|Breast Cancer|breast cancer
617372|NCT00566618|Bone Metastases|bone metastases
617373|NCT00566618|Breast Cancer with Bone Metastases|breast cancer with bone metastases
617374|NCT00566618|Breast Cancer with Metastases to Bone|breast cancer with metastases to bone
617375|NCT00566618|Dasatinib|dasatinib
617376|NCT00566618|Zometa|zometa
617377|NCT00566618|Zoledronic Acid|zoledronic acid
617378|NCT00566618|Zoledronate|zoledronate
617379|NCT00566618|BMS-345825|bms-345825
617380|NCT00566618|Sprycel®|sprycel®
617381|NCT00566579|Human papillomavirus|human papillomavirus
617382|NCT00566579|Clearance|clearance
617383|NCT00566579|Cryotherapy|cryotherapy
617384|NCT00566566|adipocytokines|adipocytokines
617385|NCT00566566|inflammatory markers|inflammatory markers
617386|NCT00566566|cardiovascular disease|cardiovascular disease
617387|NCT00566566|diabetes mellitus|diabetes mellitus
617388|NCT00566566|Leptin|leptin
617389|NCT00566553|Grape Seed Extract|grape seed extract
617390|NCT00566553|Breast Cancer|breast cancer
617391|NCT00566553|Estrogen Levels|estrogen levels
617392|NCT00566553|Aromatase Inhibitor|aromatase inhibitor
617393|NCT00566540|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
617394|NCT00566540|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
617395|NCT00566540|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
617396|NCT00566540|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
617397|NCT00566540|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
617398|NCT00566540|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
617399|NCT00566540|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
617400|NCT00566514|fibromyalgia|fibromyalgia
617401|NCT00566514|ribose|ribose
617402|NCT00566514|d-ribose|d-ribose
617403|NCT00566514|dextrose|dextrose
617404|NCT00566501|Moderate-to-severe|moderate-to-severe
617405|NCT00566501|Alzheimer's|alzheimer's
617406|NCT00566501|Disease|disease
617407|NCT00566488|Thymus Transplantation|thymus transplantation
617408|NCT00566488|Parathyroid Transplantation|parathyroid transplantation
617409|NCT00566488|DiGeorge Syndrome|digeorge syndrome
617410|NCT00566488|Hypoparathyroidism|hypoparathyroidism
617411|NCT00566488|Athymia|athymia
617412|NCT00566449|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
617413|NCT00566449|ADHD|adhd
617414|NCT00566449|JNJ-31001074|jnj-31001074
617415|NCT00566436|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
617416|NCT00566436|Superficial Femoral Artery|superficial femoral artery
617417|NCT00566436|Remote Endarterectomy|remote endarterectomy
617418|NCT00566436|Suprageniculate Bypass Surgery|suprageniculate bypass surgery
617419|NCT00566436|Blood Vessel Prosthesis Implantation|blood vessel prosthesis implantation
617420|NCT00566436|Vascular Patency|vascular patency
617421|NCT00566423|PAH|pah
617422|NCT00566423|Biomarkers|biomarkers
617423|NCT00566423|MIF|mif
617424|NCT00566423|BNP|bnp
617425|NCT00566423|6 Minute Walk (6MW)|6 minute walk (6mw)
617426|NCT00566410|DCA|dca
617427|NCT00566410|Phase I|phase i
617428|NCT00566410|Dose Escalation|dose escalation
617429|NCT00566410|Solid Tumours|solid tumours
617430|NCT00566410|Dichloroacetate|dichloroacetate
617431|NCT00566410|Pharmacokinetic|pharmacokinetic
617432|NCT00566397|RI RI Study Rage Inhibitors|ri ri study rage inhibitors
617433|NCT00566384|Loss of libido|loss of libido
617434|NCT00566384|Acquired, oral contraceptive -associated female sexual dysfunction|acquired, oral contraceptive -associated female sexual dysfunction
617435|NCT00566371|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
617436|NCT00566371|insomnia|insomnia
617437|NCT00566371|atomoxetine|atomoxetine
617438|NCT00566358|diabetes mellitus, type 2|diabetes mellitus, type 2
617439|NCT00566358|duodenal exclusion|duodenal exclusion
617440|NCT00566358|bariatric surgery|bariatric surgery
617441|NCT00566358|Glucagon-Like Peptide 1|glucagon-like peptide 1
617442|NCT00566358|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
617443|NCT00566358|insulin|insulin
617444|NCT00566358|glucagon|glucagon
617445|NCT00566358|ghrelin|ghrelin
617446|NCT00566332|Waldenström Macroglobulinemia|waldenström macroglobulinemia
617447|NCT00566332|Lymphoplasmacytic lymphoma|lymphoplasmacytic lymphoma
617448|NCT00566332|Splenic Marginal Zone Lymphoma|splenic marginal zone lymphoma
617449|NCT00566332|Fludarabine|fludarabine
617450|NCT00566332|Chlorambucil|chlorambucil
617451|NCT00566319|Exercise|exercise
617452|NCT00566306|Clostridium difficile|clostridium difficile
617453|NCT00566306|disinfectant|disinfectant
617454|NCT00566280|MBI|mbi
617455|NCT00566280|Mammogram|mammogram
617456|NCT00566280|Breast Cancer|breast cancer
617457|NCT00566280|Breast Ultrasound|breast ultrasound
617458|NCT00566280|Bloody Nipple Discharge|bloody nipple discharge
617459|NCT00566280|Molecular Breast Imaging|molecular breast imaging
617460|NCT00566254|Epilepsy|epilepsy
617461|NCT00566254|paediatric|paediatric
617462|NCT00566254|partial onset seizures|partial onset seizures
617463|NCT00566241|Body weight|body weight
617464|NCT00566241|Body composition|body composition
617465|NCT00566241|Pulmonary function|pulmonary function
617466|NCT00566241|Carbohydrate tolerance|carbohydrate tolerance
617467|NCT00566228|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
617468|NCT00566228|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
617469|NCT00566228|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
617470|NCT00566228|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
617471|NCT00566215|diabetes mellitus, type 2|diabetes mellitus, type 2
617472|NCT00566215|Insulin resistance|insulin resistance
617473|NCT00566215|Intra-Abdominal Fat|intra-abdominal fat
617474|NCT00566215|Omentum|omentum
617475|NCT00566215|duodenal exclusion|duodenal exclusion
617476|NCT00566215|bariatric surgery|bariatric surgery
617477|NCT00566215|Glucagon-Like Peptide 1|glucagon-like peptide 1
617478|NCT00566215|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
617479|NCT00566215|insulin|insulin
617480|NCT00566215|glucagon|glucagon
617481|NCT00566215|ghrelin|ghrelin
617482|NCT00566215|adiponectin|adiponectin
617483|NCT00566215|Cytokines|cytokines
617484|NCT00566202|Major Depressive Disorder|major depressive disorder
617485|NCT00566202|Depression|depression
617486|NCT00566202|JNJ-18038683|jnj-18038683
617487|NCT00566202|Escitalopram|escitalopram
617488|NCT00566189|diabetes mellitus, type 2|diabetes mellitus, type 2
617489|NCT00566189|Insulin resistance|insulin resistance
617490|NCT00566189|Intra-Abdominal Fat|intra-abdominal fat
617491|NCT00566189|Omentum|omentum
617492|NCT00566189|duodenal exclusion|duodenal exclusion
617493|NCT00566189|bariatric surgery|bariatric surgery
617494|NCT00566189|Glucagon-Like Peptide 1|glucagon-like peptide 1
617495|NCT00566189|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
617496|NCT00566189|insulin|insulin
617497|NCT00566189|glucagon|glucagon
617498|NCT00566189|ghrelin|ghrelin
617499|NCT00566189|adiponectin|adiponectin
617500|NCT00566189|Cytokines|cytokines
617501|NCT00566176|Atrial Fibrillation|atrial fibrillation
617502|NCT00566176|AF|af
617503|NCT00566176|AFIB|afib
617504|NCT00566176|racing heart|racing heart
617505|NCT00566176|pulmonary vein isolation|pulmonary vein isolation
617506|NCT00566176|pvi|pvi
617507|NCT00566176|mini maze|mini maze
617508|NCT00566176|maze|maze
617509|NCT00566150|Keppra|keppra
617510|NCT00566150|Levetiracetam|levetiracetam
617511|NCT00566150|Anticonvulsant|anticonvulsant
617512|NCT00566150|Depression|depression
617513|NCT00566150|Bipolar Disorder|bipolar disorder
617514|NCT00566150|Affective Disorders|affective disorders
617515|NCT00566150|Mood Disorders|mood disorders
617516|NCT00566150|Double Blind|double blind
617517|NCT00566150|Acute Antidepressant Effects|acute antidepressant effects
617518|NCT00566137|Scleroderma|scleroderma
617519|NCT00566137|Pulmonary Hypertension|pulmonary hypertension
617520|NCT00566124|Levemir, Lantus, Insulatard, Pharmacodynamics, Healthy humans|levemir, lantus, insulatard, pharmacodynamics, healthy humans
617521|NCT00566111|Ceftriaxone|ceftriaxone
617522|NCT00566111|Acute Antidepressant Effects|acute antidepressant effects
617523|NCT00566111|Glutamatergic System|glutamatergic system
617524|NCT00566111|Double-Blind|double-blind
617525|NCT00566111|Mood Disorders|mood disorders
617526|NCT00566111|Bipolar Disorder|bipolar disorder
617527|NCT00566111|Depression|depression
617528|NCT00566111|Affective Disorders|affective disorders
617529|NCT00566098|stage II multiple myeloma|stage ii multiple myeloma
617530|NCT00566098|stage III multiple myeloma|stage iii multiple myeloma
617531|NCT00566085|MBI|mbi
617532|NCT00566085|Breast Cancer|breast cancer
617533|NCT00566085|Neoadjuvant Therapy|neoadjuvant therapy
617534|NCT00566085|Molecular Breast Imaging|molecular breast imaging
617632|NCT00565617|deep brain stimulation|deep brain stimulation
617535|NCT00566072|the effect of information on compliance of medication|the effect of information on compliance of medication
617536|NCT00566059|therapeutic advice|therapeutic advice
617537|NCT00566033|AUDIT|audit
617538|NCT00566033|Chronic kidney disease|chronic kidney disease
617539|NCT00566033|Clinical trial|clinical trial
617540|NCT00566033|Creatinine|creatinine
617541|NCT00566033|Multiple intervents|multiple intervents
617542|NCT00566033|Nephrology guidelines.|nephrology guidelines.
617543|NCT00566020|Open-label extension|open-label extension
617544|NCT00566020|Tolerability|tolerability
617545|NCT00566020|Lamotrigine|lamotrigine
617546|NCT00566020|Safety|safety
617547|NCT00566020|Bipolar I disorder|bipolar i disorder
617548|NCT00566007|disc herniation|disc herniation
617549|NCT00566007|lumbar|lumbar
617550|NCT00566007|ozone therapy|ozone therapy
617551|NCT00565994|hemodialysis|hemodialysis
617552|NCT00565994|Vascular access|vascular access
617553|NCT00565994|arteriovenous fistula|arteriovenous fistula
617554|NCT00565994|indwelling percutaneous catheters|indwelling percutaneous catheters
617555|NCT00565994|arteriovenous grafts|arteriovenous grafts
617556|NCT00565981|B-CLL|b-cll
617557|NCT00565981|refractory|refractory
617558|NCT00565981|molecular profiling|molecular profiling
617559|NCT00565981|alemtuzumab|alemtuzumab
617560|NCT00565981|fludarabinephosphate|fludarabinephosphate
617561|NCT00565968|stage IIIB melanoma|stage iiib melanoma
617562|NCT00565968|stage IIIC melanoma|stage iiic melanoma
617563|NCT00565968|recurrent melanoma|recurrent melanoma
617564|NCT00565955|Montelukast|montelukast
617565|NCT00565955|Acute Asthma|acute asthma
617566|NCT00565942|Integrative medicine|integrative medicine
617567|NCT00565942|Primary care|primary care
617568|NCT00565942|Swedish massage therapy|swedish massage therapy
617569|NCT00565942|Manual therapy|manual therapy
617570|NCT00565942|Naprapathy|naprapathy
617571|NCT00565942|Shiatsu|shiatsu
617572|NCT00565942|Acupuncture/TCM|acupuncture/tcm
617573|NCT00565942|Qigong|qigong
617574|NCT00565942|Pragmatic RCT|pragmatic rct
617575|NCT00565942|Health services research|health services research
617576|NCT00565929|Variola major, smallpox, vaccine, hematopoietic stem cell transplant|variola major, smallpox, vaccine, hematopoietic stem cell transplant
617577|NCT00565916|Post-Menopausal|post-menopausal
617578|NCT00565916|PET|pet
617579|NCT00565916|Estrogen|estrogen
617580|NCT00565916|Progesterone|progesterone
617581|NCT00565916|Heart Metabolism|heart metabolism
617582|NCT00565916|Cardiovascular Disease|cardiovascular disease
617583|NCT00565903|pleuropulmonary blastoma|pleuropulmonary blastoma
617584|NCT00565903|PPB|ppb
617585|NCT00565903|cystic nephroma|cystic nephroma
617586|NCT00565903|DICER1|dicer1
617587|NCT00565903|miRNA|mirna
617588|NCT00565890|very low birth weight infant|very low birth weight infant
617589|NCT00565890|hypothyroxinemia|hypothyroxinemia
617590|NCT00565890|outcomes|outcomes
617591|NCT00565877|Catheter|catheter
617592|NCT00565877|Peripherally inserted central catheter|peripherally inserted central catheter
617593|NCT00565877|ultrasound|ultrasound
617594|NCT00565877|malposition|malposition
617595|NCT00565864|Hypothyroidism|hypothyroidism
617596|NCT00565864|Cognition|cognition
617597|NCT00565864|Metabolism|metabolism
617598|NCT00565838|Randomized study|randomized study
617599|NCT00565838|surgical treatment|surgical treatment
617600|NCT00565838|autologous fascial sling|autologous fascial sling
617601|NCT00565838|TVT|tvt
617602|NCT00565838|stress urinary incontinence.|stress urinary incontinence.
617603|NCT00565812|knee Osteoarthritis Disease Modifying Osteoarthritis Drug|knee osteoarthritis disease modifying osteoarthritis drug
617604|NCT00565799|DM|dm
617605|NCT00565760|Acute|acute
617606|NCT00565760|Pain|pain
617607|NCT00565747|GM-CSF|gm-csf
617608|NCT00565747|infertility|infertility
617609|NCT00565721|Static PET imaging|static pet imaging
617610|NCT00565721|Dynamic PET imaging|dynamic pet imaging
617611|NCT00565721|Angiogenesis|angiogenesis
617612|NCT00565721|αvβ3 integrins|αvβ3 integrins
617613|NCT00565721|oncology imaging|oncology imaging
617614|NCT00565708|stage II colon cancer|stage ii colon cancer
617615|NCT00565708|stage III colon cancer|stage iii colon cancer
617616|NCT00565708|stage II rectal cancer|stage ii rectal cancer
617617|NCT00565708|stage III rectal cancer|stage iii rectal cancer
617618|NCT00565695|Visual Outcomes|visual outcomes
617619|NCT00565695|Patient Satisfaction|patient satisfaction
617620|NCT00565695|Cataract Extraction|cataract extraction
617621|NCT00565669|Treatment|treatment
617622|NCT00565669|Dry Eye|dry eye
617623|NCT00565656|Myelodysplastic syndromes (int-1, int-2 and high risk according to IPSS) with excess of marrow blasts including CMML with leucocytes<10 000/mm3|myelodysplastic syndromes (int-1, int-2 and high risk according to ipss) with excess of marrow blasts including cmml with leucocytes<10 000/mm3
617624|NCT00565643|Adhesion|adhesion
617625|NCT00565643|Seprafilm|seprafilm
617626|NCT00565643|Cesarean section|cesarean section
617627|NCT00565617|depression|depression
617628|NCT00565617|epidural|epidural
617629|NCT00565617|cortical stimulation|cortical stimulation
617630|NCT00565617|brain stimulation|brain stimulation
617631|NCT00565617|treatment-resistant|treatment-resistant
617633|NCT00565617|TMS|tms
617636|NCT00565604|Perforator Veins|perforator veins
617637|NCT00565604|Incompetent Veins|incompetent veins
617638|NCT00565604|Varicose Veins|varicose veins
617639|NCT00565591|asthma|asthma
617640|NCT00565591|inhaler device|inhaler device
617641|NCT00565591|albuterol sulfate|albuterol sulfate
617642|NCT00565565|Biventriular chronic heart failure, Pulmonary hypertension|biventriular chronic heart failure, pulmonary hypertension
617643|NCT00565552|silicone gel|silicone gel
617644|NCT00565552|cicatrix|cicatrix
617645|NCT00565552|wound healing|wound healing
617646|NCT00565552|scar|scar
617647|NCT00565552|keloid|keloid
617648|NCT00565539|PEGylated recombinant interleukin 29|pegylated recombinant interleukin 29
617649|NCT00565539|interferon lambda|interferon lambda
617650|NCT00565539|interleukin 29|interleukin 29
617651|NCT00565539|hepatitis C|hepatitis c
617652|NCT00565539|virus|virus
617653|NCT00565539|infection|infection
617654|NCT00565539|liver|liver
617655|NCT00565526|Autonomic Nervous System|autonomic nervous system
617656|NCT00565526|Sjogren's Syndrome|sjogren's syndrome
617657|NCT00565526|Pathogenesis|pathogenesis
617658|NCT00565526|Cholinergic|cholinergic
617659|NCT00565526|Parasympathetic|parasympathetic
617660|NCT00565526|Sjogren Syndrome|sjogren syndrome
617661|NCT00565487|Radiotherapy|radiotherapy
617662|NCT00565487|Non-operable pancreatic cancer|non-operable pancreatic cancer
617663|NCT00565487|locally advanced pancreatic cancer|locally advanced pancreatic cancer
617664|NCT00565474|Renal transplantation|renal transplantation
617665|NCT00565474|fluvastatin|fluvastatin
617666|NCT00565448|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
617667|NCT00565435|Chiari I Malformation|chiari i malformation
617668|NCT00565422|Internet addiction|internet addiction
617669|NCT00565422|Problematic internet use|problematic internet use
617670|NCT00565422|Escitalopram|escitalopram
617671|NCT00565422|Lexapro|lexapro
617672|NCT00565409|Active Rheumatoid Arthritis|active rheumatoid arthritis
617673|NCT00565383|Pregnancy|pregnancy
617674|NCT00565383|37 Weeks Gestation|37 weeks gestation
617675|NCT00565383|Breech Presentation|breech presentation
617676|NCT00565383|Version Procedure|version procedure
617677|NCT00565383|Pain Control|pain control
617678|NCT00565383|Neuraxial analgesia|neuraxial analgesia
617679|NCT00565370|Gastric cancer|gastric cancer
617680|NCT00565370|capecitabine|capecitabine
617681|NCT00565370|cisplatin|cisplatin
617682|NCT00565370|sorafenib|sorafenib
617683|NCT00565370|phase I|phase i
617684|NCT00565370|phase II|phase ii
617685|NCT00565357|Postnatal Growth|postnatal growth
617686|NCT00565357|Postnatal Development|postnatal development
617687|NCT00565357|Noise|noise
617688|NCT00565357|Neonatal Intensive Care Unit|neonatal intensive care unit
617689|NCT00565344|Medicaid|medicaid
617690|NCT00565344|Disenrollment|disenrollment
617691|NCT00565318|Benfotiamine|benfotiamine
617692|NCT00565318|Diabetes|diabetes
617693|NCT00565318|Nephropathy|nephropathy
617694|NCT00565305|Healing Touch|healing touch
617695|NCT00565305|NK cytotoxicity|nk cytotoxicity
617696|NCT00565305|cytokines|cytokines
617697|NCT00565305|fatigue|fatigue
617698|NCT00565279|Seborrhoeic dermatitis|seborrhoeic dermatitis
617699|NCT00565253|pulmonary embolism|pulmonary embolism
617700|NCT00565253|inhaled nitric oxide|inhaled nitric oxide
617701|NCT00565240|ovarian synchronization|ovarian synchronization
617702|NCT00565240|folliculogenesis|folliculogenesis
617703|NCT00565214|vitamin supplements|vitamin supplements
617704|NCT00565214|healthy smokers|healthy smokers
617705|NCT00565214|epithelial lung tissue|epithelial lung tissue
617706|NCT00565214|bronchoscopy|bronchoscopy
617707|NCT00565214|antioxidant levels|antioxidant levels
617708|NCT00565201|Stroke, Cerebrovascular accident, Spasticity, Arm, Hand|stroke, cerebrovascular accident, spasticity, arm, hand
617709|NCT00565175|Treatment resistant|treatment resistant
617710|NCT00565175|Chronic|chronic
617711|NCT00565136|Device study|device study
617712|NCT00565136|Pelvic floor weakness|pelvic floor weakness
617713|NCT00565136|Fecal incontinence|fecal incontinence
617714|NCT00565123|bacterial conjunctivitis levofloxacin fluoroquinolone|bacterial conjunctivitis levofloxacin fluoroquinolone
617715|NCT00565097|Polycystic Liver Disease|polycystic liver disease
617716|NCT00565097|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
617717|NCT00565097|Liver cyst|liver cyst
617718|NCT00565097|Lanreotide|lanreotide
617719|NCT00565071|Cost-effectiveness|cost-effectiveness
617720|NCT00565071|Diagnosis|diagnosis
617721|NCT00565071|Treatment|treatment
617722|NCT00565071|Malaria|malaria
617723|NCT00565045|hand|hand
617724|NCT00565045|stroke|stroke
617725|NCT00565045|hemiplegia|hemiplegia
617726|NCT00565045|electrical stimulation|electrical stimulation
617727|NCT00565045|recovery|recovery
617728|NCT00565032|postpartum depression|postpartum depression
617729|NCT00565032|thyroxine|thyroxine
617730|NCT00565032|thyroid antibodies|thyroid antibodies
617731|NCT00565032|thyroid stimulating hormone|thyroid stimulating hormone
617732|NCT00565032|Edinburgh Postnatal Depression Scale (EPDS)|edinburgh postnatal depression scale (epds)
617733|NCT00564980|Randomized|randomized
617734|NCT00564980|Prospective|prospective
617735|NCT00564980|Procedure / Surgery|procedure / surgery
617736|NCT00564954|ADHD|adhd
617737|NCT00564954|children|children
617738|NCT00564954|laboratory classroom|laboratory classroom
617739|NCT00564954|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
617740|NCT00564941|Myelodysplastic Syndromes|myelodysplastic syndromes
617741|NCT00564941|beta-Thalassemia|beta-thalassemia
617742|NCT00564941|Iron Overload|iron overload
617743|NCT00564941|Iron Chelating Agents|iron chelating agents
617744|NCT00564941|deferasirox|deferasirox
617745|NCT00564928|Hormone resistant prostate cancer|hormone resistant prostate cancer
617746|NCT00564928|castrate resistant prostate cancer|castrate resistant prostate cancer
617747|NCT00564928|HRPC|hrpc
617748|NCT00564928|CRPC|crpc
617749|NCT00564915|Epilepsy|epilepsy
617750|NCT00564902|Macular Pigment Optical Density|macular pigment optical density
617751|NCT00564902|Skin Carotenoids|skin carotenoids
617752|NCT00564902|Lipofuscin|lipofuscin
617753|NCT00564902|Photostress (Glare Recovery)|photostress (glare recovery)
617754|NCT00564902|Visual Field Progression|visual field progression
617755|NCT00564902|Contrast Sensitivity|contrast sensitivity
617756|NCT00564902|Color Vision|color vision
617757|NCT00564902|Cognitive Function|cognitive function
617758|NCT00564889|primary systemic amyloidosis|primary systemic amyloidosis
617759|NCT00564876|Non Small Cell Lung Cancer (NSCLC)|non small cell lung cancer (nsclc)
617760|NCT00564876|carcinoma|carcinoma
617761|NCT00564876|dasatinib|dasatinib
617762|NCT00564876|neoadjuvant|neoadjuvant
617763|NCT00564876|adjuvant|adjuvant
617764|NCT00564876|resection|resection
617765|NCT00564876|genomic signature|genomic signature
617766|NCT00564876|predictor|predictor
617767|NCT00564876|microarray|microarray
617768|NCT00564863|Diarrhea|diarrhea
617769|NCT00564863|ETEC|etec
617770|NCT00564837|Anterior cruciate ligament|anterior cruciate ligament
617771|NCT00564837|Reconstruction|reconstruction
617772|NCT00564837|Rehabilitation|rehabilitation
617773|NCT00564837|Home-based|home-based
617774|NCT00564824|coronary disease|coronary disease
617775|NCT00564824|atherosclerosis|atherosclerosis
617776|NCT00564824|endothelial function|endothelial function
617777|NCT00564824|caffeine|caffeine
617778|NCT00564824|cerebrovascular disease|cerebrovascular disease
617779|NCT00564824|prevention|prevention
617780|NCT00564811|Agaricus blazei (Murrill) ss. Heinemann,|agaricus blazei (murrill) ss. heinemann,
617781|NCT00564811|Hepatitis C|hepatitis c
617782|NCT00564811|Nutritional status|nutritional status
617783|NCT00564811|Liver Function Tests|liver function tests
617784|NCT00564811|Antiviral Agents|antiviral agents
617785|NCT00564798|protocoladolescents|protocoladolescents
617786|NCT00564798|children|children
617787|NCT00564798|health behaviours/attitudes|health behaviours/attitudes
617788|NCT00564798|weight loss/management|weight loss/management
617789|NCT00564798|program evaluation|program evaluation
617790|NCT00564772|raltegravir|raltegravir
617791|NCT00564772|lopinavir|lopinavir
617792|NCT00564772|ritonavir|ritonavir
617793|NCT00564772|pharmacokinetics|pharmacokinetics
617794|NCT00564759|CGD|cgd
617795|NCT00564746|SB-681323,|sb-681323,
617796|NCT00564746|ADME,|adme,
617797|NCT00564746|radiolabel|radiolabel
617798|NCT00564694|adenocarcinoma of the colon|adenocarcinoma of the colon
617799|NCT00564694|recurrent colon cancer|recurrent colon cancer
617800|NCT00564694|stage I colon cancer|stage i colon cancer
617801|NCT00564694|stage II colon cancer|stage ii colon cancer
617802|NCT00564694|stage III colon cancer|stage iii colon cancer
617803|NCT00564694|stage IV colon cancer|stage iv colon cancer
617804|NCT00564694|adenocarcinoma of the rectum|adenocarcinoma of the rectum
617805|NCT00564694|recurrent rectal cancer|recurrent rectal cancer
617806|NCT00564694|stage I rectal cancer|stage i rectal cancer
617807|NCT00564694|stage II rectal cancer|stage ii rectal cancer
617808|NCT00564694|stage III rectal cancer|stage iii rectal cancer
617809|NCT00564694|stage IV rectal cancer|stage iv rectal cancer
617810|NCT00564655|pediatrics|pediatrics
617811|NCT00564655|Gastric Tube Insertion|gastric tube insertion
617812|NCT00564655|Anesthesia|anesthesia
617813|NCT00564655|Regional Anesthetic|regional anesthetic
617814|NCT00564655|Transversus Abdominal Plane|transversus abdominal plane
617815|NCT00564616|cardiac arrest|cardiac arrest
617816|NCT00564616|video cell phone|video cell phone
617817|NCT00564616|dispatcher-assisted CPR|dispatcher-assisted cpr
617818|NCT00564603|Glucocorticoid|glucocorticoid
617819|NCT00564603|Opioids|opioids
617820|NCT00564603|Balanced analgesia|balanced analgesia
617821|NCT00564577|Diarrhea ETEC|diarrhea etec
617822|NCT00564564|obsessive compulsive disorder|obsessive compulsive disorder
617823|NCT00564564|pharmacological treatment|pharmacological treatment
617824|NCT00564564|quetiapine|quetiapine
617825|NCT00564564|clomipramine|clomipramine
617826|NCT00564564|SSRI|ssri
617827|NCT00564551|Prediabetes|prediabetes
617828|NCT00564551|Type 2 diabetes|type 2 diabetes
617829|NCT00564551|Metabolic syndrome|metabolic syndrome
617830|NCT00564551|Insulin resistance syndrome|insulin resistance syndrome
617831|NCT00564551|Weight loss|weight loss
617832|NCT00564551|Milk products|milk products
617833|NCT00564551|Calcium|calcium
617834|NCT00564538|liver transplant|liver transplant
617835|NCT00564525|children|children
617836|NCT00564525|abdominal pain|abdominal pain
617837|NCT00564525|amitriptyline|amitriptyline
617838|NCT00564512|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
617839|NCT00564512|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
617840|NCT00564512|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
617841|NCT00564512|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
617842|NCT00564512|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
617843|NCT00564499|COPD|copd
617844|NCT00564499|Symbicort|symbicort
617845|NCT00564499|General Practitioners|general practitioners
617846|NCT00564486|Abdominal Laparoscopic Surgery|abdominal laparoscopic surgery
617847|NCT00564473|internal medicine|internal medicine
617848|NCT00564473|herbal medicine|herbal medicine
617849|NCT00564473|prevalence|prevalence
617850|NCT00564473|attitudes|attitudes
617851|NCT00564473|herb-drug interaction|herb-drug interaction
617852|NCT00564434|delirium|delirium
617853|NCT00564434|pathophysiology|pathophysiology
617854|NCT00564434|risk factors|risk factors
617855|NCT00564434|pain|pain
617856|NCT00564434|dementia|dementia
617857|NCT00564382|Acute coronary syndrome|acute coronary syndrome
617858|NCT00564382|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
617859|NCT00564382|Contrast agents|contrast agents
617860|NCT00564382|Gadolinium|gadolinium
617861|NCT00564369|HIV testing|hiv testing
617862|NCT00564369|HIV Seronegativity|hiv seronegativity
617863|NCT00564356|cataract, phacoemulsification, coumadin, antiaggregants|cataract, phacoemulsification, coumadin, antiaggregants
617864|NCT00564343|Balance|balance
617865|NCT00564343|Water based training|water based training
617866|NCT00564343|Physical functioning|physical functioning
617867|NCT00564343|stepping behavior|stepping behavior
617868|NCT00564330|dental erosion|dental erosion
617869|NCT00564330|OCT|oct
617870|NCT00564330|proton pump inhibitor|proton pump inhibitor
617871|NCT00564317|PTSD|ptsd
617872|NCT00564317|Depression|depression
617873|NCT00564317|Suicidality|suicidality
617874|NCT00564317|trauma-focussed treatment|trauma-focussed treatment
617875|NCT00564317|KIDNET|kidnet
617876|NCT00564317|Narrative Exposure Therapy for Children|narrative exposure therapy for children
617877|NCT00564317|Meditation|meditation
617878|NCT00564317|Relaxation|relaxation
617879|NCT00564317|War|war
617880|NCT00564304|Nasal Potential Difference|nasal potential difference
617881|NCT00564291|OCT|oct
617882|NCT00564278|Hispanic Americans|hispanic americans
617883|NCT00564278|Major Depressive Disorder|major depressive disorder
617884|NCT00564278|Antidepressant Therapy|antidepressant therapy
617885|NCT00564278|Motivational Interviewing|motivational interviewing
617886|NCT00564278|Treatment Retention|treatment retention
617887|NCT00564278|Treatment Adherence|treatment adherence
617888|NCT00564265|GIST|gist
617889|NCT00564226|urge urinary incontinence|urge urinary incontinence
617890|NCT00564213|Myopia|myopia
617891|NCT00564213|Mitomycin|mitomycin
617892|NCT00564200|Multiple Myeloma, transplant|multiple myeloma, transplant
617893|NCT00564174|recurrent pregnancy loss|recurrent pregnancy loss
617894|NCT00564174|lupus anticoagulant|lupus anticoagulant
617895|NCT00564174|anti cardiolipin antibodies|anti cardiolipin antibodies
617896|NCT00564174|thrombophilia|thrombophilia
617897|NCT00564174|low molecular weight heparin|low molecular weight heparin
617898|NCT00564174|aspirin|aspirin
617899|NCT00564174|randomized clinical trial|randomized clinical trial
617900|NCT00564148|antiVEGF therapy|antivegf therapy
617901|NCT00564135|hysterectomy|hysterectomy
617902|NCT00564135|laparoscopy|laparoscopy
617903|NCT00564135|urinary retention|urinary retention
617904|NCT00564135|urinary tract infection|urinary tract infection
617905|NCT00564135|catheterization|catheterization
617906|NCT00564122|Murmur|murmur
617907|NCT00564122|Artificial-Intelligence|artificial-intelligence
617908|NCT00564122|Stethoscope|stethoscope
617909|NCT00564122|Congenital Heart Disease|congenital heart disease
617910|NCT00564122|Structural Heart Disease|structural heart disease
617911|NCT00564083|Compare the relative differences between the organic and sythentic materials for sacryl colpopexy.|compare the relative differences between the organic and sythentic materials for sacryl colpopexy.
617912|NCT00564070|Depression|depression
617913|NCT00564070|Diabetes|diabetes
617914|NCT00564070|Adherence|adherence
617915|NCT00564057|HIV|hiv
617916|NCT00564057|blood pressure|blood pressure
617917|NCT00564057|left ventricle|left ventricle
617918|NCT00564057|metabolic profile|metabolic profile
617919|NCT00564057|treatment experienced|treatment experienced
617920|NCT00564044|biofilm-infection-related immune hyperreactivity|biofilm-infection-related immune hyperreactivity
617921|NCT00564044|mesh extrusion|mesh extrusion
617922|NCT00564044|mid-urethral sling|mid-urethral sling
617923|NCT00564044|determine the immune reactivity of biofilms in mesh erosion|determine the immune reactivity of biofilms in mesh erosion
617924|NCT00564031|hormone replacement therapy; endothelial function;|hormone replacement therapy; endothelial function;
617925|NCT00564018|type 1 diabetes, basal-bolus, honeymoon, C-peptide|type 1 diabetes, basal-bolus, honeymoon, c-peptide
617926|NCT00564005|stroke rehabilitation|stroke rehabilitation
617927|NCT00564005|cortical reorganization|cortical reorganization
617928|NCT00564005|kinematic analysis|kinematic analysis
617929|NCT00563979|age related macular degeneration|age related macular degeneration
617930|NCT00563979|supplementation|supplementation
617931|NCT00563979|macular pigment|macular pigment
617932|NCT00563966|smoking pregnancy behaviour polymorphisms|smoking pregnancy behaviour polymorphisms
617933|NCT00563953|Breast|breast
617934|NCT00563953|Cancer|cancer
617935|NCT00563953|Anthracyclines|anthracyclines
617936|NCT00563953|Cardiopathy|cardiopathy
617937|NCT00563940|diabetic macular edema|diabetic macular edema
617938|NCT00563940|OCT|oct
617939|NCT00563927|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
617940|NCT00563927|T1-4N2-3M0|t1-4n2-3m0
617941|NCT00563914|Malaria|malaria
617942|NCT00563901|CHD|chd
617943|NCT00563901|Combined CHD|combined chd
617944|NCT00563901|Stroke|stroke
617945|NCT00563901|Combined Cardiovascular Disease (CVD)|combined cardiovascular disease (cvd)
617946|NCT00563901|Pharmacogenetics|pharmacogenetics
617947|NCT00563901|End-Stage Renal Disease|end-stage renal disease
617948|NCT00563901|Heart Failure|heart failure
617949|NCT00563901|Hospitalized/Fatal Heart Failure|hospitalized/fatal heart failure
617950|NCT00563901|Angina|angina
617951|NCT00563901|Coronary Revascularizations|coronary revascularizations
617952|NCT00563901|CHD Mortality|chd mortality
617953|NCT00563901|Lisinopril|lisinopril
617954|NCT00563901|Chlorthalidone|chlorthalidone
617955|NCT00563901|Amlodipine|amlodipine
617956|NCT00563901|Doxazosin|doxazosin
617957|NCT00563888|PTSD|ptsd
617958|NCT00563888|torture survivors|torture survivors
617959|NCT00563888|Narrative Exposure Therapy|narrative exposure therapy
617960|NCT00563888|trauma-related memory processes|trauma-related memory processes
617961|NCT00563888|steady state visual evoked fields|steady state visual evoked fields
617962|NCT00563875|Platelets|platelets
617963|NCT00563875|Platelet aggregation|platelet aggregation
617964|NCT00563875|Drug resistance|drug resistance
617965|NCT00563875|Aspirin|aspirin
617966|NCT00563875|Diabetes mellitus|diabetes mellitus
617967|NCT00563862|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
617968|NCT00563862|T3-4N0-1M0|t3-4n0-1m0
617969|NCT00563836|ovarian cancer|ovarian cancer
617970|NCT00563836|catumaxomab|catumaxomab
617971|NCT00563836|phase II|phase ii
617972|NCT00563836|intraoperative|intraoperative
617973|NCT00563836|adjuvant|adjuvant
617974|NCT00563836|trifunctional antibody|trifunctional antibody
617975|NCT00563823|stage IV melanoma|stage iv melanoma
617976|NCT00563823|recurrent melanoma|recurrent melanoma
617977|NCT00563810|Adult|adult
617978|NCT00563810|Aged|aged
617979|NCT00563797|treatment|treatment
617980|NCT00563797|alcohol dependence|alcohol dependence
617981|NCT00563797|depression|depression
617982|NCT00563797|mecamylamine|mecamylamine
617983|NCT00563784|Non-Small Cell Lung Cancer|non-small cell lung cancer
617984|NCT00563784|Lung Cancer|lung cancer
617985|NCT00563784|Squamous Cell Carcinoma|squamous cell carcinoma
617986|NCT00563784|Adenocarcinoma|adenocarcinoma
617987|NCT00563784|Bronchoalveolar Cell Carcinoma|bronchoalveolar cell carcinoma
617988|NCT00563784|Large Cell Anaplastic Carcinoma|large cell anaplastic carcinoma
617989|NCT00563784|Giant Cell Carcinoma|giant cell carcinoma
617990|NCT00563784|Clear Cell Carcinoma|clear cell carcinoma
617991|NCT00563784|Erlotinib|erlotinib
617992|NCT00563784|Erlotinib Hydrocholoride|erlotinib hydrocholoride
617993|NCT00563784|OSI-774|osi-774
617994|NCT00563784|Tarceva|tarceva
617995|NCT00563784|Carboplatin|carboplatin
617996|NCT00563784|Paraplatin|paraplatin
617997|NCT00563784|Paclitaxel|paclitaxel
617998|NCT00563784|Taxol|taxol
617999|NCT00563784|NSCLC|nsclc
618000|NCT00563758|Chronic constipation|chronic constipation
618001|NCT00563745|COPD|copd
618002|NCT00563745|ALS|als
618003|NCT00563745|Telemedicine|telemedicine
618004|NCT00563745|mechanical ventilation|mechanical ventilation
618005|NCT00563745|Integrated care|integrated care
618006|NCT00563745|strict follow up|strict follow up
618007|NCT00563745|impact and costs on health care resources|impact and costs on health care resources
618008|NCT00563745|telemedicine programme|telemedicine programme
618009|NCT00563745|home mechanical ventilation (HMV)|home mechanical ventilation (hmv)
618010|NCT00563745|frail patients|frail patients
618011|NCT00563745|chronic respiratory failure (CRF)|chronic respiratory failure (crf)
618012|NCT00563693|heart failure|heart failure
618013|NCT00563693|cheyne stokes respiration|cheyne stokes respiration
618014|NCT00563693|adaptive servo ventilator|adaptive servo ventilator
618015|NCT00563680|AMG 479|amg 479
618016|NCT00563680|IGF-1R|igf-1r
618017|NCT00563680|Insulin-like growth factor|insulin-like growth factor
618018|NCT00563680|Insulin-like growth factor receptor|insulin-like growth factor receptor
618019|NCT00563680|Ewing's|ewing's
618020|NCT00563680|Sarcoma|sarcoma
618021|NCT00563667|Pterygium|pterygium
618022|NCT00563667|Cataract|cataract
618023|NCT00563667|Astigmatism|astigmatism
618024|NCT00563654|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
618025|NCT00563654|Acute Retention of Urine (AUR)|acute retention of urine (aur)
618026|NCT00563641|NCPAP|ncpap
618948|NCT00559663|HDL|hdl
618027|NCT00563641|Very early surfactant|very early surfactant
618028|NCT00563628|Pattern Scan Laser.|pattern scan laser.
618029|NCT00563628|Photocoagulation.|photocoagulation.
618030|NCT00563628|Diabetic retinopathy treatment.|diabetic retinopathy treatment.
618031|NCT00563628|Laser treatment|laser treatment
618032|NCT00563615|Constipation (idiopathic)|constipation (idiopathic)
618033|NCT00563602|Portal hypertension|portal hypertension
618034|NCT00563602|Prevention of rebleeding|prevention of rebleeding
618035|NCT00563602|Complications of cirrhosis|complications of cirrhosis
618036|NCT00563602|Portal hemodynamic|portal hemodynamic
618037|NCT00563602|Prazosine|prazosine
618038|NCT00563602|Nadolol|nadolol
618039|NCT00563602|isosorbide mononitrate|isosorbide mononitrate
618040|NCT00563589|Acute graft-versus-host disease post high risk allogeneic stem cell transplantation|acute graft-versus-host disease post high risk allogeneic stem cell transplantation
618041|NCT00563576|Depo-Provera|depo-provera
618042|NCT00563576|Medroxyprogesterone Acetate|medroxyprogesterone acetate
618043|NCT00563576|Metrorrhagia|metrorrhagia
618044|NCT00563576|Irregular Bleeding|irregular bleeding
618045|NCT00563563|Nicotine-dependence in overweight and obese subjects|nicotine-dependence in overweight and obese subjects
618046|NCT00563537|neurology|neurology
618047|NCT00563537|sclerosis|sclerosis
618048|NCT00563537|imaging|imaging
618049|NCT00563537|tomography|tomography
618050|NCT00563511|smoking cessation|smoking cessation
618051|NCT00563498|Veno-occlusive disease|veno-occlusive disease
618052|NCT00563498|Mucositis|mucositis
618053|NCT00563485|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
618054|NCT00563485|Acute Retention of Urine (AUR)|acute retention of urine (aur)
618055|NCT00563472|Healthy female volunteers will participate in this study|healthy female volunteers will participate in this study
618056|NCT00563459|Epilepsy, seizures|epilepsy, seizures
618057|NCT00563459|partial onset seizures|partial onset seizures
618058|NCT00563459|anti-epileptic drugs (AED)|anti-epileptic drugs (aed)
618059|NCT00563459|carisbamate|carisbamate
618060|NCT00563459|topiramate|topiramate
618061|NCT00563459|levetiracetam|levetiracetam
618062|NCT00563446|Anemia|anemia
618063|NCT00563446|End-stage renal failure|end-stage renal failure
618064|NCT00563446|Continuous ambulatory peritoneal dialysis|continuous ambulatory peritoneal dialysis
618065|NCT00563433|diabetic|diabetic
618066|NCT00563433|diabetes mellitus|diabetes mellitus
618067|NCT00563433|foot|foot
618068|NCT00563433|ulcers|ulcers
618069|NCT00563433|Floxin|floxin
618070|NCT00563433|oral antibiotic|oral antibiotic
618071|NCT00563433|topical cream|topical cream
618072|NCT00563420|Lung cancer|lung cancer
618073|NCT00563407|skin toxicity prediction|skin toxicity prediction
618074|NCT00563407|cardiac toxicity prediction|cardiac toxicity prediction
618075|NCT00563394|diabetic|diabetic
618076|NCT00563394|diabetes mellitus|diabetes mellitus
618077|NCT00563394|foot|foot
618078|NCT00563394|ulcers|ulcers
618079|NCT00563394|Floxin|floxin
618080|NCT00563394|oral antibiotic|oral antibiotic
618081|NCT00563394|topical cream|topical cream
618082|NCT00563355|chronic kidney disease|chronic kidney disease
618083|NCT00563355|cardiovascular disease|cardiovascular disease
618084|NCT00563342|Ethanol, lock solution, infection|ethanol, lock solution, infection
618085|NCT00563329|Smokers who are not willing to quit in the near future but intend to reduce smoking|smokers who are not willing to quit in the near future but intend to reduce smoking
618086|NCT00563316|colorectal cancer|colorectal cancer
618087|NCT00563316|chemotherapy|chemotherapy
618088|NCT00563316|cancer|cancer
618089|NCT00563316|metastatic|metastatic
618090|NCT00563316|irinotecan|irinotecan
618091|NCT00563316|EGFr|egfr
618092|NCT00563316|epidermal growth factor|epidermal growth factor
618093|NCT00563277|Pterygium|pterygium
618094|NCT00563277|Cataract|cataract
618095|NCT00563277|Intraocular lens power calculation accuracy|intraocular lens power calculation accuracy
618096|NCT00563264|obesity|obesity
618097|NCT00563264|parenting|parenting
618098|NCT00563264|postpartum period|postpartum period
618099|NCT00563264|family research|family research
618100|NCT00563251|Bronchiolitis obliterans in bone marrow transplant recipients|bronchiolitis obliterans in bone marrow transplant recipients
618101|NCT00563238|Extubation|extubation
618102|NCT00563212|Lung Diseases, Interstitial|lung diseases, interstitial
618103|NCT00563212|Fibrosis|fibrosis
618104|NCT00563212|Interferons|interferons
618105|NCT00563212|Pulmonary Fibrosis|pulmonary fibrosis
618106|NCT00563212|Pathologic Processes|pathologic processes
618107|NCT00563212|Lung Diseases|lung diseases
618108|NCT00563212|Fibrosing alveolitis|fibrosing alveolitis
618109|NCT00563212|Interferon-gamma, Recombinant|interferon-gamma, recombinant
618110|NCT00563212|Aerosols|aerosols
618111|NCT00563199|smoking cessation|smoking cessation
618112|NCT00563199|smoking behaviors|smoking behaviors
618113|NCT00563186|infection control|infection control
618114|NCT00563186|nosocomial infection|nosocomial infection
618115|NCT00563186|hospital design|hospital design
618116|NCT00563186|physical plant design|physical plant design
618117|NCT00563186|antibiotic resistant organisms|antibiotic resistant organisms
618118|NCT00563160|lung cancer|lung cancer
618119|NCT00563147|tivozanib|tivozanib
618120|NCT00563147|AV-951|av-951
618121|NCT00563134|Suspected or confirmed severe Gram-negative sepsis|suspected or confirmed severe gram-negative sepsis
618122|NCT00563121|Retinopathy of Prematurity|retinopathy of prematurity
618123|NCT00563121|ROP|rop
618124|NCT00563121|Vascular Endothelial Growth Factor|vascular endothelial growth factor
618125|NCT00563121|VEGF|vegf
618126|NCT00563121|Vitreous|vitreous
618127|NCT00563121|Subretinal Fluid|subretinal fluid
618128|NCT00563121|ELISA|elisa
618129|NCT00563121|VEGF levels in Aqueous, Vitreous and subretinal Fluid|vegf levels in aqueous, vitreous and subretinal fluid
618130|NCT00563108|Acute graft-versus-host disease post allogeneic stem cell transplantation|acute graft-versus-host disease post allogeneic stem cell transplantation
618131|NCT00563095|Hepatocellular carcinoma|hepatocellular carcinoma
618132|NCT00563082|SLE|sle
618133|NCT00563082|Genetics|genetics
618134|NCT00563069|diagnostic and therapeutic rigid cystoscopy|diagnostic and therapeutic rigid cystoscopy
618135|NCT00563056|Formoterol|formoterol
618136|NCT00563056|Fluticasone|fluticasone
618137|NCT00563056|Asthma|asthma
618138|NCT00563043|Pattern Scan Laser.|pattern scan laser.
618139|NCT00563043|Photocoagulation.|photocoagulation.
618140|NCT00563043|Diabetic retinopathy treatment.|diabetic retinopathy treatment.
618141|NCT00563043|Laser treatment.|laser treatment.
618142|NCT00563043|Electroretinogram.|electroretinogram.
618143|NCT00563043|a wave.|a wave.
618144|NCT00563043|b wave.|b wave.
618145|NCT00563043|Implicit time.|implicit time.
618146|NCT00563030|Cardiopulmonary bypass|cardiopulmonary bypass
618147|NCT00563030|Neutrophils|neutrophils
618148|NCT00563030|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
618149|NCT00563017|Catatonic Schizophrenia|catatonic schizophrenia
618150|NCT00563017|Disorganized Schizophrenia|disorganized schizophrenia
618151|NCT00563017|Paranoid Schizophrenia|paranoid schizophrenia
618152|NCT00563017|Undifferentiated Schizophrenia|undifferentiated schizophrenia
618153|NCT00563017|Schizo-affective disorders|schizo-affective disorders
618154|NCT00563004|Diabetes mellitus|diabetes mellitus
618155|NCT00563004|Herbal treatment|herbal treatment
618156|NCT00563004|Food supplement|food supplement
618157|NCT00562991|exhaled NO|exhaled no
618158|NCT00562991|asthma|asthma
618159|NCT00562991|child|child
618160|NCT00562978|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
618161|NCT00562978|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
618162|NCT00562978|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
618163|NCT00562978|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
618164|NCT00562978|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
618165|NCT00562978|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
618166|NCT00562978|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
618167|NCT00562978|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
618168|NCT00562978|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
618169|NCT00562978|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
618170|NCT00562978|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
618171|NCT00562978|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
618172|NCT00562978|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
618173|NCT00562978|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
618174|NCT00562978|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
618175|NCT00562978|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
618176|NCT00562978|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
618177|NCT00562978|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
618178|NCT00562978|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
618179|NCT00562978|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
618180|NCT00562978|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
618181|NCT00562978|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
618182|NCT00562978|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
618183|NCT00562978|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
618184|NCT00562952|Natriuretic peptide|natriuretic peptide
618185|NCT00562952|Prognosis|prognosis
618186|NCT00562952|Diabetes|diabetes
618187|NCT00562952|Heart failure|heart failure
618188|NCT00562952|Heart disease|heart disease
618189|NCT00562939|Antibody Formation|antibody formation
618190|NCT00562939|Antibody Affinity|antibody affinity
618191|NCT00562939|Immunity|immunity
618192|NCT00562939|Pneumococcal Vaccines|pneumococcal vaccines
618193|NCT00562939|Oligodeoxyribonucleotides|oligodeoxyribonucleotides
618194|NCT00562926|Schizophrenia|schizophrenia
618195|NCT00562926|Schizophrenia spectrum disorder|schizophrenia spectrum disorder
618196|NCT00562913|Cancer|cancer
618197|NCT00562913|Sorafenib|sorafenib
618198|NCT00562913|Cyclophosphamide|cyclophosphamide
618199|NCT00562913|Doxorubicin|doxorubicin
618200|NCT00562887|Crohn's Disease|crohn's disease
618201|NCT00562874|HIV|hiv
618202|NCT00562874|AIDS|aids
618203|NCT00562874|WOMEN|women
618204|NCT00562874|KENYA|kenya
618207|NCT00562874|treatment naive|treatment naive
618208|NCT00562861|Bipolar Disorder|bipolar disorder
618209|NCT00562861|Bipolar Depression|bipolar depression
618210|NCT00562861|Clinical Trials, Phase II|clinical trials, phase ii
618211|NCT00562861|Clinical Pharmacology|clinical pharmacology
618212|NCT00562848|gastric emptying|gastric emptying
618213|NCT00562848|pharmacokinetic|pharmacokinetic
618214|NCT00562848|tolerability|tolerability
618215|NCT00562848|safety|safety
618216|NCT00562848|GSK962040|gsk962040
618217|NCT00562848|gut motility|gut motility
618218|NCT00562848|First Time in Human|first time in human
618219|NCT00562835|ARDS|ards
618220|NCT00562835|Adult|adult
618221|NCT00562835|Methylprednisolone|methylprednisolone
618222|NCT00562796|Growth Hormone Deficiency|growth hormone deficiency
618223|NCT00562796|Cardiovascular Disease|cardiovascular disease
618224|NCT00562796|Intra-abdominal Fat|intra-abdominal fat
618225|NCT00562796|Insulin Resistance|insulin resistance
618226|NCT00562783|HBV|hbv
618227|NCT00562783|HCV|hcv
618228|NCT00562783|Liver cirrhosis|liver cirrhosis
618229|NCT00562770|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
618230|NCT00562770|CLL|cll
618231|NCT00562770|Leukemia|leukemia
618232|NCT00562757|Wedensky modulation|wedensky modulation
618233|NCT00562757|Risk stratification|risk stratification
618234|NCT00562757|Electrophysiology|electrophysiology
618235|NCT00562757|Noninvasive|noninvasive
618236|NCT00562757|Ischemic heart disease|ischemic heart disease
618237|NCT00562757|ICD guidelines|icd guidelines
618238|NCT00562757|Myocardial infarction|myocardial infarction
618239|NCT00562718|stage II breast cancer|stage ii breast cancer
618240|NCT00562718|stage IIIA breast cancer|stage iiia breast cancer
618241|NCT00562718|stage IIIB breast cancer|stage iiib breast cancer
618242|NCT00562718|male breast cancer|male breast cancer
618243|NCT00562718|recurrent breast cancer|recurrent breast cancer
618244|NCT00562705|growth hormone|growth hormone
618245|NCT00562705|eating regulation|eating regulation
618246|NCT00562705|nutritional intervention|nutritional intervention
618247|NCT00562705|short stature|short stature
618248|NCT00562705|ISS|iss
618249|NCT00562705|SGA|sga
618250|NCT00562705|IGHD|ighd
618251|NCT00562705|MPHD|mphd
618252|NCT00562692|Heart failure|heart failure
618253|NCT00562692|OAD|oad
618254|NCT00562692|BNP|bnp
618255|NCT00562692|Heart Failure patients who present to the emergency department|heart failure patients who present to the emergency department
618256|NCT00562679|Patients with coronary artery disease|patients with coronary artery disease
618257|NCT00562666|cell therapy|cell therapy
618258|NCT00562666|T lymphocytes|t lymphocytes
618259|NCT00562666|hepatic intra-arterial injection|hepatic intra-arterial injection
618260|NCT00562653|profile autoantibodies|profile autoantibodies
618261|NCT00562653|clinical symptoms|clinical symptoms
618262|NCT00562640|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
618263|NCT00562640|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
618264|NCT00562640|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
618265|NCT00562640|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
618266|NCT00562640|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
618267|NCT00562640|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
618268|NCT00562640|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
618269|NCT00562640|recurrent fallopian tube cancer|recurrent fallopian tube cancer
618270|NCT00562640|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
618271|NCT00562640|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
618272|NCT00562640|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
618273|NCT00562640|stage IV fallopian tube cancer|stage iv fallopian tube cancer
618274|NCT00562640|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
618275|NCT00562640|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
618276|NCT00562640|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
618277|NCT00562640|06-155|06-155
618278|NCT00562627|osteoarthritis|osteoarthritis
618279|NCT00562627|knee arthroplasty|knee arthroplasty
618280|NCT00562627|local infiltration analgesia|local infiltration analgesia
618281|NCT00562627|TKA|tka
618282|NCT00562627|epidural analgesia|epidural analgesia
618283|NCT00562627|operation|operation
618284|NCT00562627|surgery|surgery
618285|NCT00562601|Leukapheresis|leukapheresis
618286|NCT00562601|Plasmapheresis|plasmapheresis
618287|NCT00562601|Lymphocytes|lymphocytes
618288|NCT00562601|Neutrophils|neutrophils
618289|NCT00562536|Umbilical cord clamping|umbilical cord clamping
618290|NCT00562536|Preterm infants|preterm infants
618291|NCT00562536|Randomized controlled trial|randomized controlled trial
618292|NCT00562536|For women giving birth to singleton infants 32 weeks gestational age or less|for women giving birth to singleton infants 32 weeks gestational age or less
618293|NCT00562523|Cancer|cancer
618294|NCT00562523|Docetaxel|docetaxel
618295|NCT00562523|Sorafenib|sorafenib
618296|NCT00562510|HIV-1 infection|hiv-1 infection
618297|NCT00562510|raltegravir|raltegravir
618298|NCT00562510|immune discordance|immune discordance
618299|NCT00562510|treatment experienced|treatment experienced
618301|NCT00562497|Acute Graft Versus Host Disease|acute graft versus host disease
618302|NCT00562471|adhesions|adhesions
618303|NCT00562471|gynecologic surgery|gynecologic surgery
618304|NCT00562471|laparoscopy|laparoscopy
618305|NCT00562471|laparotomy|laparotomy
618306|NCT00562471|polyethylene glycol|polyethylene glycol
618307|NCT00562471|hydrogel|hydrogel
618308|NCT00562471|Adhesions following gynecologic surgery to remove myomas|adhesions following gynecologic surgery to remove myomas
618309|NCT00562458|Advanced breast cancer|advanced breast cancer
618310|NCT00562458|Advanced breast cancer in postmenopausal women|advanced breast cancer in postmenopausal women
618311|NCT00562445|Adrenal insufficiency|adrenal insufficiency
618312|NCT00562445|GI bleeding|gi bleeding
618313|NCT00562445|Portal hypertension|portal hypertension
618314|NCT00562445|Acute pancreatitis|acute pancreatitis
618315|NCT00562445|Critical emergencies in digestive diseases|critical emergencies in digestive diseases
618316|NCT00562445|Severe acute pancreatitis|severe acute pancreatitis
618317|NCT00562432|atrial fibrillation|atrial fibrillation
618318|NCT00562432|CABG|cabg
618319|NCT00562432|ganglionated plexi|ganglionated plexi
618320|NCT00562406|Macular edema secondary to branch retinal vein occlusion|macular edema secondary to branch retinal vein occlusion
618321|NCT00562380|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
618322|NCT00562380|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
618323|NCT00562380|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
618324|NCT00562380|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
618325|NCT00562380|anaplastic large cell lymphoma|anaplastic large cell lymphoma
618326|NCT00562380|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
618327|NCT00562380|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
618328|NCT00562380|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
618329|NCT00562380|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
618330|NCT00562380|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
618331|NCT00562380|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
618332|NCT00562380|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
618333|NCT00562380|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
618334|NCT00562380|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
618335|NCT00562380|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
618336|NCT00562380|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
618337|NCT00562380|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
618338|NCT00562380|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
618339|NCT00562380|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
618340|NCT00562380|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
618341|NCT00562380|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
618342|NCT00562380|small intestine lymphoma|small intestine lymphoma
618343|NCT00562380|splenic marginal zone lymphoma|splenic marginal zone lymphoma
618344|NCT00562380|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
618345|NCT00562380|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
618346|NCT00562380|adult desmoplastic small round cell tumor|adult desmoplastic small round cell tumor
618347|NCT00562380|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
618348|NCT00562380|recurrent prostate cancer|recurrent prostate cancer
618349|NCT00562354|Vaccines, Pneumococcal Conjugate Vaccine|vaccines, pneumococcal conjugate vaccine
618350|NCT00562341|obesity|obesity
618351|NCT00562341|psa|psa
618352|NCT00562341|prostate cancer|prostate cancer
618353|NCT00562328|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
618354|NCT00562328|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
618355|NCT00562328|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
618356|NCT00562302|lung biopsy|lung biopsy
618357|NCT00562289|Stroke|stroke
618358|NCT00562289|Patent Foramen Ovale|patent foramen ovale
618359|NCT00562289|Atrial septal aneurysm|atrial septal aneurysm
618360|NCT00562289|Antiplatelet therapy|antiplatelet therapy
618361|NCT00562289|Oral anticoagulants|oral anticoagulants
618362|NCT00562289|Transcatheter closure|transcatheter closure
618363|NCT00562289|Migraine|migraine
618364|NCT00562276|IUD|iud
618365|NCT00562276|insertion timing|insertion timing
618366|NCT00562263|overweight|overweight
618367|NCT00562263|obesity|obesity
618368|NCT00562263|adolescent|adolescent
618369|NCT00562263|insulin resistance|insulin resistance
618370|NCT00562263|treatment|treatment
618371|NCT00562237|immunogenicity|immunogenicity
618372|NCT00562237|safety|safety
618373|NCT00562237|adjuvanted pandemic vaccine|adjuvanted pandemic vaccine
618374|NCT00562224|PCI-24781|pci-24781
618375|NCT00562224|Neoplasms by site|neoplasms by site
618376|NCT00562224|Lymphoma, non-hodgkin|lymphoma, non-hodgkin
618377|NCT00562224|Hodgkin disease|hodgkin disease
618378|NCT00562224|Multiple myeloma|multiple myeloma
618379|NCT00562224|Leukemia, lymphocytic, chronic|leukemia, lymphocytic, chronic
618381|NCT00562185|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
618382|NCT00562185|ovarian sarcoma|ovarian sarcoma
618383|NCT00562185|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
618384|NCT00562185|ovarian stromal cancer|ovarian stromal cancer
618385|NCT00562159|rhinoconjunctivitis|rhinoconjunctivitis
618386|NCT00562159|rhinitis|rhinitis
618387|NCT00562159|conjunctivitis|conjunctivitis
618388|NCT00562159|allergy|allergy
618389|NCT00562159|allergen|allergen
618390|NCT00562159|immunotherapy|immunotherapy
618391|NCT00562146|nutrition|nutrition
618392|NCT00562146|enteral access|enteral access
618393|NCT00562107|Minimized ventricular pacing, clinical outcome, SafeR, AAIsafeR, dual chamber pacemaker therapy, % of ventricular pacing, hospitalizations, symptomatic AF|minimized ventricular pacing, clinical outcome, safer, aaisafer, dual chamber pacemaker therapy, % of ventricular pacing, hospitalizations, symptomatic af
618394|NCT00562094|Pantoprazole|pantoprazole
618395|NCT00562094|eGERD (Erosive Gastroesophageal Reflux Disease)|egerd (erosive gastroesophageal reflux disease)
618396|NCT00562094|NERD (Non-Erosive Reflux Disease)|nerd (non-erosive reflux disease)
618397|NCT00562094|sleep disorders|sleep disorders
618398|NCT00562081|asthma|asthma
618399|NCT00562081|Virtual Asthma Clinic|virtual asthma clinic
618400|NCT00562081|metabolites|metabolites
618401|NCT00562081|asthma education|asthma education
618402|NCT00562068|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
618403|NCT00562068|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
618404|NCT00562068|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
618405|NCT00562068|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
618406|NCT00562068|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
618407|NCT00562068|anaplastic large cell lymphoma|anaplastic large cell lymphoma
618408|NCT00562068|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
618409|NCT00562068|small intestine lymphoma|small intestine lymphoma
618410|NCT00562068|peripheral T-cell lymphoma|peripheral t-cell lymphoma
618411|NCT00562042|pulmonary embolism|pulmonary embolism
618412|NCT00562042|risk stratification|risk stratification
618413|NCT00562042|prognosis|prognosis
618414|NCT00562042|troponin|troponin
618415|NCT00562042|Brain natriuretic peptide|brain natriuretic peptide
618416|NCT00562042|echocardiogram|echocardiogram
618417|NCT00562029|Diabetes Mellitus|diabetes mellitus
618418|NCT00562029|Surgery|surgery
618419|NCT00562029|Duodenal Bypass|duodenal bypass
618420|NCT00562029|Resolution|resolution
618421|NCT00562029|Surgical Procedures|surgical procedures
618422|NCT00562016|Patient undergoing scheduled PCI|patient undergoing scheduled pci
618423|NCT00562003|Ovarian cancer study|ovarian cancer study
618424|NCT00561990|pancreatic cancer|pancreatic cancer
618425|NCT00561977|Nutrition|nutrition
618426|NCT00561977|Dietary Quality|dietary quality
618427|NCT00561977|Weight loss|weight loss
618428|NCT00561938|Confocal laser endomicroscopy|confocal laser endomicroscopy
618429|NCT00561938|cancerous and non-cancerous conditions|cancerous and non-cancerous conditions
618430|NCT00561938|tolerance|tolerance
618431|NCT00561938|intravenous fluorescein|intravenous fluorescein
618432|NCT00561938|Digestive symptoms or disease requiring an endoscopy procedure (upper GI endoscopy or colonoscopy) performed under general anaesthesia|digestive symptoms or disease requiring an endoscopy procedure (upper gi endoscopy or colonoscopy) performed under general anaesthesia
618433|NCT00561912|Renal Cell Carcinoma|renal cell carcinoma
618434|NCT00561912|Renal Cell Cancer|renal cell cancer
618435|NCT00561912|Clear Cell|clear cell
618436|NCT00561912|Kidney|kidney
618437|NCT00561912|Decitabine|decitabine
618438|NCT00561912|Dacogen|dacogen
618439|NCT00561912|5-Aza-Deoxycytidine|5-aza-deoxycytidine
618440|NCT00561912|Interferon Alfa-2b|interferon alfa-2b
618441|NCT00561912|Intron A®|intron a®
618443|NCT00561899|safety|safety
618444|NCT00561899|tolerability|tolerability
618445|NCT00561899|efficacy|efficacy
618446|NCT00561899|intermittent prevetive treatment|intermittent prevetive treatment
618447|NCT00561899|children|children
618448|NCT00561886|COPD|copd
618449|NCT00561886|lung function|lung function
618450|NCT00561886|dysnpea|dysnpea
618451|NCT00561873|astrocytoma, glioblastoma, intrinsic pontine glioma|astrocytoma, glioblastoma, intrinsic pontine glioma
618452|NCT00561860|Obstructive sleep apnea-hypopnea|obstructive sleep apnea-hypopnea
618453|NCT00561860|Telemedicine|telemedicine
618454|NCT00561834|non-arteritic ischemic optic neuropathy|non-arteritic ischemic optic neuropathy
618455|NCT00561834|ranibizumab|ranibizumab
618456|NCT00561834|naion|naion
618457|NCT00561821|elderly|elderly
618458|NCT00561821|randomized|randomized
618459|NCT00561821|placebo controlled|placebo controlled
618460|NCT00561808|PCO/PCOD|pco/pcod
618461|NCT00561808|IVM|ivm
618462|NCT00561808|Immature Oocytes|immature oocytes
618463|NCT00561795|AGO|ago
618464|NCT00561795|Advanced,|advanced,
618465|NCT00561795|Gynaecologic cancer(s),|gynaecologic cancer(s),
618466|NCT00561795|Genetics|genetics
618467|NCT00561795|GW786034,|gw786034,
618468|NCT00561795|Pazopanib,|pazopanib,
618469|NCT00561782|Spinal Cord Injury Pain|spinal cord injury pain
618470|NCT00561782|Chronic Neuropathic Pain|chronic neuropathic pain
618471|NCT00561782|SCI Pain|sci pain
618472|NCT00561782|Pain, Chronic Neuropathic|pain, chronic neuropathic
618473|NCT00561782|Spectroscopy, Magnetic Resonance|spectroscopy, magnetic resonance
618474|NCT00561782|MRS|mrs
618475|NCT00561782|Traumatic Brain Injury Pain|traumatic brain injury pain
618476|NCT00561769|poor responder|poor responder
618477|NCT00561769|growth hormone|growth hormone
618478|NCT00561769|luteal|luteal
618479|NCT00561756|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
618480|NCT00561756|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
618481|NCT00561756|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
618482|NCT00561756|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
618483|NCT00561756|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
618484|NCT00561756|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
618485|NCT00561756|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
618486|NCT00561756|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
618487|NCT00561756|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
618488|NCT00561743|Multiple myeloma|multiple myeloma
618489|NCT00561743|response rate|response rate
618490|NCT00561743|peripheral stem cell transplant|peripheral stem cell transplant
618491|NCT00561743|safety|safety
618492|NCT00561743|tolerability|tolerability
618493|NCT00561730|PPI (Proton Pump Inhibitor) therapy|ppi (proton pump inhibitor) therapy
618494|NCT00561730|Pantoprazole|pantoprazole
618495|NCT00561730|eGERD (Erosive Gastroesophageal Reflux Disease)|egerd (erosive gastroesophageal reflux disease)
618496|NCT00561730|NERD (Non-Erosive Reflux Disease)|nerd (non-erosive reflux disease)
618497|NCT00561717|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
618498|NCT00561717|Ragweed|ragweed
618499|NCT00561717|Pollen|pollen
618500|NCT00561717|Allergy|allergy
618501|NCT00561704|obese female|obese female
618502|NCT00561704|Type 2 Diabetes|type 2 diabetes
618503|NCT00561704|Diabetic Nephropathy|diabetic nephropathy
618504|NCT00561704|Glucose Metabolism|glucose metabolism
618505|NCT00561704|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
618506|NCT00561704|Adiponectin|adiponectin
618507|NCT00561691|diffuse instrinsic ponitine glioma, brainstem|diffuse instrinsic ponitine glioma, brainstem
618508|NCT00561678|Postoperative Confusion|postoperative confusion
618509|NCT00561678|Postoperative Delirium|postoperative delirium
618510|NCT00561678|PD|pd
618511|NCT00561678|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
618512|NCT00561678|POCD|pocd
618513|NCT00561652|Low back pain|low back pain
618514|NCT00561652|Chiropractic|chiropractic
618515|NCT00561652|Exercise|exercise
618516|NCT00561652|Veterans|veterans
618517|NCT00561639|sepsis|sepsis
618518|NCT00561639|immunosuppressed|immunosuppressed
618519|NCT00561639|multiplex PCR|multiplex pcr
618520|NCT00561639|diagnosis|diagnosis
618521|NCT00561639|therapeutic|therapeutic
618522|NCT00561613|Diaphragm|diaphragm
618523|NCT00561613|postcoital test|postcoital test
618524|NCT00561613|SILCS|silcs
618525|NCT00561613|nonoxynol-9|nonoxynol-9
618526|NCT00561600|Hip arthroplasty|hip arthroplasty
618527|NCT00561600|Acetabular cup replacement|acetabular cup replacement
618528|NCT00561600|Acetabulum arthroplasty|acetabulum arthroplasty
618529|NCT00561587|novel antipsychotic|novel antipsychotic
618530|NCT00561587|quetiapine|quetiapine
618531|NCT00561587|depression|depression
618532|NCT00561587|psychopathology|psychopathology
618533|NCT00561574|elderly|elderly
618534|NCT00561574|randomized|randomized
618535|NCT00561574|double blind|double blind
618536|NCT00561561|Schizophrenia|schizophrenia
618537|NCT00561561|Prepulse Inhibition|prepulse inhibition
618538|NCT00561561|Acoustic Startle|acoustic startle
618539|NCT00561535|IBS|ibs
618540|NCT00561535|Diarrhea|diarrhea
618541|NCT00561535|Rome III|rome iii
618542|NCT00561522|Recurrence|recurrence
618543|NCT00561522|Metastasis|metastasis
618544|NCT00561522|Hepatocellular Carcinoma|hepatocellular carcinoma
618545|NCT00561522|Radical Hepatic Resection|radical hepatic resection
618546|NCT00561522|Drug Prevention|drug prevention
618547|NCT00561522|Capecitabine|capecitabine
618548|NCT00561522|Surgery|surgery
618549|NCT00561496|HIV prevention|hiv prevention
618550|NCT00561496|Microbicides|microbicides
618551|NCT00561496|Pharmacokinetics|pharmacokinetics
618552|NCT00561496|vaginal biopsies|vaginal biopsies
618553|NCT00561483|Acute heart failure|acute heart failure
618554|NCT00561483|cystatin C|cystatin c
618555|NCT00561483|renal failure|renal failure
618556|NCT00561483|biomarker|biomarker
618557|NCT00561470|colorectal cancer|colorectal cancer
618558|NCT00561470|metastatic|metastatic
618559|NCT00561470|anti-angiogenic|anti-angiogenic
618560|NCT00561470|irinotecan|irinotecan
618561|NCT00561470|5-FU|5-fu
618562|NCT00561470|FOLFIRI|folfiri
618563|NCT00561457|Iliac|iliac
618564|NCT00561457|Artery|artery
618565|NCT00561457|Occlusive|occlusive
618566|NCT00561457|Stenosis|stenosis
618567|NCT00561444|Prostate Cancer|prostate cancer
618568|NCT00561444|Radical retropubic prostatectomy|radical retropubic prostatectomy
618569|NCT00561444|Robotic prostatectomy|robotic prostatectomy
618570|NCT00561444|Photon external beam radiation|photon external beam radiation
618571|NCT00561444|Photon external beam radiation with hormone therapy|photon external beam radiation with hormone therapy
618572|NCT00561444|Proton radiation|proton radiation
618573|NCT00561444|Radioisotopic implant|radioisotopic implant
618574|NCT00561444|Cryotherapy|cryotherapy
618575|NCT00561444|Quality of Life|quality of life
618576|NCT00561444|Questionnaire|questionnaire
618577|NCT00561444|Survey|survey
618578|NCT00561444|QOL|qol
618579|NCT00561431|CVVHDF Dose Study|cvvhdf dose study
618580|NCT00561418|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
618581|NCT00561418|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
618582|NCT00561418|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
618583|NCT00561418|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
618584|NCT00561418|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
618585|NCT00561418|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
618586|NCT00561418|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
618587|NCT00561418|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
618588|NCT00561418|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
618589|NCT00561418|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
618590|NCT00561418|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
618591|NCT00561418|small intestine lymphoma|small intestine lymphoma
618592|NCT00561418|anaplastic large cell lymphoma|anaplastic large cell lymphoma
618593|NCT00561405|Stroke|stroke
618594|NCT00561405|Walking|walking
618595|NCT00561405|Motor learning|motor learning
618596|NCT00561405|Skill acquisition|skill acquisition
618597|NCT00561392|Alzheimer's Disease|alzheimer's disease
618598|NCT00561392|Rivastigmine|rivastigmine
618599|NCT00561392|Patch|patch
618600|NCT00561379|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
618601|NCT00561379|not previously treated|not previously treated
618602|NCT00561366|ALS|als
618603|NCT00561366|Lou Gehrig's disease|lou gehrig's disease
618604|NCT00561353|Hepatitis C, Chronic|hepatitis c, chronic
618605|NCT00561353|Tibotec|tibotec
618606|NCT00561353|TMC435350-TiDP16-C201|tmc435350-tidp16-c201
618607|NCT00561353|TMC435350-C201|tmc435350-c201
618608|NCT00561353|TMC435|tmc435
618609|NCT00561353|PEGASYS (peginterferon alpha-2a, PegIFNα-2a)|pegasys (peginterferon alpha-2a, pegifnα-2a)
618610|NCT00561353|COPEGUS (ribavirin)|copegus (ribavirin)
618611|NCT00561340|ADHD|adhd
618612|NCT00561340|Growth|growth
618613|NCT00561340|Atomoxetine|atomoxetine
618614|NCT00561340|Pediasure|pediasure
618615|NCT00561327|hypertension|hypertension
618616|NCT00561327|angiotensin receptor blockers|angiotensin receptor blockers
618617|NCT00561327|peroxisome proliferator activated receptor gamma|peroxisome proliferator activated receptor gamma
618618|NCT00561314|sexual dysfunction|sexual dysfunction
618619|NCT00561314|urinary incontinence|urinary incontinence
618620|NCT00561314|adenocarcinoma of the prostate|adenocarcinoma of the prostate
618621|NCT00561314|stage I prostate cancer|stage i prostate cancer
618622|NCT00561314|stage IIB prostate cancer|stage iib prostate cancer
618623|NCT00561314|stage IIA prostate cancer|stage iia prostate cancer
618624|NCT00561288|Acetaminophen|acetaminophen
618625|NCT00561288|Social Psychology|social psychology
618626|NCT00561288|Affect|affect
618627|NCT00561288|Interpersonal Rejection|interpersonal rejection
618628|NCT00561262|adenocarcinoma of the prostate|adenocarcinoma of the prostate
618629|NCT00561262|stage I prostate cancer|stage i prostate cancer
618630|NCT00561262|stage IIB prostate cancer|stage iib prostate cancer
618631|NCT00561262|stage IIA prostate cancer|stage iia prostate cancer
618632|NCT00561262|stage III prostate cancer|stage iii prostate cancer
618633|NCT00561223|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
618634|NCT00561223|pulmonary hypertension|pulmonary hypertension
618635|NCT00561210|infections|infections
618636|NCT00561184|H5N1 Pandemic|h5n1 pandemic
618637|NCT00561145|Anorexia of ageing|anorexia of ageing
618638|NCT00561145|Anorexia of aging|anorexia of aging
618639|NCT00561145|Energy balance|energy balance
618640|NCT00561145|Elderly|elderly
618641|NCT00561132|vanadium|vanadium
618642|NCT00561132|insulin sensitivity|insulin sensitivity
618643|NCT00561132|impaired glucose tolerance|impaired glucose tolerance
618644|NCT00561132|triglycerides|triglycerides
618645|NCT00561119|maintenance chemotherapy|maintenance chemotherapy
618646|NCT00561119|metastatic or recurrent breast cancer|metastatic or recurrent breast cancer
618647|NCT00561119|gemcitabine|gemcitabine
618648|NCT00561119|paclitaxel(GP)|paclitaxel(gp)
618649|NCT00561106|Bell´s palsy|bell´s palsy
618650|NCT00561106|prednisone|prednisone
618651|NCT00561106|valacyclovir|valacyclovir
618652|NCT00561093|Hypoalbuminemia|hypoalbuminemia
618653|NCT00561093|Protein-energy malnutrition|protein-energy malnutrition
618654|NCT00561093|Inflammation|inflammation
618655|NCT00561093|Oxidative stress|oxidative stress
618656|NCT00561093|Chronic Kidney disease (CKD) stage 5|chronic kidney disease (ckd) stage 5
618657|NCT00561093|maintenance hemodialysis|maintenance hemodialysis
618949|NCT00559663|LDL|ldl
618658|NCT00561067|Spinal cord injury|spinal cord injury
618659|NCT00561067|spinal shock|spinal shock
618660|NCT00561067|erythropoietin|erythropoietin
618661|NCT00561054|Coimbra|coimbra
618662|NCT00561054|NSCLC|nsclc
618663|NCT00561054|CETUXIMAB|cetuximab
618664|NCT00561041|alcohol|alcohol
618665|NCT00561041|alcohol use disorder|alcohol use disorder
618666|NCT00561041|cognitive-behavioral therapy|cognitive-behavioral therapy
618667|NCT00561041|brief phone aftercare intervention|brief phone aftercare intervention
618668|NCT00561041|individual aftercare therapy|individual aftercare therapy
618669|NCT00561028|Atherosclerosis|atherosclerosis
618670|NCT00561028|Coronary artery disease|coronary artery disease
618671|NCT00561028|Chlamydia pneumoniae|chlamydia pneumoniae
618672|NCT00561028|Mycoplasma pneumoniae|mycoplasma pneumoniae
618673|NCT00561015|Hepatitis C, Chronic|hepatitis c, chronic
618674|NCT00561015|Genotype 2|genotype 2
618675|NCT00561015|Genotype 3|genotype 3
618676|NCT00561015|Telaprevir|telaprevir
618677|NCT00561002|Influenza Vaccine|influenza vaccine
618678|NCT00561002|Influenza Virus|influenza virus
618679|NCT00561002|Orthomyxoviridae Infections|orthomyxoviridae infections
618680|NCT00561002|Fluzone®|fluzone®
618681|NCT00560989|Chronic Beryllium Disease|chronic beryllium disease
618682|NCT00560989|CBD|cbd
618683|NCT00560989|Beryllium|beryllium
618684|NCT00560989|Genetic|genetic
618685|NCT00560989|Environmental|environmental
618686|NCT00560976|neutrophil gelatinase associated lipocalin|neutrophil gelatinase associated lipocalin
618687|NCT00560976|hemodialysis|hemodialysis
618688|NCT00560976|iron|iron
618689|NCT00560976|inflammation|inflammation
618690|NCT00560976|Oxidative Stress|oxidative stress
618691|NCT00560963|Advanced or metastatic pancreas carcinoma|advanced or metastatic pancreas carcinoma
618692|NCT00560963|gemcitabine|gemcitabine
618693|NCT00560963|everolimus|everolimus
618694|NCT00560937|Schizophrenia|schizophrenia
618695|NCT00560937|Pregnenolone|pregnenolone
618696|NCT00560937|Cognition|cognition
618697|NCT00560937|Negative Symptoms|negative symptoms
618698|NCT00560911|oral anticoagulation|oral anticoagulation
618699|NCT00560911|self-management|self-management
618700|NCT00560911|elderly patients|elderly patients
618701|NCT00560911|randomised controlled trial|randomised controlled trial
618702|NCT00560898|staining|staining
618703|NCT00560898|epithelial barrier function|epithelial barrier function
618704|NCT00560885|atrial fibrillation|atrial fibrillation
618705|NCT00560885|af|af
618706|NCT00560885|ablation|ablation
618707|NCT00560885|arrhythmia|arrhythmia
618708|NCT00560885|racing heart|racing heart
618709|NCT00560885|afib|afib
618710|NCT00560885|surgical ablation|surgical ablation
618711|NCT00560872|atrial flutter|atrial flutter
618712|NCT00560872|ablation|ablation
618713|NCT00560872|navigation|navigation
618714|NCT00560859|Sleep disordered breathing|sleep disordered breathing
618715|NCT00560859|Sleep apnea|sleep apnea
618716|NCT00560859|Tonsillectomy|tonsillectomy
618717|NCT00560859|Adenoidectomy|adenoidectomy
618718|NCT00560859|Snoring|snoring
618719|NCT00560859|Neurobehavioral Manifestations|neurobehavioral manifestations
618720|NCT00560859|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
618721|NCT00560846|Gastric cancer|gastric cancer
618722|NCT00560846|Esophageal cancer|esophageal cancer
618723|NCT00560846|Surgical complications|surgical complications
618724|NCT00560846|Immunonutrition|immunonutrition
618725|NCT00560820|β-thalassemia|β-thalassemia
618726|NCT00560820|transfusional iron overload|transfusional iron overload
618727|NCT00560820|renal function|renal function
618728|NCT00560820|renal biomarkers|renal biomarkers
618729|NCT00560820|deferasirox|deferasirox
618730|NCT00560807|WAD II|wad ii
618731|NCT00560807|WAD III|wad iii
618732|NCT00560807|mobilization|mobilization
618733|NCT00560807|dosage|dosage
618734|NCT00560807|acute whiplash associated disorders (WAD) II and III (113) with a symptom duration of less than 30 days|acute whiplash associated disorders (wad) ii and iii (113) with a symptom duration of less than 30 days
618735|NCT00560807|neck pain|neck pain
618736|NCT00560794|Minimal Residual Disease|minimal residual disease
618737|NCT00560794|adult ALL|adult all
618738|NCT00560794|immunotherapeutic treatment|immunotherapeutic treatment
618739|NCT00560794|anti-CD19 bispecific antibody derivative|anti-cd19 bispecific antibody derivative
618740|NCT00560794|Blinatumomab|blinatumomab
618741|NCT00560794|MT103|mt103
618742|NCT00560781|PTSD|ptsd
618743|NCT00560781|Pregnenolone|pregnenolone
618744|NCT00560781|Cognition|cognition
618745|NCT00560768|Risk stratification method, negative predictive value, fast ventricular arrhythmias, ICD|risk stratification method, negative predictive value, fast ventricular arrhythmias, icd
618746|NCT00560768|The negative predictive value of the T amplitude variance as a method for risk stratification for patients with an increased risk for SCD.|the negative predictive value of the t amplitude variance as a method for risk stratification for patients with an increased risk for scd.
618747|NCT00560755|Prevention of: measles, mumps, rubella and varicella|prevention of: measles, mumps, rubella and varicella
618748|NCT00560729|elderly people|elderly people
618749|NCT00560690|Hepatitis C|hepatitis c
618750|NCT00560690|metformin|metformin
618751|NCT00560690|Insulin Resistance|insulin resistance
618752|NCT00560677|Schizophrenia|schizophrenia
618753|NCT00560677|PTSD|ptsd
618754|NCT00560677|Cognition|cognition
618755|NCT00560664|knee|knee
618756|NCT00560664|chondral defect|chondral defect
618757|NCT00560664|osteochondral defect|osteochondral defect
618758|NCT00560651|keratoconus|keratoconus
618759|NCT00560651|cornea|cornea
618760|NCT00560651|cross linking|cross linking
618761|NCT00560651|UV-light|uv-light
618762|NCT00560651|riboflavin|riboflavin
618763|NCT00560612|PTSD|ptsd
618764|NCT00560612|Paroxetine|paroxetine
618765|NCT00560612|Subthreshold|subthreshold
618766|NCT00560599|MRSA|mrsa
618767|NCT00560599|Methicillin Resistant Staphylococcus aureus|methicillin resistant staphylococcus aureus
618768|NCT00560599|Staphylococcus aureus|staphylococcus aureus
618769|NCT00560599|Skin Infections|skin infections
618770|NCT00560599|Body Decolonization|body decolonization
618771|NCT00560599|Environmental Decolonization|environmental decolonization
618772|NCT00560586|sleep fragmentation|sleep fragmentation
618773|NCT00560586|apnea|apnea
618774|NCT00560586|hypoxia|hypoxia
618775|NCT00560560|Refractory Colorectal|refractory colorectal
618776|NCT00560560|Single arm|single arm
618777|NCT00560560|Phase 2|phase 2
618778|NCT00560534|Magnetic resonance|magnetic resonance
618779|NCT00560534|whole body|whole body
618780|NCT00560534|angiography|angiography
618781|NCT00560534|venous compression|venous compression
618782|NCT00560534|MRI|mri
618783|NCT00560521|CPAP|cpap
618784|NCT00560521|Tuberculosis|tuberculosis
618785|NCT00560521|Pleural effusion|pleural effusion
618786|NCT00560521|Physiotherapy|physiotherapy
618787|NCT00560495|stage I non-small cell lung cancer|stage i non-small cell lung cancer
618788|NCT00560495|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
618789|NCT00560495|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
618790|NCT00560495|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
618791|NCT00560495|adenocarcinoma of the lung|adenocarcinoma of the lung
618792|NCT00560495|adenosquamous cell lung cancer|adenosquamous cell lung cancer
618793|NCT00560495|large cell lung cancer|large cell lung cancer
618794|NCT00560495|squamous cell lung cancer|squamous cell lung cancer
618795|NCT00560482|prostate|prostate
618796|NCT00560482|cancer|cancer
618797|NCT00560482|prostatic cancer|prostatic cancer
618798|NCT00560482|castrate-resistant prostate cancer (CRPC)|castrate-resistant prostate cancer (crpc)
618799|NCT00560469|Adipokines|adipokines
618800|NCT00560469|Inflammation|inflammation
618801|NCT00560469|Metabolic syndrome|metabolic syndrome
618802|NCT00560456|Age, Snoring, Driving simulator, Sleep deprivation, chronic sleep restriction, objective and subjective sleepiness|age, snoring, driving simulator, sleep deprivation, chronic sleep restriction, objective and subjective sleepiness
618803|NCT00560443|bone fracture|bone fracture
618804|NCT00560443|ketorolac|ketorolac
618805|NCT00560443|tramadol|tramadol
618806|NCT00560378|Tacrolimus|tacrolimus
618807|NCT00560378|Administration, topical|administration, topical
618808|NCT00560378|Drug safety|drug safety
618809|NCT00560378|Adults|adults
618810|NCT00560378|Children|children
618811|NCT00560365|stage I colon cancer|stage i colon cancer
618812|NCT00560365|stage II colon cancer|stage ii colon cancer
618813|NCT00560365|stage III colon cancer|stage iii colon cancer
618814|NCT00560365|stage I rectal cancer|stage i rectal cancer
618815|NCT00560365|stage II rectal cancer|stage ii rectal cancer
618816|NCT00560365|stage III rectal cancer|stage iii rectal cancer
618817|NCT00560339|Congestive Heart Failure|congestive heart failure
618818|NCT00560339|Implantable Defibrillators|implantable defibrillators
618819|NCT00560339|Intrathoracic Impedance|intrathoracic impedance
618820|NCT00560326|Paediatric patients|paediatric patients
618821|NCT00560326|Tacrolimus|tacrolimus
618822|NCT00560326|Dermatitis, Atopic|dermatitis, atopic
618823|NCT00560313|Meningococcal disease|meningococcal disease
618824|NCT00560313|prevention|prevention
618825|NCT00560313|vaccination|vaccination
618826|NCT00560287|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
618827|NCT00560287|Non-invasive ventilation|non-invasive ventilation
618828|NCT00560287|Chronic Respiratory Failure|chronic respiratory failure
618829|NCT00560261|Sickle cell disease;|sickle cell disease;
618830|NCT00560261|Lung capillary blood volume;|lung capillary blood volume;
618831|NCT00560261|Children|children
618832|NCT00560248|Chest Pain|chest pain
618833|NCT00560248|STEMI|stemi
618834|NCT00560248|UA/NSTEMI|ua/nstemi
618835|NCT00560248|ACS|acs
618836|NCT00560248|Emergency Department|emergency department
618837|NCT00560222|randomized controlled trial|randomized controlled trial
618838|NCT00560222|lactoferrin|lactoferrin
618839|NCT00560222|children|children
618840|NCT00560222|diarrhea|diarrhea
618841|NCT00560222|malnutrition|malnutrition
618842|NCT00560222|growth|growth
618843|NCT00560209|ONO-1101|ono-1101
618844|NCT00560209|Coronary Artery Disease|coronary artery disease
618845|NCT00560209|Multi-slice CT|multi-slice ct
618846|NCT00560196|Neuropathic pain|neuropathic pain
618847|NCT00560196|Chronic pain|chronic pain
618848|NCT00560196|Depression|depression
618849|NCT00560196|Anxiety|anxiety
618850|NCT00560183|Acute|acute
618851|NCT00560183|Bunionectomy|bunionectomy
618852|NCT00560170|HMG-CoA Reductase Inhibitors|hmg-coa reductase inhibitors
618853|NCT00560170|endothelial function|endothelial function
618854|NCT00560170|HMG-CoA Reductase Inhibitors on vascular protection|hmg-coa reductase inhibitors on vascular protection
618855|NCT00560157|ICU patients|icu patients
618856|NCT00560118|recurrent melanoma|recurrent melanoma
618857|NCT00560118|stage IV melanoma|stage iv melanoma
618858|NCT00560105|COPD|copd
618859|NCT00560092|Magnesium|magnesium
618860|NCT00560092|Pain|pain
618861|NCT00560092|Morphine|morphine
618862|NCT00560092|Intrathecal|intrathecal
618863|NCT00560092|NMDA|nmda
618864|NCT00560092|Elective total hip replacement under intrathecal anesthesia|elective total hip replacement under intrathecal anesthesia
618865|NCT00560066|influenza|influenza
618866|NCT00560066|vaccine|vaccine
618867|NCT00560053|Multiple Myeloma|multiple myeloma
618868|NCT00560053|Alternating chemotherapy|alternating chemotherapy
618869|NCT00560053|Transplantation|transplantation
618870|NCT00560040|Troponin|troponin
618871|NCT00560040|Natriuretic Peptide, Brain|natriuretic peptide, brain
618872|NCT00560040|Exercise|exercise
618873|NCT00560040|Echocardiography|echocardiography
618874|NCT00560027|postpartum depression|postpartum depression
618875|NCT00560027|intimate partner violence|intimate partner violence
618876|NCT00560001|frail elderly|frail elderly
618877|NCT00560001|medication errors|medication errors
618878|NCT00560001|patient compliance & attitudes|patient compliance & attitudes
618879|NCT00560001|guideline adherence|guideline adherence
618880|NCT00559988|Implanted Cardioverter Defibrillator|implanted cardioverter defibrillator
618881|NCT00559988|Cardiac Resynchronization Therapy Defibrillator|cardiac resynchronization therapy defibrillator
618882|NCT00559988|Home Monitoring|home monitoring
618883|NCT00559988|Oral Anticoagulation|oral anticoagulation
618884|NCT00559975|Adjuvanted Influenza Vaccine|adjuvanted influenza vaccine
618885|NCT00559962|LDL|ldl
618886|NCT00559962|hepatic fat|hepatic fat
618887|NCT00559897|bone metastases|bone metastases
618888|NCT00559897|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
618889|NCT00559897|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
618890|NCT00559897|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
618891|NCT00559884|pharmacokinetics,|pharmacokinetics,
618892|NCT00559884|healthy male and females,|healthy male and females,
618893|NCT00559884|pharmacodynamics|pharmacodynamics
618894|NCT00559871|dyskinesia|dyskinesia
618895|NCT00559871|movement disorders|movement disorders
618896|NCT00559871|basal ganglia diseases|basal ganglia diseases
618897|NCT00559871|JP-1730|jp-1730
618898|NCT00559871|Parkinson|parkinson
618899|NCT00559871|end-of-dose wearing off|end-of-dose wearing off
618900|NCT00559871|fluctuations|fluctuations
618901|NCT00559858|palmar-plantar erythrodysesthesia|palmar-plantar erythrodysesthesia
618902|NCT00559858|breast cancer|breast cancer
618903|NCT00559858|male breast cancer|male breast cancer
618904|NCT00559858|colon cancer|colon cancer
618905|NCT00559858|rectal cancer|rectal cancer
618906|NCT00559832|acute mountain sickness|acute mountain sickness
618907|NCT00559832|intermittent hypoxia|intermittent hypoxia
618908|NCT00559832|acclimatization|acclimatization
618909|NCT00559819|Alcohol|alcohol
618910|NCT00559819|Driving|driving
618911|NCT00559819|Impairment|impairment
618912|NCT00559806|immobilisation|immobilisation
618913|NCT00559806|aging|aging
618914|NCT00559806|resistance training|resistance training
618915|NCT00559806|atrophy|atrophy
618916|NCT00559806|The effect of immobilisation in elderly compared to young individuals|the effect of immobilisation in elderly compared to young individuals
618917|NCT00559780|Resistance training|resistance training
618918|NCT00559780|Aging|aging
618919|NCT00559780|hip-surgery|hip-surgery
618920|NCT00559767|Kidney Function|kidney function
618921|NCT00559767|Genes|genes
618922|NCT00559767|Association Analysis|association analysis
618923|NCT00559767|Polymorphisms|polymorphisms
618924|NCT00559767|Diabetes|diabetes
618925|NCT00559741|stage IV colon cancer|stage iv colon cancer
618926|NCT00559741|recurrent colon cancer|recurrent colon cancer
618927|NCT00559741|stage IV rectal cancer|stage iv rectal cancer
618928|NCT00559741|recurrent rectal cancer|recurrent rectal cancer
618929|NCT00559715|bevacizumab|bevacizumab
618930|NCT00559715|ranibizumab|ranibizumab
618931|NCT00559715|macular degeneration|macular degeneration
618932|NCT00559715|age-related|age-related
618933|NCT00559715|neovascular|neovascular
618934|NCT00559715|intravitreal injection|intravitreal injection
618935|NCT00559715|vision loss|vision loss
618936|NCT00559715|outpatient setting|outpatient setting
618937|NCT00559702|natalizumab|natalizumab
618938|NCT00559702|multiple sclerosis|multiple sclerosis
618939|NCT00559702|Tysabri ®|tysabri ®
618940|NCT00559689|asthma patients|asthma patients
618941|NCT00559689|well-controlled|well-controlled
618942|NCT00559676|recurrent colon cancer|recurrent colon cancer
618943|NCT00559676|stage IV colon cancer|stage iv colon cancer
618944|NCT00559676|recurrent rectal cancer|recurrent rectal cancer
618945|NCT00559676|stage IV rectal cancer|stage iv rectal cancer
618946|NCT00559663|Flavonoid|flavonoid
618947|NCT00559663|hsCRP|hscrp
618950|NCT00559663|platelet reactivity|platelet reactivity
618951|NCT00559650|Acute decompensated heart failure|acute decompensated heart failure
618952|NCT00559650|Double blind study,|double blind study,
618953|NCT00559650|BAY58-2667|bay58-2667
618954|NCT00559650|Soluble guanylate cyclase activator|soluble guanylate cyclase activator
618955|NCT00559624|safety|safety
618956|NCT00559624|tolerability|tolerability
618957|NCT00559624|dose-escalation|dose-escalation
618958|NCT00559611|Non-Small Lung Cancer|non-small lung cancer
618959|NCT00559611|Lung Cancer|lung cancer
618960|NCT00559611|Endobronchial Ultrasound|endobronchial ultrasound
618961|NCT00559611|Fine Needle Aspiration|fine needle aspiration
618962|NCT00559611|Mediastinoscopy|mediastinoscopy
618963|NCT00559611|EBUS-FNA|ebus-fna
618964|NCT00559611|EBUS|ebus
618965|NCT00559611|Needle Biopsy|needle biopsy
618966|NCT00559611|NSCLC|nsclc
618967|NCT00559598|pancreatic cancer|pancreatic cancer
618968|NCT00559598|extrahepatic bile duct cancer|extrahepatic bile duct cancer
618969|NCT00559572|Exercise|exercise
618970|NCT00559572|Group Counseling|group counseling
618971|NCT00559572|Obesity|obesity
618972|NCT00559559|Primary and secondary prevention for ventricular tachycardia|primary and secondary prevention for ventricular tachycardia
618973|NCT00559520|Patients|patients
618974|NCT00559520|Suffering|suffering
618975|NCT00559520|Undernutrition|undernutrition
618976|NCT00559520|Requiring|requiring
618977|NCT00559520|Vascular|vascular
618978|NCT00559520|Surgery|surgery
618979|NCT00559494|complete spinal cord injury|complete spinal cord injury
618980|NCT00559494|incomplete spinal cord injury|incomplete spinal cord injury
618981|NCT00559494|central cord spinal cord injury|central cord spinal cord injury
618982|NCT00559494|traumatic|traumatic
618983|NCT00559481|recurrent prostate cancer|recurrent prostate cancer
618984|NCT00559442|high altitude pulmonary edema|high altitude pulmonary edema
618985|NCT00559442|hypoxic pulmonary vasoconstriction|hypoxic pulmonary vasoconstriction
618986|NCT00559442|right ventricular function|right ventricular function
618987|NCT00559442|hypoxia|hypoxia
618988|NCT00559429|Prostate Cancer|prostate cancer
618989|NCT00559416|HIV/AIDS|hiv/aids
618990|NCT00559416|HLA-B*57|hla-b*57
618991|NCT00559416|Cell Transfer|cell transfer
618992|NCT00559416|HIV|hiv
618993|NCT00559416|treatment experienced|treatment experienced
618994|NCT00559403|Human immunodeficiency virus|human immunodeficiency virus
618995|NCT00559403|South Africa|south africa
618996|NCT00559403|Intervention Studies|intervention studies
618997|NCT00559403|Sexual Behavior|sexual behavior
618998|NCT00559403|Adolescents|adolescents
618999|NCT00559403|STD|std
619000|NCT00559403|HIV Seronegativity|hiv seronegativity
619001|NCT00559390|Polycystic Ovary Syndrome|polycystic ovary syndrome
619002|NCT00559390|Metabolic Syndrome|metabolic syndrome
619003|NCT00559390|PCOS|pcos
619004|NCT00559390|children|children
619005|NCT00559390|girls|girls
619006|NCT00559390|daughters|daughters
619007|NCT00559390|sisters|sisters
619008|NCT00559390|irregular periods|irregular periods
619009|NCT00559351|esophagectomy|esophagectomy
619010|NCT00559351|chemotherapy|chemotherapy
619011|NCT00559351|chemoradiotherapy|chemoradiotherapy
619012|NCT00559351|combined modality therapy|combined modality therapy
619013|NCT00559338|CHF|chf
619014|NCT00559338|Heart Failure|heart failure
619015|NCT00559338|Dyspnea|dyspnea
619016|NCT00559338|Cardiomyopathy|cardiomyopathy
619017|NCT00559312|mild COPD|mild copd
619018|NCT00559312|dyspnea|dyspnea
619019|NCT00559312|exercise|exercise
619020|NCT00559312|combination therapy|combination therapy
619021|NCT00559299|163090|163090
619022|NCT00559299|placebo-controlled|placebo-controlled
619023|NCT00559299|MDD|mdd
619024|NCT00559299|Depression|depression
619025|NCT00559299|Tolerability|tolerability
619026|NCT00559299|MDE|mde
619027|NCT00559286|perfusion|perfusion
619028|NCT00559286|microcirculation|microcirculation
619029|NCT00559286|RBC function|rbc function
619030|NCT00559286|NO metabolism|no metabolism
619031|NCT00559286|AT receptor blocker|at receptor blocker
619032|NCT00559234|Optic Nerve|optic nerve
619033|NCT00559234|Retina|retina
619034|NCT00559234|Cornea|cornea
619035|NCT00559234|Lens|lens
619036|NCT00559234|Ocular Genetic Diseases|ocular genetic diseases
619037|NCT00559234|Inherited Eye Disease|inherited eye disease
619038|NCT00559234|Genetic Eye Disease|genetic eye disease
619039|NCT00559221|AML|aml
619040|NCT00559208|Children and Youth|children and youth
619041|NCT00559208|Families|families
619042|NCT00559208|Differential Response|differential response
619043|NCT00559195|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
619044|NCT00559195|anemia|anemia
619045|NCT00559195|fatigue|fatigue
619046|NCT00559169|epilepsy|epilepsy
619047|NCT00559169|seizures|seizures
619048|NCT00559169|menstrual cycle|menstrual cycle
619049|NCT00559156|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
619050|NCT00559156|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
619127|NCT00559000|trauma-focused Treatment|trauma-focused treatment
619051|NCT00559156|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
619052|NCT00559156|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
619053|NCT00559156|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
619054|NCT00559156|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
619055|NCT00559156|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
619056|NCT00559156|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
619057|NCT00559156|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
619058|NCT00559156|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
619059|NCT00559156|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
619060|NCT00559156|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
619061|NCT00559156|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
619062|NCT00559156|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
619063|NCT00559156|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
619064|NCT00559156|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
619065|NCT00559156|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
619066|NCT00559156|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
619067|NCT00559156|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
619068|NCT00559156|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
619069|NCT00559156|recurrent salivary gland cancer|recurrent salivary gland cancer
619070|NCT00559156|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
619071|NCT00559156|stage III salivary gland cancer|stage iii salivary gland cancer
619072|NCT00559156|stage IV salivary gland cancer|stage iv salivary gland cancer
619073|NCT00559143|AV conduction disturbances|av conduction disturbances
619074|NCT00559143|LV function|lv function
619075|NCT00559143|Biventricular Pacing|biventricular pacing
619076|NCT00559143|Conductance Catheters|conductance catheters
619077|NCT00559130|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
619078|NCT00559130|Acute Lung Injury|acute lung injury
619079|NCT00559130|Sepsis|sepsis
619080|NCT00559130|Hemoperfusion|hemoperfusion
619081|NCT00559104|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
619082|NCT00559104|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
619083|NCT00559104|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
619084|NCT00559104|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
619085|NCT00559104|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
619086|NCT00559104|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
619087|NCT00559104|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
619088|NCT00559104|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
619089|NCT00559104|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
619090|NCT00559104|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
619091|NCT00559091|AML|aml
619092|NCT00559091|Acute myelocytic leukemia|acute myelocytic leukemia
619093|NCT00559091|leukemia|leukemia
619094|NCT00559091|relapsed|relapsed
619095|NCT00559091|refractory|refractory
619096|NCT00559091|M4|m4
619097|NCT00559091|M5|m5
619098|NCT00559078|Adrenal Hyperplasia, Congenital|adrenal hyperplasia, congenital
619099|NCT00559078|Psychosexual Development|psychosexual development
619100|NCT00559078|Sexual Development|sexual development
619101|NCT00559078|Intersex|intersex
619102|NCT00559078|Qualitative|qualitative
619103|NCT00559078|CAH|cah
619104|NCT00559078|Interview|interview
619105|NCT00559078|Disorder of Sex Development|disorder of sex development
619106|NCT00559078|Telephone|telephone
619107|NCT00559078|Quality of Life|quality of life
619108|NCT00559078|Mental Health|mental health
619109|NCT00559078|Counseling|counseling
619110|NCT00559065|Case-Cohort Study|case-cohort study
619111|NCT00559065|Leukemia|leukemia
619112|NCT00559065|Lymphoma|lymphoma
619113|NCT00559065|Benzene|benzene
619114|NCT00559065|Blood Disorders|blood disorders
619115|NCT00559065|Solvent Exposure|solvent exposure
619116|NCT00559065|Cancer Risk|cancer risk
619117|NCT00559052|Enzymes|enzymes
619118|NCT00559052|VIOKASE|viokase
619119|NCT00559052|Bioavailability|bioavailability
619120|NCT00559039|breast cancer|breast cancer
619121|NCT00559039|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
619122|NCT00559013|Staple line reinforcement|staple line reinforcement
619123|NCT00559013|Staple line buttress|staple line buttress
619124|NCT00559013|Anastomotic reinforcement|anastomotic reinforcement
619125|NCT00559000|PTSD|ptsd
619126|NCT00559000|Children|children
619128|NCT00559000|KIDNET|kidnet
619129|NCT00559000|Narrative Exposure Therapy for Children|narrative exposure therapy for children
619130|NCT00558987|Discipline|discipline
619131|NCT00558987|Parenting|parenting
619132|NCT00558987|Primary Care|primary care
619133|NCT00558987|Videos|videos
619134|NCT00558961|CLL|cll
619135|NCT00558961|chronic lymphocytic leukemia|chronic lymphocytic leukemia
619136|NCT00558961|leukemia|leukemia
619137|NCT00558961|gleevec|gleevec
619138|NCT00558961|chlorambucil|chlorambucil
619139|NCT00558948|Bone Marrow Transplant|bone marrow transplant
619140|NCT00558948|Bone Mineral Density|bone mineral density
619141|NCT00558948|Survivors|survivors
619142|NCT00558948|Muscle Strength|muscle strength
619143|NCT00558922|Lung|lung
619144|NCT00558922|Non small cell|non small cell
619145|NCT00558922|antisense|antisense
619146|NCT00558922|oligonucleotide|oligonucleotide
619147|NCT00558922|paclitaxel|paclitaxel
619148|NCT00558922|carboplatin|carboplatin
619149|NCT00558896|stage II multiple myeloma|stage ii multiple myeloma
619150|NCT00558896|stage III multiple myeloma|stage iii multiple myeloma
619151|NCT00558896|refractory multiple myeloma|refractory multiple myeloma
619152|NCT00558870|Solid Tumors|solid tumors
619153|NCT00558870|Morphine|morphine
619154|NCT00558870|Methadone|methadone
619155|NCT00558870|Co-Opioid Analgesic|co-opioid analgesic
619156|NCT00558870|Pain|pain
619157|NCT00558844|Cystic Fibrosis|cystic fibrosis
619158|NCT00558844|Respiratory Infections|respiratory infections
619159|NCT00558844|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
619160|NCT00558844|CFTR|cftr
619161|NCT00558831|Acne|acne
619162|NCT00558779|Coronary artery bypass|coronary artery bypass
619163|NCT00558779|off pump coronary artery bypass grafting (OPCAB)|off pump coronary artery bypass grafting (opcab)
619164|NCT00558766|Disruptive Behavior Disorders|disruptive behavior disorders
619165|NCT00558766|Behavior|behavior
619166|NCT00558766|Gambling|gambling
619167|NCT00558766|Dopaminergic Mechanisms|dopaminergic mechanisms
619168|NCT00558766|Dopamine|dopamine
619169|NCT00558766|Parkinson Disease|parkinson disease
619170|NCT00558766|PD|pd
619171|NCT00558740|Dietary protein|dietary protein
619172|NCT00558740|Fructose|fructose
619173|NCT00558740|VLDL-triglycerides|vldl-triglycerides
619174|NCT00558740|Hepatic de novo lipogenesis|hepatic de novo lipogenesis
619175|NCT00558740|Lipid oxidation|lipid oxidation
619176|NCT00558727|Advanced Solid Tumors|advanced solid tumors
619177|NCT00558727|Solid Tumors|solid tumors
619178|NCT00558727|Tumor|tumor
619179|NCT00558727|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
619180|NCT00558727|Chemotherapy|chemotherapy
619181|NCT00558727|Benzoquinone|benzoquinone
619182|NCT00558701|burns|burns
619183|NCT00558701|donor site|donor site
619184|NCT00558701|healing|healing
619185|NCT00558701|microcurrent|microcurrent
619186|NCT00558675|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
619187|NCT00558675|Hodgkins Lymphoma|hodgkins lymphoma
619188|NCT00558675|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
619189|NCT00558675|Chronic Myeloid Leukemia|chronic myeloid leukemia
619190|NCT00558675|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
619191|NCT00558675|Multiple Myeloma|multiple myeloma
619192|NCT00558675|Immunotherapy|immunotherapy
619193|NCT00558675|Allogeneic Cell Therapy|allogeneic cell therapy
619194|NCT00558662|compression therapy|compression therapy
619195|NCT00558662|venous leg ulcer|venous leg ulcer
619196|NCT00558662|sub bandage pressure|sub bandage pressure
619197|NCT00558636|NSCLC|nsclc
619198|NCT00558623|lead, blood|lead, blood
619199|NCT00558623|pregnancy|pregnancy
619200|NCT00558623|calcium|calcium
619201|NCT00558623|randomized trial|randomized trial
619202|NCT00558623|dietary supplementation|dietary supplementation
619203|NCT00558623|bone resorption|bone resorption
619204|NCT00558597|Proteomics|proteomics
619205|NCT00558597|Lung Transplantation|lung transplantation
619206|NCT00558584|dilated cardiomyopathy|dilated cardiomyopathy
619207|NCT00558584|immunoadsorption|immunoadsorption
619208|NCT00558584|immunoglobulin G|immunoglobulin g
619209|NCT00558558|Solid Tumors|solid tumors
619210|NCT00558558|Cancer-Associated Anorexia|cancer-associated anorexia
619211|NCT00558558|Weight Loss|weight loss
619212|NCT00558558|Haelan|haelan
619213|NCT00558558|Fermented Soy Product|fermented soy product
619214|NCT00558558|Nutrition|nutrition
619215|NCT00558558|Cachexia|cachexia
619216|NCT00558545|Breast|breast
619217|NCT00558545|paclitaxel|paclitaxel
619218|NCT00558545|antisense|antisense
619219|NCT00558545|oligonucleotide|oligonucleotide
619220|NCT00558532|Morbid obesity|morbid obesity
619221|NCT00558532|Omega-3 fatty acid levels|omega-3 fatty acid levels
619222|NCT00558519|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
619223|NCT00558519|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
619224|NCT00558519|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
619225|NCT00558506|Ankylosing spondylitis|ankylosing spondylitis
619226|NCT00558506|activity|activity
619227|NCT00558506|treatment|treatment
619228|NCT00558506|clinical trial|clinical trial
619329|NCT00558103|GW786034|gw786034
619229|NCT00558454|Iron supplements|iron supplements
619230|NCT00558454|Infant|infant
619231|NCT00558454|Low birth weight|low birth weight
619232|NCT00558454|Prevention of iron deficiency and its physiological consequences|prevention of iron deficiency and its physiological consequences
619233|NCT00558454|Safety|safety
619234|NCT00558376|Colonoscopy|colonoscopy
619235|NCT00558363|Prostate Cancer|prostate cancer
619236|NCT00558363|AVODART|avodart
619237|NCT00558363|PSA|psa
619238|NCT00558363|dutasteride|dutasteride
619239|NCT00558363|PSADT|psadt
619240|NCT00558363|Prostate specific antigen|prostate specific antigen
619241|NCT00558363|radical therapy|radical therapy
619242|NCT00558363|doubling time|doubling time
619243|NCT00558350|lobectomy|lobectomy
619244|NCT00558350|inflammatory reaction|inflammatory reaction
619245|NCT00558350|intrapulmonary|intrapulmonary
619246|NCT00558350|intrapleural|intrapleural
619247|NCT00558337|Treatment of Parkinson's Disease|treatment of parkinson's disease
619248|NCT00558324|LASIK|lasik
619249|NCT00558324|Confocal microscopy|confocal microscopy
619250|NCT00558324|Flap|flap
619251|NCT00558311|Aneurysmal|aneurysmal
619252|NCT00558311|Subarachnoid|subarachnoid
619253|NCT00558311|Hemorrhage|hemorrhage
619254|NCT00558311|vasospasm|vasospasm
619255|NCT00558311|clazosentan|clazosentan
619256|NCT00558311|PIVLAZ|pivlaz
619257|NCT00558311|Actelion|actelion
619258|NCT00558311|surgical clipping|surgical clipping
619259|NCT00558298|schizophrenia|schizophrenia
619260|NCT00558298|schizoaffective disorder|schizoaffective disorder
619261|NCT00558298|risperidone|risperidone
619262|NCT00558298|intramuscular injection|intramuscular injection
619263|NCT00558298|long-acting injectable|long-acting injectable
619264|NCT00558285|COPD|copd
619265|NCT00558285|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
619266|NCT00558285|Indacaterol|indacaterol
619267|NCT00558285|QVA149|qva149
619268|NCT00558272|breast cancer|breast cancer
619269|NCT00558272|prostate cancer|prostate cancer
619270|NCT00558272|metastatic bone disease|metastatic bone disease
619271|NCT00558272|Subjects with breast cancer or prostate cancer with metastatic bone disease|subjects with breast cancer or prostate cancer with metastatic bone disease
619272|NCT00558246|Breast Lift|breast lift
619273|NCT00558246|Breast Reduction|breast reduction
619274|NCT00558246|Breast Reconstruction|breast reconstruction
619275|NCT00558246|Plastic Surgery|plastic surgery
619276|NCT00558246|Skin Closure|skin closure
619277|NCT00558246|Wound Healing|wound healing
619278|NCT00558246|Dermabond|dermabond
619279|NCT00558233|Colorectal cancer|colorectal cancer
619280|NCT00558233|Screening|screening
619281|NCT00558233|Health literacy|health literacy
619282|NCT00558233|Patient education|patient education
619283|NCT00558233|Computer assisted instruction|computer assisted instruction
619284|NCT00558220|Lymphoma, B-cell|lymphoma, b-cell
619285|NCT00558220|Immunotherapy, passive|immunotherapy, passive
619286|NCT00558220|Remission induction|remission induction
619287|NCT00558220|Autologous transplantation|autologous transplantation
619288|NCT00558207|Pancreatic cancer|pancreatic cancer
619289|NCT00558207|pancreas cancer|pancreas cancer
619290|NCT00558207|Locally advanced or metastatic pancreatic adenocarcioma|locally advanced or metastatic pancreatic adenocarcioma
619291|NCT00558194|Weight loss|weight loss
619292|NCT00558181|B CLL|b cll
619293|NCT00558181|Chronic B Lymphocytic Leukemia|chronic b lymphocytic leukemia
619294|NCT00558181|Methylprednisolone|methylprednisolone
619295|NCT00558181|Rituximab|rituximab
619296|NCT00558168|Anastrazole|anastrazole
619297|NCT00558168|safety|safety
619298|NCT00558168|early breast cancer|early breast cancer
619299|NCT00558155|immunonutrition|immunonutrition
619300|NCT00558155|enteral nutrition|enteral nutrition
619301|NCT00558155|parenteral nutrition|parenteral nutrition
619302|NCT00558155|surgery|surgery
619303|NCT00558142|contrast nephropathy|contrast nephropathy
619304|NCT00558142|radiocontrast-induced nephropathy|radiocontrast-induced nephropathy
619305|NCT00558142|chronic kidney disease|chronic kidney disease
619306|NCT00558142|acetylcysteine|acetylcysteine
619307|NCT00558142|clinical study|clinical study
619308|NCT00558129|Lumbar Spinal Stenosis|lumbar spinal stenosis
619309|NCT00558129|X-STOP® IPD|x-stop® ipd
619310|NCT00558129|Interspinous process decompression|interspinous process decompression
619311|NCT00558129|Neurogenic Intermittent Claudication|neurogenic intermittent claudication
619312|NCT00558116|Carpal Tunnel Syndrome|carpal tunnel syndrome
619313|NCT00558116|Dynamic Splinting|dynamic splinting
619314|NCT00558116|Nerve Conduction Studies|nerve conduction studies
619315|NCT00558116|Splinting|splinting
619316|NCT00558116|Levine Katz Survey|levine katz survey
619317|NCT00558103|GW572016|gw572016
619318|NCT00558103|Breast Cancer|breast cancer
619319|NCT00558103|RECIST|recist
619320|NCT00558103|Inflammatory Breast Cancer|inflammatory breast cancer
619321|NCT00558103|Pazopanib|pazopanib
619322|NCT00558103|ErbB2|erbb2
619323|NCT00558103|Cutaneous Disease|cutaneous disease
619324|NCT00558103|Tykerb|tykerb
619325|NCT00558103|Inflammatory|inflammatory
619326|NCT00558103|Skin|skin
619327|NCT00558103|Her2|her2
619328|NCT00558103|Lapatinib|lapatinib
619330|NCT00558090|pain|pain
619331|NCT00558090|Intensive Care Unit|intensive care unit
619332|NCT00558090|morphine|morphine
619333|NCT00558090|pKpD|pkpd
619334|NCT00558090|numerical rating scale|numerical rating scale
619335|NCT00558090|critically ill patients|critically ill patients
619336|NCT00558077|Anovulation|anovulation
619337|NCT00558077|Clomiphene citrate|clomiphene citrate
619338|NCT00558077|Fertility|fertility
619339|NCT00558077|Metformin|metformin
619340|NCT00558077|Ovulation induction|ovulation induction
619341|NCT00558077|PCOS|pcos
619342|NCT00558077|Sterility|sterility
619343|NCT00558077|Treatment|treatment
619344|NCT00558077|Clomiphene citrate-resistance|clomiphene citrate-resistance
619345|NCT00558051|Colorectal Cancer|colorectal cancer
619346|NCT00558051|Colorectal Carcinoma|colorectal carcinoma
619347|NCT00558051|Colorectal Tumors|colorectal tumors
619348|NCT00558051|Neoplasms, Colorectal|neoplasms, colorectal
619349|NCT00558038|Hepatic|hepatic
619350|NCT00558038|Encephalopathy|encephalopathy
619351|NCT00558038|Liver|liver
619352|NCT00558038|Liver Disease|liver disease
619353|NCT00558038|Liver Failure|liver failure
619354|NCT00558038|Lactulose|lactulose
619355|NCT00558038|AST-120|ast-120
619356|NCT00558012|Osteoporosis|osteoporosis
619357|NCT00558012|Bone loss|bone loss
619358|NCT00558012|Frail Geriatric Women|frail geriatric women
619359|NCT00558012|Nursing Home Patients|nursing home patients
619360|NCT00558012|Fragility Fractures|fragility fractures
619361|NCT00557999|Cardiology|cardiology
619362|NCT00557999|Mechanical ventilation|mechanical ventilation
619363|NCT00557999|Intensive care|intensive care
619364|NCT00557986|1-Metastatic breast cancer|1-metastatic breast cancer
619365|NCT00557986|2-Surgery|2-surgery
619366|NCT00557986|3-Survival|3-survival
619367|NCT00557947|Abdominoplasty|abdominoplasty
619368|NCT00557947|Body Lift|body lift
619369|NCT00557947|Plastic Surgery|plastic surgery
619370|NCT00557947|Skin Closure|skin closure
619371|NCT00557947|Wound Healing|wound healing
619372|NCT00557947|Dermabond|dermabond
619373|NCT00557934|tetralogy of Fallot|tetralogy of fallot
619374|NCT00557934|right ventricular dysfunction|right ventricular dysfunction
619375|NCT00557934|pulmonary insufficiency|pulmonary insufficiency
619376|NCT00557934|pulmonary valve replacement|pulmonary valve replacement
619377|NCT00557934|pressure-volume loops|pressure-volume loops
619378|NCT00557934|long-term follow-up in tetralogy of Fallot|long-term follow-up in tetralogy of fallot
619379|NCT00557921|ACS|acs
619380|NCT00557921|CAD|cad
619381|NCT00557921|MI|mi
619382|NCT00557921|PCI|pci
619383|NCT00557921|PTCA|ptca
619384|NCT00557921|NSTEMI|nstemi
619385|NCT00557921|STEMI|stemi
619386|NCT00557921|acute coronary syndrome|acute coronary syndrome
619387|NCT00557921|cerebrovascular disorders|cerebrovascular disorders
619388|NCT00557921|coronary artery stent placement|coronary artery stent placement
619389|NCT00557921|coronary thrombosis|coronary thrombosis
619390|NCT00557921|myocardial infarction|myocardial infarction
619391|NCT00557921|myocardial ischemia|myocardial ischemia
619392|NCT00557921|percutaneous coronary intervention|percutaneous coronary intervention
619393|NCT00557921|percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
619394|NCT00557921|peripheral vascular diseases|peripheral vascular diseases
619395|NCT00557921|duodenal obstruction|duodenal obstruction
619396|NCT00557921|duodenal ulcer|duodenal ulcer
619397|NCT00557921|dyspepsia|dyspepsia
619398|NCT00557921|esophagitis, peptic|esophagitis, peptic
619399|NCT00557921|gastric outlet obstruction|gastric outlet obstruction
619400|NCT00557921|gastroduodenal ulcer|gastroduodenal ulcer
619401|NCT00557921|gastroesophageal reflux disease|gastroesophageal reflux disease
619402|NCT00557921|gastrointestinal hemorrhage|gastrointestinal hemorrhage
619403|NCT00557921|peptic ulcer|peptic ulcer
619404|NCT00557921|peptic ulcer perforation|peptic ulcer perforation
619405|NCT00557908|Von Willebrand Disease|von willebrand disease
619406|NCT00557908|VWD|vwd
619407|NCT00557908|prophylaxis|prophylaxis
619408|NCT00557895|Asthma|asthma
619409|NCT00557895|Hypersensitivity|hypersensitivity
619410|NCT00557895|Peanut Allergy|peanut allergy
619411|NCT00557895|Eosinophilic Esophagitis|eosinophilic esophagitis
619412|NCT00557895|Eosinophilic Gastroenteritis|eosinophilic gastroenteritis
619413|NCT00557882|prolapse|prolapse
619414|NCT00557882|uterus|uterus
619415|NCT00557882|mesh|mesh
619416|NCT00557882|bladder|bladder
619417|NCT00557856|Solid Tumors Transforming Growth Factor Beta Activin Receptor-like Kinase 1|solid tumors transforming growth factor beta activin receptor-like kinase 1
619418|NCT00557843|Bupivacaine|bupivacaine
619419|NCT00557843|Colon|colon
619420|NCT00557843|Surgery|surgery
619421|NCT00557843|Oxygenation|oxygenation
619422|NCT00557830|Renal Cell Carcinoma|renal cell carcinoma
619423|NCT00557830|Kidney Cancer|kidney cancer
619424|NCT00557817|HCT|hct
619425|NCT00557817|autologous|autologous
619426|NCT00557817|erythropoiesis|erythropoiesis
619427|NCT00557817|iron saccharate|iron saccharate
619428|NCT00557817|erythropoietin|erythropoietin
619429|NCT00557817|darbepoetin alpha|darbepoetin alpha
619430|NCT00557804|Congestive Heart Failure|congestive heart failure
619431|NCT00557791|AMD|amd
619432|NCT00557791|ARMD|armd
619433|NCT00557791|Exudative Macular Degeneration|exudative macular degeneration
619434|NCT00557791|Bevasiranib|bevasiranib
619435|NCT00557791|siRNA|sirna
619436|NCT00557778|prevention|prevention
619437|NCT00557778|dyslipidemia|dyslipidemia
619438|NCT00557765|Tuberculosis|tuberculosis
619439|NCT00557765|Latent tuberculosis infection|latent tuberculosis infection
619440|NCT00557765|Interferon gamma release assay|interferon gamma release assay
619441|NCT00557765|Contact tracing|contact tracing
619442|NCT00557739|CRx-191|crx-191
619443|NCT00557739|Plaque|plaque
619444|NCT00557739|Psoriasis|psoriasis
619445|NCT00557739|nortriptyline hydrochloride|nortriptyline hydrochloride
619446|NCT00557739|mometasone furoate|mometasone furoate
619447|NCT00557739|psoriatic infiltrate|psoriatic infiltrate
619448|NCT00557726|Inflammation|inflammation
619449|NCT00557726|Infection|infection
619450|NCT00557726|Fever|fever
619451|NCT00557700|Mild to moderate asthma|mild to moderate asthma
619452|NCT00557687|IVF|ivf
619453|NCT00557687|ovarian reserve|ovarian reserve
619454|NCT00557687|poor response|poor response
619455|NCT00557661|Heart failure|heart failure
619456|NCT00557661|CD-NP|cd-np
619457|NCT00557648|Anxiety|anxiety
619458|NCT00557648|Children|children
619459|NCT00557648|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
619460|NCT00557648|School-Based Interventions|school-based interventions
619461|NCT00557635|pseudo-arthrosis, osseous matrix, cell therapy|pseudo-arthrosis, osseous matrix, cell therapy
619462|NCT00557622|PTSD (Posttraumatic Stress Disorder)|ptsd (posttraumatic stress disorder)
619463|NCT00557622|CAPS|caps
619464|NCT00557622|fMRI|fmri
619465|NCT00557622|Paroxetine|paroxetine
619466|NCT00557609|Microphthalmia transcription (MiT) factor associated tumors|microphthalmia transcription (mit) factor associated tumors
619467|NCT00557609|Alveolar soft part sarcoma (ASPS)|alveolar soft part sarcoma (asps)
619468|NCT00557609|Clear cell sarcoma (CCS)|clear cell sarcoma (ccs)
619469|NCT00557609|Renal cell carcinoma (RCC)|renal cell carcinoma (rcc)
619470|NCT00557596|Pancreatic|pancreatic
619471|NCT00557596|antisense|antisense
619472|NCT00557596|oligonucleotide|oligonucleotide
619473|NCT00557596|gemcitabine|gemcitabine
619474|NCT00557583|VBY-376 Hepatitis C pharmacokinetics safety|vby-376 hepatitis c pharmacokinetics safety
619475|NCT00557570|Antiretroviral|antiretroviral
619476|NCT00557570|Opportunistic Infection|opportunistic infection
619477|NCT00557570|treatment experienced|treatment experienced
619478|NCT00557570|treatment naive|treatment naive
619479|NCT00557557|Colorectal|colorectal
619480|NCT00557557|liver|liver
619481|NCT00557557|cancer|cancer
619482|NCT00557557|metastases|metastases
619483|NCT00557544|migraine|migraine
619484|NCT00557544|metoclopramide|metoclopramide
619485|NCT00557544|ketoprofen|ketoprofen
619486|NCT00557544|child|child
619487|NCT00557492|pancreas|pancreas
619488|NCT00557492|pancreatic|pancreatic
619489|NCT00557492|cancer|cancer
619490|NCT00557492|resectable|resectable
619491|NCT00557466|QMF|qmf
619492|NCT00557466|indacaterol|indacaterol
619493|NCT00557466|TWISTHALER® device|twisthaler® device
619494|NCT00557440|Asthma|asthma
619495|NCT00557440|QMF|qmf
619496|NCT00557440|Indacaterol|indacaterol
619497|NCT00557440|Mometasone|mometasone
619498|NCT00557427|mild to moderate depression according to the DSM-IV scale|mild to moderate depression according to the dsm-iv scale
619499|NCT00557414|acute respiratory distress syndrome|acute respiratory distress syndrome
619500|NCT00557414|soluble triggering receptor expressed on myeloid cells-1|soluble triggering receptor expressed on myeloid cells-1
619501|NCT00557414|prognosis|prognosis
619502|NCT00557388|muscle loss|muscle loss
619503|NCT00557388|aging|aging
619504|NCT00557388|protein|protein
619505|NCT00557388|amino acids|amino acids
619506|NCT00557388|exercise|exercise
619507|NCT00557388|protein synthesis|protein synthesis
619508|NCT00557375|Brain Tumors|brain tumors
619509|NCT00557375|Survey|survey
619510|NCT00557362|Keratitis|keratitis
619511|NCT00557362|Eye Infection, Fungal|eye infection, fungal
619512|NCT00557362|Fungal Eye Infection|fungal eye infection
619513|NCT00557362|Ocular Infection, Fungal|ocular infection, fungal
619514|NCT00557362|Fungal Keratitis|fungal keratitis
619515|NCT00557362|Mycotic Infections, Ocular|mycotic infections, ocular
619516|NCT00557362|Voriconazole|voriconazole
619517|NCT00557362|Natamycin|natamycin
619518|NCT00557349|gastric bypass surgery|gastric bypass surgery
619519|NCT00557349|anastomosis, Roux-en-Y|anastomosis, roux-en-y
619520|NCT00557349|Complication, Postoperative|complication, postoperative
619521|NCT00557310|osteoporosis, teriparatide, postmenopausal, MRI, finite element analysis|osteoporosis, teriparatide, postmenopausal, mri, finite element analysis
619522|NCT00557297|asthma|asthma
619523|NCT00557297|SMART|smart
619524|NCT00557297|inhaled|inhaled
619525|NCT00557297|glucocorticosteroid|glucocorticosteroid
619526|NCT00557297|reliever|reliever
619527|NCT00557297|maintenance|maintenance
619528|NCT00557297|single inhaler|single inhaler
619529|NCT00557284|Atopic Dermatitis (Eczema) associated with food allergies|atopic dermatitis (eczema) associated with food allergies
619530|NCT00557245|HIV infection|hiv infection
619531|NCT00557245|HIV uninfected partners|hiv uninfected partners
619532|NCT00557245|Double Blind|double blind
619533|NCT00557245|Placebo|placebo
619534|NCT00557245|Seroconversion|seroconversion
619535|NCT00557245|TDF|tdf
619536|NCT00557245|FTC TDF|ftc tdf
619537|NCT00557245|Safety|safety
619538|NCT00557245|HIV Seronegativity|hiv seronegativity
619539|NCT00557232|bevacizumab|bevacizumab
619540|NCT00557232|rubeosis iridis|rubeosis iridis
619541|NCT00557232|glaucoma|glaucoma
619542|NCT00557219|cardiac surgery|cardiac surgery
619543|NCT00557219|fenoldopam|fenoldopam
619544|NCT00557219|ketanserin|ketanserin
619545|NCT00557219|renal replacement therapy|renal replacement therapy
619546|NCT00557206|Recurrent Disease|recurrent disease
619547|NCT00557206|Metastatic Disease|metastatic disease
619548|NCT00557206|Squamous Cell Carcinoma|squamous cell carcinoma
619549|NCT00557206|Multicenter|multicenter
619550|NCT00557206|Phase II|phase ii
619551|NCT00557180|Steroid Resistance|steroid resistance
619552|NCT00557180|Inflammation|inflammation
619553|NCT00557154|Pediatrics|pediatrics
619554|NCT00557154|Venous access|venous access
619555|NCT00557154|Emergency|emergency
619556|NCT00557141|Single arm observational retrospective and prospective study|single arm observational retrospective and prospective study
619557|NCT00557128|COREG CR,|coreg cr,
619558|NCT00557128|lisinopril,|lisinopril,
619559|NCT00557128|hypertension,|hypertension,
619560|NCT00557128|dose proportionality,|dose proportionality,
619561|NCT00557128|fixed dose combination (FDC)|fixed dose combination (fdc)
619562|NCT00557115|Quality of life|quality of life
619563|NCT00557115|Quadriceps|quadriceps
619564|NCT00557115|Muscle|muscle
619565|NCT00557115|Exacerbation|exacerbation
619566|NCT00557102|liver metastases|liver metastases
619567|NCT00557102|lung metastases|lung metastases
619568|NCT00557102|recurrent rectal cancer|recurrent rectal cancer
619569|NCT00557102|stage IV rectal cancer|stage iv rectal cancer
619570|NCT00557102|adenocarcinoma of the rectum|adenocarcinoma of the rectum
619571|NCT00557102|adenocarcinoma of the colon|adenocarcinoma of the colon
619572|NCT00557102|recurrent colon cancer|recurrent colon cancer
619573|NCT00557102|stage IV colon cancer|stage iv colon cancer
619574|NCT00557089|Pediatrics|pediatrics
619575|NCT00557089|Cystic Fibrosis|cystic fibrosis
619576|NCT00557089|Lung Clearance Index|lung clearance index
619577|NCT00557089|rhDNAse|rhdnase
619578|NCT00557076|Randomized Clinical Trial|randomized clinical trial
619579|NCT00557076|Auditory Stimulation|auditory stimulation
619580|NCT00557050|Hamstring|hamstring
619581|NCT00557050|Muscle|muscle
619582|NCT00557050|Injury|injury
619583|NCT00557050|Prevention|prevention
619584|NCT00557050|Muscles|muscles
619585|NCT00557037|Castrate and Non-Castrate Prostate Cancer|castrate and non-castrate prostate cancer
619586|NCT00557024|hepatocellular carcinoma|hepatocellular carcinoma
619587|NCT00557024|liver cancer|liver cancer
619588|NCT00557024|radiofrequency ablation|radiofrequency ablation
619589|NCT00557024|radiotherapy|radiotherapy
619590|NCT00557024|adjuvant therapy|adjuvant therapy
619591|NCT00556998|pharmacokinetics and safety data of voriconazole in immunocompromised adolescents|pharmacokinetics and safety data of voriconazole in immunocompromised adolescents
619592|NCT00556959|ADHD|adhd
619593|NCT00556959|Clonidine|clonidine
619594|NCT00556959|Attention Deficit|attention deficit
619595|NCT00556959|Hyperactivity|hyperactivity
619596|NCT00556959|CLONICEL|clonicel
619597|NCT00556959|Addrenex|addrenex
619598|NCT00556946|Vascular Malformation|vascular malformation
619599|NCT00556933|Induction|induction
619600|NCT00556933|rATG|ratg
619601|NCT00556933|Calcineurin-inhibitor withdrawal|calcineurin-inhibitor withdrawal
619602|NCT00556920|Coreg CR|coreg cr
619603|NCT00556907|DCIS|dcis
619604|NCT00556907|To evaluate Preoperative mammagraphy and MRI to select candiates with DCIS for IORT|to evaluate preoperative mammagraphy and mri to select candiates with dcis for iort
619605|NCT00556868|High school students|high school students
619606|NCT00556868|Boarding school|boarding school
619607|NCT00556868|Breakfast|breakfast
619609|NCT00556868|Memory|memory
619610|NCT00556868|Attention|attention
619611|NCT00556868|Mood|mood
619612|NCT00556855|chronic hand dermatitis|chronic hand dermatitis
619613|NCT00556855|research study|research study
619614|NCT00556855|E-do|e-do
619615|NCT00556855|HK-03|hk-03
619616|NCT00556842|Hemi-Arthroplasty|hemi-arthroplasty
619617|NCT00556842|Total Hip Arthroplasty|total hip arthroplasty
619618|NCT00556816|COPD|copd
619619|NCT00556816|outpatient on demand clinic|outpatient on demand clinic
619620|NCT00556803|hepatocellular carcinoma|hepatocellular carcinoma
619621|NCT00556803|liver cancer|liver cancer
619622|NCT00556803|radiofrequency ablation|radiofrequency ablation
619623|NCT00556803|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
619624|NCT00556803|adjuvant therapy|adjuvant therapy
619625|NCT00556777|stage I breast cancer|stage i breast cancer
619626|NCT00556764|ANAM|anam
619627|NCT00556764|Parkinson's|parkinson's
619628|NCT00556751|Electrocardiogram|electrocardiogram
619629|NCT00556751|Electrocardiography|electrocardiography
619630|NCT00556751|Cardiovascular Risk Factors|cardiovascular risk factors
619631|NCT00556751|Cholesterol|cholesterol
619632|NCT00556751|Blood Pressure|blood pressure
619633|NCT00556751|Diabetes|diabetes
619634|NCT00556738|HFPV|hfpv
619635|NCT00556738|neonatal respiratory distress|neonatal respiratory distress
619636|NCT00556699|NHL|nhl
619637|NCT00556699|Rituxan|rituxan
619638|NCT00556699|anti-CD40|anti-cd40
619639|NCT00556673|Asthma, QMF149, fixed combination of indacaterol and mometasone furoate|asthma, qmf149, fixed combination of indacaterol and mometasone furoate
619640|NCT00556660|Alzheimer|alzheimer
619641|NCT00556660|SPECT|spect
619642|NCT00556647|fast-track diagnosis|fast-track diagnosis
619643|NCT00556647|PET-CT|pet-ct
619644|NCT00556647|endoscopic techniques|endoscopic techniques
619645|NCT00556647|lung cancer|lung cancer
619646|NCT00556634|HIV|hiv
619647|NCT00556634|efavirenz|efavirenz
619648|NCT00556634|central nervous system|central nervous system
619649|NCT00556634|adverse effects|adverse effects
619650|NCT00556621|stage II bladder cancer|stage ii bladder cancer
619651|NCT00556621|stage III bladder cancer|stage iii bladder cancer
619652|NCT00556621|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
619653|NCT00556595|atrial fibrillation|atrial fibrillation
619654|NCT00556595|paroxysmal|paroxysmal
619655|NCT00556595|symptomatic|symptomatic
619656|NCT00556595|drug-refractory|drug-refractory
619657|NCT00556569|Physical activity|physical activity
619658|NCT00556569|Obesity|obesity
619659|NCT00556543|Rib Fracture|rib fracture
619660|NCT00556543|Rib Fracture Repair|rib fracture repair
619661|NCT00556543|Rib Fracture ORIF|rib fracture orif
619662|NCT00556543|Flail Chest|flail chest
619663|NCT00556543|Implant|implant
619664|NCT00556543|Prosthesis|prosthesis
619665|NCT00556543|Rib fracture non-union|rib fracture non-union
619666|NCT00556543|Chest wall deformity|chest wall deformity
619667|NCT00556530|Congenital Heart Defects|congenital heart defects
619668|NCT00556530|Single Nucleotide Polymorphisms|single nucleotide polymorphisms
619669|NCT00556530|Copy Number Variations|copy number variations
619670|NCT00556530|Whole Genome Association Study|whole genome association study
619671|NCT00556517|Hamstring|hamstring
619672|NCT00556517|Strain|strain
619673|NCT00556517|Rehabilitation|rehabilitation
619674|NCT00556517|muscles|muscles
619675|NCT00556504|add-on treatment|add-on treatment
619676|NCT00556504|botanical drug|botanical drug
619677|NCT00556504|HCV genotype 1|hcv genotype 1
619678|NCT00556504|TCM-700C|tcm-700c
619679|NCT00556504|genotype I|genotype i
619680|NCT00556491|renal|renal
619681|NCT00556491|kidney|kidney
619682|NCT00556491|injury|injury
619683|NCT00556491|acute|acute
619684|NCT00556491|bypass|bypass
619685|NCT00556491|cardiac|cardiac
619686|NCT00556491|minocycline|minocycline
619687|NCT00556491|prevention|prevention
619688|NCT00556491|Acute Kidney Failure|acute kidney failure
619689|NCT00556478|Premature Ejaculation|premature ejaculation
619690|NCT00556478|Lidocaine|lidocaine
619691|NCT00556478|Prilocaine|prilocaine
619692|NCT00556478|EMLA® cream|emla® cream
619693|NCT00556478|topical anesthetics|topical anesthetics
619694|NCT00556465|diabetic nephropathy|diabetic nephropathy
619695|NCT00556465|proteinuria|proteinuria
619696|NCT00556465|antioxidant|antioxidant
619697|NCT00556439|Vasculitis|vasculitis
619698|NCT00556439|Arteritis|arteritis
619699|NCT00556439|Takayasu's|takayasu's
619700|NCT00556439|Temporal Arteritis|temporal arteritis
619701|NCT00556439|Abatacept|abatacept
619702|NCT00556426|Venous Thromboembolic Disease|venous thromboembolic disease
619703|NCT00556426|IVC Filter|ivc filter
619704|NCT00556426|Pulmonary Embolism|pulmonary embolism
619705|NCT00556413|stage IV colon cancer|stage iv colon cancer
619706|NCT00556413|stage IV rectal cancer|stage iv rectal cancer
619707|NCT00556413|recurrent colon cancer|recurrent colon cancer
619708|NCT00556413|recurrent rectal cancer|recurrent rectal cancer
619709|NCT00556400|Uterine Bleeding|uterine bleeding
619710|NCT00556400|Thrombocytopenia|thrombocytopenia
619711|NCT00556400|Aplastic Anemia|aplastic anemia
619712|NCT00556400|Oral Contraceptive Pills|oral contraceptive pills
619713|NCT00556400|Menorrhagia|menorrhagia
619714|NCT00556387|traumatic brain injury|traumatic brain injury
619715|NCT00556374|confirmed adenocarcinoma|confirmed adenocarcinoma
619716|NCT00556374|non-metastatic breast cancer|non-metastatic breast cancer
619717|NCT00556374|estrogen receptor positive|estrogen receptor positive
619718|NCT00556374|progesterone receptor positive|progesterone receptor positive
619719|NCT00556374|non-steroidal aromatase|non-steroidal aromatase
619720|NCT00556374|aromatase inhibitor therapy|aromatase inhibitor therapy
619721|NCT00556374|postmenopausal woman|postmenopausal woman
619722|NCT00556374|adjuvant chemotherapy|adjuvant chemotherapy
619723|NCT00556374|neoadjuvant chemotherapy|neoadjuvant chemotherapy
619724|NCT00556348|bevacizumab|bevacizumab
619725|NCT00556348|AMD|amd
619726|NCT00556348|Complications|complications
619727|NCT00556348|Visual acuity|visual acuity
619728|NCT00556348|OCt|oct
619729|NCT00556348|Age Macular Degeneration|age macular degeneration
619730|NCT00556335|manual aspiration|manual aspiration
619731|NCT00556335|conventional|conventional
619732|NCT00556335|length of stay|length of stay
619733|NCT00556283|outlet obstruction|outlet obstruction
619734|NCT00556283|rectocele|rectocele
619735|NCT00556270|pain|pain
619736|NCT00556270|fentanyl|fentanyl
619737|NCT00556270|transdermal patch|transdermal patch
619738|NCT00556257|Immunosuppression, JAK3 inhibitor, kidney transplantation|immunosuppression, jak3 inhibitor, kidney transplantation
619739|NCT00556231|NIRS|nirs
619740|NCT00556231|cardiac output|cardiac output
619741|NCT00556231|anaerobic threshold|anaerobic threshold
619742|NCT00556231|exercise stress|exercise stress
619743|NCT00556231|congenital heart defect|congenital heart defect
619744|NCT00556218|Breast Cancer|breast cancer
619745|NCT00556218|Tibetan Meditation|tibetan meditation
619746|NCT00556218|Quality of Life|quality of life
619747|NCT00556218|Cognitive Function|cognitive function
619748|NCT00556218|QOL|qol
619749|NCT00556205|mRCC|mrcc
619750|NCT00556205|sunitinib|sunitinib
619751|NCT00556205|bevacizumab|bevacizumab
619752|NCT00556192|SLE|sle
619753|NCT00556192|Rituximab|rituximab
619754|NCT00556192|Methylprednisolone|methylprednisolone
619755|NCT00556192|Cyclophosphamide|cyclophosphamide
619756|NCT00556166|Enterra therapy|enterra therapy
619757|NCT00556166|Gastric Simulation System|gastric simulation system
619758|NCT00556153|brain tumors, children|brain tumors, children
619759|NCT00556127|Large B-cell Lymphoma|large b-cell lymphoma
619760|NCT00556127|Rituximab|rituximab
619761|NCT00556127|ASCT|asct
619762|NCT00556114|eye exam|eye exam
619763|NCT00556114|Retina|retina
619764|NCT00556101|Magnetic resonance|magnetic resonance
619765|NCT00556101|whole body|whole body
619766|NCT00556101|angiography|angiography
619767|NCT00556101|questionnaire|questionnaire
619768|NCT00556088|LBH589|lbh589
619769|NCT00556088|Phase I|phase i
619770|NCT00556088|Solid Tumors|solid tumors
619771|NCT00556088|Paclitaxel|paclitaxel
619772|NCT00556088|Carboplatin|carboplatin
619773|NCT00556088|Bevacizumab|bevacizumab
619774|NCT00556088|Dose escalation|dose escalation
619775|NCT00556075|Endometriosis|endometriosis
619776|NCT00556075|Pelvic pain|pelvic pain
619777|NCT00556075|Oral progesterone blocker|oral progesterone blocker
619778|NCT00556049|mRCC|mrcc
619779|NCT00556049|sunitinib|sunitinib
619780|NCT00556049|gemcitabine|gemcitabine
619781|NCT00556036|healthy|healthy
619782|NCT00556036|overweight|overweight
619783|NCT00556036|obese|obese
619784|NCT00556036|anorexia nervosa|anorexia nervosa
619785|NCT00556036|weight|weight
619786|NCT00556036|cortisol|cortisol
619787|NCT00556036|hormone|hormone
619788|NCT00556036|bone density|bone density
619789|NCT00556036|bone|bone
619790|NCT00556036|osteopenia|osteopenia
619791|NCT00556036|osteoporosis|osteoporosis
619792|NCT00556036|amenorrhea|amenorrhea
619793|NCT00556036|menses|menses
619794|NCT00556036|irregular|irregular
619795|NCT00556036|stress|stress
619796|NCT00556036|depression|depression
619797|NCT00556036|exercise|exercise
619798|NCT00556036|diet|diet
619799|NCT00556023|interventional|interventional
619800|NCT00556023|dose-finding|dose-finding
619801|NCT00555997|Major Depressive Disorder|major depressive disorder
619802|NCT00555997|Major Depression|major depression
619803|NCT00555997|Depression|depression
619804|NCT00555997|Geodon|geodon
619805|NCT00555997|Ziprasidone|ziprasidone
619806|NCT00555984|Intracranial tumors|intracranial tumors
619807|NCT00555984|Inflammatory markers|inflammatory markers
619808|NCT00555984|Craniotomy|craniotomy
619809|NCT00555984|Postoperative complications|postoperative complications
619810|NCT00555958|Obesity|obesity
619811|NCT00555958|Bariatric surgery|bariatric surgery
619812|NCT00555958|Excess weight loss|excess weight loss
619813|NCT00555958|Vagus nerve|vagus nerve
619814|NCT00555958|Vagal blocking|vagal blocking
619815|NCT00555958|VBLOC(TM) therapy|vbloc(tm) therapy
619816|NCT00555945|Intertrochanteric fracture|intertrochanteric fracture
619817|NCT00555945|Gamma3 intramedullary nail|gamma3 intramedullary nail
619818|NCT00555945|Sliding hip screw|sliding hip screw
619819|NCT00555932|Intracranial Thrombosis|intracranial thrombosis
619820|NCT00555932|Cerebral Sinovenous Thrombosis|cerebral sinovenous thrombosis
619821|NCT00555932|Pediatrics|pediatrics
619822|NCT00555932|Cranial Ultrasound|cranial ultrasound
619823|NCT00555919|Metastatic breast cancer stage IV|metastatic breast cancer stage iv
619824|NCT00555919|Metastatic breast cancer|metastatic breast cancer
619825|NCT00555919|mBC|mbc
619826|NCT00555919|Stage IV breast cancer|stage iv breast cancer
619827|NCT00555919|Hormone receptor positive breast cancer|hormone receptor positive breast cancer
619828|NCT00555893|randomized|randomized
619829|NCT00555893|blinded|blinded
619830|NCT00555893|controlled|controlled
619831|NCT00555893|efficacy|efficacy
619832|NCT00555867|hormone-receptor positive primary breast cancer|hormone-receptor positive primary breast cancer
619833|NCT00555867|compliance|compliance
619834|NCT00555867|Postmenopausal women|postmenopausal women
619835|NCT00555854|Motivational interviewing,|motivational interviewing,
619836|NCT00555854|Multidisciplinary|multidisciplinary
619837|NCT00555854|Life style changes|life style changes
619838|NCT00555854|Prevention|prevention
619839|NCT00555854|Compliance|compliance
619840|NCT00555854|Self Care|self care
619841|NCT00555854|Behaviour|behaviour
619842|NCT00555841|breast cancer|breast cancer
619843|NCT00555828|Myocardial Infarction|myocardial infarction
619844|NCT00555828|Myocardial infarct|myocardial infarct
619845|NCT00555828|Infarction|infarction
619846|NCT00555802|Low Back Pain|low back pain
619847|NCT00555802|Motor Control Exercise|motor control exercise
619848|NCT00555802|General exercise|general exercise
619849|NCT00555802|Ultrasonography, Multifidus|ultrasonography, multifidus
619850|NCT00555802|Transversus abdominis|transversus abdominis
619851|NCT00555802|Randomized Controlled trial.|randomized controlled trial.
619852|NCT00555789|kidney transplantation|kidney transplantation
619853|NCT00555789|rejection|rejection
619854|NCT00555789|AEB071|aeb071
619855|NCT00555789|tacrolimus|tacrolimus
619856|NCT00555789|mycophenolic acid|mycophenolic acid
619857|NCT00555789|immunosuppression|immunosuppression
619858|NCT00555776|tinnitus|tinnitus
619859|NCT00555776|gabapentin|gabapentin
619860|NCT00555763|Intraocular pressure|intraocular pressure
619861|NCT00555763|Goldmann tonometry|goldmann tonometry
619862|NCT00555763|applanation tonometry|applanation tonometry
619863|NCT00555763|Tonometry, Ocular|tonometry, ocular
619864|NCT00555750|sleep|sleep
619865|NCT00555750|metabolism|metabolism
619866|NCT00555750|insulin|insulin
619867|NCT00555750|glucose|glucose
619868|NCT00555750|actigraphy|actigraphy
619869|NCT00555750|diary|diary
619870|NCT00555750|volumetry|volumetry
619871|NCT00555750|GABA|gaba
619872|NCT00555737|Celiac Disease|celiac disease
619873|NCT00555737|Capsule Endoscopy|capsule endoscopy
619874|NCT00555737|small Bowel Disease|small bowel disease
619875|NCT00555724|Relapsed|relapsed
619876|NCT00555724|refractory|refractory
619877|NCT00555724|solid tumor|solid tumor
619878|NCT00555711|Brain tumor|brain tumor
619880|NCT00555698|Depression|depression
619881|NCT00555685|Heart Failure|heart failure
619882|NCT00555685|Renal failure|renal failure
619883|NCT00555685|Hyponatremia|hyponatremia
619884|NCT00555659|Degeneration|degeneration
619885|NCT00555659|Spondylosis|spondylosis
619886|NCT00555659|Spondylolisthesis|spondylolisthesis
619887|NCT00555659|Stenosis|stenosis
619888|NCT00555633|Photoprotection|photoprotection
619889|NCT00555633|Sunscreen|sunscreen
619890|NCT00555633|After-sun-lotion|after-sun-lotion
619891|NCT00555633|DNA repair enzymes|dna repair enzymes
619892|NCT00555633|liposomes|liposomes
619893|NCT00555633|skin cancer|skin cancer
619894|NCT00555633|Xeroderma pigmentosum|xeroderma pigmentosum
619895|NCT00555633|Basal cell nevus syndrome|basal cell nevus syndrome
619896|NCT00555607|asthma|asthma
619897|NCT00555607|COPD|copd
619898|NCT00555607|severe|severe
619899|NCT00555607|controlled|controlled
619900|NCT00555607|mild|mild
619901|NCT00555607|biomarker|biomarker
619902|NCT00555607|exacerbation|exacerbation
619903|NCT00555594|corneal neovascularization|corneal neovascularization
619904|NCT00555594|Bevacizumab (Avastin)|bevacizumab (avastin)
619905|NCT00555594|Immunologic rejection|immunologic rejection
619906|NCT00555594|vascular endothelial growth factor|vascular endothelial growth factor
619907|NCT00555581|Systemic Sclerosis|systemic sclerosis
619908|NCT00555568|mental health|mental health
619909|NCT00555568|group processes|group processes
619910|NCT00555555|Factor VIII deficiency|factor viii deficiency
619911|NCT00555555|Von Willebrand disease|von willebrand disease
619912|NCT00555555|FVIII/VWF concentrate|fviii/vwf concentrate
619913|NCT00555555|Bleeding disorders|bleeding disorders
619914|NCT00555555|Blood disorders|blood disorders
619915|NCT00555542|B-cell|b-cell
619916|NCT00555542|rituximab|rituximab
619917|NCT00555542|Rheumatoid Arthritis|rheumatoid arthritis
619918|NCT00555529|COPD|copd
619919|NCT00555529|exhaled breath condensate|exhaled breath condensate
619920|NCT00555529|applanation tonometry|applanation tonometry
619921|NCT00555529|induced sputum|induced sputum
619922|NCT00555529|smokers|smokers
619923|NCT00555529|healthy control|healthy control
619924|NCT00555516|Breast Cancer、 Chemotherapy、 Neutropenia、WBC|breast cancer、 chemotherapy、 neutropenia、wbc
619925|NCT00555503|prospective study|prospective study
619926|NCT00555503|registry|registry
619927|NCT00555503|quality of life|quality of life
619928|NCT00555503|mastectomy|mastectomy
619929|NCT00555503|reconstructive surgical procedures|reconstructive surgical procedures
619930|NCT00555503|BrCa1|brca1
619931|NCT00555503|BrCa2|brca2
619932|NCT00555503|breast cancer prevention|breast cancer prevention
619933|NCT00555490|Soy|soy
619934|NCT00555490|Diabetes|diabetes
619935|NCT00555490|Nephropathy|nephropathy
619936|NCT00555477|premenopausal breast cancer with chemotherapy-induced ovarian failure|premenopausal breast cancer with chemotherapy-induced ovarian failure
619937|NCT00555464|hemangioma, steroid, prednisolone, vincristine|hemangioma, steroid, prednisolone, vincristine
619938|NCT00555451|phase I|phase i
619939|NCT00555451|safety|safety
619940|NCT00555451|tolerance|tolerance
619941|NCT00555451|insulin resistance|insulin resistance
619942|NCT00555451|obese|obese
619943|NCT00555451|pharmacokinetics|pharmacokinetics
619944|NCT00555438|major orthopaedic surgery|major orthopaedic surgery
619945|NCT00555438|venous thromboembolic events prevention|venous thromboembolic events prevention
619946|NCT00555438|renal impairment|renal impairment
619947|NCT00555438|Arixtra|arixtra
619948|NCT00555438|anti-Xa activity|anti-xa activity
619949|NCT00555425|Buprenorphine|buprenorphine
619950|NCT00555425|Buprenorphine/naloxone|buprenorphine/naloxone
619951|NCT00555425|Counseling|counseling
619952|NCT00555425|Primary care|primary care
619953|NCT00555412|pharmacokinetic|pharmacokinetic
619954|NCT00555412|multidose|multidose
619955|NCT00555412|Staccato Loxapine|staccato loxapine
619956|NCT00555399|Glioblastoma Multiforme|glioblastoma multiforme
619957|NCT00555399|Anaplastic Glioma|anaplastic glioma
619958|NCT00555399|Vorinostat|vorinostat
619959|NCT00555399|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
619960|NCT00555399|SAHA|saha
619961|NCT00555399|MSK-390|msk-390
619962|NCT00555399|Zolinza|zolinza
619963|NCT00555399|Isotretinoin|isotretinoin
619964|NCT00555399|Accutane|accutane
619965|NCT00555399|13-cis-Retinoic Acid|13-cis-retinoic acid
619966|NCT00555399|Carboplatin|carboplatin
619967|NCT00555399|Paraplatin|paraplatin
619968|NCT00555399|CBT|cbt
619969|NCT00555399|Temozolomide|temozolomide
619970|NCT00555399|Temodar|temodar
619971|NCT00555386|Selenium|selenium
619972|NCT00555386|Soy|soy
619973|NCT00555386|Breast Cancer Risk|breast cancer risk
619974|NCT00555373|Pediatric|pediatric
619975|NCT00555373|Renal|renal
619976|NCT00555373|Transplant|transplant
619977|NCT00555360|Health Information Technology|health information technology
619978|NCT00555360|Patient Care Management|patient care management
619979|NCT00555360|Self Care|self care
619980|NCT00555360|Quality of Life|quality of life
619981|NCT00555360|Family or non-Family Informal Caregivers|family or non-family informal caregivers
619982|NCT00555347|Sarcoidosis|sarcoidosis
619983|NCT00555347|Fatigue|fatigue
619984|NCT00555334|hepatocellular carcinoma|hepatocellular carcinoma
619985|NCT00555334|liver cancer|liver cancer
619986|NCT00555334|radiofrequency ablation|radiofrequency ablation
619987|NCT00555334|lamivudine|lamivudine
619988|NCT00555308|urolithiasis|urolithiasis
619989|NCT00555308|ultrasound|ultrasound
619990|NCT00555308|hydronephrosis|hydronephrosis
619991|NCT00555282|central venous catheter|central venous catheter
619993|NCT00555282|coated catheter|coated catheter
619994|NCT00555282|bacteriaemia|bacteriaemia
619995|NCT00555282|bloodstream infection|bloodstream infection
619996|NCT00555269|Macular pucker|macular pucker
619997|NCT00555269|Macular hole|macular hole
619998|NCT00555269|Membrane Blue|membrane blue
619999|NCT00555269|Infracyanine Green|infracyanine green
620000|NCT00555269|Peripheral Visual Field|peripheral visual field
620001|NCT00555256|NSCLC|nsclc
620002|NCT00555243|Laparoscopic Surgical Simulation|laparoscopic surgical simulation
620003|NCT00555230|HMG-CoA reductase inhibitors|hmg-coa reductase inhibitors
620004|NCT00555230|Crestor|crestor
620005|NCT00555230|Rosuvastatin|rosuvastatin
620006|NCT00555217|kidney disease|kidney disease
620007|NCT00555217|nephropathy|nephropathy
620008|NCT00555217|type 2 diabetes|type 2 diabetes
620009|NCT00555217|hyperkalemia|hyperkalemia
620010|NCT00555217|acute kidney injury|acute kidney injury
620011|NCT00555204|mild to moderate Alzheimer's disease, memory, cognition, dementia|mild to moderate alzheimer's disease, memory, cognition, dementia
620012|NCT00555191|fructose|fructose
620013|NCT00555191|Irritable bowel syndrome|irritable bowel syndrome
620014|NCT00555191|malabsorption|malabsorption
620015|NCT00555191|Glut5 transporter gene|glut5 transporter gene
620016|NCT00555178|Polymorphic light eruption|polymorphic light eruption
620017|NCT00555178|Regulatory T cells (Tregs)|regulatory t cells (tregs)
620018|NCT00555178|Seasonal fluctuation|seasonal fluctuation
620019|NCT00555178|UV radiation|uv radiation
620020|NCT00555178|Phototherapy|phototherapy
620021|NCT00555165|Macular Degeneration|macular degeneration
620022|NCT00555165|Visual Impairment|visual impairment
620023|NCT00555165|Quality of Life|quality of life
620024|NCT00555165|Implantable Telescope|implantable telescope
620025|NCT00555139|anxiety,|anxiety,
620026|NCT00555139|depression,|depression,
620027|NCT00555139|fMRI|fmri
620028|NCT00555139|CRF-1 antagonists,|crf-1 antagonists,
620029|NCT00555126|Polytrauma|polytrauma
620030|NCT00555126|Hypothermia|hypothermia
620031|NCT00555126|Wound Infection|wound infection
620032|NCT00555126|Blood Loss|blood loss
620033|NCT00555126|Combined perioperative morbidity|combined perioperative morbidity
620034|NCT00555113|pseudoxanthoma elasticum|pseudoxanthoma elasticum
620035|NCT00555113|Visual acuity|visual acuity
620036|NCT00555113|Choroidal neovascularization|choroidal neovascularization
620037|NCT00555113|angioid streaks|angioid streaks
620038|NCT00555087|Erectile dysfunction|erectile dysfunction
620039|NCT00555087|Hypogonadotrophic males|hypogonadotrophic males
620040|NCT00555061|SID|sid
620041|NCT00555061|impetigo|impetigo
620042|NCT00555061|pharmacokinetics|pharmacokinetics
620043|NCT00555061|Retapamulin ointment, 1%|retapamulin ointment, 1%
620498|NCT00553228|pertussis|pertussis
620044|NCT00555061|Skin abnormalities|skin abnormalities
620045|NCT00555061|Dermatoses|dermatoses
620046|NCT00555061|pediatric|pediatric
620047|NCT00555061|infection|infection
620048|NCT00555061|SITL|sitl
620049|NCT00555048|graft versus host disease|graft versus host disease
620050|NCT00555048|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
620051|NCT00555048|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
620052|NCT00555048|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
620053|NCT00555048|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
620054|NCT00555048|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
620055|NCT00555048|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
620056|NCT00555048|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
620057|NCT00555048|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
620058|NCT00555048|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
620059|NCT00555048|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
620060|NCT00555048|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
620061|NCT00555048|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
620062|NCT00555048|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
620063|NCT00555048|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
620064|NCT00555048|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
620065|NCT00555048|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
620066|NCT00555048|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
620067|NCT00555048|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
620068|NCT00555048|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
620069|NCT00555048|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
620070|NCT00555048|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
620071|NCT00555048|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
620072|NCT00555048|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
620073|NCT00555048|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
620074|NCT00555048|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
620075|NCT00555048|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
620076|NCT00555048|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
620077|NCT00555048|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
620078|NCT00555048|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
620079|NCT00555048|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
620080|NCT00555048|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
620081|NCT00555048|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
620082|NCT00555048|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
620083|NCT00555048|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
620084|NCT00555048|secondary acute myeloid leukemia|secondary acute myeloid leukemia
620085|NCT00555048|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
620086|NCT00555048|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
620087|NCT00555048|myelodysplastic/myeloproliferative diseases|myelodysplastic/myeloproliferative diseases
620088|NCT00555048|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
620089|NCT00555035|GSK1349572,|gsk1349572,
620090|NCT00555035|healthy volunteers|healthy volunteers
620091|NCT00555022|Anticholinergic,|anticholinergic,
620092|NCT00555022|FTIH,|ftih,
620093|NCT00555022|Muscarinic Receptor Antagonist,|muscarinic receptor antagonist,
620094|NCT00555022|Plethysmography|plethysmography
620095|NCT00555022|COPD,|copd,
620096|NCT00555009|traumatic brain Injury, cognitive function|traumatic brain injury, cognitive function
620097|NCT00554996|urinary tract infection|urinary tract infection
620098|NCT00554996|urinary catheter|urinary catheter
620099|NCT00554996|Escherichia coli|escherichia coli
620100|NCT00554996|biofilm|biofilm
620101|NCT00554983|Recombinant birch pollen allergy|recombinant birch pollen allergy
620102|NCT00554983|IgE-mediated allergic disease attributed to birch pollen|ige-mediated allergic disease attributed to birch pollen
620103|NCT00554970|Adult Asthmatics|adult asthmatics
620104|NCT00554944|Fluid Management|fluid management
620105|NCT00554944|surgery|surgery
620106|NCT00554944|Obesity|obesity
620107|NCT00554918|adenocarcinoma of the prostate|adenocarcinoma of the prostate
620108|NCT00554918|recurrent prostate cancer|recurrent prostate cancer
620109|NCT00554918|stage IV prostate cancer|stage iv prostate cancer
620110|NCT00554918|bone metastases|bone metastases
620111|NCT00554905|ablation|ablation
620112|NCT00554905|catheter|catheter
620113|NCT00554905|Carcinoma, Hepatocellular|carcinoma, hepatocellular
620114|NCT00554905|therapy|therapy
620115|NCT00554905|Chemoembolization, Therapeutic|chemoembolization, therapeutic
620116|NCT00554905|Humans|humans
620117|NCT00554905|Liver Neoplasms|liver neoplasms
620118|NCT00554892|Rectal cancer|rectal cancer
620119|NCT00554892|Sphincter preservation|sphincter preservation
620120|NCT00554892|Mechanical bowel preparation|mechanical bowel preparation
620121|NCT00554892|Post operative morbidity|post operative morbidity
620122|NCT00554892|Anastomotic leakage|anastomotic leakage
620123|NCT00554827|Relapsed or Refractory Cutaneous T-cell Lymphoma|relapsed or refractory cutaneous t-cell lymphoma
620124|NCT00554827|Lymphoma|lymphoma
620125|NCT00554827|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
620126|NCT00554827|T-cell Lymphoma|t-cell lymphoma
620127|NCT00554827|Mycosis fungoides|mycosis fungoides
620128|NCT00554827|Sézary syndrome|sézary syndrome
620129|NCT00554827|Primary cutaneous anaplastic large cell|primary cutaneous anaplastic large cell
620130|NCT00554814|Iron deficiency|iron deficiency
620131|NCT00554814|Ferritin|ferritin
620132|NCT00554814|Encapsulated iron|encapsulated iron
620133|NCT00554814|Infant formula|infant formula
620134|NCT00554801|Central Auditory Processing|central auditory processing
620135|NCT00554801|Traumatic Brain Injury|traumatic brain injury
620136|NCT00554801|Hearing Loss|hearing loss
620137|NCT00554775|tumors metastatic to brain|tumors metastatic to brain
620138|NCT00554775|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
620139|NCT00554775|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
620140|NCT00554762|mechanical pain,|mechanical pain,
620141|NCT00554762|heat pain,|heat pain,
620142|NCT00554762|dose,|dose,
620143|NCT00554762|efficacy|efficacy
620144|NCT00554762|dose response,|dose response,
620145|NCT00554762|GW842166,|gw842166,
620146|NCT00554762|Single,|single,
620147|NCT00554762|pharmacodynamics,|pharmacodynamics,
620148|NCT00554762|repeat dose,|repeat dose,
620149|NCT00554749|Selective mutism|selective mutism
620150|NCT00554749|Children|children
620151|NCT00554749|Treatment|treatment
620152|NCT00554736|Pollen Allergy|pollen allergy
620153|NCT00554736|Allergy|allergy
620154|NCT00554723|Stroke|stroke
620155|NCT00554723|Cerebral infarct|cerebral infarct
620156|NCT00554723|Recovery|recovery
620157|NCT00554723|Double blind|double blind
620158|NCT00554723|Randomized|randomized
620159|NCT00554723|Placebo|placebo
620160|NCT00554723|Traditional Chinese Medicine|traditional chinese medicine
620161|NCT00554723|Neuroaid|neuroaid
620162|NCT00554710|Crohn's disease|crohn's disease
620163|NCT00554710|immunomodulators|immunomodulators
620164|NCT00554710|biologicals|biologicals
620165|NCT00554697|tissue oxygenation|tissue oxygenation
620166|NCT00554697|perioperative|perioperative
620167|NCT00554697|outcome|outcome
620168|NCT00554684|Outcome|outcome
620169|NCT00554684|Elderly|elderly
620170|NCT00554684|ICU|icu
620171|NCT00554684|Quality of Life|quality of life
620172|NCT00554671|Diabetes Mellitus|diabetes mellitus
620173|NCT00554671|Clinical pharmacists|clinical pharmacists
620174|NCT00554671|guideline adherence|guideline adherence
620175|NCT00554671|group medical visits|group medical visits
620176|NCT00554671|behavioral modification|behavioral modification
620177|NCT00554671|pharmacotherapy|pharmacotherapy
620178|NCT00554645|obesity|obesity
620179|NCT00554645|children|children
620180|NCT00554645|psychological intervention|psychological intervention
620181|NCT00554632|Contraceptive|contraceptive
620182|NCT00554632|Venous thrombosis|venous thrombosis
620183|NCT00554632|Coagulation parameter|coagulation parameter
620184|NCT00554619|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
620185|NCT00554619|Ambrisentan|ambrisentan
620186|NCT00554606|Rheumatoid Arthritis|rheumatoid arthritis
620187|NCT00554606|Anit-interleukin-1 beta|anit-interleukin-1 beta
620188|NCT00554606|ACZ885|acz885
620189|NCT00554580|continuous positive airway pressure|continuous positive airway pressure
620190|NCT00554580|outcome measure|outcome measure
620191|NCT00554580|clinical trial|clinical trial
620192|NCT00554567|HIV/AIDS|hiv/aids
620193|NCT00554567|Voluntary Counseling and Testing|voluntary counseling and testing
620194|NCT00554567|Rural India|rural india
620195|NCT00554567|HIV Care|hiv care
620196|NCT00554567|Health Services Research|health services research
620197|NCT00554528|Cervical|cervical
620198|NCT00554528|disc|disc
620199|NCT00554528|prosthesis|prosthesis
620200|NCT00554528|adjacent|adjacent
620201|NCT00554528|disease|disease
620202|NCT00554528|randomized|randomized
620203|NCT00554528|prospective|prospective
620204|NCT00554528|study|study
620205|NCT00554515|Kidney|kidney
620206|NCT00554515|Renal Cell|renal cell
620207|NCT00554515|Metastatic|metastatic
620208|NCT00554515|interleukin-2|interleukin-2
620209|NCT00554515|select|select
620210|NCT00554489|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
620211|NCT00554489|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
620212|NCT00554489|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
620213|NCT00554489|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
620214|NCT00554489|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
620215|NCT00554489|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
620216|NCT00554476|Lateral Epicondylitis|lateral epicondylitis
620217|NCT00554476|Treatment|treatment
620218|NCT00554476|Corticosteroid|corticosteroid
620219|NCT00554476|Elbow Cast|elbow cast
620220|NCT00554476|Icing|icing
620221|NCT00554476|NSAIDs|nsaids
620222|NCT00554463|limited stage small cell lung cancer|limited stage small cell lung cancer
620223|NCT00554437|Accidental Falls|accidental falls
620224|NCT00554437|RCT|rct
620225|NCT00554437|Age 65 and older|age 65 and older
620226|NCT00554437|noninstitualized populations|noninstitualized populations
620227|NCT00554424|oocyte retrieval|oocyte retrieval
620228|NCT00554424|pain relief|pain relief
620229|NCT00554424|Local anaesthetic|local anaesthetic
620230|NCT00554411|Travatan Z|travatan z
620231|NCT00554411|glaucoma|glaucoma
620232|NCT00554411|tear film break up time|tear film break up time
620233|NCT00554398|Raltegravir|raltegravir
620234|NCT00554398|MK-0518|mk-0518
620235|NCT00554398|Treatment intensification|treatment intensification
620236|NCT00554398|HIV-1 latency|hiv-1 latency
620237|NCT00554398|HIV eradication|hiv eradication
620238|NCT00554398|treatment experienced|treatment experienced
620239|NCT00554372|Jennerex|jennerex
620240|NCT00554372|HCC|hcc
620241|NCT00554372|unresectable primary hepatocellular carcinoma|unresectable primary hepatocellular carcinoma
620242|NCT00554372|hepatocellular carcinoma|hepatocellular carcinoma
620243|NCT00554372|liver cancer|liver cancer
620244|NCT00554372|Phase 2|phase 2
620245|NCT00554372|oncolytic virus|oncolytic virus
620246|NCT00554372|Pexa-Vec|pexa-vec
620247|NCT00554359|Acute Kidney Injury|acute kidney injury
620248|NCT00554359|Acute Renal Failure|acute renal failure
620249|NCT00554346|COX-2; post-operative ; sports injury; surgical pain|cox-2; post-operative ; sports injury; surgical pain
620250|NCT00554320|vulvodynia|vulvodynia
620251|NCT00554320|painful bladder syndrome|painful bladder syndrome
620252|NCT00554320|myofascial pain syndrome|myofascial pain syndrome
620253|NCT00554320|pelvic floor tension myalgia|pelvic floor tension myalgia
620254|NCT00554307|patent ductus arteriosus|patent ductus arteriosus
620255|NCT00554307|indomethacin|indomethacin
620256|NCT00554307|neoprofen|neoprofen
620257|NCT00554307|blood flow|blood flow
620258|NCT00554294|children|children
620259|NCT00554294|primary prevention|primary prevention
620260|NCT00554294|environmental change|environmental change
620261|NCT00554294|behavioural change|behavioural change
620262|NCT00554294|school setting|school setting
620263|NCT00554294|changing of drinking habits|changing of drinking habits
620264|NCT00554294|promotion of drinking tap water|promotion of drinking tap water
620265|NCT00554281|Type 1 diabetes|type 1 diabetes
620266|NCT00554281|Hypoglycemia|hypoglycemia
620267|NCT00554281|Glucose sensor|glucose sensor
620268|NCT00554268|Advanced Cancers|advanced cancers
620269|NCT00554268|Solid Tumors|solid tumors
620270|NCT00554268|PBI-05204|pbi-05204
620271|NCT00554255|Pharmacodynamics|pharmacodynamics
620272|NCT00554255|Japanese|japanese
620273|NCT00554255|safety|safety
620274|NCT00554255|Pharmacokinetics|pharmacokinetics
620275|NCT00554242|endothelium|endothelium
620276|NCT00554242|antioxidants|antioxidants
620277|NCT00554242|flavonoids|flavonoids
620278|NCT00554229|Hormone Resistant Prostate Cancer|hormone resistant prostate cancer
620279|NCT00554229|Endothelin A Receptor Antagonist|endothelin a receptor antagonist
620280|NCT00554229|Endothelin A|endothelin a
620281|NCT00554229|Endothelin A antagonist|endothelin a antagonist
620282|NCT00554216|Obesity, morbid obesity|obesity, morbid obesity
620283|NCT00554190|rhinosinusitis, ethmoid|rhinosinusitis, ethmoid
620284|NCT00554177|sexual|sexual
620285|NCT00554177|combat|combat
620286|NCT00554177|PTSD|ptsd
620287|NCT00554177|Clinical trial|clinical trial
620288|NCT00554177|Trauma|trauma
620289|NCT00554177|PTSD treatment|ptsd treatment
620290|NCT00554177|PTSD medication|ptsd medication
620291|NCT00554177|Post traumatic stress disorder|post traumatic stress disorder
620292|NCT00554164|Aggressive non-Hodgkin's lymphoma|aggressive non-hodgkin's lymphoma
620293|NCT00554164|Positron emission tomography|positron emission tomography
620294|NCT00554164|Chemotherapy|chemotherapy
620295|NCT00554138|rosuvastatin|rosuvastatin
620296|NCT00554138|dipyridamole|dipyridamole
620297|NCT00554138|caffeine|caffeine
620298|NCT00554125|Sirolimus; Orthotopic liver transplantation; HCC|sirolimus; orthotopic liver transplantation; hcc
620299|NCT00554112|Exercise Training|exercise training
620300|NCT00554112|Glucose Intolerance|glucose intolerance
620301|NCT00554112|Human Aging|human aging
620302|NCT00554112|Insulin Secretion|insulin secretion
620303|NCT00554073|Magnetic resonance|magnetic resonance
620304|NCT00554073|whole body|whole body
620305|NCT00554073|angiography|angiography
620306|NCT00554073|vasovist|vasovist
620307|NCT00554073|gadofosveset|gadofosveset
620308|NCT00554073|blood pool agent|blood pool agent
620309|NCT00554073|3T|3t
620310|NCT00554073|1.5T|1.5t
620311|NCT00554073|Field strength|field strength
620312|NCT00554047|Dementia|dementia
620313|NCT00554047|Caregivers|caregivers
620314|NCT00554047|Costs and cost analysis|costs and cost analysis
620315|NCT00554047|Multicenter study|multicenter study
620316|NCT00554047|Randomized controlled trial|randomized controlled trial
620317|NCT00554047|Quality Adjusted Life Years|quality adjusted life years
620318|NCT00554047|Quality of life|quality of life
620319|NCT00554047|Technology assessment, biomedical; Methods|technology assessment, biomedical; methods
620320|NCT00554034|gingivitis, localized treatment|gingivitis, localized treatment
620321|NCT00554021|Central venous catheter|central venous catheter
620322|NCT00554021|nosocomial infection|nosocomial infection
620323|NCT00554008|Appendicitis|appendicitis
620324|NCT00554008|laparoscopy|laparoscopy
620325|NCT00554008|randomized trial|randomized trial
620326|NCT00554008|children|children
620327|NCT00554008|pediatric|pediatric
620328|NCT00553982|Replacement|replacement
620329|NCT00553982|Knee|knee
620330|NCT00553982|Patella|patella
620331|NCT00553982|Arthroplasty|arthroplasty
620332|NCT00553969|cardiovascular disease prevention|cardiovascular disease prevention
620333|NCT00553943|lymphoma|lymphoma
620334|NCT00553943|cerebral lymphoma|cerebral lymphoma
620335|NCT00553943|central nervous system|central nervous system
620336|NCT00553943|cytarabine|cytarabine
620337|NCT00553943|rituximab|rituximab
620338|NCT00553943|Diffuse large B-cell lymphomas, with cerebral or neuromeningeal involvement|diffuse large b-cell lymphomas, with cerebral or neuromeningeal involvement
620339|NCT00553930|HCV/HIV-coinfected patients|hcv/hiv-coinfected patients
620340|NCT00553930|Peginterferon alfa-2a|peginterferon alfa-2a
620341|NCT00553917|Pregnancy|pregnancy
620342|NCT00553917|Depression|depression
620343|NCT00553917|Antidepressants|antidepressants
620344|NCT00553852|Very Severe Obesity|very severe obesity
620345|NCT00553852|Body Composition|body composition
620346|NCT00553852|GH deficiency|gh deficiency
620347|NCT00553852|IGF-I|igf-i
620348|NCT00553852|LASGB|lasgb
620349|NCT00553852|GH therapy|gh therapy
620350|NCT00553839|anesthesia|anesthesia
620351|NCT00553839|children|children
620352|NCT00553839|ketamine|ketamine
620353|NCT00553839|pharmacokinetics|pharmacokinetics
620354|NCT00553813|Unresectable|unresectable
620355|NCT00553813|Gemcitabine|gemcitabine
620356|NCT00553813|Taxane|taxane
620357|NCT00553813|TPI 287|tpi 287
620358|NCT00553787|Obesity, Type 2 diabetes|obesity, type 2 diabetes
620359|NCT00553774|CAD Patients on Optimal Treatment|cad patients on optimal treatment
620360|NCT00553761|Band atrophy|band atrophy
620361|NCT00553761|Pattern electroretinogram|pattern electroretinogram
620362|NCT00553761|Chiasmal compression|chiasmal compression
620363|NCT00553761|Neural loss|neural loss
620364|NCT00553761|Electrophysiological tests|electrophysiological tests
620365|NCT00553735|Dry Eye|dry eye
620366|NCT00553735|Graft versus Host Disease|graft versus host disease
620367|NCT00553735|GVHD|gvhd
620368|NCT00553722|hypertension|hypertension
620369|NCT00553722|dialysis|dialysis
620370|NCT00553722|hyperaldosteronism|hyperaldosteronism
620371|NCT00553709|nausea|nausea
620372|NCT00553709|vomiting|vomiting
620373|NCT00553709|retching|retching
620374|NCT00553709|emesis|emesis
620375|NCT00553709|surgery|surgery
620376|NCT00553709|anesthesia|anesthesia
620377|NCT00553696|chemotherapy|chemotherapy
620378|NCT00553696|combination|combination
620379|NCT00553683|stage IV pancreatic cancer|stage iv pancreatic cancer
620380|NCT00553683|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
620381|NCT00553683|advanced adult primary liver cancer|advanced adult primary liver cancer
620382|NCT00553683|recurrent adult primary liver cancer|recurrent adult primary liver cancer
620383|NCT00553683|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
620384|NCT00553683|recurrent pancreatic cancer|recurrent pancreatic cancer
620385|NCT00553683|recurrent colon cancer|recurrent colon cancer
620386|NCT00553683|recurrent breast cancer|recurrent breast cancer
620387|NCT00553683|recurrent gastric cancer|recurrent gastric cancer
620388|NCT00553683|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
620389|NCT00553683|recurrent melanoma|recurrent melanoma
620390|NCT00553683|stage IV breast cancer|stage iv breast cancer
620391|NCT00553683|stage IV gastric cancer|stage iv gastric cancer
620392|NCT00553683|stage IV colon cancer|stage iv colon cancer
620393|NCT00553683|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
620394|NCT00553683|stage IV melanoma|stage iv melanoma
620395|NCT00553683|liver metastases|liver metastases
620396|NCT00553670|coronary artery|coronary artery
620397|NCT00553670|bifurcation|bifurcation
620398|NCT00553670|stent|stent
620399|NCT00553670|intravascular ultrasound|intravascular ultrasound
620400|NCT00553670|fractional flow reserve|fractional flow reserve
620401|NCT00553657|Experimental Medicine|experimental medicine
620402|NCT00553631|Enzyme Replacement Therapy|enzyme replacement therapy
620403|NCT00553631|Gaucher disease|gaucher disease
620404|NCT00553631|glucocerebrosidase|glucocerebrosidase
620405|NCT00553631|beta-glucocerebrosidase|beta-glucocerebrosidase
620406|NCT00553631|Acid beta-glucocerebrosidase|acid beta-glucocerebrosidase
620407|NCT00553631|glucosylceramidase|glucosylceramidase
620408|NCT00553631|D-glucosyl-N-acylsphingosine glucohydrolase|d-glucosyl-n-acylsphingosine glucohydrolase
620409|NCT00553631|gene activation|gene activation
620410|NCT00553631|human|human
620411|NCT00553618|Interleukin 2|interleukin 2
620412|NCT00553618|Proleukin|proleukin
620413|NCT00553618|DTIC|dtic
620414|NCT00553618|Dacarbazine|dacarbazine
620415|NCT00553618|metastatic melanoma|metastatic melanoma
620416|NCT00553618|adjuvant|adjuvant
620417|NCT00553605|Renal Colic Pain Urinary Tract Colic|renal colic pain urinary tract colic
620418|NCT00553579|contrast sensitivity, retention time|contrast sensitivity, retention time
620419|NCT00553566|stage 0 bladder cancer|stage 0 bladder cancer
620420|NCT00553566|stage I bladder cancer|stage i bladder cancer
620421|NCT00553566|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
620422|NCT00553553|Intrathecal morphine ITM intravenous morphine remifentanil hepatic resection|intrathecal morphine itm intravenous morphine remifentanil hepatic resection
620423|NCT00553553|Adult|adult
620424|NCT00553553|ASA I-III (stable)|asa i-iii (stable)
620425|NCT00553553|Liver dysfunction requiring primary parenchymal resection|liver dysfunction requiring primary parenchymal resection
620426|NCT00553540|backache|backache
620427|NCT00553540|low backpain|low backpain
620428|NCT00553540|sciatica|sciatica
620429|NCT00553514|Infertility|infertility
620430|NCT00553514|Oligo-anovulation|oligo-anovulation
620431|NCT00553514|GONAL-f®|gonal-f®
620432|NCT00553514|AS900672-Enriched|as900672-enriched
620433|NCT00553514|hyperglycosylated recombinant human follicle stimulating hormone (r-hFSH)|hyperglycosylated recombinant human follicle stimulating hormone (r-hfsh)
620434|NCT00553501|stage II grade 1 follicular lymphoma|stage ii grade 1 follicular lymphoma
620435|NCT00553501|stage II grade 2 follicular lymphoma|stage ii grade 2 follicular lymphoma
620436|NCT00553501|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
620437|NCT00553501|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
620438|NCT00553501|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
620439|NCT00553501|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
620440|NCT00553501|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
620441|NCT00553501|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
620442|NCT00553501|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
620443|NCT00553488|diabetes|diabetes
620444|NCT00553488|insulin|insulin
620445|NCT00553488|subcutaneous|subcutaneous
620446|NCT00553488|intra-dermal|intra-dermal
620447|NCT00553488|blood glucose|blood glucose
620448|NCT00553462|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
620449|NCT00553462|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
620450|NCT00553462|adenocarcinoma of the lung|adenocarcinoma of the lung
620451|NCT00553462|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
620452|NCT00553462|large cell lung cancer|large cell lung cancer
620453|NCT00553462|squamous cell lung cancer|squamous cell lung cancer
620454|NCT00553449|nocturnal heartburn|nocturnal heartburn
620455|NCT00553449|day-time heartburn|day-time heartburn
620456|NCT00553449|rabeprazole|rabeprazole
620457|NCT00553449|GERD|gerd
620458|NCT00553436|colon|colon
620459|NCT00553436|rectum|rectum
620460|NCT00553436|polyp|polyp
620461|NCT00553436|EMR|emr
620462|NCT00553436|Established indication for a procedure greater than colonoscopy and colonic polypectomy|established indication for a procedure greater than colonoscopy and colonic polypectomy
620463|NCT00553410|stage IA breast cancer|stage ia breast cancer
620464|NCT00553410|stage IB breast cancer|stage ib breast cancer
620465|NCT00553410|stage II breast cancer|stage ii breast cancer
620466|NCT00553410|stage IIIA breast cancer|stage iiia breast cancer
620467|NCT00553397|Living donor lung transplant|living donor lung transplant
620468|NCT00553397|End stage lung disease|end stage lung disease
620469|NCT00553384|smell|smell
620470|NCT00553384|olfaction|olfaction
620471|NCT00553384|androstadienone|androstadienone
620472|NCT00553384|women|women
620473|NCT00553384|pheromones|pheromones
620474|NCT00553384|Healthy Volunteers|healthy volunteers
620475|NCT00553384|Physiological Effects of Androstadienone Exposure|physiological effects of androstadienone exposure
620476|NCT00553371|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
620477|NCT00553371|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
620478|NCT00553358|Lapatinib|lapatinib
620479|NCT00553358|ErbB2+|erbb2+
620480|NCT00553358|Early Breast Cancer|early breast cancer
620481|NCT00553358|Neoadjuvant|neoadjuvant
620482|NCT00553345|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
620483|NCT00553345|stage 0 bladder cancer|stage 0 bladder cancer
620484|NCT00553345|stage I bladder cancer|stage i bladder cancer
620485|NCT00553319|ADHD|adhd
620486|NCT00553319|Cocaine|cocaine
620487|NCT00553319|Treatment|treatment
620488|NCT00553293|infertility|infertility
620489|NCT00553293|in vitro fertilization|in vitro fertilization
620490|NCT00553293|LH supplementation|lh supplementation
620491|NCT00553293|Benefits|benefits
620492|NCT00553241|TIA|tia
620493|NCT00553241|prognosis|prognosis
620494|NCT00553241|evaluation|evaluation
620495|NCT00553241|management|management
620496|NCT00553228|maternal immunization|maternal immunization
620497|NCT00553228|whooping cough|whooping cough
620499|NCT00553215|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
620500|NCT00553215|stage 0 bladder cancer|stage 0 bladder cancer
620501|NCT00553215|stage I bladder cancer|stage i bladder cancer
620502|NCT00553215|stage II bladder cancer|stage ii bladder cancer
620503|NCT00553202|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
620504|NCT00553202|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
620505|NCT00553189|PARP Inhibitor|parp inhibitor
620506|NCT00553189|Advanced Cancer|advanced cancer
620507|NCT00553189|Combination Therapy|combination therapy
620508|NCT00553189|Early Trial|early trial
620509|NCT00553189|DNA Damage Repair|dna damage repair
620510|NCT00553189|Topotecan|topotecan
620511|NCT00553189|Cancer|cancer
620512|NCT00553189|Solid Tumor|solid tumor
620513|NCT00553189|Lymphoma|lymphoma
620514|NCT00553176|Infliximab|infliximab
620515|NCT00553176|Immune disorder|immune disorder
620516|NCT00553176|Remicade|remicade
620517|NCT00553176|Registry|registry
620518|NCT00553176|Crohn's Disease|crohn's disease
620519|NCT00553163|Hypnotherapy|hypnotherapy
620520|NCT00553163|Prevention of relapse|prevention of relapse
620521|NCT00553163|ulcerative colitis|ulcerative colitis
620522|NCT00553150|adult gliosarcoma|adult gliosarcoma
620523|NCT00553150|adult giant cell glioblastoma|adult giant cell glioblastoma
620524|NCT00553150|adult glioblastoma|adult glioblastoma
620525|NCT00553150|adult anaplastic astrocytoma|adult anaplastic astrocytoma
620526|NCT00553150|adult diffuse astrocytoma|adult diffuse astrocytoma
620527|NCT00553150|adult pilocytic astrocytoma|adult pilocytic astrocytoma
620528|NCT00553150|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
620529|NCT00553137|oropharyngeal candidiasis|oropharyngeal candidiasis
620530|NCT00553124|stage 0 bladder cancer|stage 0 bladder cancer
620531|NCT00553124|stage I bladder cancer|stage i bladder cancer
620532|NCT00553124|stage II bladder cancer|stage ii bladder cancer
620533|NCT00553124|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
620534|NCT00553111|syphilis|syphilis
620535|NCT00553111|video education|video education
620536|NCT00553111|knowledge|knowledge
620537|NCT00553111|black|black
620538|NCT00553111|hispanic|hispanic
620539|NCT00553085|anxiety disorders|anxiety disorders
620540|NCT00553085|children|children
620541|NCT00553085|neurodevelopmental disorder|neurodevelopmental disorder
620542|NCT00553085|neurodevelopmental delay|neurodevelopmental delay
620543|NCT00553085|temperament|temperament
620544|NCT00553072|Asphyxia|asphyxia
620545|NCT00553072|perinatal|perinatal
620546|NCT00553072|magnesium sulphate|magnesium sulphate
620547|NCT00553059|nausea and vomiting|nausea and vomiting
620548|NCT00553059|unspecified adult solid tumor|unspecified adult solid tumor
620549|NCT00553059|Palonosetron|palonosetron
620550|NCT00553059|Dexamethasone|dexamethasone
620551|NCT00553046|ethics|ethics
620552|NCT00553046|COPD|copd
620553|NCT00553046|end of life|end of life
620554|NCT00553046|mechanical ventilation|mechanical ventilation
620555|NCT00553046|CRF home ventilated patients|crf home ventilated patients
620556|NCT00553033|Patients must be candidable to liver resection|patients must be candidable to liver resection
620557|NCT00553007|Periodontal disease|periodontal disease
620558|NCT00553007|Metabolic Syndrome|metabolic syndrome
620559|NCT00552994|Drug eluting stent|drug eluting stent
620560|NCT00552994|Diabetics|diabetics
620561|NCT00552994|Intravascular ultrasound|intravascular ultrasound
620562|NCT00552994|Pathophysiologic (neointimal hyperplasia and peri-stent remodeling)|pathophysiologic (neointimal hyperplasia and peri-stent remodeling)
620563|NCT00552981|common cold|common cold
620564|NCT00552981|Finnish sauna|finnish sauna
620565|NCT00552981|rct|rct
620566|NCT00552968|trauma|trauma
620567|NCT00552968|pain|pain
620568|NCT00552955|Lymphangioleiomyomatosis|lymphangioleiomyomatosis
620569|NCT00552955|Abdominal Lymphangioleiomyomas|abdominal lymphangioleiomyomas
620570|NCT00552955|Chyle|chyle
620571|NCT00552955|Ascites|ascites
620572|NCT00552955|Tuberous Sclerosis Complex|tuberous sclerosis complex
620573|NCT00552955|LAM|lam
620574|NCT00552942|obesity|obesity
620575|NCT00552942|diabetes|diabetes
620576|NCT00552942|cytokines|cytokines
620577|NCT00552890|obesity|obesity
620578|NCT00552890|atkins|atkins
620579|NCT00552890|weight reduction|weight reduction
620580|NCT00552890|kidney function|kidney function
620581|NCT00552877|PCI|pci
620582|NCT00552877|Drug-eluting stent|drug-eluting stent
620583|NCT00552851|acromegaly|acromegaly
620584|NCT00552851|heart failure|heart failure
620585|NCT00552851|hypertrophy|hypertrophy
620586|NCT00552851|cardiomegaly|cardiomegaly
620587|NCT00552838|Antimicrobial prescribing|antimicrobial prescribing
620588|NCT00552838|Antimicrobial utilization|antimicrobial utilization
620589|NCT00552825|acute lymphoblastic leukemia|acute lymphoblastic leukemia
620590|NCT00552825|long-term lung function|long-term lung function
620591|NCT00552812|Aortic Coarctation|aortic coarctation
620592|NCT00552812|Heart Defects, Congenital|heart defects, congenital
620593|NCT00552812|Stents|stents
620594|NCT00552812|Heart Catheterization|heart catheterization
620595|NCT00552799|cellulitis|cellulitis
620596|NCT00552799|lymphoedema|lymphoedema
620597|NCT00552799|penicillin|penicillin
620598|NCT00552799|clinical trial|clinical trial
620599|NCT00552786|noise|noise
620600|NCT00552786|hearing loss|hearing loss
620601|NCT00552786|temporary threshold shift|temporary threshold shift
620602|NCT00552773|SINUSITIS|sinusitis
620603|NCT00552773|CYCLAMEN|cyclamen
620604|NCT00552747|fenofibrate|fenofibrate
620605|NCT00552747|coronary heart disease|coronary heart disease
620606|NCT00552747|mixed hyperlipidemia|mixed hyperlipidemia
620607|NCT00552734|Type 1 diabetes|type 1 diabetes
620608|NCT00552734|Improved glycemic control|improved glycemic control
620609|NCT00552734|Glucose excursions|glucose excursions
620610|NCT00552734|Target range glucose levels|target range glucose levels
620611|NCT00552734|Insulin guidance software|insulin guidance software
620612|NCT00552734|Advisor|advisor
620613|NCT00552721|Motor control|motor control
620614|NCT00552721|Spasticity|spasticity
620615|NCT00552708|COREG CR|coreg cr
620616|NCT00552695|intravenous catheter|intravenous catheter
620617|NCT00552695|emergency department|emergency department
620618|NCT00552695|pain|pain
620619|NCT00552682|HIV|hiv
620620|NCT00552682|fibromialgy|fibromialgy
620621|NCT00552682|chronic fatigue syndrome|chronic fatigue syndrome
620622|NCT00552682|duloxetine|duloxetine
620623|NCT00552682|pain|pain
620624|NCT00552682|treatment experienced|treatment experienced
620625|NCT00552682|Fibromialgy in patients with HIV-1 infection|fibromialgy in patients with hiv-1 infection
620626|NCT00552669|Drug Eluting Stents|drug eluting stents
620627|NCT00552669|Stents Bare Metal|stents bare metal
620628|NCT00552669|Stent Thrombosis|stent thrombosis
620629|NCT00552669|Coronary revascularization|coronary revascularization
620630|NCT00552669|Survival|survival
620631|NCT00552656|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
620632|NCT00552656|Drug-eluting stents|drug-eluting stents
620633|NCT00552656|Treatment Outcome|treatment outcome
620634|NCT00552643|Recalcitrant ulcers|recalcitrant ulcers
620635|NCT00552643|Chronic wounds|chronic wounds
620636|NCT00552643|Venous insufficiency wounds|venous insufficiency wounds
620637|NCT00552643|Ulcers|ulcers
620638|NCT00552643|Exposed bones|exposed bones
620639|NCT00552643|Exposed Tendons|exposed tendons
620640|NCT00552643|Granulation tissue|granulation tissue
620641|NCT00552643|Polyheal 1|polyheal 1
620642|NCT00552643|Wound care|wound care
620643|NCT00552643|Wound healing|wound healing
620644|NCT00552643|Diabetic wounds healing|diabetic wounds healing
620645|NCT00552643|Post trauma|post trauma
620646|NCT00552643|Post surgery complication|post surgery complication
620647|NCT00552643|Recalcitrant wounds including venous, post-operative and post-traumatic chronic wounds with different etiologies including wounds with exposed bone and tendon.|recalcitrant wounds including venous, post-operative and post-traumatic chronic wounds with different etiologies including wounds with exposed bone and tendon.
620648|NCT00552630|lead poisoning|lead poisoning
620649|NCT00552630|chelation|chelation
620650|NCT00552604|multiple sclerosis|multiple sclerosis
620651|NCT00552604|muscle stiffness|muscle stiffness
620652|NCT00552604|spasticity|spasticity
620653|NCT00552604|pain|pain
620654|NCT00552604|treatment|treatment
620655|NCT00552604|cannabinoids|cannabinoids
620656|NCT00552591|family risk|family risk
620657|NCT00552591|behavior modification|behavior modification
620658|NCT00552591|lifestyle change|lifestyle change
620659|NCT00552591|prevention of CHD|prevention of chd
620660|NCT00552591|health care costs|health care costs
620661|NCT00552578|drug dependence|drug dependence
620662|NCT00552578|substance abuse|substance abuse
620663|NCT00552578|substance use disorders|substance use disorders
620664|NCT00552578|myofascial pain syndrome|myofascial pain syndrome
620665|NCT00552578|neuralgia|neuralgia
620666|NCT00552578|back pain|back pain
620667|NCT00552565|IBS, IBS-D, R-verapamil, Arverpamil, Rezular|ibs, ibs-d, r-verapamil, arverpamil, rezular
620668|NCT00552552|cancer-related fatigue|cancer-related fatigue
620669|NCT00552552|self-management|self-management
620670|NCT00552552|patient education|patient education
620671|NCT00552552|cancer survivors|cancer survivors
620672|NCT00552552|chronic disease|chronic disease
620673|NCT00552539|syphilis|syphilis
620674|NCT00552539|educational video|educational video
620675|NCT00552539|knowledge|knowledge
620676|NCT00552539|black|black
620677|NCT00552539|Hispanic|hispanic
620678|NCT00552526|Epilepsy|epilepsy
620679|NCT00552526|Children|children
620680|NCT00552526|Mental retardation|mental retardation
620681|NCT00552526|Ketogenic diet|ketogenic diet
620682|NCT00552526|Diet|diet
620683|NCT00552513|timing|timing
620684|NCT00552513|intervention|intervention
620685|NCT00552513|early|early
620686|NCT00552513|delayed|delayed
620687|NCT00552513|acute coronary syndromes|acute coronary syndromes
620688|NCT00552513|PCI|pci
620689|NCT00552513|angiography|angiography
620690|NCT00552513|Non ST-segment elevation myocardial infarction|non st-segment elevation myocardial infarction
620691|NCT00552513|unstable angina|unstable angina
620692|NCT00552487|isolated ACTH deficiency|isolated acth deficiency
620693|NCT00552487|Hashimoto disease|hashimoto disease
620694|NCT00552487|Hashimoto thyroiditis|hashimoto thyroiditis
620695|NCT00552487|autoimmune thyroiditis|autoimmune thyroiditis
620696|NCT00552474|Parkinson disease|parkinson disease
620697|NCT00552474|Movement disorders|movement disorders
620698|NCT00552474|Deep Brain Stimulation|deep brain stimulation
620699|NCT00552474|Libra|libra
620700|NCT00552474|l-dopa|l-dopa
620701|NCT00552474|levodopa|levodopa
620702|NCT00552474|neuromodulation|neuromodulation
620703|NCT00552474|neurostimulation|neurostimulation
620704|NCT00552474|Electrical stimulation of the brain|electrical stimulation of the brain
620705|NCT00552474|STN|stn
620706|NCT00552474|Subthalamic nucleus|subthalamic nucleus
620707|NCT00552461|Pulmonary alveolar proteinosis|pulmonary alveolar proteinosis
620708|NCT00552461|Primary Pulmonary alveolar proteinosis|primary pulmonary alveolar proteinosis
620709|NCT00552461|Rituximab|rituximab
620710|NCT00552461|Idiopathic|idiopathic
620711|NCT00552461|Symptomatic|symptomatic
620712|NCT00552461|GM-CSF Antibody|gm-csf antibody
620713|NCT00552448|Pediatric, asthma, pediatric ICU|pediatric, asthma, pediatric icu
620714|NCT00552422|gastroparesis|gastroparesis
620715|NCT00552422|gastroesophageal reflux|gastroesophageal reflux
620716|NCT00552409|Diabetes mellitus|diabetes mellitus
620717|NCT00552409|Type 2 diabetes|type 2 diabetes
620718|NCT00552409|Chronic kidney disease|chronic kidney disease
620719|NCT00552409|Diabetic kidney disease|diabetic kidney disease
620720|NCT00552409|Microalbuminuria|microalbuminuria
620721|NCT00552409|Albuminuria|albuminuria
620722|NCT00552409|Vitamin D|vitamin d
620723|NCT00552409|Cholecalciferol|cholecalciferol
620724|NCT00552409|Kidney|kidney
620725|NCT00552409|Renal|renal
620726|NCT00552409|Cardiovascular|cardiovascular
620727|NCT00552409|Clinical trial|clinical trial
620728|NCT00552409|Placebo|placebo
620729|NCT00552396|multiple myeloma|multiple myeloma
620730|NCT00552396|Anti-KIR (1-7F9)|anti-kir (1-7f9)
620731|NCT00552383|Preterm Infant|preterm infant
620732|NCT00552383|Behaviour|behaviour
620733|NCT00552383|Developmental Care|developmental care
620734|NCT00552383|NIDCAP|nidcap
620735|NCT00552383|Family Centred Care|family centred care
620736|NCT00552383|Neurodevelopmental Outcome, preterm infant|neurodevelopmental outcome, preterm infant
620737|NCT00552344|CDP 870|cdp 870
620738|NCT00552344|Certolizumab Pegol|certolizumab pegol
620739|NCT00552344|CIMZIA|cimzia
620740|NCT00552344|Crohn's Disease|crohn's disease
620741|NCT00552344|Crohn Disease|crohn disease
620742|NCT00552344|CD Induction|cd induction
620743|NCT00552344|Induction|induction
620744|NCT00552344|Clinical response|clinical response
620745|NCT00552344|Clinical remission|clinical remission
620746|NCT00552292|metabolic syndrome|metabolic syndrome
620747|NCT00552292|hypertension|hypertension
620748|NCT00552292|obesity|obesity
620749|NCT00552292|dyslipidemia|dyslipidemia
620750|NCT00552292|hyperglycemia|hyperglycemia
620751|NCT00552292|cardiovascular complications|cardiovascular complications
620752|NCT00552279|HPV|hpv
620753|NCT00552279|cervical cancer|cervical cancer
620754|NCT00552279|papillomavirus|papillomavirus
620755|NCT00552279|Human papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
620756|NCT00552266|Methylphenidate|methylphenidate
620757|NCT00552266|Trichotillomania|trichotillomania
620758|NCT00552266|Attention deficit|attention deficit
620759|NCT00552214|Nucleic acid test|nucleic acid test
620760|NCT00552214|HIV-1|hiv-1
620761|NCT00552214|hepatitis|hepatitis
620762|NCT00552214|HBV|hbv
620763|NCT00552214|HCV|hcv
620764|NCT00552214|TMA|tma
620765|NCT00552214|HIV Seronegativity|hiv seronegativity
620766|NCT00552201|kidney transplantation|kidney transplantation
620767|NCT00552201|Tacrolimus|tacrolimus
620768|NCT00552201|P450 3A5 cytochrome|p450 3a5 cytochrome
620769|NCT00552201|genotype|genotype
620770|NCT00552188|Atherosclerosis|atherosclerosis
620771|NCT00552084|Fish Oil|fish oil
620772|NCT00552071|Acromegaly|acromegaly
620773|NCT00552071|Octreotide LAR|octreotide lar
620774|NCT00552071|Ultrasound guidance|ultrasound guidance
620775|NCT00552058|CDP 870|cdp 870
620776|NCT00552058|Certolizumab Pegol|certolizumab pegol
620777|NCT00552058|CIMZIA ®|cimzia ®
620778|NCT00552058|Crohn's disease|crohn's disease
620779|NCT00552058|Induction|induction
620780|NCT00552058|Clinical remission|clinical remission
620781|NCT00552058|Clinical response|clinical response
620782|NCT00552045|epilepsy|epilepsy
620783|NCT00552045|localization-related epilepsy|localization-related epilepsy
620784|NCT00552045|idiopathic generalized epilepsy|idiopathic generalized epilepsy
620785|NCT00552045|infantile spasms|infantile spasms
620786|NCT00552045|Lennox-Gastaut syndrome|lennox-gastaut syndrome
620787|NCT00552045|polymicrogyria|polymicrogyria
620788|NCT00552045|periventricular heterotopias|periventricular heterotopias
620789|NCT00552045|malformations of cortical development|malformations of cortical development
620790|NCT00552045|phenome|phenome
620791|NCT00552045|genome|genome
620792|NCT00552045|genotype|genotype
620793|NCT00552045|phenotype|phenotype
620794|NCT00552006|PTSD|ptsd
620795|NCT00552006|Treatment|treatment
620796|NCT00552006|Randomized Controlled Clinical Trial|randomized controlled clinical trial
620797|NCT00552006|Combat|combat
621242|NCT00550030|PASI|pasi
620798|NCT00552006|Child Soldiers|child soldiers
620799|NCT00552006|Dissemination|dissemination
620800|NCT00552006|Narrative Exposure Therapy|narrative exposure therapy
620801|NCT00552006|Africa|africa
620802|NCT00551993|laparoscopy|laparoscopy
620803|NCT00551993|robot|robot
620804|NCT00551993|vaginal prolapse|vaginal prolapse
620805|NCT00551993|sacrocolpopexy|sacrocolpopexy
620806|NCT00551993|sacral colpopexy|sacral colpopexy
620807|NCT00551980|Headache|headache
620808|NCT00551980|Cervical Pain|cervical pain
620809|NCT00551980|Cognitive treatment|cognitive treatment
620810|NCT00551980|Relaxation|relaxation
620811|NCT00551980|Exercise|exercise
620812|NCT00551967|clinical outcomes|clinical outcomes
620813|NCT00551967|radiographic outcomes|radiographic outcomes
620814|NCT00551967|total hip arthroplasty|total hip arthroplasty
620815|NCT00551967|survivorship|survivorship
620816|NCT00551928|Multiple Myeloma|multiple myeloma
620817|NCT00551928|Lenalidomide|lenalidomide
620818|NCT00551928|High dose Melphalan|high dose melphalan
620819|NCT00551928|Mobilization|mobilization
620820|NCT00551928|CD34|cd34
620821|NCT00551902|Glaucoma|glaucoma
620822|NCT00551902|trabeculectomy|trabeculectomy
620823|NCT00551902|anterior chamber maintainer|anterior chamber maintainer
620824|NCT00551902|anterior chamber infusion|anterior chamber infusion
620825|NCT00551889|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
620826|NCT00551863|alcohol, drugs, aggression, substance use disorder treatment|alcohol, drugs, aggression, substance use disorder treatment
620827|NCT00551850|epidermal growth factor inhibitor|epidermal growth factor inhibitor
620828|NCT00551850|solid tumors|solid tumors
620829|NCT00551850|advanced cancer|advanced cancer
620830|NCT00551837|Lung Transplantation|lung transplantation
620831|NCT00551837|Kidney Transplnatation|kidney transplnatation
620832|NCT00551837|Chroinic Kidney Disease|chroinic kidney disease
620833|NCT00551837|Influenza|influenza
620834|NCT00551824|esophageal stricture|esophageal stricture
620835|NCT00551811|SB-656933-AAA,|sb-656933-aaa,
620836|NCT00551811|ozone challenge|ozone challenge
620837|NCT00551811|single dose,|single dose,
620838|NCT00551798|Hodgkin's Disease|hodgkin's disease
620839|NCT00551798|Malignant lymphomas high grade|malignant lymphomas high grade
620840|NCT00551798|Chemoresistance|chemoresistance
620841|NCT00551798|MIBI|mibi
620842|NCT00551798|PGP|pgp
620843|NCT00551798|MRP1|mrp1
620844|NCT00551798|Tumor response|tumor response
620845|NCT00551785|Hypoactive Sexual Desire Disorder|hypoactive sexual desire disorder
620846|NCT00551785|Menopause|menopause
620847|NCT00551785|Androgen|androgen
620848|NCT00551772|Bio-availability, healthy elderly volunteers|bio-availability, healthy elderly volunteers
620849|NCT00551759|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
620850|NCT00551759|chemoradiotherapy|chemoradiotherapy
620851|NCT00551759|oxaliplatin|oxaliplatin
620852|NCT00551759|cetuximab|cetuximab
620853|NCT00551759|docetaxel|docetaxel
620854|NCT00551746|purple grape juice|purple grape juice
620855|NCT00551746|antioxidants|antioxidants
620856|NCT00551746|platelet aggregation|platelet aggregation
620857|NCT00551746|anti-thrombotic|anti-thrombotic
620858|NCT00551733|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
620859|NCT00551733|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
620860|NCT00551733|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
620861|NCT00551720|HIV|hiv
620862|NCT00551720|HIV positive|hiv positive
620863|NCT00551720|AIDS|aids
620864|NCT00551720|smoking cessation|smoking cessation
620865|NCT00551720|smoking|smoking
620866|NCT00551720|smoking counseling|smoking counseling
620867|NCT00551707|CombinatoRx|combinatorx
620868|NCT00551707|CRx-102|crx-102
620869|NCT00551707|Rheumatoid Arthritis|rheumatoid arthritis
620870|NCT00551707|Prednisolone|prednisolone
620871|NCT00551707|Dipyridamole|dipyridamole
620872|NCT00551707|ACR20|acr20
620873|NCT00551694|GSK256073A|gsk256073a
620874|NCT00551681|cardiac resynchronisation therapy|cardiac resynchronisation therapy
620875|NCT00551681|epicardial lead|epicardial lead
620876|NCT00551681|coronary sinus|coronary sinus
620877|NCT00551655|Human Immunodeficiency Viruses|human immunodeficiency viruses
620878|NCT00551655|Glomerular Filtration Rate|glomerular filtration rate
620879|NCT00551655|Tenofovir|tenofovir
620880|NCT00551655|Treatment Experienced|treatment experienced
620881|NCT00551642|Preemie, Inhaled Nitric Oxide|preemie, inhaled nitric oxide
620882|NCT00551603|epoetinum beta once-weekly|epoetinum beta once-weekly
620883|NCT00551603|darbepoetinum once-fortnightly|darbepoetinum once-fortnightly
620884|NCT00551603|anemia correction|anemia correction
620885|NCT00551603|hemoglobin stability|hemoglobin stability
620886|NCT00551590|diabetes mellitus|diabetes mellitus
620887|NCT00551590|DPP-4 inhibitor|dpp-4 inhibitor
620888|NCT00551590|sitagliptin|sitagliptin
620889|NCT00551590|exendin(9-39)|exendin(9-39)
620890|NCT00551590|GLP-1|glp-1
620891|NCT00551577|Ovarian neoplasms,|ovarian neoplasms,
620892|NCT00551577|Neoadjuvant Therapy,|neoadjuvant therapy,
620893|NCT00551577|Docetaxel,|docetaxel,
620894|NCT00551577|Neoplasm, Residual|neoplasm, residual
621540|NCT00548522|Islet Mass|islet mass
620895|NCT00551564|total body water|total body water
620896|NCT00551564|T2DM,|t2dm,
620897|NCT00551564|Healthy Obese,|healthy obese,
620898|NCT00551564|Insulin Resistance,|insulin resistance,
620899|NCT00551564|Rosiglitazone maleate,|rosiglitazone maleate,
620900|NCT00551564|Glucose Disposal,|glucose disposal,
620901|NCT00551564|hyperinsulinemic-euglycemic clamp,|hyperinsulinemic-euglycemic clamp,
620902|NCT00551551|Pelvic floor|pelvic floor
620903|NCT00551551|Kegel exercises|kegel exercises
620904|NCT00551551|Quality of Life|quality of life
620905|NCT00551551|Pelvic Pain|pelvic pain
620906|NCT00551538|Diabetes|diabetes
620907|NCT00551538|Diabetic|diabetic
620908|NCT00551538|Insulin|insulin
620909|NCT00551538|Glargine|glargine
620910|NCT00551538|Lispro|lispro
620911|NCT00551525|stage IIB prostate cancer|stage iib prostate cancer
620912|NCT00551525|stage IIA prostate cancer|stage iia prostate cancer
620913|NCT00551525|stage III prostate cancer|stage iii prostate cancer
620914|NCT00551525|stage IV prostate cancer|stage iv prostate cancer
620915|NCT00551512|cancer|cancer
620916|NCT00551512|solid tumors|solid tumors
620917|NCT00551499|Sleep Apnea, CRT|sleep apnea, crt
620918|NCT00551486|Pyrosequencing|pyrosequencing
620919|NCT00551486|BRAFV600E mutation|brafv600e mutation
620920|NCT00551486|Thyroid incidentaloma|thyroid incidentaloma
620921|NCT00551486|Ultrasound-guided fine-needle aspiration biopsy|ultrasound-guided fine-needle aspiration biopsy
620922|NCT00551473|pharmacodynamics,|pharmacodynamics,
620923|NCT00551473|tolerance|tolerance
620924|NCT00551473|H2 antagonist,|h2 antagonist,
620925|NCT00551473|AH23844,|ah23844,
620926|NCT00551473|lavoltidine,|lavoltidine,
620927|NCT00551473|gastroesophageal reflux disease (GERD), pharmacokinetics,|gastroesophageal reflux disease (gerd), pharmacokinetics,
620928|NCT00551460|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
620929|NCT00551460|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
620930|NCT00551460|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
620931|NCT00551460|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
620932|NCT00551460|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
620933|NCT00551395|glaucoma|glaucoma
620934|NCT00551395|laser|laser
620935|NCT00551395|trabeculoplasty|trabeculoplasty
620936|NCT00551382|Montelukast|montelukast
620937|NCT00551382|Upper respiratory tract infection|upper respiratory tract infection
620938|NCT00551382|leukotriene|leukotriene
620939|NCT00551382|Children|children
620940|NCT00551369|stage I non-small cell lung cancer|stage i non-small cell lung cancer
620941|NCT00551369|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
620942|NCT00551369|adenocarcinoma of the lung|adenocarcinoma of the lung
620943|NCT00551369|large cell lung cancer|large cell lung cancer
620944|NCT00551369|squamous cell lung cancer|squamous cell lung cancer
620945|NCT00551369|adenosquamous cell lung cancer|adenosquamous cell lung cancer
620946|NCT00551356|Diabetes|diabetes
620947|NCT00551356|Diabetic|diabetic
620948|NCT00551356|Insulin|insulin
620949|NCT00551356|Humalog|humalog
620950|NCT00551356|Lantus|lantus
620951|NCT00551356|Glargine|glargine
620952|NCT00551356|Lispro|lispro
620953|NCT00551330|Treatment Experienced|treatment experienced
620954|NCT00551317|SB480848,|sb480848,
620955|NCT00551317|Japanese healthy volunteers|japanese healthy volunteers
620956|NCT00551317|darapladib,|darapladib,
620957|NCT00551278|sentinel lymph node|sentinel lymph node
620958|NCT00551278|metastasis|metastasis
620959|NCT00551278|molecular pathology|molecular pathology
620960|NCT00551239|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
620961|NCT00551239|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
620962|NCT00551239|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
620963|NCT00551239|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
620964|NCT00551239|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
620965|NCT00551239|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
620966|NCT00551239|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
620967|NCT00551239|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
620968|NCT00551239|splenic marginal zone lymphoma|splenic marginal zone lymphoma
620969|NCT00551239|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
620970|NCT00551239|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
620971|NCT00551239|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
620972|NCT00551239|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
620973|NCT00551239|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
620974|NCT00551239|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
620975|NCT00551239|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
620976|NCT00551239|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
620977|NCT00551239|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
620978|NCT00551239|stage I marginal zone lymphoma|stage i marginal zone lymphoma
621541|NCT00548522|C-peptide|c-peptide
620979|NCT00551239|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
620980|NCT00551239|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
620981|NCT00551239|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
620982|NCT00551239|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
620983|NCT00551239|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
620984|NCT00551239|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
620985|NCT00551239|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
620986|NCT00551239|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
620987|NCT00551239|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
620988|NCT00551239|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
620989|NCT00551239|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
620990|NCT00551239|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
620991|NCT00551239|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
620992|NCT00551226|TB|tb
620993|NCT00551226|Patients with tuberculosis|patients with tuberculosis
620994|NCT00551213|anti-IGF-1R|anti-igf-1r
620995|NCT00551200|Buphenyl|buphenyl
620996|NCT00551200|Sodium Phenylbutyrate|sodium phenylbutyrate
620997|NCT00551200|Urea Cycle Disorder|urea cycle disorder
620998|NCT00551200|UCD|ucd
620999|NCT00551161|Alzheimer disease|alzheimer disease
621000|NCT00551161|memantine|memantine
621001|NCT00551161|cholinesterase inhibitors|cholinesterase inhibitors
621002|NCT00551161|magnetic resonance spectroscopy|magnetic resonance spectroscopy
621003|NCT00551161|N-acetylaspartate|n-acetylaspartate
621004|NCT00551161|inositol|inositol
621005|NCT00551161|cerebrospinal fluid|cerebrospinal fluid
621006|NCT00551161|tau proteins|tau proteins
621007|NCT00551161|amyloid beta-protein|amyloid beta-protein
621008|NCT00551135|postoperative pain chronic pain|postoperative pain chronic pain
621009|NCT00551122|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
621010|NCT00551122|testicular seminoma|testicular seminoma
621011|NCT00551122|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
621012|NCT00551122|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
621013|NCT00551122|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
621014|NCT00551122|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
621015|NCT00551122|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
621016|NCT00551122|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
621017|NCT00551122|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
621018|NCT00551122|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
621019|NCT00551122|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
621020|NCT00551122|recurrent extragonadal seminoma|recurrent extragonadal seminoma
621021|NCT00551122|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
621022|NCT00551122|stage IV extragonadal seminoma|stage iv extragonadal seminoma
621023|NCT00551122|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
621024|NCT00551122|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
621025|NCT00551122|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
621026|NCT00551096|Advanced Solid Tumors|advanced solid tumors
621027|NCT00551096|Biliary or Pancreatic Malignancies|biliary or pancreatic malignancies
621028|NCT00551044|prostatic neoplasms|prostatic neoplasms
621029|NCT00551044|bicalutamide|bicalutamide
621030|NCT00551044|quality of life|quality of life
621031|NCT00551044|osteoporosis|osteoporosis
621032|NCT00551031|Influenza|influenza
621033|NCT00551031|Orthomyxoviruses|orthomyxoviruses
621034|NCT00551031|Myxovirus Infection|myxovirus infection
621035|NCT00551031|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
621036|NCT00551031|Elderly|elderly
621037|NCT00551018|Treatment Naive|treatment naive
621038|NCT00551005|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
621039|NCT00550992|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
621040|NCT00550992|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
621041|NCT00550992|acute undifferentiated leukemia|acute undifferentiated leukemia
621042|NCT00550979|gestational diabetes mellitus|gestational diabetes mellitus
621043|NCT00550979|cardiovascular disease risk|cardiovascular disease risk
621044|NCT00550979|heart disease risk|heart disease risk
621045|NCT00550966|Fibromyalgia|fibromyalgia
621046|NCT00550966|Quality of life|quality of life
621047|NCT00550966|Primary Care|primary care
621048|NCT00550966|Non-pharmacological treatment|non-pharmacological treatment
621049|NCT00550966|Cost / Cost-efficacy|cost / cost-efficacy
621050|NCT00550940|epilepsy|epilepsy
621051|NCT00550940|attention|attention
621052|NCT00550940|emotion|emotion
621053|NCT00550940|behavior problems|behavior problems
621054|NCT00550940|child|child
621055|NCT00550940|adolescent|adolescent
621056|NCT00550927|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
623184|NCT00541385|malaria|malaria
621057|NCT00550914|Papilloma, Papillomatosis, Laser, Laser Surgery|papilloma, papillomatosis, laser, laser surgery
621058|NCT00550901|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
621059|NCT00550888|uterus|uterus
621060|NCT00550888|abdominal delivery|abdominal delivery
621061|NCT00550888|suture techniques|suture techniques
621062|NCT00550875|Allergic rhinoconjunctivitis,|allergic rhinoconjunctivitis,
621063|NCT00550875|Immunotherapy|immunotherapy
621064|NCT00550862|PBC, Primary Biliary Cirrhosis, Liver,|pbc, primary biliary cirrhosis, liver,
621065|NCT00550836|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
621184|NCT00550342|B cell|b cell
621066|NCT00550836|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
621067|NCT00550836|stage IV pancreatic cancer|stage iv pancreatic cancer
621068|NCT00550810|Sutent|sutent
621069|NCT00550797|Steroid-naive, non-smokers|steroid-naive, non-smokers
621070|NCT00550797|Mild to moderate allergic asthmatic adults|mild to moderate allergic asthmatic adults
621071|NCT00550784|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
621072|NCT00550784|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
621073|NCT00550784|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
621074|NCT00550784|fallopian tube cancer|fallopian tube cancer
621075|NCT00550784|peritoneal cavity cancer|peritoneal cavity cancer
621076|NCT00550758|Methacholine challenge; Spirometry, Early childhood|methacholine challenge; spirometry, early childhood
621077|NCT00550732|Triazoles|triazoles
621078|NCT00550706|Prescription point prevalence|prescription point prevalence
621079|NCT00550706|Drug utilization|drug utilization
621080|NCT00550706|Define Daily Dose|define daily dose
621081|NCT00550693|bloodstream infections|bloodstream infections
621082|NCT00550693|hemodialysis catheter|hemodialysis catheter
621083|NCT00550667|Attention-deficit hyperactivity disorder|attention-deficit hyperactivity disorder
621084|NCT00550667|adult|adult
621085|NCT00550667|diagnostic validity|diagnostic validity
621086|NCT00550667|neuropsychological functions|neuropsychological functions
621087|NCT00550667|social functioning|social functioning
621088|NCT00550654|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
621089|NCT00550654|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
621090|NCT00550654|recurrent melanoma|recurrent melanoma
621091|NCT00550654|recurrent osteosarcoma|recurrent osteosarcoma
621092|NCT00550654|recurrent renal cell cancer|recurrent renal cell cancer
621093|NCT00550654|recurrent uterine sarcoma|recurrent uterine sarcoma
621094|NCT00550654|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
621095|NCT00550654|stage IV melanoma|stage iv melanoma
621096|NCT00550654|stage IV uterine sarcoma|stage iv uterine sarcoma
621097|NCT00550654|ovarian sarcoma|ovarian sarcoma
621098|NCT00550654|chondrosarcoma|chondrosarcoma
621099|NCT00550654|metastatic osteosarcoma|metastatic osteosarcoma
621100|NCT00550654|stage IV renal cell cancer|stage iv renal cell cancer
621101|NCT00550654|lung metastases|lung metastases
621102|NCT00550654|liver metastases|liver metastases
621103|NCT00550654|bone metastases|bone metastases
621104|NCT00550641|fibromyalgia|fibromyalgia
621105|NCT00550641|pool-based exercise|pool-based exercise
621106|NCT00550628|neoplasm of uncertain malignant potential|neoplasm of uncertain malignant potential
621107|NCT00550628|colon cancer|colon cancer
621108|NCT00550615|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
621109|NCT00550615|Relapsed Non Hodgkins Lymphoma|relapsed non hodgkins lymphoma
621110|NCT00550615|Refractory Non Hodgkins Lymphoma|refractory non hodgkins lymphoma
621111|NCT00550615|Dasatinib|dasatinib
621112|NCT00550602|Tracheomalacia|tracheomalacia
621113|NCT00550602|Tracheobronchomalacia|tracheobronchomalacia
621114|NCT00550602|Airway Stabilization|airway stabilization
621115|NCT00550602|Bronchoscopy|bronchoscopy
621116|NCT00550602|Stent Placement|stent placement
621117|NCT00550602|Tracheobronchoplasty|tracheobronchoplasty
621118|NCT00550602|COPD|copd
621119|NCT00550589|high-grade squamous intraepithelial lesion|high-grade squamous intraepithelial lesion
621120|NCT00550589|stage 0 anal cancer|stage 0 anal cancer
621121|NCT00550576|Digoxin Antibodies|digoxin antibodies
621122|NCT00550576|Bipolar Disorder|bipolar disorder
621123|NCT00550563|recurrent colon cancer|recurrent colon cancer
621124|NCT00550563|stage I colon cancer|stage i colon cancer
621125|NCT00550563|stage II colon cancer|stage ii colon cancer
621126|NCT00550563|stage III colon cancer|stage iii colon cancer
621127|NCT00550563|stage IV colon cancer|stage iv colon cancer
621128|NCT00550563|recurrent rectal cancer|recurrent rectal cancer
621129|NCT00550563|stage I rectal cancer|stage i rectal cancer
621130|NCT00550563|stage II rectal cancer|stage ii rectal cancer
621131|NCT00550563|stage III rectal cancer|stage iii rectal cancer
621132|NCT00550563|stage IV rectal cancer|stage iv rectal cancer
621133|NCT00550550|rhinoconjunctivitis|rhinoconjunctivitis
621134|NCT00550550|rhinitis|rhinitis
621135|NCT00550550|conjunctivitis|conjunctivitis
621136|NCT00550550|allergy|allergy
621137|NCT00550550|allergen|allergen
621138|NCT00550550|immunotherapy|immunotherapy
621139|NCT00550537|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
621140|NCT00550537|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
621141|NCT00550537|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
621142|NCT00550537|squamous cell lung cancer|squamous cell lung cancer
621143|NCT00550537|adenosquamous cell lung cancer|adenosquamous cell lung cancer
621144|NCT00550537|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
621145|NCT00550537|large cell lung cancer|large cell lung cancer
621146|NCT00550537|adenocarcinoma of the lung|adenocarcinoma of the lung
621147|NCT00550524|Knee osteoarthritis|knee osteoarthritis
621148|NCT00550511|Abdominal pain|abdominal pain
621149|NCT00550511|ultrasound|ultrasound
621150|NCT00550511|surgery|surgery
621151|NCT00550511|emergency department|emergency department
621152|NCT00550511|diagnostic accuracy|diagnostic accuracy
621153|NCT00550498|Retinal Vasculitis|retinal vasculitis
621154|NCT00550498|Retinal Edema|retinal edema
621155|NCT00550498|Behcet's Disease|behcet's disease
621156|NCT00550472|probiotics|probiotics
621157|NCT00550472|atopic dermatitis|atopic dermatitis
621158|NCT00550472|immune system|immune system
621159|NCT00550472|human|human
621160|NCT00550472|Lactobacillus|lactobacillus
621161|NCT00550472|Bifidobacterium|bifidobacterium
621162|NCT00550472|healthy subjects|healthy subjects
621163|NCT00550459|Hyponatremia|hyponatremia
621164|NCT00550459|Cognitive|cognitive
621165|NCT00550459|Neurological Function|neurological function
621166|NCT00550459|Elderly|elderly
621167|NCT00550446|Janus Kinase 3 Clinical Trial|janus kinase 3 clinical trial
621168|NCT00550420|open-label extension|open-label extension
621169|NCT00550420|tolerability|tolerability
621170|NCT00550420|Alzheimer's disease|alzheimer's disease
621171|NCT00550420|Rosiglitazone extended-release (XR)|rosiglitazone extended-release (xr)
621172|NCT00550420|safety|safety
621173|NCT00550420|cognition|cognition
621174|NCT00550420|BRL-049653|brl-049653
621175|NCT00550407|Lamotrigine|lamotrigine
621176|NCT00550407|Prevention of relapse or recurrence of a mood episode|prevention of relapse or recurrence of a mood episode
621177|NCT00550407|Bipolar I disorder|bipolar i disorder
621178|NCT00550394|Adolescents|adolescents
621179|NCT00550381|healthy subjects|healthy subjects
621180|NCT00550342|Focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
621181|NCT00550342|FSGS|fsgs
621182|NCT00550342|Proteinuria|proteinuria
621183|NCT00550342|rituximab|rituximab
621185|NCT00550342|autoimmune|autoimmune
621186|NCT00550342|CD20|cd20
621187|NCT00550342|treatment|treatment
621188|NCT00550342|children|children
621189|NCT00550290|vulvectomy|vulvectomy
621190|NCT00550290|wound infection|wound infection
621191|NCT00550290|wound complication|wound complication
621192|NCT00550290|prophylactic antibiotic|prophylactic antibiotic
621193|NCT00550290|Post-operative wound complications following vulvectomy|post-operative wound complications following vulvectomy
621194|NCT00550277|Renal Cell Carcinoma|renal cell carcinoma
621195|NCT00550277|Refractory|refractory
621196|NCT00550277|LBH589|lbh589
621197|NCT00550264|Hospital Readmission|hospital readmission
621198|NCT00550264|Continuity of Care|continuity of care
621199|NCT00550264|Quality of Health Care|quality of health care
621200|NCT00550251|Nausea|nausea
621201|NCT00550251|Vomiting|vomiting
621202|NCT00550251|Emesis|emesis
621203|NCT00550251|Palliative|palliative
621204|NCT00550251|Terminal|terminal
621205|NCT00550251|Cancer|cancer
621206|NCT00550238|Parkinson's Disease Psychosis|parkinson's disease psychosis
621207|NCT00550225|succinate|succinate
621208|NCT00550225|anti-muscarinic|anti-muscarinic
621209|NCT00550225|b-agonist|b-agonist
621210|NCT00550212|healthy subjects|healthy subjects
621211|NCT00550199|Solid Tumors|solid tumors
621212|NCT00550199|Phase I|phase i
621213|NCT00550199|LBH589|lbh589
621214|NCT00550199|Gemcitabine|gemcitabine
621215|NCT00550186|spinal anesthesia|spinal anesthesia
621216|NCT00550186|preload|preload
621217|NCT00550186|diuresis|diuresis
621218|NCT00550186|bladder retention|bladder retention
621219|NCT00550147|ADHD-Combined TypeDisruptive behavior Disorder|adhd-combined typedisruptive behavior disorder
621220|NCT00550134|Breast Cancer|breast cancer
621221|NCT00550134|Quality of life|quality of life
621222|NCT00550108|pancreatic cyst|pancreatic cyst
621223|NCT00550108|ethanol injection|ethanol injection
621224|NCT00550095|Microalbuminuria/proteinuria|microalbuminuria/proteinuria
621225|NCT00550095|hypertensive patients with type 2 diabetes|hypertensive patients with type 2 diabetes
621226|NCT00550095|Valsartan|valsartan
621227|NCT00550095|microalbuminuria/proteinuria in hypertensive patients with type 2 diabetes|microalbuminuria/proteinuria in hypertensive patients with type 2 diabetes
621228|NCT00550082|Anticoagulation|anticoagulation
621229|NCT00550082|High-Risk|high-risk
621230|NCT00550082|Deep Vein Thrombosis|deep vein thrombosis
621231|NCT00550082|Pulmonary Embolism|pulmonary embolism
621232|NCT00550082|Surgery|surgery
621233|NCT00550069|late preterm infants|late preterm infants
621234|NCT00550069|near term infants|near term infants
621235|NCT00550069|outcome|outcome
621236|NCT00550056|PTSD, Posttraumatic Stress Disorder, refugees, war|ptsd, posttraumatic stress disorder, refugees, war
621237|NCT00550043|Rheumatoid arthritis|rheumatoid arthritis
621238|NCT00550030|Psoriasis|psoriasis
621239|NCT00550030|UVB radiation|uvb radiation
621240|NCT00550030|Biologics|biologics
621241|NCT00550030|Etanercept|etanercept
621243|NCT00550004|Unresectable|unresectable
621244|NCT00550004|locally advanced|locally advanced
621245|NCT00550004|metastatic pancreatic adenocarcinoma|metastatic pancreatic adenocarcinoma
621246|NCT00550004|Stage III|stage iii
621247|NCT00550004|Stage IV|stage iv
621248|NCT00549991|High Blood Pressure|high blood pressure
621249|NCT00549978|Safety and Pharmacokinetics in healthy subjects|safety and pharmacokinetics in healthy subjects
621250|NCT00549939|child|child
621251|NCT00549939|bladder|bladder
621252|NCT00549939|neuropathic|neuropathic
621253|NCT00549939|alpha blockers|alpha blockers
621254|NCT00549913|adjacent vertebral levels between L1 and S1|adjacent vertebral levels between l1 and s1
621255|NCT00549900|HPV vaccine,|hpv vaccine,
621256|NCT00549900|Cervical cancer|cervical cancer
621257|NCT00549900|Human papillomavirus infection,|human papillomavirus infection,
621258|NCT00549874|insulin resistance|insulin resistance
621259|NCT00549874|type 2 diabetes|type 2 diabetes
621260|NCT00549874|myocardial perfusion|myocardial perfusion
621261|NCT00549874|nitrosative stress|nitrosative stress
621262|NCT00549874|thiazolidinediones|thiazolidinediones
621263|NCT00549861|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
621264|NCT00549861|Contrast agents|contrast agents
621265|NCT00549861|Gadobutrol|gadobutrol
621266|NCT00549861|Fibrosis|fibrosis
621267|NCT00549861|Prognosis|prognosis
621268|NCT00549861|Magnetic Resonance|magnetic resonance
621269|NCT00549861|Gadolinium|gadolinium
621270|NCT00549848|Leukemia|leukemia
621271|NCT00549835|mucositis pain|mucositis pain
621272|NCT00549835|cancer|cancer
621273|NCT00549835|pain|pain
621274|NCT00549835|acupuncture|acupuncture
621275|NCT00549835|mucositis|mucositis
621276|NCT00549835|cancer pain|cancer pain
621277|NCT00549822|aromatase inhibitor|aromatase inhibitor
621278|NCT00549822|CA 15-3|ca 15-3
621279|NCT00549822|Hormone receptor positive|hormone receptor positive
621280|NCT00549809|mechanical ventilation; respiratory failure|mechanical ventilation; respiratory failure
621281|NCT00549796|coronary artery disease|coronary artery disease
621282|NCT00549796|angioplasty|angioplasty
621283|NCT00549796|stent|stent
621284|NCT00549796|percutaneous coronary intervention|percutaneous coronary intervention
621285|NCT00549796|on-site cardiac surgery|on-site cardiac surgery
621286|NCT00549796|randomized trial|randomized trial
621287|NCT00549770|Hypertension, valsartan, LCZ696|hypertension, valsartan, lcz696
621288|NCT00549757|Type 2 diabetes mellitus|type 2 diabetes mellitus
621289|NCT00549757|renal morbidity and mortality|renal morbidity and mortality
621290|NCT00549757|cardiovascular disease|cardiovascular disease
621291|NCT00549757|micro-albuminuria|micro-albuminuria
621292|NCT00549757|macro-albuminuria|macro-albuminuria
621293|NCT00549757|RAAS|raas
621294|NCT00549757|renin inhibitor|renin inhibitor
621295|NCT00549757|Reduced estimated glomerular filtration rate|reduced estimated glomerular filtration rate
621296|NCT00549744|ASTHMA|asthma
621297|NCT00549744|CLINICAL ENDPOINT,|clinical endpoint,
621298|NCT00549731|autism|autism
621299|NCT00549731|autistic|autistic
621300|NCT00549731|language|language
621301|NCT00549731|development|development
621302|NCT00549731|developmental|developmental
621303|NCT00549731|assessment|assessment
621304|NCT00549718|Schizophrenia|schizophrenia
621305|NCT00549718|SM-13496|sm-13496
621306|NCT00549718|Latuda|latuda
621307|NCT00549718|Lurasidone|lurasidone
621308|NCT00549705|Anticoagulation|anticoagulation
621309|NCT00549705|Thrombosis|thrombosis
621310|NCT00549705|Bleeding|bleeding
621311|NCT00549705|Clotting|clotting
621312|NCT00549705|Pulmonary Embolism|pulmonary embolism
621313|NCT00549705|Deep Vein Thrombosis|deep vein thrombosis
621314|NCT00549679|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
621315|NCT00549679|COPD|copd
621316|NCT00549679|Repeat Dose|repeat dose
621317|NCT00549679|GSK256066|gsk256066
621318|NCT00549666|OC DDI|oc ddi
621319|NCT00549666|lurasidone|lurasidone
621320|NCT00549666|Latuda|latuda
621321|NCT00549666|schizophenia|schizophenia
621322|NCT00549653|GW856553,|gw856553,
621323|NCT00549653|drug-drug interactions,|drug-drug interactions,
621324|NCT00549653|rosuvastatin|rosuvastatin
621325|NCT00549640|nicotine dependence|nicotine dependence
621326|NCT00549640|tobacco dependence|tobacco dependence
621327|NCT00549614|heart failure|heart failure
621328|NCT00549601|Alzheimer's|alzheimer's
621329|NCT00549601|rivastigmine|rivastigmine
621330|NCT00549601|transdermal|transdermal
621331|NCT00549601|safety|safety
621332|NCT00549601|randomized|randomized
621333|NCT00549601|switch|switch
621334|NCT00549601|patch|patch
621335|NCT00549588|Polymorphic light eruption|polymorphic light eruption
621336|NCT00549588|UV radiation|uv radiation
621337|NCT00549588|photoprotection|photoprotection
621338|NCT00549588|sunscreen|sunscreen
621339|NCT00549588|DNA repair enzymes|dna repair enzymes
621340|NCT00549588|after-sun-lotion|after-sun-lotion
621341|NCT00549575|Severe Intra uterine growth retardation below the third centile with abnormal uterine doppler|severe intra uterine growth retardation below the third centile with abnormal uterine doppler
621542|NCT00548496|fractured wrist|fractured wrist
623185|NCT00541385|pediatric|pediatric
621342|NCT00549575|Severe growth retardation with pathologic uterine Doppler|severe growth retardation with pathologic uterine doppler
621343|NCT00549575|L-Arginine|l-arginine
621344|NCT00549575|Nitric Oxide Donor|nitric oxide donor
621345|NCT00549562|Autistic Disorder|autistic disorder
621346|NCT00549536|calcium supplementation|calcium supplementation
621347|NCT00549536|intracellular ions|intracellular ions
621348|NCT00549536|sodium/hydrogen exchange activity|sodium/hydrogen exchange activity
621349|NCT00549523|HIV|hiv
621350|NCT00549523|Alternative Medicine|alternative medicine
621351|NCT00549523|Complementary Medicine|complementary medicine
621352|NCT00549510|COREG CR,|coreg cr,
621353|NCT00549510|lisinopril,|lisinopril,
621354|NCT00549510|hypertension,|hypertension,
621355|NCT00549510|dose proportionality,|dose proportionality,
621356|NCT00549510|fixed dose combination (FDC)|fixed dose combination (fdc)
621357|NCT00549497|GW870086X, inhaled, asthma, cortisol, pharmacokinetics, osteocalcin|gw870086x, inhaled, asthma, cortisol, pharmacokinetics, osteocalcin
621358|NCT00549484|Thrombocytopenia|thrombocytopenia
621359|NCT00549484|Thrombopoietin|thrombopoietin
621360|NCT00549484|Platelet Transfusion|platelet transfusion
621361|NCT00549484|Platelet Factor 4|platelet factor 4
621362|NCT00549471|children with cerebral palsy ages eight to eleven.|children with cerebral palsy ages eight to eleven.
621363|NCT00549458|Week pelvic floor muscle in females|week pelvic floor muscle in females
621364|NCT00549445|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
621365|NCT00549445|COPD|copd
621366|NCT00549445|Exacerbation|exacerbation
621367|NCT00549445|Macrolide|macrolide
621368|NCT00549406|Vision|vision
621369|NCT00549406|Visual attention|visual attention
621370|NCT00549406|Postural balance|postural balance
621371|NCT00549406|Geriatrics|geriatrics
621372|NCT00549393|intensive care unit|intensive care unit
621373|NCT00549393|Healthcare associated infections (HAI)|healthcare associated infections (hai)
621374|NCT00549393|pediatric|pediatric
621375|NCT00549380|Aneurysmal Disease in Thorax, Abdominal or Extremity|aneurysmal disease in thorax, abdominal or extremity
621376|NCT00549367|Nutritional status|nutritional status
621377|NCT00549367|Nutrition counselling|nutrition counselling
621378|NCT00549367|Nutrition assessment|nutrition assessment
621379|NCT00549367|HIV|hiv
621380|NCT00549367|Alternative Medicine|alternative medicine
621381|NCT00549367|Complementary Medicine|complementary medicine
621382|NCT00549354|Abdominal Infrarenal Aortic|abdominal infrarenal aortic
621383|NCT00549354|Aorto-Iliac Aneurysms|aorto-iliac aneurysms
621384|NCT00549341|Torticollis|torticollis
621385|NCT00549341|Cervical Dystonia|cervical dystonia
621386|NCT00549328|anti-angiogenesis|anti-angiogenesis
621387|NCT00549328|Non-small cell lung cancer,|non-small cell lung cancer,
621388|NCT00549328|pazopanib (GW786034)|pazopanib (gw786034)
621389|NCT00549263|Safety|safety
621390|NCT00549263|Pharmacokinetics|pharmacokinetics
621391|NCT00549263|Bioequivalence|bioequivalence
621392|NCT00549250|Human papillomavirus 6/11|human papillomavirus 6/11
621393|NCT00549250|Neonates|neonates
621394|NCT00549250|Human papillomavirus 6 or 11 infection|human papillomavirus 6 or 11 infection
621395|NCT00549237|RYGBP|rygbp
621396|NCT00549237|Early nutrition|early nutrition
621397|NCT00549237|Lean body mass|lean body mass
621398|NCT00549237|Length of stay|length of stay
621399|NCT00549237|Body Composition|body composition
621400|NCT00549211|Healthy Subjects,|healthy subjects,
621401|NCT00549211|Safety,|safety,
621402|NCT00549211|Tolerability,|tolerability,
621403|NCT00549211|Pharmacokinetics|pharmacokinetics
621404|NCT00549198|tenofovir|tenofovir
621405|NCT00549198|HIV|hiv
621406|NCT00549198|efavirenz|efavirenz
621407|NCT00549198|naive|naive
621408|NCT00549198|lamivudine|lamivudine
621409|NCT00549198|abacavir|abacavir
621410|NCT00549198|emtricitabine|emtricitabine
621411|NCT00549198|renal|renal
621412|NCT00549172|Osteoarthritis, Knee|osteoarthritis, knee
621413|NCT00549172|Arthroscopic Surgery|arthroscopic surgery
621414|NCT00549172|Menisci, Medial|menisci, medial
621415|NCT00549172|Placebo Effect|placebo effect
621416|NCT00549172|Treatment Efficacy|treatment efficacy
621417|NCT00549159|menorrhagia|menorrhagia
621418|NCT00549159|dysfunctional uterine bleeding|dysfunctional uterine bleeding
621419|NCT00549159|endometrial ablation|endometrial ablation
621420|NCT00549146|reversibility|reversibility
621421|NCT00549146|COPD|copd
621422|NCT00549146|lung function|lung function
621423|NCT00549133|Microalbuminaria in hypertensive patients with type II diabetes mellitus|microalbuminaria in hypertensive patients with type ii diabetes mellitus
621424|NCT00549120|Healthy Subjects|healthy subjects
621425|NCT00549120|muscarinic receptor antagonist|muscarinic receptor antagonist
621426|NCT00549120|propranolol|propranolol
621427|NCT00549120|beta-blocker|beta-blocker
621428|NCT00549120|beta-agonist|beta-agonist
621429|NCT00549107|low cardiac output syndrome|low cardiac output syndrome
621430|NCT00549107|open heart surgery|open heart surgery
621431|NCT00549107|infants|infants
621432|NCT00549107|Low cardiac output syndrome in infants undergoing corrective open heart surgery|low cardiac output syndrome in infants undergoing corrective open heart surgery
621433|NCT00549081|DHEA|dhea
621434|NCT00549081|IVF|ivf
621435|NCT00549081|low ovarian response|low ovarian response
621436|NCT00549055|Macugen Age-related macular degeneration (AMD) Observational study|macugen age-related macular degeneration (amd) observational study
621437|NCT00549042|Back Pain|back pain
621438|NCT00549042|Chronic Low Back Pain|chronic low back pain
621439|NCT00549042|Chronic Back Pain|chronic back pain
621440|NCT00549042|Pain|pain
621441|NCT00549042|Chronic Pain|chronic pain
621442|NCT00549029|muscle disorder|muscle disorder
621443|NCT00549029|statins|statins
621444|NCT00549029|creatine kinase|creatine kinase
621445|NCT00549016|Aneurysm Exclusion|aneurysm exclusion
621446|NCT00548977|spermatogenesis defect|spermatogenesis defect
621447|NCT00548977|male infertility|male infertility
621448|NCT00548977|azoospermia|azoospermia
621449|NCT00548977|oligozoospermia|oligozoospermia
621450|NCT00548977|Y chromosome markers|y chromosome markers
621451|NCT00548977|estrogen gene|estrogen gene
621452|NCT00548964|Ketamine|ketamine
621453|NCT00548964|glutamate|glutamate
621454|NCT00548964|N-methyl-D-aspartate|n-methyl-d-aspartate
621455|NCT00548964|treatment resistant|treatment resistant
621456|NCT00548964|major depressive disorder|major depressive disorder
621457|NCT00548964|lithium|lithium
621458|NCT00548951|Dementia|dementia
621459|NCT00548938|Brain Tumor|brain tumor
621460|NCT00548938|GBM|gbm
621461|NCT00548938|Glioblastoma Multiforme|glioblastoma multiforme
621462|NCT00548938|Giladel|giladel
621463|NCT00548938|Temozolomide|temozolomide
621464|NCT00548912|Kidney Failure, Chronic|kidney failure, chronic
621465|NCT00548912|Hemodialysis|hemodialysis
621466|NCT00548912|Spironolactone|spironolactone
621467|NCT00548899|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
621468|NCT00548899|Targeted therapy|targeted therapy
621469|NCT00548886|QT Prolongation|qt prolongation
621470|NCT00548886|QT Interval|qt interval
621471|NCT00548886|Epinephrine|epinephrine
621472|NCT00548886|Stress test|stress test
621473|NCT00548847|Leukemia|leukemia
621474|NCT00548834|CDP870|cdp870
621475|NCT00548834|Certolizumab Pegol|certolizumab pegol
621476|NCT00548795|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
621477|NCT00548795|ARDS|ards
621478|NCT00548795|Neutrophil|neutrophil
621479|NCT00548769|PK,|pk,
621480|NCT00548769|SB-683699,|sb-683699,
621481|NCT00548769|multiple sclerosis|multiple sclerosis
621482|NCT00548769|firategrast,|firategrast,
621483|NCT00548769|surface area,|surface area,
621484|NCT00548756|Brain Cancer|brain cancer
621485|NCT00548756|Whole Brain Radiation Therapy|whole brain radiation therapy
621486|NCT00548756|Quality of Life|quality of life
621487|NCT00548756|QOL|qol
621488|NCT00548756|Questionnaire|questionnaire
621489|NCT00548756|Survey|survey
621490|NCT00548756|WBRT|wbrt
621491|NCT00548743|Depression|depression
621492|NCT00548743|Postpartum|postpartum
621493|NCT00548743|Dyad satisfaction|dyad satisfaction
621494|NCT00548743|Parenting comfort|parenting comfort
621495|NCT00548743|Screening|screening
621496|NCT00548743|Management|management
621497|NCT00548743|Follow up|follow up
621498|NCT00548743|Primary care|primary care
621499|NCT00548743|Practice based research|practice based research
621500|NCT00548730|Bronchoscopy|bronchoscopy
621501|NCT00548730|Endoscopy|endoscopy
621502|NCT00548730|Image Enhancement|image enhancement
621503|NCT00548730|Autofluorescence|autofluorescence
621504|NCT00548730|Narrow Band Image|narrow band image
621505|NCT00548717|GVHD|gvhd
621506|NCT00548717|Stem cell transplantation|stem cell transplantation
621507|NCT00548717|Sirolimus|sirolimus
621508|NCT00548704|Extravasation|extravasation
621509|NCT00548704|Anthracyclines|anthracyclines
621510|NCT00548678|diclofenac, platelet aggregation, ketorolac, aspirin|diclofenac, platelet aggregation, ketorolac, aspirin
621511|NCT00548665|Atherosclerosis|atherosclerosis
621512|NCT00548665|Smoking cessation|smoking cessation
621513|NCT00548665|Diagnostic techniques, cardiovascular|diagnostic techniques, cardiovascular
621514|NCT00548665|Ultrasonography|ultrasonography
621515|NCT00548665|Health behavior|health behavior
621516|NCT00548652|apathy|apathy
621517|NCT00548652|obesity|obesity
621518|NCT00548652|methylphenidate|methylphenidate
621519|NCT00548652|MOVE|move
621520|NCT00548652|medical crisis counselling|medical crisis counselling
621521|NCT00548626|Pancreatic Cancer|pancreatic cancer
621522|NCT00548626|Endoscopic Ultrasonography|endoscopic ultrasonography
621523|NCT00548626|Fine-Needle Aspiration|fine-needle aspiration
621524|NCT00548626|Cytopathology|cytopathology
621525|NCT00548613|Myocardial Infarction|myocardial infarction
621526|NCT00548613|Heart Attack|heart attack
621527|NCT00548613|Coronary Artery Bypass Grafting|coronary artery bypass grafting
621528|NCT00548600|Prostate Cancer|prostate cancer
621529|NCT00548600|Iridium|iridium
621530|NCT00548600|Implant|implant
621531|NCT00548600|Radiotherapy|radiotherapy
621532|NCT00548587|Acute Coronary Syndrome|acute coronary syndrome
621533|NCT00548561|extravasation|extravasation
621534|NCT00548561|anthracyclines|anthracyclines
621535|NCT00548548|Avastin|avastin
621536|NCT00548548|Metastatic Adenocarcinoma|metastatic adenocarcinoma
621537|NCT00548548|AVAGAST|avagast
621538|NCT00548522|Type 1 Diabetes|type 1 diabetes
621539|NCT00548522|Pregnancy|pregnancy
621543|NCT00548496|Distal radial fracture,|distal radial fracture,
621544|NCT00548483|Endotracheal intubation|endotracheal intubation
621545|NCT00548483|Laryngeal edema|laryngeal edema
621546|NCT00548483|Cuff-leak test|cuff-leak test
621547|NCT00548483|Corticosteroids|corticosteroids
621548|NCT00548483|This study was to ascertain whether administration of dexamethasone to critically intubated patients prevent postextubation airway obstruction.|this study was to ascertain whether administration of dexamethasone to critically intubated patients prevent postextubation airway obstruction.
621549|NCT00548483|This study was to compare high dose and low dose dexamethasone in preventing noninvasive ventilation or reintubation among critically ill intubated patients|this study was to compare high dose and low dose dexamethasone in preventing noninvasive ventilation or reintubation among critically ill intubated patients
621550|NCT00548470|schizophrenia|schizophrenia
621551|NCT00548470|varenicline|varenicline
621552|NCT00548470|cognition|cognition
621553|NCT00548470|cigarette smoking|cigarette smoking
621554|NCT00548457|the function of the endothelium of the arteries in patients suffering from ectatic coronary arteries|the function of the endothelium of the arteries in patients suffering from ectatic coronary arteries
621555|NCT00548444|Tuberculosis|tuberculosis
621556|NCT00548444|Lymphocyte kinetics|lymphocyte kinetics
621557|NCT00548444|MVA85A|mva85a
621558|NCT00548444|Deuterium|deuterium
621559|NCT00548431|Leukemia, Lymphocytic, Acute [C04.557.337.428.511]|leukemia, lymphocytic, acute [c04.557.337.428.511]
621560|NCT00548431|6-mercaptopurine|6-mercaptopurine
621561|NCT00548431|methotrexate|methotrexate
621562|NCT00548431|asparaginase|asparaginase
621563|NCT00548405|Multiple Sclerosis|multiple sclerosis
621564|NCT00548392|breast|breast
621565|NCT00548392|cancer|cancer
621566|NCT00548392|ultrasound|ultrasound
621567|NCT00548392|high risk|high risk
621568|NCT00548392|marker clip|marker clip
621569|NCT00548379|vitamin D|vitamin d
621570|NCT00548379|pneumonia|pneumonia
621571|NCT00548366|cirrhosis|cirrhosis
621572|NCT00548366|portal hypertension|portal hypertension
621573|NCT00548366|ascites|ascites
621574|NCT00548366|sodium restriction|sodium restriction
621575|NCT00548327|Genes|genes
621576|NCT00548327|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
621577|NCT00548327|Dopamine|dopamine
621578|NCT00548327|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
621579|NCT00548327|Neuropsychological Testing|neuropsychological testing
621580|NCT00548327|Schizophrenia|schizophrenia
621581|NCT00548327|Atomoxetine|atomoxetine
621582|NCT00548327|Cognitive Study|cognitive study
621583|NCT00548327|Pharmacogenetics|pharmacogenetics
621584|NCT00548327|Normal Volunteers|normal volunteers
621585|NCT00548327|Catechol-O-Methyltransferase|catechol-o-methyltransferase
621586|NCT00548327|Healthy Volunteer|healthy volunteer
621587|NCT00548314|Matriderm|matriderm
621588|NCT00548314|Dermal matrix|dermal matrix
621589|NCT00548314|VAC therapy|vac therapy
621590|NCT00548314|Split skin graft|split skin graft
621591|NCT00548314|Burns|burns
621592|NCT00548314|Scar quality|scar quality
621593|NCT00548275|Buprenorphine|buprenorphine
621594|NCT00548275|Drug counseling|drug counseling
621595|NCT00548275|HIV risk reduction counseling|hiv risk reduction counseling
621596|NCT00548275|HIV Seronegativity|hiv seronegativity
621597|NCT00548275|HIV risk behaviors|hiv risk behaviors
621598|NCT00548262|Open-label|open-label
621599|NCT00548262|non-comparative study to evaluate short course of IV anidulafungin|non-comparative study to evaluate short course of iv anidulafungin
621600|NCT00548262|followed by oral voriconazole|followed by oral voriconazole
621601|NCT00548262|for tx of candidemia/invasive candidiasis.|for tx of candidemia/invasive candidiasis.
621602|NCT00548249|Subjects with ESRD receiving chronic Hemodialysis|subjects with esrd receiving chronic hemodialysis
621603|NCT00548236|exercise intervention|exercise intervention
621604|NCT00548236|AACT|aact
621605|NCT00548223|recurrence of stroke|recurrence of stroke
621606|NCT00548223|Dengzhan Shengmai Capsule|dengzhan shengmai capsule
621607|NCT00548223|Traditional Chinese Medicine|traditional chinese medicine
621608|NCT00548210|Hypertrophy|hypertrophy
621609|NCT00548210|scarring|scarring
621610|NCT00548210|scar treatment|scar treatment
621611|NCT00548210|silicone|silicone
621612|NCT00548197|Intravitreal Bevacizumab injection|intravitreal bevacizumab injection
621613|NCT00548197|Pars plana vitrectomy|pars plana vitrectomy
621614|NCT00548197|tractional retinal detachment|tractional retinal detachment
621615|NCT00548197|Diabetic retinopathy|diabetic retinopathy
621616|NCT00548184|primary breast cancers|primary breast cancers
621617|NCT00548184|Locally advanced breast cancers|locally advanced breast cancers
621618|NCT00548158|diabetes|diabetes
621619|NCT00548145|Pitavastatin|pitavastatin
621620|NCT00548145|Statins|statins
621621|NCT00548145|Donepezil|donepezil
621622|NCT00548145|Alzheimer's Disease|alzheimer's disease
621623|NCT00548145|Hypercholesterolemia|hypercholesterolemia
621624|NCT00548145|ADAS-Jcog|adas-jcog
621625|NCT00548145|Alzheimer Disease (MMSE 15-23 and CDR1 or 2)|alzheimer disease (mmse 15-23 and cdr1 or 2)
621626|NCT00548106|infant formula, milk allergy, hydrolized whey|infant formula, milk allergy, hydrolized whey
621627|NCT00548093|non-small cell lung cancer|non-small cell lung cancer
621628|NCT00548093|advanced|advanced
621629|NCT00548093|previously treated|previously treated
622535|NCT00544245|pedometer|pedometer
621630|NCT00548067|High blood pressure, hypertension, drug interaction, steady state, valsartan, hydrochlorothiazide, amlodipine|high blood pressure, hypertension, drug interaction, steady state, valsartan, hydrochlorothiazide, amlodipine
621631|NCT00548054|cholera|cholera
621632|NCT00548054|vaccine|vaccine
621633|NCT00548054|Kolkata|kolkata
621634|NCT00548054|West Bengal|west bengal
621635|NCT00548054|India|india
621636|NCT00548054|immunogenicity|immunogenicity
621637|NCT00548054|safety|safety
621638|NCT00548054|infants|infants
621639|NCT00548054|expanded programme on immunization|expanded programme on immunization
621640|NCT00548041|HIV|hiv
621641|NCT00548041|Emergency Department|emergency department
621642|NCT00548041|HIV Seronegativity|hiv seronegativity
621643|NCT00548002|Staphylococcus aureus|staphylococcus aureus
621644|NCT00548002|bacteremia|bacteremia
621645|NCT00548002|endocarditis|endocarditis
621646|NCT00548002|sepsis|sepsis
621647|NCT00548002|fluoroquinolone|fluoroquinolone
621648|NCT00548002|rifampin|rifampin
621649|NCT00548002|levofloxacin|levofloxacin
621650|NCT00548002|trovafloxacin|trovafloxacin
621651|NCT00547989|ASA class I and II|asa class i and ii
621652|NCT00547976|Inflammation|inflammation
621653|NCT00547976|Unstable Plaque|unstable plaque
621654|NCT00547976|Macrophage|macrophage
621655|NCT00547976|Thrombosis|thrombosis
621656|NCT00547976|Autoradiography|autoradiography
621657|NCT00547976|Atherosclerosis|atherosclerosis
621658|NCT00547976|Vasculitis|vasculitis
621659|NCT00547963|Alcohol Drinking|alcohol drinking
621660|NCT00547963|Marijuana Smoking|marijuana smoking
621661|NCT00547963|Substance Use|substance use
621662|NCT00547963|Emergency Department (ED)|emergency department (ed)
621663|NCT00547937|Sleep Apnea|sleep apnea
621664|NCT00547937|Oxidative Stress|oxidative stress
621665|NCT00547937|Nitric oxide|nitric oxide
621666|NCT00547937|Cardiovascular disease|cardiovascular disease
621667|NCT00547911|Entacapone|entacapone
621668|NCT00547911|Carbidopa|carbidopa
621669|NCT00547911|Locus Ceruleus/Norepinephrine-Autonomic System|locus ceruleus/norepinephrine-autonomic system
621670|NCT00547911|Norepinephrine|norepinephrine
621671|NCT00547911|Adrenergic Nervous System|adrenergic nervous system
621672|NCT00547898|HIV|hiv
621673|NCT00547898|AIDS|aids
621674|NCT00547898|Diarrhea|diarrhea
621675|NCT00547898|HIV Associated Diarrhea|hiv associated diarrhea
621676|NCT00547885|dihydrocodeine|dihydrocodeine
621677|NCT00547885|opioids, long acting|opioids, long acting
621678|NCT00547885|opioids, short acting|opioids, short acting
621679|NCT00547885|Chronic pain|chronic pain
621680|NCT00547885|non-malignant pain|non-malignant pain
621681|NCT00547859|microcirculation|microcirculation
621682|NCT00547859|cardiac surgery|cardiac surgery
621683|NCT00547859|metabolism|metabolism
621684|NCT00547859|capnometry|capnometry
621685|NCT00547846|Cough|cough
621686|NCT00547846|Antitussive|antitussive
621687|NCT00547846|PDC-748|pdc-748
621688|NCT00547846|PhytoHealth|phytohealth
621689|NCT00547833|language disorders|language disorders
621690|NCT00547833|language learning disabilities|language learning disabilities
621691|NCT00547833|vocabulary|vocabulary
621692|NCT00547833|reading|reading
621693|NCT00547820|radiation dose|radiation dose
621694|NCT00547820|VCUG|vcug
621695|NCT00547820|pediatric patients|pediatric patients
621696|NCT00547807|Pain, neonate, nursing care|pain, neonate, nursing care
621697|NCT00547729|Heart Failure|heart failure
621698|NCT00547729|Left Atrial Pressure Monitoring|left atrial pressure monitoring
621699|NCT00547716|Hepatitis C|hepatitis c
621700|NCT00547716|Omega 3 fatty acids|omega 3 fatty acids
621701|NCT00547716|Omacor|omacor
621702|NCT00547716|Interferon|interferon
621703|NCT00547703|Nonulcer dyspepsia|nonulcer dyspepsia
621704|NCT00547703|Functional dyspepsia|functional dyspepsia
621705|NCT00547703|Antidepressant use in dyspepsia|antidepressant use in dyspepsia
621706|NCT00547703|Nortriptyline|nortriptyline
621707|NCT00547703|Tricyclic antidepressants|tricyclic antidepressants
621708|NCT00547677|liver metastases|liver metastases
621709|NCT00547677|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
621710|NCT00547664|Hylenex, time tagged pain pain reduction, hospice population|hylenex, time tagged pain pain reduction, hospice population
621711|NCT00547651|Small Cell Lung Cancer|small cell lung cancer
621712|NCT00547651|Lung Cancer|lung cancer
621713|NCT00547651|Limited Disease Sensitive Small Cell Lung Cancer|limited disease sensitive small cell lung cancer
621714|NCT00547651|Extensive Disease Sensitive Small Cell Lung Cancer|extensive disease sensitive small cell lung cancer
621715|NCT00547651|Limited Disease Refractory Small Cell Lung Cancer|limited disease refractory small cell lung cancer
621716|NCT00547651|Extensive Disease Refractory Small Cell Lung Cancer|extensive disease refractory small cell lung cancer
621717|NCT00547651|Refractory Small Cell Lung Cancer|refractory small cell lung cancer
621718|NCT00547651|Sensitive Small Cell Lung Cancer|sensitive small cell lung cancer
621719|NCT00547638|laceration/wound closure|laceration/wound closure
621720|NCT00547638|topical skin adhesive|topical skin adhesive
621721|NCT00547612|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
621722|NCT00547612|stage I pancreatic cancer|stage i pancreatic cancer
621723|NCT00547612|stage II pancreatic cancer|stage ii pancreatic cancer
621724|NCT00547612|stage III pancreatic cancer|stage iii pancreatic cancer
621725|NCT00547612|stage IV pancreatic cancer|stage iv pancreatic cancer
621726|NCT00547612|recurrent pancreatic cancer|recurrent pancreatic cancer
621727|NCT00547560|Alzheimer Disease|alzheimer disease
621728|NCT00547547|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
621729|NCT00547534|Bortezomib|bortezomib
621730|NCT00547534|Bendamustine|bendamustine
621731|NCT00547534|Rituximab|rituximab
621732|NCT00547534|Relapsed|relapsed
621733|NCT00547534|Refractory|refractory
621734|NCT00547534|Mantle Cell|mantle cell
621735|NCT00547534|Indolent|indolent
621736|NCT00547482|Type 2 Diabetes|type 2 diabetes
621737|NCT00547482|Overweight|overweight
621738|NCT00547482|Obese|obese
621739|NCT00547469|Irritable Bowel Syndrome|irritable bowel syndrome
621740|NCT00547469|IBS-c|ibs-c
621741|NCT00547469|IBS constipation|ibs constipation
621742|NCT00547469|women with IBS|women with ibs
621743|NCT00547469|women with constipation|women with constipation
621744|NCT00547443|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
621745|NCT00547443|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
621746|NCT00547443|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
621747|NCT00547443|adenocarcinoma of the lung|adenocarcinoma of the lung
621748|NCT00547443|squamous cell lung cancer|squamous cell lung cancer
621749|NCT00547443|large cell lung cancer|large cell lung cancer
621750|NCT00547443|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
621751|NCT00547443|adenosquamous cell lung cancer|adenosquamous cell lung cancer
621752|NCT00547391|adults|adults
621753|NCT00547391|children|children
621754|NCT00547391|tonsillectomy|tonsillectomy
621755|NCT00547378|overactive bladder, urinary incontinence, incontinence,Urgency-frequency|overactive bladder, urinary incontinence, incontinence,urgency-frequency
621756|NCT00547365|primary systemic amyloidosis|primary systemic amyloidosis
621757|NCT00547339|adenocarcinoma of the prostate|adenocarcinoma of the prostate
621758|NCT00547339|stage I prostate cancer|stage i prostate cancer
621759|NCT00547339|stage IIB prostate cancer|stage iib prostate cancer
621760|NCT00547339|stage IIA prostate cancer|stage iia prostate cancer
621761|NCT00547300|Hypertension|hypertension
621762|NCT00547300|Nebivolol|nebivolol
621763|NCT00547300|Beta blocker|beta blocker
621764|NCT00547300|Tolerability|tolerability
621765|NCT00547261|solid tumor|solid tumor
621766|NCT00547261|antimitotic|antimitotic
621767|NCT00547261|tubulin binder|tubulin binder
621768|NCT00547248|Booster vaccination.|booster vaccination.
621769|NCT00547248|Immunogenicity|immunogenicity
621770|NCT00547248|Pneumococcal vaccine|pneumococcal vaccine
621771|NCT00547248|Safety|safety
621772|NCT00547248|Pneumococcal disease|pneumococcal disease
621773|NCT00547235|infection|infection
621774|NCT00547235|precancerous/nonmalignant condition|precancerous/nonmalignant condition
621775|NCT00547196|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
621776|NCT00547196|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
621777|NCT00547196|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
621778|NCT00547196|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
621779|NCT00547196|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
621780|NCT00547196|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
621781|NCT00547196|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
621782|NCT00547196|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
621783|NCT00547196|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
621784|NCT00547196|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
621785|NCT00547196|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
621786|NCT00547196|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
621787|NCT00547196|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
621788|NCT00547196|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
621789|NCT00547196|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
621790|NCT00547196|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
621791|NCT00547196|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
621792|NCT00547196|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
621793|NCT00547196|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
621794|NCT00547196|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
621795|NCT00547196|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
621796|NCT00547196|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
621797|NCT00547196|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
621798|NCT00547196|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
621799|NCT00547196|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
621800|NCT00547196|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
621801|NCT00547196|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
621802|NCT00547196|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
621803|NCT00547196|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
621804|NCT00547196|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
621805|NCT00547196|splenic marginal zone lymphoma|splenic marginal zone lymphoma
621806|NCT00547196|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
621807|NCT00547196|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
621808|NCT00547196|secondary acute myeloid leukemia|secondary acute myeloid leukemia
621809|NCT00547170|pelvic infection|pelvic infection
621810|NCT00547170|abortion|abortion
621811|NCT00547170|doxycycline|doxycycline
621812|NCT00547157|head and neck|head and neck
621813|NCT00547157|squamous cell carcinoma|squamous cell carcinoma
621814|NCT00547157|radiotherapy|radiotherapy
621815|NCT00547157|chemoradiotherapy|chemoradiotherapy
621816|NCT00547157|panitumumab|panitumumab
621817|NCT00547157|locally advanced head & neck cancer|locally advanced head & neck cancer
621818|NCT00547157|EGFr|egfr
621819|NCT00547157|epidermal growth factor receptor|epidermal growth factor receptor
621820|NCT00547157|SCCHN|scchn
621821|NCT00547157|locally advanced SCCHN|locally advanced scchn
621822|NCT00547157|HNC|hnc
621823|NCT00547157|epidermal growth factor|epidermal growth factor
621824|NCT00547131|tumors metastatic to brain|tumors metastatic to brain
621825|NCT00547131|recurrent adult brain tumor|recurrent adult brain tumor
621826|NCT00547118|Metabolic abnormalities|metabolic abnormalities
621827|NCT00547118|Safety|safety
621828|NCT00547118|Satiety|satiety
621829|NCT00547105|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
621830|NCT00547105|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
621831|NCT00547105|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
621832|NCT00547105|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
621833|NCT00547066|ITP|itp
621834|NCT00547066|hA20|ha20
621835|NCT00547066|Treatment|treatment
621836|NCT00547040|calcification|calcification
621837|NCT00547040|bone lesions|bone lesions
621838|NCT00547027|diabetes|diabetes
621839|NCT00547027|physical activity|physical activity
621840|NCT00547027|print-based intervention|print-based intervention
621841|NCT00547027|tailored intervention|tailored intervention
621842|NCT00547014|treatment, parallel assignment, double blind, randomized, placebo control, safety study,SLE (Systemic Lupus Erythematosus)|treatment, parallel assignment, double blind, randomized, placebo control, safety study,sle (systemic lupus erythematosus)
621843|NCT00547001|Menopause|menopause
621844|NCT00547001|Hot flashes|hot flashes
621845|NCT00547001|vasomotor symptoms|vasomotor symptoms
621846|NCT00547001|tapering regimen|tapering regimen
621847|NCT00547001|hormonal therapy|hormonal therapy
621848|NCT00547001|Other menopausal symptoms including mood changes|other menopausal symptoms including mood changes
621849|NCT00546988|primary treatment|primary treatment
621850|NCT00546988|allogeneic stem-cell transplantation|allogeneic stem-cell transplantation
621851|NCT00546988|high-dose therapy|high-dose therapy
621852|NCT00546988|cytogenetics|cytogenetics
621853|NCT00546975|gastrointestinal surgery|gastrointestinal surgery
621854|NCT00546975|nutritional intervention|nutritional intervention
621855|NCT00546975|functional status|functional status
621856|NCT00546975|quality of life|quality of life
621857|NCT00546949|Decompression, Surgical|decompression, surgical
621858|NCT00546949|x-stop|x-stop
621859|NCT00546949|lumbar decompression|lumbar decompression
621860|NCT00546949|spinal stenosis|spinal stenosis
621861|NCT00546949|radiculopathy|radiculopathy
621862|NCT00546936|Histoplasmosis|histoplasmosis
621863|NCT00546884|End of Life|end of life
621864|NCT00546884|Advance Directives|advance directives
621865|NCT00546884|Randomized controlled trial|randomized controlled trial
621866|NCT00546884|End of life care|end of life care
621867|NCT00546884|End of life advance care planning|end of life advance care planning
621868|NCT00546858|Pelvic pain|pelvic pain
621869|NCT00546858|Vulvar pain|vulvar pain
621870|NCT00546806|Rehabilitation,|rehabilitation,
621871|NCT00546806|Treatment outcome,|treatment outcome,
621872|NCT00546806|Whiplash injuries,|whiplash injuries,
621873|NCT00546806|Randomized Clinical Trials|randomized clinical trials
621874|NCT00546793|humanized anti-CD20 veltuzumab (IMMU-106) administered subcutaneously|humanized anti-cd20 veltuzumab (immu-106) administered subcutaneously
621875|NCT00546780|Multiple Myeloma|multiple myeloma
621876|NCT00546780|Heat Shock Protein 90|heat shock protein 90
621877|NCT00546780|Hsp90|hsp90
621878|NCT00546780|KOS-953|kos-953
621879|NCT00546780|17-AAG|17-aag
621880|NCT00546780|bortezomib|bortezomib
621881|NCT00546780|first relapse|first relapse
621882|NCT00546780|tanespimycin|tanespimycin
621883|NCT00546780|TIME-1|time-1
621884|NCT00546741|Diabetes,NOS|diabetes,nos
621885|NCT00546689|HIV|hiv
621886|NCT00546689|aids|aids
621887|NCT00546689|intestinal parasites|intestinal parasites
621888|NCT00546689|eosinophils|eosinophils
621889|NCT00546689|immunoglobulins|immunoglobulins
621890|NCT00546689|HIV/aids|hiv/aids
621891|NCT00546689|Treatment Experienced|treatment experienced
623186|NCT00541385|Africa|africa
621892|NCT00546663|Cystic Fibrosis, hypertonic saline|cystic fibrosis, hypertonic saline
621893|NCT00546650|Focus of study is to compare pharmacokinetics|focus of study is to compare pharmacokinetics
621894|NCT00546611|PEP005|pep005
621895|NCT00546611|Common Wart(s)|common wart(s)
621896|NCT00546611|Common warts (verruca[e] vulgaris)|common warts (verruca[e] vulgaris)
621897|NCT00546598|Total hip replacement, Total hip arthroplasty|total hip replacement, total hip arthroplasty
621898|NCT00546585|influenza, inactivated influenza A/H7N7 vaccine, parent protocol|influenza, inactivated influenza a/h7n7 vaccine, parent protocol
621899|NCT00546559|Lipophilic statins|lipophilic statins
621900|NCT00546559|Insulin resistance|insulin resistance
621901|NCT00546559|simvastatin and pravastatin may have differential metabolic effects in hypercholesterolemic patients.|simvastatin and pravastatin may have differential metabolic effects in hypercholesterolemic patients.
621902|NCT00546546|Crohn|crohn
621903|NCT00546546|immunosuppressants|immunosuppressants
621904|NCT00546546|natural history|natural history
621905|NCT00546546|steroids|steroids
621906|NCT00546520|Asthma|asthma
621907|NCT00546520|Ciclesonide|ciclesonide
621908|NCT00546520|Airway hyperresponsiveness|airway hyperresponsiveness
621909|NCT00546520|Sputum|sputum
621910|NCT00546520|Nitric oxide|nitric oxide
621911|NCT00546468|stomach cancer|stomach cancer
621912|NCT00546468|laparoscopy|laparoscopy
621913|NCT00546468|gastrectomy|gastrectomy
621914|NCT00546468|QOL|qol
621915|NCT00546468|survival|survival
621916|NCT00546468|clinical study|clinical study
621917|NCT00546455|Obesity|obesity
621918|NCT00546455|insulin resistance|insulin resistance
621919|NCT00546442|insulin resistance|insulin resistance
621920|NCT00546442|chronic hepatitis C|chronic hepatitis c
621921|NCT00546442|genotype 1|genotype 1
621922|NCT00546429|Proximal femoral fracture|proximal femoral fracture
621923|NCT00546429|Trochanteric fracture|trochanteric fracture
621924|NCT00546429|Intramedullary nailing|intramedullary nailing
621925|NCT00546403|Excessive Daytime Sleepiness|excessive daytime sleepiness
621926|NCT00546377|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
621927|NCT00546377|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
621928|NCT00546377|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
621929|NCT00546377|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
621930|NCT00546377|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
621931|NCT00546377|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
621932|NCT00546377|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
621933|NCT00546377|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
621934|NCT00546377|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
621935|NCT00546351|Lacosamide|lacosamide
621936|NCT00546299|Ambulatory oxygen therapy|ambulatory oxygen therapy
621937|NCT00546299|COPD|copd
621938|NCT00546299|exertional hypoxemia|exertional hypoxemia
621939|NCT00546273|LTBI (Latent tuberculosis infection)|ltbi (latent tuberculosis infection)
621940|NCT00546273|TB(Tuberculosis)|tb(tuberculosis)
621941|NCT00546273|Vaccine|vaccine
621942|NCT00546260|STEMI|stemi
621943|NCT00546260|ACS|acs
621944|NCT00546234|asthma|asthma
621945|NCT00546234|tiotropium|tiotropium
621946|NCT00546234|smoking|smoking
621947|NCT00546234|eNO|eno
621948|NCT00546234|metabolites|metabolites
621949|NCT00546234|Virtual Asthma Clinic|virtual asthma clinic
621950|NCT00546221|Depression|depression
621951|NCT00546221|Mental health|mental health
621952|NCT00546221|Exercise|exercise
621953|NCT00546221|Prescribed exercise|prescribed exercise
621954|NCT00546221|Physical health|physical health
621955|NCT00546221|Social wellbeing|social wellbeing
621956|NCT00546208|bladder function|bladder function
621957|NCT00546208|cutaneous ureterostomy|cutaneous ureterostomy
621958|NCT00546208|hydronephrosis|hydronephrosis
621959|NCT00546195|Cord Blood|cord blood
621960|NCT00546195|Neutrophils|neutrophils
621961|NCT00546195|Polysaccharide|polysaccharide
621962|NCT00546195|Gene Expression|gene expression
621963|NCT00546182|Lipophilic statins|lipophilic statins
621964|NCT00546182|Insulin resistance|insulin resistance
621965|NCT00546182|hypercholesterolemic patients|hypercholesterolemic patients
621966|NCT00546169|Patients undergoing elective or acute cholecystectomy|patients undergoing elective or acute cholecystectomy
621967|NCT00546156|ER positive|er positive
621968|NCT00546156|PR positive|pr positive
621969|NCT00546143|Asthma, anti-immunoglobulin E, omalizumab|asthma, anti-immunoglobulin e, omalizumab
621970|NCT00546130|ED-SCLC|ed-sclc
621971|NCT00546130|small cell lung cancer|small cell lung cancer
621972|NCT00546130|CPT-11|cpt-11
621973|NCT00546130|irinotecan hydrochloride|irinotecan hydrochloride
621974|NCT00546130|CDDP|cddp
621975|NCT00546130|cisplatin|cisplatin
621976|NCT00546130|PSK|psk
621977|NCT00546130|Krestin|krestin
621978|NCT00546117|otitis media with effusion|otitis media with effusion
621979|NCT00546117|gastroesophageal reflux|gastroesophageal reflux
621980|NCT00546117|ear infection|ear infection
621981|NCT00546117|proton pump inhibitor|proton pump inhibitor
621982|NCT00546104|Advanced Breast Cancer|advanced breast cancer
621983|NCT00546104|Breast cancer|breast cancer
621984|NCT00546104|Dasatinib|dasatinib
623187|NCT00541385|Phillipines|phillipines
621985|NCT00546104|Inoperable Stage III Breast Cancer|inoperable stage iii breast cancer
621986|NCT00546104|Metastatic Breast Cancer|metastatic breast cancer
621987|NCT00546104|Stage IV Breast Cancer|stage iv breast cancer
621988|NCT00546091|Imaging|imaging
621989|NCT00546091|Multi-Spectral Imaging|multi-spectral imaging
621990|NCT00546091|Thermography|thermography
621991|NCT00546091|Laser Doppler Imaging|laser doppler imaging
621992|NCT00546091|Vasculature|vasculature
621993|NCT00546091|Healthy Volunteer|healthy volunteer
621994|NCT00546091|HV|hv
621995|NCT00546078|HPV vaccine|hpv vaccine
621996|NCT00546078|Cervical cancer|cervical cancer
621997|NCT00546078|Human papillomavirus infection|human papillomavirus infection
621998|NCT00546065|Barrett's esophagus|barrett's esophagus
621999|NCT00546065|ablation|ablation
622000|NCT00546065|esomeprazole|esomeprazole
622001|NCT00546065|Barrett's cancer|barrett's cancer
622002|NCT00546065|Ablation of Barrett's esophagus|ablation of barrett's esophagus
622003|NCT00546065|Surveillance of Barrett's esophagus after endoscopic resection of Barrett's cancer|surveillance of barrett's esophagus after endoscopic resection of barrett's cancer
622004|NCT00546065|Recurrence of Barrett's cancer|recurrence of barrett's cancer
622005|NCT00546039|Prostate cancer|prostate cancer
622006|NCT00546039|Localized prostatectomy|localized prostatectomy
622007|NCT00546039|Laparoscopic prostatectomy|laparoscopic prostatectomy
622008|NCT00546039|Chemoprevention|chemoprevention
622009|NCT00546039|Genistein|genistein
622010|NCT00546039|BONISTEIN™|bonistein™
622011|NCT00546026|placental function|placental function
622012|NCT00546026|high-risk pregnancies|high-risk pregnancies
622013|NCT00546026|psychological distress|psychological distress
622014|NCT00546013|abdominal aortic aneurysms|abdominal aortic aneurysms
622015|NCT00546013|pseudoexfoliation syndrome|pseudoexfoliation syndrome
622016|NCT00546013|glaucoma|glaucoma
622017|NCT00545987|HIV vaccine|hiv vaccine
622018|NCT00545987|HIV|hiv
622019|NCT00545987|AIDS|aids
622020|NCT00545987|prevention|prevention
622021|NCT00545987|HIV/AIDS|hiv/aids
622022|NCT00545987|HIV Preventative Vaccine|hiv preventative vaccine
622023|NCT00545987|HIV Seronegativity|hiv seronegativity
622024|NCT00545974|Randomized|randomized
622025|NCT00545974|Double-Blind|double-blind
622026|NCT00545974|Placebo-Controlled|placebo-controlled
622027|NCT00545974|memantine|memantine
622028|NCT00545974|Namenda|namenda
622029|NCT00545974|Frontotemporal Dementia|frontotemporal dementia
622030|NCT00545974|Semantic Dementia|semantic dementia
622031|NCT00545974|FTD|ftd
622032|NCT00545974|SD|sd
622033|NCT00545974|dementia|dementia
622034|NCT00545974|behavioral decline|behavioral decline
622035|NCT00545974|cognitive decline|cognitive decline
622036|NCT00545961|respiratory infection|respiratory infection
622037|NCT00545961|sinusitis|sinusitis
622038|NCT00545961|rhinosinusitis|rhinosinusitis
622039|NCT00545961|children|children
622040|NCT00545961|middle meatal specimens|middle meatal specimens
622041|NCT00545961|respiratory track bacteria|respiratory track bacteria
622042|NCT00545961|amoxicillin-clavulanate|amoxicillin-clavulanate
622043|NCT00545961|pneumococci|pneumococci
622044|NCT00545961|haemophilus|haemophilus
622045|NCT00545961|moraxella|moraxella
622046|NCT00545948|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
622047|NCT00545948|NSCLC|nsclc
622048|NCT00545948|Non-Squamous|non-squamous
622049|NCT00545948|Genomics|genomics
622050|NCT00545948|Guided Therapy|guided therapy
622051|NCT00545948|Directed Therapy|directed therapy
622052|NCT00545948|Genomic Expression Profiles|genomic expression profiles
622053|NCT00545948|Chemotherapy Sensitivity|chemotherapy sensitivity
622054|NCT00545922|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
622055|NCT00545922|anxiety|anxiety
622056|NCT00545922|depression|depression
622057|NCT00545922|cognitive behavioral therapy|cognitive behavioral therapy
622058|NCT00545883|GERD|gerd
622059|NCT00545883|esophagitis|esophagitis
622060|NCT00545883|PPI|ppi
622061|NCT00545857|Type 1 diabetes|type 1 diabetes
622062|NCT00545857|Insulin dependent diabetes|insulin dependent diabetes
622063|NCT00545857|Juvenile onset diabetes|juvenile onset diabetes
622064|NCT00545857|pioglitazone|pioglitazone
622065|NCT00545831|Home Parenteral Nutrition|home parenteral nutrition
622066|NCT00545831|Sepsis Prevention|sepsis prevention
622067|NCT00545831|Central Venous Catheters|central venous catheters
622068|NCT00545831|Taurolidine|taurolidine
622069|NCT00545805|Insulin resistance|insulin resistance
622070|NCT00545805|Metabolic syndrome X|metabolic syndrome x
622071|NCT00545805|Obesity|obesity
622072|NCT00545805|Intra-Abdominal Fat|intra-abdominal fat
622073|NCT00545805|Omentum|omentum
622074|NCT00545805|Bariatric surgery|bariatric surgery
622075|NCT00545805|Glucose Clamp Technique|glucose clamp technique
622076|NCT00545805|Intravenous Glucose Tolerance Test|intravenous glucose tolerance test
622077|NCT00545805|Adiponectin|adiponectin
622078|NCT00545805|Cytokines|cytokines
622079|NCT00545792|Recurrent Endometrial cancer|recurrent endometrial cancer
622080|NCT00545792|Recurrent Cervical cancer|recurrent cervical cancer
622081|NCT00545792|Recurrent Ovarian cancer|recurrent ovarian cancer
622082|NCT00545792|Recurrent Vaginal cancer|recurrent vaginal cancer
622083|NCT00545792|Recurrent Vulvar cancer|recurrent vulvar cancer
622084|NCT00545792|Vaginal recurrence|vaginal recurrence
622085|NCT00545792|Brachytherapy|brachytherapy
622086|NCT00545792|Radiation Treatment|radiation treatment
622087|NCT00545792|External Beam Radiation|external beam radiation
622088|NCT00545792|Avastin|avastin
622089|NCT00545792|Bevacizumab|bevacizumab
622090|NCT00545766|Prostate Cancer|prostate cancer
622091|NCT00545766|Hormone Refractory|hormone refractory
622092|NCT00545766|Vinflunine|vinflunine
622093|NCT00545766|Salvage Chemotherapy|salvage chemotherapy
622094|NCT00545753|Human Head lice|human head lice
622095|NCT00545727|Diabetes|diabetes
622096|NCT00545727|Children|children
622097|NCT00545727|Adolescents|adolescents
622098|NCT00545727|Diet|diet
622099|NCT00545727|Glycemic index|glycemic index
622100|NCT00545701|Influenza|influenza
622101|NCT00545701|A/H5N1 strain|a/h5n1 strain
622102|NCT00545701|Orthomyxoviridae Infections|orthomyxoviridae infections
622103|NCT00545701|Influenza Pandemics|influenza pandemics
622104|NCT00545662|traumatic brain injury|traumatic brain injury
622105|NCT00545662|cognition|cognition
622106|NCT00545662|behavioral outcome|behavioral outcome
622107|NCT00545662|functional outcome|functional outcome
622108|NCT00545662|treatment|treatment
622109|NCT00545662|early intervention|early intervention
622110|NCT00545662|citicoline|citicoline
622111|NCT00545649|Fibromyalgia|fibromyalgia
622112|NCT00545649|chronic pain|chronic pain
622113|NCT00545649|physical|physical
622114|NCT00545649|exercise|exercise
622115|NCT00545649|activity|activity
622116|NCT00545649|education|education
622117|NCT00545623|HIV/AIDS|hiv/aids
622118|NCT00545623|Alternative Medicine|alternative medicine
622119|NCT00545623|Complementary Medicine|complementary medicine
622120|NCT00545597|adrenoleukodystrophy|adrenoleukodystrophy
622121|NCT00545597|adrenomyeloneuropathy|adrenomyeloneuropathy
622122|NCT00545558|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
622123|NCT00545558|Coinfection|coinfection
622124|NCT00545558|Treatment Naive|treatment naive
622125|NCT00545545|Colorectal|colorectal
622126|NCT00545545|Carcinoma|carcinoma
622127|NCT00545545|Recurrent|recurrent
622128|NCT00545545|Progressive|progressive
622129|NCT00545545|Cetuximab|cetuximab
622130|NCT00545545|Irinotecan|irinotecan
622131|NCT00545545|5-Fluorouracil|5-fluorouracil
622132|NCT00545519|Multiple Myeloma|multiple myeloma
622133|NCT00545519|Thymoglobulin|thymoglobulin
622134|NCT00545506|wound infection|wound infection
622135|NCT00545506|tissue oxygen tension|tissue oxygen tension
622136|NCT00545506|local warming|local warming
622137|NCT00545493|Rasmussen encephalitis|rasmussen encephalitis
622138|NCT00545493|Chronic encephalitis|chronic encephalitis
622139|NCT00545493|Cerebral hemiatrophy|cerebral hemiatrophy
622140|NCT00545493|Hemiparesis|hemiparesis
622141|NCT00545493|Epilepsy|epilepsy
622142|NCT00545467|Aripiprazole|aripiprazole
622143|NCT00545467|schizophrenia|schizophrenia
622144|NCT00545467|antipsychotics|antipsychotics
622145|NCT00545467|pharmacogenomics|pharmacogenomics
622146|NCT00545467|cytochrome P450 enzyme|cytochrome p450 enzyme
622147|NCT00545454|Inflammation|inflammation
622148|NCT00545454|anti-cytokine|anti-cytokine
622149|NCT00545454|anti-chemokine|anti-chemokine
622150|NCT00545441|Anal fistula|anal fistula
622151|NCT00545441|fistula in ano|fistula in ano
622152|NCT00545441|anorectal fistula|anorectal fistula
622153|NCT00545428|Nasal acquired diseases|nasal acquired diseases
622154|NCT00545428|Nasal congenital diseases|nasal congenital diseases
622155|NCT00545428|Rhinoplasty|rhinoplasty
622156|NCT00545428|Grafts|grafts
622157|NCT00545415|fruit|fruit
622158|NCT00545415|antioxidant|antioxidant
622159|NCT00545415|Healthy subjects|healthy subjects
622160|NCT00545350|Prevention|prevention
622161|NCT00545350|Falls, accidental falls|falls, accidental falls
622162|NCT00545350|Fractures|fractures
622163|NCT00545350|Physical injuries|physical injuries
622164|NCT00545350|Women|women
622165|NCT00545350|Elderly|elderly
622166|NCT00545350|Physical exercise|physical exercise
622167|NCT00545350|Balance exercise|balance exercise
622168|NCT00545311|multiple inhaled, NVA237, COPD|multiple inhaled, nva237, copd
622169|NCT00545298|Nitric Oxide|nitric oxide
622170|NCT00545298|Venous Leg Ulcers|venous leg ulcers
622171|NCT00545285|clinical outcomes|clinical outcomes
622172|NCT00545285|radiographic outcomes|radiographic outcomes
622173|NCT00545285|total hip arthroplasty|total hip arthroplasty
622174|NCT00545285|survivorship|survivorship
622175|NCT00545272|QMF|qmf
622176|NCT00545272|indacaterol|indacaterol
622177|NCT00545272|Twisthaler®|twisthaler®
622178|NCT00545259|Organ transplant, liver, pharmacokinetics, AEB071, immunosuppression|organ transplant, liver, pharmacokinetics, aeb071, immunosuppression
622179|NCT00545246|VEGF Trap|vegf trap
622180|NCT00545194|Prostaglandin E2|prostaglandin e2
622181|NCT00545194|Intravaginal gel|intravaginal gel
622182|NCT00545194|Bishop score|bishop score
622183|NCT00545194|Induction of labor|induction of labor
622184|NCT00545194|randomized trial|randomized trial
622185|NCT00545194|Vaginal insert|vaginal insert
622186|NCT00545181|bacterial vaginosis|bacterial vaginosis
622187|NCT00545181|vaginal acidifying gel|vaginal acidifying gel
622188|NCT00545181|recurrence|recurrence
622189|NCT00545168|head lice|head lice
622190|NCT00545025|Influenza|influenza
622191|NCT00545025|Influenza vaccine|influenza vaccine
622192|NCT00545012|Levetiracetam|levetiracetam
622193|NCT00545012|Keppra|keppra
622194|NCT00544999|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
622195|NCT00544999|secondary acute myeloid leukemia|secondary acute myeloid leukemia
622196|NCT00544999|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
622197|NCT00544999|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
622198|NCT00544999|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
622199|NCT00544999|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
622200|NCT00544999|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
622201|NCT00544999|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
622202|NCT00544999|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
622203|NCT00544999|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
622204|NCT00544999|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
622205|NCT00544999|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
622206|NCT00544986|breast cancer|breast cancer
622207|NCT00544986|post menopausal women|post menopausal women
622208|NCT00544986|Post menopausal women with hormone sensitive advanced breast cancer|post menopausal women with hormone sensitive advanced breast cancer
622209|NCT00544960|AT101|at101
622210|NCT00544960|AT-101|at-101
622211|NCT00544960|cancer|cancer
622212|NCT00544960|lung|lung
622213|NCT00544960|non-small cell|non-small cell
622214|NCT00544960|docetaxel|docetaxel
622215|NCT00544960|bcl|bcl
622216|NCT00544947|Respiratory Depression|respiratory depression
622217|NCT00544947|Caesarean Section|caesarean section
622218|NCT00544947|Diamorphine|diamorphine
622219|NCT00544947|Fentanyl|fentanyl
622220|NCT00544908|stage IV pancreatic cancer|stage iv pancreatic cancer
622221|NCT00544869|Vasopressin antagonist , Cardiac Edema ,Diuretics|vasopressin antagonist , cardiac edema ,diuretics
622222|NCT00544856|mild Alzheimer's disease|mild alzheimer's disease
622223|NCT00544856|mild cognitive impairment|mild cognitive impairment
622224|NCT00544830|stage IV prostate cancer|stage iv prostate cancer
622225|NCT00544830|adenocarcinoma of the prostate|adenocarcinoma of the prostate
622226|NCT00544830|recurrent prostate cancer|recurrent prostate cancer
622227|NCT00544817|Concurrent Radiation Therapy|concurrent radiation therapy
622228|NCT00544817|Temozolomide|temozolomide
622229|NCT00544817|Sorafenib|sorafenib
622230|NCT00544817|First-line|first-line
622231|NCT00544817|Glioblastoma Multiforme|glioblastoma multiforme
622232|NCT00544817|Phase II|phase ii
622233|NCT00544804|recurrent breast cancer|recurrent breast cancer
622234|NCT00544804|stage IIIA breast cancer|stage iiia breast cancer
622235|NCT00544804|stage IIIB breast cancer|stage iiib breast cancer
622236|NCT00544804|stage IIIC breast cancer|stage iiic breast cancer
622237|NCT00544804|stage IV breast cancer|stage iv breast cancer
622238|NCT00544804|bone metastases|bone metastases
622239|NCT00544791|Mild Cognitive Impairment|mild cognitive impairment
622240|NCT00544791|Melatonin|melatonin
622241|NCT00544791|Antioxidant|antioxidant
622242|NCT00544791|Memory|memory
622243|NCT00544791|Alzheimer|alzheimer
622244|NCT00544778|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
622245|NCT00544778|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
622246|NCT00544778|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
622247|NCT00544778|metastatic osteosarcoma|metastatic osteosarcoma
622248|NCT00544778|recurrent osteosarcoma|recurrent osteosarcoma
622249|NCT00544778|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
622250|NCT00544778|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
622251|NCT00544778|Ewing sarcoma of bone|ewing sarcoma of bone
622252|NCT00544765|Breast cancer|breast cancer
622253|NCT00544765|neoadjuvant therapy|neoadjuvant therapy
622254|NCT00544765|pCR rates|pcr rates
622255|NCT00544752|sleep apnea syndromes, ambient indoor temperature|sleep apnea syndromes, ambient indoor temperature
622256|NCT00544739|Coronary Artery Disease|coronary artery disease
622257|NCT00544739|Premature|premature
622258|NCT00544739|Female|female
622259|NCT00544726|Rehabilitation|rehabilitation
622260|NCT00544700|stage IV colon cancer|stage iv colon cancer
622261|NCT00544700|stage IV rectal cancer|stage iv rectal cancer
622262|NCT00544687|Skin|skin
622263|NCT00544687|Atrophy|atrophy
622264|NCT00544687|CRX-191|crx-191
622265|NCT00544687|mometasone furoate|mometasone furoate
622266|NCT00544687|nortriptyline hydrochloride|nortriptyline hydrochloride
622267|NCT00544687|Skin Thickness in Normal Healthy Volunteers|skin thickness in normal healthy volunteers
622268|NCT00544674|extensive stage small cell lung cancer|extensive stage small cell lung cancer
622269|NCT00544674|limited stage small cell lung cancer|limited stage small cell lung cancer
622270|NCT00544674|recurrent small cell lung cancer|recurrent small cell lung cancer
622271|NCT00544648|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
622272|NCT00544648|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
622273|NCT00544622|Stroke treatment|stroke treatment
622274|NCT00544622|Rehabilitation|rehabilitation
622275|NCT00544622|Stroke chain|stroke chain
622276|NCT00544622|Stroke unit|stroke unit
622277|NCT00544609|Bladder|bladder
622278|NCT00544609|Sorafenib|sorafenib
622279|NCT00544609|Radiotherapy|radiotherapy
622280|NCT00544583|Abdominal wall|abdominal wall
622281|NCT00544570|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
622282|NCT00544570|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
622283|NCT00544544|Bipolar|bipolar
622284|NCT00544544|depression|depression
622285|NCT00544531|MI oocytes, FISH,chromosomal aberrations|mi oocytes, fish,chromosomal aberrations
622286|NCT00544518|type 2 diabetes|type 2 diabetes
622287|NCT00544518|Benfluorex|benfluorex
622288|NCT00544518|Metformin|metformin
622289|NCT00544518|insulin secretion|insulin secretion
622290|NCT00544518|glucose control|glucose control
622291|NCT00544492|arteriovenous fistula|arteriovenous fistula
622292|NCT00544492|dialysis access|dialysis access
622293|NCT00544492|pain|pain
622294|NCT00544492|anxiety|anxiety
622295|NCT00544492|fistula related complications|fistula related complications
622296|NCT00544492|aneurysm|aneurysm
622297|NCT00544466|acute myeloid leukemia with multilineage dysplasia following myelodysplastic syndrome|acute myeloid leukemia with multilineage dysplasia following myelodysplastic syndrome
622298|NCT00544466|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
622299|NCT00544466|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
622300|NCT00544466|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
622301|NCT00544466|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
622302|NCT00544466|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
622303|NCT00544466|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
622304|NCT00544466|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
622305|NCT00544466|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
622306|NCT00544466|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
622307|NCT00544466|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
622308|NCT00544466|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
622309|NCT00544466|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
622310|NCT00544466|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
622311|NCT00544466|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
622312|NCT00544466|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
622313|NCT00544466|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
622314|NCT00544466|secondary acute myeloid leukemia|secondary acute myeloid leukemia
622315|NCT00544466|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
622316|NCT00544466|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
622317|NCT00544466|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
622318|NCT00544466|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
622319|NCT00544466|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
622320|NCT00544466|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
622321|NCT00544453|SPECT|spect
622322|NCT00544453|Alzheimer disease|alzheimer disease
622323|NCT00544440|Prostate neoplasms|prostate neoplasms
622324|NCT00544440|Prostate cancer|prostate cancer
622325|NCT00544440|Castration-resistant prostate cancer|castration-resistant prostate cancer
622326|NCT00544440|Abiraterone acetate|abiraterone acetate
622327|NCT00544440|CB7630|cb7630
622328|NCT00544440|Prednisone|prednisone
622329|NCT00544440|Testosterone|testosterone
622330|NCT00544440|Bone marrow|bone marrow
622331|NCT00544427|Upper Areo-Digestive tract|upper areo-digestive tract
622332|NCT00544414|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
622333|NCT00544414|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
622334|NCT00544414|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
622335|NCT00544414|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
622336|NCT00544414|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
622337|NCT00544414|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
622338|NCT00544414|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
622339|NCT00544414|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
622340|NCT00544414|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
622341|NCT00544414|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
622342|NCT00544414|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
622343|NCT00544401|infertility|infertility
622344|NCT00544401|in vitro fertilization|in vitro fertilization
622345|NCT00544401|intracytoplasmic sperm implantation|intracytoplasmic sperm implantation
622346|NCT00544401|acupuncture|acupuncture
622347|NCT00544401|hypnosis|hypnosis
622348|NCT00544401|hypnopuncture|hypnopuncture
622349|NCT00544388|Levocetirizine dihydrochloride|levocetirizine dihydrochloride
622350|NCT00544388|Xyzal tablet|xyzal tablet
622351|NCT00544362|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
622352|NCT00544362|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
622353|NCT00544362|stage IIIA esophageal cancer|stage iiia esophageal cancer
622354|NCT00544362|stage IIIB esophageal cancer|stage iiib esophageal cancer
622355|NCT00544362|stage IIIC esophageal cancer|stage iiic esophageal cancer
622356|NCT00544362|stage IV esophageal cancer|stage iv esophageal cancer
622357|NCT00544349|stage IV colon cancer|stage iv colon cancer
622358|NCT00544349|recurrent colon cancer|recurrent colon cancer
622359|NCT00544349|stage IV rectal cancer|stage iv rectal cancer
622360|NCT00544349|recurrent rectal cancer|recurrent rectal cancer
622361|NCT00544349|liver metastases|liver metastases
622362|NCT00544336|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
622363|NCT00544336|recurrent breast cancer|recurrent breast cancer
622364|NCT00544336|stage I breast cancer|stage i breast cancer
622365|NCT00544336|stage II breast cancer|stage ii breast cancer
622366|NCT00544336|stage IIIA breast cancer|stage iiia breast cancer
622367|NCT00544336|stage IIIB breast cancer|stage iiib breast cancer
622368|NCT00544336|stage IIIC breast cancer|stage iiic breast cancer
622369|NCT00544336|stage IV breast cancer|stage iv breast cancer
622370|NCT00544336|recurrent prostate cancer|recurrent prostate cancer
622371|NCT00544336|stage I prostate cancer|stage i prostate cancer
622372|NCT00544336|stage II prostate cancer|stage ii prostate cancer
622373|NCT00544336|stage III prostate cancer|stage iii prostate cancer
622374|NCT00544336|stage IV prostate cancer|stage iv prostate cancer
622375|NCT00544336|extensive stage small cell lung cancer|extensive stage small cell lung cancer
622376|NCT00544336|limited stage small cell lung cancer|limited stage small cell lung cancer
622377|NCT00544336|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
622378|NCT00544336|recurrent small cell lung cancer|recurrent small cell lung cancer
622379|NCT00544336|stage I non-small cell lung cancer|stage i non-small cell lung cancer
622380|NCT00544336|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
622381|NCT00544336|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
622382|NCT00544336|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
622383|NCT00544336|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
622384|NCT00544336|recurrent colon cancer|recurrent colon cancer
622385|NCT00544336|stage I colon cancer|stage i colon cancer
622386|NCT00544336|stage II colon cancer|stage ii colon cancer
622387|NCT00544336|stage III colon cancer|stage iii colon cancer
622388|NCT00544336|stage IV colon cancer|stage iv colon cancer
622389|NCT00544336|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
622390|NCT00544336|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
622391|NCT00544336|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
622392|NCT00544336|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
622393|NCT00544336|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
622394|NCT00544336|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
622395|NCT00544336|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
622396|NCT00544336|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
622397|NCT00544336|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
622398|NCT00544336|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
622399|NCT00544336|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
622400|NCT00544336|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
622401|NCT00544336|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
622402|NCT00544336|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
622403|NCT00544336|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
622404|NCT00544336|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
622405|NCT00544336|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
622406|NCT00544336|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
622407|NCT00544336|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
622408|NCT00544336|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
622409|NCT00544336|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
622410|NCT00544336|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
622411|NCT00544336|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
622412|NCT00544336|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
622413|NCT00544336|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
622414|NCT00544336|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
622415|NCT00544336|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
622416|NCT00544336|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
622417|NCT00544336|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
622418|NCT00544336|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
622419|NCT00544336|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
622420|NCT00544336|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
622421|NCT00544336|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
622422|NCT00544336|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
622423|NCT00544336|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
622424|NCT00544336|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
622425|NCT00544336|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
622426|NCT00544336|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
622427|NCT00544336|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
622428|NCT00544336|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
622429|NCT00544336|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
622430|NCT00544336|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
622431|NCT00544336|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
622432|NCT00544336|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
622433|NCT00544336|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
622434|NCT00544336|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
622435|NCT00544336|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
622436|NCT00544336|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
622437|NCT00544336|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
622438|NCT00544336|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
622439|NCT00544336|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
622440|NCT00544336|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
622441|NCT00544336|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
622442|NCT00544336|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
622443|NCT00544336|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
622444|NCT00544336|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
622445|NCT00544336|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
622446|NCT00544336|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
622447|NCT00544336|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
622448|NCT00544336|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
622449|NCT00544336|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
622450|NCT00544336|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
622451|NCT00544336|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
622452|NCT00544336|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
622453|NCT00544336|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
622454|NCT00544336|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
622455|NCT00544336|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
622456|NCT00544336|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
622457|NCT00544336|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
622458|NCT00544336|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
623037|NCT00542230|Erythrocytes|erythrocytes
622459|NCT00544336|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
622460|NCT00544336|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
622461|NCT00544336|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
622462|NCT00544336|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
622463|NCT00544336|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
622464|NCT00544336|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
622465|NCT00544336|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
622466|NCT00544336|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
622467|NCT00544336|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
622468|NCT00544336|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
622469|NCT00544336|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
622470|NCT00544336|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
622471|NCT00544336|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
622472|NCT00544336|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
622473|NCT00544336|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
622474|NCT00544336|recurrent salivary gland cancer|recurrent salivary gland cancer
622475|NCT00544336|salivary gland acinic cell tumor|salivary gland acinic cell tumor
622476|NCT00544336|salivary gland adenocarcinoma|salivary gland adenocarcinoma
622477|NCT00544336|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
622478|NCT00544336|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
622479|NCT00544336|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
622480|NCT00544336|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
622481|NCT00544336|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
622482|NCT00544336|stage I salivary gland cancer|stage i salivary gland cancer
622483|NCT00544336|stage II salivary gland cancer|stage ii salivary gland cancer
622484|NCT00544336|stage III salivary gland cancer|stage iii salivary gland cancer
622485|NCT00544336|stage IV salivary gland cancer|stage iv salivary gland cancer
622486|NCT00544323|alveolar bone|alveolar bone
622487|NCT00544323|radiographic alveolar bone changes around oral implants of various designs 12 m post loading|radiographic alveolar bone changes around oral implants of various designs 12 m post loading
622488|NCT00544297|Actinic Keratosis|actinic keratosis
622489|NCT00544297|Topical|topical
622490|NCT00544297|Dermatology|dermatology
622491|NCT00544297|Hand|hand
622492|NCT00544284|adult glioblastoma|adult glioblastoma
622493|NCT00544284|adult anaplastic astrocytoma|adult anaplastic astrocytoma
622494|NCT00544284|adult giant cell glioblastoma|adult giant cell glioblastoma
622495|NCT00544284|recurrent adult brain tumor|recurrent adult brain tumor
622496|NCT00544284|adult gliosarcoma|adult gliosarcoma
622497|NCT00544284|adult mixed glioma|adult mixed glioma
622498|NCT00544284|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
622499|NCT00544284|primary central nervous system lymphoma|primary central nervous system lymphoma
622500|NCT00544284|adult diffuse astrocytoma|adult diffuse astrocytoma
622501|NCT00544284|adult brain stem glioma|adult brain stem glioma
622502|NCT00544284|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
622503|NCT00544284|adult choroid plexus tumor|adult choroid plexus tumor
622504|NCT00544284|adult craniopharyngioma|adult craniopharyngioma
622505|NCT00544284|adult ependymoblastoma|adult ependymoblastoma
622506|NCT00544284|adult medulloblastoma|adult medulloblastoma
622507|NCT00544284|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
622508|NCT00544284|adult anaplastic ependymoma|adult anaplastic ependymoma
622509|NCT00544284|adult ependymoma|adult ependymoma
622510|NCT00544284|adult myxopapillary ependymoma|adult myxopapillary ependymoma
622511|NCT00544284|adult subependymoma|adult subependymoma
622512|NCT00544284|adult anaplastic meningioma|adult anaplastic meningioma
622513|NCT00544284|adult melanocytic lesion|adult melanocytic lesion
622514|NCT00544284|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
622515|NCT00544284|adult grade I meningioma|adult grade i meningioma
622516|NCT00544284|adult grade II meningioma|adult grade ii meningioma
622517|NCT00544284|adult grade III meningioma|adult grade iii meningioma
622518|NCT00544284|adult papillary meningioma|adult papillary meningioma
622519|NCT00544284|adult oligodendroglioma|adult oligodendroglioma
622520|NCT00544284|adult pineoblastoma|adult pineoblastoma
622521|NCT00544284|adult pineocytoma|adult pineocytoma
622522|NCT00544284|tumors metastatic to brain|tumors metastatic to brain
622523|NCT00544284|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
622524|NCT00544284|adult pilocytic astrocytoma|adult pilocytic astrocytoma
622525|NCT00544284|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
622526|NCT00544271|BOOSTRIX|boostrix
622527|NCT00544271|INFANRIX|infanrix
622528|NCT00544258|Pharmacokinetic study|pharmacokinetic study
622529|NCT00544258|Actinic Keratosis|actinic keratosis
622530|NCT00544258|Topical|topical
622531|NCT00544258|Dermatology|dermatology
622532|NCT00544245|overweight|overweight
622533|NCT00544245|obesity|obesity
622534|NCT00544245|accelerometer|accelerometer
622536|NCT00544245|energy balance|energy balance
622537|NCT00544245|weight loss|weight loss
622538|NCT00544245|weight maintenance|weight maintenance
622539|NCT00544232|Breast Cancer|breast cancer
622540|NCT00544232|neoadjuvant therapy|neoadjuvant therapy
622541|NCT00544232|pCR rates|pcr rates
622542|NCT00544219|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
622543|NCT00544219|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
622544|NCT00544219|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
622545|NCT00544219|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
622546|NCT00544219|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
622547|NCT00544193|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
622548|NCT00544193|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
622549|NCT00544193|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
622550|NCT00544193|adenocarcinoma of the stomach|adenocarcinoma of the stomach
622551|NCT00544193|stage I pancreatic cancer|stage i pancreatic cancer
622552|NCT00544193|stage II pancreatic cancer|stage ii pancreatic cancer
622553|NCT00544193|stage III pancreatic cancer|stage iii pancreatic cancer
622554|NCT00544193|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
622555|NCT00544193|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
622556|NCT00544193|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
622557|NCT00544193|localized gallbladder cancer|localized gallbladder cancer
622558|NCT00544193|recurrent gallbladder cancer|recurrent gallbladder cancer
622559|NCT00544193|unresectable gallbladder cancer|unresectable gallbladder cancer
622560|NCT00544193|recurrent gastric cancer|recurrent gastric cancer
622561|NCT00544193|stage II gastric cancer|stage ii gastric cancer
622562|NCT00544193|stage III gastric cancer|stage iii gastric cancer
622563|NCT00544193|stage IV gastric cancer|stage iv gastric cancer
622564|NCT00544193|stage I gastric cancer|stage i gastric cancer
622565|NCT00544193|recurrent pancreatic cancer|recurrent pancreatic cancer
622566|NCT00544193|small intestine adenocarcinoma|small intestine adenocarcinoma
622567|NCT00544193|stage IV pancreatic cancer|stage iv pancreatic cancer
622568|NCT00544167|Breast Cancer|breast cancer
622569|NCT00544167|Early Stage|early stage
622570|NCT00544167|High Risk|high risk
622571|NCT00544167|Node Positive|node positive
622572|NCT00544167|Doxorubicin|doxorubicin
622573|NCT00544167|Cyclophosphamide|cyclophosphamide
622574|NCT00544167|Paclitaxel|paclitaxel
622575|NCT00544167|Sorafenib|sorafenib
622576|NCT00544154|CDP870|cdp870
622577|NCT00544154|Certolizumab pegol|certolizumab pegol
622578|NCT00544141|Temperature measurement|temperature measurement
622579|NCT00544128|HIV|hiv
622580|NCT00544128|initial therapy|initial therapy
622581|NCT00544128|once daily|once daily
622582|NCT00544128|randomized trial|randomized trial
622583|NCT00544128|non inferiority|non inferiority
622584|NCT00544128|Treatment Naive|treatment naive
622585|NCT00544115|graft versus host disease|graft versus host disease
622586|NCT00544115|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
622587|NCT00544115|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
622588|NCT00544115|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
622589|NCT00544115|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
622590|NCT00544115|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
622591|NCT00544115|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
622592|NCT00544115|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
622593|NCT00544115|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
622594|NCT00544115|refractory anemia with excess blasts|refractory anemia with excess blasts
622595|NCT00544115|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
622596|NCT00544115|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
622597|NCT00544115|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
622598|NCT00544115|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
622599|NCT00544115|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
622600|NCT00544115|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
622601|NCT00544115|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
622602|NCT00544115|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
622603|NCT00544115|secondary acute myeloid leukemia|secondary acute myeloid leukemia
622604|NCT00544115|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
622605|NCT00544115|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
622606|NCT00544115|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
622607|NCT00544115|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
622608|NCT00544115|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
622609|NCT00544115|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
622682|NCT00543881|remote patient monitoring|remote patient monitoring
622610|NCT00544115|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
622611|NCT00544115|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
622612|NCT00544115|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
622613|NCT00544115|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
622614|NCT00544115|chronic eosinophilic leukemia|chronic eosinophilic leukemia
622615|NCT00544115|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
622616|NCT00544115|chronic neutrophilic leukemia|chronic neutrophilic leukemia
622617|NCT00544115|essential thrombocythemia|essential thrombocythemia
622618|NCT00544115|polycythemia vera|polycythemia vera
622619|NCT00544115|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
622620|NCT00544115|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
622621|NCT00544115|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
622622|NCT00544115|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
622623|NCT00544115|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
622624|NCT00544115|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
622625|NCT00544115|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
622626|NCT00544115|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
622627|NCT00544115|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
622628|NCT00544115|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
622629|NCT00544115|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
622630|NCT00544115|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
622631|NCT00544115|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
622632|NCT00544115|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
622633|NCT00544115|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
622634|NCT00544115|splenic marginal zone lymphoma|splenic marginal zone lymphoma
622635|NCT00544115|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
622636|NCT00544115|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
622637|NCT00544115|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
622638|NCT00544115|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
622639|NCT00544115|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
622640|NCT00544115|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
622641|NCT00544115|Burkitt lymphoma|burkitt lymphoma
622642|NCT00544115|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
622643|NCT00544115|anaplastic large cell lymphoma|anaplastic large cell lymphoma
622644|NCT00544115|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
622645|NCT00544115|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
622646|NCT00544115|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
622647|NCT00544115|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
622648|NCT00544115|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
622649|NCT00544115|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
622650|NCT00544115|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
622651|NCT00544115|refractory multiple myeloma|refractory multiple myeloma
622652|NCT00544115|stage III multiple myeloma|stage iii multiple myeloma
622653|NCT00544115|aplastic anemia|aplastic anemia
622654|NCT00544115|paroxysmal nocturnal hemoglobinuria|paroxysmal nocturnal hemoglobinuria
622655|NCT00544115|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
622656|NCT00544115|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
622657|NCT00544115|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
622658|NCT00544115|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
622659|NCT00544115|stage II multiple myeloma|stage ii multiple myeloma
622660|NCT00544102|Insulin Resistance|insulin resistance
622661|NCT00544102|Systemic Lupus Erythematosus|systemic lupus erythematosus
622662|NCT00544102|Atherosclerosis|atherosclerosis
622663|NCT00544102|Lupus|lupus
622664|NCT00544102|SLE|sle
622665|NCT00544089|azoospermia FISH IL-18 TESTICULAR BIOPSY|azoospermia fish il-18 testicular biopsy
622666|NCT00544063|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
622667|NCT00544050|Levetiracetam|levetiracetam
622668|NCT00544050|Keppra|keppra
622669|NCT00544024|Mefloquine|mefloquine
622670|NCT00544011|stage IV colon cancer|stage iv colon cancer
622671|NCT00544011|stage IV rectal cancer|stage iv rectal cancer
622672|NCT00544011|adenocarcinoma of the colon|adenocarcinoma of the colon
622673|NCT00544011|adenocarcinoma of the rectum|adenocarcinoma of the rectum
622674|NCT00543998|Sinusitis|sinusitis
622675|NCT00543985|metabolic syndrome|metabolic syndrome
622676|NCT00543985|obesity|obesity
622677|NCT00543985|exercise|exercise
622678|NCT00543907|breast reconstruction|breast reconstruction
622679|NCT00543907|DIEP flap|diep flap
622680|NCT00543894|Antibiotic, ICU, hospital acquired infection.|antibiotic, icu, hospital acquired infection.
622681|NCT00543881|telemedicine|telemedicine
622683|NCT00543881|chronic heart failure|chronic heart failure
622684|NCT00543881|mortality|mortality
622685|NCT00543881|health economics|health economics
622686|NCT00543855|Lewy Body Disease|lewy body disease
622687|NCT00543855|Dementia|dementia
622688|NCT00543855|Clinical Trial|clinical trial
622689|NCT00543855|Phase II|phase ii
622690|NCT00543855|E2020|e2020
622691|NCT00543855|donepezil hydrochloride|donepezil hydrochloride
622692|NCT00543842|Rectal Cancer|rectal cancer
622693|NCT00543842|Bevacizumab|bevacizumab
622694|NCT00543842|Erlotinib|erlotinib
622695|NCT00543842|Capecitabine|capecitabine
622696|NCT00543829|breast cancer|breast cancer
622697|NCT00543829|doxorubicin|doxorubicin
622698|NCT00543829|docetaxel|docetaxel
622699|NCT00543829|tamoxifen|tamoxifen
622700|NCT00543777|Liver Cancer|liver cancer
622701|NCT00543777|Magnetic Resonance Elastography|magnetic resonance elastography
622702|NCT00543777|2-Point Dixon Magnetic Resonance Imaging|2-point dixon magnetic resonance imaging
622703|NCT00543777|Liver Disease|liver disease
622704|NCT00543777|Fatty Liver|fatty liver
622705|NCT00543777|Liver Fibrosis|liver fibrosis
622706|NCT00543777|Liver Cirrhosis|liver cirrhosis
622707|NCT00543777|MRE|mre
622708|NCT00543777|2PD MRI|2pd mri
622709|NCT00543777|phase correction algorithm|phase correction algorithm
622710|NCT00543764|Intraoperative Pathway|intraoperative pathway
622711|NCT00543764|Breast Reconstruction|breast reconstruction
622712|NCT00543764|DIEP flap|diep flap
622713|NCT00543725|Antiretroviral|antiretroviral
622714|NCT00543725|HIV-1|hiv-1
622715|NCT00543725|AIDS|aids
622716|NCT00543725|TMC278-C215|tmc278-c215
622717|NCT00543725|TMC278-TiDP6-C215|tmc278-tidp6-c215
622718|NCT00543725|Treatment Naive|treatment naive
622719|NCT00543712|Sarcoma|sarcoma
622720|NCT00543712|synovial sarcoma|synovial sarcoma
622721|NCT00543712|APM4171g|apm4171g
622722|NCT00543686|Pre-School Asthma|pre-school asthma
622723|NCT00543686|Responder Profiles|responder profiles
622724|NCT00543686|Fluticasone|fluticasone
622725|NCT00543686|Montelukast|montelukast
622726|NCT00543686|Leukotriene|leukotriene
622727|NCT00543686|Children with Pre-School Asthma|children with pre-school asthma
622728|NCT00543673|Healthy term infants|healthy term infants
622729|NCT00543660|Corneal transplantation, Descemet membrane, endothelium|corneal transplantation, descemet membrane, endothelium
622730|NCT00543647|Fenofibrate|fenofibrate
622731|NCT00543647|Glomerular filtration rate|glomerular filtration rate
622732|NCT00543647|inulin clearance|inulin clearance
622733|NCT00543647|creatinine|creatinine
622734|NCT00543647|healthy volunteers|healthy volunteers
622735|NCT00543647|cross-over|cross-over
622736|NCT00543608|pneumonia|pneumonia
622737|NCT00543608|nosocomial pneumonia|nosocomial pneumonia
622738|NCT00543569|kidney transplant|kidney transplant
622739|NCT00543569|alefacept|alefacept
622740|NCT00543530|HIV|hiv
622741|NCT00543530|Treatment Experienced|treatment experienced
622742|NCT00543504|Advanced Cancer|advanced cancer
622743|NCT00543504|Bevacizumab|bevacizumab
622744|NCT00543504|Avastin|avastin
622745|NCT00543504|Sorafenib|sorafenib
622746|NCT00543504|BAY 43-9006|bay 43-9006
622747|NCT00543504|Erlotinib|erlotinib
622748|NCT00543504|OSI-774|osi-774
622749|NCT00543504|Tarceva|tarceva
622750|NCT00543504|Trastuzumab|trastuzumab
622751|NCT00543504|Herceptin|herceptin
622752|NCT00543504|Sunitinib|sunitinib
622753|NCT00543504|SU011248|su011248
622754|NCT00543504|Sutent|sutent
622755|NCT00543504|Cetuximab|cetuximab
622756|NCT00543504|Lapatinib|lapatinib
622757|NCT00543504|Tykerb|tykerb
622758|NCT00543504|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
622759|NCT00543504|rhuMAb-VEGF|rhumab-vegf
622760|NCT00543504|Erlotinib hydrochloride|erlotinib hydrochloride
622761|NCT00543504|GW572016|gw572016
622762|NCT00543504|Sunitinib Malate|sunitinib malate
622763|NCT00543478|Irritable bowel syndrome|irritable bowel syndrome
622764|NCT00543478|Diarrhea|diarrhea
622765|NCT00543478|Probiotics|probiotics
622766|NCT00543426|Fuzheng Huayu Tablets|fuzheng huayu tablets
622767|NCT00543426|Multicenter clinical study|multicenter clinical study
622768|NCT00543400|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
622769|NCT00543348|BALLOON ANGIOPLASTY|balloon angioplasty
622770|NCT00543348|AUTOGENOUS FISTULA|autogenous fistula
622771|NCT00543335|Non-Small Cell Lung Cancer|non-small cell lung cancer
622772|NCT00543335|Lung Cancer|lung cancer
622773|NCT00543335|NSCLC|nsclc
622774|NCT00543335|Radiation Therapy|radiation therapy
622775|NCT00543335|Sorafenib|sorafenib
622776|NCT00543335|BAY 43-9006|bay 43-9006
622777|NCT00543335|Thoracic Radiation|thoracic radiation
622778|NCT00543309|Fontan Operation|fontan operation
622779|NCT00543309|Cardiopulmonary Bypass|cardiopulmonary bypass
622780|NCT00543309|Heart Defects, Congenital|heart defects, congenital
622781|NCT00543309|Milrinone|milrinone
623038|NCT00542230|Drug Screen|drug screen
622782|NCT00543309|Natriuretic peptide, brain|natriuretic peptide, brain
622783|NCT00543296|uveitis|uveitis
622784|NCT00543296|Cystoid Macular Edema (CME)|cystoid macular edema (cme)
622785|NCT00543296|fluocinolone acetonide|fluocinolone acetonide
622786|NCT00543296|non-infectious uveitis affecting the posterior segment|non-infectious uveitis affecting the posterior segment
622787|NCT00543270|EVAR|evar
622788|NCT00543270|AAA|aaa
622789|NCT00543270|Aneurysm|aneurysm
622790|NCT00543270|Powerlink|powerlink
622791|NCT00543244|Chronic hepatitis C|chronic hepatitis c
622792|NCT00543244|Pegylated interferon|pegylated interferon
622793|NCT00543244|Ribavirin|ribavirin
622794|NCT00543244|Virokinetics|virokinetics
622795|NCT00543231|ECOG|ecog
622796|NCT00543231|MRT|mrt
622797|NCT00543231|NCI CTC|nci ctc
622798|NCT00543231|SAE|sae
622799|NCT00543231|Short Intravenous Infusion to Patients with Solid Tumors|short intravenous infusion to patients with solid tumors
622800|NCT00543192|Endometrial Cancer|endometrial cancer
622801|NCT00543192|Sexual Function|sexual function
622802|NCT00543166|Sjögren's syndrome|sjögren's syndrome
622803|NCT00543166|fatigue|fatigue
622804|NCT00543166|salivary gland|salivary gland
622805|NCT00543166|dehydroepiandrosterone|dehydroepiandrosterone
622806|NCT00543153|Advanced Cancer|advanced cancer
622807|NCT00543153|Exceptional Patient|exceptional patient
622808|NCT00543153|Cancer Care|cancer care
622809|NCT00543153|Interview|interview
622810|NCT00543140|Obesity|obesity
622811|NCT00543140|Morbid Obesity|morbid obesity
622812|NCT00543114|CLL|cll
622813|NCT00543114|SLL|sll
622814|NCT00543114|Revlimid|revlimid
622815|NCT00543114|lenalidomide|lenalidomide
622816|NCT00543101|HIV/AIDS|hiv/aids
622817|NCT00543101|darunavir|darunavir
622818|NCT00543101|Protease inhibitors|protease inhibitors
622819|NCT00543101|Dual boosted|dual boosted
622820|NCT00543101|Treatment experienced|treatment experienced
622821|NCT00543088|Schizophrenia|schizophrenia
622822|NCT00543088|Bipolar Disorder|bipolar disorder
622823|NCT00543088|manic episode|manic episode
622824|NCT00543088|atypical antipsychotic|atypical antipsychotic
622825|NCT00543088|Schizophrenia or Bipolar Disorder (currently in a manic episode)|schizophrenia or bipolar disorder (currently in a manic episode)
622826|NCT00543075|Renal Function|renal function
622827|NCT00543075|Adult|adult
622828|NCT00543075|Genasense|genasense
622829|NCT00543075|oblimersen|oblimersen
622830|NCT00543075|G3139|g3139
622831|NCT00543075|Genta|genta
622832|NCT00543075|Pharmacokinetics|pharmacokinetics
622833|NCT00543049|platinum refractory|platinum refractory
622834|NCT00543049|epithelial ovarian cancer|epithelial ovarian cancer
622835|NCT00543049|primary cancer of the peritoneum|primary cancer of the peritoneum
622836|NCT00543049|cancer of the fallopian tube|cancer of the fallopian tube
622837|NCT00543036|Cannabis|cannabis
622838|NCT00543036|Addiction|addiction
622839|NCT00543036|Craving|craving
622840|NCT00543036|TMS|tms
622841|NCT00542997|Subcutaneous immune globulin|subcutaneous immune globulin
622842|NCT00542997|SCIG|scig
622843|NCT00542971|Leukemia|leukemia
622844|NCT00542971|AML|aml
622845|NCT00542971|High-Risk MDS|high-risk mds
622846|NCT00542971|Acute Myeloid Leukemia|acute myeloid leukemia
622847|NCT00542971|High-Risk Myelodysplastic Disorder|high-risk myelodysplastic disorder
622848|NCT00542971|Idarubicin|idarubicin
622849|NCT00542971|Ara-C|ara-c
622850|NCT00542971|Cytarabine|cytarabine
622851|NCT00542971|Sorafenib|sorafenib
622852|NCT00542971|BAY43-9006|bay43-9006
622853|NCT00542958|Cancer|cancer
622854|NCT00542958|Refractory solid tumor|refractory solid tumor
622855|NCT00542945|Heart Failure|heart failure
622856|NCT00542945|ICD|icd
622857|NCT00542945|Dilated cardiomyopathy|dilated cardiomyopathy
622858|NCT00542932|COPD|copd
622859|NCT00542932|Exercise|exercise
622860|NCT00542932|Home|home
622861|NCT00542906|healthy volunteers|healthy volunteers
622862|NCT00542906|Somatosensory stimuli|somatosensory stimuli
622863|NCT00542906|fMRI|fmri
622864|NCT00542906|second somatosensory area|second somatosensory area
622865|NCT00542906|insular cortex|insular cortex
622866|NCT00542906|functional anatomy|functional anatomy
622867|NCT00542893|bcl-2|bcl-2
622868|NCT00542893|CFR|cfr
622869|NCT00542893|DTIC|dtic
622870|NCT00542893|ECOG|ecog
622871|NCT00542893|EMEA|emea
622872|NCT00542893|MedDRA|meddra
622873|NCT00542893|NCI CTC|nci ctc
622874|NCT00542893|SAE|sae
622875|NCT00542880|COPD|copd
622876|NCT00542880|Symbicort|symbicort
622877|NCT00542880|Seretide|seretide
622878|NCT00542867|Hypercholesterolemia|hypercholesterolemia
622879|NCT00542867|Third Joint European Task Force guidelines|third joint european task force guidelines
622880|NCT00542867|Survey|survey
622881|NCT00542854|arrhythmia|arrhythmia
622882|NCT00542854|pacemaker|pacemaker
622883|NCT00542854|defibrillator|defibrillator
622884|NCT00542854|electromagnetic interference|electromagnetic interference
622885|NCT00542841|Adrenal Hyperplasia, Congenital|adrenal hyperplasia, congenital
622886|NCT00542841|Steroid Biosynthesis Disorders|steroid biosynthesis disorders
622887|NCT00542815|Chronic Kidney Disease|chronic kidney disease
622888|NCT00542815|Dialysis|dialysis
622889|NCT00542815|Hyperphosphatemia|hyperphosphatemia
622890|NCT00542802|post stroke epileptic late onset seizures|post stroke epileptic late onset seizures
622891|NCT00542789|gastrointestinal|gastrointestinal
622892|NCT00542789|GI|gi
622893|NCT00542789|NSAID|nsaid
622894|NCT00542789|Japan|japan
622895|NCT00542789|Japanese|japanese
622896|NCT00542789|Gastric ulcer|gastric ulcer
622897|NCT00542789|duodenal ulcer|duodenal ulcer
622898|NCT00542776|inflammatory bowel disease (IBD)|inflammatory bowel disease (ibd)
622899|NCT00542776|immunosuppressed or non-immunosuppressed|immunosuppressed or non-immunosuppressed
622900|NCT00542776|influenza vaccine|influenza vaccine
622901|NCT00542776|antibody titers|antibody titers
622902|NCT00542776|seroprotective titers|seroprotective titers
622903|NCT00542776|vaccine-associated adverse events|vaccine-associated adverse events
622904|NCT00542763|Sjogren's syndrome|sjogren's syndrome
622905|NCT00542763|Mycophenolate sodium|mycophenolate sodium
622906|NCT00542750|Cannabis|cannabis
622907|NCT00542750|Marijuana|marijuana
622908|NCT00542750|Pharmacotherapy|pharmacotherapy
622909|NCT00542750|Adolescent|adolescent
622910|NCT00542737|Acute Lung Injury|acute lung injury
622911|NCT00542737|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
622912|NCT00542737|Acute Respiratory Failure|acute respiratory failure
622913|NCT00542737|Web-Based Intervention|web-based intervention
622914|NCT00542737|Lung Preventive Ventilation|lung preventive ventilation
622915|NCT00542724|Insulin|insulin
622916|NCT00542724|Diabetes Mellitus type I|diabetes mellitus type i
622917|NCT00542724|Juvenile diabetes|juvenile diabetes
622918|NCT00542711|Curcumin|curcumin
622919|NCT00542711|Bioavilability|bioavilability
622920|NCT00542711|Healthy subjects|healthy subjects
622921|NCT00542698|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
622922|NCT00542698|Glucose Monitor graphs|glucose monitor graphs
622923|NCT00542698|Physical Activity|physical activity
622924|NCT00542672|Mexican American|mexican american
622925|NCT00542672|Dietary Intake|dietary intake
622926|NCT00542672|Child-Feeding Practices|child-feeding practices
622927|NCT00542672|Weight|weight
622928|NCT00542672|Cultural Values|cultural values
622929|NCT00542659|Atrial fibrillation|atrial fibrillation
622930|NCT00542659|Maze procedure|maze procedure
622931|NCT00542633|Diabetes mellitus type 2|diabetes mellitus type 2
622932|NCT00542633|Diabetes|diabetes
622933|NCT00542633|Insulin|insulin
622934|NCT00542633|NIDDM|niddm
622935|NCT00542633|Rapid acting|rapid acting
622936|NCT00542607|Levocetirizine dihydrochloride|levocetirizine dihydrochloride
622937|NCT00542607|Xyzal tablets|xyzal tablets
622938|NCT00542594|breast cancer|breast cancer
622939|NCT00542594|anastrozole|anastrozole
622940|NCT00542581|Visual Outcomes|visual outcomes
622941|NCT00542581|Patient Satisfaction|patient satisfaction
622942|NCT00542581|Ophthalmology|ophthalmology
622943|NCT00542581|Cataractous Lens|cataractous lens
622944|NCT00542542|Breast Cancer|breast cancer
622945|NCT00542542|Reconstructive Surgery|reconstructive surgery
622946|NCT00542542|Paravertebral Block|paravertebral block
622947|NCT00542542|Anesthesia|anesthesia
622948|NCT00542542|Propofol|propofol
622949|NCT00542542|Fentanyl|fentanyl
622950|NCT00542542|Ropivacaine|ropivacaine
622951|NCT00542542|Midazolam|midazolam
622952|NCT00542529|Healthy Subjects|healthy subjects
622953|NCT00542516|Hip Replacement Arthroplasty|hip replacement arthroplasty
622954|NCT00542516|Hydroxyethyl Starch|hydroxyethyl starch
622955|NCT00542516|Hemodilution|hemodilution
622956|NCT00542516|Hetastarch|hetastarch
622957|NCT00542516|Colloids|colloids
622958|NCT00542503|Cardiac Outcomes|cardiac outcomes
622959|NCT00542503|MRI|mri
622960|NCT00542503|Cardiac Stress Testing|cardiac stress testing
622961|NCT00542490|Endometrial cancer|endometrial cancer
622962|NCT00542490|Gynecologic Cancer|gynecologic cancer
622963|NCT00542490|Vaginal Cuff Brachytherapy|vaginal cuff brachytherapy
622964|NCT00542490|Vaginal radiation|vaginal radiation
622965|NCT00542464|Safety in Healthy Adult Subjects|safety in healthy adult subjects
622966|NCT00542451|node-negative breast cancer|node-negative breast cancer
622967|NCT00542451|HER-2 positive|her-2 positive
622968|NCT00542438|Cardiovascular Disease|cardiovascular disease
622969|NCT00542438|Cancer Prevention|cancer prevention
622970|NCT00542438|Physical Activity|physical activity
622971|NCT00542438|Body Composition|body composition
622972|NCT00542438|Environment|environment
622973|NCT00542438|Exercise|exercise
622974|NCT00542425|osteoporosis|osteoporosis
622975|NCT00542425|postmenopausal|postmenopausal
622976|NCT00542425|bone loss|bone loss
622977|NCT00542399|levemir|levemir
622978|NCT00542399|type 1 diabetes|type 1 diabetes
622979|NCT00542386|Chronic Kidney Disease|chronic kidney disease
622980|NCT00542386|Dialysis|dialysis
622981|NCT00542386|Hyperphosphatemia|hyperphosphatemia
622982|NCT00542386|Dyslipidemia|dyslipidemia
622983|NCT00542386|Phosphate binder|phosphate binder
622984|NCT00542373|Oral Cancer|oral cancer
622985|NCT00542373|Oral Cavity Mucosa|oral cavity mucosa
622986|NCT00542373|Leukoplakia|leukoplakia
622987|NCT00542373|Erythroplakia|erythroplakia
622988|NCT00542373|Fluorescence Imaging|fluorescence imaging
622989|NCT00542373|Reflectance Imaging|reflectance imaging
622990|NCT00542373|Multispectral Digital Microscope|multispectral digital microscope
622991|NCT00542373|Portable Spectroscopy System|portable spectroscopy system
622992|NCT00542373|Fast Excitation-Emission Matrix|fast excitation-emission matrix
622993|NCT00542373|PS2|ps2
622994|NCT00542373|MDM|mdm
622995|NCT00542373|Fast EEM4|fast eem4
622996|NCT00542360|Accidental Falls|accidental falls
622997|NCT00542360|Aged|aged
622998|NCT00542360|Social Marketing|social marketing
622999|NCT00542360|Exercise|exercise
623000|NCT00542360|Accident Prevention|accident prevention
623001|NCT00542360|Religion|religion
623002|NCT00542360|Randomized Controlled Trial|randomized controlled trial
623003|NCT00542347|gastric acid|gastric acid
623004|NCT00542347|proton pump inhibitors|proton pump inhibitors
623005|NCT00542347|omeprazole|omeprazole
623006|NCT00542347|esomeprazole|esomeprazole
623007|NCT00542334|Nocturnal Hypoglycemia|nocturnal hypoglycemia
623008|NCT00542334|Type 1 diabetes|type 1 diabetes
623009|NCT00542334|Children|children
623010|NCT00542334|Adolescents|adolescents
623011|NCT00542334|CGMS|cgms
623012|NCT00542321|lateral rotation|lateral rotation
623013|NCT00542321|kinetic therapy|kinetic therapy
623014|NCT00542321|mechanical ventilation|mechanical ventilation
623015|NCT00542321|pulmonary complications|pulmonary complications
623016|NCT00542282|lung sounds,|lung sounds,
623017|NCT00542282|airway obstruction,|airway obstruction,
623018|NCT00542282|asthma,|asthma,
623019|NCT00542282|auscultation|auscultation
623020|NCT00542269|Hypertension|hypertension
623021|NCT00542269|Metabolic Syndrome|metabolic syndrome
623022|NCT00542269|Dual combination therapy|dual combination therapy
623023|NCT00542269|Triple combination therapy|triple combination therapy
623024|NCT00542269|Aliskiren|aliskiren
623025|NCT00542269|Direct Renin inhibitor|direct renin inhibitor
623026|NCT00542256|Apoplexy|apoplexy
623027|NCT00542256|Cerebral Stroke|cerebral stroke
623028|NCT00542256|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
623029|NCT00542256|Cerebrovascular Apoplexy|cerebrovascular apoplexy
623030|NCT00542256|Cerebrovascular Stroke|cerebrovascular stroke
623031|NCT00542256|CVA (Cerebrovascular Accident)|cva (cerebrovascular accident)
623032|NCT00542256|Stroke|stroke
623033|NCT00542256|Stroke, Acute|stroke, acute
623034|NCT00542256|Vascular Accident, Brain|vascular accident, brain
623035|NCT00542243|enlarged prostate|enlarged prostate
623036|NCT00542243|finasteride|finasteride
623039|NCT00542230|Sickle Cell Trait|sickle cell trait
623040|NCT00542230|Sickle Cell Disease|sickle cell disease
623041|NCT00542217|Healthy Volunteers|healthy volunteers
623042|NCT00542204|Diabetes|diabetes
623043|NCT00542204|Blood Glucose Self-Monitoring|blood glucose self-monitoring
623044|NCT00542204|Home Blood Glucose Monitoring|home blood glucose monitoring
623045|NCT00542204|Internet|internet
623046|NCT00542204|Personal Health Record (PHR)|personal health record (phr)
623047|NCT00542204|Health Information Technology (HIT)|health information technology (hit)
623048|NCT00542204|Care management|care management
623049|NCT00542204|Disease Management|disease management
623050|NCT00542204|Diabetes self-management|diabetes self-management
623051|NCT00542204|Consumer Health Information|consumer health information
623052|NCT00542204|Medical Records Systems, Computerized|medical records systems, computerized
623053|NCT00542204|Computerized Medical Records System|computerized medical records system
623054|NCT00542204|Automated Medical Records System|automated medical records system
623055|NCT00542204|Electronic Health Record (EHR)|electronic health record (ehr)
623056|NCT00542204|Remote patient monitoring|remote patient monitoring
623057|NCT00542191|Triple negative (ER/PR negative; HER2 negative)|triple negative (er/pr negative; her2 negative)
623058|NCT00542178|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
623059|NCT00542178|Cardiovascular Diseases|cardiovascular diseases
623061|NCT00542152|Ulcerative colitis|ulcerative colitis
623062|NCT00542152|refractory to steroids|refractory to steroids
623063|NCT00542139|Osteoarthritis|osteoarthritis
623064|NCT00542139|Knee arthroplasty|knee arthroplasty
623065|NCT00542139|Steroid injection|steroid injection
623066|NCT00542139|Rehabilitation|rehabilitation
623067|NCT00542126|GnRH analog, IVF, infertility, frozen-thawed embryos|gnrh analog, ivf, infertility, frozen-thawed embryos
623068|NCT00542113|Parental|parental
623069|NCT00542113|Parents|parents
623070|NCT00542113|Prevention|prevention
623071|NCT00542113|Energy balance|energy balance
623072|NCT00542113|Glucose regulation|glucose regulation
623073|NCT00542113|Healthy lifestyles|healthy lifestyles
623074|NCT00542113|Healthy families|healthy families
623075|NCT00542113|Active living|active living
623076|NCT00542074|Bacterial vaginosis|bacterial vaginosis
623077|NCT00542074|recurrence|recurrence
623078|NCT00542074|male factor|male factor
623079|NCT00542061|COPD|copd
623080|NCT00542061|Asthma|asthma
623081|NCT00542061|Lung function|lung function
623082|NCT00542061|Monitoring|monitoring
623083|NCT00542061|Primary Care|primary care
623084|NCT00542048|Hepatic metastases|hepatic metastases
623085|NCT00542048|Angiogenesis|angiogenesis
623086|NCT00542048|EndoTAG-1|endotag-1
623087|NCT00542048|Pharmacokinetics|pharmacokinetics
623088|NCT00542048|Pharmacodynamics|pharmacodynamics
623089|NCT00542048|Metastases of the liver|metastases of the liver
623090|NCT00542035|Analgesia|analgesia
623091|NCT00542009|Phase 2A, safety and efficacy trial with CE-326,597 in patients with T2DM.|phase 2a, safety and efficacy trial with ce-326,597 in patients with t2dm.
623092|NCT00541983|Diabetes|diabetes
623093|NCT00541983|Type 2|type 2
623094|NCT00541983|Mellitus|mellitus
623095|NCT00541970|viral infections|viral infections
623096|NCT00541970|Human Papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
623097|NCT00541970|safety|safety
623098|NCT00541970|vaccine|vaccine
623099|NCT00541970|immunogenicity|immunogenicity
623100|NCT00541970|cervical cancer|cervical cancer
623101|NCT00541957|Major depression|major depression
623102|NCT00541957|Primary care|primary care
623103|NCT00541944|hyponatremia|hyponatremia
623104|NCT00541944|diagnosis and treatment of hyponatremia|diagnosis and treatment of hyponatremia
623105|NCT00541944|classification of hyponatremia|classification of hyponatremia
623106|NCT00541918|sevoflurane,|sevoflurane,
623107|NCT00541918|propofol,|propofol,
623108|NCT00541918|heart surgery,|heart surgery,
623109|NCT00541918|cardiopulmonary bypass,|cardiopulmonary bypass,
623110|NCT00541918|memory disorders,|memory disorders,
623111|NCT00541892|Cell Culture Techniques|cell culture techniques
623112|NCT00541879|Childhood|childhood
623113|NCT00541879|Prevention|prevention
623114|NCT00541879|Energy balance|energy balance
623115|NCT00541879|Glucose regulation|glucose regulation
623116|NCT00541879|Healthy lifestyle|healthy lifestyle
623117|NCT00541879|Healthy eating|healthy eating
623118|NCT00541879|Active living|active living
623119|NCT00541866|Leukemia|leukemia
623120|NCT00541866|Acute Myeloid|acute myeloid
623121|NCT00541866|Relapsed|relapsed
623122|NCT00541866|Refractory|refractory
623123|NCT00541866|Cancer|cancer
623124|NCT00541866|AML|aml
623125|NCT00541866|Cytarabine|cytarabine
623126|NCT00541866|SNS-595|sns-595
623127|NCT00541866|Phase 1|phase 1
623128|NCT00541866|Voreloxin|voreloxin
623129|NCT00541853|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
623130|NCT00541853|Hypertension|hypertension
623131|NCT00541853|Angiotensin-2 Receptor Blocker|angiotensin-2 receptor blocker
623132|NCT00541853|Calcium Channel Blocker|calcium channel blocker
623133|NCT00541853|Kidney Volume|kidney volume
623134|NCT00541840|Sarcoma|sarcoma
623135|NCT00541840|Sorafenib|sorafenib
623136|NCT00541840|GEIS|geis
623137|NCT00541827|Sepsis. Shock, septic. Mitochondria.|sepsis. shock, septic. mitochondria.
623138|NCT00541814|Renal Transplantation|renal transplantation
623139|NCT00541814|Calcineurin Inhibitor|calcineurin inhibitor
623140|NCT00541814|Cyclosporine|cyclosporine
623141|NCT00541814|Withdrawal|withdrawal
623142|NCT00541814|Minimisation|minimisation
623143|NCT00541762|Neurotensin|neurotensin
623144|NCT00541762|Human|human
623145|NCT00541762|Physiology of neurotensin|physiology of neurotensin
623146|NCT00541762|fat perfusion|fat perfusion
623147|NCT00541762|healthy subjects|healthy subjects
623148|NCT00541749|SLE|sle
623149|NCT00541736|Familial Hemiplegic Migraine|familial hemiplegic migraine
623150|NCT00541710|menopause|menopause
623151|NCT00541710|genistein|genistein
623152|NCT00541710|pre-diabetes|pre-diabetes
623153|NCT00541671|Narcotics|narcotics
623154|NCT00541671|Nausea|nausea
623155|NCT00541619|hypertension|hypertension
623156|NCT00541619|sympathetic activity|sympathetic activity
623157|NCT00541619|early renal damage|early renal damage
623158|NCT00541606|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
623159|NCT00541606|Pharmaceutical Care|pharmaceutical care
623160|NCT00541606|Collaborative Practice|collaborative practice
623161|NCT00541593|Pancreatic pseudocyst|pancreatic pseudocyst
623162|NCT00541593|NOTES|notes
623163|NCT00541567|Wheight management in T2D|wheight management in t2d
623164|NCT00541515|Type 1 diabetes|type 1 diabetes
623165|NCT00541515|Artificial pancreas|artificial pancreas
623166|NCT00541515|Insulin Pump|insulin pump
623167|NCT00541502|evaluate the effectiveness of improving cognitive function of aripiprazole in treating adolescents and young adults with psychotic disorder in Taiwan|evaluate the effectiveness of improving cognitive function of aripiprazole in treating adolescents and young adults with psychotic disorder in taiwan
623168|NCT00541489|Osteoarthritis|osteoarthritis
623169|NCT00541489|Osteoarthritis, Hip|osteoarthritis, hip
623170|NCT00541463|HIV|hiv
623171|NCT00541463|Treatment Experienced|treatment experienced
623172|NCT00541437|Change from baseline of HbA1c after 16 weeks of treatment|change from baseline of hba1c after 16 weeks of treatment
623173|NCT00541437|Change from baseline of FPG after 16 weeks of treatment|change from baseline of fpg after 16 weeks of treatment
623174|NCT00541437|Change from baseline of diabetes self-care scale by patient on drug administration after 16 weeks of treatment|change from baseline of diabetes self-care scale by patient on drug administration after 16 weeks of treatment
623175|NCT00541424|Mantle Cell Lymphoma|mantle cell lymphoma
623176|NCT00541424|Lymphoma|lymphoma
623177|NCT00541424|CT Colonography|ct colonography
623178|NCT00541424|PET Scan|pet scan
623179|NCT00541424|PET/CT Scan|pet/ct scan
623180|NCT00541424|Gas Insufflation|gas insufflation
623181|NCT00541398|Antipsychotic polypharmacy|antipsychotic polypharmacy
623182|NCT00541398|Schizophrenia|schizophrenia
623183|NCT00541398|Implementation of clinical guidelines|implementation of clinical guidelines
623188|NCT00541385|Coartem|coartem
623189|NCT00541385|Artesunate|artesunate
623190|NCT00541385|lumefantrine|lumefantrine
623191|NCT00541385|Arthemeter|arthemeter
623192|NCT00541385|pyronaridine|pyronaridine
623193|NCT00541385|Pyramax|pyramax
623194|NCT00541346|Autism|autism
623195|NCT00541346|Autism Spectrum Disorders|autism spectrum disorders
623196|NCT00541346|ADHD|adhd
623197|NCT00541333|Dry Age Related Macular Degeneration|dry age related macular degeneration
623198|NCT00541333|Dry AMD|dry amd
623199|NCT00541320|Anti-thrombolytic direct Factor Xa inhibitor|anti-thrombolytic direct factor xa inhibitor
623200|NCT00541307|Peripheral Arterial Disease|peripheral arterial disease
623201|NCT00541307|Peripheral Vascular Disease|peripheral vascular disease
623202|NCT00541294|Tuberculosis|tuberculosis
623203|NCT00541294|HIV|hiv
623204|NCT00541294|Diagnostics|diagnostics
623205|NCT00541294|Pediatrics|pediatrics
623206|NCT00541281|prostate cancer|prostate cancer
623207|NCT00541281|hormone resistant|hormone resistant
623208|NCT00541281|metastatic|metastatic
623209|NCT00541281|estramustine combine to docetaxel|estramustine combine to docetaxel
623210|NCT00541281|randomized study|randomized study
623211|NCT00541268|Heart Failure|heart failure
623212|NCT00541268|ICD|icd
623213|NCT00541268|Dilated cardiomyopathy|dilated cardiomyopathy
623214|NCT00541255|Bronchial Asthma|bronchial asthma
623215|NCT00541255|Food Allergy|food allergy
623216|NCT00541255|Bronchial Hyperresponsiveness|bronchial hyperresponsiveness
623217|NCT00541216|congenital myasthenia|congenital myasthenia
623218|NCT00541216|ephedrine|ephedrine
623219|NCT00541203|tomography|tomography
623220|NCT00541203|coronary artery disease|coronary artery disease
623221|NCT00541203|Stress Test|stress test
623222|NCT00541203|Coronary Angiography|coronary angiography
623223|NCT00541190|cystic fibrosis|cystic fibrosis
623224|NCT00541190|mucociliary clearance|mucociliary clearance
623225|NCT00541190|outcome measures|outcome measures
623226|NCT00541177|prevention myopia|prevention myopia
623227|NCT00541164|CMT|cmt
623228|NCT00541164|Charcot-Marie Tooth|charcot-marie tooth
623229|NCT00541164|CoQ10|coq10
623230|NCT00541164|Coenzyme Q10|coenzyme q10
623231|NCT00541151|Stress urinary incontinence in Women|stress urinary incontinence in women
623232|NCT00541138|tumors metastatic to brain|tumors metastatic to brain
623233|NCT00541138|recurrent adult brain tumor|recurrent adult brain tumor
623234|NCT00541138|adult anaplastic astrocytoma|adult anaplastic astrocytoma
623235|NCT00541138|adult diffuse astrocytoma|adult diffuse astrocytoma
623236|NCT00541138|adult giant cell glioblastoma|adult giant cell glioblastoma
623237|NCT00541138|adult gliosarcoma|adult gliosarcoma
623238|NCT00541138|adult pilocytic astrocytoma|adult pilocytic astrocytoma
623239|NCT00541138|adult pineal gland astrocytoma|adult pineal gland astrocytoma
623240|NCT00541138|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
623241|NCT00541138|adult brain stem glioma|adult brain stem glioma
623242|NCT00541138|adult anaplastic ependymoma|adult anaplastic ependymoma
623243|NCT00541138|adult ependymoma|adult ependymoma
623244|NCT00541138|adult myxopapillary ependymoma|adult myxopapillary ependymoma
623245|NCT00541138|adult subependymoma|adult subependymoma
623246|NCT00541138|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
623247|NCT00541138|adult oligodendroglioma|adult oligodendroglioma
623248|NCT00541138|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
623249|NCT00541138|adult mixed glioma|adult mixed glioma
623250|NCT00541125|recurrent colon cancer|recurrent colon cancer
623251|NCT00541125|stage IV colon cancer|stage iv colon cancer
623252|NCT00541125|recurrent rectal cancer|recurrent rectal cancer
623253|NCT00541125|stage IV rectal cancer|stage iv rectal cancer
623254|NCT00541125|adenocarcinoma of the colon|adenocarcinoma of the colon
623255|NCT00541125|adenocarcinoma of the rectum|adenocarcinoma of the rectum
623256|NCT00541112|stage III rectal cancer|stage iii rectal cancer
623257|NCT00541112|stage IV rectal cancer|stage iv rectal cancer
623258|NCT00541112|adenocarcinoma of the rectum|adenocarcinoma of the rectum
623259|NCT00541099|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
623260|NCT00541099|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
623261|NCT00541099|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
623262|NCT00541086|stage IA breast cancer|stage ia breast cancer
623263|NCT00541086|stage IB breast cancer|stage ib breast cancer
623264|NCT00541086|stage II breast cancer|stage ii breast cancer
623265|NCT00541086|stage IIIA breast cancer|stage iiia breast cancer
623266|NCT00541086|stage IIIB breast cancer|stage iiib breast cancer
623267|NCT00541086|stage IIIC breast cancer|stage iiic breast cancer
623268|NCT00541086|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
623269|NCT00541086|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
623270|NCT00541073|advanced malignant mesothelioma|advanced malignant mesothelioma
623271|NCT00541073|recurrent malignant mesothelioma|recurrent malignant mesothelioma
623272|NCT00541060|caries susceptibility,enamel matrix,candidate genes,mutation|caries susceptibility,enamel matrix,candidate genes,mutation
623273|NCT00541047|sexual dysfunction|sexual dysfunction
623274|NCT00541047|urinary complications|urinary complications
623275|NCT00541047|gastrointestinal complications|gastrointestinal complications
623276|NCT00541047|adenocarcinoma of the prostate|adenocarcinoma of the prostate
623277|NCT00541047|stage I prostate cancer|stage i prostate cancer
623278|NCT00541047|stage IIB prostate cancer|stage iib prostate cancer
623279|NCT00541047|stage IIA prostate cancer|stage iia prostate cancer
623280|NCT00541047|stage III prostate cancer|stage iii prostate cancer
623281|NCT00541034|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
623282|NCT00541034|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
623283|NCT00541034|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
623284|NCT00541034|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
623285|NCT00541034|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
623286|NCT00541034|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
623287|NCT00541034|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
623288|NCT00541034|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
623289|NCT00541034|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
623290|NCT00541021|stage III pancreatic cancer|stage iii pancreatic cancer
623291|NCT00541021|stage IV pancreatic cancer|stage iv pancreatic cancer
623292|NCT00541021|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
623293|NCT00541021|recurrent pancreatic cancer|recurrent pancreatic cancer
623294|NCT00541008|type 1 papillary renal cell carcinoma|type 1 papillary renal cell carcinoma
623295|NCT00541008|type 2 papillary renal cell carcinoma|type 2 papillary renal cell carcinoma
623296|NCT00541008|stage IV renal cell cancer|stage iv renal cell cancer
623297|NCT00541008|stage III renal cell cancer|stage iii renal cell cancer
623298|NCT00540982|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
623299|NCT00540982|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
623300|NCT00540982|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
623301|NCT00540982|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
623302|NCT00540982|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
623303|NCT00540969|bone metastases|bone metastases
623304|NCT00540969|pain|pain
623305|NCT00540969|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
623306|NCT00540969|stage IV melanoma|stage iv melanoma
623307|NCT00540969|stage IV renal cell cancer|stage iv renal cell cancer
623308|NCT00540956|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
623309|NCT00540956|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
623310|NCT00540956|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
623311|NCT00540956|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
623312|NCT00540956|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
623313|NCT00540956|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
623314|NCT00540956|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
623315|NCT00540956|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
623316|NCT00540956|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
623317|NCT00540956|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
623318|NCT00540956|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
623319|NCT00540956|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
623320|NCT00540956|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
623321|NCT00540956|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
623322|NCT00540943|cetuximab|cetuximab
623323|NCT00540943|irinotecan,|irinotecan,
623324|NCT00540943|pazopanib,|pazopanib,
623325|NCT00540943|Colorectal cancer,|colorectal cancer,
623326|NCT00540904|contrast|contrast
623327|NCT00540904|nephropathy|nephropathy
623328|NCT00540904|bicarbonate|bicarbonate
623329|NCT00540904|prevention|prevention
623330|NCT00540878|Formulation Drug Study|formulation drug study
623331|NCT00540865|Homebound Persons|homebound persons
623332|NCT00540865|Case Management|case management
623333|NCT00540865|Problem Solving Therapy|problem solving therapy
623334|NCT00540852|Breast cancer receiving chemotherapy|breast cancer receiving chemotherapy
623335|NCT00540813|bifurcation stenosis|bifurcation stenosis
623336|NCT00540813|Patients with documented ischemia due to a de-novo bifurcation stenosis|patients with documented ischemia due to a de-novo bifurcation stenosis
623337|NCT00540800|anthracycline pre-treated|anthracycline pre-treated
623338|NCT00540800|chemotherapy|chemotherapy
623339|NCT00540800|first-line|first-line
623340|NCT00540800|metastatic breast cancer|metastatic breast cancer
623341|NCT00540800|locally advanced breast cancer|locally advanced breast cancer
623342|NCT00540774|oral cancer|oral cancer
623343|NCT00540774|oral mucositis|oral mucositis
623344|NCT00540774|oral stomatitis|oral stomatitis
623345|NCT00540774|Dry mouth|dry mouth
623346|NCT00540774|Gingivitis|gingivitis
623347|NCT00540761|Coronary Artery Disease|coronary artery disease
623348|NCT00540761|Atherosclerosis|atherosclerosis
623349|NCT00540748|first trimester abortion|first trimester abortion
623350|NCT00540748|oxytocin|oxytocin
623351|NCT00540696|Anemia|anemia
623352|NCT00540696|Non-Myeloid Malignancies|non-myeloid malignancies
623744|NCT00538928|hypoxia|hypoxia
623353|NCT00540696|darbepoetin alfa|darbepoetin alfa
623354|NCT00540696|chemotherapy|chemotherapy
623355|NCT00540670|Coronary artery disease|coronary artery disease
623356|NCT00540644|Multiple Myeloma|multiple myeloma
623357|NCT00540644|Revlimid|revlimid
623358|NCT00540631|House Dust Mite Allergen|house dust mite allergen
623359|NCT00540631|Aluminium hydroxide-adsorbed|aluminium hydroxide-adsorbed
623360|NCT00540605|Microbicide|microbicide
623361|NCT00540605|Pregnancy|pregnancy
623362|NCT00540605|HIV Seronegativity|hiv seronegativity
623363|NCT00540592|Influenza vaccine GSK576389A|influenza vaccine gsk576389a
623364|NCT00540592|Influenza infection|influenza infection
623365|NCT00540592|Fluarix|fluarix
623366|NCT00540579|Pancreas|pancreas
623367|NCT00540579|Untreated|untreated
623368|NCT00540579|Advanced|advanced
623369|NCT00540579|Gemcitabine|gemcitabine
623370|NCT00540579|CC-4047|cc-4047
623371|NCT00540553|SARM,|sarm,
623372|NCT00540553|FTIH,|ftih,
623373|NCT00540553|pharmacokinetics|pharmacokinetics
623374|NCT00540527|acute ischemic stroke;thrombolysis;intraarterial thrombolysis|acute ischemic stroke;thrombolysis;intraarterial thrombolysis
623375|NCT00540514|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
623376|NCT00540501|zanamivir,|zanamivir,
623377|NCT00540501|influenza virus,|influenza virus,
623378|NCT00540501|healthy volunteer,|healthy volunteer,
623379|NCT00540501|PK, drug interaction,|pk, drug interaction,
623380|NCT00540501|IV, and oseltamivir.|iv, and oseltamivir.
623381|NCT00540475|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
623382|NCT00540475|Interstitial Lung Disease|interstitial lung disease
623383|NCT00540462|Type II Diabetes Mellitus|type ii diabetes mellitus
623384|NCT00540462|Gastric bypass|gastric bypass
623385|NCT00540462|Obese-related diabetes mellitus|obese-related diabetes mellitus
623386|NCT00540462|Sugar control|sugar control
623387|NCT00540462|treatment of obesity related diabetes mellitus|treatment of obesity related diabetes mellitus
623388|NCT00540449|TMC278-C209|tmc278-c209
623389|NCT00540449|Antiretroviral|antiretroviral
623390|NCT00540449|Non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
623391|NCT00540449|HIV-1|hiv-1
623392|NCT00540449|AIDS|aids
623393|NCT00540449|TMC278-TiDP6-C209|tmc278-tidp6-c209
623394|NCT00540449|Treatment Naive|treatment naive
623395|NCT00540436|Ambrisentan|ambrisentan
623396|NCT00540436|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
623397|NCT00540436|6MWD|6mwd
623398|NCT00540423|thrombopoietin,|thrombopoietin,
623399|NCT00540423|immunosuppressive therapy,|immunosuppressive therapy,
623400|NCT00540423|eltrombopag,|eltrombopag,
623401|NCT00540423|idiopathic thrombocytopenic purpura,|idiopathic thrombocytopenic purpura,
623402|NCT00540423|blood platelet,|blood platelet,
623403|NCT00540423|splenectomy|splenectomy
623404|NCT00540384|Anemia|anemia
623405|NCT00540384|Solid tumors|solid tumors
623406|NCT00540384|Multicycle chemotherapy|multicycle chemotherapy
623407|NCT00540384|NESP|nesp
623408|NCT00540371|Port Wine Stain|port wine stain
623409|NCT00540358|Triple negative breast cancer|triple negative breast cancer
623410|NCT00540345|chronic hepatitis C|chronic hepatitis c
623411|NCT00540345|genotype 2|genotype 2
623412|NCT00540345|rapid virological response|rapid virological response
623413|NCT00540345|sustained virological response|sustained virological response
623414|NCT00540345|peginterferon|peginterferon
623415|NCT00540345|ribavirin|ribavirin
623416|NCT00540345|treatment duration|treatment duration
623417|NCT00540332|Oncology|oncology
623418|NCT00540332|KGF|kgf
623419|NCT00540332|HNC|hnc
623420|NCT00540332|head and neck|head and neck
623421|NCT00540332|oral mucositis|oral mucositis
623422|NCT00540332|OM|om
623423|NCT00540332|proteinurea|proteinurea
623424|NCT00540332|palifermin|palifermin
623425|NCT00540332|clinical trial|clinical trial
623426|NCT00540319|Risky behaviors|risky behaviors
623427|NCT00540319|Prenatal care|prenatal care
623428|NCT00540319|Substance use|substance use
623429|NCT00540319|Domestic violence|domestic violence
623430|NCT00540306|breast tissue|breast tissue
623431|NCT00540280|NSCLC|nsclc
623432|NCT00540267|Schizophrenia|schizophrenia
623433|NCT00540267|Alcohol Abuse|alcohol abuse
623434|NCT00540267|Bone Density|bone density
623435|NCT00540254|Chronic Fatigue|chronic fatigue
623436|NCT00540254|Insomnia|insomnia
623437|NCT00540254|Cognitive Behavioral Therapy|cognitive behavioral therapy
623438|NCT00540228|Influenza|influenza
623439|NCT00540228|Influenza Vaccine|influenza vaccine
623440|NCT00540202|Effectiveness|effectiveness
623441|NCT00540202|Oral quinine|oral quinine
623442|NCT00540202|Coartem|coartem
623443|NCT00540202|Uncomplicated malaria|uncomplicated malaria
623444|NCT00540202|Children|children
623445|NCT00540189|appendicitis, perforated, children|appendicitis, perforated, children
623446|NCT00540176|Dichloroacetate|dichloroacetate
623447|NCT00540176|Glioblastoma Multiforme|glioblastoma multiforme
623448|NCT00540176|Glioma|glioma
623449|NCT00540150|Immunotherapy|immunotherapy
623450|NCT00540150|Mite|mite
623451|NCT00540150|Asthma|asthma
623452|NCT00540150|bronchial provocation|bronchial provocation
623453|NCT00540150|SIT|sit
623454|NCT00540150|specific immunotherapy|specific immunotherapy
623455|NCT00540137|Antiretroviral therapy|antiretroviral therapy
623456|NCT00540137|Neurocognitive function|neurocognitive function
623457|NCT00540137|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
623458|NCT00540137|HIV disease|hiv disease
623459|NCT00540137|Treatment Naive|treatment naive
623460|NCT00540111|Soluble fiber|soluble fiber
623461|NCT00540111|HIV/aids|hiv/aids
623462|NCT00540111|Hypertriglyceridemia|hypertriglyceridemia
623463|NCT00540111|Cytokines|cytokines
623464|NCT00540111|Alternative Medicine|alternative medicine
623465|NCT00540111|Complementary Medicine|complementary medicine
623466|NCT00540098|panic disorder|panic disorder
623467|NCT00540098|pharmacotherapy|pharmacotherapy
623468|NCT00540098|non-pharmacological treatment|non-pharmacological treatment
623469|NCT00540098|SSRI|ssri
623470|NCT00540098|paroxetine|paroxetine
623471|NCT00540098|exercise|exercise
623472|NCT00540072|Moderate to Severe Community-Acquired Acute Bacterial Pneumonia Due to S. Pneumoniae|moderate to severe community-acquired acute bacterial pneumonia due to s. pneumoniae
623473|NCT00540059|Prostate carcinoma|prostate carcinoma
623474|NCT00540059|LHRH|lhrh
623475|NCT00540059|Zoladex|zoladex
623476|NCT00540046|IUD|iud
623477|NCT00540046|Second trimester termination|second trimester termination
623478|NCT00540046|Contraception|contraception
623479|NCT00540033|probiotics|probiotics
623480|NCT00540033|necrotizing enterocolitis|necrotizing enterocolitis
623481|NCT00540033|preterm very low birth weight infants (VLBW)|preterm very low birth weight infants (vlbw)
623482|NCT00540020|Brain Injuries|brain injuries
623483|NCT00540020|Cognition|cognition
623484|NCT00540020|Randomized Trials|randomized trials
623485|NCT00540020|Rehabilitation|rehabilitation
623486|NCT00540020|Treatment Outcome|treatment outcome
623487|NCT00540007|Hodgkin Lymphoma|hodgkin lymphoma
623488|NCT00540007|Lenalidomide|lenalidomide
623489|NCT00540007|Anti-neoplastic agents|anti-neoplastic agents
623490|NCT00540007|Thalidomide|thalidomide
623491|NCT00539994|Altabax|altabax
623492|NCT00539994|SB-275833|sb-275833
623493|NCT00539994|retapamulin|retapamulin
623494|NCT00539994|nasal colonization|nasal colonization
623495|NCT00539994|PK|pk
623496|NCT00539994|tolerability|tolerability
623497|NCT00539994|safety|safety
623498|NCT00539994|efficacy|efficacy
623499|NCT00539981|Influenza|influenza
623500|NCT00539955|intimate partner violence|intimate partner violence
623501|NCT00539955|alcohol use|alcohol use
623502|NCT00539955|substance use|substance use
623503|NCT00539942|Randomized Clinical Trials|randomized clinical trials
623504|NCT00539942|Randomized Controlled Trial|randomized controlled trial
623505|NCT00539942|Venous thrombosis|venous thrombosis
623506|NCT00539942|Anticoagulant Drugs|anticoagulant drugs
623507|NCT00539942|Doppler Ultrasound|doppler ultrasound
623508|NCT00539942|Postoperative complications|postoperative complications
623509|NCT00539903|Activity Level|activity level
623510|NCT00539877|Gstric cancer|gstric cancer
623511|NCT00539877|Pritoneal seeding|pritoneal seeding
623512|NCT00539877|Intraperitoneal chemotherapy|intraperitoneal chemotherapy
623513|NCT00539877|Irinotecan|irinotecan
623514|NCT00539864|Influenza|influenza
623515|NCT00539851|Allogenic Stem Cell Transplantation|allogenic stem cell transplantation
623516|NCT00539851|Diabetes Mellitus|diabetes mellitus
623517|NCT00539838|SLE|sle
623518|NCT00539825|Anticholinergic,|anticholinergic,
623519|NCT00539825|Plethysmography|plethysmography
623520|NCT00539825|Muscarinic Receptor Antagonist,|muscarinic receptor antagonist,
623521|NCT00539825|COPD,|copd,
623522|NCT00539825|FTIH,|ftih,
623523|NCT00539812|Intimate partner violence|intimate partner violence
623524|NCT00539812|alcohol use|alcohol use
623525|NCT00539812|substance use|substance use
623526|NCT00539799|systemic lupus erythematosus|systemic lupus erythematosus
623527|NCT00539799|lupus nephritis|lupus nephritis
623528|NCT00539786|Patients with extraesophageal manifestation of gastroesophageal reflux disease|patients with extraesophageal manifestation of gastroesophageal reflux disease
623529|NCT00539760|domain antibody|domain antibody
623530|NCT00539760|Rheumatoid Arthritis,|rheumatoid arthritis,
623531|NCT00539747|Presymptomatic|presymptomatic
623532|NCT00539747|Huntington Disease|huntington disease
623533|NCT00539747|Meaning Making|meaning making
623534|NCT00539747|Genetic Testing|genetic testing
623535|NCT00539747|HD|hd
623536|NCT00539734|age-related macular degeneration (AMD)|age-related macular degeneration (amd)
623537|NCT00539734|choroidal neovascularization membrane(CNVM)|choroidal neovascularization membrane(cnvm)
623538|NCT00539734|ranibizumab|ranibizumab
623539|NCT00539734|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
623540|NCT00539734|electrophysiology|electrophysiology
623541|NCT00539734|electroretinography|electroretinography
623542|NCT00539721|Nausea|nausea
623543|NCT00539721|Vomiting|vomiting
623544|NCT00539708|Non-invasive ventilation|non-invasive ventilation
623545|NCT00539708|Hypercapnic respiratory failure|hypercapnic respiratory failure
623546|NCT00539708|Mechanical ventilation|mechanical ventilation
623547|NCT00539708|Respiratory failure after extubation|respiratory failure after extubation
623548|NCT00539695|Stem Cell transplant|stem cell transplant
623745|NCT00538928|hypercapnia|hypercapnia
623549|NCT00539695|Graft verus host disease|graft verus host disease
623550|NCT00539695|IL-2|il-2
623551|NCT00539695|acute lymphoblastic leukemia|acute lymphoblastic leukemia
623552|NCT00539695|ALL|all
623553|NCT00539695|acute myelogenous leukemia|acute myelogenous leukemia
623554|NCT00539695|AML|aml
623555|NCT00539695|chronic myelogenous leukemia|chronic myelogenous leukemia
623556|NCT00539695|myelodysplastic syndrome|myelodysplastic syndrome
623557|NCT00539695|myeloproliferative disorder|myeloproliferative disorder
623558|NCT00539695|Hodgkin lymphoma|hodgkin lymphoma
623559|NCT00539695|non-Hodgkin lymphoma|non-hodgkin lymphoma
623560|NCT00539695|non-malignant diseases requiring allogeneic HSCT|non-malignant diseases requiring allogeneic hsct
623561|NCT00539656|Cord blood stem cell transplantation|cord blood stem cell transplantation
623562|NCT00539656|Ex vivo expansion|ex vivo expansion
623563|NCT00539656|Alternative donor|alternative donor
623564|NCT00539643|Liver Cancer|liver cancer
623565|NCT00539643|Hepatoma|hepatoma
623566|NCT00539643|07-099|07-099
623567|NCT00539617|metastatic esophageal cancer|metastatic esophageal cancer
623568|NCT00539617|erlotinib|erlotinib
623569|NCT00539617|folfox|folfox
623570|NCT00539617|advanced esophageal cancer|advanced esophageal cancer
623571|NCT00539617|unresectable esophageal cancer|unresectable esophageal cancer
623572|NCT00539604|Comparison study between MDCT and coronary angiography|comparison study between mdct and coronary angiography
623573|NCT00539591|Cutaneous Melanoma|cutaneous melanoma
623574|NCT00539565|biliary atresia|biliary atresia
623575|NCT00539565|Kasai portoenterostomy|kasai portoenterostomy
623576|NCT00539565|corticosteroids|corticosteroids
623577|NCT00539513|obsessive-compulsive disorder|obsessive-compulsive disorder
623578|NCT00539513|OCD|ocd
623579|NCT00539513|glutamate|glutamate
623580|NCT00539513|N-Acetylcysteine|n-acetylcysteine
623581|NCT00539513|augmentation|augmentation
623582|NCT00539500|Neuroblastoma|neuroblastoma
623583|NCT00539500|ClinicMACS|clinicmacs
623584|NCT00539500|CliniMACS|clinimacs
623585|NCT00539500|Stem Cell Transplantation|stem cell transplantation
623586|NCT00539500|Blood And Marrow Transplantation|blood and marrow transplantation
623587|NCT00539500|Pediatric|pediatric
623588|NCT00539500|Solid Tumors|solid tumors
623589|NCT00539500|Carboplatin|carboplatin
623590|NCT00539500|Paraplatin|paraplatin
623591|NCT00539500|Etoposide|etoposide
623592|NCT00539500|VePesid|vepesid
623593|NCT00539500|Melphalan|melphalan
623594|NCT00539500|Alkeran|alkeran
623595|NCT00539500|CD133+ Cells|cd133+ cells
623596|NCT00539474|ROLL trial|roll trial
623597|NCT00539474|Minimally invasive surgery|minimally invasive surgery
623598|NCT00539474|Non palpable breast cancer|non palpable breast cancer
623599|NCT00539435|Diabetes Mellitus|diabetes mellitus
623600|NCT00539435|Pulsatile Intravenous Insulin Therapy|pulsatile intravenous insulin therapy
623601|NCT00539435|Diabetic Cardiac Quality of Life|diabetic cardiac quality of life
623602|NCT00539435|Cardiac Disease|cardiac disease
623603|NCT00539422|breast cancer|breast cancer
623604|NCT00539422|cytochrome 450|cytochrome 450
623605|NCT00539422|CYP2D6*4|cyp2d6*4
623606|NCT00539422|Ferritin|ferritin
623607|NCT00539422|oxidative stress|oxidative stress
623608|NCT00539422|cancer|cancer
623609|NCT00539422|cancer breast|cancer breast
623610|NCT00539409|Diabetes Mellitus|diabetes mellitus
623611|NCT00539409|Pulsatile Intravenous Insulin Therapy|pulsatile intravenous insulin therapy
623612|NCT00539409|Diabetic Quality of Life|diabetic quality of life
623613|NCT00539409|Orthostatic Hypotension|orthostatic hypotension
623614|NCT00539409|Brittle or Labile diabetes|brittle or labile diabetes
623615|NCT00539383|Lung cancer|lung cancer
623616|NCT00539383|Breast cancer|breast cancer
623617|NCT00539383|Melanoma|melanoma
623618|NCT00539383|Hepatocellular carcinoma|hepatocellular carcinoma
623619|NCT00539383|Brain metastases|brain metastases
623620|NCT00539370|Scleritis|scleritis
623621|NCT00539370|Intermediate Uveitis|intermediate uveitis
623622|NCT00539370|Posterior Uveitis|posterior uveitis
623623|NCT00539370|Intraocular Inflammatory Disease|intraocular inflammatory disease
623624|NCT00539370|Data Analysis|data analysis
623625|NCT00539370|Data Collection|data collection
623626|NCT00539370|Sample Analysis|sample analysis
623627|NCT00539357|Cranial Electrostimulation Therapy|cranial electrostimulation therapy
623628|NCT00539344|Glioblastoma multiforme|glioblastoma multiforme
623629|NCT00539344|Anaplastic astrocytoma|anaplastic astrocytoma
623630|NCT00539344|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
623631|NCT00539331|Non-small Cell Lung Cancer|non-small cell lung cancer
623632|NCT00539331|NSCLC|nsclc
623633|NCT00539331|AZD2171|azd2171
623634|NCT00539331|Paclitaxel/Carboplatin|paclitaxel/carboplatin
623635|NCT00539331|Non-small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
623636|NCT00539305|selective androgen receptor modulators (SARMs)|selective androgen receptor modulators (sarms)
623637|NCT00539305|hormone replacement therapy|hormone replacement therapy
623638|NCT00539305|age-associated cognitive decline|age-associated cognitive decline
623639|NCT00539305|testosterone supplementation|testosterone supplementation
623640|NCT00539292|pediatrics|pediatrics
623641|NCT00539292|gastroschisis|gastroschisis
623642|NCT00539292|silastic spring-loaded silo|silastic spring-loaded silo
623643|NCT00539279|Cognitive- Behavior Therapy|cognitive- behavior therapy
623644|NCT00539279|Combat Disorders|combat disorders
623645|NCT00539279|Elderly|elderly
623646|NCT00539279|Geriatrics|geriatrics
623647|NCT00539279|Implosive therapy|implosive therapy
623648|NCT00539279|Neuropsychological Test|neuropsychological test
623649|NCT00539279|Post-traumatic Stress Disorder|post-traumatic stress disorder
623650|NCT00539279|Psychotherapy|psychotherapy
623651|NCT00539279|Randomized Controlled Trial|randomized controlled trial
623652|NCT00539279|Relaxation techniques|relaxation techniques
623653|NCT00539266|Claudication|claudication
623654|NCT00539266|Critical limb ischemia|critical limb ischemia
623655|NCT00539266|Cell therapy|cell therapy
623656|NCT00539266|Bone marrow|bone marrow
623657|NCT00539253|liver cancer|liver cancer
623658|NCT00539253|transarterial chemoembolization|transarterial chemoembolization
623659|NCT00539240|acid reflux|acid reflux
623660|NCT00539240|acid regurgitation|acid regurgitation
623661|NCT00539240|esophagitis|esophagitis
623662|NCT00539240|GERD|gerd
623663|NCT00539240|heartburn|heartburn
623664|NCT00539240|pain|pain
623665|NCT00539240|peptic|peptic
623666|NCT00539227|Breast Cancer|breast cancer
623667|NCT00539227|Nipple-Areolar Complex|nipple-areolar complex
623668|NCT00539227|Mastectomy|mastectomy
623669|NCT00539227|Prophylactic mastectomy|prophylactic mastectomy
623670|NCT00539227|Immediate reconstruction|immediate reconstruction
623671|NCT00539227|Reconstructive surgery|reconstructive surgery
623672|NCT00539227|Questionnaire|questionnaire
623673|NCT00539227|Survey|survey
623674|NCT00539227|NAC|nac
623675|NCT00539201|GSK706769,|gsk706769,
623676|NCT00539201|CCR5 inhibitor,|ccr5 inhibitor,
623677|NCT00539201|HIV|hiv
623678|NCT00539188|Borderline Personality Disorder(BPD)|borderline personality disorder(bpd)
623679|NCT00539188|Dialectical Behavioral Therapy (DBT)|dialectical behavioral therapy (dbt)
623680|NCT00539188|glutamate|glutamate
623681|NCT00539188|N-Acetylcysteine|n-acetylcysteine
623682|NCT00539188|Borderline Personality Disorder with Self-Injurious Behavior|borderline personality disorder with self-injurious behavior
623683|NCT00539175|diabetes mellitus|diabetes mellitus
623684|NCT00539175|neuropathy|neuropathy
623685|NCT00539175|diabetic neuropathy|diabetic neuropathy
623686|NCT00539162|Ovarian Cancer|ovarian cancer
623687|NCT00539162|CA 125 Algorithm|ca 125 algorithm
623688|NCT00539162|Cancer Detection|cancer detection
623689|NCT00539162|Questionnaire|questionnaire
623690|NCT00539162|Survey|survey
623691|NCT00539149|Acute otitis media|acute otitis media
623692|NCT00539149|Otitis media with effusion|otitis media with effusion
623693|NCT00539149|Tympanic membrane perforation|tympanic membrane perforation
623694|NCT00539136|GSK561679,|gsk561679,
623695|NCT00539136|Pharmacokinetic,|pharmacokinetic,
623696|NCT00539136|healthy volunteers,|healthy volunteers,
623697|NCT00539136|Gamma Scintigraphy,|gamma scintigraphy,
623698|NCT00539136|PillCam™,|pillcam™,
623699|NCT00539136|acoustic vest|acoustic vest
623700|NCT00539123|buprenorphine|buprenorphine
623701|NCT00539123|drug counseling|drug counseling
623702|NCT00539123|HIV risk reduction counseling|hiv risk reduction counseling
623703|NCT00539097|pediatrics|pediatrics
623704|NCT00539084|microneedles|microneedles
623705|NCT00539084|microneedle|microneedle
623706|NCT00539084|intradermal|intradermal
623707|NCT00539071|schizophrenia|schizophrenia
623708|NCT00539071|schizoaffective disorder|schizoaffective disorder
623709|NCT00539071|long acting injectable|long acting injectable
623710|NCT00539071|treatment resistant|treatment resistant
623711|NCT00539045|myocardial infarction, thrombus|myocardial infarction, thrombus
623712|NCT00539032|N. meningitidis|n. meningitidis
623713|NCT00539032|Meningitis|meningitis
623714|NCT00539032|Meningococcemia|meningococcemia
623715|NCT00539019|nutrition assessment|nutrition assessment
623716|NCT00539019|pediatric|pediatric
623717|NCT00539006|fluticasone propionate|fluticasone propionate
623718|NCT00539006|seasonal allergic rhinitis|seasonal allergic rhinitis
623719|NCT00539006|fluticasone furoate|fluticasone furoate
623720|NCT00539006|experience|experience
623721|NCT00539006|GW685698X|gw685698x
623722|NCT00539006|preference|preference
623723|NCT00538980|Polycythemia Vera|polycythemia vera
623724|NCT00538980|PV|pv
623725|NCT00538980|P Vera|p vera
623726|NCT00538967|Collagenases|collagenases
623727|NCT00538967|MMP|mmp
623728|NCT00538967|Cathepsins|cathepsins
623729|NCT00538967|Doxycycline|doxycycline
623730|NCT00538967|Aneurysm|aneurysm
623731|NCT00538954|Perioperative|perioperative
623732|NCT00538954|recovery|recovery
623733|NCT00538954|nutrition|nutrition
623734|NCT00538954|enhanced|enhanced
623735|NCT00538954|laxative|laxative
623736|NCT00538941|chocolate,|chocolate,
623737|NCT00538941|heart failure,|heart failure,
623738|NCT00538941|endothelial function,|endothelial function,
623739|NCT00538941|platelet adhesion,|platelet adhesion,
623740|NCT00538941|oxidative stress,|oxidative stress,
623741|NCT00538941|baroreceptor function,|baroreceptor function,
623742|NCT00538928|acute respiratory distress syndrome|acute respiratory distress syndrome
623743|NCT00538928|extracorporeal lung support|extracorporeal lung support
623746|NCT00538928|acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
623747|NCT00538915|immunodeficiency|immunodeficiency
623748|NCT00538915|humoral immunity|humoral immunity
623749|NCT00538915|antibody deficiency|antibody deficiency
623750|NCT00538915|PID|pid
623751|NCT00538915|PIDD|pidd
623752|NCT00538902|Humira, methotrexate|humira, methotrexate
623753|NCT00538889|Adult|adult
623754|NCT00538850|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
623755|NCT00538850|pain|pain
623756|NCT00538850|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
623757|NCT00538850|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
623758|NCT00538850|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
623759|NCT00538850|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
623760|NCT00538850|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
623761|NCT00538850|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
623762|NCT00538850|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
623763|NCT00538850|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
623764|NCT00538850|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
623765|NCT00538850|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
623766|NCT00538850|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
623767|NCT00538850|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
623768|NCT00538850|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
623769|NCT00538850|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
623770|NCT00538850|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
623771|NCT00538850|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
623772|NCT00538850|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
623773|NCT00538850|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
623774|NCT00538850|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
623775|NCT00538850|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
623776|NCT00538850|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
623777|NCT00538850|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
623778|NCT00538850|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
623779|NCT00538850|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
623780|NCT00538850|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
623781|NCT00538850|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
623782|NCT00538850|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
623783|NCT00538850|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
623784|NCT00538850|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
623785|NCT00538850|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
623786|NCT00538850|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
623787|NCT00538850|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
623788|NCT00538850|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
623789|NCT00538850|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
623790|NCT00538850|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
623791|NCT00538850|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
623792|NCT00538850|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
623793|NCT00538850|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
623794|NCT00538850|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
623795|NCT00538850|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
623796|NCT00538850|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
623797|NCT00538850|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
623798|NCT00538850|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
623799|NCT00538850|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
623800|NCT00538850|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
623801|NCT00538850|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
623802|NCT00538850|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
623803|NCT00538850|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
623804|NCT00538850|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
623805|NCT00538850|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
623806|NCT00538850|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
623807|NCT00538850|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
623808|NCT00538850|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
623809|NCT00538850|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
623810|NCT00538850|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
623811|NCT00538850|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
623812|NCT00538850|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
623813|NCT00538850|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
623814|NCT00538850|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
623815|NCT00538850|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
623816|NCT00538850|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
623817|NCT00538850|stage I multiple myeloma|stage i multiple myeloma
623818|NCT00538850|stage II multiple myeloma|stage ii multiple myeloma
623819|NCT00538850|stage III multiple myeloma|stage iii multiple myeloma
623820|NCT00538850|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
623821|NCT00538850|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
623822|NCT00538850|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
623823|NCT00538850|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
623824|NCT00538850|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
623825|NCT00538850|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
623826|NCT00538850|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
623827|NCT00538850|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
623828|NCT00538850|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
623829|NCT00538850|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
623830|NCT00538850|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
623831|NCT00538850|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
623832|NCT00538850|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
623833|NCT00538850|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
623834|NCT00538850|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
623835|NCT00538850|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
623836|NCT00538850|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
623837|NCT00538850|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
623838|NCT00538850|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
623839|NCT00538850|stage I marginal zone lymphoma|stage i marginal zone lymphoma
623840|NCT00538850|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
623841|NCT00538850|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
623842|NCT00538850|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
623843|NCT00538850|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
623844|NCT00538850|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
623845|NCT00538850|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
623846|NCT00538850|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
623847|NCT00538850|stage I mantle cell lymphoma|stage i mantle cell lymphoma
623848|NCT00538850|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
624237|NCT00538850|stage IIB melanoma|stage iib melanoma
623849|NCT00538850|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
623850|NCT00538850|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
623851|NCT00538850|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
623852|NCT00538850|refractory multiple myeloma|refractory multiple myeloma
623853|NCT00538850|anaplastic large cell lymphoma|anaplastic large cell lymphoma
623854|NCT00538850|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
623855|NCT00538850|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
623856|NCT00538850|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
623857|NCT00538850|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
623858|NCT00538850|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
623859|NCT00538850|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
623860|NCT00538850|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
623861|NCT00538850|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
623862|NCT00538850|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
623863|NCT00538850|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
623864|NCT00538850|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
623865|NCT00538850|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
623866|NCT00538850|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
623867|NCT00538850|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
623868|NCT00538850|chronic eosinophilic leukemia|chronic eosinophilic leukemia
623869|NCT00538850|primary myelofibrosis|primary myelofibrosis
623870|NCT00538850|chronic neutrophilic leukemia|chronic neutrophilic leukemia
623871|NCT00538850|essential thrombocythemia|essential thrombocythemia
623872|NCT00538850|polycythemia vera|polycythemia vera
623873|NCT00538850|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
623874|NCT00538850|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
623875|NCT00538850|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
623876|NCT00538850|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
623877|NCT00538850|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
623878|NCT00538850|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
623879|NCT00538850|secondary acute myeloid leukemia|secondary acute myeloid leukemia
623880|NCT00538850|acute undifferentiated leukemia|acute undifferentiated leukemia
623881|NCT00538850|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
623882|NCT00538850|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
623883|NCT00538850|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
623884|NCT00538850|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
623885|NCT00538850|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
623886|NCT00538850|refractory hairy cell leukemia|refractory hairy cell leukemia
623887|NCT00538850|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
623888|NCT00538850|prolymphocytic leukemia|prolymphocytic leukemia
623889|NCT00538850|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
623890|NCT00538850|Waldenström macroglobulinemia|waldenström macroglobulinemia
623891|NCT00538850|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
623892|NCT00538850|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
623893|NCT00538850|splenic marginal zone lymphoma|splenic marginal zone lymphoma
623894|NCT00538850|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
623895|NCT00538850|extramedullary plasmacytoma|extramedullary plasmacytoma
623896|NCT00538850|isolated plasmacytoma of bone|isolated plasmacytoma of bone
623897|NCT00538850|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
623898|NCT00538850|primary systemic amyloidosis|primary systemic amyloidosis
623899|NCT00538850|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
623900|NCT00538850|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
623901|NCT00538850|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
623902|NCT00538850|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
623903|NCT00538850|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
623904|NCT00538850|intraocular lymphoma|intraocular lymphoma
623905|NCT00538850|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
623906|NCT00538850|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
623907|NCT00538850|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
623908|NCT00538850|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
623909|NCT00538850|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
623910|NCT00538850|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
623911|NCT00538850|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
623912|NCT00538850|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
623913|NCT00538850|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
623914|NCT00538850|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
623915|NCT00538850|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
623916|NCT00538850|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
623917|NCT00538850|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
623918|NCT00538850|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
623919|NCT00538850|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
623920|NCT00538850|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
623921|NCT00538850|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
623922|NCT00538850|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
623923|NCT00538850|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
623924|NCT00538850|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
623925|NCT00538850|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
623926|NCT00538850|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
623927|NCT00538850|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
623928|NCT00538850|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
623929|NCT00538850|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
623930|NCT00538850|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
623931|NCT00538850|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
623932|NCT00538850|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
623933|NCT00538850|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
624055|NCT00538850|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
623934|NCT00538850|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
623935|NCT00538850|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
623936|NCT00538850|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
623937|NCT00538850|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
623938|NCT00538850|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
623939|NCT00538850|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
623940|NCT00538850|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
623941|NCT00538850|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
623942|NCT00538850|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
623943|NCT00538850|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
623944|NCT00538850|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
623945|NCT00538850|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
623946|NCT00538850|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
623947|NCT00538850|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
623948|NCT00538850|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
623949|NCT00538850|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
623950|NCT00538850|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
623951|NCT00538850|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
623952|NCT00538850|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
623953|NCT00538850|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
623954|NCT00538850|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
623955|NCT00538850|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
623956|NCT00538850|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
623957|NCT00538850|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
623958|NCT00538850|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
623959|NCT00538850|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
623960|NCT00538850|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
623961|NCT00538850|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
623962|NCT00538850|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
623963|NCT00538850|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
623964|NCT00538850|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
623965|NCT00538850|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
623966|NCT00538850|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
623967|NCT00538850|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
623968|NCT00538850|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
623969|NCT00538850|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
623970|NCT00538850|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
623971|NCT00538850|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
623972|NCT00538850|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
623973|NCT00538850|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
623974|NCT00538850|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
623975|NCT00538850|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
623976|NCT00538850|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
623977|NCT00538850|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
623978|NCT00538850|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
623979|NCT00538850|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
623980|NCT00538850|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
623981|NCT00538850|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
623982|NCT00538850|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
623983|NCT00538850|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
623984|NCT00538850|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
623985|NCT00538850|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
623986|NCT00538850|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
623987|NCT00538850|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
623988|NCT00538850|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
623989|NCT00538850|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
623990|NCT00538850|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
623991|NCT00538850|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
623992|NCT00538850|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
623993|NCT00538850|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
623994|NCT00538850|recurrent salivary gland cancer|recurrent salivary gland cancer
623995|NCT00538850|salivary gland acinic cell tumor|salivary gland acinic cell tumor
623996|NCT00538850|salivary gland adenocarcinoma|salivary gland adenocarcinoma
623997|NCT00538850|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
623998|NCT00538850|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
623999|NCT00538850|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
624000|NCT00538850|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
624001|NCT00538850|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
624002|NCT00538850|stage I salivary gland cancer|stage i salivary gland cancer
624003|NCT00538850|stage II salivary gland cancer|stage ii salivary gland cancer
624004|NCT00538850|stage III salivary gland cancer|stage iii salivary gland cancer
624005|NCT00538850|stage IV salivary gland cancer|stage iv salivary gland cancer
624006|NCT00538850|adult grade I meningioma|adult grade i meningioma
624007|NCT00538850|adult choroid plexus tumor|adult choroid plexus tumor
624008|NCT00538850|adult craniopharyngioma|adult craniopharyngioma
624009|NCT00538850|adult myxopapillary ependymoma|adult myxopapillary ependymoma
624010|NCT00538850|adult diffuse astrocytoma|adult diffuse astrocytoma
624011|NCT00538850|adult pilocytic astrocytoma|adult pilocytic astrocytoma
624012|NCT00538850|adult pineocytoma|adult pineocytoma
624013|NCT00538850|adult ependymoma|adult ependymoma
624014|NCT00538850|adult subependymoma|adult subependymoma
624015|NCT00538850|adult oligodendroglioma|adult oligodendroglioma
624016|NCT00538850|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
624017|NCT00538850|meningeal melanocytoma|meningeal melanocytoma
624018|NCT00538850|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
624019|NCT00538850|adult pineal gland astrocytoma|adult pineal gland astrocytoma
624020|NCT00538850|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
624021|NCT00538850|adult medulloblastoma|adult medulloblastoma
624022|NCT00538850|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
624023|NCT00538850|adult ependymoblastoma|adult ependymoblastoma
624024|NCT00538850|adult anaplastic astrocytoma|adult anaplastic astrocytoma
624025|NCT00538850|adult anaplastic ependymoma|adult anaplastic ependymoma
624026|NCT00538850|adult glioblastoma|adult glioblastoma
624027|NCT00538850|adult gliosarcoma|adult gliosarcoma
624028|NCT00538850|adult giant cell glioblastoma|adult giant cell glioblastoma
624029|NCT00538850|adult grade III meningioma|adult grade iii meningioma
624030|NCT00538850|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
624031|NCT00538850|adult pineoblastoma|adult pineoblastoma
624032|NCT00538850|adult mixed glioma|adult mixed glioma
624033|NCT00538850|recurrent adult brain tumor|recurrent adult brain tumor
624034|NCT00538850|adult anaplastic meningioma|adult anaplastic meningioma
624035|NCT00538850|adult papillary meningioma|adult papillary meningioma
624036|NCT00538850|adult brain stem glioma|adult brain stem glioma
624037|NCT00538850|stage IA cervical cancer|stage ia cervical cancer
624038|NCT00538850|stage IB cervical cancer|stage ib cervical cancer
624039|NCT00538850|stage IIA cervical cancer|stage iia cervical cancer
624040|NCT00538850|stage IIB cervical cancer|stage iib cervical cancer
624041|NCT00538850|stage III cervical cancer|stage iii cervical cancer
624042|NCT00538850|stage IVA cervical cancer|stage iva cervical cancer
624043|NCT00538850|stage IVB cervical cancer|stage ivb cervical cancer
624044|NCT00538850|recurrent cervical cancer|recurrent cervical cancer
624045|NCT00538850|recurrent endometrial carcinoma|recurrent endometrial carcinoma
624046|NCT00538850|stage I endometrial carcinoma|stage i endometrial carcinoma
624047|NCT00538850|stage II endometrial carcinoma|stage ii endometrial carcinoma
624048|NCT00538850|stage III endometrial carcinoma|stage iii endometrial carcinoma
624049|NCT00538850|stage IV endometrial carcinoma|stage iv endometrial carcinoma
624050|NCT00538850|fallopian tube cancer|fallopian tube cancer
624051|NCT00538850|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
624052|NCT00538850|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
624053|NCT00538850|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
624054|NCT00538850|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
624300|NCT00538538|Wet AMD|wet amd
624056|NCT00538850|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
624057|NCT00538850|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
624058|NCT00538850|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
624059|NCT00538850|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
624060|NCT00538850|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
624061|NCT00538850|ovarian sarcoma|ovarian sarcoma
624062|NCT00538850|ovarian stromal cancer|ovarian stromal cancer
624063|NCT00538850|recurrent uterine sarcoma|recurrent uterine sarcoma
624064|NCT00538850|stage I uterine sarcoma|stage i uterine sarcoma
624065|NCT00538850|stage II uterine sarcoma|stage ii uterine sarcoma
624066|NCT00538850|stage III uterine sarcoma|stage iii uterine sarcoma
624067|NCT00538850|stage IV uterine sarcoma|stage iv uterine sarcoma
624068|NCT00538850|recurrent colon cancer|recurrent colon cancer
624069|NCT00538850|stage I colon cancer|stage i colon cancer
624070|NCT00538850|stage II colon cancer|stage ii colon cancer
624071|NCT00538850|stage III colon cancer|stage iii colon cancer
624072|NCT00538850|stage IV colon cancer|stage iv colon cancer
624073|NCT00538850|recurrent bladder cancer|recurrent bladder cancer
624074|NCT00538850|recurrent gallbladder cancer|recurrent gallbladder cancer
624075|NCT00538850|stage I bladder cancer|stage i bladder cancer
624076|NCT00538850|stage II bladder cancer|stage ii bladder cancer
624077|NCT00538850|stage III bladder cancer|stage iii bladder cancer
624078|NCT00538850|stage IV bladder cancer|stage iv bladder cancer
624079|NCT00538850|recurrent gastric cancer|recurrent gastric cancer
624080|NCT00538850|stage I gastric cancer|stage i gastric cancer
624081|NCT00538850|stage II gastric cancer|stage ii gastric cancer
624082|NCT00538850|stage III gastric cancer|stage iii gastric cancer
624083|NCT00538850|stage IV gastric cancer|stage iv gastric cancer
624084|NCT00538850|advanced adult primary liver cancer|advanced adult primary liver cancer
624085|NCT00538850|recurrent small intestine cancer|recurrent small intestine cancer
624086|NCT00538850|localized transitional cell cancer of the renal pelvis and ureter|localized transitional cell cancer of the renal pelvis and ureter
624087|NCT00538850|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
624088|NCT00538850|recurrent renal cell cancer|recurrent renal cell cancer
624089|NCT00538850|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
624090|NCT00538850|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
624091|NCT00538850|stage I renal cell cancer|stage i renal cell cancer
624092|NCT00538850|stage II renal cell cancer|stage ii renal cell cancer
624093|NCT00538850|stage III renal cell cancer|stage iii renal cell cancer
624094|NCT00538850|stage IV renal cell cancer|stage iv renal cell cancer
624095|NCT00538850|distal urethral cancer|distal urethral cancer
624096|NCT00538850|proximal urethral cancer|proximal urethral cancer
624097|NCT00538850|recurrent urethral cancer|recurrent urethral cancer
624098|NCT00538850|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
624099|NCT00538850|stage I adrenocortical carcinoma|stage i adrenocortical carcinoma
624100|NCT00538850|stage II adrenocortical carcinoma|stage ii adrenocortical carcinoma
624101|NCT00538850|stage III adrenocortical carcinoma|stage iii adrenocortical carcinoma
624102|NCT00538850|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
624103|NCT00538850|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
624104|NCT00538850|extragonadal germ cell tumor|extragonadal germ cell tumor
624105|NCT00538850|localized gastrointestinal carcinoid tumor|localized gastrointestinal carcinoid tumor
624106|NCT00538850|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
624107|NCT00538850|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
624108|NCT00538850|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
624109|NCT00538850|gastrinoma|gastrinoma
624110|NCT00538850|insulinoma|insulinoma
624111|NCT00538850|WDHA syndrome|wdha syndrome
624112|NCT00538850|glucagonoma|glucagonoma
624113|NCT00538850|pancreatic polypeptide tumor|pancreatic polypeptide tumor
624114|NCT00538850|somatostatinoma|somatostatinoma
624115|NCT00538850|recurrent islet cell carcinoma|recurrent islet cell carcinoma
624116|NCT00538850|carcinoma of the appendix|carcinoma of the appendix
624117|NCT00538850|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
624118|NCT00538850|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
624119|NCT00538850|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
624120|NCT00538850|localized gallbladder cancer|localized gallbladder cancer
624121|NCT00538850|unresectable gallbladder cancer|unresectable gallbladder cancer
624122|NCT00538850|gastrointestinal stromal tumor|gastrointestinal stromal tumor
624123|NCT00538850|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
624124|NCT00538850|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
624125|NCT00538850|recurrent adult primary liver cancer|recurrent adult primary liver cancer
624126|NCT00538850|stage I pancreatic cancer|stage i pancreatic cancer
624127|NCT00538850|stage II pancreatic cancer|stage ii pancreatic cancer
624128|NCT00538850|stage III pancreatic cancer|stage iii pancreatic cancer
624129|NCT00538850|stage IV pancreatic cancer|stage iv pancreatic cancer
624130|NCT00538850|recurrent pancreatic cancer|recurrent pancreatic cancer
624131|NCT00538850|small intestine adenocarcinoma|small intestine adenocarcinoma
624132|NCT00538850|small intestine leiomyosarcoma|small intestine leiomyosarcoma
624133|NCT00538850|small intestine lymphoma|small intestine lymphoma
624134|NCT00538850|stage I non-small cell lung cancer|stage i non-small cell lung cancer
624135|NCT00538850|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
624136|NCT00538850|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
624137|NCT00538850|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
624138|NCT00538850|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
624139|NCT00538850|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
624140|NCT00538850|pulmonary carcinoid tumor|pulmonary carcinoid tumor
624141|NCT00538850|extensive stage small cell lung cancer|extensive stage small cell lung cancer
624142|NCT00538850|limited stage small cell lung cancer|limited stage small cell lung cancer
624143|NCT00538850|recurrent small cell lung cancer|recurrent small cell lung cancer
624144|NCT00538850|liver metastases|liver metastases
624145|NCT00538850|lung metastases|lung metastases
624146|NCT00538850|primary peritoneal cavity cancer|primary peritoneal cavity cancer
624147|NCT00538850|lung papilloma|lung papilloma
624148|NCT00538850|peripheral primitive neuroectodermal tumor of the kidney|peripheral primitive neuroectodermal tumor of the kidney
624149|NCT00538850|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
624150|NCT00538850|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
624151|NCT00538850|congenital mesoblastic nephroma|congenital mesoblastic nephroma
624152|NCT00538850|stage II breast cancer|stage ii breast cancer
624153|NCT00538850|stage IIIA breast cancer|stage iiia breast cancer
624154|NCT00538850|stage IIIB breast cancer|stage iiib breast cancer
624155|NCT00538850|stage IIIC breast cancer|stage iiic breast cancer
624156|NCT00538850|stage IV breast cancer|stage iv breast cancer
624157|NCT00538850|recurrent breast cancer|recurrent breast cancer
624158|NCT00538850|male breast cancer|male breast cancer
624159|NCT00538850|breast cancer in situ|breast cancer in situ
624160|NCT00538850|localized osteosarcoma|localized osteosarcoma
624161|NCT00538850|metastatic osteosarcoma|metastatic osteosarcoma
624162|NCT00538850|recurrent osteosarcoma|recurrent osteosarcoma
624163|NCT00538850|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
624164|NCT00538850|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
624165|NCT00538850|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
624166|NCT00538850|chondrosarcoma|chondrosarcoma
624167|NCT00538850|malignant giant cell tumor of bone|malignant giant cell tumor of bone
624168|NCT00538850|desmoid tumor|desmoid tumor
624169|NCT00538850|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
624170|NCT00538850|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
624171|NCT00538850|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
624172|NCT00538850|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
624173|NCT00538850|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
624174|NCT00538850|recurrent thymoma and thymic carcinoma|recurrent thymoma and thymic carcinoma
624175|NCT00538850|advanced malignant mesothelioma|advanced malignant mesothelioma
624176|NCT00538850|localized malignant mesothelioma|localized malignant mesothelioma
624177|NCT00538850|recurrent malignant mesothelioma|recurrent malignant mesothelioma
624178|NCT00538850|phosphaturic mesenchymal tumor|phosphaturic mesenchymal tumor
624179|NCT00538850|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
624180|NCT00538850|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
624181|NCT00538850|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
624182|NCT00538850|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
624183|NCT00538850|stage 0 penile cancer|stage 0 penile cancer
624184|NCT00538850|stage I penile cancer|stage i penile cancer
624185|NCT00538850|stage II penile cancer|stage ii penile cancer
624186|NCT00538850|stage III penile cancer|stage iii penile cancer
624187|NCT00538850|stage IV penile cancer|stage iv penile cancer
624188|NCT00538850|recurrent penile cancer|recurrent penile cancer
624189|NCT00538850|stage I prostate cancer|stage i prostate cancer
624190|NCT00538850|stage IIB prostate cancer|stage iib prostate cancer
624191|NCT00538850|stage IIA prostate cancer|stage iia prostate cancer
624192|NCT00538850|stage III prostate cancer|stage iii prostate cancer
624193|NCT00538850|stage IV prostate cancer|stage iv prostate cancer
624194|NCT00538850|recurrent prostate cancer|recurrent prostate cancer
624195|NCT00538850|stage 0 vaginal cancer|stage 0 vaginal cancer
624196|NCT00538850|stage I vaginal cancer|stage i vaginal cancer
624197|NCT00538850|stage II vaginal cancer|stage ii vaginal cancer
624198|NCT00538850|stage III vaginal cancer|stage iii vaginal cancer
624199|NCT00538850|stage IVA vaginal cancer|stage iva vaginal cancer
624200|NCT00538850|stage IVB vaginal cancer|stage ivb vaginal cancer
624201|NCT00538850|recurrent vaginal cancer|recurrent vaginal cancer
624202|NCT00538850|stage 0 vulvar cancer|stage 0 vulvar cancer
624203|NCT00538850|stage I vulvar cancer|stage i vulvar cancer
624204|NCT00538850|stage II vulvar cancer|stage ii vulvar cancer
624205|NCT00538850|stage III vulvar cancer|stage iii vulvar cancer
624301|NCT00538512|Influenza|influenza
624206|NCT00538850|stage IVB vulvar cancer|stage ivb vulvar cancer
624207|NCT00538850|recurrent vulvar cancer|recurrent vulvar cancer
624208|NCT00538850|stage 0 anal cancer|stage 0 anal cancer
624209|NCT00538850|stage I anal cancer|stage i anal cancer
624210|NCT00538850|stage II anal cancer|stage ii anal cancer
624211|NCT00538850|stage IIIA anal cancer|stage iiia anal cancer
624212|NCT00538850|stage IIIB anal cancer|stage iiib anal cancer
624213|NCT00538850|stage IV anal cancer|stage iv anal cancer
624214|NCT00538850|recurrent anal cancer|recurrent anal cancer
624215|NCT00538850|stage 0 rectal cancer|stage 0 rectal cancer
624216|NCT00538850|stage I rectal cancer|stage i rectal cancer
624217|NCT00538850|stage II rectal cancer|stage ii rectal cancer
624218|NCT00538850|stage III rectal cancer|stage iii rectal cancer
624219|NCT00538850|stage IV rectal cancer|stage iv rectal cancer
624220|NCT00538850|recurrent rectal cancer|recurrent rectal cancer
624221|NCT00538850|stage 0 esophageal cancer|stage 0 esophageal cancer
624222|NCT00538850|stage I esophageal cancer|stage i esophageal cancer
624223|NCT00538850|stage II esophageal cancer|stage ii esophageal cancer
624224|NCT00538850|stage III esophageal cancer|stage iii esophageal cancer
624225|NCT00538850|stage IV esophageal cancer|stage iv esophageal cancer
624226|NCT00538850|recurrent esophageal cancer|recurrent esophageal cancer
624227|NCT00538850|stage I thymoma|stage i thymoma
624228|NCT00538850|stage II thymoma|stage ii thymoma
624229|NCT00538850|stage III thymoma|stage iii thymoma
624230|NCT00538850|stage IVA thymoma|stage iva thymoma
624231|NCT00538850|stage IVB thymoma|stage ivb thymoma
624232|NCT00538850|recurrent melanoma|recurrent melanoma
624233|NCT00538850|stage 0 melanoma|stage 0 melanoma
624234|NCT00538850|stage IA melanoma|stage ia melanoma
624235|NCT00538850|stage IB melanoma|stage ib melanoma
624236|NCT00538850|stage IIA melanoma|stage iia melanoma
624238|NCT00538850|stage IIC melanoma|stage iic melanoma
624239|NCT00538850|stage IIIA melanoma|stage iiia melanoma
624240|NCT00538850|stage IIIB melanoma|stage iiib melanoma
624241|NCT00538850|stage IIIC melanoma|stage iiic melanoma
624242|NCT00538850|stage IV melanoma|stage iv melanoma
624243|NCT00538824|myeloma|myeloma
624244|NCT00538824|relapsed or refractory multiple myeloma|relapsed or refractory multiple myeloma
624245|NCT00538798|Pharmacokinetics|pharmacokinetics
624246|NCT00538798|Binding Potential|binding potential
624247|NCT00538798|Glutamate|glutamate
624248|NCT00538798|Positron Emission Tomography|positron emission tomography
624249|NCT00538798|Metabolic Glutamate Receptors|metabolic glutamate receptors
624250|NCT00538798|Healthy Volunteer|healthy volunteer
624251|NCT00538798|HV|hv
624252|NCT00538785|Synagis, motavizumab, palivizumab, children, MEDI-524, RSV, congenital hear disease|synagis, motavizumab, palivizumab, children, medi-524, rsv, congenital hear disease
624253|NCT00538772|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
624254|NCT00538772|Biomarkers|biomarkers
624255|NCT00538772|Biomarkers in patients with Metastatic Renal Cell Carcinoma Who Have Progressed After Sunitinib Therapy|biomarkers in patients with metastatic renal cell carcinoma who have progressed after sunitinib therapy
624256|NCT00538759|Aortic valve stenosis|aortic valve stenosis
624257|NCT00538759|Balloon aortic valvuloplasty|balloon aortic valvuloplasty
624258|NCT00538759|Aortic valve restenosis|aortic valve restenosis
624259|NCT00538733|myeloma|myeloma
624260|NCT00538733|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
624261|NCT00538720|Primary Hyperparathyroidism|primary hyperparathyroidism
624262|NCT00538720|PHPT|phpt
624263|NCT00538720|Parathyroid glands|parathyroid glands
624264|NCT00538720|Vitamin D deficiency|vitamin d deficiency
624265|NCT00538720|Vitamin D|vitamin d
624266|NCT00538720|Ergocalciferol|ergocalciferol
624267|NCT00538707|mental stress|mental stress
624268|NCT00538707|platelet adhesion|platelet adhesion
624269|NCT00538707|platelet function|platelet function
624270|NCT00538707|catecholamines|catecholamines
624271|NCT00538694|Moderate to severe community-acquired acute bacterial pneumonia due to S. Pneumoniae|moderate to severe community-acquired acute bacterial pneumonia due to s. pneumoniae
624272|NCT00538668|Prostate|prostate
624273|NCT00538668|Prostate Cancer|prostate cancer
624274|NCT00538668|Prostate Ca|prostate ca
624275|NCT00538655|amphetamine|amphetamine
624276|NCT00538655|methamphetamine|methamphetamine
624277|NCT00538655|addition|addition
624278|NCT00538655|treatment study|treatment study
624279|NCT00538655|drug use|drug use
624280|NCT00538655|modafinil|modafinil
624281|NCT00538642|schizophrenia|schizophrenia
624282|NCT00538642|antipsychotics|antipsychotics
624283|NCT00538642|diabetes|diabetes
624284|NCT00538642|bipolar disorder|bipolar disorder
624285|NCT00538616|Brain Injury|brain injury
624286|NCT00538590|ologen|ologen
624287|NCT00538590|collagen matrix|collagen matrix
624288|NCT00538590|glaucoma|glaucoma
624289|NCT00538590|trabeculectomy|trabeculectomy
624290|NCT00538590|Mitomycin-C|mitomycin-c
624291|NCT00538577|Necrotizing fasciitis|necrotizing fasciitis
624292|NCT00538564|prolonged, painful erection|prolonged, painful erection
624293|NCT00538564|priapism|priapism
624294|NCT00538564|sickle cell anemia|sickle cell anemia
624295|NCT00538551|HD|hd
624296|NCT00538551|NHL|nhl
624297|NCT00538538|Macular Degeneration|macular degeneration
624298|NCT00538538|AMD|amd
624299|NCT00538538|Hemorrhage|hemorrhage
624302|NCT00538512|Live attenuated influenza vaccine|live attenuated influenza vaccine
624303|NCT00538512|Inactivated influenza vaccine|inactivated influenza vaccine
624304|NCT00538512|Vaccine Efficacy|vaccine efficacy
624305|NCT00538499|pain|pain
624306|NCT00538499|perioperative/postoperative complications|perioperative/postoperative complications
624307|NCT00538486|Hypertension|hypertension
624308|NCT00538486|Abdominal obesity|abdominal obesity
624309|NCT00538486|Treatment|treatment
624310|NCT00538473|GSK Bio's influenza vaccine GSK576389A|gsk bio's influenza vaccine gsk576389a
624311|NCT00538473|Influenza Infection|influenza infection
624312|NCT00538473|Fluarix|fluarix
624313|NCT00538460|tomography|tomography
624314|NCT00538460|coronary artery disease|coronary artery disease
624315|NCT00538460|magnetic resonance imaging|magnetic resonance imaging
624316|NCT00538447|CML|cml
624317|NCT00538434|Eosinophilic Esophagitis|eosinophilic esophagitis
624318|NCT00538434|GERD|gerd
624319|NCT00538434|EE|ee
624320|NCT00538434|Reslizumab|reslizumab
624321|NCT00538434|IL-5|il-5
624322|NCT00538434|Interleukin-5|interleukin-5
624323|NCT00538434|Cinquil|cinquil
624324|NCT00538421|propofol|propofol
624325|NCT00538421|Anaesthesia|anaesthesia
624326|NCT00538421|Sevoflurane|sevoflurane
624327|NCT00538421|Abdominal|abdominal
624328|NCT00538421|Aortic|aortic
624329|NCT00538421|Aneurysm|aneurysm
624330|NCT00538408|Magnetic resonance|magnetic resonance
624331|NCT00538408|whole body|whole body
624332|NCT00538408|angiography|angiography
624333|NCT00538408|vasovist|vasovist
624334|NCT00538408|gadofosveset|gadofosveset
624335|NCT00538408|dotarem|dotarem
624336|NCT00538408|blood pool agent|blood pool agent
624337|NCT00538382|Malaria|malaria
624338|NCT00538382|Pregnancy|pregnancy
624339|NCT00538382|Artesunate|artesunate
624340|NCT00538382|Pharmacokinetics|pharmacokinetics
624341|NCT00538382|Pharmacodynamics|pharmacodynamics
624342|NCT00538382|Democratic Republic of Congo|democratic republic of congo
624343|NCT00538369|Nursing|nursing
624344|NCT00538369|critical care|critical care
624345|NCT00538369|sedation assessment|sedation assessment
624346|NCT00538369|Bispectral index|bispectral index
624347|NCT00538356|Heart failure|heart failure
624348|NCT00538356|Rehospitalization:|rehospitalization:
624349|NCT00538356|Packer composite score|packer composite score
624350|NCT00538356|Home Monitoring|home monitoring
624351|NCT00538356|Cardiac resynchronization therapy|cardiac resynchronization therapy
624352|NCT00538356|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
624353|NCT00538343|brain metastases|brain metastases
624354|NCT00538343|breast cancer|breast cancer
624355|NCT00538317|Acute myocardial infarction,|acute myocardial infarction,
624356|NCT00538317|GPIIbIIIa inhibitors,|gpiibiiia inhibitors,
624357|NCT00538317|primary angioplasty,|primary angioplasty,
624358|NCT00538317|tirofiban|tirofiban
624359|NCT00538291|recurrent colon cancer|recurrent colon cancer
624360|NCT00538291|stage IV colon cancer|stage iv colon cancer
624361|NCT00538291|recurrent rectal cancer|recurrent rectal cancer
624362|NCT00538291|stage IV rectal cancer|stage iv rectal cancer
624363|NCT00538278|AML|aml
624364|NCT00538265|liver transplantation, hepatitis C virus, immunoprophylaxis|liver transplantation, hepatitis c virus, immunoprophylaxis
624365|NCT00538252|drug use, antisocial behavior, early intervention, prevention|drug use, antisocial behavior, early intervention, prevention
624366|NCT00538213|Influenza vaccine GSK576389A|influenza vaccine gsk576389a
624367|NCT00538213|Fluarix|fluarix
624368|NCT00538213|Influenza infection|influenza infection
624369|NCT00538200|Nutrition|nutrition
624370|NCT00538200|COPD|copd
624371|NCT00538161|Acute lung injury|acute lung injury
624372|NCT00538161|cardiac surgery|cardiac surgery
624373|NCT00538161|The incidence of ARDS after elective cardiac surgery is 1-3%|the incidence of ards after elective cardiac surgery is 1-3%
624374|NCT00538161|The impairment of lung function and oxygenation may occur in 20-80% of patients undergoing surgery.|the impairment of lung function and oxygenation may occur in 20-80% of patients undergoing surgery.
624375|NCT00538161|The purpose of this study is to assess the efficacy of low tidal volume ventilation.|the purpose of this study is to assess the efficacy of low tidal volume ventilation.
624376|NCT00538161|Reducing interleukin and cytokine production may prevent or reduce the incidence of acute lung injury.|reducing interleukin and cytokine production may prevent or reduce the incidence of acute lung injury.
624377|NCT00538135|randomised controlled trial|randomised controlled trial
624378|NCT00538135|borderline personality disorder|borderline personality disorder
624379|NCT00538135|cognitive behavioural therapy|cognitive behavioural therapy
624380|NCT00538135|treatment as usual|treatment as usual
624381|NCT00538122|schizophrenia|schizophrenia
624382|NCT00538122|schizoaffective disorder|schizoaffective disorder
624383|NCT00538122|bipolar disorder|bipolar disorder
624384|NCT00538122|antipsychotic drug treatment|antipsychotic drug treatment
624385|NCT00538122|safety|safety
624386|NCT00538122|arrythmias|arrythmias
624387|NCT00538109|CML in Blast Crisis|cml in blast crisis
624388|NCT00538109|Accelerated Phase oe Chronic Phase|accelerated phase oe chronic phase
624389|NCT00538096|B-cell Non-Hodgkin's Lymphoma|b-cell non-hodgkin's lymphoma
624390|NCT00538083|Cocoa|cocoa
624391|NCT00538083|Overweight adults|overweight adults
624590|NCT00537134|Unruptured|unruptured
624392|NCT00538083|Endothelial function|endothelial function
624393|NCT00538083|Blood pressure|blood pressure
624394|NCT00538083|Cardiovascular disease risk|cardiovascular disease risk
624395|NCT00538083|Dark chocolate|dark chocolate
624396|NCT00538083|Sugar|sugar
624397|NCT00538070|Sarcosine|sarcosine
624398|NCT00538070|Glycine|glycine
624399|NCT00538070|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
624400|NCT00538070|Schizophrenia|schizophrenia
624401|NCT00538057|Healthy volunteers|healthy volunteers
624402|NCT00538044|pulmonary hypertension|pulmonary hypertension
624403|NCT00538044|simvastatin|simvastatin
624404|NCT00538044|advanced pulmonary hypertension secondary to congenital heart disease|advanced pulmonary hypertension secondary to congenital heart disease
624405|NCT00538044|advanced pulmonary hypertension secondary to chronic pulmonary embolism|advanced pulmonary hypertension secondary to chronic pulmonary embolism
624406|NCT00538005|recurrent melanoma|recurrent melanoma
624407|NCT00538005|stage IV melanoma|stage iv melanoma
624408|NCT00537992|combined surgery,|combined surgery,
624409|NCT00537992|cataract surgery,|cataract surgery,
624410|NCT00537992|vitrectomy,|vitrectomy,
624411|NCT00537992|blue light-filter iols|blue light-filter iols
624412|NCT00537979|Dialysis|dialysis
624413|NCT00537979|Hyperparathyroidism|hyperparathyroidism
624414|NCT00537979|Zemplar|zemplar
624415|NCT00537966|Primary HIV Infection|primary hiv infection
624416|NCT00537953|Leishmaniasis|leishmaniasis
624417|NCT00537953|Cutaneous leishmaniasis|cutaneous leishmaniasis
624418|NCT00537953|Miltefosine|miltefosine
624419|NCT00537953|Glucantime|glucantime
624420|NCT00537953|Antimony|antimony
624421|NCT00537953|Pentavalent antimonials|pentavalent antimonials
624422|NCT00537953|Combination therapy|combination therapy
624423|NCT00537927|laparoscopic correction|laparoscopic correction
624424|NCT00537927|ventral and incisional hernia|ventral and incisional hernia
624425|NCT00537927|mesh fixation|mesh fixation
624426|NCT00537927|postoperative pain|postoperative pain
624427|NCT00537914|Small for Gestational Age, Omnitrope®/Somatropin, rhGH,SGA|small for gestational age, omnitrope®/somatropin, rhgh,sga
624428|NCT00537901|Colon and Rectum Cancer|colon and rectum cancer
624429|NCT00537862|Kidney Transplant Patients|kidney transplant patients
624430|NCT00537862|Immunosuppresion|immunosuppresion
624431|NCT00537862|Enteric-coated mycophenolate sodium|enteric-coated mycophenolate sodium
624432|NCT00537836|Hot flushes|hot flushes
624433|NCT00537836|Therapy of hot flushes|therapy of hot flushes
624434|NCT00537836|17ß-estradiol (E2)|17ß-estradiol (e2)
624435|NCT00537836|Hormone replacement therapy|hormone replacement therapy
624436|NCT00537823|Colorectal Cancer|colorectal cancer
624437|NCT00537823|Metastasis|metastasis
624438|NCT00537823|Neoadjuvant Therapy|neoadjuvant therapy
624439|NCT00537810|Obesity|obesity
624440|NCT00537810|Binge eating|binge eating
624441|NCT00537810|Sibutramine|sibutramine
624442|NCT00537810|Self-help|self-help
624443|NCT00537810|Primary care|primary care
624444|NCT00537797|Thyroid Neoplasms|thyroid neoplasms
624445|NCT00537797|Positron Emission Tomography|positron emission tomography
624446|NCT00537797|18FDG|18fdg
624447|NCT00537784|platelets tendon ligament|platelets tendon ligament
624448|NCT00537771|Early Breast cancer|early breast cancer
624449|NCT00537771|adjuvant therapy|adjuvant therapy
624450|NCT00537771|hormone receptor|hormone receptor
624451|NCT00537771|hormonal therapy|hormonal therapy
624452|NCT00537771|anastrozole|anastrozole
624453|NCT00537771|tamoxifen|tamoxifen
624454|NCT00537758|binge eating disorder|binge eating disorder
624455|NCT00537758|cognitive behavior therapy|cognitive behavior therapy
624456|NCT00537758|combination therapy|combination therapy
624457|NCT00537758|obesity|obesity
624458|NCT00537758|weight loss|weight loss
624459|NCT00537758|body weight|body weight
624460|NCT00537758|clinical trial|clinical trial
624461|NCT00537758|dietary restriction|dietary restriction
624462|NCT00537758|overeating|overeating
624463|NCT00537758|weight control|weight control
624464|NCT00537732|gastro-oesophageal reflux disease|gastro-oesophageal reflux disease
624465|NCT00537719|healthy|healthy
624466|NCT00537719|pharmacodynamics|pharmacodynamics
624467|NCT00537719|glucagon-like peptide 1|glucagon-like peptide 1
624468|NCT00537719|pharmacokinetics|pharmacokinetics
624469|NCT00537719|scintigraphy|scintigraphy
624470|NCT00537719|radiation|radiation
624471|NCT00537719|albiglutide|albiglutide
624472|NCT00537706|Socioeconomic Determinants|socioeconomic determinants
624473|NCT00537706|Health Status|health status
624474|NCT00537706|Low-income|low-income
624475|NCT00537706|Priority-setting|priority-setting
624476|NCT00537706|Group Discussion|group discussion
624477|NCT00537693|Continuous Renal Replacement Therapy (CRRT)|continuous renal replacement therapy (crrt)
624478|NCT00537693|Sepsis|sepsis
624479|NCT00537693|Convection|convection
624480|NCT00537693|Diffusion|diffusion
624481|NCT00537680|Friedreich's Ataxia|friedreich's ataxia
624482|NCT00537680|Idebenone|idebenone
624483|NCT00537680|ICARS|icars
624484|NCT00537667|IL-1ra|il-1ra
624485|NCT00537667|PEG sTNF-RI|peg stnf-ri
624486|NCT00537667|Synovial biopsy|synovial biopsy
624487|NCT00537667|Inflammation|inflammation
624488|NCT00537667|Bone and Cartilage Destruction|bone and cartilage destruction
624489|NCT00537667|Rheumatoid Arthritis|rheumatoid arthritis
624490|NCT00537654|benign prostatic hyperplasia,|benign prostatic hyperplasia,
624491|NCT00537654|AVODART,|avodart,
624492|NCT00537654|FLOMAX|flomax
624493|NCT00537641|noninvasive ventilation|noninvasive ventilation
624494|NCT00537602|cystic fibrosis|cystic fibrosis
624495|NCT00537602|miglustat|miglustat
624496|NCT00537602|Zavesca|zavesca
624497|NCT00537602|Actelion|actelion
624498|NCT00537602|nasal potential difference|nasal potential difference
624499|NCT00537602|transmembrane conductance regulator (CFTR)|transmembrane conductance regulator (cftr)
624500|NCT00537589|arthrocentesis|arthrocentesis
624501|NCT00537589|ultrasound|ultrasound
624502|NCT00537589|emergency|emergency
624503|NCT00537550|ALL|all
624504|NCT00537550|Adult|adult
624505|NCT00537537|Hepatitis B, Chronic, Hepatitis B e Antigen positive, Adults, Telbivudine, Adefovir|hepatitis b, chronic, hepatitis b e antigen positive, adults, telbivudine, adefovir
624506|NCT00537524|Bird flu|bird flu
624507|NCT00537524|seasonal influenza vaccine|seasonal influenza vaccine
624508|NCT00537524|influenza vaccine|influenza vaccine
624509|NCT00537524|prepandemic vaccine|prepandemic vaccine
624510|NCT00537524|virus strain with the potential to cause pandemic|virus strain with the potential to cause pandemic
624511|NCT00537524|toddlers|toddlers
624512|NCT00537524|children|children
624513|NCT00537524|adolescents|adolescents
624514|NCT00537498|urokinase, diabetes, wound healing, major amputation|urokinase, diabetes, wound healing, major amputation
624515|NCT00537485|SPM 962|spm 962
624516|NCT00537485|rotigotine|rotigotine
624517|NCT00537485|Parkinson's disease|parkinson's disease
624518|NCT00537485|monotherapy|monotherapy
624519|NCT00537472|Bupivacaine|bupivacaine
624520|NCT00537472|spinal anesthesia|spinal anesthesia
624521|NCT00537472|total knee arthroplasty|total knee arthroplasty
624522|NCT00537459|Premature ejaculation (PE) ejaculatory latency time (ELT)|premature ejaculation (pe) ejaculatory latency time (elt)
624523|NCT00537446|noninvasive ventilation|noninvasive ventilation
624524|NCT00537433|Medication errors|medication errors
624525|NCT00537433|Patient nonadherence|patient nonadherence
624526|NCT00537433|Literacy|literacy
624527|NCT00537433|Communication|communication
624528|NCT00537420|weight loss|weight loss
624529|NCT00537420|dieting|dieting
624530|NCT00537407|Hepatitis|hepatitis
624531|NCT00537407|Hepatitis C|hepatitis c
624532|NCT00537394|Treatment Experienced|treatment experienced
624533|NCT00537381|Prostatic neoplasms|prostatic neoplasms
624534|NCT00537381|CNTO 95|cnto 95
624535|NCT00537381|Intetumumab|intetumumab
624536|NCT00537381|Docetaxel|docetaxel
624537|NCT00537381|Prednisone|prednisone
624538|NCT00537368|infusion|infusion
624539|NCT00537368|CNTO 888|cnto 888
624540|NCT00537368|Phase 1|phase 1
624541|NCT00537368|solid tumor|solid tumor
624542|NCT00537368|cancer|cancer
624543|NCT00537355|ragweed|ragweed
624544|NCT00537355|ragweed allergy|ragweed allergy
624545|NCT00537355|allergy|allergy
624546|NCT00537355|allergies|allergies
624547|NCT00537355|allergic|allergic
624548|NCT00537355|seasonal allergic rhinitis|seasonal allergic rhinitis
624549|NCT00537355|allergic rhinitis|allergic rhinitis
624550|NCT00537342|Immunotherapy|immunotherapy
624551|NCT00537342|Allergoid|allergoid
624552|NCT00537342|Depigmented|depigmented
624553|NCT00537342|Polymerized|polymerized
624554|NCT00537342|Allergen-extract|allergen-extract
624555|NCT00537342|Rhinoconjunctivitis|rhinoconjunctivitis
624556|NCT00537290|antiphospholipid syndrome|antiphospholipid syndrome
624557|NCT00537264|health-related quality of life|health-related quality of life
624558|NCT00537264|primary care|primary care
624559|NCT00537264|computer-assisted instruction|computer-assisted instruction
624560|NCT00537238|Epilepsies partial|epilepsies partial
624561|NCT00537238|Partial Seizure Disorder|partial seizure disorder
624562|NCT00537238|Complex Partial Seizure Disorder|complex partial seizure disorder
624563|NCT00537238|Epilepsy|epilepsy
624564|NCT00537225|peripheral arterial disease|peripheral arterial disease
624565|NCT00537225|walking time|walking time
624566|NCT00537225|lifestyle modification|lifestyle modification
624567|NCT00537225|cardiovascular risk reduction|cardiovascular risk reduction
624568|NCT00537225|exercise|exercise
624569|NCT00537225|diet|diet
624570|NCT00537225|claudication|claudication
624571|NCT00537212|Psoriasis|psoriasis
624572|NCT00537212|Weight loss|weight loss
624573|NCT00537212|diet|diet
624574|NCT00537199|Head And Neck|head and neck
624575|NCT00537199|Oropharynx|oropharynx
624576|NCT00537199|Oral Cancer|oral cancer
624577|NCT00537199|OraTest|oratest
624578|NCT00537199|OraTest Dye|oratest dye
624579|NCT00537199|Rinse Staining Procedure|rinse staining procedure
624580|NCT00537199|Visual Examination|visual examination
624581|NCT00537186|Congestive heart failure|congestive heart failure
624582|NCT00537186|Anaemia|anaemia
624583|NCT00537186|Iron oligosaccharide|iron oligosaccharide
624584|NCT00537160|Pediatrics|pediatrics
624585|NCT00537147|Chimeric West Nile Virus|chimeric west nile virus
624586|NCT00537147|West Nile Virus|west nile virus
624587|NCT00537147|Dengue Virus|dengue virus
624588|NCT00537134|Aneurysm|aneurysm
624589|NCT00537134|Brain|brain
624591|NCT00537134|observation|observation
624592|NCT00537134|treatment|treatment
624593|NCT00537134|Endovascular|endovascular
624594|NCT00537121|recurrent gastric cancer|recurrent gastric cancer
624595|NCT00537121|stage IV gastric cancer|stage iv gastric cancer
624596|NCT00537121|recurrent esophageal cancer|recurrent esophageal cancer
624597|NCT00537121|stage IV esophageal cancer|stage iv esophageal cancer
624598|NCT00537121|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
624599|NCT00537121|adenocarcinoma of the stomach|adenocarcinoma of the stomach
624600|NCT00537121|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
624601|NCT00537121|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
624602|NCT00537121|stage III gastric cancer|stage iii gastric cancer
624716|NCT00536783|Open Label|open label
624603|NCT00537121|stage III esophageal cancer|stage iii esophageal cancer
624604|NCT00537121|advanced adult primary liver cancer|advanced adult primary liver cancer
624605|NCT00537121|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
624606|NCT00537121|recurrent adult primary liver cancer|recurrent adult primary liver cancer
624607|NCT00537108|Pregnancy in adolescence|pregnancy in adolescence
624608|NCT00537095|follicular|follicular
624609|NCT00537095|papillary|papillary
624610|NCT00537082|FTY720,|fty720,
624611|NCT00537082|MS|ms
624612|NCT00537043|hypertension,|hypertension,
624613|NCT00537043|carvedilol,|carvedilol,
624614|NCT00537043|repeat-dosing|repeat-dosing
624615|NCT00537004|primary progressive aphasia|primary progressive aphasia
624616|NCT00537004|frontotemporal dementia|frontotemporal dementia
624617|NCT00537004|semantic dementia|semantic dementia
624618|NCT00537004|progressive nonfluent aphasia|progressive nonfluent aphasia
624619|NCT00537004|progressive aphasia|progressive aphasia
624620|NCT00537004|frontotemporal lobar degeneration|frontotemporal lobar degeneration
624621|NCT00536978|Lymphoma|lymphoma
624622|NCT00536978|Leukemia|leukemia
624623|NCT00536978|B-Cell Lymphoid Malignancies|b-cell lymphoid malignancies
624624|NCT00536978|CLL|cll
624625|NCT00536978|Cll/Small Lymphocytic Lymphoma|cll/small lymphocytic lymphoma
624626|NCT00536978|Follicular Lymphoma|follicular lymphoma
624627|NCT00536978|Mantle Cell Lymphoma|mantle cell lymphoma
624628|NCT00536978|Diffuse Large Cell Lymphoma|diffuse large cell lymphoma
624629|NCT00536978|Splenic Lymphoma|splenic lymphoma
624630|NCT00536978|MALT|malt
624631|NCT00536978|Lymphoplasmacytic Lymphoma|lymphoplasmacytic lymphoma
624632|NCT00536978|Burkitt's Lymphoma|burkitt's lymphoma
624633|NCT00536978|ARA-C|ara-c
624634|NCT00536978|BCNU|bcnu
624635|NCT00536978|Campath-1H|campath-1h
624636|NCT00536978|Cytoxan|cytoxan
624637|NCT00536978|Etoposide|etoposide
624638|NCT00536978|Fludarabine|fludarabine
624639|NCT00536978|Melphalan|melphalan
624640|NCT00536978|Rituximab|rituximab
624641|NCT00536978|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
624642|NCT00536978|T-Cell Cell Adback|t-cell cell adback
624643|NCT00536978|Natural Killer (NK) Cell Adback|natural killer (nk) cell adback
624644|NCT00536965|Hyperlipidemia|hyperlipidemia
624645|NCT00536965|Need-to-treat|need-to-treat
624646|NCT00536965|NIS|nis
624647|NCT00536965|Secondary prevention patients with hyperlipidemia and atherosclerosis (coronary heart disease, carotid stenosis, PVD, etc.) and/or diabetes|secondary prevention patients with hyperlipidemia and atherosclerosis (coronary heart disease, carotid stenosis, pvd, etc.) and/or diabetes
624648|NCT00536952|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
624649|NCT00536952|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
624650|NCT00536952|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
624651|NCT00536952|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
624652|NCT00536952|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
624653|NCT00536952|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
624654|NCT00536952|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
624655|NCT00536952|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
624656|NCT00536952|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
624657|NCT00536952|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
624658|NCT00536952|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
624659|NCT00536952|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
624660|NCT00536952|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
624661|NCT00536952|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
624662|NCT00536952|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
624663|NCT00536926|telemedicine|telemedicine
624664|NCT00536926|lung transplantation|lung transplantation
624665|NCT00536926|home spirometry|home spirometry
624666|NCT00536913|Symbicort pMDI|symbicort pmdi
624667|NCT00536913|spacer|spacer
624668|NCT00536913|children|children
624669|NCT00536900|Substance abuse|substance abuse
624670|NCT00536900|Behavior therapy|behavior therapy
624671|NCT00536900|representative payee|representative payee
624672|NCT00536900|cocaine abuse|cocaine abuse
624673|NCT00536900|alcohol abuse|alcohol abuse
624674|NCT00536900|case management|case management
624675|NCT00536900|dual diagnosis|dual diagnosis
624676|NCT00536874|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
624677|NCT00536874|stage IA pancreatic cancer|stage ia pancreatic cancer
624678|NCT00536874|stage IB pancreatic cancer|stage ib pancreatic cancer
624679|NCT00536874|stage IIA pancreatic cancer|stage iia pancreatic cancer
624680|NCT00536874|stage IIB pancreatic cancer|stage iib pancreatic cancer
624681|NCT00536874|stage III pancreatic cancer|stage iii pancreatic cancer
624682|NCT00536861|erlotinib|erlotinib
624683|NCT00536861|cranial radiotherapy|cranial radiotherapy
624684|NCT00536848|Probiotics|probiotics
624685|NCT00536848|HIV|hiv
624686|NCT00536848|AIDS|aids
624687|NCT00536848|Diarrhea|diarrhea
624688|NCT00536848|Lactobacillus rhamnosus GR-1|lactobacillus rhamnosus gr-1
624689|NCT00536848|Lactobacillus reuteri RC-14|lactobacillus reuteri rc-14
624690|NCT00536848|Immune system|immune system
624691|NCT00536848|Infectious Diseases|infectious diseases
624692|NCT00536848|Complementary Therapies|complementary therapies
624693|NCT00536848|Treatment Naive|treatment naive
624694|NCT00536835|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
624695|NCT00536835|Cancer|cancer
624696|NCT00536835|First time in human|first time in human
624697|NCT00536835|PLK1 inhibitor|plk1 inhibitor
624698|NCT00536835|Advanced Solid Tumor|advanced solid tumor
624699|NCT00536835|GSK461364|gsk461364
624700|NCT00536822|rehabilitation|rehabilitation
624701|NCT00536822|pediatrics|pediatrics
624702|NCT00536809|Metastatic Colorectal Cancer|metastatic colorectal cancer
624703|NCT00536809|oxaliplatin|oxaliplatin
624704|NCT00536809|fluoropyrimidines cancers|fluoropyrimidines cancers
624705|NCT00536809|Advanced Colorectal Cancer|advanced colorectal cancer
624706|NCT00536809|capecitabine|capecitabine
624707|NCT00536809|lapatinib|lapatinib
624708|NCT00536796|Hyperlipidemia|hyperlipidemia
624709|NCT00536796|Need-to-treat|need-to-treat
624710|NCT00536796|NIS|nis
624711|NCT00536796|Secondary prevention patients with hyperlipidemia and atherosclerosis (coronary heart disease, carotid stenosis, PVD, etc.) and/or diabetes|secondary prevention patients with hyperlipidemia and atherosclerosis (coronary heart disease, carotid stenosis, pvd, etc.) and/or diabetes
624712|NCT00536783|Psychiatry|psychiatry
624713|NCT00536783|Antipsychotic|antipsychotic
624714|NCT00536783|Psychopharmacology|psychopharmacology
624715|NCT00536783|Clinical Trial|clinical trial
624717|NCT00536783|Schizophrenia|schizophrenia
624718|NCT00536783|Sensory Gating|sensory gating
624719|NCT00536783|Attention|attention
624720|NCT00536783|Memory|memory
624721|NCT00536731|Asthma|asthma
624722|NCT00536731|Symbicort|symbicort
624723|NCT00536718|invasive lobular breast carcinoma with predominant in situ component|invasive lobular breast carcinoma with predominant in situ component
624724|NCT00536718|invasive lobular breast carcinoma|invasive lobular breast carcinoma
624725|NCT00536718|lobular breast carcinoma in situ|lobular breast carcinoma in situ
624726|NCT00536705|asthma|asthma
624727|NCT00536705|child|child
624728|NCT00536705|transforming growth factor beta(TGF-β)|transforming growth factor beta(tgf-β)
624729|NCT00536705|Leukotriene Antagonists(Montelukast)|leukotriene antagonists(montelukast)
624730|NCT00536692|macular edema|macular edema
624731|NCT00536692|DME|dme
624732|NCT00536692|diabetic|diabetic
624733|NCT00536692|mecamylamine|mecamylamine
624734|NCT00536692|Comentis|comentis
624735|NCT00536679|Relative Bioavailability|relative bioavailability
624736|NCT00536679|Randomised|randomised
624737|NCT00536679|GSK163090|gsk163090
624738|NCT00536679|Food Effect|food effect
624739|NCT00536666|Chronic kidney disease|chronic kidney disease
624740|NCT00536666|Aneamia|aneamia
624741|NCT00536666|Iron oligosaccharide|iron oligosaccharide
624742|NCT00536666|Chronic kidney disease patients|chronic kidney disease patients
624743|NCT00536653|prostate cancer|prostate cancer
624744|NCT00536653|bone density|bone density
624745|NCT00536653|osteoporosis|osteoporosis
624746|NCT00536653|androgen antagonists|androgen antagonists
624747|NCT00536640|Non Small Cell Lung Carcinoma (NSCLC Stage III an IV)|non small cell lung carcinoma (nsclc stage iii an iv)
624748|NCT00536627|DNA vaccine|dna vaccine
624749|NCT00536614|pancreatic cancer|pancreatic cancer
624750|NCT00536614|metastatic|metastatic
624751|NCT00536614|EGFR|egfr
624752|NCT00536614|locally advanced pancreatic cancer|locally advanced pancreatic cancer
624753|NCT00536575|Multiple Myeloma|multiple myeloma
624754|NCT00536575|Relapsed|relapsed
624755|NCT00536575|Refractory|refractory
624756|NCT00536575|Sorafenib|sorafenib
624757|NCT00536575|Bortezomib|bortezomib
624758|NCT00536562|Comprehensive Cardiac Rehabilitation|comprehensive cardiac rehabilitation
624759|NCT00536562|Randomized Controlled Trial|randomized controlled trial
624760|NCT00536562|TIA (Transient Ischemic Attack)|tia (transient ischemic attack)
624761|NCT00536562|Mild Non-Disabling Stroke|mild non-disabling stroke
624762|NCT00536562|Vascular Protection|vascular protection
624763|NCT00536549|Glucose monitoring system|glucose monitoring system
624764|NCT00536549|life style intervention|life style intervention
624765|NCT00536536|Childhood|childhood
624766|NCT00536536|Obesity|obesity
624767|NCT00536536|Primary Care|primary care
624768|NCT00536523|constipation, impaction, and bowel obstruction|constipation, impaction, and bowel obstruction
624769|NCT00536523|ovarian epithelial cancer|ovarian epithelial cancer
624770|NCT00536523|peritoneal cavity cancer|peritoneal cavity cancer
624771|NCT00536523|fallopian tube cancer|fallopian tube cancer
624772|NCT00536510|High Cholesterol|high cholesterol
624773|NCT00536510|Excess lipids|excess lipids
624774|NCT00536497|GW842166,|gw842166,
624775|NCT00536497|Healthy volunteers,|healthy volunteers,
624776|NCT00536497|Inflammatory Pain.|inflammatory pain.
624777|NCT00536484|Overactive Bladder|overactive bladder
624778|NCT00536458|localized low grade lymphoma|localized low grade lymphoma
624779|NCT00536458|Chemotherapy|chemotherapy
624780|NCT00536458|Radiotherapy|radiotherapy
624781|NCT00536458|Molecular analyses|molecular analyses
624782|NCT00536458|primary|primary
624783|NCT00536445|NAVA|nava
624784|NCT00536445|Preterm|preterm
624785|NCT00536445|Case study|case study
624786|NCT00536406|Geriatric|geriatric
624787|NCT00536406|Nursing Homes|nursing homes
624788|NCT00536393|diffuse larg cells lymphoma|diffuse larg cells lymphoma
624789|NCT00536393|chemotherapy|chemotherapy
624790|NCT00536393|toxicity|toxicity
624791|NCT00536393|diffuse high grade lymphoma|diffuse high grade lymphoma
624792|NCT00536367|Heart Failure, Congestive|heart failure, congestive
624793|NCT00536367|Mortality Prediction Model|mortality prediction model
624794|NCT00536341|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
624795|NCT00536341|untreated|untreated
624796|NCT00536341|minimally treated|minimally treated
624797|NCT00536341|fludarabine|fludarabine
624798|NCT00536341|rituximab|rituximab
624799|NCT00536341|lenalidomide|lenalidomide
624800|NCT00536328|Reflux Impact Scale (RIS)|reflux impact scale (ris)
624801|NCT00536328|predictive value|predictive value
624802|NCT00536328|treatment success|treatment success
624803|NCT00536328|patient satisfaction|patient satisfaction
624804|NCT00536328|proton pump inhibitor|proton pump inhibitor
624805|NCT00536328|gastro-esophageal reflux disease|gastro-esophageal reflux disease
624806|NCT00536328|PPU|ppu
624807|NCT00536315|COPD|copd
624808|NCT00536302|OA|oa
624809|NCT00536302|Knee arthritis|knee arthritis
624810|NCT00536302|Osteoarthritis|osteoarthritis
624811|NCT00536302|Nutritional supplement|nutritional supplement
624812|NCT00536302|CAM|cam
624813|NCT00536302|MRI|mri
624814|NCT00536289|Blunt needles|blunt needles
624815|NCT00536289|obstetric lacerations|obstetric lacerations
624816|NCT00536289|Needlestick injuries|needlestick injuries
624817|NCT00536289|Needlestick injuries to physicians|needlestick injuries to physicians
624818|NCT00536276|vitamin D|vitamin d
624819|NCT00536250|Pre-Diabetes|pre-diabetes
624820|NCT00536250|Childhood Obesity|childhood obesity
624821|NCT00536250|Metabolic Syndrome|metabolic syndrome
624822|NCT00536250|insulin resistance|insulin resistance
624823|NCT00536250|Impaired Glucose Tolerance|impaired glucose tolerance
624824|NCT00536250|Non Alcoholic Fatty Liver Disease|non alcoholic fatty liver disease
624825|NCT00536250|High Molecular Weight Adiponectin|high molecular weight adiponectin
624826|NCT00536250|Hypoadiponectinemia|hypoadiponectinemia
624827|NCT00536224|Health promotion|health promotion
624828|NCT00536224|Emergency Medical Services|emergency medical services
624829|NCT00536224|Randomized controlled trial|randomized controlled trial
624830|NCT00536224|Chest pain observation unit|chest pain observation unit
624831|NCT00536224|Cardiovascular risk factors|cardiovascular risk factors
624832|NCT00536211|Exercise|exercise
624833|NCT00536211|Physical Activity|physical activity
624834|NCT00536211|Metformin|metformin
624835|NCT00536211|Hyperinsulinemic-Euglycemic Clamp|hyperinsulinemic-euglycemic clamp
624836|NCT00536211|Muscle Biopsy|muscle biopsy
624837|NCT00536211|Fatty Acid Oxidation|fatty acid oxidation
624838|NCT00536211|Peroxisome proliferator-activated receptor gamma|peroxisome proliferator-activated receptor gamma
624839|NCT00536211|Detraining|detraining
624840|NCT00536211|Inactivity|inactivity
624841|NCT00536211|Skeletal muscle|skeletal muscle
624842|NCT00536198|Premenstrual Syndrome|premenstrual syndrome
624843|NCT00536185|ALOX5|alox5
624844|NCT00536185|5-lipoxygenase|5-lipoxygenase
624845|NCT00536185|Heart Disease|heart disease
624846|NCT00536185|Blacks|blacks
624847|NCT00536172|Antidepressant|antidepressant
624848|NCT00536172|Major depression|major depression
624849|NCT00536172|Prevention|prevention
624850|NCT00536172|Head and neck cancer|head and neck cancer
624851|NCT00536159|nurse-community health worker team|nurse-community health worker team
624852|NCT00536159|perinatal depression|perinatal depression
624853|NCT00536159|stress|stress
624854|NCT00536159|Medicaid enhanced prenatal programs|medicaid enhanced prenatal programs
624855|NCT00536146|Glucocorticoid|glucocorticoid
624856|NCT00536146|Steroids|steroids
624857|NCT00536146|Dose-Responsive Curve|dose-responsive curve
624858|NCT00536146|EC50|ec50
624859|NCT00536146|Stress Response|stress response
624860|NCT00536146|Alcoholism|alcoholism
624861|NCT00536133|zinc|zinc
624862|NCT00536133|aute lower respiratory infections|aute lower respiratory infections
624863|NCT00536120|MS|ms
624864|NCT00536120|Multiple sclerosis|multiple sclerosis
624865|NCT00536120|Relapsing forms of Multiple Sclerosis|relapsing forms of multiple sclerosis
624866|NCT00536107|Non-Small Cell Lung Cancer|non-small cell lung cancer
624867|NCT00536107|Locally Advanced or Metastatic NSCL Cancer|locally advanced or metastatic nscl cancer
624868|NCT00536094|Cognitive behavioral therapy|cognitive behavioral therapy
624869|NCT00536094|Youth|youth
624870|NCT00536094|School|school
624871|NCT00536094|African American|african american
624872|NCT00536081|Breast cancer|breast cancer
624873|NCT00536081|Adjuvant|adjuvant
624874|NCT00536081|Advanced|advanced
624875|NCT00536081|Chemotherapy|chemotherapy
624876|NCT00536081|G-CSF|g-csf
624877|NCT00536081|Pegfilgrastim|pegfilgrastim
624878|NCT00536081|Prevention|prevention
624879|NCT00536081|Febrile neutropenia|febrile neutropenia
624880|NCT00536068|platelet|platelet
624881|NCT00536068|aggregation|aggregation
624882|NCT00536068|aspirin|aspirin
624883|NCT00536055|breast cancer|breast cancer
624884|NCT00536055|prostate cancer|prostate cancer
624885|NCT00536055|dyadic coping|dyadic coping
624886|NCT00536042|minocycline|minocycline
624887|NCT00536042|asthma|asthma
624888|NCT00536042|oral steroids|oral steroids
624889|NCT00536042|IgE|ige
624890|NCT00536029|Melanoma|melanoma
624891|NCT00536029|SIAscope|siascope
624892|NCT00536029|pigmented skin lesions|pigmented skin lesions
624893|NCT00536016|AMD|amd
624894|NCT00536016|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
624895|NCT00536003|preterm delivery|preterm delivery
624896|NCT00536003|preterm labor|preterm labor
624897|NCT00536003|perinatal morbidity|perinatal morbidity
624898|NCT00536003|perinatal mortality|perinatal mortality
624899|NCT00535990|Cholecystectomy|cholecystectomy
624900|NCT00535990|Appendectomy|appendectomy
624901|NCT00535990|Esophageal|esophageal
624902|NCT00535990|Surgical|surgical
624903|NCT00535990|Procedures|procedures
624904|NCT00535990|Surgery|surgery
624905|NCT00535990|Gastric|gastric
624906|NCT00535990|bypass|bypass
624907|NCT00535977|Gene expression|gene expression
624908|NCT00535977|Prostate|prostate
624909|NCT00535977|Broccoli|broccoli
624910|NCT00535977|Cancer|cancer
624911|NCT00535977|Men diagnosed with high-grade Prostatic Intraepithelia Neoplasia|men diagnosed with high-grade prostatic intraepithelia neoplasia
624912|NCT00535964|Cigarette Smoking|cigarette smoking
624913|NCT00535964|Tobacco Use|tobacco use
624914|NCT00535964|Adolescents|adolescents
624915|NCT00535964|Anxiety Sensitivity (AS)|anxiety sensitivity (as)
624916|NCT00535951|Non-small cell lung cancer|non-small cell lung cancer
624917|NCT00535951|NSCLC|nsclc
624918|NCT00535951|lung cancer|lung cancer
624919|NCT00535951|pleural mesothelioma|pleural mesothelioma
624920|NCT00535951|malignant|malignant
624921|NCT00535951|advanced stage|advanced stage
624922|NCT00535951|mesothelioma|mesothelioma
624923|NCT00535951|phase I|phase i
624924|NCT00535951|LBH589|lbh589
624925|NCT00535951|dextromethorphan|dextromethorphan
624926|NCT00535951|CYP2D6|cyp2d6
624927|NCT00535951|oral|oral
624928|NCT00535925|type 2 diabetes|type 2 diabetes
624929|NCT00535925|nephropathy|nephropathy
624930|NCT00535925|CV events|cv events
624931|NCT00535912|CLL|cll
624932|NCT00535899|Aortic stenosis|aortic stenosis
624933|NCT00535899|Speckle tracking imaging|speckle tracking imaging
624934|NCT00535899|Low ejection fraction|low ejection fraction
624935|NCT00535899|Aortic valve replacement|aortic valve replacement
624936|NCT00535899|Strain|strain
624937|NCT00535886|Trans Fatty Acids|trans fatty acids
624938|NCT00535886|conjugated linoleic acid|conjugated linoleic acid
624939|NCT00535886|vaccenic acid|vaccenic acid
624940|NCT00535886|High Density Lipoprotein Cholesterol|high density lipoprotein cholesterol
624941|NCT00535886|Low Density Lipoprotein Cholesterol|low density lipoprotein cholesterol
624942|NCT00535886|Beef|beef
624943|NCT00535873|Leukemia|leukemia
624944|NCT00535873|CLL|cll
624945|NCT00535873|chronic lymphocytic leukemia|chronic lymphocytic leukemia
624946|NCT00535873|SLL|sll
624947|NCT00535873|small lymphocytic lymphoma|small lymphocytic lymphoma
624948|NCT00535873|Untreated CLL|untreated cll
624949|NCT00535873|Lenalidomide|lenalidomide
624950|NCT00535873|CC-5013|cc-5013
624951|NCT00535873|Revlimid|revlimid
624952|NCT00535873|Oral|oral
624953|NCT00535860|Osteoporosis|osteoporosis
624954|NCT00535860|Transdermal|transdermal
624955|NCT00535860|hPTH(1-34)|hpth(1-34)
624956|NCT00535847|Genotype 1|genotype 1
624957|NCT00535834|stage I prostate cancer|stage i prostate cancer
624958|NCT00535834|stage II prostate cancer|stage ii prostate cancer
624959|NCT00535834|stage III prostate cancer|stage iii prostate cancer
624960|NCT00535834|adenocarcinoma of the prostate|adenocarcinoma of the prostate
624961|NCT00535821|Emergency Department|emergency department
624962|NCT00535821|Hemodynamic Optimization|hemodynamic optimization
624963|NCT00535821|Esophageal Doppler monitoring|esophageal doppler monitoring
624964|NCT00535821|Early Goal-Directed Therapy|early goal-directed therapy
624965|NCT00535769|topical|topical
624966|NCT00535769|medication adherence|medication adherence
624967|NCT00535769|adherence|adherence
624968|NCT00535769|compliance|compliance
624969|NCT00535769|medication compliance|medication compliance
624970|NCT00535769|sunscreen|sunscreen
624971|NCT00535769|reminder|reminder
624972|NCT00535756|Pancreatic Exocrine Insufficiency After Pancreatic Surgery|pancreatic exocrine insufficiency after pancreatic surgery
624973|NCT00535717|Urethral stricture|urethral stricture
624974|NCT00535717|Ayurvedic treatment|ayurvedic treatment
624975|NCT00535717|mutra marg sankoch|mutra marg sankoch
624976|NCT00535717|uttarbasti|uttarbasti
624977|NCT00535717|Sesame oil|sesame oil
624978|NCT00535717|Honey|honey
624979|NCT00535717|Rock salt|rock salt
624980|NCT00535678|Mammography|mammography
624981|NCT00535678|mammogram|mammogram
624982|NCT00535678|breast|breast
624983|NCT00535678|Abnormal and normal breast tissue|abnormal and normal breast tissue
624984|NCT00535639|Tolerability of ALK Tree Tablet in patients with birch pollen induced allergy|tolerability of alk tree tablet in patients with birch pollen induced allergy
624985|NCT00535600|Bariatric Surgery|bariatric surgery
624986|NCT00535600|Insulin Action|insulin action
624987|NCT00535600|Insulin Secretion|insulin secretion
624988|NCT00535600|Insulin Resistance|insulin resistance
624989|NCT00535600|Gut Hormones|gut hormones
624990|NCT00535600|Obesity|obesity
624991|NCT00535587|Fibromyalgia|fibromyalgia
624992|NCT00535587|Exercise|exercise
624993|NCT00535587|Mestinon|mestinon
624994|NCT00535574|retinoids|retinoids
624995|NCT00535574|bexarotene|bexarotene
624996|NCT00535574|schizophrenia|schizophrenia
624997|NCT00535574|PANSS|panss
624998|NCT00535574|Positive and negative symptoms of schizophrenia|positive and negative symptoms of schizophrenia
624999|NCT00535561|iron deficiency anemia|iron deficiency anemia
625000|NCT00535561|anemia|anemia
625001|NCT00535561|hypothyroidism|hypothyroidism
625002|NCT00535561|subclinical hypothyroidism|subclinical hypothyroidism
625003|NCT00535548|Chronic wounds|chronic wounds
625004|NCT00535548|Pressure sores|pressure sores
625005|NCT00535548|Hematopoietic stem cells|hematopoietic stem cells
625006|NCT00535548|Wound healing|wound healing
625007|NCT00535535|Elevated triglycerides|elevated triglycerides
625008|NCT00535535|Diabetes|diabetes
625009|NCT00535535|Cardiovascular disease|cardiovascular disease
625010|NCT00535522|Pharmacokinetics|pharmacokinetics
625011|NCT00535522|pharmacodynamics|pharmacodynamics
625012|NCT00535522|maximal tolerated dose|maximal tolerated dose
625013|NCT00535483|blood microdialysis|blood microdialysis
625014|NCT00535483|glucose monitoring|glucose monitoring
625015|NCT00535483|glucose control|glucose control
625016|NCT00535483|automated blood sampling|automated blood sampling
625017|NCT00535483|online-sensor|online-sensor
625018|NCT00535483|algorithm|algorithm
625019|NCT00535483|type 1 diabetes|type 1 diabetes
625020|NCT00535457|anxiety|anxiety
625021|NCT00535457|maladaptive behavior|maladaptive behavior
625022|NCT00535457|anesthesia|anesthesia
625023|NCT00535457|Anxiety before anesthesia and maladaptive behavior after anesthesia.|anxiety before anesthesia and maladaptive behavior after anesthesia.
625024|NCT00535444|Hypertension|hypertension
625025|NCT00535444|parish nurse|parish nurse
625026|NCT00535431|Asthma|asthma
625027|NCT00535431|allergy|allergy
625028|NCT00535431|interleukin-4|interleukin-4
625029|NCT00535431|interleukin-13|interleukin-13
625030|NCT00535431|IL-4|il-4
625031|NCT00535431|IL-13|il-13
625032|NCT00535418|Breast cancer|breast cancer
625033|NCT00535418|neoadjuvant treatment|neoadjuvant treatment
625034|NCT00535418|treatment duration|treatment duration
625035|NCT00535418|Primary hormone receptor positive|primary hormone receptor positive
625036|NCT00535418|breast cancer in postmenopausal women|breast cancer in postmenopausal women
625037|NCT00535405|High Cholesterol|high cholesterol
625038|NCT00535392|Epilepsy|epilepsy
625039|NCT00535392|Child|child
625040|NCT00535392|Levetiracetam|levetiracetam
625041|NCT00535392|Keppra®|keppra®
625042|NCT00535392|Infusion|infusion
625043|NCT00535392|Intravenous|intravenous
625044|NCT00535379|glioblastoma multiforme|glioblastoma multiforme
625045|NCT00535379|sunitinib|sunitinib
625046|NCT00535379|recurrent|recurrent
625047|NCT00535379|progressive|progressive
625048|NCT00535353|recurrent colon cancer|recurrent colon cancer
625049|NCT00535353|stage IV colon cancer|stage iv colon cancer
625050|NCT00535353|recurrent rectal cancer|recurrent rectal cancer
625051|NCT00535353|stage IV rectal cancer|stage iv rectal cancer
625052|NCT00535353|stage III rectal cancer|stage iii rectal cancer
625053|NCT00535353|stage III colon cancer|stage iii colon cancer
625054|NCT00535340|Anxiety|anxiety
625055|NCT00535340|Anti-Anxiety Agents|anti-anxiety agents
625056|NCT00535327|Mammography|mammography
625057|NCT00535327|mammogram|mammogram
625058|NCT00535327|breast|breast
625059|NCT00535327|Abnormal and normal breast tissue|abnormal and normal breast tissue
625060|NCT00535314|Melanoma|melanoma
625061|NCT00535301|cystocele|cystocele
625062|NCT00535301|uterine prolapse|uterine prolapse
625063|NCT00535301|urinary incontinence|urinary incontinence
625064|NCT00535275|NSCLC relapse after adjuvant chemotherapy|nsclc relapse after adjuvant chemotherapy
625065|NCT00535262|Bipolar|bipolar
625066|NCT00535262|depression|depression
625067|NCT00535236|Prevention of herpes zoster and HZ-related complications|prevention of herpes zoster and hz-related complications
625068|NCT00535223|Cognitive Behavior Therapy|cognitive behavior therapy
625069|NCT00535223|Group therapy|group therapy
625070|NCT00535223|Posttraumatic Stress Disorder|posttraumatic stress disorder
625071|NCT00535223|Randomized Controlled Trial|randomized controlled trial
625072|NCT00535223|Treatment outcome|treatment outcome
625073|NCT00535223|Veterans|veterans
625074|NCT00535223|War|war
625075|NCT00535210|spinal cord injury|spinal cord injury
625076|NCT00535210|exercise rehabilitation|exercise rehabilitation
625077|NCT00535210|inpatient|inpatient
625078|NCT00535210|RCT|rct
625079|NCT00535210|physical function|physical function
625080|NCT00535184|Mammography|mammography
625081|NCT00535184|mammogram|mammogram
625082|NCT00535184|breast|breast
625083|NCT00535184|Abnormal and normal breast tissue|abnormal and normal breast tissue
625084|NCT00535158|Chronic Kidney disease|chronic kidney disease
625085|NCT00535158|Dialysis|dialysis
625086|NCT00535158|Vitamin D|vitamin d
625087|NCT00535158|Chronic kidney disease is associated with impaired muscle strength, pain and fractures.|chronic kidney disease is associated with impaired muscle strength, pain and fractures.
625088|NCT00535145|antipsychotic|antipsychotic
625089|NCT00535145|paliperidone ER|paliperidone er
625090|NCT00535145|liver disease|liver disease
625091|NCT00535145|Schizophrenia|schizophrenia
625092|NCT00535145|Schizoaffective Disorder|schizoaffective disorder
625093|NCT00535145|Invega|invega
625094|NCT00535132|schizophrenia|schizophrenia
625095|NCT00535132|medication satisfaction, Invega|medication satisfaction, invega
625096|NCT00535106|Ventricular fibrillation|ventricular fibrillation
625097|NCT00535106|Cardiac arrest|cardiac arrest
625098|NCT00535106|Automated external defibrillator|automated external defibrillator
625099|NCT00535106|AED|aed
625100|NCT00535106|Waveform based algorithms|waveform based algorithms
625101|NCT00535106|VF waveform analysis|vf waveform analysis
625102|NCT00535093|Pharyngitis|pharyngitis
625103|NCT00535093|Community infections|community infections
625104|NCT00535093|Rapid Testing|rapid testing
625105|NCT00535093|Group A Streptococcus|group a streptococcus
625106|NCT00535080|actinic|actinic
625107|NCT00535080|keratoses|keratoses
625108|NCT00535080|superficial|superficial
625109|NCT00535080|basal|basal
625110|NCT00535080|carcinomas|carcinomas
625111|NCT00535080|Bowen's|bowen's
625112|NCT00535080|large or multiple superficial Basal Carcinomas|large or multiple superficial basal carcinomas
625113|NCT00535067|Breast Cancer|breast cancer
625114|NCT00535067|Questionnaire|questionnaire
625115|NCT00535067|Survey|survey
625116|NCT00535067|Neuropathic Pain|neuropathic pain
625117|NCT00535067|Cancer Survivors|cancer survivors
625118|NCT00535067|Quality of Life|quality of life
625119|NCT00535067|QOL|qol
625120|NCT00535054|Dry Eye Syndrome|dry eye syndrome
625121|NCT00535041|Pilot trial of pre-operative chemo/RT using Xeloda and external beam RT followed by definite surgery in patients with localized rectal CA|pilot trial of pre-operative chemo/rt using xeloda and external beam rt followed by definite surgery in patients with localized rectal ca
625122|NCT00535028|asthma|asthma
625123|NCT00535028|allergy|allergy
625124|NCT00535028|interleukin-4|interleukin-4
625125|NCT00535028|interleukin-13|interleukin-13
625126|NCT00535028|IL-4|il-4
625127|NCT00535028|IL-13|il-13
625128|NCT00535028|atopic|atopic
625129|NCT00535028|late asthmatic response|late asthmatic response
625130|NCT00535028|inflammation|inflammation
625131|NCT00535002|Cocaine Addiction|cocaine addiction
625132|NCT00535002|Cocaine Dependence|cocaine dependence
625133|NCT00534989|NHL and HD|nhl and hd
625134|NCT00534963|sonohysterography, catheter placement|sonohysterography, catheter placement
625135|NCT00534950|Randomized multicenter study of 5 vs 6 weekly fraction of RT in the treatment of SCC of the head and neck|randomized multicenter study of 5 vs 6 weekly fraction of rt in the treatment of scc of the head and neck
625136|NCT00534937|Venous stasis ulcer|venous stasis ulcer
625137|NCT00534937|Compression pump|compression pump
625138|NCT00534937|Randomized trial|randomized trial
625139|NCT00534937|Flexitouch compression|flexitouch compression
625140|NCT00534924|IR injury|ir injury
625141|NCT00534924|MRI|mri
625142|NCT00534924|Vitamin C|vitamin c
625143|NCT00534924|Postconditioning|postconditioning
625144|NCT00534911|Depression|depression
625145|NCT00534911|Physical Illness|physical illness
625146|NCT00534911|Inflammatory Bowel Disease|inflammatory bowel disease
625147|NCT00534911|Cognitive Behavioral Therapy|cognitive behavioral therapy
625148|NCT00534885|inactivated hepatitis A vaccine|inactivated hepatitis a vaccine
625149|NCT00534885|Healive|healive
625150|NCT00534885|safety|safety
625151|NCT00534885|immunogenicity|immunogenicity
625152|NCT00534885|immune persistence|immune persistence
625153|NCT00534872|4 Parallel cohorts|4 parallel cohorts
625154|NCT00534872|Healthy Female|healthy female
625155|NCT00534872|Healthy Elderly|healthy elderly
625156|NCT00534872|Pharmacokinetic|pharmacokinetic
625157|NCT00534872|Safety and Tolerability|safety and tolerability
625158|NCT00534846|premenstrual syndrome|premenstrual syndrome
625159|NCT00534846|mastalgia|mastalgia
625160|NCT00534846|toremifene|toremifene
625161|NCT00534846|selective estrogen receptor modulators|selective estrogen receptor modulators
625162|NCT00534833|Diphtheria|diphtheria
625163|NCT00534833|Tetanus|tetanus
625164|NCT00534833|Pertussis|pertussis
625165|NCT00534833|Hepatitis B Hansenula (HB)|hepatitis b hansenula (hb)
625166|NCT00534833|Haemophilus influenzae type b|haemophilus influenzae type b
625167|NCT00534820|Cytogenetic Analysis of Bone Marrow Specimen in Non-Hodgkin's Lymphoma or Hodgkin's Disease|cytogenetic analysis of bone marrow specimen in non-hodgkin's lymphoma or hodgkin's disease
625168|NCT00534781|Achilles|achilles
625169|NCT00534781|Tendinosis|tendinosis
625170|NCT00534781|Tendinitis|tendinitis
625171|NCT00534781|Achilles Tendinosis|achilles tendinosis
625172|NCT00534781|Achilles Tendinitis|achilles tendinitis
625173|NCT00534781|Coblation|coblation
625174|NCT00534781|Bipolar Radiofrequency|bipolar radiofrequency
625175|NCT00534781|Surgical Debridement|surgical debridement
625176|NCT00534781|Debridement|debridement
625177|NCT00534781|Heel Pain|heel pain
625178|NCT00534781|Achilles Pain|achilles pain
625179|NCT00534742|Siblings|siblings
625180|NCT00534729|Organ Preservation|organ preservation
625181|NCT00534729|Carboplatin|carboplatin
625182|NCT00534729|Taxol|taxol
625183|NCT00534729|RT|rt
625184|NCT00534729|laryngeal & Hypopharyngeal CA|laryngeal & hypopharyngeal ca
625185|NCT00534729|Locally advanced laryngeal & Hypopharyngeal CA|locally advanced laryngeal & hypopharyngeal ca
625186|NCT00534716|Cannabis|cannabis
625187|NCT00534716|doping|doping
625188|NCT00534716|THC|thc
625189|NCT00534716|GC/MS|gc/ms
625190|NCT00534716|Pharmacokinetics|pharmacokinetics
625191|NCT00534716|Volunteers|volunteers
625192|NCT00534690|Pulmonary disease|pulmonary disease
625193|NCT00534690|Intubation, Intratracheal|intubation, intratracheal
625194|NCT00534690|Positive-pressure ventilation|positive-pressure ventilation
625195|NCT00534677|Variceal bleed|variceal bleed
625196|NCT00534677|Cirrhosis|cirrhosis
625197|NCT00534677|Vasoactive agents|vasoactive agents
625198|NCT00534677|Terlipressin|terlipressin
625199|NCT00534677|Octreotide|octreotide
625200|NCT00534677|Safety & Efficacy|safety & efficacy
625201|NCT00534638|HPV vaccine|hpv vaccine
625202|NCT00534638|Healthy adolescents|healthy adolescents
625203|NCT00534638|Cervical cancer|cervical cancer
625204|NCT00534638|Safety|safety
625205|NCT00534638|Immunogenicity|immunogenicity
625206|NCT00534638|Cervarix|cervarix
625207|NCT00534625|Asthma, exacerbation, pulmonary function|asthma, exacerbation, pulmonary function
625208|NCT00534612|Parotid gland neoplasms|parotid gland neoplasms
625209|NCT00534599|Generalized anxiety disorders|generalized anxiety disorders
625210|NCT00534599|anxiety|anxiety
625211|NCT00534599|adjunct treatment in anxiety|adjunct treatment in anxiety
625212|NCT00534599|anxiety disorder|anxiety disorder
625213|NCT00534599|partial or non-responder in anxiety|partial or non-responder in anxiety
625214|NCT00534586|Pain|pain
625215|NCT00534586|SSEP|ssep
625216|NCT00534586|CHEPS|cheps
625217|NCT00534586|Propofol|propofol
625218|NCT00534586|Sevoflurane|sevoflurane
625219|NCT00534586|S-Ketamine|s-ketamine
625220|NCT00534586|Remifentanil|remifentanil
625221|NCT00534586|Healthy volunteers|healthy volunteers
625222|NCT00534534|Pancreatitis|pancreatitis
625223|NCT00534534|acute|acute
625224|NCT00534534|alcoholic|alcoholic
625225|NCT00534534|recurrence|recurrence
625226|NCT00534534|alcoholism|alcoholism
625227|NCT00534534|treatment|treatment
625228|NCT00534534|Acute alcoholic pancreatitis|acute alcoholic pancreatitis
625229|NCT00534521|overactive bladder|overactive bladder
625230|NCT00534521|posterior tibial nerve stimulation|posterior tibial nerve stimulation
625231|NCT00534508|Skin|skin
625232|NCT00534508|Pharmacokinetics|pharmacokinetics
625233|NCT00534508|Tacrolimus|tacrolimus
625234|NCT00534508|dermatitis, atopic|dermatitis, atopic
625235|NCT00534495|Systemic Juvenile Idiopathic Arthritis|systemic juvenile idiopathic arthritis
625236|NCT00534495|Juvenile Rheumatoid Arthritis|juvenile rheumatoid arthritis
625237|NCT00534495|Systemic Juvenile Rheumatoid Arthritis|systemic juvenile rheumatoid arthritis
625238|NCT00534482|fitness|fitness
625239|NCT00534469|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
625240|NCT00534469|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
625241|NCT00534469|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
625242|NCT00534469|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
625243|NCT00534469|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
625244|NCT00534469|adult acute basophilic leukemia|adult acute basophilic leukemia
625245|NCT00534469|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
625246|NCT00534469|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
625247|NCT00534469|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
625248|NCT00534469|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
625249|NCT00534469|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
625250|NCT00534469|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
625251|NCT00534469|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
625252|NCT00534469|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
625253|NCT00534469|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
625254|NCT00534469|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
625255|NCT00534456|exploratory study|exploratory study
625256|NCT00534456|anemia|anemia
625257|NCT00534456|pharmacogenetics testing|pharmacogenetics testing
625258|NCT00534456|biomarkers|biomarkers
625259|NCT00534456|echocardiography|echocardiography
625260|NCT00534443|peptic ulcer|peptic ulcer
625261|NCT00534443|gastritis|gastritis
625262|NCT00534443|sTREM-1|strem-1
625263|NCT00534443|cytokines|cytokines
625264|NCT00534443|Changes of inflammatory status in gastric mucosa|changes of inflammatory status in gastric mucosa
625265|NCT00534443|sTREM-1 as a disease marker|strem-1 as a disease marker
625266|NCT00534430|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
625267|NCT00534430|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
625268|NCT00534430|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
625269|NCT00534430|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
625270|NCT00534430|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
625271|NCT00534430|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
625272|NCT00534430|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
625273|NCT00534430|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
625274|NCT00534430|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
625275|NCT00534430|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
625276|NCT00534430|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
625277|NCT00534430|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
625278|NCT00534430|refractory anemia with excess blasts|refractory anemia with excess blasts
625279|NCT00534430|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
625280|NCT00534430|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
625281|NCT00534417|Hormone|hormone
625282|NCT00534417|Receptor|receptor
625283|NCT00534417|Positive|positive
625284|NCT00534417|Metastatic|metastatic
625285|NCT00534417|Breast|breast
625286|NCT00534417|Cancer|cancer
625287|NCT00534404|Internet-Assisted Tobacco Treatments|internet-assisted tobacco treatments
625288|NCT00534404|Online Smoking Cessation Programs|online smoking cessation programs
625289|NCT00534404|Nicotine Patches|nicotine patches
625290|NCT00534404|Telephone Counseling|telephone counseling
625291|NCT00534404|Smoking Abstinence|smoking abstinence
625292|NCT00534391|Antibiotics|antibiotics
625293|NCT00534391|hordeolum|hordeolum
625294|NCT00534378|Nerve agent|nerve agent
625295|NCT00534378|Midazolam|midazolam
625296|NCT00534378|Seizures|seizures
625297|NCT00534378|Severe recurrent convulsive seizures induced by nerve agent exposure|severe recurrent convulsive seizures induced by nerve agent exposure
625298|NCT00534365|stress urinary incontinence|stress urinary incontinence
625299|NCT00534365|sling procedures|sling procedures
625300|NCT00534365|tension-free vaginal tape|tension-free vaginal tape
625302|NCT00534352|AIDS|aids
625303|NCT00534352|Immunodeficiency Virus, Human|immunodeficiency virus, human
625304|NCT00534352|PREZISTA|prezista
625305|NCT00534352|darunavir|darunavir
625306|NCT00534352|TMC114|tmc114
625307|NCT00534352|TMC125|tmc125
625308|NCT00534352|Protease Inhibitor|protease inhibitor
625309|NCT00534352|Non-Nucleoside Reverse Transcriptase Inhibitor|non-nucleoside reverse transcriptase inhibitor
625310|NCT00534352|Truvada|truvada
625311|NCT00534352|Treatment Naive|treatment naive
625312|NCT00534300|ICD-pacemaker|icd-pacemaker
625313|NCT00534287|sepsis|sepsis
625314|NCT00534287|antibiotics|antibiotics
625315|NCT00534287|carbapenems|carbapenems
625316|NCT00534287|fluoroquinolones|fluoroquinolones
625317|NCT00534287|Severe sepsis and septic shock|severe sepsis and septic shock
625318|NCT00534274|stage II breast cancer|stage ii breast cancer
625319|NCT00534274|stage IIIA breast cancer|stage iiia breast cancer
625320|NCT00534261|Multiple Sclerosis|multiple sclerosis
625321|NCT00534261|Avonex|avonex
625322|NCT00534261|Interferon beta-1a|interferon beta-1a
625323|NCT00534222|Patients with a manic episode|patients with a manic episode
625426|NCT00533988|Catheter-related infection|catheter-related infection
625427|NCT00533988|Insertion site|insertion site
625324|NCT00534222|Patients diagnosed w/schizophrenia, who start a treatment with an atypical antipsychotic & who are at least scored as moderately ill on the CGI at baseline|patients diagnosed w/schizophrenia, who start a treatment with an atypical antipsychotic & who are at least scored as moderately ill on the cgi at baseline
625325|NCT00534209|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
625326|NCT00534209|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
625327|NCT00534196|recurrent prostate cancer|recurrent prostate cancer
625328|NCT00534196|stage I prostate cancer|stage i prostate cancer
625329|NCT00534196|stage IIB prostate cancer|stage iib prostate cancer
625330|NCT00534196|stage IIA prostate cancer|stage iia prostate cancer
625331|NCT00534196|stage III prostate cancer|stage iii prostate cancer
625332|NCT00534183|Metabolic syndrome|metabolic syndrome
625333|NCT00534183|Obesity|obesity
625334|NCT00534183|Diabetes|diabetes
625335|NCT00534170|Probiotic|probiotic
625336|NCT00534170|Prevention of diarrhoea|prevention of diarrhoea
625337|NCT00534170|Nutritional status|nutritional status
625338|NCT00534157|intracranial pressure|intracranial pressure
625339|NCT00534157|intraocular pressure|intraocular pressure
625340|NCT00534157|tonometry|tonometry
625341|NCT00534118|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
625342|NCT00534118|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
625343|NCT00534118|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
625344|NCT00534118|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
625345|NCT00534118|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
625346|NCT00534118|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
625347|NCT00534118|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
625348|NCT00534118|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
625349|NCT00534118|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
625350|NCT00534118|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
625351|NCT00534118|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
625352|NCT00534118|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
625353|NCT00534118|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
625354|NCT00534118|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
625355|NCT00534118|stage I multiple myeloma|stage i multiple myeloma
625356|NCT00534118|stage II multiple myeloma|stage ii multiple myeloma
625357|NCT00534118|stage III multiple myeloma|stage iii multiple myeloma
625358|NCT00534118|refractory multiple myeloma|refractory multiple myeloma
625359|NCT00534118|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
625360|NCT00534118|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
625361|NCT00534118|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
625362|NCT00534118|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
625363|NCT00534118|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
625364|NCT00534118|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
625365|NCT00534118|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
625366|NCT00534118|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
625367|NCT00534118|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
625368|NCT00534118|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
625369|NCT00534118|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
625370|NCT00534118|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
625371|NCT00534118|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
625372|NCT00534118|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
625373|NCT00534118|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
625374|NCT00534118|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
625375|NCT00534118|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
625376|NCT00534118|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
625377|NCT00534118|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
625378|NCT00534118|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
625379|NCT00534118|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
625380|NCT00534118|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
625381|NCT00534118|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
625382|NCT00534118|secondary acute myeloid leukemia|secondary acute myeloid leukemia
625383|NCT00534118|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
625384|NCT00534118|splenic marginal zone lymphoma|splenic marginal zone lymphoma
625385|NCT00534118|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
625386|NCT00534118|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
625387|NCT00534118|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
625388|NCT00534118|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
625389|NCT00534118|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
625390|NCT00534105|Pregnancy|pregnancy
625391|NCT00534105|Gestational diabetes|gestational diabetes
625392|NCT00534105|Hyperlipidemia|hyperlipidemia
625393|NCT00534092|Lumbar Spinal Stenosis|lumbar spinal stenosis
625394|NCT00534092|X STOP|x stop
625395|NCT00534079|Cystic Fibrosis and chronic rhinosinusitis|cystic fibrosis and chronic rhinosinusitis
625396|NCT00534066|Natriuretic Peptide, Brain|natriuretic peptide, brain
625397|NCT00534053|colon cancer screening|colon cancer screening
625398|NCT00534053|mail reminders|mail reminders
625399|NCT00534053|fecal occult blood test|fecal occult blood test
625400|NCT00534053|compliance|compliance
625401|NCT00534027|NSCLC|nsclc
625402|NCT00534027|Non-Small Cell Lung Cancer|non-small cell lung cancer
625403|NCT00534027|Paclitaxel|paclitaxel
625404|NCT00534027|Carboplatin|carboplatin
625405|NCT00534027|AMG 655|amg 655
625406|NCT00534001|bladder cancer|bladder cancer
625407|NCT00534001|cervical cancer|cervical cancer
625408|NCT00534001|esophageal cancer|esophageal cancer
625409|NCT00534001|gastric cancer|gastric cancer
625410|NCT00534001|renal cell carcinoma|renal cell carcinoma
625411|NCT00534001|adult primary liver cancer|adult primary liver cancer
625412|NCT00534001|non-small cell lung cancer|non-small cell lung cancer
625413|NCT00534001|small cell lung cancer|small cell lung cancer
625414|NCT00534001|pancreatic cancer|pancreatic cancer
625415|NCT00534001|hypopharyngeal cancer|hypopharyngeal cancer
625416|NCT00534001|laryngeal cancer|laryngeal cancer
625417|NCT00534001|lip and oral cavity cancer|lip and oral cavity cancer
625418|NCT00534001|nasopharyngeal cancer|nasopharyngeal cancer
625419|NCT00534001|oropharyngeal cancer|oropharyngeal cancer
625420|NCT00534001|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
625421|NCT00534001|adult acute myeloid leukemia|adult acute myeloid leukemia
625422|NCT00534001|tobacco use disorder|tobacco use disorder
625423|NCT00533988|Central venous catheters|central venous catheters
625424|NCT00533988|Antimicrobial impregnated catheters|antimicrobial impregnated catheters
625425|NCT00533988|Duration of catheter use|duration of catheter use
625428|NCT00533988|Parenteral nutrition|parenteral nutrition
625429|NCT00533988|Critically ill patients (multidisciplinary)|critically ill patients (multidisciplinary)
625430|NCT00533975|Colon Cancer screening|colon cancer screening
625431|NCT00533975|immunofecal occult blood test|immunofecal occult blood test
625432|NCT00533975|colonoscopy|colonoscopy
625433|NCT00533975|diagnostic validity|diagnostic validity
625434|NCT00533962|Glaucoma|glaucoma
625435|NCT00533962|Anecortave Acetate|anecortave acetate
625436|NCT00533962|Intraocular pressure|intraocular pressure
625437|NCT00533962|Advanced glaucoma cases with uncontrolled IOP|advanced glaucoma cases with uncontrolled iop
625438|NCT00533949|radiation toxicity|radiation toxicity
625439|NCT00533949|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
625440|NCT00533949|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
625441|NCT00533936|stage II breast cancer|stage ii breast cancer
625442|NCT00533936|stage IIIA breast cancer|stage iiia breast cancer
625443|NCT00533936|stage IIIB breast cancer|stage iiib breast cancer
625444|NCT00533936|stage IIIC breast cancer|stage iiic breast cancer
625445|NCT00533923|Nonmyeloablative Allogeneic Stem Cell Transplantation|nonmyeloablative allogeneic stem cell transplantation
625446|NCT00533923|mini-transplant|mini-transplant
625447|NCT00533923|AML|aml
625448|NCT00533923|ALL|all
625449|NCT00533923|CML|cml
625450|NCT00533923|CLL|cll
625451|NCT00533923|Myelodysplastic syndrome|myelodysplastic syndrome
625452|NCT00533923|Relapsed non-Hodgkin's or Hodgkin's lymphoma|relapsed non-hodgkin's or hodgkin's lymphoma
625453|NCT00533923|Relapsed multiple myeloma|relapsed multiple myeloma
625454|NCT00533923|Aplastic anemia|aplastic anemia
625455|NCT00533923|Myeloproliferative disorder|myeloproliferative disorder
625456|NCT00533923|GM-CSF|gm-csf
625457|NCT00533923|Cyclosporin|cyclosporin
625458|NCT00533923|Fludarabine (FLUDARA)|fludarabine (fludara)
625459|NCT00533923|Cyclophosphamide|cyclophosphamide
625460|NCT00533923|CAMPATH-1H|campath-1h
625461|NCT00533923|GVHD|gvhd
625462|NCT00533923|CMV|cmv
625463|NCT00533923|AML in first remission, first relapse or subsequent remission|aml in first remission, first relapse or subsequent remission
625464|NCT00533923|ALL in first relapse, second or subsequent remission|all in first relapse, second or subsequent remission
625465|NCT00533923|ALL in first remission, in a high-risk category|all in first remission, in a high-risk category
625466|NCT00533923|Aplastic anemia characterized by ANC< 1000 and/or platelets < 30 without transfusional support|aplastic anemia characterized by anc< 1000 and/or platelets < 30 without transfusional support
625467|NCT00533923|Myeloproliferative disorder (P Vera, CMML, ET)|myeloproliferative disorder (p vera, cmml, et)
625468|NCT00533910|Minimal hepatic encephalopathy|minimal hepatic encephalopathy
625469|NCT00533897|Rheumatoid Arthritis (RA)|rheumatoid arthritis (ra)
625470|NCT00533884|delirium|delirium
625471|NCT00533884|cognitive/functional effects|cognitive/functional effects
625472|NCT00533884|hypopharyngeal cancer|hypopharyngeal cancer
625473|NCT00533884|laryngeal cancer|laryngeal cancer
625474|NCT00533884|lip and oral cavity cancer|lip and oral cavity cancer
625475|NCT00533884|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
625476|NCT00533884|nasopharyngeal cancer|nasopharyngeal cancer
625477|NCT00533884|oropharyngeal cancer|oropharyngeal cancer
625478|NCT00533884|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
625479|NCT00533884|salivary gland cancer|salivary gland cancer
625480|NCT00533884|esophageal cancer|esophageal cancer
625481|NCT00533884|non-small cell lung cancer|non-small cell lung cancer
625482|NCT00533884|small cell lung cancer|small cell lung cancer
625483|NCT00533871|Natriuretic Peptide Brain|natriuretic peptide brain
625484|NCT00533858|Systolic hypertension|systolic hypertension
625485|NCT00533832|depression|depression
625486|NCT00533832|vagus nerve stimulation|vagus nerve stimulation
625487|NCT00533819|Exercise intervention|exercise intervention
625488|NCT00533819|Maths Scores|maths scores
625489|NCT00533819|Blood pressure|blood pressure
625490|NCT00533819|Female school children|female school children
625491|NCT00533819|Body mass index|body mass index
625492|NCT00533806|Cognitive Behavior Therapy|cognitive behavior therapy
625493|NCT00533806|Active Control|active control
625494|NCT00533806|Relaxation Therapy|relaxation therapy
625495|NCT00533806|Young Children|young children
625496|NCT00533793|bone, tibial shaft fracture|bone, tibial shaft fracture
625497|NCT00533767|Hantavirus cardiopulmonary syndrome, Andes virus, Chile|hantavirus cardiopulmonary syndrome, andes virus, chile
625498|NCT00533754|age-related macular degeneration, genetics|age-related macular degeneration, genetics
625499|NCT00533741|Severe Acute Respiratory Syndrome, Coronavirus, vaccine|severe acute respiratory syndrome, coronavirus, vaccine
625500|NCT00533715|Inspiratory Spirometry; Preschool Children; Computer games|inspiratory spirometry; preschool children; computer games
625501|NCT00533715|Health|health
625502|NCT00533702|Phase II|phase ii
625503|NCT00533702|Melanoma|melanoma
625504|NCT00533702|IMC-1121B|imc-1121b
625505|NCT00533702|ImClone|imclone
625506|NCT00533637|Allergic rhinitis|allergic rhinitis
625507|NCT00533637|Nasal spray|nasal spray
625508|NCT00533637|Anti-histamine|anti-histamine
625509|NCT00533637|Tolerability|tolerability
625510|NCT00533624|Gastrointestinal toxicity|gastrointestinal toxicity
625511|NCT00533585|Non-Small Cell Lung Cancer|non-small cell lung cancer
625512|NCT00533585|Lung Cancer|lung cancer
625513|NCT00533585|NSCLC|nsclc
625514|NCT00533585|malignant pleural effusions|malignant pleural effusions
625515|NCT00533585|Sorafenib|sorafenib
625516|NCT00533585|Paclitaxel|paclitaxel
625517|NCT00533585|Taxol|taxol
625518|NCT00533585|Carboplatin|carboplatin
625519|NCT00533585|Paraplatin|paraplatin
625520|NCT00533585|Bevacizumab|bevacizumab
625521|NCT00533585|Avastin|avastin
625522|NCT00533585|BAY 43-9006|bay 43-9006
625523|NCT00533585|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
625524|NCT00533585|rhuMAb-VEGF|rhumab-vegf
625525|NCT00533559|type 2 diabetes|type 2 diabetes
625526|NCT00533559|free fatty acids|free fatty acids
625527|NCT00533559|insulin resistance|insulin resistance
625528|NCT00533559|beta cell lipotoxic effect|beta cell lipotoxic effect
625529|NCT00533546|Acute Ischemic Stroke|acute ischemic stroke
625530|NCT00533533|Docetaxel,Oxaliplatin|docetaxel,oxaliplatin
625531|NCT00533533|Phase I/II study|phase i/ii study
625532|NCT00533533|Advanced gastric cancer|advanced gastric cancer
625533|NCT00533533|First line treatment|first line treatment
625534|NCT00533533|Advanced gastric cancer with measurable disease|advanced gastric cancer with measurable disease
625535|NCT00533507|Pneumococcal vaccine.|pneumococcal vaccine.
625536|NCT00533507|Pneumococcal disease|pneumococcal disease
625537|NCT00533507|Safety|safety
625538|NCT00533507|Immunogenicity|immunogenicity
625539|NCT00533507|Primary vaccination|primary vaccination
625540|NCT00533468|pain|pain
625541|NCT00533468|lumbar puncture|lumbar puncture
625542|NCT00533468|neonates|neonates
625543|NCT00533468|infants|infants
625544|NCT00533468|emergency department|emergency department
625545|NCT00533468|topical anesthesia|topical anesthesia
625546|NCT00533468|LMX4|lmx4
625547|NCT00533455|Antipsychotics, tremor|antipsychotics, tremor
625548|NCT00533442|Rapamycin|rapamycin
625549|NCT00533442|Mycophenolate Mofetil (MMF)|mycophenolate mofetil (mmf)
625550|NCT00533442|Kidney-Pancreas Transplant|kidney-pancreas transplant
625551|NCT00533416|Myelodyplastic Syndrome (MDS)|myelodyplastic syndrome (mds)
625552|NCT00533416|Selective Mitotic Inhibitor|selective mitotic inhibitor
625553|NCT00533416|Targeted Therapy|targeted therapy
625554|NCT00533416|Myelodysplastic Syndrome|myelodysplastic syndrome
625555|NCT00533416|MDS|mds
625556|NCT00533390|efavirenz|efavirenz
625557|NCT00533390|tuberculosis|tuberculosis
625558|NCT00533390|AIDS|aids
625559|NCT00533390|rifampicin|rifampicin
625560|NCT00533390|efficacy|efficacy
625561|NCT00533390|safety|safety
625562|NCT00533390|Treatment Naive|treatment naive
625563|NCT00533338|Breast Cancer|breast cancer
625564|NCT00533338|Cancer Survivors|cancer survivors
625565|NCT00533338|Weight Gain Prevention|weight gain prevention
625566|NCT00533338|Diet|diet
625567|NCT00533338|Exercise|exercise
625568|NCT00533338|Questionnaire|questionnaire
625569|NCT00533338|Survey|survey
625570|NCT00533299|Epigenetics, hydralazine, valproate, ovarian cancer|epigenetics, hydralazine, valproate, ovarian cancer
625571|NCT00533286|physiotherapy|physiotherapy
625572|NCT00533286|Tuebingen concept|tuebingen concept
625573|NCT00533286|benzodiazepines|benzodiazepines
625574|NCT00533286|muscle relaxants|muscle relaxants
625575|NCT00533286|disc herniation|disc herniation
625576|NCT00533260|Patients with a manic episode or patients diagnosed with schizophrenia , patients who are being treated with quetiapine and are on a stable dosing regime|patients with a manic episode or patients diagnosed with schizophrenia , patients who are being treated with quetiapine and are on a stable dosing regime
625577|NCT00533247|Cox-2 Inhibitor|cox-2 inhibitor
625578|NCT00533247|Pre-emptive Pain|pre-emptive pain
625579|NCT00533247|Preoperative Pain|preoperative pain
625580|NCT00533247|Pain Prophylaxis|pain prophylaxis
625581|NCT00533247|Celebrex|celebrex
625582|NCT00533247|Celecoxib|celecoxib
625583|NCT00533234|Elbow fracture|elbow fracture
625584|NCT00533234|Elbow dislocation|elbow dislocation
625585|NCT00533234|Radial head fracture|radial head fracture
625586|NCT00533234|Radial neck fracture|radial neck fracture
625587|NCT00533221|growth hormone|growth hormone
625588|NCT00533221|strength|strength
625589|NCT00533221|Spinal muscular atrophy type II and III|spinal muscular atrophy type ii and iii
625590|NCT00533195|UVA1|uva1
625591|NCT00533195|PUVA|puva
625592|NCT00533195|atopic dermatitis|atopic dermatitis
625593|NCT00533182|Influenza Infection|influenza infection
625594|NCT00533182|Immunocompromised Host|immunocompromised host
625595|NCT00533182|Resistance Mutations|resistance mutations
625596|NCT00533182|Prolonged Infection|prolonged infection
625597|NCT00533169|Neuroblastoma|neuroblastoma
625598|NCT00533169|ZD6474|zd6474
625599|NCT00533169|Zactima|zactima
625600|NCT00533169|Isotretinoin|isotretinoin
625601|NCT00533169|13-Cis Retinoic Acid|13-cis retinoic acid
625602|NCT00533169|Accutane|accutane
625603|NCT00533169|Pediatric Neuroblastoma|pediatric neuroblastoma
625604|NCT00533156|Closure Device|closure device
625605|NCT00533156|Angiography|angiography
625606|NCT00533156|Angioplasty|angioplasty
625607|NCT00533156|Hemostasis|hemostasis
625608|NCT00533156|Heart Catheterization|heart catheterization
625609|NCT00533156|Vascular Closure|vascular closure
625610|NCT00533156|Peripheral Closure|peripheral closure
625611|NCT00533156|Coronary Angiography|coronary angiography
625612|NCT00533143|Solid cancer patient|solid cancer patient
625613|NCT00533143|Non-invasive ventilation|non-invasive ventilation
625614|NCT00533143|Acute Respiratory Failure|acute respiratory failure
625615|NCT00533130|AO|ao
625616|NCT00533130|Pediatric|pediatric
625617|NCT00533130|Classification|classification
625618|NCT00533130|Long Bones|long bones
625619|NCT00533130|fractures|fractures
625620|NCT00533130|bones|bones
625621|NCT00533117|suicide|suicide
625622|NCT00533117|self-mutilation|self-mutilation
625623|NCT00533117|fluoxetine|fluoxetine
625624|NCT00533117|placebo|placebo
625625|NCT00533117|dialectical behavior therapy|dialectical behavior therapy
625626|NCT00533117|supportive therapy|supportive therapy
625627|NCT00533104|Limb ischemia|limb ischemia
625628|NCT00533104|Cell Therapy|cell therapy
625629|NCT00533078|omega3 fatty acid|omega3 fatty acid
625630|NCT00533078|parenteral nutrition|parenteral nutrition
625631|NCT00533078|chemotherapy|chemotherapy
625632|NCT00533078|infection|infection
625633|NCT00533078|neutropenia|neutropenia
625634|NCT00533065|Aging|aging
625635|NCT00533052|Behavioral weight loss|behavioral weight loss
625636|NCT00532974|HIV|hiv
625637|NCT00532974|Human Immunodeficiency Virus|human immunodeficiency virus
625638|NCT00532974|Vaccines|vaccines
625639|NCT00532974|HIV Vaccines|hiv vaccines
625640|NCT00532974|Peptide|peptide
625641|NCT00532974|Peptide Vaccines|peptide vaccines
625642|NCT00532974|HIV 1|hiv 1
625643|NCT00532883|Sickle Cell Disease|sickle cell disease
625644|NCT00532883|Vaso-occlusive Event|vaso-occlusive event
625645|NCT00532883|Painful Crises|painful crises
625646|NCT00532883|Acute Chest Syndrome|acute chest syndrome
625647|NCT00532870|laparoscopy|laparoscopy
625648|NCT00532870|ventral hernia|ventral hernia
625649|NCT00532870|mesh|mesh
625650|NCT00532870|Ventral hernias are the second most common type of abdominal hernias after inguinal hernias.|ventral hernias are the second most common type of abdominal hernias after inguinal hernias.
625651|NCT00532870|The majority of ventral hernias are incisional hernias that develop in 11% to 20% of patients who undergo Laparotomy .|the majority of ventral hernias are incisional hernias that develop in 11% to 20% of patients who undergo laparotomy .
625652|NCT00532870|Surgeons have struggled to reduce the morbidity from incarceration (6% to 15% of cases) and strangulation (2%) of these hernias.|surgeons have struggled to reduce the morbidity from incarceration (6% to 15% of cases) and strangulation (2%) of these hernias.
625653|NCT00532857|Patients with HER2 + stage II/III breast cancer|patients with her2 + stage ii/iii breast cancer
625654|NCT00532844|6R-BH4|6r-bh4
625655|NCT00532844|BH4|bh4
625656|NCT00532844|BH4 deficiency|bh4 deficiency
625657|NCT00532844|sapropterin dihydrochloride|sapropterin dihydrochloride
625658|NCT00532844|endothelial dysfunction|endothelial dysfunction
625659|NCT00532844|NO|no
625660|NCT00532844|Hypertension|hypertension
625661|NCT00532844|Nitric Oxide|nitric oxide
625662|NCT00532844|Vitamin C|vitamin c
625663|NCT00532818|Epigenetic therapy|epigenetic therapy
625664|NCT00532818|Hydralazine|hydralazine
625665|NCT00532818|Valproate|valproate
625666|NCT00532818|Cervical cancer|cervical cancer
625667|NCT00532818|Randomized|randomized
625668|NCT00532818|Phase III|phase iii
625669|NCT00532805|Alpha 1-Antitrypsin Deficiency|alpha 1-antitrypsin deficiency
625670|NCT00532792|Avian|avian
625671|NCT00532792|Pandemic|pandemic
625672|NCT00532792|Influenza|influenza
625673|NCT00532792|A/H5N1|a/h5n1
625674|NCT00532779|Obesity|obesity
625675|NCT00532779|Antiobesity agents|antiobesity agents
625676|NCT00532779|Antiobesity drugs|antiobesity drugs
625677|NCT00532779|Overweight drug therapy|overweight drug therapy
625678|NCT00532779|Obese drug therapy|obese drug therapy
625679|NCT00532779|Weight loss drug effects|weight loss drug effects
625680|NCT00532779|Bupropion administration and dosage|bupropion administration and dosage
625681|NCT00532779|Naltrexone administration and dosage|naltrexone administration and dosage
625682|NCT00532779|Double blind method|double blind method
625683|NCT00532779|Combination drug therapy|combination drug therapy
625684|NCT00532779|Delayed action preparations|delayed action preparations
625685|NCT00532766|Healthy subjects|healthy subjects
625686|NCT00532753|empowerment|empowerment
625687|NCT00532753|health|health
625688|NCT00532753|education|education
625689|NCT00532740|liver metastases|liver metastases
625690|NCT00532740|advanced adult primary liver cancer|advanced adult primary liver cancer
625691|NCT00532727|Breast Cancer|breast cancer
625692|NCT00532727|Triple Negative|triple negative
625693|NCT00532701|Chronic hepatitis C|chronic hepatitis c
625694|NCT00532701|Genotype|genotype
625695|NCT00532701|Interferon|interferon
625696|NCT00532701|Ribavirin|ribavirin
625697|NCT00532701|Genotype 2|genotype 2
625698|NCT00532701|Peginterferon|peginterferon
625699|NCT00532688|acetylcysteine|acetylcysteine
625700|NCT00532688|N-acetylcysteine|n-acetylcysteine
625701|NCT00532688|heart failure|heart failure
625702|NCT00532688|renal failure|renal failure
625703|NCT00532675|Myeloma|myeloma
625704|NCT00532675|Multiple Myeloma|multiple myeloma
625705|NCT00532675|Lenalidomide|lenalidomide
625706|NCT00532675|Revlimid|revlimid
625707|NCT00532675|Dexamethasone|dexamethasone
625708|NCT00532675|LBH589|lbh589
625709|NCT00532675|Combination|combination
625710|NCT00532662|Epidural|epidural
625711|NCT00532662|Intravenous|intravenous
625712|NCT00532662|Ketamine|ketamine
625713|NCT00532662|Analgesia|analgesia
625714|NCT00532662|Caudal|caudal
625715|NCT00532662|Pediatric|pediatric
625716|NCT00532662|Regional|regional
625717|NCT00532662|Local Anesthetics|local anesthetics
625718|NCT00532636|Airway|airway
625719|NCT00532636|Airway obstruction|airway obstruction
625720|NCT00532636|Mouth-to-mask resuscitation|mouth-to-mask resuscitation
625721|NCT00532636|Respiration artificial|respiration artificial
625722|NCT00532636|Ventilation|ventilation
625723|NCT00532636|Ventilation of an unprotected airway|ventilation of an unprotected airway
625724|NCT00532636|Safety and efficiency of mask ventilation|safety and efficiency of mask ventilation
625725|NCT00532636|Avoidance of stomach inflation|avoidance of stomach inflation
625726|NCT00532610|Diabetes,|diabetes,
625727|NCT00532610|ECG,|ecg,
625728|NCT00532610|Healthy Volunteers|healthy volunteers
625729|NCT00532610|GSK189075,|gsk189075,
625730|NCT00532597|Vascular Endothelium-Dependent Relaxation|vascular endothelium-dependent relaxation
625731|NCT00532597|Hemodialysis|hemodialysis
625732|NCT00532597|Hemodiafiltration|hemodiafiltration
625733|NCT00532584|COPD|copd
625734|NCT00532584|inhaled steroids|inhaled steroids
625735|NCT00532584|bronchodilator|bronchodilator
625736|NCT00532584|gene expression|gene expression
625737|NCT00532584|smoker's lungs|smoker's lungs
625738|NCT00532571|CoQ10|coq10
625739|NCT00532571|PSP|psp
625740|NCT00532571|CBD|cbd
625741|NCT00532558|Hyperlipidemia|hyperlipidemia
625742|NCT00532558|Drug Therapy|drug therapy
625743|NCT00532532|Multiple sclerosis|multiple sclerosis
625744|NCT00532493|Combat Trauma|combat trauma
625745|NCT00532493|Post traumatic stress disorder|post traumatic stress disorder
625746|NCT00532493|PTSD|ptsd
625747|NCT00532493|Sleep Disturbance|sleep disturbance
625748|NCT00532493|Trauma-Related Nightmares|trauma-related nightmares
625749|NCT00532480|Depression|depression
625750|NCT00532480|Duloxetine|duloxetine
625751|NCT00532480|fMRI|fmri
625752|NCT00532480|pictures|pictures
625753|NCT00532467|healthy volunteers|healthy volunteers
625754|NCT00532415|Vitrectomy|vitrectomy
625755|NCT00532415|Visualization|visualization
625756|NCT00532402|Monitoring|monitoring
625757|NCT00532402|Breathing Gas|breathing gas
625758|NCT00532402|Propofol|propofol
625759|NCT00532389|Myeloma|myeloma
625760|NCT00532389|Multiple Myeloma|multiple myeloma
625761|NCT00532389|Bortezomib|bortezomib
625762|NCT00532389|LBH589|lbh589
625763|NCT00532389|Combination|combination
625764|NCT00532376|epilepsy|epilepsy
625765|NCT00532376|depression|depression
625766|NCT00532376|fMRI|fmri
625767|NCT00532376|emotion|emotion
625768|NCT00532350|COPD|copd
625769|NCT00532350|pharmacokinetics|pharmacokinetics
625770|NCT00532350|plethysmography|plethysmography
625771|NCT00532350|cycle ergometry|cycle ergometry
625772|NCT00532350|exercise testing|exercise testing
625773|NCT00532350|spirometry|spirometry
625774|NCT00532337|ONO-5334|ono-5334
625775|NCT00532337|osteoporosis|osteoporosis
625776|NCT00532337|osteopenia|osteopenia
625777|NCT00532324|Methicillin resistant Staphylococcus aureus|methicillin resistant staphylococcus aureus
625778|NCT00532324|Staphylococcus aureus|staphylococcus aureus
625779|NCT00532324|Healthy term and near term neonates|healthy term and near term neonates
625780|NCT00532324|Prevention|prevention
625781|NCT00532324|Nasal and Vaginal Colonization rates|nasal and vaginal colonization rates
625782|NCT00532324|Pregnant women|pregnant women
625783|NCT00532311|Hyperlipidemia|hyperlipidemia
625784|NCT00532311|Drug Therapy|drug therapy
625785|NCT00532298|Fluarix|fluarix
625786|NCT00532298|Influenza Infection|influenza infection
625787|NCT00532298|GSK Biologicals' influenza vaccine GSK576389A|gsk biologicals' influenza vaccine gsk576389a
625788|NCT00532259|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
625789|NCT00532259|Transformed Follicular Lymphoma|transformed follicular lymphoma
625790|NCT00532259|Stem cell transplantation|stem cell transplantation
625791|NCT00532259|Relapsed|relapsed
625792|NCT00532259|Refractory|refractory
625793|NCT00532233|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
625794|NCT00532220|osteonecrosis|osteonecrosis
625795|NCT00532220|bone marrow edema|bone marrow edema
625796|NCT00532220|ibandronate|ibandronate
625797|NCT00532220|bisphosphonate|bisphosphonate
625798|NCT00532220|knee|knee
625799|NCT00532194|ovarian cancer|ovarian cancer
625800|NCT00532194|fallopian tube cancer|fallopian tube cancer
625801|NCT00532194|primary serous peritoneal cancer|primary serous peritoneal cancer
625802|NCT00532194|gynaecological carcinoma|gynaecological carcinoma
625803|NCT00532194|randomised controlled trial|randomised controlled trial
625804|NCT00532194|Cediranib|cediranib
625805|NCT00532194|AZD2171|azd2171
625806|NCT00532194|efficacy|efficacy
625807|NCT00532181|Health insurance|health insurance
625808|NCT00532181|Health utilization rates|health utilization rates
625809|NCT00532181|Saving Behavior|saving behavior
625810|NCT00532181|Risk aversion|risk aversion
625811|NCT00532168|advanced HIV-infected patients|advanced hiv-infected patients
625812|NCT00532168|late presenters|late presenters
625813|NCT00532168|antiretroviral therapy|antiretroviral therapy
625814|NCT00532168|immune reconstitution|immune reconstitution
625815|NCT00532168|Treatment Naive|treatment naive
625816|NCT00532155|lung cancer|lung cancer
625817|NCT00532155|angiogenesis inhibitor|angiogenesis inhibitor
625818|NCT00532155|chemotherapy|chemotherapy
625819|NCT00532116|Healthy|healthy
625820|NCT00532116|Elderly|elderly
625821|NCT00532116|Non Elderly|non elderly
625822|NCT00532116|Healthy Volunteers|healthy volunteers
625823|NCT00532103|Suicidal Ideation|suicidal ideation
625824|NCT00532103|Major Depressive Disorder|major depressive disorder
625825|NCT00532103|Suicide Risk|suicide risk
625826|NCT00532103|Antidepressant Medication|antidepressant medication
625827|NCT00532077|renal,|renal,
625828|NCT00532077|pharmacology,|pharmacology,
625829|NCT00532077|Osteoporosis|osteoporosis
625830|NCT00532064|Advanced Cancers|advanced cancers
625831|NCT00532064|Cardiotoxicity Detection|cardiotoxicity detection
625832|NCT00532064|Heart Damage|heart damage
625833|NCT00532064|Troponin 1 Blood Test|troponin 1 blood test
625834|NCT00532064|B-type Natriuretic Peptide Blood Test|b-type natriuretic peptide blood test
625835|NCT00532064|Questionnaire|questionnaire
625836|NCT00532064|Survey|survey
625837|NCT00532064|BNP|bnp
625838|NCT00532051|cataract, lasik, laser refractive surgery|cataract, lasik, laser refractive surgery
625839|NCT00532038|Osteoarthritis|osteoarthritis
625840|NCT00532038|Pain|pain
625841|NCT00532025|Sorafenib|sorafenib
625842|NCT00532025|NSCLC|nsclc
625843|NCT00532025|Adjuvant Treatment|adjuvant treatment
625844|NCT00532025|resected Non-Small Cell Lung Carcinoma|resected non-small cell lung carcinoma
625845|NCT00532012|Rheumatoid Arthritis|rheumatoid arthritis
625846|NCT00532012|RhuDex®|rhudex®
625847|NCT00532012|Meglumine|meglumine
625848|NCT00532012|Oral Bioavailability|oral bioavailability
625849|NCT00531999|Raltegravir|raltegravir
625850|NCT00531999|Euglycaemic clamp|euglycaemic clamp
625851|NCT00531999|healthy volunteer|healthy volunteer
625852|NCT00531986|Monotherapy|monotherapy
625853|NCT00531986|Neuropsychological tests|neuropsychological tests
625854|NCT00531986|HIV viral load in ZNS|hiv viral load in zns
625855|NCT00531986|HIV viral load in genital|hiv viral load in genital
625856|NCT00531986|Lumbar puncture and HIV viral load in ZNS|lumbar puncture and hiv viral load in zns
625857|NCT00531986|Monotherapy and compartment failure (ZNS and genital)|monotherapy and compartment failure (zns and genital)
625858|NCT00531986|ZNS viral load under monotherapy|zns viral load under monotherapy
625859|NCT00531986|Genital viral load under monotherapy|genital viral load under monotherapy
625860|NCT00531986|Neuropsychological tests (HIV Dementia)|neuropsychological tests (hiv dementia)
625861|NCT00531986|Treatment Experienced|treatment experienced
625862|NCT00531973|breast cancer|breast cancer
625863|NCT00531973|echocardiography|echocardiography
625864|NCT00531973|neoplasia|neoplasia
625865|NCT00531947|Mental Health|mental health
625866|NCT00531947|Adolescents|adolescents
625867|NCT00531947|Major Depressive Disorder|major depressive disorder
625868|NCT00531947|Depression|depression
625869|NCT00531947|Adolescent Depression|adolescent depression
625870|NCT00531947|Pediatric Depression|pediatric depression
625871|NCT00531921|Heart Diseases|heart diseases
625872|NCT00531921|Kidney Diseases|kidney diseases
625873|NCT00531921|Liver Diseases|liver diseases
625874|NCT00531921|Liver Failure|liver failure
625875|NCT00531921|Lung Diseases|lung diseases
625876|NCT00531921|Transplant|transplant
625877|NCT00531921|Transplantation, Homologous|transplantation, homologous
625878|NCT00531921|Rejection|rejection
625879|NCT00531921|Kidney Failure|kidney failure
625880|NCT00531908|Growth Hormone|growth hormone
625881|NCT00531908|Epithelial sodium channel|epithelial sodium channel
625882|NCT00531908|Hypertension|hypertension
625883|NCT00531908|A Furosemide|a furosemide
625884|NCT00531908|Nasal Mucosa|nasal mucosa
625885|NCT00531895|major depression|major depression
625886|NCT00531895|chronic headache|chronic headache
625887|NCT00531895|antidepressant|antidepressant
625888|NCT00531895|duloxetine|duloxetine
625889|NCT00531882|healthy volunteers|healthy volunteers
625890|NCT00531882|neutrophil migration|neutrophil migration
625891|NCT00531882|anti inflammatory non-steroidal agent|anti inflammatory non-steroidal agent
625892|NCT00531882|simvastatin|simvastatin
625893|NCT00531882|pioglitazone|pioglitazone
625894|NCT00531869|safewater|safewater
625895|NCT00531869|randomized|randomized
625896|NCT00531856|Kidney Transplant, Carbon Monoxide|kidney transplant, carbon monoxide
625897|NCT00531843|deep vein thrombosis|deep vein thrombosis
625898|NCT00531843|venous thromboembolism|venous thromboembolism
625899|NCT00531843|pulmonary embolism|pulmonary embolism
625900|NCT00531830|children with PDD|children with pdd
625901|NCT00531791|COPD|copd
625902|NCT00531791|exacerbation|exacerbation
625903|NCT00531791|fluticasone|fluticasone
625904|NCT00531791|salmeterol|salmeterol
625905|NCT00531791|steroid|steroid
625906|NCT00531778|Women with increased risk for developing ovarian cancer|women with increased risk for developing ovarian cancer
625907|NCT00531778|early detection|early detection
625908|NCT00531778|biomarker for ovarian cancer|biomarker for ovarian cancer
625909|NCT00531765|contrast-induced-nephropathy,|contrast-induced-nephropathy,
625910|NCT00531765|cardiac cath|cardiac cath
625911|NCT00531765|creatinine|creatinine
625912|NCT00531765|contrast|contrast
625913|NCT00531765|nephropathy|nephropathy
625914|NCT00531739|Surgery|surgery
625915|NCT00531739|Colectomy|colectomy
625916|NCT00531739|Proctocolectomy|proctocolectomy
625917|NCT00531739|Adhesions|adhesions
625918|NCT00531713|hypothyroidism, quality og life, depression|hypothyroidism, quality og life, depression
625919|NCT00531700|influenza|influenza
625920|NCT00531700|risk behaviors|risk behaviors
625921|NCT00531700|immunization|immunization
625922|NCT00531700|knowledge attitudes behaviors|knowledge attitudes behaviors
625923|NCT00531700|personally controlled health record|personally controlled health record
625924|NCT00531700|Indivo|indivo
625925|NCT00531687|relapse|relapse
625926|NCT00531674|Efficacy of public health intervention (nutrition)|efficacy of public health intervention (nutrition)
625927|NCT00531648|Toddlers that having feeding disorders and SPD|toddlers that having feeding disorders and spd
625928|NCT00531635|Mixed hemopoietic chimerism, Fludarabine, TBI, PBSC, immunosuppression, Mycophenolate Mofetil|mixed hemopoietic chimerism, fludarabine, tbi, pbsc, immunosuppression, mycophenolate mofetil
625929|NCT00531622|Depression|depression
625930|NCT00531622|Major Depressive Episode|major depressive episode
625931|NCT00531622|Antidepressant|antidepressant
625932|NCT00531596|Elderly|elderly
625933|NCT00531596|Non Elderly|non elderly
625934|NCT00531596|Healthy Volunteers|healthy volunteers
625935|NCT00531583|AML in 1st & 2nd complete remission w/no HLA matched related donor|aml in 1st & 2nd complete remission w/no hla matched related donor
625936|NCT00531570|Women with ultrasound defined complex pelvic masses|women with ultrasound defined complex pelvic masses
625937|NCT00531557|Darunavir|darunavir
625938|NCT00531557|Euglycaemic clamp|euglycaemic clamp
625939|NCT00531557|HIV|hiv
625940|NCT00531557|Treatment Experienced|treatment experienced
625941|NCT00531531|pulmonary infection|pulmonary infection
625942|NCT00531531|transmission|transmission
625943|NCT00531531|P.Aeruginosa|p.aeruginosa
625944|NCT00531531|surfaces|surfaces
625945|NCT00531518|Schizophrenia|schizophrenia
625946|NCT00531518|Bipolar disorder|bipolar disorder
625947|NCT00531518|Psychosis|psychosis
625948|NCT00531518|Prodromal psychosis|prodromal psychosis
625949|NCT00531518|Family psychoeducation|family psychoeducation
625950|NCT00531518|Supported education|supported education
625951|NCT00531518|Supported employment|supported employment
625952|NCT00531518|Ulra-high-risk for psychosis|ulra-high-risk for psychosis
625953|NCT00531518|Major depression|major depression
625954|NCT00531518|Bipolar disorder, with psychotic features|bipolar disorder, with psychotic features
625955|NCT00531518|Major depression, with psychotic features|major depression, with psychotic features
625956|NCT00531518|Attenuated, prodromal psychotic symptoms|attenuated, prodromal psychotic symptoms
625957|NCT00531505|Obesity|obesity
625958|NCT00531492|Maternal and child health|maternal and child health
625959|NCT00531492|Developing country|developing country
625960|NCT00531492|Skin to skin care|skin to skin care
625961|NCT00531492|Newly born low birth weight infants and their mothers|newly born low birth weight infants and their mothers
625962|NCT00531492|(Delivery at University Hospital Center, Mahajanga, Madagascar)|(delivery at university hospital center, mahajanga, madagascar)
625963|NCT00531466|Spinal cord injury|spinal cord injury
625964|NCT00531440|Renal transplantation, everolimus, Immunosuppressants|renal transplantation, everolimus, immunosuppressants
625965|NCT00531427|Chronic pain,|chronic pain,
625966|NCT00531427|OA of the knee,|oa of the knee,
625967|NCT00531427|opioid,|opioid,
625968|NCT00531427|transdermal|transdermal
625969|NCT00531414|Asthmatic|asthmatic
625970|NCT00531414|healthy|healthy
625971|NCT00531401|Non-Small-Cell Lung|non-small-cell lung
625972|NCT00531362|Atherosclerosis|atherosclerosis
625973|NCT00531362|Aspirin|aspirin
625974|NCT00531362|Resistance,|resistance,
625975|NCT00531362|Acute coronary syndromes|acute coronary syndromes
625976|NCT00531349|Endometrial Cancer|endometrial cancer
625977|NCT00531349|Anesthesia; regional|anesthesia; regional
625978|NCT00531349|cancer recurrence|cancer recurrence
625979|NCT00531349|Analgesia; opioid|analgesia; opioid
625980|NCT00531336|age-related Macular degeneration|age-related macular degeneration
625981|NCT00531336|Macugen|macugen
625982|NCT00531336|Avastin|avastin
625983|NCT00531323|Pharmacokinetic|pharmacokinetic
625984|NCT00531323|TMC125|tmc125
625985|NCT00531323|Healthy volunteers|healthy volunteers
625986|NCT00531323|Efavarinz|efavarinz
625987|NCT00531310|CML|cml
625988|NCT00531310|allogeneic SCT|allogeneic sct
625989|NCT00531310|matched family donor|matched family donor
625990|NCT00531310|unrelated donor|unrelated donor
625991|NCT00531310|cord blood donor|cord blood donor
625992|NCT00531310|persistent disease|persistent disease
625993|NCT00531284|Non-small cell lung carcinoma|non-small cell lung carcinoma
625994|NCT00531284|Small-cell lung carcinoma|small-cell lung carcinoma
625995|NCT00531284|Ovarian Cancer|ovarian cancer
625996|NCT00531284|Renal Cancer|renal cancer
625997|NCT00531284|Other solid tumors|other solid tumors
625998|NCT00531284|multiple myeloma|multiple myeloma
625999|NCT00531284|lymphoma|lymphoma
626000|NCT00531258|Depression|depression
626001|NCT00531258|TBI|tbi
626002|NCT00531258|TMS|tms
626003|NCT00531258|Major Depression resulting from a mild to moderate closed head injury|major depression resulting from a mild to moderate closed head injury
626004|NCT00531245|TS-1 and oxaliplatin|ts-1 and oxaliplatin
626005|NCT00531245|Phase I/II study|phase i/ii study
626006|NCT00531245|Colorectal cancer|colorectal cancer
626007|NCT00531245|First line treatment|first line treatment
626008|NCT00531232|Previously treated Myelodysplastic Syndromes (MDS)|previously treated myelodysplastic syndromes (mds)
626009|NCT00531232|oral clofarabine|oral clofarabine
626010|NCT00531232|Intermediate-1, Intermediate-2 and High Risk Myelodysplastic Syndromes (MDS)|intermediate-1, intermediate-2 and high risk myelodysplastic syndromes (mds)
626011|NCT00531232|secondary AML (with history of MDS)|secondary aml (with history of mds)
626012|NCT00531219|appendicitis|appendicitis
626013|NCT00531219|cholelithiasis|cholelithiasis
626014|NCT00531219|gallstones|gallstones
626015|NCT00531193|Healthy male volunteers|healthy male volunteers
626016|NCT00531180|Esophageal Cancer|esophageal cancer
626017|NCT00531180|Lung Cancer|lung cancer
626018|NCT00531180|Thoracic Malignancies|thoracic malignancies
626019|NCT00531180|4D CT scans|4d ct scans
626020|NCT00531180|Lung Function|lung function
626021|NCT00531167|lamivudine resistant mutations|lamivudine resistant mutations
626022|NCT00531167|rescue therapy|rescue therapy
626023|NCT00531141|age-related macular degeneration|age-related macular degeneration
626024|NCT00531141|optical coherence tomography|optical coherence tomography
626025|NCT00531141|retinal thickness|retinal thickness
626026|NCT00531141|exudative age-related macular degeneration|exudative age-related macular degeneration
626027|NCT00531128|Sitosterol|sitosterol
626028|NCT00531128|Nutrigenomics|nutrigenomics
626029|NCT00531128|Gene Expression|gene expression
626030|NCT00531128|Insulin Resistance|insulin resistance
626031|NCT00531128|Sitosterolemia|sitosterolemia
626032|NCT00531115|metastatic colorectal cancer|metastatic colorectal cancer
626033|NCT00531115|elderly patients|elderly patients
626034|NCT00531115|cetuximab, oxaliplatin, capecitabine|cetuximab, oxaliplatin, capecitabine
626035|NCT00531102|oxygen|oxygen
626036|NCT00531102|continuous positive airway pressure|continuous positive airway pressure
626037|NCT00531102|infant, newborn|infant, newborn
626038|NCT00531102|resuscitation|resuscitation
626039|NCT00531089|TTP|ttp
626040|NCT00531089|thrombotic thrombocytopenic purpura|thrombotic thrombocytopenic purpura
626041|NCT00531089|HUS|hus
626042|NCT00531089|hemolytic uremic syndrome|hemolytic uremic syndrome
626043|NCT00531089|plasma exchange|plasma exchange
626044|NCT00531076|bevacizumab|bevacizumab
626045|NCT00531076|thoracic radiotherapy|thoracic radiotherapy
626046|NCT00531076|locally-advanced non-small cell lung cancer|locally-advanced non-small cell lung cancer
626047|NCT00531063|Renal transplantation, everolimus, Immunosuppressants|renal transplantation, everolimus, immunosuppressants
626048|NCT00531050|COPD|copd
626049|NCT00531050|cycle ergometry|cycle ergometry
626050|NCT00531050|exercise testing|exercise testing
626051|NCT00531050|spirometry|spirometry
626052|NCT00531050|cardiovascular|cardiovascular
626053|NCT00531050|salbutamol|salbutamol
626054|NCT00531050|indacaterol|indacaterol
626055|NCT00531050|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
626056|NCT00531037|AV block, SND, BTS, AAIsafeR, SafeR, PM implanted|av block, snd, bts, aaisafer, safer, pm implanted
626057|NCT00531024|Exudative Neovascular|exudative neovascular
626058|NCT00531024|AMD|amd
626059|NCT00531024|Avastin|avastin
626060|NCT00531024|Systemic|systemic
626061|NCT00531024|Exudative Age-Related Macular Degeneration|exudative age-related macular degeneration
626062|NCT00531011|Stents|stents
626063|NCT00531011|Drug-eluting Stent|drug-eluting stent
626064|NCT00531011|Angioplasty|angioplasty
626065|NCT00531011|Coronary Artery stenosis|coronary artery stenosis
626066|NCT00531011|Coronary Artery Stent Restenosis|coronary artery stent restenosis
626067|NCT00531011|Stent Thrombosis|stent thrombosis
626068|NCT00530998|appendicitis|appendicitis
626069|NCT00530998|cholelithiasis|cholelithiasis
626070|NCT00530998|Gallstones|gallstones
626071|NCT00530985|disability|disability
626072|NCT00530985|substance abuse|substance abuse
626073|NCT00530985|vocational rehabilitation|vocational rehabilitation
626074|NCT00530985|case management|case management
626075|NCT00530972|co-infected HCV/HIV|co-infected hcv/hiv
626076|NCT00530972|relapsers|relapsers
626077|NCT00530907|Advanced Cancer|advanced cancer
626078|NCT00530907|Valproic Acid|valproic acid
626079|NCT00530907|Depakene|depakene
626080|NCT00530907|Bevacizumab|bevacizumab
626081|NCT00530907|Avastin|avastin
626082|NCT00530907|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
626083|NCT00530907|rhuMAb-VEGF|rhumab-vegf
626084|NCT00530894|Valvular Heart Disease|valvular heart disease
626085|NCT00530894|Critical/Severe Aortic Stenosis|critical/severe aortic stenosis
626086|NCT00530894|High risk symptomatic patients|high risk symptomatic patients
626087|NCT00530868|Hormonal and antibody therapy for breast cancer|hormonal and antibody therapy for breast cancer
626088|NCT00530868|Hormonal therapy for breast cancer|hormonal therapy for breast cancer
626089|NCT00530868|Antibody therapy for breast cancer|antibody therapy for breast cancer
626090|NCT00530855|Epilepsy|epilepsy
626091|NCT00530855|Partial-onset Seizures|partial-onset seizures
626092|NCT00530855|Lacosamide|lacosamide
626093|NCT00530855|Monotherapy|monotherapy
626094|NCT00530855|Vimpat|vimpat
626095|NCT00530829|diarrhea|diarrhea
626096|NCT00530829|zinc|zinc
626097|NCT00530829|oral rehydration therapy|oral rehydration therapy
626098|NCT00530803|pain|pain
626099|NCT00530803|venipuncture|venipuncture
626100|NCT00530803|children|children
626101|NCT00530790|Restless Legs Syndrome|restless legs syndrome
626102|NCT00530777|Disease Transmission, Vertical|disease transmission, vertical
626103|NCT00530777|valacyclovir|valacyclovir
626104|NCT00530777|Randomized Controlled Trials|randomized controlled trials
626105|NCT00530777|HIV|hiv
626106|NCT00530777|herpes|herpes
626107|NCT00530777|Herpesvirus 2, Human|herpesvirus 2, human
626108|NCT00530777|HIV Seronegativity|hiv seronegativity
626109|NCT00530764|Pain|pain
626110|NCT00530764|Cancer|cancer
626111|NCT00530764|Palliative|palliative
626112|NCT00530751|breast cancer|breast cancer
626113|NCT00530738|HPN|hpn
626114|NCT00530738|lipid emulsion|lipid emulsion
626115|NCT00530738|long term|long term
626116|NCT00530738|insufficient enteral resorption capacity|insufficient enteral resorption capacity
626117|NCT00530725|occult pneumothorax|occult pneumothorax
626118|NCT00530725|mechanical ventilation|mechanical ventilation
626119|NCT00530725|critical care|critical care
626120|NCT00530725|pneumothorax|pneumothorax
626121|NCT00530725|thoracostomy|thoracostomy
626122|NCT00530712|SFA|sfa
626123|NCT00530712|Popliteal|popliteal
626124|NCT00530712|Stent|stent
626125|NCT00530712|EverFlex|everflex
626126|NCT00530699|Acute Myeloid Leukaemia|acute myeloid leukaemia
626127|NCT00530699|Phase 1|phase 1
626128|NCT00530699|AZD1152|azd1152
626129|NCT00530686|Diabetes Mellitus|diabetes mellitus
626130|NCT00530686|Hypoglycemia|hypoglycemia
626131|NCT00530686|Hyperglycemia|hyperglycemia
626132|NCT00530686|Type 1 Diabetes|type 1 diabetes
626133|NCT00530686|Islet cell transplantation|islet cell transplantation
626134|NCT00530660|Pandemic influenza|pandemic influenza
626135|NCT00530647|Brain motor network, Plasticity, functional MRI, Stroke|brain motor network, plasticity, functional mri, stroke
626136|NCT00530634|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
626137|NCT00530634|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
626138|NCT00530634|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
626139|NCT00530595|hemodialysis|hemodialysis
626140|NCT00530582|progesterone, postmenopause, sleep-EEG|progesterone, postmenopause, sleep-eeg
626141|NCT00530569|Breast Cancer|breast cancer
626142|NCT00530569|Herceptin Therapy|herceptin therapy
626143|NCT00530543|Robot|robot
626144|NCT00530543|Gait|gait
626145|NCT00530543|Stroke|stroke
626146|NCT00530530|ASP8825|asp8825
626147|NCT00530530|Restless legs Syndrome|restless legs syndrome
626148|NCT00530530|XP13512|xp13512
626149|NCT00530517|migraine|migraine
626150|NCT00530517|sumatripatan|sumatripatan
626151|NCT00530504|Carotid Artery Disease|carotid artery disease
626152|NCT00530504|Embolic Protection|embolic protection
626153|NCT00530491|lung resection|lung resection
626154|NCT00530491|reduced pulmonary function|reduced pulmonary function
626155|NCT00530478|Donepezil|donepezil
626156|NCT00530478|Stroke|stroke
626157|NCT00530478|Cognitive function|cognitive function
626158|NCT00530478|Cognitive neural network|cognitive neural network
626159|NCT00530452|COX-2|cox-2
626160|NCT00530452|carbonic anhydrase|carbonic anhydrase
626161|NCT00530452|osteoarthritis|osteoarthritis
626162|NCT00530452|anti-inflammatory|anti-inflammatory
626163|NCT00530452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors
626164|NCT00530426|Heart Failure, Congestive|heart failure, congestive
626165|NCT00530426|Registry|registry
626166|NCT00530426|Acute Decompensated Heart Failure|acute decompensated heart failure
626167|NCT00530426|Dyspnea|dyspnea
626168|NCT00530400|Antibiotic prophylaxis|antibiotic prophylaxis
626169|NCT00530400|Bacterial Infections / prevention & control|bacterial infections / prevention & control
626170|NCT00530400|Surgical wound infection / prevention & control|surgical wound infection / prevention & control
626171|NCT00530400|Neurosurgery|neurosurgery
626172|NCT00530400|Postoperative Complications / prevention & control|postoperative complications / prevention & control
626173|NCT00530400|Clinical trial [publication type]|clinical trial [publication type]
626174|NCT00530387|Photocontact|photocontact
626175|NCT00530387|Dermatitis|dermatitis
626176|NCT00530387|NSAID|nsaid
626177|NCT00530387|Sunscreen|sunscreen
626178|NCT00530387|Photopatch|photopatch
626179|NCT00530374|Pediatrics|pediatrics
626180|NCT00530374|Malnutrition|malnutrition
626181|NCT00530374|Iron Deficiency|iron deficiency
626182|NCT00530374|Sprinkles|sprinkles
626183|NCT00530374|Oral Iron Supplementation|oral iron supplementation
626184|NCT00530361|Myocardial Ischemia|myocardial ischemia
626185|NCT00530361|Kidney failure|kidney failure
626186|NCT00530361|CABG|cabg
626187|NCT00530361|Cardiopulmonary bypass (CPB) pump|cardiopulmonary bypass (cpb) pump
626188|NCT00530361|Coronary Artery Bypass Surgery|coronary artery bypass surgery
626189|NCT00530361|Heart surgery|heart surgery
626190|NCT00530361|Nesiritide|nesiritide
626191|NCT00530361|Coronary Heart Disease|coronary heart disease
626192|NCT00530348|Multiple Sclerosis|multiple sclerosis
626193|NCT00530322|Adhesions|adhesions
626194|NCT00530322|Laparoscopy|laparoscopy
626195|NCT00530322|Colorectal surgery|colorectal surgery
626196|NCT00530322|Colorectal disease|colorectal disease
626197|NCT00530309|GLP-1|glp-1
626198|NCT00530309|type 2 diabeted mellitus|type 2 diabeted mellitus
626199|NCT00530309|safety|safety
626200|NCT00530309|GSK716155|gsk716155
626201|NCT00530309|GLP-1 receptor agonist|glp-1 receptor agonist
626202|NCT00530309|tolerability|tolerability
626203|NCT00530309|pharmacokinetics|pharmacokinetics
626204|NCT00530309|pharmacodynamics|pharmacodynamics
626205|NCT00530296|Depression|depression
626206|NCT00530296|End stage renal disease|end stage renal disease
626207|NCT00530296|Quality of Life|quality of life
626208|NCT00530296|Cognitive Behavioral Therapy|cognitive behavioral therapy
626209|NCT00530283|Squamous|squamous
626210|NCT00530283|Unknown Primary|unknown primary
626211|NCT00530283|Patients with Squamous cell cancer neck nodes|patients with squamous cell cancer neck nodes
626212|NCT00530270|Sickle Cell Disease|sickle cell disease
626214|NCT00530270|Acute Chest Syndrome|acute chest syndrome
626215|NCT00530270|Hgb SS|hgb ss
626216|NCT00530270|Hgb Sβ0|hgb sβ0
626217|NCT00530270|Dexamethasone|dexamethasone
626218|NCT00530257|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
626219|NCT00530257|Methylphenidate|methylphenidate
626220|NCT00530257|Attention|attention
626221|NCT00530257|Working Memory|working memory
626222|NCT00530244|cystic fibrosis|cystic fibrosis
626223|NCT00530244|fatty acids|fatty acids
626224|NCT00530244|docosahexaenoic acid|docosahexaenoic acid
626225|NCT00530244|infant formula|infant formula
626226|NCT00530244|growth|growth
626227|NCT00530244|pancreatic function|pancreatic function
626228|NCT00530231|Capsule endoscopy|capsule endoscopy
626229|NCT00530231|Missing rate|missing rate
626230|NCT00530205|weight changes|weight changes
626231|NCT00530205|malnutrition|malnutrition
626232|NCT00530205|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
626233|NCT00530192|Refractory Cancer|refractory cancer
626234|NCT00530192|Molecular Profile|molecular profile
626235|NCT00530179|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
626236|NCT00530179|Positron Emission Tomography|positron emission tomography
626237|NCT00530179|CHOP Chemotherapy protocol|chop chemotherapy protocol
626238|NCT00530179|Stem Cell Transplantation|stem cell transplantation
626239|NCT00530179|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
626240|NCT00530166|Asthma|asthma
626241|NCT00530166|persistant asthma|persistant asthma
626242|NCT00530166|controller medications|controller medications
626243|NCT00530166|FEV1|fev1
626244|NCT00530153|Eating|eating
626245|NCT00530153|Food Habits|food habits
626246|NCT00530153|Adolescent|adolescent
626247|NCT00530153|Dental Research|dental research
626248|NCT00530140|Follicular Lymphoma|follicular lymphoma
626249|NCT00530140|Idiotype vaccine|idiotype vaccine
626250|NCT00530127|Friedreich's ataxia|friedreich's ataxia
626251|NCT00530088|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
626252|NCT00530088|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
626253|NCT00530088|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
626254|NCT00530088|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
626255|NCT00530088|stage 0 laryngeal cancer|stage 0 laryngeal cancer
626256|NCT00530088|stage 0 lip and oral cavity cancer|stage 0 lip and oral cavity cancer
626257|NCT00530075|Wegener Granulomatosis|wegener granulomatosis
626258|NCT00530075|Vasculitis|vasculitis
626259|NCT00530075|Gusperimus|gusperimus
626260|NCT00530075|Immunosuppression|immunosuppression
626261|NCT00530062|Asthma and Poor Coordinators of Asthma Inhalers|asthma and poor coordinators of asthma inhalers
626262|NCT00530049|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
626263|NCT00530049|hypopharyngeal cancer|hypopharyngeal cancer
626264|NCT00530049|laryngeal cancer|laryngeal cancer
626265|NCT00530049|lip and oral cavity cancer|lip and oral cavity cancer
626266|NCT00530049|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
626267|NCT00530049|nasopharyngeal cancer|nasopharyngeal cancer
626268|NCT00530049|oropharyngeal cancer|oropharyngeal cancer
626269|NCT00530049|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
626270|NCT00530049|salivary gland cancer|salivary gland cancer
626271|NCT00530049|tongue cancer|tongue cancer
626272|NCT00530049|07-098|07-098
626273|NCT00530036|Mortality|mortality
626274|NCT00530036|Patient readmission|patient readmission
626275|NCT00530036|Institutionalization|institutionalization
626276|NCT00530010|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
626277|NCT00530010|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
626278|NCT00530010|advanced adult primary liver cancer|advanced adult primary liver cancer
626279|NCT00529997|Lumbar Spine|lumbar spine
626280|NCT00529997|Lumbar Spinal Stenosis|lumbar spinal stenosis
626281|NCT00529997|Spondylolisthesis|spondylolisthesis
626282|NCT00529997|Dynamic Stabilization|dynamic stabilization
626283|NCT00529997|Motion Preserving|motion preserving
626284|NCT00529997|Arthroplasty|arthroplasty
626285|NCT00529997|Randomized|randomized
626286|NCT00529997|Investigational|investigational
626287|NCT00529997|Back Pain|back pain
626288|NCT00529997|Leg Pain|leg pain
626289|NCT00529984|CEA|cea
626290|NCT00529984|CEA-expressing malignancies|cea-expressing malignancies
626291|NCT00529984|Metastatic malignancies|metastatic malignancies
626292|NCT00529984|VRP Vaccine|vrp vaccine
626293|NCT00529984|Alphavirus replicons|alphavirus replicons
626294|NCT00529984|Molecular therapeutics|molecular therapeutics
626295|NCT00529984|Stage III colon cancer|stage iii colon cancer
626296|NCT00529971|Mindfulness|mindfulness
626297|NCT00529971|HIV|hiv
626298|NCT00529971|Male|male
626299|NCT00529971|Living with HIV|living with hiv
626300|NCT00529971|18-70 years of age|18-70 years of age
626301|NCT00529971|live within one hour of hospital|live within one hour of hospital
626302|NCT00529971|fluent in English|fluent in english
626303|NCT00529971|Complementary Therapies|complementary therapies
626304|NCT00529971|HIV Therapeutic Vaccine|hiv therapeutic vaccine
626305|NCT00529958|Anterior Cruciate Ligament (ACL) Reconstruction|anterior cruciate ligament (acl) reconstruction
626306|NCT00529958|Patellar Tendon|patellar tendon
626307|NCT00529958|Hamstring Tendon|hamstring tendon
626308|NCT00529958|Double-Bundle|double-bundle
626309|NCT00529958|Autograft|autograft
626310|NCT00529945|PFO|pfo
626311|NCT00529945|Stroke|stroke
626312|NCT00529945|Transient Ischemic Attack|transient ischemic attack
626313|NCT00529945|Migraine|migraine
626314|NCT00529945|Decompression Illness|decompression illness
626315|NCT00529932|Acute Myocardial Infarction|acute myocardial infarction
626316|NCT00529932|Celltherapy|celltherapy
626317|NCT00529932|Bone Marrow|bone marrow
626318|NCT00529919|Overweight|overweight
626319|NCT00529919|Obesity|obesity
626320|NCT00529919|Weight loss|weight loss
626321|NCT00529919|Medium chain triglycerides|medium chain triglycerides
626322|NCT00529919|Cardiovascular disease risk|cardiovascular disease risk
626323|NCT00529906|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
626324|NCT00529906|neuropsychological deficits|neuropsychological deficits
626325|NCT00529906|endophenotype|endophenotype
626326|NCT00529906|molecular genetics|molecular genetics
626327|NCT00529906|candidate gene|candidate gene
626328|NCT00529906|family-based association study|family-based association study
626329|NCT00529893|Attention-deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
626330|NCT00529893|neuropsychological functioning|neuropsychological functioning
626331|NCT00529893|Atomoxetine|atomoxetine
626332|NCT00529880|AML|aml
626333|NCT00529867|Artemether/Lumefantrine suspension|artemether/lumefantrine suspension
626334|NCT00529867|P. falciparum malaria|p. falciparum malaria
626335|NCT00529867|children|children
626336|NCT00529867|uncomplicated Plasmodium falciparum malaria|uncomplicated plasmodium falciparum malaria
626337|NCT00529854|Intensive care unit|intensive care unit
626338|NCT00529854|medical documentation|medical documentation
626339|NCT00529854|medical billing|medical billing
626340|NCT00529841|Salt Wasting Congenital Adrenal Hyperplasia|salt wasting congenital adrenal hyperplasia
626341|NCT00529841|Subcutaneous Hydrocortisone|subcutaneous hydrocortisone
626342|NCT00529828|CLA|cla
626343|NCT00529828|Industrial trans fatty acids|industrial trans fatty acids
626344|NCT00529828|Oleic acid|oleic acid
626345|NCT00529828|Controlled dietary trial|controlled dietary trial
626346|NCT00529815|Continuous|continuous
626347|NCT00529815|blood|blood
626348|NCT00529815|glucose|glucose
626349|NCT00529815|monitoring|monitoring
626350|NCT00529815|diabetes|diabetes
626351|NCT00529815|type2|type2
626352|NCT00529802|metastatic|metastatic
626353|NCT00529802|renal|renal
626354|NCT00529802|cell|cell
626355|NCT00529802|carcinoma|carcinoma
626356|NCT00529802|cancer|cancer
626357|NCT00529776|Prevention of ventilator associated pneumonia|prevention of ventilator associated pneumonia
626358|NCT00529763|Chronic Phase, Advanced Phase chronic myeloid leukemia|chronic phase, advanced phase chronic myeloid leukemia
626359|NCT00529763|Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia|philadelphia chromosome positive acute lymphoblastic leukemia
626360|NCT00529737|Breast Cancer|breast cancer
626361|NCT00529737|Marker Clip Migration|marker clip migration
626362|NCT00529737|Vacuum-Assisted Biopsy|vacuum-assisted biopsy
626363|NCT00529737|Postprocedure Mammogram|postprocedure mammogram
626364|NCT00529737|Breast Biopsy|breast biopsy
626365|NCT00529724|Energy metabolism, metabolic syndrome, by chronic bilateral subthalamic stimulation, Parkinson's disease|energy metabolism, metabolic syndrome, by chronic bilateral subthalamic stimulation, parkinson's disease
626366|NCT00529724|Patients with Parkinson's disease and will be treated by chronic bilateral subthalamic stimulation.|patients with parkinson's disease and will be treated by chronic bilateral subthalamic stimulation.
626367|NCT00529711|coronary|coronary
626368|NCT00529711|artery|artery
626369|NCT00529711|bypass|bypass
626370|NCT00529711|grafting|grafting
626371|NCT00529711|IV|iv
626372|NCT00529711|cardiac output|cardiac output
626373|NCT00529698|HIV|hiv
626374|NCT00529698|Tat protein|tat protein
626375|NCT00529698|Preventative vaccine|preventative vaccine
626376|NCT00529698|Healthy volunteers|healthy volunteers
626377|NCT00529698|HIV-1/2 uninfected|hiv-1/2 uninfected
626378|NCT00529698|HIV Preventive Vaccine|hiv preventive vaccine
626379|NCT00529672|endovenous laser therapy|endovenous laser therapy
626380|NCT00529672|sclerotherapy|sclerotherapy
626381|NCT00529672|crossectomy and stripping|crossectomy and stripping
626382|NCT00529672|surgery|surgery
626383|NCT00529672|treatment|treatment
626384|NCT00529672|varicose veins|varicose veins
626385|NCT00529659|Sarcopenia (loss of muscle mass)|sarcopenia (loss of muscle mass)
626386|NCT00529646|Healthy adult volunteers|healthy adult volunteers
626387|NCT00529633|Inflammation|inflammation
626388|NCT00529633|albumin|albumin
626389|NCT00529620|Malaria|malaria
626390|NCT00529620|IPT|ipt
626391|NCT00529620|preventive treatment|preventive treatment
626392|NCT00529607|myocardial infarction, reperfusion injury, echocardiography, magnetic resonance imaging, inflammation, nitric oxide|myocardial infarction, reperfusion injury, echocardiography, magnetic resonance imaging, inflammation, nitric oxide
626393|NCT00529594|Laser Photocoagulation|laser photocoagulation
626394|NCT00529594|Pain relief|pain relief
626395|NCT00529581|multiple sclerosis|multiple sclerosis
626396|NCT00529581|cognitive impairment|cognitive impairment
626397|NCT00529581|cognitive dysfunction|cognitive dysfunction
626521|NCT00529048|Type 2 diabetes mellitus|type 2 diabetes mellitus
626398|NCT00529581|Cognitive Dysfunction associated with Multiple Sclerosis|cognitive dysfunction associated with multiple sclerosis
626399|NCT00529568|hepatitis C|hepatitis c
626400|NCT00529568|ribavirin|ribavirin
626401|NCT00529568|Hepatitis C-related thrombocytopenia|hepatitis c-related thrombocytopenia
626402|NCT00529568|thrombopoietin|thrombopoietin
626403|NCT00529568|peginterferon alfa-2b|peginterferon alfa-2b
626404|NCT00529568|platelets|platelets
626405|NCT00529542|Polycystic Ovary Syndrome|polycystic ovary syndrome
626406|NCT00529529|asthma|asthma
626407|NCT00529529|QAB149|qab149
626408|NCT00529529|indacaterol|indacaterol
626409|NCT00529516|Fluarix|fluarix
626410|NCT00529516|GSK Bio's influenza vaccine GSK576389A|gsk bio's influenza vaccine gsk576389a
626411|NCT00529516|Influenza infection|influenza infection
626412|NCT00529503|Lymphoproliferative Disorders|lymphoproliferative disorders
626413|NCT00529503|Lymphoma|lymphoma
626414|NCT00529503|Antigens, CD40|antigens, cd40
626415|NCT00529503|Antibody, Monoclonal|antibody, monoclonal
626416|NCT00529503|Combined Modality Therapy|combined modality therapy
626417|NCT00529503|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
626418|NCT00529503|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
626419|NCT00529503|Hematologic Diseases|hematologic diseases
626420|NCT00529503|Immunoproliferative Disorders|immunoproliferative disorders
626421|NCT00529503|Lymphatic Diseases|lymphatic diseases
626422|NCT00529490|coronary|coronary
626423|NCT00529490|artery|artery
626424|NCT00529490|bypass|bypass
626425|NCT00529490|grafting|grafting
626426|NCT00529490|I.V.|i.v.
626427|NCT00529490|cardiac output|cardiac output
626428|NCT00529464|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
626429|NCT00529464|Cervical Dysplasia|cervical dysplasia
626430|NCT00529464|Cervical Cancer|cervical cancer
626431|NCT00529464|Fluorescence Spectroscopy|fluorescence spectroscopy
626432|NCT00529464|Colposcopy|colposcopy
626433|NCT00529464|Loop Electrical Excision Procedure|loop electrical excision procedure
626434|NCT00529464|LEEP|leep
626435|NCT00529451|Hypertension, Aliskiren, Ramipril|hypertension, aliskiren, ramipril
626436|NCT00529425|Femoral neck fracture|femoral neck fracture
626437|NCT00529425|Hip fracture|hip fracture
626438|NCT00529399|immune tolerance|immune tolerance
626439|NCT00529399|immunotherapy|immunotherapy
626541|NCT00529022|Vidaza|vidaza
626440|NCT00529399|antigen-specific tolerance|antigen-specific tolerance
626441|NCT00529399|vaccine induced tolerance|vaccine induced tolerance
626442|NCT00529399|Beta-cell function|beta-cell function
626443|NCT00529399|T-cells|t-cells
626444|NCT00529399|DPT-1|dpt-1
626445|NCT00529399|treatment of type 1 diabetes|treatment of type 1 diabetes
626446|NCT00529399|new onset type 1 diabetes|new onset type 1 diabetes
626447|NCT00529399|juvenile diabetes|juvenile diabetes
626449|NCT00529399|diabetes mellitus|diabetes mellitus
626450|NCT00529399|Type 1 diabetes TrialNet|type 1 diabetes trialnet
626451|NCT00529399|TrialNet|trialnet
626452|NCT00529386|prostatitis|prostatitis
626453|NCT00529386|Botox|botox
626454|NCT00529360|Acute Leukemia|acute leukemia
626455|NCT00529360|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
626456|NCT00529360|Clofarabine|clofarabine
626457|NCT00529360|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
626458|NCT00529360|Acute Myelogenous Leukemia|acute myelogenous leukemia
626459|NCT00529334|Breast Cancer|breast cancer
626460|NCT00529334|Partial breast irradiation|partial breast irradiation
626461|NCT00529334|Radiosurgery|radiosurgery
626462|NCT00529334|CyberKnife|cyberknife
626463|NCT00529334|Radiotherapy|radiotherapy
626464|NCT00529334|PBI|pbi
626465|NCT00529308|Tourette|tourette
626466|NCT00529308|Tourette's|tourette's
626467|NCT00529295|misoprostol|misoprostol
626468|NCT00529295|labor induction|labor induction
626469|NCT00529282|Low numbers of neutrophils in the blood|low numbers of neutrophils in the blood
626470|NCT00529282|increased body temperature|increased body temperature
626471|NCT00529282|cancer chemotherapy|cancer chemotherapy
626472|NCT00529282|ceftobiprole|ceftobiprole
626473|NCT00529282|pseudomonas infections|pseudomonas infections
626474|NCT00529269|Renal Transplant Patients, GI symptom, Enteric-coated mycophenolate sodium|renal transplant patients, gi symptom, enteric-coated mycophenolate sodium
626475|NCT00529256|Adult smokers|adult smokers
626476|NCT00529243|Treatment Experience|treatment experience
626477|NCT00529243|On enfuvirtide|on enfuvirtide
626478|NCT00529230|Advanced Cancer|advanced cancer
626479|NCT00529230|Chronic Opioid Therapy|chronic opioid therapy
626480|NCT00529230|Secondary Hypogonadism|secondary hypogonadism
626481|NCT00529230|Cancer-Related Pain Syndromes|cancer-related pain syndromes
626482|NCT00529230|Questionnaire|questionnaire
626483|NCT00529217|Dissociative|dissociative
626484|NCT00529217|Dissociation|dissociation
626485|NCT00529217|Depersonalization|depersonalization
626486|NCT00529217|Depersonalization Disorder|depersonalization disorder
626487|NCT00529217|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
626488|NCT00529217|TMS|tms
626489|NCT00529217|Depersonalization Disorder (DPD)|depersonalization disorder (dpd)
626490|NCT00529217|rTMS|rtms
626491|NCT00529204|Fatty Liver|fatty liver
626492|NCT00529204|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
626493|NCT00529204|NAFDL|nafdl
626494|NCT00529204|Diabetes|diabetes
626495|NCT00529204|ALT|alt
626496|NCT00529204|exenatide|exenatide
626497|NCT00529191|Type I Diabetes (T1DM)|type i diabetes (t1dm)
626498|NCT00529191|Atorvastatin (Lipitor)|atorvastatin (lipitor)
626499|NCT00529191|Insulin|insulin
626500|NCT00529191|Pancreas|pancreas
626501|NCT00529191|Beta Cells|beta cells
626502|NCT00529165|injection to meal time|injection to meal time
626503|NCT00529165|human insulin|human insulin
626504|NCT00529152|Iron Overload|iron overload
626505|NCT00529139|Extended dialysis|extended dialysis
626506|NCT00529139|Acute kidney injury|acute kidney injury
626507|NCT00529139|Intensive care unit|intensive care unit
626508|NCT00529139|Renal replacement therapy|renal replacement therapy
626509|NCT00529139|Survival|survival
626510|NCT00529139|Dialysis|dialysis
626511|NCT00529126|hemorrhoidectomy|hemorrhoidectomy
626512|NCT00529126|pain|pain
626513|NCT00529126|Postoperative|postoperative
626514|NCT00529126|analgesia|analgesia
626515|NCT00529113|pancreatic cancer|pancreatic cancer
626516|NCT00529113|gemcitabine|gemcitabine
626517|NCT00529087|Opioid-Induced Constipation|opioid-induced constipation
626518|NCT00529074|Epidural Analgesia|epidural analgesia
626519|NCT00529061|Sickle Cell Disease|sickle cell disease
626520|NCT00529061|Sickle Cell Anemia|sickle cell anemia
626522|NCT00529048|Incretin effect|incretin effect
626523|NCT00529048|Glucagon-Like Peptide 1|glucagon-like peptide 1
626524|NCT00529048|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
626525|NCT00529035|Chronic GVHD|chronic gvhd
626526|NCT00529035|Steroid refractory GVHD|steroid refractory gvhd
626527|NCT00529035|allogeneic stem cell transplantation|allogeneic stem cell transplantation
626528|NCT00529022|Advanced Cancer|advanced cancer
626529|NCT00529022|Solid Tumors|solid tumors
626530|NCT00529022|Ovarian Cancer|ovarian cancer
626531|NCT00529022|Fallopian Tube Cancer|fallopian tube cancer
626532|NCT00529022|Peritoneal Cancer|peritoneal cancer
626533|NCT00529022|Azacitidine|azacitidine
626534|NCT00529022|5-Azacitidine|5-azacitidine
626535|NCT00529022|5-Aza|5-aza
626536|NCT00529022|Vidaza™|vidaza™
626537|NCT00529022|5-AZC|5-azc
626538|NCT00529022|AZA-CR|aza-cr
626539|NCT00529022|Ladakamycin|ladakamycin
626540|NCT00529022|NSC-102816|nsc-102816
626542|NCT00529022|Valproic Acid|valproic acid
626543|NCT00529022|Depakene|depakene
626544|NCT00529022|Carboplatin|carboplatin
626545|NCT00529022|Paraplatin|paraplatin
626546|NCT00529009|PK analysis|pk analysis
626547|NCT00528983|Myelodysplastic Syndromes MDS|myelodysplastic syndromes mds
626548|NCT00528983|Acute Myelogenous Leukemia AML|acute myelogenous leukemia aml
626549|NCT00528983|Chronic Myelomonocytic Leukemia CMML|chronic myelomonocytic leukemia cmml
626550|NCT00528970|POI|poi
626551|NCT00528970|Hernia|hernia
626552|NCT00528970|Ventral Wall Hernia Repair|ventral wall hernia repair
626553|NCT00528970|Post Operative Ileus|post operative ileus
626554|NCT00528957|Phase 3|phase 3
626555|NCT00528957|Randomized, Open-Label|randomized, open-label
626556|NCT00528957|Treatment-Experienced|treatment-experienced
626557|NCT00528957|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
626558|NCT00528957|HIV|hiv
626559|NCT00528957|Tenofovir DF|tenofovir df
626560|NCT00528957|Pediatrics|pediatrics
626561|NCT00528944|alveolar volume|alveolar volume
626562|NCT00528944|pulmonary function testing|pulmonary function testing
626563|NCT00528944|emphysema|emphysema
626564|NCT00528931|Assessment of AUX I and/or AUX II in human plasma|assessment of aux i and/or aux ii in human plasma
626565|NCT00528918|diabetes|diabetes
626566|NCT00528918|hyperglycemia|hyperglycemia
626567|NCT00528918|insulin|insulin
626568|NCT00528918|Apidra|apidra
626569|NCT00528918|Glargine|glargine
626570|NCT00528905|Schizophrenia|schizophrenia
626571|NCT00528905|Cognitive Deficits|cognitive deficits
626572|NCT00528892|Treatment Experienced|treatment experienced
626573|NCT00528879|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
626574|NCT00528879|Diabetes Mellitus|diabetes mellitus
626575|NCT00528879|Endocrine System Diseases|endocrine system diseases
626576|NCT00528879|Glucose Metabolism Disorders|glucose metabolism disorders
626577|NCT00528879|Metabolic Diseases|metabolic diseases
626578|NCT00528879|Metformin|metformin
626579|NCT00528879|Hypoglycemic Agents|hypoglycemic agents
626580|NCT00528879|Pharmacologic Actions|pharmacologic actions
626581|NCT00528879|Physiological Effects of Drugs|physiological effects of drugs
626582|NCT00528866|adenocarcinoma of the prostate|adenocarcinoma of the prostate
626583|NCT00528866|stage IIB prostate cancer|stage iib prostate cancer
626584|NCT00528866|stage IIA prostate cancer|stage iia prostate cancer
626585|NCT00528866|stage III prostate cancer|stage iii prostate cancer
626586|NCT00528866|stage IV prostate cancer|stage iv prostate cancer
626587|NCT00528853|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
626588|NCT00528827|Hypertension, High Blood Pressure, Pediatric Hypertension, High blood pressure in children|hypertension, high blood pressure, pediatric hypertension, high blood pressure in children
626589|NCT00528814|Hand Sanitizer|hand sanitizer
626590|NCT00528814|Respiratory Infection|respiratory infection
626591|NCT00528801|Sickle Cell Disease|sickle cell disease
626592|NCT00528801|Sickle Cell Anemia|sickle cell anemia
626593|NCT00528801|Hemoglobin SS|hemoglobin ss
626594|NCT00528801|Hemoglobin SB0|hemoglobin sb0
626595|NCT00528775|adenocarcinoma of the lung|adenocarcinoma of the lung
626596|NCT00528775|large cell lung cancer|large cell lung cancer
626597|NCT00528775|squamous cell lung cancer|squamous cell lung cancer
626598|NCT00528775|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
626599|NCT00528775|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
626600|NCT00528775|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
626601|NCT00528775|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
626602|NCT00528762|Epidemiology|epidemiology
626603|NCT00528762|Puberty|puberty
626604|NCT00528762|Body Weight|body weight
626605|NCT00528762|Body Image|body image
626606|NCT00528762|Focus Group|focus group
626607|NCT00528749|Respiratory effort|respiratory effort
626608|NCT00528749|Upper Airway Resistance Syndrome|upper airway resistance syndrome
626609|NCT00528736|preterm infants < 28 weeks|preterm infants < 28 weeks
626610|NCT00528736|B-type natriuretic peptide|b-type natriuretic peptide
626611|NCT00528736|prediction|prediction
626612|NCT00528736|ductus intervention|ductus intervention
626613|NCT00528723|beclomethasone|beclomethasone
626614|NCT00528723|as needed|as needed
626615|NCT00528723|salbutamol|salbutamol
626616|NCT00528723|wheezing|wheezing
626617|NCT00528710|S-Adenosylmethionine|s-adenosylmethionine
626618|NCT00528684|Oncolytics Biotech|oncolytics biotech
626619|NCT00528684|cancer alternative therapies|cancer alternative therapies
626620|NCT00528684|malignant glioma|malignant glioma
626621|NCT00528684|glioblastoma multiforme|glioblastoma multiforme
626622|NCT00528684|oncolytic virus|oncolytic virus
626623|NCT00528684|reovirus|reovirus
626624|NCT00528684|REOLYSIN|reolysin
626625|NCT00528671|phenprocoumon|phenprocoumon
626626|NCT00528671|INR self-management|inr self-management
626627|NCT00528671|mechanical heart valve replacement|mechanical heart valve replacement
626628|NCT00528671|bleeding|bleeding
626629|NCT00528671|thromboembolism|thromboembolism
626630|NCT00528658|Soft Tissue Injuries|soft tissue injuries
626631|NCT00528632|Gallstones|gallstones
626632|NCT00528632|Gallbladder|gallbladder
626633|NCT00528632|Cholesterolosis|cholesterolosis
626634|NCT00528632|Serum cholesterol|serum cholesterol
626635|NCT00528632|triglycerides|triglycerides
626636|NCT00528632|Body Mass Index|body mass index
626637|NCT00528619|Solid tumor malignancy|solid tumor malignancy
626638|NCT00528619|non-small cell lung cancer|non-small cell lung cancer
626639|NCT00528619|sunitinib|sunitinib
626640|NCT00528619|pemetrexed|pemetrexed
626641|NCT00528619|Phase 1|phase 1
626642|NCT00528619|Mesothelioma|mesothelioma
626643|NCT00528593|HIV|hiv
626644|NCT00528593|AIDS|aids
626645|NCT00528593|neuropathy|neuropathy
626646|NCT00528593|Procrit|procrit
626647|NCT00528593|epoetin alfa|epoetin alfa
626648|NCT00528593|erythropoetin|erythropoetin
626649|NCT00528593|Treatment Experienced|treatment experienced
626650|NCT00528580|Sepsis|sepsis
626651|NCT00528580|Statin|statin
626652|NCT00528580|Infection|infection
626653|NCT00528580|Immunomodulatory|immunomodulatory
626654|NCT00528554|CINV|cinv
626655|NCT00528554|chemotherapy induced nausea and vomiting (CINV)|chemotherapy induced nausea and vomiting (cinv)
626656|NCT00528528|Chronic Hepatitis C|chronic hepatitis c
626657|NCT00528528|Genotype 1|genotype 1
626658|NCT00528528|Telaprevir|telaprevir
626659|NCT00528528|Treatment-naïve|treatment-naïve
626660|NCT00528528|VX-950-C208|vx-950-c208
626661|NCT00528528|VX-950-TiDP24-C208|vx-950-tidp24-c208
626662|NCT00528515|anesthesia intravenous|anesthesia intravenous
626663|NCT00528515|propofol|propofol
626664|NCT00528515|anesthesia inhalation|anesthesia inhalation
626665|NCT00528515|desflurane|desflurane
626666|NCT00528515|heart surgery|heart surgery
626667|NCT00528515|coronary artery by-pass off-pump|coronary artery by-pass off-pump
626668|NCT00528515|hemodynamic processes|hemodynamic processes
626669|NCT00528515|anesthesia|anesthesia
626670|NCT00528502|Parathyroid Disease|parathyroid disease
626671|NCT00528502|Minimal Invasive Parathyroid Surgery|minimal invasive parathyroid surgery
626672|NCT00528502|MIPS|mips
626673|NCT00528502|Laryngeal Reflexes|laryngeal reflexes
626674|NCT00528502|Lidocaine|lidocaine
626675|NCT00528502|Saline|saline
626676|NCT00528489|HIV Seronegativity|hiv seronegativity
626677|NCT00528489|DNA Plasmid Vaccine|dna plasmid vaccine
626678|NCT00528489|HIV Preventive Vaccine|hiv preventive vaccine
626679|NCT00528476|pyelonephritis|pyelonephritis
626680|NCT00528476|cystitis|cystitis
626681|NCT00528476|risk factor|risk factor
626682|NCT00528476|children|children
626683|NCT00528476|urodynamics|urodynamics
626684|NCT00528463|Pre-emptive analgesia|pre-emptive analgesia
626685|NCT00528463|Peripheral nerve block (sciatic)|peripheral nerve block (sciatic)
626686|NCT00528463|phantom lomb pain|phantom lomb pain
626687|NCT00528450|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
626688|NCT00528450|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
626689|NCT00528450|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
626690|NCT00528437|Recurrent or refractory medulloblastoma/PNET|recurrent or refractory medulloblastoma/pnet
626691|NCT00528437|CNS germ cell tumors|cns germ cell tumors
626692|NCT00528437|Ependymomas|ependymomas
626693|NCT00528437|AT/RT|at/rt
626694|NCT00528437|High grade glioma|high grade glioma
626695|NCT00528437|Other malignant brain tumors|other malignant brain tumors
626696|NCT00528411|Coronary artery disease|coronary artery disease
626697|NCT00528411|CAD|cad
626698|NCT00528411|heart attack|heart attack
626699|NCT00528411|stable angina|stable angina
626700|NCT00528411|Stable coronary artery disease|stable coronary artery disease
626701|NCT00528398|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
626702|NCT00528398|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
626703|NCT00528398|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
626704|NCT00528398|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
626705|NCT00528398|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
626706|NCT00528398|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
626707|NCT00528398|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
626708|NCT00528398|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
626709|NCT00528398|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
626710|NCT00528398|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
626711|NCT00528398|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
626712|NCT00528398|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
626713|NCT00528398|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
626714|NCT00528398|secondary acute myeloid leukemia|secondary acute myeloid leukemia
626715|NCT00528398|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
626716|NCT00528385|Proteinuria|proteinuria
626717|NCT00528385|Renin-Angiotensin-Aldosterone System|renin-angiotensin-aldosterone system
626718|NCT00528385|Aldosterone Antagonists|aldosterone antagonists
626719|NCT00528359|antipsychotic drugs|antipsychotic drugs
626720|NCT00528359|schizophrenia|schizophrenia
626721|NCT00528359|β-cell function|β-cell function
626722|NCT00528359|insulin resistance|insulin resistance
626723|NCT00528346|chronic pain|chronic pain
626724|NCT00528346|functional magnetic resonance imaging|functional magnetic resonance imaging
626725|NCT00528346|fMRI|fmri
626726|NCT00528346|cognitive training|cognitive training
626727|NCT00528333|Lintuzumab|lintuzumab
626728|NCT00528333|Antigens, CD33|antigens, cd33
626729|NCT00528333|Antibodies, Monoclonal|antibodies, monoclonal
626730|NCT00528333|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
626731|NCT00528333|Hematologic Diseases|hematologic diseases
626732|NCT00528333|Leukemia|leukemia
626733|NCT00528320|Congestive Heart Failure|congestive heart failure
626734|NCT00528320|Heart Failure|heart failure
626735|NCT00528320|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
626736|NCT00528320|ICD|icd
626737|NCT00528320|Implantable Cardioverter-Defibrillator|implantable cardioverter-defibrillator
626738|NCT00528320|Defibrillator|defibrillator
626739|NCT00528307|myocardial perfusion|myocardial perfusion
626740|NCT00528307|His ablation|his ablation
626741|NCT00528307|biventricular pacing|biventricular pacing
626742|NCT00528307|His bundle ablation for atrial fibrillation|his bundle ablation for atrial fibrillation
626743|NCT00528294|Recurrent head and neck tumors|recurrent head and neck tumors
626744|NCT00528281|Non Small Cell Lung Cancer (NSCLC)|non small cell lung cancer (nsclc)
626745|NCT00528281|Pemetrexed,|pemetrexed,
626746|NCT00528281|Lapatinib (GW572016),|lapatinib (gw572016),
626747|NCT00528268|Spinal Muscular Atrophy|spinal muscular atrophy
626748|NCT00528268|SMA|sma
626749|NCT00528268|Sodium Phenylbutyrate|sodium phenylbutyrate
626750|NCT00528255|cervical ripening|cervical ripening
626751|NCT00528255|induction of labor|induction of labor
626752|NCT00528216|Analgesics|analgesics
626753|NCT00528216|Capsaicin|capsaicin
626754|NCT00528203|Sickle Cell Disease|sickle cell disease
626755|NCT00528203|Sickle Cell Anemia|sickle cell anemia
626756|NCT00528203|DNA|dna
626757|NCT00528190|Cystic Fibrosis|cystic fibrosis
626758|NCT00528190|Aspergillus Fumigatus|aspergillus fumigatus
626759|NCT00528190|randomized controlled clinical trials|randomized controlled clinical trials
626760|NCT00528177|kappa-opioid receptor|kappa-opioid receptor
626761|NCT00528177|my-opioid receptor|my-opioid receptor
626762|NCT00528177|oxycodone|oxycodone
626763|NCT00528177|morphine|morphine
626764|NCT00528177|postoperative pain|postoperative pain
626765|NCT00528164|children|children
626766|NCT00528164|overweight|overweight
626767|NCT00528164|obesity|obesity
626768|NCT00528164|family|family
626769|NCT00528164|intervention|intervention
626770|NCT00528164|control|control
626771|NCT00528164|randomized|randomized
626772|NCT00528164|physical activity|physical activity
626773|NCT00528164|diet|diet
626774|NCT00528164|nutrition|nutrition
626775|NCT00528164|behavior|behavior
626776|NCT00528164|body mass index|body mass index
626777|NCT00528151|Curcumin, LHON, antioxidant, visual outcome|curcumin, lhon, antioxidant, visual outcome
626778|NCT00528138|Appendicitis|appendicitis
626779|NCT00528138|Hyperbilirubinemia|hyperbilirubinemia
626780|NCT00528138|CRP|crp
626781|NCT00528138|Values of bilirubin|values of bilirubin
626782|NCT00528138|Values of liver function test|values of liver function test
626783|NCT00528138|Values of white blood cells|values of white blood cells
626784|NCT00528138|Values of CRP|values of crp
626785|NCT00528125|pain prevention|pain prevention
626786|NCT00528125|neonatal pain|neonatal pain
626787|NCT00528125|laser acupuncture|laser acupuncture
626788|NCT00528125|complementary and alternative medicine|complementary and alternative medicine
626789|NCT00528112|Contraception|contraception
626790|NCT00528112|Intrauterine|intrauterine
626791|NCT00528112|IUD|iud
626792|NCT00528112|IUS|ius
626793|NCT00528086|Group visits|group visits
626794|NCT00528073|Rifaximin-EIR|rifaximin-eir
626795|NCT00528073|Crohn's disease|crohn's disease
626796|NCT00528073|remission|remission
626797|NCT00528060|HIV infections|hiv infections
626798|NCT00528060|atazanavir|atazanavir
626799|NCT00528060|Pharmacokinetics|pharmacokinetics
626800|NCT00528060|Treatment Naive|treatment naive
626801|NCT00528047|Cancer|cancer
626802|NCT00528047|Solid Tumor|solid tumor
626803|NCT00528047|Metastatic|metastatic
626804|NCT00528047|Neoplasm, Malignant|neoplasm, malignant
626805|NCT00528034|Vaginal Cancer|vaginal cancer
626806|NCT00528034|Lymphoscintigraphy|lymphoscintigraphy
626807|NCT00528034|Lymphatic Mapping|lymphatic mapping
626808|NCT00528034|Sentinel Lymph Node|sentinel lymph node
626809|NCT00528034|Isosulfan Blue|isosulfan blue
626810|NCT00528034|Lymph|lymph
626811|NCT00528021|Head Lice|head lice
626812|NCT00528021|Lice Infestation|lice infestation
626813|NCT00528021|Pediculosis|pediculosis
626814|NCT00528021|Pediculosis Capitis|pediculosis capitis
626815|NCT00528008|infection|infection
626816|NCT00528008|sepsis|sepsis
626817|NCT00528008|povidone-iodine|povidone-iodine
626818|NCT00528008|chlorhexidine gluconate|chlorhexidine gluconate
626819|NCT00528008|fever|fever
626820|NCT00528008|erythema|erythema
626821|NCT00528008|leukocytosis|leukocytosis
626822|NCT00528008|drainage|drainage
626823|NCT00528008|vaginal discharge|vaginal discharge
626824|NCT00528008|elective cesarean section|elective cesarean section
626825|NCT00527982|Head and Neck Cancer|head and neck cancer
626826|NCT00527982|Lung Cancer|lung cancer
626827|NCT00527982|Non-Small Cell Lung Cancer|non-small cell lung cancer
626828|NCT00527982|Celecoxib|celecoxib
626829|NCT00527982|Celebrex|celebrex
626830|NCT00527969|American ginseng extract|american ginseng extract
626831|NCT00527969|Panax quinquefolius|panax quinquefolius
626832|NCT00527969|Memory enhancement|memory enhancement
626833|NCT00527969|Cognitive function|cognitive function
626834|NCT00527969|Working memory|working memory
626835|NCT00527969|Declarative memory|declarative memory
626836|NCT00527969|Psychomotor speed|psychomotor speed
626837|NCT00527969|Executive skills|executive skills
626838|NCT00527969|Psychosocial adaptation|psychosocial adaptation
626839|NCT00527956|Breastfeeding premature infants|breastfeeding premature infants
626840|NCT00527930|Breast Neoplasms|breast neoplasms
626841|NCT00527930|Oxaliplatin|oxaliplatin
626842|NCT00527930|S1|s1
626843|NCT00527917|IC/PBS|ic/pbs
626844|NCT00527917|Interstitial Cystitis/Painful Bladder Syndrome|interstitial cystitis/painful bladder syndrome
626845|NCT00527904|osteoarthritis|osteoarthritis
626846|NCT00527904|rheumatoid arthritis|rheumatoid arthritis
626847|NCT00527904|ankylosing spondylisit|ankylosing spondylisit
626848|NCT00527904|NSAIDS|nsaids
626849|NCT00527891|Liver Cancer|liver cancer
626850|NCT00527891|Magnetic Resonance Imaging|magnetic resonance imaging
626851|NCT00527891|Signa Excite 3.0T MRI Scan|signa excite 3.0t mri scan
626852|NCT00527878|Hyper-IgE Recurrent Infection Syndrome|hyper-ige recurrent infection syndrome
626853|NCT00527878|Ranitidine Therapy|ranitidine therapy
626854|NCT00527878|Job's Syndrome|job's syndrome
626855|NCT00527878|Cross-Over Study|cross-over study
626856|NCT00527878|Double-Blind Placebo Controlled|double-blind placebo controlled
626857|NCT00527878|Hyper-IgE Syndrome|hyper-ige syndrome
626858|NCT00527878|Job Syndrome|job syndrome
626859|NCT00527878|Immune Deficiency|immune deficiency
626860|NCT00527865|Influenza, Flu, DAS181, Fludase|influenza, flu, das181, fludase
626861|NCT00527852|Flocked swab|flocked swab
626862|NCT00527852|Group A streptococcus pharyngitis|group a streptococcus pharyngitis
626863|NCT00527826|Severe and very severe COPD (GOLD stage III / IV) exacerbations|severe and very severe copd (gold stage iii / iv) exacerbations
626864|NCT00527826|health care utilisation|health care utilisation
626865|NCT00527826|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
626866|NCT00527826|quality of life|quality of life
626867|NCT00527826|compliance|compliance
626868|NCT00527826|salmeterol/fluticasone combination|salmeterol/fluticasone combination
626869|NCT00527813|acute respiratory distress syndrome|acute respiratory distress syndrome
626870|NCT00527813|prone position|prone position
626871|NCT00527813|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
626872|NCT00527800|Malaria|malaria
626873|NCT00527800|HIV|hiv
626874|NCT00527800|Trimethoprim-sulfamethoxazole|trimethoprim-sulfamethoxazole
626875|NCT00527800|Artemether-lumefantrine|artemether-lumefantrine
626876|NCT00527800|Dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
626877|NCT00527800|Acute Infection|acute infection
626878|NCT00527787|NSAID|nsaid
626879|NCT00527787|gastric ulcers|gastric ulcers
626880|NCT00527787|Vimovo|vimovo
626881|NCT00527787|Naproxen|naproxen
626882|NCT00527787|Esomeprazole|esomeprazole
626883|NCT00527774|Hepatitis C|hepatitis c
626884|NCT00527774|malnutrition-inflammation complex syndrome (MICS)|malnutrition-inflammation complex syndrome (mics)
626885|NCT00527774|dialysis|dialysis
626886|NCT00527774|mortality|mortality
626887|NCT00527774|hospitalization|hospitalization
626888|NCT00527774|health-related quality of life (HRQOL)|health-related quality of life (hrqol)
626889|NCT00527774|peripheral arterial occlusive disease (PAOD)|peripheral arterial occlusive disease (paod)
626890|NCT00527761|Metastatic Melanoma|metastatic melanoma
626891|NCT00527761|Temozolomide|temozolomide
626892|NCT00527761|Temodar|temodar
626893|NCT00527761|Taxotere|taxotere
626894|NCT00527761|Cisplatin|cisplatin
626895|NCT00527761|TTC|ttc
626896|NCT00527748|Range of Motion|range of motion
626897|NCT00527748|Ankle Fractures|ankle fractures
626898|NCT00527748|Elderly patients|elderly patients
626899|NCT00527735|Non Small Cell Lung Cancer (NSCLC)|non small cell lung cancer (nsclc)
626900|NCT00527735|Small Cell Lung Cancer (SCLC)|small cell lung cancer (sclc)
626901|NCT00527722|Lung Cancer|lung cancer
626902|NCT00527722|Bio-Seal Track Plug|bio-seal track plug
626903|NCT00527722|Lung Biopsy|lung biopsy
626904|NCT00527722|Lung Plug|lung plug
626905|NCT00527722|Air Leaks|air leaks
626906|NCT00527683|vigabatrin|vigabatrin
626907|NCT00527683|GVG|gvg
626908|NCT00527683|addiction|addiction
626909|NCT00527683|treatment|treatment
626910|NCT00527683|cocaine dependence|cocaine dependence
626911|NCT00527670|Genomics|genomics
626912|NCT00527657|Brain Neoplasms|brain neoplasms
626913|NCT00527657|Melanoma|melanoma
626914|NCT00527657|Metastatic Melanoma|metastatic melanoma
626915|NCT00527657|Brain Metastasis|brain metastasis
626916|NCT00527657|Temozolomide|temozolomide
626917|NCT00527657|Temodar|temodar
626918|NCT00527657|Thalidomide|thalidomide
626919|NCT00527657|Thalomid|thalomid
626920|NCT00527657|Lomustine|lomustine
626921|NCT00527657|CCNU|ccnu
626922|NCT00527657|CeeNU|ceenu
626923|NCT00527644|biliary leaks after laparoscopic cholecystectomy|biliary leaks after laparoscopic cholecystectomy
626924|NCT00527631|advanced ovarian cancer|advanced ovarian cancer
626925|NCT00527631|whole abdominal irradiation|whole abdominal irradiation
626926|NCT00527631|intensity modulated radiotherapy|intensity modulated radiotherapy
626927|NCT00527631|ovarian cancer stage FIGO III|ovarian cancer stage figo iii
626928|NCT00527618|Herpes Simplex Virus Type 2|herpes simplex virus type 2
626929|NCT00527618|Human Immunodeficiency Virus|human immunodeficiency virus
626930|NCT00527618|Treatment Naive|treatment naive
626931|NCT00527605|placebo control|placebo control
626932|NCT00527605|Chinese|chinese
626933|NCT00527605|Dutasteride|dutasteride
626934|NCT00527605|Randomized|randomized
626935|NCT00527605|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
626936|NCT00527605|Double blind|double blind
626937|NCT00527592|Comfort|comfort
626938|NCT00527579|Epilepsy|epilepsy
626939|NCT00527579|Taenia Solium|taenia solium
626940|NCT00527579|Microglia|microglia
626941|NCT00527579|Neuroinflammation|neuroinflammation
626942|NCT00527579|Compartment Model|compartment model
626943|NCT00527579|Neurocysticercosis|neurocysticercosis
626944|NCT00527579|Healthy Volunteer|healthy volunteer
626945|NCT00527579|HV|hv
626946|NCT00527566|Churg Strauss Syndrome|churg strauss syndrome
626947|NCT00527553|Macular pigment|macular pigment
626948|NCT00527553|AMD|amd
626949|NCT00527553|ARM|arm
626950|NCT00527514|Hypertension|hypertension
626951|NCT00527514|Angiotensin Receptor Blocker|angiotensin receptor blocker
626952|NCT00527514|Calcium Channel Blocker|calcium channel blocker
626953|NCT00527514|Stage I and II Hypertension|stage i and ii hypertension
626954|NCT00527501|Open-angle glaucoma|open-angle glaucoma
626955|NCT00527501|ocular hypertension|ocular hypertension
626956|NCT00527488|Benign Prostate Hyperplasia|benign prostate hyperplasia
626957|NCT00527488|BPH|bph
626958|NCT00527488|PK/PD|pk/pd
626959|NCT00527488|GnRH antagonist|gnrh antagonist
626960|NCT00527475|Anti-VEGF therapy|anti-vegf therapy
626961|NCT00527475|photodynamic therapy|photodynamic therapy
626962|NCT00527475|neovascularization|neovascularization
626963|NCT00527462|Asthma GINA 1|asthma gina 1
626964|NCT00527423|VEGF Trap-Eye|vegf trap-eye
626965|NCT00527423|Macular Degeneration|macular degeneration
626966|NCT00527423|AMD|amd
626967|NCT00527423|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
626968|NCT00527397|Diabetes Mellitus|diabetes mellitus
626969|NCT00527384|Stress|stress
626970|NCT00527371|Benign hyperplasia of the prostate|benign hyperplasia of the prostate
626971|NCT00527358|violence|violence
626972|NCT00527345|Asthma|asthma
626973|NCT00527345|Diesel exhaust|diesel exhaust
626974|NCT00527332|Hospitalization|hospitalization
626975|NCT00527332|Postoperative care|postoperative care
626976|NCT00527332|Quality of Life|quality of life
626977|NCT00527332|Health economy|health economy
626978|NCT00527332|Anesthesia. Spinal|anesthesia. spinal
626979|NCT00527332|Anesthesia, General|anesthesia, general
626980|NCT00527319|NSCLC|nsclc
626981|NCT00527319|anorexia|anorexia
626982|NCT00527319|cachexia|cachexia
626983|NCT00527319|grip strength|grip strength
626984|NCT00527319|lean body mass|lean body mass
626985|NCT00527306|aphthous stomatitis|aphthous stomatitis
626986|NCT00527306|canker sores|canker sores
626987|NCT00527306|multivitamins|multivitamins
626988|NCT00527306|vitamin deficiency|vitamin deficiency
626989|NCT00527293|stage I breast cancer|stage i breast cancer
626990|NCT00527293|stage II breast cancer|stage ii breast cancer
626991|NCT00527293|invasive ductal breast carcinoma|invasive ductal breast carcinoma
626992|NCT00527293|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
626993|NCT00527293|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
626994|NCT00527293|tubular ductal breast carcinoma|tubular ductal breast carcinoma
626995|NCT00527293|papillary ductal breast carcinoma|papillary ductal breast carcinoma
626996|NCT00527280|Allotransplantation:composite tissue|allotransplantation:composite tissue
626997|NCT00527280|Face transplantation|face transplantation
626998|NCT00527241|partner violence, spouse abuse|partner violence, spouse abuse
626999|NCT00527228|Muscular dystrophy|muscular dystrophy
627000|NCT00527228|therapy|therapy
627001|NCT00527228|steroids|steroids
627002|NCT00527228|deflazacort|deflazacort
627003|NCT00527228|dysferlinopathy|dysferlinopathy
627004|NCT00527228|LGMD|lgmd
627005|NCT00527228|MM|mm
627006|NCT00527189|Arthritis|arthritis
627007|NCT00527189|Exercise|exercise
627008|NCT00527189|Balance - Postural Control|balance - postural control
627009|NCT00527176|Systemic Lupus Erythematosus|systemic lupus erythematosus
627010|NCT00527176|Corticosteroid|corticosteroid
627011|NCT00527176|Pulse therapy|pulse therapy
627012|NCT00527176|Diffusion weighted imaging|diffusion weighted imaging
627013|NCT00527176|q Space Imaging|q space imaging
627014|NCT00527163|Echocardiogram|echocardiogram
627015|NCT00527163|Endothelial Dysfunction|endothelial dysfunction
627016|NCT00527163|Malaria|malaria
627017|NCT00527163|Mali|mali
627018|NCT00527163|Screening|screening
627019|NCT00527098|Trauma Resuscitation|trauma resuscitation
627020|NCT00527072|plaque psoriasis|plaque psoriasis
627021|NCT00527072|psoriasis|psoriasis
627022|NCT00527072|infliximab|infliximab
627023|NCT00527072|remicade|remicade
627024|NCT00527072|etanercept|etanercept
627025|NCT00527072|enbrel|enbrel
627026|NCT00527072|psunrise|psunrise
627027|NCT00527072|C0168Z04|c0168z04
627028|NCT00527059|Cardiorenal syndrome|cardiorenal syndrome
627029|NCT00527033|YM178|ym178
627030|NCT00527033|Urinary Bladder, Overactive|urinary bladder, overactive
627031|NCT00527020|qEEG,|qeeg,
627032|NCT00527020|GlyT-1 inhibitor,|glyt-1 inhibitor,
627033|NCT00527020|ERP|erp
627034|NCT00527020|GSK1018921,|gsk1018921,
627035|NCT00527020|FTIH,|ftih,
627036|NCT00527020|schizophrenia,|schizophrenia,
627037|NCT00527020|single-dose,|single-dose,
627038|NCT00527020|healthy volunteers,|healthy volunteers,
627039|NCT00527020|MMN,|mmn,
627040|NCT00527007|Vasopressor|vasopressor
627041|NCT00527007|Epinephrine|epinephrine
627042|NCT00527007|Norepinephrine|norepinephrine
627043|NCT00527007|Cooling|cooling
627044|NCT00527007|Fever|fever
627045|NCT00527007|ICU|icu
627046|NCT00526994|intimate partner violence|intimate partner violence
627047|NCT00526994|domestic violence|domestic violence
627048|NCT00526994|spouse abuse|spouse abuse
627049|NCT00526994|screening|screening
627050|NCT00526955|Manual muscle testing|manual muscle testing
627051|NCT00526942|ACRD|acrd
627052|NCT00526942|Visual Memory|visual memory
627053|NCT00526942|Visual Perception|visual perception
627054|NCT00526942|Speed|speed
627055|NCT00526942|Computerized|computerized
627056|NCT00526942|SAAGE|saage
627057|NCT00526942|Cognitive Decline|cognitive decline
627058|NCT00526916|Epilepsy|epilepsy
627059|NCT00526916|Taenia Solium|taenia solium
627060|NCT00526916|Microglia|microglia
627061|NCT00526916|Neuroinflammation|neuroinflammation
627062|NCT00526916|Compartment Model|compartment model
627063|NCT00526916|Neurocysticercosis|neurocysticercosis
627064|NCT00526916|Healthy Volunteer|healthy volunteer
627065|NCT00526916|HV|hv
627066|NCT00526903|IBS|ibs
627067|NCT00526903|abdominal pain|abdominal pain
627068|NCT00526903|recurrent abdominal pain|recurrent abdominal pain
627069|NCT00526903|irritable bowel syndrome|irritable bowel syndrome
627070|NCT00526903|diarrhea|diarrhea
627071|NCT00526903|constipation|constipation
627072|NCT00526903|bloating|bloating
627073|NCT00526890|squamous cell lung cancer|squamous cell lung cancer
627074|NCT00526890|adenocarcinoma of the lung|adenocarcinoma of the lung
627075|NCT00526890|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
627076|NCT00526890|large cell lung cancer|large cell lung cancer
627077|NCT00526890|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
627078|NCT00526890|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
627079|NCT00526890|adenosquamous cell lung cancer|adenosquamous cell lung cancer
627080|NCT00526877|Schizophrenia|schizophrenia
627081|NCT00526877|Schizoaffective disorders|schizoaffective disorders
627082|NCT00526877|Risperidone|risperidone
627083|NCT00526877|Risperdal Consta|risperdal consta
627084|NCT00526864|Burden of Illness for Herpes zoster in Thailand.|burden of illness for herpes zoster in thailand.
627085|NCT00526851|lip and oral cavity cancer|lip and oral cavity cancer
627086|NCT00526851|oropharyngeal cancer|oropharyngeal cancer
627087|NCT00526838|Solid Tumor|solid tumor
627088|NCT00526838|Multiple Myeloma|multiple myeloma
627089|NCT00526786|Low Grade Dysplasia|low grade dysplasia
627090|NCT00526786|High Grade Dysplasia|high grade dysplasia
627091|NCT00526786|Barrett's Esophagus|barrett's esophagus
627092|NCT00526786|Cryospray ablation|cryospray ablation
627093|NCT00526786|ICE|ice
627094|NCT00526786|Cryotherapy|cryotherapy
627095|NCT00526786|Cryo|cryo
627096|NCT00526786|CryoSpray|cryospray
627097|NCT00526773|motivational therapy|motivational therapy
627098|NCT00526760|Dexmedetomidine, Sedation, Long-term, Phase 3|dexmedetomidine, sedation, long-term, phase 3
627099|NCT00526734|stage I multiple myeloma|stage i multiple myeloma
627100|NCT00526734|stage II multiple myeloma|stage ii multiple myeloma
627101|NCT00526734|stage III multiple myeloma|stage iii multiple myeloma
627102|NCT00526721|Hypercholesterolemia|hypercholesterolemia
627103|NCT00526721|Crestor|crestor
627104|NCT00526721|LDL target goal|ldl target goal
627105|NCT00526721|high risk patients|high risk patients
627106|NCT00526721|Naturalistic|naturalistic
627107|NCT00526721|Observational|observational
627108|NCT00526708|dyslipidemia|dyslipidemia
627109|NCT00526708|hypertension|hypertension
627110|NCT00526708|rosuvastatin|rosuvastatin
627111|NCT00526708|efficacy|efficacy
627112|NCT00526708|Naturalistic|naturalistic
627113|NCT00526708|Observational|observational
627114|NCT00526695|Ischemia/Reperfusion|ischemia/reperfusion
627115|NCT00526695|Organ Protection|organ protection
627116|NCT00526695|Anesthetics|anesthetics
627117|NCT00526682|Antiobesity|antiobesity
627118|NCT00526682|Weight loss|weight loss
627119|NCT00526669|tumor biopsy|tumor biopsy
627120|NCT00526669|capecitabine|capecitabine
627121|NCT00526669|first line|first line
627501|NCT00525603|Fludarabine|fludarabine
627122|NCT00526669|Gastro Esophageal (GE) Junction Cancer|gastro esophageal (ge) junction cancer
627123|NCT00526669|Gastric cancer|gastric cancer
627124|NCT00526669|newly diagnosed|newly diagnosed
627125|NCT00526669|GE junction|ge junction
627126|NCT00526669|lapatinib|lapatinib
627127|NCT00526669|metastatic or unresectable|metastatic or unresectable
627128|NCT00526656|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
627129|NCT00526656|stage II bladder cancer|stage ii bladder cancer
627130|NCT00526656|stage III bladder cancer|stage iii bladder cancer
627131|NCT00526656|stage IV bladder cancer|stage iv bladder cancer
627132|NCT00526643|stage IIIB|stage iiib
627133|NCT00526643|Stage IV|stage iv
627134|NCT00526643|chemotherapy|chemotherapy
627135|NCT00526643|monotherapy|monotherapy
627136|NCT00526643|combination chemotherapy|combination chemotherapy
627137|NCT00526643|poor performance status|poor performance status
627138|NCT00526630|freezing|freezing
627139|NCT00526630|gait|gait
627140|NCT00526630|festination|festination
627141|NCT00526630|shuffling|shuffling
627142|NCT00526630|balance|balance
627143|NCT00526617|Solid Tumor|solid tumor
627144|NCT00526617|Melanoma|melanoma
627145|NCT00526617|Breast cancer|breast cancer
627146|NCT00526617|Ovarian cancer|ovarian cancer
627147|NCT00526617|Primary peritoneal cancer|primary peritoneal cancer
627148|NCT00526617|Fallopian tube cancer|fallopian tube cancer
627149|NCT00526617|Hepatocellular carcinoma|hepatocellular carcinoma
627150|NCT00526617|HCC|hcc
627151|NCT00526617|BRCA deficient|brca deficient
627152|NCT00526617|BRCA mutation|brca mutation
627153|NCT00526617|Temozolomide|temozolomide
627154|NCT00526617|Temodar|temodar
627155|NCT00526617|TMZ|tmz
627156|NCT00526617|ABT-888|abt-888
627157|NCT00526617|PARP inhibitor|parp inhibitor
627158|NCT00526604|return to work|return to work
627159|NCT00526604|low back pain|low back pain
627160|NCT00526604|work related rehabilitation|work related rehabilitation
627161|NCT00526591|adenocarcinoma of the prostate|adenocarcinoma of the prostate
627162|NCT00526591|stage I prostate cancer|stage i prostate cancer
627163|NCT00526591|stage II prostate cancer|stage ii prostate cancer
627164|NCT00526591|stage III prostate cancer|stage iii prostate cancer
627165|NCT00526578|Pancreatic Cancer|pancreatic cancer
627166|NCT00526578|Pancreatic Cancer Genetic Epidemiology|pancreatic cancer genetic epidemiology
627167|NCT00526578|PACGENE|pacgene
627168|NCT00526578|Healthy Control|healthy control
627169|NCT00526578|Familial Pancreatic Cancer|familial pancreatic cancer
627170|NCT00526578|FPC|fpc
627171|NCT00526578|Questionnaire|questionnaire
627172|NCT00526552|dyslipidemia|dyslipidemia
627173|NCT00526552|rosuvastatin|rosuvastatin
627174|NCT00526552|diabetes|diabetes
627175|NCT00526552|cholesterol|cholesterol
627176|NCT00526552|Naturalistic|naturalistic
627177|NCT00526552|Observational|observational
627178|NCT00526539|THR|thr
627179|NCT00526539|reversed hybrid|reversed hybrid
627180|NCT00526539|wear|wear
627181|NCT00526500|Severe Traumatic Brain Injury|severe traumatic brain injury
627182|NCT00526500|Subarachnoid Hemorrhage|subarachnoid hemorrhage
627183|NCT00526500|Anoxic Brain Injury|anoxic brain injury
627184|NCT00526500|Passive Gait Training|passive gait training
627185|NCT00526500|Tilt Table With Integrated Stepping System|tilt table with integrated stepping system
627186|NCT00526500|Electroencephalogram|electroencephalogram
627187|NCT00526500|Event Related Potentials|event related potentials
627188|NCT00526487|Thoracic Dissection|thoracic dissection
627189|NCT00526487|Dissection|dissection
627190|NCT00526487|Endovascular|endovascular
627191|NCT00526461|stage 0 non-small cell lung cancer|stage 0 non-small cell lung cancer
627192|NCT00526461|adenocarcinoma of the lung|adenocarcinoma of the lung
627193|NCT00526461|squamous cell lung cancer|squamous cell lung cancer
627194|NCT00526461|large cell lung cancer|large cell lung cancer
627195|NCT00526448|high dose of ribavirin|high dose of ribavirin
627196|NCT00526448|extend treatment duration|extend treatment duration
627197|NCT00526448|tailoring treatment|tailoring treatment
627198|NCT00526435|Arthritis|arthritis
627199|NCT00526435|osteoarthritis|osteoarthritis
627200|NCT00526435|rheumatoid arthritis|rheumatoid arthritis
627201|NCT00526435|fibromyalgia|fibromyalgia
627202|NCT00526435|lupus|lupus
627203|NCT00526422|Questionnaire, dental caries, diagnosis,treatment|questionnaire, dental caries, diagnosis,treatment
627204|NCT00526409|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
627205|NCT00526396|chemotherapy|chemotherapy
627206|NCT00526396|toxicity adjusted dose|toxicity adjusted dose
627207|NCT00526383|Major depressive disorder|major depressive disorder
627208|NCT00526383|Antidepressants|antidepressants
627209|NCT00526383|Weight gain|weight gain
627210|NCT00526383|Metabolic syndromes|metabolic syndromes
627211|NCT00526370|self test|self test
627212|NCT00526370|PAP smear|pap smear
627213|NCT00526370|tampon test|tampon test
627214|NCT00526370|E6/E7|e6/e7
627215|NCT00526370|mRNA|mrna
627216|NCT00526370|HPV|hpv
627217|NCT00526357|omega-3 fatty acids|omega-3 fatty acids
627218|NCT00526357|asthma|asthma
627219|NCT00526357|airway hyperresponsiveness|airway hyperresponsiveness
627220|NCT00526357|inflammation|inflammation
627221|NCT00526344|remission of asthma|remission of asthma
627222|NCT00526331|Perioperative Therapy|perioperative therapy
627223|NCT00526331|Perioperative Hydration|perioperative hydration
627224|NCT00526331|Arterial Pressure Based Cardiac Output|arterial pressure based cardiac output
627225|NCT00526331|Vigileo Monitor|vigileo monitor
627226|NCT00526331|FloTrac Sensor|flotrac sensor
627227|NCT00526331|Fluid Volume|fluid volume
627228|NCT00526331|APCO|apco
627229|NCT00526318|localized resectable neuroblastoma|localized resectable neuroblastoma
627230|NCT00526318|localized unresectable neuroblastoma|localized unresectable neuroblastoma
627231|NCT00526318|regional neuroblastoma|regional neuroblastoma
627232|NCT00526318|stage 4S neuroblastoma|stage 4s neuroblastoma
627233|NCT00526318|disseminated neuroblastoma|disseminated neuroblastoma
627234|NCT00526305|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
627235|NCT00526305|Chromosome Philadelphia positive|chromosome philadelphia positive
627236|NCT00526292|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
627237|NCT00526292|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
627238|NCT00526292|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
627239|NCT00526292|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
627240|NCT00526292|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
627241|NCT00526292|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
627242|NCT00526292|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
627243|NCT00526292|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
627244|NCT00526292|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
627245|NCT00526292|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
627246|NCT00526292|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
627247|NCT00526292|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
627248|NCT00526292|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
627249|NCT00526292|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
627250|NCT00526279|Hypertension|hypertension
627251|NCT00526279|Atacand/Atacand plus|atacand/atacand plus
627252|NCT00526279|COMBAT|combat
627253|NCT00526279|Compliance|compliance
627254|NCT00526279|Naturalistic|naturalistic
627255|NCT00526279|Observational|observational
627256|NCT00526253|Congestive Heart Failure|congestive heart failure
627257|NCT00526253|CHF|chf
627258|NCT00526253|Heart Disease|heart disease
627259|NCT00526253|Heart Attack|heart attack
627260|NCT00526253|Stem Cell|stem cell
627261|NCT00526253|Myoblast|myoblast
627262|NCT00526253|Bioheart|bioheart
627263|NCT00526214|Spontaneous intracerebral hemorrhage|spontaneous intracerebral hemorrhage
627264|NCT00526214|Acute Spontaneous, Supratentorial intracerebral hemorrhage|acute spontaneous, supratentorial intracerebral hemorrhage
627265|NCT00526201|Arthritis|arthritis
627266|NCT00526201|Osteoarthritis|osteoarthritis
627267|NCT00526201|Rheumatoid Arthritis|rheumatoid arthritis
627268|NCT00526201|Fibromyalgia|fibromyalgia
627269|NCT00526201|Lupus|lupus
627270|NCT00526188|Primovist|primovist
627271|NCT00526188|Chinese patients|chinese patients
627272|NCT00526188|Liver MRI|liver mri
627273|NCT00526175|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
627274|NCT00526175|Minimal Residual Disease|minimal residual disease
627275|NCT00526149|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
627276|NCT00526149|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
627277|NCT00526149|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
627278|NCT00526149|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
627279|NCT00526149|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
627280|NCT00526149|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
627281|NCT00526149|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
627282|NCT00526149|recurrent breast cancer|recurrent breast cancer
627283|NCT00526149|stage IV breast cancer|stage iv breast cancer
627284|NCT00526149|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
627285|NCT00526149|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
627286|NCT00526149|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
627287|NCT00526149|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
627288|NCT00526149|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
627289|NCT00526149|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
627290|NCT00526149|adult leiomyosarcoma|adult leiomyosarcoma
627291|NCT00526149|uterine leiomyosarcoma|uterine leiomyosarcoma
627292|NCT00526149|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
627293|NCT00526149|adult angiosarcoma|adult angiosarcoma
627294|NCT00526149|adult desmoplastic small round cell tumor|adult desmoplastic small round cell tumor
627295|NCT00526149|adult epithelioid sarcoma|adult epithelioid sarcoma
627296|NCT00526149|adult fibrosarcoma|adult fibrosarcoma
627297|NCT00526149|adult liposarcoma|adult liposarcoma
627298|NCT00526149|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
627299|NCT00526149|adult malignant mesenchymoma|adult malignant mesenchymoma
627300|NCT00526149|adult neurofibrosarcoma|adult neurofibrosarcoma
627301|NCT00526149|adult rhabdomyosarcoma|adult rhabdomyosarcoma
627302|NCT00526149|adult synovial sarcoma|adult synovial sarcoma
627303|NCT00526149|endometrial stromal sarcoma|endometrial stromal sarcoma
627304|NCT00526149|ovarian carcinosarcoma|ovarian carcinosarcoma
627305|NCT00526149|ovarian sarcoma|ovarian sarcoma
627306|NCT00526149|recurrent uterine sarcoma|recurrent uterine sarcoma
627307|NCT00526149|stage IV uterine sarcoma|stage iv uterine sarcoma
627308|NCT00526149|recurrent melanoma|recurrent melanoma
627309|NCT00526149|stage IV melanoma|stage iv melanoma
627310|NCT00526136|Atrial Fibrillation|atrial fibrillation
627311|NCT00526123|Dialysis|dialysis
627312|NCT00526123|Dialysis Catheter|dialysis catheter
627313|NCT00526123|Kidney Disease|kidney disease
627314|NCT00526123|Dialysis Clinic|dialysis clinic
627315|NCT00526123|Chronic Catheter|chronic catheter
627316|NCT00526123|Catheter|catheter
627317|NCT00526123|Kidney|kidney
627318|NCT00526110|Gastrointestinal Diseases|gastrointestinal diseases
627319|NCT00526110|Adenocarcinoma of the Stomach|adenocarcinoma of the stomach
627320|NCT00526110|Gastroesophageal Junction Cancer|gastroesophageal junction cancer
627321|NCT00526110|Cancer of the Stomach|cancer of the stomach
627322|NCT00526110|5-Fluorouracil|5-fluorouracil
627323|NCT00526110|5-FU|5-fu
627324|NCT00526110|Adrucil|adrucil
627325|NCT00526110|Efudex|efudex
627326|NCT00526110|Docetaxel|docetaxel
627327|NCT00526110|Oxaliplatin|oxaliplatin
627328|NCT00526110|Eloxatin|eloxatin
627329|NCT00526110|Taxotere|taxotere
627330|NCT00526110|Esophagus|esophagus
627331|NCT00526084|ALL|all
627332|NCT00526084|Healthy subjects|healthy subjects
627333|NCT00526071|Fabry Disease|fabry disease
627334|NCT00526071|Lysosomal Storage Disorder|lysosomal storage disorder
627335|NCT00526058|Heparin|heparin
627336|NCT00526058|Extracorporeal|extracorporeal
627337|NCT00526058|Low Density Lipo-Protein (LDL) Cholesterol|low density lipo-protein (ldl) cholesterol
627338|NCT00526058|Apheresis|apheresis
627339|NCT00526058|Device|device
627340|NCT00526045|AUY922|auy922
627341|NCT00526045|Solid tumors|solid tumors
627342|NCT00526045|Breast Cancer|breast cancer
627343|NCT00526045|Phase I/II|phase i/ii
627344|NCT00526045|Advanced Solid malignancies (Phase I)|advanced solid malignancies (phase i)
627345|NCT00526045|Breast Cancer ( Phase II )|breast cancer ( phase ii )
627346|NCT00526045|HER2+|her2+
627347|NCT00526045|ER+|er+
627348|NCT00526045|HSP90|hsp90
627349|NCT00526032|Skin Cancer|skin cancer
627350|NCT00526032|Cancerous skin lesions|cancerous skin lesions
627351|NCT00526032|Melanoma Detection|melanoma detection
627352|NCT00526032|Spectroscopic Oblique-Incidence Reflectometry|spectroscopic oblique-incidence reflectometry
627353|NCT00526032|OIR Imaging Probe|oir imaging probe
627354|NCT00526019|remission of asthma|remission of asthma
627355|NCT00526006|Clinical significance of the acid rebound phenomenon after withdrawal of treatment with a PPI|clinical significance of the acid rebound phenomenon after withdrawal of treatment with a ppi
627356|NCT00525993|sports|sports
627357|NCT00525993|ankle|ankle
627358|NCT00525993|sprain|sprain
627359|NCT00525993|etoricoxib|etoricoxib
627360|NCT00525993|antiinflammatory|antiinflammatory
627361|NCT00525993|treatment outcome|treatment outcome
627362|NCT00525980|Breast Cancer|breast cancer
627363|NCT00525980|Cancer Risk|cancer risk
627364|NCT00525980|CD-ROM|cd-rom
627365|NCT00525980|Focus Group|focus group
627366|NCT00525980|Cancer Genetics|cancer genetics
627367|NCT00525967|Cancer Pain|cancer pain
627368|NCT00525967|Methadone|methadone
627369|NCT00525967|Morphine|morphine
627370|NCT00525967|Acetaminophen|acetaminophen
627371|NCT00525967|Palliative Care|palliative care
627372|NCT00525954|Coronary|coronary
627373|NCT00525954|Artery|artery
627374|NCT00525954|Artheroschlerosis|artheroschlerosis
627375|NCT00525954|Phospholipase|phospholipase
627376|NCT00525954|CAD|cad
627377|NCT00525954|Coronary Artery Disease (CAD)|coronary artery disease (cad)
627378|NCT00525928|craving|craving
627379|NCT00525928|smoking|smoking
627380|NCT00525928|depression|depression
627381|NCT00525915|Esophageal Cancer|esophageal cancer
627382|NCT00525915|Gastroesophageal Cancer|gastroesophageal cancer
627383|NCT00525915|Gastroesophageal Junction|gastroesophageal junction
627384|NCT00525915|Radiation Therapy|radiation therapy
627385|NCT00525915|5-Fluorouracil|5-fluorouracil
627386|NCT00525915|5-FU|5-fu
627387|NCT00525915|Adrucil|adrucil
627388|NCT00525915|Efudex|efudex
627389|NCT00525915|Oxaliplatin|oxaliplatin
627390|NCT00525889|diabetes|diabetes
627391|NCT00525889|juvenile diabetes|juvenile diabetes
627392|NCT00525889|type 1 diabetes|type 1 diabetes
627393|NCT00525889|diabetes mellitus|diabetes mellitus
627394|NCT00525889|recent onset|recent onset
627395|NCT00525889|new onset|new onset
627396|NCT00525876|Mantle Cell Lymphoma|mantle cell lymphoma
627397|NCT00525876|Lymphoma|lymphoma
627500|NCT00525603|Cyclophosphamide|cyclophosphamide
627398|NCT00525876|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
627399|NCT00525876|Rituximab|rituximab
627400|NCT00525876|Cyclophosphamide|cyclophosphamide
627401|NCT00525876|Neosar|neosar
627402|NCT00525876|Cytoxan|cytoxan
627403|NCT00525876|Fludarabine|fludarabine
627404|NCT00525876|Fludara|fludara
627405|NCT00525876|Fludarabine phosphate|fludarabine phosphate
627406|NCT00525876|Rituxan|rituxan
627407|NCT00525876|Alemtuzumab|alemtuzumab
627408|NCT00525876|CAMPATH-1H|campath-1h
627409|NCT00525876|Campath|campath
627410|NCT00525876|Total Body Irradiation|total body irradiation
627411|NCT00525876|TBI|tbi
627412|NCT00525863|schizophrenia|schizophrenia
627413|NCT00525863|oxygen therapy|oxygen therapy
627414|NCT00525850|cardiovascular disease|cardiovascular disease
627415|NCT00525850|weight loss|weight loss
627416|NCT00525837|varenicline|varenicline
627417|NCT00525837|depression|depression
627418|NCT00525837|anhedonia|anhedonia
627419|NCT00525837|smoking|smoking
627420|NCT00525824|Hypercholesterolaemia|hypercholesterolaemia
627421|NCT00525824|Coronary Heart Disease (CHD)|coronary heart disease (chd)
627422|NCT00525824|Atherosclerosis|atherosclerosis
627423|NCT00525798|Osteoporosis, oral salmon calcitonin, treatment, efficacy, tolerability|osteoporosis, oral salmon calcitonin, treatment, efficacy, tolerability
627424|NCT00525785|Stomach Cancer|stomach cancer
627425|NCT00525785|Gastric Cancer|gastric cancer
627426|NCT00525785|Adenocarcinoma of the Stomach|adenocarcinoma of the stomach
627427|NCT00525785|Gastroesophageal Junction|gastroesophageal junction
627428|NCT00525785|Esophageal|esophageal
627429|NCT00525785|Gastric|gastric
627430|NCT00525785|5-Fluorouracil|5-fluorouracil
627431|NCT00525785|5-FU|5-fu
627432|NCT00525785|Adrucil|adrucil
627433|NCT00525785|Efudex|efudex
627434|NCT00525785|Folinic Acid|folinic acid
627435|NCT00525785|Oxaliplatin|oxaliplatin
627436|NCT00525785|Eloxatin|eloxatin
627437|NCT00525785|Chemoradiotherapy|chemoradiotherapy
627438|NCT00525785|Radiation|radiation
627439|NCT00525785|Radiotherapy|radiotherapy
627440|NCT00525785|XRT|xrt
627441|NCT00525772|asthma|asthma
627442|NCT00525772|exercise induced bronchoconstriction|exercise induced bronchoconstriction
627443|NCT00525772|sputum eosinophils|sputum eosinophils
627444|NCT00525759|Breast cancer|breast cancer
627445|NCT00525759|Zoledronic acid|zoledronic acid
627446|NCT00525759|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
627447|NCT00525759|Synergy|synergy
627448|NCT00525759|Apoptosis|apoptosis
627449|NCT00525746|Acute Myeloid Leukemia|acute myeloid leukemia
627450|NCT00525746|Myelodysplastic Syndrome|myelodysplastic syndrome
627451|NCT00525746|Leukemia|leukemia
627452|NCT00525746|MDS|mds
627453|NCT00525746|AML|aml
627454|NCT00525746|Malignancy|malignancy
627455|NCT00525746|Molecular Epidemiology|molecular epidemiology
627456|NCT00525746|Epidemiologic markers|epidemiologic markers
627457|NCT00525746|Clinical markers|clinical markers
627458|NCT00525746|Constitutional genetic markers|constitutional genetic markers
627459|NCT00525746|Case-comparison study|case-comparison study
627460|NCT00525733|HIV-1|hiv-1
627461|NCT00525733|Acute Infection|acute infection
627462|NCT00525733|Treatment Naive|treatment naive
627463|NCT00525720|Prostate Cancer|prostate cancer
627464|NCT00525720|Prostatic Carcinoma|prostatic carcinoma
627465|NCT00525720|Intermediate prostate cancer|intermediate prostate cancer
627466|NCT00525720|Transperineal Interstitial Permanent Brachytherapy|transperineal interstitial permanent brachytherapy
627467|NCT00525720|Brachytherapy|brachytherapy
627468|NCT00525720|Prostate brachytherapy|prostate brachytherapy
627469|NCT00525720|Prostate implant|prostate implant
627470|NCT00525720|Prostate|prostate
627471|NCT00525720|Questionnaire|questionnaire
627472|NCT00525720|Survey|survey
627473|NCT00525707|acute heart failure|acute heart failure
627474|NCT00525707|Actelion|actelion
627475|NCT00525707|tezosentan|tezosentan
627476|NCT00525707|acute decompensation of chronic heart failure|acute decompensation of chronic heart failure
627477|NCT00525707|New onset of heart failure|new onset of heart failure
627478|NCT00525681|Obese|obese
627479|NCT00525681|Calcineurine inhibitor|calcineurine inhibitor
627480|NCT00525681|Pharmacokinetics|pharmacokinetics
627481|NCT00525681|Interaction|interaction
627482|NCT00525668|multiple sclerosis|multiple sclerosis
627483|NCT00525668|inflammation|inflammation
627484|NCT00525668|neurodegeneration|neurodegeneration
627485|NCT00525668|neuroprotection|neuroprotection
627486|NCT00525655|Familial Adenomatous Polyposis|familial adenomatous polyposis
627487|NCT00525655|Colorectal Cancer|colorectal cancer
627488|NCT00525655|Multimedia Intervention|multimedia intervention
627489|NCT00525655|Questionnaire|questionnaire
627490|NCT00525655|Survey|survey
627491|NCT00525655|FAP|fap
627492|NCT00525642|Breast-adjuvant|breast-adjuvant
627493|NCT00525642|Breast-chemotherapy|breast-chemotherapy
627494|NCT00525642|Combination chemotherapy regimens|combination chemotherapy regimens
627495|NCT00525616|bullous pemphigoid|bullous pemphigoid
627496|NCT00525616|mabthera|mabthera
627497|NCT00525603|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
627498|NCT00525603|CML|cml
627499|NCT00525603|Leukemia|leukemia
627502|NCT00525603|Alemtuzumab|alemtuzumab
627503|NCT00525603|Rituximab|rituximab
627504|NCT00525603|CFAR|cfar
627505|NCT00525590|Gliadel|gliadel
627506|NCT00525577|Type 2 diabetes, glycemic control|type 2 diabetes, glycemic control
627507|NCT00525564|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
627508|NCT00525564|Exercise|exercise
627509|NCT00525564|Endurance shuttle walking test|endurance shuttle walking test
627510|NCT00525564|Bronchodilation|bronchodilation
627511|NCT00525564|Salmeterol|salmeterol
627512|NCT00525525|Glioblastoma|glioblastoma
627513|NCT00525525|Gliosarcoma|gliosarcoma
627514|NCT00525525|Bevacizumab|bevacizumab
627515|NCT00525525|Avastin|avastin
627516|NCT00525525|Erlotinib|erlotinib
627517|NCT00525525|Tarceva|tarceva
627518|NCT00525525|Temozolomide|temozolomide
627519|NCT00525525|Temodar|temodar
627520|NCT00525499|acne|acne
627521|NCT00525486|Nifedipine|nifedipine
627522|NCT00525486|Tocolysis|tocolysis
627523|NCT00525486|Maintenance|maintenance
627524|NCT00525486|Preterm delivery|preterm delivery
627525|NCT00525486|extended release nifedipine|extended release nifedipine
627527|NCT00525460|fertility|fertility
627528|NCT00525460|stage I ovarian cancer|stage i ovarian cancer
627529|NCT00525460|stage II ovarian cancer|stage ii ovarian cancer
627530|NCT00525460|fertility sparing|fertility sparing
627531|NCT00525447|Antigens, CD40|antigens, cd40
627532|NCT00525447|Antibodies, Monoclonal|antibodies, monoclonal
627533|NCT00525447|Combined Modality Therapy|combined modality therapy
627534|NCT00525447|Multiple Myeloma|multiple myeloma
627535|NCT00525447|Blood Coagulation Disorders|blood coagulation disorders
627536|NCT00525447|Hematologic Diseases|hematologic diseases
627537|NCT00525447|Hemorrhagic Disorders|hemorrhagic disorders
627538|NCT00525447|Hemostatic Disorders|hemostatic disorders
627539|NCT00525447|Immunoproliferative Disorders|immunoproliferative disorders
627540|NCT00525447|Lymphoproliferative Disorders|lymphoproliferative disorders
627541|NCT00525447|Paraproteinemias|paraproteinemias
627542|NCT00525447|Vascular Diseases|vascular diseases
627543|NCT00525447|Antibody-Dependent Cell Cytotoxicity|antibody-dependent cell cytotoxicity
627544|NCT00525434|Laser bonding soft tissue albumin|laser bonding soft tissue albumin
627545|NCT00525421|curcuminoids|curcuminoids
627546|NCT00525421|oral lichen planus|oral lichen planus
627547|NCT00525421|c reactive protein|c reactive protein
627548|NCT00525421|interleukin 6|interleukin 6
627549|NCT00525408|HRPC|hrpc
627550|NCT00525408|Metastatic Hormone Refractory Prostate Cancer|metastatic hormone refractory prostate cancer
627551|NCT00525408|Docetaxel|docetaxel
627552|NCT00525408|Mycobacterium w|mycobacterium w
627553|NCT00525395|Phototherapy|phototherapy
627554|NCT00525395|Vitiligo scoring system|vitiligo scoring system
627555|NCT00525382|Levocetirizine dihydrochloride|levocetirizine dihydrochloride
627556|NCT00525382|Xyzal tablets|xyzal tablets
627557|NCT00525356|Aorta|aorta
627558|NCT00525356|Dissection|dissection
627559|NCT00525356|Thoracic|thoracic
627560|NCT00525343|Avonex pivotal trial|avonex pivotal trial
627561|NCT00525343|Avonex|avonex
627562|NCT00525343|Avonex long term follow-up|avonex long term follow-up
627563|NCT00525343|Avonex outcomes|avonex outcomes
627564|NCT00525317|Pregnancy|pregnancy
627565|NCT00525317|Magnesium|magnesium
627566|NCT00525317|Leg Pain|leg pain
627567|NCT00525304|medical co-morbidity|medical co-morbidity
627568|NCT00525304|diabetes|diabetes
627569|NCT00525304|heart disease|heart disease
627570|NCT00525304|respiratory illness|respiratory illness
627571|NCT00525291|Exercise Therapy|exercise therapy
627572|NCT00525291|Biofeedback (Psychology)|biofeedback (psychology)
627573|NCT00525291|Adult|adult
627574|NCT00525291|Fecal Incontinence/*therapy|fecal incontinence/*therapy
627575|NCT00525291|EMG - Biofeedback|emg - biofeedback
627576|NCT00525291|EMG - Triggered Stimulation|emg - triggered stimulation
627577|NCT00525291|Augmented biofeedback|augmented biofeedback
627578|NCT00525278|Levocetirizine dihydrochloride|levocetirizine dihydrochloride
627579|NCT00525278|Xyzal tablets|xyzal tablets
627580|NCT00525265|Vasopressin antagonist|vasopressin antagonist
627581|NCT00525265|Cardiac Edema|cardiac edema
627582|NCT00525265|Diuretics|diuretics
627583|NCT00525252|Liver cirrhosis|liver cirrhosis
627584|NCT00525252|Alcoholism|alcoholism
627585|NCT00525252|Craving|craving
627586|NCT00525239|Lipids|lipids
627587|NCT00525239|lipoproteins|lipoproteins
627588|NCT00525239|VLDL|vldl
627589|NCT00525239|triglycerides|triglycerides
627590|NCT00525239|apo B100|apo b100
627591|NCT00525239|HDL|hdl
627592|NCT00525239|apo A1|apo a1
627593|NCT00525239|endothelial dysfunction|endothelial dysfunction
627594|NCT00525239|insulin secretion|insulin secretion
627595|NCT00525239|hyperglycemic clamp|hyperglycemic clamp
627596|NCT00525239|HIV-seronegative Volunteers|hiv-seronegative volunteers
627597|NCT00525239|HIV-infected subjects starting an efavirenz-based regimen|hiv-infected subjects starting an efavirenz-based regimen
627598|NCT00525239|Treatment Experienced|treatment experienced
627599|NCT00525226|Psychiatry|psychiatry
627600|NCT00525226|Psychology|psychology
627601|NCT00525226|Pregnancy|pregnancy
627602|NCT00525226|Stress|stress
627603|NCT00525226|Anxiety|anxiety
627604|NCT00525213|Rheumatoid Arthritis|rheumatoid arthritis
627605|NCT00525200|predictive marker|predictive marker
627606|NCT00525200|personalized therapy|personalized therapy
627607|NCT00525200|response assessment|response assessment
627608|NCT00525200|p53 genotype|p53 genotype
627609|NCT00525187|onychomycosis|onychomycosis
627610|NCT00525187|diabetic neuropathic patients|diabetic neuropathic patients
627611|NCT00525187|reliability of the diagnostic of onychomycosis|reliability of the diagnostic of onychomycosis
627612|NCT00525174|Amblyopia|amblyopia
627613|NCT00525174|Patching|patching
627614|NCT00525174|Bangerter filters|bangerter filters
627615|NCT00525161|breast cancer|breast cancer
627616|NCT00525161|Sorafenib|sorafenib
627617|NCT00525161|Nexavar|nexavar
627618|NCT00525161|Endocrine Therapy|endocrine therapy
627619|NCT00525122|hyperthyroidism|hyperthyroidism
627620|NCT00525122|radioactive iodine|radioactive iodine
627621|NCT00525122|antithyroid drugs|antithyroid drugs
627622|NCT00525122|Hyperthyroidism, treatment with radioactive iodine without antithyroid drugs|hyperthyroidism, treatment with radioactive iodine without antithyroid drugs
627623|NCT00525109|Cholesterol|cholesterol
627624|NCT00525109|Hyperlipidemia|hyperlipidemia
627625|NCT00525109|Gene array|gene array
627626|NCT00525083|hyperlipidemia|hyperlipidemia
627627|NCT00525083|HDL-C|hdl-c
627628|NCT00525083|low density lipoprotein|low density lipoprotein
627629|NCT00525057|Bone Cancer|bone cancer
627630|NCT00525057|Orthopaedic Oncology|orthopaedic oncology
627631|NCT00525057|Orthopaedics|orthopaedics
627632|NCT00525057|Myeloma|myeloma
627633|NCT00525057|Lymphoma|lymphoma
627634|NCT00525057|Deep Venous Thrombosis|deep venous thrombosis
627635|NCT00525057|DVT Prophylaxis|dvt prophylaxis
627636|NCT00525057|Thromboembolic disease|thromboembolic disease
627637|NCT00525057|Blood clots|blood clots
627638|NCT00525057|Dalteparin|dalteparin
627639|NCT00525057|Fragmin|fragmin
627640|NCT00525057|Surgery|surgery
627641|NCT00525057|Bone Tumor|bone tumor
627642|NCT00525057|Tumor of soft tissue|tumor of soft tissue
627643|NCT00525057|Lower extremity|lower extremity
627644|NCT00525057|Leg|leg
627645|NCT00525057|TED hose|ted hose
627646|NCT00525057|Mechanical compression stocking|mechanical compression stocking
627647|NCT00525031|Melanoma|melanoma
627648|NCT00525031|Temozolomide|temozolomide
627649|NCT00525031|Temodar|temodar
627650|NCT00525031|Pegylated Interferon Alpha-2b|pegylated interferon alpha-2b
627651|NCT00525031|PEG-Intron|peg-intron
627652|NCT00525031|PGI|pgi
627653|NCT00525031|Resectable metastatic melanoma|resectable metastatic melanoma
627654|NCT00525031|Surgery|surgery
627655|NCT00525018|Pain|pain
627656|NCT00525018|Functional neuroimaging|functional neuroimaging
627657|NCT00525018|Neuropathy|neuropathy
627658|NCT00525018|Thermal sensation|thermal sensation
627659|NCT00525005|Stomach Neoplasm|stomach neoplasm
627660|NCT00525005|Docetaxel|docetaxel
627661|NCT00525005|Oxaliplatin|oxaliplatin
627662|NCT00525005|S-1|s-1
627663|NCT00524992|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
627664|NCT00524992|Collapsing Glomerulopathy|collapsing glomerulopathy
627665|NCT00524992|Anti-Retroviral Toxicity|anti-retroviral toxicity
627666|NCT00524992|Lipodystrophy|lipodystrophy
627667|NCT00524992|Metabolic Syndrome|metabolic syndrome
627668|NCT00524992|Tubular Injury|tubular injury
627669|NCT00524992|Renal Biopsy|renal biopsy
627670|NCT00524992|Proteinuria|proteinuria
627671|NCT00524992|Tenofovir Toxicity|tenofovir toxicity
627672|NCT00524992|HAART Toxicity|haart toxicity
627673|NCT00524992|HIV Positive|hiv positive
627674|NCT00524992|HIV-Associated Focal Segmental Glomerulosclerosis|hiv-associated focal segmental glomerulosclerosis
627675|NCT00524953|allogeneic bone marrow transplantation|allogeneic bone marrow transplantation
627676|NCT00524953|non-T-cell depleted|non-t-cell depleted
627677|NCT00524953|UV-c|uv-c
627678|NCT00524953|GVHD|gvhd
627679|NCT00524940|Influenza|influenza
627680|NCT00524940|Orthomyxoviruses|orthomyxoviruses
627681|NCT00524940|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
627682|NCT00524927|Incident Pain|incident pain
627683|NCT00524927|Bone Marrow Biopsy|bone marrow biopsy
627684|NCT00524914|Parkinson's disease|parkinson's disease
627685|NCT00524914|Pain|pain
627686|NCT00524914|Nociceptive threshold|nociceptive threshold
627687|NCT00524914|Functional imaging|functional imaging
627688|NCT00524914|Cerebral activity|cerebral activity
627689|NCT00524914|Dopamine agonist.|dopamine agonist.
627690|NCT00524901|Apoptosis|apoptosis
627691|NCT00524901|CABG|cabg
627692|NCT00524901|Coronary Artery Disease|coronary artery disease
627693|NCT00524901|Three Vessel Disease|three vessel disease
627694|NCT00524901|Erythropoietin|erythropoietin
627695|NCT00524901|EPO-receptor signaling|epo-receptor signaling
627696|NCT00524888|Hand|hand
627697|NCT00524888|Laceration|laceration
627698|NCT00524888|bioadhesive|bioadhesive
627699|NCT00524888|ER|er
627700|NCT00524888|Hand laceration distal to the volar wrist crease|hand laceration distal to the volar wrist crease
627701|NCT00524875|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
627702|NCT00524875|Bevacizumab|bevacizumab
627703|NCT00524875|Early post-vitrectomy vitreous hemorrhage|early post-vitrectomy vitreous hemorrhage
627704|NCT00524862|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
627705|NCT00524862|Ejection Fraction|ejection fraction
627706|NCT00524862|QRS duration|qrs duration
627707|NCT00524849|Breast cancer|breast cancer
627708|NCT00524849|Bone metastasis|bone metastasis
627709|NCT00524849|Circulating VEGF|circulating vegf
627710|NCT00524849|Zoledronic acid|zoledronic acid
627711|NCT00524849|Angiogenesis|angiogenesis
627712|NCT00524836|levocetirizine dihydrochloride|levocetirizine dihydrochloride
627713|NCT00524836|Xyzal tablets|xyzal tablets
627714|NCT00524823|Prostate Cancer|prostate cancer
627715|NCT00524823|Hyperplasia - BPH|hyperplasia - bph
627716|NCT00524823|FACS|facs
627717|NCT00524823|Prostate Cancer, Hyperplasia - BPH, Malignancy|prostate cancer, hyperplasia - bph, malignancy
627718|NCT00524797|Myelosuppression,|myelosuppression,
627719|NCT00524797|chemotherapeutic agents,|chemotherapeutic agents,
627720|NCT00524797|leucopenia,|leucopenia,
627721|NCT00524797|thrombocytopenia,|thrombocytopenia,
627722|NCT00524797|Profonycia|profonycia
627723|NCT00524784|GVHD|gvhd
627724|NCT00524784|HSCT|hsct
627725|NCT00524784|BMT|bmt
627726|NCT00524784|APOPTOTIC CELLS|apoptotic cells
627727|NCT00524771|Contraception|contraception
627728|NCT00524771|Contraceptive Vaginal Ring|contraceptive vaginal ring
627729|NCT00524758|ologen|ologen
627730|NCT00524758|oculusgen|oculusgen
627731|NCT00524758|collagen matrix|collagen matrix
627732|NCT00524758|trabeculectomy|trabeculectomy
627733|NCT00524758|filtering surgery|filtering surgery
627734|NCT00524758|mitomycin-C|mitomycin-c
627735|NCT00524758|MMC|mmc
627736|NCT00524758|Aeon Astron|aeon astron
627737|NCT00524745|Gardasil|gardasil
627738|NCT00524745|Human Papillomavirus|human papillomavirus
627739|NCT00524745|HPV vaccine|hpv vaccine
627740|NCT00524745|Cervical cancer|cervical cancer
627741|NCT00524732|Pertussis|pertussis
627742|NCT00524732|Tetanus|tetanus
627743|NCT00524732|Diphtheria|diphtheria
627744|NCT00524706|S-1|s-1
627745|NCT00524706|oral fluoropyrimidine|oral fluoropyrimidine
627746|NCT00524706|tegafur|tegafur
627747|NCT00524706|Gimeracil|gimeracil
627748|NCT00524706|Oteracil Potassium|oteracil potassium
627749|NCT00524706|Leucovorin|leucovorin
627750|NCT00524706|Calcium Folinate|calcium folinate
627751|NCT00524706|Oxaliplatin|oxaliplatin
627752|NCT00524706|L-OHP|l-ohp
627753|NCT00524706|colorectal cancer|colorectal cancer
627754|NCT00524693|Bronchiolitis|bronchiolitis
627755|NCT00524693|controlled clinical trial|controlled clinical trial
627756|NCT00524693|pediatrics|pediatrics
627757|NCT00524693|Infants|infants
627758|NCT00524693|montelukast|montelukast
627759|NCT00524693|Respiratory syncytial virus|respiratory syncytial virus
627760|NCT00524680|adenocarcinoma of the prostate|adenocarcinoma of the prostate
627761|NCT00524680|recurrent prostate cancer|recurrent prostate cancer
627762|NCT00524680|stage I prostate cancer|stage i prostate cancer
627763|NCT00524680|stage II prostate cancer|stage ii prostate cancer
627764|NCT00524680|stage III prostate cancer|stage iii prostate cancer
627765|NCT00524680|stage IV prostate cancer|stage iv prostate cancer
627766|NCT00524667|Active CLL|active cll
627767|NCT00524654|To determine the effects of cervical spine manipulation on postural control.|to determine the effects of cervical spine manipulation on postural control.
627768|NCT00524641|Asthma|asthma
627769|NCT00524641|Symbicort|symbicort
627770|NCT00524641|NIS|nis
627771|NCT00524615|resistant hypertension treatment|resistant hypertension treatment
627772|NCT00524615|spironolactone|spironolactone
627773|NCT00524615|aldosterone antagonists|aldosterone antagonists
627774|NCT00524615|resistant arterial hypertension|resistant arterial hypertension
627775|NCT00524615|refractory arterial hypertension|refractory arterial hypertension
627776|NCT00524602|Stereotaxis|stereotaxis
627777|NCT00524602|Arrythmia|arrythmia
627778|NCT00524602|Catheter ablation|catheter ablation
627779|NCT00524602|Heart|heart
627780|NCT00524589|recurrent prostate cancer|recurrent prostate cancer
627781|NCT00524576|Hepatitis B|hepatitis b
627782|NCT00524576|Persistence|persistence
627783|NCT00524576|Challenge dose|challenge dose
627784|NCT00524563|Acinetobacter|acinetobacter
627785|NCT00524563|bloodstream infection|bloodstream infection
627786|NCT00524563|Isolate|isolate
627787|NCT00524550|Moderate alcohol consumption|moderate alcohol consumption
627788|NCT00524550|insulin secretion|insulin secretion
627789|NCT00524550|insulin sensitivity|insulin sensitivity
627790|NCT00524550|Beta-cell function|beta-cell function
627791|NCT00524550|Adiponectin|adiponectin
627792|NCT00524550|Appetite|appetite
627793|NCT00524550|Satiety|satiety
627794|NCT00524550|Alcohol-induced gene expression|alcohol-induced gene expression
627795|NCT00524550|Endocannabinoids|endocannabinoids
627796|NCT00524550|Glucose metabolism|glucose metabolism
627797|NCT00524550|Lipid metabolism|lipid metabolism
627798|NCT00524550|Ratio HMW/total adiponectin|ratio hmw/total adiponectin
627799|NCT00524550|Appetite regulation|appetite regulation
627800|NCT00524550|Alcohol-induced adiponectin increase|alcohol-induced adiponectin increase
627801|NCT00524537|Crohn's Disease|crohn's disease
628103|NCT00523523|hemiplegia|hemiplegia
627802|NCT00524524|solid tumors|solid tumors
627803|NCT00524524|biopsy|biopsy
627804|NCT00524511|cesarean|cesarean
627805|NCT00524511|wound|wound
627806|NCT00524511|Dermabond|dermabond
627807|NCT00524511|superglue|superglue
627808|NCT00524511|staples|staples
627809|NCT00524511|wound complications|wound complications
627810|NCT00524498|OPC-18|opc-18
627811|NCT00524498|Interferon-alpha|interferon-alpha
627812|NCT00524498|Fluorouracil|fluorouracil
627813|NCT00524485|actinic keratosis|actinic keratosis
627814|NCT00524472|Hyperinsulinemic glucose control|hyperinsulinemic glucose control
627815|NCT00524472|cardiac surgery|cardiac surgery
627816|NCT00524472|Outcome|outcome
627817|NCT00524459|stage IIIA breast cancer|stage iiia breast cancer
627818|NCT00524459|stage IIIB breast cancer|stage iiib breast cancer
627819|NCT00524446|Infant|infant
627820|NCT00524446|Sub-Saharan Africa|sub-saharan africa
627821|NCT00524446|Complementary feeding|complementary feeding
627822|NCT00524446|Fortified spread|fortified spread
627823|NCT00524446|Lipid-based nutrient supplement|lipid-based nutrient supplement
627824|NCT00524446|Malnutrition|malnutrition
627825|NCT00524446|Stunting|stunting
627826|NCT00524446|Growth|growth
627827|NCT00524446|Morbidity|morbidity
627828|NCT00524446|Development|development
627829|NCT00524446|Haemoglobin|haemoglobin
627830|NCT00524433|acute heart failure|acute heart failure
627831|NCT00524433|acute decompensation of chronic heart failure|acute decompensation of chronic heart failure
627832|NCT00524433|new onset of heart failure|new onset of heart failure
627833|NCT00524433|tezosentan|tezosentan
627834|NCT00524433|Actelion|actelion
627835|NCT00524420|Pain|pain
627836|NCT00524420|Fatigue|fatigue
627837|NCT00524420|Chronic Fatigue Syndrome|chronic fatigue syndrome
627838|NCT00524420|Chronic Fatigue-Fibromyalgia Syndrome|chronic fatigue-fibromyalgia syndrome
627839|NCT00524420|Depression|depression
627840|NCT00524420|Major Depressive Disorder|major depressive disorder
627841|NCT00524407|Anemia|anemia
627842|NCT00524407|hemoglobin|hemoglobin
627843|NCT00524407|chemotherapy|chemotherapy
627844|NCT00524407|hematologic response|hematologic response
627845|NCT00524407|subcutaneous injection|subcutaneous injection
627846|NCT00524407|Epoetin alfa|epoetin alfa
627847|NCT00524407|FACT-An|fact-an
627848|NCT00524407|LASA|lasa
627849|NCT00524407|PROCRIT|procrit
627850|NCT00524394|VLBW|vlbw
627851|NCT00524394|sepsis|sepsis
627852|NCT00524394|diagnosis|diagnosis
627853|NCT00524394|suspected sepsis|suspected sepsis
627854|NCT00524368|Human immunodeficiency virus - type 1|human immunodeficiency virus - type 1
627855|NCT00524368|HIV-1 Infection|hiv-1 infection
627856|NCT00524368|TMC-114|tmc-114
627857|NCT00524368|Darunavir|darunavir
627858|NCT00524368|Ritonavir|ritonavir
627859|NCT00524355|GERD|gerd
627860|NCT00524355|GIS|gis
627861|NCT00524355|heartburn|heartburn
627862|NCT00524355|NIS|nis
627863|NCT00524355|PPI|ppi
627864|NCT00524342|IL-11|il-11
627865|NCT00524342|von Willebrand disease|von willebrand disease
627866|NCT00524342|von Willebrand factor|von willebrand factor
627867|NCT00524342|VWFmRNA|vwfmrna
627868|NCT00524342|menorrhagia|menorrhagia
627869|NCT00524329|upper GI-symptoms|upper gi-symptoms
627870|NCT00524329|heartburn|heartburn
627871|NCT00524329|NSAID|nsaid
627872|NCT00524329|risk|risk
627873|NCT00524329|PPI|ppi
627874|NCT00524329|Bloating|bloating
627875|NCT00524329|Regurgitation|regurgitation
627876|NCT00524316|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
627877|NCT00524316|advanced adult primary liver cancer|advanced adult primary liver cancer
627878|NCT00524316|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
627879|NCT00524316|recurrent adult primary liver cancer|recurrent adult primary liver cancer
627880|NCT00524303|ErbB2 Overexpressing|erbb2 overexpressing
627881|NCT00524303|ErbB2 Positive|erbb2 positive
627882|NCT00524303|Lapatinib|lapatinib
627883|NCT00524303|Invasive Breast Cancer|invasive breast cancer
627884|NCT00524290|Acinetobacter|acinetobacter
627885|NCT00524290|infection|infection
627886|NCT00524290|isolate|isolate
627887|NCT00524277|stage I breast cancer|stage i breast cancer
627888|NCT00524277|stage II breast cancer|stage ii breast cancer
627889|NCT00524277|stage IIIA breast cancer|stage iiia breast cancer
627890|NCT00524277|stage IIIB breast cancer|stage iiib breast cancer
627891|NCT00524277|stage IIIC breast cancer|stage iiic breast cancer
627892|NCT00524277|male breast cancer|male breast cancer
627893|NCT00524251|Patients with reflux complaints|patients with reflux complaints
627894|NCT00524251|GERD|gerd
627895|NCT00524251|quality of life|quality of life
627896|NCT00524251|lifestyle adjustments|lifestyle adjustments
627897|NCT00524238|hypothyroidism|hypothyroidism
627898|NCT00524238|glucose turnover|glucose turnover
627899|NCT00524238|clamp|clamp
627900|NCT00524238|insulin resistance|insulin resistance
627901|NCT00524238|lipid turnover|lipid turnover
627902|NCT00524238|amino acid turnover|amino acid turnover
627903|NCT00524225|IL-11|il-11
627904|NCT00524225|von Willebrand disease|von willebrand disease
627905|NCT00524225|von Willebrand factor|von willebrand factor
627906|NCT00524225|VWFmRNA|vwfmrna
627907|NCT00524225|surgery|surgery
627908|NCT00524199|homocysteine|homocysteine
627909|NCT00524199|hemodialysis|hemodialysis
627910|NCT00524199|mesna|mesna
627911|NCT00524186|stage III gastric cancer|stage iii gastric cancer
627912|NCT00524186|stage IV gastric cancer|stage iv gastric cancer
627913|NCT00524186|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
627914|NCT00524186|stage IV esophageal cancer|stage iv esophageal cancer
627915|NCT00524186|recurrent gastric cancer|recurrent gastric cancer
627916|NCT00524186|recurrent esophageal cancer|recurrent esophageal cancer
627917|NCT00524186|adenocarcinoma of the stomach|adenocarcinoma of the stomach
627918|NCT00524173|Emtricitabine|emtricitabine
627919|NCT00524173|Tenofovir|tenofovir
627920|NCT00524173|Antiviral Therapy|antiviral therapy
627921|NCT00524173|Hepatitis B|hepatitis b
627922|NCT00524173|HBV|hbv
627923|NCT00524160|Fentanyl|fentanyl
627924|NCT00524160|opioid analgesics|opioid analgesics
627925|NCT00524160|arthritis|arthritis
627926|NCT00524160|osteoarthritis|osteoarthritis
627927|NCT00524160|rheumatoid arthritis|rheumatoid arthritis
627928|NCT00524160|transdermal administration|transdermal administration
627929|NCT00524147|loculated pleural effusion|loculated pleural effusion
627930|NCT00524147|pigtail drainage|pigtail drainage
627931|NCT00524147|pleural effusion|pleural effusion
627932|NCT00524147|pleural thickening|pleural thickening
627933|NCT00524147|tuberculosis|tuberculosis
627934|NCT00524134|Epilepsy|epilepsy
627935|NCT00524134|Seizure|seizure
627936|NCT00524134|p-glycoprotein|p-glycoprotein
627937|NCT00524121|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
627938|NCT00524121|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
627939|NCT00524121|stage I esophageal cancer|stage i esophageal cancer
627940|NCT00524121|stage II esophageal cancer|stage ii esophageal cancer
627941|NCT00524121|stage III esophageal cancer|stage iii esophageal cancer
627942|NCT00524121|stage IV esophageal cancer|stage iv esophageal cancer
627943|NCT00524108|shunt|shunt
627944|NCT00524108|internal ventriculoperitoneal|internal ventriculoperitoneal
627945|NCT00524095|prophylaxis|prophylaxis
627946|NCT00524095|Antibiotic|antibiotic
627947|NCT00524095|inhaled steroids|inhaled steroids
627948|NCT00524095|bronchiectasis|bronchiectasis
627949|NCT00524095|prevalence|prevalence
627950|NCT00524095|chronic bronchitis|chronic bronchitis
627951|NCT00524069|stage I pancreatic cancer|stage i pancreatic cancer
627952|NCT00524069|stage II pancreatic cancer|stage ii pancreatic cancer
627953|NCT00524069|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
627954|NCT00524056|Essential Tremor|essential tremor
627955|NCT00524056|Tremor|tremor
627956|NCT00524056|Anti-epileptic drug (AED)|anti-epileptic drug (aed)
627957|NCT00524043|Schizophrenia|schizophrenia
627958|NCT00524030|Epilepsy|epilepsy
627959|NCT00524030|partial seizures|partial seizures
627960|NCT00524030|pregabalin monotherapy|pregabalin monotherapy
627961|NCT00524030|double-blind and randomized trial|double-blind and randomized trial
627962|NCT00524017|hypopharyngeal cancer|hypopharyngeal cancer
627963|NCT00524017|laryngeal cancer|laryngeal cancer
627964|NCT00524017|lip and oral cavity cancer|lip and oral cavity cancer
627965|NCT00524017|nasopharyngeal cancer|nasopharyngeal cancer
627966|NCT00524017|oropharyngeal cancer|oropharyngeal cancer
627967|NCT00524017|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
627968|NCT00524017|salivary gland cancer|salivary gland cancer
627969|NCT00524017|precancerous condition|precancerous condition
627970|NCT00524004|Passive immunization, Bovine Milk Immunoglobulin|passive immunization, bovine milk immunoglobulin
627971|NCT00523978|Atrial Fibrillation|atrial fibrillation
627972|NCT00523965|Kala-azar|kala-azar
627973|NCT00523965|miltefosine|miltefosine
627974|NCT00523965|liposomal amphotericin B|liposomal amphotericin b
627975|NCT00523952|dermatitis, atopic|dermatitis, atopic
627976|NCT00523952|tacrolimus|tacrolimus
627977|NCT00523952|adult|adult
627978|NCT00523939|Lymphoma|lymphoma
627979|NCT00523939|Leukemia|leukemia
627980|NCT00523939|Leukemic Meningitis|leukemic meningitis
627981|NCT00523939|Lymphomatous Meningitis|lymphomatous meningitis
627982|NCT00523926|Tuberculosis|tuberculosis
627983|NCT00523913|type 2 diabetes mellitus;|type 2 diabetes mellitus;
627984|NCT00523913|diabetes;|diabetes;
627985|NCT00523913|rosiglitazone|rosiglitazone
627986|NCT00523913|Avandia;|avandia;
627987|NCT00523900|malnutrition|malnutrition
627988|NCT00523900|underweight|underweight
627989|NCT00523900|low body weight|low body weight
627990|NCT00523900|BMI under 19|bmi under 19
627991|NCT00523900|under nourished|under nourished
627992|NCT00523900|malnourished|malnourished
627993|NCT00523887|Radiation pain|radiation pain
627994|NCT00523887|Duragesic|duragesic
627995|NCT00523887|Fentanyl|fentanyl
627996|NCT00523887|Pain|pain
627997|NCT00523861|Glucose|glucose
627998|NCT00523861|Insulin sensitivity|insulin sensitivity
627999|NCT00523861|Glucose metabolism|glucose metabolism
628000|NCT00523861|Appetite|appetite
628001|NCT00523861|Satiety|satiety
628002|NCT00523848|stage I multiple myeloma|stage i multiple myeloma
628003|NCT00523848|stage II multiple myeloma|stage ii multiple myeloma
628004|NCT00523848|stage III multiple myeloma|stage iii multiple myeloma
628133|NCT00523458|Therapy|therapy
628134|NCT00523458|Treatment Naive|treatment naive
628005|NCT00523822|This study seeks to determine if the correction of a sacroiliac lesion can produce a functional change in cervical spine.|this study seeks to determine if the correction of a sacroiliac lesion can produce a functional change in cervical spine.
628006|NCT00523809|Breast Cancer|breast cancer
628007|NCT00523809|Ovarian Cancer|ovarian cancer
628008|NCT00523809|Stem Cell Transplantation|stem cell transplantation
628009|NCT00523809|Bevacizumab|bevacizumab
628010|NCT00523809|Fludarabine|fludarabine
628011|NCT00523809|Melphalan|melphalan
628012|NCT00523809|Avastin|avastin
628013|NCT00523809|Thymoglobulin|thymoglobulin
628014|NCT00523809|ATG|atg
628015|NCT00523809|Antithymocyte Globulin|antithymocyte globulin
628016|NCT00523809|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
628017|NCT00523809|AHSCT|ahsct
628018|NCT00523796|dyslipidemia|dyslipidemia
628019|NCT00523796|in practice survey|in practice survey
628020|NCT00523796|Vietnam|vietnam
628021|NCT00523783|Schizophrenia|schizophrenia
628022|NCT00523783|Schizoaffective|schizoaffective
628023|NCT00523783|quetiapine|quetiapine
628024|NCT00523783|long-term efficacy|long-term efficacy
628025|NCT00523783|Naturalistic|naturalistic
628026|NCT00523783|Observational|observational
628027|NCT00523770|Invasive Pneumococcal Diseases|invasive pneumococcal diseases
628028|NCT00523770|Pneumonia|pneumonia
628029|NCT00523757|heart failure|heart failure
628030|NCT00523757|collagen|collagen
628031|NCT00523757|diastolic function|diastolic function
628032|NCT00523744|hypertension, valsartan, amlodipine|hypertension, valsartan, amlodipine
628033|NCT00523731|Stem cells|stem cells
628034|NCT00523731|Rest pain|rest pain
628035|NCT00523731|claudication|claudication
628036|NCT00523731|chronic ischemic or non-healing ulcers|chronic ischemic or non-healing ulcers
628037|NCT00523731|Angiogenesis|angiogenesis
628038|NCT00523731|no-option cases|no-option cases
628039|NCT00523718|obsessive-compulsive disorder|obsessive-compulsive disorder
628040|NCT00523718|OCD|ocd
628041|NCT00523718|glutamate|glutamate
628042|NCT00523718|riluzole|riluzole
628043|NCT00523718|augmentation|augmentation
628044|NCT00523718|treatment|treatment
628045|NCT00523705|premenstrual syndrome|premenstrual syndrome
628046|NCT00523705|PMS|pms
628047|NCT00523705|PMDD|pmdd
628048|NCT00523705|treatment|treatment
628049|NCT00523705|SSRI|ssri
628050|NCT00523692|Early arthritis|early arthritis
628051|NCT00523692|Rheumatoid arthritis|rheumatoid arthritis
628052|NCT00523692|Rheumatoid factor|rheumatoid factor
628053|NCT00523692|Anti CCP antibody|anti ccp antibody
628054|NCT00523692|Remission|remission
628055|NCT00523692|Anti-TNF therapy|anti-tnf therapy
628056|NCT00523692|methotrexate|methotrexate
628057|NCT00523679|Asthma|asthma
628058|NCT00523679|Symbicort|symbicort
628059|NCT00523679|SMART|smart
628060|NCT00523679|inhaler|inhaler
628061|NCT00523679|compliance|compliance
628062|NCT00523679|Naturalistic|naturalistic
628063|NCT00523679|Observational|observational
628064|NCT00523666|Alzheimer's disease|alzheimer's disease
628065|NCT00523666|diffusion tensor imaging|diffusion tensor imaging
628066|NCT00523640|metastatic|metastatic
628067|NCT00523640|renal cell|renal cell
628068|NCT00523640|kidney|kidney
628069|NCT00523640|neoplasm|neoplasm
628070|NCT00523627|Energy Expenditure|energy expenditure
628071|NCT00523627|Adaptive Thermogenesis|adaptive thermogenesis
628072|NCT00523627|Low-protein Overfeeding|low-protein overfeeding
628073|NCT00523627|Fasting|fasting
628074|NCT00523627|Weight Gain|weight gain
628075|NCT00523614|venous thromboembolism|venous thromboembolism
628076|NCT00523601|Bipolar depression|bipolar depression
628077|NCT00523601|quetiapine|quetiapine
628078|NCT00523601|observational|observational
628079|NCT00523601|Naturalistic|naturalistic
628080|NCT00523588|Cutaneous lupus erythematosus|cutaneous lupus erythematosus
628081|NCT00523588|Pulsed dye laser|pulsed dye laser
628082|NCT00523575|Elderly|elderly
628083|NCT00523575|Osteoporosis|osteoporosis
628084|NCT00523575|hip fracture|hip fracture
628085|NCT00523575|malnutrition|malnutrition
628086|NCT00523575|nutritional support|nutritional support
628087|NCT00523562|fructose|fructose
628088|NCT00523562|dietary lipids|dietary lipids
628089|NCT00523562|dietary proteins|dietary proteins
628090|NCT00523562|hepatic steatosis|hepatic steatosis
628091|NCT00523562|insulin resistance|insulin resistance
628092|NCT00523562|Healthy humans|healthy humans
628093|NCT00523562|overweight humans|overweight humans
628094|NCT00523562|obese humans|obese humans
628095|NCT00523549|Hypertension|hypertension
628096|NCT00523549|systolic blood pressure|systolic blood pressure
628097|NCT00523549|diastolic dysfunction|diastolic dysfunction
628098|NCT00523549|valsartan|valsartan
628099|NCT00523549|amlodipine|amlodipine
628100|NCT00523536|High Blood Pressure|high blood pressure
628101|NCT00523536|Cardiovascular|cardiovascular
628102|NCT00523523|Rehabilitation|rehabilitation
628104|NCT00523523|stroke|stroke
628105|NCT00523523|upper extremity|upper extremity
628106|NCT00523523|motor skills|motor skills
628107|NCT00523523|therapy|therapy
628108|NCT00523510|breastmilk|breastmilk
628109|NCT00523510|perinatal HIV|perinatal hiv
628110|NCT00523510|infant feeding|infant feeding
628111|NCT00523510|flash heat|flash heat
628112|NCT00523510|pasteurization|pasteurization
628113|NCT00523510|pmtct|pmtct
628114|NCT00523510|HIV|hiv
628115|NCT00523510|HIV Seronegativity|hiv seronegativity
628116|NCT00523510|Treatment Naive|treatment naive
628117|NCT00523497|Severe community-acquired pneumonia|severe community-acquired pneumonia
628118|NCT00523497|Noninvasive mechanical ventilation|noninvasive mechanical ventilation
628119|NCT00523497|Acute hypoxemic respiratory failure.|acute hypoxemic respiratory failure.
628120|NCT00523484|Beck Anxiety Inventory|beck anxiety inventory
628121|NCT00523484|Prostate Cancer|prostate cancer
628122|NCT00523484|Prostate Specific Antigen|prostate specific antigen
628123|NCT00523484|Naturalistic|naturalistic
628124|NCT00523484|Observational|observational
628125|NCT00523471|prostate cancer|prostate cancer
628126|NCT00523471|gamma H2AX|gamma h2ax
628127|NCT00523471|radiosensitivity|radiosensitivity
628128|NCT00523458|Co-infection|co-infection
628129|NCT00523458|Tuberculosis|tuberculosis
628130|NCT00523458|HIV|hiv
628131|NCT00523458|Drug interactions|drug interactions
628132|NCT00523458|Non nucleoside reverse transcriptase inhibitors|non nucleoside reverse transcriptase inhibitors
628135|NCT00523445|Schizophrenia|schizophrenia
628136|NCT00523445|Cognition|cognition
628137|NCT00523445|Varenicline|varenicline
628138|NCT00523432|ovarian cancer|ovarian cancer
628139|NCT00523432|cervical cancer|cervical cancer
628140|NCT00523432|uterine cancer|uterine cancer
628141|NCT00523432|fallopian tube cancer|fallopian tube cancer
628142|NCT00523432|endometrial cancer|endometrial cancer
628143|NCT00523432|vaginal cancer|vaginal cancer
628144|NCT00523432|peritoneal cancer|peritoneal cancer
628145|NCT00523432|reproductive cancer|reproductive cancer
628146|NCT00523406|choroidal neovascularisation,|choroidal neovascularisation,
628147|NCT00523406|vision,|vision,
628148|NCT00523406|macula,|macula,
628149|NCT00523406|macular degeneration|macular degeneration
628150|NCT00523406|optical coherence tomography|optical coherence tomography
628151|NCT00523406|neovascular age related macular degeneration|neovascular age related macular degeneration
628152|NCT00523367|Gastro Esophageal Reflux Disease (GERD)|gastro esophageal reflux disease (gerd)
628153|NCT00523367|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
628154|NCT00523354|Eosinophilic Esophagitis|eosinophilic esophagitis
628155|NCT00523354|TNF-alpha|tnf-alpha
628156|NCT00523354|TNF-alpha Blockade|tnf-alpha blockade
628157|NCT00523354|Infliximab|infliximab
628158|NCT00523341|postmenopausal osteoporosis|postmenopausal osteoporosis
628159|NCT00523341|low bone density|low bone density
628160|NCT00523341|fractures|fractures
628161|NCT00523341|low bone mass|low bone mass
628162|NCT00523328|Rheumatoid Arthritis|rheumatoid arthritis
628163|NCT00523328|Arthritis|arthritis
628164|NCT00523328|BG9924|bg9924
628165|NCT00523328|methotrexate|methotrexate
628166|NCT00523315|Aromatase Inhibitor|aromatase inhibitor
628167|NCT00523315|Breast Cancer|breast cancer
628168|NCT00523315|compliance|compliance
628169|NCT00523315|Naturalistic|naturalistic
628170|NCT00523315|Observational|observational
628171|NCT00523302|Major Depression|major depression
628172|NCT00523302|Fibromyalgia|fibromyalgia
628173|NCT00523302|TMS|tms
628174|NCT00523289|Ropivacaine|ropivacaine
628175|NCT00523289|Bupivacaine|bupivacaine
628176|NCT00523289|Upper Extremity|upper extremity
628177|NCT00523289|Local anesthetic|local anesthetic
628178|NCT00523276|Severe acute respiratory syndrome, SARS, China|severe acute respiratory syndrome, sars, china
628179|NCT00523250|Glaucoma|glaucoma
628180|NCT00523224|Stem cells|stem cells
628181|NCT00523224|Coronary Artery Bypass grafting|coronary artery bypass grafting
628182|NCT00523224|Congestive Heart Failure|congestive heart failure
628183|NCT00523224|Coronary Artery Disease|coronary artery disease
628184|NCT00523224|Angiogenesis|angiogenesis
628185|NCT00523211|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
628186|NCT00523211|Treatment Experienced|treatment experienced
628187|NCT00523198|Cortisol|cortisol
628188|NCT00523185|alcohol withdrawal|alcohol withdrawal
628189|NCT00523185|lorazepam|lorazepam
628190|NCT00523185|diazepam|diazepam
628191|NCT00523172|Chiropractic Manipulation|chiropractic manipulation
628192|NCT00523159|clear cell renal cell carcinoma|clear cell renal cell carcinoma
628193|NCT00523146|primary dysmenorrhea|primary dysmenorrhea
628194|NCT00523146|Herbal remedy|herbal remedy
628195|NCT00523133|alcoholism|alcoholism
628196|NCT00523133|naltrexone|naltrexone
628197|NCT00523133|motivational enhancement therapy|motivational enhancement therapy
628198|NCT00523107|Fatigue|fatigue
628199|NCT00523107|Standard Palliative Care|standard palliative care
628200|NCT00523107|PG2|pg2
628201|NCT00523107|QLQ-C30|qlq-c30
628202|NCT00523107|Compassionate|compassionate
628203|NCT00523081|adolescent depression treatment, cognitive behavioral therapy,|adolescent depression treatment, cognitive behavioral therapy,
628204|NCT00523081|collaborative care|collaborative care
628205|NCT00523068|overactive bladder|overactive bladder
628206|NCT00523068|stress urinary incontinence|stress urinary incontinence
628207|NCT00523068|detrusor overactivity|detrusor overactivity
628208|NCT00523068|urodynamics|urodynamics
628209|NCT00523055|Pain|pain
628210|NCT00523055|Brachial Plexus Anesthesia|brachial plexus anesthesia
628211|NCT00523055|Plasma Lidocaine Levels|plasma lidocaine levels
628212|NCT00523055|Ultrasound|ultrasound
628213|NCT00523029|Self-management programs|self-management programs
628214|NCT00523029|Chronic medical illness|chronic medical illness
628215|NCT00523016|acupuncture|acupuncture
628216|NCT00523016|electroacupuncture|electroacupuncture
628217|NCT00523016|sham acupuncture|sham acupuncture
628218|NCT00523016|spinal cord injury|spinal cord injury
628219|NCT00523016|neuropathic pain|neuropathic pain
628220|NCT00523016|burning pain|burning pain
628221|NCT00523003|weight loss|weight loss
628222|NCT00523003|obesity|obesity
628223|NCT00523003|high protein|high protein
628224|NCT00523003|meal replacement|meal replacement
628225|NCT00522977|Myocardial strain|myocardial strain
628226|NCT00522977|Myocardial function|myocardial function
628227|NCT00522977|Pregnancy|pregnancy
628228|NCT00522977|Postpartum|postpartum
628229|NCT00522977|Echocardiography|echocardiography
628230|NCT00522977|Myocardial adaptation to pregnancy|myocardial adaptation to pregnancy
628231|NCT00522977|Systolic function|systolic function
628232|NCT00522977|Diastolic function|diastolic function
628233|NCT00522964|Chinese-American|chinese-american
628234|NCT00522964|Children|children
628235|NCT00522964|Obesity|obesity
628236|NCT00522964|health behaviors|health behaviors
628237|NCT00522964|Behavioral intervention|behavioral intervention
628238|NCT00522964|normal|normal
628239|NCT00522951|MRI|mri
628240|NCT00522951|Brain Metastasis|brain metastasis
628241|NCT00522951|Gadolinium|gadolinium
628242|NCT00522951|Imaging|imaging
628243|NCT00522951|Diagnostic Agent|diagnostic agent
628244|NCT00522938|Lung|lung
628245|NCT00522938|Cancer|cancer
628246|NCT00522938|Non-small|non-small
628247|NCT00522938|Lung Cancer|lung cancer
628248|NCT00522938|NSCLC|nsclc
628249|NCT00522938|erlotinib|erlotinib
628250|NCT00522938|oral|oral
628251|NCT00522938|Locally Advanced Non-small Cell Lung Cancer|locally advanced non-small cell lung cancer
628252|NCT00522938|Metastatic Non-small Cell Lung Cancer|metastatic non-small cell lung cancer
628253|NCT00522925|hypertension|hypertension
628254|NCT00522925|high blood pressure|high blood pressure
628255|NCT00522912|Trachoma|trachoma
628256|NCT00522912|Trichiasis|trichiasis
628257|NCT00522912|Surgery|surgery
628258|NCT00522912|Epilation|epilation
628259|NCT00522912|Ethiopia|ethiopia
628260|NCT00522899|aged|aged
628261|NCT00522899|exercise|exercise
628262|NCT00522899|cognitive therapy|cognitive therapy
628263|NCT00522899|dementia|dementia
628264|NCT00522899|prevention|prevention
628265|NCT00522886|cetuximab|cetuximab
628266|NCT00522886|concurrent|concurrent
628267|NCT00522886|iso-toxic|iso-toxic
628268|NCT00522886|NSCLC|nsclc
628269|NCT00522873|Postmenopausal Symptoms e.g.|postmenopausal symptoms e.g.
628270|NCT00522873|Hot flushes|hot flushes
628271|NCT00522873|Sweating episodes|sweating episodes
628272|NCT00522873|Vaginal dryness|vaginal dryness
628273|NCT00522860|Trichiasis|trichiasis
628274|NCT00522860|Trachoma|trachoma
628275|NCT00522860|Surgery|surgery
628276|NCT00522860|Suture|suture
628277|NCT00522860|Ethiopia|ethiopia
628278|NCT00522847|Postmenopausal|postmenopausal
628279|NCT00522847|non dry eye|non dry eye
628280|NCT00522834|melanoma|melanoma
628281|NCT00522834|oncology|oncology
628282|NCT00522834|Stage IV Metastatic Melanoma|stage iv metastatic melanoma
628283|NCT00522821|IgG subclass deficiency|igg subclass deficiency
628284|NCT00522821|Anti-polysaccharide deficiency|anti-polysaccharide deficiency
628285|NCT00522821|therapy|therapy
628286|NCT00522821|Immunoglobulins, Intravenous|immunoglobulins, intravenous
628287|NCT00522821|co-trimoxazole|co-trimoxazole
628288|NCT00522808|HCV|hcv
628289|NCT00522808|antiviral|antiviral
628290|NCT00522808|PK|pk
628291|NCT00522808|Safety|safety
628292|NCT00522795|Esophageal Cancer|esophageal cancer
628293|NCT00522769|binge eating|binge eating
628294|NCT00522769|adolescent girls|adolescent girls
628295|NCT00522769|cognitive behavioral therapy|cognitive behavioral therapy
628296|NCT00522756|Kidney Failure, Acute|kidney failure, acute
628297|NCT00522756|Cardiac Surgical Procedures|cardiac surgical procedures
628298|NCT00522756|Sodium Bicarbonate|sodium bicarbonate
628299|NCT00522756|Sodium Chloride|sodium chloride
628300|NCT00522756|Prevention and control|prevention and control
628301|NCT00522743|SGA|sga
628302|NCT00522743|GH|gh
628303|NCT00522743|GnRHa|gnrha
628304|NCT00522743|IGF-1|igf-1
628305|NCT00522730|Liver failure|liver failure
628306|NCT00522730|Liver cirrhosis|liver cirrhosis
628307|NCT00522730|Parenteral nutrition|parenteral nutrition
628308|NCT00522730|Enteral nutrition|enteral nutrition
628309|NCT00522730|Lipids|lipids
628310|NCT00522730|Safety|safety
628311|NCT00522730|Drug tolerance|drug tolerance
628312|NCT00522704|Arteriovenous fistula|arteriovenous fistula
628313|NCT00522704|Access blood flow|access blood flow
628314|NCT00522704|Extracorporeal blood flow|extracorporeal blood flow
628315|NCT00522704|Dynamic arterial line pressure|dynamic arterial line pressure
628316|NCT00522704|Hemodialysis treatment|hemodialysis treatment
628317|NCT00522691|Fecal incontinence|fecal incontinence
628318|NCT00522691|sacral nerve stimulation|sacral nerve stimulation
628319|NCT00522678|Healthy Volunteers|healthy volunteers
628320|NCT00522652|cancer|cancer
628321|NCT00522652|advanced cancer|advanced cancer
628322|NCT00522652|lymphoma|lymphoma
628323|NCT00522639|lung cancer|lung cancer
628324|NCT00522639|FDG-PET-CT|fdg-pet-ct
628325|NCT00522639|blood proteins|blood proteins
628326|NCT00522639|prognose|prognose
628327|NCT00522626|Fetus|fetus
628328|NCT00522626|Drug abuse|drug abuse
628329|NCT00522626|Fetal development|fetal development
628330|NCT00522626|Substance abuse|substance abuse
628331|NCT00522626|Opioids|opioids
628332|NCT00522626|Methadone|methadone
628333|NCT00522613|recovery|recovery
628334|NCT00522613|serious mental illness|serious mental illness
628335|NCT00522613|bipolar disorder|bipolar disorder
628336|NCT00522613|schizophrenia|schizophrenia
628337|NCT00522613|schizoaffective disorder|schizoaffective disorder
628338|NCT00522600|eyedrops|eyedrops
628339|NCT00522600|compliance|compliance
628340|NCT00522600|glaucoma medications|glaucoma medications
628341|NCT00522600|adherence|adherence
628342|NCT00522574|Myeloproliferative Disorders|myeloproliferative disorders
628343|NCT00522561|Healthy volunteers|healthy volunteers
628344|NCT00522561|running|running
628345|NCT00522561|energetic cost|energetic cost
628346|NCT00522561|limb mechanical characteristics|limb mechanical characteristics
628347|NCT00522561|contractile components|contractile components
628348|NCT00522561|elastic components|elastic components
628349|NCT00522561|healthy men doing regularly physical activities|healthy men doing regularly physical activities
628350|NCT00522548|African American|african american
628351|NCT00522548|Kidney Transplant|kidney transplant
628352|NCT00522535|AAA|aaa
628353|NCT00522535|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
628354|NCT00522535|Endovascular|endovascular
628355|NCT00522535|EVAR|evar
628356|NCT00522535|Aorta|aorta
628357|NCT00522535|Stent Graft|stent graft
628358|NCT00522535|Stent|stent
628359|NCT00522535|Tortuous|tortuous
628360|NCT00522535|High Angle|high angle
628361|NCT00522535|Angled Necks|angled necks
628362|NCT00522522|Naturalistic, retrospective, utilization of care services, diagnosis, epilepsy|naturalistic, retrospective, utilization of care services, diagnosis, epilepsy
628363|NCT00522496|Craniocerebral trauma|craniocerebral trauma
628364|NCT00522496|matrix metalloproteinase|matrix metalloproteinase
628365|NCT00522496|microdialysis|microdialysis
628366|NCT00522457|Breast Cancer|breast cancer
628367|NCT00522457|investigational drug|investigational drug
628368|NCT00522457|drug therapy|drug therapy
628369|NCT00522457|Antineoplastic Protocols|antineoplastic protocols
628370|NCT00522457|Immunotherapy|immunotherapy
628371|NCT00522457|Metastatic breast cancer|metastatic breast cancer
628372|NCT00522457|Advanced breast cancer|advanced breast cancer
628373|NCT00522457|Stage IV breast cancer|stage iv breast cancer
628374|NCT00522457|Her-2/neu expressing breast cancer|her-2/neu expressing breast cancer
628375|NCT00522457|Her-2/neu|her-2/neu
628376|NCT00522457|Trastuzumab refractory|trastuzumab refractory
628377|NCT00522431|Hypogonadism|hypogonadism
628378|NCT00522418|Epilepsy|epilepsy
628379|NCT00522418|VNS Therapy|vns therapy
628380|NCT00522405|Transarterial chemoembolisation|transarterial chemoembolisation
628381|NCT00522405|Thalidomide|thalidomide
628382|NCT00522405|Capecitabine|capecitabine
628383|NCT00522405|Treatment|treatment
628384|NCT00522392|Consolidation therapy|consolidation therapy
628385|NCT00522392|First-line therapy|first-line therapy
628386|NCT00522392|Proteasome inhibitor|proteasome inhibitor
628387|NCT00522392|Thalidomide analogue|thalidomide analogue
628388|NCT00522392|Quality of life|quality of life
628389|NCT00522379|Parkinson's disease|parkinson's disease
628390|NCT00522379|rotigotine|rotigotine
628391|NCT00522379|patch|patch
628392|NCT00522379|transdermal|transdermal
628393|NCT00522379|dopamine agonist|dopamine agonist
628394|NCT00522379|off time|off time
628395|NCT00522379|Neupro|neupro
628396|NCT00522353|obesity|obesity
628397|NCT00522353|weight loss|weight loss
628398|NCT00522353|satiety hormones|satiety hormones
628399|NCT00522353|body composition|body composition
628400|NCT00522353|appetite ratings|appetite ratings
628401|NCT00522340|Implantable Cardioverter Defibrillators|implantable cardioverter defibrillators
628402|NCT00522340|ICD|icd
628403|NCT00522340|Exercise|exercise
628404|NCT00522340|Cardiac|cardiac
628405|NCT00522340|Inflammation|inflammation
628406|NCT00522327|Immigrant|immigrant
628407|NCT00522327|Interpreting|interpreting
628408|NCT00522314|Non-invasive ventilation|non-invasive ventilation
628409|NCT00522314|Airway clearance|airway clearance
628410|NCT00522314|Bronchiectasis|bronchiectasis
628411|NCT00522301|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
628412|NCT00522301|fallopian tube cancer|fallopian tube cancer
628413|NCT00522301|primary peritoneal cavity cancer|primary peritoneal cavity cancer
628414|NCT00522301|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
628415|NCT00522301|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
628416|NCT00522301|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
628417|NCT00522301|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
628418|NCT00522288|Myopia|myopia
628419|NCT00522288|Self-Perception|self-perception
628420|NCT00522288|Contact Lenses|contact lenses
628421|NCT00522288|Glasses|glasses
628422|NCT00522288|Randomized|randomized
628423|NCT00522288|Children|children
628424|NCT00522288|Self-esteem|self-esteem
628425|NCT00522275|Adjunctive treatment in epilepsy|adjunctive treatment in epilepsy
628426|NCT00522275|add-on treatment for epilepsy|add-on treatment for epilepsy
628427|NCT00522275|partial seizures|partial seizures
628428|NCT00522275|AEDs|aeds
628429|NCT00522275|antiepileptic drugs|antiepileptic drugs
628430|NCT00522275|seizures|seizures
628431|NCT00522262|Breast Neoplasms|breast neoplasms
628432|NCT00522262|Exercise|exercise
628433|NCT00522262|Physical activity|physical activity
628434|NCT00522262|Estrone|estrone
628435|NCT00522262|Estradiol|estradiol
628436|NCT00522262|Adiposity|adiposity
628437|NCT00522262|Breast density|breast density
628438|NCT00522262|Mammographic density|mammographic density
628439|NCT00522262|Insulin-Like Growth Factor I|insulin-like growth factor i
628440|NCT00522262|Insulin Resistance|insulin resistance
628441|NCT00522262|Women|women
628442|NCT00522262|Postmenopause|postmenopause
628443|NCT00522249|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
628444|NCT00522249|RCC|rcc
628445|NCT00522249|M3thodist|m3thodist
628446|NCT00522249|Pegylated Alfa Interferon|pegylated alfa interferon
628447|NCT00522249|Sunitinib|sunitinib
628448|NCT00522249|Tarceva|tarceva
628449|NCT00522249|Peg IFN|peg ifn
628450|NCT00522236|Adjuvanted Influenza Vaccine|adjuvanted influenza vaccine
628451|NCT00522223|Cervical Cancer|cervical cancer
628452|NCT00522223|Cancer Survivors|cancer survivors
628453|NCT00522223|Cervix Cancer|cervix cancer
628454|NCT00522223|Sexual Functioning|sexual functioning
628455|NCT00522223|Quality Of Life|quality of life
628456|NCT00522223|Questionnaire|questionnaire
628457|NCT00522223|Radiation Therapy|radiation therapy
628458|NCT00522223|Radical Hysterectomy|radical hysterectomy
628459|NCT00522210|type 1 diabetes|type 1 diabetes
628460|NCT00522210|children|children
628461|NCT00522210|long acting insulin analogue|long acting insulin analogue
628462|NCT00522210|hemoglobin A1c|hemoglobin a1c
628463|NCT00522197|non-small cell lung cancer|non-small cell lung cancer
628464|NCT00522197|small cell lung cancer|small cell lung cancer
628465|NCT00522197|squamous lung dysplasia|squamous lung dysplasia
628466|NCT00522184|intra-articular injection|intra-articular injection
628467|NCT00522184|acute synovitis|acute synovitis
628468|NCT00522184|etanercept|etanercept
628469|NCT00522171|Harmonic|harmonic
628470|NCT00522171|Massive Weight Loss|massive weight loss
628471|NCT00522171|Electro Surgery|electro surgery
628472|NCT00522171|Skin and Fat Redundancy after massive weight loss|skin and fat redundancy after massive weight loss
628473|NCT00522171|Obesity|obesity
628474|NCT00522145|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
628475|NCT00522132|intravenous artesunate|intravenous artesunate
628476|NCT00522132|severe malaria|severe malaria
628477|NCT00522132|Plasmodium falciparum|plasmodium falciparum
628478|NCT00522132|Africa|africa
628479|NCT00522132|Severe Plasmodium falciparum Malaria|severe plasmodium falciparum malaria
628480|NCT00522119|Essential Hypertension|essential hypertension
628481|NCT00522119|High Blood Pressure|high blood pressure
628482|NCT00522106|Behavioral graded activity|behavioral graded activity
628483|NCT00522106|Hip|hip
628484|NCT00522106|Knee|knee
628485|NCT00522106|Physical therapy|physical therapy
628486|NCT00522106|Exercise therapy|exercise therapy
628487|NCT00522093|constipation|constipation
628488|NCT00522067|influenza|influenza
628489|NCT00522067|influenza vaccine|influenza vaccine
628490|NCT00522067|adjuvanted influenza vaccine|adjuvanted influenza vaccine
628491|NCT00522067|subunit influenza vaccine|subunit influenza vaccine
628492|NCT00522067|surface antigen|surface antigen
628493|NCT00522054|Exercise|exercise
628494|NCT00522054|Physical function|physical function
628495|NCT00522054|Rheumatoid arthritis|rheumatoid arthritis
628496|NCT00522054|Tai Chi|tai chi
628497|NCT00522041|Pain associated with chronic anal fissure|pain associated with chronic anal fissure
628498|NCT00522028|QoL|qol
628499|NCT00522028|Osteodensitometry|osteodensitometry
628500|NCT00522028|Arterial pressure|arterial pressure
628501|NCT00522028|PTH|pth
628502|NCT00522015|PSP|psp
628503|NCT00522015|dementia|dementia
628504|NCT00522015|neuropsychology|neuropsychology
628505|NCT00522015|treatment|treatment
628506|NCT00522002|Connective tissue diseases|connective tissue diseases
628507|NCT00522002|Blood coagulation disorders|blood coagulation disorders
628508|NCT00522002|Leg ulcers|leg ulcers
628509|NCT00522002|Rheumatoid Arthritis|rheumatoid arthritis
628510|NCT00522002|Systemic Lupus Erythematosus|systemic lupus erythematosus
628511|NCT00522002|Systemic Scleroderma|systemic scleroderma
628512|NCT00522002|Mixed Connective Tissue Disease|mixed connective tissue disease
628513|NCT00521989|Osteoarthritis|osteoarthritis
628514|NCT00521989|Knee|knee
628515|NCT00521989|CRx-102|crx-102
628516|NCT00521989|prednisolone|prednisolone
628517|NCT00521989|dipyridamole|dipyridamole
628518|NCT00521989|CombinatoRx|combinatorx
628519|NCT00521989|WOMAC|womac
628520|NCT00521976|Risk assessment|risk assessment
628521|NCT00521976|Chest pain|chest pain
628522|NCT00521976|Coronary Artery Disease|coronary artery disease
628523|NCT00521976|Acute coronary syndromes|acute coronary syndromes
628524|NCT00521976|Factor XIIa|factor xiia
628525|NCT00521976|B-type natriuretic peptide (BNP)|b-type natriuretic peptide (bnp)
628526|NCT00521976|high-sensitive C-reactive protein (hsCRP)|high-sensitive c-reactive protein (hscrp)
628527|NCT00521976|Omega-3|omega-3
628528|NCT00521963|Intraarticular injection|intraarticular injection
628529|NCT00521963|Infliximab|infliximab
628530|NCT00521950|Pharmacogenetics|pharmacogenetics
628531|NCT00521950|Cost Effectiveness|cost effectiveness
628532|NCT00521950|Inflammatory Bowel Diseases|inflammatory bowel diseases
628533|NCT00521950|Crohn Disease|crohn disease
628534|NCT00521950|Ulcerative Colitis|ulcerative colitis
628535|NCT00521950|Randomized Controlled Trials|randomized controlled trials
628536|NCT00521911|Intervention Studies|intervention studies
628537|NCT00521911|Randomized Controlled Trials|randomized controlled trials
628538|NCT00521911|Cognitive Therapy|cognitive therapy
628539|NCT00521911|Hospitals, General|hospitals, general
628540|NCT00521911|Prevalence|prevalence
628541|NCT00521898|Corneal transplantation, Descemet membrane|corneal transplantation, descemet membrane
628542|NCT00521885|Bleeding rates|bleeding rates
628543|NCT00521885|Prophylaxis for deep vein thrombosis|prophylaxis for deep vein thrombosis
628544|NCT00521872|surgery (STARR operation)|surgery (starr operation)
628545|NCT00521859|Hematologic Malignancies|hematologic malignancies
628546|NCT00521859|Leukemia|leukemia
628547|NCT00521859|Lymphoma|lymphoma
628548|NCT00521859|Myeloma|myeloma
628549|NCT00521859|Hodgkin's Disease|hodgkin's disease
628550|NCT00521859|Hematopoietic Cell Transplantation|hematopoietic cell transplantation
628551|NCT00521859|Cloretazine|cloretazine
628552|NCT00521859|VNP40101M|vnp40101m
628553|NCT00521859|Fludarabine|fludarabine
628554|NCT00521859|Fludarabine Phosphate|fludarabine phosphate
628555|NCT00521859|Fludara|fludara
628556|NCT00521859|ATG|atg
628557|NCT00521859|Antithymocyte|antithymocyte
628558|NCT00521859|Thymoglobulin|thymoglobulin
628559|NCT00521833|Kataract|kataract
628560|NCT00521833|Astigmatism|astigmatism
628561|NCT00521833|phacoemulsification|phacoemulsification
628562|NCT00521820|Glucose Metabolism Disorder|glucose metabolism disorder
628563|NCT00521820|Dysmetabolic Syndrome|dysmetabolic syndrome
628564|NCT00521820|Type II Diabetes|type ii diabetes
628565|NCT00521820|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
628566|NCT00521820|Dyslipidemia|dyslipidemia
628567|NCT00521820|Drug Therapy|drug therapy
628568|NCT00521807|Hypnosis,|hypnosis,
628569|NCT00521807|Chronic widespread pain,|chronic widespread pain,
628570|NCT00521807|CWP,|cwp,
628571|NCT00521807|General Practice|general practice
628572|NCT00521794|Arrhythmia|arrhythmia
628573|NCT00521794|Muscle Weakness|muscle weakness
628574|NCT00521794|Periodic Paralysis|periodic paralysis
628575|NCT00521794|Channelopathy|channelopathy
628576|NCT00521781|Unresectable or Metastatic Adenocarcinoma Prostate Cancer|unresectable or metastatic adenocarcinoma prostate cancer
628577|NCT00521781|Hormonal Therapy|hormonal therapy
628578|NCT00521781|Abraxane|abraxane
628579|NCT00521781|M3thodist|m3thodist
628580|NCT00521768|Post traumatic stress disorder|post traumatic stress disorder
628581|NCT00521768|Anxiety disorder|anxiety disorder
628582|NCT00521768|Comunity base intervention|comunity base intervention
628583|NCT00521768|Education|education
628584|NCT00521768|Behavioural treatment|behavioural treatment
628585|NCT00521755|Laser bonding soft tissue albumin|laser bonding soft tissue albumin
628586|NCT00521742|Glucose Metabolism Disorder|glucose metabolism disorder
628587|NCT00521742|Dysmetabolic Syndrome|dysmetabolic syndrome
628588|NCT00521742|Type II Diabetes|type ii diabetes
628589|NCT00521742|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
628590|NCT00521742|Dyslipidemia|dyslipidemia
628591|NCT00521742|Drug Therapy|drug therapy
628592|NCT00521729|Thyroid|thyroid
628593|NCT00521729|Thermoregulation|thermoregulation
628594|NCT00521729|Catecholamines|catecholamines
628595|NCT00521729|Energy Expenditure|energy expenditure
628596|NCT00521729|Obesity|obesity
628597|NCT00521729|Healthy Volunteer|healthy volunteer
628598|NCT00521729|HV|hv
628599|NCT00521716|Hip Prosthesis Implantation|hip prosthesis implantation
628600|NCT00521703|endoscopy, gastrointestinal|endoscopy, gastrointestinal
628601|NCT00521703|lidocaine|lidocaine
628602|NCT00521703|propofol|propofol
628603|NCT00521703|child|child
628604|NCT00521703|adolescent|adolescent
628605|NCT00521677|VAP|vap
628606|NCT00521677|Oral care|oral care
628607|NCT00521677|Acquired pneumonia|acquired pneumonia
628608|NCT00521677|Mortality|mortality
628609|NCT00521677|LOS in ICU|los in icu
628610|NCT00521677|LOS in hospital|los in hospital
628611|NCT00521677|All patients on ventilator in the ICU|all patients on ventilator in the icu
628612|NCT00521664|proof of safety and cost effectiveness of the new therapeutic platelet transfusion strategy|proof of safety and cost effectiveness of the new therapeutic platelet transfusion strategy
628613|NCT00521651|Physical Activity|physical activity
628614|NCT00521651|Cancer Risk|cancer risk
628615|NCT00521612|sevoflurane|sevoflurane
628616|NCT00521612|isoflurane|isoflurane
628617|NCT00521612|anaesthesia|anaesthesia
628618|NCT00521586|Pneumococcal Conjugate Vaccine|pneumococcal conjugate vaccine
628619|NCT00521560|High-Dose Radio-Immuno- and Chemotherapy|high-dose radio-immuno- and chemotherapy
628620|NCT00521560|stem cell transplantation|stem cell transplantation
628621|NCT00521560|90Y-Ibritumomab-Tiuxetan|90y-ibritumomab-tiuxetan
628622|NCT00521547|Acupuncture|acupuncture
628623|NCT00521547|Analgesia|analgesia
628624|NCT00521547|Functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
628625|NCT00521547|Neuronal Mechanisms|neuronal mechanisms
628626|NCT00521547|Quantitative Peripheral Sensory Testings|quantitative peripheral sensory testings
628627|NCT00521547|Normal Volunteers|normal volunteers
628628|NCT00521534|Sleep related Breathing Disorder|sleep related breathing disorder
628629|NCT00521534|Congestive Heart Failure|congestive heart failure
628630|NCT00521534|Atrial Overdrive Pacing|atrial overdrive pacing
628631|NCT00521534|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
628632|NCT00521508|IgA|iga
628633|NCT00521508|kidney|kidney
628634|NCT00521508|Berger'disease|berger'disease
628635|NCT00521508|regulatory T cells|regulatory t cells
628636|NCT00521508|pathogenesis of Berger's disease|pathogenesis of berger's disease
628637|NCT00521495|static magnetic field|static magnetic field
628638|NCT00521495|permanent magnet|permanent magnet
628639|NCT00521495|carpal tunnel syndrome|carpal tunnel syndrome
628640|NCT00521495|median nerve|median nerve
628641|NCT00521482|recurrent|recurrent
628642|NCT00521482|after standard therapy|after standard therapy
628643|NCT00521469|Disequilibrium|disequilibrium
628644|NCT00521469|Spinal Manipulation|spinal manipulation
628645|NCT00521469|Postural control|postural control
628646|NCT00521430|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
628647|NCT00521430|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
628648|NCT00521430|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
628649|NCT00521430|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
628650|NCT00521430|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
628651|NCT00521430|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
628652|NCT00521430|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
628653|NCT00521430|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
628654|NCT00521430|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
628655|NCT00521430|aplastic anemia|aplastic anemia
628656|NCT00521430|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
628657|NCT00521430|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
628658|NCT00521430|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
628659|NCT00521430|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
628660|NCT00521430|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
628661|NCT00521430|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
628662|NCT00521430|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
628663|NCT00521430|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
628664|NCT00521430|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
628665|NCT00521430|refractory anemia with excess blasts|refractory anemia with excess blasts
628666|NCT00521430|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
628667|NCT00521430|refractory anemia|refractory anemia
628668|NCT00521430|refractory multiple myeloma|refractory multiple myeloma
628669|NCT00521430|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
628670|NCT00521430|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
628671|NCT00521430|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
628672|NCT00521430|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
628673|NCT00521430|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
628674|NCT00521430|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
628675|NCT00521430|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
628676|NCT00521430|anaplastic large cell lymphoma|anaplastic large cell lymphoma
628677|NCT00521430|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
628678|NCT00521430|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
628679|NCT00521430|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
628680|NCT00521430|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
628681|NCT00521430|Waldenström macroglobulinemia|waldenström macroglobulinemia
628682|NCT00521430|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
628683|NCT00521430|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
628684|NCT00521430|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
628685|NCT00521430|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
628686|NCT00521430|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
628687|NCT00521430|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
628688|NCT00521430|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
628689|NCT00521430|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
628690|NCT00521430|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
628691|NCT00521430|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
628692|NCT00521430|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
628693|NCT00521430|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
628694|NCT00521430|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
628695|NCT00521430|stage I multiple myeloma|stage i multiple myeloma
628696|NCT00521430|stage II multiple myeloma|stage ii multiple myeloma
628697|NCT00521430|stage III multiple myeloma|stage iii multiple myeloma
628698|NCT00521430|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
628699|NCT00521430|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
628700|NCT00521430|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
628701|NCT00521430|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
628702|NCT00521430|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
628703|NCT00521430|splenic marginal zone lymphoma|splenic marginal zone lymphoma
628704|NCT00521430|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
628705|NCT00521430|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
628706|NCT00521430|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
628707|NCT00521430|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
628708|NCT00521430|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
628709|NCT00521430|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
628710|NCT00521430|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
628711|NCT00521417|RCT|rct
628712|NCT00521404|Pancreatic cancer|pancreatic cancer
628713|NCT00521404|chemotherapy naive|chemotherapy naive
628714|NCT00521404|unresectable or metastatic pancreatic cancer|unresectable or metastatic pancreatic cancer
628715|NCT00521404|CS1008|cs1008
628716|NCT00521404|Gemcitabine|gemcitabine
628717|NCT00521404|Gemzar|gemzar
628718|NCT00521391|smoking cessation|smoking cessation
628719|NCT00521391|nicotine|nicotine
628720|NCT00521391|physical activity|physical activity
628721|NCT00521378|Diabetes|diabetes
628722|NCT00521378|Type 1 and Type 2 Diabetes|type 1 and type 2 diabetes
628723|NCT00521365|Bipolar Disorder|bipolar disorder
628724|NCT00521365|Bipolar Affective Psychosis|bipolar affective psychosis
628725|NCT00521365|Mania|mania
628726|NCT00521365|Manic Disorder|manic disorder
628727|NCT00521365|Manic State|manic state
628728|NCT00521352|TMS|tms
628729|NCT00521352|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
628730|NCT00521339|Apremilast,|apremilast,
628731|NCT00521339|Psoriasis,|psoriasis,
628732|NCT00521339|PASI-75,|pasi-75,
628733|NCT00521339|sPGA|spga
628734|NCT00521326|doppler|doppler
628735|NCT00521326|coronary stenosis|coronary stenosis
628736|NCT00521326|non-invasive testing|non-invasive testing
628737|NCT00521326|A prospective study of a new diagnostic method.|a prospective study of a new diagnostic method.
628738|NCT00521326|Study consists of a transthoracic doppler of LAD.|study consists of a transthoracic doppler of lad.
628739|NCT00521326|Doppler to be performed prior to coronary angiography.|doppler to be performed prior to coronary angiography.
628740|NCT00521326|F/U doppler examination for those who undergo PCI.|f/u doppler examination for those who undergo pci.
628741|NCT00521326|Doppler results will be compared with coronary angiography.|doppler results will be compared with coronary angiography.
628742|NCT00521300|Acromegaly|acromegaly
628743|NCT00521287|Immunologic Surveillance|immunologic surveillance
628744|NCT00521287|Vaccination|vaccination
628745|NCT00521287|Immunotherapy|immunotherapy
628746|NCT00521287|Dendritic Cells|dendritic cells
628747|NCT00521274|Progressive Hormone Refractory Prostate Cancer|progressive hormone refractory prostate cancer
628748|NCT00521274|HRPC|hrpc
628749|NCT00521274|MVA 5T4|mva 5t4
628750|NCT00521274|Trovax®|trovax®
628751|NCT00521274|Docetaxel|docetaxel
628752|NCT00521274|M3thodist|m3thodist
628753|NCT00521261|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
628754|NCT00521261|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
628755|NCT00521261|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
628756|NCT00521261|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
629142|NCT00519506|PE|pe
628757|NCT00521261|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
628758|NCT00521261|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
628759|NCT00521261|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
628760|NCT00521261|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
628761|NCT00521261|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
628762|NCT00521261|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
628763|NCT00521261|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
628764|NCT00521261|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
628765|NCT00521261|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
628766|NCT00521261|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
628767|NCT00521261|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
628768|NCT00521261|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
628769|NCT00521261|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
628770|NCT00521261|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
628771|NCT00521248|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
628772|NCT00521248|buprenorphine|buprenorphine
628773|NCT00521248|neonatal|neonatal
628774|NCT00521248|opioid withdrawal|opioid withdrawal
628775|NCT00521235|risk factors|risk factors
628776|NCT00521235|metabolic syndrome|metabolic syndrome
628777|NCT00521235|dentists|dentists
628778|NCT00521235|trainers|trainers
628779|NCT00521235|Healthy subjects|healthy subjects
628780|NCT00521235|students|students
628781|NCT00521235|seniors|seniors
628782|NCT00521222|asthma|asthma
628783|NCT00521222|beta agonist|beta agonist
628784|NCT00521222|bronchodilator|bronchodilator
628785|NCT00521222|pulmonary|pulmonary
628786|NCT00521222|genotype|genotype
628787|NCT00521222|pharmacogenomics|pharmacogenomics
628788|NCT00521222|corticosteroid|corticosteroid
628789|NCT00521222|allergy|allergy
628790|NCT00521222|immunology|immunology
628791|NCT00521209|Impoverished Population|impoverished population
628792|NCT00521196|migraine|migraine
628793|NCT00521196|headache|headache
628794|NCT00521196|chronic|chronic
628795|NCT00521196|pain|pain
628796|NCT00521196|brain|brain
628797|NCT00521196|neurology|neurology
628798|NCT00521196|stimulation|stimulation
628799|NCT00521196|noninvasive|noninvasive
628800|NCT00521196|transcranial|transcranial
628801|NCT00521196|direct|direct
628802|NCT00521196|current|current
628803|NCT00521196|tDCS|tdcs
628805|NCT00521196|rTMS|rtms
628806|NCT00521196|BIDMC|bidmc
628807|NCT00521183|adult tumors metastatic to brain|adult tumors metastatic to brain
628808|NCT00521170|Levocetirizine|levocetirizine
628809|NCT00521170|Wheal and flare|wheal and flare
628810|NCT00521170|Allergic|allergic
628811|NCT00521157|Substance abuse|substance abuse
628812|NCT00521157|Opiate dependency|opiate dependency
628813|NCT00521157|Treatment|treatment
628814|NCT00521157|Relapse prevention|relapse prevention
628815|NCT00521131|Levocetirizine dihydrochloride|levocetirizine dihydrochloride
628816|NCT00521131|Xyzal tablets|xyzal tablets
628817|NCT00521105|Type 1 Diabetes|type 1 diabetes
628818|NCT00521105|Telemedicine|telemedicine
628819|NCT00521105|Children|children
628820|NCT00521092|Treatment Experienced|treatment experienced
628821|NCT00521079|Obesity|obesity
628822|NCT00521079|Bariatric surgery|bariatric surgery
628823|NCT00521079|Excess weight loss|excess weight loss
628824|NCT00521079|Vagus nerve|vagus nerve
628825|NCT00521079|Vagal blocking|vagal blocking
628826|NCT00521079|vBloc(TM) therapy|vbloc(tm) therapy
628827|NCT00521053|immune|immune
628828|NCT00521053|vaccine|vaccine
628829|NCT00521053|systemic|systemic
628830|NCT00521053|Metastatic Melanoma (AJCC Stage III or IV)|metastatic melanoma (ajcc stage iii or iv)
628831|NCT00521040|Levocetirizine dihydrochloride|levocetirizine dihydrochloride
628832|NCT00521040|Xyzal tablets|xyzal tablets
628833|NCT00521027|Debridement|debridement
628834|NCT00521027|hydrosurgery|hydrosurgery
628835|NCT00521027|Versajet|versajet
628836|NCT00521027|leg ulcer|leg ulcer
628837|NCT00521014|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
628838|NCT00521014|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
628839|NCT00521014|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
628840|NCT00521001|stage IV melanoma|stage iv melanoma
628841|NCT00520988|hypertension|hypertension
628842|NCT00520988|intervention|intervention
628843|NCT00520988|disease management|disease management
628844|NCT00520988|telephone-based|telephone-based
628845|NCT00520988|Hypertension: diagnosed but uncontrolled|hypertension: diagnosed but uncontrolled
628846|NCT00520975|Trastuzumab|trastuzumab
628847|NCT00520975|Bevacizumab|bevacizumab
628848|NCT00520975|Metastatic Breast Cancer|metastatic breast cancer
628849|NCT00520975|HER2/NEU|her2/neu
628850|NCT00520962|cardiovascular disease|cardiovascular disease
628851|NCT00520962|glucose intolerance|glucose intolerance
628852|NCT00520962|type 2 diabetes|type 2 diabetes
629143|NCT00519493|Clozex|clozex
628853|NCT00520962|endothelial dysfunction|endothelial dysfunction
628854|NCT00520962|inflammation|inflammation
628855|NCT00520962|Age> 30 years, male and female|age> 30 years, male and female
628856|NCT00520962|Fasting glucose below 126 mg/dl|fasting glucose below 126 mg/dl
628857|NCT00520949|H.pylori|h.pylori
628858|NCT00520949|Triple therapy failure|triple therapy failure
628859|NCT00520949|Quadruple therapy|quadruple therapy
628860|NCT00520910|Polypodium leucotomos, Ultraviolet Rays, Heliocare, calaguala, anapsos|polypodium leucotomos, ultraviolet rays, heliocare, calaguala, anapsos
628861|NCT00520910|Skin Aging and Damage|skin aging and damage
628862|NCT00520897|chronic HIV infection|chronic hiv infection
628863|NCT00520897|Human Immunodeficiency Virus|human immunodeficiency virus
628864|NCT00520897|Treatment Experienced|treatment experienced
628865|NCT00520884|frailty|frailty
628866|NCT00520884|ghrelin|ghrelin
628867|NCT00520884|appetite|appetite
628868|NCT00520884|weight loss|weight loss
628869|NCT00520871|Cardiovascular disease|cardiovascular disease
628870|NCT00520871|Blueberruy|blueberruy
628871|NCT00520871|Antioxidants|antioxidants
628872|NCT00520871|Oxidative stress|oxidative stress
628873|NCT00520871|Inflammation|inflammation
628874|NCT00520845|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
628875|NCT00520845|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
628876|NCT00520845|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
628877|NCT00520845|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
628878|NCT00520832|Primary Insomnia|primary insomnia
628879|NCT00520832|Microcurrent Therapy|microcurrent therapy
628880|NCT00520832|Sleep Surveys|sleep surveys
628881|NCT00520819|Antioxidants|antioxidants
628882|NCT00520819|Phytochemicals|phytochemicals
628883|NCT00520819|Oxidative stress|oxidative stress
628884|NCT00520819|Inflammation|inflammation
628885|NCT00520819|Endothelial function|endothelial function
628886|NCT00520806|Heart failure|heart failure
628887|NCT00520806|Renal dysfunction|renal dysfunction
628888|NCT00520806|Relaxin|relaxin
628889|NCT00520806|Vasodilator|vasodilator
628890|NCT00520780|Chronic Heart Failure|chronic heart failure
628891|NCT00520780|Iron deficiency|iron deficiency
628892|NCT00520780|Iron deficiency anaemia|iron deficiency anaemia
628893|NCT00520780|Anaemia|anaemia
628894|NCT00520780|Heart disease|heart disease
628895|NCT00520767|primary systemic amyloidosis|primary systemic amyloidosis
628896|NCT00520767|light chain deposition disease|light chain deposition disease
628897|NCT00520754|levocetirizine dihydrochloride Xyzal tablets|levocetirizine dihydrochloride xyzal tablets
628898|NCT00520741|Epilepsy|epilepsy
628899|NCT00520741|Partial Onset Seizures|partial onset seizures
628900|NCT00520741|Lacosamide|lacosamide
628901|NCT00520741|Monotherapy|monotherapy
628902|NCT00520741|Vimpat|vimpat
628903|NCT00520728|Schizophrenia|schizophrenia
628904|NCT00520728|Psychosis|psychosis
628905|NCT00520728|Occupational Disengagement|occupational disengagement
628906|NCT00520728|Occupational Imbalance|occupational imbalance
628907|NCT00520715|fluoroquinolone resistance|fluoroquinolone resistance
628908|NCT00520715|commensal flora|commensal flora
628909|NCT00520715|carriage|carriage
628910|NCT00520702|Non-Small Cell Lung Cancer|non-small cell lung cancer
628911|NCT00520702|Lung Cancer|lung cancer
628912|NCT00520702|3-Dimensional Conformal Radiation Therapy|3-dimensional conformal radiation therapy
628913|NCT00520702|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
628914|NCT00520702|3D CRT|3d crt
628915|NCT00520702|IMRT|imrt
628916|NCT00520702|NSCLC|nsclc
628917|NCT00520702|TRP|trp
628918|NCT00520702|Treatment related pneumonitis|treatment related pneumonitis
628919|NCT00520663|Distribution,|distribution,
628920|NCT00520663|SB-649868,|sb-649868,
628921|NCT00520663|Healthy,|healthy,
628922|NCT00520663|Excretion,|excretion,
628923|NCT00520663|Sleep disturbances|sleep disturbances
628924|NCT00520663|Volunteer,|volunteer,
628925|NCT00520663|Metabolism,|metabolism,
628926|NCT00520663|Absorption,|absorption,
628927|NCT00520624|EIL|eil
628928|NCT00520611|Obesity|obesity
628929|NCT00520611|Weight Loss|weight loss
628930|NCT00520611|Financial Incentives|financial incentives
628931|NCT00520611|Lottery|lottery
628932|NCT00520611|Deposit|deposit
628933|NCT00520585|atorvastatin|atorvastatin
628934|NCT00520585|repolarisation|repolarisation
628935|NCT00520585|cardiomyocytes|cardiomyocytes
628936|NCT00520572|Rheumatoid Arthritis|rheumatoid arthritis
628937|NCT00520546|PET|pet
628938|NCT00520546|MRI|mri
628939|NCT00520546|Choline|choline
628940|NCT00520546|FEC|fec
628941|NCT00520546|prostate cancer|prostate cancer
628942|NCT00520533|Clinical trials|clinical trials
628943|NCT00520533|cG250 mAb|cg250 mab
628944|NCT00520533|monoclonal antibody G250|monoclonal antibody g250
628945|NCT00520533|sunitinib|sunitinib
628946|NCT00520533|angiogenesis inhibitors|angiogenesis inhibitors
628947|NCT00520533|Positron-Emission Tomography|positron-emission tomography
628948|NCT00520533|Pharmacokinetics|pharmacokinetics
628949|NCT00520533|Pharmacodynamics|pharmacodynamics
628950|NCT00520520|post resuscitation|post resuscitation
629144|NCT00519493|Sutures|sutures
628951|NCT00520520|post ventricular fibrillation|post ventricular fibrillation
628952|NCT00520520|patients receiving mild therapeutic hypothermia|patients receiving mild therapeutic hypothermia
628953|NCT00520507|Depression|depression
628954|NCT00520507|Bipolar Disorder|bipolar disorder
628955|NCT00520507|Major|major
628956|NCT00520494|Previously Untreated Patient (PUP)|previously untreated patient (pup)
628957|NCT00520494|Primary Immunodeficiency (PID)|primary immunodeficiency (pid)
628958|NCT00520494|CVID|cvid
628959|NCT00520494|XLA|xla
628960|NCT00520494|Subcutaneous immunoglobulin (SCIG)|subcutaneous immunoglobulin (scig)
628961|NCT00520494|IgG trough level|igg trough level
628962|NCT00520494|Quality of life|quality of life
628963|NCT00520494|Common variable immunodeficiency (CVID)|common variable immunodeficiency (cvid)
628964|NCT00520494|X-linked agammaglobulinemia (XLA)|x-linked agammaglobulinemia (xla)
628965|NCT00520468|Myelodysplastic Syndrome|myelodysplastic syndrome
628966|NCT00520468|MDS|mds
628967|NCT00520468|Erythropoietin|erythropoietin
628968|NCT00520468|Darbepoetin alfa|darbepoetin alfa
628969|NCT00520468|Aranesp|aranesp
628970|NCT00520468|Erythropoiesis stimulating protein|erythropoiesis stimulating protein
628971|NCT00520468|G-CSF|g-csf
628972|NCT00520468|Filgrastim|filgrastim
628973|NCT00520468|Neupogen|neupogen
628974|NCT00520468|Prednisone|prednisone
628975|NCT00520468|Cyclosporin A|cyclosporin a
628976|NCT00520468|Sandimmune|sandimmune
628977|NCT00520468|CYA|cya
628978|NCT00520468|Cyclosporine|cyclosporine
628979|NCT00520442|fracture|fracture
628980|NCT00520429|Depression|depression
628981|NCT00520429|Anxiety|anxiety
628982|NCT00520429|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
628983|NCT00520429|Heart Failure, Congestive|heart failure, congestive
628984|NCT00520377|Sinus Lift Surgery|sinus lift surgery
628985|NCT00520377|Sinus Floor Augmentation|sinus floor augmentation
628986|NCT00520377|Insufficient Bone Height|insufficient bone height
628987|NCT00520338|celecoxib|celecoxib
628988|NCT00520338|postoperative pain|postoperative pain
628989|NCT00520338|thyroidectomy|thyroidectomy
628990|NCT00520325|MBL deficient oncologic hematologic pediatric fever neutropenia|mbl deficient oncologic hematologic pediatric fever neutropenia
628991|NCT00520312|Peripheral Arterial Disease|peripheral arterial disease
628992|NCT00520312|PAD|pad
628993|NCT00520312|Functional Impairment|functional impairment
628994|NCT00520312|Magnetic Resonance Imaging|magnetic resonance imaging
628995|NCT00520299|metastatic melanoma|metastatic melanoma
628996|NCT00520299|ADI|adi
628997|NCT00520299|ADI-PEG 20|adi-peg 20
628998|NCT00520299|ADI SS PEG 20,000mw|adi ss peg 20,000mw
628999|NCT00520299|arginine|arginine
629000|NCT00520299|enzyme therapy|enzyme therapy
629001|NCT00520286|Methamphetamine Dependence|methamphetamine dependence
629002|NCT00520247|enalapril|enalapril
629003|NCT00520247|folic acid|folic acid
629004|NCT00520247|hyperglycemia|hyperglycemia
629005|NCT00520247|hypertension|hypertension
629006|NCT00520247|fasting plasma glucose|fasting plasma glucose
629007|NCT00520234|Candida|candida
629008|NCT00520234|Prophylaxis|prophylaxis
629009|NCT00520234|High risk adults|high risk adults
629010|NCT00520234|Intensive care unit (ICU)|intensive care unit (icu)
629011|NCT00520221|minocycline|minocycline
629012|NCT00520221|pleurodesis|pleurodesis
629013|NCT00520221|aspiration|aspiration
629014|NCT00520221|pneumothorax|pneumothorax
629015|NCT00520221|Primary spontaneous pneumothorax|primary spontaneous pneumothorax
629016|NCT00520221|First attack|first attack
629017|NCT00520221|Successful aspiration|successful aspiration
629018|NCT00520208|ATRA|atra
629019|NCT00520208|Trisenox|trisenox
629020|NCT00520208|Arsenic|arsenic
629021|NCT00520208|Arsenic Trioxide|arsenic trioxide
629022|NCT00520208|APL|apl
629023|NCT00520169|bioavailability|bioavailability
629024|NCT00520143|GSD-II, Pompe Disease, Glycogen Storage Disease II|gsd-ii, pompe disease, glycogen storage disease ii
629025|NCT00520130|Unrelated Donors|unrelated donors
629026|NCT00520130|Reduced Intensity Stem Cell Transplant|reduced intensity stem cell transplant
629027|NCT00520130|Leukemia|leukemia
629028|NCT00520130|Lymphoma|lymphoma
629029|NCT00520130|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
629030|NCT00520130|Myelodysplastic Syndrome|myelodysplastic syndrome
629031|NCT00520130|Multiple Myeloma|multiple myeloma
629032|NCT00520091|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
629033|NCT00520091|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
629034|NCT00520091|stage II esophageal cancer|stage ii esophageal cancer
629035|NCT00520091|stage III esophageal cancer|stage iii esophageal cancer
629036|NCT00520091|stage IV esophageal cancer|stage iv esophageal cancer
629037|NCT00520052|bisphosphonates, prostate cancer, bone density, osteoporosis|bisphosphonates, prostate cancer, bone density, osteoporosis
629038|NCT00520039|Otitis Media|otitis media
629039|NCT00520039|Effusion|effusion
629040|NCT00520039|OMM|omm
629041|NCT00520039|OMT|omt
629042|NCT00520039|Resolution|resolution
629043|NCT00520026|suicide|suicide
629044|NCT00520026|prevention|prevention
629045|NCT00520026|lithium|lithium
629046|NCT00520026|suicidality|suicidality
629141|NCT00519506|Pulmonary Embolism|pulmonary embolism
629047|NCT00520000|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
629048|NCT00519987|pharmacokinetics|pharmacokinetics
629049|NCT00519974|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
629050|NCT00519974|stage I breast cancer|stage i breast cancer
629051|NCT00519974|stage II breast cancer|stage ii breast cancer
629052|NCT00519974|stage IIIA breast cancer|stage iiia breast cancer
629053|NCT00519974|stage IIIB breast cancer|stage iiib breast cancer
629054|NCT00519974|stage IIIC breast cancer|stage iiic breast cancer
629055|NCT00519974|stage IV breast cancer|stage iv breast cancer
629056|NCT00519974|recurrent breast cancer|recurrent breast cancer
629057|NCT00519935|Insulin Dependent Diabetes Mellitus|insulin dependent diabetes mellitus
629058|NCT00519935|family therapy|family therapy
629059|NCT00519935|adolescents|adolescents
629060|NCT00519909|dairy products, calcium, fat excretion, energy excretion|dairy products, calcium, fat excretion, energy excretion
629061|NCT00519883|Anastrozole|anastrozole
629062|NCT00519883|Exercise|exercise
629063|NCT00519870|Pulmonary hypertension|pulmonary hypertension
629064|NCT00519870|Angiotensin receptor blocker|angiotensin receptor blocker
629065|NCT00519870|Calcium channel blocker|calcium channel blocker
629066|NCT00519831|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
629067|NCT00519831|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
629068|NCT00519831|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
629069|NCT00519818|Congenital Adrenal Hyperplasia|congenital adrenal hyperplasia
629070|NCT00519818|Hydrocortisone|hydrocortisone
629071|NCT00519818|Pharmacokinetic|pharmacokinetic
629072|NCT00519818|Pharmacodynamic|pharmacodynamic
629073|NCT00519805|thromboembolism|thromboembolism
629074|NCT00519805|extensive stage small cell lung cancer|extensive stage small cell lung cancer
629075|NCT00519805|limited stage small cell lung cancer|limited stage small cell lung cancer
629076|NCT00519805|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
629077|NCT00519805|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
629078|NCT00519805|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
629079|NCT00519805|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
629080|NCT00519805|stage I non-small cell lung cancer|stage i non-small cell lung cancer
629081|NCT00519792|Relapse|relapse
629082|NCT00519792|HCV|hcv
629083|NCT00519792|Hepatitis C|hepatitis c
629084|NCT00519792|Interferon|interferon
629085|NCT00519792|Ribavirin|ribavirin
629086|NCT00519779|affect|affect
629087|NCT00519779|inflammation|inflammation
629088|NCT00519766|Ratio of 3-Hydroxycotinine to Cotinine|ratio of 3-hydroxycotinine to cotinine
629089|NCT00519766|Nicotine Metabolism|nicotine metabolism
629090|NCT00519766|Pregnancy|pregnancy
629091|NCT00519753|Glaucoma|glaucoma
629092|NCT00519740|grass-pollen|grass-pollen
629093|NCT00519740|allergy|allergy
629094|NCT00519740|bronchial hyperreactivity|bronchial hyperreactivity
629095|NCT00519740|asthma|asthma
629096|NCT00519727|diabetes|diabetes
629097|NCT00519701|sickle cell anemia|sickle cell anemia
629098|NCT00519701|hydroxyurea|hydroxyurea
629099|NCT00519688|tegafur|tegafur
629100|NCT00519688|thalidomide|thalidomide
629101|NCT00519688|advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
629102|NCT00519675|Chronic hand eczema|chronic hand eczema
629103|NCT00519675|Chronic hand dermatitis|chronic hand dermatitis
629104|NCT00519675|Patients with chronic hand eczema, who are refractory to topical corticosteroids|patients with chronic hand eczema, who are refractory to topical corticosteroids
629105|NCT00519662|Solid|solid
629106|NCT00519662|Tumors|tumors
629107|NCT00519662|Advanced|advanced
629108|NCT00519649|Hepatitis B vaccine|hepatitis b vaccine
629109|NCT00519649|Challenge dose|challenge dose
629110|NCT00519636|experience|experience
629111|NCT00519636|GW685698X|gw685698x
629112|NCT00519636|fluticasone furoate|fluticasone furoate
629113|NCT00519636|preference|preference
629114|NCT00519636|seasonal allergic rhinitis|seasonal allergic rhinitis
629115|NCT00519636|fluticasone propionate|fluticasone propionate
629116|NCT00519623|diabetes|diabetes
629117|NCT00519623|insulin|insulin
629118|NCT00519623|blood sugar|blood sugar
629119|NCT00519623|type 1 diabetes|type 1 diabetes
629120|NCT00519623|insulin dependent diabetes|insulin dependent diabetes
629121|NCT00519623|transdermal|transdermal
629122|NCT00519610|portal hypertension, H-graft shunt|portal hypertension, h-graft shunt
629123|NCT00519597|Coronary Artery Disease|coronary artery disease
629124|NCT00519597|Sleep Apnea|sleep apnea
629125|NCT00519597|CPAP|cpap
629126|NCT00519597|Revascularization|revascularization
629127|NCT00519597|Mortality|mortality
629128|NCT00519584|Interscalene nerve block|interscalene nerve block
629129|NCT00519584|Dexamethasone|dexamethasone
629130|NCT00519584|Ropivacaine|ropivacaine
629131|NCT00519571|Dental Implantation, Endosseous|dental implantation, endosseous
629132|NCT00519545|breast|breast
629133|NCT00519545|cancer|cancer
629134|NCT00519545|stage|stage
629136|NCT00519545|four|four
629137|NCT00519532|Neupro®|neupro®
629138|NCT00519532|Rotigotine|rotigotine
629139|NCT00519532|Parkinson's Disease|parkinson's disease
629140|NCT00519519|Rebleeding after endoscopic therapy|rebleeding after endoscopic therapy
629145|NCT00519480|Tolerability|tolerability
629146|NCT00519480|GSK189075,|gsk189075,
629147|NCT00519480|Metformin,|metformin,
629148|NCT00519480|Safety,|safety,
629149|NCT00519480|Diabetes,|diabetes,
629150|NCT00519467|dose-ranging study|dose-ranging study
629151|NCT00519467|SB-714703|sb-714703
629152|NCT00519467|artesunate,|artesunate,
629153|NCT00519467|malaria|malaria
629154|NCT00519467|CDA,|cda,
629155|NCT00519467|chlorproguanil,|chlorproguanil,
629156|NCT00519467|dapsone,|dapsone,
629157|NCT00519454|Systemic Lupus Erythematosus|systemic lupus erythematosus
629158|NCT00519454|Estrogen receptors|estrogen receptors
629159|NCT00519454|T cells|t cells
629160|NCT00519454|Hormones|hormones
629161|NCT00519454|Female adult SLE|female adult sle
629162|NCT00519441|laparoscopic Heller myotomy, achalasia, reflux|laparoscopic heller myotomy, achalasia, reflux
629163|NCT00519428|depression|depression
629164|NCT00519428|Major Depressive Disorder|major depressive disorder
629165|NCT00519415|Tongue plate|tongue plate
629166|NCT00519415|Facemask|facemask
629167|NCT00519415|class III maxillary deficiency|class iii maxillary deficiency
629168|NCT00519415|orthodontic angle class three|orthodontic angle class three
629169|NCT00519402|partial tonsillectomy|partial tonsillectomy
629170|NCT00519402|complete tonsillectomy|complete tonsillectomy
629171|NCT00519402|tonsillectomy|tonsillectomy
629172|NCT00519402|obstruction sleep disordered breathing OSDB|obstruction sleep disordered breathing osdb
629173|NCT00519402|apnea|apnea
629174|NCT00519376|pharmacodynamics,|pharmacodynamics,
629175|NCT00519376|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
629176|NCT00519376|safety,|safety,
629177|NCT00519376|COPD patients|copd patients
629178|NCT00519376|pharmacokinetics,|pharmacokinetics,
629179|NCT00519376|tolerability,|tolerability,
629180|NCT00519376|GW642444,|gw642444,
629181|NCT00519363|Lupus|lupus
629182|NCT00519363|TLR's|tlr's
629183|NCT00519363|Hyperlipidemia|hyperlipidemia
629184|NCT00519363|age eighteen to sixty|age eighteen to sixty
629185|NCT00519363|female with SLE|female with sle
629186|NCT00519363|SLEDAI, greater than four|sledai, greater than four
629187|NCT00519363|LDL cholesterol elevated|ldl cholesterol elevated
629188|NCT00519350|SIRS, sepsis and related syndromes|sirs, sepsis and related syndromes
629189|NCT00519337|Atrial Fibrillation|atrial fibrillation
629190|NCT00519337|cardiac surgery|cardiac surgery
629191|NCT00519337|ascorbic acid|ascorbic acid
629192|NCT00519337|vitamin-c|vitamin-c
629193|NCT00519337|inflammation|inflammation
629194|NCT00519324|Gastric Cancer|gastric cancer
629195|NCT00519324|RAD001|rad001
629196|NCT00519324|mTOR|mtor
629197|NCT00519311|Intellectual disability|intellectual disability
629198|NCT00519311|Health promotion|health promotion
629199|NCT00519311|RCT|rct
629200|NCT00519298|Alzheimer Disease|alzheimer disease
629201|NCT00519285|metastatic|metastatic
629202|NCT00519285|prostate|prostate
629203|NCT00519285|cancer|cancer
629204|NCT00519272|Cervical Cancer|cervical cancer
629205|NCT00519272|Cervix|cervix
629206|NCT00519272|Precancerous Lesions|precancerous lesions
629207|NCT00519272|Cervical carcinoma in situ|cervical carcinoma in situ
629208|NCT00519272|CIS|cis
629209|NCT00519272|Early cervical cancer detection and treatment|early cervical cancer detection and treatment
629210|NCT00519272|Barriers to Care|barriers to care
629211|NCT00519272|Harris County|harris county
629212|NCT00519272|Questionnaire|questionnaire
629213|NCT00519246|Breast Neoplasms|breast neoplasms
629214|NCT00519246|Non-Steroidal Anti-Inflammatory Agents|non-steroidal anti-inflammatory agents
629215|NCT00519246|Analgesia|analgesia
629216|NCT00519233|HRPC|hrpc
629217|NCT00519233|Advanced hormone refractory prostate cancer|advanced hormone refractory prostate cancer
629218|NCT00519220|achalasia, Heller myotomy|achalasia, heller myotomy
629219|NCT00519207|pediatrics|pediatrics
629220|NCT00519207|pain|pain
629221|NCT00519207|infants|infants
629222|NCT00519207|newborn screening|newborn screening
629223|NCT00519207|venipuncture|venipuncture
629224|NCT00519207|lidocaine|lidocaine
629225|NCT00519207|sucrose|sucrose
629226|NCT00519194|Arrhythmia|arrhythmia
629227|NCT00519194|Atrial Fibrillation|atrial fibrillation
629228|NCT00519181|HTLV|htlv
629229|NCT00519181|HAM/TSP|ham/tsp
629230|NCT00519181|VALPROIC ACID|valproic acid
629231|NCT00519181|PROVIRAL LOAD|proviral load
629232|NCT00519129|Pain|pain
629233|NCT00519129|Patient satisfaction|patient satisfaction
629234|NCT00519103|microarray|microarray
629235|NCT00519103|Inflammtion|inflammtion
629236|NCT00519103|fibrosis|fibrosis
629237|NCT00519090|leukemia|leukemia
629238|NCT00519090|bone marrow|bone marrow
629239|NCT00519090|leukemia symptoms|leukemia symptoms
629240|NCT00519090|cml|cml
629241|NCT00519090|complete blood count|complete blood count
629242|NCT00519090|lymphocyte|lymphocyte
629243|NCT00519090|blood cancer|blood cancer
629244|NCT00519090|leukocytes|leukocytes
629245|NCT00519090|chronic leukemia|chronic leukemia
629246|NCT00519090|bone marrow biopsy|bone marrow biopsy
629247|NCT00519090|leukemia research|leukemia research
629248|NCT00519090|leukemia cells|leukemia cells
629249|NCT00519090|bone marrow disease|bone marrow disease
629250|NCT00519090|chronic myeloid leukemia|chronic myeloid leukemia
629251|NCT00519090|blood cancer symptoms|blood cancer symptoms
629252|NCT00519090|white blood cell diseases|white blood cell diseases
629253|NCT00519090|chronic myelogenous leukemia|chronic myelogenous leukemia
629254|NCT00519090|leukemia treatment|leukemia treatment
629255|NCT00519090|leukemia facts|leukemia facts
629256|NCT00519090|leucemia|leucemia
629257|NCT00519090|facts about leukemia|facts about leukemia
629258|NCT00519090|myelogenous leukemia|myelogenous leukemia
629259|NCT00519090|newly diagnosed CML|newly diagnosed cml
629260|NCT00519090|suboptimal response|suboptimal response
629261|NCT00519090|Philadelphia chromosome positive (Ph+)|philadelphia chromosome positive (ph+)
629262|NCT00519090|chronic myelogenous leukemia in chronic phase (CML-CP)|chronic myelogenous leukemia in chronic phase (cml-cp)
629263|NCT00519077|cancer|cancer
629264|NCT00519077|squamous cell|squamous cell
629265|NCT00519077|carcinoma|carcinoma
629266|NCT00519077|head|head
629267|NCT00519077|neck|neck
629268|NCT00519064|influenza|influenza
629269|NCT00519064|influenza vaccine|influenza vaccine
629270|NCT00519064|adjuvanted influenza vaccine|adjuvanted influenza vaccine
629271|NCT00519064|H5N1 influenza antigen|h5n1 influenza antigen
629272|NCT00519051|depression|depression
629273|NCT00519051|primary care|primary care
629274|NCT00519051|pharmacotherapy|pharmacotherapy
629275|NCT00519038|Critical Pathways|critical pathways
629276|NCT00519038|Congestive Heart Failure|congestive heart failure
629277|NCT00519038|Randomized Controlled Trial|randomized controlled trial
629278|NCT00519038|Effectiveness|effectiveness
629279|NCT00519025|Linezolid|linezolid
629280|NCT00519025|Staphylococcus Aureus|staphylococcus aureus
629281|NCT00519025|Infections|infections
629282|NCT00519012|early nonresponse|early nonresponse
629283|NCT00518999|cognition, attention, memory, executive functions, illness-awareness, insight.|cognition, attention, memory, executive functions, illness-awareness, insight.
629284|NCT00518986|Obstructive Sleep Apnea/Hypopnea Syndrome|obstructive sleep apnea/hypopnea syndrome
629285|NCT00518986|Excessive Sleepiness|excessive sleepiness
629286|NCT00518960|ProAlgaZyme|proalgazyme
629287|NCT00518960|Algae|algae
629288|NCT00518960|High density lipoprotein; HDL|high density lipoprotein; hdl
629289|NCT00518960|C-Reactive Protein; CRP|c-reactive protein; crp
629290|NCT00518960|Hyperlipidemia|hyperlipidemia
629291|NCT00518960|Metabolic Syndrome|metabolic syndrome
629292|NCT00518947|Bipolar Disorder|bipolar disorder
629293|NCT00518947|Mania|mania
629294|NCT00518947|Antimanic|antimanic
629295|NCT00518947|Verapamil|verapamil
629296|NCT00518947|Lithium|lithium
629297|NCT00518934|Safety and efficiency of angiogenesis for patients with limb|safety and efficiency of angiogenesis for patients with limb
629298|NCT00518934|ischemia by transplantation of human cord blood mononuclear|ischemia by transplantation of human cord blood mononuclear
629299|NCT00518934|cells|cells
629300|NCT00518921|adenosin agonist|adenosin agonist
629301|NCT00518921|chronic stable angina|chronic stable angina
629302|NCT00518908|Ischemia reperfusion injury|ischemia reperfusion injury
629303|NCT00518908|Organ protection|organ protection
629304|NCT00518895|Melanoma|melanoma
629305|NCT00518895|Advanced Melanoma|advanced melanoma
629306|NCT00518895|Malignant Melanoma|malignant melanoma
629307|NCT00518895|Metastatic Melanoma|metastatic melanoma
629308|NCT00518895|Skin Cancer|skin cancer
629309|NCT00518895|Genasense|genasense
629310|NCT00518895|oblimersen|oblimersen
629311|NCT00518895|antisense|antisense
629312|NCT00518895|Bcl-2 antisense|bcl-2 antisense
629313|NCT00518895|G3139|g3139
629314|NCT00518895|dacarbazine|dacarbazine
629315|NCT00518869|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
629316|NCT00518869|Complementary and Alternative Medicine (CAM)|complementary and alternative medicine (cam)
629317|NCT00518869|Chemotherapy|chemotherapy
629318|NCT00518869|Myelosuppression|myelosuppression
629319|NCT00518869|Quality of Life|quality of life
629320|NCT00518869|Fatigue|fatigue
629321|NCT00518869|EORTC QLQ-C30 and LC13|eortc qlq-c30 and lc13
629322|NCT00518856|birth asphyxia|birth asphyxia
629323|NCT00518856|neonatal sepsis|neonatal sepsis
629324|NCT00518856|maternal to child transmission of HIV|maternal to child transmission of hiv
629325|NCT00518843|binge eating|binge eating
629326|NCT00518843|purging|purging
629327|NCT00518830|postnatal depression|postnatal depression
629328|NCT00518830|primary care|primary care
629329|NCT00518830|depressed women|depressed women
629330|NCT00518817|Dystrophy|dystrophy
629331|NCT00518817|Cardiomyopathy|cardiomyopathy
629332|NCT00518791|Integrated health care system|integrated health care system
629333|NCT00518791|Treatment effectiveness|treatment effectiveness
629334|NCT00518791|Cost effectiveness|cost effectiveness
629335|NCT00518791|Program evaluation|program evaluation
629336|NCT00518778|fusariosis|fusariosis
629337|NCT00518778|solid organ transplants|solid organ transplants
629338|NCT00518765|aliskiren, renal hemodynamics, hormonal response, renin pathway, RAAS biomarkers|aliskiren, renal hemodynamics, hormonal response, renin pathway, raas biomarkers
629339|NCT00518752|Ventilator Acquired Pneumonia|ventilator acquired pneumonia
629340|NCT00518752|Oral Hygiene|oral hygiene
629341|NCT00518752|Oral Care|oral care
629342|NCT00518752|Xerostomia|xerostomia
629343|NCT00518726|Adjuvanted Influenza Vaccine|adjuvanted influenza vaccine
629344|NCT00518713|Epilepsy|epilepsy
629345|NCT00518713|Lennox-Gastaut Syndrome|lennox-gastaut syndrome
629346|NCT00518713|Drop seizures|drop seizures
629347|NCT00518713|Clobazam|clobazam
629348|NCT00518674|pain|pain
629349|NCT00518674|local infiltration analgesia|local infiltration analgesia
629350|NCT00518661|quinolone resistance|quinolone resistance
629351|NCT00518661|ESBL|esbl
629352|NCT00518661|Klebsiella species|klebsiella species
629353|NCT00518661|Infection|infection
629354|NCT00518648|Accidental falls|accidental falls
629355|NCT00518648|Prevention|prevention
629356|NCT00518648|Treatment effectiveness|treatment effectiveness
629357|NCT00518635|Growth hormone|growth hormone
629358|NCT00518635|Insulin sensitivity|insulin sensitivity
629359|NCT00518635|Polycystic ovary|polycystic ovary
629360|NCT00518609|Neonatal|neonatal
629361|NCT00518609|Sepsis|sepsis
629362|NCT00518609|Global Network|global network
629363|NCT00518609|Antibiotics|antibiotics
629364|NCT00518609|India|india
629365|NCT00518609|International|international
629366|NCT00518609|Maternal and child health|maternal and child health
629367|NCT00518596|Neonatal|neonatal
629368|NCT00518596|Sepsis|sepsis
629369|NCT00518596|Global Network|global network
629370|NCT00518596|Probiotics|probiotics
629371|NCT00518596|India|india
629372|NCT00518596|International|international
629373|NCT00518596|Maternal and child health|maternal and child health
629374|NCT00518583|Breast cancer|breast cancer
629375|NCT00518583|Over-expressing Her2-neu|over-expressing her2-neu
629376|NCT00518570|PMDD|pmdd
629377|NCT00518570|PMS|pms
629378|NCT00518570|Levetiracetam|levetiracetam
629379|NCT00518557|liver cancer|liver cancer
629380|NCT00518557|interventional radiology|interventional radiology
629381|NCT00518557|Chemoembolization|chemoembolization
629382|NCT00518557|Safety|safety
629383|NCT00518557|Effectiveness|effectiveness
629384|NCT00518544|hydroxyethyl starch, blood type, coagulation|hydroxyethyl starch, blood type, coagulation
629385|NCT00518531|osteoporosis|osteoporosis
629386|NCT00518531|low bone mineral density|low bone mineral density
629387|NCT00518531|alendronate|alendronate
629388|NCT00518531|denosumab|denosumab
629389|NCT00518531|adherence|adherence
629390|NCT00518531|preference|preference
629391|NCT00518531|satisfaction|satisfaction
629392|NCT00518531|postmenopausal|postmenopausal
629393|NCT00518531|women|women
629394|NCT00518518|Asthma|asthma
629395|NCT00518518|Sublingual immunotherapy|sublingual immunotherapy
629396|NCT00518518|Children|children
629397|NCT00518505|GERD, laparoscopic surgery|gerd, laparoscopic surgery
629398|NCT00518479|Hypertension|hypertension
629399|NCT00518479|Left Ventricular Hypertrophy|left ventricular hypertrophy
629400|NCT00518466|Obesity|obesity
629401|NCT00518453|Influenza vaccine|influenza vaccine
629402|NCT00518440|Liver disease|liver disease
629403|NCT00518440|Liver injury|liver injury
629404|NCT00518414|infant, formula, LC PUFA|infant, formula, lc pufa
629405|NCT00518401|A hypoperfusion of the blood through a leg|a hypoperfusion of the blood through a leg
629406|NCT00518401|Stem cells|stem cells
629407|NCT00518401|Stem cell transplantation|stem cell transplantation
629408|NCT00518401|Stem cell autologous transplantation|stem cell autologous transplantation
629409|NCT00518388|Epidemiology|epidemiology
629410|NCT00518388|Cervical Cancer|cervical cancer
629411|NCT00518388|Human Papillomavirus|human papillomavirus
629412|NCT00518388|Focus Group|focus group
629413|NCT00518388|Questionnaire|questionnaire
629414|NCT00518388|Survey|survey
629415|NCT00518388|HPV|hpv
629416|NCT00518362|TW|tw
629417|NCT00518362|Valsartan|valsartan
629418|NCT00518362|treatment|treatment
629419|NCT00518362|diabetic nephropathy|diabetic nephropathy
629420|NCT00518362|Proteinuria|proteinuria
629421|NCT00518323|Schizophrenia|schizophrenia
629422|NCT00518323|Antipsychotic|antipsychotic
629423|NCT00518310|Interstitial lung disease|interstitial lung disease
629424|NCT00518310|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
629425|NCT00518310|Usual interstitial pneumonia|usual interstitial pneumonia
629426|NCT00518310|Cryptogenic fibrosing alveolitis|cryptogenic fibrosing alveolitis
629427|NCT00518310|Therapy|therapy
629428|NCT00518310|Azathioprine|azathioprine
629429|NCT00518310|Steroids|steroids
629430|NCT00518310|Glucocorticoids|glucocorticoids
629431|NCT00518310|Corticosteroids|corticosteroids
629432|NCT00518310|Prednisone|prednisone
629433|NCT00518297|Antivirals / HIV|antivirals / hiv
629434|NCT00518284|Restenosis|restenosis
629435|NCT00518284|Superficial Femoral Artery|superficial femoral artery
629436|NCT00518284|Prevention of restenosis|prevention of restenosis
629437|NCT00518284|Revascularization of the superficial Femoral Artery|revascularization of the superficial femoral artery
629438|NCT00518258|Parkinson's Disease|parkinson's disease
629439|NCT00518258|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
629440|NCT00518258|neuropsychological assessment|neuropsychological assessment
629441|NCT00518245|unstable angina|unstable angina
629442|NCT00518245|drug therapy|drug therapy
629443|NCT00518245|myocardial ischemia|myocardial ischemia
629444|NCT00518245|myocardial infarction|myocardial infarction
629445|NCT00518245|hemorrhage|hemorrhage
629446|NCT00518232|Methylphenidate|methylphenidate
629447|NCT00518232|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
629448|NCT00518219|TW|tw
629449|NCT00518219|Valsartan|valsartan
629450|NCT00518219|treatment|treatment
629451|NCT00518219|membranous nephropathy|membranous nephropathy
629452|NCT00518219|proteinuria|proteinuria
629453|NCT00518206|Clinical Trial|clinical trial
629454|NCT00518206|Phase 2|phase 2
629455|NCT00518206|Cancer Vaccine|cancer vaccine
629456|NCT00518206|NY-ESO-1 protein, human|ny-eso-1 protein, human
629457|NCT00518206|ISCOMATRIX, immunological adjuvant|iscomatrix, immunological adjuvant
629458|NCT00518206|Cyclophosphamide|cyclophosphamide
629459|NCT00518206|T-Cells, Regulatory|t-cells, regulatory
629460|NCT00518180|Meningococcal|meningococcal
629461|NCT00518180|meningitis|meningitis
629462|NCT00518180|vaccine|vaccine
629463|NCT00518180|adolescents|adolescents
629464|NCT00518167|Type 2 diabetes|type 2 diabetes
629465|NCT00518167|primary prevention|primary prevention
629466|NCT00518167|diet|diet
629467|NCT00518167|physical activity|physical activity
629468|NCT00518167|intervention|intervention
629469|NCT00518167|impaired glucose tolerance|impaired glucose tolerance
629470|NCT00518167|lifestyle|lifestyle
629471|NCT00518167|randomized controlled study|randomized controlled study
629472|NCT00518154|AIDS|aids
629473|NCT00518154|Immunological non-responders|immunological non-responders
629474|NCT00518154|Neuroimmune modulation|neuroimmune modulation
629475|NCT00518154|Pyridostigmine|pyridostigmine
629476|NCT00518154|Treatment Experienced|treatment experienced
629477|NCT00518128|Obstructive Sleep Apnea|obstructive sleep apnea
629478|NCT00518128|Leptin|leptin
629479|NCT00518128|Homocysteine|homocysteine
629480|NCT00518128|C-reactive protein|c-reactive protein
629481|NCT00518115|GLP-1,|glp-1,
629482|NCT00518115|Type 2 Diabetes,|type 2 diabetes,
629483|NCT00518115|pharmacokinetics,|pharmacokinetics,
629484|NCT00518115|pharmacodynamics,|pharmacodynamics,
629485|NCT00518115|GSK716155,|gsk716155,
629486|NCT00518115|metformin,|metformin,
629487|NCT00518115|exenatide|exenatide
629488|NCT00518115|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
629489|NCT00518102|REGRANEX (becaplermin)|regranex (becaplermin)
629490|NCT00518102|Platelet-derived growth factor BB|platelet-derived growth factor bb
629491|NCT00518102|Cancer|cancer
629492|NCT00518102|Cancer incidence|cancer incidence
629493|NCT00518102|Cancer mortality|cancer mortality
629494|NCT00518076|Staphylococcus aureus carriers students nursing|staphylococcus aureus carriers students nursing
629495|NCT00518050|Health Behaviors|health behaviors
629496|NCT00518050|Surveillance|surveillance
629497|NCT00518050|06-128|06-128
629498|NCT00518024|tinnitus|tinnitus
629499|NCT00518024|transcranial magnetic stimulation|transcranial magnetic stimulation
629500|NCT00518024|treatment|treatment
629501|NCT00518024|cortex|cortex
629502|NCT00517998|Lung volume reduction|lung volume reduction
629503|NCT00517998|Bronchoscopy|bronchoscopy
629504|NCT00517998|Emphysema|emphysema
629505|NCT00517998|COPD|copd
629506|NCT00517998|NETT|nett
629507|NCT00517998|Lung disease|lung disease
629508|NCT00517998|COLD|cold
629509|NCT00517998|BLVR|blvr
629510|NCT00517985|perimenopausal depression|perimenopausal depression
629511|NCT00517985|duloxetine|duloxetine
629512|NCT00517985|cymbalta|cymbalta
629513|NCT00517985|major depressive disorder|major depressive disorder
629514|NCT00517985|women|women
629515|NCT00517972|perimenopausal depression|perimenopausal depression
629516|NCT00517972|omacor|omacor
629517|NCT00517972|major depressive disorder|major depressive disorder
629518|NCT00517972|women|women
629519|NCT00517959|Stereotactic radiotherapy|stereotactic radiotherapy
629520|NCT00517959|conformal radiotherapy|conformal radiotherapy
629521|NCT00517959|late sequelae|late sequelae
629522|NCT00517959|cognition|cognition
629523|NCT00517959|endocrine dysfunction|endocrine dysfunction
629524|NCT00517946|anti-allergy.|anti-allergy.
629525|NCT00517946|seasonal allergic rhinitis (SAR),|seasonal allergic rhinitis (sar),
629526|NCT00517946|intranasal allergen challenge,|intranasal allergen challenge,
629527|NCT00517946|MRI,|mri,
629528|NCT00517933|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
629529|NCT00517933|Pulmonary Hypertension|pulmonary hypertension
629530|NCT00517894|lymphoma|lymphoma
629531|NCT00517894|aggressive|aggressive
629532|NCT00517894|chemotherapy|chemotherapy
629533|NCT00517894|dose-dense|dose-dense
629534|NCT00517868|bladder|bladder
629535|NCT00517868|pain|pain
629536|NCT00517868|urgency|urgency
629537|NCT00517868|frequency|frequency
629538|NCT00517842|Parkinson's disease|parkinson's disease
629539|NCT00517829|metastatic gastric or adenocarcinoma of the GE junction|metastatic gastric or adenocarcinoma of the ge junction
629540|NCT00517803|micronutrients|micronutrients
629541|NCT00517803|immunodeficiency|immunodeficiency
629542|NCT00517803|probiotics|probiotics
629543|NCT00517803|yogurt|yogurt
629544|NCT00517803|Healthy|healthy
629545|NCT00517803|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
629546|NCT00517803|Complementary Therapies|complementary therapies
629547|NCT00517790|Refractory|refractory
629548|NCT00517790|Metastatic|metastatic
629549|NCT00517777|sleep apnea syndrome|sleep apnea syndrome
629550|NCT00517777|metabolic syndrome|metabolic syndrome
629551|NCT00517777|cardiac remodelling|cardiac remodelling
629552|NCT00517777|continuous positive airway pressure ventilation|continuous positive airway pressure ventilation
629553|NCT00517764|major depressive disorder|major depressive disorder
629554|NCT00517764|MDD|mdd
629555|NCT00517764|escitalopram|escitalopram
629556|NCT00517764|open-label|open-label
629557|NCT00517764|major depression|major depression
629558|NCT00517764|serotonin transporter|serotonin transporter
629559|NCT00517764|brain-derived neurotrophic factor|brain-derived neurotrophic factor
629560|NCT00517751|Lumbar Spinal Stenosis|lumbar spinal stenosis
629561|NCT00517751|X-STOP Spacer|x-stop spacer
629562|NCT00517751|Interspinous process decompression|interspinous process decompression
629563|NCT00517751|Neurogenic Intermittent Claudication|neurogenic intermittent claudication
629564|NCT00517725|exercise|exercise
629565|NCT00517725|lung diffusion|lung diffusion
629566|NCT00517725|hypoxia|hypoxia
629567|NCT00517725|chemoreceptor|chemoreceptor
629568|NCT00517725|beta-blockers|beta-blockers
629569|NCT00517725|heart failure|heart failure
629570|NCT00517712|Acute promyelocytic leukemia|acute promyelocytic leukemia
629571|NCT00517712|Arsenic trioxide|arsenic trioxide
629572|NCT00517712|Molecular remission|molecular remission
629573|NCT00517712|Toxicity profile|toxicity profile
629574|NCT00517712|Maintenance therapy|maintenance therapy
629575|NCT00517686|Poor risk factor control|poor risk factor control
629576|NCT00517686|Treatment intensification|treatment intensification
629577|NCT00517686|Medication adherence|medication adherence
629578|NCT00517686|Cardiovascular disease (CVD)|cardiovascular disease (cvd)
629579|NCT00517673|Healthy Volunteer|healthy volunteer
629580|NCT00517660|Healthy subjects|healthy subjects
629581|NCT00517660|Lower Respiratory Tract Infections|lower respiratory tract infections
629582|NCT00517660|Upper Respiratory Tract Infections|upper respiratory tract infections
629583|NCT00517647|ADHD|adhd
629584|NCT00517647|atomoxetine|atomoxetine
629585|NCT00517647|preschool children|preschool children
629586|NCT00517647|efficacy|efficacy
629587|NCT00517647|safety|safety
629588|NCT00517634|asthma|asthma
629589|NCT00517634|allergen challenge|allergen challenge
629590|NCT00517634|IL-5|il-5
629591|NCT00517634|eosinophils|eosinophils
629592|NCT00517621|Peritoneal cancer|peritoneal cancer
629593|NCT00517621|Relapse or progression|relapse or progression
629594|NCT00517595|Non-Small Cell Lung Cancer|non-small cell lung cancer
629595|NCT00517582|ACE Inhibitor|ace inhibitor
629596|NCT00517582|Angioedema|angioedema
629597|NCT00517582|Bradykinin|bradykinin
629598|NCT00517582|Swelling|swelling
629599|NCT00517569|Gene Therapy|gene therapy
629600|NCT00517569|GX-12|gx-12
629601|NCT00517569|HIV-1|hiv-1
629602|NCT00517569|Interleukin|interleukin
629603|NCT00517569|AIDS|aids
629604|NCT00517569|HIV-1 type B infection|hiv-1 type b infection
629605|NCT00517569|Treatment Naive|treatment naive
629606|NCT00517556|Dysmenorrhea|dysmenorrhea
629607|NCT00517556|continuous OCP|continuous ocp
629608|NCT00517543|inflammation|inflammation
629609|NCT00517517|Pandemic influenza|pandemic influenza
629610|NCT00517504|methylphenidate|methylphenidate
629611|NCT00517504|ritalin|ritalin
629612|NCT00517504|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
629613|NCT00517504|developmental disorder|developmental disorder
629614|NCT00517504|preschool children|preschool children
629615|NCT00517426|heart failure,|heart failure,
629616|NCT00517426|exercise|exercise
629617|NCT00517426|periodic breathing,|periodic breathing,
629618|NCT00517426|acetazolamide|acetazolamide
629619|NCT00517400|PTSD|ptsd
629620|NCT00517387|Depression|depression
629621|NCT00517387|SSRI|ssri
629622|NCT00517387|Atypical Antipsychotic|atypical antipsychotic
629623|NCT00517387|Cognition|cognition
629624|NCT00517387|Mood|mood
629625|NCT00517387|Quality of Life|quality of life
629626|NCT00517348|Adult|adult
629627|NCT00517335|anorexia nervosa|anorexia nervosa
629628|NCT00517335|bulimia nervosa|bulimia nervosa
629629|NCT00517322|left atrial volume|left atrial volume
629630|NCT00517322|hypertension|hypertension
629631|NCT00517322|ramipril|ramipril
629632|NCT00517322|irbesartan|irbesartan
629633|NCT00517322|diastolic function|diastolic function
629634|NCT00517283|diabetes|diabetes
629635|NCT00517283|gastric emptying|gastric emptying
629636|NCT00517283|exenatide|exenatide
629637|NCT00517283|Byetta|byetta
629638|NCT00517283|Amylin|amylin
629639|NCT00517283|Lilly|lilly
629640|NCT00517270|Non-cardiac chest pain|non-cardiac chest pain
629641|NCT00517257|Retinal vein occlusion|retinal vein occlusion
629642|NCT00517257|Retinal vein thrombosis|retinal vein thrombosis
629643|NCT00517257|Central retinal vein occlusion|central retinal vein occlusion
629736|NCT00516841|peritoneal cancer|peritoneal cancer
629644|NCT00517257|Branch retinal vein occlusion|branch retinal vein occlusion
629645|NCT00517257|Visual loss|visual loss
629646|NCT00517257|Atorvastatin|atorvastatin
629647|NCT00517257|Statin|statin
629648|NCT00517257|Neovascularization|neovascularization
629649|NCT00517257|Thrombosis|thrombosis
629650|NCT00517244|Children|children
629651|NCT00517244|Healthy Controls|healthy controls
629652|NCT00517244|Assessment|assessment
629653|NCT00517231|Pulmonary tuberculosis|pulmonary tuberculosis
629654|NCT00517231|Mycobacterium tuberculosis|mycobacterium tuberculosis
629655|NCT00517231|Cytokines|cytokines
629656|NCT00517231|Acute Phase Response|acute phase response
629657|NCT00517231|Treatment|treatment
629658|NCT00517218|Evaluate the Effect of Genasense on the Efficacy/Safety of Rituximab/Fludarabine Treatment in Untreated Subjects With Chronic Lymphocyctic Leukemia|evaluate the effect of genasense on the efficacy/safety of rituximab/fludarabine treatment in untreated subjects with chronic lymphocyctic leukemia
629659|NCT00517205|upper ureteric stone|upper ureteric stone
629660|NCT00517179|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
629661|NCT00517179|Erectile Dysfunction (ED)|erectile dysfunction (ed)
629662|NCT00517166|tourniquet|tourniquet
629663|NCT00517166|extremity injury|extremity injury
629664|NCT00517166|hemostatic device|hemostatic device
629665|NCT00517153|Zavesca|zavesca
629666|NCT00517153|miglustat|miglustat
629667|NCT00517153|Niemann-Pick Type C|niemann-pick type c
629668|NCT00517153|Actelion|actelion
629669|NCT00517140|Pregnancy women with a scarred uterus due to previous caesarean section|pregnancy women with a scarred uterus due to previous caesarean section
629670|NCT00517127|Intraoperative care|intraoperative care
629671|NCT00517127|Ringer's lactate|ringer's lactate
629672|NCT00517127|Voluven|voluven
629673|NCT00517127|Cardiovascular diagnostic technique|cardiovascular diagnostic technique
629674|NCT00517127|Doppler effect|doppler effect
629675|NCT00517114|Reflux laryngitis|reflux laryngitis
629676|NCT00517101|spondyloarthropathy|spondyloarthropathy
629677|NCT00517101|inflammatory bowel disease|inflammatory bowel disease
629678|NCT00517101|antibodies|antibodies
629679|NCT00517088|Physical Activity|physical activity
629680|NCT00517088|Breast Cancer|breast cancer
629681|NCT00517075|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
629682|NCT00517075|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
629683|NCT00517075|Schizophrenia|schizophrenia
629684|NCT00517075|Schizoaffective Disorder|schizoaffective disorder
629685|NCT00517075|Treatment|treatment
629686|NCT00517075|Negative Symptoms|negative symptoms
629687|NCT00517075|Social Dysfunction|social dysfunction
629688|NCT00517075|TMS|tms
629689|NCT00517075|rTMS|rtms
629690|NCT00517062|Growth hormone|growth hormone
629691|NCT00517062|insulin sensitivity|insulin sensitivity
629692|NCT00517062|cortisol|cortisol
629693|NCT00517049|NHL|nhl
629694|NCT00517049|Rituxan|rituxan
629695|NCT00517049|Lymphoma|lymphoma
629696|NCT00517049|CD20-positive|cd20-positive
629697|NCT00517049|B-Cell|b-cell
629698|NCT00517049|APM4083g|apm4083g
629699|NCT00517036|Major Depression|major depression
629700|NCT00517036|Omega-3|omega-3
629701|NCT00517036|Major Depressive Disorder|major depressive disorder
629702|NCT00517023|Implantable Loop Recorder|implantable loop recorder
629703|NCT00517023|Home monitoring|home monitoring
629704|NCT00517023|Syncope/ Falls Clinic|syncope/ falls clinic
629705|NCT00517010|Age-related macular degeneration|age-related macular degeneration
629706|NCT00517010|Exudative age-related macular degeneration|exudative age-related macular degeneration
629707|NCT00517010|Wet macular degeneration|wet macular degeneration
629708|NCT00517010|Intravitreal injection|intravitreal injection
629709|NCT00517010|Proton beam irradiation|proton beam irradiation
629710|NCT00517010|Lucentis|lucentis
629711|NCT00517010|Ranibizumab|ranibizumab
629712|NCT00516984|Relationship between Osteopathic Manipulative Therapy (OMT) and the autonomic nervous system|relationship between osteopathic manipulative therapy (omt) and the autonomic nervous system
629713|NCT00516984|LF/HF ratio|lf/hf ratio
629714|NCT00516971|Non-erosive reflux disease|non-erosive reflux disease
629715|NCT00516958|diabetic|diabetic
629716|NCT00516958|ulcer|ulcer
629717|NCT00516958|infection|infection
629718|NCT00516958|topical|topical
629719|NCT00516958|wound|wound
629720|NCT00516945|hepatitis B during cancer chemotherapy|hepatitis b during cancer chemotherapy
629721|NCT00516932|Suicidal Event|suicidal event
629722|NCT00516932|Behavioral Activation|behavioral activation
629723|NCT00516919|Obesity|obesity
629724|NCT00516919|Binge Eating|binge eating
629725|NCT00516919|Monolingual Hispanic Persons|monolingual hispanic persons
629726|NCT00516919|Orlistat|orlistat
629727|NCT00516919|Behavioral Weight Loss Treatment|behavioral weight loss treatment
629728|NCT00516893|natalizumab|natalizumab
629729|NCT00516893|Tysabri|tysabri
629730|NCT00516893|Multiple Sclerosis|multiple sclerosis
629731|NCT00516893|Relapsing Forms of Multiple Sclerosis|relapsing forms of multiple sclerosis
629732|NCT00516880|chronic kidney disease|chronic kidney disease
629733|NCT00516880|cardiovascular disease|cardiovascular disease
629734|NCT00516854|Non-cardiac chest pain|non-cardiac chest pain
629735|NCT00516841|epithelial ovarian cancer|epithelial ovarian cancer
629737|NCT00516841|platinum-resistant ovarian cancer|platinum-resistant ovarian cancer
629738|NCT00516841|Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer|platinum-resistant advanced epithelial ovarian cancer or primary peritoneal cancer
629739|NCT00516828|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
629740|NCT00516828|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
629741|NCT00516828|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
629742|NCT00516828|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
629743|NCT00516828|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
629744|NCT00516828|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
629745|NCT00516828|secondary acute myeloid leukemia|secondary acute myeloid leukemia
629746|NCT00516828|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
629747|NCT00516828|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
629748|NCT00516802|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
629749|NCT00516802|dacarbazine|dacarbazine
629750|NCT00516750|recurrent bladder cancer|recurrent bladder cancer
629751|NCT00516750|stage II bladder cancer|stage ii bladder cancer
629752|NCT00516750|stage III bladder cancer|stage iii bladder cancer
629753|NCT00516750|stage IV bladder cancer|stage iv bladder cancer
629754|NCT00516724|malignant solid tumours|malignant solid tumours
629755|NCT00516724|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
629756|NCT00516711|Surgery with Pringle maneuver needed for liver resection|surgery with pringle maneuver needed for liver resection
629757|NCT00516698|stage I breast cancer|stage i breast cancer
629758|NCT00516698|stage II breast cancer|stage ii breast cancer
629759|NCT00516698|stage IIIA breast cancer|stage iiia breast cancer
629760|NCT00516698|stage IIIC breast cancer|stage iiic breast cancer
629761|NCT00516685|LUNG CANCER|lung cancer
629762|NCT00516685|NSCLC|nsclc
629763|NCT00516685|EGF|egf
629764|NCT00516685|CANCER VACCINE|cancer vaccine
629765|NCT00516685|IMMUNOTHERAPY|immunotherapy
629766|NCT00516672|lapatinib,|lapatinib,
629767|NCT00516672|cancer|cancer
629768|NCT00516672|pharmacokinetics,|pharmacokinetics,
629769|NCT00516672|safety,|safety,
629770|NCT00516672|pazopanib,|pazopanib,
629771|NCT00516672|Japanese patients,|japanese patients,
629772|NCT00516659|ETEC|etec
629773|NCT00516659|Traveler's diarrhea|traveler's diarrhea
629774|NCT00516659|TCI|tci
629775|NCT00516659|patch vaccine|patch vaccine
629776|NCT00516659|diarrhea prevention|diarrhea prevention
629777|NCT00516659|epidemiology ETEC|epidemiology etec
629778|NCT00516659|Escherichia coli|escherichia coli
629779|NCT00516646|Advanced Glycation End-products (AGEs)|advanced glycation end-products (ages)
629780|NCT00516646|Alegebrium|alegebrium
629781|NCT00516633|Asthma|asthma
629782|NCT00516633|Adherence|adherence
629783|NCT00516633|Burden of asthma|burden of asthma
629784|NCT00516633|Quality of life|quality of life
629785|NCT00516633|Questionnaires|questionnaires
629786|NCT00516620|Body Weight|body weight
629787|NCT00516607|recurrent adult brain tumor|recurrent adult brain tumor
629788|NCT00516607|adult mixed glioma|adult mixed glioma
629789|NCT00516607|adult anaplastic astrocytoma|adult anaplastic astrocytoma
629790|NCT00516607|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
629791|NCT00516607|adult glioblastoma|adult glioblastoma
629792|NCT00516607|adult anaplastic ependymoma|adult anaplastic ependymoma
629793|NCT00516607|adult giant cell glioblastoma|adult giant cell glioblastoma
629794|NCT00516607|adult gliosarcoma|adult gliosarcoma
629795|NCT00516607|adult pineal gland astrocytoma|adult pineal gland astrocytoma
629796|NCT00516581|Pneumocystis Pneumonia|pneumocystis pneumonia
629797|NCT00516581|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
629798|NCT00516581|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
629799|NCT00516581|Treatment Experienced|treatment experienced
629800|NCT00516581|Treatment Naive|treatment naive
629801|NCT00516555|Breech Presentation|breech presentation
629802|NCT00516555|External Cephalic version|external cephalic version
629803|NCT00516555|Thyroid Function Tests|thyroid function tests
629804|NCT00516542|stage IV breast cancer|stage iv breast cancer
629805|NCT00516542|recurrent breast cancer|recurrent breast cancer
629806|NCT00516542|male breast cancer|male breast cancer
629807|NCT00516516|muscle cramp|muscle cramp
629808|NCT00516516|pregnancy|pregnancy
629809|NCT00516516|carnitine|carnitine
629810|NCT00516516|randomized controlled clinical trials|randomized controlled clinical trials
629811|NCT00516490|GnRH agonist|gnrh agonist
629812|NCT00516490|IVF/ICSI outcome|ivf/icsi outcome
629813|NCT00516490|luteal phase|luteal phase
629814|NCT00516477|Adeno-Associated Virus (AAV)|adeno-associated virus (aav)
629815|NCT00516477|Leber Congenital Amaurosis|leber congenital amaurosis
629816|NCT00516477|Gene transfer|gene transfer
629817|NCT00516464|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
629818|NCT00516464|Vitrectomy|vitrectomy
629819|NCT00516464|Ranibizumab|ranibizumab
629820|NCT00516438|malignant solid tumours|malignant solid tumours
629821|NCT00516438|Poly(ADP ribose)|poly(adp ribose)
629822|NCT00516438|polymerases|polymerases
629823|NCT00516425|stage IA breast cancer|stage ia breast cancer
629824|NCT00516425|stage IB breast cancer|stage ib breast cancer
629825|NCT00516425|stage II breast cancer|stage ii breast cancer
629826|NCT00516425|stage IIIA breast cancer|stage iiia breast cancer
629827|NCT00516412|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
629828|NCT00516412|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
629829|NCT00516412|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
629830|NCT00516412|stage I mantle cell lymphoma|stage i mantle cell lymphoma
629831|NCT00516412|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
629832|NCT00516412|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
629833|NCT00516399|Fungal keratitis|fungal keratitis
629834|NCT00516399|povidone iodine|povidone iodine
629835|NCT00516399|childhood blindness|childhood blindness
629836|NCT00516399|povidone-iodine|povidone-iodine
629837|NCT00516386|Adolescents|adolescents
629838|NCT00516386|Anorexia nervosa (AN)|anorexia nervosa (an)
629839|NCT00516386|Bone formation markers|bone formation markers
629840|NCT00516386|Insulin like growth factor-1 (IGF-I)|insulin like growth factor-1 (igf-i)
629841|NCT00516373|advanced ovarian cancer|advanced ovarian cancer
629842|NCT00516373|BRCA 1 protein|brca 1 protein
629843|NCT00516373|BRCA 2 protein|brca 2 protein
629844|NCT00516373|Poly(ADP ribose)polymerases|poly(adp ribose)polymerases
629845|NCT00516360|Catheter related bloodstream infections|catheter related bloodstream infections
629846|NCT00516360|Infant, Newborn|infant, newborn
629847|NCT00516360|Intensive Care Units, Neonatal|intensive care units, neonatal
629848|NCT00516360|Neonatal Central Line Infections|neonatal central line infections
629849|NCT00516347|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
629850|NCT00516347|esophageal cancer|esophageal cancer
629851|NCT00516347|Barrett esophagus|barrett esophagus
629852|NCT00516334|brain|brain
629853|NCT00516334|electroencephalography|electroencephalography
629854|NCT00516334|premature infant|premature infant
629855|NCT00516334|neurodevelopment|neurodevelopment
629856|NCT00516321|thrombopoietin|thrombopoietin
629857|NCT00516321|hepatitis C|hepatitis c
629858|NCT00516321|ribavirin|ribavirin
629859|NCT00516321|platelets|platelets
629860|NCT00516321|Hepatitis C-related thrombocytopenia|hepatitis c-related thrombocytopenia
629861|NCT00516321|peginterferon alfa-2a|peginterferon alfa-2a
629862|NCT00516308|CLI|cli
629863|NCT00516308|Critical Limb Ischemia|critical limb ischemia
629864|NCT00516308|PAD|pad
629865|NCT00516308|Paripheral Arterial Disease|paripheral arterial disease
629866|NCT00516308|Artherosclerosis|artherosclerosis
629867|NCT00516308|Leg pain|leg pain
629868|NCT00516308|Cardiovascular|cardiovascular
629869|NCT00516308|Atherectomy|atherectomy
629870|NCT00516308|NightHawk|nighthawk
629871|NCT00516282|adult glioblastoma|adult glioblastoma
629872|NCT00516282|adult giant cell glioblastoma|adult giant cell glioblastoma
629873|NCT00516282|adult gliosarcoma|adult gliosarcoma
629874|NCT00516282|adult anaplastic astrocytoma|adult anaplastic astrocytoma
629875|NCT00516282|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
629876|NCT00516282|adult mixed glioma|adult mixed glioma
629877|NCT00516269|Breast Cancer|breast cancer
629878|NCT00516269|Gastrointestinal Cancer|gastrointestinal cancer
629879|NCT00516269|GI Cancer|gi cancer
629880|NCT00516269|Fatigue|fatigue
629881|NCT00516269|OROS Methylphenidate HCl|oros methylphenidate hcl
629882|NCT00516269|Methylphenidate|methylphenidate
629883|NCT00516269|Methylphenidate Hydrochloride|methylphenidate hydrochloride
629884|NCT00516269|Concerta|concerta
629885|NCT00516269|Ritalin|ritalin
629886|NCT00516269|Placebo|placebo
629887|NCT00516256|Prostate Cancer|prostate cancer
629888|NCT00516256|Quality of Life|quality of life
629889|NCT00516256|Cancer Information Mentor|cancer information mentor
629890|NCT00516256|CHESS|chess
629891|NCT00516256|the Comprehensive Health Enhancement Support System|the comprehensive health enhancement support system
629892|NCT00516256|Social support|social support
629893|NCT00516256|Skill-building tools|skill-building tools
629894|NCT00516230|Colonic Neoplasms|colonic neoplasms
629895|NCT00516230|Lynch syndrome|lynch syndrome
629896|NCT00516217|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
629897|NCT00516217|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
629898|NCT00516204|Hyperlipidemia|hyperlipidemia
629899|NCT00516204|Diabetics|diabetics
629900|NCT00516204|NIS|nis
629901|NCT00516204|Diabetics with hyperlipidemia and atherosclerosis (coronary heart disease, carotid stenosis, PAVK, etc.)|diabetics with hyperlipidemia and atherosclerosis (coronary heart disease, carotid stenosis, pavk, etc.)
629902|NCT00516191|Multiple Myeloma|multiple myeloma
629903|NCT00516191|Velcade|velcade
629904|NCT00516191|Doxil|doxil
629905|NCT00516191|Melphalan|melphalan
629906|NCT00516178|Fish oil supplement|fish oil supplement
629907|NCT00516178|n-3 PUFA|n-3 pufa
629908|NCT00516178|Cardiac function|cardiac function
629909|NCT00516178|Membrane incorporation|membrane incorporation
629910|NCT00516178|Inflammation|inflammation
629911|NCT00516178|Clinical outcome|clinical outcome
629912|NCT00516165|liver cancer|liver cancer
629913|NCT00516165|RAD001|rad001
629914|NCT00516152|Matched Unrelated Donor|matched unrelated donor
629915|NCT00516152|Stem Cell Transplantation|stem cell transplantation
629916|NCT00516152|Busulfan|busulfan
629917|NCT00516152|fludarabine|fludarabine
629918|NCT00516152|Hematopoietic Disorder|hematopoietic disorder
629919|NCT00516139|Epilepsy elderly seizure|epilepsy elderly seizure
629920|NCT00516126|hemostasis monitoring|hemostasis monitoring
629921|NCT00516126|perioperative blood loss|perioperative blood loss
629922|NCT00516113|paroxetine|paroxetine
629923|NCT00516113|onset of action|onset of action
629924|NCT00516113|serotonin reuptake inhibitors|serotonin reuptake inhibitors
629925|NCT00516100|NSCLC|nsclc
629926|NCT00516087|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
629927|NCT00516074|exenatide|exenatide
629928|NCT00516074|Byetta|byetta
629929|NCT00516074|type 2 diabetes|type 2 diabetes
629930|NCT00516074|heart rate|heart rate
629931|NCT00516074|Amylin|amylin
629932|NCT00516074|Lilly|lilly
629933|NCT00516048|exenatide|exenatide
629934|NCT00516048|Byetta|byetta
629935|NCT00516048|antibodies|antibodies
629936|NCT00516048|Amylin|amylin
629937|NCT00516048|Lilly|lilly
629938|NCT00516035|Bird Flu|bird flu
629939|NCT00516009|RADICULAR PAIN|radicular pain
629940|NCT00516009|DISC HERNIATION|disc herniation
629941|NCT00516009|DEXAMETHASONE|dexamethasone
629942|NCT00516009|VAS|vas
629943|NCT00515996|panic disorder|panic disorder
629944|NCT00515996|paroxetine|paroxetine
629945|NCT00515996|genetic polymorphism|genetic polymorphism
629946|NCT00515996|serotonin|serotonin
629947|NCT00515983|melanoma|melanoma
629948|NCT00515983|dendritic cells|dendritic cells
629949|NCT00515983|apoptotic/necrotic cells|apoptotic/necrotic cells
629950|NCT00515983|therapeutic vaccine|therapeutic vaccine
629951|NCT00515970|Carcinoma, Basal Cell|carcinoma, basal cell
629952|NCT00515970|Curettage|curettage
629953|NCT00515970|Excision|excision
629954|NCT00515970|Recurrence|recurrence
629955|NCT00515970|Complication|complication
629956|NCT00515970|Esthetic outcome|esthetic outcome
629957|NCT00515944|No condition|no condition
629958|NCT00515944|healthy volunteers|healthy volunteers
629959|NCT00515931|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
629960|NCT00515931|GIST|gist
629961|NCT00515931|Sarcoma|sarcoma
629962|NCT00515931|Radiation therapy|radiation therapy
629963|NCT00515931|Radiotherapy|radiotherapy
629964|NCT00515918|Iron deficiency|iron deficiency
629965|NCT00515918|brain|brain
629966|NCT00515918|cognition|cognition
629967|NCT00515918|behavior|behavior
629968|NCT00515879|Generalized subtype|generalized subtype
629969|NCT00515866|Advanced pancreatic cancer|advanced pancreatic cancer
629970|NCT00515866|Poly (ADP ribose) polymerases|poly (adp ribose) polymerases
629971|NCT00515866|Advanced Solid Tumours|advanced solid tumours
629972|NCT00515853|Rectal neoplasms|rectal neoplasms
629973|NCT00515853|Biofeedback (Psychology)|biofeedback (psychology)
629974|NCT00515853|Fecal Incontinence|fecal incontinence
629975|NCT00515853|Aged|aged
629976|NCT00515853|Anterior resection|anterior resection
629977|NCT00515827|Treatment Experienced|treatment experienced
629978|NCT00515814|Legal blindness|legal blindness
629979|NCT00515814|Retinopathy pigmentosa|retinopathy pigmentosa
629980|NCT00515814|Hereditary condition|hereditary condition
629981|NCT00515814|Photo-receptor degeneration|photo-receptor degeneration
629982|NCT00515814|Retina implant|retina implant
629983|NCT00515814|Subretinal implant|subretinal implant
629984|NCT00515801|diabetes mellitus type 1|diabetes mellitus type 1
629985|NCT00515801|hypoglycemia|hypoglycemia
629986|NCT00515801|sulfonylurea|sulfonylurea
629987|NCT00515801|glucagon|glucagon
629988|NCT00515788|Neoplastic Meningitis|neoplastic meningitis
629989|NCT00515788|Leptomeningeal Disease|leptomeningeal disease
629990|NCT00515788|Temozolomide|temozolomide
629991|NCT00515788|Temodar|temodar
629992|NCT00515788|DepoCyt|depocyt
629993|NCT00515788|Liposomal Cytarabine|liposomal cytarabine
629994|NCT00515788|Liposomal ara-C|liposomal ara-c
629995|NCT00515762|persistent alopecia|persistent alopecia
629996|NCT00515762|docetaxel|docetaxel
629997|NCT00515762|breast cancer|breast cancer
629998|NCT00515736|selenium|selenium
629999|NCT00515736|oxidative stress|oxidative stress
630000|NCT00515736|glutathione peroxidase|glutathione peroxidase
630001|NCT00515736|critically ill|critically ill
630002|NCT00515736|outcome|outcome
630003|NCT00515736|supplementation|supplementation
630004|NCT00515723|control|control
630005|NCT00515723|risperidone|risperidone
630006|NCT00515723|olanzapine|olanzapine
630007|NCT00515723|quetiapine|quetiapine
630008|NCT00515723|ziprasidone|ziprasidone
630009|NCT00515710|Hemophilia B|hemophilia b
630010|NCT00515710|Gene Transfer|gene transfer
630011|NCT00515710|Adeno-Associated Virus (AAV)|adeno-associated virus (aav)
630012|NCT00515710|Coagulation Factor IX|coagulation factor ix
630013|NCT00515710|Long-term Follow-up|long-term follow-up
630014|NCT00515710|Delayed Adverse Events|delayed adverse events
630015|NCT00515671|self-management|self-management
630016|NCT00515671|recovery|recovery
630017|NCT00515671|severe mental illness|severe mental illness
630018|NCT00515658|Major depression|major depression
630019|NCT00515658|Theta-burst rTMS|theta-burst rtms
630020|NCT00515658|Cortical excitability|cortical excitability
630021|NCT00515658|Hamilton depression rating scale|hamilton depression rating scale
630022|NCT00515645|Autonomic nervous system|autonomic nervous system
630023|NCT00515645|Immersion|immersion
630024|NCT00515645|Heart rate variability|heart rate variability
630025|NCT00515645|Head-down tilt|head-down tilt
630026|NCT00515645|Healthy volunteers|healthy volunteers
630027|NCT00515632|Type 2 diabetes mellitus on Stable insulin therapy|type 2 diabetes mellitus on stable insulin therapy
630028|NCT00515632|Balaglitazone|balaglitazone
630029|NCT00515632|Pioglitazone (Actos®)|pioglitazone (actos®)
630030|NCT00515632|HbA1c|hba1c
630031|NCT00515632|Weight gain|weight gain
630032|NCT00515632|Oedema|oedema
630033|NCT00515632|Fasting blood glucose|fasting blood glucose
630034|NCT00515593|osteoporosis|osteoporosis
630035|NCT00515593|postmenopausal women|postmenopausal women
630036|NCT00515593|Severe postmenopausal osteoporosis|severe postmenopausal osteoporosis
630037|NCT00515580|obstructive sleep apnea|obstructive sleep apnea
630038|NCT00515580|upper airway resistance syndrome|upper airway resistance syndrome
630039|NCT00515580|tongue suture|tongue suture
630040|NCT00515580|retrolingual tongue collapse|retrolingual tongue collapse
630041|NCT00515580|minimally invasive|minimally invasive
630042|NCT00515567|explanted lungs|explanted lungs
630043|NCT00515567|pulmonary fibrosis|pulmonary fibrosis
630044|NCT00515554|Hodgkin lymphoma|hodgkin lymphoma
630045|NCT00515554|PET|pet
630046|NCT00515554|advances stages|advances stages
630047|NCT00515554|Rituximab|rituximab
630048|NCT00515541|Platelet|platelet
630049|NCT00515541|Cardiovascular|cardiovascular
630050|NCT00515541|Lipid|lipid
630051|NCT00515541|Fish Oil|fish oil
630052|NCT00515541|Omega 3|omega 3
630053|NCT00515541|DHA|dha
630054|NCT00515541|EPA|epa
630055|NCT00515541|Bleeding|bleeding
630056|NCT00515541|Clotting|clotting
630057|NCT00515541|platelet function|platelet function
630058|NCT00515541|Lipid profile|lipid profile
630059|NCT00515541|Weight and Bleeding risk|weight and bleeding risk
630060|NCT00515528|metastatic melanoma|metastatic melanoma
630061|NCT00515502|chronic obstructive pulmonary disease,|chronic obstructive pulmonary disease,
630062|NCT00515502|GSK573719,|gsk573719,
630063|NCT00515502|muscarinic receptor antagonist|muscarinic receptor antagonist
630064|NCT00515489|Schizophrenia|schizophrenia
630065|NCT00515489|Schizoaffective Disorder|schizoaffective disorder
630066|NCT00515489|Schizophreniform Disorders|schizophreniform disorders
630067|NCT00515476|metabolic syndrome|metabolic syndrome
630068|NCT00515476|HDL-Cholesterol|hdl-cholesterol
630069|NCT00515476|EPC|epc
630070|NCT00515476|endothelial function|endothelial function
630071|NCT00515476|reduced blood HDL-Cholesterol level|reduced blood hdl-cholesterol level
630072|NCT00515463|Osteopenia|osteopenia
630073|NCT00515463|Osteoporosis|osteoporosis
630074|NCT00515463|AMG 162|amg 162
630075|NCT00515463|Postmenopausal|postmenopausal
630076|NCT00515463|Pre-filled syringe|pre-filled syringe
630077|NCT00515450|Myasthenia Gravis|myasthenia gravis
630078|NCT00515437|Sialorrhea|sialorrhea
630079|NCT00515424|Glaucoma|glaucoma
630080|NCT00515424|Ocular Hypertension|ocular hypertension
630081|NCT00515424|RKI983|rki983
630082|NCT00515424|Primary Open Angle Glaucoma and Ocular Hypertension|primary open angle glaucoma and ocular hypertension
630083|NCT00515411|gastroesophageal junction|gastroesophageal junction
630084|NCT00515411|gastric cancer|gastric cancer
630085|NCT00515411|adenocarcinoma|adenocarcinoma
630086|NCT00515411|unresectable gastric cancer|unresectable gastric cancer
630087|NCT00515411|metastatic gastric|metastatic gastric
630088|NCT00515385|Randomized|randomized
630089|NCT00515385|Double-Blind|double-blind
630090|NCT00515385|Dose-Escalation|dose-escalation
630091|NCT00515385|Cohort Study|cohort study
630092|NCT00515372|Ovarian Cancer|ovarian cancer
630093|NCT00515372|Peritoneal Cancer|peritoneal cancer
630094|NCT00515372|Fallopian Tube Cancer|fallopian tube cancer
630095|NCT00515372|Depression|depression
630096|NCT00515372|Telephone Counseling|telephone counseling
630097|NCT00515372|Quality of Life|quality of life
630098|NCT00515359|Sedation|sedation
630099|NCT00515359|MRI|mri
630100|NCT00515359|pediatric|pediatric
630101|NCT00515359|propofol|propofol
630102|NCT00515359|brain|brain
630103|NCT00515359|spine|spine
630104|NCT00515359|quality of MRI|quality of mri
630105|NCT00515359|Continuous propofol dosing|continuous propofol dosing
630106|NCT00515359|continuous propofol administration|continuous propofol administration
630107|NCT00515359|Intermittent propofol dosing|intermittent propofol dosing
630108|NCT00515359|intermittent propofol administration|intermittent propofol administration
630109|NCT00515359|Sedative agent|sedative agent
630110|NCT00515359|propofol continuous infusions|propofol continuous infusions
630111|NCT00515359|Recovery time|recovery time
630112|NCT00515359|Complications of sedation|complications of sedation
630113|NCT00515359|bolus dosing|bolus dosing
630114|NCT00515346|CLI|cli
630115|NCT00515346|Critical Limb Ischemia|critical limb ischemia
630116|NCT00515333|Alzheimer|alzheimer
630117|NCT00515333|Dementia|dementia
630118|NCT00515320|Autism|autism
630119|NCT00515320|children|children
630120|NCT00515320|adolescent|adolescent
630121|NCT00515320|Fluoxetine|fluoxetine
630122|NCT00515320|Autistic Disorder|autistic disorder
630123|NCT00515320|Repetitive behavior|repetitive behavior
630124|NCT00515320|SSRI|ssri
630125|NCT00515320|Selective Serotonin Reuptake Inhibitor|selective serotonin reuptake inhibitor
630126|NCT00515307|Hypercholesterolemia, Familial|hypercholesterolemia, familial
630127|NCT00515307|Bone marrow|bone marrow
630128|NCT00515307|Mesenchymal stem cell|mesenchymal stem cell
630129|NCT00515307|Hepatocyte|hepatocyte
630130|NCT00515294|Caffeine|caffeine
630131|NCT00515294|Alcohol|alcohol
630132|NCT00515294|Alcohol Consumption|alcohol consumption
630133|NCT00515294|Residual Effects|residual effects
630134|NCT00515294|Family History|family history
630135|NCT00515294|Psychomotor Vigilance Test|psychomotor vigilance test
630136|NCT00515294|Driving Simulation|driving simulation
630137|NCT00515294|Reaction Time|reaction time
630138|NCT00515281|prematurity|prematurity
630139|NCT00515281|nitric oxide|nitric oxide
630140|NCT00515281|bronchopulmonary dysplasia|bronchopulmonary dysplasia
630141|NCT00515281|intraventricular hemorrhage|intraventricular hemorrhage
630142|NCT00515281|periventricular leukomalacia|periventricular leukomalacia
630143|NCT00515281|neurodevelopment|neurodevelopment
630144|NCT00515268|LPS challenge,|lps challenge,
630145|NCT00515268|Healthy volunteers|healthy volunteers
630146|NCT00515255|Obsessive Compulsive Disorder|obsessive compulsive disorder
630147|NCT00515255|Neuropharm|neuropharm
630148|NCT00515255|NPL-2003|npl-2003
630149|NCT00515242|massage therapy|massage therapy
630150|NCT00515242|relaxation treatments|relaxation treatments
630151|NCT00515229|cystic fibrosis|cystic fibrosis
630152|NCT00515229|ceramide|ceramide
630153|NCT00515229|amitriptyline|amitriptyline
630154|NCT00515229|Pseudomonas aeruginosa|pseudomonas aeruginosa
630155|NCT00515229|lung function|lung function
630156|NCT00515216|Phase II|phase ii
630157|NCT00515216|Gastric cancer|gastric cancer
630158|NCT00515216|Gastroesophageal cancer|gastroesophageal cancer
630159|NCT00515216|Metastatic|metastatic
630160|NCT00515216|FOLFOX|folfox
630161|NCT00515216|Thymidylate synthase|thymidylate synthase
630162|NCT00515216|Pharmacogenomic|pharmacogenomic
630163|NCT00515203|Immune (Idiopathic) Thrombocytopenic Purpura|immune (idiopathic) thrombocytopenic purpura
630164|NCT00515203|Pediatric Idiopathic Thrombocytopenic Purpura|pediatric idiopathic thrombocytopenic purpura
630165|NCT00515190|Stomach Neoplasms|stomach neoplasms
630166|NCT00515190|Secondary|secondary
630167|NCT00515190|Combination chemotherapy|combination chemotherapy
630168|NCT00515190|S-1|s-1
630169|NCT00515190|oxaliplatin|oxaliplatin
630170|NCT00515177|mindfulness|mindfulness
630171|NCT00515177|meditation|meditation
630172|NCT00515177|MBSR|mbsr
630173|NCT00515177|mindfulness meditation|mindfulness meditation
630174|NCT00515177|sleep|sleep
630175|NCT00515177|insomnia|insomnia
630176|NCT00515177|chronic insomnia|chronic insomnia
630177|NCT00515177|primary insomnia|primary insomnia
630178|NCT00515177|Minnesota|minnesota
630179|NCT00515164|lung volume reduction|lung volume reduction
630180|NCT00515164|emphysema|emphysema
630181|NCT00515164|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
630182|NCT00515151|Bloodstream Infection|bloodstream infection
630183|NCT00515151|Bacteremia|bacteremia
630184|NCT00515151|Central Venous Catheter|central venous catheter
630185|NCT00515151|Alcohol|alcohol
630186|NCT00515151|Disinfection|disinfection
630187|NCT00515151|Octenidine Dihydrochloride|octenidine dihydrochloride
630188|NCT00515138|B-Cell NHL|b-cell nhl
630189|NCT00515138|Autologous Stem Cell Transplant|autologous stem cell transplant
630190|NCT00515138|RICE|rice
630191|NCT00515125|Quality of life|quality of life
630192|NCT00515125|Supplement|supplement
630193|NCT00515125|Care home|care home
630194|NCT00515125|Elderly|elderly
630195|NCT00515125|Malnutrition|malnutrition
630196|NCT00515112|prostate|prostate
630197|NCT00515112|cancer|cancer
630198|NCT00515112|testosterone replacement|testosterone replacement
630199|NCT00515112|AndroGel|androgel
630200|NCT00515112|prostatic cancer|prostatic cancer
630201|NCT00515112|prostatic neoplasms|prostatic neoplasms
630202|NCT00515099|New-onset Type 1 Diabetes Mellitus|new-onset type 1 diabetes mellitus
630203|NCT00515099|New-onset T1DM|new-onset t1dm
630204|NCT00515099|New-onset Type 1 Diabetes|new-onset type 1 diabetes
630205|NCT00515099|New-onset T1D|new-onset t1d
630206|NCT00515099|Newly Diagnosed Type 1 Diabetes Mellitus|newly diagnosed type 1 diabetes mellitus
630207|NCT00515099|Autoimmune diabetes|autoimmune diabetes
630208|NCT00515099|Thymoglobulin|thymoglobulin
630209|NCT00515099|ATG|atg
630210|NCT00515099|Rabbit antithymocyte globulin|rabbit antithymocyte globulin
630211|NCT00515086|Glioblastoma Multiforme, GBM, RAD001, RAD|glioblastoma multiforme, gbm, rad001, rad
630212|NCT00515073|Endometrial Cancer|endometrial cancer
630213|NCT00515073|Papillary Serous Carcinoma|papillary serous carcinoma
630214|NCT00515073|Pelvic Radiation Therapy|pelvic radiation therapy
630215|NCT00515073|Paclitaxel|paclitaxel
630216|NCT00515073|Taxol|taxol
630217|NCT00515060|Advanced Cancer|advanced cancer
630218|NCT00515060|Therapy-Induced Pain|therapy-induced pain
630219|NCT00515060|Pain Threshold|pain threshold
630220|NCT00515060|Sensory Tests|sensory tests
630221|NCT00515060|Stimuli|stimuli
630222|NCT00515060|Pain|pain
630223|NCT00515047|Atopic Dermatitis|atopic dermatitis
630224|NCT00515047|Eczema|eczema
630225|NCT00515047|Eczema Herpeticum|eczema herpeticum
630226|NCT00515047|Molluscum Contagiousum|molluscum contagiousum
630227|NCT00515047|Herpes Simplex|herpes simplex
630228|NCT00515047|Vaccinia|vaccinia
630229|NCT00515034|Doripenem|doripenem
630230|NCT00515034|Imipenem|imipenem
630231|NCT00515034|Cilastatin|cilastatin
630232|NCT00515034|Vancomycin|vancomycin
630233|NCT00515034|DORIBAX, DORIPREX, FINIBAX, DURAPTA, PRIMAXIN, Anti Bacterial Agents|doribax, doriprex, finibax, durapta, primaxin, anti bacterial agents
630234|NCT00515034|Ileus|ileus
630235|NCT00515034|Hospitalized|hospitalized
630236|NCT00515034|Fever|fever
630237|NCT00515021|Metabolic syndrome|metabolic syndrome
630238|NCT00515021|Aldosterone inhibitor|aldosterone inhibitor
630239|NCT00515021|Diurnal drug regimen|diurnal drug regimen
630240|NCT00515021|PAI-1 levels|pai-1 levels
630241|NCT00514982|Hermansky-Pudlak Syndrome|hermansky-pudlak syndrome
630242|NCT00514982|Colitis|colitis
630243|NCT00514982|Medical Therapy|medical therapy
630244|NCT00514982|Immunopathogenesis|immunopathogenesis
630245|NCT00514982|Cytokine|cytokine
630246|NCT00514982|Hermansky-Pudlak Syndrome Associated Colitis|hermansky-pudlak syndrome associated colitis
630247|NCT00514982|HPS|hps
630248|NCT00514969|accelerated and blastic phase|accelerated and blastic phase
630249|NCT00514969|STI571|sti571
630250|NCT00514956|Post-Traumatic Stress Syndrome (PTSD)|post-traumatic stress syndrome (ptsd)
630251|NCT00514930|radiofrequency ablation|radiofrequency ablation
630252|NCT00514930|liver cancer|liver cancer
630253|NCT00514930|complications|complications
630254|NCT00514930|liver tumors|liver tumors
630255|NCT00514904|safety|safety
630256|NCT00514904|meningococcal vaccine|meningococcal vaccine
630257|NCT00514904|immunogenicity|immunogenicity
630258|NCT00514878|nausea|nausea
630259|NCT00514878|postoperative nausea and vomiting|postoperative nausea and vomiting
630260|NCT00514878|postoperative pain|postoperative pain
630261|NCT00514865|ONO-2333Ms|ono-2333ms
630262|NCT00514865|Major Depressive Disorder|major depressive disorder
630263|NCT00514839|Prescription drug use disorder|prescription drug use disorder
630264|NCT00514839|Brief intervention|brief intervention
630265|NCT00514839|General hospital|general hospital
630266|NCT00514839|Motivational Interviewing|motivational interviewing
630267|NCT00514800|Home monitoring|home monitoring
630268|NCT00514800|Primary care|primary care
630269|NCT00514800|Hypertension|hypertension
630270|NCT00514800|TIA|tia
630271|NCT00514787|Asthma|asthma
630272|NCT00514787|NIS|nis
630273|NCT00514774|Huntington chorea|huntington chorea
630274|NCT00514774|chorea|chorea
630275|NCT00514774|hereditary|hereditary
630276|NCT00514774|tauroursodeoxycholic acid|tauroursodeoxycholic acid
630277|NCT00514774|ursodeoxycholic acid|ursodeoxycholic acid
630278|NCT00514774|TUDCA|tudca
630279|NCT00514774|UDCA|udca
630280|NCT00514761|colorectal cancer|colorectal cancer
630281|NCT00514761|AZD6244|azd6244
630282|NCT00514748|breast reconstruction|breast reconstruction
630283|NCT00514748|DIEP|diep
630284|NCT00514748|vessel pedicle|vessel pedicle
630285|NCT00514735|atrial fibrillation|atrial fibrillation
630286|NCT00514722|Hematopoietic malignancies|hematopoietic malignancies
630287|NCT00514722|Umbilical cord blood transplantation|umbilical cord blood transplantation
630288|NCT00514722|Lymphoma: diffuse large cell, mantle cell, peripheral T-cell, T-NK cell, or Hodgkin's|lymphoma: diffuse large cell, mantle cell, peripheral t-cell, t-nk cell, or hodgkin's
630289|NCT00514709|Diphtheria|diphtheria
630290|NCT00514709|Tetanus|tetanus
630291|NCT00514709|Pertussis|pertussis
630292|NCT00514709|Hepatitis B Hansenula (HB)|hepatitis b hansenula (hb)
630293|NCT00514709|Haemophilus influenzae type b|haemophilus influenzae type b
630294|NCT00514696|Cancer|cancer
630295|NCT00514696|Leukemia|leukemia
630296|NCT00514696|GCS-100|gcs-100
630297|NCT00514696|CLL|cll
630298|NCT00514670|Prevention of gastrointestinal and respiratory illness|prevention of gastrointestinal and respiratory illness
630299|NCT00514644|Panorama|panorama
630300|NCT00514644|Carotid stenoses|carotid stenoses
630301|NCT00514618|Term Pregnancy|term pregnancy
630302|NCT00514618|Diabetes|diabetes
630303|NCT00514618|Cervical Ripening|cervical ripening
630304|NCT00514618|Induction|induction
630305|NCT00514618|misoprostol|misoprostol
630306|NCT00514618|Term Gestational Diabetics|term gestational diabetics
630307|NCT00514605|HIV 1|hiv 1
630308|NCT00514605|AIDS|aids
630309|NCT00514605|Assay|assay
630310|NCT00514605|Rapid Test|rapid test
630311|NCT00514605|HIV-1|hiv-1
630312|NCT00514605|HIV Seronegativity|hiv seronegativity
630313|NCT00514592|Carotid stenosis|carotid stenosis
630314|NCT00514592|Carotid endarterectomy|carotid endarterectomy
630315|NCT00514579|Cord Blood Stem Cell Transplantation|cord blood stem cell transplantation
630316|NCT00514579|Hematologic Malignancies|hematologic malignancies
630317|NCT00514579|Leukemia|leukemia
630318|NCT00514579|Myelodysplastic Syndrome|myelodysplastic syndrome
630319|NCT00514566|Polyamide|polyamide
630320|NCT00514566|Polydioxanone|polydioxanone
630321|NCT00514566|Midline|midline
630322|NCT00514566|Abdominal|abdominal
630323|NCT00514566|Closure|closure
630324|NCT00514553|Prenatal Testing|prenatal testing
630325|NCT00514553|Test Decision-Making|test decision-making
630326|NCT00514553|Decision-Making Intervention|decision-making intervention
630327|NCT00514553|Theory of Unconscious Thought|theory of unconscious thought
630328|NCT00514553|Informed Choice|informed choice
630329|NCT00514553|Decision Making|decision making
630330|NCT00514553|Counseling|counseling
630331|NCT00514540|Prostate Cancer|prostate cancer
630332|NCT00514540|Anaplastic Prostate Cancer|anaplastic prostate cancer
630333|NCT00514540|Carboplatin|carboplatin
630334|NCT00514540|Docetaxel|docetaxel
630335|NCT00514540|Taxotere|taxotere
630336|NCT00514540|Paraplatin|paraplatin
630337|NCT00514514|Everolimus|everolimus
630338|NCT00514514|mycophenolate|mycophenolate
630339|NCT00514514|CNI-free|cni-free
630340|NCT00514514|kidney transplantation|kidney transplantation
630341|NCT00514488|chronic myeloid leukemia|chronic myeloid leukemia
630342|NCT00514488|STI 571|sti 571
630343|NCT00514488|CML022|cml022
630344|NCT00514475|Mantle cell lymphoma|mantle cell lymphoma
630345|NCT00514475|Zevalin|zevalin
630346|NCT00514475|90Y-ibritumomab tiuxetan|90y-ibritumomab tiuxetan
630347|NCT00514475|Radioimmunotherapy|radioimmunotherapy
630348|NCT00514475|High-dose therapy|high-dose therapy
630349|NCT00514475|First line|first line
630350|NCT00514436|Asthma|asthma
630351|NCT00514436|children|children
630352|NCT00514436|low-income, underserved|low-income, underserved
630353|NCT00514436|Reduction in hospitalization|reduction in hospitalization
630354|NCT00514410|Depression|depression
630355|NCT00514410|Folate|folate
630356|NCT00514410|Folic acid|folic acid
630357|NCT00514410|Antidepressants|antidepressants
630358|NCT00514397|untreated childhood brain stem glioma|untreated childhood brain stem glioma
630359|NCT00514371|Multiple Myeloma|multiple myeloma
630360|NCT00514371|Heat Shock Protein 90|heat shock protein 90
630361|NCT00514371|Hsp90|hsp90
630362|NCT00514371|KOS-953|kos-953
630363|NCT00514371|17-AAG|17-aag
630364|NCT00514371|bortezomib|bortezomib
630365|NCT00514371|relapsed-refractory|relapsed-refractory
630366|NCT00514371|tanespimycin|tanespimycin
630367|NCT00514358|Fungal|fungal
630368|NCT00514358|Infection|infection
630369|NCT00514358|sepsis|sepsis
630370|NCT00514358|pharmacokinetics|pharmacokinetics
630371|NCT00514345|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
630372|NCT00514345|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
630373|NCT00514345|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
630374|NCT00514345|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
630375|NCT00514345|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
630376|NCT00514345|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
630377|NCT00514345|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
630378|NCT00514345|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
630379|NCT00514345|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
630380|NCT00514345|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
630381|NCT00514332|colorectal stents|colorectal stents
630382|NCT00514332|colonic obstruction|colonic obstruction
630383|NCT00514332|colonic adenocarcinoma|colonic adenocarcinoma
630384|NCT00514332|colorectal surgery|colorectal surgery
630385|NCT00514306|Advanced Cancer|advanced cancer
630386|NCT00514306|Breast cancer|breast cancer
630387|NCT00514306|Renal cancer|renal cancer
630388|NCT00514306|Ovarian Cancer|ovarian cancer
630389|NCT00514306|Metastatic Cancer|metastatic cancer
630390|NCT00514306|Non-small cell lung cancer|non-small cell lung cancer
630391|NCT00514306|Colorectal cancer|colorectal cancer
630392|NCT00514293|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
630393|NCT00514293|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
630394|NCT00514293|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
630395|NCT00514280|Lead and Smoke Study in D.C.|lead and smoke study in d.c.
630396|NCT00514280|Birth Weight|birth weight
630397|NCT00514280|Gestational Age|gestational age
630398|NCT00514280|Lead|lead
630399|NCT00514280|Tobacco Smoke|tobacco smoke
630400|NCT00514267|Prostate Cancer|prostate cancer
630401|NCT00514267|HRPC|hrpc
630402|NCT00514267|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
630403|NCT00514267|YM155|ym155
630404|NCT00514267|Treatment Outcome|treatment outcome
630405|NCT00514267|Solid Tumors|solid tumors
630406|NCT00514254|endometrial cancer|endometrial cancer
630407|NCT00514254|risk factors|risk factors
630408|NCT00514254|questionnaire|questionnaire
630409|NCT00514254|07-093|07-093
630410|NCT00514228|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
630411|NCT00514228|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
630412|NCT00514228|advanced adult primary liver cancer|advanced adult primary liver cancer
630413|NCT00514228|recurrent adult primary liver cancer|recurrent adult primary liver cancer
630414|NCT00514215|lung metastases|lung metastases
630415|NCT00514215|stage I non-small cell lung cancer|stage i non-small cell lung cancer
630416|NCT00514215|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
630417|NCT00514215|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
630418|NCT00514215|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
630419|NCT00514215|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
630420|NCT00514215|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
630421|NCT00514215|recurrent renal cell cancer|recurrent renal cell cancer
630422|NCT00514215|stage IV renal cell cancer|stage iv renal cell cancer
630423|NCT00514215|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
630424|NCT00514202|cocaine|cocaine
630425|NCT00514202|ADHD|adhd
630426|NCT00514202|attention|attention
630427|NCT00514202|hyperactivity|hyperactivity
630428|NCT00514202|drug|drug
630429|NCT00514202|dependence|dependence
630430|NCT00514189|Acute Myelogenous Leukemia|acute myelogenous leukemia
630431|NCT00514189|Leukemia|leukemia
630432|NCT00514189|Autologous Dendritic Cells|autologous dendritic cells
630433|NCT00514189|Vaccine|vaccine
630434|NCT00514189|AML|aml
630435|NCT00514189|mRNA|mrna
630436|NCT00514163|pancreatic carcinoma|pancreatic carcinoma
630437|NCT00514163|gemcitabine|gemcitabine
630438|NCT00514163|S-1|s-1
630439|NCT00514163|phaseⅡstudy|phaseⅱstudy
630440|NCT00514150|angiography|angiography
630441|NCT00514150|complications|complications
630442|NCT00514150|contrast media|contrast media
630443|NCT00514150|kidney|kidney
630444|NCT00514150|prevention|prevention
630445|NCT00514098|Microbicide|microbicide
630446|NCT00514098|Seroconversion|seroconversion
630447|NCT00514098|Treatment Experienced|treatment experienced
630448|NCT00514098|Treatment Naive|treatment naive
630449|NCT00514085|recurrent melanoma|recurrent melanoma
630450|NCT00514085|stage IV melanoma|stage iv melanoma
630451|NCT00514072|stage IV prostate cancer|stage iv prostate cancer
630452|NCT00514072|recurrent prostate cancer|recurrent prostate cancer
630453|NCT00514059|Diphteria-tetanus-pertussis-polio vaccine|diphteria-tetanus-pertussis-polio vaccine
630454|NCT00514059|Booster immunization|booster immunization
630455|NCT00514059|Vaccine effect (Diphtheria-tetanus-acellular pertussis-polio)|vaccine effect (diphtheria-tetanus-acellular pertussis-polio)
630456|NCT00514059|Immunity|immunity
630457|NCT00514059|Safety|safety
630458|NCT00514046|Multiple Endocrine Neoplasia (MEN)|multiple endocrine neoplasia (men)
630459|NCT00514046|Medullary Thyroid Carcinoma|medullary thyroid carcinoma
630460|NCT00514046|Molecularly-Targeted Therapy|molecularly-targeted therapy
630461|NCT00514046|Pediatric|pediatric
630462|NCT00514046|Pharmacokinetics|pharmacokinetics
630463|NCT00514046|MTC|mtc
630464|NCT00514046|Multiple Endocrine Neoplasia|multiple endocrine neoplasia
630465|NCT00514046|MEN|men
630466|NCT00514020|adenocarcinoma of the stomach|adenocarcinoma of the stomach
630467|NCT00514020|stage IV gastric cancer|stage iv gastric cancer
630468|NCT00514020|recurrent gastric cancer|recurrent gastric cancer
630469|NCT00514007|Non-small cell lung cancer|non-small cell lung cancer
630470|NCT00514007|Ovarian cancer|ovarian cancer
630471|NCT00514007|Renal cancer|renal cancer
630472|NCT00514007|Advanced Cancer|advanced cancer
630473|NCT00514007|Metastatic cancer|metastatic cancer
630474|NCT00514007|Breast cancer|breast cancer
630475|NCT00514007|Colorectal cancer|colorectal cancer
630476|NCT00513994|Pharmacokinetics|pharmacokinetics
630477|NCT00513994|Nitroglycerin|nitroglycerin
630478|NCT00513994|pharmacokinetics study of nitroglycerin containing treatments|pharmacokinetics study of nitroglycerin containing treatments
630479|NCT00513981|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
630480|NCT00513981|recurrent osteosarcoma|recurrent osteosarcoma
630481|NCT00513981|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
630482|NCT00513981|recurrent childhood ependymoma|recurrent childhood ependymoma
630483|NCT00513981|untreated childhood brain stem glioma|untreated childhood brain stem glioma
630484|NCT00513981|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
630485|NCT00513955|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
630486|NCT00513942|Fetal Movement|fetal movement
630487|NCT00513942|Maternal-Fetal-Attachment|maternal-fetal-attachment
630488|NCT00513942|Fetus|fetus
630489|NCT00513929|Severe Pneumonia|severe pneumonia
630490|NCT00513929|Zinc|zinc
630491|NCT00513929|Associated pathogens|associated pathogens
630492|NCT00513929|Severe Pneumonia by type of associated pathogens|severe pneumonia by type of associated pathogens
630493|NCT00513929|Severe Pneumonia by basal plasma zinc status|severe pneumonia by basal plasma zinc status
630494|NCT00513916|breast cancer|breast cancer
630495|NCT00513916|healthy, no evidence of disease|healthy, no evidence of disease
630496|NCT00513903|Pulmonary Diseases|pulmonary diseases
630497|NCT00513903|Continuity of Pharmacy Care|continuity of pharmacy care
630498|NCT00513890|Bronchiolitis|bronchiolitis
630499|NCT00513890|Esophageal pressure mesurement|esophageal pressure mesurement
630500|NCT00513890|Clinical score|clinical score
630501|NCT00513890|Citical care|citical care
630502|NCT00513890|Infant|infant
630503|NCT00513877|recurrent malignant mesothelioma|recurrent malignant mesothelioma
630504|NCT00513877|stage IA malignant mesothelioma|stage ia malignant mesothelioma
630505|NCT00513877|stage IB malignant mesothelioma|stage ib malignant mesothelioma
630506|NCT00513877|stage II malignant mesothelioma|stage ii malignant mesothelioma
630507|NCT00513877|stage III malignant mesothelioma|stage iii malignant mesothelioma
630508|NCT00513877|stage IV malignant mesothelioma|stage iv malignant mesothelioma
630509|NCT00513864|Opioid Analgesics|opioid analgesics
630510|NCT00513864|Morphine|morphine
630511|NCT00513864|Codeine|codeine
630512|NCT00513864|Sickle Cell Disease|sickle cell disease
630513|NCT00513851|Advanced Cancer|advanced cancer
630514|NCT00513851|Non-small cell lung cancer|non-small cell lung cancer
630515|NCT00513851|Small cell lung cancer|small cell lung cancer
630516|NCT00513851|Uterine cancer|uterine cancer
630517|NCT00513851|Ovarian cancer|ovarian cancer
630518|NCT00513851|Renal cancer|renal cancer
630519|NCT00513851|Head and neck cancer|head and neck cancer
630520|NCT00513851|Cervical cancer|cervical cancer
630521|NCT00513851|Metastatic cancer|metastatic cancer
630522|NCT00513851|Colorectal cancer|colorectal cancer
630523|NCT00513851|Gastrointestinal stromal tumors|gastrointestinal stromal tumors
630524|NCT00513825|Contrast Nephropathy|contrast nephropathy
630525|NCT00513825|Sodium Bicarbonate|sodium bicarbonate
630526|NCT00513825|Prevention|prevention
630527|NCT00513786|Endometrial Cancer|endometrial cancer
630528|NCT00513786|Advanced Stage Endometrial Cancer|advanced stage endometrial cancer
630529|NCT00513786|Stage 3 or 4 endometrial cancer|stage 3 or 4 endometrial cancer
630530|NCT00513786|Cancer treatment|cancer treatment
630531|NCT00513786|gyn cancer|gyn cancer
630532|NCT00513773|Abdominal Aortic Aneurysm,|abdominal aortic aneurysm,
630533|NCT00513773|Inflammation and Risk Prediction|inflammation and risk prediction
630534|NCT00513773|Diagnostic Tool Efficacy|diagnostic tool efficacy
630535|NCT00513760|Pharmacogenetics|pharmacogenetics
630536|NCT00513760|Singulair|singulair
630537|NCT00513760|montelukast|montelukast
630538|NCT00513760|Leukotriene Antagonists|leukotriene antagonists
630539|NCT00513760|Anti-Asthmatic Agents|anti-asthmatic agents
630540|NCT00513760|Intestinal Absorption|intestinal absorption
630541|NCT00513760|pharmacokinetics|pharmacokinetics
630542|NCT00513760|absorption|absorption
630543|NCT00513760|biochemical transport|biochemical transport
630544|NCT00513760|Membrane Transport Proteins|membrane transport proteins
630545|NCT00513760|Drug Interactions|drug interactions
630546|NCT00513747|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
630547|NCT00513747|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
630548|NCT00513747|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
630549|NCT00513734|keratopathy|keratopathy
630550|NCT00513734|exposure|exposure
630551|NCT00513734|intensive care|intensive care
630552|NCT00513734|eye|eye
630553|NCT00513734|ulcer|ulcer
630554|NCT00513734|Corneal|corneal
630555|NCT00513721|prostate|prostate
630556|NCT00513721|prostate cancer|prostate cancer
630557|NCT00513721|surgical margins|surgical margins
630558|NCT00513721|gleason score|gleason score
630559|NCT00513721|positive lateral biopsies|positive lateral biopsies
630560|NCT00513708|Detoxification|detoxification
630561|NCT00513708|Treatment|treatment
630562|NCT00513682|Cystic Fibrosis|cystic fibrosis
630563|NCT00513682|Pancreatic insufficiency|pancreatic insufficiency
630564|NCT00513682|Steatorrhea|steatorrhea
630565|NCT00513682|Children 7 to 11 years|children 7 to 11 years
630566|NCT00513682|Pancreatic enzyme|pancreatic enzyme
630567|NCT00513669|Malaria|malaria
630568|NCT00513669|Vaccine|vaccine
630569|NCT00513669|Falciparum|falciparum
630570|NCT00513669|Trial|trial
630571|NCT00513669|Phase I|phase i
630572|NCT00513669|Safety|safety
630573|NCT00513669|Immunogenicity|immunogenicity
630574|NCT00513656|Efficacy|efficacy
630575|NCT00513656|chronic|chronic
630576|NCT00513656|cancer|cancer
630577|NCT00513656|pain|pain
630578|NCT00513656|constipation|constipation
630579|NCT00513656|oxycodone|oxycodone
630580|NCT00513656|naloxone|naloxone
630581|NCT00513656|Moderate to severe chronic cancer pain|moderate to severe chronic cancer pain
630582|NCT00513643|euglycaemic glucose clamp|euglycaemic glucose clamp
630583|NCT00513643|duration of action|duration of action
630584|NCT00513643|late metabolic activity|late metabolic activity
630585|NCT00513643|hypoglycaemia|hypoglycaemia
630586|NCT00513617|Sickle Cell Disease|sickle cell disease
630587|NCT00513617|Anemia|anemia
630588|NCT00513617|Nitric Oxide|nitric oxide
630589|NCT00513617|Vaso Occlusive Events|vaso occlusive events
630590|NCT00513617|Arginine Supplementation|arginine supplementation
630591|NCT00513604|Clinical Response|clinical response
630592|NCT00513604|Immunotherapy|immunotherapy
630593|NCT00513604|Cancer|cancer
630594|NCT00513604|Cytokines|cytokines
630595|NCT00513604|Adoptive Cell Therapy|adoptive cell therapy
630596|NCT00513604|Melanoma|melanoma
630597|NCT00513604|Skin Cancer|skin cancer
630598|NCT00513604|Malignant Melanoma|malignant melanoma
630599|NCT00513591|Pregnancy|pregnancy
630600|NCT00513591|Lupus (systemic lupus erythematosus or cutaneous lupus)|lupus (systemic lupus erythematosus or cutaneous lupus)
630601|NCT00513591|Rheumatoid Arthritis|rheumatoid arthritis
630602|NCT00513591|Sjogren's Syndrome|sjogren's syndrome
630603|NCT00513591|Scleroderma|scleroderma
630604|NCT00513578|refractory anemia with excess blasts|refractory anemia with excess blasts
630605|NCT00513578|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
630606|NCT00513578|refractory anemia|refractory anemia
630607|NCT00513578|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
630608|NCT00513578|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
630609|NCT00513578|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
630610|NCT00513565|GSK561679,|gsk561679,
630611|NCT00513565|single,|single,
630612|NCT00513565|dose,|dose,
630613|NCT00513565|lorazepam,|lorazepam,
630614|NCT00513565|fMRI,|fmri,
630615|NCT00513565|BOLD,|bold,
630616|NCT00513565|healthy volunteers|healthy volunteers
630617|NCT00513539|unresectable gallbladder cancer|unresectable gallbladder cancer
630618|NCT00513539|recurrent gallbladder cancer|recurrent gallbladder cancer
630619|NCT00513539|metastatic gallbladder cancer|metastatic gallbladder cancer
630620|NCT00513539|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
630621|NCT00513539|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
630622|NCT00513539|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
630623|NCT00513539|metastatic extrahepatic bile duct cancer|metastatic extrahepatic bile duct cancer
630624|NCT00513539|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
630625|NCT00513526|infection|infection
630626|NCT00513526|low-grade squamous intraepithelial lesion|low-grade squamous intraepithelial lesion
630627|NCT00513526|atypical squamous cells of undetermined significance|atypical squamous cells of undetermined significance
630628|NCT00513513|HIV|hiv
630629|NCT00513513|AIDS|aids
630630|NCT00513513|TMC114|tmc114
630631|NCT00513513|Protease inhibitor|protease inhibitor
630632|NCT00513513|Darunavir|darunavir
630633|NCT00513513|Antiretroviral agents|antiretroviral agents
630634|NCT00513513|Treatment Naive|treatment naive
630635|NCT00513500|community health care|community health care
630636|NCT00513500|community health worker|community health worker
630637|NCT00513500|malaria|malaria
630638|NCT00513500|pneumonia|pneumonia
630639|NCT00513500|rapid diagnostic test|rapid diagnostic test
630640|NCT00513487|Allergic Rhinitis|allergic rhinitis
630641|NCT00513487|dust mites|dust mites
630642|NCT00513487|IgE|ige
630643|NCT00513487|IL-13|il-13
630644|NCT00513487|nasal|nasal
630645|NCT00513487|inflammation|inflammation
630646|NCT00513474|graft versus host disease|graft versus host disease
630647|NCT00513474|anaplastic large cell lymphoma|anaplastic large cell lymphoma
630648|NCT00513474|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
630649|NCT00513474|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
630650|NCT00513474|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
630651|NCT00513474|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
630652|NCT00513474|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
630653|NCT00513474|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
630654|NCT00513474|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
630655|NCT00513474|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
630656|NCT00513474|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
630657|NCT00513474|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
630658|NCT00513474|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
630659|NCT00513474|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
630660|NCT00513474|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
630661|NCT00513474|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
630662|NCT00513474|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
630663|NCT00513474|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
630664|NCT00513474|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
630665|NCT00513474|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
630666|NCT00513474|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
630667|NCT00513474|splenic marginal zone lymphoma|splenic marginal zone lymphoma
630668|NCT00513474|Waldenström macroglobulinemia|waldenström macroglobulinemia
630669|NCT00513474|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
630670|NCT00513474|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
630671|NCT00513474|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
630672|NCT00513474|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
630673|NCT00513474|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
630762|NCT00513201|lyspro|lyspro
631166|NCT00511810|Fatigue|fatigue
630674|NCT00513474|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
630675|NCT00513474|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
630676|NCT00513474|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
630677|NCT00513474|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
630678|NCT00513474|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
630679|NCT00513474|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
630680|NCT00513474|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
630681|NCT00513474|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
630682|NCT00513474|primary myelofibrosis|primary myelofibrosis
630683|NCT00513474|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
630684|NCT00513474|chronic eosinophilic leukemia|chronic eosinophilic leukemia
630685|NCT00513474|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
630686|NCT00513474|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
630810|NCT00513110|AMPD1 polymorphism|ampd1 polymorphism
630687|NCT00513474|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
630688|NCT00513474|refractory hairy cell leukemia|refractory hairy cell leukemia
630689|NCT00513474|refractory multiple myeloma|refractory multiple myeloma
630690|NCT00513474|secondary acute myeloid leukemia|secondary acute myeloid leukemia
630691|NCT00513474|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
630692|NCT00513448|Chronic Disabling Condition|chronic disabling condition
630693|NCT00513448|Comparative Evaluation|comparative evaluation
630694|NCT00513448|Physical Activity|physical activity
630695|NCT00513448|Physical Therapy|physical therapy
630696|NCT00513448|Rehabilitation|rehabilitation
630697|NCT00513422|Osteoarthritis, knee|osteoarthritis, knee
630698|NCT00513422|Glucosamine|glucosamine
630699|NCT00513422|Chondroitin|chondroitin
630700|NCT00513422|Disease progression|disease progression
630702|NCT00513409|Immunogenicity|immunogenicity
630703|NCT00513409|Pneumococcal disease|pneumococcal disease
630704|NCT00513409|Safety|safety
630705|NCT00513409|Booster vaccination|booster vaccination
630706|NCT00513409|Pneumococcal vaccine|pneumococcal vaccine
630707|NCT00513396|Randomized control trial|randomized control trial
630708|NCT00513396|multidrug resistant tuberculosis|multidrug resistant tuberculosis
630709|NCT00513396|isoniazid|isoniazid
630710|NCT00513396|standardized regimen|standardized regimen
630711|NCT00513396|adjuvant therapy|adjuvant therapy
630712|NCT00513383|basaloid squamous cell carcinoma|basaloid squamous cell carcinoma
630713|NCT00513383|undifferentiated carcinoma|undifferentiated carcinoma
630714|NCT00513383|adenosquamous cell carcinoma|adenosquamous cell carcinoma
630715|NCT00513370|Psoriasis|psoriasis
630716|NCT00513370|adalimumab|adalimumab
630717|NCT00513357|Gastrointestinal Cancer|gastrointestinal cancer
630718|NCT00513357|Lung Cancer|lung cancer
630719|NCT00513357|Cachexia|cachexia
630720|NCT00513357|Melatonin|melatonin
630721|NCT00513357|Placebo|placebo
630722|NCT00513357|Anorexia|anorexia
630723|NCT00513357|Weight Loss|weight loss
630724|NCT00513344|Endothelial function|endothelial function
630725|NCT00513344|Arterial stiffness|arterial stiffness
630726|NCT00513344|Dark chocolate|dark chocolate
630727|NCT00513344|Milk chocolate|milk chocolate
630728|NCT00513344|Polyphenols|polyphenols
630729|NCT00513331|Barrett's Esophagus|barrett's esophagus
630730|NCT00513331|GERD|gerd
630731|NCT00513331|Carcinoma|carcinoma
630732|NCT00513318|Umbilical cord blood transplantation|umbilical cord blood transplantation
630733|NCT00513318|hematopoietic malignancies|hematopoietic malignancies
630734|NCT00513305|acute myeloid leukemia, cytarabine, arsenic trioxide.|acute myeloid leukemia, cytarabine, arsenic trioxide.
630735|NCT00513279|Safety,|safety,
630736|NCT00513279|GSK618334|gsk618334
630737|NCT00513279|pharmacokinetics,|pharmacokinetics,
630738|NCT00513279|repeat dose,|repeat dose,
630739|NCT00513279|tolerability,|tolerability,
630740|NCT00513279|pharmacodynamics,|pharmacodynamics,
630741|NCT00513279|placebo,|placebo,
630742|NCT00513266|recurrent rectal cancer|recurrent rectal cancer
630743|NCT00513266|stage IV rectal cancer|stage iv rectal cancer
630744|NCT00513266|recurrent colon cancer|recurrent colon cancer
630745|NCT00513266|stage IV colon cancer|stage iv colon cancer
630746|NCT00513266|adenocarcinoma of the colon|adenocarcinoma of the colon
630747|NCT00513266|adenocarcinoma of the rectum|adenocarcinoma of the rectum
630748|NCT00513266|liver metastases|liver metastases
630749|NCT00513266|lung metastases|lung metastases
630750|NCT00513253|lapatinib|lapatinib
630751|NCT00513253|Healthy Adult Volunteer|healthy adult volunteer
630752|NCT00513240|erythropoetin|erythropoetin
630753|NCT00513240|neuroprotection|neuroprotection
630754|NCT00513240|neonate|neonate
630755|NCT00513240|cardiac|cardiac
630756|NCT00513240|magnetic resonance imaging|magnetic resonance imaging
630757|NCT00513240|brain magnetic resonance imaging|brain magnetic resonance imaging
630758|NCT00513240|electroencephalogram|electroencephalogram
630759|NCT00513214|Diabetes|diabetes
630760|NCT00513214|Type 2|type 2
630761|NCT00513214|Mellitus|mellitus
630763|NCT00513201|regular insulin|regular insulin
630764|NCT00513201|cirrhotic patients|cirrhotic patients
630765|NCT00513188|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
630766|NCT00513188|anaplastic large cell lymphoma|anaplastic large cell lymphoma
630767|NCT00513188|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
630768|NCT00513188|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
630769|NCT00513188|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
630770|NCT00513175|Allogeneic SCT|allogeneic sct
630771|NCT00513175|Matched unrelated donors|matched unrelated donors
630772|NCT00513175|hematologic malignancies|hematologic malignancies
630773|NCT00513175|renal cell carcinoma|renal cell carcinoma
630774|NCT00513175|aplastic anemia|aplastic anemia
630775|NCT00513162|Advanced Cancers|advanced cancers
630776|NCT00513162|Brain|brain
630777|NCT00513162|CNS|cns
630778|NCT00513162|Neural|neural
630779|NCT00513162|Pediatrics|pediatrics
630780|NCT00513162|Spinal|spinal
630781|NCT00513162|Neuroectodermal Tumor|neuroectodermal tumor
630782|NCT00513162|Brain Metastases|brain metastases
630783|NCT00513162|Valproate|valproate
630784|NCT00513162|Valproic Acid|valproic acid
630785|NCT00513162|Depakene|depakene
630786|NCT00513162|Etoposide|etoposide
630787|NCT00513162|VePesid|vepesid
630788|NCT00513149|angioplasty|angioplasty
630789|NCT00513149|clopidogrel|clopidogrel
630790|NCT00513149|coronary artery disease|coronary artery disease
630791|NCT00513149|PFA|pfa
630792|NCT00513136|Fatigue|fatigue
630793|NCT00513136|Breast Cancer|breast cancer
630794|NCT00513136|Behavioral Research|behavioral research
630795|NCT00513136|Quality of Life|quality of life
630796|NCT00513123|Digital Colposcopy for Fluorescence|digital colposcopy for fluorescence
630797|NCT00513123|DCF|dcf
630798|NCT00513123|Fluorescence Spectroscopy|fluorescence spectroscopy
630799|NCT00513123|Digital Colposcopy|digital colposcopy
630800|NCT00513123|DC|dc
630801|NCT00513123|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
630802|NCT00513123|Cervical Cancer|cervical cancer
630803|NCT00513123|Cervix|cervix
630804|NCT00513123|Vagina|vagina
630805|NCT00513123|Lesions of the cervix|lesions of the cervix
630806|NCT00513123|Precancerous lesions|precancerous lesions
630807|NCT00513110|Endotoxin|endotoxin
630808|NCT00513110|Adenosine|adenosine
630809|NCT00513110|Caffeine|caffeine
630811|NCT00513097|Epidemiology|epidemiology
630812|NCT00513097|Cancer Prevention|cancer prevention
630813|NCT00513097|Smoking Cessation|smoking cessation
630814|NCT00513097|Smoking Prevention|smoking prevention
630815|NCT00513097|Focus Groups|focus groups
630816|NCT00513084|Behavioral,|behavioral,
630817|NCT00513084|Self-Determination Theory,|self-determination theory,
630818|NCT00513084|Motivational Interviewing,|motivational interviewing,
630819|NCT00513084|Exercise, Physical Activity,|exercise, physical activity,
630820|NCT00513084|Motivation,|motivation,
630821|NCT00513084|Moderators,|moderators,
630822|NCT00513084|Mediators,|mediators,
630823|NCT00513084|Predictors,|predictors,
630824|NCT00513084|Weight|weight
630825|NCT00513058|metastatic breast cancer|metastatic breast cancer
630826|NCT00513058|advanced breast cancer|advanced breast cancer
630827|NCT00513045|Nightmares|nightmares
630828|NCT00513045|treatment|treatment
630829|NCT00513045|self-help|self-help
630830|NCT00513032|propofol|propofol
630831|NCT00513032|anaesthesia induction|anaesthesia induction
630832|NCT00513032|parathyroidectomy|parathyroidectomy
630833|NCT00513032|methylene blue|methylene blue
630834|NCT00513032|General anesthesia|general anesthesia
630835|NCT00513019|Neurotic Excoriation|neurotic excoriation
630836|NCT00513019|Pathologic Skin Picking|pathologic skin picking
630837|NCT00513019|Psychogenic Excoriation|psychogenic excoriation
630838|NCT00512993|Postoperative treatment with zoledronic acid|postoperative treatment with zoledronic acid
630839|NCT00512993|Preoperative anthracycline/taxane containing chemotherapy|preoperative anthracycline/taxane containing chemotherapy
630840|NCT00512980|intermediate stages|intermediate stages
630841|NCT00512967|oxidative stress|oxidative stress
630842|NCT00512967|antioxidants|antioxidants
630843|NCT00512967|inflammation|inflammation
630844|NCT00512967|quercetin|quercetin
630845|NCT00512954|airway inflammation|airway inflammation
630846|NCT00512954|susceptibility to infections|susceptibility to infections
630847|NCT00512954|inflammatory response in blood and urine|inflammatory response in blood and urine
630848|NCT00512954|infective exacerbations|infective exacerbations
630849|NCT00512954|asthma|asthma
630850|NCT00512954|COPD|copd
630851|NCT00512928|vitamin K2|vitamin k2
630852|NCT00512928|oral anticoagulation|oral anticoagulation
630853|NCT00512928|interference|interference
630854|NCT00512928|level of anticoagulation|level of anticoagulation
630855|NCT00512928|carboxylation level of osteocalcin and matrix-gla protein|carboxylation level of osteocalcin and matrix-gla protein
630856|NCT00512915|Farfield Sensing|farfield sensing
630857|NCT00512915|Pacing lead|pacing lead
630858|NCT00512915|Postventricular atrial blanking|postventricular atrial blanking
630859|NCT00512915|Bradycardia|bradycardia
631062|NCT00512122|respiratory failure|respiratory failure
630860|NCT00512902|active alveolitis in systemic sclerosis|active alveolitis in systemic sclerosis
630861|NCT00512889|CTL|ctl
630862|NCT00512889|MART-1|mart-1
630863|NCT00512889|Melan-A|melan-a
630864|NCT00512889|artificial APC|artificial apc
630865|NCT00512889|melanoma|melanoma
630866|NCT00512889|metastatic melanoma|metastatic melanoma
630867|NCT00512889|adoptive immunotherapy|adoptive immunotherapy
630868|NCT00512889|adoptive cell transfer|adoptive cell transfer
630869|NCT00512889|immunotherapy|immunotherapy
630870|NCT00512850|Folic acid|folic acid
630871|NCT00512850|Adenoma of Large Intestine|adenoma of large intestine
630872|NCT00512837|Telemedicine|telemedicine
630873|NCT00512837|clinical management|clinical management
630874|NCT00512837|empowerment|empowerment
630875|NCT00512837|engagement|engagement
630876|NCT00512837|education|education
630877|NCT00512824|calcium|calcium
630878|NCT00512824|probiotics|probiotics
630879|NCT00512824|diarrhea|diarrhea
630880|NCT00512824|children|children
630881|NCT00512824|Indonesia|indonesia
630882|NCT00512824|Healthy children|healthy children
630883|NCT00512824|acute diarrhea|acute diarrhea
630884|NCT00512811|furosemide|furosemide
630885|NCT00512811|inhalation|inhalation
630886|NCT00512811|dyspnea|dyspnea
630887|NCT00512811|spirometry|spirometry
630888|NCT00512811|mustard gas|mustard gas
630889|NCT00512811|bronchiolitis|bronchiolitis
630890|NCT00512811|sulfur mustard|sulfur mustard
630891|NCT00512798|stage III melanoma|stage iii melanoma
630892|NCT00512798|stage IV melanoma|stage iv melanoma
630893|NCT00512798|recurrent melanoma|recurrent melanoma
630894|NCT00512798|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
630895|NCT00512798|recurrent adult brain tumor|recurrent adult brain tumor
630896|NCT00512798|melanoma (skin)|melanoma (skin)
630897|NCT00512785|Imidafenacin|imidafenacin
630898|NCT00512785|KRP-197/ONO-8025|krp-197/ono-8025
630899|NCT00512785|overactive bladder|overactive bladder
630900|NCT00512785|antimuscarinic|antimuscarinic
630901|NCT00512772|Time series|time series
630902|NCT00512772|Implementation|implementation
630903|NCT00512746|small cell lung cancer|small cell lung cancer
630904|NCT00512746|non-small cell lung cancer|non-small cell lung cancer
630905|NCT00512746|precancerous condition|precancerous condition
630906|NCT00512733|Healthy volunteers|healthy volunteers
630907|NCT00512720|PAD|pad
630908|NCT00512720|Peripheral Artery Disease|peripheral artery disease
630909|NCT00512720|PVD|pvd
630910|NCT00512720|Peripheral Vascular Disease|peripheral vascular disease
630911|NCT00512720|Leg Blockage|leg blockage
630912|NCT00512720|Angioplasty|angioplasty
630913|NCT00512720|Stent|stent
630914|NCT00512720|Claudication|claudication
630915|NCT00512707|testosterone|testosterone
630916|NCT00512707|erectile dysfunction|erectile dysfunction
630917|NCT00512707|sildenafil|sildenafil
630918|NCT00512694|Lupus|lupus
630919|NCT00512694|Systemic Lupus Erythematosus|systemic lupus erythematosus
630920|NCT00512694|Cutaneous Lupus|cutaneous lupus
630921|NCT00512681|Stomach Neoplasms|stomach neoplasms
630922|NCT00512681|Secondary|secondary
630923|NCT00512681|Combination chemotherapy|combination chemotherapy
630924|NCT00512681|S-1|s-1
630925|NCT00512681|irinotecan|irinotecan
630926|NCT00512681|oxaliplatin|oxaliplatin
630927|NCT00512655|Fear of falling|fear of falling
630928|NCT00512655|Intraindividual variability|intraindividual variability
630929|NCT00512655|Cognition|cognition
630930|NCT00512655|Fall prevention|fall prevention
630931|NCT00512655|Fear|fear
630932|NCT00512655|Frail elderly|frail elderly
630933|NCT00512655|Intervention|intervention
630934|NCT00512642|Non-Small Cell Lung Cancer|non-small cell lung cancer
630935|NCT00512642|p53|p53
630936|NCT00512642|Smoking|smoking
630937|NCT00512642|Carcinogenesis|carcinogenesis
630938|NCT00512642|Loss of Heterozygosity|loss of heterozygosity
630939|NCT00512629|PN|pn
630940|NCT00512629|cholestasis|cholestasis
630941|NCT00512629|gastrointestinal disease in infants|gastrointestinal disease in infants
630942|NCT00512629|short bowel syndrome|short bowel syndrome
630943|NCT00512616|Ceftriaxone|ceftriaxone
630944|NCT00512616|Acute Antidepressant Effects|acute antidepressant effects
630945|NCT00512616|Glutamatergic System|glutamatergic system
630946|NCT00512616|Double-Blind|double-blind
630947|NCT00512616|Mood Disorders|mood disorders
630948|NCT00512616|Bipolar Disorder|bipolar disorder
630949|NCT00512616|Depression|depression
630950|NCT00512603|cerebro vascular event|cerebro vascular event
630951|NCT00512590|fibromyalgia|fibromyalgia
630952|NCT00512590|relaxation|relaxation
630953|NCT00512590|imagery|imagery
630954|NCT00512590|pain|pain
630955|NCT00512590|functional status|functional status
630956|NCT00512590|self efficacy|self efficacy
630957|NCT00512590|minority health|minority health
630958|NCT00512577|sickle cell disease|sickle cell disease
630959|NCT00512577|pre-operative transfusion|pre-operative transfusion
630960|NCT00512577|blood transfusion|blood transfusion
630961|NCT00512564|Sickle Cell Anemia|sickle cell anemia
630962|NCT00512564|Sickle Cell Thalassemia|sickle cell thalassemia
630963|NCT00512564|Iron overload|iron overload
630964|NCT00512564|Non transferrin binding iron|non transferrin binding iron
630965|NCT00512564|Hepcidin|hepcidin
630966|NCT00512551|Cervical Cancer|cervical cancer
630967|NCT00512551|DNA Array Analysis|dna array analysis
630968|NCT00512551|Gene Expression|gene expression
630969|NCT00512551|DNA|dna
630970|NCT00512538|Diabetic foot|diabetic foot
630971|NCT00512512|transoral|transoral
630972|NCT00512512|transluminal|transluminal
630973|NCT00512512|endoscopic|endoscopic
630974|NCT00512512|laparoscopic|laparoscopic
630975|NCT00512512|liver|liver
630976|NCT00512512|biopsy|biopsy
630977|NCT00512499|Osteoporosis|osteoporosis
630978|NCT00512499|Fragility fractures|fragility fractures
630979|NCT00512499|Fracture clinics|fracture clinics
630980|NCT00512499|Orthopedic surgeons|orthopedic surgeons
630981|NCT00512473|GH, GH receptor blockade, GH signaling, insulin resistance|gh, gh receptor blockade, gh signaling, insulin resistance
630982|NCT00512460|Neoplastic Meningitis|neoplastic meningitis
630983|NCT00512460|Leptomeningeal Disease|leptomeningeal disease
630984|NCT00512460|Solid Tumor|solid tumor
630985|NCT00512460|Lymphoma|lymphoma
630986|NCT00512460|Leukemia|leukemia
630987|NCT00512460|Brain Tumor|brain tumor
630988|NCT00512460|RTA 744|rta 744
630989|NCT00512447|Aging|aging
630990|NCT00512434|tibial|tibial
630991|NCT00512434|shaft|shaft
630992|NCT00512434|fracture|fracture
630993|NCT00512434|open|open
630994|NCT00512434|bone-marrow|bone-marrow
630995|NCT00512434|graft|graft
630996|NCT00512434|injection|injection
630997|NCT00512434|mesenchymal stem cell|mesenchymal stem cell
630998|NCT00512408|To assess the effect of a 12 week testosterone administration on maximal exercise capacity, muscle strength and insulin resistance in elderly CHF patients|to assess the effect of a 12 week testosterone administration on maximal exercise capacity, muscle strength and insulin resistance in elderly chf patients
630999|NCT00512395|laparoscopic colorectal surgery|laparoscopic colorectal surgery
631000|NCT00512395|epidural analgesia|epidural analgesia
631001|NCT00512395|pain score|pain score
631002|NCT00512395|postoperative ileus|postoperative ileus
631003|NCT00512382|GER Gastrointestinal reflux|ger gastrointestinal reflux
631004|NCT00512382|Aspiration|aspiration
631005|NCT00512382|ASHTMA|ashtma
631006|NCT00512382|COUGH|cough
631007|NCT00512382|WHEEZE|wheeze
631008|NCT00512382|PH-IMPEDANCE|ph-impedance
631009|NCT00512382|WEEM Wheezy Monitor|weem wheezy monitor
631010|NCT00512369|Metabolic pathways|metabolic pathways
631011|NCT00512369|Atherosclerosis|atherosclerosis
631012|NCT00512369|Monocyte Function|monocyte function
631013|NCT00512343|Synovial Fluid|synovial fluid
631014|NCT00512343|Arthritis|arthritis
631015|NCT00512343|Paired serum/synovial fluid samples|paired serum/synovial fluid samples
631016|NCT00512330|childhood|childhood
631017|NCT00512330|tuberculosis|tuberculosis
631018|NCT00512330|diagnostic|diagnostic
631019|NCT00512330|lipoarabinomannan|lipoarabinomannan
631020|NCT00512330|ELISA|elisa
631021|NCT00512330|Tuberculosis in Childhood|tuberculosis in childhood
631022|NCT00512317|partial onset epilepsy|partial onset epilepsy
631023|NCT00512317|adult epilepsy|adult epilepsy
631024|NCT00512317|partial seizures|partial seizures
631025|NCT00512317|anticonvulsant|anticonvulsant
631026|NCT00512317|catamenial epilepsy|catamenial epilepsy
631027|NCT00512317|adult partial onset epilepsy|adult partial onset epilepsy
631028|NCT00512291|Advanced Cancer|advanced cancer
631029|NCT00512291|Hyperactive Delirium|hyperactive delirium
631030|NCT00512291|Mixed Delirium|mixed delirium
631031|NCT00512291|Olanzapine|olanzapine
631032|NCT00512278|Hepatitis|hepatitis
631033|NCT00512278|HCV|hcv
631034|NCT00512278|Hepatitis C|hepatitis c
631035|NCT00512265|n-acetylcysteine|n-acetylcysteine
631036|NCT00512265|esophagectomy|esophagectomy
631037|NCT00512265|inflammatory reaction|inflammatory reaction
631038|NCT00512265|pulmonary morbidity|pulmonary morbidity
631039|NCT00512252|Plerixafor|plerixafor
631040|NCT00512252|CXCR4|cxcr4
631041|NCT00512252|Chemosensitization|chemosensitization
631042|NCT00512239|Early Rheumatoid Arthritis|early rheumatoid arthritis
631043|NCT00512239|Early inflammatory arthritis|early inflammatory arthritis
631044|NCT00512239|Biomarkers|biomarkers
631045|NCT00512239|Autoantibodies|autoantibodies
631046|NCT00512239|Anti-Sa antibodies|anti-sa antibodies
631047|NCT00512239|Anti-CCP antibodies|anti-ccp antibodies
631048|NCT00512226|Sickle Cell Anemia|sickle cell anemia
631049|NCT00512226|Sickle Cell Thalassemia|sickle cell thalassemia
631050|NCT00512226|Iron Overload|iron overload
631051|NCT00512226|MRI|mri
631052|NCT00512213|preoperative Immunonutrition|preoperative immunonutrition
631053|NCT00512213|major abdominal surgery|major abdominal surgery
631054|NCT00512213|complication|complication
631055|NCT00512174|Portable Ultrasound Scanner|portable ultrasound scanner
631056|NCT00512174|Non Invasive Bladder Volume Measurement|non invasive bladder volume measurement
631057|NCT00512174|Radical Cystectomy|radical cystectomy
631058|NCT00512174|Bladder Reconstruction|bladder reconstruction
631059|NCT00512161|Any patient undergoing elective cardiac surgery|any patient undergoing elective cardiac surgery
631060|NCT00512122|early parenteral nutrition|early parenteral nutrition
631061|NCT00512122|critical illness|critical illness
631063|NCT00512122|kidney failure|kidney failure
631064|NCT00512122|hepatic failure|hepatic failure
631065|NCT00512122|muscle strength|muscle strength
631066|NCT00512122|rehabilitation|rehabilitation
631067|NCT00512122|overfeeding|overfeeding
631068|NCT00512122|Reduced Oral Intake|reduced oral intake
631069|NCT00512109|vascular risk|vascular risk
631070|NCT00512109|perioperative|perioperative
631071|NCT00512109|vascular events|vascular events
631072|NCT00512109|cohort study|cohort study
631073|NCT00512109|surgery|surgery
631074|NCT00512096|Genitourinary|genitourinary
631075|NCT00512096|Penile Cancer|penile cancer
631076|NCT00512096|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
631077|NCT00512096|Extirpative Surgery|extirpative surgery
631078|NCT00512096|TanyN2-3M0 Squamous Cell Carcinoma of the Penis|tanyn2-3m0 squamous cell carcinoma of the penis
631079|NCT00512096|Cisplatin|cisplatin
631080|NCT00512096|Platinol-AQ|platinol-aq
631081|NCT00512096|Platinol|platinol
631082|NCT00512096|CDDP|cddp
631083|NCT00512096|Ifosfamide|ifosfamide
631084|NCT00512096|Ifex|ifex
631085|NCT00512096|Paclitaxel|paclitaxel
631086|NCT00512096|Taxol|taxol
631087|NCT00512083|Leukemia, Myeloid + Acute Disease|leukemia, myeloid + acute disease
631088|NCT00512070|schizophrenia|schizophrenia
631089|NCT00512070|schizoaffective disorder|schizoaffective disorder
631090|NCT00512070|bipolar disorder|bipolar disorder
631091|NCT00512070|olanzapine|olanzapine
631092|NCT00512070|melatonin|melatonin
631093|NCT00512070|obesity|obesity
631094|NCT00512070|metabolic syndrome|metabolic syndrome
631095|NCT00512057|cardiac syndrome X|cardiac syndrome x
631096|NCT00512057|endothelial function|endothelial function
631097|NCT00512044|anesthesia, Longo, mucosectomy, hemorrhoids|anesthesia, longo, mucosectomy, hemorrhoids
631098|NCT00512031|atherosclerosis|atherosclerosis
631099|NCT00512031|metabolic pathways|metabolic pathways
631100|NCT00512031|monocyte adhesion,|monocyte adhesion,
631101|NCT00512018|Electric Stimulation|electric stimulation
631102|NCT00512018|Quadriceps Muscle|quadriceps muscle
631103|NCT00512018|Muscle Strength|muscle strength
631104|NCT00512018|Neuromuscular Properties|neuromuscular properties
631105|NCT00512018|Tension-Length Relationship|tension-length relationship
631106|NCT00512018|Healthy young adults|healthy young adults
631107|NCT00512005|Functional Mitral Regurgitation (FMR)|functional mitral regurgitation (fmr)
631108|NCT00512005|Ischemic Mitral Regurgitation|ischemic mitral regurgitation
631109|NCT00512005|Less invasive repair|less invasive repair
631110|NCT00512005|Percutaneous MV repair|percutaneous mv repair
631111|NCT00512005|Mitral Valve Repair|mitral valve repair
631112|NCT00512005|Heart Failure|heart failure
631113|NCT00512005|Left Ventricular Dysfunction|left ventricular dysfunction
631114|NCT00511992|Ovarian Cancer|ovarian cancer
631115|NCT00511992|Gynecologic Cancer|gynecologic cancer
631116|NCT00511992|Ovarian Carcinoma|ovarian carcinoma
631117|NCT00511992|Peritoneal Carcinoma|peritoneal carcinoma
631118|NCT00511992|IP chemotherapy|ip chemotherapy
631119|NCT00511992|Intraperitoneal|intraperitoneal
631120|NCT00511992|Avastin|avastin
631121|NCT00511992|Bevacizumab|bevacizumab
631122|NCT00511979|Healthy Patients|healthy patients
631123|NCT00511966|Gastroesophageal Reflux|gastroesophageal reflux
631124|NCT00511966|Rabeprazole|rabeprazole
631125|NCT00511953|Hot flashes|hot flashes
631126|NCT00511953|Hot flushes|hot flushes
631127|NCT00511953|Postmenopausal symptoms|postmenopausal symptoms
631128|NCT00511927|heart|heart
631129|NCT00511927|failure|failure
631130|NCT00511927|growth|growth
631131|NCT00511927|hormone|hormone
631132|NCT00511927|igf|igf
631133|NCT00511927|dilative|dilative
631134|NCT00511927|cardiomyopathy|cardiomyopathy
631135|NCT00511914|Influenza vaccine|influenza vaccine
631136|NCT00511901|anemia|anemia
631137|NCT00511901|function|function
631138|NCT00511901|rehabilitation|rehabilitation
631139|NCT00511888|chronic heart failure|chronic heart failure
631140|NCT00511888|hypertension|hypertension
631141|NCT00511888|beta blockers|beta blockers
631142|NCT00511875|diabetic retinopathy|diabetic retinopathy
631143|NCT00511875|diabetes|diabetes
631144|NCT00511875|diabetic eye studies|diabetic eye studies
631145|NCT00511875|neovascularization|neovascularization
631146|NCT00511862|TheraSphere|therasphere
631147|NCT00511862|radioactive microspheres|radioactive microspheres
631148|NCT00511862|Yttrium-90|yttrium-90
631149|NCT00511862|Yttrium glass microspheres|yttrium glass microspheres
631150|NCT00511836|alcoholism|alcoholism
631151|NCT00511836|addiction|addiction
631152|NCT00511836|alcohol detoxification|alcohol detoxification
631153|NCT00511823|drug-drug interaction,|drug-drug interaction,
631154|NCT00511823|rosiglitazone,|rosiglitazone,
631155|NCT00511823|safety|safety
631156|NCT00511823|CYP2C8,|cyp2c8,
631157|NCT00511823|pharmacokinetics,|pharmacokinetics,
631158|NCT00511823|CYP3A4,|cyp3a4,
631159|NCT00511823|granisetron,|granisetron,
631160|NCT00511823|dolasetron,|dolasetron,
631161|NCT00511823|CYP2D6,|cyp2d6,
631162|NCT00511823|casopitant,|casopitant,
631163|NCT00511810|Sadness|sadness
631164|NCT00511810|Insomnia|insomnia
631165|NCT00511810|Loss of appetite|loss of appetite
631167|NCT00511810|Trouble thinking|trouble thinking
631168|NCT00511797|Dysmenorrhea|dysmenorrhea
631169|NCT00511797|Dysmenorrheal score|dysmenorrheal score
631170|NCT00511797|Drospirenone|drospirenone
631171|NCT00511797|DRSP|drsp
631172|NCT00511797|Ethinylestradiol|ethinylestradiol
631173|NCT00511784|Contraception|contraception
631174|NCT00511784|Hormonal contraception|hormonal contraception
631175|NCT00511784|Oral contraception|oral contraception
631176|NCT00511784|Ethinyl estradiol, Levonorgestrel, Contraception|ethinyl estradiol, levonorgestrel, contraception
631177|NCT00511784|Transdermal|transdermal
631178|NCT00511784|Venous thromboembolism|venous thromboembolism
631179|NCT00511784|Norelgestromin|norelgestromin
631180|NCT00511771|Tegaserod, treatment IND, irritable bowel syndrome with constipation, IBS-C, chronic idiopathic constipation, CIC, chronic constipation, CC|tegaserod, treatment ind, irritable bowel syndrome with constipation, ibs-c, chronic idiopathic constipation, cic, chronic constipation, cc
631181|NCT00511758|Cervical Dysplasia|cervical dysplasia
631182|NCT00511758|Digital Imaging|digital imaging
631183|NCT00511758|Colposcopy|colposcopy
631184|NCT00511758|Cervix|cervix
631185|NCT00511745|Interactions|interactions
631186|NCT00511745|Adjusted doses|adjusted doses
631187|NCT00511745|Duodenal Ulcer|duodenal ulcer
631188|NCT00511745|Gastric Ulcer|gastric ulcer
631189|NCT00511745|Erosive or ulcerate Gastroesophageal Reflux|erosive or ulcerate gastroesophageal reflux
631190|NCT00511745|Rabeprazole|rabeprazole
631191|NCT00511745|Gastroesophageal reflux|gastroesophageal reflux
631192|NCT00511693|fragility fracture|fragility fracture
631193|NCT00511693|management of osteoporosis|management of osteoporosis
631194|NCT00511693|osteoporosis coordinator|osteoporosis coordinator
631195|NCT00511693|small volume hospitals|small volume hospitals
631196|NCT00511654|depression|depression
631197|NCT00511654|NK1 receptor antagonists,|nk1 receptor antagonists,
631198|NCT00511641|Ovarian Cancer|ovarian cancer
631199|NCT00511641|Cancer Screening|cancer screening
631200|NCT00511641|Quality of Life|quality of life
631201|NCT00511641|Questionnaire|questionnaire
631202|NCT00511641|Screening|screening
631203|NCT00511641|Survey|survey
631204|NCT00511628|Schizophrenia|schizophrenia
631205|NCT00511628|Risperidone|risperidone
631206|NCT00511628|Schizoaffective disorder|schizoaffective disorder
631207|NCT00511628|Schizophreniform disorder|schizophreniform disorder
631208|NCT00511628|Weight gain|weight gain
631209|NCT00511615|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
631210|NCT00511615|Loop Electrosurgical Excision Procedure|loop electrosurgical excision procedure
631211|NCT00511615|Cervical Cancer|cervical cancer
631212|NCT00511615|Colposcopy|colposcopy
631213|NCT00511615|Molecular Imaging|molecular imaging
631214|NCT00511615|LEEP|leep
631215|NCT00511576|Advanced or Metastatic Breast Cancer|advanced or metastatic breast cancer
631216|NCT00511576|Breast Cancer|breast cancer
631217|NCT00511576|Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC)|advanced or metastatic non-small-cell lung cancer (nsclc)
631218|NCT00511576|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
631219|NCT00511576|Prostate Cancer|prostate cancer
631220|NCT00511576|Gastric Cancer|gastric cancer
631221|NCT00511576|Advanced Gastric Adenocarcinoma|advanced gastric adenocarcinoma
631222|NCT00511576|HDAC Inhibitor|hdac inhibitor
631223|NCT00511576|Taxotere|taxotere
631224|NCT00511576|Docetaxel|docetaxel
631225|NCT00511563|Cortisol,|cortisol,
631226|NCT00511563|stress,|stress,
631227|NCT00511563|response,|response,
631228|NCT00511563|Irritable Bowel Syndrome,|irritable bowel syndrome,
631229|NCT00511563|cytokine.|cytokine.
631230|NCT00511550|peripheral blood stem cells|peripheral blood stem cells
631231|NCT00511550|filgrastim-mobilized|filgrastim-mobilized
631232|NCT00511550|allogeneic transplantation|allogeneic transplantation
631233|NCT00511550|Unrelated Donors for allogeneic transplantation|unrelated donors for allogeneic transplantation
631234|NCT00511537|AML|aml
631235|NCT00511537|ALL|all
631236|NCT00511537|CML|cml
631237|NCT00511537|Lymphoma|lymphoma
631238|NCT00511537|Myelodysplasia|myelodysplasia
631239|NCT00511537|Unrelated stem cell transplantation|unrelated stem cell transplantation
631240|NCT00511537|Hematopoietic disorders|hematopoietic disorders
631241|NCT00511524|brain,|brain,
631242|NCT00511524|inflammation,|inflammation,
631243|NCT00511524|CB2,|cb2,
631244|NCT00511524|PET|pet
631245|NCT00511524|analgesia,|analgesia,
631246|NCT00511511|hypertension|hypertension
631247|NCT00511511|angiogenesis inhibitors|angiogenesis inhibitors
631248|NCT00511511|tyrosine kinase inhibitor|tyrosine kinase inhibitor
631249|NCT00511511|Sunitinib|sunitinib
631250|NCT00511498|Laparoscopic Radical Prostatectomy|laparoscopic radical prostatectomy
631251|NCT00511498|Nightly sildenafil|nightly sildenafil
631252|NCT00511485|Cancer|cancer
631253|NCT00511485|Adenocarcinoma|adenocarcinoma
631254|NCT00511485|Phase II|phase ii
631255|NCT00511485|Lung|lung
631256|NCT00511485|Non-small cell lung cancer|non-small cell lung cancer
631257|NCT00511485|NSCLC|nsclc
631258|NCT00511485|EC145|ec145
631259|NCT00511485|EC20|ec20
631260|NCT00511459|Randomized|randomized
631261|NCT00511459|4-Arm|4-arm
631262|NCT00511459|Placebo controlled|placebo controlled
631263|NCT00511459|Phase 2 Trial|phase 2 trial
631264|NCT00511459|AMG 386|amg 386
631265|NCT00511459|Paclitaxel|paclitaxel
631266|NCT00511459|Bevacizumab|bevacizumab
631267|NCT00511459|First-line Therapy|first-line therapy
631268|NCT00511459|Her-2 Negative|her-2 negative
631269|NCT00511459|Metastatic or Locally Recurrent Breast Cancer|metastatic or locally recurrent breast cancer
631270|NCT00511446|Stomach neoplasms|stomach neoplasms
631271|NCT00511446|docetaxel|docetaxel
631272|NCT00511446|oxaliplatin|oxaliplatin
631273|NCT00511446|capecitabine|capecitabine
631274|NCT00511420|cocoa|cocoa
631275|NCT00511420|cardiovascular disease|cardiovascular disease
631276|NCT00511420|blood pressure|blood pressure
631277|NCT00511407|Acute renal failure|acute renal failure
631278|NCT00511407|Bioartificial kidney|bioartificial kidney
631279|NCT00511407|Cell therapy|cell therapy
631280|NCT00511407|Hemofiltration|hemofiltration
631281|NCT00511407|Septic shock|septic shock
631282|NCT00511394|Decompensated Cirrhosis with Ascites|decompensated cirrhosis with ascites
631283|NCT00511381|Hearing Loss|hearing loss
631284|NCT00511381|Late-Onset Hearing Loss|late-onset hearing loss
631285|NCT00511381|Deafness|deafness
631286|NCT00511368|HIV|hiv
631287|NCT00511368|treatment experienced|treatment experienced
631288|NCT00511368|AIDS|aids
631289|NCT00511329|growth hormone|growth hormone
631290|NCT00511329|short stature|short stature
631291|NCT00511329|growth failure|growth failure
631292|NCT00511329|chronic illness|chronic illness
631293|NCT00511303|Philadelphia chromosome|philadelphia chromosome
631294|NCT00511303|protein-tyrosine kinases|protein-tyrosine kinases
631295|NCT00511290|Primary disease or condition being studied: Asthma -COPD-Interstitial Lung Diseases-Occupational Lung Diseases|primary disease or condition being studied: asthma -copd-interstitial lung diseases-occupational lung diseases
631296|NCT00511277|quetiapine|quetiapine
631297|NCT00511277|schizophrenia|schizophrenia
631298|NCT00511277|first-episode psychosis|first-episode psychosis
631299|NCT00511277|depression|depression
631300|NCT00511277|psychopathology|psychopathology
631301|NCT00511264|Laparoscopy|laparoscopy
631302|NCT00511264|Ultrasound|ultrasound
631303|NCT00511264|Cancer|cancer
631304|NCT00511264|Biopsy|biopsy
631305|NCT00511251|IS-SEM|is-sem
631306|NCT00511238|Onyx|onyx
631307|NCT00511238|PR171|pr171
631308|NCT00511238|carfilzomib|carfilzomib
631309|NCT00511238|multiple myeloma|multiple myeloma
631310|NCT00511238|relapsed|relapsed
631311|NCT00511238|refractory|refractory
631312|NCT00511225|dialysis|dialysis
631313|NCT00511225|Vitamin D|vitamin d
631314|NCT00511212|severe peritonitis|severe peritonitis
631315|NCT00511212|SSI|ssi
631316|NCT00511212|lower digestive tract surgery|lower digestive tract surgery
631317|NCT00511212|Severe peritonitis after lower digestive tract surgery|severe peritonitis after lower digestive tract surgery
631318|NCT00511186|Sepsis|sepsis
631319|NCT00511186|Alkaline Phosphatase|alkaline phosphatase
631320|NCT00511186|inflammation|inflammation
631321|NCT00511186|infection|infection
631322|NCT00511186|renal failure|renal failure
631323|NCT00511173|mechanical valve|mechanical valve
631324|NCT00511160|myocarditis|myocarditis
631325|NCT00511160|parvovirus B19 (PVB19)|parvovirus b19 (pvb19)
631326|NCT00511160|human herpes virus 6 (HHV6)|human herpes virus 6 (hhv6)
631327|NCT00511160|cardiac magnetic resonance tomography (CMR)|cardiac magnetic resonance tomography (cmr)
631328|NCT00511147|IVIG|ivig
631329|NCT00511147|ITP|itp
631330|NCT00511134|insomnia|insomnia
631331|NCT00511134|nicotine dependence|nicotine dependence
631332|NCT00511134|smoking|smoking
631333|NCT00511134|smoking cessation|smoking cessation
631334|NCT00511134|zyban|zyban
631335|NCT00511121|chronic myeloid leukemia|chronic myeloid leukemia
631336|NCT00511121|tyrosine kinase|tyrosine kinase
631337|NCT00511108|Type 2 Diabetes Mellitus (T2DM)|type 2 diabetes mellitus (t2dm)
631338|NCT00511095|Hepatitis B vaccine|hepatitis b vaccine
631339|NCT00511095|HBV vaccine|hbv vaccine
631340|NCT00511095|Hepatitis B|hepatitis b
631341|NCT00511095|Hepatitis|hepatitis
631342|NCT00511095|HBV|hbv
631343|NCT00511069|Bortezomib|bortezomib
631344|NCT00511069|CML033|cml033
631345|NCT00511056|HIV|hiv
631346|NCT00511056|Adherence|adherence
631347|NCT00511056|Compliance|compliance
631348|NCT00511056|Highly Active Antiretroviral Therapy (HAART)|highly active antiretroviral therapy (haart)
631349|NCT00511056|ARV|arv
631350|NCT00511056|ART|art
631351|NCT00511056|Sexual Risk Behavior|sexual risk behavior
631352|NCT00511056|Unsafe|unsafe
631353|NCT00511056|Transmission|transmission
631354|NCT00511043|PTK787|ptk787
631355|NCT00511043|DLCL|dlcl
631356|NCT00511043|Diffuse large cell lymphoma|diffuse large cell lymphoma
631357|NCT00511030|Diabetes|diabetes
631358|NCT00511017|Solid Tumors|solid tumors
631359|NCT00511017|Doxercalciferol|doxercalciferol
631360|NCT00511017|Pediatric Cancer|pediatric cancer
631361|NCT00511017|Recurrent Pediatric Solid Tumors|recurrent pediatric solid tumors
631362|NCT00511017|Calcium|calcium
631363|NCT00511017|Vitamin D|vitamin d
631364|NCT00511004|Brugia Malayi|brugia malayi
631365|NCT00511004|Lymphatic Filariasis|lymphatic filariasis
631366|NCT00511004|Albendazole|albendazole
631367|NCT00511004|Diethylcarbamazine|diethylcarbamazine
631368|NCT00510991|ASTHMA|asthma
631369|NCT00510978|Inflammatory Bowel Disease IBD|inflammatory bowel disease ibd
631370|NCT00510978|Ulcerative Colitis|ulcerative colitis
631371|NCT00510978|Crohn's disease|crohn's disease
631372|NCT00510978|Probiotics|probiotics
631373|NCT00510978|Gastrointestinal|gastrointestinal
631374|NCT00510965|choroidal neovascularization|choroidal neovascularization
631375|NCT00510965|angioid streaks|angioid streaks
631376|NCT00510965|pseudoxanthoma elasticum|pseudoxanthoma elasticum
631377|NCT00510965|Groenblad-Strandberg-Syndrome|groenblad-strandberg-syndrome
631378|NCT00510965|therapy|therapy
631379|NCT00510965|ranibizumab|ranibizumab
631380|NCT00510965|lucentis|lucentis
631381|NCT00510965|Choroidal neovascularization in patients with PXE|choroidal neovascularization in patients with pxe
631382|NCT00510952|diabetes|diabetes
631383|NCT00510952|type 2|type 2
631384|NCT00510939|Acute myeloid leukemia|acute myeloid leukemia
631385|NCT00510939|NFkB activity and leukemia|nfkb activity and leukemia
631386|NCT00510939|expression of NFkB|expression of nfkb
631387|NCT00510913|Treatment efficacy|treatment efficacy
631388|NCT00510913|Transplantation rejection|transplantation rejection
631389|NCT00510913|Kidney transplantation|kidney transplantation
631390|NCT00510913|Cyclosporine|cyclosporine
631391|NCT00510913|tacrolimus|tacrolimus
631392|NCT00510887|follicular lymphoma|follicular lymphoma
631393|NCT00510887|Velcade|velcade
631394|NCT00510887|VR-FND|vr-fnd
631395|NCT00510874|Influenza|influenza
631396|NCT00510874|GSK 1557484A vaccine|gsk 1557484a vaccine
631397|NCT00510861|male age, assisted reproduction, sperm, pregnancy outcome|male age, assisted reproduction, sperm, pregnancy outcome
631398|NCT00510835|septic shock|septic shock
631399|NCT00510835|resuscitation|resuscitation
631400|NCT00510835|sepsis|sepsis
631401|NCT00510835|cost-effectiveness|cost-effectiveness
631402|NCT00510835|sepsis-induced organ dysfunction|sepsis-induced organ dysfunction
631403|NCT00510835|early goal directed therapy|early goal directed therapy
631404|NCT00510835|emergency medicine|emergency medicine
631405|NCT00510835|critical care medicine|critical care medicine
631406|NCT00510822|Cimicoxib|cimicoxib
631407|NCT00510822|Cox-2 inhibitor|cox-2 inhibitor
631408|NCT00510822|Sertraline|sertraline
631409|NCT00510796|Hereditary Non-Polyposis Colon Cancer|hereditary non-polyposis colon cancer
631410|NCT00510796|Colon Cancer|colon cancer
631411|NCT00510796|Endometrial Cancer|endometrial cancer
631412|NCT00510796|Cancer Screening|cancer screening
631413|NCT00510796|Interview|interview
631414|NCT00510796|HNPCC|hnpcc
631415|NCT00510783|tonic-clonic seizure|tonic-clonic seizure
631416|NCT00510783|emergency department|emergency department
631417|NCT00510783|IV levetiracetam|iv levetiracetam
631418|NCT00510783|Keppra|keppra
631419|NCT00510783|seizures|seizures
631420|NCT00510783|phenytoin|phenytoin
631421|NCT00510783|Dilantin|dilantin
631422|NCT00510783|Grand Mal seizure|grand mal seizure
631423|NCT00510770|CPAP|cpap
631424|NCT00510770|Post-opreative|post-opreative
631425|NCT00510770|ARF|arf
631426|NCT00510770|liver transplant|liver transplant
631427|NCT00510770|Post-operative hypoxemia in liver transplant|post-operative hypoxemia in liver transplant
631428|NCT00510744|obesity, bariatric surgery, pancreatic secretion|obesity, bariatric surgery, pancreatic secretion
631429|NCT00510731|Ventricular Tachycardia|ventricular tachycardia
631430|NCT00510731|Cardiac Sudden Death|cardiac sudden death
631431|NCT00510731|Ventricular Fibrillation|ventricular fibrillation
631432|NCT00510731|Heart Rate Variability|heart rate variability
631433|NCT00510718|Prostate|prostate
631434|NCT00510718|Cancer|cancer
631435|NCT00510718|Hormone|hormone
631436|NCT00510718|Refractory|refractory
631437|NCT00510718|Castration|castration
631438|NCT00510705|adiposity|adiposity
631439|NCT00510692|Eicosapentaenoic Acid|eicosapentaenoic acid
631440|NCT00510692|EPA|epa
631441|NCT00510692|EPA 99%|epa 99%
631442|NCT00510692|Fatty acid|fatty acid
631443|NCT00510692|omega-3|omega-3
631444|NCT00510692|apoptosis|apoptosis
631445|NCT00510692|cell proliferation|cell proliferation
631446|NCT00510692|colonic mucosa|colonic mucosa
631447|NCT00510692|polyp|polyp
631448|NCT00510692|Familial Adenomatous Polyposis Coli|familial adenomatous polyposis coli
631449|NCT00510692|FAP|fap
631450|NCT00510692|resolvin|resolvin
631451|NCT00510692|Ileo-rectal anastomosis|ileo-rectal anastomosis
631452|NCT00510692|IRA|ira
631453|NCT00510692|PUFA|pufa
631454|NCT00510692|Endoscopy|endoscopy
631455|NCT00510679|Benin|benin
631456|NCT00510679|child health|child health
631457|NCT00510679|developing country|developing country
631458|NCT00510679|health services research|health services research
631459|NCT00510679|health worker performance|health worker performance
631460|NCT00510679|Integrated Management of Childhood Illness|integrated management of childhood illness
631461|NCT00510666|Pain, Postoperative|pain, postoperative
631462|NCT00510666|Analgesics, Opioid|analgesics, opioid
631463|NCT00510666|Analgesia, Patient-Controlled|analgesia, patient-controlled
631464|NCT00510666|Pain Measurement|pain measurement
631873|NCT00509496|Skin Cancer|skin cancer
631465|NCT00510653|Ovarian Cancer|ovarian cancer
631466|NCT00510653|Primary Peritoneal Cancer|primary peritoneal cancer
631467|NCT00510653|Fallopian Tube Cancer|fallopian tube cancer
631468|NCT00510653|Recurrent Platinum-Resistant|recurrent platinum-resistant
631469|NCT00510653|Taxane-Resistant|taxane-resistant
631470|NCT00510653|Epithelial Ovarian Cancer|epithelial ovarian cancer
631471|NCT00510653|Imatinib Mesylate|imatinib mesylate
631472|NCT00510653|Gleevec|gleevec
631473|NCT00510653|STI571|sti571
631474|NCT00510653|Protein tyrosine kinase inhibitor|protein tyrosine kinase inhibitor
631475|NCT00510640|thyroid carcinoma|thyroid carcinoma
631476|NCT00510640|Sunitinib|sunitinib
631477|NCT00510640|RECIST guidelines|recist guidelines
631478|NCT00510627|Metastatic Liver Cancer|metastatic liver cancer
631479|NCT00510627|Colorectal Cancer|colorectal cancer
631480|NCT00510627|Radiofrequency Ablation|radiofrequency ablation
631481|NCT00510627|Chemotherapy|chemotherapy
631482|NCT00510614|Bacterial Vaginosis|bacterial vaginosis
631483|NCT00510614|Recurrent Bacterial Vaginosis|recurrent bacterial vaginosis
631484|NCT00510588|adiposity|adiposity
631485|NCT00510575|Juvenile Scoliosis|juvenile scoliosis
631486|NCT00510575|Adolescent Scoliosis|adolescent scoliosis
631487|NCT00510575|Scoliosis Management|scoliosis management
631488|NCT00510575|Spinal Fusion|spinal fusion
631489|NCT00510575|Scoliosis instrumentation|scoliosis instrumentation
631490|NCT00510575|Juvenile or Adolescent Idiopathic Scoliosis|juvenile or adolescent idiopathic scoliosis
631491|NCT00510562|Cranial manipulation|cranial manipulation
631492|NCT00510562|Visual function|visual function
631493|NCT00510536|Psoriasis, arthritis, arthralgia|psoriasis, arthritis, arthralgia
631494|NCT00510523|MS|ms
631495|NCT00510523|Balance|balance
631496|NCT00510523|Multiple Sclerosis|multiple sclerosis
631497|NCT00510510|COPD|copd
631498|NCT00510510|glycopyrronium bromide|glycopyrronium bromide
631499|NCT00510510|antimuscarinic|antimuscarinic
631500|NCT00510497|dendritic cell|dendritic cell
631501|NCT00510497|therapeutic vaccine|therapeutic vaccine
631502|NCT00510497|HIV-1|hiv-1
631503|NCT00510497|apoptotic cells|apoptotic cells
631504|NCT00510497|Phase I/II|phase i/ii
631505|NCT00510484|Pancreatic exocrine insufficiency|pancreatic exocrine insufficiency
631506|NCT00510484|Cystic Fibrosis|cystic fibrosis
631507|NCT00510445|Non Small Cell Lung Cancer|non small cell lung cancer
631508|NCT00510445|Advanced Non Small Cell Lung Cancer|advanced non small cell lung cancer
631509|NCT00510445|Metastatic Non Small Cell Lung Cancer|metastatic non small cell lung cancer
631510|NCT00510432|heparin|heparin
631511|NCT00510432|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
631512|NCT00510432|HIT|hit
631513|NCT00510432|allergy|allergy
631514|NCT00510432|skin|skin
631515|NCT00510432|dermatology|dermatology
631516|NCT00510432|DTH|dth
631517|NCT00510432|delayed-type hypersensitivity|delayed-type hypersensitivity
631518|NCT00510432|histology|histology
631519|NCT00510432|Patients receiving sc heparin therapy|patients receiving sc heparin therapy
631520|NCT00510432|Age over 18 years|age over 18 years
631521|NCT00510432|Recruitment will stop when 20 patients with skin lesions are included|recruitment will stop when 20 patients with skin lesions are included
631522|NCT00510419|Migraine|migraine
631523|NCT00510406|Lower Urinary Tract Symptoms|lower urinary tract symptoms
631524|NCT00510406|Treatment|treatment
631525|NCT00510406|Solifenacin succinate|solifenacin succinate
631526|NCT00510406|Tamsulosin hydrochloride|tamsulosin hydrochloride
631527|NCT00510406|Prostatic Hyperplasia|prostatic hyperplasia
631528|NCT00510393|Critical Limb Ischemia|critical limb ischemia
631529|NCT00510393|CLI|cli
631530|NCT00510393|Drug Eluting Stent|drug eluting stent
631531|NCT00510393|DES|des
631532|NCT00510393|Bare Metal Stent|bare metal stent
631533|NCT00510393|BMS|bms
631534|NCT00510367|Breast Cancer|breast cancer
631535|NCT00510367|FAC|fac
631536|NCT00510367|Doxorubicin|doxorubicin
631537|NCT00510367|Adriamycin|adriamycin
631538|NCT00510367|Rubex|rubex
631539|NCT00510367|5-Fluorouracil|5-fluorouracil
631540|NCT00510367|5-FU|5-fu
631541|NCT00510367|Adrucil|adrucil
631542|NCT00510367|Efudex|efudex
631543|NCT00510367|Cyclophosphamide|cyclophosphamide
631544|NCT00510367|Cytoxan|cytoxan
631545|NCT00510367|Neosar|neosar
631546|NCT00510367|Pregnancy|pregnancy
631547|NCT00510354|Progressive GIST|progressive gist
631548|NCT00510354|Resistance to Imatinib mesylate|resistance to imatinib mesylate
631549|NCT00510341|Behavior Change Counseling|behavior change counseling
631550|NCT00510341|Motivational Interviewing|motivational interviewing
631551|NCT00510341|Chronic Care Model|chronic care model
631552|NCT00510341|Communication|communication
631553|NCT00510341|Residency Training|residency training
631554|NCT00510341|Skill Assessment|skill assessment
631555|NCT00510328|whole body vibration|whole body vibration
631556|NCT00510328|muscle physiology|muscle physiology
631557|NCT00510315|leukemia|leukemia
631558|NCT00510315|survivors|survivors
631559|NCT00510315|women|women
631560|NCT00510315|leukemia survivors|leukemia survivors
631561|NCT00510315|cancer or a related illness|cancer or a related illness
631562|NCT00510315|Hodgkin's Lymphoma|hodgkin's lymphoma
632158|NCT00508586|VEGF|vegf
631563|NCT00510315|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
631564|NCT00510315|myelodysplastic syndrome|myelodysplastic syndrome
631565|NCT00510315|aplastic anemia|aplastic anemia
631566|NCT00510315|treated with total body irradiation|treated with total body irradiation
631567|NCT00510315|followed by an allogeneic or autologous stem cell transplant|followed by an allogeneic or autologous stem cell transplant
631568|NCT00510302|Ultraviolet Radiation|ultraviolet radiation
631569|NCT00510302|Melanoma|melanoma
631570|NCT00510302|Questionnaire|questionnaire
631571|NCT00510302|Survey|survey
631572|NCT00510302|First Degree Relative|first degree relative
631573|NCT00510302|Interview|interview
631574|NCT00510289|Sorafenib|sorafenib
631575|NCT00510289|Myelodysplastic Syndromes|myelodysplastic syndromes
631576|NCT00510289|MDS|mds
631577|NCT00510263|Prednisolone|prednisolone
631578|NCT00510263|Valacyclovir|valacyclovir
631579|NCT00510250|Cervix Cancer|cervix cancer
631580|NCT00510250|Cervical Cancer|cervical cancer
631581|NCT00510250|Sorafenib|sorafenib
631582|NCT00510250|Cisplatin|cisplatin
631583|NCT00510250|Radiation|radiation
631584|NCT00510250|Radiotherapy|radiotherapy
631585|NCT00510250|Phase I|phase i
631586|NCT00510250|Phase II|phase ii
631587|NCT00510250|Carcinoma|carcinoma
631588|NCT00510250|Cancer|cancer
631589|NCT00510250|Cervix|cervix
631590|NCT00510237|HIV|hiv
631591|NCT00510237|Adolescents newly diagnosed with HIV|adolescents newly diagnosed with hiv
631592|NCT00510198|Heart Disease|heart disease
631593|NCT00510198|Congestive Heart Failure|congestive heart failure
631594|NCT00510198|Thoracic Fluid Monitoring|thoracic fluid monitoring
631595|NCT00510185|coronary artery disease|coronary artery disease
631596|NCT00510185|coronary angioplasty|coronary angioplasty
631597|NCT00510185|coronary artery bypass surgery|coronary artery bypass surgery
631598|NCT00510185|elderly|elderly
631599|NCT00510172|Headache|headache
631600|NCT00510172|Migraine|migraine
631601|NCT00510172|Vasodilatation|vasodilatation
631602|NCT00510159|Schistosoma haematobium|schistosoma haematobium
631603|NCT00510159|Praziquantel|praziquantel
631604|NCT00510159|Artesunate + Sulfamethoxypyrazine/pyrimethamine|artesunate + sulfamethoxypyrazine/pyrimethamine
631605|NCT00510159|Randomized double blind placebo controlled clinical trial|randomized double blind placebo controlled clinical trial
631606|NCT00510120|Attention Deficit and Disruptive Behavior Disorders|attention deficit and disruptive behavior disorders
631607|NCT00510120|Conduct Disorder|conduct disorder
631608|NCT00510120|Behavior Problems in Youth|behavior problems in youth
631609|NCT00510120|Argumentativeness|argumentativeness
631610|NCT00510120|Children|children
631611|NCT00510120|Therapy|therapy
631612|NCT00510120|Attention Deficit Disorder|attention deficit disorder
631613|NCT00510094|Social Skills|social skills
631614|NCT00510094|Anger Management|anger management
631615|NCT00510094|Relational Aggression|relational aggression
631616|NCT00510068|Phase III|phase iii
631617|NCT00510068|Advanced Neuroendocrine Tumor in adults|advanced neuroendocrine tumor in adults
631618|NCT00510068|RAD001|rad001
631619|NCT00510068|NET|net
631620|NCT00510068|everolimus|everolimus
631621|NCT00510068|mTOr|mtor
631622|NCT00510068|islet cell|islet cell
631623|NCT00510068|neuroendocrine|neuroendocrine
631624|NCT00510042|von Willebrand disease|von willebrand disease
631625|NCT00510042|von Willebrand factor|von willebrand factor
631626|NCT00510042|national study|national study
631627|NCT00510042|bleeding disorder|bleeding disorder
631628|NCT00510042|quality of life|quality of life
631629|NCT00510016|infants|infants
631630|NCT00510016|opioid withdrawal|opioid withdrawal
631631|NCT00510016|abstinence syndrome|abstinence syndrome
631632|NCT00510016|methadone|methadone
631633|NCT00510016|heroin|heroin
631634|NCT00510003|Atopic dermatitis, children, pimecrolimus, eczema|atopic dermatitis, children, pimecrolimus, eczema
631635|NCT00509990|Atopic dermatitis, pimecrolimus, children|atopic dermatitis, pimecrolimus, children
631636|NCT00509951|Neuroses|neuroses
631637|NCT00509951|Evidence-Based Treatment|evidence-based treatment
631638|NCT00509951|Clinical Investigation|clinical investigation
631639|NCT00509951|Young Patients|young patients
631640|NCT00509951|Phobic Disorders|phobic disorders
631641|NCT00509951|Fear|fear
631642|NCT00509951|Phobias|phobias
631643|NCT00509938|immunocompromized|immunocompromized
631644|NCT00509938|hLF1-11|hlf1-11
631645|NCT00509938|antimicrobial|antimicrobial
631646|NCT00509938|peptide|peptide
631647|NCT00509938|lactoferrin|lactoferrin
631648|NCT00509860|Advanced Sarcomas|advanced sarcomas
631649|NCT00509860|Irinotecan|irinotecan
631650|NCT00509860|Camptosar|camptosar
631651|NCT00509860|CPT-11|cpt-11
631652|NCT00509847|S. epidermidis|s. epidermidis
631653|NCT00509847|Staphylococcus|staphylococcus
631654|NCT00509847|Lactoferrin|lactoferrin
631655|NCT00509847|hLF1-11|hlf1-11
631656|NCT00509847|Bacteraemia|bacteraemia
631657|NCT00509834|hLF1-11|hlf1-11
631658|NCT00509834|Candida|candida
631659|NCT00509834|candidaemia|candidaemia
631660|NCT00509834|lactoferrin|lactoferrin
631661|NCT00509782|Solid Tumors|solid tumors
631662|NCT00509782|Anti-Tumor Effects|anti-tumor effects
631663|NCT00509782|ZIO-101|zio-101
631664|NCT00509769|Trastuzumab emtansine|trastuzumab emtansine
631665|NCT00509769|MBC|mbc
631666|NCT00509769|Breast cancer|breast cancer
631667|NCT00509769|HER2-positive breast cancer|her2-positive breast cancer
631668|NCT00509769|HER2|her2
631669|NCT00509756|healthy subjects|healthy subjects
631670|NCT00509743|Adult volunteers|adult volunteers
631671|NCT00509730|stress urinary incontinence|stress urinary incontinence
631672|NCT00509730|urodynamics|urodynamics
631673|NCT00509730|randomized clinical trial|randomized clinical trial
631674|NCT00509730|surgery|surgery
631675|NCT00509717|quality of health care|quality of health care
631676|NCT00509717|prescriptions, drug|prescriptions, drug
631677|NCT00509717|anticholesteremic agents|anticholesteremic agents
631678|NCT00509717|community pharmacy services|community pharmacy services
631679|NCT00509704|Sutent|sutent
631680|NCT00509704|tumor necrosis|tumor necrosis
631681|NCT00509704|DCE-MRI (Dynamic enhanced magnetic resonance imaging)|dce-mri (dynamic enhanced magnetic resonance imaging)
631682|NCT00509691|infection|infection
631683|NCT00509691|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
631684|NCT00509691|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
631685|NCT00509691|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
631686|NCT00509691|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
631687|NCT00509691|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
631688|NCT00509691|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
631689|NCT00509691|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
631690|NCT00509691|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
631691|NCT00509691|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
631692|NCT00509691|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
631693|NCT00509691|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
631694|NCT00509691|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
631695|NCT00509691|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
631696|NCT00509691|chronic eosinophilic leukemia|chronic eosinophilic leukemia
631697|NCT00509691|primary myelofibrosis|primary myelofibrosis
631698|NCT00509691|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
631699|NCT00509691|chronic neutrophilic leukemia|chronic neutrophilic leukemia
631700|NCT00509691|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
631701|NCT00509691|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
631702|NCT00509691|disseminated neuroblastoma|disseminated neuroblastoma
631703|NCT00509691|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
631704|NCT00509691|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
631705|NCT00509691|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
631706|NCT00509691|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
631707|NCT00509691|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
631708|NCT00509691|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
631709|NCT00509691|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
631710|NCT00509691|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
631711|NCT00509691|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
631712|NCT00509691|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
631713|NCT00509691|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
631714|NCT00509691|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
631715|NCT00509691|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
631716|NCT00509691|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
631717|NCT00509691|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
631718|NCT00509691|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
631719|NCT00509691|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
631720|NCT00509691|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
631721|NCT00509691|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
631722|NCT00509691|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
631723|NCT00509691|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
631724|NCT00509691|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
631725|NCT00509691|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
631726|NCT00509691|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
631727|NCT00509691|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
631728|NCT00509691|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
631729|NCT00509691|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
631730|NCT00509691|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
631731|NCT00509691|recurrent breast cancer|recurrent breast cancer
631732|NCT00509691|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
631733|NCT00509691|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
631734|NCT00509691|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
631735|NCT00509691|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
631736|NCT00509691|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
631737|NCT00509691|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
631738|NCT00509691|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
631739|NCT00509691|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
631740|NCT00509691|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
631741|NCT00509691|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
631742|NCT00509691|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
631743|NCT00509691|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
631744|NCT00509691|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
631745|NCT00509691|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
631746|NCT00509691|recurrent neuroblastoma|recurrent neuroblastoma
631747|NCT00509691|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
631748|NCT00509691|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
631749|NCT00509691|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
631750|NCT00509691|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
631751|NCT00509691|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
631752|NCT00509691|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
631753|NCT00509691|refractory hairy cell leukemia|refractory hairy cell leukemia
631754|NCT00509691|refractory multiple myeloma|refractory multiple myeloma
631755|NCT00509691|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
631756|NCT00509691|secondary acute myeloid leukemia|secondary acute myeloid leukemia
631757|NCT00509691|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
631758|NCT00509691|splenic marginal zone lymphoma|splenic marginal zone lymphoma
631759|NCT00509691|stage I multiple myeloma|stage i multiple myeloma
631760|NCT00509691|stage II multiple myeloma|stage ii multiple myeloma
631761|NCT00509691|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
631762|NCT00509691|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
631763|NCT00509691|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
631764|NCT00509691|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
631765|NCT00509691|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
631766|NCT00509691|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
631767|NCT00509691|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
631768|NCT00509691|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
631769|NCT00509691|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
631770|NCT00509691|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
631771|NCT00509691|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
631772|NCT00509691|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
631773|NCT00509691|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
631774|NCT00509691|stage III multiple myeloma|stage iii multiple myeloma
631775|NCT00509691|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
631776|NCT00509691|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
631777|NCT00509691|stage IIIA breast cancer|stage iiia breast cancer
631778|NCT00509691|stage IIIB breast cancer|stage iiib breast cancer
631779|NCT00509691|stage IIIC breast cancer|stage iiic breast cancer
631780|NCT00509691|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
631781|NCT00509691|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
631782|NCT00509691|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
631783|NCT00509691|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
631784|NCT00509691|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
631785|NCT00509691|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
631786|NCT00509691|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
631787|NCT00509691|stage IV breast cancer|stage iv breast cancer
631788|NCT00509691|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
631789|NCT00509691|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
631790|NCT00509691|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
631791|NCT00509691|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
631792|NCT00509691|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
631793|NCT00509691|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
631794|NCT00509691|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
631795|NCT00509691|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
631796|NCT00509691|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
631797|NCT00509691|stage IIA ovarian germ cell tumor|stage iia ovarian germ cell tumor
631798|NCT00509691|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
631799|NCT00509691|stage IIB ovarian germ cell tumor|stage iib ovarian germ cell tumor
631800|NCT00509691|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
631801|NCT00509691|stage IIC ovarian germ cell tumor|stage iic ovarian germ cell tumor
631802|NCT00509691|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
631803|NCT00509691|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
631804|NCT00509691|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
631805|NCT00509691|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
631806|NCT00509691|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
631807|NCT00509691|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
631808|NCT00509691|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
631809|NCT00509678|Rituximab|rituximab
631810|NCT00509678|Rituxan|rituxan
631811|NCT00509678|Psoriatic Arthritis|psoriatic arthritis
631812|NCT00509678|Arthritis|arthritis
631813|NCT00509665|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
631814|NCT00509665|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
631815|NCT00509665|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
631816|NCT00509665|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
631817|NCT00509665|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
631818|NCT00509665|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
631819|NCT00509665|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
631820|NCT00509665|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
631821|NCT00509665|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
631822|NCT00509665|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
631823|NCT00509665|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
631824|NCT00509665|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
631825|NCT00509665|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
631826|NCT00509665|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
631827|NCT00509665|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
631828|NCT00509665|recurrent salivary gland cancer|recurrent salivary gland cancer
631829|NCT00509665|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
631830|NCT00509665|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
631831|NCT00509652|Hemochromatosis|hemochromatosis
631832|NCT00509652|Primary hemochromatosis|primary hemochromatosis
631833|NCT00509652|Hereditary hemochromatosis|hereditary hemochromatosis
631834|NCT00509652|Therapy|therapy
631835|NCT00509652|Erythrocyte apheresis|erythrocyte apheresis
631836|NCT00509652|Phlebotomy|phlebotomy
631837|NCT00509652|Apheresis|apheresis
631838|NCT00509652|Efficacy|efficacy
631839|NCT00509626|fatigue|fatigue
631840|NCT00509626|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
631841|NCT00509626|weight changes|weight changes
631842|NCT00509626|depression|depression
631843|NCT00509626|stage I breast cancer|stage i breast cancer
631844|NCT00509626|stage II breast cancer|stage ii breast cancer
631845|NCT00509600|Juvenile Myelomonocytic Leukemia|juvenile myelomonocytic leukemia
631846|NCT00509600|JMML|jmml
631847|NCT00509600|Leukemia|leukemia
631848|NCT00509600|Etanercept|etanercept
631849|NCT00509600|Enbrel|enbrel
631850|NCT00509574|Single Nucleotide Polymorphism|single nucleotide polymorphism
631851|NCT00509574|statins|statins
631852|NCT00509574|hyperlipidemia|hyperlipidemia
631853|NCT00509561|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
631854|NCT00509561|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
631855|NCT00509561|stage IA esophageal cancer|stage ia esophageal cancer
631856|NCT00509561|stage IB esophageal cancer|stage ib esophageal cancer
631857|NCT00509561|stage IIA esophageal cancer|stage iia esophageal cancer
631858|NCT00509561|stage IIB esophageal cancer|stage iib esophageal cancer
631859|NCT00509561|stage IIIA esophageal cancer|stage iiia esophageal cancer
631860|NCT00509561|stage IIIB esophageal cancer|stage iiib esophageal cancer
631861|NCT00509561|stage IIIC esophageal cancer|stage iiic esophageal cancer
631862|NCT00509535|Vitreoscilla filiformis extract|vitreoscilla filiformis extract
631863|NCT00509535|SCORAD|scorad
631864|NCT00509535|pruritus|pruritus
631865|NCT00509535|microflora|microflora
631866|NCT00509535|TEWL|tewl
631867|NCT00509509|Hereditary Breast Cancer (BRCA1, BRCA2)|hereditary breast cancer (brca1, brca2)
631868|NCT00509496|Refractory|refractory
631869|NCT00509496|Gene Therapy|gene therapy
631870|NCT00509496|HLA-A2 Positive|hla-a2 positive
631871|NCT00509496|Stage IV Melanoma|stage iv melanoma
631872|NCT00509496|Melanoma|melanoma
631874|NCT00509496|Malignant Melanoma|malignant melanoma
631875|NCT00509483|multinodular|multinodular
631876|NCT00509483|goitre|goitre
631877|NCT00509483|recombinant human TSH|recombinant human tsh
631878|NCT00509457|NSCLC, vaccination|nsclc, vaccination
631879|NCT00509457|Inoperable NSCLC stage IIIA/B in good performance status|inoperable nsclc stage iiia/b in good performance status
631880|NCT00509431|adult giant cell glioblastoma|adult giant cell glioblastoma
631881|NCT00509431|adult gliosarcoma|adult gliosarcoma
631882|NCT00509431|adult anaplastic astrocytoma|adult anaplastic astrocytoma
631883|NCT00509431|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
631884|NCT00509431|adult mixed glioma|adult mixed glioma
631885|NCT00509431|recurrent adult brain tumor|recurrent adult brain tumor
631886|NCT00509431|adult glioblastoma|adult glioblastoma
631887|NCT00509431|adult pilocytic astrocytoma|adult pilocytic astrocytoma
631888|NCT00509431|adult diffuse astrocytoma|adult diffuse astrocytoma
631889|NCT00509431|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
631890|NCT00509431|adult oligodendroglioma|adult oligodendroglioma
631891|NCT00509418|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
631892|NCT00509418|Nonalcoholic Fatty Liver|nonalcoholic fatty liver
631893|NCT00509418|Nutritional supplement|nutritional supplement
631894|NCT00509418|Diet|diet
631895|NCT00509418|Exercise|exercise
631896|NCT00509405|Endogenous acid production|endogenous acid production
631897|NCT00509405|metabolic acidosis|metabolic acidosis
631898|NCT00509405|potassium citrate|potassium citrate
631899|NCT00509405|osteoporosis|osteoporosis
631900|NCT00509405|sarcopenia|sarcopenia
631901|NCT00509405|hypertension|hypertension
631902|NCT00509405|Effect of potassium citrate on bone mineral density and bone mass|effect of potassium citrate on bone mineral density and bone mass
631903|NCT00509392|Varicose veins, venous reflux, GSV disease|varicose veins, venous reflux, gsv disease
631904|NCT00509379|Relapsed/refractory indolent lymphoma|relapsed/refractory indolent lymphoma
631905|NCT00509379|Non-follicular Lymphoma|non-follicular lymphoma
631906|NCT00509379|Mantle cell non-Hodgkin Lymphoma|mantle cell non-hodgkin lymphoma
631907|NCT00509379|Patients naïve or sensitive to rituximab|patients naïve or sensitive to rituximab
631908|NCT00509379|Patients not eligible for high dose chemotherapy with ASCT|patients not eligible for high dose chemotherapy with asct
631909|NCT00509366|genomics|genomics
631910|NCT00509366|genomics predictor|genomics predictor
631911|NCT00509366|genomics analysis|genomics analysis
631912|NCT00509366|squamous|squamous
631913|NCT00509366|non-squamous|non-squamous
631914|NCT00509353|recurrent neuroblastoma|recurrent neuroblastoma
631915|NCT00509340|antiretroviral|antiretroviral
631916|NCT00509340|adherence|adherence
631917|NCT00509340|poor antiretroviral adherence|poor antiretroviral adherence
631918|NCT00509327|postoperative ileus|postoperative ileus
631919|NCT00509327|colorectal surgery|colorectal surgery
631920|NCT00509327|bisacodyl|bisacodyl
631921|NCT00509327|laxatives|laxatives
631922|NCT00509301|brain cancer|brain cancer
631923|NCT00509301|Cotara|cotara
631924|NCT00509301|radioactive isotope|radioactive isotope
631925|NCT00509301|monoclonal antibody|monoclonal antibody
631926|NCT00509301|radiation distribution|radiation distribution
631927|NCT00509288|Refractory|refractory
631928|NCT00509288|Gene Therapy|gene therapy
631929|NCT00509288|HLA-A2 Positive|hla-a2 positive
631930|NCT00509288|Stage IV Melanoma|stage iv melanoma
631931|NCT00509288|Melanoma|melanoma
631932|NCT00509288|Skin Cancer|skin cancer
631933|NCT00509288|Malignant Melanoma|malignant melanoma
631934|NCT00509223|Type 2 diabetes|type 2 diabetes
631935|NCT00509223|Obstructive sleep apnea|obstructive sleep apnea
631936|NCT00509223|Glycemic control|glycemic control
631937|NCT00509223|Insulin resistance|insulin resistance
631938|NCT00509223|Sleep disordered breathing|sleep disordered breathing
631939|NCT00509210|Liver Disease|liver disease
631940|NCT00509197|Asthma|asthma
631941|NCT00509197|Non-eosinophilic Asthma|non-eosinophilic asthma
631942|NCT00509197|sputum eosinophils|sputum eosinophils
631943|NCT00509197|Inhaled Corticosteroids|inhaled corticosteroids
631944|NCT00509184|untreated|untreated
631945|NCT00509171|embolism|embolism
631946|NCT00509171|femur fracture|femur fracture
631947|NCT00509171|lavage|lavage
631948|NCT00509171|TEE|tee
631949|NCT00509171|reamer|reamer
631950|NCT00509171|IM nail|im nail
631951|NCT00509158|safety|safety
631952|NCT00509158|immunogenicity|immunogenicity
631953|NCT00509158|efficacy|efficacy
631954|NCT00509145|Relapsing|relapsing
631955|NCT00509145|Remitting|remitting
631956|NCT00509119|apoplexia|apoplexia
631957|NCT00509119|Intracranial and intraarterial pressure curves in acute apoplectic patients|intracranial and intraarterial pressure curves in acute apoplectic patients
631958|NCT00509106|ceftaroline|ceftaroline
631959|NCT00509106|Community-acquired pneumonia|community-acquired pneumonia
631960|NCT00509106|CAP|cap
631961|NCT00509106|Streptococcus pneumoniae|streptococcus pneumoniae
631962|NCT00509106|Haemophilus influenzae|haemophilus influenzae
631963|NCT00509106|Mycoplasma pneumoniae|mycoplasma pneumoniae
631964|NCT00509106|Chlamydophila spp|chlamydophila spp
631965|NCT00509106|Legionella ssp|legionella ssp
632056|NCT00508911|repeat-dose,|repeat-dose,
632057|NCT00508911|female,|female,
631966|NCT00509106|multi-drug resistant Streptococcus pneumoniae (MDRSP)|multi-drug resistant streptococcus pneumoniae (mdrsp)
631967|NCT00509106|antimicrobial resistance|antimicrobial resistance
631968|NCT00509106|pneumococci|pneumococci
631969|NCT00509106|beta-lactam|beta-lactam
631970|NCT00509106|ceftaroline fosamil|ceftaroline fosamil
631971|NCT00509106|ceftriaxone|ceftriaxone
631972|NCT00509106|antibiotic|antibiotic
631973|NCT00509093|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
631974|NCT00509093|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
631975|NCT00509093|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
631976|NCT00509093|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
631977|NCT00509093|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
631978|NCT00509093|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
631979|NCT00509093|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
631980|NCT00509093|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
631981|NCT00509093|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
631982|NCT00509093|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
631983|NCT00509093|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
631984|NCT00509093|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
631985|NCT00509093|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
631986|NCT00509093|adult acute basophilic leukemia|adult acute basophilic leukemia
631987|NCT00509093|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
631988|NCT00509093|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
631989|NCT00509080|mitral regurgitation|mitral regurgitation
631990|NCT00509080|BNP|bnp
631991|NCT00509080|NT-proBNP|nt-probnp
631992|NCT00509080|natriuretic peptides|natriuretic peptides
631993|NCT00509080|valvular heart disease|valvular heart disease
631994|NCT00509067|Schizoaffective Disorder|schizoaffective disorder
631995|NCT00509067|Acetylcholine|acetylcholine
631996|NCT00509067|Nicotinic Receptors|nicotinic receptors
631997|NCT00509067|Nicotine|nicotine
631998|NCT00509067|Galantamine|galantamine
631999|NCT00509067|negative symptoms|negative symptoms
632000|NCT00509054|Parastomal hernia, wound infection, stoma care.|parastomal hernia, wound infection, stoma care.
632001|NCT00509041|advanced malignant mesothelioma|advanced malignant mesothelioma
632002|NCT00509041|epithelial mesothelioma|epithelial mesothelioma
632003|NCT00509041|recurrent malignant mesothelioma|recurrent malignant mesothelioma
632004|NCT00509041|sarcomatous mesothelioma|sarcomatous mesothelioma
632005|NCT00509028|Asthma|asthma
632006|NCT00509028|Bronchial|bronchial
632007|NCT00509015|antimalarials|antimalarials
632008|NCT00509015|malaria transmission|malaria transmission
632009|NCT00509015|mass drug administration|mass drug administration
632010|NCT00509015|artemisinin-based combination therapy|artemisinin-based combination therapy
632011|NCT00509015|primaquine|primaquine
632012|NCT00509015|gametocytes|gametocytes
632013|NCT00509015|QT-NASBA|qt-nasba
632014|NCT00509002|Salivary Gland Cancer|salivary gland cancer
632015|NCT00509002|Iressa|iressa
632016|NCT00509002|ZD1839|zd1839
632017|NCT00508989|Acetylcholine|acetylcholine
632018|NCT00508989|Forearm Blood Flow|forearm blood flow
632019|NCT00508989|HDL|hdl
632020|NCT00508989|L-NMMA|l-nmma
632021|NCT00508989|Sickle Cell Anemia|sickle cell anemia
632022|NCT00508989|Sickle Cell Disease|sickle cell disease
632023|NCT00508976|bupivacaine|bupivacaine
632024|NCT00508976|marcaine|marcaine
632025|NCT00508976|lidocaine|lidocaine
632026|NCT00508976|normal saline|normal saline
632027|NCT00508976|narcotics|narcotics
632028|NCT00508976|analog pain scale|analog pain scale
632029|NCT00508976|postoperative pain|postoperative pain
632030|NCT00508976|preemptive|preemptive
632031|NCT00508976|aerosolization|aerosolization
632032|NCT00508976|streamed|streamed
632033|NCT00508963|New World Cutaneous or Mucocutaneous Leishmaniasis|new world cutaneous or mucocutaneous leishmaniasis
632034|NCT00508950|Vaccines|vaccines
632035|NCT00508950|Pneumococcal Conjugate Vaccine|pneumococcal conjugate vaccine
632036|NCT00508950|Adult|adult
632037|NCT00508937|Diet|diet
632038|NCT00508937|Protein|protein
632039|NCT00508937|Glucose|glucose
632040|NCT00508937|Insulin|insulin
632041|NCT00508937|Cholesterol|cholesterol
632042|NCT00508937|Triglycerides|triglycerides
632043|NCT00508937|LDL subclasses|ldl subclasses
632044|NCT00508924|Argatroban|argatroban
632045|NCT00508924|Direct thrombin inhibitor|direct thrombin inhibitor
632046|NCT00508924|Percutaneous coronary intervention|percutaneous coronary intervention
632047|NCT00508924|Activated clotting time|activated clotting time
632048|NCT00508924|PCI|pci
632049|NCT00508924|ACT|act
632050|NCT00508911|open-label,|open-label,
632051|NCT00508911|oral contraceptive,|oral contraceptive,
632052|NCT00508911|Combine Oral Contraceptives,|combine oral contraceptives,
632053|NCT00508911|single-sequence,|single-sequence,
632054|NCT00508911|volunteers|volunteers
632055|NCT00508911|GW876008,|gw876008,
632058|NCT00508911|pharmacokinetics,|pharmacokinetics,
632059|NCT00508898|lupus nephritis|lupus nephritis
632060|NCT00508898|proteinuria|proteinuria
632061|NCT00508898|chronic kidney diseases|chronic kidney diseases
632062|NCT00508898|SLE|sle
632063|NCT00508885|hyperphosphatemia|hyperphosphatemia
632064|NCT00508885|niacinamide|niacinamide
632065|NCT00508885|ESRD|esrd
632066|NCT00508885|peritoneal dialysis|peritoneal dialysis
632067|NCT00508885|renal osteodystrophy|renal osteodystrophy
632068|NCT00508872|Colorectal Liver Metastases|colorectal liver metastases
632069|NCT00508872|Oxaliplatin|oxaliplatin
632070|NCT00508872|Eloxatin|eloxatin
632071|NCT00508872|Fluorouracil|fluorouracil
632072|NCT00508872|Leucovorin|leucovorin
632073|NCT00508872|Bevacizumab|bevacizumab
632074|NCT00508872|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
632075|NCT00508872|rhuMAb-VEGF|rhumab-vegf
632076|NCT00508872|Folfox-B|folfox-b
632077|NCT00508872|5-FU|5-fu
632078|NCT00508872|Avastin|avastin
632079|NCT00508859|depression|depression
632080|NCT00508859|adolescents|adolescents
632081|NCT00508859|maintenance treatment|maintenance treatment
632082|NCT00508859|antidepressant|antidepressant
632083|NCT00508846|Hereditary Non-Polyposis Colon Cancer|hereditary non-polyposis colon cancer
632084|NCT00508846|Gynecologic Cancers|gynecologic cancers
632085|NCT00508846|Genetic Counseling|genetic counseling
632086|NCT00508846|Questionnaire|questionnaire
632087|NCT00508846|Survey|survey
632088|NCT00508846|HNPCC|hnpcc
632089|NCT00508833|Adjuvants|adjuvants
632090|NCT00508833|HBsAg|hbsag
632091|NCT00508820|Platelet|platelet
632092|NCT00508820|AMG 531|amg 531
632093|NCT00508820|Thrombopoietin|thrombopoietin
632094|NCT00508820|blood disorder|blood disorder
632095|NCT00508820|bleeding disorder|bleeding disorder
632096|NCT00508820|immune thrombocytopenic purpura|immune thrombocytopenic purpura
632097|NCT00508820|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
632098|NCT00508820|immune (idiopathic) thrombocytopenic purpura|immune (idiopathic) thrombocytopenic purpura
632099|NCT00508820|TPO|tpo
632100|NCT00508820|thrombopoietic protein|thrombopoietic protein
632101|NCT00508807|Lymphoid Malignancies|lymphoid malignancies
632102|NCT00508807|Solid Tumors|solid tumors
632103|NCT00508807|RTA 402|rta 402
632104|NCT00508794|Breast Cancer|breast cancer
632105|NCT00508794|Tibetan Yoga|tibetan yoga
632106|NCT00508794|Stretching Program|stretching program
632107|NCT00508794|Yoga|yoga
632108|NCT00508794|Quality of Life|quality of life
632109|NCT00508794|Questionnaire|questionnaire
632110|NCT00508794|Survey|survey
632111|NCT00508768|Rheumatoid Arthritis|rheumatoid arthritis
632112|NCT00508768|Methotrexate|methotrexate
632113|NCT00508755|cerebrovascular accident|cerebrovascular accident
632114|NCT00508755|electrical stimulation|electrical stimulation
632115|NCT00508755|gait training|gait training
632116|NCT00508755|motor learning|motor learning
632117|NCT00508742|Nasopharyngeal Colonization|nasopharyngeal colonization
632118|NCT00508742|Streptococcus pneumoniae|streptococcus pneumoniae
632119|NCT00508742|Healthy Infants|healthy infants
632120|NCT00508742|Vaccines|vaccines
632121|NCT00508742|Pneumococcal Conjugate Vaccine|pneumococcal conjugate vaccine
632122|NCT00508716|Congestive Heart Failure|congestive heart failure
632123|NCT00508716|Health Literacy|health literacy
632124|NCT00508716|Health Education|health education
632125|NCT00508716|Congestive Heart Failure (inpatients)|congestive heart failure (inpatients)
632126|NCT00508703|Uterine Cancer|uterine cancer
632127|NCT00508703|Cervical Cancer|cervical cancer
632128|NCT00508703|Endometrial Cancer|endometrial cancer
632129|NCT00508703|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
632130|NCT00508703|IMRT|imrt
632131|NCT00508703|Computed Tomography|computed tomography
632132|NCT00508703|CT|ct
632133|NCT00508703|CT Scan|ct scan
632134|NCT00508690|Antibiotic Prophylaxis|antibiotic prophylaxis
632135|NCT00508690|Colorectal Surgery|colorectal surgery
632136|NCT00508690|Laparoscopy|laparoscopy
632137|NCT00508677|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
632138|NCT00508677|Mazindol|mazindol
632139|NCT00508664|by laryngectomy operable carcinoma of the larynx and the hypopharynx|by laryngectomy operable carcinoma of the larynx and the hypopharynx
632140|NCT00508651|parainfluenza virus, children, vaccine|parainfluenza virus, children, vaccine
632141|NCT00508638|Heart Failure|heart failure
632142|NCT00508612|Blood Pressure|blood pressure
632143|NCT00508612|Systolic Blood Pressure|systolic blood pressure
632144|NCT00508612|Diastolic Blood Pressure|diastolic blood pressure
632145|NCT00508612|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
632146|NCT00508612|Relaxation|relaxation
632147|NCT00508612|Meditation|meditation
632148|NCT00508612|Coping Skills|coping skills
632149|NCT00508612|Adolescents|adolescents
632150|NCT00508599|type 2 diabetes|type 2 diabetes
632151|NCT00508599|bed rest|bed rest
632152|NCT00508599|insulin resistance|insulin resistance
632153|NCT00508599|insulin|insulin
632154|NCT00508599|glucose|glucose
632155|NCT00508599|orthostatic response|orthostatic response
632156|NCT00508586|Breast cancer|breast cancer
632157|NCT00508586|PTC299|ptc299
632159|NCT00508586|Angiogenesis|angiogenesis
632160|NCT00508586|Post-transcriptional control|post-transcriptional control
632161|NCT00508586|Aromatase inhibitors|aromatase inhibitors
632162|NCT00508573|Hereditary Nonpolyposis Colorectal Cancer|hereditary nonpolyposis colorectal cancer
632163|NCT00508573|Lynch Syndrome|lynch syndrome
632164|NCT00508573|HNPCC|hnpcc
632165|NCT00508573|Syndrome Registry|syndrome registry
632166|NCT00508573|Questionnaire|questionnaire
632167|NCT00508573|Endometrial cancer|endometrial cancer
632168|NCT00508573|Ovarian cancer|ovarian cancer
632169|NCT00508560|Contingency management|contingency management
632170|NCT00508560|Smoking cessation|smoking cessation
632171|NCT00508560|Psychotic disorders|psychotic disorders
632172|NCT00508560|Veterans|veterans
632173|NCT00508547|Methotrexate|methotrexate
632174|NCT00508547|Acitretin|acitretin
632175|NCT00508547|Cyclosporine|cyclosporine
632176|NCT00508547|Systemic PUVA|systemic puva
632177|NCT00508547|Infliximab|infliximab
632178|NCT00508547|Adalimumab|adalimumab
632179|NCT00508547|Alefacept|alefacept
632180|NCT00508547|Efalizumab|efalizumab
632181|NCT00508547|Etanercept|etanercept
632182|NCT00508547|Psoriasis|psoriasis
632183|NCT00508547|Psoriatic arthritis|psoriatic arthritis
632184|NCT00508547|Skin disease|skin disease
632185|NCT00508547|Cosentyx|cosentyx
632186|NCT00508534|pharmacokinetic study,|pharmacokinetic study,
632187|NCT00508534|gastric pH|gastric ph
632188|NCT00508521|cerebrovascular accident|cerebrovascular accident
632189|NCT00508521|electrical stimulation|electrical stimulation
632190|NCT00508521|motor learning|motor learning
632191|NCT00508521|upper extremity rehabilitation|upper extremity rehabilitation
632192|NCT00508508|Heart Failure|heart failure
632193|NCT00508508|Peer Support|peer support
632194|NCT00508508|Self Management|self management
632195|NCT00508495|pain, postoperative|pain, postoperative
632196|NCT00508495|replacement, total hip|replacement, total hip
632197|NCT00508495|total hip replacement|total hip replacement
632198|NCT00508495|arthroplasty, replacement, hip|arthroplasty, replacement, hip
632199|NCT00508482|Acupuncture|acupuncture
632200|NCT00508482|Functional constipation|functional constipation
632201|NCT00508469|Intraocular pressure|intraocular pressure
632202|NCT00508469|Open-angle glaucoma|open-angle glaucoma
632203|NCT00508469|Ocular hypertension|ocular hypertension
632204|NCT00508469|Adherence|adherence
632205|NCT00508469|Compliance|compliance
632206|NCT00508456|Glioblastoma Multiforme|glioblastoma multiforme
632207|NCT00508456|Methionine Restriction|methionine restriction
632208|NCT00508456|Hominex-2|hominex-2
632209|NCT00508456|Methionine Restriction Diet|methionine restriction diet
632210|NCT00508456|Hominex-2 Amino Acid-Modified Medical Food|hominex-2 amino acid-modified medical food
632211|NCT00508456|Temozolomide|temozolomide
632212|NCT00508456|Temodar|temodar
632213|NCT00508443|Stereotactic Spine Radiotherapy System|stereotactic spine radiotherapy system
632214|NCT00508443|SSRS|ssrs
632215|NCT00508443|CT-on-Rails|ct-on-rails
632216|NCT00508443|Metastatic Spine Disease|metastatic spine disease
632217|NCT00508443|Spinal Neoplasms|spinal neoplasms
632218|NCT00508443|Radiation Therapy|radiation therapy
632219|NCT00508443|Trilogy|trilogy
632220|NCT00508443|Cancer|cancer
632221|NCT00508443|Breast Cancer|breast cancer
632222|NCT00508443|Gastrointestinal Cancer|gastrointestinal cancer
632223|NCT00508443|Genitourinary Disease|genitourinary disease
632224|NCT00508443|Lung Cancer|lung cancer
632225|NCT00508443|Lymphoma|lymphoma
632226|NCT00508443|Melanoma|melanoma
632227|NCT00508443|Sarcoma|sarcoma
632228|NCT00508443|Spinal Cancer|spinal cancer
632229|NCT00508430|ASP8825|asp8825
632230|NCT00508430|Diabetic Neuropathies|diabetic neuropathies
632231|NCT00508430|Pain|pain
632232|NCT00508417|Malaria Incidence|malaria incidence
632233|NCT00508417|Anemia|anemia
632234|NCT00508417|Clinical Malaria|clinical malaria
632235|NCT00508378|Ovarian Cancer|ovarian cancer
632236|NCT00508378|Quality of Life|quality of life
632237|NCT00508378|Chemotherapy Side-Effects|chemotherapy side-effects
632238|NCT00508378|Interview|interview
632239|NCT00508378|Questionnaire|questionnaire
632240|NCT00508378|Caregivers|caregivers
632241|NCT00508365|lisinopril|lisinopril
632242|NCT00508365|carvedilol|carvedilol
632243|NCT00508365|hypertension|hypertension
632244|NCT00508352|breast|breast
632245|NCT00508352|cancer|cancer
632246|NCT00508352|locoregional|locoregional
632247|NCT00508352|IMRT|imrt
632248|NCT00508352|tomotherapy|tomotherapy
632249|NCT00508339|Soft Tissue Sarcoma|soft tissue sarcoma
632250|NCT00508339|Limb Sparing Surgery|limb sparing surgery
632251|NCT00508339|Toronto Extremity Salvage Score|toronto extremity salvage score
632252|NCT00508339|Radiotherapy|radiotherapy
632253|NCT00508339|Quality of Life|quality of life
632254|NCT00508339|Questionnaire|questionnaire
632255|NCT00508339|Survey|survey
632256|NCT00508339|TESS|tess
632257|NCT00508326|Advanced Cancer|advanced cancer
632258|NCT00508326|Solid Tumor|solid tumor
632259|NCT00508326|Liver Metastasis|liver metastasis
632260|NCT00508326|Hepatic Artery Infusion|hepatic artery infusion
632261|NCT00508326|Liver|liver
632262|NCT00508326|Paclitaxel|paclitaxel
632263|NCT00508326|Taxol|taxol
632264|NCT00508313|Lung Cancer|lung cancer
632265|NCT00508313|Healthy Control|healthy control
632266|NCT00508313|Thermal Imaging|thermal imaging
632267|NCT00508313|Thermal Signatures|thermal signatures
632268|NCT00508313|Radiation Therapy|radiation therapy
632269|NCT00508313|Chemoradiation Therapy|chemoradiation therapy
632270|NCT00508300|laparoscopic|laparoscopic
632271|NCT00508300|colectomy|colectomy
632272|NCT00508300|Fast Track|fast track
632273|NCT00508300|epidural|epidural
632274|NCT00508274|Advanced Metastatic Breast Cancer|advanced metastatic breast cancer
632275|NCT00508274|breast cancer|breast cancer
632276|NCT00508274|lapatinib|lapatinib
632277|NCT00508274|HER2+ positive|her2+ positive
632278|NCT00508274|TYVERB|tyverb
632279|NCT00508274|TYKERB|tykerb
632280|NCT00508261|Meningococcal vaccine|meningococcal vaccine
632281|NCT00508261|Immunogenicity|immunogenicity
632282|NCT00508261|Routine infancy vaccination|routine infancy vaccination
632283|NCT00508261|Safety|safety
632284|NCT00508248|omega 3fatty acids|omega 3fatty acids
632285|NCT00508235|Neurofibromatosis|neurofibromatosis
632286|NCT00508235|Quality of Friendships|quality of friendships
632287|NCT00508235|Disease Severity|disease severity
632288|NCT00508235|Questionnaire|questionnaire
632289|NCT00508235|NF-1|nf-1
632290|NCT00508222|HIV|hiv
632291|NCT00508222|HCV|hcv
632292|NCT00508222|HIV/HCV Co-infection|hiv/hcv co-infection
632293|NCT00508222|Kaletra Monotherapy|kaletra monotherapy
632294|NCT00508222|Treatment Experienced|treatment experienced
632295|NCT00508209|high-dose melphalan|high-dose melphalan
632296|NCT00508209|bortezomib|bortezomib
632297|NCT00508209|response|response
632298|NCT00508209|toxicity|toxicity
632299|NCT00508209|relapse|relapse
632300|NCT00508196|right ventricular pacing|right ventricular pacing
632301|NCT00508196|endothelial function|endothelial function
632302|NCT00508196|cardiac output|cardiac output
632303|NCT00508183|full thickness rotator cuff tear|full thickness rotator cuff tear
632304|NCT00508170|Head and Neck Cancer|head and neck cancer
632305|NCT00508170|Human Papillomavirus Infection|human papillomavirus infection
632306|NCT00508170|Oropharyngeal Patients|oropharyngeal patients
632307|NCT00508170|Sexual Behavior|sexual behavior
632308|NCT00508170|Questionnaire|questionnaire
632309|NCT00508144|Non-Small Cell Lung Cancer|non-small cell lung cancer
632310|NCT00508144|Lung Cancer|lung cancer
632311|NCT00508144|NSCLC|nsclc
632312|NCT00508144|Malignant pleural effusion|malignant pleural effusion
632313|NCT00508144|Pericardial effusion|pericardial effusion
632314|NCT00508144|Pemetrexed|pemetrexed
632315|NCT00508144|Alimta|alimta
632316|NCT00508144|LY231514|ly231514
632317|NCT00508144|Poor Performance Status|poor performance status
632318|NCT00508144|Asymptomatic Brain Metastases|asymptomatic brain metastases
632319|NCT00508131|Milk fortification|milk fortification
632320|NCT00508131|Effectivness evaluation|effectivness evaluation
632321|NCT00508131|Iron deficiency anemia|iron deficiency anemia
632322|NCT00508131|Stunting|stunting
632323|NCT00508131|Zinc deficiency|zinc deficiency
632324|NCT00508118|Aortic Arch Reconstruction Surgery|aortic arch reconstruction surgery
632325|NCT00508105|Osteoarthritis|osteoarthritis
632326|NCT00508105|Shoulder|shoulder
632327|NCT00508105|tenotomy|tenotomy
632328|NCT00508105|ostotomy|ostotomy
632329|NCT00508092|appendicectomy|appendicectomy
632330|NCT00508092|pain|pain
632331|NCT00508092|local anaesthetic|local anaesthetic
632332|NCT00508092|nerve block|nerve block
632333|NCT00508092|Post operative pain following appendicectomy|post operative pain following appendicectomy
632334|NCT00508079|Venous Disease|venous disease
632335|NCT00508079|Varicose Veins|varicose veins
632336|NCT00508079|Chronic Venous Insufficiency|chronic venous insufficiency
632337|NCT00508079|PAD|pad
632338|NCT00508066|Congenital Scoliosis|congenital scoliosis
632339|NCT00508066|Idiopathic Scoliosis|idiopathic scoliosis
632340|NCT00508066|Spinal Fusion|spinal fusion
632341|NCT00508066|Post-Operative Pain Management|post-operative pain management
632342|NCT00508066|Infusion Catheter|infusion catheter
632343|NCT00508053|wound infection|wound infection
632344|NCT00508053|incisional hernia|incisional hernia
632345|NCT00508053|wound dehiscence|wound dehiscence
632346|NCT00508053|wound healing|wound healing
632347|NCT00508053|postoperative complications|postoperative complications
632348|NCT00508053|surgical techniques|surgical techniques
632349|NCT00508040|Birdshot Retine choroidopathy|birdshot retine choroidopathy
632350|NCT00508040|Macular edema|macular edema
632351|NCT00508040|Prednisone|prednisone
632352|NCT00508040|Interferon alpha 2a|interferon alpha 2a
632353|NCT00508040|Associated with Cystoid macular edema|associated with cystoid macular edema
632354|NCT00508040|With Visual acuity loss|with visual acuity loss
632355|NCT00508027|sickle cell disease|sickle cell disease
632356|NCT00508027|simvastatin|simvastatin
632357|NCT00508027|statin drugs|statin drugs
632358|NCT00508027|nitric oxide donors|nitric oxide donors
632359|NCT00508027|vascular injury|vascular injury
632360|NCT00508014|Cardiovascular disease|cardiovascular disease
632361|NCT00508014|Diabetes|diabetes
632362|NCT00508014|Quality improvement|quality improvement
632363|NCT00508014|Peer review|peer review
632364|NCT00508001|Hepatocellular carcinoma|hepatocellular carcinoma
632365|NCT00508001|Advanced solid, malignant tumour|advanced solid, malignant tumour
632366|NCT00507988|Cognitive Training|cognitive training
632367|NCT00507988|Complex Problem Solving|complex problem solving
632368|NCT00507988|Goal Management|goal management
632369|NCT00507988|Planning|planning
632370|NCT00507975|Smoking|smoking
632371|NCT00507975|pregnancy|pregnancy
632372|NCT00507975|newborn|newborn
632373|NCT00507975|birth weight|birth weight
632374|NCT00507975|nicotine patch|nicotine patch
632375|NCT00507975|birth|birth
632376|NCT00507962|Advanced Cancer|advanced cancer
632377|NCT00507962|Dominant Liver Involvement|dominant liver involvement
632378|NCT00507962|Hepatic Intraarterial Cisplatin|hepatic intraarterial cisplatin
632379|NCT00507962|Cisplatin|cisplatin
632380|NCT00507962|Liposomal Doxorubicin|liposomal doxorubicin
632381|NCT00507962|Platinol-AQ|platinol-aq
632382|NCT00507962|Platinol|platinol
632383|NCT00507962|CDDP|cddp
632384|NCT00507962|Doxil|doxil
632385|NCT00507962|Liposomal|liposomal
632386|NCT00507962|Doxorubicin Hydrochloride|doxorubicin hydrochloride
632387|NCT00507949|COPD|copd
632388|NCT00507949|body weight|body weight
632389|NCT00507949|megestrol acetate|megestrol acetate
632390|NCT00507949|cytokines|cytokines
632391|NCT00507936|Diabetic Neuropathy|diabetic neuropathy
632392|NCT00507936|Painful|painful
632393|NCT00507936|Diabetic Polyneuropathy|diabetic polyneuropathy
632394|NCT00507936|Neuralgia|neuralgia
632395|NCT00507936|Diabetic|diabetic
632396|NCT00507936|Diabetic Neuropathies|diabetic neuropathies
632397|NCT00507936|Diabetic Neuralgia|diabetic neuralgia
632398|NCT00507923|Breast Cancer|breast cancer
632399|NCT00507923|Tibetan Yoga|tibetan yoga
632400|NCT00507923|Stretching|stretching
632401|NCT00507923|Yoga|yoga
632402|NCT00507923|Fatigue|fatigue
632403|NCT00507923|Sleep|sleep
632404|NCT00507923|Questionnaire|questionnaire
632405|NCT00507923|Survey|survey
632406|NCT00507910|ankle fracture|ankle fracture
632407|NCT00507910|pes planus|pes planus
632408|NCT00507897|thyroid nodules, blood pressure, thyroid hormones|thyroid nodules, blood pressure, thyroid hormones
632409|NCT00507884|Kidney Neoplasms|kidney neoplasms
632410|NCT00507884|Renal Tumors|renal tumors
632411|NCT00507884|Magnetic Resonance Imaging|magnetic resonance imaging
632412|NCT00507884|3 Tesla MRI|3 tesla mri
632413|NCT00507884|MRI|mri
632414|NCT00507871|cryptosporidiosis, Cryptosporidium, Uganda, diarrhea|cryptosporidiosis, cryptosporidium, uganda, diarrhea
632415|NCT00507858|Head and Neck Cancer|head and neck cancer
632416|NCT00507858|Squamous Cell Cancer|squamous cell cancer
632417|NCT00507858|Alimta|alimta
632418|NCT00507858|Pemetrexed|pemetrexed
632419|NCT00507858|Dexamethasone|dexamethasone
632420|NCT00507858|HNSCC|hnscc
632421|NCT00507858|Decadron|decadron
632422|NCT00507832|Prurigo nodularis|prurigo nodularis
632423|NCT00507819|Other Single Ventricle Anatomy|other single ventricle anatomy
632424|NCT00507819|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
632425|NCT00507819|Tricuspid Atresia|tricuspid atresia
632426|NCT00507806|Acute Ischemic Stroke|acute ischemic stroke
632427|NCT00507806|Microbubbles|microbubbles
632428|NCT00507806|Transcranial Doppler ultrasound|transcranial doppler ultrasound
632429|NCT00507806|TIBI|tibi
632430|NCT00507806|Symptomatic Intracranial Hemorrhage|symptomatic intracranial hemorrhage
632431|NCT00507806|modified Rankin Scale|modified rankin scale
632432|NCT00507806|Recanalization|recanalization
632433|NCT00507806|Perflutren|perflutren
632434|NCT00507780|GnRH Antagonist|gnrh antagonist
632435|NCT00507780|Premature Ovarian Failure|premature ovarian failure
632436|NCT00507780|Fertility|fertility
632437|NCT00507780|Chemotherapy|chemotherapy
632438|NCT00507780|POF|pof
632439|NCT00507754|Advanced Cancer|advanced cancer
632440|NCT00507754|Solid Tumors|solid tumors
632441|NCT00507754|Latent Mycobacterium Tuberculosis|latent mycobacterium tuberculosis
632442|NCT00507754|Tuberculin Skin Test|tuberculin skin test
632443|NCT00507754|Tuberculosis|tuberculosis
632444|NCT00507754|T-SPOT TB test|t-spot tb test
632445|NCT00507754|TB|tb
632446|NCT00507741|Cancer|cancer
632447|NCT00507741|Ovarian|ovarian
632448|NCT00507741|Endometrial|endometrial
632449|NCT00507741|Phase II|phase ii
632450|NCT00507741|EC145|ec145
632451|NCT00507741|EC20|ec20
632452|NCT00507728|Pharmacogenetics|pharmacogenetics
632453|NCT00507728|Emotional Reactivity|emotional reactivity
632454|NCT00507728|Smoking Cessation Counseling|smoking cessation counseling
632455|NCT00507728|Smoking|smoking
632456|NCT00507728|Bupropion|bupropion
632457|NCT00507728|Wellbutrin|wellbutrin
632458|NCT00507728|Wellbutrin SR|wellbutrin sr
632459|NCT00507728|Zyban|zyban
632460|NCT00507728|Varenicline|varenicline
632461|NCT00507728|Chantix|chantix
632462|NCT00507728|Placebo|placebo
632463|NCT00507715|Parkinson's Disease, Idiopathic|parkinson's disease, idiopathic
632464|NCT00507715|l-dopa levels|l-dopa levels
632465|NCT00507715|plantago ovata husk|plantago ovata husk
632466|NCT00507689|Truvada|truvada
632467|NCT00507689|HBIg|hbig
632468|NCT00507689|Chronic Hepatitis B Recurrence|chronic hepatitis b recurrence
632469|NCT00507689|Post Orthotopic Liver Transplant|post orthotopic liver transplant
632470|NCT00507676|Asthma|asthma
632471|NCT00507676|Wheezing|wheezing
632472|NCT00507676|Infant|infant
632473|NCT00507663|beta blocker|beta blocker
632474|NCT00507663|functional recovery|functional recovery
632475|NCT00507650|Pressure ulcers|pressure ulcers
632476|NCT00507650|Geriatrics|geriatrics
632477|NCT00507650|Nursing home|nursing home
632478|NCT00507650|Fluid balance|fluid balance
632479|NCT00507650|Collagen deposition|collagen deposition
632480|NCT00507611|breast|breast
632481|NCT00507611|sentinel lymph node|sentinel lymph node
632482|NCT00507611|node mapping|node mapping
632483|NCT00507598|colorectal cancer|colorectal cancer
632484|NCT00507598|metabolomics|metabolomics
632485|NCT00507585|Liver Cancer|liver cancer
632486|NCT00507585|Liver metastases|liver metastases
632487|NCT00507585|Metastatic advanced solid tumors|metastatic advanced solid tumors
632488|NCT00507585|Advanced solid tumors metastatic to the liver|advanced solid tumors metastatic to the liver
632489|NCT00507585|Hepatic Arterial Infusion|hepatic arterial infusion
632490|NCT00507585|Intra-arterial hepatic oxaliplatin|intra-arterial hepatic oxaliplatin
632491|NCT00507585|Fluorouracil|fluorouracil
632492|NCT00507585|5-FU|5-fu
632493|NCT00507585|Adrucil|adrucil
632494|NCT00507585|Efudex|efudex
632495|NCT00507585|5-fluorouracil|5-fluorouracil
632496|NCT00507585|Avastin|avastin
632497|NCT00507585|Leucovorin|leucovorin
632498|NCT00507585|Oxaliplatin|oxaliplatin
632499|NCT00507585|Bevacizumab|bevacizumab
632500|NCT00507572|Solid Tumors|solid tumors
632501|NCT00507572|Pregnancy|pregnancy
632502|NCT00507572|Data Collection|data collection
632503|NCT00507546|sleep|sleep
632504|NCT00507546|melatonin|melatonin
632505|NCT00507546|spinal cord injury|spinal cord injury
632506|NCT00507546|insomnia|insomnia
632507|NCT00507546|tetraplegia|tetraplegia
632508|NCT00507533|CPAP|cpap
632509|NCT00507533|Hematologic|hematologic
632510|NCT00507533|Neutropenic|neutropenic
632511|NCT00507533|ARF|arf
632512|NCT00507520|RCT|rct
632513|NCT00507520|Almonds|almonds
632514|NCT00507520|Hyperlipidemia|hyperlipidemia
632515|NCT00507520|Blood Lipids|blood lipids
632516|NCT00507507|tenofovir|tenofovir
632517|NCT00507507|monotherapy|monotherapy
632518|NCT00507507|emtricitabine|emtricitabine
632519|NCT00507507|combination|combination
632520|NCT00507507|hepatitis B|hepatitis b
632521|NCT00507494|posttransplant diabetes mellitus|posttransplant diabetes mellitus
632522|NCT00507494|kidney transplantation|kidney transplantation
632523|NCT00507494|filtration fraction|filtration fraction
632524|NCT00507494|proteinuria|proteinuria
632525|NCT00507481|Sleep|sleep
632526|NCT00507481|ICU|icu
632527|NCT00507481|Delirium|delirium
632528|NCT00507481|Post surgical ventilated patients|post surgical ventilated patients
632529|NCT00507481|ICU patients|icu patients
632530|NCT00507468|bone marrow|bone marrow
632531|NCT00507468|autologous|autologous
632532|NCT00507468|ejection fraction|ejection fraction
632533|NCT00507468|left ventricle|left ventricle
632534|NCT00507468|heart attack|heart attack
632535|NCT00507468|myocardial infarction|myocardial infarction
632536|NCT00507468|left ventricular dysfunction post myocardial infarction|left ventricular dysfunction post myocardial infarction
632537|NCT00507455|Lower Urinary Tract Symptoms|lower urinary tract symptoms
632538|NCT00507455|Bladder Outlet Obstruction|bladder outlet obstruction
632539|NCT00507455|Treatment|treatment
632540|NCT00507455|Solifenacin Succinate|solifenacin succinate
632541|NCT00507455|Tamsulosin hydrochloride|tamsulosin hydrochloride
632542|NCT00507442|Treatment for patients with multiple myeloma|treatment for patients with multiple myeloma
632543|NCT00507442|who have received no prior treatment|who have received no prior treatment
632544|NCT00507429|thyroid neoplasms|thyroid neoplasms
632545|NCT00507429|thyroid cancer|thyroid cancer
632546|NCT00507429|thyroid carcinoma|thyroid carcinoma
632547|NCT00507390|fish oils|fish oils
632548|NCT00507377|Esophageal Benign Disease|esophageal benign disease
632549|NCT00507377|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
632550|NCT00507377|Hiatal Hernia|hiatal hernia
632551|NCT00507377|Antireflux Surgery|antireflux surgery
632552|NCT00507377|Short Esophagus|short esophagus
632553|NCT00507351|Breast Cancer|breast cancer
632554|NCT00507351|Colorectal Cancer|colorectal cancer
632555|NCT00507351|Lung Cancer|lung cancer
632556|NCT00507351|Prostate Cancer|prostate cancer
632557|NCT00507351|Pain Management|pain management
632558|NCT00507351|Questionnaire|questionnaire
632559|NCT00507351|Survey|survey
632560|NCT00507338|percutaneous coronary intervention|percutaneous coronary intervention
632561|NCT00507325|Malignant Melanoma|malignant melanoma
632562|NCT00507325|Blood Sample|blood sample
632563|NCT00507325|Tumor Sample|tumor sample
632564|NCT00507325|Long-term storage|long-term storage
632565|NCT00507325|Sample Collection|sample collection
632666|NCT00506922|Leukemia|leukemia
632667|NCT00506922|Lymphoma|lymphoma
632566|NCT00507312|To assess two new diagnostic devices for detecting early Heart Failure.|to assess two new diagnostic devices for detecting early heart failure.
632567|NCT00507299|Child maltreatment|child maltreatment
632568|NCT00507299|Physician education|physician education
632569|NCT00507299|Prevention|prevention
632570|NCT00507273|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
632571|NCT00507273|Gastrointestinal Cancer|gastrointestinal cancer
632572|NCT00507273|GISTs|gists
632573|NCT00507273|GIST Registry|gist registry
632574|NCT00507273|Registry|registry
632575|NCT00507260|Leukemia|leukemia
632576|NCT00507260|Lymphoma|lymphoma
632577|NCT00507260|Post-Allogeneic Blood and Marrow Transplantation|post-allogeneic blood and marrow transplantation
632578|NCT00507260|Blood and Marrow Transplantation|blood and marrow transplantation
632579|NCT00507260|BMT|bmt
632580|NCT00507260|Cancer-Related Fatigue|cancer-related fatigue
632581|NCT00507260|Fatigue|fatigue
632582|NCT00507260|Nutritional Assessment|nutritional assessment
632583|NCT00507260|Nutritional Intervention|nutritional intervention
632584|NCT00507260|Malnutrition|malnutrition
632585|NCT00507247|Catheter-Related Infection|catheter-related infection
632586|NCT00507247|Bloodstream Infections|bloodstream infections
632587|NCT00507247|Staphylococcus Aureus|staphylococcus aureus
632588|NCT00507247|Daptomycin|daptomycin
632589|NCT00507234|COPD|copd
632590|NCT00507221|HIV|hiv
632591|NCT00507221|Helminthiasis|helminthiasis
632592|NCT00507221|Co-infection|co-infection
632593|NCT00507221|Treatment Naive|treatment naive
632594|NCT00507208|trismus|trismus
632595|NCT00507208|head and neck cancer|head and neck cancer
632596|NCT00507195|Postanethesia cognitive recovery|postanethesia cognitive recovery
632597|NCT00507195|Postoperative delirium|postoperative delirium
632598|NCT00507195|hypnotics|hypnotics
632599|NCT00507195|propofol|propofol
632600|NCT00507195|sevoflurane|sevoflurane
632601|NCT00507195|desflurane|desflurane
632602|NCT00507195|postoperative cognitive recovery|postoperative cognitive recovery
632603|NCT00507182|Oral Mucosa Lesions|oral mucosa lesions
632604|NCT00507182|Oral Cancer|oral cancer
632605|NCT00507182|Neoplasia and Dysplasia in oral cavity mucosa|neoplasia and dysplasia in oral cavity mucosa
632606|NCT00507182|Fluorescence Spectroscopy|fluorescence spectroscopy
632607|NCT00507182|Reflectance Spectroscopy|reflectance spectroscopy
632608|NCT00507182|Pre-cancerous lesions|pre-cancerous lesions
632609|NCT00507182|Cancerous lesions|cancerous lesions
632610|NCT00507182|Mouth|mouth
632611|NCT00507143|Colorectal neoplasms|colorectal neoplasms
632612|NCT00507143|Secondary|secondary
632613|NCT00507143|irinotecan|irinotecan
632614|NCT00507143|Pharmacokinetics|pharmacokinetics
632615|NCT00507143|Pharmacodynamics|pharmacodynamics
632616|NCT00507143|SLCO1B1|slco1b1
632617|NCT00507143|PXR|pxr
632618|NCT00507117|Obstructive Sleep Apnea|obstructive sleep apnea
632619|NCT00507117|Polysomnography|polysomnography
632620|NCT00507117|Non-benzodiazepine hypnotics|non-benzodiazepine hypnotics
632621|NCT00507104|traumatic brain injury|traumatic brain injury
632622|NCT00507104|Subarachnoid Hemorrhage|subarachnoid hemorrhage
632623|NCT00507104|Hypopituitarism|hypopituitarism
632624|NCT00507091|ZD6474|zd6474
632625|NCT00507091|Irinotecan|irinotecan
632626|NCT00507091|5-Fluorouracil|5-fluorouracil
632627|NCT00507091|Leucovorin|leucovorin
632628|NCT00507091|colorectal|colorectal
632629|NCT00507078|Obstructive Sleep Apnea|obstructive sleep apnea
632630|NCT00507078|Leptin|leptin
632631|NCT00507078|Homocysteine|homocysteine
632632|NCT00507078|C-reactive Protein|c-reactive protein
632633|NCT00507052|Hemodialysis|hemodialysis
632634|NCT00507052|Residual Renal Function|residual renal function
632635|NCT00507039|PD20 FEV1|pd20 fev1
632636|NCT00507039|grass pollen|grass pollen
632637|NCT00507039|one-step|one-step
632638|NCT00507013|vascular closure device|vascular closure device
632639|NCT00506974|sleep|sleep
632640|NCT00506974|normal sleepers|normal sleepers
632641|NCT00506948|Hematological Malignancies|hematological malignancies
632642|NCT00506948|Myelodysplastic Syndrome|myelodysplastic syndrome
632643|NCT00506948|Graft Versus Host Disease|graft versus host disease
632644|NCT00506948|GVHD|gvhd
632645|NCT00506948|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
632646|NCT00506948|AHSCT|ahsct
632647|NCT00506948|Leukemia|leukemia
632648|NCT00506948|Lymphoma|lymphoma
632649|NCT00506948|T-Cells|t-cells
632650|NCT00506948|Thymoglobulin|thymoglobulin
632651|NCT00506948|ATG|atg
632652|NCT00506948|rATG|ratg
632653|NCT00506948|Rabbit Antithymocyte Globulin|rabbit antithymocyte globulin
632654|NCT00506948|Rapamune|rapamune
632655|NCT00506948|Sirolimus|sirolimus
632656|NCT00506948|Mycophenolate Mofetil|mycophenolate mofetil
632657|NCT00506948|Cellcept|cellcept
632658|NCT00506948|MMF|mmf
632659|NCT00506935|methamphetamine|methamphetamine
632660|NCT00506935|GVG|gvg
632661|NCT00506935|vigabatrin|vigabatrin
632662|NCT00506935|stimulant|stimulant
632663|NCT00506922|Graft-Versus-Host Disease|graft-versus-host disease
632664|NCT00506922|GVHD Prevention|gvhd prevention
632665|NCT00506922|Hodgkin's Disease|hodgkin's disease
632668|NCT00506922|Methotrexate|methotrexate
632669|NCT00506922|Tacrolimus|tacrolimus
632670|NCT00506922|Pentostatin|pentostatin
632671|NCT00506909|oxytocin|oxytocin
632672|NCT00506896|Rheumatoid Arthritis|rheumatoid arthritis
632673|NCT00506896|glucocorticoid|glucocorticoid
632674|NCT00506896|intraarticular injection|intraarticular injection
632675|NCT00506896|arthritis|arthritis
632676|NCT00506870|Heart Valve Prosthesis Implantation|heart valve prosthesis implantation
632677|NCT00506870|INR self monitoring|inr self monitoring
632678|NCT00506870|cost benefit evaluation|cost benefit evaluation
632679|NCT00506857|Hematologic Malignancies|hematologic malignancies
632680|NCT00506857|Blood And Marrow Transplantation|blood and marrow transplantation
632681|NCT00506857|Leukemia|leukemia
632682|NCT00506857|MDS|mds
632683|NCT00506857|Lymphoma|lymphoma
632684|NCT00506857|Myeloma|myeloma
632685|NCT00506857|Fludarabine|fludarabine
632686|NCT00506857|Fludara|fludara
632687|NCT00506857|Fludarabine Phosphate|fludarabine phosphate
632688|NCT00506857|Busulfan|busulfan
632689|NCT00506857|Busulfex|busulfex
632690|NCT00506857|Myleran|myleran
632691|NCT00506857|Progenitor Cell Transplantation|progenitor cell transplantation
632692|NCT00506857|Granulocyte colony stimulating factor|granulocyte colony stimulating factor
632693|NCT00506857|G-CSF|g-csf
632694|NCT00506857|Apheresis|apheresis
632695|NCT00506857|Blood cell infusion|blood cell infusion
632696|NCT00506844|Rectal neoplasms|rectal neoplasms
632697|NCT00506844|Neoadjuvant treatment|neoadjuvant treatment
632698|NCT00506844|Cetuximab|cetuximab
632699|NCT00506844|Irinotecan|irinotecan
632700|NCT00506844|Capecitabine|capecitabine
632701|NCT00506844|Radiotherapy|radiotherapy
632702|NCT00506844|Combination chemotherapy|combination chemotherapy
632703|NCT00506818|emotional symptoms|emotional symptoms
632704|NCT00506818|vascular risk-factors|vascular risk-factors
632705|NCT00506805|solid tumor malignancy; Hsp90|solid tumor malignancy; hsp90
632706|NCT00506792|Cystic fibrosis, QAU145, nasal potential difference|cystic fibrosis, qau145, nasal potential difference
632707|NCT00506779|Uterine Papillary Serous Carcinoma|uterine papillary serous carcinoma
632708|NCT00506779|Uterine Cancer|uterine cancer
632709|NCT00506779|UPSC|upsc
632710|NCT00506779|Taxol|taxol
632711|NCT00506779|Paclitaxel|paclitaxel
632712|NCT00506779|Gleevec|gleevec
632713|NCT00506779|Imatinib Mesylate|imatinib mesylate
632714|NCT00506779|STI571|sti571
632715|NCT00506766|Urinary Incontinence|urinary incontinence
632716|NCT00506766|Self efficacy|self efficacy
632717|NCT00506766|Pelvic floor muscle training|pelvic floor muscle training
632718|NCT00506766|Bladder training|bladder training
632719|NCT00506753|substance abuse|substance abuse
632720|NCT00506714|Osteoarthritis|osteoarthritis
632721|NCT00506714|Walking Sticks|walking sticks
632722|NCT00506714|Canes|canes
632723|NCT00506675|Amblyopia|amblyopia
632724|NCT00506675|Atropine|atropine
632725|NCT00506675|Patching|patching
632726|NCT00506649|protocol|protocol
632727|NCT00506649|analgesia|analgesia
632728|NCT00506649|sedation|sedation
632729|NCT00506649|delirium|delirium
632730|NCT00506649|coma|coma
632731|NCT00506623|Rectal neoplasm|rectal neoplasm
632732|NCT00506623|Neoadjuvant therapy|neoadjuvant therapy
632733|NCT00506623|Radiotherapy|radiotherapy
632734|NCT00506623|Combination chemotherapy|combination chemotherapy
632735|NCT00506623|Irinotecan|irinotecan
632736|NCT00506623|Capecitabine|capecitabine
632737|NCT00506610|Pain|pain
632738|NCT00506610|Postherpetic Neuralgia|postherpetic neuralgia
632739|NCT00506610|Neuralgia, Postherpetic|neuralgia, postherpetic
632740|NCT00506610|Shingles|shingles
632741|NCT00506610|Herpes Zoster|herpes zoster
632742|NCT00506610|Neuropathic Pain|neuropathic pain
632743|NCT00506597|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
632744|NCT00506597|Leukemia|leukemia
632745|NCT00506597|Erwinia L-Asparaginase|erwinia l-asparaginase
632746|NCT00506597|Erwinase|erwinase
632747|NCT00506584|Human milk nutritional intervention|human milk nutritional intervention
632748|NCT00506584|Pre-term, very low birth weight|pre-term, very low birth weight
632749|NCT00506584|Fortification of human breast milk|fortification of human breast milk
632750|NCT00506571|colorectal neoplasms|colorectal neoplasms
632751|NCT00506571|secondary|secondary
632752|NCT00506571|Combination chemotherapy|combination chemotherapy
632753|NCT00506571|S-1|s-1
632754|NCT00506571|irinotecan|irinotecan
632755|NCT00506571|oxaliplatin|oxaliplatin
632756|NCT00506558|cervical spondylotic myelopathy|cervical spondylotic myelopathy
632757|NCT00506558|degenerative cervical spondylosis|degenerative cervical spondylosis
632758|NCT00506558|spinal fusion|spinal fusion
632759|NCT00506532|Pulmonary Surfactants|pulmonary surfactants
632760|NCT00506532|Lung transplantation|lung transplantation
632761|NCT00506532|Primary Graft Dysfunction|primary graft dysfunction
632762|NCT00506519|DIC associated with severe sepsis|dic associated with severe sepsis
632763|NCT00506506|N-acetylcysteine|n-acetylcysteine
632764|NCT00506506|Chronic kidney disease|chronic kidney disease
632765|NCT00506506|eGFR|egfr
632766|NCT00506506|Cystatin C|cystatin c
632767|NCT00506506|proteinuria|proteinuria
632768|NCT00506506|Stage 3 chronic kidney disease|stage 3 chronic kidney disease
632769|NCT00506493|Persistent Atrial Fibrillation Surgical RF Ablation|persistent atrial fibrillation surgical rf ablation
632770|NCT00506493|Perisistent Atrial Fibrillation|perisistent atrial fibrillation
632771|NCT00506493|Surgical Ablation|surgical ablation
632772|NCT00506480|Embryo Implantation|embryo implantation
632773|NCT00506480|Endometrium|endometrium
632774|NCT00506480|endometrial implantation|endometrial implantation
632775|NCT00506480|Oocyte Donation|oocyte donation
632776|NCT00506480|in vitro fertilization|in vitro fertilization
632777|NCT00506480|endometrial sampling|endometrial sampling
632778|NCT00506467|Intrathoracic Malignancy|intrathoracic malignancy
632779|NCT00506467|Lung Cancer|lung cancer
632780|NCT00506467|Vibration Response Imaging|vibration response imaging
632781|NCT00506467|VRI|vri
632782|NCT00506454|Fatigue|fatigue
632783|NCT00506454|Hemodialysis|hemodialysis
632784|NCT00506454|Endotoxemia|endotoxemia
632785|NCT00506454|Phospholipid|phospholipid
632786|NCT00506454|Emulsion|emulsion
632787|NCT00506441|Chronic Kidney Disease|chronic kidney disease
632788|NCT00506441|Dialysis|dialysis
632789|NCT00506441|Hyperphosphatemia|hyperphosphatemia
632790|NCT00506441|Phosphate binder|phosphate binder
632791|NCT00506428|aging|aging
632792|NCT00506428|sleep|sleep
632793|NCT00506428|sleep deprivation|sleep deprivation
632794|NCT00506428|performance|performance
632795|NCT00506428|memory|memory
632796|NCT00506428|metabolism|metabolism
632797|NCT00506415|Alzheimer's|alzheimer's
632798|NCT00506415|Patch|patch
632799|NCT00506415|Cognitive|cognitive
632800|NCT00506415|Decline|decline
632801|NCT00506402|Adult patients with refractory leukemias, MDS or AMM|adult patients with refractory leukemias, mds or amm
632802|NCT00506389|Sleep Initiation and Maintenance Disorders, Sleep Disorders, Intrinsic Dyssomnias, Sleep Disorders, Nervous System Diseases, Mental Disorders|sleep initiation and maintenance disorders, sleep disorders, intrinsic dyssomnias, sleep disorders, nervous system diseases, mental disorders
632803|NCT00506376|Cervical Cancer|cervical cancer
632804|NCT00506376|Hysterectomy|hysterectomy
632805|NCT00506376|Interview|interview
632806|NCT00506363|scar|scar
632807|NCT00506363|surgery|surgery
632808|NCT00506363|lasers|lasers
632809|NCT00506324|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
632810|NCT00506324|Chemotherapy|chemotherapy
632811|NCT00506324|Head and Neck Neoplasms|head and neck neoplasms
632812|NCT00506324|Dysphagia|dysphagia
632813|NCT00506311|Superficial Groin Dissection|superficial groin dissection
632814|NCT00506311|Melanoma|melanoma
632815|NCT00506311|Fibrin Tissue Adhesive|fibrin tissue adhesive
632816|NCT00506311|Fibrin Sealant|fibrin sealant
632817|NCT00506311|Tisseel|tisseel
632818|NCT00506311|Seroma|seroma
632819|NCT00506298|Diabetes|diabetes
632820|NCT00506298|CRx-401|crx-401
632821|NCT00506298|Bezafibrate|bezafibrate
632822|NCT00506298|Diflunisal|diflunisal
632823|NCT00506298|Metformin|metformin
632824|NCT00506298|plasma glucose|plasma glucose
632825|NCT00506285|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
632826|NCT00506285|ADHD|adhd
632827|NCT00506285|Adult|adult
632828|NCT00506285|Methylphenidate Transdermal System|methylphenidate transdermal system
632829|NCT00506285|Daytrana|daytrana
632830|NCT00506272|diabetes mellitus|diabetes mellitus
632831|NCT00506272|hyperglycemia|hyperglycemia
632832|NCT00506272|hypoglycemia|hypoglycemia
632833|NCT00506272|self care|self care
632834|NCT00506259|Deletion 17p11.2|deletion 17p11.2
632835|NCT00506259|Melatonin|melatonin
632836|NCT00506259|Phototherapy|phototherapy
632837|NCT00506259|Behavioral Phenotype|behavioral phenotype
632838|NCT00506259|Developmental Delay/MR|developmental delay/mr
632839|NCT00506259|Smith-Magenis Syndrome|smith-magenis syndrome
632840|NCT00506259|Sleep Disturbance|sleep disturbance
632841|NCT00506259|SMS|sms
632842|NCT00506259|Sleep Disorder|sleep disorder
632843|NCT00506246|anaesthesia|anaesthesia
632844|NCT00506233|Graft-Versus-Host Disease|graft-versus-host disease
632845|NCT00506233|GVHD|gvhd
632846|NCT00506233|Questionnaire|questionnaire
632847|NCT00506207|Gastrointestinal neoplasms|gastrointestinal neoplasms
632848|NCT00506207|Combination chemotherapy|combination chemotherapy
632849|NCT00506207|S-1|s-1
632850|NCT00506207|Irinotecan|irinotecan
632851|NCT00506207|Oxaliplatin|oxaliplatin
632852|NCT00506194|type 2 diabetes|type 2 diabetes
632853|NCT00506194|oral glucose tolerance test|oral glucose tolerance test
632854|NCT00506194|insulin|insulin
632855|NCT00506194|oral anti-diabetic drug|oral anti-diabetic drug
632856|NCT00506194|ß-cell function|ß-cell function
632857|NCT00506168|Colorectal neoplasms|colorectal neoplasms
632858|NCT00506168|Secondary|secondary
632859|NCT00506168|Drug therapy, combination|drug therapy, combination
632860|NCT00506168|Irinotecan|irinotecan
632861|NCT00506168|Capecitabine|capecitabine
632862|NCT00506155|Bladder Cancer|bladder cancer
632863|NCT00506155|Urothelial Cancer|urothelial cancer
632864|NCT00506155|Avastin|avastin
632865|NCT00506155|Bevacizumab|bevacizumab
632866|NCT00506155|Cisplatin|cisplatin
632867|NCT00506155|Doxorubicin|doxorubicin
632868|NCT00506155|Methotrexate|methotrexate
632869|NCT00506155|Vinblastine|vinblastine
632870|NCT00506155|M-VAC|m-vac
632871|NCT00506129|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
632872|NCT00506129|CTCL|ctcl
632873|NCT00506129|Allogeneic Transplantation|allogeneic transplantation
632874|NCT00506129|Lymphoma|lymphoma
632875|NCT00506129|Allogeneic peripheral blood progenitor cell|allogeneic peripheral blood progenitor cell
632876|NCT00506129|PBPC|pbpc
632877|NCT00506129|Bone Marrow transplantation|bone marrow transplantation
632878|NCT00506129|Stem Cell Transplant|stem cell transplant
632879|NCT00506129|SCT|sct
632880|NCT00506129|Fludarabine|fludarabine
632881|NCT00506129|Fludarabine Phosphate|fludarabine phosphate
632882|NCT00506129|Fludara|fludara
632883|NCT00506129|Melphalan|melphalan
632884|NCT00506116|Pelvic floor muscle training|pelvic floor muscle training
632885|NCT00506116|Self-directed pushing|self-directed pushing
632886|NCT00506116|Antenatal perineal massage|antenatal perineal massage
632887|NCT00506103|Thyroidectomy|thyroidectomy
632888|NCT00506103|Central neck dissection|central neck dissection
632889|NCT00506103|Harmonic scalpel|harmonic scalpel
632890|NCT00506103|Perioperative complications|perioperative complications
632892|NCT00506090|surgery|surgery
632893|NCT00506090|lasers|lasers
632894|NCT00506077|Undifferentiated schizophrenia|undifferentiated schizophrenia
632895|NCT00506077|residual schizophrenia|residual schizophrenia
632896|NCT00506064|Breast Cancer|breast cancer
632897|NCT00506064|Sleep|sleep
632898|NCT00506064|Melatonin|melatonin
632899|NCT00506064|Placebo|placebo
632900|NCT00506064|Survey|survey
632901|NCT00506064|Postoperative Srejic Sleep SAT Survey|postoperative srejic sleep sat survey
632902|NCT00506051|Non-small cell lung cancer|non-small cell lung cancer
632903|NCT00506051|lung cancer|lung cancer
632904|NCT00506051|alimta|alimta
632905|NCT00506051|vandetanib|vandetanib
632906|NCT00506051|phase 1|phase 1
632907|NCT00506038|Calcific Tendinitis|calcific tendinitis
632908|NCT00506025|Pregnancy|pregnancy
632909|NCT00506025|Cranberry|cranberry
632910|NCT00506025|Asymptomatic Bacteruria|asymptomatic bacteruria
632911|NCT00506012|Myoclonus Dystonia|myoclonus dystonia
632912|NCT00506012|Essential Myoclonus|essential myoclonus
632913|NCT00506012|Inherited Myoclonus|inherited myoclonus
632914|NCT00506012|Dyskinesia|dyskinesia
632915|NCT00506012|Movement Disorder|movement disorder
632916|NCT00505999|Multiple Myeloma|multiple myeloma
632917|NCT00505999|Etiology|etiology
632918|NCT00505999|Risk Factors|risk factors
632919|NCT00505999|Healthy Controls|healthy controls
632920|NCT00505999|Questionnaire|questionnaire
632921|NCT00505999|Survey|survey
632922|NCT00505947|macular edema|macular edema
632923|NCT00505947|diabetes mellitus|diabetes mellitus
632924|NCT00505947|visual loss|visual loss
632925|NCT00505947|diabetic retinopathy|diabetic retinopathy
632926|NCT00505947|macula|macula
632927|NCT00505947|maculopathy|maculopathy
632928|NCT00505947|infliximab|infliximab
632929|NCT00505934|Epilepsy|epilepsy
632930|NCT00505934|Child|child
632931|NCT00505934|Levetiracetam|levetiracetam
632932|NCT00505934|Keppra®|keppra®
632933|NCT00505934|Infusion|infusion
632934|NCT00505934|Intravenous|intravenous
632935|NCT00505921|T-Cell Lymphoma|t-cell lymphoma
632936|NCT00505921|Lymphoma|lymphoma
632937|NCT00505921|Campath-1H|campath-1h
632938|NCT00505921|Allogenic Transplantation|allogenic transplantation
632939|NCT00505921|Stem Cell Transplant|stem cell transplant
632940|NCT00505921|Alemtuzumab|alemtuzumab
632941|NCT00505895|Multiple Myeloma|multiple myeloma
632942|NCT00505895|Fludarabine|fludarabine
632943|NCT00505895|Fludara|fludara
632944|NCT00505895|Fludarabine Phosphate|fludarabine phosphate
632945|NCT00505895|Melphalan|melphalan
632946|NCT00505895|Alkeran|alkeran
632947|NCT00505895|Stem Cell Infusion|stem cell infusion
632948|NCT00505895|Stem Cell Transfusion|stem cell transfusion
632949|NCT00505895|SCT|sct
632950|NCT00505895|Allogeneic Peripheral Blood Stem Cell Transfusion|allogeneic peripheral blood stem cell transfusion
632951|NCT00505895|APBSCT|apbsct
632952|NCT00505895|Bone Marrow Transplantation|bone marrow transplantation
632953|NCT00505895|BMT|bmt
632954|NCT00505895|Rituxan|rituxan
632955|NCT00505895|Rituximab|rituximab
632956|NCT00505895|FM140|fm140
632957|NCT00505895|FM100|fm100
632958|NCT00505882|Type 1 diabetes|type 1 diabetes
632959|NCT00505882|Pramlintide|pramlintide
632960|NCT00505882|Weight gain|weight gain
632961|NCT00505882|Intensive insulin therapy|intensive insulin therapy
632962|NCT00505882|Beta cell|beta cell
632963|NCT00505869|Pregnant Smokers|pregnant smokers
632964|NCT00505869|Mood Management Intervention|mood management intervention
632965|NCT00505869|Health & Wellness Intervention|health & wellness intervention
632966|NCT00505869|Smoking Cessation|smoking cessation
632967|NCT00505869|Questionnaire|questionnaire
632968|NCT00505869|Survey|survey
632969|NCT00505830|Asperger Syndrom|asperger syndrom
632970|NCT00505830|Autism Quotient|autism quotient
632971|NCT00505830|French version|french version
632972|NCT00505830|screening|screening
632973|NCT00505830|diagnostic test|diagnostic test
632974|NCT00505830|accuracy|accuracy
632975|NCT00505804|dexmedetomidine|dexmedetomidine
632976|NCT00505804|haloperidol|haloperidol
632977|NCT00505791|Acute decompensated heart failure|acute decompensated heart failure
632978|NCT00505791|Normal left ventricular ejection fraction|normal left ventricular ejection fraction
632979|NCT00505791|Vasodilator therapy|vasodilator therapy
632980|NCT00505765|Cognition|cognition
632981|NCT00505765|Schizophrenia|schizophrenia
632982|NCT00505752|Assisted reproductive technology, follicle stimulating hormone|assisted reproductive technology, follicle stimulating hormone
632983|NCT00505739|Endometrial Cancer|endometrial cancer
632984|NCT00505739|Low Grade Endometrial Stromal Sarcoma|low grade endometrial stromal sarcoma
632985|NCT00505739|RU-486|ru-486
632986|NCT00505739|Mifepristone|mifepristone
632987|NCT00505739|LGESS|lgess
632988|NCT00505726|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
632989|NCT00505726|Cervical Cancer|cervical cancer
632990|NCT00505726|Reflectance Confocal Imaging|reflectance confocal imaging
632991|NCT00505726|Colposcopy|colposcopy
632992|NCT00505713|Sarcoma|sarcoma
632993|NCT00505713|Rexin-G|rexin-g
632994|NCT00505713|Gene Therapy|gene therapy
632995|NCT00505700|acute myeloid leukemia|acute myeloid leukemia
632996|NCT00505687|Rotigotine|rotigotine
632997|NCT00505687|Neupro®|neupro®
632998|NCT00505661|Ovarian Cancer|ovarian cancer
632999|NCT00505661|Fallopian Tube Cancer|fallopian tube cancer
633000|NCT00505661|Peritoneal Cancer|peritoneal cancer
633001|NCT00505661|Letrozole|letrozole
633002|NCT00505661|Femara|femara
633003|NCT00505648|Hypersensitivity|hypersensitivity
633004|NCT00505648|Syndrome|syndrome
633005|NCT00505648|Tegeline|tegeline
633006|NCT00505635|advanced stage IV melanoma|advanced stage iv melanoma
633007|NCT00505635|unresectable stage III melanoma|unresectable stage iii melanoma
633008|NCT00505635|Melanoma|melanoma
633009|NCT00505635|Temozolomide|temozolomide
633010|NCT00505635|Velban|velban
633011|NCT00505635|Vinblastine|vinblastine
633012|NCT00505635|Cisplatin|cisplatin
633013|NCT00505635|Interleukin-2|interleukin-2
633014|NCT00505635|Intron-A|intron-a
633015|NCT00505635|Interferon Alpha-2b|interferon alpha-2b
633016|NCT00505635|Thalidomide|thalidomide
633017|NCT00505635|Thalomid|thalomid
633018|NCT00505635|Temodar|temodar
633019|NCT00505635|Proleukin|proleukin
633020|NCT00505609|fertility awareness-based method|fertility awareness-based method
633021|NCT00505609|family planning|family planning
633022|NCT00505609|Standard Days Method|standard days method
633023|NCT00505609|Institute for Reproductive Health|institute for reproductive health
633024|NCT00505609|Efficacy|efficacy
633025|NCT00505609|CycleBeads|cyclebeads
633026|NCT00505596|Prenatal testing|prenatal testing
633027|NCT00505596|Decisionmaking|decisionmaking
633028|NCT00505596|Decision aid|decision aid
633029|NCT00505596|Informed choice|informed choice
633030|NCT00505570|Migraine|migraine
633031|NCT00505570|Migraine with aura|migraine with aura
633032|NCT00505570|Patent foramen ovale|patent foramen ovale
633033|NCT00505570|PFO|pfo
633034|NCT00505557|augmentation mammoplasty|augmentation mammoplasty
633035|NCT00505557|Dual plane|dual plane
633036|NCT00505557|Endoscope|endoscope
633037|NCT00505557|Transaxillary incision|transaxillary incision
633038|NCT00505544|Advanced Cancer|advanced cancer
633039|NCT00505544|Questionnaire|questionnaire
633040|NCT00505544|Survey|survey
633041|NCT00505544|Sleep Disturbance|sleep disturbance
633042|NCT00505544|Sleep Quality|sleep quality
633043|NCT00505531|Pain|pain
633044|NCT00505518|Major Depressive Disorder|major depressive disorder
633045|NCT00505518|Telepsychiatry|telepsychiatry
633046|NCT00505518|Chinese American|chinese american
633047|NCT00505518|Nursing Home|nursing home
633048|NCT00505505|Neurointensive care|neurointensive care
633049|NCT00505505|Intensive insulin infusion|intensive insulin infusion
633050|NCT00505505|Hypoglycemia|hypoglycemia
633051|NCT00505505|Postoperative Mortality|postoperative mortality
633052|NCT00505505|Postoperative Morbidity|postoperative morbidity
633053|NCT00505505|Neurologic outcome|neurologic outcome
633054|NCT00505492|Malignant Mixed Mesodermal Tumor|malignant mixed mesodermal tumor
633055|NCT00505492|MMMT|mmmt
633056|NCT00505492|Uterine Neoplasms|uterine neoplasms
633057|NCT00505492|Radiation Therapy|radiation therapy
633058|NCT00505492|Paclitaxel|paclitaxel
633059|NCT00505492|Carboplatin|carboplatin
633060|NCT00505492|Cisplatin|cisplatin
633061|NCT00505492|Taxol|taxol
633062|NCT00505479|Congenital Hypothyroidism|congenital hypothyroidism
633063|NCT00505479|pregnancy|pregnancy
633064|NCT00505479|iodine|iodine
633065|NCT00505479|deficiency|deficiency
633066|NCT00505466|Human Genetics|human genetics
633067|NCT00505466|Genetic Counseling|genetic counseling
633068|NCT00505466|Genetic Testing|genetic testing
633069|NCT00505466|p53 Mutation|p53 mutation
633070|NCT00505466|Genetics|genetics
633071|NCT00505453|Influenza|influenza
633072|NCT00505427|PCOS|pcos
633073|NCT00505427|polycystic ovary syndrome|polycystic ovary syndrome
633074|NCT00505427|polycystic ovarian syndrome|polycystic ovarian syndrome
633075|NCT00505427|alpha lipoic acid|alpha lipoic acid
633076|NCT00505427|insulin resistance|insulin resistance
633077|NCT00505427|oxidative stress|oxidative stress
633078|NCT00505414|Chronic Tumor Related Pain|chronic tumor related pain
633079|NCT00505414|Analgesic|analgesic
633080|NCT00505414|Tapentadol Extended Release|tapentadol extended release
633081|NCT00505414|Morphine Sulfate Controlled Release|morphine sulfate controlled release
633082|NCT00505414|Pain assessment|pain assessment
633083|NCT00505414|Placebo|placebo
633084|NCT00505401|HIV|hiv
633085|NCT00505401|Tat protein|tat protein
633086|NCT00505401|HIV Therapeutic Vaccine|hiv therapeutic vaccine
633087|NCT00505388|asthma|asthma
633088|NCT00505388|bronchial|bronchial
633089|NCT00505388|Symbicort|symbicort
633090|NCT00505375|CTLA4-Ig|ctla4-ig
633091|NCT00505375|Abatacept|abatacept
633092|NCT00505375|Beta-cell function|beta-cell function
633093|NCT00505375|T-cells|t-cells
633094|NCT00505375|DPT-1|dpt-1
633095|NCT00505375|treatment|treatment
633096|NCT00505375|treatment of type 1 diabetes|treatment of type 1 diabetes
633097|NCT00505375|new onset type 1 diabetes|new onset type 1 diabetes
633098|NCT00505375|juvenile diabetes|juvenile diabetes
633099|NCT00505375|T1D|t1d
633100|NCT00505375|diabetes mellitus|diabetes mellitus
633101|NCT00505375|Type 1 diabetes TrialNet|type 1 diabetes trialnet
633102|NCT00505375|TrialNet|trialnet
633103|NCT00505349|neurotrophic factors|neurotrophic factors
633104|NCT00505349|cognitive status|cognitive status
633105|NCT00505349|young adults|young adults
633106|NCT00505349|mature adults|mature adults
633107|NCT00505349|cognitive training|cognitive training
633108|NCT00505336|Diastolic heart failure|diastolic heart failure
633109|NCT00505336|Markers of collagen turnover|markers of collagen turnover
633110|NCT00505336|Statins|statins
633111|NCT00505336|Aldosterone receptor blockers|aldosterone receptor blockers
633112|NCT00505323|Cortex stimulation|cortex stimulation
633113|NCT00505323|Focal secondary Dystonia|focal secondary dystonia
633114|NCT00505323|Effectiveness|effectiveness
633115|NCT00505323|Quality of life improvement|quality of life improvement
633116|NCT00505323|Focal dystonias secondary to central grey nuclei lesions|focal dystonias secondary to central grey nuclei lesions
633117|NCT00505310|Kidney Cancer|kidney cancer
633118|NCT00505310|Renal Cell Carcinoma|renal cell carcinoma
633119|NCT00505310|Emotional Expression|emotional expression
633120|NCT00505310|Writing|writing
633121|NCT00505310|Questionnaire|questionnaire
633122|NCT00505310|Survey|survey
633123|NCT00505297|Osteoarthritis (OA)|osteoarthritis (oa)
633124|NCT00505297|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
633125|NCT00505297|delayed Gadolinium Enhanced MRI of cartilage (dGEMRIC)|delayed gadolinium enhanced mri of cartilage (dgemric)
633126|NCT00505297|disease modifying osteoarthritis drug (DMOAD)|disease modifying osteoarthritis drug (dmoad)
633127|NCT00505297|Potentially rapidly progressing osteoarthritis|potentially rapidly progressing osteoarthritis
633128|NCT00505297|MRI measurement of cartilage|mri measurement of cartilage
633129|NCT00505284|Diabetic neuropathy|diabetic neuropathy
633130|NCT00505271|Breast Cancer|breast cancer
633131|NCT00505271|Rexin-G|rexin-g
633132|NCT00505271|Gene Therapy|gene therapy
633133|NCT00505258|Bacteremia|bacteremia
633134|NCT00505258|Bloodstream infection|bloodstream infection
633135|NCT00505258|Staphylococcus aureus|staphylococcus aureus
633136|NCT00505258|Staphylococcal Infections|staphylococcal infections
633137|NCT00505258|MRSA|mrsa
633138|NCT00505258|MSSA|mssa
633139|NCT00505245|Advanced Cancer|advanced cancer
633140|NCT00505245|Symptom Distress|symptom distress
633141|NCT00505245|MDASI|mdasi
633142|NCT00505245|M.D. Anderson Symptom Inventory|m.d. anderson symptom inventory
633143|NCT00505245|Quality of Life|quality of life
633144|NCT00505245|Questionnaire|questionnaire
633145|NCT00505245|Interactive voice response telephone system|interactive voice response telephone system
633146|NCT00505245|IVR|ivr
633147|NCT00505232|Y-90 Ibritumomab tiuxetan|y-90 ibritumomab tiuxetan
633148|NCT00505232|Rituximab|rituximab
633149|NCT00505232|Hyper-CVAD|hyper-cvad
633150|NCT00505232|Mantle Cell Lymphoma Patients|mantle cell lymphoma patients
633151|NCT00505232|Zevalin(R)|zevalin(r)
633152|NCT00505219|Osteonecrosis|osteonecrosis
633153|NCT00505180|Hemodialysis|hemodialysis
633154|NCT00505180|Mortality|mortality
633155|NCT00505167|Alzheimer's disease|alzheimer's disease
633156|NCT00505167|Memantine|memantine
633157|NCT00505167|Donepezil|donepezil
633158|NCT00505167|Magnetic resonance Spectroscopy|magnetic resonance spectroscopy
633159|NCT00505167|randomized trial|randomized trial
633160|NCT00505154|Heart failure|heart failure
633161|NCT00505154|inflammation|inflammation
633162|NCT00505154|cytokines|cytokines
633163|NCT00505141|Childhood Brain Cancer|childhood brain cancer
633164|NCT00505141|Childhood Acute Lymphoblastic Leukemia|childhood acute lymphoblastic leukemia
633165|NCT00505128|Biliary pancreatitis|biliary pancreatitis
633166|NCT00505128|Bile duct stones|bile duct stones
633167|NCT00505128|EUS Endoscopic UltraSonography|eus endoscopic ultrasonography
633168|NCT00505128|Endoscopic sphincterotomy|endoscopic sphincterotomy
633169|NCT00505128|ERCP|ercp
633170|NCT00505102|Kidney Diseases|kidney diseases
633171|NCT00505102|Heart Transplantation|heart transplantation
633172|NCT00505102|Everolimus|everolimus
633173|NCT00505102|Cyclosporine Toxicity|cyclosporine toxicity
633174|NCT00505089|pharmacokinetic, pharmacodynamic, subcutaneous, intravenous, ACZ885, patients, rheumatoid, arthritis.|pharmacokinetic, pharmacodynamic, subcutaneous, intravenous, acz885, patients, rheumatoid, arthritis.
633175|NCT00505076|Cognition|cognition
633176|NCT00505076|Schizophrenia|schizophrenia
633177|NCT00505063|vaccine|vaccine
633178|NCT00505063|childhood|childhood
633179|NCT00505063|cancer|cancer
633180|NCT00505050|heart failure, disease program management, treatment, education|heart failure, disease program management, treatment, education
633181|NCT00505037|ASP1585|asp1585
633182|NCT00505037|Renal Dialysis|renal dialysis
633183|NCT00505037|Chronic Kidney Disease|chronic kidney disease
633184|NCT00505037|Hyperphosphatemia|hyperphosphatemia
633185|NCT00505024|Non-Small Cell Lung Cancer|non-small cell lung cancer
633186|NCT00505024|Esophageal Cancer|esophageal cancer
633187|NCT00505024|Lung Cancer|lung cancer
633188|NCT00505024|Interactive Voice Response System|interactive voice response system
633189|NCT00505024|IVRS|ivrs
633190|NCT00505011|susceptibility|susceptibility
633191|NCT00505011|genes|genes
633192|NCT00505011|environment|environment
633193|NCT00505011|ophthalmopathy|ophthalmopathy
633194|NCT00505011|outcome|outcome
633195|NCT00504998|Pancreatic cancer|pancreatic cancer
633196|NCT00504998|Rexin-G|rexin-g
633197|NCT00504998|Treatment|treatment
633198|NCT00504985|Advanced Cancer|advanced cancer
633199|NCT00504985|Hematologic Malignancy|hematologic malignancy
633200|NCT00504985|Fatigue|fatigue
633201|NCT00504985|Emergency Center|emergency center
633202|NCT00504985|Survey|survey
633203|NCT00504959|Age-related macular degeneration (AMD),|age-related macular degeneration (amd),
633204|NCT00504959|choroidal neovascularization (CNV),|choroidal neovascularization (cnv),
633205|NCT00504959|vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
633206|NCT00504946|allergen immunotherapy premedication|allergen immunotherapy premedication
633207|NCT00504933|Rhinitis|rhinitis
633208|NCT00504933|Allergic|allergic
633209|NCT00504933|Seasonal|seasonal
633210|NCT00504933|Hay Fever|hay fever
633211|NCT00504933|Pollen Allergy|pollen allergy
633212|NCT00504933|Pollinosis|pollinosis
633213|NCT00504933|Rhinoconjunctivitis|rhinoconjunctivitis
633214|NCT00504920|Leukemia|leukemia
633215|NCT00504920|Myelodysplastic Syndrome|myelodysplastic syndrome
633216|NCT00504920|Acute Myeloblastic Leukemia|acute myeloblastic leukemia
633217|NCT00504920|Symptom-Related Cytokines|symptom-related cytokines
633218|NCT00504920|Blood or Marrow Transplantation|blood or marrow transplantation
633219|NCT00504920|Questionnaire|questionnaire
633220|NCT00504907|RSV|rsv
633221|NCT00504894|N/A healthy volunteers|n/a healthy volunteers
633222|NCT00504881|Epilepsy|epilepsy
633223|NCT00504881|Brivaracetam|brivaracetam
633224|NCT00504881|Partial Onset Seizures|partial onset seizures
633225|NCT00504855|Pressure ulcer|pressure ulcer
633226|NCT00504855|Waterproof|waterproof
633227|NCT00504855|Gortex|gortex
633228|NCT00504855|Cast padding|cast padding
633229|NCT00504855|Pediatric|pediatric
633230|NCT00504855|Heel|heel
633231|NCT00504842|Acute Ischemic Stroke|acute ischemic stroke
633232|NCT00504842|Microbubbles|microbubbles
633233|NCT00504842|Transcranial Doppler ultrasound|transcranial doppler ultrasound
633234|NCT00504842|TIBI|tibi
633235|NCT00504842|Symptomatic Intracranial Hemorrhage|symptomatic intracranial hemorrhage
633236|NCT00504842|modified Rankin Scale|modified rankin scale
633237|NCT00504842|Recanalization|recanalization
633238|NCT00504842|Perflutren|perflutren
633239|NCT00504829|LCP-AtorFen|lcp-atorfen
633240|NCT00504829|Non-HDL cholesterol|non-hdl cholesterol
633241|NCT00504829|Triglycerides|triglycerides
633242|NCT00504829|HDL cholesterol|hdl cholesterol
633243|NCT00504829|LDL cholesterol|ldl cholesterol
633244|NCT00504829|Atorvastatin|atorvastatin
633245|NCT00504829|Fenofibrate|fenofibrate
633246|NCT00504816|healthy female,|healthy female,
633247|NCT00504816|pharmacokinetics,|pharmacokinetics,
633248|NCT00504816|pharmacodynamics|pharmacodynamics
633249|NCT00504816|drug interaction,|drug interaction,
633250|NCT00504803|HCT, nonmyeloablative, mesenchymal stem cells, GVHD|hct, nonmyeloablative, mesenchymal stem cells, gvhd
633251|NCT00504790|GSK923295,|gsk923295,
633252|NCT00504790|First Time in Human,|first time in human,
633253|NCT00504790|pharmacodynamics|pharmacodynamics
633254|NCT00504790|cancer,|cancer,
633255|NCT00504790|maximally tolerated dose, pharmacokinetics,|maximally tolerated dose, pharmacokinetics,
633256|NCT00504790|Refractory Cancer|refractory cancer
633257|NCT00504790|CENPE,|cenpe,
633258|NCT00504790|Phase I,|phase i,
633259|NCT00504764|Relapsed Acute Promyelocytic Leukemia|relapsed acute promyelocytic leukemia
633260|NCT00504764|Arsenic Trioxide|arsenic trioxide
633261|NCT00504751|diffuse large b cell|diffuse large b cell
633262|NCT00504738|lung disease|lung disease
633263|NCT00504738|chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
633264|NCT00504738|asthma|asthma
633265|NCT00504738|smokers|smokers
633266|NCT00504738|non-smokers|non-smokers
633267|NCT00504725|Lobectomy|lobectomy
633268|NCT00504725|VATS|vats
633269|NCT00504712|Testosterone|testosterone
633270|NCT00504712|Hypogonadism|hypogonadism
633271|NCT00504712|Diabetes|diabetes
633272|NCT00504712|PVD|pvd
633273|NCT00504712|RCT|rct
633274|NCT00504699|breast cancer|breast cancer
633275|NCT00504699|ovarian stimulation|ovarian stimulation
633276|NCT00504699|aromatase inhibitors|aromatase inhibitors
633277|NCT00504699|letrozole|letrozole
633278|NCT00504699|fertility preservation|fertility preservation
633279|NCT00504699|recurrence|recurrence
633280|NCT00504660|Anaplastic Glioma|anaplastic glioma
633281|NCT00504660|Glioblastoma Multiforme|glioblastoma multiforme
633282|NCT00504660|Brain Cancer|brain cancer
633283|NCT00504660|6-Thioguanine|6-thioguanine
633284|NCT00504660|Capecitabine|capecitabine
633285|NCT00504660|Celecoxib|celecoxib
633286|NCT00504660|Temozolomide|temozolomide
633287|NCT00504660|Xeloda|xeloda
633288|NCT00504660|Temodar|temodar
633289|NCT00504660|TMZ|tmz
633290|NCT00504660|CCNU|ccnu
633291|NCT00504660|6-TG|6-tg
633292|NCT00504647|Hypertrophic|hypertrophic
633293|NCT00504647|Cardiomyopathy|cardiomyopathy
633294|NCT00504647|Diastolic|diastolic
633295|NCT00504647|Ventricular|ventricular
633296|NCT00504647|Interaction|interaction
633297|NCT00504647|Biventricular|biventricular
633298|NCT00504647|Pacemaker|pacemaker
633299|NCT00504634|Multiple Myeloma|multiple myeloma
633300|NCT00504634|Post Allogeneic Transplantation|post allogeneic transplantation
633301|NCT00504634|Bortezomib|bortezomib
633302|NCT00504634|Velcade|velcade
633303|NCT00504634|PS-341|ps-341
633304|NCT00504621|personality|personality
633305|NCT00504621|fatigue|fatigue
633306|NCT00504621|quality of life|quality of life
633307|NCT00504621|health care consumption|health care consumption
633308|NCT00504595|Rheumatoid Arthritis|rheumatoid arthritis
633309|NCT00504582|Axillary Node Dissection|axillary node dissection
633310|NCT00504582|Fibrin Sealant|fibrin sealant
633311|NCT00504582|Tisseel|tisseel
633312|NCT00504582|Melanoma|melanoma
633313|NCT00504582|Seroma|seroma
633314|NCT00504556|Anti-coagulant|anti-coagulant
633315|NCT00504556|Non-valvular|non-valvular
633316|NCT00504556|Venous Thromboembolism|venous thromboembolism
633317|NCT00504556|Prevention of Blood Clots|prevention of blood clots
633318|NCT00504556|Atrial Fibrillation|atrial fibrillation
633319|NCT00504556|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
633320|NCT00504543|Kidney transplant, AEB071|kidney transplant, aeb071
633321|NCT00504517|Outpatient continuity training|outpatient continuity training
633322|NCT00504517|Relevant, Patient-centered curriculum|relevant, patient-centered curriculum
633323|NCT00504517|Evaluation|evaluation
633324|NCT00504517|New graduation requirements|new graduation requirements
633325|NCT00504504|Hodgkin's Disease|hodgkin's disease
633326|NCT00504504|Lymphoma|lymphoma
633327|NCT00504504|Rituximab|rituximab
633328|NCT00504504|Rituxan|rituxan
633329|NCT00504504|Adriamycin|adriamycin
633330|NCT00504504|Doxorubicin|doxorubicin
633331|NCT00504504|Rubex|rubex
633332|NCT00504504|Bleomycin|bleomycin
633333|NCT00504504|Bleomycin sulfate|bleomycin sulfate
633334|NCT00504504|Blenoxane|blenoxane
633335|NCT00504504|BLM|blm
633336|NCT00504504|Dacarbazine|dacarbazine
633337|NCT00504504|DTIC|dtic
633338|NCT00504504|DTIC-Dome|dtic-dome
633339|NCT00504504|Vincristine|vincristine
633340|NCT00504504|Vinblastine|vinblastine
633341|NCT00504504|Vinblastine Sulfate|vinblastine sulfate
633342|NCT00504504|ABVD|abvd
633343|NCT00504504|ABVD Chemotherapy Treatment|abvd chemotherapy treatment
633344|NCT00504491|Rituximab-CHOP|rituximab-chop
633345|NCT00504491|Alemtuzumab|alemtuzumab
633346|NCT00504491|Chronic lymphocytic leukaemia|chronic lymphocytic leukaemia
633347|NCT00504478|Inflammation|inflammation
633348|NCT00504478|carbohydrates|carbohydrates
633349|NCT00504478|omega-3|omega-3
633350|NCT00504478|overweight|overweight
633351|NCT00504478|diet|diet
633352|NCT00504465|Labor|labor
633353|NCT00504465|Labor induction|labor induction
633354|NCT00504465|Cervical ripening|cervical ripening
633355|NCT00504465|Dinoprostone|dinoprostone
633356|NCT00504465|Fetal safety|fetal safety
633357|NCT00504465|Oxytocin|oxytocin
633358|NCT00504465|Cesarean delivery|cesarean delivery
633359|NCT00504452|HIV|hiv
633360|NCT00504452|viral|viral
633361|NCT00504452|Viral decay acceleration|viral decay acceleration
633362|NCT00504452|ART|art
633363|NCT00504452|HAART|haart
633364|NCT00504452|Treatment Experienced|treatment experienced
633365|NCT00504439|COPD,|copd,
633366|NCT00504439|CD11b,|cd11b,
633367|NCT00504439|CXCR2,|cxcr2,
633368|NCT00504439|safety,|safety,
633369|NCT00504439|repeat dose,|repeat dose,
633370|NCT00504439|tolerability.|tolerability.
633371|NCT00504439|SB-656933,|sb-656933,
633372|NCT00504413|Metabolic Networks and Pathways|metabolic networks and pathways
633373|NCT00504413|Methadone|methadone
633374|NCT00504413|Polymorphism, genetic|polymorphism, genetic
633375|NCT00504413|Cytochrome P-450 Enzyme System|cytochrome p-450 enzyme system
633376|NCT00504400|macular telangiectasia|macular telangiectasia
633377|NCT00504400|parafoveal telangiectasis|parafoveal telangiectasis
633378|NCT00504400|nonproliferative|nonproliferative
633379|NCT00504400|therapy|therapy
633380|NCT00504400|intravitreal injection|intravitreal injection
633381|NCT00504400|ranibizumab|ranibizumab
633382|NCT00504400|lucentis|lucentis
633383|NCT00504387|Burning mouth disorder|burning mouth disorder
633384|NCT00504387|Taste disorder|taste disorder
633385|NCT00504387|Quantitative sensory testing|quantitative sensory testing
633386|NCT00504387|Gustatory testing|gustatory testing
633387|NCT00504387|Neuropathic orofacial pain|neuropathic orofacial pain
633388|NCT00504387|Oral burning|oral burning
633389|NCT00504374|Lung Cancer|lung cancer
633390|NCT00504374|Epidemiology|epidemiology
633391|NCT00504374|Symptoms|symptoms
633392|NCT00504374|Gene Polymorphisms|gene polymorphisms
633393|NCT00504374|Questionnaire|questionnaire
633394|NCT00504374|Survey|survey
633395|NCT00504361|Asthma|asthma
633396|NCT00504361|COPD|copd
633397|NCT00504361|Interstitial Lung Disease|interstitial lung disease
633398|NCT00504361|Cystic Fibrosis|cystic fibrosis
633399|NCT00504361|Lung Cancer|lung cancer
633400|NCT00504361|smokers|smokers
633401|NCT00504361|non-smokers|non-smokers
633402|NCT00504348|Interstitial pneumonitis|interstitial pneumonitis
633403|NCT00504348|Polymyositis|polymyositis
633404|NCT00504348|Dermatomyositis|dermatomyositis
633405|NCT00504348|Tacrolimus|tacrolimus
633406|NCT00504348|Corticosteroids|corticosteroids
633407|NCT00504335|Acute Radiation Syndrome|acute radiation syndrome
633408|NCT00504335|Hematopoietic Syndrome|hematopoietic syndrome
633409|NCT00504335|Radiation Injury|radiation injury
633410|NCT00504335|BIO 300|bio 300
633411|NCT00504322|Esophageal Neoplasms|esophageal neoplasms
633412|NCT00504309|triglycerides|triglycerides
633413|NCT00504309|hypertriglyceridemia|hypertriglyceridemia
633414|NCT00504309|omega-3|omega-3
633415|NCT00504309|n-3|n-3
633416|NCT00504309|eicosapentaenoic acid|eicosapentaenoic acid
633417|NCT00504309|EPA|epa
633418|NCT00504309|docosahexaenoic acid|docosahexaenoic acid
633419|NCT00504309|DHA|dha
633420|NCT00504309|flow mediated dilation|flow mediated dilation
633421|NCT00504309|fish|fish
633422|NCT00504309|Moderate hypertriglyceridemia|moderate hypertriglyceridemia
633423|NCT00504296|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
633424|NCT00504283|Renal colic, pain, protocol, emergency department|renal colic, pain, protocol, emergency department
633425|NCT00504257|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
633426|NCT00504257|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
633427|NCT00504257|recurrent fallopian tube cancer|recurrent fallopian tube cancer
633428|NCT00504244|SLE|sle
633429|NCT00504244|SLEDAI|sledai
633430|NCT00504244|Azathioprine|azathioprine
633431|NCT00504244|Myfortic|myfortic
633432|NCT00504231|influenza|influenza
633433|NCT00504231|prevention|prevention
633434|NCT00504231|intradermal|intradermal
633435|NCT00504231|vaccine|vaccine
633436|NCT00504231|delivery|delivery
633437|NCT00504231|elderly|elderly
633438|NCT00504218|Growth Factor|growth factor
633439|NCT00504218|Hypothalamic-Pituitary Dysfunction|hypothalamic-pituitary dysfunction
633440|NCT00504218|Primary Disorders of the Thyroid|primary disorders of the thyroid
633441|NCT00504218|Decreased Bone Mineral Density|decreased bone mineral density
633442|NCT00504218|Endocrine Side Effects Related to Cancer Therapy|endocrine side effects related to cancer therapy
633443|NCT00504218|Primary Gonadal Dysfunction|primary gonadal dysfunction
633444|NCT00504218|Obesity|obesity
633445|NCT00504218|Impaired Glucose Tolerance|impaired glucose tolerance
633446|NCT00504218|Thyroid Disorder|thyroid disorder
633447|NCT00504218|Cancer Therapy Endocrine Side Effects|cancer therapy endocrine side effects
633448|NCT00504218|Pituitary Dysfunction|pituitary dysfunction
633449|NCT00504218|Childhood Cancer Survivors|childhood cancer survivors
633450|NCT00504205|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
633451|NCT00504205|anaplastic large cell lymphoma|anaplastic large cell lymphoma
633452|NCT00504205|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
633453|NCT00504205|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
633454|NCT00504205|intraocular lymphoma|intraocular lymphoma
633455|NCT00504205|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
633456|NCT00504205|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
633457|NCT00504205|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
633458|NCT00504205|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
633459|NCT00504205|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
633460|NCT00504205|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
633461|NCT00504205|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
633462|NCT00504205|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
633463|NCT00504205|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
633464|NCT00504205|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
633465|NCT00504205|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
633543|NCT00504036|Obesity|obesity
633466|NCT00504205|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
633467|NCT00504205|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
633468|NCT00504205|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
633469|NCT00504205|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
633470|NCT00504205|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
633471|NCT00504205|splenic marginal zone lymphoma|splenic marginal zone lymphoma
633472|NCT00504205|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
633473|NCT00504205|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
633474|NCT00504205|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
633475|NCT00504205|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
633476|NCT00504205|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
633477|NCT00504205|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
633478|NCT00504205|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
633479|NCT00504205|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
633480|NCT00504205|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
633481|NCT00504205|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
633482|NCT00504205|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
633483|NCT00504205|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
633484|NCT00504205|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
633485|NCT00504205|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
633486|NCT00504205|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
633487|NCT00504205|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
633488|NCT00504205|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
633489|NCT00504205|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
633490|NCT00504205|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
633491|NCT00504205|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
633492|NCT00504205|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
633493|NCT00504205|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
633494|NCT00504205|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
633495|NCT00504205|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
633496|NCT00504205|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
633497|NCT00504205|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
633498|NCT00504205|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
633499|NCT00504205|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
633500|NCT00504205|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
633501|NCT00504205|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
633502|NCT00504205|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
633503|NCT00504205|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
633504|NCT00504205|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
633622|NCT00503854|Fatigue|fatigue
633505|NCT00504205|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
633506|NCT00504179|coronary artery bypass graft|coronary artery bypass graft
633507|NCT00504179|osteopathic manipulative treatment|osteopathic manipulative treatment
633508|NCT00504179|cardiovascular disease|cardiovascular disease
633509|NCT00504140|Osteosarcoma|osteosarcoma
633510|NCT00504140|Interferon Alpha|interferon alpha
633511|NCT00504140|IFN-|ifn-
633512|NCT00504140|Roferon|roferon
633513|NCT00504140|Recombinant Interferon Alpha|recombinant interferon alpha
633514|NCT00504140|Etoposide|etoposide
633515|NCT00504140|VP-16|vp-16
633516|NCT00504127|Arthritis|arthritis
633517|NCT00504127|Degenerative|degenerative
633518|NCT00504114|Osteoarthritis, knee|osteoarthritis, knee
633519|NCT00504114|anterior cruciate ligament|anterior cruciate ligament
633520|NCT00504114|Magnetic Resonance Imaging|magnetic resonance imaging
633521|NCT00504101|stage I multiple myeloma|stage i multiple myeloma
633522|NCT00504101|stage II multiple myeloma|stage ii multiple myeloma
633523|NCT00504101|stage III multiple myeloma|stage iii multiple myeloma
633524|NCT00504088|CLI|cli
633525|NCT00504088|Critical Limb Ischemia|critical limb ischemia
633526|NCT00504088|PAD|pad
633527|NCT00504088|Peripheral Arterial Disease|peripheral arterial disease
633528|NCT00504088|Artherosclerosis|artherosclerosis
633529|NCT00504088|Leg Pain|leg pain
633530|NCT00504088|Cardiovascular|cardiovascular
633531|NCT00504088|Artherectomy|artherectomy
633532|NCT00504088|Bypass|bypass
633533|NCT00504088|Peripheral Bypass|peripheral bypass
633534|NCT00504088|PROOF|proof
633535|NCT00504075|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
633536|NCT00504075|Bleeding disorders|bleeding disorders
633537|NCT00504075|Immune System and Disorders|immune system and disorders
633538|NCT00504062|asthma|asthma
633539|NCT00504062|bronchial|bronchial
633540|NCT00504049|Cerebral Palsy|cerebral palsy
633541|NCT00504049|Electromyography|electromyography
633542|NCT00504049|Wavelet Analysis|wavelet analysis
633544|NCT00504036|Morbid obesity|morbid obesity
633545|NCT00504036|Gastric balloon|gastric balloon
633546|NCT00504036|Gastric by-pass|gastric by-pass
633547|NCT00504036|Morbid obesity with BMI > 45 kg/m²|morbid obesity with bmi > 45 kg/m²
633548|NCT00504023|Paget disease of the vulva|paget disease of the vulva
633549|NCT00504023|recurrent vulvar cancer|recurrent vulvar cancer
633550|NCT00504023|stage 0 vulvar cancer|stage 0 vulvar cancer
633551|NCT00504023|stage I vulvar cancer|stage i vulvar cancer
633552|NCT00504023|stage II vulvar cancer|stage ii vulvar cancer
633553|NCT00504023|stage III vulvar cancer|stage iii vulvar cancer
633554|NCT00504023|imiquimod|imiquimod
633555|NCT00504023|07-029|07-029
633556|NCT00504010|arnica|arnica
633557|NCT00504010|muscle soreness|muscle soreness
633558|NCT00504010|exercise|exercise
633559|NCT00504010|eccentric|eccentric
633560|NCT00503997|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
633561|NCT00503997|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
633562|NCT00503997|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
633563|NCT00503997|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
633564|NCT00503997|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
633565|NCT00503997|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
633566|NCT00503997|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
633567|NCT00503997|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
633568|NCT00503997|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
633569|NCT00503997|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
633570|NCT00503997|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
633571|NCT00503984|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
633572|NCT00503984|Recurrent prostate cancer|recurrent prostate cancer
633573|NCT00503984|Stage IV prostate cancer|stage iv prostate cancer
633574|NCT00503984|Pain|pain
633575|NCT00503971|Vorinostat|vorinostat
633576|NCT00503971|NSCLC|nsclc
633577|NCT00503971|EGFR|egfr
633578|NCT00503971|Erlotinib|erlotinib
633579|NCT00503958|non-small cell lung cancer|non-small cell lung cancer
633580|NCT00503958|small cell lung cancer|small cell lung cancer
633581|NCT00503958|health status unknown|health status unknown
633582|NCT00503945|sleep apnea|sleep apnea
633583|NCT00503945|continuous positive airway pressure|continuous positive airway pressure
633584|NCT00503945|echocardiography|echocardiography
633585|NCT00503945|Natriuretic peptide|natriuretic peptide
633586|NCT00503932|Rectal Cancer|rectal cancer
633587|NCT00503932|Capecitabine|capecitabine
633588|NCT00503932|Proton Therapy|proton therapy
633589|NCT00503932|Adenocarcinoma of the rectum|adenocarcinoma of the rectum
633590|NCT00503932|Gastrointestinal|gastrointestinal
633591|NCT00503932|Proton Radiotherapy|proton radiotherapy
633592|NCT00503919|Cervix|cervix
633593|NCT00503919|Cervical dysplasia|cervical dysplasia
633594|NCT00503919|Cervical neoplasia|cervical neoplasia
633595|NCT00503919|Cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
633596|NCT00503919|Multi-spectral Digital Colposcopy|multi-spectral digital colposcopy
633597|NCT00503919|MDC|mdc
633598|NCT00503919|Acetic acid|acetic acid
633599|NCT00503919|Colposcopy|colposcopy
633600|NCT00503919|Spectroscopy|spectroscopy
633601|NCT00503919|Fluorescence Spectroscopy|fluorescence spectroscopy
633602|NCT00503919|Abnormal Pap Smear|abnormal pap smear
633603|NCT00503906|stage IV breast cancer|stage iv breast cancer
633604|NCT00503906|recurrent breast cancer|recurrent breast cancer
633605|NCT00503893|Wilms' Tumor|wilms' tumor
633606|NCT00503893|Genitourinary Anomalies|genitourinary anomalies
633607|NCT00503893|Beckwith-Wiedemann Hemihypertrophy|beckwith-wiedemann hemihypertrophy
633608|NCT00503893|Aniridia|aniridia
633609|NCT00503893|Questionnaire|questionnaire
633610|NCT00503880|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
633611|NCT00503880|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
633612|NCT00503880|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
633613|NCT00503867|unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
633614|NCT00503867|HCC|hcc
633615|NCT00503867|SIR-Spheres|sir-spheres
633616|NCT00503867|Y-90 Microspheres|y-90 microspheres
633617|NCT00503867|brachytherapy|brachytherapy
633618|NCT00503867|SIRT|sirt
633619|NCT00503867|liver cancer|liver cancer
633620|NCT00503854|Solid Tumors|solid tumors
633621|NCT00503854|Febrile Neutropenia|febrile neutropenia
633623|NCT00503854|Symptom Burden|symptom burden
633624|NCT00503854|Questionnaire|questionnaire
633625|NCT00503854|Survey|survey
633626|NCT00503841|stage I breast cancer|stage i breast cancer
633627|NCT00503841|recurrent breast cancer|recurrent breast cancer
633628|NCT00503841|stage II breast cancer|stage ii breast cancer
633629|NCT00503841|stage IIIA breast cancer|stage iiia breast cancer
633630|NCT00503841|stage IIIB breast cancer|stage iiib breast cancer
633631|NCT00503841|stage IIIC breast cancer|stage iiic breast cancer
633632|NCT00503828|Derris Scandens Benth extract|derris scandens benth extract
633633|NCT00503828|Osteoarthritis|osteoarthritis
633634|NCT00503828|WOMAC|womac
633635|NCT00503828|6-minute walk|6-minute walk
633636|NCT00503815|colonoscopy|colonoscopy
633637|NCT00503815|bowel preparation|bowel preparation
633638|NCT00503815|prep|prep
633639|NCT00503802|Sleep Apnea|sleep apnea
633640|NCT00503802|Sleep disordered breathing|sleep disordered breathing
633641|NCT00503802|Nasal Obstruction|nasal obstruction
633642|NCT00503802|Turbinate|turbinate
633643|NCT00503802|Radiofrequency|radiofrequency
633644|NCT00503802|Continuous positive airway pressure|continuous positive airway pressure
633645|NCT00503802|CPAP|cpap
633646|NCT00503802|Sleep surgery|sleep surgery
633647|NCT00503789|Healthy infants|healthy infants
633648|NCT00503776|xerostomia|xerostomia
633649|NCT00503776|mucositis|mucositis
633650|NCT00503776|dysphagia|dysphagia
633651|NCT00503776|radiation toxicity|radiation toxicity
633652|NCT00503776|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
633653|NCT00503776|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
633654|NCT00503776|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
633655|NCT00503776|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
633656|NCT00503776|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
633657|NCT00503776|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
633658|NCT00503776|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
633659|NCT00503776|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
633660|NCT00503776|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
633661|NCT00503776|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
633662|NCT00503776|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
633663|NCT00503776|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
633664|NCT00503776|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
633665|NCT00503776|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
633666|NCT00503776|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
633667|NCT00503776|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
633668|NCT00503776|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
633669|NCT00503776|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
633670|NCT00503776|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
633671|NCT00503776|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
633672|NCT00503776|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
633673|NCT00503776|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
633674|NCT00503776|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
633675|NCT00503776|stage III salivary gland cancer|stage iii salivary gland cancer
633676|NCT00503776|stage IV salivary gland cancer|stage iv salivary gland cancer
633677|NCT00503776|recurrent salivary gland cancer|recurrent salivary gland cancer
633678|NCT00503763|Smoldering multiple myeloma|smoldering multiple myeloma
633679|NCT00503763|Simvastatin|simvastatin
633680|NCT00503763|Paraprotein|paraprotein
633681|NCT00503750|Breast Cancer|breast cancer
633682|NCT00503737|colorectal cancer screening|colorectal cancer screening
633683|NCT00503737|National Colorectal Cancer Roundtable Toolbox|national colorectal cancer roundtable toolbox
633684|NCT00503724|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
633685|NCT00503724|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
633686|NCT00503724|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
633687|NCT00503724|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
633688|NCT00503724|childhood choroid plexus tumor|childhood choroid plexus tumor
633689|NCT00503724|childhood craniopharyngioma|childhood craniopharyngioma
633690|NCT00503724|childhood infratentorial ependymoma|childhood infratentorial ependymoma
633691|NCT00503724|childhood supratentorial ependymoma|childhood supratentorial ependymoma
633692|NCT00503724|recurrent childhood ependymoma|recurrent childhood ependymoma
633693|NCT00503724|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
633694|NCT00503724|childhood oligodendroglioma|childhood oligodendroglioma
633695|NCT00503724|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
633696|NCT00503724|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
633697|NCT00503724|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
633698|NCT00503724|childhood grade I meningioma|childhood grade i meningioma
633699|NCT00503724|childhood grade II meningioma|childhood grade ii meningioma
633700|NCT00503724|childhood grade III meningioma|childhood grade iii meningioma
633701|NCT00503724|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
633702|NCT00503724|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
633703|NCT00503724|recurrent childhood brain tumor|recurrent childhood brain tumor
633704|NCT00503724|disseminated neuroblastoma|disseminated neuroblastoma
633705|NCT00503724|recurrent neuroblastoma|recurrent neuroblastoma
633706|NCT00503711|ZD6474 PK|zd6474 pk
633707|NCT00503685|Metastatic Colorectal Cancer with Disease Progression|metastatic colorectal cancer with disease progression
633708|NCT00503685|Failed prior to Anti-EGFr Therapy|failed prior to anti-egfr therapy
633709|NCT00503672|Motor Activity|motor activity
633710|NCT00503672|Pregnancy|pregnancy
633711|NCT00503672|Accelerometer|accelerometer
633712|NCT00503659|PC20 FEV1|pc20 fev1
633713|NCT00503659|PD20FEV1|pd20fev1
633714|NCT00503659|bronchial hyperreactivity|bronchial hyperreactivity
633715|NCT00503659|bronchial asthma|bronchial asthma
633716|NCT00503646|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
633717|NCT00503646|sexual dysfunction and infertility|sexual dysfunction and infertility
633718|NCT00503646|sexuality and reproductive issues|sexuality and reproductive issues
633719|NCT00503646|stage IIB prostate cancer|stage iib prostate cancer
633720|NCT00503646|stage IIA prostate cancer|stage iia prostate cancer
633721|NCT00503646|stage I prostate cancer|stage i prostate cancer
633722|NCT00503633|sleep disorders|sleep disorders
633723|NCT00503633|genetics|genetics
633724|NCT00503620|Cerebral Palsy|cerebral palsy
633725|NCT00503620|Botulinum Toxin|botulinum toxin
633726|NCT00503620|Neuromuscular Function|neuromuscular function
633727|NCT00503607|colonoscopy|colonoscopy
633728|NCT00503607|bowel preparation|bowel preparation
633729|NCT00503607|prep|prep
633730|NCT00503594|Primary central nervous system lymphoma|primary central nervous system lymphoma
633731|NCT00503594|Brain lymphoma|brain lymphoma
633732|NCT00503594|Elderly|elderly
633733|NCT00503594|Chemotherapy|chemotherapy
633734|NCT00503594|Methotrexate|methotrexate
633735|NCT00503594|Temozolomide|temozolomide
633736|NCT00503594|Procarbazine|procarbazine
633737|NCT00503594|Vincristine|vincristine
633738|NCT00503594|Cytarabine|cytarabine
633739|NCT00503568|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
633740|NCT00503568|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
633741|NCT00503568|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
633742|NCT00503555|Primary Health Care|primary health care
633743|NCT00503555|Hispanic Americans|hispanic americans
633744|NCT00503542|Vaginitis|vaginitis
633745|NCT00503542|Bacterial Vaginosis|bacterial vaginosis
633746|NCT00503542|Vaginal trichomoniasis|vaginal trichomoniasis
633747|NCT00503542|Vulvovaginal candidiasis|vulvovaginal candidiasis
633748|NCT00503516|weight loss, appetite, dementia, megestrol acetate|weight loss, appetite, dementia, megestrol acetate
633749|NCT00503477|Japan|japan
633750|NCT00503477|Phase I|phase i
633751|NCT00503477|solid tumor|solid tumor
633752|NCT00503477|AZD2171|azd2171
633753|NCT00503464|guideline|guideline
633754|NCT00503464|adherence|adherence
633755|NCT00503451|Advanced cancer|advanced cancer
633756|NCT00503451|solid tumors|solid tumors
633757|NCT00503451|lymphoma|lymphoma
633758|NCT00503451|HDAC|hdac
633759|NCT00503451|LBH589|lbh589
633760|NCT00503451|adults|adults
633761|NCT00503451|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
633762|NCT00503438|Arthritis|arthritis
633763|NCT00503438|Osteoarthritis|osteoarthritis
633764|NCT00503438|Arthroplasty|arthroplasty
633765|NCT00503412|phase I|phase i
633766|NCT00503412|AZD2171|azd2171
633767|NCT00503412|solid tumor|solid tumor
633768|NCT00503412|metastatic tumor|metastatic tumor
633769|NCT00503399|Glucocorticoid Induced|glucocorticoid induced
633770|NCT00503386|chemotherapy-induced nausea and vomiting|chemotherapy-induced nausea and vomiting
633771|NCT00503386|acute|acute
633772|NCT00503386|delayed|delayed
633773|NCT00503386|emesis|emesis
633774|NCT00503386|antiemetics|antiemetics
633775|NCT00503386|5-HT3 receptor antagonist|5-ht3 receptor antagonist
633776|NCT00503386|granisetron|granisetron
633777|NCT00503386|palonosetron|palonosetron
633778|NCT00503360|Ocular Hypertension|ocular hypertension
633779|NCT00503360|SAD448|sad448
633780|NCT00503347|coinfection with chronic hepatitis C virus and HIV|coinfection with chronic hepatitis c virus and hiv
633781|NCT00503347|Treatment Naive|treatment naive
633782|NCT00503321|gastric cancer, TS-1, PSK|gastric cancer, ts-1, psk
633783|NCT00503308|HIV Seronegativity|hiv seronegativity
633784|NCT00503295|reovirus|reovirus
633785|NCT00503295|oncolytic virus|oncolytic virus
633786|NCT00503295|sarcoma|sarcoma
633787|NCT00503295|REOLYSIN|reolysin
633788|NCT00503295|Oncolytics Biotech|oncolytics biotech
633789|NCT00503269|Haemorrhoidectomy|haemorrhoidectomy
633790|NCT00503269|Local anaesthesia|local anaesthesia
633791|NCT00503256|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
633792|NCT00503256|Leukemia|leukemia
633793|NCT00503256|Lymphoma|lymphoma
633794|NCT00503256|Questionnaire|questionnaire
633795|NCT00503256|Survey|survey
633796|NCT00503256|CLL|cll
633797|NCT00503230|tobacco|tobacco
633798|NCT00503230|smoking|smoking
633799|NCT00503230|HIV|hiv
633800|NCT00503230|Latino|latino
633801|NCT00503217|intrauterine insemination|intrauterine insemination
633802|NCT00503217|GnRH agonist|gnrh agonist
633803|NCT00503217|implantation|implantation
633804|NCT00503204|cancer|cancer
633805|NCT00503204|tumor|tumor
633806|NCT00503204|advance solid tumour|advance solid tumour
633807|NCT00503204|glioblastoma|glioblastoma
633808|NCT00503204|malignant brain tumour|malignant brain tumour
633809|NCT00503191|Autism|autism
633810|NCT00503191|Neurodevelopmental disorder|neurodevelopmental disorder
633811|NCT00503165|Menitorix|menitorix
633812|NCT00503165|vaccine|vaccine
633813|NCT00503126|pediatrics|pediatrics
633814|NCT00503126|bivalirudin|bivalirudin
633815|NCT00503100|Pain|pain
633816|NCT00503100|Preterm-Born Adolescents|preterm-born adolescents
633817|NCT00503087|Injections|injections
633818|NCT00503087|Vacuum|vacuum
633819|NCT00503087|Pain|pain
633820|NCT00503087|Pneumatic Skin Flattening|pneumatic skin flattening
633821|NCT00503087|PSF|psf
633822|NCT00503074|Diet, reducing|diet, reducing
633823|NCT00503074|Television|television
633824|NCT00503074|Child Behavior|child behavior
633825|NCT00503061|pharmaceopidemiological|pharmaceopidemiological
633826|NCT00503061|Symbicort SMART|symbicort smart
633827|NCT00503061|GPRD|gprd
633828|NCT00503048|atopy|atopy
633829|NCT00503048|atopic diseases|atopic diseases
633830|NCT00503048|children|children
633831|NCT00503048|orphanages|orphanages
633832|NCT00503035|Familial Adenomatous Polyposis|familial adenomatous polyposis
633833|NCT00503035|Colorectal Tumors|colorectal tumors
633834|NCT00503035|Molecular Targeting|molecular targeting
633835|NCT00503035|Celecoxib|celecoxib
633836|NCT00503035|Celebrex|celebrex
633837|NCT00503035|SC-58635|sc-58635
633838|NCT00503035|Apoptosis Induction|apoptosis induction
633839|NCT00503035|Colon|colon
633840|NCT00503035|Rectum|rectum
633841|NCT00503035|colonoscopy|colonoscopy
633842|NCT00503035|Biopsy|biopsy
633843|NCT00503022|Wet age-related macular degeneration|wet age-related macular degeneration
633844|NCT00503022|ACZ885|acz885
633845|NCT00503009|Rhinovirus|rhinovirus
633846|NCT00503009|Asthma|asthma
633847|NCT00502983|Acute Myelogenous Leukemia|acute myelogenous leukemia
633848|NCT00502983|Epidemiology|epidemiology
633849|NCT00502983|Leukemia|leukemia
633850|NCT00502983|Healthy Control|healthy control
633851|NCT00502983|Lifestyle Factors|lifestyle factors
633852|NCT00502983|Genetic Susceptibility|genetic susceptibility
633853|NCT00502983|Interview|interview
633854|NCT00502983|AML|aml
633855|NCT00502970|Chronic HCV|chronic hcv
633856|NCT00502970|Treatment|treatment
633857|NCT00502957|biofeedback|biofeedback
633858|NCT00502957|constipation|constipation
633859|NCT00502944|HIV|hiv
633860|NCT00502944|Testing|testing
633861|NCT00502944|HIV Seronegativity|hiv seronegativity
633862|NCT00502905|Acute Myeloid Leukemia|acute myeloid leukemia
633863|NCT00502905|Myelodysplastic Syndromes|myelodysplastic syndromes
633864|NCT00502905|Busulfan|busulfan
633865|NCT00502905|Busulfex|busulfex
633866|NCT00502905|Myleran|myleran
633867|NCT00502905|Fludarabine|fludarabine
633868|NCT00502905|Fludarabine Phosphate|fludarabine phosphate
633869|NCT00502905|Fludara|fludara
633870|NCT00502892|Solid Tumors|solid tumors
633871|NCT00502892|Topotecan|topotecan
633872|NCT00502892|Hycamtin|hycamtin
633873|NCT00502892|Ifosfamide|ifosfamide
633874|NCT00502892|Ifex|ifex
633875|NCT00502892|Carboplatin|carboplatin
633876|NCT00502892|Paraplatin|paraplatin
633877|NCT00502892|Pediatric|pediatric
633878|NCT00502892|Children|children
633879|NCT00502892|Young Adults|young adults
633880|NCT00502866|breastfeeding|breastfeeding
633881|NCT00502866|vitamin D supplementation|vitamin d supplementation
633882|NCT00502866|rickets|rickets
633883|NCT00502827|Human Immunodeficiency Virus|human immunodeficiency virus
633884|NCT00502827|HIV positive|hiv positive
633885|NCT00502827|HIV Positive Smokers|hiv positive smokers
633886|NCT00502827|AIDS|aids
633887|NCT00502827|Cell Phone Intervention|cell phone intervention
633888|NCT00502827|CPI|cpi
633889|NCT00502827|Smoking Cessation|smoking cessation
633890|NCT00502827|Interview|interview
633891|NCT00502814|Breast Cancer|breast cancer
633892|NCT00502814|3-D Optical Surface Scan|3-d optical surface scan
633893|NCT00502814|Soft Tissue Biomechanics|soft tissue biomechanics
633894|NCT00502814|Mechanical Testing|mechanical testing
633895|NCT00502814|Skin Ultrasound|skin ultrasound
633896|NCT00502814|Magnetic Resonance Imaging|magnetic resonance imaging
633897|NCT00502814|CT Scan|ct scan
633898|NCT00502801|Pneumonia|pneumonia
633899|NCT00502801|Lung Infection|lung infection
633900|NCT00502801|Bacterial Infection|bacterial infection
633901|NCT00502801|Hospital-Acquired Infection|hospital-acquired infection
633902|NCT00502801|Ventilator Infection|ventilator infection
633903|NCT00502801|Antibiotic Therapy|antibiotic therapy
633904|NCT00502775|ragweed|ragweed
633905|NCT00502775|once daily|once daily
633906|NCT00502775|fexofenadine|fexofenadine
633907|NCT00502775|fluticasone furoate|fluticasone furoate
633908|NCT00502775|allergic rhinitis|allergic rhinitis
633909|NCT00502762|small-cell lung cancer|small-cell lung cancer
633910|NCT00502762|refractory|refractory
633911|NCT00502762|topotecan|topotecan
633912|NCT00502749|Leukemia|leukemia
633913|NCT00502749|Lymphoma|lymphoma
633914|NCT00502749|Exercise|exercise
633915|NCT00502749|Quality of Life|quality of life
633916|NCT00502749|Questionnaire|questionnaire
633917|NCT00502749|Survey|survey
633918|NCT00502723|Retropubic Prostatectomy|retropubic prostatectomy
633919|NCT00502723|Surgical Procedures|surgical procedures
633920|NCT00502723|Laparoscopic|laparoscopic
633921|NCT00502697|preterm|preterm
633922|NCT00502697|prematurity|prematurity
633923|NCT00502697|home visitation|home visitation
633924|NCT00502697|system of care|system of care
633925|NCT00502684|breast cancer|breast cancer
633926|NCT00502684|surgery|surgery
633927|NCT00502684|immune suppression|immune suppression
633928|NCT00502684|beta blockers|beta blockers
633929|NCT00502684|COX2 inhibitors|cox2 inhibitors
633930|NCT00502658|Overweight|overweight
633931|NCT00502658|Obese|obese
633932|NCT00502658|Dietary Supplements|dietary supplements
633933|NCT00502658|Shakes|shakes
633934|NCT00502658|Nutrition|nutrition
633935|NCT00502658|Overweight and Obese Adults (BMI 25-35)|overweight and obese adults (bmi 25-35)
633936|NCT00502645|algorithm|algorithm
633937|NCT00502645|cs-1 decision support system|cs-1 decision support system
633938|NCT00502645|insulin|insulin
633939|NCT00502645|hyperglycemia|hyperglycemia
633940|NCT00502645|tight glycemic control|tight glycemic control
633941|NCT00502645|intensive care|intensive care
633942|NCT00502645|adults|adults
633943|NCT00502632|Pleural empyema|pleural empyema
633944|NCT00502632|Pleural effusion|pleural effusion
633945|NCT00502632|Dornase alfa|dornase alfa
633946|NCT00502632|Urokinase|urokinase
633947|NCT00502632|Children|children
633948|NCT00502619|Low back pain|low back pain
633949|NCT00502619|acupuncture|acupuncture
633950|NCT00502619|treadmill exercise|treadmill exercise
633951|NCT00502606|provisional restoration|provisional restoration
633952|NCT00502606|antibacterial nanoparticles|antibacterial nanoparticles
633953|NCT00502606|cement|cement
633954|NCT00502606|biofilm|biofilm
633955|NCT00502606|bacteria|bacteria
633956|NCT00502606|flora|flora
633957|NCT00502606|plaque|plaque
633958|NCT00502606|dental|dental
633959|NCT00502606|prosthesis|prosthesis
633960|NCT00502593|Influenza|influenza
633961|NCT00502593|Pandemic Influenza Vaccine (GSK1562902A)|pandemic influenza vaccine (gsk1562902a)
633962|NCT00502580|Oral Cancer|oral cancer
633963|NCT00502580|Multispectral Digital Microscope|multispectral digital microscope
633964|NCT00502580|Multispectral Digital Imaging|multispectral digital imaging
633965|NCT00502580|Interview|interview
633966|NCT00502580|MDM|mdm
633967|NCT00502567|advanced solid tumors|advanced solid tumors
633968|NCT00502567|AZD2171|azd2171
633969|NCT00502567|Phase I|phase i
633970|NCT00502554|lung function|lung function
633971|NCT00502554|FEV1|fev1
633972|NCT00502528|Infarction|infarction
633973|NCT00502528|Endothelin|endothelin
633974|NCT00502528|Perfusion|perfusion
633975|NCT00502515|Diabetes|diabetes
633976|NCT00502515|Neuropathy|neuropathy
633977|NCT00502502|Anal Cancer|anal cancer
633978|NCT00502502|Colorectal Cancer|colorectal cancer
633979|NCT00502502|Esophageal Cancer|esophageal cancer
633980|NCT00502502|Gastric Cancer|gastric cancer
633981|NCT00502502|Lung Cancer|lung cancer
633982|NCT00502502|Questionnaire|questionnaire
633983|NCT00502502|Survey|survey
633984|NCT00502502|Chemoradiation Therapy|chemoradiation therapy
633985|NCT00502502|Symptoms|symptoms
633986|NCT00502502|Cytokines|cytokines
633987|NCT00502489|prolonged mechanical ventilation; weaning;rehabilitation|prolonged mechanical ventilation; weaning;rehabilitation
633988|NCT00502476|MRSA|mrsa
633989|NCT00502476|VRE|vre
633990|NCT00502476|BSI|bsi
633991|NCT00502463|head and neck cancer, stage III/IV|head and neck cancer, stage iii/iv
633992|NCT00502463|no prior radiotherapy of head and neck region|no prior radiotherapy of head and neck region
633993|NCT00502450|Acute mastoiditis|acute mastoiditis
633994|NCT00502450|Hearing loss|hearing loss
633995|NCT00502450|Mastoidectomy|mastoidectomy
633996|NCT00502450|Audiogram|audiogram
633997|NCT00502424|Rheumatoid Arthritis|rheumatoid arthritis
633998|NCT00502424|Hand|hand
633999|NCT00502424|Splint|splint
634000|NCT00502424|Occupational Therapy|occupational therapy
634001|NCT00502411|Soft Tissue Sarcoma|soft tissue sarcoma
634002|NCT00502411|External Beam Radiotherapy|external beam radiotherapy
634003|NCT00502411|Radiation Therapy|radiation therapy
634004|NCT00502411|Extremity and Trunk|extremity and trunk
634005|NCT00502411|EBRT|ebrt
634006|NCT00502411|Sarcoma|sarcoma
634007|NCT00502411|Doxorubicin|doxorubicin
634008|NCT00502411|AD|ad
634009|NCT00502411|Hydroxydaunomycin hydrochloride|hydroxydaunomycin hydrochloride
634010|NCT00502411|XRT|xrt
634011|NCT00502411|RT|rt
634012|NCT00502411|Radiotherapy|radiotherapy
634013|NCT00502385|Phase I|phase i
634014|NCT00502385|AML|aml
634015|NCT00502385|de novo or secondary AML|de novo or secondary aml
634016|NCT00502385|AZD2171|azd2171
634017|NCT00502359|Gestational diabetes, screening, glucose monitoring|gestational diabetes, screening, glucose monitoring
634018|NCT00502346|Pharmacodynamics|pharmacodynamics
634019|NCT00502333|back pain|back pain
634020|NCT00502333|neck pain|neck pain
634021|NCT00502333|prognosis|prognosis
634022|NCT00502333|catastrophizing|catastrophizing
634023|NCT00502333|coping strategies|coping strategies
634024|NCT00502333|disability|disability
634025|NCT00502333|Prognosis for back and neck pain|prognosis for back and neck pain
634026|NCT00502320|Seasonal Affective Disorder|seasonal affective disorder
634027|NCT00502320|Ramelteon|ramelteon
634028|NCT00502320|Psychiatry|psychiatry
634029|NCT00502320|Randomized Controlled Trial|randomized controlled trial
634030|NCT00502320|Hamilton Depression Rating Scale- SAD Version|hamilton depression rating scale- sad version
634031|NCT00502320|Circadian Rhythm|circadian rhythm
634032|NCT00502307|Renal Cell Carcinoma|renal cell carcinoma
634033|NCT00502307|AV-951|av-951
634034|NCT00502307|tivozanib|tivozanib
634035|NCT00502294|Ulcerative Colitis, UC, Intravenous Steroid-Refractory Ulcerative Colitis, IVSR-UC|ulcerative colitis, uc, intravenous steroid-refractory ulcerative colitis, ivsr-uc
634036|NCT00502281|Gonadotropins|gonadotropins
634037|NCT00502281|Infertility|infertility
634038|NCT00502281|Intrauterine insemination|intrauterine insemination
634039|NCT00502281|PCOS|pcos
634040|NCT00502281|Timed intercourse|timed intercourse
634041|NCT00502281|Treatment|treatment
634042|NCT00502268|Coronary Calcification|coronary calcification
634043|NCT00502268|Endstage Renal Disease|endstage renal disease
634044|NCT00502268|Parathyroid hormone|parathyroid hormone
634045|NCT00502255|Telemonitoring|telemonitoring
634046|NCT00502255|Cost-effectiveness|cost-effectiveness
634047|NCT00502255|Heart failure|heart failure
634048|NCT00502255|Case management|case management
634049|NCT00502229|Clomiphene citrate|clomiphene citrate
634050|NCT00502229|Controlled overian stimulation|controlled overian stimulation
634051|NCT00502229|Infertility|infertility
634052|NCT00502229|Metformin|metformin
634053|NCT00502229|Polycystic ovary syndrome|polycystic ovary syndrome
634054|NCT00502229|Treatment|treatment
634055|NCT00502216|Tobacco|tobacco
634056|NCT00502216|Smoking|smoking
634057|NCT00502216|Weight|weight
634058|NCT00502216|Naltrexone|naltrexone
634059|NCT00502216|Varenicline|varenicline
634060|NCT00502203|Uterine Neoplasms|uterine neoplasms
634061|NCT00502203|Endometrial Cancer|endometrial cancer
634062|NCT00502203|Paclitaxel|paclitaxel
634063|NCT00502203|Taxol|taxol
634064|NCT00502203|Carboplatin|carboplatin
634065|NCT00502203|Paraplatin|paraplatin
634066|NCT00502203|Malignant Mixed Mullerian Tumors|malignant mixed mullerian tumors
634067|NCT00502203|MMMT|mmmt
634068|NCT00502203|Immunohistochemical markers|immunohistochemical markers
634069|NCT00502190|pessary|pessary
634070|NCT00502190|extending pregnancy|extending pregnancy
634071|NCT00502177|Continuous Hyperthermic Peritoneal Perfusion|continuous hyperthermic peritoneal perfusion
634072|NCT00502177|Peritoneal Neoplasms|peritoneal neoplasms
634073|NCT00502177|Quality of Life|quality of life
634074|NCT00502177|Questionnaire|questionnaire
634075|NCT00502177|Survey|survey
634076|NCT00502177|CHPP|chpp
634077|NCT00502164|Advanced Prostate Cancer|advanced prostate cancer
634078|NCT00502138|diabetes|diabetes
634079|NCT00502138|insulin|insulin
634080|NCT00502138|pramlintide|pramlintide
634081|NCT00502138|IDDM|iddm
634082|NCT00502125|Reflectance Confocal Imaging|reflectance confocal imaging
634083|NCT00502125|Oral Mucosal Lesions|oral mucosal lesions
634084|NCT00502125|Oral Mucosa Disease|oral mucosa disease
634085|NCT00502125|Neoplasia Detection|neoplasia detection
634086|NCT00502112|Lintuzumab|lintuzumab
634087|NCT00502112|Antigens, CD33|antigens, cd33
634088|NCT00502112|Antibodies, Monoclonal|antibodies, monoclonal
634089|NCT00502112|Combined Modality Therapy|combined modality therapy
634090|NCT00502112|Myelodysplastic Syndromes|myelodysplastic syndromes
634091|NCT00502112|Hematologic Diseases|hematologic diseases
634092|NCT00502112|Preleukemia|preleukemia
634093|NCT00502099|Chronic hepatitis C|chronic hepatitis c
634094|NCT00502099|pegylated interferon alfa-2a|pegylated interferon alfa-2a
634095|NCT00502099|ribavirin, rapid virologic response|ribavirin, rapid virologic response
634096|NCT00502099|early virologic response|early virologic response
634097|NCT00502099|sustained virologic response|sustained virologic response
634098|NCT00502086|Chronic hepatitis C|chronic hepatitis c
634099|NCT00502086|Cirrhosis of the liver|cirrhosis of the liver
634100|NCT00502086|Mortality|mortality
634101|NCT00502086|Complications|complications
634102|NCT00502086|Health-related quality of live|health-related quality of live
634103|NCT00502086|Hepatocellular carcinoma|hepatocellular carcinoma
634104|NCT00502086|Nutritional supplement|nutritional supplement
634105|NCT00502060|Phase I|phase i
634106|NCT00502060|AZD2171|azd2171
634107|NCT00502060|ZD1839|zd1839
634108|NCT00502060|solid tumor|solid tumor
634109|NCT00502047|plantago ovata husk|plantago ovata husk
634110|NCT00502047|soluble fibre|soluble fibre
634111|NCT00502047|hypercholesterolemia|hypercholesterolemia
634112|NCT00502047|cardiovascular risk factor|cardiovascular risk factor
634214|NCT00501735|T-Cell|t-cell
634113|NCT00502034|Carcinoma, Renal Cell|carcinoma, renal cell
634114|NCT00502034|Low-dose Interleukin|low-dose interleukin
634115|NCT00502034|Adjuvant Immunotherapy|adjuvant immunotherapy
634116|NCT00502021|obesity|obesity
634117|NCT00502021|alpha linolenic acid|alpha linolenic acid
634118|NCT00502021|flaxseed|flaxseed
634119|NCT00502021|C-reactive protein|c-reactive protein
634120|NCT00502021|inflammation|inflammation
634121|NCT00502008|Diabetes|diabetes
634122|NCT00502008|India|india
634123|NCT00502008|Coccinia Cordifolia|coccinia cordifolia
634124|NCT00502008|Coccinia indica|coccinia indica
634125|NCT00502008|Blood glucose levels|blood glucose levels
634126|NCT00501995|High Dose Cyclophosphamide|high dose cyclophosphamide
634127|NCT00501995|Systemic Sclerosis|systemic sclerosis
634128|NCT00501995|Scleroderma|scleroderma
634129|NCT00501995|immunoablation|immunoablation
634130|NCT00501982|surfactant|surfactant
634131|NCT00501982|RDS|rds
634132|NCT00501982|nCPAP|ncpap
634133|NCT00501982|Mechanical Ventilation|mechanical ventilation
634134|NCT00501982|Premature Infants|premature infants
634135|NCT00501982|Neonatal Respiratory Distress Syndrome (nRDS)|neonatal respiratory distress syndrome (nrds)
634136|NCT00501969|Rotigotine|rotigotine
634137|NCT00501969|Neupro®|neupro®
634138|NCT00501956|chronic renal replacement therapy|chronic renal replacement therapy
634139|NCT00501956|malnutrition anorexia|malnutrition anorexia
634140|NCT00501956|parenteral nutrition|parenteral nutrition
634141|NCT00501930|Dose Escalation;|dose escalation;
634142|NCT00501930|Supratherapeutic;|supratherapeutic;
634143|NCT00501930|GSK189075;|gsk189075;
634144|NCT00501930|Diabetes|diabetes
634145|NCT00501917|acute myocardial infarction|acute myocardial infarction
634146|NCT00501904|Anovulation|anovulation
634147|NCT00501904|Infertility|infertility
634148|NCT00501904|Metformin|metformin
634149|NCT00501904|PCOS|pcos
634150|NCT00501904|Treatment|treatment
634151|NCT00501891|Glioblastoma Multiforme|glioblastoma multiforme
634152|NCT00501891|Brain and Central Nervous System Tumors|brain and central nervous system tumors
634153|NCT00501891|Recurrent Malignant Glioma|recurrent malignant glioma
634154|NCT00501891|Recurrent Glioblastoma Multiforme|recurrent glioblastoma multiforme
634155|NCT00501891|Avastin|avastin
634156|NCT00501891|Bevacizumab|bevacizumab
634157|NCT00501891|Temodar|temodar
634158|NCT00501891|Temozolomide|temozolomide
634159|NCT00501878|phenylephrine|phenylephrine
634160|NCT00501878|mydriasis|mydriasis
634161|NCT00501878|diabetes mellitus|diabetes mellitus
634162|NCT00501865|healthy volunteers|healthy volunteers
634163|NCT00501865|food effect,|food effect,
634164|NCT00501865|quantitative pharmacokinetic analysis,|quantitative pharmacokinetic analysis,
634165|NCT00501865|GW273225,|gw273225,
634166|NCT00501852|COPD, Age≥40 yrs, Glycopyrronium Bromide|copd, age≥40 yrs, glycopyrronium bromide
634167|NCT00501839|Anovulation|anovulation
634168|NCT00501839|Clomiphene citrate|clomiphene citrate
634169|NCT00501839|Infertility|infertility
634170|NCT00501839|PCOS|pcos
634171|NCT00501839|Treatment|treatment
634172|NCT00501826|Leukemia|leukemia
634173|NCT00501826|ALL|all
634174|NCT00501826|T-cell ALL|t-cell all
634175|NCT00501826|Lymphoblastic Lymphoma|lymphoblastic lymphoma
634176|NCT00501826|Hyper-CVAD|hyper-cvad
634177|NCT00501826|Doxorubicin|doxorubicin
634178|NCT00501826|Cyclophosphamide|cyclophosphamide
634179|NCT00501826|Cytarabine|cytarabine
634180|NCT00501826|Dexamethasone|dexamethasone
634181|NCT00501826|Methotrexate|methotrexate
634182|NCT00501826|Vincristine|vincristine
634183|NCT00501826|Nelarabine|nelarabine
634184|NCT00501813|Hepatocellular carcinoma|hepatocellular carcinoma
634185|NCT00501813|Intrahepatic vessels invasion|intrahepatic vessels invasion
634186|NCT00501813|Hepatectomy|hepatectomy
634187|NCT00501813|Transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
634188|NCT00501813|Local regional treatment|local regional treatment
634189|NCT00501800|Reproductive Health|reproductive health
634190|NCT00501800|Fertility|fertility
634191|NCT00501800|Infertility|infertility
634192|NCT00501800|Genetics|genetics
634193|NCT00501800|Continental Population Groups|continental population groups
634194|NCT00501800|Epidemiology|epidemiology
634195|NCT00501800|Aging|aging
634196|NCT00501800|Health|health
634197|NCT00501787|Anovulation|anovulation
634198|NCT00501787|metformin|metformin
634199|NCT00501787|PCOS|pcos
634200|NCT00501787|treatment|treatment
634201|NCT00501774|Localized vulvodynia|localized vulvodynia
634202|NCT00501774|Helicobacter pylori|helicobacter pylori
634203|NCT00501774|peptic disease|peptic disease
634204|NCT00501774|omeprazole|omeprazole
634205|NCT00501761|Endometrial Cancer|endometrial cancer
634206|NCT00501761|Healthy Controls|healthy controls
634207|NCT00501761|Social Cognitive Theory|social cognitive theory
634208|NCT00501761|Behavioral Intervention|behavioral intervention
634209|NCT00501761|Physical Activity|physical activity
634210|NCT00501761|Exercise Program|exercise program
634211|NCT00501761|Questionnaire|questionnaire
634212|NCT00501748|Neuromyelitis Optica|neuromyelitis optica
634213|NCT00501748|acute transverse myelitis|acute transverse myelitis
634215|NCT00501735|Lymphoma|lymphoma
634216|NCT00501735|Forodesine|forodesine
634217|NCT00501735|Mycosis Fungoides|mycosis fungoides
634218|NCT00501722|cirrhotic ascites|cirrhotic ascites
634219|NCT00501722|hyponatraemia|hyponatraemia
634220|NCT00501683|metabolite profiling|metabolite profiling
634221|NCT00501683|excretion,|excretion,
634222|NCT00501683|radioactivity,|radioactivity,
634223|NCT00501683|pharmacokinetic,|pharmacokinetic,
634224|NCT00501683|mass balance,|mass balance,
634225|NCT00501670|Herpes zoster|herpes zoster
634226|NCT00501670|PCR|pcr
634227|NCT00501670|Varicella zoster Virus (VZV)|varicella zoster virus (vzv)
634228|NCT00501670|Shingles|shingles
634229|NCT00501670|GSK Biologicals|gsk biologicals
634230|NCT00501657|gastric emptying|gastric emptying
634231|NCT00501657|glycemia|glycemia
634232|NCT00501657|appetite|appetite
634233|NCT00501657|incretin hormones|incretin hormones
634234|NCT00501644|Müllerian Carcinomas|müllerian carcinomas
634235|NCT00501644|Ovarian Cancer|ovarian cancer
634236|NCT00501644|Fallopian Tube Cancer|fallopian tube cancer
634237|NCT00501644|Peritoneal Cancer|peritoneal cancer
634238|NCT00501644|Epithelial Ovarian|epithelial ovarian
634239|NCT00501644|Peritoneal|peritoneal
634240|NCT00501644|Fallopian Tube|fallopian tube
634241|NCT00501644|Chemoimmunotherapy|chemoimmunotherapy
634242|NCT00501644|Platinum Sensitive Müllerian|platinum sensitive müllerian
634243|NCT00501644|Carboplatin|carboplatin
634244|NCT00501644|Paraplatin|paraplatin
634245|NCT00501644|GM-CSF|gm-csf
634246|NCT00501644|Sargramostim|sargramostim
634247|NCT00501644|Interferon Gamma|interferon gamma
634248|NCT00501644|Quality of Life|quality of life
634249|NCT00501644|QOL|qol
634250|NCT00501631|Addiction|addiction
634251|NCT00501631|Alcoholism|alcoholism
634252|NCT00501631|Inpatient detoxification|inpatient detoxification
634253|NCT00501618|Schizophrenia|schizophrenia
634254|NCT00501618|Schizoaffective Disorder|schizoaffective disorder
634255|NCT00501618|Orally dissolving clozapine|orally dissolving clozapine
634256|NCT00501618|orally disintegrating clozapine|orally disintegrating clozapine
634257|NCT00501618|bio-equivalence|bio-equivalence
634258|NCT00501618|desmethylclozapine|desmethylclozapine
634259|NCT00501618|clozapine plasma level|clozapine plasma level
634260|NCT00501618|equivalence|equivalence
634261|NCT00501618|fazaclo|fazaclo
634262|NCT00501618|generic clozapine|generic clozapine
634263|NCT00501605|Phase I|phase i
634264|NCT00501605|AZD2171|azd2171
634265|NCT00501605|advanced solid tumors|advanced solid tumors
634266|NCT00501592|Farnesoid X receptor agonist|farnesoid x receptor agonist
634267|NCT00501592|Metabolic Disorder|metabolic disorder
634268|NCT00501592|Diabetes|diabetes
634269|NCT00501592|NAFLD|nafld
634270|NCT00501566|cirrhotic ascites|cirrhotic ascites
634271|NCT00501553|Heart Failure,|heart failure,
634272|NCT00501553|Vitamin D status,|vitamin d status,
634273|NCT00501553|NT-proBNP|nt-probnp
634274|NCT00501540|low-grade neuroendocrine tumors|low-grade neuroendocrine tumors
634275|NCT00501540|lithium|lithium
634276|NCT00501527|Allergoid|allergoid
634277|NCT00501527|Depigmented|depigmented
634278|NCT00501527|Polymerized|polymerized
634279|NCT00501527|Allergen-extract|allergen-extract
634280|NCT00501527|Rhinoconjunctivitis|rhinoconjunctivitis
634281|NCT00501527|Asthma|asthma
634282|NCT00501514|chronic heart failure|chronic heart failure
634283|NCT00501514|cardiopulmonary exercise|cardiopulmonary exercise
634284|NCT00501514|oxygen consumption|oxygen consumption
634285|NCT00501514|growth hormone|growth hormone
634286|NCT00501501|Rehospitalization|rehospitalization
634287|NCT00501501|Cesarean|cesarean
634288|NCT00501501|Vaginal delivery|vaginal delivery
634289|NCT00501488|pharmacodynamics|pharmacodynamics
634290|NCT00501488|insulin resistance|insulin resistance
634291|NCT00501488|therapy|therapy
634292|NCT00501488|volunteer|volunteer
634293|NCT00501475|N-acetylcysteine|n-acetylcysteine
634294|NCT00501475|nephropathy|nephropathy
634295|NCT00501475|bicarbonate|bicarbonate
634296|NCT00501462|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
634297|NCT00501462|renal insufficiency|renal insufficiency
634298|NCT00501449|Multiple Endocrine Neoplasia|multiple endocrine neoplasia
634299|NCT00501449|Questionnaire|questionnaire
634300|NCT00501449|Psychosocial|psychosocial
634301|NCT00501449|Surveillance Behaviors|surveillance behaviors
634302|NCT00501449|MEN Syndromes|men syndromes
634303|NCT00501423|antiplatelet drug|antiplatelet drug
634304|NCT00501423|resistance|resistance
634305|NCT00501423|atherothrombosis|atherothrombosis
634306|NCT00501410|Colorectal Cancer|colorectal cancer
634307|NCT00501410|Dual Inhibition of EGFR|dual inhibition of egfr
634308|NCT00501410|FOLFOX Chemotherapy|folfox chemotherapy
634309|NCT00501410|5-FU|5-fu
634310|NCT00501410|Cetuximab|cetuximab
634311|NCT00501410|Dasatinib|dasatinib
634312|NCT00501410|Leucovorin|leucovorin
634313|NCT00501410|Oxaliplatin|oxaliplatin
634314|NCT00501410|5-Fluorouracil|5-fluorouracil
634315|NCT00501410|BMS-354825|bms-354825
634316|NCT00501410|Eloxatin|eloxatin
634317|NCT00501410|Sprycel|sprycel
634318|NCT00501410|C225|c225
634319|NCT00501410|Erbitux|erbitux
634320|NCT00501410|IMC-C225|imc-c225
634321|NCT00501410|Adrucil|adrucil
634322|NCT00501410|Efudex|efudex
634323|NCT00501410|Folinic Acid|folinic acid
634324|NCT00501397|ketoconazole,|ketoconazole,
634325|NCT00501397|drug interaction,|drug interaction,
634326|NCT00501397|pharmacokinetics|pharmacokinetics
634327|NCT00501397|T2DM,|t2dm,
634328|NCT00501384|cirrhotic ascites|cirrhotic ascites
634329|NCT00501371|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
634330|NCT00501371|MCS|mcs
634331|NCT00501371|Lower Urinary Tract Symptoms|lower urinary tract symptoms
634332|NCT00501371|International prostate symptom score|international prostate symptom score
634333|NCT00501371|Voiding|voiding
634334|NCT00501371|Alpha-blockers|alpha-blockers
634335|NCT00501358|SLEEP APNEA|sleep apnea
634336|NCT00501358|venous thromboembolism|venous thromboembolism
634337|NCT00501358|COAGULABILITY|coagulability
634338|NCT00501358|COAGULATION FACTORS|coagulation factors
634339|NCT00501358|HYPOXIA|hypoxia
634340|NCT00501345|Thrombocytopenia|thrombocytopenia
634341|NCT00501345|Platelet Function|platelet function
634342|NCT00501345|Acute Coronary Syndrome|acute coronary syndrome
634343|NCT00501345|Myocardial Infarction|myocardial infarction
634344|NCT00501345|Heart Attack|heart attack
634345|NCT00501345|Aspirin|aspirin
634346|NCT00501332|neutropenia|neutropenia
634347|NCT00501332|breast|breast
634348|NCT00501332|cancer|cancer
634349|NCT00501332|chemotherapy|chemotherapy
634350|NCT00501319|Interactive Voice Response Telephone System|interactive voice response telephone system
634351|NCT00501319|Non-Small Cell Lung Cancer|non-small cell lung cancer
634352|NCT00501319|Lung Cancer|lung cancer
634353|NCT00501319|Questionnaire|questionnaire
634354|NCT00501319|Survey|survey
634355|NCT00501319|NSCLC|nsclc
634356|NCT00501319|IVR|ivr
634357|NCT00501306|Condyloma Accuminata|condyloma accuminata
634358|NCT00501306|Low Grade Squamous Intraepithelial Lesion|low grade squamous intraepithelial lesion
634359|NCT00501306|High Grade Squamous Intraepithelial Lesion|high grade squamous intraepithelial lesion
634360|NCT00501306|Anal Cancer Screening|anal cancer screening
634361|NCT00501280|Epidemiology|epidemiology
634362|NCT00501280|Genetic Susceptibility|genetic susceptibility
634363|NCT00501280|Migrant Farmworker Children|migrant farmworker children
634364|NCT00501280|Migrant Education Program|migrant education program
634365|NCT00501280|Interview|interview
634366|NCT00501280|Questionnaire|questionnaire
634367|NCT00501267|solabegron,|solabegron,
634368|NCT00501267|oxybutynin,|oxybutynin,
634369|NCT00501267|healthy adults,|healthy adults,
634370|NCT00501267|drug interaction|drug interaction
634371|NCT00501254|Slow release ASA|slow release asa
634372|NCT00501254|Platelet functionalism|platelet functionalism
634373|NCT00501254|Secondary cardiovascular prevention|secondary cardiovascular prevention
634374|NCT00501228|Graft-Versus-Host Disease|graft-versus-host disease
634375|NCT00501228|Stem Cell Transplantation|stem cell transplantation
634376|NCT00501228|Tissue Repair|tissue repair
634377|NCT00501228|Organ-Specific Tissue Damage|organ-specific tissue damage
634378|NCT00501228|Filgrastim|filgrastim
634379|NCT00501228|RhG-CSF|rhg-csf
634380|NCT00501215|Primary Hyperparathyroidism|primary hyperparathyroidism
634381|NCT00501215|PHPT|phpt
634382|NCT00501215|Parathyroidectomy|parathyroidectomy
634383|NCT00501215|Polysomnogram|polysomnogram
634384|NCT00501215|PSG|psg
634385|NCT00501215|Sleep Quality|sleep quality
634386|NCT00501215|Interview|interview
634387|NCT00501202|diabetes mellitus|diabetes mellitus
634388|NCT00501202|diabetic microvascular injury|diabetic microvascular injury
634389|NCT00501202|painful polyneuropathy.|painful polyneuropathy.
634390|NCT00501189|Gardasil|gardasil
634391|NCT00501189|Human Papilloma Virus|human papilloma virus
634392|NCT00501189|Papanicolaou Smear|papanicolaou smear
634393|NCT00501189|ASCUS|ascus
634394|NCT00501189|LGSIL|lgsil
634395|NCT00501189|Human Papilloma Virus Vaccine|human papilloma virus vaccine
634396|NCT00501189|Human Papillomavirus Infection|human papillomavirus infection
634397|NCT00501176|Pancreas|pancreas
634398|NCT00501176|cancer|cancer
634399|NCT00501176|SEMS|sems
634400|NCT00501176|Plastic|plastic
634401|NCT00501176|stent|stent
634402|NCT00501176|Whipple|whipple
634403|NCT00501176|Jaundicie|jaundicie
634404|NCT00501163|Schizophrenia|schizophrenia
634405|NCT00501163|Cardiovascular|cardiovascular
634406|NCT00501163|Risk|risk
634407|NCT00501150|linezolid|linezolid
634408|NCT00501150|vancomycin|vancomycin
634409|NCT00501150|glycopeptides|glycopeptides
634410|NCT00501150|methicillin resistant staphylococcus aureus|methicillin resistant staphylococcus aureus
634411|NCT00501150|resistant gram positive infections|resistant gram positive infections
634412|NCT00501137|HPV|hpv
634413|NCT00501137|HPV vaccine|hpv vaccine
634414|NCT00501137|Gardasil|gardasil
634415|NCT00501137|Human Papillomavirus|human papillomavirus
634416|NCT00501137|vaccine|vaccine
634417|NCT00501137|2 dose versus 3|2 dose versus 3
634418|NCT00501111|Dementia|dementia
634419|NCT00501111|Alzheimer Type|alzheimer type
634420|NCT00501111|Alzheimer Disease|alzheimer disease
634421|NCT00501098|Leukemia|leukemia
634422|NCT00501098|Prophylaxis|prophylaxis
634423|NCT00501098|Fungal Infections|fungal infections
634424|NCT00501098|Caspofungin|caspofungin
634425|NCT00501072|hyperglycemia|hyperglycemia
634426|NCT00501072|hypoglycemia|hypoglycemia
634427|NCT00501072|glucose variability|glucose variability
634428|NCT00501072|insulin infusion system; implantable insulin pump|insulin infusion system; implantable insulin pump
634429|NCT00501072|continuous glucose monitoring|continuous glucose monitoring
634430|NCT00501059|Primary prevention of coronary heart disease|primary prevention of coronary heart disease
634431|NCT00501059|Stroke and cardiovascular death|stroke and cardiovascular death
634432|NCT00501059|Aspirin|aspirin
634433|NCT00501046|Kidney Diseases|kidney diseases
634434|NCT00501033|Induction of labor|induction of labor
634435|NCT00501033|Cesarean|cesarean
634436|NCT00501033|Endometritis|endometritis
634437|NCT00501033|Foley|foley
634438|NCT00501033|Infections|infections
634439|NCT00501020|Type 2 Diabetes|type 2 diabetes
634440|NCT00501020|metformin|metformin
634441|NCT00501020|rosiglitazone|rosiglitazone
634442|NCT00500994|Conversion Disorder|conversion disorder
634443|NCT00500994|Psychogenic Movement Disorders|psychogenic movement disorders
634444|NCT00500994|Non-Epileptic Seizure|non-epileptic seizure
634445|NCT00500994|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
634446|NCT00500994|Genetic Polymorphisms|genetic polymorphisms
634447|NCT00500994|Psychogenic Movement Disorder|psychogenic movement disorder
634448|NCT00500994|PMD|pmd
634449|NCT00500994|NES|nes
634450|NCT00500994|Healthy Volunteer|healthy volunteer
634451|NCT00500994|HV|hv
634452|NCT00500981|Fluid responsiveness|fluid responsiveness
634453|NCT00500968|Pancreas|pancreas
634454|NCT00500968|Leakage|leakage
634455|NCT00500968|Fistula|fistula
634456|NCT00500968|tail|tail
634457|NCT00500955|microalbuminuria,|microalbuminuria,
634458|NCT00500955|Type 2 Diabetes|type 2 diabetes
634459|NCT00500955|rosiglitazone,|rosiglitazone,
634460|NCT00500942|Interventional Radiology|interventional radiology
634461|NCT00500942|Pain Quantification|pain quantification
634462|NCT00500942|Pain Management|pain management
634463|NCT00500942|Patient Satisfaction|patient satisfaction
634464|NCT00500942|Questionnaire|questionnaire
634465|NCT00500942|Survey|survey
634466|NCT00500929|OHSP|ohsp
634467|NCT00500929|High risk|high risk
634468|NCT00500929|Geriatrics|geriatrics
634469|NCT00500903|Advanced malignancies|advanced malignancies
634470|NCT00500890|Choroid Plexus Tumors|choroid plexus tumors
634471|NCT00500890|Carboplatin|carboplatin
634472|NCT00500890|Cyclophosphamide|cyclophosphamide
634473|NCT00500890|Etoposide|etoposide
634474|NCT00500890|Vincristine|vincristine
634475|NCT00500890|Paraplatin|paraplatin
634476|NCT00500890|Cytoxan|cytoxan
634477|NCT00500890|Neosar|neosar
634478|NCT00500877|Smoking cessation|smoking cessation
634479|NCT00500877|Phone Counseling|phone counseling
634480|NCT00500864|COPD|copd
634481|NCT00500864|Magnesium|magnesium
634482|NCT00500864|Pulmonary function|pulmonary function
634483|NCT00500864|Exercise Physiology|exercise physiology
634484|NCT00500851|critical illness|critical illness
634485|NCT00500851|enteral nutrition|enteral nutrition
634486|NCT00500851|gastrointestinal intubation|gastrointestinal intubation
634487|NCT00500838|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
634488|NCT00500838|Transthoracic Impedance|transthoracic impedance
634489|NCT00500825|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
634490|NCT00500825|Therapeutic hypothermia|therapeutic hypothermia
634491|NCT00500825|resting energy expenditure|resting energy expenditure
634492|NCT00500812|biologic drug|biologic drug
634493|NCT00500812|transport sequence|transport sequence
634494|NCT00500812|rho|rho
634495|NCT00500812|spinal cord injury|spinal cord injury
634496|NCT00500812|paralysis|paralysis
634497|NCT00500812|paraplegia|paraplegia
634498|NCT00500812|tetraplegia|tetraplegia
634499|NCT00500812|quadraplegia|quadraplegia
634500|NCT00500812|trauma|trauma
634501|NCT00500812|nervous system|nervous system
634502|NCT00500812|fibrin sealant|fibrin sealant
634503|NCT00500812|neurosurgery|neurosurgery
634504|NCT00500799|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
634505|NCT00500799|Blink Reflex|blink reflex
634506|NCT00500799|Blepharospasm|blepharospasm
634507|NCT00500799|Healthy Volunteer|healthy volunteer
634508|NCT00500799|HV|hv
634509|NCT00500773|cardiovascular risc factors|cardiovascular risc factors
634510|NCT00500773|inflammation|inflammation
634511|NCT00500773|aerobic and exertional exercise|aerobic and exertional exercise
634512|NCT00500760|Head and Neck Cancer|head and neck cancer
634513|NCT00500760|panitumumab|panitumumab
634514|NCT00500747|hepatitis C, HCV, vaccine, recombinant vaccine, adjuvant|hepatitis c, hcv, vaccine, recombinant vaccine, adjuvant
634515|NCT00500734|Cardiomyopathy|cardiomyopathy
634516|NCT00500734|Tissue Bank|tissue bank
634517|NCT00500734|Heart Disease|heart disease
634518|NCT00500734|Heart Failure|heart failure
634519|NCT00500734|Congestive Heart Failure|congestive heart failure
634520|NCT00500721|healthy subjects|healthy subjects
634521|NCT00500708|Heart failure|heart failure
634522|NCT00500708|Implanted Cardioverter Defibrillator|implanted cardioverter defibrillator
634523|NCT00500708|Biological Markers|biological markers
634524|NCT00500708|Molecular Genetics|molecular genetics
634525|NCT00500708|Coronary Heart Disease|coronary heart disease
634526|NCT00500708|Gene Expression|gene expression
634527|NCT00500708|GES|ges
634528|NCT00500708|CVD|cvd
634529|NCT00500708|CHD|chd
634530|NCT00500708|Precision Medicine|precision medicine
634531|NCT00500708|Genome-wide association study|genome-wide association study
634532|NCT00500708|Cardiovascular Disease|cardiovascular disease
634533|NCT00500708|CAD|cad
634534|NCT00500708|GWAS|gwas
634535|NCT00500708|DISCERN|discern
634536|NCT00500682|Kidney Diseases|kidney diseases
634537|NCT00500669|Varicose veins|varicose veins
634538|NCT00500669|wound infection|wound infection
634539|NCT00500669|recurrence|recurrence
634540|NCT00500617|Atherosclerosis|atherosclerosis
634541|NCT00500617|Biological Markers|biological markers
634542|NCT00500617|Molecular Genetics|molecular genetics
634543|NCT00500617|Gene Expression|gene expression
634544|NCT00500617|GES|ges
634545|NCT00500617|CAD|cad
634546|NCT00500617|CVD|cvd
634547|NCT00500617|CHD|chd
634548|NCT00500617|Clinical Validity|clinical validity
634549|NCT00500617|Precision Medicine|precision medicine
634550|NCT00500617|ASGES|asges
634551|NCT00500617|CT Angiography|ct angiography
634552|NCT00500617|Corus CAD|corus cad
634553|NCT00500617|Coronary angiorgram|coronary angiorgram
634554|NCT00500617|Age/Sex/Gene expression Score|age/sex/gene expression score
634555|NCT00500617|Coronary Artery Disease|coronary artery disease
634556|NCT00500617|Angina Pectoris|angina pectoris
634557|NCT00500617|Chest Pain|chest pain
634558|NCT00500617|Cardiovascular Disease|cardiovascular disease
634559|NCT00500617|Coronary Heart Disease|coronary heart disease
634560|NCT00500617|CTA|cta
634561|NCT00500617|PREDICT|predict
634562|NCT00500591|Endometrial Abnormalities|endometrial abnormalities
634563|NCT00500591|Endometrial Cancer|endometrial cancer
634564|NCT00500591|Obesity|obesity
634565|NCT00500591|Survey|survey
634566|NCT00500591|Questionnaire|questionnaire
634567|NCT00500578|Hematological Malignancies|hematological malignancies
634568|NCT00500578|Respiratory Infection|respiratory infection
634569|NCT00500578|Respiratory Syncytial Virus|respiratory syncytial virus
634570|NCT00500578|RSV|rsv
634571|NCT00500578|Ribavirin|ribavirin
634572|NCT00500578|Virazole|virazole
634573|NCT00500565|Breast Cancer|breast cancer
634574|NCT00500565|On-Q Pain Relief System|on-q pain relief system
634575|NCT00500565|Transverse Rectus Abdominous Myocutaneous|transverse rectus abdominous myocutaneous
634576|NCT00500565|Breast Reconstruction|breast reconstruction
634577|NCT00500565|TRAM flap|tram flap
634578|NCT00500565|Bupivicaine|bupivicaine
634579|NCT00500565|Pain Management|pain management
634580|NCT00500552|Perhexiline|perhexiline
634581|NCT00500552|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
634582|NCT00500539|Asthma|asthma
634583|NCT00500539|omalizumab|omalizumab
634584|NCT00500539|safety|safety
634585|NCT00500539|allergic asthma|allergic asthma
634586|NCT00500539|adolescents|adolescents
634587|NCT00500526|COPD|copd
634588|NCT00500526|Pulmonary function|pulmonary function
634589|NCT00500526|Respiratory muscle|respiratory muscle
634590|NCT00500526|Dyspnea|dyspnea
634591|NCT00500526|Quality of life|quality of life
634592|NCT00500513|Lung Cancer|lung cancer
634593|NCT00500513|Respiratory-Induced Tumor Motion|respiratory-induced tumor motion
634594|NCT00500513|Tumor Motion|tumor motion
634595|NCT00500513|Pulmonary Function|pulmonary function
634596|NCT00500513|Fiducial Marker|fiducial marker
634597|NCT00500487|HIV prevention|hiv prevention
634598|NCT00500487|HIV seronegativity|hiv seronegativity
634599|NCT00500474|Meniere's disease|meniere's disease
634600|NCT00500474|inner ear|inner ear
634601|NCT00500474|endolymphatic sac drainage|endolymphatic sac drainage
634602|NCT00500474|steroids|steroids
634603|NCT00500474|declined surgery|declined surgery
634604|NCT00500474|natural course|natural course
634605|NCT00500474|Efficacy of steroids via endolymphatic sac|efficacy of steroids via endolymphatic sac
634606|NCT00500474|for intractable Meniere's disease|for intractable meniere's disease
634607|NCT00500461|Muscarinic Receptor Antagonist,|muscarinic receptor antagonist,
634608|NCT00500461|intravenous infusion,|intravenous infusion,
634609|NCT00500461|pharmacokinetics|pharmacokinetics
634610|NCT00500461|healthy subjects,|healthy subjects,
634611|NCT00500461|safety,|safety,
634612|NCT00500461|tolerability,|tolerability,
634613|NCT00500461|Anticholinergic,|anticholinergic,
634614|NCT00500461|oral dosing,|oral dosing,
634615|NCT00500448|Arthritis, Knee, Quadriceps, Electrical Stimulation, Women|arthritis, knee, quadriceps, electrical stimulation, women
634616|NCT00500435|Cervical Cancer|cervical cancer
634617|NCT00500435|Laparoscopy|laparoscopy
634618|NCT00500435|Lymph Node Dissection|lymph node dissection
634619|NCT00500435|Extraperitoneal Laparoscopic Lymphadenectomy|extraperitoneal laparoscopic lymphadenectomy
634620|NCT00500422|Solid Tumors|solid tumors
634621|NCT00500422|Doxil|doxil
634622|NCT00500422|Adriamycin|adriamycin
634623|NCT00500422|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
634624|NCT00500422|Liposomal Doxorubicin|liposomal doxorubicin
634625|NCT00500422|Doxorubicin Hydrochloride|doxorubicin hydrochloride
634626|NCT00500422|Gemcitabine|gemcitabine
634627|NCT00500422|Gemzar|gemzar
634628|NCT00500422|Bortezomib|bortezomib
634629|NCT00500422|Velcade|velcade
634630|NCT00500422|PS341|ps341
634631|NCT00500422|PS-341|ps-341
634632|NCT00500422|LDP-341|ldp-341
634633|NCT00500422|MLN341|mln341
634634|NCT00500409|rhPTH(1-34)|rhpth(1-34)
634635|NCT00500409|Osteoporosis|osteoporosis
634636|NCT00500396|Retinopathy of Prematurity.|retinopathy of prematurity.
634637|NCT00500396|ROP.|rop.
634638|NCT00500396|Vascular Endothelial Growth Factor.|vascular endothelial growth factor.
634639|NCT00500396|VEGF.|vegf.
634640|NCT00500396|Vitreous.|vitreous.
634641|NCT00500396|Subretinal Fluid.|subretinal fluid.
634642|NCT00500396|ELISA.|elisa.
634643|NCT00500383|Breast Cancer Risk|breast cancer risk
634644|NCT00500383|BRCA1|brca1
634645|NCT00500383|BRCA2|brca2
634646|NCT00500383|Breast Cancer Susceptibility gene|breast cancer susceptibility gene
634647|NCT00500383|Optical Transillumination Spectroscopy|optical transillumination spectroscopy
634648|NCT00500383|Transillumination Breast Spectroscopy|transillumination breast spectroscopy
634649|NCT00500370|exenatide|exenatide
634650|NCT00500370|obesity|obesity
634651|NCT00500370|diabetes|diabetes
634652|NCT00500370|Amylin|amylin
634653|NCT00500370|Lilly|lilly
634654|NCT00500344|Age-related Macular Degeneration|age-related macular degeneration
634655|NCT00500344|Choroidal Neovascularization|choroidal neovascularization
634656|NCT00500344|Electroretinography|electroretinography
634657|NCT00500344|Retinal Function|retinal function
634658|NCT00500331|Pioglitazone|pioglitazone
634659|NCT00500331|HbA1c|hba1c
634660|NCT00500331|Diabetes mellitus|diabetes mellitus
634661|NCT00500318|Bronchitis, Chronic; Emphysema|bronchitis, chronic; emphysema
634662|NCT00500305|indomethacin therapy|indomethacin therapy
634663|NCT00500305|patent ductus arteriosus|patent ductus arteriosus
634664|NCT00500292|colorectal|colorectal
634665|NCT00500292|cancer|cancer
634666|NCT00500292|zactima|zactima
634667|NCT00500279|Drug-eluting stent|drug-eluting stent
634668|NCT00500279|Restenosis|restenosis
634669|NCT00500279|Celecoxib|celecoxib
634670|NCT00500253|exhaled nitric oxide|exhaled nitric oxide
634671|NCT00500253|asthma|asthma
634672|NCT00500253|children|children
634673|NCT00500253|inhaled glucocorticosteroids|inhaled glucocorticosteroids
634674|NCT00500240|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
634675|NCT00500240|Leukemia|leukemia
634676|NCT00500240|Lymphoma|lymphoma
634677|NCT00500240|Burkitts Lymphoma|burkitts lymphoma
634678|NCT00500240|Lymphoblastic Leukemia|lymphoblastic leukemia
634679|NCT00500240|Blood Sugar|blood sugar
634680|NCT00500240|Hyperglycemia|hyperglycemia
634681|NCT00500240|Insulin Aspart|insulin aspart
634682|NCT00500240|Insulin Glargine|insulin glargine
634683|NCT00500240|Hyper-CVAD|hyper-cvad
634684|NCT00500214|inguinal hernia|inguinal hernia
634685|NCT00500214|herniorrhaphy|herniorrhaphy
634686|NCT00500214|mesh repair|mesh repair
634687|NCT00500214|ilioinguinal neurectomy|ilioinguinal neurectomy
634688|NCT00500214|postoperative pain in cases and controls during one year.|postoperative pain in cases and controls during one year.
634689|NCT00500214|postoperative hyposthesia in cases and controls during one year.|postoperative hyposthesia in cases and controls during one year.
634690|NCT00500201|Healthy Volunteer|healthy volunteer
634691|NCT00500188|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
634692|NCT00500188|GIST|gist
634693|NCT00500188|Kit expression|kit expression
634694|NCT00500188|Resectable|resectable
634695|NCT00500188|Imatinib Mesylate|imatinib mesylate
634696|NCT00500188|Gleevec|gleevec
634697|NCT00500188|STI-571|sti-571
634698|NCT00500188|Imatinib|imatinib
634699|NCT00500188|NSC-716051|nsc-716051
634700|NCT00500175|diabetes|diabetes
634701|NCT00500175|ulceration|ulceration
634702|NCT00500175|amputation|amputation
634703|NCT00500175|pressure sores|pressure sores
634704|NCT00500175|shear friction|shear friction
634705|NCT00500136|bias|bias
634706|NCT00500123|alpha-1|alpha-1
634707|NCT00500123|antitrypsin|antitrypsin
634708|NCT00500123|AAT|aat
634709|NCT00500123|genetic testing|genetic testing
634710|NCT00500123|alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
634711|NCT00500123|AATD|aatd
634712|NCT00500110|Prostate Cancer|prostate cancer
634713|NCT00500110|Hormonal Ablation|hormonal ablation
634714|NCT00500110|Docetaxel|docetaxel
634715|NCT00500110|Imatinib Mesylate|imatinib mesylate
634716|NCT00500110|STI571|sti571
634717|NCT00500110|Gleevec|gleevec
634718|NCT00500110|Taxotere|taxotere
634719|NCT00500110|Goserelin Acetate|goserelin acetate
634720|NCT00500110|Zoladex|zoladex
634721|NCT00500110|Leuprolide|leuprolide
634722|NCT00500110|Lupron|lupron
634723|NCT00500084|Chronic Pancreatitis|chronic pancreatitis
634724|NCT00500084|Pancreatectomy|pancreatectomy
634725|NCT00500058|Rituximab,|rituximab,
634726|NCT00500058|oncology|oncology
634727|NCT00500058|IL-18,|il-18,
634728|NCT00500058|combination study,|combination study,
634729|NCT00500058|cytokine,|cytokine,
634730|NCT00500045|CRVO|crvo
634731|NCT00500045|HRVO|hrvo
634732|NCT00500045|BRVO|brvo
634733|NCT00500032|Adult|adult
634734|NCT00499980|Breast cancer|breast cancer
634735|NCT00499980|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
634736|NCT00499980|Oximetry|oximetry
634737|NCT00499967|genital warts|genital warts
634738|NCT00499967|venereal warts|venereal warts
634739|NCT00499967|human papilloma virus|human papilloma virus
634740|NCT00499954|microdialysis|microdialysis
634741|NCT00499954|subcutaneous adipose tissue|subcutaneous adipose tissue
634742|NCT00499954|glucose sensor|glucose sensor
634743|NCT00499954|glucose monitoring|glucose monitoring
634744|NCT00499954|type 1 diabetes|type 1 diabetes
634745|NCT00499954|Guardian RT|guardian rt
634746|NCT00499954|Glucoday S|glucoday s
634747|NCT00499941|Alpha 1-Antitrypsin Deficiency|alpha 1-antitrypsin deficiency
634748|NCT00499928|SB-751689|sb-751689
634749|NCT00499928|osteoporosis|osteoporosis
634750|NCT00499928|metabolism|metabolism
634751|NCT00499928|excretion|excretion
634752|NCT00499902|AIS|ais
634753|NCT00499902|acute ischemic stroke|acute ischemic stroke
634754|NCT00499902|stroke|stroke
634755|NCT00499902|alfimeprase|alfimeprase
634756|NCT00499902|blood clot|blood clot
634757|NCT00499902|brain|brain
634758|NCT00499902|thrombus|thrombus
634759|NCT00499902|thrombolytic|thrombolytic
634760|NCT00499902|thrombosis|thrombosis
634761|NCT00499902|plasminogen activator|plasminogen activator
634762|NCT00499902|arterial flow|arterial flow
634763|NCT00499902|neurology|neurology
634764|NCT00499902|intra-arterial|intra-arterial
634765|NCT00499902|intra-thrombus|intra-thrombus
634766|NCT00499902|catheter-directed|catheter-directed
634767|NCT00499902|symptomatic ICH|symptomatic ich
634768|NCT00499902|ICH|ich
634769|NCT00499902|AOL|aol
634770|NCT00499902|arterial occlusive lesion|arterial occlusive lesion
634771|NCT00499902|recanalization|recanalization
634772|NCT00499889|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
634773|NCT00499889|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
634774|NCT00499889|Leukemia|leukemia
634775|NCT00499889|Imatinib Mesylate|imatinib mesylate
634776|NCT00499889|Gleevec|gleevec
634777|NCT00499889|Busulfan|busulfan
634778|NCT00499889|Busulfex|busulfex
634779|NCT00499889|Myleran|myleran
634780|NCT00499889|Fludarabine|fludarabine
634781|NCT00499889|ATG|atg
634782|NCT00499889|STI571|sti571
634783|NCT00499889|Antithymocyte Globulin|antithymocyte globulin
634784|NCT00499889|Thymoglobulin|thymoglobulin
634785|NCT00499876|Human immune deficiency virus|human immune deficiency virus
634786|NCT00499876|Acquired immune deficiency syndrome|acquired immune deficiency syndrome
634787|NCT00499876|malaria|malaria
634788|NCT00499876|mefloquine|mefloquine
634789|NCT00499876|prophylaxis|prophylaxis
634790|NCT00499876|HIV/AIDS|hiv/aids
634791|NCT00499876|Treatment Naive|treatment naive
634792|NCT00499850|ZD6474|zd6474
634793|NCT00499850|FOLFOX|folfox
634794|NCT00499850|colorectal|colorectal
634795|NCT00499850|adenocarcinoma|adenocarcinoma
634796|NCT00500266|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
634797|NCT00500266|vaccine|vaccine
634798|NCT00499824|Diabetes|diabetes
634799|NCT00499824|Management guidelines|management guidelines
634800|NCT00499824|Efficacy|efficacy
634801|NCT00499798|infertility|infertility
634802|NCT00499798|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
634803|NCT00499798|adult anaplastic astrocytoma|adult anaplastic astrocytoma
634804|NCT00499798|adult diffuse astrocytoma|adult diffuse astrocytoma
634805|NCT00499798|adult giant cell glioblastoma|adult giant cell glioblastoma
634806|NCT00499798|adult gliosarcoma|adult gliosarcoma
634807|NCT00499798|adult pilocytic astrocytoma|adult pilocytic astrocytoma
634808|NCT00499798|adult brain stem glioma|adult brain stem glioma
634809|NCT00499798|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
634810|NCT00499798|adult choroid plexus tumor|adult choroid plexus tumor
634811|NCT00499798|adult craniopharyngioma|adult craniopharyngioma
634812|NCT00499798|adult ependymoblastoma|adult ependymoblastoma
634813|NCT00499798|adult medulloblastoma|adult medulloblastoma
634814|NCT00499798|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
634815|NCT00499798|adult anaplastic ependymoma|adult anaplastic ependymoma
634816|NCT00499798|adult ependymoma|adult ependymoma
634817|NCT00499798|adult myxopapillary ependymoma|adult myxopapillary ependymoma
634818|NCT00499798|adult subependymoma|adult subependymoma
634819|NCT00499798|adult anaplastic meningioma|adult anaplastic meningioma
634820|NCT00499798|meningeal melanocytoma|meningeal melanocytoma
634821|NCT00499798|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
634822|NCT00499798|adult papillary meningioma|adult papillary meningioma
634823|NCT00499798|adult grade I meningioma|adult grade i meningioma
634824|NCT00499798|adult grade II meningioma|adult grade ii meningioma
634825|NCT00499798|adult grade III meningioma|adult grade iii meningioma
634898|NCT00499733|stage IV colon cancer|stage iv colon cancer
634826|NCT00499798|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
634827|NCT00499798|adult oligodendroglioma|adult oligodendroglioma
634828|NCT00499798|adult pineoblastoma|adult pineoblastoma
634829|NCT00499798|adult pineocytoma|adult pineocytoma
634830|NCT00499798|adult mixed glioma|adult mixed glioma
634831|NCT00499798|recurrent adult brain tumor|recurrent adult brain tumor
634832|NCT00499798|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
634833|NCT00499785|depression|depression
634834|NCT00499785|cognitive/functional effects|cognitive/functional effects
634835|NCT00499785|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
634836|NCT00499785|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
634837|NCT00499785|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
634838|NCT00499785|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
634839|NCT00499785|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
634840|NCT00499785|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
634841|NCT00499759|fatigue|fatigue
634842|NCT00499759|depression|depression
634843|NCT00499759|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
634844|NCT00499759|musculoskeletal complications|musculoskeletal complications
634845|NCT00499759|acute undifferentiated leukemia|acute undifferentiated leukemia
634846|NCT00499759|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
634847|NCT00499759|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
634848|NCT00499759|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
634849|NCT00499759|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
634850|NCT00499759|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
634851|NCT00499759|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
634852|NCT00499759|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
634853|NCT00499759|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
634854|NCT00499759|secondary acute myeloid leukemia|secondary acute myeloid leukemia
634855|NCT00499759|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
634856|NCT00499746|drug discrimination|drug discrimination
634857|NCT00499746|opioid pharmacology|opioid pharmacology
634858|NCT00499746|behavioral pharmacology|behavioral pharmacology
634859|NCT00499746|human research|human research
634860|NCT00499733|carcinoma of unknown primary|carcinoma of unknown primary
634861|NCT00499733|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
634862|NCT00499733|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
634863|NCT00499733|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
634864|NCT00499733|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
634865|NCT00499733|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
634866|NCT00499733|extensive stage small cell lung cancer|extensive stage small cell lung cancer
634867|NCT00499733|recurrent small cell lung cancer|recurrent small cell lung cancer
634868|NCT00499733|stage III renal cell cancer|stage iii renal cell cancer
634869|NCT00499733|stage IV renal cell cancer|stage iv renal cell cancer
634870|NCT00499733|recurrent renal cell cancer|recurrent renal cell cancer
634871|NCT00499733|stage III prostate cancer|stage iii prostate cancer
634872|NCT00499733|stage IV prostate cancer|stage iv prostate cancer
634873|NCT00499733|recurrent prostate cancer|recurrent prostate cancer
634874|NCT00499733|male breast cancer|male breast cancer
634875|NCT00499733|recurrent breast cancer|recurrent breast cancer
634876|NCT00499733|stage IIIA breast cancer|stage iiia breast cancer
634877|NCT00499733|stage IIIB breast cancer|stage iiib breast cancer
634878|NCT00499733|stage IIIC breast cancer|stage iiic breast cancer
634879|NCT00499733|stage IV breast cancer|stage iv breast cancer
634880|NCT00499733|chondrosarcoma|chondrosarcoma
634881|NCT00499733|metastatic osteosarcoma|metastatic osteosarcoma
634882|NCT00499733|recurrent osteosarcoma|recurrent osteosarcoma
634883|NCT00499733|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
634884|NCT00499733|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
634885|NCT00499733|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
634886|NCT00499733|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
634887|NCT00499733|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
634888|NCT00499733|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
634889|NCT00499733|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
634890|NCT00499733|ovarian sarcoma|ovarian sarcoma
634891|NCT00499733|stage III uterine sarcoma|stage iii uterine sarcoma
634892|NCT00499733|stage IV uterine sarcoma|stage iv uterine sarcoma
634893|NCT00499733|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
634894|NCT00499733|classic Kaposi sarcoma|classic kaposi sarcoma
634895|NCT00499733|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
634896|NCT00499733|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
634897|NCT00499733|stage III colon cancer|stage iii colon cancer
634899|NCT00499733|recurrent colon cancer|recurrent colon cancer
634900|NCT00499733|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
634901|NCT00499733|recurrent adult primary liver cancer|recurrent adult primary liver cancer
634902|NCT00499733|recurrent childhood liver cancer|recurrent childhood liver cancer
634903|NCT00499733|stage III childhood liver cancer|stage iii childhood liver cancer
634904|NCT00499733|stage IV childhood liver cancer|stage iv childhood liver cancer
634905|NCT00499733|stage III pancreatic cancer|stage iii pancreatic cancer
634906|NCT00499733|localized osteosarcoma|localized osteosarcoma
634907|NCT00499733|malignant giant cell tumor of bone|malignant giant cell tumor of bone
634908|NCT00499733|stage IV melanoma|stage iv melanoma
634909|NCT00499733|recurrent melanoma|recurrent melanoma
634910|NCT00499733|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
634911|NCT00499733|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
634912|NCT00499733|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
634913|NCT00499733|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
634914|NCT00499733|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
634915|NCT00499733|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
634916|NCT00499733|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
634917|NCT00499733|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
634918|NCT00499733|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
634919|NCT00499733|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
634920|NCT00499733|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
634921|NCT00499733|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
634922|NCT00499733|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
634923|NCT00499733|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
634924|NCT00499733|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
634925|NCT00499733|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
634926|NCT00499733|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
634927|NCT00499733|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
634928|NCT00499733|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
634929|NCT00499733|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
634930|NCT00499733|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
634931|NCT00499733|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
634932|NCT00499733|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
634933|NCT00499733|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
634934|NCT00499733|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
634935|NCT00499733|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
634936|NCT00499733|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
634937|NCT00499733|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
634938|NCT00499733|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
634939|NCT00499733|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
634940|NCT00499733|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
634941|NCT00499733|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
634942|NCT00499733|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
634943|NCT00499733|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
634944|NCT00499733|salivary gland adenocarcinoma|salivary gland adenocarcinoma
634945|NCT00499733|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
634946|NCT00499733|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
634947|NCT00499733|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
634948|NCT00499733|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
634949|NCT00499733|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
634950|NCT00499733|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
634951|NCT00499733|salivary gland acinic cell tumor|salivary gland acinic cell tumor
634952|NCT00499733|stage III salivary gland cancer|stage iii salivary gland cancer
634953|NCT00499733|stage IV salivary gland cancer|stage iv salivary gland cancer
634954|NCT00499733|recurrent salivary gland cancer|recurrent salivary gland cancer
634955|NCT00499733|intraocular lymphoma|intraocular lymphoma
634956|NCT00499733|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
634957|NCT00499733|recurrent pancreatic cancer|recurrent pancreatic cancer
634958|NCT00499733|recurrent uterine sarcoma|recurrent uterine sarcoma
634959|NCT00499733|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
634960|NCT00499733|advanced adult primary liver cancer|advanced adult primary liver cancer
634961|NCT00499733|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
634962|NCT00499733|conjunctival melanoma|conjunctival melanoma
634963|NCT00499733|stage IV pancreatic cancer|stage iv pancreatic cancer
634964|NCT00499733|stage IIIA melanoma|stage iiia melanoma
634965|NCT00499733|stage IIIB melanoma|stage iiib melanoma
634966|NCT00499733|stage IIIC melanoma|stage iiic melanoma
634967|NCT00499733|tongue cancer|tongue cancer
634968|NCT00499720|Cystic Fibrosis|cystic fibrosis
634969|NCT00499720|Pseudomonas aeruginosa|pseudomonas aeruginosa
634970|NCT00499720|airway infection|airway infection
634971|NCT00499720|Aztreonam Lysine for Inhalation|aztreonam lysine for inhalation
634972|NCT00499707|HbA1c|hba1c
634973|NCT00499707|Drug-naive|drug-naive
634974|NCT00499707|type 2 diabetes|type 2 diabetes
634975|NCT00499694|stage IV prostate cancer|stage iv prostate cancer
634976|NCT00499694|recurrent prostate cancer|recurrent prostate cancer
634977|NCT00499694|adenocarcinoma of the prostate|adenocarcinoma of the prostate
634978|NCT00499681|stage I breast cancer|stage i breast cancer
634979|NCT00499681|stage II breast cancer|stage ii breast cancer
634980|NCT00499681|stage IIIA breast cancer|stage iiia breast cancer
634981|NCT00499681|stage IIIB breast cancer|stage iiib breast cancer
634982|NCT00499668|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
634983|NCT00499668|nausea and vomiting|nausea and vomiting
634984|NCT00499668|chronic myelogenous leukemia|chronic myelogenous leukemia
634985|NCT00499668|chronic eosinophilic leukemia|chronic eosinophilic leukemia
634986|NCT00499668|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
634987|NCT00499668|chronic neutrophilic leukemia|chronic neutrophilic leukemia
634988|NCT00499668|essential thrombocythemia|essential thrombocythemia
634989|NCT00499668|polycythemia vera|polycythemia vera
634990|NCT00499668|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
634991|NCT00499668|adult acute myeloid leukemia|adult acute myeloid leukemia
634992|NCT00499668|acute undifferentiated leukemia|acute undifferentiated leukemia
634993|NCT00499668|mast cell leukemia|mast cell leukemia
634994|NCT00499668|adult T-cell leukemia/lymphoma|adult t-cell leukemia/lymphoma
634995|NCT00499668|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
634996|NCT00499668|chronic lymphocytic leukemia|chronic lymphocytic leukemia
634997|NCT00499668|hairy cell leukemia|hairy cell leukemia
634998|NCT00499668|prolymphocytic leukemia|prolymphocytic leukemia
634999|NCT00499668|AIDS-related lymphoma|aids-related lymphoma
635000|NCT00499668|adult Hodgkin lymphoma|adult hodgkin lymphoma
635001|NCT00499668|anaplastic large cell lymphoma|anaplastic large cell lymphoma
635002|NCT00499668|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
635003|NCT00499668|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
635004|NCT00499668|cutaneous T-cell non-Hodgkin lymphoma|cutaneous t-cell non-hodgkin lymphoma
635005|NCT00499668|mycosis fungoides/Sezary syndrome|mycosis fungoides/sezary syndrome
635006|NCT00499668|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
635007|NCT00499668|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
635008|NCT00499668|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
635009|NCT00499668|adult Burkitt lymphoma|adult burkitt lymphoma
635010|NCT00499668|adult diffuse large cell lymphoma|adult diffuse large cell lymphoma
635011|NCT00499668|adult diffuse mixed cell lymphoma|adult diffuse mixed cell lymphoma
635012|NCT00499668|adult diffuse small cleaved cell lymphoma|adult diffuse small cleaved cell lymphoma
635013|NCT00499668|adult immunoblastic large cell lymphoma|adult immunoblastic large cell lymphoma
635014|NCT00499668|adult lymphoblastic lymphoma|adult lymphoblastic lymphoma
635015|NCT00499668|grade 1 follicular lymphoma|grade 1 follicular lymphoma
635016|NCT00499668|grade 2 follicular lymphoma|grade 2 follicular lymphoma
635017|NCT00499668|grade 3 follicular lymphoma|grade 3 follicular lymphoma
635018|NCT00499668|mantle cell lymphoma|mantle cell lymphoma
635019|NCT00499668|marginal zone lymphoma|marginal zone lymphoma
635020|NCT00499668|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
635021|NCT00499668|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
635022|NCT00499668|splenic marginal zone lymphoma|splenic marginal zone lymphoma
635023|NCT00499668|small lymphocytic lymphoma|small lymphocytic lymphoma
635024|NCT00499668|intraocular lymphoma|intraocular lymphoma
635025|NCT00499668|primary central nervous system lymphoma|primary central nervous system lymphoma
635026|NCT00499668|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
635027|NCT00499668|multiple myeloma and other plasma cell neoplasms|multiple myeloma and other plasma cell neoplasms
635028|NCT00499668|myelodysplastic syndromes|myelodysplastic syndromes
635029|NCT00499668|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
635030|NCT00499668|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
635031|NCT00499668|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
635032|NCT00499668|chronic myeloproliferative disorders|chronic myeloproliferative disorders
635033|NCT00499668|myelodysplastic/myeloproliferative diseases|myelodysplastic/myeloproliferative diseases
635034|NCT00499642|Healthy Subjects|healthy subjects
635035|NCT00499629|healthy subjects|healthy subjects
635036|NCT00499616|regional neuroblastoma|regional neuroblastoma
635037|NCT00499616|disseminated neuroblastoma|disseminated neuroblastoma
635038|NCT00499616|stage 4S neuroblastoma|stage 4s neuroblastoma
635039|NCT00499616|localized unresectable neuroblastoma|localized unresectable neuroblastoma
635040|NCT00499616|localized resectable neuroblastoma|localized resectable neuroblastoma
635041|NCT00499603|Breast Cancer|breast cancer
635042|NCT00499603|ER negative|er negative
635043|NCT00499603|PR negative|pr negative
635044|NCT00499603|HER2neu negative|her2neu negative
635045|NCT00499603|Tumor Triple Negative Receptors|tumor triple negative receptors
635046|NCT00499603|Paclitaxel|paclitaxel
635047|NCT00499603|Taxol|taxol
635048|NCT00499603|RAD001|rad001
635049|NCT00499603|FEC|fec
635050|NCT00499603|5-Fluorouracil|5-fluorouracil
635051|NCT00499603|5-FU|5-fu
635052|NCT00499603|Adrucil|adrucil
635053|NCT00499603|Efudex|efudex
635054|NCT00499603|Epirubicin|epirubicin
635055|NCT00499603|Cyclophosphamide|cyclophosphamide
635056|NCT00499590|AMD|amd
635057|NCT00499590|Macular Degeneration|macular degeneration
635058|NCT00499590|bevasiranib|bevasiranib
635059|NCT00499590|COBALT study|cobalt study
635060|NCT00499590|age related macular degeneration|age related macular degeneration
635061|NCT00499590|wet AMD|wet amd
635062|NCT00499590|wet age related macular degeneration|wet age related macular degeneration
635063|NCT00499577|stage I multiple myeloma|stage i multiple myeloma
635064|NCT00499577|stage II multiple myeloma|stage ii multiple myeloma
635065|NCT00499577|stage III multiple myeloma|stage iii multiple myeloma
635066|NCT00499577|refractory multiple myeloma|refractory multiple myeloma
635067|NCT00499551|Anterior Uveitis|anterior uveitis
635068|NCT00499551|Posterior Uveitis|posterior uveitis
635069|NCT00499551|Intermediate Uveitis|intermediate uveitis
635070|NCT00499551|Panuveitis|panuveitis
635071|NCT00499551|Iontophoresis|iontophoresis
635072|NCT00499551|Dexamethasone|dexamethasone
635073|NCT00499538|healthy subjects|healthy subjects
635074|NCT00499525|male breast cancer|male breast cancer
635075|NCT00499525|recurrent breast cancer|recurrent breast cancer
635076|NCT00499525|stage IIIB breast cancer|stage iiib breast cancer
635077|NCT00499525|stage IIIC breast cancer|stage iiic breast cancer
635078|NCT00499525|stage IV breast cancer|stage iv breast cancer
635079|NCT00499525|stage IIIA breast cancer|stage iiia breast cancer
635080|NCT00499512|Ovarian Cancer|ovarian cancer
635081|NCT00499512|Peritoneal Cancer|peritoneal cancer
635082|NCT00499512|Fallopian Tube Cancer|fallopian tube cancer
635083|NCT00499512|Spirituality|spirituality
635084|NCT00499512|Religion|religion
635085|NCT00499512|Quality of Life|quality of life
635086|NCT00499512|Questionnaire|questionnaire
635088|NCT00499499|Cancer|cancer
635089|NCT00499499|solid tumors|solid tumors
635090|NCT00499486|recurrent pancreatic cancer|recurrent pancreatic cancer
635091|NCT00499486|stage III pancreatic cancer|stage iii pancreatic cancer
635092|NCT00499486|stage IV pancreatic cancer|stage iv pancreatic cancer
635093|NCT00499486|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
635094|NCT00499460|Healthy, No Evidence of Disease|healthy, no evidence of disease
635095|NCT00499447|stage I non-small cell lung cancer|stage i non-small cell lung cancer
635096|NCT00499447|adenocarcinoma of the lung|adenocarcinoma of the lung
635097|NCT00499447|adenosquamous cell lung cancer|adenosquamous cell lung cancer
635098|NCT00499447|large cell lung cancer|large cell lung cancer
635099|NCT00499447|squamous cell lung cancer|squamous cell lung cancer
635100|NCT00499434|aids|aids
635101|NCT00499421|Prostate Cancer|prostate cancer
635102|NCT00499421|External Beam Radiation Therapy|external beam radiation therapy
635103|NCT00499421|Fiducial Markers|fiducial markers
635104|NCT00499421|Acculoc System|acculoc system
635105|NCT00499421|Center Of Mass|center of mass
635106|NCT00499421|EBRT|ebrt
635107|NCT00499408|adenocarcinoma of the prostate|adenocarcinoma of the prostate
635108|NCT00499408|stage I prostate cancer|stage i prostate cancer
635109|NCT00499408|stage II prostate cancer|stage ii prostate cancer
635110|NCT00499408|stage III prostate cancer|stage iii prostate cancer
635111|NCT00499395|stage IV colon cancer|stage iv colon cancer
635112|NCT00499395|stage IV rectal cancer|stage iv rectal cancer
635113|NCT00499395|recurrent colon cancer|recurrent colon cancer
635114|NCT00499395|recurrent rectal cancer|recurrent rectal cancer
635115|NCT00499395|liver metastases|liver metastases
635116|NCT00499382|Advanced Cancers|advanced cancers
635117|NCT00499382|Cardiac Function|cardiac function
635118|NCT00499382|Nuclear Medicine Cardiac Scan|nuclear medicine cardiac scan
635119|NCT00499382|Positron Emission Tomography|positron emission tomography
635120|NCT00499382|Radionuclide Ventriculography|radionuclide ventriculography
635121|NCT00499382|Ventricular Ejection Fraction|ventricular ejection fraction
635122|NCT00499382|PET/CT|pet/ct
635123|NCT00499382|RNV|rnv
635124|NCT00499356|friction|friction
635125|NCT00499356|pressure|pressure
635126|NCT00499356|insole|insole
635127|NCT00499356|ulcer|ulcer
635128|NCT00499356|prevention|prevention
635129|NCT00499343|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
635130|NCT00499343|Lymphoma|lymphoma
635131|NCT00499343|Etoposide|etoposide
635132|NCT00499343|G-CSF|g-csf
635133|NCT00499343|GM-CSF|gm-csf
635134|NCT00499343|Isophosphamide|isophosphamide
635135|NCT00499343|Rituximab|rituximab
635136|NCT00499343|Ifosfamide|ifosfamide
635137|NCT00499343|Sargramostim|sargramostim
635138|NCT00499343|Leukine|leukine
635139|NCT00499343|Filgrastim|filgrastim
635140|NCT00499343|Neupogen|neupogen
635141|NCT00499343|Apheresis|apheresis
635142|NCT00499343|Stem Cell Collection|stem cell collection
635143|NCT00499330|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
635144|NCT00499330|adenocarcinoma of the lung|adenocarcinoma of the lung
635145|NCT00499330|squamous cell lung cancer|squamous cell lung cancer
635146|NCT00499330|large cell lung cancer|large cell lung cancer
635147|NCT00499330|adenosquamous cell lung cancer|adenosquamous cell lung cancer
635148|NCT00499330|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
635149|NCT00499317|Urgency|urgency
635150|NCT00499317|Frequency|frequency
635151|NCT00499317|Pelvic pain|pelvic pain
635152|NCT00499317|Sexual dysfunction|sexual dysfunction
635153|NCT00499317|Erectile dysfunction|erectile dysfunction
635154|NCT00499317|Painful intercourse|painful intercourse
635155|NCT00499304|Forced oscillation Technique (FOT)|forced oscillation technique (fot)
635156|NCT00499304|Expiratory flow limitation (EFL)|expiratory flow limitation (efl)
635157|NCT00499304|Breathing artifacts|breathing artifacts
635158|NCT00499304|COPD|copd
635159|NCT00499291|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
635160|NCT00499291|recurrent breast cancer|recurrent breast cancer
635161|NCT00499291|stage IIIA breast cancer|stage iiia breast cancer
635162|NCT00499291|stage IIIB breast cancer|stage iiib breast cancer
635163|NCT00499291|stage IIIC breast cancer|stage iiic breast cancer
635164|NCT00499291|recurrent prostate cancer|recurrent prostate cancer
635165|NCT00499291|stage III prostate cancer|stage iii prostate cancer
635166|NCT00499291|stage IV prostate cancer|stage iv prostate cancer
635167|NCT00499291|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
635168|NCT00499291|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
635169|NCT00499291|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
635170|NCT00499291|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
635171|NCT00499291|extensive stage small cell lung cancer|extensive stage small cell lung cancer
635172|NCT00499291|recurrent small cell lung cancer|recurrent small cell lung cancer
635173|NCT00499291|recurrent bladder cancer|recurrent bladder cancer
635174|NCT00499291|stage III bladder cancer|stage iii bladder cancer
635175|NCT00499291|stage IV bladder cancer|stage iv bladder cancer
635176|NCT00499291|recurrent renal cell cancer|recurrent renal cell cancer
635177|NCT00499291|stage III renal cell cancer|stage iii renal cell cancer
635178|NCT00499291|stage IV renal cell cancer|stage iv renal cell cancer
635179|NCT00499291|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
635180|NCT00499291|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
635181|NCT00499291|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
635182|NCT00499291|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
635183|NCT00499291|recurrent cervical cancer|recurrent cervical cancer
635184|NCT00499291|stage III cervical cancer|stage iii cervical cancer
635185|NCT00499291|stage IVA cervical cancer|stage iva cervical cancer
635186|NCT00499291|stage IVB cervical cancer|stage ivb cervical cancer
635187|NCT00499291|recurrent endometrial carcinoma|recurrent endometrial carcinoma
635188|NCT00499291|stage III endometrial carcinoma|stage iii endometrial carcinoma
635189|NCT00499291|stage IV endometrial carcinoma|stage iv endometrial carcinoma
635190|NCT00499291|fallopian tube cancer|fallopian tube cancer
635191|NCT00499291|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
635192|NCT00499291|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
635193|NCT00499291|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
635194|NCT00499291|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
635195|NCT00499291|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
635196|NCT00499291|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
635197|NCT00499291|ovarian sarcoma|ovarian sarcoma
635198|NCT00499291|ovarian stromal cancer|ovarian stromal cancer
635199|NCT00499291|recurrent uterine sarcoma|recurrent uterine sarcoma
635200|NCT00499291|stage III uterine sarcoma|stage iii uterine sarcoma
635201|NCT00499291|stage IV uterine sarcoma|stage iv uterine sarcoma
635202|NCT00499291|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
635203|NCT00499291|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
635204|NCT00499291|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
635205|NCT00499291|recurrent laryngeal cancer|recurrent laryngeal cancer
635206|NCT00499291|stage III laryngeal cancer|stage iii laryngeal cancer
635207|NCT00499291|stage IV laryngeal cancer|stage iv laryngeal cancer
635208|NCT00499291|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
635209|NCT00499291|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
635210|NCT00499291|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
635387|NCT00498719|Brain Tumor|brain tumor
635211|NCT00499291|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
635212|NCT00499291|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
635213|NCT00499291|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
635214|NCT00499291|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
635215|NCT00499291|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
635216|NCT00499291|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
635217|NCT00499291|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
635218|NCT00499291|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
635219|NCT00499291|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
635220|NCT00499291|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
635221|NCT00499291|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
635222|NCT00499291|recurrent salivary gland cancer|recurrent salivary gland cancer
635223|NCT00499291|stage III salivary gland cancer|stage iii salivary gland cancer
635224|NCT00499291|stage IV salivary gland cancer|stage iv salivary gland cancer
635225|NCT00499291|recurrent esophageal cancer|recurrent esophageal cancer
635226|NCT00499291|stage III esophageal cancer|stage iii esophageal cancer
635227|NCT00499291|stage IV esophageal cancer|stage iv esophageal cancer
635228|NCT00499291|recurrent gastric cancer|recurrent gastric cancer
635229|NCT00499291|stage III gastric cancer|stage iii gastric cancer
635230|NCT00499291|stage IV gastric cancer|stage iv gastric cancer
635231|NCT00499291|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
635232|NCT00499291|adult teratoma|adult teratoma
635233|NCT00499291|ovarian teratoma|ovarian teratoma
635234|NCT00499291|testicular teratoma|testicular teratoma
635235|NCT00499291|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
635236|NCT00499291|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
635237|NCT00499291|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
635238|NCT00499291|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
635239|NCT00499278|Osteoarthritis|osteoarthritis
635240|NCT00499278|joint|joint
635241|NCT00499278|knee|knee
635243|NCT00499278|surgery|surgery
635244|NCT00499265|recurrent pancreatic cancer|recurrent pancreatic cancer
635245|NCT00499265|stage III pancreatic cancer|stage iii pancreatic cancer
635246|NCT00499265|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
635247|NCT00499239|Hematologic Malignancies|hematologic malignancies
635248|NCT00499239|CLL|cll
635249|NCT00499239|NHL|nhl
635250|NCT00499239|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
635251|NCT00499239|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
635252|NCT00499239|CLL and NHL|cll and nhl
635253|NCT00499239|Multiple Myeloma|multiple myeloma
635254|NCT00499239|MM|mm
635255|NCT00499187|Fanconi|fanconi
635256|NCT00499187|Kidney|kidney
635257|NCT00499187|Renal|renal
635258|NCT00499187|HIV|hiv
635259|NCT00499187|HIV-1|hiv-1
635260|NCT00499187|Treatment Experienced|treatment experienced
635261|NCT00499174|stage II prostate cancer|stage ii prostate cancer
635262|NCT00499174|adenocarcinoma of the prostate|adenocarcinoma of the prostate
635263|NCT00499161|Individualized care|individualized care
635264|NCT00499161|Relationship based care|relationship based care
635265|NCT00499161|Negotiated care|negotiated care
635266|NCT00499161|Patient focused care|patient focused care
635267|NCT00499122|stage II breast cancer|stage ii breast cancer
635268|NCT00499122|stage IIIC breast cancer|stage iiic breast cancer
635269|NCT00499122|inflammatory breast cancer|inflammatory breast cancer
635270|NCT00499109|RRM1|rrm1
635271|NCT00499109|ERCC1|ercc1
635272|NCT00499109|Customized Chemotherapy|customized chemotherapy
635273|NCT00499096|Chronic Illness|chronic illness
635274|NCT00499096|Disease management|disease management
635275|NCT00499096|Health Behaviors|health behaviors
635276|NCT00499096|Mood Disorders-Bipolar|mood disorders-bipolar
635277|NCT00499083|stage II breast cancer|stage ii breast cancer
635278|NCT00499083|stage IIIA breast cancer|stage iiia breast cancer
635279|NCT00499083|stage IIIB breast cancer|stage iiib breast cancer
635280|NCT00499083|stage IIIC breast cancer|stage iiic breast cancer
635281|NCT00499070|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
635282|NCT00499070|aplastic anemia|aplastic anemia
635283|NCT00499070|Fanconi anemia|fanconi anemia
635284|NCT00499070|dyskeratosis congenita|dyskeratosis congenita
635285|NCT00499070|Shwachman-Diamond syndrome|shwachman-diamond syndrome
635286|NCT00499070|Pearson marrow-pancreas syndrome|pearson marrow-pancreas syndrome
635287|NCT00499057|early stage breast cancer|early stage breast cancer
635288|NCT00499044|cognition|cognition
635289|NCT00499044|attention|attention
635290|NCT00499044|memory|memory
635291|NCT00499044|concentration|concentration
635292|NCT00499044|schizophrenia|schizophrenia
635293|NCT00499018|Large B-Cell Lymphoma|large b-cell lymphoma
635294|NCT00499018|Rituximab|rituximab
635295|NCT00499018|Autologous Stem Cell Transplantation|autologous stem cell transplantation
635296|NCT00498992|dermatologic complications|dermatologic complications
635297|NCT00498992|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
635298|NCT00498979|stage IV melanoma|stage iv melanoma
635299|NCT00498979|adult anaplastic astrocytoma|adult anaplastic astrocytoma
635300|NCT00498979|adult diffuse astrocytoma|adult diffuse astrocytoma
635301|NCT00498979|adult glioblastoma|adult glioblastoma
635302|NCT00498979|adult giant cell glioblastoma|adult giant cell glioblastoma
635303|NCT00498979|adult pilocytic astrocytoma|adult pilocytic astrocytoma
635304|NCT00498979|adult brain stem glioma|adult brain stem glioma
635305|NCT00498979|adult anaplastic ependymoma|adult anaplastic ependymoma
635306|NCT00498979|adult ependymoma|adult ependymoma
635307|NCT00498979|adult myxopapillary ependymoma|adult myxopapillary ependymoma
635308|NCT00498979|adult subependymoma|adult subependymoma
635309|NCT00498979|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
635310|NCT00498979|adult oligodendroglioma|adult oligodendroglioma
635311|NCT00498979|mixed gliomas|mixed gliomas
635312|NCT00498979|recurrent adult brain tumor|recurrent adult brain tumor
635313|NCT00498979|recurrent melanoma|recurrent melanoma
635314|NCT00498979|adult gliosarcoma|adult gliosarcoma
635315|NCT00498979|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
635316|NCT00498979|adult pineal gland astrocytoma|adult pineal gland astrocytoma
635317|NCT00498966|Kidney|kidney
635318|NCT00498966|perifosine|perifosine
635319|NCT00498966|Progression on treatment with sunitinib or sorafenib|progression on treatment with sunitinib or sorafenib
635320|NCT00498953|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
635321|NCT00498953|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
635322|NCT00498953|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
635323|NCT00498953|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
635324|NCT00498953|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
635325|NCT00498940|LV function, Compliance, wall motion, echocardiography|lv function, compliance, wall motion, echocardiography
635326|NCT00498927|recurrent adult brain tumor|recurrent adult brain tumor
635327|NCT00498927|adult giant cell glioblastoma|adult giant cell glioblastoma
635328|NCT00498927|adult glioblastoma|adult glioblastoma
635329|NCT00498927|adult gliosarcoma|adult gliosarcoma
635330|NCT00498927|adult anaplastic astrocytoma|adult anaplastic astrocytoma
635331|NCT00498927|adult diffuse astrocytoma|adult diffuse astrocytoma
635332|NCT00498927|adult pilocytic astrocytoma|adult pilocytic astrocytoma
635333|NCT00498927|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
635334|NCT00498927|adult anaplastic ependymoma|adult anaplastic ependymoma
635335|NCT00498927|adult ependymoma|adult ependymoma
635336|NCT00498927|adult myxopapillary ependymoma|adult myxopapillary ependymoma
635337|NCT00498927|adult subependymoma|adult subependymoma
635338|NCT00498927|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
635339|NCT00498927|adult oligodendroglioma|adult oligodendroglioma
635340|NCT00498927|adult brain stem glioma|adult brain stem glioma
635341|NCT00498927|adult mixed glioma|adult mixed glioma
635342|NCT00498927|adult pineal gland astrocytoma|adult pineal gland astrocytoma
635343|NCT00498914|Lymphoma, Large-Cell, Diffuse|lymphoma, large-cell, diffuse
635344|NCT00498914|Lymphoma, B-Cell|lymphoma, b-cell
635345|NCT00498914|YM155|ym155
635346|NCT00498914|Treatment outcomes|treatment outcomes
635347|NCT00498914|Refractory|refractory
635348|NCT00498901|stage IV breast cancer|stage iv breast cancer
635349|NCT00498901|recurrent breast cancer|recurrent breast cancer
635350|NCT00498888|urge urinary incontinence|urge urinary incontinence
635351|NCT00498888|rehabilitation|rehabilitation
635352|NCT00498888|anticholinergic|anticholinergic
635353|NCT00498875|Oropharyngeal Cancer|oropharyngeal cancer
635354|NCT00498875|Head and Neck Cancer|head and neck cancer
635355|NCT00498875|Depression|depression
635356|NCT00498875|Questionnaire|questionnaire
635357|NCT00498875|Survey|survey
635358|NCT00498875|Interview|interview
635359|NCT00498849|Sleep apnea|sleep apnea
635360|NCT00498849|Continuous positive airway pressure|continuous positive airway pressure
635361|NCT00498849|Microarray|microarray
635362|NCT00498849|Polysomnography|polysomnography
635363|NCT00498836|CP-4055|cp-4055
635364|NCT00498836|Elacyt|elacyt
635365|NCT00498836|Cancer|cancer
635366|NCT00498836|Metastatic|metastatic
635367|NCT00498836|Malignant melanoma|malignant melanoma
635368|NCT00498836|Combination treatment|combination treatment
635369|NCT00498836|Sorafenib|sorafenib
635370|NCT00498836|Nexavar|nexavar
635371|NCT00498797|prostate cancer|prostate cancer
635372|NCT00498797|zactima|zactima
635373|NCT00498797|vandetanib|vandetanib
635374|NCT00498797|metastatic|metastatic
635375|NCT00498784|Intra-uterine contraception|intra-uterine contraception
635376|NCT00498784|Intrauterine Devices|intrauterine devices
635377|NCT00498771|Lymphedema|lymphedema
635378|NCT00498771|Aquatic Exercise|aquatic exercise
635379|NCT00498771|Breast Cancer|breast cancer
635380|NCT00498758|Parkinson's disease|parkinson's disease
635381|NCT00498758|Gait Disturbances|gait disturbances
635382|NCT00498758|Mobility|mobility
635383|NCT00498758|Quality of life|quality of life
635384|NCT00498732|Obstructive sleep apnea syndrome; CPAP, microarray|obstructive sleep apnea syndrome; cpap, microarray
635385|NCT00498719|Leukemia|leukemia
635386|NCT00498719|Lymphoma|lymphoma
635388|NCT00498719|Attention Deficit|attention deficit
635389|NCT00498719|Cognitive Training Program|cognitive training program
635390|NCT00498719|Central Nervous System|central nervous system
635392|NCT00498719|CTP|ctp
635393|NCT00498706|Depressive Disorder, Major|depressive disorder, major
635394|NCT00498706|Cognitive Behavioral Therapy|cognitive behavioral therapy
635395|NCT00498706|Psychotherapy|psychotherapy
635396|NCT00498706|Telemedicine|telemedicine
635397|NCT00498706|Primary Care|primary care
635398|NCT00498680|Erectile Dysfunction|erectile dysfunction
635399|NCT00498680|Treatment|treatment
635400|NCT00498680|PDE5i|pde5i
635401|NCT00498667|PET/CT|pet/ct
635402|NCT00498667|Aggressive non-Hodgkin Lymphoma|aggressive non-hodgkin lymphoma
635403|NCT00498654|Prevention of Typhoid Fever in Adult Travelers|prevention of typhoid fever in adult travelers
635404|NCT00498641|perceptual learning|perceptual learning
635405|NCT00498641|occlusion therapy|occlusion therapy
635406|NCT00498628|Alcoholism|alcoholism
635407|NCT00498628|Alcohol dependence|alcohol dependence
635408|NCT00498628|Quetiapine|quetiapine
635409|NCT00498615|scleroderma|scleroderma
635410|NCT00498615|Raynaud's phenomenon|raynaud's phenomenon
635411|NCT00498615|Rho-kinase inhibitor|rho-kinase inhibitor
635412|NCT00498576|hypertension|hypertension
635413|NCT00498576|kidney transplant|kidney transplant
635414|NCT00498576|melatonin|melatonin
635415|NCT00498576|adiponectin|adiponectin
635416|NCT00498563|high altitude|high altitude
635417|NCT00498563|sleep|sleep
635418|NCT00498563|altitude illness|altitude illness
635419|NCT00498563|neurobehavioral manifestations|neurobehavioral manifestations
635420|NCT00498563|psychomotor performance|psychomotor performance
635421|NCT00498563|mood states|mood states
635422|NCT00498550|Clozapine|clozapine
635423|NCT00498550|Schizophrenia|schizophrenia
635424|NCT00498550|Dual Diagnosis|dual diagnosis
635425|NCT00498550|Substance Abuse|substance abuse
635426|NCT00498550|Cannabis Abuse|cannabis abuse
635427|NCT00498537|spironolactone|spironolactone
635428|NCT00498537|aldosterone|aldosterone
635429|NCT00498537|diabetic nephropathy|diabetic nephropathy
635430|NCT00498537|proteinuria|proteinuria
635431|NCT00498537|hyperkalemia|hyperkalemia
635432|NCT00498537|albuminuria|albuminuria
635433|NCT00498537|renal failure|renal failure
635434|NCT00498524|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
635435|NCT00498524|ischemic cardiomyopathy|ischemic cardiomyopathy
635436|NCT00498524|ventricular arrhythmias|ventricular arrhythmias
635437|NCT00498524|sibling concordance|sibling concordance
635438|NCT00498511|Anemia, Iron-Deficiency|anemia, iron-deficiency
635439|NCT00498511|Endoscopy, Gastrointestinal|endoscopy, gastrointestinal
635440|NCT00498511|Male, aged 18 to 40|male, aged 18 to 40
635441|NCT00498498|severe head injury|severe head injury
635442|NCT00498498|Endothelin|endothelin
635444|NCT00498498|Plasma|plasma
635445|NCT00498498|Cellular Apoptosis|cellular apoptosis
635446|NCT00498485|chronic|chronic
635447|NCT00498485|fatigue|fatigue
635448|NCT00498485|pain|pain
635449|NCT00498485|sleep|sleep
635450|NCT00498485|xyrem|xyrem
635451|NCT00498485|must have chronic fatigue syndrome|must have chronic fatigue syndrome
635452|NCT00498485|no hypertension|no hypertension
635453|NCT00498485|no sleep apnea|no sleep apnea
635454|NCT00498472|BNP|bnp
635455|NCT00498472|heart failure|heart failure
635456|NCT00498459|Physical activity|physical activity
635457|NCT00498459|Randomised trial|randomised trial
635458|NCT00498459|Prevention|prevention
635459|NCT00498459|Adolescents|adolescents
635460|NCT00498459|Obesity|obesity
635461|NCT00498459|Cardiovascular risk factors|cardiovascular risk factors
635462|NCT00498433|Aliskiren|aliskiren
635463|NCT00498433|Renin-Angiotensin System (RAS)|renin-angiotensin system (ras)
635464|NCT00498433|Hypertension|hypertension
635465|NCT00498433|Abdominal obesity|abdominal obesity
635466|NCT00498420|HUE-MAN|hue-man
635467|NCT00498420|Rare disorder|rare disorder
635468|NCT00498420|Hepatosplenomegaly|hepatosplenomegaly
635469|NCT00498420|Dysostosis|dysostosis
635470|NCT00498407|CP-4055|cp-4055
635471|NCT00498407|ELACYT(TM)|elacyt(tm)
635472|NCT00498407|Cancer|cancer
635473|NCT00498407|Colorectal cancer|colorectal cancer
635474|NCT00498407|CRC|crc
635475|NCT00498407|Second line therapy|second line therapy
635476|NCT00498394|Obesity|obesity
635477|NCT00498394|Weight loss|weight loss
635478|NCT00498394|Diet fads|diet fads
635479|NCT00498368|Estimated glomerular filtration rate (GFR)|estimated glomerular filtration rate (gfr)
635480|NCT00498368|Proteinuria|proteinuria
635481|NCT00498368|Renal Fibrosis|renal fibrosis
635482|NCT00498355|uveitis|uveitis
635483|NCT00498355|cytoid macular edema|cytoid macular edema
635484|NCT00498355|steroid|steroid
635485|NCT00498355|Lucentis|lucentis
635486|NCT00498329|fMRI|fmri
635487|NCT00498329|Electroencephalogram (EEG)|electroencephalogram (eeg)
635488|NCT00498329|Attention|attention
635489|NCT00498329|Sensorimotor Integration|sensorimotor integration
635490|NCT00498329|Human Brain|human brain
635491|NCT00498329|Healthy Volunteer|healthy volunteer
635492|NCT00498329|HV|hv
635493|NCT00498316|Myelodysplastic Syndrome|myelodysplastic syndrome
635494|NCT00498316|Leukemia|leukemia
635495|NCT00498316|Cord Blood Expansion|cord blood expansion
635496|NCT00498316|Umbilical Cord Blood|umbilical cord blood
635497|NCT00498316|Mesenchymal Stem Cells|mesenchymal stem cells
635498|NCT00498316|Acute Myelogenous Leukemia|acute myelogenous leukemia
635499|NCT00498316|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
635500|NCT00498316|ALL|all
635501|NCT00498316|AML|aml
635502|NCT00498316|MDS|mds
635503|NCT00498303|influenza vaccine|influenza vaccine
635504|NCT00498290|Enhanced Recovery After Surgery Protocol(ERAS)|enhanced recovery after surgery protocol(eras)
635505|NCT00498290|Colorectal Surgery|colorectal surgery
635506|NCT00498277|Osteoporosis|osteoporosis
635507|NCT00498277|Magnetic Resonance Imaging|magnetic resonance imaging
635508|NCT00498277|Vertebral Fractures|vertebral fractures
635509|NCT00498277|Quantitative Diffusion|quantitative diffusion
635510|NCT00498277|Fat Imaging|fat imaging
635511|NCT00498277|Spine|spine
635512|NCT00498264|Exercise|exercise
635513|NCT00498264|Rehabilitation|rehabilitation
635514|NCT00498264|Strength exercise|strength exercise
635515|NCT00498264|Aerobic exercise|aerobic exercise
635516|NCT00498264|Pain|pain
635517|NCT00498251|lung injury, acute|lung injury, acute
635518|NCT00498251|thoracic surgical procedures|thoracic surgical procedures
635519|NCT00498251|lung cancer|lung cancer
635520|NCT00498251|salbutamol|salbutamol
635521|NCT00498238|Arterial stiffness, Augmentation index, Subclinical Hypothyroidism|arterial stiffness, augmentation index, subclinical hypothyroidism
635522|NCT00498225|Pancreatic Cancer|pancreatic cancer
635523|NCT00498212|Heplisav|heplisav
635524|NCT00498212|Hepatitis B|hepatitis b
635525|NCT00498212|Hepatitis|hepatitis
635526|NCT00498212|HBV|hbv
635527|NCT00498212|Hepatitis B vaccine|hepatitis b vaccine
635528|NCT00498212|kidney disease|kidney disease
635529|NCT00498212|renal disease|renal disease
635530|NCT00498212|kidney failure|kidney failure
635531|NCT00498212|renal failure|renal failure
635532|NCT00498199|Multiples sclerosis|multiples sclerosis
635533|NCT00498199|oscillopsia|oscillopsia
635534|NCT00498199|eye movements|eye movements
635535|NCT00498199|motion detection|motion detection
635536|NCT00498199|retinal slip|retinal slip
635537|NCT00498199|nystagmus|nystagmus
635538|NCT00498186|Rotigotine|rotigotine
635539|NCT00498186|Neupro®|neupro®
635540|NCT00498173|Autistic Disorder|autistic disorder
635541|NCT00498173|Autism Spectrum Disorder|autism spectrum disorder
635542|NCT00498160|Kidney transplant|kidney transplant
635543|NCT00498160|Tolerance|tolerance
635544|NCT00498160|Marrow/stem cell transplant|marrow/stem cell transplant
635545|NCT00498147|amputation|amputation
635546|NCT00498147|angina|angina
635547|NCT00498147|angiography|angiography
635548|NCT00498147|angioplasty|angioplasty
635549|NCT00498147|arterial disease|arterial disease
635550|NCT00498147|artery disease|artery disease
635551|NCT00498147|bypass|bypass
635552|NCT00498147|CABG|cabg
635553|NCT00498147|cad|cad
635554|NCT00498147|carotid|carotid
635555|NCT00498147|cerebral accident|cerebral accident
635556|NCT00498147|CHF|chf
635557|NCT00498147|CRF|crf
635558|NCT00498147|CVA|cva
635559|NCT00498147|endarterectomy|endarterectomy
635560|NCT00498147|heart attack|heart attack
635561|NCT00498147|heart failure|heart failure
635562|NCT00498147|infarct|infarct
635563|NCT00498147|kidney disease|kidney disease
635564|NCT00498147|kidney failure|kidney failure
635565|NCT00498147|laser|laser
635566|NCT00498147|nephropathy|nephropathy
635567|NCT00498147|neuropathy|neuropathy
635568|NCT00498147|pad|pad
635569|NCT00498147|PCI|pci
635570|NCT00498147|percutaneous coronary|percutaneous coronary
635571|NCT00498147|percutaneous transluminal|percutaneous transluminal
635572|NCT00498147|pvd|pvd
635573|NCT00498147|renal failure|renal failure
635574|NCT00498147|retinopathy|retinopathy
635575|NCT00498147|revascularization|revascularization
635576|NCT00498147|schemia|schemia
635577|NCT00498147|stenosis|stenosis
635578|NCT00498147|stent|stent
635579|NCT00498147|stroke|stroke
635580|NCT00498147|transient|transient
635581|NCT00498147|ulcer|ulcer
635582|NCT00498147|vascular disease|vascular disease
635583|NCT00498134|Gastric cancer|gastric cancer
635584|NCT00498121|Ventilator associated pneumonia.|ventilator associated pneumonia.
635585|NCT00498121|Procalcitonin.|procalcitonin.
635586|NCT00498108|Rotigotine|rotigotine
635587|NCT00498108|Restless Legs Syndrome|restless legs syndrome
635588|NCT00498095|Delayed renal graft function|delayed renal graft function
635589|NCT00498095|Acute renal allograft dysfunction|acute renal allograft dysfunction
635590|NCT00498069|Critical limb ischemia due to peripheral arterial occlusive disease|critical limb ischemia due to peripheral arterial occlusive disease
635591|NCT00498069|Autologous bone marrow concentrate|autologous bone marrow concentrate
635592|NCT00498056|HIV Seronegativity|hiv seronegativity
635593|NCT00498056|HIV Preventive Vaccine|hiv preventive vaccine
635594|NCT00498043|Lymphoma|lymphoma
635595|NCT00498043|PET|pet
635596|NCT00498043|Chemotherapy|chemotherapy
635597|NCT00498043|Rituximab|rituximab
635999|NCT00496509|ZD6474|zd6474
635598|NCT00498030|Insulin Resistance|insulin resistance
635599|NCT00498030|Stress, Psychological|stress, psychological
635600|NCT00498017|Infections|infections
635601|NCT00498004|Quality of Life|quality of life
635602|NCT00498004|Schizophrenia|schizophrenia
635603|NCT00498004|Quetiapine|quetiapine
635604|NCT00498004|Risperidone|risperidone
635605|NCT00497991|AML|aml
635606|NCT00497991|phase I/II|phase i/ii
635607|NCT00497991|AZD1152|azd1152
635608|NCT00497991|Acute Myeloid Leukaemia|acute myeloid leukaemia
635609|NCT00497965|Balance|balance
635610|NCT00497965|Chiropractic|chiropractic
635611|NCT00497965|Older Adults|older adults
635612|NCT00497952|Relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
635613|NCT00497952|Marrow/Stem cell transplant|marrow/stem cell transplant
635614|NCT00497939|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
635615|NCT00497939|Currently on alpha blocker|currently on alpha blocker
635616|NCT00497926|Kidney transplant|kidney transplant
635617|NCT00497926|Tolerance|tolerance
635618|NCT00497926|Marrow/Enriched Hematopoetic Stem Cell Transplant|marrow/enriched hematopoetic stem cell transplant
635619|NCT00497913|Tennis Elbow|tennis elbow
635620|NCT00497913|Botulinum Toxin|botulinum toxin
635621|NCT00497874|depression|depression
635622|NCT00497874|stage of change|stage of change
635623|NCT00497874|intervention|intervention
635624|NCT00497874|randomized clinical trial|randomized clinical trial
635625|NCT00497874|population-based|population-based
635626|NCT00497874|expert system|expert system
635627|NCT00497861|Low back pain|low back pain
635628|NCT00497861|Chiropractic|chiropractic
635629|NCT00497861|Spinal manipulation|spinal manipulation
635630|NCT00497861|Activator Methods Chiropractic Technique|activator methods chiropractic technique
635631|NCT00497835|motor seizures|motor seizures
635632|NCT00497835|accelerometer|accelerometer
635633|NCT00497835|algorithm|algorithm
635634|NCT00497835|detection|detection
635635|NCT00497835|alert|alert
635636|NCT00497822|Dementia|dementia
635637|NCT00497809|Breast Cancer|breast cancer
635638|NCT00497809|Neutropenia|neutropenia
635639|NCT00497809|Chemotherapy|chemotherapy
635640|NCT00497809|High risk|high risk
635641|NCT00497796|cytomegalovirus|cytomegalovirus
635642|NCT00497796|CMV|cmv
635643|NCT00497796|prophylaxis|prophylaxis
635644|NCT00497796|liver|liver
635645|NCT00497796|liver transplant|liver transplant
635646|NCT00497757|Marrow/hematopoietic stem cell transplant|marrow/hematopoietic stem cell transplant
635647|NCT00497744|CAPD peritonitis|capd peritonitis
635648|NCT00497744|Peritoneal Dialysis, Continuous Ambulatory|peritoneal dialysis, continuous ambulatory
635649|NCT00497731|Advanced solid tumors|advanced solid tumors
635650|NCT00497705|Ebsteins Anomaly|ebsteins anomaly
635651|NCT00497705|Heart Septal Defects, Ventricle|heart septal defects, ventricle
635652|NCT00497705|Heart Defects, Congenital|heart defects, congenital
635653|NCT00497705|Double Outlet Right Ventricle|double outlet right ventricle
635654|NCT00497705|Truncus Arteriosus Persistant|truncus arteriosus persistant
635655|NCT00497705|Ebstein's Anomaly|ebstein's anomaly
635656|NCT00497705|Congenital Heart Disease|congenital heart disease
635657|NCT00497705|Heart Defects|heart defects
635658|NCT00497679|advanced solid tumours|advanced solid tumours
635659|NCT00497666|Diabetes|diabetes
635660|NCT00497666|Diabetic nephropathy|diabetic nephropathy
635661|NCT00497666|renal protection|renal protection
635662|NCT00497640|sleep apnea, titration, CPAP, neural network|sleep apnea, titration, cpap, neural network
635663|NCT00497614|Rheumatoid arthritis|rheumatoid arthritis
635664|NCT00497614|Positron emission tomodensitometry|positron emission tomodensitometry
635665|NCT00497614|Tumor necrosis factor alpha inhibitor|tumor necrosis factor alpha inhibitor
635666|NCT00497601|Visceral Leishmaniasis|visceral leishmaniasis
635667|NCT00497601|Amphotericin B|amphotericin b
635668|NCT00497601|Fat emulsion|fat emulsion
635669|NCT00497588|laryngeal cancer|laryngeal cancer
635670|NCT00497588|RADIOTHERAPY|radiotherapy
635671|NCT00497588|Voice Quality|voice quality
635672|NCT00497575|Congenital Hypothyroidism|congenital hypothyroidism
635673|NCT00497575|diagnosis|diagnosis
635674|NCT00497575|L-thyroxine|l-thyroxine
635675|NCT00497575|newborn screening|newborn screening
635676|NCT00497562|Fibromyalgia|fibromyalgia
635677|NCT00497562|growth hormone|growth hormone
635678|NCT00497562|IGF-1|igf-1
635679|NCT00497562|FIQ|fiq
635680|NCT00497549|Esophagectomy|esophagectomy
635681|NCT00497549|hand sewn anastomosis|hand sewn anastomosis
635682|NCT00497549|side-to-side stapled|side-to-side stapled
635683|NCT00497536|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
635684|NCT00497536|Continuous Subcutaneous Insulin Infusion (CSII)|continuous subcutaneous insulin infusion (csii)
635685|NCT00497523|Asthma|asthma
635686|NCT00497523|Young Children|young children
635687|NCT00497523|Corticosteroids|corticosteroids
635688|NCT00497523|Beclomethasone|beclomethasone
635689|NCT00497523|Salbutamol|salbutamol
635690|NCT00497523|Beclomethasone/Salbutamol fixed combination|beclomethasone/salbutamol fixed combination
635691|NCT00497523|Suspension for nebulisation|suspension for nebulisation
635692|NCT00497510|Balance|balance
635693|NCT00497510|Chiropractic|chiropractic
635694|NCT00497510|Older Adults|older adults
635695|NCT00497497|CRC|crc
635696|NCT00497497|Colon cancer|colon cancer
635697|NCT00497497|Avastin|avastin
635698|NCT00497497|APM4187g|apm4187g
635699|NCT00497471|Plasmodium Falciparum|plasmodium falciparum
635700|NCT00497471|Antimlarial chemoprophylaxis|antimlarial chemoprophylaxis
635701|NCT00497471|Iron supplementation|iron supplementation
635702|NCT00497471|Tanzania|tanzania
635703|NCT00497458|breast|breast
635704|NCT00497458|neoplasms|neoplasms
635705|NCT00497458|anastrazole|anastrazole
635706|NCT00497458|testosterone|testosterone
635707|NCT00497445|Peripheral arterial disease|peripheral arterial disease
635708|NCT00497445|Exercise therapy|exercise therapy
635709|NCT00497445|Angioplasty|angioplasty
635710|NCT00497445|Bypass surgery|bypass surgery
635711|NCT00497432|Hyperbaric Oxygen|hyperbaric oxygen
635712|NCT00497419|STEMI|stemi
635713|NCT00497419|ST elevation myocardial infarction|st elevation myocardial infarction
635714|NCT00497406|submandibular salivary gland transfer|submandibular salivary gland transfer
635715|NCT00497406|intensity-modulated radiation therapy|intensity-modulated radiation therapy
635716|NCT00497406|helical tomotherapy|helical tomotherapy
635717|NCT00497406|reduction of xerostomia|reduction of xerostomia
635718|NCT00497393|Emergency department, administration, overcrowding|emergency department, administration, overcrowding
635719|NCT00497367|safety|safety
635720|NCT00497367|feasibility|feasibility
635721|NCT00497367|bifurcation|bifurcation
635722|NCT00497367|lesion|lesion
635723|NCT00497367|de novo|de novo
635724|NCT00497367|intervention|intervention
635725|NCT00497354|Ultrasound, Complications, Regional Anesthesia|ultrasound, complications, regional anesthesia
635726|NCT00497341|infection after total knee arthroplasty|infection after total knee arthroplasty
635727|NCT00497328|contrast induced nephropathy|contrast induced nephropathy
635728|NCT00497315|Non-Small Cell Lung Cancer|non-small cell lung cancer
635729|NCT00497315|NSCLC|nsclc
635730|NCT00497315|Chemoradiation|chemoradiation
635731|NCT00497315|locally advanced NSCLC|locally advanced nsclc
635732|NCT00497315|pemetrexed|pemetrexed
635733|NCT00497315|lung cancer|lung cancer
635734|NCT00497302|cocaine|cocaine
635735|NCT00497302|opiate|opiate
635736|NCT00497302|pregnancy|pregnancy
635737|NCT00497302|post-partum|post-partum
635738|NCT00497302|neonatal abstinence syndrome|neonatal abstinence syndrome
635739|NCT00497302|contingency management|contingency management
635740|NCT00497302|Reinforcement Based Treatment|reinforcement based treatment
635741|NCT00497302|women|women
635742|NCT00497289|n-3 PUFA|n-3 pufa
635743|NCT00497289|parenteral nutrition|parenteral nutrition
635744|NCT00497289|preterm infant|preterm infant
635745|NCT00497276|Adults|adults
635746|NCT00497276|Anesthesia recovery period|anesthesia recovery period
635747|NCT00497276|Comparative study|comparative study
635748|NCT00497276|Electric stimulation|electric stimulation
635749|NCT00497276|Humans|humans
635750|NCT00497276|Nerve blocks/methods/indications|nerve blocks/methods/indications
635751|NCT00497276|Patient satisfaction|patient satisfaction
635752|NCT00497276|Peripheral nerves|peripheral nerves
635753|NCT00497276|Sciatic nerve/ultrasonography|sciatic nerve/ultrasonography
635754|NCT00497276|Ultrasonography|ultrasonography
635755|NCT00497276|Treatment outcome|treatment outcome
635756|NCT00497276|Nerve blocks/economics|nerve blocks/economics
635757|NCT00497250|Phase 1 Clinical Trials|phase 1 clinical trials
635758|NCT00497250|Iressa|iressa
635759|NCT00497250|radiation therapy|radiation therapy
635760|NCT00497250|Chinese|chinese
635761|NCT00497250|NSCLC|nsclc
635762|NCT00497250|chemotherapy|chemotherapy
635763|NCT00497237|Asthma|asthma
635764|NCT00497237|Stepdown|stepdown
635765|NCT00497237|Beclomethasone|beclomethasone
635766|NCT00497237|Formoterol|formoterol
635767|NCT00497237|Corticosteroids|corticosteroids
635768|NCT00497224|Pancreatic Cancer|pancreatic cancer
635769|NCT00497224|Pancreatic Carcinoma|pancreatic carcinoma
635770|NCT00497224|Pancreas|pancreas
635771|NCT00497224|Adenocarcinoma|adenocarcinoma
635772|NCT00497224|Erlotinib|erlotinib
635773|NCT00497224|Tarceva|tarceva
635774|NCT00497224|OSI-774|osi-774
635775|NCT00497224|Phase II|phase ii
635776|NCT00497211|First large acute myocardial infarction|first large acute myocardial infarction
635777|NCT00497198|Type 2 Diabetes|type 2 diabetes
635778|NCT00497198|anion-exchange resin|anion-exchange resin
635779|NCT00497185|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
635780|NCT00497185|Somatization Disorder|somatization disorder
635781|NCT00497185|Medically Unexplained Symptoms|medically unexplained symptoms
635782|NCT00497185|Functional Somatic Symptoms|functional somatic symptoms
635783|NCT00497185|SF-36|sf-36
635784|NCT00497159|Trial of Dimebon to treat patients with mild-to-moderate Huntington's disease.|trial of dimebon to treat patients with mild-to-moderate huntington's disease.
635785|NCT00497146|paricalcitol|paricalcitol
635786|NCT00497146|Zemplar|zemplar
635787|NCT00497146|PRIMO|primo
635788|NCT00497146|Chronic Kidney Disease Stage 3B/4|chronic kidney disease stage 3b/4
635789|NCT00497133|glucoseintolerance|glucoseintolerance
635790|NCT00497120|sleep apnea|sleep apnea
635791|NCT00497120|snoring|snoring
635792|NCT00497120|acetazolamide|acetazolamide
635793|NCT00497120|uvulopalatopharyngoplasty|uvulopalatopharyngoplasty
635794|NCT00497120|daytime sleepiness|daytime sleepiness
635795|NCT00497120|upper airway|upper airway
635796|NCT00497107|UFT/LV|uft/lv
635797|NCT00497107|PSK|psk
635798|NCT00497107|Colorectal cancer|colorectal cancer
635799|NCT00497107|Adjuvant therapy|adjuvant therapy
635800|NCT00497094|carotid artery stenting|carotid artery stenting
635801|NCT00497094|atherosclerosis|atherosclerosis
635802|NCT00497094|cerebrovascular|cerebrovascular
635803|NCT00497094|stroke|stroke
635804|NCT00497081|Methamphetamine|methamphetamine
635805|NCT00497081|HIV|hiv
635806|NCT00497081|MSM|msm
635807|NCT00497081|HIV Seronegativity|hiv seronegativity
635808|NCT00497068|smoking|smoking
635809|NCT00497068|pregnancy|pregnancy
635810|NCT00497068|neonatal abstinence syndrome|neonatal abstinence syndrome
635811|NCT00497055|Methamphetamine|methamphetamine
635812|NCT00497055|HIV|hiv
635813|NCT00497055|MSM|msm
635814|NCT00497055|HIV Seronegativity|hiv seronegativity
635815|NCT00497029|dental caries|dental caries
635816|NCT00497029|early childhood caries|early childhood caries
635817|NCT00497029|caries prevention|caries prevention
635818|NCT00497029|infants|infants
635819|NCT00497016|hypertension|hypertension
635820|NCT00497016|statin|statin
635821|NCT00497016|sympathetic|sympathetic
635822|NCT00497003|Endothelial function|endothelial function
635823|NCT00497003|Beta blocker|beta blocker
635824|NCT00497003|Type 2 diabetes|type 2 diabetes
635825|NCT00497003|Chronic heart failure|chronic heart failure
635826|NCT00496990|male|male
635827|NCT00496990|female|female
635828|NCT00496990|couple|couple
635829|NCT00496990|cocaine|cocaine
635830|NCT00496990|opiate|opiate
635831|NCT00496990|methadone|methadone
635832|NCT00496990|detoxification|detoxification
635833|NCT00496990|pregnancy|pregnancy
635834|NCT00496977|lung cancer|lung cancer
635835|NCT00496977|CT scan|ct scan
635836|NCT00496977|screening|screening
635837|NCT00496964|Botulinum toxin type A|botulinum toxin type a
635838|NCT00496964|Patellofemoral pain syndrome|patellofemoral pain syndrome
635839|NCT00496964|Knee Injuries|knee injuries
635840|NCT00496964|Exercise Therapy|exercise therapy
635841|NCT00496951|Neonatal abstinence syndrome|neonatal abstinence syndrome
635842|NCT00496951|Methadone|methadone
635843|NCT00496951|Vagal tone|vagal tone
635844|NCT00496938|Stents|stents
635845|NCT00496938|Angioplasty|angioplasty
635846|NCT00496938|Total coronary occlusions|total coronary occlusions
635847|NCT00496938|Coronary restenosis|coronary restenosis
635848|NCT00496938|Stent thrombosis|stent thrombosis
635849|NCT00496938|Everolimus|everolimus
635850|NCT00496899|Labor|labor
635851|NCT00496899|Obstetric|obstetric
635852|NCT00496899|cervical dilatation|cervical dilatation
635853|NCT00496886|Pain|pain
635854|NCT00496886|Nociception|nociception
635855|NCT00496873|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
635856|NCT00496873|NHL|nhl
635857|NCT00496873|Lymphoma|lymphoma
635858|NCT00496873|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
635859|NCT00496873|SLL|sll
635860|NCT00496873|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
635861|NCT00496873|Lymphoplasmacytic lymphoma/immunocytoma|lymphoplasmacytic lymphoma/immunocytoma
635862|NCT00496873|Follicular lymphoma|follicular lymphoma
635863|NCT00496873|Extranodal marginal zone B-cell lymphoma of MALT type|extranodal marginal zone b-cell lymphoma of malt type
635864|NCT00496873|Nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
635865|NCT00496873|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
635866|NCT00496873|CLL|cll
635867|NCT00496873|Bulky Lymphoma|bulky lymphoma
635868|NCT00496873|Nipent|nipent
635869|NCT00496873|Cytoxan|cytoxan
635870|NCT00496873|Rituxan|rituxan
635871|NCT00496873|Cyclophosphamide|cyclophosphamide
635872|NCT00496873|Rituximab|rituximab
635873|NCT00496873|Pentostatin|pentostatin
635874|NCT00496860|cancer|cancer
635875|NCT00496860|p53|p53
635876|NCT00496860|immunotherapy|immunotherapy
635877|NCT00496860|targeted|targeted
635878|NCT00496860|metastatic|metastatic
635879|NCT00496860|malignancy|malignancy
635880|NCT00496860|malignancies|malignancies
635881|NCT00496860|interleukin-2|interleukin-2
635882|NCT00496860|IL-2|il-2
635883|NCT00496860|fusion protein|fusion protein
635884|NCT00496860|antitumor|antitumor
635885|NCT00496860|melanoma|melanoma
635886|NCT00496860|renal cancer|renal cancer
635887|NCT00496860|lung cancer|lung cancer
635888|NCT00496860|kidney cancer|kidney cancer
635889|NCT00496860|breast cancer|breast cancer
635890|NCT00496860|colorectal cancer|colorectal cancer
635891|NCT00496860|colon cancer|colon cancer
635892|NCT00496860|renal cell carcinoma|renal cell carcinoma
635893|NCT00496860|advanced cancer|advanced cancer
635894|NCT00496860|head and neck cancer|head and neck cancer
635895|NCT00496860|breast tumors|breast tumors
635896|NCT00496860|cancer of head and neck|cancer of head and neck
635897|NCT00496860|esophagus cancer|esophagus cancer
635898|NCT00496860|lymphoma|lymphoma
636195|NCT00495664|titanium|titanium
635899|NCT00496860|ovarian cancer|ovarian cancer
635900|NCT00496860|ovary cancer|ovary cancer
635901|NCT00496860|bladder cancer|bladder cancer
635902|NCT00496860|stomach cancer|stomach cancer
635903|NCT00496860|TCR|tcr
635904|NCT00496860|T-cell receptor|t-cell receptor
635905|NCT00496860|P53 gene|p53 gene
635906|NCT00496860|p53 tumor suppressor protein|p53 tumor suppressor protein
635907|NCT00496847|rhPDGF,|rhpdgf,
635908|NCT00496847|periodontal disease|periodontal disease
635909|NCT00496821|Respiratory Syncytial Virus|respiratory syncytial virus
635910|NCT00496808|Ductal Carcinoma In Situ|ductal carcinoma in situ
635911|NCT00496808|Breast Cancer|breast cancer
635912|NCT00496808|Herceptin|herceptin
635913|NCT00496808|Trastuzumab|trastuzumab
635914|NCT00496808|DCIS|dcis
635915|NCT00496795|Breast cancer, chemoresistance, predictive markers.|breast cancer, chemoresistance, predictive markers.
635916|NCT00496782|Treatment Experienced|treatment experienced
635917|NCT00496756|clear cell renal cell carcinoma|clear cell renal cell carcinoma
635918|NCT00496756|stage III renal cell cancer|stage iii renal cell cancer
635919|NCT00496756|stage IV renal cell cancer|stage iv renal cell cancer
635920|NCT00496756|recurrent renal cell cancer|recurrent renal cell cancer
635921|NCT00496730|Metabolic Disorder|metabolic disorder
635922|NCT00496717|Calcium scoring/aorta/ cardiovascular risk factor/scann|calcium scoring/aorta/ cardiovascular risk factor/scann
635923|NCT00496717|Patients with at least one cardiovascular risk factor|patients with at least one cardiovascular risk factor
635924|NCT00496704|adenocarcinoma of the colon|adenocarcinoma of the colon
635925|NCT00496704|recurrent colon cancer|recurrent colon cancer
635926|NCT00496704|stage III colon cancer|stage iii colon cancer
635927|NCT00496704|stage IV colon cancer|stage iv colon cancer
635928|NCT00496704|adenocarcinoma of the rectum|adenocarcinoma of the rectum
635929|NCT00496704|recurrent rectal cancer|recurrent rectal cancer
635930|NCT00496704|stage III rectal cancer|stage iii rectal cancer
635931|NCT00496704|stage IV rectal cancer|stage iv rectal cancer
635932|NCT00496691|HIV prevention|hiv prevention
635933|NCT00496691|HIV Seronegativity|hiv seronegativity
635935|NCT00496678|navigation|navigation
635936|NCT00496678|navigator|navigator
635937|NCT00496678|activation|activation
635938|NCT00496678|disparities|disparities
635939|NCT00496678|randomized control trial|randomized control trial
635940|NCT00496678|primary care|primary care
635941|NCT00496678|racial and ethnic minorities|racial and ethnic minorities
635942|NCT00496665|Stage IV breast cancer|stage iv breast cancer
635943|NCT00496665|metronomic chemotherapy|metronomic chemotherapy
635944|NCT00496652|Squamous Cell Carcinomas of the Head and Neck|squamous cell carcinomas of the head and neck
635945|NCT00496652|Epidermal Growth Factor receptor|epidermal growth factor receptor
635946|NCT00496652|Antibody|antibody
635947|NCT00496652|Radiotherapy|radiotherapy
635948|NCT00496639|hemodialysis|hemodialysis
635949|NCT00496639|arterio-venous grafts|arterio-venous grafts
635950|NCT00496639|angioplasty|angioplasty
635951|NCT00496639|stents|stents
635952|NCT00496639|mechanical thrombectomy|mechanical thrombectomy
635953|NCT00496626|HPV infections|hpv infections
635954|NCT00496613|Breast cancer|breast cancer
635955|NCT00496613|survivor|survivor
635956|NCT00496587|Genitourinary|genitourinary
635957|NCT00496587|Kidney Cancer|kidney cancer
635958|NCT00496587|Sarcomatoid Renal Cell Carcinoma|sarcomatoid renal cell carcinoma
635959|NCT00496587|Renal Cell Carcinoma|renal cell carcinoma
635960|NCT00496587|RCC|rcc
635961|NCT00496587|Sarcomatoid Carcinoma of the Kidney|sarcomatoid carcinoma of the kidney
635962|NCT00496587|Unresectable renal cell carcinoma|unresectable renal cell carcinoma
635963|NCT00496587|Capecitabine|capecitabine
635964|NCT00496587|Xeloda|xeloda
635965|NCT00496587|Gemcitabine|gemcitabine
635966|NCT00496587|Gemzar|gemzar
635967|NCT00496587|Bevacizumab|bevacizumab
635968|NCT00496587|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
635969|NCT00496587|rhuMAb-VEGF|rhumab-vegf
635970|NCT00496587|Avastin|avastin
635971|NCT00496587|Vascular Endothelial Growth Factor|vascular endothelial growth factor
635972|NCT00496587|VEGF|vegf
635973|NCT00496574|asthma|asthma
635974|NCT00496574|immunotherapy|immunotherapy
635975|NCT00496574|efficacy|efficacy
635976|NCT00496574|children|children
635977|NCT00496574|symptoms score|symptoms score
635978|NCT00496574|quality of life|quality of life
635979|NCT00496574|spirometry|spirometry
635980|NCT00496574|PC20M|pc20m
635981|NCT00496561|asthma|asthma
635982|NCT00496561|immunotherapy|immunotherapy
635983|NCT00496561|children|children
635984|NCT00496561|regulatory T cells|regulatory t cells
635985|NCT00496561|ECP|ecp
635986|NCT00496561|PC20M|pc20m
635987|NCT00496561|Quality of Life|quality of life
635988|NCT00496561|Symptoms score|symptoms score
635989|NCT00496561|Spirometry|spirometry
635990|NCT00496548|Crohn's Disease|crohn's disease
635991|NCT00496535|head|head
635992|NCT00496535|neck|neck
635993|NCT00496535|cancer|cancer
635994|NCT00496535|neoplasm|neoplasm
635995|NCT00496522|Skull Base Chondrosarcoma|skull base chondrosarcoma
635996|NCT00496522|Proton Beam Therapy|proton beam therapy
635997|NCT00496522|Chondrosarcoma|chondrosarcoma
635998|NCT00496522|CNS|cns
636000|NCT00496509|Colorectal Cancer|colorectal cancer
636001|NCT00496509|Liver Metastases|liver metastases
636002|NCT00496509|Biomarkers|biomarkers
636003|NCT00496483|Tacrolimus|tacrolimus
636004|NCT00496483|Pharmacokinetics|pharmacokinetics
636005|NCT00496483|Kidney Transplantation|kidney transplantation
636006|NCT00496470|Chronic Obstructive Pulmonary Disease, COPD|chronic obstructive pulmonary disease, copd
636007|NCT00496457|Diabetic Neuropathy|diabetic neuropathy
636008|NCT00496457|Painful Peripheral Diabetic Neuropathy|painful peripheral diabetic neuropathy
636009|NCT00496457|TRO19622|tro19622
636010|NCT00496457|Trophos|trophos
636011|NCT00496444|Advanced Cancers|advanced cancers
636012|NCT00496444|Azacytidine|azacytidine
636013|NCT00496444|5-Azacitidine|5-azacitidine
636014|NCT00496444|5-aza|5-aza
636015|NCT00496444|Vidaza|vidaza
636016|NCT00496444|5-AZC|5-azc
636017|NCT00496444|AZA-CR|aza-cr
636018|NCT00496444|Ladakamycin|ladakamycin
636019|NCT00496444|NSC-102816|nsc-102816
636020|NCT00496444|Valproic Acid|valproic acid
636021|NCT00496444|Depakene|depakene
636022|NCT00496418|colostomy|colostomy
636023|NCT00496418|parastomal|parastomal
636024|NCT00496418|peristomal|peristomal
636025|NCT00496418|hernia|hernia
636026|NCT00496418|mesh|mesh
636027|NCT00496418|surgery|surgery
636028|NCT00496418|Indication for permanent end colostomy|indication for permanent end colostomy
636029|NCT00496405|Vascular endothelial growth factor.|vascular endothelial growth factor.
636030|NCT00496405|Retinal Thickness|retinal thickness
636031|NCT00496405|Diabetic Macular Edema|diabetic macular edema
636032|NCT00496405|Optical Coherent Tomography|optical coherent tomography
636033|NCT00496392|breakthrough pain in patients with cancer|breakthrough pain in patients with cancer
636034|NCT00496379|metastatic breast cancer|metastatic breast cancer
636035|NCT00496379|invasive breast cancer|invasive breast cancer
636036|NCT00496379|brain metastases|brain metastases
636037|NCT00496379|ZK-EPO|zk-epo
636038|NCT00496353|Neoplasm Malignant|neoplasm malignant
636039|NCT00496340|Pentostatin|pentostatin
636040|NCT00496340|Busulfan|busulfan
636041|NCT00496340|Rituxan|rituxan
636042|NCT00496340|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
636043|NCT00496301|renal|renal
636044|NCT00496301|sorafenib|sorafenib
636045|NCT00496301|Unresectable and/or metastatic renal cell cancer|unresectable and/or metastatic renal cell cancer
636046|NCT00496288|BRCA mutation|brca mutation
636047|NCT00496288|Breast cancer|breast cancer
636048|NCT00496288|Prophylactic breast irradiation|prophylactic breast irradiation
636049|NCT00496288|Prevention of contralateral breast cancer|prevention of contralateral breast cancer
636050|NCT00496275|NSCLC|nsclc
636051|NCT00496275|ZACTIMA|zactima
636052|NCT00496262|Congenital fibrinogen deficiency|congenital fibrinogen deficiency
636053|NCT00496262|Fibrinogen concentrate|fibrinogen concentrate
636054|NCT00496262|Pharmacokinetics|pharmacokinetics
636055|NCT00496262|Thrombelastography|thrombelastography
636056|NCT00496249|Prostate|prostate
636057|NCT00496249|cancer|cancer
636058|NCT00496249|brachytherapy|brachytherapy
636059|NCT00496249|radiation|radiation
636060|NCT00496249|semen|semen
636061|NCT00496249|fertility|fertility
636062|NCT00496236|head|head
636063|NCT00496236|neck|neck
636064|NCT00496236|cancer|cancer
636065|NCT00496236|neoplasm|neoplasm
636066|NCT00496223|Sunitinib|sunitinib
636067|NCT00496223|Dacarbazine|dacarbazine
636068|NCT00496223|Melanoma|melanoma
636069|NCT00496210|Adaptation|adaptation
636070|NCT00496210|Pervasive Developmental Disorder|pervasive developmental disorder
636071|NCT00496210|Autism Spectrum Disorders|autism spectrum disorders
636072|NCT00496210|Pervasive Developmental Disorders|pervasive developmental disorders
636073|NCT00496210|Caregiver Adaptation|caregiver adaptation
636074|NCT00496197|candidemia|candidemia
636075|NCT00496197|invasive candidiasis|invasive candidiasis
636076|NCT00496197|fungal bloodstream infection|fungal bloodstream infection
636077|NCT00496184|Nifedipine treatment|nifedipine treatment
636078|NCT00496184|Vestibulitis|vestibulitis
636079|NCT00496184|Placebo|placebo
636080|NCT00496158|Nucleoside Treatment-Naïve Patients with HBeAg Negative Chronic Hepatitis due to Hepatitis B Virus|nucleoside treatment-naïve patients with hbeag negative chronic hepatitis due to hepatitis b virus
636081|NCT00496158|hepatitis b virus|hepatitis b virus
636082|NCT00496145|diabetes|diabetes
636083|NCT00496145|self management|self management
636084|NCT00496145|patient education|patient education
636085|NCT00496145|telephone reinforcement|telephone reinforcement
636086|NCT00496145|Spanish Diabetes|spanish diabetes
636087|NCT00496145|Tomando Control de su Diabetes|tomando control de su diabetes
636088|NCT00496132|CLL|cll
636089|NCT00496132|Leukemia|leukemia
636090|NCT00496132|Lymph|lymph
636091|NCT00496119|Proton Beam Therapy|proton beam therapy
636092|NCT00496119|Skull Base Chordoma|skull base chordoma
636093|NCT00496119|Chordoma of the Skull Base|chordoma of the skull base
636094|NCT00496119|Chordoma|chordoma
636095|NCT00496080|Menorrhagia associated with Uterine Fibroids|menorrhagia associated with uterine fibroids
636096|NCT00496067|Fibroids|fibroids
636097|NCT00496067|Menorrhagia|menorrhagia
636098|NCT00496067|Menorrhagia associated with uterine fibroids|menorrhagia associated with uterine fibroids
636099|NCT00496041|Stenosis (> 75%) or occlusion of the superficial femoral artery|stenosis (> 75%) or occlusion of the superficial femoral artery
636100|NCT00496028|Solid tumors|solid tumors
636101|NCT00496028|locally advanced or Metastatic Cancer suitable for treatment with carboplatin and/or paclitaxel|locally advanced or metastatic cancer suitable for treatment with carboplatin and/or paclitaxel
636102|NCT00496015|Streptococcus Pneumoniae Vaccines|streptococcus pneumoniae vaccines
636103|NCT00496015|Meningococcal disease|meningococcal disease
636104|NCT00496015|Carriage|carriage
636105|NCT00496015|Prophylactic antipyretic|prophylactic antipyretic
636106|NCT00496015|Safety|safety
636107|NCT00496015|Pneumococcal vaccine|pneumococcal vaccine
636108|NCT00496015|Fever|fever
636109|NCT00496015|Pneumococcal disease|pneumococcal disease
636110|NCT00496015|Immunogenicity|immunogenicity
636111|NCT00496015|Meningococcal vaccine|meningococcal vaccine
636112|NCT00496015|Booster vaccination|booster vaccination
636113|NCT00496002|Hepatitis B virus|hepatitis b virus
636114|NCT00496002|Nucleoside Treatment-Naïve Patients with HBeAg Positive|nucleoside treatment-naïve patients with hbeag positive
636115|NCT00495989|Handicapped individuals|handicapped individuals
636116|NCT00495976|common cold|common cold
636117|NCT00495976|flu|flu
636118|NCT00495976|influenza|influenza
636119|NCT00495963|Mechanical ventilation, Ventilator- associated pneumonia, Bronchoalveolar lavage, Pediatric intensive care unit, Flexible bronchoscopy, Critical care|mechanical ventilation, ventilator- associated pneumonia, bronchoalveolar lavage, pediatric intensive care unit, flexible bronchoscopy, critical care
636120|NCT00495950|Melanoma|melanoma
636121|NCT00495950|Lymphedema|lymphedema
636122|NCT00495950|Limb Swelling|limb swelling
636123|NCT00495950|Questionnaire|questionnaire
636124|NCT00495950|Quality of Life|quality of life
636125|NCT00495950|Physical Function|physical function
636126|NCT00495950|Survey|survey
636127|NCT00495885|Sleep problems|sleep problems
636128|NCT00495885|insomnia|insomnia
636129|NCT00495885|sleeplessness|sleeplessness
636130|NCT00495885|primary insomnia|primary insomnia
636131|NCT00495885|insomnia disorder|insomnia disorder
636132|NCT00495872|Solid Tumors|solid tumors
636133|NCT00495872|Advanced Cancer|advanced cancer
636134|NCT00495872|Dasatinib|dasatinib
636135|NCT00495872|Erlotinib|erlotinib
636136|NCT00495872|Lapatinib|lapatinib
636137|NCT00495872|Lenalidomide|lenalidomide
636138|NCT00495872|Sorafenib|sorafenib
636139|NCT00495872|Erlotinib Hydrochloride|erlotinib hydrochloride
636140|NCT00495872|Sunitinib Malate|sunitinib malate
636141|NCT00495872|Sunitinib|sunitinib
636142|NCT00495872|Valproic Acid|valproic acid
636143|NCT00495872|SU011248|su011248
636144|NCT00495859|Immunonutrition|immunonutrition
636145|NCT00495859|immune enhancing diets|immune enhancing diets
636146|NCT00495859|arginine|arginine
636147|NCT00495859|ω-3 fatty acids|ω-3 fatty acids
636148|NCT00495859|nucleotides|nucleotides
636149|NCT00495859|liver transplantation|liver transplantation
636150|NCT00495859|clinical trial|clinical trial
636151|NCT00495846|Hepatocellular carcinoma|hepatocellular carcinoma
636152|NCT00495846|Somatostatin analogues|somatostatin analogues
636153|NCT00495846|Somatostatin receptors|somatostatin receptors
636154|NCT00495846|Octreotide|octreotide
636155|NCT00495846|Lanreotide|lanreotide
636156|NCT00495846|IGF-I|igf-i
636157|NCT00495846|IGF-II|igf-ii
636158|NCT00495833|Hypertension|hypertension
636159|NCT00495820|Alzheimer's Disease|alzheimer's disease
636160|NCT00495820|Apathy|apathy
636161|NCT00495820|Dementia|dementia
636162|NCT00495820|Methylphenidate|methylphenidate
636163|NCT00495807|Psychological Tests|psychological tests
636164|NCT00495807|Pain, Postoperative|pain, postoperative
636165|NCT00495807|Nurses|nurses
636166|NCT00495794|diabetes|diabetes
636167|NCT00495794|hypertension|hypertension
636168|NCT00495794|adherence|adherence
636169|NCT00495794|implementation|implementation
636170|NCT00495794|medications|medications
636171|NCT00495794|organization of care|organization of care
636172|NCT00495781|functional iron deficiency|functional iron deficiency
636173|NCT00495781|renal anemia|renal anemia
636174|NCT00495781|dialysis|dialysis
636175|NCT00495781|erythropoietin|erythropoietin
636176|NCT00495781|darbepoetin|darbepoetin
636177|NCT00495768|Hepatitis C|hepatitis c
636178|NCT00495768|HCV|hcv
636179|NCT00495768|Depression|depression
636180|NCT00495768|Interferons|interferons
636181|NCT00495768|Ribavirin|ribavirin
636182|NCT00495755|Chronic Graft-vs-Host Disease|chronic graft-vs-host disease
636183|NCT00495729|SB-649868,|sb-649868,
636184|NCT00495729|Simvastatin|simvastatin
636185|NCT00495729|Repeated dose,|repeated dose,
636186|NCT00495703|Cancer survivors|cancer survivors
636187|NCT00495703|Chemotherapy|chemotherapy
636188|NCT00495703|Cognitive function|cognitive function
636189|NCT00495703|Exercise|exercise
636190|NCT00495703|Physical Activity|physical activity
636191|NCT00495690|Zinc recipients|zinc recipients
636192|NCT00495690|Placebo recipients|placebo recipients
636193|NCT00495677|Treatment Experienced|treatment experienced
636194|NCT00495677|Treatment Naive|treatment naive
636196|NCT00495664|paclitaxel|paclitaxel
636197|NCT00495664|stent|stent
636198|NCT00495664|myocardial infarction|myocardial infarction
636199|NCT00495664|angioplasty|angioplasty
636200|NCT00495664|PCI|pci
636201|NCT00495651|HIV|hiv
636202|NCT00495651|HAART|haart
636203|NCT00495651|Early Intervention|early intervention
636204|NCT00495651|Naive patients|naive patients
636205|NCT00495638|6-Minute Walk|6-minute walk
636206|NCT00495638|Chuvash Polycythemia|chuvash polycythemia
636207|NCT00495638|Echocardiogram|echocardiogram
636208|NCT00495638|Sickle Cell Anemia|sickle cell anemia
636209|NCT00495638|Pulmonary Function Tests|pulmonary function tests
636210|NCT00495638|Sickle Cell Disease|sickle cell disease
636211|NCT00495638|SCD|scd
636212|NCT00495638|Pulmonary Hypertension|pulmonary hypertension
636213|NCT00495625|Hepatocellular cancer (HCC)|hepatocellular cancer (hcc)
636214|NCT00495625|Sunitinib malate|sunitinib malate
636215|NCT00495625|Vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
636216|NCT00495625|Platelet-derived growth factor (PDGF)|platelet-derived growth factor (pdgf)
636217|NCT00495625|Tyrosine kinases|tyrosine kinases
636218|NCT00495625|Liver|liver
636219|NCT00495612|Xolair|xolair
636220|NCT00495612|Allergic asthma|allergic asthma
636221|NCT00495612|Cat allergy|cat allergy
636222|NCT00495599|Obese|obese
636223|NCT00495599|Adipose Tissue|adipose tissue
636224|NCT00495599|Visfatin|visfatin
636225|NCT00495599|Gastric Bypass Surgery|gastric bypass surgery
636226|NCT00495586|COPD|copd
636227|NCT00495586|Antibiotics|antibiotics
636228|NCT00495560|induction|induction
636229|NCT00495560|abortion|abortion
636230|NCT00495560|injection, intra-amniotic|injection, intra-amniotic
636231|NCT00495560|misoprostol|misoprostol
636232|NCT00495547|Myelodysplastic Syndrome|myelodysplastic syndrome
636233|NCT00495547|Red Cell transfusion dependent|red cell transfusion dependent
636234|NCT00495521|Crohn's|crohn's
636235|NCT00495521|Crohn's Disease|crohn's disease
636236|NCT00495521|Acute Flare|acute flare
636237|NCT00495521|Mild to Moderate Crohn's Disease|mild to moderate crohn's disease
636238|NCT00495521|Children|children
636239|NCT00495521|Pediatrics|pediatrics
636240|NCT00495521|Ileo-cecal|ileo-cecal
636241|NCT00495521|Pediatric Crohn's Disease|pediatric crohn's disease
636242|NCT00495521|New Onset Crohn's Disease|new onset crohn's disease
636243|NCT00495521|Recently diagnosed Crohn's Disease|recently diagnosed crohn's disease
636244|NCT00495508|Quinine|quinine
636245|NCT00495508|Artemether|artemether
636246|NCT00495508|Lumefantrine|lumefantrine
636247|NCT00495508|malaria|malaria
636248|NCT00495508|Uganda|uganda
636249|NCT00495508|Artemisinin- based combination therapy|artemisinin- based combination therapy
636250|NCT00495508|pregnancy|pregnancy
636251|NCT00495508|Malaria In Pregnancy|malaria in pregnancy
636252|NCT00495482|Euthanasia|euthanasia
636253|NCT00495482|Assisted Suicide|assisted suicide
636254|NCT00495482|Assisted Dying|assisted dying
636255|NCT00495482|Palliative Care Medicine|palliative care medicine
636256|NCT00495469|Diabetes mellitus HbA1c|diabetes mellitus hba1c
636257|NCT00495456|cardiovascular|cardiovascular
636258|NCT00495456|risk|risk
636259|NCT00495456|longitudinal|longitudinal
636260|NCT00495456|prospective|prospective
636261|NCT00495430|Healthy|healthy
636262|NCT00495430|Lung sounds|lung sounds
636263|NCT00495430|Breath sounds|breath sounds
636264|NCT00495417|Alzheimer|alzheimer
636265|NCT00495417|Morbus Alzheimer|morbus alzheimer
636266|NCT00495417|Alzheimer Vaccine|alzheimer vaccine
636267|NCT00495417|Vaccine|vaccine
636268|NCT00495417|AD|ad
636269|NCT00495417|Aβ immunotherapy|aβ immunotherapy
636270|NCT00495404|chronic non-malignant pain|chronic non-malignant pain
636271|NCT00495404|opiates|opiates
636272|NCT00495404|prescriptions|prescriptions
636273|NCT00495404|addiction|addiction
636274|NCT00495391|Hepatitis C, Chronic|hepatitis c, chronic
636275|NCT00495378|PROCRIT|procrit
636276|NCT00495378|Epoetin alfa|epoetin alfa
636277|NCT00495378|chemotherapy related anemia|chemotherapy related anemia
636278|NCT00495365|Anemia|anemia
636279|NCT00495365|low blood count|low blood count
636280|NCT00495365|chronic kidney disease|chronic kidney disease
636281|NCT00495365|chronic kidney failure|chronic kidney failure
636282|NCT00495365|darbepoetin alfa|darbepoetin alfa
636283|NCT00495365|epoetin alfa|epoetin alfa
636284|NCT00495365|recombinant human erythropoietin|recombinant human erythropoietin
636285|NCT00495352|Schizophrenia|schizophrenia
636286|NCT00495352|NRT|nrt
636287|NCT00495352|Bupropion|bupropion
636288|NCT00495352|Stages of change|stages of change
636289|NCT00495326|drug interactions|drug interactions
636290|NCT00495326|Treatment Naive|treatment naive
636291|NCT00495313|Rosacea|rosacea
636292|NCT00495300|HSC/MUD Transplant|hsc/mud transplant
636293|NCT00495300|NMDP|nmdp
636294|NCT00495300|NMDP Data Collection|nmdp data collection
636295|NCT00495300|NMDP Samples|nmdp samples
636296|NCT00495300|BMT|bmt
636297|NCT00495300|Samples|samples
636298|NCT00495287|Acute myelogenous leukemia|acute myelogenous leukemia
636299|NCT00495287|Adult patients|adult patients
636300|NCT00495287|Cytogenetic risk class|cytogenetic risk class
636301|NCT00495287|Clinico-cytogenetic risk model|clinico-cytogenetic risk model
636302|NCT00495287|Risk-oriented therapy|risk-oriented therapy
636303|NCT00495274|Bioequivalent|bioequivalent
636304|NCT00495274|pharmacodynamic|pharmacodynamic
636305|NCT00495274|Reference formulation|reference formulation
636306|NCT00495274|5 new formulation|5 new formulation
636307|NCT00495274|Food effect|food effect
636308|NCT00495274|Pharmacokinetics|pharmacokinetics
636309|NCT00495261|Gambling|gambling
636310|NCT00495261|Mindfulness|mindfulness
636311|NCT00495261|Cognitive Behavioural Therapy|cognitive behavioural therapy
636312|NCT00495248|group intervention|group intervention
636313|NCT00495248|stroke|stroke
636314|NCT00495248|senior centres|senior centres
636315|NCT00495248|health promotion|health promotion
636316|NCT00495235|Endometrial Cancer|endometrial cancer
636317|NCT00495235|Polycystic Ovarian Syndrome|polycystic ovarian syndrome
636318|NCT00495235|Insulin Resistance|insulin resistance
636319|NCT00495235|Pre-diabetes|pre-diabetes
636320|NCT00495235|Harris County|harris county
636321|NCT00495235|PCOS|pcos
636322|NCT00495235|Uterus|uterus
636323|NCT00495235|Questionnaire|questionnaire
636324|NCT00495235|Body mass index|body mass index
636325|NCT00495235|BMI|bmi
636326|NCT00495222|gastrojejunostomy|gastrojejunostomy
636327|NCT00495222|stoma|stoma
636328|NCT00495209|Complementary and Alternative Medicine|complementary and alternative medicine
636329|NCT00495209|Breast Cancer|breast cancer
636330|NCT00495209|Qigong|qigong
636331|NCT00495209|Medical Qigong|medical qigong
636332|NCT00495209|External Qi Therapy|external qi therapy
636333|NCT00495209|EQT|eqt
636334|NCT00495183|cocaine dependence|cocaine dependence
636335|NCT00495183|cocaine use|cocaine use
636336|NCT00495183|CNS stimulants|cns stimulants
636337|NCT00495183|caffeine|caffeine
636338|NCT00495183|biperiden|biperiden
636339|NCT00495183|placebo|placebo
636340|NCT00495170|Non-Small Cell Lung Cancer|non-small cell lung cancer
636341|NCT00495170|Lung Cancer|lung cancer
636342|NCT00495170|Proton Radiotherapy|proton radiotherapy
636343|NCT00495170|Proton Beam|proton beam
636344|NCT00495170|Paclitaxel|paclitaxel
636345|NCT00495170|Taxol|taxol
636346|NCT00495170|Carboplatin|carboplatin
636347|NCT00495170|Paraplatin|paraplatin
636348|NCT00495170|NSCLC|nsclc
636349|NCT00495144|Phase I|phase i
636350|NCT00495144|Advanced Solid Tumors|advanced solid tumors
636351|NCT00495144|Hypoxia|hypoxia
636352|NCT00495144|Prodrug|prodrug
636353|NCT00495144|Multi-Center|multi-center
636354|NCT00495144|Open-Label|open-label
636355|NCT00495144|Dose-Escalation|dose-escalation
636356|NCT00495131|Chronic hepatitis C|chronic hepatitis c
636357|NCT00495131|Genotype 1|genotype 1
636358|NCT00495131|Interferon|interferon
636359|NCT00495131|Ribavirin|ribavirin
636360|NCT00495118|schizophrenia|schizophrenia
636361|NCT00495118|schizoaffective disorder|schizoaffective disorder
636362|NCT00495118|risperidone|risperidone
636363|NCT00495118|intramuscular injection|intramuscular injection
636364|NCT00495118|long-acting injectable|long-acting injectable
636365|NCT00495092|cocaine dependence|cocaine dependence
636366|NCT00495092|cocaine use|cocaine use
636367|NCT00495092|cocaine craving|cocaine craving
636368|NCT00495079|acute|acute
636369|NCT00495079|lymphoblastic|lymphoblastic
636370|NCT00495079|lymphocytic|lymphocytic
636371|NCT00495079|leukemia|leukemia
636372|NCT00495079|leukaemia|leukaemia
636373|NCT00495079|lukemia|lukemia
636374|NCT00495079|leukimia|leukimia
636375|NCT00495079|ALL|all
636376|NCT00495079|Marqibo|marqibo
636377|NCT00495079|Hana Biosciences|hana biosciences
636378|NCT00495079|vincristine|vincristine
636379|NCT00495079|liposomal|liposomal
636380|NCT00495079|liposome|liposome
636381|NCT00495079|optisome|optisome
636382|NCT00495079|hematology|hematology
636383|NCT00495079|malignancy|malignancy
636384|NCT00495079|hematological|hematological
636385|NCT00495079|relapsed|relapsed
636386|NCT00495079|anti-leukemia|anti-leukemia
636387|NCT00495079|adult|adult
636388|NCT00495079|chemotherapy|chemotherapy
636389|NCT00495053|overactive bladder, urinary urgency|overactive bladder, urinary urgency
636390|NCT00495040|Non-Small Cell Lung Cancer|non-small cell lung cancer
636391|NCT00495040|Lung Cancer|lung cancer
636392|NCT00495040|Proton Radiotherapy|proton radiotherapy
636393|NCT00495040|Proton Beam|proton beam
636394|NCT00495040|NSCLC|nsclc
636395|NCT00495027|PTSD|ptsd
636396|NCT00495027|prevention|prevention
636397|NCT00495027|World Wide Web|world wide web
636398|NCT00495027|Behavior Therapy|behavior therapy
636399|NCT00495014|GSK376501,|gsk376501,
636400|NCT00495014|Single Dose,|single dose,
636401|NCT00495014|Dose Escalation,|dose escalation,
636402|NCT00495014|Healthy Overweight/Obese Volunteer|healthy overweight/obese volunteer
636403|NCT00494949|Anesthesia, spinal|anesthesia, spinal
636404|NCT00494949|Blood substitutes|blood substitutes
636405|NCT00494949|Oxygen therapeutics|oxygen therapeutics
636406|NCT00494949|Orthopedic surgery|orthopedic surgery
636407|NCT00494949|Plasma expanders|plasma expanders
636408|NCT00494949|Vasoconstriction|vasoconstriction
636409|NCT00494949|Hemospan|hemospan
636410|NCT00494936|HIV|hiv
636411|NCT00494936|HCV|hcv
636412|NCT00494936|Treatment Naive|treatment naive
636413|NCT00494936|Treatment Experienced|treatment experienced
636414|NCT00494936|HIV and HCV Coinfection|hiv and hcv coinfection
636415|NCT00494910|Palliative Care|palliative care
636416|NCT00494910|Terminally Ill|terminally ill
636417|NCT00494910|Group Therapy|group therapy
636418|NCT00494910|07-094|07-094
636419|NCT00494884|Type 2 diabetes|type 2 diabetes
636420|NCT00494884|vildagliptin|vildagliptin
636421|NCT00494884|metformin combination|metformin combination
636422|NCT00494871|BAY59-7939|bay59-7939
636423|NCT00494871|Rivaroxaban|rivaroxaban
636424|NCT00494871|Non-Valvular Atrial Fibrillation|non-valvular atrial fibrillation
636425|NCT00494871|Japanese Patients|japanese patients
636426|NCT00494871|Phase III|phase iii
636427|NCT00494871|12620|12620
636428|NCT00494858|Bulimia nervosa|bulimia nervosa
636429|NCT00494858|Cognitive Behavioral Therapy|cognitive behavioral therapy
636430|NCT00494858|Personality Disorders|personality disorders
636431|NCT00494845|Mindfulness|mindfulness
636432|NCT00494845|Elderly|elderly
636433|NCT00494845|Chronic Illness|chronic illness
636434|NCT00494845|Back Pain|back pain
636435|NCT00494845|Chronic Low Back Pain|chronic low back pain
636436|NCT00494845|Older adults over the age of sixty-five|older adults over the age of sixty-five
636437|NCT00494845|MMSE score of over 23|mmse score of over 23
636438|NCT00494845|Speaks English|speaks english
636439|NCT00494832|Dexmedetomidine|dexmedetomidine
636440|NCT00494832|Evoked potentials|evoked potentials
636441|NCT00494832|Spine surgery|spine surgery
636442|NCT00494819|ADHD, subtype, methylphenidate, neuropsychological measures|adhd, subtype, methylphenidate, neuropsychological measures
636443|NCT00494806|Postoperative Ileus (POI)|postoperative ileus (poi)
636444|NCT00494806|Rocking Chair|rocking chair
636445|NCT00494806|Abdominal Cancer|abdominal cancer
636446|NCT00494793|Open abdomen|open abdomen
636447|NCT00494793|Fascial closure|fascial closure
636448|NCT00494793|Vacuum assisted wound closure|vacuum assisted wound closure
636449|NCT00494793|Mesh|mesh
636450|NCT00494793|Abdominal compartment syndrome|abdominal compartment syndrome
636451|NCT00494793|Intraabdominal pressure|intraabdominal pressure
636452|NCT00494793|Incisional hernia|incisional hernia
636453|NCT00494780|CHOP (cyclophosphamide,doxorubicin,vincristine,prednisolone)|chop (cyclophosphamide,doxorubicin,vincristine,prednisolone)
636454|NCT00494780|ofatumumab|ofatumumab
636455|NCT00494767|body composition|body composition
636456|NCT00494767|obesity|obesity
636457|NCT00494767|4C model|4c model
636458|NCT00494767|hunger|hunger
636459|NCT00494767|weight loss|weight loss
636460|NCT00494754|autism spectrum disorder|autism spectrum disorder
636461|NCT00494754|family genetic study|family genetic study
636462|NCT00494754|gene|gene
636463|NCT00494754|phenotype|phenotype
636464|NCT00494754|endophenotype|endophenotype
636465|NCT00494728|Smoking|smoking
636466|NCT00494728|Depression|depression
636467|NCT00494728|Major Depressive Disorder|major depressive disorder
636468|NCT00494728|Cognitive Behavioral Analysis System of Psychotherapy|cognitive behavioral analysis system of psychotherapy
636469|NCT00494728|Smoking Cessation Treatment|smoking cessation treatment
636470|NCT00494728|Nicotine Replacement Therapy|nicotine replacement therapy
636471|NCT00494728|Nicotine Patch|nicotine patch
636472|NCT00494728|CBASP|cbasp
636473|NCT00494728|MDD|mdd
636474|NCT00494702|Asphyxia|asphyxia
636475|NCT00494702|Resuscitation|resuscitation
636476|NCT00494702|Oxidative stress|oxidative stress
636477|NCT00494702|Prematurity|prematurity
636478|NCT00494702|Follow up|follow up
636479|NCT00494689|transcranial sonolysis or monitoring|transcranial sonolysis or monitoring
636480|NCT00494689|rapid magnetic stimulation|rapid magnetic stimulation
636481|NCT00494689|cerebral ischemia|cerebral ischemia
636482|NCT00494689|hydrocephalus|hydrocephalus
636483|NCT00494689|Barthel's index|barthel's index
636484|NCT00494676|Hemianopia|hemianopia
636485|NCT00494676|Mobility|mobility
636486|NCT00494676|Rehabilitation|rehabilitation
636487|NCT00494676|Low vision|low vision
636488|NCT00494663|diabetes|diabetes
636489|NCT00494663|type 2 diabetes|type 2 diabetes
636490|NCT00494663|cholesterol|cholesterol
636491|NCT00494650|PTSD|ptsd
636492|NCT00494650|Schizophrenia|schizophrenia
636493|NCT00494650|Schizoaffective Disorder|schizoaffective disorder
636494|NCT00494650|Bipolar Disorder|bipolar disorder
636495|NCT00494650|Major Depression|major depression
636496|NCT00494624|Wheezing|wheezing
636497|NCT00494624|virus|virus
636498|NCT00494624|child|child
636499|NCT00494598|opioids, cerebral perfusion, arterial pharmacokinetics|opioids, cerebral perfusion, arterial pharmacokinetics
636500|NCT00494585|CEP-701|cep-701
636501|NCT00494585|Leukemia|leukemia
636502|NCT00494585|Myelofibrosis|myelofibrosis
636503|NCT00494585|MF|mf
636504|NCT00494585|JAK2|jak2
636505|NCT00494585|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
636506|NCT00494585|Lestaurtinib|lestaurtinib
636507|NCT00494585|Chronic Idiopathic Myelofibrosis|chronic idiopathic myelofibrosis
636508|NCT00494585|CIMF|cimf
636509|NCT00494572|Montelukast|montelukast
636510|NCT00494572|Albuterol|albuterol
636511|NCT00494572|Status Asthmaticus|status asthmaticus
636512|NCT00494572|Asthma|asthma
636513|NCT00494559|Type 2 Diabetes|type 2 diabetes
636514|NCT00494559|Pioglitazone|pioglitazone
636515|NCT00494559|restenosis|restenosis
636516|NCT00494546|prostate|prostate
636517|NCT00494546|brachytherapy|brachytherapy
636518|NCT00494533|pulmonary arterial hypertension|pulmonary arterial hypertension
636519|NCT00494533|prostacyclin analogue|prostacyclin analogue
636520|NCT00494533|intravenous|intravenous
636521|NCT00494520|Anomia|anomia
636522|NCT00494520|Aphasia|aphasia
636523|NCT00494520|Traumatic Brain Injury|traumatic brain injury
636524|NCT00494520|Cerebrovascular Accident|cerebrovascular accident
636525|NCT00494507|periodic paralysis|periodic paralysis
636526|NCT00494507|dichlorphenamide|dichlorphenamide
636527|NCT00494494|cystoid macular edema|cystoid macular edema
636528|NCT00494494|cataract|cataract
636529|NCT00494494|nonsteroidal antiinflammatory drugs|nonsteroidal antiinflammatory drugs
636530|NCT00494494|optical coherence tomography|optical coherence tomography
636531|NCT00494481|Zactima|zactima
636532|NCT00494468|Insomnia|insomnia
636533|NCT00494468|Sleep Disorder|sleep disorder
636534|NCT00494468|Sleep Deprivation|sleep deprivation
636535|NCT00494455|critical illness|critical illness
636536|NCT00494455|hyperglycemia|hyperglycemia
636537|NCT00494455|intensive insulin therapy|intensive insulin therapy
636538|NCT00494455|glucose monitoring|glucose monitoring
636539|NCT00494455|shock|shock
636540|NCT00494442|Advanced ovarian cancer|advanced ovarian cancer
636541|NCT00494442|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
636542|NCT00494442|KU-0059436|ku-0059436
636543|NCT00494442|AZD2281|azd2281
636544|NCT00494442|BRCA1 protein|brca1 protein
636545|NCT00494442|BRCA2 protein|brca2 protein
636546|NCT00494429|Preterm Neonates|preterm neonates
636547|NCT00494429|Morphine|morphine
636548|NCT00494429|Critically ill|critically ill
636549|NCT00494403|sprain proprioception|sprain proprioception
636550|NCT00494390|Biometry|biometry
636551|NCT00494390|corneal opacity|corneal opacity
636552|NCT00494390|astigmatism|astigmatism
636553|NCT00494390|refraction|refraction
636554|NCT00494364|ear disease|ear disease
636555|NCT00494364|otitis|otitis
636556|NCT00494364|Eustachian tube|eustachian tube
636557|NCT00494364|mastoid air cells|mastoid air cells
636558|NCT00494364|Normal healthy volunteers|normal healthy volunteers
636559|NCT00494351|Hidradenitis Suppurativa|hidradenitis suppurativa
636560|NCT00494351|Nd:YAG laser|nd:yag laser
636561|NCT00494338|Metastatic Androgen Independent Prostate Cancer (MAIPC)|metastatic androgen independent prostate cancer (maipc)
636562|NCT00494325|age related maculopathy, macular pigment|age related maculopathy, macular pigment
636563|NCT00494312|Glucose Metabolism Disorder|glucose metabolism disorder
636564|NCT00494312|Dysmetabolic Syndrome|dysmetabolic syndrome
636565|NCT00494312|Type II Diabetes|type ii diabetes
636566|NCT00494312|Diabetes Mellitus|diabetes mellitus
636567|NCT00494312|Lipoatrophic|lipoatrophic
636568|NCT00494312|Dyslipidemia|dyslipidemia
636569|NCT00494312|Liver|liver
636570|NCT00494312|Drug Therapy|drug therapy
636571|NCT00494299|HCC|hcc
636572|NCT00494299|Cancer|cancer
636573|NCT00494299|Liver Cancer|liver cancer
636574|NCT00494299|TACE|tace
636575|NCT00494286|Abuse Focused Cognitive Behavioral Therapy|abuse focused cognitive behavioral therapy
636576|NCT00494286|Treatment Effectiveness Research|treatment effectiveness research
636577|NCT00494286|Treatment Dissemination|treatment dissemination
636578|NCT00494273|Haitian American Adolescents|haitian american adolescents
636579|NCT00494273|HIV Prevention|hiv prevention
636580|NCT00494273|Cognitive Behavioral Intervention|cognitive behavioral intervention
636581|NCT00494260|recurrent abdominal pain|recurrent abdominal pain
636582|NCT00494260|illness behavior|illness behavior
636583|NCT00494260|social learning|social learning
636584|NCT00494260|cognitive behavioral therapy|cognitive behavioral therapy
636585|NCT00494247|acute coronary syndromes|acute coronary syndromes
636586|NCT00494247|endothelial progenitor cells|endothelial progenitor cells
636587|NCT00494247|coronary stent|coronary stent
636588|NCT00494234|Advanced breast cancer|advanced breast cancer
636589|NCT00494234|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
636590|NCT00494234|AZD2281,KU-0059436 (olaparib)|azd2281,ku-0059436 (olaparib)
636591|NCT00494234|BRCA1 protein|brca1 protein
636592|NCT00494234|BRCA2 protein|brca2 protein
636593|NCT00494221|Colorectal cancer|colorectal cancer
636594|NCT00494221|Recentin|recentin
636595|NCT00494221|Metastatic Cancer|metastatic cancer
636596|NCT00494221|FOLFOX|folfox
636597|NCT00494208|androgens|androgens
636598|NCT00494208|testosterone|testosterone
636599|NCT00494208|testosterone deficiency|testosterone deficiency
636600|NCT00494208|women|women
636601|NCT00494208|menopause|menopause
636602|NCT00494208|surgical Menopause|surgical menopause
636603|NCT00494208|hysterectomy|hysterectomy
636604|NCT00494208|oophorectomy|oophorectomy
636605|NCT00494208|ovariectomy|ovariectomy
636606|NCT00494208|sexual dysfunction|sexual dysfunction
636607|NCT00494208|sexual function|sexual function
636608|NCT00494208|muscle function|muscle function
636609|NCT00494208|insulin sensitivity|insulin sensitivity
636610|NCT00494208|body composition|body composition
636611|NCT00494195|limb girdle muscular dystrophy type 2D|limb girdle muscular dystrophy type 2d
636612|NCT00494195|alpha-sarcoglycanopathy|alpha-sarcoglycanopathy
636613|NCT00494195|LGMD|lgmd
636614|NCT00494195|LGMD2D|lgmd2d
636615|NCT00494195|gene therapy|gene therapy
636616|NCT00494195|gene transfer|gene transfer
636617|NCT00494195|muscular dystrophy|muscular dystrophy
636618|NCT00494195|SGCA|sgca
636619|NCT00494195|sarcoglycan|sarcoglycan
636620|NCT00494195|limb girdle|limb girdle
636621|NCT00494195|adeno-associated virus|adeno-associated virus
636622|NCT00494195|AAV|aav
636623|NCT00494195|AAV1|aav1
636624|NCT00494182|Head and Neck Cancer|head and neck cancer
636625|NCT00494182|Squamous Cell Carcinoma|squamous cell carcinoma
636626|NCT00494182|Sorafenib|sorafenib
636627|NCT00494182|BAY 43-9006|bay 43-9006
636628|NCT00494182|Carboplatin|carboplatin
636629|NCT00494182|Paclitaxel|paclitaxel
636630|NCT00494182|SCCHN|scchn
636631|NCT00494169|Idiopathic Hypogonadotropic Hypogonadism|idiopathic hypogonadotropic hypogonadism
636632|NCT00494169|Kallmann Syndrome|kallmann syndrome
636633|NCT00494169|Puberty|puberty
636634|NCT00494169|Pituitary Abnormalities|pituitary abnormalities
636635|NCT00494169|Hypothalamus|hypothalamus
636636|NCT00494169|anosmia|anosmia
636637|NCT00494169|GnRH deficiency|gnrh deficiency
636638|NCT00494143|Amputee|amputee
636639|NCT00494143|Economy|economy
636640|NCT00494143|Efficiency|efficiency
636641|NCT00494143|Foot|foot
636642|NCT00494143|Gait|gait
636643|NCT00494143|Kinematics|kinematics
636644|NCT00494143|Kinetics|kinetics
636645|NCT00494143|Prosthesis|prosthesis
636646|NCT00494104|vitamin D deficiency|vitamin d deficiency
636647|NCT00494104|breastfed infant|breastfed infant
636648|NCT00494104|northern latitude|northern latitude
636649|NCT00494104|infant|infant
636650|NCT00494104|breastfed|breastfed
636651|NCT00494104|winter|winter
636652|NCT00494104|vitamin D status|vitamin d status
636653|NCT00494078|critical illness|critical illness
636654|NCT00494078|hyperglycemia|hyperglycemia
636655|NCT00494078|intensive insulin therapy|intensive insulin therapy
636656|NCT00494078|glucose monitoring|glucose monitoring
636657|NCT00494052|Coronary Heart Disease|coronary heart disease
636658|NCT00494052|Choice Behavior|choice behavior
636659|NCT00494052|Risk Factors|risk factors
636660|NCT00494052|Risk Assessment|risk assessment
636661|NCT00494052|Primary Prevention|primary prevention
636662|NCT00494052|Decision Making|decision making
636663|NCT00494052|Decision Aids|decision aids
636664|NCT00494052|Patient Compliance|patient compliance
636665|NCT00494039|prostate|prostate
636666|NCT00494039|cancer|cancer
636667|NCT00494039|radiation|radiation
636668|NCT00494039|brachytherapy|brachytherapy
636669|NCT00494013|diabetes|diabetes
636670|NCT00494013|type 2|type 2
636671|NCT00493987|Testosterone|testosterone
636672|NCT00493987|Androgens|androgens
636673|NCT00493987|Dihydrotestosterone|dihydrotestosterone
636674|NCT00493987|5-alpha reductase|5-alpha reductase
636675|NCT00493987|Body Composition|body composition
636676|NCT00493987|Muscle|muscle
636677|NCT00493987|Sexual function|sexual function
636678|NCT00493987|Men|men
636679|NCT00493987|Healthy Men|healthy men
636680|NCT00493974|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
636681|NCT00493974|COPD|copd
636682|NCT00493974|Exacerbation|exacerbation
636683|NCT00493974|Anti-leukotriene|anti-leukotriene
636684|NCT00493974|Length of Stay|length of stay
636685|NCT00493974|LOS|los
636686|NCT00493961|Kallmann Syndrome|kallmann syndrome
636687|NCT00493961|Idiopathic Hypogonadotropic Hypogonadism|idiopathic hypogonadotropic hypogonadism
636688|NCT00493961|GnRH deficiency|gnrh deficiency
636689|NCT00493935|bedtime snack|bedtime snack
636690|NCT00493935|hypoglycemia|hypoglycemia
636691|NCT00493935|Diabetes Mellitus, Type I|diabetes mellitus, type i
636692|NCT00493935|glucose monitoring|glucose monitoring
636693|NCT00493922|Malaria|malaria
636694|NCT00493922|Diagnosis|diagnosis
636695|NCT00493922|Rapid diagnostic tests|rapid diagnostic tests
636696|NCT00493922|Microscopy|microscopy
636697|NCT00493922|Clinical diagnosis|clinical diagnosis
636698|NCT00493922|Africa|africa
636699|NCT00493909|thoracotomy|thoracotomy
636700|NCT00493909|pain therapy|pain therapy
636701|NCT00493909|thoracic paravertebral blockade|thoracic paravertebral blockade
636702|NCT00493909|intrathecal opioids|intrathecal opioids
636703|NCT00493909|thoracic epidural analgesia|thoracic epidural analgesia
636704|NCT00493909|Analgesia after thoracotomy|analgesia after thoracotomy
636705|NCT00493896|Venous Thromboembolism Prophylaxis|venous thromboembolism prophylaxis
636706|NCT00493896|VTE prophylaxis|vte prophylaxis
636707|NCT00493883|Therasphere|therasphere
636708|NCT00493883|Yttrium|yttrium
636709|NCT00493883|liver|liver
636710|NCT00493883|cancer|cancer
636711|NCT00493883|radiation|radiation
636712|NCT00493857|Colorectal cancer|colorectal cancer
636713|NCT00493857|Monoclonal antibody|monoclonal antibody
636714|NCT00493857|Anti-EGFR|anti-egfr
636715|NCT00493844|Chest pain|chest pain
636716|NCT00493844|Unstable angina|unstable angina
636717|NCT00493844|NT-proBNP|nt-probnp
636718|NCT00493844|Exercise test.|exercise test.
636719|NCT00493831|smoking reduction|smoking reduction
636720|NCT00493831|inflammation|inflammation
636721|NCT00493831|harm reduction|harm reduction
636722|NCT00493831|lipid biomarkers|lipid biomarkers
636723|NCT00493818|GSK690693,|gsk690693,
636724|NCT00493818|Solid Tumors,|solid tumors,
636725|NCT00493818|Lymphoma,|lymphoma,
636726|NCT00493818|AKT|akt
636727|NCT00493805|homeostasis model assessment of insulin resistance|homeostasis model assessment of insulin resistance
636728|NCT00493766|LBH589|lbh589
636729|NCT00493766|Prostate Cancer|prostate cancer
636730|NCT00493766|HRPC|hrpc
636731|NCT00493766|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
636732|NCT00493740|Cephalic phase, oncology patients|cephalic phase, oncology patients
636733|NCT00493727|Oxidative stress|oxidative stress
636734|NCT00493727|N-acetylcysteine|n-acetylcysteine
636735|NCT00493727|NAC|nac
636736|NCT00493727|Isoprostane|isoprostane
636737|NCT00493727|Proteinuria|proteinuria
636738|NCT00493727|Diabetes|diabetes
636739|NCT00493727|Mucomyst|mucomyst
636740|NCT00493727|albuminuria|albuminuria
636741|NCT00493714|Advanced Cancer|advanced cancer
636742|NCT00493714|Delirium|delirium
636743|NCT00493714|Restlessness|restlessness
636744|NCT00493714|Confusion|confusion
636745|NCT00493714|Caregivers|caregivers
636746|NCT00493714|Questionnaire|questionnaire
636747|NCT00493688|Abdominal Cancer|abdominal cancer
636748|NCT00493688|Pelvic Cancer|pelvic cancer
636749|NCT00493688|Perioperative Energy Dynamics|perioperative energy dynamics
636750|NCT00493688|Cardiopulmonary Exercise Testing|cardiopulmonary exercise testing
636751|NCT00493688|CPET|cpet
636752|NCT00493675|Cystic duct leakage|cystic duct leakage
636753|NCT00493636|Breast Cancer|breast cancer
636754|NCT00493610|Oxidant stress|oxidant stress
636755|NCT00493610|N-acetylcysteine|n-acetylcysteine
636756|NCT00493610|Hepatitis C|hepatitis c
636757|NCT00493610|Liver disease|liver disease
636758|NCT00493610|Mucomyst|mucomyst
636759|NCT00493610|Isoprostane|isoprostane
636760|NCT00493597|Atherosclerosis|atherosclerosis
636761|NCT00493597|Restenosis|restenosis
636762|NCT00493597|EPC|epc
636763|NCT00493597|DC|dc
636764|NCT00493584|Myocardial Infarction|myocardial infarction
636765|NCT00493584|Myocardial Ischemia|myocardial ischemia
636766|NCT00493584|Myocardial Revascularization|myocardial revascularization
636767|NCT00493584|Telemedicine|telemedicine
636768|NCT00493584|Percutaneous Transluminal Coronary Angioplasty|percutaneous transluminal coronary angioplasty
636769|NCT00493571|Myelodysplastic Syndromes|myelodysplastic syndromes
636770|NCT00493571|MDS|mds
636771|NCT00493571|Gimatecan|gimatecan
636772|NCT00493571|Leukemia|leukemia
636773|NCT00493558|Roentgen Stereophotogrammetric Analysis|roentgen stereophotogrammetric analysis
636774|NCT00493558|Trabecular Metal Posterior Lumbar Interbody Cage|trabecular metal posterior lumbar interbody cage
636775|NCT00493558|Posterior Lumbar Interbody Fusion Cage|posterior lumbar interbody fusion cage
636776|NCT00493558|Posterior Lumbar spine fusion surgery|posterior lumbar spine fusion surgery
636777|NCT00493545|Multicenter|multicenter
636778|NCT00493545|Open-Label|open-label
636779|NCT00493545|Nonrandomized|nonrandomized
636780|NCT00493545|Safety|safety
636781|NCT00493519|Cephalic phase|cephalic phase
636782|NCT00493519|Anorexia nervosa|anorexia nervosa
636783|NCT00493519|Bulimia nervosa|bulimia nervosa
636784|NCT00493519|obese binge eaters|obese binge eaters
636785|NCT00493519|VAS|vas
636786|NCT00493519|EDI|edi
636787|NCT00493519|shame-feed procedure|shame-feed procedure
636788|NCT00493506|ProAlgaZyme|proalgazyme
636789|NCT00493506|HIV|hiv
636790|NCT00493506|HAART|haart
636791|NCT00493506|hsCRP|hscrp
636792|NCT00493506|Oxidative stress|oxidative stress
636793|NCT00493506|CD4+ lymphocytes|cd4+ lymphocytes
636794|NCT00493506|Algae|algae
636795|NCT00493506|HAART adverse effects|haart adverse effects
636796|NCT00493506|HBV|hbv
636797|NCT00493493|Cymetra|cymetra
636798|NCT00493467|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
636799|NCT00493467|Lymphoma|lymphoma
636800|NCT00493467|Indolent Lymphomas|indolent lymphomas
636801|NCT00493467|Ibritumomab Tiuxetan|ibritumomab tiuxetan
636802|NCT00493467|Zevalin|zevalin
636803|NCT00493454|Indolent Lymphoma|indolent lymphoma
636804|NCT00493454|Extranodal Marginal|extranodal marginal
636805|NCT00493454|Nodal Marginal Zone|nodal marginal zone
636806|NCT00493454|Splenic Marginal|splenic marginal
636807|NCT00493454|MALT Type|malt type
636808|NCT00493454|Zevalin|zevalin
636809|NCT00493454|Ibritumomab Tiuxetan|ibritumomab tiuxetan
636810|NCT00493454|Rituximab|rituximab
636811|NCT00493428|Hepatocellular Carcinoma|hepatocellular carcinoma
636812|NCT00493428|GABAergic Activity|gabaergic activity
636813|NCT00493428|Baclofen|baclofen
636814|NCT00493415|microcirculation|microcirculation
636815|NCT00493415|sepsis|sepsis
636816|NCT00493415|nitroglycerine|nitroglycerine
636817|NCT00493415|SDF imaging|sdf imaging
636818|NCT00493402|Antineoplastic Agents|antineoplastic agents
636819|NCT00493402|administration & dosage|administration & dosage
636820|NCT00493402|Carcinoma, Hepatocellular|carcinoma, hepatocellular
636821|NCT00493402|Chemoembolization, Therapeutic|chemoembolization, therapeutic
636822|NCT00493402|Humans|humans
636823|NCT00493402|Liver Neoplasms|liver neoplasms
636824|NCT00493402|therapy|therapy
636825|NCT00493389|ACTH stimulation test|acth stimulation test
636826|NCT00493389|cortisol|cortisol
636827|NCT00493389|stress|stress
636828|NCT00493376|tirapazamine|tirapazamine
636829|NCT00493376|DNA damage|dna damage
636830|NCT00493376|comet assay|comet assay
636831|NCT00493363|falciparum malaria|falciparum malaria
636832|NCT00493363|artemisinins|artemisinins
636833|NCT00493363|artesunate|artesunate
636834|NCT00493363|resistance|resistance
636835|NCT00493350|Breast Cancer|breast cancer
636836|NCT00493350|Circulating Tumor Cells|circulating tumor cells
636837|NCT00493350|Gene Profiling|gene profiling
636838|NCT00493350|International Stage Stratification Study|international stage stratification study
636839|NCT00493350|Blood Sample|blood sample
636840|NCT00493350|ISSS|isss
636841|NCT00493337|Adherence|adherence
636842|NCT00493337|Compliance|compliance
636843|NCT00493337|Statins|statins
636844|NCT00493337|Intervention|intervention
636845|NCT00493337|Hypercholesterolemia|hypercholesterolemia
636846|NCT00493324|psoriasis|psoriasis
636847|NCT00493324|alefacept|alefacept
636848|NCT00493324|polyvalent pneumococcal vaccine|polyvalent pneumococcal vaccine
636849|NCT00493324|Immunization|immunization
636850|NCT00493298|disease progression|disease progression
636851|NCT00493298|Multiple Sclerosis|multiple sclerosis
636852|NCT00493298|disease activity|disease activity
636853|NCT00493298|Tysabri|tysabri
636854|NCT00493298|natalizumab|natalizumab
636855|NCT00493298|long-term safety|long-term safety
636856|NCT00493285|Lower Respiratory Tract Illness|lower respiratory tract illness
636857|NCT00493285|RSV and PIV3 infection|rsv and piv3 infection
636858|NCT00493272|Blood coagulation disorder, acquired|blood coagulation disorder, acquired
636859|NCT00493272|Hemodilution|hemodilution
636860|NCT00493272|Fibrinogen|fibrinogen
636861|NCT00493272|Hemostasis|hemostasis
636862|NCT00493272|HES|hes
636863|NCT00493259|Health-Related Quality of Life|health-related quality of life
636864|NCT00493233|schizophrenia|schizophrenia
636865|NCT00493233|antipsychotics|antipsychotics
636866|NCT00493233|polypharmacy|polypharmacy
636867|NCT00493233|double-blind|double-blind
636868|NCT00493233|randomized|randomized
636869|NCT00493220|ceftriaxone|ceftriaxone
636870|NCT00493220|cephalosporins|cephalosporins
636871|NCT00493220|pharmacokinetics|pharmacokinetics
636872|NCT00493220|subcutaneous|subcutaneous
636873|NCT00493220|hyaluronoglucosaminidase|hyaluronoglucosaminidase
636874|NCT00493220|hyaluronidase|hyaluronidase
636875|NCT00493220|hyaluronan|hyaluronan
636876|NCT00493220|rHuPH20|rhuph20
636877|NCT00493194|Cyclosporine toxicity|cyclosporine toxicity
636878|NCT00493194|Interstitial Fibrosis|interstitial fibrosis
636879|NCT00493194|Chronic allograft nephropathy|chronic allograft nephropathy
636880|NCT00493194|Sirolimus|sirolimus
636881|NCT00493181|oprelvekin|oprelvekin
636882|NCT00493181|tyrosine kinase inhibitor|tyrosine kinase inhibitor
636883|NCT00493181|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
636884|NCT00493181|Leukemia|leukemia
636885|NCT00493181|CML|cml
636886|NCT00493181|Thrombocytopenia|thrombocytopenia
636887|NCT00493181|Imatinib|imatinib
636888|NCT00493181|IL-11|il-11
636889|NCT00493181|Interleukin 11|interleukin 11
636890|NCT00493181|Neumega|neumega
636891|NCT00493129|Systemic Mastocytosis|systemic mastocytosis
636892|NCT00493129|SM|sm
636893|NCT00493129|Mast Cell Leukemia|mast cell leukemia
636894|NCT00493129|Leukemia|leukemia
636895|NCT00493129|Denileukin Diftitox|denileukin diftitox
636896|NCT00493129|Ontak|ontak
636897|NCT00493116|recovery of efficacy|recovery of efficacy
636898|NCT00493116|MxA protein|mxa protein
636899|NCT00493116|neutralizing antibodies|neutralizing antibodies
636900|NCT00493116|Multiple sclerosis|multiple sclerosis
636901|NCT00493103|thyroglobulin gene|thyroglobulin gene
636902|NCT00493103|congenital hypothyroidism|congenital hypothyroidism
636903|NCT00493103|gene mutations|gene mutations
636904|NCT00493103|fetal goiter|fetal goiter
636905|NCT00493103|iodine nutrition|iodine nutrition
636906|NCT00493090|Professional|professional
636907|NCT00493090|patient partnership|patient partnership
636908|NCT00493090|patient satisfaction|patient satisfaction
636909|NCT00493090|professional training|professional training
636910|NCT00493077|Multiple Sclerosis|multiple sclerosis
636911|NCT00493077|Neutralizing antibodies|neutralizing antibodies
636912|NCT00493077|Safety|safety
636913|NCT00493077|Low immunogenicity|low immunogenicity
636914|NCT00493077|interferon|interferon
636915|NCT00493077|interferon-beta-1a|interferon-beta-1a
636916|NCT00493051|diabetes|diabetes
636917|NCT00493051|nonhealing|nonhealing
636918|NCT00493051|ulcers|ulcers
636919|NCT00493051|neuropathic|neuropathic
637317|NCT00491478|Stereotypy|stereotypy
636920|NCT00493038|Treatment of acute bacterial rhinosinusitis|treatment of acute bacterial rhinosinusitis
636921|NCT00493025|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
636922|NCT00493025|stage II esophageal cancer|stage ii esophageal cancer
636923|NCT00493025|stage III esophageal cancer|stage iii esophageal cancer
636924|NCT00493025|stage IV esophageal cancer|stage iv esophageal cancer
636925|NCT00493012|body weight|body weight
636926|NCT00493012|body compostion|body compostion
636927|NCT00493012|vitamin D|vitamin d
636928|NCT00493012|blood pressure|blood pressure
636929|NCT00492999|recurrent colon cancer|recurrent colon cancer
636930|NCT00492999|stage IV colon cancer|stage iv colon cancer
636931|NCT00492999|recurrent rectal cancer|recurrent rectal cancer
636932|NCT00492999|stage IV rectal cancer|stage iv rectal cancer
636933|NCT00492999|adenocarcinoma of the colon|adenocarcinoma of the colon
636934|NCT00492999|adenocarcinoma of the rectum|adenocarcinoma of the rectum
636935|NCT00492999|liver metastases|liver metastases
636936|NCT00492986|Renal Cell Cancer (RCC)|renal cell cancer (rcc)
636937|NCT00492986|Cancer|cancer
636938|NCT00492973|arthroplasty|arthroplasty
636939|NCT00492973|replacement|replacement
636940|NCT00492973|knee|knee
636941|NCT00492960|larazotide acetate|larazotide acetate
636942|NCT00492947|Phase I|phase i
636943|NCT00492947|dendritic cell|dendritic cell
636944|NCT00492947|vaccine|vaccine
636945|NCT00492947|intra tumoral|intra tumoral
636946|NCT00492947|squamous cell carcinoma|squamous cell carcinoma
636947|NCT00492934|subfertility|subfertility
636948|NCT00492934|endometrium thickness|endometrium thickness
636949|NCT00492934|implantation rate|implantation rate
636950|NCT00492934|embryo cryopreservation|embryo cryopreservation
636951|NCT00492934|embryo transfer|embryo transfer
636952|NCT00492921|graft versus host disease|graft versus host disease
636953|NCT00492908|Coronary Revascularization|coronary revascularization
636954|NCT00492908|Titanium-Nitride-Oxide Coated Stent|titanium-nitride-oxide coated stent
636955|NCT00492908|Zotarolimus-Eluting Stent|zotarolimus-eluting stent
636956|NCT00492882|Polycystic Ovary Syndrome|polycystic ovary syndrome
636957|NCT00492882|Follicular Arrest|follicular arrest
636958|NCT00492882|Anti-Mullerian Hormone|anti-mullerian hormone
636959|NCT00492882|FSH|fsh
636960|NCT00492869|kidney transplantation|kidney transplantation
636961|NCT00492869|rejection|rejection
636962|NCT00492869|AEB071|aeb071
636963|NCT00492869|tacrolimus|tacrolimus
636964|NCT00492869|mycophenolic|mycophenolic
636965|NCT00492869|basiliximab|basiliximab
636966|NCT00492869|immunosuppression|immunosuppression
636967|NCT00492856|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
636968|NCT00492856|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
636969|NCT00492856|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
636970|NCT00492843|Ibandronate, Lung cancer, bone metastasis|ibandronate, lung cancer, bone metastasis
636971|NCT00492830|Phase 1|phase 1
636972|NCT00492830|TRC093|trc093
636973|NCT00492830|denatured collagen|denatured collagen
636974|NCT00492830|solid tumor|solid tumor
636975|NCT00492830|antibody|antibody
636976|NCT00492830|TRACON|tracon
636977|NCT00492830|Locally advanced solid tumors|locally advanced solid tumors
636978|NCT00492830|Metastatic solid tumors|metastatic solid tumors
636979|NCT00492817|Spinal Neoplasms|spinal neoplasms
636980|NCT00492817|Paraspinal Metastases|paraspinal metastases
636981|NCT00492817|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
636982|NCT00492817|CT-on-Rails|ct-on-rails
636983|NCT00492817|Spinal Cord|spinal cord
636984|NCT00492817|SBRT|sbrt
636985|NCT00492804|inguinal hernia|inguinal hernia
636986|NCT00492804|chronic pain|chronic pain
636987|NCT00492804|neurectomy|neurectomy
636988|NCT00492804|hypesthesia|hypesthesia
636989|NCT00492791|crohn's disease|crohn's disease
636990|NCT00492791|capsule endoscopes|capsule endoscopes
636991|NCT00492765|Combination therapy|combination therapy
636992|NCT00492765|Simvastatin|simvastatin
636993|NCT00492765|Multiple Sclerosis|multiple sclerosis
636994|NCT00492765|Interferon-beta-1a|interferon-beta-1a
636995|NCT00492739|Orthotopic liver transplantation|orthotopic liver transplantation
636996|NCT00492739|Pediatric|pediatric
636997|NCT00492739|Immunosuppression|immunosuppression
636998|NCT00492739|Varicella vaccine|varicella vaccine
636999|NCT00492739|B cell response|b cell response
637000|NCT00492739|T cell response|t cell response
637001|NCT00492739|Antibodies|antibodies
637002|NCT00492739|Varicella|varicella
637003|NCT00492739|Chickenpox|chickenpox
637004|NCT00492739|transplantation|transplantation
637005|NCT00492726|Complicated Intra-Abdominal Infections|complicated intra-abdominal infections
637006|NCT00492713|Bioavailability|bioavailability
637007|NCT00492713|Dark Chocolate|dark chocolate
637008|NCT00492713|Milk Chocolate|milk chocolate
637009|NCT00492713|Polyphenols|polyphenols
637010|NCT00492700|steatosis,|steatosis,
637011|NCT00492700|fibrosis,|fibrosis,
637012|NCT00492700|diabetes,|diabetes,
637013|NCT00492700|obesity|obesity
637014|NCT00492687|adult anaplastic astrocytoma|adult anaplastic astrocytoma
637015|NCT00492687|adult giant cell glioblastoma|adult giant cell glioblastoma
637016|NCT00492687|adult gliosarcoma|adult gliosarcoma
637017|NCT00492687|adult glioblastoma|adult glioblastoma
637018|NCT00492674|TKA|tka
637019|NCT00492674|Arthroplasty|arthroplasty
637020|NCT00492674|Knee|knee
637021|NCT00492674|Osteoarthritis|osteoarthritis
637022|NCT00492674|Rehabilitation|rehabilitation
637023|NCT00492661|Tacrolimus|tacrolimus
637024|NCT00492661|Prograf|prograf
637025|NCT00492661|PRIDE|pride
637026|NCT00492648|GSK Biologicals|gsk biologicals
637027|NCT00492648|Varicella Zoster Virus (VZV)|varicella zoster virus (vzv)
637028|NCT00492648|Intracellular cytokine staining (ICS)|intracellular cytokine staining (ics)
637029|NCT00492648|Vaccine|vaccine
637030|NCT00492648|Cell mediated immunity (CMI)|cell mediated immunity (cmi)
637031|NCT00492648|Herpes Zoster (HZ)|herpes zoster (hz)
637032|NCT00492648|Shingles|shingles
637033|NCT00492622|Gastroparesis|gastroparesis
637034|NCT00492622|Gastroesophageal reflux disease|gastroesophageal reflux disease
637035|NCT00492622|heartburn|heartburn
637036|NCT00492609|Surgery|surgery
637037|NCT00492609|Navigation|navigation
637038|NCT00492609|ACL|acl
637039|NCT00492609|IKDC|ikdc
637040|NCT00492609|comparative study|comparative study
637041|NCT00492583|probiotic|probiotic
637042|NCT00492583|health|health
637043|NCT00492583|bifidobacterium lactis|bifidobacterium lactis
637044|NCT00492583|BB-12|bb-12
637045|NCT00492570|Multiple Sclerosis|multiple sclerosis
637046|NCT00492570|Cognitive Dysfunction in Multiple sclerosis|cognitive dysfunction in multiple sclerosis
637047|NCT00492570|early treatment|early treatment
637048|NCT00492570|Avonex|avonex
637049|NCT00492570|interferon beta 1a|interferon beta 1a
637050|NCT00492570|Cognitive Dysfunction|cognitive dysfunction
637051|NCT00492557|Pneumococcal Disease|pneumococcal disease
637052|NCT00492557|Pneumococcal Conjugate Vaccine|pneumococcal conjugate vaccine
637053|NCT00492544|Human Papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
637054|NCT00492544|safety|safety
637055|NCT00492544|cervical cancer|cervical cancer
637056|NCT00492544|immunogenicity|immunogenicity
637057|NCT00492544|vaccine|vaccine
637058|NCT00492544|viral infections|viral infections
637059|NCT00492544|pre-adolescent and adolescent females|pre-adolescent and adolescent females
637060|NCT00492531|Interventional Study|interventional study
637061|NCT00492531|6-Minute Walk|6-minute walk
637062|NCT00492531|Sickle Cell Anemia|sickle cell anemia
637063|NCT00492531|Sildenafil/Viagra|sildenafil/viagra
637064|NCT00492531|Tricuspid Regurgitant Velocity|tricuspid regurgitant velocity
637065|NCT00492531|Sickle Cell Disease|sickle cell disease
637066|NCT00492531|Pulmonary Hypertension|pulmonary hypertension
637067|NCT00492518|Contrast Induced Nephropathy|contrast induced nephropathy
637068|NCT00492518|Prophylaxis|prophylaxis
637069|NCT00492518|Theophylline|theophylline
637070|NCT00492518|Acetylcysteine|acetylcysteine
637071|NCT00492518|Coronary angiography|coronary angiography
637072|NCT00492505|stage IIIA melanoma|stage iiia melanoma
637073|NCT00492505|stage IIIB melanoma|stage iiib melanoma
637074|NCT00492505|stage IIIC melanoma|stage iiic melanoma
637075|NCT00492492|radius,|radius,
637076|NCT00492492|pinning,|pinning,
637077|NCT00492492|fixed-angle plate,|fixed-angle plate,
637078|NCT00492492|quick-DASH,|quick-dash,
637079|NCT00492492|HERZBERG-score.|herzberg-score.
637080|NCT00492466|Multiple Sclerosis|multiple sclerosis
637081|NCT00492466|antibody|antibody
637082|NCT00492466|Neutralizing antibody|neutralizing antibody
637083|NCT00492466|Binding antibody|binding antibody
637084|NCT00492466|MxA protein|mxa protein
637085|NCT00492440|recurrent renal cell cancer|recurrent renal cell cancer
637086|NCT00492440|stage IV renal cell cancer|stage iv renal cell cancer
637087|NCT00492440|stage III renal cell cancer|stage iii renal cell cancer
637088|NCT00492440|recurrent melanoma|recurrent melanoma
637089|NCT00492440|stage IV melanoma|stage iv melanoma
637090|NCT00492414|Panic disorder (PD)|panic disorder (pd)
637091|NCT00492388|breakthrough|breakthrough
637092|NCT00492388|pain|pain
637093|NCT00492388|cancer|cancer
637094|NCT00492362|hemodialysis|hemodialysis
637095|NCT00492362|exercise|exercise
637096|NCT00492362|physical fitness|physical fitness
637097|NCT00492362|dialysis adequacy|dialysis adequacy
637098|NCT00492349|Varenicline|varenicline
637099|NCT00492349|Neurobiology|neurobiology
637100|NCT00492349|clinical trial|clinical trial
637101|NCT00492349|cognitive deficits|cognitive deficits
637102|NCT00492349|Schizophreniform Disorder|schizophreniform disorder
637103|NCT00492336|Cognitive impairments|cognitive impairments
637104|NCT00492336|Negative symptoms|negative symptoms
637105|NCT00492323|pain following the healing of rashes and blisters|pain following the healing of rashes and blisters
637106|NCT00492323|herpes virus|herpes virus
637107|NCT00492323|rash|rash
637108|NCT00492323|varicella-zoster virus|varicella-zoster virus
637109|NCT00492323|shingles.|shingles.
637110|NCT00492310|Smoking|smoking
637111|NCT00492310|tobacco|tobacco
637112|NCT00492310|women|women
637113|NCT00492310|yoga|yoga
637114|NCT00492284|Macular Degeneration|macular degeneration
637115|NCT00492284|AMD|amd
637116|NCT00492284|CNV|cnv
637117|NCT00492284|Choroidal neovascularization|choroidal neovascularization
637318|NCT00491478|Sertraline|sertraline
637118|NCT00492284|Photodynamic therapy|photodynamic therapy
637119|NCT00492284|CNV Secondary to Age Related Macular Degeneration|cnv secondary to age related macular degeneration
637120|NCT00492271|Friulimicin B|friulimicin b
637121|NCT00492271|Lipopeptide Antibiotic|lipopeptide antibiotic
637122|NCT00492271|First in Man|first in man
637123|NCT00492258|stage II renal cell cancer|stage ii renal cell cancer
637124|NCT00492258|stage III renal cell cancer|stage iii renal cell cancer
637125|NCT00492258|stage IV renal cell cancer|stage iv renal cell cancer
637126|NCT00492258|stage I renal cell cancer|stage i renal cell cancer
637127|NCT00492258|clear cell renal cell carcinoma|clear cell renal cell carcinoma
637128|NCT00492258|papillary renal cell carcinoma|papillary renal cell carcinoma
637129|NCT00492245|PTK|ptk
637130|NCT00492245|corneal opacity|corneal opacity
637131|NCT00492245|mitomycin|mitomycin
637132|NCT00492232|Chronic Insomnia|chronic insomnia
637133|NCT00492232|Sleep Initiation and Maintenance Disorder|sleep initiation and maintenance disorder
637134|NCT00492232|Drug Therapy|drug therapy
637135|NCT00492219|arthroplasty|arthroplasty
637136|NCT00492219|replacement|replacement
637137|NCT00492219|knee|knee
637138|NCT00492219|prosthesis|prosthesis
637139|NCT00492206|Non Small Cell Lung Cancer|non small cell lung cancer
637140|NCT00492206|NSCLC|nsclc
637141|NCT00492206|EGFR Inhibitor|egfr inhibitor
637142|NCT00492206|Radiation Therapy|radiation therapy
637143|NCT00492193|Hand assist laparoscopic partial large bowel resection|hand assist laparoscopic partial large bowel resection
637144|NCT00492193|Laparoscopic partial large bowel resection|laparoscopic partial large bowel resection
637145|NCT00492167|recurrent neuroblastoma|recurrent neuroblastoma
637146|NCT00492167|regional neuroblastoma|regional neuroblastoma
637147|NCT00492167|stage 4S neuroblastoma|stage 4s neuroblastoma
637148|NCT00492167|disseminated neuroblastoma|disseminated neuroblastoma
637149|NCT00492154|FRACTURE OF DISTAL RADIUS|fracture of distal radius
637150|NCT00492141|Ewing's Sarcoma|ewing's sarcoma
637151|NCT00492141|Lung Involvement|lung involvement
637152|NCT00492141|Temozolomide|temozolomide
637153|NCT00492141|Temodar|temodar
637154|NCT00492141|Aerosol Liposomal 9-Nitro-20(S)-Camptothecin|aerosol liposomal 9-nitro-20(s)-camptothecin
637155|NCT00492141|Aerosol L9-NC|aerosol l9-nc
637156|NCT00492141|L9-NC|l9-nc
637157|NCT00492128|hypertension|hypertension
637158|NCT00492128|angiotensin receptor blocker|angiotensin receptor blocker
637159|NCT00492128|diuretic|diuretic
637160|NCT00492128|combination therapy|combination therapy
637161|NCT00492115|sleep|sleep
637162|NCT00492115|dementia|dementia
637163|NCT00492115|apnea|apnea
637164|NCT00492115|memory|memory
637165|NCT00492115|Parkinson's disease|parkinson's disease
637166|NCT00492102|pharmacokinetics|pharmacokinetics
637167|NCT00492102|Montelukast|montelukast
637168|NCT00492102|bronchopulmonary dysplasia|bronchopulmonary dysplasia
637169|NCT00492102|Pharmacokinetics of Montelukast|pharmacokinetics of montelukast
637170|NCT00492076|Specific immunotherapy|specific immunotherapy
637171|NCT00492076|Mite|mite
637172|NCT00492076|Asthma|asthma
637173|NCT00492063|safety|safety
637174|NCT00492063|immunogenicity|immunogenicity
637175|NCT00492063|non-inferiority|non-inferiority
637176|NCT00492063|MDCK|mdck
637177|NCT00492063|cell culture-derived|cell culture-derived
637178|NCT00492063|subunit influenza vaccine|subunit influenza vaccine
637179|NCT00492063|influenza prevention|influenza prevention
637180|NCT00492050|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
637181|NCT00492050|Macroglobulinemic Lymphoma|macroglobulinemic lymphoma
637182|NCT00492050|Stem Cell Collection|stem cell collection
637183|NCT00492050|Bortezomib|bortezomib
637184|NCT00492050|LDP-341|ldp-341
637185|NCT00492050|MLN341|mln341
637186|NCT00492050|PS-341|ps-341
637187|NCT00492050|Velcade|velcade
637188|NCT00492050|Rituximab|rituximab
637189|NCT00492050|Rituxan|rituxan
637190|NCT00492037|hyponatremia|hyponatremia
637191|NCT00492037|hypervolemic|hypervolemic
637192|NCT00492037|euvolemic|euvolemic
637193|NCT00492037|conivaptan|conivaptan
637194|NCT00492024|Respiratory Tract Infection|respiratory tract infection
637195|NCT00492024|Bacterial Sinusitis|bacterial sinusitis
637196|NCT00492011|Circadian Rhythm Disorders|circadian rhythm disorders
637197|NCT00492011|Biological Clock Disturbances|biological clock disturbances
637198|NCT00492011|Jet Lag Syndrome|jet lag syndrome
637199|NCT00492011|Time Zone Change Syndrome|time zone change syndrome
637200|NCT00492011|Drug Therapy|drug therapy
637201|NCT00491985|Influenza A/H5N1 Virus|influenza a/h5n1 virus
637202|NCT00491985|Influenza Pandemic|influenza pandemic
637203|NCT00491985|Orthomyxoviridae Infections|orthomyxoviridae infections
637204|NCT00491959|oral mucosa|oral mucosa
637205|NCT00491959|limbal insufficiency|limbal insufficiency
637206|NCT00491959|transplantation|transplantation
637207|NCT00491959|cornea|cornea
637208|NCT00491959|ocular surface|ocular surface
637209|NCT00491946|Cancer|cancer
637210|NCT00491946|Actinomycin|actinomycin
637211|NCT00491946|Vincristine|vincristine
637212|NCT00491920|osteoporosis|osteoporosis
637213|NCT00491920|bone mineral density|bone mineral density
637214|NCT00491920|vitamin D|vitamin d
637215|NCT00491907|folic acid|folic acid
637216|NCT00491907|endothelial function|endothelial function
637217|NCT00491907|baroreceptor function|baroreceptor function
637218|NCT00491907|heart failure|heart failure
637219|NCT00491894|Mental Retardation|mental retardation
637220|NCT00491894|Neurological Impairment|neurological impairment
637221|NCT00491894|Cerebral Palsy|cerebral palsy
637222|NCT00491894|Drooling|drooling
637223|NCT00491894|Neurological Conditions|neurological conditions
637224|NCT00491881|blood pressure|blood pressure
637225|NCT00491881|No added salt diet|no added salt diet
637226|NCT00491881|urinary sodium|urinary sodium
637227|NCT00491855|Advanced Peritoneal Carcinomatosis|advanced peritoneal carcinomatosis
637228|NCT00491855|Peritoneal Cancer|peritoneal cancer
637229|NCT00491855|Bevacizumab|bevacizumab
637230|NCT00491855|Avastin|avastin
637231|NCT00491855|vascular endothelial growth factor|vascular endothelial growth factor
637232|NCT00491855|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
637233|NCT00491855|rhuMAb-VEGF|rhumab-vegf
637234|NCT00491855|Oxaliplatin|oxaliplatin
637235|NCT00491855|Eloxatin|eloxatin
637236|NCT00491855|Paclitaxel|paclitaxel
637237|NCT00491855|Taxol|taxol
637238|NCT00491842|Huntington's Disease|huntington's disease
637239|NCT00491842|Disclosure|disclosure
637240|NCT00491842|Adaptation|adaptation
637241|NCT00491842|Communication About Huntington's Disease|communication about huntington's disease
637242|NCT00491842|Huntington Disease|huntington disease
637243|NCT00491842|HD|hd
637244|NCT00491842|Phone Interview|phone interview
637245|NCT00491816|breast|breast
637246|NCT00491816|cancer|cancer
637247|NCT00491816|breast cancer|breast cancer
637248|NCT00491803|COPD|copd
637249|NCT00491790|montelukast|montelukast
637250|NCT00491790|Albuterol|albuterol
637251|NCT00491790|Status Asthmaticus|status asthmaticus
637252|NCT00491790|Asthma|asthma
637253|NCT00491777|Noninvasive|noninvasive
637254|NCT00491777|Hemodynamic|hemodynamic
637255|NCT00491777|Monitoring|monitoring
637256|NCT00491777|Critical Care|critical care
637257|NCT00491777|Swan-Ganz|swan-ganz
637258|NCT00491751|endothelium|endothelium
637259|NCT00491751|nitric oxide|nitric oxide
637260|NCT00491751|statins|statins
637261|NCT00491751|ascorbic acid|ascorbic acid
637262|NCT00491738|RCC|rcc
637263|NCT00491738|Renal cell cancer|renal cell cancer
637264|NCT00491738|Avastin|avastin
637265|NCT00491738|Sutent|sutent
637266|NCT00491712|Glaucoma|glaucoma
637267|NCT00491712|Neovascular Glaucoma|neovascular glaucoma
637268|NCT00491712|Drainage implant devices|drainage implant devices
637269|NCT00491712|Silicone Ahmed Tube|silicone ahmed tube
637270|NCT00491712|Triamcinolone|triamcinolone
637271|NCT00491699|NSCLC|nsclc
637272|NCT00491686|Long-term depression|long-term depression
637273|NCT00491673|Fracture|fracture
637274|NCT00491673|Femoral neck|femoral neck
637275|NCT00491673|Arthroplasty|arthroplasty
637276|NCT00491660|Gravity|gravity
637277|NCT00491660|Mechanical ventilation|mechanical ventilation
637278|NCT00491660|Infants|infants
637279|NCT00491660|Ventilator-associated pneumonia|ventilator-associated pneumonia
637280|NCT00491660|Types of bacterial colonies in subjects at 2-5 days of mechanical ventilation|types of bacterial colonies in subjects at 2-5 days of mechanical ventilation
637281|NCT00491660|Colony count of an organism was cultured|colony count of an organism was cultured
637282|NCT00491647|ADHD, time perception, treatments|adhd, time perception, treatments
637283|NCT00491634|acute myeloid leukemia|acute myeloid leukemia
637284|NCT00491634|myelodysplastic syndrome|myelodysplastic syndrome
637285|NCT00491634|allogeneic stem cell transplantation|allogeneic stem cell transplantation
637286|NCT00491634|reduced-intensity conditioning|reduced-intensity conditioning
637287|NCT00491634|treosulfan|treosulfan
637288|NCT00491621|kidney|kidney
637289|NCT00491621|tumor|tumor
637290|NCT00491621|Molecular Markers|molecular markers
637291|NCT00491621|Cytology|cytology
637292|NCT00491621|Histology|histology
637293|NCT00491621|Cystic kidney tumor|cystic kidney tumor
637294|NCT00491608|Phase 3b|phase 3b
637295|NCT00491608|rThrombin|rthrombin
637296|NCT00491608|spine surgery|spine surgery
637297|NCT00491608|vascular surgery|vascular surgery
637298|NCT00491608|hemostasis|hemostasis
637299|NCT00491608|immunogenicity|immunogenicity
637300|NCT00491608|safety|safety
637301|NCT00491595|Soy isoflavones|soy isoflavones
637302|NCT00491595|Genotoxicity|genotoxicity
637303|NCT00491595|Apoptosis|apoptosis
637304|NCT00491595|Estrogenic effects|estrogenic effects
637305|NCT00491569|Schizophrenia|schizophrenia
637306|NCT00491569|sarcosine|sarcosine
637307|NCT00491569|D-serine|d-serine
637308|NCT00491569|NMDA|nmda
637309|NCT00491556|Atazanavir/Ritonavir (ATV/r)|atazanavir/ritonavir (atv/r)
637310|NCT00491556|highly-active antiretroviral therapy (HAART)|highly-active antiretroviral therapy (haart)
637311|NCT00491556|Treatment Naive|treatment naive
637312|NCT00491491|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
637313|NCT00491491|autologous stem cell transplantation|autologous stem cell transplantation
637314|NCT00491491|radioimmunotherapy|radioimmunotherapy
637315|NCT00491491|zevalin|zevalin
637316|NCT00491478|Repetitive behavior disorder|repetitive behavior disorder
637319|NCT00491465|Type 1 Diabetes, physical activity, pediatric, metabolic control|type 1 diabetes, physical activity, pediatric, metabolic control
637320|NCT00491452|Ischemic MR|ischemic mr
637321|NCT00491452|Annuloplasty|annuloplasty
637322|NCT00491439|in vivo confocal microscopy|in vivo confocal microscopy
637323|NCT00491439|vitrectomy|vitrectomy
637324|NCT00491439|corneal transplantation|corneal transplantation
637325|NCT00491439|Epi-LASIK|epi-lasik
637326|NCT00491439|wound healing|wound healing
637327|NCT00491426|Infection|infection
637328|NCT00491426|Anti-Infective Agents|anti-infective agents
637329|NCT00491426|Antifungal Agents|antifungal agents
637330|NCT00491426|Proteomics|proteomics
637331|NCT00491413|neurodevelopmental outcomes|neurodevelopmental outcomes
637332|NCT00491400|endothelium|endothelium
637333|NCT00491400|obesity|obesity
637334|NCT00491400|diabetes mellitus|diabetes mellitus
637335|NCT00491400|dyslipidemia|dyslipidemia
637336|NCT00491387|hypertension|hypertension
637337|NCT00491387|sympathetic nervous system|sympathetic nervous system
637338|NCT00491361|ADHD, SNAP-IV, SDQ, ASRS, reliability, validity|adhd, snap-iv, sdq, asrs, reliability, validity
637339|NCT00491348|Generalized anxiety disorder|generalized anxiety disorder
637340|NCT00491348|fMRI|fmri
637341|NCT00491348|Worry|worry
637342|NCT00491335|AIDS|aids
637343|NCT00491335|Lung Cancer|lung cancer
637344|NCT00491335|Emphysema|emphysema
637345|NCT00491335|Nicotine|nicotine
637346|NCT00491335|HIV Infection|hiv infection
637347|NCT00491335|Smoking|smoking
637348|NCT00491322|Vitamin D|vitamin d
637349|NCT00491322|Vitamin D deficiency|vitamin d deficiency
637350|NCT00491322|Insulin resistance|insulin resistance
637351|NCT00491322|Diabetes|diabetes
637352|NCT00491322|Diabetes mellitus|diabetes mellitus
637353|NCT00491322|FGF-23|fgf-23
637354|NCT00491322|FGF23|fgf23
637355|NCT00491322|Phosphate|phosphate
637356|NCT00491296|S/P Transuretral resection of bladder tumor|s/p transuretral resection of bladder tumor
637357|NCT00491296|Recurrent tumor after BCG Treatment|recurrent tumor after bcg treatment
637358|NCT00491270|Vaginosis, Bacterial|vaginosis, bacterial
637359|NCT00491270|Abortion, Spontaneous|abortion, spontaneous
637360|NCT00491270|Premature Birth|premature birth
637361|NCT00491257|Influenza|influenza
637362|NCT00491257|Orthomyxoviridae Infections|orthomyxoviridae infections
637363|NCT00491257|Orthomyxoviruses|orthomyxoviruses
637364|NCT00491257|Split-virion influenza vaccine|split-virion influenza vaccine
637365|NCT00491244|Chronic hepatitis C|chronic hepatitis c
637366|NCT00491244|Hemodialysis|hemodialysis
637367|NCT00491244|Interferon|interferon
637368|NCT00491244|Ribavirin|ribavirin
637369|NCT00491231|orthostatic hypotension|orthostatic hypotension
637370|NCT00491231|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
637371|NCT00491218|impact of cardiac computed tomography on outpatient angina evaluation|impact of cardiac computed tomography on outpatient angina evaluation
637372|NCT00491218|downstream resource utilization|downstream resource utilization
637373|NCT00491192|Fever|fever
637374|NCT00491192|Acute cerebral damage|acute cerebral damage
637375|NCT00491192|Normothermia|normothermia
637376|NCT00491192|Diclofenac|diclofenac
637377|NCT00491192|ICU|icu
637378|NCT00491192|Outcome|outcome
637379|NCT00491192|Intracranial pressure|intracranial pressure
637380|NCT00491192|Cerebral perfusion pressure|cerebral perfusion pressure
637381|NCT00491192|Traumatic brain injury|traumatic brain injury
637382|NCT00491192|Subarachnoid hemorrhage|subarachnoid hemorrhage
637383|NCT00491179|Chronic hepatitis C|chronic hepatitis c
637384|NCT00491179|hemodialysis|hemodialysis
637385|NCT00491179|interferon|interferon
637386|NCT00491179|ribavirin|ribavirin
637387|NCT00491166|diabetic macular edema|diabetic macular edema
637388|NCT00491166|bromfenac ophthalmic solution|bromfenac ophthalmic solution
637389|NCT00491153|asthma|asthma
637390|NCT00491153|airway hyperresponsiveness|airway hyperresponsiveness
637391|NCT00491153|dry powder mannitol inhalation|dry powder mannitol inhalation
637392|NCT00491153|methacholine|methacholine
637393|NCT00491140|EGFR|egfr
637394|NCT00491140|KRAS|kras
637395|NCT00491140|BRAF|braf
637396|NCT00491140|MET|met
637397|NCT00491140|IGFR1|igfr1
637398|NCT00491101|Asthma Control|asthma control
637399|NCT00491101|Quality of Life|quality of life
637400|NCT00491101|Children|children
637401|NCT00491101|Polish Version of PAQLQ(S) by Juniper|polish version of paqlq(s) by juniper
637402|NCT00491075|Renal Cell Carcinoma|renal cell carcinoma
637403|NCT00491075|Non-Clear Cell|non-clear cell
637404|NCT00491075|Pemetrexed|pemetrexed
637405|NCT00491075|Gemcitabine|gemcitabine
637406|NCT00491075|LY231514|ly231514
637407|NCT00491075|Alimta|alimta
637408|NCT00491075|MTA|mta
637409|NCT00491075|Multitargeted Antifolate|multitargeted antifolate
637410|NCT00491075|NSC-698037|nsc-698037
637411|NCT00491075|Gemcitabine Hydrochloride|gemcitabine hydrochloride
637412|NCT00491075|Gemzar|gemzar
637413|NCT00491075|RCC|rcc
637414|NCT00491062|Parkinson's disease|parkinson's disease
637415|NCT00491062|enteric nervous system|enteric nervous system
637416|NCT00491049|prophylaxis|prophylaxis
637417|NCT00491049|intraocular surgery|intraocular surgery
637418|NCT00491049|endophthalmitis|endophthalmitis
637419|NCT00491049|antibiotic|antibiotic
637420|NCT00491036|Acute myocardial infarction|acute myocardial infarction
637421|NCT00491036|cardiogenic shock|cardiogenic shock
637422|NCT00491036|percutaneous coronary intervention|percutaneous coronary intervention
637423|NCT00491036|intraaortic balloon counterpulsation|intraaortic balloon counterpulsation
637424|NCT00491036|Acute myocardial infarction - cardiogenic shock|acute myocardial infarction - cardiogenic shock
637425|NCT00491010|atrial flutter|atrial flutter
637426|NCT00491010|ablation|ablation
637427|NCT00491010|voltage targeted|voltage targeted
637428|NCT00490997|ketamine|ketamine
637429|NCT00490997|propofol|propofol
637430|NCT00490997|sedation|sedation
637431|NCT00490997|pediatric|pediatric
637432|NCT00490997|emergency department|emergency department
637433|NCT00490997|fracture|fracture
637434|NCT00490984|obstructive sleep apena|obstructive sleep apena
637435|NCT00490984|tongue|tongue
637436|NCT00490984|surgery|surgery
637437|NCT00490971|Bipolar Disorder|bipolar disorder
637438|NCT00490971|Mania|mania
637439|NCT00490971|Depression|depression
637440|NCT00490971|Manic-Depressive Disorder|manic-depressive disorder
637441|NCT00490958|heart Failure|heart failure
637442|NCT00490958|haemodialysis|haemodialysis
637443|NCT00490958|telmisartan|telmisartan
637444|NCT00490958|angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
637445|NCT00490932|Watery diarrhea|watery diarrhea
637446|NCT00490932|Bloody diarrhea|bloody diarrhea
637447|NCT00490919|Chronic pain|chronic pain
637448|NCT00490919|opioid|opioid
637449|NCT00490919|transdermal|transdermal
637450|NCT00490919|Moderate to severe chronic low back pain|moderate to severe chronic low back pain
637451|NCT00490906|MS (Multiple Sclerosis)|ms (multiple sclerosis)
637452|NCT00490893|counterregulation|counterregulation
637453|NCT00490893|hypoglycemia unawareness|hypoglycemia unawareness
637454|NCT00490893|insulin therapy|insulin therapy
637455|NCT00490828|Cardiac surgery|cardiac surgery
637456|NCT00490828|systemic inflammatory response syndrome|systemic inflammatory response syndrome
637457|NCT00490828|health-related quality of life|health-related quality of life
637458|NCT00490802|Autism|autism
637459|NCT00490802|Treatment|treatment
637460|NCT00490802|Oxytocin|oxytocin
637461|NCT00490802|Adults|adults
637462|NCT00490802|Autism Spectrum Disorder|autism spectrum disorder
637463|NCT00490789|tuberous sclerosis|tuberous sclerosis
637464|NCT00490789|lymphangioleiomyomatosis|lymphangioleiomyomatosis
637465|NCT00490789|sirolimus|sirolimus
637466|NCT00490789|angiomyolioma|angiomyolioma
637467|NCT00490789|rapamycin|rapamycin
637468|NCT00490789|mTOR|mtor
637469|NCT00490776|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
637470|NCT00490776|adults|adults
637471|NCT00490776|Mycosis Fungoides|mycosis fungoides
637472|NCT00490776|Sézary Syndrome|sézary syndrome
637473|NCT00490776|CTCL|ctcl
637474|NCT00490763|Prostate Cancer|prostate cancer
637475|NCT00490763|Active Surveillance|active surveillance
637476|NCT00490763|Prostate Specific Antigen|prostate specific antigen
637477|NCT00490763|Questionnaire|questionnaire
637478|NCT00490763|Survey|survey
637479|NCT00490750|Heller Dor|heller dor
637480|NCT00490750|Heller Toupet|heller toupet
637481|NCT00490750|Myotomy|myotomy
637482|NCT00490737|ESRD|esrd
637483|NCT00490737|dialysis|dialysis
637484|NCT00490737|hemodialysis|hemodialysis
637485|NCT00490737|continuous ambulatory peritoneal dialysis|continuous ambulatory peritoneal dialysis
637486|NCT00490724|Heart failure, congestive|heart failure, congestive
637487|NCT00490724|Nesiritide and|nesiritide and
637488|NCT00490724|JNS004|jns004
637489|NCT00490698|Kidney Cancer|kidney cancer
637490|NCT00490698|Renal Cell Carcinoma|renal cell carcinoma
637491|NCT00490698|Bone-Targeted Therapy|bone-targeted therapy
637492|NCT00490698|Zoledronate|zoledronate
637493|NCT00490698|Zometa|zometa
637494|NCT00490698|Atorvastatin|atorvastatin
637495|NCT00490698|Lipitor|lipitor
637496|NCT00490698|RCC|rcc
637497|NCT00490672|Hypertension|hypertension
637498|NCT00490672|Diabetes Mellitus|diabetes mellitus
637499|NCT00490672|Hyperlipidaemia|hyperlipidaemia
637500|NCT00490672|Primary Care|primary care
637501|NCT00490672|Community Care|community care
637502|NCT00490672|Multiple Risk Factors Interventional Strategies|multiple risk factors interventional strategies
637503|NCT00490646|Locally advanced and/or metastatic breast cancer|locally advanced and/or metastatic breast cancer
637504|NCT00490633|Influenza|influenza
637505|NCT00490633|Non Pharmaceutical Intervention|non pharmaceutical intervention
637506|NCT00490633|Face Mask|face mask
637507|NCT00490633|Hand Hygiene|hand hygiene
637508|NCT00490620|primary biliary cirrhosis C06.552.630.400|primary biliary cirrhosis c06.552.630.400
637509|NCT00490620|retroviral infection C02.782.815|retroviral infection c02.782.815
637510|NCT00490607|Hemagiomas of infancy|hemagiomas of infancy
637511|NCT00490594|ACL|acl
637512|NCT00490594|ligament|ligament
637513|NCT00490594|ACL injury|acl injury
637514|NCT00490581|Early housing after hospitalization|early housing after hospitalization
637515|NCT00490568|cognition|cognition
637516|NCT00490568|Alzheimer's disease|alzheimer's disease
637517|NCT00490568|Rosiglitazone extended-release (XR)|rosiglitazone extended-release (xr)
637518|NCT00490568|safety|safety
637519|NCT00490568|adjunctive therapy|adjunctive therapy
637520|NCT00490568|BRL-049653|brl-049653
637521|NCT00490568|tolerability|tolerability
637522|NCT00490568|open-label extension|open-label extension
637523|NCT00490555|Male Contraception|male contraception
637524|NCT00490555|Testosterone|testosterone
637525|NCT00490555|Testis|testis
637526|NCT00490555|Contraception|contraception
637527|NCT00490555|Prostate|prostate
637528|NCT00490542|Bipolar Disorder|bipolar disorder
637529|NCT00490542|Major Depression|major depression
637530|NCT00490542|Clinical pharmacology|clinical pharmacology
637531|NCT00490542|Clinical Trial|clinical trial
637532|NCT00490516|Schizophrenia, psychotic disorders|schizophrenia, psychotic disorders
637533|NCT00490503|Breast Cancer|breast cancer
637534|NCT00490503|Magnetic Resonance Imaging|magnetic resonance imaging
637535|NCT00490503|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
637536|NCT00490503|DCE-MRI|dce-mri
637537|NCT00490503|DW-MRI|dw-mri
637538|NCT00490503|MRS|mrs
637539|NCT00490503|MRI|mri
637540|NCT00490477|acute renal failure|acute renal failure
637541|NCT00490477|lipopolysaccharide|lipopolysaccharide
637542|NCT00490477|tubular apoptosis|tubular apoptosis
637543|NCT00490477|Polymyxin-B fiber|polymyxin-b fiber
637544|NCT00490477|Severe sepsis from gram negative infection|severe sepsis from gram negative infection
637545|NCT00490464|Patients with SAH or ICH|patients with sah or ich
637546|NCT00490438|perineometry|perineometry
637547|NCT00490438|Modified Oxford Score|modified oxford score
637548|NCT00490438|pelvic muscles evaluation|pelvic muscles evaluation
637549|NCT00490438|urinary incontinence|urinary incontinence
637550|NCT00490438|vaginal palpation|vaginal palpation
637551|NCT00490425|probiotics|probiotics
637552|NCT00490425|LGG|lgg
637553|NCT00490425|praevention|praevention
637554|NCT00490425|allergic asthma|allergic asthma
637555|NCT00490425|children|children
637556|NCT00490412|Vitamin D|vitamin d
637557|NCT00490412|Treatment Experienced|treatment experienced
637558|NCT00490386|Retrospective|retrospective
637559|NCT00490386|Length of Stay|length of stay
637560|NCT00490386|Helicobacter pylori|helicobacter pylori
637561|NCT00490347|VentrAssistTM|ventrassisttm
637562|NCT00490347|LVAD|lvad
637563|NCT00490347|End-stage heart failure|end-stage heart failure
637564|NCT00490347|Cardiomyopathy|cardiomyopathy
637565|NCT00490334|Carcinomas|carcinomas
637566|NCT00490334|Squamous Cel|squamous cel
637567|NCT00490334|Adenocarcinoma|adenocarcinoma
637568|NCT00490334|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
637569|NCT00490321|VentrAssistTM|ventrassisttm
637570|NCT00490321|LVAD|lvad
637571|NCT00490321|End-stage heart failure|end-stage heart failure
637572|NCT00490321|Cardiomyopathy|cardiomyopathy
637573|NCT00490308|luteal|luteal
637574|NCT00490308|phase|phase
637575|NCT00490308|estradiol|estradiol
637576|NCT00490308|pregnancy|pregnancy
637577|NCT00490308|rate|rate
637578|NCT00490295|biomarkers|biomarkers
637579|NCT00490295|brain ischemia|brain ischemia
637580|NCT00490295|neonates|neonates
637581|NCT00490295|cardiac surgery|cardiac surgery
637582|NCT00490295|congenital heart disease|congenital heart disease
637583|NCT00490282|Head and Neck Cancer|head and neck cancer
637584|NCT00490282|Oropharyngeal Cancer|oropharyngeal cancer
637585|NCT00490282|Adaptive Radiotherapy|adaptive radiotherapy
637586|NCT00490282|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
637587|NCT00490282|IMRT|imrt
637588|NCT00490282|ART|art
637589|NCT00490269|Marijuana dependence|marijuana dependence
637590|NCT00490256|Selective Cerebral Perfusion|selective cerebral perfusion
637591|NCT00490256|Renal Complications|renal complications
637592|NCT00490256|Gastrointestinal Complications|gastrointestinal complications
637593|NCT00490256|Aortic Arch Reconstruction|aortic arch reconstruction
637594|NCT00490256|Modified Perfusion|modified perfusion
637595|NCT00490256|Cardiopulmonary Bypass|cardiopulmonary bypass
637596|NCT00490256|Pediatrics|pediatrics
637597|NCT00490256|Cardiac Defects|cardiac defects
637598|NCT00490256|intestinal ischemia|intestinal ischemia
637599|NCT00490256|necrotizing entercolitis|necrotizing entercolitis
637600|NCT00490256|Near Infra-red spectroscopy|near infra-red spectroscopy
637601|NCT00490256|Creatinine|creatinine
637602|NCT00490256|C-reactive protein levels|c-reactive protein levels
637603|NCT00490243|Asthma|asthma
637604|NCT00490243|Children|children
637605|NCT00490243|Exercise|exercise
637606|NCT00490243|Pulmonary Function|pulmonary function
637607|NCT00490243|Budesonide|budesonide
637608|NCT00490243|Montelukast|montelukast
637609|NCT00490243|Formoterol|formoterol
637610|NCT00490230|Paromomycin|paromomycin
637611|NCT00490230|Gentamicin|gentamicin
637612|NCT00490217|Spontaneous bacterial peritonitis|spontaneous bacterial peritonitis
637613|NCT00490217|incidence|incidence
637614|NCT00490217|Finland|finland
637615|NCT00490217|etiology|etiology
637616|NCT00490217|liver cirrhosis|liver cirrhosis
637617|NCT00490204|Perennial Allergic Rhinitis|perennial allergic rhinitis
637618|NCT00490204|Placebo control|placebo control
637619|NCT00490204|anti-histamine|anti-histamine
637620|NCT00490204|Cetirizine|cetirizine
637621|NCT00490178|Type II diabetes|type ii diabetes
637622|NCT00490178|dyslipidemia|dyslipidemia
637623|NCT00490178|metformin|metformin
637624|NCT00490178|fenofibrate|fenofibrate
637625|NCT00490178|synordia|synordia
637626|NCT00490152|HIV|hiv
637627|NCT00490152|Microbicide Gel|microbicide gel
637628|NCT00490152|HIV Seronegativity|hiv seronegativity
637629|NCT00490139|Adjuvant|adjuvant
637630|NCT00490139|ErbB2-overexpressing|erbb2-overexpressing
637631|NCT00490139|Early stage breast cancer|early stage breast cancer
637632|NCT00490139|HER2/neu gene amplified|her2/neu gene amplified
637633|NCT00490126|Laparoscopic Surgery|laparoscopic surgery
637634|NCT00490126|Laparoscopy|laparoscopy
637635|NCT00490126|Gynecology|gynecology
637636|NCT00490126|Demographics|demographics
637637|NCT00490126|Perioperative Care|perioperative care
637638|NCT00490100|X-Linked Severe Combined Immune Deficiency (XSCID)|x-linked severe combined immune deficiency (xscid)
637639|NCT00490100|Growth Hormone|growth hormone
637640|NCT00490100|Insulin-Like Growth Factor 1 (IGF)-1|insulin-like growth factor 1 (igf)-1
637641|NCT00490100|Bone Age|bone age
637642|NCT00490100|Growth Failure|growth failure
637643|NCT00490100|XSCID|xscid
637644|NCT00490100|X-Linked Severe Combined Immunodeficiency|x-linked severe combined immunodeficiency
637645|NCT00490087|Atypical endometrial polyps|atypical endometrial polyps
637646|NCT00490087|Atypical Endometrial Hyperplasia|atypical endometrial hyperplasia
637647|NCT00490087|Hysteroscopic resection|hysteroscopic resection
637648|NCT00490087|Conservative treatment|conservative treatment
637649|NCT00490087|Fertile women|fertile women
637650|NCT00490074|AIDS Vaccines|aids vaccines
637651|NCT00490074|Vaccines, DNA|vaccines, dna
637652|NCT00490074|HIV Preventive Vaccine|hiv preventive vaccine
637653|NCT00490074|HIV Seronegativity|hiv seronegativity
637654|NCT00490048|Ulcerative colits|ulcerative colits
637655|NCT00490048|lung|lung
637656|NCT00490048|Induced sputum|induced sputum
637657|NCT00490048|Our aim to evaluate lung involvement in Ulcerative colitis patients by induced sputum|our aim to evaluate lung involvement in ulcerative colitis patients by induced sputum
637658|NCT00490035|Epilepsy|epilepsy
637659|NCT00490035|Brivaracetam|brivaracetam
637660|NCT00490035|Partial Onset Seizures|partial onset seizures
637661|NCT00490022|Dihydrotestosterone|dihydrotestosterone
637662|NCT00490022|Androgen|androgen
637663|NCT00490022|Prostate|prostate
637664|NCT00489970|Persistence|persistence
637665|NCT00489970|immunogenicity|immunogenicity
637666|NCT00489957|congenital cardiac disorders|congenital cardiac disorders
637667|NCT00489957|echocardiography|echocardiography
637668|NCT00489944|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
637669|NCT00489944|extraocular extension melanoma|extraocular extension melanoma
637670|NCT00489944|iris melanoma|iris melanoma
637671|NCT00489944|epithelioid cell intraocular melanoma|epithelioid cell intraocular melanoma
637672|NCT00489944|stage IIB intraocular melanoma|stage iib intraocular melanoma
637673|NCT00489944|stage IIIA intraocular melanoma|stage iiia intraocular melanoma
637674|NCT00489944|stage IIIB intraocular melanoma|stage iiib intraocular melanoma
637675|NCT00489944|stage IIIC intraocular melanoma|stage iiic intraocular melanoma
637676|NCT00489944|stage IV intraocular melanoma|stage iv intraocular melanoma
637677|NCT00489931|Avian Influenza|avian influenza
637678|NCT00489931|Healthy|healthy
637679|NCT00489931|Immunity|immunity
637680|NCT00489931|Preventive|preventive
637681|NCT00489931|Bird Flu|bird flu
637682|NCT00489931|Healthy Volunteer|healthy volunteer
637683|NCT00489931|HV|hv
637684|NCT00489905|prostate cancer|prostate cancer
637685|NCT00489905|bone mineral density|bone mineral density
637686|NCT00489892|traumatic brain injury|traumatic brain injury
637687|NCT00489892|TBI|tbi
637688|NCT00489892|working memory|working memory
637689|NCT00489892|modafinil|modafinil
637690|NCT00489892|fMRI|fmri
637691|NCT00489892|MRI|mri
637692|NCT00489879|Mobile Health Units|mobile health units
637693|NCT00489879|Chronic Disease|chronic disease
637694|NCT00489866|PTSD|ptsd
637695|NCT00489866|Antidepressant|antidepressant
637696|NCT00489866|Aripiprazole|aripiprazole
637697|NCT00489866|OEF|oef
637698|NCT00489866|OIF|oif
637699|NCT00489853|COPD|copd
637700|NCT00489840|Chronic Central Serous Chorioretinopathy|chronic central serous chorioretinopathy
637701|NCT00489827|Coronary Artery Bypass|coronary artery bypass
637702|NCT00489827|Myocardial Protection|myocardial protection
637703|NCT00489827|Angina, Unstable|angina, unstable
637704|NCT00489827|Myocardial Ischemia|myocardial ischemia
637705|NCT00489827|Myocardial Infarction|myocardial infarction
637706|NCT00489827|Unstable Coronary Artery Disease|unstable coronary artery disease
637707|NCT00489827|Glutamate|glutamate
637708|NCT00489814|Prostate Cancer|prostate cancer
637709|NCT00489814|Prostate Proton Therapy|prostate proton therapy
637710|NCT00489814|Proton Radiation Therapy|proton radiation therapy
637711|NCT00489814|Proton Radiotherapy|proton radiotherapy
637712|NCT00489814|Quality of Life|quality of life
637713|NCT00489814|QOL|qol
637714|NCT00489814|Questionnaire|questionnaire
637715|NCT00489801|Cardiac Rehabilitation|cardiac rehabilitation
637716|NCT00489801|Exercise|exercise
637717|NCT00489801|Heart failure|heart failure
637718|NCT00489801|Coronary heart disease|coronary heart disease
637719|NCT00489788|MRI|mri
637720|NCT00489788|Ventricular Strain|ventricular strain
637721|NCT00489788|Pulmonary Valve Replacement|pulmonary valve replacement
637722|NCT00489788|Post Tetralogy of Fallot|post tetralogy of fallot
637723|NCT00489762|Childhood|childhood
637724|NCT00489762|Asthma|asthma
637725|NCT00489762|Heating|heating
637726|NCT00489762|Insulation|insulation
637727|NCT00489762|Respiratory symptoms|respiratory symptoms
637728|NCT00489749|Achilles tendon rupture|achilles tendon rupture
637729|NCT00489749|Open surgical repair|open surgical repair
637730|NCT00489749|Early functional mobilization|early functional mobilization
637731|NCT00489749|Weightbearing|weightbearing
637732|NCT00489749|Rehabilitation|rehabilitation
637733|NCT00489736|Atrial Fibrillation|atrial fibrillation
637734|NCT00489736|sinus rhythm|sinus rhythm
637735|NCT00489736|amiodarone|amiodarone
637736|NCT00489723|size of stone 1-2 cm|size of stone 1-2 cm
637737|NCT00489723|Pt. with no use of alfa bloker prior ESWL|pt. with no use of alfa bloker prior eswl
637738|NCT00489723|Pt. without internal stent|pt. without internal stent
637739|NCT00489710|stage IV renal cell cancer|stage iv renal cell cancer
637740|NCT00489710|recurrent renal cell cancer|recurrent renal cell cancer
637741|NCT00489697|colorectal cancer|colorectal cancer
637742|NCT00489697|hepatic metastases|hepatic metastases
637743|NCT00489697|bevacizumab|bevacizumab
637744|NCT00489697|anti-angiogenic agent|anti-angiogenic agent
637745|NCT00489697|chemotherapy regimens|chemotherapy regimens
637746|NCT00489697|tumor vascularity|tumor vascularity
637747|NCT00489697|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
637748|NCT00489671|pancreatic cancer|pancreatic cancer
637749|NCT00489671|precancerous condition|precancerous condition
637750|NCT00489658|Human African trypanosomiasis|human african trypanosomiasis
637751|NCT00489658|sleeping sickness|sleeping sickness
637752|NCT00489658|Trypanosoma brucei gambiense|trypanosoma brucei gambiense
637753|NCT00489658|combination|combination
637754|NCT00489658|eflornithine|eflornithine
637755|NCT00489658|nifurtimox|nifurtimox
637756|NCT00489658|Human African trypanosomiasis (sleeping sickness) due to Trypanosoma brucei gambiense in the late stage (stage 2 or meningo-encephalitic)|human african trypanosomiasis (sleeping sickness) due to trypanosoma brucei gambiense in the late stage (stage 2 or meningo-encephalitic)
637757|NCT00489645|pramlintide|pramlintide
637758|NCT00489645|gastric emptying|gastric emptying
637759|NCT00489645|T1DM|t1dm
637760|NCT00489645|postprandial|postprandial
637761|NCT00489632|Leukemia|leukemia
637762|NCT00489632|Pediatrics|pediatrics
637763|NCT00489632|Cancer|cancer
637764|NCT00489632|Coping|coping
637765|NCT00489632|Caregiver|caregiver
637766|NCT00489632|Questionnaire|questionnaire
637767|NCT00489632|Children|children
637768|NCT00489632|Resiliency|resiliency
637769|NCT00489632|Adjustment|adjustment
637770|NCT00489632|Illness-related factors|illness-related factors
637771|NCT00489619|Infectious diseases|infectious diseases
637772|NCT00489619|Democratic Republic of Congo|democratic republic of congo
637773|NCT00489619|Malaria|malaria
637774|NCT00489619|International|international
637775|NCT00489619|Maternal and child health|maternal and child health
637776|NCT00489619|Women's Health|women's health
637777|NCT00489619|Global Network|global network
637778|NCT00489619|Sexually transmitted infections (STIs)|sexually transmitted infections (stis)
637779|NCT00489606|SK3530|sk3530
637780|NCT00489606|tamsulosin|tamsulosin
637781|NCT00489606|hemodynamic interaction|hemodynamic interaction
637782|NCT00489606|safety|safety
637783|NCT00489593|Advanced Cancer|advanced cancer
637784|NCT00489593|Weight Loss|weight loss
637785|NCT00489593|Cachexia|cachexia
637786|NCT00489593|Olanzapine|olanzapine
637787|NCT00489593|Zyprexa|zyprexa
637788|NCT00489593|Fluoxetine|fluoxetine
637789|NCT00489593|Symbyax|symbyax
637790|NCT00489580|stroke|stroke
637791|NCT00489580|weakness|weakness
637792|NCT00489580|motor recovery|motor recovery
637793|NCT00489567|Rotavirus gastroenteritis|rotavirus gastroenteritis
637794|NCT00489554|Primary vaccination|primary vaccination
637795|NCT00489554|Safety|safety
637796|NCT00489554|Pneumococcal vaccine.|pneumococcal vaccine.
637797|NCT00489554|Pneumococcal disease|pneumococcal disease
637798|NCT00489554|Immunogenicity|immunogenicity
637799|NCT00489541|paclitaxel-eluting stent|paclitaxel-eluting stent
637800|NCT00489541|PES|pes
637801|NCT00489528|serostim|serostim
637802|NCT00489528|Dose-Response Relationship, Drug|dose-response relationship, drug
637803|NCT00489528|Body Composition|body composition
637804|NCT00489515|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
637805|NCT00489515|stage I pancreatic cancer|stage i pancreatic cancer
637806|NCT00489515|stage II pancreatic cancer|stage ii pancreatic cancer
637807|NCT00489515|stage III pancreatic cancer|stage iii pancreatic cancer
637808|NCT00489515|stage IV pancreatic cancer|stage iv pancreatic cancer
637809|NCT00489515|stage I colon cancer|stage i colon cancer
637810|NCT00489515|stage II colon cancer|stage ii colon cancer
637811|NCT00489515|stage III colon cancer|stage iii colon cancer
637812|NCT00489515|stage IV colon cancer|stage iv colon cancer
637813|NCT00489515|stage I gastric cancer|stage i gastric cancer
637814|NCT00489515|stage II gastric cancer|stage ii gastric cancer
637815|NCT00489515|stage III gastric cancer|stage iii gastric cancer
637816|NCT00489515|stage IV gastric cancer|stage iv gastric cancer
637817|NCT00489515|localized gallbladder cancer|localized gallbladder cancer
637818|NCT00489515|small intestine adenocarcinoma|small intestine adenocarcinoma
637819|NCT00489515|adenocarcinoma of the colon|adenocarcinoma of the colon
637820|NCT00489515|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
637821|NCT00489515|adenocarcinoma of the stomach|adenocarcinoma of the stomach
637822|NCT00489489|MS|ms
637823|NCT00489489|interferon-beta|interferon-beta
637824|NCT00489489|adjunctive therapy|adjunctive therapy
637825|NCT00489489|relapses|relapses
637826|NCT00489476|Staccato® Loxapine, Migraine|staccato® loxapine, migraine
637827|NCT00489463|LNG-IUS|lng-ius
637828|NCT00489463|TCu 380A|tcu 380a
637829|NCT00489463|Ultrasonography|ultrasonography
637830|NCT00489463|Doppler color|doppler color
637831|NCT00489463|power Doppler|power doppler
637832|NCT00489463|female|female
637833|NCT00489463|Volunteers|volunteers
637834|NCT00489450|SK3530|sk3530
637835|NCT00489450|alcohol|alcohol
637836|NCT00489450|pharmacokinetics|pharmacokinetics
637837|NCT00489450|safety|safety
637838|NCT00489437|diagnosis|diagnosis
637839|NCT00489424|zoledronic acid|zoledronic acid
637840|NCT00489424|post dose symptoms|post dose symptoms
637841|NCT00489424|transient|transient
637842|NCT00489424|acetaminophen|acetaminophen
637843|NCT00489424|fluvastatin|fluvastatin
637844|NCT00489411|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
637845|NCT00489411|neurotoxicity|neurotoxicity
637846|NCT00489411|pain|pain
637847|NCT00489411|peripheral neuropathy|peripheral neuropathy
637848|NCT00489385|Fibrosis|fibrosis
637849|NCT00489385|Viral Kinetics|viral kinetics
637850|NCT00489385|Hepatotoxicity|hepatotoxicity
637851|NCT00489385|Immunity|immunity
637852|NCT00489385|HIV Infection|hiv infection
637853|NCT00489385|Hepatitis C|hepatitis c
637854|NCT00489385|HCV|hcv
637855|NCT00489385|Treatment Experienced|treatment experienced
637856|NCT00489385|Treatment Naive|treatment naive
637857|NCT00489333|ProAlgaZyme|proalgazyme
637858|NCT00489333|Metabolic syndrome|metabolic syndrome
637859|NCT00489333|Inflammation|inflammation
637860|NCT00489333|Cardiovascular|cardiovascular
637861|NCT00489333|hsCRP|hscrp
637862|NCT00489333|Lipids|lipids
637863|NCT00489333|Algae|algae
637864|NCT00489320|Coronary disease|coronary disease
637865|NCT00489320|Arteries|arteries
637866|NCT00489320|Atherosclerosis|atherosclerosis
637867|NCT00489320|Arteriosclerosis|arteriosclerosis
637868|NCT00489307|Advanced Cancer|advanced cancer
637869|NCT00489307|Solid Tumors|solid tumors
637870|NCT00489307|Fatigue|fatigue
637871|NCT00489307|Pain|pain
637872|NCT00489307|Nausea|nausea
637873|NCT00489307|Anorexia|anorexia
637874|NCT00489307|Dexamethasone|dexamethasone
637875|NCT00489307|Decadron|decadron
637876|NCT00489307|Placebo|placebo
637877|NCT00489294|Human growth hormone|human growth hormone
637878|NCT00489294|idiopathic short stature|idiopathic short stature
637879|NCT00489294|short stature|short stature
637880|NCT00489281|sickle cell disease|sickle cell disease
637881|NCT00489268|Barrett's Esophagus|barrett's esophagus
637882|NCT00489268|Intestinal Metaplasia|intestinal metaplasia
637883|NCT00489268|Radiofrequency Ablation|radiofrequency ablation
637884|NCT00489255|Parkinson's disease|parkinson's disease
637885|NCT00489255|Anti-emetic|anti-emetic
637886|NCT00489255|Nausea|nausea
637887|NCT00489255|Vomiting|vomiting
637888|NCT00489229|Rosiglitazone|rosiglitazone
637889|NCT00489229|Ramipril|ramipril
637890|NCT00489229|Impaired glucose tolerance|impaired glucose tolerance
637891|NCT00489229|Arterial stiffness|arterial stiffness
637892|NCT00489229|Diabetic vasculopathy|diabetic vasculopathy
637893|NCT00489216|Graft Versus Host Disease|graft versus host disease
637894|NCT00489216|GVHD|gvhd
637895|NCT00489216|Efalizumab|efalizumab
637896|NCT00489216|Raptiva|raptiva
637897|NCT00489216|Steroid|steroid
637898|NCT00489216|Refractory|refractory
637899|NCT00489216|Skin|skin
637900|NCT00489216|Liver|liver
637901|NCT00489216|Lineberger|lineberger
637902|NCT00489216|University of North Carolina|university of north carolina
637903|NCT00489177|cardiac resynchronization therapy|cardiac resynchronization therapy
637904|NCT00489177|response|response
637905|NCT00489177|Defibrillators|defibrillators
637906|NCT00489164|DIABETIC PATIENTS WITH NATIVE CORONARY ARTERY LESIONS|diabetic patients with native coronary artery lesions
637907|NCT00489151|HBV|hbv
637908|NCT00489125|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
637909|NCT00489125|recurrent breast cancer|recurrent breast cancer
637910|NCT00489125|stage I breast cancer|stage i breast cancer
637911|NCT00489125|stage II breast cancer|stage ii breast cancer
637912|NCT00489125|stage IIIA breast cancer|stage iiia breast cancer
637913|NCT00489125|stage IIIB breast cancer|stage iiib breast cancer
637914|NCT00489125|stage IIIC breast cancer|stage iiic breast cancer
637915|NCT00489125|stage IV breast cancer|stage iv breast cancer
637916|NCT00489086|nevoid basal cell carcinoma syndrome|nevoid basal cell carcinoma syndrome
637917|NCT00489086|basal cell carcinoma of the skin|basal cell carcinoma of the skin
637918|NCT00489060|Cryoablation|cryoablation
637919|NCT00489060|Radiation|radiation
637920|NCT00489060|Prostate Cancer|prostate cancer
637921|NCT00489034|HIV|hiv
637922|NCT00489034|adolescent females|adolescent females
637923|NCT00489034|adherence|adherence
637924|NCT00489034|clinical care|clinical care
637925|NCT00489034|risk behaviors|risk behaviors
637926|NCT00489021|Subacute care|subacute care
637927|NCT00489021|Activities of Daily Living|activities of daily living
637928|NCT00489021|Cognition assessment|cognition assessment
637929|NCT00489021|Mood assessment|mood assessment
637930|NCT00489021|Incontinence control|incontinence control
637931|NCT00489008|Lung Cancer|lung cancer
637932|NCT00489008|Non-Small Cell|non-small cell
637933|NCT00489008|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
637934|NCT00489008|SBRT|sbrt
637935|NCT00489008|NSCLC|nsclc
637936|NCT00488995|HIV Therapeutic Vaccine|hiv therapeutic vaccine
637937|NCT00488982|Metastatic Hormone Refractory Prostate Cancer|metastatic hormone refractory prostate cancer
637938|NCT00488969|Morphine|morphine
637939|NCT00488969|Chronic Pain|chronic pain
637940|NCT00488969|Spinal Cord Injury|spinal cord injury
637941|NCT00488969|Neuropathic Pain|neuropathic pain
637942|NCT00488956|foot|foot
637943|NCT00488956|ankle|ankle
637944|NCT00488956|edema|edema
637945|NCT00488943|Stent-Graft|stent-graft
637946|NCT00488943|AAA|aaa
637947|NCT00488943|Abdominal Aortic Anuerysm|abdominal aortic anuerysm
637948|NCT00488943|Zenith|zenith
637949|NCT00488943|Endovascular|endovascular
637950|NCT00488943|Treatment with Zenith Aortic Stent-Graft for repair Abdominal Aortic Aneurysm|treatment with zenith aortic stent-graft for repair abdominal aortic aneurysm
637951|NCT00488930|Obesity|obesity
637952|NCT00488930|Hyperglycemia|hyperglycemia
637953|NCT00488930|Diabetes Mellitus Type I|diabetes mellitus type i
637954|NCT00488930|Diabetes Mellitus Type II|diabetes mellitus type ii
637955|NCT00488917|Liver cirrhosis|liver cirrhosis
637956|NCT00488917|acute liver failure|acute liver failure
637957|NCT00488917|liver transplantation|liver transplantation
637958|NCT00488917|sepsis, infection|sepsis, infection
637959|NCT00488917|endothelium|endothelium
637960|NCT00488917|lipids|lipids
637961|NCT00488917|diagnosis|diagnosis
637962|NCT00488917|prognosis|prognosis
637963|NCT00488904|infection|infection
637964|NCT00488904|colorectalcancer|colorectalcancer
637965|NCT00488904|omega-3 fedtsyre|omega-3 fedtsyre
637966|NCT00488904|complications|complications
637967|NCT00488891|Schizophrenia|schizophrenia
637968|NCT00488891|Paliperdone ER|paliperdone er
637969|NCT00488891|Invega|invega
637970|NCT00488891|Observational|observational
637971|NCT00488891|Antipsychotic agents|antipsychotic agents
637972|NCT00488878|Ovarian Cancer|ovarian cancer
637973|NCT00488878|Ovarian Carcinoma|ovarian carcinoma
637974|NCT00488878|Low-Grade Serous Carcinoma|low-grade serous carcinoma
637975|NCT00488878|Low Malignant Potential|low malignant potential
637976|NCT00488878|Peritoneum Tumors|peritoneum tumors
637977|NCT00488878|Psammocarcinoma|psammocarcinoma
637978|NCT00488878|Data Collection|data collection
637979|NCT00488878|Research Database|research database
637980|NCT00488865|increased risk for PE require caval interruption|increased risk for pe require caval interruption
637981|NCT00488839|Spasticity|spasticity
637982|NCT00488839|Multiple Sclerosis|multiple sclerosis
637983|NCT00488826|Vaccines, Pneumococcal Conjugate Vaccine|vaccines, pneumococcal conjugate vaccine
637984|NCT00488813|Tzh-Chi ESBL study|tzh-chi esbl study
637985|NCT00488800|Pneumococcal Infections/PC (Prevention & Control)|pneumococcal infections/pc (prevention & control)
637986|NCT00488787|dental|dental
637987|NCT00488787|surgery|surgery
637988|NCT00488787|analgesia|analgesia
637989|NCT00488787|2-4 impacted third molars|2-4 impacted third molars
637990|NCT00488774|Colitis, ulcerative|colitis, ulcerative
637991|NCT00488774|Golimumab|golimumab
637992|NCT00488774|CNTO 148|cnto 148
637993|NCT00488761|Tigecycline|tigecycline
637994|NCT00488761|cSSSI|csssi
637995|NCT00488761|complicated skin and skin structure infections|complicated skin and skin structure infections
637996|NCT00488748|MST|mst
637997|NCT00488748|Magnetic Seizure Therapy|magnetic seizure therapy
637998|NCT00488748|ECT|ect
637999|NCT00488748|Electroconvulsive Therapy|electroconvulsive therapy
638000|NCT00488748|Depression|depression
638001|NCT00488748|Magnetic|magnetic
638002|NCT00488735|Randomized controlled trial|randomized controlled trial
638003|NCT00488735|Back pain|back pain
638004|NCT00488735|Neck pain|neck pain
638005|NCT00488735|Rehabilitation|rehabilitation
638006|NCT00488735|Cognitive-behavioral|cognitive-behavioral
638007|NCT00488735|Primary care|primary care
638008|NCT00488735|Sick-listing|sick-listing
638009|NCT00488735|Health-care utilization.|health-care utilization.
638106|NCT00488410|ventricular asynchrony|ventricular asynchrony
638107|NCT00488410|systolic dysynchrony index|systolic dysynchrony index
638108|NCT00488397|Tygacil|tygacil
638213|NCT00487955|REE|ree
638010|NCT00488722|To observe the biological changes under concurrent Zoladex and CEF as neoadjuvant regimen with respect to the ER,PR,cerbB-2 status before and after therapy|to observe the biological changes under concurrent zoladex and cef as neoadjuvant regimen with respect to the er,pr,cerbb-2 status before and after therapy
638011|NCT00488709|Acute Myeloid Leukemia|acute myeloid leukemia
638012|NCT00488709|Multi Drug Resistance|multi drug resistance
638013|NCT00488696|Aneurysm|aneurysm
638014|NCT00488696|Aortic Arch|aortic arch
638015|NCT00488696|Endovascular|endovascular
638016|NCT00488696|Stent-Graft|stent-graft
638017|NCT00488683|Meningococcal disease|meningococcal disease
638018|NCT00488683|Prevention|prevention
638019|NCT00488683|Vaccination|vaccination
638020|NCT00488670|Alzheimer's disease|alzheimer's disease
638021|NCT00488670|elderly|elderly
638022|NCT00488670|open-label|open-label
638023|NCT00488670|escitalopram|escitalopram
638024|NCT00488657|speech|speech
638025|NCT00488657|Parkinson's disease|parkinson's disease
638026|NCT00488657|treatment|treatment
638027|NCT00488657|speech intelligibility|speech intelligibility
638028|NCT00488657|speaking rate|speaking rate
638029|NCT00488644|Hypothyroidism|hypothyroidism
638030|NCT00488644|Brain Tumor|brain tumor
638031|NCT00488644|Levothyroxine|levothyroxine
638032|NCT00488644|Liothyronine|liothyronine
638033|NCT00488644|Synthroid|synthroid
638034|NCT00488644|Cytomel|cytomel
638035|NCT00488631|Colitis, Ulcerative|colitis, ulcerative
638036|NCT00488631|Golimumab|golimumab
638037|NCT00488631|CNTO 148|cnto 148
638038|NCT00488618|Mania|mania
638039|NCT00488618|Bipolar I Disorder|bipolar i disorder
638040|NCT00488618|Acute Mania Associated with Bipolar I Disorder|acute mania associated with bipolar i disorder
638041|NCT00488592|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
638042|NCT00488592|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
638043|NCT00488592|Chronic Myeloid Leukemia (CML)|chronic myeloid leukemia (cml)
638044|NCT00488592|Wilm's Tumor-1|wilm's tumor-1
638045|NCT00488592|Proteinase-3|proteinase-3
638046|NCT00488592|Myelodysplastic Syndrome|myelodysplastic syndrome
638047|NCT00488592|MDS|mds
638048|NCT00488592|Acute Myeloid Leukemia|acute myeloid leukemia
638049|NCT00488592|AML|aml
638050|NCT00488592|Chronic Myeloid Leukemia|chronic myeloid leukemia
638051|NCT00488592|CML|cml
638052|NCT00488579|iron prophylaxis|iron prophylaxis
638053|NCT00488579|pregnancy|pregnancy
638054|NCT00488579|birth weight|birth weight
638055|NCT00488579|prematurity|prematurity
638056|NCT00488579|perinatal mortality|perinatal mortality
638057|NCT00488566|bipolar disorder,|bipolar disorder,
638058|NCT00488566|single doses,|single doses,
638059|NCT00488566|resting motor threshold|resting motor threshold
638060|NCT00488566|TMS,|tms,
638061|NCT00488553|Lymphoma|lymphoma
638062|NCT00488553|Epidemiology|epidemiology
638063|NCT00488553|Lifestyle Factors|lifestyle factors
638064|NCT00488553|Questionnaire|questionnaire
638065|NCT00488553|Survey|survey
638066|NCT00488540|newborn|newborn
638067|NCT00488540|infant|infant
638068|NCT00488540|pain|pain
638069|NCT00488540|acetaminophen|acetaminophen
638070|NCT00488540|paracetamol|paracetamol
638071|NCT00488540|mode of delivery|mode of delivery
638072|NCT00488540|vacuum extraction|vacuum extraction
638073|NCT00488540|forceps extraction|forceps extraction
638074|NCT00488540|cesarean section|cesarean section
638075|NCT00488540|EDIN scale|edin scale
638076|NCT00488540|Bernese Pain Scale for Neonates|bernese pain scale for neonates
638077|NCT00488540|pain after different modes of delivery in newborn infants|pain after different modes of delivery in newborn infants
638078|NCT00488540|efficacy of acetaminophen as analgesia for newborn infants|efficacy of acetaminophen as analgesia for newborn infants
638079|NCT00488514|Long-term Safety|long-term safety
638080|NCT00488514|Migraine|migraine
638081|NCT00488514|Adolescent Migraine Headache|adolescent migraine headache
638082|NCT00488514|sumatriptan succinate|sumatriptan succinate
638083|NCT00488514|naproxen sodium|naproxen sodium
638084|NCT00488501|intrathoracic impedance|intrathoracic impedance
638085|NCT00488501|cardiac resynchronization therapy|cardiac resynchronization therapy
638086|NCT00488501|heart failure|heart failure
638087|NCT00488462|obstetric hemorrhage|obstetric hemorrhage
638088|NCT00488462|hypovolemic shock|hypovolemic shock
638089|NCT00488462|non-pneumatic anti-shock garment|non-pneumatic anti-shock garment
638090|NCT00488462|safe motherhood|safe motherhood
638091|NCT00488462|maternal mortality|maternal mortality
638092|NCT00488462|maternal morbidity|maternal morbidity
638093|NCT00488449|Dose Escalation|dose escalation
638094|NCT00488449|GSK256073A,|gsk256073a,
638095|NCT00488436|Myelodysplastic Syndrome|myelodysplastic syndrome
638096|NCT00488436|Antithymocyte Globulin|antithymocyte globulin
638097|NCT00488436|Cyclosporine|cyclosporine
638098|NCT00488423|diabetes|diabetes
638099|NCT00488423|MIDAS|midas
638100|NCT00488423|gut hormones|gut hormones
638101|NCT00488423|gastric bypass|gastric bypass
638102|NCT00488423|lap band|lap band
638103|NCT00488410|Chronic heart failure|chronic heart failure
638104|NCT00488410|real time three-dimensional echocardiography|real time three-dimensional echocardiography
638105|NCT00488410|cardiac resynchronization therapy|cardiac resynchronization therapy
638109|NCT00488397|microdilution method|microdilution method
638110|NCT00488397|Tigecycline|tigecycline
638111|NCT00488397|In-Vitro|in-vitro
638112|NCT00488384|Squamous cell carcinoma of the skin under hemodialysis|squamous cell carcinoma of the skin under hemodialysis
638113|NCT00488371|Streptococcus pneumoniae nasopharyngeal carriage|streptococcus pneumoniae nasopharyngeal carriage
638114|NCT00488358|abdominal|abdominal
638115|NCT00488358|aortic|aortic
638116|NCT00488358|aneurysm|aneurysm
638117|NCT00488358|Zenith|zenith
638118|NCT00488358|blood pressure|blood pressure
638119|NCT00488345|cIAI|ciai
638120|NCT00488345|cSSSI|csssi
638121|NCT00488345|CAP|cap
638122|NCT00488345|Child|child
638123|NCT00488332|Head and Neck Cancer|head and neck cancer
638124|NCT00488332|Oral Mucositis|oral mucositis
638125|NCT00488332|Optical Coherence Tomography|optical coherence tomography
638126|NCT00488332|Fluorescence Spectroscopy|fluorescence spectroscopy
638127|NCT00488332|Optical Assessment|optical assessment
638128|NCT00488319|Schizophrenia|schizophrenia
638129|NCT00488319|Adolescent|adolescent
638130|NCT00488319|Paliperidone|paliperidone
638131|NCT00488319|Antipsychotic agents|antipsychotic agents
638132|NCT00488319|Antipsychotic drugs|antipsychotic drugs
638133|NCT00488319|Psychosis.|psychosis.
638134|NCT00488306|Tigecycline|tigecycline
638135|NCT00488306|Complicated intra-abdominal infections|complicated intra-abdominal infections
638136|NCT00488306|cIAI|ciai
638137|NCT00488293|Telemedicine|telemedicine
638138|NCT00488293|Skin diseases|skin diseases
638139|NCT00488293|Dermatology|dermatology
638140|NCT00488293|Quality of life|quality of life
638141|NCT00488293|Economics|economics
638142|NCT00488280|walking|walking
638143|NCT00488280|walking recovery|walking recovery
638144|NCT00488280|physical therapy|physical therapy
638145|NCT00488280|locomotor training|locomotor training
638146|NCT00488280|body weight support|body weight support
638147|NCT00488280|neuroplasticity|neuroplasticity
638148|NCT00488280|step|step
638149|NCT00488280|treadmill|treadmill
638150|NCT00488280|treadmill training|treadmill training
638151|NCT00488280|locomotion|locomotion
638152|NCT00488267|Osteoarthritis|osteoarthritis
638153|NCT00488267|Pain|pain
638154|NCT00488254|Long QT Syndrome|long qt syndrome
638155|NCT00488254|Romano Ward|romano ward
638156|NCT00488254|Jervell-Lange Nielson Syndrome|jervell-lange nielson syndrome
638157|NCT00488241|Eczema|eczema
638158|NCT00488241|Medical device|medical device
638159|NCT00488215|constipation|constipation
638160|NCT00488215|prucalopride|prucalopride
638161|NCT00488215|MTD|mtd
638162|NCT00488215|cardiovascular safety|cardiovascular safety
638163|NCT00488202|Advanced Ovarian Cancer|advanced ovarian cancer
638164|NCT00488202|Sexual Function|sexual function
638165|NCT00488176|seasonal allergic rhinitis|seasonal allergic rhinitis
638166|NCT00488176|children|children
638167|NCT00488176|montelukast|montelukast
638168|NCT00488176|cetirizine|cetirizine
638169|NCT00488163|schizophrenia|schizophrenia
638170|NCT00488163|cognition|cognition
638171|NCT00488163|atomoxetine|atomoxetine
638172|NCT00488163|norepinephrine|norepinephrine
638173|NCT00488163|dopamine|dopamine
638174|NCT00488137|constipation|constipation
638175|NCT00488137|prucalopride|prucalopride
638176|NCT00488137|QOL|qol
638177|NCT00488137|SCBM|scbm
638178|NCT00488137|PAC-SYM|pac-sym
638179|NCT00488124|short stature|short stature
638180|NCT00488111|Regional anesthesia|regional anesthesia
638181|NCT00488111|Fluid Therapy|fluid therapy
638182|NCT00488111|Hemostasis, Surgical|hemostasis, surgical
638183|NCT00488098|Healthy Bioequivalence|healthy bioequivalence
638184|NCT00488085|Crohn’s disease, obesity, REE, body composition, fat absorption|crohn’s disease, obesity, ree, body composition, fat absorption
638185|NCT00488072|Advanced Cancer|advanced cancer
638186|NCT00488072|Anorexia|anorexia
638187|NCT00488072|Weight Loss|weight loss
638188|NCT00488072|Insomnia|insomnia
638189|NCT00488072|Appetite|appetite
638190|NCT00488072|Mirtazapine|mirtazapine
638191|NCT00488072|Placebo|placebo
638192|NCT00488059|Treatment Experienced|treatment experienced
638193|NCT00488046|Bird Flu|bird flu
638194|NCT00488033|Coronary Artery Disease|coronary artery disease
638195|NCT00488033|Diabetes|diabetes
638196|NCT00488033|CT Angiography|ct angiography
638197|NCT00488020|rest pain|rest pain
638198|NCT00488020|ischemic ulcers|ischemic ulcers
638199|NCT00488007|Alzheimer disease|alzheimer disease
638200|NCT00488007|Cognitive impairment|cognitive impairment
638201|NCT00488007|Sensorineural hearing loss|sensorineural hearing loss
638202|NCT00488007|Hearing aids|hearing aids
638203|NCT00487994|Hypercholesterolemia|hypercholesterolemia
638204|NCT00487994|Hyperlipidemia|hyperlipidemia
638205|NCT00487994|Drug Therapy|drug therapy
638206|NCT00487981|Pain|pain
638207|NCT00487981|Implantable stimulation device|implantable stimulation device
638208|NCT00487981|Neuropathy|neuropathy
638209|NCT00487968|healthy adult volunteers|healthy adult volunteers
638210|NCT00487968|eltrombopag|eltrombopag
638211|NCT00487955|gastritis|gastritis
638212|NCT00487955|helicobacter pylori|helicobacter pylori
638214|NCT00487955|patients with gastritis that refers to helicobacter pylori treatment|patients with gastritis that refers to helicobacter pylori treatment
638215|NCT00487929|sleep apnea|sleep apnea
638216|NCT00487929|morbidity|morbidity
638217|NCT00487929|cardiovascular|cardiovascular
638218|NCT00487929|cpap|cpap
638219|NCT00487929|oxidative stress|oxidative stress
638220|NCT00487916|Blood Stage|blood stage
638221|NCT00487916|Investigational|investigational
638222|NCT00487916|Vaccine|vaccine
638223|NCT00487916|Malaria|malaria
638224|NCT00487916|Healthy Volunteer|healthy volunteer
638225|NCT00487916|HV|hv
638226|NCT00487903|Coronary Artery Disease|coronary artery disease
638227|NCT00487903|Echocardiogram|echocardiogram
638228|NCT00487903|Contrast|contrast
638229|NCT00487903|Perfusion|perfusion
638230|NCT00487903|Ultrasound|ultrasound
638231|NCT00487903|Normal volunteers|normal volunteers
638232|NCT00487890|Geriatric|geriatric
638233|NCT00487890|Abdominal|abdominal
638234|NCT00487890|Surgery|surgery
638235|NCT00487890|gastrointestinal surgery|gastrointestinal surgery
638236|NCT00487890|intrabdominal surgery|intrabdominal surgery
638237|NCT00487877|metabolism, temperature changing, skin, heart rate|metabolism, temperature changing, skin, heart rate
638238|NCT00487851|Pancreatic|pancreatic
638239|NCT00487851|cancer|cancer
638240|NCT00487851|Periampullay|periampullay
638241|NCT00487851|Neoplasms|neoplasms
638242|NCT00487851|Biliary|biliary
638243|NCT00487851|Duodenal|duodenal
638244|NCT00487851|Jaundice|jaundice
638245|NCT00487851|obstruction|obstruction
638246|NCT00487851|pancreas cancer|pancreas cancer
638247|NCT00487851|Pancreatic cancer|pancreatic cancer
638248|NCT00487838|Autofluorescence Imaging|autofluorescence imaging
638249|NCT00487838|Early Age-Related Maculopathy|early age-related maculopathy
638250|NCT00487838|Photochemical Changes|photochemical changes
638251|NCT00487838|Colored Sunglasses|colored sunglasses
638252|NCT00487838|Pseudophakes|pseudophakes
638253|NCT00487838|Fundus Camera|fundus camera
638254|NCT00487838|Confocal Scanning Laser Ophthalmoscope|confocal scanning laser ophthalmoscope
638255|NCT00487838|Molecular Imaging within Retina|molecular imaging within retina
638256|NCT00487838|Spectral Balance among Photochemical Processes|spectral balance among photochemical processes
638257|NCT00487838|Noninvasive Autofluorescence Imaging|noninvasive autofluorescence imaging
638258|NCT00487838|Age-Related Maculopathy (AMD)|age-related maculopathy (amd)
638259|NCT00487838|Age-Related Macular Degeneration|age-related macular degeneration
638260|NCT00487838|AMD|amd
638261|NCT00487838|Age-Related Macular Changes|age-related macular changes
638262|NCT00487838|Early Age-Related Macular Changes|early age-related macular changes
638263|NCT00487825|ACR20, ACR50, ACZ885 (anti-interleukin-1beta monoclonal antibody), rheumatoid arthritis, methotrexate|acr20, acr50, acz885 (anti-interleukin-1beta monoclonal antibody), rheumatoid arthritis, methotrexate
638264|NCT00487812|Acute myocardial infarction|acute myocardial infarction
638265|NCT00487812|left ventricular remodelling|left ventricular remodelling
638266|NCT00487812|SPECT imaging|spect imaging
638267|NCT00487799|Acute Decompensated Heart Failure|acute decompensated heart failure
638268|NCT00487799|ADHF|adhf
638269|NCT00487799|Heart Failure|heart failure
638270|NCT00487786|Antisense|antisense
638271|NCT00487786|Heat Shock Protein|heat shock protein
638272|NCT00487773|asthma|asthma
638273|NCT00487773|children|children
638274|NCT00487773|inhaled glucocorticosteroids|inhaled glucocorticosteroids
638275|NCT00487773|bone metabolism|bone metabolism
638276|NCT00487760|Lung Cancer|lung cancer
638277|NCT00487760|African-American Families|african-american families
638278|NCT00487760|Genetic Risk Communication|genetic risk communication
638279|NCT00487760|Interest in Genetic Testing and Genetics Research|interest in genetic testing and genetics research
638280|NCT00487760|Health Disparities|health disparities
638281|NCT00487760|Smoking Cessation|smoking cessation
638282|NCT00487734|Metabolic Syndrome|metabolic syndrome
638283|NCT00487734|Hypogonadism|hypogonadism
638284|NCT00487734|Insulin Resistance|insulin resistance
638285|NCT00487721|Prostate cancer|prostate cancer
638286|NCT00487708|ACZ885|acz885
638287|NCT00487708|NALP3 mutations|nalp3 mutations
638288|NCT00487708|Interleukin-1beta|interleukin-1beta
638289|NCT00487708|Muckle-Wells Syndrome|muckle-wells syndrome
638290|NCT00487695|Barrett's esophagus|barrett's esophagus
638291|NCT00487695|Esophageal adenocarcinoma|esophageal adenocarcinoma
638292|NCT00487695|Endoscopy|endoscopy
638293|NCT00487695|Confocal laser endomicroscopy|confocal laser endomicroscopy
638294|NCT00487682|herpes zoster|herpes zoster
638295|NCT00487682|ASP2151|asp2151
638296|NCT00487682|Valacyclovir hydrochloride|valacyclovir hydrochloride
638297|NCT00487669|paclitaxel poliglumex|paclitaxel poliglumex
638298|NCT00487669|xyotax|xyotax
638299|NCT00487669|alimta|alimta
638300|NCT00487669|advanced non-small cell lung cancer|advanced non-small cell lung cancer
638301|NCT00487643|Lacritin|lacritin
638302|NCT00487630|Heterozygous females|heterozygous females
638303|NCT00487630|Cardiomyopathy|cardiomyopathy
638304|NCT00487617|Arteriopathy|arteriopathy
638305|NCT00487617|endothelial function|endothelial function
638306|NCT00487617|fruit juice|fruit juice
638307|NCT00487604|Coronary Artery Disease|coronary artery disease
638308|NCT00487604|Drug Eluting Stent|drug eluting stent
638309|NCT00487604|Bare Metal Stent|bare metal stent
638310|NCT00487604|Subacute thrombosis|subacute thrombosis
638311|NCT00487604|Bleeding|bleeding
638312|NCT00487604|Economic|economic
638313|NCT00487591|cholesterol|cholesterol
638314|NCT00487591|dyslipidemia|dyslipidemia
638315|NCT00487591|omega 3|omega 3
638316|NCT00487578|Post traumatic headache|post traumatic headache
638317|NCT00487578|Head trauma|head trauma
638318|NCT00487578|Head injury|head injury
638319|NCT00487578|Headache|headache
638320|NCT00487578|Naratriptan|naratriptan
638321|NCT00487565|Total knee replacement|total knee replacement
638322|NCT00487565|Total knee arthroplasty|total knee arthroplasty
638323|NCT00487565|Osteoarthritis|osteoarthritis
638324|NCT00487565|Rheumatoid or other inflammatory arthritis|rheumatoid or other inflammatory arthritis
638325|NCT00487565|Post-traumatic or juvenile arthritis|post-traumatic or juvenile arthritis
638326|NCT00487552|endoscopy|endoscopy
638327|NCT00487552|esophagogastroduodenoscopy|esophagogastroduodenoscopy
638328|NCT00487552|gastric outlet obstruction|gastric outlet obstruction
638329|NCT00487552|gastro-jejunostomy|gastro-jejunostomy
638330|NCT00487552|gastric malignancy|gastric malignancy
638331|NCT00487552|duodenal stent|duodenal stent
638332|NCT00487552|Malignant Gastric Outlet Obstruction|malignant gastric outlet obstruction
638333|NCT00487539|Colitis, Ulcerative|colitis, ulcerative
638334|NCT00487539|Golimumab|golimumab
638335|NCT00487539|CNTO 148|cnto 148
638336|NCT00487526|Bypass|bypass
638337|NCT00487526|Duodenal jejunal|duodenal jejunal
638338|NCT00487526|type 2 diabetes|type 2 diabetes
638339|NCT00487526|non-obese adults|non-obese adults
638340|NCT00487513|Follicular B Cell lymphoma|follicular b cell lymphoma
638341|NCT00487513|vaccination|vaccination
638342|NCT00487500|Major Depressive Disorder|major depressive disorder
638343|NCT00487500|Electroconvulsive Therapy|electroconvulsive therapy
638344|NCT00487487|Candidates for this study are survivors of paralytic poliomyelitis|candidates for this study are survivors of paralytic poliomyelitis
638345|NCT00487461|SAH|sah
638346|NCT00487461|Vasospasm|vasospasm
638347|NCT00487448|Myelodysplastic Syndrome|myelodysplastic syndrome
638348|NCT00487448|Chemotherapy|chemotherapy
638349|NCT00487448|Peripheral blood stem cells transplantation|peripheral blood stem cells transplantation
638350|NCT00487448|Bone marrow transplantation|bone marrow transplantation
638351|NCT00487448|Secondary Acute Myeloblastic Leukemia|secondary acute myeloblastic leukemia
638352|NCT00487435|CG5503|cg5503
638353|NCT00487435|Tapentadol|tapentadol
638354|NCT00487435|chronic non-malignant pain|chronic non-malignant pain
638355|NCT00487435|osteoarthritis|osteoarthritis
638356|NCT00487435|lower back pain|lower back pain
638357|NCT00487435|analgesic|analgesic
638358|NCT00487435|opioid|opioid
638359|NCT00487422|constipation|constipation
638360|NCT00487422|prucalopride|prucalopride
638361|NCT00487422|QOL|qol
638362|NCT00487422|SCBM|scbm
638363|NCT00487422|PAC-SYM|pac-sym
638364|NCT00487409|Ulcerative colitis|ulcerative colitis
638365|NCT00487409|Crohn's disease|crohn's disease
638366|NCT00487409|Colorectal polyps|colorectal polyps
638367|NCT00487409|Colorectal malignancy|colorectal malignancy
638368|NCT00487409|Endometriosis|endometriosis
638369|NCT00487409|Diverticulitis|diverticulitis
638370|NCT00487409|Colonic inertia|colonic inertia
638371|NCT00487396|capsule endoscopy|capsule endoscopy
638372|NCT00487396|Crohn's disease|crohn's disease
638373|NCT00487396|small bowel disease|small bowel disease
638374|NCT00487396|inflammatory bowel disease|inflammatory bowel disease
638375|NCT00487396|Patients with suspected small bowel Crohn's disease|patients with suspected small bowel crohn's disease
638376|NCT00487383|Cerebellum|cerebellum
638377|NCT00487383|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
638378|NCT00487383|Blepharospasm|blepharospasm
638379|NCT00487383|DYT-1 Generalized Dystonia|dyt-1 generalized dystonia
638380|NCT00487383|Focal Dystonia|focal dystonia
638381|NCT00487383|Dystonia|dystonia
638382|NCT00487383|Healthy Volunteer|healthy volunteer
638383|NCT00487383|HV|hv
638384|NCT00487370|Acupuncture|acupuncture
638385|NCT00487370|Gold implantation|gold implantation
638386|NCT00487370|Osteoarthritis|osteoarthritis
638387|NCT00487370|Knee osteoarthritis|knee osteoarthritis
638388|NCT00487370|Double-blind, randomized controlled trial|double-blind, randomized controlled trial
638389|NCT00487370|Intervention|intervention
638390|NCT00487370|Family practice|family practice
638391|NCT00487357|Epidemiology|epidemiology
638392|NCT00487357|Cancer Prevention|cancer prevention
638393|NCT00487357|Questionnaire|questionnaire
638394|NCT00487357|MATCh|match
638395|NCT00487357|Survey|survey
638396|NCT00487344|medicaid|medicaid
638397|NCT00487344|insurance|insurance
638398|NCT00487344|education|education
638399|NCT00487344|clinical|clinical
638400|NCT00487344|trial|trial
638401|NCT00487344|healthcare|healthcare
638402|NCT00487344|reimburse|reimburse
638403|NCT00487344|pay|pay
638404|NCT00487344|free|free
638405|NCT00487344|assist|assist
638406|NCT00487344|study|study
638407|NCT00487344|oklahoma|oklahoma
638408|NCT00487344|edmond|edmond
638409|NCT00487344|Oklahoma City|oklahoma city
638410|NCT00487344|diet|diet
638411|NCT00487344|nutrition|nutrition
638412|NCT00487344|weight loss|weight loss
638413|NCT00487344|body|body
638414|NCT00487344|fat|fat
638415|NCT00487344|obese|obese
638416|NCT00487344|overweight|overweight
638417|NCT00487344|health|health
638418|NCT00487344|medical|medical
638419|NCT00487344|therapy|therapy
638420|NCT00487344|meal plan|meal plan
638421|NCT00487344|jenny craig|jenny craig
638422|NCT00487344|weight watcher|weight watcher
638423|NCT00487344|LA Weightloss|la weightloss
638424|NCT00487344|Bryan Attebery|bryan attebery
638425|NCT00487344|Results|results
638426|NCT00487344|YMCA|ymca
638427|NCT00487344|UCO|uco
638428|NCT00487344|OSU|osu
638429|NCT00487344|OU|ou
638430|NCT00487344|clinics|clinics
638431|NCT00487344|physicians|physicians
638432|NCT00487344|surgery|surgery
638433|NCT00487344|pills|pills
638434|NCT00487344|financial|financial
638435|NCT00487344|money|money
638436|NCT00487331|Solid Tumors|solid tumors
638437|NCT00487331|Acupuncture|acupuncture
638438|NCT00487331|Uncontrolled Pain|uncontrolled pain
638439|NCT00487331|Pain|pain
638440|NCT00487318|fluvastatin|fluvastatin
638441|NCT00487318|hepatitis C|hepatitis c
638442|NCT00487318|chronic hepatitis C|chronic hepatitis c
638443|NCT00487318|not previously treated with pegylated interferon and ribavirin|not previously treated with pegylated interferon and ribavirin
638444|NCT00487305|GM-CSF|gm-csf
638445|NCT00487305|vaccine|vaccine
638446|NCT00487305|K562|k562
638447|NCT00487292|accidents|accidents
638448|NCT00487292|shift work|shift work
638449|NCT00487292|sleepiness|sleepiness
638450|NCT00487292|naps|naps
638451|NCT00487292|bright light pulses|bright light pulses
638452|NCT00487292|sleep|sleep
638453|NCT00487279|Coronary|coronary
638454|NCT00487279|Artery|artery
638455|NCT00487279|Disease|disease
638456|NCT00487279|Sudden|sudden
638457|NCT00487279|Cardiac|cardiac
638458|NCT00487279|Death|death
638459|NCT00487279|ICD|icd
638460|NCT00487266|Acupuncture|acupuncture
638461|NCT00487266|Torque|torque
638462|NCT00487266|Force Decay|force decay
638463|NCT00487253|Cutaneous Leishmaniasis|cutaneous leishmaniasis
638464|NCT00487253|Leishmania Viannia|leishmania viannia
638465|NCT00487253|Pediatric|pediatric
638466|NCT00487253|Miltefosine|miltefosine
638467|NCT00487253|Randomized|randomized
638468|NCT00487253|Colombia|colombia
638469|NCT00487240|diabetes|diabetes
638470|NCT00487240|type 1|type 1
638471|NCT00487227|caffeine|caffeine
638472|NCT00487227|coffee|coffee
638473|NCT00487227|decaffeinated|decaffeinated
638474|NCT00487227|cognition|cognition
638475|NCT00487227|mood|mood
638476|NCT00487227|autonomic|autonomic
638477|NCT00487201|liver transplantation|liver transplantation
638478|NCT00487201|biliary strictures|biliary strictures
638479|NCT00487201|ERCP|ercp
638480|NCT00487175|Pain|pain
638481|NCT00487175|sensitization|sensitization
638482|NCT00487175|analgesia|analgesia
638483|NCT00487175|Healthy volunteers and pain|healthy volunteers and pain
638484|NCT00487162|glycemic control, diabetes, obesity, comorbidities|glycemic control, diabetes, obesity, comorbidities
638485|NCT00487149|Repeatability|repeatability
638486|NCT00487149|Respiratory Muscle Strength|respiratory muscle strength
638487|NCT00487136|Drug Interaction|drug interaction
638488|NCT00487136|Pharmacokinetics|pharmacokinetics
638489|NCT00487136|Pharmacodynamics|pharmacodynamics
638490|NCT00487123|Hypertension, compliance, Valsartan, hydrochlorothiazide (HCTZ)|hypertension, compliance, valsartan, hydrochlorothiazide (hctz)
638491|NCT00487110|Pain|pain
638492|NCT00487110|serotonin|serotonin
638493|NCT00487110|interaction|interaction
638494|NCT00487110|Patients with postsurgical pain, after ear surgery|patients with postsurgical pain, after ear surgery
638495|NCT00487097|intensive care|intensive care
638496|NCT00487097|critically ill|critically ill
638497|NCT00487097|fish oil|fish oil
638498|NCT00487097|pressure sores|pressure sores
638499|NCT00487084|analgesia|analgesia
638500|NCT00487084|tubal ligation|tubal ligation
638501|NCT00487084|chloroprocaine|chloroprocaine
638502|NCT00487071|Anal fistula|anal fistula
638503|NCT00487071|High-type|high-type
638504|NCT00487071|Anal fistula plug|anal fistula plug
638505|NCT00487071|Efficacy|efficacy
638506|NCT00487071|Recurrence|recurrence
638507|NCT00487058|Gimatecan|gimatecan
638508|NCT00487058|topoisomerase I inhibitor|topoisomerase i inhibitor
638509|NCT00487058|advanced solid tumors|advanced solid tumors
638510|NCT00487045|Hemorrhoids|hemorrhoids
638511|NCT00487045|Thrombosed External Hemorrhoids (TEH)|thrombosed external hemorrhoids (teh)
638512|NCT00487045|Reduction|reduction
638513|NCT00487045|Prevention|prevention
638514|NCT00487045|Stabilizer Device|stabilizer device
638515|NCT00487045|Pregnant|pregnant
638516|NCT00487045|Vaginal Birth|vaginal birth
638517|NCT00487045|Single Birth|single birth
638518|NCT00487045|Asymptomatic Hemorrhoids|asymptomatic hemorrhoids
638519|NCT00487032|allergic rhinitis|allergic rhinitis
638520|NCT00487032|rhinitis medicamentosa|rhinitis medicamentosa
638521|NCT00487032|imidazolines|imidazolines
638522|NCT00487032|corticosteroid|corticosteroid
638523|NCT00487019|ampicillin|ampicillin
638524|NCT00487019|penicillin G|penicillin g
638525|NCT00487019|gentamicin|gentamicin
638526|NCT00487019|neonatal sepsis|neonatal sepsis
638527|NCT00487019|empiric therapy|empiric therapy
638528|NCT00486993|Diet|diet
638529|NCT00486993|Exercise|exercise
638530|NCT00486993|Smoking|smoking
638531|NCT00486993|Stress|stress
638532|NCT00486993|Polyphenols|polyphenols
638533|NCT00486980|influenza|influenza
638534|NCT00486967|Insulin resistance, heart failure, congestive heart failure,|insulin resistance, heart failure, congestive heart failure,
638535|NCT00486967|Peak VO2, Endothelial Function, Leptin, TNF.|peak vo2, endothelial function, leptin, tnf.
638536|NCT00486954|lapatinib|lapatinib
638537|NCT00486954|paclitaxel|paclitaxel
638538|NCT00486954|ErbB2|erbb2
638539|NCT00486954|Gastric cancer|gastric cancer
638540|NCT00486954|Advanced gastric cancer|advanced gastric cancer
638541|NCT00486941|Primary Prevention|primary prevention
638542|NCT00486941|Health Promotion|health promotion
638543|NCT00486941|Diet|diet
638544|NCT00486941|Exercise|exercise
638545|NCT00486941|Risk Factors|risk factors
638546|NCT00486941|Randomized Controlled Trial|randomized controlled trial
638547|NCT00486928|Valves, heart disease, prosthesis.|valves, heart disease, prosthesis.
638548|NCT00486915|Atrial Fibrillation|atrial fibrillation
638549|NCT00486915|Left Atrial Appendage|left atrial appendage
638550|NCT00486915|Surgical Ligation|surgical ligation
638551|NCT00486915|Thromboembolism|thromboembolism
638552|NCT00486915|Cerebrovascular Accident|cerebrovascular accident
638553|NCT00486902|Ketamine|ketamine
638554|NCT00486902|Spinal Anesthesia|spinal anesthesia
638555|NCT00486902|C-section|c-section
638556|NCT00486889|Glycogenesis 2|glycogenesis 2
638557|NCT00486876|Irritable bowel syndrome|irritable bowel syndrome
638558|NCT00486876|Diarrhea predominant Irritable Bowel Syndrome|diarrhea predominant irritable bowel syndrome
638559|NCT00486876|Alternating Irritable Bowel Syndrome|alternating irritable bowel syndrome
638560|NCT00486863|Philippines, Schistosoma japonicum, Schistosomiasis, pregnant women, fetuses, 08-0049|philippines, schistosoma japonicum, schistosomiasis, pregnant women, fetuses, 08-0049
638561|NCT00486850|RDS|rds
638562|NCT00486850|Preterm|preterm
638563|NCT00486850|SIMV|simv
638564|NCT00486850|NIPPV|nippv
638565|NCT00486811|Osteoarthritis|osteoarthritis
638566|NCT00486811|Knee|knee
638567|NCT00486811|Pain Assessment|pain assessment
638568|NCT00486811|CG5503 PR|cg5503 pr
638569|NCT00486811|Centrally acting analgesic|centrally acting analgesic
638570|NCT00486811|Placebo|placebo
638571|NCT00486811|Oxycodone|oxycodone
638572|NCT00486811|Chronic Pain due to knee Osteoarthritis|chronic pain due to knee osteoarthritis
638573|NCT00486811|Tapentadol|tapentadol
638574|NCT00486798|acute schizophrenia|acute schizophrenia
638575|NCT00486798|schizoaffective disorder|schizoaffective disorder
638576|NCT00486798|psychosis Not Otherwise Specified (NOS)|psychosis not otherwise specified (nos)
638577|NCT00486798|bipolar mania with psychotic symptoms|bipolar mania with psychotic symptoms
638695|NCT00486265|AML|aml
638578|NCT00486772|This study was designed to investigate whether the suggested beneficial effects of sevelamer on VC were related to fetuin-A levels in patients with CKD.|this study was designed to investigate whether the suggested beneficial effects of sevelamer on vc were related to fetuin-a levels in patients with ckd.
638579|NCT00486746|sleep apnea|sleep apnea
638580|NCT00486746|lifestyle intervention|lifestyle intervention
638581|NCT00486746|cardiovascular|cardiovascular
638582|NCT00486733|extracorporeal shock wave therapy|extracorporeal shock wave therapy
638583|NCT00486733|soft tissue wounds|soft tissue wounds
638584|NCT00486707|Ovarian Cancer|ovarian cancer
638585|NCT00486707|Questionnaire|questionnaire
638586|NCT00486707|Genetic Testing|genetic testing
638587|NCT00486707|Survey|survey
638588|NCT00486694|Malaria, vivax|malaria, vivax
638589|NCT00486694|Afghanistan|afghanistan
638590|NCT00486694|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
638591|NCT00486694|drug resistance|drug resistance
638592|NCT00486681|Glucose monitoring|glucose monitoring
638593|NCT00486681|Diabetes management|diabetes management
638594|NCT00486681|Information system|information system
638595|NCT00486681|In-patient glycemic control|in-patient glycemic control
638596|NCT00486668|HER2 positive breast cancer|her2 positive breast cancer
638597|NCT00486668|invasive breast cancer|invasive breast cancer
638598|NCT00486668|lapatinib|lapatinib
638599|NCT00486668|neoadjuvant|neoadjuvant
638600|NCT00486668|NSABP|nsabp
638601|NCT00486668|paclitaxel|paclitaxel
638602|NCT00486668|trastuzumab|trastuzumab
638603|NCT00486668|doxorubicin|doxorubicin
638604|NCT00486668|cyclophosphamide|cyclophosphamide
638605|NCT00486655|Cholecystectomy|cholecystectomy
638606|NCT00486655|NOTES|notes
638607|NCT00486655|Transgastric|transgastric
638608|NCT00486629|Exercise|exercise
638609|NCT00486629|Diet|diet
638610|NCT00486629|Pregnancy|pregnancy
638611|NCT00486629|Obesity|obesity
638612|NCT00486629|Macrosomia|macrosomia
638613|NCT00486603|adult glioblastoma|adult glioblastoma
638614|NCT00486603|adult gliosarcoma|adult gliosarcoma
638615|NCT00486603|adult giant cell glioblastoma|adult giant cell glioblastoma
638616|NCT00486590|Human milk fortification|human milk fortification
638617|NCT00486590|Premature neonate|premature neonate
638618|NCT00486590|Very low birth weight|very low birth weight
638619|NCT00486577|Hearing Disorders, Hearing Loss, Hyperacusis, Tinnitus, chronic cortical stimulation, functional magnetic resonance imaging|hearing disorders, hearing loss, hyperacusis, tinnitus, chronic cortical stimulation, functional magnetic resonance imaging
638620|NCT00486564|Treatment|treatment
638621|NCT00486564|Refractory or Relapsed|refractory or relapsed
638622|NCT00486551|Anger control training|anger control training
638623|NCT00486551|Cognitive behavioral therapy|cognitive behavioral therapy
638624|NCT00486551|Behavior therapy|behavior therapy
638625|NCT00486551|Tourette Syndrome|tourette syndrome
638626|NCT00486551|Randomized trial|randomized trial
638627|NCT00486551|Anger|anger
638628|NCT00486551|Aggression|aggression
638629|NCT00486525|fatigue|fatigue
638630|NCT00486525|depression|depression
638631|NCT00486525|pain|pain
638632|NCT00486525|cancer survivor|cancer survivor
638633|NCT00486525|stage IA breast cancer|stage ia breast cancer
638634|NCT00486525|stage IB breast cancer|stage ib breast cancer
638635|NCT00486525|stage II breast cancer|stage ii breast cancer
638636|NCT00486525|stage IIIA breast cancer|stage iiia breast cancer
638637|NCT00486525|breast cancer in situ|breast cancer in situ
638638|NCT00486512|colorectal, adenomas, prevention|colorectal, adenomas, prevention
638639|NCT00486499|radiation|radiation
638640|NCT00486499|brachytherapy|brachytherapy
638641|NCT00486499|prostate|prostate
638642|NCT00486499|cancer|cancer
638643|NCT00486486|24-hour IOP control|24-hour iop control
638644|NCT00486460|Locally advanced or metastatic adenocarcinoma of the|locally advanced or metastatic adenocarcinoma of the
638645|NCT00486460|pancreas|pancreas
638646|NCT00486460|confirmed by histology or cytology|confirmed by histology or cytology
638647|NCT00486460|Inoperatable|inoperatable
638648|NCT00486434|Osteoarthritis, oral salmon calcitonin, treatment, efficacy, tolerability|osteoarthritis, oral salmon calcitonin, treatment, efficacy, tolerability
638649|NCT00486421|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
638650|NCT00486408|HIV Seronegativity|hiv seronegativity
638651|NCT00486408|HIV Preventive Vaccine|hiv preventive vaccine
638652|NCT00486408|Adenovirus|adenovirus
638653|NCT00486395|prematurity|prematurity
638654|NCT00486395|randomized trial|randomized trial
638655|NCT00486395|RDS|rds
638656|NCT00486395|surfactant|surfactant
638657|NCT00486395|CPAP|cpap
638658|NCT00486395|ventilation|ventilation
638659|NCT00486382|visceral leishmaniasis|visceral leishmaniasis
638660|NCT00486382|vaccine|vaccine
638661|NCT00486369|Osteoarthritis, oral salmon calcitonin, tolerability, biomarkers|osteoarthritis, oral salmon calcitonin, tolerability, biomarkers
638662|NCT00486356|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
638663|NCT00486356|recurrent gastric cancer|recurrent gastric cancer
638664|NCT00486356|stage IV gastric cancer|stage iv gastric cancer
638665|NCT00486356|advanced adult primary liver cancer|advanced adult primary liver cancer
638666|NCT00486356|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
638667|NCT00486356|recurrent adult primary liver cancer|recurrent adult primary liver cancer
638668|NCT00486356|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
638669|NCT00486356|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
638670|NCT00486356|recurrent gallbladder cancer|recurrent gallbladder cancer
638671|NCT00486356|unresectable gallbladder cancer|unresectable gallbladder cancer
638672|NCT00486343|Asthma|asthma
638673|NCT00486343|ICS|ics
638674|NCT00486343|5-LO Inhibition|5-lo inhibition
638675|NCT00486343|Leukotrienes|leukotrienes
638676|NCT00486343|Asthma control|asthma control
638677|NCT00486343|Asthma exacerbations|asthma exacerbations
638678|NCT00486330|HIV|hiv
638679|NCT00486330|Pharmacokinetics|pharmacokinetics
638680|NCT00486330|Buprenorphine|buprenorphine
638681|NCT00486330|Tipranavir|tipranavir
638682|NCT00486330|HIV Seronegativity|hiv seronegativity
638683|NCT00486317|Osteoarthritis, oral salmon calcitonin, tolerability, biomarkers|osteoarthritis, oral salmon calcitonin, tolerability, biomarkers
638684|NCT00486304|cachexia|cachexia
638685|NCT00486304|weight changes|weight changes
638686|NCT00486304|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
638687|NCT00486304|stage I oropharyngeal cancer|stage i oropharyngeal cancer
638688|NCT00486304|stage II oropharyngeal cancer|stage ii oropharyngeal cancer
638689|NCT00486304|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
638690|NCT00486304|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
638691|NCT00486291|Diabetes, Obese diabetics|diabetes, obese diabetics
638692|NCT00486265|Phase I|phase i
638693|NCT00486265|Phase II|phase ii
638694|NCT00486265|acute myelogenous leukemia|acute myelogenous leukemia
638696|NCT00486265|cancer|cancer
638697|NCT00486239|Epilepsy|epilepsy
638698|NCT00486239|memory|memory
638699|NCT00486239|emotion|emotion
638700|NCT00486213|dermatologic complications|dermatologic complications
638701|NCT00486213|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
638702|NCT00486213|palmar-plantar erythrodysesthesia|palmar-plantar erythrodysesthesia
638804|NCT00485732|Randomized|randomized
638703|NCT00486213|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
638704|NCT00486200|ASP2151|asp2151
638705|NCT00486200|Herpes Genitalis|herpes genitalis
638706|NCT00486200|Sexually Transmitted Disease|sexually transmitted disease
638707|NCT00486200|Herpes Simplex Virus Genital Infection|herpes simplex virus genital infection
638708|NCT00486200|Treatment Outcome|treatment outcome
638709|NCT00486200|Genital Herpes|genital herpes
638710|NCT00486187|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
638711|NCT00486187|Thiazolidinediones|thiazolidinediones
638712|NCT00486187|Rosiglitazone|rosiglitazone
638713|NCT00486187|Adipokine|adipokine
638714|NCT00486187|Inflammation|inflammation
638715|NCT00486187|Cardiometabolic risk|cardiometabolic risk
638716|NCT00486187|Angiotensin receptor blocker|angiotensin receptor blocker
638717|NCT00486174|Sepsis|sepsis
638718|NCT00486174|Methylene Blue|methylene blue
638719|NCT00486174|Norepinephrine|norepinephrine
638720|NCT00486161|Obesity|obesity
638721|NCT00486161|Ghrelin|ghrelin
638722|NCT00486161|Non-esterified fatty acids|non-esterified fatty acids
638723|NCT00486161|Growth hormone|growth hormone
638724|NCT00486161|Insulin|insulin
638725|NCT00486161|Cycloergometer exercise|cycloergometer exercise
638726|NCT00486148|Formula|formula
638727|NCT00486148|Feeding|feeding
638728|NCT00486148|Healthy|healthy
638729|NCT00486148|Full|full
638730|NCT00486148|Term|term
638731|NCT00486148|Infants|infants
638732|NCT00486135|Cancer|cancer
638733|NCT00486135|Solid tumors|solid tumors
638734|NCT00486135|Lymphoma|lymphoma
638735|NCT00486109|Diabetes|diabetes
638736|NCT00486096|cannulation|cannulation
638737|NCT00486096|infant|infant
638738|NCT00486096|femoral arterial|femoral arterial
638739|NCT00486070|cardiac anomaly|cardiac anomaly
638740|NCT00486070|pulmonary veins|pulmonary veins
638741|NCT00486070|cyanosis|cyanosis
638742|NCT00486070|flow reversal|flow reversal
638743|NCT00486070|TAPAVC|tapavc
638744|NCT00486057|Daclizumab|daclizumab
638745|NCT00486057|Immuno-suppression protocol|immuno-suppression protocol
638746|NCT00486057|Heart Transplant|heart transplant
638747|NCT00486057|Rejection|rejection
638748|NCT00486044|amyloid protein|amyloid protein
638749|NCT00486044|apolipoprotein|apolipoprotein
638750|NCT00486044|cerebrospinal fluid|cerebrospinal fluid
638751|NCT00486044|cerebrovascular circulation|cerebrovascular circulation
638752|NCT00486044|inflammation|inflammation
638753|NCT00486044|magnetic resonance imaging|magnetic resonance imaging
638754|NCT00486044|prevention & control|prevention & control
638755|NCT00486031|IBD|ibd
638756|NCT00486031|UC|uc
638757|NCT00486031|Ulcerative Colitis|ulcerative colitis
638758|NCT00486031|Inflammatory Bowel Disease|inflammatory bowel disease
638759|NCT00486018|Lucentis|lucentis
638760|NCT00486018|RVO|rvo
638761|NCT00486018|BRVO|brvo
638762|NCT00486018|Edema|edema
638763|NCT00485992|blood stream infection|blood stream infection
638764|NCT00485992|CICU|cicu
638765|NCT00485992|pediatric|pediatric
638766|NCT00485992|chlorhexidine swabs|chlorhexidine swabs
638767|NCT00485979|Breast Cancer|breast cancer
638768|NCT00485979|Neoadjuvant therapy|neoadjuvant therapy
638769|NCT00485966|Adult Leukemia|adult leukemia
638770|NCT00485966|CLL|cll
638771|NCT00485966|B-CLL|b-cll
638772|NCT00485966|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
638773|NCT00485966|B-cell CLL|b-cell cll
638774|NCT00485953|Osteoporosis|osteoporosis
638775|NCT00485953|breast cancer|breast cancer
638776|NCT00485953|aromatase inhibitors|aromatase inhibitors
638777|NCT00485953|bone loss|bone loss
638778|NCT00485953|bone mineral density|bone mineral density
638779|NCT00485940|constipation|constipation
638780|NCT00485940|prucalopride|prucalopride
638781|NCT00485940|QOL|qol
638782|NCT00485940|SCBM|scbm
638783|NCT00485940|PAC-SYM|pac-sym
638784|NCT00485927|Trauma|trauma
638785|NCT00485927|Stress|stress
638786|NCT00485927|Simulation|simulation
638787|NCT00485914|employment|employment
638788|NCT00485914|work|work
638789|NCT00485836|CRVO|crvo
638790|NCT00485836|RVO|rvo
638791|NCT00485836|Lucentis|lucentis
638792|NCT00485836|Edema|edema
638793|NCT00485797|attention deficit hyperactivity disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
638794|NCT00485797|Dual tasking|dual tasking
638795|NCT00485797|Postural Control|postural control
638796|NCT00485797|Methylphenidate (Ritalin)|methylphenidate (ritalin)
638797|NCT00485797|The focus of the study is To explore the effects of Ritalin on postural control in ADHD Children, during single and dual task conditions.|the focus of the study is to explore the effects of ritalin on postural control in adhd children, during single and dual task conditions.
638798|NCT00485784|Identify in a population of patients with a PE, an IUGR and a FD a modification of circulating endothelial biomarkers compared with normal pregnancy.|identify in a population of patients with a pe, an iugr and a fd a modification of circulating endothelial biomarkers compared with normal pregnancy.
638799|NCT00485745|surgery|surgery
638800|NCT00485745|repeat sternotomy|repeat sternotomy
638801|NCT00485745|pediatrics|pediatrics
638802|NCT00485732|Cervical neoplasia|cervical neoplasia
638803|NCT00485732|AS04|as04
638805|NCT00485732|Cervical cancer|cervical cancer
638806|NCT00485732|HPV-16/18 L1 VLP AS04|hpv-16/18 l1 vlp as04
638807|NCT00485732|Phase IIIb|phase iiib
638808|NCT00485732|Korea|korea
638809|NCT00485732|HPV|hpv
638810|NCT00485732|Double-blind|double-blind
638811|NCT00485732|Controlled|controlled
638812|NCT00485719|Cancer|cancer
638813|NCT00485719|Solid Tumors|solid tumors
638814|NCT00485706|dialysis|dialysis
638815|NCT00485706|vascular calcification|vascular calcification
638816|NCT00485706|bone mineralism|bone mineralism
638817|NCT00485706|arterial stiffness|arterial stiffness
638818|NCT00485706|bone metabolism|bone metabolism
638819|NCT00485706|chronic kidney disease|chronic kidney disease
638820|NCT00485693|pain|pain
638821|NCT00485693|postoperative|postoperative
638822|NCT00485693|total knee arthroplasty|total knee arthroplasty
638823|NCT00485693|analgesia|analgesia
638824|NCT00485667|pain|pain
638825|NCT00485667|postoperative|postoperative
638826|NCT00485654|Heterotaxy Syndrome|heterotaxy syndrome
638827|NCT00485654|Intestinal Malrotation|intestinal malrotation
638828|NCT00485654|Functional Asplenia|functional asplenia
638829|NCT00485654|Complex Cyanotic heart disease|complex cyanotic heart disease
638830|NCT00485641|Stroke|stroke
638831|NCT00485641|SaeboFlex|saeboflex
638832|NCT00485641|Hand function|hand function
638833|NCT00485615|eicosapentaenoic acid|eicosapentaenoic acid
638834|NCT00485615|fish oil|fish oil
638835|NCT00485615|Omega 3|omega 3
638836|NCT00485615|Social Anxiety Disorder|social anxiety disorder
638837|NCT00485602|malocclusion|malocclusion
638838|NCT00485602|aligner|aligner
638839|NCT00485602|crowding|crowding
638840|NCT00485602|expansion|expansion
638841|NCT00485602|orthodontic treatment|orthodontic treatment
638842|NCT00485589|FILM|film
638843|NCT00485589|RA|ra
638844|NCT00485589|anti-CD20|anti-cd20
638845|NCT00485589|CD20|cd20
638846|NCT00485563|Cancer|cancer
638847|NCT00485563|Vaccine|vaccine
638848|NCT00485563|Phase 2|phase 2
638849|NCT00485563|folate-hapten conjugate|folate-hapten conjugate
638850|NCT00485563|Progressive|progressive
638851|NCT00485563|Metastatic|metastatic
638852|NCT00485563|Experimental|experimental
638853|NCT00485537|GnRH antagonist|gnrh antagonist
638854|NCT00485537|GnRH agonist|gnrh agonist
638855|NCT00485537|ICSI|icsi
638856|NCT00485537|miscarriage rate|miscarriage rate
638857|NCT00485537|pregnancy outcome|pregnancy outcome
638858|NCT00485524|Near Infrared Spectroscopy|near infrared spectroscopy
638859|NCT00485524|Serum Lactate Levels|serum lactate levels
638860|NCT00485524|post operative outcomes|post operative outcomes
638861|NCT00485485|Head and Neck Cancer|head and neck cancer
638862|NCT00485485|Squamous Cell Cancer|squamous cell cancer
638863|NCT00485485|Imatinib Mesylate|imatinib mesylate
638864|NCT00485485|Gleevec|gleevec
638865|NCT00485485|Imatinib|imatinib
638866|NCT00485485|STI571|sti571
638867|NCT00485485|Docetaxel|docetaxel
638868|NCT00485485|Taxotere|taxotere
638869|NCT00485472|Osteoarthritis|osteoarthritis
638870|NCT00485472|lacosamide|lacosamide
638871|NCT00485472|VIMPAT|vimpat
638872|NCT00485433|hernia|hernia
638873|NCT00485433|unilateral|unilateral
638874|NCT00485433|postoperative|postoperative
638875|NCT00485433|analgesia|analgesia
638876|NCT00485420|Internet based disease management program|internet based disease management program
638877|NCT00485394|AMD|amd
638878|NCT00485394|age-related macular degeneration|age-related macular degeneration
638879|NCT00485394|geographic atrophy|geographic atrophy
638880|NCT00485394|GA|ga
638881|NCT00485368|marfan syndrome|marfan syndrome
638882|NCT00485368|aortic root diameter|aortic root diameter
638883|NCT00485355|hysterectomy|hysterectomy
638884|NCT00485355|Laparoscopy|laparoscopy
638885|NCT00485355|robotics|robotics
638886|NCT00485342|Chronic hepatitis C,Genotype1,Naïf,bitherapy,Ribavirin adaptation,ribavirin AUC|chronic hepatitis c,genotype1,naïf,bitherapy,ribavirin adaptation,ribavirin auc
638887|NCT00485329|Chronic Wounds, Venous Ulcers, Papain, Debridement, Continuous streaming|chronic wounds, venous ulcers, papain, debridement, continuous streaming
638888|NCT00485329|DermaStream-EnzyStream|dermastream-enzystream
638889|NCT00485316|Colorectal carcinoma|colorectal carcinoma
638890|NCT00485316|Rectal carcinoma|rectal carcinoma
638891|NCT00485316|Laparoscopy|laparoscopy
638892|NCT00485316|Laparoscopic surgery|laparoscopic surgery
638893|NCT00485316|Open surgery|open surgery
638894|NCT00485316|Randomized trial|randomized trial
638895|NCT00485303|Prostatic Neoplasms|prostatic neoplasms
638896|NCT00485303|Prostate cancer|prostate cancer
638897|NCT00485303|Abiraterone acetate|abiraterone acetate
638898|NCT00485303|CB7630|cb7630
638899|NCT00485303|Prednisone|prednisone
638900|NCT00485290|cirrhosis, Portal Hypertension, Esophageal Varices, Meal|cirrhosis, portal hypertension, esophageal varices, meal
638901|NCT00485277|Breast cancer|breast cancer
638902|NCT00485277|Vaccine|vaccine
638903|NCT00485277|Metastatic|metastatic
638904|NCT00485277|HER-2-positive|her-2-positive
638905|NCT00485277|Phase I|phase i
638906|NCT00485277|HER-2 Positive Metastatic Breast Cancer|her-2 positive metastatic breast cancer
638907|NCT00485251|operation time in minutes|operation time in minutes
638908|NCT00485251|pain score from 1-10|pain score from 1-10
638909|NCT00485251|recurrence|recurrence
638910|NCT00485251|survival|survival
638911|NCT00485238|glaucoma|glaucoma
638912|NCT00485212|postoperative pain|postoperative pain
638913|NCT00485199|Pneumatic Retinopexy|pneumatic retinopexy
638914|NCT00485199|vitrectomy|vitrectomy
638915|NCT00485199|retinal detachment|retinal detachment
638916|NCT00485199|macular hole|macular hole
638917|NCT00485199|treatment|treatment
638918|NCT00485199|multi-center|multi-center
638919|NCT00485199|Retinal Detachment due to Myopic Macular hole|retinal detachment due to myopic macular hole
638920|NCT00485160|Patent Ductus Arteriosus|patent ductus arteriosus
638921|NCT00485160|Indomethacin|indomethacin
638922|NCT00485160|Ibuprofen|ibuprofen
638923|NCT00485160|Renal effects|renal effects
638924|NCT00485147|Claudication|claudication
638925|NCT00485147|peripheral arterial disease|peripheral arterial disease
638926|NCT00485147|Diagnosis|diagnosis
638927|NCT00485147|Exercise|exercise
638928|NCT00485147|Walking impairment|walking impairment
638929|NCT00485147|Disability|disability
638930|NCT00485121|Ezetimibe|ezetimibe
638931|NCT00485121|Statin|statin
638932|NCT00485121|Low- density lipoprotein cholesterol|low- density lipoprotein cholesterol
638933|NCT00485121|Adipokine|adipokine
638934|NCT00485121|Adiponectin|adiponectin
638935|NCT00485121|C-reactive protein|c-reactive protein
638936|NCT00485121|Coronary artery disease|coronary artery disease
638937|NCT00485121|Metabolic Syndrome|metabolic syndrome
638938|NCT00485121|Obesity|obesity
638939|NCT00485108|primary open angle glaucoma|primary open angle glaucoma
638940|NCT00485108|pseudoexfoliation glaucoma|pseudoexfoliation glaucoma
638941|NCT00485108|selective laser trabeculoplasty|selective laser trabeculoplasty
638942|NCT00485108|intra ocular pressure|intra ocular pressure
638943|NCT00485108|anti-inflammatory therapy|anti-inflammatory therapy
638944|NCT00485108|prednisolone acetate 1%|prednisolone acetate 1%
638945|NCT00485108|ketorolac tromethamine 0.5%|ketorolac tromethamine 0.5%
638946|NCT00485082|Cystic Fibrosis|cystic fibrosis
638947|NCT00485082|Disclosure|disclosure
638948|NCT00485082|Dating Partner|dating partner
638949|NCT00485082|Phone Interview|phone interview
638950|NCT00485069|Ropinirole hydrochloride|ropinirole hydrochloride
638951|NCT00485069|L-dopa|l-dopa
638952|NCT00485069|Parkinson's Disease|parkinson's disease
638953|NCT00485069|Dopamine agonist|dopamine agonist
638954|NCT00485056|Diabetes|diabetes
638955|NCT00485056|Tissue doppler imaging|tissue doppler imaging
638956|NCT00485056|Wave intensity analysis.|wave intensity analysis.
638957|NCT00485043|T'ai Chi|t'ai chi
638958|NCT00485043|Osteoarthritis|osteoarthritis
638959|NCT00485043|Exercise|exercise
638960|NCT00485043|Older adults|older adults
638961|NCT00485030|coronary artery disease|coronary artery disease
638962|NCT00485030|stent|stent
638963|NCT00485030|angioplasty|angioplasty
638964|NCT00485017|Obesity|obesity
638965|NCT00485017|Weight Loss|weight loss
638966|NCT00485004|Coronary artery disease|coronary artery disease
638967|NCT00485004|Stent|stent
638968|NCT00485004|Angioplasty|angioplasty
638969|NCT00484991|Phenylketonuria|phenylketonuria
638970|NCT00484991|PKU|pku
638971|NCT00484991|Phenylketonurias|phenylketonurias
638972|NCT00484991|Hyperphenylalaninaemia|hyperphenylalaninaemia
638973|NCT00484991|Hydroxylase Deficiency|hydroxylase deficiency
638974|NCT00484978|Stereotactic Radiosurgery|stereotactic radiosurgery
638975|NCT00484978|Surgery|surgery
638976|NCT00484978|Metastatic tumor to brain|metastatic tumor to brain
638977|NCT00484978|radiation|radiation
638978|NCT00484978|Brain Metastases of all pathologies|brain metastases of all pathologies
638979|NCT00484965|Coronary stent|coronary stent
638980|NCT00484965|Inflammation|inflammation
638981|NCT00484965|Atherosclerosis|atherosclerosis
638982|NCT00484965|Immunosuppressive|immunosuppressive
638983|NCT00484952|rotavirus|rotavirus
638984|NCT00484952|diarrheal diseases|diarrheal diseases
638985|NCT00484952|hospitalizations|hospitalizations
638986|NCT00484952|multicenter|multicenter
638987|NCT00484952|children|children
638988|NCT00484952|under five year old|under five year old
638989|NCT00484952|Hospitalization due to diarhheal diseases|hospitalization due to diarhheal diseases
638990|NCT00484952|Hospitalization due to rotavirus gastroenteritis|hospitalization due to rotavirus gastroenteritis
638991|NCT00484952|Nosocomial rotavirus infections|nosocomial rotavirus infections
638992|NCT00484926|coronary disease|coronary disease
638993|NCT00484926|stents|stents
638994|NCT00484926|antiplatelet drugs|antiplatelet drugs
638995|NCT00484926|drug-eluting stents|drug-eluting stents
638996|NCT00484913|healthy subjects|healthy subjects
638997|NCT00484900|Open randomized multi-centre clinical trial in Africa|open randomized multi-centre clinical trial in africa
638998|NCT00484900|Uncomplicated P. falciparum malaria|uncomplicated p. falciparum malaria
638999|NCT00484900|Artemisinin-based Combination Therapy|artemisinin-based combination therapy
639000|NCT00484900|Artesunate + sulfalene + pyrimethamine|artesunate + sulfalene + pyrimethamine
639001|NCT00484900|24 hour treatment|24 hour treatment
639002|NCT00484900|Artemether + lumefantrine|artemether + lumefantrine
639003|NCT00484887|Hernia mesh|hernia mesh
639004|NCT00484887|Implanted mesh material|implanted mesh material
639005|NCT00484887|Explanted mesh material|explanted mesh material
639006|NCT00484874|Hodgkin's lymphoma|hodgkin's lymphoma
639007|NCT00484874|Radioimmunotherapy|radioimmunotherapy
639008|NCT00484874|Bexxar|bexxar
639009|NCT00484874|I-131 Tositumomab|i-131 tositumomab
639010|NCT00484874|Safety|safety
639011|NCT00484874|Efficacy|efficacy
639012|NCT00484874|Nuclear Medicine|nuclear medicine
639013|NCT00484874|Monoclonal antibody|monoclonal antibody
639014|NCT00484874|Radiolabeled|radiolabeled
639015|NCT00484861|Women|women
639016|NCT00484861|Healthy Volunteers|healthy volunteers
639017|NCT00484861|Triglyceride|triglyceride
639018|NCT00484861|Healthy Volunteer|healthy volunteer
639019|NCT00484861|HV|hv
639020|NCT00484848|oncology, medical|oncology, medical
639021|NCT00484848|implantable catheter|implantable catheter
639022|NCT00484848|vascular access ports|vascular access ports
639023|NCT00484848|persistent withdrawal occlusion|persistent withdrawal occlusion
639024|NCT00484848|Vortex®|vortex®
639025|NCT00484848|Celsite®|celsite®
639026|NCT00484848|Vacutainer®|vacutainer®
639027|NCT00484848|venous cut-down|venous cut-down
639028|NCT00484835|Abdominal|abdominal
639029|NCT00484835|Hysterectomy|hysterectomy
639030|NCT00484835|Electrocoagulation forceps|electrocoagulation forceps
639031|NCT00484835|Electrosurgery|electrosurgery
639032|NCT00484835|Gyrus plasma open seal forceps|gyrus plasma open seal forceps
639033|NCT00484835|Patients undergoing abdominal hysterectomy for various reasons|patients undergoing abdominal hysterectomy for various reasons
639034|NCT00484809|rheumatoid arthritis|rheumatoid arthritis
639035|NCT00484809|juvenile rheumatoid arthritis|juvenile rheumatoid arthritis
639036|NCT00484796|Carotid Surgery|carotid surgery
639037|NCT00484796|Cerebral Ischemia|cerebral ischemia
639038|NCT00484796|Cognitive Deficits|cognitive deficits
639039|NCT00484796|Somatosensory-evoked Potentials|somatosensory-evoked potentials
639040|NCT00484796|Neuromonitoring|neuromonitoring
639041|NCT00484783|Laparoscopic Surgical Procedures|laparoscopic surgical procedures
639042|NCT00484783|Endoscopic Surgical Procedures|endoscopic surgical procedures
639043|NCT00484783|Laparoscopic & endoscopic procedures with a gastrotomy|laparoscopic & endoscopic procedures with a gastrotomy
639044|NCT00484783|or opening in bladder or urethra|or opening in bladder or urethra
639045|NCT00484770|heart failure, brain natriuretic peptide|heart failure, brain natriuretic peptide
639046|NCT00484757|Narcolepsy|narcolepsy
639047|NCT00484757|Orexines|orexines
639048|NCT00484757|sleep|sleep
639049|NCT00484757|cognition|cognition
639050|NCT00484757|cytokines|cytokines
639051|NCT00484744|pain|pain
639052|NCT00484744|orthodontic|orthodontic
639053|NCT00484744|acetaminophen|acetaminophen
639054|NCT00484744|ibuprofen|ibuprofen
639055|NCT00484744|separator|separator
639056|NCT00484705|Androgens|androgens
639057|NCT00484705|Menstrual pattern|menstrual pattern
639058|NCT00484705|Insulin resistance|insulin resistance
639059|NCT00484705|Adipocytes|adipocytes
639060|NCT00484705|Obesity|obesity
639061|NCT00484705|Stress|stress
639062|NCT00484705|Muscle sympathetic nerve activity|muscle sympathetic nerve activity
639063|NCT00484705|Psychological distress and quality of life|psychological distress and quality of life
639064|NCT00484692|randomized controlled trial|randomized controlled trial
639065|NCT00484692|smoking cessation|smoking cessation
639066|NCT00484692|nicotine dependence|nicotine dependence
639067|NCT00484692|sustained-release bupropion|sustained-release bupropion
639068|NCT00484692|psychotherapy|psychotherapy
639069|NCT00484692|psychodynamic model training|psychodynamic model training
639070|NCT00484666|recurrent|recurrent
639071|NCT00484666|platinum|platinum
639072|NCT00484666|resistant|resistant
639073|NCT00484666|ovarian|ovarian
639074|NCT00484666|primary|primary
639075|NCT00484666|peritoneal|peritoneal
639076|NCT00484666|cancer|cancer
639077|NCT00484653|To achieve a quality and quantitative molecular biology assay for vaginal flora abnormalities|to achieve a quality and quantitative molecular biology assay for vaginal flora abnormalities
639078|NCT00484627|Exercise|exercise
639079|NCT00484627|HIV|hiv
639080|NCT00484627|Creatine|creatine
639081|NCT00484627|Muscle|muscle
639082|NCT00484614|Breast Cancer, breast conserving surgery|breast cancer, breast conserving surgery
639083|NCT00484588|VAP|vap
639084|NCT00484575|Sevoflurane|sevoflurane
639085|NCT00484575|CABG|cabg
639086|NCT00484575|cardioprotection|cardioprotection
639087|NCT00484575|AnaConDa|anaconda
639088|NCT00484562|oxygen|oxygen
639089|NCT00484562|COPD|copd
639090|NCT00484562|exercise|exercise
639091|NCT00484549|Fabry disease, Screening, Ischemic stroke|fabry disease, screening, ischemic stroke
639092|NCT00484536|CDP323|cdp323
639093|NCT00484536|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
639094|NCT00484536|Magnetic Resonance Imaging|magnetic resonance imaging
639095|NCT00484536|Oral Compound|oral compound
639096|NCT00484536|MS|ms
639097|NCT00484523|To constitute a standardized database of multimode neural imaging.|to constitute a standardized database of multimode neural imaging.
639098|NCT00484510|Ascorbic Acid|ascorbic acid
639099|NCT00484510|Vitamin C|vitamin c
639100|NCT00484510|Charcot Marie Tooth|charcot marie tooth
639101|NCT00484510|CMT|cmt
639102|NCT00484510|CMT1a|cmt1a
639103|NCT00484497|Sleep quality|sleep quality
639104|NCT00484497|food supplement|food supplement
639105|NCT00484497|randomized controlled trial|randomized controlled trial
639106|NCT00484497|actigraphy|actigraphy
639107|NCT00484497|Leeds|leeds
639108|NCT00484497|Volunteers presenting moderate primary insomnia|volunteers presenting moderate primary insomnia
639109|NCT00484484|Cancer|cancer
639110|NCT00484484|Refractory pain|refractory pain
639111|NCT00484484|Uncontrolled pain|uncontrolled pain
639112|NCT00484484|Ketamine|ketamine
639113|NCT00484484|Uncontrolled cancer pain|uncontrolled cancer pain
639114|NCT00484458|Degenerative Disc Disease|degenerative disc disease
639115|NCT00484458|Total Disc Replacement|total disc replacement
639116|NCT00484445|Chronic critical illness|chronic critical illness
639117|NCT00484445|Functional status|functional status
639118|NCT00484445|Outcomes|outcomes
639119|NCT00484445|Post-ICU|post-icu
639120|NCT00484432|NGR-hTNF|ngr-htnf
639121|NCT00484432|Ovarian cancer|ovarian cancer
639122|NCT00484432|Doxorubicin|doxorubicin
639123|NCT00484419|Colesevelam HCl,|colesevelam hcl,
639124|NCT00484419|rosiglitazone|rosiglitazone
639125|NCT00484419|sitagliptin|sitagliptin
639126|NCT00484419|Type 2 diabetes|type 2 diabetes
639127|NCT00484419|metformin|metformin
639128|NCT00484406|Matrix Metalloproteinases|matrix metalloproteinases
639129|NCT00484406|Atherosclerosis|atherosclerosis
639130|NCT00484406|Genetic polymorphism|genetic polymorphism
639131|NCT00484406|Acute coronary syndromes|acute coronary syndromes
639132|NCT00484380|Valvular surgery|valvular surgery
639133|NCT00484380|Diagnostic accuracy of coronary angiography|diagnostic accuracy of coronary angiography
639134|NCT00484380|Coronary stenosis|coronary stenosis
639135|NCT00484380|Coronary revascularisation|coronary revascularisation
639136|NCT00484367|Alcohol abuse|alcohol abuse
639137|NCT00484367|Substance abuse|substance abuse
639138|NCT00484367|Cannabis abuse|cannabis abuse
639139|NCT00484367|Adolescents|adolescents
639140|NCT00484367|Group therapy|group therapy
639141|NCT00484367|Family therapy|family therapy
639142|NCT00484354|Acute Renal Failure|acute renal failure
639143|NCT00484354|Cardiac Surgery|cardiac surgery
639144|NCT00484354|Sodium Bicarbonate|sodium bicarbonate
639145|NCT00484354|Length of Stay|length of stay
639146|NCT00484354|Mortality|mortality
639147|NCT00484341|NGR-hTNF|ngr-htnf
639148|NCT00484341|Doxorubicin|doxorubicin
639149|NCT00484341|Soft Tissue Sarcoma|soft tissue sarcoma
639150|NCT00484328|hepatitis C|hepatitis c
639151|NCT00484328|Ribavirin|ribavirin
639152|NCT00484328|Dosage|dosage
639153|NCT00484328|Pharmacokinetics|pharmacokinetics
639154|NCT00484315|drug-eluting stent|drug-eluting stent
639155|NCT00484315|paclitaxel-eluting stent|paclitaxel-eluting stent
639156|NCT00484315|DES|des
639157|NCT00484302|Marijuana Abuse|marijuana abuse
639158|NCT00484302|Psychotic Disorders|psychotic disorders
639159|NCT00484302|Schizophrenia|schizophrenia
639160|NCT00484276|NGR-hTNF|ngr-htnf
639161|NCT00484276|malignant pleural mesothelioma|malignant pleural mesothelioma
639162|NCT00484250|Oral Lichen Planus|oral lichen planus
639163|NCT00484250|Metronidazole|metronidazole
639164|NCT00484250|Doxycycline|doxycycline
639165|NCT00484237|Rheumatoid Arthritis|rheumatoid arthritis
639166|NCT00484211|NGR-hTNF, Hepatocellular Carcinoma (HCC)|ngr-htnf, hepatocellular carcinoma (hcc)
639167|NCT00484185|Hemophilia B|hemophilia b
639168|NCT00484185|BeneFIX|benefix
639169|NCT00484185|Safety|safety
639170|NCT00484185|Efficacy|efficacy
639171|NCT00484172|Obesity|obesity
639172|NCT00484159|Low back pain of suspected lumbar zygapophysial etiology|low back pain of suspected lumbar zygapophysial etiology
639173|NCT00484146|Sepsis|sepsis
639174|NCT00484146|Early Stage|early stage
639175|NCT00484146|Immune System|immune system
639176|NCT00484146|Receptors|receptors
639177|NCT00484146|Cytokines|cytokines
639178|NCT00484133|sepsis|sepsis
639179|NCT00484133|severe sepsis|severe sepsis
639180|NCT00484133|microcirculation|microcirculation
639181|NCT00484133|Orthogonal polarisation spectral|orthogonal polarisation spectral
639182|NCT00484120|Osteoarthritis|osteoarthritis
639183|NCT00484120|Diclofenac|diclofenac
639184|NCT00484120|Nano-emulsion|nano-emulsion
639185|NCT00484094|Rapamune|rapamune
639186|NCT00484094|Safety|safety
639187|NCT00484094|Efficacy|efficacy
639188|NCT00484094|Kidney Transplantation|kidney transplantation
639189|NCT00484081|TESE|tese
639190|NCT00484081|NON-OBSTRUCTIVE|non-obstructive
639191|NCT00484081|MICRODISSECTION|microdissection
639192|NCT00484081|AZOOSPERMIA|azoospermia
639193|NCT00484081|ICSI|icsi
639194|NCT00484068|type 2 diabetes|type 2 diabetes
639195|NCT00484068|microalbuminuria|microalbuminuria
639196|NCT00484068|chicken-based diet|chicken-based diet
639197|NCT00484068|ACE inhibitor|ace inhibitor
639198|NCT00484055|Antibiotic Prophylaxis|antibiotic prophylaxis
639199|NCT00484042|pancreatitis|pancreatitis
639200|NCT00484042|polyamine|polyamine
639201|NCT00484042|cytokine|cytokine
639202|NCT00484029|Temporomandibular Disorders|temporomandibular disorders
639203|NCT00484029|TMD|tmd
639204|NCT00484029|TMJ/TMD|tmj/tmd
639205|NCT00484029|Pain Management|pain management
639206|NCT00484029|Pain|pain
639207|NCT00484029|Headaches|headaches
639208|NCT00484016|adjuvant|adjuvant
639209|NCT00484016|chemotherapy|chemotherapy
639210|NCT00484016|observation|observation
639211|NCT00484016|resected|resected
639212|NCT00484016|cancers|cancers
639213|NCT00484003|Atopic eczema|atopic eczema
639214|NCT00484003|Pimecrolimus|pimecrolimus
639215|NCT00484003|Children|children
639216|NCT00484003|Quality of life|quality of life
639217|NCT00484003|Safety|safety
639218|NCT00484003|Atopic dermatitis|atopic dermatitis
639219|NCT00483990|Phase I Study in healthy subjects|phase i study in healthy subjects
639220|NCT00483964|Schizophrenia|schizophrenia
639221|NCT00483964|Herbal extracts|herbal extracts
639222|NCT00483964|Randomized|randomized
639223|NCT00483964|Controlled|controlled
639224|NCT00483964|Clinical Trial|clinical trial
639225|NCT00483951|Myocardial Infarction|myocardial infarction
639226|NCT00483951|Myocardial Ischemia|myocardial ischemia
639227|NCT00483951|Atherosclerosis|atherosclerosis
639228|NCT00483951|Congenital Heart Disease|congenital heart disease
639229|NCT00483951|Valvular Heart Disease|valvular heart disease
639230|NCT00483951|Heart Disease|heart disease
639231|NCT00483951|Cardiovascular Disease|cardiovascular disease
639232|NCT00483951|Heart Valve Disease|heart valve disease
639233|NCT00483925|Langerhans cell histiocytosis|langerhans cell histiocytosis
639234|NCT00483925|flow mediated dilatation|flow mediated dilatation
639235|NCT00483925|intima media thickness|intima media thickness
639236|NCT00483925|insulin resistance|insulin resistance
639237|NCT00483925|hypopituitarism|hypopituitarism
639238|NCT00483925|glucose and lipid metabolism,|glucose and lipid metabolism,
639239|NCT00483925|structural arterial and functional endothelial properties in patients with multisystem LCH|structural arterial and functional endothelial properties in patients with multisystem lch
639240|NCT00483912|pancreatitis, MARS|pancreatitis, mars
639241|NCT00483912|severe acute pancreatitis with early multiple organ failure|severe acute pancreatitis with early multiple organ failure
639242|NCT00483899|GW870086X Asthma Crossover repeat dose inhaled|gw870086x asthma crossover repeat dose inhaled
639243|NCT00483886|constipation|constipation
639244|NCT00483886|prucalopride|prucalopride
639245|NCT00483886|QOL|qol
639246|NCT00483886|SCBM|scbm
639247|NCT00483886|PAC-SYM|pac-sym
639248|NCT00483873|Cardiac Arrest, Neurological Recovery, EEG, Quantitative EEG|cardiac arrest, neurological recovery, eeg, quantitative eeg
639249|NCT00483860|Cancer|cancer
639250|NCT00483860|Solid tumor,|solid tumor,
639251|NCT00483860|normal renal function|normal renal function
639252|NCT00483860|renal impairment,|renal impairment,
639253|NCT00483860|prior platinum-based chemotherapy,|prior platinum-based chemotherapy,
639254|NCT00483847|TYGRIS - Rest of World (ROW)|tygris - rest of world (row)
639255|NCT00483847|TYSABRI|tysabri
639256|NCT00483847|natalizumab|natalizumab
639257|NCT00483847|Multiple Sclerosis|multiple sclerosis
639258|NCT00483834|Bevacizumab|bevacizumab
639259|NCT00483834|Avastin|avastin
639260|NCT00483834|CPT-11|cpt-11
639261|NCT00483834|Irinotecan|irinotecan
639262|NCT00483834|Camptothecin-11|camptothecin-11
639263|NCT00483834|Capecitabine|capecitabine
639264|NCT00483834|Xeloda|xeloda
639265|NCT00483834|Metastatic|metastatic
639266|NCT00483834|Colorectal|colorectal
639267|NCT00483834|Colon|colon
639268|NCT00483834|Rectal|rectal
639269|NCT00483821|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
639270|NCT00483821|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
639271|NCT00483821|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
639272|NCT00483821|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
639273|NCT00483821|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
639274|NCT00483821|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
639275|NCT00483821|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
639276|NCT00483821|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
639277|NCT00483821|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
639278|NCT00483821|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
639279|NCT00483821|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
639280|NCT00483821|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
639281|NCT00483821|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
639282|NCT00483821|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
639283|NCT00483821|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
639284|NCT00483821|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
639285|NCT00483821|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
639286|NCT00483821|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
639287|NCT00483821|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
639288|NCT00483821|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
639289|NCT00483821|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
639290|NCT00483821|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
639291|NCT00483821|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
639292|NCT00483821|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
639293|NCT00483782|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
639294|NCT00483782|Brenner tumor|brenner tumor
639295|NCT00483782|ovarian carcinosarcoma|ovarian carcinosarcoma
639296|NCT00483782|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
639297|NCT00483782|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
639298|NCT00483782|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
639299|NCT00483782|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
639300|NCT00483782|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
639301|NCT00483782|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
639302|NCT00483782|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
639303|NCT00483782|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
639304|NCT00483782|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
639305|NCT00483782|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
639306|NCT00483782|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
639307|NCT00483782|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
639425|NCT00483301|Sorafenib|sorafenib
639308|NCT00483782|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
639309|NCT00483782|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
639310|NCT00483782|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
639311|NCT00483782|stage IA fallopian tube cancer|stage ia fallopian tube cancer
639312|NCT00483782|stage IB fallopian tube cancer|stage ib fallopian tube cancer
639313|NCT00483782|stage IC fallopian tube cancer|stage ic fallopian tube cancer
639314|NCT00483782|stage IIA fallopian tube cancer|stage iia fallopian tube cancer
639315|NCT00483782|stage IIB fallopian tube cancer|stage iib fallopian tube cancer
639316|NCT00483782|stage IIC fallopian tube cancer|stage iic fallopian tube cancer
639317|NCT00483782|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
639318|NCT00483782|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
639319|NCT00483782|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
639320|NCT00483782|stage IV fallopian tube cancer|stage iv fallopian tube cancer
639321|NCT00483782|stage IA primary peritoneal cavity cancer|stage ia primary peritoneal cavity cancer
639322|NCT00483782|stage IB primary peritoneal cavity cancer|stage ib primary peritoneal cavity cancer
639323|NCT00483782|stage IC primary peritoneal cavity cancer|stage ic primary peritoneal cavity cancer
639324|NCT00483782|stage IIA primary peritoneal cavity cancer|stage iia primary peritoneal cavity cancer
639325|NCT00483782|stage IIB primary peritoneal cavity cancer|stage iib primary peritoneal cavity cancer
639326|NCT00483782|stage IIC primary peritoneal cavity cancer|stage iic primary peritoneal cavity cancer
639327|NCT00483782|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
639328|NCT00483782|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
639329|NCT00483782|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
639330|NCT00483782|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
639331|NCT00483769|Cystis Fibrosis|cystis fibrosis
639332|NCT00483769|Glucose intolerance|glucose intolerance
639333|NCT00483769|Glargine|glargine
639334|NCT00483769|FEV1%|fev1%
639335|NCT00483756|Immunosuppression|immunosuppression
639336|NCT00483756|JAK3 inhibitor|jak3 inhibitor
639337|NCT00483756|kidney transplantation.|kidney transplantation.
639338|NCT00483717|Migraine|migraine
639339|NCT00483717|Ketorolac|ketorolac
639340|NCT00483704|multiple attacks of moderate to severe migraine headaches|multiple attacks of moderate to severe migraine headaches
639341|NCT00483691|Intervention|intervention
639342|NCT00483691|Home Visit|home visit
639343|NCT00483691|Growth|growth
639344|NCT00483691|Child Development|child development
639345|NCT00483678|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
639346|NCT00483678|sexual dysfunction|sexual dysfunction
639347|NCT00483678|sexuality and reproductive issues|sexuality and reproductive issues
639348|NCT00483678|recurrent prostate cancer|recurrent prostate cancer
639349|NCT00483678|stage III prostate cancer|stage iii prostate cancer
639350|NCT00483678|stage IV prostate cancer|stage iv prostate cancer
639351|NCT00483665|endoleak|endoleak
639352|NCT00483652|multiple sclerosis|multiple sclerosis
639353|NCT00483652|MS|ms
639354|NCT00483652|walking|walking
639355|NCT00483652|leg strength|leg strength
639356|NCT00483652|demyelination|demyelination
639357|NCT00483639|anxiety disorder|anxiety disorder
639358|NCT00483639|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
639359|NCT00483639|head and neck cancer|head and neck cancer
639360|NCT00483639|non-small cell lung cancer|non-small cell lung cancer
639361|NCT00483639|small cell lung cancer|small cell lung cancer
639362|NCT00483626|hemodynamic|hemodynamic
639363|NCT00483626|pulmonary hypertension|pulmonary hypertension
639364|NCT00483626|sildenafil|sildenafil
639365|NCT00483613|Daily stress|daily stress
639366|NCT00483613|Cognitive-behavioral therapy|cognitive-behavioral therapy
639367|NCT00483613|Quality of life|quality of life
639368|NCT00483613|SLEDAI|sledai
639369|NCT00483600|Fondaparinux|fondaparinux
639370|NCT00483600|Pharmacokinetic|pharmacokinetic
639371|NCT00483587|NSTEMI|nstemi
639372|NCT00483587|Acute coronary syndrome|acute coronary syndrome
639373|NCT00483587|Heme arginate|heme arginate
639374|NCT00483587|HO-1|ho-1
639375|NCT00483587|Heme oxygenase-1|heme oxygenase-1
639376|NCT00483574|Menactra® vaccine|menactra® vaccine
639377|NCT00483574|Meningococcal meningitis|meningococcal meningitis
639378|NCT00483574|Measles|measles
639379|NCT00483574|Mumps|mumps
639380|NCT00483574|Rubella|rubella
639381|NCT00483574|Varicella virus|varicella virus
639382|NCT00483574|Haemophilus influenzae type b|haemophilus influenzae type b
639383|NCT00483574|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
639384|NCT00483561|adenocarcinoma of the prostate|adenocarcinoma of the prostate
639385|NCT00483561|recurrent prostate cancer|recurrent prostate cancer
639386|NCT00483561|stage III prostate cancer|stage iii prostate cancer
639387|NCT00483561|stage IV prostate cancer|stage iv prostate cancer
639388|NCT00483535|Gw273225, Oral Contraceptive Interaction|gw273225, oral contraceptive interaction
639389|NCT00483522|Rehabilitation|rehabilitation
639390|NCT00483522|Directive counseling|directive counseling
639391|NCT00483522|Brain injuries|brain injuries
639392|NCT00483509|NGR-hTNF|ngr-htnf
639393|NCT00483509|SCLC|sclc
639394|NCT00483483|HIV|hiv
639395|NCT00483483|Unsafe sex|unsafe sex
639396|NCT00483483|High-risk sex|high-risk sex
639397|NCT00483483|Needle sharing|needle sharing
639398|NCT00483483|STDs|stds
639399|NCT00483470|Hepatitis A|hepatitis a
639400|NCT00483457|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
639401|NCT00483444|Rehabilitation|rehabilitation
639402|NCT00483444|Brain injuries|brain injuries
639403|NCT00483444|Directive counseling|directive counseling
639404|NCT00483431|vitamin K2|vitamin k2
639405|NCT00483431|dosis-response|dosis-response
639406|NCT00483431|osteocalcin|osteocalcin
639407|NCT00483431|matrix-gla protein|matrix-gla protein
639408|NCT00483418|male|male
639409|NCT00483418|cancer|cancer
639410|NCT00483405|advanced adult primary liver cancer|advanced adult primary liver cancer
639411|NCT00483405|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
639412|NCT00483405|recurrent adult primary liver cancer|recurrent adult primary liver cancer
639413|NCT00483405|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
639414|NCT00483392|insulin|insulin
639415|NCT00483392|rosiglitazone|rosiglitazone
639416|NCT00483392|metformin|metformin
639417|NCT00483392|hiv|hiv
639418|NCT00483392|protease inhibitors|protease inhibitors
639419|NCT00483366|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
639420|NCT00483327|Well|well
639421|NCT00483327|Moderately|moderately
639422|NCT00483327|Differentiated|differentiated
639423|NCT00483301|Melanoma|melanoma
639424|NCT00483301|Abraxane|abraxane
639426|NCT00483301|BAY 43-9006|bay 43-9006
639427|NCT00483301|Abraxis|abraxis
639428|NCT00483288|cervical cancer|cervical cancer
639429|NCT00483275|Accidental Falls|accidental falls
639430|NCT00483275|Accident Prevention|accident prevention
639431|NCT00483275|Patient Education|patient education
639432|NCT00483275|Exercise Training|exercise training
639433|NCT00483275|Alfacalcidol|alfacalcidol
639434|NCT00483262|Temsirolimus|temsirolimus
639435|NCT00483262|Bortezomib|bortezomib
639436|NCT00483249|Thoracoabdominal|thoracoabdominal
639437|NCT00483249|Paravisceral|paravisceral
639438|NCT00483249|Aneurysm|aneurysm
639439|NCT00483249|Endovascular|endovascular
639440|NCT00483249|Stent-Graft|stent-graft
639441|NCT00483249|Aorta|aorta
639442|NCT00483236|Non-Ischaemic Cardiomyopathy|non-ischaemic cardiomyopathy
639443|NCT00483223|ER negative|er negative
639444|NCT00483223|PgR negative|pgr negative
639445|NCT00483223|HER2 negative|her2 negative
639446|NCT00483223|cisplatin|cisplatin
639447|NCT00483223|carboplatinum|carboplatinum
639448|NCT00483223|platinum|platinum
639449|NCT00483223|p63|p63
639450|NCT00483223|p73|p73
639451|NCT00483197|VentrAssistTM|ventrassisttm
639452|NCT00483197|LVAD|lvad
639453|NCT00483197|End-stage heart failure|end-stage heart failure
639454|NCT00483197|Cardiomyopathy|cardiomyopathy
639455|NCT00483158|Helicobacter pylori|helicobacter pylori
639456|NCT00483158|Fluoroquinolones|fluoroquinolones
639457|NCT00483158|First in Man|first in man
639458|NCT00483119|pemphigus vulgaris|pemphigus vulgaris
639459|NCT00483119|IVIg|ivig
639460|NCT00483119|cyclophosphamide|cyclophosphamide
639461|NCT00483119|treatment|treatment
639462|NCT00483119|pemphigus antibodies|pemphigus antibodies
639463|NCT00483106|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
639464|NCT00483106|Genetics|genetics
639465|NCT00483106|Pharmacogenetics|pharmacogenetics
639466|NCT00483093|NGR-hTNF|ngr-htnf
639467|NCT00483093|cisplatin|cisplatin
639468|NCT00483093|solid tumors|solid tumors
639469|NCT00483080|NGR-hTNF|ngr-htnf
639470|NCT00483080|CRC|crc
639471|NCT00483067|Idiopathic Hypereosinophilic Syndrome|idiopathic hypereosinophilic syndrome
639472|NCT00483067|Leukemia|leukemia
639473|NCT00483067|2-Chlorodeoxyadenosine|2-chlorodeoxyadenosine
639474|NCT00483067|Cladribine|cladribine
639475|NCT00483067|Cytarabine|cytarabine
639476|NCT00483067|Ara-C|ara-c
639477|NCT00483067|2-CdA|2-cda
639478|NCT00483067|G-CSF|g-csf
639479|NCT00483067|HES|hes
639480|NCT00483054|HIV|hiv
639481|NCT00483054|tuberculosis|tuberculosis
639482|NCT00483054|efavirenz|efavirenz
639483|NCT00483054|nevirapine|nevirapine
639484|NCT00483054|rifampicin|rifampicin
639485|NCT00483054|co-infected HIV and tuberculosis patients|co-infected hiv and tuberculosis patients
639486|NCT00483015|presentation|presentation
639487|NCT00483015|outcome|outcome
639488|NCT00483015|response|response
639489|NCT00483015|never- smokers|never- smokers
639490|NCT00483002|A prospective and observational program to monitor use in real practice including efficacy of Varenicline in Korea.|a prospective and observational program to monitor use in real practice including efficacy of varenicline in korea.
639491|NCT00482963|HIV|hiv
639492|NCT00482963|Contraception|contraception
639493|NCT00482963|Antiretroviral agents|antiretroviral agents
639494|NCT00482963|Pharmacokinetics|pharmacokinetics
639495|NCT00482937|Safety|safety
639496|NCT00482937|Heart Failure|heart failure
639497|NCT00482924|obesity|obesity
639498|NCT00482924|cardiovascular risk profiles|cardiovascular risk profiles
639499|NCT00482924|adipokines|adipokines
639500|NCT00482924|preatherosclerosis|preatherosclerosis
639501|NCT00482924|low grade inflammation|low grade inflammation
639502|NCT00482924|dyslipidemia|dyslipidemia
639503|NCT00482924|insulin resistance|insulin resistance
639504|NCT00482924|brown adipose tissue|brown adipose tissue
639505|NCT00482924|white adipose tissue|white adipose tissue
639506|NCT00482911|recurrent intraocular melanoma|recurrent intraocular melanoma
639507|NCT00482911|metastatic intraocular melanoma|metastatic intraocular melanoma
639508|NCT00482911|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
639509|NCT00482911|extraocular extension melanoma|extraocular extension melanoma
639510|NCT00482911|iris melanoma|iris melanoma
639511|NCT00482911|conjunctival melanoma|conjunctival melanoma
639512|NCT00482885|Esophagus|esophagus
639513|NCT00482885|Peristalsis|peristalsis
639514|NCT00482885|Contractile Pressure|contractile pressure
639515|NCT00482885|Coordination of contraction|coordination of contraction
639516|NCT00482885|Bolus transport|bolus transport
639517|NCT00482885|Esophageal function|esophageal function
639518|NCT00482872|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
639519|NCT00482872|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
639520|NCT00482872|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
639521|NCT00482872|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
639522|NCT00482872|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
639523|NCT00482872|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
639524|NCT00482872|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
639525|NCT00482872|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
639526|NCT00482872|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
639527|NCT00482872|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
639528|NCT00482872|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
639529|NCT00482872|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
639530|NCT00482872|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
639531|NCT00482872|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
639532|NCT00482872|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
639533|NCT00482872|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
639534|NCT00482872|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
639535|NCT00482872|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
639536|NCT00482872|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
639537|NCT00482872|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
639538|NCT00482872|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
639539|NCT00482872|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
639540|NCT00482872|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
639541|NCT00482872|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
639542|NCT00482872|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
639543|NCT00482872|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
639544|NCT00482872|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
639545|NCT00482872|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
639546|NCT00482872|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
639547|NCT00482872|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
639548|NCT00482872|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
639549|NCT00482872|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
639550|NCT00482872|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
639551|NCT00482872|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
639552|NCT00482872|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
639553|NCT00482872|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
639554|NCT00482872|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
639555|NCT00482872|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
639556|NCT00482872|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
639557|NCT00482872|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
639558|NCT00482872|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
639559|NCT00482872|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
639560|NCT00482872|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
639561|NCT00482872|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
639562|NCT00482859|Fibromyalgia Syndrome|fibromyalgia syndrome
639563|NCT00482846|mucositis|mucositis
639564|NCT00482846|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
639565|NCT00482846|stage II multiple myeloma|stage ii multiple myeloma
639566|NCT00482846|stage III multiple myeloma|stage iii multiple myeloma
639567|NCT00482846|refractory multiple myeloma|refractory multiple myeloma
639568|NCT00482833|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
639569|NCT00482833|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
639570|NCT00482833|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
639571|NCT00482820|anxiety|anxiety
639572|NCT00482820|attention-biases|attention-biases
639573|NCT00482820|children|children
639574|NCT00482807|stage I prostate cancer|stage i prostate cancer
639575|NCT00482807|stage II prostate cancer|stage ii prostate cancer
639576|NCT00482807|stage III prostate cancer|stage iii prostate cancer
639577|NCT00482807|stage IV prostate cancer|stage iv prostate cancer
639578|NCT00482807|adenocarcinoma of the prostate|adenocarcinoma of the prostate
639579|NCT00482807|recurrent prostate cancer|recurrent prostate cancer
639580|NCT00482794|Antiphospholipid Antibody Syndrome|antiphospholipid antibody syndrome
639581|NCT00482781|Apnea|apnea
639582|NCT00482781|Bradycardia|bradycardia
639583|NCT00482781|Preterm Infant|preterm infant
639584|NCT00482781|Immunization|immunization
639585|NCT00482781|DTaP|dtap
639586|NCT00482768|Diabetes, type II; Primary Health Care; Outpatient Care|diabetes, type ii; primary health care; outpatient care
639587|NCT00482755|male breast cancer|male breast cancer
639588|NCT00482755|stage II breast cancer|stage ii breast cancer
639589|NCT00482755|stage IIIA breast cancer|stage iiia breast cancer
639590|NCT00482742|Chronic Total Occlusion|chronic total occlusion
639591|NCT00482716|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
639592|NCT00482716|refractory multiple myeloma|refractory multiple myeloma
639593|NCT00482716|stage I multiple myeloma|stage i multiple myeloma
639594|NCT00482716|stage II multiple myeloma|stage ii multiple myeloma
639595|NCT00482716|stage III multiple myeloma|stage iii multiple myeloma
639596|NCT00482716|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
639597|NCT00482716|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
639598|NCT00482716|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
639599|NCT00482716|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
639600|NCT00482716|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
639601|NCT00482716|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
639602|NCT00482716|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
639603|NCT00482716|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
639604|NCT00482716|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
639605|NCT00482716|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
639606|NCT00482716|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
639607|NCT00482716|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
639608|NCT00482716|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
639609|NCT00482716|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
639610|NCT00482716|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
639611|NCT00482716|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
639612|NCT00482716|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
639613|NCT00482716|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
639614|NCT00482716|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
639615|NCT00482716|stage I marginal zone lymphoma|stage i marginal zone lymphoma
639616|NCT00482716|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
639617|NCT00482716|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
639618|NCT00482716|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
639619|NCT00482716|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
639620|NCT00482716|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
639621|NCT00482716|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
639622|NCT00482716|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
639623|NCT00482716|splenic marginal zone lymphoma|splenic marginal zone lymphoma
639624|NCT00482716|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
639625|NCT00482716|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
639626|NCT00482716|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
639627|NCT00482716|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
639628|NCT00482716|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
639629|NCT00482716|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
639630|NCT00482716|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
639631|NCT00482716|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
639632|NCT00482716|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
639633|NCT00482716|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
639634|NCT00482716|anemia|anemia
639635|NCT00482703|Imatinib resistant or intolerant chronic phase CML|imatinib resistant or intolerant chronic phase cml
639636|NCT00482690|Smoking cessation|smoking cessation
639637|NCT00482690|Biomarkers|biomarkers
639638|NCT00482690|Aldehydes|aldehydes
639639|NCT00482690|Exhaled breath|exhaled breath
639640|NCT00482690|Harm Reduction|harm reduction
639641|NCT00482690|Cigarette smoking|cigarette smoking
639642|NCT00482690|cessation|cessation
639643|NCT00482690|reduction|reduction
639644|NCT00482677|adult glioblastoma|adult glioblastoma
639645|NCT00482677|adult giant cell glioblastoma|adult giant cell glioblastoma
639646|NCT00482677|adult gliosarcoma|adult gliosarcoma
639647|NCT00482586|adult primary liver cancer|adult primary liver cancer
639648|NCT00482586|liver metastases|liver metastases
639649|NCT00482573|Electrocardiography, ambulatory/methods|electrocardiography, ambulatory/methods
639650|NCT00482573|Blood Pressure monitoring, ambulatory/methods|blood pressure monitoring, ambulatory/methods
639651|NCT00482573|Cardiotocography/methods|cardiotocography/methods
639652|NCT00482573|Dental restoration, permanent|dental restoration, permanent
639653|NCT00482573|Anesthesia, local /methods|anesthesia, local /methods
639654|NCT00482573|Lidocaine|lidocaine
639655|NCT00482573|Vasoconstrictor Agents|vasoconstrictor agents
639656|NCT00482573|Epinephrine|epinephrine
639657|NCT00482573|Pregnancy|pregnancy
639658|NCT00482573|Rheumatic Heart Disease|rheumatic heart disease
639659|NCT00482560|Sucrose|sucrose
639660|NCT00482560|Breastfeeding|breastfeeding
639661|NCT00482560|Heel lance|heel lance
639662|NCT00482547|urinary tract infection|urinary tract infection
639663|NCT00482547|urinary catheter|urinary catheter
639664|NCT00482521|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
639665|NCT00482508|Asthma|asthma
639666|NCT00482508|anti immunoglobulin E|anti immunoglobulin e
639667|NCT00482508|omalizumab|omalizumab
639668|NCT00482495|refractory multiple myeloma|refractory multiple myeloma
639669|NCT00482495|stage I multiple myeloma|stage i multiple myeloma
639670|NCT00482495|stage II multiple myeloma|stage ii multiple myeloma
639671|NCT00482495|stage III multiple myeloma|stage iii multiple myeloma
639672|NCT00482482|Yoga|yoga
639673|NCT00482482|Bipolar disorder|bipolar disorder
639674|NCT00482482|Major depression|major depression
639675|NCT00482482|Dysthymia|dysthymia
639676|NCT00482482|Randomized|randomized
639677|NCT00482469|ischemia-reperfusion|ischemia-reperfusion
639678|NCT00482469|ischemia|ischemia
639679|NCT00482469|reperfusion|reperfusion
639680|NCT00482469|DIEP-flap|diep-flap
639681|NCT00482469|flap|flap
639682|NCT00482456|Nitrous oxide|nitrous oxide
639683|NCT00482456|Homocysteine|homocysteine
639684|NCT00482456|folate|folate
639685|NCT00482456|vitamin B12|vitamin b12
639686|NCT00482430|Undifferentiated schizophrenia|undifferentiated schizophrenia
639687|NCT00482430|Residual schizophrenia|residual schizophrenia
639688|NCT00482391|recurrent breast cancer|recurrent breast cancer
639689|NCT00482391|stage I breast cancer|stage i breast cancer
639690|NCT00482391|stage II breast cancer|stage ii breast cancer
639691|NCT00482391|stage IIIA breast cancer|stage iiia breast cancer
639692|NCT00482391|stage IIIB breast cancer|stage iiib breast cancer
639693|NCT00482391|stage IIIC breast cancer|stage iiic breast cancer
639694|NCT00482391|male breast cancer|male breast cancer
639695|NCT00482378|stage I multiple myeloma|stage i multiple myeloma
639696|NCT00482378|stage II multiple myeloma|stage ii multiple myeloma
639697|NCT00482378|stage III multiple myeloma|stage iii multiple myeloma
639698|NCT00482378|refractory multiple myeloma|refractory multiple myeloma
639699|NCT00482378|pain|pain
639700|NCT00482365|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
639701|NCT00482365|advanced adult primary liver cancer|advanced adult primary liver cancer
639702|NCT00482365|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
639703|NCT00482365|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
639704|NCT00482365|recurrent adult primary liver cancer|recurrent adult primary liver cancer
639705|NCT00482339|bacterial contamination|bacterial contamination
639706|NCT00482339|platelet concentrates|platelet concentrates
639707|NCT00482339|blood donation|blood donation
639708|NCT00482339|looxster|looxster
639709|NCT00482339|pureprove|pureprove
639710|NCT00482339|bacterial genomic DNA|bacterial genomic dna
639711|NCT00482339|bacterial contamination of platelet concentrates|bacterial contamination of platelet concentrates
639712|NCT00482339|"Preparation of bacterial DNA in blood"|"preparation of bacterial dna in blood"
639713|NCT00482339|comparison of blood culture versus NAT|comparison of blood culture versus nat
639714|NCT00482313|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
639715|NCT00482313|ADHD|adhd
639716|NCT00482313|Prison|prison
639717|NCT00482313|Treatment|treatment
639718|NCT00482313|Randomized|randomized
639719|NCT00482313|Double-Blind|double-blind
639720|NCT00482313|Placebo Control|placebo control
639721|NCT00482313|Parallel Assignment|parallel assignment
639722|NCT00482313|Efficacy Study|efficacy study
639723|NCT00482300|Histologically proved endometrial carcinoma preoperatively supposed stage I-II|histologically proved endometrial carcinoma preoperatively supposed stage i-ii
639724|NCT00482274|adenocarcinoma of the prostate|adenocarcinoma of the prostate
639725|NCT00482274|recurrent prostate cancer|recurrent prostate cancer
639726|NCT00482274|stage I prostate cancer|stage i prostate cancer
639727|NCT00482274|stage II prostate cancer|stage ii prostate cancer
639728|NCT00482274|stage III prostate cancer|stage iii prostate cancer
639729|NCT00482274|stage IV prostate cancer|stage iv prostate cancer
639730|NCT00482261|myeloma|myeloma
639731|NCT00482261|relapse|relapse
639732|NCT00482261|refractory|refractory
639733|NCT00482261|elderly|elderly
639734|NCT00482261|lenalidomide|lenalidomide
639735|NCT00482248|Asthma|asthma
639736|NCT00482248|anti-immunoglobulin E|anti-immunoglobulin e
639737|NCT00482248|omalizumab|omalizumab
639738|NCT00482248|allergic asthma|allergic asthma
639739|NCT00482222|adenocarcinoma of the colon|adenocarcinoma of the colon
639740|NCT00482222|stage IV colon cancer|stage iv colon cancer
639741|NCT00482222|adenocarcinoma of the rectum|adenocarcinoma of the rectum
639742|NCT00482222|stage IV rectal cancer|stage iv rectal cancer
639743|NCT00482222|liver metastases|liver metastases
639744|NCT00482222|recurrent colon cancer|recurrent colon cancer
639745|NCT00482222|recurrent rectal cancer|recurrent rectal cancer
639746|NCT00482209|mifepristone, misoprostol, medical abortion|mifepristone, misoprostol, medical abortion
639747|NCT00482183|Bare metal stent|bare metal stent
639748|NCT00482183|Major adverse cardiac events|major adverse cardiac events
639749|NCT00482183|Pioglitazone|pioglitazone
639750|NCT00482183|Restenosis|restenosis
639751|NCT00482183|Sirolimus eluting stent|sirolimus eluting stent
639752|NCT00482144|Pulsed-Dye Laser|pulsed-dye laser
639753|NCT00482118|Air Pollution|air pollution
639754|NCT00482118|Tumor Markers|tumor markers
639755|NCT00482118|Genetic Polymorphisms|genetic polymorphisms
639756|NCT00482118|Molecular Epidemiology|molecular epidemiology
639757|NCT00482118|Environmental Epidemiology|environmental epidemiology
639758|NCT00482118|Lung Cancer|lung cancer
639759|NCT00482105|melanoma|melanoma
639760|NCT00482092|Crohn's disease|crohn's disease
639761|NCT00482092|adult stem cell therapy|adult stem cell therapy
639762|NCT00482066|Wegener's granulomatosis|wegener's granulomatosis
639763|NCT00482066|Microscopic polyangiitis|microscopic polyangiitis
639764|NCT00482066|Churg Strauss Syndrome|churg strauss syndrome
639765|NCT00482066|ANCA|anca
639766|NCT00482040|CPAP|cpap
639767|NCT00482040|Preterm|preterm
639768|NCT00482040|Prematurity|prematurity
639769|NCT00482040|Apnea of prematurity|apnea of prematurity
639770|NCT00482027|HIV vaccine|hiv vaccine
639771|NCT00482027|Adeno-associated virus vactored vaccine|adeno-associated virus vactored vaccine
639772|NCT00482027|HIV-1 subtype C|hiv-1 subtype c
639773|NCT00482027|Safety|safety
639774|NCT00482027|Immunogenicity|immunogenicity
639775|NCT00482027|Biodistribution|biodistribution
639776|NCT00482027|HIV prevention|hiv prevention
639777|NCT00482001|Donepezil|donepezil
639778|NCT00482001|Driving|driving
639779|NCT00482001|Cholinesterase Inhibitors|cholinesterase inhibitors
639780|NCT00482001|Geriatric Psychiatry|geriatric psychiatry
639781|NCT00482001|Psychopharmacology|psychopharmacology
639782|NCT00482001|Aricept|aricept
639783|NCT00481988|depression|depression
639880|NCT00481611|Industry Hygiene|industry hygiene
639784|NCT00481988|transcranial direct current stimulation|transcranial direct current stimulation
639785|NCT00481988|direct current stimulation|direct current stimulation
639786|NCT00481988|tdcs|tdcs
639787|NCT00481975|binge eating|binge eating
639788|NCT00481975|eating disorders|eating disorders
639789|NCT00481975|obesity|obesity
639790|NCT00481949|Gastro-oesophageal reflux disease|gastro-oesophageal reflux disease
639791|NCT00481949|pH measurement|ph measurement
639792|NCT00481949|symptom association|symptom association
639793|NCT00481949|wireless pH monitoring system|wireless ph monitoring system
639794|NCT00481949|Functional Heartburn|functional heartburn
639795|NCT00481949|Gastro-esophageal reflux disease|gastro-esophageal reflux disease
639796|NCT00481936|Neoplasms|neoplasms
639797|NCT00481936|Neoplasm, Epithelial|neoplasm, epithelial
639798|NCT00481936|Neoplasm, Glandular|neoplasm, glandular
639799|NCT00481923|hypocaloric diet|hypocaloric diet
639800|NCT00481923|energy intake|energy intake
639801|NCT00481897|overweight|overweight
639802|NCT00481897|obesity|obesity
639803|NCT00481897|type 2 diabetes|type 2 diabetes
639804|NCT00481897|diabetes|diabetes
639805|NCT00481897|worksite cost|worksite cost
639806|NCT00481897|nutrition|nutrition
639807|NCT00481884|Breast Cancer|breast cancer
639808|NCT00481884|Radiation Dermatitis|radiation dermatitis
639809|NCT00481884|RadiaPlexRx Gel|radiaplexrx gel
639810|NCT00481884|Aquaphor|aquaphor
639811|NCT00481871|Lymphoproliferative malignancies|lymphoproliferative malignancies
639812|NCT00481871|Lymphoma|lymphoma
639813|NCT00481871|Hodgkin's lymphoma (HL)|hodgkin's lymphoma (hl)
639814|NCT00481871|Non-Hodgkin's lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
639815|NCT00481871|PTCL|ptcl
639816|NCT00481871|T/NK-cell leukemia/lymphoma|t/nk-cell leukemia/lymphoma
639817|NCT00481871|T-cell lymphoma/leukemia (HTLV 1+)|t-cell lymphoma/leukemia (htlv 1+)
639818|NCT00481871|Angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
639819|NCT00481871|Blastic NK lymphoma|blastic nk lymphoma
639820|NCT00481871|Anaplastic large cell lymphoma|anaplastic large cell lymphoma
639821|NCT00481871|T/NK-cell lymphoma|t/nk-cell lymphoma
639822|NCT00481871|Enteropathy-type intestinal lymphoma|enteropathy-type intestinal lymphoma
639823|NCT00481871|Hepatosplenic T-cell lymphoma|hepatosplenic t-cell lymphoma
639824|NCT00481871|Extranodal peripheral T/NK-cell lymphoma|extranodal peripheral t/nk-cell lymphoma
639825|NCT00481871|Subcutaneous panniculitis T-cell lymphoma|subcutaneous panniculitis t-cell lymphoma
639826|NCT00481871|Transformed mycosis fungoides|transformed mycosis fungoides
639827|NCT00481871|PDX|pdx
639828|NCT00481871|Pralatrexate|pralatrexate
639829|NCT00481871|Gemcitabine|gemcitabine
639830|NCT00481871|Gemzar|gemzar
639831|NCT00481871|Vitamin B12|vitamin b12
639832|NCT00481871|Folic acid|folic acid
639833|NCT00481858|chronic lymphocytic leukemia|chronic lymphocytic leukemia
639834|NCT00481858|biomarker|biomarker
639835|NCT00481858|prognosis|prognosis
639836|NCT00481858|apoptosis|apoptosis
639837|NCT00481858|neoplasm/cancer diagnosis|neoplasm/cancer diagnosis
639838|NCT00481858|stable isotope|stable isotope
639839|NCT00481858|diagnosis evaluation|diagnosis evaluation
639840|NCT00481858|outcomes|outcomes
639841|NCT00481858|CD19|cd19
639842|NCT00481858|CD5|cd5
639843|NCT00481819|Kidney Transplantation|kidney transplantation
639844|NCT00481819|Tacrolimus|tacrolimus
639845|NCT00481819|Methylprednisolone|methylprednisolone
639846|NCT00481819|Prednisolone|prednisolone
639847|NCT00481819|Mycophenolate Mofetil|mycophenolate mofetil
639848|NCT00481806|Virchow's Triad|virchow's triad
639849|NCT00481806|Thrombin|thrombin
639850|NCT00481806|Graft Failure|graft failure
639851|NCT00481793|Plutonium|plutonium
639852|NCT00481793|Ionizing Radiation|ionizing radiation
639853|NCT00481793|Polymorphism|polymorphism
639854|NCT00481793|Biological Marker|biological marker
639855|NCT00481793|Russia|russia
639856|NCT00481767|Safety|safety
639857|NCT00481767|Immunogenicity|immunogenicity
639858|NCT00481767|Human Papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
639859|NCT00481754|Endometrium|endometrium
639860|NCT00481754|PTEN|pten
639861|NCT00481754|Hormones|hormones
639862|NCT00481754|Carcinogenesis|carcinogenesis
639863|NCT00481754|Etiology|etiology
639864|NCT00481754|Tissue Evaluation|tissue evaluation
639865|NCT00481754|Questionnaire|questionnaire
639866|NCT00481741|Angioplasty, Percutaneous TransluminalCoronary|angioplasty, percutaneous transluminalcoronary
639867|NCT00481715|Web-Based Weight Loss Program|web-based weight loss program
639868|NCT00481715|Cash Incentive Weight Loss Program|cash incentive weight loss program
639869|NCT00481715|North Carolina|north carolina
639870|NCT00481689|Cipro|cipro
639871|NCT00481689|Complicated UTI|complicated uti
639872|NCT00481689|Pseudomonas aeruginosa|pseudomonas aeruginosa
639873|NCT00481676|Chronic urticaria, omalizumab, thyroperoxidase, IgE|chronic urticaria, omalizumab, thyroperoxidase, ige
639874|NCT00481637|paraneoplastic; autoimmunity;|paraneoplastic; autoimmunity;
639875|NCT00481624|advanced lung cancer|advanced lung cancer
639876|NCT00481624|Procrit|procrit
639877|NCT00481624|Epoetin Alfa|epoetin alfa
639878|NCT00481624|Ferric Gluconate|ferric gluconate
639879|NCT00481624|iron supplementation|iron supplementation
639881|NCT00481611|Molecular Epidemiology|molecular epidemiology
639882|NCT00481611|Cancer Susceptibility|cancer susceptibility
639883|NCT00481611|Genotoxicity|genotoxicity
639884|NCT00481611|Immune Function|immune function
639885|NCT00481611|Cancer Susceptability|cancer susceptability
639886|NCT00481585|claudin|claudin
639887|NCT00481585|electrophysiology|electrophysiology
639888|NCT00481585|breast|breast
639889|NCT00481585|screening|screening
639890|NCT00481572|Sepsis|sepsis
639891|NCT00481572|Septic Shock|septic shock
639892|NCT00481572|vasopressin|vasopressin
639893|NCT00481572|terlipressin|terlipressin
639894|NCT00481559|Voraxaze|voraxaze
639895|NCT00481559|glucarpidase|glucarpidase
639896|NCT00481559|carboxypeptidase|carboxypeptidase
639897|NCT00481559|cancer|cancer
639898|NCT00481559|lymphoma|lymphoma
639899|NCT00481559|leukemia|leukemia
639900|NCT00481559|osteosarcoma|osteosarcoma
639901|NCT00481559|methotrexate|methotrexate
639902|NCT00481559|delayed elimination|delayed elimination
639903|NCT00481559|renal insufficiency|renal insufficiency
639904|NCT00481559|toxicity|toxicity
639905|NCT00481546|Leber congenital amaurosis|leber congenital amaurosis
639906|NCT00481546|LCA|lca
639907|NCT00481546|RPE65|rpe65
639908|NCT00481546|Retinal disease due to RPE65 mutations|retinal disease due to rpe65 mutations
639909|NCT00481546|RPE65-associated Leber congenital amaurosis|rpe65-associated leber congenital amaurosis
639910|NCT00481533|Cesarean Delivery|cesarean delivery
639911|NCT00481533|Uterine Contractility|uterine contractility
639912|NCT00481507|Probiotic|probiotic
639913|NCT00481507|Cultured dairy drink|cultured dairy drink
639914|NCT00481507|Health|health
639915|NCT00481507|10 day antibiotic|10 day antibiotic
639916|NCT00481507|Otherwise healthy|otherwise healthy
639917|NCT00481494|Glaucoma|glaucoma
639918|NCT00481494|Drug compliance|drug compliance
639919|NCT00481494|Personality|personality
639920|NCT00481481|Tacrolimus, Kidney Transplantation|tacrolimus, kidney transplantation
639921|NCT00481468|Coronary artery disease|coronary artery disease
639922|NCT00481468|chest pain|chest pain
639923|NCT00481455|Glioblastoma Multiforme|glioblastoma multiforme
639924|NCT00481455|temozolomide|temozolomide
639925|NCT00481442|Septic shock|septic shock
639926|NCT00481442|Sepsis|sepsis
639927|NCT00481442|Norepinephrine|norepinephrine
639928|NCT00481442|Phenylephrine|phenylephrine
639929|NCT00481429|Biomarker|biomarker
639930|NCT00481429|Glitazone|glitazone
639931|NCT00481429|Diabetes|diabetes
639932|NCT00481416|Esophageal Varices|esophageal varices
639933|NCT00481416|PillCam Eso|pillcam eso
639934|NCT00481416|Capsule Endoscopy|capsule endoscopy
639935|NCT00481416|Given Imaging|given imaging
639936|NCT00481416|Inscope|inscope
639937|NCT00481403|Sperm, male fertility, microarrays|sperm, male fertility, microarrays
639938|NCT00481390|HIV|hiv
639939|NCT00481390|HLA-B*5701|hla-b*5701
639940|NCT00481390|prevalence|prevalence
639941|NCT00481390|Treatment Experienced|treatment experienced
639942|NCT00481390|Treatment Naive|treatment naive
639943|NCT00481377|Ablation|ablation
639944|NCT00481377|Ventricular tachycardia|ventricular tachycardia
639945|NCT00481377|coronary artery disease|coronary artery disease
639946|NCT00481377|Implantable cardioverter defibrillator interventions|implantable cardioverter defibrillator interventions
639947|NCT00481364|hemodialysis|hemodialysis
639948|NCT00481364|endothelial function|endothelial function
639949|NCT00481364|coronary artery calcification|coronary artery calcification
639950|NCT00481364|atherosclerosis|atherosclerosis
639951|NCT00481364|statin|statin
639952|NCT00481351|artificial chilomicrons kinetics|artificial chilomicrons kinetics
639953|NCT00481351|ezetimibe plus statin|ezetimibe plus statin
639954|NCT00481351|lipid lowering therapy|lipid lowering therapy
639955|NCT00481338|Cohort|cohort
639956|NCT00481338|Quality of life|quality of life
639957|NCT00481338|Health resource use|health resource use
639958|NCT00481338|Disability|disability
639959|NCT00481338|Prognosis|prognosis
639960|NCT00481312|Initial Sedation|initial sedation
639961|NCT00481312|Mechanical ventilation|mechanical ventilation
639962|NCT00481299|Insulin|insulin
639963|NCT00481299|glucose|glucose
639964|NCT00481299|lipids|lipids
639965|NCT00481299|prolactinoma|prolactinoma
639966|NCT00481299|hyperprolactinemia|hyperprolactinemia
639967|NCT00481286|Group clinics|group clinics
639968|NCT00481286|Goal setting|goal setting
639969|NCT00481286|Diabetes|diabetes
639970|NCT00481286|Hypertension|hypertension
639971|NCT00481286|Age 50+|age 50+
639972|NCT00481273|MDS|mds
639973|NCT00481260|Hgb C|hgb c
639974|NCT00481260|Screening|screening
639975|NCT00481247|Chronic Phase Philadelphia Chromosome Positive Chronic Myeloid Leukemia|chronic phase philadelphia chromosome positive chronic myeloid leukemia
639976|NCT00481234|Anesthesia, General|anesthesia, general
639977|NCT00481234|Abnormalities, Cardiovascular|abnormalities, cardiovascular
639978|NCT00481234|Heart Rate|heart rate
639979|NCT00481234|Forecasting|forecasting
639980|NCT00481221|Thalassemia|thalassemia
639981|NCT00481221|Iron Deficiency|iron deficiency
639982|NCT00481221|Carrier screening|carrier screening
640288|NCT00480025|ASCI|asci
639983|NCT00481208|open-angle glaucoma|open-angle glaucoma
639984|NCT00481208|diurnal fluctuation|diurnal fluctuation
639985|NCT00481208|intraocular pressure|intraocular pressure
639986|NCT00481208|peripapillary retinal blood flow|peripapillary retinal blood flow
639987|NCT00481208|latent asymmetric intraocular pressure|latent asymmetric intraocular pressure
639988|NCT00481182|PK|pk
639989|NCT00481182|PD|pd
639990|NCT00481182|FPV|fpv
639991|NCT00481182|RTV|rtv
639992|NCT00481182|APV|apv
639993|NCT00481182|ritonavir|ritonavir
639994|NCT00481182|fosamprenavir|fosamprenavir
639995|NCT00481182|amprenavir|amprenavir
639996|NCT00481182|methadone|methadone
639997|NCT00481182|pharmacokinetics|pharmacokinetics
639998|NCT00481182|pharmacodynamics|pharmacodynamics
639999|NCT00481169|Postmenopausal Osteoporosis|postmenopausal osteoporosis
640000|NCT00481143|Myelodysplastic Syndrome|myelodysplastic syndrome
640001|NCT00481143|MDS|mds
640002|NCT00481143|iron overload|iron overload
640003|NCT00481143|chelation|chelation
640004|NCT00481143|chelators|chelators
640005|NCT00481143|ICL670|icl670
640006|NCT00481143|Deferasirox|deferasirox
640007|NCT00481143|serum ferritin|serum ferritin
640008|NCT00481143|LIC|lic
640009|NCT00481143|transfusional hemosiderosis|transfusional hemosiderosis
640010|NCT00481143|Refractory Anemia|refractory anemia
640011|NCT00481143|RA|ra
640012|NCT00481143|Refractory Anemia with Ringed Sideroblasts|refractory anemia with ringed sideroblasts
640013|NCT00481143|RARS|rars
640014|NCT00481143|blood transfusions|blood transfusions
640015|NCT00481143|Mydelodysplastic Syndrome(s)|mydelodysplastic syndrome(s)
640016|NCT00481130|Alport Syndrome|alport syndrome
640017|NCT00481130|x linked|x linked
640018|NCT00481130|autosomal dominant Alport syndrome|autosomal dominant alport syndrome
640019|NCT00481130|glomerular basement membrane|glomerular basement membrane
640020|NCT00481130|hereditary nephritis|hereditary nephritis
640021|NCT00481130|familial benign haematuria|familial benign haematuria
640022|NCT00481130|type IV collagen|type iv collagen
640023|NCT00481130|hereditary nephritis with neurosensory deafness|hereditary nephritis with neurosensory deafness
640024|NCT00481130|vison loss|vison loss
640025|NCT00481104|Obesity|obesity
640026|NCT00481065|Bird flu|bird flu
640027|NCT00481065|influenza vaccine|influenza vaccine
640028|NCT00481065|Seasonal influenza vaccine|seasonal influenza vaccine
640029|NCT00481065|Prepandemic vaccine|prepandemic vaccine
640030|NCT00481052|Adult|adult
640031|NCT00481052|CML|cml
640032|NCT00481052|Philadelphia positive|philadelphia positive
640033|NCT00481052|Nilotinib|nilotinib
640034|NCT00481052|early chronic phase|early chronic phase
640035|NCT00481052|untreated or treated only with Hydroxyurea or Anagrelide|untreated or treated only with hydroxyurea or anagrelide
640036|NCT00481052|Chronic Myeloid Leukemia|chronic myeloid leukemia
640037|NCT00481039|Sickle cell disease|sickle cell disease
640038|NCT00481039|Sickle cell thalassemia|sickle cell thalassemia
640039|NCT00481039|Population screening|population screening
640040|NCT00481013|Spinal Muscular Atrophy|spinal muscular atrophy
640041|NCT00481013|Adult|adult
640042|NCT00481000|Dialectical Cognitive Therapy|dialectical cognitive therapy
640043|NCT00481000|Clinical Psychology|clinical psychology
640044|NCT00480987|High-Risk Myelodysplastic Syndromes|high-risk myelodysplastic syndromes
640045|NCT00480987|Acute Myeloid Leukemia|acute myeloid leukemia
640046|NCT00480987|Leukemia|leukemia
640047|NCT00480987|Oxaliplatin|oxaliplatin
640048|NCT00480987|Fludarabine|fludarabine
640049|NCT00480987|Cytarabine|cytarabine
640050|NCT00480987|AML|aml
640051|NCT00480987|MDS|mds
640052|NCT00480974|Sickle cell anemia|sickle cell anemia
640053|NCT00480974|Sickle cell thalassemia|sickle cell thalassemia
640054|NCT00480974|Hydroxyurea|hydroxyurea
640055|NCT00480948|infant|infant
640056|NCT00480948|infant formula|infant formula
640057|NCT00480948|fatty acids|fatty acids
640058|NCT00480948|palmitic acid|palmitic acid
640059|NCT00480948|stool|stool
640060|NCT00480948|calcium|calcium
640061|NCT00480935|Localized|localized
640062|NCT00480935|Renal Cell Carcinoma|renal cell carcinoma
640063|NCT00480935|Neoadjuvant|neoadjuvant
640064|NCT00480935|Sunitinib Malate (Sutent)|sunitinib malate (sutent)
640065|NCT00480922|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
640066|NCT00480922|steatohepatitis|steatohepatitis
640067|NCT00480922|overweight|overweight
640068|NCT00480922|insulin resistance|insulin resistance
640069|NCT00480896|Dermatitis, atopic|dermatitis, atopic
640070|NCT00480896|Tacrolimus|tacrolimus
640071|NCT00480896|Child|child
640072|NCT00480896|treatment outcomes|treatment outcomes
640073|NCT00480883|cutaneous leishmaniasis of the old world|cutaneous leishmaniasis of the old world
640074|NCT00480870|Alzheimer|alzheimer
640075|NCT00480870|polysomnography|polysomnography
640076|NCT00480870|REM sleep|rem sleep
640077|NCT00480870|donepezil|donepezil
640078|NCT00480870|sleep apnea|sleep apnea
640079|NCT00480870|oxygen saturation|oxygen saturation
640080|NCT00480857|Prostate|prostate
640081|NCT00480857|Radiation|radiation
640082|NCT00480844|schizophrenia|schizophrenia
640083|NCT00480844|Sertindole|sertindole
640084|NCT00480844|Risperidone|risperidone
640085|NCT00480844|cognitive impairment|cognitive impairment
640086|NCT00480831|NSCLC|nsclc
640087|NCT00480831|Cancer|cancer
640088|NCT00480831|Avastin|avastin
640089|NCT00480831|APM4074g|apm4074g
640090|NCT00480792|Hepatitis B vaccination|hepatitis b vaccination
640091|NCT00480792|GenHevac-B Pasteur|genhevac-b pasteur
640092|NCT00480792|HIV Infections|hiv infections
640093|NCT00480779|Prediabetes|prediabetes
640094|NCT00480779|Metabolic syndrome|metabolic syndrome
640095|NCT00480779|Prevention|prevention
640096|NCT00480779|Lifestyle intervention|lifestyle intervention
640097|NCT00480766|Glucocorticoid|glucocorticoid
640098|NCT00480753|Raynaud's phenomenon|raynaud's phenomenon
640099|NCT00480753|Raynaud's Disease|raynaud's disease
640100|NCT00480753|Raynaud's disease secondary to scleroderma|raynaud's disease secondary to scleroderma
640101|NCT00480753|Raynaud's phenomenon secondary to autoimmune disease|raynaud's phenomenon secondary to autoimmune disease
640102|NCT00480740|Dexmedetomidine|dexmedetomidine
640103|NCT00480740|Congenital heart disease|congenital heart disease
640104|NCT00480740|pharmacokinetics|pharmacokinetics
640105|NCT00480740|pharmacodynamics|pharmacodynamics
640106|NCT00480740|pediatric|pediatric
640107|NCT00480740|Bidirectional cavopulmonary anastomosis|bidirectional cavopulmonary anastomosis
640108|NCT00480740|Fontan physiology|fontan physiology
640109|NCT00480740|Cardiac transplant|cardiac transplant
640110|NCT00480727|Halo Thoracic Orthosis|halo thoracic orthosis
640111|NCT00480727|Re-tension|re-tension
640112|NCT00480727|Pin loosening|pin loosening
640113|NCT00480714|TB|tb
640114|NCT00480714|Vaccine|vaccine
640115|NCT00480714|BCG|bcg
640116|NCT00480701|Alzheimer|alzheimer
640117|NCT00480701|Parkinson|parkinson
640118|NCT00480701|dementia|dementia
640119|NCT00480701|neurologic|neurologic
640120|NCT00480688|TB|tb
640121|NCT00480688|BCG|bcg
640122|NCT00480675|bursitis|bursitis
640123|NCT00480675|injection|injection
640124|NCT00480675|fluoroscopy|fluoroscopy
640125|NCT00480662|Paget's bone disease|paget's bone disease
640126|NCT00480649|SERETIDE|seretide
640127|NCT00480649|asthma|asthma
640128|NCT00480649|Korean|korean
640129|NCT00480649|ACT|act
640130|NCT00480623|Prostate Cancer|prostate cancer
640131|NCT00480623|Biochemical Failure|biochemical failure
640132|NCT00480623|Radical Prostatectomy|radical prostatectomy
640133|NCT00480610|Dermatitis, atopic|dermatitis, atopic
640134|NCT00480610|Tacrolimus|tacrolimus
640136|NCT00480610|treatment outcomes|treatment outcomes
640137|NCT00480597|gemcitabine|gemcitabine
640138|NCT00480597|vinorelbine|vinorelbine
640139|NCT00480597|cisplatin|cisplatin
640140|NCT00480597|capecitabine|capecitabine
640141|NCT00480597|pretreated metastatic breast cancer|pretreated metastatic breast cancer
640142|NCT00480584|pancreatic|pancreatic
640143|NCT00480584|gemcitabine|gemcitabine
640144|NCT00480584|erlotinib (HER1/epidermal growth factor receptor [EGFR] tyrosine kinase inhibitor)|erlotinib (her1/epidermal growth factor receptor [egfr] tyrosine kinase inhibitor)
640145|NCT00480584|capecitabine|capecitabine
640146|NCT00480571|chronic schizophrenia or schizo-affective disorder|chronic schizophrenia or schizo-affective disorder
640147|NCT00480558|HIV|hiv
640148|NCT00480558|MVA85A|mva85a
640149|NCT00480558|TB|tb
640150|NCT00480558|Tuberculosis|tuberculosis
640151|NCT00480558|Human Immunodeficiency Virus|human immunodeficiency virus
640152|NCT00480558|Safety|safety
640153|NCT00480558|Immunogenicity|immunogenicity
640154|NCT00480558|Efficacy|efficacy
640155|NCT00480558|Treatment Naive|treatment naive
640156|NCT00480545|Women with bleeding disorders|women with bleeding disorders
640157|NCT00480545|Menstrual cycle|menstrual cycle
640158|NCT00480545|Women|women
640159|NCT00480545|Healthy volunteers|healthy volunteers
640160|NCT00480532|birth control|birth control
640161|NCT00480532|continuous contraception|continuous contraception
640162|NCT00480532|break-through bleeding|break-through bleeding
640163|NCT00480519|meatotomy|meatotomy
640164|NCT00480519|meatal stenosis|meatal stenosis
640165|NCT00480519|local anaesthesia|local anaesthesia
640166|NCT00480519|feasibility|feasibility
640167|NCT00480519|pain control|pain control
640168|NCT00480506|chimerism|chimerism
640169|NCT00480506|allogenic hematopoietic transplantation|allogenic hematopoietic transplantation
640170|NCT00480506|assay|assay
640171|NCT00480480|Trauma|trauma
640172|NCT00480480|Grief|grief
640173|NCT00480480|Depression|depression
640174|NCT00480480|Adolescent|adolescent
640175|NCT00480480|War|war
640176|NCT00480480|Group|group
640177|NCT00480480|Therapy|therapy
640178|NCT00480480|Treatment|treatment
640179|NCT00480480|Intervention|intervention
640180|NCT00480480|School|school
640181|NCT00480480|Development|development
640182|NCT00480454|TB|tb
640183|NCT00480454|Tuberculosis|tuberculosis
640184|NCT00480454|Infants|infants
640185|NCT00480454|EPI|epi
640186|NCT00480441|Marijuana|marijuana
640187|NCT00480441|Addiction|addiction
640188|NCT00480441|Substance Withdrawal Syndrome|substance withdrawal syndrome
640189|NCT00480441|Clinical Trial|clinical trial
640190|NCT00480441|Dronabinol|dronabinol
640703|NCT00478465|herpes|herpes
640191|NCT00480441|Behavioral Therapy|behavioral therapy
640192|NCT00480441|Adults|adults
640193|NCT00480441|Neuroimaging|neuroimaging
640194|NCT00480441|Neuropsychological Testing|neuropsychological testing
640195|NCT00480441|Neurocognitive Testing|neurocognitive testing
640196|NCT00480441|Behavioral Probes|behavioral probes
640197|NCT00480428|Radioactive Fallout|radioactive fallout
640198|NCT00480428|Childhood Exposures|childhood exposures
640199|NCT00480428|External Radiation Dose|external radiation dose
640200|NCT00480428|Internal Radiation Dose to Thyroid Gland|internal radiation dose to thyroid gland
640201|NCT00480428|Pasture-Dairy Animal- Milk- Thyroid Pathway|pasture-dairy animal- milk- thyroid pathway
640202|NCT00480402|preterm birth|preterm birth
640203|NCT00480402|progesterone|progesterone
640204|NCT00480402|twins|twins
640205|NCT00480402|Preterm birth in twin gestations|preterm birth in twin gestations
640206|NCT00480389|Clear cell Renal cell carcinoma|clear cell renal cell carcinoma
640207|NCT00480389|Metastatic|metastatic
640208|NCT00480389|Sorafenib tosylate|sorafenib tosylate
640209|NCT00480389|Preoperative treatment|preoperative treatment
640210|NCT00480376|transrectal biopsy|transrectal biopsy
640211|NCT00480376|prostate|prostate
640212|NCT00480376|prophylaxis antibiotic|prophylaxis antibiotic
640213|NCT00480363|Smoldering Multiple Myeloma|smoldering multiple myeloma
640214|NCT00480363|PETHEMA|pethema
640215|NCT00480363|Smoldering|smoldering
640216|NCT00480350|HIV|hiv
640217|NCT00480350|virological response|virological response
640218|NCT00480350|CD4|cd4
640219|NCT00480350|food supplement|food supplement
640220|NCT00480350|Human Immunodeficiency Virus|human immunodeficiency virus
640221|NCT00480350|Complementary Therapies|complementary therapies
640222|NCT00480337|PCOS|pcos
640223|NCT00480337|Fertility Preservation|fertility preservation
640224|NCT00480337|Repeated IVF Failure|repeated ivf failure
640225|NCT00480337|S/P Hyperstimulation|s/p hyperstimulation
640226|NCT00480311|symptomatic|symptomatic
640227|NCT00480311|lumbar spinal stenosis|lumbar spinal stenosis
640228|NCT00480311|disability|disability
640229|NCT00480311|fear avoidance beliefs|fear avoidance beliefs
640230|NCT00480311|quality of life|quality of life
640231|NCT00480285|Gastroesophageal reflux disease|gastroesophageal reflux disease
640232|NCT00480285|Laparoscopic Nissen Fundoplication|laparoscopic nissen fundoplication
640233|NCT00480285|Laparoscopic anterior partial fundoplication|laparoscopic anterior partial fundoplication
640234|NCT00480272|rheumatoid arthritis|rheumatoid arthritis
640235|NCT00480272|clinical remission|clinical remission
640236|NCT00480259|blood urea nitrogen|blood urea nitrogen
640237|NCT00480259|nitrogen balance|nitrogen balance
640238|NCT00480259|nutrition|nutrition
640239|NCT00480259|intensive care|intensive care
640240|NCT00480246|receptor oocupancy|receptor oocupancy
640241|NCT00480233|depression|depression
640242|NCT00480233|screening|screening
640243|NCT00480233|primary care|primary care
640244|NCT00480233|validity|validity
640245|NCT00480233|Hebrew|hebrew
640246|NCT00480233|Primary care and general medical patients|primary care and general medical patients
640247|NCT00480220|specific care|specific care
640248|NCT00480220|assistance plan|assistance plan
640249|NCT00480220|Alzheimer's disease|alzheimer's disease
640250|NCT00480181|Neuropathic pain|neuropathic pain
640251|NCT00480181|Multiple Sclerosis|multiple sclerosis
640252|NCT00480181|Nabilone|nabilone
640253|NCT00480181|Gabapentin|gabapentin
640254|NCT00480168|child|child
640255|NCT00480168|adolescent|adolescent
640256|NCT00480168|weight gain|weight gain
640257|NCT00480168|endocrine disruptors|endocrine disruptors
640258|NCT00480129|grass allergies,|grass allergies,
640259|NCT00480129|ragweed allergies,|ragweed allergies,
640260|NCT00480129|probiotics, lactobacillus,|probiotics, lactobacillus,
640261|NCT00480129|bifidobacterium,|bifidobacterium,
640262|NCT00480129|functional foods,|functional foods,
640263|NCT00480129|yogurt,|yogurt,
640264|NCT00480129|inflammatory cytokines|inflammatory cytokines
640265|NCT00480116|Consistency|consistency
640266|NCT00480116|Immunogenicity|immunogenicity
640267|NCT00480103|Embryo morphological and chromosomal features|embryo morphological and chromosomal features
640268|NCT00480103|Implantation and pregnancy rate|implantation and pregnancy rate
640269|NCT00480090|Prostate|prostate
640270|NCT00480090|Androgen independent|androgen independent
640271|NCT00480090|Phase II|phase ii
640272|NCT00480090|Second line|second line
640273|NCT00480090|Androgen-independent prostate cancer|androgen-independent prostate cancer
640274|NCT00480077|Heart Failure, randomized, OptiVol® Fluid status monitoring|heart failure, randomized, optivol® fluid status monitoring
640275|NCT00480064|AML|aml
640276|NCT00480064|older patients|older patients
640277|NCT00480064|lomustine|lomustine
640278|NCT00480051|Cardiac Failure|cardiac failure
640279|NCT00480051|Pacemaker|pacemaker
640280|NCT00480051|Dyssynchrony|dyssynchrony
640281|NCT00480051|Cardiac Magnetic Resonance|cardiac magnetic resonance
640282|NCT00480051|Narrow QRS|narrow qrs
640283|NCT00480038|symptomatic|symptomatic
640284|NCT00480038|lumbar disc herniation|lumbar disc herniation
640285|NCT00480038|disability|disability
640286|NCT00480038|fear avoidance beliefs|fear avoidance beliefs
640287|NCT00480038|quality of life|quality of life
640289|NCT00480025|Immunotherapeutic|immunotherapeutic
640290|NCT00480025|MAGRIT|magrit
640291|NCT00480025|Tumor antigen|tumor antigen
640292|NCT00480025|Non-small-cell lung cancer|non-small-cell lung cancer
640293|NCT00480025|Adjuvant cancer therapy|adjuvant cancer therapy
640294|NCT00480012|healthy subjects|healthy subjects
640295|NCT00479999|HIV-Negative|hiv-negative
640296|NCT00479999|Healthy|healthy
640297|NCT00479999|Immunity|immunity
640298|NCT00479999|Preventive|preventive
640299|NCT00479999|Virus|virus
640300|NCT00479999|Healthy Volunteer|healthy volunteer
640301|NCT00479999|HV|hv
640302|NCT00479999|HIV Preventive Vaccine|hiv preventive vaccine
640303|NCT00479986|diabetes mellitus|diabetes mellitus
640304|NCT00479986|monocyte activation|monocyte activation
640305|NCT00479986|cardiovascular risk|cardiovascular risk
640306|NCT00479973|diabetes|diabetes
640307|NCT00479973|non-insulin dependant diabetes|non-insulin dependant diabetes
640308|NCT00479973|type 2 diabetes|type 2 diabetes
640309|NCT00479973|cinnamon|cinnamon
640310|NCT00479973|natural health product|natural health product
640311|NCT00479973|hypercholesterolemia|hypercholesterolemia
640312|NCT00479973|dyslipidemia|dyslipidemia
640313|NCT00479973|elevated cholesterol|elevated cholesterol
640314|NCT00479960|Asthenozoospermia|asthenozoospermia
640315|NCT00479960|Azoospermia|azoospermia
640316|NCT00479960|Oligospermia|oligospermia
640317|NCT00479960|Omega-3|omega-3
640318|NCT00479960|Fatty Acids|fatty acids
640319|NCT00479947|Yeast vaginitis|yeast vaginitis
640320|NCT00479947|Probiotics|probiotics
640321|NCT00479947|Lactobacilli|lactobacilli
640322|NCT00479947|Fluconazole|fluconazole
640323|NCT00479934|scleroderma|scleroderma
640324|NCT00479934|imatinib|imatinib
640325|NCT00479934|PDGFR|pdgfr
640326|NCT00479934|Rodnan|rodnan
640327|NCT00479921|Influenza|influenza
640328|NCT00479921|Vaccine|vaccine
640329|NCT00479921|CHMP criteria|chmp criteria
640330|NCT00479908|Blood pressure|blood pressure
640331|NCT00479908|Angina|angina
640332|NCT00479908|Sildenafil|sildenafil
640333|NCT00479908|Phosphodiesterase type 5|phosphodiesterase type 5
640334|NCT00479908|Organic nitrate|organic nitrate
640335|NCT00479908|Glyceryl trinitrate|glyceryl trinitrate
640336|NCT00479908|Drug interaction|drug interaction
640337|NCT00479895|Percutaneous Coronary Intervention|percutaneous coronary intervention
640338|NCT00479895|Myocardial Ischemia|myocardial ischemia
640339|NCT00479895|Balloon Occlusion|balloon occlusion
640340|NCT00479895|Catheter Lab|catheter lab
640341|NCT00479856|ErbB1|erbb1
640342|NCT00479856|ErbB2|erbb2
640343|NCT00479856|GW572016|gw572016
640344|NCT00479856|lapatinib|lapatinib
640345|NCT00479856|Relapsed breast cancer|relapsed breast cancer
640346|NCT00479856|dual tyrosine kinase inhibitor|dual tyrosine kinase inhibitor
640347|NCT00479856|MBC|mbc
640348|NCT00479856|EGFR|egfr
640349|NCT00479856|Her-2/neu|her-2/neu
640350|NCT00479856|FISH amplification|fish amplification
640351|NCT00479843|Alzheimer Disease|alzheimer disease
640352|NCT00479843|Dementia|dementia
640353|NCT00479843|Elderly|elderly
640354|NCT00479843|Nutrition|nutrition
640355|NCT00479843|Malnutrition|malnutrition
640356|NCT00479843|Weight Loss|weight loss
640357|NCT00479830|Epidemiology|epidemiology
640358|NCT00479830|Health Risks|health risks
640359|NCT00479830|Questionnaire|questionnaire
640360|NCT00479830|Interview|interview
640361|NCT00479830|South Asian|south asian
640362|NCT00479830|Asian Indian|asian indian
640363|NCT00479830|Bangladeshi|bangladeshi
640364|NCT00479830|Pakistani|pakistani
640365|NCT00479830|Sri Lankan|sri lankan
640366|NCT00479817|Advanced Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|advanced recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer
640367|NCT00479804|indication for CMR|indication for cmr
640368|NCT00479791|Type 2 diabetes mellitus|type 2 diabetes mellitus
640369|NCT00479791|Fatty acids|fatty acids
640370|NCT00479791|Postprandial response|postprandial response
640371|NCT00479791|Insulin|insulin
640372|NCT00479791|Glucose|glucose
640373|NCT00479791|Triglycerides|triglycerides
640374|NCT00479778|Postmenopause|postmenopause
640375|NCT00479765|glioblastoma multiforme|glioblastoma multiforme
640376|NCT00479765|recurrent|recurrent
640377|NCT00479765|Phase 1|phase 1
640378|NCT00479765|Phase 2|phase 2
640379|NCT00479765|Phase I|phase i
640380|NCT00479765|Phase II|phase ii
640381|NCT00479765|brain|brain
640382|NCT00479765|cancer|cancer
640383|NCT00479765|paclitaxel|paclitaxel
640384|NCT00479765|intracranial|intracranial
640385|NCT00479765|tumor|tumor
640386|NCT00479765|local|local
640387|NCT00479765|chemotherapy|chemotherapy
640388|NCT00479765|brain tumor|brain tumor
640389|NCT00479765|brain cancer|brain cancer
640390|NCT00479765|glioma|glioma
640391|NCT00479765|OncoGel|oncogel
640392|NCT00479739|formoterol/budesonide|formoterol/budesonide
640393|NCT00479739|exacerbations|exacerbations
640394|NCT00479739|Salmeterol/fluticasone propionate|salmeterol/fluticasone propionate
640395|NCT00479739|adjustable maintenance dosing|adjustable maintenance dosing
640396|NCT00479739|asthma control|asthma control
640397|NCT00479713|High Cholesterol|high cholesterol
640398|NCT00479687|Osteoarthritis|osteoarthritis
640399|NCT00479687|Shoulder|shoulder
640400|NCT00479687|HA|ha
640401|NCT00479674|Metastatic Breast Cancer|metastatic breast cancer
640402|NCT00479674|Advanced Breast Cancer|advanced breast cancer
640403|NCT00479674|Hormone Receptor AND Her2/neu Negative|hormone receptor and her2/neu negative
640404|NCT00479674|Triple Negative|triple negative
640405|NCT00479674|Triple Negative Breast Cancer|triple negative breast cancer
640406|NCT00479674|Stage IV or Inoperable Stage III Breast Cancer|stage iv or inoperable stage iii breast cancer
640407|NCT00479661|initial sedation|initial sedation
640408|NCT00479661|mechanical ventilation|mechanical ventilation
640409|NCT00479635|HRPC|hrpc
640410|NCT00479635|TPI 287|tpi 287
640411|NCT00479635|Taxane|taxane
640412|NCT00479635|MDR|mdr
640413|NCT00479635|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
640414|NCT00479622|Membranous Nephropathy|membranous nephropathy
640415|NCT00479622|Systemic Lupus Erythematosus|systemic lupus erythematosus
640416|NCT00479609|Insulin resistance|insulin resistance
640417|NCT00479609|Glucose tolerance|glucose tolerance
640418|NCT00479609|Type 2 diabetes|type 2 diabetes
640419|NCT00479609|Androgen sensitivity|androgen sensitivity
640420|NCT00479596|Overactive Bladder|overactive bladder
640421|NCT00479596|OAB|oab
640422|NCT00479596|Refractory OAB|refractory oab
640423|NCT00479596|Botox|botox
640424|NCT00479596|Bladder|bladder
640425|NCT00479583|Cancer (solid tumors)|cancer (solid tumors)
640426|NCT00479557|Alzheimer's Disease|alzheimer's disease
640427|NCT00479557|active immunization|active immunization
640428|NCT00479531|Restless Legs Syndrome|restless legs syndrome
640429|NCT00479531|Sequential Compression Device|sequential compression device
640430|NCT00479531|Sleep Quality|sleep quality
640431|NCT00479531|Quality of Life|quality of life
640432|NCT00479518|stroke|stroke
640433|NCT00479518|transient ischemic attack|transient ischemic attack
640434|NCT00479518|albuminuria|albuminuria
640435|NCT00479518|BNP|bnp
640436|NCT00479518|Cystatin C|cystatin c
640437|NCT00479492|Obesity, weight loss|obesity, weight loss
640438|NCT00479479|cobalamin|cobalamin
640439|NCT00479479|methylmalonic acid|methylmalonic acid
640440|NCT00479479|homocysteine|homocysteine
640441|NCT00479479|folate|folate
640442|NCT00479479|newborns|newborns
640443|NCT00479479|infants|infants
640444|NCT00479479|Deficiency Disease|deficiency disease
640445|NCT00479479|Breastfeeding|breastfeeding
640446|NCT00479479|Infant|infant
640447|NCT00479427|osteoarthritis pain assessments|osteoarthritis pain assessments
640448|NCT00479375|screening|screening
640449|NCT00479375|human papillomavirus|human papillomavirus
640450|NCT00479362|Pacemaker|pacemaker
640451|NCT00479362|Cardioverter-defibrillator|cardioverter-defibrillator
640452|NCT00479362|Hemorrhage|hemorrhage
640453|NCT00479362|Hematoma|hematoma
640454|NCT00479362|Thrombosis|thrombosis
640455|NCT00479362|Embolism|embolism
640456|NCT00479336|OPC-41061|opc-41061
640457|NCT00479336|Tolvaptan|tolvaptan
640458|NCT00479336|ascites|ascites
640459|NCT00479336|Cirrhosis|cirrhosis
640460|NCT00479323|pneumococcal vaccine, Pneumovax, reference sera, serum 89SF|pneumococcal vaccine, pneumovax, reference sera, serum 89sf
640461|NCT00479284|Non-invasive ventilation|non-invasive ventilation
640462|NCT00479284|Polysomnography|polysomnography
640463|NCT00479284|Average volume assured pressure support|average volume assured pressure support
640464|NCT00479271|RCT|rct
640465|NCT00479271|Dementia|dementia
640466|NCT00479271|community trial|community trial
640467|NCT00479271|Homebased care|homebased care
640468|NCT00479271|caregiver burden|caregiver burden
640469|NCT00479271|Behavioural problems|behavioural problems
640470|NCT00479271|Dementia in subjects|dementia in subjects
640471|NCT00479271|behavioral problems in subjects|behavioral problems in subjects
640472|NCT00479271|Mental health of carers|mental health of carers
640473|NCT00479245|nonspecific low back pain|nonspecific low back pain
640474|NCT00479245|disability|disability
640475|NCT00479245|fear avoidance beliefs|fear avoidance beliefs
640476|NCT00479245|quality of life|quality of life
640477|NCT00479232|Leukemia|leukemia
640478|NCT00479232|Myelocytic|myelocytic
640479|NCT00479232|Acute Myelodysplastic Syndromes|acute myelodysplastic syndromes
640480|NCT00479206|artesuante|artesuante
640481|NCT00479206|falciparum malaria|falciparum malaria
640482|NCT00479206|Cambodia|cambodia
640483|NCT00479206|Artemisinin resistance|artemisinin resistance
640484|NCT00479193|Burns|burns
640485|NCT00479193|Dressing change|dressing change
640486|NCT00479180|Hemodialysis access|hemodialysis access
640487|NCT00479180|Arteriovenous graft|arteriovenous graft
640488|NCT00479180|Arteriovenous fistula|arteriovenous fistula
640489|NCT00479180|End stage renal disease|end stage renal disease
640490|NCT00479167|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
640491|NCT00479167|Follicular Non-Hodgkin's Lymphoma|follicular non-hodgkin's lymphoma
640492|NCT00479167|Lymphoma|lymphoma
640493|NCT00479154|Restless Leg Syndrome|restless leg syndrome
640494|NCT00479154|Botulinum Toxin|botulinum toxin
640495|NCT00479154|RLS|rls
640496|NCT00479141|Treatment Naive|treatment naive
640497|NCT00479141|Treatment Experienced|treatment experienced
640498|NCT00479141|Complementary Therapies|complementary therapies
640499|NCT00479128|Solid Tumor|solid tumor
640500|NCT00479128|Bladder Cancer|bladder cancer
640501|NCT00479128|Ureteral Cancer|ureteral cancer
640502|NCT00479128|Urothelial Cancer|urothelial cancer
640503|NCT00479128|Urethral Cancer|urethral cancer
640504|NCT00479128|Renal Pelvis Tumor|renal pelvis tumor
640505|NCT00479128|Bortezomib|bortezomib
640506|NCT00479128|Gemcitabine|gemcitabine
640507|NCT00479128|Doxorubicin|doxorubicin
640508|NCT00479128|Gemzar|gemzar
640509|NCT00479128|Adriamycin|adriamycin
640510|NCT00479128|Velcade|velcade
640511|NCT00479128|LDP-341|ldp-341
640512|NCT00479128|MLN341|mln341
640513|NCT00479128|PS-341|ps-341
640641|NCT00478686|Xeloda|xeloda
640514|NCT00479128|Gemcitabine Hydrochloride|gemcitabine hydrochloride
640515|NCT00479128|AD|ad
640516|NCT00479128|Hydroxydaunomycin hydrochloride|hydroxydaunomycin hydrochloride
640517|NCT00479102|Iron supplementation|iron supplementation
640518|NCT00479102|Babies|babies
640519|NCT00479102|Prevention|prevention
640520|NCT00479089|Transitional Cell Carcinoma|transitional cell carcinoma
640521|NCT00479089|Urothelium|urothelium
640522|NCT00479089|Urothelial Cancer|urothelial cancer
640523|NCT00479089|Bladder Cancer|bladder cancer
640524|NCT00479089|Docetaxel|docetaxel
640525|NCT00479089|Taxotere|taxotere
640526|NCT00479089|ZD1839|zd1839
640527|NCT00479089|Gefitinib|gefitinib
640528|NCT00479089|Iressa|iressa
640529|NCT00479089|Consolidation Therapy|consolidation therapy
640530|NCT00479076|antineoplastic agents|antineoplastic agents
640531|NCT00479076|VEGF Trap|vegf trap
640532|NCT00479063|MODIC changes|modic changes
640533|NCT00479063|chronic low back pain|chronic low back pain
640534|NCT00479063|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
640535|NCT00479063|vertebrae|vertebrae
640536|NCT00479063|intervertebral disc|intervertebral disc
640537|NCT00479050|Hepatocellular carcinoma,treatment|hepatocellular carcinoma,treatment
640538|NCT00479037|postmenopausal women with primary osteoporosis|postmenopausal women with primary osteoporosis
640539|NCT00479011|fluid management|fluid management
640540|NCT00479011|arterial pulse pressure variation|arterial pulse pressure variation
640541|NCT00479011|high-risk surgery|high-risk surgery
640542|NCT00478998|expulsion therapy|expulsion therapy
640543|NCT00478998|tamsulosin|tamsulosin
640544|NCT00478998|ureterolithiasis|ureterolithiasis
640545|NCT00478998|stents|stents
640546|NCT00478985|Leukemia|leukemia
640547|NCT00478985|Adult Chronic|adult chronic
640548|NCT00478985|Myeloid|myeloid
640549|NCT00478972|obese|obese
640550|NCT00478972|diabetes|diabetes
640551|NCT00478972|cannabinoid-1 receptor|cannabinoid-1 receptor
640552|NCT00478959|Lenalidomide|lenalidomide
640553|NCT00478959|Revlimid|revlimid
640554|NCT00478959|Hodgkin's|hodgkin's
640555|NCT00478959|Hodgkin|hodgkin
640556|NCT00478959|Hodgkin's Lymphoma|hodgkin's lymphoma
640557|NCT00478959|Hodgkin's Disease|hodgkin's disease
640558|NCT00478959|Lymphoma|lymphoma
640559|NCT00478946|colorectal cancer|colorectal cancer
640560|NCT00478946|picoplatin|picoplatin
640561|NCT00478946|FOLFOX|folfox
640562|NCT00478946|FOLPI|folpi
640563|NCT00478946|chemotherapy|chemotherapy
640564|NCT00478933|Arrhythmia|arrhythmia
640565|NCT00478933|Ventricular|ventricular
640566|NCT00478933|Atrial|atrial
640567|NCT00478933|Tachycardia|tachycardia
640568|NCT00478933|Fibrillation|fibrillation
640569|NCT00478933|Flutter|flutter
640570|NCT00478933|GNB3|gnb3
640571|NCT00478933|GNAS|gnas
640572|NCT00478933|GNAQ|gnaq
640573|NCT00478907|oculocardiac reflex; strabismus surgery;|oculocardiac reflex; strabismus surgery;
640574|NCT00478894|Anterior cruciate ligament / injuries|anterior cruciate ligament / injuries
640575|NCT00478894|Anterior cruciate ligament / surgery|anterior cruciate ligament / surgery
640576|NCT00478894|knee injuries / surgery|knee injuries / surgery
640577|NCT00478894|outcomes research|outcomes research
640578|NCT00478894|prospective studies|prospective studies
640579|NCT00478894|osteoarthritis|osteoarthritis
640580|NCT00478868|MODIC changes|modic changes
640581|NCT00478868|chronic low back pain|chronic low back pain
640582|NCT00478868|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
640583|NCT00478868|vertebrae|vertebrae
640584|NCT00478868|intervertebral disc|intervertebral disc
640585|NCT00478842|Gilles de la Tourette syndrome|gilles de la tourette syndrome
640586|NCT00478842|Deep brain stimulation|deep brain stimulation
640587|NCT00478842|Globus PALLIDUS|globus pallidus
640588|NCT00478816|Bird flu|bird flu
640589|NCT00478816|influenza vaccine|influenza vaccine
640590|NCT00478816|prepandemic vaccine|prepandemic vaccine
640591|NCT00478803|Standardized surgical procedure|standardized surgical procedure
640592|NCT00478803|Aortic root aneurysm|aortic root aneurysm
640593|NCT00478803|Dystrophic aortic insufficiency|dystrophic aortic insufficiency
640594|NCT00478803|Conservative aortic valve surgery|conservative aortic valve surgery
640595|NCT00478803|Aortic annuloplasty|aortic annuloplasty
640596|NCT00478803|Mechanical aortic valve replacement|mechanical aortic valve replacement
640597|NCT00478803|Sinus of Valsalva|sinus of valsalva
640598|NCT00478803|Cardiac Surgical Procedures|cardiac surgical procedures
640599|NCT00478790|Glaucoma|glaucoma
640600|NCT00478790|Pterygium|pterygium
640601|NCT00478790|collagen matrix|collagen matrix
640602|NCT00478790|OculusGen|oculusgen
640603|NCT00478790|trabeculectomy|trabeculectomy
640604|NCT00478790|Anti scarring|anti scarring
640605|NCT00478790|pterygium recurrence|pterygium recurrence
640606|NCT00478790|tissue engineering|tissue engineering
640607|NCT00478790|ologen|ologen
640608|NCT00478790|Aeon Astron|aeon astron
640609|NCT00478777|CC-5013|cc-5013
640610|NCT00478777|Revlimid|revlimid
640611|NCT00478777|Lenalidomide|lenalidomide
640612|NCT00478777|Celgene|celgene
640613|NCT00478777|Multiple Myeloma|multiple myeloma
640614|NCT00478764|intraocular|intraocular
640615|NCT00478764|triamcinolone|triamcinolone
640616|NCT00478764|gatifloxicin|gatifloxicin
640617|NCT00478764|inflammation|inflammation
640618|NCT00478764|visual acuity|visual acuity
640619|NCT00478751|Visible light, Long UVA,Pigmentation|visible light, long uva,pigmentation
640620|NCT00478751|Normal healthy volunteers with dark skin type.|normal healthy volunteers with dark skin type.
640621|NCT00478738|b-agonist,|b-agonist,
640622|NCT00478738|COPD.|copd.
640623|NCT00478738|pharmacodynamic,|pharmacodynamic,
640624|NCT00478738|pharmacokinetic,|pharmacokinetic,
640625|NCT00478738|anti muscarinic,|anti muscarinic,
640626|NCT00478725|Metastatic Cancer|metastatic cancer
640627|NCT00478725|Advanced Cancer|advanced cancer
640628|NCT00478712|Hirschsprung|hirschsprung
640629|NCT00478699|SCAT|scat
640630|NCT00478699|BRCA1|brca1
640631|NCT00478699|BRCA1 mRNA Levels|brca1 mrna levels
640632|NCT00478699|ADJUVANT|adjuvant
640633|NCT00478699|LUNG|lung
640634|NCT00478699|GECP-SCAT|gecp-scat
640635|NCT00478686|Breast Cancer|breast cancer
640636|NCT00478686|Dihydropyrimidine Dehydrogenase|dihydropyrimidine dehydrogenase
640637|NCT00478686|DPYD|dpyd
640638|NCT00478686|DPYD Variants|dpyd variants
640639|NCT00478686|Toxicity|toxicity
640640|NCT00478686|Capecitabine|capecitabine
640642|NCT00478673|NexStent|nexstent
640643|NCT00478673|FilterWire EZ|filterwire ez
640644|NCT00478673|Boston Scientific|boston scientific
640645|NCT00478673|Carotid Artery|carotid artery
640646|NCT00478673|Carotid Endarterectomy|carotid endarterectomy
640647|NCT00478673|Carotid Revascularization|carotid revascularization
640648|NCT00478647|Enzyme Replacement Therapy|enzyme replacement therapy
640649|NCT00478647|Gaucher disease|gaucher disease
640650|NCT00478647|glucocerebrosidase|glucocerebrosidase
640651|NCT00478647|beta-glucocerebrosidase|beta-glucocerebrosidase
640652|NCT00478647|Acid beta-glucocerebrosidase|acid beta-glucocerebrosidase
640653|NCT00478647|glucosylceramidase|glucosylceramidase
640654|NCT00478647|D-glucosyl-N-acylsphingosine glucohydrolase|d-glucosyl-n-acylsphingosine glucohydrolase
640655|NCT00478647|gene activation|gene activation
640657|NCT00478634|Colorectal Cancer|colorectal cancer
640658|NCT00478634|Colorectal Carcinoma|colorectal carcinoma
640659|NCT00478634|Colorectal Tumors|colorectal tumors
640660|NCT00478634|Neoplasms, Colorectal|neoplasms, colorectal
640661|NCT00478621|HPV|hpv
640662|NCT00478595|obese|obese
640663|NCT00478595|diabetes|diabetes
640664|NCT00478595|cannabinoid-1 receptor|cannabinoid-1 receptor
640665|NCT00478582|Anemia|anemia
640666|NCT00478582|Visual scale|visual scale
640667|NCT00478582|nephrological patients|nephrological patients
640668|NCT00478582|Anemia in nephrological patients|anemia in nephrological patients
640669|NCT00478556|CT scan|ct scan
640670|NCT00478556|oral contrast|oral contrast
640671|NCT00478543|Loop diuretics|loop diuretics
640672|NCT00478543|Chronic Kidney Disease|chronic kidney disease
640673|NCT00478543|Hypertension|hypertension
640674|NCT00478543|Blood pressure control|blood pressure control
640675|NCT00478543|Left ventricular mass|left ventricular mass
640676|NCT00478517|Spinal trauma|spinal trauma
640677|NCT00478517|erythropoietin|erythropoietin
640678|NCT00478517|dose escalation study|dose escalation study
640679|NCT00478504|anovulation|anovulation
640680|NCT00478504|ovulation induction,|ovulation induction,
640681|NCT00478504|polycystic ovarian syndrome|polycystic ovarian syndrome
640682|NCT00478504|clomifene citrate|clomifene citrate
640683|NCT00478504|letrozole|letrozole
640684|NCT00478478|Stroke|stroke
640685|NCT00478478|Ischemic|ischemic
640686|NCT00478478|Thrombus|thrombus
640687|NCT00478478|Embolectomy|embolectomy
640688|NCT00478478|Thrombectomy|thrombectomy
640689|NCT00478478|Merci|merci
640690|NCT00478478|Concentric|concentric
640691|NCT00478478|Embolus|embolus
640692|NCT00478478|Embolism|embolism
640693|NCT00478478|Mechanical|mechanical
640694|NCT00478465|chronic fatigue syndrome|chronic fatigue syndrome
640695|NCT00478465|fatigue|fatigue
640696|NCT00478465|valganciclovir|valganciclovir
640697|NCT00478465|valcyte|valcyte
640698|NCT00478465|Epstein-Barr virus|epstein-barr virus
640699|NCT00478465|EBV|ebv
640700|NCT00478465|Human herpes virus 6|human herpes virus 6
640701|NCT00478465|HHV 6|hhv 6
640702|NCT00478465|herpes viruses|herpes viruses
640704|NCT00478439|aging|aging
640705|NCT00478439|age-related macular degeneration|age-related macular degeneration
640706|NCT00478439|macular pigment|macular pigment
640707|NCT00478439|dark adaptation|dark adaptation
640708|NCT00478400|Recovery|recovery
640709|NCT00478400|Magnetic resonance imaging|magnetic resonance imaging
640710|NCT00478400|Awareness|awareness
640711|NCT00478400|Neurologic deficits|neurologic deficits
640712|NCT00478387|Advanced Ovarian and Primary Peritoneal Cancer in Remission|advanced ovarian and primary peritoneal cancer in remission
640713|NCT00478348|Postoperative Complications|postoperative complications
640714|NCT00478348|Drainage|drainage
640715|NCT00478348|Infection|infection
640716|NCT00478348|Seroma|seroma
640717|NCT00478348|Hematoma|hematoma
640718|NCT00478348|Recurrence|recurrence
640719|NCT00478348|Abdominal Wall|abdominal wall
640720|NCT00478348|Hernia|hernia
640721|NCT00478348|Surgical Mesh|surgical mesh
640722|NCT00478335|congenital nephrogenic diabetes insipidus|congenital nephrogenic diabetes insipidus
640723|NCT00478335|polyuria|polyuria
640724|NCT00478335|urine osmolality|urine osmolality
640725|NCT00478335|aquaporin-2|aquaporin-2
640726|NCT00478335|vasopressin V2 receptor|vasopressin v2 receptor
640727|NCT00478322|Diabetes;|diabetes;
640728|NCT00478322|Type II diabetes;|type ii diabetes;
640729|NCT00478322|Non-insulin dependent diabetes;|non-insulin dependent diabetes;
640730|NCT00478322|Obesity|obesity
640731|NCT00478309|colon cancer|colon cancer
640732|NCT00478309|rectal cancer|rectal cancer
640733|NCT00478309|healthy, no evidence of disease|healthy, no evidence of disease
640734|NCT00478296|Pulmonary hypertension|pulmonary hypertension
640735|NCT00478296|Sildenafil|sildenafil
640736|NCT00478296|Bosentan|bosentan
640737|NCT00478296|Trisomy 21|trisomy 21
640738|NCT00478296|Atrial septal defect|atrial septal defect
640739|NCT00478283|breast cancer|breast cancer
640740|NCT00478257|fatigue|fatigue
640741|NCT00478257|sleep|sleep
640742|NCT00478257|quality of life|quality of life
640743|NCT00478257|light|light
640744|NCT00478257|cancer|cancer
640745|NCT00478244|epidermolysis bullosa|epidermolysis bullosa
640746|NCT00478244|dystrophic epidermolysis bullosa|dystrophic epidermolysis bullosa
640747|NCT00478231|Multicenter|multicenter
640748|NCT00478231|Open Label|open label
640749|NCT00478231|Non-Comparative Safety Study Of Maraviroc|non-comparative safety study of maraviroc
640750|NCT00478231|Treatment Experienced|treatment experienced
640751|NCT00478218|stage I multiple myeloma|stage i multiple myeloma
640752|NCT00478218|stage II multiple myeloma|stage ii multiple myeloma
640753|NCT00478218|stage III multiple myeloma|stage iii multiple myeloma
640754|NCT00478205|Moderate to Severe Alzheimer's Disease|moderate to severe alzheimer's disease
640755|NCT00478192|hyponatremia|hyponatremia
640756|NCT00478192|hypervolemic|hypervolemic
640757|NCT00478192|euvolemic|euvolemic
640758|NCT00478192|edematous|edematous
640759|NCT00478192|conivaptan|conivaptan
640760|NCT00478179|herpes zoster|herpes zoster
640761|NCT00478179|shingles|shingles
640762|NCT00478179|PHN|phn
640763|NCT00478179|post herpetic neuralgia|post herpetic neuralgia
640764|NCT00478179|neuropathic pain|neuropathic pain
640765|NCT00478114|Renal Cell Carcinoma|renal cell carcinoma
640766|NCT00478114|Sorafenib|sorafenib
640767|NCT00478101|Pain|pain
640768|NCT00478088|Single Level|single level
640769|NCT00478088|Cervical Disc Disease|cervical disc disease
640770|NCT00478075|stage I multiple myeloma|stage i multiple myeloma
640771|NCT00478075|stage II multiple myeloma|stage ii multiple myeloma
640772|NCT00478075|stage III multiple myeloma|stage iii multiple myeloma
640773|NCT00478075|refractory multiple myeloma|refractory multiple myeloma
640774|NCT00478062|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
640775|NCT00478062|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
640776|NCT00478062|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
640777|NCT00478062|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
640778|NCT00478049|Non-Small Cell Lung Cancer|non-small cell lung cancer
640779|NCT00478036|glaucoma|glaucoma
640780|NCT00478036|selective laser trabeculoplasty|selective laser trabeculoplasty
640781|NCT00478036|anterior chamber flare|anterior chamber flare
640782|NCT00478023|Opioid|opioid
640783|NCT00478023|Central acting analgesic|central acting analgesic
640784|NCT00478023|Pain postoperative|pain postoperative
640785|NCT00478023|Abdomen acute|abdomen acute
640786|NCT00478023|CG5503 IR|cg5503 ir
640787|NCT00478023|Morphine|morphine
640788|NCT00478023|Placebo|placebo
640789|NCT00478010|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
640790|NCT00478010|stage III colon cancer|stage iii colon cancer
640791|NCT00478010|stage IV colon cancer|stage iv colon cancer
640792|NCT00478010|stage III rectal cancer|stage iii rectal cancer
640793|NCT00478010|stage IV rectal cancer|stage iv rectal cancer
640794|NCT00478010|stage II pancreatic cancer|stage ii pancreatic cancer
640795|NCT00478010|stage III pancreatic cancer|stage iii pancreatic cancer
640796|NCT00478010|stage IV pancreatic cancer|stage iv pancreatic cancer
640797|NCT00477997|Growth Hormone|growth hormone
640798|NCT00477997|Insulin Signaling|insulin signaling
640799|NCT00477997|GH signaling|gh signaling
640800|NCT00477984|Alcohol|alcohol
640801|NCT00477984|Driving|driving
640802|NCT00477984|Multitasking|multitasking
640803|NCT00477984|ERP|erp
640804|NCT00477984|social drinkers|social drinkers
640805|NCT00477971|primary systemic amyloidosis|primary systemic amyloidosis
640806|NCT00477958|cognitive/functional effects|cognitive/functional effects
640807|NCT00477958|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
640808|NCT00477958|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
640809|NCT00477945|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
640810|NCT00477945|High Risk or Refractory Non Hodgkin's Lymphoma|high risk or refractory non hodgkin's lymphoma
640811|NCT00477945|APBSCT|apbsct
640812|NCT00477945|clofarabine|clofarabine
640813|NCT00477932|Pentalogy of Cantrell|pentalogy of cantrell
640814|NCT00477932|mutations|mutations
640815|NCT00477932|DNA|dna
640816|NCT00477932|RNA|rna
640817|NCT00477919|stage IV melanoma|stage iv melanoma
640818|NCT00477919|stage IV renal cell cancer|stage iv renal cell cancer
640819|NCT00477919|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
640820|NCT00477919|advanced malignant mesothelioma|advanced malignant mesothelioma
640821|NCT00477919|stage IV prostate cancer|stage iv prostate cancer
640822|NCT00477919|adult giant cell glioblastoma|adult giant cell glioblastoma
640823|NCT00477919|adult gliosarcoma|adult gliosarcoma
640824|NCT00477919|extensive stage small cell lung cancer|extensive stage small cell lung cancer
640825|NCT00477919|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
640826|NCT00477919|stage IV colon cancer|stage iv colon cancer
640827|NCT00477919|stage IV gastric cancer|stage iv gastric cancer
640828|NCT00477919|stage IV esophageal cancer|stage iv esophageal cancer
640829|NCT00477919|stage IV bladder cancer|stage iv bladder cancer
640830|NCT00477919|male breast cancer|male breast cancer
640831|NCT00477919|stage IV breast cancer|stage iv breast cancer
640832|NCT00477919|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
640833|NCT00477919|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
640834|NCT00477919|ovarian sarcoma|ovarian sarcoma
640835|NCT00477919|ovarian stromal cancer|ovarian stromal cancer
640836|NCT00477919|fatigue|fatigue
640837|NCT00477919|anorexia|anorexia
640838|NCT00477919|cachexia|cachexia
640839|NCT00477919|pain|pain
640840|NCT00477919|weight changes|weight changes
640841|NCT00477919|depression|depression
640842|NCT00477919|poor performance status|poor performance status
640843|NCT00477919|recurrent adult brain tumor|recurrent adult brain tumor
640844|NCT00477919|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
640845|NCT00477919|advanced adult primary liver cancer|advanced adult primary liver cancer
640846|NCT00477919|recurrent adult primary liver cancer|recurrent adult primary liver cancer
640847|NCT00477919|recurrent small cell lung cancer|recurrent small cell lung cancer
640848|NCT00477919|recurrent bladder cancer|recurrent bladder cancer
640849|NCT00477919|recurrent breast cancer|recurrent breast cancer
640850|NCT00477919|recurrent colon cancer|recurrent colon cancer
640851|NCT00477919|recurrent esophageal cancer|recurrent esophageal cancer
640852|NCT00477919|recurrent gastric cancer|recurrent gastric cancer
640853|NCT00477919|recurrent melanoma|recurrent melanoma
640854|NCT00477919|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
640855|NCT00477919|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
640856|NCT00477919|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
640857|NCT00477919|stage IV pancreatic cancer|stage iv pancreatic cancer
640858|NCT00477919|recurrent prostate cancer|recurrent prostate cancer
640859|NCT00477919|recurrent renal cell cancer|recurrent renal cell cancer
640860|NCT00477919|recurrent pancreatic cancer|recurrent pancreatic cancer
640861|NCT00477919|stage IV rectal cancer|stage iv rectal cancer
640862|NCT00477919|recurrent rectal cancer|recurrent rectal cancer
640863|NCT00477919|recurrent malignant mesothelioma|recurrent malignant mesothelioma
640864|NCT00477919|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
640865|NCT00477919|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
640866|NCT00477919|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
640867|NCT00477919|stage IV uterine sarcoma|stage iv uterine sarcoma
640868|NCT00477919|recurrent uterine sarcoma|recurrent uterine sarcoma
640869|NCT00477919|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
640870|NCT00477919|unresectable gallbladder cancer|unresectable gallbladder cancer
640871|NCT00477919|recurrent gallbladder cancer|recurrent gallbladder cancer
640872|NCT00477919|adult glioblastoma|adult glioblastoma
640873|NCT00477906|melanoma|melanoma
640874|NCT00477906|vaccine|vaccine
640875|NCT00477906|metastatic|metastatic
640876|NCT00477906|autologous|autologous
640877|NCT00477880|gastric cancer|gastric cancer
640878|NCT00477880|giant hypertrophic gastritis|giant hypertrophic gastritis
640879|NCT00477867|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
640880|NCT00477841|esophageal Cancer|esophageal cancer
640881|NCT00477841|Dysphagia|dysphagia
640882|NCT00477841|Stent|stent
641009|NCT00477334|Black population|black population
640883|NCT00477841|interstitial brachytherapy|interstitial brachytherapy
640884|NCT00477828|sleep apnea|sleep apnea
640885|NCT00477828|dementia|dementia
640886|NCT00477828|excessive sleepiness|excessive sleepiness
640887|NCT00477828|cognition|cognition
640888|NCT00477815|stage I multiple myeloma|stage i multiple myeloma
640889|NCT00477815|refractory multiple myeloma|refractory multiple myeloma
640890|NCT00477815|stage II multiple myeloma|stage ii multiple myeloma
640891|NCT00477815|stage III multiple myeloma|stage iii multiple myeloma
640892|NCT00477802|Parkinson's disease|parkinson's disease
640893|NCT00477802|levodopa-induced cervical dyskinesias|levodopa-induced cervical dyskinesias
640894|NCT00477789|chronic heart failure|chronic heart failure
640895|NCT00477789|diastolic dysfunction|diastolic dysfunction
640896|NCT00477789|uric acid|uric acid
640897|NCT00477776|Beginning of breastfeeding|beginning of breastfeeding
640898|NCT00477750|stage I multiple myeloma|stage i multiple myeloma
640899|NCT00477750|stage II multiple myeloma|stage ii multiple myeloma
640900|NCT00477750|stage III multiple myeloma|stage iii multiple myeloma
640901|NCT00477737|cardioprotection|cardioprotection
640902|NCT00477737|sevoflurane|sevoflurane
640903|NCT00477737|esophageal Doppler|esophageal doppler
640904|NCT00477737|thermodilution|thermodilution
640905|NCT00477737|coronary artery bypass|coronary artery bypass
640906|NCT00477724|latent|latent
640907|NCT00477711|Cetuximab|cetuximab
640908|NCT00477711|cisplatin|cisplatin
640909|NCT00477711|capecitabine|capecitabine
640910|NCT00477711|first line treatment|first line treatment
640911|NCT00477685|Glaucoma|glaucoma
640912|NCT00477685|Collagen matrix|collagen matrix
640913|NCT00477685|OculusGen|oculusgen
640914|NCT00477685|Phacotrabeculectomy|phacotrabeculectomy
640915|NCT00477685|anti scarring|anti scarring
640916|NCT00477685|tissue engineering|tissue engineering
640917|NCT00477685|ologen|ologen
640918|NCT00477685|Aeon Astron|aeon astron
640919|NCT00477672|Parkinson's disease, psychotic disorders|parkinson's disease, psychotic disorders
640920|NCT00477659|fMRI study; open-label donepezil|fmri study; open-label donepezil
640921|NCT00477646|colon cancer|colon cancer
640922|NCT00477646|rectal cancer|rectal cancer
640923|NCT00477646|breast cancer|breast cancer
640924|NCT00477646|cervical cancer|cervical cancer
640925|NCT00477633|Contraception|contraception
640926|NCT00477620|Myopia|myopia
640927|NCT00477620|Prevention|prevention
640928|NCT00477594|Familial Hypercholesterolemia|familial hypercholesterolemia
640929|NCT00477594|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
640930|NCT00477594|Homozygous Familial Hypercholesterolemia|homozygous familial hypercholesterolemia
640931|NCT00477594|ISIS 301012|isis 301012
640932|NCT00477594|mipomersen|mipomersen
640933|NCT00477594|Open Label Extension|open label extension
640934|NCT00477581|diabetes|diabetes
640935|NCT00477581|exenatide|exenatide
640936|NCT00477581|sitagliptin|sitagliptin
640937|NCT00477581|Amylin|amylin
640938|NCT00477581|Lilly|lilly
640939|NCT00477568|Wheelchair users|wheelchair users
640940|NCT00477568|Back pain|back pain
640941|NCT00477568|Prevalence|prevalence
640942|NCT00477568|Risk factors|risk factors
640943|NCT00477555|aortic valve|aortic valve
640944|NCT00477555|concomitant procedures|concomitant procedures
640945|NCT00477555|porcine bioprosthesis|porcine bioprosthesis
640946|NCT00477555|stented valve|stented valve
640947|NCT00477542|Clofarabine|clofarabine
640948|NCT00477542|allogeneic HSCT|allogeneic hsct
640949|NCT00477542|refractory malignancies|refractory malignancies
640950|NCT00477503|Central Nervous System Tumors|central nervous system tumors
640951|NCT00477503|Brain Tumors|brain tumors
640952|NCT00477503|Leptomeningeal Metastasis|leptomeningeal metastasis
640953|NCT00477503|Cerebral Spinal Fluid|cerebral spinal fluid
640954|NCT00477503|Human CSF Flow|human csf flow
640955|NCT00477503|Nuclear Imaging|nuclear imaging
640956|NCT00477503|Gallium-67 Citrate|gallium-67 citrate
640957|NCT00477503|In-111 DTPA|in-111 dtpa
640958|NCT00477477|overweight|overweight
640959|NCT00477477|metabolic syndrome|metabolic syndrome
640960|NCT00477477|adolescent|adolescent
640961|NCT00477477|cardiovascular|cardiovascular
640962|NCT00477477|risk factors|risk factors
640963|NCT00477477|hypertension|hypertension
640964|NCT00477477|dyslipidemia|dyslipidemia
640965|NCT00477477|inflammation|inflammation
640966|NCT00477477|coagulopathy|coagulopathy
640967|NCT00477464|dual kinase inhibitor,|dual kinase inhibitor,
640968|NCT00477464|EGFR/ErbB1,|egfr/erbb1,
640969|NCT00477464|ErbB2-overexpressing,|erbb2-overexpressing,
640970|NCT00477464|GW572016,|gw572016,
640971|NCT00477464|advanced/metastatic breast cancer, Lapatinib,|advanced/metastatic breast cancer, lapatinib,
640972|NCT00477464|HER-2/new,|her-2/new,
640973|NCT00477464|pharmacokinetics|pharmacokinetics
640974|NCT00477451|Staccato™ Alprazolam, Panic Attack, Inhaled alprazolam|staccato™ alprazolam, panic attack, inhaled alprazolam
640975|NCT00477425|Avastin|avastin
640976|NCT00477412|Mantle Cell Lymphoma|mantle cell lymphoma
640977|NCT00477412|Lymphoma|lymphoma
640978|NCT00477412|Bortezomib|bortezomib
640979|NCT00477412|LDP-341|ldp-341
640980|NCT00477412|MLN341|mln341
640981|NCT00477412|Velcade|velcade
640982|NCT00477412|Cyclophosphamide|cyclophosphamide
640983|NCT00477412|Neosar|neosar
640984|NCT00477412|Cytoxan|cytoxan
640985|NCT00477412|Doxorubicin|doxorubicin
640986|NCT00477412|Adriamycin|adriamycin
640987|NCT00477412|Rubex|rubex
640988|NCT00477412|Rituximab|rituximab
640989|NCT00477412|Vincristine|vincristine
640990|NCT00477412|Methotrexate|methotrexate
640991|NCT00477412|Cytarabine|cytarabine
640992|NCT00477412|Cytosar|cytosar
640993|NCT00477412|DepoCyt|depocyt
640994|NCT00477412|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
640995|NCT00477412|Mesna|mesna
640996|NCT00477412|Dexamethasone|dexamethasone
640997|NCT00477399|Obesity|obesity
640998|NCT00477399|Weight loss maintenance|weight loss maintenance
641000|NCT00477399|Life Style|life style
641001|NCT00477399|Follow Up|follow up
641002|NCT00477386|recurrent ovarian cancer|recurrent ovarian cancer
641003|NCT00477386|platinum resistant|platinum resistant
641004|NCT00477386|decitabine|decitabine
641005|NCT00477347|Liver Transplantation|liver transplantation
641006|NCT00477347|Anesthesia, general|anesthesia, general
641007|NCT00477347|Closed-loop|closed-loop
641008|NCT00477334|Recurrent genital herpes|recurrent genital herpes
641010|NCT00477321|Interleukin 7|interleukin 7
641011|NCT00477321|Immune Reconstitution|immune reconstitution
641012|NCT00477321|T Cell Turnover|t cell turnover
641013|NCT00477321|CD4 Lymphenia|cd4 lymphenia
641014|NCT00477321|Immune-Based Therapies|immune-based therapies
641015|NCT00477321|HIV Infection|hiv infection
641016|NCT00477308|HIV children|hiv children
641017|NCT00477308|genotypic resistance|genotypic resistance
641018|NCT00477308|dual NRTIs|dual nrtis
641019|NCT00477308|Salvage therapy|salvage therapy
641020|NCT00477308|treatment outcome|treatment outcome
641021|NCT00477308|Salvage therapy based on genotyping results|salvage therapy based on genotyping results
641022|NCT00477308|Treatment Failure|treatment failure
641023|NCT00477295|Epilepsy|epilepsy
641024|NCT00477282|Ovarian|ovarian
641025|NCT00477282|Cancer|cancer
641026|NCT00477282|Advanced Ovarian Cancer|advanced ovarian cancer
641027|NCT00477269|Pulmonary Arterial Hypertension, tyrosine kinase inhibitor, STI571|pulmonary arterial hypertension, tyrosine kinase inhibitor, sti571
641028|NCT00477256|Pediatric Cancer|pediatric cancer
641029|NCT00477256|Child Adjustment|child adjustment
641030|NCT00477256|School Reintegration|school reintegration
641031|NCT00477256|Caregiver|caregiver
641032|NCT00477256|Questionnaire|questionnaire
641033|NCT00477256|Quality of Life|quality of life
641034|NCT00477256|Survey|survey
641035|NCT00477243|Advanced Cancer|advanced cancer
641036|NCT00477243|Palliative Care Patients|palliative care patients
641037|NCT00477243|Spirituality|spirituality
641038|NCT00477243|Locus of Control|locus of control
641039|NCT00477243|Questionnaire|questionnaire
641040|NCT00477230|AF|af
641041|NCT00477230|PAF|paf
641042|NCT00477230|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
641043|NCT00477230|ablation|ablation
641044|NCT00477230|failed drugs|failed drugs
641045|NCT00477217|Osteonecrosis|osteonecrosis
641046|NCT00477217|zoledronic acid|zoledronic acid
641047|NCT00477217|knee|knee
641048|NCT00477204|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
641049|NCT00477204|dyslipidemia|dyslipidemia
641050|NCT00477204|adolescents|adolescents
641051|NCT00477191|psoriasis|psoriasis
641052|NCT00477191|metabolic syndrome|metabolic syndrome
641053|NCT00477191|Syndrome X|syndrome x
641054|NCT00477191|diabetes|diabetes
641055|NCT00477191|insulin resistance|insulin resistance
641056|NCT00477191|obesity|obesity
641057|NCT00477191|hypertension|hypertension
641058|NCT00477191|hyperlipidemia|hyperlipidemia
641059|NCT00477191|hypercholesterolemia|hypercholesterolemia
641060|NCT00477178|possible problems using codeine when driving|possible problems using codeine when driving
641061|NCT00477165|Irritable bowel syndrome|irritable bowel syndrome
641062|NCT00477165|Antidepressant|antidepressant
641063|NCT00477165|IBS|ibs
641064|NCT00477165|Serotonin-reuptake inhibitor|serotonin-reuptake inhibitor
641065|NCT00477165|SSRI|ssri
641066|NCT00477165|Visceral sensitivity|visceral sensitivity
641067|NCT00477165|Barostat|barostat
641068|NCT00477165|Quality of life|quality of life
641069|NCT00477165|Depression|depression
641070|NCT00477152|dehydration|dehydration
641071|NCT00477152|fluid therapy|fluid therapy
641072|NCT00477152|pediatrics|pediatrics
641073|NCT00477152|emergency medicine|emergency medicine
641074|NCT00477152|hyaluronoglucosaminidase|hyaluronoglucosaminidase
641075|NCT00477152|hyaluronidase|hyaluronidase
641076|NCT00477152|hypodermoclysis|hypodermoclysis
641077|NCT00477152|clysis|clysis
641078|NCT00477152|subcutaneous hydration|subcutaneous hydration
641079|NCT00477152|subcutaneous rehydration|subcutaneous rehydration
641080|NCT00477152|hyaluronan|hyaluronan
641081|NCT00477152|rHuPH20|rhuph20
641082|NCT00477126|ritonavir generic capsule|ritonavir generic capsule
641083|NCT00477126|Norvir®|norvir®
641084|NCT00477126|Thailand|thailand
641085|NCT00477126|Determine bioequivalence between Norvir and GPO ritonavir|determine bioequivalence between norvir and gpo ritonavir
641086|NCT00477113|natalizumab|natalizumab
641087|NCT00477113|MS|ms
641088|NCT00477113|Tysabri|tysabri
641089|NCT00477113|Multiple Sclerosis|multiple sclerosis
641090|NCT00477113|TYGRIS|tygris
641091|NCT00477100|Inflammatory Breast Cancer|inflammatory breast cancer
641092|NCT00477100|Cancer Registry|cancer registry
641093|NCT00477100|Core Biopsy|core biopsy
641094|NCT00477100|Skin Biopsy|skin biopsy
641095|NCT00477100|IBC|ibc
641096|NCT00477074|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
641097|NCT00477074|emphysema|emphysema
641098|NCT00477074|inflammation|inflammation
641099|NCT00477074|repair|repair
641100|NCT00477061|MORPHINE|morphine
641101|NCT00477061|ANALGESIA|analgesia
641102|NCT00477061|ACUTE APPENDICITS|acute appendicits
641103|NCT00477048|IDV nephrotoxicity|idv nephrotoxicity
641104|NCT00477022|Diabetic Foot Ulcer|diabetic foot ulcer
641105|NCT00477022|Vacuum compression therapy|vacuum compression therapy
641106|NCT00477022|Stereology|stereology
641107|NCT00477022|Ulcer Area|ulcer area
641108|NCT00477022|Vasotrain|vasotrain
641109|NCT00477022|Random Controlled Trial.|random controlled trial.
641110|NCT00477009|Sleep apnea syndromes|sleep apnea syndromes
641111|NCT00477009|Snoring|snoring
641112|NCT00477009|Mandibular advancement|mandibular advancement
641113|NCT00477009|Activator appliances|activator appliances
641114|NCT00477009|Disorders of excessive somnolence|disorders of excessive somnolence
641115|NCT00477009|Blood pressure|blood pressure
641116|NCT00477009|Inflammation|inflammation
641117|NCT00477009|Oxidative stress|oxidative stress
641118|NCT00477009|Hormones|hormones
641119|NCT00477009|Markers of Metabolic Syndrome X|markers of metabolic syndrome x
641120|NCT00476996|RA|ra
641121|NCT00476996|SCRIPT|script
641122|NCT00476996|anti-CD20|anti-cd20
641123|NCT00476996|CD20|cd20
641124|NCT00476983|saquinavir/ritonavir 1500/100 mg once daily|saquinavir/ritonavir 1500/100 mg once daily
641125|NCT00476970|Colorectal Cancer|colorectal cancer
641126|NCT00476970|Cancer Screening|cancer screening
641127|NCT00476970|Patient Navigation|patient navigation
641128|NCT00476970|Low English Proficiency|low english proficiency
641129|NCT00476957|Drug Eluting Stents|drug eluting stents
641130|NCT00476957|Interventional Cardiology|interventional cardiology
641131|NCT00476944|CAD|cad
641132|NCT00476944|Coronary Artery Disease|coronary artery disease
641133|NCT00476944|Angiomax|angiomax
641134|NCT00476944|Bivalirudin|bivalirudin
641135|NCT00476944|PCI|pci
641136|NCT00476944|MAVE|mave
641137|NCT00476944|Heparin|heparin
641138|NCT00476931|Diabetic neuropathy|diabetic neuropathy
641139|NCT00476931|Diabetes Type 1 or 2|diabetes type 1 or 2
641140|NCT00476931|Moderate to severe sensorimotor diabetic polyneuropathy|moderate to severe sensorimotor diabetic polyneuropathy
641141|NCT00476931|Unmeasurable nerve conduction velocity|unmeasurable nerve conduction velocity
641142|NCT00476918|diabetic macular edema|diabetic macular edema
641143|NCT00476918|triamcinolone acetonide|triamcinolone acetonide
641144|NCT00476918|intravitreal|intravitreal
641145|NCT00476918|steroid|steroid
641146|NCT00476905|Basal Cell Carcinoma|basal cell carcinoma
641147|NCT00476905|Squamous Cell Carcinoma|squamous cell carcinoma
641148|NCT00476905|Pre-Cancer Lesions|pre-cancer lesions
641149|NCT00476905|Pigmented Lesions|pigmented lesions
641150|NCT00476905|Benign Lesions|benign lesions
641151|NCT00476905|Skin Cancer|skin cancer
641152|NCT00476905|Spectral Diagnosis|spectral diagnosis
641153|NCT00476905|Optical Spectroscopy|optical spectroscopy
641154|NCT00476892|Pelvic organ prolapse|pelvic organ prolapse
641155|NCT00476892|Pelvic floor muscle training|pelvic floor muscle training
641156|NCT00476892|Prolapse symptoms|prolapse symptoms
641157|NCT00476892|Urinary symptoms|urinary symptoms
641158|NCT00476892|Sexual function|sexual function
641159|NCT00476892|randomised controlled trial|randomised controlled trial
641160|NCT00476879|Growth hormone|growth hormone
641161|NCT00476879|Fasting|fasting
641162|NCT00476879|Signaltransduction|signaltransduction
641163|NCT00476879|fatty liver|fatty liver
641164|NCT00476879|insulin sensitivity|insulin sensitivity
641165|NCT00476879|forearm model|forearm model
641166|NCT00476879|protein metabolism|protein metabolism
641167|NCT00476879|respiratory quotient|respiratory quotient
641168|NCT00476866|Paraplegia|paraplegia
641169|NCT00476866|tetraplegia|tetraplegia
641170|NCT00476866|lung compliance|lung compliance
641171|NCT00476866|work of breathing|work of breathing
641172|NCT00476866|hyperinflation|hyperinflation
641173|NCT00476866|rehabilitation|rehabilitation
641174|NCT00476853|HIV-TB|hiv-tb
641175|NCT00476853|nevirapine based HAART with rifampin treated TB|nevirapine based haart with rifampin treated tb
641176|NCT00476853|Compare PK profile, efficacy, safety and tolerability of HAART containing nevirapine 400mg/day versus 600 mg/day in HIV/TB co-infected patients|compare pk profile, efficacy, safety and tolerability of haart containing nevirapine 400mg/day versus 600 mg/day in hiv/tb co-infected patients
641177|NCT00476853|Treatment Naive|treatment naive
641178|NCT00476827|Breast Cancer|breast cancer
641179|NCT00476827|Metastatic|metastatic
641180|NCT00476827|Brain|brain
641181|NCT00476827|Anti-angiogenesis|anti-angiogenesis
641182|NCT00476814|cystic fibrosis,|cystic fibrosis,
641183|NCT00476814|nasal potential difference,|nasal potential difference,
641184|NCT00476814|primary sclerosing cholangitis|primary sclerosing cholangitis
641185|NCT00476801|UVA1|uva1
641186|NCT00476801|scleroderma|scleroderma
641187|NCT00476801|keloids|keloids
641188|NCT00476801|light therapy|light therapy
641189|NCT00476801|morphea|morphea
641190|NCT00476788|pediatrics|pediatrics
641191|NCT00476788|CSII|csii
641192|NCT00476788|diabetes|diabetes
641193|NCT00476788|C-peptide|c-peptide
641194|NCT00476788|adverse events|adverse events
641195|NCT00476775|obesity|obesity
641196|NCT00476775|prevention|prevention
641197|NCT00476775|girls|girls
641198|NCT00476775|Latina/Hispanic|latina/hispanic
641199|NCT00476775|Dance|dance
641200|NCT00476775|television|television
641201|NCT00476775|screen time|screen time
641202|NCT00476736|COPD|copd
641203|NCT00476736|Pulmonary function|pulmonary function
641204|NCT00476736|Air trapping|air trapping
641205|NCT00476736|Acetyl cystein|acetyl cystein
641206|NCT00476723|HIV infection|hiv infection
641207|NCT00476723|Hepatitis coinfection|hepatitis coinfection
641208|NCT00476710|Type 2 diabetes mellitus|type 2 diabetes mellitus
641209|NCT00476710|Bile acid|bile acid
641210|NCT00476710|Stable isotope|stable isotope
641211|NCT00476710|Colesevelam HCl|colesevelam hcl
641212|NCT00476710|Impaired Glucose Tolerance|impaired glucose tolerance
641213|NCT00476697|UVA1|uva1
641214|NCT00476697|scleroderma|scleroderma
641215|NCT00476697|keloids|keloids
641216|NCT00476697|morphea|morphea
641217|NCT00476697|light therapy|light therapy
641218|NCT00476684|radiofrequency|radiofrequency
641219|NCT00476671|neuropsychiatric|neuropsychiatric
641220|NCT00476671|neurocognitive|neurocognitive
641221|NCT00476671|psychiatric|psychiatric
641222|NCT00476671|HIV related dementia|hiv related dementia
641223|NCT00476671|MCMD|mcmd
641224|NCT00476671|HIV-1|hiv-1
641225|NCT00476671|Prevalence, risk factors of neurocognitive impairment and psychiatric comorbidities in HIV-1 infected patients with undetectable viral load in the HAART era.|prevalence, risk factors of neurocognitive impairment and psychiatric comorbidities in hiv-1 infected patients with undetectable viral load in the haart era.
641226|NCT00476671|Treatment Experienced|treatment experienced
641227|NCT00476658|Obesity|obesity
641228|NCT00476658|macrophage infiltration|macrophage infiltration
641229|NCT00476658|insulinoresistance|insulinoresistance
641230|NCT00476658|inflammation|inflammation
641231|NCT00476632|Epidemiology|epidemiology
641232|NCT00476632|Questionnaire|questionnaire
641233|NCT00476632|Controls|controls
641234|NCT00476619|Contrast|contrast
641235|NCT00476619|Nephropathy|nephropathy
641236|NCT00476619|acute renal failure|acute renal failure
641237|NCT00476619|Erythropoietin|erythropoietin
641238|NCT00476619|CT scan|ct scan
641239|NCT00476606|HIV children|hiv children
641240|NCT00476606|HAART|haart
641241|NCT00476606|ARV|arv
641242|NCT00476606|Second line HAART|second line haart
641243|NCT00476606|Viral Load|viral load
641244|NCT00476606|Combination drug|combination drug
641245|NCT00476606|Treatment Experienced|treatment experienced
641246|NCT00476606|Treatment Naive|treatment naive
641247|NCT00476593|Uveitis|uveitis
641248|NCT00476593|Iritis|iritis
641249|NCT00476593|Macular Thickness|macular thickness
641250|NCT00476593|HLA-B27 related|hla-b27 related
641251|NCT00476593|Macular edema|macular edema
641252|NCT00476593|Macular thickening|macular thickening
641253|NCT00476593|OCT|oct
641254|NCT00476593|mfERG|mferg
641255|NCT00476593|Eye drops|eye drops
641256|NCT00476593|Dexamethosone|dexamethosone
641257|NCT00476593|Diclofenac|diclofenac
641258|NCT00476593|Retinal aging|retinal aging
641259|NCT00476580|Sri Lankan Sinhalese|sri lankan sinhalese
641260|NCT00476580|Epidemiology|epidemiology
641261|NCT00476580|Cancer Risk|cancer risk
641262|NCT00476580|US Migrant|us migrant
641263|NCT00476580|Questionnaire|questionnaire
641264|NCT00476580|Survey|survey
641265|NCT00476580|Acculturation|acculturation
641266|NCT00476580|Health and Cancer Risks|health and cancer risks
641267|NCT00476580|Health Habits|health habits
641268|NCT00476567|exercise|exercise
641269|NCT00476567|pregnancy|pregnancy
641270|NCT00476567|prevention|prevention
641271|NCT00476567|pregnancy-related diseases|pregnancy-related diseases
641272|NCT00476567|labor|labor
641273|NCT00476567|complications|complications
641274|NCT00476567|physiotherapy|physiotherapy
641275|NCT00476554|CTCL|ctcl
641276|NCT00476541|AML|aml
641277|NCT00476541|Children|children
641278|NCT00476541|Gemtuzumab ozogamicin|gemtuzumab ozogamicin
641279|NCT00476541|Stem cell transplantation|stem cell transplantation
641280|NCT00476528|Posttraumatic amnesia|posttraumatic amnesia
641281|NCT00476528|Early intervention|early intervention
641282|NCT00476528|A systematic nursing programme in the ICU|a systematic nursing programme in the icu
641283|NCT00476528|Early identification of patients with posttraumatic amnesia|early identification of patients with posttraumatic amnesia
641284|NCT00476515|Kidney transplantation|kidney transplantation
641285|NCT00476515|Donor specific antibodies|donor specific antibodies
641286|NCT00476515|Positive cross match|positive cross match
641287|NCT00476502|genetic polymorphism|genetic polymorphism
641288|NCT00476502|CYP 3A|cyp 3a
641289|NCT00476502|MDR-1|mdr-1
641290|NCT00476502|Thai|thai
641291|NCT00476502|HIV|hiv
641292|NCT00476502|Treatment Experienced|treatment experienced
641293|NCT00476489|secondary adrenal insuffiency|secondary adrenal insuffiency
641294|NCT00476489|hypothalamus-pituitary-adrenal axis impairement|hypothalamus-pituitary-adrenal axis impairement
641295|NCT00476489|topical steroids|topical steroids
641296|NCT00476476|Tarceva|tarceva
641297|NCT00476476|erlotinib|erlotinib
641298|NCT00476476|squamous cell carcinoma of the vulvar|squamous cell carcinoma of the vulvar
641299|NCT00476463|TDF+FTC|tdf+ftc
641300|NCT00476463|FTC|ftc
641301|NCT00476463|HIV/HBV|hiv/hbv
641302|NCT00476463|TDF compared to TDF+FTC in HIV/HBV|tdf compared to tdf+ftc in hiv/hbv
641303|NCT00476463|Treatment Naive|treatment naive
641304|NCT00476450|Oral Microbial Flora|oral microbial flora
641305|NCT00476450|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
641306|NCT00476450|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
641307|NCT00476424|once daily Efavirenz 400 mg|once daily efavirenz 400 mg
641308|NCT00476424|PK once daily Efavirenz 400 mg versus 600 mg|pk once daily efavirenz 400 mg versus 600 mg
641309|NCT00476424|Treatment Experienced|treatment experienced
641310|NCT00476411|isolated HBc|isolated hbc
641311|NCT00476411|HBV vaccine response|hbv vaccine response
641312|NCT00476411|occult HBV in isolated antiHBC compared HIV to non HIV|occult hbv in isolated antihbc compared hiv to non hiv
641313|NCT00476398|Capsule endoscopy|capsule endoscopy
641314|NCT00476398|Wireless imaging|wireless imaging
641315|NCT00476398|esophagus|esophagus
641316|NCT00476398|stomach|stomach
641317|NCT00476372|neuropsychology|neuropsychology
641318|NCT00476372|cognitive impairment|cognitive impairment
641319|NCT00476372|motor disorder|motor disorder
641320|NCT00476372|parkinson's disease|parkinson's disease
641321|NCT00476359|Lopinavir/r|lopinavir/r
641322|NCT00476359|Saquinavir|saquinavir
641323|NCT00476359|Dual boosted PIs|dual boosted pis
641324|NCT00476359|Pharmacokinetics|pharmacokinetics
641325|NCT00476359|HIV children|hiv children
641326|NCT00476359|C min|c min
641327|NCT00476359|Second line HAART|second line haart
641328|NCT00476359|ARV|arv
641329|NCT00476359|VL failure|vl failure
641330|NCT00476359|Dosage|dosage
641331|NCT00476359|To evaluate treatment response|to evaluate treatment response
641332|NCT00476359|Treatment Experienced|treatment experienced
641333|NCT00476346|physical training|physical training
641334|NCT00476346|military training|military training
641335|NCT00476346|bone|bone
641336|NCT00476346|fracture prevention|fracture prevention
641337|NCT00476346|young adult|young adult
641338|NCT00476333|EMG|emg
641339|NCT00476333|Kinetics|kinetics
641340|NCT00476333|Kinematics|kinematics
641341|NCT00476333|Perturbation|perturbation
641342|NCT00476333|Footwear|footwear
641343|NCT00476320|echocardiography|echocardiography
641344|NCT00476320|myocardial infarction|myocardial infarction
641345|NCT00476320|magnetic resonance imaging|magnetic resonance imaging
641346|NCT00476320|revascularization|revascularization
641347|NCT00476320|viability|viability
641348|NCT00476307|Flu vaccine|flu vaccine
641349|NCT00476294|Multiple Myeloma|multiple myeloma
641350|NCT00476294|Disease-Free Survival|disease-free survival
641351|NCT00476294|AMD3100|amd3100
641352|NCT00476294|G-CSF|g-csf
641353|NCT00476294|Autologous Transplantation|autologous transplantation
641354|NCT00476255|child safety restraint|child safety restraint
641355|NCT00476255|injury prevention|injury prevention
641356|NCT00476255|automotive|automotive
641357|NCT00476242|heroin abuse|heroin abuse
641358|NCT00476242|opiate abuse|opiate abuse
641359|NCT00476242|opioid dependence|opioid dependence
641360|NCT00476242|naltrexone|naltrexone
641361|NCT00476242|memantine|memantine
641362|NCT00476229|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
641363|NCT00476229|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
641364|NCT00476229|Hodgkin's Lymphoma|hodgkin's lymphoma
641365|NCT00476229|Lymphoma|lymphoma
641366|NCT00476229|Leukemia|leukemia
641367|NCT00476229|Mycophenolate Mofetil|mycophenolate mofetil
641368|NCT00476229|Tacrolimus|tacrolimus
641369|NCT00476229|Thymoglobulin|thymoglobulin
641370|NCT00476229|Total Lymphoid Irradiation|total lymphoid irradiation
641371|NCT00476216|Non-Small Cell Lung Cancer|non-small cell lung cancer
641372|NCT00476216|Venous Thromboembolism|venous thromboembolism
641373|NCT00476216|VTE|vte
641374|NCT00476216|Arixtra|arixtra
641375|NCT00476203|Breast Cancer|breast cancer
641376|NCT00476203|Yoga|yoga
641377|NCT00476203|Quality of Life|quality of life
641378|NCT00476203|Obesity|obesity
641379|NCT00476203|Fatigue|fatigue
641380|NCT00476203|Weight|weight
641381|NCT00476190|ALL|all
641382|NCT00476177|DC|dc
641383|NCT00476177|DLI|dli
641384|NCT00476177|graft vs. host disease|graft vs. host disease
641385|NCT00476177|GVHD|gvhd
641386|NCT00476164|chronic allograft nephropathy|chronic allograft nephropathy
641387|NCT00476164|C4d|c4d
641388|NCT00476164|Anti-CD20|anti-cd20
641389|NCT00476164|B cells|b cells
641390|NCT00476164|Antibody|antibody
641391|NCT00476151|DPN|dpn
641392|NCT00476151|Diabetic|diabetic
641393|NCT00476151|Nerve Pain|nerve pain
641394|NCT00476138|Epigallocatechin-Gallate|epigallocatechin-gallate
641395|NCT00476138|Glaucoma|glaucoma
641396|NCT00476138|Optic Nerve|optic nerve
641397|NCT00476138|Pattern Electroretinogram|pattern electroretinogram
641398|NCT00476138|Retinal Ganglion Cells|retinal ganglion cells
641399|NCT00476112|Atrial flutter|atrial flutter
641400|NCT00476112|RSD1235|rsd1235
641401|NCT00476086|oxaliplatin|oxaliplatin
641402|NCT00476086|gemcitabine|gemcitabine
641403|NCT00476086|MMMT|mmmt
641404|NCT00476060|Cirrhosis|cirrhosis
641405|NCT00476060|Bone marrow|bone marrow
641406|NCT00476060|Mesenchymal stem cell|mesenchymal stem cell
641407|NCT00476060|MELD score|meld score
641408|NCT00476060|Quality of life|quality of life
641409|NCT00476034|Osteoarthritis|osteoarthritis
641410|NCT00476034|lumiracoxib|lumiracoxib
641411|NCT00476034|celecoxib|celecoxib
641412|NCT00476034|Cox-2|cox-2
641413|NCT00476034|knee|knee
641414|NCT00476021|postpartum|postpartum
641415|NCT00476021|contraception|contraception
641416|NCT00476021|postplacental IUD|postplacental iud
641417|NCT00476021|intrauterine devices|intrauterine devices
641418|NCT00476008|Alzheimer's Disease|alzheimer's disease
641419|NCT00476008|Mild Alzheimer's Disease|mild alzheimer's disease
641420|NCT00476008|Driving|driving
641421|NCT00476008|Driving Impairment|driving impairment
641422|NCT00475982|Diet|diet
641423|NCT00475982|Insulin-like Growth Factor|insulin-like growth factor
641424|NCT00475982|Weight Loss|weight loss
641425|NCT00475956|Cancer|cancer
641426|NCT00475956|Tumour|tumour
641427|NCT00475956|Advanced Solid Tumour|advanced solid tumour
641428|NCT00475956|Lung Cancer|lung cancer
641429|NCT00475956|Breast Cancer|breast cancer
641430|NCT00475956|Cholangiocarcinoma|cholangiocarcinoma
641431|NCT00475956|Colon Cancer|colon cancer
641432|NCT00475956|Gastric Cancer|gastric cancer
641433|NCT00475956|Choriocarcinoma|choriocarcinoma
641434|NCT00475956|Liver Cancer|liver cancer
641435|NCT00475956|Myeloma|myeloma
641436|NCT00475956|Ovarian Cancer|ovarian cancer
641437|NCT00475956|Pancreatic Cancer|pancreatic cancer
641438|NCT00475956|Peritoneal Cancer|peritoneal cancer
641439|NCT00475943|Swallowing Disorders|swallowing disorders
641440|NCT00475943|Swallowing|swallowing
641441|NCT00475943|Videofluoroscopy|videofluoroscopy
641442|NCT00475943|Dysphagia|dysphagia
641443|NCT00475943|Epiglottis|epiglottis
641444|NCT00475943|Healthy Volunteer|healthy volunteer
641445|NCT00475943|HV|hv
641446|NCT00475930|MRSA|mrsa
641447|NCT00475930|Staphylococcus aureus|staphylococcus aureus
641448|NCT00475917|Advanced malignancies|advanced malignancies
641449|NCT00475917|Solid tumor|solid tumor
641450|NCT00475904|Post Herpetic Neuralgia|post herpetic neuralgia
641451|NCT00475904|PHN|phn
641452|NCT00475904|Neuropathy|neuropathy
641453|NCT00475904|Nerve Pain|nerve pain
641454|NCT00475904|Topical|topical
641455|NCT00475891|isolate|isolate
641456|NCT00475891|infection|infection
641457|NCT00475891|linezolid|linezolid
641458|NCT00475878|opiate use|opiate use
641459|NCT00475878|depression|depression
641460|NCT00475878|buprenorphine|buprenorphine
641461|NCT00475878|escitalopram|escitalopram
641462|NCT00475865|MS|ms
641463|NCT00475865|glatiramer acetate|glatiramer acetate
641464|NCT00475865|adjunctive therapy|adjunctive therapy
641465|NCT00475865|relapses|relapses
641466|NCT00475852|Heart Decompensation|heart decompensation
641467|NCT00475852|Dyspnea|dyspnea
641468|NCT00475852|Heart failure|heart failure
641469|NCT00475852|Nesiritide|nesiritide
641470|NCT00475852|Decompensated|decompensated
641471|NCT00475852|ADHF|adhf
641472|NCT00475839|stress urinary incontinence|stress urinary incontinence
641473|NCT00475839|sling procedures|sling procedures
641474|NCT00475839|tension-free vaginal tape|tension-free vaginal tape
641475|NCT00475839|transobturator|transobturator
641476|NCT00475826|Heterozigous Familial Hypercholesterolemia|heterozigous familial hypercholesterolemia
641477|NCT00475826|Sub-clinical atherosclerosis|sub-clinical atherosclerosis
641478|NCT00475826|Chylomicrons metabolism|chylomicrons metabolism
641479|NCT00475826|Statin plus ezetimibe|statin plus ezetimibe
641480|NCT00475826|Coronary artery calcification|coronary artery calcification
641481|NCT00475813|Paediatric subjects with asthma|paediatric subjects with asthma
641482|NCT00475800|Osteoarthritis|osteoarthritis
641483|NCT00475800|lumiracoxib|lumiracoxib
641484|NCT00475800|celecoxib|celecoxib
641485|NCT00475800|Cox-2|cox-2
641486|NCT00475800|knee|knee
641487|NCT00475787|Older Adults|older adults
641488|NCT00475787|Patient Education|patient education
641489|NCT00475787|Randomized Controlled Trial|randomized controlled trial
641490|NCT00475787|Sham procedure|sham procedure
641491|NCT00475787|Spinal Manipulation|spinal manipulation
641492|NCT00475787|Veterans|veterans
641493|NCT00475761|Breast biopsy|breast biopsy
641494|NCT00475761|Breast imaging|breast imaging
641495|NCT00475761|Breast Cancer|breast cancer
641496|NCT00475761|Mammographic Density|mammographic density
641497|NCT00475761|Breast|breast
641498|NCT00475748|cervical spine|cervical spine
641499|NCT00475748|spinal cord|spinal cord
641500|NCT00475748|trauma|trauma
641501|NCT00475748|spinal cord injury|spinal cord injury
641502|NCT00475748|central cord syndrome|central cord syndrome
641503|NCT00475722|cancer|cancer
641504|NCT00475722|colon|colon
641505|NCT00475722|prevention|prevention
641506|NCT00475722|healthy eating|healthy eating
641507|NCT00475722|Mediterranean diet|mediterranean diet
641508|NCT00475722|PGE2|pge2
641509|NCT00475722|cyclooxygenase|cyclooxygenase
641510|NCT00475722|lipoxygenase|lipoxygenase
641511|NCT00475722|Healthy People 2010 diet|healthy people 2010 diet
641512|NCT00475722|dietary prevention of colon cancer|dietary prevention of colon cancer
641513|NCT00475709|aortic valve|aortic valve
641514|NCT00475709|heart valve|heart valve
641515|NCT00475709|tissue valve|tissue valve
641516|NCT00475709|bioprosthesis|bioprosthesis
641517|NCT00475709|valve disorder|valve disorder
641518|NCT00475709|valve disease|valve disease
641519|NCT00475709|cardiac surgery|cardiac surgery
641520|NCT00475709|aortic valve stenosis|aortic valve stenosis
641521|NCT00475709|aortic valve regurgitation|aortic valve regurgitation
641522|NCT00475683|Doxorubicin|doxorubicin
641523|NCT00475683|Mucositis|mucositis
641524|NCT00475683|Prevention|prevention
641525|NCT00475683|Curcumin|curcumin
641526|NCT00475631|Clubfoot|clubfoot
641527|NCT00475631|Chart review|chart review
641528|NCT00475618|Early chilhood caries|early chilhood caries
641529|NCT00475618|Prevention|prevention
641530|NCT00475618|Fluoride varnish|fluoride varnish
641531|NCT00475618|fluoride toothpaste|fluoride toothpaste
641532|NCT00475618|non fluoride tooth paste|non fluoride tooth paste
641533|NCT00475618|Professional cleaning|professional cleaning
641534|NCT00475605|atopic dermatitis|atopic dermatitis
641535|NCT00475605|child|child
641536|NCT00475605|tacrolimus ointment|tacrolimus ointment
641537|NCT00475605|Protopic Ointment|protopic ointment
641538|NCT00475592|Esophageal Varices|esophageal varices
641539|NCT00475592|Gastric Varices|gastric varices
641540|NCT00475592|Capsule Endoscopy|capsule endoscopy
641541|NCT00475592|Portal Hypertension|portal hypertension
641542|NCT00475592|Cirrhosis|cirrhosis
641543|NCT00475592|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
641544|NCT00475579|ventilator-associated pneumonia|ventilator-associated pneumonia
641545|NCT00475579|endotracheal tube|endotracheal tube
641546|NCT00475579|polyurethane cuff|polyurethane cuff
641547|NCT00475579|polyvinyl cuff|polyvinyl cuff
641548|NCT00475579|subglottic secretion drainage|subglottic secretion drainage
641549|NCT00475553|spotting|spotting
641550|NCT00475553|PMS|pms
641551|NCT00475553|nuvaring|nuvaring
641552|NCT00475553|birth control|birth control
641553|NCT00475553|pelvic pain|pelvic pain
641554|NCT00475553|headache|headache
641555|NCT00475553|mood swings|mood swings
641556|NCT00475553|continuous use|continuous use
641557|NCT00475540|prolapse|prolapse
641558|NCT00475540|uterus|uterus
641559|NCT00475540|pelvic organ|pelvic organ
641560|NCT00475540|vaginal prolpase|vaginal prolpase
641561|NCT00475514|Menstrually-related Migraine Headache|menstrually-related migraine headache
641562|NCT00475514|'Difficult to Treat' as specified in protocol|'difficult to treat' as specified in protocol
641563|NCT00475501|anabolic effects|anabolic effects
641564|NCT00475501|finasteride|finasteride
641565|NCT00475501|male hypogonadism|male hypogonadism
641566|NCT00475501|sarcopenia|sarcopenia
641567|NCT00475501|testosterone|testosterone
641568|NCT00475488|radial artery|radial artery
641569|NCT00475488|right internal thoracic artery|right internal thoracic artery
641570|NCT00475488|saphenous vein|saphenous vein
641571|NCT00475488|grafts|grafts
641572|NCT00475488|coronary bypass surgery|coronary bypass surgery
641573|NCT00475475|Overweight|overweight
641574|NCT00475475|Obesity|obesity
641575|NCT00475475|Appetite|appetite
641576|NCT00475475|Dietary sugars|dietary sugars
641577|NCT00475475|Fructose|fructose
641578|NCT00475475|Glucose|glucose
641579|NCT00475475|Leptin|leptin
641580|NCT00475475|Insulin|insulin
641581|NCT00475475|Ghrelin|ghrelin
641582|NCT00475462|Metoprolol and Syncope|metoprolol and syncope
641583|NCT00475449|percutaneous coronary intervention|percutaneous coronary intervention
641584|NCT00475449|Stent|stent
641585|NCT00475449|coronary artery bypass grafting|coronary artery bypass grafting
641586|NCT00475436|muscarinic receptor antagonist|muscarinic receptor antagonist
641587|NCT00475436|GSK573719,|gsk573719,
641588|NCT00475436|chronic obstructive pulmonary disease,|chronic obstructive pulmonary disease,
641589|NCT00475410|Autologous adipose-derived stem cells|autologous adipose-derived stem cells
641590|NCT00475410|Complex perianal fistula|complex perianal fistula
641591|NCT00475410|Inflammatory Bowel Disease|inflammatory bowel disease
641592|NCT00475410|Advanced cell therapy|advanced cell therapy
641593|NCT00475410|Fibrin glue|fibrin glue
641594|NCT00475384|Acute Myelogenous Leukemia|acute myelogenous leukemia
641595|NCT00475384|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
641596|NCT00475384|Myelodysplastic Syndrome|myelodysplastic syndrome
641597|NCT00475384|Stem Cell Transplant|stem cell transplant
641598|NCT00475384|Haploidentical Donor|haploidentical donor
641599|NCT00475384|Leukemia|leukemia
641600|NCT00475384|Fludarabine|fludarabine
641601|NCT00475384|Total Body Irradiation|total body irradiation
641602|NCT00475384|Thiotepa|thiotepa
641603|NCT00475371|Healthy|healthy
641604|NCT00475371|Diabetes Mellitus: Type II|diabetes mellitus: type ii
641605|NCT00475345|Nocturnal hypoglycemia|nocturnal hypoglycemia
641606|NCT00475345|Bedtime snacks|bedtime snacks
641607|NCT00475345|Continuous glucose monitoring|continuous glucose monitoring
641608|NCT00475345|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
641609|NCT00475345|CSII|csii
641610|NCT00475345|Intensive therapy|intensive therapy
641611|NCT00475319|Dry Eye Syndromes|dry eye syndromes
641612|NCT00475319|OPC-12759|opc-12759
641613|NCT00475306|Metoclopramide|metoclopramide
641614|NCT00475306|Nausea|nausea
641615|NCT00475306|Akathisia|akathisia
641616|NCT00475306|Emergency department|emergency department
641617|NCT00475293|metastatic colorectal cancer|metastatic colorectal cancer
641618|NCT00475293|2nd-line Therapy|2nd-line therapy
641619|NCT00475293|panitumumab|panitumumab
641620|NCT00475293|irinotecan|irinotecan
641621|NCT00475280|geriatric assessment adapted therapy|geriatric assessment adapted therapy
641622|NCT00475280|Leukemia, Lymphoblastic, Acute|leukemia, lymphoblastic, acute
641623|NCT00475280|Older patients|older patients
641624|NCT00475280|> 60 years old|> 60 years old
641625|NCT00475280|Ph negative|ph negative
641626|NCT00475267|aortic valve|aortic valve
641627|NCT00475267|heart valve|heart valve
641628|NCT00475267|tissue valve|tissue valve
641629|NCT00475267|bioprosthesis|bioprosthesis
641630|NCT00475267|valve disorder|valve disorder
641631|NCT00475267|valve disease|valve disease
641632|NCT00475267|cardiac surgery|cardiac surgery
641633|NCT00475267|aortic valve stenosis|aortic valve stenosis
641634|NCT00475267|aortic valve regurgitation|aortic valve regurgitation
641635|NCT00475254|Retinitis Pigmentosa|retinitis pigmentosa
641636|NCT00475254|stress|stress
641637|NCT00475254|sleepiness|sleepiness
641638|NCT00475254|low vision|low vision
641639|NCT00475254|mind-body|mind-body
641640|NCT00475241|Combat Disorders|combat disorders
641641|NCT00475241|Cortisol|cortisol
641642|NCT00475241|Posttraumatic Stress Disorder (PTSD)|posttraumatic stress disorder (ptsd)
641643|NCT00475241|Psychophysiology|psychophysiology
641644|NCT00475241|Therapy|therapy
641645|NCT00475241|Treatment|treatment
641646|NCT00475241|Veterans|veterans
641647|NCT00475228|levonorgestrel IUD|levonorgestrel iud
641648|NCT00475228|IUD|iud
641649|NCT00475228|dilation and evacuation|dilation and evacuation
641650|NCT00475228|contraception|contraception
641651|NCT00475189|birth control|birth control
641652|NCT00475189|PMS|pms
641653|NCT00475189|headaches|headaches
641654|NCT00475189|mood swings|mood swings
641655|NCT00475189|pelvic pain|pelvic pain
641656|NCT00475176|Hepatitis C Virus Genotype 1|hepatitis c virus genotype 1
641657|NCT00475176|Non-Responders|non-responders
641658|NCT00475176|SAMe|same
641659|NCT00475176|Natural Killer Cells|natural killer cells
641660|NCT00475176|Interferon Signaling|interferon signaling
641661|NCT00475176|Ribavirin|ribavirin
641662|NCT00475176|Peginterferon|peginterferon
641663|NCT00475176|Hemolysis|hemolysis
641664|NCT00475176|STAT|stat
641665|NCT00475176|Hepatitis C|hepatitis c
641666|NCT00475163|Obesity|obesity
641667|NCT00475163|Mentoring|mentoring
641668|NCT00475163|Fitness|fitness
641669|NCT00475163|Self-esteem|self-esteem
641670|NCT00475137|Bipolar II Disorder|bipolar ii disorder
641671|NCT00475137|depression|depression
641672|NCT00475137|Lamotrigine|lamotrigine
641673|NCT00475137|Add On antidepressant|add on antidepressant
641674|NCT00475137|randomized|randomized
641675|NCT00475137|single blind|single blind
641676|NCT00475137|parallel group|parallel group
641677|NCT00475124|Pacemaker follow-up|pacemaker follow-up
641678|NCT00475124|Telecardiology|telecardiology
641679|NCT00475124|Home Monitoring|home monitoring
641680|NCT00475111|Cognitive Behavioral Intervention|cognitive behavioral intervention
641681|NCT00475111|Emotion Regulation|emotion regulation
641682|NCT00475111|Pain Management|pain management
641683|NCT00475111|Psychological Adaptation|psychological adaptation
641684|NCT00475111|Coping Efficacy|coping efficacy
641685|NCT00475111|Markers of Disease Activity|markers of disease activity
641686|NCT00475098|Low molecular weight heparin|low molecular weight heparin
641687|NCT00475098|Lung cancer|lung cancer
641688|NCT00475098|Non small cell lung cancer|non small cell lung cancer
641689|NCT00475098|Adjuvant therapy|adjuvant therapy
641690|NCT00475098|Anticoagulants|anticoagulants
641691|NCT00475098|Heparin|heparin
641692|NCT00475085|nausea and vomiting|nausea and vomiting
641693|NCT00475085|recurrent breast cancer|recurrent breast cancer
641694|NCT00475085|stage I breast cancer|stage i breast cancer
641695|NCT00475085|stage II breast cancer|stage ii breast cancer
641696|NCT00475085|stage IIIA breast cancer|stage iiia breast cancer
641697|NCT00475085|stage IIIB breast cancer|stage iiib breast cancer
641698|NCT00475085|stage IIIC breast cancer|stage iiic breast cancer
641699|NCT00475085|stage IV breast cancer|stage iv breast cancer
641700|NCT00475085|inflammatory breast cancer|inflammatory breast cancer
641701|NCT00475085|male breast cancer|male breast cancer
641702|NCT00475059|kidney transplantation|kidney transplantation
641703|NCT00475059|Glomerular filtration rate|glomerular filtration rate
641704|NCT00475059|inulin clearance|inulin clearance
641705|NCT00475059|MDRD equation|mdrd equation
641706|NCT00475059|cystatin C|cystatin c
641707|NCT00475059|cimetidine|cimetidine
641708|NCT00475046|smoking|smoking
641709|NCT00475046|post partum|post partum
641710|NCT00475046|relapse prevention|relapse prevention
641711|NCT00475046|motivational interviewing|motivational interviewing
641712|NCT00475046|TTM|ttm
641713|NCT00475046|implement motivational enhancement interventions in pediatric practices|implement motivational enhancement interventions in pediatric practices
641714|NCT00475046|examine the effectiveness of the intervention|examine the effectiveness of the intervention
641715|NCT00475046|develop measurements appropriate to tailor interventions|develop measurements appropriate to tailor interventions
641716|NCT00475046|analyze further unfavorable and favorable factors outlined by previous research|analyze further unfavorable and favorable factors outlined by previous research
641717|NCT00475020|Idiopathic Myelofibrosis|idiopathic myelofibrosis
641718|NCT00475020|Myelofibrosis|myelofibrosis
641719|NCT00475020|Essential Thrombocythemia|essential thrombocythemia
641720|NCT00475020|Polycythemia Vera|polycythemia vera
641721|NCT00475020|Busulfan|busulfan
641722|NCT00475020|Antithymocyte Globulin|antithymocyte globulin
641723|NCT00475020|ATG|atg
641724|NCT00475020|Fludarabine|fludarabine
641725|NCT00475020|Thymoglobulin|thymoglobulin
641726|NCT00475007|Emphysema|emphysema
641727|NCT00475007|IBV® Valve|ibv® valve
641728|NCT00475007|COPD|copd
641729|NCT00475007|Shortness of Breath|shortness of breath
641730|NCT00475007|Spiration|spiration
641731|NCT00474994|chondrosarcoma|chondrosarcoma
641732|NCT00474994|recurrent osteosarcoma|recurrent osteosarcoma
641733|NCT00474994|localized adult malignant fibrous histiocytoma of bone|localized adult malignant fibrous histiocytoma of bone
641734|NCT00474994|metastatic adult malignant fibrous histiocytoma of bone|metastatic adult malignant fibrous histiocytoma of bone
641735|NCT00474994|recurrent adult malignant fibrous histiocytoma of bone|recurrent adult malignant fibrous histiocytoma of bone
641736|NCT00474994|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
641737|NCT00474994|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
641738|NCT00474994|recurrent uterine sarcoma|recurrent uterine sarcoma
641739|NCT00474994|adult leiomyosarcoma|adult leiomyosarcoma
641740|NCT00474994|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
641741|NCT00474994|adult rhabdomyosarcoma|adult rhabdomyosarcoma
641742|NCT00474994|dermatofibrosarcoma protuberans|dermatofibrosarcoma protuberans
641743|NCT00474994|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
641744|NCT00474994|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
641745|NCT00474994|ovarian sarcoma|ovarian sarcoma
641746|NCT00474994|uterine leiomyosarcoma|uterine leiomyosarcoma
641747|NCT00474994|stage III uterine sarcoma|stage iii uterine sarcoma
641748|NCT00474994|stage IV uterine sarcoma|stage iv uterine sarcoma
641749|NCT00474994|desmoid tumor|desmoid tumor
641750|NCT00474994|adult angiosarcoma|adult angiosarcoma
641751|NCT00474994|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
641752|NCT00474994|uterine carcinosarcoma|uterine carcinosarcoma
641753|NCT00474994|endometrial stromal sarcoma|endometrial stromal sarcoma
641754|NCT00474994|fibrosarcomatous osteosarcoma|fibrosarcomatous osteosarcoma
641755|NCT00474994|chondrosarcomatous osteosarcoma|chondrosarcomatous osteosarcoma
641756|NCT00474994|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
641757|NCT00474994|adult epithelioid sarcoma|adult epithelioid sarcoma
641758|NCT00474994|adult extraskeletal chondrosarcoma|adult extraskeletal chondrosarcoma
641759|NCT00474994|adult extraskeletal osteosarcoma|adult extraskeletal osteosarcoma
641760|NCT00474994|adult fibrosarcoma|adult fibrosarcoma
641761|NCT00474994|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
641762|NCT00474994|adult malignant mesenchymoma|adult malignant mesenchymoma
641763|NCT00474994|adult neurofibrosarcoma|adult neurofibrosarcoma
641764|NCT00474994|adult synovial sarcoma|adult synovial sarcoma
641765|NCT00474994|adult desmoplastic small round cell tumor|adult desmoplastic small round cell tumor
641766|NCT00474994|adult liposarcoma|adult liposarcoma
641767|NCT00474994|anaplastic osteosarcoma|anaplastic osteosarcoma
641768|NCT00474994|mixed osteosarcoma|mixed osteosarcoma
641769|NCT00474994|small intestine leiomyosarcoma|small intestine leiomyosarcoma
641770|NCT00474994|osteoblastic osteosarcoma|osteoblastic osteosarcoma
641771|NCT00474994|telangiectatic osteosarcoma|telangiectatic osteosarcoma
641772|NCT00474994|classic Kaposi sarcoma|classic kaposi sarcoma
641773|NCT00474994|immunosuppressive treatment related Kaposi sarcoma|immunosuppressive treatment related kaposi sarcoma
641774|NCT00474994|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
641775|NCT00474981|neonatal mortality|neonatal mortality
641776|NCT00474981|infant mortality|infant mortality
641777|NCT00474981|newborn caring practices|newborn caring practices
641778|NCT00474942|Hypertension|hypertension
641779|NCT00474942|Metabolic Alkalosis|metabolic alkalosis
641780|NCT00474942|Hypokalemia|hypokalemia
641781|NCT00474929|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
641782|NCT00474929|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
641783|NCT00474929|stage III multiple myeloma|stage iii multiple myeloma
641784|NCT00474929|refractory multiple myeloma|refractory multiple myeloma
641785|NCT00474929|Waldenström macroglobulinemia|waldenström macroglobulinemia
641786|NCT00474929|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
641787|NCT00474929|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
641788|NCT00474929|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
641789|NCT00474929|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
641790|NCT00474929|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
641791|NCT00474929|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
641792|NCT00474929|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
641793|NCT00474929|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
641794|NCT00474929|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
641795|NCT00474929|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
641796|NCT00474929|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
641797|NCT00474929|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
641798|NCT00474929|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
641799|NCT00474929|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
641800|NCT00474929|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
641801|NCT00474929|splenic marginal zone lymphoma|splenic marginal zone lymphoma
641802|NCT00474929|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
641803|NCT00474929|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
641804|NCT00474916|Neuropathic pain|neuropathic pain
641805|NCT00474916|Cancer|cancer
641806|NCT00474890|Seasonal allergic rhinitis|seasonal allergic rhinitis
641807|NCT00474877|Clinical|clinical
641808|NCT00474877|Splints|splints
641809|NCT00474877|Rheumatoid|rheumatoid
641810|NCT00474864|Endothelial Function,|endothelial function,
641811|NCT00474864|vascular compliance,|vascular compliance,
641812|NCT00474864|atherosclerosis|atherosclerosis
641813|NCT00474851|Endometriosis|endometriosis
641814|NCT00474851|Adolescents|adolescents
641815|NCT00474851|Bone density|bone density
641816|NCT00474851|GnRH Agonist|gnrh agonist
641817|NCT00474851|Add-back therapy|add-back therapy
641818|NCT00474838|type 2 diabetes mellitus|type 2 diabetes mellitus
641819|NCT00474838|intensive insulin therapy|intensive insulin therapy
641820|NCT00474786|Metastatic or Advanced Renal Cell Carcinoma|metastatic or advanced renal cell carcinoma
641821|NCT00474747|Severe Aplastic Anemia|severe aplastic anemia
641822|NCT00474747|Total Body Irradiation|total body irradiation
641823|NCT00474747|Antithymocyte Globulin|antithymocyte globulin
641824|NCT00474747|Cyclophosphamide|cyclophosphamide
641825|NCT00474747|Cytoxan|cytoxan
641826|NCT00474747|Neosar|neosar
641827|NCT00474747|Fludarabine|fludarabine
641828|NCT00474747|Fludara|fludara
641829|NCT00474747|Fludarabine Phosphate|fludarabine phosphate
641830|NCT00474747|Thymoglobulin|thymoglobulin
641831|NCT00474747|ATG|atg
641832|NCT00474747|TBI|tbi
641833|NCT00474747|Cyclosporine|cyclosporine
641834|NCT00474747|Tacrolimus|tacrolimus
641835|NCT00474734|hepatocellular carcinoma|hepatocellular carcinoma
641836|NCT00474734|liver transplantation|liver transplantation
641837|NCT00474734|staging|staging
641838|NCT00474734|intravascular ultrasound|intravascular ultrasound
641839|NCT00474721|child|child
641840|NCT00474721|pain|pain
641841|NCT00474721|analgesics|analgesics
641842|NCT00474695|Exudative age-related macular degeneration|exudative age-related macular degeneration
641843|NCT00474682|ferric pyrophosphate, iron bioavailability, fortification,|ferric pyrophosphate, iron bioavailability, fortification,
641844|NCT00474669|Ovarian Carcinoma|ovarian carcinoma
641845|NCT00474656|high frequency oscillation|high frequency oscillation
641846|NCT00474656|lung-protective ventilation|lung-protective ventilation
641847|NCT00474656|ARDS|ards
641848|NCT00474656|ventilator-induced lung injury|ventilator-induced lung injury
641849|NCT00474630|Obesity|obesity
641850|NCT00474630|Overweight|overweight
641851|NCT00474630|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
641852|NCT00474604|breast cancer|breast cancer
641853|NCT00474591|Coronary artery bypass surgery, fondaparinux, graft patency, graft occlusion, graft failure, anticoagulation|coronary artery bypass surgery, fondaparinux, graft patency, graft occlusion, graft failure, anticoagulation
641854|NCT00474565|Catheter,|catheter,
641855|NCT00474565|Aortic root injection,|aortic root injection,
641856|NCT00474565|low dose contrast injection,|low dose contrast injection,
641857|NCT00474565|coronary artery angiogarm and|coronary artery angiogarm and
641858|NCT00474565|coronary artery bypass graft imaging.|coronary artery bypass graft imaging.
641859|NCT00474539|Vaccine|vaccine
641860|NCT00474526|Meningococcal|meningococcal
641861|NCT00474526|meningitis|meningitis
641862|NCT00474526|vaccine|vaccine
641863|NCT00474526|infants|infants
641864|NCT00474526|Meningococcal meningitis|meningococcal meningitis
641865|NCT00474526|Meningococcal disease|meningococcal disease
641866|NCT00474513|AD, H3, Brain, Cognitive Impairment|ad, h3, brain, cognitive impairment
641867|NCT00474500|Iron absorption|iron absorption
641868|NCT00474500|Coca-Cola|coca-cola
641869|NCT00474487|Meningococcal|meningococcal
641870|NCT00474487|meningitis|meningitis
641871|NCT00474487|vaccine|vaccine
641872|NCT00474487|adolescents|adolescents
641873|NCT00474487|adults|adults
641874|NCT00474474|virtual patient|virtual patient
641875|NCT00474474|therapeutic decision making|therapeutic decision making
641876|NCT00474461|coronary artery disease|coronary artery disease
641877|NCT00474461|Heart Attack|heart attack
641878|NCT00474461|Heart failure|heart failure
641879|NCT00474461|Cardiac Stem Cells|cardiac stem cells
641880|NCT00474461|Coronary Artery Bypass|coronary artery bypass
641881|NCT00474448|Hereditary Multiple Exostoses|hereditary multiple exostoses
641882|NCT00474448|Survey|survey
641883|NCT00474448|Quality of Life|quality of life
641884|NCT00474448|Hereditary Multiple Exostoses,|hereditary multiple exostoses,
641885|NCT00474448|also known as Multiple Hereditary Exostoses,|also known as multiple hereditary exostoses,
641886|NCT00474448|also known as Hereditary Multiple Osteochondromas|also known as hereditary multiple osteochondromas
641887|NCT00474435|Tuberculosis|tuberculosis
641889|NCT00474435|Coinfection|coinfection
641890|NCT00474435|Pharmacokinetics|pharmacokinetics
641891|NCT00474435|Emtricitabine|emtricitabine
641892|NCT00474435|Tenofovir|tenofovir
641893|NCT00474435|Rifampin|rifampin
641894|NCT00474435|Efavirenz|efavirenz
641895|NCT00474435|Treatment Naive|treatment naive
641896|NCT00474422|breastfeeding|breastfeeding
641897|NCT00474422|support|support
641898|NCT00474409|Vertigo|vertigo
641899|NCT00474409|Posterior circulation infarction|posterior circulation infarction
641900|NCT00474396|Uric acid|uric acid
641901|NCT00474396|Dairy|dairy
641902|NCT00474396|Diet|diet
641903|NCT00474383|Prostate neoplasms|prostate neoplasms
641904|NCT00474383|CB7630|cb7630
641905|NCT00474383|Abiraterone acetate|abiraterone acetate
641906|NCT00474383|Glucocorticoid|glucocorticoid
641907|NCT00474383|Prednisone|prednisone
641908|NCT00474383|Prednisolone|prednisolone
641909|NCT00474370|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
641910|NCT00474357|Bipolar affective disorder|bipolar affective disorder
641911|NCT00474357|myths|myths
641912|NCT00474357|preconceived notions|preconceived notions
641913|NCT00474357|stigma|stigma
641914|NCT00474357|hope|hope
641915|NCT00474344|Genetics|genetics
641916|NCT00474344|Clubfoot|clubfoot
641917|NCT00474344|DNA|dna
641918|NCT00474344|Idiopathic Talipes Equinovarus also known as Clubfoot|idiopathic talipes equinovarus also known as clubfoot
641919|NCT00474331|DNA sequencing|dna sequencing
641920|NCT00474331|EXT genes|ext genes
641921|NCT00474331|Hereditary Multiple Exostoses,|hereditary multiple exostoses,
641922|NCT00474331|also known as Multiple Hereditary Exostoses,|also known as multiple hereditary exostoses,
641923|NCT00474331|also known as Hereditary Multiple Osteochondromas|also known as hereditary multiple osteochondromas
641924|NCT00474318|Adolescents|adolescents
641925|NCT00474318|Obesity|obesity
641926|NCT00474318|Bariatrics|bariatrics
641927|NCT00474318|Surgery for Weight Loss|surgery for weight loss
641928|NCT00474318|Teen-LABS|teen-labs
641929|NCT00474305|PTSD|ptsd
641930|NCT00474305|Prolonged Exposure|prolonged exposure
641931|NCT00474305|Virtual Reality|virtual reality
641932|NCT00474292|Stroke|stroke
641933|NCT00474292|Rehabilitation|rehabilitation
641934|NCT00474292|Plasticity|plasticity
641935|NCT00474292|fMRI|fmri
641936|NCT00474292|Reorganization|reorganization
641937|NCT00474279|Growth hormone secretagogue|growth hormone secretagogue
641938|NCT00474279|Body composition|body composition
641939|NCT00474279|Functional ability|functional ability
641940|NCT00474279|Aging|aging
641941|NCT00474279|Sarcopenia|sarcopenia
641942|NCT00474266|MMRV vaccine|mmrv vaccine
641943|NCT00474266|co-administration|co-administration
641944|NCT00474266|immunogenicity|immunogenicity
641945|NCT00474266|meningococcal vaccine|meningococcal vaccine
641946|NCT00474266|conjugate vaccine|conjugate vaccine
641947|NCT00474240|cholesterol|cholesterol
641948|NCT00474227|obesity|obesity
641949|NCT00474227|weight gain|weight gain
641950|NCT00474227|schizophrenia|schizophrenia
641951|NCT00474227|schizoaffective disorder|schizoaffective disorder
641952|NCT00474227|antipsychotic induced weight gain|antipsychotic induced weight gain
641953|NCT00474214|STEMI|stemi
641954|NCT00474214|Primary PCI|primary pci
641955|NCT00474214|Length of Stay|length of stay
641956|NCT00474214|Early Discharge|early discharge
641957|NCT00474201|Pharmacokinetic|pharmacokinetic
641958|NCT00474201|HIV|hiv
641959|NCT00474201|Drug-Drug Interaction|drug-drug interaction
641960|NCT00474201|Lopinavir/Ritonavir|lopinavir/ritonavir
641961|NCT00474201|Gemfibrozil|gemfibrozil
641962|NCT00474201|Healthy Volunteer|healthy volunteer
641963|NCT00474201|HV|hv
641964|NCT00474188|Celgene|celgene
641965|NCT00474188|Revlimid|revlimid
641966|NCT00474188|Lenalidomide|lenalidomide
641967|NCT00474188|Diffuse Large B-cell lymphoma|diffuse large b-cell lymphoma
641968|NCT00474188|Non-Hodgkins lymphoma|non-hodgkins lymphoma
641969|NCT00474188|CC-5013|cc-5013
641970|NCT00474188|Response Rate|response rate
641971|NCT00474188|Tumor Control Rate|tumor control rate
641972|NCT00474188|Duration of Response|duration of response
641973|NCT00474188|Time to Progression|time to progression
641974|NCT00474188|Progression-free survival and safety|progression-free survival and safety
641975|NCT00474162|Cesarean section|cesarean section
641976|NCT00474162|coagulation changes|coagulation changes
641977|NCT00474123|angina|angina
641978|NCT00474123|atherosclerosis|atherosclerosis
641979|NCT00474123|simvastatin|simvastatin
641980|NCT00474123|ezetimibe|ezetimibe
641981|NCT00474123|inflammation|inflammation
641982|NCT00474110|Ketamine|ketamine
641983|NCT00474110|hydromorphone|hydromorphone
641984|NCT00474110|pediatric mucositis|pediatric mucositis
641985|NCT00474097|Colorectal Neoplasms|colorectal neoplasms
641986|NCT00474097|Colitis, Ulcerative|colitis, ulcerative
641987|NCT00474097|Diverticulitis|diverticulitis
641988|NCT00474097|Colonic Polyps|colonic polyps
641989|NCT00474097|Crohn Disease|crohn disease
641990|NCT00474084|Stent|stent
641991|NCT00474084|Hydroxyapatite|hydroxyapatite
641992|NCT00474084|Coronary Artery Stenosis|coronary artery stenosis
641993|NCT00474084|Angioplasty|angioplasty
641994|NCT00474071|Remifentanil|remifentanil
641995|NCT00474071|endotracheal intubation|endotracheal intubation
641996|NCT00474071|pediatrics|pediatrics
641997|NCT00474058|rotigotine|rotigotine
641998|NCT00474058|Neupro®|neupro®
641999|NCT00474058|Parkinson's Disease|parkinson's disease
642000|NCT00474032|Idiopathic clubfoot|idiopathic clubfoot
642001|NCT00474032|Botox injection|botox injection
642002|NCT00474032|Idiopathic Talipes Equinovarus, also known as Idiopathic clubfoot|idiopathic talipes equinovarus, also known as idiopathic clubfoot
642003|NCT00474019|pediatrics|pediatrics
642004|NCT00474019|neonates|neonates
642005|NCT00473993|Hepatitis C|hepatitis c
642006|NCT00473993|Opioid Maintenance Treatment|opioid maintenance treatment
642007|NCT00473993|Methadone|methadone
642008|NCT00473993|Buprenorphine|buprenorphine
642010|NCT00473993|Interferon, pegylated|interferon, pegylated
642011|NCT00473980|MHC|mhc
642012|NCT00473980|CTLs|ctls
642013|NCT00473980|Colon carcinoma|colon carcinoma
642014|NCT00473980|NSAID|nsaid
642015|NCT00473980|Survival|survival
642016|NCT00473967|Vaccine|vaccine
642017|NCT00473967|Hookworm|hookworm
642018|NCT00473967|Phase 1|phase 1
642019|NCT00473967|Na-ASP-2|na-asp-2
642020|NCT00473941|colorectal cancer|colorectal cancer
642021|NCT00473941|colon cancer|colon cancer
642022|NCT00473941|rectal cancer|rectal cancer
642023|NCT00473928|Macular|macular
642024|NCT00473928|degeration|degeration
642025|NCT00473928|Complement|complement
642026|NCT00473876|Chronic Heart Failure|chronic heart failure
642027|NCT00473876|Insulin Resistance|insulin resistance
642028|NCT00473876|Metformin|metformin
642029|NCT00473876|Peak VO2|peak vo2
642030|NCT00473863|Acute coronary syndrome|acute coronary syndrome
642031|NCT00473863|Acute myocardial infarction|acute myocardial infarction
642032|NCT00473863|Unstable angina|unstable angina
642033|NCT00473863|Coronary computed tomographic angiography|coronary computed tomographic angiography
642034|NCT00473863|Coronary Angiography|coronary angiography
642035|NCT00473863|Tomography, X-Ray Computed|tomography, x-ray computed
642036|NCT00473863|Tomography, Spiral Computed|tomography, spiral computed
642037|NCT00473850|DNA sequencing|dna sequencing
642038|NCT00473850|EXT genes|ext genes
642039|NCT00473850|Hereditary Multiple Exostoses,|hereditary multiple exostoses,
642040|NCT00473850|also known as Multiple Hereditary Exostoses,|also known as multiple hereditary exostoses,
642041|NCT00473850|also known as Hereditary Multiple Osteochondromas|also known as hereditary multiple osteochondromas
642042|NCT00473837|malaria|malaria
642043|NCT00473837|anaemia|anaemia
642044|NCT00473837|chloroquine|chloroquine
642045|NCT00473837|iron delocalisation|iron delocalisation
642046|NCT00473837|macrophages|macrophages
642047|NCT00473824|hepatitis C|hepatitis c
642048|NCT00473824|liver transplantation|liver transplantation
642049|NCT00473824|immune globulin|immune globulin
642050|NCT00473811|Glycemic index|glycemic index
642051|NCT00473811|carbohydrates|carbohydrates
642052|NCT00473811|diabetes mellitus, type 2|diabetes mellitus, type 2
642053|NCT00473811|randomized clinical trial|randomized clinical trial
642054|NCT00473798|Patient Satisfaction|patient satisfaction
642055|NCT00473798|Quality of Life|quality of life
642056|NCT00473798|Psychological Distress|psychological distress
642057|NCT00473798|Cervical Cancer|cervical cancer
642058|NCT00473798|Cervical Cancer Screening|cervical cancer screening
642059|NCT00473798|Questionnaire|questionnaire
642060|NCT00473785|Cardiovascular disease|cardiovascular disease
642061|NCT00473785|Prevention|prevention
642062|NCT00473785|Lifestyle|lifestyle
642063|NCT00473772|cobalt chromium stent|cobalt chromium stent
642064|NCT00473772|paclitaxel coated balloon catheter|paclitaxel coated balloon catheter
642065|NCT00473772|DEBlue|deblue
642066|NCT00473772|drug eluting balloon|drug eluting balloon
642067|NCT00473746|Prostate neoplasms|prostate neoplasms
642068|NCT00473746|Hormone refractory prostate cancer|hormone refractory prostate cancer
642069|NCT00473746|Abiraterone acetate|abiraterone acetate
642070|NCT00473746|CB7630|cb7630
642071|NCT00473733|PATIENTS WITH DIABETES MELLITUS TYPE 2|patients with diabetes mellitus type 2
642072|NCT00473733|UNDERGO UPPER ENDOSCOPY|undergo upper endoscopy
642073|NCT00473733|BIOPSIES FOR GLP RECEPTORS EXPRESSION|biopsies for glp receptors expression
642074|NCT00473733|PCR ANALYSIS|pcr analysis
642075|NCT00473707|Third stage of labor|third stage of labor
642076|NCT00473668|Hepatitis B|hepatitis b
642077|NCT00473668|Tetanus|tetanus
642078|NCT00473668|Diphtheria|diphtheria
642079|NCT00473668|Pertussis|pertussis
642080|NCT00473668|Haemophilus influenzae type b Vaccines|haemophilus influenzae type b vaccines
642081|NCT00473655|Triglycerides|triglycerides
642082|NCT00473655|hypertriglyceridemia|hypertriglyceridemia
642083|NCT00473655|statins|statins
642084|NCT00473655|rosuvastatin|rosuvastatin
642085|NCT00473655|hyperlipoproteinemia|hyperlipoproteinemia
642086|NCT00473655|Fredrickson Type IIb or IV|fredrickson type iib or iv
642087|NCT00473642|Ranibizumab|ranibizumab
642088|NCT00473642|Lucentis|lucentis
642089|NCT00473642|Verteporfin|verteporfin
642090|NCT00473642|Visudyne|visudyne
642091|NCT00473642|Photodynamic therapy|photodynamic therapy
642092|NCT00473616|Phase I|phase i
642093|NCT00473616|solid tumors|solid tumors
642094|NCT00473616|solid malignancies|solid malignancies
642095|NCT00473616|cancer Eligibility|cancer eligibility
642096|NCT00473603|androgens|androgens
642097|NCT00473603|fatty acids|fatty acids
642098|NCT00473590|Avastin|avastin
642099|NCT00473590|AMBER|amber
642100|NCT00473590|Myeloma|myeloma
642101|NCT00473590|Velcade|velcade
642102|NCT00473564|Lesions|lesions
642103|NCT00473564|Biopsy|biopsy
642104|NCT00473564|Surgery|surgery
642105|NCT00473551|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
642106|NCT00473551|Lymphoma|lymphoma
642107|NCT00473551|Myeloma|myeloma
642108|NCT00473551|Leukemia|leukemia
642109|NCT00473551|Anti-Third Party Cytolytic Lymphocytes|anti-third party cytolytic lymphocytes
642110|NCT00473551|Indolent Lymphoid Malignancies|indolent lymphoid malignancies
642111|NCT00473551|Fludarabine|fludarabine
642112|NCT00473551|Fludara|fludara
642113|NCT00473551|Rituximab|rituximab
642114|NCT00473551|Rituxan|rituxan
642115|NCT00473551|Cyclophosphamide|cyclophosphamide
642116|NCT00473551|Cytoxan®|cytoxan®
642117|NCT00473551|Neosar®|neosar®
642118|NCT00473551|Stem Cell Transplantation|stem cell transplantation
642119|NCT00473551|T-lymphocytes|t-lymphocytes
642120|NCT00473551|Miltenyi CliniMACS System|miltenyi clinimacs system
642121|NCT00473551|Graft vs. Host Disease|graft vs. host disease
642122|NCT00473551|GVHD|gvhd
642123|NCT00473551|Allogenic Transplant|allogenic transplant
642124|NCT00473551|Sirolimus|sirolimus
642125|NCT00473551|Rapamycin|rapamycin
642126|NCT00473538|Structured exercise training program|structured exercise training program
642127|NCT00473538|Infertility|infertility
642128|NCT00473538|Menstrual cycle|menstrual cycle
642129|NCT00473538|PCOS|pcos
642130|NCT00473538|Treatment|treatment
642131|NCT00473512|Abiraterone acetate|abiraterone acetate
642132|NCT00473512|CB7630|cb7630
642133|NCT00473512|Prostatic neoplasms|prostatic neoplasms
642134|NCT00473512|Hormone refractory prostate cancer|hormone refractory prostate cancer
642135|NCT00473512|Castration resistant prostate cancer|castration resistant prostate cancer
642136|NCT00473512|Castration refractory prostate cancer|castration refractory prostate cancer
642137|NCT00473499|drug eluting balloon|drug eluting balloon
642138|NCT00473499|drug eluting stent|drug eluting stent
642139|NCT00473499|stem cells|stem cells
642140|NCT00473473|homeopathy|homeopathy
642141|NCT00473473|Traumeel|traumeel
642142|NCT00473473|mechanical ventilation|mechanical ventilation
642143|NCT00473473|secretions|secretions
642144|NCT00473460|Chronic bronchitis|chronic bronchitis
642145|NCT00473460|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
642146|NCT00473460|Acute exacerbation of chronic bronchitis|acute exacerbation of chronic bronchitis
642147|NCT00473460|Prevention therapy|prevention therapy
642148|NCT00473460|Antibiotics|antibiotics
642149|NCT00473460|Fluoroquinolone|fluoroquinolone
642150|NCT00473460|Moxifloxacin|moxifloxacin
642151|NCT00473460|AECB|aecb
642152|NCT00473447|Rehabilitation|rehabilitation
642153|NCT00473447|Children|children
642154|NCT00473447|Cerebral Palsy|cerebral palsy
642155|NCT00473447|Arm|arm
642156|NCT00473447|Paresis|paresis
642157|NCT00473434|Schizophrenia|schizophrenia
642158|NCT00473434|Drug Therapy|drug therapy
642159|NCT00473434|Treatment Outcome|treatment outcome
642160|NCT00473408|Glioma|glioma
642161|NCT00473408|DCE-MRI|dce-mri
642162|NCT00473408|Angiogenesis|angiogenesis
642163|NCT00473408|Cancer stem cells|cancer stem cells
642164|NCT00473408|Tumor vasculature|tumor vasculature
642165|NCT00473382|Lucentis|lucentis
642166|NCT00473382|DME|dme
642167|NCT00473382|Diabetes|diabetes
642168|NCT00473382|Vision loss|vision loss
642169|NCT00473369|atypical adenoma|atypical adenoma
642170|NCT00473369|Ki-67|ki-67
642171|NCT00473369|p53|p53
642172|NCT00473369|pituitary|pituitary
642173|NCT00473369|prognosis|prognosis
642174|NCT00473356|Morbid obesity|morbid obesity
642175|NCT00473356|Lean body mass|lean body mass
642176|NCT00473356|amino acid supplement|amino acid supplement
642177|NCT00473356|laparoscopic gastric bypass|laparoscopic gastric bypass
642178|NCT00473343|Photodynamic therapy (PDT)|photodynamic therapy (pdt)
642179|NCT00473343|PDT with Metvix cream|pdt with metvix cream
642180|NCT00473343|"High risk BCC"|"high risk bcc"
642181|NCT00473343|Basal Cell carcinoma|basal cell carcinoma
642182|NCT00473343|Histologically confirmed complete response|histologically confirmed complete response
642183|NCT00473330|Lucentis|lucentis
642184|NCT00473330|DME|dme
642185|NCT00473330|Diabetes|diabetes
642186|NCT00473330|Vision loss|vision loss
642187|NCT00473317|sunlight|sunlight
642188|NCT00473317|UVB|uvb
642189|NCT00473317|Vitamin D|vitamin d
642190|NCT00473304|Safety|safety
642191|NCT00473304|Efficacy|efficacy
642192|NCT00473304|Adaptation|adaptation
642193|NCT00473304|myopia and contact lens wear in children|myopia and contact lens wear in children
642194|NCT00473291|pleural effusion|pleural effusion
642195|NCT00473291|lung sounds|lung sounds
642196|NCT00473291|acoustic monitoring|acoustic monitoring
642197|NCT00473278|tear protein|tear protein
642198|NCT00473252|aspergillus infections|aspergillus infections
642199|NCT00473252|immunosuppression|immunosuppression
642200|NCT00473252|kidney transplantation|kidney transplantation
642201|NCT00473252|hemodialysis|hemodialysis
642202|NCT00473252|galactomannan test|galactomannan test
642203|NCT00473252|fine dust|fine dust
642204|NCT00473252|construction activity|construction activity
642205|NCT00473252|airborne aspergillus spores|airborne aspergillus spores
642206|NCT00473239|vitamin D|vitamin d
642207|NCT00473239|cholecalciferol|cholecalciferol
642208|NCT00473239|25-hydroxyvitamin D|25-hydroxyvitamin d
642209|NCT00473213|Multiple Sclerosis|multiple sclerosis
642210|NCT00473213|Interferon|interferon
642211|NCT00473213|Magnetic Resonance|magnetic resonance
642212|NCT00473200|hyperhomocysteinemia|hyperhomocysteinemia
642213|NCT00473200|homocysteine|homocysteine
642214|NCT00473200|S-adenosylmethionine|s-adenosylmethionine
642215|NCT00473200|SAMe|same
642216|NCT00473200|Asymmetric dimethylagrinine (ADMA)|asymmetric dimethylagrinine (adma)
642217|NCT00473187|X-linked dominant hypophosphatemic rickets|x-linked dominant hypophosphatemic rickets
642218|NCT00473187|growth disorders|growth disorders
642219|NCT00473187|anthropometry|anthropometry
642220|NCT00473187|human growth hormone|human growth hormone
642221|NCT00473174|Ramipril|ramipril
642222|NCT00473174|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
642223|NCT00473174|Chronotherapy|chronotherapy
642224|NCT00473174|Circadian|circadian
642225|NCT00473174|Non-dipper|non-dipper
642226|NCT00473161|movement disorders|movement disorders
642227|NCT00473161|childhood|childhood
642228|NCT00473148|Duration of weaning from invasive ventilation|duration of weaning from invasive ventilation
642229|NCT00473148|Mechanical ventilation|mechanical ventilation
642230|NCT00473148|Weaning|weaning
642231|NCT00473148|B-type natriuretic peptide|b-type natriuretic peptide
642232|NCT00473148|Fluid balance|fluid balance
642233|NCT00473148|Diuretics|diuretics
642234|NCT00473148|Intubated patient receiving mechanical ventilation|intubated patient receiving mechanical ventilation
642235|NCT00473148|for at least 24 hours|for at least 24 hours
642236|NCT00473148|Respiratory insufficiency|respiratory insufficiency
642237|NCT00473135|Dengue Fever|dengue fever
642238|NCT00473135|Dengue Vaccine|dengue vaccine
642239|NCT00473135|Dengue Virus|dengue virus
642240|NCT00473135|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
642241|NCT00473135|Dengue Shock Syndrome|dengue shock syndrome
642242|NCT00473122|Breast Cancer|breast cancer
642243|NCT00473122|Breast Reconstruction|breast reconstruction
642244|NCT00473122|Delayed-Immediate Reconstruction|delayed-immediate reconstruction
642245|NCT00473122|Postmastectomy Radiation Therapy|postmastectomy radiation therapy
642246|NCT00473122|Mastectomy|mastectomy
642247|NCT00473122|XRT|xrt
642248|NCT00473109|Hemodialysis|hemodialysis
642249|NCT00473109|Heparin|heparin
642250|NCT00473109|Clotting|clotting
642251|NCT00473096|Decision making|decision making
642252|NCT00473096|Patient Education|patient education
642253|NCT00473096|Indigency|indigency
642254|NCT00473096|Minority group|minority group
642255|NCT00473083|Rash|rash
642256|NCT00473083|Erlotinib|erlotinib
642257|NCT00473083|Lung Cancer|lung cancer
642258|NCT00473057|acute stroke|acute stroke
642259|NCT00473057|middle cerebral artery|middle cerebral artery
642387|NCT00472459|Actinic keratosis|actinic keratosis
642260|NCT00473057|autologous transplantation|autologous transplantation
642261|NCT00473057|bone marrow cells|bone marrow cells
642262|NCT00473057|stem cells|stem cells
642263|NCT00473057|cell therapy|cell therapy
642264|NCT00473031|bone mass|bone mass
642265|NCT00473031|calcium absorption|calcium absorption
642266|NCT00473031|bone quality|bone quality
642267|NCT00473031|fracture risk|fracture risk
642268|NCT00473018|postexposure prophylaxis|postexposure prophylaxis
642269|NCT00473018|HIV Seronegativity|hiv seronegativity
642270|NCT00472992|Pregnancy|pregnancy
642271|NCT00472992|TYSABRI|tysabri
642272|NCT00472940|Cancer|cancer
642273|NCT00472940|Hypogonadism|hypogonadism
642274|NCT00472940|testosterone|testosterone
642275|NCT00472940|cachexia|cachexia
642276|NCT00472914|Hypertonia|hypertonia
642277|NCT00472914|Childhood|childhood
642278|NCT00472901|Polymorphic Light Eruption (PLE)|polymorphic light eruption (ple)
642279|NCT00472901|Afamelanotide|afamelanotide
642280|NCT00472901|CUV1647|cuv1647
642281|NCT00472901|photoprotection|photoprotection
642282|NCT00472901|sun poisoning|sun poisoning
642283|NCT00472888|Alpha-adrenergic blockers|alpha-adrenergic blockers
642284|NCT00472888|cataract surgery|cataract surgery
642285|NCT00472888|pseudoexfoliation syndrome|pseudoexfoliation syndrome
642286|NCT00472888|diabetes mellitus|diabetes mellitus
642287|NCT00472888|hypertension|hypertension
642288|NCT00472888|pupil|pupil
642289|NCT00472875|hypoglycaemia|hypoglycaemia
642290|NCT00472875|type 1 diabetes mellitus|type 1 diabetes mellitus
642291|NCT00472849|OFAR 2|ofar 2
642292|NCT00472849|Oxaliplatin|oxaliplatin
642293|NCT00472849|Fludarabine|fludarabine
642294|NCT00472849|Cytarabine|cytarabine
642295|NCT00472849|Ara-C|ara-c
642296|NCT00472849|Rituximab|rituximab
642297|NCT00472849|Richter's Transformation|richter's transformation
642298|NCT00472849|Prolymphocytic Leukemia|prolymphocytic leukemia
642299|NCT00472849|B-Cell Chronic Lymphocytic Leukemia|b-cell chronic lymphocytic leukemia
642300|NCT00472849|Leukemia|leukemia
642301|NCT00472849|CLL|cll
642302|NCT00472823|cholecalciferol|cholecalciferol
642303|NCT00472823|vitamin D deficiency|vitamin d deficiency
642304|NCT00472823|bone density|bone density
642305|NCT00472823|dietary calcium|dietary calcium
642306|NCT00472823|hypercalcemia|hypercalcemia
642307|NCT00472823|hypercalciuria|hypercalciuria
642308|NCT00472810|Glaucoma|glaucoma
642309|NCT00472810|Collagen matrix|collagen matrix
642310|NCT00472810|ologen|ologen
642311|NCT00472810|OculusGen|oculusgen
642312|NCT00472810|Antifibrotic|antifibrotic
642313|NCT00472810|Trabeculectomy|trabeculectomy
642314|NCT00472810|anti scarring|anti scarring
642315|NCT00472810|tissue engineering|tissue engineering
642316|NCT00472810|high risk patient for trabeculectomy|high risk patient for trabeculectomy
642317|NCT00472810|Aeon Astron|aeon astron
642318|NCT00472771|Recurrent extensive small cell lung cancer|recurrent extensive small cell lung cancer
642319|NCT00472745|bone mass|bone mass
642320|NCT00472745|calcium absorption|calcium absorption
642321|NCT00472745|bone quality|bone quality
642322|NCT00472745|fracture risk|fracture risk
642323|NCT00472745|arthritis|arthritis
642324|NCT00472745|osteoporosis|osteoporosis
642325|NCT00472732|UCD|ucd
642326|NCT00472732|OTCD|otcd
642327|NCT00472732|Ammonia|ammonia
642328|NCT00472732|Urea Metabolism|urea metabolism
642329|NCT00472732|Inborn Errors|inborn errors
642330|NCT00472719|HIV Seronegativity|hiv seronegativity
642331|NCT00472719|HIV Preventive Vaccine|hiv preventive vaccine
642332|NCT00472719|Adenovirus|adenovirus
642333|NCT00472706|Treatment|treatment
642334|NCT00472706|Excision|excision
642335|NCT00472706|Photodynamic therapy|photodynamic therapy
642336|NCT00472706|Recurrence rate|recurrence rate
642337|NCT00472706|Cosmetic outcome|cosmetic outcome
642338|NCT00472693|Breast cancer|breast cancer
642339|NCT00472693|Metastatic breast cancer|metastatic breast cancer
642340|NCT00472693|Second-Line Therapy|second-line therapy
642341|NCT00472693|Triple Negative|triple negative
642342|NCT00472693|Her-2 negative|her-2 negative
642343|NCT00472693|Hormone receptor negative|hormone receptor negative
642344|NCT00472693|Abraxane|abraxane
642345|NCT00472693|Bevacizumab|bevacizumab
642346|NCT00472680|bone mass|bone mass
642347|NCT00472680|calcium absorption|calcium absorption
642348|NCT00472680|bone quality|bone quality
642349|NCT00472680|fracture risk|fracture risk
642350|NCT00472667|Bacterial infections|bacterial infections
642351|NCT00472667|Procalcitonin|procalcitonin
642352|NCT00472667|Intensive care unit|intensive care unit
642353|NCT00472667|Antibiotic therapy|antibiotic therapy
642354|NCT00472667|Suspicion of bacterial infection or proven|suspicion of bacterial infection or proven
642355|NCT00472654|bone mass|bone mass
642356|NCT00472654|calcium absorption|calcium absorption
642357|NCT00472654|bone quality|bone quality
642358|NCT00472654|fracture risk|fracture risk
642359|NCT00472615|Bipolar Disorder|bipolar disorder
642360|NCT00472615|Menstrual Cycle|menstrual cycle
642361|NCT00472615|Depression|depression
642362|NCT00472615|Mania or Hypomania|mania or hypomania
642363|NCT00472615|Predictor|predictor
642364|NCT00472602|Opisthorchis viverrini, liver fluke, Thailand, cancer|opisthorchis viverrini, liver fluke, thailand, cancer
642365|NCT00472576|NMDA Receptor|nmda receptor
642366|NCT00472576|Depression Treatment|depression treatment
642367|NCT00472576|Unipolar Depression|unipolar depression
642368|NCT00472576|Treatment Resistant|treatment resistant
642369|NCT00472576|Glutamatergic|glutamatergic
642370|NCT00472576|Depression|depression
642371|NCT00472576|Major Depression|major depression
642372|NCT00472563|bicarbonate|bicarbonate
642373|NCT00472563|nephropathy|nephropathy
642374|NCT00472563|contrast|contrast
642375|NCT00472550|esomeprazole, gastric emptying, reflux|esomeprazole, gastric emptying, reflux
642376|NCT00472537|Ventral hernia|ventral hernia
642377|NCT00472537|Incisional hernia|incisional hernia
642378|NCT00472498|Cardiac Arrest|cardiac arrest
642379|NCT00472498|Biphasic Defibrillator|biphasic defibrillator
642380|NCT00472472|restenosis|restenosis
642381|NCT00472472|peripheral arterial disease|peripheral arterial disease
642382|NCT00472472|paccocath|paccocath
642383|NCT00472472|drug-coated balloon|drug-coated balloon
642384|NCT00472459|Non-melanoma skin cancer|non-melanoma skin cancer
642385|NCT00472459|Organ transplant recipients|organ transplant recipients
642386|NCT00472459|Photodynamic therapy|photodynamic therapy
642388|NCT00472446|Surgery|surgery
642389|NCT00472446|Thyroid gland|thyroid gland
642390|NCT00472446|cervical block|cervical block
642391|NCT00472446|Pain, Postoperative|pain, postoperative
642392|NCT00472433|Alemtuzumab in autoimmune cytopenias|alemtuzumab in autoimmune cytopenias
642393|NCT00472407|Normal|normal
642394|NCT00472394|Medical abortion|medical abortion
642395|NCT00472394|Preferences|preferences
642396|NCT00472394|Willingness to Pay|willingness to pay
642397|NCT00472381|Acute Ischemic Stroke|acute ischemic stroke
642398|NCT00472381|Post-Stroke Hyperglycaemia|post-stroke hyperglycaemia
642399|NCT00472381|Insulin treatment|insulin treatment
642400|NCT00472381|Insulin|insulin
642401|NCT00472381|DWI|dwi
642402|NCT00472381|MRI|mri
642403|NCT00472368|Advanced cancer|advanced cancer
642404|NCT00472368|lymphoma|lymphoma
642405|NCT00472368|chronic hematological malignancies|chronic hematological malignancies
642406|NCT00472368|adult|adult
642407|NCT00472355|Parkinson's disease|parkinson's disease
642408|NCT00472355|PD|pd
642409|NCT00472355|apomorphine|apomorphine
642410|NCT00472342|impaired glucose tolerance|impaired glucose tolerance
642411|NCT00472342|impaired fasting glucose|impaired fasting glucose
642412|NCT00472342|diabetes|diabetes
642413|NCT00472342|adipokine|adipokine
642414|NCT00472342|adiponectin|adiponectin
642415|NCT00472342|RBP-4|rbp-4
642416|NCT00472342|adrenomedullin|adrenomedullin
642417|NCT00472303|Opioid|opioid
642418|NCT00472303|Central acting analgesic|central acting analgesic
642419|NCT00472303|CG5503 PR|cg5503 pr
642420|NCT00472303|Tumor related pain|tumor related pain
642421|NCT00472303|Cancer related pain|cancer related pain
642422|NCT00472303|Morphine|morphine
642423|NCT00472303|Pain assessment|pain assessment
642424|NCT00472303|Placebo|placebo
642425|NCT00472290|Hematology|hematology
642426|NCT00472290|MDS|mds
642427|NCT00472290|Myelodysplastic Syndromes|myelodysplastic syndromes
642428|NCT00472290|Thrombocytopenia|thrombocytopenia
642429|NCT00472264|methodology study, PET Imaging, COPD patients|methodology study, pet imaging, copd patients
642430|NCT00472251|dutasteride|dutasteride
642431|NCT00472251|body mass index|body mass index
642432|NCT00472251|testosterone|testosterone
642433|NCT00472225|Chronic graft-versus-host disease|chronic graft-versus-host disease
642434|NCT00472225|rituximab|rituximab
642435|NCT00472186|Tonsillectomy|tonsillectomy
642436|NCT00472186|Pain|pain
642437|NCT00472173|Apexification|apexification
642438|NCT00472173|Pulp necrosis|pulp necrosis
642439|NCT00472173|Calcium hydroxide|calcium hydroxide
642440|NCT00472173|MTA|mta
642441|NCT00472173|pulp necrosis of an anterior immature tooth|pulp necrosis of an anterior immature tooth
642442|NCT00472160|Preoxygenation|preoxygenation
642443|NCT00472160|Non Invasive Ventilation|non invasive ventilation
642444|NCT00472160|Continuous Positive Airway Pressure,|continuous positive airway pressure,
642445|NCT00472160|Intubation,|intubation,
642446|NCT00472160|Organ failure|organ failure
642447|NCT00472134|Hernia|hernia
642448|NCT00472134|Ventral|ventral
642449|NCT00472134|Laparoscopic Hernia Repair|laparoscopic hernia repair
642450|NCT00472108|Nodular Basal Cell Carcinoma|nodular basal cell carcinoma
642451|NCT00472108|Basal Cell Carcinoma|basal cell carcinoma
642452|NCT00472108|PDT with Metvix 160 mg/g cream|pdt with metvix 160 mg/g cream
642453|NCT00472108|PDT with placebo cream|pdt with placebo cream
642454|NCT00472108|Histological verification|histological verification
642455|NCT00472095|diabetes|diabetes
642456|NCT00472095|fotonovela|fotonovela
642457|NCT00472095|Latino|latino
642458|NCT00472082|Immunosuppression|immunosuppression
642459|NCT00472082|Renal Transplantation|renal transplantation
642460|NCT00472069|Stress Urinary Incontinence|stress urinary incontinence
642461|NCT00472069|striated urethral sphincter insufficiency|striated urethral sphincter insufficiency
642462|NCT00472069|myofibers|myofibers
642463|NCT00472069|satellite cells|satellite cells
642464|NCT00472069|myotubes|myotubes
642465|NCT00472069|urethral|urethral
642466|NCT00472069|Muscle fibres|muscle fibres
642467|NCT00472056|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
642468|NCT00472056|Lymphoid Malignancies|lymphoid malignancies
642469|NCT00472056|Lymphoma|lymphoma
642470|NCT00472056|BEAM Chemotherapy|beam chemotherapy
642471|NCT00472056|Carmustine|carmustine
642472|NCT00472056|BCNU|bcnu
642473|NCT00472056|BiCNU|bicnu
642474|NCT00472056|Etoposide|etoposide
642475|NCT00472056|VePesid|vepesid
642476|NCT00472056|Cytarabine|cytarabine
642477|NCT00472056|Cytosar|cytosar
642478|NCT00472056|DepoCyt|depocyt
642479|NCT00472056|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
642480|NCT00472056|Ara-C|ara-c
642481|NCT00472056|Melphalan|melphalan
642482|NCT00472056|Rituximab|rituximab
642483|NCT00472056|Rituxan|rituxan
642484|NCT00472043|Nodular Basal Cell Carcinoma|nodular basal cell carcinoma
642485|NCT00472043|Basal Cell Carcinoma|basal cell carcinoma
642486|NCT00472043|Photodynamic therapy (PDT)|photodynamic therapy (pdt)
642487|NCT00472043|Metvix|metvix
642488|NCT00472043|Histological verification|histological verification
642489|NCT00472043|PDT with Metvix cream|pdt with metvix cream
642490|NCT00472043|PDT with Placebo cream|pdt with placebo cream
642491|NCT00472030|bullous pemphigoid|bullous pemphigoid
642492|NCT00472030|omalizumab|omalizumab
642493|NCT00472030|xolair|xolair
642494|NCT00472030|IgE|ige
642495|NCT00472030|autoimmunity|autoimmunity
642496|NCT00472030|skin disease|skin disease
642497|NCT00472017|untreated childhood brain stem glioma|untreated childhood brain stem glioma
642498|NCT00471991|Oral contraceptive|oral contraceptive
642499|NCT00471991|ovulation inhibitory effect|ovulation inhibitory effect
642500|NCT00471978|non-small cell lung cancer|non-small cell lung cancer
642501|NCT00471978|small cell lung cancer|small cell lung cancer
642502|NCT00471978|pulmonary carcinoid tumor|pulmonary carcinoid tumor
642503|NCT00471952|Migraine|migraine
642504|NCT00471939|Burn, Meshed skin graft, PDGF|burn, meshed skin graft, pdgf
642505|NCT00471939|deep partial thickness or full thickness burns|deep partial thickness or full thickness burns
642506|NCT00471926|Diabetes Care|diabetes care
642507|NCT00471913|Femur|femur
642508|NCT00471913|Fracture|fracture
642509|NCT00471913|Antegrade|antegrade
642510|NCT00471913|Nailing|nailing
642511|NCT00471913|Shaft|shaft
642512|NCT00471913|Abductor|abductor
642513|NCT00471887|stage III melanoma|stage iii melanoma
642514|NCT00471887|stage IV melanoma|stage iv melanoma
642515|NCT00471887|recurrent melanoma|recurrent melanoma
642516|NCT00471861|Inflammatory Markers|inflammatory markers
642517|NCT00471861|Migraine|migraine
642518|NCT00471848|Thymoglobuline|thymoglobuline
642519|NCT00471848|Rabbit ATG|rabbit atg
642520|NCT00471848|Ciclosporin|ciclosporin
642521|NCT00471848|Aplastic Anemia|aplastic anemia
642522|NCT00471835|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
642523|NCT00471835|stage I non-small cell lung cancer|stage i non-small cell lung cancer
642524|NCT00471835|adenocarcinoma of the lung|adenocarcinoma of the lung
642525|NCT00471835|adenosquamous cell lung cancer|adenosquamous cell lung cancer
642526|NCT00471835|large cell lung cancer|large cell lung cancer
642527|NCT00471835|squamous cell lung cancer|squamous cell lung cancer
642528|NCT00471822|Streptococcus pneumoniae nasopharyngeal carriage|streptococcus pneumoniae nasopharyngeal carriage
642529|NCT00471796|Patients with functional chest pain and functional heartburns|patients with functional chest pain and functional heartburns
642530|NCT00471783|gingivitis|gingivitis
642531|NCT00471783|chlorhexidine|chlorhexidine
642532|NCT00471783|dental floss|dental floss
642534|NCT00471783|bleeding on probing|bleeding on probing
642535|NCT00471783|gingival and plaque indices|gingival and plaque indices
642536|NCT00471757|pnuemonia|pnuemonia
642537|NCT00471757|influenca|influenca
642538|NCT00471744|benign epilepsy|benign epilepsy
642539|NCT00471744|pediatrics|pediatrics
642540|NCT00471744|children|children
642541|NCT00471744|rolandic epilepsy|rolandic epilepsy
642542|NCT00471744|levetiracetam|levetiracetam
642543|NCT00471744|sulthiame|sulthiame
642544|NCT00471731|Ocular Surface Disease|ocular surface disease
642545|NCT00471731|Imprinting|imprinting
642546|NCT00471731|Eye Abnormalities|eye abnormalities
642547|NCT00471731|Ovarian Insufficiency|ovarian insufficiency
642548|NCT00471731|Women's Eye Health and Disease|women's eye health and disease
642549|NCT00471731|Turner Syndrome|turner syndrome
642550|NCT00471731|TS|ts
642551|NCT00471731|Premature Ovarian Failure|premature ovarian failure
642552|NCT00471731|POF|pof
642553|NCT00471731|Healthy Volunteer|healthy volunteer
642554|NCT00471731|HV|hv
642555|NCT00471718|adenocarcinoma of the prostate|adenocarcinoma of the prostate
642556|NCT00471718|stage IV prostate cancer|stage iv prostate cancer
642557|NCT00471718|recurrent prostate cancer|recurrent prostate cancer
642558|NCT00471705|Miltefosine|miltefosine
642559|NCT00471705|Leishmaniasis|leishmaniasis
642560|NCT00471705|Glucantime|glucantime
642561|NCT00471705|Thermotherapy|thermotherapy
642562|NCT00471705|Colombia|colombia
642563|NCT00471679|disseminated neuroblastoma|disseminated neuroblastoma
642564|NCT00471679|localized unresectable neuroblastoma|localized unresectable neuroblastoma
642565|NCT00471679|recurrent neuroblastoma|recurrent neuroblastoma
642566|NCT00471679|regional neuroblastoma|regional neuroblastoma
642567|NCT00471679|stage 4S neuroblastoma|stage 4s neuroblastoma
642568|NCT00471666|Malaria|malaria
642569|NCT00471666|Filariasis|filariasis
642570|NCT00471666|Coinfection|coinfection
642571|NCT00471666|Co-Infection|co-infection
642572|NCT00471653|thrombocytopenia|thrombocytopenia
642573|NCT00471653|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
642574|NCT00471653|adult brain stem glioma|adult brain stem glioma
642575|NCT00471653|adult mixed glioma|adult mixed glioma
642576|NCT00471653|adult giant cell glioblastoma|adult giant cell glioblastoma
642577|NCT00471653|adult gliosarcoma|adult gliosarcoma
642578|NCT00471653|adult glioblastoma|adult glioblastoma
642579|NCT00471653|adult anaplastic astrocytoma|adult anaplastic astrocytoma
642580|NCT00471653|adult anaplastic ependymoma|adult anaplastic ependymoma
642581|NCT00471653|adult pineal gland astrocytoma|adult pineal gland astrocytoma
642582|NCT00471640|pneumonia|pneumonia
642583|NCT00471640|dexamethasone|dexamethasone
642584|NCT00471640|community-acquired pneumonia|community-acquired pneumonia
642585|NCT00471614|HIV|hiv
642586|NCT00471614|AIDS|aids
642587|NCT00471614|uridine|uridine
642588|NCT00471614|mitochondria|mitochondria
642589|NCT00471614|insulin resistance|insulin resistance
642590|NCT00471614|Treatment Experienced|treatment experienced
642591|NCT00471601|recurrent breast cancer|recurrent breast cancer
642592|NCT00471601|stage IA breast cancer|stage ia breast cancer
642593|NCT00471601|stage IB breast cancer|stage ib breast cancer
642594|NCT00471601|stage II breast cancer|stage ii breast cancer
642595|NCT00471601|stage IIIA breast cancer|stage iiia breast cancer
642596|NCT00471601|stage IIIB breast cancer|stage iiib breast cancer
642597|NCT00471601|stage IIIC breast cancer|stage iiic breast cancer
642598|NCT00471601|stage IV breast cancer|stage iv breast cancer
642599|NCT00471588|Dopamine|dopamine
642600|NCT00471588|OCD|ocd
642601|NCT00471588|MRI|mri
642602|NCT00471588|stimulant users|stimulant users
642603|NCT00471575|fatty liver|fatty liver
642604|NCT00471575|pregnancy|pregnancy
642605|NCT00471575|ultra sound|ultra sound
642606|NCT00471575|Pregnant women at the end of pregnancy or immediately after birth.|pregnant women at the end of pregnancy or immediately after birth.
642607|NCT00471575|controls-women with normal liver|controls-women with normal liver
642608|NCT00471575|correlation between ultrasonography and nutritional, obsthetric and laboratory data.|correlation between ultrasonography and nutritional, obsthetric and laboratory data.
642609|NCT00471562|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
642610|NCT00471549|Diabetes|diabetes
642611|NCT00471549|Dyslipidaemia|dyslipidaemia
642612|NCT00471549|Atherosclerosis|atherosclerosis
642613|NCT00471549|Osteoprotegerin|osteoprotegerin
642614|NCT00471549|Adhesion molecules|adhesion molecules
642615|NCT00471549|Simvastatin|simvastatin
642616|NCT00471523|Anovulation|anovulation
642617|NCT00471523|Clomiphene citrate|clomiphene citrate
642618|NCT00471523|Infertility|infertility
642619|NCT00471523|Metformin|metformin
642620|NCT00471523|PCOS|pcos
642621|NCT00471523|Treatment|treatment
642622|NCT00471510|androgenetic alopecia|androgenetic alopecia
642623|NCT00471510|male pattern hair loss|male pattern hair loss
642624|NCT00471510|male pattern baldness|male pattern baldness
642625|NCT00471510|androgenetic alopecia or male pattern hair loss|androgenetic alopecia or male pattern hair loss
642626|NCT00471497|leukemia|leukemia
642627|NCT00471497|bone marrow|bone marrow
642628|NCT00471497|leukemia symptoms|leukemia symptoms
642629|NCT00471497|lukemia|lukemia
642630|NCT00471497|cml|cml
642631|NCT00471497|complete blood count|complete blood count
642632|NCT00471497|lymphocyte|lymphocyte
642633|NCT00471497|blood cancer|blood cancer
642634|NCT00471497|leukocytes|leukocytes
642635|NCT00471497|chronic leukemia|chronic leukemia
642636|NCT00471497|bone marrow biopsy|bone marrow biopsy
642637|NCT00471497|leukemia research|leukemia research
642638|NCT00471497|leukemia cells|leukemia cells
642639|NCT00471497|bone marrow disease|bone marrow disease
642640|NCT00471497|chronic myeloid leukemia|chronic myeloid leukemia
642641|NCT00471497|blood cancer symptoms|blood cancer symptoms
642642|NCT00471497|white blood cell diseases|white blood cell diseases
642643|NCT00471497|chronic myelogenous leukemia|chronic myelogenous leukemia
642644|NCT00471497|leukemia treatment|leukemia treatment
642645|NCT00471497|leukemia facts|leukemia facts
642646|NCT00471497|leucemia|leucemia
642647|NCT00471497|facts about leukemia|facts about leukemia
642648|NCT00471497|myelogenous leukemia|myelogenous leukemia
642649|NCT00471497|newly diagnosed CML|newly diagnosed cml
642650|NCT00471497|newly diagnosed Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia in chronic phase (CML-CP)|newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukemia in chronic phase (cml-cp)
642651|NCT00471484|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
642652|NCT00471484|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
642653|NCT00471484|advanced adult primary liver cancer|advanced adult primary liver cancer
642654|NCT00471484|childhood hepatocellular carcinoma|childhood hepatocellular carcinoma
642655|NCT00471484|stage III childhood liver cancer|stage iii childhood liver cancer
642656|NCT00471484|stage IV childhood liver cancer|stage iv childhood liver cancer
642657|NCT00471471|recurrent melanoma|recurrent melanoma
642658|NCT00471471|stage IV melanoma|stage iv melanoma
642659|NCT00471471|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
642660|NCT00471471|extraocular extension melanoma|extraocular extension melanoma
642661|NCT00471471|iris melanoma|iris melanoma
642662|NCT00471471|recurrent intraocular melanoma|recurrent intraocular melanoma
642663|NCT00471471|metastatic intraocular melanoma|metastatic intraocular melanoma
642664|NCT00471471|conjunctival melanoma|conjunctival melanoma
642665|NCT00471471|stage IIIA melanoma|stage iiia melanoma
642666|NCT00471471|stage IIIB melanoma|stage iiib melanoma
642667|NCT00471471|stage IIIC melanoma|stage iiic melanoma
642668|NCT00471458|Radioiodine|radioiodine
642669|NCT00471458|Hyperthyroidism|hyperthyroidism
642670|NCT00471458|Morbidity|morbidity
642671|NCT00471458|Cardiovascular diseases|cardiovascular diseases
642672|NCT00471445|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
642673|NCT00471445|pain|pain
642674|NCT00471445|neurotoxicity|neurotoxicity
642675|NCT00471445|peripheral neuropathy|peripheral neuropathy
642676|NCT00471432|recurrent prostate cancer|recurrent prostate cancer
642677|NCT00471432|stage IV prostate cancer|stage iv prostate cancer
642678|NCT00471432|recurrent renal cell cancer|recurrent renal cell cancer
642679|NCT00471432|stage IV renal cell cancer|stage iv renal cell cancer
642680|NCT00471432|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
642681|NCT00471432|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
642682|NCT00471432|recurrent bladder cancer|recurrent bladder cancer
642683|NCT00471432|stage IV bladder cancer|stage iv bladder cancer
642684|NCT00471432|recurrent breast cancer|recurrent breast cancer
642685|NCT00471432|stage IV breast cancer|stage iv breast cancer
642686|NCT00471432|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
642687|NCT00471432|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
642688|NCT00471432|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
642689|NCT00471432|male breast cancer|male breast cancer
642690|NCT00471393|TMJ|tmj
642691|NCT00471393|Osteoarthritis|osteoarthritis
642692|NCT00471393|Degenerative Joint disease|degenerative joint disease
642693|NCT00471367|Phase I|phase i
642694|NCT00471367|AZD4877|azd4877
642695|NCT00471367|Lymphoma|lymphoma
642696|NCT00471367|B-cell non-Hodgkin lymphoma|b-cell non-hodgkin lymphoma
642697|NCT00471341|arteriosclerosis|arteriosclerosis
642698|NCT00471341|coronary disease|coronary disease
642699|NCT00471341|inflammation|inflammation
642700|NCT00471341|COX-2 inhibition|cox-2 inhibition
642701|NCT00471341|hypertension|hypertension
642702|NCT00471328|GIST|gist
642703|NCT00471328|adults|adults
642704|NCT00471328|imatinib resistant|imatinib resistant
642705|NCT00471328|sunitinib resistant|sunitinib resistant
642706|NCT00471328|AMN107|amn107
642707|NCT00471328|nilotinib|nilotinib
642708|NCT00471328|treatment|treatment
642709|NCT00471328|Gastrointestinal stromal tumor (GIST)|gastrointestinal stromal tumor (gist)
642710|NCT00471315|SOD|sod
642711|NCT00471315|Common Bile Duct Diseases|common bile duct diseases
642712|NCT00471315|Sphincterotomy|sphincterotomy
642713|NCT00471315|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
642714|NCT00471302|Healthy Volunteers|healthy volunteers
642715|NCT00471302|Immunological Parameters|immunological parameters
642716|NCT00471302|Mali|mali
642717|NCT00471302|B Lymphocyte|b lymphocyte
642718|NCT00471302|Malaria|malaria
642719|NCT00471302|Healthy Volunteer|healthy volunteer
642720|NCT00471289|Critical Limb Ischemia|critical limb ischemia
642721|NCT00471289|Stents|stents
642722|NCT00471289|Drug Eluting Stents|drug eluting stents
642723|NCT00471289|Peripheral arterial disease|peripheral arterial disease
642724|NCT00471289|PAD|pad
642725|NCT00471289|Paclitaxel|paclitaxel
642726|NCT00471289|TAXUS|taxus
642727|NCT00471289|Infrapopliteal|infrapopliteal
642728|NCT00471289|Infragenicular|infragenicular
642729|NCT00471289|Interventional Radiology|interventional radiology
642730|NCT00471289|CLI|cli
642731|NCT00471289|DES|des
642732|NCT00471276|Metastatic Breast Cancer|metastatic breast cancer
642733|NCT00471250|Bronchoscopy|bronchoscopy
642734|NCT00471250|Bronchoalveolar Lavage|bronchoalveolar lavage
642735|NCT00471250|Nasal Mucosal Biopsy|nasal mucosal biopsy
642736|NCT00471250|Research Procedures|research procedures
642737|NCT00471250|Infection Susceptibility|infection susceptibility
642738|NCT00471250|Lung Infection Susceptibility|lung infection susceptibility
642739|NCT00471250|Healthy Volunteer|healthy volunteer
642740|NCT00471250|HV|hv
642741|NCT00471237|bone mineral density,|bone mineral density,
642742|NCT00471237|Ronacaleret|ronacaleret
642743|NCT00471237|teriparatide|teriparatide
642744|NCT00471237|alendronate,|alendronate,
642745|NCT00471237|Post-menopausal women,|post-menopausal women,
642746|NCT00471237|osteoporosis,|osteoporosis,
642747|NCT00471237|SB-751689|sb-751689
642748|NCT00471185|Male Contraception|male contraception
642749|NCT00471185|Acyline|acyline
642750|NCT00471146|Randomized Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine Plus Placebo For Advanced Pancreatic Cancer.|randomized study of gemcitabine plus ag-013736 versus gemcitabine plus placebo for advanced pancreatic cancer.
642751|NCT00471133|melanoma|melanoma
642752|NCT00471133|DNA vaccine|dna vaccine
642753|NCT00471133|tyrosinase|tyrosinase
642754|NCT00471133|electroporation|electroporation
642755|NCT00471107|Frontal Lobe|frontal lobe
642756|NCT00471107|Language|language
642757|NCT00471107|Dementia|dementia
642758|NCT00471107|Healthy Volunteer|healthy volunteer
642760|NCT00471094|heartburn|heartburn
642761|NCT00471094|erosive esophagitis|erosive esophagitis
642762|NCT00471094|healing|healing
642763|NCT00471094|population pharmacokinetics|population pharmacokinetics
642764|NCT00471094|Quality of Life (QoL)|quality of life (qol)
642765|NCT00471081|Neisseria meningitidis;|neisseria meningitidis;
642766|NCT00471081|Humans;|humans;
642767|NCT00471081|Meningococcal vaccines;|meningococcal vaccines;
642768|NCT00471081|Safety|safety
642769|NCT00471081|Vaccines, conjugate;|vaccines, conjugate;
642770|NCT00471081|Toddlers;|toddlers;
642771|NCT00471081|Immunogenicity;|immunogenicity;
642772|NCT00471055|osteoarthritis|osteoarthritis
642773|NCT00471055|knee|knee
642774|NCT00471055|capsaicin gel|capsaicin gel
642775|NCT00471055|capsicum|capsicum
642776|NCT00471042|Heroin Dependence|heroin dependence
642777|NCT00471042|Opioid Dependence|opioid dependence
642778|NCT00471042|Primary Care|primary care
642779|NCT00471042|Buprenorphine|buprenorphine
642780|NCT00471029|pH study, peptic ulcer, proton pump inhibitor|ph study, peptic ulcer, proton pump inhibitor
642781|NCT00471003|Hypertension|hypertension
642782|NCT00470990|IHH|ihh
642783|NCT00470990|Kallmann syndrome|kallmann syndrome
642784|NCT00470990|hypogonadism|hypogonadism
642785|NCT00470964|laser trabeculoplasty, glaucoma, argon, titanium-sapphire|laser trabeculoplasty, glaucoma, argon, titanium-sapphire
642786|NCT00470964|IOP lowering effect|iop lowering effect
642787|NCT00470964|Adverse effects|adverse effects
642788|NCT00470964|IOP spikes|iop spikes
642789|NCT00470951|rectal cancer|rectal cancer
642790|NCT00470951|laparoscopic assisted resection|laparoscopic assisted resection
642791|NCT00470951|open resection|open resection
642792|NCT00470951|preoperative chemoradiation|preoperative chemoradiation
642793|NCT00470951|randomized trial|randomized trial
642794|NCT00470925|Neurological|neurological
642795|NCT00470925|Dopamine|dopamine
642796|NCT00470912|cutaneous lupus erythemaosus|cutaneous lupus erythemaosus
642797|NCT00470912|photoprotection|photoprotection
642798|NCT00470912|photoprovocation|photoprovocation
642799|NCT00470912|Sunscreen RV 2547C|sunscreen rv 2547c
642800|NCT00470899|Feto-maternal transfusion|feto-maternal transfusion
642801|NCT00470899|Kleihauer-Betke|kleihauer-betke
642802|NCT00470847|Herceptin|herceptin
642803|NCT00470847|breast cancer|breast cancer
642804|NCT00470847|radiation therapy|radiation therapy
642805|NCT00470847|stereotactic radiosurgery|stereotactic radiosurgery
642806|NCT00470847|SRS|srs
642807|NCT00470847|whole brain radiation|whole brain radiation
642808|NCT00470847|WBRT|wbrt
642809|NCT00470834|prostate cancer|prostate cancer
642810|NCT00470834|androgen deprivation therapy|androgen deprivation therapy
642811|NCT00470821|melatonin|melatonin
642812|NCT00470821|actigraphy|actigraphy
642813|NCT00470821|sedation|sedation
642814|NCT00470821|critical patients|critical patients
642815|NCT00470821|ICU|icu
642816|NCT00470808|Minors|minors
642817|NCT00470808|Enrollment in another study|enrollment in another study
642818|NCT00470808|Males|males
642819|NCT00470808|HBA1C greater than 7|hba1c greater than 7
642820|NCT00470808|Drug therapy for DM|drug therapy for dm
642821|NCT00470795|diabetes|diabetes
642822|NCT00470795|gastroparesis|gastroparesis
642823|NCT00470795|acupuncture|acupuncture
642824|NCT00470795|symptoms|symptoms
642825|NCT00470795|gastric emptying|gastric emptying
642826|NCT00470782|colonic neoplasms|colonic neoplasms
642827|NCT00470782|exercise|exercise
642828|NCT00470782|body composition|body composition
642829|NCT00470782|anthropometry|anthropometry
642830|NCT00470769|Color-Doppler Ultrasonography|color-doppler ultrasonography
642831|NCT00470769|Renal scintigraphy|renal scintigraphy
642832|NCT00470769|Kidney failure|kidney failure
642833|NCT00470769|GFR|gfr
642834|NCT00470743|Ibuprofen|ibuprofen
642835|NCT00470743|Indomethacin|indomethacin
642836|NCT00470743|Infant, very low birth weight|infant, very low birth weight
642837|NCT00470743|Prematurity|prematurity
642838|NCT00470743|Ductus Arteriosus, patent|ductus arteriosus, patent
642839|NCT00470717|late preterm infant|late preterm infant
642840|NCT00470717|breastfeeding|breastfeeding
642841|NCT00470717|formula feeding|formula feeding
642842|NCT00470717|rehospitalization|rehospitalization
642843|NCT00470717|telephone|telephone
642844|NCT00470704|HER2-positive breast cancer|her2-positive breast cancer
642845|NCT00470704|Herceptin|herceptin
642846|NCT00470704|trastuzumab|trastuzumab
642847|NCT00470678|Age-related|age-related
642848|NCT00470678|macular|macular
642849|NCT00470678|degeneration|degeneration
642850|NCT00470678|AMD|amd
642851|NCT00470678|Ranibizumab|ranibizumab
642852|NCT00470678|Anti-VEGF|anti-vegf
642853|NCT00470678|choroidal|choroidal
642854|NCT00470678|neovascularization|neovascularization
642855|NCT00470678|CNV|cnv
642856|NCT00470678|Asian patients|asian patients
642857|NCT00470678|Korea|korea
642858|NCT00470678|Taiwan|taiwan
642859|NCT00470678|associated|associated
642860|NCT00470652|pain|pain
642861|NCT00470652|Pain Measurement|pain measurement
642862|NCT00470652|Decision Making, Computer-Assisted|decision making, computer-assisted
642863|NCT00470652|Informatics|informatics
642864|NCT00470639|TMS|tms
642865|NCT00470639|Treatment|treatment
642866|NCT00470639|Bipolar|bipolar
642867|NCT00470639|Efficacy|efficacy
642868|NCT00470626|Pulmonary Embolism|pulmonary embolism
643384|NCT00469053|multidose|multidose
642869|NCT00470626|Venous Thromboembolism|venous thromboembolism
642870|NCT00470626|Inferior Vena Cava Filter|inferior vena cava filter
642871|NCT00470626|IVC|ivc
642872|NCT00470626|PE|pe
642873|NCT00470613|Neoplasm|neoplasm
642874|NCT00470587|chest pain|chest pain
642875|NCT00470587|myocardial infarction|myocardial infarction
642876|NCT00470587|unstable angina|unstable angina
642877|NCT00470574|recurrent breast cancer|recurrent breast cancer
642878|NCT00470574|stage IV breast cancer|stage iv breast cancer
642879|NCT00470574|male breast cancer|male breast cancer
642880|NCT00470561|mammographic breast density aspirin|mammographic breast density aspirin
642881|NCT00470548|male breast cancer|male breast cancer
642882|NCT00470548|recurrent breast cancer|recurrent breast cancer
642883|NCT00470548|stage IIIA breast cancer|stage iiia breast cancer
642884|NCT00470548|stage IIIB breast cancer|stage iiib breast cancer
642885|NCT00470548|stage IIIC breast cancer|stage iiic breast cancer
642886|NCT00470548|stage IV breast cancer|stage iv breast cancer
642887|NCT00470548|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
642888|NCT00470548|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
642889|NCT00470548|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
642890|NCT00470548|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
642891|NCT00470548|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
642892|NCT00470535|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
642893|NCT00470535|recurrent pancreatic cancer|recurrent pancreatic cancer
642894|NCT00470535|stage III pancreatic cancer|stage iii pancreatic cancer
642895|NCT00470535|stage IV pancreatic cancer|stage iv pancreatic cancer
642896|NCT00470522|methotrexate|methotrexate
642897|NCT00470522|folic acid|folic acid
642898|NCT00470522|systemic lupus erythematosus|systemic lupus erythematosus
642899|NCT00470522|steroid|steroid
642901|NCT00470483|Social Anxiety Disorder|social anxiety disorder
642902|NCT00470483|fRMI|frmi
642903|NCT00470444|Cardiac Surgery|cardiac surgery
642904|NCT00470444|Transfusion Medicine|transfusion medicine
642905|NCT00470444|Cardiac Anesthesia Risk Evaluation (CARE) Score of 3 or 4|cardiac anesthesia risk evaluation (care) score of 3 or 4
642906|NCT00470444|(Dupuis J-Y et al, Anesthesiology 2001;94: 194-204)|(dupuis j-y et al, anesthesiology 2001;94: 194-204)
642907|NCT00470418|Alzheimer Disease|alzheimer disease
642908|NCT00470418|Alzheimer Type Senile Dementia|alzheimer type senile dementia
642909|NCT00470418|Alzheimer's Disease|alzheimer's disease
642910|NCT00470418|clinical trial|clinical trial
642911|NCT00470418|dementia|dementia
642912|NCT00470418|diabetes|diabetes
642913|NCT00470418|dietary supplements|dietary supplements
642914|NCT00470418|Senile Dementia, Alzheimer Type|senile dementia, alzheimer type
642915|NCT00470418|Therapeutics|therapeutics
642916|NCT00470405|adult solid tumor|adult solid tumor
642917|NCT00470405|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
642918|NCT00470405|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
642919|NCT00470405|anaplastic large cell lymphoma|anaplastic large cell lymphoma
642920|NCT00470405|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
642921|NCT00470405|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
642922|NCT00470405|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
642923|NCT00470405|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
642924|NCT00470405|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
642925|NCT00470405|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
642926|NCT00470405|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
642927|NCT00470405|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
642928|NCT00470405|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
642929|NCT00470405|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
642930|NCT00470405|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
642931|NCT00470405|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
642932|NCT00470405|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
642933|NCT00470405|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
642934|NCT00470405|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
642935|NCT00470405|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
642936|NCT00470405|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
642937|NCT00470405|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
642938|NCT00470405|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
642939|NCT00470405|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
642940|NCT00470405|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
642941|NCT00470405|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
642942|NCT00470405|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
642943|NCT00470405|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
642944|NCT00470405|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
642945|NCT00470405|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
642946|NCT00470405|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
642947|NCT00470405|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
642948|NCT00470405|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
642949|NCT00470405|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
642950|NCT00470405|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
642951|NCT00470405|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
642952|NCT00470405|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
642953|NCT00470405|splenic marginal zone lymphoma|splenic marginal zone lymphoma
642954|NCT00470405|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
642955|NCT00470405|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
642956|NCT00470405|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
642957|NCT00470405|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
642958|NCT00470392|Erythema|erythema
642959|NCT00470392|optimization|optimization
642960|NCT00470392|Papule|papule
642961|NCT00470392|Plaque|plaque
642962|NCT00470392|pretreatment|pretreatment
642963|NCT00470392|T cells|t cells
642964|NCT00470392|UVB laser light|uvb laser light
642965|NCT00470392|psoriasis|psoriasis
642966|NCT00470392|topical administration|topical administration
642967|NCT00470379|stage II melanoma|stage ii melanoma
642968|NCT00470379|stage III melanoma|stage iii melanoma
642969|NCT00470379|stage IV melanoma|stage iv melanoma
642970|NCT00470366|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
642971|NCT00470366|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
642972|NCT00470366|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
642973|NCT00470366|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
642974|NCT00470366|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
642975|NCT00470366|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
642976|NCT00470366|testicular choriocarcinoma|testicular choriocarcinoma
642977|NCT00470366|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
642978|NCT00470366|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
642979|NCT00470366|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
642980|NCT00470366|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
642981|NCT00470366|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
642982|NCT00470366|testicular embryonal carcinoma|testicular embryonal carcinoma
642983|NCT00470366|testicular seminoma|testicular seminoma
642984|NCT00470366|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
642985|NCT00470366|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
642986|NCT00470366|testicular yolk sac tumor|testicular yolk sac tumor
642987|NCT00470366|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
642988|NCT00470366|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
642989|NCT00470366|ovarian choriocarcinoma|ovarian choriocarcinoma
642990|NCT00470366|ovarian dysgerminoma|ovarian dysgerminoma
642991|NCT00470366|ovarian embryonal carcinoma|ovarian embryonal carcinoma
642992|NCT00470366|ovarian yolk sac tumor|ovarian yolk sac tumor
642993|NCT00470366|ovarian immature teratoma|ovarian immature teratoma
642994|NCT00470366|ovarian mature teratoma|ovarian mature teratoma
642995|NCT00470366|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
642996|NCT00470366|ovarian polyembryoma|ovarian polyembryoma
642997|NCT00470366|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
642998|NCT00470366|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
642999|NCT00470366|stage IV extragonadal seminoma|stage iv extragonadal seminoma
643000|NCT00470366|stage I extragonadal non-seminomatous germ cell tumor|stage i extragonadal non-seminomatous germ cell tumor
643001|NCT00470366|stage II extragonadal non-seminomatous germ cell tumor|stage ii extragonadal non-seminomatous germ cell tumor
643002|NCT00470366|stage III extragonadal non-seminomatous germ cell tumor|stage iii extragonadal non-seminomatous germ cell tumor
643003|NCT00470366|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
643004|NCT00470366|adult teratoma|adult teratoma
643005|NCT00470366|testicular immature teratoma|testicular immature teratoma
643006|NCT00470366|testicular mature teratoma|testicular mature teratoma
643007|NCT00470366|stage IA ovarian germ cell tumor|stage ia ovarian germ cell tumor
643008|NCT00470366|stage IB ovarian germ cell tumor|stage ib ovarian germ cell tumor
643009|NCT00470366|stage IC ovarian germ cell tumor|stage ic ovarian germ cell tumor
643010|NCT00470366|stage IIA ovarian germ cell tumor|stage iia ovarian germ cell tumor
643011|NCT00470366|stage IIB ovarian germ cell tumor|stage iib ovarian germ cell tumor
643012|NCT00470366|stage IIC ovarian germ cell tumor|stage iic ovarian germ cell tumor
643013|NCT00470366|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
643014|NCT00470366|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
643015|NCT00470366|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
643016|NCT00470353|recurrent colon cancer|recurrent colon cancer
643783|NCT00467415|Treadmill|treadmill
643017|NCT00470353|stage I colon cancer|stage i colon cancer
643018|NCT00470353|stage II colon cancer|stage ii colon cancer
643019|NCT00470353|stage III colon cancer|stage iii colon cancer
643020|NCT00470340|Recurrence|recurrence
643021|NCT00470340|Neoplasm Recurrence, Local|neoplasm recurrence, local
643022|NCT00470340|Liver|liver
643023|NCT00470340|Liver Neoplasms|liver neoplasms
643024|NCT00470340|Liver Cirrhosis|liver cirrhosis
643025|NCT00470340|Carcinoma, Hepatocellular|carcinoma, hepatocellular
643026|NCT00470340|Iodized Oil|iodized oil
643027|NCT00470340|gemcitabine [Substance Name]|gemcitabine [substance name]
643028|NCT00470340|oxaliplatin [Substance Name]|oxaliplatin [substance name]
643029|NCT00470340|gemcitabine-oxaliplatin regimen [Substance Name]|gemcitabine-oxaliplatin regimen [substance name]
643030|NCT00470340|Randomized Controlled Trials|randomized controlled trials
643031|NCT00470340|Multicenter Studies|multicenter studies
643032|NCT00470340|Cisplatin|cisplatin
643033|NCT00470340|Injections, Intra-Arterial|injections, intra-arterial
643034|NCT00470340|Injections, Intravenous|injections, intravenous
643035|NCT00470340|Chemotherapy, Adjuvant|chemotherapy, adjuvant
643036|NCT00470327|Interstitial lung diseases|interstitial lung diseases
643037|NCT00470327|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
643038|NCT00470327|Sarcoidosis|sarcoidosis
643039|NCT00470327|mRNA and cytokine expression|mrna and cytokine expression
643040|NCT00470314|Acute liver failure|acute liver failure
643041|NCT00470314|Ornithine Aspartate|ornithine aspartate
643042|NCT00470314|Ammonia|ammonia
643043|NCT00470314|Encephalopathy|encephalopathy
643044|NCT00470288|cesarean delivery|cesarean delivery
643045|NCT00470288|bladder flaps|bladder flaps
643046|NCT00470275|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
643047|NCT00470262|fatty acid oxidation complex|fatty acid oxidation complex
643048|NCT00470262|fenofibrate|fenofibrate
643049|NCT00470262|Inflammation|inflammation
643050|NCT00470262|Peroxisome Proliferator-Activated Receptors|peroxisome proliferator-activated receptors
643051|NCT00470262|pioglitazone|pioglitazone
643052|NCT00470262|Prediabetic State|prediabetic state
643053|NCT00470262|insulin resistance|insulin resistance
643054|NCT00470249|stage IIIB breast cancer|stage iiib breast cancer
643055|NCT00470249|stage IIIC breast cancer|stage iiic breast cancer
643056|NCT00470249|stage IV breast cancer|stage iv breast cancer
643057|NCT00470249|recurrent breast cancer|recurrent breast cancer
643058|NCT00470249|male breast cancer|male breast cancer
643059|NCT00470249|stage IIIA breast cancer|stage iiia breast cancer
643060|NCT00470236|Ductal carcinoma in-situ|ductal carcinoma in-situ
643061|NCT00470236|Breast conserving therapy|breast conserving therapy
643062|NCT00470236|Whole breast radiation therapy|whole breast radiation therapy
643063|NCT00470236|Tumour bed boost|tumour bed boost
643064|NCT00470236|Fractionation schedules|fractionation schedules
643065|NCT00470236|Completely excised non-low risk DCIS|completely excised non-low risk dcis
643066|NCT00470223|localized osteosarcoma|localized osteosarcoma
643067|NCT00470223|metastatic osteosarcoma|metastatic osteosarcoma
643068|NCT00470210|Ribavirin|ribavirin
643069|NCT00470210|non-responders|non-responders
643070|NCT00470210|HCV co-infected patients|hcv co-infected patients
643071|NCT00470210|sustained virological response|sustained virological response
643072|NCT00470210|Treatment Experienced|treatment experienced
643073|NCT00470184|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
643074|NCT00470184|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
643075|NCT00470184|stage II esophageal cancer|stage ii esophageal cancer
643076|NCT00470184|stage III esophageal cancer|stage iii esophageal cancer
643077|NCT00470184|stage IV esophageal cancer|stage iv esophageal cancer
643078|NCT00470158|zinc|zinc
643079|NCT00470158|iron|iron
643080|NCT00470158|interaction|interaction
643081|NCT00470158|diarrhea|diarrhea
643082|NCT00470158|delivery|delivery
643083|NCT00470145|unmilled formulation,|unmilled formulation,
643084|NCT00470145|micronised formulation|micronised formulation
643085|NCT00470145|relative bioavailability,|relative bioavailability,
643086|NCT00470132|ventricular shunt|ventricular shunt
643087|NCT00470119|breast cancer|breast cancer
643088|NCT00470119|obesity|obesity
643089|NCT00470119|weight changes|weight changes
643090|NCT00470106|Cognition|cognition
643091|NCT00470106|Remediation|remediation
643092|NCT00470106|Schizophrenia|schizophrenia
643093|NCT00470106|Social Cognition|social cognition
643094|NCT00470093|refractory multiple myeloma|refractory multiple myeloma
643207|NCT00469742|Cardiac Defects|cardiac defects
643095|NCT00470093|stage I multiple myeloma|stage i multiple myeloma
643096|NCT00470093|stage II multiple myeloma|stage ii multiple myeloma
643097|NCT00470093|stage III multiple myeloma|stage iii multiple myeloma
643098|NCT00470080|Venepuncture|venepuncture
643099|NCT00470080|Pain|pain
643100|NCT00470080|Emla cream|emla cream
643101|NCT00470080|Oral sucrose solution|oral sucrose solution
643102|NCT00470080|Premature infant|premature infant
643103|NCT00470080|Premature infant admitted to the care baby unit were|premature infant admitted to the care baby unit were
643104|NCT00470080|included in the study.|included in the study.
643284|NCT00469456|Alzheimer's Disease|alzheimer's disease
643105|NCT00470080|Programed venepuncture is performed with analgesia.|programed venepuncture is performed with analgesia.
643106|NCT00470067|recurrent endometrial carcinoma|recurrent endometrial carcinoma
643107|NCT00470067|stage III endometrial carcinoma|stage iii endometrial carcinoma
643108|NCT00470067|stage IV endometrial carcinoma|stage iv endometrial carcinoma
643109|NCT00470041|Healthy volunteers|healthy volunteers
643110|NCT00470028|TMS|tms
643111|NCT00470028|Treatment|treatment
643112|NCT00470028|Adolescents|adolescents
643113|NCT00470028|Safety|safety
643114|NCT00470028|Efficacy|efficacy
643115|NCT00470015|stage II melanoma|stage ii melanoma
643116|NCT00470015|stage III melanoma|stage iii melanoma
643117|NCT00470015|stage IV melanoma|stage iv melanoma
643118|NCT00470015|recurrent melanoma|recurrent melanoma
643119|NCT00470002|growth hormone|growth hormone
643120|NCT00470002|nitric oxide|nitric oxide
643121|NCT00470002|nitrate|nitrate
643122|NCT00470002|cyclic guanosine monophosphate|cyclic guanosine monophosphate
643123|NCT00470002|insulin-like growth factor-1|insulin-like growth factor-1
643124|NCT00470002|asymmetric dimethylarginine|asymmetric dimethylarginine
643125|NCT00470002|blood pressure|blood pressure
643126|NCT00470002|endothelial progenitor cells|endothelial progenitor cells
643127|NCT00469989|immune system|immune system
643128|NCT00469989|allergy|allergy
643129|NCT00469989|hookworm infection|hookworm infection
643130|NCT00469989|parasite infection|parasite infection
643131|NCT00469989|asthma|asthma
643132|NCT00469976|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
643133|NCT00469976|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
643134|NCT00469976|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
643135|NCT00469963|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
643136|NCT00469963|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
643137|NCT00469963|recurrent adult primary liver cancer|recurrent adult primary liver cancer
643138|NCT00469963|advanced adult primary liver cancer|advanced adult primary liver cancer
643139|NCT00469950|PCI|pci
643140|NCT00469950|stent|stent
643141|NCT00469950|training|training
643142|NCT00469950|endothelial function|endothelial function
643143|NCT00469950|restenosis|restenosis
643144|NCT00469950|late luminal loss|late luminal loss
643145|NCT00469950|heart rate variability|heart rate variability
643146|NCT00469950|oxygen uptake capacity|oxygen uptake capacity
643147|NCT00469950|inflammatory markers|inflammatory markers
643148|NCT00469937|radiation toxicity|radiation toxicity
643149|NCT00469937|neurotoxicity|neurotoxicity
643150|NCT00469937|cognitive/functional effects|cognitive/functional effects
643151|NCT00469937|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
643152|NCT00469937|adult tumors metastatic to brain|adult tumors metastatic to brain
643153|NCT00469924|Informatics|informatics
643154|NCT00469924|Clinical Laboratory Information Systems|clinical laboratory information systems
643155|NCT00469924|Hospital Communication Systems|hospital communication systems
643156|NCT00469924|Laboratory Techniques and Procedures|laboratory techniques and procedures
643157|NCT00469924|Point-of-Care Systems|point-of-care systems
643158|NCT00469924|Therapy, Computer-Assisted|therapy, computer-assisted
643159|NCT00469911|Heart|heart
643160|NCT00469911|Transplant|transplant
643161|NCT00469911|MRS|mrs
643162|NCT00469911|MRI|mri
643163|NCT00469911|Spectroscopy|spectroscopy
643164|NCT00469898|extensive stage small cell lung cancer|extensive stage small cell lung cancer
643165|NCT00469885|Smoking cessation|smoking cessation
643166|NCT00469885|cardiovascular disease|cardiovascular disease
643167|NCT00469885|smoking reduction|smoking reduction
643168|NCT00469885|nicotine replacement|nicotine replacement
643169|NCT00469859|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
643170|NCT00469859|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
643171|NCT00469859|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
643172|NCT00469859|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
643173|NCT00469859|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
643174|NCT00469859|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
643175|NCT00469859|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
643176|NCT00469859|secondary acute myeloid leukemia|secondary acute myeloid leukemia
643177|NCT00469846|Pre-Eclampsia|pre-eclampsia
643178|NCT00469846|Hypertension,pregnancy-induced|hypertension,pregnancy-induced
643179|NCT00469846|Preterm labor|preterm labor
643180|NCT00469833|Diabetes|diabetes
643181|NCT00469833|Glucose Tolerance|glucose tolerance
643182|NCT00469833|Incretin|incretin
643183|NCT00469833|Insulin|insulin
643184|NCT00469820|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
643185|NCT00469820|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
643186|NCT00469820|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
643187|NCT00469820|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
643285|NCT00469456|communication|communication
643188|NCT00469820|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
643189|NCT00469820|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
643190|NCT00469820|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
643191|NCT00469820|secondary acute myeloid leukemia|secondary acute myeloid leukemia
643192|NCT00469820|stage III multiple myeloma|stage iii multiple myeloma
643193|NCT00469820|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
643194|NCT00469820|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
643195|NCT00469820|stage I multiple myeloma|stage i multiple myeloma
643196|NCT00469820|stage II multiple myeloma|stage ii multiple myeloma
643197|NCT00469820|refractory multiple myeloma|refractory multiple myeloma
643198|NCT00469807|Ghrelin|ghrelin
643199|NCT00469807|Pregnancy outcome|pregnancy outcome
643200|NCT00469794|arrhythmias|arrhythmias
643201|NCT00469794|Athletes|athletes
643202|NCT00469794|exercise|exercise
643203|NCT00469768|HIV-1 infection|hiv-1 infection
643204|NCT00469768|HIV Seronegativity|hiv seronegativity
643205|NCT00469742|Cardiology|cardiology
643206|NCT00469742|Pediatrics|pediatrics
643208|NCT00469742|Cardiopulmonary Bypass Surgery|cardiopulmonary bypass surgery
643209|NCT00469742|Aprotinin|aprotinin
643210|NCT00469742|thrombosis|thrombosis
643211|NCT00469742|renal dysfunction|renal dysfunction
643212|NCT00469729|Tetraethylenepentamine|tetraethylenepentamine
643213|NCT00469729|Umbilical Cord Blood Stem Cell Transplantation|umbilical cord blood stem cell transplantation
643214|NCT00469729|Hematological Malignancies|hematological malignancies
643215|NCT00469729|Acute Lymphoid Leukemia|acute lymphoid leukemia
643216|NCT00469729|Subjects with high-risk hematologic malignancies who are candidates for allogeneic stem cell transplantation|subjects with high-risk hematologic malignancies who are candidates for allogeneic stem cell transplantation
643217|NCT00469716|Fluid balance|fluid balance
643218|NCT00469716|respiratory function|respiratory function
643219|NCT00469716|cardiac function|cardiac function
643220|NCT00469716|inflammation|inflammation
643221|NCT00469716|Cardiopulmonary bypass|cardiopulmonary bypass
643222|NCT00469703|Pancreatitis|pancreatitis
643223|NCT00469664|Schizophrenia|schizophrenia
643224|NCT00469664|Schizoaffective|schizoaffective
643225|NCT00469664|Cognitive Impairment|cognitive impairment
643226|NCT00469664|Cognition|cognition
643227|NCT00469664|Memory|memory
643228|NCT00469664|Attention|attention
643229|NCT00469664|Concentration|concentration
643230|NCT00469651|Malaria|malaria
643231|NCT00469651|vaccine|vaccine
643232|NCT00469651|MSP3LSP|msp3lsp
643233|NCT00469651|Safety|safety
643234|NCT00469651|children|children
643235|NCT00469651|Tanzania|tanzania
643236|NCT00469638|atrial fibrillation|atrial fibrillation
643237|NCT00469638|paroxysmal|paroxysmal
643238|NCT00469638|persistent|persistent
643239|NCT00469638|symptomatic|symptomatic
643240|NCT00469638|ablation|ablation
643241|NCT00469638|catheter|catheter
643242|NCT00469638|introducer|introducer
643243|NCT00469638|Agilis NxT|agilis nxt
643244|NCT00469638|sinus rhythm|sinus rhythm
643245|NCT00469638|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
643246|NCT00469638|persistent atrial fibrillation|persistent atrial fibrillation
643247|NCT00469638|symptomatic atrial fibrillation|symptomatic atrial fibrillation
643248|NCT00469612|Myopia|myopia
643249|NCT00469612|NeuroVision|neurovision
643250|NCT00469612|Visual acuity|visual acuity
643251|NCT00469612|Contrast sensitivity|contrast sensitivity
643252|NCT00469599|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
643253|NCT00469599|Kidney Failure, Chronic|kidney failure, chronic
643254|NCT00469599|Renal Insufficiency, Chronic|renal insufficiency, chronic
643255|NCT00469599|Vitamin D Deficiency|vitamin d deficiency
643256|NCT00469599|Renal Osteodystrophy|renal osteodystrophy
643257|NCT00469599|Hemodialysis|hemodialysis
643258|NCT00469560|MDS|mds
643259|NCT00469560|Chronic transfusional hemosiderosis|chronic transfusional hemosiderosis
643260|NCT00469560|Deferasirox|deferasirox
643261|NCT00469547|ethanol, microbicide, sexually transmitted, Kenya, males|ethanol, microbicide, sexually transmitted, kenya, males
643262|NCT00469547|HIV Seronegativity|hiv seronegativity
643263|NCT00469534|minimized time to beam|minimized time to beam
643264|NCT00469534|hypofractionated 3D CRT plus IMRT|hypofractionated 3d crt plus imrt
643265|NCT00469534|PET-scan|pet-scan
643266|NCT00469508|Methamphetamine|methamphetamine
643267|NCT00469508|Modafinil|modafinil
643268|NCT00469508|Medication|medication
643269|NCT00469508|Contingency Management|contingency management
643270|NCT00469508|Crystal meth|crystal meth
643271|NCT00469508|Los Angeles|los angeles
643272|NCT00469508|Addiction|addiction
643273|NCT00469508|Meth|meth
643274|NCT00469482|Delirium|delirium
643275|NCT00469482|Cognitive Impairment|cognitive impairment
643276|NCT00469482|Sleep|sleep
643277|NCT00469482|Polysomnography|polysomnography
643278|NCT00469482|Sedation|sedation
643279|NCT00469482|Mechanical Ventilation|mechanical ventilation
643280|NCT00469482|Critical Illness|critical illness
643281|NCT00469469|Adrenal Cortex|adrenal cortex
643282|NCT00469469|ACC|acc
643283|NCT00469456|memantine|memantine
643286|NCT00469443|Metastatic colorectal cancer|metastatic colorectal cancer
643287|NCT00469443|Irinotecan|irinotecan
643288|NCT00469443|Capecitabine|capecitabine
643289|NCT00469443|Bevacizumab|bevacizumab
643290|NCT00469430|appendicitis|appendicitis
643291|NCT00469430|treatment|treatment
643292|NCT00469430|antibiotics|antibiotics
643293|NCT00469417|Methyl aminolevulinate|methyl aminolevulinate
643294|NCT00469417|Photodynamic therapy|photodynamic therapy
643295|NCT00469417|Primary Superficial Basal Cell Carcinoma|primary superficial basal cell carcinoma
643296|NCT00469404|Transdermal patch|transdermal patch
643297|NCT00469404|Centrally acting analgesic|centrally acting analgesic
643298|NCT00469404|Plasma level|plasma level
643299|NCT00469404|Healthy volunteers|healthy volunteers
643300|NCT00469391|Weight Reduction|weight reduction
643301|NCT00469378|firategrast|firategrast
643302|NCT00469378|lymphocytes|lymphocytes
643303|NCT00469378|leukocytes|leukocytes
643304|NCT00469378|SB-683699|sb-683699
643305|NCT00469378|cerebrospinal fluid|cerebrospinal fluid
643306|NCT00469378|relapsing forms of multiple sclerosis|relapsing forms of multiple sclerosis
643307|NCT00469365|clinical trial, medication adherence, pharmacy intervention|clinical trial, medication adherence, pharmacy intervention
643308|NCT00469365|Patients with specific chronic diseases|patients with specific chronic diseases
643309|NCT00469352|Pharmacogenetics|pharmacogenetics
643310|NCT00469352|Genetics|genetics
643311|NCT00469352|Treatment response|treatment response
643312|NCT00469352|AMD|amd
643313|NCT00469352|Wet AMD|wet amd
643314|NCT00469352|Age-related macular degeneration|age-related macular degeneration
643315|NCT00469339|Diabetes|diabetes
643316|NCT00469339|Colon Cancer|colon cancer
643317|NCT00469339|Cardiovascular Disease|cardiovascular disease
643318|NCT00469326|coronary artery disease|coronary artery disease
643319|NCT00469326|percutaneous coronary intervention|percutaneous coronary intervention
643320|NCT00469326|atorvastatin|atorvastatin
643321|NCT00469313|copd|copd
643322|NCT00469313|inspiratory muscle training|inspiratory muscle training
643323|NCT00469313|IF|if
643324|NCT00469300|herpes labialis|herpes labialis
643325|NCT00469300|cold sore|cold sore
643326|NCT00469300|acyclovir|acyclovir
643327|NCT00469300|iontophoresis|iontophoresis
643328|NCT00469300|topical|topical
643329|NCT00469287|diabetes mellitus|diabetes mellitus
643330|NCT00469287|blood sugar|blood sugar
643331|NCT00469287|overweight|overweight
643332|NCT00469287|obesity|obesity
643333|NCT00469287|Traditional Chinese medicine|traditional chinese medicine
643334|NCT00469274|Pertussis|pertussis
643335|NCT00469274|Healthcare worker|healthcare worker
643336|NCT00469274|Post-exposure prophylaxis|post-exposure prophylaxis
643337|NCT00469274|Vaccination|vaccination
643338|NCT00469274|Pertussis in healthcare workers following occupational|pertussis in healthcare workers following occupational
643339|NCT00469274|exposure to pertussis|exposure to pertussis
643340|NCT00469261|Myocardial infarction|myocardial infarction
643341|NCT00469261|Ventricular remodeling|ventricular remodeling
643342|NCT00469261|Matrix metalloproteinases|matrix metalloproteinases
643343|NCT00469261|Doxycycline|doxycycline
643344|NCT00469248|Myocardial infarction|myocardial infarction
643345|NCT00469248|Cardiogenic shock|cardiogenic shock
643346|NCT00469248|Systemic inflammatory response syndrome|systemic inflammatory response syndrome
643347|NCT00469248|Percutaneous coronary intervention|percutaneous coronary intervention
643348|NCT00469248|aortic balloon counterpulsation|aortic balloon counterpulsation
643349|NCT00469222|small cell lung cancer|small cell lung cancer
643350|NCT00469222|radiotherapy dose escalation|radiotherapy dose escalation
643351|NCT00469209|Multiple Myeloma|multiple myeloma
643352|NCT00469209|Melphalan|melphalan
643353|NCT00469209|Trisenox|trisenox
643354|NCT00469209|Arsenic Trioxide|arsenic trioxide
643355|NCT00469209|Ascorbic Acid|ascorbic acid
643356|NCT00469209|Vitamin C|vitamin c
643357|NCT00469209|Velcade|velcade
643358|NCT00469209|Bortezomib|bortezomib
643359|NCT00469196|mesothelioma|mesothelioma
643360|NCT00469196|tomotherapy|tomotherapy
643361|NCT00469170|HIV-1|hiv-1
643362|NCT00469170|HIV seronegativity|hiv seronegativity
643363|NCT00469157|compatibility of Optive after PRK or LASIK|compatibility of optive after prk or lasik
643364|NCT00469144|Stem Cell Transplantation|stem cell transplantation
643365|NCT00469144|Leukemia|leukemia
643366|NCT00469144|Busulfan|busulfan
643367|NCT00469144|Fludarabine|fludarabine
643368|NCT00469144|MDS|mds
643369|NCT00469144|AML|aml
643370|NCT00469131|liver transplantation,|liver transplantation,
643371|NCT00469131|HCV recurrence,|hcv recurrence,
643372|NCT00469131|immunosuppression|immunosuppression
643373|NCT00469105|Type 2 Diabetes|type 2 diabetes
643374|NCT00469105|Diabetes Education|diabetes education
643375|NCT00469105|Health Literacy|health literacy
643376|NCT00469079|Biomarkers|biomarkers
643377|NCT00469079|Smoking|smoking
643378|NCT00469079|Tobacco|tobacco
643379|NCT00469079|Cessation|cessation
643380|NCT00469066|small cell lung cancer|small cell lung cancer
643381|NCT00469066|bladder cancer|bladder cancer
643382|NCT00469066|conformal radiotherapy|conformal radiotherapy
643383|NCT00469053|Transdermal patch|transdermal patch
643385|NCT00469053|Centrally acting analgesic|centrally acting analgesic
643386|NCT00469053|Plasma level|plasma level
643387|NCT00469053|Healthy volunteers|healthy volunteers
643388|NCT00469040|GW642444,|gw642444,
643389|NCT00469040|healthy subjects|healthy subjects
643390|NCT00469040|magnesium stearate,|magnesium stearate,
643391|NCT00469027|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
643392|NCT00469014|Acute Myeloid Leukemia|acute myeloid leukemia
643393|NCT00469014|AML|aml
643394|NCT00469014|Myelodysplastic Syndrome|myelodysplastic syndrome
643395|NCT00469014|MDS|mds
643396|NCT00469014|Chronic Myeloid Leukemia|chronic myeloid leukemia
643397|NCT00469014|CML|cml
643398|NCT00469014|Busulfan|busulfan
643399|NCT00469014|Busulfex|busulfex
643400|NCT00469014|Myleran|myleran
643401|NCT00469014|Fludarabine|fludarabine
643402|NCT00469014|Fludara|fludara
643403|NCT00469014|Fludarabine Phosphate|fludarabine phosphate
643404|NCT00469014|Clofarabine|clofarabine
643405|NCT00469014|Clofarex|clofarex
643406|NCT00469014|Clolar|clolar
643407|NCT00469014|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
643408|NCT00469014|ASCT|asct
643409|NCT00469014|Stem Cell|stem cell
643410|NCT00469014|Gleevec|gleevec
643411|NCT00469014|Imatinib Mesylate|imatinib mesylate
643412|NCT00469001|Hospitalization and death from exacerbation CHF.|hospitalization and death from exacerbation chf.
643413|NCT00468949|Health-Related Quality of Life|health-related quality of life
643414|NCT00468949|Dupuytren's Disease|dupuytren's disease
643415|NCT00468949|Health Utilities Index|health utilities index
643416|NCT00468949|Short Form-36;|short form-36;
643417|NCT00468949|Michigan Hand Outcomes Questionnaire|michigan hand outcomes questionnaire
643418|NCT00468936|anti-rejection|anti-rejection
643419|NCT00468936|GI side effects|gi side effects
643420|NCT00468936|heart transplant patients|heart transplant patients
643421|NCT00468923|Primary prevention|primary prevention
643422|NCT00468923|Cholesterol lowering|cholesterol lowering
643423|NCT00468923|Blood pressure lowering|blood pressure lowering
643424|NCT00468923|Cardiovascular disease prevention|cardiovascular disease prevention
643425|NCT00468897|Alzheimers Disease|alzheimers disease
643426|NCT00468897|healthy volunteers|healthy volunteers
643427|NCT00468897|bioequivalence|bioequivalence
643428|NCT00468884|Kinetics of GLP-1 and PYY3-36; increasing oral doses|kinetics of glp-1 and pyy3-36; increasing oral doses
643429|NCT00468858|Dengue|dengue
643430|NCT00468858|Virus|virus
643431|NCT00468858|Live-attenuated|live-attenuated
643432|NCT00468858|Vaccine|vaccine
643433|NCT00468858|Dengue viral infection|dengue viral infection
643434|NCT00468858|Dengue Vaccine|dengue vaccine
643435|NCT00468845|pain after hysterectomy|pain after hysterectomy
643436|NCT00468845|amount of opioids used|amount of opioids used
643437|NCT00468819|Contrast-enhanced MRI|contrast-enhanced mri
643438|NCT00468819|MR angiography (MRA) Children 2-17 years|mr angiography (mra) children 2-17 years
643439|NCT00468806|PET scan|pet scan
643440|NCT00468806|Health Males|health males
643441|NCT00468793|central venous saturation|central venous saturation
643442|NCT00468793|bowel surgery|bowel surgery
643443|NCT00468793|morbidity|morbidity
643444|NCT00468793|intravenous infusions|intravenous infusions
643445|NCT00468780|Canadian Triage Acuity Scale|canadian triage acuity scale
643446|NCT00468780|paramedics|paramedics
643447|NCT00468780|triage nurse|triage nurse
643448|NCT00468780|triage levels|triage levels
643449|NCT00468780|inter-rater reliability|inter-rater reliability
643450|NCT00468780|health services outcomes|health services outcomes
643451|NCT00468767|Atrial fibrillation|atrial fibrillation
643452|NCT00468767|RSD1235|rsd1235
643453|NCT00468767|Atrial fibrillation of 3 hours to 7 days duration.|atrial fibrillation of 3 hours to 7 days duration.
643454|NCT00468767|Atrial fibrillation of 3 hours to 45 days duration.|atrial fibrillation of 3 hours to 45 days duration.
643455|NCT00468741|Breast Cancer|breast cancer
643456|NCT00468741|Internet|internet
643457|NCT00468741|Computer|computer
643458|NCT00468741|Support|support
643459|NCT00468741|Information|information
643460|NCT00468741|Education|education
643461|NCT00468741|Control Group: Usual care and Internet access|control group: usual care and internet access
643462|NCT00468741|CHESS Information Services only|chess information services only
643463|NCT00468741|CHESS Social Support & Information Services|chess social support & information services
643464|NCT00468741|CHESS Information, Social Support & Skills Services|chess information, social support & skills services
643465|NCT00468728|CDAD, Clostridium difficile, diarrhea|cdad, clostridium difficile, diarrhea
643466|NCT00468728|Clostridium difficile-Associated Diarrhea|clostridium difficile-associated diarrhea
643467|NCT00468715|stage IV breast cancer|stage iv breast cancer
643468|NCT00468715|recurrent breast cancer|recurrent breast cancer
643469|NCT00468715|male breast cancer|male breast cancer
643470|NCT00468689|SB-751689,|sb-751689,
643471|NCT00468689|Calcium-sensing receptor antagonist (CaR),|calcium-sensing receptor antagonist (car),
643472|NCT00468689|Osteoporosis,|osteoporosis,
643473|NCT00468689|Parathyroid hormone (PTH),|parathyroid hormone (pth),
643474|NCT00468689|Oral dose|oral dose
643475|NCT00468676|major Depressive Disorder|major depressive disorder
643476|NCT00468676|Diabetes|diabetes
643477|NCT00468676|Heart Disease|heart disease
643478|NCT00468663|preeclampsia|preeclampsia
643479|NCT00468663|preterm delivery|preterm delivery
643480|NCT00468663|lipid peroxidation|lipid peroxidation
643481|NCT00468663|inflammation|inflammation
643482|NCT00468637|heart failure|heart failure
643483|NCT00468637|cardiovascular high risk|cardiovascular high risk
643484|NCT00468637|erectile dysfunction|erectile dysfunction
643485|NCT00468637|cardiovascular disease|cardiovascular disease
643486|NCT00468624|Growth hormone|growth hormone
643487|NCT00468624|insulin-like growth factor 1|insulin-like growth factor 1
643488|NCT00468624|pegvisomant|pegvisomant
643489|NCT00468611|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
643490|NCT00468611|Multiple Sclerosis|multiple sclerosis
643491|NCT00468598|troponin|troponin
643492|NCT00468598|long-term outcome|long-term outcome
643493|NCT00468598|on-pump cardiac surgery|on-pump cardiac surgery
643494|NCT00468585|Breast cancer|breast cancer
643495|NCT00468585|Metastatic breast cancer|metastatic breast cancer
643496|NCT00468585|Breast|breast
643497|NCT00468585|Metastatic|metastatic
643498|NCT00468572|Emotion|emotion
643499|NCT00468572|Oxytocin|oxytocin
643500|NCT00468572|Cortisol|cortisol
643501|NCT00468559|pediatrics|pediatrics
643502|NCT00468559|neonates|neonates
643503|NCT00468533|Arupiprazole, prolacin, PANSS, CGI, AIMS|arupiprazole, prolacin, panss, cgi, aims
643504|NCT00468520|induction of labor|induction of labor
643505|NCT00468520|cervical ripening|cervical ripening
643506|NCT00468520|Foley catheter|foley catheter
643507|NCT00468520|oxytocin|oxytocin
643508|NCT00468507|CCK release|cck release
643509|NCT00468494|non diabetic|non diabetic
643510|NCT00468494|catabolic energy state|catabolic energy state
643511|NCT00468481|Healthy women requesting contraception|healthy women requesting contraception
643512|NCT00468481|Folic Acid|folic acid
643513|NCT00468468|breast cancer|breast cancer
643514|NCT00468468|Internet|internet
643515|NCT00468468|computer|computer
643516|NCT00468468|support|support
643517|NCT00468468|information|information
643518|NCT00468468|education|education
643519|NCT00468455|Colorectal Surgery|colorectal surgery
643520|NCT00468455|Abdominal Surgery|abdominal surgery
643521|NCT00468455|Diverticulitis|diverticulitis
643522|NCT00468455|Colon Cancer|colon cancer
643523|NCT00468455|Rectal Cancer|rectal cancer
643524|NCT00468455|Colon Polyp|colon polyp
643525|NCT00468455|Rectal Polyp|rectal polyp
643526|NCT00468455|Crohn's Disease|crohn's disease
643527|NCT00468442|Insulin dependence|insulin dependence
643528|NCT00468442|Hypoglycemia|hypoglycemia
643529|NCT00468442|Hypoglycemia unawareness|hypoglycemia unawareness
643530|NCT00468429|Glaucoma|glaucoma
643531|NCT00468429|Bevacizumab|bevacizumab
643532|NCT00468429|Glaucoma Filtration Surgery|glaucoma filtration surgery
643533|NCT00468429|Mitomycin C|mitomycin c
643534|NCT00468429|Intraocular Pressure|intraocular pressure
643535|NCT00468403|Insulin dependence|insulin dependence
643536|NCT00468403|Hypoglycemia|hypoglycemia
643537|NCT00468403|Hypoglycemia unawareness|hypoglycemia unawareness
643538|NCT00468364|Hypoglycemia, bedtime insulin, long-acting insulin|hypoglycemia, bedtime insulin, long-acting insulin
643539|NCT00468351|bevacizumab|bevacizumab
643540|NCT00468351|diabetes|diabetes
643541|NCT00468351|intravitreal|intravitreal
643542|NCT00468351|macular edema|macular edema
643543|NCT00468351|triamcinolone|triamcinolone
643544|NCT00468351|VEGF|vegf
643545|NCT00468338|general anesthesia|general anesthesia
643546|NCT00468338|dental rehabilitation|dental rehabilitation
643547|NCT00468338|mental retardation|mental retardation
643548|NCT00468325|coronary artery disease|coronary artery disease
643549|NCT00468325|chest pain|chest pain
643550|NCT00468325|emergency room|emergency room
643551|NCT00468299|early|early
643552|NCT00468299|pregnancy|pregnancy
643553|NCT00468299|failure|failure
643554|NCT00468299|mifepristone|mifepristone
643555|NCT00468299|misoprostol|misoprostol
643556|NCT00468299|buccal|buccal
643557|NCT00468299|miscarriage|miscarriage
643558|NCT00468299|fetal|fetal
643559|NCT00468299|demise|demise
643560|NCT00468299|anembryonic|anembryonic
643561|NCT00468299|progesterone|progesterone
643562|NCT00468286|Prostate Cancer|prostate cancer
643563|NCT00468273|Deficiency Syndromes, Antibody|deficiency syndromes, antibody
643564|NCT00468273|Antibody Deficiency Syndrome|antibody deficiency syndrome
643565|NCT00468273|Bruton's agammaglobulinemia|bruton's agammaglobulinemia
643566|NCT00468273|Common Variable Immune Deficiency|common variable immune deficiency
643567|NCT00468273|Hyper IgM syndromes|hyper igm syndromes
643568|NCT00468260|Cancer|cancer
643569|NCT00468260|EPO906|epo906
643570|NCT00468260|Patupilone|patupilone
643571|NCT00468247|mean systemic pressure|mean systemic pressure
643572|NCT00468247|fluid therapy|fluid therapy
643573|NCT00468247|closed loop control|closed loop control
643574|NCT00468247|circulation modelling|circulation modelling
643575|NCT00468234|smoking cessation|smoking cessation
643576|NCT00468234|harm reduction|harm reduction
643577|NCT00468234|biomarker|biomarker
643578|NCT00468234|exhaled breath condensate|exhaled breath condensate
643579|NCT00468221|Ozone|ozone
643580|NCT00468221|Healthy Adults|healthy adults
643581|NCT00468208|Vasculitis|vasculitis
643582|NCT00468208|Relapse|relapse
643583|NCT00468208|Wegener's|wegener's
643584|NCT00468208|Treatment|treatment
643585|NCT00468195|tomography|tomography
643586|NCT00468195|coronary artery disease|coronary artery disease
643587|NCT00468195|obesity|obesity
643588|NCT00468182|Multiple sclerosis|multiple sclerosis
643589|NCT00468182|Interferon beta|interferon beta
643590|NCT00468182|plasmacytoid dendritic cells|plasmacytoid dendritic cells
643591|NCT00468169|Cetuximab|cetuximab
643592|NCT00468169|Erbitux|erbitux
643593|NCT00468169|locally|locally
643594|NCT00468169|advanced|advanced
643595|NCT00468169|head|head
643596|NCT00468169|neck|neck
643597|NCT00468169|cancer|cancer
643598|NCT00468169|neoplasms|neoplasms
643599|NCT00468169|squamous|squamous
643600|NCT00468169|carcinoma|carcinoma
643601|NCT00468169|lymphoepithelioma|lymphoepithelioma
643602|NCT00468156|fruit|fruit
643603|NCT00468156|vegetables|vegetables
643604|NCT00468156|prevention|prevention
643605|NCT00468156|cancer|cancer
643606|NCT00468156|counseling|counseling
643607|NCT00468156|cancer risk|cancer risk
643608|NCT00468130|Aggression|aggression
643609|NCT00468130|Irritability|irritability
643610|NCT00468130|Global autism severity|global autism severity
643611|NCT00468117|Hypoglycemia|hypoglycemia
643612|NCT00468117|Kidney Transplant|kidney transplant
643613|NCT00468117|Insulin independence|insulin independence
643614|NCT00468117|Islet Transplantation|islet transplantation
643615|NCT00468117|Intensive Insulin Therapy|intensive insulin therapy
643616|NCT00468104|parapneumonic pleural effusion|parapneumonic pleural effusion
643617|NCT00468104|empyema|empyema
643618|NCT00468104|TPA (Activase, Alteplase)|tpa (activase, alteplase)
643619|NCT00468091|GLP-1|glp-1
643620|NCT00468091|exendin(9-39)|exendin(9-39)
643621|NCT00468091|atropine|atropine
643622|NCT00468091|human|human
643623|NCT00468091|motility|motility
643624|NCT00468078|Parkinson's disease|parkinson's disease
643625|NCT00468078|Essential tremor|essential tremor
643626|NCT00468078|F-18 FPCIT|f-18 fpcit
643627|NCT00468078|PET|pet
643628|NCT00468065|intravenous|intravenous
643629|NCT00468065|catheter|catheter
643630|NCT00468065|IV|iv
643631|NCT00468052|obstructive sleep apnea|obstructive sleep apnea
643632|NCT00468052|tonsillectomy|tonsillectomy
643633|NCT00468052|adenoidectomy|adenoidectomy
643634|NCT00468039|metformin|metformin
643635|NCT00468039|vildagliptin|vildagliptin
643636|NCT00468039|initial combination|initial combination
643637|NCT00468026|BPH|bph
643638|NCT00468026|Prostate|prostate
643639|NCT00468026|Stent|stent
643640|NCT00468026|Benign prostatic hyperplasia (BPH)|benign prostatic hyperplasia (bph)
643641|NCT00468013|Fibromyalgia|fibromyalgia
643642|NCT00468013|Irritable Bowel|irritable bowel
643643|NCT00468013|Chronic Fatigue|chronic fatigue
643644|NCT00468013|Medically Unexplained Symptoms|medically unexplained symptoms
643645|NCT00468013|Resilience Building Exercises|resilience building exercises
643646|NCT00468013|Depression|depression
643647|NCT00468013|Well-Being|well-being
643648|NCT00468000|Peripheral Arterial Disease|peripheral arterial disease
643649|NCT00468000|Critical Limb Ischemia|critical limb ischemia
643650|NCT00468000|Ischemia|ischemia
643651|NCT00468000|Peripheral Vascular Disease|peripheral vascular disease
643652|NCT00468000|ixmyelocel-T|ixmyelocel-t
643653|NCT00467961|CML (Chronic Myelogenous Leukemia)|cml (chronic myelogenous leukemia)
643654|NCT00467961|CLL (Chronic Lymphocytic Leukemia)|cll (chronic lymphocytic leukemia)
643655|NCT00467961|AML (Acute Myelogenous Leukemia)|aml (acute myelogenous leukemia)
643656|NCT00467961|Leukemia|leukemia
643657|NCT00467961|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
643658|NCT00467961|CLL|cll
643659|NCT00467961|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
643660|NCT00467961|CML|cml
643661|NCT00467961|Acute Myelogenous Leukemia|acute myelogenous leukemia
643662|NCT00467961|AML|aml
643663|NCT00467961|Acute B-Lymphoblastic Leukemia|acute b-lymphoblastic leukemia
643664|NCT00467961|ALL|all
643665|NCT00467961|Myelodysplastic Syndrome|myelodysplastic syndrome
643666|NCT00467961|MDS|mds
643667|NCT00467948|clean contaminated, laryngectomy, wound infection|clean contaminated, laryngectomy, wound infection
643668|NCT00467935|amd|amd
643669|NCT00467935|disciform|disciform
643670|NCT00467935|fibrosis|fibrosis
643671|NCT00467935|Lucentis|lucentis
643672|NCT00467935|scotoma|scotoma
643673|NCT00467922|Hand-assisted colorectal surgery|hand-assisted colorectal surgery
643674|NCT00467922|colorectal disease|colorectal disease
643675|NCT00467922|Crohn's|crohn's
643676|NCT00467922|diverticulitis|diverticulitis
643677|NCT00467922|Colorectal resections|colorectal resections
643678|NCT00467909|micronutrients|micronutrients
643679|NCT00467909|cognition|cognition
643680|NCT00467909|DHA|dha
643681|NCT00467909|healthy children|healthy children
643682|NCT00467896|PAH|pah
643683|NCT00467896|iloprost|iloprost
643684|NCT00467896|Ventavis|ventavis
643685|NCT00467896|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
643686|NCT00467896|Actelion Pharmaceuticals|actelion pharmaceuticals
643687|NCT00467896|Cotherix|cotherix
643688|NCT00467883|Zygomycosis|zygomycosis
643689|NCT00467883|High dose liposomal amphotericin B|high dose liposomal amphotericin b
643690|NCT00467870|investigational|investigational
643691|NCT00467870|testosterone|testosterone
643692|NCT00467870|testosterone undecanoate|testosterone undecanoate
643693|NCT00467870|TU|tu
643694|NCT00467870|Hypogonadism|hypogonadism
643695|NCT00467870|primary hypogonadism|primary hypogonadism
643696|NCT00467870|secondary hypogonadism|secondary hypogonadism
643697|NCT00467857|cyanoacrylates|cyanoacrylates
643698|NCT00467857|microbial sealants|microbial sealants
643699|NCT00467857|skin flora contamination|skin flora contamination
643700|NCT00467857|surgery|surgery
643701|NCT00467844|Cachexia|cachexia
643702|NCT00467844|Muscle Wasting|muscle wasting
643703|NCT00467844|Non-Small Cell Lung Cancer|non-small cell lung cancer
643704|NCT00467844|Colorectal Cancer|colorectal cancer
643705|NCT00467844|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
643706|NCT00467844|Stage 3 or 4 Breast Cancer|stage 3 or 4 breast cancer
643707|NCT00467844|Chronis Lymphocytic Leukemia|chronis lymphocytic leukemia
643708|NCT00467831|Restrictive Lung Disease|restrictive lung disease
643709|NCT00467831|Pulmonary Fibrosis|pulmonary fibrosis
643710|NCT00467831|Albinism|albinism
643711|NCT00467831|Platelet Storage Pool Deficiency|platelet storage pool deficiency
643712|NCT00467831|Metabolic Disease|metabolic disease
643713|NCT00467831|Hermansky-Pudlak Syndrome|hermansky-pudlak syndrome
643714|NCT00467831|HPS|hps
643715|NCT00467831|Lung Disease|lung disease
643716|NCT00467818|Aggression|aggression
643717|NCT00467818|Irritability|irritability
643718|NCT00467818|Global severity|global severity
643719|NCT00467805|Light exposure|light exposure
643720|NCT00467805|light spectrum|light spectrum
643721|NCT00467805|reproductive hormones|reproductive hormones
643722|NCT00467805|women|women
643723|NCT00467792|urticaria pigmentosa|urticaria pigmentosa
643724|NCT00467792|mastocytosis|mastocytosis
643725|NCT00467792|mastocytomas|mastocytomas
643726|NCT00467766|dementia|dementia
643727|NCT00467766|Counseling|counseling
643728|NCT00467753|Irritability|irritability
643729|NCT00467753|Functional Ability|functional ability
643730|NCT00467753|Aggression|aggression
643731|NCT00467753|Mood Instability|mood instability
643732|NCT00467727|Diagnostic Mammography|diagnostic mammography
643733|NCT00467727|Breast Imaging|breast imaging
643734|NCT00467727|Phase Contrast Mammography|phase contrast mammography
643735|NCT00467727|X-Ray Mammography|x-ray mammography
643736|NCT00467714|RHINOPLASTY ,ESTHETIC SURGERY|rhinoplasty ,esthetic surgery
643737|NCT00467701|pneumonia|pneumonia
643738|NCT00467701|Legionnaires disease|legionnaires disease
643739|NCT00467701|risk factors|risk factors
643740|NCT00467688|type 1 diabetes|type 1 diabetes
643741|NCT00467688|glucose excursion|glucose excursion
643742|NCT00467688|hypoglycemia awareness|hypoglycemia awareness
643743|NCT00467688|continuous glucose monitoring|continuous glucose monitoring
643744|NCT00467675|NonDiabetes|nondiabetes
643745|NCT00467675|CGM|cgm
643746|NCT00467649|Symlin|symlin
643747|NCT00467649|Amylin|amylin
643748|NCT00467649|insulin|insulin
643749|NCT00467649|Humalog|humalog
643750|NCT00467649|Novolog|novolog
643751|NCT00467649|Apidra|apidra
643752|NCT00467636|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
643753|NCT00467636|Corticosteroid induced hyperglycaemia|corticosteroid induced hyperglycaemia
643754|NCT00467636|Insulin|insulin
643755|NCT00467623|Pregnancy|pregnancy
643756|NCT00467623|holotranscobalamin|holotranscobalamin
643757|NCT00467623|cobalamin|cobalamin
643758|NCT00467623|vitamin B12 analogues|vitamin b12 analogues
643759|NCT00467623|reference interval|reference interval
643760|NCT00467610|myelodysplastic|myelodysplastic
643761|NCT00467610|MDS|mds
643762|NCT00467610|Panhematin|panhematin
643763|NCT00467610|Hemin|hemin
643764|NCT00467597|Dyskinesia|dyskinesia
643765|NCT00467597|Levodopa|levodopa
643766|NCT00467597|Movement Disorders|movement disorders
643767|NCT00467597|Parkinson Disease|parkinson disease
643768|NCT00467571|chronic idiopathic thrombocytopenic purpura|chronic idiopathic thrombocytopenic purpura
643769|NCT00467571|Helicobacter pylori infection|helicobacter pylori infection
643770|NCT00467571|platelet|platelet
643771|NCT00467558|Impulse Control Disorder|impulse control disorder
643772|NCT00467558|Compulsive Sexual Behavior|compulsive sexual behavior
643773|NCT00467545|HBeAg-positive|hbeag-positive
643774|NCT00467545|chronic hepatitis B|chronic hepatitis b
643775|NCT00467545|telbivudine|telbivudine
643776|NCT00467519|Tetanus; Diphtheria; Pertussis; ADACEL; DAPTACEL|tetanus; diphtheria; pertussis; adacel; daptacel
643777|NCT00467506|Recurrence of medullary thyroid carcinoma: abnormal calcitonin level and biomarkers doubling time lower than 5 years after initial surgery|recurrence of medullary thyroid carcinoma: abnormal calcitonin level and biomarkers doubling time lower than 5 years after initial surgery
643778|NCT00467454|Pyromania|pyromania
643779|NCT00467454|Fire Setting|fire setting
643780|NCT00467454|Compulsive Fire Setting|compulsive fire setting
643781|NCT00467428|ADHD|adhd
643782|NCT00467415|Walking|walking
643784|NCT00467415|Partial Weightbearing|partial weightbearing
643785|NCT00467402|agomelatine, Major Depressive Disorder, MDD, depression|agomelatine, major depressive disorder, mdd, depression
643786|NCT00467389|Acetylcholine|acetylcholine
643787|NCT00467389|Acetylcholinesterase|acetylcholinesterase
643788|NCT00467389|Butyrylcholinesterase|butyrylcholinesterase
643789|NCT00467389|Cholinesterase Inhibitor|cholinesterase inhibitor
643790|NCT00467350|constipation|constipation
643791|NCT00467350|treatment|treatment
643792|NCT00467350|fecal impaction|fecal impaction
643793|NCT00467350|pediatric|pediatric
643794|NCT00467337|insole|insole
643795|NCT00467337|osteoarthritis|osteoarthritis
643796|NCT00467337|pain|pain
643797|NCT00467337|valgus knee|valgus knee
643798|NCT00467324|obstructive sleep apnea|obstructive sleep apnea
643799|NCT00467324|surgery|surgery
643800|NCT00467324|tongue|tongue
643801|NCT00467311|Contrast-induced nephropathy|contrast-induced nephropathy
643802|NCT00467311|Cystatin C|cystatin c
643803|NCT00467311|Contrast media|contrast media
643804|NCT00467311|Creatinine|creatinine
643805|NCT00467311|Cardiac Catheterization|cardiac catheterization
643806|NCT00467298|Exercise|exercise
643807|NCT00467298|heart failure|heart failure
643808|NCT00467298|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
643809|NCT00467298|patient education|patient education
643810|NCT00467298|costs|costs
643811|NCT00467298|quality of life|quality of life
643812|NCT00467285|Bone Density|bone density
643813|NCT00467285|C-telopeptide|c-telopeptide
643814|NCT00467285|Dual-Energy X-Ray Absorptiometry|dual-energy x-ray absorptiometry
643815|NCT00467285|N-telopeptide|n-telopeptide
643816|NCT00467285|Osteocalcin|osteocalcin
643817|NCT00467285|Osteoporosis|osteoporosis
643818|NCT00467285|Thiazolidinediones|thiazolidinediones
643819|NCT00467285|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
643820|NCT00467272|Catheter-Related Bloodstream Infections|catheter-related bloodstream infections
643821|NCT00467272|Bloodstream Infection|bloodstream infection
643822|NCT00467272|Daptomycin|daptomycin
643823|NCT00467272|Cubicin|cubicin
643824|NCT00467272|CRBSI|crbsi
643825|NCT00467259|Natural Menopause|natural menopause
643826|NCT00467246|Diabetes emergencies|diabetes emergencies
643827|NCT00467220|Calorie restriction|calorie restriction
643828|NCT00467220|alternate day fasting|alternate day fasting
643829|NCT00467220|calorie intake|calorie intake
643830|NCT00467194|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
643831|NCT00467194|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
643832|NCT00467194|recurrent adult primary liver cancer|recurrent adult primary liver cancer
643833|NCT00467194|advanced adult primary liver cancer|advanced adult primary liver cancer
643834|NCT00467181|cardiac surgery|cardiac surgery
643835|NCT00467181|renal dysfunction|renal dysfunction
643836|NCT00467168|dietary fatty acid composition|dietary fatty acid composition
643837|NCT00467168|postprandial|postprandial
643838|NCT00467168|triglyceride-rich lipoprotein|triglyceride-rich lipoprotein
643839|NCT00467168|type 2 diabetes|type 2 diabetes
643840|NCT00467155|Helicobacter pylori, children, infants, Gambia|helicobacter pylori, children, infants, gambia
643841|NCT00467142|stage IV colon cancer|stage iv colon cancer
643842|NCT00467142|stage IV rectal cancer|stage iv rectal cancer
643843|NCT00467142|adenocarcinoma of the colon|adenocarcinoma of the colon
643844|NCT00467142|adenocarcinoma of the rectum|adenocarcinoma of the rectum
643845|NCT00467142|recurrent colon cancer|recurrent colon cancer
643846|NCT00467142|recurrent rectal cancer|recurrent rectal cancer
643847|NCT00467129|stage IV colon cancer|stage iv colon cancer
643848|NCT00467129|stage IV rectal cancer|stage iv rectal cancer
643849|NCT00467116|stage III pancreatic cancer|stage iii pancreatic cancer
643850|NCT00467116|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
643851|NCT00467116|stage II pancreatic cancer|stage ii pancreatic cancer
643852|NCT00467116|recurrent pancreatic cancer|recurrent pancreatic cancer
643853|NCT00467103|Adult Aphasia|adult aphasia
643854|NCT00467103|Diffusion Tensor Imaging|diffusion tensor imaging
643855|NCT00467103|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
643856|NCT00467103|Language Recovery|language recovery
643857|NCT00467103|Left Middle Cerebral Artery Stroke|left middle cerebral artery stroke
643858|NCT00467103|Nonfluent Aphasia|nonfluent aphasia
643859|NCT00467090|Parkinson's Disease|parkinson's disease
643860|NCT00467090|Gene|gene
643861|NCT00467090|Genetic|genetic
643862|NCT00467090|Family Studies|family studies
643863|NCT00467090|LRRK-2|lrrk-2
643864|NCT00467090|Parkinson Disease|parkinson disease
643865|NCT00467090|PD|pd
643866|NCT00467077|recurrent renal cell cancer|recurrent renal cell cancer
643867|NCT00467077|stage IV renal cell cancer|stage iv renal cell cancer
643868|NCT00467077|stage III renal cell cancer|stage iii renal cell cancer
643869|NCT00467064|Disease self-management|disease self-management
643870|NCT00467064|Community programs|community programs
643871|NCT00467038|affect|affect
643872|NCT00467038|aggression|aggression
643873|NCT00467038|anger|anger
643874|NCT00467038|behavior therapy|behavior therapy
643875|NCT00467038|borderline personality disorder|borderline personality disorder
643876|NCT00467038|MRI, functional|mri, functional
643877|NCT00467025|Metastatic clear cell carcinoma of the kidney|metastatic clear cell carcinoma of the kidney
643878|NCT00467025|RCC|rcc
643879|NCT00467012|Inoperable metastatic breast cancer|inoperable metastatic breast cancer
643880|NCT00466999|misoprostol|misoprostol
643881|NCT00466999|incomplete abortion|incomplete abortion
643882|NCT00466999|PAC|pac
643883|NCT00466986|recurrent|recurrent
643884|NCT00466986|ovarian|ovarian
643885|NCT00466986|cancer|cancer
643886|NCT00466986|platinum sensitive|platinum sensitive
643887|NCT00466973|Atrial fibrillation|atrial fibrillation
643888|NCT00466973|ablation device comparison|ablation device comparison
643889|NCT00466973|ablation in right atria|ablation in right atria
643890|NCT00466947|Otitis media|otitis media
643891|NCT00466947|Pneumonia|pneumonia
643892|NCT00466947|Community acquired pneumonia (CAP)|community acquired pneumonia (cap)
643893|NCT00466947|Pneumococcal disease|pneumococcal disease
643894|NCT00466947|Booster vaccination|booster vaccination
643895|NCT00466947|Immunogenicity|immunogenicity
643896|NCT00466947|Pneumococcal vaccine|pneumococcal vaccine
643897|NCT00466947|Safety|safety
643898|NCT00466947|Efficacy|efficacy
643899|NCT00466947|Carriage|carriage
643900|NCT00466934|Cerebral Blood Flow|cerebral blood flow
643901|NCT00466934|Cerebral Cortex|cerebral cortex
643902|NCT00466934|Cognition|cognition
643903|NCT00466934|Optical Imaging|optical imaging
643904|NCT00466934|Healthy Volunteer|healthy volunteer
643905|NCT00466934|HV|hv
643906|NCT00466921|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
643907|NCT00466921|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
643908|NCT00466921|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
643909|NCT00466921|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
643910|NCT00466921|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
643911|NCT00466895|Leukemia|leukemia
643912|NCT00466895|Lenalidomide|lenalidomide
643913|NCT00466882|obese|obese
643914|NCT00466882|renal failure|renal failure
643915|NCT00466882|renal transplant candidate|renal transplant candidate
643916|NCT00466882|Hemodialysis BMI between 36 and 42|hemodialysis bmi between 36 and 42
643917|NCT00466856|neoplastic syndrome|neoplastic syndrome
643918|NCT00466856|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
643919|NCT00466856|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
643920|NCT00466856|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
643921|NCT00466856|metastatic pheochromocytoma|metastatic pheochromocytoma
643922|NCT00466856|recurrent islet cell carcinoma|recurrent islet cell carcinoma
643923|NCT00466856|liver metastases|liver metastases
643924|NCT00466856|recurrent pheochromocytoma|recurrent pheochromocytoma
643925|NCT00466856|gastrinoma|gastrinoma
643926|NCT00466856|insulinoma|insulinoma
643927|NCT00466856|WDHA syndrome|wdha syndrome
643928|NCT00466856|glucagonoma|glucagonoma
643929|NCT00466856|pancreatic polypeptide tumor|pancreatic polypeptide tumor
643930|NCT00466856|somatostatinoma|somatostatinoma
643931|NCT00466843|Abnormal hematopoiesis|abnormal hematopoiesis
643932|NCT00466843|Leukemia|leukemia
643933|NCT00466843|Autoimmune Disease|autoimmune disease
643934|NCT00466830|pain|pain
643935|NCT00466830|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
643936|NCT00466830|stage IIIA breast cancer|stage iiia breast cancer
643937|NCT00466830|stage IIIB breast cancer|stage iiib breast cancer
643938|NCT00466830|stage I breast cancer|stage i breast cancer
643939|NCT00466830|stage II breast cancer|stage ii breast cancer
643940|NCT00466830|stage IIIC breast cancer|stage iiic breast cancer
643941|NCT00466817|Cytomegalovirus, congenital, infants|cytomegalovirus, congenital, infants
643942|NCT00466804|heart transplant recipients|heart transplant recipients
643943|NCT00466804|organ transplantation|organ transplantation
643944|NCT00466804|immune biomarkers|immune biomarkers
643945|NCT00466804|transplant rejection|transplant rejection
643946|NCT00466765|Fat Grafting|fat grafting
643947|NCT00466765|Breast Augmentation|breast augmentation
643948|NCT00466765|Liposuctioned Fat Transfer|liposuctioned fat transfer
643949|NCT00466765|Lumpectomy|lumpectomy
643950|NCT00466765|Mastectomy|mastectomy
643951|NCT00466765|Micromastia|micromastia
643952|NCT00466765|Asymmetry|asymmetry
643953|NCT00466765|Post Lumpectomy Filling Defects|post lumpectomy filling defects
643954|NCT00466765|Post implant removal filling defect|post implant removal filling defect
643955|NCT00466765|Post Mastectomy|post mastectomy
643956|NCT00466765|Autologous Fat Transfer|autologous fat transfer
643957|NCT00466765|Tubular breasts|tubular breasts
643958|NCT00466765|Tuberous breasts|tuberous breasts
643959|NCT00466765|Constricted breasts|constricted breasts
643960|NCT00466726|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
643961|NCT00466726|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
643962|NCT00466726|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
643963|NCT00466726|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
643964|NCT00466726|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
643965|NCT00466713|Nonischemic dilated cardiomyopathy|nonischemic dilated cardiomyopathy
643966|NCT00466700|Helicobacter pylori, Gambia, endoscopy, Africa|helicobacter pylori, gambia, endoscopy, africa
643967|NCT00466687|stage IV melanoma|stage iv melanoma
643968|NCT00466687|recurrent melanoma|recurrent melanoma
643969|NCT00466674|Myeloma|myeloma
643970|NCT00466674|RICT|rict
643971|NCT00466674|conditioning|conditioning
643972|NCT00466674|allograft|allograft
643973|NCT00466661|Acamprosate|acamprosate
643974|NCT00466661|Alcoholism|alcoholism
643975|NCT00466661|Bipolar disorder|bipolar disorder
643976|NCT00466661|Comorbidity|comorbidity
643977|NCT00466661|Craving|craving
643978|NCT00466661|Depression|depression
643979|NCT00466661|GABA|gaba
643980|NCT00466661|Glutamate|glutamate
643981|NCT00466661|Mania|mania
643982|NCT00466661|Pharmacotherapy|pharmacotherapy
643983|NCT00466661|Withdrawal|withdrawal
643984|NCT00466648|laparoscopy, port site, closure, Dermabond|laparoscopy, port site, closure, dermabond
643985|NCT00466635|Clostridium difficile Disease|clostridium difficile disease
643986|NCT00466635|Infectious diarrhea|infectious diarrhea
643987|NCT00466635|C. difficile|c. difficile
643988|NCT00466635|CDAD|cdad
643989|NCT00466635|Clostridium difficile-associated diarrhea|clostridium difficile-associated diarrhea
643990|NCT00466635|Clostridium difficile diarrhea|clostridium difficile diarrhea
643991|NCT00466635|Antibiotic-Associated Colitis|antibiotic-associated colitis
643992|NCT00466635|Clostridium Enterocolitis|clostridium enterocolitis
643993|NCT00466635|Antibiotic-Associated Diarrhea|antibiotic-associated diarrhea
643994|NCT00466635|Pseudomembranous Colitis|pseudomembranous colitis
643995|NCT00466635|Clostridium difficile|clostridium difficile
643996|NCT00466622|PCOS|pcos
643997|NCT00466622|pregnancy|pregnancy
643998|NCT00466622|metformin|metformin
643999|NCT00466622|blood flow|blood flow
644000|NCT00466622|Pulsatility index|pulsatility index
644001|NCT00466609|clomipramine|clomipramine
644002|NCT00466609|quetiapine|quetiapine
644003|NCT00466609|fluoxetine|fluoxetine
644004|NCT00466609|placebo|placebo
644005|NCT00466609|augmentation|augmentation
644006|NCT00466609|obsessive compulsive disorder|obsessive compulsive disorder
644007|NCT00466596|allergic rhinitis|allergic rhinitis
644008|NCT00466596|mild asthma|mild asthma
644009|NCT00466596|dust mite allergy|dust mite allergy
644010|NCT00466596|gamma tocopherol|gamma tocopherol
644011|NCT00466583|Carcinoma, Lymphoma|carcinoma, lymphoma
644012|NCT00466557|Malaria, Plasmodium falciparum, mosquito, Africa, Anopheles|malaria, plasmodium falciparum, mosquito, africa, anopheles
644013|NCT00466544|Chronic tonsillitis|chronic tonsillitis
644014|NCT00466544|Recurrent tonsillitis|recurrent tonsillitis
644015|NCT00466531|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
644016|NCT00466531|06-138|06-138
644017|NCT00466518|Kidney transplant|kidney transplant
644018|NCT00466518|type 2 diabetes|type 2 diabetes
644019|NCT00466518|sitagliptin|sitagliptin
644020|NCT00466505|recurrent colon cancer|recurrent colon cancer
644021|NCT00466505|stage IV colon cancer|stage iv colon cancer
644022|NCT00466505|recurrent rectal cancer|recurrent rectal cancer
644023|NCT00466505|stage IV rectal cancer|stage iv rectal cancer
644024|NCT00466492|Drug Administration Schedule|drug administration schedule
644025|NCT00466492|Intensive Care Units|intensive care units
644026|NCT00466492|Length of Stay|length of stay
644027|NCT00466492|Respiration, Artificial|respiration, artificial
644028|NCT00466492|Stress Disorders, Post-Traumatic/etiology/*psychology|stress disorders, post-traumatic/etiology/*psychology
644029|NCT00466492|Critical Illness/*psychology|critical illness/*psychology
644030|NCT00466492|Pneumonia/prevention & control|pneumonia/prevention & control
644031|NCT00466492|Hypnotics and Sedatives/*administration & dosage|hypnotics and sedatives/*administration & dosage
644032|NCT00466479|neuroprotection|neuroprotection
644033|NCT00466479|alpha one agonists|alpha one agonists
644034|NCT00466479|glaucoma|glaucoma
644035|NCT00466479|visual field|visual field
644036|NCT00466466|Small-Cell Lung Cancer|small-cell lung cancer
644037|NCT00466466|SCLC|sclc
644038|NCT00466466|Advanced Lung Cancer|advanced lung cancer
644039|NCT00466466|RAD|rad
644040|NCT00466466|RAD001|rad001
644041|NCT00466466|Chemotherapy|chemotherapy
644042|NCT00466466|Cisplatin|cisplatin
644043|NCT00466466|Etoposide|etoposide
644044|NCT00466375|hemangioma|hemangioma
644045|NCT00466375|vascular anomaly|vascular anomaly
644046|NCT00466375|infantile hemangioma|infantile hemangioma
644047|NCT00466362|Obesity|obesity
644048|NCT00466362|Diabetes|diabetes
644049|NCT00466362|Weight|weight
644050|NCT00466362|Lifestyle|lifestyle
644051|NCT00466362|Follow up|follow up
644052|NCT00466349|SMA Type I|sma type i
644053|NCT00466349|SMA Type II|sma type ii
644054|NCT00466349|SMA Type III|sma type iii
644055|NCT00466349|SMN|smn
644056|NCT00466349|Werdnig-Hoffman Disease|werdnig-hoffman disease
644057|NCT00466349|Spinal Muscular Atrophy|spinal muscular atrophy
644058|NCT00466349|Registry|registry
644059|NCT00466349|SMA Type IV|sma type iv
644060|NCT00466336|Chronic hepatitis C|chronic hepatitis c
644061|NCT00466336|Non-invasive diagnosis|non-invasive diagnosis
644062|NCT00466336|Duplex Doppler ultrasonography|duplex doppler ultrasonography
644063|NCT00466336|Biochemical indices|biochemical indices
644064|NCT00466336|Hepatic fibrosis|hepatic fibrosis
644065|NCT00466336|Cirrhosis|cirrhosis
644066|NCT00466323|Mental Illness|mental illness
644067|NCT00466323|Schizophrenia|schizophrenia
644068|NCT00466323|Education|education
644069|NCT00466323|Family member treatment|family member treatment
644070|NCT00466323|Active psychoses|active psychoses
644071|NCT00466310|Schizophrenia|schizophrenia
644072|NCT00466310|Metabolomics|metabolomics
644073|NCT00466297|Interprofessional|interprofessional
644074|NCT00466297|Collaboration|collaboration
644075|NCT00466297|Teamwork|teamwork
644076|NCT00466297|General internal medicine|general internal medicine
644077|NCT00466297|Cluster randomized|cluster randomized
644078|NCT00466271|Chronic hepatitis C|chronic hepatitis c
644079|NCT00466271|Persistently normal alanine aminotransferase levels|persistently normal alanine aminotransferase levels
644080|NCT00466271|Hepatic fibrosis|hepatic fibrosis
644081|NCT00466271|Non-invasive diagnosis|non-invasive diagnosis
644082|NCT00466271|Splenic arterial pulsatility index|splenic arterial pulsatility index
644083|NCT00466258|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
644084|NCT00466258|HIV|hiv
644085|NCT00466258|R-CHOP|r-chop
644086|NCT00466258|Highly active antiretroviral therapy|highly active antiretroviral therapy
644087|NCT00466258|Treatment Experienced|treatment experienced
644088|NCT00466245|MVA Vaccine|mva vaccine
644089|NCT00466232|Small Cell|small cell
644090|NCT00466232|Lung Cancer|lung cancer
644091|NCT00466232|Treatment|treatment
644092|NCT00466219|Presence of HCV RNA in serum|presence of hcv rna in serum
644093|NCT00466219|Absence of graft rejection|absence of graft rejection
644094|NCT00466219|Recurrent hepatitis C after liver transplantation|recurrent hepatitis c after liver transplantation
644095|NCT00466206|pectus excavatum|pectus excavatum
644096|NCT00466206|magnetic alteration|magnetic alteration
644097|NCT00466206|chest wall deformity|chest wall deformity
644098|NCT00466193|Insomnia|insomnia
644099|NCT00466180|Once-a-day|once-a-day
644100|NCT00466180|Adherence|adherence
644101|NCT00466180|Nevirapine|nevirapine
644102|NCT00466180|Patient noncompliance|patient noncompliance
644103|NCT00466180|Administration and dosage|administration and dosage
644104|NCT00466180|Treatment Experienced|treatment experienced
644105|NCT00466154|Aspirin resistance|aspirin resistance
644106|NCT00466154|Platelet activation|platelet activation
644107|NCT00466154|Hypercholesterolemia|hypercholesterolemia
644108|NCT00466128|fetal membranes, preterm rupture|fetal membranes, preterm rupture
644109|NCT00466128|preterm rupture|preterm rupture
644110|NCT00466128|PPROM|pprom
644111|NCT00466102|Breast Cancer|breast cancer
644112|NCT00466102|Bone metastases as only metastatic site|bone metastases as only metastatic site
644113|NCT00466102|Breast cancer, HER2 negative|breast cancer, her2 negative
644114|NCT00466102|Bone metastasis as only metastatic site|bone metastasis as only metastatic site
644115|NCT00466102|Pretreated with endocrine therapy|pretreated with endocrine therapy
644116|NCT00466102|Up to one previous chemotherapy|up to one previous chemotherapy
644117|NCT00466102|Previous treatment with bisphosphonates allowed|previous treatment with bisphosphonates allowed
644118|NCT00466089|NSCLC, lung cancer|nsclc, lung cancer
644119|NCT00466089|Patients with localized-unresectable (IA-IIIB) non-small cell lung cancer non susceptible for chemotherapy treatment.|patients with localized-unresectable (ia-iiib) non-small cell lung cancer non susceptible for chemotherapy treatment.
644120|NCT00466076|Drusen|drusen
644121|NCT00466076|AMD|amd
644122|NCT00466076|Dry form of Age related Macular Degeneration|dry form of age related macular degeneration
644123|NCT00466063|Iron overload|iron overload
644124|NCT00466063|children|children
644125|NCT00466063|deferasirox|deferasirox
644126|NCT00466063|Transfusion-dependent anemia|transfusion-dependent anemia
644127|NCT00466050|plaque rupture,|plaque rupture,
644128|NCT00466050|acute coronary thrombose,|acute coronary thrombose,
644129|NCT00466050|coronary angiography,|coronary angiography,
644130|NCT00466050|IVUS|ivus
644131|NCT00466037|Rheumatoid|rheumatoid
644132|NCT00466037|rituximab|rituximab
644133|NCT00466037|influenza|influenza
644134|NCT00466024|Asthma|asthma
644135|NCT00466024|persistent|persistent
644136|NCT00466024|children|children
644137|NCT00466024|particulates|particulates
644138|NCT00466024|ETS|ets
644139|NCT00465998|Ultrasound|ultrasound
644140|NCT00465998|Induced labor|induced labor
644141|NCT00465998|Cervical length|cervical length
644142|NCT00465998|Engagement of fetal head|engagement of fetal head
644143|NCT00465998|Occiput posterior|occiput posterior
644144|NCT00465998|Outcome of labor|outcome of labor
644145|NCT00465985|Muckle-Wells Syndrome|muckle-wells syndrome
644146|NCT00465985|children|children
644147|NCT00465985|systemic autoinflammatory disease|systemic autoinflammatory disease
644148|NCT00465985|CIAS-1 gene|cias-1 gene
644149|NCT00465985|NALP-3|nalp-3
644150|NCT00465985|ACZ885|acz885
644151|NCT00465985|human monoclonal anti-human interleukin-1beta (IL-1beta)|human monoclonal anti-human interleukin-1beta (il-1beta)
644152|NCT00465985|antibody|antibody
644153|NCT00465985|autosomal dominant|autosomal dominant
644154|NCT00465985|familial autoinflammatory syndrome|familial autoinflammatory syndrome
644155|NCT00465972|HIV|hiv
644156|NCT00465972|Insomnia|insomnia
644157|NCT00465972|Cytokines|cytokines
644158|NCT00465972|Adherence|adherence
644159|NCT00465959|COPD|copd
644160|NCT00465946|Salt supplementation|salt supplementation
644161|NCT00465946|Vasovagal syncope|vasovagal syncope
644162|NCT00465946|Orthostatic tolerance|orthostatic tolerance
644163|NCT00465946|Healthy volunteers|healthy volunteers
644164|NCT00465933|Acute Promyelocytic Leukemia|acute promyelocytic leukemia
644165|NCT00465933|AIDA|aida
644166|NCT00465920|schizophrenia|schizophrenia
644167|NCT00465920|cognitive behavioural therapy|cognitive behavioural therapy
644168|NCT00465920|early onset psychosis|early onset psychosis
644169|NCT00465920|Psychotic disorders (schizophrenia, schizoaffective disorder, delusional disorder, schizophreniform disorder according to DSM IV) in adolescents|psychotic disorders (schizophrenia, schizoaffective disorder, delusional disorder, schizophreniform disorder according to dsm iv) in adolescents
644170|NCT00465907|lung cancer with malignant pleural effusion|lung cancer with malignant pleural effusion
644171|NCT00465894|overactive bladder|overactive bladder
644172|NCT00465894|urge leakage|urge leakage
644173|NCT00465894|nightime urination|nightime urination
644174|NCT00465894|incontinence|incontinence
644175|NCT00465894|urinary frequency|urinary frequency
644176|NCT00465881|Diabetes|diabetes
644177|NCT00465881|CGM|cgm
644178|NCT00465868|Acute Myocardial Infarction|acute myocardial infarction
644179|NCT00465868|Coronary Revascularization|coronary revascularization
644180|NCT00465868|Microvascular Obstruction|microvascular obstruction
644181|NCT00465868|Cardiac MR|cardiac mr
644182|NCT00465868|Collagen Turnover|collagen turnover
644183|NCT00465868|Heart failure, post-mi|heart failure, post-mi
644184|NCT00465855|Carbon monoxide poisoning|carbon monoxide poisoning
644185|NCT00465855|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
644186|NCT00465855|Randomized controlled trial|randomized controlled trial
644187|NCT00465855|Clinical investigation|clinical investigation
644188|NCT00465842|Hepatitis|hepatitis
644189|NCT00465842|Liver Cirrhosis|liver cirrhosis
644190|NCT00465842|HCC|hcc
644191|NCT00465829|Obesity|obesity
644192|NCT00465816|non-inferiority|non-inferiority
644193|NCT00465816|adolescents|adolescents
644194|NCT00465816|meningococcal vaccine|meningococcal vaccine
644195|NCT00465803|Open-angle glaucoma or ocular hypertension|open-angle glaucoma or ocular hypertension
644196|NCT00465790|biomarkers|biomarkers
644197|NCT00465790|neuroimaging|neuroimaging
644198|NCT00465790|genetics|genetics
644199|NCT00465790|PET|pet
644200|NCT00465790|Genetic and Idiopathic Parkinson|genetic and idiopathic parkinson
644201|NCT00465790|Multiple Systemic Atrophy|multiple systemic atrophy
644202|NCT00465790|Huntington|huntington
644203|NCT00465790|Dopa Responsive Dystonia|dopa responsive dystonia
644204|NCT00465777|malaria|malaria
644205|NCT00465777|mortality|mortality
644206|NCT00465777|hospital|hospital
644207|NCT00465777|incentive|incentive
644208|NCT00465777|personnel|personnel
644209|NCT00465777|paediatric|paediatric
644210|NCT00465764|healthy infants|healthy infants
644211|NCT00465725|Picoplatin|picoplatin
644212|NCT00465725|tumor|tumor
644213|NCT00465725|cancer|cancer
644214|NCT00465725|sarcoma|sarcoma
644215|NCT00465725|neoplasm|neoplasm
644216|NCT00465725|advanced|advanced
644217|NCT00465725|platinum|platinum
644218|NCT00465725|chemotherapy|chemotherapy
644219|NCT00465725|Solid Tumor|solid tumor
644220|NCT00465712|transabdominal amnioinfusion|transabdominal amnioinfusion
644221|NCT00465712|external cephalic version|external cephalic version
644222|NCT00465712|breech presentation|breech presentation
644223|NCT00465699|Eczema|eczema
644224|NCT00465699|Pediatric|pediatric
644225|NCT00465699|Vitamin B12|vitamin b12
644226|NCT00465686|handwriting|handwriting
644227|NCT00465686|child|child
644228|NCT00465686|primary school|primary school
644229|NCT00465686|posture|posture
644230|NCT00465686|assistive device|assistive device
644231|NCT00465673|breast cancer|breast cancer
644232|NCT00465673|brain metastatsis|brain metastatsis
644233|NCT00465673|Lipo-Dox|lipo-dox
644234|NCT00465660|Osteoarthritis|osteoarthritis
644235|NCT00465660|Cartilage|cartilage
644236|NCT00465660|Exercise|exercise
644237|NCT00465660|Progressive Resistance Training|progressive resistance training
644238|NCT00465647|Postoperative pain|postoperative pain
644239|NCT00465647|Hydromorphone oral solution|hydromorphone oral solution
644240|NCT00465647|opioid|opioid
644241|NCT00465647|pharmacokinetics|pharmacokinetics
644242|NCT00465647|pharmacodynamics|pharmacodynamics
644243|NCT00465634|Screening|screening
644244|NCT00465634|uterine artery Doppler|uterine artery doppler
644245|NCT00465634|HELLP syndrome|hellp syndrome
644246|NCT00465634|abruption|abruption
644247|NCT00465621|Open-angle glaucoma|open-angle glaucoma
644248|NCT00465621|ocular hypertension|ocular hypertension
644249|NCT00465608|adults|adults
644250|NCT00465608|PTSD|ptsd
644251|NCT00465608|trauma|trauma
644252|NCT00465608|AZF|azf
644253|NCT00465608|propranolol|propranolol
644254|NCT00465608|reconsolidation|reconsolidation
644255|NCT00465608|Post traumatic stress disorder|post traumatic stress disorder
644256|NCT00465608|chronic form|chronic form
644353|NCT00465179|Chromophobe|chromophobe
644257|NCT00465608|PTSD (Post-Traumatic Stress Disorder)|ptsd (post-traumatic stress disorder)
644258|NCT00465582|carriage|carriage
644259|NCT00465582|Neisseria meningitidis|neisseria meningitidis
644260|NCT00465582|risk factors|risk factors
644261|NCT00465569|Food Allergy|food allergy
644262|NCT00465569|Oral Immunotherapy|oral immunotherapy
644263|NCT00465569|Immunoglobulin E|immunoglobulin e
644264|NCT00465543|Nasal polyposis|nasal polyposis
644265|NCT00465543|Mint tea|mint tea
644266|NCT00465543|Double-blind|double-blind
644267|NCT00465543|Placebo-controlled|placebo-controlled
644268|NCT00465543|Crossover|crossover
644269|NCT00465517|Partial onset seizures|partial onset seizures
644270|NCT00465517|Complex-partial seizures|complex-partial seizures
644271|NCT00465517|Anticonvulsant|anticonvulsant
644272|NCT00465517|Partial seizures|partial seizures
644273|NCT00465517|Catamenial epilepsy|catamenial epilepsy
644274|NCT00465504|local analgesia|local analgesia
644275|NCT00465504|intra-articular corticosteroid injection|intra-articular corticosteroid injection
644276|NCT00465504|iontophoresis|iontophoresis
644277|NCT00465504|Local analgesia for intra-articular corticosteroid injection|local analgesia for intra-articular corticosteroid injection
644278|NCT00465491|refractory|refractory
644279|NCT00465491|chemotherapy|chemotherapy
644280|NCT00465491|progressed|progressed
644281|NCT00465491|second-line treatment|second-line treatment
644282|NCT00465491|small cell lung cancer|small cell lung cancer
644283|NCT00465491|best supportive care|best supportive care
644284|NCT00465491|picoplatin|picoplatin
644285|NCT00465478|Diabetes Mellitus|diabetes mellitus
644286|NCT00465478|Bone Marros Mononuclear Cells|bone marros mononuclear cells
644287|NCT00465478|Transplantation|transplantation
644288|NCT00465465|Tuberculosis|tuberculosis
644289|NCT00465465|TB|tb
644290|NCT00465465|MVA 85A|mva 85a
644291|NCT00465465|BCG|bcg
644292|NCT00465439|femoral artery sheath|femoral artery sheath
644293|NCT00465439|vasovagal reaction|vasovagal reaction
644294|NCT00465439|pain|pain
644295|NCT00465439|perception|perception
644296|NCT00465426|HIV Infection|hiv infection
644297|NCT00465426|Cardiovascular Disease|cardiovascular disease
644298|NCT00465426|Antiretroviral Therapy|antiretroviral therapy
644299|NCT00465426|Inflammatory Markers|inflammatory markers
644300|NCT00465426|Treatment Experienced|treatment experienced
644301|NCT00465413|metered-dose inhalers (MDI)|metered-dose inhalers (mdi)
644302|NCT00465413|forced expiratory volume in 1 second (FEV1)|forced expiratory volume in 1 second (fev1)
644303|NCT00465413|forced expiratory flow rate (FEF25-75%)|forced expiratory flow rate (fef25-75%)
644304|NCT00465400|exudative age-related macular degeneration (AMD)|exudative age-related macular degeneration (amd)
644305|NCT00465400|non-exudative age-related macular degeneration (AMD)|non-exudative age-related macular degeneration (amd)
644306|NCT00465400|oxidative stress|oxidative stress
644307|NCT00465400|photodynamic therapy|photodynamic therapy
644308|NCT00465374|ARDS|ards
644309|NCT00465374|Pressure/time curve|pressure/time curve
644310|NCT00465374|Stress Index|stress index
644311|NCT00465361|Growth and Development|growth and development
644312|NCT00465361|Child Development|child development
644313|NCT00465361|Developmental Surveillance|developmental surveillance
644314|NCT00465361|Medical Education|medical education
644315|NCT00465361|Internship and Residency|internship and residency
644316|NCT00465348|normal tension glaucoma|normal tension glaucoma
644317|NCT00465348|vascular dysregulation|vascular dysregulation
644318|NCT00465335|computed tomography|computed tomography
644319|NCT00465335|stress test|stress test
644320|NCT00465335|equivocal|equivocal
644321|NCT00465335|catheterization|catheterization
644322|NCT00465309|Respiratory Insufficiency|respiratory insufficiency
644323|NCT00465309|CO2 removal|co2 removal
644324|NCT00465309|protective ventilation|protective ventilation
644325|NCT00465309|ARDS|ards
644326|NCT00466388|dry mouth|dry mouth
644327|NCT00465283|Donepezil, ECT, Memory Disfunction|donepezil, ect, memory disfunction
644328|NCT00465270|Cryptogenic|cryptogenic
644329|NCT00465270|Stroke|stroke
644330|NCT00465270|PFO|pfo
644331|NCT00465244|Prehospital and ED seizures|prehospital and ed seizures
644332|NCT00465231|Induction of labour|induction of labour
644333|NCT00465231|Bupivacaine consumption|bupivacaine consumption
644334|NCT00465231|Prevention|prevention
644335|NCT00465218|Bioprosthesis|bioprosthesis
644336|NCT00465218|Thrombosis|thrombosis
644337|NCT00465218|Cerebral emboli|cerebral emboli
644338|NCT00465218|Transcranial Doppler|transcranial doppler
644339|NCT00465218|Platelet function tests|platelet function tests
644340|NCT00465205|HIV infection|hiv infection
644341|NCT00465205|HIV Shedding|hiv shedding
644342|NCT00465205|HSV suppression|hsv suppression
644343|NCT00465205|Co-infected|co-infected
644344|NCT00465205|Women|women
644345|NCT00465205|Reactivation|reactivation
644346|NCT00465205|Valacyclovir|valacyclovir
644347|NCT00465205|Treatment Naive|treatment naive
644348|NCT00465179|Non-Clear Cell Renal Carcinoma|non-clear cell renal carcinoma
644349|NCT00465179|Non-clear cell renal cell cancer|non-clear cell renal cell cancer
644350|NCT00465179|Renal Cell Cancer|renal cell cancer
644351|NCT00465179|Kidney Cancer|kidney cancer
644352|NCT00465179|Papillary|papillary
644354|NCT00465179|Collecting duct carcinoma|collecting duct carcinoma
644355|NCT00465179|CDC|cdc
644356|NCT00465179|Renal medullary carcinoma|renal medullary carcinoma
644357|NCT00465179|RMC|rmc
644358|NCT00465179|Sunitinib Malate|sunitinib malate
644359|NCT00465179|Sutent|sutent
644360|NCT00465179|SU011248|su011248
644361|NCT00465166|Accidental dural puncture|accidental dural puncture
644362|NCT00465166|Labour epidural|labour epidural
644363|NCT00465166|Ultrasound|ultrasound
644364|NCT00465166|Ligamentum flavum|ligamentum flavum
644365|NCT00465153|Inflammation|inflammation
644366|NCT00465153|cytokines|cytokines
644367|NCT00465153|sarcopenia|sarcopenia
644368|NCT00465153|strength|strength
644369|NCT00465153|muscle|muscle
644370|NCT00465153|aging|aging
644371|NCT00465153|exercise|exercise
644372|NCT00465114|Preeclampsia|preeclampsia
644373|NCT00465114|Hemodynamic monitoring|hemodynamic monitoring
644374|NCT00465101|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
644375|NCT00465101|Transurethral resection of the prostate|transurethral resection of the prostate
644376|NCT00465101|Lower urinary tract symptoms|lower urinary tract symptoms
644377|NCT00465101|GreenLight|greenlight
644378|NCT00465101|Laserscope|laserscope
644379|NCT00465101|Photoselective vaporization of the prostate|photoselective vaporization of the prostate
644380|NCT00465101|enlarged prostate|enlarged prostate
644381|NCT00465062|Lysosomal Disease|lysosomal disease
644382|NCT00465062|Lipids|lipids
644383|NCT00465062|B Lymphocytes|b lymphocytes
644384|NCT00465062|Brain Damage|brain damage
644385|NCT00465062|Gaucher Disease|gaucher disease
644386|NCT00465062|GD|gd
644387|NCT00465049|abscess, primary closure, secondary closure|abscess, primary closure, secondary closure
644388|NCT00465036|fat absorption|fat absorption
644389|NCT00465036|fibres|fibres
644390|NCT00465023|proton beam irradiation|proton beam irradiation
644391|NCT00465023|liver cancer|liver cancer
644392|NCT00465010|Adolescence|adolescence
644393|NCT00465010|Sexual health|sexual health
644394|NCT00465010|Communication|communication
644395|NCT00465010|Parenting|parenting
644396|NCT00464997|methotrexate aspirin pharmacokinetics|methotrexate aspirin pharmacokinetics
644397|NCT00464984|Weight loss|weight loss
644398|NCT00464984|Physical fitness|physical fitness
644399|NCT00464984|Quality of life|quality of life
644400|NCT00464958|Fatigue|fatigue
644401|NCT00464958|Spasticity|spasticity
644402|NCT00464958|Sublingual Tizanidine|sublingual tizanidine
644403|NCT00464958|Epworth Sleepiness Scale|epworth sleepiness scale
644404|NCT00464958|Fatigue Severity Scale|fatigue severity scale
644405|NCT00464932|COPD|copd
644406|NCT00464932|Vasoactive Intestinal Peptide|vasoactive intestinal peptide
644407|NCT00464932|Lung Function|lung function
644408|NCT00464919|Advance, hepatocellular carcinoma|advance, hepatocellular carcinoma
644409|NCT00464893|gastric cancer|gastric cancer
644410|NCT00464893|catumaxomab|catumaxomab
644411|NCT00464893|neoadjuvant chemotherapy|neoadjuvant chemotherapy
644412|NCT00464893|phase II|phase ii
644413|NCT00464893|interoperative|interoperative
644414|NCT00464893|trifunctional antibody|trifunctional antibody
644415|NCT00464880|Placebo-controlled study|placebo-controlled study
644416|NCT00464880|assess the renoprotective effect of renin inhibition|assess the renoprotective effect of renin inhibition
644417|NCT00464880|Aliskiren as an alternative to irbesartan|aliskiren as an alternative to irbesartan
644418|NCT00464880|Type 2 diabetes patients|type 2 diabetes patients
644419|NCT00464880|incipient/overt diabetic nephropathy|incipient/overt diabetic nephropathy
644420|NCT00464867|Bifidobacterium breve|bifidobacterium breve
644421|NCT00464867|oral whole cell cholera vaccine|oral whole cell cholera vaccine
644422|NCT00464867|immunogenicity|immunogenicity
644423|NCT00464867|Supplementation with probiotic improves vibriocidal antibody response in 2-5 year old childern given the killed oral cholera vaccine|supplementation with probiotic improves vibriocidal antibody response in 2-5 year old childern given the killed oral cholera vaccine
644424|NCT00464867|Supplementation with probiotics results in improving the ASC responses to CT and LPS of V. cholerae O1|supplementation with probiotics results in improving the asc responses to ct and lps of v. cholerae o1
644425|NCT00464854|Glucose control|glucose control
644426|NCT00464854|Subcutaneous insulin treatment|subcutaneous insulin treatment
644427|NCT00464854|Multiple daily injections|multiple daily injections
644428|NCT00464841|Tsui Test|tsui test
644429|NCT00464841|Combined Spinal Epidural|combined spinal epidural
644430|NCT00464841|Labour|labour
644431|NCT00464828|Central venous cannulation|central venous cannulation
644432|NCT00464828|Internal jugular vein|internal jugular vein
644433|NCT00464828|Ultrasound|ultrasound
644434|NCT00464828|Obstetrics|obstetrics
644435|NCT00464815|immunogenicity|immunogenicity
644436|NCT00464815|safety|safety
644437|NCT00464815|meningococcal vaccine|meningococcal vaccine
644438|NCT00464802|healthy|healthy
644439|NCT00464802|safety|safety
644440|NCT00464789|Postmenopausal|postmenopausal
644441|NCT00464776|Randomized|randomized
644442|NCT00464776|double-blind|double-blind
644443|NCT00464776|cross-over|cross-over
644444|NCT00464776|4-period|4-period
644445|NCT00464776|4 treatment|4 treatment
644446|NCT00464776|within-subject placebo-controlled study|within-subject placebo-controlled study
644447|NCT00464776|assess optimal renoprotective dose of Aliskiren|assess optimal renoprotective dose of aliskiren
644448|NCT00464776|hypertensive type 2 diabetes patients|hypertensive type 2 diabetes patients
644449|NCT00464776|incipient or overt nephropathy|incipient or overt nephropathy
644450|NCT00464763|Mental Health|mental health
644451|NCT00464763|Neurological Disease|neurological disease
644452|NCT00464763|Heart Valve Repair Surgery|heart valve repair surgery
644453|NCT00464750|Cardiac output|cardiac output
644454|NCT00464750|Thermodilution|thermodilution
644455|NCT00464737|Fibromyalgia Syndrome|fibromyalgia syndrome
644456|NCT00464737|Rotigotine|rotigotine
644457|NCT00464737|Neupro|neupro
644458|NCT00464724|Prostate Cancer|prostate cancer
644459|NCT00464724|Magnetic Resonance Spectroscopic Imaging|magnetic resonance spectroscopic imaging
644460|NCT00464724|Perfluorocarbon Compound|perfluorocarbon compound
644461|NCT00464724|AIR-MRSI|air-mrsi
644462|NCT00464724|PFC-MRSI|pfc-mrsi
644463|NCT00464724|3 Tesla|3 tesla
644464|NCT00464724|MRSI|mrsi
644465|NCT00464724|PFC|pfc
644466|NCT00464711|depression|depression
644467|NCT00464711|biology|biology
644468|NCT00464698|OCD|ocd
644469|NCT00464698|Obsessive Compulsive Disorder|obsessive compulsive disorder
644470|NCT00464698|Obsessions|obsessions
644471|NCT00464698|Compulsions|compulsions
644472|NCT00464698|Duloxetine|duloxetine
644473|NCT00464698|Cymbalta|cymbalta
644474|NCT00464672|Influenza, Egg-Derived, Healthy Children, Healthy Adolescents, Healthy Adults, Safety, Immunogenicity, Trivalent, Inactivated, Vaccination|influenza, egg-derived, healthy children, healthy adolescents, healthy adults, safety, immunogenicity, trivalent, inactivated, vaccination
644475|NCT00464659|Sleep apnea obstructive syndrome (SAOS)|sleep apnea obstructive syndrome (saos)
644476|NCT00464659|memory deficit|memory deficit
644477|NCT00464659|Continuous Positive Airway Pression (CPAP)|continuous positive airway pression (cpap)
644478|NCT00464659|Sham CPAP|sham cpap
644479|NCT00464646|NSABP|nsabp
644480|NCT00464646|Epirubicin|epirubicin
644481|NCT00464646|Cyclophosphamide|cyclophosphamide
644482|NCT00464646|Docetaxel|docetaxel
644483|NCT00464646|Trastuzumab|trastuzumab
644484|NCT00464646|Bevacizumab|bevacizumab
644485|NCT00464646|Neoadjuvant Therapy|neoadjuvant therapy
644486|NCT00464646|HER2|her2
644487|NCT00464646|Locally Advanced Breast Cancer|locally advanced breast cancer
644488|NCT00464646|Adjuvant Therapy|adjuvant therapy
644489|NCT00464646|Pathologic Stage III Breast Cancer|pathologic stage iii breast cancer
644490|NCT00464646|Inflammatory Breast Cancer|inflammatory breast cancer
644491|NCT00464633|CLL|cll
644492|NCT00464633|PLL|pll
644493|NCT00464633|flavopiridol|flavopiridol
644494|NCT00464620|Dasatinib|dasatinib
644495|NCT00464620|Rhabdomyosarcoma|rhabdomyosarcoma
644496|NCT00464620|Malignant peripheral nerve sheath tumor|malignant peripheral nerve sheath tumor
644497|NCT00464620|Chondrosarcoma|chondrosarcoma
644498|NCT00464620|Ewing's|ewing's
644499|NCT00464620|Alveolar soft part sarcoma (ASPS)|alveolar soft part sarcoma (asps)
644500|NCT00464620|Chordoma|chordoma
644501|NCT00464620|Epithelioid sarcoma|epithelioid sarcoma
644502|NCT00464620|Giant cell tumor of bone|giant cell tumor of bone
644503|NCT00464620|Hemangiopericytoma/solitary fibrous tumor|hemangiopericytoma/solitary fibrous tumor
644504|NCT00464620|Gastrointestinal Stromal Tumor (GIST)|gastrointestinal stromal tumor (gist)
644505|NCT00464594|Japan Early Diabetes Intervention Study|japan early diabetes intervention study
644506|NCT00464581|non-ischemic retinopathy|non-ischemic retinopathy
644507|NCT00464568|Seasonal allergic rhinitis,|seasonal allergic rhinitis,
644508|NCT00464568|hayfever|hayfever
644509|NCT00464555|Allogeneic Islets|allogeneic islets
644510|NCT00464555|Allogeneic Islet Transplantation|allogeneic islet transplantation
644511|NCT00464555|Type 1 diabetes mellitus|type 1 diabetes mellitus
644512|NCT00464555|Type 1 diabetes|type 1 diabetes
644513|NCT00464555|T1D|t1d
644514|NCT00464555|T1DM|t1dm
644515|NCT00464555|Insulin dependence|insulin dependence
644516|NCT00464555|Hypoglycemia unawareness in T1D|hypoglycemia unawareness in t1d
644517|NCT00464555|Islet transplant|islet transplant
644518|NCT00464555|Islet transplantation|islet transplantation
644519|NCT00464555|Islet graft|islet graft
644520|NCT00464542|herpes simplex virus|herpes simplex virus
644521|NCT00464529|blood glucose|blood glucose
644522|NCT00464529|hyperglycemia|hyperglycemia
644523|NCT00464529|hypoglycemia|hypoglycemia
644524|NCT00464529|Perioperative care|perioperative care
644525|NCT00464529|inpatient|inpatient
644526|NCT00464516|Breast cancer (Estrogen Receptor positive)|breast cancer (estrogen receptor positive)
644527|NCT00464503|statins|statins
644528|NCT00464503|proteinuria|proteinuria
644529|NCT00464503|proteomic analysis|proteomic analysis
644530|NCT00464503|healthy volunteers|healthy volunteers
644531|NCT00464490|Weaning|weaning
644532|NCT00464490|Extuvation|extuvation
644533|NCT00464490|Dexmedetomidine|dexmedetomidine
644534|NCT00464477|Autism|autism
644535|NCT00464477|Autistic disorder|autistic disorder
644536|NCT00464477|Pervasive developmental disorder|pervasive developmental disorder
644537|NCT00464477|Asperger syndrome|asperger syndrome
644538|NCT00464477|Childhood disintegrative disorder|childhood disintegrative disorder
644539|NCT00464477|Rett syndrome|rett syndrome
644540|NCT00464464|Parkinson's disease|parkinson's disease
644541|NCT00464464|PD|pd
644542|NCT00464464|depression|depression
644543|NCT00464464|cognitive-behavioral therapy|cognitive-behavioral therapy
644544|NCT00464464|social support|social support
644545|NCT00464425|Electroacupuncture|electroacupuncture
644546|NCT00464425|Postoperative ileus|postoperative ileus
644547|NCT00464425|Colorectal surgery|colorectal surgery
644548|NCT00464425|Laparoscopic surgery|laparoscopic surgery
644549|NCT00464425|Randomised trial|randomised trial
644550|NCT00464412|Osteoporosis|osteoporosis
644551|NCT00464412|Knowledge|knowledge
644552|NCT00464412|Beliefs|beliefs
644553|NCT00464412|Education|education
644554|NCT00464412|Women|women
644555|NCT00464399|De novo renal transplantation|de novo renal transplantation
644556|NCT00464399|CNI-free protocol|cni-free protocol
644557|NCT00464399|adults|adults
644558|NCT00464399|everolimus|everolimus
644559|NCT00464399|rejections|rejections
644560|NCT00464386|Severe burns|severe burns
644561|NCT00464386|Severe Trauma|severe trauma
644562|NCT00464386|Closed loop insulin|closed loop insulin
644563|NCT00464386|continuous glucose monitoring|continuous glucose monitoring
644564|NCT00464373|Prostatitis|prostatitis
644565|NCT00464373|Chronic Prostatitis with Chronic Pelvic Pain Syndrome|chronic prostatitis with chronic pelvic pain syndrome
644566|NCT00464373|Botulinum Toxin Type A|botulinum toxin type a
644567|NCT00464373|Drug therapy|drug therapy
644568|NCT00464373|Injections, intramuscular|injections, intramuscular
644569|NCT00464347|AMD|amd
644570|NCT00464347|wet AMD|wet amd
644571|NCT00464347|verteporfin PDT|verteporfin pdt
644572|NCT00464347|Avastin|avastin
644573|NCT00464347|TAC-PF|tac-pf
644574|NCT00464308|Gastroesophageal Reflux|gastroesophageal reflux
644575|NCT00464308|Heartburn|heartburn
644576|NCT00464308|Proton pump inhibitor|proton pump inhibitor
644577|NCT00464308|GORD|gord
644578|NCT00464295|Hepatocellular Carcinoma|hepatocellular carcinoma
644579|NCT00464295|Phase 2 Trial|phase 2 trial
644580|NCT00464295|Capecitabine|capecitabine
644581|NCT00464295|Treatment Efficacy|treatment efficacy
644582|NCT00464282|Fluorine–18-α–methyltyrosine,|fluorine–18-α–methyltyrosine,
644583|NCT00464282|Positron emission tomography,|positron emission tomography,
644584|NCT00464282|Fluorodeoxyglucose|fluorodeoxyglucose
644585|NCT00464282|Lung cancer,|lung cancer,
644586|NCT00464282|Amino acid transportor 1,|amino acid transportor 1,
644587|NCT00464282|Ki-67|ki-67
644588|NCT00464282|Proven or suspected non-small cell lung cancer were enrolled in the study|proven or suspected non-small cell lung cancer were enrolled in the study
644589|NCT00464269|Epilepsy|epilepsy
644590|NCT00464269|Brivaracetam|brivaracetam
644591|NCT00464269|Partial Onset Seizures, Adolescents & Adults|partial onset seizures, adolescents & adults
644592|NCT00464256|abstinence|abstinence
644593|NCT00464243|Sleep problems|sleep problems
644594|NCT00464243|Insomnia|insomnia
644595|NCT00464243|Sleeplessness|sleeplessness
644596|NCT00464243|Polysomnographic|polysomnographic
644597|NCT00464230|Displaced Femoral Neck Fractures|displaced femoral neck fractures
644598|NCT00464230|Treatment|treatment
644599|NCT00464230|Function|function
644600|NCT00464230|Pain|pain
644601|NCT00464230|Quality of life|quality of life
644602|NCT00464230|Complications|complications
644603|NCT00464230|Reoperations|reoperations
644604|NCT00464230|Internal Fixation|internal fixation
644605|NCT00464230|Hemiarthroplasty|hemiarthroplasty
644606|NCT00464230|Activities of Daily Living|activities of daily living
644607|NCT00464217|Acute Myeloblastic Leukaemia|acute myeloblastic leukaemia
644608|NCT00464191|bipolar depression|bipolar depression
644609|NCT00464191|SSRI|ssri
644610|NCT00464191|escitalopram|escitalopram
644611|NCT00464191|bipolar disorder|bipolar disorder
644612|NCT00464191|antidepressant|antidepressant
644613|NCT00464191|treatment trial|treatment trial
644614|NCT00464191|RCT|rct
644615|NCT00464178|multiple myeloma|multiple myeloma
644616|NCT00464178|myeloma|myeloma
644617|NCT00464178|relapsed myeloma|relapsed myeloma
644618|NCT00464178|refractory myeloma|refractory myeloma
644619|NCT00464178|relapsed, refractory myeloma|relapsed, refractory myeloma
644620|NCT00464178|relapsed, refractory multiple myeloma|relapsed, refractory multiple myeloma
644621|NCT00464178|refractory multiple myeloma|refractory multiple myeloma
644622|NCT00464178|relapsed multiple myeloma|relapsed multiple myeloma
644623|NCT00464178|B lymphoid malignancies|b lymphoid malignancies
644624|NCT00464178|Myeloma, Plasma-Cell|myeloma, plasma-cell
644625|NCT00464178|Myeloma Proteins|myeloma proteins
644626|NCT00464178|hnRNP A1|hnrnp a1
644627|NCT00464178|myeloma helix-destabilizing protein, mouse|myeloma helix-destabilizing protein, mouse
644628|NCT00464178|IgC3kappa Jir protein, human|igc3kappa jir protein, human
644629|NCT00464178|gamma 3 myeloma protein Jir, human|gamma 3 myeloma protein jir, human
644630|NCT00464178|M-proteins (Myeloma)|m-proteins (myeloma)
644631|NCT00464178|M315 myeloma protein, mouse|m315 myeloma protein, mouse
644632|NCT00464178|myeloma protein M 315, mouse|myeloma protein m 315, mouse
644633|NCT00464178|McPC603 antibody|mcpc603 antibody
644634|NCT00464178|myeloma protein McPC603 antibody|myeloma protein mcpc603 antibody
644635|NCT00464178|multiple myeloma M-proteins|multiple myeloma m-proteins
644732|NCT00463879|Cognition|cognition
644636|NCT00464178|M protein, multiple myeloma|m protein, multiple myeloma
644637|NCT00464178|myeloma cell activator|myeloma cell activator
644638|NCT00464178|myeloma immunoglobulins|myeloma immunoglobulins
644639|NCT00464178|myeloma immunoglobulin M603|myeloma immunoglobulin m603
644640|NCT00464178|myeloma immunoglobulin S15|myeloma immunoglobulin s15
644641|NCT00464178|myeloma protein A48, mouse|myeloma protein a48, mouse
644642|NCT00464178|A48 myeloma protein, mouse|a48 myeloma protein, mouse
644643|NCT00464178|ABPC48 myeloma protein, mouse|abpc48 myeloma protein, mouse
644644|NCT00464178|myeloma protein A 48, mouse|myeloma protein a 48, mouse
644645|NCT00464178|myeloma protein Dob|myeloma protein dob
644646|NCT00464178|myeloma protein M 467|myeloma protein m 467
644647|NCT00464178|myeloma protein M467|myeloma protein m467
644648|NCT00464178|myeloma protein MOPC 141, mouse|myeloma protein mopc 141, mouse
644649|NCT00464178|MOPC141 myeloma protein, mouse|mopc141 myeloma protein, mouse
644650|NCT00464178|myeloma protein MOPC 173|myeloma protein mopc 173
644651|NCT00464178|myeloma protein Rou|myeloma protein rou
644652|NCT00464178|IgA2 myeloma protein Rou|iga2 myeloma protein rou
644653|NCT00464178|myeloma protein TEPC15|myeloma protein tepc15
644654|NCT00464178|myeloma protein T15|myeloma protein t15
644655|NCT00464178|myeloma protein TEPC 15|myeloma protein tepc 15
644656|NCT00464178|myeloma protein W3129|myeloma protein w3129
644657|NCT00464178|myeloma protein WIE|myeloma protein wie
644658|NCT00464178|myeloma-associated membrane antigen KMA|myeloma-associated membrane antigen kma
644659|NCT00464178|myeloma antigen KMA|myeloma antigen kma
644660|NCT00464178|MYEOV protein, human|myeov protein, human
644661|NCT00464178|protein 460|protein 460
644662|NCT00464178|myeloma protein MOPC 460|myeloma protein mopc 460
644663|NCT00464178|TRAPPC1 protein, human|trappc1 protein, human
644664|NCT00464178|multiple myeloma protein 2, human|multiple myeloma protein 2, human
644665|NCT00464178|Wis heavy-chain disease protein, human|wis heavy-chain disease protein, human
644666|NCT00464178|myeloma protein Wis, human|myeloma protein wis, human
644667|NCT00464165|abstinence|abstinence
644668|NCT00464139|endometriosis|endometriosis
644669|NCT00464139|prevalence|prevalence
644670|NCT00464139|fertility|fertility
644671|NCT00464139|pain|pain
644672|NCT00464139|ultrasound|ultrasound
644673|NCT00464126|crystalloid|crystalloid
644674|NCT00464126|colloid|colloid
644675|NCT00464126|pediatric|pediatric
644676|NCT00464126|cardiac|cardiac
644677|NCT00464126|resuscitation|resuscitation
644678|NCT00464126|Postoperative|postoperative
644679|NCT00464113|Myeloid Leukemia|myeloid leukemia
644680|NCT00464113|Lymphocytic Leukemia|lymphocytic leukemia
644681|NCT00464113|Ph+ ALL|ph+ all
644682|NCT00464100|Neurodevelopmental outcomes|neurodevelopmental outcomes
644683|NCT00464100|congenital heart disease|congenital heart disease
644684|NCT00464100|NIRS monitoring|nirs monitoring
644685|NCT00464100|hypoxia|hypoxia
644686|NCT00464074|fatigue|fatigue
644687|NCT00464074|Tysabri|tysabri
644688|NCT00464074|cognition|cognition
644689|NCT00464061|Sleep problems|sleep problems
644690|NCT00464061|Insomnia|insomnia
644691|NCT00464061|Sleeplessness|sleeplessness
644692|NCT00464061|Primary insomnia|primary insomnia
644693|NCT00464061|Insomnia disorder|insomnia disorder
644694|NCT00464035|Obesity|obesity
644695|NCT00464035|Calcium|calcium
644696|NCT00464035|Fat absorption|fat absorption
644697|NCT00464035|Postprandial lipid profile|postprandial lipid profile
644698|NCT00464035|appetite|appetite
644699|NCT00464022|pain, endoscopy|pain, endoscopy
644700|NCT00464022|Pain, endoscopy, randomised trial|pain, endoscopy, randomised trial
644701|NCT00464009|Early childhood caries - ECC|early childhood caries - ecc
644702|NCT00464009|Prevention|prevention
644703|NCT00464009|Continuing medical education|continuing medical education
644704|NCT00464009|Randomized controlled trial|randomized controlled trial
644705|NCT00463996|Ovarian cancer|ovarian cancer
644706|NCT00463996|MRI|mri
644707|NCT00463996|Contrast agent|contrast agent
644708|NCT00463970|Chronic low back pain|chronic low back pain
644709|NCT00463970|Brief cognitive intervention|brief cognitive intervention
644710|NCT00463970|Cognitive behavior therapy|cognitive behavior therapy
644711|NCT00463970|Seal oil|seal oil
644712|NCT00463957|sildenafil|sildenafil
644713|NCT00463957|tadalafil|tadalafil
644714|NCT00463957|phosphodiesterase|phosphodiesterase
644715|NCT00463957|visual persistence|visual persistence
644716|NCT00463957|reaction time|reaction time
644717|NCT00463944|Electronic voting system|electronic voting system
644718|NCT00463931|Schistosomiasis|schistosomiasis
644719|NCT00463931|Soiltransmitted helminthiasis|soiltransmitted helminthiasis
644720|NCT00463931|Community-based volunteer|community-based volunteer
644721|NCT00463931|School based treatment approach|school based treatment approach
644722|NCT00463905|osteoporosis|osteoporosis
644723|NCT00463905|vertebral fractures|vertebral fractures
644724|NCT00463905|randomised controlled trial|randomised controlled trial
644725|NCT00463905|screening|screening
644726|NCT00463892|melanoma|melanoma
644727|NCT00463892|lymph nodes|lymph nodes
644728|NCT00463892|magnetic resonance imaging|magnetic resonance imaging
644729|NCT00463892|screening|screening
644730|NCT00463892|detection|detection
644731|NCT00463879|Schizophrenia|schizophrenia
644733|NCT00463879|Smoking|smoking
644734|NCT00463879|Galantamine|galantamine
644735|NCT00463879|Nicotine|nicotine
644736|NCT00463879|Cognitive Deficits|cognitive deficits
644737|NCT00463866|Asthma|asthma
644738|NCT00463853|Bone Marrow Cells|bone marrow cells
644739|NCT00463853|Cardiovascular Surgery|cardiovascular surgery
644740|NCT00463853|Coronary Artery Bypass Graft|coronary artery bypass graft
644741|NCT00463853|Phase I Study|phase i study
644742|NCT00463853|Stem Cells|stem cells
644743|NCT00463840|Locally advanced pancreatic cancer|locally advanced pancreatic cancer
644744|NCT00463840|oxaliplatin|oxaliplatin
644745|NCT00463840|chemoradiation|chemoradiation
644746|NCT00463840|5FU|5fu
644747|NCT00463827|asthma|asthma
644748|NCT00463827|smokers|smokers
644749|NCT00463827|statin|statin
644750|NCT00463827|atorvastatin|atorvastatin
644751|NCT00463827|randomised|randomised
644752|NCT00463827|placebo|placebo
644753|NCT00463827|cigarette|cigarette
644754|NCT00463827|blind|blind
644755|NCT00463827|COPD|copd
644756|NCT00463814|Advanced Malignancy|advanced malignancy
644757|NCT00463814|Cancer Eligibility|cancer eligibility
644758|NCT00463814|Malignancy|malignancy
644759|NCT00463801|Complicated Skin and Skin-Structure Infections, Daptomycin, MRSA, Diabetic Foot, Abscess, Cellulitis|complicated skin and skin-structure infections, daptomycin, mrsa, diabetic foot, abscess, cellulitis
644760|NCT00463801|Complicated skin and skin-structure infections|complicated skin and skin-structure infections
644761|NCT00463788|cancer|cancer
644762|NCT00463788|breast|breast
644763|NCT00463788|metastatic|metastatic
644764|NCT00463788|triple negative|triple negative
644765|NCT00463775|Treatment|treatment
644766|NCT00463775|Topiramate|topiramate
644767|NCT00463775|Alcohol Dependence|alcohol dependence
644768|NCT00463775|Borderline Personality Disorder|borderline personality disorder
644769|NCT00463749|primary PCI|primary pci
644770|NCT00463749|nephropathy|nephropathy
644771|NCT00463749|infarct size|infarct size
644772|NCT00463749|infarction|infarction
644773|NCT00463749|ST-elevation myocardial infarction|st-elevation myocardial infarction
644774|NCT00463736|short term tocolysis|short term tocolysis
644775|NCT00463736|preterm premature rupture of membranes|preterm premature rupture of membranes
644776|NCT00463723|penetrating keratoplasty|penetrating keratoplasty
644777|NCT00463723|graft rejection|graft rejection
644778|NCT00463723|immunosuppression|immunosuppression
644779|NCT00463710|MTI, DWI, Avonex, MRI|mti, dwi, avonex, mri
644780|NCT00463697|GW642444,|gw642444,
644781|NCT00463697|magnesium stearate,|magnesium stearate,
644782|NCT00463697|asthmatic patients|asthmatic patients
644783|NCT00463658|Falls|falls
644784|NCT00463658|Home Care|home care
644785|NCT00463658|Aging Population|aging population
644786|NCT00463658|Clinical Effectiveness|clinical effectiveness
644787|NCT00463658|Health Economics|health economics
644788|NCT00463632|schistosomiasis|schistosomiasis
644789|NCT00463632|anaemia|anaemia
644790|NCT00463632|pregnancy|pregnancy
644791|NCT00463593|schistosomiasis|schistosomiasis
644792|NCT00463593|helminthes|helminthes
644793|NCT00463593|anaemia|anaemia
644794|NCT00463580|depression|depression
644795|NCT00463580|TNF-alpha antagonist|tnf-alpha antagonist
644796|NCT00463580|infliximab|infliximab
644797|NCT00463580|treatment resistant depression|treatment resistant depression
644798|NCT00463580|major depressive disorder (MDD)|major depressive disorder (mdd)
644799|NCT00463580|bipolar I disorder|bipolar i disorder
644800|NCT00463580|bipolar II disorder|bipolar ii disorder
644801|NCT00463567|indacaterol|indacaterol
644802|NCT00463567|long acting beta-2 agonist|long acting beta-2 agonist
644803|NCT00463554|Incontinence|incontinence
644804|NCT00463554|Stress Urinary|stress urinary
644805|NCT00463541|Urinary Bladder, Overactive|urinary bladder, overactive
644806|NCT00463541|Urgency|urgency
644807|NCT00463541|VESIcare®|vesicare®
644808|NCT00463541|Solifenacin succinate|solifenacin succinate
644809|NCT00463528|schistosomiasis|schistosomiasis
644810|NCT00463528|gender perspectives|gender perspectives
644811|NCT00463515|Non-Small Cell Lung Cancer|non-small cell lung cancer
644812|NCT00463515|NSCLC|nsclc
644813|NCT00463515|Chemoradiation|chemoradiation
644814|NCT00463515|lung cancer|lung cancer
644815|NCT00463515|induction chemotherapy|induction chemotherapy
644816|NCT00463515|chemo-radiotherapy|chemo-radiotherapy
644817|NCT00463502|The purpose of study was investigated the effect of|the purpose of study was investigated the effect of
644818|NCT00463502|metformin on thyroid hormone metabolism in euthyroid patients|metformin on thyroid hormone metabolism in euthyroid patients
644819|NCT00463502|with type 2 DM. The results revealed significant decreases|with type 2 dm. the results revealed significant decreases
644820|NCT00463502|in TSH and fT4|in tsh and ft4
644821|NCT00463489|lifestyle intervention|lifestyle intervention
644822|NCT00463489|breast|breast
644823|NCT00463489|cancer|cancer
644824|NCT00463489|adjuvant|adjuvant
644825|NCT00463489|letrozole|letrozole
644826|NCT00463489|weight loss|weight loss
644827|NCT00463489|BMI|bmi
644828|NCT00463489|post-menopausal|post-menopausal
644829|NCT00463489|estrogen receptor positive|estrogen receptor positive
644830|NCT00463489|progesterone receptor positive|progesterone receptor positive
645408|NCT00461526|d-IBS|d-ibs
644831|NCT00463450|Hormone Replacement Therapy|hormone replacement therapy
644832|NCT00463450|Impaired well-being, mood and sexuality|impaired well-being, mood and sexuality
644833|NCT00463437|Fever.|fever.
644834|NCT00463437|Meningococcal disease.|meningococcal disease.
644835|NCT00463437|Pneumococcal disease.|pneumococcal disease.
644836|NCT00463437|Meningococcal vaccine.|meningococcal vaccine.
644837|NCT00463437|Pneumococcal vaccine.|pneumococcal vaccine.
644838|NCT00463437|Immunogenicity.|immunogenicity.
644839|NCT00463437|Booster vaccination.|booster vaccination.
644840|NCT00463437|Safety.|safety.
644841|NCT00463424|Metacarpophalangeal Joint|metacarpophalangeal joint
644842|NCT00463424|Arthroplasty, Replacement|arthroplasty, replacement
644843|NCT00463424|Range of Motion, Articular|range of motion, articular
644844|NCT00463424|Randomized Controlled Trials|randomized controlled trials
644845|NCT00463424|Swanson|swanson
644846|NCT00463424|NeuFlex|neuflex
644847|NCT00463411|osteoporosis|osteoporosis
644848|NCT00463411|male|male
644849|NCT00463411|fracture risk|fracture risk
644850|NCT00463411|genetical epidemiology|genetical epidemiology
644851|NCT00463398|Endometriosis|endometriosis
644852|NCT00463398|Fertility Surgery|fertility surgery
644853|NCT00463398|Quality of Life|quality of life
644854|NCT00463398|Pain|pain
644855|NCT00463398|Sexual Function|sexual function
644856|NCT00463398|Health economics|health economics
644857|NCT00463398|Recurrence|recurrence
644858|NCT00463398|Pregnancy|pregnancy
644859|NCT00463385|Celgene|celgene
644860|NCT00463385|CC-4047|cc-4047
644861|NCT00463385|Myelofibrosis|myelofibrosis
644862|NCT00463385|myelofibrosis with myeloid metaplasia|myelofibrosis with myeloid metaplasia
644863|NCT00463385|myeloid metaplasia|myeloid metaplasia
644864|NCT00463385|JAK2|jak2
644865|NCT00463385|CC-4047-MMM-001|cc-4047-mmm-001
644866|NCT00463385|Prednisone|prednisone
644867|NCT00463385|Phase II|phase ii
644868|NCT00463385|pomalidomide|pomalidomide
644869|NCT00463385|bone marrow histology|bone marrow histology
644870|NCT00463385|imids|imids
644871|NCT00463385|MMM|mmm
644872|NCT00463385|Ashkenazi Jewish Population|ashkenazi jewish population
644873|NCT00463385|exposure to Thorotrast|exposure to thorotrast
644874|NCT00463385|exposure to solvents (benzene and toluene)|exposure to solvents (benzene and toluene)
644875|NCT00463385|acute megakaryocytic leukemia|acute megakaryocytic leukemia
644876|NCT00463385|history of polycythemia vera|history of polycythemia vera
644877|NCT00463359|basal cell carcinoma|basal cell carcinoma
644878|NCT00463359|curettage|curettage
644879|NCT00463359|Imiquimod|imiquimod
644880|NCT00463359|treatment|treatment
644881|NCT00463346|Treatment|treatment
644882|NCT00463346|Alcohol Dependence|alcohol dependence
644883|NCT00463346|Schizophrenia|schizophrenia
644884|NCT00463333|postoperative delirium|postoperative delirium
644885|NCT00463333|psychometric testing|psychometric testing
644886|NCT00463333|EEG|eeg
644887|NCT00463333|serum markers|serum markers
644888|NCT00463320|Age-related macular degeneration (AMD),|age-related macular degeneration (amd),
644889|NCT00463320|vascular endothelial growth factor (VEGF)receptor (VEGFR)|vascular endothelial growth factor (vegf)receptor (vegfr)
644890|NCT00463320|choroidal neovascularization,|choroidal neovascularization,
644891|NCT00463307|schistosomiasis|schistosomiasis
644892|NCT00463307|Schistosoma mansoni|schistosoma mansoni
644893|NCT00463307|Circulating cathodic antigen urine dipstick|circulating cathodic antigen urine dipstick
644894|NCT00463294|CABG|cabg
644895|NCT00463294|On-pump|on-pump
644896|NCT00463294|Off-pump|off-pump
644897|NCT00463281|stroke, ischemic|stroke, ischemic
644898|NCT00463281|computed tomography|computed tomography
644899|NCT00463281|thrombolysis|thrombolysis
644900|NCT00463268|osteopenia|osteopenia
644901|NCT00463268|osteoporosis prevention|osteoporosis prevention
644902|NCT00463268|alendronate|alendronate
644903|NCT00463255|Diet|diet
644904|NCT00463255|elderly|elderly
644905|NCT00463255|age-related diseases|age-related diseases
644906|NCT00463255|prevention|prevention
644907|NCT00463255|cognitive decline|cognitive decline
644908|NCT00463255|Clinical study|clinical study
644909|NCT00463242|agomelatine, Major Depressive Disorder, MDD, depression|agomelatine, major depressive disorder, mdd, depression
644910|NCT00463229|stroke|stroke
644911|NCT00463229|rehabilitation|rehabilitation
644912|NCT00463229|home care services|home care services
644913|NCT00463229|effectiveness|effectiveness
644914|NCT00463229|quantitative research|quantitative research
644915|NCT00463229|interdisciplinary|interdisciplinary
644916|NCT00463229|cost|cost
644917|NCT00463229|health services research, integrated|health services research, integrated
644918|NCT00463216|back, neck, pain, sick leave|back, neck, pain, sick leave
644919|NCT00463203|primary malignant brain tumor|primary malignant brain tumor
644920|NCT00463203|grade II glioma|grade ii glioma
644921|NCT00463203|meningeoma|meningeoma
644922|NCT00463203|ependymoma|ependymoma
644923|NCT00463203|Recurrence or progression after standard treatment|recurrence or progression after standard treatment
644924|NCT00463190|Probiotics|probiotics
644925|NCT00463190|Diarrhea|diarrhea
644926|NCT00463190|Enterocolitis|enterocolitis
644927|NCT00463177|Pain|pain
644928|NCT00463177|Chronic pain|chronic pain
644929|NCT00463177|Pain disorder|pain disorder
644930|NCT00463177|Functional MRI|functional mri
644931|NCT00463177|Sensitization|sensitization
644932|NCT00463164|functional MRI|functional mri
644933|NCT00463151|Rebamipide|rebamipide
644934|NCT00463151|Enema|enema
644935|NCT00463151|Ulcerative Colitis|ulcerative colitis
644936|NCT00463138|perceived increase or decrease in symptoms post treatment|perceived increase or decrease in symptoms post treatment
644937|NCT00463138|Satisfaction with the treatment|satisfaction with the treatment
644938|NCT00463125|Scleroderma, systemic|scleroderma, systemic
644939|NCT00463125|therapeutic|therapeutic
644940|NCT00463125|platelet gel|platelet gel
644941|NCT00463112|Obesity|obesity
644942|NCT00463112|Polycystic Ovary Syndrome|polycystic ovary syndrome
644943|NCT00463112|weight loss|weight loss
644944|NCT00463112|Hyperadrogonemia|hyperadrogonemia
644945|NCT00463112|Sibutramine|sibutramine
644946|NCT00463099|Anterior Cruciate Ligament/injuries|anterior cruciate ligament/injuries
644947|NCT00463099|Anterior Cruciate Ligament/surgery|anterior cruciate ligament/surgery
644948|NCT00463099|Knee injuries/surgery|knee injuries/surgery
644949|NCT00463099|Outcomes research|outcomes research
644950|NCT00463099|Prospective Studies|prospective studies
644951|NCT00463086|Tuberculosis|tuberculosis
644952|NCT00463086|TB|tb
644953|NCT00463086|Mycobacteria|mycobacteria
644954|NCT00463086|HIV|hiv
644955|NCT00463086|Human immunodeficiency virus|human immunodeficiency virus
644956|NCT00463086|Latent tuberculosis infection|latent tuberculosis infection
644957|NCT00463086|HAART|haart
644958|NCT00463086|Highly active anti-retroviral therapy|highly active anti-retroviral therapy
644959|NCT00463086|Isoniazid preventive therapy|isoniazid preventive therapy
644960|NCT00463086|INH|inh
644961|NCT00463086|Opportunistic infections|opportunistic infections
644962|NCT00463086|HIV-1|hiv-1
644963|NCT00463086|Treatment Experienced|treatment experienced
644964|NCT00463086|AIDS|aids
644965|NCT00463086|Mycobacterium Tuberculosis|mycobacterium tuberculosis
644966|NCT00463073|Progressive primary Glioblastoma multiforme|progressive primary glioblastoma multiforme
644967|NCT00463047|Breakthrough pain|breakthrough pain
644968|NCT00463047|Opioid-tolerant|opioid-tolerant
644969|NCT00463047|Chronic pain|chronic pain
644970|NCT00463034|stage IV breast cancer|stage iv breast cancer
644971|NCT00463034|stage I breast cancer|stage i breast cancer
644972|NCT00463034|stage II breast cancer|stage ii breast cancer
644973|NCT00463034|stage IIIA breast cancer|stage iiia breast cancer
644974|NCT00463034|stage IIIB breast cancer|stage iiib breast cancer
644975|NCT00463034|stage IIIC breast cancer|stage iiic breast cancer
644976|NCT00463021|Hectorol (doxercalciferol capsules)|hectorol (doxercalciferol capsules)
644977|NCT00463021|Zemplar (paricalcitol injection)|zemplar (paricalcitol injection)
644978|NCT00463008|adult anaplastic astrocytoma|adult anaplastic astrocytoma
644979|NCT00463008|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
644980|NCT00463008|adult glioblastoma|adult glioblastoma
644981|NCT00463008|recurrent adult brain tumor|recurrent adult brain tumor
644982|NCT00463008|adult gliosarcoma|adult gliosarcoma
644983|NCT00463008|adult giant cell glioblastoma|adult giant cell glioblastoma
644984|NCT00462995|Non Small Cell Lung Cancer|non small cell lung cancer
644985|NCT00462995|Lung Cancer|lung cancer
644986|NCT00462995|Erlotinib|erlotinib
644987|NCT00462995|Neoadjuvant Treatment|neoadjuvant treatment
644988|NCT00462982|stage IV melanoma|stage iv melanoma
644989|NCT00462982|tumors metastatic to brain|tumors metastatic to brain
644990|NCT00462982|stage IV renal cell cancer|stage iv renal cell cancer
644991|NCT00462982|recurrent melanoma|recurrent melanoma
644992|NCT00462982|recurrent renal cell cancer|recurrent renal cell cancer
644993|NCT00462969|Endometrial cancer|endometrial cancer
644994|NCT00462969|Sonohysterography|sonohysterography
644995|NCT00462956|lapatinib|lapatinib
644996|NCT00462956|metastatic breast cancer|metastatic breast cancer
644997|NCT00462956|trastuzumab (Herceptin)|trastuzumab (herceptin)
644998|NCT00462956|Stage IV breast cancer|stage iv breast cancer
644999|NCT00462956|ErbB2|erbb2
645000|NCT00462956|ErbB1|erbb1
645001|NCT00462943|CML|cml
645002|NCT00462943|HHT|hht
645003|NCT00462943|Homoharringtonine|homoharringtonine
645004|NCT00462943|Omacetaxine|omacetaxine
645005|NCT00462917|disease /disorder proneness /risk|disease /disorder proneness /risk
645006|NCT00462917|family genetics|family genetics
645007|NCT00462917|genetic counseling|genetic counseling
645008|NCT00462917|genetic marker|genetic marker
645009|NCT00462917|genetic polymorphism|genetic polymorphism
645010|NCT00462917|genetic screening|genetic screening
645011|NCT00462917|genetic susceptibility|genetic susceptibility
645012|NCT00462891|breast cancer|breast cancer
645013|NCT00462878|Febrile neutropenia|febrile neutropenia
645014|NCT00462865|breast cancer|breast cancer
645015|NCT00462865|neoadjuvant chemotherapy|neoadjuvant chemotherapy
645016|NCT00462865|adjuvant treatment|adjuvant treatment
645017|NCT00462865|consolidation therapy|consolidation therapy
645018|NCT00462865|anti-angiogenesis therapy|anti-angiogenesis therapy
645019|NCT00462852|thromboembolism|thromboembolism
645020|NCT00462852|stage III pancreatic cancer|stage iii pancreatic cancer
645021|NCT00462852|stage IV pancreatic cancer|stage iv pancreatic cancer
645913|NCT00459589|morbidity|morbidity
645022|NCT00462852|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
645023|NCT00462852|recurrent pancreatic cancer|recurrent pancreatic cancer
645024|NCT00462852|stage II pancreatic cancer|stage ii pancreatic cancer
645025|NCT00462839|Estimated Blood Loss|estimated blood loss
645026|NCT00462839|Obstetrics|obstetrics
645027|NCT00462839|postpartum hemorrhage|postpartum hemorrhage
645028|NCT00462813|cervical cancer|cervical cancer
645029|NCT00462813|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
645030|NCT00462813|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
645031|NCT00462813|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
645032|NCT00462787|acute undifferentiated leukemia|acute undifferentiated leukemia
645033|NCT00462787|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
645034|NCT00462787|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
645035|NCT00462787|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
645036|NCT00462787|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
645037|NCT00462774|Myocardial infarction|myocardial infarction
645038|NCT00462774|Heart failure|heart failure
645039|NCT00462774|Cell therapy|cell therapy
645040|NCT00462774|Bone marrow|bone marrow
645041|NCT00462774|CD133|cd133
645042|NCT00462774|Bypass surgery|bypass surgery
645043|NCT00462774|Stem cells|stem cells
645044|NCT00462761|RTK|rtk
645045|NCT00462761|kinase|kinase
645046|NCT00462761|inhibitor|inhibitor
645047|NCT00462761|tyrosine|tyrosine
645048|NCT00462761|acute|acute
645049|NCT00462761|FLT3|flt3
645050|NCT00462761|AC220|ac220
645051|NCT00462761|pharmacokinetic|pharmacokinetic
645052|NCT00462761|pharmacokinetics|pharmacokinetics
645053|NCT00462761|PK|pk
645054|NCT00462761|pharmacodynamic|pharmacodynamic
645055|NCT00462761|pharmacodynamics|pharmacodynamics
645056|NCT00462761|mutations|mutations
645057|NCT00462761|PD|pd
645058|NCT00462761|receptor|receptor
645059|NCT00462761|class III|class iii
645060|NCT00462761|relapsed|relapsed
645061|NCT00462761|refractory|refractory
645062|NCT00462761|t(8;21)|t(8;21)
645063|NCT00462761|q22;q22|q22;q22
645064|NCT00462761|AML1/ETO|aml1/eto
645065|NCT00462761|t(16;16|t(16;16
645066|NCT00462761|p13;q22|p13;q22
645067|NCT00462761|CBFbeta/MYH11|cbfbeta/myh11
645068|NCT00462761|inv(16)|inv(16)
645069|NCT00462761|p13q22|p13q22
645070|NCT00462761|11q23|11q23
645071|NCT00462761|dysplasia|dysplasia
645072|NCT00462761|myeloid|myeloid
645073|NCT00462761|myelomonocytic|myelomonocytic
645074|NCT00462761|monoblastic|monoblastic
645075|NCT00462761|monocytic|monocytic
645076|NCT00462761|erythroid|erythroid
645077|NCT00462761|erythroleukemia|erythroleukemia
645078|NCT00462761|megakaryoblastic|megakaryoblastic
645079|NCT00462761|basophilic|basophilic
645080|NCT00462761|panmyelosis|panmyelosis
645081|NCT00462761|myelofibrosis|myelofibrosis
645082|NCT00462735|Cancer of the Nasal Cavity|cancer of the nasal cavity
645083|NCT00462722|body composition|body composition
645084|NCT00462722|bone density|bone density
645085|NCT00462722|cyclooxygenase inhibitor|cyclooxygenase inhibitor
645086|NCT00462722|bone metabolism|bone metabolism
645087|NCT00462722|muscle function|muscle function
645088|NCT00462722|muscle strength|muscle strength
645089|NCT00462709|Hereditary angioedema|hereditary angioedema
645090|NCT00462709|C1 esterase inhibitor (human)|c1 esterase inhibitor (human)
645091|NCT00462696|stage II breast cancer|stage ii breast cancer
645092|NCT00462696|stage IIIA breast cancer|stage iiia breast cancer
645093|NCT00462696|stage IIIB breast cancer|stage iiib breast cancer
645094|NCT00462696|stage IIIC breast cancer|stage iiic breast cancer
645095|NCT00462683|Stroke|stroke
645096|NCT00462683|Anoxia|anoxia
645097|NCT00462683|Brain Injury|brain injury
645098|NCT00462683|Rehabilitation|rehabilitation
645099|NCT00462683|Osteoporosis|osteoporosis
645100|NCT00462683|Osteopenia|osteopenia
645101|NCT00462670|Cardiac edema|cardiac edema
645102|NCT00462670|OPC-41061|opc-41061
645103|NCT00462670|Vasopressin antagonist|vasopressin antagonist
645104|NCT00462657|infection|infection
645105|NCT00462657|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
645106|NCT00462657|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
645107|NCT00462657|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
645108|NCT00462657|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
645109|NCT00462657|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
645110|NCT00462657|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
645111|NCT00462657|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
645112|NCT00462657|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
645113|NCT00462657|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
645114|NCT00462657|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
645914|NCT00459576|Asthma|asthma
645115|NCT00462657|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
645116|NCT00462657|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
645117|NCT00462657|secondary acute myeloid leukemia|secondary acute myeloid leukemia
645118|NCT00462657|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
645119|NCT00462657|graft versus host disease|graft versus host disease
645120|NCT00462644|adrenal insufficiency|adrenal insufficiency
645121|NCT00462644|etomidate|etomidate
645122|NCT00462644|rapid sequence induction|rapid sequence induction
645123|NCT00462631|coronary artery|coronary artery
645124|NCT00462631|Diabetes|diabetes
645125|NCT00462618|Insomnia|insomnia
645126|NCT00462618|Elderly|elderly
645127|NCT00462618|Affective disorders|affective disorders
645128|NCT00462592|exercise-induced bronchoconstriction (EIB)|exercise-induced bronchoconstriction (eib)
645129|NCT00462592|airway inflammation|airway inflammation
645130|NCT00462579|carbapenem-resistant acinetobacter baumannii|carbapenem-resistant acinetobacter baumannii
645131|NCT00462579|positive culture|positive culture
645132|NCT00462579|positive culture for carbapenem-resistant acinetobacter|positive culture for carbapenem-resistant acinetobacter
645133|NCT00462566|Motor cortex stimulation|motor cortex stimulation
645134|NCT00462566|neuropathic|neuropathic
645135|NCT00462566|pain|pain
645136|NCT00462566|complex regional pain syndrome|complex regional pain syndrome
645137|NCT00462566|deafferentation facial pain|deafferentation facial pain
645138|NCT00462540|COPD|copd
645139|NCT00462540|Formoterol|formoterol
645140|NCT00462540|Ipratropium|ipratropium
645141|NCT00462540|Crossover|crossover
645142|NCT00462527|Cystatin C|cystatin c
645143|NCT00462527|Acute renal failure|acute renal failure
645144|NCT00462527|Gastroenteritis|gastroenteritis
645145|NCT00462527|Dehydration|dehydration
645146|NCT00462501|stage II rectal cancer|stage ii rectal cancer
645147|NCT00462501|stage III rectal cancer|stage iii rectal cancer
645148|NCT00462501|adenocarcinoma of the rectum|adenocarcinoma of the rectum
645149|NCT00462475|GH|gh
645150|NCT00462475|IGF-I|igf-i
645151|NCT00462475|GH deficiency|gh deficiency
645152|NCT00462475|Atherosclerosis|atherosclerosis
645153|NCT00462475|Insulin resistance syndrome|insulin resistance syndrome
645154|NCT00462449|Botulinum Toxin|botulinum toxin
645155|NCT00462449|Ness H200|ness h200
645156|NCT00462449|Functional Electrical Stimulation|functional electrical stimulation
645157|NCT00462449|Repetitive Task Practice|repetitive task practice
645158|NCT00462436|functional foods|functional foods
645159|NCT00462436|soy|soy
645160|NCT00462436|nuts|nuts
645161|NCT00462436|LDL cholesterol|ldl cholesterol
645162|NCT00462436|fibre|fibre
645163|NCT00462436|secondary prevention|secondary prevention
645164|NCT00462436|risk reduction|risk reduction
645165|NCT00462436|endothelial function|endothelial function
645166|NCT00462436|endothelial progenitor cells|endothelial progenitor cells
645167|NCT00462436|inflammation|inflammation
645168|NCT00462436|glycemic control|glycemic control
645169|NCT00462436|HOMA|homa
645170|NCT00462423|Metastatic malignant melanoma|metastatic malignant melanoma
645171|NCT00462423|First-line therapy|first-line therapy
645172|NCT00462410|recurrent breast cancer|recurrent breast cancer
645173|NCT00462410|stage I breast cancer|stage i breast cancer
645174|NCT00462410|stage II breast cancer|stage ii breast cancer
645175|NCT00462410|stage IIIA breast cancer|stage iiia breast cancer
645176|NCT00462410|stage IIIB breast cancer|stage iiib breast cancer
645177|NCT00462410|stage IIIC breast cancer|stage iiic breast cancer
645178|NCT00462410|stage IV breast cancer|stage iv breast cancer
645179|NCT00462397|cervical adenocarcinoma|cervical adenocarcinoma
645180|NCT00462397|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
645181|NCT00462397|cervical squamous cell carcinoma|cervical squamous cell carcinoma
645182|NCT00462397|stage IB cervical cancer|stage ib cervical cancer
645183|NCT00462397|stage IIA cervical cancer|stage iia cervical cancer
645184|NCT00462397|stage IIB cervical cancer|stage iib cervical cancer
645185|NCT00462397|stage III cervical cancer|stage iii cervical cancer
645186|NCT00462397|stage IVA cervical cancer|stage iva cervical cancer
645187|NCT00462397|recurrent cervical cancer|recurrent cervical cancer
645188|NCT00462371|quality of life|quality of life
645189|NCT00462371|child diabetes mellitus type 1|child diabetes mellitus type 1
645190|NCT00462371|Continuous subcutaneous insulin infusion(CSII)|continuous subcutaneous insulin infusion(csii)
645191|NCT00462371|metabolic control|metabolic control
645192|NCT00462332|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
645193|NCT00462332|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
645194|NCT00462306|Obstructive Sleep Apnea|obstructive sleep apnea
645195|NCT00462306|Pregnancy|pregnancy
645196|NCT00462306|Berlin Questionnaire|berlin questionnaire
645197|NCT00462267|Nutrition|nutrition
645198|NCT00462267|Exercise|exercise
645199|NCT00462267|Body mass index|body mass index
645200|NCT00462267|Lifestyle change|lifestyle change
645201|NCT00462267|Obesity|obesity
645202|NCT00462267|Overweight|overweight
645203|NCT00462267|Adolescents|adolescents
645204|NCT00462267|Teens|teens
645205|NCT00462254|Ramelteon|ramelteon
645206|NCT00462254|Parkinson's disease|parkinson's disease
645207|NCT00462254|Sleep disturbances|sleep disturbances
645208|NCT00462241|Chest pain|chest pain
645209|NCT00462241|Chest wall|chest wall
645210|NCT00462241|Atypical chest pain|atypical chest pain
645211|NCT00462241|Non-cardiac chest pain|non-cardiac chest pain
645212|NCT00462241|Undiagnosed chest pain|undiagnosed chest pain
645213|NCT00462241|Physical examination|physical examination
645214|NCT00462241|Randomized controlled trial|randomized controlled trial
645215|NCT00462241|Treatment study|treatment study
645216|NCT00462241|Chiropractor|chiropractor
645217|NCT00462228|traumatic brain injury|traumatic brain injury
645218|NCT00462228|memory|memory
645219|NCT00462228|attention|attention
645220|NCT00462202|Diabetes|diabetes
645221|NCT00462202|Microalbuminuria|microalbuminuria
645222|NCT00462202|Proteinuria|proteinuria
645223|NCT00462202|Albuminuria|albuminuria
645224|NCT00462202|KRX-101|krx-101
645225|NCT00462202|Sulodexide|sulodexide
645226|NCT00462202|Nephropathy|nephropathy
645227|NCT00462202|Keryx|keryx
645228|NCT00462202|Collaborative Study Group|collaborative study group
645229|NCT00462202|Diabetic nephropathy with persistent microalbuminuria|diabetic nephropathy with persistent microalbuminuria
645230|NCT00462189|CAT-8015|cat-8015
645231|NCT00462189|HA22|ha22
645232|NCT00462189|HCL|hcl
645233|NCT00462189|Relapse|relapse
645234|NCT00462189|Refractory|refractory
645235|NCT00462189|immunotherapy|immunotherapy
645236|NCT00462189|immunotoxin|immunotoxin
645237|NCT00462176|colorectal endometriosis|colorectal endometriosis
645238|NCT00462176|deep infiltrating endometriosis|deep infiltrating endometriosis
645239|NCT00462176|dysmenorroe|dysmenorroe
645240|NCT00462176|dyspareunia|dyspareunia
645241|NCT00462176|quality of life|quality of life
645242|NCT00462150|arthritis, rheumatoid|arthritis, rheumatoid
645243|NCT00462150|expressed emotion|expressed emotion
645244|NCT00462150|randomized controlled trial|randomized controlled trial
645245|NCT00462150|affect|affect
645246|NCT00462150|blood sedimentation|blood sedimentation
645247|NCT00462150|psychophysiology|psychophysiology
645248|NCT00462150|feasibility studies|feasibility studies
645249|NCT00462150|intervention studies|intervention studies
645250|NCT00462150|time management|time management
645251|NCT00462137|GERD|gerd
645252|NCT00462137|Gastroesphageal Reflux Disease (GERD)|gastroesphageal reflux disease (gerd)
645253|NCT00462124|Prostate|prostate
645254|NCT00462124|cancer|cancer
645255|NCT00462124|radiation|radiation
645256|NCT00462124|biodegradable implantable balloon|biodegradable implantable balloon
645257|NCT00462124|intrarectal balloon|intrarectal balloon
645258|NCT00462111|indometacin|indometacin
645259|NCT00462111|reaction time|reaction time
645260|NCT00462111|postural balance|postural balance
645261|NCT00462111|obstacle avoidance|obstacle avoidance
645262|NCT00462111|accidental falls|accidental falls
645263|NCT00462098|Osteonecrosis of the jaw|osteonecrosis of the jaw
645264|NCT00462098|hyperbaric oxygen|hyperbaric oxygen
645265|NCT00462098|bisphosphonates|bisphosphonates
645266|NCT00462085|cerebral palsy|cerebral palsy
645267|NCT00462085|ankle foot orthosis|ankle foot orthosis
645268|NCT00462085|emg|emg
645269|NCT00462085|surface electromyography|surface electromyography
645270|NCT00462085|gait analysis|gait analysis
645271|NCT00462059|Transition of care|transition of care
645272|NCT00462059|Continuity of care|continuity of care
645273|NCT00462046|Berberine|berberine
645274|NCT00462046|Type 2 diabetes|type 2 diabetes
645275|NCT00462046|Dyslipidemia|dyslipidemia
645276|NCT00462020|appendicitis, perforation, abscess, treatment|appendicitis, perforation, abscess, treatment
645277|NCT00461994|OBESITY|obesity
645278|NCT00461994|CHILDREN|children
645279|NCT00461994|METABOLIC PARAMETERS|metabolic parameters
645280|NCT00461994|DIET|diet
645281|NCT00461994|EXERCISE|exercise
645282|NCT00461981|Live, attenuated influenza virus vaccine (LAIV)|live, attenuated influenza virus vaccine (laiv)
645283|NCT00461981|Trivalent inactivated influenza virus vaccine (TIV)|trivalent inactivated influenza virus vaccine (tiv)
645284|NCT00461981|FluMist|flumist
645285|NCT00461968|Cholesterol|cholesterol
645286|NCT00461968|LDL|ldl
645287|NCT00461968|Ezetimibe|ezetimibe
645288|NCT00461968|Statin|statin
645289|NCT00461968|Zetia|zetia
645290|NCT00461968|Zocor|zocor
645291|NCT00461968|Simvastin|simvastin
645292|NCT00461955|Symptomatic Multiple Myeloma|symptomatic multiple myeloma
645293|NCT00461955|first line treatment|first line treatment
645294|NCT00461955|first autologous Stem Cell Transplantation|first autologous stem cell transplantation
645295|NCT00461955|ex vivo amplified autologous peripheral blood stem cells|ex vivo amplified autologous peripheral blood stem cells
645296|NCT00461942|Health Food;|health food;
645297|NCT00461942|Green Tea;|green tea;
645298|NCT00461942|Neuroprotection|neuroprotection
645299|NCT00461929|chronic myeloid leukemia|chronic myeloid leukemia
645300|NCT00461929|gastrointestinal stromal cell tumors|gastrointestinal stromal cell tumors
645301|NCT00461929|chromosome abnormality|chromosome abnormality
645302|NCT00461929|imatinib|imatinib
645303|NCT00461929|bone marrow aspiration|bone marrow aspiration
645304|NCT00461916|half-dose depot triptorelin|half-dose depot triptorelin
645305|NCT00461916|reduced-dose daily buserelin|reduced-dose daily buserelin
645306|NCT00461916|controlled ovarian stimulation|controlled ovarian stimulation
645307|NCT00461916|long protocol|long protocol
645308|NCT00461916|ICSI|icsi
645309|NCT00461903|essential hypertension|essential hypertension
645310|NCT00461903|symptomatic paroxysmal or persistent atrial fibrillation|symptomatic paroxysmal or persistent atrial fibrillation
645311|NCT00461890|Alcohol|alcohol
645312|NCT00461890|Veterans|veterans
645313|NCT00461890|Primary Care|primary care
645314|NCT00461890|Naltrexone|naltrexone
645315|NCT00461864|fracture|fracture
645316|NCT00461864|occult|occult
645317|NCT00461864|hip|hip
645318|NCT00461851|Advanced/Metastatic Bladder Carcinoma|advanced/metastatic bladder carcinoma
645319|NCT00461838|colorectal endometriosis|colorectal endometriosis
645320|NCT00461838|deep infiltrating endometriosis|deep infiltrating endometriosis
645321|NCT00461838|dysmenorroe|dysmenorroe
645322|NCT00461838|dyspareunia|dyspareunia
645323|NCT00461838|quality of life|quality of life
645324|NCT00461825|Immunosuppression|immunosuppression
645325|NCT00461825|Kidney transplantation|kidney transplantation
645326|NCT00461825|multicenter study|multicenter study
645327|NCT00461799|Crigler-Najjar disease.|crigler-najjar disease.
645328|NCT00461799|Bilirubin.|bilirubin.
645329|NCT00461799|Phototherapy.|phototherapy.
645330|NCT00461799|Orlistat.|orlistat.
645331|NCT00461799|Unconjugated hyperbilirubinemia.|unconjugated hyperbilirubinemia.
645332|NCT00461773|Neoadjuvant treatment|neoadjuvant treatment
645333|NCT00461760|HPV Screening/Testing for cervical cancer screening|hpv screening/testing for cervical cancer screening
645334|NCT00461747|Untreated|untreated
645335|NCT00461747|Transplant|transplant
645336|NCT00461747|Younger|younger
645337|NCT00461734|Right Ventricular High Septal Pacing|right ventricular high septal pacing
645338|NCT00461734|Right Ventricular Apical Pacing|right ventricular apical pacing
645339|NCT00461734|Left Ventricular Dysfunction|left ventricular dysfunction
645340|NCT00461734|Heart Block|heart block
645341|NCT00461734|Pacemaker|pacemaker
645342|NCT00461734|Atrial Fibrillation|atrial fibrillation
645343|NCT00461734|Ejection Fraction|ejection fraction
645344|NCT00461695|Cytomegalovirus (CMV)|cytomegalovirus (cmv)
645345|NCT00461695|Tick-borne encephalitis virus (TBEV)|tick-borne encephalitis virus (tbev)
645346|NCT00461695|Ageing|ageing
645347|NCT00461695|Vaccine|vaccine
645348|NCT00461695|Immunity|immunity
645349|NCT00461682|TRPV1 antagonist|trpv1 antagonist
645350|NCT00461682|Fecal Urgency|fecal urgency
645351|NCT00461682|rectal pain|rectal pain
645352|NCT00461682|IBS|ibs
645353|NCT00461669|hip|hip
645354|NCT00461669|fracture|fracture
645355|NCT00461669|ultrasound|ultrasound
645356|NCT00461656|Antiseptic|antiseptic
645357|NCT00461656|Povidone-Iodine|povidone-iodine
645358|NCT00461643|Anovulation|anovulation
645359|NCT00461643|Clomiphene citrate|clomiphene citrate
645360|NCT00461643|Infertility|infertility
645361|NCT00461643|Metformin|metformin
645362|NCT00461643|PCOS|pcos
645363|NCT00461643|RCT|rct
645364|NCT00461643|Treatment|treatment
645365|NCT00461630|coronary heart disease|coronary heart disease
645366|NCT00461630|cardiovascular disease|cardiovascular disease
645367|NCT00461630|stroke|stroke
645368|NCT00461630|peripheral arterial disease|peripheral arterial disease
645369|NCT00461630|diabetes mellitus|diabetes mellitus
645370|NCT00461630|cholesterol|cholesterol
645371|NCT00461630|HDL cholesterol|hdl cholesterol
645372|NCT00461630|simvastatin|simvastatin
645373|NCT00461630|ezetimibe|ezetimibe
645374|NCT00461630|ER niacin|er niacin
645375|NCT00461630|laropiprant|laropiprant
645376|NCT00461617|diabetes|diabetes
645377|NCT00461617|rapid and short acting insulin secretagogue|rapid and short acting insulin secretagogue
645378|NCT00461617|α-glucosidase inhibitor|α-glucosidase inhibitor
645379|NCT00461617|HbA1C|hba1c
645380|NCT00461617|insulin|insulin
645381|NCT00461604|gastroesophageal reflux disease|gastroesophageal reflux disease
645382|NCT00461604|baclofen|baclofen
645383|NCT00461604|impedance|impedance
645384|NCT00461591|Noninvasive Bladder Cancer|noninvasive bladder cancer
645385|NCT00461578|P.falciparum|p.falciparum
645386|NCT00461578|malaria|malaria
645387|NCT00461578|lapdap+artesunate|lapdap+artesunate
645388|NCT00461578|safety|safety
645389|NCT00461578|efficay|efficay
645390|NCT00461565|Retina|retina
645391|NCT00461565|PDE-5|pde-5
645392|NCT00461565|Levitra|levitra
645393|NCT00461565|Viagra|viagra
645394|NCT00461565|Normal healthy volunteers for evaluation of retinal function|normal healthy volunteers for evaluation of retinal function
645395|NCT00461552|Lipodystrophy|lipodystrophy
645396|NCT00461552|HIV|hiv
645397|NCT00461552|HAART|haart
645398|NCT00461552|HIV Lipodystrophy Syndrome|hiv lipodystrophy syndrome
645399|NCT00461552|Lipodystrophy syndrome|lipodystrophy syndrome
645400|NCT00461552|HIV-Associated Lipodystrophy|hiv-associated lipodystrophy
645401|NCT00461552|HIV-Associated Lipodystrophy Syndrome|hiv-associated lipodystrophy syndrome
645402|NCT00461552|Treatment Experienced|treatment experienced
645403|NCT00461539|Tobacco Use|tobacco use
645404|NCT00461539|Alcohol and Drug Use|alcohol and drug use
645405|NCT00461539|Obesity|obesity
645406|NCT00461539|Risky Sexual Behavior|risky sexual behavior
645407|NCT00461526|IBS|ibs
645409|NCT00461526|Irritable Bowel Syndrome|irritable bowel syndrome
645410|NCT00461513|Heart Failure, Congestive|heart failure, congestive
645411|NCT00461513|Disease Management|disease management
645412|NCT00461513|Health Status|health status
645413|NCT00461513|Quality of Life|quality of life
645414|NCT00461513|Telemedicine|telemedicine
645415|NCT00461513|Depression|depression
645416|NCT00461500|persistent|persistent
645417|NCT00461500|moderate|moderate
645418|NCT00461500|asthma|asthma
645419|NCT00461500|adults|adults
645420|NCT00461500|Initial|initial
645421|NCT00461500|Maintenance|maintenance
645423|NCT00461487|Adolescent Behavior|adolescent behavior
645424|NCT00461487|Communication|communication
645425|NCT00461487|Health Behavior|health behavior
645426|NCT00461487|Risk-Taking|risk-taking
645427|NCT00461487|Sexual Behavior|sexual behavior
645428|NCT00461474|Shoulder pain|shoulder pain
645429|NCT00461474|Chronic Spinal Cord Injury|chronic spinal cord injury
645430|NCT00461474|Exercise|exercise
645431|NCT00461474|Physical therapy techniques|physical therapy techniques
645432|NCT00461474|Motor performance|motor performance
645433|NCT00461448|Potassium supplement|potassium supplement
645434|NCT00461448|Rheumatoid Arthritis|rheumatoid arthritis
645435|NCT00461448|Pain|pain
645436|NCT00461448|Disease Activity|disease activity
645437|NCT00461422|IVF|ivf
645438|NCT00461422|GnRH antagonist|gnrh antagonist
645439|NCT00461409|Neonatal Seizures|neonatal seizures
645440|NCT00461409|Treatment|treatment
645441|NCT00461409|Anticonvulsant|anticonvulsant
645442|NCT00461409|Levetiracetam|levetiracetam
645443|NCT00461396|Relapsing-Remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
645444|NCT00461396|First demyelinating event|first demyelinating event
645445|NCT00461396|MRI features consistent with MS|mri features consistent with ms
645446|NCT00461370|safety|safety
645447|NCT00461370|Phase 1|phase 1
645448|NCT00461370|pharmacokinetics|pharmacokinetics
645449|NCT00461370|SRX251|srx251
645450|NCT00461370|Azevan|azevan
645451|NCT00461370|safety in healthy volunteers|safety in healthy volunteers
645452|NCT00461357|Old for Old|old for old
645453|NCT00461357|Eurotransplant Senior Program|eurotransplant senior program
645454|NCT00461357|Glomerular Filtration Rate|glomerular filtration rate
645455|NCT00461344|Breast|breast
645456|NCT00461331|Type 1 diabetes mellitus|type 1 diabetes mellitus
645457|NCT00461331|Glycemic control|glycemic control
645458|NCT00461331|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
645459|NCT00461331|Continuous glucose monitoring system|continuous glucose monitoring system
645460|NCT00461318|vocational rehabilitation|vocational rehabilitation
645461|NCT00461318|psychosis|psychosis
645462|NCT00461318|cross country comparison|cross country comparison
645463|NCT00461305|Dysmenorrhea|dysmenorrhea
645464|NCT00461305|Intracyclic bleeding|intracyclic bleeding
645465|NCT00461305|Drospirenone (DRSP)|drospirenone (drsp)
645466|NCT00461305|Ethinylestradiol|ethinylestradiol
645467|NCT00461279|attachment|attachment
645468|NCT00461279|depression|depression
645469|NCT00461279|IPT|ipt
645470|NCT00461279|CBT|cbt
645471|NCT00461279|pharmacotherapy|pharmacotherapy
645472|NCT00461266|Treatment Experienced|treatment experienced
645473|NCT00461253|breast cancer|breast cancer
645474|NCT00461240|heart|heart
645475|NCT00461240|MRS|mrs
645476|NCT00461240|acromegaly|acromegaly
645477|NCT00461240|growth hormone|growth hormone
645478|NCT00461227|Puerto Rican|puerto rican
645479|NCT00461227|Allergies|allergies
645480|NCT00461214|laparoscopy|laparoscopy
645481|NCT00461214|surgery|surgery
645482|NCT00461214|technical skills|technical skills
645483|NCT00461214|outcomes|outcomes
645484|NCT00461214|resident training|resident training
645485|NCT00461201|Health Services Research|health services research
645486|NCT00461201|Nurse Practitioners|nurse practitioners
645487|NCT00461201|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
645488|NCT00461201|Patient Acceptance of Health Care|patient acceptance of health care
645489|NCT00461201|Patient Satisfaction|patient satisfaction
645490|NCT00461201|Primary Health Care|primary health care
645491|NCT00461201|Professional Autonomy|professional autonomy
645492|NCT00461188|acromegaly|acromegaly
645493|NCT00461188|gigantism|gigantism
645494|NCT00461188|familial pituitary adenoma|familial pituitary adenoma
645495|NCT00461188|Familial acromegaly|familial acromegaly
645496|NCT00461188|Familial Isolated Pituitary Adenoma|familial isolated pituitary adenoma
645497|NCT00461188|FIPA|fipa
645498|NCT00461188|Pituitary adenoma predisposition|pituitary adenoma predisposition
645499|NCT00461188|PAP|pap
645500|NCT00461175|Uterine Perforation|uterine perforation
645501|NCT00461149|Acromegaly|acromegaly
645502|NCT00461149|GH|gh
645503|NCT00461149|IGF-I|igf-i
645504|NCT00461149|Pituitary tumors|pituitary tumors
645505|NCT00461149|Octreotide|octreotide
645506|NCT00461136|Time course|time course
645507|NCT00461136|antiproteinuric|antiproteinuric
645508|NCT00461136|blood pressure|blood pressure
645509|NCT00461136|lowering effect|lowering effect
645510|NCT00461136|initiation of renin inhibition|initiation of renin inhibition
645511|NCT00461136|Aliskiren in Type 2 diabetes|aliskiren in type 2 diabetes
645512|NCT00461136|incipient and/or established nephropathy|incipient and/or established nephropathy
645513|NCT00461097|Egg Allergy|egg allergy
645514|NCT00461097|Egg Oral Immunotherapy (OIT)|egg oral immunotherapy (oit)
645515|NCT00461097|Food Allergy|food allergy
645516|NCT00461084|Lymphoma|lymphoma
645517|NCT00461084|Advanced Stage|advanced stage
645518|NCT00461084|Untreated|untreated
645519|NCT00461084|Advanced Stage Lymphoma|advanced stage lymphoma
645520|NCT00461084|Untreated Lymphoma|untreated lymphoma
645521|NCT00461084|07-038|07-038
645522|NCT00461071|Bulimia nervosa|bulimia nervosa
645523|NCT00461071|Guided Self-help|guided self-help
645524|NCT00461071|Psycho-education|psycho-education
645525|NCT00461045|multiple myeloma|multiple myeloma
645526|NCT00461045|proteasome inhibitor|proteasome inhibitor
645527|NCT00461045|relapsed|relapsed
645528|NCT00461045|refractory|refractory
645529|NCT00460993|Aging|aging
645530|NCT00460993|Sleep|sleep
645531|NCT00460993|Nursing Home|nursing home
645532|NCT00460993|Sleep in nursing homes|sleep in nursing homes
645533|NCT00460980|resident training|resident training
645534|NCT00460980|laparoscopic skills|laparoscopic skills
645535|NCT00460980|surgical skills assessment|surgical skills assessment
645536|NCT00460967|non-Exudative (Dry) Age-Related Macular Degeneration|non-exudative (dry) age-related macular degeneration
645537|NCT00460928|congenital heart block|congenital heart block
645538|NCT00460928|neonatal lupus|neonatal lupus
645539|NCT00460928|systemic lupus erythematosus|systemic lupus erythematosus
645540|NCT00460928|Sjogren syndrome|sjogren syndrome
645541|NCT00460928|autoantibodies|autoantibodies
645542|NCT00460928|SSA/Ro|ssa/ro
645543|NCT00460928|SSB/La|ssb/la
645544|NCT00460928|autoimmunity|autoimmunity
645545|NCT00460928|pregnancy|pregnancy
645546|NCT00460928|intravenous immune globulin|intravenous immune globulin
645547|NCT00460928|IVIG|ivig
645548|NCT00460928|immunoglobulin|immunoglobulin
645549|NCT00460915|Lacidipine|lacidipine
645550|NCT00460915|Amlodipine|amlodipine
645552|NCT00460902|drug resistant depression|drug resistant depression
645553|NCT00460889|hand assist|hand assist
645554|NCT00460889|laparoscopy|laparoscopy
645555|NCT00460889|renal donor|renal donor
645556|NCT00460889|outcomes|outcomes
645557|NCT00460876|topotecan|topotecan
645558|NCT00460876|periocular|periocular
645559|NCT00460876|chemotherapy|chemotherapy
645560|NCT00460863|sleep|sleep
645561|NCT00460863|hemodialysis|hemodialysis
645562|NCT00460863|daytime sleepiness|daytime sleepiness
645563|NCT00460863|temperature|temperature
645564|NCT00460837|colorectal cancer|colorectal cancer
645565|NCT00460837|bowel preparation regimen|bowel preparation regimen
645566|NCT00460837|patients with symptoms attributable to colorectal cancer|patients with symptoms attributable to colorectal cancer
645567|NCT00460824|transplant|transplant
645568|NCT00460824|HLA antibodies matching|hla antibodies matching
645569|NCT00460824|immunologic mismatching|immunologic mismatching
645570|NCT00460811|Irritable Bowel Syndrome with Constipation|irritable bowel syndrome with constipation
645571|NCT00460811|IBS|ibs
645572|NCT00460811|Irritable Bowel Syndrome|irritable bowel syndrome
645573|NCT00460811|linaclotide acetate|linaclotide acetate
645574|NCT00460811|linaclotide|linaclotide
645575|NCT00460811|MD-1100|md-1100
645576|NCT00460798|Sunitinib|sunitinib
645577|NCT00460798|kidney diseases|kidney diseases
645578|NCT00460798|urogenital neoplasms|urogenital neoplasms
645579|NCT00460798|kidney cancer|kidney cancer
645580|NCT00460759|Mycobacterium tuberculosis, rifapentine, moxifloxacin|mycobacterium tuberculosis, rifapentine, moxifloxacin
645581|NCT00460746|HIV|hiv
645582|NCT00460746|AIDS|aids
645583|NCT00460746|Immunodeficiency Virus, Human|immunodeficiency virus, human
645584|NCT00460746|PREZISTA|prezista
645585|NCT00460746|darunavir|darunavir
645586|NCT00460746|TMC114|tmc114
645587|NCT00460746|TMC125|tmc125
645588|NCT00460746|Protease Inhibitor|protease inhibitor
645589|NCT00460746|Non-Nucleoside Reverse Transcriptase Inhibitor|non-nucleoside reverse transcriptase inhibitor
645590|NCT00460746|enfuvirtide|enfuvirtide
645591|NCT00460746|Treatment Experienced|treatment experienced
645592|NCT00460720|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
645593|NCT00460720|ADHD|adhd
645594|NCT00460720|Methylphenidate|methylphenidate
645595|NCT00460720|MPH|mph
645596|NCT00460720|Extended-Release Methylphenidate|extended-release methylphenidate
645597|NCT00460707|GW679769|gw679769
645598|NCT00460707|healthy adult subjects|healthy adult subjects
645599|NCT00460707|casopitant|casopitant
645600|NCT00460707|ketoconazole|ketoconazole
645601|NCT00460694|allogeneic transplant|allogeneic transplant
645602|NCT00460694|haematological malignancies|haematological malignancies
645603|NCT00460694|allogeneic CIK cells|allogeneic cik cells
645604|NCT00460681|Hepatocellular Carcinoma|hepatocellular carcinoma
645605|NCT00460681|Thymopentin|thymopentin
645606|NCT00460681|Recurrence|recurrence
645607|NCT00460681|Resection|resection
645608|NCT00460668|elective thoracotomy|elective thoracotomy
645609|NCT00460668|pulmonary rehabilitation|pulmonary rehabilitation
645915|NCT00459576|Eczema|eczema
645610|NCT00460668|quality of life|quality of life
645611|NCT00460655|Post-Stroke|post-stroke
645612|NCT00460655|Lower Limb|lower limb
645613|NCT00460655|botulinum toxin type A|botulinum toxin type a
645614|NCT00460655|Spasticity|spasticity
645615|NCT00460642|Frozen embryo transfers (FET).|frozen embryo transfers (fet).
645616|NCT00460642|Egg donation (ED).|egg donation (ed).
645617|NCT00460642|IVF.|ivf.
645618|NCT00460642|ART.|art.
645619|NCT00460642|Implantation.|implantation.
645620|NCT00460642|GnRH antagonist.|gnrh antagonist.
645621|NCT00460642|Cetrotide.|cetrotide.
645622|NCT00460642|Endometrial response.|endometrial response.
645623|NCT00460642|Infertility treatments:|infertility treatments:
645624|NCT00460642|Transfer of embryos from egg donation (ED) to recipients.|transfer of embryos from egg donation (ed) to recipients.
645625|NCT00460629|Adoptive immunotherapy|adoptive immunotherapy
645626|NCT00460629|BCR-ABL reactive T cells|bcr-abl reactive t cells
645627|NCT00460629|Allogeneic Transplantation|allogeneic transplantation
645628|NCT00460616|Prolactin|prolactin
645629|NCT00460616|Prolactinomas|prolactinomas
645630|NCT00460616|Dopamine-Agonists|dopamine-agonists
645631|NCT00460616|Cabergoline|cabergoline
645632|NCT00460616|Cardiac valve disease|cardiac valve disease
645633|NCT00460603|GI neoplasms (phase 1)|gi neoplasms (phase 1)
645634|NCT00460590|Tuberculosis|tuberculosis
645635|NCT00460590|TB|tb
645636|NCT00460590|MVA 85A|mva 85a
645637|NCT00460577|Asthma, Formoterol, Bronchial Obstruction, Children|asthma, formoterol, bronchial obstruction, children
645638|NCT00460564|Spasticity|spasticity
645639|NCT00460564|Post-Stroke|post-stroke
645640|NCT00460564|botulinum toxin type A|botulinum toxin type a
645641|NCT00460564|Upper Limb|upper limb
645642|NCT00460538|Seasonal allergic rhinitis|seasonal allergic rhinitis
645643|NCT00460538|lectranal|lectranal
645644|NCT00460538|allergy|allergy
645645|NCT00460525|malaria, Mali, children, Plasmodium falciparum, vaccine|malaria, mali, children, plasmodium falciparum, vaccine
645646|NCT00460512|Schizophrenia|schizophrenia
645647|NCT00460512|Flexible dosing|flexible dosing
645648|NCT00460512|Non-acute patients|non-acute patients
645649|NCT00460512|Antipsychotic|antipsychotic
645650|NCT00460512|Atypical|atypical
645651|NCT00460512|INVEGA|invega
645652|NCT00460499|Diabetes|diabetes
645653|NCT00460473|Mental Health|mental health
645654|NCT00460473|Neurological Disease|neurological disease
645655|NCT00460473|Hip Injuries and Disorders|hip injuries and disorders
645656|NCT00460460|Phase I|phase i
645657|NCT00460460|cancer|cancer
645658|NCT00460460|lymphoma|lymphoma
645659|NCT00460460|leukemia|leukemia
645660|NCT00460460|myeloma|myeloma
645661|NCT00460460|AML|aml
645662|NCT00460460|ALL|all
645663|NCT00460460|NHL|nhl
645664|NCT00460460|MM|mm
645665|NCT00460447|anti-CD33|anti-cd33
645666|NCT00460447|Immunotoxin|immunotoxin
645667|NCT00460447|Acute myeloid leukemia|acute myeloid leukemia
645668|NCT00460434|Prolapse|prolapse
645669|NCT00460434|Urinary incontinence|urinary incontinence
645670|NCT00460434|TVT|tvt
645671|NCT00460421|Oral Mucositis|oral mucositis
645672|NCT00460421|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
645673|NCT00460421|Acute Myeloid Leukemia|acute myeloid leukemia
645674|NCT00460421|Palifermin|palifermin
645675|NCT00460421|Kepivance|kepivance
645676|NCT00460408|Macular degeneration|macular degeneration
645677|NCT00460408|Safety|safety
645678|NCT00460408|Non-interventional|non-interventional
645679|NCT00460408|Non-randomized|non-randomized
645680|NCT00460395|Brain Metastasis|brain metastasis
645681|NCT00460395|Cerebral Metastases|cerebral metastases
645682|NCT00460395|Brain Cancer|brain cancer
645683|NCT00460395|Stereotactic Radiosurgery|stereotactic radiosurgery
645684|NCT00460395|Craniotomy|craniotomy
645685|NCT00460382|HIV infections|hiv infections
645686|NCT00460382|HIV integrase inhibitor|hiv integrase inhibitor
645687|NCT00460382|etravirine|etravirine
645688|NCT00460382|darunavir|darunavir
645689|NCT00460382|MK 0518|mk 0518
645690|NCT00460382|raltegravir|raltegravir
645691|NCT00460382|Treatment Experienced|treatment experienced
645692|NCT00460382|Antiviral drug resistance|antiviral drug resistance
645693|NCT00460369|uncomplicated malaria|uncomplicated malaria
645694|NCT00460369|children|children
645695|NCT00460369|treatment|treatment
645696|NCT00460369|effectiveness|effectiveness
645697|NCT00460343|patient non-adherence|patient non-adherence
645698|NCT00460343|antihypertensive agents|antihypertensive agents
645699|NCT00460343|community pharmacy services|community pharmacy services
645700|NCT00460343|professional roles|professional roles
645701|NCT00460330|diagnosis|diagnosis
645702|NCT00460330|galactomannan|galactomannan
645703|NCT00460330|glucan|glucan
645704|NCT00460330|real-time PCR|real-time pcr
645705|NCT00460330|invasive fungal infection|invasive fungal infection
645706|NCT00460330|aspergillosis|aspergillosis
645707|NCT00460330|Chinese patients|chinese patients
645708|NCT00460317|lung|lung
645709|NCT00460317|cancer|cancer
645710|NCT00460317|chemotherapy|chemotherapy
645711|NCT00460317|paclitaxel|paclitaxel
645712|NCT00460317|carboplatin|carboplatin
645713|NCT00460317|placebo|placebo
645714|NCT00460317|angiogenesis|angiogenesis
645715|NCT00460317|VEGF|vegf
645716|NCT00460317|multi kinase inhibitor|multi kinase inhibitor
645717|NCT00460304|Type I diabetes|type i diabetes
645718|NCT00460304|Insulin pump|insulin pump
645719|NCT00460304|Continuous glucose monitoring|continuous glucose monitoring
645720|NCT00460304|Insulin to carbohydrate ratio|insulin to carbohydrate ratio
645721|NCT00460304|Correction factor|correction factor
645722|NCT00460304|Pramlintide|pramlintide
645723|NCT00460291|PAD|pad
645724|NCT00460291|vein bypass|vein bypass
645725|NCT00460291|supported varicose veins|supported varicose veins
645726|NCT00460278|Cancer|cancer
645727|NCT00460278|Solid Tumors|solid tumors
645728|NCT00460265|Squamous Cell Carcinoma|squamous cell carcinoma
645729|NCT00460265|Epidermal Growth Factor|epidermal growth factor
645730|NCT00460265|Epidermal Growth Factor Receptor|epidermal growth factor receptor
645731|NCT00460265|SCCHN|scchn
645732|NCT00460265|Metastatic Head and Neck Cancer|metastatic head and neck cancer
645733|NCT00460265|EGFr|egfr
645734|NCT00460265|Head and Neck Cancer|head and neck cancer
645735|NCT00460265|Recurrent Head and Neck Cancer|recurrent head and neck cancer
645736|NCT00460252|algorithm|algorithm
645737|NCT00460252|insulin|insulin
645738|NCT00460252|hyperglycemia|hyperglycemia
645739|NCT00460252|tight glycemic control|tight glycemic control
645740|NCT00460252|intensive care|intensive care
645741|NCT00460252|adults|adults
645742|NCT00460239|Opioid addiction|opioid addiction
645743|NCT00460239|Opioid dependence|opioid dependence
645744|NCT00460239|Buprenorphine|buprenorphine
645745|NCT00460226|Korean|korean
645746|NCT00460226|Bipolar I disorder|bipolar i disorder
645747|NCT00460226|Non-serious rash|non-serious rash
645748|NCT00460226|Lamotrigine|lamotrigine
645749|NCT00460213|home blood pressure|home blood pressure
645750|NCT00460200|depression|depression
645751|NCT00460200|fatigue|fatigue
645752|NCT00460200|sleep disorders|sleep disorders
645753|NCT00460200|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
645754|NCT00460200|ovarian epithelial cancer|ovarian epithelial cancer
645755|NCT00460187|carotid artery, distal protection device, carotid stenting|carotid artery, distal protection device, carotid stenting
645756|NCT00460174|stage I pancreatic cancer|stage i pancreatic cancer
645757|NCT00460174|stage II pancreatic cancer|stage ii pancreatic cancer
645758|NCT00460174|stage III pancreatic cancer|stage iii pancreatic cancer
645759|NCT00460161|acupuncture|acupuncture
645760|NCT00460161|amputation|amputation
645761|NCT00460161|phantom limb pain|phantom limb pain
645762|NCT00460148|ropinirole PR/CR,|ropinirole pr/cr,
645763|NCT00460148|pharmacokinetic,|pharmacokinetic,
645764|NCT00460148|formulation,|formulation,
645765|NCT00460148|food effect,|food effect,
645766|NCT00460148|SK&F101468,|sk&f101468,
645767|NCT00460148|PD|pd
645768|NCT00460135|Resistance|resistance
645769|NCT00460135|Training|training
645770|NCT00460135|Obesity|obesity
645771|NCT00460135|Children|children
645772|NCT00460122|Human Leukocyte Antigens (HLA)|human leukocyte antigens (hla)
645773|NCT00460122|Transfusion Reactions|transfusion reactions
645774|NCT00460122|Platelet Donors|platelet donors
645775|NCT00460109|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
645776|NCT00460109|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
645777|NCT00460109|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
645778|NCT00460109|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
645779|NCT00460096|Pulmonary Emphysema|pulmonary emphysema
645780|NCT00460083|Atopic Dermatitis|atopic dermatitis
645781|NCT00460083|eczema|eczema
645782|NCT00460083|dermatitis|dermatitis
645783|NCT00460083|skin barrier|skin barrier
645784|NCT00460083|barrier repair|barrier repair
645785|NCT00460083|ceramide|ceramide
645786|NCT00460083|physiologic lipid|physiologic lipid
645787|NCT00460083|pruritus|pruritus
645788|NCT00460083|Elidel|elidel
645789|NCT00460083|Epiceram|epiceram
645790|NCT00460083|topical steroid|topical steroid
645791|NCT00460057|osteoporosis|osteoporosis
645792|NCT00460057|alendronate|alendronate
645793|NCT00460057|bone marker|bone marker
645794|NCT00460044|ADMA|adma
645795|NCT00460044|Preterms|preterms
645796|NCT00460044|infants|infants
645797|NCT00460044|mechanical ventilation|mechanical ventilation
645798|NCT00460044|Preterm infants|preterm infants
645799|NCT00460031|adenocarcinoma of the prostate|adenocarcinoma of the prostate
645800|NCT00460031|stage III prostate cancer|stage iii prostate cancer
645801|NCT00460031|stage IV prostate cancer|stage iv prostate cancer
645802|NCT00460031|recurrent prostate cancer|recurrent prostate cancer
645803|NCT00460018|Gestational Diabetes Mellitus|gestational diabetes mellitus
645804|NCT00460018|Weight Loss|weight loss
645805|NCT00460018|Physical Activity|physical activity
645806|NCT00460018|Breastfeeding|breastfeeding
645807|NCT00460018|Pregnancy|pregnancy
645808|NCT00460018|Postpartum|postpartum
645809|NCT00460018|Intervention|intervention
645810|NCT00460018|Prevention|prevention
645811|NCT00460005|Migraine|migraine
645812|NCT00460005|headache|headache
646377|NCT00457951|COPD|copd
645813|NCT00460005|observational|observational
645815|NCT00459992|Weight Gain|weight gain
645816|NCT00459992|Adult|adult
645817|NCT00459992|Histamine|histamine
645818|NCT00459992|Metabolism|metabolism
645819|NCT00459992|Overweight|overweight
645820|NCT00459979|clear cell renal cell carcinoma|clear cell renal cell carcinoma
645821|NCT00459979|stage III renal cell cancer|stage iii renal cell cancer
645822|NCT00459979|stage IV renal cell cancer|stage iv renal cell cancer
645823|NCT00459979|papillary renal cell carcinoma|papillary renal cell carcinoma
645824|NCT00459940|Growth hormone|growth hormone
645825|NCT00459940|Lipolysis|lipolysis
645826|NCT00459940|Insulin resistance|insulin resistance
645827|NCT00459940|Pioglitazone|pioglitazone
645828|NCT00459940|Growth hormone replaced growth hormone deficient adults|growth hormone replaced growth hormone deficient adults
645829|NCT00459927|Adenotonsillectomy|adenotonsillectomy
645830|NCT00459927|Coblation tonsillectomy|coblation tonsillectomy
645831|NCT00459927|Floseal|floseal
645832|NCT00459914|sleep apnea|sleep apnea
645833|NCT00459914|refractory hypertension|refractory hypertension
645834|NCT00459914|continuous positive airway pressure|continuous positive airway pressure
645835|NCT00459901|Metastatic Colorectal Cancer|metastatic colorectal cancer
645836|NCT00459888|CLI|cli
645837|NCT00459888|Critical Limb Ischemia|critical limb ischemia
645838|NCT00459888|Infrapopliteal|infrapopliteal
645839|NCT00459888|Cryoplasty|cryoplasty
645840|NCT00459875|recurrent renal cell cancer|recurrent renal cell cancer
645841|NCT00459875|stage IV renal cell cancer|stage iv renal cell cancer
645842|NCT00459849|Melanoma|melanoma
645843|NCT00459849|Brachytherapy|brachytherapy
645844|NCT00459849|Ultrasonography|ultrasonography
645845|NCT00459836|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
645846|NCT00459823|Cancer|cancer
645847|NCT00459823|solid tumors|solid tumors
645848|NCT00459810|adenocarcinoma of the prostate|adenocarcinoma of the prostate
645849|NCT00459810|recurrent prostate cancer|recurrent prostate cancer
645850|NCT00459810|stage IV prostate cancer|stage iv prostate cancer
645851|NCT00459797|GlideScope|glidescope
645852|NCT00459797|cobalt|cobalt
645853|NCT00459797|single-use|single-use
645854|NCT00459797|intubation|intubation
645855|NCT00459797|airway|airway
645856|NCT00459797|Elective surgical patients requiring orotracheal intubation|elective surgical patients requiring orotracheal intubation
645857|NCT00459784|Improvement|improvement
645858|NCT00459784|Dementia early diagnosis|dementia early diagnosis
645859|NCT00459784|Dementia management|dementia management
645860|NCT00459784|Primary care|primary care
645861|NCT00459771|angiotensin II-receptor (AT1) blocker|angiotensin ii-receptor (at1) blocker
645862|NCT00459771|prevention|prevention
645863|NCT00459771|trastuzumab|trastuzumab
645864|NCT00459771|cardiotoxicity|cardiotoxicity
645865|NCT00459758|hypertension|hypertension
645866|NCT00459758|Hans|hans
645867|NCT00459758|Electrical stimulation|electrical stimulation
645868|NCT00459745|Cardiovascular Disease|cardiovascular disease
645869|NCT00459745|Fenofibrate|fenofibrate
645870|NCT00459745|LDL cholesterol|ldl cholesterol
645871|NCT00459745|HDL cholesterol|hdl cholesterol
645872|NCT00459745|Hyperlipidemia|hyperlipidemia
645873|NCT00459745|Pravastatin|pravastatin
645874|NCT00459745|Triglycerides|triglycerides
645875|NCT00459732|zinc, thalassemia, bone mineral density|zinc, thalassemia, bone mineral density
645876|NCT00459719|Liver Transplantation|liver transplantation
645877|NCT00459719|Tacrolimus|tacrolimus
645878|NCT00459719|Methylprednisolone|methylprednisolone
645879|NCT00459719|Prednisolone|prednisolone
645880|NCT00459706|Rheumatoid Arthritis|rheumatoid arthritis
645881|NCT00459693|HIV-Dementia|hiv-dementia
645882|NCT00459693|Brain|brain
645883|NCT00459693|PET|pet
645884|NCT00459693|PBR28|pbr28
645885|NCT00459693|MCMD|mcmd
645886|NCT00459693|HIV Positive|hiv positive
645887|NCT00459693|HIV Dementia|hiv dementia
645888|NCT00459693|AIDS Related Dementia|aids related dementia
645889|NCT00459693|Minor Cognitive Motor Disorder|minor cognitive motor disorder
645890|NCT00459693|Healthy Volunteer|healthy volunteer
645891|NCT00459693|HV|hv
645892|NCT00459680|hypertension|hypertension
645893|NCT00459680|acupuncture|acupuncture
645894|NCT00459680|laser|laser
645895|NCT00459667|Relapsing multiple sclerosis|relapsing multiple sclerosis
645896|NCT00459667|interferon beta 1b|interferon beta 1b
645897|NCT00459667|Betaferon|betaferon
645898|NCT00459667|Betaseron|betaseron
645899|NCT00459654|HRPC|hrpc
645900|NCT00459654|Recurrent Prostate Cancer|recurrent prostate cancer
645901|NCT00459654|Metastatic Cancer|metastatic cancer
645902|NCT00459641|Osteogenic Gel|osteogenic gel
645903|NCT00459641|Solitary Bone Cysts|solitary bone cysts
645904|NCT00459628|early breast cancer|early breast cancer
645905|NCT00459628|post-operative radiation treatment|post-operative radiation treatment
645906|NCT00459602|laparoscopic surgery|laparoscopic surgery
645907|NCT00459589|Cancer|cancer
645908|NCT00459589|elderly|elderly
645909|NCT00459589|malnutrition|malnutrition
645910|NCT00459589|chemotherapy|chemotherapy
645911|NCT00459589|survival|survival
645912|NCT00459589|comprehensive geriatric assessment|comprehensive geriatric assessment
645916|NCT00459576|Dermatitis, Atopic|dermatitis, atopic
645917|NCT00459576|Infant|infant
645918|NCT00459563|vitamin D|vitamin d
645919|NCT00459563|blood pressure|blood pressure
645920|NCT00459563|hypertension|hypertension
645921|NCT00459563|Vitamin D insufficient|vitamin d insufficient
645922|NCT00459563|Systolic blood pressure between 130 and 150 mmHg|systolic blood pressure between 130 and 150 mmhg
645923|NCT00459550|Alzheimer's Disease|alzheimer's disease
645924|NCT00459550|First Time in Human (FTIH) Study|first time in human (ftih) study
645925|NCT00459537|Toenail fungus|toenail fungus
645926|NCT00459537|Onychomycosis|onychomycosis
645927|NCT00459537|Nail fungus|nail fungus
645928|NCT00459537|Toenail fungal infection|toenail fungal infection
645929|NCT00459537|Tinea unguium|tinea unguium
645930|NCT00459537|Dermatophytes|dermatophytes
645931|NCT00459537|Foot dermatoses|foot dermatoses
645932|NCT00459524|Acute Myelogenous Leukemia|acute myelogenous leukemia
645933|NCT00459524|Myelodysplastic Syndrome|myelodysplastic syndrome
645934|NCT00459524|Leukemia|leukemia
645935|NCT00459524|Quality of Life|quality of life
645936|NCT00459524|Questionnaire|questionnaire
645937|NCT00459524|Survey|survey
645938|NCT00459524|Neurocognitive Function|neurocognitive function
645939|NCT00459524|AML|aml
645940|NCT00459524|MDS|mds
645941|NCT00459524|QOL|qol
645942|NCT00459511|Adrenomedullin|adrenomedullin
645943|NCT00459511|Glucose|glucose
645944|NCT00459511|Insulin|insulin
645945|NCT00459511|Systemic Inflammatory response Syndrome|systemic inflammatory response syndrome
645946|NCT00459511|Pediatric|pediatric
645947|NCT00459511|Cortisol|cortisol
645948|NCT00459511|ACTH|acth
645949|NCT00459498|NIS|nis
645950|NCT00459498|thyroid adenoma|thyroid adenoma
645951|NCT00459498|thyroid cancer|thyroid cancer
645952|NCT00459498|Iodine uptake|iodine uptake
645953|NCT00459498|expression|expression
645954|NCT00459485|Plasm zinc concentration|plasm zinc concentration
645955|NCT00459485|Zinc supplementation|zinc supplementation
645956|NCT00459485|Assessment of zinc status|assessment of zinc status
645957|NCT00459485|Plasma zinc concentration|plasma zinc concentration
645958|NCT00459472|resident training|resident training
645959|NCT00459472|laparoscopy|laparoscopy
645960|NCT00459472|virtual reality|virtual reality
645961|NCT00459472|surgical education|surgical education
645962|NCT00459446|Magnetic Resonance Imaging|magnetic resonance imaging
645963|NCT00459446|Gadolinium Contrast|gadolinium contrast
645964|NCT00459446|Gadofosveset|gadofosveset
645965|NCT00459446|Atherosclerosis|atherosclerosis
645966|NCT00459446|Chronic Total Arterial Occlusions|chronic total arterial occlusions
645967|NCT00459446|Cardiovascular Disease|cardiovascular disease
645968|NCT00459446|Blocked Arteries|blocked arteries
645969|NCT00459446|Peripheral Artery Disease|peripheral artery disease
645970|NCT00459446|PAD|pad
645971|NCT00459446|Intermittent Claudication|intermittent claudication
645972|NCT00459446|Chronic Total Arterial Occlusion|chronic total arterial occlusion
645973|NCT00459433|Low back pain|low back pain
645974|NCT00459433|Return to work|return to work
645975|NCT00459433|Biopsychosocial|biopsychosocial
645976|NCT00459433|Screening|screening
645977|NCT00459433|SMS|sms
645978|NCT00459433|Non specific low back pain|non specific low back pain
645979|NCT00459420|Parkinson's disease|parkinson's disease
645980|NCT00459420|Excessive Daytime Somnolence|excessive daytime somnolence
645981|NCT00459420|Caffeine|caffeine
645982|NCT00459420|Disease-Modifying|disease-modifying
645983|NCT00459368|asthma|asthma
645984|NCT00459368|patient compliance|patient compliance
645985|NCT00459368|metered dose inhalers|metered dose inhalers
645986|NCT00459368|corticosteroids|corticosteroids
645987|NCT00459368|health behaviour|health behaviour
645988|NCT00459368|prevention & control|prevention & control
645989|NCT00459355|Alzheimer's disease|alzheimer's disease
645990|NCT00459355|Dementia|dementia
645991|NCT00459355|Safety|safety
645992|NCT00459355|Home Care Services|home care services
645993|NCT00459329|Depression|depression
645994|NCT00459329|Epilepsy|epilepsy
645995|NCT00459329|Problem-Solving Therapy|problem-solving therapy
645996|NCT00459329|Mental Health|mental health
645997|NCT00459329|Neurology|neurology
645998|NCT00459329|Home-based health care|home-based health care
645999|NCT00459329|Community-based program|community-based program
646000|NCT00459329|Collaborative care|collaborative care
646001|NCT00459303|cataract|cataract
646002|NCT00459303|aspherical intraocular lenses|aspherical intraocular lenses
646003|NCT00459303|functional vision|functional vision
646004|NCT00459290|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
646005|NCT00459290|primary peritoneal cavity cancer|primary peritoneal cavity cancer
646006|NCT00459290|fallopian tube cancer|fallopian tube cancer
646007|NCT00459277|Pain|pain
646008|NCT00459277|Cancer|cancer
646009|NCT00459264|Folic Acid|folic acid
646010|NCT00459264|Prevention|prevention
646011|NCT00459264|Depression|depression
646012|NCT00459264|Bipolar Disorder|bipolar disorder
646013|NCT00459264|Teenagers|teenagers
646014|NCT00459251|N-acetyltransferase|n-acetyltransferase
646015|NCT00459251|Pharmacogenetics|pharmacogenetics
646378|NCT00457951|Heparin|heparin
646016|NCT00459238|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
646017|NCT00459225|Pediatrics|pediatrics
646018|NCT00459225|Cardiac Defect|cardiac defect
646019|NCT00459225|Cardiac Surgery|cardiac surgery
646020|NCT00459225|Single Ventricle|single ventricle
646021|NCT00459225|Anemia|anemia
646022|NCT00459225|blood transfusions|blood transfusions
646023|NCT00459225|red cell volume|red cell volume
646024|NCT00459225|red cell distribution|red cell distribution
646025|NCT00459225|oral iron|oral iron
646026|NCT00459225|ferrous sulfate|ferrous sulfate
646027|NCT00459225|Congenital Cardiac Defects|congenital cardiac defects
646028|NCT00459225|Hemoglobin|hemoglobin
646029|NCT00459225|Iron Deficiency|iron deficiency
646030|NCT00459186|prostate cancer|prostate cancer
646031|NCT00459186|RAD001|rad001
646032|NCT00459186|mTOR inhibition|mtor inhibition
646033|NCT00459186|docetaxel|docetaxel
646034|NCT00459173|abstinence|abstinence
646035|NCT00459173|maintenance|maintenance
646036|NCT00459160|Hypotensive Resuscitation|hypotensive resuscitation
646037|NCT00459160|Hypotensive Anesthesia|hypotensive anesthesia
646038|NCT00459160|Hemorrhagic Shock|hemorrhagic shock
646039|NCT00459160|Penetrating Trauma|penetrating trauma
646040|NCT00459134|sexual dysfunction|sexual dysfunction
646041|NCT00459134|sexuality and reproductive issues|sexuality and reproductive issues
646042|NCT00459134|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
646043|NCT00459121|stage I non-small cell lung cancer|stage i non-small cell lung cancer
646044|NCT00459121|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
646045|NCT00459121|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
646046|NCT00459082|Dexmedetomine|dexmedetomine
646047|NCT00459082|Post-operative cardiac surgery|post-operative cardiac surgery
646048|NCT00459069|tumor vaccine|tumor vaccine
646050|NCT00459043|SCCHN|scchn
646051|NCT00459030|colon cancer|colon cancer
646052|NCT00459030|rectal cancer|rectal cancer
646053|NCT00459017|24 hour ambulatory blood pressure measurement|24 hour ambulatory blood pressure measurement
646054|NCT00459017|Mean blood pressure|mean blood pressure
646055|NCT00459017|Wrist manometer|wrist manometer
646056|NCT00459017|Frequent measurement|frequent measurement
646057|NCT00459004|weight loss|weight loss
646058|NCT00458991|Recombinant Human Growth Hormone|recombinant human growth hormone
646059|NCT00458991|growth hormone deficiency|growth hormone deficiency
646060|NCT00458991|short stature|short stature
646061|NCT00458991|phenotyping|phenotyping
646062|NCT00458952|MIBG|mibg
646063|NCT00458952|iobenguane|iobenguane
646064|NCT00458952|iodine|iodine
646065|NCT00458952|I 131|i 131
646066|NCT00458952|radiotherapy|radiotherapy
646067|NCT00458952|radiopharmaceutical|radiopharmaceutical
646068|NCT00458952|dosimetry|dosimetry
646069|NCT00458952|neuroendocrine tumor|neuroendocrine tumor
646070|NCT00458952|Ultratrace|ultratrace
646071|NCT00458952|no carrier added|no carrier added
646072|NCT00458952|metaiodobenzyl-guanidine|metaiodobenzyl-guanidine
646073|NCT00458926|ventilation, mechanical|ventilation, mechanical
646074|NCT00458926|intubation, endotracheal|intubation, endotracheal
646075|NCT00458926|respiratory insufficiency|respiratory insufficiency
646076|NCT00458913|localized malignant mesothelioma|localized malignant mesothelioma
646077|NCT00458913|recurrent malignant mesothelioma|recurrent malignant mesothelioma
646078|NCT00458913|advanced malignant mesothelioma|advanced malignant mesothelioma
646079|NCT00458887|ototoxicity|ototoxicity
646080|NCT00458887|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
646081|NCT00458874|CV risk factors|cv risk factors
646082|NCT00458874|subclinical atherosclerosis|subclinical atherosclerosis
646083|NCT00458874|lifestyle intervention|lifestyle intervention
646084|NCT00458874|motivation|motivation
646085|NCT00458861|Active Rheumatoid Arthritis (RA)|active rheumatoid arthritis (ra)
646086|NCT00458848|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
646087|NCT00458848|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
646088|NCT00458848|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
646089|NCT00458848|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
646090|NCT00458848|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
646091|NCT00458848|TdT positive adult acute lymphoblastic leukemia|tdt positive adult acute lymphoblastic leukemia
646092|NCT00458835|Allergic rhinitis|allergic rhinitis
646093|NCT00458822|primary systemic amyloidosis|primary systemic amyloidosis
646094|NCT00458809|recurrent colon cancer|recurrent colon cancer
646095|NCT00458809|stage IV colon cancer|stage iv colon cancer
646096|NCT00458809|carcinoma of the appendix|carcinoma of the appendix
646097|NCT00458809|recurrent rectal cancer|recurrent rectal cancer
646098|NCT00458809|stage IV rectal cancer|stage iv rectal cancer
646099|NCT00458809|primary peritoneal cavity cancer|primary peritoneal cavity cancer
646100|NCT00458796|hypercalcemia of malignancy|hypercalcemia of malignancy
646101|NCT00458796|musculoskeletal complications|musculoskeletal complications
646102|NCT00458796|pain|pain
646103|NCT00458796|stage IV breast cancer|stage iv breast cancer
646104|NCT00458796|male breast cancer|male breast cancer
646105|NCT00458796|recurrent breast cancer|recurrent breast cancer
646106|NCT00458796|bone metastases|bone metastases
646107|NCT00458783|Transfusion|transfusion
646108|NCT00458783|Cardiac|cardiac
646109|NCT00458783|Blood storage duration|blood storage duration
646110|NCT00458770|Comparison of a spontaneous acute cluster headache attack and rest (no pain) in ten patients with cluster headache defined with IHS criteria|comparison of a spontaneous acute cluster headache attack and rest (no pain) in ten patients with cluster headache defined with ihs criteria
646111|NCT00458757|Amputees|amputees
646112|NCT00458757|Affordance|affordance
646113|NCT00458757|Peripersonal space|peripersonal space
646114|NCT00458757|Pseudo neglect|pseudo neglect
646115|NCT00458757|Reaching|reaching
646116|NCT00458757|Spatial|spatial
646117|NCT00458757|visual|visual
646118|NCT00458744|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
646119|NCT00458744|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
646120|NCT00458744|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
646121|NCT00458744|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
646122|NCT00458744|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
646123|NCT00458744|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
646124|NCT00458744|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
646125|NCT00458744|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
646126|NCT00458744|childhood choroid plexus tumor|childhood choroid plexus tumor
646127|NCT00458744|childhood craniopharyngioma|childhood craniopharyngioma
646128|NCT00458744|childhood infratentorial ependymoma|childhood infratentorial ependymoma
646129|NCT00458744|childhood grade I meningioma|childhood grade i meningioma
646130|NCT00458744|childhood grade II meningioma|childhood grade ii meningioma
646131|NCT00458744|childhood grade III meningioma|childhood grade iii meningioma
646132|NCT00458744|childhood supratentorial ependymoma|childhood supratentorial ependymoma
646133|NCT00458744|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
646134|NCT00458744|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
646135|NCT00458744|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
646136|NCT00458744|recurrent childhood ependymoma|recurrent childhood ependymoma
646137|NCT00458744|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
646138|NCT00458744|recurrent childhood supratentorial primitive neuroectodermal tumors|recurrent childhood supratentorial primitive neuroectodermal tumors
646139|NCT00458744|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
646140|NCT00458744|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
646141|NCT00458744|high-grade childhood cerebral astrocytoma|high-grade childhood cerebral astrocytoma
646142|NCT00458744|low-grade childhood cerebral astrocytoma|low-grade childhood cerebral astrocytoma
646143|NCT00458744|recurrent childhood brain tumor|recurrent childhood brain tumor
646144|NCT00458744|childhood spinal cord tumor|childhood spinal cord tumor
646145|NCT00458744|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
646146|NCT00458744|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
646147|NCT00458744|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
646148|NCT00458744|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
646149|NCT00458744|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
646150|NCT00458744|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
646151|NCT00458744|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
646152|NCT00458744|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
646153|NCT00458744|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
646154|NCT00458744|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
646155|NCT00458744|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
646156|NCT00458744|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
646157|NCT00458718|abstinence|abstinence
646158|NCT00458718|nicotine patch|nicotine patch
646159|NCT00458705|stage I multiple myeloma|stage i multiple myeloma
646160|NCT00458705|stage II multiple myeloma|stage ii multiple myeloma
646161|NCT00458705|stage III multiple myeloma|stage iii multiple myeloma
646162|NCT00458705|refractory multiple myeloma|refractory multiple myeloma
646163|NCT00458679|CHRONIC LYMPHOCYTIC LEUKEMIA (B-CLL)|chronic lymphocytic leukemia (b-cll)
646164|NCT00458679|CD40 LIGAND AND IL-2-EXPRESSING TUMOR CELLS|cd40 ligand and il-2-expressing tumor cells
646165|NCT00458666|Amniotic fluid|amniotic fluid
646166|NCT00458666|D-dimer|d-dimer
646167|NCT00458666|coagulation|coagulation
646168|NCT00458666|factor X activation|factor x activation
646169|NCT00458653|DC/tumor cell fusions|dc/tumor cell fusions
646170|NCT00458653|GM-CSF|gm-csf
646171|NCT00458653|high dose chemotherapy|high dose chemotherapy
646172|NCT00458627|Plethysmograpy|plethysmograpy
646173|NCT00458627|preschool|preschool
646174|NCT00458627|methacholine challenge|methacholine challenge
646175|NCT00458627|spirometry|spirometry
646176|NCT00458627|asthma|asthma
646177|NCT00458614|Cystic Fibrosis|cystic fibrosis
646178|NCT00458601|EGFRvIII vaccinetemozolomidecancer vaccineimmunotherapy|egfrviii vaccinetemozolomidecancer vaccineimmunotherapy
646179|NCT00458588|breast cancer|breast cancer
646180|NCT00458575|Retinitis Pigmentosa|retinitis pigmentosa
646181|NCT00458575|Advanced retinitis pigmentosa (RP)|advanced retinitis pigmentosa (rp)
646182|NCT00458575|CNTO 2476|cnto 2476
646183|NCT00458575|Subretinal|subretinal
646184|NCT00458575|Human umbilical tissue-derived cells (hUTC)|human umbilical tissue-derived cells (hutc)
646185|NCT00458575|Light perception (LP)|light perception (lp)
646186|NCT00458575|Hand motion (HM)|hand motion (hm)
646187|NCT00458562|cervical cancer|cervical cancer
646188|NCT00458562|atypical squamous cells of undetermined significance|atypical squamous cells of undetermined significance
646189|NCT00458562|stage 0 cervical cancer|stage 0 cervical cancer
646190|NCT00458562|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
646191|NCT00458562|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
646192|NCT00458562|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
646193|NCT00458549|stage I prostate cancer|stage i prostate cancer
646194|NCT00458549|stage II prostate cancer|stage ii prostate cancer
646195|NCT00458549|stage III prostate cancer|stage iii prostate cancer
646196|NCT00458549|stage IV prostate cancer|stage iv prostate cancer
646197|NCT00458536|GM-CSF|gm-csf
646198|NCT00458536|vaccine|vaccine
646199|NCT00458536|debulking nephrectomy|debulking nephrectomy
646200|NCT00458536|dendritic cells|dendritic cells
646201|NCT00458523|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
646202|NCT00458523|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
646203|NCT00458523|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
646204|NCT00458523|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
646205|NCT00458523|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
646206|NCT00458523|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
646207|NCT00458510|Pain|pain
646208|NCT00458510|Cancer|cancer
646209|NCT00458510|Breakthrough|breakthrough
646210|NCT00458497|Holofiber|holofiber
646211|NCT00458497|chronic foot pain|chronic foot pain
646212|NCT00458497|sleep quality|sleep quality
646213|NCT00458484|stage I renal cell cancer|stage i renal cell cancer
646214|NCT00458484|stage II renal cell cancer|stage ii renal cell cancer
646215|NCT00458484|stage III renal cell cancer|stage iii renal cell cancer
646216|NCT00458484|stage IV renal cell cancer|stage iv renal cell cancer
646217|NCT00458471|Urinary Catheter|urinary catheter
646218|NCT00458471|Spinal Cord Injury|spinal cord injury
646219|NCT00458471|Escherichia Coli|escherichia coli
646220|NCT00458471|Urinary Tract Infection|urinary tract infection
646221|NCT00458458|Endometriosis|endometriosis
646222|NCT00458458|Dysmenorrhea|dysmenorrhea
646223|NCT00458458|Pelvic Pain|pelvic pain
646224|NCT00458458|Period Pain|period pain
646225|NCT00458458|Menstrual Cramps|menstrual cramps
646226|NCT00458458|Dyspareunia|dyspareunia
646227|NCT00458458|Norethindrone Acetate|norethindrone acetate
646228|NCT00458458|Lupron Depot|lupron depot
646229|NCT00458458|Bone Density|bone density
646230|NCT00458458|Lipid Profile|lipid profile
646231|NCT00458445|Attention-Deficit Hyperactivity Disorder (ADHD)|attention-deficit hyperactivity disorder (adhd)
646232|NCT00458432|fMRI|fmri
646233|NCT00458432|Pavlovian Conditioning|pavlovian conditioning
646234|NCT00458432|Functional Activity|functional activity
646235|NCT00458432|Brain|brain
646236|NCT00458432|Fear|fear
646237|NCT00458432|Healthy Volunteer|healthy volunteer
646238|NCT00458432|HV|hv
646239|NCT00458419|dyspnea; leg discomfort; exercise duration|dyspnea; leg discomfort; exercise duration
646240|NCT00458406|obstructive sleep apnea|obstructive sleep apnea
646241|NCT00458406|child|child
646242|NCT00458406|CPAP|cpap
646243|NCT00458393|HIV|hiv
646244|NCT00458393|Chemoprophylaxis|chemoprophylaxis
646245|NCT00458393|Hepatitis|hepatitis
646246|NCT00458393|Viral human hepatitis|viral human hepatitis
646247|NCT00458393|HIV Seronegativity|hiv seronegativity
646248|NCT00458380|Doppler ultrasonography|doppler ultrasonography
646249|NCT00458380|Embryos|embryos
646250|NCT00458380|Infertility|infertility
646251|NCT00458380|IVF|ivf
646252|NCT00458380|Oocytes|oocytes
646253|NCT00458380|Tubal factor|tubal factor
646254|NCT00458380|unexplained infertility|unexplained infertility
646255|NCT00458367|PASS|pass
646256|NCT00458367|Safety Assessment|safety assessment
646257|NCT00458367|Efficacy Assessment|efficacy assessment
646258|NCT00458367|long-acting injectable risperidone|long-acting injectable risperidone
646259|NCT00458354|Spinal Sealant|spinal sealant
646260|NCT00458354|Spinal Sealant System|spinal sealant system
646261|NCT00458354|Dural Repair|dural repair
646262|NCT00458354|Spinal Surgery|spinal surgery
646263|NCT00458341|Cystic fibrosis|cystic fibrosis
646264|NCT00458341|Nonsense mutation|nonsense mutation
646265|NCT00458341|Premature stop codon|premature stop codon
646266|NCT00458302|HIV|hiv
646267|NCT00458302|Monotherapy|monotherapy
646268|NCT00458302|Darunavir|darunavir
646269|NCT00458302|Protease inhibitor|protease inhibitor
646270|NCT00458302|Early pre-treated|early pre-treated
646271|NCT00458302|Undetectable|undetectable
646272|NCT00458302|Treatment Experienced|treatment experienced
646273|NCT00458276|Left sided heart disease|left sided heart disease
646274|NCT00458276|Elevated pulmonary arterial pressure|elevated pulmonary arterial pressure
646275|NCT00458276|Right ventricular failure|right ventricular failure
646276|NCT00458276|Cardiac surgery|cardiac surgery
646277|NCT00458276|heart-lung machine|heart-lung machine
646278|NCT00458276|cardiopulmonary bypass|cardiopulmonary bypass
646279|NCT00458276|tezosentan|tezosentan
646280|NCT00458276|Actelion|actelion
646281|NCT00458263|Growth Hormone treatment|growth hormone treatment
646282|NCT00458263|ISS|iss
646283|NCT00458263|Biochemical markers|biochemical markers
646284|NCT00458263|Growth response|growth response
646285|NCT00458250|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
646286|NCT00458250|Haploidentical|haploidentical
646287|NCT00458250|Hematologic Neoplasms|hematologic neoplasms
646288|NCT00458250|human, Bone Marrow|human, bone marrow
646289|NCT00458250|Granulocyte Colony-stimulating Factor|granulocyte colony-stimulating factor
646290|NCT00458250|CAMPATH|campath
646291|NCT00458250|Alemtuzumab|alemtuzumab
646292|NCT00458250|AML|aml
646293|NCT00458250|ALL|all
646294|NCT00458250|10. Eligibility|10. eligibility
646295|NCT00458237|HER2 positive|her2 positive
646296|NCT00458237|metastatic breast cancer|metastatic breast cancer
646297|NCT00458237|RAD001|rad001
646298|NCT00458237|Herceptin|herceptin
646299|NCT00458224|overweight|overweight
646300|NCT00458224|obesity|obesity
646301|NCT00458224|child|child
646302|NCT00458211|Schizophrenia|schizophrenia
646303|NCT00458211|Ziprasidone|ziprasidone
646304|NCT00458198|Selective Mutism|selective mutism
646305|NCT00458172|lay theories|lay theories
646306|NCT00458172|health concepts|health concepts
646307|NCT00458172|survey|survey
646308|NCT00458172|internet research|internet research
646309|NCT00458172|Ideas about health|ideas about health
646310|NCT00458159|CC-11006|cc-11006
646311|NCT00458159|RA|ra
646312|NCT00458159|MDS|mds
646313|NCT00458159|Celgene|celgene
646314|NCT00458159|RCMD-RS|rcmd-rs
646315|NCT00458159|RARS|rars
646316|NCT00458159|RAEB-1|raeb-1
646317|NCT00458159|Low-or Intermediate-1-Risk Myelodysplastic Syndrome (MDS)|low-or intermediate-1-risk myelodysplastic syndrome (mds)
646318|NCT00458133|aerobic exercise|aerobic exercise
646319|NCT00458133|resistance exercise|resistance exercise
646320|NCT00458133|type 2 diabetes|type 2 diabetes
646321|NCT00458133|hemoglobin A1C|hemoglobin a1c
646322|NCT00458133|exercise|exercise
646323|NCT00458120|Dengue Fever|dengue fever
646324|NCT00458120|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
646325|NCT00458120|Dengue Vaccination|dengue vaccination
646326|NCT00458107|Pharmacokinetics|pharmacokinetics
646327|NCT00458107|Pharmacodynamics|pharmacodynamics
646328|NCT00458094|Exercise|exercise
646329|NCT00458094|Mental Illness|mental illness
646330|NCT00458094|Community Psychiatry|community psychiatry
646331|NCT00458094|Peer Support|peer support
646332|NCT00458094|Mental Disorders|mental disorders
646333|NCT00458068|preterm infant|preterm infant
646334|NCT00458068|iron supplementation|iron supplementation
646335|NCT00458068|iron deficiency|iron deficiency
646336|NCT00458068|blood transfusion|blood transfusion
646337|NCT00458055|Lipid lowering agents|lipid lowering agents
646338|NCT00458055|Drug treatment|drug treatment
646339|NCT00458055|Statin|statin
646340|NCT00458055|Fibrate|fibrate
646341|NCT00458055|Niacin|niacin
646342|NCT00458055|Cellular cholesterol efflux|cellular cholesterol efflux
646343|NCT00458042|Ventavis|ventavis
646344|NCT00458042|iloporst|iloporst
646345|NCT00458042|Remodulin|remodulin
646346|NCT00458042|treprostinil|treprostinil
646347|NCT00458042|PAH|pah
646348|NCT00458042|prostacyclin|prostacyclin
646349|NCT00458029|type 2 diabetes risk factors|type 2 diabetes risk factors
646350|NCT00458029|obesity|obesity
646351|NCT00458029|prevention|prevention
646352|NCT00458029|adolescence|adolescence
646353|NCT00458029|school based|school based
646354|NCT00458003|Preeclampsia|preeclampsia
646355|NCT00458003|Spinal Anesthesia|spinal anesthesia
646356|NCT00458003|Hypotension|hypotension
646357|NCT00458003|Cesarean Delivery|cesarean delivery
646358|NCT00458003|Phenylephrine|phenylephrine
646359|NCT00458003|Ephedrine|ephedrine
646360|NCT00457990|Neurocognitive outcome|neurocognitive outcome
646361|NCT00457990|preterm infant|preterm infant
646362|NCT00457990|very low birth weight|very low birth weight
646363|NCT00457990|iron deficiency|iron deficiency
646364|NCT00457990|iron supplementation|iron supplementation
646365|NCT00457977|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
646366|NCT00457977|COPD|copd
646367|NCT00457977|Pneumococcal|pneumococcal
646368|NCT00457977|Vaccine|vaccine
646369|NCT00457977|Opsonization|opsonization
646370|NCT00457977|Antibodies|antibodies
646371|NCT00457964|Tuberous Sclerosis Complex (TSC)|tuberous sclerosis complex (tsc)
646372|NCT00457964|Lymyphangioleiomyomatosis|lymyphangioleiomyomatosis
646373|NCT00457964|Mammalian Target of Rapamycin (mTOR)|mammalian target of rapamycin (mtor)
646374|NCT00457964|RAD001|rad001
646375|NCT00457964|Angiomyolipmas|angiomyolipmas
646376|NCT00457951|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
646379|NCT00457951|ODSH|odsh
646380|NCT00457951|Exacerbations of COPD|exacerbations of copd
646381|NCT00457938|lipodystrophy|lipodystrophy
646382|NCT00457925|absorption,|absorption,
646383|NCT00457925|metabolism,|metabolism,
646384|NCT00457925|excretion|excretion
646385|NCT00457925|distribution,|distribution,
646386|NCT00457899|schizophrenia|schizophrenia
646387|NCT00457899|schizoaffective disorder|schizoaffective disorder
646388|NCT00457899|quetiapine|quetiapine
646389|NCT00457899|seroquel|seroquel
646390|NCT00457899|titration|titration
646391|NCT00457873|surgery|surgery
646392|NCT00457860|CLL|cll
646393|NCT00457860|PLL|pll
646394|NCT00457860|SLL|sll
646395|NCT00457860|Relapse|relapse
646396|NCT00457860|Refractory|refractory
646397|NCT00457860|immunotoxin|immunotoxin
646398|NCT00457860|HA22|ha22
646399|NCT00457860|CAT-8015|cat-8015
646400|NCT00457860|immunotherapy|immunotherapy
646401|NCT00457847|PGD|pgd
646402|NCT00457834|Heart failure|heart failure
646403|NCT00457834|Dyssynchrony|dyssynchrony
646404|NCT00457834|Cardiac resynchronization therapy|cardiac resynchronization therapy
646405|NCT00457834|Atrial fibrillation|atrial fibrillation
646406|NCT00457834|RVOT|rvot
646407|NCT00457834|RVapex|rvapex
646408|NCT00457821|G551D mutation|g551d mutation
646409|NCT00457821|Fibrosis|fibrosis
646410|NCT00457821|Pancreatic Diseases|pancreatic diseases
646411|NCT00457821|Digestive System Diseases|digestive system diseases
646412|NCT00457821|Lung Diseases|lung diseases
646413|NCT00457821|Respiratory Tract Diseases|respiratory tract diseases
646414|NCT00457821|Genetic Diseases, Inborn|genetic diseases, inborn
646415|NCT00457821|Infant, Newborn, Diseases|infant, newborn, diseases
646416|NCT00457821|Pathologic Processes|pathologic processes
646417|NCT00457808|TSC and LAM|tsc and lam
646418|NCT00457808|Tuberous Sclerosis Complex and sporadic LAM|tuberous sclerosis complex and sporadic lam
646419|NCT00457782|Cancer|cancer
646420|NCT00457782|Blood disorders|blood disorders
646421|NCT00457782|Leukaemia, Adult Chronic|leukaemia, adult chronic
646422|NCT00457782|Lymphoma|lymphoma
646423|NCT00457782|Multiple Myeloma|multiple myeloma
646424|NCT00457769|Aricept|aricept
646425|NCT00457769|Donepezil|donepezil
646426|NCT00457769|Memory|memory
646427|NCT00457769|vascular dementia|vascular dementia
646428|NCT00457769|stroke|stroke
646429|NCT00457769|functional tasks|functional tasks
646430|NCT00457769|self-generation|self-generation
646431|NCT00457756|LDL cholesterol|ldl cholesterol
646432|NCT00457756|HDL cholesterol|hdl cholesterol
646433|NCT00457756|natural supplement|natural supplement
646434|NCT00457756|guar gum|guar gum
646435|NCT00457756|phytosterols|phytosterols
646436|NCT00457756|policosanol|policosanol
646437|NCT00457756|chrysanthemum|chrysanthemum
646438|NCT00457743|Evaluate of RTD for Japanese GIST patients|evaluate of rtd for japanese gist patients
646439|NCT00457730|Multiple Sclerosis|multiple sclerosis
646440|NCT00457730|Duloxetine|duloxetine
646441|NCT00457730|Pain|pain
646442|NCT00457717|myopia, auricular acupoint, atropine, RCT|myopia, auricular acupoint, atropine, rct
646443|NCT00457704|MRSA|mrsa
646444|NCT00457704|Home Care|home care
646445|NCT00457704|Risk factors|risk factors
646446|NCT00457704|transmissions|transmissions
646447|NCT00457704|observational study|observational study
646448|NCT00457691|colorectal neoplasms|colorectal neoplasms
646449|NCT00457678|Vision loss|vision loss
646450|NCT00457678|Retina|retina
646451|NCT00457678|VEG-F|veg-f
646452|NCT00457678|Fovea|fovea
646454|NCT00457665|HIV|hiv
646455|NCT00457665|Lipodystrophy|lipodystrophy
646456|NCT00457665|Treatment Experienced|treatment experienced
646457|NCT00457652|Rosuvastatin|rosuvastatin
646458|NCT00457652|Caffeine|caffeine
646459|NCT00457652|Ischemia|ischemia
646460|NCT00457652|Reperfusion|reperfusion
646461|NCT00457639|lipodystrophy|lipodystrophy
646462|NCT00457626|Children|children
646463|NCT00457626|pediatrics|pediatrics
646464|NCT00457626|High Blood Pressure|high blood pressure
646465|NCT00457626|Hypertension|hypertension
646466|NCT00457626|Valsartan|valsartan
646467|NCT00457613|alkaline phosphatase|alkaline phosphatase
646468|NCT00457613|sepsis|sepsis
646469|NCT00457613|kidney function|kidney function
646470|NCT00457600|information technology|information technology
646471|NCT00457600|emergency department|emergency department
646472|NCT00457600|medication error|medication error
646473|NCT00457600|quality of care|quality of care
646474|NCT00457600|patient-centered care|patient-centered care
646475|NCT00457561|The relationship between all-cause mortality in patients introduced hemodialysis and recombinant human erythropoietin dose and serum adiponectin level|the relationship between all-cause mortality in patients introduced hemodialysis and recombinant human erythropoietin dose and serum adiponectin level
646476|NCT00457548|Alcohol use|alcohol use
646477|NCT00457548|Brief Interventions|brief interventions
646478|NCT00457548|Injuries|injuries
646479|NCT00457548|Emergency Department Patients|emergency department patients
646480|NCT00457548|Harmful and hazardous alcohol use among ED injured patients|harmful and hazardous alcohol use among ed injured patients
646579|NCT00457119|bevacizumab|bevacizumab
646481|NCT00457535|recombinant human erythropoietin|recombinant human erythropoietin
646482|NCT00457535|adiponectin|adiponectin
646483|NCT00457535|mortality|mortality
646484|NCT00457522|intimate partner violence|intimate partner violence
646485|NCT00457522|depression|depression
646486|NCT00457522|PTSD|ptsd
646487|NCT00457522|fatigue|fatigue
646488|NCT00457509|Pandemic influenza|pandemic influenza
646489|NCT00457509|Avian influenza|avian influenza
646490|NCT00457509|Orthomyxoviridae Infections|orthomyxoviridae infections
646491|NCT00457509|A/H5N1|a/h5n1
646492|NCT00457496|Behavior Therapy|behavior therapy
646493|NCT00457496|Relaxation Techniques|relaxation techniques
646494|NCT00457496|Cognitive Therapy|cognitive therapy
646495|NCT00457496|Exercise Movement Techniques|exercise movement techniques
646496|NCT00457483|hypertension|hypertension
646497|NCT00457483|diuretic|diuretic
646498|NCT00457483|angiotensin receptor blockers|angiotensin receptor blockers
646499|NCT00457483|prediction|prediction
646500|NCT00457457|With or without erectile dysfunction|with or without erectile dysfunction
646501|NCT00457431|in-hospital cardiac arrest|in-hospital cardiac arrest
646502|NCT00457431|resuscitation|resuscitation
646503|NCT00457431|mild therapeutic hypothermia|mild therapeutic hypothermia
646504|NCT00457405|ischemia-reperfusion injury|ischemia-reperfusion injury
646505|NCT00457405|atherosclerosis|atherosclerosis
646506|NCT00457405|dipyridamole|dipyridamole
646507|NCT00457405|annexin A5 targeting|annexin a5 targeting
646508|NCT00457392|Non-small cell lung cancer|non-small cell lung cancer
646509|NCT00457392|sunitinib|sunitinib
646510|NCT00457392|erlotinib|erlotinib
646511|NCT00457392|Phase 3|phase 3
646512|NCT00457379|Coronary artery disease|coronary artery disease
646513|NCT00457379|HDL-Cholesterol|hdl-cholesterol
646514|NCT00457379|Endothelial Function|endothelial function
646515|NCT00457379|Endothelial Progenitor Cells|endothelial progenitor cells
646516|NCT00457379|normal blood HDL-Cholesterol level|normal blood hdl-cholesterol level
646517|NCT00457340|Tachycardia, Ventricular|tachycardia, ventricular
646518|NCT00457340|Ventricular Fibrillation|ventricular fibrillation
646519|NCT00457327|protective ileostomy|protective ileostomy
646520|NCT00457327|rectal cancer|rectal cancer
646521|NCT00457327|low anterior resection|low anterior resection
646522|NCT00457314|single-large scale deletions|single-large scale deletions
646523|NCT00457314|point mutations in mtDNA|point mutations in mtdna
646524|NCT00457301|Lung transplantation, health-related quality of life.|lung transplantation, health-related quality of life.
646525|NCT00457288|Cutaneous Mastocytosis|cutaneous mastocytosis
646526|NCT00457288|Topical treatment|topical treatment
646527|NCT00457262|paraoxonase1 activity|paraoxonase1 activity
646528|NCT00457262|LDL|ldl
646529|NCT00457262|HDL|hdl
646530|NCT00457262|postmenopausal women|postmenopausal women
646531|NCT00457262|postmenopausal women and hyperlipidemia|postmenopausal women and hyperlipidemia
646532|NCT00457249|Pertussis|pertussis
646533|NCT00457249|Tetanus|tetanus
646534|NCT00457249|Diphtheria|diphtheria
646535|NCT00457249|Tdap|tdap
646536|NCT00457236|Clopidogrel|clopidogrel
646537|NCT00457236|Coronary Artery Disease|coronary artery disease
646538|NCT00457236|Dose-Response Relationship, Drug|dose-response relationship, drug
646539|NCT00457236|Drug Resistance|drug resistance
646540|NCT00457236|PCI|pci
646541|NCT00457223|pterygium|pterygium
646542|NCT00457223|pterygia|pterygia
646543|NCT00457223|excision|excision
646544|NCT00457223|amniotic membrane transplantation|amniotic membrane transplantation
646545|NCT00457223|fibrin glue|fibrin glue
646546|NCT00457223|suture|suture
646547|NCT00457210|Psychology|psychology
646548|NCT00457197|bipolar disorder|bipolar disorder
646549|NCT00457197|alcohol dependence|alcohol dependence
646550|NCT00457197|mania|mania
646551|NCT00457197|manic disorder|manic disorder
646552|NCT00457197|depression|depression
646553|NCT00457184|Migraine|migraine
646554|NCT00457184|Thrombosis|thrombosis
646555|NCT00457184|Thrombophilia|thrombophilia
646556|NCT00457171|GI-270384 colitis patients ECAM oral|gi-270384 colitis patients ecam oral
646557|NCT00457158|pulmonary embolism|pulmonary embolism
646558|NCT00457158|inferior vena cava filters|inferior vena cava filters
646559|NCT00457158|venous thrombosis|venous thrombosis
646560|NCT00457158|randomized controlled trial|randomized controlled trial
646561|NCT00457145|Hyperfluorescence on Fluorescein|hyperfluorescence on fluorescein
646562|NCT00457145|Idiopathic Juxtafoveal Telangiectasia|idiopathic juxtafoveal telangiectasia
646563|NCT00457145|Retinal Edema/Thinning|retinal edema/thinning
646564|NCT00457145|Vascular Endothelial Growth Factor|vascular endothelial growth factor
646565|NCT00457145|Macular Telangiectasia|macular telangiectasia
646566|NCT00457132|Knee|knee
646567|NCT00457132|Osteoarthritis|osteoarthritis
646568|NCT00457132|WOMAC|womac
646569|NCT00457132|ALF|alf
646570|NCT00457132|Wedging|wedging
646571|NCT00457119|Non Small Cell Lung Cancer|non small cell lung cancer
646572|NCT00457119|NSCLC|nsclc
646573|NCT00457119|Advanced Lung Cancer|advanced lung cancer
646574|NCT00457119|RAD|rad
646575|NCT00457119|RAD001|rad001
646576|NCT00457119|chemotherapy|chemotherapy
646577|NCT00457119|carboplatin|carboplatin
646578|NCT00457119|paclitaxel|paclitaxel
646580|NCT00457106|panic|panic
646581|NCT00457093|Type 2 Diabetes|type 2 diabetes
646582|NCT00457093|continuous glucose monitoring|continuous glucose monitoring
646583|NCT00457093|basal insulin|basal insulin
646584|NCT00457080|capnography|capnography
646585|NCT00457080|safety|safety
646586|NCT00457080|opioids|opioids
646587|NCT00457080|respiratory depression|respiratory depression
646588|NCT00457080|postoperative|postoperative
646589|NCT00457080|orthopedic|orthopedic
646590|NCT00457080|OSA|osa
646591|NCT00457080|apnea|apnea
646592|NCT00457067|Hyperfluorescence on Fluorescein|hyperfluorescence on fluorescein
646593|NCT00457067|Idiopathic Juxtafoveal Telangiectasia|idiopathic juxtafoveal telangiectasia
646594|NCT00457067|Retinal Edema/Thinning|retinal edema/thinning
646595|NCT00457067|Vascular Endothelial Growth Factor|vascular endothelial growth factor
646596|NCT00457067|Macular Telangiectasia|macular telangiectasia
646597|NCT00457054|Mood Regulating Circuit|mood regulating circuit
646598|NCT00457054|Lithium|lithium
646599|NCT00457054|fMRI|fmri
646600|NCT00457041|Trust|trust
646601|NCT00457041|Decision Making|decision making
646602|NCT00457041|Vulnerability|vulnerability
646603|NCT00457041|Survey|survey
646604|NCT00457028|Obsessive Compulsive Disorder|obsessive compulsive disorder
646605|NCT00457028|Anxiety|anxiety
646606|NCT00457028|Treatment efficacy|treatment efficacy
646607|NCT00457002|Prevention of deep vein thrombosis and pulmonary embolism with acutely ill hospitalized patients|prevention of deep vein thrombosis and pulmonary embolism with acutely ill hospitalized patients
646608|NCT00456989|Androgen Independent|androgen independent
646609|NCT00456989|Prostate Cancer|prostate cancer
646610|NCT00456989|Taxotere|taxotere
646611|NCT00456989|Doxil|doxil
646612|NCT00456989|AIPC|aipc
646613|NCT00456989|Advanced Androgen-Independent Prostate Cancer|advanced androgen-independent prostate cancer
646614|NCT00456976|Seligiline|seligiline
646615|NCT00456976|Negative symptoms|negative symptoms
646616|NCT00456976|Schizopherenia|schizopherenia
646617|NCT00456963|angiotensin converting enzyme inhibitors|angiotensin converting enzyme inhibitors
646618|NCT00456963|angiotensin receptor blockers|angiotensin receptor blockers
646619|NCT00456963|diabetes|diabetes
646620|NCT00456963|hypertension|hypertension
646621|NCT00456963|therapeutic strategies|therapeutic strategies
646622|NCT00456950|coronary atherosclerosis|coronary atherosclerosis
646623|NCT00456950|magnetic resonance imaging|magnetic resonance imaging
646624|NCT00456950|vulnerable plaque|vulnerable plaque
646625|NCT00456924|progesterone receptor modulator|progesterone receptor modulator
646626|NCT00456911|obesity|obesity
646627|NCT00456911|prevention|prevention
646628|NCT00456911|children|children
646629|NCT00456911|adults|adults
646630|NCT00456911|family|family
646631|NCT00456911|dietary|dietary
646632|NCT00456911|coaching|coaching
646633|NCT00456911|body mass index|body mass index
646634|NCT00456911|fat mass|fat mass
646635|NCT00456885|obesity|obesity
646636|NCT00456885|double blind|double blind
646637|NCT00456885|placebo controlled|placebo controlled
646638|NCT00456885|weight loss|weight loss
646639|NCT00456885|appetite|appetite
646640|NCT00456885|energy expenditure|energy expenditure
646641|NCT00456872|Pain during injection of the pre-procedure anesthetic|pain during injection of the pre-procedure anesthetic
646642|NCT00456859|chronic kidney disease|chronic kidney disease
646643|NCT00456859|oral carbonaceous adsorbent|oral carbonaceous adsorbent
646644|NCT00456859|randomized clinical trial|randomized clinical trial
646645|NCT00456859|composite endpoint|composite endpoint
646646|NCT00456846|Metastatic Breast Cancer, ABI-007, Abraxane|metastatic breast cancer, abi-007, abraxane
646647|NCT00456833|Non Small Cell Lung Cancer|non small cell lung cancer
646648|NCT00456833|NSCLC|nsclc
646649|NCT00456833|Advanced lung cancer|advanced lung cancer
646650|NCT00456833|RAD|rad
646651|NCT00456833|RAD001|rad001
646652|NCT00456833|erlotinib|erlotinib
646653|NCT00456820|Mood Regulating Circuit|mood regulating circuit
646654|NCT00456820|SSRI|ssri
646655|NCT00456820|fMRI|fmri
646656|NCT00456807|Human Papillomavirus|human papillomavirus
646657|NCT00456794|Parkinson's disease|parkinson's disease
646658|NCT00456794|Levodopa|levodopa
646659|NCT00456794|End of dose wearing off|end of dose wearing off
646660|NCT00456794|OFF time|off time
646661|NCT00456781|rotator cuff|rotator cuff
646662|NCT00456781|randomized clinical trial|randomized clinical trial
646663|NCT00456768|Panic Disorder|panic disorder
646664|NCT00456768|Anxiety|anxiety
646665|NCT00456768|Treatment efficacy|treatment efficacy
646666|NCT00456755|Perennial Allergic rhinitis|perennial allergic rhinitis
646667|NCT00456755|Traditional Chinese Medicine|traditional chinese medicine
646668|NCT00456742|Generalized Anxiety Disorder|generalized anxiety disorder
646669|NCT00456742|Anxiety|anxiety
646670|NCT00456742|Treatment efficacy|treatment efficacy
646671|NCT00456729|Iron deficiency|iron deficiency
646672|NCT00456729|Malabsorption|malabsorption
646673|NCT00456729|Giardiasis|giardiasis
646674|NCT00456716|BAC lung cancer|bac lung cancer
646675|NCT00456716|adenocarcinoma of the lung|adenocarcinoma of the lung
646676|NCT00456703|fluids,|fluids,
646677|NCT00456703|restriction,|restriction,
646678|NCT00456703|infection,|infection,
646679|NCT00456703|bowel surgery,|bowel surgery,
646680|NCT00456703|open abdominal|open abdominal
646681|NCT00456690|Thalassemia|thalassemia
646682|NCT00456690|Nutrition|nutrition
646683|NCT00456690|Endocrine|endocrine
646684|NCT00456690|BMI|bmi
646685|NCT00456677|minocycline|minocycline
646686|NCT00456677|asthma|asthma
646687|NCT00456677|oral corticosteroids|oral corticosteroids
646688|NCT00456664|CMV|cmv
646689|NCT00456664|IRIS|iris
646690|NCT00456651|Sleep Apnea|sleep apnea
646691|NCT00456651|Obesity|obesity
646692|NCT00456651|Neuropeptides|neuropeptides
646693|NCT00456651|Hormones|hormones
646694|NCT00456638|OP-CABG|op-cabg
646695|NCT00456638|Depodur traditional drug|depodur traditional drug
646696|NCT00456625|Hepatitis B vaccine|hepatitis b vaccine
646697|NCT00456625|Challenge dose|challenge dose
646698|NCT00456586|Parkinson's disease|parkinson's disease
646699|NCT00456586|Levodopa therapy|levodopa therapy
646700|NCT00456586|End of dose wearing off|end of dose wearing off
646701|NCT00456586|Off time|off time
646702|NCT00456573|Pediatric Obstructive sleep apnea syndrome|pediatric obstructive sleep apnea syndrome
646703|NCT00456547|Cesarean hysterectomy|cesarean hysterectomy
646704|NCT00456547|Postpartum hemorrhage|postpartum hemorrhage
646705|NCT00456547|Coagulation|coagulation
646706|NCT00456534|Smoking|smoking
646707|NCT00456521|Obesity|obesity
646708|NCT00456521|Behavior Modification|behavior modification
646709|NCT00456469|TB|tb
646710|NCT00456469|latent|latent
646711|NCT00456469|infection|infection
646712|NCT00456469|Ethiopia|ethiopia
646713|NCT00456443|Thalassemia|thalassemia
646714|NCT00456443|Sickle cell anemia|sickle cell anemia
646715|NCT00456443|Splenectomy|splenectomy
646716|NCT00456443|Infections|infections
646717|NCT00456443|Streptococcal Pneumonia|streptococcal pneumonia
646718|NCT00456417|Neurological|neurological
646719|NCT00456417|Alzheimers|alzheimers
646720|NCT00456404|peppermint water|peppermint water
646721|NCT00456404|nipple crack|nipple crack
646722|NCT00456404|lactating women|lactating women
646723|NCT00456391|Brain CT scan|brain ct scan
646724|NCT00456391|Pediatric emergency room|pediatric emergency room
646725|NCT00456365|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
646726|NCT00456365|Cystic kidney disease|cystic kidney disease
646727|NCT00456365|High blood pressure|high blood pressure
646728|NCT00456365|Statin|statin
646729|NCT00456339|Obstructive sleep apnea syndrome (OSAS) in children|obstructive sleep apnea syndrome (osas) in children
646730|NCT00456326|Heparin|heparin
646731|NCT00456326|Unfractionated Heparin|unfractionated heparin
646732|NCT00456326|Low Molecular Weight Heparin|low molecular weight heparin
646733|NCT00456326|Anticoagulation|anticoagulation
646734|NCT00456326|Thrombocytopenia|thrombocytopenia
646735|NCT00456326|Thrombosis|thrombosis
646736|NCT00456326|Venous Thrombosis|venous thrombosis
646737|NCT00456326|Pulmonary Embolism|pulmonary embolism
646738|NCT00456313|asthma|asthma
646739|NCT00456313|fluticasone propionate|fluticasone propionate
646740|NCT00456313|salmeterol/fluticasone propionate|salmeterol/fluticasone propionate
646741|NCT00456313|combination product|combination product
646742|NCT00456313|innate immune response|innate immune response
646743|NCT00456313|neutrophil priming|neutrophil priming
646744|NCT00456300|Type 1 Diabetes|type 1 diabetes
646745|NCT00456300|Hyperglycemia|hyperglycemia
646746|NCT00456300|Hypoglycemia|hypoglycemia
646747|NCT00456287|Sleep Apnea|sleep apnea
646748|NCT00456287|Clotting- fibrinolysis patterns|clotting- fibrinolysis patterns
646749|NCT00456287|Platelet function markers|platelet function markers
646750|NCT00456287|Endothelial dysfunction|endothelial dysfunction
646751|NCT00456274|Hypothalamic Amenorrhea|hypothalamic amenorrhea
646752|NCT00456274|Idiopathic hypogonadotropic hypogonadism|idiopathic hypogonadotropic hypogonadism
646753|NCT00456274|Acquired hypogonadotropic hypogonadism|acquired hypogonadotropic hypogonadism
646754|NCT00456274|Kallmann's Syndrome|kallmann's syndrome
646755|NCT00456274|Amenorrhea|amenorrhea
646756|NCT00456274|Gonadotropin Releasing Hormone|gonadotropin releasing hormone
646757|NCT00456261|Non Small Cell Lung Cancer|non small cell lung cancer
646758|NCT00456248|Chronic Hepatitis C|chronic hepatitis c
646759|NCT00456248|Liver|liver
646760|NCT00456248|Pegylated|pegylated
646761|NCT00456248|Interferon|interferon
646762|NCT00456248|Ribavirin|ribavirin
646763|NCT00456248|Combination|combination
646764|NCT00456248|Nonresponder|nonresponder
646765|NCT00456248|Relapser|relapser
646766|NCT00456248|HCV|hcv
646767|NCT00456248|Infergen|infergen
646768|NCT00456248|SVR|svr
646769|NCT00456222|Sleep|sleep
646770|NCT00456222|Circadian rhythms|circadian rhythms
646771|NCT00456222|Menstrual cycle|menstrual cycle
646772|NCT00456209|Lived Experiences|lived experiences
646773|NCT00456209|Adolescents|adolescents
646774|NCT00456209|Cancer Treatment|cancer treatment
646775|NCT00456209|Occupations|occupations
646776|NCT00456196|COPD|copd
646777|NCT00456196|Thrombosis|thrombosis
646778|NCT00456196|Cancer|cancer
646779|NCT00456196|Renal|renal
646780|NCT00456196|Elderly|elderly
646781|NCT00456196|Surgery|surgery
646782|NCT00456196|Orthopedic Surgery|orthopedic surgery
646783|NCT00456196|Medically Ill|medically ill
646784|NCT00456196|Deep Vein Thrombosis|deep vein thrombosis
646785|NCT00456196|Pulmonary Embolism|pulmonary embolism
646786|NCT00456196|Anticoagulation|anticoagulation
646787|NCT00456183|Tuberculosis|tuberculosis
646788|NCT00456183|Latent|latent
646790|NCT00456183|Vaccine|vaccine
646791|NCT00456183|MVA 85A|mva 85a
646792|NCT00456170|Vaginal|vaginal
646793|NCT00456170|Hysterectomy|hysterectomy
646794|NCT00456170|Harmonic|harmonic
646795|NCT00456170|Ligasure|ligasure
646796|NCT00456170|Sutures|sutures
646797|NCT00456170|Modern|modern
646798|NCT00456170|Patients undergoing vaginal hysterectomy for various reasons|patients undergoing vaginal hysterectomy for various reasons
646799|NCT00456157|Osteoarthritis|osteoarthritis
646800|NCT00456157|Osteophytes|osteophytes
646801|NCT00456157|Knee|knee
646802|NCT00456157|Intra-articular|intra-articular
646803|NCT00456157|OP-1|op-1
646804|NCT00456144|GnRH|gnrh
646805|NCT00456144|Insulin sensitivity|insulin sensitivity
646806|NCT00456118|recurrent pregnancy losses|recurrent pregnancy losses
646807|NCT00456118|preeclampsia|preeclampsia
646808|NCT00456118|intervillositis|intervillositis
646809|NCT00456118|maternofetal alloimmunization|maternofetal alloimmunization
646810|NCT00456105|Type 2 diabetes|type 2 diabetes
646811|NCT00456105|Post-op dysglycemia|post-op dysglycemia
646812|NCT00456105|Peripheral vascular disease|peripheral vascular disease
646813|NCT00456105|Infrainguinal bypass surgery|infrainguinal bypass surgery
646814|NCT00456092|psoriatic arthritis|psoriatic arthritis
646815|NCT00456092|ACR|acr
646816|NCT00456092|PASI|pasi
646817|NCT00456092|DAS|das
646818|NCT00456092|pharmacokinetic|pharmacokinetic
646819|NCT00456092|biopsy|biopsy
646820|NCT00456066|Acute myocardial infarction|acute myocardial infarction
646821|NCT00456066|Thromboaspiration|thromboaspiration
646822|NCT00456066|Infarct size|infarct size
646823|NCT00456066|Left ventricular remodelling|left ventricular remodelling
646824|NCT00456053|Renal Anemia|renal anemia
646825|NCT00456053|Renal Failure|renal failure
646826|NCT00456053|Kidney Disease|kidney disease
646827|NCT00456053|Human EPO|human epo
646828|NCT00456040|amyloidosis|amyloidosis
646829|NCT00456040|heart failure|heart failure
646830|NCT00456040|heart transplant|heart transplant
646831|NCT00456040|stem cell transplant|stem cell transplant
646832|NCT00456027|Type 2 Diabetes|type 2 diabetes
646833|NCT00456027|LADA|lada
646834|NCT00456027|Latent Autoimmune Diabetes in Adult|latent autoimmune diabetes in adult
646835|NCT00456027|Autoimmunity|autoimmunity
646836|NCT00456027|HbA1c|hba1c
646837|NCT00456027|C-peptide|c-peptide
646838|NCT00456014|Major Depression|major depression
646839|NCT00456014|Antidepressants|antidepressants
646840|NCT00456001|heparin|heparin
646841|NCT00456001|low molecular weight heparin|low molecular weight heparin
646842|NCT00456001|enoxaparin|enoxaparin
646843|NCT00456001|anticoagulation|anticoagulation
646844|NCT00456001|thrombosis|thrombosis
646845|NCT00456001|venous thrombosis|venous thrombosis
646846|NCT00456001|thromboembolism|thromboembolism
646847|NCT00456001|pulmonary embolism|pulmonary embolism
646848|NCT00456001|medication|medication
646849|NCT00455988|questionnaire developement|questionnaire developement
646850|NCT00455988|regularity|regularity
646851|NCT00455988|lifestyle|lifestyle
646852|NCT00455988|type 2 diabetes|type 2 diabetes
646853|NCT00455975|Kidney Cancer|kidney cancer
646854|NCT00455975|Renal Cancer|renal cancer
646855|NCT00455975|Clear Cell Carcinoma|clear cell carcinoma
646856|NCT00455962|estrogen|estrogen
646857|NCT00455962|progesterone|progesterone
646858|NCT00455962|African-American|african-american
646859|NCT00455962|Caucasian|caucasian
646860|NCT00455962|infusion|infusion
646861|NCT00455962|gonadotropins|gonadotropins
646862|NCT00455962|healthy|healthy
646863|NCT00455936|Adenocarcinoma|adenocarcinoma
646864|NCT00455936|NSCLC|nsclc
646865|NCT00455936|gemcitabine|gemcitabine
646866|NCT00455936|Cisplatin|cisplatin
646867|NCT00455936|Gefitinib|gefitinib
646868|NCT00455936|Never smoker|never smoker
646869|NCT00455923|asthma|asthma
646870|NCT00455923|exacerbation|exacerbation
646871|NCT00455923|persistent|persistent
646872|NCT00455923|bronchial hyperresponsiveness|bronchial hyperresponsiveness
646873|NCT00455923|mild|mild
646874|NCT00455923|GINAII|ginaii
646875|NCT00455910|Low risk myelodysplastic syndromes|low risk myelodysplastic syndromes
646876|NCT00455910|MDS|mds
646877|NCT00455910|Bone marrow diseases|bone marrow diseases
646878|NCT00455910|Thalidomide|thalidomide
646879|NCT00455910|Cytopenias|cytopenias
646880|NCT00455910|Anemia|anemia
646881|NCT00455897|granulocyte monocyte colony stimulating factor|granulocyte monocyte colony stimulating factor
646882|NCT00455897|Leukine|leukine
646883|NCT00455897|Sargramostim|sargramostim
646884|NCT00455897|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
646885|NCT00455897|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
646886|NCT00455871|macular degeneration|macular degeneration
646887|NCT00455845|Endometriosis|endometriosis
646888|NCT00455845|Lng IUD|lng iud
647273|NCT00454272|neutropenia|neutropenia
646889|NCT00455832|sperm chromatin structure integrity|sperm chromatin structure integrity
646890|NCT00455832|sperm concentration|sperm concentration
646891|NCT00455832|sperm motility|sperm motility
646892|NCT00455832|sperm morphology|sperm morphology
646893|NCT00455832|peginterferon|peginterferon
646894|NCT00455832|ribavirin|ribavirin
646895|NCT00455832|hepatitis C|hepatitis c
646896|NCT00455819|pulmonary embolism|pulmonary embolism
646897|NCT00455819|pro-BNP|pro-bnp
646898|NCT00455819|home treatment|home treatment
646899|NCT00455806|Helicobacter pylori|helicobacter pylori
646900|NCT00455806|rescue therapy|rescue therapy
646901|NCT00455806|eradication therapy|eradication therapy
646902|NCT00455806|esomeprazole|esomeprazole
646903|NCT00455806|moxifloxacin|moxifloxacin
646904|NCT00455806|resistance|resistance
646905|NCT00455793|HIV|hiv
646906|NCT00455793|atherosclerosis|atherosclerosis
646907|NCT00455780|Eating|eating
646908|NCT00455780|Dieting|dieting
646909|NCT00455780|Meal replacements|meal replacements
646910|NCT00455780|Energy Density|energy density
646911|NCT00455780|Weight Loss Maintenance|weight loss maintenance
646912|NCT00455767|persistent ARDS|persistent ards
646913|NCT00455767|alveolar inflammation|alveolar inflammation
646914|NCT00455767|early pulmonary fibrosis|early pulmonary fibrosis
646915|NCT00455767|mechanichal ventilation|mechanichal ventilation
646916|NCT00455767|P/V curve|p/v curve
646917|NCT00455767|Static compliance|static compliance
646918|NCT00455767|elastase activity|elastase activity
646919|NCT00455767|inhibitor of Human Neutrophil Elastase|inhibitor of human neutrophil elastase
646920|NCT00455741|menopause|menopause
646921|NCT00455741|estrogen|estrogen
646922|NCT00455741|progesterone|progesterone
646923|NCT00455741|hormone replacement|hormone replacement
646924|NCT00455741|aging|aging
646926|NCT00455715|Schizophrenia|schizophrenia
646927|NCT00455715|Cognition|cognition
646928|NCT00455715|Sildenafil|sildenafil
646929|NCT00455715|PDE5 Inhibitor|pde5 inhibitor
646930|NCT00455702|schizophrenia|schizophrenia
646931|NCT00455702|cognition|cognition
646932|NCT00455702|d-cycloserine|d-cycloserine
646933|NCT00455702|memory|memory
646934|NCT00455689|Lupron|lupron
646935|NCT00455689|Premenopausal|premenopausal
646936|NCT00455689|Hot flashes|hot flashes
646937|NCT00455689|PET|pet
646938|NCT00455689|MRI|mri
646939|NCT00455676|Scarf Osteotomy|scarf osteotomy
646940|NCT00455676|Chevron Osteotomy|chevron osteotomy
646941|NCT00455676|Comparison|comparison
646942|NCT00455663|Schizoaffective Disorder|schizoaffective disorder
646943|NCT00455663|Medication Adherence|medication adherence
646944|NCT00455650|schizophrenia|schizophrenia
646945|NCT00455650|cognition|cognition
646946|NCT00455650|nicotinic receptors|nicotinic receptors
646947|NCT00455650|mecamylamine|mecamylamine
646948|NCT00455650|varenicline|varenicline
646949|NCT00455624|androgen deprivation therapy|androgen deprivation therapy
646950|NCT00455624|insulin resistance|insulin resistance
646951|NCT00455611|Heart Failure, Congestive|heart failure, congestive
646952|NCT00455611|Continuous Positive Airway Pressure|continuous positive airway pressure
646953|NCT00455611|Baroreflex|baroreflex
646954|NCT00455611|Echocardiography|echocardiography
646955|NCT00455598|Diabetes|diabetes
646956|NCT00455585|Pharmacokinetics|pharmacokinetics
646957|NCT00455585|Antiretrovirals|antiretrovirals
646958|NCT00455585|Uganda|uganda
646959|NCT00455585|HIV|hiv
646960|NCT00455585|Treatment Experienced|treatment experienced
646961|NCT00455572|Immunotherapeutic|immunotherapeutic
646962|NCT00455572|Adjuvant cancer therapy|adjuvant cancer therapy
646963|NCT00455572|Non-small-cell lung cancer|non-small-cell lung cancer
646964|NCT00455572|ASCI|asci
646965|NCT00455559|Resistant Gastrointestinal Stromal Tumor|resistant gastrointestinal stromal tumor
646966|NCT00455559|GIST|gist
646967|NCT00455559|Perifosine|perifosine
646968|NCT00455559|Gleevec|gleevec
646969|NCT00455546|Coronary|coronary
646970|NCT00455546|Artery|artery
646971|NCT00455546|Atherosclerosis|atherosclerosis
646972|NCT00455546|Phospholipase|phospholipase
646973|NCT00455546|CAD|cad
646974|NCT00455533|Early Breast Cancer|early breast cancer
646975|NCT00455520|Diabetic neuropathy|diabetic neuropathy
646976|NCT00455520|Painful Diabetic Polyneuropathy|painful diabetic polyneuropathy
646977|NCT00455520|Polyneuropathy|polyneuropathy
646978|NCT00455520|Peripheral neuropathy|peripheral neuropathy
646979|NCT00455507|Parkinson's disease|parkinson's disease
646980|NCT00455507|levodopa|levodopa
646981|NCT00455507|end of dose wearing off|end of dose wearing off
646982|NCT00455507|OFF time|off time
646983|NCT00455494|Drug-resistant malaria|drug-resistant malaria
646984|NCT00455494|Bioavailability|bioavailability
646985|NCT00455494|Food-effect study|food-effect study
646986|NCT00455468|Severe pneumonia|severe pneumonia
646987|NCT00455468|children|children
646988|NCT00455468|day care management|day care management
646989|NCT00455468|hospitalized management|hospitalized management
646990|NCT00455468|Randomized controlled trial|randomized controlled trial
646991|NCT00455468|Under five children|under five children
646992|NCT00455429|Atopic Dermatitis|atopic dermatitis
646993|NCT00455429|JNJ-26113100|jnj-26113100
646994|NCT00455416|Low grade lymphoma|low grade lymphoma
646995|NCT00455416|Diet|diet
646996|NCT00455416|Antioxidants|antioxidants
646997|NCT00455416|Non Hodgkin Lymphoma - Follicular Lymphoma grade 1&2 stage III/IV|non hodgkin lymphoma - follicular lymphoma grade 1&2 stage iii/iv
646998|NCT00455403|Metabolic Syndrome|metabolic syndrome
646999|NCT00455403|Atherosclerosis|atherosclerosis
647000|NCT00455390|Post immediate Psychotherapeutic Intervention|post immediate psychotherapeutic intervention
647001|NCT00455390|Psychotraumatic disorders|psychotraumatic disorders
647002|NCT00455390|PTSD post traumatic syndrome disorder|ptsd post traumatic syndrome disorder
647003|NCT00455390|CUMP Cellules d’Urgence Médico Psychologique|cump cellules d’urgence médico psychologique
647004|NCT00455377|Cement dust exposure|cement dust exposure
647005|NCT00455377|Induced sputum|induced sputum
647006|NCT00455377|Airway inflammation|airway inflammation
647007|NCT00455377|Peripheral blood inflammation markers|peripheral blood inflammation markers
647008|NCT00455364|Fungal infection prophylaxis|fungal infection prophylaxis
647009|NCT00455364|Lung transplant|lung transplant
647010|NCT00455364|Fungal infection post lung transplant|fungal infection post lung transplant
647011|NCT00455351|Palliative treatment|palliative treatment
647012|NCT00455351|Max. tolerable dose|max. tolerable dose
647013|NCT00455338|meal|meal
647014|NCT00455338|composition|composition
647015|NCT00455338|postprandial|postprandial
647016|NCT00455338|PCOS|pcos
647017|NCT00455338|androgen|androgen
647018|NCT00455325|Insulin Resistance|insulin resistance
647019|NCT00455325|Atherosclerosis|atherosclerosis
647020|NCT00455325|Metabolic Syndrome|metabolic syndrome
647021|NCT00455312|Dyskeratosis Congenita|dyskeratosis congenita
647022|NCT00455312|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
647023|NCT00455312|Severe Aplastic Anemia|severe aplastic anemia
647024|NCT00455299|Laparoscopy, ventral, hernia, repair, surgery|laparoscopy, ventral, hernia, repair, surgery
647025|NCT00455286|CNS Lymphoma|cns lymphoma
647026|NCT00455273|Breast Cancer|breast cancer
647027|NCT00455273|DCE MRI|dce mri
647028|NCT00455234|Aggression|aggression
647029|NCT00455234|Violent behaviour in people with psychotic illness|violent behaviour in people with psychotic illness
647030|NCT00455221|CML|cml
647031|NCT00455221|Imatinib|imatinib
647032|NCT00455221|vaccine|vaccine
647033|NCT00455221|peptide|peptide
647034|NCT00455221|gene|gene
647035|NCT00455221|MRD|mrd
647036|NCT00455221|DNA|dna
647037|NCT00455182|Acupuncture|acupuncture
647038|NCT00455182|Hip Arthroplasty|hip arthroplasty
647039|NCT00455182|Knee Arthroplasty|knee arthroplasty
647040|NCT00455182|Pain Management|pain management
647041|NCT00455169|Influenza|influenza
647042|NCT00455169|Infant, Premature|infant, premature
647043|NCT00455169|Immunization|immunization
647044|NCT00455169|Vaccination|vaccination
647045|NCT00455156|Contraception|contraception
647046|NCT00455156|Vaginal Ring|vaginal ring
647047|NCT00455143|Postoperative delirium|postoperative delirium
647048|NCT00455143|PD|pd
647049|NCT00455143|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
647050|NCT00455143|POCD|pocd
647051|NCT00455130|mannitol|mannitol
647052|NCT00455130|cystic fibrosis|cystic fibrosis
647053|NCT00455130|mucolytic|mucolytic
647054|NCT00455130|mucoactive|mucoactive
647055|NCT00455117|analgesia|analgesia
647056|NCT00455117|pain|pain
647057|NCT00455117|neurosurgery|neurosurgery
647058|NCT00455117|NSAIDS|nsaids
647059|NCT00455117|parecoxib|parecoxib
647060|NCT00455117|morphine consumption|morphine consumption
647061|NCT00455104|Fabry Disease|fabry disease
647062|NCT00455104|National Registry|national registry
647063|NCT00455091|Post-operative Hepatocellular Carcinoma.|post-operative hepatocellular carcinoma.
647064|NCT00455078|Gastric reflux|gastric reflux
647065|NCT00455078|Lung transplant|lung transplant
647066|NCT00455078|chronic rejection|chronic rejection
647067|NCT00455078|Gastric reflux in lung transplant as it relates to chronic rejection|gastric reflux in lung transplant as it relates to chronic rejection
647068|NCT00455065|whole grain|whole grain
647069|NCT00455065|metabolic syndrome|metabolic syndrome
647070|NCT00455065|weight loss|weight loss
647071|NCT00455052|XMT-1001|xmt-1001
647072|NCT00455052|cancer|cancer
647073|NCT00455052|tumor|tumor
647074|NCT00455052|camptothecin|camptothecin
647075|NCT00455052|Fleximer|fleximer
647076|NCT00455052|polymer|polymer
647077|NCT00455052|Phase 1|phase 1
647078|NCT00455052|safety|safety
647079|NCT00455052|pharmacokinetics|pharmacokinetics
647080|NCT00455052|maximum tolerated dose|maximum tolerated dose
647081|NCT00455052|NSCLC|nsclc
647082|NCT00455052|non-small cell lung cancer|non-small cell lung cancer
647083|NCT00455052|SCLC|sclc
647084|NCT00455052|small cell lung cancer|small cell lung cancer
647085|NCT00455039|neoadjuvant, HER2, Breast,GSK,lapatinib|neoadjuvant, her2, breast,gsk,lapatinib
647086|NCT00455013|Kidney transplant|kidney transplant
647087|NCT00454987|antibody persistence|antibody persistence
647088|NCT00454987|Meningococcal serogroup C vaccine|meningococcal serogroup c vaccine
647089|NCT00454987|conjugate vaccine|conjugate vaccine
647090|NCT00454987|Haemophilus influenzae type b vaccine|haemophilus influenzae type b vaccine
647091|NCT00454974|end stage renal failure|end stage renal failure
647092|NCT00454974|dialysis|dialysis
647093|NCT00454974|wearable artificial kidney|wearable artificial kidney
647094|NCT00454961|Malaria|malaria
647095|NCT00454961|Plasmodium falciparum|plasmodium falciparum
647096|NCT00454961|artemether-lumefantrine|artemether-lumefantrine
647097|NCT00454961|effectiveness|effectiveness
647098|NCT00454948|Obesity prevention|obesity prevention
647099|NCT00454948|Dietary intake|dietary intake
647100|NCT00454948|Physical activity|physical activity
647101|NCT00454948|Mexican American|mexican american
647102|NCT00454948|Family Characteristics|family characteristics
647103|NCT00454935|epilepsy|epilepsy
647104|NCT00454935|glioma|glioma
647105|NCT00454922|glaucoma|glaucoma
647106|NCT00454922|patient educator|patient educator
647107|NCT00454909|Meningococcal Serogroups A, C, W-135 and/or Y Disease|meningococcal serogroups a, c, w-135 and/or y disease
647108|NCT00454896|Urinary Bladder, Overactive|urinary bladder, overactive
647109|NCT00454896|Urgency|urgency
647110|NCT00454896|VESIcare®|vesicare®
647111|NCT00454896|Solifenacin succinate|solifenacin succinate
647112|NCT00454883|Safety of ziprasidone, efficacy of ziprasidone, manic episodes in bipolar disorder, mixed episodes in bipolar disorder, schizoaffective disorder.|safety of ziprasidone, efficacy of ziprasidone, manic episodes in bipolar disorder, mixed episodes in bipolar disorder, schizoaffective disorder.
647113|NCT00454870|Alzheimer's Disease|alzheimer's disease
647114|NCT00454870|Cognition|cognition
647115|NCT00454870|Cognitive impairment|cognitive impairment
647116|NCT00454857|Thrombocytopenia|thrombocytopenia
647117|NCT00454857|Chart Review|chart review
647118|NCT00454857|Platelet|platelet
647119|NCT00454857|Retrospective|retrospective
647120|NCT00454857|Prospective|prospective
647121|NCT00454857|Non-interventional|non-interventional
647122|NCT00454857|Health Resource Utilization (HRU)|health resource utilization (hru)
647123|NCT00454857|Quality of Life (QOL)|quality of life (qol)
647124|NCT00454857|Immune Thrombocytopenic Purpura (ITP)|immune thrombocytopenic purpura (itp)
647125|NCT00454857|Idiopathic Thrombocytopenic Purpura (ITP)|idiopathic thrombocytopenic purpura (itp)
647126|NCT00454857|Immune (Idiopathic) Thrombocytopenic Purpura (ITP)|immune (idiopathic) thrombocytopenic purpura (itp)
647127|NCT00454857|Observational|observational
647128|NCT00454831|Hypercholesterolemia|hypercholesterolemia
647129|NCT00454831|LDL-cholesterol|ldl-cholesterol
647130|NCT00454831|chitosan|chitosan
647131|NCT00454831|HEP-40|hep-40
647132|NCT00454805|Advanced Breast Cancer|advanced breast cancer
647133|NCT00454792|Low back pain|low back pain
647134|NCT00454792|Modic changes|modic changes
647135|NCT00454779|SCCHNC|scchnc
647136|NCT00454779|Metastatic|metastatic
647137|NCT00454779|Recurrent|recurrent
647138|NCT00454766|Patient Education|patient education
647139|NCT00454766|Cervical Dysplasia|cervical dysplasia
647140|NCT00454766|Questionnaire|questionnaire
647141|NCT00454753|Myeloid, Chronic|myeloid, chronic
647142|NCT00454753|Lymphocytic, Acute|lymphocytic, acute
647143|NCT00454740|Urinary Bladder, Overactive|urinary bladder, overactive
647144|NCT00454740|Urgency|urgency
647145|NCT00454740|VESIcare®|vesicare®
647146|NCT00454740|Solifenacin succinate|solifenacin succinate
647147|NCT00454701|Psoriasis|psoriasis
647148|NCT00454701|Alefacept|alefacept
647149|NCT00454701|Amevive®|amevive®
647150|NCT00454701|Drug exposure|drug exposure
647151|NCT00454688|Irritable Bowel Syndrome|irritable bowel syndrome
647152|NCT00454688|Asimadoline|asimadoline
647153|NCT00454675|Smokers|smokers
647154|NCT00454675|Chronic Bronchitis|chronic bronchitis
647155|NCT00454675|Pulmonary Function Test Abnormalities|pulmonary function test abnormalities
647156|NCT00454675|COPD|copd
647157|NCT00454662|Elderly|elderly
647158|NCT00454662|Hypertension|hypertension
647159|NCT00454662|Cardiovascular Diseases|cardiovascular diseases
647277|NCT00454259|Human volunteer|human volunteer
647160|NCT00454662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
647161|NCT00454662|Calcium Channel Blockers|calcium channel blockers
647162|NCT00454662|Diuretics|diuretics
647163|NCT00454662|Combination Drug Therapy|combination drug therapy
647164|NCT00454662|Diabetes|diabetes
647165|NCT00454649|axitinib|axitinib
647166|NCT00454649|chemotherapy|chemotherapy
647167|NCT00454649|anti-angiogenesis|anti-angiogenesis
647168|NCT00454649|VEGF inhibition|vegf inhibition
647169|NCT00454623|Adiponectin|adiponectin
647170|NCT00454623|diabetes|diabetes
647171|NCT00454623|metabolism|metabolism
647172|NCT00454623|Adiponectin levels|adiponectin levels
647173|NCT00454610|Pediatric|pediatric
647174|NCT00454610|Overweight|overweight
647175|NCT00454610|Obesity|obesity
647176|NCT00454610|Intervention|intervention
647177|NCT00454610|Prevention|prevention
647178|NCT00454610|Mexican American|mexican american
647179|NCT00454584|Psoriasis|psoriasis
647180|NCT00454584|CNTO 1275|cnto 1275
647181|NCT00454584|Etanercept|etanercept
647182|NCT00454584|Immune diorder|immune diorder
647183|NCT00454584|Skin disorder|skin disorder
647184|NCT00454558|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
647185|NCT00454558|Chronic Thromboembolic Pulmonary Hypertension (CTEPH)|chronic thromboembolic pulmonary hypertension (cteph)
647186|NCT00454532|Breast Cancer|breast cancer
647187|NCT00454532|Bionovo|bionovo
647188|NCT00454532|BZL101|bzl101
647189|NCT00454532|Chinese Herbs|chinese herbs
647190|NCT00454519|peritoneal carcinomatosis|peritoneal carcinomatosis
647191|NCT00454519|cisplatin|cisplatin
647192|NCT00454519|mitomycin|mitomycin
647193|NCT00454519|gastric cancer|gastric cancer
647194|NCT00454519|colorectal cancer|colorectal cancer
647195|NCT00454493|omacor|omacor
647196|NCT00454493|fish oil|fish oil
647197|NCT00454493|omega 3|omega 3
647198|NCT00454493|fatty acids|fatty acids
647199|NCT00454493|coronary artery disease|coronary artery disease
647200|NCT00454493|endothelial function|endothelial function
647201|NCT00454493|heart rate variability|heart rate variability
647202|NCT00454493|carotid intimal media thickness|carotid intimal media thickness
647203|NCT00454493|QT dispersion|qt dispersion
647204|NCT00454480|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
647205|NCT00454480|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
647206|NCT00454480|secondary acute myeloid leukemia|secondary acute myeloid leukemia
647207|NCT00454480|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
647208|NCT00454480|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
647209|NCT00454480|refractory anemia with excess blasts|refractory anemia with excess blasts
647210|NCT00454480|adult acute basophilic leukemia|adult acute basophilic leukemia
647211|NCT00454480|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
647212|NCT00454480|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
647213|NCT00454480|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
647214|NCT00454480|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
647215|NCT00454480|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
647216|NCT00454480|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
647217|NCT00454480|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
647218|NCT00454480|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
647219|NCT00454480|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
647220|NCT00454480|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
647221|NCT00454480|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
647222|NCT00454480|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
647223|NCT00454480|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
647224|NCT00454480|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
647225|NCT00454480|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
647226|NCT00454454|memory|memory
647227|NCT00454454|display enhanced testing|display enhanced testing
647228|NCT00454441|Sleep Quality|sleep quality
647229|NCT00454441|Menopausal Symptoms|menopausal symptoms
647230|NCT00454441|Actigraph|actigraph
647231|NCT00454441|Bionovo|bionovo
647232|NCT00454441|MF101|mf101
647233|NCT00454428|Bypass Surgery|bypass surgery
647234|NCT00454428|Coronary Artery|coronary artery
647235|NCT00454415|Diet|diet
647236|NCT00454415|Body Mass Index|body mass index
647237|NCT00454415|BMI|bmi
647238|NCT00454389|Macular|macular
647239|NCT00454389|Degeneration|degeneration
647240|NCT00454389|AMD|amd
647241|NCT00454389|Wet Age-Related macular degeneration|wet age-related macular degeneration
647242|NCT00454376|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
647243|NCT00454376|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
647244|NCT00454376|pulmonary carcinoid tumor|pulmonary carcinoid tumor
647245|NCT00454376|gastrinoma|gastrinoma
647246|NCT00454376|insulinoma|insulinoma
647247|NCT00454376|WDHA syndrome|wdha syndrome
647248|NCT00454376|pancreatic polypeptide tumor|pancreatic polypeptide tumor
647249|NCT00454376|somatostatinoma|somatostatinoma
647250|NCT00454376|glucagonoma|glucagonoma
647251|NCT00454376|liver metastases|liver metastases
647252|NCT00454350|Hectorol (doxercalciferol injection)|hectorol (doxercalciferol injection)
647253|NCT00454350|Zemplar (paricalcitol injection)|zemplar (paricalcitol injection)
647254|NCT00454337|HIV-1 infection|hiv-1 infection
647255|NCT00454337|enfuvirtide|enfuvirtide
647256|NCT00454337|raltegravir|raltegravir
647257|NCT00454337|treatment experienced|treatment experienced
647258|NCT00454324|Lung cancer|lung cancer
647259|NCT00454324|Small cell lung cancer|small cell lung cancer
647260|NCT00454324|Abraxane|abraxane
647261|NCT00454324|Paclitaxel|paclitaxel
647262|NCT00454324|Carboplatin|carboplatin
647263|NCT00454324|Phase II|phase ii
647264|NCT00454324|Randomized|randomized
647265|NCT00454324|Lineberger|lineberger
647266|NCT00454324|LCCC|lccc
647267|NCT00454311|Pregnancy and implantation rates|pregnancy and implantation rates
647268|NCT00454311|Efficiency and accuracy of the genetic testing|efficiency and accuracy of the genetic testing
647269|NCT00454298|Severe Osteoarthritis|severe osteoarthritis
647270|NCT00454298|Arthritis|arthritis
647271|NCT00454285|bacteremia,cultures, infective endocarditis, prophylaxis|bacteremia,cultures, infective endocarditis, prophylaxis
647272|NCT00454272|febrile|febrile
647274|NCT00454272|cancer|cancer
647275|NCT00454272|Gram positive infection|gram positive infection
647276|NCT00454259|Postoperative Hyperalgesia|postoperative hyperalgesia
647278|NCT00454259|Fentanyl|fentanyl
647279|NCT00454259|Randomized Controlled Trial|randomized controlled trial
647280|NCT00454259|Pain chronicisation|pain chronicisation
647281|NCT00454259|Predictive test|predictive test
647282|NCT00454233|Diabetes Mellitus Type 2|diabetes mellitus type 2
647283|NCT00454233|YM543|ym543
647284|NCT00454233|Treatment|treatment
647285|NCT00454233|Safety|safety
647286|NCT00454233|efficacy|efficacy
647287|NCT00454207|Pulmonary Arterial Hypertension, PAH|pulmonary arterial hypertension, pah
647288|NCT00454194|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
647289|NCT00454194|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
647290|NCT00454194|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
647291|NCT00454194|adenosquamous cell lung cancer|adenosquamous cell lung cancer
647292|NCT00454194|adenocarcinoma of the lung|adenocarcinoma of the lung
647293|NCT00454181|human immunodeficiency virus|human immunodeficiency virus
647294|NCT00454181|human papilloma virus|human papilloma virus
647295|NCT00454181|warts, oral|warts, oral
647296|NCT00454181|papillomatosis|papillomatosis
647297|NCT00454181|treatment experienced|treatment experienced
647298|NCT00454168|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
647299|NCT00454168|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
647300|NCT00454168|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
647301|NCT00454168|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
647302|NCT00454168|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
647303|NCT00454168|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
647304|NCT00454168|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
647305|NCT00454168|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
647306|NCT00454168|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
647307|NCT00454168|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
647308|NCT00454168|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
647309|NCT00454168|secondary acute myeloid leukemia|secondary acute myeloid leukemia
647310|NCT00454168|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
647311|NCT00454168|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
647312|NCT00454168|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
647313|NCT00454168|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
647314|NCT00454168|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
647315|NCT00454155|HSCT|hsct
647316|NCT00454155|AGVHD|agvhd
647317|NCT00454155|Myeloablative|myeloablative
647318|NCT00454155|Allogeneic|allogeneic
647319|NCT00454155|Hematopoietic|hematopoietic
647320|NCT00454155|Stem|stem
647321|NCT00454155|Cell|cell
647322|NCT00454155|Transplantation|transplantation
647323|NCT00454129|Feasibilty of cholangiography via double-balloon enteroscopy|feasibilty of cholangiography via double-balloon enteroscopy
647324|NCT00454116|Colon Cancer|colon cancer
647325|NCT00454116|Rectal Cancer|rectal cancer
647326|NCT00454103|adrenocortical carcinoma (ACC)|adrenocortical carcinoma (acc)
647327|NCT00454103|adrenal tumor|adrenal tumor
647328|NCT00454103|metastastic adrenocortical carcinoma|metastastic adrenocortical carcinoma
647329|NCT00454090|Advanced Malignancies|advanced malignancies
647330|NCT00454077|thyroid cancer; rhTSH; thyroid ablation|thyroid cancer; rhtsh; thyroid ablation
647331|NCT00454064|cognitive-behavioral therapy|cognitive-behavioral therapy
647332|NCT00454064|back pain|back pain
647333|NCT00454064|low back pain|low back pain
647334|NCT00454064|biofeedback|biofeedback
647335|NCT00454064|randomized controlled study|randomized controlled study
647336|NCT00454064|EMG biofeedback|emg biofeedback
647337|NCT00454051|Asthma, anti-immunoglobulin E, omalizumab, IgE receptors|asthma, anti-immunoglobulin e, omalizumab, ige receptors
647338|NCT00454038|cystectomy|cystectomy
647339|NCT00454038|augmentation|augmentation
647340|NCT00454038|sinus|sinus
647341|NCT00454038|amputation|amputation
647342|NCT00454038|implant|implant
647343|NCT00454025|glaucoma|glaucoma
647344|NCT00454025|intraocular pressure|intraocular pressure
647345|NCT00454025|postural changes|postural changes
647346|NCT00454012|non reassuring fetal heart rate tracing|non reassuring fetal heart rate tracing
647347|NCT00454012|biophysical profile|biophysical profile
647348|NCT00454012|assessing fetal wellbeing|assessing fetal wellbeing
647349|NCT00453999|influenza|influenza
647350|NCT00453999|flu|flu
647351|NCT00453986|immunogenicity|immunogenicity
647352|NCT00453986|Meningococcal serogroups A, C, W-135 and/or Y disease|meningococcal serogroups a, c, w-135 and/or y disease
647353|NCT00453986|co-administration|co-administration
647354|NCT00453986|meningococcal vaccine|meningococcal vaccine
647355|NCT00453986|lot-to-lot consistency|lot-to-lot consistency
647356|NCT00453986|conjugate vaccine|conjugate vaccine
647357|NCT00453973|anemia|anemia
648575|NCT00450034|Vulnerable|vulnerable
647358|NCT00453973|chronic kidney disease|chronic kidney disease
647359|NCT00453973|CKD|ckd
647360|NCT00453973|chronic renal failure|chronic renal failure
647361|NCT00453973|CRF|crf
647362|NCT00453973|dialysis|dialysis
647363|NCT00453973|erythropoietin|erythropoietin
647364|NCT00453973|EPO|epo
647365|NCT00453973|erythropoiesis stimulating agent|erythropoiesis stimulating agent
647366|NCT00453973|ESA|esa
647367|NCT00453973|Hematide™|hematide™
647368|NCT00453973|hemodialysis|hemodialysis
647369|NCT00453973|hemoglobin|hemoglobin
647370|NCT00453973|Hb|hb
647371|NCT00453973|Hgb|hgb
647372|NCT00453973|Omontys|omontys
647373|NCT00453973|peginesatide|peginesatide
647374|NCT00453973|red blood cell|red blood cell
647375|NCT00453973|red blood cell production|red blood cell production
647376|NCT00453960|Endometrial hyperplasia|endometrial hyperplasia
647377|NCT00453960|Genistein|genistein
647378|NCT00453960|Isoflavones|isoflavones
647379|NCT00453960|dysfunctional uterine bleeding|dysfunctional uterine bleeding
647380|NCT00453934|Diabetes|diabetes
647381|NCT00453934|Type 1 Diabetes|type 1 diabetes
647382|NCT00453934|Type 2 Diabetes|type 2 diabetes
647383|NCT00453934|Physiologic Insulin|physiologic insulin
647384|NCT00453934|Basal Insulin|basal insulin
647385|NCT00453934|Bolus Insulin|bolus insulin
647386|NCT00453934|Mealtime insulin|mealtime insulin
647387|NCT00453934|Insulin patch|insulin patch
647388|NCT00453934|Multiple daily injections|multiple daily injections
647389|NCT00453921|TBI|tbi
647390|NCT00453921|Memory|memory
647391|NCT00453921|Methylphenidate|methylphenidate
647392|NCT00453921|Ritalin|ritalin
647393|NCT00453921|Memory and Attention Training|memory and attention training
647394|NCT00453895|Adrenal cancer refractory to cytotoxic therapy|adrenal cancer refractory to cytotoxic therapy
647395|NCT00453895|Sunitinib|sunitinib
647396|NCT00453895|Multitargeted tyrosine-kinase inhibitor|multitargeted tyrosine-kinase inhibitor
647397|NCT00453869|Liver fibrosis|liver fibrosis
647398|NCT00453869|Hepatitis B virus and C virus|hepatitis b virus and c virus
647399|NCT00453869|FibroMeter|fibrometer
647400|NCT00453869|FibroScan®|fibroscan®
647401|NCT00453856|Malaria|malaria
647402|NCT00453856|Sulfadoxine|sulfadoxine
647403|NCT00453856|Pyrimethamine|pyrimethamine
647404|NCT00453856|Resistance|resistance
647405|NCT00453856|Gabon|gabon
647406|NCT00453843|Stroke|stroke
647407|NCT00453843|movement therapy|movement therapy
647408|NCT00453843|robotics|robotics
647409|NCT00453843|rehabilitation robotics|rehabilitation robotics
647410|NCT00453843|shoulder, elbow, wrist|shoulder, elbow, wrist
647411|NCT00453830|Diverticulitis; laparoscopy; short term outcome|diverticulitis; laparoscopy; short term outcome
647412|NCT00453817|islet transplantation|islet transplantation
647413|NCT00453817|imaging|imaging
647414|NCT00453817|graft monitoring|graft monitoring
647415|NCT00453817|magnetic resonance imaging|magnetic resonance imaging
647416|NCT00453804|Alcohol dependence|alcohol dependence
647417|NCT00453804|Major Mental Illness|major mental illness
647418|NCT00453804|Injectable naltrexone|injectable naltrexone
647419|NCT00453791|GW805858|gw805858
647420|NCT00453791|MDI|mdi
647421|NCT00453791|asthma|asthma
647422|NCT00453791|surfactant|surfactant
647423|NCT00453778|mild asthma|mild asthma
647424|NCT00453778|FLIXOTIDE|flixotide
647425|NCT00453778|methacholine|methacholine
647426|NCT00453778|bronchial challenge|bronchial challenge
647427|NCT00453778|leukotriene D4|leukotriene d4
647428|NCT00453765|cough|cough
647429|NCT00453765|hyperreactivity|hyperreactivity
647430|NCT00453765|montelukast|montelukast
647431|NCT00453752|systemic sclerosis|systemic sclerosis
647432|NCT00453752|pulmonary hypertension|pulmonary hypertension
647433|NCT00453752|echocardiography|echocardiography
647434|NCT00453752|N-Terminal proBNP|n-terminal probnp
647435|NCT00453726|Natriuretic peptide brain|natriuretic peptide brain
647436|NCT00453726|Continuous positive airway pressure|continuous positive airway pressure
647437|NCT00453726|Intermittent positive pressure breathing|intermittent positive pressure breathing
647438|NCT00453726|Respiratory insufficiency|respiratory insufficiency
647439|NCT00453713|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
647440|NCT00453713|Interstitial lung disease|interstitial lung disease
647441|NCT00453713|Diffuse parenchymal lung disease|diffuse parenchymal lung disease
647442|NCT00453713|Health disparities|health disparities
647443|NCT00453700|chagas|chagas
647444|NCT00453700|trypanosoma cruzi|trypanosoma cruzi
647445|NCT00453687|COPD|copd
647446|NCT00453687|GSK233705,|gsk233705,
647447|NCT00453687|Magnesium Stearate,|magnesium stearate,
647448|NCT00453674|Adrenal cancer|adrenal cancer
647449|NCT00453674|Treatment|treatment
647450|NCT00453674|Surgery|surgery
647451|NCT00453674|Mitotane|mitotane
647452|NCT00453661|Breast Cancer|breast cancer
647453|NCT00453661|Cervical Cancer|cervical cancer
647454|NCT00453661|Prostate Cancer|prostate cancer
647455|NCT00453661|Colorectal Cancer|colorectal cancer
647456|NCT00453661|Lung Cancer|lung cancer
647457|NCT00453661|Cancer Prevention|cancer prevention
647458|NCT00453661|Treatment Demonstration for Ethnic and Racial Minorities|treatment demonstration for ethnic and racial minorities
648673|NCT00449605|Metformin|metformin
647459|NCT00453661|Centers for Medicare and Medicaid Services|centers for medicare and medicaid services
647460|NCT00453661|CMS|cms
647461|NCT00453661|Hispanic American|hispanic american
647462|NCT00453661|Cancer Screening Assessment|cancer screening assessment
647463|NCT00453661|Annual Questionnaire|annual questionnaire
647464|NCT00453661|Patient Navigator|patient navigator
647465|NCT00453661|Educational Materials|educational materials
647466|NCT00453648|stable isotopes|stable isotopes
647467|NCT00453648|vitamin A|vitamin a
647468|NCT00453648|beta-carotene|beta-carotene
647469|NCT00453648|orange-fleshed sweet potatoes|orange-fleshed sweet potatoes
647470|NCT00453648|iron|iron
647471|NCT00453648|zinc|zinc
647472|NCT00453648|absorption|absorption
647473|NCT00453648|bioavailability|bioavailability
647474|NCT00453648|vitamin A equivalency|vitamin a equivalency
647475|NCT00453648|Bangladesh|bangladesh
647476|NCT00453648|women|women
647477|NCT00453635|Cancer|cancer
647478|NCT00453635|Breast cancer|breast cancer
647479|NCT00453635|First line treatment|first line treatment
647480|NCT00453635|Docetaxel|docetaxel
647481|NCT00453635|Carboplatin|carboplatin
647482|NCT00453635|Herceptin|herceptin
647483|NCT00453635|Vinorelbine|vinorelbine
647484|NCT00453622|Heart Failure|heart failure
647485|NCT00453622|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
647486|NCT00453622|Risk stratification|risk stratification
647487|NCT00453622|Prediction|prediction
647488|NCT00453622|Proteomics|proteomics
647489|NCT00453622|Chemokine|chemokine
647490|NCT00453622|cardiac enzymes|cardiac enzymes
647491|NCT00453622|Brain Natriuretic Peptide|brain natriuretic peptide
647492|NCT00453609|Bipolar Disorders|bipolar disorders
647493|NCT00453609|Schizophrenia|schizophrenia
647494|NCT00453609|Schizoaffective Disorders|schizoaffective disorders
647495|NCT00453609|Alcohol Dependence|alcohol dependence
647496|NCT00453609|Long-lasting injectable naltrexone|long-lasting injectable naltrexone
647497|NCT00453596|infertile women|infertile women
647498|NCT00453596|thin endometrial thickness|thin endometrial thickness
647499|NCT00453596|implantation failure|implantation failure
647500|NCT00453583|Pediatric|pediatric
647501|NCT00453583|Allergies|allergies
647502|NCT00453583|Antihistamines|antihistamines
647503|NCT00453583|Non-interventional|non-interventional
647504|NCT00453570|Diphteria|diphteria
647505|NCT00453570|Tetanus|tetanus
647506|NCT00453570|Haemophilus influenzae type b|haemophilus influenzae type b
647507|NCT00453570|Poliomyelitis|poliomyelitis
647508|NCT00453570|Pertussis|pertussis
647509|NCT00453557|growth hormone, obesity, visceral adiposity|growth hormone, obesity, visceral adiposity
647510|NCT00453544|computer assisted instruction|computer assisted instruction
647511|NCT00453544|decision making|decision making
647512|NCT00453544|educational resource design /development|educational resource design /development
647513|NCT00453544|executive function|executive function
647514|NCT00453531|Forearm Ischemia|forearm ischemia
647515|NCT00453531|Endothelial Function|endothelial function
647516|NCT00453531|Acetyicholine Vasodilation|acetyicholine vasodilation
647517|NCT00453531|Venous Plethysmography|venous plethysmography
647518|NCT00453531|Healthy Volunteer|healthy volunteer
647519|NCT00453531|HV|hv
647520|NCT00453518|SVG|svg
647521|NCT00453518|Saphenous Vein Graft|saphenous vein graft
647522|NCT00453518|Embolic Protection|embolic protection
647523|NCT00453518|Distal Protection|distal protection
647524|NCT00453518|EPD|epd
647525|NCT00453518|FiberNet|fibernet
647526|NCT00453518|Saphenous Vein Graft intervention|saphenous vein graft intervention
647527|NCT00453505|Transcranial Direct Current Stimulation (TDCS)|transcranial direct current stimulation (tdcs)
647528|NCT00453505|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
647529|NCT00453505|Peripheral Nerve Stimulation|peripheral nerve stimulation
647530|NCT00453505|Primary Motor Cortex|primary motor cortex
647531|NCT00453505|Corticomotor Excitability|corticomotor excitability
647532|NCT00453505|Healthy Volunteer|healthy volunteer
647533|NCT00453505|HV|hv
647534|NCT00453479|muscarinic receptor,|muscarinic receptor,
647535|NCT00453479|bronchodilators|bronchodilators
647536|NCT00453479|Chronic obstructive pulmonary disease,|chronic obstructive pulmonary disease,
647537|NCT00453466|women experiencing domestic violence|women experiencing domestic violence
647538|NCT00453453|Congestive heart failure|congestive heart failure
647539|NCT00453453|observation unit|observation unit
647540|NCT00453453|nesiritide|nesiritide
647541|NCT00453440|HIV|hiv
647542|NCT00453440|HLA-B*5701|hla-b*5701
647543|NCT00453440|Abacavir hypersensitivity reaction|abacavir hypersensitivity reaction
647544|NCT00453440|HIV Infection|hiv infection
647545|NCT00453427|PTL NOS|ptl nos
647546|NCT00453427|AILD|aild
647547|NCT00453427|NHL|nhl
647548|NCT00453427|CHOP|chop
647549|NCT00453414|PAH|pah
647550|NCT00453414|Pediatric|pediatric
647551|NCT00453414|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
647552|NCT00453401|cold sore|cold sore
647553|NCT00453375|Diabetic|diabetic
647554|NCT00453375|Diabetes|diabetes
647555|NCT00453375|Type 1 Diabetes|type 1 diabetes
647556|NCT00453375|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
647557|NCT00453375|autoimmune disease|autoimmune disease
647558|NCT00453362|NSCLC|nsclc
647559|NCT00453362|Tarceva|tarceva
647560|NCT00453362|Positron emission technology|positron emission technology
647561|NCT00453362|PET|pet
647562|NCT00453362|Computerized tomography|computerized tomography
647563|NCT00453362|CT|ct
647564|NCT00453349|Uncomplicated pelvic inflammatory disease|uncomplicated pelvic inflammatory disease
647565|NCT00453336|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
647566|NCT00453336|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
647567|NCT00453336|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
647568|NCT00453336|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
647569|NCT00453336|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
647570|NCT00453336|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
647571|NCT00453336|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
647572|NCT00453336|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
647573|NCT00453336|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
647574|NCT00453336|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
647575|NCT00453336|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
647576|NCT00453336|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
647577|NCT00453336|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
647578|NCT00453336|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
647579|NCT00453336|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
647580|NCT00453336|oral leukoplakia|oral leukoplakia
647581|NCT00453323|Esophageal Cancer|esophageal cancer
647582|NCT00453323|Phase II|phase ii
647583|NCT00453323|Metastatic esophageal cancer|metastatic esophageal cancer
647584|NCT00453323|Recurrent esophageal cancer|recurrent esophageal cancer
647585|NCT00453310|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
647586|NCT00453310|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
647587|NCT00453310|ovarian choriocarcinoma|ovarian choriocarcinoma
647588|NCT00453310|ovarian immature teratoma|ovarian immature teratoma
647589|NCT00453310|ovarian mature teratoma|ovarian mature teratoma
647590|NCT00453310|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
647591|NCT00453310|testicular choriocarcinoma|testicular choriocarcinoma
647592|NCT00453310|testicular seminoma|testicular seminoma
647593|NCT00453310|testicular yolk sac tumor|testicular yolk sac tumor
647594|NCT00453310|ovarian dysgerminoma|ovarian dysgerminoma
647595|NCT00453310|ovarian embryonal carcinoma|ovarian embryonal carcinoma
647596|NCT00453310|ovarian yolk sac tumor|ovarian yolk sac tumor
647597|NCT00453310|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
647598|NCT00453310|ovarian polyembryoma|ovarian polyembryoma
647599|NCT00453310|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
647600|NCT00453310|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
647601|NCT00453310|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
647602|NCT00453310|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
647603|NCT00453310|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
647604|NCT00453310|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
647605|NCT00453310|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
647606|NCT00453310|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
647607|NCT00453310|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
647608|NCT00453310|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
647609|NCT00453310|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
647610|NCT00453310|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
647611|NCT00453310|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
647612|NCT00453310|testicular embryonal carcinoma|testicular embryonal carcinoma
647613|NCT00453310|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
647614|NCT00453310|recurrent extragonadal seminoma|recurrent extragonadal seminoma
647615|NCT00453310|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
647616|NCT00453310|stage IV extragonadal seminoma|stage iv extragonadal seminoma
647617|NCT00453310|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
647618|NCT00453310|testicular immature teratoma|testicular immature teratoma
647619|NCT00453310|testicular mature teratoma|testicular mature teratoma
647620|NCT00453310|adult teratoma|adult teratoma
647621|NCT00453297|Bionovo|bionovo
647622|NCT00453297|MF101|mf101
647623|NCT00453297|Herbs|herbs
647715|NCT00453206|stage III multiple myeloma|stage iii multiple myeloma
647823|NCT00453024|Sutures|sutures
647684|NCT00453206|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
647624|NCT00453297|The primary goal of this study is to identify the highest safe oral dose of MF101 that is well tolerated in humans.|the primary goal of this study is to identify the highest safe oral dose of mf101 that is well tolerated in humans.
647625|NCT00453271|chronic persistent infection of the nail bed or plate|chronic persistent infection of the nail bed or plate
647626|NCT00453258|ocular proteomics|ocular proteomics
647627|NCT00453258|eye disease|eye disease
647628|NCT00453258|proteomics|proteomics
647629|NCT00453232|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
647630|NCT00453232|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
647631|NCT00453232|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
647632|NCT00453232|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
647633|NCT00453232|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
647634|NCT00453232|testicular choriocarcinoma|testicular choriocarcinoma
647635|NCT00453232|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
647636|NCT00453232|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
647637|NCT00453232|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
647638|NCT00453232|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
647639|NCT00453232|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
647640|NCT00453232|testicular embryonal carcinoma|testicular embryonal carcinoma
647641|NCT00453232|testicular seminoma|testicular seminoma
647642|NCT00453232|testicular yolk sac tumor|testicular yolk sac tumor
647643|NCT00453232|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
647644|NCT00453232|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
647645|NCT00453232|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
647646|NCT00453232|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
647647|NCT00453232|recurrent extragonadal seminoma|recurrent extragonadal seminoma
647648|NCT00453232|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
647649|NCT00453232|stage IV extragonadal seminoma|stage iv extragonadal seminoma
647650|NCT00453232|adult teratoma|adult teratoma
647651|NCT00453232|testicular immature teratoma|testicular immature teratoma
647652|NCT00453232|testicular mature teratoma|testicular mature teratoma
647653|NCT00453232|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
647654|NCT00453206|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
647655|NCT00453206|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
647656|NCT00453206|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
647657|NCT00453206|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
647658|NCT00453206|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
647659|NCT00453206|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
647660|NCT00453206|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
647661|NCT00453206|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
647662|NCT00453206|primary myelofibrosis|primary myelofibrosis
647663|NCT00453206|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
647664|NCT00453206|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
647665|NCT00453206|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
647666|NCT00453206|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
647667|NCT00453206|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
647668|NCT00453206|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
647669|NCT00453206|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
647670|NCT00453206|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
647671|NCT00453206|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
647672|NCT00453206|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
647673|NCT00453206|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
647674|NCT00453206|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
647675|NCT00453206|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
647676|NCT00453206|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
647677|NCT00453206|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
647678|NCT00453206|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
647679|NCT00453206|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
647680|NCT00453206|prolymphocytic leukemia|prolymphocytic leukemia
647681|NCT00453206|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
647682|NCT00453206|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
647683|NCT00453206|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
647838|NCT00452920|stage IIB cervical cancer|stage iib cervical cancer
647685|NCT00453206|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
647686|NCT00453206|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
647687|NCT00453206|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
647688|NCT00453206|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
647689|NCT00453206|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
647690|NCT00453206|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
647691|NCT00453206|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
647692|NCT00453206|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
647693|NCT00453206|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
647694|NCT00453206|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
647695|NCT00453206|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
647696|NCT00453206|refractory multiple myeloma|refractory multiple myeloma
647697|NCT00453206|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
647698|NCT00453206|secondary acute myeloid leukemia|secondary acute myeloid leukemia
647699|NCT00453206|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
647700|NCT00453206|splenic marginal zone lymphoma|splenic marginal zone lymphoma
647701|NCT00453206|stage I multiple myeloma|stage i multiple myeloma
647702|NCT00453206|stage II multiple myeloma|stage ii multiple myeloma
647703|NCT00453206|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
647704|NCT00453206|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
647705|NCT00453206|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
647706|NCT00453206|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
647707|NCT00453206|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
647708|NCT00453206|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
647709|NCT00453206|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
647710|NCT00453206|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
647711|NCT00453206|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
647712|NCT00453206|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
647713|NCT00453206|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
647714|NCT00453206|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
647716|NCT00453206|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
647717|NCT00453206|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
647718|NCT00453206|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
647719|NCT00453206|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
647720|NCT00453206|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
647721|NCT00453206|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
647722|NCT00453206|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
647723|NCT00453206|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
647724|NCT00453206|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
647725|NCT00453206|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
647726|NCT00453206|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
647727|NCT00453206|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
647728|NCT00453206|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
647729|NCT00453206|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
647730|NCT00453206|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
647731|NCT00453206|polycythemia vera|polycythemia vera
647732|NCT00453206|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
647733|NCT00453206|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
647734|NCT00453206|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
647735|NCT00453206|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
647736|NCT00453206|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
647737|NCT00453206|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
647738|NCT00453206|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
647739|NCT00453206|stage I childhood anaplastic large cell lymphoma|stage i childhood anaplastic large cell lymphoma
647740|NCT00453206|stage II childhood anaplastic large cell lymphoma|stage ii childhood anaplastic large cell lymphoma
647741|NCT00453206|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
647742|NCT00453206|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
647743|NCT00453206|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
647744|NCT00453206|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
647745|NCT00453206|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
647746|NCT00453206|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
647747|NCT00453206|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
647748|NCT00453206|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
647749|NCT00453206|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
647750|NCT00453206|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
647751|NCT00453206|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
647752|NCT00453206|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
647753|NCT00453206|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
647754|NCT00453206|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
647755|NCT00453206|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
647756|NCT00453206|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
647757|NCT00453206|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
647758|NCT00453206|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
647759|NCT00453206|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
647760|NCT00453193|T-Cell Neoplasms|t-cell neoplasms
647761|NCT00453193|Alemtuzumab|alemtuzumab
647762|NCT00453193|Pentostatin|pentostatin
647763|NCT00453193|Campath-1H|campath-1h
647764|NCT00453193|Deoxycoformycin|deoxycoformycin
647765|NCT00453193|Lymphoma|lymphoma
647766|NCT00453193|Leukemia|leukemia
647767|NCT00453180|Autistic Disorder|autistic disorder
647768|NCT00453180|Asperger's|asperger's
647769|NCT00453180|PDD NOS|pdd nos
647770|NCT00453180|Pervasive Developmental Disorder|pervasive developmental disorder
647771|NCT00453180|Autism|autism
647772|NCT00453180|N-acetylcysteine|n-acetylcysteine
647773|NCT00453180|acetylcysteine|acetylcysteine
647774|NCT00453180|NAC|nac
647775|NCT00453180|antioxidant|antioxidant
647776|NCT00453180|treatment|treatment
647777|NCT00453180|core symptoms|core symptoms
647778|NCT00453180|Autism Spectrum Disorders|autism spectrum disorders
647779|NCT00453180|Asperger's Disorder|asperger's disorder
647780|NCT00453180|Pervasive Developmental Disorder Not Otherwise Specified|pervasive developmental disorder not otherwise specified
647781|NCT00453180|Pervasive Developmental Disorders|pervasive developmental disorders
647782|NCT00453167|Small cell lung cancer|small cell lung cancer
647783|NCT00453167|second-line therapy|second-line therapy
647784|NCT00453141|Betamethasone for preterm labor|betamethasone for preterm labor
647785|NCT00453141|Preterm delivery|preterm delivery
647786|NCT00453141|Infant Respiratory Distress Syndrome|infant respiratory distress syndrome
647787|NCT00453128|Calcium Pyrophosphate|calcium pyrophosphate
647788|NCT00453128|associated conditions|associated conditions
647789|NCT00453115|Non small cell lung cancer|non small cell lung cancer
647790|NCT00453115|advanced stage IIIB|advanced stage iiib
647791|NCT00453115|Stage IV|stage iv
647792|NCT00453102|Marginal Zone Lymphoma|marginal zone lymphoma
647793|NCT00453102|Non-gastric extranodal Marginal Zone Lymphoma|non-gastric extranodal marginal zone lymphoma
647794|NCT00453102|Splenic Marginal Zone Lymphoma|splenic marginal zone lymphoma
647795|NCT00453102|Nodal Marginal Zone Lymphoma|nodal marginal zone lymphoma
647796|NCT00453102|Gastric Marginal Zone Lymphoma|gastric marginal zone lymphoma
647797|NCT00453102|MZL|mzl
647798|NCT00453102|Non-gastric extranodal MZL|non-gastric extranodal mzl
647799|NCT00453102|Splenic MZL|splenic mzl
647800|NCT00453102|Nodal MZL|nodal mzl
647801|NCT00453102|Gastric MZL|gastric mzl
647802|NCT00453089|Chinese Herbs|chinese herbs
647803|NCT00453089|Postmenopausal|postmenopausal
647804|NCT00453089|Vaginal Atrophy|vaginal atrophy
647805|NCT00453089|Vulvar Atrophy|vulvar atrophy
647806|NCT00453089|Symptoms|symptoms
647807|NCT00453089|Bionovo|bionovo
647808|NCT00453089|VG101|vg101
647809|NCT00453076|Biliary Obstruction|biliary obstruction
647810|NCT00453050|stage III melanoma|stage iii melanoma
647811|NCT00453050|stage IV melanoma|stage iv melanoma
647812|NCT00453050|skin metastases|skin metastases
647813|NCT00453037|hypertension|hypertension
647814|NCT00453037|self measurement of blood pressure|self measurement of blood pressure
647815|NCT00453037|education program|education program
647816|NCT00453037|life style|life style
647817|NCT00453024|Advanced glaucoma|advanced glaucoma
647818|NCT00453024|Ahmed glaucoma implant|ahmed glaucoma implant
647819|NCT00453024|Anterior segment optical coherence tomography|anterior segment optical coherence tomography
647820|NCT00453024|Pericardial patch graft|pericardial patch graft
647821|NCT00453024|Tissue glue|tissue glue
647822|NCT00453024|Scleral flap|scleral flap
647824|NCT00453011|vitreous loss|vitreous loss
647825|NCT00453011|intraocular lenses|intraocular lenses
647826|NCT00453011|Patients undergoing extracapsular cataract surgery|patients undergoing extracapsular cataract surgery
647827|NCT00453011|Vitreous loss with sufficient capsular support for an unsutured posterior chamber lens|vitreous loss with sufficient capsular support for an unsutured posterior chamber lens
647828|NCT00453011|5% random sample of patients with no vitreous loss|5% random sample of patients with no vitreous loss
647829|NCT00452998|Sequential Laser Iridotomy|sequential laser iridotomy
647830|NCT00452998|Q-Switched 532 nm Laser|q-switched 532 nm laser
647831|NCT00452998|Frequency Doubled Neodymium Yag Laser|frequency doubled neodymium yag laser
647832|NCT00452972|Cesarean delivery|cesarean delivery
647833|NCT00452972|Spinal anesthesia|spinal anesthesia
647834|NCT00452972|Nausea|nausea
647835|NCT00452972|Vomiting|vomiting
647836|NCT00452972|Pain|pain
647837|NCT00452920|cervical squamous cell carcinoma|cervical squamous cell carcinoma
647924|NCT00452556|Docetaxel|docetaxel
647839|NCT00452920|stage III cervical cancer|stage iii cervical cancer
647840|NCT00452920|stage IVA cervical cancer|stage iva cervical cancer
647841|NCT00452881|Non-small cell lung cancer|non-small cell lung cancer
647842|NCT00452881|adjuvant chemotherapy|adjuvant chemotherapy
647843|NCT00452868|cognitive/functional effects|cognitive/functional effects
647844|NCT00452868|neurotoxicity|neurotoxicity
647845|NCT00452868|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
647846|NCT00452868|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
647847|NCT00452868|radiation toxicity|radiation toxicity
647848|NCT00452868|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
647849|NCT00452868|childhood choroid plexus tumor|childhood choroid plexus tumor
647850|NCT00452868|childhood craniopharyngioma|childhood craniopharyngioma
647851|NCT00452868|childhood grade I meningioma|childhood grade i meningioma
647852|NCT00452868|childhood grade II meningioma|childhood grade ii meningioma
647853|NCT00452868|childhood grade III meningioma|childhood grade iii meningioma
647854|NCT00452868|childhood spinal cord neoplasm|childhood spinal cord neoplasm
647855|NCT00452868|childhood brain stem glioma|childhood brain stem glioma
647856|NCT00452868|childhood cerebellar astrocytoma|childhood cerebellar astrocytoma
647857|NCT00452868|childhood medulloblastoma|childhood medulloblastoma
647858|NCT00452868|childhood supratentorial primitive neuroectodermal tumor|childhood supratentorial primitive neuroectodermal tumor
647859|NCT00452868|childhood visual pathway and hypothalamic glioma|childhood visual pathway and hypothalamic glioma
647860|NCT00452868|childhood subependymal giant cell astrocytoma|childhood subependymal giant cell astrocytoma
647861|NCT00452868|childhood ependymoma|childhood ependymoma
647862|NCT00452868|childhood cerebral astrocytoma/malignant glioma|childhood cerebral astrocytoma/malignant glioma
647863|NCT00452855|Nausea|nausea
647864|NCT00452855|Vomiting|vomiting
647865|NCT00452855|Post operative|post operative
647866|NCT00452855|Propofol remifentanil anaesthesia|propofol remifentanil anaesthesia
647867|NCT00452855|Sevoflurane remifentanil anaesthesia|sevoflurane remifentanil anaesthesia
647868|NCT00452816|Chronic Disease|chronic disease
647869|NCT00452816|Employer Health Costs|employer health costs
647870|NCT00452816|Health Promotion|health promotion
647871|NCT00452816|Insurance Benefits|insurance benefits
647872|NCT00452816|Marketing of Health Services|marketing of health services
647873|NCT00452816|Mass Screening|mass screening
647874|NCT00452816|Prevention & Control|prevention & control
647875|NCT00452816|Tobacco Use Cessation|tobacco use cessation
647876|NCT00452816|Workplace|workplace
647877|NCT00452803|Non small cell lung cancer|non small cell lung cancer
647878|NCT00452790|Vaccines, Pneumococcal|vaccines, pneumococcal
647879|NCT00452777|Diabetic neuropathy, painful|diabetic neuropathy, painful
647880|NCT00452777|Adenosine A2A receptor|adenosine a2a receptor
647881|NCT00452764|COPD|copd
647882|NCT00452764|Healthy|healthy
647883|NCT00452764|Regulatory T cell|regulatory t cell
647884|NCT00452764|Heme oxygenase-1|heme oxygenase-1
647885|NCT00452764|peripheral blood|peripheral blood
647886|NCT00452751|gastric cancer|gastric cancer
647887|NCT00452751|laparoscopic surgery|laparoscopic surgery
647888|NCT00452751|survival|survival
647889|NCT00452751|preoperative staging|preoperative staging
647890|NCT00452751|morbidity|morbidity
647891|NCT00452751|quality of life|quality of life
647892|NCT00452751|acute inflammatory reaction|acute inflammatory reaction
647893|NCT00452751|cost|cost
647894|NCT00452738|animal-assisted intervention|animal-assisted intervention
647895|NCT00452738|pre surgery anxiety|pre surgery anxiety
647896|NCT00452738|post surgery pain medication consumption|post surgery pain medication consumption
647897|NCT00452712|orthostatism|orthostatism
647898|NCT00452712|fever|fever
647899|NCT00452699|fluticasone propionate|fluticasone propionate
647900|NCT00452699|long-term study|long-term study
647901|NCT00452699|Salmeterol|salmeterol
647902|NCT00452699|FLOVENT 250|flovent 250
647903|NCT00452699|Asthma|asthma
647904|NCT00452699|ADVAIR 250|advair 250
647905|NCT00452686|Chinese DT vaccin|chinese dt vaccin
647906|NCT00452660|IRON|iron
647907|NCT00452660|oxidative stress|oxidative stress
647908|NCT00452660|MDS|mds
647909|NCT00452647|Condition: No specific disease is being studied, few procedures are excluded.|condition: no specific disease is being studied, few procedures are excluded.
647910|NCT00452647|Focus: To obtain blood pressure data and detect any trends to a statistically significant degree.|focus: to obtain blood pressure data and detect any trends to a statistically significant degree.
647911|NCT00452634|Irinotecan|irinotecan
647912|NCT00452634|cisplatin|cisplatin
647913|NCT00452634|Simvastatin|simvastatin
647914|NCT00452634|Extensive disease|extensive disease
647915|NCT00452634|SCLC|sclc
647916|NCT00452621|blood draw five years after booster-immunization with TBE vaccine to investigate immunogenicity in children|blood draw five years after booster-immunization with tbe vaccine to investigate immunogenicity in children
647917|NCT00452621|TBE|tbe
647918|NCT00452582|ischemic stroke|ischemic stroke
647919|NCT00452582|recovery|recovery
647920|NCT00452582|sildenafil|sildenafil
647921|NCT00452569|Relapsed Refractory Multiple Myeloma|relapsed refractory multiple myeloma
647922|NCT00452556|Prostatic Neoplasms|prostatic neoplasms
647923|NCT00452556|Radiotherapy|radiotherapy
647925|NCT00452556|Leuprolide Acetate|leuprolide acetate
647926|NCT00452543|Major depressive disorder|major depressive disorder
647927|NCT00452543|Alcoholism|alcoholism
647928|NCT00452543|Alcohol abuse|alcohol abuse
647929|NCT00452543|Alcohol dependence|alcohol dependence
647930|NCT00452530|Prevention of deep vein thrombosis and pulmonary embolism after total knee replacement surgery|prevention of deep vein thrombosis and pulmonary embolism after total knee replacement surgery
647931|NCT00452517|bare metal stents|bare metal stents
647932|NCT00452517|sirolimus-eluting stents|sirolimus-eluting stents
647933|NCT00452517|coronary polytetrafluoroethylene stent graft|coronary polytetrafluoroethylene stent graft
647934|NCT00452517|acute coronary syndrome|acute coronary syndrome
648059|NCT00452023|PEG-IFNa-2a|peg-ifna-2a
647935|NCT00452517|quantitative coronary angiography analysis|quantitative coronary angiography analysis
647936|NCT00452517|major adverse cardiac events|major adverse cardiac events
647937|NCT00452517|in-stent restenosis|in-stent restenosis
647938|NCT00452517|target lesion revascularisation|target lesion revascularisation
647939|NCT00452478|Hyperphosphataemia|hyperphosphataemia
647940|NCT00452465|Elderly|elderly
647941|NCT00452465|Nursing care plan|nursing care plan
647942|NCT00452465|Quality of Life|quality of life
647943|NCT00452452|Pneumococcal Vaccines|pneumococcal vaccines
647944|NCT00452439|Leukemia|leukemia
647945|NCT00452439|Lymphoma|lymphoma
647946|NCT00452439|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
647947|NCT00452439|Lymphoblastic Lymphoma|lymphoblastic lymphoma
647948|NCT00452439|Actonel|actonel
647949|NCT00452439|Risedronate|risedronate
647950|NCT00452439|Bone Loss|bone loss
647951|NCT00452439|Osteoporosis|osteoporosis
647952|NCT00452426|Propofol|propofol
647953|NCT00452426|Diprivan|diprivan
647954|NCT00452426|Colonoscopy|colonoscopy
647955|NCT00452426|Endoscopy, Digestive System|endoscopy, digestive system
647956|NCT00452426|Conscious Sedation|conscious sedation
647957|NCT00452387|Prostate Cancer|prostate cancer
647958|NCT00452374|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
647959|NCT00452374|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
647960|NCT00452374|CLL|cll
647961|NCT00452374|Prolymphocytic Leukemia|prolymphocytic leukemia
647962|NCT00452374|PLL|pll
647963|NCT00452374|Richter's Transformation|richter's transformation
647964|NCT00452374|High-grade non-Hodgkin's lymphoma|high-grade non-hodgkin's lymphoma
647965|NCT00452374|Hodgkin's disease|hodgkin's disease
647966|NCT00452374|Acute leukemia|acute leukemia
647967|NCT00452374|Small lymphocytic lymphoma|small lymphocytic lymphoma
647968|NCT00452374|Oxaliplatin|oxaliplatin
647969|NCT00452374|Eloxatin|eloxatin
647970|NCT00452374|Fludarabine|fludarabine
647971|NCT00452374|Cytarabine|cytarabine
647972|NCT00452374|Ara-C|ara-c
647973|NCT00452374|Cytosar|cytosar
647974|NCT00452374|DepoCyt|depocyt
647975|NCT00452374|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
647976|NCT00452374|Rituximab|rituximab
647977|NCT00452374|Rituxan|rituxan
647978|NCT00452348|FLOVENT|flovent
647979|NCT00452348|fluticasone|fluticasone
647980|NCT00452348|12 month|12 month
647981|NCT00452348|salmeterol|salmeterol
647982|NCT00452348|asthma|asthma
647983|NCT00452348|ADVAIR|advair
647984|NCT00452322|Testosterone|testosterone
647985|NCT00452322|Hypogonadism|hypogonadism
647986|NCT00452322|Safety|safety
647987|NCT00452309|peripheral arterial disease|peripheral arterial disease
647988|NCT00452309|pad|pad
647989|NCT00452309|ankle brachial index|ankle brachial index
647990|NCT00452309|abi|abi
647991|NCT00452296|inpatients with COPD|inpatients with copd
647992|NCT00452296|glucose control|glucose control
647993|NCT00452270|Common cold, xylometazoline|common cold, xylometazoline
647994|NCT00452244|Gefitinib|gefitinib
647995|NCT00452244|Simvastatin|simvastatin
647996|NCT00452244|NSCLC|nsclc
647997|NCT00452244|Advanced NSCLC|advanced nsclc
647998|NCT00452231|Post-traumatic Stress Disorder|post-traumatic stress disorder
647999|NCT00452231|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
648000|NCT00452218|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
648001|NCT00452218|PAH|pah
648002|NCT00452205|bone marrow-derived stem cell|bone marrow-derived stem cell
648003|NCT00452205|bone marrow transplantation|bone marrow transplantation
648004|NCT00452205|graft versus host disease|graft versus host disease
648005|NCT00452205|gastrointestinal cancer|gastrointestinal cancer
648006|NCT00452205|after receiving bone marrow transplantation|after receiving bone marrow transplantation
648007|NCT00452192|Metabolic syndrome|metabolic syndrome
648008|NCT00452179|Sleep maintenance|sleep maintenance
648009|NCT00452179|Insomnia|insomnia
648010|NCT00452179|Sleep Consolidation|sleep consolidation
648011|NCT00452179|Sleep|sleep
648012|NCT00452179|Insomnia, primarily sleep maintenance|insomnia, primarily sleep maintenance
648013|NCT00452153|legionellosis|legionellosis
648014|NCT00452153|diagnosis of legionellosis|diagnosis of legionellosis
648015|NCT00452153|PCR|pcr
648016|NCT00452140|Breast Cancer|breast cancer
648017|NCT00452140|investigational drug|investigational drug
648018|NCT00452140|drug therapy|drug therapy
648019|NCT00452140|Antineoplastic Protocols|antineoplastic protocols
648020|NCT00452140|Immunotherapy|immunotherapy
648021|NCT00452140|Metastatic breast cancer|metastatic breast cancer
648022|NCT00452140|Advanced breast cancer|advanced breast cancer
648023|NCT00452140|Stage III to IV breast cancer|stage iii to iv breast cancer
648024|NCT00452140|Hormonal therapy refractory|hormonal therapy refractory
648025|NCT00452140|Failure of hormonal therapy|failure of hormonal therapy
648026|NCT00452140|Her-2/neu expressing breast cancer|her-2/neu expressing breast cancer
648027|NCT00452140|Her-2/neu|her-2/neu
648028|NCT00452127|NHL|nhl
648029|NCT00452127|Indolent|indolent
648030|NCT00452127|Follicular|follicular
648031|NCT00452114|Bronchiectasis|bronchiectasis
648032|NCT00452101|Osteoarthritis|osteoarthritis
648033|NCT00452101|Clinical trial|clinical trial
648034|NCT00452101|Aquamin F|aquamin f
648035|NCT00452101|Glucosamine|glucosamine
648036|NCT00452088|Malaria vaccine|malaria vaccine
648037|NCT00452088|Safety of MSP 3 LSP|safety of msp 3 lsp
648038|NCT00452088|Immunogenicity of MSP 3 LSP|immunogenicity of msp 3 lsp
648039|NCT00452088|Burkina Faso children|burkina faso children
648040|NCT00452075|EGFR expression|egfr expression
648041|NCT00452075|erlotinib|erlotinib
648042|NCT00452062|cuff-leak test|cuff-leak test
648043|NCT00452062|intubation|intubation
648044|NCT00452062|corticosteroids|corticosteroids
648045|NCT00452062|dexamethasone to reduce the occurrence of post-extubation airway obstruction|dexamethasone to reduce the occurrence of post-extubation airway obstruction
648046|NCT00452049|parathyroidectomy|parathyroidectomy
648047|NCT00452049|arterial stiffness|arterial stiffness
648048|NCT00452049|renal function|renal function
648049|NCT00452036|risk factors|risk factors
648050|NCT00452036|plain x ray|plain x ray
648051|NCT00452036|cranial computed tomography|cranial computed tomography
648052|NCT00452036|minor head injury|minor head injury
648053|NCT00452023|Myeloproliferative Disorders|myeloproliferative disorders
648054|NCT00452023|Essential Thrombocythemia|essential thrombocythemia
648055|NCT00452023|Polycythemia Vera|polycythemia vera
648056|NCT00452023|Pegasys|pegasys
648057|NCT00452023|IFN-alpha2a|ifn-alpha2a
648058|NCT00452023|Pegylated-Interferon Alpha-2A|pegylated-interferon alpha-2a
648060|NCT00452010|TENS|tens
648061|NCT00452010|chronic low back pain|chronic low back pain
648062|NCT00452010|chronic lumbo-radiculalgia|chronic lumbo-radiculalgia
648063|NCT00452010|placebo|placebo
648064|NCT00452010|Roland scale|roland scale
648065|NCT00451997|AML|aml
648066|NCT00451997|MDS|mds
648067|NCT00451997|Gleevec|gleevec
648068|NCT00451997|Ara-C|ara-c
648069|NCT00451997|C-Kit Positive Acute Myeloid Leukemia|c-kit positive acute myeloid leukemia
648070|NCT00451997|High-Risk Myelodysplastic Syndromes|high-risk myelodysplastic syndromes
648071|NCT00451984|interleukin-2|interleukin-2
648072|NCT00451984|vaccination|vaccination
648073|NCT00451984|treatment experienced|treatment experienced
648074|NCT00451958|Degarelix|degarelix
648075|NCT00451958|prostate cancer|prostate cancer
648076|NCT00451932|Malononitrilamide|malononitrilamide
648077|NCT00451932|Immunosuppression|immunosuppression
648078|NCT00451932|treatment efficacy|treatment efficacy
648079|NCT00451932|treatment effectiveness|treatment effectiveness
648080|NCT00451919|MRI|mri
648081|NCT00451919|Neuropsychology|neuropsychology
648082|NCT00451893|Inguinal hernia|inguinal hernia
648083|NCT00451893|polypropylene mesh|polypropylene mesh
648084|NCT00451893|heavy-weight mesh|heavy-weight mesh
648085|NCT00451893|light-weight mesh|light-weight mesh
648086|NCT00451880|Cancer|cancer
648087|NCT00451880|Solid Tumors|solid tumors
648088|NCT00451880|NSCLC|nsclc
648089|NCT00451867|interstitial cystitis research|interstitial cystitis research
648090|NCT00451867|painful bladder syndrome research|painful bladder syndrome research
648091|NCT00451867|pelvic pain research|pelvic pain research
648092|NCT00451867|interstitial cystitis and autoimmune|interstitial cystitis and autoimmune
648093|NCT00451867|interstitial cystitis and cellcept|interstitial cystitis and cellcept
648094|NCT00451867|interstitial cystitis and mycophenolate mofetil|interstitial cystitis and mycophenolate mofetil
648095|NCT00451867|interstitial cystitis and MMF|interstitial cystitis and mmf
648096|NCT00451867|interstitial cystitis and inflammation|interstitial cystitis and inflammation
648097|NCT00451867|inflammatory diseases and immunosupression|inflammatory diseases and immunosupression
648098|NCT00451854|Drug testing|drug testing
648099|NCT00451854|Adolescence|adolescence
648100|NCT00451854|Student athlete|student athlete
648101|NCT00451854|Substance abuse|substance abuse
648102|NCT00451854|Alcohol use|alcohol use
648103|NCT00451854|Drug use|drug use
648104|NCT00451841|Cough|cough
648105|NCT00451841|Gastroesophageal reflux|gastroesophageal reflux
648106|NCT00451841|Exhaled breath condensate|exhaled breath condensate
648107|NCT00451828|Statins|statins
648108|NCT00451828|Cholesterol|cholesterol
648109|NCT00451828|Pharmacogenetics|pharmacogenetics
648110|NCT00451802|Biotechnology|biotechnology
648111|NCT00451802|Specimen|specimen
648112|NCT00451802|Health Management Center|health management center
648113|NCT00451789|Minor head injury|minor head injury
648114|NCT00451789|iintracranial bleeding|iintracranial bleeding
648115|NCT00451789|traumatic brain injury|traumatic brain injury
648116|NCT00451789|Cranial computed tomography|cranial computed tomography
648117|NCT00451789|anticoagulatory drugs|anticoagulatory drugs
648118|NCT00451776|cardiac surgery|cardiac surgery
648119|NCT00451776|adrenal insufficiency|adrenal insufficiency
648120|NCT00451776|etomidate|etomidate
648121|NCT00451776|propofol|propofol
648122|NCT00451763|Fovea centralis/pathology|fovea centralis/pathology
648123|NCT00451763|Fundus oculi|fundus oculi
648124|NCT00451763|Retinal neovascularization|retinal neovascularization
648125|NCT00451763|Telangiectasis/diagnosis|telangiectasis/diagnosis
648126|NCT00451763|Tomography, optical coherence|tomography, optical coherence
648127|NCT00451763|Vitreous Body/drug effects|vitreous body/drug effects
648128|NCT00451750|phobia|phobia
648129|NCT00451750|cortisol|cortisol
648130|NCT00451750|memory|memory
648131|NCT00451750|treatment|treatment
648132|NCT00451737|Six-minute walk test|six-minute walk test
648133|NCT00451737|Neuromuscular system|neuromuscular system
648134|NCT00451737|Influence factors|influence factors
648135|NCT00451724|Prospective|prospective
648136|NCT00451724|Randomized|randomized
648137|NCT00451724|Double blinded|double blinded
648138|NCT00451724|Sedation|sedation
648139|NCT00451724|Ketamine|ketamine
648140|NCT00451724|Intranasal|intranasal
648141|NCT00451711|Prophylaxis|prophylaxis
648142|NCT00451711|Liposomal Amphotericin B|liposomal amphotericin b
648143|NCT00451711|Acute myeloid leukaemia|acute myeloid leukaemia
648144|NCT00451711|Invasive Fungal Infections|invasive fungal infections
648145|NCT00451698|Erythropoietin|erythropoietin
648146|NCT00451698|Congenital heart surgery|congenital heart surgery
648147|NCT00451672|aldosteronism, bromocriptin, hypertension|aldosteronism, bromocriptin, hypertension
648148|NCT00451659|PTSD|ptsd
648149|NCT00451659|Veterans|veterans
648150|NCT00451659|Deployed|deployed
648151|NCT00451620|Type 2 diabetes|type 2 diabetes
648152|NCT00451620|Hypoglycemia|hypoglycemia
648153|NCT00451620|Oral hypoglycemic agents|oral hypoglycemic agents
648154|NCT00451620|Insulin levels|insulin levels
648155|NCT00451607|premature|premature
648156|NCT00451607|newborn|newborn
648157|NCT00451607|heart rate variability|heart rate variability
648158|NCT00451607|individualized sensorimotor care|individualized sensorimotor care
648159|NCT00451607|noise|noise
648160|NCT00451594|ITP|itp
648161|NCT00451581|Endoscopic papillary balloon dilatation|endoscopic papillary balloon dilatation
648162|NCT00451581|Endoscopic sphincterotomy|endoscopic sphincterotomy
648163|NCT00451581|Choledocholithiasis|choledocholithiasis
648164|NCT00451581|Efficacy|efficacy
648165|NCT00451581|Complication|complication
648166|NCT00451568|Polycystic ovary syndrome|polycystic ovary syndrome
648167|NCT00451542|Bipolar Disorder|bipolar disorder
648168|NCT00451542|Relapse|relapse
648169|NCT00451542|Retrospective|retrospective
648170|NCT00451516|Plant, medicine|plant, medicine
648171|NCT00451516|Psychiatry|psychiatry
648172|NCT00451516|Major depressive disorder|major depressive disorder
648173|NCT00451516|Anxiety|anxiety
648174|NCT00451516|Major Depressive Disorder with comorbid anxiety|major depressive disorder with comorbid anxiety
648175|NCT00451503|Hearing|hearing
648176|NCT00451503|Auditory rehabilitation|auditory rehabilitation
648177|NCT00451503|Middle ear implant|middle ear implant
648178|NCT00451503|Surgery|surgery
648179|NCT00451490|agomelatin|agomelatin
648180|NCT00451490|prozac|prozac
648181|NCT00451490|heart rate variability|heart rate variability
648182|NCT00451490|major depression|major depression
648183|NCT00451490|sleep|sleep
648184|NCT00451490|depressive symptoms|depressive symptoms
648185|NCT00451464|Apolipoprotein, Gene polymorphism, Hyperlipidemia|apolipoprotein, gene polymorphism, hyperlipidemia
648186|NCT00451451|relapsing|relapsing
648187|NCT00451451|multiple sclerosis|multiple sclerosis
648188|NCT00451451|oral|oral
648189|NCT00451451|remitting|remitting
648190|NCT00451438|patellofemoral pain syndrome|patellofemoral pain syndrome
648191|NCT00451438|electromyography|electromyography
648192|NCT00451438|gluteus medius|gluteus medius
648193|NCT00451438|tensor fascia lata|tensor fascia lata
648194|NCT00451425|pregnancy|pregnancy
648195|NCT00451425|weight gain|weight gain
648196|NCT00451425|obesity|obesity
648197|NCT00451425|macrosomia|macrosomia
648198|NCT00451412|Venous thromboembolism|venous thromboembolism
648199|NCT00451412|Medical patients|medical patients
648200|NCT00451412|Heparin|heparin
648201|NCT00451412|Low molecular weight heparin|low molecular weight heparin
648202|NCT00451412|Deep vein thrombosis|deep vein thrombosis
648203|NCT00451412|Certoparin|certoparin
648204|NCT00451412|Embolism and Thrombosis|embolism and thrombosis
648205|NCT00451399|Weight gain|weight gain
648206|NCT00451399|antipsychotic|antipsychotic
648207|NCT00451399|lifestyle interventions|lifestyle interventions
648208|NCT00451399|metformin|metformin
648209|NCT00451399|antipsychotic-induced weight gain.|antipsychotic-induced weight gain.
648210|NCT00451373|ARF, dialysis, cytokine, free radical, major operations|arf, dialysis, cytokine, free radical, major operations
648211|NCT00451360|Diacerein|diacerein
648212|NCT00451360|Hip osteoarthritis|hip osteoarthritis
648213|NCT00451360|Structure-modifying effect / Chondromodulating effect|structure-modifying effect / chondromodulating effect
648214|NCT00451360|Double blind study|double blind study
648215|NCT00451321|type 1 diabetes mellitus|type 1 diabetes mellitus
648216|NCT00451321|diabetes mellitus type 1|diabetes mellitus type 1
648217|NCT00451321|type 1 diabetes|type 1 diabetes
648218|NCT00451321|diabetes mellitus|diabetes mellitus
648219|NCT00451321|diabetes|diabetes
648220|NCT00451308|Induction of labor|induction of labor
648221|NCT00451308|vaginal delivery|vaginal delivery
648222|NCT00451308|cesarean section|cesarean section
648223|NCT00451308|foley balloon cathether|foley balloon cathether
648224|NCT00451308|method of labor induction|method of labor induction
648225|NCT00451308|perinatal outcomes|perinatal outcomes
648226|NCT00451295|Chronic Kidney Disease|chronic kidney disease
648227|NCT00451295|Dialysis|dialysis
648228|NCT00451295|Hyperphosphatemia|hyperphosphatemia
648229|NCT00451269|Malaria|malaria
648230|NCT00451269|Diagnosis|diagnosis
648232|NCT00451269|pLDH|pldh
648233|NCT00451269|HRP2|hrp2
648234|NCT00451269|Patients with fever and history of travel in a malaria|patients with fever and history of travel in a malaria
648235|NCT00451269|country|country
648236|NCT00451256|coronary artery bypass|coronary artery bypass
648237|NCT00451256|cardiovascular disease|cardiovascular disease
648238|NCT00451243|psoriatic arthritis|psoriatic arthritis
648239|NCT00451230|craving, insulin, leptin|craving, insulin, leptin
648240|NCT00451204|Multiple sclerosis|multiple sclerosis
648241|NCT00451204|estrogen|estrogen
648242|NCT00451204|estriol|estriol
648243|NCT00451204|progesterone|progesterone
648244|NCT00451191|benign prostatic hyperplasia|benign prostatic hyperplasia
648245|NCT00451191|BPH|bph
648246|NCT00451191|botulinum toxin|botulinum toxin
648247|NCT00451191|BoNT/A|bont/a
648248|NCT00451165|Laparoscopic|laparoscopic
648249|NCT00451165|Colon|colon
648250|NCT00451165|Rectal|rectal
648251|NCT00451165|Surgery|surgery
648252|NCT00451165|Urinary function|urinary function
648253|NCT00451165|Sexual function|sexual function
648254|NCT00451165|Bowel function|bowel function
648255|NCT00451165|Male|male
648256|NCT00451152|glaucoma|glaucoma
648257|NCT00451126|emotion|emotion
648258|NCT00451126|personality|personality
648259|NCT00451126|social stress|social stress
648260|NCT00451126|appraisal|appraisal
648261|NCT00451113|Type 2 diabetes|type 2 diabetes
648262|NCT00451113|Older adults|older adults
648263|NCT00451113|Incretins|incretins
648264|NCT00451113|Hyperglycemia|hyperglycemia
648265|NCT00451113|Insulin resistance|insulin resistance
648266|NCT00451087|mechanical properties|mechanical properties
648267|NCT00451087|electromechanical delay|electromechanical delay
648268|NCT00451087|viscoelasticity|viscoelasticity
648269|NCT00451087|VMO|vmo
648270|NCT00451087|patellofemoral pain syndrome|patellofemoral pain syndrome
648271|NCT00451074|Stop codon mutations|stop codon mutations
648272|NCT00451061|distal ureterolithiasis|distal ureterolithiasis
648273|NCT00451061|α adrenoreceptors antagonist|α adrenoreceptors antagonist
648274|NCT00451035|Refractory Chronic Myeloid Leukemia in Chronic Phase|refractory chronic myeloid leukemia in chronic phase
648275|NCT00451035|adults|adults
648276|NCT00451035|oral LBH589|oral lbh589
648277|NCT00451022|Fowlpox|fowlpox
648278|NCT00451022|Vaccinia|vaccinia
648279|NCT00451022|PSA|psa
648280|NCT00451022|CEA|cea
648281|NCT00451022|MUC-1|muc-1
648282|NCT00451022|Gene Therapy|gene therapy
648283|NCT00451022|Long Term Survivor|long term survivor
648284|NCT00451022|Research Specimen|research specimen
648285|NCT00451009|IVF|ivf
648286|NCT00451009|Male factor infertility|male factor infertility
648287|NCT00451009|Cryopreservation|cryopreservation
648288|NCT00451009|Cryoprotective agents|cryoprotective agents
648289|NCT00451009|Egg Freezing|egg freezing
648290|NCT00450983|graft versus host disease|graft versus host disease
648291|NCT00450983|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
648292|NCT00450983|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
648293|NCT00450983|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
648294|NCT00450983|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
648295|NCT00450983|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
648296|NCT00450983|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
648297|NCT00450983|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
648298|NCT00450983|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
648299|NCT00450983|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
648300|NCT00450983|secondary acute myeloid leukemia|secondary acute myeloid leukemia
648301|NCT00450983|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
648302|NCT00450983|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
648303|NCT00450983|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
648304|NCT00450983|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
648305|NCT00450983|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
648306|NCT00450983|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
648307|NCT00450983|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
648391|NCT00450645|Cancer|cancer
648308|NCT00450983|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
648309|NCT00450983|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
648310|NCT00450983|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
648311|NCT00450983|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
648312|NCT00450983|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
648313|NCT00450970|Hormone Refractory Prostate Cancer (HRPC)|hormone refractory prostate cancer (hrpc)
648314|NCT00450970|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
648315|NCT00450970|Unlimited Prior Cytotoxic Chemotherapy Regimens|unlimited prior cytotoxic chemotherapy regimens
648316|NCT00450944|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
648317|NCT00450944|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
648318|NCT00450931|health status unknown|health status unknown
648319|NCT00450918|Kartagener Syndrome|kartagener syndrome
648320|NCT00450905|Chronic musculoskeletal pain secondary to Fibromyalgia|chronic musculoskeletal pain secondary to fibromyalgia
648321|NCT00450892|inflammatory breast cancer|inflammatory breast cancer
648322|NCT00450892|stage II breast cancer|stage ii breast cancer
648323|NCT00450892|stage IIIA breast cancer|stage iiia breast cancer
648324|NCT00450892|stage IIIB breast cancer|stage iiib breast cancer
648325|NCT00450892|stage IIIC breast cancer|stage iiic breast cancer
648326|NCT00450866|recurrent breast cancer|recurrent breast cancer
648327|NCT00450866|stage IV breast cancer|stage iv breast cancer
648328|NCT00450866|tumors metastatic to brain|tumors metastatic to brain
648329|NCT00450866|leptomeningeal metastases|leptomeningeal metastases
648330|NCT00450866|male breast cancer|male breast cancer
648331|NCT00450853|emesis|emesis
648332|NCT00450853|granisetron|granisetron
648333|NCT00450853|pharmacokinetics|pharmacokinetics
648334|NCT00450853|subcutaneous.|subcutaneous.
648335|NCT00450840|septic shock|septic shock
648336|NCT00450840|simvastatin|simvastatin
648337|NCT00450827|recurrent neuroblastoma|recurrent neuroblastoma
648338|NCT00450801|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
648339|NCT00450801|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
648340|NCT00450801|stage I mantle cell lymphoma|stage i mantle cell lymphoma
648341|NCT00450801|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
648342|NCT00450801|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
648343|NCT00450788|Etiology|etiology
648344|NCT00450788|Carcinogens|carcinogens
648345|NCT00450788|Esophageal Cancer|esophageal cancer
648346|NCT00450762|pretreated|pretreated
648347|NCT00450762|metastatic|metastatic
648348|NCT00450736|chondrosarcoma|chondrosarcoma
648349|NCT00450736|adult angiosarcoma|adult angiosarcoma
648350|NCT00450736|adult fibrosarcoma|adult fibrosarcoma
648351|NCT00450736|adult leiomyosarcoma|adult leiomyosarcoma
648352|NCT00450736|adult liposarcoma|adult liposarcoma
648353|NCT00450736|adult neurofibrosarcoma|adult neurofibrosarcoma
648354|NCT00450736|adult synovial sarcoma|adult synovial sarcoma
648355|NCT00450736|childhood angiosarcoma|childhood angiosarcoma
648356|NCT00450736|childhood fibrosarcoma|childhood fibrosarcoma
648357|NCT00450736|childhood leiomyosarcoma|childhood leiomyosarcoma
648358|NCT00450736|childhood liposarcoma|childhood liposarcoma
648359|NCT00450736|childhood neurofibrosarcoma|childhood neurofibrosarcoma
648360|NCT00450736|childhood synovial sarcoma|childhood synovial sarcoma
648361|NCT00450736|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
648362|NCT00450736|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
648363|NCT00450736|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
648364|NCT00450736|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
648365|NCT00450736|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
648366|NCT00450736|childhood malignant hemangiopericytoma|childhood malignant hemangiopericytoma
648367|NCT00450736|localized childhood malignant fibrous histiocytoma of bone|localized childhood malignant fibrous histiocytoma of bone
648368|NCT00450723|stage I breast cancer|stage i breast cancer
648369|NCT00450723|stage II breast cancer|stage ii breast cancer
648370|NCT00450723|male breast cancer|male breast cancer
648371|NCT00450697|Feeding intolerance in premature infants|feeding intolerance in premature infants
648372|NCT00450697|Bolus feeding every 4 hours versus every 3 hours|bolus feeding every 4 hours versus every 3 hours
648373|NCT00450697|Feeding method in premature infants|feeding method in premature infants
648374|NCT00450671|Fistula-in-ano|fistula-in-ano
648375|NCT00450671|Anal fistula|anal fistula
648376|NCT00450671|Perirectal fistula|perirectal fistula
648377|NCT00450671|Collagen plug|collagen plug
648378|NCT00450671|Surgisis|surgisis
648379|NCT00450671|Seton|seton
648380|NCT00450658|ibuprofen|ibuprofen
648381|NCT00450658|famotidine|famotidine
648382|NCT00450658|ulcers|ulcers
648383|NCT00450658|NSAIDS|nsaids
648384|NCT00450658|pain|pain
648385|NCT00450658|arthritis|arthritis
648386|NCT00450658|chronic regional pain syndrome|chronic regional pain syndrome
648387|NCT00450658|chronic soft tissue pain|chronic soft tissue pain
648388|NCT00450658|osteoarthritis|osteoarthritis
648389|NCT00450658|rheumatoid arthritis|rheumatoid arthritis
648390|NCT00450658|chronic low back pain|chronic low back pain
648392|NCT00450645|Residual vein thrombosis|residual vein thrombosis
648393|NCT00450645|Low Molecular Weight Heparin|low molecular weight heparin
648394|NCT00450645|Optimal duration|optimal duration
648395|NCT00450632|meningococcal infections|meningococcal infections
648396|NCT00450632|biotheque|biotheque
648397|NCT00450632|genetic markers|genetic markers
648398|NCT00450619|Radionuclide|radionuclide
648399|NCT00450619|Immunotherapy|immunotherapy
648400|NCT00450619|Radiation|radiation
648401|NCT00450619|PSA|psa
648402|NCT00450619|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
648403|NCT00450619|Prostate Cancer|prostate cancer
648404|NCT00450593|melanoma|melanoma
648405|NCT00450593|hereditary multiple melanoma|hereditary multiple melanoma
648406|NCT00450593|recurrent melanoma|recurrent melanoma
648407|NCT00450593|stage 0 melanoma|stage 0 melanoma
648408|NCT00450593|stage IV melanoma|stage iv melanoma
648409|NCT00450593|stage IA melanoma|stage ia melanoma
648410|NCT00450593|stage IB melanoma|stage ib melanoma
648411|NCT00450593|stage IIA melanoma|stage iia melanoma
648412|NCT00450593|stage IIB melanoma|stage iib melanoma
648413|NCT00450593|stage IIC melanoma|stage iic melanoma
648414|NCT00450593|stage IIIA melanoma|stage iiia melanoma
648415|NCT00450593|stage IIIB melanoma|stage iiib melanoma
648416|NCT00450593|stage IIIC melanoma|stage iiic melanoma
648417|NCT00450580|protease inhibitor,|protease inhibitor,
648418|NCT00450580|HIV-1,|hiv-1,
648419|NCT00450580|Fosamprenavir,|fosamprenavir,
648420|NCT00450580|non-HDL cholesterol|non-hdl cholesterol
648421|NCT00450580|ritonavir,|ritonavir,
648422|NCT00450580|naive,|naive,
648423|NCT00450567|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
648424|NCT00450567|stage I non-small cell lung cancer|stage i non-small cell lung cancer
648425|NCT00450567|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
648426|NCT00450567|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
648427|NCT00450567|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
648428|NCT00450567|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
648429|NCT00450554|Neisseria meningitidis B:14, P1-7, 16|neisseria meningitidis b:14, p1-7, 16
648430|NCT00450554|Serum bactericidal activity|serum bactericidal activity
648431|NCT00450554|Menbvac|menbvac
648432|NCT00450541|Advanced Cancer|advanced cancer
648433|NCT00450541|Fatigue|fatigue
648434|NCT00450541|Interview|interview
648435|NCT00450541|Questionnaire|questionnaire
648436|NCT00450541|Survey|survey
648437|NCT00450528|D-dimers|d-dimers
648438|NCT00450528|surgery|surgery
648439|NCT00450528|kinetics|kinetics
648440|NCT00450515|recurrent breast cancer|recurrent breast cancer
648441|NCT00450515|stage IV breast cancer|stage iv breast cancer
648442|NCT00450515|male breast cancer|male breast cancer
648443|NCT00450502|Cytotoxic|cytotoxic
648444|NCT00450502|Pharmacokinetics|pharmacokinetics
648445|NCT00450502|Toxicity|toxicity
648446|NCT00450502|Neoplasms|neoplasms
648447|NCT00450502|Pharmacogenomics|pharmacogenomics
648448|NCT00450502|Solid Tumor|solid tumor
648449|NCT00450502|Lymphoma|lymphoma
648450|NCT00450489|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
648451|NCT00450489|Quality of Life|quality of life
648452|NCT00450489|Satisfaction of medical care delivery|satisfaction of medical care delivery
648453|NCT00450476|ventilator associated pneumonia|ventilator associated pneumonia
648454|NCT00450476|prevention|prevention
648455|NCT00450476|endotracheal intubation|endotracheal intubation
648456|NCT00450476|mechanical ventilation|mechanical ventilation
648457|NCT00450463|Immunotherapy|immunotherapy
648458|NCT00450463|Hormonal Therapy|hormonal therapy
648459|NCT00450463|Combination Therapy|combination therapy
648460|NCT00450463|Prostate Specific Antigen|prostate specific antigen
648461|NCT00450463|Immunoassay|immunoassay
648462|NCT00450463|Prostate Cancer|prostate cancer
648463|NCT00450437|Meningococcal|meningococcal
648464|NCT00450437|meningitis|meningitis
648465|NCT00450437|vaccine|vaccine
648466|NCT00450437|adolescents|adolescents
648467|NCT00450437|adults|adults
648468|NCT00450424|colon cancer|colon cancer
648469|NCT00450424|rectal cancer|rectal cancer
648470|NCT00450424|hereditary non-polyposis colon cancer|hereditary non-polyposis colon cancer
648471|NCT00450424|recurrent colon cancer|recurrent colon cancer
648472|NCT00450424|stage I colon cancer|stage i colon cancer
648473|NCT00450424|stage IIA colon cancer|stage iia colon cancer
648474|NCT00450424|stage IIB colon cancer|stage iib colon cancer
648475|NCT00450424|stage IIIA colon cancer|stage iiia colon cancer
648476|NCT00450424|stage IIIB colon cancer|stage iiib colon cancer
648477|NCT00450424|stage IIIC colon cancer|stage iiic colon cancer
648478|NCT00450424|stage IVA colon cancer|stage iva colon cancer
648479|NCT00450424|stage IVB colon cancer|stage ivb colon cancer
648480|NCT00450424|recurrent rectal cancer|recurrent rectal cancer
648481|NCT00450424|stage I rectal cancer|stage i rectal cancer
648482|NCT00450424|stage IIA rectal cancer|stage iia rectal cancer
648483|NCT00450424|stage IIB rectal cancer|stage iib rectal cancer
648484|NCT00450424|stage IIC rectal cancer|stage iic rectal cancer
648485|NCT00450424|stage IIIA rectal cancer|stage iiia rectal cancer
648486|NCT00450424|stage IIIB rectal cancer|stage iiib rectal cancer
648574|NCT00450034|Underuse|underuse
648487|NCT00450424|stage IIIC rectal cancer|stage iiic rectal cancer
648488|NCT00450424|stage IVA rectal cancer|stage iva rectal cancer
648489|NCT00450424|stage IVB rectal cancer|stage ivb rectal cancer
648490|NCT00450411|adenocarcinoma of the prostate|adenocarcinoma of the prostate
648491|NCT00450411|recurrent prostate cancer|recurrent prostate cancer
648492|NCT00450411|stage I prostate cancer|stage i prostate cancer
648493|NCT00450411|stage IIB prostate cancer|stage iib prostate cancer
648494|NCT00450411|stage IIA prostate cancer|stage iia prostate cancer
648495|NCT00450398|Delayed graft function|delayed graft function
648496|NCT00450385|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
648497|NCT00450385|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
648498|NCT00450385|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
648499|NCT00450385|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
648500|NCT00450385|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
648501|NCT00450385|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
648502|NCT00450372|recurrent melanoma|recurrent melanoma
648503|NCT00450372|stage IV melanoma|stage iv melanoma
648504|NCT00450359|breast cancer|breast cancer
648505|NCT00450333|Chronic|chronic
648506|NCT00450320|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
648507|NCT00450320|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
648508|NCT00450307|recurrent neuroblastoma|recurrent neuroblastoma
648509|NCT00450307|stage 4S neuroblastoma|stage 4s neuroblastoma
648510|NCT00450307|disseminated neuroblastoma|disseminated neuroblastoma
648511|NCT00450307|localized unresectable neuroblastoma|localized unresectable neuroblastoma
648512|NCT00450307|regional neuroblastoma|regional neuroblastoma
648513|NCT00450281|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
648514|NCT00450281|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
648515|NCT00450281|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
648516|NCT00450281|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
648517|NCT00450281|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
648518|NCT00450281|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
648519|NCT00450268|Graft versus host disease|graft versus host disease
648520|NCT00450268|Allogeneic hematpoietic stem cell transplantation|allogeneic hematpoietic stem cell transplantation
648521|NCT00450242|vulvar vestibulitis|vulvar vestibulitis
648522|NCT00450242|vestibulitis|vestibulitis
648523|NCT00450216|ibuprofen|ibuprofen
648524|NCT00450216|famotidine|famotidine
648525|NCT00450216|ulcers|ulcers
648526|NCT00450216|NSAIDS|nsaids
648527|NCT00450216|pain|pain
648528|NCT00450216|arthritis|arthritis
648529|NCT00450216|chronic regional pain syndrome|chronic regional pain syndrome
648530|NCT00450216|chronic soft tissue pain|chronic soft tissue pain
648531|NCT00450216|osteoarthritis|osteoarthritis
648532|NCT00450216|rheumatoid arthritis|rheumatoid arthritis
648533|NCT00450216|chronic low back pain|chronic low back pain
648534|NCT00450203|adenocarcinoma of the stomach|adenocarcinoma of the stomach
648535|NCT00450203|adenocarcinoma of the gastro oesophageal junction|adenocarcinoma of the gastro oesophageal junction
648536|NCT00450203|adenocarcinoma of the lower oesophagus|adenocarcinoma of the lower oesophagus
648537|NCT00450190|Growth disorders/drug therapy|growth disorders/drug therapy
648538|NCT00450177|iron|iron
648539|NCT00450177|critical illness|critical illness
648540|NCT00450177|anemia|anemia
648541|NCT00450177|infection|infection
648542|NCT00450164|Variceal bleeding|variceal bleeding
648543|NCT00450164|Secondary profilaxis|secondary profilaxis
648544|NCT00450164|Hemodynamic|hemodynamic
648545|NCT00450164|Portal hypertension|portal hypertension
648546|NCT00450151|Pediatric|pediatric
648547|NCT00450151|Cardiopulmonary bypass Surgery|cardiopulmonary bypass surgery
648548|NCT00450151|Cardiac Surgery|cardiac surgery
648549|NCT00450151|Platelet|platelet
648550|NCT00450151|Platelet Activation Markers|platelet activation markers
648551|NCT00450151|Platelet Factor4|platelet factor4
648552|NCT00450151|Transforming Growth Factor Beta|transforming growth factor beta
648553|NCT00450138|Squamous Cell Carcinoma|squamous cell carcinoma
648554|NCT00450125|Lung Cancer|lung cancer
648555|NCT00450125|Lung Resection|lung resection
648556|NCT00450125|Exercise Stress Test|exercise stress test
648557|NCT00450125|Six-Minute Walk Test|six-minute walk test
648558|NCT00450099|Epidural|epidural
648559|NCT00450099|Labor Analgesia|labor analgesia
648560|NCT00450099|Bupivacaine|bupivacaine
648561|NCT00450099|Dose-response|dose-response
648562|NCT00450099|Minimum effective volume|minimum effective volume
648563|NCT00450060|postlumbar puncture headache|postlumbar puncture headache
648564|NCT00450060|atraumatic needle|atraumatic needle
648565|NCT00450060|Sprotte|sprotte
648566|NCT00450060|Quincke|quincke
648567|NCT00450060|lumbar puncture|lumbar puncture
648568|NCT00450060|headache|headache
648569|NCT00450060|backache|backache
648570|NCT00450047|cognitive impairment, ergometer, speed-feedback therapy|cognitive impairment, ergometer, speed-feedback therapy
648571|NCT00450034|Frail Elderly|frail elderly
648572|NCT00450034|Patient Education|patient education
648573|NCT00450034|Drug optimization|drug optimization
648576|NCT00450034|Drug related hospitalization|drug related hospitalization
648577|NCT00450034|Medical intervention|medical intervention
648578|NCT00450021|PET|pet
648579|NCT00450021|CB1 Receptor|cb1 receptor
648580|NCT00450021|Cannabinoid|cannabinoid
648581|NCT00450021|[11C] MePPEP|[11c] meppep
648582|NCT00450021|Brain Imaging|brain imaging
648583|NCT00450021|Healthy Volunteer|healthy volunteer
648584|NCT00450021|HV|hv
648585|NCT00450008|Prostate Cancer|prostate cancer
648586|NCT00450008|Hormone-Naïve Prostate Cancer|hormone-naïve prostate cancer
648587|NCT00450008|adenocarcinoma of the prostate|adenocarcinoma of the prostate
648588|NCT00449982|Genital warts|genital warts
648589|NCT00449982|Condylomata acuminata|condylomata acuminata
648590|NCT00449982|Human Papillomavirus|human papillomavirus
648591|NCT00449982|Polyphenon E|polyphenon e
648592|NCT00449982|Green tea extract|green tea extract
648593|NCT00449982|Vulva|vulva
648594|NCT00449982|Penis|penis
648595|NCT00449982|Anus|anus
648596|NCT00449969|AED (automated external defibrillation)|aed (automated external defibrillation)
648597|NCT00449969|feedback|feedback
648598|NCT00449969|out of hospital resuscitation|out of hospital resuscitation
648599|NCT00449943|Cardiac Invasive Catheterization Angiography|cardiac invasive catheterization angiography
648600|NCT00449943|Single Photon Emission Computed Tomography|single photon emission computed tomography
648601|NCT00449943|Computed Tomography Angiography|computed tomography angiography
648602|NCT00449917|visual caracteristics|visual caracteristics
648603|NCT00449917|macular pigment optical density|macular pigment optical density
648604|NCT00449917|visual acuity|visual acuity
648605|NCT00449917|contrast sensibility|contrast sensibility
648606|NCT00449917|lutein|lutein
648607|NCT00449917|docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
648608|NCT00449904|Cystic fibrosis-related exocrine pancreatic insufficiency|cystic fibrosis-related exocrine pancreatic insufficiency
648609|NCT00449891|Type 1 diabetes mellitus|type 1 diabetes mellitus
648610|NCT00449878|cystic fibrosis-related pancreatic insufficiency|cystic fibrosis-related pancreatic insufficiency
648611|NCT00449865|Parkinson's disease|parkinson's disease
648612|NCT00449865|creatine|creatine
648613|NCT00449865|NET-PD|net-pd
648614|NCT00449865|neuroprotection|neuroprotection
648615|NCT00449865|PD|pd
648616|NCT00449852|Randomized Control Trial|randomized control trial
648617|NCT00449852|Smoking Cessation|smoking cessation
648618|NCT00449852|Secondary Prevention|secondary prevention
648619|NCT00449852|Rehabilitation|rehabilitation
648620|NCT00449852|Counseling|counseling
648621|NCT00449839|Insulin pump treatment CSII|insulin pump treatment csii
648622|NCT00449839|Absorption|absorption
648623|NCT00449839|Insulin Aspart|insulin aspart
648624|NCT00449826|ACS|acs
648625|NCT00449826|Unstable Angina|unstable angina
648626|NCT00449826|NSTEMI|nstemi
648627|NCT00449813|Gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
648628|NCT00449813|Non erosive reflux disease (NERD)|non erosive reflux disease (nerd)
648629|NCT00449800|Sepsis|sepsis
648630|NCT00449800|Ceftriaxone|ceftriaxone
648631|NCT00449800|Pharmacokinetic|pharmacokinetic
648632|NCT00449800|Intensive care unit|intensive care unit
648633|NCT00449787|Emergency department|emergency department
648634|NCT00449787|headache|headache
648635|NCT00449787|migraine|migraine
648636|NCT00449774|Food effect|food effect
648637|NCT00449774|Safety|safety
648638|NCT00449774|Tolerability|tolerability
648639|NCT00449774|Water effect|water effect
648640|NCT00449774|Bioequivalence|bioequivalence
648641|NCT00449761|Refractory|refractory
648642|NCT00449761|Chronic Myeloid|chronic myeloid
648643|NCT00449761|Leukemia|leukemia
648644|NCT00449761|accelerated phase|accelerated phase
648645|NCT00449761|blast phase (blast crisis)|blast phase (blast crisis)
648646|NCT00449761|adults|adults
648647|NCT00449761|oral LBH589|oral lbh589
648648|NCT00449748|Systemic Mastocytosis|systemic mastocytosis
648649|NCT00449748|RAD001|rad001
648650|NCT00449735|positive isolates|positive isolates
648651|NCT00449735|ecoli|ecoli
648652|NCT00449735|blood cultures|blood cultures
648653|NCT00449735|positive cultures for ecoli|positive cultures for ecoli
648654|NCT00449735|blood stream infections|blood stream infections
648655|NCT00449709|Pre-term labor,|pre-term labor,
648656|NCT00449709|modified release formulation|modified release formulation
648657|NCT00449709|pharmacokinetics,|pharmacokinetics,
648658|NCT00449683|Depressive Disorders|depressive disorders
648659|NCT00449683|Excessive Sweating|excessive sweating
648660|NCT00449683|Sweating caused by antidepressants for those a depressive disorder|sweating caused by antidepressants for those a depressive disorder
648661|NCT00449670|Influenza|influenza
648662|NCT00449670|Influenza Vaccine|influenza vaccine
648663|NCT00449644|Tuberculosis|tuberculosis
648664|NCT00449644|MDR TB|mdr tb
648665|NCT00449631|Glaucoma|glaucoma
648666|NCT00449631|Drug Resistance, Multiple|drug resistance, multiple
648667|NCT00449631|Trabeculectomy|trabeculectomy
648668|NCT00449618|Aspirin|aspirin
648669|NCT00449618|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
648670|NCT00449618|Chronotherapy|chronotherapy
648671|NCT00449618|Circadian|circadian
648672|NCT00449605|Diabetes|diabetes
648674|NCT00449592|Stem cell transplantation|stem cell transplantation
648675|NCT00449592|Mucositis|mucositis
648676|NCT00449592|Zinc|zinc
648677|NCT00449579|Ischemia|ischemia
648678|NCT00449579|Myocardial|myocardial
648679|NCT00449579|HF-ECG|hf-ecg
648680|NCT00449566|Magnetic Resonance Imaging|magnetic resonance imaging
648681|NCT00449566|Diffusion Tensor Imaging|diffusion tensor imaging
648682|NCT00449553|Glucose Metabolism Disorder|glucose metabolism disorder
648683|NCT00449553|Dysmetabolic Syndrome|dysmetabolic syndrome
648684|NCT00449553|Type II Diabetes|type ii diabetes
648685|NCT00449553|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
648686|NCT00449553|Dyslipidemia|dyslipidemia
648687|NCT00449553|Drug Therapy|drug therapy
648688|NCT00449540|Migraine with aura|migraine with aura
648689|NCT00449540|aura|aura
648690|NCT00449540|TMS|tms
648691|NCT00449527|Mild asthma|mild asthma
648692|NCT00449527|Moderate asthma|moderate asthma
648693|NCT00449514|infertility|infertility
648694|NCT00449514|ovulation dysfunction|ovulation dysfunction
648695|NCT00449514|endometrium|endometrium
648696|NCT00449514|tamoxifen|tamoxifen
648697|NCT00449514|clomiphene citrate|clomiphene citrate
648698|NCT00449501|Mild Asthma|mild asthma
648699|NCT00449501|Moderate Asthma|moderate asthma
648700|NCT00449488|erythropoietin|erythropoietin
648701|NCT00449488|myocardial infarction|myocardial infarction
648702|NCT00449488|PCI|pci
648703|NCT00449488|left ventricular function|left ventricular function
648704|NCT00449462|CLA|cla
648705|NCT00449462|liver|liver
648706|NCT00449462|kidney|kidney
648707|NCT00449449|Pertubation, tubal flushing, intrauterine insemination.|pertubation, tubal flushing, intrauterine insemination.
648708|NCT00449436|HIV|hiv
648709|NCT00449436|treatment experienced|treatment experienced
648710|NCT00449423|Acute heart failure|acute heart failure
648711|NCT00449423|Metabolic modulation|metabolic modulation
648712|NCT00449410|Atrial Fibrillation|atrial fibrillation
648713|NCT00449410|elderly|elderly
648714|NCT00449410|cholesterol lowering|cholesterol lowering
648715|NCT00449410|neurocognitive function|neurocognitive function
648716|NCT00449410|cerebrovascular lesion|cerebrovascular lesion
648717|NCT00449397|First Episode Psychosis|first episode psychosis
648718|NCT00449384|Severe Impairment Battery|severe impairment battery
648719|NCT00449384|Clinical Dementia Rating|clinical dementia rating
648720|NCT00449358|bcc|bcc
648721|NCT00449345|Latent tuberculosis infection|latent tuberculosis infection
648722|NCT00449345|Health care workers|health care workers
648723|NCT00449345|Tuberculin skin test|tuberculin skin test
648724|NCT00449345|Mantoux skin test|mantoux skin test
648725|NCT00449345|Interferon gamma|interferon gamma
648726|NCT00449345|Quantiferon|quantiferon
648727|NCT00449345|Cost effectiveness|cost effectiveness
648728|NCT00449332|Chronic rejection, lung transplant, cytokines, bos|chronic rejection, lung transplant, cytokines, bos
648729|NCT00449319|AML|aml
648730|NCT00449319|adult|adult
648731|NCT00449319|Hydroxyurea|hydroxyurea
648732|NCT00449319|Transplant|transplant
648733|NCT00449319|Toevaluate biological characteristics at diagnosis.|toevaluate biological characteristics at diagnosis.
648734|NCT00449319|To identify genetic alterations with prognostic relevance.|to identify genetic alterations with prognostic relevance.
648735|NCT00449319|To follow up cases monitoring minimal disease during remission.|to follow up cases monitoring minimal disease during remission.
648736|NCT00449319|To evaluate pretreatment therapy in terms of response rate and toxicity.|to evaluate pretreatment therapy in terms of response rate and toxicity.
648737|NCT00449319|Disease free survival.|disease free survival.
648738|NCT00449319|Overal survival.|overal survival.
648739|NCT00449306|Atherosclerosis|atherosclerosis
648740|NCT00449306|Carotid plaque|carotid plaque
648741|NCT00449306|Abdominal aortic aneurysm|abdominal aortic aneurysm
648742|NCT00449306|Vulnerable plaque|vulnerable plaque
648743|NCT00449306|Angiogenesis|angiogenesis
648744|NCT00449306|Intraplaque hemorrhage|intraplaque hemorrhage
648745|NCT00449306|Carotid artery atherosclerosis|carotid artery atherosclerosis
648746|NCT00449293|Smoking cessation|smoking cessation
648747|NCT00449293|Tobacco dependence|tobacco dependence
648748|NCT00449293|Mindfulness|mindfulness
648749|NCT00449293|fMRI|fmri
648750|NCT00449293|Craving|craving
648751|NCT00449280|metastatic|metastatic
648752|NCT00449280|advanced disease|advanced disease
648753|NCT00449280|phase I|phase i
648754|NCT00449267|Lenses, Intraocular|lenses, intraocular
648755|NCT00449267|Prospective Studies|prospective studies
648756|NCT00449267|Visual acuity|visual acuity
648757|NCT00449267|Clinical Trial|clinical trial
648758|NCT00449241|Acupuncture, Endoscopy|acupuncture, endoscopy
648759|NCT00449228|Osteoarthritis,|osteoarthritis,
648760|NCT00449228|hip replacement,|hip replacement,
648761|NCT00449228|education,|education,
648762|NCT00449228|randomized controlled trial,|randomized controlled trial,
648763|NCT00449228|mini-invasive surgery|mini-invasive surgery
648764|NCT00449215|Peak Bone Mass; Male; Genetic Polymorphisms|peak bone mass; male; genetic polymorphisms
648765|NCT00449176|Low Back Pain|low back pain
648766|NCT00449176|Chronic Pain|chronic pain
648767|NCT00449176|Pain Assessment|pain assessment
648768|NCT00449176|Tapentadol|tapentadol
648769|NCT00449163|stage IV colon cancer|stage iv colon cancer
648770|NCT00449163|stage IV rectal cancer|stage iv rectal cancer
648771|NCT00449163|adenocarcinoma of the colon|adenocarcinoma of the colon
648772|NCT00449163|adenocarcinoma of the rectum|adenocarcinoma of the rectum
648773|NCT00449150|Cetrorelix|cetrorelix
648774|NCT00449137|recurrent colon cancer|recurrent colon cancer
648775|NCT00449137|stage IV colon cancer|stage iv colon cancer
648776|NCT00449137|recurrent rectal cancer|recurrent rectal cancer
648777|NCT00449137|stage IV rectal cancer|stage iv rectal cancer
648778|NCT00449124|hepatitis C, vaccine, TG4040|hepatitis c, vaccine, tg4040
648779|NCT00449098|Glaucoma|glaucoma
648780|NCT00449098|Collagen matrix|collagen matrix
648781|NCT00449098|ologen|ologen
648782|NCT00449098|OculusGen|oculusgen
648783|NCT00449098|Trabeculectomy|trabeculectomy
648784|NCT00449098|anti scarring|anti scarring
648785|NCT00449098|tissue engineering|tissue engineering
648786|NCT00449098|high risk patient for trabeculectomy|high risk patient for trabeculectomy
648787|NCT00449098|Aeon Astron|aeon astron
648788|NCT00449059|heart transplantation|heart transplantation
648789|NCT00449059|cyclosporine|cyclosporine
648790|NCT00449059|hypertension|hypertension
648791|NCT00449059|nitroglycerin|nitroglycerin
648792|NCT00449046|salmeterol/fluticasone propionate combination|salmeterol/fluticasone propionate combination
648793|NCT00449046|pediatric bronchial asthma|pediatric bronchial asthma
648794|NCT00449033|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
648795|NCT00449033|Cancer|cancer
648796|NCT00449020|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
648797|NCT00449020|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
648798|NCT00449007|Major depressive disorder|major depressive disorder
648799|NCT00449007|Alcohol abuse|alcohol abuse
648800|NCT00449007|Alcohol dependence|alcohol dependence
648801|NCT00449007|Suicide|suicide
648802|NCT00448994|adenovirus, fungal, diagnostics, children|adenovirus, fungal, diagnostics, children
648803|NCT00448981|Preventing upper respiratory tract infections|preventing upper respiratory tract infections
648804|NCT00448981|Preventing influenza|preventing influenza
648805|NCT00448981|Preventing the common cold|preventing the common cold
648806|NCT00448981|Hand hygiene and upper respiratory infections|hand hygiene and upper respiratory infections
648807|NCT00448981|Mask use in preventing upper respiratory infections|mask use in preventing upper respiratory infections
648808|NCT00448968|Sepsis|sepsis
648809|NCT00448968|Ischemia Modified Albumin|ischemia modified albumin
648810|NCT00448968|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
648811|NCT00448942|Staphylococcus aureus [B03.510.400.790.750.100]|staphylococcus aureus [b03.510.400.790.750.100]
648812|NCT00448942|Enterococcus faecalis [B03.510.400.800.280.280]|enterococcus faecalis [b03.510.400.800.280.280]
648813|NCT00448942|Enterococcus faecium [B03.510.400.800.280.300]|enterococcus faecium [b03.510.400.800.280.300]
648814|NCT00448942|Bacteremia [C01.252.100]|bacteremia [c01.252.100]
648815|NCT00448942|Fungemia [C01.703.360]|fungemia [c01.703.360]
648816|NCT00448942|Infection Control [G03.850.780.200.450]|infection control [g03.850.780.200.450]
648817|NCT00448942|Antisepsis [G03.850.780.200.450.150]|antisepsis [g03.850.780.200.450.150]
648818|NCT00448929|Glaucoma|glaucoma
648819|NCT00448929|Collagen matrix|collagen matrix
648820|NCT00448929|ologen|ologen
648821|NCT00448929|OculusGen|oculusgen
648822|NCT00448929|Trabeculectomy|trabeculectomy
648823|NCT00448916|Partial-onset seizures; epilepsy; pediatric; pregabalin; 1 year extension study; safety; tolerability|partial-onset seizures; epilepsy; pediatric; pregabalin; 1 year extension study; safety; tolerability
648824|NCT00448903|diabetic|diabetic
648825|NCT00448903|foot|foot
648826|NCT00448903|ulcer|ulcer
648827|NCT00448903|bemiparin|bemiparin
648828|NCT00448903|neuropathy|neuropathy
648829|NCT00448903|neuroishemic|neuroishemic
648830|NCT00448903|diabetes|diabetes
648831|NCT00448890|AMPA positive modulator, healthy volunteers|ampa positive modulator, healthy volunteers
648832|NCT00448877|No specific disease is being studied, few procedures are excluded.|no specific disease is being studied, few procedures are excluded.
648833|NCT00448877|The focus of the study is to rule out the efficacy of the device, so the aim is to include as wide a variety of procedures as possible.|the focus of the study is to rule out the efficacy of the device, so the aim is to include as wide a variety of procedures as possible.
648834|NCT00448851|asthma|asthma
648835|NCT00448851|allergy|allergy
648836|NCT00448838|recurrent pancreatic cancer|recurrent pancreatic cancer
648837|NCT00448838|stage III pancreatic cancer|stage iii pancreatic cancer
648838|NCT00448838|stage IV pancreatic cancer|stage iv pancreatic cancer
648839|NCT00448838|stage II pancreatic cancer|stage ii pancreatic cancer
648840|NCT00448825|alcohol dependence|alcohol dependence
648841|NCT00448825|alcoholism|alcoholism
648842|NCT00448825|cocaine addiction|cocaine addiction
648843|NCT00448825|cocaine dependence|cocaine dependence
648844|NCT00448799|neurological|neurological
648845|NCT00448799|alzheimers|alzheimers
648846|NCT00448786|gallbladder|gallbladder
648847|NCT00448786|AMG 706|amg 706
648848|NCT00448786|solid tumors|solid tumors
648849|NCT00448786|Phase 1b|phase 1b
648850|NCT00448786|Amgen|amgen
648851|NCT00448760|stage II esophageal cancer|stage ii esophageal cancer
648852|NCT00448760|stage III esophageal cancer|stage iii esophageal cancer
648853|NCT00448760|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
650540|NCT00444535|Her2-neu|her2-neu
648854|NCT00448747|Ghrelin mimetic, growth hormone secretagogue|ghrelin mimetic, growth hormone secretagogue
648855|NCT00448734|metastatic|metastatic
648856|NCT00448734|hormone-refractory|hormone-refractory
648857|NCT00448734|prostate cancer|prostate cancer
648858|NCT00448734|picoplatin|picoplatin
648859|NCT00448734|platinum drug|platinum drug
648860|NCT00448734|chemotherapy|chemotherapy
648861|NCT00448734|docetaxel|docetaxel
648862|NCT00448721|renal cell carcinoma|renal cell carcinoma
648863|NCT00448721|tyrosine kinase inhibitor failure|tyrosine kinase inhibitor failure
648864|NCT00448708|Hemodialysis Access|hemodialysis access
648866|NCT00448695|Laser Thermal Therapy|laser thermal therapy
648867|NCT00448695|Focal Ablation|focal ablation
648868|NCT00448695|Prostate Cancer|prostate cancer
648869|NCT00448682|recurrent gastric cancer|recurrent gastric cancer
648870|NCT00448682|stage IV gastric cancer|stage iv gastric cancer
648871|NCT00448682|adenocarcinoma of the stomach|adenocarcinoma of the stomach
648872|NCT00448669|HIV incidence|hiv incidence
648873|NCT00448669|HIV prevention|hiv prevention
648874|NCT00448669|Tenofovir|tenofovir
648875|NCT00448669|Emtricitabine|emtricitabine
648876|NCT00448669|Botswana|botswana
648877|NCT00448669|HIV seronegativity|hiv seronegativity
648878|NCT00448656|atrial fibrillation|atrial fibrillation
648879|NCT00448656|epicardial ablation pulmonary veins|epicardial ablation pulmonary veins
648880|NCT00448656|video assisted thoracic surgery|video assisted thoracic surgery
648881|NCT00448643|endometrial adenocarcinoma|endometrial adenocarcinoma
648882|NCT00448643|endometrial clear cell carcinoma|endometrial clear cell carcinoma
648883|NCT00448643|endometrial papillary carcinoma|endometrial papillary carcinoma
648884|NCT00448643|stage III endometrial carcinoma|stage iii endometrial carcinoma
648885|NCT00448643|stage IV endometrial carcinoma|stage iv endometrial carcinoma
648886|NCT00448630|Atypical antipsychotics, Metabolic syndrome, Safety|atypical antipsychotics, metabolic syndrome, safety
648887|NCT00448617|live attenuated influenza virus|live attenuated influenza virus
648888|NCT00448617|inflammation|inflammation
648889|NCT00448617|flu vaccine|flu vaccine
648890|NCT00448617|FluMist|flumist
648891|NCT00448617|smokers|smokers
648892|NCT00448604|procalcitonin|procalcitonin
648893|NCT00448604|acute exacerbation|acute exacerbation
648894|NCT00448604|RT-PCR|rt-pcr
648895|NCT00448604|Biological Markers|biological markers
648896|NCT00448578|Acute Mania|acute mania
648897|NCT00448565|extubation|extubation
648898|NCT00448565|prediction|prediction
648899|NCT00448552|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
648900|NCT00448552|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
648901|NCT00448552|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
648902|NCT00448552|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
648903|NCT00448552|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
648904|NCT00448552|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
648905|NCT00448552|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
648906|NCT00448552|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
648907|NCT00448552|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
648908|NCT00448552|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
648909|NCT00448552|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
648910|NCT00448552|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
648911|NCT00448552|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
648912|NCT00448552|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
648913|NCT00448552|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
648914|NCT00448552|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
648915|NCT00448552|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
648916|NCT00448552|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
648917|NCT00448552|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
648918|NCT00448552|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
648919|NCT00448552|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
648920|NCT00448552|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
648921|NCT00448552|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
648922|NCT00448552|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
648923|NCT00448552|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
648924|NCT00448552|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
648925|NCT00448552|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
648926|NCT00448552|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
650908|NCT00020345|cancer|cancer
648927|NCT00448552|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
648928|NCT00448552|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
648929|NCT00448552|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
648930|NCT00448552|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
648931|NCT00448552|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
648932|NCT00448552|recurrent salivary gland cancer|recurrent salivary gland cancer
648933|NCT00448552|stage IV salivary gland cancer|stage iv salivary gland cancer
648934|NCT00448552|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
648935|NCT00448552|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
648936|NCT00448539|Refractory Partial Onset Seizures, epilepsy|refractory partial onset seizures, epilepsy
648937|NCT00448526|Low protein diet, type 2 Diabetic nephropathy|low protein diet, type 2 diabetic nephropathy
648938|NCT00448526|Comparing the effect of Low protein Diet on diabetic nephropathy to that of normal protein diet|comparing the effect of low protein diet on diabetic nephropathy to that of normal protein diet
648939|NCT00448513|catechin|catechin
648940|NCT00448513|oxidative stress|oxidative stress
648941|NCT00448513|chromosome damage|chromosome damage
648942|NCT00448513|aged|aged
648943|NCT00448500|COPD|copd
648944|NCT00448500|exhaled breath condenate|exhaled breath condenate
648945|NCT00448500|Exhaled breath condenate, acute exacerbation of COPD|exhaled breath condenate, acute exacerbation of copd
648946|NCT00448487|Diabetes|diabetes
648947|NCT00448487|Cardiovascular Disease|cardiovascular disease
648948|NCT00448487|Haptoglobin|haptoglobin
648949|NCT00448474|Disease self-management|disease self-management
648950|NCT00448474|Community program|community program
648951|NCT00448461|coronary artery disease|coronary artery disease
648952|NCT00448461|percutaneous coronary interventions|percutaneous coronary interventions
648953|NCT00448448|adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
648954|NCT00448448|orthotics|orthotics
648955|NCT00448448|bracing|bracing
648956|NCT00448448|partially randomized preference design|partially randomized preference design
648957|NCT00448435|Salmeterol|salmeterol
648958|NCT00448435|Fluticasone propionate|fluticasone propionate
648959|NCT00448435|Salmeterol/Fluticasone propionate combination|salmeterol/fluticasone propionate combination
648960|NCT00448435|Pediatric bronchial asthma|pediatric bronchial asthma
648961|NCT00448422|Traveler's|traveler's
648962|NCT00448422|Diarrhea|diarrhea
648963|NCT00448409|Prostate cancer|prostate cancer
648964|NCT00448409|hormone refractory prostate cancer|hormone refractory prostate cancer
648965|NCT00448409|androgen resistant prostate cancer|androgen resistant prostate cancer
648966|NCT00448396|Cancer|cancer
648967|NCT00448396|EPO|epo
648968|NCT00448396|Patupilone|patupilone
648969|NCT00448396|Solid tumors|solid tumors
648970|NCT00448396|Advanced malignancies|advanced malignancies
648971|NCT00448370|Anemia, sickle cell|anemia, sickle cell
648972|NCT00448357|refractory multiple myeloma|refractory multiple myeloma
648973|NCT00448357|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
648974|NCT00448357|secondary acute myeloid leukemia|secondary acute myeloid leukemia
648975|NCT00448357|stage II multiple myeloma|stage ii multiple myeloma
648976|NCT00448357|stage III multiple myeloma|stage iii multiple myeloma
648977|NCT00448357|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
648978|NCT00448357|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
648979|NCT00448357|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
648980|NCT00448357|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
648981|NCT00448357|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
648982|NCT00448357|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
648983|NCT00448357|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
648984|NCT00448357|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
648985|NCT00448357|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
648986|NCT00448357|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
648987|NCT00448357|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
648988|NCT00448357|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
648989|NCT00448357|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
648990|NCT00448357|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
649311|NCT00447655|Amputation|amputation
648991|NCT00448357|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
648992|NCT00448357|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
648993|NCT00448357|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
648994|NCT00448357|chronic eosinophilic leukemia|chronic eosinophilic leukemia
648995|NCT00448357|chronic neutrophilic leukemia|chronic neutrophilic leukemia
648996|NCT00448357|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
648997|NCT00448357|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
648998|NCT00448357|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
648999|NCT00448357|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
649000|NCT00448357|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
649001|NCT00448357|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
649002|NCT00448357|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
649003|NCT00448357|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
649004|NCT00448357|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
649005|NCT00448357|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
649006|NCT00448357|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
649007|NCT00448357|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
649008|NCT00448357|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
649009|NCT00448357|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
649010|NCT00448357|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
649011|NCT00448357|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
649012|NCT00448357|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
649013|NCT00448357|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
649014|NCT00448357|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
649015|NCT00448357|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
649016|NCT00448357|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
649017|NCT00448357|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
649018|NCT00448357|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
649019|NCT00448357|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
649020|NCT00448357|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
649021|NCT00448357|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
649022|NCT00448357|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
649023|NCT00448357|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
649024|NCT00448357|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
649025|NCT00448357|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
649026|NCT00448357|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
649027|NCT00448357|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
649028|NCT00448357|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
649029|NCT00448357|primary myelofibrosis|primary myelofibrosis
649030|NCT00448357|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
649031|NCT00448357|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
649032|NCT00448357|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
649033|NCT00448357|prolymphocytic leukemia|prolymphocytic leukemia
649034|NCT00448357|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
649035|NCT00448357|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
649036|NCT00448357|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
649037|NCT00448357|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
649038|NCT00448357|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
649039|NCT00448357|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
649040|NCT00448357|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
649041|NCT00448357|polycythemia vera|polycythemia vera
649042|NCT00448357|essential thrombocythemia|essential thrombocythemia
649043|NCT00448357|splenic marginal zone lymphoma|splenic marginal zone lymphoma
649044|NCT00448357|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
649045|NCT00448357|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
649046|NCT00448357|stage I multiple myeloma|stage i multiple myeloma
649047|NCT00448357|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
649048|NCT00448357|adult nasal type extranodal natural killer (NK)/T-cell lymphoma|adult nasal type extranodal natural killer (nk)/t-cell lymphoma
649049|NCT00448344|veterans|veterans
649050|NCT00448344|smoking cessation|smoking cessation
649051|NCT00448331|Mental Disorders|mental disorders
649052|NCT00448331|Mentally Ill Persons|mentally ill persons
649053|NCT00448331|Emergency Medicine|emergency medicine
649054|NCT00448331|Emergency Department|emergency department
649055|NCT00448331|Screening|screening
649056|NCT00448318|Controlled clinical trial|controlled clinical trial
649057|NCT00448305|breast cancer|breast cancer
649058|NCT00448305|metastatic|metastatic
649059|NCT00448305|relapsed|relapsed
649060|NCT00448305|triple-receptor negative|triple-receptor negative
649061|NCT00448305|EndoTAG-1|endotag-1
649062|NCT00448305|metastatic or relapsed breast neoplasm|metastatic or relapsed breast neoplasm
649063|NCT00448292|Depression|depression
649064|NCT00448292|Major Depressive Disorder|major depressive disorder
649065|NCT00448292|Major Depression|major depression
649067|NCT00448266|Breast cancer|breast cancer
649068|NCT00448266|high-dose chemotherapy|high-dose chemotherapy
651093|NCT00442923|anxiety|anxiety
649069|NCT00448266|Homologous Recombination Deficiency|homologous recombination deficiency
649070|NCT00448266|Alkylator therapy|alkylator therapy
649071|NCT00448266|Peripheral Blood Progenitor Cell Support|peripheral blood progenitor cell support
649072|NCT00448253|Inhalational Anthrax|inhalational anthrax
649073|NCT00448253|Human Immune globulin|human immune globulin
649074|NCT00448227|Infants, Herpes simplex infection|infants, herpes simplex infection
649075|NCT00448214|Factor Xa inhibitor|factor xa inhibitor
649076|NCT00448214|Atrial fibrillation|atrial fibrillation
649077|NCT00448214|Stroke|stroke
649078|NCT00448214|Ischemic attack|ischemic attack
649079|NCT00448214|thromboembolism|thromboembolism
649080|NCT00448214|Prevention and control|prevention and control
649081|NCT00448201|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
649082|NCT00448201|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
649083|NCT00448201|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
649084|NCT00448201|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
649085|NCT00448201|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
649086|NCT00448201|prolymphocytic leukemia|prolymphocytic leukemia
649087|NCT00448201|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
649088|NCT00448201|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
649089|NCT00448201|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
649090|NCT00448201|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
649091|NCT00448201|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
649092|NCT00448201|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
649093|NCT00448201|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
649094|NCT00448201|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
649095|NCT00448201|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
649096|NCT00448201|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
649097|NCT00448201|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
649098|NCT00448201|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
649099|NCT00448201|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
649100|NCT00448201|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
649101|NCT00448201|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
649102|NCT00448201|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
649103|NCT00448201|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
649104|NCT00448201|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
649105|NCT00448201|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
649106|NCT00448201|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
649107|NCT00448201|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
649108|NCT00448201|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
649109|NCT00448201|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
649110|NCT00448201|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
649111|NCT00448201|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
649112|NCT00448201|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
649113|NCT00448201|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
649114|NCT00448201|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
649115|NCT00448201|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
649116|NCT00448201|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
649117|NCT00448201|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
649118|NCT00448201|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
649119|NCT00448201|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
649120|NCT00448201|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
649121|NCT00448201|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
649122|NCT00448201|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
649123|NCT00448201|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
649124|NCT00448201|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
649125|NCT00448201|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
649126|NCT00448201|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
649127|NCT00448201|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
649128|NCT00448201|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
649129|NCT00448201|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
649130|NCT00448201|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
652275|NCT00439361|Carboplatin|carboplatin
649131|NCT00448201|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
649132|NCT00448201|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
649133|NCT00448201|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
649134|NCT00448201|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
649135|NCT00448201|refractory multiple myeloma|refractory multiple myeloma
649136|NCT00448201|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
649137|NCT00448201|secondary acute myeloid leukemia|secondary acute myeloid leukemia
649138|NCT00448201|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
649139|NCT00448201|splenic marginal zone lymphoma|splenic marginal zone lymphoma
649140|NCT00448201|stage I multiple myeloma|stage i multiple myeloma
649141|NCT00448201|stage II multiple myeloma|stage ii multiple myeloma
649142|NCT00448201|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
649143|NCT00448201|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
649144|NCT00448201|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
649145|NCT00448201|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
649146|NCT00448201|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
649147|NCT00448201|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
649148|NCT00448201|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
649149|NCT00448201|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
649150|NCT00448201|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
649151|NCT00448201|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
649152|NCT00448201|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
649153|NCT00448201|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
649154|NCT00448201|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
649155|NCT00448201|stage III multiple myeloma|stage iii multiple myeloma
649156|NCT00448201|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
649157|NCT00448201|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
649158|NCT00448201|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
649159|NCT00448201|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
649160|NCT00448201|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
649161|NCT00448201|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
649162|NCT00448201|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
649163|NCT00448201|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
649164|NCT00448201|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
649165|NCT00448201|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
649166|NCT00448201|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
649167|NCT00448201|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
649168|NCT00448201|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
649169|NCT00448201|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
649170|NCT00448201|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
649171|NCT00448201|primary myelofibrosis|primary myelofibrosis
649172|NCT00448201|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
649173|NCT00448201|adult nasal type extranodal natural killer (NK)/T-cell lymphoma|adult nasal type extranodal natural killer (nk)/t-cell lymphoma
649174|NCT00448201|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
649175|NCT00448201|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
649176|NCT00448188|central venous catheter|central venous catheter
649177|NCT00448188|international normalized ratio|international normalized ratio
649178|NCT00448188|thrombocytes|thrombocytes
649179|NCT00448188|bleeding risk|bleeding risk
649180|NCT00448188|all patients in need of central venous line|all patients in need of central venous line
649181|NCT00448188|comparison of patients with normal hemostasis to such with disorders in hemostasis|comparison of patients with normal hemostasis to such with disorders in hemostasis
649182|NCT00448175|OAB symptoms of urgency, frequency, and urge incontinence|oab symptoms of urgency, frequency, and urge incontinence
649183|NCT00448162|hypertension, ENaC, Liddle's syndrome, variation|hypertension, enac, liddle's syndrome, variation
649184|NCT00448149|Kidney cancer|kidney cancer
649185|NCT00448149|Renal cell carcinoma|renal cell carcinoma
649186|NCT00448149|Metastatic RCC|metastatic rcc
649187|NCT00448123|Kidney Stones|kidney stones
649188|NCT00448123|Ureteral Stones|ureteral stones
649189|NCT00448123|Flomax|flomax
649190|NCT00448123|Emergency Medicine|emergency medicine
649191|NCT00448123|Urology|urology
649192|NCT00448097|Adenocarcinoma of the Prostate|adenocarcinoma of the prostate
649193|NCT00448097|Prostate cancer|prostate cancer
649194|NCT00448097|Pre-Prostatectomy|pre-prostatectomy
649195|NCT00448097|Neoadjuvant|neoadjuvant
649196|NCT00448084|Psychogenic Movement Disorders|psychogenic movement disorders
649197|NCT00448084|Volition|volition
649198|NCT00448084|fMRI|fmri
649199|NCT00448084|Functional MRI|functional mri
649200|NCT00448084|Functional Movement Disorder|functional movement disorder
649201|NCT00448084|Healthy Volunteer|healthy volunteer
649202|NCT00448084|HV|hv
649203|NCT00448071|Hypotension|hypotension
649204|NCT00448071|End Stage Renal Disease|end stage renal disease
649205|NCT00448071|Intra Dialytic Hypotension|intra dialytic hypotension
649206|NCT00448071|ESRD|esrd
649207|NCT00448071|Blood Pressure|blood pressure
649208|NCT00448071|Dialysis|dialysis
649209|NCT00448058|Flexible-dose|flexible-dose
649210|NCT00448058|GSK372475|gsk372475
649211|NCT00448058|MDD|mdd
649212|NCT00448058|Venlafaxine XR|venlafaxine xr
649213|NCT00448058|Major Depressive Disorder|major depressive disorder
649214|NCT00448045|Spinal cord injuries|spinal cord injuries
649215|NCT00448045|Cough|cough
649216|NCT00448045|Peak cough flow|peak cough flow
649217|NCT00448045|Respiratory therapy|respiratory therapy
649218|NCT00448045|Rehabilitation|rehabilitation
649219|NCT00448019|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
649220|NCT00448019|Fludarabine|fludarabine
649221|NCT00448019|Cyclophosphamide|cyclophosphamide
649222|NCT00448019|Rituximab|rituximab
649223|NCT00448019|Bevacizumab|bevacizumab
649224|NCT00448019|CLL|cll
649225|NCT00448006|common|common
649226|NCT00448006|bile|bile
649227|NCT00448006|duct|duct
649228|NCT00448006|biliary|biliary
649229|NCT00448006|malignant|malignant
649230|NCT00448006|obstruction|obstruction
649231|NCT00448006|stent|stent
649232|NCT00447993|Retinitis Pigmentosa|retinitis pigmentosa
649233|NCT00447993|eye disease|eye disease
649234|NCT00447993|retinal disorder|retinal disorder
649235|NCT00447993|CNTF|cntf
649236|NCT00447980|Retinitis Pigmentosa|retinitis pigmentosa
649237|NCT00447980|eye disease|eye disease
649238|NCT00447980|retinal disorder|retinal disorder
649239|NCT00447980|CNTF|cntf
649240|NCT00447967|Metastatic Gastric Cancer|metastatic gastric cancer
649241|NCT00447967|Oxaliplatin|oxaliplatin
649242|NCT00447967|Irinotecan|irinotecan
649243|NCT00447954|eye disease|eye disease
649244|NCT00447954|retinal disorder|retinal disorder
649245|NCT00447954|CNTF|cntf
649246|NCT00447928|tendonitis|tendonitis
649247|NCT00447928|nitroglycerin|nitroglycerin
649248|NCT00447928|nitric oxide|nitric oxide
649249|NCT00447928|lateral epicondylitis|lateral epicondylitis
649250|NCT00447902|treatment experienced|treatment experienced
649251|NCT00447837|Chronic Sinusitis|chronic sinusitis
649252|NCT00447824|Pain|pain
649253|NCT00447824|Neonates|neonates
649254|NCT00447824|NIDCAP|nidcap
649255|NCT00447824|Venous|venous
649256|NCT00447824|Capillary|capillary
649257|NCT00447811|Methadone|methadone
649258|NCT00447798|HIV positive|hiv positive
649259|NCT00447798|crack cocaine user|crack cocaine user
649260|NCT00447798|inpatient hospital setting|inpatient hospital setting
649261|NCT00447798|HIV knowledge|hiv knowledge
649262|NCT00447798|motivation|motivation
649263|NCT00447798|perceived self-efficacy|perceived self-efficacy
649264|NCT00447798|risky sexual behavior|risky sexual behavior
649265|NCT00447798|HIV seronegativity|hiv seronegativity
649266|NCT00447785|alcoholism|alcoholism
649267|NCT00447785|nutrition|nutrition
649268|NCT00447785|craving|craving
649269|NCT00447785|energy supplies|energy supplies
649270|NCT00447785|water supplies|water supplies
649271|NCT00447772|Dysport, Cervical Dystonia|dysport, cervical dystonia
649272|NCT00447759|Celecoxib|celecoxib
649273|NCT00447759|Celebrex|celebrex
649274|NCT00447759|Ibuprofen|ibuprofen
649275|NCT00447759|Diclofenac|diclofenac
649276|NCT00447759|NSAID|nsaid
649277|NCT00447759|Osteoarthritis|osteoarthritis
649278|NCT00447759|Rheumatoid Arthritis|rheumatoid arthritis
649279|NCT00447759|Arthritis|arthritis
649280|NCT00447759|Safety study|safety study
649281|NCT00447759|Cardiovascular safety|cardiovascular safety
649282|NCT00447759|Clinical trial|clinical trial
649283|NCT00447759|PROBE design|probe design
649284|NCT00447759|University of Dundee|university of dundee
649285|NCT00447759|Medicines Monitoring Unit|medicines monitoring unit
649286|NCT00447759|MEMO|memo
649287|NCT00447759|Professor Tom MacDonald|professor tom macdonald
649288|NCT00447746|Comparison between D1 and D2 lymphadenectomy for gastric cancer|comparison between d1 and d2 lymphadenectomy for gastric cancer
649289|NCT00447733|mental health|mental health
649290|NCT00447733|substance use|substance use
649291|NCT00447733|treatment|treatment
649292|NCT00447720|HIV prevention skills|hiv prevention skills
649293|NCT00447720|Seriously Mentally Ill (SMI)|seriously mentally ill (smi)
649294|NCT00447720|Substance abuse|substance abuse
649295|NCT00447720|Philadelphia|philadelphia
649296|NCT00447720|HIV seronegativity|hiv seronegativity
649297|NCT00447707|Substance use|substance use
649298|NCT00447707|Unprotected sex|unprotected sex
649299|NCT00447707|Behavioral intervention|behavioral intervention
649300|NCT00447707|HIV care|hiv care
649301|NCT00447707|Prevention with Positives|prevention with positives
649302|NCT00447707|HIV seronegativity|hiv seronegativity
649303|NCT00447694|Iron Chelation|iron chelation
649304|NCT00447694|Deferasirox|deferasirox
649305|NCT00447694|Chelator|chelator
649306|NCT00447694|Desferal|desferal
649307|NCT00447694|beta-thalassemia|beta-thalassemia
649308|NCT00447694|Iron overload|iron overload
649309|NCT00447668|Chronic Low Back Pain|chronic low back pain
649310|NCT00447668|Yoga|yoga
649312|NCT00447655|Self-management|self-management
649313|NCT00447655|Rehabilitation|rehabilitation
649314|NCT00447655|Peer support|peer support
649315|NCT00447642|immunology|immunology
649316|NCT00447642|cornea|cornea
649317|NCT00447642|allograft|allograft
649318|NCT00447642|corneal allograft rejection|corneal allograft rejection
649319|NCT00447642|graft failure|graft failure
649320|NCT00447616|Prostate Cancer|prostate cancer
649321|NCT00447616|Prostatectomy|prostatectomy
649322|NCT00447564|opioid dependence|opioid dependence
649323|NCT00447564|opioid addiction|opioid addiction
649324|NCT00447564|buprenorphine|buprenorphine
649325|NCT00447564|methadone|methadone
649326|NCT00447564|heroin|heroin
649327|NCT00447564|implant|implant
649328|NCT00447564|opioid withdrawal|opioid withdrawal
649329|NCT00447564|opioid pain medication|opioid pain medication
649330|NCT00447564|suboxone|suboxone
649331|NCT00447551|Aesthetic facial volume enhancement|aesthetic facial volume enhancement
649332|NCT00447525|Prevention of : Diphtheria, Tetanus and Poliomyelitis|prevention of : diphtheria, tetanus and poliomyelitis
649333|NCT00447499|Acromegaly|acromegaly
649334|NCT00447499|Somatostatin Analogs|somatostatin analogs
649335|NCT00447499|Somatuline® Autogel®|somatuline® autogel®
649336|NCT00447499|lanreotide|lanreotide
649337|NCT00447499|growth hormone|growth hormone
649338|NCT00447499|IGF-1|igf-1
649339|NCT00447499|Inappropriate Growth Hormone Secretion Syndrome|inappropriate growth hormone secretion syndrome
649340|NCT00447499|Somatotropin Hypersecretion Syndrome|somatotropin hypersecretion syndrome
649341|NCT00447499|Inappropriate GH Secretion Syndrome|inappropriate gh secretion syndrome
649342|NCT00447486|Osteoarthritis,|osteoarthritis,
649343|NCT00447486|knee,|knee,
649344|NCT00447486|GW842166,|gw842166,
649345|NCT00447486|pain,|pain,
649346|NCT00447486|efficacy,|efficacy,
649347|NCT00447486|safety|safety
649348|NCT00447473|Prostate Cancer|prostate cancer
649349|NCT00447473|progressive hormone refractory prostate cancer|progressive hormone refractory prostate cancer
649350|NCT00447460|Graft-vs-host disease (GVHD)|graft-vs-host disease (gvhd)
649351|NCT00447460|Mesenchymal stem cell (MSC)|mesenchymal stem cell (msc)
649352|NCT00447460|Allogeneic hematopoietic stem cell transplant|allogeneic hematopoietic stem cell transplant
649353|NCT00447460|Allotransplant|allotransplant
649354|NCT00447460|Allogenic|allogenic
649355|NCT00447460|Refractory|refractory
649356|NCT00447460|CSM/EICH2005|csm/eich2005
649357|NCT00447434|Nattokinase|nattokinase
649358|NCT00447434|fibrinolytic factors|fibrinolytic factors
649359|NCT00447434|blood lipids|blood lipids
649360|NCT00447434|nutrimental supplement|nutrimental supplement
649361|NCT00447408|hemodialysis|hemodialysis
649362|NCT00447408|dietary adherence|dietary adherence
649363|NCT00447408|sodium|sodium
649364|NCT00447369|pregabalin|pregabalin
649365|NCT00447369|Valproic acid|valproic acid
649366|NCT00447369|migraine|migraine
649367|NCT00447369|prophylaxis|prophylaxis
649368|NCT00447369|prevention|prevention
649369|NCT00447369|treatment|treatment
649370|NCT00447343|Functional MRI|functional mri
649371|NCT00447343|Cervical myelopathy|cervical myelopathy
649372|NCT00447343|Cervical radiculopathy|cervical radiculopathy
649373|NCT00447343|Brain plasticity and regeneration|brain plasticity and regeneration
649374|NCT00447330|metastatic esophagogastric adenocarcinomas|metastatic esophagogastric adenocarcinomas
649375|NCT00447330|ESOPHAGEAL CANCER|esophageal cancer
649376|NCT00447330|GASTRIC CANCER|gastric cancer
649377|NCT00447330|ADENOCARCINOMA|adenocarcinoma
649378|NCT00447330|TARGTED THERAPY|targted therapy
649379|NCT00447330|BEVACIZUMAB|bevacizumab
649380|NCT00447330|CAPECITBAINE|capecitbaine
649381|NCT00447330|OXALIPLATIN|oxaliplatin
649382|NCT00447330|METASTATIC|metastatic
649383|NCT00447317|peritoneal dialysis|peritoneal dialysis
649384|NCT00447317|diet|diet
649385|NCT00447317|sodium|sodium
649386|NCT00447304|acute cholecystitis|acute cholecystitis
649387|NCT00447304|cholecystectomy|cholecystectomy
649388|NCT00447304|antibiotic treatment|antibiotic treatment
649389|NCT00447304|moxifloxacin|moxifloxacin
649390|NCT00447304|intraabdominal infection|intraabdominal infection
649391|NCT00447304|morbidity and mortality of patients with acute cholecystitis, early surgery versus conservative therapy|morbidity and mortality of patients with acute cholecystitis, early surgery versus conservative therapy
649392|NCT00447291|Overweight|overweight
649393|NCT00447291|Obesity|obesity
649394|NCT00447291|Fish Oil|fish oil
649395|NCT00447252|bereavement|bereavement
649396|NCT00447252|grief|grief
649397|NCT00447239|mechanical ventilated|mechanical ventilated
649398|NCT00447239|surgical patients|surgical patients
649399|NCT00447239|pneumonia|pneumonia
649400|NCT00447239|blood glucose|blood glucose
649401|NCT00447239|insulin infusion|insulin infusion
649402|NCT00447239|hospital stay|hospital stay
649403|NCT00447226|Ovarian Cancer|ovarian cancer
649404|NCT00447226|Bladder Cancer|bladder cancer
649405|NCT00447226|ErbB2 positive|erbb2 positive
649406|NCT00447226|Lapatinib|lapatinib
649407|NCT00447226|Gastric/Esophageal Cancer|gastric/esophageal cancer
649408|NCT00447226|Uterine Serous Papillary Cancer|uterine serous papillary cancer
649409|NCT00447200|Stroke volume|stroke volume
649410|NCT00447200|SV variation|sv variation
649411|NCT00447200|Esophagus Doppler|esophagus doppler
649412|NCT00447200|Goal Directed Therapy|goal directed therapy
649413|NCT00447187|corneal graft failure|corneal graft failure
649414|NCT00447187|corneal graft rejection|corneal graft rejection
649415|NCT00447187|corneal transplant rejection|corneal transplant rejection
649416|NCT00447174|Grief|grief
649417|NCT00447174|parental bereavement|parental bereavement
649418|NCT00447135|Elderly|elderly
649419|NCT00447135|Trauma|trauma
649420|NCT00447135|Polymorphonuclear Leukocyte|polymorphonuclear leukocyte
649421|NCT00447135|Immunity|immunity
649422|NCT00447122|Pancreatic Cancer|pancreatic cancer
649423|NCT00447096|Bipolar Type II|bipolar type ii
649424|NCT00447096|Depression|depression
649425|NCT00447096|rTMS|rtms
649426|NCT00447083|Tanning|tanning
649427|NCT00447083|Musculoskeletal|musculoskeletal
649428|NCT00447083|Fibromyalgia Syndrome|fibromyalgia syndrome
649429|NCT00447070|HIV-infection|hiv-infection
649430|NCT00447070|Dyslipidemia|dyslipidemia
649431|NCT00447070|Endothelial Dysfunction|endothelial dysfunction
649432|NCT00447070|Atherosclerosis|atherosclerosis
649433|NCT00447070|Protease inhibitor|protease inhibitor
649434|NCT00447070|treatment experienced|treatment experienced
649435|NCT00447057|nonsquamous|nonsquamous
649436|NCT00447044|Muscle loss and Maintenance of Muscle function|muscle loss and maintenance of muscle function
649688|NCT00446147|prevention|prevention
649437|NCT00447031|age related macular degeneration|age related macular degeneration
649438|NCT00447031|intravitreal bevacizumab|intravitreal bevacizumab
649439|NCT00447031|intravitreal triamcinolone acetonide|intravitreal triamcinolone acetonide
649440|NCT00447031|neovascular age related macular degeneration|neovascular age related macular degeneration
649441|NCT00447018|intracranial pressure|intracranial pressure
649442|NCT00447018|mannitol|mannitol
649443|NCT00447018|hypertonic saline solution|hypertonic saline solution
649444|NCT00447018|brain injury|brain injury
649445|NCT00447018|traumatic brain injury|traumatic brain injury
649446|NCT00447018|Adult patients|adult patients
649447|NCT00447018|With elevation of intracranial pressure (ICP > 20 mmHg)|with elevation of intracranial pressure (icp > 20 mmhg)
649448|NCT00447005|Safety|safety
649449|NCT00447005|PK|pk
649450|NCT00447005|Biomarker|biomarker
649451|NCT00446992|Schizophrenia|schizophrenia
649452|NCT00446992|Schizoaffective|schizoaffective
649453|NCT00446992|psychosis|psychosis
649454|NCT00446992|olanzapine|olanzapine
649455|NCT00446979|Microbicides|microbicides
649456|NCT00446979|HIV seronegativity|hiv seronegativity
649457|NCT00446966|atrial fibrillation|atrial fibrillation
649458|NCT00446966|coronary artery disease bypass graft surgery|coronary artery disease bypass graft surgery
649459|NCT00446953|Caesarean section|caesarean section
649460|NCT00446953|Corticosteroids|corticosteroids
649461|NCT00446953|Betamethasone|betamethasone
649462|NCT00446953|Neonatal distress|neonatal distress
649463|NCT00446927|Pediatrics|pediatrics
649464|NCT00446927|Cardiology|cardiology
649465|NCT00446927|Cardiopulmonary Bypass|cardiopulmonary bypass
649466|NCT00446927|Heart Surgery|heart surgery
649467|NCT00446927|Cardiac Catheterization|cardiac catheterization
649468|NCT00446927|Echocardiography|echocardiography
649469|NCT00446927|Imaging|imaging
649470|NCT00446927|ICG green dye|icg green dye
649471|NCT00446914|Hypertension|hypertension
649472|NCT00446914|Blood Pressure|blood pressure
649473|NCT00446901|Prostate Cancer|prostate cancer
649474|NCT00446901|Selenium|selenium
649475|NCT00446901|Chemoprevention|chemoprevention
649476|NCT00446901|Gene expression|gene expression
649477|NCT00446888|cancer|cancer
649478|NCT00446888|metastasis|metastasis
649479|NCT00446875|Pain|pain
649480|NCT00446875|Procedural pain|procedural pain
649481|NCT00446875|Sucrose|sucrose
649482|NCT00446875|Infant|infant
649483|NCT00446862|Definition: Fabry disease|definition: fabry disease
649484|NCT00446862|Definition: Progression|definition: progression
649485|NCT00446862|Definition: MDRD GFR|definition: mdrd gfr
649486|NCT00446862|Definition: Chronic Kidney Disease|definition: chronic kidney disease
649487|NCT00446862|Definition: Proteinuria|definition: proteinuria
649488|NCT00446862|Definition: Enzyme Replacement Therapy|definition: enzyme replacement therapy
649489|NCT00446862|Definition: Anti-proteinuric therapy|definition: anti-proteinuric therapy
649490|NCT00446849|ulcerative colitis|ulcerative colitis
649491|NCT00446849|compliance|compliance
649492|NCT00446849|mesalamine|mesalamine
649493|NCT00446849|clinical study|clinical study
649494|NCT00446849|clinical trial|clinical trial
649495|NCT00446849|clinical research|clinical research
649496|NCT00446849|maintenance|maintenance
649497|NCT00446849|long term|long term
649498|NCT00446849|uc study|uc study
649499|NCT00446849|uc trial|uc trial
649500|NCT00446849|uc research|uc research
649501|NCT00446849|open label|open label
649502|NCT00446849|once a day|once a day
649503|NCT00446849|once|once
649504|NCT00446849|daily|daily
649505|NCT00446849|daily dosing|daily dosing
649506|NCT00446849|simple|simple
649507|NCT00446849|oral|oral
649508|NCT00446836|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
649509|NCT00446836|Recurrent prostate cancer|recurrent prostate cancer
649510|NCT00446836|Hormone refractory prostate cancer|hormone refractory prostate cancer
649511|NCT00446823|Wound healing|wound healing
649512|NCT00446823|Venous stasis ulcer|venous stasis ulcer
649513|NCT00446823|Cellulose dressing|cellulose dressing
649514|NCT00446823|Gauze dressing|gauze dressing
649515|NCT00446823|Chronic wound|chronic wound
649516|NCT00446810|diabetes|diabetes
649517|NCT00446810|endothelial dysfunction|endothelial dysfunction
649518|NCT00446810|benfotiamine|benfotiamine
649519|NCT00446810|postprandial|postprandial
649520|NCT00446810|autonomic neuropathy|autonomic neuropathy
649521|NCT00446810|advanced glycation end products|advanced glycation end products
649522|NCT00446797|Ankle sprain, acute pain, NSAID, celecoxib,|ankle sprain, acute pain, nsaid, celecoxib,
649523|NCT00446758|Zinc|zinc
649524|NCT00446758|HIV|hiv
649525|NCT00446758|Infants|infants
649526|NCT00446758|Children|children
649527|NCT00446758|Morbidity|morbidity
649528|NCT00446758|Child health outcomes|child health outcomes
649529|NCT00446758|treatment naive|treatment naive
649530|NCT00446758|treatment experienced|treatment experienced
649531|NCT00446745|Nutritional and Metabolic Diseases|nutritional and metabolic diseases
649532|NCT00446745|Insulin resistance|insulin resistance
649533|NCT00446745|Energy Metabolisms|energy metabolisms
649534|NCT00446745|Skeletal muscle|skeletal muscle
649535|NCT00446745|Visceral Adipose Tissue|visceral adipose tissue
649536|NCT00446719|major depression|major depression
649537|NCT00446719|antidepressant|antidepressant
649538|NCT00446719|quality of life|quality of life
649539|NCT00446719|anxiety|anxiety
649540|NCT00446706|Intrinsic PEEP|intrinsic peep
649541|NCT00446680|Mannitol|mannitol
649542|NCT00446680|Cystic Fibrosis|cystic fibrosis
649543|NCT00446680|Mucolytic|mucolytic
649544|NCT00446680|Exacerbation|exacerbation
649545|NCT00446680|FEV1|fev1
649546|NCT00446680|Quality of Life|quality of life
649547|NCT00446641|Infarction, Cerebral|infarction, cerebral
649548|NCT00446641|Cilostazol|cilostazol
649549|NCT00446641|Aspirin Resistance|aspirin resistance
649550|NCT00446628|Non-pharmaceutical|non-pharmaceutical
649551|NCT00446628|influenza|influenza
649552|NCT00446628|pandemic|pandemic
649553|NCT00446615|computer decision support|computer decision support
649554|NCT00446615|primary care|primary care
649555|NCT00446615|kidney disease, chronic|kidney disease, chronic
649556|NCT00446615|prescribing|prescribing
649557|NCT00446602|PROCRIT|procrit
649558|NCT00446602|Epoetin alfa|epoetin alfa
649559|NCT00446602|Myelodysplastic Syndromes|myelodysplastic syndromes
649560|NCT00446602|MDS|mds
649561|NCT00446576|Anemia|anemia
649562|NCT00446576|early renal insufficiency|early renal insufficiency
650190|NCT00445549|Peritoneal Cancer|peritoneal cancer
649563|NCT00446563|Left ventricular hypertrophy, hypertension, valsartan, amlodipine|left ventricular hypertrophy, hypertension, valsartan, amlodipine
649564|NCT00446537|Skill Acquisition and the Evolution of Long Term Procedural Memory in participants with ADHD: The Effect of Methylphenidate|skill acquisition and the evolution of long term procedural memory in participants with adhd: the effect of methylphenidate
649565|NCT00446524|Hypertension, Valsartan, Amlodipine, high blood pressure|hypertension, valsartan, amlodipine, high blood pressure
649566|NCT00446511|children|children
649567|NCT00446511|pediatrics|pediatrics
649568|NCT00446511|high blood pressure|high blood pressure
649569|NCT00446511|hypertension|hypertension
649570|NCT00446511|valsartan|valsartan
649571|NCT00446511|enalapril|enalapril
649572|NCT00446485|ginkgo biloba|ginkgo biloba
649573|NCT00446485|cerebrovascular insufficiency|cerebrovascular insufficiency
649574|NCT00446485|mild cognitive impairment|mild cognitive impairment
649575|NCT00446485|concentration impairment|concentration impairment
649576|NCT00446472|diabetes mellitus|diabetes mellitus
649577|NCT00446472|diabetic neuropathies|diabetic neuropathies
649578|NCT00446472|peripheral vascular diseases|peripheral vascular diseases
649579|NCT00446459|CellCept|cellcept
649580|NCT00446459|Dialysis|dialysis
649581|NCT00446459|Kidney|kidney
649582|NCT00446459|Renal|renal
649583|NCT00446459|Nephropathy|nephropathy
649584|NCT00446459|Glomerulonephropathy|glomerulonephropathy
649585|NCT00446459|Immunosuppression|immunosuppression
649586|NCT00446459|Allograft|allograft
649587|NCT00446459|Compatibility|compatibility
649588|NCT00446459|HLA|hla
649589|NCT00446459|PRA|pra
649590|NCT00446459|Transplant|transplant
649591|NCT00446459|Sensitization|sensitization
649592|NCT00446459|Antibodies|antibodies
649593|NCT00446459|Diabetes|diabetes
649594|NCT00446459|Hypertension|hypertension
649595|NCT00446459|Transplantation, Kidney|transplantation, kidney
649596|NCT00446407|Depression|depression
649597|NCT00446407|Primary Care|primary care
649598|NCT00446407|Developing Countries|developing countries
649599|NCT00446407|Common mental disorders (depressive and anxiety disorders)|common mental disorders (depressive and anxiety disorders)
649600|NCT00446394|cognition disorder|cognition disorder
649601|NCT00446394|functional ability|functional ability
649602|NCT00446394|psychomotor function|psychomotor function
649603|NCT00446394|psychopathology|psychopathology
649604|NCT00446394|quality of life|quality of life
649605|NCT00446381|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
649606|NCT00446381|Clinically Significant Diabetic Macular Edema|clinically significant diabetic macular edema
649607|NCT00446381|VEGF|vegf
649608|NCT00446381|Macugen (pegaptanib)|macugen (pegaptanib)
649609|NCT00446368|metastatic kidney cancer|metastatic kidney cancer
649610|NCT00446368|metastatic renal cell cancer|metastatic renal cell cancer
649611|NCT00446355|C diff|c diff
649612|NCT00446355|antibiotics|antibiotics
649613|NCT00446342|leukemia|leukemia
649614|NCT00446342|lymphoma|lymphoma
649615|NCT00446342|myeloma|myeloma
649616|NCT00446342|non-Hodgkin's|non-hodgkin's
649617|NCT00446342|CLL|cll
649618|NCT00446342|MCL|mcl
649619|NCT00446342|MM|mm
649620|NCT00446342|Phase 1|phase 1
649621|NCT00446342|hematological malignancy|hematological malignancy
649622|NCT00446316|Pharmacokinetics|pharmacokinetics
649623|NCT00446316|Healthy volunteers|healthy volunteers
649624|NCT00446316|No condition|no condition
649625|NCT00446316|Pharmacokinetics study|pharmacokinetics study
649626|NCT00446303|MDS|mds
649627|NCT00446303|Myelodysplastic Syndromes|myelodysplastic syndromes
649628|NCT00446303|AML|aml
649629|NCT00446303|Intensive chemotherapy|intensive chemotherapy
649630|NCT00446303|azacitidine|azacitidine
649631|NCT00446290|To determine maximal tolerated dose of DXO regimen|to determine maximal tolerated dose of dxo regimen
649632|NCT00446277|cataract surgery, endothelial cell, cell loss, diabetes|cataract surgery, endothelial cell, cell loss, diabetes
649633|NCT00446277|mellitus type II|mellitus type ii
649634|NCT00446264|diabetes|diabetes
649635|NCT00446264|hypoglycemia|hypoglycemia
649636|NCT00446251|Dialysis|dialysis
649637|NCT00446251|Kidney|kidney
649638|NCT00446251|Renal|renal
649639|NCT00446251|Nephropathy|nephropathy
649640|NCT00446251|Glomerulonephropathy|glomerulonephropathy
649641|NCT00446251|Immunosuppression|immunosuppression
649642|NCT00446251|Graft|graft
649643|NCT00446251|Compatibility|compatibility
649644|NCT00446251|Transplant|transplant
649645|NCT00446251|Diabetes|diabetes
649646|NCT00446251|Hypertension|hypertension
649647|NCT00446251|Transplantation, Kidney|transplantation, kidney
649648|NCT00446238|Depression|depression
649649|NCT00446238|Physical Illness|physical illness
649650|NCT00446238|Inflammatory Bowel Disease|inflammatory bowel disease
649651|NCT00446238|Cognitive Behavioral Therapy|cognitive behavioral therapy
649652|NCT00446225|Lung|lung
649653|NCT00446225|cancer|cancer
649654|NCT00446225|EGFR|egfr
649655|NCT00446225|Epidermal Growth Factor Receptor|epidermal growth factor receptor
649656|NCT00446225|tyrosine kinase|tyrosine kinase
649657|NCT00446225|Tarceva®|tarceva®
649658|NCT00446225|Erlotinib|erlotinib
649659|NCT00446212|anaesthesia|anaesthesia
649660|NCT00446212|propofol|propofol
649661|NCT00446212|desflurane|desflurane
649662|NCT00446212|dreaming|dreaming
649663|NCT00446212|electroencephalography|electroencephalography
649664|NCT00446199|Vasomotor symptom relief|vasomotor symptom relief
649665|NCT00446199|Postmenopausal women|postmenopausal women
649666|NCT00446199|Severe to Moderate Vasomotor symptoms|severe to moderate vasomotor symptoms
649667|NCT00446173|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
649668|NCT00446173|Leukemia|leukemia
649669|NCT00446173|Philadelphia (Ph) chromosome positive CML|philadelphia (ph) chromosome positive cml
649670|NCT00446173|Busulfan|busulfan
649671|NCT00446173|Busulfex|busulfex
649672|NCT00446173|Myleran|myleran
649673|NCT00446173|Cyclophosphamide|cyclophosphamide
649674|NCT00446173|Cytoxan|cytoxan
649675|NCT00446173|Neosar|neosar
649676|NCT00446173|G-CSF|g-csf
649677|NCT00446173|Filgrastim|filgrastim
649678|NCT00446173|Neupogen|neupogen
649679|NCT00446173|GM-CSF|gm-csf
649680|NCT00446173|Sargramostim|sargramostim
649681|NCT00446173|Leukine|leukine
649682|NCT00446160|Congenital Heart Disease|congenital heart disease
649683|NCT00446160|Surgery|surgery
649684|NCT00446160|Adult|adult
649685|NCT00446147|hand-foot syndrome|hand-foot syndrome
649686|NCT00446147|capecitabine|capecitabine
649687|NCT00446147|pyridoxine|pyridoxine
649689|NCT00446134|Phase 2b Dose-Ranging Study|phase 2b dose-ranging study
649690|NCT00446121|COPD|copd
649691|NCT00446108|Pulmonary Stenosis|pulmonary stenosis
649692|NCT00446108|Right Ventricular Dilation|right ventricular dilation
649693|NCT00446108|Right Heart Failure|right heart failure
649694|NCT00446108|Imaging|imaging
649695|NCT00446108|Tetralogy of Fallot|tetralogy of fallot
649696|NCT00446095|DLCL|dlcl
649697|NCT00446095|Nodular lymphoma|nodular lymphoma
649698|NCT00446095|Mantle cell lymphoma|mantle cell lymphoma
649699|NCT00446095|Syk kinase|syk kinase
649700|NCT00446082|Refractory/ resistant carcinoid disease|refractory/ resistant carcinoid disease
649701|NCT00446082|acromegaly|acromegaly
649702|NCT00446082|adults|adults
649703|NCT00446082|pasireotide LAR|pasireotide lar
649704|NCT00446082|somatostatin analogue|somatostatin analogue
649705|NCT00446082|SOM230|som230
649706|NCT00446082|pharmacokinetics|pharmacokinetics
649707|NCT00446082|Refractory or resistant carcinoid disease and acromegaly|refractory or resistant carcinoid disease and acromegaly
649708|NCT00446043|Acne Vulgaris|acne vulgaris
649709|NCT00446043|Adapalene|adapalene
649710|NCT00446043|Benzoyl Peroxide|benzoyl peroxide
649711|NCT00446017|coronary artery bypass grafting|coronary artery bypass grafting
649712|NCT00446017|inotropes|inotropes
649713|NCT00446017|metabolism|metabolism
649714|NCT00446017|renal failure|renal failure
649715|NCT00446004|Pharmacokinetics|pharmacokinetics
649716|NCT00446004|Healthy volunteers|healthy volunteers
649717|NCT00446004|No condition|no condition
649718|NCT00446004|Pharmacokinetics study|pharmacokinetics study
649719|NCT00445978|Sickle Cell Disease|sickle cell disease
649720|NCT00445978|SCD|scd
649721|NCT00445978|6R-BH4|6r-bh4
649722|NCT00445978|BH4|bh4
649723|NCT00445978|sapropterin dihydrochloride|sapropterin dihydrochloride
649724|NCT00445978|endothelial dysfunction|endothelial dysfunction
649725|NCT00445978|Nitric Oxide|nitric oxide
649726|NCT00445978|NO|no
649727|NCT00445965|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
649728|NCT00445965|untreated childhood medulloblastoma|untreated childhood medulloblastoma
649729|NCT00445965|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
649730|NCT00445965|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
649731|NCT00445965|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
649732|NCT00445965|adult anaplastic astrocytoma|adult anaplastic astrocytoma
649733|NCT00445965|adult diffuse astrocytoma|adult diffuse astrocytoma
649734|NCT00445965|adult pilocytic astrocytoma|adult pilocytic astrocytoma
649735|NCT00445965|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
649736|NCT00445965|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
649737|NCT00445965|untreated childhood subependymal giant cell astrocytoma|untreated childhood subependymal giant cell astrocytoma
649738|NCT00445965|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
649739|NCT00445965|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
649740|NCT00445965|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
649741|NCT00445965|adult brain stem glioma|adult brain stem glioma
649742|NCT00445965|adult mixed glioma|adult mixed glioma
649743|NCT00445965|childhood mixed glioma|childhood mixed glioma
649744|NCT00445965|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
649745|NCT00445965|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
649746|NCT00445965|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
649747|NCT00445965|untreated childhood brain stem glioma|untreated childhood brain stem glioma
649748|NCT00445965|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
649749|NCT00445965|untreated childhood visual pathway glioma|untreated childhood visual pathway glioma
649750|NCT00445965|regional neuroblastoma|regional neuroblastoma
649751|NCT00445965|disseminated neuroblastoma|disseminated neuroblastoma
649752|NCT00445965|recurrent neuroblastoma|recurrent neuroblastoma
649753|NCT00445965|extraocular retinoblastoma|extraocular retinoblastoma
649754|NCT00445965|recurrent retinoblastoma|recurrent retinoblastoma
649755|NCT00445965|adult anaplastic ependymoma|adult anaplastic ependymoma
649756|NCT00445965|adult ependymoblastoma|adult ependymoblastoma
649757|NCT00445965|adult ependymoma|adult ependymoma
649758|NCT00445965|adult myxopapillary ependymoma|adult myxopapillary ependymoma
649759|NCT00445965|adult subependymoma|adult subependymoma
649760|NCT00445965|childhood infratentorial ependymoma|childhood infratentorial ependymoma
649761|NCT00445965|childhood supratentorial ependymoma|childhood supratentorial ependymoma
649762|NCT00445965|recurrent childhood ependymoma|recurrent childhood ependymoma
649763|NCT00445965|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
649764|NCT00445965|recurrent melanoma|recurrent melanoma
649765|NCT00445965|stage IV melanoma|stage iv melanoma
649766|NCT00445965|adult medulloblastoma|adult medulloblastoma
649767|NCT00445965|chondrosarcoma|chondrosarcoma
649768|NCT00445965|metastatic osteosarcoma|metastatic osteosarcoma
649769|NCT00445965|recurrent osteosarcoma|recurrent osteosarcoma
649770|NCT00445965|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
649771|NCT00445965|ovarian sarcoma|ovarian sarcoma
649772|NCT00445965|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
649773|NCT00445965|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
649774|NCT00445965|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
649775|NCT00445965|stage III uterine sarcoma|stage iii uterine sarcoma
649776|NCT00445965|stage IV uterine sarcoma|stage iv uterine sarcoma
649777|NCT00445965|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
649778|NCT00445965|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
649779|NCT00445965|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
649780|NCT00445965|adult desmoplastic small round cell tumor|adult desmoplastic small round cell tumor
649781|NCT00445965|adult oligodendroglioma|adult oligodendroglioma
649782|NCT00445965|adult giant cell glioblastoma|adult giant cell glioblastoma
649783|NCT00445965|adult gliosarcoma|adult gliosarcoma
649784|NCT00445965|tumors metastatic to brain|tumors metastatic to brain
649785|NCT00445965|adult rhabdomyosarcoma|adult rhabdomyosarcoma
649786|NCT00445965|childhood oligodendroglioma|childhood oligodendroglioma
649787|NCT00445965|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
649788|NCT00445965|extensive stage small cell lung cancer|extensive stage small cell lung cancer
649789|NCT00445965|intraocular retinoblastoma|intraocular retinoblastoma
649790|NCT00445965|recurrent adult brain tumor|recurrent adult brain tumor
649791|NCT00445965|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
649792|NCT00445965|recurrent uterine sarcoma|recurrent uterine sarcoma
649793|NCT00445965|small intestine leiomyosarcoma|small intestine leiomyosarcoma
649794|NCT00445965|recurrent small intestine cancer|recurrent small intestine cancer
649795|NCT00445965|recurrent small cell lung cancer|recurrent small cell lung cancer
649796|NCT00445965|extraocular extension melanoma|extraocular extension melanoma
649797|NCT00445965|recurrent intraocular melanoma|recurrent intraocular melanoma
649798|NCT00445965|metastatic intraocular melanoma|metastatic intraocular melanoma
649799|NCT00445965|iris melanoma|iris melanoma
649800|NCT00445965|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
649801|NCT00445965|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
649802|NCT00445965|adult glioblastoma|adult glioblastoma
649803|NCT00445965|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
649804|NCT00445965|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
649805|NCT00445965|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
649806|NCT00445965|untreated childhood pineoblastoma|untreated childhood pineoblastoma
649807|NCT00445965|adult pineal gland astrocytoma|adult pineal gland astrocytoma
649808|NCT00445965|stage IIIA melanoma|stage iiia melanoma
649809|NCT00445965|stage IIIB melanoma|stage iiib melanoma
649810|NCT00445965|stage IIIC melanoma|stage iiic melanoma
649811|NCT00445965|recurrent childhood anaplastic astrocytoma|recurrent childhood anaplastic astrocytoma
649812|NCT00445965|untreated childhood anaplastic astrocytoma|untreated childhood anaplastic astrocytoma
649813|NCT00445965|recurrent childhood anaplastic oligoastrocytoma|recurrent childhood anaplastic oligoastrocytoma
649814|NCT00445965|recurrent childhood anaplastic oligodendroglioma|recurrent childhood anaplastic oligodendroglioma
649815|NCT00445965|untreated childhood anaplastic oligoastrocytoma|untreated childhood anaplastic oligoastrocytoma
649816|NCT00445965|untreated childhood anaplastic oligodendroglioma|untreated childhood anaplastic oligodendroglioma
649817|NCT00445965|recurrent childhood giant cell glioblastoma|recurrent childhood giant cell glioblastoma
649818|NCT00445965|recurrent childhood glioblastoma|recurrent childhood glioblastoma
649819|NCT00445965|untreated childhood giant cell glioblastoma|untreated childhood giant cell glioblastoma
649820|NCT00445965|untreated childhood glioblastoma|untreated childhood glioblastoma
649821|NCT00445965|recurrent childhood gliosarcoma|recurrent childhood gliosarcoma
649822|NCT00445965|untreated childhood gliosarcoma|untreated childhood gliosarcoma
649823|NCT00445965|recurrent childhood gliomatosis cerebri|recurrent childhood gliomatosis cerebri
649824|NCT00445965|untreated childhood gliomatosis cerebri|untreated childhood gliomatosis cerebri
649825|NCT00445965|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
649826|NCT00445965|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
649827|NCT00445952|breast cancer in situ|breast cancer in situ
649828|NCT00445952|stage I breast cancer|stage i breast cancer
649829|NCT00445952|stage II breast cancer|stage ii breast cancer
649830|NCT00445952|stage IIIA breast cancer|stage iiia breast cancer
649831|NCT00445952|stage IIIB breast cancer|stage iiib breast cancer
649832|NCT00445952|stage IIIC breast cancer|stage iiic breast cancer
649833|NCT00445952|stage IV breast cancer|stage iv breast cancer
649834|NCT00445952|recurrent breast cancer|recurrent breast cancer
649835|NCT00445952|male breast cancer|male breast cancer
649836|NCT00445952|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
649837|NCT00445952|stage I non-small cell lung cancer|stage i non-small cell lung cancer
649838|NCT00445952|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
649839|NCT00445952|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
649840|NCT00445952|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
649841|NCT00445952|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
649842|NCT00445952|extensive stage small cell lung cancer|extensive stage small cell lung cancer
649843|NCT00445952|recurrent colon cancer|recurrent colon cancer
649844|NCT00445952|stage I colon cancer|stage i colon cancer
649845|NCT00445952|stage II colon cancer|stage ii colon cancer
649846|NCT00445952|stage III colon cancer|stage iii colon cancer
649847|NCT00445952|stage IV colon cancer|stage iv colon cancer
649848|NCT00445952|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
649849|NCT00445952|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
649850|NCT00445952|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
649851|NCT00445952|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
649852|NCT00445952|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
649853|NCT00445952|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
649854|NCT00445952|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
652276|NCT00439361|Paraplatin|paraplatin
649855|NCT00445952|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
649856|NCT00445952|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
649857|NCT00445952|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
649858|NCT00445952|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
649859|NCT00445952|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
649860|NCT00445952|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
649861|NCT00445952|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
649862|NCT00445952|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
649863|NCT00445952|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
649864|NCT00445952|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
649865|NCT00445952|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
649866|NCT00445952|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
649867|NCT00445952|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
649868|NCT00445952|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
649869|NCT00445952|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
649870|NCT00445952|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
649871|NCT00445952|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
649872|NCT00445952|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
649873|NCT00445952|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
649874|NCT00445952|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
649875|NCT00445952|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
649876|NCT00445952|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
649877|NCT00445952|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
649878|NCT00445952|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
649879|NCT00445952|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
649880|NCT00445952|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
649881|NCT00445952|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
649882|NCT00445952|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
649883|NCT00445952|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
649884|NCT00445952|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
649885|NCT00445952|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
649886|NCT00445952|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
649887|NCT00445952|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
649888|NCT00445952|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
649889|NCT00445952|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
649890|NCT00445952|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
649891|NCT00445952|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
649892|NCT00445952|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
649893|NCT00445952|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
649894|NCT00445952|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
649895|NCT00445952|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
649896|NCT00445952|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
649897|NCT00445952|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
649898|NCT00445952|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
649899|NCT00445952|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
649900|NCT00445952|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
649901|NCT00445952|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
649902|NCT00445952|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
649903|NCT00445952|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
649904|NCT00445952|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
649905|NCT00445952|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
649906|NCT00445952|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
649907|NCT00445952|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
649908|NCT00445952|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
649909|NCT00445952|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
649910|NCT00445952|stage I multiple myeloma|stage i multiple myeloma
649911|NCT00445952|stage II multiple myeloma|stage ii multiple myeloma
649912|NCT00445952|stage III multiple myeloma|stage iii multiple myeloma
649913|NCT00445952|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
649914|NCT00445952|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
649915|NCT00445952|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
649916|NCT00445952|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
649917|NCT00445952|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
649918|NCT00445952|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
649919|NCT00445952|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
649920|NCT00445952|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
649921|NCT00445952|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
649922|NCT00445952|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
649923|NCT00445952|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
649924|NCT00445952|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
649925|NCT00445952|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
649926|NCT00445952|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
649927|NCT00445952|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
649928|NCT00445952|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
649929|NCT00445952|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
649930|NCT00445952|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
649931|NCT00445952|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
649932|NCT00445952|stage I marginal zone lymphoma|stage i marginal zone lymphoma
649933|NCT00445952|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
649934|NCT00445952|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
649935|NCT00445952|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
649936|NCT00445952|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
649937|NCT00445952|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
649938|NCT00445952|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
649939|NCT00445952|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
649940|NCT00445952|stage I mantle cell lymphoma|stage i mantle cell lymphoma
649941|NCT00445952|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
649942|NCT00445952|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
649943|NCT00445952|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
649944|NCT00445952|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
649945|NCT00445952|refractory multiple myeloma|refractory multiple myeloma
649946|NCT00445952|anaplastic large cell lymphoma|anaplastic large cell lymphoma
649947|NCT00445952|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
649948|NCT00445952|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
649949|NCT00445952|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
649950|NCT00445952|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
649951|NCT00445952|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
649952|NCT00445952|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
649953|NCT00445952|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
649954|NCT00445952|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
649955|NCT00445952|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
649956|NCT00445952|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
649957|NCT00445952|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
649958|NCT00445952|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
649959|NCT00445952|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
649960|NCT00445952|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
649961|NCT00445952|chronic eosinophilic leukemia|chronic eosinophilic leukemia
649962|NCT00445952|primary myelofibrosis|primary myelofibrosis
649963|NCT00445952|chronic neutrophilic leukemia|chronic neutrophilic leukemia
649964|NCT00445952|essential thrombocythemia|essential thrombocythemia
649965|NCT00445952|polycythemia vera|polycythemia vera
649966|NCT00445952|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
649967|NCT00445952|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
649968|NCT00445952|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
649969|NCT00445952|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
649970|NCT00445952|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
649971|NCT00445952|secondary acute myeloid leukemia|secondary acute myeloid leukemia
649972|NCT00445952|acute undifferentiated leukemia|acute undifferentiated leukemia
649973|NCT00445952|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
649974|NCT00445952|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
649975|NCT00445952|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
649976|NCT00445952|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
649977|NCT00445952|refractory hairy cell leukemia|refractory hairy cell leukemia
649978|NCT00445952|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
649979|NCT00445952|prolymphocytic leukemia|prolymphocytic leukemia
649980|NCT00445952|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
649981|NCT00445952|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
649982|NCT00445952|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
649983|NCT00445952|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
649984|NCT00445952|splenic marginal zone lymphoma|splenic marginal zone lymphoma
649985|NCT00445952|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
649986|NCT00445952|extramedullary plasmacytoma|extramedullary plasmacytoma
649987|NCT00445952|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
649988|NCT00445952|primary systemic amyloidosis|primary systemic amyloidosis
649989|NCT00445952|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
649990|NCT00445952|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
649991|NCT00445952|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
649992|NCT00445952|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
649993|NCT00445952|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
649994|NCT00445952|intraocular lymphoma|intraocular lymphoma
649995|NCT00445952|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
649996|NCT00445952|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
649997|NCT00445952|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
649998|NCT00445952|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
649999|NCT00445952|infection|infection
650000|NCT00445952|limited stage small cell lung cancer|limited stage small cell lung cancer
650001|NCT00445952|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
650002|NCT00445913|type 1 diabetes|type 1 diabetes
650003|NCT00445913|dendritic cells|dendritic cells
650004|NCT00445913|cell vaccine|cell vaccine
650005|NCT00445913|safety|safety
650006|NCT00445913|reversal|reversal
650007|NCT00445900|primary myelofibrosis|primary myelofibrosis
650008|NCT00445900|essential thrombocythemia|essential thrombocythemia
650009|NCT00445900|polycythemia vera|polycythemia vera
650010|NCT00445900|secondary myelofibrosis|secondary myelofibrosis
650011|NCT00445874|allergic conjunctivitis, ophthalmology, multicenter, controlled|allergic conjunctivitis, ophthalmology, multicenter, controlled
650012|NCT00445861|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
650013|NCT00445861|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
650014|NCT00445861|stage II esophageal cancer|stage ii esophageal cancer
650015|NCT00445861|stage III esophageal cancer|stage iii esophageal cancer
650016|NCT00445848|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
650017|NCT00445848|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
650018|NCT00445848|adenocarcinoma of the lung|adenocarcinoma of the lung
650019|NCT00445835|coronary artery disease|coronary artery disease
650020|NCT00445835|myocardial infarction|myocardial infarction
650021|NCT00445835|atherothrombosis|atherothrombosis
650022|NCT00445835|atherosclerosis|atherosclerosis
650023|NCT00445822|CML|cml
650024|NCT00445822|Children|children
650025|NCT00445822|Imatinib|imatinib
650026|NCT00445822|bcr-abl|bcr-abl
650027|NCT00445822|Response|response
650028|NCT00445822|Imatinib mesylate|imatinib mesylate
650029|NCT00445809|Kidney|kidney
650030|NCT00445809|Renal|renal
650031|NCT00445809|Cardiac Surgery with bypass|cardiac surgery with bypass
650032|NCT00445809|Cardiovascular surgery with cardiopulmonary bypass|cardiovascular surgery with cardiopulmonary bypass
650033|NCT00445783|lentigo maligna malignant melanoma|lentigo maligna malignant melanoma
650034|NCT00445783|stage IV melanoma|stage iv melanoma
650035|NCT00445783|acral lentiginous malignant melanoma|acral lentiginous malignant melanoma
650036|NCT00445783|nodular malignant melanoma|nodular malignant melanoma
650037|NCT00445783|stage IA melanoma|stage ia melanoma
650038|NCT00445783|stage IB melanoma|stage ib melanoma
650039|NCT00445783|stage IIA melanoma|stage iia melanoma
650040|NCT00445783|stage IIB melanoma|stage iib melanoma
650041|NCT00445783|stage IIC melanoma|stage iic melanoma
650042|NCT00445783|stage IIIA melanoma|stage iiia melanoma
650043|NCT00445783|stage IIIB melanoma|stage iiib melanoma
650044|NCT00445783|stage IIIC melanoma|stage iiic melanoma
650045|NCT00445770|Rheumatoid Arthritis|rheumatoid arthritis
650046|NCT00445770|Arthritis|arthritis
650047|NCT00445757|stage I renal cell cancer|stage i renal cell cancer
650048|NCT00445757|stage II renal cell cancer|stage ii renal cell cancer
650049|NCT00445731|poor performance status|poor performance status
650050|NCT00445731|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
650051|NCT00445731|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
650052|NCT00445731|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
650053|NCT00445731|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
650054|NCT00445731|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
650055|NCT00445731|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
650056|NCT00445731|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
650057|NCT00445731|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
650058|NCT00445731|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
650059|NCT00445731|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
650060|NCT00445731|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
650061|NCT00445731|chronic eosinophilic leukemia|chronic eosinophilic leukemia
650062|NCT00445731|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
650063|NCT00445731|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
650064|NCT00445731|chronic neutrophilic leukemia|chronic neutrophilic leukemia
650065|NCT00445731|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
650066|NCT00445731|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
650067|NCT00445731|disseminated neuroblastoma|disseminated neuroblastoma
650068|NCT00445731|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
650069|NCT00445731|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
650070|NCT00445731|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
650071|NCT00445731|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
650072|NCT00445731|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
650073|NCT00445731|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
650074|NCT00445731|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
650075|NCT00445731|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
650076|NCT00445731|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
650077|NCT00445731|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
650078|NCT00445731|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
650079|NCT00445731|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
650080|NCT00445731|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
650081|NCT00445731|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
650082|NCT00445731|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
650083|NCT00445731|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
650084|NCT00445731|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
650085|NCT00445731|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
650086|NCT00445731|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
650087|NCT00445731|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
650088|NCT00445731|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
650089|NCT00445731|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
650090|NCT00445731|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
650091|NCT00445731|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
650092|NCT00445731|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
650093|NCT00445731|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
650094|NCT00445731|recurrent breast cancer|recurrent breast cancer
650095|NCT00445731|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
650096|NCT00445731|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
650097|NCT00445731|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
650098|NCT00445731|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
650099|NCT00445731|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
650100|NCT00445731|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
650101|NCT00445731|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
650102|NCT00445731|recurrent neuroblastoma|recurrent neuroblastoma
650103|NCT00445731|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
650104|NCT00445731|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
650105|NCT00445731|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
650106|NCT00445731|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
650107|NCT00445731|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
650108|NCT00445731|refractory hairy cell leukemia|refractory hairy cell leukemia
650109|NCT00445731|refractory multiple myeloma|refractory multiple myeloma
650110|NCT00445731|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
650111|NCT00445731|secondary acute myeloid leukemia|secondary acute myeloid leukemia
650112|NCT00445731|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
650113|NCT00445731|splenic marginal zone lymphoma|splenic marginal zone lymphoma
650114|NCT00445731|stage I multiple myeloma|stage i multiple myeloma
650115|NCT00445731|stage II multiple myeloma|stage ii multiple myeloma
650116|NCT00445731|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
650117|NCT00445731|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
650118|NCT00445731|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
650119|NCT00445731|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
650120|NCT00445731|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
650121|NCT00445731|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
650122|NCT00445731|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
650123|NCT00445731|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
650124|NCT00445731|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
650125|NCT00445731|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
650126|NCT00445731|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
650127|NCT00445731|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
650128|NCT00445731|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
650129|NCT00445731|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
650130|NCT00445731|stage III multiple myeloma|stage iii multiple myeloma
650131|NCT00445731|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
650132|NCT00445731|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
650133|NCT00445731|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
650134|NCT00445731|stage IIIA breast cancer|stage iiia breast cancer
650135|NCT00445731|stage IIIB breast cancer|stage iiib breast cancer
650136|NCT00445731|stage IIIC breast cancer|stage iiic breast cancer
650137|NCT00445731|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
650138|NCT00445731|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
650139|NCT00445731|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
650140|NCT00445731|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
650141|NCT00445731|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
650142|NCT00445731|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
650143|NCT00445731|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
650144|NCT00445731|stage IV breast cancer|stage iv breast cancer
650145|NCT00445731|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
650146|NCT00445731|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
650147|NCT00445731|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
650148|NCT00445731|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
650149|NCT00445731|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
650150|NCT00445731|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
650151|NCT00445731|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
650152|NCT00445731|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
650153|NCT00445679|major depressive disorder|major depressive disorder
650154|NCT00445679|MDD|mdd
650155|NCT00445679|depression|depression
650156|NCT00445653|Barrett esophagus|barrett esophagus
650157|NCT00445627|Type 2 Diabetes|type 2 diabetes
650158|NCT00445627|Obesity|obesity
650159|NCT00445627|Overweight|overweight
650160|NCT00445614|nutrition|nutrition
650161|NCT00445614|cardiovascular risk|cardiovascular risk
650162|NCT00445614|inflammation|inflammation
650163|NCT00445614|vascular function|vascular function
650164|NCT00445601|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
650165|NCT00445601|stage 0 bladder cancer|stage 0 bladder cancer
650166|NCT00445601|stage I bladder cancer|stage i bladder cancer
650167|NCT00445601|recurrent bladder cancer|recurrent bladder cancer
650168|NCT00445575|fibrous dysplasia of bone|fibrous dysplasia of bone
650169|NCT00445575|Mac Cune Albright syndrome|mac cune albright syndrome
650170|NCT00445575|bisphosphonates|bisphosphonates
650171|NCT00445575|risedronate|risedronate
650172|NCT00445562|male breast cancer|male breast cancer
650173|NCT00445562|recurrent breast cancer|recurrent breast cancer
650174|NCT00445562|stage IA breast cancer|stage ia breast cancer
650175|NCT00445562|stage IB breast cancer|stage ib breast cancer
650176|NCT00445562|stage II breast cancer|stage ii breast cancer
650177|NCT00445562|stage IIIA breast cancer|stage iiia breast cancer
650178|NCT00445562|stage IIIB breast cancer|stage iiib breast cancer
650179|NCT00445562|stage IIIC breast cancer|stage iiic breast cancer
650180|NCT00445562|stage IV breast cancer|stage iv breast cancer
650181|NCT00445549|Ovarian|ovarian
650182|NCT00445549|VEGFR2|vegfr2
650183|NCT00445549|EGFR|egfr
650184|NCT00445549|Angiogenesis|angiogenesis
650185|NCT00445549|Tyrosine Kinase|tyrosine kinase
650186|NCT00445549|Protein Phosphorylation|protein phosphorylation
650187|NCT00445549|Vandetanib|vandetanib
650188|NCT00445549|Ovarian Cancer|ovarian cancer
650189|NCT00445549|Fallopian Tube Cancer|fallopian tube cancer
650191|NCT00445523|Advanced renal cancer|advanced renal cancer
650192|NCT00445523|metastatic renal cancer|metastatic renal cancer
650193|NCT00445523|RCC|rcc
650194|NCT00445523|kidney cancer|kidney cancer
650195|NCT00445523|M3thodist|m3thodist
650196|NCT00445510|GSK256066,|gsk256066,
650197|NCT00445510|allergen,|allergen,
650198|NCT00445510|challenge,|challenge,
650199|NCT00445510|repeat dose,|repeat dose,
650200|NCT00445510|AMP,|amp,
650201|NCT00445510|mild asthmatics|mild asthmatics
650202|NCT00445497|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
650203|NCT00445497|anaplastic large cell lymphoma|anaplastic large cell lymphoma
650204|NCT00445497|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
650205|NCT00445497|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
650206|NCT00445497|intraocular lymphoma|intraocular lymphoma
650207|NCT00445497|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
650208|NCT00445497|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
650209|NCT00445497|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
650210|NCT00445497|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
650211|NCT00445497|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
650212|NCT00445497|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
650213|NCT00445497|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
650214|NCT00445497|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
650215|NCT00445497|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
650216|NCT00445497|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
650217|NCT00445497|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
650218|NCT00445497|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
650219|NCT00445497|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
650220|NCT00445497|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
650221|NCT00445497|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
650222|NCT00445497|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
650223|NCT00445497|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
650224|NCT00445497|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
650225|NCT00445497|small intestine lymphoma|small intestine lymphoma
650226|NCT00445497|splenic marginal zone lymphoma|splenic marginal zone lymphoma
650227|NCT00445497|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
650228|NCT00445497|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
650229|NCT00445497|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
650230|NCT00445497|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
650231|NCT00445497|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
650232|NCT00445497|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
650233|NCT00445497|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
650234|NCT00445497|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
650235|NCT00445497|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
650236|NCT00445497|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
650237|NCT00445497|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
650238|NCT00445497|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
650239|NCT00445497|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
650240|NCT00445497|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
650241|NCT00445497|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
650242|NCT00445497|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
650243|NCT00445497|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
650244|NCT00445497|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
650245|NCT00445497|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
650246|NCT00445497|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
650247|NCT00445497|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
650248|NCT00445497|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
650249|NCT00445497|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
650250|NCT00445497|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
650251|NCT00445497|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
650252|NCT00445497|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
650253|NCT00445497|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
650254|NCT00445497|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
650255|NCT00445497|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
650256|NCT00445497|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
650257|NCT00445497|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
650258|NCT00445497|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
650259|NCT00445497|Waldenström macroglobulinemia|waldenström macroglobulinemia
650260|NCT00445497|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
650261|NCT00445497|neutropenia|neutropenia
650262|NCT00445497|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
650263|NCT00445497|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
650264|NCT00445497|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
650265|NCT00445497|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
650266|NCT00445497|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
650267|NCT00445497|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
650268|NCT00445497|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
652277|NCT00439361|Etoposide|etoposide
650269|NCT00445497|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
650270|NCT00445497|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
650271|NCT00445497|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
650272|NCT00445497|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
650273|NCT00445497|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
650274|NCT00445497|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
650275|NCT00445497|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
650276|NCT00445497|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
650277|NCT00445497|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
650278|NCT00445497|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
650279|NCT00445497|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
650280|NCT00445497|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
650281|NCT00445497|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
650282|NCT00445497|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
650283|NCT00445497|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
650284|NCT00445497|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
650285|NCT00445497|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
650526|NCT00444600|Lucentis|lucentis
650286|NCT00445497|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
650287|NCT00445497|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
650288|NCT00445497|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
650289|NCT00445497|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
650290|NCT00445497|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
650291|NCT00445497|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
650292|NCT00445497|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
650293|NCT00445497|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
650294|NCT00445497|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
650295|NCT00445497|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
650296|NCT00445497|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
650297|NCT00445497|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
650298|NCT00445497|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
650299|NCT00445497|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
650300|NCT00445497|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
650301|NCT00445497|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
650302|NCT00445497|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
650303|NCT00445497|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
650304|NCT00445484|stage II multiple myeloma|stage ii multiple myeloma
650305|NCT00445484|stage III multiple myeloma|stage iii multiple myeloma
650306|NCT00445484|refractory multiple myeloma|refractory multiple myeloma
650307|NCT00445471|Autism Spectrum Disorder|autism spectrum disorder
650308|NCT00445471|Autistic Disorder|autistic disorder
650309|NCT00445471|Pervasive Developmental Disorder|pervasive developmental disorder
650310|NCT00445458|cancer|cancer
650311|NCT00445458|HKI-272|hki-272
650312|NCT00445458|neratinib|neratinib
650313|NCT00445458|paclitaxel|paclitaxel
650314|NCT00445458|Taxol|taxol
650315|NCT00445458|breast cancer|breast cancer
650316|NCT00445458|Nerlynx|nerlynx
650317|NCT00445445|stage I breast cancer|stage i breast cancer
650318|NCT00445445|stage II breast cancer|stage ii breast cancer
650319|NCT00445445|stage IIIA breast cancer|stage iiia breast cancer
650320|NCT00445445|stage IIIB breast cancer|stage iiib breast cancer
650321|NCT00445445|stage IIIC breast cancer|stage iiic breast cancer
650322|NCT00445445|stage IV breast cancer|stage iv breast cancer
650323|NCT00445445|recurrent breast cancer|recurrent breast cancer
650324|NCT00445445|breast cancer in situ|breast cancer in situ
650325|NCT00445419|Hepatitis C|hepatitis c
650326|NCT00445419|Liver disease|liver disease
650327|NCT00445419|Viral infection|viral infection
650328|NCT00445419|Virosome|virosome
650329|NCT00445419|Vaccine|vaccine
650330|NCT00445419|therapeutic vaccine|therapeutic vaccine
650331|NCT00445419|Chronic hepatitis C virus infection|chronic hepatitis c virus infection
650332|NCT00445406|recurrent breast cancer|recurrent breast cancer
650333|NCT00445406|stage IV breast cancer|stage iv breast cancer
650334|NCT00445393|Observation|observation
650335|NCT00445393|Mental health|mental health
650336|NCT00445393|Scoliosis|scoliosis
650337|NCT00445393|Screening|screening
650338|NCT00445393|Adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
650339|NCT00445367|Multiple Sclerosis|multiple sclerosis
650340|NCT00445367|Clinically Isolated Syndrome|clinically isolated syndrome
650341|NCT00445367|Transverse Myelitis|transverse myelitis
650342|NCT00445367|Neuromyelitis Optica|neuromyelitis optica
650343|NCT00445367|Acute Disseminated Encephalomyelitis|acute disseminated encephalomyelitis
650344|NCT00445367|Optic Neuritis|optic neuritis
650345|NCT00445367|Repository|repository
650346|NCT00445367|Biobank|biobank
650347|NCT00445354|cinnamon|cinnamon
650348|NCT00445354|diabetes|diabetes
650349|NCT00445354|hemoglobin a1c|hemoglobin a1c
650350|NCT00445341|Microarray|microarray
650351|NCT00445341|Proteomics|proteomics
650352|NCT00445341|Hybrid Schedule|hybrid schedule
650353|NCT00445341|Tumor Lysis Syndrome|tumor lysis syndrome
650354|NCT00445341|Cyclin D1|cyclin d1
650355|NCT00445341|Lymphoma|lymphoma
650356|NCT00445341|Mantle Cell Lymphoma|mantle cell lymphoma
650358|NCT00445341|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
650359|NCT00445341|DLBCL|dlbcl
650360|NCT00445328|hospitalised acutely medically ill patients; Venous Thromboembolism, Infection, Inflammatory Bowel Diseases, Heart Failure, Congestive, Sciatica|hospitalised acutely medically ill patients; venous thromboembolism, infection, inflammatory bowel diseases, heart failure, congestive, sciatica
650361|NCT00445302|AMD3100|amd3100
650362|NCT00445289|mechanical ventilation|mechanical ventilation
650363|NCT00445289|ventilator weaning|ventilator weaning
650364|NCT00445289|closed-loop|closed-loop
650365|NCT00445289|ventilation time|ventilation time
650366|NCT00445276|Osteoarthritis|osteoarthritis
650367|NCT00445276|Knee|knee
650368|NCT00445276|Diacerein|diacerein
650369|NCT00445276|Painful osteoarthritis|painful osteoarthritis
650370|NCT00445276|Clinical trial|clinical trial
650371|NCT00445263|CORONARY DISEASE|coronary disease
650372|NCT00445250|Calcipotriol|calcipotriol
650373|NCT00445250|Breast|breast
650374|NCT00445250|Cancer|cancer
650375|NCT00445250|Radiotherapy|radiotherapy
650376|NCT00445250|Radiodermatitis in Breast Cancer|radiodermatitis in breast cancer
650377|NCT00445237|major depression|major depression
650378|NCT00445237|TMS|tms
650379|NCT00445224|Knee pain|knee pain
650380|NCT00445224|Rehabilitation|rehabilitation
650381|NCT00445211|Intraaortic balloon pumping|intraaortic balloon pumping
650382|NCT00445211|Heparin|heparin
650383|NCT00445211|Limb ischemia|limb ischemia
650384|NCT00445211|Bleeding|bleeding
650385|NCT00445198|SCLC|sclc
650386|NCT00445185|Dialysis|dialysis
650387|NCT00445185|Pre-dialysis|pre-dialysis
650388|NCT00445185|Hepatitis B vaccine|hepatitis b vaccine
650389|NCT00445185|vaccine|vaccine
650390|NCT00445172|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
650391|NCT00445172|Motor Neurons|motor neurons
650392|NCT00445172|Muscular Atrophy|muscular atrophy
650393|NCT00445159|UT-15C SR, Peripheral Vascular Disease, treprostinil|ut-15c sr, peripheral vascular disease, treprostinil
650394|NCT00445146|Phase 2|phase 2
650395|NCT00445146|Open-label|open-label
650396|NCT00445146|Rollover|rollover
650397|NCT00445146|Integrase Inhibitor|integrase inhibitor
650398|NCT00445146|Antiretroviral Agents|antiretroviral agents
650399|NCT00445146|Highly Active Antiretroviral Activity|highly active antiretroviral activity
650400|NCT00445146|HAART|haart
650401|NCT00445146|HIV, HIV-1, AIDS virus, Human Immunodeficiency Virus|hiv, hiv-1, aids virus, human immunodeficiency virus
650402|NCT00445146|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
650403|NCT00445146|treatment experienced|treatment experienced
650404|NCT00445133|Neck Pain/Lumbar pain/Magnets/sleep deficiency/ insomnia/|neck pain/lumbar pain/magnets/sleep deficiency/ insomnia/
650405|NCT00445120|Vernal keratoconjunctivitis|vernal keratoconjunctivitis
650406|NCT00445120|probiotic|probiotic
650407|NCT00445120|Lactobacillus Rhamnosus GG|lactobacillus rhamnosus gg
650408|NCT00445120|Children|children
650409|NCT00445120|Clinical trial|clinical trial
650410|NCT00445081|atopic dermatitis|atopic dermatitis
650411|NCT00445081|prednisolone|prednisolone
650412|NCT00445081|ciclosporine|ciclosporine
650413|NCT00445081|SCORAD|scorad
650414|NCT00445081|DLQI|dlqi
650415|NCT00445081|QALY|qaly
650416|NCT00445081|WLQ|wlq
650417|NCT00445068|Multiple myeloma|multiple myeloma
650418|NCT00445068|adults|adults
650419|NCT00445068|LBH589|lbh589
650420|NCT00445068|refractory|refractory
650421|NCT00445055|Thyroidectomy|thyroidectomy
650422|NCT00445055|Nausea|nausea
650423|NCT00445055|Vomiting|vomiting
650424|NCT00445055|Droperidol|droperidol
650425|NCT00445042|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
650426|NCT00445042|Metastatic RCC|metastatic rcc
650427|NCT00445042|Kidney Cancer|kidney cancer
650428|NCT00445042|M3thodist|m3thodist
650429|NCT00445029|Allergic contact dermatitis|allergic contact dermatitis
650430|NCT00445029|para-phenylenediamine|para-phenylenediamine
650431|NCT00445029|effector cells|effector cells
650432|NCT00445029|regulatory cells|regulatory cells
650433|NCT00445029|pathophysiology|pathophysiology
650434|NCT00445016|peripheral regional anesthesia|peripheral regional anesthesia
650435|NCT00445016|nerve damage|nerve damage
650436|NCT00445016|adverse effects|adverse effects
650437|NCT00445016|neurologic complication|neurologic complication
650438|NCT00445016|neuropathy|neuropathy
650439|NCT00445003|Diabetic Retinopathy|diabetic retinopathy
650440|NCT00445003|Diabetic Macular Edema|diabetic macular edema
650441|NCT00445003|Lucentis|lucentis
650442|NCT00445003|Ranibizumab|ranibizumab
650443|NCT00445003|Triamcinolone|triamcinolone
650444|NCT00445003|Panretinal Photocoagulation|panretinal photocoagulation
650445|NCT00445003|Combination Therapy|combination therapy
650446|NCT00445003|pdr|pdr
650447|NCT00444990|Lumbar pain|lumbar pain
650448|NCT00444990|magnets|magnets
650449|NCT00444990|Reduce low back pain|reduce low back pain
650450|NCT00444977|HIV positive persons|hiv positive persons
650451|NCT00444977|Not received oral health care in the preceding 12 months.|not received oral health care in the preceding 12 months.
650452|NCT00444977|treatment naive|treatment naive
650453|NCT00444977|treatment experienced|treatment experienced
650454|NCT00444951|N meningitidis|n meningitidis
650455|NCT00444912|AMD3100|amd3100
650456|NCT00444912|stem cell mobilization|stem cell mobilization
650457|NCT00444912|autologous transplant|autologous transplant
650458|NCT00444912|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
650459|NCT00444912|Hodgkin Disease|hodgkin disease
650460|NCT00444899|Intensive treatment|intensive treatment
650461|NCT00444899|dietician|dietician
650462|NCT00444886|Thoracic Outlet Syndrome (TOS)|thoracic outlet syndrome (tos)
650463|NCT00444886|Botulinum Toxin|botulinum toxin
650464|NCT00444886|Botox|botox
650465|NCT00444886|Pain|pain
650466|NCT00444873|Inappropriate Growth Hormone Secretion Syndrome (Acromegaly)|inappropriate growth hormone secretion syndrome (acromegaly)
650467|NCT00444847|AIDS|aids
650468|NCT00444847|HIV|hiv
650469|NCT00444847|Hyperbaric Chamber|hyperbaric chamber
650470|NCT00444847|treatment experienced|treatment experienced
650471|NCT00444821|AAA|aaa
650472|NCT00444821|Aneurysm|aneurysm
650473|NCT00444821|AneuRx|aneurx
650474|NCT00444821|Talent|talent
650475|NCT00444808|Rib fracture|rib fracture
650476|NCT00444808|Pain|pain
650477|NCT00444808|intranasal calcitonin|intranasal calcitonin
650478|NCT00444795|SUTENE|sutene
650479|NCT00444795|post-marketing surveillance|post-marketing surveillance
650480|NCT00444795|GIST|gist
650481|NCT00444795|RCC|rcc
650482|NCT00444795|Korea|korea
650483|NCT00444782|Advanced Carcinoma, Hepatocellular|advanced carcinoma, hepatocellular
650484|NCT00444769|analgesia|analgesia
650485|NCT00444769|post-operative pain|post-operative pain
650486|NCT00444769|GW842166|gw842166
650487|NCT00444769|non-cannabinoid agonist|non-cannabinoid agonist
650488|NCT00444769|third molar tooth extraction|third molar tooth extraction
650489|NCT00444756|local anesthesia|local anesthesia
650490|NCT00444756|analgesia|analgesia
650491|NCT00444756|peripheral IV|peripheral iv
650492|NCT00444756|Local anesthesia prior to peripheral IV insertion|local anesthesia prior to peripheral iv insertion
650493|NCT00444730|Prostate Cancer|prostate cancer
650494|NCT00444730|Prostatectomy|prostatectomy
650495|NCT00444730|Pelvic pain|pelvic pain
650496|NCT00444730|urgency|urgency
650497|NCT00444730|incontinence|incontinence
650498|NCT00444730|frequency|frequency
650499|NCT00444717|statin|statin
650500|NCT00444717|metabolic syndrome|metabolic syndrome
650501|NCT00444717|oxidative stress|oxidative stress
650502|NCT00444717|inflammation|inflammation
650503|NCT00444691|synovitis score|synovitis score
650504|NCT00444691|sensitivity to change|sensitivity to change
650505|NCT00444691|clinical examination|clinical examination
650506|NCT00444691|ultra-sonography|ultra-sonography
650507|NCT00444678|Previously untreated metastatic colorectal cancer|previously untreated metastatic colorectal cancer
650508|NCT00444678|Metastatic Colorectal Cancer|metastatic colorectal cancer
650509|NCT00444678|combined therapy|combined therapy
650510|NCT00444678|biologics therapy|biologics therapy
650511|NCT00444678|antibody|antibody
650512|NCT00444678|chemotherapy|chemotherapy
650513|NCT00444678|EGFR|egfr
650514|NCT00444665|Glaucoma|glaucoma
650515|NCT00444652|Thromboprophylaxis|thromboprophylaxis
650516|NCT00444652|Bariatric surgery|bariatric surgery
650517|NCT00444652|prevention of venous thromboembolism in bariatric surgery|prevention of venous thromboembolism in bariatric surgery
650518|NCT00444626|nasolabial folds|nasolabial folds
650519|NCT00444626|facial wrinkles|facial wrinkles
650520|NCT00444613|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
650521|NCT00444613|motor neurons|motor neurons
650522|NCT00444613|muscular atrophy|muscular atrophy
650523|NCT00444613|Lou Gehrig's Disease|lou gehrig's disease
650524|NCT00444600|Diabetic Retinopathy|diabetic retinopathy
650525|NCT00444600|Diabetic Macular Edema|diabetic macular edema
650527|NCT00444600|Ranibizumab|ranibizumab
650528|NCT00444600|Triamcinolone|triamcinolone
650529|NCT00444600|Laser photocoagulation|laser photocoagulation
650530|NCT00444600|Combination Therapy|combination therapy
650531|NCT00444574|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
650532|NCT00444561|pramlintide|pramlintide
650534|NCT00444561|Amylin|amylin
650535|NCT00444548|Equipment|equipment
650536|NCT00444548|Supplies|supplies
650537|NCT00444535|VEGF|vegf
650538|NCT00444535|Tyrosine kinase|tyrosine kinase
650539|NCT00444535|ErbB2|erbb2
650541|NCT00444535|metastatic breast cancer|metastatic breast cancer
650542|NCT00444535|EGFR|egfr
650543|NCT00444535|ErbB1|erbb1
650544|NCT00444535|bevacizumab|bevacizumab
650545|NCT00444535|lapatinib|lapatinib
650546|NCT00444522|Panic attacks, Staccato® Alprazolam|panic attacks, staccato® alprazolam
650547|NCT00444509|Asthmatic Patients|asthmatic patients
650548|NCT00444470|tranexamic acid|tranexamic acid
650549|NCT00444470|safety|safety
650550|NCT00444470|efficacy|efficacy
650551|NCT00444470|spine surgery|spine surgery
650552|NCT00444470|spinal fusion and decompression|spinal fusion and decompression
650553|NCT00444470|adult|adult
650554|NCT00444470|perioperative|perioperative
650555|NCT00444470|blood loss|blood loss
650556|NCT00444470|bleeding|bleeding
650557|NCT00444470|blood transfusion|blood transfusion
650558|NCT00444457|Vaccine|vaccine
650559|NCT00444457|Infants|infants
650560|NCT00444457|Pneumococcal Conjugate Vaccines|pneumococcal conjugate vaccines
650561|NCT00444457|Vaccines, Pneumococcal|vaccines, pneumococcal
650562|NCT00444444|Autoimmune pancreatitis, HLA, relapse, Sequence-based typing|autoimmune pancreatitis, hla, relapse, sequence-based typing
650563|NCT00444418|Drinking|drinking
650564|NCT00444418|Alcohol problems|alcohol problems
650565|NCT00444418|Alcoholism|alcoholism
650566|NCT00444418|Gay men|gay men
650567|NCT00444418|Bisexual men|bisexual men
650568|NCT00444418|Moderation-oriented treatment|moderation-oriented treatment
650569|NCT00444418|Controlled drinking|controlled drinking
650570|NCT00444418|Non-abstinence based treatment|non-abstinence based treatment
650571|NCT00444405|lumbar|lumbar
650572|NCT00444405|disc|disc
650573|NCT00444405|herniation|herniation
650574|NCT00444405|discectomy|discectomy
650575|NCT00444405|fusion|fusion
650576|NCT00444405|spine|spine
650577|NCT00444392|Obese|obese
650578|NCT00444392|type 2 Diabetes Mellitus|type 2 diabetes mellitus
650579|NCT00444392|Gastric Bypass Surgery|gastric bypass surgery
650580|NCT00444392|Risk of CVD|risk of cvd
650581|NCT00444379|Kaposi's sarcoma|kaposi's sarcoma
650582|NCT00444379|KSHV|kshv
650583|NCT00444379|AIDS|aids
650584|NCT00444379|HHV-8|hhv-8
650585|NCT00444379|treatment naive|treatment naive
650586|NCT00444327|single nucleotide polymorphism|single nucleotide polymorphism
650587|NCT00444301|Heart failure|heart failure
650588|NCT00444301|Pain|pain
650589|NCT00444301|Symptoms|symptoms
650590|NCT00444301|Advanced heart failure|advanced heart failure
650591|NCT00444301|Pain frequency, severity, location, treatments|pain frequency, severity, location, treatments
650592|NCT00444301|Shortness of breath, anxiety, depression, cognitive function|shortness of breath, anxiety, depression, cognitive function
650593|NCT00444301|Social support, other conditions and illnesses|social support, other conditions and illnesses
650594|NCT00444288|Cystic Ovaries|cystic ovaries
650595|NCT00444288|Hyperandrogenism|hyperandrogenism
650596|NCT00444288|Anovulation|anovulation
650597|NCT00444288|Concordance Rates|concordance rates
650598|NCT00444288|Baseline Heritability|baseline heritability
650599|NCT00444288|Polycystic Ovary Syndrome|polycystic ovary syndrome
650600|NCT00444288|POS|pos
650601|NCT00444275|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
650602|NCT00444275|Acid Reflux|acid reflux
650603|NCT00444262|Hemodynamic optimisation|hemodynamic optimisation
650604|NCT00444262|Esophageal Doppler|esophageal doppler
650605|NCT00444262|Hydroxy ethyl starch|hydroxy ethyl starch
650606|NCT00444262|Hip fracture|hip fracture
650607|NCT00444262|Outcome|outcome
650608|NCT00444262|Elderly subjects (≥ 70 year old)|elderly subjects (≥ 70 year old)
650609|NCT00444262|General anesthesia|general anesthesia
650610|NCT00444249|age-related macular degeneration|age-related macular degeneration
650611|NCT00444249|melatonin|melatonin
650612|NCT00444249|blue-light filter|blue-light filter
650613|NCT00444236|asthma|asthma
650614|NCT00444236|GERD|gerd
650615|NCT00444236|reflux|reflux
650616|NCT00444236|exercise|exercise
650617|NCT00444223|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
650618|NCT00444223|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
650619|NCT00444223|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
650620|NCT00444184|travoprost/timolol fixed combination|travoprost/timolol fixed combination
650621|NCT00444171|critically ill|critically ill
650622|NCT00444171|insulin resistance|insulin resistance
650623|NCT00444171|intensive insulin therapy|intensive insulin therapy
650624|NCT00444171|computer algorithm|computer algorithm
650625|NCT00444158|opioids|opioids
650626|NCT00444158|chronic pain|chronic pain
650627|NCT00444132|clopidogrel|clopidogrel
650628|NCT00444132|platelets|platelets
650629|NCT00444132|acute coronary syndrome|acute coronary syndrome
650630|NCT00444132|percutaneous coronary intervention|percutaneous coronary intervention
650631|NCT00444119|adrenal insufficiency|adrenal insufficiency
650632|NCT00444119|subjective health status|subjective health status
650633|NCT00444119|quality of life|quality of life
650634|NCT00444119|adrenal crisis|adrenal crisis
650635|NCT00444119|hormone replacement|hormone replacement
650636|NCT00444119|DHEA|dhea
650637|NCT00444106|Malaria|malaria
650638|NCT00444106|hearing|hearing
650639|NCT00444106|co-artemether|co-artemether
650640|NCT00444106|auditory|auditory
650641|NCT00444106|Plasmodium falciparum|plasmodium falciparum
650642|NCT00444106|marsh fever|marsh fever
650643|NCT00444106|Plasmodium infections|plasmodium infections
650644|NCT00444106|remittent fever|remittent fever
650645|NCT00444106|paludism|paludism
650646|NCT00444106|artemether|artemether
650647|NCT00444106|artemisinins|artemisinins
650648|NCT00444106|benflumetol|benflumetol
650649|NCT00444106|lumefantrine|lumefantrine
650650|NCT00444093|radiation therapy|radiation therapy
650651|NCT00444093|diarrhea|diarrhea
650652|NCT00444093|enteritis|enteritis
650653|NCT00444093|supportive therapy|supportive therapy
650654|NCT00444093|therapy associated diarrhea|therapy associated diarrhea
650655|NCT00444093|therapy associated enteritis|therapy associated enteritis
650656|NCT00444093|radiation therapy of the small pelvis|radiation therapy of the small pelvis
650657|NCT00444080|Ex-PRESS|ex-press
650658|NCT00444080|TRABECULECTOMY|trabeculectomy
650659|NCT00444067|Prevention of CSF leak|prevention of csf leak
650660|NCT00444054|Diet|diet
650661|NCT00444054|Cancer|cancer
650662|NCT00444054|Alternative|alternative
650663|NCT00444054|Breast|breast
650664|NCT00444054|Colon|colon
650665|NCT00444054|Cervix|cervix
650666|NCT00444054|Uterus|uterus
650667|NCT00444054|Ovary|ovary
650668|NCT00444054|Metastatic|metastatic
650669|NCT00444054|Nutrition|nutrition
650670|NCT00444054|Carbohydrate|carbohydrate
650671|NCT00444041|metastatic colorectal cancer|metastatic colorectal cancer
650672|NCT00444041|surgery|surgery
650673|NCT00444041|chemotherapy|chemotherapy
650674|NCT00444028|Schizophrenia, Staccato Loxapine|schizophrenia, staccato loxapine
650675|NCT00444015|Erlotinib|erlotinib
650676|NCT00444015|Dasatinib|dasatinib
650677|NCT00444015|Epidermal growth factor receptor (EGFR)|epidermal growth factor receptor (egfr)
650678|NCT00444015|Tyrosine kinase|tyrosine kinase
650679|NCT00444015|NSCLC|nsclc
650680|NCT00444015|Pharmacokinetics (PK)|pharmacokinetics (pk)
650681|NCT00444015|Lung|lung
650682|NCT00444002|Hepatitis C|hepatitis c
650683|NCT00444002|Steatosis|steatosis
650684|NCT00444002|Oxidative Stress|oxidative stress
650685|NCT00444002|Antioxidants|antioxidants
650686|NCT00444002|Inflammation|inflammation
650687|NCT00444002|Fatty acids|fatty acids
650688|NCT00443989|Perioperative Myocardial Infarction|perioperative myocardial infarction
650689|NCT00443989|Stroke|stroke
650690|NCT00443989|Cardiac Death|cardiac death
650691|NCT00443989|Cardiac Arrest|cardiac arrest
650692|NCT00443989|Troponin-T|troponin-t
650693|NCT00443989|Non-Cardiac surgery|non-cardiac surgery
650694|NCT00443989|Death|death
650695|NCT00443976|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
650696|NCT00443976|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
650697|NCT00443976|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
650698|NCT00443976|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
650699|NCT00443976|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
650700|NCT00443976|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
650701|NCT00443976|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
650702|NCT00443976|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
650703|NCT00443976|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
650704|NCT00443976|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
650705|NCT00443976|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
650706|NCT00443976|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
650707|NCT00443976|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
650708|NCT00443976|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
650709|NCT00443976|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
650710|NCT00443976|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
650711|NCT00443976|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
650712|NCT00443976|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
650713|NCT00443976|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
650714|NCT00443976|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
650715|NCT00443976|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
650716|NCT00443976|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
650717|NCT00443976|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
650718|NCT00443976|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
650719|NCT00443976|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
650720|NCT00443976|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
650721|NCT00443976|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
650722|NCT00443976|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
650723|NCT00443976|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
650724|NCT00443976|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
650725|NCT00443976|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
650726|NCT00443976|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
650727|NCT00443976|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
650728|NCT00443976|splenic marginal zone lymphoma|splenic marginal zone lymphoma
650729|NCT00443976|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
650730|NCT00443976|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
650731|NCT00443976|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
650732|NCT00443976|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
650733|NCT00443976|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
650734|NCT00443976|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
650735|NCT00443976|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
650736|NCT00443976|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
650737|NCT00443976|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
650738|NCT00443963|Dyspepsia in patients taking NSAIDs|dyspepsia in patients taking nsaids
650739|NCT00443950|Arthritis|arthritis
650740|NCT00443950|Chinese|chinese
650741|NCT00443937|Kidney Transplantation|kidney transplantation
650742|NCT00443937|Renal Transplantation|renal transplantation
650743|NCT00443937|Mycophenolate|mycophenolate
650744|NCT00443937|Cyclosporine|cyclosporine
650745|NCT00443937|Everolimus|everolimus
650746|NCT00443924|Bilateral ocular hypertension or early primary open angle glaucoma|bilateral ocular hypertension or early primary open angle glaucoma
650747|NCT00443911|age-related macular degeneration, rheopheresis, lutein|age-related macular degeneration, rheopheresis, lutein
650748|NCT00443898|Toenail fungus|toenail fungus
650749|NCT00443898|Onychomycosis|onychomycosis
650750|NCT00443898|Nail fungus|nail fungus
650751|NCT00443898|Toenail fungal infection|toenail fungal infection
650752|NCT00443898|Tinea unguium|tinea unguium
650753|NCT00443898|Dermatophytes|dermatophytes
650754|NCT00443898|Foot dermatoses|foot dermatoses
650755|NCT00443885|meropenem|meropenem
650756|NCT00443885|imipenem|imipenem
650757|NCT00443885|gram negative organism|gram negative organism
650758|NCT00443872|Parkinson's disease|parkinson's disease
650759|NCT00443872|Dopamine agonist adverse effects|dopamine agonist adverse effects
650760|NCT00443872|MAO-B inhibitor|mao-b inhibitor
650761|NCT00443872|orally disintegrating selegiline|orally disintegrating selegiline
650762|NCT00443872|Zelapar|zelapar
650886|NCT00443378|HIV seronegativity|hiv seronegativity
650763|NCT00443859|Persistent Pulmonary Hypertension|persistent pulmonary hypertension
650764|NCT00443859|N-terminal pro brain natriuretic peptide|n-terminal pro brain natriuretic peptide
650765|NCT00443846|Prevention of Gastroenteritis due to rotavirus infection. And prevention of Invasive disease caused by Neisseria meningitidis serogroup C.|prevention of gastroenteritis due to rotavirus infection. and prevention of invasive disease caused by neisseria meningitidis serogroup c.
650766|NCT00443833|Thyrotoxicosis|thyrotoxicosis
650767|NCT00443833|genetic association study|genetic association study
650768|NCT00443833|periodic paralysis|periodic paralysis
650769|NCT00443833|whole genome scan|whole genome scan
650770|NCT00443820|Toenail fungus|toenail fungus
650771|NCT00443820|Onychomycosis|onychomycosis
650772|NCT00443820|Nail fungus|nail fungus
650773|NCT00443820|Toenail fungal infection|toenail fungal infection
650774|NCT00443820|Tinea unguium|tinea unguium
650775|NCT00443820|Dermatophytes|dermatophytes
650776|NCT00443820|Foot dermatoses|foot dermatoses
650777|NCT00443794|POLYCAP, Primary Prevention,CVD|polycap, primary prevention,cvd
650778|NCT00443781|low back pain, degenerative disc disease|low back pain, degenerative disc disease
650779|NCT00443768|Medication|medication
650780|NCT00443768|Diagnosis|diagnosis
650781|NCT00443768|Community|community
650782|NCT00443755|Inflammatory cytokine|inflammatory cytokine
650783|NCT00443755|Cardiovascular Disease|cardiovascular disease
650784|NCT00443755|Thrombotic factors|thrombotic factors
650785|NCT00443755|Dyslipidemia|dyslipidemia
650786|NCT00443742|Depression|depression
650787|NCT00443742|Validation|validation
650788|NCT00443742|Adolescent|adolescent
650789|NCT00443742|Validation of three key questions and questionnaire|validation of three key questions and questionnaire
650790|NCT00443729|treatment experienced|treatment experienced
650791|NCT00443703|treatment experienced|treatment experienced
650792|NCT00443690|heart failure|heart failure
650793|NCT00443690|diuretic|diuretic
650794|NCT00443690|renal impairment|renal impairment
650795|NCT00443690|renal function|renal function
650796|NCT00443664|Primary Open Angle Glaucoma|primary open angle glaucoma
650797|NCT00443651|Rituxan|rituxan
650798|NCT00443651|RA|ra
650799|NCT00443651|DMARD|dmard
650800|NCT00443651|Active Rheumatoid Arthritis|active rheumatoid arthritis
650801|NCT00443625|SK3530|sk3530
650802|NCT00443625|Food effect|food effect
650803|NCT00443625|Pharmacokinetics|pharmacokinetics
650804|NCT00443599|Congenital Heart Defects|congenital heart defects
650805|NCT00443599|Insulin|insulin
650806|NCT00443599|Euglycemia|euglycemia
650807|NCT00443599|Normoglycemia|normoglycemia
650808|NCT00443586|Nurse|nurse
650809|NCT00443586|Home Visitation|home visitation
650810|NCT00443586|Welfare|welfare
650811|NCT00443586|Social Behavior|social behavior
650812|NCT00443573|metastatic colorectal carcinoma (mCRC)|metastatic colorectal carcinoma (mcrc)
650813|NCT00443573|colorectal carcinoma (CRC)|colorectal carcinoma (crc)
650814|NCT00443573|tissue factor|tissue factor
650815|NCT00443573|factor VIIa|factor viia
650816|NCT00443573|rNAPc2|rnapc2
650817|NCT00443573|adenocarcinoma|adenocarcinoma
650818|NCT00443573|targeted therapy|targeted therapy
650819|NCT00443573|coagulation-dependent|coagulation-dependent
650820|NCT00443573|RECIST|recist
650821|NCT00443573|5-FU-based chemotherapy|5-fu-based chemotherapy
650822|NCT00443573|FOLFOX|folfox
650823|NCT00443573|FOLFIRI|folfiri
650824|NCT00443573|leucovorin|leucovorin
650825|NCT00443573|XELOX|xelox
650826|NCT00443560|Labor|labor
650827|NCT00443560|Epidural Analgesia|epidural analgesia
650828|NCT00443560|delivery|delivery
650829|NCT00443560|vacuum extraction|vacuum extraction
650830|NCT00443560|obstetrical Forceps|obstetrical forceps
650831|NCT00443547|Prospective|prospective
650832|NCT00443547|Degenerative Disc Disease|degenerative disc disease
650833|NCT00443547|Cervical|cervical
650834|NCT00443547|Translational Plate|translational plate
650835|NCT00443521|Diabetes Mellitus/ complications|diabetes mellitus/ complications
650836|NCT00443521|Diabetic Retinopathy|diabetic retinopathy
650837|NCT00443521|Triamcinolone|triamcinolone
650838|NCT00443521|Laser coagulation|laser coagulation
650839|NCT00443521|Tomography, optical coherence|tomography, optical coherence
650840|NCT00443508|everolimus|everolimus
650841|NCT00443508|renal transplant|renal transplant
650842|NCT00443508|tacrolimus|tacrolimus
650843|NCT00443508|Certican|certican
650844|NCT00443508|CHRONIC ALLOGRAFT NEPHROPATHY|chronic allograft nephropathy
650845|NCT00443508|Renal transplant patients|renal transplant patients
650846|NCT00443482|Asthma|asthma
650847|NCT00443482|adults|adults
650848|NCT00443482|B2 agonist|b2 agonist
650849|NCT00443482|formoterol|formoterol
650850|NCT00443469|magnetic stimulation|magnetic stimulation
650851|NCT00443469|neuropathic pain|neuropathic pain
650852|NCT00443469|spinal|spinal
650853|NCT00443469|lower limb|lower limb
650854|NCT00443469|clinical trial|clinical trial
650855|NCT00443443|Rituximab|rituximab
650856|NCT00443443|RA|ra
650857|NCT00443443|Sunstone|sunstone
650858|NCT00443443|anti-TNF|anti-tnf
650859|NCT00443443|Rituxan|rituxan
650860|NCT00443430|Childhood Arthritis|childhood arthritis
650861|NCT00443430|Juvenile Arthritis|juvenile arthritis
650862|NCT00443430|Juvenile Arthritis Treatment|juvenile arthritis treatment
650863|NCT00443430|Childhood Arthritis Drug Treatment|childhood arthritis drug treatment
650864|NCT00443430|Juvenile Arthritis Remission|juvenile arthritis remission
650865|NCT00443430|Inactive Disease in Juvenile Arthritis|inactive disease in juvenile arthritis
650866|NCT00443430|Childhood Polyarthritis|childhood polyarthritis
650867|NCT00443430|Extended Oligoarthritis|extended oligoarthritis
650868|NCT00443404|phantom|phantom
650869|NCT00443404|amputation|amputation
650870|NCT00443404|analgesia|analgesia
650871|NCT00443404|pain|pain
650872|NCT00443404|preemptive|preemptive
650873|NCT00443404|perioperative|perioperative
650874|NCT00443404|lower limb amputation|lower limb amputation
650875|NCT00443404|intensity of phantom limb pain|intensity of phantom limb pain
650876|NCT00443404|preemptive analgesia reduces phantom pain|preemptive analgesia reduces phantom pain
650877|NCT00443404|perioperative analgesia reduces phantom pain|perioperative analgesia reduces phantom pain
650878|NCT00443404|Severe Phantom Limb Pain (VAS>70 mm)|severe phantom limb pain (vas>70 mm)
650879|NCT00443404|resistant to medical treatment one week before amputation|resistant to medical treatment one week before amputation
650880|NCT00443391|ADHD|adhd
650881|NCT00443378|computer counseling|computer counseling
650882|NCT00443378|HIV|hiv
650883|NCT00443378|antiretroviral adherence|antiretroviral adherence
650884|NCT00443378|sexual behavior|sexual behavior
650885|NCT00443378|prevention with positives|prevention with positives
650887|NCT00443339|Myelodysplastic syndromes with IPSS Low or Int-1|myelodysplastic syndromes with ipss low or int-1
650888|NCT00443339|Anemia|anemia
650889|NCT00020475|adult solid tumor|adult solid tumor
650890|NCT00020475|body system/site cancer|body system/site cancer
650891|NCT00020475|cancer|cancer
650892|NCT00020475|extraocular extension melanoma|extraocular extension melanoma
650893|NCT00020475|eye cancer|eye cancer
650894|NCT00020475|intraocular melanoma|intraocular melanoma
650895|NCT00020475|recurrent intraocular melanoma|recurrent intraocular melanoma
650896|NCT00020475|solid tumor|solid tumor
650897|NCT00020475|stage, intraocular melanoma|stage, intraocular melanoma
650898|NCT00020371|adult solid tumor|adult solid tumor
650899|NCT00020371|bone marrow suppression|bone marrow suppression
650900|NCT00020371|cancer|cancer
650901|NCT00020371|cancer-related problem/condition|cancer-related problem/condition
650902|NCT00020371|neutropenia|neutropenia
650903|NCT00020371|solid tumor|solid tumor
650904|NCT00020371|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
650905|NCT00020345|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
650906|NCT00020345|adult solid tumor|adult solid tumor
650907|NCT00020345|body system/site cancer|body system/site cancer
650909|NCT00020345|cellular diagnosis, pancreatic cancer|cellular diagnosis, pancreatic cancer
650910|NCT00020345|gastrointestinal cancer|gastrointestinal cancer
650911|NCT00020345|pancreatic cancer|pancreatic cancer
650912|NCT00020345|solid tumor|solid tumor
650913|NCT00020345|stage III pancreatic cancer|stage iii pancreatic cancer
650914|NCT00020345|stage IV pancreatic cancer|stage iv pancreatic cancer
650915|NCT00020345|stage IVA pancreatic cancer|stage iva pancreatic cancer
650916|NCT00020345|stage, pancreatic cancer|stage, pancreatic cancer
650917|NCT00020267|Ewing's family of tumors|ewing's family of tumors
650918|NCT00020267|adult soft tissue sarcoma|adult soft tissue sarcoma
650919|NCT00020267|adult solid tumor|adult solid tumor
650920|NCT00020267|body system/site cancer|body system/site cancer
650921|NCT00020267|bone cancer|bone cancer
650922|NCT00020267|breast cancer|breast cancer
650923|NCT00020267|cancer|cancer
650924|NCT00020267|childhood cancer|childhood cancer
650925|NCT00020267|childhood solid tumor|childhood solid tumor
650926|NCT00020267|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
650927|NCT00020267|colon cancer|colon cancer
650928|NCT00020267|colorectal cancer|colorectal cancer
650929|NCT00020267|extraocular extension melanoma|extraocular extension melanoma
650930|NCT00020267|eye cancer|eye cancer
650931|NCT00020267|female reproductive cancer|female reproductive cancer
650932|NCT00020267|gastrointestinal cancer|gastrointestinal cancer
650933|NCT00020267|genetic condition|genetic condition
650934|NCT00020267|intraocular melanoma|intraocular melanoma
650935|NCT00020267|lung cancer|lung cancer
650936|NCT00020267|male breast cancer|male breast cancer
650937|NCT00020267|melanoma|melanoma
650938|NCT00020267|metastatic osteosarcoma|metastatic osteosarcoma
650939|NCT00020267|metastatic tumors of the Ewing's family|metastatic tumors of the ewing's family
650940|NCT00020267|muscle cancer|muscle cancer
650941|NCT00020267|musculoskeletal cancer|musculoskeletal cancer
650942|NCT00020267|non-small cell lung cancer|non-small cell lung cancer
650943|NCT00020267|osteosarcoma|osteosarcoma
650944|NCT00020267|osteosarcoma/malignant fibrous histiocytoma of bone|osteosarcoma/malignant fibrous histiocytoma of bone
650945|NCT00020267|ovarian sarcoma|ovarian sarcoma
650946|NCT00020267|rectal cancer|rectal cancer
650947|NCT00020267|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
650948|NCT00020267|recurrent breast cancer|recurrent breast cancer
650949|NCT00020267|recurrent colon cancer|recurrent colon cancer
650950|NCT00020267|recurrent intraocular melanoma|recurrent intraocular melanoma
650951|NCT00020267|recurrent melanoma|recurrent melanoma
650952|NCT00020267|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
650953|NCT00020267|recurrent osteosarcoma|recurrent osteosarcoma
650954|NCT00020267|recurrent rectal cancer|recurrent rectal cancer
650955|NCT00020267|recurrent tumors of the Ewing's family|recurrent tumors of the ewing's family
650956|NCT00020267|recurrent uterine sarcoma|recurrent uterine sarcoma
650957|NCT00020267|skin tumor|skin tumor
650958|NCT00020267|solid tumor|solid tumor
650959|NCT00020267|stage IIIB, IV, recurrent, and metastatic breast cancer|stage iiib, iv, recurrent, and metastatic breast cancer
650960|NCT00020267|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
650961|NCT00020267|stage IV breast cancer|stage iv breast cancer
650962|NCT00020267|stage IV colon cancer|stage iv colon cancer
650963|NCT00020267|stage IV melanoma|stage iv melanoma
650964|NCT00020267|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
650965|NCT00020267|stage IV rectal cancer|stage iv rectal cancer
650966|NCT00020267|stage IV uterine sarcoma|stage iv uterine sarcoma
650967|NCT00020267|stage IVA adult soft tissue sarcoma|stage iva adult soft tissue sarcoma
650968|NCT00020267|stage IVB adult soft tissue sarcoma|stage ivb adult soft tissue sarcoma
650969|NCT00020267|stage, Ewing's family of tumors|stage, ewing's family of tumors
650970|NCT00020267|stage, adult soft tissue sarcoma|stage, adult soft tissue sarcoma
650971|NCT00020267|stage, breast cancer|stage, breast cancer
650972|NCT00020267|stage, colon cancer|stage, colon cancer
650973|NCT00020267|stage, intraocular melanoma|stage, intraocular melanoma
650974|NCT00020267|stage, melanoma|stage, melanoma
650975|NCT00020267|stage, non-small cell lung cancer|stage, non-small cell lung cancer
650976|NCT00020267|stage, osteosarcoma|stage, osteosarcoma
650977|NCT00020267|stage, rectal cancer|stage, rectal cancer
650978|NCT00020267|stage, uterine sarcoma|stage, uterine sarcoma
650979|NCT00020267|thorax/respiratory cancer|thorax/respiratory cancer
650980|NCT00020267|uterine sarcoma|uterine sarcoma
650981|NCT00019643|adult solid tumor|adult solid tumor
650982|NCT00019643|body system/site cancer|body system/site cancer
650983|NCT00019643|breast cancer|breast cancer
650984|NCT00019643|cancer|cancer
650985|NCT00019643|cancer-related problem/condition|cancer-related problem/condition
650986|NCT00019643|depression|depression
650987|NCT00019643|depression and suicide|depression and suicide
650988|NCT00019643|nutrition|nutrition
650989|NCT00019643|psychosocial effects/treatment|psychosocial effects/treatment
650990|NCT00019643|quality of life|quality of life
650991|NCT00019643|solid tumor|solid tumor
650992|NCT00019643|stage I breast cancer|stage i breast cancer
650993|NCT00019643|stage I, II, and IIIA breast cancer|stage i, ii, and iiia breast cancer
650994|NCT00019643|stage II breast cancer|stage ii breast cancer
650995|NCT00019643|stage III breast cancer|stage iii breast cancer
650996|NCT00019643|stage IIIA breast cancer|stage iiia breast cancer
650997|NCT00019643|stage IIIB, IV, recurrent, and metastatic breast cancer|stage iiib, iv, recurrent, and metastatic breast cancer
650998|NCT00019643|stage, breast cancer|stage, breast cancer
650999|NCT00443326|Psoriasis|psoriasis
651000|NCT00443326|PASI|pasi
651001|NCT00443326|Skin Biopsy|skin biopsy
651002|NCT00443326|Human Monoclonal Antibody|human monoclonal antibody
651003|NCT00443313|Cervical neoplasia|cervical neoplasia
651004|NCT00443313|Screening|screening
651006|NCT00443313|Cervical Cancer Screening|cervical cancer screening
651007|NCT00443300|AML|aml
651008|NCT00443300|MDS|mds
651009|NCT00443300|Protected Environment|protected environment
651010|NCT00443287|Peripheral|peripheral
651011|NCT00443287|Artery|artery
651012|NCT00443287|Disease|disease
651013|NCT00443261|Head and Neck Cancer|head and neck cancer
651014|NCT00443235|Older patients|older patients
651015|NCT00443235|untreated patients|untreated patients
651016|NCT00443222|infliximab|infliximab
651017|NCT00443222|polymyositis|polymyositis
651018|NCT00443222|dermatomyositis|dermatomyositis
651019|NCT00443222|inclusion body myositis|inclusion body myositis
651020|NCT00443196|Chemosensitivity|chemosensitivity
651021|NCT00443196|Ovarian Cancer|ovarian cancer
651022|NCT00443196|Chemotherapy|chemotherapy
651023|NCT00443196|Fallopian Adenocarcinoma|fallopian adenocarcinoma
651024|NCT00443196|Peritoneal Adenocarcinoma|peritoneal adenocarcinoma
651025|NCT00443196|Patients with pathological diagnoses of ovarian, fallopian and primary peritoneal adenocarcinomas.|patients with pathological diagnoses of ovarian, fallopian and primary peritoneal adenocarcinomas.
651026|NCT00443196|Patients with de novo malignancies and no previous chemotherapy|patients with de novo malignancies and no previous chemotherapy
651027|NCT00443196|Patients with advanced refractory malignancies who received no more than 2 standard chemotherapy treatment protocols.|patients with advanced refractory malignancies who received no more than 2 standard chemotherapy treatment protocols.
651028|NCT00443170|repeat dose,|repeat dose,
651029|NCT00443170|GSK626616AC,|gsk626616ac,
651030|NCT00443170|pharmacokinetic,|pharmacokinetic,
651031|NCT00443170|single dose,|single dose,
651032|NCT00443170|cytochrome P450,|cytochrome p450,
651033|NCT00443170|First time in human,|first time in human,
651034|NCT00443170|healthy volunteers|healthy volunteers
651035|NCT00443157|meningococcal B vaccine|meningococcal b vaccine
651036|NCT00443144|growth hormone receptor polymorphism|growth hormone receptor polymorphism
651037|NCT00443144|pharmacogenomics|pharmacogenomics
651038|NCT00443144|growth promoting therapy|growth promoting therapy
651039|NCT00443131|Adjuvant|adjuvant
651040|NCT00443131|Malaria|malaria
651041|NCT00443131|Safety|safety
651042|NCT00443131|Immunogenicity|immunogenicity
651043|NCT00443118|Bag and mask|bag and mask
651044|NCT00443118|Neopuff|neopuff
651045|NCT00443118|Resuscitation|resuscitation
651046|NCT00443118|Newborn|newborn
651047|NCT00443118|Intubation|intubation
651048|NCT00443118|devices|devices
651049|NCT00443118|PEEP|peep
651050|NCT00443092|osteoarthritis|osteoarthritis
651051|NCT00443092|gout|gout
651052|NCT00443092|pain|pain
651053|NCT00443092|uric acid|uric acid
651054|NCT00443092|tart cherry|tart cherry
651055|NCT00443092|alternative medicine|alternative medicine
651056|NCT00443092|knees|knees
651057|NCT00443079|Clinical Trials|clinical trials
651058|NCT00443079|Pilot Projects|pilot projects
651059|NCT00443079|Milk Thistle|milk thistle
651060|NCT00443079|Liver Function Tests|liver function tests
651061|NCT00443066|pediatric|pediatric
651062|NCT00443066|neuromuscular disease|neuromuscular disease
651063|NCT00443053|superficial vein thrombosis|superficial vein thrombosis
651064|NCT00443053|superficial thrombophlebitis|superficial thrombophlebitis
651065|NCT00443053|fondaparinux|fondaparinux
651066|NCT00443053|deep vein thrombosis|deep vein thrombosis
651067|NCT00443053|venous thromboembolism treatment|venous thromboembolism treatment
651068|NCT00443053|thrombosis|thrombosis
651069|NCT00443014|Stimulation therapy|stimulation therapy
651070|NCT00443014|Acetylcholinesterase inhibitors|acetylcholinesterase inhibitors
651071|NCT00443014|Synergetic|synergetic
651072|NCT00443001|Non-Invasive Blood Pressure|non-invasive blood pressure
651073|NCT00443001|Sinus Rhythm|sinus rhythm
651074|NCT00443001|Oscillometric|oscillometric
651075|NCT00443001|Invasive Blood Pressure|invasive blood pressure
651076|NCT00443001|AAMI/ANSI SP10 Standard|aami/ansi sp10 standard
651077|NCT00443001|Compliance with ANSI/AAMI SP10 2002 standard|compliance with ansi/aami sp10 2002 standard
651078|NCT00442988|NODAT|nodat
651079|NCT00442988|OGTT|ogtt
651080|NCT00442988|FPG|fpg
651081|NCT00442988|Renal Transplanation|renal transplanation
651082|NCT00442988|Risk Factors|risk factors
651083|NCT00442988|Predictive value|predictive value
651084|NCT00442975|Influenza Vaccine|influenza vaccine
651085|NCT00442975|CMV|cmv
651086|NCT00442949|Acute coronary syndrome|acute coronary syndrome
651087|NCT00442949|Angioplasty|angioplasty
651088|NCT00442949|Abciximab|abciximab
651089|NCT00442949|Troponin release|troponin release
651090|NCT00442923|Methamphetamine|methamphetamine
651091|NCT00442923|Coreg|coreg
651092|NCT00442923|Withdrawal|withdrawal
651094|NCT00442923|Substance Addiction|substance addiction
651095|NCT00442910|Safety and Acceptability|safety and acceptability
651096|NCT00442897|Hypercholesterolaemia|hypercholesterolaemia
651097|NCT00442884|glucose control in acute stress|glucose control in acute stress
651098|NCT00442871|Renal Impairment,|renal impairment,
651099|NCT00442871|chronic immune thrombocytopenia purpura,|chronic immune thrombocytopenia purpura,
651100|NCT00442871|thrombocytopenia,|thrombocytopenia,
651101|NCT00442871|chemotherapy induced thrombocytopenia|chemotherapy induced thrombocytopenia
651102|NCT00442858|cardiac disease|cardiac disease
651103|NCT00442858|cerebrovascular disease|cerebrovascular disease
651104|NCT00442858|GH deficiency|gh deficiency
651105|NCT00442858|diabetes mellitus|diabetes mellitus
651106|NCT00442858|hypertension|hypertension
651107|NCT00442858|GH therapy|gh therapy
651108|NCT00442858|GH deficiency and hypopituitarims|gh deficiency and hypopituitarims
651109|NCT00020202|adult solid tumor|adult solid tumor
651110|NCT00020202|body system/site cancer|body system/site cancer
651111|NCT00020202|cancer|cancer
651112|NCT00020202|extensive stage small cell lung cancer|extensive stage small cell lung cancer
651113|NCT00020202|genetic condition|genetic condition
651114|NCT00020202|lung cancer|lung cancer
651115|NCT00020202|non-small cell lung cancer|non-small cell lung cancer
651116|NCT00020202|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
651117|NCT00020202|recurrent small cell lung cancer|recurrent small cell lung cancer
651118|NCT00020202|small cell lung cancer|small cell lung cancer
651119|NCT00020202|solid tumor|solid tumor
651120|NCT00020202|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
651121|NCT00020202|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
651122|NCT00020202|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
651123|NCT00020202|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
651124|NCT00020202|stage, non-small cell lung cancer|stage, non-small cell lung cancer
651125|NCT00020202|stage, small cell lung cancer|stage, small cell lung cancer
651126|NCT00020202|thorax/respiratory cancer|thorax/respiratory cancer
651127|NCT00020046|adenocarcinoma of the prostate|adenocarcinoma of the prostate
651128|NCT00020046|adult solid tumor|adult solid tumor
651129|NCT00020046|body system/site cancer|body system/site cancer
651130|NCT00020046|cancer|cancer
651131|NCT00020046|cellular diagnosis, prostate cancer|cellular diagnosis, prostate cancer
651132|NCT00020046|genetic condition|genetic condition
651133|NCT00020046|male reproductive cancer|male reproductive cancer
651134|NCT00020046|prostate cancer|prostate cancer
651135|NCT00020046|recurrent prostate cancer|recurrent prostate cancer
651136|NCT00020046|solid tumor|solid tumor
651137|NCT00020046|stage IV prostate cancer|stage iv prostate cancer
651138|NCT00020046|stage, prostate cancer|stage, prostate cancer
651139|NCT00019968|adult soft tissue sarcoma|adult soft tissue sarcoma
651140|NCT00019968|adult solid tumor|adult solid tumor
651141|NCT00019968|body system/site cancer|body system/site cancer
651142|NCT00019968|cancer|cancer
651143|NCT00019968|muscle cancer|muscle cancer
651144|NCT00019968|musculoskeletal cancer|musculoskeletal cancer
651145|NCT00019968|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
651146|NCT00019968|solid tumor|solid tumor
651147|NCT00019968|stage IA, IB, and IIA adult soft tissue sarcoma|stage ia, ib, and iia adult soft tissue sarcoma
651148|NCT00019968|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
651149|NCT00019968|stage IIB adult soft tissue sarcoma|stage iib adult soft tissue sarcoma
651150|NCT00019968|stage IIB, IIC, and III adult soft tissue sarcoma|stage iib, iic, and iii adult soft tissue sarcoma
651151|NCT00019968|stage IIC adult soft tissue sarcoma|stage iic adult soft tissue sarcoma
651152|NCT00019968|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
651153|NCT00019968|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
651154|NCT00019968|stage IVA adult soft tissue sarcoma|stage iva adult soft tissue sarcoma
651155|NCT00019968|stage IVB adult soft tissue sarcoma|stage ivb adult soft tissue sarcoma
651156|NCT00019968|stage, adult soft tissue sarcoma|stage, adult soft tissue sarcoma
651157|NCT00019890|adult solid tumor|adult solid tumor
651158|NCT00019890|body system/site cancer|body system/site cancer
651159|NCT00019890|cancer|cancer
651160|NCT00019890|melanoma|melanoma
651161|NCT00019890|recurrent melanoma|recurrent melanoma
651162|NCT00019890|skin tumor|skin tumor
651163|NCT00019890|solid tumor|solid tumor
651164|NCT00019890|stage III melanoma|stage iii melanoma
651165|NCT00019890|stage IV melanoma|stage iv melanoma
651166|NCT00019890|stage, melanoma|stage, melanoma
651167|NCT00019760|adult solid tumor|adult solid tumor
651168|NCT00019760|body system/site cancer|body system/site cancer
651169|NCT00019760|cancer|cancer
651170|NCT00019760|colon cancer|colon cancer
651171|NCT00019760|colorectal cancer|colorectal cancer
651172|NCT00019760|gastrointestinal cancer|gastrointestinal cancer
651173|NCT00019760|genetic condition|genetic condition
651174|NCT00019760|liver and intrahepatic biliary tract cancer|liver and intrahepatic biliary tract cancer
651175|NCT00019760|liver metastases|liver metastases
651176|NCT00019760|metastatic cancer|metastatic cancer
651177|NCT00019760|rectal cancer|rectal cancer
651178|NCT00019760|recurrent colon cancer|recurrent colon cancer
651179|NCT00019760|recurrent rectal cancer|recurrent rectal cancer
651180|NCT00019760|site, metastatic cancer|site, metastatic cancer
651181|NCT00019760|solid tumor|solid tumor
651182|NCT00019760|stage IV colon cancer|stage iv colon cancer
651183|NCT00019760|stage IV rectal cancer|stage iv rectal cancer
651184|NCT00019760|stage, colon cancer|stage, colon cancer
651185|NCT00019760|stage, rectal cancer|stage, rectal cancer
651186|NCT00019760|unclassified/other cancer|unclassified/other cancer
651187|NCT00019695|adenocarcinoma of the prostate|adenocarcinoma of the prostate
651188|NCT00019695|adult solid tumor|adult solid tumor
651189|NCT00019695|body system/site cancer|body system/site cancer
651190|NCT00019695|bone metastases|bone metastases
651191|NCT00019695|cancer|cancer
651192|NCT00019695|cellular diagnosis, prostate cancer|cellular diagnosis, prostate cancer
651193|NCT00019695|genetic condition|genetic condition
651194|NCT00019695|male reproductive cancer|male reproductive cancer
651195|NCT00019695|metastatic cancer|metastatic cancer
651196|NCT00019695|prostate cancer|prostate cancer
651197|NCT00019695|recurrent prostate cancer|recurrent prostate cancer
651198|NCT00019695|site, metastatic cancer|site, metastatic cancer
651199|NCT00019695|solid tumor|solid tumor
651200|NCT00019695|stage IV prostate cancer|stage iv prostate cancer
651201|NCT00019695|stage, prostate cancer|stage, prostate cancer
651202|NCT00019695|unclassified/other cancer|unclassified/other cancer
651203|NCT00019630|Ewing's family of tumors|ewing's family of tumors
651204|NCT00019630|Wilms' tumor|wilms' tumor
651205|NCT00019630|adult solid tumor|adult solid tumor
651206|NCT00019630|body system/site cancer|body system/site cancer
651207|NCT00019630|bone cancer|bone cancer
651208|NCT00019630|brain tumor|brain tumor
651209|NCT00019630|cancer|cancer
651210|NCT00019630|central nervous system cancer|central nervous system cancer
651211|NCT00019630|childhood brain stem glioma|childhood brain stem glioma
651212|NCT00019630|childhood brain tumor|childhood brain tumor
651213|NCT00019630|childhood cancer|childhood cancer
651214|NCT00019630|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
651215|NCT00019630|childhood cerebellar astrocytoma|childhood cerebellar astrocytoma
651216|NCT00019630|childhood cerebral astrocytoma|childhood cerebral astrocytoma
651217|NCT00019630|childhood choroid plexus tumor|childhood choroid plexus tumor
651218|NCT00019630|childhood craniopharyngioma|childhood craniopharyngioma
651219|NCT00019630|childhood ependymoma|childhood ependymoma
651220|NCT00019630|childhood extracranial germ cell tumor|childhood extracranial germ cell tumor
651221|NCT00019630|childhood extragonadal malignant germ cell tumor|childhood extragonadal malignant germ cell tumor
651222|NCT00019630|childhood liver cancer|childhood liver cancer
651223|NCT00019630|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
651224|NCT00019630|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
651225|NCT00019630|childhood mature and immature teratomas|childhood mature and immature teratomas
651226|NCT00019630|childhood medulloblastoma|childhood medulloblastoma
651227|NCT00019630|childhood meningioma|childhood meningioma
651228|NCT00019630|childhood oligodendroglioma|childhood oligodendroglioma
651229|NCT00019630|childhood rhabdomyosarcoma|childhood rhabdomyosarcoma
651230|NCT00019630|childhood soft tissue sarcoma|childhood soft tissue sarcoma
651231|NCT00019630|childhood solid tumor|childhood solid tumor
651232|NCT00019630|childhood supratentorial primitive neuroectodermal and pineal tumors|childhood supratentorial primitive neuroectodermal and pineal tumors
651233|NCT00019630|childhood visual pathway and hypothalamic glioma|childhood visual pathway and hypothalamic glioma
651234|NCT00019630|endocrine cancer|endocrine cancer
651235|NCT00019630|gastrointestinal cancer|gastrointestinal cancer
651236|NCT00019630|genetic condition|genetic condition
651237|NCT00019630|kidney tumor|kidney tumor
651238|NCT00019630|kidney/urinary cancer|kidney/urinary cancer
651239|NCT00019630|liver and intrahepatic biliary tract cancer|liver and intrahepatic biliary tract cancer
651240|NCT00019630|muscle cancer|muscle cancer
651241|NCT00019630|musculoskeletal cancer|musculoskeletal cancer
651242|NCT00019630|neuroblastoma|neuroblastoma
651243|NCT00019630|osteosarcoma|osteosarcoma
651244|NCT00019630|osteosarcoma/malignant fibrous histiocytoma of bone|osteosarcoma/malignant fibrous histiocytoma of bone
651245|NCT00019630|pediatric germ cell tumor|pediatric germ cell tumor
651246|NCT00019630|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
651247|NCT00019630|recurrent Wilms' tumor|recurrent wilms' tumor
651248|NCT00019630|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
651249|NCT00019630|recurrent childhood brain tumor|recurrent childhood brain tumor
651250|NCT00019630|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
651251|NCT00019630|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
651252|NCT00019630|recurrent childhood ependymoma|recurrent childhood ependymoma
651253|NCT00019630|recurrent childhood liver cancer|recurrent childhood liver cancer
651254|NCT00019630|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
651255|NCT00019630|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
651256|NCT00019630|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
651257|NCT00019630|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
651258|NCT00019630|recurrent childhood supratentorial primitive neuroectodermal and pineal tumors|recurrent childhood supratentorial primitive neuroectodermal and pineal tumors
651259|NCT00019630|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
651260|NCT00019630|recurrent neuroblastoma|recurrent neuroblastoma
651261|NCT00019630|recurrent osteosarcoma|recurrent osteosarcoma
651262|NCT00019630|recurrent tumors of the Ewing's family|recurrent tumors of the ewing's family
651263|NCT00019630|solid tumor|solid tumor
651264|NCT00019630|stage, Ewing's family of tumors|stage, ewing's family of tumors
651265|NCT00019630|stage, Wilms' tumor|stage, wilms' tumor
651266|NCT00019630|stage, childhood extracranial germ cell tumor|stage, childhood extracranial germ cell tumor
651267|NCT00019630|stage, childhood liver cancer|stage, childhood liver cancer
651268|NCT00019630|stage, childhood medulloblastoma|stage, childhood medulloblastoma
651269|NCT00019630|stage, childhood rhabdomyosarcoma|stage, childhood rhabdomyosarcoma
651270|NCT00019630|stage, childhood soft tissue sarcoma|stage, childhood soft tissue sarcoma
651271|NCT00019630|stage, neuroblastoma|stage, neuroblastoma
651272|NCT00019630|stage, osteosarcoma|stage, osteosarcoma
651273|NCT00019630|stage/type, childhood brain tumor|stage/type, childhood brain tumor
651274|NCT00019630|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
651275|NCT00019448|adult solid tumor|adult solid tumor
651276|NCT00019448|body system/site cancer|body system/site cancer
651277|NCT00019448|cancer|cancer
651278|NCT00019448|melanoma|melanoma
651279|NCT00019448|recurrent melanoma|recurrent melanoma
651280|NCT00019448|skin tumor|skin tumor
651281|NCT00019448|solid tumor|solid tumor
651282|NCT00019448|stage IV melanoma|stage iv melanoma
651283|NCT00019448|stage, melanoma|stage, melanoma
651284|NCT00019396|adult solid tumor|adult solid tumor
651285|NCT00019396|body system/site cancer|body system/site cancer
651286|NCT00019396|cancer|cancer
651287|NCT00019396|kidney tumor|kidney tumor
651288|NCT00019396|kidney/urinary cancer|kidney/urinary cancer
651289|NCT00019396|melanoma|melanoma
651290|NCT00019396|recurrent melanoma|recurrent melanoma
651291|NCT00019396|recurrent renal cell cancer|recurrent renal cell cancer
651292|NCT00019396|renal cell cancer|renal cell cancer
651293|NCT00019396|skin tumor|skin tumor
651294|NCT00019396|solid tumor|solid tumor
651295|NCT00019396|stage IV melanoma|stage iv melanoma
651296|NCT00019396|stage IV renal cell cancer|stage iv renal cell cancer
651297|NCT00019396|stage, melanoma|stage, melanoma
651298|NCT00019396|stage, renal cell cancer|stage, renal cell cancer
651299|NCT00019188|AIDS-related malignancies|aids-related malignancies
651300|NCT00019188|Kaposi's sarcoma|kaposi's sarcoma
651301|NCT00019188|adult solid tumor|adult solid tumor
651302|NCT00019188|body system/site cancer|body system/site cancer
651303|NCT00019188|cancer|cancer
651304|NCT00019188|epidemic Kaposi's sarcoma|epidemic kaposi's sarcoma
651305|NCT00019188|recurrent Kaposi's sarcoma|recurrent kaposi's sarcoma
651306|NCT00019188|skin tumor|skin tumor
651307|NCT00019188|solid tumor|solid tumor
651308|NCT00019188|stage, Kaposi's sarcoma|stage, kaposi's sarcoma
651309|NCT00019097|body system/site cancer|body system/site cancer
651310|NCT00019097|cancer|cancer
651311|NCT00019097|genetic condition|genetic condition
651312|NCT00019097|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
651313|NCT00019097|multiple myeloma|multiple myeloma
651314|NCT00019097|multiple myeloma and other plasma cell neoplasms|multiple myeloma and other plasma cell neoplasms
651315|NCT00019097|plasma cell neoplasm|plasma cell neoplasm
651316|NCT00019097|refractory plasma cell neoplasm|refractory plasma cell neoplasm
651317|NCT00019097|stage II multiple myeloma|stage ii multiple myeloma
651318|NCT00019097|stage III multiple myeloma|stage iii multiple myeloma
651319|NCT00019097|stage, plasma cell neoplasm|stage, plasma cell neoplasm
651320|NCT00003552|adult solid tumor|adult solid tumor
651321|NCT00003552|body system/site cancer|body system/site cancer
651322|NCT00003552|cancer|cancer
651323|NCT00003552|melanoma|melanoma
651324|NCT00003552|recurrent melanoma|recurrent melanoma
651325|NCT00003552|skin tumor|skin tumor
651326|NCT00003552|solid tumor|solid tumor
651327|NCT00003552|stage IV melanoma|stage iv melanoma
651328|NCT00003552|stage, melanoma|stage, melanoma
651329|NCT00442832|cSSSI|csssi
651330|NCT00442832|Staph|staph
651331|NCT00442832|MRSA|mrsa
651332|NCT00442819|Uremic Pruritus|uremic pruritus
651333|NCT00442819|Cytokines|cytokines
651334|NCT00442819|Polymethylmethacrylate Artificial Kidney|polymethylmethacrylate artificial kidney
651335|NCT00442819|Hemodialysis|hemodialysis
651336|NCT00442806|ADRC|adrc
651337|NCT00442806|Stem Cells|stem cells
651338|NCT00442806|Myocardial Infarction|myocardial infarction
651339|NCT00442806|STEMI|stemi
651340|NCT00442806|Heart Disease|heart disease
651341|NCT00442806|Coronary Artery Disease|coronary artery disease
651342|NCT00442806|Coronary Disease|coronary disease
651343|NCT00442806|ST-Elevation|st-elevation
651345|NCT00442806|Interventional Cardiology|interventional cardiology
651346|NCT00442806|Heart Attack|heart attack
651347|NCT00442780|early Parkinson's Disease|early parkinson's disease
651348|NCT00442780|MOBILE|mobile
651349|NCT00442780|BIIB014|biib014
651350|NCT00442767|pediatric|pediatric
651351|NCT00442767|juvenile|juvenile
651352|NCT00442767|diabetes mellitus|diabetes mellitus
651450|NCT00019006|body system/site cancer|body system/site cancer
651353|NCT00442767|Pediatric type 1 diabetes mellitus|pediatric type 1 diabetes mellitus
651354|NCT00442754|dendritic cell|dendritic cell
651355|NCT00442754|tumor vaccine|tumor vaccine
651356|NCT00442754|NSCLC|nsclc
651357|NCT00442741|Cancer|cancer
651358|NCT00442741|EPO906|epo906
651359|NCT00442741|Patupilone|patupilone
651360|NCT00442728|Functional electrical stimulation|functional electrical stimulation
651361|NCT00442728|muscular atrophy|muscular atrophy
651362|NCT00442728|intensive care|intensive care
651363|NCT00442715|Exercise-induced asthma,|exercise-induced asthma,
651364|NCT00442715|early childhood;|early childhood;
651365|NCT00442715|spirometry,|spirometry,
651366|NCT00442715|exercise challenge|exercise challenge
651367|NCT00442715|Data from preschool children who were referred to the Pediatric|data from preschool children who were referred to the pediatric
651368|NCT00442715|Pulmonary Clinic over a 1-year period were recruited|pulmonary clinic over a 1-year period were recruited
651369|NCT00442689|Polycystic Ovary Syndrome|polycystic ovary syndrome
651370|NCT00442689|Metabolic Syndrome|metabolic syndrome
651371|NCT00442689|PCOS|pcos
651372|NCT00442689|overweight|overweight
651373|NCT00442689|infertility|infertility
651374|NCT00442689|Insulin Resistance|insulin resistance
651375|NCT00442689|menstrual cycle|menstrual cycle
651376|NCT00442663|Labor Induction|labor induction
651377|NCT00442663|Cervical Ripening|cervical ripening
651378|NCT00442663|Foley Catheter|foley catheter
651379|NCT00442637|CAIRO3|cairo3
651380|NCT00442637|DCCG|dccg
651381|NCT00442637|colorectal cancer|colorectal cancer
651382|NCT00442637|induction|induction
651383|NCT00442637|metronomic chemotherapy|metronomic chemotherapy
651384|NCT00442637|observation|observation
651385|NCT00442637|capecitabine|capecitabine
651386|NCT00442637|bevacizumab|bevacizumab
651387|NCT00442637|oxaliplatin|oxaliplatin
651388|NCT00442624|insomnia|insomnia
651389|NCT00442624|glucose metabolism|glucose metabolism
651390|NCT00442624|insulin resistance|insulin resistance
651391|NCT00442598|Ovarian|ovarian
651392|NCT00442598|Cancer|cancer
651393|NCT00442598|CA-125|ca-125
651394|NCT00442598|Third-line|third-line
651395|NCT00442598|Glufosfamide|glufosfamide
651396|NCT00442546|opioid|opioid
651397|NCT00442533|Carcinoid|carcinoid
651398|NCT00442533|Islet Cell Cancer|islet cell cancer
651399|NCT00442533|Paraganglioma|paraganglioma
651400|NCT00442533|Pheochromocytoma|pheochromocytoma
651401|NCT00442507|Esophagus|esophagus
651402|NCT00442507|Esophagogastric Junction|esophagogastric junction
651403|NCT00442507|Avastin|avastin
651404|NCT00442507|Bevacizumab|bevacizumab
651405|NCT00442507|Erlotinib|erlotinib
651406|NCT00442494|Atrial fibrillation after cardiac surgery|atrial fibrillation after cardiac surgery
651407|NCT00442481|MDD|mdd
651408|NCT00442481|Escitalopram|escitalopram
651409|NCT00442481|Cipralex|cipralex
651410|NCT00442481|Sleep|sleep
651411|NCT00442481|REM|rem
651412|NCT00442481|SWS|sws
651413|NCT00442481|Polysomnography|polysomnography
651414|NCT00442468|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
651415|NCT00442468|Chronic Bronchitis|chronic bronchitis
651416|NCT00442468|Spirometry|spirometry
651417|NCT00442455|Head Neck Carcinoma Erlotinib|head neck carcinoma erlotinib
651418|NCT00442442|Malaria|malaria
651419|NCT00442442|mosquito control|mosquito control
651420|NCT00442442|mosquito coils|mosquito coils
651421|NCT00442442|LLIN|llin
651422|NCT00442429|depression; dialysis; kidney failure, chronic|depression; dialysis; kidney failure, chronic
651423|NCT00019578|adult brain stem glioma|adult brain stem glioma
651424|NCT00019578|adult brain tumor|adult brain tumor
651425|NCT00019578|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
651426|NCT00019578|adult craniopharyngioma|adult craniopharyngioma
651427|NCT00019578|adult ependymoma|adult ependymoma
651428|NCT00019578|adult infiltrating astrocytoma|adult infiltrating astrocytoma
651429|NCT00019578|adult malignant meningioma|adult malignant meningioma
651430|NCT00019578|adult medulloblastoma|adult medulloblastoma
651431|NCT00019578|adult meningioma|adult meningioma
651432|NCT00019578|adult noninfiltrating astrocytoma|adult noninfiltrating astrocytoma
651433|NCT00019578|adult oligodendroglioma|adult oligodendroglioma
651434|NCT00019578|adult pineal parenchymal tumor|adult pineal parenchymal tumor
651435|NCT00019578|adult solid tumor|adult solid tumor
651436|NCT00019578|body system/site cancer|body system/site cancer
651437|NCT00019578|brain metastases|brain metastases
651438|NCT00019578|brain tumor|brain tumor
651439|NCT00019578|cancer|cancer
651440|NCT00019578|central nervous system cancer|central nervous system cancer
651441|NCT00019578|genetic condition|genetic condition
651442|NCT00019578|metastatic cancer|metastatic cancer
651443|NCT00019578|mixed gliomas|mixed gliomas
651444|NCT00019578|site, metastatic cancer|site, metastatic cancer
651445|NCT00019578|solid tumor|solid tumor
651446|NCT00019578|stage IV peripheral primitive neuroectodermal tumor|stage iv peripheral primitive neuroectodermal tumor
651447|NCT00019578|stage/type, adult brain tumor|stage/type, adult brain tumor
651448|NCT00019578|unclassified/other cancer|unclassified/other cancer
651449|NCT00019006|adult solid tumor|adult solid tumor
651451|NCT00019006|cancer|cancer
651452|NCT00019006|colon cancer|colon cancer
651453|NCT00019006|colorectal cancer|colorectal cancer
651454|NCT00019006|extensive stage small cell lung cancer|extensive stage small cell lung cancer
651455|NCT00019006|gastrointestinal cancer|gastrointestinal cancer
651456|NCT00019006|genetic condition|genetic condition
651457|NCT00019006|limited stage small cell lung cancer|limited stage small cell lung cancer
651458|NCT00019006|lung cancer|lung cancer
651459|NCT00019006|non-small cell lung cancer|non-small cell lung cancer
651460|NCT00019006|pancreatic cancer|pancreatic cancer
651461|NCT00019006|rectal cancer|rectal cancer
651462|NCT00019006|recurrent colon cancer|recurrent colon cancer
651463|NCT00019006|recurrent pancreatic cancer|recurrent pancreatic cancer
651464|NCT00019006|recurrent rectal cancer|recurrent rectal cancer
651465|NCT00019006|small cell lung cancer|small cell lung cancer
651466|NCT00019006|solid tumor|solid tumor
651467|NCT00019006|stage I pancreatic cancer|stage i pancreatic cancer
651468|NCT00019006|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
651469|NCT00019006|stage II pancreatic cancer|stage ii pancreatic cancer
651470|NCT00019006|stage III colon cancer|stage iii colon cancer
651471|NCT00019006|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
651472|NCT00019006|stage III pancreatic cancer|stage iii pancreatic cancer
651473|NCT00019006|stage III rectal cancer|stage iii rectal cancer
651474|NCT00019006|stage IV pancreatic cancer|stage iv pancreatic cancer
651475|NCT00019006|stage IVA pancreatic cancer|stage iva pancreatic cancer
651476|NCT00019006|stage IVB pancreatic cancer|stage ivb pancreatic cancer
651477|NCT00019006|stage, colon cancer|stage, colon cancer
651478|NCT00019006|stage, non-small cell lung cancer|stage, non-small cell lung cancer
651479|NCT00019006|stage, pancreatic cancer|stage, pancreatic cancer
651480|NCT00019006|stage, rectal cancer|stage, rectal cancer
651481|NCT00019006|stage, small cell lung cancer|stage, small cell lung cancer
651482|NCT00019006|thorax/respiratory cancer|thorax/respiratory cancer
651483|NCT00442403|Malaria|malaria
651484|NCT00442403|Plasmodium falciparum|plasmodium falciparum
651485|NCT00442403|Chemotherapy|chemotherapy
651486|NCT00442403|Chloroquine|chloroquine
651487|NCT00442403|Dehydroepiandrosterone sulphate|dehydroepiandrosterone sulphate
651488|NCT00442390|Cortisol|cortisol
651489|NCT00442390|adrenal insufficiency|adrenal insufficiency
651490|NCT00442390|glucose metabolism|glucose metabolism
651491|NCT00442390|protein metabolism|protein metabolism
651492|NCT00442390|lipid metabolism|lipid metabolism
651493|NCT00442390|insulin sensitivity.|insulin sensitivity.
651494|NCT00442377|Falciparum|falciparum
651495|NCT00442377|Plasmodium|plasmodium
651496|NCT00442377|Malaria|malaria
651497|NCT00442364|PFO|pfo
651498|NCT00442364|Patent Foramen Ovale|patent foramen ovale
651499|NCT00442364|Right-to-Left Shunt|right-to-left shunt
651500|NCT00442364|Sclerotherapy|sclerotherapy
651501|NCT00442312|Combigan|combigan
651502|NCT00442299|hemodialysis, urmeic retention solute, biocompatibility|hemodialysis, urmeic retention solute, biocompatibility
651503|NCT00442286|Hypertension|hypertension
651504|NCT00442286|High Blood Pressure|high blood pressure
651505|NCT00442286|Blood Pressure|blood pressure
651506|NCT00442286|Cardiovascular Disease|cardiovascular disease
651507|NCT00442286|Resistant Hypertension|resistant hypertension
651508|NCT00442286|Stage 2 Hypertension|stage 2 hypertension
651509|NCT00442286|Hypertension that is resistant to treatment|hypertension that is resistant to treatment
651510|NCT00442260|breast cancer|breast cancer
651511|NCT00442260|advanced breast cancer|advanced breast cancer
651512|NCT00442247|anterior vaginal wall prolapse, Pelvicol, biomesh|anterior vaginal wall prolapse, pelvicol, biomesh
651513|NCT00442247|Anterior vaginal wall prolapse|anterior vaginal wall prolapse
651514|NCT00442234|Acute|acute
651515|NCT00442234|pulmonary|pulmonary
651516|NCT00442234|embolism|embolism
651517|NCT00442234|accompanying|accompanying
651518|NCT00442234|hemodynamic|hemodynamic
651519|NCT00442234|instability|instability
651520|NCT00442221|Migrane headaches|migrane headaches
651521|NCT00442208|Healthy adults|healthy adults
651522|NCT00442208|Phase I|phase i
651523|NCT00442195|Tissue Procurement|tissue procurement
651524|NCT00442195|Sample Collection|sample collection
651525|NCT00442195|Biologic Samples|biologic samples
651526|NCT00442195|Laboratory Research|laboratory research
651527|NCT00442195|Healthy Volunteer|healthy volunteer
651528|NCT00442195|HV|hv
651529|NCT00442182|autoinflammatory syndromes|autoinflammatory syndromes
651530|NCT00442169|West Nile Disease|west nile disease
651531|NCT00442169|Antibody response|antibody response
651532|NCT00442169|Viremia|viremia
651533|NCT00442169|Safety|safety
651534|NCT00442169|Tolerability|tolerability
651535|NCT00442169|Prevention|prevention
651536|NCT00442156|Laser photocoagulation|laser photocoagulation
651537|NCT00442143|CLI|cli
651538|NCT00442143|PAOD|paod
651539|NCT00442143|Severe lower limb ischemia|severe lower limb ischemia
651540|NCT00442130|GM-CSF|gm-csf
651541|NCT00442130|GM-K562|gm-k562
651542|NCT00442130|vaccine|vaccine
651543|NCT00442104|infantile spasms|infantile spasms
651544|NCT00442104|anticonvulsant|anticonvulsant
651545|NCT00442104|pediatric epilepsy|pediatric epilepsy
651546|NCT00442104|West Syndrome|west syndrome
651547|NCT00442104|epileptic spasms|epileptic spasms
651548|NCT00442091|Dandelion|dandelion
651549|NCT00442091|herbal remedy|herbal remedy
651550|NCT00442091|hand eczema|hand eczema
651551|NCT00442091|Compositae|compositae
651552|NCT00442078|Incontinence|incontinence
651553|NCT00442078|Urinary|urinary
651554|NCT00442078|Male|male
651555|NCT00442078|Tape|tape
651556|NCT00442078|Transobturator|transobturator
651557|NCT00442065|Abdominal aortic aneurysm study|abdominal aortic aneurysm study
651558|NCT00442052|Gastroprotective effects|gastroprotective effects
651559|NCT00442052|Aspirin|aspirin
651560|NCT00442039|Mania, Lithium, Bipolar, BPCA, pediatrics|mania, lithium, bipolar, bpca, pediatrics
651561|NCT00442026|Cancer|cancer
651562|NCT00442026|NSCLC|nsclc
651563|NCT00442026|Elderly|elderly
651564|NCT00442026|Chemotherapy|chemotherapy
651565|NCT00442026|Docetaxel|docetaxel
651566|NCT00442026|Gemcitabine|gemcitabine
651567|NCT00442000|Prostate Cancer|prostate cancer
651568|NCT00442000|Prostatectomy|prostatectomy
651569|NCT00441987|Japanese|japanese
651570|NCT00441987|Healthy|healthy
651571|NCT00441987|Alzheimers Disease|alzheimers disease
651572|NCT00441974|adefovir dipivoxil|adefovir dipivoxil
651573|NCT00441974|compensated|compensated
651574|NCT00441974|chronic hepatitis B|chronic hepatitis b
651575|NCT00441974|Chinese|chinese
651576|NCT00441961|Eosinophilic fasciitis, Shulman's syndrome, methotrexate|eosinophilic fasciitis, shulman's syndrome, methotrexate
651577|NCT00441948|Hirsutism|hirsutism
651578|NCT00441948|Hypertrichosis|hypertrichosis
651579|NCT00441935|Urinary Retention|urinary retention
651580|NCT00441935|Urinary Incontinence|urinary incontinence
651581|NCT00441935|Pelvic Pain|pelvic pain
651582|NCT00441922|Cancer|cancer
651583|NCT00441922|Elderly|elderly
651584|NCT00441922|Chemotherapy|chemotherapy
651585|NCT00441922|Docetaxel|docetaxel
651586|NCT00441922|Vinorelbine|vinorelbine
651587|NCT00441909|Anti-Infective Agents, Local|anti-infective agents, local
651588|NCT00441909|Healthy Women|healthy women
651589|NCT00441909|Microbicides|microbicides
651590|NCT00441909|UC-781|uc-781
651591|NCT00441909|Vaginal Gel|vaginal gel
651592|NCT00441909|HIV Seronegativity|hiv seronegativity
651593|NCT00441896|infantile spasms|infantile spasms
651594|NCT00441896|anticonvulsant|anticonvulsant
651595|NCT00441896|pediatric epilepsy|pediatric epilepsy
651596|NCT00441896|West Syndrome|west syndrome
651597|NCT00441896|epileptic spasms|epileptic spasms
651598|NCT00441870|Cancer|cancer
651599|NCT00441870|Phase 1|phase 1
651600|NCT00441870|EC0225|ec0225
651601|NCT00441870|EC20|ec20
651602|NCT00441870|Refractory|refractory
651603|NCT00441870|Metastatic|metastatic
651604|NCT00441870|Experimental|experimental
651605|NCT00441857|plant sterols|plant sterols
651606|NCT00441857|plant stanols|plant stanols
651607|NCT00441857|cholesterol absorption|cholesterol absorption
651608|NCT00441844|diabetes, statin, monocyte, crp, inflammation|diabetes, statin, monocyte, crp, inflammation
651609|NCT00441831|Helicobacter pylori infection|helicobacter pylori infection
651610|NCT00441831|peptic ulcer disease|peptic ulcer disease
651611|NCT00441831|distal partial gastrectomy|distal partial gastrectomy
651612|NCT00441831|bile reflux|bile reflux
651613|NCT00441831|gastritis|gastritis
651614|NCT00441831|gastrectomy|gastrectomy
651615|NCT00441805|Acne|acne
651616|NCT00441805|RadioFrequency|radiofrequency
651617|NCT00441792|Sepsis|sepsis
651618|NCT00441792|Etomidate|etomidate
651619|NCT00441792|midazolam|midazolam
651620|NCT00441792|ketamine|ketamine
651621|NCT00441779|Microchimerism|microchimerism
651622|NCT00441779|Injuries|injuries
651623|NCT00441779|Burns|burns
651624|NCT00441779|Orthopedic Surgery|orthopedic surgery
651625|NCT00441779|Leukocytes|leukocytes
651626|NCT00441740|NSCLC|nsclc
651627|NCT00441740|1st line treatment|1st line treatment
651628|NCT00441740|Gemcitabine|gemcitabine
651629|NCT00441740|Vinorelbine|vinorelbine
651630|NCT00441740|Docetaxel|docetaxel
651631|NCT00441727|Peptic ulcer|peptic ulcer
651632|NCT00441727|low-dose ASA|low-dose asa
651633|NCT00441714|cardiovascular disease|cardiovascular disease
651634|NCT00441714|ischemia-reperfusion injury|ischemia-reperfusion injury
651635|NCT00441714|postconditioning|postconditioning
651636|NCT00441714|annexin targeting|annexin targeting
651637|NCT00441688|Human Immunodeficiency virus|human immunodeficiency virus
651638|NCT00441688|HLAgenetics polymorphism|hlagenetics polymorphism
651639|NCT00441675|Adolescents|adolescents
651640|NCT00441675|Asthma|asthma
651641|NCT00441675|long-term follow-up|long-term follow-up
651642|NCT00441675|symptoms|symptoms
651643|NCT00441675|bronchial hyperresponsiveness|bronchial hyperresponsiveness
651644|NCT00441662|Melanoma|melanoma
651645|NCT00441662|Uvea|uvea
651646|NCT00441662|Macula|macula
651647|NCT00441662|Edema|edema
651648|NCT00441662|Plaque radiotherapy|plaque radiotherapy
651649|NCT00441662|Brachytherapy|brachytherapy
651650|NCT00441662|Triamcinolone|triamcinolone
651651|NCT00441649|ADHD|adhd
651652|NCT00441636|depression|depression
651653|NCT00441636|CPAP|cpap
651654|NCT00441636|obstructive sleep apnea|obstructive sleep apnea
651655|NCT00441623|chronic kidney disease|chronic kidney disease
651656|NCT00441623|cardiovascular disease|cardiovascular disease
651657|NCT00441623|risk stratification|risk stratification
651658|NCT00441610|Gimatecan|gimatecan
651659|NCT00441610|topoisomerase I inhibitor|topoisomerase i inhibitor
651660|NCT00441610|advanced solid tumors|advanced solid tumors
651661|NCT00441597|ischemia reperfusion injury|ischemia reperfusion injury
651662|NCT00441597|atorvastatine|atorvastatine
651663|NCT00441597|preconditioning|preconditioning
651664|NCT00441597|cardiovascular disease|cardiovascular disease
651665|NCT00441571|prostate cancer|prostate cancer
651666|NCT00441571|radiolabeled antibody|radiolabeled antibody
651667|NCT00441532|prostate|prostate
651668|NCT00441519|Gastroprotective effects|gastroprotective effects
651669|NCT00441519|Aspirin|aspirin
651670|NCT00441506|interruption|interruption
651671|NCT00441506|critically ill|critically ill
651672|NCT00441506|sedation|sedation
651673|NCT00441506|pediatrics|pediatrics
651674|NCT00441506|critically ill, ventilated children|critically ill, ventilated children
651675|NCT00441493|Hepatitis C|hepatitis c
651676|NCT00441493|fluvastatin|fluvastatin
651677|NCT00441480|Hypercholesterolemia|hypercholesterolemia
651678|NCT00441480|Hypertriglyceridemia|hypertriglyceridemia
651679|NCT00441480|Plant sterol|plant sterol
651680|NCT00441480|Cholesterol|cholesterol
651681|NCT00441480|Fish oil|fish oil
651682|NCT00441454|stress urinary incontinence|stress urinary incontinence
651683|NCT00441454|surgery|surgery
651684|NCT00441454|tension-free vaginal tape|tension-free vaginal tape
651685|NCT00441454|retropubic|retropubic
651686|NCT00441454|transobturator|transobturator
651687|NCT00441454|quality-of-life|quality-of-life
651688|NCT00441441|asthma|asthma
651689|NCT00441441|fluticasone propionate|fluticasone propionate
651690|NCT00441441|children|children
651691|NCT00441441|fluticasone propionate/salmeterol|fluticasone propionate/salmeterol
651692|NCT00441389|Bacteria|bacteria
651693|NCT00441389|Viruses|viruses
651694|NCT00441389|COPD|copd
651695|NCT00441389|infectious etiology for acute exacerbation of COPD|infectious etiology for acute exacerbation of copd
651696|NCT00441376|Radiofrequency ablation|radiofrequency ablation
651698|NCT00441376|Doxorubicin|doxorubicin
651699|NCT00441376|Liposome|liposome
651700|NCT00441376|HCC|hcc
651701|NCT00441376|MLC|mlc
651702|NCT00441376|hepatocellular carcinoma|hepatocellular carcinoma
651703|NCT00441376|liver tumor|liver tumor
651704|NCT00441376|tumor|tumor
651705|NCT00441376|ablation|ablation
651706|NCT00441376|heat therapy|heat therapy
651707|NCT00441376|anti-tumor|anti-tumor
651708|NCT00441376|liver cancer|liver cancer
651709|NCT00441376|metastatic liver cancer (MLC)|metastatic liver cancer (mlc)
651710|NCT00441363|diabetes|diabetes
651711|NCT00441363|diabetes mellitus|diabetes mellitus
651712|NCT00441337|malignancies|malignancies
651713|NCT00441337|cancer|cancer
651714|NCT00441337|non small cell lung cancer|non small cell lung cancer
651715|NCT00441337|lung cancer|lung cancer
651716|NCT00441337|colorectal cancer|colorectal cancer
651717|NCT00441337|adenocarcinoma|adenocarcinoma
651718|NCT00441337|melanoma|melanoma
651719|NCT00441337|malignant melanoma|malignant melanoma
651720|NCT00441337|renal cancer|renal cancer
651721|NCT00441337|renal carcinoma|renal carcinoma
651722|NCT00441337|carcinoma|carcinoma
651723|NCT00441337|prostate cancer|prostate cancer
651724|NCT00441337|prostate adenocarcinoma|prostate adenocarcinoma
651725|NCT00441337|Recurrent or treatment refractory malignancies|recurrent or treatment refractory malignancies
651726|NCT00441324|Ovarian follicle|ovarian follicle
651727|NCT00441324|Thecal cells|thecal cells
651728|NCT00441324|Androgens|androgens
651729|NCT00441324|FSH sensitivity|fsh sensitivity
651730|NCT00441311|colorectal cancer screening|colorectal cancer screening
651731|NCT00441311|primary care physicians|primary care physicians
651732|NCT00441311|health disparities|health disparities
651733|NCT00441311|stratified randomized clinical trial|stratified randomized clinical trial
651734|NCT00441298|microbicides|microbicides
651735|NCT00441298|safety|safety
651736|NCT00441298|effectiveness|effectiveness
651737|NCT00441298|Tenofovir gel|tenofovir gel
651738|NCT00441298|HIV|hiv
651739|NCT00441298|young women|young women
651740|NCT00441298|HIV Seronegativity|hiv seronegativity
651741|NCT00441285|neurocysticercosis|neurocysticercosis
651742|NCT00441285|NCC|ncc
651743|NCT00441285|praziquantel|praziquantel
651744|NCT00441285|PZQ|pzq
651745|NCT00441285|albendazole|albendazole
651746|NCT00441285|ABZ|abz
651747|NCT00441285|parasite|parasite
651748|NCT00441285|pig tapeworm|pig tapeworm
651749|NCT00441285|Taenia solium|taenia solium
651750|NCT00441285|epilepsy|epilepsy
651751|NCT00441285|late-onset epilepsy|late-onset epilepsy
651752|NCT00441285|acquired epilepsy|acquired epilepsy
651753|NCT00441272|Pioglitazone|pioglitazone
651754|NCT00441272|Hepatic Steatosis|hepatic steatosis
651755|NCT00441272|Liver Toxicity|liver toxicity
651756|NCT00441272|Liver Biopsy|liver biopsy
651757|NCT00441272|HIV|hiv
652272|NCT00439361|LDP-341|ldp-341
651758|NCT00441272|Treatment Experienced|treatment experienced
651759|NCT00441272|Treatment Naive|treatment naive
651760|NCT00441259|Japanese Encephalitis|japanese encephalitis
651761|NCT00441246|Acute Respiratory Infection|acute respiratory infection
651762|NCT00441246|Bronchitis|bronchitis
651763|NCT00441246|Rhinosinusitis|rhinosinusitis
651764|NCT00441220|Genetic polymorphisms|genetic polymorphisms
651765|NCT00441220|Cyclophosphamide|cyclophosphamide
651766|NCT00441220|Cytochrome p450 CYP2C19 (Human)|cytochrome p450 cyp2c19 (human)
651767|NCT00441220|Systemic Lupus Erythematosus|systemic lupus erythematosus
651768|NCT00441207|IV Ascorbic Acid|iv ascorbic acid
651769|NCT00441207|IV Vitamin C|iv vitamin c
651770|NCT00441207|Cancer|cancer
651771|NCT00441207|Advanced Solid Tumors|advanced solid tumors
651772|NCT00441194|Perimetry|perimetry
651773|NCT00441194|Visual Field|visual field
651774|NCT00441194|Octopus|octopus
651775|NCT00441181|Neovascular glaucoma|neovascular glaucoma
651776|NCT00441181|Travoprost|travoprost
651777|NCT00441168|Multiple Myeloma|multiple myeloma
651778|NCT00441168|bortezomib|bortezomib
651779|NCT00441168|Cancer|cancer
651780|NCT00441168|Hematology|hematology
651781|NCT00441168|bone marrow|bone marrow
651782|NCT00441168|immunoglobulin|immunoglobulin
651783|NCT00441168|relapse|relapse
651784|NCT00441168|refractory|refractory
651785|NCT00441168|plasma cell|plasma cell
651786|NCT00441168|Velcade|velcade
651787|NCT00441168|adriamycin|adriamycin
651788|NCT00441168|dexamethasone|dexamethasone
651789|NCT00441168|vincristine|vincristine
651790|NCT00441155|Oncology|oncology
651791|NCT00441155|Cancer|cancer
651792|NCT00441155|Imatinib-Resistant Gastrointestinal Stromal Tumors|imatinib-resistant gastrointestinal stromal tumors
651793|NCT00441155|GIST|gist
651794|NCT00441155|Nilotinib|nilotinib
651795|NCT00441155|Imatinib-Resistant Gastrointestinal Stromal Tumors (GIST)|imatinib-resistant gastrointestinal stromal tumors (gist)
651796|NCT00441142|Newly diagnosed malignant brain tumors.|newly diagnosed malignant brain tumors.
651797|NCT00441129|Improvement of the blood glucose control|improvement of the blood glucose control
651798|NCT00441116|dutasteride|dutasteride
651799|NCT00441116|Androgenic alopecia|androgenic alopecia
651800|NCT00441116|phase 3|phase 3
651801|NCT00441103|Subjects with relapsing remitting multiple sclerosis|subjects with relapsing remitting multiple sclerosis
651802|NCT00441090|Chronic Idiopathic Thrombocytopenic Purpura|chronic idiopathic thrombocytopenic purpura
651803|NCT00441090|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
651804|NCT00441090|ITP|itp
651805|NCT00441077|Genetics|genetics
651806|NCT00441077|Family History|family history
651807|NCT00441077|Latino|latino
651808|NCT00441077|Information Seeking|information seeking
651809|NCT00441077|Lay Health Advisors|lay health advisors
651810|NCT00441077|Cancer|cancer
651811|NCT00441077|Heart Disease|heart disease
651812|NCT00441077|Diabetes|diabetes
651813|NCT00441077|Information|information
651814|NCT00441064|High blood pressure, hypertension, aliskiren, low sodium diet|high blood pressure, hypertension, aliskiren, low sodium diet
651815|NCT00441051|Sunburn, diclofenac, topical NSAID|sunburn, diclofenac, topical nsaid
651816|NCT00441038|Low back pain|low back pain
651817|NCT00441038|disability|disability
651818|NCT00441038|health education|health education
651819|NCT00441025|MabCampath + CHOP in PTCL|mabcampath + chop in ptcl
651820|NCT00441012|Haemophilus Influenza, type b and Hepatitis B|haemophilus influenza, type b and hepatitis b
651821|NCT00440999|P vivax|p vivax
651822|NCT00440999|malaria|malaria
651823|NCT00440999|ACT|act
651824|NCT00440986|Clinical Management|clinical management
651825|NCT00440986|Phlebotomy|phlebotomy
651826|NCT00440986|Eritrocytoapheresis|eritrocytoapheresis
651827|NCT00440973|kidney cancer|kidney cancer
651828|NCT00440973|M3thodist|m3thodist
651829|NCT00440960|alfentanil|alfentanil
651830|NCT00440960|anesthesia|anesthesia
651831|NCT00440960|bronchoscopy|bronchoscopy
651832|NCT00440960|lidocaine|lidocaine
651833|NCT00440960|midazolam|midazolam
651834|NCT00440960|propofol.|propofol.
651835|NCT00440947|NORVIR|norvir
651836|NCT00440947|ARIES|aries
651837|NCT00440947|EPZICOM|epzicom
651838|NCT00440947|REYATAZ|reyataz
651839|NCT00440947|HIV|hiv
651840|NCT00440947|simplification|simplification
651841|NCT00440947|Antiretroviral-naive|antiretroviral-naive
651842|NCT00440934|carcinoma, hepatocellular|carcinoma, hepatocellular
651843|NCT00440934|electromagnetic fields|electromagnetic fields
651844|NCT00440921|fibrin sealnat|fibrin sealnat
651845|NCT00440921|knee replacement|knee replacement
651846|NCT00440921|hip replacement|hip replacement
651847|NCT00440921|woud healing|woud healing
651848|NCT00440921|blood loss|blood loss
651849|NCT00440921|clinical trial|clinical trial
651850|NCT00440921|randomized|randomized
651851|NCT00440908|Dialyzer reuse|dialyzer reuse
651852|NCT00440908|Inflammatory markers|inflammatory markers
651853|NCT00440908|Nutritional status|nutritional status
651854|NCT00440895|Coronary artery stenting|coronary artery stenting
651855|NCT00440895|Trans-radial|trans-radial
651856|NCT00440895|Intracoronary|intracoronary
651857|NCT00440895|Rescue-PCI|rescue-pci
651858|NCT00440869|N-acetylcysteine|n-acetylcysteine
651859|NCT00440869|oxidative stress|oxidative stress
651860|NCT00440869|muscle fatigue|muscle fatigue
651861|NCT00440869|end-stage renal disease|end-stage renal disease
651862|NCT00440869|hemodialysis|hemodialysis
651863|NCT00440856|Intervertebral disc|intervertebral disc
651864|NCT00440856|Lumbar discectomy|lumbar discectomy
651865|NCT00440856|Outcome|outcome
651866|NCT00440856|Radiculopathy due to prolapsed intervertebral disc.|radiculopathy due to prolapsed intervertebral disc.
651867|NCT00440843|schizophrenia|schizophrenia
651868|NCT00440843|attention|attention
651869|NCT00440843|task engagement|task engagement
651870|NCT00440843|antipsychotics|antipsychotics
651871|NCT00440843|cognition|cognition
651872|NCT00440843|cognitive rehabilitation|cognitive rehabilitation
651873|NCT00440830|acute pain|acute pain
651874|NCT00440830|nicotine|nicotine
651875|NCT00440830|nausea|nausea
651876|NCT00440830|sedation|sedation
651877|NCT00440817|Lymphoma|lymphoma
651878|NCT00440817|Rheumatoid arthritis|rheumatoid arthritis
651879|NCT00440817|Crohn's disease|crohn's disease
651880|NCT00440817|Remicade|remicade
651881|NCT00440817|Infliximab|infliximab
651882|NCT00440804|patent ductus arterious|patent ductus arterious
651883|NCT00440791|Colon|colon
651884|NCT00440791|colonic disease|colonic disease
651885|NCT00440791|capsule endoscopy|capsule endoscopy
651886|NCT00440791|Suspected or known colonic disease|suspected or known colonic disease
651887|NCT00440778|Coronary artery stenting|coronary artery stenting
651888|NCT00440778|Trans-radial|trans-radial
651889|NCT00440778|Intracoronary|intracoronary
651890|NCT00440765|Multiple Myeloma|multiple myeloma
651891|NCT00440765|hematological Neoplasms|hematological neoplasms
651892|NCT00440765|chemotherapy|chemotherapy
651893|NCT00440765|efficacy|efficacy
651894|NCT00440765|safety|safety
651895|NCT00440765|bortezomib|bortezomib
651896|NCT00440765|proteasome inhibitor|proteasome inhibitor
651897|NCT00440752|Artemether-lumefantrine|artemether-lumefantrine
651898|NCT00440752|Plasmodium falciparum|plasmodium falciparum
651899|NCT00440752|drug resistance genes|drug resistance genes
651900|NCT00440739|postoperative pain, etoticoxib, etoricoxib|postoperative pain, etoticoxib, etoricoxib
651901|NCT00440739|Pain relief after transurethral resection of prostate.|pain relief after transurethral resection of prostate.
651902|NCT00440726|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
651903|NCT00440726|Pediatrics|pediatrics
651904|NCT00440726|Relapsed|relapsed
651905|NCT00440726|Recurrence|recurrence
651906|NCT00440726|Bortezomib|bortezomib
651907|NCT00440726|Velcade|velcade
651908|NCT00440726|Therapeutic Advances in Childhood Leukemia|therapeutic advances in childhood leukemia
651909|NCT00440726|Investigational|investigational
651910|NCT00440726|Childhood|childhood
651911|NCT00440726|ALL|all
651912|NCT00440726|Relapsed ALL|relapsed all
651913|NCT00440726|Refractory ALL|refractory all
651914|NCT00440726|Relapsed pediatric ALL|relapsed pediatric all
651915|NCT00440726|Refractory pediatric ALL|refractory pediatric all
651916|NCT00440726|TACL|tacl
651917|NCT00440726|Recurrent Pediatric ALL|recurrent pediatric all
651918|NCT00440713|Posttraumatic Stress Disorder|posttraumatic stress disorder
651919|NCT00440713|Depression|depression
651920|NCT00440713|Anxiety|anxiety
651921|NCT00440713|Efficacy|efficacy
651922|NCT00440700|Ventilator|ventilator
651923|NCT00440700|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
651924|NCT00440700|Anxiety|anxiety
651925|NCT00440687|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
651926|NCT00440687|primary care|primary care
651927|NCT00440687|randomised trials|randomised trials
651928|NCT00440687|therapeutic interventions|therapeutic interventions
651929|NCT00440674|Direct Stenting|direct stenting
651930|NCT00440674|Angioplasty|angioplasty
651931|NCT00440674|Pre-dilatation|pre-dilatation
651932|NCT00440674|Drug-eluting stent|drug-eluting stent
651933|NCT00440661|Osteoarthritis, IL-1|osteoarthritis, il-1
651934|NCT00440635|Multiple myeloma|multiple myeloma
651935|NCT00440635|bortezomib, Hematology|bortezomib, hematology
651936|NCT00440622|Cancer|cancer
651937|NCT00440622|Metastatic Breast cancer|metastatic breast cancer
651938|NCT00440622|Her-2 expression|her-2 expression
651939|NCT00440622|Gemcitabine|gemcitabine
651940|NCT00440622|Capecitabine|capecitabine
651941|NCT00440622|Herceptin|herceptin
651942|NCT00440583|CHOP-Z|chop-z
651943|NCT00440570|cancer|cancer
651944|NCT00440570|electromagnetic fields|electromagnetic fields
651945|NCT00440570|treatment|treatment
651946|NCT00440557|Anemia|anemia
651947|NCT00440557|Chronic Kidney disease|chronic kidney disease
651948|NCT00440557|Kidney disease|kidney disease
651949|NCT00440557|Epoetin alfa|epoetin alfa
651950|NCT00440557|Procrit|procrit
651951|NCT00440544|Tuberculosis|tuberculosis
651952|NCT00440544|vaccine|vaccine
651953|NCT00440544|nasal immunization|nasal immunization
651954|NCT00440518|Lacosamide|lacosamide
651955|NCT00440518|migraine prophylaxis|migraine prophylaxis
651956|NCT00440518|Vimpat|vimpat
651957|NCT00440505|chronic pain|chronic pain
651958|NCT00440505|pelvic pain|pelvic pain
651959|NCT00440505|nicotine patch|nicotine patch
651960|NCT00440479|Multiple Myeloma|multiple myeloma
651961|NCT00440479|hematological neoplasms|hematological neoplasms
651962|NCT00440479|chemotherapy|chemotherapy
651963|NCT00440479|efficacy|efficacy
651964|NCT00440479|safety|safety
651965|NCT00440479|bortezomib|bortezomib
651966|NCT00440479|proteasome inhibitor|proteasome inhibitor
651967|NCT00440466|Anemia|anemia
651968|NCT00440466|Reduction in the number of erythrocytes|reduction in the number of erythrocytes
651969|NCT00440466|Hemoglobin low level|hemoglobin low level
651970|NCT00440466|Red blood cell deficiency|red blood cell deficiency
651971|NCT00440466|Procrit|procrit
651972|NCT00440466|Epoetin alfa|epoetin alfa
651973|NCT00440466|Chronic kidney disease|chronic kidney disease
651974|NCT00440453|Internal medicine patients|internal medicine patients
651975|NCT00440440|hypogonadism|hypogonadism
651976|NCT00440440|diabetes|diabetes
651977|NCT00440440|visceral fat|visceral fat
651978|NCT00440440|hepatic fat|hepatic fat
651979|NCT00440440|lean mass|lean mass
651980|NCT00440427|Major Depressive Disorder|major depressive disorder
651981|NCT00440427|MDD|mdd
651982|NCT00440414|Cancer|cancer
651983|NCT00440414|Non-small-cell lung cancer|non-small-cell lung cancer
651984|NCT00440414|Chemotherapy|chemotherapy
651985|NCT00440414|Pemetrexed|pemetrexed
651986|NCT00440414|Erlotinib|erlotinib
651987|NCT00440401|Surgical treatment of haemorrhage|surgical treatment of haemorrhage
651988|NCT00440388|cancer|cancer
651989|NCT00440388|lymphoma|lymphoma
651990|NCT00440388|Non-Hodgkin's|non-hodgkin's
651991|NCT00440388|Non-Hodgkins|non-hodgkins
651992|NCT00440388|AT-101|at-101
651993|NCT00440388|AT101|at101
651994|NCT00440388|Rituxan|rituxan
651995|NCT00440388|Rituximab|rituximab
651996|NCT00440362|Influenza|influenza
651997|NCT00440362|Flu|flu
651998|NCT00440362|A/Wyoming/03/2003|a/wyoming/03/2003
651999|NCT00440362|Alphavirus|alphavirus
652000|NCT00440349|Retroperitoneal fibrosis|retroperitoneal fibrosis
652001|NCT00440349|Tamoxifen|tamoxifen
652002|NCT00440349|Corticosteroids|corticosteroids
652003|NCT00440349|Obstructive uropathy|obstructive uropathy
652004|NCT00440349|Periaortic fibrosis|periaortic fibrosis
652005|NCT00440349|Chronic periaortitis|chronic periaortitis
652006|NCT00440336|IOP|iop
652007|NCT00440336|SLT|slt
652008|NCT00440336|Laser|laser
652009|NCT00440336|Cosopt|cosopt
652010|NCT00440323|Noise induced Situational insomnia,|noise induced situational insomnia,
652011|NCT00440323|healthy volunteers|healthy volunteers
652012|NCT00440323|SB-649868,|sb-649868,
652013|NCT00440323|Zolpidem,|zolpidem,
652014|NCT00440310|Liver neoplasms|liver neoplasms
652015|NCT00440310|Liver metastases|liver metastases
652016|NCT00440310|MCRC|mcrc
652017|NCT00440310|Litx™|litx™
652018|NCT00440310|LS11|ls11
652019|NCT00440310|Colorectal cancer with recurrent liver metastases|colorectal cancer with recurrent liver metastases
652020|NCT00440297|hepatitis B virus|hepatitis b virus
652021|NCT00440284|conventional insulin therapy|conventional insulin therapy
652022|NCT00440284|intensive insulin therapy|intensive insulin therapy
652023|NCT00440284|self-management|self-management
652024|NCT00440284|patient education|patient education
652025|NCT00440284|RCT|rct
652026|NCT00440284|glycosylated hemoglobin|glycosylated hemoglobin
652027|NCT00440284|hypoglycemia|hypoglycemia
652028|NCT00440284|patient preference|patient preference
652029|NCT00440258|Ovarian hyperstimulation syndrome, dopamine agonists, cabergoline, hemoconcentration, ascites, ovarian perfusion, dopamine receptor 2|ovarian hyperstimulation syndrome, dopamine agonists, cabergoline, hemoconcentration, ascites, ovarian perfusion, dopamine receptor 2
652030|NCT00440219|Nasal polyps|nasal polyps
652031|NCT00440219|Steroids|steroids
652032|NCT00440219|Prednisone|prednisone
652033|NCT00440219|Nasal polypectomy|nasal polypectomy
652034|NCT00440219|Blood loss, surgical|blood loss, surgical
652035|NCT00440206|HIV|hiv
652036|NCT00440206|Immune Markers|immune markers
652037|NCT00440180|Obesity|obesity
652038|NCT00440180|Low sperm count|low sperm count
652039|NCT00440180|Male infertility|male infertility
652040|NCT00440167|capecitabine|capecitabine
652041|NCT00440167|gemcitabine|gemcitabine
652042|NCT00440167|Erlotinib|erlotinib
652043|NCT00440167|pancreatic cancer|pancreatic cancer
652044|NCT00440167|advanced|advanced
652045|NCT00440128|Casopitant,|casopitant,
652046|NCT00440128|Neurokinin-1 Receptor Antagonist,|neurokinin-1 receptor antagonist,
652047|NCT00440128|Drug-Interaction,|drug-interaction,
652048|NCT00440128|CYP3A|cyp3a
652049|NCT00440128|NK-1 Receptor Antagonist,|nk-1 receptor antagonist,
652050|NCT00440128|GW679769,|gw679769,
652051|NCT00440128|Docetaxel,|docetaxel,
652052|NCT00440102|ETOMIDATE|etomidate
652053|NCT00440102|KETAMINE|ketamine
652054|NCT00440102|RAPID SEQUENCE INTUBATION|rapid sequence intubation
652055|NCT00440102|PREHOSPITAL|prehospital
652056|NCT00440102|During rapid sequence intubation|during rapid sequence intubation
652057|NCT00440089|Cancer|cancer
652058|NCT00440089|Fatigue|fatigue
652059|NCT00440089|Breast Cancer|breast cancer
652060|NCT00440089|Healing|healing
652061|NCT00440089|Energy Healing|energy healing
652273|NCT00439361|MLN341|mln341
652062|NCT00440089|Complementary|complementary
652063|NCT00440089|Alternative|alternative
652064|NCT00440089|Immune|immune
652065|NCT00440089|Cytokine|cytokine
652066|NCT00440089|Hormone|hormone
652067|NCT00440089|Cortisol|cortisol
652068|NCT00440089|Placebo|placebo
652069|NCT00440089|Mock Healing|mock healing
652070|NCT00440076|MDS|mds
652071|NCT00440076|Velcade|velcade
652072|NCT00440050|fish oil|fish oil
652073|NCT00440050|omega-3 fatty acids|omega-3 fatty acids
652074|NCT00440050|EPA|epa
652075|NCT00440037|AMG 531|amg 531
652076|NCT00440037|ITP|itp
652077|NCT00440037|Long term treatment|long term treatment
652078|NCT00440037|Japanese|japanese
652079|NCT00440037|Romiplostim|romiplostim
652080|NCT00440024|Sun-Damaged Skin|sun-damaged skin
652081|NCT00440024|Retinoid Intolerance|retinoid intolerance
652082|NCT00440024|Tazarotene Cream|tazarotene cream
652083|NCT00440024|Dove facial cleanser|dove facial cleanser
652084|NCT00440024|Dove moisturizer|dove moisturizer
652085|NCT00439998|Ultrasound|ultrasound
652086|NCT00439998|Obesity|obesity
652087|NCT00439998|Needle Depth|needle depth
652088|NCT00439985|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
652089|NCT00439985|Metabolic Control|metabolic control
652090|NCT00439985|Adherence|adherence
652091|NCT00439985|Optimism|optimism
652092|NCT00439985|Parent-Child Collaboration|parent-child collaboration
652093|NCT00439985|Prevention|prevention
652094|NCT00439972|Lipoproteins|lipoproteins
652095|NCT00439972|Apolipoproteins|apolipoproteins
652096|NCT00439972|Insulin sensitivity|insulin sensitivity
652097|NCT00439972|Inflammation|inflammation
652098|NCT00439972|Clotting|clotting
652099|NCT00439972|Antioxidant status|antioxidant status
652100|NCT00439972|Vascular reactivity|vascular reactivity
652101|NCT00439972|Metabolism|metabolism
652102|NCT00439959|GSK625433,|gsk625433,
652103|NCT00439959|Hepatitis C,|hepatitis c,
652104|NCT00439959|metabolic probe,|metabolic probe,
652105|NCT00439959|food-effect,|food-effect,
652106|NCT00439959|HCV,|hcv,
652107|NCT00439959|FTIH|ftih
652108|NCT00439959|polymerase,|polymerase,
652109|NCT00439946|pulmonary hypertension|pulmonary hypertension
652110|NCT00439946|PAH|pah
652111|NCT00439946|Remodulin|remodulin
652112|NCT00439946|treprostinil|treprostinil
652113|NCT00439946|Quality of Life|quality of life
652114|NCT00439946|rapid switch|rapid switch
652115|NCT00439933|Obesity|obesity
652116|NCT00439933|Children|children
652117|NCT00439933|Weight loss|weight loss
652118|NCT00439933|Endothelial dysfunction|endothelial dysfunction
652119|NCT00439933|Intervention|intervention
652120|NCT00439920|ALL|all
652121|NCT00439907|Anal sphincter Delivery|anal sphincter delivery
652122|NCT00439907|Primary repair|primary repair
652123|NCT00439907|End-to-end repair|end-to-end repair
652124|NCT00439907|Over-lap repair|over-lap repair
652125|NCT00439907|Anal manometry|anal manometry
652126|NCT00439907|Anal sonography|anal sonography
652127|NCT00439907|Weksner Score|weksner score
652128|NCT00439907|Rupture of the external anal sphincter during delivery|rupture of the external anal sphincter during delivery
652129|NCT00439907|Anal sphincter|anal sphincter
652130|NCT00439907|Anal sphincter rupture|anal sphincter rupture
652131|NCT00439894|Rheumatoid Arthritis|rheumatoid arthritis
652132|NCT00439894|etanercept|etanercept
652133|NCT00439894|Enbrel|enbrel
652134|NCT00439894|Amgen|amgen
652135|NCT00439881|inflammation,|inflammation,
652136|NCT00439881|intravenous,|intravenous,
652137|NCT00439881|Chronic Obstructive Pulmonary Disease,|chronic obstructive pulmonary disease,
652138|NCT00439881|P38 inhibitor|p38 inhibitor
652139|NCT00439881|SB-681323,|sb-681323,
652140|NCT00439881|rheumatoid arthritis,|rheumatoid arthritis,
652141|NCT00439868|WELLBUTRIN XL, intraocular pressure, healthy volunteers|wellbutrin xl, intraocular pressure, healthy volunteers
652142|NCT00439855|Enoxaparin, heparin, hemorrhages|enoxaparin, heparin, hemorrhages
652143|NCT00439829|follicle|follicle
652144|NCT00439829|ovary|ovary
652145|NCT00439829|poor responder|poor responder
652146|NCT00439829|stimulation|stimulation
652147|NCT00439829|follicle wave emergence|follicle wave emergence
652148|NCT00439816|Hypertension Outcomes|hypertension outcomes
652149|NCT00439816|Health Outcomes|health outcomes
652150|NCT00439816|Outpatient|outpatient
652151|NCT00439816|Racial Preference|racial preference
652152|NCT00439816|Blood Pressure Control|blood pressure control
652153|NCT00439816|Clinical Trial|clinical trial
652154|NCT00439816|Intervention|intervention
652155|NCT00439816|Lifestyle modifications|lifestyle modifications
652156|NCT00439816|Ethnic Differences|ethnic differences
652157|NCT00439816|Randomized|randomized
652158|NCT00439803|CMV|cmv
652159|NCT00439803|cytomegalovirus|cytomegalovirus
652160|NCT00439803|Alphavirus|alphavirus
652161|NCT00439790|implantable cardioverter defibrillator|implantable cardioverter defibrillator
652162|NCT00439790|Heart failure|heart failure
652163|NCT00439790|Sudden Cardiac Arrest|sudden cardiac arrest
652164|NCT00439790|appropriate shock|appropriate shock
652165|NCT00439790|Defibrillators, Implantable|defibrillators, implantable
652274|NCT00439361|PS-341|ps-341
652166|NCT00439764|Low back pain, health education, physical therapy|low back pain, health education, physical therapy
652167|NCT00439751|Prostate Cancer|prostate cancer
652168|NCT00439751|Androgen Deprivation Therapy|androgen deprivation therapy
652169|NCT00439751|Recurrence|recurrence
652170|NCT00439751|Biochemical Failure|biochemical failure
652171|NCT00439751|Goserelin|goserelin
652172|NCT00439738|Obesity, hypertension, valsartan/hydrochlorothiazide|obesity, hypertension, valsartan/hydrochlorothiazide
652173|NCT00439699|Essential Tremor|essential tremor
652174|NCT00439699|Memantine|memantine
652175|NCT00439699|Clinical Trial|clinical trial
652176|NCT00439673|MDS|mds
652177|NCT00439673|5-Azacytidine|5-azacytidine
652178|NCT00439673|valproic acid|valproic acid
652179|NCT00439673|atra|atra
652180|NCT00439673|intermediate or high risk|intermediate or high risk
652181|NCT00439673|Age ≥18 yearsAge|age ≥18 yearsage
652182|NCT00439660|Rotavirus, diarrhea, vaccine|rotavirus, diarrhea, vaccine
652183|NCT00439647|Osteoporosis|osteoporosis
652184|NCT00439647|males|males
652185|NCT00439647|vertebral fractures|vertebral fractures
652186|NCT00439647|clinical fractures|clinical fractures
652187|NCT00439647|bone mineral density|bone mineral density
652188|NCT00439647|bone biomarkers|bone biomarkers
652189|NCT00439647|zoledronic acid|zoledronic acid
652190|NCT00439634|psychometrics|psychometrics
652191|NCT00439634|schizophrenia|schizophrenia
652192|NCT00439621|immunotherapy|immunotherapy
652193|NCT00439621|allergy|allergy
652194|NCT00439608|esophageal cancer|esophageal cancer
652195|NCT00439608|gastroesophageal cancer|gastroesophageal cancer
652196|NCT00439608|gastric cancer|gastric cancer
652197|NCT00439595|Anaemia|anaemia
652198|NCT00439595|Diagnosis|diagnosis
652199|NCT00439595|Primary|primary
652200|NCT00439595|Care|care
652201|NCT00439595|Treatment|treatment
652202|NCT00439582|Lipoproteins|lipoproteins
652203|NCT00439582|Milk fat|milk fat
652204|NCT00439582|Public health nutrition|public health nutrition
652205|NCT00439582|trans fatty acid|trans fatty acid
652206|NCT00439569|spinal muscular atrophy type II/III|spinal muscular atrophy type ii/iii
652207|NCT00439569|SMA type II/III|sma type ii/iii
652208|NCT00439569|spinal muscular atrophy|spinal muscular atrophy
652209|NCT00439569|SMA|sma
652210|NCT00439569|sodium phenylbutyrate|sodium phenylbutyrate
652211|NCT00439569|motor neuron disease|motor neuron disease
652212|NCT00439569|neuromuscular|neuromuscular
652213|NCT00439569|survival motor neuron|survival motor neuron
652214|NCT00439569|SMN|smn
652215|NCT00439569|dose escalation|dose escalation
652216|NCT00439556|Lymphoma|lymphoma
652217|NCT00439556|Bortezomib|bortezomib
652218|NCT00439556|Velcade|velcade
652219|NCT00439556|LDP-341|ldp-341
652220|NCT00439556|MLN341|mln341
652221|NCT00439556|PS-341|ps-341
652222|NCT00439556|Carmustine|carmustine
652223|NCT00439556|Cytarabine|cytarabine
652224|NCT00439556|Etoposide|etoposide
652225|NCT00439556|Melphalan|melphalan
652226|NCT00439556|Rituximab|rituximab
652227|NCT00439556|BEAM|beam
652228|NCT00439556|BCNU|bcnu
652229|NCT00439556|BiCNU®|bicnu®
652230|NCT00439556|ARA-C|ara-c
652231|NCT00439556|Cytosar|cytosar
652232|NCT00439556|DepoCyt®|depocyt®
652233|NCT00439556|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
652234|NCT00439556|VePesid®|vepesid®
652235|NCT00439556|Rituxan|rituxan
652236|NCT00439543|Pulmonary fibrosis|pulmonary fibrosis
652237|NCT00439543|pulmonary hypertension|pulmonary hypertension
652238|NCT00439543|Iloprost|iloprost
652239|NCT00439543|Efficacy|efficacy
652240|NCT00439530|oseltamivir|oseltamivir
652241|NCT00439530|pharmacokinetics|pharmacokinetics
652242|NCT00439530|probenecid|probenecid
652243|NCT00439530|avian influenza|avian influenza
652244|NCT00439517|Cancer|cancer
652245|NCT00439517|Colorectal|colorectal
652246|NCT00439517|Metastatic|metastatic
652247|NCT00439517|Untreated|untreated
652248|NCT00439491|Obesity|obesity
652249|NCT00439491|Insulin resistance|insulin resistance
652250|NCT00439491|Hypocaloric diet|hypocaloric diet
652251|NCT00439491|Adipose tissue|adipose tissue
652252|NCT00439491|adipocytokine|adipocytokine
652253|NCT00439478|Radioiodine, Thyroid Cancer, Sialadenitis, Xerostomia|radioiodine, thyroid cancer, sialadenitis, xerostomia
652254|NCT00439387|Serotonin|serotonin
652255|NCT00439387|Epilepsy|epilepsy
652256|NCT00439387|Healthy Volunteer|healthy volunteer
652257|NCT00439387|HV|hv
652258|NCT00439374|nulliparous|nulliparous
652259|NCT00439374|pregnancy|pregnancy
652260|NCT00439374|short cervix|short cervix
652261|NCT00439374|progesterone|progesterone
652262|NCT00439361|Hodgkin Lymphoma|hodgkin lymphoma
652263|NCT00439361|HL|hl
652264|NCT00439361|Relapsed Classical Hodgkin Lymphoma|relapsed classical hodgkin lymphoma
652265|NCT00439361|Refractory|refractory
652266|NCT00439361|Lymphoma|lymphoma
652267|NCT00439361|Nodular sclerosis|nodular sclerosis
652268|NCT00439361|Mixed cellularity|mixed cellularity
652269|NCT00439361|Lymphocyte-rich classical HL|lymphocyte-rich classical hl
652270|NCT00439361|Bortezomib|bortezomib
652271|NCT00439361|Velcade|velcade
652278|NCT00439361|VePesid®|vepesid®
652279|NCT00439361|Ifosfamide|ifosfamide
652280|NCT00439361|Mesna|mesna
652281|NCT00439361|Mesnex|mesnex
652282|NCT00439361|ICE|ice
652283|NCT00439348|Calcium|calcium
652284|NCT00439348|Compliance|compliance
652285|NCT00439348|Medication compliance|medication compliance
652286|NCT00439348|electronic prescription|electronic prescription
652287|NCT00439348|over-the-counter medications|over-the-counter medications
652288|NCT00439348|OTC medications|otc medications
652289|NCT00439335|Influenza, vaccine, A/H5N1|influenza, vaccine, a/h5n1
652290|NCT00439322|PTSD|ptsd
652291|NCT00439296|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
652292|NCT00439296|Pediatrics|pediatrics
652293|NCT00439296|Relapsed|relapsed
652294|NCT00439296|Recurrence|recurrence
652295|NCT00439296|ABT-751|abt-751
652296|NCT00439296|Therapeutic Advances in Childhood Leukemia|therapeutic advances in childhood leukemia
652297|NCT00439296|Investigational|investigational
652298|NCT00439296|Childhood|childhood
652299|NCT00439296|ALL|all
652300|NCT00439296|Relapsed ALL|relapsed all
652301|NCT00439296|Refractory ALL|refractory all
652302|NCT00439296|Relapsed pediatric ALL|relapsed pediatric all
652303|NCT00439296|Refractory pediatric ALL|refractory pediatric all
652304|NCT00439296|TACL|tacl
652305|NCT00439283|Ankylosing spondylitis|ankylosing spondylitis
652306|NCT00439283|infliximab|infliximab
652307|NCT00439283|Systematic regimen|systematic regimen
652308|NCT00439283|On-demand regimen|on-demand regimen
652309|NCT00439270|Metastatic hormone refractory prostate cancer|metastatic hormone refractory prostate cancer
652310|NCT00439244|Bone Mineral Density (BMD)|bone mineral density (bmd)
652311|NCT00439244|C-Telopeptides (CTx)|c-telopeptides (ctx)
652312|NCT00439244|dual x-ray absorptiometry (DXA)|dual x-ray absorptiometry (dxa)
652313|NCT00439244|pro-collagen type 1 N-propeptide (P1NP)|pro-collagen type 1 n-propeptide (p1np)
652314|NCT00439244|teriparatide|teriparatide
652315|NCT00439244|zoledronic acid|zoledronic acid
652316|NCT00439244|Osteoporosis|osteoporosis
652317|NCT00439244|postmenopausal women|postmenopausal women
652318|NCT00439231|Monoclonal Antibody Therapy|monoclonal antibody therapy
652319|NCT00439231|Biologic Response Modifier Therapy|biologic response modifier therapy
652320|NCT00439231|CLL|cll
652321|NCT00439231|SLL|sll
652322|NCT00439231|chemo-care (CC) 5013- Revlimid|chemo-care (cc) 5013- revlimid
652323|NCT00439231|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
652324|NCT00439231|Small Lymphocytic Leukemia|small lymphocytic leukemia
652325|NCT00439218|spinal muscular atrophy type I|spinal muscular atrophy type i
652326|NCT00439218|SMA type I|sma type i
652327|NCT00439218|spinal muscular atrophy|spinal muscular atrophy
652328|NCT00439218|SMA|sma
652329|NCT00439218|sodium phenylbutyrate|sodium phenylbutyrate
652330|NCT00439218|motor neuron disease|motor neuron disease
652331|NCT00439218|neuromuscular|neuromuscular
652332|NCT00439218|survival motor neuron|survival motor neuron
652333|NCT00439218|SMN|smn
652334|NCT00439218|dose escalation|dose escalation
652335|NCT00439205|Oral Tumors|oral tumors
652336|NCT00439205|Oral Margin Spectroscopy|oral margin spectroscopy
652337|NCT00439205|Oral Spectroscopy|oral spectroscopy
652338|NCT00439205|Optical Spectroscopy|optical spectroscopy
652339|NCT00439205|Oral neoplastic lesions|oral neoplastic lesions
652340|NCT00439205|FastEEM4 System|fasteem4 system
652341|NCT00439205|Multispectral Digital Microscope|multispectral digital microscope
652342|NCT00439205|MDM|mdm
652343|NCT00439205|Nonstandard imaging technology|nonstandard imaging technology
652344|NCT00439192|OAB, proof of concept|oab, proof of concept
652345|NCT00439192|Overactive Bladder (OAB)|overactive bladder (oab)
652346|NCT00439192|with incontinence|with incontinence
652347|NCT00439179|Pancreatic Cancer|pancreatic cancer
652348|NCT00439166|doxycycline|doxycycline
652349|NCT00439166|rifampicin|rifampicin
652350|NCT00439166|cerebrospinal fluid|cerebrospinal fluid
652351|NCT00439166|biomarkers|biomarkers
652352|NCT00439166|beta amyloid|beta amyloid
652353|NCT00439166|tau|tau
652354|NCT00439127|thyroglobulin|thyroglobulin
652355|NCT00439127|thyroid carcinoma|thyroid carcinoma
652356|NCT00439127|tumour marker|tumour marker
652357|NCT00439127|radioiodine|radioiodine
652358|NCT00439127|recombinant human TSH|recombinant human tsh
652359|NCT00439114|Corneal topography, corneal opacity, keratitis, trachoma|corneal topography, corneal opacity, keratitis, trachoma
652360|NCT00439101|weight loss|weight loss
652361|NCT00439101|malignancy|malignancy
652362|NCT00439101|corticosteroids|corticosteroids
652363|NCT00439101|supplemental feeding|supplemental feeding
652364|NCT00439101|adrenal insufficiency|adrenal insufficiency
652365|NCT00439101|diabetes|diabetes
652366|NCT00439088|Ambulation|ambulation
652367|NCT00439088|Ambulatory Monitoring|ambulatory monitoring
652368|NCT00439088|Activities of Daily Living|activities of daily living
652369|NCT00439088|Pedometer|pedometer
652370|NCT00439088|Validation Studies [PT]|validation studies [pt]
652371|NCT00439075|pulmonary disease|pulmonary disease
652372|NCT00439075|CPO|cpo
652373|NCT00439075|CPAP|cpap
652374|NCT00439075|oxygenation|oxygenation
652375|NCT00439075|out-of-hospital intervention|out-of-hospital intervention
653024|NCT00436631|seizures|seizures
652376|NCT00439062|Roxithromycin,Rheumatoid arthritis,Macrolides|roxithromycin,rheumatoid arthritis,macrolides
652377|NCT00439049|Substance Abuse|substance abuse
652378|NCT00439049|Treatment|treatment
652379|NCT00439049|Eligibility|eligibility
652380|NCT00439036|Opiate|opiate
652381|NCT00439036|Behavior Therapy|behavior therapy
652382|NCT00439036|Methadone|methadone
652383|NCT00439036|Acceptance and Commitment Therapy (ACT)|acceptance and commitment therapy (act)
652384|NCT00439023|Chronic renal failure, dialysis, hemodialysis,|chronic renal failure, dialysis, hemodialysis,
652385|NCT00439010|neurological|neurological
652386|NCT00439010|alzheimer|alzheimer
652387|NCT00438971|Panic Disorder|panic disorder
652388|NCT00438971|Anxiety Disorder|anxiety disorder
652389|NCT00438971|Duloxetine|duloxetine
652390|NCT00438958|graft versus host disease|graft versus host disease
652391|NCT00438958|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
652392|NCT00438958|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
652393|NCT00438958|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
652394|NCT00438958|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
652395|NCT00438958|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
652396|NCT00438958|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
652397|NCT00438958|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
652398|NCT00438958|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
652399|NCT00438958|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
652400|NCT00438958|refractory anemia with excess blasts|refractory anemia with excess blasts
652401|NCT00438958|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
652402|NCT00438958|refractory anemia|refractory anemia
652403|NCT00438958|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
652404|NCT00438958|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
652405|NCT00438958|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
652406|NCT00438958|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
652407|NCT00438958|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
652408|NCT00438958|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
652409|NCT00438958|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
652410|NCT00438958|primary myelofibrosis|primary myelofibrosis
652411|NCT00438958|secondary myelofibrosis|secondary myelofibrosis
652412|NCT00438958|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
652413|NCT00438958|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
652414|NCT00438958|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
652415|NCT00438958|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
652416|NCT00438958|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
652417|NCT00438958|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
652418|NCT00438958|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
652419|NCT00438958|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
652420|NCT00438958|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
652421|NCT00438958|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
652422|NCT00438958|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
652423|NCT00438958|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
652424|NCT00438958|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
652425|NCT00438958|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
652426|NCT00438958|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
652427|NCT00438958|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
652428|NCT00438958|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
652429|NCT00438958|splenic marginal zone lymphoma|splenic marginal zone lymphoma
652430|NCT00438958|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
652431|NCT00438958|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
652432|NCT00438958|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
652433|NCT00438958|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
652434|NCT00438958|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
652435|NCT00438958|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
652436|NCT00438958|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
652437|NCT00438958|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
652438|NCT00438958|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
652439|NCT00438958|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
652440|NCT00438958|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
652441|NCT00438958|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
652442|NCT00438958|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
652443|NCT00438958|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
653025|NCT00436631|intractable|intractable
652444|NCT00438958|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
652445|NCT00438958|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
652446|NCT00438958|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
652447|NCT00438958|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
652448|NCT00438958|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
652449|NCT00438958|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
652450|NCT00438958|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
652451|NCT00438958|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
652452|NCT00438958|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
652453|NCT00438958|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
652454|NCT00438958|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
652455|NCT00438958|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
652456|NCT00438958|Waldenström macroglobulinemia|waldenström macroglobulinemia
652457|NCT00438958|secondary acute myeloid leukemia|secondary acute myeloid leukemia
652458|NCT00438958|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
652459|NCT00438932|phosphate, phosphorus, FGF-23, PTH, 1,25D|phosphate, phosphorus, fgf-23, pth, 1,25d
652460|NCT00438906|pancreatic lesions|pancreatic lesions
652461|NCT00438906|pancreatic cancer|pancreatic cancer
652462|NCT00438906|peutz-jeghers syndrome|peutz-jeghers syndrome
652463|NCT00438906|BRCA 2 gene mutation|brca 2 gene mutation
652464|NCT00438906|FAMMM/p16|fammm/p16
652465|NCT00438906|Genes, BRCA2|genes, brca2
652466|NCT00438893|Viscous dietary fiber|viscous dietary fiber
652467|NCT00438893|Soy protein|soy protein
652468|NCT00438893|Nuts|nuts
652469|NCT00438893|Plant sterols|plant sterols
652470|NCT00438893|Dietary Portfolio|dietary portfolio
652471|NCT00438893|Compliance|compliance
652472|NCT00438893|Blood lipids|blood lipids
652473|NCT00438893|Blood pressure|blood pressure
652474|NCT00438867|angina|angina
652475|NCT00438867|FGF-4|fgf-4
652476|NCT00438867|angiogenesis|angiogenesis
652477|NCT00438867|growth factor|growth factor
652478|NCT00438867|myocardia ischemia|myocardia ischemia
652479|NCT00438867|revascularization|revascularization
652480|NCT00438854|dasatinib|dasatinib
652481|NCT00438854|BMS-354825|bms-354825
652482|NCT00438854|CLL|cll
652483|NCT00438854|SLL|sll
652484|NCT00438854|LYN kinase|lyn kinase
652485|NCT00438841|stage I multiple myeloma|stage i multiple myeloma
652486|NCT00438841|stage II multiple myeloma|stage ii multiple myeloma
652487|NCT00438841|stage III multiple myeloma|stage iii multiple myeloma
652488|NCT00438828|radiation therapy|radiation therapy
652489|NCT00438828|palliative|palliative
652490|NCT00438828|pain|pain
652491|NCT00438815|Hereditary angioedema|hereditary angioedema
652492|NCT00438815|C1 esterase inhibitor (human)|c1 esterase inhibitor (human)
652493|NCT00438802|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
652494|NCT00438802|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
652495|NCT00438802|anaplastic large cell lymphoma|anaplastic large cell lymphoma
652496|NCT00438802|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
652497|NCT00438802|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
652498|NCT00438763|CMC arthritis|cmc arthritis
652499|NCT00438763|splint treatment|splint treatment
652500|NCT00438763|patient satisfaction|patient satisfaction
652501|NCT00438763|DASH questionnaire|dash questionnaire
652502|NCT00438750|distal radius fracture|distal radius fracture
652503|NCT00438750|rehabilitation|rehabilitation
652504|NCT00438750|volar plate fixation|volar plate fixation
652505|NCT00438750|DASH questionnaire|dash questionnaire
652506|NCT00438737|liver metastases|liver metastases
652507|NCT00438737|stage IV colon cancer|stage iv colon cancer
652508|NCT00438737|stage IV rectal cancer|stage iv rectal cancer
652509|NCT00438737|recurrent colon cancer|recurrent colon cancer
652510|NCT00438737|recurrent rectal cancer|recurrent rectal cancer
652511|NCT00438724|Caregivers|caregivers
652512|NCT00438724|Caregiving|caregiving
652513|NCT00438724|Spousal relationships|spousal relationships
652514|NCT00438724|cognition disorders|cognition disorders
652515|NCT00438724|therapy|therapy
652516|NCT00438724|mental health|mental health
652517|NCT00438724|psychosocial|psychosocial
652518|NCT00438698|Nutrition|nutrition
652519|NCT00438698|Type 2 Diabetes|type 2 diabetes
652520|NCT00438685|Substance-Related Disorders|substance-related disorders
652521|NCT00438685|Depressive Disorder|depressive disorder
652522|NCT00438685|Anxiety Disorder|anxiety disorder
652523|NCT00438685|Adolescent|adolescent
652524|NCT00438685|Behavior Therapy|behavior therapy
652525|NCT00438685|Cognitive Therapy|cognitive therapy
652526|NCT00438685|Outpatients|outpatients
652527|NCT00438685|Family Relations|family relations
652528|NCT00438685|Systems Theory|systems theory
652529|NCT00438672|lateral elbow pain|lateral elbow pain
652530|NCT00438672|tennis elbow|tennis elbow
652531|NCT00438672|pain|pain
652532|NCT00438672|psychology|psychology
652533|NCT00438659|dermatologic complications|dermatologic complications
653026|NCT00436631|ketosis|ketosis
652534|NCT00438659|skin reactions secondary to radiation therapy|skin reactions secondary to radiation therapy
652535|NCT00438659|radiation toxicity|radiation toxicity
652536|NCT00438659|breast cancer in situ|breast cancer in situ
652537|NCT00438659|recurrent breast cancer|recurrent breast cancer
652538|NCT00438659|stage I breast cancer|stage i breast cancer
652539|NCT00438659|stage II breast cancer|stage ii breast cancer
652540|NCT00438659|stage IIIA breast cancer|stage iiia breast cancer
652541|NCT00438659|stage IIIB breast cancer|stage iiib breast cancer
652542|NCT00438659|stage IIIC breast cancer|stage iiic breast cancer
652543|NCT00438659|male breast cancer|male breast cancer
652544|NCT00438659|ductal breast carcinoma in situ|ductal breast carcinoma in situ
652545|NCT00438659|stage IV breast cancer|stage iv breast cancer
652546|NCT00438646|Allergy|allergy
652547|NCT00438646|Asthma|asthma
652548|NCT00438646|Eczema|eczema
652549|NCT00438646|Hay Fever|hay fever
652550|NCT00438646|Epidemiology|epidemiology
652551|NCT00438633|proximal humerus fracture|proximal humerus fracture
652552|NCT00438633|rehabilitation|rehabilitation
652553|NCT00438633|non-operative treatment|non-operative treatment
652554|NCT00438633|DASH and Constant instruments|dash and constant instruments
652555|NCT00438607|Moderate to late stage Parkinson's Disease|moderate to late stage parkinson's disease
652556|NCT00438594|nurse|nurse
652557|NCT00438594|paraprofessional|paraprofessional
652558|NCT00438594|home visits|home visits
652559|NCT00438594|pregnancy|pregnancy
652560|NCT00438594|welfare|welfare
652561|NCT00438594|child development|child development
652562|NCT00438581|Zevalin|zevalin
652563|NCT00438581|Autologous one Marrow Transplant|autologous one marrow transplant
652564|NCT00438581|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
652565|NCT00438568|amyloid protein|amyloid protein
652566|NCT00438568|brain metabolism|brain metabolism
652567|NCT00438568|glucose metabolism|glucose metabolism
652568|NCT00438568|insulin sensitivity /resistance|insulin sensitivity /resistance
652569|NCT00438568|cognition disorders|cognition disorders
652570|NCT00438555|obesity,prevention,pediatric|obesity,prevention,pediatric
652571|NCT00438542|Adiponectin, cord blood, pre-eclampsia|adiponectin, cord blood, pre-eclampsia
652572|NCT00438516|home visits|home visits
652573|NCT00438516|pregnancy|pregnancy
652574|NCT00438516|welfare|welfare
652575|NCT00438516|child development|child development
652576|NCT00438516|mortality|mortality
652577|NCT00438503|Hemodialysis, diabetes mellitus,|hemodialysis, diabetes mellitus,
652578|NCT00438503|Chronic renal failure, dialysis ,|chronic renal failure, dialysis ,
652579|NCT00438490|galactorrhea|galactorrhea
652580|NCT00438490|prolactin|prolactin
652581|NCT00438490|bone turnover|bone turnover
652582|NCT00438490|menstrual cycle|menstrual cycle
652583|NCT00438490|Control Groups|control groups
652584|NCT00438490|Women|women
652585|NCT00438477|recurrent breast cancer|recurrent breast cancer
652586|NCT00438477|stage IIIA breast cancer|stage iiia breast cancer
652587|NCT00438477|stage IIIB breast cancer|stage iiib breast cancer
652588|NCT00438477|stage IIIC breast cancer|stage iiic breast cancer
652589|NCT00438477|stage II breast cancer|stage ii breast cancer
652590|NCT00438451|elderly|elderly
652591|NCT00438451|focal epilepsy|focal epilepsy
652592|NCT00438451|anticonvulsive|anticonvulsive
652593|NCT00438451|treatment|treatment
652594|NCT00438451|levetiracetam|levetiracetam
652595|NCT00438451|lamotrigine|lamotrigine
652596|NCT00438451|carbamazepine|carbamazepine
652597|NCT00438438|forced desynchrony|forced desynchrony
652598|NCT00438438|circadian rhythms|circadian rhythms
652599|NCT00438438|sleep restriction|sleep restriction
652600|NCT00438438|sleep homeostasis|sleep homeostasis
652601|NCT00438438|neurobehavioral performance|neurobehavioral performance
652602|NCT00438425|Hyperlipidemia|hyperlipidemia
652603|NCT00438425|Hypercholesterolemia|hypercholesterolemia
652604|NCT00438425|Dietary modification|dietary modification
652605|NCT00438425|Portfolio|portfolio
652606|NCT00438412|Noradrenalin|noradrenalin
652607|NCT00438412|Endothelin-1|endothelin-1
652608|NCT00438412|Angiotensin II|angiotensin ii
652609|NCT00438412|Arginine vasopressin|arginine vasopressin
652610|NCT00438412|Aldosterone|aldosterone
652611|NCT00438412|Renin|renin
652612|NCT00438412|Atrial natriuretic peptide|atrial natriuretic peptide
652613|NCT00438412|Brain natriuretic peptide|brain natriuretic peptide
652614|NCT00438412|Blood pressure|blood pressure
652615|NCT00438412|Apnea|apnea
652616|NCT00438399|1 Galderma,|1 galderma,
652617|NCT00438399|2 Scalp Psoriasis|2 scalp psoriasis
652618|NCT00438399|3 Subject preference|3 subject preference
652619|NCT00438399|4 Clobetasol propionate|4 clobetasol propionate
652620|NCT00438399|5 Shampoo|5 shampoo
652621|NCT00438386|Generalized Anxiety Disorder|generalized anxiety disorder
652622|NCT00438386|Panic Disorder|panic disorder
652623|NCT00438386|Anxiety Disorder|anxiety disorder
652624|NCT00438386|Aripiprazole|aripiprazole
652625|NCT00438373|Subfertility, Luteinizing hormone, receptor|subfertility, luteinizing hormone, receptor
652626|NCT00438360|Cyclosporine, chronic plaque psoriasis, intermittent therapy|cyclosporine, chronic plaque psoriasis, intermittent therapy
652627|NCT00438347|Mild Cognitive Impairment|mild cognitive impairment
652628|NCT00438347|cognition disorders|cognition disorders
652629|NCT00438347|brain health|brain health
652630|NCT00438347|psychological aspect of aging|psychological aspect of aging
652631|NCT00438347|exercise|exercise
652632|NCT00438347|physical fitness|physical fitness
652633|NCT00438334|Benefit|benefit
652634|NCT00438334|Directional microphones|directional microphones
652635|NCT00438334|Hearing|hearing
652636|NCT00438334|Hearing aids|hearing aids
652637|NCT00438334|Hearing loss|hearing loss
652638|NCT00438334|Noise|noise
652639|NCT00438334|Objective benefit|objective benefit
652640|NCT00438334|Signal-to-noise ratio|signal-to-noise ratio
652641|NCT00438334|Speech understanding|speech understanding
652642|NCT00438334|Subjective benefit|subjective benefit
652643|NCT00438321|Overweight|overweight
652644|NCT00438321|obesity|obesity
652645|NCT00438321|testosterone|testosterone
652646|NCT00438321|diabetes|diabetes
652647|NCT00438321|metabolic syndrome|metabolic syndrome
652648|NCT00438321|aging|aging
652649|NCT00438308|distal radius fracture|distal radius fracture
652650|NCT00438308|rehabilitation|rehabilitation
652651|NCT00438308|volar plate fixation|volar plate fixation
652652|NCT00438308|DASH questionnaire|dash questionnaire
652653|NCT00438295|glucose in dialysis water, dialysis treatment, temperature|glucose in dialysis water, dialysis treatment, temperature
652654|NCT00438282|nurse|nurse
652655|NCT00438282|home visits|home visits
652656|NCT00438282|pregnancy|pregnancy
652657|NCT00438282|welfare|welfare
652658|NCT00438282|child development|child development
652659|NCT00438269|Infection|infection
652660|NCT00438269|Empiric|empiric
652661|NCT00438269|Antibiotics|antibiotics
652662|NCT00438269|Nosocomial|nosocomial
652663|NCT00438269|Pyrexia|pyrexia
652664|NCT00438269|Leukocytosis|leukocytosis
652665|NCT00438269|Resistance|resistance
652666|NCT00438256|accelerated short course|accelerated short course
652667|NCT00438256|proton beam radiation|proton beam radiation
652668|NCT00438243|Pseudophakic macular edema|pseudophakic macular edema
652669|NCT00438230|Residual vein thrombosis|residual vein thrombosis
652670|NCT00438230|Optimal duration|optimal duration
652671|NCT00438230|Oral anticoagulants|oral anticoagulants
652672|NCT00438217|precocious puberty, genetics, environmental factors|precocious puberty, genetics, environmental factors
652673|NCT00438204|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
652674|NCT00438204|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
652675|NCT00438204|adenocarcinoma of the lung|adenocarcinoma of the lung
652676|NCT00438204|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
652677|NCT00438204|large cell lung cancer|large cell lung cancer
652678|NCT00438204|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
652679|NCT00438191|DeQuervain's tenosynovitis|dequervain's tenosynovitis
652680|NCT00438191|splinting|splinting
652681|NCT00438191|grip strength|grip strength
652682|NCT00438191|satisfaction|satisfaction
652683|NCT00438191|DASH questionnaire|dash questionnaire
652684|NCT00438165|nurse|nurse
652685|NCT00438165|home visits|home visits
652686|NCT00438165|pregnancy|pregnancy
652687|NCT00438165|welfare|welfare
652688|NCT00438165|child development|child development
652689|NCT00438152|Lopinavir|lopinavir
652690|NCT00438152|Saquinavir|saquinavir
652691|NCT00438152|Lipids|lipids
652692|NCT00438152|HIV-1|hiv-1
652693|NCT00438152|Treatment Experienced|treatment experienced
652694|NCT00438139|marijuana dependence|marijuana dependence
652695|NCT00438126|diabetes|diabetes
652696|NCT00438126|Prevention|prevention
652697|NCT00438126|American Indian|american indian
652698|NCT00438113|blood pressure|blood pressure
652699|NCT00438113|atrial fibrillation|atrial fibrillation
652700|NCT00438113|catheter ablation|catheter ablation
652701|NCT00438100|Breast Neoplasms|breast neoplasms
652702|NCT00438100|Drug Therapy|drug therapy
652703|NCT00438087|Facial palsy|facial palsy
652704|NCT00438087|Vestibular schwannoma|vestibular schwannoma
652705|NCT00438087|Anti-inflammatory drugs|anti-inflammatory drugs
652706|NCT00438087|Post surgery of vestibular schwannoma|post surgery of vestibular schwannoma
652707|NCT00438087|or of cranial base tumors|or of cranial base tumors
652708|NCT00438074|Breast Cancer|breast cancer
652709|NCT00438074|Diffuse Optical Spectroscopy|diffuse optical spectroscopy
652710|NCT00438061|Lipoprotein metabolism|lipoprotein metabolism
652711|NCT00438061|Cardiovascular disease|cardiovascular disease
652712|NCT00438061|Obesity|obesity
652713|NCT00438048|Pilocarpine|pilocarpine
652714|NCT00438048|Artificial saliva|artificial saliva
652715|NCT00438048|Xerostomia|xerostomia
652716|NCT00438048|Xerostomy|xerostomy
652717|NCT00438048|Primary Sjogren|primary sjogren
652718|NCT00438048|Secondary Sjogren|secondary sjogren
652719|NCT00438035|Postoperative pain|postoperative pain
652846|NCT00437359|Breast Neoplasms|breast neoplasms
652720|NCT00438035|Heart rate variability, sympathetic, parasympathetic|heart rate variability, sympathetic, parasympathetic
652721|NCT00438035|Visual analog pain scale|visual analog pain scale
652722|NCT00438035|Spectral analysis of ECG|spectral analysis of ecg
652723|NCT00438022|Atopic Dermatitis|atopic dermatitis
652724|NCT00438022|Eczema Herpeticum|eczema herpeticum
652725|NCT00438009|coxsackievirus type a21|coxsackievirus type a21
652726|NCT00438009|oncolytic virus|oncolytic virus
652727|NCT00438009|melanoma|melanoma
652728|NCT00437996|Labor analgesia - clonidine - epidural|labor analgesia - clonidine - epidural
652729|NCT00437957|histone deacetylase|histone deacetylase
652730|NCT00437957|unresectable brain metastases|unresectable brain metastases
652731|NCT00437931|hypothyroidism|hypothyroidism
652732|NCT00437931|hyperthyroidism|hyperthyroidism
652733|NCT00437931|thyroid dysfunction|thyroid dysfunction
652734|NCT00437931|ultrasound|ultrasound
652735|NCT00437931|doppler|doppler
652736|NCT00437905|peripheral vascular disease|peripheral vascular disease
652737|NCT00437905|percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
652738|NCT00437905|cutting balloon|cutting balloon
652739|NCT00437905|balloon angioplasty|balloon angioplasty
652740|NCT00437905|randomized controlled trial|randomized controlled trial
652741|NCT00437905|restenosis|restenosis
652742|NCT00437905|inflammation|inflammation
652743|NCT00437892|Statins|statins
652744|NCT00437892|secondary prevention|secondary prevention
652745|NCT00437892|venous thromboembolism|venous thromboembolism
652746|NCT00437892|d-dimer|d-dimer
652747|NCT00437879|Breast Cancer|breast cancer
652748|NCT00437879|Ultrasound|ultrasound
652749|NCT00437840|healthy volunteers,|healthy volunteers,
652750|NCT00437840|tolerability,|tolerability,
652751|NCT00437840|pharmacokinetics,|pharmacokinetics,
652752|NCT00437840|pharmacodynamics|pharmacodynamics
652753|NCT00437840|safety,|safety,
652754|NCT00437840|smoking,|smoking,
652755|NCT00437827|Depression|depression
652756|NCT00437814|Ketamine|ketamine
652757|NCT00437814|Traumatic Brain Injury|traumatic brain injury
652758|NCT00437814|Intracranial Hypertension|intracranial hypertension
652759|NCT00437788|imaging|imaging
652760|NCT00437775|Diabetes Mellitus type 2|diabetes mellitus type 2
652761|NCT00437775|ACE Inhibitors|ace inhibitors
652762|NCT00437775|ARBs|arbs
652763|NCT00437775|Adverse drug effect|adverse drug effect
652764|NCT00437762|Lateral epicondylitis, tennis elbow, treatment|lateral epicondylitis, tennis elbow, treatment
652765|NCT00437749|Non small cell lung cancer|non small cell lung cancer
652766|NCT00437749|Advanced|advanced
652767|NCT00437749|Inoperable|inoperable
652768|NCT00437749|taxanes|taxanes
652769|NCT00437749|carboplatin|carboplatin
652770|NCT00437749|multi-drug resistance|multi-drug resistance
652771|NCT00437736|solid tumor|solid tumor
652772|NCT00437736|phase I study|phase i study
652773|NCT00437736|dose-escalation|dose-escalation
652774|NCT00437710|bone marrow, cell transplantation, stem cells, PTCA|bone marrow, cell transplantation, stem cells, ptca
652775|NCT00437697|dalteparin, critically ill, thromboprophylaxis|dalteparin, critically ill, thromboprophylaxis
652776|NCT00437684|HIV/HCV|hiv/hcv
652777|NCT00437684|HIV and HCV coinfected patients|hiv and hcv coinfected patients
652778|NCT00437684|Treatment Experienced|treatment experienced
652779|NCT00437671|trismus|trismus
652780|NCT00437671|lockjaw|lockjaw
652781|NCT00437645|Essential hypertension|essential hypertension
652782|NCT00437645|blood pressure|blood pressure
652783|NCT00437645|edema|edema
652784|NCT00437645|valsartan|valsartan
652785|NCT00437645|amlodipine|amlodipine
652786|NCT00437645|combination treatment|combination treatment
652787|NCT00437632|repeat dose,|repeat dose,
652788|NCT00437632|placebo,|placebo,
652789|NCT00437632|Safety,|safety,
652790|NCT00437632|pharmacodynamics,|pharmacodynamics,
652791|NCT00437632|tolerability,|tolerability,
652792|NCT00437632|GSK598809|gsk598809
652793|NCT00437632|pharmacokinetics,|pharmacokinetics,
652794|NCT00437593|preretinal membrane|preretinal membrane
652795|NCT00437593|vitrectomy|vitrectomy
652796|NCT00437593|uhr-oct|uhr-oct
652797|NCT00437593|hd-oct|hd-oct
652798|NCT00437580|Vancomycin Resistant Enterococcus, probiotic|vancomycin resistant enterococcus, probiotic
652799|NCT00437567|galacto-oligosaccharides|galacto-oligosaccharides
652800|NCT00437567|prebiotics|prebiotics
652801|NCT00437567|NEC|nec
652802|NCT00437541|Insulation|insulation
652803|NCT00437541|Warmth|warmth
652804|NCT00437541|Humidity|humidity
652805|NCT00437541|Damp|damp
652806|NCT00437541|Cold|cold
652807|NCT00437541|Respiratory|respiratory
652808|NCT00437541|Mould|mould
652809|NCT00437528|Heat flow|heat flow
652810|NCT00437528|Sensor|sensor
652811|NCT00437528|Overactive bladder|overactive bladder
652812|NCT00437528|Urinary incontinence|urinary incontinence
652813|NCT00437502|Immunotherapeutic vaccine|immunotherapeutic vaccine
652814|NCT00437502|Ovarian cancer|ovarian cancer
652815|NCT00437502|epithelial ovarian cancer|epithelial ovarian cancer
652816|NCT00437502|tubal cancer|tubal cancer
652817|NCT00437502|peritoneal cancer|peritoneal cancer
652818|NCT00437502|immunotherapy|immunotherapy
652819|NCT00437476|HIV/HCV|hiv/hcv
652820|NCT00437476|HIV and HCV coinfected patients|hiv and hcv coinfected patients
652821|NCT00437476|Treatment Naive|treatment naive
652822|NCT00437450|Anemia|anemia
652823|NCT00437450|myelodysplastic syndromes|myelodysplastic syndromes
652824|NCT00437450|Low risk|low risk
652825|NCT00437450|Bone Marrow diseases|bone marrow diseases
652826|NCT00437437|Advanced or metastatic solid tumors|advanced or metastatic solid tumors
653027|NCT00436631|ketogenic|ketogenic
652827|NCT00437424|Hepatocellular cancer|hepatocellular cancer
652828|NCT00437424|Other advanced solid malignancies|other advanced solid malignancies
652829|NCT00437411|Fibromyalgia|fibromyalgia
652830|NCT00437411|Affect|affect
652831|NCT00437411|Pain|pain
652832|NCT00437411|Fatigue|fatigue
652833|NCT00437411|Sleep|sleep
652834|NCT00437411|Stress|stress
652835|NCT00437411|Quality of Life|quality of life
652836|NCT00437411|Stress, Psychological|stress, psychological
652837|NCT00437411|Psychophysiology|psychophysiology
652838|NCT00437411|Randomized Controlled Trials|randomized controlled trials
652839|NCT00437398|hypoglycemic unawareness|hypoglycemic unawareness
652840|NCT00437385|therapy resistant depression, severe depression|therapy resistant depression, severe depression
652841|NCT00437372|solid tumor|solid tumor
652842|NCT00437372|central nervous system|central nervous system
652843|NCT00437372|head and neck|head and neck
652844|NCT00437372|thorax|thorax
652845|NCT00437372|pelvic area|pelvic area
652847|NCT00437359|Drug Therapy|drug therapy
652848|NCT00437346|dyspepsia|dyspepsia
652849|NCT00437346|functional dyspepsia|functional dyspepsia
652850|NCT00437346|treatment|treatment
652851|NCT00437346|drug therapy|drug therapy
652852|NCT00437346|information|information
652853|NCT00437333|Insulin sensitivity|insulin sensitivity
652854|NCT00437333|Insulin-sensitizing drug|insulin-sensitizing drug
652855|NCT00437333|Metformin|metformin
652856|NCT00437333|PCOS|pcos
652857|NCT00437333|Treatment|treatment
652858|NCT00437320|PDT|pdt
652859|NCT00437320|Photoaging|photoaging
652860|NCT00437320|Galderma|galderma
652861|NCT00437281|Partial-onset seizures; epilepsy; pediatric; pregabalin; safety; tolerability; pharmacokinetics|partial-onset seizures; epilepsy; pediatric; pregabalin; safety; tolerability; pharmacokinetics
652862|NCT00437242|interval,|interval,
652863|NCT00437242|atrial fibrillation|atrial fibrillation
652864|NCT00437242|QT,|qt,
652865|NCT00437242|odiparcil,|odiparcil,
652866|NCT00437229|GW679769,|gw679769,
652867|NCT00437229|Casopitant,|casopitant,
652868|NCT00437229|Dexamethasone,|dexamethasone,
652869|NCT00437229|Healthy Human Volunteer|healthy human volunteer
652870|NCT00437229|Ondansetron,|ondansetron,
652871|NCT00437203|Advanced cancer|advanced cancer
652872|NCT00437190|Cervical Disc Replacement|cervical disc replacement
652873|NCT00437190|Spondylotic radiculopathy|spondylotic radiculopathy
652874|NCT00437190|Spondylotic myelopathy|spondylotic myelopathy
652875|NCT00437190|Myelopathy|myelopathy
652876|NCT00437190|Radiculopathy|radiculopathy
652877|NCT00437177|alcoholism|alcoholism
652878|NCT00437177|apomorphine|apomorphine
652879|NCT00437177|iodobenzamide|iodobenzamide
652880|NCT00437177|imaging|imaging
652881|NCT00437177|spect|spect
652882|NCT00437177|relapse|relapse
652883|NCT00437164|NaBr|nabr
652884|NCT00437164|Sodium Bromide|sodium bromide
652885|NCT00437164|DEXA Deuterium|dexa deuterium
652886|NCT00437164|Total Body Water|total body water
652887|NCT00437164|Insulin|insulin
652888|NCT00437164|D2O|d2o
652889|NCT00437164|GW677954|gw677954
652890|NCT00437164|Randomized Withdrawal|randomized withdrawal
652891|NCT00437164|T2DM|t2dm
652892|NCT00437138|Air pollution|air pollution
652893|NCT00437138|Myocardial ischemia|myocardial ischemia
652894|NCT00437138|Endothelium|endothelium
652895|NCT00437138|Fibrinolysis|fibrinolysis
652896|NCT00437138|Pathophysiology|pathophysiology
652897|NCT00437138|Diesel exhaust|diesel exhaust
652898|NCT00437086|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
652899|NCT00437086|primary myelofibrosis|primary myelofibrosis
652900|NCT00437073|brain metastases|brain metastases
652901|NCT00437073|ErbB2|erbb2
652902|NCT00437073|lapatinib|lapatinib
652903|NCT00437073|Breast Cancer|breast cancer
652904|NCT00437073|HYCAMTIN|hycamtin
652905|NCT00437073|topotecan|topotecan
652906|NCT00437073|capecitabine|capecitabine
652907|NCT00437073|metastatic breast cancer|metastatic breast cancer
652908|NCT00437073|TYKERB|tykerb
652909|NCT00437073|XELODA|xeloda
652910|NCT00437021|smallpox, vaccine, IMVAMUNE®|smallpox, vaccine, imvamune®
652911|NCT00437008|endothelial dysfunction|endothelial dysfunction
652912|NCT00437008|flow-mediated dilatation|flow-mediated dilatation
652913|NCT00437008|advanced glycation end products|advanced glycation end products
652914|NCT00437008|postprandial|postprandial
652915|NCT00436995|Dialysis|dialysis
652916|NCT00436995|Anaemia|anaemia
652917|NCT00436969|Orthovisc|orthovisc
652918|NCT00436969|Osteoarthritis|osteoarthritis
652919|NCT00436969|Shoulder|shoulder
652920|NCT00436969|Randomized|randomized
652921|NCT00436956|VEGF|vegf
652922|NCT00436956|Angiogenesis|angiogenesis
652923|NCT00436956|Hormone-Refractory|hormone-refractory
652924|NCT00436956|Bone Metastases|bone metastases
652925|NCT00436956|Docetaxel-Resistant|docetaxel-resistant
652926|NCT00436956|Prostate Cancer|prostate cancer
652927|NCT00436943|smoking cessation|smoking cessation
652928|NCT00436943|nicotine replacement therapy|nicotine replacement therapy
652929|NCT00436943|bupropion|bupropion
652930|NCT00436943|smoking|smoking
652931|NCT00436930|recurrent melanoma|recurrent melanoma
652932|NCT00436930|stage IV melanoma|stage iv melanoma
652933|NCT00436917|stage I breast cancer|stage i breast cancer
652934|NCT00436917|stage II breast cancer|stage ii breast cancer
652935|NCT00436917|stage IIIA breast cancer|stage iiia breast cancer
652936|NCT00436917|osteoporosis|osteoporosis
652937|NCT00436904|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
652938|NCT00436904|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
652939|NCT00436904|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
652940|NCT00436904|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
652941|NCT00436891|Group A Streptococcus, scabies, pyoderma, Fiji|group a streptococcus, scabies, pyoderma, fiji
652942|NCT00436878|Eating Behavior|eating behavior
652943|NCT00436878|Children|children
652944|NCT00436878|Portion size|portion size
652945|NCT00436878|Experimental|experimental
652946|NCT00436826|Multiple Sclerosis|multiple sclerosis
652947|NCT00436826|Relapsing forms|relapsing forms
652948|NCT00436826|Interferon-beta therapy|interferon-beta therapy
652949|NCT00436787|Anticoagulation Prophylaxis|anticoagulation prophylaxis
652950|NCT00436787|Venous Thrombosis|venous thrombosis
652951|NCT00436787|Deep Vein Thrombosis|deep vein thrombosis
652952|NCT00436787|Pulmonary Embolism|pulmonary embolism
652953|NCT00436787|Fondaparinux Sodium|fondaparinux sodium
652954|NCT00436787|Arixtra|arixtra
652955|NCT00436787|Pharmakinetics|pharmakinetics
652956|NCT00436774|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
652957|NCT00436774|neurotoxicity|neurotoxicity
652958|NCT00436774|gastrointestinal complications|gastrointestinal complications
652959|NCT00436774|pulmonary complications|pulmonary complications
652960|NCT00436774|sexual dysfunction|sexual dysfunction
652961|NCT00436774|infertility|infertility
652962|NCT00436774|urinary complications|urinary complications
652963|NCT00436774|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
652964|NCT00436774|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
652965|NCT00436774|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
652966|NCT00436774|childhood teratoma|childhood teratoma
652967|NCT00436761|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
652968|NCT00436748|Chronic Kidney Disease|chronic kidney disease
652969|NCT00436748|Dialysis|dialysis
652970|NCT00436748|Anemia|anemia
652971|NCT00436748|Nephrology|nephrology
652972|NCT00436748|Pediatric|pediatric
652973|NCT00436748|Hemodialysis|hemodialysis
652974|NCT00436748|Peritoneal Dialysis|peritoneal dialysis
652975|NCT00436748|Chronic Renal Insufficiency|chronic renal insufficiency
652976|NCT00436722|Liver|liver
652977|NCT00436722|Transplantation|transplantation
652978|NCT00436722|Tolerance|tolerance
652979|NCT00436722|Induction|induction
652980|NCT00436722|Tacrolimus|tacrolimus
652981|NCT00436722|Liver transplantation|liver transplantation
652982|NCT00436722|Adult|adult
652983|NCT00436709|male breast cancer|male breast cancer
652984|NCT00436709|stage I breast cancer|stage i breast cancer
652985|NCT00436709|stage II breast cancer|stage ii breast cancer
652986|NCT00436709|stage IIIA breast cancer|stage iiia breast cancer
652987|NCT00436696|disseminated neuroblastoma|disseminated neuroblastoma
652988|NCT00436696|localized resectable neuroblastoma|localized resectable neuroblastoma
652989|NCT00436696|localized unresectable neuroblastoma|localized unresectable neuroblastoma
652990|NCT00436696|recurrent neuroblastoma|recurrent neuroblastoma
652991|NCT00436696|regional neuroblastoma|regional neuroblastoma
652992|NCT00436683|Hyperphosphataemia|hyperphosphataemia
652993|NCT00436683|Phosphate binder|phosphate binder
652994|NCT00436670|Asthma|asthma
652995|NCT00436670|Allergy|allergy
652996|NCT00436670|IL-13|il-13
652997|NCT00436670|IL-4|il-4
652998|NCT00436670|IL-4R|il-4r
652999|NCT00436657|Children|children
653000|NCT00436657|Pediatric|pediatric
653001|NCT00436657|Peritoneal Tumor|peritoneal tumor
653002|NCT00436657|Retroperitoneal Tumor|retroperitoneal tumor
653003|NCT00436657|Gastrointestinal Adenocarcinoma|gastrointestinal adenocarcinoma
653004|NCT00436657|Desmoplastic Round Cell Tumor|desmoplastic round cell tumor
653005|NCT00436657|Neuroblastoma|neuroblastoma
653006|NCT00436657|Ovarian Germ Cell|ovarian germ cell
653007|NCT00436657|Sarcoma|sarcoma
653008|NCT00436657|Adrenocorticocarcinoma|adrenocorticocarcinoma
653009|NCT00436657|Wilms' Tumor|wilms' tumor
653010|NCT00436657|Rhabdomyosarcoma|rhabdomyosarcoma
653011|NCT00436657|Desmoplastic Small Round Cell Tumor|desmoplastic small round cell tumor
653012|NCT00436657|Recurrent Tumors|recurrent tumors
653013|NCT00436657|Cisplatin|cisplatin
653014|NCT00436657|Platinol®-AQ|platinol®-aq
653015|NCT00436657|Platinol®|platinol®
653016|NCT00436657|CDDP|cddp
653017|NCT00436657|Abdominal Wash|abdominal wash
653018|NCT00436657|Hyperthermic Perfusion|hyperthermic perfusion
653019|NCT00436657|Continuous Hyperthermic Peritoneal Perfusion|continuous hyperthermic peritoneal perfusion
653020|NCT00436657|CHPP|chpp
653021|NCT00436644|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
653022|NCT00436644|peritoneal cavity cancer|peritoneal cavity cancer
653023|NCT00436631|epilepsy|epilepsy
653028|NCT00436631|diet|diet
653029|NCT00436618|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
653030|NCT00436618|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
653031|NCT00436618|anaplastic large cell lymphoma|anaplastic large cell lymphoma
653032|NCT00436618|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
653033|NCT00436618|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
653034|NCT00436618|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
653035|NCT00436618|splenic marginal zone lymphoma|splenic marginal zone lymphoma
653036|NCT00436618|small intestine lymphoma|small intestine lymphoma
653037|NCT00436618|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
653038|NCT00436618|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
653039|NCT00436618|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
653040|NCT00436618|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
653041|NCT00436618|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
653042|NCT00436618|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
653043|NCT00436618|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
653044|NCT00436618|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
653045|NCT00436618|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
653046|NCT00436618|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
653047|NCT00436618|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
653048|NCT00436618|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
653049|NCT00436618|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
653050|NCT00436618|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
653051|NCT00436618|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
653052|NCT00436618|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
653053|NCT00436618|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
653054|NCT00436618|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
653055|NCT00436592|acute|acute
653056|NCT00436592|ischemic|ischemic
653057|NCT00436592|stroke|stroke
653058|NCT00436592|device|device
653059|NCT00436592|treatment|treatment
653060|NCT00436566|cardiac toxicity|cardiac toxicity
653061|NCT00436566|male breast cancer|male breast cancer
653062|NCT00436566|stage I breast cancer|stage i breast cancer
653063|NCT00436566|stage II breast cancer|stage ii breast cancer
653064|NCT00436566|stage IIIA breast cancer|stage iiia breast cancer
653065|NCT00436553|Age-related macular degeneration; AMD|age-related macular degeneration; amd
653066|NCT00436553|choroidal neovascularization|choroidal neovascularization
653067|NCT00436553|verteporfin|verteporfin
653068|NCT00436553|ranibizumab|ranibizumab
653069|NCT00436514|patients|patients
653070|NCT00436514|medium risk|medium risk
653071|NCT00436514|asymptomatic|asymptomatic
653072|NCT00436514|between 50 and 74 years old|between 50 and 74 years old
653073|NCT00436514|high risk|high risk
653074|NCT00436514|case|case
653075|NCT00436514|history of neoplastic colic|history of neoplastic colic
653076|NCT00436514|cancers|cancers
653077|NCT00436514|polyps|polyps
653078|NCT00436501|primary peritoneal cavity cancer|primary peritoneal cavity cancer
653079|NCT00436501|Ovarian Epithelial Cancer|ovarian epithelial cancer
653080|NCT00436501|Peritoneal Cancer|peritoneal cancer
653081|NCT00436501|Fallopian Tube Cancer|fallopian tube cancer
653082|NCT00436501|VEGF Trap|vegf trap
653083|NCT00436501|aflibercept|aflibercept
653084|NCT00436501|vascular endothelial growth factor trap|vascular endothelial growth factor trap
653085|NCT00436501|Zaltrap|zaltrap
653086|NCT00436501|docetaxel|docetaxel
653087|NCT00436501|RP 56976|rp 56976
653088|NCT00436501|Taxotere|taxotere
653089|NCT00436501|TXT|txt
653090|NCT00436488|ICAM-1|icam-1
653091|NCT00436488|Obesity|obesity
653092|NCT00436488|Gene variants|gene variants
653093|NCT00436475|Glucose intolerance|glucose intolerance
653094|NCT00436475|Type 2 diabetes mellitus|type 2 diabetes mellitus
653095|NCT00436475|Metabolic syndrome|metabolic syndrome
653096|NCT00436462|Steroid receptors|steroid receptors
653097|NCT00436462|Endometrium|endometrium
653098|NCT00436462|IVF|ivf
653099|NCT00436462|Follicular phase|follicular phase
653100|NCT00436436|adult giant cell glioblastoma|adult giant cell glioblastoma
653101|NCT00436436|adult gliosarcoma|adult gliosarcoma
653102|NCT00436436|recurrent adult brain tumor|recurrent adult brain tumor
653103|NCT00436436|adult glioblastoma|adult glioblastoma
653104|NCT00436423|pancreatic neoplasm|pancreatic neoplasm
653105|NCT00436423|drug therapy|drug therapy
653106|NCT00436423|gemcitabine|gemcitabine
653107|NCT00436423|TS-1|ts-1
653108|NCT00436410|stage IV colon cancer|stage iv colon cancer
653109|NCT00436410|stage IV rectal cancer|stage iv rectal cancer
653110|NCT00436410|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
653111|NCT00436410|stage IV pancreatic cancer|stage iv pancreatic cancer
653112|NCT00436410|male breast cancer|male breast cancer
653113|NCT00436410|stage IV breast cancer|stage iv breast cancer
653114|NCT00436410|stage IV melanoma|stage iv melanoma
653115|NCT00436410|stage I breast cancer|stage i breast cancer
653116|NCT00436410|stage II breast cancer|stage ii breast cancer
653117|NCT00436410|stage IIIA breast cancer|stage iiia breast cancer
653118|NCT00436410|stage IIIB breast cancer|stage iiib breast cancer
653119|NCT00436410|stage IIIC breast cancer|stage iiic breast cancer
653120|NCT00436410|recurrent breast cancer|recurrent breast cancer
653121|NCT00436410|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
653122|NCT00436410|stage I adrenocortical carcinoma|stage i adrenocortical carcinoma
653123|NCT00436410|stage II adrenocortical carcinoma|stage ii adrenocortical carcinoma
653124|NCT00436410|stage III adrenocortical carcinoma|stage iii adrenocortical carcinoma
653125|NCT00436410|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
653126|NCT00436410|recurrent colon cancer|recurrent colon cancer
653127|NCT00436410|stage I colon cancer|stage i colon cancer
653128|NCT00436410|stage II colon cancer|stage ii colon cancer
653129|NCT00436410|stage III colon cancer|stage iii colon cancer
653130|NCT00436410|recurrent rectal cancer|recurrent rectal cancer
653131|NCT00436410|stage I rectal cancer|stage i rectal cancer
653132|NCT00436410|stage II rectal cancer|stage ii rectal cancer
653133|NCT00436410|stage III rectal cancer|stage iii rectal cancer
653134|NCT00436410|advanced adult primary liver cancer|advanced adult primary liver cancer
653135|NCT00436410|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
653136|NCT00436410|recurrent adult primary liver cancer|recurrent adult primary liver cancer
653137|NCT00436410|recurrent pancreatic cancer|recurrent pancreatic cancer
653138|NCT00436410|stage I pancreatic cancer|stage i pancreatic cancer
653139|NCT00436410|stage II pancreatic cancer|stage ii pancreatic cancer
653140|NCT00436410|stage III pancreatic cancer|stage iii pancreatic cancer
653141|NCT00436410|recurrent melanoma|recurrent melanoma
653142|NCT00436410|stage I melanoma|stage i melanoma
653143|NCT00436410|stage II melanoma|stage ii melanoma
653144|NCT00436410|stage III melanoma|stage iii melanoma
653145|NCT00436410|stage I renal cell cancer|stage i renal cell cancer
653146|NCT00436410|stage II renal cell cancer|stage ii renal cell cancer
653147|NCT00436410|stage III renal cell cancer|stage iii renal cell cancer
653148|NCT00436410|stage IV renal cell cancer|stage iv renal cell cancer
653149|NCT00436410|recurrent renal cell cancer|recurrent renal cell cancer
653150|NCT00436410|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
653151|NCT00436410|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
653152|NCT00436410|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
653153|NCT00436410|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
653154|NCT00436410|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
653155|NCT00436410|gastrointestinal cancer|gastrointestinal cancer
653156|NCT00436410|adult fibrosarcoma|adult fibrosarcoma
653157|NCT00436410|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
653158|NCT00436410|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
653159|NCT00436410|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
653160|NCT00436410|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
653161|NCT00436410|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
653162|NCT00436397|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
653163|NCT00436384|liver transplant|liver transplant
653164|NCT00436384|lung transplant|lung transplant
653165|NCT00436384|kidney transplant|kidney transplant
653166|NCT00436384|heart transplant|heart transplant
653167|NCT00436384|CMV CMI|cmv cmi
653168|NCT00436358|Mexico|mexico
653169|NCT00436358|Intussusception|intussusception
653170|NCT00436358|Epidemiology|epidemiology
653171|NCT00436345|analgesia|analgesia
653172|NCT00436345|Mechanical ventilation|mechanical ventilation
653173|NCT00436345|pharmaco-economic|pharmaco-economic
653174|NCT00436345|ICU|icu
653175|NCT00436332|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
653176|NCT00436332|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
653177|NCT00436332|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
653178|NCT00436332|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
653179|NCT00436332|adenocarcinoma of the lung|adenocarcinoma of the lung
653180|NCT00436319|Infertility, downregulation, stimulation, agonists, long|infertility, downregulation, stimulation, agonists, long
653181|NCT00436306|prevention|prevention
653182|NCT00436306|behavior|behavior
653183|NCT00436306|risk reduction behavior|risk reduction behavior
653184|NCT00436267|recurrent pancreatic cancer|recurrent pancreatic cancer
653185|NCT00436267|stage IV pancreatic cancer|stage iv pancreatic cancer
653186|NCT00436267|liver metastases|liver metastases
653187|NCT00436228|healthy volunteer,|healthy volunteer,
653188|NCT00436228|Bioavailability,|bioavailability,
653189|NCT00436228|safety|safety
653190|NCT00436228|Phase I,|phase i,
653191|NCT00436215|Sorafenib|sorafenib
653192|NCT00436215|Ovarian Cancer|ovarian cancer
653193|NCT00436215|Fallopian Cancer|fallopian cancer
653194|NCT00436215|Bevacizumab|bevacizumab
653195|NCT00436215|Peritoneal Cancer|peritoneal cancer
653196|NCT00436215|Fallopian Tube Cancer|fallopian tube cancer
653197|NCT00436202|Anemia|anemia
653198|NCT00436202|Iron|iron
653199|NCT00436202|Supplement|supplement
653200|NCT00436189|Ovarian|ovarian
653201|NCT00436189|Cancer|cancer
653202|NCT00436189|Pelvic|pelvic
653203|NCT00436189|Mass|mass
653204|NCT00436189|Tumor|tumor
653205|NCT00436189|Adnexal|adnexal
653206|NCT00436189|Proteomics|proteomics
653207|NCT00436176|Diabetes mellitus|diabetes mellitus
653208|NCT00436176|Quality of Health Care|quality of health care
653209|NCT00436176|Cultural Competency|cultural competency
653210|NCT00436176|Performance Feedback|performance feedback
653211|NCT00436176|Health navigator|health navigator
653212|NCT00436176|Health disparities|health disparities
653213|NCT00436176|Racial disparities|racial disparities
653214|NCT00436150|Adolescents|adolescents
653215|NCT00436150|Depression, postpartum|depression, postpartum
653216|NCT00436137|Colorectal cancer|colorectal cancer
653217|NCT00436137|Fecal occult blood test|fecal occult blood test
653218|NCT00436137|Abnormal test result|abnormal test result
653219|NCT00436137|Missed diagnosis|missed diagnosis
653220|NCT00436137|Delayed diagnosis|delayed diagnosis
653221|NCT00436111|hyperprolactinemia|hyperprolactinemia
653222|NCT00436111|autoantibody|autoantibody
653223|NCT00436098|congenital heart disease|congenital heart disease
653224|NCT00436098|exercise training|exercise training
653225|NCT00436098|motorpedagogical exercise|motorpedagogical exercise
653226|NCT00436098|children|children
653227|NCT00436098|CHD: hemodynamically not significant defects|chd: hemodynamically not significant defects
653228|NCT00436098|CHD: acyanotic defects after repair|chd: acyanotic defects after repair
653229|NCT00436098|CHD: cyanotic defects after repair|chd: cyanotic defects after repair
653230|NCT00436072|ZD6474|zd6474
653231|NCT00436072|cetuximab|cetuximab
653232|NCT00436072|irinotecan|irinotecan
653233|NCT00436046|interferon, vaccine, influenza|interferon, vaccine, influenza
653234|NCT00436020|clinical trial|clinical trial
653235|NCT00436020|TMS|tms
653236|NCT00436020|depression|depression
653237|NCT00436020|bipolar disorder|bipolar disorder
653238|NCT00436007|Africa|africa
653239|NCT00436007|Plasmodium falciparum|plasmodium falciparum
653240|NCT00436007|Malaria|malaria
653241|NCT00435994|Infant|infant
653242|NCT00435994|Respiratory Syncytial Virus|respiratory syncytial virus
653243|NCT00435994|Bronchiolitis|bronchiolitis
653244|NCT00435981|Type 1 diabetes|type 1 diabetes
653245|NCT00435981|GAD65|gad65
653246|NCT00435981|Autoimmunity|autoimmunity
653247|NCT00435981|C-peptide|c-peptide
653248|NCT00435981|Children|children
653249|NCT00435968|NK Cells|nk cells
653250|NCT00435968|Cytokines|cytokines
653251|NCT00435968|Lymphocytes|lymphocytes
653252|NCT00435968|Immunoglobulins|immunoglobulins
653253|NCT00435968|Th1 response|th1 response
653254|NCT00435955|Follicular lymphoma|follicular lymphoma
653255|NCT00435955|age adjusted IPI >1|age adjusted ipi >1
653256|NCT00435955|IIL score > 2|iil score > 2
653257|NCT00435955|Molecular remission|molecular remission
653258|NCT00435955|High dose chemotherapy and autologous transplantation|high dose chemotherapy and autologous transplantation
653259|NCT00435955|Rituximab|rituximab
653260|NCT00435929|Treatment Naive|treatment naive
653261|NCT00435916|Antigens, CD40|antigens, cd40
653262|NCT00435916|Antibody, Monoclonal|antibody, monoclonal
653263|NCT00435916|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
653264|NCT00435916|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
653265|NCT00435916|Hematologic Diseases|hematologic diseases
653266|NCT00435916|Immunoproliferative Disorders|immunoproliferative disorders
653267|NCT00435916|Lymphatic Diseases|lymphatic diseases
653268|NCT00435916|Lymphoproliferative Disorders|lymphoproliferative disorders
653269|NCT00435916|Lymphoma|lymphoma
653270|NCT00435903|smoking|smoking
653271|NCT00435903|self-monitoring|self-monitoring
653272|NCT00435903|major mental illness|major mental illness
653273|NCT00435903|palm pilots|palm pilots
653274|NCT00435903|subjects with DSM-IV Axis I diagnosis|subjects with dsm-iv axis i diagnosis
653275|NCT00435890|ED Overcrowding|ed overcrowding
653276|NCT00435890|Length of stay|length of stay
653277|NCT00435890|Emergency triage|emergency triage
653278|NCT00435890|triage|triage
653279|NCT00435877|Connective Tissue|connective tissue
653280|NCT00435877|Stromal Cells|stromal cells
653281|NCT00435877|Surgical Waste|surgical waste
653282|NCT00435877|In Vivo Studies|in vivo studies
653283|NCT00435877|Tissue Analysis|tissue analysis
653284|NCT00435864|recipient of a HSC graft in Acute Myeloblastic Leukemia therapy|recipient of a hsc graft in acute myeloblastic leukemia therapy
653285|NCT00435864|recipient of a HSC graft in others pathologies treated in hematology of Nantes university hospital or Angers university hospital|recipient of a hsc graft in others pathologies treated in hematology of nantes university hospital or angers university hospital
653286|NCT00435864|donors are healthy subjects|donors are healthy subjects
653287|NCT00435838|HLa-B*5701 Abacavir|hla-b*5701 abacavir
653288|NCT00435812|HBV vaccine|hbv vaccine
653289|NCT00435812|Hepatitis B vaccine|hepatitis b vaccine
653290|NCT00435812|Hepatitis B|hepatitis b
653291|NCT00435812|Hepatitis|hepatitis
653292|NCT00435812|HBV|hbv
653293|NCT00435812|Immunostimulatory sequence (ISS)|immunostimulatory sequence (iss)
653294|NCT00435799|keratoconus|keratoconus
653295|NCT00435799|corneal cross-linking|corneal cross-linking
653296|NCT00435799|riboflavine|riboflavine
653297|NCT00435799|ultraviolet type A rays (UVA)|ultraviolet type a rays (uva)
653298|NCT00435773|Osteoarthritis|osteoarthritis
653299|NCT00435773|Leeching|leeching
653300|NCT00435773|Randomized Controlled Trial|randomized controlled trial
653301|NCT00435773|Arthralgia|arthralgia
653302|NCT00435760|COPD|copd
653303|NCT00435721|schizophrenia|schizophrenia
653304|NCT00435721|family psychoeducation|family psychoeducation
653305|NCT00435708|COPD|copd
653306|NCT00435708|Fruit|fruit
653307|NCT00435708|Vegetables|vegetables
653308|NCT00435708|Oxidative stress|oxidative stress
653309|NCT00435708|Inflammation|inflammation
653310|NCT00435695|PET scan|pet scan
653311|NCT00435695|healthy males|healthy males
653312|NCT00435682|The trial is performed on healthy normal males.|the trial is performed on healthy normal males.
653313|NCT00435669|Advanced or metastatic solid tumors|advanced or metastatic solid tumors
653314|NCT00435656|Human immunodeficiency virus|human immunodeficiency virus
653315|NCT00435643|Sleep apnea,|sleep apnea,
653316|NCT00435643|adiponectin ,|adiponectin ,
653317|NCT00435643|HPA axis|hpa axis
653318|NCT00435630|Education|education
653319|NCT00435630|Virtual Reality|virtual reality
653320|NCT00435630|Laparoscopic Surgery|laparoscopic surgery
653321|NCT00435630|Learning Curve|learning curve
653322|NCT00435617|stroke rehabilitation|stroke rehabilitation
653323|NCT00435617|stroke therapy|stroke therapy
653324|NCT00435617|hand therapy|hand therapy
653325|NCT00435617|stroke|stroke
653326|NCT00435617|cerebrovascular stroke|cerebrovascular stroke
653327|NCT00435617|cerebral stroke|cerebral stroke
653328|NCT00435604|hyaluronidase|hyaluronidase
653329|NCT00435604|subcutaneous drug delivery|subcutaneous drug delivery
653330|NCT00435604|Volunteer Subjects|volunteer subjects
653331|NCT00435591|Hyponatremia|hyponatremia
653332|NCT00435591|Euvolemia|euvolemia
653333|NCT00435591|Hypervolemia|hypervolemia
653334|NCT00435591|Conivaptan|conivaptan
653335|NCT00435591|Vaprisol®|vaprisol®
653336|NCT00435591|YM087|ym087
653337|NCT00435578|Recurrent Sensitive Small-Cell Lung Cancer|recurrent sensitive small-cell lung cancer
653338|NCT00435539|Vitreomacular Traction|vitreomacular traction
653339|NCT00435539|Maculopathy|maculopathy
653340|NCT00435539|VMT|vmt
653341|NCT00435539|PVD|pvd
653342|NCT00435526|traveler's diarrhea|traveler's diarrhea
653343|NCT00435526|ETEC diarrhea|etec diarrhea
653344|NCT00435526|passive immunization|passive immunization
653345|NCT00435526|bovine milk prophylaxis|bovine milk prophylaxis
653346|NCT00435500|Dental caries, topical fluorides|dental caries, topical fluorides
653347|NCT00435487|Non-ST Elevation Acute Coronary Syndromes coronary interventions|non-st elevation acute coronary syndromes coronary interventions
653348|NCT00435474|Cancer|cancer
653349|NCT00435474|Malignant wounds|malignant wounds
653350|NCT00435474|Quality of life|quality of life
653351|NCT00435474|Body-Image|body-image
653352|NCT00435474|Cancer patients|cancer patients
653353|NCT00435461|once daily|once daily
653354|NCT00435461|mountain cedar|mountain cedar
653355|NCT00435461|fexofenadine|fexofenadine
653356|NCT00435461|allergic rhinitis|allergic rhinitis
653357|NCT00435461|fluticasone furoate|fluticasone furoate
653358|NCT00435448|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
653359|NCT00435448|BPH|bph
653360|NCT00435448|Enlarged Prostate|enlarged prostate
653361|NCT00435435|Alcoholism|alcoholism
653362|NCT00435435|Dependence|dependence
653363|NCT00435435|Randomization|randomization
653364|NCT00435435|Effect|effect
653365|NCT00435435|Disulfiram|disulfiram
653366|NCT00435435|Naltrexone|naltrexone
653367|NCT00435435|Acamprosate|acamprosate
653368|NCT00435383|Caudal Block|caudal block
653369|NCT00435383|Oxygen Saturation|oxygen saturation
653370|NCT00435383|Uni or Bilateral Orchidopexy|uni or bilateral orchidopexy
653371|NCT00435357|Mobile-bearing|mobile-bearing
653372|NCT00435357|arthroplasty|arthroplasty
653373|NCT00435357|fixed-bearing|fixed-bearing
653374|NCT00435357|knee|knee
653375|NCT00435357|patella|patella
653376|NCT00435357|posterior stabilized TKA|posterior stabilized tka
653377|NCT00435344|Pediatric practice|pediatric practice
653378|NCT00435344|Smoking cessation|smoking cessation
653379|NCT00435344|Smoking prevention|smoking prevention
653380|NCT00435344|Adolescents|adolescents
653381|NCT00435331|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
653382|NCT00435331|PPH|pph
653383|NCT00435305|continuous infusion|continuous infusion
653384|NCT00435305|epithelial lining fluid|epithelial lining fluid
653385|NCT00435305|antibiotics|antibiotics
653386|NCT00435305|pneumonia|pneumonia
653387|NCT00435305|critical illness|critical illness
653388|NCT00435279|Insomnia|insomnia
653389|NCT00435279|Depression|depression
653390|NCT00435279|Major Depressive Disorder|major depressive disorder
653391|NCT00435266|myocardial infarction|myocardial infarction
653392|NCT00435266|remote|remote
653393|NCT00435266|preconditioning|preconditioning
653394|NCT00435266|perconditioning|perconditioning
653395|NCT00435266|cardioprotection|cardioprotection
653396|NCT00435253|emphysema|emphysema
653397|NCT00435253|COPD|copd
653398|NCT00435253|lung volume reduction|lung volume reduction
653399|NCT00435253|NETT|nett
653400|NCT00435253|BLVR|blvr
653401|NCT00435253|biologic lung volume reduction|biologic lung volume reduction
653402|NCT00435253|bronchoscopic lung volume reduction|bronchoscopic lung volume reduction
653403|NCT00435227|Respiratory Syncytial Viruses|respiratory syncytial viruses
653404|NCT00435214|Cytology|cytology
653405|NCT00435214|papilloma virus|papilloma virus
653406|NCT00435214|CIN|cin
653407|NCT00435214|Screening|screening
653408|NCT00435214|Cervix|cervix
653409|NCT00435214|Cervical Cancer|cervical cancer
653410|NCT00435188|Aging|aging
653411|NCT00435188|Cost analysis|cost analysis
653412|NCT00435188|Counseling|counseling
653413|NCT00435188|Disabled Persons|disabled persons
653414|NCT00435188|Health Promotion|health promotion
653415|NCT00435188|Mobility Limitation|mobility limitation
653416|NCT00435188|Physical Activity|physical activity
653417|NCT00435188|Primary Care|primary care
653418|NCT00435188|Randomized Clinical Trial|randomized clinical trial
653419|NCT00435188|Veterans|veterans
653420|NCT00435175|Estradiol|estradiol
653421|NCT00435175|Lipolysis|lipolysis
653422|NCT00435175|Estrogen receptor|estrogen receptor
653423|NCT00435175|Adrenergic receptors|adrenergic receptors
653424|NCT00435175|UCP2|ucp2
653425|NCT00435175|Postmenopausal women|postmenopausal women
653426|NCT00435162|Children|children
653427|NCT00435162|pediatrics|pediatrics
653428|NCT00435162|High Blood Pressure|high blood pressure
653429|NCT00435162|Hypertension|hypertension
653430|NCT00435162|Valsartan|valsartan
653431|NCT00435123|Malnutrition|malnutrition
653432|NCT00435123|ESRD|esrd
653433|NCT00435123|Hemodialysis|hemodialysis
653434|NCT00435110|ARDS|ards
653435|NCT00435110|ALI|ali
653436|NCT00435110|Mechanical Ventilation|mechanical ventilation
653437|NCT00435110|Outcome|outcome
653438|NCT00435097|colon cancer|colon cancer
653439|NCT00435097|metastatic colorectal cancer|metastatic colorectal cancer
653440|NCT00435097|MRI|mri
653441|NCT00435097|Magnetic resonance imaging|magnetic resonance imaging
653442|NCT00435097|Early cancer detection|early cancer detection
653443|NCT00435097|medical image processing|medical image processing
653444|NCT00435097|machine learning|machine learning
653445|NCT00435097|disease modeling|disease modeling
653446|NCT00435097|Colon Cancer Stage III|colon cancer stage iii
653447|NCT00435084|Refractory B-CLL|refractory b-cll
653448|NCT00435084|phase I/II|phase i/ii
653449|NCT00435084|CD38|cd38
653450|NCT00435058|intraocular pressure|intraocular pressure
653451|NCT00435058|contrast sensitivity|contrast sensitivity
653452|NCT00435058|visual function|visual function
653453|NCT00435045|Lovaza|lovaza
653454|NCT00435045|Hyperlipidemias|hyperlipidemias
653455|NCT00435045|Triglycerides|triglycerides
653456|NCT00435045|Lipids|lipids
653457|NCT00435045|omega-3 fatty acids|omega-3 fatty acids
653458|NCT00435045|Hypercholesterolemia|hypercholesterolemia
653459|NCT00435045|Hypertriglyceridemia|hypertriglyceridemia
653460|NCT00435045|omega-3-acid ethyl esters|omega-3-acid ethyl esters
653461|NCT00435045|Omacor|omacor
653462|NCT00435045|Dyslipidemias|dyslipidemias
653463|NCT00435032|ruptured appendicitis|ruptured appendicitis
653464|NCT00435032|children|children
653465|NCT00435032|surgery|surgery
653466|NCT00435032|randomized trial|randomized trial
653467|NCT00434993|Acute Lung Injury|acute lung injury
653468|NCT00434993|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
653469|NCT00434993|Albuterol|albuterol
653470|NCT00434993|Aerosolized|aerosolized
653471|NCT00434993|Critical Care|critical care
653472|NCT00434993|Ventilator|ventilator
653473|NCT00434980|Cognitive adaption|cognitive adaption
653474|NCT00434980|Schizophrenia|schizophrenia
653475|NCT00434980|Cognitive rehabilitation|cognitive rehabilitation
653476|NCT00434980|Family treatment|family treatment
653477|NCT00434980|Cognitive deficits|cognitive deficits
653478|NCT00434980|Serious mental illness|serious mental illness
653479|NCT00434967|Blood pressure reduction|blood pressure reduction
653480|NCT00434967|combination therapy|combination therapy
653481|NCT00434967|candesartan cilexetil|candesartan cilexetil
653482|NCT00434967|hydrochlorothiazide|hydrochlorothiazide
653483|NCT00434954|diabetes|diabetes
653484|NCT00434954|exenatide|exenatide
653485|NCT00434954|Byetta|byetta
653486|NCT00434954|Amylin|amylin
653487|NCT00434954|Lilly|lilly
653488|NCT00434941|Administration of capecitabine concomitant to radiotherapy|administration of capecitabine concomitant to radiotherapy
653489|NCT00434941|Her2: negative|her2: negative
653490|NCT00434928|observational|observational
653491|NCT00434928|dietary intake|dietary intake
653492|NCT00434928|nutrient status|nutrient status
653493|NCT00434928|serum assessors|serum assessors
653494|NCT00434928|Attention-Deficit/Hyperactivity Disorder (ADHD)|attention-deficit/hyperactivity disorder (adhd)
653495|NCT00434902|Doppler Echocardiography|doppler echocardiography
653496|NCT00434902|Pulmonary hypertension|pulmonary hypertension
653497|NCT00434902|Sickle cell disease|sickle cell disease
653498|NCT00434889|dementia|dementia
653499|NCT00434889|falls|falls
653500|NCT00434889|risk factors|risk factors
653501|NCT00434876|Alcoholism|alcoholism
653502|NCT00434876|Insomnia|insomnia
653503|NCT00434876|Quetiapine|quetiapine
653504|NCT00434876|Seroquel|seroquel
653505|NCT00434863|botulinum toxin type A|botulinum toxin type a
653506|NCT00434863|Dysport®|dysport®
653507|NCT00434863|Botox®|botox®
653508|NCT00434863|hyperfunctional forehead lines|hyperfunctional forehead lines
653509|NCT00434863|randomized controlled trial|randomized controlled trial
653510|NCT00434863|double-blinded trial|double-blinded trial
653511|NCT00434863|electromyogram (EMG)|electromyogram (emg)
653512|NCT00434850|Insulin dependence|insulin dependence
653513|NCT00434850|Hypoglycemia|hypoglycemia
653514|NCT00434850|Hyperglycemia unawareness|hyperglycemia unawareness
653515|NCT00434837|Knee|knee
653516|NCT00434837|Ligament|ligament
653518|NCT00434837|Reconstruction|reconstruction
653519|NCT00434837|Cartilage|cartilage
653520|NCT00434837|Osteoarthritis|osteoarthritis
653521|NCT00434811|Insulin dependence|insulin dependence
653522|NCT00434811|Hypoglycemia|hypoglycemia
653523|NCT00434811|Hypoglycemia unawareness|hypoglycemia unawareness
653524|NCT00434798|Campylobacter infections|campylobacter infections
653525|NCT00434772|hypoglycemia|hypoglycemia
653526|NCT00434772|glucagon|glucagon
653527|NCT00434772|neonatal|neonatal
653528|NCT00434772|gestational diabetes|gestational diabetes
653529|NCT00434772|insulin|insulin
653530|NCT00434772|glyburide|glyburide
653531|NCT00434759|randomized controlled trial|randomized controlled trial
653532|NCT00434759|stepped-care program|stepped-care program
653533|NCT00434759|cognitive therapy of social phobia according to D.M. Clark|cognitive therapy of social phobia according to d.m. clark
653534|NCT00434733|Influenza H5N1, pandemic|influenza h5n1, pandemic
653535|NCT00434720|GlideScope|glidescope
653536|NCT00434720|Stylet|stylet
653537|NCT00434707|glaucoma|glaucoma
653538|NCT00434707|catarat|catarat
653539|NCT00434707|small pupils|small pupils
653540|NCT00434694|Atrial Fibrillation|atrial fibrillation
653541|NCT00434694|Catheter ablation|catheter ablation
653542|NCT00434694|Pulmonary Vein|pulmonary vein
653543|NCT00434668|Non-Small Cell Lung Cancer|non-small cell lung cancer
653544|NCT00434668|NSCLC|nsclc
653545|NCT00434668|Adjuvant chemotherapy for completely resected NSCLC|adjuvant chemotherapy for completely resected nsclc
653546|NCT00434655|Morbid obesity|morbid obesity
653547|NCT00434655|Bariatric surgery|bariatric surgery
653548|NCT00434655|Obesity surgery|obesity surgery
653549|NCT00434655|Gastric banding|gastric banding
653550|NCT00434655|Sleeve gastrectomy|sleeve gastrectomy
653551|NCT00434642|Avastin|avastin
653552|NCT00434642|Ovarian carcinoma|ovarian carcinoma
653553|NCT00434642|Peritoneal carcinoma|peritoneal carcinoma
653554|NCT00434642|Peritoneal cancer|peritoneal cancer
653555|NCT00434642|Fallopian tube cancer|fallopian tube cancer
653556|NCT00434642|Fallopian tube carcinoma|fallopian tube carcinoma
653557|NCT00434642|OCEANS|oceans
653558|NCT00434629|lymphoma|lymphoma
653559|NCT00434629|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
653560|NCT00434629|B-cell lymphoma|b-cell lymphoma
653561|NCT00434629|Radioimmunotherapy|radioimmunotherapy
653562|NCT00434629|Bexxar|bexxar
653563|NCT00434629|tositumomab|tositumomab
653564|NCT00434629|autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
653565|NCT00434616|angiogenesis|angiogenesis
653566|NCT00434616|Arterial Occlusive Diseases|arterial occlusive diseases
653567|NCT00434616|Leg Ulcer|leg ulcer
653568|NCT00434616|Gangrene|gangrene
653569|NCT00434616|Ischemia|ischemia
653570|NCT00434616|PAOD|paod
653571|NCT00434616|Amputation|amputation
653572|NCT00434616|bone marrow|bone marrow
653573|NCT00434590|Kidney Transplantation|kidney transplantation
653574|NCT00434590|Mycophenolic Acid|mycophenolic acid
653575|NCT00434590|Immunosuppression|immunosuppression
653576|NCT00434590|Cyclosporine|cyclosporine
653577|NCT00434577|GSK Biologicals|gsk biologicals
653578|NCT00434577|Herpes Zoster (HZ)|herpes zoster (hz)
653579|NCT00434577|Vaccine|vaccine
653580|NCT00434577|Varicella Zoster Virus (VZV)|varicella zoster virus (vzv)
653581|NCT00434577|Shingles|shingles
653582|NCT00434564|Stress nuclear scan|stress nuclear scan
653583|NCT00434564|Acute chest pain|acute chest pain
653584|NCT00434551|small bowel Crohn's disease|small bowel crohn's disease
653585|NCT00434551|capsule endoscopy|capsule endoscopy
653586|NCT00434551|PillCam SB|pillcam sb
653587|NCT00434551|Patients with suspected small bowel Crohn's disease|patients with suspected small bowel crohn's disease
653588|NCT00434538|Diabetic|diabetic
653589|NCT00434538|Foot|foot
653590|NCT00434538|Ulcer|ulcer
653591|NCT00434538|Neuropathic|neuropathic
653592|NCT00434538|Chitosan|chitosan
653593|NCT00434525|Morbid obesity|morbid obesity
653594|NCT00434525|Bariatric Surgery|bariatric surgery
653595|NCT00434525|Obesity Surgery|obesity surgery
653596|NCT00434525|Omentectomy|omentectomy
653597|NCT00434525|Sleeve gastrectomy|sleeve gastrectomy
653598|NCT00434512|Gag|gag
653599|NCT00434512|vaccine|vaccine
653600|NCT00434512|adjuvant|adjuvant
653601|NCT00434512|HIV|hiv
653602|NCT00434512|Pol|pol
653603|NCT00434512|Nef|nef
653604|NCT00434499|Green Tea|green tea
653605|NCT00434499|Insulin Resistance|insulin resistance
653606|NCT00434499|Endothelial Dysfunction|endothelial dysfunction
653607|NCT00434499|Nitric Oxide|nitric oxide
653608|NCT00434499|Inflammation|inflammation
653609|NCT00434499|Obesity|obesity
653610|NCT00434499|Overweight|overweight
653611|NCT00434499|Diabetes Type 2|diabetes type 2
653612|NCT00434499|High Blood Pressure|high blood pressure
653613|NCT00434499|Healthy Volunteer|healthy volunteer
653614|NCT00434499|HV|hv
653615|NCT00434460|Ventilator Associated Pneumonia|ventilator associated pneumonia
653616|NCT00434460|Knowledge Translation|knowledge translation
653617|NCT00434460|Clinical Practice Guidelines|clinical practice guidelines
653618|NCT00434460|Education|education
653619|NCT00434460|Behaviour Change|behaviour change
653620|NCT00434447|Prostate Cancer|prostate cancer
653621|NCT00434447|Breast Cancer|breast cancer
653622|NCT00434447|Multiple Myeloma|multiple myeloma
653623|NCT00434447|Zoledronic acid|zoledronic acid
653624|NCT00434447|Bone metastases|bone metastases
653625|NCT00434447|Skeletal Related Events (SREs)|skeletal related events (sres)
653626|NCT00434447|Renal Impairment|renal impairment
653627|NCT00434447|Osteonecrosis of the Jaw (ONJ)|osteonecrosis of the jaw (onj)
653628|NCT00434447|Bone involvement|bone involvement
653629|NCT00434447|Multiple Myeloma (MM)|multiple myeloma (mm)
653630|NCT00434434|AQUA|aqua
653631|NCT00434434|anti-CD11|anti-cd11
653632|NCT00434434|CD11a|cd11a
653633|NCT00434434|Asthma|asthma
653634|NCT00434434|Allergy|allergy
653635|NCT00434421|Perennial Allergic Rhinitis|perennial allergic rhinitis
653636|NCT00434421|Asthma|asthma
653637|NCT00434421|Sublingual Immunotherapy (SLIT)|sublingual immunotherapy (slit)
653638|NCT00434408|omphalitis|omphalitis
653639|NCT00434408|neonates|neonates
653640|NCT00434408|umbilical cord|umbilical cord
653641|NCT00434408|infection|infection
653642|NCT00434408|infant mortality|infant mortality
653643|NCT00434408|neonate morbidity|neonate morbidity
653644|NCT00434408|chlorhexidine|chlorhexidine
653645|NCT00434382|auditory evoked potentials|auditory evoked potentials
653646|NCT00434382|sensory processing|sensory processing
653647|NCT00434382|monitoring|monitoring
653648|NCT00434382|general anesthesia|general anesthesia
653649|NCT00434356|Avastin|avastin
653650|NCT00434356|MBC|mbc
653651|NCT00434356|Breast Cancer|breast cancer
653652|NCT00434356|Sutent|sutent
653653|NCT00434343|Interstitial Cystitis|interstitial cystitis
653654|NCT00434343|Painful Bladder Syndrome|painful bladder syndrome
653655|NCT00434343|Chronic Prostatitis|chronic prostatitis
653656|NCT00434343|Chronic Pelvic Pain Syndrome|chronic pelvic pain syndrome
653657|NCT00434330|anemia|anemia
653658|NCT00434330|chronic kidney disease|chronic kidney disease
653659|NCT00434330|CKD|ckd
653660|NCT00434330|chronic renal failure|chronic renal failure
653661|NCT00434330|CRF|crf
653662|NCT00434330|dialysis|dialysis
653663|NCT00434330|erythropoietin|erythropoietin
653664|NCT00434330|EPO|epo
653665|NCT00434330|erythropoiesis stimulating agent|erythropoiesis stimulating agent
653666|NCT00434330|ESA|esa
653667|NCT00434330|Hematide™|hematide™
653668|NCT00434330|hemodialysis|hemodialysis
653669|NCT00434330|hemoglobin|hemoglobin
653670|NCT00434330|Hb|hb
653671|NCT00434330|Hgb|hgb
653672|NCT00434330|Omontys|omontys
653673|NCT00434330|peginesatide|peginesatide
653674|NCT00434330|red blood cell|red blood cell
653675|NCT00434330|red blood cell production|red blood cell production
653676|NCT00434317|Metastasis|metastasis
653677|NCT00434317|Neoplasm|neoplasm
653678|NCT00434317|pain|pain
653679|NCT00434317|breast cancer|breast cancer
653680|NCT00434317|prostate cancer|prostate cancer
653681|NCT00434317|bone metastasis|bone metastasis
653682|NCT00434304|Parkinson's Disease|parkinson's disease
653683|NCT00434304|PD|pd
653684|NCT00434291|Community-acquired Pneumonia|community-acquired pneumonia
653685|NCT00434291|fluoroquinolone|fluoroquinolone
653686|NCT00434291|TG-873870|tg-873870
653687|NCT00434291|Nemonoxacin|nemonoxacin
653688|NCT00434278|Lung disease|lung disease
653689|NCT00434278|CF|cf
653690|NCT00434278|Pulmozyme|pulmozyme
653691|NCT00434265|Obesity|obesity
653692|NCT00434265|Exercise|exercise
653693|NCT00434265|Fat oxidation|fat oxidation
653694|NCT00434265|Overweigh (IMC>25 and IMC<30)|overweigh (imc>25 and imc<30)
653695|NCT00434252|Avastin|avastin
653696|NCT00434252|BEAM|beam
653697|NCT00434252|Metastatic melanoma|metastatic melanoma
653698|NCT00434239|Myelodysplasia|myelodysplasia
653699|NCT00434239|Lenalidomide|lenalidomide
653700|NCT00434239|Ancestim|ancestim
653701|NCT00434239|Pilot trial|pilot trial
653702|NCT00434239|Biomarkers|biomarkers
653703|NCT00434226|SABER-L|saber-l
653704|NCT00434226|NSCLC|nsclc
653705|NCT00434226|Avastin|avastin
653706|NCT00434226|Sutent|sutent
653707|NCT00434200|rheumatoid arthritis|rheumatoid arthritis
653708|NCT00434200|exercise|exercise
653709|NCT00434200|damage|damage
653710|NCT00434187|healthy|healthy
653711|NCT00434174|Lung cancer|lung cancer
653712|NCT00434174|Non small cell lung cancer|non small cell lung cancer
653713|NCT00434174|NSCLC|nsclc
653714|NCT00434174|RAD001|rad001
653715|NCT00434174|Everolimus|everolimus
653716|NCT00434174|Afinitor|afinitor
653717|NCT00434174|Pemetrexed|pemetrexed
653718|NCT00434161|Palifermin|palifermin
653720|NCT00434161|Clinical Trial|clinical trial
653721|NCT00434161|Oncology|oncology
653722|NCT00434161|Oral Mucositis|oral mucositis
653723|NCT00434161|Multiple Myeloma|multiple myeloma
653724|NCT00434161|Cataract|cataract
653725|NCT00434148|Cushing's Disease|cushing's disease
653726|NCT00434148|pasireotide|pasireotide
653727|NCT00434148|SOM230|som230
653728|NCT00434135|gemcitabine|gemcitabine
653729|NCT00434135|pemetrexed|pemetrexed
653730|NCT00434135|non-small cell lung cancer|non-small cell lung cancer
653731|NCT00434122|Assisted Reproductive Technology (ART)|assisted reproductive technology (art)
653732|NCT00434122|oocyte donors undergoing controlled ovarian hyperstimulation for assisted reproductive technologies|oocyte donors undergoing controlled ovarian hyperstimulation for assisted reproductive technologies
653733|NCT00434109|Carcinoid|carcinoid
653734|NCT00434109|Pancreatic|pancreatic
653735|NCT00434109|Metastatic|metastatic
653736|NCT00434109|Neuroendocrine|neuroendocrine
653737|NCT00434109|Tumors|tumors
653738|NCT00434109|Hepatic|hepatic
653739|NCT00434109|Artery|artery
653740|NCT00434109|Embolization|embolization
653741|NCT00434109|Angiogenesis|angiogenesis
653742|NCT00434109|Sunitinib|sunitinib
653743|NCT00434109|Malate|malate
653744|NCT00434109|Sutent|sutent
653745|NCT00434109|Tyrosine|tyrosine
653746|NCT00434109|Kinase|kinase
653747|NCT00434109|Inhibitor|inhibitor
653748|NCT00434096|Obesity disease|obesity disease
653749|NCT00434096|cannabinoid-1 receptor|cannabinoid-1 receptor
653750|NCT00434083|TREXIMA|trexima
653751|NCT00434083|MIGRAINE HEADACHES|migraine headaches
653752|NCT00434083|Subjects may be enrolled if they are 18-65 years of age, have a demonstrated history of migraine headaches|subjects may be enrolled if they are 18-65 years of age, have a demonstrated history of migraine headaches
653753|NCT00434070|HIV|hiv
653754|NCT00434070|Antiretrovial Therapy|antiretrovial therapy
653755|NCT00434070|Resistance|resistance
653756|NCT00434070|Monitoring|monitoring
653757|NCT00434070|TAMS|tams
653758|NCT00434070|Treatment Experienced|treatment experienced
653759|NCT00434057|Pigmented Skin Lesions|pigmented skin lesions
653760|NCT00434057|Dermatology|dermatology
653761|NCT00434057|Skin Cancer|skin cancer
653762|NCT00434057|Melanoma|melanoma
653763|NCT00434057|MelaFind|melafind
653764|NCT00434031|locally advanced|locally advanced
653765|NCT00434031|stage II|stage ii
653766|NCT00434031|stage IIIa|stage iiia
653767|NCT00434031|stage IIIb|stage iiib
653768|NCT00434031|HER-2 positive|her-2 positive
653769|NCT00434031|primary|primary
653770|NCT00434018|Wheelchairs|wheelchairs
653771|NCT00434018|Safety|safety
653772|NCT00434005|Air pollution|air pollution
653773|NCT00434005|diesel|diesel
653774|NCT00434005|antioxidant|antioxidant
653775|NCT00434005|oxidative stress|oxidative stress
653776|NCT00434005|endothelial|endothelial
653777|NCT00434005|HRV|hrv
653778|NCT00434005|BAR|bar
653779|NCT00433992|Mitochondria|mitochondria
653780|NCT00433992|Fat apoptosis|fat apoptosis
653781|NCT00433992|Lipoatrophy|lipoatrophy
653782|NCT00433992|Lipodystrophy|lipodystrophy
653783|NCT00433992|Thymidine|thymidine
653784|NCT00433992|Treatment experienced|treatment experienced
653785|NCT00433979|Anti-HIV agents|anti-hiv agents
653786|NCT00433979|Physiological Effects of Drugs|physiological effects of drugs
653787|NCT00433979|ARV-associated Adverse Events|arv-associated adverse events
653788|NCT00433979|HAART|haart
653789|NCT00433979|Pharmacokinetics|pharmacokinetics
653790|NCT00433979|Protease Inhibitors|protease inhibitors
653791|NCT00433979|Non-nucleoside Reverse Transcriptase Inhibitors|non-nucleoside reverse transcriptase inhibitors
653792|NCT00433979|Women|women
653793|NCT00433966|Myocardial Infarction|myocardial infarction
653794|NCT00433966|Angioplasty|angioplasty
653795|NCT00433966|Myocardial Ischemia|myocardial ischemia
653796|NCT00433966|Myocardial Reperfusion|myocardial reperfusion
653797|NCT00433966|Stents|stents
653798|NCT00433966|Heart Disease|heart disease
653799|NCT00433953|Pediatric Kidney Transplant|pediatric kidney transplant
653800|NCT00433953|Kidney Transplant|kidney transplant
653801|NCT00433953|CellCept|cellcept
653802|NCT00433953|Mycophenolate Mofetil|mycophenolate mofetil
653803|NCT00433953|Mycophenolic Acid|mycophenolic acid
653804|NCT00433940|Hemangioma|hemangioma
653805|NCT00433940|Corticosteroid|corticosteroid
653806|NCT00433940|Prednisone|prednisone
653807|NCT00433927|metastatic|metastatic
653808|NCT00433914|Meningococcal disease, prevention, vaccination|meningococcal disease, prevention, vaccination
653809|NCT00433901|obesity in children|obesity in children
653810|NCT00433901|childhood disorders|childhood disorders
653811|NCT00433901|overweight children|overweight children
653812|NCT00433901|physical activity|physical activity
653813|NCT00433901|home environment|home environment
653814|NCT00433862|Polycythemia Vera|polycythemia vera
653815|NCT00433862|Essential Thrombocytosis|essential thrombocytosis
653816|NCT00433862|Idiopathic Myelofibrosis|idiopathic myelofibrosis
653817|NCT00433862|Janus Kinase 2|janus kinase 2
653818|NCT00433862|CD177|cd177
653819|NCT00433862|Chronic Myeloproliferative Disorders|chronic myeloproliferative disorders
653820|NCT00433862|PV|pv
653821|NCT00433862|Essential Thrombocythemia|essential thrombocythemia
653822|NCT00433862|ET|et
653823|NCT00433862|IM|im
653824|NCT00433836|Children|children
653825|NCT00433836|pediatrics|pediatrics
653826|NCT00433836|High Blood Pressure|high blood pressure
653827|NCT00433836|Hypertension|hypertension
653828|NCT00433836|Valsartan|valsartan
653829|NCT00433836|enalapril|enalapril
653830|NCT00433823|Very low level of LDL|very low level of ldl
653831|NCT00433823|Steroid hormones|steroid hormones
653832|NCT00433823|Atorvastatin|atorvastatin
653833|NCT00433823|Ezetimibe|ezetimibe
653834|NCT00433823|Lipoprotein-a|lipoprotein-a
653835|NCT00433810|obesity|obesity
653836|NCT00433810|bariatric surgery|bariatric surgery
653837|NCT00433810|30-day mortality|30-day mortality
653838|NCT00433797|Prostate cancer|prostate cancer
653839|NCT00433797|PSA|psa
653840|NCT00433797|antioxidant|antioxidant
653841|NCT00433797|phytochemical|phytochemical
653842|NCT00433797|tomatoes|tomatoes
653843|NCT00433797|PUFA|pufa
653844|NCT00433797|selenium|selenium
653845|NCT00433797|soy|soy
653846|NCT00433797|pomegranate|pomegranate
653847|NCT00433797|grapes|grapes
653848|NCT00433784|clopidogrel|clopidogrel
653849|NCT00433784|platelet aggregation|platelet aggregation
653850|NCT00433784|CYP3A|cyp3a
653851|NCT00433784|H2 haplotype|h2 haplotype
653852|NCT00433784|polymorphisms|polymorphisms
653853|NCT00433771|Malignant|malignant
653854|NCT00433771|Cholestasis, Extrahepatic|cholestasis, extrahepatic
653855|NCT00433771|Biliary obstruction|biliary obstruction
653856|NCT00433758|Diabetes|diabetes
653857|NCT00433758|Blood glucose monitoring|blood glucose monitoring
653858|NCT00433758|Non invasive Blood glucose monitoring|non invasive blood glucose monitoring
653859|NCT00433745|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
653860|NCT00433745|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
653861|NCT00433745|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
653862|NCT00433745|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
653863|NCT00433745|Wilm's Tumor-1 Peptide|wilm's tumor-1 peptide
653864|NCT00433745|Leukemia|leukemia
653865|NCT00433745|Myelodysplastic Syndrome|myelodysplastic syndrome
653866|NCT00433745|MDS|mds
653867|NCT00433745|Acute Myelogenous Leukemia|acute myelogenous leukemia
653868|NCT00433745|AML|aml
653869|NCT00433745|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
653870|NCT00433745|CML|cml
653871|NCT00433745|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
653872|NCT00433745|ALL|all
653873|NCT00433732|TREXIMA|trexima
653874|NCT00433732|MIGRAINE HEADACHES|migraine headaches
653875|NCT00433732|Subjects may be enrolled if they are 18-65 years of age, have a demonstrated history of migraine headaches|subjects may be enrolled if they are 18-65 years of age, have a demonstrated history of migraine headaches
653876|NCT00433719|Human immunodeficiency virus|human immunodeficiency virus
653877|NCT00433719|Tuberculous meningitis|tuberculous meningitis
653878|NCT00433719|Treatment Naive|treatment naive
653879|NCT00433706|Prostate adenocarcinoma treated by radiotherapy|prostate adenocarcinoma treated by radiotherapy
653880|NCT00433680|adolescent|adolescent
653881|NCT00433680|female|female
653882|NCT00433680|obesity|obesity
653883|NCT00433680|body dissatisfaction|body dissatisfaction
653884|NCT00433667|RWJ-333369|rwj-333369
653885|NCT00433667|anticonvulsants|anticonvulsants
653886|NCT00433667|antiepileptic drugs|antiepileptic drugs
653887|NCT00433654|Bradycardia|bradycardia
653888|NCT00433654|Slow heart beat|slow heart beat
653889|NCT00433654|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
653890|NCT00433641|obesity|obesity
653891|NCT00433641|pharmacogenetics|pharmacogenetics
653892|NCT00433641|sibutramine|sibutramine
653893|NCT00433641|adrenergic|adrenergic
653894|NCT00433641|serotonergic|serotonergic
653895|NCT00433641|body composition|body composition
653896|NCT00433641|gastric emptying|gastric emptying
653897|NCT00433628|Hemoglobin A1C|hemoglobin a1c
653898|NCT00433628|HIV|hiv
653899|NCT00433628|Diabetes|diabetes
653900|NCT00433628|Diabetes Type 2|diabetes type 2
653901|NCT00433628|Hyperglycemia|hyperglycemia
653902|NCT00433602|thromboembolism|thromboembolism
653903|NCT00433602|recurrent breast cancer|recurrent breast cancer
653904|NCT00433602|stage IV breast cancer|stage iv breast cancer
653905|NCT00433602|recurrent colon cancer|recurrent colon cancer
653906|NCT00433602|stage I colon cancer|stage i colon cancer
653907|NCT00433602|stage II colon cancer|stage ii colon cancer
653908|NCT00433602|stage III colon cancer|stage iii colon cancer
653909|NCT00433602|stage IV colon cancer|stage iv colon cancer
653910|NCT00433602|recurrent rectal cancer|recurrent rectal cancer
653911|NCT00433602|stage I rectal cancer|stage i rectal cancer
653912|NCT00433602|stage II rectal cancer|stage ii rectal cancer
653913|NCT00433602|stage III rectal cancer|stage iii rectal cancer
653914|NCT00433602|stage IV rectal cancer|stage iv rectal cancer
653915|NCT00433602|recurrent gastric cancer|recurrent gastric cancer
653916|NCT00433602|stage I gastric cancer|stage i gastric cancer
653917|NCT00433602|stage II gastric cancer|stage ii gastric cancer
653918|NCT00433602|stage III gastric cancer|stage iii gastric cancer
653919|NCT00433602|stage IV gastric cancer|stage iv gastric cancer
653920|NCT00433602|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
653921|NCT00433602|stage I non-small cell lung cancer|stage i non-small cell lung cancer
653922|NCT00433602|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
653923|NCT00433602|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
653924|NCT00433602|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
653925|NCT00433602|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
653926|NCT00433602|recurrent small cell lung cancer|recurrent small cell lung cancer
653927|NCT00433602|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
653928|NCT00433602|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
653929|NCT00433602|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
653930|NCT00433602|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
653931|NCT00433602|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
653932|NCT00433602|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
653933|NCT00433602|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
653934|NCT00433602|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
653935|NCT00433602|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
653936|NCT00433602|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
653937|NCT00433602|ovarian sarcoma|ovarian sarcoma
653938|NCT00433602|ovarian stromal cancer|ovarian stromal cancer
653939|NCT00433602|recurrent pancreatic cancer|recurrent pancreatic cancer
653940|NCT00433602|stage I pancreatic cancer|stage i pancreatic cancer
653941|NCT00433602|stage II pancreatic cancer|stage ii pancreatic cancer
653942|NCT00433602|stage III pancreatic cancer|stage iii pancreatic cancer
653943|NCT00433602|stage IV pancreatic cancer|stage iv pancreatic cancer
653944|NCT00433602|recurrent prostate cancer|recurrent prostate cancer
653945|NCT00433602|stage III prostate cancer|stage iii prostate cancer
653946|NCT00433602|stage IV prostate cancer|stage iv prostate cancer
653947|NCT00433602|extensive stage small cell lung cancer|extensive stage small cell lung cancer
653948|NCT00433602|limited stage small cell lung cancer|limited stage small cell lung cancer
653949|NCT00433602|stage IIB prostate cancer|stage iib prostate cancer
653950|NCT00433602|stage IIA prostate cancer|stage iia prostate cancer
653951|NCT00433602|male breast cancer|male breast cancer
653952|NCT00433589|invasive ductal breast carcinoma|invasive ductal breast carcinoma
653953|NCT00433589|invasive lobular breast carcinoma|invasive lobular breast carcinoma
653954|NCT00433589|stage IA breast cancer|stage ia breast cancer
653955|NCT00433589|stage IB breast cancer|stage ib breast cancer
653956|NCT00433589|stage II breast cancer|stage ii breast cancer
653957|NCT00433589|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
654068|NCT00433173|insulin resistance|insulin resistance
653958|NCT00433589|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
653959|NCT00433563|limited stage small cell lung cancer|limited stage small cell lung cancer
653960|NCT00433524|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
653961|NCT00433498|extensive stage small cell lung cancer|extensive stage small cell lung cancer
653962|NCT00433498|limited stage small cell lung cancer|limited stage small cell lung cancer
653963|NCT00433485|basal cell carcinoma of the skin|basal cell carcinoma of the skin
653964|NCT00433485|nevoid basal cell carcinoma syndrome|nevoid basal cell carcinoma syndrome
653965|NCT00433472|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
653966|NCT00433472|adult giant cell glioblastoma|adult giant cell glioblastoma
653967|NCT00433472|adult anaplastic astrocytoma|adult anaplastic astrocytoma
653968|NCT00433472|recurrent adult brain tumor|recurrent adult brain tumor
653969|NCT00433472|adult glioblastoma|adult glioblastoma
653970|NCT00433472|adult gliosarcoma|adult gliosarcoma
653971|NCT00433459|childhood lymphocyte depletion Hodgkin lymphoma|childhood lymphocyte depletion hodgkin lymphoma
653972|NCT00433459|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
653973|NCT00433459|childhood nodular sclerosis Hodgkin lymphoma|childhood nodular sclerosis hodgkin lymphoma
653974|NCT00433459|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
653975|NCT00433459|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
653976|NCT00433459|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
653977|NCT00433459|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
653978|NCT00433446|adenocarcinoma of the prostate|adenocarcinoma of the prostate
653979|NCT00433446|stage IV prostate cancer|stage iv prostate cancer
653980|NCT00433446|recurrent prostate cancer|recurrent prostate cancer
653981|NCT00433433|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
653982|NCT00433433|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
653983|NCT00433433|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
653984|NCT00433433|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
653985|NCT00433433|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
653986|NCT00433420|stage II breast cancer|stage ii breast cancer
654076|NCT00433121|Dementia|dementia
653987|NCT00433420|stage IIIA breast cancer|stage iiia breast cancer
653988|NCT00433420|stage IIIB breast cancer|stage iiib breast cancer
653989|NCT00433420|stage IIIC breast cancer|stage iiic breast cancer
653990|NCT00433407|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
653991|NCT00433407|stage I breast cancer|stage i breast cancer
653992|NCT00433407|stage II breast cancer|stage ii breast cancer
653993|NCT00433407|stage IIIA breast cancer|stage iiia breast cancer
653994|NCT00433407|stage IIIB breast cancer|stage iiib breast cancer
653995|NCT00433407|stage IIIC breast cancer|stage iiic breast cancer
653996|NCT00433407|stage IV breast cancer|stage iv breast cancer
653997|NCT00433407|male breast cancer|male breast cancer
653998|NCT00433407|recurrent breast cancer|recurrent breast cancer
653999|NCT00433407|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
654000|NCT00433407|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
654001|NCT00433407|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
654002|NCT00433407|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
654003|NCT00433407|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
654004|NCT00433407|stage I non-small cell lung cancer|stage i non-small cell lung cancer
654005|NCT00433407|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
654006|NCT00433407|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
654007|NCT00433407|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
654008|NCT00433407|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
654009|NCT00433407|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
654010|NCT00433407|extensive stage small cell lung cancer|extensive stage small cell lung cancer
654011|NCT00433407|limited stage small cell lung cancer|limited stage small cell lung cancer
654012|NCT00433407|recurrent small cell lung cancer|recurrent small cell lung cancer
654013|NCT00433407|stage I prostate cancer|stage i prostate cancer
654014|NCT00433407|stage IIB prostate cancer|stage iib prostate cancer
654015|NCT00433407|stage IIA prostate cancer|stage iia prostate cancer
654016|NCT00433407|stage III prostate cancer|stage iii prostate cancer
654017|NCT00433407|stage IV prostate cancer|stage iv prostate cancer
654018|NCT00433407|recurrent prostate cancer|recurrent prostate cancer
654019|NCT00433407|stage I uterine sarcoma|stage i uterine sarcoma
654020|NCT00433407|stage II uterine sarcoma|stage ii uterine sarcoma
654021|NCT00433407|stage III uterine sarcoma|stage iii uterine sarcoma
654022|NCT00433407|stage IV uterine sarcoma|stage iv uterine sarcoma
654023|NCT00433407|recurrent uterine sarcoma|recurrent uterine sarcoma
654024|NCT00433394|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
654025|NCT00433368|L-ornithine-L-aspartate,|l-ornithine-l-aspartate,
654026|NCT00433368|porto-systemic encephalopathy,|porto-systemic encephalopathy,
654027|NCT00433368|hepatic encephalopathy,|hepatic encephalopathy,
654028|NCT00433368|liver cirrhosis,|liver cirrhosis,
654029|NCT00433368|mental state|mental state
654030|NCT00433355|Chronic Fatigue Syndrome|chronic fatigue syndrome
654031|NCT00433355|Epstein-Barr Virus|epstein-barr virus
654032|NCT00433342|Antibiotic|antibiotic
654033|NCT00433342|p-cresol|p-cresol
654034|NCT00433342|peritoneal dialysis|peritoneal dialysis
654035|NCT00433329|pulmonary arterial hypertension|pulmonary arterial hypertension
654036|NCT00433329|bosentan|bosentan
654037|NCT00433329|sildenafil|sildenafil
654038|NCT00433329|combination therapy|combination therapy
654039|NCT00433329|Compass 3|compass 3
654040|NCT00433316|ropivacaine|ropivacaine
654041|NCT00433316|laparoscopy|laparoscopy
654042|NCT00433316|intraperitoneal|intraperitoneal
654043|NCT00433316|nebulization|nebulization
654044|NCT00433316|pain|pain
654045|NCT00433316|local analgesic|local analgesic
654046|NCT00433316|gynecology|gynecology
654047|NCT00433264|peritoneal dialysis|peritoneal dialysis
654048|NCT00433264|endothelium|endothelium
654049|NCT00433264|endothelial dysfunction|endothelial dysfunction
654050|NCT00433238|elderly|elderly
654051|NCT00433238|Chinese|chinese
654052|NCT00433238|community living|community living
654053|NCT00433238|measurement|measurement
654054|NCT00433238|depression|depression
654055|NCT00433238|dementia|dementia
654056|NCT00433238|Geriatric Depression Scale|geriatric depression scale
654057|NCT00433238|MiniCog|minicog
654058|NCT00433212|prematurity|prematurity
654059|NCT00433212|respiratory insufficiency|respiratory insufficiency
654060|NCT00433212|non-invasive ventilation|non-invasive ventilation
654061|NCT00433212|bronchopulmonary dysplasia|bronchopulmonary dysplasia
654062|NCT00433212|hyaline membrane disease|hyaline membrane disease
654063|NCT00433199|Hypogonadism|hypogonadism
654064|NCT00433199|Testosterone Deficiency|testosterone deficiency
654065|NCT00433186|Scleroderma|scleroderma
654066|NCT00433173|testosterone|testosterone
654067|NCT00433173|insulin sensitivity|insulin sensitivity
654069|NCT00433173|metabolic disorders|metabolic disorders
654070|NCT00433134|renal transplant recipient|renal transplant recipient
654071|NCT00433134|adherence|adherence
654072|NCT00433134|compliance|compliance
654073|NCT00433134|immunosuppression|immunosuppression
654074|NCT00433121|Antidepressive Agents|antidepressive agents
654075|NCT00433121|Neuroleptica|neuroleptica
654077|NCT00433121|Discontinuation study|discontinuation study
654078|NCT00433121|Behavioural- and Psychological Symptoms in Dementia|behavioural- and psychological symptoms in dementia
654079|NCT00433108|Hepatitis C|hepatitis c
654080|NCT00433108|antioxidant|antioxidant
654081|NCT00433108|liver enzymes|liver enzymes
654082|NCT00433108|ALT|alt
654083|NCT00433095|Navelbine|navelbine
654084|NCT00433095|Herceptin|herceptin
654085|NCT00433095|oral|oral
654086|NCT00433095|breast cancer|breast cancer
654087|NCT00433082|Metabolic syndrome,Ramadan,Fasting,Inflammatory markers,|metabolic syndrome,ramadan,fasting,inflammatory markers,
654088|NCT00433082|Iran|iran
654089|NCT00433069|Chronic hepatitis C|chronic hepatitis c
654090|NCT00433069|Insulin resistance|insulin resistance
654091|NCT00433069|Pioglitazone|pioglitazone
654092|NCT00433069|Non-responders|non-responders
654093|NCT00433056|STI|sti
654094|NCT00433056|HIV|hiv
654095|NCT00433056|CD4|cd4
654096|NCT00433056|HIV-RNA|hiv-rna
654097|NCT00433056|HAART|haart
654098|NCT00433043|Heart Failure|heart failure
654099|NCT00433043|Beta blockers|beta blockers
654100|NCT00433043|Resynchronization|resynchronization
654101|NCT00433043|Congestive Heart Failure, NYHA III-IV|congestive heart failure, nyha iii-iv
654102|NCT00433043|Candidate for BIVPM|candidate for bivpm
654103|NCT00433043|Not on Target Dose (Coreg 25 Bid or Toprol XL 200 qd)|not on target dose (coreg 25 bid or toprol xl 200 qd)
654104|NCT00433030|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
654105|NCT00433030|HIV Viral load|hiv viral load
654106|NCT00433030|HIV drug Resistance|hiv drug resistance
654107|NCT00433030|Thailand|thailand
654108|NCT00433017|Age-related macular degeneration|age-related macular degeneration
654109|NCT00433017|AMD|amd
654110|NCT00433017|Choroidal neovascularization|choroidal neovascularization
654111|NCT00433017|Verteporfin|verteporfin
654112|NCT00433017|Ranibizumab|ranibizumab
654113|NCT00433004|Teen|teen
654114|NCT00433004|Plan B|plan b
654115|NCT00433004|Post Partum|post partum
654116|NCT00433004|Emergency Contraception|emergency contraception
654117|NCT00432991|Nausea|nausea
654118|NCT00432991|Vomiting|vomiting
654119|NCT00432991|Cesarean Section|cesarean section
654120|NCT00432978|hypoxia|hypoxia
654121|NCT00432978|endothelin|endothelin
654122|NCT00432978|exercise|exercise
654123|NCT00432965|Wound closure|wound closure
654124|NCT00432965|Accelerated healing|accelerated healing
654125|NCT00432952|Cardiovascular Heart Disease|cardiovascular heart disease
654126|NCT00432939|Primary Hyperparathyroidism|primary hyperparathyroidism
654127|NCT00432926|HIV|hiv
654128|NCT00432926|STDs|stds
654129|NCT00432926|Methamphetamine abuse|methamphetamine abuse
654130|NCT00432926|MSM|msm
654131|NCT00432926|HIV Seronegativity|hiv seronegativity
654132|NCT00432913|Eicosapentaenoic acid|eicosapentaenoic acid
654133|NCT00432913|EPA|epa
654134|NCT00432913|EPA 99%|epa 99%
654135|NCT00432913|Fatty acid|fatty acid
654136|NCT00432913|omega-3|omega-3
654137|NCT00432913|apoptosis|apoptosis
654138|NCT00432913|cell proliferation|cell proliferation
654139|NCT00432913|colonic mucosa|colonic mucosa
654140|NCT00432913|polyps|polyps
654141|NCT00432913|adenomatous polyps|adenomatous polyps
654142|NCT00432913|endoscopy|endoscopy
654143|NCT00432913|PUFA|pufa
654144|NCT00432900|Inflammation|inflammation
654145|NCT00432900|Neuroimmunology|neuroimmunology
654146|NCT00432900|Multiple Sclerosis|multiple sclerosis
654147|NCT00432900|MS|ms
654148|NCT00432900|Healthy Volunteer|healthy volunteer
654149|NCT00432900|HV|hv
654150|NCT00432887|caffeine|caffeine
654151|NCT00432887|coffee|coffee
654152|NCT00432887|glucose|glucose
654153|NCT00432887|insulin|insulin
654154|NCT00432861|cystic fibrosis|cystic fibrosis
654155|NCT00432861|pancreatic insufficiency|pancreatic insufficiency
654156|NCT00432861|PANCRECARB® MS-16 (pancrelipase)|pancrecarb® ms-16 (pancrelipase)
654157|NCT00432861|steatorrhea|steatorrhea
654158|NCT00432835|Nausea|nausea
654159|NCT00432835|Vomiting|vomiting
654160|NCT00432835|Delayed gastric emptying|delayed gastric emptying
654161|NCT00432835|Diabetes Mellitus|diabetes mellitus
654162|NCT00432835|Post-Surgical|post-surgical
654163|NCT00432835|Idiopathic|idiopathic
654164|NCT00432822|phenylketonuria|phenylketonuria
654165|NCT00432822|phenylalanine hydroxylase deficiency|phenylalanine hydroxylase deficiency
654166|NCT00432822|BH4|bh4
654167|NCT00432822|responsive|responsive
654168|NCT00432822|tetrahydrobiopterin|tetrahydrobiopterin
654169|NCT00432822|newborns|newborns
654170|NCT00432822|infants|infants
654171|NCT00432822|children|children
654172|NCT00432822|adolescents|adolescents
654173|NCT00432809|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
654174|NCT00432809|Obesity|obesity
654175|NCT00432796|Anticoagulation|anticoagulation
654176|NCT00432796|Prosthetic heart valves|prosthetic heart valves
654177|NCT00432796|Atrial fibrillation|atrial fibrillation
654178|NCT00432796|Bridging Therapy|bridging therapy
654179|NCT00432796|Thromboembolism|thromboembolism
654180|NCT00432796|Warfarin|warfarin
654181|NCT00432796|Low Molecular Weight Heparin|low molecular weight heparin
654456|NCT00431743|Colloid|colloid
654182|NCT00432783|HIV, antiretroviral therapy, adherence, ritonavir|hiv, antiretroviral therapy, adherence, ritonavir
654183|NCT00432757|allergic conjunctivitis, ophthalmology, multicenter, controlled|allergic conjunctivitis, ophthalmology, multicenter, controlled
654184|NCT00432744|mitochondrial diseases|mitochondrial diseases
654185|NCT00432744|respiratory chain complex I deficiencies|respiratory chain complex i deficiencies
654186|NCT00432744|respiratory chain complex II deficiencies|respiratory chain complex ii deficiencies
654187|NCT00432744|respiratory chain complex III deficiencies|respiratory chain complex iii deficiencies
654188|NCT00432744|respiratory chain complex IV deficiencies|respiratory chain complex iv deficiencies
654189|NCT00432744|mutations of a gene coding for a respiratory chain component|mutations of a gene coding for a respiratory chain component
654190|NCT00432731|Prevention of : Varicella|prevention of : varicella
654191|NCT00432731|Measles|measles
654192|NCT00432731|Mumps|mumps
654193|NCT00432731|Rubella|rubella
654194|NCT00432718|Pneumonia|pneumonia
654195|NCT00432718|Ventilator Associated Pneumonia|ventilator associated pneumonia
654196|NCT00432718|Prevention|prevention
654197|NCT00432705|ankle|ankle
654198|NCT00432705|sensorimotor|sensorimotor
654199|NCT00432705|reflex|reflex
654200|NCT00432705|training|training
654201|NCT00432692|osteoporosis|osteoporosis
654202|NCT00432692|falls|falls
654203|NCT00432692|prevention|prevention
654204|NCT00432692|elderly|elderly
654205|NCT00432692|exercise|exercise
654206|NCT00432692|incidence|incidence
654207|NCT00432692|obstacle avoidance|obstacle avoidance
654208|NCT00432679|rosiglitazone|rosiglitazone
654209|NCT00432679|Avandia|avandia
654210|NCT00432679|type 2 diabetes mellitus|type 2 diabetes mellitus
654211|NCT00432679|diabetes|diabetes
654212|NCT00432653|ankylosing spondylitis|ankylosing spondylitis
654213|NCT00432653|rituximab|rituximab
654214|NCT00432653|therapy|therapy
654215|NCT00432653|magnetic resonance imaging|magnetic resonance imaging
654216|NCT00432640|(suspected) Non Small Cell Lung Cancer|(suspected) non small cell lung cancer
654217|NCT00432627|Hepatic impairment|hepatic impairment
654218|NCT00432627|adults|adults
654219|NCT00432627|deferasirox|deferasirox
654220|NCT00432614|Mental Disorder|mental disorder
654221|NCT00432614|Mood Disorder|mood disorder
654222|NCT00432614|Depressive Disorder|depressive disorder
654223|NCT00432601|decision aid|decision aid
654224|NCT00432601|prostate cancer|prostate cancer
654225|NCT00432601|patient-physician communication|patient-physician communication
654226|NCT00432601|decision making|decision making
654227|NCT00432601|literacy|literacy
654228|NCT00432588|IUFD|iufd
654229|NCT00432588|POSTTERM|postterm
654230|NCT00432588|ROM|rom
654231|NCT00432575|tobacco use cessation|tobacco use cessation
654232|NCT00432575|cigarette smokers|cigarette smokers
654233|NCT00432549|Medication overuse|medication overuse
654234|NCT00432536|Neuro-monitoring|neuro-monitoring
654235|NCT00432536|Quality Improvement|quality improvement
654236|NCT00432536|Cerebral emboli|cerebral emboli
654237|NCT00432536|Cerebral desaturation|cerebral desaturation
654238|NCT00432536|Hypotension|hypotension
654239|NCT00432523|Prevention of : Measles, Mumps, Rubella and Varicella diseases|prevention of : measles, mumps, rubella and varicella diseases
654240|NCT00432510|Hereditary angioedema|hereditary angioedema
654241|NCT00432510|C1 esterase inhibitor (human)|c1 esterase inhibitor (human)
654242|NCT00432484|Lingzhi|lingzhi
654243|NCT00432484|Sen Miao San|sen miao san
654244|NCT00432484|Rheumatoid Arthritis|rheumatoid arthritis
654245|NCT00432471|Skin Cancer|skin cancer
654246|NCT00432471|Non-Melanoma Skin Cancer|non-melanoma skin cancer
654247|NCT00432471|Optical Imaging|optical imaging
654248|NCT00432471|Multispectral Digital Microscope System|multispectral digital microscope system
654249|NCT00432471|MDM|mdm
654250|NCT00432458|stage I multiple myeloma|stage i multiple myeloma
654251|NCT00432445|Children with retinoblastoma|children with retinoblastoma
654252|NCT00432445|Retinoblastoma|retinoblastoma
654253|NCT00432445|Pediatrics|pediatrics
654254|NCT00432445|Proton Beam Radiation Therapy|proton beam radiation therapy
654255|NCT00432445|Radiation Therapy|radiation therapy
654256|NCT00432445|Tumor of the Eye|tumor of the eye
654257|NCT00432445|Ophthalmic EUA|ophthalmic eua
654258|NCT00432445|Examination under anesthesia|examination under anesthesia
654259|NCT00432445|Bilateral retinoblastoma|bilateral retinoblastoma
654260|NCT00432445|Unilateral retinoblastoma|unilateral retinoblastoma
654261|NCT00432445|Extraocular disease|extraocular disease
654262|NCT00432445|Intraocular procedure|intraocular procedure
654263|NCT00432432|Ankylosing Spondylitis|ankylosing spondylitis
654264|NCT00432432|MTX|mtx
654265|NCT00432432|Infliximab|infliximab
654266|NCT00432419|HIV|hiv
654267|NCT00432419|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
654268|NCT00432419|Peripheral blood stem cells transplantation|peripheral blood stem cells transplantation
654269|NCT00432406|Psoriatic Arthritis|psoriatic arthritis
654270|NCT00432406|TNF-α|tnf-α
654271|NCT00432406|Cardiovascular risk|cardiovascular risk
654272|NCT00432406|Immunomodulatory activities|immunomodulatory activities
654273|NCT00432380|Placebo|placebo
654274|NCT00432380|Double blind|double blind
654275|NCT00432380|Gastroenteritis|gastroenteritis
654276|NCT00432380|Randomized|randomized
654277|NCT00432380|Oral live attenuated human rotavirus liquid vaccine|oral live attenuated human rotavirus liquid vaccine
654278|NCT00432367|Malaria in pregnancy|malaria in pregnancy
654279|NCT00432367|Case management|case management
654280|NCT00432367|Screening|screening
654281|NCT00432367|RDT|rdt
654282|NCT00432367|IPTp|iptp
654283|NCT00432367|Amodiaquine|amodiaquine
654284|NCT00432367|Artesunate|artesunate
654285|NCT00432354|statin|statin
654286|NCT00432354|systemic lupus erythematosus|systemic lupus erythematosus
654287|NCT00432354|microcirculation|microcirculation
654288|NCT00432302|Cancer|cancer
654289|NCT00432302|Tumor|tumor
654290|NCT00432302|Malignancy|malignancy
654291|NCT00432302|Mass Balance|mass balance
654292|NCT00432302|Chemotherapy|chemotherapy
654293|NCT00432302|Drug|drug
654294|NCT00432302|Cancer Treatment|cancer treatment
654295|NCT00432302|Intravenous Infusion|intravenous infusion
654296|NCT00432302|Epothilone|epothilone
654297|NCT00432302|Solid Tumor|solid tumor
654298|NCT00432289|neurological function|neurological function
654299|NCT00432276|Glucose Metabolism Disorder|glucose metabolism disorder
654300|NCT00432276|Dysmetabolic Syndrome|dysmetabolic syndrome
654301|NCT00432276|Type II Diabetes|type ii diabetes
654302|NCT00432276|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
654303|NCT00432276|Dyslipidemia|dyslipidemia
654304|NCT00432276|Hyperglycemia|hyperglycemia
654305|NCT00432276|Drug Therapy|drug therapy
654306|NCT00432250|Preterm labor|preterm labor
654307|NCT00432250|Cervical ultrasonography|cervical ultrasonography
654308|NCT00432250|Hospital stay|hospital stay
654309|NCT00432198|Insomnia|insomnia
654310|NCT00432198|Zolpidem|zolpidem
654311|NCT00432198|Adolescent|adolescent
654312|NCT00432185|sBCC|sbcc
654313|NCT00432185|Topical|topical
654314|NCT00432185|Dermatology|dermatology
654315|NCT00432172|Her2neu negative breast cancer.|her2neu negative breast cancer.
654316|NCT00432172|Neoadjuvant treatment.|neoadjuvant treatment.
654317|NCT00432159|cervical|cervical
654318|NCT00432159|spinal|spinal
654319|NCT00432159|arthroplasty|arthroplasty
654320|NCT00432159|disc|disc
654321|NCT00432159|surgical|surgical
654322|NCT00432159|ACDF|acdf
654323|NCT00432159|DDD|ddd
654324|NCT00432146|Graves' disease, Lugol's solution|graves' disease, lugol's solution
654325|NCT00432133|Physical Activity|physical activity
654326|NCT00432133|Behavior Change|behavior change
654327|NCT00432133|Mechanism|mechanism
654328|NCT00432133|Environmental|environmental
654329|NCT00432133|Ecological Model of Physical Activity|ecological model of physical activity
654330|NCT00432107|Advanced cutaneous melanoma|advanced cutaneous melanoma
654331|NCT00432107|Phase II study|phase ii study
654332|NCT00432094|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
654333|NCT00432094|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
654334|NCT00432094|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
654335|NCT00432094|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
654336|NCT00432094|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
654337|NCT00432094|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
654338|NCT00432094|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
654339|NCT00432094|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
654340|NCT00432094|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
654341|NCT00432094|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
654342|NCT00432094|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
654343|NCT00432094|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
654344|NCT00432094|testicular choriocarcinoma|testicular choriocarcinoma
654345|NCT00432094|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
654346|NCT00432094|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
654347|NCT00432094|testicular embryonal carcinoma|testicular embryonal carcinoma
654348|NCT00432094|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
654349|NCT00432094|testicular yolk sac tumor|testicular yolk sac tumor
654350|NCT00432094|testicular seminoma|testicular seminoma
654351|NCT00432094|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
654352|NCT00432094|stage IV extragonadal seminoma|stage iv extragonadal seminoma
654353|NCT00432094|stage I extragonadal non-seminomatous germ cell tumor|stage i extragonadal non-seminomatous germ cell tumor
654354|NCT00432094|stage I extragonadal seminoma|stage i extragonadal seminoma
654355|NCT00432094|stage II extragonadal non-seminomatous germ cell tumor|stage ii extragonadal non-seminomatous germ cell tumor
654356|NCT00432094|stage II extragonadal seminoma|stage ii extragonadal seminoma
654357|NCT00432094|stage III extragonadal non-seminomatous germ cell tumor|stage iii extragonadal non-seminomatous germ cell tumor
654358|NCT00432094|stage III extragonadal seminoma|stage iii extragonadal seminoma
654359|NCT00432094|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
654360|NCT00432094|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
654361|NCT00432094|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
654362|NCT00432094|adult teratoma|adult teratoma
654363|NCT00432094|childhood teratoma|childhood teratoma
654364|NCT00432094|testicular immature teratoma|testicular immature teratoma
654365|NCT00432094|testicular mature teratoma|testicular mature teratoma
654366|NCT00432094|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
654367|NCT00432094|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
654368|NCT00432081|Dementia|dementia
654369|NCT00432081|Inflammation|inflammation
654370|NCT00432081|Anti-Inflammatory Agents|anti-inflammatory agents
654371|NCT00432081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
654372|NCT00432081|Drug Therapy|drug therapy
654373|NCT00432068|Healthy volunteers|healthy volunteers
654374|NCT00432068|octreotide pamoate|octreotide pamoate
654375|NCT00432068|pharmacokinetics|pharmacokinetics
654376|NCT00432055|Adult|adult
654377|NCT00432055|Cerebral Palsy|cerebral palsy
654378|NCT00432055|Spastic contractures|spastic contractures
654379|NCT00432055|Botulinum toxin type A|botulinum toxin type a
654380|NCT00432042|Mumps and Rubella|mumps and rubella
654381|NCT00432042|Haemophilus influenzae type b (Infanrix® hexa)|haemophilus influenzae type b (infanrix® hexa)
654382|NCT00432029|Flicker induced vasodilatation|flicker induced vasodilatation
654383|NCT00432029|Flow mediated vasodilatation|flow mediated vasodilatation
654384|NCT00432029|Forearm blood flow|forearm blood flow
654385|NCT00432029|Retinal vessel diameter|retinal vessel diameter
654386|NCT00432029|Endothelial dysfunction|endothelial dysfunction
654387|NCT00432016|HIV|hiv
654388|NCT00432016|pharmacokinetics|pharmacokinetics
654389|NCT00432016|zidovudine|zidovudine
654390|NCT00432016|amdoxovir|amdoxovir
654391|NCT00432016|DAPD|dapd
654392|NCT00432016|AMDX|amdx
654393|NCT00432016|Treatment Naive|treatment naive
654394|NCT00432003|Treatment Experienced|treatment experienced
654395|NCT00432003|HIV|hiv
654396|NCT00432003|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
654397|NCT00431977|Coronary Atherosclerosis|coronary atherosclerosis
654398|NCT00431977|Diabetes Mellitus|diabetes mellitus
654399|NCT00431964|azithromycin, Zithromax|azithromycin, zithromax
654400|NCT00431951|Healthy Volunteers|healthy volunteers
654401|NCT00431925|head and neck cancer|head and neck cancer
654402|NCT00431925|radiation therapy|radiation therapy
654403|NCT00431925|chemotherapy|chemotherapy
654404|NCT00431925|mucositis|mucositis
654405|NCT00431925|cytokines|cytokines
654406|NCT00431925|gastrostomy|gastrostomy
654407|NCT00431925|radiotherapy|radiotherapy
654408|NCT00431912|cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
654409|NCT00431912|mycosis fungoides|mycosis fungoides
654410|NCT00431912|Sézary syndrome|sézary syndrome
654411|NCT00431912|APO866|apo866
654412|NCT00431912|phase II study|phase ii study
654413|NCT00431899|nutrition|nutrition
654414|NCT00431899|omega 3 fatty acids|omega 3 fatty acids
654415|NCT00431899|insulin resistance|insulin resistance
654416|NCT00431886|Chest pains|chest pains
654417|NCT00431886|Computed tomography|computed tomography
654418|NCT00431886|Emergency|emergency
654419|NCT00431873|Lymphocytic Leukemia, Chronic (Refractory)|lymphocytic leukemia, chronic (refractory)
654420|NCT00431873|Phase II|phase ii
654421|NCT00431860|Coronary atherosclerosis, Spiral Computed Tomography|coronary atherosclerosis, spiral computed tomography
654422|NCT00431847|Anesthesia, Regional|anesthesia, regional
654423|NCT00431847|Causalgia|causalgia
654424|NCT00431847|Trauma|trauma
654425|NCT00431847|Complex Regional Pain Syndrome Type II|complex regional pain syndrome type ii
654426|NCT00431847|Neuropathic Pain|neuropathic pain
654427|NCT00431847|PTSD|ptsd
654428|NCT00431847|Combat Stress Disorders|combat stress disorders
654429|NCT00431847|Afghan War, 2001-|afghan war, 2001-
654430|NCT00431847|Iraq War, 2003-|iraq war, 2003-
654431|NCT00431834|Permanent Atrial Fibrillation Surgical RF Ablation|permanent atrial fibrillation surgical rf ablation
654432|NCT00431834|Permanent Atrial Fibrillation|permanent atrial fibrillation
654433|NCT00431821|Exercise|exercise
654434|NCT00431821|Rehabilitation|rehabilitation
654435|NCT00431821|Stroke|stroke
654436|NCT00431808|Malaria|malaria
654437|NCT00431808|vaccine|vaccine
654438|NCT00431808|Apical Membrane Antigene|apical membrane antigene
654439|NCT00431808|Mali|mali
654440|NCT00431808|Adults|adults
654441|NCT00431795|Advanced breast cancer|advanced breast cancer
654442|NCT00431795|Pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
654443|NCT00431795|Epirubicin|epirubicin
654444|NCT00431782|Atrial fibrillation|atrial fibrillation
654445|NCT00431782|Anticoagulation|anticoagulation
654446|NCT00431769|Multiple myeloma|multiple myeloma
654447|NCT00431769|Bortezomib|bortezomib
654448|NCT00431769|Dexamethasone|dexamethasone
654449|NCT00431769|VELCADE|velcade
654450|NCT00431756|Barrett's esophagus|barrett's esophagus
654451|NCT00431756|gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
654452|NCT00431756|esophageal cancer|esophageal cancer
654453|NCT00431756|DNA methylation|dna methylation
654454|NCT00431743|Fluid Therapy|fluid therapy
654455|NCT00431743|Crystalloid|crystalloid
654457|NCT00431743|Perioperative|perioperative
654458|NCT00431743|Optimization|optimization
654459|NCT00431743|Goal-directed Therapy|goal-directed therapy
654460|NCT00431717|Coronary Atherosclerosis|coronary atherosclerosis
654461|NCT00431717|Diabetes Mellitus|diabetes mellitus
654462|NCT00431704|advanced|advanced
654463|NCT00431704|her-2 positive|her-2 positive
654464|NCT00431678|Community-acquired Pneumonia|community-acquired pneumonia
654465|NCT00431665|Renal Plasma Flow|renal plasma flow
654466|NCT00431665|Glomerular Filtration Rate|glomerular filtration rate
654467|NCT00431665|Free fatty acids|free fatty acids
654468|NCT00431639|Animal-Assisted Therapy|animal-assisted therapy
654469|NCT00431639|Pain|pain
654470|NCT00431639|Oncology|oncology
654471|NCT00431639|Cancer Pain|cancer pain
654472|NCT00431626|Benign|benign
654473|NCT00431626|Prostatic|prostatic
654474|NCT00431626|Hyperplasia|hyperplasia
654475|NCT00431626|Lower|lower
654476|NCT00431626|Urinary|urinary
654477|NCT00431626|Track|track
654478|NCT00431626|Symptoms|symptoms
654479|NCT00431626|Laser|laser
654480|NCT00431626|Transurethral|transurethral
654481|NCT00431626|Prostate|prostate
654482|NCT00431613|NSCLC|nsclc
654483|NCT00431613|Induction chemotherapy|induction chemotherapy
654484|NCT00431613|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
654485|NCT00431613|Consolidation therapy|consolidation therapy
654486|NCT00431613|Docetaxel|docetaxel
654487|NCT00431613|Gemcitabine|gemcitabine
654488|NCT00431613|Carboplatin|carboplatin
654489|NCT00431600|Regional Blood Flow|regional blood flow
654490|NCT00431600|Color Doppler Optical Coherence Tomography|color doppler optical coherence tomography
654491|NCT00431600|CDOCT|cdoct
654492|NCT00431600|Retinal Blood Flow|retinal blood flow
654493|NCT00431600|Hyperoxia|hyperoxia
654494|NCT00431600|Vasoconstriction|vasoconstriction
654495|NCT00431600|Laser Doppler Velocimetry|laser doppler velocimetry
654496|NCT00431600|Retinal Vessel Analyzer|retinal vessel analyzer
654497|NCT00431587|morbid obesity|morbid obesity
654498|NCT00431587|metabolic syndrome|metabolic syndrome
654499|NCT00431587|visceral fat|visceral fat
654500|NCT00431587|peripheral fat|peripheral fat
654501|NCT00431574|schizophrenia|schizophrenia
654502|NCT00431574|schizoaffective|schizoaffective
654503|NCT00431574|antipsychotic|antipsychotic
654504|NCT00431574|randomized control trial|randomized control trial
654505|NCT00431561|Glioblastoma|glioblastoma
654506|NCT00431561|Anaplastic astrocytoma|anaplastic astrocytoma
654507|NCT00431561|Antisense|antisense
654508|NCT00431561|Cancer|cancer
654509|NCT00431561|Transforming growth factor beta2 (TGF-beta2)|transforming growth factor beta2 (tgf-beta2)
654510|NCT00431561|Targeted therapy|targeted therapy
654511|NCT00431561|Immunotherapy|immunotherapy
654512|NCT00431561|Brain tumor|brain tumor
654513|NCT00431561|Central nervous system (CNS)|central nervous system (cns)
654514|NCT00431561|Convection-enhanced delivery (CED) / microperfusion|convection-enhanced delivery (ced) / microperfusion
654515|NCT00431561|Locoregional application|locoregional application
654516|NCT00431535|Fluid|fluid
654517|NCT00431535|SvO2|svo2
654518|NCT00431535|Mobilisation|mobilisation
654519|NCT00431535|Orthostatic function|orthostatic function
654520|NCT00431509|Osteoarthritis|osteoarthritis
654521|NCT00431509|Arthroplasty|arthroplasty
654522|NCT00431509|Replacement|replacement
654523|NCT00431509|Knee|knee
654524|NCT00431509|Instrumentation|instrumentation
654525|NCT00431496|Anemia|anemia
654526|NCT00431496|Intact Parathyroid Hormone (iPTH)|intact parathyroid hormone (ipth)
654527|NCT00431496|Secondary Hyperparathyroidism (SHPT)|secondary hyperparathyroidism (shpt)
654528|NCT00431483|antibacterial agents|antibacterial agents
654529|NCT00431483|surgery|surgery
654530|NCT00431483|pharmacist|pharmacist
654531|NCT00431483|economics, pharmaceutical|economics, pharmaceutical
654532|NCT00431470|Classroom violence, character, bullying, self esteem|classroom violence, character, bullying, self esteem
654533|NCT00431444|Osteoporosis|osteoporosis
654534|NCT00431444|Post-menopausal|post-menopausal
654535|NCT00431444|Bone mineral density|bone mineral density
654536|NCT00431405|rheumatoid arthritis|rheumatoid arthritis
654537|NCT00431405|cardiovascular disease|cardiovascular disease
654538|NCT00431405|coronary disease|coronary disease
654539|NCT00431392|Choroidal blood flow|choroidal blood flow
654540|NCT00431392|NO-synthase|no-synthase
654541|NCT00431392|light/dark transition|light/dark transition
654542|NCT00431366|Fatigue|fatigue
654543|NCT00431366|Repetitive TMS (rTMS)|repetitive tms (rtms)
654544|NCT00431366|Parkinson's Disease|parkinson's disease
654545|NCT00431366|Peg Board Test|peg board test
654546|NCT00431366|Levodopa|levodopa
654547|NCT00431366|Parkinson Disease|parkinson disease
654548|NCT00431366|PD|pd
654549|NCT00431340|Multiple myeloma|multiple myeloma
654550|NCT00431340|myeloma|myeloma
654551|NCT00431340|plasma cell myeloma|plasma cell myeloma
654552|NCT00431340|bone marrow cancer|bone marrow cancer
654553|NCT00431340|myelomatosis|myelomatosis
654554|NCT00431340|Kahler's disease|kahler's disease
654555|NCT00431340|PXD101|pxd101
654556|NCT00431340|belinostat|belinostat
654557|NCT00431340|bortezomib|bortezomib
654558|NCT00431327|patient navigator|patient navigator
654559|NCT00431327|peer support|peer support
654560|NCT00431327|colonoscopy|colonoscopy
654561|NCT00431327|adherence|adherence
654562|NCT00431327|None: have to be scheduled for screening or diagnostic colonoscopy|none: have to be scheduled for screening or diagnostic colonoscopy
654563|NCT00431314|End Stage Renal Disease|end stage renal disease
654564|NCT00431314|Hemodialysis|hemodialysis
654565|NCT00431314|Critical Limb Ischemia|critical limb ischemia
654566|NCT00431314|Autofluorescence|autofluorescence
654567|NCT00431301|Progressive Supranuclear Palsy|progressive supranuclear palsy
654568|NCT00431301|Epidemiology|epidemiology
654569|NCT00431301|Case-Control|case-control
654570|NCT00431301|Genetic|genetic
654571|NCT00431301|Environmental|environmental
654572|NCT00431301|Neurodegenerative Disease|neurodegenerative disease
654573|NCT00431301|Movement Disorders|movement disorders
654574|NCT00431301|Atypical Parkinsonism|atypical parkinsonism
654575|NCT00431301|Parkinson Plus|parkinson plus
654576|NCT00431301|Steele-Richardson-Olszewski|steele-richardson-olszewski
654577|NCT00431301|PSP|psp
654578|NCT00431288|nutrition|nutrition
654579|NCT00431288|adolescent nutrition|adolescent nutrition
654580|NCT00431288|blood pressure|blood pressure
654581|NCT00431288|hypertension|hypertension
654582|NCT00431288|diet therapy|diet therapy
654583|NCT00431288|patient education|patient education
654584|NCT00431262|alcoholism|alcoholism
654585|NCT00431262|antabuse|antabuse
654586|NCT00431262|disulfiram|disulfiram
654587|NCT00431262|abstinence|abstinence
654588|NCT00431262|cognitive behavioural therapy|cognitive behavioural therapy
654589|NCT00431236|cisplatin|cisplatin
654590|NCT00431236|CINV|cinv
654591|NCT00431236|highly emetogenic|highly emetogenic
654592|NCT00431223|fMRI|fmri
654593|NCT00431223|working memory|working memory
654594|NCT00431223|schizophrenia|schizophrenia
654595|NCT00431223|treatment refractory|treatment refractory
654596|NCT00431223|cognitive skills training|cognitive skills training
654597|NCT00431223|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
654598|NCT00431223|cognitive remediation|cognitive remediation
654599|NCT00431223|treatment refractory schizophrenia of > 5 years duration|treatment refractory schizophrenia of > 5 years duration
654600|NCT00431210|NPC|npc
654601|NCT00431210|EPV|epv
654602|NCT00431184|bipolar disorder|bipolar disorder
654603|NCT00431184|bipolar mania|bipolar mania
654604|NCT00431184|schizoaffective disorder|schizoaffective disorder
654605|NCT00431184|schizoaffective mania|schizoaffective mania
654606|NCT00431184|mania|mania
654607|NCT00431184|kappa opiates|kappa opiates
654608|NCT00431184|opiates|opiates
654609|NCT00431171|spinal cord injuries|spinal cord injuries
654610|NCT00431171|lithium|lithium
654611|NCT00431158|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
654612|NCT00431158|ARDS|ards
654613|NCT00431158|Respiratory failure|respiratory failure
654614|NCT00431158|Mechanical Ventilation|mechanical ventilation
654615|NCT00431158|Positive end expiratory pressure|positive end expiratory pressure
654616|NCT00431158|Lung recruitment maneuver|lung recruitment maneuver
654617|NCT00431119|bullous autoimmune disease|bullous autoimmune disease
654618|NCT00431119|bullous pemphigoid|bullous pemphigoid
654619|NCT00431119|immunosuppressants|immunosuppressants
654620|NCT00431119|corticosteroids|corticosteroids
654621|NCT00431119|mycophenolate mofetil|mycophenolate mofetil
654622|NCT00431106|Breast cancer|breast cancer
654623|NCT00431106|Chemotherapy|chemotherapy
654624|NCT00431106|Vinorelbine|vinorelbine
654625|NCT00431106|Gemcitabine|gemcitabine
654626|NCT00431106|Capecitabine|capecitabine
654627|NCT00431080|Early breast cancer|early breast cancer
654628|NCT00431080|Axillary node positive|axillary node positive
654629|NCT00431080|Adjuvant chemotherapy|adjuvant chemotherapy
654630|NCT00431080|Dose dense|dose dense
654631|NCT00431080|Docetaxel|docetaxel
654632|NCT00431080|Paclitaxel|paclitaxel
654633|NCT00431080|FEC|fec
654634|NCT00431054|Ovarian Cancer|ovarian cancer
654635|NCT00431054|Fallopian Tube Cancer|fallopian tube cancer
654636|NCT00431054|Peritoneal Cancer|peritoneal cancer
654637|NCT00431054|Perifosine|perifosine
654638|NCT00431054|Docetaxel|docetaxel
654639|NCT00431054|Taxotere|taxotere
654640|NCT00431041|Solifenacin succinate|solifenacin succinate
654641|NCT00431041|Oxybutynin immediate release|oxybutynin immediate release
654642|NCT00431041|Xerostomia|xerostomia
654643|NCT00431041|Overactive bladder|overactive bladder
654644|NCT00431028|Cataract|cataract
654645|NCT00431028|Endophthalmitis|endophthalmitis
654646|NCT00431028|Antibiotics|antibiotics
654647|NCT00431028|Anti-Inflammatory Agents|anti-inflammatory agents
654648|NCT00431028|Drug Delivery Systems|drug delivery systems
654649|NCT00431015|Lung Cancer|lung cancer
654650|NCT00431015|Cancer of the lung|cancer of the lung
654651|NCT00431015|Non-small cell lung cancer|non-small cell lung cancer
654652|NCT00431002|Exercise|exercise
654653|NCT00431002|Resistance training|resistance training
654654|NCT00430989|Anaesthesia|anaesthesia
654655|NCT00430989|Major Surgery|major surgery
654656|NCT00430989|Coronary artery disease|coronary artery disease
654657|NCT00430989|Nitrous oxide|nitrous oxide
654658|NCT00430989|Effects of Nitrous Oxide following Anaesthesia|effects of nitrous oxide following anaesthesia
654659|NCT00430989|Anaesthesia and coronary artery disease|anaesthesia and coronary artery disease
654660|NCT00430976|psychomotor function|psychomotor function
654661|NCT00430976|neuromuscular system|neuromuscular system
654662|NCT00430976|memory|memory
654663|NCT00430976|brain electrical activity|brain electrical activity
654664|NCT00430976|Mental Processes|mental processes
654665|NCT00430950|Moderate-to-Severe Hypertension|moderate-to-severe hypertension
654666|NCT00430950|Essential Hypertension|essential hypertension
654667|NCT00430950|Combination Therapy|combination therapy
654668|NCT00430950|Fixed-Combination Dose|fixed-combination dose
654669|NCT00430937|Complicated Skin and Soft Tissue Infections. Daptomycin, Vancomycin, Teicoplanin|complicated skin and soft tissue infections. daptomycin, vancomycin, teicoplanin
654670|NCT00430937|Complicated skin and soft tissue infections|complicated skin and soft tissue infections
654671|NCT00430924|Kidney Failure, Chronic|kidney failure, chronic
654672|NCT00430924|Proteinuria|proteinuria
654673|NCT00430924|Aldosterone|aldosterone
654674|NCT00430924|Renin-Angiotensin System|renin-angiotensin system
654675|NCT00430911|malignant gliomas|malignant gliomas
654676|NCT00430898|ulcerative colitis basiliximab|ulcerative colitis basiliximab
654677|NCT00430885|Heart failure|heart failure
654678|NCT00430885|Myocardial infarction|myocardial infarction
654679|NCT00430885|Patients with acute myocardial infarction|patients with acute myocardial infarction
654680|NCT00430872|Spinal Cord Tumor|spinal cord tumor
654681|NCT00430872|Intramedullary Spinal Cord Tumor|intramedullary spinal cord tumor
654682|NCT00430872|Extramedullary Spinal Cord Tumor|extramedullary spinal cord tumor
654683|NCT00430872|Symptoms|symptoms
654684|NCT00430872|Survey|survey
654685|NCT00430859|Sepsis|sepsis
654686|NCT00430859|Alkaline|alkaline
654687|NCT00430859|Phosphatase|phosphatase
654688|NCT00430859|Lipopolysaccharide|lipopolysaccharide
654689|NCT00430846|Antigens,CD30|antigens,cd30
654690|NCT00430846|Antibody-Drug Conjugate|antibody-drug conjugate
654691|NCT00430846|Antibodies, Monoclonal|antibodies, monoclonal
654692|NCT00430846|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
654693|NCT00430846|Disease, Hodgkin|disease, hodgkin
654694|NCT00430846|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
654695|NCT00430846|Hematologic Diseases|hematologic diseases
654696|NCT00430846|Lymphoma|lymphoma
654697|NCT00430820|Biomarkers|biomarkers
654698|NCT00430820|Proteomics|proteomics
654699|NCT00430820|Mass spectrometry|mass spectrometry
654700|NCT00430820|Atherosclerosis|atherosclerosis
654701|NCT00430820|Acute coronary syndromes|acute coronary syndromes
654702|NCT00430820|Myocardial infarction|myocardial infarction
654703|NCT00430820|Coronary artery disease|coronary artery disease
654704|NCT00430807|giant cell arteritis,|giant cell arteritis,
654705|NCT00430807|hydroxychloroquine,|hydroxychloroquine,
654706|NCT00430807|corticosteroid sparing,|corticosteroid sparing,
654707|NCT00430807|corticodependence|corticodependence
654708|NCT00430794|resistant hypertension|resistant hypertension
654709|NCT00430794|Spironolactone|spironolactone
654710|NCT00430794|double-blind|double-blind
654711|NCT00430794|randomised controlled trial|randomised controlled trial
654712|NCT00430794|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
654713|NCT00430781|pazopanib|pazopanib
654714|NCT00430781|ErB1/ErB2|erb1/erb2
654715|NCT00430781|lapatinib|lapatinib
654716|NCT00430781|persistent|persistent
654717|NCT00430781|VEGF|vegf
654718|NCT00430781|recurrent|recurrent
654719|NCT00430781|metastatic cervical cancer|metastatic cervical cancer
654720|NCT00430781|advanced|advanced
654721|NCT00430781|FIGO Stage IVB|figo stage ivb
654722|NCT00430768|Gene Transfer Techniques|gene transfer techniques
654723|NCT00430768|Gene Therapy|gene therapy
654724|NCT00430768|AAV|aav
654725|NCT00430768|AAT|aat
654726|NCT00430768|Phase I|phase i
654727|NCT00430768|Intramuscular transfer|intramuscular transfer
654728|NCT00430729|Roflumilast|roflumilast
654729|NCT00430703|severe traumatic brain injury|severe traumatic brain injury
654730|NCT00430703|body weight support treadmill training|body weight support treadmill training
654731|NCT00430703|Electroencephalogram|electroencephalogram
654732|NCT00430703|Event Related Potentials|event related potentials
654733|NCT00430664|pleurodesis|pleurodesis
654734|NCT00430664|talc|talc
654735|NCT00430664|iodopovidone|iodopovidone
654736|NCT00430651|Non Small Cell Lung Cancer|non small cell lung cancer
654737|NCT00430651|2nd line chemotherapy|2nd line chemotherapy
654738|NCT00430651|Docetaxel|docetaxel
654739|NCT00430638|Hypertension|hypertension
654740|NCT00430638|Angiotensin Receptor Blocker|angiotensin receptor blocker
654741|NCT00430638|Calcium Channel Blocker|calcium channel blocker
654742|NCT00430638|Angiotensin Converting Enzyme Inhibitor|angiotensin converting enzyme inhibitor
654743|NCT00430638|Hydrochlorothiazide|hydrochlorothiazide
654744|NCT00430638|Stage I and II Hypertension|stage i and ii hypertension
654745|NCT00430625|VPRIV®|vpriv®
654746|NCT00430625|Enzyme Replacement Therapy|enzyme replacement therapy
654747|NCT00430625|Gaucher disease|gaucher disease
654748|NCT00430625|glucocerebrosidase|glucocerebrosidase
655908|NCT00426556|trastuzumab|trastuzumab
654749|NCT00430625|beta-glucocerebrosidase|beta-glucocerebrosidase
654750|NCT00430625|Acid beta-glucocerebrosidase|acid beta-glucocerebrosidase
654751|NCT00430625|glucosylceramidase|glucosylceramidase
654752|NCT00430625|D-glucosyl-N-acylsphingosine glucohydrolase|d-glucosyl-n-acylsphingosine glucohydrolase
654753|NCT00430625|gene activation|gene activation
654754|NCT00430625|human|human
654755|NCT00430612|Myocardial Infarction|myocardial infarction
654756|NCT00430612|Heart Attack|heart attack
654757|NCT00430612|Beta Blockers|beta blockers
654758|NCT00430612|Survival|survival
654759|NCT00430573|cognitive-behavior therapy|cognitive-behavior therapy
654760|NCT00430573|d-cycloserine|d-cycloserine
654761|NCT00430573|cognitive enhancer|cognitive enhancer
654762|NCT00430573|drug dependence|drug dependence
654763|NCT00430573|opiate dependence|opiate dependence
654764|NCT00430573|exposure|exposure
654765|NCT00430573|isolated doses of d-cycloserine|isolated doses of d-cycloserine
654766|NCT00430573|isolated doses of matching pill placebo|isolated doses of matching pill placebo
654767|NCT00430573|DCS|dcs
654768|NCT00430560|work therapy|work therapy
654769|NCT00430560|cognitive rehabilitation|cognitive rehabilitation
654770|NCT00430560|schizophrenia|schizophrenia
654771|NCT00430560|schizoaffective disorder|schizoaffective disorder
654772|NCT00430560|treatment outcome|treatment outcome
654773|NCT00430534|Epstein Barr Virus|epstein barr virus
654774|NCT00430534|Belgium|belgium
654775|NCT00430534|Infectious mononucleosis|infectious mononucleosis
654776|NCT00430521|Pandemic Flu|pandemic flu
654777|NCT00430521|Pandemic influenza vaccine (GSK1119711A)|pandemic influenza vaccine (gsk1119711a)
654778|NCT00430508|Moderate-to-Severe Hypertension|moderate-to-severe hypertension
654779|NCT00430508|Essential Hypertension|essential hypertension
654780|NCT00430508|Combination Therapy|combination therapy
654781|NCT00430508|Fixed-Combination Dose|fixed-combination dose
654782|NCT00430495|atacicept|atacicept
654783|NCT00430495|arthritis|arthritis
654784|NCT00430482|Substance Dependence|substance dependence
654785|NCT00430482|Cognitive-Behavior Therapy|cognitive-behavior therapy
654786|NCT00430482|Opiate Dependence|opiate dependence
654787|NCT00430482|Treatment Moderators|treatment moderators
654788|NCT00430469|Lactoferrin|lactoferrin
654789|NCT00430469|hLF|hlf
654790|NCT00430469|Neutropenia|neutropenia
654791|NCT00430469|Myeloablative|myeloablative
654792|NCT00430469|Treatment|treatment
654793|NCT00430469|Fungal|fungal
654794|NCT00430469|Bacterial|bacterial
654795|NCT00430469|Infections|infections
654796|NCT00430469|Bone marrow transplant|bone marrow transplant
654797|NCT00430456|Aerobic exercise|aerobic exercise
654798|NCT00430456|Balance, postural|balance, postural
654799|NCT00430456|Cardiovascular deconditioning|cardiovascular deconditioning
654800|NCT00430456|Gait|gait
654801|NCT00430456|MRI, functional|mri, functional
654802|NCT00430456|Physical therapy techniques|physical therapy techniques
654803|NCT00430456|Self Efficacy|self efficacy
654804|NCT00430456|Treadmill test|treadmill test
654805|NCT00430443|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
654806|NCT00430443|Acute Myelogenous Leukemia|acute myelogenous leukemia
654807|NCT00430443|Annamycin|annamycin
654808|NCT00430443|Liposomal Annamycin|liposomal annamycin
654809|NCT00430417|Pregnancy|pregnancy
654810|NCT00430417|Lactation|lactation
654811|NCT00430417|Endocrine System Diseases|endocrine system diseases
654812|NCT00430417|MusculoSkeletal System Disease|musculoskeletal system disease
654813|NCT00430417|Hormone|hormone
654814|NCT00430417|Physiologic Properties|physiologic properties
654815|NCT00430391|DVD|dvd
654816|NCT00430391|Multi-media|multi-media
654817|NCT00430391|Schizophrenia|schizophrenia
654818|NCT00430391|Normal Comparison|normal comparison
654819|NCT00430391|Consent procedures|consent procedures
654820|NCT00430378|Xerostomia|xerostomia
654821|NCT00430378|Dry Mouth|dry mouth
654822|NCT00430378|Mouth Dryness|mouth dryness
654823|NCT00430378|Nasopharyngeal Cancer|nasopharyngeal cancer
654824|NCT00430378|Acupuncture|acupuncture
654825|NCT00430365|Myeloma|myeloma
654826|NCT00430365|Revlimid|revlimid
654827|NCT00430365|Maintenance therapy|maintenance therapy
654828|NCT00430365|Autologous Stem Cell Transplantation|autologous stem cell transplantation
654829|NCT00430313|Nausea|nausea
654830|NCT00430313|Vomiting|vomiting
654831|NCT00430313|Electro-Stimulation|electro-stimulation
654832|NCT00430313|ES|es
654833|NCT00430313|K1 Acupuncture Point|k1 acupuncture point
654834|NCT00430313|Yongquan Acupuncture Point|yongquan acupuncture point
654835|NCT00430313|TAI|tai
654836|NCT00430313|transarterial infusion|transarterial infusion
654837|NCT00430313|liver metastasis|liver metastasis
654838|NCT00430313|chemotherapy induced nausea and vomiting|chemotherapy induced nausea and vomiting
654839|NCT00430313|CINV|cinv
654840|NCT00430313|Cisplatin|cisplatin
654841|NCT00430313|Oxaliplatin|oxaliplatin
654842|NCT00430300|Dry Powder for Inhalation|dry powder for inhalation
654843|NCT00430300|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
654844|NCT00430300|Lung Function testing|lung function testing
654845|NCT00430287|primary open angle glaucoma|primary open angle glaucoma
654846|NCT00430287|low tension glaucoma|low tension glaucoma
654847|NCT00430287|pigmentary glaucoma|pigmentary glaucoma
654848|NCT00430287|exfoliative glaucoma|exfoliative glaucoma
654849|NCT00430274|glaucoma|glaucoma
654850|NCT00430274|retinal gliosis-like alterations|retinal gliosis-like alterations
654851|NCT00430274|optical coherence tomography|optical coherence tomography
654852|NCT00430274|automated microperimetry|automated microperimetry
654853|NCT00430261|bronchoalveolar carcinoma|bronchoalveolar carcinoma
654854|NCT00430261|BAC|bac
654855|NCT00430261|adenocarcinoma|adenocarcinoma
654856|NCT00430261|lung cancer|lung cancer
654857|NCT00430261|oral|oral
654858|NCT00430261|Stage IIIB and IV lung cancer|stage iiib and iv lung cancer
654859|NCT00430261|Any bronchoalveolar carcinoma (BAC)|any bronchoalveolar carcinoma (bac)
654860|NCT00430261|Any adenocarcinoma in a never-smoker|any adenocarcinoma in a never-smoker
654861|NCT00430248|tophi|tophi
654862|NCT00430248|hyperuricemia|hyperuricemia
654863|NCT00430248|uric acid|uric acid
654864|NCT00430248|Drug Therapy|drug therapy
654865|NCT00430235|prostate|prostate
654866|NCT00430235|cancer|cancer
654867|NCT00430235|BAY 43-9006|bay 43-9006
654868|NCT00430183|stage I prostate cancer|stage i prostate cancer
654869|NCT00430183|stage IIB prostate cancer|stage iib prostate cancer
654870|NCT00430183|stage IIA prostate cancer|stage iia prostate cancer
654871|NCT00430183|stage III prostate cancer|stage iii prostate cancer
654872|NCT00430183|adenocarcinoma of the prostate|adenocarcinoma of the prostate
654873|NCT00430170|ischemia-reperfusion injury|ischemia-reperfusion injury
654874|NCT00430170|adenosine|adenosine
654875|NCT00430170|dipyridamole|dipyridamole
654876|NCT00430170|caffeine|caffeine
654877|NCT00430157|Vienna Challenge Chamber|vienna challenge chamber
654878|NCT00430157|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
654879|NCT00430157|Inflammation|inflammation
654880|NCT00430118|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
654881|NCT00430118|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
654882|NCT00430118|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
654883|NCT00430118|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
654884|NCT00430105|Vasculitis|vasculitis
654885|NCT00430105|ANCA|anca
654886|NCT00430105|Wegener's granulomatosis|wegener's granulomatosis
654887|NCT00430105|Renal vasculitis|renal vasculitis
654888|NCT00430105|Cyclophosphamide|cyclophosphamide
654889|NCT00430053|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
654890|NCT00430053|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
654891|NCT00430053|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
654892|NCT00430053|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
654893|NCT00430053|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
654894|NCT00430053|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
654895|NCT00430053|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
654896|NCT00430053|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
654897|NCT00430040|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
654898|NCT00430040|Hypertension|hypertension
654899|NCT00430040|Carvedilol CR|carvedilol cr
654900|NCT00430040|Beta-blocker|beta-blocker
654901|NCT00430040|Oxidative stress|oxidative stress
654902|NCT00430040|Inflammation|inflammation
654903|NCT00430040|Vascular benefits|vascular benefits
654904|NCT00430027|Esophageal|esophageal
654905|NCT00430027|Esophagus|esophagus
654906|NCT00430014|Advanced Cancer|advanced cancer
654907|NCT00430014|Relapsed|relapsed
654908|NCT00430014|Atiprimod|atiprimod
654909|NCT00430014|Guanylyl cyclase receptor antagonist|guanylyl cyclase receptor antagonist
654910|NCT00430001|Metastatic breast neoplasm|metastatic breast neoplasm
654911|NCT00429988|breast cancer|breast cancer
654912|NCT00429975|fluorquinolones,|fluorquinolones,
654913|NCT00429975|b-lactams,|b-lactams,
654914|NCT00429975|immunomodulation.|immunomodulation.
654915|NCT00429962|subfoveal choroidal neovascularization (CNV)|subfoveal choroidal neovascularization (cnv)
654916|NCT00429962|age-related macular degeneration|age-related macular degeneration
654917|NCT00429962|ranibizumab monotherapy|ranibizumab monotherapy
654918|NCT00429962|combined verteporfin-therapy|combined verteporfin-therapy
654919|NCT00429962|Lucentis® (ranibizumab)|lucentis® (ranibizumab)
654920|NCT00429962|Visudyne®|visudyne®
654921|NCT00429962|photodynamic therapy|photodynamic therapy
654922|NCT00429949|Dasatinib|dasatinib
654923|NCT00429949|Plateau phase|plateau phase
654924|NCT00429936|Dry Age Related Macular Degeneration|dry age related macular degeneration
654925|NCT00429936|Geographic Atrophy|geographic atrophy
654926|NCT00429910|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
654927|NCT00429910|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
654928|NCT00429910|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
654929|NCT00429910|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
654930|NCT00429897|Hypertension|hypertension
654931|NCT00429897|Low Renin|low renin
655909|NCT00426556|paclitaxel|paclitaxel
654932|NCT00429884|Atrial fibrillation|atrial fibrillation
654933|NCT00429871|Metastatic breast cancer;|metastatic breast cancer;
654934|NCT00429871|First line chemotherapy;|first line chemotherapy;
654935|NCT00429871|Docetaxel;|docetaxel;
654936|NCT00429871|Epirubicin;|epirubicin;
654937|NCT00429871|Capecitabine|capecitabine
654938|NCT00429858|recurrent pancreatic cancer|recurrent pancreatic cancer
654939|NCT00429858|stage III pancreatic cancer|stage iii pancreatic cancer
654940|NCT00429858|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
654941|NCT00429858|stage IV pancreatic cancer|stage iv pancreatic cancer
654942|NCT00429845|HIV|hiv
654943|NCT00429845|HAART|haart
654944|NCT00429845|Nutrition|nutrition
654945|NCT00429845|Dyslipidemia|dyslipidemia
654946|NCT00429832|Nausea, vomiting, antiemetic|nausea, vomiting, antiemetic
654947|NCT00429806|Vaginal atrophy|vaginal atrophy
654948|NCT00429806|DHEA|dhea
654949|NCT00429806|Prasterone|prasterone
654950|NCT00429806|Menopause|menopause
654951|NCT00429780|Leishmaniasis vaccine|leishmaniasis vaccine
654952|NCT00429780|Alum-ALM|alum-alm
654953|NCT00429780|First generation vaccine|first generation vaccine
654954|NCT00429780|Leishmanin positive|leishmanin positive
654955|NCT00429780|Healthy Volunteers|healthy volunteers
654956|NCT00429780|Response to Leishmanin (Leishmanin Skin Test>0)|response to leishmanin (leishmanin skin test>0)
654957|NCT00429780|No History of Cutaneous Leishmaniasis|no history of cutaneous leishmaniasis
654958|NCT00429767|Opioid|opioid
654959|NCT00429767|Cocaine|cocaine
654960|NCT00429767|Drug Self Administration|drug self administration
654961|NCT00429754|Nausea and vomiting after using cytostatic drugs|nausea and vomiting after using cytostatic drugs
654962|NCT00429728|Pharmacokinetics,|pharmacokinetics,
654963|NCT00429728|tolerability,|tolerability,
654964|NCT00429728|healthy,|healthy,
654965|NCT00429728|subjects,|subjects,
654966|NCT00429728|smokers,|smokers,
654967|NCT00429728|non-smokers|non-smokers
654968|NCT00429715|Leishmaniasis vaccine|leishmaniasis vaccine
654969|NCT00429715|Alum-ALM|alum-alm
654970|NCT00429715|First generation vaccine|first generation vaccine
654971|NCT00429715|Healthy volunteers|healthy volunteers
654972|NCT00429715|No response to leishmanin|no response to leishmanin
654973|NCT00429715|No history of cutaneous leishmaniasis|no history of cutaneous leishmaniasis
654974|NCT00429702|nausea|nausea
654975|NCT00429702|vomiting|vomiting
654976|NCT00429702|emetic chemotherapy|emetic chemotherapy
654977|NCT00429702|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
654978|NCT00429689|Male, MDD, Testosterone, DHEA-S,Cortisol|male, mdd, testosterone, dhea-s,cortisol
654979|NCT00429689|Male|male
654980|NCT00429689|18-65|18-65
654981|NCT00429689|Major Depression|major depression
654982|NCT00429676|Randomized|randomized
654983|NCT00429676|Controlled|controlled
654984|NCT00429676|Trial|trial
654985|NCT00429676|Delirium|delirium
654986|NCT00429676|Haloperidol|haloperidol
654987|NCT00429663|distal femur|distal femur
654988|NCT00429663|femur fracture|femur fracture
654989|NCT00429650|Weight maintenance|weight maintenance
654990|NCT00429650|Weight loss|weight loss
654991|NCT00429637|EBC pH|ebc ph
654992|NCT00429637|Airway acidification|airway acidification
654993|NCT00429637|Condensimetry|condensimetry
654994|NCT00429637|ARDS|ards
654995|NCT00429637|RSV|rsv
654996|NCT00429637|ALI|ali
654997|NCT00429637|Airway reconstruction|airway reconstruction
654998|NCT00429624|Neck Pain|neck pain
654999|NCT00429624|Chiropractic manipulation|chiropractic manipulation
655000|NCT00429624|Randomized controlled trial|randomized controlled trial
655001|NCT00429611|biphasic defibrillation|biphasic defibrillation
655002|NCT00429611|inhospital|inhospital
655003|NCT00429611|post-resuscitation myocardial function|post-resuscitation myocardial function
655004|NCT00429611|defibrillation efficacy|defibrillation efficacy
655005|NCT00429611|high energy versus low energy|high energy versus low energy
655006|NCT00429611|cardiac arrest patients|cardiac arrest patients
655007|NCT00429585|tibia fracture|tibia fracture
655008|NCT00429585|proximal tibia|proximal tibia
655009|NCT00429572|Breast Cancer|breast cancer
655010|NCT00429572|PBPC Transplantation|pbpc transplantation
655011|NCT00429572|Stem Cell Infusion|stem cell infusion
655012|NCT00429572|Fludarabine|fludarabine
655013|NCT00429572|Melphalan|melphalan
655014|NCT00429559|Cancer;|cancer;
655015|NCT00429559|Ovarian cancer;|ovarian cancer;
655016|NCT00429559|Recurrent ovarian cancer platinum-resistant|recurrent ovarian cancer platinum-resistant
655017|NCT00429546|Disclosure|disclosure
655018|NCT00429546|Serostatus|serostatus
655019|NCT00429507|Breast Cancer|breast cancer
655020|NCT00429507|Blood Stem Cell|blood stem cell
655021|NCT00429507|Bone Metastases|bone metastases
655022|NCT00429507|Radiation Therapy|radiation therapy
655023|NCT00429507|Gamma Camera|gamma camera
655024|NCT00429507|Sm-EDTMP|sm-edtmp
655025|NCT00429507|Samarium 153-EDTMP|samarium 153-edtmp
655026|NCT00429507|Stem Cell Transplant|stem cell transplant
655027|NCT00429507|Autologous Peripheral Blood Stem Cell Transplantation|autologous peripheral blood stem cell transplantation
655028|NCT00429507|PBSCT|pbsct
655029|NCT00429507|Questionnaire|questionnaire
655030|NCT00429494|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
655031|NCT00429494|GnRH Analogue|gnrh analogue
655032|NCT00429494|Gonadotropin-releasing hormone analogue|gonadotropin-releasing hormone analogue
655033|NCT00429494|GnRH-a|gnrh-a
655034|NCT00429494|Ovarian Function|ovarian function
655035|NCT00429494|Fertility|fertility
655036|NCT00429494|Leuprolide Acetate|leuprolide acetate
655037|NCT00429494|Lupron Depot|lupron depot
655038|NCT00429494|premature ovarian failure|premature ovarian failure
655039|NCT00429494|POF|pof
655040|NCT00429494|Abnormal suppression of menstruation|abnormal suppression of menstruation
655041|NCT00429494|absence of menstruation|absence of menstruation
655042|NCT00429481|Oral live attenuated human rotavirus vaccine|oral live attenuated human rotavirus vaccine
655043|NCT00429481|Gastroenteritis|gastroenteritis
655044|NCT00429481|Vomiting|vomiting
655045|NCT00429455|Fertility|fertility
655046|NCT00429455|Menopause|menopause
655047|NCT00429455|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
655048|NCT00429455|Questionnaire|questionnaire
655049|NCT00429455|Survey|survey
655050|NCT00429442|Simvastatin|simvastatin
655051|NCT00429442|CNS Inflammation|cns inflammation
655052|NCT00429442|Copaxone|copaxone
655053|NCT00429429|Peanut allergy|peanut allergy
655054|NCT00429416|Hematologic Malignancies|hematologic malignancies
655055|NCT00429416|GVHD|gvhd
655056|NCT00429416|Graft-Versus-Host-Disease|graft-versus-host-disease
655057|NCT00429416|LLME|llme
655058|NCT00429416|CD34+ stem cell infusions|cd34+ stem cell infusions
655059|NCT00429416|CD34- fraction|cd34- fraction
655060|NCT00429416|Cyclosporine|cyclosporine
655061|NCT00429416|Mycophenolate Mofetil|mycophenolate mofetil
655062|NCT00429416|HSCT|hsct
655063|NCT00429416|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
655064|NCT00429403|Breast Cancer|breast cancer
655065|NCT00429403|Chemotherapy|chemotherapy
655066|NCT00429403|Ovarian Function|ovarian function
655067|NCT00429403|Goserelin|goserelin
655068|NCT00429403|Zoladex|zoladex
655069|NCT00429403|Ovary function|ovary function
655070|NCT00429403|Fertility|fertility
655071|NCT00429403|Early Menopause|early menopause
655072|NCT00429390|Metabolic syndrome|metabolic syndrome
655073|NCT00429390|Ramadan Fasting|ramadan fasting
655074|NCT00429390|Insulin sensitivity|insulin sensitivity
655075|NCT00429390|Iran|iran
655076|NCT00429377|tacrolimus|tacrolimus
655077|NCT00429377|FK506|fk506
655078|NCT00429377|lupus nephritis|lupus nephritis
655079|NCT00429364|Aortic Root Dissection|aortic root dissection
655080|NCT00429364|Aortic Root Dilation|aortic root dilation
655081|NCT00429364|Pediatric Heart Network|pediatric heart network
655082|NCT00429338|Genitourinary|genitourinary
655083|NCT00429338|Prostate Cancer|prostate cancer
655084|NCT00429338|Magnetic Resonance Imaging|magnetic resonance imaging
655085|NCT00429338|MRI|mri
655086|NCT00429338|Magnetic Resonance Spectroscopic Imaging|magnetic resonance spectroscopic imaging
655087|NCT00429338|MRSI|mrsi
655088|NCT00429338|Endorectal MRSI|endorectal mrsi
655089|NCT00429338|Endorectal magnetic resonance spectroscopy imaging|endorectal magnetic resonance spectroscopy imaging
655090|NCT00429338|3 Tesla|3 tesla
655091|NCT00429338|3T Scan|3t scan
655092|NCT00429338|Endorectal coil|endorectal coil
655093|NCT00429338|Perfluorocarbon compound|perfluorocarbon compound
655094|NCT00429338|PFC|pfc
655095|NCT00429338|PFC-filled endorectal coil|pfc-filled endorectal coil
655096|NCT00429338|PFC-MRSI|pfc-mrsi
655097|NCT00429338|AIR-MRSI|air-mrsi
655098|NCT00429325|acute infectious diarrhea,|acute infectious diarrhea,
655099|NCT00429325|fecal calprotectin,|fecal calprotectin,
655100|NCT00429325|stool culture,|stool culture,
655101|NCT00429325|hemoccult test,|hemoccult test,
655102|NCT00429325|Guaiac fecal occult blood test (FOBT)|guaiac fecal occult blood test (fobt)
655103|NCT00429325|fecal lactoferrin|fecal lactoferrin
655104|NCT00429312|Melanoma|melanoma
655105|NCT00429312|Oncolytic virus|oncolytic virus
655106|NCT00429312|Pexa-Vec|pexa-vec
655107|NCT00429299|neo-adjuvant trastuzumab early breast cancer lapatinib|neo-adjuvant trastuzumab early breast cancer lapatinib
655108|NCT00429286|Health Services Research|health services research
655109|NCT00429273|ADHD|adhd
655110|NCT00429273|Guanfacine|guanfacine
655111|NCT00429273|Methylphenidate|methylphenidate
655112|NCT00429273|Focalin XR|focalin xr
655113|NCT00429273|Pediatric|pediatric
655114|NCT00429273|Cognitive function|cognitive function
655115|NCT00429273|Combination therapy|combination therapy
655116|NCT00429260|depression|depression
655117|NCT00429260|antidepressive agents|antidepressive agents
655118|NCT00429247|Occult tumor cells|occult tumor cells
655119|NCT00429247|Micrometastatic cells|micrometastatic cells
655120|NCT00429247|Cytokeratin-19|cytokeratin-19
655121|NCT00429247|Trastuzumab|trastuzumab
655122|NCT00429247|Completion of Adjuvant Treatment|completion of adjuvant treatment
655123|NCT00429234|Advanced Cancer|advanced cancer
655124|NCT00429234|Solid Tumors|solid tumors
655125|NCT00429234|Dasatinib|dasatinib
655126|NCT00429234|BMS-354825|bms-354825
655127|NCT00429234|Sprycel|sprycel
655128|NCT00429234|Gemcitabine|gemcitabine
656896|NCT00423410|Cancer|cancer
655129|NCT00429234|Gemcitabine Hydrochloride|gemcitabine hydrochloride
655130|NCT00429234|Gemzar|gemzar
655131|NCT00429221|ADHD|adhd
655132|NCT00429208|Nicotine Dependence|nicotine dependence
655133|NCT00429208|Smoking|smoking
655134|NCT00429208|Tobacco Use Disorder|tobacco use disorder
655135|NCT00429208|Nicotine Use Disorder|nicotine use disorder
655136|NCT00429195|LIPGENE|lipgene
655137|NCT00429195|Fatty acid|fatty acid
655138|NCT00429195|Dietary intervention|dietary intervention
655139|NCT00429195|Metabolic syndrome|metabolic syndrome
655140|NCT00429195|Insulin resistance|insulin resistance
655141|NCT00429182|Breast Cancer|breast cancer
655142|NCT00429182|breast carcinoma|breast carcinoma
655143|NCT00429182|Carboplatin|carboplatin
655144|NCT00429182|Paraplatin|paraplatin
655145|NCT00429182|Cyclophosphamide|cyclophosphamide
655146|NCT00429182|Neosar|neosar
655147|NCT00429182|Cytoxan|cytoxan
655148|NCT00429182|Thiotepa|thiotepa
655149|NCT00429182|Purged Autologous Stem Cells|purged autologous stem cells
655150|NCT00429182|Circulating Tumor Cells|circulating tumor cells
655151|NCT00429182|CTCs|ctcs
655152|NCT00429169|Major Depressive Disorder|major depressive disorder
655153|NCT00429169|MDD|mdd
655154|NCT00429156|Non-invasive ventilation|non-invasive ventilation
655155|NCT00429156|Non-invasive positive pressure ventilation|non-invasive positive pressure ventilation
655156|NCT00429156|Home ventilation|home ventilation
655157|NCT00429156|Domiciliary ventilation|domiciliary ventilation
655158|NCT00429156|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
655159|NCT00429156|COPD|copd
655160|NCT00429156|Respiratory failure|respiratory failure
655161|NCT00429156|Acute hypercapnic respiratory failure|acute hypercapnic respiratory failure
655162|NCT00429156|NIV|niv
655163|NCT00429156|NIPPV|nippv
655164|NCT00429156|Type II respiratory failure|type ii respiratory failure
655165|NCT00429143|Hematologic Malignancies|hematologic malignancies
655166|NCT00429143|Two Step Approach|two step approach
655167|NCT00429143|Haploidentical Transplant|haploidentical transplant
655168|NCT00429117|Spirituality|spirituality
655169|NCT00429117|Work Related Stress|work related stress
655170|NCT00429117|Religious Beliefs|religious beliefs
655171|NCT00429117|Survey|survey
655172|NCT00429104|Breast Cancer|breast cancer
655173|NCT00429104|Carcinoma of the Breast|carcinoma of the breast
655174|NCT00429104|HER-2/neu Overexpression|her-2/neu overexpression
655175|NCT00429104|Herceptin|herceptin
655176|NCT00429104|Trastuzumab|trastuzumab
655177|NCT00429104|GM-CSF|gm-csf
655178|NCT00429104|Sargramostim|sargramostim
655179|NCT00429104|Leukine|leukine
655180|NCT00429078|Gastric Cancer|gastric cancer
655181|NCT00429078|T Cells|t cells
655182|NCT00429078|Gene Transfer|gene transfer
655183|NCT00429065|Non-Hodgkin lymphoma|non-hodgkin lymphoma
655184|NCT00429065|rituximab|rituximab
655185|NCT00429065|immunotherapy|immunotherapy
655186|NCT00429052|Coronary Disease|coronary disease
655187|NCT00429052|Coronary Stenosis|coronary stenosis
655188|NCT00429052|Percutaneous Transluminal Coronary Angioplasty|percutaneous transluminal coronary angioplasty
655189|NCT00429052|Stents|stents
655190|NCT00429052|Sirolimus|sirolimus
655191|NCT00429026|Kidney Cancer|kidney cancer
655192|NCT00429026|Renal Cell Cancer|renal cell cancer
655193|NCT00429026|Stem Cell Transplant|stem cell transplant
655194|NCT00429026|Cyclophosphamide|cyclophosphamide
655195|NCT00429026|Fludarabine|fludarabine
655196|NCT00429026|Melphalan|melphalan
655197|NCT00429026|NST|nst
655198|NCT00429013|Pressure ulcer|pressure ulcer
655199|NCT00429013|Lingual electric stimulation|lingual electric stimulation
655200|NCT00429013|Paraplegic patient|paraplegic patient
655201|NCT00429013|Pressure Ulcer/Prevention & control|pressure ulcer/prevention & control
655202|NCT00429000|Hypothermia|hypothermia
655203|NCT00429000|Infant mortality|infant mortality
655204|NCT00429000|Infant morbidity|infant morbidity
655205|NCT00429000|Intervention|intervention
655206|NCT00429000|Randomisation|randomisation
655207|NCT00429000|Longitudinal research.|longitudinal research.
655208|NCT00429000|Low-income country|low-income country
655209|NCT00428987|Energy Expenditure|energy expenditure
655210|NCT00428987|Neurocognitive Function|neurocognitive function
655211|NCT00428987|Obesity|obesity
655212|NCT00428987|Metabolism|metabolism
655213|NCT00428987|Phenotype|phenotype
655214|NCT00428987|Body Composition|body composition
655215|NCT00428987|Morbid Obesity|morbid obesity
655216|NCT00428987|Overweight|overweight
655217|NCT00428987|Healthy Volunteer|healthy volunteer
655218|NCT00428974|Psoriasis|psoriasis
655219|NCT00428961|diabetes mellitus|diabetes mellitus
655220|NCT00428961|insulin resistance|insulin resistance
655221|NCT00428961|atherosclerosis|atherosclerosis
655222|NCT00428948|ADPKD|adpkd
655223|NCT00428948|Polycystic|polycystic
655224|NCT00428948|kidney|kidney
655225|NCT00428948|ADPKD (Autosomal Dominant Polycystic Kidney Disease)|adpkd (autosomal dominant polycystic kidney disease)
655226|NCT00428935|Duchenne|duchenne
655227|NCT00428935|Muscle|muscle
655228|NCT00428935|Muscular Dystrophy|muscular dystrophy
655229|NCT00428935|Gene Therapy|gene therapy
655230|NCT00428935|Dystrophin|dystrophin
655231|NCT00428935|Adeno-Associated Virus|adeno-associated virus
655232|NCT00428935|AAV|aav
655233|NCT00428922|Metastatic|metastatic
655234|NCT00428922|Breast Cancer|breast cancer
655235|NCT00428922|MBC|mbc
655236|NCT00428909|Pharmacokinetic|pharmacokinetic
655237|NCT00428909|STI571|sti571
655238|NCT00428909|imatinib|imatinib
655239|NCT00428909|CML|cml
655240|NCT00428909|Chronic Myeloid Leukemia|chronic myeloid leukemia
655241|NCT00428909|Philadelphia Chromosome|philadelphia chromosome
655242|NCT00428909|acetaminophen|acetaminophen
655243|NCT00428896|Breast cancer|breast cancer
655244|NCT00428896|iressa circulating tumor cells|iressa circulating tumor cells
655245|NCT00428883|Scleroderma, Systemic|scleroderma, systemic
655246|NCT00428883|Scleroderma, Diffuse|scleroderma, diffuse
655247|NCT00428870|Shoulder|shoulder
655248|NCT00428870|impingement|impingement
655249|NCT00428870|conservative|conservative
655250|NCT00428870|acromioplasty|acromioplasty
655251|NCT00428870|arthroscopy|arthroscopy
655252|NCT00428844|Osteomyelitis|osteomyelitis
655253|NCT00428844|Prosthetic Hip|prosthetic hip
655254|NCT00428844|Prosthetic Knee|prosthetic knee
655255|NCT00428844|MRSA|mrsa
655256|NCT00428844|Osteomyelitis Associated with an Infected Prosthetic Hip or Knee Joint|osteomyelitis associated with an infected prosthetic hip or knee joint
655257|NCT00428844|Staphylococci|staphylococci
655258|NCT00428831|influenza, genomic data, nasopharyngeal aspirate|influenza, genomic data, nasopharyngeal aspirate
655259|NCT00428818|MRSA|mrsa
655260|NCT00428805|body composition|body composition
655261|NCT00428805|physical activity|physical activity
655262|NCT00428805|dietary intake|dietary intake
655263|NCT00428805|children|children
655264|NCT00428792|ADHD|adhd
655265|NCT00428792|methylphenidate|methylphenidate
655266|NCT00428792|children|children
655267|NCT00428792|food effect|food effect
655268|NCT00428792|Attention-Deficit Hyperactivity Disorder (ADHD) in children|attention-deficit hyperactivity disorder (adhd) in children
655269|NCT00428779|Running during 24 hours|running during 24 hours
655270|NCT00428779|Voluntary evoked force on the muscles|voluntary evoked force on the muscles
655271|NCT00428779|Electrically evoked force on the muscles|electrically evoked force on the muscles
655272|NCT00428779|EMG activity|emg activity
655273|NCT00428779|Muscle biopsy|muscle biopsy
655274|NCT00428779|subjects will be recruited among experienced ultra-runners|subjects will be recruited among experienced ultra-runners
655275|NCT00428753|avian influenza, China, H5N1|avian influenza, china, h5n1
655276|NCT00428727|Diabetic foot|diabetic foot
655277|NCT00428727|Ulcer|ulcer
655278|NCT00428727|nitric oxide|nitric oxide
655279|NCT00428727|treatment|treatment
655280|NCT00428727|donor|donor
655281|NCT00428727|controlled trial|controlled trial
655282|NCT00428701|stress ulcer|stress ulcer
655283|NCT00428701|critically ill|critically ill
655284|NCT00428701|gastric acid|gastric acid
655285|NCT00428701|gastric aspirates|gastric aspirates
655286|NCT00428701|esomeprazole|esomeprazole
655287|NCT00428688|Hodgkin's lymphoma|hodgkin's lymphoma
655288|NCT00428688|cardiovascular disease|cardiovascular disease
655289|NCT00428688|radiation therapy|radiation therapy
655290|NCT00428688|Brachial artery flow-mediated dilation (FMD)|brachial artery flow-mediated dilation (fmd)
655291|NCT00428675|screening|screening
655292|NCT00428675|fatigue|fatigue
655293|NCT00428662|coronary stenting|coronary stenting
655294|NCT00428662|drug eluting stents|drug eluting stents
655295|NCT00428662|paclitaxel|paclitaxel
655296|NCT00428662|nanoporous|nanoporous
655297|NCT00428649|Selenium supplements|selenium supplements
655298|NCT00428649|Selenoprotein P|selenoprotein p
655299|NCT00428649|Optimization|optimization
655300|NCT00428636|ileostomy|ileostomy
655301|NCT00428636|rectal resection|rectal resection
655302|NCT00428636|proctectomy|proctectomy
655303|NCT00428636|stoma closure|stoma closure
655304|NCT00428623|Patient comfort|patient comfort
655305|NCT00428623|Wound dressings|wound dressings
655306|NCT00428623|infection|infection
655307|NCT00428623|vascular surgery|vascular surgery
655308|NCT00428571|Type 2 Diabetes|type 2 diabetes
655309|NCT00428571|Bariatric surgery|bariatric surgery
655310|NCT00428571|Obesity|obesity
655311|NCT00428571|Laparoscopic gastric bypass|laparoscopic gastric bypass
655312|NCT00428571|Laparoscopic adjustable gastric banding|laparoscopic adjustable gastric banding
655313|NCT00428558|acute myeloid leukemia|acute myeloid leukemia
655314|NCT00428558|Core Binding Factor|core binding factor
655315|NCT00428558|t(8;21)|t(8;21)
655316|NCT00428558|inv(16)|inv(16)
655317|NCT00428558|timed-sequential induction|timed-sequential induction
655318|NCT00428545|Advanced Malignancy|advanced malignancy
655319|NCT00428545|Lymphoma|lymphoma
655320|NCT00428545|Myeloma|myeloma
655321|NCT00428545|Solid Tumors|solid tumors
655322|NCT00428545|Bevacizumab|bevacizumab
655323|NCT00428545|Avastin|avastin
655324|NCT00428545|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
655325|NCT00428545|rhuMAb-VEGF|rhumab-vegf
655326|NCT00428545|Bortezomib|bortezomib
655327|NCT00428545|Velcade|velcade
655328|NCT00428545|PS-341|ps-341
655329|NCT00428545|LDP-341|ldp-341
655330|NCT00428545|MLN341|mln341
656897|NCT00423410|Tumor|tumor
655331|NCT00428519|HIV infection|hiv infection
655332|NCT00428519|Neurokinin-1 receptor antagonist|neurokinin-1 receptor antagonist
655333|NCT00428519|CCR5 expression|ccr5 expression
655334|NCT00428519|Treatment Naive|treatment naive
655335|NCT00428506|ascites|ascites
655336|NCT00428506|cirrhosis|cirrhosis
655337|NCT00428506|post-paracentesis circulatory dysfunction|post-paracentesis circulatory dysfunction
655338|NCT00428506|albumin|albumin
655339|NCT00428506|portal-hypertension|portal-hypertension
655340|NCT00428493|human influenza A, H5N1, bird flu, avian influenza, China|human influenza a, h5n1, bird flu, avian influenza, china
655341|NCT00428467|Heart Failure|heart failure
655342|NCT00428467|LV Geometry|lv geometry
655343|NCT00428467|Heart MRT|heart mrt
655344|NCT00428454|drug-eluting stent|drug-eluting stent
655345|NCT00428454|chronic total occlusion|chronic total occlusion
655346|NCT00428454|sirolimus-eluting stent|sirolimus-eluting stent
655347|NCT00428454|zotarolimus-eluting stent|zotarolimus-eluting stent
655348|NCT00428454|QCA|qca
655349|NCT00428441|D-dimer|d-dimer
655350|NCT00428441|Recurrence|recurrence
655351|NCT00428441|Venous thromboembolism|venous thromboembolism
655352|NCT00428428|kidney stone|kidney stone
655353|NCT00428428|ureteroscopy|ureteroscopy
655354|NCT00428402|Education|education
655355|NCT00428402|4th-8th Grade Student|4th-8th grade student
655356|NCT00428402|MIDAS Project|midas project
655357|NCT00428402|Focus Group Discussion|focus group discussion
655358|NCT00428402|Bastrop|bastrop
655359|NCT00428389|Dementia, Alzheimer's, Rivastigmine, donepezil|dementia, alzheimer's, rivastigmine, donepezil
655360|NCT00428363|posterior capsule opacification|posterior capsule opacification
655361|NCT00428363|PCO|pco
655362|NCT00428363|after cataract|after cataract
655363|NCT00428363|intraocular lens|intraocular lens
655364|NCT00428363|optic edge design|optic edge design
655365|NCT00428363|sharp optic edge|sharp optic edge
655366|NCT00428337|HIV Seronegativity|hiv seronegativity
655367|NCT00428337|EP1233|ep1233
655368|NCT00428337|MVA-mBN32|mva-mbn32
655369|NCT00428337|HIV Preventive Vaccine|hiv preventive vaccine
655370|NCT00428311|Polycystic ovary syndrome|polycystic ovary syndrome
655371|NCT00428311|Hyperandrogenism|hyperandrogenism
655372|NCT00428311|Hirsutism|hirsutism
655373|NCT00428311|Cardiovascular risk|cardiovascular risk
655374|NCT00428311|Chronic inflammation|chronic inflammation
655375|NCT00428311|Metformin|metformin
655376|NCT00428311|Cyproterone acetate|cyproterone acetate
655377|NCT00428311|Oral contraceptives|oral contraceptives
655378|NCT00428298|Bipolar|bipolar
655379|NCT00428298|Cognitive|cognitive
655380|NCT00428298|Attention|attention
655381|NCT00428298|Memory|memory
655382|NCT00428298|Manic Depression|manic depression
655383|NCT00428298|Bi-polar|bi-polar
655384|NCT00428285|Human Papilloma Virus|human papilloma virus
655385|NCT00428285|HIV infected MSM|hiv infected msm
655386|NCT00428285|Treatment Experienced|treatment experienced
655387|NCT00428285|Treatment Naive|treatment naive
655388|NCT00428285|Anal Intraepithelial Neoplasia|anal intraepithelial neoplasia
655389|NCT00428272|Monoclonal Antibody Lexatumumab|monoclonal antibody lexatumumab
655390|NCT00428272|Interferon Gamma|interferon gamma
655391|NCT00428272|Solid Tumor|solid tumor
655392|NCT00428272|Phase I|phase i
655393|NCT00428272|Malignant Tumor|malignant tumor
655394|NCT00428272|Metastatic Tumor|metastatic tumor
655395|NCT00428272|Pediatric Solid Tumor|pediatric solid tumor
655396|NCT00428272|Ewing Sarcoma|ewing sarcoma
655397|NCT00428272|Osteosarcoma|osteosarcoma
655398|NCT00428272|Neuroblastoma|neuroblastoma
655399|NCT00428272|Rhabdomyosarcoma|rhabdomyosarcoma
655400|NCT00428246|Chronic Kidney Disease|chronic kidney disease
655401|NCT00428246|Endothelial dysfunction|endothelial dysfunction
655402|NCT00428246|Inflammation|inflammation
655403|NCT00428246|Hypertension|hypertension
655404|NCT00428246|paricalcitol|paricalcitol
655405|NCT00428246|Blood pressure|blood pressure
655406|NCT00428246|Vitamin D|vitamin d
655407|NCT00428246|Glomerular filtration rate|glomerular filtration rate
655408|NCT00428233|CLL|cll
655409|NCT00428233|vaccine|vaccine
655410|NCT00428220|Potentially other tumor types in the future|potentially other tumor types in the future
655411|NCT00428207|type 1 diabetes, insulin pump therapy, glycemic stability|type 1 diabetes, insulin pump therapy, glycemic stability
655412|NCT00428194|stage IIA cervical cancer|stage iia cervical cancer
655413|NCT00428194|stage IB cervical cancer|stage ib cervical cancer
655414|NCT00428194|stage IIB cervical cancer|stage iib cervical cancer
655415|NCT00428194|stage III cervical cancer|stage iii cervical cancer
655416|NCT00428194|stage IVA cervical cancer|stage iva cervical cancer
655417|NCT00428194|cervical squamous cell carcinoma|cervical squamous cell carcinoma
655418|NCT00428181|Brief alcohol intervention|brief alcohol intervention
655419|NCT00428181|Booster session|booster session
655420|NCT00428181|Personalized feedback|personalized feedback
655421|NCT00428181|Motivational interview|motivational interview
655422|NCT00428181|Injury recidivism|injury recidivism
655423|NCT00428181|Psychological Interview|psychological interview
655424|NCT00428181|Risk Reduction Behaviors|risk reduction behaviors
655425|NCT00428168|Betahistine|betahistine
655426|NCT00428168|Weight Gain Control|weight gain control
655427|NCT00428168|Weight Gain due to Olanzapine Treatment|weight gain due to olanzapine treatment
655428|NCT00428168|Obesity|obesity
655429|NCT00428168|Schizophrenic disorder|schizophrenic disorder
655430|NCT00428155|hemostasis|hemostasis
655431|NCT00428155|angioplasty|angioplasty
655432|NCT00428155|stenting|stenting
655433|NCT00428155|closure device|closure device
655434|NCT00428155|angioseal|angioseal
655435|NCT00428155|starclose|starclose
655436|NCT00428142|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
655437|NCT00428142|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
655438|NCT00428142|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
655439|NCT00428142|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
655440|NCT00428142|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
655441|NCT00428142|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
655442|NCT00428129|Acute Iliofemoral Deep Vein Thrombosis|acute iliofemoral deep vein thrombosis
655443|NCT00428116|HIV-1|hiv-1
655444|NCT00428116|Pediatric|pediatric
655445|NCT00428116|HAART|haart
655446|NCT00428116|Treatment Naive|treatment naive
655447|NCT00428103|Mitral valve regurgitation|mitral valve regurgitation
655448|NCT00428090|apolipoprotein E|apolipoprotein e
655449|NCT00428090|monotherapy|monotherapy
655450|NCT00428090|cognition|cognition
655451|NCT00428090|mild|mild
655452|NCT00428090|rosiglitazone|rosiglitazone
655453|NCT00428090|Alzheimer's disease|alzheimer's disease
655454|NCT00428090|moderate|moderate
655455|NCT00428077|Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia|philadelphia chromosome positive (ph+) chronic myelogenous leukemia
655456|NCT00428077|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
655457|NCT00428064|Renal allograft|renal allograft
655458|NCT00428064|Renal|renal
655459|NCT00428064|Kidney|kidney
655460|NCT00428064|Transplant|transplant
655461|NCT00428051|Epidemiology|epidemiology
655462|NCT00428051|Surveillance|surveillance
655463|NCT00428051|Streptococcal Pneumonia|streptococcal pneumonia
655464|NCT00428038|Infant, Premature|infant, premature
655465|NCT00428038|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
655466|NCT00428038|Asthma|asthma
655467|NCT00428025|pancreatitis|pancreatitis
655468|NCT00428012|quality of life, kidney transplantation|quality of life, kidney transplantation
655469|NCT00427999|Hormone-refractory|hormone-refractory
655470|NCT00427999|prostate cancer|prostate cancer
655471|NCT00427999|multitargeted|multitargeted
655472|NCT00427999|tyrosinkinase|tyrosinkinase
655473|NCT00427986|Diabetes|diabetes
655474|NCT00427986|Macular oedema|macular oedema
655475|NCT00427986|Osmosis|osmosis
655476|NCT00427986|Galactose|galactose
655477|NCT00427986|Intravenous|intravenous
655478|NCT00427986|Retinal thickness|retinal thickness
655479|NCT00427986|Starling|starling
655480|NCT00427960|cholesterol|cholesterol
655481|NCT00427960|statin|statin
655482|NCT00427960|Asian|asian
655483|NCT00427960|LDL-cholesterol|ldl-cholesterol
655484|NCT00427947|phantom limb pain|phantom limb pain
655485|NCT00427947|amputation|amputation
655486|NCT00427947|anesthetics, local|anesthetics, local
655487|NCT00427947|postoperative analgesia|postoperative analgesia
655488|NCT00427947|ropivacaine|ropivacaine
655489|NCT00427947|analgesia|analgesia
655490|NCT00427908|Meningococcal serogroups A, C, W-135 and/or Y diseases|meningococcal serogroups a, c, w-135 and/or y diseases
655491|NCT00427908|Conjugate vaccine|conjugate vaccine
655492|NCT00427908|Immunogenicity|immunogenicity
655493|NCT00427908|Meningococcal vaccine|meningococcal vaccine
655494|NCT00427908|Persistence|persistence
655495|NCT00427908|Non-inferiority|non-inferiority
655496|NCT00427895|Vaccine|vaccine
655497|NCT00427895|Pneumococcal Infections Prevention and Control|pneumococcal infections prevention and control
655498|NCT00427843|osteoarthritis|osteoarthritis
655499|NCT00427843|knee|knee
655500|NCT00427843|gait|gait
655501|NCT00427843|muscle strength|muscle strength
655503|NCT00427843|exercise|exercise
655504|NCT00427830|Mycobacterium tuberculosis|mycobacterium tuberculosis
655505|NCT00427830|85A antigen|85a antigen
655506|NCT00427830|Recombinant Modified Vaccinia Ankara|recombinant modified vaccinia ankara
655507|NCT00427830|Phase I study|phase i study
655508|NCT00427830|Immunogenicity|immunogenicity
655509|NCT00427830|BCG|bcg
655510|NCT00427817|Adenoma, Prostatic|adenoma, prostatic
655511|NCT00427817|Prostate|prostate
655512|NCT00427817|Proteomics|proteomics
655513|NCT00427817|Urology|urology
655514|NCT00427804|Calcium absorption|calcium absorption
655515|NCT00427804|Vitamin D|vitamin d
655516|NCT00427791|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
655517|NCT00427791|Leukemia|leukemia
655518|NCT00427791|Total Body Irradiation|total body irradiation
655519|NCT00427791|Etoposide|etoposide
655520|NCT00427791|Rituximab|rituximab
655521|NCT00427791|Rituxan|rituxan
655522|NCT00427791|TBI|tbi
655523|NCT00427791|ALL|all
655524|NCT00427778|incontinence ring|incontinence ring
655525|NCT00427778|pessary|pessary
655526|NCT00427778|urinary incontinence|urinary incontinence
655527|NCT00427778|urodynamic study|urodynamic study
655528|NCT00427778|quality of life|quality of life
655529|NCT00427778|crossover trial|crossover trial
655530|NCT00427778|randomised trial|randomised trial
655531|NCT00427765|Multiple Myeloma|multiple myeloma
655532|NCT00427765|Hodgkin's Disease|hodgkin's disease
655533|NCT00427765|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
655534|NCT00427765|Leukemia|leukemia
655535|NCT00427765|Lymphoma|lymphoma
655536|NCT00427765|Busulfan|busulfan
655537|NCT00427765|Melphalan|melphalan
655538|NCT00427765|Autologous bone marrow|autologous bone marrow
655539|NCT00427765|BMT|bmt
655540|NCT00427765|Peripheral blood stem cell transplant|peripheral blood stem cell transplant
655541|NCT00427765|PBSCT|pbsct
655542|NCT00427752|Transgastric|transgastric
655543|NCT00427752|Endoluminal|endoluminal
655544|NCT00427752|Peritoneoscopy|peritoneoscopy
655545|NCT00427752|Diagnostic|diagnostic
655546|NCT00427752|Feasibility|feasibility
655547|NCT00427739|Axial Flow Ventricular Assist Device|axial flow ventricular assist device
655548|NCT00427739|Cardiac CT|cardiac ct
655549|NCT00427739|Stage IV heart failure|stage iv heart failure
655550|NCT00427726|Gene Transfer|gene transfer
655551|NCT00427726|Hematopoietic Stem Cells|hematopoietic stem cells
655552|NCT00427726|Follow-Up|follow-up
655553|NCT00427713|adenocarcinoma of the rectum|adenocarcinoma of the rectum
655554|NCT00427713|stage III rectal cancer|stage iii rectal cancer
655555|NCT00427713|stage II rectal cancer|stage ii rectal cancer
655556|NCT00427700|Polycystic Ovary Syndrome|polycystic ovary syndrome
655557|NCT00427700|clomiphene citrate|clomiphene citrate
655558|NCT00427700|Raloxifene|raloxifene
655559|NCT00427674|Parkinson|parkinson
655561|NCT00427661|Sickle Cell Disease|sickle cell disease
655562|NCT00427661|Thalassemia|thalassemia
655563|NCT00427661|Hemoglobinopathies|hemoglobinopathies
655564|NCT00427648|Administration, Intravesical|administration, intravesical
655565|NCT00427648|Anesthetics, Local|anesthetics, local
655566|NCT00427635|neonates|neonates
655567|NCT00427635|infants|infants
655568|NCT00427635|GERD|gerd
655569|NCT00427635|reflux|reflux
655570|NCT00427622|hot flashes|hot flashes
655571|NCT00427609|Treatment|treatment
655572|NCT00427609|Psoriasis|psoriasis
655573|NCT00427609|efficacy|efficacy
655574|NCT00427609|Bicillin|bicillin
655575|NCT00427596|GW427353 oral tablets,|gw427353 oral tablets,
655576|NCT00427596|healthy adult subjects,|healthy adult subjects,
655577|NCT00427596|food effect|food effect
655578|NCT00427583|Malignant,|malignant,
655579|NCT00427583|peripheral,|peripheral,
655580|NCT00427583|nerve sheath tumors,|nerve sheath tumors,
655581|NCT00427583|MPNST,|mpnst,
655582|NCT00427583|neurofibromatosis,|neurofibromatosis,
655583|NCT00427583|NF1,|nf1,
655584|NCT00427583|Imatinib mesylate|imatinib mesylate
655585|NCT00427570|stage II colon cancer|stage ii colon cancer
655586|NCT00427570|stage III colon cancer|stage iii colon cancer
655587|NCT00427557|Multiple Myeloma|multiple myeloma
655588|NCT00427557|Acute Myeloid Leukemia|acute myeloid leukemia
655589|NCT00427557|Myelodysplastic Syndrome|myelodysplastic syndrome
655590|NCT00427557|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
655591|NCT00427557|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
655592|NCT00427557|Hodgkin's Lymphoma|hodgkin's lymphoma
655593|NCT00427557|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
655594|NCT00427557|Cellular Therapy|cellular therapy
655595|NCT00427557|Umbilical Cord Blood Cells|umbilical cord blood cells
655596|NCT00427557|Cord Blood Transplantation|cord blood transplantation
655597|NCT00427557|Stem Cells|stem cells
655598|NCT00427557|Stem Cell Transplantation|stem cell transplantation
655599|NCT00427557|Allogeneic|allogeneic
655600|NCT00427557|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
655601|NCT00427557|Graft vs. Host Disease|graft vs. host disease
655602|NCT00427557|GVD|gvd
655603|NCT00427557|Fludarabine|fludarabine
655604|NCT00427557|Fludarabine Phosphate|fludarabine phosphate
655605|NCT00427557|Fludara|fludara
655606|NCT00427557|Melphalan|melphalan
655607|NCT00427557|Rituximab|rituximab
655608|NCT00427557|Rituxan|rituxan
655609|NCT00427557|Leukemia|leukemia
655610|NCT00427557|Lymphoma|lymphoma
655611|NCT00427544|Uterine leiomyomata (Fibroids)|uterine leiomyomata (fibroids)
655612|NCT00427531|hot flashes|hot flashes
655613|NCT00427505|Interaction|interaction
655614|NCT00427505|healthy volunteers|healthy volunteers
655615|NCT00427505|deferasirox|deferasirox
655616|NCT00427505|midazolam|midazolam
655617|NCT00427479|Allergy|allergy
655618|NCT00427479|Food|food
655619|NCT00427479|Hay fever|hay fever
655620|NCT00427479|Screening|screening
655621|NCT00427453|Mycobacterium tuberculosis|mycobacterium tuberculosis
655622|NCT00427453|85A antigen|85a antigen
655623|NCT00427453|Recombinant Modified Vaccinia Virus Ankara|recombinant modified vaccinia virus ankara
655624|NCT00427453|Phase I study|phase i study
655625|NCT00427453|Immunogenicity|immunogenicity
655626|NCT00427453|BCG|bcg
655627|NCT00427440|Glioma|glioma
655628|NCT00427440|Brain Tumor|brain tumor
655629|NCT00427427|non-metastatic breast cancer|non-metastatic breast cancer
655630|NCT00427427|HER-2 positive breast cancer|her-2 positive breast cancer
655631|NCT00427427|Herceptin (trastuzumab)|herceptin (trastuzumab)
655632|NCT00427427|delayed adjuvant therapy|delayed adjuvant therapy
655633|NCT00427427|acceptability rate|acceptability rate
655634|NCT00427427|non-metastatic, HER-2 positive breast cancer|non-metastatic, her-2 positive breast cancer
655635|NCT00427414|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
655636|NCT00427414|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
655637|NCT00427388|Cardiac Surgical Procedures|cardiac surgical procedures
655638|NCT00427388|Cardiopulmonary Bypass|cardiopulmonary bypass
655639|NCT00427388|Systemic inflammatory Response Syndrome|systemic inflammatory response syndrome
655640|NCT00427388|Steroid|steroid
655641|NCT00427388|Myocardial Infarction|myocardial infarction
655642|NCT00427388|Randomized Clinical Trial|randomized clinical trial
655643|NCT00427375|Rectal cancer surgery|rectal cancer surgery
655644|NCT00427375|Neoadjuvant radiochemotherapy|neoadjuvant radiochemotherapy
655645|NCT00427375|Randomized clinical trial|randomized clinical trial
655646|NCT00427375|Multicenter study|multicenter study
655647|NCT00427349|localized gastrointestinal carcinoid tumor|localized gastrointestinal carcinoid tumor
655648|NCT00427349|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
655649|NCT00427349|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
655650|NCT00427349|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
655651|NCT00427349|gastrinoma|gastrinoma
655652|NCT00427349|insulinoma|insulinoma
655653|NCT00427349|WDHA syndrome|wdha syndrome
655654|NCT00427349|glucagonoma|glucagonoma
655655|NCT00427349|pancreatic polypeptide tumor|pancreatic polypeptide tumor
655656|NCT00427349|somatostatinoma|somatostatinoma
655657|NCT00427349|recurrent islet cell carcinoma|recurrent islet cell carcinoma
655658|NCT00427349|neuroendocrine tumor|neuroendocrine tumor
655659|NCT00427336|Severe Aplastic Anemia|severe aplastic anemia
655660|NCT00427336|Bone Marrow Failure|bone marrow failure
655661|NCT00427336|Stem Cell Transplantation|stem cell transplantation
655662|NCT00427336|Fludarabine|fludarabine
655663|NCT00427336|Cyclophosphamide|cyclophosphamide
655664|NCT00427336|Antithymocyte Globulin|antithymocyte globulin
655665|NCT00427336|SAA|saa
655666|NCT00427336|ATG|atg
655667|NCT00427336|Cytoxan|cytoxan
655668|NCT00427336|Neosar|neosar
655669|NCT00427336|Fludarabine Phosphate|fludarabine phosphate
655670|NCT00427336|Thymoglobulin|thymoglobulin
655671|NCT00427323|sleep|sleep
655672|NCT00427323|aging|aging
655673|NCT00427323|biological rhythm|biological rhythm
655674|NCT00427323|melatonin|melatonin
655675|NCT00427323|alertness|alertness
655676|NCT00427323|early morning awakening|early morning awakening
655677|NCT00427323|daytime sleepiness|daytime sleepiness
655678|NCT00427323|difficulty maintaining sleep|difficulty maintaining sleep
655679|NCT00427323|sleep maintenance insomnia|sleep maintenance insomnia
655680|NCT00427310|stage I colon cancer|stage i colon cancer
655681|NCT00427310|stage II colon cancer|stage ii colon cancer
655682|NCT00427310|stage III colon cancer|stage iii colon cancer
655683|NCT00427310|adenocarcinoma of the colon|adenocarcinoma of the colon
655685|NCT00427297|Pediatric|pediatric
655686|NCT00427297|nevirapine|nevirapine
655687|NCT00427297|HAART|haart
655688|NCT00427297|Resistance|resistance
655689|NCT00427297|Treatment Naive|treatment naive
655690|NCT00427284|Eplerenone auf die Endothelfunktion bei Patienten mit stabiler koronarer Herzkrankheit|eplerenone auf die endothelfunktion bei patienten mit stabiler koronarer herzkrankheit
655691|NCT00427271|aspirin|aspirin
655692|NCT00427271|enalapril|enalapril
655693|NCT00427271|microalbuminuria|microalbuminuria
655694|NCT00427271|glomerular filtration rate|glomerular filtration rate
655695|NCT00427258|healthy subjects|healthy subjects
655696|NCT00427245|menopausal symptoms|menopausal symptoms
655697|NCT00427245|infertility|infertility
655698|NCT00427245|stage IA breast cancer|stage ia breast cancer
655699|NCT00427245|stage IB breast cancer|stage ib breast cancer
655700|NCT00427245|stage II breast cancer|stage ii breast cancer
655701|NCT00427245|stage IIIA breast cancer|stage iiia breast cancer
655702|NCT00427245|stage IIIB breast cancer|stage iiib breast cancer
655703|NCT00427245|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
655704|NCT00427245|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
655705|NCT00427245|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
655706|NCT00427232|coronary heart disease|coronary heart disease
655707|NCT00427232|endothelins|endothelins
655708|NCT00427232|coronary angiography|coronary angiography
655709|NCT00427232|blood flow velocity|blood flow velocity
655710|NCT00427232|fractional flow reserve, myocardial|fractional flow reserve, myocardial
655711|NCT00427219|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
655712|NCT00427219|Prostatic Adenoma, Benign|prostatic adenoma, benign
655713|NCT00427219|Prostatic Hypertrophy, Benign|prostatic hypertrophy, benign
655714|NCT00427219|Enlarged Prostate|enlarged prostate
655715|NCT00427219|Prostatism|prostatism
655716|NCT00427219|Adenoma, Prostatic|adenoma, prostatic
655717|NCT00427206|acetaminophen|acetaminophen
655718|NCT00427206|alcohol|alcohol
655719|NCT00427206|liver injury|liver injury
655720|NCT00427193|dietary restriction|dietary restriction
655805|NCT00426907|Rehabilitation|rehabilitation
655721|NCT00427193|disease /disorder prevention /control|disease /disorder prevention /control
655722|NCT00427193|nutrition of aging|nutrition of aging
655723|NCT00427193|bioenergetics|bioenergetics
655724|NCT00427193|cardiovascular function|cardiovascular function
655725|NCT00427193|disease /disorder proneness /risk|disease /disorder proneness /risk
655726|NCT00427193|insulin sensitivity / resistance|insulin sensitivity / resistance
655727|NCT00427180|Visual Perception|visual perception
655728|NCT00427180|Retina|retina
655729|NCT00427180|Light|light
655730|NCT00427180|Retinitis Pigmentosa|retinitis pigmentosa
655731|NCT00427180|Visual acuity|visual acuity
655732|NCT00427180|Retinal Implant|retinal implant
655733|NCT00427180|Electrical stimulation|electrical stimulation
655734|NCT00427167|Blood Stage|blood stage
655735|NCT00427167|Investigational|investigational
655736|NCT00427167|Vaccine|vaccine
655737|NCT00427167|Malaria|malaria
655738|NCT00427167|Healthy Volunteer|healthy volunteer
655739|NCT00427167|HV|hv
655740|NCT00427141|tolerability,|tolerability,
655741|NCT00427141|pharmacokinetics,|pharmacokinetics,
655742|NCT00427141|first time in human,|first time in human,
655743|NCT00427141|food effect|food effect
655744|NCT00427141|safety,|safety,
655745|NCT00427128|Major Depression|major depression
655746|NCT00427128|"true drug response"|"true drug response"
655747|NCT00427128|"placebo response pattern"|"placebo response pattern"
655748|NCT00427128|continuation treatment outcomes|continuation treatment outcomes
655749|NCT00427115|Patients undergoing allogeneic stem cell transplantations|patients undergoing allogeneic stem cell transplantations
655750|NCT00427102|Oral MRX-1024|oral mrx-1024
655751|NCT00427102|High-Dose Cisplatin Chemotherapy|high-dose cisplatin chemotherapy
655752|NCT00427102|Standard Radiation Therapy|standard radiation therapy
655753|NCT00427089|Colon cleansing|colon cleansing
655754|NCT00427089|Polyethylene Glycol|polyethylene glycol
655755|NCT00427089|Sodium Phosphate|sodium phosphate
655756|NCT00427076|vancomycin|vancomycin
655757|NCT00427076|cotrimoxazole|cotrimoxazole
655758|NCT00427076|trimethoprim/ sulfamethoxazole|trimethoprim/ sulfamethoxazole
655759|NCT00427076|methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
655760|NCT00427076|Health care association infections|health care association infections
655761|NCT00427076|MRSA bacteremia or other microbiologically documented MRSA infections (defined clinically by CDC criteria)|mrsa bacteremia or other microbiologically documented mrsa infections (defined clinically by cdc criteria)
655762|NCT00427076|Suspected neurosurgical meningitis|suspected neurosurgical meningitis
655763|NCT00427076|Sepsis during hemodialysis, catheter-associated and catheter-related infections|sepsis during hemodialysis, catheter-associated and catheter-related infections
655764|NCT00427076|Ventilator-associated pneumonia|ventilator-associated pneumonia
655765|NCT00427076|Surgical site infection in the presence of a foreign body|surgical site infection in the presence of a foreign body
655766|NCT00427063|retinal vessels|retinal vessels
655767|NCT00427063|tortuosity|tortuosity
655768|NCT00427050|Actinic Keratoses (AK)|actinic keratoses (ak)
655769|NCT00427050|PEP005|pep005
655770|NCT00427050|Topical|topical
655771|NCT00427050|Dermatology|dermatology
655772|NCT00427037|Vitamin D deficiency|vitamin d deficiency
655773|NCT00427037|Chronic Kidney Disease|chronic kidney disease
655774|NCT00427024|renal transplantation|renal transplantation
655775|NCT00427024|acute rejection|acute rejection
655776|NCT00427024|transport|transport
655777|NCT00427024|transporter|transporter
655778|NCT00427024|acute rejection after renal transplantation|acute rejection after renal transplantation
655779|NCT00426998|Choroidal neovascularization due to age-related macular degeneration|choroidal neovascularization due to age-related macular degeneration
655780|NCT00426985|Tendonitis|tendonitis
655781|NCT00426985|Bursitis|bursitis
655782|NCT00426985|Pain|pain
655783|NCT00426985|Shoulder Pain|shoulder pain
655784|NCT00426985|Elbow Pain|elbow pain
655785|NCT00426985|Knee Pain|knee pain
655786|NCT00426985|Tendon Injury|tendon injury
655787|NCT00426985|Muscle, Bone and Cartilage Disorders|muscle, bone and cartilage disorders
655788|NCT00426959|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
655789|NCT00426959|PSA of less than 10 ng/mL|psa of less than 10 ng/ml
655790|NCT00426959|Combined Gleason score 6 or less|combined gleason score 6 or less
655791|NCT00426959|International Prostate Symptom Score (IPSS) must <or= to 18|international prostate symptom score (ipss) must <or= to 18
655792|NCT00426946|Depression Children Reboxetine|depression children reboxetine
655793|NCT00426946|A diagnosis of major depressive disorder or a dysthimic disorder according to DSM-IV-TR.|a diagnosis of major depressive disorder or a dysthimic disorder according to dsm-iv-tr.
655794|NCT00426946|Drug naïve or without chronic medication for at least one month.|drug naïve or without chronic medication for at least one month.
655795|NCT00426946|Only children who agree to participate and whose parents will sign and informed consent form will be included.|only children who agree to participate and whose parents will sign and informed consent form will be included.
655796|NCT00426933|cSSSI|csssi
655797|NCT00426933|MRSA|mrsa
655798|NCT00426920|pharmacokinetics|pharmacokinetics
655799|NCT00426920|pharmacodynamics|pharmacodynamics
655800|NCT00426920|inhaled|inhaled
655801|NCT00426920|recombinant human insulin|recombinant human insulin
655802|NCT00426907|Osteoarthritis, Knee|osteoarthritis, knee
655803|NCT00426907|Osteotomy|osteotomy
655804|NCT00426907|Healing|healing
655806|NCT00426907|Roentgen Stereometric Analysis|roentgen stereometric analysis
655807|NCT00426894|surveillance cultures|surveillance cultures
655808|NCT00426894|children|children
655809|NCT00426894|cardiac surgery|cardiac surgery
655810|NCT00426894|perioperative prophylaxis|perioperative prophylaxis
655811|NCT00426881|Exercise|exercise
655812|NCT00426881|Resistance training|resistance training
655813|NCT00426868|ADRC|adrc
655814|NCT00426868|Stem Cells|stem cells
655815|NCT00426868|chronic ischemia|chronic ischemia
655816|NCT00426868|heart disease|heart disease
655817|NCT00426868|coronary artery disease|coronary artery disease
655818|NCT00426868|inducible reversible ischemia|inducible reversible ischemia
655819|NCT00426855|Lymphoma, Non-Hodgkin, Low-Grade|lymphoma, non-hodgkin, low-grade
655820|NCT00426842|Blood pressure|blood pressure
655821|NCT00426842|Orthostatic hypotension|orthostatic hypotension
655822|NCT00426842|Spinal Cord Injury|spinal cord injury
655823|NCT00426842|Sympathetic vascular control|sympathetic vascular control
655824|NCT00426842|Midodrine|midodrine
655825|NCT00426829|Liver Cancer|liver cancer
655826|NCT00426829|Biliary Tract|biliary tract
655827|NCT00426829|Hepatocellular Carcinoma|hepatocellular carcinoma
655828|NCT00426829|Cholangiocarcinoma|cholangiocarcinoma
655829|NCT00426829|Bevacizumab|bevacizumab
655830|NCT00426829|Proton Therapy|proton therapy
655831|NCT00426829|Radiation Therapy|radiation therapy
655832|NCT00426829|PT|pt
655833|NCT00426829|RT|rt
655834|NCT00426829|Proton RT|proton rt
655835|NCT00426829|Avastin|avastin
655836|NCT00426829|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
655837|NCT00426829|rhuMAb-VEGF|rhumab-vegf
655838|NCT00426816|primary insomnia|primary insomnia
655839|NCT00426816|PSG sleep recordings|psg sleep recordings
655840|NCT00426816|daytime cognitive function|daytime cognitive function
655841|NCT00426816|Insomnia|insomnia
655842|NCT00426816|SB-649868|sb-649868
655843|NCT00426777|prostate cancer|prostate cancer
655844|NCT00426777|prostatic adenoma|prostatic adenoma
655845|NCT00426777|prostatic neoplasm|prostatic neoplasm
655846|NCT00426764|peripheral T-cell lymphoma|peripheral t-cell lymphoma
655847|NCT00426764|T-cell lymphoma|t-cell lymphoma
655848|NCT00426764|romidepsin|romidepsin
655849|NCT00426751|Eptifibatide|eptifibatide
655850|NCT00426751|ST-elevation Myocardial Infarction|st-elevation myocardial infarction
655851|NCT00426751|STEMI|stemi
655852|NCT00426751|Abciximab|abciximab
655853|NCT00426725|labor|labor
655854|NCT00426725|pain|pain
655855|NCT00426725|relief|relief
655856|NCT00426725|labour|labour
655857|NCT00426725|device|device
655858|NCT00426712|Chronic kidney failure|chronic kidney failure
655859|NCT00426712|Chronic kidney disease|chronic kidney disease
655860|NCT00426712|Hemodialysis|hemodialysis
655861|NCT00426712|HBV vaccine|hbv vaccine
655862|NCT00426712|Hepatitis B vaccine|hepatitis b vaccine
655863|NCT00426712|Hepatitis B|hepatitis b
655864|NCT00426712|Hepatitis|hepatitis
655865|NCT00426712|HBV|hbv
655866|NCT00426712|Prevention & Control|prevention & control
655867|NCT00426699|enterovirus|enterovirus
655868|NCT00426699|meningitis|meningitis
655869|NCT00426699|sepsis|sepsis
655870|NCT00426699|myocarditis|myocarditis
655871|NCT00426699|kidney|kidney
655872|NCT00426699|urine|urine
655873|NCT00426699|glomerulonephritis|glomerulonephritis
655874|NCT00426686|thrombotic thrombocytopenic purpura|thrombotic thrombocytopenic purpura
655875|NCT00426686|prognostic factors|prognostic factors
655876|NCT00426686|ADAMTS13|adamts13
655877|NCT00426673|partial onset seizures, phenytoin, dilatin, brivaracetam, interaction|partial onset seizures, phenytoin, dilatin, brivaracetam, interaction
655878|NCT00426660|HIV Infections|hiv infections
655879|NCT00426647|Osteoarthritis|osteoarthritis
655880|NCT00426647|Pain|pain
655881|NCT00426647|Norspan|norspan
655882|NCT00426647|Buprenorphine|buprenorphine
655883|NCT00426647|Tramadol|tramadol
655884|NCT00426634|Asthma|asthma
655885|NCT00426634|Allergens|allergens
655886|NCT00426634|Mold|mold
655887|NCT00426634|Asthma Counselor|asthma counselor
655888|NCT00426634|Environmental Remediation|environmental remediation
655889|NCT00426621|Knee osteoarthritis, degenerative joint disease, knee pain, joint pain, topical NSAID,|knee osteoarthritis, degenerative joint disease, knee pain, joint pain, topical nsaid,
655890|NCT00426621|diclofenac sodium|diclofenac sodium
655891|NCT00426608|HPA axis,|hpa axis,
655892|NCT00426608|Healthy volunteers|healthy volunteers
655893|NCT00426608|hormones,|hormones,
655894|NCT00426608|GSK561679,|gsk561679,
655895|NCT00426608|cortisol,|cortisol,
655896|NCT00426582|Cancer|cancer
655897|NCT00426582|maximum tolerated dose|maximum tolerated dose
655898|NCT00426582|dose-limiting toxicity|dose-limiting toxicity
655899|NCT00426582|patupilone|patupilone
655900|NCT00426582|carboplatin|carboplatin
655901|NCT00426582|pharmacokinetics|pharmacokinetics
655902|NCT00426556|Breast cancer|breast cancer
655903|NCT00426556|Cancer of the breast|cancer of the breast
655904|NCT00426556|Human mammary carcinoma|human mammary carcinoma
655905|NCT00426556|HER-2|her-2
655906|NCT00426556|Metastatic|metastatic
655907|NCT00426556|everolimus|everolimus
655910|NCT00426543|Clinical trial|clinical trial
655911|NCT00426543|Intervention study|intervention study
655912|NCT00426543|Double-blind randomised controlled study|double-blind randomised controlled study
655913|NCT00426530|HER2-overexpressing metastatic breast cancer|her2-overexpressing metastatic breast cancer
655914|NCT00426530|Breast cancer|breast cancer
655915|NCT00426530|Cancer of the breast|cancer of the breast
655916|NCT00426530|Human mammary carcinoma|human mammary carcinoma
655917|NCT00426530|HER-2|her-2
655918|NCT00426530|metastatic|metastatic
655919|NCT00426530|everolimus|everolimus
655920|NCT00426530|trastuzumab|trastuzumab
655921|NCT00426530|vinorelbine|vinorelbine
655922|NCT00426517|MUD Transplant|mud transplant
655923|NCT00426517|Transplant|transplant
655924|NCT00426517|AlloPBSC|allopbsc
655925|NCT00426517|HLA Matched Transplant|hla matched transplant
655926|NCT00426517|BMT|bmt
655927|NCT00426517|Congenital Immunodeficiency|congenital immunodeficiency
655928|NCT00426517|Bone Marrow Transplant|bone marrow transplant
655929|NCT00426504|Head,|head,
655930|NCT00426504|Neck,|neck,
655931|NCT00426504|Cancer,|cancer,
655932|NCT00426504|Tomotherapy,|tomotherapy,
655933|NCT00426504|IMRT,|imrt,
655934|NCT00426478|AMPM, SBP, DBP, Valsartan plus Hydrochlorothiazide, Amlodipine, high blood pressure|ampm, sbp, dbp, valsartan plus hydrochlorothiazide, amlodipine, high blood pressure
655935|NCT00426465|Motor Practice|motor practice
655936|NCT00426465|Magnetic Stimulation|magnetic stimulation
655937|NCT00426465|Stroke|stroke
655938|NCT00426465|Spacing Effect|spacing effect
655939|NCT00426465|Massed Practice|massed practice
655940|NCT00426465|Healthy Volunteer|healthy volunteer
655941|NCT00426465|HV|hv
655942|NCT00426452|Vascular endothelial growth factor receptor (VEGF-R) tyrosine kinase inhibitor|vascular endothelial growth factor receptor (vegf-r) tyrosine kinase inhibitor
655943|NCT00426452|Vatalinib|vatalinib
655944|NCT00426452|Proton-pump inhibitors|proton-pump inhibitors
655945|NCT00426452|Omeprazole|omeprazole
655946|NCT00426452|Healthy Postmenopausal Female Volunteers|healthy postmenopausal female volunteers
655947|NCT00426439|malaria|malaria
655948|NCT00426439|Plasmodium falciparum|plasmodium falciparum
655949|NCT00426439|children|children
655950|NCT00426439|Guinea-Bissau|guinea-bissau
655951|NCT00426439|artemether|artemether
655952|NCT00426439|lumefantrine|lumefantrine
655953|NCT00426439|chloroquine|chloroquine
655954|NCT00426439|Coartem|coartem
655955|NCT00426413|ketosis-prone diabetes|ketosis-prone diabetes
655956|NCT00426413|diabetic ketoacidosis|diabetic ketoacidosis
655957|NCT00426413|obesity|obesity
655958|NCT00426413|insulin dependence|insulin dependence
655959|NCT00426413|mechanisms|mechanisms
655960|NCT00426374|HIV|hiv
655961|NCT00426374|AIDS|aids
655962|NCT00426374|Troponin|troponin
655963|NCT00426374|natriuretic peptide|natriuretic peptide
655964|NCT00426374|heart failure|heart failure
655965|NCT00426374|heart disease children|heart disease children
655966|NCT00426374|HIV pediatric|hiv pediatric
655967|NCT00426374|AIDS pediatric|aids pediatric
655968|NCT00426361|Human Papillomavirus|human papillomavirus
655969|NCT00426348|IgA nephropathy|iga nephropathy
655970|NCT00426348|probucol|probucol
655971|NCT00426348|valsartan|valsartan
655972|NCT00426348|treatment|treatment
655973|NCT00426348|antioxidant|antioxidant
655974|NCT00426348|IGA nephropathy：a kind of glomerulonephritis,which IgA is the dominant immunodeposit in mesangial areas|iga nephropathy：a kind of glomerulonephritis,which iga is the dominant immunodeposit in mesangial areas
655975|NCT00426335|breast|breast
655976|NCT00426335|cancer|cancer
655977|NCT00426335|cognitive behaviour therapy|cognitive behaviour therapy
655978|NCT00426335|psychological|psychological
655979|NCT00426322|maxillary sinus augmentation|maxillary sinus augmentation
655980|NCT00426322|bone graft|bone graft
655981|NCT00426322|bovine bone mineral|bovine bone mineral
655982|NCT00426322|dental implants|dental implants
655983|NCT00426296|HIV|hiv
655984|NCT00426296|Reyataz|reyataz
655985|NCT00426296|atazanavir|atazanavir
655986|NCT00426296|Norvir|norvir
655987|NCT00426296|ritonavir|ritonavir
655988|NCT00426296|Boosted|boosted
655989|NCT00426296|Lipodystrophy|lipodystrophy
655990|NCT00426296|Treatment Experienced|treatment experienced
655991|NCT00426283|Eosinophilic Esophagitis|eosinophilic esophagitis
655992|NCT00426257|Ovarian Cancer|ovarian cancer
655993|NCT00426257|stage III|stage iii
655994|NCT00426257|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
655995|NCT00426257|debulking surgery|debulking surgery
655996|NCT00426257|HIPEC|hipec
655997|NCT00426244|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
655998|NCT00426244|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
655999|NCT00426244|Pregnancy|pregnancy
656000|NCT00426244|Physiologic|physiologic
656001|NCT00426244|Gait|gait
656002|NCT00426244|Low back pain|low back pain
656003|NCT00426244|Heart rate variability|heart rate variability
656004|NCT00426231|Randomized Controlled Trials|randomized controlled trials
656005|NCT00426231|Health Education|health education
656006|NCT00426231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
656007|NCT00426231|Patient Nonadherence|patient nonadherence
656008|NCT00426218|Systemic Juvenile Idiopathic Arthritis|systemic juvenile idiopathic arthritis
656009|NCT00426218|Immunogenicity|immunogenicity
656010|NCT00426218|Pharmacokinetics|pharmacokinetics
656011|NCT00426218|Anti-IL-1ß Monoclonal Antibody|anti-il-1ß monoclonal antibody
656012|NCT00426218|ACZ885|acz885
656013|NCT00426218|SJIA|sjia
656014|NCT00426218|Pediatrics|pediatrics
656015|NCT00426205|GM-CSF|gm-csf
656016|NCT00426205|GVAX|gvax
656017|NCT00426205|Cancer vaccine|cancer vaccine
656018|NCT00426205|blood stem cell transplantation|blood stem cell transplantation
656019|NCT00426205|MDS|mds
656020|NCT00426205|AML|aml
656021|NCT00426205|CML|cml
656022|NCT00426192|Immunedefense Suppression|immunedefense suppression
656023|NCT00426192|Cardiopulmonary Bypass|cardiopulmonary bypass
656024|NCT00426192|Mannitol|mannitol
656025|NCT00426192|Hemofiltration|hemofiltration
656026|NCT00426192|Cytokines|cytokines
656027|NCT00426192|Receptors, Surface CD14|receptors, surface cd14
656028|NCT00426179|Imatinib, allergic inflammation, out of allergy season, repeated nasal allergen, seasonal allergic rhinitis, sensitive, Timothy grass pollen, c-kit inhibition|imatinib, allergic inflammation, out of allergy season, repeated nasal allergen, seasonal allergic rhinitis, sensitive, timothy grass pollen, c-kit inhibition
656029|NCT00426140|EPO|epo
656030|NCT00426140|Patupilone|patupilone
656031|NCT00426140|Solid Tumors|solid tumors
656032|NCT00426127|Pancreatic|pancreatic
656033|NCT00426127|Docetaxel|docetaxel
656034|NCT00426127|Doxorubicin|doxorubicin
656035|NCT00426127|Enoxaparin|enoxaparin
656036|NCT00426101|Hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
656037|NCT00426075|Deep vein thrombosis of the lower extremities|deep vein thrombosis of the lower extremities
656038|NCT00426062|Squamous Cell Carcinoma of Tongue and mouth floor|squamous cell carcinoma of tongue and mouth floor
656039|NCT00426049|Coronary artery disease|coronary artery disease
656040|NCT00426049|Stents|stents
656041|NCT00426049|Immunosuppressive Agents|immunosuppressive agents
656042|NCT00426049|Coronary restenosis|coronary restenosis
656043|NCT00426049|Safety|safety
656044|NCT00426036|Open-label study, healthy subjects, stable impaired renal function, licarbazepine, pharmacokinetics, metabolism, safety.|open-label study, healthy subjects, stable impaired renal function, licarbazepine, pharmacokinetics, metabolism, safety.
656045|NCT00426023|Vernal keratoconjunctivitis|vernal keratoconjunctivitis
656046|NCT00426023|Cyclosporine|cyclosporine
656047|NCT00426023|Children|children
656048|NCT00426023|Clinical trial|clinical trial
656049|NCT00426010|Placebo effect|placebo effect
656050|NCT00426010|Caffeine|caffeine
656051|NCT00426010|Systolic BP|systolic bp
656052|NCT00426010|VAS|vas
656053|NCT00425997|Hypertension, valsartan/HCTZ, amlodipine and HCTZ|hypertension, valsartan/hctz, amlodipine and hctz
656054|NCT00425984|HIV|hiv
656055|NCT00425984|Male circumcision|male circumcision
656056|NCT00425984|Sexually transmitted infections|sexually transmitted infections
656057|NCT00425984|Sexual risk behaviors|sexual risk behaviors
656058|NCT00425984|Adult males|adult males
656059|NCT00425984|Haemophilus ducreyi|haemophilus ducreyi
656060|NCT00425984|Human papillomavirus|human papillomavirus
656061|NCT00425984|Rakai|rakai
656062|NCT00425984|Uganda|uganda
656063|NCT00425984|HIV seronegativity|hiv seronegativity
656064|NCT00425984|HPV|hpv
656065|NCT00425984|STI|sti
656066|NCT00425958|year and more after TBI|year and more after tbi
656067|NCT00425958|good vision|good vision
656068|NCT00425958|at least one functinal hand|at least one functinal hand
656069|NCT00425958|cap[able od doing shopping during everyday life|cap[able od doing shopping during everyday life
656070|NCT00425932|Magnetic Resonance Imaging|magnetic resonance imaging
656071|NCT00425932|Rituximab|rituximab
656072|NCT00425932|Low Field MRI|low field mri
656073|NCT00425932|Biomarkers|biomarkers
656074|NCT00425919|Type 2 Diabetes|type 2 diabetes
656075|NCT00425919|Diabetes|diabetes
656076|NCT00425906|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
656077|NCT00425906|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
656078|NCT00425906|constipation, impaction, and bowel obstruction|constipation, impaction, and bowel obstruction
656079|NCT00425906|anorexia|anorexia
656080|NCT00425906|pain|pain
656081|NCT00425893|influenza|influenza
656082|NCT00425893|masks|masks
656083|NCT00425893|transmission|transmission
656084|NCT00425893|hand hygiene|hand hygiene
656085|NCT00425893|non-pharmacologic interventions|non-pharmacologic interventions
656086|NCT00425880|Pregnancy|pregnancy
656087|NCT00425880|Asthma|asthma
656088|NCT00425880|Tobacco Abuse|tobacco abuse
656089|NCT00425880|Exhaled Nitric Oxide|exhaled nitric oxide
656090|NCT00425867|PAR1 gene|par1 gene
656091|NCT00425867|polymorphisms|polymorphisms
656092|NCT00425867|abortions|abortions
656093|NCT00425867|reccurent abortions|reccurent abortions
656094|NCT00425867|premature delivery|premature delivery
656095|NCT00425841|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
656096|NCT00425841|stage III pancreatic cancer|stage iii pancreatic cancer
656097|NCT00425841|stage II pancreatic cancer|stage ii pancreatic cancer
656098|NCT00425815|Cognition|cognition
656099|NCT00425815|Ampakines|ampakines
656100|NCT00425815|Schizophrenia|schizophrenia
656898|NCT00423410|Lymphoma|lymphoma
656101|NCT00425802|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
656102|NCT00425802|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
656103|NCT00425802|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
656104|NCT00425802|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
656105|NCT00425802|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
656106|NCT00425802|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
656107|NCT00425802|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
656108|NCT00425802|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
656109|NCT00425802|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
656110|NCT00425802|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
656111|NCT00425802|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
656112|NCT00425802|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
656113|NCT00425802|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
656114|NCT00425802|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
656115|NCT00425802|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
656116|NCT00425802|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
656117|NCT00425802|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
656118|NCT00425802|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
656119|NCT00425802|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
656120|NCT00425802|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
656121|NCT00425802|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
656122|NCT00425802|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
656123|NCT00425802|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
656124|NCT00425802|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
656125|NCT00425802|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
656126|NCT00425802|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
656127|NCT00425802|splenic marginal zone lymphoma|splenic marginal zone lymphoma
656128|NCT00425802|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
656129|NCT00425802|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
656130|NCT00425802|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
656131|NCT00425802|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
656132|NCT00425802|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
656133|NCT00425802|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
656134|NCT00425802|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
656135|NCT00425802|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
656136|NCT00425789|Deep Chemical Peeling|deep chemical peeling
656137|NCT00425789|Hyperbaric Therapy|hyperbaric therapy
656138|NCT00425789|post-deep peel|post-deep peel
656139|NCT00425776|Breast cancer|breast cancer
656140|NCT00425776|Acupuncture|acupuncture
656141|NCT00425776|Post-menopausal hot flushes|post-menopausal hot flushes
656142|NCT00425776|Se-estradiol|se-estradiol
656143|NCT00425776|Se-endorphine|se-endorphine
656144|NCT00425763|malaria|malaria
656145|NCT00425763|efficacy|efficacy
656146|NCT00425763|intermittent preventive therapy in infants|intermittent preventive therapy in infants
656147|NCT00425763|drug resistance|drug resistance
656148|NCT00425750|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
656149|NCT00425750|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
656150|NCT00425750|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
656151|NCT00425750|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
656152|NCT00425750|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
656153|NCT00425750|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
656154|NCT00425750|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
656155|NCT00425750|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
656156|NCT00425737|Oral live attenuated human rotavirus vaccine|oral live attenuated human rotavirus vaccine
656157|NCT00425737|Gastroenteritis|gastroenteritis
656158|NCT00425724|proteinuria|proteinuria
656159|NCT00425724|nephritis|nephritis
656160|NCT00425724|nephrotic syndrome|nephrotic syndrome
656161|NCT00425724|glomerulonephritis|glomerulonephritis
656162|NCT00425711|Acamprosate|acamprosate
656163|NCT00425711|Alcohol Dependence|alcohol dependence
656164|NCT00425711|Driving Under the Influence|driving under the influence
656165|NCT00425711|Drug Court|drug court
656166|NCT00425711|DUI Court|dui court
656167|NCT00425685|cardiopulmonary resuscitation, ECMO, shock, survival, heart failure, transplantation, heart assist device.|cardiopulmonary resuscitation, ecmo, shock, survival, heart failure, transplantation, heart assist device.
656168|NCT00425659|Health utility|health utility
656169|NCT00425659|Home sleep study|home sleep study
656170|NCT00425646|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
656171|NCT00425646|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
656172|NCT00425646|adenocarcinoma of the lung|adenocarcinoma of the lung
656173|NCT00425646|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
656174|NCT00425646|large cell lung cancer|large cell lung cancer
656175|NCT00425646|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
656176|NCT00425633|Homeopathic|homeopathic
656177|NCT00425633|Potassium|potassium
656178|NCT00425633|Dichromate|dichromate
656179|NCT00425633|Kalium|kalium
656180|NCT00425633|Bichromicum|bichromicum
656181|NCT00425633|Mechanical|mechanical
656182|NCT00425633|Ventilation|ventilation
656183|NCT00425633|Secretions|secretions
656184|NCT00425620|Chronic Sinusitis|chronic sinusitis
656185|NCT00425620|Chronic Rhinosinusitis|chronic rhinosinusitis
656186|NCT00425607|Hutchinson-Gilford Progeria Syndrome|hutchinson-gilford progeria syndrome
656187|NCT00425607|HGPS|hgps
656188|NCT00425607|Progeria|progeria
656189|NCT00425607|FTI|fti
656190|NCT00425607|Farnesyltransferase Inhibitor|farnesyltransferase inhibitor
656191|NCT00425607|Lonafarnib|lonafarnib
656192|NCT00425594|colonoscopy|colonoscopy
656193|NCT00425594|bowel preparation|bowel preparation
656194|NCT00425594|prep|prep
656195|NCT00425581|N-terminal pro-BNP,|n-terminal pro-bnp,
656196|NCT00425581|Cardiac Troponin-T,|cardiac troponin-t,
656197|NCT00425581|Very low birth weight infants|very low birth weight infants
656198|NCT00425581|hemodynamic instability|hemodynamic instability
656199|NCT00425581|myocardial dysfunction|myocardial dysfunction
656200|NCT00425568|hypogonadism|hypogonadism
656201|NCT00425568|low testosterone level|low testosterone level
656202|NCT00425568|gonadal deficiency|gonadal deficiency
656203|NCT00425555|Cutaneous T-Cell Lymphoma, adults|cutaneous t-cell lymphoma, adults
656204|NCT00425555|Mycosis Fungoides|mycosis fungoides
656205|NCT00425555|Sézary Syndrome|sézary syndrome
656206|NCT00425555|CTCL|ctcl
656207|NCT00425542|Pulmonary embolism|pulmonary embolism
656208|NCT00425542|Outpatient care|outpatient care
656209|NCT00425542|Prognosis|prognosis
656210|NCT00425516|neoadjuvant chemotherapy|neoadjuvant chemotherapy
656211|NCT00425516|breast cancer|breast cancer
656212|NCT00425516|sequential treatment|sequential treatment
656213|NCT00425503|Prostate Cancer|prostate cancer
656214|NCT00425503|Bortezomib|bortezomib
656215|NCT00425503|Radical Prostatectomy|radical prostatectomy
656216|NCT00425503|Phase 2 Clinical Trial|phase 2 clinical trial
656217|NCT00425477|refractory anemia with excess blasts|refractory anemia with excess blasts
656218|NCT00425477|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
656219|NCT00425477|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
656220|NCT00425477|secondary acute myeloid leukemia|secondary acute myeloid leukemia
656221|NCT00425477|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
656222|NCT00425477|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
656223|NCT00425477|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
656224|NCT00425477|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
656225|NCT00425477|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
656226|NCT00425477|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
656227|NCT00425477|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
656228|NCT00425477|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
656229|NCT00425477|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
656230|NCT00425477|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
656231|NCT00425477|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
656232|NCT00425477|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
656233|NCT00425477|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
656234|NCT00425477|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
656235|NCT00425477|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
656236|NCT00425477|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
656237|NCT00425477|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
656238|NCT00425477|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
656239|NCT00425477|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
656240|NCT00425477|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
656241|NCT00425451|Periodontitis|periodontitis
656242|NCT00425451|Dental Care|dental care
656243|NCT00425451|Efficacy|efficacy
656244|NCT00425451|Safety|safety
656245|NCT00425425|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
656246|NCT00425425|stage IIA esophageal cancer|stage iia esophageal cancer
656247|NCT00425425|stage IIB esophageal cancer|stage iib esophageal cancer
656248|NCT00425425|stage IIIA esophageal cancer|stage iiia esophageal cancer
656249|NCT00425425|stage IIIB esophageal cancer|stage iiib esophageal cancer
656250|NCT00425425|stage IIIC esophageal cancer|stage iiic esophageal cancer
656251|NCT00425399|Schizophrenia|schizophrenia
656252|NCT00425399|Shiatsu|shiatsu
656253|NCT00425386|stage III renal cell cancer|stage iii renal cell cancer
656254|NCT00425386|stage IV renal cell cancer|stage iv renal cell cancer
656255|NCT00425386|clear cell renal cell carcinoma|clear cell renal cell carcinoma
656256|NCT00425386|recurrent renal cell cancer|recurrent renal cell cancer
656257|NCT00425373|Hypertension, Valsartan, Amlodipine, high blood pressure|hypertension, valsartan, amlodipine, high blood pressure
656258|NCT00425360|stage III pancreatic cancer|stage iii pancreatic cancer
656259|NCT00425360|stage IV pancreatic cancer|stage iv pancreatic cancer
656260|NCT00425360|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
656261|NCT00425360|recurrent pancreatic cancer|recurrent pancreatic cancer
656262|NCT00425347|Multiple myeloma, MM, plasma cell myeloma, cancer|multiple myeloma, mm, plasma cell myeloma, cancer
656263|NCT00425334|Blood loss|blood loss
656264|NCT00425334|Ischemia|ischemia
656265|NCT00425334|Hemoglobin|hemoglobin
656266|NCT00425334|Blood Substitutes|blood substitutes
656267|NCT00425334|Plasma Expanders|plasma expanders
656268|NCT00425321|Arthritis|arthritis
656269|NCT00425321|Joints|joints
656270|NCT00425321|Auto immune|auto immune
656271|NCT00425308|Everolimus, calcineurine inhibitor, renal transplantation in maintenance, chronic allograft nephropathy|everolimus, calcineurine inhibitor, renal transplantation in maintenance, chronic allograft nephropathy
656272|NCT00425282|RWJ-333369|rwj-333369
656273|NCT00425282|anticonvulsants|anticonvulsants
656274|NCT00425282|antiepileptic drugs|antiepileptic drugs
656275|NCT00425269|lifestyle intervention|lifestyle intervention
656276|NCT00425269|Type 2 Diabetes|type 2 diabetes
656277|NCT00425269|Metabolic syndrome|metabolic syndrome
656278|NCT00425269|Pakistani women|pakistani women
656279|NCT00425269|dietary change|dietary change
656280|NCT00425269|Physical activity|physical activity
656281|NCT00425269|Norway|norway
656282|NCT00425243|primary insomnia|primary insomnia
656283|NCT00425243|chronic insomnia|chronic insomnia
656284|NCT00425178|Chronic wounds|chronic wounds
656285|NCT00425178|Diabetes|diabetes
656286|NCT00425178|Ulcers|ulcers
656287|NCT00425178|Arterial bypass|arterial bypass
656288|NCT00425178|Angioplasty|angioplasty
656289|NCT00425178|Diabetic ulcers|diabetic ulcers
656290|NCT00425152|stage II colon cancer|stage ii colon cancer
656291|NCT00425152|stage III colon cancer|stage iii colon cancer
656292|NCT00425139|Cancer|cancer
656293|NCT00425139|Video game|video game
656294|NCT00425139|Adolescent|adolescent
656295|NCT00425139|Young adult|young adult
656296|NCT00425126|Delayed Graft Function|delayed graft function
656297|NCT00425126|Kidney Transplantation|kidney transplantation
656298|NCT00425113|Mycobacterium Tuberculosis|mycobacterium tuberculosis
656299|NCT00425113|Anaerobic|anaerobic
656300|NCT00425113|FDG-PET-HRCT|fdg-pet-hrct
656301|NCT00425113|HRCT|hrct
656302|NCT00425113|Lesion Matrix|lesion matrix
656303|NCT00425113|Tuberculosis|tuberculosis
656304|NCT00425113|TB|tb
656305|NCT00425074|slow release ASA|slow release asa
656306|NCT00425074|platelet functionalism|platelet functionalism
656307|NCT00425074|secondary cardiovascular prevention|secondary cardiovascular prevention
656308|NCT00425035|Renal Cancer|renal cancer
656309|NCT00425022|lung cancer|lung cancer
656310|NCT00425022|video-assisted thoracic surgery|video-assisted thoracic surgery
656311|NCT00425009|Berberine|berberine
656312|NCT00425009|Type 2 diabetes|type 2 diabetes
656313|NCT00425009|Treatment|treatment
656314|NCT00424983|Multiple myeloma|multiple myeloma
656315|NCT00424983|breast cancer|breast cancer
656316|NCT00424983|zoledronic acid|zoledronic acid
656317|NCT00424983|pharmacokinetics|pharmacokinetics
656318|NCT00424970|high altitude|high altitude
656319|NCT00424970|hypoxia|hypoxia
656320|NCT00424970|pulmonary hypertension|pulmonary hypertension
656321|NCT00424970|polycythemia|polycythemia
656322|NCT00424970|hypoventilation|hypoventilation
656323|NCT00424957|Ammonia|ammonia
656324|NCT00424957|Astrocytes|astrocytes
656325|NCT00424957|Citric acid cycle|citric acid cycle
656326|NCT00424957|Alpha ketoglutarate dehydrogenase|alpha ketoglutarate dehydrogenase
656327|NCT00424944|Malaria|malaria
656328|NCT00424944|Vaccine|vaccine
656329|NCT00424944|GMZ2|gmz2
656330|NCT00424944|Safety|safety
656331|NCT00424944|African|african
656332|NCT00424944|immunogenicity|immunogenicity
656333|NCT00424931|narcolepsy|narcolepsy
656334|NCT00424931|sleepiness|sleepiness
656335|NCT00424918|Dance|dance
656336|NCT00424918|Peers|peers
656337|NCT00424918|middle school-based|middle school-based
656338|NCT00424918|feasibility|feasibility
656339|NCT00424866|Peripheral Arterial Disease|peripheral arterial disease
656340|NCT00424866|Ischemia|ischemia
656341|NCT00424866|Intermittent Claudication|intermittent claudication
656342|NCT00424840|lung cancer, Carboplatin, bortezomib, Bevacizumab|lung cancer, carboplatin, bortezomib, bevacizumab
656343|NCT00424827|pancreatic cancer, gemcitabine, 5-FU, cetuximab, radiation|pancreatic cancer, gemcitabine, 5-fu, cetuximab, radiation
656344|NCT00424814|HIV mother to child prevention|hiv mother to child prevention
656345|NCT00424814|HIV Infections|hiv infections
656346|NCT00424814|Kaletra|kaletra
656347|NCT00424814|Combivir|combivir
656348|NCT00424814|HIV Seronegativity|hiv seronegativity
656349|NCT00424788|multiple sclerosis (MS)|multiple sclerosis (ms)
656350|NCT00424775|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
656351|NCT00424762|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
656352|NCT00424762|Congestive Heart Failure|congestive heart failure
656353|NCT00424762|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
656354|NCT00424762|intracellular cardiomyocyte triglycerides|intracellular cardiomyocyte triglycerides
656355|NCT00424762|thiazolidinedione|thiazolidinedione
656356|NCT00424762|rosiglitazone|rosiglitazone
656357|NCT00424762|nuclear magnetic resonance|nuclear magnetic resonance
656358|NCT00424749|Antineutrophil cytoplasmic antibody associated vasculitis|antineutrophil cytoplasmic antibody associated vasculitis
656359|NCT00424749|Glomerulonephritis|glomerulonephritis
656360|NCT00424749|Rituximab|rituximab
656361|NCT00424736|blunt trauma, pediatric patient, imaging, computer tomography|blunt trauma, pediatric patient, imaging, computer tomography
656362|NCT00424723|pemetrexed|pemetrexed
656363|NCT00424723|neuroendocrine tumors|neuroendocrine tumors
656364|NCT00424723|metastatic neuroendocrine tumors|metastatic neuroendocrine tumors
656365|NCT00424710|choroidal neovascularization|choroidal neovascularization
656366|NCT00424697|Brain imaging,|brain imaging,
656367|NCT00424697|fMRI,|fmri,
656368|NCT00424697|stimulation,|stimulation,
656369|NCT00424697|pharmacodynamics,|pharmacodynamics,
656370|NCT00424697|tolerability,|tolerability,
656371|NCT00424697|healthy subjects|healthy subjects
656372|NCT00424684|TB|tb
656373|NCT00424684|Chronic Liver Disease|chronic liver disease
656374|NCT00424658|breathing disorders|breathing disorders
656375|NCT00424645|Hematologic Malignancy|hematologic malignancy
656376|NCT00424645|Solid Tumor|solid tumor
656377|NCT00424645|Glucarpidase|glucarpidase
656378|NCT00424645|Voraxaze|voraxaze
656379|NCT00424645|Delayed Methotrexate Clearance|delayed methotrexate clearance
656380|NCT00424645|Placebo|placebo
656381|NCT00424619|Vitamin D|vitamin d
656382|NCT00424619|Hip fracture|hip fracture
656383|NCT00424619|Optimal level|optimal level
656384|NCT00424619|Deficiency|deficiency
656385|NCT00424619|Functional muscle strength|functional muscle strength
656386|NCT00424606|High risk node negative|high risk node negative
656387|NCT00424567|Fracture|fracture
656388|NCT00424567|non union fracture|non union fracture
656389|NCT00424567|ununited fracture|ununited fracture
656390|NCT00424567|pseudarthrosis|pseudarthrosis
656391|NCT00424541|Pharmacokinetics, pharmacodynamics, safety, RAS profile, SPP100, aliskiren, Japanese, essential hypertension|pharmacokinetics, pharmacodynamics, safety, ras profile, spp100, aliskiren, japanese, essential hypertension
656392|NCT00424541|Mild to moderate essential hypertension|mild to moderate essential hypertension
656393|NCT00424528|COPD including chronic bronchitis and emphysema|copd including chronic bronchitis and emphysema
656394|NCT00424515|Imatinib|imatinib
656395|NCT00424515|Gleevec|gleevec
656396|NCT00424489|Refractory Myasthenia Gravis|refractory myasthenia gravis
656397|NCT00424489|Autologous Stem Cell Transplantation|autologous stem cell transplantation
656398|NCT00424489|Cyclophosphamide and ATG|cyclophosphamide and atg
656399|NCT00424476|Autoimmune Diseases|autoimmune diseases
656400|NCT00424476|Lupus|lupus
656401|NCT00424476|SLE|sle
656402|NCT00424476|Systemic Lupus Erythematosus|systemic lupus erythematosus
656403|NCT00424476|Belimumab|belimumab
656404|NCT00424476|Antibodies|antibodies
656405|NCT00424463|Amyotrophic lateral sclerosis (ALS)|amyotrophic lateral sclerosis (als)
656406|NCT00424450|contrast ultrasound|contrast ultrasound
656407|NCT00424450|muscle perfusion|muscle perfusion
656408|NCT00424424|Postoperative Dental Pain|postoperative dental pain
656409|NCT00424385|AIPC, Prostate cancer|aipc, prostate cancer
656410|NCT00424385|prostate|prostate
656411|NCT00424359|Mulitple Sclerosis|mulitple sclerosis
656412|NCT00424359|Ambulation|ambulation
656413|NCT00424346|Active Rheumatoid Arthritis|active rheumatoid arthritis
656414|NCT00424346|anti-interleukin-1beta monoclonal antibody|anti-interleukin-1beta monoclonal antibody
656415|NCT00424346|methotrexate|methotrexate
656416|NCT00424320|Acute kidney failure|acute kidney failure
656417|NCT00424320|Contrast-induced nephropathy|contrast-induced nephropathy
656418|NCT00424320|Non-ionic contrast media|non-ionic contrast media
656419|NCT00424320|Ionic contrast media|ionic contrast media
656420|NCT00424320|Iopamidol|iopamidol
656421|NCT00424320|Percutaneous coronary intervention|percutaneous coronary intervention
656422|NCT00424320|Coronariography|coronariography
656423|NCT00424281|Arixtra, fondaparinux, vasopressor, venous thrombolism|arixtra, fondaparinux, vasopressor, venous thrombolism
656424|NCT00424268|COPD|copd
656425|NCT00424268|Roflumilast|roflumilast
656426|NCT00424255|Cancer of the Head and Neck|cancer of the head and neck
656427|NCT00424255|Neck cancer|neck cancer
656428|NCT00424255|Adjuvant|adjuvant
656429|NCT00424255|Head and neck cancer|head and neck cancer
656430|NCT00424255|High-risk head and neck cancer|high-risk head and neck cancer
656431|NCT00424255|Post-surgery|post-surgery
656432|NCT00424255|Head cancer|head cancer
656433|NCT00424242|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
656434|NCT00424242|tumors metastatic to brain|tumors metastatic to brain
656435|NCT00424242|leptomeningeal metastases|leptomeningeal metastases
656501|NCT00424242|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
656436|NCT00424242|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
656437|NCT00424242|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
656438|NCT00424242|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
656439|NCT00424242|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
656440|NCT00424242|chronic eosinophilic leukemia|chronic eosinophilic leukemia
656441|NCT00424242|primary myelofibrosis|primary myelofibrosis
656442|NCT00424242|chronic neutrophilic leukemia|chronic neutrophilic leukemia
656443|NCT00424242|essential thrombocythemia|essential thrombocythemia
656444|NCT00424242|polycythemia vera|polycythemia vera
656445|NCT00424242|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
656446|NCT00424242|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
656447|NCT00424242|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
656448|NCT00424242|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
656449|NCT00424242|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
656450|NCT00424242|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
656451|NCT00424242|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
656452|NCT00424242|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
656453|NCT00424242|secondary acute myeloid leukemia|secondary acute myeloid leukemia
656454|NCT00424242|acute undifferentiated leukemia|acute undifferentiated leukemia
656455|NCT00424242|mast cell leukemia|mast cell leukemia
656456|NCT00424242|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
656457|NCT00424242|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
656458|NCT00424242|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
656459|NCT00424242|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
656460|NCT00424242|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
656461|NCT00424242|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
656462|NCT00424242|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
656463|NCT00424242|refractory hairy cell leukemia|refractory hairy cell leukemia
656464|NCT00424242|prolymphocytic leukemia|prolymphocytic leukemia
656465|NCT00424242|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
656466|NCT00424242|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
656467|NCT00424242|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
656468|NCT00424242|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
656469|NCT00424242|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
656470|NCT00424242|intraocular lymphoma|intraocular lymphoma
656471|NCT00424242|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
656472|NCT00424242|refractory multiple myeloma|refractory multiple myeloma
656473|NCT00424242|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
656474|NCT00424242|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
656475|NCT00424242|anaplastic large cell lymphoma|anaplastic large cell lymphoma
656476|NCT00424242|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
656477|NCT00424242|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
656478|NCT00424242|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
656479|NCT00424242|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
656480|NCT00424242|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
656481|NCT00424242|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
656482|NCT00424242|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
656483|NCT00424242|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
656484|NCT00424242|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
656485|NCT00424242|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
656486|NCT00424242|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
656487|NCT00424242|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
656488|NCT00424242|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
656489|NCT00424242|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
656490|NCT00424242|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
656491|NCT00424242|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
656492|NCT00424242|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
656493|NCT00424242|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
656494|NCT00424242|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
656495|NCT00424242|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
656496|NCT00424242|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
656497|NCT00424242|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
656498|NCT00424242|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
656499|NCT00424242|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
656500|NCT00424242|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
656502|NCT00424242|splenic marginal zone lymphoma|splenic marginal zone lymphoma
656503|NCT00424242|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
656504|NCT00424242|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
656505|NCT00424242|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
656506|NCT00424242|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
656507|NCT00424242|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
656508|NCT00424242|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
656509|NCT00424242|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
656510|NCT00424242|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
656511|NCT00424242|secondary myelofibrosis|secondary myelofibrosis
656512|NCT00424242|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
656513|NCT00424242|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
656514|NCT00424242|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
656515|NCT00424242|stage III multiple myeloma|stage iii multiple myeloma
656516|NCT00424242|primary systemic amyloidosis|primary systemic amyloidosis
656517|NCT00424242|extramedullary plasmacytoma|extramedullary plasmacytoma
656518|NCT00424242|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
656519|NCT00424242|isolated plasmacytoma of bone|isolated plasmacytoma of bone
656520|NCT00424229|MDS INT-2MDS HIGH RISKDELETION 5q[31]Lenalidomide|mds int-2mds high riskdeletion 5q[31]lenalidomide
656521|NCT00424216|Mood|mood
656522|NCT00424216|Emotion|emotion
656523|NCT00424216|Judgment|judgment
656524|NCT00424216|Cortex|cortex
656525|NCT00424216|Brain Stimulation|brain stimulation
656526|NCT00424216|Healthy Volunteer|healthy volunteer
656527|NCT00424216|HV|hv
656528|NCT00424203|cognitive/functional effects|cognitive/functional effects
656529|NCT00424203|depression|depression
656530|NCT00424203|malnutrition|malnutrition
656531|NCT00424203|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
656532|NCT00424203|stage IA breast cancer|stage ia breast cancer
656533|NCT00424203|stage IB breast cancer|stage ib breast cancer
656534|NCT00424203|stage II breast cancer|stage ii breast cancer
656535|NCT00424203|stage IIIA breast cancer|stage iiia breast cancer
656536|NCT00424203|stage IIIB breast cancer|stage iiib breast cancer
656537|NCT00424203|stage IIIC breast cancer|stage iiic breast cancer
656538|NCT00424203|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
656539|NCT00424203|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
656540|NCT00424190|Abscess|abscess
656541|NCT00424190|Antibacterial|antibacterial
656542|NCT00424190|Antibiotic|antibiotic
656543|NCT00424190|Antimicrobial|antimicrobial
656544|NCT00424190|Bacterial infection, skin|bacterial infection, skin
656545|NCT00424190|Ceftaroline|ceftaroline
656546|NCT00424190|Ceftaroline acetate|ceftaroline acetate
656547|NCT00424190|Cellulitis|cellulitis
656548|NCT00424190|Cephalosporin|cephalosporin
656549|NCT00424190|Complicated skin and skin structure infection|complicated skin and skin structure infection
656550|NCT00424190|cSSSI|csssi
656551|NCT00424190|Intravenous|intravenous
656552|NCT00424190|Methicillin-resistant Staphylococcus Aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
656553|NCT00424190|PPI-0903|ppi-0903
656554|NCT00424190|Prodrug|prodrug
656555|NCT00424190|Skin disease, bacterial|skin disease, bacterial
656556|NCT00424190|Skin infection|skin infection
656557|NCT00424190|Staphylococcal skin infection|staphylococcal skin infection
656558|NCT00424190|Staphylococcus aureus|staphylococcus aureus
656559|NCT00424190|Streptococcal skin infection|streptococcal skin infection
656560|NCT00424190|Surgical site infection|surgical site infection
656561|NCT00424190|TAK-599|tak-599
656562|NCT00424177|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
656563|NCT00424177|ITP|itp
656564|NCT00424177|thrombocytopenia|thrombocytopenia
656565|NCT00424177|platelets|platelets
656566|NCT00424164|male breast cancer|male breast cancer
656567|NCT00424164|stage IIIB breast cancer|stage iiib breast cancer
656568|NCT00424164|stage IIIC breast cancer|stage iiic breast cancer
656569|NCT00424164|stage IV breast cancer|stage iv breast cancer
656570|NCT00424164|recurrent breast cancer|recurrent breast cancer
656571|NCT00424151|Graves' Disease|graves' disease
656572|NCT00424151|Dysthyroid Ophthalmopathy|dysthyroid ophthalmopathy
656573|NCT00424151|Thyroid related orbitopathy|thyroid related orbitopathy
656574|NCT00424138|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
656575|NCT00424138|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
656576|NCT00424138|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
656577|NCT00424138|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
656578|NCT00424125|Asthma|asthma
656579|NCT00424125|Compliance|compliance
656580|NCT00424125|Randomized clinical trial|randomized clinical trial
656581|NCT00424112|motivation to change|motivation to change
656582|NCT00424112|treatment motivation|treatment motivation
656583|NCT00424112|alcohol use disorders|alcohol use disorders
656584|NCT00424099|Advanced Cancer|advanced cancer
656585|NCT00424099|Fatigue|fatigue
656894|NCT00423436|Survey|survey
656586|NCT00424099|Nursing Telephone Intervention|nursing telephone intervention
656587|NCT00424099|NTI|nti
656588|NCT00424099|Methylphenidate|methylphenidate
656589|NCT00424099|Placebo|placebo
656590|NCT00424099|Ritalin|ritalin
656591|NCT00424060|adult glioblastoma|adult glioblastoma
656592|NCT00424060|recurrent adult brain tumor|recurrent adult brain tumor
656593|NCT00424060|adult giant cell glioblastoma|adult giant cell glioblastoma
656594|NCT00424060|adult gliosarcoma|adult gliosarcoma
656595|NCT00424047|Multiple Myeloma|multiple myeloma
656596|NCT00424047|Celgene|celgene
656597|NCT00424047|Revlimid|revlimid
656598|NCT00424047|CC-5013|cc-5013
656599|NCT00424034|safety|safety
656600|NCT00424034|Pharmacokinetics|pharmacokinetics
656601|NCT00424034|effect of food on pharmacokinetics|effect of food on pharmacokinetics
656602|NCT00424008|Glucocorticosteroids|glucocorticosteroids
656603|NCT00424008|Dry Powder Inhaler|dry powder inhaler
656604|NCT00424008|Bronchodilator|bronchodilator
656605|NCT00424008|Metered-Dose Inhaler|metered-dose inhaler
656606|NCT00423969|Depression|depression
656607|NCT00423969|Cognitive Impairment|cognitive impairment
656608|NCT00423956|Teeth root resorption, ultrasound, therapy|teeth root resorption, ultrasound, therapy
656609|NCT00423943|cognition|cognition
656610|NCT00423943|memory|memory
656611|NCT00423930|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
656612|NCT00423930|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
656613|NCT00423930|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
656614|NCT00423930|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
656615|NCT00423930|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
656616|NCT00423930|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
656617|NCT00423930|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
656618|NCT00423930|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
656619|NCT00423930|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
656620|NCT00423930|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
656621|NCT00423930|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
656622|NCT00423930|tongue cancer|tongue cancer
656623|NCT00423917|stage IV breast cancer|stage iv breast cancer
656624|NCT00423917|male breast cancer|male breast cancer
656625|NCT00423917|recurrent breast cancer|recurrent breast cancer
656626|NCT00423904|Early intervention|early intervention
656627|NCT00423904|Brief intervention|brief intervention
656628|NCT00423904|alcohol|alcohol
656629|NCT00423904|general hospital|general hospital
656630|NCT00423865|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
656631|NCT00423865|CISPLATIN|cisplatin
656632|NCT00423865|RAD001 (EVEROLIMUS)|rad001 (everolimus)
656633|NCT00423865|06-129|06-129
656634|NCT00423852|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
656635|NCT00423852|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
656636|NCT00423852|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
656637|NCT00423852|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
656638|NCT00423852|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
656639|NCT00423852|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
656640|NCT00423852|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
656641|NCT00423852|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
656642|NCT00423852|recurrent extragonadal seminoma|recurrent extragonadal seminoma
656643|NCT00423852|stage III extragonadal non-seminomatous germ cell tumor|stage iii extragonadal non-seminomatous germ cell tumor
656644|NCT00423852|stage III extragonadal seminoma|stage iii extragonadal seminoma
656645|NCT00423852|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
656646|NCT00423852|stage IV extragonadal seminoma|stage iv extragonadal seminoma
656647|NCT00423852|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
656648|NCT00423852|adult teratoma|adult teratoma
656649|NCT00423852|testicular immature teratoma|testicular immature teratoma
656650|NCT00423852|testicular mature teratoma|testicular mature teratoma
656651|NCT00423839|Mycobacterium tuberculosis|mycobacterium tuberculosis
656652|NCT00423839|Antigen 85A|antigen 85a
656653|NCT00423839|Modified Vaccinia Virus Ankara (MVA).|modified vaccinia virus ankara (mva).
656654|NCT00423826|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
656655|NCT00423826|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
656656|NCT00423826|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
656657|NCT00423826|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
656658|NCT00423826|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
656659|NCT00423826|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
656660|NCT00423826|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
656661|NCT00423826|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
656662|NCT00423826|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
656663|NCT00423826|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
656664|NCT00423826|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
656665|NCT00423826|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
656666|NCT00423826|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
656667|NCT00423826|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
656668|NCT00423826|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
656669|NCT00423826|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
656670|NCT00423826|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
656671|NCT00423826|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
656672|NCT00423826|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
656673|NCT00423826|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
656674|NCT00423826|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
656675|NCT00423826|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
656676|NCT00423826|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
656677|NCT00423826|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
656678|NCT00423826|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
656679|NCT00423826|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
656680|NCT00423826|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
656681|NCT00423826|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
656682|NCT00423826|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
656683|NCT00423826|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
656684|NCT00423826|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
656685|NCT00423826|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
656686|NCT00423826|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
656687|NCT00423826|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
656688|NCT00423826|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
656689|NCT00423826|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
656690|NCT00423826|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
656691|NCT00423826|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
656692|NCT00423826|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
656693|NCT00423826|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
656694|NCT00423826|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
656695|NCT00423826|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
656696|NCT00423826|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
656697|NCT00423826|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
656698|NCT00423826|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
656699|NCT00423826|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
656700|NCT00423826|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
656701|NCT00423826|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
656702|NCT00423826|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
656703|NCT00423826|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
656704|NCT00423826|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
656705|NCT00423826|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
656706|NCT00423826|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
656707|NCT00423826|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
656708|NCT00423826|secondary acute myeloid leukemia|secondary acute myeloid leukemia
656709|NCT00423826|stage I multiple myeloma|stage i multiple myeloma
656710|NCT00423826|stage II multiple myeloma|stage ii multiple myeloma
656711|NCT00423826|stage III multiple myeloma|stage iii multiple myeloma
656712|NCT00423826|extramedullary plasmacytoma|extramedullary plasmacytoma
656713|NCT00423826|isolated plasmacytoma of bone|isolated plasmacytoma of bone
656714|NCT00423826|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
656715|NCT00423826|primary systemic amyloidosis|primary systemic amyloidosis
656716|NCT00423826|refractory multiple myeloma|refractory multiple myeloma
656717|NCT00423826|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
656718|NCT00423826|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
656719|NCT00423826|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
656720|NCT00423826|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
656721|NCT00423826|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
656895|NCT00423436|NSCLC|nsclc
656722|NCT00423826|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
656723|NCT00423826|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
656724|NCT00423826|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
656725|NCT00423826|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
656726|NCT00423826|Burkitt lymphoma|burkitt lymphoma
656727|NCT00423826|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
656728|NCT00423826|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
656729|NCT00423826|splenic marginal zone lymphoma|splenic marginal zone lymphoma
656730|NCT00423826|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
656731|NCT00423826|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
656732|NCT00423826|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
656733|NCT00423826|secondary myelofibrosis|secondary myelofibrosis
656734|NCT00423813|FMS|fms
656735|NCT00423813|Fibro|fibro
656736|NCT00423813|pain|pain
656737|NCT00423813|Body pain|body pain
656738|NCT00423813|tenderness|tenderness
656739|NCT00423813|stiffness|stiffness
656740|NCT00423813|muscular pain|muscular pain
656741|NCT00423813|joint pain|joint pain
656742|NCT00423787|Allergy|allergy
656743|NCT00423787|Allergoid|allergoid
656744|NCT00423787|Specific Immunotherapy|specific immunotherapy
656745|NCT00423774|Allogeneic Hematopoietic Stem Cell Transplant|allogeneic hematopoietic stem cell transplant
656746|NCT00423774|Psychological Distress|psychological distress
656747|NCT00423774|Coping|coping
656748|NCT00423774|Cognitive Behavior Therapy|cognitive behavior therapy
656749|NCT00423774|Bone Marrow Transplant|bone marrow transplant
656750|NCT00423774|Coping Skills|coping skills
656751|NCT00423761|Pharmacokinetics,|pharmacokinetics,
656752|NCT00423761|tolerability,|tolerability,
656753|NCT00423761|healthy,|healthy,
656754|NCT00423761|subjects|subjects
656755|NCT00423722|Advanced Cancer|advanced cancer
656756|NCT00423722|Hospice Care|hospice care
656757|NCT00423722|Caregiver|caregiver
656758|NCT00423722|Saline|saline
656759|NCT00423722|Hydration|hydration
656760|NCT00423722|Dehydration|dehydration
656761|NCT00423709|Hodgkin's Disease|hodgkin's disease
656762|NCT00423709|Allogeneic Blood Stem Cell Transplantation|allogeneic blood stem cell transplantation
656763|NCT00423709|Bone Marrow Transplantation|bone marrow transplantation
656764|NCT00423709|Fludarabine|fludarabine
656765|NCT00423709|Melphalan|melphalan
656766|NCT00423696|stage IV colon cancer|stage iv colon cancer
656767|NCT00423696|stage IV rectal cancer|stage iv rectal cancer
656768|NCT00423696|recurrent colon cancer|recurrent colon cancer
656769|NCT00423696|recurrent rectal cancer|recurrent rectal cancer
656770|NCT00423683|Cancer|cancer
656771|NCT00423683|thromboembolism|thromboembolism
656772|NCT00423657|Abscess|abscess
656773|NCT00423657|Antibacterial|antibacterial
656774|NCT00423657|Antibiotic|antibiotic
656775|NCT00423657|Antimicrobial|antimicrobial
656776|NCT00423657|Bacterial infection, skin|bacterial infection, skin
656777|NCT00423657|Ceftaroline|ceftaroline
656778|NCT00423657|Ceftaroline acetate|ceftaroline acetate
656779|NCT00423657|Cellulitis|cellulitis
656780|NCT00423657|Cephalosporin|cephalosporin
656781|NCT00423657|Complicated skin and skin structure infection (cSSSI)|complicated skin and skin structure infection (csssi)
656782|NCT00423657|cSSSI|csssi
656783|NCT00423657|Intravenous|intravenous
656784|NCT00423657|Methicillin-resistant Staphylococcus Aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
656785|NCT00423657|PPI-0903|ppi-0903
656786|NCT00423657|Prodrug|prodrug
656787|NCT00423657|Skin disease, bacterial|skin disease, bacterial
656788|NCT00423657|Skin infection|skin infection
656789|NCT00423657|Staphylococcal skin infection|staphylococcal skin infection
656790|NCT00423657|Staphylococcus aureus|staphylococcus aureus
656791|NCT00423657|Streptococcal skin infection|streptococcal skin infection
656792|NCT00423657|Surgical site infection|surgical site infection
656793|NCT00423657|TAK-599|tak-599
656794|NCT00423644|Multiple Myeloma|multiple myeloma
656795|NCT00423644|arsenic|arsenic
656796|NCT00423644|cancer study|cancer study
656797|NCT00423644|failed treatment|failed treatment
656798|NCT00423631|Pain|pain
656799|NCT00423631|Fibromyalgia|fibromyalgia
656800|NCT00423631|Internet|internet
656801|NCT00423618|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
656802|NCT00423618|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
656803|NCT00423618|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
656804|NCT00423618|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
656805|NCT00423618|adult synovial sarcoma|adult synovial sarcoma
656806|NCT00423618|adult angiosarcoma|adult angiosarcoma
656807|NCT00423618|adult epithelioid sarcoma|adult epithelioid sarcoma
656808|NCT00423618|adult extraskeletal chondrosarcoma|adult extraskeletal chondrosarcoma
656809|NCT00423618|adult leiomyosarcoma|adult leiomyosarcoma
656810|NCT00423618|adult liposarcoma|adult liposarcoma
656811|NCT00423618|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
656812|NCT00423618|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
656813|NCT00423618|adult malignant mesenchymoma|adult malignant mesenchymoma
656814|NCT00423618|adult fibrosarcoma|adult fibrosarcoma
656815|NCT00423618|adult neurofibrosarcoma|adult neurofibrosarcoma
656816|NCT00423618|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
656817|NCT00423605|FMS|fms
656818|NCT00423605|Fibro|fibro
656819|NCT00423605|Pain|pain
656820|NCT00423605|Body Pain|body pain
656821|NCT00423605|Tenderness|tenderness
656822|NCT00423605|Joint pain|joint pain
656823|NCT00423605|Stiffness|stiffness
656824|NCT00423605|Muscular Pain|muscular pain
656825|NCT00423566|Mycobacterium tuberculosis|mycobacterium tuberculosis
656826|NCT00423566|85A antigen|85a antigen
656827|NCT00423566|Recombinant Modified Vaccinia virus Ankara|recombinant modified vaccinia virus ankara
656828|NCT00423566|Phase I study|phase i study
656829|NCT00423566|Immunogenicity|immunogenicity
656830|NCT00423553|Nitrite and Cytoprotection|nitrite and cytoprotection
656831|NCT00423553|Ischemic Preconditioning|ischemic preconditioning
656832|NCT00423553|Atrial Trabeculae Contractile Function|atrial trabeculae contractile function
656833|NCT00423553|Ischemia|ischemia
656834|NCT00423540|magnesium infusion|magnesium infusion
656835|NCT00423540|magnesium sulfate|magnesium sulfate
656836|NCT00423540|rest cramps|rest cramps
656837|NCT00423540|nocturnal leg cramps|nocturnal leg cramps
656838|NCT00423540|muscle cramps|muscle cramps
656839|NCT00423540|fractional urinary excretion|fractional urinary excretion
656840|NCT00423540|urinary excretion|urinary excretion
656841|NCT00423540|24 hour urine|24 hour urine
656842|NCT00423540|serum magnesium|serum magnesium
656843|NCT00423540|magnesium deficiency|magnesium deficiency
656844|NCT00423540|family practice|family practice
656845|NCT00423540|general practice|general practice
656846|NCT00423540|richmond|richmond
656847|NCT00423540|cramp frequency|cramp frequency
656848|NCT00423540|magnesium status|magnesium status
656849|NCT00423540|urinary magnesium|urinary magnesium
656850|NCT00423540|cramp diary|cramp diary
656851|NCT00423540|sf 36|sf 36
656852|NCT00423527|multiple sclerosis|multiple sclerosis
656853|NCT00423527|central pain|central pain
656854|NCT00423527|levetiracetam|levetiracetam
656855|NCT00423514|graft versus host disease|graft versus host disease
656856|NCT00423514|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
656857|NCT00423514|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
656858|NCT00423514|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
656859|NCT00423514|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
656860|NCT00423514|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
656861|NCT00423514|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
656862|NCT00423514|acute undifferentiated leukemia|acute undifferentiated leukemia
656863|NCT00423514|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
656864|NCT00423514|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
656865|NCT00423514|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
656866|NCT00423514|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
656867|NCT00423514|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
656868|NCT00423514|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
656869|NCT00423514|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
656870|NCT00423514|secondary acute myeloid leukemia|secondary acute myeloid leukemia
656871|NCT00423514|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
656872|NCT00423514|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
656873|NCT00423514|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
656874|NCT00423514|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
656875|NCT00423514|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
656876|NCT00423514|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
656877|NCT00423514|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
656878|NCT00423514|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
656879|NCT00423514|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
656880|NCT00423514|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
656881|NCT00423475|adenocarcinoma of the prostate|adenocarcinoma of the prostate
656882|NCT00423475|stage IIB prostate cancer|stage iib prostate cancer
656883|NCT00423475|stage IIA prostate cancer|stage iia prostate cancer
656884|NCT00423475|stage III prostate cancer|stage iii prostate cancer
656885|NCT00423475|recurrent prostate cancer|recurrent prostate cancer
656886|NCT00423475|stage IV prostate cancer|stage iv prostate cancer
656887|NCT00423462|Psychotherapy|psychotherapy
656888|NCT00423462|Long-term effects|long-term effects
656889|NCT00423449|Advanced Stage IIIB/IV Non-Small Cell Lung Cancer|advanced stage iiib/iv non-small cell lung cancer
656890|NCT00423436|Non-Small Cell Lung Cancer|non-small cell lung cancer
656891|NCT00423436|Small Cell Lung Cancer|small cell lung cancer
656892|NCT00423436|Voice Response System|voice response system
656893|NCT00423436|Questionnaire|questionnaire
656899|NCT00423397|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
656900|NCT00423397|recurrent skin cancer|recurrent skin cancer
656901|NCT00423384|Ibandronate|ibandronate
656902|NCT00423384|Placebo|placebo
656903|NCT00423384|Doubleblind|doubleblind
656904|NCT00423384|Bone|bone
656905|NCT00423384|loss|loss
656906|NCT00423384|Kidney|kidney
656907|NCT00423384|transplant|transplant
656908|NCT00423371|first Carpometacarpal (CMC) Joint|first carpometacarpal (cmc) joint
656909|NCT00423358|rheumatoid arthritis|rheumatoid arthritis
656910|NCT00423358|hypovitaminosis D|hypovitaminosis d
656911|NCT00423358|bone turnover|bone turnover
656912|NCT00423358|ergocalciferol|ergocalciferol
656913|NCT00423332|cancer|cancer
656914|NCT00423332|tumour|tumour
656915|NCT00423332|advanced cancer|advanced cancer
656916|NCT00423332|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
656917|NCT00423332|kidney cancer|kidney cancer
656918|NCT00423332|RECENTIN|recentin
656919|NCT00423319|Prevention of deep vein thrombosis and|prevention of deep vein thrombosis and
656920|NCT00423319|pulmonary embolism after total hip replacement surgery|pulmonary embolism after total hip replacement surgery
656921|NCT00423293|stage II anal cancer|stage ii anal cancer
656922|NCT00423293|stage IIIA anal cancer|stage iiia anal cancer
656923|NCT00423293|stage IIIB anal cancer|stage iiib anal cancer
656924|NCT00423293|basaloid carcinoma of the anus|basaloid carcinoma of the anus
656925|NCT00423293|cloacogenic carcinoma of the anus|cloacogenic carcinoma of the anus
656926|NCT00423293|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
656927|NCT00423280|Endothelium|endothelium
656928|NCT00423280|Nitric Oxide|nitric oxide
656929|NCT00423280|Magnetic Resonance Imaging|magnetic resonance imaging
656930|NCT00423280|Tetrahydrobiopterin|tetrahydrobiopterin
656931|NCT00423254|Cancer Vaccine|cancer vaccine
656932|NCT00423228|Alzheimer's disease|alzheimer's disease
656933|NCT00423228|cognitive impairment|cognitive impairment
656934|NCT00423228|cholinesterase inhibitors|cholinesterase inhibitors
656935|NCT00423228|sustained-release implants|sustained-release implants
656936|NCT00423228|long acting treatment|long acting treatment
656937|NCT00423189|LUV|luv
656938|NCT00423189|Lucentis|lucentis
656939|NCT00423189|Visudyne|visudyne
656940|NCT00423189|PDT|pdt
656941|NCT00423189|AMD|amd
656942|NCT00423189|ARMD|armd
656943|NCT00423189|Age|age
656944|NCT00423189|Related|related
656945|NCT00423189|Macular|macular
656946|NCT00423189|Degeneration|degeneration
656947|NCT00423163|Aspergillosis/blood|aspergillosis/blood
656948|NCT00423163|micafungin|micafungin
656949|NCT00423163|voriconazole|voriconazole
656950|NCT00423163|Aspergillus|aspergillus
656951|NCT00423124|Hematological malignancies|hematological malignancies
656952|NCT00423124|HSV-TK|hsv-tk
656953|NCT00423124|Haploidentical HCT|haploidentical hct
656954|NCT00423124|GvHD|gvhd
656955|NCT00423124|GvL|gvl
656956|NCT00423111|Multiple sclerosis|multiple sclerosis
656957|NCT00423111|Memory|memory
656958|NCT00423111|Cognitive deficits|cognitive deficits
656959|NCT00423111|MRI|mri
656960|NCT00423111|Hippocampus|hippocampus
656961|NCT00423111|Prefrontal cortex|prefrontal cortex
656962|NCT00423098|Lupus Nephritis|lupus nephritis
656963|NCT00423098|enteric-coated mycophenolate sodium|enteric-coated mycophenolate sodium
656964|NCT00423098|EC-MPS|ec-mps
656965|NCT00423098|Myfortic|myfortic
656966|NCT00423085|rivastigmine，Alzheimer's Disease, transdermal patch|rivastigmine，alzheimer's disease, transdermal patch
656967|NCT00423072|cleft palate|cleft palate
656968|NCT00423072|palatoplasty|palatoplasty
656969|NCT00423072|otitis|otitis
656970|NCT00423072|middle ear|middle ear
656971|NCT00423072|Eustachian tube|eustachian tube
656972|NCT00423059|intravitreal bevacizumab|intravitreal bevacizumab
656973|NCT00423059|proliferative diabetic retinopathy|proliferative diabetic retinopathy
656974|NCT00423059|VEGF|vegf
656975|NCT00423059|PEDF|pedf
656976|NCT00423046|Vaccines|vaccines
656977|NCT00423046|Cervical cancer|cervical cancer
656978|NCT00423046|Immunogenicity|immunogenicity
656979|NCT00423046|Humans|humans
656980|NCT00423046|Safety|safety
656981|NCT00423046|Viral infections|viral infections
656982|NCT00423046|Human papillomavirus (HPV)|human papillomavirus (hpv)
656983|NCT00423046|Comparative study|comparative study
656984|NCT00423046|Human papillomavirus vaccine|human papillomavirus vaccine
656985|NCT00423046|Adults|adults
656986|NCT00423020|Acute myocardial infarction|acute myocardial infarction
656987|NCT00423020|Restenosis|restenosis
656988|NCT00423020|erythropoietin|erythropoietin
656989|NCT00423020|EPOC-AMI|epoc-ami
656990|NCT00422994|end stage renal impairment|end stage renal impairment
656991|NCT00422994|tolerability|tolerability
656992|NCT00422994|ropinirole|ropinirole
656993|NCT00422994|pharmacokinetics|pharmacokinetics
656994|NCT00422994|hemodialysis|hemodialysis
656995|NCT00422981|Dementia|dementia
656996|NCT00422981|Memory|memory
656997|NCT00422981|Alzheimers|alzheimers
656998|NCT00422981|Cognition|cognition
656999|NCT00422981|Mind|mind
657000|NCT00422981|Aging|aging
657001|NCT00422968|Coronary artery disease|coronary artery disease
657002|NCT00422968|Stent|stent
657003|NCT00422968|Bypass surgery, coronary artery|bypass surgery, coronary artery
657004|NCT00422955|fluid retention|fluid retention
657005|NCT00422955|Autonomic Neuropathy|autonomic neuropathy
657006|NCT00422929|otitis media|otitis media
657007|NCT00422929|ear|ear
657008|NCT00422929|acute otitis|acute otitis
657009|NCT00422929|middle ear|middle ear
657010|NCT00422929|Eustachian tube|eustachian tube
657011|NCT00422929|recurrent acute otitis media|recurrent acute otitis media
657012|NCT00422929|chronic otitis media with effusion|chronic otitis media with effusion
657013|NCT00422929|no significant history of otitis media|no significant history of otitis media
657014|NCT00422903|neo-adjuvant|neo-adjuvant
657015|NCT00422903|letrozole|letrozole
657016|NCT00422903|lapatinib|lapatinib
657017|NCT00422903|primary breast cancer|primary breast cancer
657018|NCT00422890|Acute myeloid leukaemia or Myelodysplastic syndrome|acute myeloid leukaemia or myelodysplastic syndrome
657019|NCT00422877|Liver Cancer|liver cancer
657020|NCT00422851|otitis|otitis
657021|NCT00422851|gas diffusion|gas diffusion
657022|NCT00422851|Eustachian tube|eustachian tube
657023|NCT00422851|tympanic membrane|tympanic membrane
657024|NCT00422838|Hepatitis C|hepatitis c
657025|NCT00422838|Liver|liver
657026|NCT00422838|immunology|immunology
657027|NCT00422838|regulation|regulation
657028|NCT00422838|Genotype 1,2,3|genotype 1,2,3
657029|NCT00422838|Treatment|treatment
657030|NCT00422838|Chronic|chronic
657031|NCT00422838|Pegylated interferon|pegylated interferon
657032|NCT00422838|Ribavirin|ribavirin
657033|NCT00422825|Food effect|food effect
657034|NCT00422825|bioavailability|bioavailability
657035|NCT00422825|pharmacokinetic|pharmacokinetic
657036|NCT00422825|imatinib|imatinib
657037|NCT00422825|STI571|sti571
657038|NCT00422825|modified release formulation of STI571|modified release formulation of sti571
657039|NCT00422825|CML|cml
657040|NCT00422825|Chronic Myeloid Leukemia|chronic myeloid leukemia
657041|NCT00422825|Philadelphia Chromosome|philadelphia chromosome
657042|NCT00422812|Migraine, Staccato Prochlorperazine|migraine, staccato prochlorperazine
657043|NCT00422812|Migraine headache with or without aura.|migraine headache with or without aura.
657044|NCT00422799|relapsed Waldenstrom's macroglobulinemia|relapsed waldenstrom's macroglobulinemia
657045|NCT00422799|refractory Waldenstrom's macroglobulinemia|refractory waldenstrom's macroglobulinemia
657046|NCT00422799|Velcade|velcade
657047|NCT00422799|WM|wm
657048|NCT00422786|Refractory Clear Cell Renal Cell Carcinoma|refractory clear cell renal cell carcinoma
657049|NCT00422786|Phase II|phase ii
657050|NCT00422786|Thallion|thallion
657051|NCT00422786|TLN-232|tln-232
657052|NCT00422786|CAP-232|cap-232
657053|NCT00422786|M2PK|m2pk
657054|NCT00422773|phase I/II|phase i/ii
657055|NCT00422773|cetuximab|cetuximab
657056|NCT00422773|oxaliplatin|oxaliplatin
657057|NCT00422773|irinotecan|irinotecan
657058|NCT00422773|5-FU|5-fu
657059|NCT00422773|chemotherapy|chemotherapy
657060|NCT00422773|dose escalation|dose escalation
657061|NCT00422773|safety|safety
657062|NCT00422760|esophageal perforation|esophageal perforation
657063|NCT00422760|COPD|copd
657064|NCT00422747|asthma|asthma
657065|NCT00422747|transient wheezing|transient wheezing
657066|NCT00422747|early diagnosis|early diagnosis
657067|NCT00422747|exhaled air|exhaled air
657068|NCT00422747|nitrogen monoxide|nitrogen monoxide
657069|NCT00422747|airway resistance|airway resistance
657070|NCT00422721|early severe retinal dystrophy|early severe retinal dystrophy
657071|NCT00422721|amaurosis of leber|amaurosis of leber
657072|NCT00422695|HIV|hiv
657073|NCT00422695|Quantitative Sensory Testing|quantitative sensory testing
657074|NCT00422695|Neuropathy|neuropathy
657075|NCT00422695|Treatment Experienced|treatment experienced
657076|NCT00422695|Treatment Naive|treatment naive
657077|NCT00422682|Solid tumors|solid tumors
657078|NCT00422669|Pacemaker|pacemaker
657079|NCT00422669|Implantable Pulse Generator (IPG)|implantable pulse generator (ipg)
657080|NCT00422669|AV Conduction Disturbance|av conduction disturbance
657081|NCT00422669|Select Site Pacing|select site pacing
657082|NCT00422656|relapsed Waldenstrom's Macroglobulinemia|relapsed waldenstrom's macroglobulinemia
657083|NCT00422656|refractory Waldenstrom's Macroglobulinemia|refractory waldenstrom's macroglobulinemia
657084|NCT00422656|WM|wm
657085|NCT00422656|perifosine|perifosine
657086|NCT00422643|OA,HA,Intra-articular|oa,ha,intra-articular
657087|NCT00422630|Weight loss|weight loss
657088|NCT00422630|Obesity|obesity
657089|NCT00422630|Metabolic Syndrome|metabolic syndrome
657090|NCT00422630|Diet|diet
657091|NCT00422630|Hypertension|hypertension
657092|NCT00422630|Diabetes|diabetes
657093|NCT00422630|Cholesterol|cholesterol
657094|NCT00422617|psoriasis|psoriasis
657095|NCT00422617|alefacept|alefacept
657096|NCT00422604|COPD|copd
657097|NCT00422604|plethysmography.|plethysmography.
657098|NCT00422604|muscarinic receptor antagonist|muscarinic receptor antagonist
657099|NCT00422604|anticholinergic|anticholinergic
657100|NCT00422591|Cytarabine, Idarubicin|cytarabine, idarubicin
657101|NCT00422591|Leukemia|leukemia
657102|NCT00422591|Acute Myeloid Leukemia|acute myeloid leukemia
657103|NCT00422591|AML|aml
657104|NCT00422591|Cytarabine|cytarabine
657105|NCT00422591|Idarubicin|idarubicin
657106|NCT00422578|erectile dysfunction|erectile dysfunction
657107|NCT00422578|tadalafil|tadalafil
657108|NCT00422565|Coronary Artery Disease|coronary artery disease
657109|NCT00422565|Stent|stent
657110|NCT00422565|Myocardial Infarction|myocardial infarction
657111|NCT00422552|inspiratory capacity, FEV1, COPD|inspiratory capacity, fev1, copd
657112|NCT00422539|trichloroacetic acid|trichloroacetic acid
657113|NCT00422539|varicella scar|varicella scar
657114|NCT00422526|Preterm delivery, short cervix, progesterone|preterm delivery, short cervix, progesterone
657115|NCT00422500|Lung Cancer|lung cancer
657116|NCT00422500|Advanced Lung Cancer|advanced lung cancer
657117|NCT00422500|Chemotherapy Symptoms|chemotherapy symptoms
657118|NCT00422500|Disease-Related Symptoms|disease-related symptoms
657119|NCT00422500|Treatment-Related Symptoms|treatment-related symptoms
657120|NCT00422500|Symptom Management|symptom management
657121|NCT00422500|Questionnaire|questionnaire
657122|NCT00422500|Telephone Interactive System|telephone interactive system
657123|NCT00422500|IVR Telephone System|ivr telephone system
657124|NCT00422500|DNA Repair Capacity|dna repair capacity
657125|NCT00422500|DRC|drc
657126|NCT00422500|Cognitive Symptoms|cognitive symptoms
657127|NCT00422487|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
657128|NCT00422474|Ischemic stroke|ischemic stroke
657129|NCT00422474|Baroreflex sensitivity|baroreflex sensitivity
657130|NCT00422474|Prognosis|prognosis
657131|NCT00422474|Cardiovascular autonomic regulation|cardiovascular autonomic regulation
657132|NCT00422461|Clinical Trial, Randomized Controlled Trial, Humans, Cyclic Nucleotide Phosphodiesterases Type 5|clinical trial, randomized controlled trial, humans, cyclic nucleotide phosphodiesterases type 5
657133|NCT00422448|Dermoscopy|dermoscopy
657134|NCT00422448|Histopathology|histopathology
657135|NCT00422448|Genetics|genetics
657136|NCT00422448|Nevi|nevi
657137|NCT00422448|Nevogenesis|nevogenesis
657138|NCT00422435|Percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
657139|NCT00422435|Drug eluting stent (DES)|drug eluting stent (des)
657140|NCT00422422|Brivaracetam|brivaracetam
657141|NCT00422422|Epilepsy|epilepsy
657142|NCT00422422|Child|child
657143|NCT00422422|Pharmacokinetics|pharmacokinetics
657144|NCT00422422|Adolescents|adolescents
657145|NCT00422409|SEMS|sems
657146|NCT00422396|Hypertrigliceridemia|hypertrigliceridemia
657147|NCT00422396|Metabolic syndrome|metabolic syndrome
657148|NCT00422396|Obesity|obesity
657149|NCT00422396|Fenofibrate|fenofibrate
657150|NCT00422396|Lipoproteins|lipoproteins
657151|NCT00422396|Cytokines|cytokines
657152|NCT00422357|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
657153|NCT00422357|Urtica Dioica (or stinging nettle)|urtica dioica (or stinging nettle)
657154|NCT00422357|Hypoglycemic agents|hypoglycemic agents
657155|NCT00422344|RAD001|rad001
657156|NCT00422344|Sunitinib|sunitinib
657157|NCT00422344|renal|renal
657158|NCT00422344|kidney|kidney
657159|NCT00422331|Bipolar I Disorder|bipolar i disorder
657160|NCT00422331|Bipolar Disorder|bipolar disorder
657161|NCT00422331|Lithium|lithium
657162|NCT00422318|Heart Failure|heart failure
657163|NCT00422318|Insulin|insulin
657164|NCT00422318|Metabolism|metabolism
657165|NCT00422318|Pharmacology|pharmacology
657166|NCT00422318|Uric Acid|uric acid
657167|NCT00422305|Infant, Premature|infant, premature
657168|NCT00422305|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
657169|NCT00422305|asthma|asthma
657170|NCT00422292|Menactra vaccine|menactra vaccine
657171|NCT00422292|Meningococcal meningitis|meningococcal meningitis
657172|NCT00422292|Measles|measles
657173|NCT00422292|Mumps|mumps
657174|NCT00422292|Rubella|rubella
657175|NCT00422292|Varicella vaccines|varicella vaccines
657176|NCT00422292|Haemophilus influenzae type b|haemophilus influenzae type b
657177|NCT00422292|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
657178|NCT00422279|Bone Inductive Implant|bone inductive implant
657179|NCT00422266|Dyslipidemia|dyslipidemia
657180|NCT00422253|insulin resistance|insulin resistance
657181|NCT00422253|insulin secretion|insulin secretion
657182|NCT00422253|advanced glycation end-products|advanced glycation end-products
657183|NCT00422240|Acne vulgaris|acne vulgaris
657184|NCT00422240|Adapalene|adapalene
657185|NCT00422240|Benzoyl Peroxide|benzoyl peroxide
657186|NCT00422214|Bipolar Disorder|bipolar disorder
657187|NCT00422214|Bipolar Depression,|bipolar depression,
657188|NCT00422214|Manic Depression|manic depression
657189|NCT00422214|Seroquel|seroquel
657190|NCT00422214|Seroquel SR|seroquel sr
657191|NCT00422214|quetiapine fumarate|quetiapine fumarate
657192|NCT00422201|Cortisol|cortisol
657193|NCT00422201|Cushing's Syndrome|cushing's syndrome
657194|NCT00422201|Ectopic ACTH Secretion|ectopic acth secretion
657195|NCT00422201|Cushing Syndrome|cushing syndrome
657196|NCT00422175|Safety, tolerability, pharmacokinetics, pharmacodynamics, oral, BAF312, healthy volunteers|safety, tolerability, pharmacokinetics, pharmacodynamics, oral, baf312, healthy volunteers
657197|NCT00422149|Sublingual immunotherapy|sublingual immunotherapy
657198|NCT00422149|Rhinoconjunctivitis|rhinoconjunctivitis
657199|NCT00422136|middle ear|middle ear
657200|NCT00422136|otitis|otitis
657201|NCT00422136|genetics|genetics
657202|NCT00422123|Bipolar Disorder|bipolar disorder
657203|NCT00422123|Bipolar Mania|bipolar mania
657204|NCT00422123|Manic Depression|manic depression
657205|NCT00422123|Seroquel|seroquel
657206|NCT00422123|Seroquel SR|seroquel sr
657207|NCT00422123|quetiapine fumarate|quetiapine fumarate
657208|NCT00422110|Seletracetam|seletracetam
657209|NCT00422110|Epilepsies|epilepsies
657210|NCT00422110|Partial|partial
657211|NCT00422110|Epilepsy|epilepsy
657212|NCT00422110|Focal|focal
657213|NCT00422084|Malaria|malaria
657214|NCT00422084|ACT|act
657215|NCT00422084|P falciparum|p falciparum
657216|NCT00422071|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
657217|NCT00422071|Dopamine|dopamine
657218|NCT00422071|Gambling|gambling
657219|NCT00422071|Healthy Volunteer|healthy volunteer
657220|NCT00422071|HV|hv
657221|NCT00422032|Myelodysplastic Syndrome|myelodysplastic syndrome
657222|NCT00422032|Leukemia|leukemia
657223|NCT00422032|Clofarabine|clofarabine
657224|NCT00422032|MDS|mds
657225|NCT00422019|Renal Cancer|renal cancer
657226|NCT00422019|Kidney Cancer|kidney cancer
657227|NCT00422006|bariatric surgery planned|bariatric surgery planned
657228|NCT00421993|Acne vulgaris|acne vulgaris
657229|NCT00421993|Adapalene|adapalene
657230|NCT00421993|Benzoyl Peroxide|benzoyl peroxide
657231|NCT00421967|Postoperative pain|postoperative pain
657232|NCT00421954|psychosis NOS|psychosis nos
657233|NCT00421954|MDD w/ psychotic features|mdd w/ psychotic features
657234|NCT00421954|bipolar disorder w. psychotic features|bipolar disorder w. psychotic features
657235|NCT00421941|enteral feeding|enteral feeding
657236|NCT00421941|critical care|critical care
657237|NCT00421941|fish oil|fish oil
657238|NCT00421941|surgical|surgical
657239|NCT00421928|Chronic Pain|chronic pain
657240|NCT00421928|Osteoarthritis, Knee|osteoarthritis, knee
657241|NCT00421928|tapentadol|tapentadol
657242|NCT00421928|Pain Assessment|pain assessment
657243|NCT00421902|Hot flashes, prostate cancer, acupuncture|hot flashes, prostate cancer, acupuncture
657244|NCT00421889|Ovarian cancer|ovarian cancer
657245|NCT00421889|Ovarian Neoplasms|ovarian neoplasms
657246|NCT00421889|Primary peritoneal|primary peritoneal
657247|NCT00421889|Epithelial ovarian|epithelial ovarian
657248|NCT00421889|Fallopian tube|fallopian tube
657249|NCT00421889|Bladder cancer|bladder cancer
657250|NCT00421889|belinostat|belinostat
657251|NCT00421889|PXD101|pxd101
657252|NCT00421889|mixed mullerian cancer of ovarian origin|mixed mullerian cancer of ovarian origin
657253|NCT00421876|cardiac rehabilitation|cardiac rehabilitation
657254|NCT00421876|lifestyle management|lifestyle management
657255|NCT00421876|risk factor management|risk factor management
657256|NCT00421876|myocardial infarction|myocardial infarction
657257|NCT00421876|randomized trials|randomized trials
657258|NCT00421863|hypertension|hypertension
657259|NCT00421863|systolic blood pressure|systolic blood pressure
657260|NCT00421837|influenza, flu, genotypic analysis, sub-study|influenza, flu, genotypic analysis, sub-study
657261|NCT00421811|cancer|cancer
657262|NCT00421811|tumors|tumors
657263|NCT00421811|melanoma|melanoma
657264|NCT00421811|anticarcinogenic agents|anticarcinogenic agents
657265|NCT00421811|antineoplastic agents|antineoplastic agents
657266|NCT00421811|cadherins|cadherins
657267|NCT00421811|solid tumors|solid tumors
657268|NCT00421798|tuberculosis, paucibacillary, mycobacteria, Mexico, Colombia|tuberculosis, paucibacillary, mycobacteria, mexico, colombia
657269|NCT00421785|N-acetylcysteine|n-acetylcysteine
657270|NCT00421785|Peritoneal Dialysis|peritoneal dialysis
657271|NCT00421785|ADMA|adma
657272|NCT00421772|cerebral ventriculomegaly|cerebral ventriculomegaly
657273|NCT00421772|prenatal diagnostic|prenatal diagnostic
657274|NCT00421772|neuropsychological outcome|neuropsychological outcome
657275|NCT00421759|Sensory loss|sensory loss
657276|NCT00421759|psychomotor function|psychomotor function
657277|NCT00421759|balance|balance
657278|NCT00421759|gait|gait
657279|NCT00421733|Type 2 Diabetic Nephropathy|type 2 diabetic nephropathy
657280|NCT00421720|remifentanil|remifentanil
657281|NCT00421720|sufentanil|sufentanil
657282|NCT00421720|propofol|propofol
657283|NCT00421720|analgesia|analgesia
657284|NCT00421720|sedation|sedation
657285|NCT00421720|mechanically ventilated|mechanically ventilated
657286|NCT00421720|intensive care|intensive care
657287|NCT00421720|pharmacoeconomic|pharmacoeconomic
657288|NCT00421720|weaning|weaning
657289|NCT00421720|delirium|delirium
657290|NCT00421720|randomized|randomized
657292|NCT00421707|Irritable Bowel Syndrome safety|irritable bowel syndrome safety
657293|NCT00421681|Aging|aging
657294|NCT00421681|exercise|exercise
657295|NCT00421681|health behavior|health behavior
657296|NCT00421668|HIV|hiv
657297|NCT00421668|Tanzania|tanzania
657298|NCT00421668|Micronutrients|micronutrients
657299|NCT00421668|Infants/children|infants/children
657300|NCT00421668|Infectious Disease|infectious disease
657301|NCT00421668|Growth faltering|growth faltering
657302|NCT00421629|health insurance|health insurance
657303|NCT00421629|hospitalization insurance|hospitalization insurance
657304|NCT00421629|community based health insurance|community based health insurance
657305|NCT00421629|health care access|health care access
657306|NCT00421629|developing countries|developing countries
657307|NCT00421629|randomized controlled trials|randomized controlled trials
657308|NCT00421616|Calorimetry|calorimetry
657309|NCT00421616|Overweight|overweight
657310|NCT00421616|Weight loss|weight loss
657311|NCT00421616|Appetite|appetite
657312|NCT00421603|Cocaine|cocaine
657313|NCT00421603|Adderall|adderall
657314|NCT00421603|Topiramate|topiramate
657315|NCT00421603|ADHD|adhd
657316|NCT00421590|Randomized, partially blind, placebo controlled, crossover, drug interaction with concomitant antacid, pharmacokinetics, pharmacodynamics, SMC021|randomized, partially blind, placebo controlled, crossover, drug interaction with concomitant antacid, pharmacokinetics, pharmacodynamics, smc021
657317|NCT00421577|Caries Diagnosis|caries diagnosis
657318|NCT00421577|Replica technique|replica technique
657319|NCT00421564|Menopausal|menopausal
657320|NCT00421564|Traditional Chinese Medicine|traditional chinese medicine
657321|NCT00421551|HIV Infections|hiv infections
657322|NCT00421551|darunavir|darunavir
657323|NCT00421551|Ritonavir|ritonavir
657324|NCT00421551|HIV Protease Inhibitors|hiv protease inhibitors
657325|NCT00421551|treatment experienced|treatment experienced
657326|NCT00421538|Deep vein Thrombosis|deep vein thrombosis
657327|NCT00421538|Calf vein thrombosis|calf vein thrombosis
657328|NCT00421538|Low-molecular weight heparin|low-molecular weight heparin
657329|NCT00421538|Placebo|placebo
657330|NCT00421538|Elastic contention|elastic contention
657331|NCT00421538|Compression Ultrasonography|compression ultrasonography
657332|NCT00421525|multiple myeloma|multiple myeloma
657333|NCT00421525|Myeloma, Plasma-Cell|myeloma, plasma-cell
657334|NCT00421525|PLASMACYTOMA|plasmacytoma
657335|NCT00421512|Renal cell carcinoma|renal cell carcinoma
657336|NCT00421512|Metastatic|metastatic
657337|NCT00421512|Kidney Cancer|kidney cancer
657338|NCT00421512|Bevacizumab|bevacizumab
657339|NCT00421512|Sunitinib|sunitinib
657340|NCT00421486|Oral human papillomavirus infection|oral human papillomavirus infection
657341|NCT00421486|HIV-infection|hiv-infection
657342|NCT00421486|High-risk HPV viral load|high-risk hpv viral load
657343|NCT00421486|Oral human papillomavirus infection in HIV-positive men|oral human papillomavirus infection in hiv-positive men
657344|NCT00421486|Treatment Experienced|treatment experienced
657345|NCT00421486|Treatment Naive|treatment naive
657346|NCT00421473|HIV|hiv
657347|NCT00421473|Malaria prophylaxis|malaria prophylaxis
657348|NCT00421473|Treatment Experienced|treatment experienced
657349|NCT00421460|Nebido in hypogonadism with erectile dysfunction|nebido in hypogonadism with erectile dysfunction
657350|NCT00421447|Breast Cancer|breast cancer
657351|NCT00421447|pQCT|pqct
657352|NCT00421447|Anastrozole|anastrozole
657353|NCT00421447|bone geometry|bone geometry
657354|NCT00421434|Hepatitis C|hepatitis c
657355|NCT00421421|Acute Urinary Retention|acute urinary retention
657356|NCT00421421|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
657357|NCT00421421|Trial Without Catheter|trial without catheter
657358|NCT00421408|Dietary protein|dietary protein
657359|NCT00421408|Calcium|calcium
657360|NCT00421408|Parathyroid hormone|parathyroid hormone
657361|NCT00421408|Bone markers|bone markers
657362|NCT00421408|Bone mineral density|bone mineral density
657363|NCT00421408|IGF-1|igf-1
657364|NCT00421408|Urine Calcium|urine calcium
657365|NCT00421395|NHL|nhl
657366|NCT00421395|B-cell NHL|b-cell nhl
657367|NCT00421395|Non-Hodgkins lymphoma|non-hodgkins lymphoma
657368|NCT00421369|Major depressive disorder|major depressive disorder
657369|NCT00421369|Antidepressants|antidepressants
657370|NCT00421369|Triiodothyronine (T3)|triiodothyronine (t3)
657371|NCT00421369|Thyroid Function|thyroid function
657372|NCT00421369|Augmentation|augmentation
657373|NCT00421369|Thyroid pathway genes|thyroid pathway genes
657374|NCT00421356|amputation, transfemoral, lower extremity, prosthetic knee|amputation, transfemoral, lower extremity, prosthetic knee
657375|NCT00421343|disease/disorder proneness/risk|disease/disorder proneness/risk
657376|NCT00421343|osteoporotic fractures|osteoporotic fractures
657377|NCT00421343|accidental falls|accidental falls
657378|NCT00421343|aging|aging
657379|NCT00421330|Abdominal aortic aneurysm|abdominal aortic aneurysm
657380|NCT00421330|AAA|aaa
657381|NCT00421330|randomised controlled trial|randomised controlled trial
657382|NCT00421330|Endovascular repair|endovascular repair
657383|NCT00421330|conventional open repair|conventional open repair
657384|NCT00421317|Ocular, Metastatic melanoma|ocular, metastatic melanoma
657385|NCT00421265|prostate cancer|prostate cancer
657386|NCT00421265|active surveillance|active surveillance
657387|NCT00421265|indolent features|indolent features
657388|NCT00421252|clopidogrel|clopidogrel
657389|NCT00421252|hemorrhagic complication|hemorrhagic complication
657390|NCT00421252|vascular complication|vascular complication
657391|NCT00421252|antiplatelet agent|antiplatelet agent
657392|NCT00421252|stenting|stenting
657393|NCT00421252|percutaneous coronary intervention|percutaneous coronary intervention
657394|NCT00421252|risk|risk
657395|NCT00421252|ischemia|ischemia
657396|NCT00421252|troponin|troponin
657397|NCT00421252|sheath size|sheath size
657398|NCT00421239|hypertensive urgency|hypertensive urgency
657399|NCT00421239|arterial hypertension|arterial hypertension
657400|NCT00421226|Safety, tolerability, pharmacokinetics, pharmacodynamics, ACZ885, Japanese,|safety, tolerability, pharmacokinetics, pharmacodynamics, acz885, japanese,
657401|NCT00421213|APL|apl
657402|NCT00421213|Lymphoma|lymphoma
657403|NCT00421213|T-cell Lymphoma|t-cell lymphoma
657404|NCT00421213|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
657405|NCT00421200|Hip arthroplasty|hip arthroplasty
657406|NCT00421200|Anesthesia, spinal|anesthesia, spinal
657407|NCT00421200|Hypotension|hypotension
657408|NCT00421200|Ischemia|ischemia
657409|NCT00421200|Blood substitutes|blood substitutes
657410|NCT00421200|Plasma expanders|plasma expanders
657411|NCT00421187|Antibiotic resistant neutropenic fever|antibiotic resistant neutropenic fever
657412|NCT00421187|ARNF|arnf
657413|NCT00421187|Ambisome|ambisome
657414|NCT00421187|Liposomal amphotericin B|liposomal amphotericin b
657415|NCT00421174|Etanercept|etanercept
657416|NCT00421174|IPS|ips
657417|NCT00421161|olive oil|olive oil
657418|NCT00421161|stasis dermatitis|stasis dermatitis
657419|NCT00421161|Patients with stasis dermatitis for at least six months.|patients with stasis dermatitis for at least six months.
657420|NCT00421122|Chinese patients|chinese patients
657421|NCT00421122|COPD|copd
657422|NCT00421109|Urticaria|urticaria
657423|NCT00421109|Hives|hives
657424|NCT00421109|Wheals|wheals
657425|NCT00421109|Flare|flare
657426|NCT00421109|Chronic|chronic
657427|NCT00421109|Idiopathic|idiopathic
657428|NCT00421109|Erythema|erythema
657429|NCT00421109|Skin diseases, vascular|skin diseases, vascular
657430|NCT00421109|Hypersensitivity, Immediate|hypersensitivity, immediate
657431|NCT00421109|Allergic|allergic
657432|NCT00421109|Cutaneous|cutaneous
657433|NCT00421096|uterine cervical cancer|uterine cervical cancer
657434|NCT00421083|Erectile dysfunction as a result of traumatic spinal cord injury|erectile dysfunction as a result of traumatic spinal cord injury
657435|NCT00421070|Aggression|aggression
657436|NCT00421070|Massage|massage
657437|NCT00421070|Stress|stress
657438|NCT00421070|Psychiatric inpatient|psychiatric inpatient
657439|NCT00421057|Breast Cancer|breast cancer
657440|NCT00421057|Cancer-Related Fatigue|cancer-related fatigue
657441|NCT00421057|Fatigue|fatigue
657442|NCT00421057|Exercise|exercise
657443|NCT00421057|Strength Training|strength training
657444|NCT00421057|Endurance Exercise|endurance exercise
657445|NCT00421057|Questionnaire|questionnaire
657446|NCT00421057|Survey|survey
657447|NCT00421044|EPO|epo
657448|NCT00421044|Patupilone|patupilone
657449|NCT00421044|Solid Tumors|solid tumors
657450|NCT00421018|Asthma|asthma
657451|NCT00421018|Allergy|allergy
657452|NCT00421018|Cytokines|cytokines
657453|NCT00421018|Glucocorticoids|glucocorticoids
657454|NCT00421018|Inflammation|inflammation
657455|NCT00421018|Nitric Oxide (NO)|nitric oxide (no)
657456|NCT00421018|Quality of Life|quality of life
657457|NCT00421018|Self-Rated Health|self-rated health
657458|NCT00421018|Stress|stress
657459|NCT00420992|hip|hip
657460|NCT00420992|knee|knee
657461|NCT00420992|pain|pain
657462|NCT00420992|osteoarthritis|osteoarthritis
657463|NCT00420992|OA|oa
657464|NCT00420992|Kadian|kadian
657465|NCT00420992|Alpharma|alpharma
657466|NCT00420992|naltrexone|naltrexone
657467|NCT00420992|Opioid|opioid
657468|NCT00420992|morphine|morphine
657469|NCT00420992|Embeda|embeda
657470|NCT00420992|ALO-01|alo-01
657471|NCT00420966|lower respiratory tract infection|lower respiratory tract infection
657472|NCT00420966|respiratory syncytial virus infections|respiratory syncytial virus infections
657473|NCT00420966|palivizumab|palivizumab
657474|NCT00420966|outcomes|outcomes
657475|NCT00420966|utilization|utilization
657476|NCT00420966|compliance|compliance
657477|NCT00420940|vibration|vibration
657478|NCT00420940|mechanical loading|mechanical loading
657479|NCT00420940|bone mineral density|bone mineral density
657480|NCT00420940|women's health|women's health
657481|NCT00420940|osteoporosis|osteoporosis
657482|NCT00420927|Early Rheumatoid Arthritis|early rheumatoid arthritis
657483|NCT00420927|Tumor Necrosis Factor Optimization|tumor necrosis factor optimization
657484|NCT00420914|Thrombocytopenia|thrombocytopenia
657485|NCT00420914|Platelets|platelets
657486|NCT00420914|Dose|dose
657487|NCT00420914|Bleeding|bleeding
657488|NCT00420901|function|function
657489|NCT00420901|inhibition|inhibition
657490|NCT00420875|plantar fasciitis|plantar fasciitis
657491|NCT00420875|plantar fasciosis|plantar fasciosis
657492|NCT00420875|Achilles tendinosis|achilles tendinosis
657493|NCT00420875|Achilles tendinitis|achilles tendinitis
657494|NCT00420875|heel pain|heel pain
657495|NCT00420875|fasciosis|fasciosis
657496|NCT00420875|fasciitis|fasciitis
657497|NCT00420875|tendinosis|tendinosis
657498|NCT00420875|tendinitis|tendinitis
657499|NCT00420875|conservative treatment|conservative treatment
657500|NCT00420862|Lung neoplasms|lung neoplasms
657501|NCT00420862|Early diagnosis|early diagnosis
657502|NCT00420862|Screening|screening
657503|NCT00420862|Spiral Computed Tomography|spiral computed tomography
657504|NCT00420862|Randomized Controlled Trial|randomized controlled trial
657505|NCT00420836|Cystic fibrosis, tobramycin, PARI eFlow, PARI LC Plus, nebulizer, pharmacokinetic|cystic fibrosis, tobramycin, pari eflow, pari lc plus, nebulizer, pharmacokinetic
657506|NCT00420823|First Episode Psychosis|first episode psychosis
657507|NCT00420797|Faecal seepage|faecal seepage
657508|NCT00420797|ileal pouch anal anastomosis (IPAA)|ileal pouch anal anastomosis (ipaa)
657509|NCT00420797|quality of life|quality of life
657510|NCT00420797|faecal incontinence|faecal incontinence
657511|NCT00420797|ileo-anal pouch construction|ileo-anal pouch construction
657512|NCT00420797|phenylephrine hydrochloride gel|phenylephrine hydrochloride gel
657513|NCT00420797|IPAA-related faecal incontinence|ipaa-related faecal incontinence
657514|NCT00420797|placebo|placebo
657515|NCT00420784|Genotype 1|genotype 1
657516|NCT00420771|Benzodiazepine|benzodiazepine
657517|NCT00420771|Gabapentin|gabapentin
657518|NCT00420771|Methadone|methadone
657519|NCT00420758|Infant|infant
657520|NCT00420758|Malnutrition|malnutrition
657521|NCT00420758|Sub-Saharan Africa|sub-saharan africa
657522|NCT00420758|Treatment|treatment
657523|NCT00420758|Growth|growth
657524|NCT00420758|Haemoglobin|haemoglobin
657525|NCT00420758|Fortified spread|fortified spread
657526|NCT00420758|Food supplement|food supplement
657527|NCT00420719|ALS|als
657528|NCT00420719|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
657529|NCT00420719|Lou Gehrig's disease|lou gehrig's disease
657530|NCT00420719|Diaphragm for Ventilatory Assist|diaphragm for ventilatory assist
657531|NCT00420719|Diaphragm Pacing|diaphragm pacing
657532|NCT00420667|unfractionated heparin|unfractionated heparin
657533|NCT00420667|enoxaparin|enoxaparin
657534|NCT00420667|low molecular weight heparin|low molecular weight heparin
657535|NCT00420667|bypass surgery|bypass surgery
657536|NCT00420667|bleeding|bleeding
657537|NCT00420654|Turner syndrome|turner syndrome
657538|NCT00420654|growth hormone treatment|growth hormone treatment
657539|NCT00420654|positron emission tomography|positron emission tomography
657540|NCT00420654|heart|heart
657541|NCT00420641|MDD|mdd
657542|NCT00420641|flexible-dose|flexible-dose
657543|NCT00420641|Major Depressive Disorder|major depressive disorder
657544|NCT00420641|paroxetine|paroxetine
657545|NCT00420641|GSK372475|gsk372475
657546|NCT00420615|Cancer|cancer
657547|NCT00420615|EPO906|epo906
657548|NCT00420615|Patupilone|patupilone
657549|NCT00420589|Weight loss|weight loss
657550|NCT00420589|Weight regain|weight regain
657551|NCT00420589|Weight maintenance|weight maintenance
657552|NCT00420576|Post-menopausal|post-menopausal
657553|NCT00420576|Traditional Chinese Medicine|traditional chinese medicine
657554|NCT00420576|Randomized|randomized
657555|NCT00420563|Cancer, palliative treatment|cancer, palliative treatment
657556|NCT00420550|Interstitial Cystitis|interstitial cystitis
657557|NCT00420550|Pelvic pain|pelvic pain
657558|NCT00420550|Guided Imagery|guided imagery
657559|NCT00420537|Kidney|kidney
657560|NCT00420537|Heart Transplantation|heart transplantation
657561|NCT00420537|Creatinine|creatinine
657562|NCT00420537|Glomerular Filtration Rate|glomerular filtration rate
657563|NCT00420524|EPO|epo
657564|NCT00420524|Patupilone|patupilone
657565|NCT00420524|Solid Tumors|solid tumors
657566|NCT00420511|Type 2 diabetes|type 2 diabetes
657567|NCT00420511|beta-cell function|beta-cell function
657568|NCT00420511|sitagliptin|sitagliptin
657569|NCT00420511|intensive insulin therapy|intensive insulin therapy
657570|NCT00420498|Schizophrenia|schizophrenia
657571|NCT00420498|Prefrontal Cortical Function|prefrontal cortical function
657572|NCT00420498|Smoking|smoking
657573|NCT00420498|Cognition|cognition
657574|NCT00420498|Positive and Negative Symptoms|positive and negative symptoms
657575|NCT00420498|Tobacco|tobacco
657576|NCT00420498|Cigarette Smoking|cigarette smoking
657577|NCT00420498|Dopamine|dopamine
657578|NCT00420485|Maximum Tolerated Dose|maximum tolerated dose
657579|NCT00420485|Solid Tumors|solid tumors
657580|NCT00420485|Dose Limiting Toxicity|dose limiting toxicity
657581|NCT00420485|Topoisomerase-1 Inhibitor|topoisomerase-1 inhibitor
657582|NCT00420433|Breast Cancer|breast cancer
657583|NCT00420433|Bone Metastases|bone metastases
657584|NCT00420433|Radiography|radiography
657585|NCT00420433|X-Ray|x-ray
657586|NCT00420433|Computed Tomography|computed tomography
657587|NCT00420433|CT Scan|ct scan
657588|NCT00420433|Skeletal Scintigraphy|skeletal scintigraphy
657589|NCT00420394|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
657590|NCT00420394|Adjuvant chemoradiotherapy|adjuvant chemoradiotherapy
657591|NCT00420394|Adenocarcinoma of stomach and gastroesophageal junction|adenocarcinoma of stomach and gastroesophageal junction
657592|NCT00420381|Recurrent Cancer|recurrent cancer
657593|NCT00420368|Infant|infant
657594|NCT00420368|Malnutrition|malnutrition
657595|NCT00420368|Sub-Saharan Africa|sub-saharan africa
657596|NCT00420368|Treatment|treatment
657597|NCT00420368|Growth|growth
657598|NCT00420368|Haemoglobin|haemoglobin
657599|NCT00420368|Fortified spread|fortified spread
657600|NCT00420368|Food supplement|food supplement
657601|NCT00420355|antiretroviral therapy|antiretroviral therapy
657602|NCT00420355|protease inhibitors|protease inhibitors
657603|NCT00420355|drug interactions|drug interactions
657604|NCT00420355|HIV infection|hiv infection
657605|NCT00420355|acquired immunodeficiency syndrome|acquired immunodeficiency syndrome
657606|NCT00420355|Treatment Experienced|treatment experienced
657607|NCT00420342|Pre-Hypertension in Postmenopausal Women|pre-hypertension in postmenopausal women
657608|NCT00420316|Intussusception|intussusception
657609|NCT00420316|Gastroenteritis|gastroenteritis
657610|NCT00420316|Finland|finland
657611|NCT00420303|Refractory Heel Enthesitis in Spondylarthropathy|refractory heel enthesitis in spondylarthropathy
657612|NCT00420303|Spondylarthropathy|spondylarthropathy
657613|NCT00420303|Refractory Heel Enthesitis|refractory heel enthesitis
657614|NCT00420290|inflammation|inflammation
657615|NCT00420290|end stage renal disease|end stage renal disease
657616|NCT00420277|Hip arthroplasty|hip arthroplasty
657617|NCT00420277|Anesthesia, spinal|anesthesia, spinal
657618|NCT00420277|Hypotension|hypotension
657619|NCT00420277|Ischemia|ischemia
657620|NCT00420277|Blood substitutes|blood substitutes
657621|NCT00420277|Plasma expanders|plasma expanders
657622|NCT00420238|Axial Ankylosing Spondylitis|axial ankylosing spondylitis
657623|NCT00420238|Adult|adult
657624|NCT00420225|Cystocele|cystocele
657625|NCT00420225|surgery|surgery
657626|NCT00420225|mesh|mesh
657627|NCT00420225|genital prolapse|genital prolapse
657628|NCT00420212|relapsing|relapsing
657629|NCT00420212|oral|oral
657630|NCT00420212|remitting|remitting
657631|NCT00420212|multiple sclerosis|multiple sclerosis
657632|NCT00420173|cutaneous lupus erythematosus|cutaneous lupus erythematosus
657633|NCT00420173|standardized evaluation|standardized evaluation
657634|NCT00420173|core set questionnaire|core set questionnaire
657635|NCT00420173|epidemiological data|epidemiological data
657636|NCT00420173|laboratory features|laboratory features
657637|NCT00420160|Smoking cessation|smoking cessation
657638|NCT00420160|Exercise|exercise
657639|NCT00420160|Nicotine Patch|nicotine patch
657640|NCT00420160|Disease Prevention|disease prevention
657641|NCT00420147|knee osteoarthritis|knee osteoarthritis
657642|NCT00420147|orthosis|orthosis
657643|NCT00420147|wedge|wedge
657644|NCT00420147|gait|gait
657645|NCT00420134|mesenchymal stem cell|mesenchymal stem cell
657646|NCT00420134|end stage liver disease|end stage liver disease
657647|NCT00420134|Cirrhosis|cirrhosis
657648|NCT00420134|stem cell therapy|stem cell therapy
657649|NCT00420121|standardized evaluation|standardized evaluation
657650|NCT00420121|core set questionnaire|core set questionnaire
657651|NCT00420121|epidemiological data|epidemiological data
657652|NCT00420121|laboratory analysis|laboratory analysis
657653|NCT00420108|Heart Failure, Congestive|heart failure, congestive
657654|NCT00420108|Cardiac Pacemaker, Artificial|cardiac pacemaker, artificial
657655|NCT00420108|Ventricular Pressure|ventricular pressure
657656|NCT00420095|diabetes|diabetes
657657|NCT00420095|type 1|type 1
657658|NCT00420095|type 2|type 2
657659|NCT00420082|Rhinitis|rhinitis
657660|NCT00420082|Seasonal|seasonal
657661|NCT00420082|Allergic|allergic
657662|NCT00420082|Pollen allergy|pollen allergy
657663|NCT00420082|Environmental Exposure Chamber|environmental exposure chamber
657664|NCT00420082|Challenge Chamber|challenge chamber
657665|NCT00420043|Food effect|food effect
657666|NCT00420043|bioavailability|bioavailability
657667|NCT00420043|pharmacokinetic|pharmacokinetic
657668|NCT00420043|STI571|sti571
657669|NCT00420043|modified release formulation of STI571|modified release formulation of sti571
657670|NCT00420043|CML|cml
657671|NCT00420043|Chronic Myeloid Leukemia|chronic myeloid leukemia
657672|NCT00420043|Philadelphia Chromosome|philadelphia chromosome
657673|NCT00420043|imatinib|imatinib
657674|NCT00420030|upfront abciximab|upfront abciximab
657675|NCT00420030|PCI|pci
657676|NCT00420030|cardiogenic shock|cardiogenic shock
657677|NCT00420017|Amiodarone|amiodarone
657678|NCT00420017|Atrial fibrillation|atrial fibrillation
657679|NCT00420017|Surgical procedures, thoracic|surgical procedures, thoracic
657680|NCT00419991|Tigecycline|tigecycline
657681|NCT00419991|Staphylococcal Infections|staphylococcal infections
657682|NCT00419991|Catheter|catheter
657683|NCT00419952|Moderate Asthma|moderate asthma
657684|NCT00419952|Severe Asthma|severe asthma
657685|NCT00419939|Severe traumatic brain injury|severe traumatic brain injury
657686|NCT00419939|Intensive neurorehabilitation|intensive neurorehabilitation
657687|NCT00419939|"Patient Participation[Professional-Patient Relations"|"patient participation[professional-patient relations"
657688|NCT00419939|Re-learning|re-learning
657689|NCT00419939|Daily life activities|daily life activities
657690|NCT00419939|Rehabilitation|rehabilitation
657691|NCT00419926|Renal, Kidney, Intensified, Enteric-coated mycophenolate sodium, Transplant|renal, kidney, intensified, enteric-coated mycophenolate sodium, transplant
657692|NCT00419913|Ovulation Induction|ovulation induction
657693|NCT00419913|In vitro Fertilization|in vitro fertilization
657694|NCT00419913|Pregnancy|pregnancy
657695|NCT00419900|breast cancer|breast cancer
657696|NCT00419900|diagnosis|diagnosis
657697|NCT00419900|x-ray diffraction|x-ray diffraction
657698|NCT00419900|synchrotron|synchrotron
657699|NCT00419900|hair|hair
657700|NCT00419887|Safety, tolerability, pharmacokinetics, pharmacodynamics, LAF237, vildagliptin, Chinese, healthy volunteers|safety, tolerability, pharmacokinetics, pharmacodynamics, laf237, vildagliptin, chinese, healthy volunteers
657701|NCT00419874|Blood-brain barrier|blood-brain barrier
657702|NCT00419874|Post traumatic epilepsy|post traumatic epilepsy
657703|NCT00419874|Seizures|seizures
657704|NCT00419861|Influenza, surveillance, flu, parent protocol|influenza, surveillance, flu, parent protocol
657705|NCT00419848|Acne|acne
657706|NCT00419848|Azithromycin|azithromycin
657707|NCT00419848|Doxycycline|doxycycline
657708|NCT00419835|diabetic nephropathy|diabetic nephropathy
657709|NCT00419835|proteinuria|proteinuria
657710|NCT00419835|CKD progression|ckd progression
657711|NCT00419835|dialysis|dialysis
657712|NCT00419822|Acupuncture|acupuncture
657713|NCT00419822|Range of Motion|range of motion
657714|NCT00419822|Quality of Life|quality of life
657715|NCT00419809|methotrexate,|methotrexate,
657716|NCT00419809|SB-681323,|sb-681323,
657717|NCT00419809|p38 MAP Kinase Inhibitor,|p38 map kinase inhibitor,
657718|NCT00419809|liver function|liver function
657719|NCT00419809|Rheumatoid Arthritis,|rheumatoid arthritis,
657720|NCT00419796|Osteoarthritis, controlled hypertension, lumiracoxib, ibuprofen, high blood pressure|osteoarthritis, controlled hypertension, lumiracoxib, ibuprofen, high blood pressure
657721|NCT00419783|Allergic rhinitis|allergic rhinitis
657722|NCT00419783|Urticaria|urticaria
657723|NCT00419770|zygomycosis|zygomycosis
657724|NCT00419770|Rhizopus|rhizopus
657725|NCT00419770|iron|iron
657726|NCT00419770|iron-chelation|iron-chelation
657727|NCT00419770|adjunctive therapy|adjunctive therapy
657728|NCT00419757|Moderate asthma|moderate asthma
657729|NCT00419757|Severe asthma|severe asthma
657730|NCT00419744|COPD|copd
657731|NCT00419731|nicotine|nicotine
657732|NCT00419731|smoking|smoking
657733|NCT00419731|addiction|addiction
657734|NCT00419705|acute stroke|acute stroke
657735|NCT00419705|infrared laser therapy|infrared laser therapy
657736|NCT00419705|clinical trial|clinical trial
657737|NCT00419705|safety|safety
657738|NCT00419705|effectiveness|effectiveness
657739|NCT00419692|pharmacokinetic,|pharmacokinetic,
657740|NCT00419692|RLS|rls
657741|NCT00419692|formulation,|formulation,
657742|NCT00419692|food effect,|food effect,
657743|NCT00419692|controlled release for RLS,|controlled release for rls,
657744|NCT00419692|SK&F101468,|sk&f101468,
657745|NCT00419679|breast cancer|breast cancer
657746|NCT00419679|hair|hair
657747|NCT00419679|fibre|fibre
657748|NCT00419679|synchrotron|synchrotron
657749|NCT00419679|x-ray diffraction|x-ray diffraction
657750|NCT00419666|Calcitriol|calcitriol
657751|NCT00419666|Psoriasis|psoriasis
657752|NCT00419666|PK|pk
657753|NCT00419666|Adolescents|adolescents
657754|NCT00419653|schizophrenia fMRI drug therapy amisulpride|schizophrenia fmri drug therapy amisulpride
657755|NCT00419640|Sinus node disease|sinus node disease
657756|NCT00419640|AV node disease|av node disease
657757|NCT00419627|proteomics of solid tumors|proteomics of solid tumors
657758|NCT00419601|ventilated newborns (≥ 36 SSW)and infants (≤60 days)|ventilated newborns (≥ 36 ssw)and infants (≤60 days)
657759|NCT00419601|of any medical condition|of any medical condition
657760|NCT00419588|infant, premature|infant, premature
657761|NCT00419588|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
657762|NCT00419588|asthma|asthma
657763|NCT00419575|renal|renal
657764|NCT00419575|transplantation|transplantation
657765|NCT00419575|immunosuppression|immunosuppression
657766|NCT00419575|monitoring|monitoring
657767|NCT00419562|oral insulin|oral insulin
657768|NCT00419562|autoantigen|autoantigen
657769|NCT00419562|self tolerance|self tolerance
657770|NCT00419562|oral tolerance|oral tolerance
657771|NCT00419562|DPT-1|dpt-1
657772|NCT00419562|prevention|prevention
657773|NCT00419562|"at risk for developing type 1 diabetes"|"at risk for developing type 1 diabetes"
657774|NCT00419562|juvenile diabetes|juvenile diabetes
657775|NCT00419562|T1D|t1d
657776|NCT00419562|diabetes mellitus|diabetes mellitus
657777|NCT00419562|Type 1 diabetes TrialNet|type 1 diabetes trialnet
657778|NCT00419562|TrialNet|trialnet
657779|NCT00419549|ERCP|ercp
657780|NCT00419549|Pancreatitis|pancreatitis
657781|NCT00419549|Nitroglycerine|nitroglycerine
657782|NCT00419549|Valdecoxib|valdecoxib
657783|NCT00419536|LBH|lbh
657784|NCT00419536|LBH589|lbh589
657785|NCT00419536|Prostate Cancer|prostate cancer
657786|NCT00419536|HRPC|hrpc
657787|NCT00419510|Genetic counseling|genetic counseling
657788|NCT00419510|BRCA1 and BRCA2|brca1 and brca2
657789|NCT00419510|African American|african american
657790|NCT00419497|Paleolithic diet|paleolithic diet
657791|NCT00419497|Mediterranean-style diet|mediterranean-style diet
657792|NCT00419497|Glucose tolerance|glucose tolerance
657793|NCT00419497|Diabetes type 2|diabetes type 2
657794|NCT00419497|Weight loss|weight loss
657795|NCT00419497|Waist|waist
657796|NCT00419471|Depression|depression
657797|NCT00419471|Myocardial infarction|myocardial infarction
657798|NCT00419471|Angina, unstable|angina, unstable
657799|NCT00419458|ventilator weaning|ventilator weaning
657800|NCT00419458|weaning|weaning
657801|NCT00419458|respiratory failure|respiratory failure
657802|NCT00419458|inspiratory muscle strength training|inspiratory muscle strength training
657803|NCT00419445|Attention Deficit Hyperactivity Disorder in adults|attention deficit hyperactivity disorder in adults
657804|NCT00419432|Pediatrics|pediatrics
657805|NCT00419432|Cerebral Palsy|cerebral palsy
657806|NCT00419432|Gait Analysis|gait analysis
657807|NCT00419432|Orthopedic Surgery|orthopedic surgery
657808|NCT00419419|Raynaud's|raynaud's
657809|NCT00419406|UVA1|uva1
657810|NCT00419406|N-B UVB|n-b uvb
657811|NCT00419406|phototherapy|phototherapy
657812|NCT00419406|atopic dermatitis|atopic dermatitis
657813|NCT00419406|SCORAD index|scorad index
657814|NCT00419393|Keppra XR|keppra xr
657815|NCT00419393|Levetiracetam XR|levetiracetam xr
657816|NCT00419393|long term|long term
657817|NCT00419393|partial seizures|partial seizures
657818|NCT00419380|clogged ear tubes|clogged ear tubes
657819|NCT00419354|Pacemaker|pacemaker
657820|NCT00419354|Tricuspid regurgitation|tricuspid regurgitation
657821|NCT00419341|Immune globulin subcutaneous|immune globulin subcutaneous
657822|NCT00419341|SCIG|scig
657823|NCT00419341|Primary immunodeficiency|primary immunodeficiency
657824|NCT00419341|PID|pid
657825|NCT00419328|solid tumors NGR-hTNF|solid tumors ngr-htnf
657826|NCT00419315|alcoholism|alcoholism
657827|NCT00419315|primary care|primary care
657828|NCT00419315|treatment|treatment
657829|NCT00419289|COPD, rehabilitation, quality of life|copd, rehabilitation, quality of life
657830|NCT00419276|Total knee arthroplasty, postoperative analgesia|total knee arthroplasty, postoperative analgesia
657831|NCT00419276|Primary, unilateral, total knee arthroplasty|primary, unilateral, total knee arthroplasty
657832|NCT00419263|influenza|influenza
657833|NCT00419263|flu|flu
657834|NCT00419250|relapsed|relapsed
657835|NCT00419250|refractory|refractory
657836|NCT00419250|fludarabine|fludarabine
657837|NCT00419250|Revlimid|revlimid
657838|NCT00419250|lenalidomide|lenalidomide
657839|NCT00419250|CLL|cll
657840|NCT00419250|B-cell CLL|b-cell cll
657841|NCT00419250|CC-5013|cc-5013
657842|NCT00419250|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
657843|NCT00419237|hepatic impairment pharmacokinetics|hepatic impairment pharmacokinetics
657844|NCT00419224|Peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
657845|NCT00419224|Non-myeloabalative|non-myeloabalative
657846|NCT00419224|Influenza vaccination|influenza vaccination
657847|NCT00419224|Humoral immune response|humoral immune response
657848|NCT00419224|Immunogenicity|immunogenicity
657849|NCT00419211|Pregnancy, Exercise, Depression|pregnancy, exercise, depression
657850|NCT00419198|Ischemia|ischemia
657851|NCT00419198|Reperfusion|reperfusion
657852|NCT00419198|Myocardial infarction|myocardial infarction
657853|NCT00419198|Postconditioning|postconditioning
657854|NCT00419185|macular hole surgery|macular hole surgery
657855|NCT00419185|indocyanine green|indocyanine green
657856|NCT00419185|trypan blue|trypan blue
657857|NCT00419185|internal limiting membrane|internal limiting membrane
657858|NCT00419172|Pharmacokinetics|pharmacokinetics
657859|NCT00419172|Deferasirox|deferasirox
657860|NCT00419172|Exjade|exjade
657861|NCT00419172|ICL670|icl670
657862|NCT00419172|Rifampicin|rifampicin
657863|NCT00419172|Healthy, Volunteers|healthy, volunteers
657864|NCT00419159|Colorectal cancer|colorectal cancer
657865|NCT00419159|metastatic colorectal adenocarcinoma|metastatic colorectal adenocarcinoma
657866|NCT00419159|anti-EGFR antibody|anti-egfr antibody
657867|NCT00419146|Schizophrenia|schizophrenia
657868|NCT00419146|Schizophreniform disorders|schizophreniform disorders
657869|NCT00419146|Schizoaffective disorder|schizoaffective disorder
657870|NCT00419146|Psychotic disorders|psychotic disorders
657871|NCT00419146|Randomized Controlled Trials|randomized controlled trials
657872|NCT00419146|Longitudinal Studies|longitudinal studies
657873|NCT00419146|Fatty Acids, Omega-3|fatty acids, omega-3
657874|NCT00419146|Eicosapentaenoic Acid|eicosapentaenoic acid
657875|NCT00419146|Vitamins|vitamins
657876|NCT00419146|Antioxidants|antioxidants
657877|NCT00419146|Ascorbic Acid|ascorbic acid
657878|NCT00419146|Alpha-Tocopherol|alpha-tocopherol
657879|NCT00419146|Placebos|placebos
657880|NCT00419146|Antipsychotic Agents|antipsychotic agents
657881|NCT00419146|Oxidative Stress|oxidative stress
657882|NCT00419146|Fatty Acids, Unsaturated|fatty acids, unsaturated
657883|NCT00419146|Phospholipases|phospholipases
657884|NCT00419146|Niacin|niacin
657885|NCT00419146|Adverse effects|adverse effects
657886|NCT00419146|Delusions|delusions
657887|NCT00419146|Hallucinations|hallucinations
657888|NCT00419146|Neuropsychological Tests|neuropsychological tests
657889|NCT00419146|Attention|attention
657890|NCT00419146|Memory|memory
657891|NCT00419146|Hypertriglyceridemia|hypertriglyceridemia
657892|NCT00419146|Models, Statistical|models, statistical
657893|NCT00419133|Cholera|cholera
657894|NCT00419133|Vaccine|vaccine
657895|NCT00419133|Kolkata|kolkata
657896|NCT00419133|West Bengal|west bengal
657897|NCT00419133|India|india
657898|NCT00419133|Immunogenicity|immunogenicity
657899|NCT00419133|Safety|safety
657900|NCT00419094|Keppra XR|keppra xr
657901|NCT00419094|conversion to monotherapy|conversion to monotherapy
657902|NCT00419094|partial seizures|partial seizures
657903|NCT00419081|leukemia|leukemia
657904|NCT00419081|lymphoma|lymphoma
657905|NCT00419055|percutaneous coronary intervention|percutaneous coronary intervention
657906|NCT00419042|cancer|cancer
657907|NCT00419042|Lung cancer|lung cancer
657908|NCT00419042|None small-cell lung cancer|none small-cell lung cancer
657909|NCT00419029|combat|combat
657910|NCT00419029|depression|depression
657911|NCT00419029|PTSD|ptsd
657912|NCT00419029|substance abuse|substance abuse
657913|NCT00418990|Multivitamin|multivitamin
657914|NCT00418990|Academic performance|academic performance
657915|NCT00418977|Anorexia Nervosa|anorexia nervosa
657916|NCT00418964|Anterior cruciate ligament rupture|anterior cruciate ligament rupture
657917|NCT00418964|Anterior cruciate ligament(A02.513.514.100)|anterior cruciate ligament(a02.513.514.100)
657918|NCT00418951|Voriconazole|voriconazole
657919|NCT00418951|Vfend|vfend
657920|NCT00418951|Liposomal amphotericin B|liposomal amphotericin b
657921|NCT00418951|Ambisome|ambisome
657922|NCT00418951|Acute Myelogenous Leukemia|acute myelogenous leukemia
657923|NCT00418951|Myelodysplastic Syndrome|myelodysplastic syndrome
657924|NCT00418951|AML|aml
657925|NCT00418951|MDS|mds
657926|NCT00418938|EGFR|egfr
657927|NCT00418938|FOLFIRI|folfiri
657928|NCT00418938|2nd Line Therapy|2nd line therapy
657929|NCT00418938|2nd Line mCRC Therapy|2nd line mcrc therapy
657930|NCT00418938|mCRC|mcrc
657931|NCT00418938|Irinotecan|irinotecan
657932|NCT00418938|panitumumab|panitumumab
657933|NCT00418938|bevacizumab|bevacizumab
657934|NCT00418899|Brain Tumor|brain tumor
657935|NCT00418899|Glioma|glioma
657936|NCT00418899|Linkage Study|linkage study
657937|NCT00418899|Survey|survey
657938|NCT00418899|Gliogene|gliogene
657939|NCT00418899|High-risk familial brain tumor pedigrees|high-risk familial brain tumor pedigrees
657940|NCT00418886|NSCLC|nsclc
657941|NCT00418886|Non Small Cell Lung Cancer|non small cell lung cancer
657942|NCT00418873|schizophrenia|schizophrenia
657943|NCT00418873|zotepine|zotepine
657944|NCT00418873|risperidone|risperidone
657945|NCT00418873|second generation antipsychotic|second generation antipsychotic
657946|NCT00418860|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
657947|NCT00418860|Stent thrombosis|stent thrombosis
657948|NCT00418860|Zotarolimus-eluting stent|zotarolimus-eluting stent
657949|NCT00418847|pediatrics|pediatrics
657950|NCT00418847|lysosomal storage diseases|lysosomal storage diseases
657951|NCT00418847|Gangliosidoses GM2|gangliosidoses gm2
657952|NCT00418847|Tay-Sachs disease|tay-sachs disease
657953|NCT00418847|Sandhoff disease|sandhoff disease
657954|NCT00418847|Infantile GM2-activator deficiency|infantile gm2-activator deficiency
657955|NCT00418847|Miglustat|miglustat
657956|NCT00418808|motor|motor
657957|NCT00418808|development|development
657958|NCT00418808|multiple pregnancies|multiple pregnancies
657959|NCT00418808|general movement|general movement
657960|NCT00418808|video recording|video recording
657961|NCT00418795|Acute Intermittent Porphyria|acute intermittent porphyria
657962|NCT00418795|treatment|treatment
657963|NCT00418795|Acute attack|acute attack
657964|NCT00418769|nilotinib|nilotinib
657965|NCT00418769|bioavailability|bioavailability
657966|NCT00418769|tablet|tablet
657967|NCT00418769|capsule|capsule
657968|NCT00418769|PK|pk
657969|NCT00418769|healthy, subject(s),|healthy, subject(s),
657970|NCT00418756|nilotinib|nilotinib
657971|NCT00418756|Rifampin|rifampin
657972|NCT00418756|PK|pk
657973|NCT00418756|healthy subjects|healthy subjects
657974|NCT00418743|cancer|cancer
657975|NCT00418743|Lung cancer|lung cancer
657976|NCT00418743|small-cell lung cancer|small-cell lung cancer
657977|NCT00418730|androgenetic alopecia|androgenetic alopecia
657978|NCT00418730|male pattern hair loss|male pattern hair loss
657979|NCT00418730|male pattern baldness|male pattern baldness
657980|NCT00418730|androgenetic alopecia or male pattern hair loss|androgenetic alopecia or male pattern hair loss
657981|NCT00418704|cancer|cancer
657982|NCT00418704|Lung cancer|lung cancer
657983|NCT00418704|None small-cell lung cancer|none small-cell lung cancer
657984|NCT00418691|Brain Tumor|brain tumor
657985|NCT00418691|Methylphenidate|methylphenidate
657986|NCT00418691|Ritalin|ritalin
657987|NCT00418691|Modafinil|modafinil
657988|NCT00418691|Provigil|provigil
657989|NCT00418691|Fatigue|fatigue
657990|NCT00418691|Concentration|concentration
657991|NCT00418665|Revlimid|revlimid
657992|NCT00418665|Lenalidomide|lenalidomide
657993|NCT00418665|Low Platelet Count|low platelet count
657994|NCT00418665|Low Risk Myelodysplastic Syndrome|low risk myelodysplastic syndrome
657995|NCT00418665|Intermediate 1 Myelodysplastic Syndrome|intermediate 1 myelodysplastic syndrome
657996|NCT00418665|MDS|mds
657997|NCT00418665|Myelodysplastic Syndrome|myelodysplastic syndrome
657998|NCT00418652|Normal Controls|normal controls
658872|NCT00416052|calcium|calcium
657999|NCT00418639|Chronic Hepatitis C|chronic hepatitis c
658000|NCT00418626|nilotinib|nilotinib
658001|NCT00418626|hepatic impairment|hepatic impairment
658002|NCT00418626|Child-Pugh scale|child-pugh scale
658003|NCT00418626|PK|pk
658004|NCT00418626|healthy, subject(s)|healthy, subject(s)
658005|NCT00418626|Subjects with impaired hepatic function and healthy subjects|subjects with impaired hepatic function and healthy subjects
658006|NCT00418600|Secondary Hyperparathyroidism|secondary hyperparathyroidism
658007|NCT00418600|Hectorol® (doxercalciferol capsules)|hectorol® (doxercalciferol capsules)
658008|NCT00418600|Hectorol® (doxercalciferol injection)|hectorol® (doxercalciferol injection)
658009|NCT00418587|Vitamin D|vitamin d
658010|NCT00418587|Lupus|lupus
658011|NCT00418574|Ovarian cancer|ovarian cancer
658012|NCT00418574|Abagovomab|abagovomab
658013|NCT00418561|rhASA|rhasa
658014|NCT00418561|MLD|mld
658015|NCT00418561|Metazym|metazym
658016|NCT00418535|Lymphoma, NK/T-Cell|lymphoma, nk/t-cell
658017|NCT00418522|Insulin Glargine Diabetes HbA1c|insulin glargine diabetes hba1c
658018|NCT00418509|Dose proportionality|dose proportionality
658019|NCT00418509|pharmacokinetics|pharmacokinetics
658020|NCT00418509|mometasone|mometasone
658021|NCT00418509|formoterol|formoterol
658022|NCT00418509|Healthy volunteers study|healthy volunteers study
658023|NCT00418496|Unresectable|unresectable
658024|NCT00418496|Metastatic|metastatic
658025|NCT00418483|thrombolytic|thrombolytic
658026|NCT00418483|thrombolysis|thrombolysis
658027|NCT00418483|acute peripheral arterial occlusion|acute peripheral arterial occlusion
658028|NCT00418483|peripheral vascular disease|peripheral vascular disease
658029|NCT00418483|thrombosis|thrombosis
658030|NCT00418483|endovascular|endovascular
658031|NCT00418470|Cystic fibrosis|cystic fibrosis
658032|NCT00418470|Catheterization, peripheral|catheterization, peripheral
658033|NCT00418470|Phlebitis|phlebitis
658034|NCT00418470|Anti-Bacterial Agents|anti-bacterial agents
658035|NCT00418470|Osmolar Concentration|osmolar concentration
658036|NCT00418457|Breast Cancer|breast cancer
658037|NCT00418457|Anesthesia; regional|anesthesia; regional
658038|NCT00418457|cancer recurrence|cancer recurrence
658039|NCT00418457|Anesthesia; inhalational|anesthesia; inhalational
658040|NCT00418457|Analgesia; opioid|analgesia; opioid
658041|NCT00418444|Breast cancer,group psychotherapy,RCT,women's mental health|breast cancer,group psychotherapy,rct,women's mental health
658042|NCT00418418|Cell transplantation|cell transplantation
658043|NCT00418418|Heart failure|heart failure
658044|NCT00418418|Clinical trials|clinical trials
658045|NCT00418405|Arthritis, Rheumatoid|arthritis, rheumatoid
658046|NCT00418405|Cohort Studies|cohort studies
658047|NCT00418392|pneumothorax, aspiration, minocycline, pleurodesis|pneumothorax, aspiration, minocycline, pleurodesis
658048|NCT00418379|Sublingual immunotherapy|sublingual immunotherapy
658049|NCT00418379|Grass pollen tablet|grass pollen tablet
658050|NCT00418379|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
658051|NCT00418366|Mild, moderate, severe renal insufficiency|mild, moderate, severe renal insufficiency
658052|NCT00418366|End stage renal disease|end stage renal disease
658053|NCT00418353|Antenatal corticosteroids|antenatal corticosteroids
658054|NCT00418353|Betamethasone|betamethasone
658055|NCT00418353|Dexamethasone|dexamethasone
658056|NCT00418353|Premature|premature
658057|NCT00418340|Irritable Bowel Syndrome,|irritable bowel syndrome,
658058|NCT00418340|Visceral hypersensitivity,|visceral hypersensitivity,
658059|NCT00418340|probiotic therapy,|probiotic therapy,
658060|NCT00418340|immune response|immune response
658061|NCT00418327|Tarceva|tarceva
658062|NCT00418327|refractory and relapsed malignant brain tumors|refractory and relapsed malignant brain tumors
658063|NCT00418327|newly diagnosed brain stem glioma|newly diagnosed brain stem glioma
658064|NCT00418301|Pain|pain
658065|NCT00418301|Neurostimulation|neurostimulation
658066|NCT00418288|GLP-1|glp-1
658067|NCT00418288|glucose metabolism|glucose metabolism
658068|NCT00418288|Type 2 diabetes|type 2 diabetes
658069|NCT00418288|brain|brain
658070|NCT00418288|PET|pet
658071|NCT00418275|Cerebrovascular Stroke|cerebrovascular stroke
658072|NCT00418262|fetal alcohol syndrome|fetal alcohol syndrome
658073|NCT00418262|attention deficit disorder|attention deficit disorder
658074|NCT00418262|attention deficit disorder with hyperactivity|attention deficit disorder with hyperactivity
658075|NCT00418262|ADD|add
658076|NCT00418262|FAS|fas
658077|NCT00418262|FASD|fasd
658078|NCT00418262|ADHD|adhd
658079|NCT00418249|Androgenetic Alopecia|androgenetic alopecia
658080|NCT00418249|Telogen effluvium|telogen effluvium
658081|NCT00418249|Chronic telogen effluvium|chronic telogen effluvium
658082|NCT00418249|Menopause|menopause
658083|NCT00418249|Female Androgenetic Alopecia (FAGA)|female androgenetic alopecia (faga)
658084|NCT00418223|Urinary retention|urinary retention
658085|NCT00418223|Child birth|child birth
658086|NCT00418223|Catheterization|catheterization
658087|NCT00418223|Ultrasound|ultrasound
658088|NCT00418210|Accelerated Partial Breast Irradiation|accelerated partial breast irradiation
658089|NCT00418210|Conformal Radiation Therapy|conformal radiation therapy
658090|NCT00418210|Feasibility|feasibility
658091|NCT00418210|Early breast cancer|early breast cancer
658092|NCT00418197|spinal stenosis|spinal stenosis
658093|NCT00418197|low back pain|low back pain
658094|NCT00418197|spondylolisthesis|spondylolisthesis
658095|NCT00418197|lumbar spinal stenosis|lumbar spinal stenosis
658096|NCT00418197|leg pain|leg pain
658097|NCT00418197|spinal diseases|spinal diseases
658098|NCT00418184|ADHD|adhd
658099|NCT00418184|inattentive|inattentive
658100|NCT00418184|impulsive|impulsive
658101|NCT00418184|hyperactive|hyperactive
658102|NCT00418184|poor academic performance|poor academic performance
658103|NCT00418184|poor self-discipline|poor self-discipline
658104|NCT00418184|low self-esteem|low self-esteem
658105|NCT00418158|Pulmonary complications|pulmonary complications
658106|NCT00418145|Relapsing Forms of Multiple Sclerosis|relapsing forms of multiple sclerosis
658107|NCT00418132|SSc|ssc
658108|NCT00418132|Systemic Sclerosis|systemic sclerosis
658109|NCT00418132|Progressive Systemic Sclerosis|progressive systemic sclerosis
658110|NCT00418106|Premature birth|premature birth
658111|NCT00418106|Pumping breast milk|pumping breast milk
658112|NCT00418106|Kangaroo holding|kangaroo holding
658113|NCT00418093|mullerian carcinoma|mullerian carcinoma
658114|NCT00418067|Coronary Artery Disease|coronary artery disease
658115|NCT00418067|Stent|stent
658116|NCT00418028|capecitabine|capecitabine
658117|NCT00418028|schedule|schedule
658118|NCT00418028|breast cancer|breast cancer
658119|NCT00418015|µ-opioid receptor|µ-opioid receptor
658120|NCT00418015|neuraxial labor analgesia|neuraxial labor analgesia
658121|NCT00418015|pharmacogenetics|pharmacogenetics
658122|NCT00418002|Single-rising dose , multiple rising dose, elderly, cognitive, , pharmacokinetic, impairment.|single-rising dose , multiple rising dose, elderly, cognitive, , pharmacokinetic, impairment.
658123|NCT00418002|Healthy elderly male and female subjects|healthy elderly male and female subjects
658124|NCT00417989|Glycemic control|glycemic control
658125|NCT00417989|Sensor|sensor
658126|NCT00417976|Advanced Pancreatic Cancer|advanced pancreatic cancer
658127|NCT00417963|Carotid|carotid
658128|NCT00417963|Artery|artery
658129|NCT00417963|Stenosis|stenosis
658130|NCT00417950|diabetes|diabetes
658131|NCT00417950|acarbose|acarbose
658132|NCT00417950|alcohol|alcohol
658133|NCT00417950|inflammation|inflammation
658134|NCT00417950|oxidative stress|oxidative stress
658135|NCT00417950|Mild diabetes mellitus|mild diabetes mellitus
658136|NCT00417924|Patient education|patient education
658137|NCT00417924|Patient satisfaction|patient satisfaction
658138|NCT00417924|Eye health|eye health
658139|NCT00417911|multiple myeloma|multiple myeloma
658140|NCT00417911|autologous stem cell transplantation|autologous stem cell transplantation
658141|NCT00417911|high-dose melphalan|high-dose melphalan
658142|NCT00417911|bortezomib|bortezomib
658143|NCT00417911|consolidation|consolidation
658144|NCT00417911|event free survival|event free survival
658145|NCT00417911|phase III|phase iii
658146|NCT00417898|Stroke|stroke
658147|NCT00417898|Cerebral Ischemia|cerebral ischemia
658148|NCT00417898|Tissue Plasminogen Activator|tissue plasminogen activator
658149|NCT00417898|Aspirin|aspirin
658150|NCT00417898|Human|human
658151|NCT00417898|Cerebral Reperfusion|cerebral reperfusion
658152|NCT00417872|Clostridium difficile|clostridium difficile
658153|NCT00417846|Age-Related Macular Degeneration|age-related macular degeneration
658154|NCT00417846|Optical Coherence Tomography, OCT|optical coherence tomography, oct
658155|NCT00417846|Preferential Hyperacuity Perimeter, PHP|preferential hyperacuity perimeter, php
658156|NCT00417846|Amsler Grid|amsler grid
658157|NCT00417820|Safety, tolerability, pharmacodynamics, single administration, BCT194, healthy volunteers, psoriasis|safety, tolerability, pharmacodynamics, single administration, bct194, healthy volunteers, psoriasis
658158|NCT00417807|refractory desmoplastic small round cell tumors|refractory desmoplastic small round cell tumors
658159|NCT00417807|PDGF-R|pdgf-r
658160|NCT00417794|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
658161|NCT00417794|ADHD|adhd
658162|NCT00417794|fetal alcohol syndrome|fetal alcohol syndrome
658163|NCT00417794|FAS|fas
658164|NCT00417794|FASD|fasd
658165|NCT00417794|atomoxetine hcl|atomoxetine hcl
658166|NCT00417781|ADHD, adolescence, family study, endophenotype, outcome|adhd, adolescence, family study, endophenotype, outcome
658167|NCT00417768|tissue plasminogen activator|tissue plasminogen activator
658168|NCT00417768|intraabdominal|intraabdominal
658169|NCT00417768|abscess|abscess
658170|NCT00417768|percutaneous drainage|percutaneous drainage
658171|NCT00417755|Nutritional intake|nutritional intake
658172|NCT00417755|Mechanical ventilation|mechanical ventilation
658173|NCT00417755|Enteral feeding|enteral feeding
658174|NCT00417742|headache|headache
658175|NCT00417742|migraine headache|migraine headache
658176|NCT00417742|tension headache|tension headache
658177|NCT00417729|Diabetes|diabetes
658178|NCT00417729|Acarobse|acarobse
658179|NCT00417729|Metformin|metformin
658180|NCT00417729|oxidative stress|oxidative stress
658181|NCT00417729|Mean amplitude Glycemic Excursion|mean amplitude glycemic excursion
658182|NCT00417729|Meal test|meal test
658183|NCT00417716|Diffuse Diabetic Macular Edema|diffuse diabetic macular edema
658184|NCT00417716|Intravitreal Bevacizumab|intravitreal bevacizumab
658185|NCT00417716|Anti-VEGF drugs|anti-vegf drugs
658186|NCT00417703|Intraocular Pressure|intraocular pressure
658187|NCT00417703|Intravitreous Injection|intravitreous injection
658188|NCT00417703|Ranibizumab|ranibizumab
658189|NCT00417690|Crohn's Disease|crohn's disease
658190|NCT00417690|Acute Flare|acute flare
658191|NCT00417690|Mild to moderate Crohn's Disease|mild to moderate crohn's disease
658192|NCT00417690|Ileocecal distribution|ileocecal distribution
658193|NCT00417677|Advanced Renal Carcinoma|advanced renal carcinoma
658194|NCT00417664|cardiac surgery|cardiac surgery
658195|NCT00417664|valvular surgery|valvular surgery
658196|NCT00417664|delirium|delirium
658197|NCT00417664|postoperative delirium|postoperative delirium
658198|NCT00417664|cognitive dysfunction|cognitive dysfunction
658199|NCT00417664|altered mental status|altered mental status
658200|NCT00417651|Bacterial|bacterial
658201|NCT00417651|contamination|contamination
658202|NCT00417651|gastrotomy|gastrotomy
658203|NCT00417651|Complications|complications
658204|NCT00417638|myocardial infarction|myocardial infarction
658205|NCT00417638|acute intervention|acute intervention
658206|NCT00417638|percutaneous intervention|percutaneous intervention
658207|NCT00417638|endovascular cooling|endovascular cooling
658208|NCT00417638|endovascular rewarming|endovascular rewarming
658209|NCT00417625|Coronary Artery Perfusion|coronary artery perfusion
658210|NCT00417625|MRI|mri
658211|NCT00417625|Fractional Flow Reserve|fractional flow reserve
658212|NCT00417625|Coronary Flow Reserve|coronary flow reserve
658213|NCT00417625|Collateral Artery Perfusion|collateral artery perfusion
658214|NCT00417625|Cardiovascular Disease|cardiovascular disease
658215|NCT00417625|Coronary Artery Disease|coronary artery disease
658216|NCT00417625|CAD|cad
658217|NCT00417612|Rickets, Hypophosphatemia|rickets, hypophosphatemia
658218|NCT00417612|Rickets, Vitamin D-Resistant|rickets, vitamin d-resistant
658219|NCT00417612|Rickets, X-linked hypophosphatemic|rickets, x-linked hypophosphatemic
658220|NCT00417599|Prevention of overweight|prevention of overweight
658221|NCT00417599|Prevention of obesity|prevention of obesity
658222|NCT00417599|Treatment of overweight|treatment of overweight
658223|NCT00417599|Treatment of obesity|treatment of obesity
658224|NCT00417586|Stroke|stroke
658225|NCT00417573|Immunodeficiency|immunodeficiency
658226|NCT00417573|Gammaglobulin|gammaglobulin
658227|NCT00417573|IgG subclass deficiency with recurrent infections|igg subclass deficiency with recurrent infections
658228|NCT00417560|Influenza A/H5N1|influenza a/h5n1
658229|NCT00417560|vaccine|vaccine
658230|NCT00417560|avian influenza H5N1|avian influenza h5n1
658231|NCT00417560|H5N1|h5n1
658232|NCT00417547|Self Concept|self concept
658233|NCT00417547|Eating Disorder|eating disorder
658234|NCT00417547|Body Mass Index|body mass index
658235|NCT00417547|Dressing|dressing
658236|NCT00417547|Islamic Veil|islamic veil
658237|NCT00417534|Coronary Disease|coronary disease
658238|NCT00417534|Inflammation|inflammation
658239|NCT00417534|Genetics|genetics
658240|NCT00417534|HLA Antigens|hla antigens
658241|NCT00417534|Aortic Valve|aortic valve
658242|NCT00417521|Adolescents|adolescents
658243|NCT00417521|Anorexia|anorexia
658244|NCT00417521|Eating disorder|eating disorder
658245|NCT00417521|Family therapy|family therapy
658246|NCT00417508|function|function
658247|NCT00417508|elderly|elderly
658248|NCT00417508|ADL|adl
658249|NCT00417508|nutritional supplementation|nutritional supplementation
658250|NCT00417508|Quality of life|quality of life
658251|NCT00417508|handgrip strength|handgrip strength
658252|NCT00417508|Body Composition|body composition
658253|NCT00417495|adenocarcinoma, breast, multifocal lesions, surgery|adenocarcinoma, breast, multifocal lesions, surgery
658254|NCT00417482|Risperidone treatment, psychosis, agitation, aggression,|risperidone treatment, psychosis, agitation, aggression,
658255|NCT00417482|discontinuation, placebo|discontinuation, placebo
658256|NCT00417456|Acne|acne
658257|NCT00417456|Telemedicine|telemedicine
658258|NCT00417456|Dermatology|dermatology
658259|NCT00417443|epidural|epidural
658260|NCT00417443|clonidine|clonidine
658261|NCT00417443|hyperalgesia|hyperalgesia
658262|NCT00417443|laparotomy|laparotomy
658263|NCT00417417|Endothelium|endothelium
658264|NCT00417417|Inflammation|inflammation
658265|NCT00417417|Nitric Oxide|nitric oxide
658266|NCT00417417|Rilonacept|rilonacept
658267|NCT00417417|Cytokines|cytokines
658268|NCT00417417|Coronary Artery Disease|coronary artery disease
658269|NCT00417417|CAD|cad
658270|NCT00417417|Atherosclerosis|atherosclerosis
658271|NCT00417404|preterm|preterm
658272|NCT00417404|nutrition|nutrition
658273|NCT00417404|vitamin A|vitamin a
658274|NCT00417404|electroretinogram|electroretinogram
658275|NCT00417404|conjunctiva|conjunctiva
658276|NCT00417404|vitamin A status|vitamin a status
658277|NCT00417404|conjunctival health|conjunctival health
658278|NCT00417378|ACS|acs
658279|NCT00417365|odor|odor
658280|NCT00417365|douching|douching
658281|NCT00417365|BV|bv
658282|NCT00417365|vaginitis|vaginitis
658283|NCT00417365|vaginal|vaginal
658284|NCT00417365|yeast|yeast
658285|NCT00417365|ecosystem|ecosystem
658286|NCT00417365|Lactobacilli|lactobacilli
658287|NCT00417365|Nugent|nugent
658288|NCT00417365|Amsel|amsel
658289|NCT00417352|no intervention|no intervention
658290|NCT00417352|bracing restricted forearm and wrist movement|bracing restricted forearm and wrist movement
658291|NCT00417352|bracing with added mass near elbow|bracing with added mass near elbow
658292|NCT00417352|bracing with added mass near wrist|bracing with added mass near wrist
658293|NCT00417339|hemodialysis|hemodialysis
658294|NCT00417339|dialysis adequacy|dialysis adequacy
658295|NCT00417339|uremic retention solute|uremic retention solute
658296|NCT00417326|ONO-5046Na|ono-5046na
658297|NCT00417326|acute respiratory failure|acute respiratory failure
658298|NCT00417326|community-acquired pneumonia|community-acquired pneumonia
658299|NCT00417313|knee pain|knee pain
658300|NCT00417313|acupuncture /acupressure|acupuncture /acupressure
658301|NCT00417313|alternative medicine|alternative medicine
658302|NCT00417313|analgesia|analgesia
658303|NCT00417313|arthritis therapy|arthritis therapy
658304|NCT00417313|chronic pain|chronic pain
658305|NCT00417313|functional ability|functional ability
658306|NCT00417300|PTSD|ptsd
658307|NCT00417300|Cognitive Behavioral Treatment|cognitive behavioral treatment
658308|NCT00417300|Child Sexual Abuse|child sexual abuse
658309|NCT00417287|Pancreas|pancreas
658310|NCT00417287|Cancer|cancer
658311|NCT00417287|Carcinoma|carcinoma
658312|NCT00417274|Cancer of Prostate|cancer of prostate
658313|NCT00417274|Prostate Cancer|prostate cancer
658314|NCT00417274|Cancer of the Prostate|cancer of the prostate
658315|NCT00417274|Neoplasms, Prostate|neoplasms, prostate
658316|NCT00417274|Neoplasms, Prostatic|neoplasms, prostatic
658317|NCT00417274|Prostate Neoplasms|prostate neoplasms
658318|NCT00417274|Prostatic Cancer|prostatic cancer
658319|NCT00417274|Androgen-Independent Prostate Cancer|androgen-independent prostate cancer
658320|NCT00417261|ATF936, AXT914, healthy subjects, pharmacokinetics, parathyroid hormone, osteoporosis|atf936, axt914, healthy subjects, pharmacokinetics, parathyroid hormone, osteoporosis
658321|NCT00417261|Healthy male and female subjects|healthy male and female subjects
658322|NCT00417235|catheter related infection|catheter related infection
658323|NCT00417235|catheter dressing|catheter dressing
658324|NCT00417235|prevention|prevention
658325|NCT00417235|Chlorhexidine impregnated dressings|chlorhexidine impregnated dressings
658326|NCT00417235|Infection|infection
658327|NCT00417235|catheterization|catheterization
658328|NCT00417209|advanced pancreatic cancer|advanced pancreatic cancer
658329|NCT00417196|pharmacodynamic effects, safety, healthy subjects,|pharmacodynamic effects, safety, healthy subjects,
658330|NCT00417196|Healthy male and female subjects|healthy male and female subjects
658331|NCT00417183|GnRH antagonist|gnrh antagonist
658332|NCT00417183|GnRH agonist|gnrh agonist
658333|NCT00417183|Long protocol|long protocol
658334|NCT00417183|Flexible|flexible
658335|NCT00417170|High Blood pressure|high blood pressure
658336|NCT00417170|Hypertension|hypertension
658337|NCT00417170|metabolic syndrome|metabolic syndrome
658338|NCT00417170|insulin resistance|insulin resistance
658339|NCT00417170|endothelial dysfunction|endothelial dysfunction
658340|NCT00417170|pre-diabetic|pre-diabetic
658341|NCT00417170|amlodipine,|amlodipine,
658342|NCT00417170|aliskiren,|aliskiren,
658343|NCT00417170|IGT,|igt,
658344|NCT00417170|IFG,|ifg,
658345|NCT00417170|MBF|mbf
658346|NCT00417157|GnRH antagonist|gnrh antagonist
658347|NCT00417157|Poor responders|poor responders
658348|NCT00417157|Oocyte donation|oocyte donation
658349|NCT00417157|Modified natural cycle|modified natural cycle
658350|NCT00417144|OHSS|ohss
658351|NCT00417144|PCOS|pcos
658352|NCT00417144|GnRH antagonist|gnrh antagonist
658353|NCT00417144|GnRH agonist|gnrh agonist
658354|NCT00417131|Islet transplantation,|islet transplantation,
658355|NCT00417131|coagulation,|coagulation,
658356|NCT00417131|graft destruction,|graft destruction,
658357|NCT00417131|islet imaging|islet imaging
658358|NCT00417118|Anxiety|anxiety
658359|NCT00417118|clinical trials|clinical trials
658360|NCT00417105|hemodialysis|hemodialysis
658361|NCT00417105|dialysis adequacy|dialysis adequacy
658362|NCT00417105|chronic kidney disease|chronic kidney disease
658363|NCT00417092|coronary artery bypass grafting|coronary artery bypass grafting
658364|NCT00417092|reduced left ventricular function|reduced left ventricular function
658365|NCT00417092|postoperative pacing|postoperative pacing
658366|NCT00417092|cardiac resynchronization|cardiac resynchronization
658367|NCT00417079|Cancer|cancer
658368|NCT00417079|Prostate|prostate
658369|NCT00417066|poor responders|poor responders
658370|NCT00417066|GnRH antagonist|gnrh antagonist
658371|NCT00417066|GnRH agonist|gnrh agonist
658372|NCT00417066|flare up|flare up
658373|NCT00417066|short protocol|short protocol
658374|NCT00417053|disseminated neuroblastoma|disseminated neuroblastoma
658375|NCT00417053|localized resectable neuroblastoma|localized resectable neuroblastoma
658376|NCT00417053|localized unresectable neuroblastoma|localized unresectable neuroblastoma
658377|NCT00417053|regional neuroblastoma|regional neuroblastoma
658378|NCT00417053|stage 4S neuroblastoma|stage 4s neuroblastoma
658379|NCT00417040|adenocarcinoma of the prostate|adenocarcinoma of the prostate
658380|NCT00417040|recurrent prostate cancer|recurrent prostate cancer
658381|NCT00417040|stage IV prostate cancer|stage iv prostate cancer
658873|NCT00416052|calciuria|calciuria
658382|NCT00417027|Patient controlled epidural analgesia|patient controlled epidural analgesia
658383|NCT00417027|Labor analgesia|labor analgesia
658384|NCT00417027|Epidural analgesia|epidural analgesia
658385|NCT00417014|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
658386|NCT00417014|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
658387|NCT00417014|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
658388|NCT00417014|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
658389|NCT00417014|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
658390|NCT00417001|sedation|sedation
658391|NCT00417001|colonoscopy|colonoscopy
658392|NCT00417001|Aroma therapy|aroma therapy
658393|NCT00416988|melanoma|melanoma
658394|NCT00416988|weight changes|weight changes
658395|NCT00416975|breast cancer|breast cancer
658396|NCT00416962|Oseltamivir, amantidine, Symmetrel, Tamiflu|oseltamivir, amantidine, symmetrel, tamiflu
658397|NCT00416949|anaplastic thyroid cancer|anaplastic thyroid cancer
658398|NCT00416949|insular thyroid cancer|insular thyroid cancer
658399|NCT00416949|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
658400|NCT00416949|recurrent thyroid cancer|recurrent thyroid cancer
658401|NCT00416949|stage I follicular thyroid cancer|stage i follicular thyroid cancer
658402|NCT00416949|stage I papillary thyroid cancer|stage i papillary thyroid cancer
658403|NCT00416949|stage II follicular thyroid cancer|stage ii follicular thyroid cancer
658404|NCT00416949|stage II papillary thyroid cancer|stage ii papillary thyroid cancer
658405|NCT00416949|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
658406|NCT00416949|stage III papillary thyroid cancer|stage iii papillary thyroid cancer
658407|NCT00416949|stage IVA follicular thyroid cancer|stage iva follicular thyroid cancer
658408|NCT00416949|stage IVB follicular thyroid cancer|stage ivb follicular thyroid cancer
658409|NCT00416949|stage IVC follicular thyroid cancer|stage ivc follicular thyroid cancer
658410|NCT00416949|stage IVA papillary thyroid cancer|stage iva papillary thyroid cancer
658411|NCT00416949|stage IVB papillary thyroid cancer|stage ivb papillary thyroid cancer
658412|NCT00416949|stage IVC papillary thyroid cancer|stage ivc papillary thyroid cancer
658413|NCT00416923|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
658414|NCT00416923|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
658415|NCT00416923|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
658416|NCT00416923|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
658417|NCT00416923|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
658418|NCT00416923|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
658419|NCT00416923|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
658420|NCT00416923|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
658421|NCT00416923|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
658422|NCT00416923|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
658423|NCT00416923|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
658424|NCT00416923|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
658425|NCT00416923|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
658426|NCT00416923|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
658427|NCT00416923|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
658428|NCT00416923|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
658429|NCT00416923|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
658430|NCT00416923|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
658431|NCT00416923|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
658432|NCT00416923|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
658433|NCT00416923|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
658434|NCT00416923|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
658435|NCT00416923|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
658436|NCT00416923|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
658437|NCT00416923|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
658438|NCT00416923|leptomeningeal metastases|leptomeningeal metastases
658439|NCT00416923|intraocular lymphoma|intraocular lymphoma
658440|NCT00416923|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
658441|NCT00416923|Waldenström macroglobulinemia|waldenström macroglobulinemia
658442|NCT00416923|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
658443|NCT00416923|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
658444|NCT00416923|splenic marginal zone lymphoma|splenic marginal zone lymphoma
658445|NCT00416910|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
658446|NCT00416910|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
658447|NCT00416910|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
658448|NCT00416910|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
658449|NCT00416910|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
658450|NCT00416897|stage I multiple myeloma|stage i multiple myeloma
658451|NCT00416897|stage II multiple myeloma|stage ii multiple myeloma
658874|NCT00416052|PTH|pth
658452|NCT00416897|stage III multiple myeloma|stage iii multiple myeloma
658453|NCT00416897|renal failure|renal failure
658454|NCT00416884|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
658455|NCT00416884|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
658456|NCT00416884|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
658457|NCT00416871|stage IV renal cell cancer|stage iv renal cell cancer
658458|NCT00416871|recurrent renal cell cancer|recurrent renal cell cancer
658459|NCT00416858|stage III esophageal cancer|stage iii esophageal cancer
658460|NCT00416845|pharmacodynamic effects, cardiac effects, healthy subjects, synthetic sphingosine 1 phosphate (S1P) receptor modulator|pharmacodynamic effects, cardiac effects, healthy subjects, synthetic sphingosine 1 phosphate (s1p) receptor modulator
658461|NCT00416845|Healthy male and female subjects|healthy male and female subjects
658462|NCT00416832|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
658463|NCT00416832|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
658464|NCT00416832|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
658465|NCT00416832|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
658466|NCT00416819|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
658467|NCT00416819|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
658468|NCT00416780|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
658469|NCT00416780|recurrent breast cancer|recurrent breast cancer
658470|NCT00416780|stage I breast cancer|stage i breast cancer
658471|NCT00416780|stage II breast cancer|stage ii breast cancer
658472|NCT00416780|stage IV breast cancer|stage iv breast cancer
658473|NCT00416767|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
658474|NCT00416767|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
658475|NCT00416767|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
658476|NCT00416767|gastrinoma|gastrinoma
658477|NCT00416767|insulinoma|insulinoma
658478|NCT00416767|WDHA syndrome|wdha syndrome
658479|NCT00416767|glucagonoma|glucagonoma
658480|NCT00416767|pancreatic polypeptide tumor|pancreatic polypeptide tumor
658481|NCT00416767|somatostatinoma|somatostatinoma
658482|NCT00416767|recurrent islet cell carcinoma|recurrent islet cell carcinoma
658483|NCT00416754|breast cancer|breast cancer
658484|NCT00416754|stage I breast cancer|stage i breast cancer
658485|NCT00416754|stage II breast cancer|stage ii breast cancer
658486|NCT00416754|stage IIIA breast cancer|stage iiia breast cancer
658487|NCT00416754|stage IIIB breast cancer|stage iiib breast cancer
658488|NCT00416754|stage IIIC breast cancer|stage iiic breast cancer
658489|NCT00416754|stage IV breast cancer|stage iv breast cancer
658490|NCT00416741|Metabolic Syndrome|metabolic syndrome
658491|NCT00416741|Obesity|obesity
658492|NCT00416741|Hyperlipidemia|hyperlipidemia
658493|NCT00416741|High blood pressure|high blood pressure
658494|NCT00416741|Diabetes|diabetes
658495|NCT00416728|Aliskiren , Valsartan , bioavailability, hypertension|aliskiren , valsartan , bioavailability, hypertension
658496|NCT00416728|Healthy male and female subjects|healthy male and female subjects
658497|NCT00416702|safety study, pharmacokinetic effects, healthy subjects, hepatic impairment, liver|safety study, pharmacokinetic effects, healthy subjects, hepatic impairment, liver
658498|NCT00416702|Subjects with mild and moderate hepatic impairment and healthy subjects|subjects with mild and moderate hepatic impairment and healthy subjects
658499|NCT00416689|nausea and vomiting|nausea and vomiting
658500|NCT00416689|pulmonary carcinoid tumor|pulmonary carcinoid tumor
658501|NCT00416689|recurrent breast cancer|recurrent breast cancer
658502|NCT00416689|stage I breast cancer|stage i breast cancer
658503|NCT00416689|stage II breast cancer|stage ii breast cancer
658504|NCT00416689|stage IIIA breast cancer|stage iiia breast cancer
658505|NCT00416689|stage IIIB breast cancer|stage iiib breast cancer
658506|NCT00416689|stage IIIC breast cancer|stage iiic breast cancer
658507|NCT00416689|stage IV breast cancer|stage iv breast cancer
658508|NCT00416689|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
658509|NCT00416689|stage I non-small cell lung cancer|stage i non-small cell lung cancer
658510|NCT00416689|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
658511|NCT00416689|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
658512|NCT00416689|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
658513|NCT00416689|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
658514|NCT00416689|extensive stage small cell lung cancer|extensive stage small cell lung cancer
658515|NCT00416689|limited stage small cell lung cancer|limited stage small cell lung cancer
658516|NCT00416689|recurrent small cell lung cancer|recurrent small cell lung cancer
658517|NCT00416676|localized resectable neuroblastoma|localized resectable neuroblastoma
658518|NCT00416676|localized unresectable neuroblastoma|localized unresectable neuroblastoma
658519|NCT00416676|regional neuroblastoma|regional neuroblastoma
658520|NCT00416663|Stem cells|stem cells
658521|NCT00416663|Progenitor cells|progenitor cells
658522|NCT00416663|Angina Pectoris|angina pectoris
658523|NCT00416663|Heart Failure|heart failure
658524|NCT00416663|Angiogenesis|angiogenesis
658525|NCT00416650|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
658526|NCT00416650|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
659803|NCT00413036|CC-5013|cc-5013
658527|NCT00416650|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
658528|NCT00416650|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
658529|NCT00416637|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
658530|NCT00416624|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
658531|NCT00416624|extramedullary plasmacytoma|extramedullary plasmacytoma
658532|NCT00416624|isolated plasmacytoma of bone|isolated plasmacytoma of bone
658533|NCT00416624|refractory multiple myeloma|refractory multiple myeloma
658534|NCT00416624|stage I multiple myeloma|stage i multiple myeloma
658535|NCT00416624|stage II multiple myeloma|stage ii multiple myeloma
658536|NCT00416624|stage III multiple myeloma|stage iii multiple myeloma
658537|NCT00416624|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
658538|NCT00416624|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
658539|NCT00416624|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
658540|NCT00416624|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
658541|NCT00416624|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
658542|NCT00416624|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
658543|NCT00416624|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
658544|NCT00416624|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
658545|NCT00416624|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
658546|NCT00416624|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
658547|NCT00416624|anaplastic large cell lymphoma|anaplastic large cell lymphoma
658548|NCT00416624|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
658549|NCT00416624|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
658550|NCT00416624|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
658551|NCT00416624|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
658552|NCT00416624|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
658553|NCT00416624|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
658554|NCT00416624|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
658555|NCT00416624|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
658556|NCT00416624|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
658557|NCT00416624|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
658558|NCT00416624|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
658559|NCT00416624|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
658560|NCT00416624|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
658561|NCT00416624|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
658562|NCT00416624|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
658563|NCT00416624|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
658564|NCT00416624|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
658565|NCT00416624|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
658566|NCT00416624|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
658567|NCT00416624|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
658568|NCT00416624|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
658569|NCT00416624|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
658570|NCT00416624|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
658571|NCT00416624|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
658572|NCT00416624|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
658573|NCT00416624|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
658574|NCT00416624|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
658575|NCT00416624|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
658576|NCT00416624|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
658577|NCT00416624|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
658578|NCT00416624|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
658579|NCT00416624|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
658580|NCT00416624|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
658581|NCT00416624|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
658582|NCT00416624|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
658583|NCT00416624|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
658584|NCT00416624|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
658585|NCT00416624|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
658586|NCT00416624|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
658587|NCT00416624|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
658875|NCT00416052|1,25-vitamin D|1,25-vitamin d
658588|NCT00416624|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
658589|NCT00416624|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
658590|NCT00416624|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
658591|NCT00416624|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
658592|NCT00416624|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
658593|NCT00416624|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
658594|NCT00416624|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
658595|NCT00416624|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
658596|NCT00416624|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
658597|NCT00416624|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
658598|NCT00416624|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
658599|NCT00416624|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
658600|NCT00416624|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
658601|NCT00416624|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
658602|NCT00416624|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
658603|NCT00416624|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
658604|NCT00416624|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
658605|NCT00416624|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
658606|NCT00416624|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
658607|NCT00416624|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
658608|NCT00416624|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
658609|NCT00416624|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
658610|NCT00416624|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
658611|NCT00416624|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
658612|NCT00416624|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
658613|NCT00416624|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
658614|NCT00416624|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
658615|NCT00416624|stage I mantle cell lymphoma|stage i mantle cell lymphoma
658616|NCT00416624|stage I marginal zone lymphoma|stage i marginal zone lymphoma
658617|NCT00416624|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
658618|NCT00416624|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
658619|NCT00416624|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
658620|NCT00416624|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
658621|NCT00416624|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
658622|NCT00416624|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
658623|NCT00416624|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
658624|NCT00416624|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
658625|NCT00416624|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
658626|NCT00416624|splenic marginal zone lymphoma|splenic marginal zone lymphoma
658627|NCT00416624|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
658628|NCT00416624|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
658629|NCT00416624|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
658630|NCT00416624|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
658631|NCT00416624|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
658632|NCT00416624|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
658633|NCT00416624|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
658634|NCT00416624|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
658635|NCT00416624|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
658636|NCT00416624|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
658637|NCT00416624|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
658638|NCT00416624|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
658639|NCT00416624|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
658640|NCT00416624|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
658641|NCT00416624|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
658642|NCT00416624|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
658643|NCT00416624|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
658644|NCT00416624|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
658645|NCT00416624|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
658646|NCT00416624|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
658647|NCT00416624|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
658648|NCT00416624|refractory hairy cell leukemia|refractory hairy cell leukemia
658649|NCT00416624|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
658650|NCT00416624|prolymphocytic leukemia|prolymphocytic leukemia
658651|NCT00416624|anemia|anemia
658652|NCT00416624|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
658653|NCT00416624|primary systemic amyloidosis|primary systemic amyloidosis
658654|NCT00416624|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
658655|NCT00416624|acute undifferentiated leukemia|acute undifferentiated leukemia
658656|NCT00416624|mast cell leukemia|mast cell leukemia
658657|NCT00416624|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
658658|NCT00416624|untreated hairy cell leukemia|untreated hairy cell leukemia
658659|NCT00416611|High blood pressure|high blood pressure
658660|NCT00416611|Awareness|awareness
658661|NCT00416611|Treatment|treatment
658662|NCT00416611|Effective Control|effective control
658663|NCT00416611|Coronary heart disease risk reduction|coronary heart disease risk reduction
658664|NCT00416611|Hypertension|hypertension
658665|NCT00416585|acne|acne
658666|NCT00416585|isotretinoin|isotretinoin
658667|NCT00416585|calcium. vitamin D|calcium. vitamin d
658668|NCT00416572|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
658669|NCT00416572|stage I breast cancer|stage i breast cancer
658670|NCT00416572|stage II breast cancer|stage ii breast cancer
658671|NCT00416559|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
658672|NCT00416559|localized resectable neuroblastoma|localized resectable neuroblastoma
658673|NCT00416559|localized unresectable neuroblastoma|localized unresectable neuroblastoma
658674|NCT00416559|regional neuroblastoma|regional neuroblastoma
658675|NCT00416546|Healthy Caucasians|healthy caucasians
658676|NCT00416546|Healthy Japanese subjects|healthy japanese subjects
658677|NCT00416546|Immunosuppressant|immunosuppressant
658678|NCT00416546|early T-cell activation blockers|early t-cell activation blockers
658679|NCT00416546|inhibition of protein kinase C|inhibition of protein kinase c
658680|NCT00416533|recurrent prostate cancer|recurrent prostate cancer
658681|NCT00416533|stage III prostate cancer|stage iii prostate cancer
658682|NCT00416533|stage IV prostate cancer|stage iv prostate cancer
658683|NCT00416533|adenocarcinoma of the prostate|adenocarcinoma of the prostate
658684|NCT00416520|Chronic Kidney Disease|chronic kidney disease
658685|NCT00416520|Dialysis|dialysis
658686|NCT00416520|Hyperphosphatemia|hyperphosphatemia
658687|NCT00416520|Phosphate binder|phosphate binder
658688|NCT00416507|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
658689|NCT00416507|stage III pancreatic cancer|stage iii pancreatic cancer
658690|NCT00416507|stage II pancreatic cancer|stage ii pancreatic cancer
658691|NCT00416494|adenocarcinoma of the colon|adenocarcinoma of the colon
658692|NCT00416494|recurrent colon cancer|recurrent colon cancer
658693|NCT00416494|stage IV colon cancer|stage iv colon cancer
658694|NCT00416494|adenocarcinoma of the rectum|adenocarcinoma of the rectum
658695|NCT00416494|recurrent rectal cancer|recurrent rectal cancer
658696|NCT00416494|stage IV rectal cancer|stage iv rectal cancer
658697|NCT00416481|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
658698|NCT00416468|Aliskiren , Valsartan, bioavailability, hypertension|aliskiren , valsartan, bioavailability, hypertension
658699|NCT00416468|Healthy male and female subjects|healthy male and female subjects
658700|NCT00416442|healthy subjects, safety, tolerability, dose escalation, pharmacokinetics, benzodiazepine|healthy subjects, safety, tolerability, dose escalation, pharmacokinetics, benzodiazepine
658701|NCT00416442|Healthy male and female subjects|healthy male and female subjects
658702|NCT00416429|recurrent renal cell cancer|recurrent renal cell cancer
658703|NCT00416429|stage IV renal cell cancer|stage iv renal cell cancer
658704|NCT00416403|breast cancer in situ|breast cancer in situ
658705|NCT00416403|ductal breast carcinoma in situ|ductal breast carcinoma in situ
658706|NCT00416403|stage IA breast cancer|stage ia breast cancer
658707|NCT00416403|stage IB breast cancer|stage ib breast cancer
658708|NCT00416390|benign prostatic hyperplasia|benign prostatic hyperplasia
658709|NCT00416390|stage I prostate cancer|stage i prostate cancer
658710|NCT00416390|stage IIB prostate cancer|stage iib prostate cancer
658711|NCT00416390|stage IIA prostate cancer|stage iia prostate cancer
658712|NCT00416390|stage III prostate cancer|stage iii prostate cancer
658713|NCT00416390|stage IV prostate cancer|stage iv prostate cancer
658714|NCT00416377|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
658715|NCT00416377|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
658716|NCT00416377|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
658717|NCT00416377|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
658718|NCT00416377|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
658719|NCT00416364|hernia|hernia
658720|NCT00416364|inguinal|inguinal
658721|NCT00416364|quality of life|quality of life
658722|NCT00416351|anaplastic large cell lymphoma|anaplastic large cell lymphoma
658723|NCT00416351|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
658724|NCT00416351|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
658725|NCT00416351|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
658726|NCT00416351|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
658727|NCT00416351|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
658728|NCT00416351|prolymphocytic leukemia|prolymphocytic leukemia
658876|NCT00416052|Calcitriol|calcitriol
658729|NCT00416351|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
658730|NCT00416351|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
658731|NCT00416351|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
658732|NCT00416351|small intestine lymphoma|small intestine lymphoma
658733|NCT00416338|renal failure|renal failure
658734|NCT00416338|infection|infection
658735|NCT00416338|peritonitis|peritonitis
658736|NCT00416325|prostate cancer|prostate cancer
658737|NCT00416312|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
658738|NCT00416312|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
658739|NCT00416312|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
658740|NCT00416312|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
658741|NCT00416312|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
658742|NCT00416312|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
658743|NCT00416312|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
658744|NCT00416312|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
658745|NCT00416312|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
658746|NCT00416312|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
658747|NCT00416312|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
658748|NCT00416312|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
658749|NCT00416312|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
658750|NCT00416312|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
658751|NCT00416312|splenic marginal zone lymphoma|splenic marginal zone lymphoma
658752|NCT00416312|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
658753|NCT00416312|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
658754|NCT00416312|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
658755|NCT00416312|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
658756|NCT00416312|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
658757|NCT00416312|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
658758|NCT00416312|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
658759|NCT00416312|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
658760|NCT00416312|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
658761|NCT00416312|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
658762|NCT00416312|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
658763|NCT00416312|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
658764|NCT00416312|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
658765|NCT00416312|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
658766|NCT00416312|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
658767|NCT00416312|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
658768|NCT00416312|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
658769|NCT00416312|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
658770|NCT00416312|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
658771|NCT00416312|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
658772|NCT00416312|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
658773|NCT00416312|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
658774|NCT00416312|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
658775|NCT00416312|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
658776|NCT00416312|Waldenström macroglobulinemia|waldenström macroglobulinemia
658777|NCT00416312|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
658778|NCT00416312|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
658779|NCT00416312|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
658780|NCT00416312|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
658781|NCT00416312|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
658782|NCT00416312|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
658783|NCT00416312|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
658784|NCT00416312|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
658785|NCT00416312|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
658786|NCT00416312|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
658787|NCT00416312|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
658788|NCT00416312|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
658789|NCT00416312|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
658790|NCT00416312|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
658791|NCT00416312|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
658979|NCT00415714|Biofeedback|biofeedback
658792|NCT00416312|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
658793|NCT00416312|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
658794|NCT00416312|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
658795|NCT00416312|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
658796|NCT00416312|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
658797|NCT00416312|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
658798|NCT00416312|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
658799|NCT00416312|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
658800|NCT00416312|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
658801|NCT00416312|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
658802|NCT00416312|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
658803|NCT00416312|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
658804|NCT00416312|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
658805|NCT00416312|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
658806|NCT00416312|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
658807|NCT00416312|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
658808|NCT00416312|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
658809|NCT00416312|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
658810|NCT00416312|stage I mantle cell lymphoma|stage i mantle cell lymphoma
658811|NCT00416312|stage I marginal zone lymphoma|stage i marginal zone lymphoma
658812|NCT00416312|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
658813|NCT00416312|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
658814|NCT00416312|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
658815|NCT00416312|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
658816|NCT00416312|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
658817|NCT00416299|Cardiac biomarker|cardiac biomarker
658818|NCT00416299|cardiac surgery|cardiac surgery
658820|NCT00416299|postoperative complications|postoperative complications
658821|NCT00416299|Patients aged 75 years or older undergoing cardiac surgery|patients aged 75 years or older undergoing cardiac surgery
658822|NCT00416286|Cetylpyridinium chlorid|cetylpyridinium chlorid
658823|NCT00416286|Sustained release|sustained release
658824|NCT00416286|orthodontic patients|orthodontic patients
658825|NCT00416286|streptococcus mutans|streptococcus mutans
658826|NCT00416286|Lactobacillus|lactobacillus
658827|NCT00416286|Rate of bacterial load in saliva of orthodontic patients|rate of bacterial load in saliva of orthodontic patients
658828|NCT00416273|Multiple Myeloma|multiple myeloma
658829|NCT00416273|Bortezomib|bortezomib
658830|NCT00416273|PS341|ps341
658831|NCT00416273|Proteasome inhibitor|proteasome inhibitor
658832|NCT00416273|Consolidation therapy|consolidation therapy
658833|NCT00416260|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
658834|NCT00416260|High-Frequency Ventilation|high-frequency ventilation
658835|NCT00416260|Respiration, Artificial|respiration, artificial
658836|NCT00416247|Hypnosis|hypnosis
658837|NCT00416247|TMS|tms
658838|NCT00416247|Cortical excitability|cortical excitability
658839|NCT00416221|Depression|depression
658840|NCT00416221|Lexapro|lexapro
658841|NCT00416208|Multiple Myeloma|multiple myeloma
658842|NCT00416208|Clinical trial|clinical trial
658843|NCT00416208|Bortezomib|bortezomib
658844|NCT00416208|PS341|ps341
658845|NCT00416208|Proteasome inhibitor|proteasome inhibitor
658846|NCT00416208|Consolidation therapy|consolidation therapy
658847|NCT00416182|Cystic fibrosis|cystic fibrosis
658848|NCT00416182|chronic sinusitis|chronic sinusitis
658849|NCT00416182|mucolytic|mucolytic
658850|NCT00416169|Frontotemporal Dementia|frontotemporal dementia
658851|NCT00416169|Pick Complex|pick complex
658852|NCT00416169|galantamine hydrobromide|galantamine hydrobromide
658853|NCT00416156|Obesity|obesity
658854|NCT00416156|Inflammation|inflammation
658855|NCT00416143|Bed rest for idiopathic sudden sensorineural hearing loss|bed rest for idiopathic sudden sensorineural hearing loss
658856|NCT00416130|Phase I/II Clinical Trial|phase i/ii clinical trial
658857|NCT00416130|Vorinostat|vorinostat
658858|NCT00416130|SAHA|saha
658859|NCT00416130|Recurrent Breast Cancer|recurrent breast cancer
658860|NCT00416130|Metastatic Breast Cancer|metastatic breast cancer
658861|NCT00416117|Neck pain|neck pain
658862|NCT00416117|Cervical pain|cervical pain
658863|NCT00416117|Radicular pain|radicular pain
658864|NCT00416117|Manual therapy|manual therapy
658865|NCT00416117|Mobilization|mobilization
658866|NCT00416117|Manipulation|manipulation
658867|NCT00416104|analgesia|analgesia
658868|NCT00416091|Tourette disorder, ADHD, comorbidity, neuropsychological|tourette disorder, adhd, comorbidity, neuropsychological
658869|NCT00416078|technology development and assessment|technology development and assessment
658870|NCT00416078|internet|internet
658871|NCT00416078|randomized control trial|randomized control trial
658877|NCT00416052|bone mineral density|bone mineral density
658878|NCT00416052|osteodensitometry|osteodensitometry
658879|NCT00416039|midazolam|midazolam
658880|NCT00416039|sublingual|sublingual
658881|NCT00416039|oral morphine|oral morphine
658882|NCT00416039|children|children
658883|NCT00416039|bone fracture|bone fracture
658884|NCT00416039|bone fracture with a deformed member|bone fracture with a deformed member
658885|NCT00416026|Quality improvement|quality improvement
658886|NCT00416026|Patient-centered care|patient-centered care
658887|NCT00416026|Acute coronary syndrome|acute coronary syndrome
658888|NCT00416026|Telephone counseling|telephone counseling
658889|NCT00416013|Beta Natriuretic Peptide|beta natriuretic peptide
658890|NCT00416013|Troponin|troponin
658891|NCT00416013|Hemodialysis|hemodialysis
658892|NCT00416000|Open/Elective EVAR patients|open/elective evar patients
658893|NCT00415987|Multiple Myeloma|multiple myeloma
658894|NCT00415974|Weight Loss|weight loss
658895|NCT00415974|Obesity|obesity
658896|NCT00415974|Overweight|overweight
658897|NCT00415974|Physical Activity|physical activity
658898|NCT00415974|Nutrition|nutrition
658899|NCT00415974|Primary Care Physicians|primary care physicians
658900|NCT00415974|Primary Care|primary care
658901|NCT00415974|Counseling|counseling
658902|NCT00415974|Adolescent|adolescent
658903|NCT00415961|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
658904|NCT00415961|Drug-eluting stent (DES)|drug-eluting stent (des)
658905|NCT00415948|Heart|heart
658906|NCT00415948|Cardiac|cardiac
658907|NCT00415948|Acute Coronary Syndrome|acute coronary syndrome
658908|NCT00415948|Sample Procurement|sample procurement
658909|NCT00415922|Bioequivalence|bioequivalence
658910|NCT00415922|bioavailability|bioavailability
658911|NCT00415922|carbidopa|carbidopa
658912|NCT00415922|levodopa|levodopa
658913|NCT00415922|entacapone|entacapone
658914|NCT00415922|fasting condition|fasting condition
658915|NCT00415922|Healthy volunteers study|healthy volunteers study
658916|NCT00415909|Leukemia|leukemia
658917|NCT00415909|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
658918|NCT00415909|CML|cml
658919|NCT00415909|Imatinib|imatinib
658920|NCT00415909|Gleevec|gleevec
658921|NCT00415909|TALL-104|tall-104
658922|NCT00415896|weaning|weaning
658923|NCT00415896|work of breathing|work of breathing
658924|NCT00415896|spontaneous breathing trial|spontaneous breathing trial
658925|NCT00415896|rapid shallow breathing|rapid shallow breathing
658926|NCT00415883|Relative bioavailability, formulation, Japanese, valsartan, healthy subjects|relative bioavailability, formulation, japanese, valsartan, healthy subjects
658927|NCT00415870|Overweight|overweight
658928|NCT00415870|Cell Phone|cell phone
658929|NCT00415870|Technology|technology
658930|NCT00415857|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
658931|NCT00415857|Leukemia|leukemia
658932|NCT00415857|Peptide Vaccine|peptide vaccine
658933|NCT00415857|PR1 Peptide|pr1 peptide
658934|NCT00415857|Imatinib|imatinib
658935|NCT00415857|Gleevec|gleevec
658936|NCT00415857|GM-CSF|gm-csf
658937|NCT00415857|Sargramostim|sargramostim
658938|NCT00415857|Leukine|leukine
658939|NCT00415857|Peginterferon alfa-2b|peginterferon alfa-2b
658940|NCT00415857|Peg-Intron|peg-intron
658941|NCT00415844|Bioequivalence|bioequivalence
658942|NCT00415844|bioavailability|bioavailability
658943|NCT00415844|carbidopa|carbidopa
658944|NCT00415844|levodopa|levodopa
658945|NCT00415844|entacapone|entacapone
658946|NCT00415844|fasting condition|fasting condition
658947|NCT00415844|Healthy volunteers study|healthy volunteers study
658948|NCT00415831|Bioequivalence|bioequivalence
658949|NCT00415831|bioavailability|bioavailability
658950|NCT00415831|carbidopa|carbidopa
658951|NCT00415831|levodopa|levodopa
658952|NCT00415831|entacapone|entacapone
658953|NCT00415831|fed condition|fed condition
658954|NCT00415831|Healthy volunteers study|healthy volunteers study
658955|NCT00415818|Lung Cancer|lung cancer
658956|NCT00415818|NSCLC|nsclc
658957|NCT00415818|Cancer Vaccine|cancer vaccine
658958|NCT00415818|Stage IV Non-Small Cell Lung Cancer|stage iv non-small cell lung cancer
658959|NCT00415818|Stage IIIb Non-Small Cell Lung Cancer with effusion|stage iiib non-small cell lung cancer with effusion
658960|NCT00415792|Ovulation induction|ovulation induction
658961|NCT00415792|hCG|hcg
658962|NCT00415792|GnRH agonist|gnrh agonist
658963|NCT00415792|hyper-responders|hyper-responders
658964|NCT00415779|hormone refractory|hormone refractory
658965|NCT00415779|bone metastasis|bone metastasis
658966|NCT00415779|chemotherapy|chemotherapy
658967|NCT00415779|biphosphonates|biphosphonates
658968|NCT00415766|recombinant hCG|recombinant hcg
658969|NCT00415766|urinary hCG|urinary hcg
658970|NCT00415740|Bioequivalence|bioequivalence
658971|NCT00415740|bioavailability|bioavailability
658972|NCT00415740|carbidopa|carbidopa
658973|NCT00415740|levodopa|levodopa
658974|NCT00415740|entacapone|entacapone
658975|NCT00415740|fasting|fasting
658976|NCT00415740|Healthy volunteers study|healthy volunteers study
658977|NCT00415714|Primary Insomnia|primary insomnia
658978|NCT00415714|Chronic Insomnia|chronic insomnia
658980|NCT00415714|Sleeplessness|sleeplessness
658981|NCT00415701|Etomidate|etomidate
658982|NCT00415701|Propofol|propofol
658983|NCT00415701|Adrenocortical Insufficiency|adrenocortical insufficiency
658984|NCT00415701|Hemodynamic Process|hemodynamic process
658985|NCT00415701|Vasoactive Agonists|vasoactive agonists
658986|NCT00415701|Coronary Artery Bypass|coronary artery bypass
658987|NCT00415701|Ischemic Coronary Heart Disease|ischemic coronary heart disease
658988|NCT00415701|Mitral valve reconstruction/replacement|mitral valve reconstruction/replacement
658989|NCT00415701|Mitral valve regurgitation|mitral valve regurgitation
658990|NCT00415701|Heart Valve Prosthesis|heart valve prosthesis
658991|NCT00415701|Cardiopulmonary Bypass|cardiopulmonary bypass
658992|NCT00415688|lifestyle modification|lifestyle modification
658993|NCT00415688|weight loss|weight loss
658994|NCT00415688|hyperglycemia|hyperglycemia
658995|NCT00415688|hypoglycemic agents|hypoglycemic agents
658996|NCT00415675|Lung Cancer|lung cancer
658997|NCT00415675|Abdominal Cancer|abdominal cancer
658998|NCT00415675|Tissue Motion|tissue motion
658999|NCT00415675|Breathing|breathing
659000|NCT00415675|Motion CT Scans|motion ct scans
659001|NCT00415649|HIV Preventive Vaccine|hiv preventive vaccine
659002|NCT00415649|HIV Seronegativity|hiv seronegativity
659003|NCT00415610|cerebral hemorrhage|cerebral hemorrhage
659004|NCT00415610|intracerebral hemorrhage|intracerebral hemorrhage
659005|NCT00415610|stroke|stroke
659006|NCT00415610|hypertension|hypertension
659007|NCT00415610|blood pressure|blood pressure
659008|NCT00415610|nicardipine|nicardipine
659009|NCT00415610|antihypertensive agent|antihypertensive agent
659010|NCT00415610|hematoma expansion|hematoma expansion
659011|NCT00415597|chronic pain|chronic pain
659012|NCT00415597|joint pain|joint pain
659013|NCT00415597|back pain|back pain
659014|NCT00415597|diabetic peripheral neuropathy|diabetic peripheral neuropathy
659015|NCT00415597|post herpetic neuralgia|post herpetic neuralgia
659016|NCT00415597|ALO-01|alo-01
659017|NCT00415597|Embeda|embeda
659018|NCT00415597|Chronic Non-Malignant Pain|chronic non-malignant pain
659019|NCT00415584|hypercalcemia|hypercalcemia
659020|NCT00415584|transplant|transplant
659021|NCT00415571|Hypogonadism|hypogonadism
659022|NCT00415571|Erectile Dysfunction|erectile dysfunction
659023|NCT00415558|Atrial Fibrillation|atrial fibrillation
659024|NCT00415545|Heart Failure|heart failure
659025|NCT00415545|Patient Education|patient education
659026|NCT00415532|splenectomy|splenectomy
659027|NCT00415532|platelet|platelet
659028|NCT00415532|AMG 531|amg 531
659029|NCT00415532|thrombopoietin|thrombopoietin
659030|NCT00415532|blood disorder|blood disorder
659031|NCT00415532|bleeding disorder|bleeding disorder
659032|NCT00415532|immune thrombocytopenic purpura|immune thrombocytopenic purpura
659033|NCT00415532|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
659151|NCT00415064|Multiple Myeloma|multiple myeloma
659034|NCT00415532|immune (idiopathic) thrombocytopenic purpura|immune (idiopathic) thrombocytopenic purpura
659035|NCT00415532|TPO|tpo
659036|NCT00415532|thrombopoietic protein|thrombopoietic protein
659037|NCT00415519|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
659038|NCT00415519|free radical scavenger|free radical scavenger
659039|NCT00415493|rhinitis|rhinitis
659040|NCT00415493|non-allergic rhinitis|non-allergic rhinitis
659041|NCT00415493|rhinomanometry|rhinomanometry
659042|NCT00415493|cold air|cold air
659043|NCT00415493|triggers: cold, dry air inhalation|triggers: cold, dry air inhalation
659044|NCT00415493|warm, most air inhalation|warm, most air inhalation
659045|NCT00415493|Nonallergic rhinitis; normal controls|nonallergic rhinitis; normal controls
659046|NCT00415467|Brain Tumor|brain tumor
659047|NCT00415467|Radiation Therapy System|radiation therapy system
659048|NCT00415467|GliaSite RTS|gliasite rts
659049|NCT00415454|Pancreatic Cancer|pancreatic cancer
659050|NCT00415441|physiotherapy|physiotherapy
659051|NCT00415441|exercise|exercise
659052|NCT00415441|manual therapy|manual therapy
659053|NCT00415441|shoulder pain|shoulder pain
659054|NCT00415441|rotator cuff|rotator cuff
659055|NCT00415415|Racial Disparities|racial disparities
659056|NCT00415415|Psychosocial Risk Factors|psychosocial risk factors
659057|NCT00415415|Neighborhood Socioeconomic Status|neighborhood socioeconomic status
659058|NCT00415415|CVD|cvd
659059|NCT00415415|CHD|chd
659060|NCT00415402|Vitamin D3|vitamin d3
659061|NCT00415402|morbidity|morbidity
659062|NCT00415402|mortality|mortality
659063|NCT00415402|low birth weight|low birth weight
659064|NCT00415402|supplementation|supplementation
659065|NCT00415402|TH1|th1
659066|NCT00415402|TH2|th2
659067|NCT00415402|CRP|crp
659068|NCT00415402|Neopterin|neopterin
659069|NCT00415402|immune response|immune response
659070|NCT00415389|Stroke|stroke
659071|NCT00415389|interactive educational program|interactive educational program
659072|NCT00415389|acute ischemic stroke|acute ischemic stroke
659073|NCT00415376|seizure|seizure
659074|NCT00415376|adult tumors metastatic to brain|adult tumors metastatic to brain
659075|NCT00415376|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
659076|NCT00415350|Bronchiectasis|bronchiectasis
659077|NCT00415350|Macrolide|macrolide
659078|NCT00415350|Azithromycin|azithromycin
659079|NCT00415350|Antibiotic prophylaxis|antibiotic prophylaxis
659080|NCT00415350|Immunomodulation|immunomodulation
659081|NCT00415350|Inflammation|inflammation
659082|NCT00415350|Lung function|lung function
659083|NCT00415350|Sputum|sputum
659084|NCT00415350|Bacterial colonization|bacterial colonization
659085|NCT00415337|lung|lung
659086|NCT00415337|neoplasm|neoplasm
659087|NCT00415337|bronchoscopy|bronchoscopy
659088|NCT00415337|ultrasonography|ultrasonography
659089|NCT00415337|histology|histology
659090|NCT00415311|Liver Transplantation|liver transplantation
659091|NCT00415311|rhMBL|rhmbl
659092|NCT00415298|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
659093|NCT00415298|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
659094|NCT00415298|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
659095|NCT00415298|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
659096|NCT00415298|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
659097|NCT00415298|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
659098|NCT00415298|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
659099|NCT00415298|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
659100|NCT00415298|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
659101|NCT00415298|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
659102|NCT00415298|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
659103|NCT00415298|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
659104|NCT00415298|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
659105|NCT00415298|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
659106|NCT00415298|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
659107|NCT00415285|Breast|breast
659108|NCT00415285|Cancer|cancer
659109|NCT00415285|Early-Stage|early-stage
659110|NCT00415285|Chemotherapy|chemotherapy
659111|NCT00415233|stage I follicular thyroid cancer|stage i follicular thyroid cancer
659112|NCT00415233|stage I papillary thyroid cancer|stage i papillary thyroid cancer
659113|NCT00415233|stage II follicular thyroid cancer|stage ii follicular thyroid cancer
659114|NCT00415233|stage II papillary thyroid cancer|stage ii papillary thyroid cancer
659115|NCT00415233|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
659116|NCT00415233|stage III papillary thyroid cancer|stage iii papillary thyroid cancer
659117|NCT00415233|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
659118|NCT00415233|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
659119|NCT00415220|Chiropractic|chiropractic
659120|NCT00415220|Manipulation|manipulation
659121|NCT00415220|Back surgery|back surgery
659122|NCT00415220|Herniated lumbar disc|herniated lumbar disc
659123|NCT00415220|Sciatica|sciatica
659124|NCT00415220|Lumbar microdiscectomy|lumbar microdiscectomy
659125|NCT00415220|Cost-effectiveness|cost-effectiveness
659126|NCT00415207|CYP2C8|cyp2c8
659127|NCT00415207|MDR1|mdr1
659128|NCT00415207|Pharmacogenetics|pharmacogenetics
659129|NCT00415207|Paclitaxel|paclitaxel
659130|NCT00415181|CYP2C8|cyp2c8
659131|NCT00415181|MDR1|mdr1
659132|NCT00415181|Pharmacogenetics|pharmacogenetics
659133|NCT00415181|Paclitaxel|paclitaxel
659134|NCT00415142|Depression|depression
659135|NCT00415142|Major depressive disorders|major depressive disorders
659136|NCT00415142|Controlled clinical trial|controlled clinical trial
659137|NCT00415129|Influenza|influenza
659138|NCT00415129|Orthomyxoviridae Infections|orthomyxoviridae infections
659139|NCT00415129|Influenza Pandemics|influenza pandemics
659140|NCT00415129|A/H5N1 strain|a/h5n1 strain
659141|NCT00415116|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
659142|NCT00415103|Emesis|emesis
659143|NCT00415103|Nausea|nausea
659144|NCT00415103|leukemia|leukemia
659145|NCT00415103|lymphoma|lymphoma
659146|NCT00415090|Nevirapine|nevirapine
659147|NCT00415090|Antiretroviral treatment|antiretroviral treatment
659148|NCT00415090|Triple nucleoside therapy|triple nucleoside therapy
659149|NCT00415090|HIV|hiv
659150|NCT00415090|Treatment Experienced|treatment experienced
659152|NCT00415064|Perifosine|perifosine
659153|NCT00415064|Lenalidomide|lenalidomide
659154|NCT00415064|Dexamethasone|dexamethasone
659155|NCT00415051|Rift Valley Fever, vaccine|rift valley fever, vaccine
659156|NCT00415038|hypertension|hypertension
659157|NCT00415038|pharmacogenomic|pharmacogenomic
659158|NCT00415038|adducin|adducin
659159|NCT00415038|ouabain|ouabain
659160|NCT00415038|rostafuroxin|rostafuroxin
659161|NCT00415025|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
659162|NCT00415025|oral complications of radiation therapy|oral complications of radiation therapy
659163|NCT00415025|radiation toxicity|radiation toxicity
660203|NCT00411385|Hepatitis C|hepatitis c
659164|NCT00415025|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
659165|NCT00415025|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
659166|NCT00415025|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
659167|NCT00415025|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
659168|NCT00415025|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
659169|NCT00415025|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
659170|NCT00415025|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
659171|NCT00415025|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
659172|NCT00415025|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
659173|NCT00415025|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
659174|NCT00415025|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
659175|NCT00415025|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
659176|NCT00415025|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
659177|NCT00415025|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
659178|NCT00415025|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
659179|NCT00415025|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
659180|NCT00415025|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
659181|NCT00415025|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
659182|NCT00415025|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
659183|NCT00415025|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
659184|NCT00415025|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
659185|NCT00415025|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
659186|NCT00415025|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
659187|NCT00415025|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
659188|NCT00415025|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
659189|NCT00415025|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
659190|NCT00415025|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
659191|NCT00415025|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
659192|NCT00415025|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
659193|NCT00415025|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
659194|NCT00415025|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
659195|NCT00415025|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
659196|NCT00415025|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
659197|NCT00415025|stage III salivary gland cancer|stage iii salivary gland cancer
659198|NCT00415025|stage IV salivary gland cancer|stage iv salivary gland cancer
659199|NCT00415025|recurrent salivary gland cancer|recurrent salivary gland cancer
659200|NCT00415025|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
659201|NCT00415025|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
659202|NCT00415025|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
659203|NCT00415025|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
659204|NCT00415025|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
659205|NCT00415025|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
659206|NCT00415025|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
659207|NCT00415025|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
659208|NCT00415025|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
659209|NCT00415025|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
659210|NCT00415025|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
659211|NCT00415025|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
659212|NCT00415025|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
659213|NCT00415025|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
659214|NCT00415025|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
659215|NCT00415025|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
659604|NCT00413387|Long acting bronchodilators|long acting bronchodilators
659216|NCT00415025|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
659217|NCT00415025|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
659218|NCT00414999|Macular degeneration|macular degeneration
659219|NCT00414999|Vascular diseases|vascular diseases
659220|NCT00414999|Retinal disorders|retinal disorders
659221|NCT00414999|Macular edema|macular edema
659222|NCT00414960|Healthy|healthy
659223|NCT00414960|Prevention|prevention
659224|NCT00414947|Bioequivalence|bioequivalence
659225|NCT00414947|safety|safety
659226|NCT00414947|LAF237|laf237
659227|NCT00414947|vildagliptin|vildagliptin
659228|NCT00414947|Chinese|chinese
659229|NCT00414947|healthy subjects|healthy subjects
659230|NCT00414934|cancer|cancer
659231|NCT00414934|bone scan|bone scan
659232|NCT00414934|NaF bone PET|naf bone pet
659233|NCT00414921|Attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
659234|NCT00414921|ADHD|adhd
659235|NCT00414921|clonidine|clonidine
659236|NCT00414921|methylphenidate|methylphenidate
659237|NCT00414921|MPH|mph
659238|NCT00414908|Chronic Pancreatitis|chronic pancreatitis
659239|NCT00414908|Pancreatectomy|pancreatectomy
659240|NCT00414908|Pancreatic Exocrine Insufficiency|pancreatic exocrine insufficiency
659241|NCT00414882|TB, tuberculosis, Mycobacterium tuberculosis, Brazil|tb, tuberculosis, mycobacterium tuberculosis, brazil
659242|NCT00414869|Liver|liver
659243|NCT00414869|Portal pressure|portal pressure
659244|NCT00414869|Fibrosis|fibrosis
659245|NCT00414869|Nitric oxide|nitric oxide
659246|NCT00414856|GERD|gerd
659247|NCT00414856|gastroesophageal reflux disease|gastroesophageal reflux disease
659248|NCT00414856|meal-induced gastroesophageal reflux events|meal-induced gastroesophageal reflux events
659249|NCT00414843|Storage|storage
659250|NCT00414843|Bile|bile
659251|NCT00414843|Biomarkers|biomarkers
659252|NCT00414843|biliary malignancies|biliary malignancies
659253|NCT00414830|prevention|prevention
659254|NCT00414830|health technology assessment|health technology assessment
659255|NCT00414830|population based|population based
659256|NCT00414830|fracture|fracture
659257|NCT00414817|Inhaled Corticosteroids|inhaled corticosteroids
659258|NCT00414817|ICS|ics
659259|NCT00414817|Adherence|adherence
659260|NCT00414804|Pain|pain
659261|NCT00414804|Neurostimulation|neurostimulation
659262|NCT00414778|Safety, pharmacokinetics, oral, single dose, multiple dose, LHT344, Chinese, healthy subjects|safety, pharmacokinetics, oral, single dose, multiple dose, lht344, chinese, healthy subjects
659263|NCT00414765|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
659264|NCT00414765|Metastatic Melanoma|metastatic melanoma
659265|NCT00414765|Aldesleukin|aldesleukin
659266|NCT00414765|IL-2|il-2
659267|NCT00414752|Smoking, abstinence, craving, smoker, AFQ056, nicotine, placebo|smoking, abstinence, craving, smoker, afq056, nicotine, placebo
659268|NCT00414739|growth of dendritic cells|growth of dendritic cells
659269|NCT00414739|prevention|prevention
659270|NCT00414726|ischemic stroke|ischemic stroke
659271|NCT00414726|normobaric oxygen therapy|normobaric oxygen therapy
659272|NCT00414713|Upper GI bleeding|upper gi bleeding
659273|NCT00414713|Cirrhosis|cirrhosis
659274|NCT00414713|Portal hypertension|portal hypertension
659275|NCT00414713|Non-variceal bleeding|non-variceal bleeding
659276|NCT00414713|Transfusion|transfusion
659277|NCT00414700|Cartilage|cartilage
659278|NCT00414700|Articular|articular
659279|NCT00414700|Femoral|femoral
659280|NCT00414700|Knee|knee
659281|NCT00414687|Primary or secondary Pulmonary hypertension|primary or secondary pulmonary hypertension
659282|NCT00414687|Iloprost|iloprost
659283|NCT00414687|Inhaled|inhaled
659284|NCT00414687|Long-term treatment|long-term treatment
659285|NCT00414661|Observational non-interventional long-term safety|observational non-interventional long-term safety
659286|NCT00414648|Lymphangiomyomatosis|lymphangiomyomatosis
659287|NCT00414648|Lung Disease|lung disease
659288|NCT00414635|HIV/AIDS|hiv/aids
659289|NCT00414635|efavirenz|efavirenz
659290|NCT00414635|tenofovir|tenofovir
659291|NCT00414635|emtricitabine|emtricitabine
659292|NCT00414635|FOTO|foto
659293|NCT00414635|treatment interruption|treatment interruption
659294|NCT00414635|Atripla|atripla
659295|NCT00414635|Truvada|truvada
659296|NCT00414635|Treatment Experienced|treatment experienced
659297|NCT00414622|Alzheimer|alzheimer
659298|NCT00414622|Probable Alzheimer disease|probable alzheimer disease
659299|NCT00414609|myocardial infarction, aliskiren, heart failure|myocardial infarction, aliskiren, heart failure
659300|NCT00414609|Post acute myocardial infarction with systolic dysfunction|post acute myocardial infarction with systolic dysfunction
659301|NCT00414583|Cerebrovascular Accident|cerebrovascular accident
659302|NCT00414583|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
659303|NCT00414583|CVA (Cerebrovascular Accident)|cva (cerebrovascular accident)
659304|NCT00414583|Cerebral Stroke|cerebral stroke
659305|NCT00414583|Stroke, Acute|stroke, acute
659306|NCT00414583|Cerebrovascular Stroke|cerebrovascular stroke
659307|NCT00414583|Fabry Disease|fabry disease
659308|NCT00414583|Anderson-Fabry Disease|anderson-fabry disease
659309|NCT00414583|Fabry's Disease|fabry's disease
659310|NCT00414570|Positron Emission Tomography (PET)|positron emission tomography (pet)
659311|NCT00414570|3'-deoxy-3'(18F)fluorothymidine ([18F]FLT)|3'-deoxy-3'(18f)fluorothymidine ([18f]flt)
659312|NCT00414557|Musculoskeletal diseases|musculoskeletal diseases
659313|NCT00414557|Joint diseases|joint diseases
659314|NCT00414544|Nasolabial folds|nasolabial folds
659315|NCT00414544|Dermal filler|dermal filler
659316|NCT00414544|Injectable dermal filler|injectable dermal filler
659317|NCT00414544|Soft tissue augmentation|soft tissue augmentation
659318|NCT00414518|Acute Infection|acute infection
659319|NCT00414518|Early HIV Infection|early hiv infection
659320|NCT00414518|Short-Term Antiretroviral Therapy|short-term antiretroviral therapy
659321|NCT00414518|Treatment Interruption|treatment interruption
659322|NCT00414518|Antiretroviral Drug (ARV)|antiretroviral drug (arv)
659323|NCT00414518|ART|art
659324|NCT00414492|metastatic colorectal cancer|metastatic colorectal cancer
659325|NCT00414492|liver metastasis|liver metastasis
659326|NCT00414492|tumor margins|tumor margins
659327|NCT00414492|neoadjuvant therapy|neoadjuvant therapy
659328|NCT00414479|schistosomiasis|schistosomiasis
659329|NCT00414479|anaemia|anaemia
659330|NCT00414479|malaria|malaria
659331|NCT00414479|iron deficiency|iron deficiency
659332|NCT00414453|Neuropathic pain|neuropathic pain
659333|NCT00414453|Chronic pain|chronic pain
659334|NCT00414453|Multiple sclerosis|multiple sclerosis
659335|NCT00414453|Central neuropathic pain|central neuropathic pain
659336|NCT00414453|Peripheral neuropathic pain|peripheral neuropathic pain
659337|NCT00414453|Opioid analgesic|opioid analgesic
659338|NCT00414453|Lidocaine|lidocaine
659339|NCT00414440|end-stage renal disease, ESRD, autosomal dominant polycystic kidney disease, ADPKD, everolimus|end-stage renal disease, esrd, autosomal dominant polycystic kidney disease, adpkd, everolimus
659340|NCT00414427|Knee Osteoarthritis|knee osteoarthritis
659341|NCT00414427|Ultrasonography|ultrasonography
659342|NCT00414427|Corticosteroids|corticosteroids
659343|NCT00414414|TB|tb
659344|NCT00414414|Tuberculosis|tuberculosis
659345|NCT00414414|HIV|hiv
659346|NCT00414414|Co-infection|co-infection
659347|NCT00414414|Steroid|steroid
659348|NCT00414414|Prednisone|prednisone
659349|NCT00414414|oral corticosteroids|oral corticosteroids
659350|NCT00414414|TB Treatment|tb treatment
659351|NCT00414414|South Africa|south africa
659352|NCT00414388|AIPC|aipc
659353|NCT00414375|Perforated Appendicitis|perforated appendicitis
659354|NCT00414375|Abscess|abscess
659355|NCT00414375|Appendectomy|appendectomy
659356|NCT00414362|Bacteremia|bacteremia
659357|NCT00414362|Urinary Tract Infections|urinary tract infections
659358|NCT00414362|Fluoroquinolone|fluoroquinolone
659359|NCT00414349|Topical analgesic|topical analgesic
659360|NCT00414349|Multiple dose|multiple dose
659361|NCT00414336|Blood Stage|blood stage
659362|NCT00414336|Investigational|investigational
659363|NCT00414336|Endemic|endemic
659364|NCT00414336|Malaria|malaria
659365|NCT00414310|Decitabine|decitabine
659366|NCT00414310|Dacogen|dacogen
659367|NCT00414310|5-AZA|5-aza
659368|NCT00414310|Valproic Acid|valproic acid
659369|NCT00414310|Myelodysplastic Syndrome|myelodysplastic syndrome
659370|NCT00414310|Acute Myelogenous Leukemia|acute myelogenous leukemia
659371|NCT00414310|MDS|mds
659372|NCT00414310|AML|aml
659373|NCT00414297|CAD|cad
659374|NCT00414297|ECP|ecp
659375|NCT00414297|CFI|cfi
659376|NCT00414297|CPI|cpi
659377|NCT00414297|MPR|mpr
659378|NCT00414284|HIV/AIDS|hiv/aids
659379|NCT00414284|viremia|viremia
659380|NCT00414284|Kaletra|kaletra
659381|NCT00414284|pharmacokinetics|pharmacokinetics
659382|NCT00414284|viral load|viral load
659383|NCT00414284|LPV/r|lpv/r
659384|NCT00414284|Treatment Experienced|treatment experienced
659385|NCT00414271|gastric cancer, neo-adjuvant chemotherapy|gastric cancer, neo-adjuvant chemotherapy
659386|NCT00414258|Pain Response|pain response
659387|NCT00414232|Rectal Cancer|rectal cancer
659388|NCT00414232|Chemoradiation|chemoradiation
659389|NCT00414232|Rectal Cancer receiving chemoradiation.|rectal cancer receiving chemoradiation.
659390|NCT00414206|AMD|amd
659391|NCT00414206|Wet AMD|wet amd
659392|NCT00414193|AmpC beta-lactamase|ampc beta-lactamase
659393|NCT00414193|Bacteremia|bacteremia
659394|NCT00414193|Piperacillin|piperacillin
659395|NCT00414193|Tazobactam|tazobactam
659396|NCT00414167|Binge eating|binge eating
659397|NCT00414167|Obesity|obesity
659398|NCT00414167|Medication|medication
659399|NCT00414167|Craving|craving
659400|NCT00414167|Emotional eating|emotional eating
659401|NCT00414154|Group based patient education,|group based patient education,
659402|NCT00414154|multidisciplinary,|multidisciplinary,
659403|NCT00414154|physical activity,|physical activity,
659404|NCT00414154|adherence to treatment,|adherence to treatment,
659405|NCT00414154|quality of life|quality of life
659406|NCT00414141|Allergy|allergy
659407|NCT00414141|Allergoid|allergoid
659408|NCT00414141|Specific Immunotherapy|specific immunotherapy
659409|NCT00414128|vasculitis|vasculitis
659410|NCT00414128|ANCA|anca
659411|NCT00414128|mycophenolate mofetil|mycophenolate mofetil
659412|NCT00414128|cyclophosphamide|cyclophosphamide
659413|NCT00414128|Anti neutrophil cytoplasm antibody associated vasculitis|anti neutrophil cytoplasm antibody associated vasculitis
659414|NCT00414115|Observational controlled study|observational controlled study
659415|NCT00414115|Genomic biomarkers|genomic biomarkers
659416|NCT00414115|Adverse drug reaction|adverse drug reaction
659417|NCT00414115|In children OR adults|in children or adults
659418|NCT00414102|Chronic Insomnia|chronic insomnia
659419|NCT00414102|Sleep Initiation and Maintenance Disorder|sleep initiation and maintenance disorder
659420|NCT00414102|Drug Therapy|drug therapy
659421|NCT00414076|Uterine Leiomyosarcoma|uterine leiomyosarcoma
659422|NCT00414076|Uterine Neoplasm|uterine neoplasm
659423|NCT00414076|Uterine Sarcomas|uterine sarcomas
659424|NCT00414076|Uterine Cancer|uterine cancer
659425|NCT00414076|Uterus|uterus
659426|NCT00414076|LMS|lms
659427|NCT00414076|ER Positivity|er positivity
659428|NCT00414076|Femara|femara
659429|NCT00414076|Letrozole|letrozole
659430|NCT00414063|Fecal Energy|fecal energy
659431|NCT00414063|Urine Energy|urine energy
659432|NCT00414063|Bomb Calorimetry|bomb calorimetry
659433|NCT00414063|Gut Maintenance Flora|gut maintenance flora
659434|NCT00414063|Obesity|obesity
659435|NCT00414063|Energy Metabolism|energy metabolism
659436|NCT00414037|insomnia|insomnia
659437|NCT00414037|lunesta|lunesta
659438|NCT00414037|eszopiclone|eszopiclone
659439|NCT00414037|pain|pain
659440|NCT00414037|fMRI|fmri
659441|NCT00414024|Opioid, constipation, tegaserod|opioid, constipation, tegaserod
659442|NCT00414011|Removal of corneal epithelium followed by excimer laser treatment during prk|removal of corneal epithelium followed by excimer laser treatment during prk
659443|NCT00413998|Functional ischaemic mitral regurgitation|functional ischaemic mitral regurgitation
659444|NCT00413985|Low Birth Weight|low birth weight
659445|NCT00413985|Fortified Human Milk|fortified human milk
659446|NCT00413985|breastfeeding|breastfeeding
659447|NCT00413985|infants|infants
659448|NCT00413985|growth|growth
659449|NCT00413959|NHL|nhl
659450|NCT00413946|Premature infant|premature infant
659451|NCT00413946|developmental outcome|developmental outcome
659452|NCT00413933|falls|falls
659453|NCT00413933|prevention|prevention
659454|NCT00413933|elderly|elderly
659455|NCT00413933|multidisciplinary intervention|multidisciplinary intervention
659456|NCT00413933|health care utilization|health care utilization
659457|NCT00413920|Steroids avoidance,|steroids avoidance,
659458|NCT00413920|enteric-coated mycophenolate sodium (EC-MPS),|enteric-coated mycophenolate sodium (ec-mps),
659459|NCT00413920|de novo renal transplantation|de novo renal transplantation
659460|NCT00413881|Residual refractive error left over from initial LASIK correction.|residual refractive error left over from initial lasik correction.
659461|NCT00413881|Higher Order aberrations measured using a wavefront analyzer.|higher order aberrations measured using a wavefront analyzer.
659462|NCT00413868|Myopia with our without astigmatism|myopia with our without astigmatism
659463|NCT00413855|Abdominal pain|abdominal pain
659464|NCT00413855|Appendectomy|appendectomy
659465|NCT00413855|Laparoscopy|laparoscopy
659466|NCT00413855|Chronic appendicitis|chronic appendicitis
659467|NCT00413855|Appendicopathy|appendicopathy
659468|NCT00413842|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
659469|NCT00413842|Plasticity|plasticity
659470|NCT00413842|Primary Motor Cortex|primary motor cortex
659471|NCT00413842|Cerebellum|cerebellum
659472|NCT00413842|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
659473|NCT00413842|Healthy Volunteer|healthy volunteer
659474|NCT00413842|HV|hv
659475|NCT00413829|age related macular degeneration|age related macular degeneration
659476|NCT00413829|anti-VEGF therapy|anti-vegf therapy
659477|NCT00413816|Anemia|anemia
659478|NCT00413816|Critically ill|critically ill
659479|NCT00413803|Hemodialysis|hemodialysis
659480|NCT00413803|Nocturnal dialysis|nocturnal dialysis
659481|NCT00413803|Cardiovascular disease|cardiovascular disease
659482|NCT00413803|Quality of Life|quality of life
659483|NCT00413803|left ventricular hypertrophy|left ventricular hypertrophy
659484|NCT00413790|Heart rate, overactive bladder|heart rate, overactive bladder
659485|NCT00413751|Large pupils rendering night vision difficulties such as haloes, glare, and monocular diplopia|large pupils rendering night vision difficulties such as haloes, glare, and monocular diplopia
659486|NCT00413738|Central venous catheter|central venous catheter
659487|NCT00413738|Catheter related bloodstream infection|catheter related bloodstream infection
659488|NCT00413738|Heparin|heparin
659489|NCT00413738|Chlorhexidine|chlorhexidine
659490|NCT00413738|Sulfadiazine|sulfadiazine
659491|NCT00413725|HIV Seronegativity|hiv seronegativity
659492|NCT00413725|HIV Preventive Vaccine|hiv preventive vaccine
659493|NCT00413725|Adenovirus|adenovirus
659621|NCT00413348|Inflammation|inflammation
659494|NCT00413712|Supraventricular Tachycardia|supraventricular tachycardia
659495|NCT00413712|Calcium Channel Blockers|calcium channel blockers
659496|NCT00413712|Verapamil|verapamil
659497|NCT00413712|Diltiazem|diltiazem
659498|NCT00413712|Adenosine|adenosine
659499|NCT00413699|long-term|long-term
659500|NCT00413699|open-label|open-label
659501|NCT00413699|safety|safety
659502|NCT00413686|Mixed solid tumors|mixed solid tumors
659802|NCT00413036|Revlimid|revlimid
659503|NCT00413673|Naturally occurring low to moderate myopia, with or without low levels of astigmatism in U.S. Army personnel|naturally occurring low to moderate myopia, with or without low levels of astigmatism in u.s. army personnel
659504|NCT00413660|DMARD therapy|dmard therapy
659505|NCT00413647|CardioPET|cardiopet
659506|NCT00413647|Coronary Artery Disease|coronary artery disease
659507|NCT00413647|Electrocardiogram|electrocardiogram
659508|NCT00413647|Radiation Dosimetry|radiation dosimetry
659509|NCT00413621|MRI|mri
659510|NCT00413621|Alzheimer Disease|alzheimer disease
659511|NCT00413621|Amyloid|amyloid
659512|NCT00413621|AD|ad
659513|NCT00413621|Healthy Volunteer|healthy volunteer
659514|NCT00413621|HV|hv
659515|NCT00413608|Human|human
659516|NCT00413608|Adults|adults
659517|NCT00413608|Male|male
659518|NCT00413608|Alleles|alleles
659519|NCT00413608|Genotype|genotype
659520|NCT00413608|Platelet Aggregation/drug effects|platelet aggregation/drug effects
659521|NCT00413608|Platelet Aggregation Inhibitors/*pharmacology|platelet aggregation inhibitors/*pharmacology
659522|NCT00413608|Platelet Function Tests|platelet function tests
659523|NCT00413608|Pharmacogenetics|pharmacogenetics
659524|NCT00413608|*Polymorphism, Genetic|*polymorphism, genetic
659525|NCT00413608|Ticlopidine/*analogs & derivatives/pharmacology|ticlopidine/*analogs & derivatives/pharmacology
659526|NCT00413608|Healthy subjects|healthy subjects
659527|NCT00413595|Cerebrovascular Accident|cerebrovascular accident
659528|NCT00413595|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
659529|NCT00413595|Fabry Disease|fabry disease
659530|NCT00413595|Fabry's Disease|fabry's disease
659531|NCT00413595|Anderson-Fabry Disease|anderson-fabry disease
659532|NCT00413595|CVA (Cerebrovascular Accident)|cva (cerebrovascular accident)
659533|NCT00413595|Stroke, acute|stroke, acute
659534|NCT00413595|Cerebral Stroke|cerebral stroke
659535|NCT00413582|Pectus Excavatum|pectus excavatum
659536|NCT00413582|Bar Repair|bar repair
659537|NCT00413582|Pain Control|pain control
659538|NCT00413582|Pectus Excavatum Repair|pectus excavatum repair
659539|NCT00413556|Rhinitis|rhinitis
659540|NCT00413556|Oral tablets|oral tablets
659541|NCT00413556|Ig G4|ig g4
659542|NCT00413556|grass pollen|grass pollen
659543|NCT00413556|inmunotherapy|inmunotherapy
659544|NCT00413543|COPD|copd
659545|NCT00413543|exacerbation|exacerbation
659546|NCT00413543|pulmonary rehabilitation|pulmonary rehabilitation
659547|NCT00413543|exercise tolerance|exercise tolerance
659548|NCT00413543|exacerbations|exacerbations
659549|NCT00413543|quality of life|quality of life
659550|NCT00413543|readmissions|readmissions
659551|NCT00413517|Naturally occurring myopia with or without astigmatism|naturally occurring myopia with or without astigmatism
659552|NCT00413504|Fondaparinux|fondaparinux
659553|NCT00413504|Monotherapy|monotherapy
659554|NCT00413504|Deep Vein thrombosis|deep vein thrombosis
659555|NCT00413504|Pulmonary Embolism|pulmonary embolism
659556|NCT00413504|Anticoagulation|anticoagulation
659557|NCT00413491|Breast Cancer|breast cancer
659558|NCT00413491|BRCA1 gene|brca1 gene
659559|NCT00413491|BRCA2 gene|brca2 gene
659560|NCT00413491|Magnetic Resonance Imaging|magnetic resonance imaging
659561|NCT00413491|Mammography|mammography
659562|NCT00413491|Ultrasonography|ultrasonography
659563|NCT00413478|5-Aza|5-aza
659564|NCT00413478|Azacytidine|azacytidine
659565|NCT00413478|Vidaza|vidaza
659566|NCT00413478|CLL|cll
659567|NCT00413478|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
659568|NCT00413478|Richter's transformation|richter's transformation
659569|NCT00413478|Leukemia|leukemia
659570|NCT00413465|Renal Plasma Flow|renal plasma flow
659571|NCT00413465|Endotoxemia|endotoxemia
659572|NCT00413465|Type 2 diabetes|type 2 diabetes
659573|NCT00413452|Rheumatoid Arthritis|rheumatoid arthritis
659574|NCT00413452|Etanercept|etanercept
659575|NCT00413452|Enbrel|enbrel
659576|NCT00413452|Amgen|amgen
659577|NCT00413439|Isavuconazole|isavuconazole
659578|NCT00413439|BAL8557|bal8557
659579|NCT00413439|ASP9766|asp9766
659580|NCT00413439|chemotherapy|chemotherapy
659581|NCT00413439|prophylaxis|prophylaxis
659582|NCT00413439|systemic fungal infection|systemic fungal infection
659583|NCT00413426|Pharmacokinetics|pharmacokinetics
659584|NCT00413426|oral|oral
659585|NCT00413426|single dose|single dose
659586|NCT00413426|table|table
659587|NCT00413426|suspension|suspension
659588|NCT00413426|release|release
659589|NCT00413426|darifenacin|darifenacin
659590|NCT00413426|healthy subjects|healthy subjects
659591|NCT00413426|Healthy volunteers study|healthy volunteers study
659592|NCT00413413|Hypertension, valsartan, amlodipine, high blood pressure|hypertension, valsartan, amlodipine, high blood pressure
659593|NCT00413400|Inflammation|inflammation
659594|NCT00413400|Visceral adiposity|visceral adiposity
659595|NCT00413400|TNF|tnf
659596|NCT00413400|Adiponectin|adiponectin
659597|NCT00413400|glucose tolerance|glucose tolerance
659598|NCT00413400|endothelial function|endothelial function
659599|NCT00413400|metabolic syndrome|metabolic syndrome
659600|NCT00413387|Asthma|asthma
659601|NCT00413387|Combinations|combinations
659602|NCT00413387|Inhaled therapy|inhaled therapy
659603|NCT00413387|Corticosteroids|corticosteroids
659605|NCT00413387|Beclomethasone|beclomethasone
659606|NCT00413387|Formoterol|formoterol
659607|NCT00413387|Budesonide|budesonide
659608|NCT00413374|Lovenox|lovenox
659609|NCT00413374|Enoxaparin|enoxaparin
659610|NCT00413374|Prophylaxis|prophylaxis
659611|NCT00413374|Pulmonary Embolism|pulmonary embolism
659612|NCT00413374|Acute Deep Vein Thrombosis|acute deep vein thrombosis
659613|NCT00413374|Venous Thrombosis|venous thrombosis
659614|NCT00413374|Thrombosis|thrombosis
659615|NCT00413374|Anticoagulation|anticoagulation
659616|NCT00413361|Systemic Lupus Erythematosus|systemic lupus erythematosus
659617|NCT00413361|Hydroxychloroquine|hydroxychloroquine
659618|NCT00413348|Type 2 diabetes|type 2 diabetes
659619|NCT00413348|Probiotics|probiotics
659620|NCT00413348|Insulin-resistance|insulin-resistance
659622|NCT00413348|Hyperinsulinemic euglycemic clamp|hyperinsulinemic euglycemic clamp
659623|NCT00413348|Endotoxin|endotoxin
659624|NCT00413335|Childhood and Adolescent Obesity|childhood and adolescent obesity
659625|NCT00413335|Metabolic phenotype|metabolic phenotype
659626|NCT00413335|Impaired Glucose Tolerance|impaired glucose tolerance
659627|NCT00413335|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
659628|NCT00413335|Insulin Sensitivity|insulin sensitivity
659629|NCT00413335|Insulin Resistance|insulin resistance
659630|NCT00413335|Abdominal fat partitioning|abdominal fat partitioning
659631|NCT00413335|Impaired Glucose Tolerance (IGT)|impaired glucose tolerance (igt)
659632|NCT00413335|Type 2 Diabetes Mellitus (T2DM)|type 2 diabetes mellitus (t2dm)
659633|NCT00413322|Advanced Solid tumor|advanced solid tumor
659634|NCT00413322|Adenosarcoma|adenosarcoma
659635|NCT00413322|Androgen-independent prostate cancer|androgen-independent prostate cancer
659636|NCT00413322|belinostat|belinostat
659637|NCT00413322|bladder cancer|bladder cancer
659638|NCT00413322|bladder neoplasms|bladder neoplasms
659639|NCT00413322|Breast cancer|breast cancer
659640|NCT00413322|Carcinoma, Bronchogenic|carcinoma, bronchogenic
659641|NCT00413322|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
659642|NCT00413322|Carcinoma, Small Cell|carcinoma, small cell
659643|NCT00413322|Carcinosarcoma|carcinosarcoma
659644|NCT00413322|Chondrosarcoma|chondrosarcoma
659645|NCT00413322|Coin Lesion, Pulmonary|coin lesion, pulmonary
659646|NCT00413322|colorectal cancer|colorectal cancer
659647|NCT00413322|Esophageal Neoplasms|esophageal neoplasms
659648|NCT00413322|Facial Neoplasms|facial neoplasms
659649|NCT00413322|Fibrosarcoma|fibrosarcoma
659650|NCT00413322|head and neck cancer|head and neck cancer
659651|NCT00413322|Hemangiosarcoma|hemangiosarcoma
659652|NCT00413322|Histiocytoma, Malignant Fibrous|histiocytoma, malignant fibrous
659653|NCT00413322|kidney cancer|kidney cancer
659654|NCT00413322|Leiomyosarcoma|leiomyosarcoma
659655|NCT00413322|Liposarcoma|liposarcoma
659656|NCT00413322|lung cancer|lung cancer
659657|NCT00413322|lung neoplasms|lung neoplasms
659658|NCT00413322|Lymphangiosarcoma|lymphangiosarcoma
659659|NCT00413322|mesothelioma|mesothelioma
659660|NCT00413322|mesothelioma, cystic|mesothelioma, cystic
659661|NCT00413322|Mixed Tumor, Mesodermal|mixed tumor, mesodermal
659662|NCT00413322|Mouth Neoplasms|mouth neoplasms
659663|NCT00413322|Myosarcoma|myosarcoma
659664|NCT00413322|Myxosarcoma|myxosarcoma
659665|NCT00413322|Osteosarcoma|osteosarcoma
659666|NCT00413322|Otorhinolaryngologic Neoplasms|otorhinolaryngologic neoplasms
659667|NCT00413322|Ovarian cancer|ovarian cancer
659668|NCT00413322|Pancoast's Syndrome|pancoast's syndrome
659669|NCT00413322|Parathyroid Neoplasms|parathyroid neoplasms
659670|NCT00413322|Phyllodes Tumor|phyllodes tumor
659671|NCT00413322|Pulmonary Sclerosing Hemangioma|pulmonary sclerosing hemangioma
659672|NCT00413322|sarcoma|sarcoma
659673|NCT00413322|thyroid cancer|thyroid cancer
659674|NCT00413322|Thyroid Neoplasms|thyroid neoplasms
659675|NCT00413322|Tracheal Neoplasms|tracheal neoplasms
659676|NCT00413322|PXD101|pxd101
659677|NCT00413309|Acute Coronary Syndrome|acute coronary syndrome
659678|NCT00413309|Percutaneous Coronary Intervention|percutaneous coronary intervention
659679|NCT00413309|Antiplatelet Therapy|antiplatelet therapy
659680|NCT00413309|PillCam|pillcam
659681|NCT00413309|Endoscopy|endoscopy
659682|NCT00413296|PTSD|ptsd
659683|NCT00413296|Anxiety|anxiety
659684|NCT00413296|Pharmacotherapy|pharmacotherapy
659685|NCT00413296|Levetiracetam|levetiracetam
659686|NCT00413296|Relapse prevention|relapse prevention
659687|NCT00413283|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
659688|NCT00413283|Chemotherapy Induced Thrombocytopenia|chemotherapy induced thrombocytopenia
659689|NCT00413283|CIT|cit
659690|NCT00413283|NSCLC|nsclc
659691|NCT00413283|Stage IIIB NSCLC|stage iiib nsclc
659692|NCT00413283|Stage IV NSCLC|stage iv nsclc
659693|NCT00413283|Gemcitabine|gemcitabine
659694|NCT00413283|Carboplatin|carboplatin
659695|NCT00413283|Cisplatin|cisplatin
659696|NCT00413270|Imatinib resistant,|imatinib resistant,
659697|NCT00413270|Imatinib intolerant,|imatinib intolerant,
659698|NCT00413270|CML- blast crisis,|cml- blast crisis,
659699|NCT00413270|CML- Accelerated phase,|cml- accelerated phase,
659700|NCT00413270|CML- chronic phase,|cml- chronic phase,
659701|NCT00413270|nilotinib,|nilotinib,
659702|NCT00413270|Chronic myelogenous leukemia,|chronic myelogenous leukemia,
659703|NCT00413270|blast crisis,|blast crisis,
659704|NCT00413270|accelerated phase,|accelerated phase,
659705|NCT00413270|chronic phase|chronic phase
659706|NCT00413257|Postoperative Hyperalgesia|postoperative hyperalgesia
659707|NCT00413257|cardiac Surgical Procedures|cardiac surgical procedures
659708|NCT00413257|Nefopam|nefopam
659709|NCT00413257|Randomized Controlled Trials|randomized controlled trials
659710|NCT00413257|Pain and chronic disease|pain and chronic disease
659711|NCT00413244|Hypogonadal|hypogonadal
659712|NCT00413244|coronary artery disease|coronary artery disease
659713|NCT00413244|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
659714|NCT00413231|Thoracic Aneurysm|thoracic aneurysm
659715|NCT00413231|Endovascular Aortic Repair (EVAR)|endovascular aortic repair (evar)
659716|NCT00413231|Endovascular Stent Graft|endovascular stent graft
659717|NCT00413231|Endograft|endograft
659718|NCT00413231|Thoracic Aortic Aneurysm|thoracic aortic aneurysm
659719|NCT00413231|Endovascular procedure|endovascular procedure
659720|NCT00413231|Descending Thoracic Aneurysm|descending thoracic aneurysm
659721|NCT00413231|Valiant Stent Graft System|valiant stent graft system
659722|NCT00413218|Invasive Candida infections|invasive candida infections
659723|NCT00413218|BAL8557|bal8557
659724|NCT00413218|ASP9766|asp9766
659725|NCT00413218|Isavuconazole|isavuconazole
659726|NCT00413218|Candidemia|candidemia
659727|NCT00413218|Candidemia and other invasive candida infections|candidemia and other invasive candida infections
659728|NCT00413218|Phase III study|phase iii study
659729|NCT00413179|Polycystic Ovarian Syndrome|polycystic ovarian syndrome
659730|NCT00413179|Chronic Anovulation|chronic anovulation
659731|NCT00413179|Chronic Oligoovulation|chronic oligoovulation
659732|NCT00413179|Infertility|infertility
659733|NCT00413179|Hyperandrogenism|hyperandrogenism
659734|NCT00413179|Metformin|metformin
659735|NCT00413179|Ovulation induction|ovulation induction
659736|NCT00413166|Acute Promyelocytic Leukemia|acute promyelocytic leukemia
659737|NCT00413166|APL|apl
659738|NCT00413166|ATRA|atra
659739|NCT00413166|All-Trans Retinoic Acid|all-trans retinoic acid
659740|NCT00413166|Arsenic Trioxide|arsenic trioxide
659741|NCT00413166|Theophylline|theophylline
659742|NCT00413166|Gemtuzumab|gemtuzumab
659743|NCT00413153|HIV|hiv
659744|NCT00413153|Kaletra|kaletra
659745|NCT00413153|Reyataz|reyataz
659746|NCT00413153|Insulin sensitivity|insulin sensitivity
659747|NCT00413153|Lipids|lipids
659748|NCT00413153|Body Composition|body composition
659749|NCT00413153|Receiving Kaletra|receiving kaletra
659750|NCT00413153|Treatment Experienced|treatment experienced
659751|NCT00413140|childhood disease|childhood disease
659752|NCT00413140|cystic fibrosis|cystic fibrosis
659753|NCT00413140|exhaled breath condensate|exhaled breath condensate
659754|NCT00413140|exhaled nitric oxide|exhaled nitric oxide
659755|NCT00413140|airway inflammation|airway inflammation
659756|NCT00413140|non-invasive inflammatory markers|non-invasive inflammatory markers
659757|NCT00413140|controls|controls
659758|NCT00413140|children|children
659759|NCT00413127|Systemic lidocaine|systemic lidocaine
659760|NCT00413127|peridural lidocaine|peridural lidocaine
659761|NCT00413127|perioperative analgesia|perioperative analgesia
659762|NCT00413127|inflammation|inflammation
659763|NCT00413127|Anesthesia|anesthesia
659764|NCT00413088|renal insufficency|renal insufficency
659765|NCT00413088|low molecular weight heparin|low molecular weight heparin
659766|NCT00413088|pharmacokinetics|pharmacokinetics
659767|NCT00413088|elderly|elderly
659768|NCT00413075|Solid tumors|solid tumors
659769|NCT00413075|Adenosarcoma|adenosarcoma
659770|NCT00413075|B-cell lymphoma|b-cell lymphoma
659771|NCT00413075|belinostat|belinostat
659772|NCT00413075|bladder cancer|bladder cancer
659773|NCT00413075|Breast cancer|breast cancer
659774|NCT00413075|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
659775|NCT00413075|Carcinoma, Small Cell|carcinoma, small cell
659776|NCT00413075|Chondrosarcoma|chondrosarcoma
659777|NCT00413075|colorectal cancer|colorectal cancer
659778|NCT00413075|Esophageal Neoplasms|esophageal neoplasms
659779|NCT00413075|Fibrosarcoma|fibrosarcoma
659780|NCT00413075|head and neck cancer|head and neck cancer
659781|NCT00413075|Hemangiosarcoma|hemangiosarcoma
659782|NCT00413075|Hodgkins Disease|hodgkins disease
659783|NCT00413075|kidney cancer|kidney cancer
659784|NCT00413075|Leiomyosarcoma|leiomyosarcoma
659785|NCT00413075|Liposarcoma|liposarcoma
659786|NCT00413075|lung cancer|lung cancer
659787|NCT00413075|lymphoma|lymphoma
659788|NCT00413075|mesothelioma|mesothelioma
659789|NCT00413075|mesothelioma, cystic|mesothelioma, cystic
659790|NCT00413075|Mixed Tumor, Mesodermal|mixed tumor, mesodermal
659791|NCT00413075|Osteosarcoma|osteosarcoma
659792|NCT00413075|Otorhinolaryngologic Neoplasms|otorhinolaryngologic neoplasms
659793|NCT00413075|Ovarian cancer|ovarian cancer
659794|NCT00413075|Parathyroid Neoplasms|parathyroid neoplasms
659795|NCT00413075|Prostate cancer|prostate cancer
659796|NCT00413075|sarcoma|sarcoma
659797|NCT00413075|T-cell lymphoma|t-cell lymphoma
659798|NCT00413075|thyroid cancer|thyroid cancer
659799|NCT00413075|PXD101|pxd101
659800|NCT00413049|Hypertension, valsartan, amlodipine, high blood pressure|hypertension, valsartan, amlodipine, high blood pressure
659801|NCT00413036|Celgene|celgene
659804|NCT00413036|Non-hodgkin's lymphoma|non-hodgkin's lymphoma
659805|NCT00413036|Lenalidomide|lenalidomide
659806|NCT00413036|CC5013|cc5013
659808|NCT00413023|depression|depression
659809|NCT00413023|major depressive disorder|major depressive disorder
659810|NCT00413023|MDD|mdd
659811|NCT00412997|advanced solid tumor|advanced solid tumor
659812|NCT00412997|Cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
659813|NCT00412997|Phase I|phase i
659814|NCT00412997|HDAC inhibitor|hdac inhibitor
659815|NCT00412997|Adult patients|adult patients
659816|NCT00412971|Recurrence of bladder cancer|recurrence of bladder cancer
659817|NCT00412971|Fluorescence cystoscopy|fluorescence cystoscopy
659818|NCT00412932|Hypertension|hypertension
659819|NCT00412932|Angiotensin Receptor Blocker|angiotensin receptor blocker
659820|NCT00412932|Calcium Channel Blocker|calcium channel blocker
659821|NCT00412932|Angiotensin Converting Enzyme Inhibitor|angiotensin converting enzyme inhibitor
659822|NCT00412932|Hydrochlorothiazide|hydrochlorothiazide
659823|NCT00412932|Stage I and II Hypertension|stage i and ii hypertension
659824|NCT00412919|Myeloma|myeloma
659825|NCT00412919|Relapsed|relapsed
659826|NCT00412919|Refractory|refractory
659827|NCT00412906|Low-grade inflammation|low-grade inflammation
659828|NCT00412906|insulin resistance|insulin resistance
659829|NCT00412906|Metabolism|metabolism
659830|NCT00412906|Type 2 diabetes|type 2 diabetes
659831|NCT00412906|Endotoxemia|endotoxemia
659832|NCT00412906|Fat tissue|fat tissue
659833|NCT00412906|Muscle tissue|muscle tissue
659834|NCT00412906|RT-PCR|rt-pcr
659835|NCT00412893|Invasive fungal disease|invasive fungal disease
659836|NCT00412893|BAL8557|bal8557
659837|NCT00412893|Isavuconazole|isavuconazole
659838|NCT00412893|ASP9766|asp9766
659839|NCT00412893|Filamentous fungi|filamentous fungi
659840|NCT00412893|Phase III|phase iii
659841|NCT00412893|Aspergillus species|aspergillus species
659842|NCT00412867|Cerebral Infarction|cerebral infarction
659843|NCT00412867|acute ischemic stroke|acute ischemic stroke
659844|NCT00412867|Brain ischemia|brain ischemia
659845|NCT00412841|Avascular Necrosis|avascular necrosis
659846|NCT00412841|Lipitor|lipitor
659847|NCT00412841|SLE|sle
659848|NCT00412828|Melanoma|melanoma
659849|NCT00412828|CR011-vcMMAE|cr011-vcmmae
659850|NCT00412815|insulin sensitivity|insulin sensitivity
659851|NCT00412815|coronary artery disease|coronary artery disease
659852|NCT00412815|exercise training|exercise training
659853|NCT00412802|enoxaparine|enoxaparine
659854|NCT00412802|acute coronary syndrome|acute coronary syndrome
659855|NCT00412802|renal failure|renal failure
659856|NCT00412802|dose adaptation|dose adaptation
659857|NCT00412789|Advanced solid tumor|advanced solid tumor
659858|NCT00412789|Patupilone|patupilone
659859|NCT00412763|Acute hepatitis|acute hepatitis
659860|NCT00412763|Acute viral hepatitis|acute viral hepatitis
659861|NCT00412763|Acute nonviral hepatitis|acute nonviral hepatitis
659862|NCT00412763|Silymarin|silymarin
659863|NCT00412763|Milk Thistle|milk thistle
659864|NCT00412750|hepatitis B|hepatitis b
659865|NCT00412750|hepatitis B Virus (HBV)|hepatitis b virus (hbv)
659866|NCT00412750|chronic hepatitis B|chronic hepatitis b
659867|NCT00412750|telbivudine|telbivudine
659868|NCT00412750|peginterferon|peginterferon
659869|NCT00412724|diet|diet
659870|NCT00412724|acceptability|acceptability
659871|NCT00412724|palatability|palatability
659872|NCT00412724|food|food
659873|NCT00412724|questionnaire|questionnaire
659874|NCT00412724|Food habits|food habits
659875|NCT00412672|Myocardial infarction|myocardial infarction
659876|NCT00412672|contrast echocardiography|contrast echocardiography
659877|NCT00412672|collateral circulation|collateral circulation
659878|NCT00412659|Sinus, Pilonidal|sinus, pilonidal
659879|NCT00412659|Pilonidal sinus|pilonidal sinus
659880|NCT00412659|Pilonidal cysts|pilonidal cysts
659881|NCT00412659|Pilonidal disease|pilonidal disease
659882|NCT00412659|midline excision|midline excision
659883|NCT00412659|Karydakis operation|karydakis operation
659884|NCT00412659|expertise based study|expertise based study
659885|NCT00412659|surgery|surgery
659886|NCT00412659|therapy|therapy
659887|NCT00412646|HIV|hiv
659888|NCT00412646|AIDS|aids
659889|NCT00412646|Dose finding study|dose finding study
659890|NCT00412646|TMC125-C203|tmc125-c203
659891|NCT00412646|Treatment Experienced|treatment experienced
659892|NCT00412633|Obesity|obesity
659893|NCT00412633|Men|men
659894|NCT00412633|Overweight|overweight
659895|NCT00412607|Ventricular Tachycardia|ventricular tachycardia
659896|NCT00412607|Heart Diseases|heart diseases
659897|NCT00412607|Arrhythmia|arrhythmia
659898|NCT00412594|Hairy Cell Leukemia|hairy cell leukemia
659899|NCT00412594|Leukemia|leukemia
659900|NCT00412594|2CDA|2cda
659901|NCT00412594|2-chlorodeoxyadenosine|2-chlorodeoxyadenosine
659902|NCT00412594|Rituximab|rituximab
659903|NCT00412594|Rituxan|rituxan
659904|NCT00412594|HCL|hcl
659905|NCT00412581|Melanoma|melanoma
659906|NCT00412581|Lenalidomide|lenalidomide
659907|NCT00412581|Dacarbazine|dacarbazine
659908|NCT00412581|CC-5013|cc-5013
659909|NCT00412581|Revlimid|revlimid
659910|NCT00412581|DTIC|dtic
659911|NCT00412568|Naturally occuring myopia with or without astigmatism.|naturally occuring myopia with or without astigmatism.
659912|NCT00412542|Glioblastoma Multiforme|glioblastoma multiforme
659913|NCT00412542|Glioma|glioma
659914|NCT00412542|Thalidomide|thalidomide
659915|NCT00412542|Thalomid|thalomid
659916|NCT00412542|CPT-11|cpt-11
659917|NCT00412542|Irinotecan|irinotecan
659918|NCT00412542|malignant glioma|malignant glioma
659919|NCT00412529|HBeAg-positive, chronic hepatitis B|hbeag-positive, chronic hepatitis b
659920|NCT00412529|telbivudine|telbivudine
659921|NCT00412529|entecavir|entecavir
659922|NCT00412529|viral kinetics|viral kinetics
659923|NCT00412516|Japanese Encephalitis|japanese encephalitis
659924|NCT00412516|Japanese B Encephalitis|japanese b encephalitis
659925|NCT00412516|Japanese B Viral Encephalitis|japanese b viral encephalitis
659926|NCT00412516|Viral Encephalitis, Japanese B|viral encephalitis, japanese b
659927|NCT00412490|Oral Cavity Cancer|oral cavity cancer
659928|NCT00412490|Body Image|body image
659929|NCT00412490|Smoking|smoking
659930|NCT00412490|Appearance|appearance
659931|NCT00412490|Questionnaire|questionnaire
659932|NCT00412490|Interview|interview
659933|NCT00412477|HIV|hiv
659934|NCT00412477|Lfn-p24|lfn-p24
659935|NCT00412477|Anthrax|anthrax
659936|NCT00412477|IM|im
659937|NCT00412477|HIV-1|hiv-1
659938|NCT00412477|HIV Preventive Vaccine|hiv preventive vaccine
659939|NCT00412464|fondaparinux|fondaparinux
659940|NCT00412464|thrombosis|thrombosis
659941|NCT00412464|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
659942|NCT00412464|pediatrics|pediatrics
659943|NCT00412451|Diabetic Macular Edema|diabetic macular edema
659944|NCT00412451|PVD|pvd
659945|NCT00412451|DME|dme
659946|NCT00412451|Diabetic Retinopathy|diabetic retinopathy
659947|NCT00412438|Atrial Fibrillation|atrial fibrillation
659948|NCT00412425|Melanoma|melanoma
659949|NCT00412425|Nausea|nausea
659950|NCT00412425|Vomiting|vomiting
659951|NCT00412425|Palonosetron|palonosetron
659952|NCT00412425|Cisplatin|cisplatin
659953|NCT00412425|Vinblastine|vinblastine
659954|NCT00412425|Loss of Appetite|loss of appetite
659955|NCT00412425|Weight loss|weight loss
659956|NCT00412412|Cancer of Breast|cancer of breast
659957|NCT00412412|Cancer of the Breast|cancer of the breast
659958|NCT00412399|Employment|employment
659959|NCT00412399|Negative workplace events|negative workplace events
659960|NCT00412399|Healthy controls|healthy controls
659961|NCT00412399|Fatigue|fatigue
659962|NCT00412399|Physical activity|physical activity
659963|NCT00412386|Pediatric|pediatric
659964|NCT00412386|Congenital Heart Disease|congenital heart disease
659965|NCT00412386|Imaging|imaging
659966|NCT00412373|Schizoaffective Disorder|schizoaffective disorder
659967|NCT00412373|antipsychotic|antipsychotic
659968|NCT00412373|paliperidone|paliperidone
659969|NCT00412373|placebo|placebo
659970|NCT00412360|Double cord blood|double cord blood
659971|NCT00412347|hyperglycemia|hyperglycemia
659972|NCT00412347|diabetes|diabetes
659973|NCT00412347|insulin drip|insulin drip
659974|NCT00412347|hypoglycemia|hypoglycemia
659975|NCT00412347|general wards|general wards
659976|NCT00412321|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
659977|NCT00412321|Multiple Myeloma|multiple myeloma
659978|NCT00412321|Castleman's disease|castleman's disease
659979|NCT00412321|intravenous|intravenous
659980|NCT00412321|IL-6|il-6
659981|NCT00412308|spinal cord injury|spinal cord injury
659982|NCT00412308|ventilator dependency|ventilator dependency
659983|NCT00412308|ventilator weaning|ventilator weaning
659984|NCT00412308|tidal volume|tidal volume
659985|NCT00412295|Naturally occuring myopia with or without astigmatism.|naturally occuring myopia with or without astigmatism.
659986|NCT00412295|Wavefront errors|wavefront errors
659987|NCT00412269|Insulin Sensitivity|insulin sensitivity
659988|NCT00412269|Total abdominal fat|total abdominal fat
659989|NCT00412269|Visceral abdominal fat|visceral abdominal fat
659990|NCT00412269|Reproductive Hormones|reproductive hormones
659991|NCT00412269|Menopause|menopause
659992|NCT00412269|Diabetes|diabetes
659993|NCT00412269|Fat Distribution|fat distribution
659994|NCT00412269|Sex Hormones|sex hormones
659995|NCT00412256|Treatment|treatment
659996|NCT00412256|Disease activity|disease activity
659997|NCT00412256|Clinical trial|clinical trial
659998|NCT00412243|Burkitt's Lymphoma|burkitt's lymphoma
659999|NCT00412243|Lymphoblastic Lymphoma|lymphoblastic lymphoma
660000|NCT00412243|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
660001|NCT00412243|Clofarabine|clofarabine
660002|NCT00412243|Clofarex|clofarex
660004|NCT00412243|Cyclophosphamide|cyclophosphamide
660005|NCT00412243|Neosar|neosar
660006|NCT00412243|Cytoxan|cytoxan
660007|NCT00412230|Pre-eclampsia|pre-eclampsia
660008|NCT00412230|Gestational diabetes|gestational diabetes
660009|NCT00412230|Insulin resistance|insulin resistance
660010|NCT00412230|hypertension in pregnancy|hypertension in pregnancy
660011|NCT00412204|double-blind|double-blind
660012|NCT00412204|placebo-controlled|placebo-controlled
660013|NCT00412204|crossover|crossover
660014|NCT00412204|effects of tiotropium bromide|effects of tiotropium bromide
660015|NCT00412204|gas exchange|gas exchange
660016|NCT00412204|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
660017|NCT00412204|exercise.|exercise.
660018|NCT00412191|healthy volunteers|healthy volunteers
660019|NCT00412191|bioequivalence|bioequivalence
660020|NCT00412191|food effects|food effects
660021|NCT00412178|Internet|internet
660022|NCT00412178|mobile communication|mobile communication
660023|NCT00412178|glucose monitoring|glucose monitoring
660024|NCT00412165|Prevention of Type 2 Diabetes|prevention of type 2 diabetes
660025|NCT00412165|Adolescents|adolescents
660026|NCT00412165|Obesity|obesity
660027|NCT00412165|Overweight|overweight
660028|NCT00412165|Internet Technology|internet technology
660029|NCT00412165|Cell Phone|cell phone
660030|NCT00412152|A randomised|a randomised
660031|NCT00412152|double blind|double blind
660032|NCT00412152|parallel group|parallel group
660033|NCT00412152|multicentre study to demonstrate improvement in symptoms of constipation in subjects with non malignant pain|multicentre study to demonstrate improvement in symptoms of constipation in subjects with non malignant pain
660034|NCT00412152|Moderate to severe chronic non-malignant pain|moderate to severe chronic non-malignant pain
660035|NCT00412139|vascular calcifications|vascular calcifications
660036|NCT00412139|uremic toxins|uremic toxins
660037|NCT00412139|renal osteodystrophy|renal osteodystrophy
660038|NCT00412139|Dialysis|dialysis
660039|NCT00412126|Diabetes Mellitus|diabetes mellitus
660040|NCT00412126|Coronary Restenosis|coronary restenosis
660041|NCT00412126|Insulin|insulin
660042|NCT00412126|Angioplasty|angioplasty
660043|NCT00412100|A randomised|a randomised
660044|NCT00412100|double-blind|double-blind
660045|NCT00412100|double-dummy|double-dummy
660046|NCT00412100|parallel-group multicentre study to demonstrate improvement in symptoms of constipation|parallel-group multicentre study to demonstrate improvement in symptoms of constipation
660047|NCT00412100|Moderate to severe, chronic non-malignant pain|moderate to severe, chronic non-malignant pain
660048|NCT00412087|vitamin D|vitamin d
660049|NCT00412087|cholecalciferol|cholecalciferol
660050|NCT00412087|pregnant women|pregnant women
660051|NCT00412074|Breastfeeding|breastfeeding
660052|NCT00412074|Vitamin D|vitamin d
660053|NCT00412074|Vitamin D deficiency|vitamin d deficiency
660054|NCT00412061|Cancer|cancer
660055|NCT00412061|Carcinoid|carcinoid
660056|NCT00412061|Tumor|tumor
660057|NCT00412061|Neuroendocrine|neuroendocrine
660058|NCT00412061|Carcinoma|carcinoma
660059|NCT00412061|Everolimus|everolimus
660060|NCT00412061|Octreotide|octreotide
660061|NCT00412022|early breast cancer|early breast cancer
660062|NCT00412022|adjuvant therapy|adjuvant therapy
660063|NCT00412022|premenopause|premenopause
660064|NCT00412022|premenopausal|premenopausal
660065|NCT00412022|menopausal status|menopausal status
660066|NCT00412022|postmenopause|postmenopause
660067|NCT00412022|bone mineral density|bone mineral density
660068|NCT00412022|hormone sensitive|hormone sensitive
660069|NCT00412022|aromatase inhibitors|aromatase inhibitors
660070|NCT00412022|letrozole|letrozole
660071|NCT00412022|disease-free survival|disease-free survival
660072|NCT00412009|tuberculosis|tuberculosis
660073|NCT00412009|control|control
660074|NCT00412009|treatment|treatment
660075|NCT00412009|adherence|adherence
660076|NCT00411996|indinavir/ritonavir|indinavir/ritonavir
660077|NCT00411996|HIV/TB|hiv/tb
660078|NCT00411996|rifampicin|rifampicin
660079|NCT00411996|PK and efficacy of IDV/RTV 600/100 mg BID with rifampicin|pk and efficacy of idv/rtv 600/100 mg bid with rifampicin
660080|NCT00411996|Treatment Naive|treatment naive
660081|NCT00411983|chronic HIV infection|chronic hiv infection
660082|NCT00411983|long term cohort of HIV infection|long term cohort of hiv infection
660083|NCT00411970|23 gauge pars plana vitrectomy|23 gauge pars plana vitrectomy
660084|NCT00411970|conjunctival erythema and injection|conjunctival erythema and injection
660085|NCT00411970|20 gauge pars plana vitrectomy|20 gauge pars plana vitrectomy
660086|NCT00411970|vitreous and retinal surgery|vitreous and retinal surgery
660087|NCT00411957|atazanavir/ritonavir|atazanavir/ritonavir
660088|NCT00411957|pharmacokinetic of ATV/r200/100 OD+2NRTIs|pharmacokinetic of atv/r200/100 od+2nrtis
660089|NCT00411944|tacrolimus pharmacokinetics|tacrolimus pharmacokinetics
660090|NCT00411944|CYP3A4 - CYP3A5|cyp3a4 - cyp3a5
660091|NCT00411944|P-glycoprotein|p-glycoprotein
660092|NCT00411944|single nucleotide polymorphisms|single nucleotide polymorphisms
660093|NCT00411944|renal transplantation|renal transplantation
660094|NCT00411944|calcineurin-inhibitor-associated nephrotoxicity|calcineurin-inhibitor-associated nephrotoxicity
660095|NCT00411905|Myelodysplastic syndromes|myelodysplastic syndromes
660096|NCT00411905|IPSS Int-2 and High risk|ipss int-2 and high risk
660097|NCT00411905|Bortezomib|bortezomib
660098|NCT00411905|Low dose Cytarabine|low dose cytarabine
660099|NCT00411905|Bone Marrow diseases|bone marrow diseases
660100|NCT00411879|Heart Arrest|heart arrest
660101|NCT00411879|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
660102|NCT00411879|Epinephrine|epinephrine
660103|NCT00411879|Vasopressin|vasopressin
660104|NCT00411879|Adrenal Cortex Hormones|adrenal cortex hormones
660105|NCT00411866|safety|safety
660106|NCT00411866|pharmacokinetics,|pharmacokinetics,
660204|NCT00411385|CHC|chc
660107|NCT00411853|Prostate, Hormone Refractory, Cancer|prostate, hormone refractory, cancer
660108|NCT00411840|stem cell therapy|stem cell therapy
660109|NCT00411840|peripheral arterial disease|peripheral arterial disease
660110|NCT00411840|limb ischemia|limb ischemia
660111|NCT00411827|Cytology|cytology
660112|NCT00411827|Keratomileusis, Laser In Situ|keratomileusis, laser in situ
660113|NCT00411827|Keratectomy, Photorefractive, Excimer Laser|keratectomy, photorefractive, excimer laser
660114|NCT00411814|melbourne,|melbourne,
660115|NCT00411814|healthy|healthy
660116|NCT00411814|antibody,|antibody,
660117|NCT00411814|male,|male,
660118|NCT00411814|Safety and pharmacokinetic study,|safety and pharmacokinetic study,
660119|NCT00411814|mild asthmatic patients,|mild asthmatic patients,
660120|NCT00411814|australia|australia
660121|NCT00411814|monoclonal|monoclonal
660122|NCT00411814|female,|female,
660123|NCT00411814|volunteers,|volunteers,
660124|NCT00411801|bleeding disorder|bleeding disorder
660125|NCT00411801|universal plasma|universal plasma
660126|NCT00411801|plasma|plasma
660127|NCT00411801|plasma exchange|plasma exchange
660128|NCT00411788|HER-2 positive|her-2 positive
660129|NCT00411788|breast cancer|breast cancer
660130|NCT00411788|HER-2 positive breast cancer|her-2 positive breast cancer
660131|NCT00411762|Pancreatic|pancreatic
660132|NCT00411736|Cystic Fibrosis|cystic fibrosis
660133|NCT00411736|Pseudomonas aeruginosa|pseudomonas aeruginosa
660134|NCT00411736|Azithromycin|azithromycin
660135|NCT00411736|Intermittent pulmonary infection|intermittent pulmonary infection
660136|NCT00411723|multiple sclerosis, chronic-progressive, relapsing-remitting|multiple sclerosis, chronic-progressive, relapsing-remitting
660137|NCT00411671|Lung Cancer|lung cancer
660138|NCT00411671|Non-Small Cell Lung Cancer|non-small cell lung cancer
660139|NCT00411671|NSCLC|nsclc
660140|NCT00411671|Sorafenib|sorafenib
660141|NCT00411671|BAY 43-9006|bay 43-9006
660142|NCT00411671|Battle Program|battle program
660143|NCT00411645|prevention|prevention
660144|NCT00411645|prophylaxis|prophylaxis
660145|NCT00411645|Cytomegalovirus|cytomegalovirus
660146|NCT00411645|CMV|cmv
660147|NCT00411645|allogeneic stem cell transplant|allogeneic stem cell transplant
660148|NCT00411645|SCT|sct
660149|NCT00411632|Lung Cancer|lung cancer
660150|NCT00411632|Non-Small Cell Lung Cancer|non-small cell lung cancer
660151|NCT00411632|NSCLC|nsclc
660152|NCT00411632|Erlotinib|erlotinib
660153|NCT00411632|Tarceva|tarceva
660154|NCT00411632|Bexarotene|bexarotene
660155|NCT00411632|Targretin|targretin
660156|NCT00411632|OSI-774|osi-774
660157|NCT00411632|Battle Program|battle program
660158|NCT00411619|Tuberous Sclerosis Complex (TSC)|tuberous sclerosis complex (tsc)
660159|NCT00411619|Subendymal Giant Cell Astrocytomas (SEGA'S)|subendymal giant cell astrocytomas (sega's)
660160|NCT00411619|Mammalian Target of Rapamycin (mTOR)|mammalian target of rapamycin (mtor)
660161|NCT00411619|Everolimus (RAD001)|everolimus (rad001)
660162|NCT00411619|Tuberous Sclerosis with Subependymal Giant Cell Astrocytomas|tuberous sclerosis with subependymal giant cell astrocytomas
660163|NCT00411606|Healthy|healthy
660164|NCT00411606|Allergy|allergy
660165|NCT00411606|Allergic Rhinoconjunctivitis|allergic rhinoconjunctivitis
660166|NCT00411593|Non-Small Cell Lung Cancer|non-small cell lung cancer
660167|NCT00411593|Lung Cancer|lung cancer
660168|NCT00411593|NSCLC|nsclc
660169|NCT00411593|Bortezomib|bortezomib
660170|NCT00411593|Bevacizumab|bevacizumab
660171|NCT00411580|Mild, moderate Alzheimer's Disease (AD), Aß-specific antibody, CAD106|mild, moderate alzheimer's disease (ad), aß-specific antibody, cad106
660172|NCT00411567|markers, inflammation, optimal, sub-optimal, corticosteroid, bronchial asthma|markers, inflammation, optimal, sub-optimal, corticosteroid, bronchial asthma
660173|NCT00411541|acute lymphoblastic leukemia, maintenance, BFM protocol|acute lymphoblastic leukemia, maintenance, bfm protocol
660174|NCT00411541|intermediate risk childhood acute lymphoblastic leukemia|intermediate risk childhood acute lymphoblastic leukemia
660175|NCT00411528|Prostate Cancer|prostate cancer
660176|NCT00411528|Hormone Refractory|hormone refractory
660177|NCT00411528|patupilone|patupilone
660178|NCT00411528|docetaxel|docetaxel
660179|NCT00411463|Interpersonal Therapy|interpersonal therapy
660180|NCT00411463|Social Rhythm Therapy|social rhythm therapy
660181|NCT00411463|Bipolar Disorder|bipolar disorder
660182|NCT00411463|Depression|depression
660183|NCT00411463|Seroquel|seroquel
660184|NCT00411450|k-ras|k-ras
660185|NCT00411450|biomarker|biomarker
660186|NCT00411450|colorectal|colorectal
660187|NCT00411450|colon|colon
660188|NCT00411450|rectal|rectal
660189|NCT00411450|FOLFOX|folfox
660190|NCT00411450|FOLFIRI|folfiri
660191|NCT00411424|Rheumatoid Arthritis|rheumatoid arthritis
660192|NCT00411424|Randomized Control Trial|randomized control trial
660193|NCT00411424|Treatment outcomes|treatment outcomes
660194|NCT00411424|Monoclonal antibody|monoclonal antibody
660195|NCT00411411|GLP-1|glp-1
660196|NCT00411411|GIP|gip
660197|NCT00411411|Incretin hormones|incretin hormones
660198|NCT00411411|DPP-IV inhibitor|dpp-iv inhibitor
660199|NCT00411411|Hyperglycaemic clamp|hyperglycaemic clamp
660200|NCT00411411|Meal test|meal test
660201|NCT00411398|Anxiety, SNRI, SSRI,GAD,SAD|anxiety, snri, ssri,gad,sad
660202|NCT00411385|Chronic Hepatitis C|chronic hepatitis c
660205|NCT00411385|HepC|hepc
660206|NCT00411385|Genotype 1|genotype 1
660207|NCT00411385|Hepatitis|hepatitis
660208|NCT00411385|HCV|hcv
660209|NCT00411372|Questionnaire|questionnaire
660210|NCT00411372|COPD|copd
660211|NCT00411372|Shortness of Breath|shortness of breath
660212|NCT00411359|Refractory angina|refractory angina
660213|NCT00411359|Cardiac rehabilitation|cardiac rehabilitation
660214|NCT00411359|Symptomology|symptomology
660215|NCT00411359|Physical ability|physical ability
660216|NCT00411359|Exercise|exercise
660217|NCT00411359|Psychology|psychology
660218|NCT00411359|Quality of life|quality of life
660219|NCT00411359|Risk factors|risk factors
660220|NCT00411346|Asthma|asthma
660221|NCT00411346|Self-Monitoring|self-monitoring
660222|NCT00411346|Cost-effectiveness|cost-effectiveness
660223|NCT00411333|diabetic retinopathy|diabetic retinopathy
660224|NCT00411333|fluorescein angiography|fluorescein angiography
660225|NCT00411333|steroid|steroid
660226|NCT00411333|anti-angiogenesis|anti-angiogenesis
660227|NCT00411320|Asthma|asthma
660228|NCT00411320|Smoking|smoking
660229|NCT00411320|Steroid Resistance|steroid resistance
660230|NCT00411320|Corticosteroid insensitivity|corticosteroid insensitivity
660231|NCT00411307|Analgesia|analgesia
660232|NCT00411307|Postoperative pain|postoperative pain
660233|NCT00411294|ergocalciferol|ergocalciferol
660234|NCT00411294|chronic kidney disease|chronic kidney disease
660235|NCT00411294|secondary hyperparathyroidism|secondary hyperparathyroidism
660236|NCT00411294|vitamin D deficiency|vitamin d deficiency
660237|NCT00411281|acute myeloid leukemia/transient myeloproliferative disorder|acute myeloid leukemia/transient myeloproliferative disorder
660238|NCT00411268|Chronic low back pain|chronic low back pain
660239|NCT00411268|OROS hydromorphone slow release tablet|oros hydromorphone slow release tablet
660240|NCT00411268|Quality of Life|quality of life
660241|NCT00411255|Blink Reflex|blink reflex
660242|NCT00411255|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
660243|NCT00411255|Dystonia|dystonia
660244|NCT00411255|Blepharospasm|blepharospasm
660245|NCT00411255|BSP|bsp
660246|NCT00411255|Focal Dystonia|focal dystonia
660247|NCT00411242|agomelatine, major depressive disorder, MDD, depression|agomelatine, major depressive disorder, mdd, depression
660248|NCT00411216|vestibular rehabilitation|vestibular rehabilitation
660249|NCT00411216|vestibular hypofunction|vestibular hypofunction
660250|NCT00411203|Protein kinase C, tamoxifen, acute mania, clinical trial|protein kinase c, tamoxifen, acute mania, clinical trial
660251|NCT00411190|Osteoarthritis|osteoarthritis
660252|NCT00411190|Postmenopausal|postmenopausal
660253|NCT00411190|Osteoporosis|osteoporosis
660254|NCT00411177|end-stage renal disease|end-stage renal disease
660255|NCT00411177|hemodialysis|hemodialysis
660256|NCT00411177|cardiovascular morbidity and mortality|cardiovascular morbidity and mortality
660257|NCT00411177|high flux dialyser|high flux dialyser
660258|NCT00411177|on-line hemodiafiltration|on-line hemodiafiltration
660259|NCT00411177|arterial stiffness|arterial stiffness
660260|NCT00411177|inflammation|inflammation
660261|NCT00411177|life quality|life quality
660262|NCT00411177|left ventricular hypertrophy|left ventricular hypertrophy
660263|NCT00411164|knee pain|knee pain
660264|NCT00411164|hip pain|hip pain
660265|NCT00411164|opioid|opioid
660266|NCT00411151|Adenocarcinoma of esophagogastric junction|adenocarcinoma of esophagogastric junction
660267|NCT00411151|Adenocarcinoma of lower esophagus (Barrett carcinoma)|adenocarcinoma of lower esophagus (barrett carcinoma)
660268|NCT00411138|endometrial clear cell carcinoma|endometrial clear cell carcinoma
660269|NCT00411138|stage II endometrial carcinoma|stage ii endometrial carcinoma
660270|NCT00411138|stage IA grade 3 endometrial carcinoma|stage ia grade 3 endometrial carcinoma
660271|NCT00411138|stage IB endometrial carcinoma|stage ib endometrial carcinoma
660272|NCT00411138|stage IIIA endometrial carcinoma|stage iiia endometrial carcinoma
660273|NCT00411138|stage IIIB endometrial carcinoma|stage iiib endometrial carcinoma
660274|NCT00411138|stage IIIC endometrial carcinoma|stage iiic endometrial carcinoma
660275|NCT00411125|Postmenopausal|postmenopausal
660276|NCT00411125|osteoporosis|osteoporosis
660277|NCT00411125|Pharmacokinetics/dynamics|pharmacokinetics/dynamics
660278|NCT00411125|Calcitonin|calcitonin
660279|NCT00411112|Sentinel node|sentinel node
660280|NCT00411112|Isosulphan blue|isosulphan blue
660281|NCT00411112|Isotopic detection|isotopic detection
660282|NCT00411112|Survival|survival
660283|NCT00411099|agomelatine, major depressive disorder, MDD, depression|agomelatine, major depressive disorder, mdd, depression
660284|NCT00411086|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
660285|NCT00411086|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
660286|NCT00411086|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
660287|NCT00411086|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
660288|NCT00411086|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
660289|NCT00411086|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
660290|NCT00411086|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
660291|NCT00411086|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
660292|NCT00411086|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
660293|NCT00411086|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
660294|NCT00411086|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
660295|NCT00411086|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
660296|NCT00411086|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
660297|NCT00411086|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
660298|NCT00411086|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
660299|NCT00411086|Granulocyte-Macrophage Colony Stimulating Factor|granulocyte-macrophage colony stimulating factor
660300|NCT00411086|GM-CSF|gm-csf
660301|NCT00411086|Rituximab|rituximab
660302|NCT00411086|Rituxan|rituxan
660303|NCT00411073|darapladib|darapladib
660304|NCT00411073|moxifloxacin|moxifloxacin
660305|NCT00411073|QT study|qt study
660306|NCT00411060|Rotator Cuff Tear|rotator cuff tear
660307|NCT00411047|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
660308|NCT00411047|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
660309|NCT00411047|adenocarcinoma of the lung|adenocarcinoma of the lung
660310|NCT00411047|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
660311|NCT00411047|large cell lung cancer|large cell lung cancer
660312|NCT00411034|Opioids|opioids
660313|NCT00411034|Chronic Cancer Pain|chronic cancer pain
660314|NCT00411034|analgesic|analgesic
660315|NCT00410995|Physically fit volunteers|physically fit volunteers
660316|NCT00410982|Lymphoid Malignancies|lymphoid malignancies
660317|NCT00410982|Hodgkin's Disease|hodgkin's disease
660318|NCT00410982|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
660319|NCT00410982|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
660320|NCT00410982|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
660321|NCT00410982|Hematopoietic Cell Transplantation|hematopoietic cell transplantation
660322|NCT00410982|Myeloma|myeloma
660323|NCT00410982|Leukemia|leukemia
660324|NCT00410982|Lymphoma|lymphoma
660325|NCT00410982|Busulfan|busulfan
660326|NCT00410982|Busulfex|busulfex
660327|NCT00410982|Myleran|myleran
660328|NCT00410982|Gemcitabine|gemcitabine
660329|NCT00410982|Gemcitabine Hydrochloride|gemcitabine hydrochloride
660330|NCT00410982|Gemzar|gemzar
660331|NCT00410982|Melphalan|melphalan
660332|NCT00410982|Alkeran|alkeran
660333|NCT00410969|resuscitation|resuscitation
660334|NCT00410969|hypothermia|hypothermia
660335|NCT00410956|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
660336|NCT00410956|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
660337|NCT00410956|advanced adult primary liver cancer|advanced adult primary liver cancer
660338|NCT00410956|recurrent adult primary liver cancer|recurrent adult primary liver cancer
660339|NCT00410956|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
660340|NCT00410943|Cancer pain|cancer pain
660341|NCT00410943|Oral analgesic|oral analgesic
660342|NCT00410943|OROS hydromorphone HCI|oros hydromorphone hci
660343|NCT00410930|Immunotherapy, major allergen, birch|immunotherapy, major allergen, birch
660344|NCT00410878|Opioids|opioids
660345|NCT00410878|Chronic cancer pain|chronic cancer pain
660346|NCT00410878|Analgesic|analgesic
660347|NCT00410865|Oral Premalignancies|oral premalignancies
660348|NCT00410865|Mouth Cancer|mouth cancer
660349|NCT00410865|Dysplasia/Carcinoma in Situ (CIS) of the Oral Cavity|dysplasia/carcinoma in situ (cis) of the oral cavity
660350|NCT00410865|Dysplasia/Carcinoma in situ (CIS) of the Oral Pharynx|dysplasia/carcinoma in situ (cis) of the oral pharynx
660351|NCT00410865|Advexin|advexin
660352|NCT00410865|Gene Therapy|gene therapy
660353|NCT00410865|INGN 201|ingn 201
660354|NCT00410865|Wild Type p53 Gene Induction|wild type p53 gene induction
660355|NCT00410852|Insulin|insulin
660356|NCT00410852|Hyperglycemia|hyperglycemia
660357|NCT00410852|Hypoglycemia|hypoglycemia
660358|NCT00410852|Intensive care|intensive care
660359|NCT00410852|Critical care|critical care
660360|NCT00410813|stage IV breast cancer|stage iv breast cancer
660361|NCT00410813|male breast cancer|male breast cancer
660362|NCT00410813|recurrent breast cancer|recurrent breast cancer
660363|NCT00410813|bone metastases|bone metastases
660364|NCT00410800|Insulin Resistance|insulin resistance
660365|NCT00410800|Body Composition|body composition
660366|NCT00410800|Kinetic Modeling|kinetic modeling
660367|NCT00410787|Chronic cancer pain|chronic cancer pain
660368|NCT00410787|OROS hydromorphone HCI (slow release)|oros hydromorphone hci (slow release)
660369|NCT00410787|long-term repeated dosing|long-term repeated dosing
660370|NCT00410774|stage III pancreatic cancer|stage iii pancreatic cancer
660371|NCT00410774|stage I pancreatic cancer|stage i pancreatic cancer
660372|NCT00410774|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
660373|NCT00410774|stage II pancreatic cancer|stage ii pancreatic cancer
660374|NCT00410761|ZD6474|zd6474
660375|NCT00410761|MTC|mtc
660376|NCT00410761|Hereditary Medullary Thyroid Cancer|hereditary medullary thyroid cancer
660377|NCT00410761|Sporadic Medullary Thyroid Cancer|sporadic medullary thyroid cancer
660378|NCT00410761|Medullary Thyroid Cancer|medullary thyroid cancer
660379|NCT00410748|Chronic cancer pain|chronic cancer pain
660380|NCT00410748|chronic pain|chronic pain
660381|NCT00410735|ONO-1078|ono-1078
660382|NCT00410735|chronic sinusitis|chronic sinusitis
660383|NCT00410722|Nutrition|nutrition
660384|NCT00410722|Type 2 Diabetes|type 2 diabetes
660385|NCT00410709|Pediculosis Capitis|pediculosis capitis
660386|NCT00410709|Head Lice|head lice
660387|NCT00410709|Crawlers|crawlers
660388|NCT00410709|Ova|ova
660389|NCT00410709|Nits|nits
660390|NCT00410696|High-dose chemotherapy|high-dose chemotherapy
660391|NCT00410696|Growth factor|growth factor
660392|NCT00410696|Pegfilgrastim|pegfilgrastim
660393|NCT00410683|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
660394|NCT00410683|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
660395|NCT00410670|Gene|gene
660396|NCT00410670|Genetics|genetics
660397|NCT00410670|Family History|family history
660398|NCT00410670|Radiation Therapy|radiation therapy
660399|NCT00410670|Children|children
660400|NCT00410657|graft versus host disease|graft versus host disease
660401|NCT00410657|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
660402|NCT00410657|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
660403|NCT00410657|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
660404|NCT00410657|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
660405|NCT00410657|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
660406|NCT00410657|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
660407|NCT00410657|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
660408|NCT00410657|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
660409|NCT00410657|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
660410|NCT00410657|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
660411|NCT00410657|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
660412|NCT00410657|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
660413|NCT00410657|chronic eosinophilic leukemia|chronic eosinophilic leukemia
660414|NCT00410657|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
660415|NCT00410657|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
660416|NCT00410657|chronic neutrophilic leukemia|chronic neutrophilic leukemia
660417|NCT00410657|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
660418|NCT00410657|disseminated neuroblastoma|disseminated neuroblastoma
660419|NCT00410657|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
660420|NCT00410657|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
660421|NCT00410657|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
660422|NCT00410657|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
660423|NCT00410657|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
660424|NCT00410657|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
660425|NCT00410657|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
660426|NCT00410657|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
660427|NCT00410657|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
660428|NCT00410657|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
660429|NCT00410657|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
660430|NCT00410657|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
660431|NCT00410657|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
660432|NCT00410657|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
660433|NCT00410657|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
660434|NCT00410657|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
660435|NCT00410657|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
660436|NCT00410657|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
660437|NCT00410657|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
660438|NCT00410657|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
660439|NCT00410657|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
660440|NCT00410657|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
660441|NCT00410657|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
660442|NCT00410657|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
660443|NCT00410657|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
660444|NCT00410657|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
660445|NCT00410657|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
660446|NCT00410657|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
660447|NCT00410657|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
660448|NCT00410657|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
660449|NCT00410657|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
660450|NCT00410657|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
660451|NCT00410657|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
660452|NCT00410657|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
660453|NCT00410657|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
660454|NCT00410657|splenic marginal zone lymphoma|splenic marginal zone lymphoma
660455|NCT00410657|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
660456|NCT00410657|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
660457|NCT00410657|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
660458|NCT00410657|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
660459|NCT00410657|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
660460|NCT00410657|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
660461|NCT00410657|stage I multiple myeloma|stage i multiple myeloma
660462|NCT00410657|stage II multiple myeloma|stage ii multiple myeloma
660463|NCT00410657|stage III multiple myeloma|stage iii multiple myeloma
660464|NCT00410657|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
660465|NCT00410657|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
660466|NCT00410657|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
660467|NCT00410657|aggressive, noncontiguous stage II adult non-Hodgkin lymphoma|aggressive, noncontiguous stage ii adult non-hodgkin lymphoma
660468|NCT00410657|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
660469|NCT00410657|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
660470|NCT00410657|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
660471|NCT00410657|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
660472|NCT00410657|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
660473|NCT00410657|stage IIIA breast cancer|stage iiia breast cancer
660474|NCT00410657|stage IIIB breast cancer|stage iiib breast cancer
660475|NCT00410657|stage IIIC breast cancer|stage iiic breast cancer
660476|NCT00410657|stage IV breast cancer|stage iv breast cancer
660477|NCT00410657|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
660478|NCT00410657|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
660479|NCT00410657|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
660480|NCT00410644|Non-malignant chronic pain|non-malignant chronic pain
660481|NCT00410644|pain|pain
660482|NCT00410644|analgesics|analgesics
660483|NCT00410644|opioid|opioid
660484|NCT00410631|localized resectable neuroblastoma|localized resectable neuroblastoma
660485|NCT00410631|localized unresectable neuroblastoma|localized unresectable neuroblastoma
660486|NCT00410631|regional neuroblastoma|regional neuroblastoma
660487|NCT00410631|stage 4S neuroblastoma|stage 4s neuroblastoma
660488|NCT00410631|disseminated neuroblastoma|disseminated neuroblastoma
660489|NCT00410631|recurrent neuroblastoma|recurrent neuroblastoma
660490|NCT00410618|cognitive/functional effects|cognitive/functional effects
660491|NCT00410618|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
660492|NCT00410618|recurrent colon cancer|recurrent colon cancer
660493|NCT00410618|stage I colon cancer|stage i colon cancer
660494|NCT00410618|stage II colon cancer|stage ii colon cancer
660495|NCT00410618|stage III colon cancer|stage iii colon cancer
660496|NCT00410618|stage IV colon cancer|stage iv colon cancer
660497|NCT00410592|GERD|gerd
660498|NCT00410592|acid reflux|acid reflux
660499|NCT00410592|heartburn|heartburn
660500|NCT00410592|PPI|ppi
660501|NCT00410592|Hispanic|hispanic
660502|NCT00410579|pain|pain
660503|NCT00410579|fatigue|fatigue
660504|NCT00410579|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
660505|NCT00410579|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
660506|NCT00410579|stage II rectal cancer|stage ii rectal cancer
660507|NCT00410579|stage III rectal cancer|stage iii rectal cancer
660508|NCT00410579|stage II colon cancer|stage ii colon cancer
660509|NCT00410579|stage III colon cancer|stage iii colon cancer
660510|NCT00410579|adenocarcinoma of the colon|adenocarcinoma of the colon
660511|NCT00410566|Acid sphingomyelinase deficiency|acid sphingomyelinase deficiency
660512|NCT00410566|Niemann-Pick disease|niemann-pick disease
660513|NCT00410566|Lysosomal storage disorder|lysosomal storage disorder
660514|NCT00410566|Enzyme replacement therapy|enzyme replacement therapy
660515|NCT00410566|Treatment|treatment
660516|NCT00410540|Cancer pain|cancer pain
660517|NCT00410540|Oral analgesic|oral analgesic
660518|NCT00410540|OROS hydromorphone HCL|oros hydromorphone hcl
660519|NCT00410540|Morphine sulfate|morphine sulfate
660520|NCT00410527|Antibacterials|antibacterials
660521|NCT00410527|Colonization|colonization
660522|NCT00410527|Infection|infection
660523|NCT00410527|Pneumonia|pneumonia
660524|NCT00410527|Resistance|resistance
660525|NCT00410514|Beta-3 Receptor Agonist|beta-3 receptor agonist
660526|NCT00410514|YM178|ym178
660527|NCT00410514|Men|men
660528|NCT00410514|Lower Urinary Tract Symptoms|lower urinary tract symptoms
660529|NCT00410514|Bladder Outlet Obstruction|bladder outlet obstruction
660530|NCT00410501|Pharmacokinetics, interaction, QAB149, indacaterol, ketoconazole, healthy subjects|pharmacokinetics, interaction, qab149, indacaterol, ketoconazole, healthy subjects
660531|NCT00410488|Sarcoma|sarcoma
660532|NCT00410488|Palonosetron|palonosetron
660533|NCT00410488|Aloxi|aloxi
660534|NCT00410488|Nausea|nausea
660535|NCT00410488|Vomiting|vomiting
660536|NCT00410475|Ionizing Radiation|ionizing radiation
660537|NCT00410475|Cohort Study|cohort study
660538|NCT00410475|Radiation-Induced Neoplasms|radiation-induced neoplasms
660539|NCT00410475|Radiologic Technologists|radiologic technologists
660540|NCT00410475|Ultraviolet Radiation|ultraviolet radiation
660541|NCT00410462|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
660542|NCT00410462|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
660543|NCT00410462|adult liposarcoma|adult liposarcoma
660544|NCT00410462|adult fibrosarcoma|adult fibrosarcoma
660545|NCT00410462|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
660546|NCT00410462|adult leiomyosarcoma|adult leiomyosarcoma
660547|NCT00410462|adult rhabdomyosarcoma|adult rhabdomyosarcoma
660548|NCT00410462|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
660549|NCT00410462|adult malignant mesenchymoma|adult malignant mesenchymoma
660550|NCT00410462|adult angiosarcoma|adult angiosarcoma
660551|NCT00410462|adult epithelioid sarcoma|adult epithelioid sarcoma
660552|NCT00410462|adult neurofibrosarcoma|adult neurofibrosarcoma
660553|NCT00410462|adult synovial sarcoma|adult synovial sarcoma
660554|NCT00410462|recurrent uterine sarcoma|recurrent uterine sarcoma
660555|NCT00410462|stage IV uterine sarcoma|stage iv uterine sarcoma
660556|NCT00410462|ovarian sarcoma|ovarian sarcoma
660557|NCT00410462|small intestine leiomyosarcoma|small intestine leiomyosarcoma
660558|NCT00410462|recurrent small intestine cancer|recurrent small intestine cancer
660559|NCT00410449|End stage renal disease treated by hemodialysis|end stage renal disease treated by hemodialysis
660560|NCT00410449|Hemodialysis vascular access patency|hemodialysis vascular access patency
660561|NCT00410449|Vitamin E|vitamin e
660562|NCT00410449|oxidative markers|oxidative markers
660563|NCT00410449|pentosidine|pentosidine
660564|NCT00410449|hydroxynonenal|hydroxynonenal
660565|NCT00410449|levuglandin|levuglandin
660566|NCT00410436|Type 1 Diabetes|type 1 diabetes
660567|NCT00410436|Resistance Exercise|resistance exercise
660568|NCT00410436|Aerobic Exercise|aerobic exercise
660569|NCT00410423|Leukemia|leukemia
660570|NCT00410423|Acute Myeloid Leukemia|acute myeloid leukemia
660571|NCT00410423|Acute Lymphoid / Lymphoblastic Leukemia|acute lymphoid / lymphoblastic leukemia
660572|NCT00410397|Low back pain|low back pain
660573|NCT00410397|Hip pain|hip pain
660574|NCT00410384|Antibodies|antibodies
660575|NCT00410384|Autoimmune Diseases|autoimmune diseases
660576|NCT00410384|Systemic Lupus Erythematosus|systemic lupus erythematosus
660577|NCT00410384|SLE|sle
660578|NCT00410384|Belimumab|belimumab
660579|NCT00410384|Lupus|lupus
660580|NCT00410371|tolerability|tolerability
660581|NCT00410371|safety|safety
660582|NCT00410371|Pharmacokinetic characteristics|pharmacokinetic characteristics
660583|NCT00410358|Gimatecan|gimatecan
660584|NCT00410358|topoisomerase I inhibitor|topoisomerase i inhibitor
660585|NCT00410358|advanced solid tumors|advanced solid tumors
660586|NCT00410332|tonsillectomy|tonsillectomy
660587|NCT00410332|pain|pain
660588|NCT00410332|homeopathy|homeopathy
660589|NCT00410332|Traumeel|traumeel
660590|NCT00410306|Hypogonadism|hypogonadism
660591|NCT00410306|Nebido|nebido
660592|NCT00410306|Testosterone|testosterone
660593|NCT00410306|Observational Study|observational study
660594|NCT00410293|Heart failure|heart failure
660595|NCT00410293|Diagnostic|diagnostic
660596|NCT00410293|Natriuretic peptide|natriuretic peptide
660597|NCT00410293|NT-pro B-type natriuretic peptide|nt-pro b-type natriuretic peptide
660598|NCT00410293|Length of stay|length of stay
660599|NCT00410293|Costs|costs
660600|NCT00410267|glaucoma|glaucoma
660601|NCT00410267|Post operative from selective laser trabeculoplasty|post operative from selective laser trabeculoplasty
660602|NCT00410241|Genome|genome
660603|NCT00410241|Cardiovascular Disease|cardiovascular disease
660604|NCT00410241|Volunteers|volunteers
660605|NCT00410241|Genes|genes
660606|NCT00410241|Atherosclerosis|atherosclerosis
660607|NCT00410241|Coronary Artery Calcification|coronary artery calcification
660608|NCT00410241|Cardiovascular|cardiovascular
660609|NCT00410228|safety, tolerability, pharmacokinetics, pharmacodynamics, AHT956|safety, tolerability, pharmacokinetics, pharmacodynamics, aht956
660610|NCT00410189|Non-Small Cell Lung Cancer|non-small cell lung cancer
660611|NCT00410189|NSCLC|nsclc
660612|NCT00410189|Lung Cancer|lung cancer
660613|NCT00410189|ZD6474|zd6474
660614|NCT00410189|Zactima|zactima
660615|NCT00410189|Vandetanib|vandetanib
660616|NCT00410189|BATTLE Program|battle program
660617|NCT00410163|B-cell|b-cell
660618|NCT00410163|cyclophosphamide|cyclophosphamide
660619|NCT00410163|fludarabine|fludarabine
660620|NCT00410163|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
660621|NCT00410163|Ofatumumab|ofatumumab
660622|NCT00410150|Status asthmaticus|status asthmaticus
660623|NCT00410150|Asthma|asthma
660624|NCT00410150|Helium|helium
660625|NCT00410150|Children|children
660626|NCT00410124|advanced kidney cancer|advanced kidney cancer
660627|NCT00410124|everolimus|everolimus
660628|NCT00410124|kidney cancer|kidney cancer
660629|NCT00410124|oral therapy|oral therapy
660630|NCT00410111|sepsis|sepsis
660631|NCT00410111|encephalopathy|encephalopathy
660632|NCT00410111|cerebral perfusion|cerebral perfusion
660633|NCT00410111|electroencephalogram|electroencephalogram
660634|NCT00410098|asthma|asthma
660635|NCT00410098|yoga|yoga
660636|NCT00410098|heat|heat
660637|NCT00410098|humidity|humidity
660638|NCT00410098|bikram|bikram
660639|NCT00410059|Non-Small Cell Lung Cancer|non-small cell lung cancer
660640|NCT00410059|Lung Cancer|lung cancer
660641|NCT00410059|NSCLC|nsclc
660642|NCT00410059|Erlotinib|erlotinib
660643|NCT00410059|Tarceva|tarceva
660644|NCT00410059|OSI-774|osi-774
660645|NCT00410059|Battle Program|battle program
660646|NCT00410020|alpha linolenic acid|alpha linolenic acid
660647|NCT00410020|atrial fibrillation|atrial fibrillation
660648|NCT00410020|omega 3 fatty acids|omega 3 fatty acids
660649|NCT00410020|diet|diet
660650|NCT00410020|rapeseed oil|rapeseed oil
660651|NCT00410020|canola oil|canola oil
660652|NCT00410020|cardiovascular diseases|cardiovascular diseases
660653|NCT00410007|ADPKD|adpkd
660654|NCT00410007|Urinary Aquaporin-2|urinary aquaporin-2
660655|NCT00410007|ENaC|enac
660656|NCT00410007|Fractional sodium excretion|fractional sodium excretion
660657|NCT00410007|High/low sodium diet|high/low sodium diet
660658|NCT00409994|Colorectal cancer|colorectal cancer
660659|NCT00409994|M-tor inhibitor|m-tor inhibitor
660660|NCT00409994|Rapamycin|rapamycin
660661|NCT00409981|in stent restenosis|in stent restenosis
660662|NCT00409981|paclitaxel coated balloon catheter|paclitaxel coated balloon catheter
660663|NCT00409981|paccocath|paccocath
660664|NCT00409981|drug eluting balloon|drug eluting balloon
660665|NCT00409968|Lung Cancer|lung cancer
660666|NCT00409968|Non Small Cell Lung Cancer|non small cell lung cancer
660667|NCT00409968|BATTLE Program|battle program
660668|NCT00409968|Umbrella Trial|umbrella trial
660669|NCT00409968|Tumor Biopsy|tumor biopsy
660670|NCT00409968|NSCLC|nsclc
660671|NCT00409955|Lamellar transplant|lamellar transplant
660672|NCT00409955|Lyophilization|lyophilization
660673|NCT00409955|Corneas storage|corneas storage
660674|NCT00409955|Keratoconus patients|keratoconus patients
660675|NCT00409955|Best corrected visual acuity < 20/60|best corrected visual acuity < 20/60
660676|NCT00409955|Signed the consent inform|signed the consent inform
660677|NCT00409942|Chronic heart failure|chronic heart failure
660678|NCT00409942|Torasemide prolonged release|torasemide prolonged release
660679|NCT00409942|Myocardial fibrosis|myocardial fibrosis
660680|NCT00409942|Loop diuretics|loop diuretics
660681|NCT00409942|Peptide of procollagen type 1|peptide of procollagen type 1
660682|NCT00409929|Safety, tolerability, pharmacokinetics, pharmacodynamics, AEB071, healthy subjects, transplantation|safety, tolerability, pharmacokinetics, pharmacodynamics, aeb071, healthy subjects, transplantation
660683|NCT00409916|chronic heart failure|chronic heart failure
660684|NCT00409916|heart failure|heart failure
660685|NCT00409916|congestive heart failure|congestive heart failure
660686|NCT00409916|impedance cardiography|impedance cardiography
660687|NCT00409916|ICG|icg
660688|NCT00409916|transthoracic electrical bioimpedance|transthoracic electrical bioimpedance
660689|NCT00409916|non-invasive|non-invasive
660690|NCT00409916|TEB|teb
660691|NCT00409890|Buscopan|buscopan
660692|NCT00409890|Hyoscine|hyoscine
660693|NCT00409890|Shortens|shortens
660694|NCT00409890|Labor|labor
660695|NCT00409890|Stage|stage
660696|NCT00409864|Gallbaldder Cancer|gallbaldder cancer
660697|NCT00409864|Endoscopic stenting|endoscopic stenting
660698|NCT00409864|Percutaneous biliary drainage|percutaneous biliary drainage
660699|NCT00409851|HYPERTENSION, VALSARTAN, AMLODIPINE,SAFETY|hypertension, valsartan, amlodipine,safety
660700|NCT00409838|Rheumatoid Arthritis, with inadequate response to methotrexate|rheumatoid arthritis, with inadequate response to methotrexate
660701|NCT00409799|Bone graft substitute|bone graft substitute
660702|NCT00409799|Promotion of bone healing|promotion of bone healing
660703|NCT00409786|Obesity|obesity
660704|NCT00409786|Diabetes|diabetes
660705|NCT00409786|Internet|internet
660706|NCT00409786|Obesity with high cardiovascular risk|obesity with high cardiovascular risk
660707|NCT00409760|HYEPRTENSION, VALSARTAN, AMLODIPINE, high blood pressure|hyeprtension, valsartan, amlodipine, high blood pressure
660708|NCT00409747|Immunology|immunology
660709|NCT00409747|Microglia|microglia
660710|NCT00409747|NF-Kappa-B|nf-kappa-b
660711|NCT00409747|Antibiotic|antibiotic
660712|NCT00409747|Autism|autism
660713|NCT00409747|Minocycline|minocycline
660714|NCT00409747|Regressive Autism|regressive autism
660715|NCT00409734|pyloric|pyloric
660716|NCT00409734|stenosis|stenosis
660717|NCT00409721|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
660718|NCT00409721|ALS|als
660719|NCT00409721|Motor Neuron Disease|motor neuron disease
660720|NCT00409721|MND|mnd
660721|NCT00409721|Memantine|memantine
660722|NCT00409708|Attention Deficit Hyperactivity Disorder,|attention deficit hyperactivity disorder,
660723|NCT00409708|ADHD|adhd
660724|NCT00409708|Cytogenetic abnormalities,|cytogenetic abnormalities,
660725|NCT00409708|extended-release methylphenidate,|extended-release methylphenidate,
660726|NCT00409695|Acute Graft versus Host Disease|acute graft versus host disease
660727|NCT00409695|aGVHD|agvhd
660728|NCT00409695|Blood And Marrow Transplantation|blood and marrow transplantation
660729|NCT00409695|Thymoglobulin|thymoglobulin
660730|NCT00409695|ATG|atg
660731|NCT00409682|Crohn's Disease|crohn's disease
660732|NCT00409669|Barraquer tonometer|barraquer tonometer
660733|NCT00409669|Intraocular pressure|intraocular pressure
660734|NCT00409669|Tonometry|tonometry
660735|NCT00409643|HYPERTENSION, VALSARTAN, AMLODIPINE, high blood pressure|hypertension, valsartan, amlodipine, high blood pressure
660736|NCT00409630|Asthma|asthma
660737|NCT00409591|Thailand|thailand
660738|NCT00409591|Developing Countries|developing countries
660739|NCT00409591|Prophylaxis|prophylaxis
660740|NCT00409591|Mother-to-child transmission|mother-to-child transmission
660741|NCT00409591|HIV-1|hiv-1
660742|NCT00409591|HIV-1 infection|hiv-1 infection
660743|NCT00409591|HIV Seronegativity|hiv seronegativity
660744|NCT00409578|Post acute coronary syndrome|post acute coronary syndrome
660745|NCT00409578|Acute|acute
660746|NCT00409578|coronary syndrome|coronary syndrome
660747|NCT00409578|B-type natriuretic peptide|b-type natriuretic peptide
660748|NCT00409578|N-terminal|n-terminal
660749|NCT00409578|pro-B-type natriuretic peptide|pro-b-type natriuretic peptide
660750|NCT00409578|myocardial infarctions|myocardial infarctions
660751|NCT00409565|head and neck cancer|head and neck cancer
660752|NCT00409565|cetuximab|cetuximab
660753|NCT00409565|bevacizumab|bevacizumab
660754|NCT00409565|squamous cell carcinoma|squamous cell carcinoma
660755|NCT00409565|SCCHN|scchn
660756|NCT00409565|Squamous Cell Carcinoma of the Head and Neck|squamous cell carcinoma of the head and neck
660757|NCT00409526|Iloprost|iloprost
660758|NCT00409526|PPHN|pphn
660759|NCT00409526|Newborn|newborn
660760|NCT00409526|Pulmonary Hypertension|pulmonary hypertension
660761|NCT00409526|Term|term
660762|NCT00409526|Persistent Pulmonary Hypertension of the Newborn|persistent pulmonary hypertension of the newborn
660763|NCT00409500|Safety, tolerability, pharmacokinetics, AQW051, food, Japanese, healthy male subjects|safety, tolerability, pharmacokinetics, aqw051, food, japanese, healthy male subjects
660764|NCT00409500|Healthy volunteers study|healthy volunteers study
660765|NCT00409487|obstructive sleep apnea|obstructive sleep apnea
660766|NCT00409487|hypertension|hypertension
660767|NCT00409487|ambulatory bloop pressure monitoring|ambulatory bloop pressure monitoring
660768|NCT00409448|TBI|tbi
660769|NCT00409448|intracranial edema|intracranial edema
660770|NCT00409448|brain edema|brain edema
660771|NCT00409448|craniocerebral trauma|craniocerebral trauma
660772|NCT00409448|head injury|head injury
660773|NCT00409448|brain hemorrhage, traumatic|brain hemorrhage, traumatic
660774|NCT00409448|subdural hematoma|subdural hematoma
660775|NCT00409448|brain concussion|brain concussion
660776|NCT00409448|head injuries, closed|head injuries, closed
660777|NCT00409448|epidural hematoma|epidural hematoma
660778|NCT00409448|extra-axial hemorrhage|extra-axial hemorrhage
660779|NCT00409448|cortical contusion|cortical contusion
660780|NCT00409435|Postural tachycardia syndrome (POTS)|postural tachycardia syndrome (pots)
660781|NCT00409422|pediatric obesity|pediatric obesity
660782|NCT00409422|overweight|overweight
660783|NCT00409422|insulin resistance|insulin resistance
660784|NCT00409422|hyperinsulinemia|hyperinsulinemia
660785|NCT00409422|weight management program|weight management program
660786|NCT00409422|family-based|family-based
660787|NCT00409409|Sublingual immunotherapy|sublingual immunotherapy
660788|NCT00409409|Grass pollen tablet|grass pollen tablet
660789|NCT00409409|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
660790|NCT00409396|Ulcerative|ulcerative
660791|NCT00409396|Colitis|colitis
660792|NCT00409396|PGE-M|pge-m
660793|NCT00409396|fecal calprotectin|fecal calprotectin
660794|NCT00409396|disease biomarkers|disease biomarkers
660795|NCT00409383|Advanced Melanoma|advanced melanoma
660796|NCT00409383|Normal baseline LDH|normal baseline ldh
660797|NCT00409383|Chemotherapy naive|chemotherapy naive
660798|NCT00409357|urinary tract|urinary tract
660799|NCT00409344|Thoracoabdominal Aortic Aneurysm|thoracoabdominal aortic aneurysm
660800|NCT00409344|Dexmedetomidine|dexmedetomidine
660801|NCT00409344|Mechanical ventilation|mechanical ventilation
660802|NCT00409331|Head and Neck Cancer|head and neck cancer
660803|NCT00409331|HNSCC|hnscc
660804|NCT00409331|Submandibular and Sublingual Salivary Sparing|submandibular and sublingual salivary sparing
660805|NCT00409331|Amifostine|amifostine
660806|NCT00409331|Ethyol|ethyol
660807|NCT00409331|Radiation Therapy|radiation therapy
660808|NCT00409318|Inflammation|inflammation
660809|NCT00409318|Visceral adiposity|visceral adiposity
660810|NCT00409318|TNF|tnf
660811|NCT00409318|CRP|crp
660812|NCT00409318|Adiponectin|adiponectin
660813|NCT00409318|Insulin resistance|insulin resistance
660814|NCT00409318|metabolic syndrome|metabolic syndrome
660815|NCT00409292|RAD001|rad001
660816|NCT00409292|metastatic pancreatic cancer|metastatic pancreatic cancer
660817|NCT00409279|Aging|aging
660923|NCT00409032|strontium|strontium
660818|NCT00409279|Parent / Adult-child interaction|parent / adult-child interaction
660819|NCT00409279|Family caregivers|family caregivers
660820|NCT00409279|Alzheimer's|alzheimer's
660821|NCT00409279|Caregiving|caregiving
660822|NCT00409253|PRE-ECLAMPSIA-URAPIDIL-NICARDIPINE|pre-eclampsia-urapidil-nicardipine
660823|NCT00409240|Group Intervention|group intervention
660824|NCT00409240|Pharmacotherapy|pharmacotherapy
660825|NCT00409240|Behavioral Modification|behavioral modification
660826|NCT00409240|Diabetes|diabetes
660827|NCT00409227|swl|swl
660828|NCT00409227|lithotripsy|lithotripsy
660829|NCT00409227|stone disease|stone disease
660830|NCT00409227|urolithiasis|urolithiasis
660831|NCT00409227|nephrolithiasis|nephrolithiasis
660832|NCT00409214|Glioma|glioma
660833|NCT00409214|Litx™|litx™
660834|NCT00409214|LS11|ls11
660835|NCT00409214|Glioblastoma multiforme|glioblastoma multiforme
660836|NCT00409214|Anaplastic Astrocytoma|anaplastic astrocytoma
660837|NCT00409214|GBM|gbm
660838|NCT00409214|AA|aa
660839|NCT00409201|schizophrenia|schizophrenia
660840|NCT00409201|reboxetine|reboxetine
660841|NCT00409201|cognitive|cognitive
660842|NCT00409201|behavior|behavior
660843|NCT00409188|Non-Small Cell Lung Carcinoma;|non-small cell lung carcinoma;
660844|NCT00409188|stage III;|stage iii;
660845|NCT00409188|unresectable;|unresectable;
660846|NCT00409188|vaccine; Tecemotide; L-BLP25;|vaccine; tecemotide; l-blp25;
660847|NCT00409188|Cyclophosphamide;|cyclophosphamide;
660848|NCT00409188|placebo controlled;|placebo controlled;
660849|NCT00409188|randomized;|randomized;
660850|NCT00409188|double blind;|double blind;
660851|NCT00409188|immunotherapy;|immunotherapy;
660852|NCT00409175|FAP|fap
660853|NCT00409175|Fx-1006A|fx-1006a
660854|NCT00409175|transthyretin|transthyretin
660855|NCT00409175|TTR|ttr
660856|NCT00409175|amyloid|amyloid
660857|NCT00409175|polyneuropathy|polyneuropathy
660858|NCT00409175|V30M|v30m
660859|NCT00409175|familial|familial
660860|NCT00409175|hereditary|hereditary
660861|NCT00409175|amyloidosis|amyloidosis
660862|NCT00409175|FoldRx|foldrx
660863|NCT00409162|Tattoo removal|tattoo removal
660864|NCT00409149|Hypertension|hypertension
660865|NCT00409149|Diet|diet
660866|NCT00409149|physical exercise|physical exercise
660867|NCT00409149|naturopathic|naturopathic
660868|NCT00409149|group therapy|group therapy
660869|NCT00409149|Qi Gong|qi gong
660870|NCT00409136|Alert|alert
660871|NCT00409136|Deep Vein Thrombosis|deep vein thrombosis
660872|NCT00409136|Pulmonary Embolism|pulmonary embolism
660873|NCT00409136|Venous Thromboembolism|venous thromboembolism
660874|NCT00409136|Prophylaxis|prophylaxis
660875|NCT00409136|Anticoagulation|anticoagulation
660876|NCT00409123|vasospastic women|vasospastic women
660877|NCT00409123|controls|controls
660878|NCT00409123|core cooling|core cooling
660879|NCT00409123|core warming|core warming
660880|NCT00409123|external cooling|external cooling
660881|NCT00409123|external warming|external warming
660882|NCT00409123|LDF|ldf
660883|NCT00409123|choroidal blood flow|choroidal blood flow
660884|NCT00409123|temperature|temperature
660885|NCT00409123|vasospastic subjects|vasospastic subjects
660886|NCT00409123|normal subjects|normal subjects
660887|NCT00409110|Ocular Pulse Amplitude|ocular pulse amplitude
660888|NCT00409110|Dynamic Contour Tonometry|dynamic contour tonometry
660889|NCT00409110|Pulsatility Index|pulsatility index
660890|NCT00409110|Choroidal Laser Doppler Flowmetry|choroidal laser doppler flowmetry
660891|NCT00409110|Finometer|finometer
660892|NCT00409097|ADMA|adma
660893|NCT00409097|MOF|mof
660894|NCT00409097|Critical illness|critical illness
660895|NCT00409084|varices|varices
660896|NCT00409084|band ligation|band ligation
660897|NCT00409084|portal hypertension|portal hypertension
660898|NCT00409084|primary prophylaxis|primary prophylaxis
660899|NCT00409084|cirrhosis|cirrhosis
660900|NCT00409084|beta blockers|beta blockers
660901|NCT00409071|Non metastatic breast cancer|non metastatic breast cancer
660902|NCT00409071|Adjuvant chemotherapy|adjuvant chemotherapy
660903|NCT00409071|Nausea|nausea
660904|NCT00409071|Vomiting|vomiting
660905|NCT00409071|Quality of life|quality of life
660906|NCT00409071|Homeopathy|homeopathy
660907|NCT00409058|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
660908|NCT00409058|Intracranial Edema|intracranial edema
660909|NCT00409058|Brain Edema|brain edema
660910|NCT00409058|Craniocerebral Trauma|craniocerebral trauma
660911|NCT00409058|Head Injury|head injury
660912|NCT00409058|Brain Hemorrhage, Traumatic|brain hemorrhage, traumatic
660913|NCT00409058|Subdural Hematoma|subdural hematoma
660914|NCT00409058|Brain Concussion|brain concussion
660915|NCT00409058|Head Injuries, Closed|head injuries, closed
660916|NCT00409045|Obstructive Sleep Apnea|obstructive sleep apnea
660917|NCT00409045|Pulmonary Embolism|pulmonary embolism
660918|NCT00409045|male and female patients suspected of having a pulmonary embolism.|male and female patients suspected of having a pulmonary embolism.
660919|NCT00409032|osteoporosis|osteoporosis
660920|NCT00409032|BMD|bmd
660921|NCT00409032|CTX|ctx
660922|NCT00409032|Post menopausal|post menopausal
660924|NCT00409032|bone turnover|bone turnover
660925|NCT00409032|clinical development|clinical development
660926|NCT00408980|diet|diet
660927|NCT00408980|breast milk fat|breast milk fat
660928|NCT00408967|Ovarian|ovarian
660929|NCT00408967|Cancer|cancer
660930|NCT00408967|Epithelial|epithelial
660931|NCT00408967|Recurrent|recurrent
660932|NCT00408967|Platinum|platinum
660933|NCT00408967|Second-line therapy|second-line therapy
660934|NCT00408967|Maintenance Therapy|maintenance therapy
660935|NCT00408967|Biologic|biologic
660936|NCT00408967|Targeted Therapy|targeted therapy
660937|NCT00408967|Antibody|antibody
660938|NCT00408941|EEG|eeg
660939|NCT00408941|AEP|aep
660940|NCT00408941|Artefacts|artefacts
660941|NCT00408941|Propofol|propofol
660942|NCT00408941|Local Anaesthesia|local anaesthesia
660943|NCT00408928|Graft-versus-Host Disease|graft-versus-host disease
660944|NCT00408928|bortezomib|bortezomib
660945|NCT00408915|Lisuride|lisuride
660946|NCT00408915|Continuous Dopaminergic Stimulation|continuous dopaminergic stimulation
660947|NCT00408915|Motor Fluctuations|motor fluctuations
660948|NCT00408915|Off-Times|off-times
660949|NCT00408915|Troublesome Dyskinesia|troublesome dyskinesia
660950|NCT00408915|Parkinson's Disease with motor fluctuations with OFF periods and/or troublesome dyskinesias of more than four hours per day|parkinson's disease with motor fluctuations with off periods and/or troublesome dyskinesias of more than four hours per day
660951|NCT00408889|liver transplantation|liver transplantation
660952|NCT00408889|organ failure|organ failure
660953|NCT00408889|outcome|outcome
660954|NCT00408863|Breast cancer|breast cancer
660955|NCT00408863|Tibolone|tibolone
660956|NCT00408863|Climacteric symptoms|climacteric symptoms
660957|NCT00408850|sympathetic nervous system, pioglitazone, metabolic syndrome|sympathetic nervous system, pioglitazone, metabolic syndrome
660958|NCT00408824|insulin resistance|insulin resistance
660959|NCT00408824|adipocytokine|adipocytokine
660960|NCT00408824|Metabolic syndrome|metabolic syndrome
660961|NCT00408824|Diabetes|diabetes
660962|NCT00408798|Treatment of Alopecia areata with intracutaneous injections of Botulinum Toxin A|treatment of alopecia areata with intracutaneous injections of botulinum toxin a
660963|NCT00408785|Botulinum Toxin Type A|botulinum toxin type a
660964|NCT00408785|safety|safety
660965|NCT00408785|efficacy|efficacy
660966|NCT00408785|glabellar lines|glabellar lines
660967|NCT00408772|liver metastases|liver metastases
660968|NCT00408772|stage IV colon cancer|stage iv colon cancer
660969|NCT00408772|stage IV rectal cancer|stage iv rectal cancer
660970|NCT00408772|adenocarcinoma of the colon|adenocarcinoma of the colon
660971|NCT00408772|adenocarcinoma of the rectum|adenocarcinoma of the rectum
660972|NCT00408772|recurrent colon cancer|recurrent colon cancer
660973|NCT00408772|recurrent rectal cancer|recurrent rectal cancer
660974|NCT00408759|xerostomia|xerostomia
660975|NCT00408759|hypnosis|hypnosis
660976|NCT00408759|dry mouth|dry mouth
660977|NCT00408759|radiotherapy|radiotherapy
660978|NCT00408759|head and neck cancer|head and neck cancer
660979|NCT00408746|stomatognathic system|stomatognathic system
660980|NCT00408746|maxilla|maxilla
660981|NCT00408746|palate|palate
660982|NCT00408746|development|development
660983|NCT00408720|Spectral OCT|spectral oct
660984|NCT00408720|SLO|slo
660985|NCT00408720|Retinal Imagining|retinal imagining
660986|NCT00408707|local infiltration analgesia|local infiltration analgesia
660987|NCT00408707|postoperative pain|postoperative pain
660988|NCT00408707|ropivacaine|ropivacaine
660989|NCT00408668|Malaria Vaccine|malaria vaccine
660990|NCT00408642|adherence|adherence
660991|NCT00408642|treatment|treatment
660992|NCT00408642|antiretroviral|antiretroviral
660993|NCT00408642|HAART|haart
660994|NCT00408642|HIV|hiv
660995|NCT00408642|Treatment Naive|treatment naive
660996|NCT00408629|Ulcerative Colitis|ulcerative colitis
660997|NCT00408629|Adalimumab|adalimumab
660998|NCT00408629|TNF Antagonist|tnf antagonist
660999|NCT00408629|Mayo Score|mayo score
661000|NCT00408603|second line treatment|second line treatment
661001|NCT00408603|platinum resistant|platinum resistant
661002|NCT00408603|ovary|ovary
661003|NCT00408603|ovaries|ovaries
661004|NCT00408603|cancer|cancer
661005|NCT00408603|epithelial|epithelial
661006|NCT00408603|carcinomas|carcinomas
661007|NCT00408603|tumor|tumor
661008|NCT00408590|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
661009|NCT00408590|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
661010|NCT00408590|primary peritoneal cavity cancer|primary peritoneal cavity cancer
661011|NCT00408590|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
661012|NCT00408590|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
661013|NCT00408590|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
661014|NCT00408590|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
661015|NCT00408590|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
661016|NCT00408590|Brenner tumor|brenner tumor
661017|NCT00408577|glucose intolerance|glucose intolerance
661018|NCT00408577|cardiovascular disease|cardiovascular disease
661019|NCT00408577|insulin resistance|insulin resistance
661020|NCT00408577|endothelial dysfunction|endothelial dysfunction
661021|NCT00408564|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
661022|NCT00408564|stage II pancreatic cancer|stage ii pancreatic cancer
661023|NCT00408564|stage III pancreatic cancer|stage iii pancreatic cancer
661024|NCT00408551|stage IV colon cancer|stage iv colon cancer
661025|NCT00408551|stage IV rectal cancer|stage iv rectal cancer
661026|NCT00408551|liver metastases|liver metastases
661027|NCT00408551|recurrent colon cancer|recurrent colon cancer
661028|NCT00408551|recurrent rectal cancer|recurrent rectal cancer
661029|NCT00408538|Microbicide|microbicide
661030|NCT00408538|HIV|hiv
661031|NCT00408538|Prevention|prevention
661032|NCT00408538|Rectal|rectal
661033|NCT00408538|HIV Prevention|hiv prevention
661034|NCT00408525|memory loss|memory loss
661035|NCT00408525|memory problems|memory problems
661036|NCT00408525|alzheimer's|alzheimer's
661037|NCT00408525|forgetfulness|forgetfulness
661038|NCT00408525|forgetting|forgetting
661039|NCT00408512|treatment|treatment
661040|NCT00408512|adverse events|adverse events
661041|NCT00408512|adherence|adherence
661042|NCT00408512|gene|gene
661043|NCT00408512|polymorphism|polymorphism
661044|NCT00408499|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
661045|NCT00408499|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
661046|NCT00408499|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
661047|NCT00408499|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
661048|NCT00408499|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
661049|NCT00408447|stem cell transplant|stem cell transplant
661050|NCT00408447|sickle cell disease|sickle cell disease
661051|NCT00408447|thalassemia|thalassemia
661052|NCT00408447|moderately ablative|moderately ablative
661053|NCT00408447|cord blood transplant|cord blood transplant
661054|NCT00408447|matched family donor|matched family donor
661055|NCT00408434|PPARgamma agonist|ppargamma agonist
661056|NCT00408434|advanced or metastatic malignancies|advanced or metastatic malignancies
661057|NCT00408434|Tumor|tumor
661058|NCT00408434|Cancer|cancer
661059|NCT00408408|stage I breast cancer|stage i breast cancer
661060|NCT00408408|stage II breast cancer|stage ii breast cancer
661061|NCT00408408|stage IIIA breast cancer|stage iiia breast cancer
661062|NCT00408395|influenza|influenza
661063|NCT00408395|children|children
661064|NCT00408395|vaccine|vaccine
661065|NCT00408395|influenza disease|influenza disease
661066|NCT00408382|Lipitor|lipitor
661067|NCT00408382|atorvastatin|atorvastatin
661068|NCT00408382|Hypercholesteremia|hypercholesteremia
661069|NCT00408382|yellow coronary plaque|yellow coronary plaque
661070|NCT00408369|prophylactic|prophylactic
661071|NCT00408369|malaria|malaria
661072|NCT00408369|challenge|challenge
661073|NCT00408356|Zinc treatment|zinc treatment
661074|NCT00408356|supplementation|supplementation
661075|NCT00408356|Enterotoxigenic E. coli|enterotoxigenic e. coli
661076|NCT00408356|diarrhoea|diarrhoea
661077|NCT00408317|Cystic Fibrosis|cystic fibrosis
661078|NCT00408317|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
661079|NCT00408317|Ultrase® MT20|ultrase® mt20
661080|NCT00408304|interferon alpha|interferon alpha
661081|NCT00408304|depression|depression
661082|NCT00408304|omega 3|omega 3
661083|NCT00408291|fracture|fracture
661084|NCT00408291|shoulder|shoulder
661085|NCT00408291|bone density|bone density
661086|NCT00408291|healing|healing
661087|NCT00408278|Acute Promyelocytic Leukemia|acute promyelocytic leukemia
661088|NCT00408265|Nicotine Dependence|nicotine dependence
661089|NCT00408265|Contingency Management|contingency management
661090|NCT00408252|recurrent or locally advanced|recurrent or locally advanced
661091|NCT00408252|cytokine failure|cytokine failure
661092|NCT00408239|Factor Xa inhibitor|factor xa inhibitor
661093|NCT00408239|Thromboembolism|thromboembolism
661094|NCT00408239|Arthroplasty|arthroplasty
661095|NCT00408239|Knee Replacement|knee replacement
661096|NCT00408239|Prevention and Control|prevention and control
661097|NCT00408200|Atrial fibrillation|atrial fibrillation
661098|NCT00408200|Atrial arrhythmia|atrial arrhythmia
661099|NCT00408187|Randomized Controlled Trials|randomized controlled trials
661100|NCT00408187|Immunosuppression|immunosuppression
661101|NCT00408187|Adult|adult
661102|NCT00408187|Chronic Disease|chronic disease
661103|NCT00408187|Dermatologic Agents|dermatologic agents
661104|NCT00408187|Female|female
661105|NCT00408187|Humans|humans
661106|NCT00408187|Male|male
661107|NCT00408187|Middle Aged|middle aged
661108|NCT00408187|Severity of Illness Index|severity of illness index
661109|NCT00408187|Treatment Outcome|treatment outcome
661110|NCT00408187|Quality of Life|quality of life
661111|NCT00408187|Double-Blind Method|double-blind method
661112|NCT00408174|IBD|ibd
661113|NCT00408174|UC|uc
661114|NCT00408174|Ulcerative Colitis|ulcerative colitis
661115|NCT00408174|Inflammatory Bowel Disease|inflammatory bowel disease
661116|NCT00408161|Contingency Management|contingency management
661117|NCT00408161|Alcohol Dependence|alcohol dependence
661118|NCT00408135|Respiratory Tract Infections|respiratory tract infections
661119|NCT00408135|Skin Diseases|skin diseases
661120|NCT00408135|Sinusitis|sinusitis
661121|NCT00408109|Avian Influenza|avian influenza
661122|NCT00408109|Healthy|healthy
661123|NCT00408109|Immunity|immunity
661124|NCT00408109|Preventive|preventive
661125|NCT00408109|Bird Flu|bird flu
661126|NCT00408109|Healthy Volunteer|healthy volunteer
661127|NCT00408109|HV|hv
661128|NCT00408096|osteoarthritis|osteoarthritis
661129|NCT00408096|shoulder|shoulder
661130|NCT00408096|resurfacing|resurfacing
661131|NCT00408096|prosthesis|prosthesis
661132|NCT00408070|ovarian cancer|ovarian cancer
661133|NCT00408070|fallopian tube cancer|fallopian tube cancer
661134|NCT00408070|peritoneal cancer|peritoneal cancer
661135|NCT00408057|lipid lowering|lipid lowering
661136|NCT00408057|target achievement|target achievement
661137|NCT00408057|Patients with established cardiovascular disease|patients with established cardiovascular disease
661138|NCT00408031|Major depressive disorder|major depressive disorder
661139|NCT00408031|NMDA receptor|nmda receptor
661140|NCT00408031|Treatment-Resistant|treatment-resistant
661141|NCT00408031|D-cycloserine|d-cycloserine
661142|NCT00407992|Headache|headache
661143|NCT00407992|Migraine|migraine
661144|NCT00407940|Thrombosis|thrombosis
661145|NCT00407940|Claudication|claudication
661146|NCT00407914|wrinkles|wrinkles
661147|NCT00407914|soft tissue filler|soft tissue filler
661148|NCT00407914|Aquamid|aquamid
661149|NCT00407901|Visually Challenged|visually challenged
661150|NCT00407901|Legally Blind|legally blind
661151|NCT00407901|Functional Assessment Questionnaire|functional assessment questionnaire
661152|NCT00407901|Low Functioning|low functioning
661153|NCT00407901|High Functioning|high functioning
661154|NCT00407875|Prostate|prostate
661155|NCT00407875|Cancer|cancer
661156|NCT00407875|Radiation|radiation
661157|NCT00407862|insulin resistance|insulin resistance
661158|NCT00407862|beta cell function|beta cell function
661159|NCT00407862|endothelial dysfunction|endothelial dysfunction
661160|NCT00407836|HIV|hiv
661161|NCT00407836|CD4 T cell level|cd4 t cell level
661162|NCT00407836|CD4 autoimmunity|cd4 autoimmunity
661163|NCT00407836|Viral load|viral load
661164|NCT00407836|T cell vaccination|t cell vaccination
661165|NCT00407836|HIV Therapeutic Vaccine|hiv therapeutic vaccine
661166|NCT00407823|Child|child
661167|NCT00407823|Septic shock|septic shock
661168|NCT00407823|Resuscitation|resuscitation
661169|NCT00407823|Central venous oxygen saturation|central venous oxygen saturation
661170|NCT00407823|Cardiac output|cardiac output
661171|NCT00407823|Goal-directed therapy|goal-directed therapy
661172|NCT00407797|Lyrica|lyrica
661173|NCT00407797|Epilepsies - Partial|epilepsies - partial
661174|NCT00407784|primary aldosteronism|primary aldosteronism
661175|NCT00407784|hypertension|hypertension
661176|NCT00407784|aldosteron-renin ratio|aldosteron-renin ratio
661177|NCT00407784|eplerenone|eplerenone
661178|NCT00407784|aldosteron-receptor antagonist|aldosteron-receptor antagonist
661179|NCT00407784|screening|screening
661180|NCT00407771|platelet function assay|platelet function assay
661181|NCT00407771|Glycoprotein inhibitors|glycoprotein inhibitors
661182|NCT00407771|percutaneous coronary intervention|percutaneous coronary intervention
661183|NCT00407771|Diabetes Mellitus|diabetes mellitus
661184|NCT00407758|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
661185|NCT00407758|primary peritoneal cavity cancer|primary peritoneal cavity cancer
661186|NCT00407745|Pain|pain
661187|NCT00407745|central neuropathic pain|central neuropathic pain
661188|NCT00407732|hepatitis C|hepatitis c
661189|NCT00407732|mental disorder|mental disorder
661190|NCT00407732|substance use|substance use
661191|NCT00407732|psychosocial intervention|psychosocial intervention
661192|NCT00407719|Choroidal Neovascularization|choroidal neovascularization
661193|NCT00407706|Breast Cancer, FACS, SCM, Malignant, Benign, Lymphocytes|breast cancer, facs, scm, malignant, benign, lymphocytes
661194|NCT00407693|Dosimetry|dosimetry
661195|NCT00407693|Effective Dose|effective dose
661196|NCT00407693|Radiation-Absorbed Dose|radiation-absorbed dose
661197|NCT00407680|Type 2 diabetes mellitus|type 2 diabetes mellitus
661198|NCT00407680|Hypertension|hypertension
661199|NCT00407680|Angiotensin II Receptor Blocker|angiotensin ii receptor blocker
661200|NCT00407680|Diabetic nephropathy|diabetic nephropathy
661201|NCT00407667|hemiparesis|hemiparesis
661202|NCT00407667|rehabilitation|rehabilitation
661203|NCT00407667|upper limb rehabilitation|upper limb rehabilitation
661204|NCT00407667|arm therapy|arm therapy
661205|NCT00407641|diabetes mellitus|diabetes mellitus
661206|NCT00407641|chronic hemodialysis|chronic hemodialysis
661207|NCT00407641|anticoagulation|anticoagulation
661208|NCT00407641|outcome|outcome
661209|NCT00407628|Stroke|stroke
661210|NCT00407628|Diffusion spectrum tractography|diffusion spectrum tractography
661211|NCT00407628|Functional MRI (fMRI)|functional mri (fmri)
661212|NCT00407628|Lower extremity|lower extremity
661213|NCT00407602|retinitis pigmentosa|retinitis pigmentosa
661214|NCT00407602|device|device
661215|NCT00407602|retinal implant|retinal implant
661216|NCT00407602|retinal prosthesis|retinal prosthesis
661217|NCT00407602|RP|rp
661218|NCT00407602|outer retinal degeneration|outer retinal degeneration
661219|NCT00407576|Alzheimer's Disease|alzheimer's disease
661220|NCT00407576|Positron Emission Tomography|positron emission tomography
661221|NCT00407576|Brain|brain
661222|NCT00407576|Neurochemistry|neurochemistry
661223|NCT00407576|Beta-Amyloid Plaques|beta-amyloid plaques
661224|NCT00407576|PET|pet
661225|NCT00407576|MeS-IMPY|mes-impy
661226|NCT00407576|Alzheimer Disease|alzheimer disease
661227|NCT00407576|AD|ad
661228|NCT00407576|Dementia|dementia
661229|NCT00407576|Healthy Volunteer|healthy volunteer
661230|NCT00407576|HV|hv
661231|NCT00407550|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
661232|NCT00407550|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
661233|NCT00407550|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
661234|NCT00407498|P 276-00|p 276-00
661235|NCT00407498|Advanced Refractory Neoplasm|advanced refractory neoplasm
661236|NCT00407498|Maximum Tolerated Dose|maximum tolerated dose
661237|NCT00407498|Dose Limiting Toxicity|dose limiting toxicity
661238|NCT00407498|Pharmacokinetics|pharmacokinetics
661239|NCT00407472|Bio-equivalence study in healthy volunteers, indication|bio-equivalence study in healthy volunteers, indication
661240|NCT00407472|of product is growth hormone deficiency|of product is growth hormone deficiency
661241|NCT00407446|PDE5 inhibition|pde5 inhibition
661242|NCT00407446|chronic heart failure|chronic heart failure
661243|NCT00407446|endothelial function|endothelial function
661244|NCT00407446|exercise ventilation|exercise ventilation
661245|NCT00407433|Gemcitabine|gemcitabine
661246|NCT00407433|Oxaliplatine|oxaliplatine
661247|NCT00407433|Paediatric solid tumors|paediatric solid tumors
661248|NCT00407433|Other CNS tumors|other cns tumors
661249|NCT00407433|Other miscellaneous solid non-CNS tumours|other miscellaneous solid non-cns tumours
661250|NCT00407420|Childhood|childhood
661251|NCT00407420|Obesity|obesity
661252|NCT00407420|Behavior modification|behavior modification
661253|NCT00407420|Insulin resistance|insulin resistance
661254|NCT00407407|Epithelial ovarian|epithelial ovarian
661255|NCT00407407|Primary peritoneal or fallopian tube carcinoma|primary peritoneal or fallopian tube carcinoma
661256|NCT00407407|Abraxane|abraxane
661257|NCT00407407|Carboplatin|carboplatin
661258|NCT00407394|Pneumonia|pneumonia
661259|NCT00407394|Wheezing|wheezing
661260|NCT00407394|Treatment|treatment
661261|NCT00407394|Children|children
661262|NCT00407394|India|india
661263|NCT00407381|DME|dme
661264|NCT00407355|vein occlusion|vein occlusion
661265|NCT00407355|macular edema|macular edema
661266|NCT00407342|Psoriasis|psoriasis
661267|NCT00407342|biologics|biologics
661268|NCT00407342|alefacept|alefacept
661269|NCT00407342|Narrowband UVB|narrowband uvb
661270|NCT00407342|Phototherapy|phototherapy
661271|NCT00407342|Half-side comparison|half-side comparison
661272|NCT00407329|BPH|bph
661273|NCT00407316|Uveitis|uveitis
661274|NCT00407316|Quality of life|quality of life
661275|NCT00407316|Visual function|visual function
661276|NCT00407290|pregnancy|pregnancy
661277|NCT00407290|vaginal delivery|vaginal delivery
661278|NCT00407277|nicotine dependence|nicotine dependence
661279|NCT00407277|smoking|smoking
661280|NCT00407277|nicotine patch|nicotine patch
661281|NCT00407277|double-blind|double-blind
661282|NCT00407277|randomized|randomized
661283|NCT00407277|placebo|placebo
661284|NCT00407277|psychosis|psychosis
661285|NCT00407277|schizophrenia|schizophrenia
661286|NCT00407277|schizophreniform|schizophreniform
661287|NCT00407277|schizoaffective disorder|schizoaffective disorder
661288|NCT00407264|bronchial squamous metaplasia|bronchial squamous metaplasia
661289|NCT00407264|bronchial squamous dysplasia|bronchial squamous dysplasia
661290|NCT00407251|refractory|refractory
661291|NCT00407251|prostate|prostate
661292|NCT00407251|hormone|hormone
661293|NCT00407238|barrier function, multi-purpose solutions, silicone hydrogel contact lenses|barrier function, multi-purpose solutions, silicone hydrogel contact lenses
661294|NCT00407212|early stage idiopathic Parkinson's disease|early stage idiopathic parkinson's disease
661295|NCT00407199|social phobia, anxiety, quetiapine|social phobia, anxiety, quetiapine
661296|NCT00407186|CRITICS|critics
661297|NCT00407186|gastric cancer|gastric cancer
661298|NCT00407186|surgery|surgery
661299|NCT00407186|adjuvant|adjuvant
661300|NCT00407186|chemotherapy|chemotherapy
661301|NCT00407186|chemoradiotherapy|chemoradiotherapy
661302|NCT00407186|capecitabine|capecitabine
661303|NCT00407186|cisplatin|cisplatin
661304|NCT00407186|epirubicin|epirubicin
661305|NCT00407160|Kidney transplant|kidney transplant
661306|NCT00407160|Tolerance induction|tolerance induction
661307|NCT00407160|High PRA kidney recipients|high pra kidney recipients
661308|NCT00407147|bacterial infection|bacterial infection
661309|NCT00407147|empiric antibiotic treatment|empiric antibiotic treatment
661310|NCT00407147|duration antibiotic treatment|duration antibiotic treatment
661311|NCT00407147|reduce antibiotic treatment|reduce antibiotic treatment
661312|NCT00407147|procalcitonin|procalcitonin
661313|NCT00407147|PCT Kryptor|pct kryptor
661314|NCT00407147|sepsis|sepsis
661315|NCT00407147|Intensive Care Unit|intensive care unit
661316|NCT00407147|antibiotic treatment|antibiotic treatment
661317|NCT00407121|Neovascular Membrane|neovascular membrane
661318|NCT00407121|Uveitis|uveitis
661319|NCT00407121|Bevacizumab|bevacizumab
661320|NCT00407108|vitreoretinal surgery|vitreoretinal surgery
661321|NCT00407095|Parkinson Disease|parkinson disease
661322|NCT00407043|Dry Eye Disease|dry eye disease
661323|NCT00407043|Lotemax|lotemax
661324|NCT00407043|Restasis|restasis
661325|NCT00407043|Loteprednol|loteprednol
661326|NCT00407043|Cyclosporine|cyclosporine
661327|NCT00407004|acute-on-chronic liver failure, MARS, Prometheus, bilirubin, bile acids, cytokines|acute-on-chronic liver failure, mars, prometheus, bilirubin, bile acids, cytokines
661328|NCT00406991|retinal blood flow|retinal blood flow
661329|NCT00406991|diabetic retinopathy|diabetic retinopathy
661330|NCT00406991|microthrombosis|microthrombosis
661331|NCT00406991|aspirin|aspirin
661332|NCT00406991|clopidogrel|clopidogrel
661333|NCT00406978|MYELOMA|myeloma
661334|NCT00406978|THALIDOMIDE|thalidomide
661335|NCT00406978|DEFIBRODITE|defibrodite
661336|NCT00406939|Gene Therapy|gene therapy
661337|NCT00406939|Immunology|immunology
661338|NCT00406939|Phase I Clinical Trial|phase i clinical trial
661339|NCT00406900|uveal melanoma|uveal melanoma
661340|NCT00406900|metastatic disease|metastatic disease
661341|NCT00406874|infertility|infertility
661342|NCT00406874|semen quality|semen quality
661343|NCT00406874|sexual function|sexual function
661344|NCT00406874|blood pressure|blood pressure
661345|NCT00406874|omega 3 fats|omega 3 fats
661346|NCT00406874|folic acid|folic acid
661347|NCT00406861|reaction|reaction
661348|NCT00406861|ENL|enl
661349|NCT00406861|leprosy|leprosy
661350|NCT00406835|Whole Brain Radiation Therapy|whole brain radiation therapy
661351|NCT00406835|Stereotactic Radiosurgery|stereotactic radiosurgery
661352|NCT00406835|Brain metastases|brain metastases
661353|NCT00406822|Glaucoma|glaucoma
661354|NCT00406822|collagen matrix|collagen matrix
661355|NCT00406822|OculusGen|oculusgen
661356|NCT00406822|trabeculectomy|trabeculectomy
661357|NCT00406822|tissue engineering|tissue engineering
661358|NCT00406809|Sezary syndrome|sezary syndrome
661359|NCT00406809|cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
661360|NCT00406809|follicular lymphoma|follicular lymphoma
661361|NCT00406809|marginal zone lymphoma|marginal zone lymphoma
661362|NCT00406809|indolent T-cell lymphoma|indolent t-cell lymphoma
661363|NCT00406809|Navitoclax|navitoclax
661364|NCT00406809|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
661365|NCT00406809|peripheral T-cell lymphoma|peripheral t-cell lymphoma
661366|NCT00406809|ABT-263|abt-263
661367|NCT00406809|lymphoid malignancies|lymphoid malignancies
661368|NCT00406809|chronic lymphoid leukemia|chronic lymphoid leukemia
661369|NCT00406809|mycosis fungoides|mycosis fungoides
661370|NCT00406809|mantle cell lymphoma|mantle cell lymphoma
661371|NCT00406783|Allergic Rhinitis|allergic rhinitis
661372|NCT00406783|Intermittent Allergic Rhinitis|intermittent allergic rhinitis
661373|NCT00406770|Obesity|obesity
661374|NCT00406770|Light therapy|light therapy
661375|NCT00406770|Hypocaloric diet|hypocaloric diet
661376|NCT00406757|T-cell|t-cell
661377|NCT00406757|T-ALL|t-all
661378|NCT00406757|T-LBL|t-lbl
661379|NCT00406757|506U78|506u78
661380|NCT00406757|ara-G|ara-g
661381|NCT00406757|ara-GTP|ara-gtp
661382|NCT00406757|Lymphoma|lymphoma
661383|NCT00406757|Leukemia|leukemia
661384|NCT00406744|neovascularization|neovascularization
661385|NCT00406731|Endothelin-1|endothelin-1
661386|NCT00406731|L-NG-Monomethyl Arginine|l-ng-monomethyl arginine
661387|NCT00406731|Optic Nerve Head blood flow|optic nerve head blood flow
661388|NCT00406718|Medication Adherence|medication adherence
661389|NCT00406718|Psychosocial Treatment|psychosocial treatment
661390|NCT00406718|Cognitive Adaptation Training|cognitive adaptation training
661391|NCT00406718|Med-e Monitor|med-e monitor
661392|NCT00406718|Adaptive Function|adaptive function
661393|NCT00406705|Exercise Tolerance|exercise tolerance
661394|NCT00406705|Dyspnea|dyspnea
661395|NCT00406705|Rehabilitation|rehabilitation
661396|NCT00406705|Helium|helium
661397|NCT00406692|Zonisamide|zonisamide
661398|NCT00406692|Alcoholism|alcoholism
661399|NCT00406692|Alcohol|alcohol
661400|NCT00406679|pain, postoperative|pain, postoperative
661401|NCT00406679|surgery, oral|surgery, oral
661402|NCT00406679|surgery, dental|surgery, dental
661403|NCT00406640|MDD|mdd
661404|NCT00406640|Major Depressive Disorder|major depressive disorder
661405|NCT00406640|Depression|depression
661406|NCT00406627|filariasis, lymphatic filariasis, Egypt|filariasis, lymphatic filariasis, egypt
661407|NCT00406614|High Blood Pressure|high blood pressure
661408|NCT00406588|Parkinson Disease|parkinson disease
661409|NCT00406575|Congestive heart failure|congestive heart failure
661410|NCT00406575|Relaxin|relaxin
661411|NCT00406575|Hemodynamics|hemodynamics
661412|NCT00406575|Renal function|renal function
661413|NCT00406562|uncontrolled|uncontrolled
661414|NCT00406549|Staphylococcus aureus|staphylococcus aureus
661415|NCT00406549|Nasal colonization|nasal colonization
661416|NCT00406549|pre-surgical patients|pre-surgical patients
661417|NCT00406549|Sensitivity|sensitivity
661418|NCT00406549|Specificity|specificity
661518|NCT00405990|MTCT|mtct
661419|NCT00406549|Nasal Staphylococcus aureus in pre-surgical patients|nasal staphylococcus aureus in pre-surgical patients
661420|NCT00406536|Cystic Fibrosis|cystic fibrosis
661421|NCT00406536|Pancreatic Insufficiency|pancreatic insufficiency
661422|NCT00406536|LYM-X-SORB™|lym-x-sorb™
661423|NCT00406536|LXS|lxs
661424|NCT00406484|Methadone|methadone
661425|NCT00406484|Counseling|counseling
661426|NCT00406484|HIV risk reduction|hiv risk reduction
661427|NCT00406484|HIV Seronegativity|hiv seronegativity
661428|NCT00406471|Ischemic|ischemic
661429|NCT00406471|Central|central
661430|NCT00406471|Retinal|retinal
661431|NCT00406471|Vein|vein
661432|NCT00406471|Occlusion|occlusion
661433|NCT00406471|Ranibizumab|ranibizumab
661434|NCT00406471|Lucentis|lucentis
661435|NCT00406471|CRVO|crvo
661436|NCT00406471|ISCRVO|iscrvo
661437|NCT00406458|Diabetic neuropathy|diabetic neuropathy
661438|NCT00406458|Diabetes Type I or II|diabetes type i or ii
661439|NCT00406458|Mild to moderate sensorimotor diabetic polyneuropathy|mild to moderate sensorimotor diabetic polyneuropathy
661440|NCT00406445|Metabolism|metabolism
661441|NCT00406445|Li-Fraumeni Syndrome|li-fraumeni syndrome
661442|NCT00406432|BRL029060/Paroxetine CR|brl029060/paroxetine cr
661443|NCT00406432|pharmacokinetics|pharmacokinetics
661444|NCT00406432|repeat dose|repeat dose
661445|NCT00406419|anti-CD20|anti-cd20
661446|NCT00406419|stage|stage
661447|NCT00406419|CD20|cd20
661448|NCT00406419|RA|ra
661449|NCT00406393|Acute Myelogenous Leukemia|acute myelogenous leukemia
661450|NCT00406393|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
661451|NCT00406393|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
661452|NCT00406380|Telangiectasias|telangiectasias
661453|NCT00406380|Leakage|leakage
661454|NCT00406380|Bevacizumab|bevacizumab
661455|NCT00406380|Telangiectasias secondary to Branch Retinal Vein Occlusion (BRVO)|telangiectasias secondary to branch retinal vein occlusion (brvo)
661456|NCT00406380|Idiopathic juxtafoveal retinal telangiectasias|idiopathic juxtafoveal retinal telangiectasias
661457|NCT00406315|ziprasidone, quetiapine (Seroquel) switch, open label, flexible dose, schizophrenia, schizoaffective disorder|ziprasidone, quetiapine (seroquel) switch, open label, flexible dose, schizophrenia, schizoaffective disorder
661458|NCT00406302|NSCLC|nsclc
661459|NCT00406302|non-small-cell lung cancer|non-small-cell lung cancer
661460|NCT00406276|Lung Cancer|lung cancer
661461|NCT00406263|nuclear sclerotic cataract|nuclear sclerotic cataract
661462|NCT00406263|cataract|cataract
661463|NCT00406211|Rubella|rubella
661464|NCT00406211|Varicella|varicella
661465|NCT00406211|Measles|measles
661466|NCT00406211|Mumps|mumps
661467|NCT00406211|Germany|germany
661468|NCT00406211|Austria|austria
661469|NCT00406198|Sepsis syndrom|sepsis syndrom
661470|NCT00406198|severe sepsis|severe sepsis
661471|NCT00406198|septic shock|septic shock
661472|NCT00406198|hemofiltration|hemofiltration
661473|NCT00406198|multiple organ failure|multiple organ failure
661474|NCT00406185|Registry|registry
661475|NCT00406185|cardiac catheterization laboratory|cardiac catheterization laboratory
661476|NCT00406185|coronary heart disease|coronary heart disease
661477|NCT00406185|cardiovascular disease|cardiovascular disease
661478|NCT00406159|Autism|autism
661479|NCT00406159|Hyperbaric Oxygen Therapy|hyperbaric oxygen therapy
661480|NCT00406159|Behavioral assessments|behavioral assessments
661481|NCT00406120|eye|eye
661482|NCT00406120|uvea|uvea
661483|NCT00406120|iris|iris
661484|NCT00406120|choroid|choroid
661485|NCT00406120|ciliary body|ciliary body
661486|NCT00406120|melanoma|melanoma
661487|NCT00406120|iris melanoma|iris melanoma
661488|NCT00406120|choroidal melanoma|choroidal melanoma
661489|NCT00406120|ciliary body melanoma|ciliary body melanoma
661490|NCT00406120|uveal melanoma|uveal melanoma
661491|NCT00406120|posterior uveal melanoma|posterior uveal melanoma
661492|NCT00406120|prognosis|prognosis
661493|NCT00406120|metastasis|metastasis
661494|NCT00406120|genetic testing|genetic testing
661495|NCT00406120|molecular testing|molecular testing
661496|NCT00406120|gene expression profiling|gene expression profiling
661497|NCT00406107|branch retinal vein occlusion|branch retinal vein occlusion
661498|NCT00406107|macular edema|macular edema
661499|NCT00406107|pegaptanib sodium|pegaptanib sodium
661500|NCT00406107|vascular endothelial growth factor|vascular endothelial growth factor
661501|NCT00406094|NARES|nares
661502|NCT00406094|eosinophils|eosinophils
661503|NCT00406094|nasal symptoms|nasal symptoms
661504|NCT00406068|Bladder neoplasm|bladder neoplasm
661505|NCT00406068|Intravesical drug administration|intravesical drug administration
661506|NCT00406068|Neoplasm recurrence, local|neoplasm recurrence, local
661507|NCT00406068|Transitional cell, carcinoma|transitional cell, carcinoma
661508|NCT00406068|Carcinoma in situ|carcinoma in situ
661509|NCT00406068|Mycobacterium|mycobacterium
661510|NCT00406042|glaucoma|glaucoma
661511|NCT00406042|trabeculoplasty|trabeculoplasty
661512|NCT00406042|steroids|steroids
661513|NCT00406016|Acute spinal cord injury;|acute spinal cord injury;
661514|NCT00406003|BRL029060/Paroxetine CR|brl029060/paroxetine cr
661515|NCT00406003|pharmacokinetics|pharmacokinetics
661516|NCT00406003|safety|safety
661517|NCT00405990|HIV|hiv
661519|NCT00405990|heterosexual behaviour|heterosexual behaviour
661520|NCT00405990|sexual risk behaviour|sexual risk behaviour
661521|NCT00405990|couple counselling|couple counselling
661522|NCT00405990|Voluntary counselling and testing|voluntary counselling and testing
661523|NCT00405990|HIV Seronegativity|hiv seronegativity
661524|NCT00405977|Neuromuscular block|neuromuscular block
661525|NCT00405977|Magnesium|magnesium
661526|NCT00405977|Rocuronium|rocuronium
661527|NCT00405977|Time course of action|time course of action
661528|NCT00405938|Breast cancer|breast cancer
661529|NCT00405938|Metastatic breast cancer|metastatic breast cancer
661530|NCT00405938|Bevacizumab|bevacizumab
661531|NCT00405938|Anastrozole|anastrozole
661532|NCT00405938|Fulvestrant|fulvestrant
661533|NCT00405925|AIDS|aids
661534|NCT00405925|Treatment Naive|treatment naive
661535|NCT00405899|Allergy|allergy
661536|NCT00405899|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
661537|NCT00405899|Perennial Allergic Rhinitis|perennial allergic rhinitis
661538|NCT00405873|Primary hepatocellular carcinoma|primary hepatocellular carcinoma
661539|NCT00405873|Liver cancer|liver cancer
661540|NCT00405873|Tumour response|tumour response
661541|NCT00405873|Quality of life|quality of life
661542|NCT00405847|Sleep|sleep
661543|NCT00405847|Critical illness|critical illness
661544|NCT00405847|Cytokine|cytokine
661545|NCT00405834|Pressure Ulcers|pressure ulcers
661546|NCT00405821|AIDS|aids
661547|NCT00405821|HIV Disease Progression|hiv disease progression
661548|NCT00405821|Quality of Life|quality of life
661549|NCT00405821|HIV Viral Load|hiv viral load
661550|NCT00405821|Genital Ulcers|genital ulcers
661551|NCT00405821|HIV|hiv
661552|NCT00405821|Treatment Naive|treatment naive
661553|NCT00405795|Pressure Ulcer|pressure ulcer
661554|NCT00405782|metastatic breast cancer|metastatic breast cancer
661555|NCT00405782|exercise intervention|exercise intervention
661556|NCT00405769|statin intolerance|statin intolerance
661557|NCT00405769|hyperlipidemia|hyperlipidemia
661558|NCT00405769|lifestyle changes|lifestyle changes
661559|NCT00405769|red yeast rice|red yeast rice
661560|NCT00405756|Newly Diagnosed Multiple Myeloma|newly diagnosed multiple myeloma
661561|NCT00405756|Celgene|celgene
661562|NCT00405756|CC-5013|cc-5013
661563|NCT00405756|Revlimid|revlimid
661564|NCT00405756|Lenalidomide|lenalidomide
661565|NCT00405756|Melphalan|melphalan
661566|NCT00405756|Prednisone|prednisone
661567|NCT00405756|Elderly|elderly
661568|NCT00405743|CP-4055|cp-4055
661569|NCT00405743|ELACYT™|elacyt™
661570|NCT00405743|Cancer|cancer
661571|NCT00405743|Refractory|refractory
661572|NCT00405743|Relapsed|relapsed
661573|NCT00405743|Hematologic Malignancies|hematologic malignancies
661574|NCT00405743|Leukemia|leukemia
661575|NCT00405743|ALL|all
661576|NCT00405743|AML|aml
661577|NCT00405743|AMM|amm
661578|NCT00405743|CLL|cll
661579|NCT00405743|CML|cml
661580|NCT00405743|CMML|cmml
661581|NCT00405743|MDS|mds
661582|NCT00405730|Cataracts|cataracts
661583|NCT00405717|ischemic heart disease|ischemic heart disease
661584|NCT00405717|acute coronary syndromes|acute coronary syndromes
661585|NCT00405717|percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
661586|NCT00405717|statin|statin
661587|NCT00405717|clopidogrel|clopidogrel
661588|NCT00405704|Vesicoureteral Reflux|vesicoureteral reflux
661589|NCT00405704|Urinary Tract Infections|urinary tract infections
661590|NCT00405704|Renal Scarring|renal scarring
661591|NCT00405704|Antibiotic Resistance|antibiotic resistance
661592|NCT00405704|Controlled Clinical Trial|controlled clinical trial
661593|NCT00405704|Trimethoprim-Sulfamethoxazole|trimethoprim-sulfamethoxazole
661594|NCT00405704|Children|children
661595|NCT00405691|Medical Device|medical device
661596|NCT00405691|Spine|spine
661597|NCT00405691|Lumbar Spinal Stenosis|lumbar spinal stenosis
661598|NCT00405691|Degenerative Spondylolisthesis|degenerative spondylolisthesis
661599|NCT00405691|Facet Arthrosis|facet arthrosis
661600|NCT00405691|Back and Leg Pain|back and leg pain
661601|NCT00405691|Spine Research|spine research
661602|NCT00405691|Medical Device Research|medical device research
661603|NCT00405691|Impliant|impliant
661604|NCT00405691|Lumbar Treatment|lumbar treatment
661605|NCT00405691|Spinal Treatment|spinal treatment
661606|NCT00405691|Spinal Device|spinal device
661607|NCT00405678|Exercise Intervention|exercise intervention
661608|NCT00405678|Breast Cancer|breast cancer
661609|NCT00405678|Neo-Adjuvant Therapy|neo-adjuvant therapy
661610|NCT00405678|Operable Breast Cancer Stage I-II receiving neo-adjuvant chemotherapy|operable breast cancer stage i-ii receiving neo-adjuvant chemotherapy
661611|NCT00405665|Cystic Fibrosis|cystic fibrosis
661612|NCT00405665|L-Arginine|l-arginine
661613|NCT00405665|Pediatrics|pediatrics
661614|NCT00405665|pulmonary function|pulmonary function
661615|NCT00405652|Liver transplantation, mycophenolate, GI problems, Quality of Life|liver transplantation, mycophenolate, gi problems, quality of life
661616|NCT00405626|post partum hemmorhage,Arnica montana,Bellis Perenis|post partum hemmorhage,arnica montana,bellis perenis
661617|NCT00405613|Aspirin|aspirin
661618|NCT00405613|Bleeding|bleeding
661619|NCT00405613|Clinical Trial|clinical trial
661620|NCT00405613|Dental Extraction|dental extraction
661621|NCT00405600|Lumbar degenerative disease|lumbar degenerative disease
661622|NCT00405600|spinal stenosis|spinal stenosis
661623|NCT00405600|spondylolisthesis|spondylolisthesis
661624|NCT00405600|non instrumented surgery|non instrumented surgery
661625|NCT00405600|instrumented surgery|instrumented surgery
661626|NCT00405600|BMP-2|bmp-2
661627|NCT00405574|prostate|prostate
661628|NCT00405574|PSA|psa
661629|NCT00405574|antiangiogenic|antiangiogenic
661630|NCT00405574|copper|copper
661631|NCT00405574|ATN-224|atn-224
661632|NCT00405561|Advanced Colorectal Carcinoma|advanced colorectal carcinoma
661633|NCT00405535|OCD|ocd
661634|NCT00405535|Obsessive Compulsive Disorder|obsessive compulsive disorder
661635|NCT00405535|Glycine|glycine
661636|NCT00405522|Lumbar Puncture|lumbar puncture
661637|NCT00405522|Pediatrics|pediatrics
661638|NCT00405522|Propofol|propofol
661639|NCT00405522|Remifentanil|remifentanil
661640|NCT00405522|sedation|sedation
661641|NCT00405522|Oncology|oncology
661642|NCT00405509|Upper Respiratory Infection|upper respiratory infection
661643|NCT00405509|Common Cold|common cold
661644|NCT00405483|arthroplasty|arthroplasty
661645|NCT00405483|RSA|rsa
661646|NCT00405483|micromotion|micromotion
661647|NCT00405483|osteoarthritis|osteoarthritis
661648|NCT00405483|minimally invasive|minimally invasive
661649|NCT00405483|ProfemurZ|profemurz
661650|NCT00405470|arthroplasty|arthroplasty
661651|NCT00405470|RSA|rsa
661652|NCT00405470|micromotion|micromotion
661653|NCT00405470|osteoarthritis|osteoarthritis
661654|NCT00405444|Pediatrics|pediatrics
661655|NCT00405444|Pain|pain
661656|NCT00405444|Voiding Cystourethrogram|voiding cystourethrogram
661657|NCT00405444|Catheterization|catheterization
661658|NCT00405444|Fentanyl|fentanyl
661659|NCT00405431|glaucoma filtering surgery|glaucoma filtering surgery
661660|NCT00405431|restasis|restasis
661661|NCT00405431|conjunctival inflammation|conjunctival inflammation
661662|NCT00405405|Head and neck cancer|head and neck cancer
661663|NCT00405405|Parotid gland cancer|parotid gland cancer
661664|NCT00405405|thyroid gland cancer|thyroid gland cancer
661665|NCT00405405|melanoma|melanoma
661666|NCT00405405|Chemoradiotherapy|chemoradiotherapy
661667|NCT00405405|bevacizumab|bevacizumab
661668|NCT00405405|erlotinib|erlotinib
661669|NCT00405392|Ibandronate|ibandronate
661670|NCT00405392|risedronate|risedronate
661671|NCT00405392|Osteoporosis|osteoporosis
661672|NCT00405392|preference|preference
661673|NCT00405379|arthroplasty|arthroplasty
661674|NCT00405379|RSA|rsa
661675|NCT00405379|Osteoarthritis|osteoarthritis
661676|NCT00405379|trabecular metal mesh|trabecular metal mesh
661677|NCT00405366|stage II renal cell cancer|stage ii renal cell cancer
661678|NCT00405366|stage III renal cell cancer|stage iii renal cell cancer
661679|NCT00405366|stage IV renal cell cancer|stage iv renal cell cancer
661680|NCT00405353|multiple sclerosis|multiple sclerosis
661681|NCT00405353|testosterone|testosterone
661682|NCT00405327|tumor vaccine|tumor vaccine
661683|NCT00405327|metastatic solid tumors|metastatic solid tumors
661684|NCT00405327|recurrent tumors|recurrent tumors
661685|NCT00405314|respiratory failure|respiratory failure
661686|NCT00405314|non invasive ventilation|non invasive ventilation
661687|NCT00405314|prehospital|prehospital
661688|NCT00405314|endotracheal intubation|endotracheal intubation
661689|NCT00405314|continuous positive airway pressure|continuous positive airway pressure
661690|NCT00405301|Tuberculosis|tuberculosis
661691|NCT00405301|Drug Induced Hepatotoxicity|drug induced hepatotoxicity
661692|NCT00405301|Anti-tuberculosis drugs|anti-tuberculosis drugs
661693|NCT00405301|India|india
661694|NCT00405288|Hemorrhoids|hemorrhoids
661695|NCT00405288|Pregnancy|pregnancy
661696|NCT00405288|antihemorrhoidal|antihemorrhoidal
661697|NCT00405288|Proctofoam|proctofoam
661698|NCT00405288|infants|infants
661699|NCT00405275|antineoplastic|antineoplastic
661700|NCT00405275|antiparasitics|antiparasitics
661701|NCT00405275|antirheumatics|antirheumatics
661702|NCT00405275|chronic diseases|chronic diseases
661703|NCT00405275|clinical trial|clinical trial
661704|NCT00405275|connective tissue|connective tissue
661705|NCT00405275|double-blind|double-blind
661706|NCT00405275|drug treatment|drug treatment
661707|NCT00405275|gastric medications|gastric medications
661708|NCT00405275|joint|joint
661709|NCT00405275|multi-site trial|multi-site trial
661710|NCT00405275|musculoskeletal|musculoskeletal
661711|NCT00405275|randomized|randomized
661712|NCT00405275|rheumatoid arthritis|rheumatoid arthritis
661713|NCT00405262|Pediatrics|pediatrics
661714|NCT00405262|Postoperative Analgesia|postoperative analgesia
661715|NCT00405262|orthopedic surgery|orthopedic surgery
661716|NCT00405262|Iliac Crest Bone Graft|iliac crest bone graft
661717|NCT00405262|Osteotomy|osteotomy
661718|NCT00405262|cleft palate|cleft palate
661719|NCT00405249|HIV-1|hiv-1
661720|NCT00405249|Treatment Experienced|treatment experienced
661721|NCT00405236|inflammation|inflammation
661722|NCT00405236|exacerbations|exacerbations
661723|NCT00405210|hormone-resistant|hormone-resistant
661724|NCT00405210|metastatic prostatic cancer|metastatic prostatic cancer
661725|NCT00405210|pharmacokinetics|pharmacokinetics
661726|NCT00405210|naïve patient|naïve patient
661727|NCT00405197|MUFA|mufa
661728|NCT00405197|Mediterranean diet|mediterranean diet
661729|NCT00405197|Insulin resistance|insulin resistance
661730|NCT00405197|metabolic syndrome X|metabolic syndrome x
661732|NCT00405184|IVIg|ivig
661733|NCT00405184|IntragamP|intragamp
661734|NCT00405171|Efavirenz|efavirenz
661735|NCT00405171|Nevirapine|nevirapine
661736|NCT00405171|Dyslipidemia|dyslipidemia
661737|NCT00405171|HIV|hiv
661738|NCT00405158|Lactation mastitis|lactation mastitis
661739|NCT00405158|Breast inflammation|breast inflammation
661740|NCT00405158|Breastfeeding|breastfeeding
661741|NCT00405158|Care interventions|care interventions
661742|NCT00405158|Acupuncture treatment|acupuncture treatment
661743|NCT00405158|Antibiotic therapy|antibiotic therapy
661744|NCT00405145|Epilepsy|epilepsy
661745|NCT00405145|MRI|mri
661746|NCT00405145|EEG|eeg
661747|NCT00405145|Neuroimaging|neuroimaging
661748|NCT00405119|tolerance|tolerance
661749|NCT00405119|pharmacodynamics|pharmacodynamics
661750|NCT00405119|ranitidine|ranitidine
661751|NCT00405119|esomeprazole|esomeprazole
661752|NCT00405119|pharmacokinetics|pharmacokinetics
661753|NCT00405119|gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
661754|NCT00405119|AH23844|ah23844
661755|NCT00405106|stress|stress
661756|NCT00405106|anxiety|anxiety
661757|NCT00405106|myopia progression|myopia progression
661758|NCT00405106|accommodation|accommodation
661759|NCT00405106|vergence|vergence
661760|NCT00405093|cardiopulmonary bypass|cardiopulmonary bypass
661761|NCT00405093|circulatory arrest|circulatory arrest
661762|NCT00405093|aprotinin|aprotinin
661763|NCT00405093|thoracic aorta surgery|thoracic aorta surgery
661764|NCT00405080|Rifampin GW679769|rifampin gw679769
661765|NCT00405067|Cholesterol|cholesterol
661766|NCT00405015|rosiglitazone|rosiglitazone
661767|NCT00405015|ischemia-reperfusion injury|ischemia-reperfusion injury
661768|NCT00405015|human|human
661769|NCT00405015|Annexin A5 scintigraphy|annexin a5 scintigraphy
661770|NCT00405015|metabolic syndrome|metabolic syndrome
661771|NCT00405002|Acute respiratory failure|acute respiratory failure
661772|NCT00404989|HIV|hiv
661773|NCT00404989|HBV|hbv
661774|NCT00404989|Hepatitis|hepatitis
661775|NCT00404989|Pregnancy|pregnancy
661776|NCT00404989|Registry|registry
661777|NCT00404976|inflammometry|inflammometry
661778|NCT00404976|exhaled breath condensate|exhaled breath condensate
661779|NCT00404976|fractional exhaled nitric oxide|fractional exhaled nitric oxide
661780|NCT00404976|asthma|asthma
661781|NCT00404976|children|children
661782|NCT00404963|GSK376501,|gsk376501,
661783|NCT00404963|First Time in Human,|first time in human,
661784|NCT00404963|Single Dose,|single dose,
661785|NCT00404963|Dose Escalation,|dose escalation,
661786|NCT00404963|Healthy Overweight/Obese Volunteer|healthy overweight/obese volunteer
661787|NCT00404950|hyperglycemia|hyperglycemia
661788|NCT00404950|cardiopulmonary bypass|cardiopulmonary bypass
661789|NCT00404950|renal injury|renal injury
661790|NCT00404950|diabetes|diabetes
661791|NCT00404924|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
661792|NCT00404924|Adenocarcinoma|adenocarcinoma
661793|NCT00404924|Squamous Cell Carcinoma|squamous cell carcinoma
661794|NCT00404924|Large Cell Carcinoma|large cell carcinoma
661795|NCT00404911|Oppositional Defiant Disorder|oppositional defiant disorder
661796|NCT00404898|World Trade Center dust|world trade center dust
661797|NCT00404885|uveitis|uveitis
661798|NCT00404885|calcineurin|calcineurin
661799|NCT00404885|inflammation|inflammation
661800|NCT00404872|Stroke|stroke
661801|NCT00404859|inflammometry|inflammometry
661802|NCT00404859|exhaled breath condensate|exhaled breath condensate
661803|NCT00404859|fractional exhaled nitric oxide|fractional exhaled nitric oxide
661804|NCT00404859|asthma|asthma
661805|NCT00404859|cystic fibrosis|cystic fibrosis
661806|NCT00404859|monitoring|monitoring
661807|NCT00404859|exacerbations|exacerbations
661808|NCT00404859|paediatric|paediatric
661809|NCT00404846|Hyperbaric oxygenation therapy|hyperbaric oxygenation therapy
661810|NCT00404846|HBOT|hbot
661811|NCT00404846|Autism|autism
661812|NCT00404833|idiopathic membranous nephropathy or focal segmental glomerulosclerosis|idiopathic membranous nephropathy or focal segmental glomerulosclerosis
661813|NCT00404820|osteoporosis|osteoporosis
661814|NCT00404820|bisphosphonate|bisphosphonate
661815|NCT00404820|biomarker|biomarker
661816|NCT00404820|zoledronic acid|zoledronic acid
661817|NCT00404820|alendronate|alendronate
661818|NCT00404820|postmenopausal|postmenopausal
661819|NCT00404807|Continuous positive airway pressure|continuous positive airway pressure
661820|NCT00404807|cardiovascular diseases|cardiovascular diseases
661821|NCT00404807|sleep apnea syndromes|sleep apnea syndromes
661822|NCT00404807|sleep breathing disorders|sleep breathing disorders
661823|NCT00404807|sham CPAP|sham cpap
661824|NCT00404794|membranous lupus nephritis|membranous lupus nephritis
661825|NCT00404781|ischemic heart disease|ischemic heart disease
662766|NCT00401349|Leishmania|leishmania
661826|NCT00404781|acute coronary syndromes|acute coronary syndromes
661827|NCT00404781|percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
661828|NCT00404781|platelet function|platelet function
661829|NCT00404781|aspirin|aspirin
661830|NCT00404781|clopidogrel|clopidogrel
661831|NCT00404781|cilostazol|cilostazol
661832|NCT00404768|Premature Labor|premature labor
661833|NCT00404768|Pre Term Labor|pre term labor
661834|NCT00404768|intravenous|intravenous
661835|NCT00404768|fetal fibronectin|fetal fibronectin
661836|NCT00404755|Depression|depression
661837|NCT00404742|uveitis|uveitis
661838|NCT00404742|calcineurin|calcineurin
661839|NCT00404729|Glaucoma|glaucoma
661840|NCT00404729|Optic Neuropathy, Ischemic|optic neuropathy, ischemic
661841|NCT00404729|Visual Pathways,|visual pathways,
661842|NCT00404729|Optic nerve|optic nerve
661843|NCT00404729|Neural conduction|neural conduction
661844|NCT00404690|Gastroschisis|gastroschisis
661845|NCT00404690|Silo|silo
661846|NCT00404690|Operative closure|operative closure
661847|NCT00404664|influenza vaccine|influenza vaccine
661848|NCT00404664|influenza immunization|influenza immunization
661849|NCT00404664|reminder letters|reminder letters
661850|NCT00404664|raffle prize|raffle prize
661851|NCT00404651|Diphtheria|diphtheria
661852|NCT00404651|Tetanus|tetanus
661853|NCT00404651|Pertussis|pertussis
661854|NCT00404651|Hepatitis B|hepatitis b
661855|NCT00404651|Poliomyelitis|poliomyelitis
661856|NCT00404651|Invasive Haemophilus influenzae type b.|invasive haemophilus influenzae type b.
661857|NCT00404638|Enuresis Nocturna|enuresis nocturna
661858|NCT00404638|Paula Method|paula method
661859|NCT00404638|Circular muscle exercise|circular muscle exercise
661860|NCT00404638|Sphincter|sphincter
661861|NCT00404625|Bacteremia caused by ESBL-producing Enterobacteriaceae|bacteremia caused by esbl-producing enterobacteriaceae
661862|NCT00404625|Pneumonia caused by ESBL-producing Enterobacteriaceae|pneumonia caused by esbl-producing enterobacteriaceae
661863|NCT00404625|Abdomen infections due to ESBL-producing Enterobacteriaceae|abdomen infections due to esbl-producing enterobacteriaceae
661864|NCT00404625|Skin infections caused by ESBL-producing Enterobacteriaceae|skin infections caused by esbl-producing enterobacteriaceae
661865|NCT00404625|Urinary infections due to ESBL-producing Enterobacteriaceae|urinary infections due to esbl-producing enterobacteriaceae
661866|NCT00404612|uveitis|uveitis
661867|NCT00404612|calcineurin|calcineurin
661868|NCT00404599|simvastatin, atorvastatin, oxidative stress|simvastatin, atorvastatin, oxidative stress
661869|NCT00404586|Environmental Challenge Chamber|environmental challenge chamber
661870|NCT00404586|GW784568X|gw784568x
661871|NCT00404586|Intranasal|intranasal
661872|NCT00404573|Schizophrenia|schizophrenia
661873|NCT00404560|CTLA4 Mutation|ctla4 mutation
661874|NCT00404560|Recurrent Infections|recurrent infections
661875|NCT00404560|Immunodeficiency|immunodeficiency
661876|NCT00404560|Phagocytes|phagocytes
661877|NCT00404560|PI3K|pi3k
661878|NCT00404560|DOCK8|dock8
661879|NCT00404560|STAT 1|stat 1
661880|NCT00404560|Genetic Mutation|genetic mutation
661881|NCT00404560|Cytokines|cytokines
661882|NCT00404560|Auto-antibodies|auto-antibodies
661883|NCT00404560|Infection Susceptibility|infection susceptibility
661884|NCT00404560|Immune Disorders|immune disorders
661885|NCT00404560|Immune Defects of Phagocytes|immune defects of phagocytes
661886|NCT00404560|Unusual, Chronic Bacterial, Mycobacterial, and Fungal Infections|unusual, chronic bacterial, mycobacterial, and fungal infections
661887|NCT00404547|Asthma|asthma
661888|NCT00404547|Alvesco®|alvesco®
661889|NCT00404547|Ciclesonide|ciclesonide
661890|NCT00404534|functional dyspepsia|functional dyspepsia
661891|NCT00404534|Helicobacter pylori|helicobacter pylori
661892|NCT00404534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
661893|NCT00404534|Gastritis|gastritis
661894|NCT00404521|Tumor|tumor
661895|NCT00404521|PM02734|pm02734
661896|NCT00404521|PharmaMar|pharmamar
661897|NCT00404508|Hydralazine|hydralazine
661898|NCT00404508|Magnesium Valproate|magnesium valproate
661899|NCT00404508|Chemotherapy resistance|chemotherapy resistance
661900|NCT00404508|Epigenetic therapy|epigenetic therapy
661901|NCT00404482|uveitis|uveitis
661902|NCT00404482|jia|jia
661903|NCT00404482|Cyclosporine A|cyclosporine a
661904|NCT00404482|MTX|mtx
661905|NCT00404443|Acupuncture|acupuncture
661906|NCT00404443|Electroacupuncture|electroacupuncture
661907|NCT00404443|Rheumatoid arthritis|rheumatoid arthritis
661908|NCT00404430|Endothelial function|endothelial function
661909|NCT00404430|Peripheral Arterial Tone|peripheral arterial tone
661910|NCT00404430|Systemic Inflammation|systemic inflammation
661911|NCT00404430|Oxidative Stress|oxidative stress
661912|NCT00404430|Respiratory and peripheral muscular function|respiratory and peripheral muscular function
661913|NCT00404430|Cardiovascular risk|cardiovascular risk
661914|NCT00404430|COPD severity|copd severity
661915|NCT00404417|pain|pain
661916|NCT00404417|lumbar|lumbar
661917|NCT00404404|recurrent breast cancer|recurrent breast cancer
661918|NCT00404404|stage IV breast cancer|stage iv breast cancer
661919|NCT00404391|Moderate to severe pain following bunionectomy surgery|moderate to severe pain following bunionectomy surgery
661920|NCT00404378|Healthy subjects|healthy subjects
661921|NCT00404378|Pharmacokinetics|pharmacokinetics
661922|NCT00404378|Drug interaction|drug interaction
661923|NCT00404378|Ketoconazole|ketoconazole
661924|NCT00404378|Casopitant|casopitant
661925|NCT00404365|depression|depression
661926|NCT00404365|extensive stage small cell lung cancer|extensive stage small cell lung cancer
661927|NCT00404365|limited stage small cell lung cancer|limited stage small cell lung cancer
661928|NCT00404365|recurrent small cell lung cancer|recurrent small cell lung cancer
661929|NCT00404365|stage I non-small cell lung cancer|stage i non-small cell lung cancer
661930|NCT00404365|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
661931|NCT00404365|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
661932|NCT00404365|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
661933|NCT00404365|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
661934|NCT00404365|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
661935|NCT00404352|Rebif New Formulation|rebif new formulation
661936|NCT00404352|Clinical Isolated Syndrome|clinical isolated syndrome
661937|NCT00404352|Multiple Sclerosis|multiple sclerosis
661938|NCT00404339|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
661939|NCT00404339|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
661940|NCT00404339|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
661941|NCT00404339|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
661942|NCT00404339|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
661943|NCT00404339|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
661944|NCT00404339|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
661945|NCT00404339|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
661946|NCT00404339|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
661947|NCT00404339|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
661948|NCT00404339|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
661949|NCT00404339|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
661950|NCT00404339|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
661951|NCT00404339|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
661952|NCT00404339|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
661953|NCT00404339|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
661954|NCT00404339|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
661955|NCT00404339|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
661956|NCT00404339|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
661957|NCT00404339|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
661958|NCT00404339|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
661959|NCT00404339|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
661960|NCT00404339|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
661961|NCT00404339|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
661962|NCT00404339|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
661963|NCT00404339|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
661964|NCT00404339|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
661965|NCT00404339|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
661966|NCT00404339|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
661967|NCT00404339|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
661968|NCT00404339|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
661969|NCT00404339|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
661970|NCT00404339|tongue cancer|tongue cancer
661971|NCT00404326|Cervical carcinoma|cervical carcinoma
661972|NCT00404326|Epigenetic therapy|epigenetic therapy
661973|NCT00404326|Hydralazine|hydralazine
661974|NCT00404326|Valproate|valproate
661975|NCT00404326|Microarray analysis|microarray analysis
661976|NCT00404287|C reactive protein|c reactive protein
661977|NCT00404287|Inflammation|inflammation
661978|NCT00404287|Aortic valve stenosis|aortic valve stenosis
661979|NCT00404287|progression|progression
661980|NCT00404274|healthy human volunteer|healthy human volunteer
661981|NCT00404274|GW679769|gw679769
661982|NCT00404274|warfarin|warfarin
661983|NCT00404274|casopitant|casopitant
661984|NCT00404261|Fluticasone Propionate|fluticasone propionate
661985|NCT00404261|healthcare professional satisfaction|healthcare professional satisfaction
661986|NCT00404261|patient satisfaction|patient satisfaction
661987|NCT00404261|metered dose inhaler with counter|metered dose inhaler with counter
661988|NCT00404261|Salmeterol|salmeterol
661989|NCT00404261|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
661990|NCT00404248|adult anaplastic astrocytoma|adult anaplastic astrocytoma
661991|NCT00404248|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
661992|NCT00404248|adult giant cell glioblastoma|adult giant cell glioblastoma
661993|NCT00404248|recurrent adult brain tumor|recurrent adult brain tumor
661994|NCT00404248|adult glioblastoma|adult glioblastoma
661995|NCT00404248|adult gliosarcoma|adult gliosarcoma
661996|NCT00404235|stage IV melanoma|stage iv melanoma
661997|NCT00404235|recurrent melanoma|recurrent melanoma
661998|NCT00404222|Acute Pain following Bunionectomy|acute pain following bunionectomy
661999|NCT00404183|Pain associated with osteoarthritis|pain associated with osteoarthritis
662000|NCT00404170|imaging|imaging
662001|NCT00404170|Parkinson|parkinson
662002|NCT00404170|progression|progression
662003|NCT00404157|Lupus|lupus
662004|NCT00404157|U2970g|u2970g
662005|NCT00404144|small vessel|small vessel
662006|NCT00404144|paclitaxel coated balloon catheter|paclitaxel coated balloon catheter
662007|NCT00404144|pepcad|pepcad
662008|NCT00404144|drug eluting balloon|drug eluting balloon
662009|NCT00404118|long-term care|long-term care
662010|NCT00404118|satisfaction|satisfaction
662011|NCT00404118|cost|cost
662012|NCT00404105|Excimer laser|excimer laser
662013|NCT00404092|aspergillosis|aspergillosis
662014|NCT00404092|caspofungin|caspofungin
662015|NCT00404092|maximum tolerated dose|maximum tolerated dose
662016|NCT00404079|Chronic low back pain|chronic low back pain
662017|NCT00404014|MCI following CABG surgery|mci following cabg surgery
662018|NCT00404001|Microbia|microbia
662019|NCT00404001|MD-0727|md-0727
662020|NCT00404001|Primary Hypercholesterolemia|primary hypercholesterolemia
662021|NCT00404001|Hypercholesterolemia|hypercholesterolemia
662022|NCT00404001|Hyperlipidemia|hyperlipidemia
662023|NCT00404001|Dyslipidemia|dyslipidemia
662024|NCT00404001|Cholesterol|cholesterol
662025|NCT00404001|LDL|ldl
662026|NCT00403962|anxiety|anxiety
662027|NCT00403962|Social Anxiety Disorder|social anxiety disorder
662028|NCT00403962|SAD|sad
662029|NCT00403936|osteopathic manipulation|osteopathic manipulation
662030|NCT00403936|autonomic nervous system|autonomic nervous system
662031|NCT00403923|Lactose intolerance|lactose intolerance
662032|NCT00403923|Ulcerative colitis|ulcerative colitis
662033|NCT00403923|Lactose|lactose
662034|NCT00403923|Threshold|threshold
662035|NCT00403897|Constipation|constipation
662036|NCT00403884|Drusen|drusen
662037|NCT00403884|Geographic atrophy|geographic atrophy
662038|NCT00403884|diabetes|diabetes
662039|NCT00403884|macular edema|macular edema
662040|NCT00403884|laser|laser
662041|NCT00403884|retinal pigment epithelium|retinal pigment epithelium
662042|NCT00403871|Anaesthesia|anaesthesia
662043|NCT00403871|Pregnency|pregnency
662044|NCT00403871|Heart disease|heart disease
662045|NCT00403845|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
662046|NCT00403845|COPD|copd
662047|NCT00403845|QAB149|qab149
662048|NCT00403845|indacaterol|indacaterol
662049|NCT00403845|long acting β2-agonist|long acting β2-agonist
662050|NCT00403806|Adenotonsillectomy|adenotonsillectomy
662051|NCT00403806|Pediatrics|pediatrics
662052|NCT00403806|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
662053|NCT00403806|Pain|pain
662054|NCT00403806|Oral intake|oral intake
662055|NCT00403806|Dexamethasone|dexamethasone
662056|NCT00403806|Dose finding|dose finding
662057|NCT00403780|Critical limb ischemia|critical limb ischemia
662058|NCT00403780|Pain control|pain control
662059|NCT00403780|Rest pain in lower limb ischemia|rest pain in lower limb ischemia
662060|NCT00403780|pregabalin|pregabalin
662061|NCT00403780|randomized controlled study|randomized controlled study
662062|NCT00403780|Ischemia, therapy|ischemia, therapy
662063|NCT00403780|Lower extremity, blood supply|lower extremity, blood supply
662064|NCT00403780|Pain, prevention & control|pain, prevention & control
662065|NCT00403780|Pain, therapy|pain, therapy
662066|NCT00403767|Atrial Fibrillation|atrial fibrillation
662067|NCT00403767|Stroke|stroke
662068|NCT00403767|Embolism|embolism
662069|NCT00403767|Non-central nervous system systemic embolism|non-central nervous system systemic embolism
662070|NCT00403767|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
662071|NCT00403767|Blood Clot|blood clot
662072|NCT00403767|Rivaroxaban|rivaroxaban
662073|NCT00403767|Warfarin|warfarin
662074|NCT00403767|Anticoagulants|anticoagulants
662075|NCT00403767|Arrhythmias, Cardiac|arrhythmias, cardiac
662076|NCT00403754|asthma|asthma
662077|NCT00403754|QAB149|qab149
662078|NCT00403754|indacaterol|indacaterol
662079|NCT00403754|long acting β2-agonist|long acting β2-agonist
662080|NCT00403754|bronchodilator|bronchodilator
662081|NCT00403741|behavior|behavior
662082|NCT00403741|physical activity|physical activity
662083|NCT00403741|motivation|motivation
662084|NCT00403728|Ischemia|ischemia
662085|NCT00403728|Reperfusion|reperfusion
662086|NCT00403728|Myocardial infarction|myocardial infarction
662087|NCT00403728|ciclosporin A|ciclosporin a
662088|NCT00403728|acute myocardial infarction|acute myocardial infarction
662089|NCT00403702|Retinal detachment|retinal detachment
662090|NCT00403702|proliferative vitreoretinopathy|proliferative vitreoretinopathy
662091|NCT00403702|heavier-than-water internal tamponades|heavier-than-water internal tamponades
662092|NCT00403689|Increased non-specific inflammatory markers|increased non-specific inflammatory markers
662093|NCT00403676|nurse practitioner|nurse practitioner
662094|NCT00403676|rheumatology care|rheumatology care
662095|NCT00403676|outpatient clinic|outpatient clinic
662096|NCT00403676|patient satisfaction|patient satisfaction
662097|NCT00403663|Body mass index|body mass index
662098|NCT00403663|Combined Spinal-Epidural Anesthesia|combined spinal-epidural anesthesia
662099|NCT00403663|Cesarean section|cesarean section
662100|NCT00403663|Obesity|obesity
662101|NCT00403650|Sarcoidosis|sarcoidosis
662102|NCT00403650|Dyspnea|dyspnea
662103|NCT00403650|Interstitial lung disease|interstitial lung disease
662104|NCT00403637|Asthma, indacaterol, long acting β2-agonist|asthma, indacaterol, long acting β2-agonist
662105|NCT00403585|Adefovir Dipivoxil(Hepsera)|adefovir dipivoxil(hepsera)
662106|NCT00403585|Chronic Hepatitis B (CHB)|chronic hepatitis b (chb)
662107|NCT00403572|Preeclampsia|preeclampsia
662108|NCT00403572|Trans cranial Doppler|trans cranial doppler
662109|NCT00403572|Cardiac output|cardiac output
662110|NCT00403572|systemic vascular resistance|systemic vascular resistance
662111|NCT00403572|blood pressure|blood pressure
662112|NCT00403559|seborrheic dermatitis|seborrheic dermatitis
662113|NCT00403546|Schizophrenia|schizophrenia
662114|NCT00403533|Hepatitis C|hepatitis c
662115|NCT00403533|viral load|viral load
662116|NCT00403533|antiviral therapy|antiviral therapy
662117|NCT00403533|cholesterol|cholesterol
662118|NCT00403533|atorvastatin|atorvastatin
662119|NCT00403520|Alzheimer's disease|alzheimer's disease
662120|NCT00403520|Mild cognitive impairment|mild cognitive impairment
662121|NCT00403507|Mild Dementia|mild dementia
662122|NCT00403507|Mild Alzheimer|mild alzheimer
662123|NCT00403507|Cognitive Impairment|cognitive impairment
662124|NCT00403507|Cholinesterase Inhibitor|cholinesterase inhibitor
662125|NCT00403507|Exercise|exercise
662126|NCT00403507|Physical activity|physical activity
662127|NCT00403507|Behavior|behavior
662128|NCT00403507|Memory loss|memory loss
662129|NCT00403494|Intermittent Claudication|intermittent claudication
662130|NCT00403494|IC|ic
662131|NCT00403494|Symptomatic Peripheral Arterial Disease|symptomatic peripheral arterial disease
662132|NCT00403494|Peripheral Arterial Disease|peripheral arterial disease
662133|NCT00403494|PAD|pad
662134|NCT00403494|6R-BH4|6r-bh4
662135|NCT00403494|BH4|bh4
662136|NCT00403494|sapropterin dihydrochloride|sapropterin dihydrochloride
662137|NCT00403494|endothelial dysfunction|endothelial dysfunction
662138|NCT00403494|Nitric Oxide|nitric oxide
662139|NCT00403494|NO|no
662140|NCT00403481|Hypertension|hypertension
662141|NCT00403481|Angiotensin Receptor Blocker|angiotensin receptor blocker
662142|NCT00403481|Calcium Channel Blocker|calcium channel blocker
662143|NCT00403481|Angiotensin Converting Enzyme Inhibitor|angiotensin converting enzyme inhibitor
662144|NCT00403481|Hydrochlorothiazide|hydrochlorothiazide
662145|NCT00403481|Stage I and II Hypertension|stage i and ii hypertension
662146|NCT00403481|Type II Diabetes|type ii diabetes
662147|NCT00403455|Clinical|clinical
662148|NCT00403455|Genetics|genetics
662149|NCT00403455|Monoamine transporter|monoamine transporter
662150|NCT00403455|Pharmacogenetics|pharmacogenetics
662151|NCT00403455|Post Traumatic Stress Disorder|post traumatic stress disorder
662152|NCT00403442|Macular Degeneration|macular degeneration
662153|NCT00403429|oral chemotherapy|oral chemotherapy
662154|NCT00403429|platinum resistant|platinum resistant
662155|NCT00403429|platinum refractory|platinum refractory
662156|NCT00403429|second line|second line
662157|NCT00403416|AEB071|aeb071
662158|NCT00403416|Tacrolimus|tacrolimus
662159|NCT00403416|Mycophenolic acid|mycophenolic acid
662160|NCT00403416|Basiliximab|basiliximab
662161|NCT00403416|Rejection|rejection
662162|NCT00403416|Kidney function|kidney function
662163|NCT00403416|Immunosuppression|immunosuppression
662164|NCT00403403|SCLC|sclc
662165|NCT00403403|SALUTE|salute
662166|NCT00403403|Lung Cancer|lung cancer
662167|NCT00403403|Avastin|avastin
662168|NCT00403377|melanoma|melanoma
662169|NCT00403377|basal cell carcinoma of the skin|basal cell carcinoma of the skin
662170|NCT00403377|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
662171|NCT00403364|Helicobacter pylori infection|helicobacter pylori infection
662172|NCT00403364|Treatment|treatment
662173|NCT00403364|Double blind placebo controlled trial|double blind placebo controlled trial
662174|NCT00403351|Risk|risk
662175|NCT00403351|Coronary artery disease|coronary artery disease
662176|NCT00403351|Heart Rate variability|heart rate variability
662177|NCT00403351|Pulse wave analysis|pulse wave analysis
662178|NCT00403351|BNP|bnp
662179|NCT00403351|CRP|crp
662180|NCT00403338|myocardial ischemia|myocardial ischemia
662181|NCT00403338|coronary disease|coronary disease
662182|NCT00403338|heart disease|heart disease
662183|NCT00403338|Coronary Stenosis [MeSH heading: C14.280.647.250.285]|coronary stenosis [mesh heading: c14.280.647.250.285]
662184|NCT00403325|Central Serous Chorioretinopathy|central serous chorioretinopathy
662185|NCT00403312|Physical Activity|physical activity
662186|NCT00403312|Wellness Programs|wellness programs
662187|NCT00403312|Pharmacological Smoking Cessation|pharmacological smoking cessation
662188|NCT00403299|Coronary artery disease|coronary artery disease
662189|NCT00403299|Cardiac transplantation|cardiac transplantation
662190|NCT00403299|Coronary artery disease in heart transplanted patients|coronary artery disease in heart transplanted patients
662191|NCT00403286|Chronic|chronic
662192|NCT00403286|Obstructive|obstructive
662193|NCT00403286|Pulmonary|pulmonary
662194|NCT00403286|Disease|disease
662195|NCT00403286|COPD|copd
662196|NCT00403286|Safety|safety
662197|NCT00403286|Efficacy|efficacy
662198|NCT00403286|Pharmacokinetic|pharmacokinetic
662199|NCT00403286|Dose-finding|dose-finding
662200|NCT00403273|Painful Knee Arthroplasty|painful knee arthroplasty
662201|NCT00403273|Botulinum Toxin A|botulinum toxin a
662202|NCT00403273|Randomized Controlled Trial|randomized controlled trial
662203|NCT00403273|Pain and Function|pain and function
662204|NCT00403260|malaria|malaria
662205|NCT00403260|ACT|act
662206|NCT00403260|P falciparum|p falciparum
662207|NCT00403260|pyronaridine|pyronaridine
662208|NCT00403260|artesunate|artesunate
662209|NCT00403247|Schizophrenia|schizophrenia
662210|NCT00403247|Schizoaffective Disorder|schizoaffective disorder
662211|NCT00403247|Homocysteine|homocysteine
662212|NCT00403247|Vitamins|vitamins
662213|NCT00403234|Postoperative pain|postoperative pain
662214|NCT00403234|opioid|opioid
662215|NCT00403234|transdermal|transdermal
662216|NCT00403234|TKA (total knee arthroplasty)|tka (total knee arthroplasty)
662217|NCT00403221|Gene therapy|gene therapy
662218|NCT00403221|Prostate cancer|prostate cancer
662219|NCT00403221|Immunology, Angiogenesis inhibition|immunology, angiogenesis inhibition
662220|NCT00403221|Phase I clinical trial|phase i clinical trial
662221|NCT00403208|Ventilation, Mechanical|ventilation, mechanical
662222|NCT00403208|Sedation|sedation
662223|NCT00403195|Ocular Ischemic Syndrome|ocular ischemic syndrome
662224|NCT00403182|recurrent breast cancer|recurrent breast cancer
662225|NCT00403182|stage IIIA breast cancer|stage iiia breast cancer
662226|NCT00403182|stage IIIB breast cancer|stage iiib breast cancer
662227|NCT00403182|stage IIIC breast cancer|stage iiic breast cancer
662228|NCT00403182|stage IV breast cancer|stage iv breast cancer
662229|NCT00403169|stage III renal cell cancer|stage iii renal cell cancer
662230|NCT00403169|stage IV renal cell cancer|stage iv renal cell cancer
662231|NCT00403169|recurrent renal cell cancer|recurrent renal cell cancer
662232|NCT00403156|Macular Degeneration|macular degeneration
662233|NCT00403143|intraocular lens, colour vision, blue-light filtering|intraocular lens, colour vision, blue-light filtering
662234|NCT00403117|Naltrexone|naltrexone
662235|NCT00403117|Smoked Marijuana|smoked marijuana
662236|NCT00403104|ONO-2506PO|ono-2506po
662237|NCT00403104|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
662238|NCT00403104|ALS|als
662239|NCT00403091|Diabetes mellitus|diabetes mellitus
662240|NCT00403091|Internet|internet
662241|NCT00403091|Education, Professional|education, professional
662242|NCT00403091|Quality Indicators, Health Care|quality indicators, health care
662243|NCT00403091|Quality of Health Care|quality of health care
662244|NCT00403091|Hypertension|hypertension
662245|NCT00403091|Hyperlipidemia|hyperlipidemia
662246|NCT00403078|Carotid Artery Stenting (Endovascular)|carotid artery stenting (endovascular)
662247|NCT00403065|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
662248|NCT00403065|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
662249|NCT00403065|tumors metastatic to brain|tumors metastatic to brain
662250|NCT00403052|colorectal|colorectal
662251|NCT00403052|cancer|cancer
662252|NCT00403052|carcinoma|carcinoma
662253|NCT00403052|metastatic|metastatic
662254|NCT00403052|colon|colon
662255|NCT00403052|rectal|rectal
662256|NCT00403052|neoplasm|neoplasm
662257|NCT00403052|cetuximab|cetuximab
662258|NCT00403052|irinotecan|irinotecan
662259|NCT00403052|1018 ISS|1018 iss
662260|NCT00403052|combination therapy|combination therapy
662261|NCT00403039|Central Retinal Vein Occlusion|central retinal vein occlusion
662262|NCT00403026|Bevacizumab (Avastin)|bevacizumab (avastin)
662263|NCT00403026|Intravitreal injection|intravitreal injection
662264|NCT00403026|VEGF|vegf
662265|NCT00403026|CRVO|crvo
662266|NCT00403026|BRVO|brvo
662267|NCT00403026|PDR|pdr
662268|NCT00403026|CNVM|cnvm
662269|NCT00403013|nerve block/*methods|nerve block/*methods
662270|NCT00403013|Anesthetics, Local/pharmacokinetics|anesthetics, local/pharmacokinetics
662271|NCT00403013|*Brachial Plexus|*brachial plexus
662272|NCT00403000|recurrent prostate cancer|recurrent prostate cancer
662273|NCT00402987|sore throat|sore throat
662274|NCT00402987|acute pain|acute pain
662275|NCT00402974|osteocalcin|osteocalcin
662276|NCT00402974|vitamin K|vitamin k
662277|NCT00402974|carboxylation|carboxylation
662278|NCT00402974|healthy children|healthy children
662279|NCT00402961|Acupuncture|acupuncture
662280|NCT00402961|Post-Colectomy Ileus|post-colectomy ileus
662281|NCT00402961|Abdominal Surgery|abdominal surgery
662282|NCT00402961|Colon Surgery|colon surgery
662283|NCT00402948|High eosinophils level in sputum|high eosinophils level in sputum
662284|NCT00402935|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
662285|NCT00402935|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
662286|NCT00402935|sexual dysfunction and infertility|sexual dysfunction and infertility
662287|NCT00402935|sexuality and reproductive issues|sexuality and reproductive issues
662288|NCT00402935|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
662289|NCT00402935|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
662290|NCT00402935|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
662291|NCT00402935|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
662292|NCT00402935|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
662293|NCT00402935|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
662294|NCT00402935|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
662295|NCT00402935|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
662296|NCT00402935|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
662297|NCT00402935|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
662298|NCT00402935|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
662299|NCT00402935|secondary acute myeloid leukemia|secondary acute myeloid leukemia
662300|NCT00402935|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
662421|NCT00402597|Aspirin|aspirin
662301|NCT00402935|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
662302|NCT00402935|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
662303|NCT00402935|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
662304|NCT00402935|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
662305|NCT00402935|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
662306|NCT00402935|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
662307|NCT00402935|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
662308|NCT00402935|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
662309|NCT00402935|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
662310|NCT00402935|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
662311|NCT00402935|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
662312|NCT00402935|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
662313|NCT00402935|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
662314|NCT00402935|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
662315|NCT00402935|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
662316|NCT00402935|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
662317|NCT00402935|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
662318|NCT00402922|Coronary Heart Disease|coronary heart disease
662319|NCT00402909|Type 2 diabetes,|type 2 diabetes,
662320|NCT00402909|fasting glucose,|fasting glucose,
662321|NCT00402909|postprandial glucose,|postprandial glucose,
662322|NCT00402909|blood sugar,|blood sugar,
662323|NCT00402909|HbA1c,|hba1c,
662324|NCT00402909|insulin,|insulin,
662325|NCT00402909|glargine,|glargine,
662326|NCT00402909|metformin,|metformin,
662327|NCT00402909|thiazolidinedione|thiazolidinedione
662328|NCT00402896|Lung Cancer|lung cancer
662329|NCT00402896|Non-Small Cell Lung Cancer|non-small cell lung cancer
662330|NCT00402896|Pleural Effusion|pleural effusion
662331|NCT00402896|Indwelling Intrapleural Denver Catheter|indwelling intrapleural denver catheter
662332|NCT00402896|ZD6474|zd6474
662333|NCT00402896|Vascular Endothelial Growth Factor Receptor|vascular endothelial growth factor receptor
662334|NCT00402896|VEGFR|vegfr
662335|NCT00402896|Epidermal Growth factor Receptor|epidermal growth factor receptor
662336|NCT00402896|EGFR|egfr
662337|NCT00402896|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
662338|NCT00402857|Parenting Education|parenting education
662339|NCT00402857|Child, Preschool|child, preschool
662340|NCT00402857|Preventive Intervention|preventive intervention
662341|NCT00402857|Primary Health Care|primary health care
662342|NCT00402857|Pediatrics|pediatrics
662343|NCT00402857|Attention Deficit Disorders|attention deficit disorders
662344|NCT00402857|Oppositional Defiant Disorder|oppositional defiant disorder
662345|NCT00402857|Disruptive Behavior Disorder|disruptive behavior disorder
662346|NCT00402844|Multicenter|multicenter
662347|NCT00402844|Pelvic organ prolapse|pelvic organ prolapse
662348|NCT00402844|Prospective|prospective
662349|NCT00402844|Transvaginal mesh|transvaginal mesh
662350|NCT00402818|Moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
662351|NCT00402805|Influenza vaccine|influenza vaccine
662352|NCT00402805|Intradermal|intradermal
662353|NCT00402805|Lung transplantation|lung transplantation
662354|NCT00402792|Acute pain following bunionectomy surgery|acute pain following bunionectomy surgery
662355|NCT00402779|Oral Cancer|oral cancer
662356|NCT00402779|Oral IEN Lesion with LOH|oral ien lesion with loh
662357|NCT00402779|Loss of Heterozygosity|loss of heterozygosity
662358|NCT00402779|Intraepithelial Neoplasia|intraepithelial neoplasia
662359|NCT00402779|Placebo|placebo
662360|NCT00402779|Erlotinib|erlotinib
662361|NCT00402779|Tarceva|tarceva
662362|NCT00402779|OSI-774|osi-774
662363|NCT00402766|Mesothelioma|mesothelioma
662364|NCT00402766|Pleural Mesothelioma|pleural mesothelioma
662365|NCT00402766|Peritoneal Mesothelioma|peritoneal mesothelioma
662366|NCT00402766|PDGF-R|pdgf-r
662367|NCT00402766|Pemetrexed|pemetrexed
662368|NCT00402766|Alimta|alimta
662369|NCT00402766|Cisplatin|cisplatin
662370|NCT00402766|Imatinib Mesylate|imatinib mesylate
662371|NCT00402766|Gleevec|gleevec
662372|NCT00402766|Platinol|platinol
662373|NCT00402766|Platinol-AQ|platinol-aq
662374|NCT00402766|CDDP|cddp
662375|NCT00402766|Ly231514|ly231514
662376|NCT00402766|Multitargeted Antifolate|multitargeted antifolate
662377|NCT00402766|NSC-698037|nsc-698037
662378|NCT00402766|STI571|sti571
662379|NCT00402766|NSSC-716051|nssc-716051
662380|NCT00402753|Cancer, Exercise, Health Related Quality of Life, PBSCT|cancer, exercise, health related quality of life, pbsct
662381|NCT00402740|Carotid|carotid
662382|NCT00402740|Artery|artery
662383|NCT00402740|Disease|disease
662384|NCT00402740|Stent|stent
662385|NCT00402740|PROTECT|protect
662386|NCT00402740|XACT|xact
662387|NCT00402740|EMBOSHIELD|emboshield
662388|NCT00402714|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
662389|NCT00402701|walking|walking
662390|NCT00402701|motor activity|motor activity
662391|NCT00402701|students|students
662392|NCT00402701|schools|schools
662393|NCT00402701|transportation|transportation
662394|NCT00402701|motor vehicles|motor vehicles
662395|NCT00402688|Chronic Prostatitis|chronic prostatitis
662396|NCT00402688|Prostatitis|prostatitis
662397|NCT00402688|levofloxacin|levofloxacin
662398|NCT00402688|Levaquin|levaquin
662399|NCT00402675|NSTEMI|nstemi
662400|NCT00402675|infarction|infarction
662401|NCT00402675|treatment|treatment
662402|NCT00402675|percutaneous coronary intervention|percutaneous coronary intervention
662403|NCT00402675|non-ST-elevation myocardial infarction|non-st-elevation myocardial infarction
662404|NCT00402662|everolimus|everolimus
662405|NCT00402662|imatinib|imatinib
662406|NCT00402649|influenza, A/H5N1, avian influenza, vaccine|influenza, a/h5n1, avian influenza, vaccine
662407|NCT00402623|sarcoidosis|sarcoidosis
662408|NCT00402623|quercetin|quercetin
662409|NCT00402623|supplementation|supplementation
662410|NCT00402623|oxidative stress|oxidative stress
662411|NCT00402623|inflammation|inflammation
662412|NCT00402610|HIV|hiv
662413|NCT00402610|Tuberculosis|tuberculosis
662414|NCT00402610|Chemoprophylaxis|chemoprophylaxis
662415|NCT00402610|Anergy|anergy
662416|NCT00402610|AIDS|aids
662417|NCT00402597|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
662418|NCT00402597|Myocardial Ischemia|myocardial ischemia
662419|NCT00402597|Rivaroxaban (BAY59-7939)|rivaroxaban (bay59-7939)
662420|NCT00402597|Anti-platelet agents|anti-platelet agents
662422|NCT00402597|Thienopyridine|thienopyridine
662423|NCT00402597|Clopidogrel|clopidogrel
662424|NCT00402571|acetaminophen|acetaminophen
662425|NCT00402571|alcohol|alcohol
662426|NCT00402571|liver injury|liver injury
662427|NCT00402558|Acute Myeloid Leukemia|acute myeloid leukemia
662428|NCT00402558|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
662429|NCT00402558|Myelodysplastic Syndrome|myelodysplastic syndrome
662430|NCT00402558|Leukemia|leukemia
662431|NCT00402558|NK Cells|nk cells
662432|NCT00402558|Natural Killer Cells|natural killer cells
662433|NCT00402558|Fludarabine|fludarabine
662434|NCT00402558|Busulfan|busulfan
662435|NCT00402558|Thymoglobulin|thymoglobulin
662436|NCT00402558|AML|aml
662437|NCT00402558|CML|cml
662438|NCT00402558|MDS|mds
662439|NCT00402558|ATG|atg
662440|NCT00402558|Antithymocyte globulin|antithymocyte globulin
662441|NCT00402558|Busulfex|busulfex
662442|NCT00402558|Myleran®|myleran®
662443|NCT00402558|Fludarabine Phosphate|fludarabine phosphate
662444|NCT00402558|G-CSF|g-csf
662445|NCT00402558|Filgrastim|filgrastim
662446|NCT00402558|Neupogen|neupogen
662447|NCT00402558|Interleukin-2|interleukin-2
662448|NCT00402558|IL-2|il-2
662449|NCT00402558|Aldesleukin|aldesleukin
662450|NCT00402558|Proleukin|proleukin
662451|NCT00402558|Tacrolimus|tacrolimus
662452|NCT00402558|Prograf|prograf
662453|NCT00402558|Methotrexate|methotrexate
662454|NCT00402545|SCCHN|scchn
662455|NCT00402545|C-TPF|c-tpf
662456|NCT00402545|5-FU|5-fu
662457|NCT00402545|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
662458|NCT00402532|Lung Transplantation|lung transplantation
662459|NCT00402532|Immunosuppression|immunosuppression
662460|NCT00402532|Mortality|mortality
662461|NCT00402532|Graft rejection|graft rejection
662767|NCT00401349|Mif Alleles|mif alleles
662462|NCT00402532|Bronchiolitis obliterans|bronchiolitis obliterans
662463|NCT00402532|Opportunistic infections|opportunistic infections
662464|NCT00402532|Nephrotoxicity|nephrotoxicity
662465|NCT00402519|accelerated partial breast irradiation|accelerated partial breast irradiation
662466|NCT00402519|multicatheter brachytherapy|multicatheter brachytherapy
662467|NCT00402519|high dose rate brachytherapy|high dose rate brachytherapy
662468|NCT00402519|pulsed dose rate brachytherapy|pulsed dose rate brachytherapy
662469|NCT00402506|coronary|coronary
662470|NCT00402506|surgery|surgery
662471|NCT00402506|ischemia|ischemia
662472|NCT00402506|reperfusion injury|reperfusion injury
662473|NCT00402506|cardiac|cardiac
662474|NCT00402506|heart|heart
662475|NCT00402506|neurological|neurological
662476|NCT00402506|cardiopulmonary bypass|cardiopulmonary bypass
662477|NCT00402506|cardioprotection|cardioprotection
662478|NCT00402506|myocardium|myocardium
662479|NCT00402506|myocardial|myocardial
662480|NCT00402506|myocardial revascularization|myocardial revascularization
662481|NCT00402493|Glaucoma|glaucoma
662482|NCT00402493|Ocular Hypertension|ocular hypertension
662483|NCT00402493|Xalatan|xalatan
662484|NCT00402493|Alpahgan|alpahgan
662485|NCT00402493|Ibuprofen|ibuprofen
662486|NCT00402493|Non-Steroidal Anti-Inflammatory|non-steroidal anti-inflammatory
662487|NCT00402493|Brimonidine|brimonidine
662488|NCT00402493|Latanoprost|latanoprost
662489|NCT00402493|Eye Pressure|eye pressure
662490|NCT00402493|Intra-Ocular Pressure|intra-ocular pressure
662491|NCT00402480|Sickle Cell Anemia with Elevated TCD flow velocity|sickle cell anemia with elevated tcd flow velocity
662492|NCT00402467|Prevention of venous thromboembolism|prevention of venous thromboembolism
662493|NCT00402454|HIV|hiv
662494|NCT00402454|Tuberculosis|tuberculosis
662495|NCT00402454|Prophylaxis|prophylaxis
662496|NCT00402454|AIDS|aids
662497|NCT00402428|Chronic Hepatitis C|chronic hepatitis c
662498|NCT00402428|Hepatitis C|hepatitis c
662499|NCT00402428|CHC|chc
662500|NCT00402428|HepC|hepc
662501|NCT00402428|Genotype 1|genotype 1
662502|NCT00402428|Hepatitis|hepatitis
662503|NCT00402428|HCV|hcv
662504|NCT00402415|metastatic|metastatic
662505|NCT00402415|malignancy|malignancy
662506|NCT00402415|advanced solid tumors|advanced solid tumors
662507|NCT00402415|unresectable|unresectable
662508|NCT00402415|Solid Tumors|solid tumors
662509|NCT00402402|Tuberculin skin test|tuberculin skin test
662510|NCT00402402|Quantiferon-TB Gold assay|quantiferon-tb gold assay
662511|NCT00402402|Chronic liver disease|chronic liver disease
662512|NCT00402402|Liver transplantation|liver transplantation
662513|NCT00402402|Latent tuberculosis infection|latent tuberculosis infection
662514|NCT00402389|Perinatal Depression|perinatal depression
662515|NCT00402389|Postpartum Depression|postpartum depression
662516|NCT00402389|Omega-3 Fatty Acids|omega-3 fatty acids
662517|NCT00402389|Eicosapentaenoic Acid (EPA)|eicosapentaenoic acid (epa)
662518|NCT00402389|Docosahexaenoic Acid (DHA)|docosahexaenoic acid (dha)
662519|NCT00402389|Pregnancy|pregnancy
662520|NCT00402389|Psychotherapy|psychotherapy
662521|NCT00402376|End-stage heart failure|end-stage heart failure
662522|NCT00402376|heart failure;|heart failure;
662523|NCT00402376|ventricular assist device;|ventricular assist device;
662524|NCT00402376|statin;|statin;
662525|NCT00402376|heart transplantation;|heart transplantation;
662526|NCT00402376|myocardial function;|myocardial function;
662527|NCT00402376|mitochondrial respiratory function;|mitochondrial respiratory function;
662528|NCT00402363|Lovaza|lovaza
662529|NCT00402363|Omega-3 fatty acids|omega-3 fatty acids
662530|NCT00402363|Omacor|omacor
662531|NCT00402363|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
662532|NCT00402350|Staccato Fentanyl, Pharmacokinetics, Pharmacodynamics, inhaled fentanyl|staccato fentanyl, pharmacokinetics, pharmacodynamics, inhaled fentanyl
662533|NCT00402337|Constipation|constipation
662534|NCT00402337|Chronic Constipation|chronic constipation
662535|NCT00402337|Microbia|microbia
662536|NCT00402337|linaclotide|linaclotide
662537|NCT00402337|linaclotide acetate|linaclotide acetate
662538|NCT00402337|MD-1100|md-1100
662539|NCT00402324|Mixed episode associated with Bipolar I|mixed episode associated with bipolar i
662540|NCT00402311|Health Services for the Aged|health services for the aged
662541|NCT00402311|Geriatric Psychiatry|geriatric psychiatry
662542|NCT00402298|PTSD|ptsd
662543|NCT00402298|MDMA|mdma
662544|NCT00402298|psychotherapy|psychotherapy
662545|NCT00402298|Posttraumatic stress disorder|posttraumatic stress disorder
662546|NCT00402298|Israel|israel
662547|NCT00402285|adenocarcinoma of the prostate|adenocarcinoma of the prostate
662548|NCT00402285|stage I prostate cancer|stage i prostate cancer
662549|NCT00402285|stage IIB prostate cancer|stage iib prostate cancer
662550|NCT00402285|stage IIA prostate cancer|stage iia prostate cancer
662551|NCT00402272|drug eluting stents|drug eluting stents
662552|NCT00402272|stents|stents
662553|NCT00402272|Angioplasty|angioplasty
662554|NCT00402272|coronary artery disease|coronary artery disease
662555|NCT00402272|total coronary occlusion|total coronary occlusion
662556|NCT00402272|coronary artery restenosis|coronary artery restenosis
662557|NCT00402272|stent thrombosis|stent thrombosis
662558|NCT00402272|vascular disease|vascular disease
662559|NCT00402272|myocardial ischemia|myocardial ischemia
662560|NCT00402272|coronary artery stenosis|coronary artery stenosis
662561|NCT00402259|acute non-variceal upper gastrointestinal bleeding|acute non-variceal upper gastrointestinal bleeding
662562|NCT00402246|Randomized Controlled Trials|randomized controlled trials
662563|NCT00402246|Defibrillators|defibrillators
662564|NCT00402246|Remote Consultation|remote consultation
662565|NCT00402207|asthma|asthma
662566|NCT00402207|non-invasive inflammometry|non-invasive inflammometry
662567|NCT00402207|exhaled nitric oxide|exhaled nitric oxide
662568|NCT00402207|exhaled breath condensate|exhaled breath condensate
662569|NCT00402207|paediatric|paediatric
662570|NCT00402207|extrafine HFA-beclomethasone|extrafine hfa-beclomethasone
662571|NCT00402207|HFA-fluticasone|hfa-fluticasone
662572|NCT00402194|Obesity|obesity
662573|NCT00402194|Insulin resistance|insulin resistance
662574|NCT00402194|Impaired glucose tolerance|impaired glucose tolerance
662575|NCT00402194|pre-diabetes|pre-diabetes
662576|NCT00402181|Myeloma|myeloma
662577|NCT00402181|Intravenous|intravenous
662578|NCT00402181|Monoclonal antibody|monoclonal antibody
662579|NCT00402181|Siltuximab|siltuximab
662580|NCT00402181|Dexamethasone|dexamethasone
662581|NCT00402181|CNTO 328|cnto 328
662582|NCT00402155|electroretinogram|electroretinogram
662583|NCT00402155|visual evoked potential|visual evoked potential
662584|NCT00402155|contrast sensitivity|contrast sensitivity
662585|NCT00402142|HIV Infection|hiv infection
662586|NCT00402142|Dendritic cell vaccine|dendritic cell vaccine
662587|NCT00402142|Autologous virus|autologous virus
662588|NCT00402142|Heat inactivated|heat inactivated
662589|NCT00402142|HIV Therapeutic Vaccine|hiv therapeutic vaccine
662590|NCT00402129|Ethnic Skin|ethnic skin
662591|NCT00402129|Laser|laser
662592|NCT00402129|Photobiology|photobiology
662593|NCT00402129|Quality of life|quality of life
662594|NCT00402103|Hypertension, aliskiren, amlodipine, HCTZ, blood pressure|hypertension, aliskiren, amlodipine, hctz, blood pressure
662595|NCT00402090|thiopurines|thiopurines
662596|NCT00402090|thiopurine methyl transferase|thiopurine methyl transferase
662597|NCT00402090|toxicity|toxicity
662598|NCT00402090|pharmacogenomics|pharmacogenomics
662599|NCT00402077|overweight|overweight
662600|NCT00402077|obesity|obesity
662601|NCT00402077|pramlintide|pramlintide
662602|NCT00402077|Symlin|symlin
662603|NCT00402077|sibutramine|sibutramine
662604|NCT00402077|Meridia|meridia
662605|NCT00402077|phentermine|phentermine
662606|NCT00402077|Amylin|amylin
662607|NCT00402064|bisphosphonates|bisphosphonates
662608|NCT00402064|children|children
662609|NCT00402064|dental|dental
662610|NCT00402064|Osteomyelitis|osteomyelitis
662611|NCT00402064|medication|medication
662612|NCT00402025|Metastatic|metastatic
662613|NCT00402025|Pancreas|pancreas
662614|NCT00402025|Adenocarcinoma|adenocarcinoma
662615|NCT00402012|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
662617|NCT00401999|C-11 Raclopride|c-11 raclopride
662618|NCT00401999|Dopamine|dopamine
662619|NCT00401999|OPRM1|oprm1
662620|NCT00401999|Alcohol|alcohol
662621|NCT00401999|Healthy Volunteer|healthy volunteer
662622|NCT00401999|HV|hv
662623|NCT00401986|Refractory Asthma|refractory asthma
662624|NCT00401986|Bronchial Thermoplasty|bronchial thermoplasty
662625|NCT00401986|Alair System|alair system
662626|NCT00401986|RISA (Research in Severe Asthma)|risa (research in severe asthma)
662627|NCT00401960|Enterococcus|enterococcus
662628|NCT00401960|Daptomycin|daptomycin
662629|NCT00401960|Endocarditis|endocarditis
662630|NCT00401947|HCV|hcv
662631|NCT00401947|Chronic|chronic
662632|NCT00401947|Hepatitis|hepatitis
662633|NCT00401934|cholera, Vibrio cholerae, diarrhea, Bangladesh, children|cholera, vibrio cholerae, diarrhea, bangladesh, children
662634|NCT00401908|Acute gastrointestinal bleeding|acute gastrointestinal bleeding
662635|NCT00401908|Acute coronary syndrome|acute coronary syndrome
662636|NCT00401895|TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT|transjugular intrahepatic portosystemic shunt
662637|NCT00401895|Covered stents|covered stents
662638|NCT00401895|portal hypertension|portal hypertension
662639|NCT00401895|hepatic encephalopathy|hepatic encephalopathy
662640|NCT00401882|Cardiac arrest|cardiac arrest
662641|NCT00401882|Sudden Cardiac Death|sudden cardiac death
662642|NCT00401882|Ventricular Fibrillation|ventricular fibrillation
662643|NCT00401882|Pulseless Ventricular Tachycardia|pulseless ventricular tachycardia
662644|NCT00401882|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
662645|NCT00401869|vigor|vigor
662646|NCT00401869|function|function
662647|NCT00401869|well-being|well-being
662648|NCT00401869|hand-strength|hand-strength
662649|NCT00401869|surgery|surgery
662650|NCT00401869|anemia|anemia
662651|NCT00401869|transfusion|transfusion
662652|NCT00401869|strength|strength
662653|NCT00401869|quality-of-life|quality-of-life
662654|NCT00401856|Cardiomyopathy|cardiomyopathy
662655|NCT00401856|Fibrosis|fibrosis
662656|NCT00401856|Magnetic-Resonance|magnetic-resonance
662657|NCT00401856|Eplerenone|eplerenone
662658|NCT00401843|multiple myeloma|multiple myeloma
662659|NCT00401843|Monoclonal Antibody|monoclonal antibody
662660|NCT00401843|Intravenous|intravenous
662661|NCT00401843|refractory or relapsed multiple myeloma|refractory or relapsed multiple myeloma
662662|NCT00401843|velcade|velcade
662663|NCT00401843|bortezomib|bortezomib
662664|NCT00401830|Fibromyalgia Syndrome|fibromyalgia syndrome
662665|NCT00401830|Lacosamide|lacosamide
662666|NCT00401830|Vimpat|vimpat
662667|NCT00401830|Harkoseride|harkoseride
662668|NCT00401804|Multiple Myeloma|multiple myeloma
662669|NCT00401804|renal impairment|renal impairment
662670|NCT00401804|Velcade|velcade
662671|NCT00401778|Lung Cancer|lung cancer
662672|NCT00401765|Prostatic neoplasm|prostatic neoplasm
662673|NCT00401765|intravenous|intravenous
662674|NCT00401765|docetaxel|docetaxel
662675|NCT00401765|monoclonal antibody|monoclonal antibody
662676|NCT00401752|NSAID-associated gastric ulcer|nsaid-associated gastric ulcer
662677|NCT00401726|Major Depressive Disorder|major depressive disorder
662678|NCT00401726|Depression|depression
662680|NCT00401713|submacular membrane|submacular membrane
662681|NCT00401713|transplantation of RPE|transplantation of rpe
662682|NCT00401713|translocation of RPE and Choroid|translocation of rpe and choroid
662683|NCT00401700|influenza|influenza
662684|NCT00401700|influenza vaccine|influenza vaccine
662685|NCT00401700|pregnancy|pregnancy
662686|NCT00401687|Reduced Heart Function|reduced heart function
662687|NCT00401674|ovarian cancer|ovarian cancer
662688|NCT00401674|elderly|elderly
662689|NCT00401674|weekly chemotherapy|weekly chemotherapy
662690|NCT00401674|first-line|first-line
662691|NCT00401648|POC|poc
662692|NCT00401648|photosensitive|photosensitive
662693|NCT00401648|epileptic|epileptic
662694|NCT00401648|brivaracetam|brivaracetam
662695|NCT00401648|PPR|ppr
662696|NCT00401648|AED|aed
662697|NCT00401635|advanced|advanced
662698|NCT00401635|recurrent|recurrent
662699|NCT00401635|chemotherapy|chemotherapy
662700|NCT00401635|first-line|first-line
662701|NCT00401609|elderly|elderly
662702|NCT00401596|ALTO|alto
662703|NCT00401583|GW786034 (pazopanib) cytochrome P450 interaction|gw786034 (pazopanib) cytochrome p450 interaction
662704|NCT00401570|Antibody|antibody
662705|NCT00401570|Pancreas|pancreas
662706|NCT00401570|Carcinoma|carcinoma
662707|NCT00401570|Cancer|cancer
662708|NCT00401570|Pancreatic|pancreatic
662709|NCT00401557|Leishmaniasis, Leishmania (Viannia), Colombia|leishmaniasis, leishmania (viannia), colombia
662710|NCT00401544|anemia|anemia
662711|NCT00401544|chemotherapy induced anemia|chemotherapy induced anemia
662712|NCT00401544|darbepoetin alfa|darbepoetin alfa
662713|NCT00401544|cancer|cancer
662714|NCT00401531|Hepatitis B|hepatitis b
662715|NCT00401531|Polio|polio
662716|NCT00401531|Diphtheria|diphtheria
662717|NCT00401531|Pertussis|pertussis
662718|NCT00401531|H. influenzae type b|h. influenzae type b
662719|NCT00401518|Spinal Stenosis|spinal stenosis
662720|NCT00401518|Lumbar Spinal Stenosis|lumbar spinal stenosis
662721|NCT00401518|Facet Arthroplasty|facet arthroplasty
662722|NCT00401518|Posterior Fusion|posterior fusion
662723|NCT00401518|Facet Arthritis|facet arthritis
662724|NCT00401505|rubella|rubella
662725|NCT00401505|rubella vaccine|rubella vaccine
662726|NCT00401505|postpartum|postpartum
662727|NCT00401505|immunity|immunity
662728|NCT00401492|elderly|elderly
662729|NCT00401492|chemotherapy|chemotherapy
662730|NCT00401492|quality of life|quality of life
662731|NCT00401492|ADL|adl
662732|NCT00401492|toxicity|toxicity
662733|NCT00401479|GW427353|gw427353
662734|NCT00401479|b3-Adrenergic Receptor Agonist|b3-adrenergic receptor agonist
662735|NCT00401479|Irritable Bowel Syndrome (IBS)|irritable bowel syndrome (ibs)
662736|NCT00401479|pharmacokinetics|pharmacokinetics
662737|NCT00401479|tolerability|tolerability
662738|NCT00401479|gastrointestinal transit|gastrointestinal transit
662739|NCT00401466|prophylactic ICD therapy|prophylactic icd therapy
662740|NCT00401466|home monitoring|home monitoring
662741|NCT00401466|follow-up interval|follow-up interval
662742|NCT00401466|remote follow-up|remote follow-up
662743|NCT00401440|Medical termination of pregnancy|medical termination of pregnancy
662744|NCT00401440|Induction of abortion|induction of abortion
662745|NCT00401440|Misoprostol|misoprostol
662746|NCT00401440|MTP in second trimester|mtp in second trimester
662747|NCT00401440|400 microgram vaginal misoprostol|400 microgram vaginal misoprostol
662748|NCT00401427|HER2 overexpression|her2 overexpression
662749|NCT00401427|combination therapy|combination therapy
662750|NCT00401414|Warfarin|warfarin
662751|NCT00401414|Thrombosis|thrombosis
662752|NCT00401414|Genetics|genetics
662753|NCT00401414|Nomogram|nomogram
662754|NCT00401414|Pulmonary Embolism|pulmonary embolism
662755|NCT00401414|Deep Vein Thrombosis|deep vein thrombosis
662756|NCT00401414|Dosing|dosing
662757|NCT00401414|INR|inr
662758|NCT00401414|Anticoagulation|anticoagulation
662759|NCT00401414|Therapy|therapy
662760|NCT00401414|Orthopedic Surgery|orthopedic surgery
662761|NCT00401388|Chemo Insensitive Sarcomas|chemo insensitive sarcomas
662762|NCT00401388|Chondrosarcomas|chondrosarcomas
662763|NCT00401388|Alveolar soft part sarcomas|alveolar soft part sarcomas
662764|NCT00401388|Extra skeletal myxoid chondrosarcomas|extra skeletal myxoid chondrosarcomas
662765|NCT00401388|Perifosine|perifosine
662768|NCT00401349|Colombia|colombia
662769|NCT00401349|children|children
662770|NCT00401336|Magnetic resonance imaging|magnetic resonance imaging
662771|NCT00401336|Hepatic iron|hepatic iron
662772|NCT00401336|Steatosis|steatosis
662773|NCT00401297|Leishmaniasis|leishmaniasis
662774|NCT00401297|L. Viannia|l. viannia
662775|NCT00401297|Leishmania|leishmania
662776|NCT00401297|Colombia|colombia
662777|NCT00401258|IBS|ibs
662778|NCT00401258|irritable bowel syndrome|irritable bowel syndrome
662779|NCT00401258|irritable bowel|irritable bowel
662780|NCT00401206|dexmedetomidine|dexmedetomidine
662781|NCT00401206|sedation|sedation
662782|NCT00401206|bronchoscopy|bronchoscopy
662783|NCT00401206|COPD|copd
662784|NCT00401193|Menorrhagia|menorrhagia
662785|NCT00401193|Heavy Menstrual Bleeding|heavy menstrual bleeding
662786|NCT00401180|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
662787|NCT00401167|Alzheimer's disease|alzheimer's disease
662788|NCT00401167|behavioral and psychological symptoms of dementia|behavioral and psychological symptoms of dementia
662789|NCT00401167|severe Alzheimer's disease|severe alzheimer's disease
662790|NCT00401167|memantine|memantine
662791|NCT00401167|agitation|agitation
662792|NCT00401167|aggression|aggression
662793|NCT00401154|Spastic Diplegia|spastic diplegia
662794|NCT00401154|Cerebral Palsy|cerebral palsy
662795|NCT00401154|Children|children
662796|NCT00401154|Adolescents|adolescents
662797|NCT00401154|Strengthening|strengthening
662798|NCT00401154|Endurance|endurance
662799|NCT00401141|Systemic lupus|systemic lupus
662800|NCT00401141|B lymphocytes|b lymphocytes
662801|NCT00401141|transcriptomas|transcriptomas
662802|NCT00401128|clear cell renal cell carcinoma|clear cell renal cell carcinoma
662803|NCT00401128|recurrent renal cell cancer|recurrent renal cell cancer
662804|NCT00401128|papillary renal cell carcinoma|papillary renal cell carcinoma
662805|NCT00401128|stage IV renal cell cancer|stage iv renal cell cancer
662806|NCT00401102|self-injurious behavior|self-injurious behavior
662807|NCT00401102|depression|depression
662808|NCT00401102|adolescents|adolescents
662809|NCT00401102|psychotherapy|psychotherapy
662810|NCT00401089|negative symptoms schizophrenia|negative symptoms schizophrenia
662811|NCT00401089|Atypical antipsychotics|atypical antipsychotics
662812|NCT00401089|Neurocognition impairment|neurocognition impairment
662813|NCT00401089|obesity risk factor|obesity risk factor
662814|NCT00401089|Diabetes insulin resistance schizophrenia|diabetes insulin resistance schizophrenia
662815|NCT00401076|SA-001|sa-001
662816|NCT00401076|Pancreatic Exocrine Insufficiency|pancreatic exocrine insufficiency
662817|NCT00401076|Chronic Pancreatitis|chronic pancreatitis
662818|NCT00401076|Pancreatectomy|pancreatectomy
662819|NCT00401063|Cancer|cancer
662820|NCT00401063|Acupuncture|acupuncture
662821|NCT00401063|Cancer Pain|cancer pain
662822|NCT00401063|Quality of life|quality of life
662823|NCT00401050|patellofemoral pain syndrome|patellofemoral pain syndrome
662824|NCT00401050|chiropractic|chiropractic
662825|NCT00401050|knee pain|knee pain
662826|NCT00401050|chiropractic manipulation|chiropractic manipulation
662827|NCT00401050|Graston Instrument Soft Tissue Mobilization(GISTM)|graston instrument soft tissue mobilization(gistm)
662828|NCT00401024|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
662829|NCT00401024|adult oligodendroglioma|adult oligodendroglioma
662830|NCT00401024|adult anaplastic astrocytoma|adult anaplastic astrocytoma
662831|NCT00401024|adult giant cell glioblastoma|adult giant cell glioblastoma
662832|NCT00401024|adult gliosarcoma|adult gliosarcoma
662833|NCT00401024|recurrent adult brain tumor|recurrent adult brain tumor
662834|NCT00401024|adult brain stem glioma|adult brain stem glioma
662835|NCT00401024|adult mixed glioma|adult mixed glioma
662836|NCT00401024|adult glioblastoma|adult glioblastoma
662837|NCT00401024|adult pilocytic astrocytoma|adult pilocytic astrocytoma
662838|NCT00401024|adult diffuse astrocytoma|adult diffuse astrocytoma
662839|NCT00401024|adult anaplastic ependymoma|adult anaplastic ependymoma
662840|NCT00401024|adult ependymoma|adult ependymoma
662841|NCT00401024|adult myxopapillary ependymoma|adult myxopapillary ependymoma
662842|NCT00401024|adult subependymoma|adult subependymoma
662843|NCT00401024|adult pineal gland astrocytoma|adult pineal gland astrocytoma
662844|NCT00401024|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
662845|NCT00401011|Perifosine|perifosine
662846|NCT00401011|Bortezomib|bortezomib
662847|NCT00401011|Dexamethasone|dexamethasone
662848|NCT00401011|Relapsed or Refractory Multiple Myeloma|relapsed or refractory multiple myeloma
662849|NCT00400998|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
662850|NCT00400998|Quality of Life|quality of life
662851|NCT00400998|Efficacy|efficacy
662852|NCT00400998|Validation|validation
662853|NCT00400998|Fluticasone Propionate|fluticasone propionate
662854|NCT00400985|Heart Failure, Congestive|heart failure, congestive
662855|NCT00400985|Diagnostic|diagnostic
662856|NCT00400985|Ambulatory Monitoring|ambulatory monitoring
662857|NCT00400985|Intrathoracic Impedance|intrathoracic impedance
662858|NCT00400972|GlideScope|glidescope
662859|NCT00400972|videolaryngoscopy|videolaryngoscopy
662860|NCT00400972|intubation|intubation
662861|NCT00400972|nasal|nasal
663153|NCT00399841|Pain|pain
662862|NCT00400972|nasotracheal|nasotracheal
662863|NCT00400972|laryngoscopy|laryngoscopy
662864|NCT00400972|anesthesia|anesthesia
662865|NCT00400959|cell therapy|cell therapy
662866|NCT00400959|acute myocardial infarction|acute myocardial infarction
662867|NCT00400946|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
662868|NCT00400946|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
662869|NCT00400946|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
662870|NCT00400946|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
662871|NCT00400946|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
662872|NCT00400933|Psycho-education|psycho-education
662873|NCT00400933|Eating disorders|eating disorders
662874|NCT00400933|Personality disorders|personality disorders
662875|NCT00400933|Relatives and close friends|relatives and close friends
662876|NCT00400933|Caregiver burden|caregiver burden
662877|NCT00400907|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
662878|NCT00400907|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
662879|NCT00400907|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
662880|NCT00400907|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
662881|NCT00400907|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
662882|NCT00400907|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
662883|NCT00400894|prostate cancer|prostate cancer
662884|NCT00400894|annexin A3|annexin a3
662885|NCT00400894|early detection|early detection
662886|NCT00400894|exprimate urine|exprimate urine
662887|NCT00400881|mechanical ventilation|mechanical ventilation
662888|NCT00400881|weaning|weaning
662889|NCT00400881|respiratory failure|respiratory failure
662890|NCT00400881|spontaneous breathing trial|spontaneous breathing trial
662891|NCT00400868|rheumatoid arthritis, occupational therapy, joint protection|rheumatoid arthritis, occupational therapy, joint protection
662892|NCT00400855|Asthma|asthma
662893|NCT00400855|AMP challenge|amp challenge
662894|NCT00400842|SA-001|sa-001
662895|NCT00400842|Pancreatic Exocrine Insufficiency|pancreatic exocrine insufficiency
662896|NCT00400842|Pancreatectomy|pancreatectomy
662897|NCT00400816|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
662898|NCT00400816|adult mixed glioma|adult mixed glioma
662899|NCT00400803|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
662900|NCT00400803|Gemcitabine|gemcitabine
662901|NCT00400803|Carboplatin|carboplatin
662902|NCT00400803|Bevacizumab|bevacizumab
662903|NCT00400803|Biological therapy|biological therapy
662904|NCT00400803|Drug therapy|drug therapy
662905|NCT00400790|neurocognitive decline|neurocognitive decline
662906|NCT00400790|coronary artery bypass surgery|coronary artery bypass surgery
662907|NCT00400790|composite morbidity|composite morbidity
662908|NCT00400790|postoperative care cost|postoperative care cost
662909|NCT00400777|Valsartan|valsartan
662910|NCT00400777|hydrochlorothiazide|hydrochlorothiazide
662911|NCT00400777|amlodipine|amlodipine
662912|NCT00400777|hypertension|hypertension
662913|NCT00400777|high blood pressure|high blood pressure
662914|NCT00400764|NHL|nhl
662915|NCT00400764|Follicular NHL|follicular nhl
662916|NCT00400764|Rituxan|rituxan
662917|NCT00400764|Apo2L/TRAIL|apo2l/trail
662918|NCT00400751|Health-compromised smokers, family cessation intervention|health-compromised smokers, family cessation intervention
662919|NCT00400738|HIV-1 infection|hiv-1 infection
662920|NCT00400738|pharmacokinetics|pharmacokinetics
662921|NCT00400738|protease inhibitor|protease inhibitor
662922|NCT00400738|double boosted protease inhibitors|double boosted protease inhibitors
662923|NCT00400738|PIs|pis
662924|NCT00400738|Treatment Naive|treatment naive
662925|NCT00400725|maintenance|maintenance
662926|NCT00400725|scalp psoriasis|scalp psoriasis
662927|NCT00400725|Galderma|galderma
662928|NCT00400712|mobility|mobility
662929|NCT00400712|strength|strength
662930|NCT00400712|balance|balance
662931|NCT00400712|function|function
662932|NCT00400712|reintegration|reintegration
662933|NCT00400712|community|community
662934|NCT00400699|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
662935|NCT00400699|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
662936|NCT00400686|anemia|anemia
662937|NCT00400686|stage I multiple myeloma|stage i multiple myeloma
662938|NCT00400686|stage II multiple myeloma|stage ii multiple myeloma
662939|NCT00400686|stage III multiple myeloma|stage iii multiple myeloma
662940|NCT00400686|refractory multiple myeloma|refractory multiple myeloma
662941|NCT00400673|Acute myelogenous leukemia|acute myelogenous leukemia
662942|NCT00400673|Adult patients|adult patients
662943|NCT00400673|Cytogenetic risk class|cytogenetic risk class
662944|NCT00400673|Clinico-cytogenetic risk model|clinico-cytogenetic risk model
662945|NCT00400673|Risk-oriented therapy|risk-oriented therapy
662946|NCT00400660|GSK615915 asthma surfactant MDI|gsk615915 asthma surfactant mdi
662947|NCT00400647|kidney transplant|kidney transplant
662948|NCT00400647|enteric-coated mycophenolate sodium|enteric-coated mycophenolate sodium
662949|NCT00400647|quality of life|quality of life
662950|NCT00400647|gastrointestinal symptoms|gastrointestinal symptoms
662951|NCT00400621|acetaminophen|acetaminophen
662952|NCT00400621|alcohol|alcohol
662953|NCT00400621|liver injury|liver injury
662954|NCT00400608|pediatrics|pediatrics
662955|NCT00400608|ADVAIR Inhaler|advair inhaler
662956|NCT00400608|Asthma|asthma
662957|NCT00400608|ADVAIR DISKUS|advair diskus
662958|NCT00400595|peritonitis|peritonitis
662959|NCT00400595|catheter related infection|catheter related infection
662960|NCT00400595|exit site ointments|exit site ointments
662961|NCT00400595|mupirocin|mupirocin
662962|NCT00400595|Polysporin Triple|polysporin triple
662963|NCT00400582|Heart failure|heart failure
662964|NCT00400582|Gene polymorphism|gene polymorphism
662965|NCT00400582|Candesartan|candesartan
662966|NCT00400582|ACE inhibitors|ace inhibitors
662967|NCT00400582|BNP|bnp
662968|NCT00400582|Pharmacogenomics|pharmacogenomics
662969|NCT00400569|Sunitinib malate|sunitinib malate
662970|NCT00400569|SUTENT|sutent
662971|NCT00400569|SU011248|su011248
662972|NCT00400569|Soft tissue sarcoma|soft tissue sarcoma
662973|NCT00400569|Gastrointestinal stromal tumors (GIST)|gastrointestinal stromal tumors (gist)
662974|NCT00400569|MFH|mfh
662975|NCT00400569|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
662976|NCT00400569|Imatinib mesylate|imatinib mesylate
662977|NCT00400569|Phase II|phase ii
662978|NCT00400556|mobilization|mobilization
662979|NCT00400556|ATRA|atra
662980|NCT00400556|G-CSF|g-csf
662981|NCT00400556|filgrastim|filgrastim
662982|NCT00400556|retinoids|retinoids
662983|NCT00400556|stem cell mobilization|stem cell mobilization
662984|NCT00400556|hematopoietic stem and progenitor cells|hematopoietic stem and progenitor cells
662985|NCT00400543|obstructive sleep apnea|obstructive sleep apnea
662986|NCT00400543|arterial stiffness|arterial stiffness
662987|NCT00400543|atherosclerosis|atherosclerosis
662988|NCT00400543|CPAP|cpap
662989|NCT00400543|heart disease|heart disease
662990|NCT00400517|stage III prostate cancer|stage iii prostate cancer
662991|NCT00400517|stage II prostate cancer|stage ii prostate cancer
662992|NCT00400517|adenocarcinoma of the prostate|adenocarcinoma of the prostate
662993|NCT00400517|stage I prostate cancer|stage i prostate cancer
662994|NCT00400517|stage IV prostate cancer|stage iv prostate cancer
662995|NCT00400504|Thrombelastograph|thrombelastograph
662996|NCT00400504|Cancer|cancer
662997|NCT00400504|Thromboembolism|thromboembolism
662998|NCT00400504|Hypercoagulable|hypercoagulable
662999|NCT00400491|diabetes|diabetes
663000|NCT00400491|insulin|insulin
663001|NCT00400491|glycated hemoglobin|glycated hemoglobin
663002|NCT00400491|cholecalciferol|cholecalciferol
663003|NCT00400491|vitamin D|vitamin d
663004|NCT00400478|DLBCL|dlbcl
663005|NCT00400478|NHL 13|nhl 13
663006|NCT00400478|Rituximab|rituximab
663007|NCT00400478|maintenance|maintenance
663008|NCT00400465|thyroid|thyroid
663009|NCT00400465|thyroidectomy|thyroidectomy
663010|NCT00400465|dressing|dressing
663011|NCT00400452|wheelchair|wheelchair
663012|NCT00400452|skills|skills
663013|NCT00400452|long-term-care|long-term-care
663014|NCT00400452|caregivers|caregivers
663015|NCT00400426|Palliative radiotherapy|palliative radiotherapy
663016|NCT00400426|Recurrent|recurrent
663017|NCT00400426|Head and neck Neoplasm|head and neck neoplasm
663018|NCT00400426|Quality of life|quality of life
663019|NCT00400413|Neuropsychology|neuropsychology
663020|NCT00400413|fMRI|fmri
663021|NCT00400413|Reading|reading
663022|NCT00400413|Phonology|phonology
663023|NCT00400413|Deafness|deafness
663024|NCT00400400|RenalTransplantation|renaltransplantation
663025|NCT00400400|KidneyTransplantation|kidneytransplantation
663026|NCT00400400|MPA|mpa
663027|NCT00400400|EC-MPS|ec-mps
663028|NCT00400387|recurrent pregnancy loss|recurrent pregnancy loss
663029|NCT00400374|Head and Neck Cancer|head and neck cancer
663030|NCT00400335|Testosterone|testosterone
663031|NCT00400335|Men|men
663032|NCT00400335|Hypogonadism|hypogonadism
663033|NCT00400335|Dutasteride|dutasteride
663034|NCT00400335|DHT|dht
663035|NCT00400335|Androgen deficiency|androgen deficiency
663036|NCT00400322|glioblastoma multiforme|glioblastoma multiforme
663037|NCT00400322|cytomegalovirus infection|cytomegalovirus infection
663038|NCT00400322|antiviral treatment|antiviral treatment
663039|NCT00400322|valganciclovir|valganciclovir
663040|NCT00400270|Asthma|asthma
663041|NCT00400270|Randomised controlled trial|randomised controlled trial
663042|NCT00400270|Breathing exercises|breathing exercises
663043|NCT00400270|Relaxation exercises|relaxation exercises
663044|NCT00400270|Primary care|primary care
663045|NCT00400257|Heart Failure|heart failure
663046|NCT00400257|BNP|bnp
663047|NCT00400244|wheelchairs|wheelchairs
663048|NCT00400244|skills|skills
663049|NCT00400244|french|french
663050|NCT00400231|metabolic syndrome|metabolic syndrome
663051|NCT00400231|Triglycerides|triglycerides
663052|NCT00400231|Insulin Resistance|insulin resistance
663053|NCT00400231|inflammation|inflammation
663054|NCT00400231|Cardiovascular Disease|cardiovascular disease
663055|NCT00400231|Elevated triglycerides|elevated triglycerides
663056|NCT00400231|without diabetes|without diabetes
663057|NCT00400205|Squamous Cell Carcinoma of the Oral Cavity|squamous cell carcinoma of the oral cavity
663058|NCT00400192|Microchimerism|microchimerism
663059|NCT00400192|Injuries|injuries
663060|NCT00400192|Leukocytes|leukocytes
663061|NCT00400192|Immunologic Techniques|immunologic techniques
663062|NCT00400179|Gastric Cancer|gastric cancer
663063|NCT00400166|Peer support|peer support
663064|NCT00400166|Psychiatric disability|psychiatric disability
663065|NCT00400166|Mutual support|mutual support
663066|NCT00400166|Psychiatric Rehabilitation|psychiatric rehabilitation
663067|NCT00400140|Myopia, defocus|myopia, defocus
663068|NCT00400127|transfemoral amputee|transfemoral amputee
663069|NCT00400127|silicon suspension|silicon suspension
663070|NCT00400127|balance|balance
663071|NCT00400127|gait|gait
663072|NCT00400114|esophageal|esophageal
663073|NCT00400114|esophagus|esophagus
663074|NCT00400114|cancer|cancer
663075|NCT00400114|sutent|sutent
663076|NCT00400114|sunitinib|sunitinib
663077|NCT00400101|Malaria|malaria
663078|NCT00400101|Vaccine|vaccine
663079|NCT00400101|Plasmodium|plasmodium
663080|NCT00400101|falciparum|falciparum
663081|NCT00400101|Phase I|phase i
663082|NCT00400101|Peptide|peptide
663083|NCT00400101|Virosome|virosome
663084|NCT00400101|safety|safety
663085|NCT00400101|immunogenicity|immunogenicity
663086|NCT00400088|Major Depressive Disorder|major depressive disorder
663087|NCT00400088|Depression|depression
663088|NCT00400088|Bipolar Disorder|bipolar disorder
663089|NCT00400088|Manic Depressive Illness|manic depressive illness
663090|NCT00400088|Randomized Trial|randomized trial
663091|NCT00400088|Antidepressant Treatment|antidepressant treatment
663092|NCT00400088|Lithium Treatment|lithium treatment
663093|NCT00400075|Polyarteritis|polyarteritis
663094|NCT00400075|Vasculitis|vasculitis
663095|NCT00400075|Therapy|therapy
663096|NCT00400075|Cyclophosphamide|cyclophosphamide
663097|NCT00400075|Azathioprine|azathioprine
663098|NCT00400062|Critical care|critical care
663099|NCT00400062|delirium|delirium
663100|NCT00400062|long-term cognitive impairment|long-term cognitive impairment
663101|NCT00400062|mechanical ventilation|mechanical ventilation
663102|NCT00400062|critical illness|critical illness
663103|NCT00400062|dementia|dementia
663104|NCT00400062|aging|aging
663105|NCT00400062|sedatives and analgesics|sedatives and analgesics
663106|NCT00400036|cod protein|cod protein
663107|NCT00400036|insulin sensitivity|insulin sensitivity
663108|NCT00400036|plasma lipids|plasma lipids
663109|NCT00400036|glucose tolerance|glucose tolerance
663110|NCT00400036|plasma inflammatory markers|plasma inflammatory markers
663111|NCT00400036|skeletal muscle insulin signaling|skeletal muscle insulin signaling
663112|NCT00400036|type 2 diabetes|type 2 diabetes
663113|NCT00400036|humans|humans
663114|NCT00400023|Advanced Solid Tumors|advanced solid tumors
663115|NCT00400010|Expert system|expert system
663116|NCT00400010|Transtheoretical Model of Behavior Change|transtheoretical model of behavior change
663117|NCT00400010|Brief intervention|brief intervention
663118|NCT00400010|General hospital|general hospital
663119|NCT00399997|Exercise|exercise
663120|NCT00399997|Exercise referral|exercise referral
663121|NCT00399997|Lifestyle diseases|lifestyle diseases
663122|NCT00399997|Sedentary behavior|sedentary behavior
663123|NCT00399984|Continuing Medical Education|continuing medical education
663124|NCT00399971|Idiopathic Aplastic Anemia|idiopathic aplastic anemia
663125|NCT00399971|Has Failed Conventional Immunosuppressive Therapy|has failed conventional immunosuppressive therapy
663126|NCT00399971|Not Eligible For Bone Marrow Transplantation|not eligible for bone marrow transplantation
663127|NCT00399971|C15.378.071.085|c15.378.071.085
663128|NCT00399945|Cystic fibrosis, tobramycin, PARI eFlow, PARI LC Plus, nebulizer, pharmacoscintigraphy|cystic fibrosis, tobramycin, pari eflow, pari lc plus, nebulizer, pharmacoscintigraphy
663129|NCT00399932|metabolic syndrome|metabolic syndrome
663130|NCT00399932|insulin resistance|insulin resistance
663131|NCT00399932|NASH|nash
663132|NCT00399932|hepatic fibrosis|hepatic fibrosis
663133|NCT00399932|Fibroscan|fibroscan
663134|NCT00399932|elastography by MRI|elastography by mri
663135|NCT00399919|Perhipheral Artery Disease|perhipheral artery disease
663136|NCT00399919|Claudication|claudication
663137|NCT00399919|Exercise|exercise
663138|NCT00399919|Intermittent Claudication due to Peripheral Artery Disease|intermittent claudication due to peripheral artery disease
663139|NCT00399893|Childhood obesity|childhood obesity
663140|NCT00399893|Prader-Willi Syndrome|prader-willi syndrome
663141|NCT00399893|Octreotide|octreotide
663142|NCT00399893|Ghrelin|ghrelin
663143|NCT00399893|Weight loss|weight loss
663144|NCT00399893|Body composition|body composition
663145|NCT00399893|Energy expenditure|energy expenditure
663146|NCT00399880|Clinical Trial|clinical trial
663147|NCT00399880|Behavioral/Social|behavioral/social
663148|NCT00399880|Cardiovascular Disease|cardiovascular disease
663149|NCT00399880|Risk Factors/Analysis|risk factors/analysis
663150|NCT00399867|multiple myeloma|multiple myeloma
663151|NCT00399867|refractory|refractory
663152|NCT00399867|cell adhesion mediated drug resistance|cell adhesion mediated drug resistance
663154|NCT00399841|Chronic Pain|chronic pain
663155|NCT00399841|Neurostimulation|neurostimulation
663156|NCT00399815|Chronic viral hepatitis C|chronic viral hepatitis c
663157|NCT00399815|HCV RNA|hcv rna
663158|NCT00399815|Fibroscan|fibroscan
663159|NCT00399815|Fibrotest|fibrotest
663160|NCT00399815|hepatic elastography by MRI|hepatic elastography by mri
663161|NCT00399789|Non-Small-Cell Lung|non-small-cell lung
663162|NCT00399789|Perifosine|perifosine
663163|NCT00399776|bone mineral|bone mineral
663164|NCT00399776|antipsychotic therapy|antipsychotic therapy
663165|NCT00399776|bone mineral accrual|bone mineral accrual
663166|NCT00399776|bone mineral content|bone mineral content
663167|NCT00399763|Adolescent|adolescent
663168|NCT00399763|ADHD|adhd
663169|NCT00399763|SUD|sud
663170|NCT00399737|ACE activity|ace activity
663171|NCT00399737|Fermented milk peptides|fermented milk peptides
663172|NCT00399737|Healthy male volunteers|healthy male volunteers
663173|NCT00399698|Severe conduct problems|severe conduct problems
663174|NCT00399698|Risperidone|risperidone
663175|NCT00399698|Risperdal|risperdal
663176|NCT00399685|HIV|hiv
663177|NCT00399672|HCV|hcv
663178|NCT00399672|injection drug users|injection drug users
663179|NCT00399672|ribavirin|ribavirin
663180|NCT00399672|pegylated interferon|pegylated interferon
663181|NCT00399672|illicit drug users|illicit drug users
663182|NCT00399659|Opioid, constipation, tegaserod|opioid, constipation, tegaserod
663183|NCT00399633|VIP|vip
663184|NCT00399633|PACAP|pacap
663185|NCT00399633|CGRP|cgrp
663186|NCT00399633|Prostanoids|prostanoids
663187|NCT00399620|Periodontitis|periodontitis
663188|NCT00399620|Diabetes|diabetes
663189|NCT00399620|Gingival crevicular fluid|gingival crevicular fluid
663190|NCT00399620|GCF|gcf
663191|NCT00399620|Saliva|saliva
663192|NCT00399620|Chromogranin|chromogranin
663193|NCT00399620|Electrophorèse|electrophorèse
663194|NCT00399620|Western Blot|western blot
663195|NCT00399620|RT-HPLC|rt-hplc
663196|NCT00399607|colonic neoplasms|colonic neoplasms
663197|NCT00399607|colorectal adenoma|colorectal adenoma
663198|NCT00399607|calcium|calcium
663199|NCT00399607|vitamin D|vitamin d
663200|NCT00399594|Mechanical dyssynchrony|mechanical dyssynchrony
663201|NCT00399594|Biventricular pacing|biventricular pacing
663202|NCT00399594|Cardiac resynchronization therapy|cardiac resynchronization therapy
663203|NCT00399581|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
663204|NCT00399581|Acute Lung Injury|acute lung injury
663205|NCT00399581|Mechanical Ventilation|mechanical ventilation
663206|NCT00399581|Lung|lung
663207|NCT00399568|Pain|pain
663208|NCT00399568|Gynecologic|gynecologic
663209|NCT00399568|IV Acetaminophen|iv acetaminophen
663210|NCT00399568|Postoperative|postoperative
663211|NCT00399568|Analgesic|analgesic
663212|NCT00399555|Single Ventricle|single ventricle
663213|NCT00399555|Hypoplastic Left Heart|hypoplastic left heart
663214|NCT00399555|Developmental|developmental
663215|NCT00399542|Irritable Bowel Syndrome With Constipation|irritable bowel syndrome with constipation
663216|NCT00399529|Stage IV HER-2/neu overexpressing breast cancer|stage iv her-2/neu overexpressing breast cancer
663217|NCT00399516|Pain|pain
663218|NCT00399516|Neurostimulation|neurostimulation
663219|NCT00399516|Back pain|back pain
663220|NCT00399516|Chronic Pain|chronic pain
663221|NCT00399503|Noninvasive assessment|noninvasive assessment
663222|NCT00399503|Combined parameter|combined parameter
663223|NCT00399503|Holter|holter
663224|NCT00399490|Monoclonal antibody|monoclonal antibody
663225|NCT00399464|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
663226|NCT00399464|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists
663227|NCT00399464|alfuzosin|alfuzosin
663228|NCT00399451|Sleep Apnea,Obstructive|sleep apnea,obstructive
663229|NCT00399451|apnea-hypopnea index (AHI)|apnea-hypopnea index (ahi)
663230|NCT00399451|polidocanol|polidocanol
663231|NCT00399451|sclerotherapy|sclerotherapy
663232|NCT00399451|pharynges|pharynges
663233|NCT00399438|Diarrhea-predominant irritable bowel syndrome|diarrhea-predominant irritable bowel syndrome
663234|NCT00399425|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight
663235|NCT00399425|Bemiparin|bemiparin
663236|NCT00399425|Foot Ulcer, Diabetic|foot ulcer, diabetic
663237|NCT00399425|Diabetic Angiopathies|diabetic angiopathies
663238|NCT00399425|Primary Health Care|primary health care
663239|NCT00399412|S-ICD|s-icd
663240|NCT00399412|ICD|icd
663241|NCT00399412|ECG signals|ecg signals
663242|NCT00399412|Resting|resting
663243|NCT00399399|Churg-Strauss|churg-strauss
663244|NCT00399399|Vasculitis|vasculitis
663245|NCT00399399|Therapy|therapy
663246|NCT00399399|Cyclophosphamide|cyclophosphamide
663247|NCT00399399|Azathioprine|azathioprine
663248|NCT00399386|S ICD|s icd
663249|NCT00399386|ICD|icd
663250|NCT00399386|Ablation|ablation
663251|NCT00399386|EP study|ep study
663252|NCT00399386|Paediatric|paediatric
663253|NCT00399386|ECG|ecg
663254|NCT00399373|disease management|disease management
663255|NCT00399373|substance abuse|substance abuse
663256|NCT00399360|HIV|hiv
663257|NCT00399360|Metabolic Syndrome|metabolic syndrome
663258|NCT00399360|Lifestyle Modification|lifestyle modification
663259|NCT00399360|Metformin|metformin
663260|NCT00399360|Treatment Experienced|treatment experienced
663261|NCT00399347|Diabetes Mellitus, prevalence , Ethiopians Jews, Israel|diabetes mellitus, prevalence , ethiopians jews, israel
663262|NCT00399334|Schizophrenia|schizophrenia
663263|NCT00399334|Schizoaffective|schizoaffective
663264|NCT00399334|relapse|relapse
663265|NCT00399334|risk factors|risk factors
663266|NCT00399334|Observational study|observational study
663267|NCT00399334|Antipsychotic medication|antipsychotic medication
663268|NCT00399321|Post menopause women receiving adjuvant care|post menopause women receiving adjuvant care
663269|NCT00399308|wound|wound
663270|NCT00399308|leg|leg
663271|NCT00399308|venous|venous
663272|NCT00399308|chronic|chronic
663273|NCT00399308|wound healing|wound healing
663274|NCT00399295|Analgesia|analgesia
663275|NCT00399282|Rheumatoid arthritis|rheumatoid arthritis
663276|NCT00399282|Health related quality of life|health related quality of life
663277|NCT00399282|Omega 3 fatty acids|omega 3 fatty acids
663278|NCT00399282|Vitamin E|vitamin e
663279|NCT00399269|Anemia|anemia
663280|NCT00399256|contrast-induced nephropathy|contrast-induced nephropathy
663281|NCT00399256|Acetylcysteine|acetylcysteine
663282|NCT00399256|Zinc|zinc
663283|NCT00399256|Cystatin C|cystatin c
663284|NCT00399256|Creatinine|creatinine
663285|NCT00399243|cluster headache|cluster headache
663286|NCT00399243|sumatriptan|sumatriptan
663287|NCT00399217|subcutaneous ICD|subcutaneous icd
663288|NCT00399217|ICD|icd
663289|NCT00399217|DFT|dft
663290|NCT00399217|Pacing threshold|pacing threshold
663291|NCT00399217|Polarity|polarity
663292|NCT00399191|anemia|anemia
663293|NCT00399191|iron deficiency anemia|iron deficiency anemia
663294|NCT00399191|iron deficiency|iron deficiency
663295|NCT00399191|absorption|absorption
663296|NCT00399191|iron absorption|iron absorption
663297|NCT00399191|iron uptake|iron uptake
663298|NCT00399178|Osteoarthritis|osteoarthritis
663299|NCT00399178|Norspan versus Tramadol|norspan versus tramadol
663300|NCT00399178|Randomised|randomised
663301|NCT00399178|Efficacy and safety|efficacy and safety
663302|NCT00399178|OA pain of the hip and/or knee|oa pain of the hip and/or knee
663303|NCT00399165|Oral Contraception for Men|oral contraception for men
663304|NCT00399165|Contraceptive agent|contraceptive agent
663305|NCT00399152|Perifosine|perifosine
663306|NCT00399152|Sunitinib Malate|sunitinib malate
663307|NCT00399152|Renal cancer|renal cancer
663308|NCT00399152|GIST|gist
663309|NCT00399152|advanced cancers|advanced cancers
663310|NCT00399074|Sickle Cell anemia|sickle cell anemia
663311|NCT00399074|Malaria|malaria
663312|NCT00399074|Presumptive treatment|presumptive treatment
663313|NCT00399074|Sulfadoxine- pyrimethamine|sulfadoxine- pyrimethamine
663314|NCT00399074|Children|children
663315|NCT00399074|Uganda|uganda
663316|NCT00399048|Pain|pain
663317|NCT00399048|Osteoarthritis|osteoarthritis
663318|NCT00399048|knee Osteoarthritis|knee osteoarthritis
663319|NCT00399048|hip Osteoarthritis .|hip osteoarthritis .
663320|NCT00399035|Colorectal Cancer|colorectal cancer
663321|NCT00399035|Cediranib|cediranib
663322|NCT00399035|RECENTIN|recentin
663323|NCT00399009|Circular stapling devices|circular stapling devices
663324|NCT00399009|anastomotic leak|anastomotic leak
663325|NCT00399009|anastomotic dehiscence|anastomotic dehiscence
663326|NCT00399009|rectal cancer|rectal cancer
663327|NCT00398996|antiretroviral therapy|antiretroviral therapy
663328|NCT00398996|HIV|hiv
663329|NCT00398996|Opportunistic infections|opportunistic infections
663330|NCT00398996|CD4|cd4
663331|NCT00398996|Viral load|viral load
663332|NCT00398996|TB/HIV co infection|tb/hiv co infection
663333|NCT00398996|Treatment Naive|treatment naive
663334|NCT00398983|Acute Myelogenous Leukemia|acute myelogenous leukemia
663335|NCT00398983|AML|aml
663336|NCT00398983|Remission|remission
663337|NCT00398983|Decitabine|decitabine
663338|NCT00398983|Maintenance Therapy|maintenance therapy
663339|NCT00398970|Endobronchial ultrasonography|endobronchial ultrasonography
663340|NCT00398970|Fluoroscopy|fluoroscopy
663341|NCT00398970|Guide sheath|guide sheath
663342|NCT00398970|Peripheral pulmonary lesion|peripheral pulmonary lesion
663343|NCT00398970|Transbronchial biopsy|transbronchial biopsy
663344|NCT00398957|Analgesia|analgesia
663345|NCT00398944|Guideline based decision support system, Hypertension, Diabetes|guideline based decision support system, hypertension, diabetes
663346|NCT00398905|Prevention of venous thromboembolism|prevention of venous thromboembolism
663347|NCT00398892|Type 2 diabetes mellitus|type 2 diabetes mellitus
663348|NCT00398892|Glycaemic control|glycaemic control
663349|NCT00398892|Lipoic acid|lipoic acid
663350|NCT00398892|Diabetic nephropathy|diabetic nephropathy
663351|NCT00398879|Capecitabine|capecitabine
663352|NCT00398866|Hyaluronan|hyaluronan
663353|NCT00398866|Carpometacarpal|carpometacarpal
663354|NCT00398866|Outcomes|outcomes
663355|NCT00398866|Carpometacarpal Joints|carpometacarpal joints
663356|NCT00398853|insulin|insulin
663357|NCT00398853|glucose|glucose
663358|NCT00398853|chromium|chromium
663359|NCT00398840|Cancer|cancer
663360|NCT00398840|Solid Tumors|solid tumors
663361|NCT00398840|advanced solid tumors|advanced solid tumors
663362|NCT00398827|American Society of Anesthesiologists (ASA)|american society of anesthesiologists (asa)
663363|NCT00398827|Observer's Assessment of Alertness Scale (OAA/S)|observer's assessment of alertness scale (oaa/s)
663364|NCT00398827|Aldrete Scoring System|aldrete scoring system
663365|NCT00398827|Surgery or procedure using monitored care anesthesia|surgery or procedure using monitored care anesthesia
663366|NCT00398827|Surgery or procedure at least 30 minutes in duration|surgery or procedure at least 30 minutes in duration
663367|NCT00398814|Perifosine|perifosine
663368|NCT00398814|Sorafenib|sorafenib
663369|NCT00398814|Renal cancer|renal cancer
663370|NCT00398814|Hepatocellular cancer|hepatocellular cancer
663371|NCT00398814|other advanced solid tumors|other advanced solid tumors
663372|NCT00398801|gastroparesis|gastroparesis
663373|NCT00398788|Pain|pain
663374|NCT00398775|procalcitonin guided antibiotic discontinuation|procalcitonin guided antibiotic discontinuation
663375|NCT00398775|fever of unknown origin|fever of unknown origin
663376|NCT00398749|Anemia|anemia
663377|NCT00398749|Neoplasms|neoplasms
663378|NCT00398749|Antineoplastic agents|antineoplastic agents
663379|NCT00398749|Chemotherapy|chemotherapy
663380|NCT00398749|Efficacy|efficacy
663381|NCT00398749|Epoetin alfa|epoetin alfa
663382|NCT00398736|Presence of severe sepsis and septic shock, mechanical ventilation|presence of severe sepsis and septic shock, mechanical ventilation
663383|NCT00398723|Narrowband UBV Phototherapy|narrowband ubv phototherapy
663384|NCT00398723|Skin biopsies|skin biopsies
663385|NCT00398710|Waldenström's Macroglobulinemia|waldenström's macroglobulinemia
663386|NCT00398710|Perifosine|perifosine
663387|NCT00398697|perifosine|perifosine
663388|NCT00398697|gemcitabine|gemcitabine
663389|NCT00398684|Thailand|thailand
663390|NCT00398684|Developing countries|developing countries
663391|NCT00398684|prophylaxis|prophylaxis
663392|NCT00398684|mother to child transmission|mother to child transmission
663393|NCT00398684|HIV-1|hiv-1
663394|NCT00398684|HIV-1 infection|hiv-1 infection
663395|NCT00398684|HIV Seronegativity|hiv seronegativity
663396|NCT00398671|primary successful cardio-pulmonary resuscitation|primary successful cardio-pulmonary resuscitation
663397|NCT00398671|pre-hospital setting|pre-hospital setting
663398|NCT00398658|Endophthalmitis|endophthalmitis
663399|NCT00398658|Post-traumatic Endophthalmitis|post-traumatic endophthalmitis
663400|NCT00398658|Bacterial Endophthalmitis|bacterial endophthalmitis
663401|NCT00398658|Prophylaxis of Endophthalmitis|prophylaxis of endophthalmitis
663402|NCT00398658|Intra Ocular Injection of antibiotics|intra ocular injection of antibiotics
663403|NCT00398645|GW685698X|gw685698x
663404|NCT00398645|Adults|adults
663405|NCT00398645|Pharmacokinetics|pharmacokinetics
663406|NCT00398645|Pharmacogenetics|pharmacogenetics
663407|NCT00398645|Asthma|asthma
663408|NCT00398645|Adolescents|adolescents
663409|NCT00398593|Adherence with therapy|adherence with therapy
663410|NCT00398593|Adherence enhancing intervention|adherence enhancing intervention
663411|NCT00398593|Nonadherence|nonadherence
663412|NCT00398593|Ulcerative colitis|ulcerative colitis
663413|NCT00398580|DHT|dht
663414|NCT00398580|Testosterone|testosterone
663415|NCT00398580|Hypogonadism|hypogonadism
663416|NCT00398580|Dutasteride|dutasteride
663417|NCT00398580|Androgen deficiency|androgen deficiency
663418|NCT00398567|HKI-272|hki-272
663419|NCT00398567|neratinib|neratinib
663420|NCT00398567|trastuzumab|trastuzumab
663421|NCT00398567|breast cancer|breast cancer
663422|NCT00398567|Nerlynx|nerlynx
663423|NCT00398567|PB-272|pb-272
663424|NCT00398567|HER2|her2
663425|NCT00398554|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
663426|NCT00398554|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
663427|NCT00398554|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
663428|NCT00398554|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
663429|NCT00398554|childhood lymphocyte depletion Hodgkin lymphoma|childhood lymphocyte depletion hodgkin lymphoma
663430|NCT00398554|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
663431|NCT00398554|childhood nodular sclerosis Hodgkin lymphoma|childhood nodular sclerosis hodgkin lymphoma
663432|NCT00398528|Multiple Sclerosis|multiple sclerosis
663433|NCT00398528|Disease Modifying Therapy|disease modifying therapy
663434|NCT00398489|stage IIIA breast cancer|stage iiia breast cancer
663435|NCT00398489|stage IIIB breast cancer|stage iiib breast cancer
663436|NCT00398489|stage IIIC breast cancer|stage iiic breast cancer
663437|NCT00398489|stage II breast cancer|stage ii breast cancer
663438|NCT00398489|inflammatory breast cancer|inflammatory breast cancer
663439|NCT00398476|taste|taste
663440|NCT00398476|questionnaire|questionnaire
663441|NCT00398476|preference|preference
663442|NCT00398476|attributes|attributes
663443|NCT00398476|odor|odor
663444|NCT00398476|after taste|after taste
663445|NCT00398476|scent|scent
663446|NCT00398463|tirofiban|tirofiban
663447|NCT00398463|aspirin resistance|aspirin resistance
663448|NCT00398463|clopidogrel resistance|clopidogrel resistance
663449|NCT00398450|recurrent melanoma|recurrent melanoma
663450|NCT00398450|stage IV melanoma|stage iv melanoma
663916|NCT00396630|Shedding|shedding
663451|NCT00398437|tumors metastatic to brain|tumors metastatic to brain
663452|NCT00398437|stage IV breast cancer|stage iv breast cancer
663453|NCT00398424|Impaired Hepatic Function|impaired hepatic function
663454|NCT00398411|prophylaxis|prophylaxis
663455|NCT00398411|bacteremia|bacteremia
663456|NCT00398411|moxifloxacin|moxifloxacin
663457|NCT00398411|stem cell transplantation|stem cell transplantation
663458|NCT00398411|Hodgkin disease|hodgkin disease
663459|NCT00398411|non-Hodgkin lymphoma|non-hodgkin lymphoma
663460|NCT00398411|multiple myeloma|multiple myeloma
663461|NCT00398411|solid tumor|solid tumor
663462|NCT00398411|autologous stem cell transplantation|autologous stem cell transplantation
663463|NCT00398398|gastric cancer|gastric cancer
663464|NCT00398398|chemotherapy|chemotherapy
663465|NCT00398398|cetuximab|cetuximab
663466|NCT00398398|capecitabine|capecitabine
663467|NCT00398398|oxaliplatin|oxaliplatin
663468|NCT00398385|squamous cell lung cancer|squamous cell lung cancer
663469|NCT00398385|adenocarcinoma of the lung|adenocarcinoma of the lung
663470|NCT00398385|adenosquamous cell lung cancer|adenosquamous cell lung cancer
663471|NCT00398385|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
663472|NCT00398385|large cell lung cancer|large cell lung cancer
663473|NCT00398385|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
663474|NCT00398385|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
663475|NCT00398385|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
663476|NCT00398359|Obesity|obesity
663477|NCT00398359|Overweight|overweight
663478|NCT00398359|Children|children
663479|NCT00398359|Behavioral|behavioral
663480|NCT00398359|Motivational|motivational
663481|NCT00398359|Family|family
663482|NCT00398359|Primary care|primary care
663483|NCT00398333|Colorectal Neoplasms|colorectal neoplasms
663484|NCT00398333|Eicosapentaenoic Acid|eicosapentaenoic acid
663485|NCT00398333|Quality of Life|quality of life
663486|NCT00398333|Nutritional Status|nutritional status
663487|NCT00398307|Renal Impairment|renal impairment
663488|NCT00398281|prostate cancer|prostate cancer
663489|NCT00398268|Fracture|fracture
663490|NCT00398268|Forearm|forearm
663491|NCT00398268|Distal|distal
663492|NCT00398268|Child|child
663493|NCT00398268|Treatment|treatment
663494|NCT00398255|arthritis|arthritis
663495|NCT00398255|self management|self management
663496|NCT00398255|patient education|patient education
663497|NCT00398242|fracture|fracture
663498|NCT00398242|forearm|forearm
663499|NCT00398242|midshaft|midshaft
663500|NCT00398242|child|child
663501|NCT00398242|treatment|treatment
663502|NCT00398229|In-Vitro Fertilization|in-vitro fertilization
663503|NCT00398229|human chorionic gonadotropin|human chorionic gonadotropin
663504|NCT00398229|frozen-thawed embryo transfer|frozen-thawed embryo transfer
663505|NCT00398229|implantation rate|implantation rate
663506|NCT00398216|Anti-coagulant|anti-coagulant
663507|NCT00398216|hip replacement|hip replacement
663508|NCT00398216|hip replacement surgery|hip replacement surgery
663509|NCT00398216|unilateral hip replacement surgery|unilateral hip replacement surgery
663510|NCT00398216|DeepVein Thrombosis|deepvein thrombosis
663511|NCT00398216|Venous Thromboembolism|venous thromboembolism
663512|NCT00398216|pulmonary embolism|pulmonary embolism
663513|NCT00398216|Prevention of Blood Clots|prevention of blood clots
663514|NCT00398203|NaviAid™ BGE Device|naviaid™ bge device
663515|NCT00398203|Small Intestine|small intestine
663516|NCT00398203|Intestinal Diseases|intestinal diseases
663517|NCT00398190|Smoking|smoking
663518|NCT00398190|Tobacco use disorder|tobacco use disorder
663519|NCT00398138|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
663520|NCT00398138|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
663521|NCT00398138|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
663522|NCT00398138|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
663523|NCT00398138|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
663524|NCT00398138|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
663525|NCT00398138|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
663526|NCT00398138|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
663527|NCT00398138|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
663528|NCT00398138|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
663529|NCT00398138|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
663530|NCT00398138|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
663531|NCT00398138|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
663532|NCT00398138|advanced malignant mesothelioma|advanced malignant mesothelioma
663533|NCT00398138|recurrent malignant mesothelioma|recurrent malignant mesothelioma
663534|NCT00398138|primary peritoneal cavity cancer|primary peritoneal cavity cancer
663535|NCT00398125|GSK364735|gsk364735
663536|NCT00398125|HIV-1|hiv-1
663537|NCT00398125|integrase inhibitor|integrase inhibitor
663772|NCT00397137|haemorrhoidectomy|haemorrhoidectomy
663629|NCT00397735|chorioamnionitis|chorioamnionitis
663538|NCT00398086|Metastatic Pancreatic Cancer, Abraxane, Gemcitabine|metastatic pancreatic cancer, abraxane, gemcitabine
663539|NCT00398073|stage II melanoma|stage ii melanoma
663540|NCT00398073|stage III melanoma|stage iii melanoma
663541|NCT00398073|stage IV melanoma|stage iv melanoma
663542|NCT00398073|recurrent melanoma|recurrent melanoma
663543|NCT00398073|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
663544|NCT00398073|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
663545|NCT00398073|recurrent intraocular melanoma|recurrent intraocular melanoma
663546|NCT00398073|metastatic intraocular melanoma|metastatic intraocular melanoma
663547|NCT00398060|life-style counseling|life-style counseling
663548|NCT00398060|type 2 diabetes|type 2 diabetes
663549|NCT00398060|prediabetes|prediabetes
663550|NCT00398060|physical activity|physical activity
663551|NCT00398060|diet|diet
663552|NCT00398060|cognitive-behavioral|cognitive-behavioral
663553|NCT00398047|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
663554|NCT00398047|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
663555|NCT00398047|refractory anemia with excess blasts|refractory anemia with excess blasts
663556|NCT00398047|refractory anemia|refractory anemia
663557|NCT00398047|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
663558|NCT00398047|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
663559|NCT00398047|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
663560|NCT00398047|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
663561|NCT00398034|opioids|opioids
663562|NCT00398034|pain|pain
663563|NCT00398034|hypogonadism|hypogonadism
663564|NCT00398034|depression|depression
663565|NCT00398034|fatigue|fatigue
663566|NCT00398034|cognition|cognition
663567|NCT00398034|libido|libido
663568|NCT00398021|constipation|constipation
663569|NCT00398021|bowel habits|bowel habits
663570|NCT00398008|Buprenorphine|buprenorphine
663571|NCT00398008|Naltrexone|naltrexone
663572|NCT00398008|HIV risk reduction behavior|hiv risk reduction behavior
663573|NCT00398008|Counseling|counseling
663574|NCT00398008|HIV Seronegativity|hiv seronegativity
663575|NCT00397995|Fracture|fracture
663576|NCT00397995|Forearm|forearm
663577|NCT00397995|Distal|distal
663578|NCT00397995|Child|child
663579|NCT00397995|Treatment|treatment
663580|NCT00397969|colon cancer|colon cancer
663581|NCT00397969|rectal cancer|rectal cancer
663582|NCT00397969|precancerous condition|precancerous condition
663583|NCT00397943|Tuberculosis|tuberculosis
663584|NCT00397930|cancer-related sleep disturbance|cancer-related sleep disturbance
663585|NCT00397930|fatigue|fatigue
663586|NCT00397930|sleep disorders|sleep disorders
663587|NCT00397904|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
663588|NCT00397904|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
663589|NCT00397904|recurrent esophageal cancer|recurrent esophageal cancer
663590|NCT00397904|recurrent gastric cancer|recurrent gastric cancer
663591|NCT00397904|adenocarcinoma of the stomach|adenocarcinoma of the stomach
663592|NCT00397904|stage IV esophageal cancer|stage iv esophageal cancer
663593|NCT00397904|stage IV gastric cancer|stage iv gastric cancer
663594|NCT00397865|Obesity|obesity
663595|NCT00397865|Overweight|overweight
663596|NCT00397852|Fracture|fracture
663597|NCT00397852|Forearm|forearm
663598|NCT00397852|Distal|distal
663599|NCT00397852|Child|child
663600|NCT00397852|Treatment|treatment
663601|NCT00397839|male osteoporosis|male osteoporosis
663602|NCT00397839|osteoporosis|osteoporosis
663603|NCT00397839|bisphonates|bisphonates
663604|NCT00397839|bone|bone
663605|NCT00397800|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
663606|NCT00397800|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
663607|NCT00397800|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
663608|NCT00397800|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
663609|NCT00397800|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
663610|NCT00397800|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
663611|NCT00397800|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
663612|NCT00397800|splenic marginal zone lymphoma|splenic marginal zone lymphoma
663613|NCT00397774|Palliative care|palliative care
663614|NCT00397774|Physical exercise|physical exercise
663615|NCT00397774|Physical function|physical function
663616|NCT00397761|inflammatory breast cancer|inflammatory breast cancer
663617|NCT00397761|stage II breast cancer|stage ii breast cancer
663618|NCT00397761|stage IIIA breast cancer|stage iiia breast cancer
663619|NCT00397761|stage IIIB breast cancer|stage iiib breast cancer
663620|NCT00397748|Phospholipase A2|phospholipase a2
663621|NCT00397748|D2 Receptors|d2 receptors
663622|NCT00397748|Apomorphine|apomorphine
663623|NCT00397748|Trimethobenzamide|trimethobenzamide
663624|NCT00397748|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
663625|NCT00397748|ADHD|adhd
663626|NCT00397748|Healthy Volunteer|healthy volunteer
663627|NCT00397748|HV|hv
663628|NCT00397735|pregnancy|pregnancy
663630|NCT00397735|preterm labor|preterm labor
663631|NCT00397735|preterm premature rupture of the membranes|preterm premature rupture of the membranes
663632|NCT00397735|Intra-amniotic infection|intra-amniotic infection
663633|NCT00397735|Intra-amniotic inflammation|intra-amniotic inflammation
663634|NCT00397722|safety|safety
663635|NCT00397722|outpatients with a diagnosis of Social Anxiety disorder (SocAD).|outpatients with a diagnosis of social anxiety disorder (socad).
663636|NCT00397722|effectiveness|effectiveness
663637|NCT00397709|Latent tuberculosis infection.|latent tuberculosis infection.
663638|NCT00397709|Isoniazid.|isoniazid.
663639|NCT00397709|Rifampin.|rifampin.
663640|NCT00397709|Clinical trial.|clinical trial.
663641|NCT00397709|treatment of latent tuberculosis infection|treatment of latent tuberculosis infection
663642|NCT00397696|Parkinson|parkinson
663643|NCT00397696|imaging|imaging
663644|NCT00397696|nicotinic receptors|nicotinic receptors
663645|NCT00397657|carotid intima media thickness|carotid intima media thickness
663646|NCT00397657|atherosclerosis|atherosclerosis
663647|NCT00397657|niacin|niacin
663648|NCT00397657|coronary heart disease|coronary heart disease
663649|NCT00397657|HDL-C|hdl-c
663650|NCT00397657|LDL-C|ldl-c
663651|NCT00397644|pediatrician|pediatrician
663652|NCT00397644|well-child care visit|well-child care visit
663653|NCT00397644|low-income children|low-income children
663654|NCT00397644|family psychosocial problem|family psychosocial problem
663655|NCT00397605|bipolar|bipolar
663656|NCT00397605|therapeutic potential|therapeutic potential
663657|NCT00397605|neurocognitive performance|neurocognitive performance
663658|NCT00397605|cannabinoids|cannabinoids
663659|NCT00397592|Growth Hormone|growth hormone
663660|NCT00397592|Cardiovascular System|cardiovascular system
663661|NCT00397592|Endothelial Progenitor Cells|endothelial progenitor cells
663662|NCT00397579|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
663663|NCT00397579|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
663664|NCT00397579|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
663665|NCT00397579|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
663666|NCT00397579|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
663667|NCT00397579|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
663668|NCT00397579|secondary acute myeloid leukemia|secondary acute myeloid leukemia
663669|NCT00397579|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
663670|NCT00397579|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
663671|NCT00397579|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
663672|NCT00397579|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
663673|NCT00397579|blastic plasmacytoid dendritic cell neoplasm|blastic plasmacytoid dendritic cell neoplasm
663674|NCT00397579|plasmacytoid dendritic cell leukemia|plasmacytoid dendritic cell leukemia
663675|NCT00397579|CD123+|cd123+
663676|NCT00397566|HIV|hiv
663677|NCT00397566|Treatment Experienced|treatment experienced
663678|NCT00397540|HBV DNA|hbv dna
663679|NCT00397540|HCC|hcc
663680|NCT00397540|recurrence|recurrence
663681|NCT00397540|PEIT|peit
663682|NCT00397540|RFTA|rfta
663683|NCT00397514|Biventricular pacing|biventricular pacing
663684|NCT00397514|Congenital heart disease|congenital heart disease
663685|NCT00397514|Tissue Doppler echocardiography|tissue doppler echocardiography
663686|NCT00397501|cognitive/functional effects|cognitive/functional effects
663687|NCT00397501|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
663688|NCT00397501|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
663689|NCT00397501|recurrent breast cancer|recurrent breast cancer
663690|NCT00397501|stage IV breast cancer|stage iv breast cancer
663691|NCT00397501|adult tumors metastatic to brain|adult tumors metastatic to brain
663692|NCT00397488|recurrent bladder cancer|recurrent bladder cancer
663693|NCT00397488|stage IV bladder cancer|stage iv bladder cancer
663694|NCT00397488|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
663695|NCT00397488|anterior urethral cancer|anterior urethral cancer
663696|NCT00397488|posterior urethral cancer|posterior urethral cancer
663697|NCT00397488|recurrent urethral cancer|recurrent urethral cancer
663698|NCT00397488|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
663699|NCT00397488|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
663700|NCT00397488|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
663701|NCT00397462|Osteoporosis|osteoporosis
663702|NCT00397462|Sarcopenia|sarcopenia
663703|NCT00397462|Calf muscle pump|calf muscle pump
663704|NCT00397462|Venous insufficiency|venous insufficiency
663705|NCT00397462|DEXA|dexa
663706|NCT00397462|Soleus muscle|soleus muscle
663707|NCT00397462|APG|apg
663708|NCT00397449|Malaria, malaria vaccine, randomised, safety, immunogenicity|malaria, malaria vaccine, randomised, safety, immunogenicity
663709|NCT00397423|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
663710|NCT00397423|Granulocyte Colony Stimulating Factor|granulocyte colony stimulating factor
663812|NCT00396981|GDC|gdc
663711|NCT00397423|Randomized Control Trial Study|randomized control trial study
663712|NCT00397410|hip protectors|hip protectors
663713|NCT00397410|uptake and adherence|uptake and adherence
663714|NCT00397410|Nursing home residents|nursing home residents
663715|NCT00397410|efficacy|efficacy
663716|NCT00397410|prevention|prevention
663717|NCT00397397|Urinary Calculi|urinary calculi
663718|NCT00397397|Rowatinex|rowatinex
663719|NCT00397397|Alfuzosin|alfuzosin
663720|NCT00397397|Drug Therapy|drug therapy
663721|NCT00397358|Peritoneal Dialysis|peritoneal dialysis
663722|NCT00397358|Hypertriglyceridemia|hypertriglyceridemia
663723|NCT00397358|Extraneal(7.5% icodextrin)Peritoneal Dialysis Solution|extraneal(7.5% icodextrin)peritoneal dialysis solution
663724|NCT00397345|Renal|renal
663725|NCT00397345|TroVax|trovax
663726|NCT00397345|survival|survival
663727|NCT00397345|metastatic|metastatic
663728|NCT00397345|Kidney|kidney
663729|NCT00397345|cancer|cancer
663730|NCT00397345|immunotherapy|immunotherapy
663731|NCT00397345|Locally advanced or metastatic, measurable, histologically proven clear cell renal carcinoma.|locally advanced or metastatic, measurable, histologically proven clear cell renal carcinoma.
663732|NCT00397332|GVHD|gvhd
663733|NCT00397319|Growth Hormone|growth hormone
663734|NCT00397319|Cardiovascular System|cardiovascular system
663735|NCT00397293|AT101|at101
663736|NCT00397293|AT-101|at-101
663737|NCT00397293|cancer|cancer
663738|NCT00397293|lung|lung
663739|NCT00397293|small-cell|small-cell
663740|NCT00397293|topotecan|topotecan
663741|NCT00397280|Neutrophil|neutrophil
663742|NCT00397280|Immunity|immunity
663743|NCT00397280|Signal Transduction|signal transduction
663744|NCT00397280|Lipopolysaccharide|lipopolysaccharide
663745|NCT00397280|Cholesterol|cholesterol
663746|NCT00397280|Healthy Volunteer|healthy volunteer
663747|NCT00397280|HV|hv
663748|NCT00397267|Dyspnea|dyspnea
663749|NCT00397267|Cough|cough
663750|NCT00397254|Migraine|migraine
663751|NCT00397254|rizatriptan|rizatriptan
663752|NCT00397228|Parkinson|parkinson
663753|NCT00397228|imaging|imaging
663754|NCT00397228|dopamine transporter|dopamine transporter
663755|NCT00397215|H5N1|h5n1
663756|NCT00397215|influenza|influenza
663757|NCT00397215|vaccine|vaccine
663758|NCT00397202|Menstruation|menstruation
663759|NCT00397189|Primary insomnia as defined by DSM IV criteria|primary insomnia as defined by dsm iv criteria
663760|NCT00397163|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
663761|NCT00397163|Remote ischemic preconditioning|remote ischemic preconditioning
663762|NCT00397163|Troponin-T|troponin-t
663763|NCT00397150|Infant Nutrition [G06.696.259.750]|infant nutrition [g06.696.259.750]
663764|NCT00397150|Infant Care [N02.421.088.120] +|infant care [n02.421.088.120] +
663765|NCT00397150|Diarrhea, Infantile [C23.888.821.214.500]|diarrhea, infantile [c23.888.821.214.500]
663766|NCT00397150|Child Health Services [N02.421.143.130] +|child health services [n02.421.143.130] +
663767|NCT00397150|Counseling [N02.421.143.303]|counseling [n02.421.143.303]
663768|NCT00397150|Growth [G07.574.249] +|growth [g07.574.249] +
663769|NCT00397150|Micronutrients [D11.430]|micronutrients [d11.430]
663770|NCT00397150|Breast Feeding [G06.696.259.750.500]|breast feeding [g06.696.259.750.500]
663771|NCT00397137|Symptomatic haemorrhoids|symptomatic haemorrhoids
663773|NCT00397137|stapled anopexy|stapled anopexy
663774|NCT00397111|Morphometry|morphometry
663775|NCT00397111|BOLD|bold
663776|NCT00397111|fMRI|fmri
663777|NCT00397111|Spectrometry|spectrometry
663778|NCT00397111|Relaxometry|relaxometry
663779|NCT00397111|Healthy Volunteer|healthy volunteer
663781|NCT00397098|Anxiety disorders, Relapse prevention|anxiety disorders, relapse prevention
663782|NCT00397072|Glioblastoma recurrent,temozolomide, epothilone|glioblastoma recurrent,temozolomide, epothilone
663783|NCT00397059|Escitalopram|escitalopram
663784|NCT00397059|Pharmacokinetics|pharmacokinetics
663785|NCT00397059|Pharmacodynamics|pharmacodynamics
663786|NCT00397059|CYP2C19|cyp2c19
663787|NCT00397059|Pupillometry|pupillometry
663788|NCT00397059|healthy volunteers|healthy volunteers
663789|NCT00397046|Advanced Malignant Solid Tumors|advanced malignant solid tumors
663790|NCT00397046|HKI-272|hki-272
663791|NCT00397046|Neratinib|neratinib
663792|NCT00397046|Nerlynx|nerlynx
663793|NCT00397033|Schizoaffective Disorder|schizoaffective disorder
663794|NCT00397033|antipsychotic|antipsychotic
663795|NCT00397033|paliperidone|paliperidone
663796|NCT00397033|placebo|placebo
663797|NCT00397020|quetiapine|quetiapine
663798|NCT00397020|divalproex|divalproex
663799|NCT00397007|tinnitus|tinnitus
663800|NCT00397007|biofeedback|biofeedback
663801|NCT00397007|psychophysiological reactivity|psychophysiological reactivity
663802|NCT00397007|intervention|intervention
663803|NCT00396994|biomechanics|biomechanics
663804|NCT00396994|osteogenesis|osteogenesis
663805|NCT00396994|osteoporosis|osteoporosis
663806|NCT00396994|bone regeneration|bone regeneration
663807|NCT00396981|Intracranial saccular aneurysms|intracranial saccular aneurysms
663808|NCT00396981|Endovascular coiling therapy|endovascular coiling therapy
663809|NCT00396981|Retreatment|retreatment
663810|NCT00396981|Raymond scale|raymond scale
663811|NCT00396981|Matrix|matrix
663813|NCT00396981|Guglielmi Detachable Coil|guglielmi detachable coil
663814|NCT00396968|AMD3100|amd3100
663815|NCT00396968|Acute Myelogenous Leukemai|acute myelogenous leukemai
663816|NCT00396968|Myelodysplastic Syndromes|myelodysplastic syndromes
663817|NCT00396968|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
663818|NCT00396955|osteoarthritis|osteoarthritis
663819|NCT00396955|arthritis|arthritis
663820|NCT00396955|pain|pain
663821|NCT00396942|Electroencephalogram (EEG)|electroencephalogram (eeg)
663822|NCT00396942|Nerve Conduction Study|nerve conduction study
663823|NCT00396942|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
663824|NCT00396942|Motor Evoked Potential|motor evoked potential
663825|NCT00396942|Parkinson Disease|parkinson disease
663826|NCT00396942|PD|pd
663827|NCT00396942|Healthy Volunteer|healthy volunteer
663828|NCT00396942|HV|hv
663829|NCT00396929|Paclitaxel|paclitaxel
663830|NCT00396929|Restenosis|restenosis
663831|NCT00396929|Stent|stent
663832|NCT00396929|Intracoronary Dosis|intracoronary dosis
663833|NCT00396929|Paclitaxel-eluting Stent|paclitaxel-eluting stent
663834|NCT00396916|cancer patients|cancer patients
663835|NCT00396903|Anaesthetic techniques|anaesthetic techniques
663836|NCT00396903|epidural catheters|epidural catheters
663837|NCT00396903|paraesthesia|paraesthesia
663838|NCT00396903|side effects.|side effects.
663839|NCT00396890|Theta Burst Stimulation|theta burst stimulation
663840|NCT00396890|Repetitive TMS (rTMS)|repetitive tms (rtms)
663841|NCT00396890|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
663842|NCT00396890|Primary Motor Cortex|primary motor cortex
663843|NCT00396890|Interhemispheric Disinhibition|interhemispheric disinhibition
663844|NCT00396890|Healthy Volunteer|healthy volunteer
663845|NCT00396890|HV|hv
663846|NCT00396877|cyanotic congenital heart disease|cyanotic congenital heart disease
663847|NCT00396877|shunt palliation|shunt palliation
663848|NCT00396877|thrombosis|thrombosis
663849|NCT00396877|clopidogrel|clopidogrel
663850|NCT00396864|cutaneous lymphoma|cutaneous lymphoma
663851|NCT00396864|marginal zone lymphoma|marginal zone lymphoma
663852|NCT00396825|Care giving|care giving
663853|NCT00396825|Alzheimer's Disease|alzheimer's disease
663854|NCT00396825|Stress management|stress management
663855|NCT00396812|Autoimmune disease|autoimmune disease
663856|NCT00396812|Biologic response modifiers|biologic response modifiers
663857|NCT00396812|Disease-modifying antirheumatic drugs (DMARDS)|disease-modifying antirheumatic drugs (dmards)
663858|NCT00396812|Immune system|immune system
663859|NCT00396812|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
663860|NCT00396812|Rituximab (anti-CD20 monoclonal antibodies)|rituximab (anti-cd20 monoclonal antibodies)
663861|NCT00396786|Prevention of venous thromboembolism|prevention of venous thromboembolism
663862|NCT00396773|electrocoagulation,pregnancy,brian waves|electrocoagulation,pregnancy,brian waves
663863|NCT00396760|cardiac surgery|cardiac surgery
663864|NCT00396760|blood transfusion|blood transfusion
663865|NCT00396760|antifibrinolytics|antifibrinolytics
663866|NCT00396760|aprotinin|aprotinin
663867|NCT00396760|tranexamic acid|tranexamic acid
663868|NCT00396747|Early rheumatoid arthritis,|early rheumatoid arthritis,
663869|NCT00396747|glucocorticoids,|glucocorticoids,
663870|NCT00396747|pulse therapy,|pulse therapy,
663871|NCT00396747|infliximab,|infliximab,
663872|NCT00396747|TNF blockade|tnf blockade
663873|NCT00396734|Imaging|imaging
663874|NCT00396734|cocaine|cocaine
663875|NCT00396734|methadone|methadone
663876|NCT00396734|craving|craving
663877|NCT00396734|PET|pet
663878|NCT00396734|FDG|fdg
663879|NCT00396734|D2|d2
663880|NCT00396734|Modafinil|modafinil
663881|NCT00396734|Topiramate|topiramate
663882|NCT00396721|Nephropathy, IGA|nephropathy, iga
663883|NCT00396721|Pilot trial|pilot trial
663884|NCT00396721|Sirolimus|sirolimus
663885|NCT00396721|Rapamune|rapamune
663886|NCT00396708|Robotics|robotics
663887|NCT00396708|Rehabilitation|rehabilitation
663888|NCT00396708|Arm|arm
663889|NCT00396708|Stroke|stroke
663890|NCT00396708|Weakness|weakness
663891|NCT00396708|Outpatient|outpatient
663892|NCT00396708|Chronic|chronic
663893|NCT00396695|PTSD, traumatic memory|ptsd, traumatic memory
663894|NCT00396682|HCC|hcc
663895|NCT00396682|T cell|t cell
663896|NCT00396669|Nicotine|nicotine
663897|NCT00396669|Dopamine|dopamine
663898|NCT00396669|Imaging|imaging
663899|NCT00396669|Raclopride|raclopride
663900|NCT00396669|Addiction|addiction
663901|NCT00396669|Genetics|genetics
663902|NCT00396656|hypertension|hypertension
663903|NCT00396656|valsartan|valsartan
663904|NCT00396656|atenolol|atenolol
663905|NCT00396656|hydrochlorothiazide|hydrochlorothiazide
663906|NCT00396656|microcirculation|microcirculation
663907|NCT00396656|arterial compliance|arterial compliance
663908|NCT00396656|pulse wave analysis|pulse wave analysis
663909|NCT00396643|Ultra-High Risk|ultra-high risk
663910|NCT00396643|Psychosis|psychosis
663911|NCT00396643|Schizophrenia|schizophrenia
663912|NCT00396643|Omega-3 fatty acids|omega-3 fatty acids
663913|NCT00396643|RCT|rct
663914|NCT00396630|Transmission|transmission
663915|NCT00396630|Gastroenteritis|gastroenteritis
663917|NCT00396630|rotavirus|rotavirus
663918|NCT00396630|HRV vaccine|hrv vaccine
663919|NCT00396617|Laryngeal or pharyngo-laryngeal's carcinoma,|laryngeal or pharyngo-laryngeal's carcinoma,
663920|NCT00396617|voice prosthesis tracheooesophageal shunt,|voice prosthesis tracheooesophageal shunt,
663921|NCT00396617|titanium beads,|titanium beads,
663922|NCT00396617|cellular colonization|cellular colonization
663923|NCT00396617|Laryngeal or pharyngo-laryngeal's carcinoma|laryngeal or pharyngo-laryngeal's carcinoma
663924|NCT00396604|indacaterol|indacaterol
663925|NCT00396604|long acting beta agonist|long acting beta agonist
663926|NCT00396591|Ovarian cancer|ovarian cancer
663927|NCT00396591|malignant ascites|malignant ascites
663928|NCT00396591|angiogenesis|angiogenesis
663929|NCT00396591|angiogenesis inhibition|angiogenesis inhibition
663930|NCT00396591|VEGF-Trap fusion recombinant protein|vegf-trap fusion recombinant protein
663931|NCT00396578|aerosolized antibiotics|aerosolized antibiotics
663932|NCT00396578|ventilator associated pneumonia|ventilator associated pneumonia
663933|NCT00396578|clinical pulmonary infection score|clinical pulmonary infection score
663934|NCT00396578|bacterial resistance|bacterial resistance
663935|NCT00396565|Schizophrenia|schizophrenia
663936|NCT00396565|JNS007ER|jns007er
663937|NCT00396565|Positive and Negative Syndrome Scale (PANSS)|positive and negative syndrome scale (panss)
663938|NCT00396565|Paliperidone|paliperidone
663939|NCT00396565|Extended Release Osmotic Controlled-Release Oral Delivery System (OROS) paliperidone|extended release osmotic controlled-release oral delivery system (oros) paliperidone
663940|NCT00396552|refractory transcranial magnetic stimulation|refractory transcranial magnetic stimulation
663941|NCT00396552|obsessive compulsive disorder|obsessive compulsive disorder
663942|NCT00396552|randomized|randomized
663943|NCT00396552|placebo-controlled|placebo-controlled
663944|NCT00396552|double-blind|double-blind
663945|NCT00396526|Nonsevere pneumonia|nonsevere pneumonia
663946|NCT00396526|treatment|treatment
663947|NCT00396526|underfives|underfives
663948|NCT00396526|children|children
663949|NCT00396526|Community|community
663950|NCT00396526|India|india
663951|NCT00396513|PCOS|pcos
663952|NCT00396513|Statin|statin
663953|NCT00396513|Metformin|metformin
663954|NCT00396513|Testosterone|testosterone
663955|NCT00396513|Menstrual cycle|menstrual cycle
663956|NCT00396513|Lipids|lipids
663957|NCT00396500|Deworming|deworming
663958|NCT00396500|Malnutrition|malnutrition
663959|NCT00396500|children|children
663960|NCT00396500|Community|community
663961|NCT00396500|India|india
663962|NCT00396487|Metastatic colorectal cancer|metastatic colorectal cancer
663963|NCT00396487|tailored treatment|tailored treatment
663964|NCT00396487|genetic markers|genetic markers
663965|NCT00396487|gene polymorphism|gene polymorphism
663966|NCT00396487|chemotherapy|chemotherapy
663967|NCT00396474|Small for gestational age, Insulin Sensitivity Index, growth hormone treatment|small for gestational age, insulin sensitivity index, growth hormone treatment
663968|NCT00396461|Critical Illness|critical illness
663969|NCT00396461|Fat Emulsions, Intravenous|fat emulsions, intravenous
663970|NCT00396461|Superinfection|superinfection
663971|NCT00396461|Parenteral Nutrition|parenteral nutrition
663972|NCT00396435|anaemia|anaemia
663973|NCT00396435|renal transplantation|renal transplantation
663974|NCT00396435|kidney failure|kidney failure
663975|NCT00396422|psoriasis|psoriasis
663976|NCT00396422|skin|skin
663977|NCT00396422|auto immune|auto immune
663978|NCT00396396|Creatinine clearance|creatinine clearance
663979|NCT00396396|Acetylcysteine|acetylcysteine
663980|NCT00396383|Multiple Myeloma|multiple myeloma
663981|NCT00396383|Stem cell mobilization|stem cell mobilization
663982|NCT00396383|apheresis|apheresis
663983|NCT00396370|tuberculosis, Bacillus Calmette-Guérin, parent protocol|tuberculosis, bacillus calmette-guérin, parent protocol
663984|NCT00396357|Type 2 diabetes|type 2 diabetes
663985|NCT00396357|vildagliptin|vildagliptin
663986|NCT00396357|hemoglobin A1c|hemoglobin a1c
663987|NCT00396357|metformin|metformin
663988|NCT00396344|Systemic sepsis|systemic sepsis
663989|NCT00396331|Multiple Myeloma|multiple myeloma
663990|NCT00396331|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
663991|NCT00396331|autologous transplantation|autologous transplantation
663992|NCT00396331|AMD3100|amd3100
663993|NCT00396331|stem cell mobilization|stem cell mobilization
663994|NCT00396331|plerixafor|plerixafor
663995|NCT00396318|TNKase|tnkase
663996|NCT00396318|CVA|cva
663997|NCT00396318|CVAD|cvad
663998|NCT00396318|Central venous access catheter|central venous access catheter
663999|NCT00396305|Influenza, vaccine, efficacy, elderly|influenza, vaccine, efficacy, elderly
664000|NCT00396292|Anemia|anemia
664001|NCT00396292|postpartum|postpartum
664002|NCT00396292|Postpartum anemia|postpartum anemia
664003|NCT00396279|Giant Cell Tumor of Bone|giant cell tumor of bone
664004|NCT00396266|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
664005|NCT00396266|Multiple Myeloma|multiple myeloma
664006|NCT00396266|stem cell mobilization|stem cell mobilization
664007|NCT00396266|AMD3100|amd3100
664008|NCT00396266|autologous transplantation|autologous transplantation
664009|NCT00396253|HD|hd
664010|NCT00396253|TNKase|tnkase
664011|NCT00396253|Hemodialysis|hemodialysis
664012|NCT00396253|Catheter clearance|catheter clearance
664013|NCT00396240|rosuvastatin|rosuvastatin
664014|NCT00396240|hypercholesterolaemia|hypercholesterolaemia
664015|NCT00396240|cholesterol|cholesterol
664016|NCT00396240|LDL-C|ldl-c
664017|NCT00396240|triglyceride|triglyceride
664018|NCT00396240|plasma lipids|plasma lipids
664019|NCT00396240|compliance|compliance
664020|NCT00396227|Type 2 diabetes|type 2 diabetes
664021|NCT00396227|vildagliptin|vildagliptin
664022|NCT00396227|hemoglobin A1c|hemoglobin a1c
664023|NCT00396227|metformin|metformin
664024|NCT00396214|Schizophrenia|schizophrenia
664025|NCT00396214|weight changes|weight changes
664026|NCT00396201|Hodgkin's Disease|hodgkin's disease
664027|NCT00396201|Stem cell mobilization|stem cell mobilization
664028|NCT00396201|apheresis|apheresis
664029|NCT00396188|Keratoconus|keratoconus
664030|NCT00396188|LASIK|lasik
664031|NCT00396188|Orthokeratology|orthokeratology
664032|NCT00396188|Pellucid Marginal Degeneration|pellucid marginal degeneration
664033|NCT00396188|Refractive Surgery|refractive surgery
664034|NCT00396188|normal cornea|normal cornea
664035|NCT00396188|post myopic LASIK|post myopic lasik
664036|NCT00396188|post hyperopic LASIK|post hyperopic lasik
664037|NCT00396188|corneal pathologies (e.g. pellucid marginal degeneration)|corneal pathologies (e.g. pellucid marginal degeneration)
664038|NCT00396149|rBet v 1|rbet v 1
664039|NCT00396149|Birch pollen allergy|birch pollen allergy
664040|NCT00396149|Sublingual Immunotherapy|sublingual immunotherapy
664041|NCT00396136|Congestive Heart Failure|congestive heart failure
664042|NCT00396136|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
664043|NCT00396136|Left Ventricular Lead|left ventricular lead
664044|NCT00396123|Chronic Kidney Disease|chronic kidney disease
664045|NCT00396123|Anemia|anemia
664046|NCT00396110|cholesterol|cholesterol
664047|NCT00396110|coronary heart disease|coronary heart disease
664048|NCT00396110|rosuvastatin|rosuvastatin
664049|NCT00396110|LDL-C goal|ldl-c goal
664050|NCT00396110|hypercholesterolemia|hypercholesterolemia
664051|NCT00396097|ISS|iss
664052|NCT00396097|human growth hormone|human growth hormone
664053|NCT00396084|tuberculosis, linezolid, gatifloxacin, levofloxacin, isoniazid, moxifloxacin, Brazil|tuberculosis, linezolid, gatifloxacin, levofloxacin, isoniazid, moxifloxacin, brazil
664054|NCT00396071|Type 2 diabetes|type 2 diabetes
664055|NCT00396071|vildagliptin|vildagliptin
664056|NCT00396071|incretin effect|incretin effect
664057|NCT00396071|metformin|metformin
664058|NCT00396045|Multiple Myeloma, Lenalidomide, elderly patients|multiple myeloma, lenalidomide, elderly patients
664059|NCT00396032|HD|hd
664060|NCT00396032|Hemodialysis|hemodialysis
664061|NCT00396032|Catheter clearance|catheter clearance
664062|NCT00396032|TNKase|tnkase
664063|NCT00396032|Renal Insufficiency|renal insufficiency
664064|NCT00395993|anemia|anemia
664065|NCT00395993|heavy uterine bleeding|heavy uterine bleeding
664066|NCT00395993|menorrhagia|menorrhagia
664067|NCT00395993|Anemia secondary to heavy uterine bleeding|anemia secondary to heavy uterine bleeding
664068|NCT00395967|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
664069|NCT00395967|Multiple Myeloma|multiple myeloma
664070|NCT00395967|stem cell mobilization|stem cell mobilization
664071|NCT00395967|autologous transplantation|autologous transplantation
664072|NCT00395967|AMD3100|amd3100
664073|NCT00395954|Lactose Intolerance|lactose intolerance
664074|NCT00395954|Lactose|lactose
664075|NCT00395954|Threshold|threshold
664076|NCT00395928|heart|heart
664077|NCT00395928|echocardiography|echocardiography
664078|NCT00395928|diastolic function|diastolic function
664079|NCT00395928|left ventricle|left ventricle
664080|NCT00395928|right ventricle|right ventricle
664081|NCT00395928|cigarette smoking|cigarette smoking
664082|NCT00395928|Smoking|smoking
664083|NCT00395928|Heart Ventricles|heart ventricles
664084|NCT00395928|Diastole|diastole
664085|NCT00395928|Doppler Echocardiography|doppler echocardiography
664086|NCT00395915|schizophrenia|schizophrenia
664087|NCT00395915|antipsychotics|antipsychotics
664088|NCT00395915|treatment non response|treatment non response
664089|NCT00395915|pragmatic trial|pragmatic trial
664090|NCT00395902|Sensipar|sensipar
664091|NCT00395902|cinacalcet|cinacalcet
664092|NCT00395902|Mimpara|mimpara
664093|NCT00395889|Lung Transplantation|lung transplantation
664094|NCT00395889|Physical Activities in Daily Life|physical activities in daily life
664095|NCT00395889|Pulmonary Rehabilitation|pulmonary rehabilitation
664096|NCT00395889|Functional Status|functional status
664097|NCT00395876|TNKase|tnkase
664098|NCT00395876|CVA|cva
664099|NCT00395876|CVAD|cvad
664100|NCT00395876|Central venous access catheter|central venous access catheter
664101|NCT00395876|CVA catheter|cva catheter
664102|NCT00395850|cocaine dependence|cocaine dependence
664103|NCT00395850|disulfiram|disulfiram
664104|NCT00395850|clinical trial|clinical trial
664105|NCT00395850|methadone maintenance|methadone maintenance
664106|NCT00395850|pharmacogenetics|pharmacogenetics
664107|NCT00395850|dopamine beta-hydroxylase|dopamine beta-hydroxylase
664108|NCT00395837|Aging|aging
664109|NCT00395837|Wellness|wellness
664110|NCT00395837|Aerobic exercise|aerobic exercise
664111|NCT00395837|Prevention|prevention
664112|NCT00395824|citrate|citrate
664113|NCT00395824|anticoagulation|anticoagulation
664114|NCT00395824|heparin-coated membrane|heparin-coated membrane
664115|NCT00395811|Myocardial Infarction|myocardial infarction
664116|NCT00395811|stem cell therapy|stem cell therapy
664117|NCT00395811|Coronary Artery Bypass Grafting|coronary artery bypass grafting
664118|NCT00395798|cervical intervertebral disc displacement|cervical intervertebral disc displacement
664119|NCT00395798|cervical spondylosis|cervical spondylosis
664120|NCT00395798|radiculopathy|radiculopathy
664121|NCT00395798|neck collar|neck collar
664122|NCT00395798|brace|brace
664123|NCT00395798|physiotherapy|physiotherapy
664124|NCT00395798|treatment|treatment
664125|NCT00395798|rehabilitation|rehabilitation
664126|NCT00395785|Carotid stenosis|carotid stenosis
664127|NCT00395785|Intracranial Embolism|intracranial embolism
664128|NCT00395785|Carotid artery|carotid artery
664129|NCT00395785|Carotid stent|carotid stent
664130|NCT00395785|Embolic protection|embolic protection
664131|NCT00395785|TriActiv ProGuard System|triactiv proguard system
664132|NCT00395785|Carotid angioplasty|carotid angioplasty
664133|NCT00395772|Treatment of venous thromboembolism|treatment of venous thromboembolism
664134|NCT00395759|contrast sensitivity|contrast sensitivity
664135|NCT00395733|Gadovist|gadovist
664136|NCT00395733|Gadavist|gadavist
664137|NCT00395733|MRI Imaging|mri imaging
664138|NCT00395733|vascular diseases|vascular diseases
664139|NCT00395733|Chinese|chinese
664140|NCT00395720|TB|tb
664141|NCT00395720|Tuberculosis|tuberculosis
664142|NCT00395720|HIV|hiv
664143|NCT00395720|Vaccine|vaccine
664144|NCT00395720|MVA85A|mva85a
664145|NCT00395720|HIV Therapeutic Vaccine|hiv therapeutic vaccine
664146|NCT00395707|Macular Degeneration|macular degeneration
664147|NCT00395707|Age Related Macular Degeneration|age related macular degeneration
664148|NCT00395707|Retinal Angiomatous Proliferations|retinal angiomatous proliferations
664149|NCT00395694|epilepsy|epilepsy
664150|NCT00395694|Incidence of rash|incidence of rash
664151|NCT00395694|safety evaluation for initial dose|safety evaluation for initial dose
664152|NCT00395694|patients with Valproic acid|patients with valproic acid
664153|NCT00395681|Obesity|obesity
664154|NCT00395681|Propofol|propofol
664155|NCT00395681|Morbidly obese|morbidly obese
664156|NCT00395681|BMI|bmi
664157|NCT00395668|TETRA|tetra
664158|NCT00395668|EMF|emf
664159|NCT00395668|Human exposure study|human exposure study
664160|NCT00395668|Symptoms|symptoms
664161|NCT00395668|Well-being|well-being
664162|NCT00395668|Cognitive function|cognitive function
664163|NCT00395655|locally advanced breast cancer|locally advanced breast cancer
664164|NCT00395655|hydralazine|hydralazine
664165|NCT00395655|magnesium valproate|magnesium valproate
664166|NCT00395655|epigenetic therapy|epigenetic therapy
664167|NCT00395655|gene expression|gene expression
664168|NCT00395642|Congestive Heart Failure|congestive heart failure
664169|NCT00395642|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
664170|NCT00395642|Home Monitoring|home monitoring
664171|NCT00395642|Telemonitoring|telemonitoring
664172|NCT00395642|Remote Monitoring|remote monitoring
664173|NCT00395629|Deferasirox|deferasirox
664174|NCT00395629|ICL670A|icl670a
664175|NCT00395629|Iron chelators|iron chelators
664176|NCT00395629|Deferiprone|deferiprone
664177|NCT00395629|Transfusional Hemochromatosis|transfusional hemochromatosis
664178|NCT00395590|OSA inflammatory cytokines, metabolic syndrome|osa inflammatory cytokines, metabolic syndrome
664179|NCT00395564|Urologic Surgery|urologic surgery
664180|NCT00395551|choroidal neovascularization|choroidal neovascularization
664181|NCT00395551|Choroidal Neovascularization Not related to Age-Related Macular Degeneration|choroidal neovascularization not related to age-related macular degeneration
664182|NCT00395538|Parathyroid|parathyroid
664183|NCT00395538|Bone Biopsy|bone biopsy
664184|NCT00395538|Calcium-Sensing Receptor|calcium-sensing receptor
664185|NCT00395538|Bone Density|bone density
664186|NCT00395538|Bone Turnover|bone turnover
664187|NCT00395538|Hypoparathyroidism|hypoparathyroidism
664188|NCT00395512|Glucose Metabolism Disorder|glucose metabolism disorder
664189|NCT00395512|Dysmetabolic Syndrome|dysmetabolic syndrome
664190|NCT00395512|Type II Diabetes|type ii diabetes
664191|NCT00395512|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
664192|NCT00395512|Dyslipidemia|dyslipidemia
664193|NCT00395512|Drug Therapy|drug therapy
664194|NCT00395499|Risperidone|risperidone
664195|NCT00395499|9-Hydroxyrisperidone|9-hydroxyrisperidone
664196|NCT00395499|Plasma|plasma
664197|NCT00395499|Saliva|saliva
664198|NCT00395499|children|children
664199|NCT00395486|rosuvastatin|rosuvastatin
664200|NCT00395486|lipoprotein|lipoprotein
664201|NCT00395486|metabolic syndrome|metabolic syndrome
664202|NCT00395460|Gadovist|gadovist
664203|NCT00395460|Gadavist|gadavist
664204|NCT00395460|Contrast agent|contrast agent
664205|NCT00395460|Brain|brain
664206|NCT00395460|Spine disease|spine disease
664207|NCT00395460|Magnetic Resonance Imaging|magnetic resonance imaging
664208|NCT00395447|Cardiac Pacemaker|cardiac pacemaker
664209|NCT00395447|Defibrillator|defibrillator
664210|NCT00395447|Replacement|replacement
664211|NCT00395447|Upgrade|upgrade
664212|NCT00395434|Advanced Solid Tumors|advanced solid tumors
664213|NCT00395434|Advanced Solid Tumours|advanced solid tumours
664214|NCT00395434|Advanced Solid Tumor|advanced solid tumor
664215|NCT00395434|Advanced Solid Tumour|advanced solid tumour
664216|NCT00395434|Advanced|advanced
664217|NCT00395434|Malignant|malignant
664218|NCT00395434|Solid|solid
664219|NCT00395434|Tumors|tumors
664220|NCT00395434|Tumours|tumours
664221|NCT00395434|Tumor|tumor
664222|NCT00395434|Tumour|tumour
664223|NCT00395434|Cancer|cancer
664224|NCT00395434|Malignant Solid Tumors|malignant solid tumors
664225|NCT00395434|Malignant Solid Tumours|malignant solid tumours
664226|NCT00395434|Malignant Solid Tumor|malignant solid tumor
664227|NCT00395434|Malignant Solid Tumour|malignant solid tumour
664228|NCT00395434|Metastatic Cancer|metastatic cancer
664229|NCT00395434|Metastatic Disease|metastatic disease
664230|NCT00395434|Advanced Cancer|advanced cancer
664231|NCT00395434|Vascular Disrupting Agent|vascular disrupting agent
664232|NCT00395434|Anti-angiogenesis agent|anti-angiogenesis agent
664233|NCT00395434|Phase 1|phase 1
664234|NCT00395421|treatment-naive|treatment-naive
664235|NCT00395395|Postmenopausal|postmenopausal
664236|NCT00395395|osteoporosis|osteoporosis
664237|NCT00395395|Pharmacokinetics/dynamics|pharmacokinetics/dynamics
664238|NCT00395395|Calcitonin|calcitonin
664239|NCT00395382|Vascular calcification|vascular calcification
664240|NCT00395382|Arterial stiffness|arterial stiffness
664241|NCT00395382|Cardiovascular risk|cardiovascular risk
664242|NCT00395382|Bone mineral metabolism|bone mineral metabolism
664243|NCT00395382|Calcium|calcium
664244|NCT00395369|aprotinin|aprotinin
664245|NCT00395369|cardiac surgery|cardiac surgery
664246|NCT00395369|neurological dysfunction|neurological dysfunction
664247|NCT00395369|optical coherance tomography|optical coherance tomography
664248|NCT00395356|Diet|diet
664249|NCT00395356|Caloric restriction|caloric restriction
664250|NCT00395356|Intermittent diet|intermittent diet
664251|NCT00395356|Obesity|obesity
664252|NCT00395356|Postmenopausal women|postmenopausal women
664253|NCT00395330|Respiratory Function Tests|respiratory function tests
664254|NCT00395330|Oscillometry|oscillometry
664255|NCT00395330|World Trade Center Disaster|world trade center disaster
664256|NCT00395330|Environmental Exposure|environmental exposure
664257|NCT00395330|Distal Airways|distal airways
664258|NCT00395317|magnetic resonance imaging|magnetic resonance imaging
664259|NCT00395317|multiple sclerosis|multiple sclerosis
664260|NCT00395317|SB-683699|sb-683699
664261|NCT00395291|Chronic kidney disease|chronic kidney disease
664262|NCT00395291|End stage renal disease|end stage renal disease
664263|NCT00395278|KSHV|kshv
664264|NCT00395278|Kaposi's Sarcoma|kaposi's sarcoma
664265|NCT00395278|HIV|hiv
664266|NCT00395278|Kaposi Sarcoma|kaposi sarcoma
664267|NCT00395265|Deep Vein Thrombosis|deep vein thrombosis
664268|NCT00395265|Chronic Venous Insufficiency|chronic venous insufficiency
664269|NCT00395265|Post Thrombotic Syndrome|post thrombotic syndrome
664270|NCT00395265|Blood Coagulation|blood coagulation
664271|NCT00395265|Inflammation|inflammation
664272|NCT00395252|pancreatic cancer|pancreatic cancer
664273|NCT00395252|adjuvant chemotherapy|adjuvant chemotherapy
664274|NCT00395252|phase 2|phase 2
664651|NCT00393705|diabetes|diabetes
664275|NCT00395252|R0 or R1 resected Adenocarcinoma of the Pancreas|r0 or r1 resected adenocarcinoma of the pancreas
664276|NCT00395239|Asthma|asthma
664277|NCT00395239|Inhaled corticosteroid|inhaled corticosteroid
664278|NCT00395239|ICS|ics
664279|NCT00395239|Metabolites|metabolites
664280|NCT00395239|Induced sputum|induced sputum
664281|NCT00395239|Virtual Asthma Clinic|virtual asthma clinic
664282|NCT00395226|Rosacea|rosacea
664283|NCT00395213|Anxiety|anxiety
664284|NCT00395213|Major Depression|major depression
664285|NCT00395213|Anorexia|anorexia
664286|NCT00395213|Bulimia|bulimia
664287|NCT00395213|OCD|ocd
664288|NCT00395213|Antidepressant|antidepressant
664289|NCT00395213|SSRI|ssri
664290|NCT00395213|SNRI|snri
664291|NCT00395200|Multiple Sclerosis|multiple sclerosis
664292|NCT00395200|Safety|safety
664293|NCT00395200|Therapeutics|therapeutics
664294|NCT00395200|Mesenchymal Stem Cells|mesenchymal stem cells
664295|NCT00395200|Multipotent Mesenchymal Stromal Cells|multipotent mesenchymal stromal cells
664296|NCT00395200|Optic Neuritis|optic neuritis
664297|NCT00395174|Influenza|influenza
664298|NCT00395161|sepsis|sepsis
664299|NCT00395161|prevention|prevention
664300|NCT00395161|mineral supplementation|mineral supplementation
664301|NCT00395135|Obesity|obesity
664302|NCT00395135|Weight loss|weight loss
664303|NCT00395135|lorcaserin|lorcaserin
664304|NCT00395135|APD356|apd356
664305|NCT00395135|BLOOM|bloom
664306|NCT00395135|Hypertension|hypertension
664307|NCT00395135|Dyslipidemia|dyslipidemia
664308|NCT00395135|Sleep apnea|sleep apnea
664309|NCT00395135|glucose tolerance|glucose tolerance
664310|NCT00395135|cardiovascular disease|cardiovascular disease
664311|NCT00395135|Arena|arena
664312|NCT00395122|Band Atrophy|band atrophy
664313|NCT00395122|Optical Coherence Tomography|optical coherence tomography
664314|NCT00395122|Scanning Laser Polarimetry|scanning laser polarimetry
664315|NCT00395122|Chiasmal Lesions|chiasmal lesions
664316|NCT00395109|cancer|cancer
664317|NCT00395109|hypoxia|hypoxia
664318|NCT00395109|PET scan|pet scan
664319|NCT00395109|CT scan|ct scan
664320|NCT00395096|Exhaled Nitric Oxide|exhaled nitric oxide
664321|NCT00395096|Asthma|asthma
664322|NCT00395096|Tobacco Smoke|tobacco smoke
664323|NCT00395096|Allergen|allergen
664324|NCT00395070|Melanoma|melanoma
664325|NCT00395070|DTIC|dtic
664326|NCT00395070|TMZ|tmz
664327|NCT00395070|Stage 3|stage 3
664328|NCT00395070|Stage 4|stage 4
664329|NCT00395070|Metastatic|metastatic
664330|NCT00395070|Metastatic Melanoma (Stage 3, Stage 4 Melanoma)|metastatic melanoma (stage 3, stage 4 melanoma)
664331|NCT00395044|Cannabis treatment|cannabis treatment
664332|NCT00395044|marijuana treatment|marijuana treatment
664333|NCT00395031|schizophrenia|schizophrenia
664334|NCT00395031|Schizoaffective Disorder|schizoaffective disorder
664335|NCT00395031|metabolic markers|metabolic markers
664336|NCT00395031|ziprasidone|ziprasidone
664337|NCT00395031|diabetes|diabetes
664338|NCT00395018|Chronic Hepatitis B Virus, Liver Transplant|chronic hepatitis b virus, liver transplant
664339|NCT00395005|Kallikrein|kallikrein
664340|NCT00395005|Cytokines|cytokines
664341|NCT00395005|Proteinuria|proteinuria
664342|NCT00395005|Renal function|renal function
664343|NCT00395005|Chronic kidney disease|chronic kidney disease
664344|NCT00394992|Colorectal cancer|colorectal cancer
664345|NCT00394992|Liver metastasis|liver metastasis
664346|NCT00394992|Radical resection|radical resection
664347|NCT00394992|Adjuvant therapy|adjuvant therapy
664348|NCT00394992|Bevacizumab|bevacizumab
664349|NCT00394992|Capecitabine|capecitabine
664350|NCT00394992|Oxaliplatin|oxaliplatin
664351|NCT00394992|Hepatica|hepatica
664352|NCT00394940|COPD|copd
664353|NCT00394940|Emphysema|emphysema
664354|NCT00394940|Chronic Bronchitis|chronic bronchitis
664355|NCT00394940|Inflammation|inflammation
664356|NCT00394940|CD14|cd14
664357|NCT00394940|TLR4|tlr4
664358|NCT00394940|Proteomics|proteomics
664359|NCT00394927|Non-Interventional|non-interventional
664360|NCT00394927|Surveillance|surveillance
664361|NCT00394927|Adverse Effects|adverse effects
664362|NCT00394927|AntiEpileptic Drug treatment|antiepileptic drug treatment
664363|NCT00394888|Hemangioma|hemangioma
664364|NCT00394888|PHACE|phace
664365|NCT00394888|Lumbosacral hemangioma|lumbosacral hemangioma
664366|NCT00394888|Occult Spinal Dysraphism|occult spinal dysraphism
664367|NCT00394875|Randomized controlled trial|randomized controlled trial
664368|NCT00394875|Delegation, Professional|delegation, professional
664369|NCT00394875|Nurses|nurses
664370|NCT00394849|Tonsillectomy|tonsillectomy
664371|NCT00394849|Suturing of tonsillar pillars|suturing of tonsillar pillars
664372|NCT00394849|pain|pain
664373|NCT00394849|postoperative hemorrhage, bleeding|postoperative hemorrhage, bleeding
664374|NCT00394836|ofatumumab|ofatumumab
664375|NCT00394836|rituximab|rituximab
664376|NCT00394836|NHL|nhl
664377|NCT00394836|CD20|cd20
664378|NCT00394836|refractory|refractory
664379|NCT00394823|Hypertension, valsartan, compliance|hypertension, valsartan, compliance
664380|NCT00394784|gram negative bacteria|gram negative bacteria
664381|NCT00394784|culture|culture
664382|NCT00394784|infection|infection
664383|NCT00394771|oral contraceptives|oral contraceptives
664384|NCT00394771|breakthrough bleeding|breakthrough bleeding
664385|NCT00394771|spotting|spotting
664386|NCT00394758|ultrasonic surgical aspiration|ultrasonic surgical aspiration
664387|NCT00394758|CO2 laser surgery|co2 laser surgery
664388|NCT00394758|vulvar dysplasia|vulvar dysplasia
664389|NCT00394758|vaginal dysplasia|vaginal dysplasia
664390|NCT00394758|recurrence|recurrence
664391|NCT00394745|Hypertension, Metabolic Syndrome, lipid subfractions|hypertension, metabolic syndrome, lipid subfractions
664392|NCT00394732|chronic low back pain|chronic low back pain
664393|NCT00394732|total disc replacement|total disc replacement
664394|NCT00394732|multidisciplinary rehabilitation|multidisciplinary rehabilitation
664395|NCT00394732|clinical effects|clinical effects
664396|NCT00394732|cost effectiveness|cost effectiveness
664397|NCT00394732|randomized controlled trial|randomized controlled trial
664398|NCT00394732|multicenter study|multicenter study
664399|NCT00394706|cardiac arrest|cardiac arrest
664400|NCT00394706|cardiopulmonary resuscitation|cardiopulmonary resuscitation
664401|NCT00394693|Primary CBCL including (WHO/EORTC classification 2005)|primary cbcl including (who/eortc classification 2005)
664652|NCT00393705|type 2|type 2
664402|NCT00394693|Primary cutaneous marginal zone B-cell lymphoma|primary cutaneous marginal zone b-cell lymphoma
664403|NCT00394693|Primary cutaneous follicle center B-cell lymphoma|primary cutaneous follicle center b-cell lymphoma
664404|NCT00394693|Primary cutaneous diffuse large B-cell other than leg type|primary cutaneous diffuse large b-cell other than leg type
664405|NCT00394693|Histologically consistent with primary CBCL|histologically consistent with primary cbcl
664406|NCT00394693|Relapse or active disease|relapse or active disease
664407|NCT00394680|coronary revascularization|coronary revascularization
664408|NCT00394680|stent inmplantation|stent inmplantation
664409|NCT00394680|coronary bypass|coronary bypass
664410|NCT00394628|Glioblastoma Multiforme|glioblastoma multiforme
664411|NCT00394628|Radiotherapy|radiotherapy
664412|NCT00394628|temozolomide|temozolomide
664413|NCT00394628|adjuvant temozolomide|adjuvant temozolomide
664414|NCT00394602|Gastric Cancer|gastric cancer
664415|NCT00394602|Pancreatic Cancer|pancreatic cancer
664416|NCT00394602|Cervical Cancer|cervical cancer
664417|NCT00394602|Vulvar Cancer|vulvar cancer
664418|NCT00394602|Endometrial Cancer|endometrial cancer
664419|NCT00394602|Anal Cancer|anal cancer
664420|NCT00394602|Quality of Life|quality of life
664421|NCT00394602|Questionnaire|questionnaire
664422|NCT00394602|Interview|interview
664423|NCT00394602|Emesis|emesis
664424|NCT00394602|Nausea|nausea
664425|NCT00394602|Survey|survey
664426|NCT00394576|Kidney School|kidney school
664427|NCT00394576|Short Test of Functional Health Literacy|short test of functional health literacy
664428|NCT00394576|Chronic Kidney Disease Knowledge Assessment Tool of Nutrition|chronic kidney disease knowledge assessment tool of nutrition
664429|NCT00394576|Short Form 12 version 2|short form 12 version 2
664430|NCT00394576|Kidney Disease Self-Management Survey|kidney disease self-management survey
664431|NCT00394576|Three Day Dietary Diary|three day dietary diary
664432|NCT00394563|osteoarthritis monoclonal antibody|osteoarthritis monoclonal antibody
664433|NCT00394550|laryngomalacia|laryngomalacia
664434|NCT00394550|supraglottoplasty|supraglottoplasty
664435|NCT00394550|Tonsillectomy|tonsillectomy
664436|NCT00394550|Adenoidectomy|adenoidectomy
664437|NCT00394550|obstructive sleep apnea|obstructive sleep apnea
664438|NCT00394550|Laser|laser
664439|NCT00394550|Polysomnogram|polysomnogram
664440|NCT00394550|airway obstruction|airway obstruction
664441|NCT00394524|ICU|icu
664442|NCT00394524|hyperglycemia|hyperglycemia
664443|NCT00394524|glucommander|glucommander
664444|NCT00394498|Myocardial Infarction|myocardial infarction
664445|NCT00394498|Stem Cells|stem cells
664446|NCT00394485|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
664447|NCT00394485|Procaterol|procaterol
664448|NCT00394485|Tiotropium|tiotropium
664449|NCT00394472|Heartburn|heartburn
664450|NCT00394472|Patient reported symptoms|patient reported symptoms
664451|NCT00394472|Proton pump inhibitor|proton pump inhibitor
664452|NCT00394459|Anaesthetic techniques|anaesthetic techniques
664453|NCT00394459|epidural|epidural
664454|NCT00394459|catheters|catheters
664455|NCT00394459|paraesthesia|paraesthesia
664456|NCT00394459|side effects|side effects
664457|NCT00394459|Anesthesia, Epidural [E03.155.086.131]|anesthesia, epidural [e03.155.086.131]
664458|NCT00394446|Solid Tumors|solid tumors
664459|NCT00394446|Refractory|refractory
664460|NCT00394446|Brain|brain
664461|NCT00394433|TPCA|tpca
664462|NCT00394433|Taxotere|taxotere
664463|NCT00394433|Platinum|platinum
664464|NCT00394433|Avastin|avastin
664465|NCT00394433|Camptosar|camptosar
664466|NCT00394433|gastric cancer|gastric cancer
664467|NCT00394407|inpatient|inpatient
664468|NCT00394407|diabetes management|diabetes management
664469|NCT00394407|insulin therapy|insulin therapy
664470|NCT00394381|acute myeloid leukemia|acute myeloid leukemia
664471|NCT00394381|myelodysplastic syndrome|myelodysplastic syndrome
664472|NCT00394381|autologous CIK cells|autologous cik cells
664473|NCT00394381|autologous peripheral blood stem cell transplant|autologous peripheral blood stem cell transplant
664474|NCT00394368|asthma|asthma
664475|NCT00394368|combinations|combinations
664476|NCT00394368|inhaled therapy|inhaled therapy
664477|NCT00394368|corticosteroids|corticosteroids
664478|NCT00394368|long acting bronchodilators|long acting bronchodilators
664479|NCT00394368|salmeterol|salmeterol
664480|NCT00394368|beclomethasone|beclomethasone
664481|NCT00394368|formoterol|formoterol
664482|NCT00394368|fluticasone|fluticasone
664483|NCT00394316|CD34 Stem Cells|cd34 stem cells
664484|NCT00394316|Busulfan|busulfan
664485|NCT00394316|Gene Therapy|gene therapy
664486|NCT00394316|Immune Reconstitution|immune reconstitution
664487|NCT00394316|Engraftment|engraftment
664488|NCT00394316|Chronic Granulomatous Disease (CGD)|chronic granulomatous disease (cgd)
664489|NCT00394316|Gp91 Phox Deficiency|gp91 phox deficiency
664490|NCT00394316|Peripheral Blood Stem Cells|peripheral blood stem cells
664491|NCT00394316|Bone Marrow Transplantation|bone marrow transplantation
664492|NCT00394316|Chronic Granulomatous Disease|chronic granulomatous disease
664493|NCT00394316|CGD|cgd
664494|NCT00394303|Open heart surgery|open heart surgery
664495|NCT00394303|Diabetes mellitus|diabetes mellitus
664496|NCT00394303|Hyperglycemia|hyperglycemia
664497|NCT00394303|Surgical site infection|surgical site infection
664498|NCT00394303|Normoglycemia|normoglycemia
664499|NCT00394290|Down Syndrome|down syndrome
664500|NCT00394290|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
664501|NCT00394290|Continuous Positive Pressure|continuous positive pressure
664502|NCT00394290|Hypersomnia|hypersomnia
664503|NCT00394264|low back pain|low back pain
664504|NCT00394264|active duty military personnel|active duty military personnel
664505|NCT00394264|manual/manipulative therapy|manual/manipulative therapy
664506|NCT00394264|osteopathic manipulative treatment|osteopathic manipulative treatment
664507|NCT00394264|physical medicine|physical medicine
664508|NCT00394251|Adjuvant therapy|adjuvant therapy
664509|NCT00394251|Bevacizumab|bevacizumab
664510|NCT00394251|Abraxane|abraxane
664511|NCT00394251|Early stage breast cancer|early stage breast cancer
664512|NCT00394225|6-Minute Walk Test|6-minute walk test
664513|NCT00394225|COPD|copd
664514|NCT00394225|Helium-Hyperoxia|helium-hyperoxia
664515|NCT00394225|Exercise|exercise
664516|NCT00394225|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
664517|NCT00394212|Weight Loss|weight loss
664518|NCT00394212|Transoral Suturing|transoral suturing
664519|NCT00394212|Dilated gastrojejunostomy|dilated gastrojejunostomy
664520|NCT00394212|Inadequate weight loss following primary RYGB|inadequate weight loss following primary rygb
664521|NCT00394199|Asthma|asthma
664522|NCT00394199|Fluticasone Propionate|fluticasone propionate
664523|NCT00394199|formoterol fumarate|formoterol fumarate
664524|NCT00394199|Pressurized metered dose inhaler|pressurized metered dose inhaler
664525|NCT00394199|Hydrofluoroalkane|hydrofluoroalkane
664526|NCT00394199|Mild to Moderate Asthma|mild to moderate asthma
664527|NCT00394186|GW427353|gw427353
664528|NCT00394186|b3-Adrenergic Receptor Agonist|b3-adrenergic receptor agonist
664529|NCT00394186|Irritable Bowel Syndrome (IBS)|irritable bowel syndrome (ibs)
664530|NCT00394186|efficacy|efficacy
664531|NCT00394186|tolerability|tolerability
664532|NCT00394186|pharmacokinetics|pharmacokinetics
664533|NCT00394173|IBS|ibs
664534|NCT00394173|diarrhea|diarrhea
664535|NCT00394173|gastrointestinal functional disorder|gastrointestinal functional disorder
664536|NCT00394173|IBS-D|ibs-d
664537|NCT00394147|advanced|advanced
664538|NCT00394147|head|head
664539|NCT00394147|neck|neck
664540|NCT00394147|cancer|cancer
664541|NCT00394134|Melanoma|melanoma
664542|NCT00394134|Sun Exposure|sun exposure
664543|NCT00394134|Sun Protection|sun protection
664544|NCT00394134|Interview|interview
664545|NCT00394121|Asthma|asthma
664546|NCT00394121|Fluticasone Propionate|fluticasone propionate
664547|NCT00394121|Formoterol Fumarate|formoterol fumarate
664548|NCT00394121|Pressurized metered does inhaler|pressurized metered does inhaler
664549|NCT00394121|Hydrofluoroalkane|hydrofluoroalkane
664550|NCT00394121|Mild to moderate-severe asthma|mild to moderate-severe asthma
664551|NCT00394095|Bipolar Disorder|bipolar disorder
664552|NCT00394095|Weight Gain|weight gain
664553|NCT00394082|Metastatic breast cancer, Abraxane, Bevacizumab|metastatic breast cancer, abraxane, bevacizumab
664554|NCT00394056|placebo|placebo
664555|NCT00394056|balanced|balanced
664556|NCT00394056|paroxetine|paroxetine
664557|NCT00394056|repeated dose|repeated dose
664558|NCT00394056|Hearing Loss|hearing loss
664559|NCT00394056|loudness|loudness
664560|NCT00394056|combination|combination
664561|NCT00394056|Tinnitus|tinnitus
664562|NCT00394056|vestipitant (GW597599)|vestipitant (gw597599)
664563|NCT00394056|randomised|randomised
664564|NCT00394056|annoyance|annoyance
664565|NCT00394056|crossover|crossover
664566|NCT00394043|Carpal Tunnel Sydrome|carpal tunnel sydrome
664567|NCT00394043|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
664568|NCT00394043|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
664569|NCT00394043|Physical Medicine|physical medicine
664570|NCT00394030|GSK716155 pharmacodynamics pharmacokinetics injection site|gsk716155 pharmacodynamics pharmacokinetics injection site
664571|NCT00394017|Heading Health Plan Implementation|heading health plan implementation
664572|NCT00394017|Computer-Assisted Instruction|computer-assisted instruction
664573|NCT00394017|General Practice|general practice
664574|NCT00394017|Dementia|dementia
664575|NCT00394017|education|education
664576|NCT00394004|Decision Making|decision making
664577|NCT00394004|Health Disparities|health disparities
664578|NCT00394004|Hispanic|hispanic
664579|NCT00394004|African-American|african-american
664580|NCT00394004|Clinical Trials|clinical trials
664581|NCT00394004|HIV Positive|hiv positive
664582|NCT00393991|Asthma|asthma
664583|NCT00393991|Fluticasone Propionate|fluticasone propionate
664584|NCT00393991|Formoterol Fumarate|formoterol fumarate
664585|NCT00393991|Pressurized metered dose inhaler|pressurized metered dose inhaler
664586|NCT00393991|Hydrofluoroalkane|hydrofluoroalkane
664587|NCT00393991|Mild to Moderate Asthma|mild to moderate asthma
664588|NCT00393978|Bipolar mania|bipolar mania
664589|NCT00393978|Cannabis consumption|cannabis consumption
664590|NCT00393965|Metastases|metastases
664591|NCT00393965|Refractory|refractory
664592|NCT00393965|Brain|brain
664593|NCT00393952|Asthma|asthma
664594|NCT00393952|Fluticasone Propionate|fluticasone propionate
664595|NCT00393952|Formoterol Fumarate|formoterol fumarate
664596|NCT00393952|Pressurized metered dose inhaler|pressurized metered dose inhaler
664597|NCT00393952|Hydrofluoroalkane|hydrofluoroalkane
664598|NCT00393952|Moderate-Severe Asthma|moderate-severe asthma
664599|NCT00393939|advanced breast cancer|advanced breast cancer
664600|NCT00393939|sunitinib|sunitinib
664601|NCT00393939|docetaxel|docetaxel
664602|NCT00393939|Phase 3|phase 3
664603|NCT00393926|Robotics|robotics
664604|NCT00393926|Rehabilitation|rehabilitation
664605|NCT00393926|Upper Extremity|upper extremity
664606|NCT00393926|CVA|cva
664607|NCT00393913|Sleep Apnea|sleep apnea
664608|NCT00393913|Sleep-Disordered Breathing|sleep-disordered breathing
664609|NCT00393913|Snoring|snoring
664610|NCT00393900|otitis media|otitis media
664611|NCT00393900|tympanostomy tube|tympanostomy tube
664612|NCT00393900|eustachian tube function|eustachian tube function
664613|NCT00393900|gas exchange|gas exchange
664614|NCT00393900|tympanostomy tubes|tympanostomy tubes
664615|NCT00393887|Inguinal hernia|inguinal hernia
664616|NCT00393887|polypropylene|polypropylene
664617|NCT00393887|Biodesign IHM|biodesign ihm
664618|NCT00393887|lichtenstein|lichtenstein
664619|NCT00393874|Anxiety D/O|anxiety d/o
664620|NCT00393874|Mood D/O|mood d/o
664621|NCT00393861|Germ Cell Tumor|germ cell tumor
664622|NCT00393861|Germ Cell Cancer|germ cell cancer
664623|NCT00393848|Hip Replacement Arthroplasty|hip replacement arthroplasty
664624|NCT00393848|Hip Replacement Surgery|hip replacement surgery
664625|NCT00393848|Hip Surgery|hip surgery
664626|NCT00393848|Hip Rehabilitation|hip rehabilitation
664627|NCT00393848|Avascular Necrosis|avascular necrosis
664628|NCT00393848|Knee replacement surgery|knee replacement surgery
664629|NCT00393848|Total knee arthroplasty|total knee arthroplasty
664630|NCT00393822|KGF|kgf
664631|NCT00393822|Palifermin|palifermin
664632|NCT00393822|Oral Mucositis|oral mucositis
664633|NCT00393822|Clinical Trial|clinical trial
664634|NCT00393822|Amgen|amgen
664635|NCT00393822|Oncology|oncology
664636|NCT00393822|Colon Cancer|colon cancer
664637|NCT00393809|transitional cell carcinoma|transitional cell carcinoma
664638|NCT00393809|H19 gene|h19 gene
664639|NCT00393809|plasmid|plasmid
664640|NCT00393809|diphtheria toxin|diphtheria toxin
664641|NCT00393783|Breast Cancer|breast cancer
664642|NCT00393783|Metastatic|metastatic
664643|NCT00393783|HER2|her2
664644|NCT00393783|04-101|04-101
664645|NCT00393770|Risk of type 2 diabetes|risk of type 2 diabetes
664646|NCT00393757|Malaria, Plasmodium falciparum, Kenya|malaria, plasmodium falciparum, kenya
664647|NCT00393731|labor|labor
664648|NCT00393731|induction|induction
664649|NCT00393731|misoprostol|misoprostol
664650|NCT00393731|oxytocin|oxytocin
664653|NCT00393692|Age-related macular degeneration|age-related macular degeneration
664654|NCT00393692|Geographic atrophy|geographic atrophy
664656|NCT00393679|Children 6-59 months|children 6-59 months
664657|NCT00393679|P.falciparum|p.falciparum
664658|NCT00393679|Haemoglobin|haemoglobin
664659|NCT00393679|Informed consent|informed consent
664660|NCT00393679|ACT|act
664661|NCT00393666|Absence|absence
664662|NCT00393666|Epilepsy|epilepsy
664663|NCT00393666|Seizure|seizure
664664|NCT00393666|Brain|brain
664665|NCT00393653|osteoarthritis|osteoarthritis
664666|NCT00393653|gastroesophageal reflux disease|gastroesophageal reflux disease
664667|NCT00393653|practice-based research|practice-based research
664668|NCT00393653|N-of-1 trial|n-of-1 trial
664669|NCT00393653|prescription|prescription
664670|NCT00393653|single-patient trial|single-patient trial
664671|NCT00393640|Early Initiation of lactogenesis II|early initiation of lactogenesis ii
664672|NCT00393627|Dementia|dementia
664673|NCT00393627|Sleep disturbance|sleep disturbance
664674|NCT00393627|Behavioral strategies|behavioral strategies
664675|NCT00393627|Alzheimer's Disease|alzheimer's disease
664676|NCT00393627|Adult Family Homes|adult family homes
664677|NCT00393614|CSWS, interiktal epileptiform activity|csws, interiktal epileptiform activity
664678|NCT00393601|Cystectomy|cystectomy
664679|NCT00393588|Brain|brain
664680|NCT00393588|Cognitive Deficits|cognitive deficits
664681|NCT00393588|Cognitive Testing|cognitive testing
664682|NCT00393588|MRI|mri
664683|NCT00393588|Multiple Sclerosis|multiple sclerosis
664684|NCT00393588|MS|ms
664685|NCT00393588|Healthy Volunteer|healthy volunteer
664686|NCT00393588|HV|hv
664687|NCT00393575|HIV Prevention|hiv prevention
664688|NCT00393575|HIV positive communities|hiv positive communities
664689|NCT00393562|excessive sleepiness|excessive sleepiness
664690|NCT00393562|hypersomnolence|hypersomnolence
664691|NCT00393562|Parkinson's disease|parkinson's disease
664692|NCT00393549|Median Neuropathy at the wrist (MNW)|median neuropathy at the wrist (mnw)
664693|NCT00393536|Depression|depression
664694|NCT00393536|Guidelines|guidelines
664695|NCT00393536|Educational outreach visiting|educational outreach visiting
664696|NCT00393536|Prescribing|prescribing
664697|NCT00393510|Diabetic Foot Ulcer|diabetic foot ulcer
664698|NCT00393510|Traditional Chinese Medicine|traditional chinese medicine
664699|NCT00393497|Breast Cancer|breast cancer
664700|NCT00393497|lymphedema|lymphedema
664701|NCT00393471|Arthritis|arthritis
664702|NCT00393471|Rheumatoid|rheumatoid
664703|NCT00393471|Safety|safety
664704|NCT00393458|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
664705|NCT00393458|COPD|copd
664706|NCT00393458|indacaterol|indacaterol
664707|NCT00393458|long-acting β2 agonist|long-acting β2 agonist
664708|NCT00393445|GLP-1|glp-1
664709|NCT00393445|Exendin(9-39)|exendin(9-39)
664710|NCT00393445|Insulin|insulin
664711|NCT00393445|Glucagon|glucagon
664712|NCT00393445|Human physiology|human physiology
664713|NCT00393432|Action Observation|action observation
664714|NCT00393432|Motor Memory|motor memory
664715|NCT00393432|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
664716|NCT00393432|Use-Dependent Plasticity|use-dependent plasticity
664717|NCT00393432|Healthy Volunteer|healthy volunteer
664718|NCT00393432|HV|hv
664719|NCT00393419|hypertension|hypertension
664720|NCT00393419|hyperlipidemia|hyperlipidemia
664721|NCT00393419|adherence|adherence
664722|NCT00393419|pharmacist|pharmacist
664723|NCT00393419|elderly|elderly
664724|NCT00393419|medication|medication
664725|NCT00393406|Objective Risk|objective risk
664726|NCT00393406|Gail Model|gail model
664727|NCT00393406|Subjective Risk|subjective risk
664728|NCT00393406|Medical Risk-Reducing Strategies|medical risk-reducing strategies
664729|NCT00393406|Physical Activity, Diet, Alcohol Use|physical activity, diet, alcohol use
664730|NCT00393406|Breast Cancer Risk|breast cancer risk
664731|NCT00393393|osteoarthritis|osteoarthritis
664732|NCT00393393|knee|knee
664733|NCT00393393|hylan|hylan
664734|NCT00393380|Myelogenous Leukemia, Chronic|myelogenous leukemia, chronic
664735|NCT00393380|Myelodysplasia|myelodysplasia
664736|NCT00393380|Parathyroid Hormone|parathyroid hormone
664737|NCT00393380|Umbilical Cord Blood Stem Cell Transplantation|umbilical cord blood stem cell transplantation
664738|NCT00393367|Asthma|asthma
664739|NCT00393367|Acute|acute
664740|NCT00393367|Treatment|treatment
664741|NCT00393367|Children|children
664742|NCT00393367|Pediatric|pediatric
664743|NCT00393367|Inhaled corticosteroid|inhaled corticosteroid
664744|NCT00393367|Budesonide|budesonide
664745|NCT00393367|Budesonide inhalation suspension|budesonide inhalation suspension
664746|NCT00393367|Asthma score|asthma score
664747|NCT00393367|Emergency|emergency
664748|NCT00393367|Emergency Department|emergency department
664749|NCT00393367|Asthma flare|asthma flare
664750|NCT00393367|Clinical trial|clinical trial
664751|NCT00393367|Randomized clinical trial|randomized clinical trial
664752|NCT00393367|Randomized trial|randomized trial
664753|NCT00393367|Pulmonary index score|pulmonary index score
664754|NCT00393367|Hospitalization|hospitalization
664755|NCT00393367|Moderate asthma|moderate asthma
664756|NCT00393367|Severe asthma|severe asthma
664757|NCT00393367|Mixing budesonide|mixing budesonide
664758|NCT00393367|Budesonide admixture|budesonide admixture
664759|NCT00393367|Albuterol|albuterol
664760|NCT00393367|Continuous albuterol|continuous albuterol
664761|NCT00393367|Ipratropium bromide|ipratropium bromide
664762|NCT00393341|Breast Cancer|breast cancer
664763|NCT00393315|in stent restenosis|in stent restenosis
664764|NCT00393315|paclitaxel coated balloon catheter|paclitaxel coated balloon catheter
664765|NCT00393315|pepcad|pepcad
664766|NCT00393315|drug eluting balloon|drug eluting balloon
664767|NCT00393302|HIV testing in pregnant women|hiv testing in pregnant women
664768|NCT00393289|Calcium absorption|calcium absorption
664769|NCT00393289|D-vitamin status|d-vitamin status
664770|NCT00393289|Whole body calcium retention|whole body calcium retention
664771|NCT00393289|Calcium intake|calcium intake
664772|NCT00393289|PTH status|pth status
664773|NCT00393276|Treatment Experienced|treatment experienced
664774|NCT00393276|Treatment Naive|treatment naive
664775|NCT00393276|Immunizations|immunizations
664776|NCT00393250|Hypnosis|hypnosis
664777|NCT00393250|Symptom Management|symptom management
664778|NCT00393250|Pain Management|pain management
664779|NCT00393250|Sickle Cell Disease|sickle cell disease
664780|NCT00393250|Pain|pain
664781|NCT00393224|Epidemiology|epidemiology
664782|NCT00393224|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
664783|NCT00393224|Genetic|genetic
664784|NCT00393224|Viruses|viruses
664785|NCT00393224|Cancer|cancer
664786|NCT00393224|NPC|npc
664787|NCT00393198|Intrauterine System|intrauterine system
664788|NCT00393198|Contraception|contraception
664789|NCT00393198|Menorrhagia|menorrhagia
664790|NCT00393185|Immunosuppression|immunosuppression
664791|NCT00393185|Primary Biliary Cirrhosis|primary biliary cirrhosis
664792|NCT00393185|Allogeneic Hematopoietic Stem Cell|allogeneic hematopoietic stem cell
664793|NCT00393172|exercise|exercise
664794|NCT00393172|breast cancer|breast cancer
664795|NCT00393172|prevention|prevention
664796|NCT00393172|obesity|obesity
664797|NCT00393172|estrogen metabolism|estrogen metabolism
664798|NCT00393172|oxidative stress|oxidative stress
664799|NCT00393172|IGF-1|igf-1
664800|NCT00393159|Effusion|effusion
664801|NCT00393159|Otitis|otitis
664802|NCT00393159|Media|media
664803|NCT00393159|Ear|ear
664804|NCT00393159|Popper|popper
664805|NCT00393159|Children|children
664806|NCT00393146|Rheumatoid arthritis|rheumatoid arthritis
664807|NCT00393146|MRI|mri
664808|NCT00393120|HIV-infection|hiv-infection
664809|NCT00393120|viral load|viral load
664810|NCT00393120|CCR5|ccr5
664811|NCT00393120|viral tropism|viral tropism
664812|NCT00393120|HIV-1 infection|hiv-1 infection
664813|NCT00393120|Treatment Naive|treatment naive
665082|NCT00392301|skin|skin
664814|NCT00393107|follicular lymphoma|follicular lymphoma
664815|NCT00393107|non-Hodgkin lymphoma|non-hodgkin lymphoma
664816|NCT00393107|Fludarabine|fludarabine
664817|NCT00393107|Cyclophosphamide|cyclophosphamide
664818|NCT00393107|Rituximab|rituximab
664819|NCT00393107|combination|combination
664820|NCT00393107|immuno-chemotherapy|immuno-chemotherapy
664821|NCT00393107|relapsed|relapsed
664822|NCT00393094|Brain Tumor|brain tumor
664823|NCT00393094|Chemotherapy|chemotherapy
664824|NCT00393094|Progression|progression
664825|NCT00393094|Radiotherapy|radiotherapy
664826|NCT00393094|Antiangiogenesis|antiangiogenesis
664827|NCT00393094|Glioma|glioma
664828|NCT00393042|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
664829|NCT00393042|sleep|sleep
664830|NCT00393042|side effects|side effects
664831|NCT00393042|stimulants|stimulants
664832|NCT00393029|Tumor Regression|tumor regression
664833|NCT00393029|In Vivo Cell Survival|in vivo cell survival
664834|NCT00393029|Toxicity Profile|toxicity profile
664835|NCT00393029|Metastatic Renal Cell Cancer|metastatic renal cell cancer
664836|NCT00393029|Cancer|cancer
664837|NCT00393029|Metastatic Cancer|metastatic cancer
664838|NCT00393003|Anesthesia|anesthesia
664839|NCT00393003|Sedation|sedation
664840|NCT00392990|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
664841|NCT00392990|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
664842|NCT00392990|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
664843|NCT00392990|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
664844|NCT00392990|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
664845|NCT00392990|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
664846|NCT00392977|Manganese|manganese
664847|NCT00392977|Neonatal Intensive Care|neonatal intensive care
664848|NCT00392977|MRI|mri
664849|NCT00392977|Parenteral Nutrition|parenteral nutrition
664850|NCT00392977|Prematurity|prematurity
664851|NCT00392964|Antacids|antacids
664852|NCT00392964|Proton pump inhibitors|proton pump inhibitors
664853|NCT00392964|aspirin|aspirin
664854|NCT00392964|ischemic heart disease|ischemic heart disease
664855|NCT00392964|Dyspepsia|dyspepsia
664856|NCT00392951|ALPS|alps
664857|NCT00392951|Autoimmune|autoimmune
664858|NCT00392951|Cytopenias|cytopenias
664859|NCT00392951|Treatment|treatment
664860|NCT00392951|Sirolimus|sirolimus
664861|NCT00392951|Rapamycin|rapamycin
664862|NCT00392951|Lymph Nodes|lymph nodes
664863|NCT00392951|Spleen|spleen
664864|NCT00392951|Hemolytic Anemia|hemolytic anemia
664865|NCT00392951|Immune Thrombocytopenia|immune thrombocytopenia
664866|NCT00392951|Neutropenia|neutropenia
664867|NCT00392951|ITP|itp
664868|NCT00392951|Lupus|lupus
664869|NCT00392938|recurrent prostate cancer|recurrent prostate cancer
664870|NCT00392938|stage IV prostate cancer|stage iv prostate cancer
664871|NCT00392938|bone metastases|bone metastases
664872|NCT00392925|overweight|overweight
664873|NCT00392925|obesity|obesity
664874|NCT00392925|pramlintide|pramlintide
664875|NCT00392925|leptin|leptin
664876|NCT00392925|Amylin|amylin
664877|NCT00392912|testosterone|testosterone
664878|NCT00392912|hypogonadal|hypogonadal
664879|NCT00392912|cerebral glucose metabolism|cerebral glucose metabolism
664880|NCT00392912|PET scan|pet scan
664881|NCT00392912|Alzheimer's disease|alzheimer's disease
664882|NCT00392899|stage II colon cancer|stage ii colon cancer
664883|NCT00392899|stage II rectal cancer|stage ii rectal cancer
664884|NCT00392899|adenocarcinoma of the colon|adenocarcinoma of the colon
664885|NCT00392899|adenocarcinoma of the rectum|adenocarcinoma of the rectum
664886|NCT00392886|untreated childhood medulloblastoma|untreated childhood medulloblastoma
664887|NCT00392886|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
664888|NCT00392886|childhood infratentorial ependymoma|childhood infratentorial ependymoma
664889|NCT00392886|childhood supratentorial ependymoma|childhood supratentorial ependymoma
664890|NCT00392886|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
664891|NCT00392886|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
664892|NCT00392886|childhood oligodendroglioma|childhood oligodendroglioma
664893|NCT00392886|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
664894|NCT00392886|childhood choroid plexus tumor|childhood choroid plexus tumor
664895|NCT00392886|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
664896|NCT00392886|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
664897|NCT00392886|untreated childhood pineoblastoma|untreated childhood pineoblastoma
664898|NCT00392873|Amenorrhea|amenorrhea
664899|NCT00392873|Energy deficiency|energy deficiency
664900|NCT00392873|Resting energy expenditure|resting energy expenditure
664901|NCT00392873|Bone metabolism|bone metabolism
664902|NCT00392873|Bone mineral density|bone mineral density
664903|NCT00392873|Exercise|exercise
664904|NCT00392860|Wheelchair|wheelchair
664905|NCT00392860|Handrims|handrims
664906|NCT00392860|Rehabilitation|rehabilitation
664907|NCT00392860|Upper extremity|upper extremity
665175|NCT00391794|Dementia|dementia
664908|NCT00392847|Child mental disorder|child mental disorder
664909|NCT00392847|Home visit|home visit
664910|NCT00392847|Postnatal depression|postnatal depression
664911|NCT00392847|Social Support|social support
664912|NCT00392847|Random selection|random selection
664913|NCT00392834|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
664914|NCT00392834|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
664915|NCT00392834|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
664916|NCT00392834|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
664917|NCT00392834|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
664918|NCT00392834|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
664919|NCT00392808|Meningococcal vaccine|meningococcal vaccine
664920|NCT00392808|Immunization, secondary|immunization, secondary
664921|NCT00392808|vaccines conjugated|vaccines conjugated
664922|NCT00392808|Meningococcal disease|meningococcal disease
664923|NCT00392795|Critical Care|critical care
664924|NCT00392795|Delirium|delirium
664925|NCT00392795|Long-term cognitive impairment|long-term cognitive impairment
664926|NCT00392795|mechanical ventilation|mechanical ventilation
664927|NCT00392795|Critical illness|critical illness
664928|NCT00392795|dementia|dementia
664929|NCT00392795|sedatives and analgesics|sedatives and analgesics
664930|NCT00392795|aging|aging
664931|NCT00392782|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
664932|NCT00392782|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
664933|NCT00392782|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
664934|NCT00392782|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
664935|NCT00392782|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
664936|NCT00392782|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
664937|NCT00392782|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
664938|NCT00392782|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
664939|NCT00392782|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
664940|NCT00392782|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
664941|NCT00392782|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
664942|NCT00392782|secondary acute myeloid leukemia|secondary acute myeloid leukemia
664943|NCT00392782|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
664944|NCT00392782|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
664945|NCT00392782|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
664946|NCT00392782|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
664947|NCT00392782|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
664948|NCT00392769|Endometrial Cancer|endometrial cancer
664949|NCT00392769|Progressive or Recurrent Endometrial Cancer|progressive or recurrent endometrial cancer
664950|NCT00392769|Cetuximab|cetuximab
664951|NCT00392769|C225|c225
664952|NCT00392769|Erbitux™|erbitux™
664953|NCT00392769|IMC-C225|imc-c225
664954|NCT00392769|Epidermal growth factor receptor|epidermal growth factor receptor
664955|NCT00392769|EGFR|egfr
664956|NCT00392769|Endometrioid Tumor|endometrioid tumor
664957|NCT00392769|Serous Tumor|serous tumor
664958|NCT00392769|Clear cell Tumor|clear cell tumor
664959|NCT00392769|Mixed malignant Mullerian Tumors|mixed malignant mullerian tumors
664960|NCT00392756|Kallmann Syndrome|kallmann syndrome
664961|NCT00392756|Hypogonadotropic Hypogonadism|hypogonadotropic hypogonadism
664962|NCT00392756|GnRH deficiency|gnrh deficiency
664963|NCT00392756|Pulsatile GnRH|pulsatile gnrh
664964|NCT00392743|Bolus|bolus
664965|NCT00392743|11C-Raclopride|11c-raclopride
664966|NCT00392743|Schizophrenia|schizophrenia
664967|NCT00392743|123I-IBZM|123i-ibzm
664968|NCT00392743|SPECT|spect
664969|NCT00392743|Receptor Occupancy|receptor occupancy
664970|NCT00392743|PET|pet
664971|NCT00392743|MRI|mri
664972|NCT00392743|Antipsychotics|antipsychotics
664973|NCT00392743|Bolus/Infusion|bolus/infusion
664974|NCT00392730|Manganese|manganese
664975|NCT00392730|Neonatal Intensive Care|neonatal intensive care
664976|NCT00392730|MRI|mri
664977|NCT00392730|Parenteral Nutrition|parenteral nutrition
664978|NCT00392730|Prematurity|prematurity
664979|NCT00392717|lipoprotein metabolism|lipoprotein metabolism
664980|NCT00392717|cardiovascular disease|cardiovascular disease
664981|NCT00392717|obesity|obesity
664982|NCT00392691|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
664983|NCT00392691|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
664984|NCT00392691|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
664985|NCT00392691|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
664986|NCT00392691|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
664987|NCT00392691|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
664988|NCT00392691|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
664989|NCT00392691|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
664990|NCT00392691|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
664991|NCT00392691|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
664992|NCT00392691|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
664993|NCT00392691|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
664994|NCT00392691|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
664995|NCT00392691|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
664996|NCT00392691|splenic marginal zone lymphoma|splenic marginal zone lymphoma
664997|NCT00392691|Waldenström macroglobulinemia|waldenström macroglobulinemia
664998|NCT00392678|Type 2 Diabetes|type 2 diabetes
664999|NCT00392678|Inflammation|inflammation
665000|NCT00392678|Obesity|obesity
665001|NCT00392678|Metabolic Syndrome|metabolic syndrome
665002|NCT00392665|SCCHN|scchn
665003|NCT00392665|erlotinib|erlotinib
665004|NCT00392665|tarceva|tarceva
665005|NCT00392639|Heart arrest|heart arrest
665006|NCT00392639|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
665007|NCT00392639|Humans|humans
665008|NCT00392639|Hypothermia|hypothermia
665009|NCT00392639|Brain diseases|brain diseases
665010|NCT00392639|Hypoxia-ischemia|hypoxia-ischemia
665011|NCT00392639|Cost Benefit Analysis|cost benefit analysis
665012|NCT00392639|Prospective study|prospective study
665013|NCT00392639|Comparative study|comparative study
665014|NCT00392639|Treatment outcome|treatment outcome
665015|NCT00392639|Hypothermia for|hypothermia for
665016|NCT00392639|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
665017|NCT00392639|from cardiac origin|from cardiac origin
665018|NCT00392639|successfully resuscitated|successfully resuscitated
665019|NCT00392587|Pharmacodynamics|pharmacodynamics
665020|NCT00392587|Pharmacokinetics|pharmacokinetics
665021|NCT00392587|Tolerability|tolerability
665022|NCT00392587|COPD|copd
665023|NCT00392587|Safety|safety
665024|NCT00392574|Gastroenteritis|gastroenteritis
665025|NCT00392548|GBM|gbm
665026|NCT00392548|glioblastoma|glioblastoma
665027|NCT00392548|urine|urine
665028|NCT00392548|VEGF|vegf
665029|NCT00392548|radiation|radiation
665030|NCT00392548|Patients must be enrolled to an RTOG GBM study that prescribes 6000 cGy of radiation therapy.|patients must be enrolled to an rtog gbm study that prescribes 6000 cgy of radiation therapy.
665031|NCT00392535|adenocarcinoma of the prostate|adenocarcinoma of the prostate
665032|NCT00392535|stage IIB prostate cancer|stage iib prostate cancer
665033|NCT00392535|stage IIA prostate cancer|stage iia prostate cancer
665034|NCT00392535|stage III prostate cancer|stage iii prostate cancer
665035|NCT00392522|Anxiety|anxiety
665036|NCT00392522|Cough|cough
665037|NCT00392522|Number of general anaesthesias (due to procedure failure)|number of general anaesthesias (due to procedure failure)
665038|NCT00392522|Patients satisfaction|patients satisfaction
665039|NCT00392522|Chest physician satisfaction|chest physician satisfaction
665040|NCT00392509|critical limb ischemia|critical limb ischemia
665041|NCT00392509|cell therapy for angiogenesis|cell therapy for angiogenesis
665042|NCT00392509|aldehyde dehydrogenase-bright cells|aldehyde dehydrogenase-bright cells
665043|NCT00392509|peripheral artery disease|peripheral artery disease
665044|NCT00392509|peripheral vascular disease|peripheral vascular disease
665045|NCT00392509|leg pain|leg pain
665046|NCT00392509|PVD|pvd
665047|NCT00392509|PAD|pad
665048|NCT00392509|CLI|cli
665049|NCT00392509|amputation|amputation
665050|NCT00392509|limb salvage|limb salvage
665051|NCT00392483|Heading Health Plan Implementation|heading health plan implementation
665052|NCT00392483|Computer-Assisted Instruction|computer-assisted instruction
665053|NCT00392483|General Practice|general practice
665054|NCT00392483|Dementia|dementia
665055|NCT00392470|adenocarcinoma of the rectum|adenocarcinoma of the rectum
665056|NCT00392470|stage III rectal cancer|stage iii rectal cancer
665057|NCT00392470|stage IV rectal cancer|stage iv rectal cancer
665058|NCT00392457|Idiopathic Hypogonadotropic Hypogonadism|idiopathic hypogonadotropic hypogonadism
665059|NCT00392457|Kallmann Syndrome|kallmann syndrome
665060|NCT00392457|Agonadal|agonadal
665061|NCT00392418|iron deficiency anemia|iron deficiency anemia
665062|NCT00392418|hematologic disease|hematologic disease
665063|NCT00392418|infancy|infancy
665064|NCT00392418|pediatrics|pediatrics
665065|NCT00392418|Sprinkles®|sprinkles®
665066|NCT00392418|iron|iron
665067|NCT00392418|micronutrient|micronutrient
665068|NCT00392405|Contrast Induced Nephropathy|contrast induced nephropathy
665069|NCT00392392|Breast Cancer|breast cancer
665070|NCT00392379|Tobacco use disorder|tobacco use disorder
665071|NCT00392379|Tobacco cessation|tobacco cessation
665072|NCT00392366|MRI guided Laser Therapy|mri guided laser therapy
665073|NCT00392366|Laser Interstitial Thermal Therapy|laser interstitial thermal therapy
665074|NCT00392366|Magnetic Resonance Thermal Imaging|magnetic resonance thermal imaging
665075|NCT00392366|Liver Metastasis|liver metastasis
665076|NCT00392340|recurrent neuroblastoma|recurrent neuroblastoma
665077|NCT00392340|disseminated neuroblastoma|disseminated neuroblastoma
665078|NCT00392314|hodgkin lymphoma|hodgkin lymphoma
665079|NCT00392314|PET/CT|pet/ct
665080|NCT00392314|Therapy|therapy
665081|NCT00392301|wound healing|wound healing
665083|NCT00392301|graft donor site|graft donor site
665084|NCT00392301|donor site|donor site
665085|NCT00392301|transepidermal water loss|transepidermal water loss
665086|NCT00392288|Bronchial Asthma|bronchial asthma
665087|NCT00392275|Cataract|cataract
665088|NCT00392275|Aqueous absorption|aqueous absorption
665089|NCT00392275|Funtioning Filtering Blebs|funtioning filtering blebs
665090|NCT00392262|Moderate essential hypertension (WHO grade II)|moderate essential hypertension (who grade ii)
665091|NCT00392249|Schizophrenia|schizophrenia
665092|NCT00392249|Drug adherence|drug adherence
665093|NCT00392236|Schizoaffective Disorder|schizoaffective disorder
665094|NCT00392197|OPC-14597|opc-14597
665095|NCT00392197|Schizophrenia|schizophrenia
665096|NCT00392184|accelerated partial breast irradiation|accelerated partial breast irradiation
665097|NCT00392184|multicatheter brachytherapy|multicatheter brachytherapy
665098|NCT00392184|high dose rate brachytherapy|high dose rate brachytherapy
665099|NCT00392184|pulsed dose rate brachytherapy|pulsed dose rate brachytherapy
665100|NCT00392145|Pediatrics|pediatrics
665101|NCT00392145|Gastroenteritis|gastroenteritis
665102|NCT00392145|Dehydration|dehydration
665103|NCT00392145|IV Rehydration|iv rehydration
665104|NCT00392132|HIV|hiv
665105|NCT00392119|MR-guided therapy|mr-guided therapy
665106|NCT00392119|Laser interstitial thermal therapy|laser interstitial thermal therapy
665107|NCT00392119|brain metastasis|brain metastasis
665108|NCT00392119|Magnetic Resonance Thermal imaging (MRTI)|magnetic resonance thermal imaging (mrti)
665109|NCT00392106|atrial fibrillation|atrial fibrillation
665110|NCT00392106|arrhythmia|arrhythmia
665111|NCT00392106|AF ablation|af ablation
665112|NCT00392106|antiarrhythmic agent|antiarrhythmic agent
665113|NCT00392106|catheter ablation|catheter ablation
665114|NCT00392106|pulmonary veins|pulmonary veins
665115|NCT00392093|Systemic lupus erythematosus|systemic lupus erythematosus
665116|NCT00392093|Menopause hormonal therapy|menopause hormonal therapy
665117|NCT00392093|Menopausal symptoms|menopausal symptoms
665118|NCT00392093|Bone mineral density|bone mineral density
665119|NCT00392054|Atrial Fibrillation|atrial fibrillation
665120|NCT00392054|Paroxysmal|paroxysmal
665121|NCT00392054|Pulmonary Vein Isolation|pulmonary vein isolation
665122|NCT00392054|Ablation Catheter|ablation catheter
665123|NCT00392054|Anti-arrhythmic Drug Therapy|anti-arrhythmic drug therapy
665124|NCT00392054|First Line Therapy|first line therapy
665125|NCT00392041|Fibromyalgia|fibromyalgia
665126|NCT00392041|Insomnia|insomnia
665127|NCT00392041|Sleep|sleep
665128|NCT00392041|Eszopiclone|eszopiclone
665129|NCT00392041|Lunesta|lunesta
665130|NCT00392028|Ertapenem|ertapenem
665131|NCT00392028|Bone drug level|bone drug level
665132|NCT00392028|Blood drug level|blood drug level
665133|NCT00392028|Tissue drug level|tissue drug level
665134|NCT00392015|Malaria Vaccine|malaria vaccine
665135|NCT00392015|Adenovirus|adenovirus
665136|NCT00392015|Plasmodium falciparum|plasmodium falciparum
665137|NCT00392002|GERD|gerd
665138|NCT00391989|Ph+ Acute Lymphoblastic Leukaemia|ph+ acute lymphoblastic leukaemia
665139|NCT00391989|Dasatinib|dasatinib
665140|NCT00391989|targeted therapy|targeted therapy
665141|NCT00391989|Patients with Ph positive and or BCR ABL positive ALL|patients with ph positive and or bcr abl positive all
665142|NCT00391976|Cystic fibrosis|cystic fibrosis
665143|NCT00391950|Prostate cancer|prostate cancer
665144|NCT00391950|Cancer treatment induced bone loss (CTIBL)|cancer treatment induced bone loss (ctibl)
665145|NCT00391950|Androgen deprivation therapy (ADT)|androgen deprivation therapy (adt)
665146|NCT00391937|"resurfacing hip [MESH]"|"resurfacing hip [mesh]"
665147|NCT00391937|"conventional position method"|"conventional position method"
665148|NCT00391937|"surgery, computer-assisted [MESH]"|"surgery, computer-assisted [mesh]"
665149|NCT00391924|Dehydroepiandrosterone|dehydroepiandrosterone
665150|NCT00391924|Fatigue|fatigue
665151|NCT00391924|Quality of life|quality of life
665152|NCT00391924|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
665153|NCT00391924|Sjogren's Syndrome|sjogren's syndrome
665154|NCT00391924|Bone mineral density|bone mineral density
665155|NCT00391911|Rhabdomyolysis|rhabdomyolysis
665156|NCT00391911|CRRT|crrt
665157|NCT00391911|N-Acetylcysteine|n-acetylcysteine
665158|NCT00391898|Parkinson's disease, adults, levodopa/carbidopa/entacapone, wearing-off, activities of daily living|parkinson's disease, adults, levodopa/carbidopa/entacapone, wearing-off, activities of daily living
665159|NCT00391872|ACS|acs
665160|NCT00391872|Acute coronary syndrome|acute coronary syndrome
665161|NCT00391872|Heart attack|heart attack
665162|NCT00391872|Unstable angina|unstable angina
665163|NCT00391872|Coronary artery disease|coronary artery disease
665164|NCT00391859|Pharmacist-initiated Intervention Trial in OsteoArthritis|pharmacist-initiated intervention trial in osteoarthritis
665165|NCT00391846|Heart Failure|heart failure
665166|NCT00391846|Ventricular Dysfunction|ventricular dysfunction
665167|NCT00391846|NTproBNP|ntprobnp
665168|NCT00391833|Alzheimer's disease, Ginseng, CD34|alzheimer's disease, ginseng, cd34
665169|NCT00391820|constipation|constipation
665170|NCT00391820|chronic|chronic
665171|NCT00391820|bowel function|bowel function
665172|NCT00391807|Contraception|contraception
665173|NCT00391794|Memory|memory
665174|NCT00391794|Alzheimer's disease|alzheimer's disease
665176|NCT00391794|Support Group|support group
665177|NCT00391794|Psychosocial|psychosocial
665178|NCT00391781|mechanical infertility|mechanical infertility
665179|NCT00391781|hysterosalpingogram|hysterosalpingogram
665180|NCT00391781|hysterosalpingography|hysterosalpingography
665181|NCT00391768|influenza, oseltamivir, Tamiflu®, antiviral, children, infants|influenza, oseltamivir, tamiflu®, antiviral, children, infants
665182|NCT00391755|Migraine Headache|migraine headache
665183|NCT00391742|Brief intervention|brief intervention
665184|NCT00391742|Motivational Interviewing|motivational interviewing
665185|NCT00391742|Primary care|primary care
665186|NCT00391742|Stepped-care|stepped-care
665187|NCT00391729|ADHD|adhd
665188|NCT00391716|Alcohol|alcohol
665189|NCT00391716|Alcohol treatment|alcohol treatment
665190|NCT00391716|Alcoholism|alcoholism
665191|NCT00391716|Alcohol Dependence|alcohol dependence
665192|NCT00391703|Cystic fibrosis|cystic fibrosis
665193|NCT00391703|mucoviscidosis|mucoviscidosis
665194|NCT00391703|electrostimulation|electrostimulation
665195|NCT00391703|retraining|retraining
665196|NCT00391690|Serum bone marker|serum bone marker
665197|NCT00391690|Prostate cancer|prostate cancer
665198|NCT00391690|Bisphosphonates|bisphosphonates
665199|NCT00391690|Early detection of metastasis|early detection of metastasis
665200|NCT00391677|Cognitive Rehabilitation|cognitive rehabilitation
665201|NCT00391677|Behavior Therapy|behavior therapy
665202|NCT00391664|Endometrial cancer|endometrial cancer
665203|NCT00391664|Ovarian Cancer|ovarian cancer
665204|NCT00391664|Cervical Cancer|cervical cancer
665205|NCT00391664|Genital Cancer|genital cancer
665206|NCT00391664|Vulvar Cancer|vulvar cancer
665207|NCT00391664|Vaginal Cancer|vaginal cancer
665208|NCT00391664|Other Gynecological Cancers|other gynecological cancers
665209|NCT00391651|UTI|uti
665210|NCT00391638|HIV and Hepatitis B coinfection|hiv and hepatitis b coinfection
665211|NCT00391638|Peg interferon|peg interferon
665212|NCT00391638|tenofovir|tenofovir
665213|NCT00391638|emtricitabine|emtricitabine
665214|NCT00391638|Hepatitis B e Antigens|hepatitis b e antigens
665215|NCT00391638|Treatment Experienced|treatment experienced
665216|NCT00391625|Gaucher disease, Enzyme Replacement Therapy|gaucher disease, enzyme replacement therapy
665217|NCT00391612|COPD (Chronic Obstructive Pulmonary Disease)|copd (chronic obstructive pulmonary disease)
665218|NCT00391612|Emphysema|emphysema
665219|NCT00391612|Hyperinflation|hyperinflation
665220|NCT00391612|Minimally Invasive|minimally invasive
665221|NCT00391599|Cesarean Section,|cesarean section,
665222|NCT00391599|Enema|enema
665223|NCT00391586|erlotinib|erlotinib
665224|NCT00391586|NSCLC|nsclc
665225|NCT00391586|chemotherapy|chemotherapy
665226|NCT00391586|platinum|platinum
665227|NCT00391586|lung|lung
665228|NCT00391586|lung cancer|lung cancer
665229|NCT00391560|refractory leukemia|refractory leukemia
665230|NCT00391547|Gingivitis Disease|gingivitis disease
665231|NCT00391534|Epilepsy|epilepsy
665232|NCT00391534|oxcarbazepine|oxcarbazepine
665233|NCT00391521|Oncology. All solid Tumour disease.|oncology. all solid tumour disease.
665234|NCT00391508|Ostomy|ostomy
665235|NCT00391508|Peristomal skin|peristomal skin
665236|NCT00391508|Skin complication|skin complication
665237|NCT00391495|ADHD|adhd
665238|NCT00391495|Cytokines|cytokines
665239|NCT00391495|CR-P|cr-p
665240|NCT00391482|IV Drug Users|iv drug users
665241|NCT00391482|Hepatitis C Virus|hepatitis c virus
665242|NCT00391482|Human Immunodeficiency Virus|human immunodeficiency virus
665243|NCT00391482|Intervention|intervention
665244|NCT00391482|HIV Seronegativity|hiv seronegativity
665245|NCT00391469|cardiac arrest|cardiac arrest
665246|NCT00391469|mild hypothermia|mild hypothermia
665247|NCT00391456|animal-assisted therapy|animal-assisted therapy
665248|NCT00391456|dog hospital visit|dog hospital visit
665249|NCT00391456|heart failure|heart failure
665250|NCT00391443|BUILD 3|build 3
665251|NCT00391443|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
665252|NCT00391443|Tracleer|tracleer
665253|NCT00391443|Interstitial Lung Disease|interstitial lung disease
665254|NCT00391443|bosentan|bosentan
665255|NCT00391443|Actelion|actelion
665256|NCT00391430|PTSD|ptsd
665257|NCT00391430|Trauma|trauma
665258|NCT00391430|Sexual Abuse|sexual abuse
665259|NCT00391430|Sexual Assault|sexual assault
665260|NCT00391417|hot flush|hot flush
665261|NCT00391417|hot flash|hot flash
665262|NCT00391417|estrogen|estrogen
665263|NCT00391417|vaginal atrophy|vaginal atrophy
665264|NCT00391404|Childhood cancer survivors|childhood cancer survivors
665265|NCT00391404|Osteoporosis|osteoporosis
665266|NCT00391404|Bone mineral density|bone mineral density
665267|NCT00391404|Therapy|therapy
665268|NCT00391404|Bisphosphonate|bisphosphonate
665269|NCT00391404|Randomized controlled trial|randomized controlled trial
665270|NCT00391391|Influenza|influenza
665271|NCT00391391|Orthomyxoviruses|orthomyxoviruses
665272|NCT00391391|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
665273|NCT00391391|Infants|infants
665274|NCT00391391|children.|children.
665275|NCT00391378|Diffusion-Weighted Magnetic Resonance Imaging|diffusion-weighted magnetic resonance imaging
665276|NCT00391378|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
665277|NCT00391378|Stroke|stroke
665278|NCT00391378|Cognition|cognition
665279|NCT00391378|Heart|heart
665280|NCT00391365|ankle osteoarthritis|ankle osteoarthritis
665281|NCT00391365|arthritis|arthritis
665282|NCT00391365|arthrodesis|arthrodesis
665283|NCT00391365|arthroplasty|arthroplasty
665284|NCT00391365|Gait|gait
665285|NCT00391365|step count|step count
665286|NCT00391365|walking|walking
665287|NCT00391352|Multiple Sclerosis|multiple sclerosis
665288|NCT00391352|Disease Modifying Therapy|disease modifying therapy
665289|NCT00391339|Bryophyllum p.|bryophyllum p.
665290|NCT00391339|Nifedipine|nifedipine
665291|NCT00391339|Tocolysis|tocolysis
665292|NCT00391326|Bivalirudin|bivalirudin
665293|NCT00391326|Heparin|heparin
665294|NCT00391326|Bleeding|bleeding
665295|NCT00391326|TIMI flow|timi flow
665296|NCT00391326|STEMI|stemi
665297|NCT00391313|Chikungunya|chikungunya
665298|NCT00391313|Chikungunya disease|chikungunya disease
665299|NCT00391300|melanoma|melanoma
665300|NCT00391300|basal cell carcinoma of the skin|basal cell carcinoma of the skin
665301|NCT00391300|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
665302|NCT00391287|Red-Cell Aplasia due to Chronic Kidney Failure|red-cell aplasia due to chronic kidney failure
665303|NCT00391287|Aplastic Anemia|aplastic anemia
665304|NCT00391287|Recombinant Erythropoietin|recombinant erythropoietin
665305|NCT00391287|Surveillance Registry|surveillance registry
665306|NCT00391287|Registries|registries
665307|NCT00391261|weight gain|weight gain
665308|NCT00391261|obesity|obesity
665309|NCT00391261|metabolism|metabolism
665310|NCT00391248|non-small cell lung cancer|non-small cell lung cancer
665311|NCT00391248|palliative radiation|palliative radiation
665312|NCT00391248|tarceva|tarceva
665313|NCT00391248|palliative thoracic radiation therapy|palliative thoracic radiation therapy
665314|NCT00391235|bipolar disorder|bipolar disorder
665315|NCT00391235|magnetic resonance imaging|magnetic resonance imaging
665316|NCT00391235|white matter|white matter
665317|NCT00391235|diffusion tensor imaging|diffusion tensor imaging
665318|NCT00391235|children|children
665319|NCT00391235|adolescents|adolescents
665320|NCT00391222|Bipolar I Disorder|bipolar i disorder
665321|NCT00391222|Intramuscular injection|intramuscular injection
665322|NCT00391222|prevention of mood episodes|prevention of mood episodes
665323|NCT00391222|long acting injectable|long acting injectable
665324|NCT00391222|risperidone|risperidone
665325|NCT00391183|Gallbladder cancer|gallbladder cancer
665326|NCT00391183|Quality of life|quality of life
665327|NCT00391183|Stenting|stenting
665328|NCT00391183|Survival|survival
665329|NCT00391183|Performance status|performance status
665330|NCT00391170|Oral Chronic GVHD|oral chronic gvhd
665331|NCT00391170|Topical Dexamethasone|topical dexamethasone
665332|NCT00391170|Tissue Markers|tissue markers
665333|NCT00391170|Salivary Proteomics|salivary proteomics
665334|NCT00391170|Quality of Life|quality of life
665335|NCT00391170|Oral Chronic Graft Versus Host Disease|oral chronic graft versus host disease
665336|NCT00391170|Oral Pain|oral pain
665337|NCT00391170|Mouth Pain|mouth pain
665338|NCT00391157|Múltiple Myeloma|múltiple myeloma
665339|NCT00391157|Transplant|transplant
665340|NCT00391157|Patients <65 years.|patients <65 years.
665341|NCT00391144|Pattern Dystrophy|pattern dystrophy
665342|NCT00391144|Choroidal Neovascularization|choroidal neovascularization
665343|NCT00391144|Intravitreal Avastin Injection|intravitreal avastin injection
665344|NCT00391131|PID|pid
665345|NCT00391131|SCIG|scig
665346|NCT00391131|Ig|ig
665347|NCT00391131|Quality of Life|quality of life
665348|NCT00391131|Serious Bacterial Infections|serious bacterial infections
665349|NCT00391105|intubation|intubation
665350|NCT00391105|Sedation|sedation
665351|NCT00391105|Analgesia|analgesia
665352|NCT00391105|preterm neonate|preterm neonate
665353|NCT00391105|remifentanil|remifentanil
665354|NCT00391105|morphine|morphine
665355|NCT00391105|respiratory distress syndrome|respiratory distress syndrome
665356|NCT00391079|Central Neuropathic Pain|central neuropathic pain
665357|NCT00391066|CD23+/CD20+ B-cell CLL|cd23+/cd20+ b-cell cll
665358|NCT00391066|CLL|cll
665359|NCT00391053|Influenza|influenza
665360|NCT00391053|Orthomyxoviruses|orthomyxoviruses
665361|NCT00391053|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
665362|NCT00391053|Adults|adults
665363|NCT00391040|diabetes mellitus, structured treatment and teaching, education,|diabetes mellitus, structured treatment and teaching, education,
665364|NCT00391040|elderly patients, geriatrics|elderly patients, geriatrics
665365|NCT00391027|type 2 diabetes, insulin, glycemic control|type 2 diabetes, insulin, glycemic control
665366|NCT00391014|Acute myeloid Leukemia|acute myeloid leukemia
665367|NCT00391014|Allogeneic haematopoietic progenitor cell transplant|allogeneic haematopoietic progenitor cell transplant
665368|NCT00391014|Acute Invasive Aspergillosis|acute invasive aspergillosis
665369|NCT00391001|mania|mania
665370|NCT00391001|bipolar disorder|bipolar disorder
665371|NCT00391001|taurine|taurine
665372|NCT00391001|adolescents|adolescents
665373|NCT00390988|blood count|blood count
665374|NCT00390988|capillary|capillary
665375|NCT00390988|venous|venous
665376|NCT00390988|Adult|adult
665377|NCT00390988|reference values|reference values
665378|NCT00390975|Tegaserod|tegaserod
665379|NCT00390975|diabetes|diabetes
665380|NCT00390975|diabetic gastroparesis|diabetic gastroparesis
665381|NCT00390975|gastric emptying|gastric emptying
665382|NCT00390975|gastric retention|gastric retention
665383|NCT00390975|electrogastrography|electrogastrography
665384|NCT00390962|copeptin|copeptin
665385|NCT00390962|vasopressin|vasopressin
665386|NCT00390962|Adh|adh
665387|NCT00390962|SIADH|siadh
665388|NCT00390962|diabetes insipidus|diabetes insipidus
665389|NCT00390962|stroke|stroke
665390|NCT00390962|risk factors|risk factors
665391|NCT00390962|Neurological patients with ischemic and hemorrhagic stroke and patients undergoing intracranial surgery.|neurological patients with ischemic and hemorrhagic stroke and patients undergoing intracranial surgery.
665392|NCT00390949|HIV prevention|hiv prevention
665393|NCT00390949|Zimbabwe|zimbabwe
665394|NCT00390949|Core groups|core groups
665395|NCT00390949|Peer education|peer education
665396|NCT00390949|Syndromic management|syndromic management
665397|NCT00390949|Commercial sex workers|commercial sex workers
665398|NCT00390949|Condom distribution|condom distribution
665399|NCT00390949|HIV Seronegativity|hiv seronegativity
665400|NCT00390923|smoking|smoking
665401|NCT00390923|nicotine dependence|nicotine dependence
665402|NCT00390923|double-blind|double-blind
665403|NCT00390923|placebo-controlled|placebo-controlled
665404|NCT00390923|randomized|randomized
665405|NCT00390923|full substitution therapy|full substitution therapy
665406|NCT00390923|selegiline|selegiline
665407|NCT00390910|Pneumococcal vaccine|pneumococcal vaccine
665408|NCT00390910|Preterm|preterm
665409|NCT00390910|Safety|safety
665410|NCT00390910|Pneumococcal disease|pneumococcal disease
665411|NCT00390910|Immunogenicity|immunogenicity
665412|NCT00390897|chronic myeloid leukaemia|chronic myeloid leukaemia
665413|NCT00390897|Glivec|glivec
665414|NCT00390897|Interferon|interferon
665415|NCT00390884|Fluzone®|fluzone®
665416|NCT00390884|Influenza|influenza
665417|NCT00390884|Influenza virus infection|influenza virus infection
665418|NCT00390884|Influenza vaccine|influenza vaccine
665419|NCT00390871|Patient|patient
665420|NCT00390871|Must be|must be
665421|NCT00390871|Under|under
665422|NCT00390858|β-thalassemia major|β-thalassemia major
665423|NCT00390858|iron overload|iron overload
665424|NCT00390858|deferasirox|deferasirox
665425|NCT00390858|pediatric rare anemia|pediatric rare anemia
665426|NCT00390845|MAP kinase|map kinase
665427|NCT00390845|SB681323|sb681323
665428|NCT00390845|neuropathic pain|neuropathic pain
665429|NCT00390845|patients|patients
665430|NCT00390845|P38|p38
665431|NCT00390845|nerve trauma|nerve trauma
665432|NCT00390832|STEMI|stemi
665433|NCT00390819|Community acquired pneumonia|community acquired pneumonia
665434|NCT00390806|Brain metastases from Non-Small Cell Lung Cancer|brain metastases from non-small cell lung cancer
665435|NCT00390806|Brain metastases brain tumor lung cancer oral chemotherapy HYCAMTIN topotecan NSCLC WBRT whole brain radiation|brain metastases brain tumor lung cancer oral chemotherapy hycamtin topotecan nsclc wbrt whole brain radiation
665436|NCT00390793|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
665437|NCT00390793|Leukemia|leukemia
665438|NCT00390793|ALL|all
665439|NCT00390793|Philadelphia-Positive ALL|philadelphia-positive all
665440|NCT00390793|BCR-ABL Positive ALL|bcr-abl positive all
665441|NCT00390793|Dasatinib|dasatinib
665442|NCT00390793|Hyper-CVAD|hyper-cvad
665443|NCT00390793|Cyclophosphamide|cyclophosphamide
665444|NCT00390793|Cytoxan|cytoxan
665445|NCT00390793|Vincristine|vincristine
665446|NCT00390793|Vincasar|vincasar
665447|NCT00390793|Doxorubicin|doxorubicin
665448|NCT00390793|Adriamycin|adriamycin
665449|NCT00390793|Dexamethasone|dexamethasone
665450|NCT00390793|Decadron|decadron
665451|NCT00390793|Sprycel|sprycel
665452|NCT00390780|Miconazole Lauriad|miconazole lauriad
665453|NCT00390780|Oropharyngeal candidiasis|oropharyngeal candidiasis
665454|NCT00390780|HIV patients|hiv patients
665455|NCT00390780|Mycology|mycology
665456|NCT00390780|Clinical picture of Oropharyngeal candidiasis|clinical picture of oropharyngeal candidiasis
665457|NCT00390780|Candida culture positive|candida culture positive
665458|NCT00390780|Treatment Experienced|treatment experienced
665459|NCT00390767|Peripheral arterial disease|peripheral arterial disease
665460|NCT00390767|Peripheral vascular disease|peripheral vascular disease
665461|NCT00390767|Claudication|claudication
665462|NCT00390767|Cell therapy|cell therapy
665463|NCT00390767|Gene therapy|gene therapy
665464|NCT00390767|Endothelial cells|endothelial cells
665465|NCT00390767|Smooth muscle cells|smooth muscle cells
665466|NCT00390767|Angiogenesis|angiogenesis
665467|NCT00390754|pregnancy|pregnancy
665468|NCT00390754|unintended|unintended
665469|NCT00390754|menses|menses
665470|NCT00390741|hip fracture|hip fracture
665471|NCT00390741|bone mineral density|bone mineral density
665472|NCT00390741|exercise|exercise
665473|NCT00390715|Acute Myeloblastic Leukemia|acute myeloblastic leukemia
665474|NCT00390702|Ventricular septal defect|ventricular septal defect
665475|NCT00390702|VSD|vsd
665476|NCT00390676|cancer|cancer
665477|NCT00390676|tumors|tumors
665478|NCT00390676|anticarcinogenic agents|anticarcinogenic agents
665479|NCT00390676|antineoplastic agents|antineoplastic agents
665480|NCT00390676|cadherins|cadherins
665481|NCT00390676|solid tumors|solid tumors
665482|NCT00390663|Paediatric|paediatric
665483|NCT00390663|Epistaxis|epistaxis
665484|NCT00390663|Nose bleed|nose bleed
665485|NCT00390663|Naseptin|naseptin
665486|NCT00390650|Anxiety|anxiety
665487|NCT00390650|clinical trials|clinical trials
665488|NCT00390637|Diogenes|diogenes
665489|NCT00390637|Diet Intervention|diet intervention
665490|NCT00390637|Family|family
665491|NCT00390637|Glycemic Index|glycemic index
665492|NCT00390637|Protein|protein
665493|NCT00390624|Urodilatin|urodilatin
665494|NCT00390624|Mannitol|mannitol
665495|NCT00390624|Acute Kidney Failure|acute kidney failure
665496|NCT00390611|Ovarian Cancer|ovarian cancer
665497|NCT00390598|colonoscopy|colonoscopy
665498|NCT00390598|large bowel preparation|large bowel preparation
665499|NCT00390598|bowel cleansing|bowel cleansing
665500|NCT00390598|randomized controlled trial|randomized controlled trial
665501|NCT00390585|Renal Insufficiency|renal insufficiency
665502|NCT00390585|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
665503|NCT00390585|Contrast media|contrast media
665504|NCT00390572|sleep|sleep
665505|NCT00390572|consultation and referral|consultation and referral
665506|NCT00390572|outcome assessment|outcome assessment
665507|NCT00390572|primary care|primary care
665508|NCT00390559|Nicotine Replacement Therapy|nicotine replacement therapy
665509|NCT00390559|Tobacco Smoking|tobacco smoking
665510|NCT00390559|Smoking stimuli|smoking stimuli
665512|NCT00390533|Anxiety|anxiety
665513|NCT00390533|clinical trials|clinical trials
665514|NCT00390520|Type 2 diabetes|type 2 diabetes
665515|NCT00390520|vildagliptin|vildagliptin
665516|NCT00390520|glucagon|glucagon
665517|NCT00390520|hypoglycemia|hypoglycemia
665518|NCT00390507|Acceleromyography|acceleromyography
665519|NCT00390507|TOF-Watch|tof-watch
665520|NCT00390507|Posttetanic count|posttetanic count
665521|NCT00390507|Train of four|train of four
665522|NCT00390507|Neuromuscular blockade|neuromuscular blockade
665523|NCT00390494|Fibroids|fibroids
665524|NCT00390494|Leiomyoma|leiomyoma
665525|NCT00390494|Hysterectomy|hysterectomy
665526|NCT00390494|Myomectomy|myomectomy
665527|NCT00390494|Uterine Fibroid Embolization|uterine fibroid embolization
665528|NCT00390494|Questionnaire|questionnaire
665529|NCT00390481|Carotid Occlusion|carotid occlusion
665530|NCT00390481|Cognition|cognition
665531|NCT00390468|Tandutinib|tandutinib
665532|NCT00390468|MLN518|mln518
665533|NCT00390468|CT53518|ct53518
665534|NCT00390468|pain|pain
665535|NCT00390468|adenocarcinoma of the prostate|adenocarcinoma of the prostate
665536|NCT00390468|recurrent prostate cancer|recurrent prostate cancer
665537|NCT00390468|stage IV prostate cancer|stage iv prostate cancer
665538|NCT00390468|bone metastases|bone metastases
665539|NCT00390468|hormone-based castration|hormone-based castration
665540|NCT00390442|cardiogenic pulmonary edema|cardiogenic pulmonary edema
665541|NCT00390442|non invasive ventilation|non invasive ventilation
665542|NCT00390442|CPAP|cpap
665543|NCT00390429|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
665544|NCT00390429|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
665545|NCT00390429|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
665546|NCT00390429|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
665547|NCT00390416|Metastatic|metastatic
665548|NCT00390416|Gastroesophageal|gastroesophageal
665549|NCT00390416|Docetaxel|docetaxel
665550|NCT00390416|Cisplatin|cisplatin
665551|NCT00390416|Fluorouracil|fluorouracil
665552|NCT00390416|Bevacizumab|bevacizumab
665553|NCT00390416|Metastatic Gastroesophageal Adenocarcinoma|metastatic gastroesophageal adenocarcinoma
665554|NCT00390416|06-096|06-096
665555|NCT00390403|adult glioblastoma|adult glioblastoma
665556|NCT00390403|adult gliosarcoma|adult gliosarcoma
665557|NCT00390403|adult giant cell glioblastoma|adult giant cell glioblastoma
665558|NCT00390390|Heartburn, frequent heartburn, proton pump inhibitor, lansoprazole|heartburn, frequent heartburn, proton pump inhibitor, lansoprazole
665559|NCT00390377|x-ray diffraction|x-ray diffraction
665560|NCT00390377|hair|hair
665561|NCT00390377|breast cancer|breast cancer
665562|NCT00390377|synchrotron|synchrotron
665563|NCT00390364|adenocarcinoma of the colon|adenocarcinoma of the colon
665564|NCT00390364|adenocarcinoma of the rectum|adenocarcinoma of the rectum
665565|NCT00390364|recurrent colon cancer|recurrent colon cancer
665566|NCT00390364|stage III colon cancer|stage iii colon cancer
665567|NCT00390364|stage IV colon cancer|stage iv colon cancer
665568|NCT00390364|recurrent rectal cancer|recurrent rectal cancer
665569|NCT00390364|stage III rectal cancer|stage iii rectal cancer
665570|NCT00390364|stage IV rectal cancer|stage iv rectal cancer
665571|NCT00390351|Optical coherence tomography|optical coherence tomography
665572|NCT00390338|recurrent melanoma|recurrent melanoma
665573|NCT00390338|stage IV melanoma|stage iv melanoma
665574|NCT00390338|stage IIIA melanoma|stage iiia melanoma
665575|NCT00390338|stage IIIB melanoma|stage iiib melanoma
665576|NCT00390338|stage IIIC melanoma|stage iiic melanoma
665577|NCT00390312|Post operative pain|post operative pain
665578|NCT00390312|Third molar extraction|third molar extraction
665579|NCT00390312|Dental surgery|dental surgery
665580|NCT00390312|Morphine|morphine
665581|NCT00390286|Telemedicine|telemedicine
665582|NCT00390273|diabetes|diabetes
665583|NCT00390273|metformin|metformin
665584|NCT00390273|hyperlactatemia|hyperlactatemia
665585|NCT00390221|MS|ms
665586|NCT00390221|multiple sclerosis|multiple sclerosis
665587|NCT00390208|Macular Degeneration|macular degeneration
665588|NCT00390208|Degenerative changes in the macula lutea of the retina.|degenerative changes in the macula lutea of the retina.
665589|NCT00390208|Maculopathy, Age-Related|maculopathy, age-related
665590|NCT00390208|Age-Related Maculopathies|age-related maculopathies
665591|NCT00390208|Age-Related Maculopathy|age-related maculopathy
665592|NCT00390208|Maculopathies, Age-Related|maculopathies, age-related
665593|NCT00390208|RETINAL DEGENERATION|retinal degeneration
665594|NCT00390208|ARMD|armd
665595|NCT00390208|AMD|amd
665596|NCT00390208|Lucentis|lucentis
665597|NCT00390208|Visudyne|visudyne
665598|NCT00390208|Photodynamic Therapy|photodynamic therapy
665599|NCT00390208|Verteporfin|verteporfin
665600|NCT00390208|Ranibizumab|ranibizumab
665601|NCT00390208|Intravitreal Dexamethasone|intravitreal dexamethasone
665602|NCT00390195|Hepatocellular carcinoma|hepatocellular carcinoma
665603|NCT00390195|RAD001|rad001
665604|NCT00390195|Rapamycin|rapamycin
665605|NCT00390195|Randomize|randomize
665606|NCT00390195|Phase I|phase i
665607|NCT00390195|Phase II|phase ii
665608|NCT00390195|Pharmacokinetics|pharmacokinetics
665609|NCT00390182|GI tumors|gi tumors
665610|NCT00390182|Locally Advanced|locally advanced
665611|NCT00390182|Metastatic|metastatic
665612|NCT00390182|Hepatobiliary|hepatobiliary
665613|NCT00390182|Ovary|ovary
665614|NCT00390169|breast neoplasms|breast neoplasms
665615|NCT00390169|stress|stress
665616|NCT00390169|personality|personality
665617|NCT00390169|psychology|psychology
665618|NCT00390156|refractory|refractory
665619|NCT00390156|prior treatment|prior treatment
665620|NCT00390156|solid tumors|solid tumors
665621|NCT00390156|phase I|phase i
665622|NCT00390156|phase 1|phase 1
665623|NCT00390143|Immunogenicity|immunogenicity
665624|NCT00390143|Meningococcal vaccine|meningococcal vaccine
665625|NCT00390143|Conjugate vaccine|conjugate vaccine
665626|NCT00390143|Persistence|persistence
665627|NCT00390130|Vaccination|vaccination
665628|NCT00390130|Pediatrics|pediatrics
665629|NCT00390130|Pain|pain
665630|NCT00390117|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
665631|NCT00390117|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
665632|NCT00390117|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
665633|NCT00390117|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
665634|NCT00390117|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
665635|NCT00390117|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
665636|NCT00390117|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
665637|NCT00390117|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
665638|NCT00390117|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
665639|NCT00390117|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
665640|NCT00390117|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
665641|NCT00390117|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
665642|NCT00390117|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
665643|NCT00390117|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
665644|NCT00390117|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
665645|NCT00390117|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
665646|NCT00390117|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
665647|NCT00390117|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
665648|NCT00390117|splenic marginal zone lymphoma|splenic marginal zone lymphoma
665649|NCT00390104|Neuromuscular Disease|neuromuscular disease
665650|NCT00390104|Muscle weakness|muscle weakness
665651|NCT00390104|Muscle atrophy|muscle atrophy
665652|NCT00390091|Lupus|lupus
665653|NCT00390091|Nephritis|nephritis
665654|NCT00390091|Kidney|kidney
665655|NCT00390091|SLE|sle
665656|NCT00390091|Systemic Lupus Erythematosus|systemic lupus erythematosus
665657|NCT00390091|Nephritis, Lupus|nephritis, lupus
665658|NCT00390078|Vaccine|vaccine
665659|NCT00390078|Safety|safety
665660|NCT00390078|T-cell epitope|t-cell epitope
665661|NCT00390078|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
665662|NCT00390078|HIV Therapeutic Vaccine|hiv therapeutic vaccine
665663|NCT00390065|Follow-up|follow-up
665664|NCT00390065|Premature infants|premature infants
665665|NCT00390065|Nitric Oxide|nitric oxide
665666|NCT00390065|Respiratory function testing|respiratory function testing
665667|NCT00390065|Neurodevelopmental outcomes|neurodevelopmental outcomes
665668|NCT00390039|Pain, postoperative|pain, postoperative
665669|NCT00390039|Surgery, orthopedic|surgery, orthopedic
665670|NCT00390039|Morphine|morphine
665671|NCT00390026|Neovascular age-related macular degeneration|neovascular age-related macular degeneration
665672|NCT00390026|Bevacizumab|bevacizumab
665673|NCT00390026|Photodynamic therapy|photodynamic therapy
665674|NCT00390013|Vulvar Pain|vulvar pain
665675|NCT00389948|Heartburn, frequent heartburn, proton pump inhibitor, lansoprazole|heartburn, frequent heartburn, proton pump inhibitor, lansoprazole
665676|NCT00389935|Gastrointestinal Bleeding|gastrointestinal bleeding
665677|NCT00389935|Arteriovenous Malformation|arteriovenous malformation
665678|NCT00389935|Angiodysplasia|angiodysplasia
665679|NCT00389935|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
665680|NCT00389935|Obscure Bleeding|obscure bleeding
665681|NCT00389922|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
665682|NCT00389909|Premature infants|premature infants
665683|NCT00389909|Apnea|apnea
665684|NCT00389909|Doxapram|doxapram
665685|NCT00389909|pharmacokinetics|pharmacokinetics
665686|NCT00389883|supratentorial brain tumors|supratentorial brain tumors
665687|NCT00389883|propofol|propofol
665688|NCT00389883|sevoflurane|sevoflurane
665689|NCT00389883|remifentanil|remifentanil
665690|NCT00389883|sufentanil.|sufentanil.
665691|NCT00389870|recurrent colon cancer|recurrent colon cancer
665692|NCT00389870|stage IV colon cancer|stage iv colon cancer
665693|NCT00389870|recurrent rectal cancer|recurrent rectal cancer
665694|NCT00389870|stage IV rectal cancer|stage iv rectal cancer
665695|NCT00389870|adenocarcinoma of the colon|adenocarcinoma of the colon
665696|NCT00389870|adenocarcinoma of the rectum|adenocarcinoma of the rectum
665697|NCT00389857|Influenza|influenza
665698|NCT00389857|Influenza Virus Vaccine|influenza virus vaccine
665699|NCT00389857|Fluzone®|fluzone®
665700|NCT00389844|hip fracture|hip fracture
665701|NCT00389844|exercise|exercise
665702|NCT00389844|motivation|motivation
665703|NCT00389831|Rotigotine|rotigotine
665704|NCT00389831|Rotigotine nasal spray|rotigotine nasal spray
665705|NCT00389831|Efficacy, safety and tolerability|efficacy, safety and tolerability
665706|NCT00389831|Restless Legs Syndrome|restless legs syndrome
665707|NCT00389818|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
665708|NCT00389818|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
665709|NCT00389818|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
665710|NCT00389818|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
665711|NCT00389818|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
665712|NCT00389818|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
665713|NCT00389818|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
665714|NCT00389818|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
665715|NCT00389818|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
665716|NCT00389818|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
665717|NCT00389818|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
665718|NCT00389818|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
665719|NCT00389818|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
665720|NCT00389818|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
665721|NCT00389818|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
665722|NCT00389818|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
665723|NCT00389818|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
665724|NCT00389818|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
665725|NCT00389805|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
665726|NCT00389805|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
665727|NCT00389805|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
665728|NCT00389805|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
665729|NCT00389766|localized unresectable neuroblastoma|localized unresectable neuroblastoma
665730|NCT00389766|recurrent neuroblastoma|recurrent neuroblastoma
665731|NCT00389766|regional neuroblastoma|regional neuroblastoma
665732|NCT00389766|localized resectable neuroblastoma|localized resectable neuroblastoma
665733|NCT00389766|disseminated neuroblastoma|disseminated neuroblastoma
665734|NCT00389753|Scars|scars
665735|NCT00389753|Hydratation|hydratation
665736|NCT00389753|After Treatment|after treatment
665737|NCT00389714|pedodontics|pedodontics
665738|NCT00389714|carious|carious
665739|NCT00389714|dental restoration|dental restoration
665740|NCT00389714|antibacterial|antibacterial
665741|NCT00389714|nanoparticles|nanoparticles
665742|NCT00389701|stage I multiple myeloma|stage i multiple myeloma
665743|NCT00389701|stage II multiple myeloma|stage ii multiple myeloma
665744|NCT00389701|stage III multiple myeloma|stage iii multiple myeloma
665745|NCT00389701|refractory multiple myeloma|refractory multiple myeloma
665746|NCT00389688|stage I non-small cell lung cancer|stage i non-small cell lung cancer
665747|NCT00389688|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
665748|NCT00389649|congestive heart failure|congestive heart failure
665749|NCT00389649|pacemaker|pacemaker
665750|NCT00389649|heart rate|heart rate
665751|NCT00389636|Diabetes|diabetes
665752|NCT00389636|Foot|foot
665753|NCT00389636|Extremity|extremity
665754|NCT00389636|Ulcer|ulcer
665755|NCT00389636|Wound|wound
665756|NCT00389636|Gauze|gauze
665757|NCT00389610|stage I pancreatic cancer|stage i pancreatic cancer
665758|NCT00389610|stage II pancreatic cancer|stage ii pancreatic cancer
665759|NCT00389610|stage III pancreatic cancer|stage iii pancreatic cancer
665760|NCT00389610|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
665761|NCT00389597|degenerative disc disease|degenerative disc disease
665762|NCT00389597|cervical arthroplasty|cervical arthroplasty
665763|NCT00389597|Mobi C|mobi c
665764|NCT00389597|multilevel|multilevel
665765|NCT00389597|anterior cervical discectomy and fusion|anterior cervical discectomy and fusion
665766|NCT00389584|cognitive/functional effects|cognitive/functional effects
665767|NCT00389584|poor performance status|poor performance status
665768|NCT00389584|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
665769|NCT00389584|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
665770|NCT00389584|adult tumors metastatic to brain|adult tumors metastatic to brain
665771|NCT00389584|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
665772|NCT00389584|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
665773|NCT00389558|Skin colonization|skin colonization
665774|NCT00389558|Antiseptic|antiseptic
665775|NCT00389558|Epicutaneocavous catheter dressing|epicutaneocavous catheter dressing
665776|NCT00389558|Infant|infant
665777|NCT00389532|Influenza|influenza
665778|NCT00389532|Influenza Vaccine|influenza vaccine
665779|NCT00389519|Hypertension/*etiology|hypertension/*etiology
665780|NCT00389519|Blood Pressure|blood pressure
665781|NCT00389519|Pediatric|pediatric
665782|NCT00389519|Adolescent|adolescent
665783|NCT00389519|Child|child
665784|NCT00389506|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
665785|NCT00389506|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
665786|NCT00389506|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
665787|NCT00389506|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
665788|NCT00389493|OCD|ocd
665789|NCT00389493|Augmentation|augmentation
665790|NCT00389493|Antipsychotics|antipsychotics
665791|NCT00389493|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
665792|NCT00389480|Solid Tumors|solid tumors
665793|NCT00389480|Solid Malignancies|solid malignancies
665794|NCT00389480|Phase I|phase i
665795|NCT00389467|stroke|stroke
665796|NCT00389467|ischemic stroke|ischemic stroke
665797|NCT00389467|blood clot|blood clot
665798|NCT00389467|Merci Retriever|merci retriever
665799|NCT00389467|Penumbra System|penumbra system
665800|NCT00389467|embolectomy|embolectomy
665801|NCT00389467|magnetic resonance imaging|magnetic resonance imaging
665802|NCT00389467|MRI|mri
665803|NCT00389467|CT|ct
665804|NCT00389467|SPOTRIAS|spotrias
665805|NCT00389454|Acetaminophen|acetaminophen
665806|NCT00389454|Fever|fever
665807|NCT00389454|cerebro spinal fluid|cerebro spinal fluid
665808|NCT00389454|Infants|infants
665809|NCT00389441|VEGFR inhibitor|vegfr inhibitor
665810|NCT00389441|tyrosine kinase inhibitor|tyrosine kinase inhibitor
665811|NCT00389441|anti-angiogenic|anti-angiogenic
665812|NCT00389441|carcinoma|carcinoma
665813|NCT00389441|papillary|papillary
665814|NCT00389441|follicular|follicular
665815|NCT00389441|medullary|medullary
665816|NCT00389441|anaplastic|anaplastic
665817|NCT00389428|Hematologic malignancies|hematologic malignancies
665818|NCT00389428|Malignancies, hematologic|malignancies, hematologic
665819|NCT00389428|Hematopoietic malignancies|hematopoietic malignancies
665820|NCT00389415|Type 2 Diabetes|type 2 diabetes
665821|NCT00389415|Vildagliptin|vildagliptin
665822|NCT00389415|HbA1c|hba1c
665823|NCT00389402|lipids|lipids
665824|NCT00389402|lipodystrophy|lipodystrophy
665825|NCT00389402|fat distribution|fat distribution
665826|NCT00389402|hiv-1|hiv-1
665827|NCT00389402|antiretroviral therapy|antiretroviral therapy
665828|NCT00389402|Treatment Naive|treatment naive
665829|NCT00389389|Advanced Solid Malignancies|advanced solid malignancies
665830|NCT00389389|Advanced solid tumors|advanced solid tumors
665831|NCT00389389|Cancer|cancer
665832|NCT00389389|Phase I|phase i
665833|NCT00389389|Solid tumors|solid tumors
665834|NCT00389389|Solid malignancies|solid malignancies
665835|NCT00389337|Sepsis|sepsis
665836|NCT00389337|SIRS|sirs
665837|NCT00389337|Biomarkers|biomarkers
665838|NCT00389337|xMAP|xmap
665839|NCT00389324|Primary immune deficiency|primary immune deficiency
665840|NCT00389311|Microbicide|microbicide
665841|NCT00389311|Safety|safety
665842|NCT00389311|HIV prevention|hiv prevention
665843|NCT00389311|HIV Seronegativity|hiv seronegativity
665844|NCT00389298|Chronic hepatitis C|chronic hepatitis c
665845|NCT00389298|Viral kinetics|viral kinetics
665846|NCT00389298|Phase II|phase ii
665847|NCT00389298|Pharmacokinetics (PK)|pharmacokinetics (pk)
665848|NCT00389298|Safety and tolerability|safety and tolerability
665849|NCT00389285|Carcinoma, renal cell|carcinoma, renal cell
665850|NCT00389285|interleukin-21|interleukin-21
665851|NCT00389285|sorafenib|sorafenib
665852|NCT00389285|Immunotherapy|immunotherapy
665853|NCT00389259|Insecticides|insecticides
665854|NCT00389259|Organophosphate|organophosphate
665855|NCT00389259|Scopolamine|scopolamine
665856|NCT00389259|randomized control study|randomized control study
665857|NCT00389259|Organophosphate or carbamate intoxication|organophosphate or carbamate intoxication
665858|NCT00389246|obesity|obesity
665859|NCT00389246|genetic consultation|genetic consultation
665860|NCT00389246|randomized controlled trial|randomized controlled trial
665861|NCT00389220|Coronary Disease|coronary disease
665862|NCT00389220|Coronary Stenosis|coronary stenosis
665863|NCT00389220|Angioplasty|angioplasty
665864|NCT00389220|Coronary Restenosis|coronary restenosis
665865|NCT00389220|Drug Eluting Stent|drug eluting stent
665866|NCT00389194|HIV-1 infection|hiv-1 infection
665867|NCT00389194|fat distribution|fat distribution
665868|NCT00389194|lipodystrophy|lipodystrophy
665869|NCT00389194|lipids|lipids
665870|NCT00389194|kidney function|kidney function
665871|NCT00389194|Treatment Experienced|treatment experienced
665872|NCT00389181|Unruptured brain arteriovenous malformation|unruptured brain arteriovenous malformation
665873|NCT00389181|AVM|avm
665874|NCT00389181|BAVM|bavm
665875|NCT00389181|Stroke|stroke
665876|NCT00389181|Intracranial Hemorrhage|intracranial hemorrhage
665877|NCT00389168|Hypertension|hypertension
665878|NCT00389168|Cardiac hypertrophy|cardiac hypertrophy
665879|NCT00389168|Angiotensin|angiotensin
665880|NCT00389168|Human|human
665881|NCT00389155|Advanced or metastatic transitional cell carcinoma of the urothelium|advanced or metastatic transitional cell carcinoma of the urothelium
665882|NCT00389142|pelvic pain|pelvic pain
665883|NCT00389142|urinary frequency|urinary frequency
665884|NCT00389142|painful bladder|painful bladder
665885|NCT00389142|urinary urgency|urinary urgency
665886|NCT00389129|Platelets|platelets
665887|NCT00389129|Aspirin Resistance|aspirin resistance
665888|NCT00389129|Platelet aggregation|platelet aggregation
665889|NCT00389090|temozolomide resistant|temozolomide resistant
665890|NCT00389090|anaplastic glioma|anaplastic glioma
665891|NCT00389090|anaplastic astrocytoma|anaplastic astrocytoma
665892|NCT00389090|anaplastic oligodendroglioma|anaplastic oligodendroglioma
665893|NCT00389090|anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
665894|NCT00389077|perifosine|perifosine
665895|NCT00389077|solid tumors|solid tumors
665896|NCT00389077|lymphomas|lymphomas
665897|NCT00389077|anticancer agent|anticancer agent
665898|NCT00389064|Generalised Anxiety Disorder|generalised anxiety disorder
665899|NCT00389064|GAD|gad
665900|NCT00389051|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
665901|NCT00389051|Malignant lymphoma|malignant lymphoma
665902|NCT00389038|headache|headache
665903|NCT00389038|coping skills training|coping skills training
665904|NCT00389038|amitriptyline|amitriptyline
665905|NCT00389038|attention control|attention control
665906|NCT00389025|Subject with clinical history of seasonal allergic conjunctivitis|subject with clinical history of seasonal allergic conjunctivitis
665907|NCT00389012|rehabilitation|rehabilitation
665908|NCT00389012|hemiplegic gait|hemiplegic gait
665909|NCT00389012|exercise therapy|exercise therapy
665910|NCT00389012|physical therapy|physical therapy
665911|NCT00388999|Multiple Myeloma|multiple myeloma
665912|NCT00388999|Stem Cell Transplant|stem cell transplant
665913|NCT00388999|rhMBL|rhmbl
665914|NCT00388973|Major Depressive Disorder|major depressive disorder
665915|NCT00388973|MDD|mdd
665916|NCT00388960|small cell lung cancer|small cell lung cancer
665917|NCT00388960|amrubicin|amrubicin
665918|NCT00388947|vaginal prolapse|vaginal prolapse
665919|NCT00388947|cystocele|cystocele
665920|NCT00388947|rectocele|rectocele
665921|NCT00388947|enterocele|enterocele
665922|NCT00388947|apical prolapse|apical prolapse
665923|NCT00388947|vaginal vault prolapse|vaginal vault prolapse
665924|NCT00388934|Percutaneous coronary intervention|percutaneous coronary intervention
665925|NCT00388934|Angina pectoris|angina pectoris
665926|NCT00388934|Stent|stent
665927|NCT00388921|Vitamin A|vitamin a
665928|NCT00388921|Children|children
665929|NCT00388921|Severe malnutrition|severe malnutrition
665930|NCT00388921|Retinol|retinol
665931|NCT00388921|Retinol binding protein|retinol binding protein
665932|NCT00388921|Diarrhoea|diarrhoea
665933|NCT00388921|ALRI|alri
665934|NCT00388921|Age 6-59 months|age 6-59 months
665935|NCT00388921|Either sex|either sex
665936|NCT00388921|Severe malnutrition as defined by the presence of any of the followings:|severe malnutrition as defined by the presence of any of the followings:
665937|NCT00388921|Bipedal oedema|bipedal oedema
666034|NCT00388622|Heart failure|heart failure
666035|NCT00388622|Adherence|adherence
665938|NCT00388921|Weight (measured after correction of dehydration) for height Z score <-3 of the National Center for Health Statistics (NCHS) reference|weight (measured after correction of dehydration) for height z score <-3 of the national center for health statistics (nchs) reference
665939|NCT00388921|Written informed consent of respective parents/ guardians for participation of the children in the study.|written informed consent of respective parents/ guardians for participation of the children in the study.
665940|NCT00388921|Children having diarrhoea (watery or invasive) or cough and cold or both for the last 48 hours.|children having diarrhoea (watery or invasive) or cough and cold or both for the last 48 hours.
665941|NCT00388908|vertebral fractures|vertebral fractures
665942|NCT00388908|osteoporosis|osteoporosis
665943|NCT00388908|prevention|prevention
665944|NCT00388908|case-finding|case-finding
665945|NCT00388908|quality improvement|quality improvement
665946|NCT00388895|Acute lymphoblastic Leukemia|acute lymphoblastic leukemia
665947|NCT00388869|renal artery|renal artery
665948|NCT00388869|calcium|calcium
665949|NCT00388869|CT|ct
665950|NCT00388869|hypertension|hypertension
665951|NCT00388856|antioxidant supplementation|antioxidant supplementation
665952|NCT00388856|preeclampsia|preeclampsia
665953|NCT00388856|prevention|prevention
665954|NCT00388843|carotid atherosclerosis|carotid atherosclerosis
665955|NCT00388843|magnetic resonance imaging|magnetic resonance imaging
665956|NCT00388843|atherosclerosis|atherosclerosis
665957|NCT00388843|ultrasound|ultrasound
665958|NCT00388843|inflammation|inflammation
665959|NCT00388843|statins|statins
665960|NCT00388843|vulnerable plaque|vulnerable plaque
665961|NCT00388843|stroke|stroke
665962|NCT00388830|Gallbladder|gallbladder
665963|NCT00388830|Ultrasound|ultrasound
665964|NCT00388830|Emergency Medicine|emergency medicine
665965|NCT00388817|Hypertension|hypertension
665966|NCT00388817|Blood pressure|blood pressure
665967|NCT00388817|Adherence|adherence
665968|NCT00388817|Compliance|compliance
665969|NCT00388817|Pharmacist|pharmacist
665970|NCT00388817|Pharmacy|pharmacy
665971|NCT00388817|Costs|costs
665972|NCT00388804|Prostate Cancer|prostate cancer
665973|NCT00388804|External Beam Radiotherapy|external beam radiotherapy
665974|NCT00388804|Radiation Therapy|radiation therapy
665975|NCT00388804|Hormone Therapy|hormone therapy
665976|NCT00388804|Bicalutamide|bicalutamide
665977|NCT00388804|Casodex|casodex
665978|NCT00388804|Leuprolide|leuprolide
665979|NCT00388804|Lupron|lupron
665980|NCT00388804|Goserelin|goserelin
665981|NCT00388804|Zoladex|zoladex
665982|NCT00388804|Flutamide|flutamide
665983|NCT00388804|EBRT|ebrt
665984|NCT00388791|symptomatology|symptomatology
665985|NCT00388791|Schein questionnaire|schein questionnaire
665986|NCT00388791|fluoresceien staining|fluoresceien staining
665987|NCT00388765|bronchoscopy|bronchoscopy
665988|NCT00388765|sample bank|sample bank
665989|NCT00388765|research study volunteer|research study volunteer
665990|NCT00388752|Acupuncture|acupuncture
665991|NCT00388752|Phantom limb pain|phantom limb pain
665992|NCT00388752|Residual limb pain|residual limb pain
665993|NCT00388752|amputation|amputation
665995|NCT00388752|traumatic|traumatic
665996|NCT00388752|surgical|surgical
665997|NCT00388752|Traumatic amputation upper extremity|traumatic amputation upper extremity
665998|NCT00388752|Traumatic amputation lower extremity|traumatic amputation lower extremity
665999|NCT00388752|Surgical amputation upper extremity|surgical amputation upper extremity
666000|NCT00388752|Surgical amputation lower extremity|surgical amputation lower extremity
666001|NCT00388739|Pediatric Asthma|pediatric asthma
666002|NCT00388739|Pulmicort|pulmicort
666003|NCT00388739|TEDAS ED|tedas ed
666004|NCT00388739|Acute exacerbation of asthma|acute exacerbation of asthma
666005|NCT00388739|Chronic asthma|chronic asthma
666006|NCT00388726|Locally recurrent breast cancer|locally recurrent breast cancer
666007|NCT00388726|metastatic breast cancer|metastatic breast cancer
666008|NCT00388713|Radiation therapy|radiation therapy
666009|NCT00388713|Radiation-Induced Atherosclerosis|radiation-induced atherosclerosis
666010|NCT00388713|Carotid Artery Diseases|carotid artery diseases
666011|NCT00388713|Breast Cancer|breast cancer
666012|NCT00388713|Intima Media thickening Ultrasound|intima media thickening ultrasound
666013|NCT00388700|Colorectal cancer, DAVANAT, colon cancer, 5-FU|colorectal cancer, davanat, colon cancer, 5-fu
666014|NCT00388687|Hypoxia|hypoxia
666015|NCT00388687|FAZA|faza
666016|NCT00388687|PET|pet
666017|NCT00388687|Radiochemotherapy|radiochemotherapy
666018|NCT00388674|Chronic Hepatitis B Virus|chronic hepatitis b virus
666019|NCT00388661|sleep problems|sleep problems
666020|NCT00388661|quality of life|quality of life
666021|NCT00388661|melatonin|melatonin
666022|NCT00388661|sleep apnea|sleep apnea
666023|NCT00388661|medication|medication
666024|NCT00388661|preload|preload
666025|NCT00388661|nutritional status|nutritional status
666026|NCT00388661|ProBNP|probnp
666027|NCT00388648|Dialysis|dialysis
666028|NCT00388648|Vegan Diet|vegan diet
666029|NCT00388648|Mortality|mortality
666030|NCT00388648|Morbidity|morbidity
666031|NCT00388648|Treatment outcome|treatment outcome
666032|NCT00388635|Multiple Myeloma|multiple myeloma
666033|NCT00388635|Patients over 65 years old|patients over 65 years old
666036|NCT00388622|Compliance|compliance
666037|NCT00388622|Pharmacy|pharmacy
666038|NCT00388622|Pharmacist|pharmacist
666039|NCT00388622|Health-related quality of life|health-related quality of life
666040|NCT00388622|Clinical exacerbation|clinical exacerbation
666041|NCT00388622|Costs|costs
666042|NCT00388596|SB-751689|sb-751689
666043|NCT00388596|osteoporosis|osteoporosis
666044|NCT00388596|drug interaction|drug interaction
666045|NCT00388596|ketoconazole|ketoconazole
666046|NCT00388596|atorvastatin|atorvastatin
666047|NCT00388596|rosuvastatin|rosuvastatin
666048|NCT00388583|Influenza|influenza
666049|NCT00388583|Orthomyxoviruses|orthomyxoviruses
666050|NCT00388583|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
666051|NCT00388583|Elderly.|elderly.
666052|NCT00388570|Asthma|asthma
666053|NCT00388570|adult|adult
666054|NCT00388570|paediatric|paediatric
666055|NCT00388570|NIOX MINO®|niox mino®
666056|NCT00388570|NIOX®|niox®
666057|NCT00388570|nitric oxide|nitric oxide
666058|NCT00388570|airway inflammation|airway inflammation
666059|NCT00388570|open−label|open−label
666060|NCT00388570|single−cohort|single−cohort
666061|NCT00388531|Acute Lymphoblastic Leucemia|acute lymphoblastic leucemia
666062|NCT00388531|Aggressive Non-Hodgkin-Lymphoma|aggressive non-hodgkin-lymphoma
666063|NCT00388531|CNS relapse|cns relapse
666064|NCT00388531|Cytarabine liposome|cytarabine liposome
666065|NCT00388505|tobramycin|tobramycin
666066|NCT00388492|HIV Infected|hiv infected
666067|NCT00388466|whole body vibration|whole body vibration
666068|NCT00388466|muscle function|muscle function
666069|NCT00388466|cystic fibrosis|cystic fibrosis
666070|NCT00388466|mechanography|mechanography
666071|NCT00388466|chair-rising-test|chair-rising-test
666072|NCT00388453|Healthy volunteers|healthy volunteers
666073|NCT00388440|Mumps|mumps
666074|NCT00388440|Singapore|singapore
666075|NCT00388440|Rubella|rubella
666076|NCT00388440|Measles|measles
666077|NCT00388427|advanced cancer|advanced cancer
666078|NCT00388427|solid tumor|solid tumor
666079|NCT00388427|solid malignancies|solid malignancies
666080|NCT00388427|phase I|phase i
666081|NCT00388401|Postoperative Ileus|postoperative ileus
666082|NCT00388388|Remodeling|remodeling
666083|NCT00388388|Resistance arteries|resistance arteries
666084|NCT00388388|angiotensin receptor blocker|angiotensin receptor blocker
666085|NCT00388388|thiazide diuretic|thiazide diuretic
666086|NCT00388362|GVHD|gvhd
666087|NCT00388336|Anemia|anemia
666088|NCT00388336|Neoplasms, Hemoglobin values|neoplasms, hemoglobin values
666089|NCT00388336|PROCRIT|procrit
666090|NCT00388336|Epoetin alfa|epoetin alfa
666091|NCT00388323|Alcohol|alcohol
666092|NCT00388323|Hepatitis|hepatitis
666093|NCT00388323|Cirrhosis|cirrhosis
666094|NCT00388323|Inflammation|inflammation
666095|NCT00388323|Cytokines|cytokines
666096|NCT00388323|ADIPOKINES|adipokines
666097|NCT00388323|Adipose tissue|adipose tissue
666098|NCT00388310|cellulitis|cellulitis
666099|NCT00388310|furuncles|furuncles
666100|NCT00388310|carbuncles|carbuncles
666101|NCT00388310|abscess|abscess
666102|NCT00388297|Subclinical Hypothyroidism|subclinical hypothyroidism
666103|NCT00388297|Hypothyroxinemia|hypothyroxinemia
666104|NCT00388297|Thyroid|thyroid
666105|NCT00388297|Pregnancy|pregnancy
666106|NCT00388297|Intellectual Development|intellectual development
666107|NCT00388284|hemostasis|hemostasis
666108|NCT00388284|arterial sealing|arterial sealing
666109|NCT00388271|Alpha-blocker|alpha-blocker
666110|NCT00388271|Alfuzosin|alfuzosin
666111|NCT00388271|Xatral|xatral
666112|NCT00388271|ESWL|eswl
666113|NCT00388258|Postoperative ileus|postoperative ileus
666114|NCT00388245|PCI|pci
666115|NCT00388245|CABG|cabg
666116|NCT00388245|Ejection Fraction|ejection fraction
666117|NCT00388245|Myocardial Revascularization|myocardial revascularization
666118|NCT00388232|COPD|copd
666119|NCT00388232|prevalence|prevalence
666120|NCT00388232|smoke|smoke
666121|NCT00388232|biomass|biomass
666122|NCT00388232|occupational|occupational
666123|NCT00388232|Malatya|malatya
666124|NCT00388232|Turkey|turkey
666125|NCT00388219|Buprenorphine|buprenorphine
666126|NCT00388219|Transdermal patch|transdermal patch
666127|NCT00388219|Centrally acting analgesic|centrally acting analgesic
666128|NCT00388219|Plasma level|plasma level
666129|NCT00388219|Healthy volunteers|healthy volunteers
666130|NCT00388206|NSCLC|nsclc
666131|NCT00388206|Avastin|avastin
666132|NCT00388206|anti-VEGF|anti-vegf
666133|NCT00388206|lung cancer|lung cancer
666134|NCT00388206|colorectal cancer|colorectal cancer
666135|NCT00388206|ARIES|aries
666136|NCT00388206|Colon Cancer|colon cancer
666137|NCT00388193|ALL (L3)|all (l3)
666138|NCT00388193|BURKITT's LYMPHOMA|burkitt's lymphoma
666139|NCT00388193|RITUXIMAB|rituximab
666140|NCT00388180|cholesterol|cholesterol
666141|NCT00388180|inflammation|inflammation
666142|NCT00388180|fat|fat
666143|NCT00388167|Invader fungal infection (IFI)|invader fungal infection (ifi)
666144|NCT00388167|Invasive Aspergillosis (AI)|invasive aspergillosis (ai)
666145|NCT00388167|Invasive Candidiasis (CI)|invasive candidiasis (ci)
666146|NCT00388167|Caspofungin acetate|caspofungin acetate
666147|NCT00388154|Endometrial Cancer|endometrial cancer
666148|NCT00388154|Gemcitabine|gemcitabine
666149|NCT00388154|Gemzar|gemzar
666150|NCT00388154|Gemcitabine Hydrochloride|gemcitabine hydrochloride
666151|NCT00388154|Cisplatin|cisplatin
666152|NCT00388154|Platinol-AQ|platinol-aq
666153|NCT00388154|Platinol|platinol
666154|NCT00388154|CDDP|cddp
666155|NCT00388141|Preterm Infant;|preterm infant;
666156|NCT00388141|NIDCAP;|nidcap;
666157|NCT00388141|Neonatal Care,|neonatal care,
666158|NCT00388141|Intervention Study;|intervention study;
666159|NCT00388141|Growth and Development;|growth and development;
666160|NCT00388141|Maternal Self-esteem.|maternal self-esteem.
666161|NCT00388141|Maternal Social support|maternal social support
666162|NCT00388141|NICU|nicu
666163|NCT00388128|Intermittent Claudication|intermittent claudication
666164|NCT00388128|PAD|pad
666165|NCT00388128|Caffeine|caffeine
666166|NCT00388128|Walking capacity|walking capacity
666167|NCT00388128|ABI|abi
666168|NCT00388128|QoL|qol
666169|NCT00388128|Growth factor|growth factor
666170|NCT00388115|ductal breast carcinoma in situ|ductal breast carcinoma in situ
666171|NCT00388115|stage I breast cancer|stage i breast cancer
666172|NCT00388115|stage II breast cancer|stage ii breast cancer
666173|NCT00388115|breast cancer in situ|breast cancer in situ
666174|NCT00388089|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
666175|NCT00388089|extensive stage small cell lung cancer|extensive stage small cell lung cancer
666176|NCT00388089|recurrent small cell lung cancer|recurrent small cell lung cancer
666177|NCT00388076|carboplatin|carboplatin
666178|NCT00388076|lapatinib|lapatinib
666179|NCT00388076|TAXOL|taxol
666180|NCT00388076|PARAPLATIN|paraplatin
666181|NCT00388076|paclitaxel|paclitaxel
666182|NCT00388076|TYKERB|tykerb
666183|NCT00388076|Pazopanib|pazopanib
666184|NCT00388063|Neuroendocrine|neuroendocrine
666185|NCT00388063|Carcinoma|carcinoma
666186|NCT00388063|Atiprimod|atiprimod
666187|NCT00388063|Carcinoid|carcinoid
666188|NCT00388050|Decision aid, diabetes, primary care|decision aid, diabetes, primary care
666189|NCT00388024|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
666190|NCT00388024|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
666191|NCT00388024|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
666192|NCT00388024|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
666193|NCT00388024|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
666194|NCT00388024|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
666195|NCT00388024|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
666196|NCT00388024|squamous cell carcinoma of unknown primary|squamous cell carcinoma of unknown primary
666197|NCT00388024|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
666198|NCT00388024|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
666199|NCT00388024|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
666200|NCT00388024|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
666201|NCT00388024|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
666202|NCT00388024|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
666203|NCT00388024|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
666204|NCT00388024|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
666205|NCT00388024|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
666206|NCT00388024|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
666207|NCT00388011|Post surgical pain|post surgical pain
666208|NCT00388011|Bunionectomy|bunionectomy
666209|NCT00388011|Hammer Toe Syndrome|hammer toe syndrome
666210|NCT00388011|Morphine|morphine
666211|NCT00387998|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
666212|NCT00387972|Type 2 diabetes mellitus (T2DM)|type 2 diabetes mellitus (t2dm)
666213|NCT00387972|glycosylated hemoglobin (HbA1c)|glycosylated hemoglobin (hba1c)
666214|NCT00387972|denagliptin|denagliptin
666215|NCT00387972|diabetes treatment|diabetes treatment
666216|NCT00387972|glycemic control|glycemic control
666217|NCT00387959|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
666218|NCT00387959|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
666219|NCT00387959|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
666220|NCT00387959|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
666221|NCT00387959|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
666222|NCT00387959|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
666223|NCT00387959|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
666224|NCT00387959|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
666225|NCT00387959|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
666226|NCT00387959|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
666227|NCT00387959|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
666228|NCT00387959|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
666229|NCT00387959|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
666230|NCT00387959|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
666231|NCT00387959|splenic marginal zone lymphoma|splenic marginal zone lymphoma
666232|NCT00387959|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
666233|NCT00387959|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
666234|NCT00387959|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
666235|NCT00387959|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
666236|NCT00387959|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
666237|NCT00387959|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
666238|NCT00387959|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
666239|NCT00387959|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
666240|NCT00387959|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
666241|NCT00387959|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
666242|NCT00387959|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
666243|NCT00387959|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
666244|NCT00387959|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
666245|NCT00387959|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
666246|NCT00387959|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
666247|NCT00387959|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
666248|NCT00387959|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
666249|NCT00387959|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
666250|NCT00387959|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
666251|NCT00387959|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
666252|NCT00387946|smoking|smoking
666253|NCT00387946|cessation|cessation
666254|NCT00387946|tobacco|tobacco
666255|NCT00387933|recurrent adult brain tumor|recurrent adult brain tumor
666256|NCT00387933|adult glioblastoma|adult glioblastoma
666257|NCT00387933|adult anaplastic astrocytoma|adult anaplastic astrocytoma
666258|NCT00387933|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
666259|NCT00387933|adult gliosarcoma|adult gliosarcoma
666260|NCT00387933|adult giant cell glioblastoma|adult giant cell glioblastoma
666261|NCT00387933|adult anaplastic ependymoma|adult anaplastic ependymoma
666262|NCT00387933|adult brain stem glioma|adult brain stem glioma
666263|NCT00387933|adult mixed glioma|adult mixed glioma
666264|NCT00387933|adult pineal gland astrocytoma|adult pineal gland astrocytoma
666265|NCT00387907|Herceptin|herceptin
666266|NCT00387907|Taxane|taxane
666267|NCT00387907|Breast Cancer|breast cancer
666268|NCT00387894|adult glioblastoma|adult glioblastoma
666269|NCT00387894|adult gliosarcoma|adult gliosarcoma
666270|NCT00387894|recurrent adult brain tumor|recurrent adult brain tumor
666271|NCT00387881|sumatriptan succinate,|sumatriptan succinate,
666272|NCT00387881|naproxen sodium,|naproxen sodium,
666273|NCT00387881|parallel group,|parallel group,
666274|NCT00387881|double-blind,|double-blind,
666275|NCT00387881|placebo-controlled,|placebo-controlled,
666276|NCT00387881|Combination product,|combination product,
666277|NCT00387881|migrainous headache|migrainous headache
666278|NCT00387881|Probable migraine, a sub-type of Migraine|probable migraine, a sub-type of migraine
666279|NCT00387881|probable migraine,|probable migraine,
666280|NCT00387868|Thymoma|thymoma
666281|NCT00387868|Thymic carcinoma|thymic carcinoma
666282|NCT00387868|Preoperative chemotherapy and radiation|preoperative chemotherapy and radiation
666283|NCT00387868|Response rate|response rate
666284|NCT00387855|suicide|suicide
666285|NCT00387855|depression|depression
666286|NCT00387777|Buprenorphine|buprenorphine
666287|NCT00387777|Transdermal patch|transdermal patch
666288|NCT00387777|multidose|multidose
666289|NCT00387777|Centrally acting analgesic|centrally acting analgesic
666290|NCT00387777|Plasma level|plasma level
666291|NCT00387777|Healthy volunteers|healthy volunteers
666292|NCT00387764|renal cell carcinoma|renal cell carcinoma
666293|NCT00387764|pazopanib|pazopanib
666294|NCT00387764|anti-angiogenic therapy|anti-angiogenic therapy
666295|NCT00387764|open label|open label
666296|NCT00387738|Ragweed|ragweed
666297|NCT00387738|Allergy|allergy
666298|NCT00387738|Allergic|allergic
666299|NCT00387738|Rhinitis|rhinitis
666300|NCT00387738|Hay Fever|hay fever
666301|NCT00387738|Seasonal|seasonal
666302|NCT00387738|Treatment|treatment
666303|NCT00387738|Immunotherapy|immunotherapy
666304|NCT00387738|Vaccine|vaccine
666305|NCT00387725|Adolescent|adolescent
666306|NCT00387725|Meningococcal|meningococcal
666307|NCT00387725|Safety|safety
666308|NCT00387712|exercise|exercise
666309|NCT00387712|inflammation|inflammation
666310|NCT00387712|motor performance|motor performance
666311|NCT00387712|skeletal muscle|skeletal muscle
666312|NCT00387712|chronic stroke survivors|chronic stroke survivors
666313|NCT00387712|treadmill exercise|treadmill exercise
666314|NCT00387699|limited stage small cell lung cancer|limited stage small cell lung cancer
666315|NCT00387673|electrical stimulation|electrical stimulation
666316|NCT00387673|hand|hand
666317|NCT00387673|Rehabilitation|rehabilitation
666318|NCT00387673|spinal cord injury|spinal cord injury
666319|NCT00387660|extensive stage small cell lung cancer|extensive stage small cell lung cancer
666320|NCT00387660|limited stage small cell lung cancer|limited stage small cell lung cancer
666321|NCT00387660|recurrent small cell lung cancer|recurrent small cell lung cancer
666322|NCT00387647|myeloid|myeloid
666323|NCT00387647|acute|acute
666324|NCT00387647|monocytic|monocytic
666325|NCT00387634|tick born encephalitis, TBE, adults|tick born encephalitis, tbe, adults
666326|NCT00387621|heart failure|heart failure
666327|NCT00387621|diastolic dysfunction|diastolic dysfunction
666328|NCT00387621|systolic dysfunction|systolic dysfunction
666329|NCT00387621|preclinical|preclinical
666330|NCT00387621|natriuretic peptide|natriuretic peptide
666331|NCT00387621|B-type natriuretic peptide|b-type natriuretic peptide
666332|NCT00387621|cyclic guanosine monophosphate|cyclic guanosine monophosphate
666333|NCT00387608|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
666334|NCT00387608|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
666335|NCT00387608|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
666336|NCT00387608|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
666337|NCT00387608|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
666338|NCT00387608|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
666339|NCT00387608|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
666340|NCT00387608|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
666341|NCT00387608|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
666461|NCT00387231|Myocardial Ischemia|myocardial ischemia
666342|NCT00387608|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
666343|NCT00387608|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
666344|NCT00387608|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
666345|NCT00387608|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
666346|NCT00387595|Family History|family history
666347|NCT00387595|CAD|cad
666348|NCT00387595|CAC|cac
666349|NCT00387595|cIMT|cimt
666350|NCT00387595|CV Risk Factors|cv risk factors
666351|NCT00387582|Diabetes|diabetes
666352|NCT00387582|Macular Edema|macular edema
666353|NCT00387582|Diabetic Retinopathy|diabetic retinopathy
666354|NCT00387582|Lucentis|lucentis
666355|NCT00387582|Ranibizumab|ranibizumab
666356|NCT00387569|Toddlers|toddlers
666357|NCT00387569|Vaccine|vaccine
666358|NCT00387569|Safety|safety
666359|NCT00387556|ketamine|ketamine
666360|NCT00387556|children|children
666361|NCT00387556|emesis|emesis
666362|NCT00387530|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
666363|NCT00387530|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
666364|NCT00387530|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
666365|NCT00387530|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
666366|NCT00387530|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
666367|NCT00387530|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
666368|NCT00387530|recurrent gastric cancer|recurrent gastric cancer
666369|NCT00387517|Diastolic|diastolic
666370|NCT00387517|systolic|systolic
666371|NCT00387517|hypertension|hypertension
666372|NCT00387517|aliskiren|aliskiren
666373|NCT00387517|blood pressure|blood pressure
666374|NCT00387517|hydrochlorothiazide|hydrochlorothiazide
666375|NCT00387517|HCTZ|hctz
666376|NCT00387504|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
666377|NCT00387478|Allergy|allergy
666378|NCT00387478|Specific Immunotherapy|specific immunotherapy
666379|NCT00387478|Tree|tree
666380|NCT00387478|Environmental Exposure Chamber|environmental exposure chamber
666381|NCT00387452|Aging|aging
666382|NCT00387452|Type 2 diabetes|type 2 diabetes
666383|NCT00387452|exercise|exercise
666384|NCT00387452|aerobic training|aerobic training
666385|NCT00387452|strength training|strength training
666386|NCT00387452|glucose metabolism arterial baroreceptors|glucose metabolism arterial baroreceptors
666387|NCT00387452|heart rate variability|heart rate variability
666388|NCT00387452|cerebral autoregulation|cerebral autoregulation
666389|NCT00387452|tilt table study|tilt table study
666390|NCT00387452|transcranial Doppler|transcranial doppler
666391|NCT00387452|autonomic nervous system|autonomic nervous system
666392|NCT00387439|Anal incontinence|anal incontinence
666393|NCT00387439|Gastroenterology|gastroenterology
666394|NCT00387439|Anoperineal physiotherapy|anoperineal physiotherapy
666798|NCT00386074|NaFeEDTA|nafeedta
666395|NCT00387439|Randomized clinical trial|randomized clinical trial
666396|NCT00387413|Duloxetine|duloxetine
666397|NCT00387413|GSK189254|gsk189254
666398|NCT00387413|Healthy volunteers|healthy volunteers
666399|NCT00387413|Phase I.|phase i.
666400|NCT00387413|Electrical hyperalgesia model|electrical hyperalgesia model
666401|NCT00387400|adult giant cell glioblastoma|adult giant cell glioblastoma
666402|NCT00387400|adult gliosarcoma|adult gliosarcoma
666403|NCT00387400|recurrent adult brain tumor|recurrent adult brain tumor
666404|NCT00387400|adult glioblastoma|adult glioblastoma
666405|NCT00387387|pharmacokinetics|pharmacokinetics
666406|NCT00387387|colorectal cancer|colorectal cancer
666407|NCT00387387|pazopanib|pazopanib
666408|NCT00387387|capecitabine|capecitabine
666409|NCT00387387|CapeOx|capeox
666410|NCT00387387|5-fluorouracil|5-fluorouracil
666411|NCT00387387|oxaliplatin|oxaliplatin
666412|NCT00387387|combination therapy|combination therapy
666413|NCT00387387|FOLFOX 6|folfox 6
666414|NCT00387361|Post-Operative Nausea|post-operative nausea
666415|NCT00387361|Nausea|nausea
666416|NCT00387361|Anesthesia|anesthesia
666417|NCT00387361|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
666418|NCT00387361|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
666419|NCT00387361|Manipulation, Osteopathic|manipulation, osteopathic
666420|NCT00387361|Osteopathy|osteopathy
666421|NCT00387361|Texas College of Osteopathic Medicine|texas college of osteopathic medicine
666422|NCT00387348|fatigue|fatigue
666423|NCT00387348|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
666424|NCT00387348|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
666425|NCT00387348|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
666426|NCT00387348|extensive stage small cell lung cancer|extensive stage small cell lung cancer
666427|NCT00387348|advanced adult primary liver cancer|advanced adult primary liver cancer
666428|NCT00387348|depression|depression
666429|NCT00387348|stage III pancreatic cancer|stage iii pancreatic cancer
666430|NCT00387348|stage IV pancreatic cancer|stage iv pancreatic cancer
666431|NCT00387348|stage IV esophageal cancer|stage iv esophageal cancer
666432|NCT00387348|stage IV gastric cancer|stage iv gastric cancer
666433|NCT00387348|stage IVA colon cancer|stage iva colon cancer
666434|NCT00387348|stage IVB colon cancer|stage ivb colon cancer
666435|NCT00387348|stage IVA rectal cancer|stage iva rectal cancer
666436|NCT00387348|stage IVB rectal cancer|stage ivb rectal cancer
666437|NCT00387348|unresectable gallbladder cancer|unresectable gallbladder cancer
666438|NCT00387348|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
666439|NCT00387322|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
666440|NCT00387322|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
666441|NCT00387322|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
666442|NCT00387322|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
666443|NCT00387309|Bowel|bowel
666444|NCT00387283|WNV|wnv
666445|NCT00387283|West Nile virus|west nile virus
666446|NCT00387283|WNV meningoencephalitis|wnv meningoencephalitis
666447|NCT00387270|Huntington's disease|huntington's disease
666448|NCT00387270|Dimebon|dimebon
666449|NCT00387270|dose-escalation|dose-escalation
666450|NCT00387270|Phase 1-2a|phase 1-2a
666451|NCT00387270|randomized|randomized
666452|NCT00387270|controlled|controlled
666453|NCT00387270|double-blind|double-blind
666454|NCT00387270|Unified Huntington's Disease Rating Scale|unified huntington's disease rating scale
666455|NCT00387257|platelet aggregation|platelet aggregation
666456|NCT00387257|SB-659032|sb-659032
666457|NCT00387257|rilapladib|rilapladib
666458|NCT00387244|Pain;|pain;
666459|NCT00387244|Back Pain;|back pain;
666460|NCT00387244|Neurostimulation|neurostimulation
666462|NCT00387231|Randomized Controlled Trials|randomized controlled trials
666463|NCT00387231|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
666464|NCT00387231|Drug Therapy|drug therapy
666465|NCT00387218|Exercise|exercise
666466|NCT00387218|Physical Functional Ability|physical functional ability
666467|NCT00387218|Spinal Range of Motion|spinal range of motion
666468|NCT00387218|Balance|balance
666469|NCT00387218|Economy of Movement|economy of movement
666470|NCT00387218|Aerobic Conditioning|aerobic conditioning
666471|NCT00387218|Quality of Life|quality of life
666472|NCT00387218|Adherence|adherence
666473|NCT00387205|chronic administration|chronic administration
666474|NCT00387205|monotherapy and combination therapies|monotherapy and combination therapies
666475|NCT00387205|solid|solid
666476|NCT00387205|lapatinib (TYKERB, TYVERB)|lapatinib (tykerb, tyverb)
666477|NCT00387205|malignant tumor|malignant tumor
666478|NCT00387205|Pazopanib|pazopanib
666479|NCT00387205|GW786034|gw786034
666480|NCT00387205|cancer|cancer
666481|NCT00387205|safety|safety
666482|NCT00387192|Von Willebrand Disease|von willebrand disease
666483|NCT00387192|Factor VIII|factor viii
666484|NCT00387192|Von Willebrand Factor|von willebrand factor
666485|NCT00387192|Pharmacokinetics|pharmacokinetics
666486|NCT00387179|Circadian Rhythm Sleep Disorders|circadian rhythm sleep disorders
666487|NCT00387166|Type 2 Diabetes|type 2 diabetes
666488|NCT00387166|Cardiovascular|cardiovascular
666489|NCT00387166|Blood Pressure|blood pressure
666490|NCT00387166|Hispanic|hispanic
666491|NCT00387166|Women|women
666492|NCT00387166|Social Context|social context
666493|NCT00387166|Psychosocial|psychosocial
666494|NCT00387153|Oncology|oncology
666495|NCT00387153|Cancer|cancer
666496|NCT00387153|Blood Cancers|blood cancers
666497|NCT00387140|Dental Pain, Postoperative|dental pain, postoperative
666498|NCT00387127|Neck Cancer|neck cancer
666499|NCT00387127|Locally advanced head and neck cancer|locally advanced head and neck cancer
666500|NCT00387127|locally advanced|locally advanced
666501|NCT00387127|Head and Neck cancer|head and neck cancer
666502|NCT00387127|lapatinib|lapatinib
666503|NCT00387127|EGFR/ErbB2 inhibitor|egfr/erbb2 inhibitor
666504|NCT00387127|Head Cancer|head cancer
666505|NCT00387114|C-reactive protein|c-reactive protein
666506|NCT00387114|nitrotyrosine|nitrotyrosine
666507|NCT00387114|oxidative stress|oxidative stress
666508|NCT00387114|resistin|resistin
666509|NCT00387114|vitamin C|vitamin c
666510|NCT00387101|Diabetic Foot Ulcer|diabetic foot ulcer
666511|NCT00387101|Diabetes Mellitus|diabetes mellitus
666512|NCT00387101|Debridement|debridement
666513|NCT00387101|Dermal-LSR|dermal-lsr
666514|NCT00387101|Standard of Care|standard of care
666515|NCT00387075|Parkinson Disease|parkinson disease
666516|NCT00387075|SPECT imaging|spect imaging
666517|NCT00387062|Breast Cancer|breast cancer
666518|NCT00387062|Cognitive Impairment|cognitive impairment
666519|NCT00387062|Chemofog|chemofog
666520|NCT00387062|Chemobrain|chemobrain
666521|NCT00387062|Post-chemotherapy cognitive impairment|post-chemotherapy cognitive impairment
666522|NCT00387049|Anxiety Sensitivity|anxiety sensitivity
666523|NCT00387023|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
666524|NCT00387023|Orbital Lymphoma|orbital lymphoma
666525|NCT00387023|Rituximab|rituximab
666526|NCT00387023|Rituxan|rituxan
666527|NCT00387023|Zevalin|zevalin
666528|NCT00387023|Ibritumomab tiuxetan|ibritumomab tiuxetan
666529|NCT00387023|IDEC-Y2B8|idec-y2b8
666530|NCT00387023|Eye|eye
666531|NCT00386984|hepatocellular carcinoma; Sandostatin-LAR; RCT|hepatocellular carcinoma; sandostatin-lar; rct
666532|NCT00386971|L-carnitine|l-carnitine
666533|NCT00386971|HIV|hiv
666534|NCT00386971|TGRL metabolism|tgrl metabolism
666535|NCT00386971|postprandial|postprandial
666536|NCT00386971|HIV Treatment Experienced|hiv treatment experienced
666537|NCT00386958|corneal ulcers|corneal ulcers
666538|NCT00386958|bacterial keratitis|bacterial keratitis
666539|NCT00386958|childhood blindness|childhood blindness
666540|NCT00386958|povidone-iodine|povidone-iodine
666541|NCT00386945|Tobacco|tobacco
666542|NCT00386945|Cessation.|cessation.
666543|NCT00386945|Chiropractic patients.|chiropractic patients.
666544|NCT00386945|Doctors of Chiropractic.|doctors of chiropractic.
666545|NCT00386945|Health care providers.|health care providers.
666546|NCT00386945|Behavioral intervention.|behavioral intervention.
666547|NCT00386945|Tobacco intervention.|tobacco intervention.
666548|NCT00386945|Cigarettes.|cigarettes.
666549|NCT00386945|Smokeless tobacco.|smokeless tobacco.
666550|NCT00386945|Smoking intervention.|smoking intervention.
666551|NCT00386906|Melanoma|melanoma
666552|NCT00386906|Conjunctival Melanoma|conjunctival melanoma
666553|NCT00386906|Malignant Melanoma of the Conjunctiva|malignant melanoma of the conjunctiva
666554|NCT00386906|Malignant Melanoma of the Eyelid|malignant melanoma of the eyelid
666555|NCT00386906|Sebaceous Cell Carcinoma|sebaceous cell carcinoma
666556|NCT00386906|Sebaceous Cell Carcinoma of the Conjunctiva|sebaceous cell carcinoma of the conjunctiva
666557|NCT00386906|Sebaceous Cell Carcinoma of the Eyelid|sebaceous cell carcinoma of the eyelid
666558|NCT00386906|Sentinel Lymph Node|sentinel lymph node
666559|NCT00386906|Lymphatic Mapping|lymphatic mapping
666560|NCT00386906|Eyelid|eyelid
666561|NCT00386906|Eyelid Lesion|eyelid lesion
666562|NCT00386867|medical abortion|medical abortion
666563|NCT00386867|mifepristone|mifepristone
666564|NCT00386867|misoprostol|misoprostol
666565|NCT00386867|buccal administration|buccal administration
666566|NCT00386854|exercise|exercise
666567|NCT00386854|lipid metabolism|lipid metabolism
666568|NCT00386854|lipoproteins|lipoproteins
666569|NCT00386854|insulin resistance|insulin resistance
666570|NCT00386854|inflammation|inflammation
666571|NCT00386841|Major depression|major depression
666572|NCT00386841|First degree relatives|first degree relatives
666573|NCT00386841|Escitalopram|escitalopram
666574|NCT00386841|Cortisol|cortisol
666575|NCT00386841|Cognition|cognition
666576|NCT00386841|Personality|personality
666577|NCT00386841|Endo-phenotype|endo-phenotype
666578|NCT00386828|colorectal cancer|colorectal cancer
666579|NCT00386828|advanced colorectal cancer|advanced colorectal cancer
666580|NCT00386802|Neutropenia|neutropenia
666581|NCT00386802|Antifungals|antifungals
666582|NCT00386789|Typhoid Fever|typhoid fever
666583|NCT00386789|Serological Survey|serological survey
666584|NCT00386789|Follow-Up|follow-up
666585|NCT00386789|Protection|protection
666586|NCT00386776|computers|computers
666587|NCT00386776|diagnosis|diagnosis
666588|NCT00386776|medical records|medical records
666589|NCT00386776|physician patient relations|physician patient relations
666590|NCT00386776|medical history taking|medical history taking
666591|NCT00386776|medical informatics applications|medical informatics applications
666592|NCT00386763|Marsh fever|marsh fever
666593|NCT00386763|Plasmodium infections|plasmodium infections
666594|NCT00386763|Remittent fever|remittent fever
666595|NCT00386763|Paludism|paludism
666596|NCT00386763|Artemether|artemether
666597|NCT00386763|Artemisinins|artemisinins
666598|NCT00386763|Malaria|malaria
666599|NCT00386763|Benflumetol|benflumetol
666600|NCT00386763|Lumefantrine|lumefantrine
666601|NCT00386750|Malaria|malaria
666602|NCT00386750|hearing|hearing
666603|NCT00386750|co-artemether|co-artemether
666604|NCT00386750|auditory|auditory
666605|NCT00386750|Plasmodium falciparum|plasmodium falciparum
666606|NCT00386750|marsh fever|marsh fever
666607|NCT00386750|Plasmodium infections|plasmodium infections
666608|NCT00386750|remittent fever|remittent fever
666609|NCT00386750|paludism|paludism
666610|NCT00386750|artemether|artemether
666611|NCT00386750|artemisinins|artemisinins
666612|NCT00386750|benflumetol|benflumetol
666613|NCT00386750|lumefantrine|lumefantrine
666614|NCT00386737|Asthma|asthma
666615|NCT00386737|Breath Testing|breath testing
666616|NCT00386737|Laser Spectroscopy|laser spectroscopy
666617|NCT00386737|eNO|eno
666618|NCT00386737|Nitric Oxide|nitric oxide
666619|NCT00386737|Lower Airway Inflammation|lower airway inflammation
666620|NCT00386737|Carbon Dioxide|carbon dioxide
666621|NCT00386737|CO2|co2
666622|NCT00386724|Pain|pain
666623|NCT00386724|Neurostimulation|neurostimulation
666624|NCT00386724|Leg Pain|leg pain
666625|NCT00386724|Back Pain|back pain
666626|NCT00386711|suicide|suicide
666627|NCT00386711|depressed patients|depressed patients
666628|NCT00386711|primary care|primary care
666629|NCT00386698|Influenza,|influenza,
666630|NCT00386698|improved vaccine,|improved vaccine,
666631|NCT00386698|influenza disease|influenza disease
666632|NCT00386698|elderly|elderly
666633|NCT00386685|Cancer|cancer
666634|NCT00386685|Breast|breast
666635|NCT00386685|metastatic breast cancer|metastatic breast cancer
666636|NCT00386672|Calcium|calcium
666637|NCT00386672|Vitamin D|vitamin d
666638|NCT00386672|Weight Loss|weight loss
666639|NCT00386672|Overweight|overweight
666640|NCT00386672|Obesity|obesity
666641|NCT00386672|Lite Orange Juice|lite orange juice
666642|NCT00386646|Dry eye syndromes therapy|dry eye syndromes therapy
666643|NCT00386633|Vaccine|vaccine
666644|NCT00386633|Safety|safety
666645|NCT00386633|T-cell epitope|t-cell epitope
666646|NCT00386633|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
666647|NCT00386633|HIV Preventive Vaccine|hiv preventive vaccine
666648|NCT00386620|Breast Cancer|breast cancer
666649|NCT00386620|Cancer Control|cancer control
666650|NCT00386620|Spousal Relationships|spousal relationships
666651|NCT00386620|Questionnaire|questionnaire
666652|NCT00386620|Interview|interview
666653|NCT00386620|Pain|pain
666654|NCT00386607|Hypertension, aliskiren, valsartan, HCTZ, blood pressure|hypertension, aliskiren, valsartan, hctz, blood pressure
666655|NCT00386594|Barrett Esophagus|barrett esophagus
666656|NCT00386594|High grade dysplasia|high grade dysplasia
666657|NCT00386594|Carcinoma in situ|carcinoma in situ
666658|NCT00386594|825A|825a
666659|NCT00386542|vaccination|vaccination
666660|NCT00386542|influenza vaccine|influenza vaccine
666661|NCT00386542|jet injection|jet injection
666662|NCT00386542|intradermal injection|intradermal injection
666663|NCT00386542|infancy|infancy
666664|NCT00386542|children|children
666665|NCT00386542|dose-sparing|dose-sparing
666666|NCT00386542|cutaneous vaccination|cutaneous vaccination
666667|NCT00386542|Dominican Republic|dominican republic
666668|NCT00386542|pandemic preparedness|pandemic preparedness
666669|NCT00386542|jet injector|jet injector
666670|NCT00386542|reduced dosage|reduced dosage
666671|NCT00386542|immunogenicity|immunogenicity
666672|NCT00386542|reactogenicity|reactogenicity
666673|NCT00386542|safety|safety
666674|NCT00386542|needle-free|needle-free
666675|NCT00386542|immune response|immune response
666676|NCT00386542|hemagglutination inhibition|hemagglutination inhibition
666677|NCT00386542|Infant|infant
666678|NCT00386529|low dose aspirin|low dose aspirin
666679|NCT00386529|Hypertension|hypertension
666680|NCT00386529|administration time dependent effect|administration time dependent effect
666681|NCT00386516|cholangiocarcinoma|cholangiocarcinoma
666682|NCT00386516|bile duct|bile duct
666683|NCT00386516|biliary|biliary
666684|NCT00386516|intra-hepatic|intra-hepatic
666685|NCT00386516|extra-hepatic|extra-hepatic
666686|NCT00386516|gall bladder|gall bladder
666687|NCT00386516|cancer|cancer
666688|NCT00386516|carcinoma|carcinoma
666689|NCT00386516|metastatic|metastatic
666690|NCT00386516|metastasis|metastasis
666691|NCT00386516|advanced|advanced
666692|NCT00386516|recurrent|recurrent
666693|NCT00386490|celiac disease|celiac disease
666694|NCT00386490|larazotide acetate|larazotide acetate
666695|NCT00386477|Povidone iodine|povidone iodine
666696|NCT00386477|postoperative infection|postoperative infection
666697|NCT00386477|presurgical cleansing|presurgical cleansing
666698|NCT00386464|bipap|bipap
666699|NCT00386464|lou gehrigs disease|lou gehrigs disease
666700|NCT00386464|motor neuron disease|motor neuron disease
666701|NCT00386464|respiratory muscles|respiratory muscles
666702|NCT00386451|Intravenous chemotherapy|intravenous chemotherapy
666703|NCT00386412|Cytomegalovirus infection|cytomegalovirus infection
666704|NCT00386399|Advanced Pancreatic Cancer|advanced pancreatic cancer
666705|NCT00386399|Mutated BRCA2 Gene|mutated brca2 gene
666706|NCT00386399|Recurrent Pancreatic Cancer|recurrent pancreatic cancer
666707|NCT00386386|hydration|hydration
666708|NCT00386386|prehospital|prehospital
666709|NCT00386386|mass casualty incident|mass casualty incident
666710|NCT00386373|Chronic Myeloid Leukemia|chronic myeloid leukemia
666711|NCT00386373|CML|cml
666712|NCT00386373|ALL|all
666713|NCT00386373|AML|aml
666714|NCT00386373|Leukemia|leukemia
666715|NCT00386373|Imatinib Mesylate|imatinib mesylate
666716|NCT00386373|Gleevec|gleevec
666717|NCT00386373|Philadelphia-Positive|philadelphia-positive
666718|NCT00386373|Bone marrow transplant|bone marrow transplant
666719|NCT00386373|BMT|bmt
666720|NCT00386373|Stem cell transplant|stem cell transplant
666721|NCT00386373|SCT|sct
666722|NCT00386347|HIV|hiv
666723|NCT00386347|repeat dose|repeat dose
666724|NCT00386347|pharmacokinetics|pharmacokinetics
666725|NCT00386347|bioavailability|bioavailability
666726|NCT00386347|single-dose|single-dose
666727|NCT00386347|food effect|food effect
666728|NCT00386334|insomnia|insomnia
666729|NCT00386334|chronic|chronic
666730|NCT00386334|primary|primary
666731|NCT00386321|Zevalin|zevalin
666732|NCT00386321|Zevalin plus CHOP|zevalin plus chop
666733|NCT00386321|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
666734|NCT00386321|First line Diffuse large B-cell lymphoma|first line diffuse large b-cell lymphoma
666735|NCT00386308|Heavy Menstrual Bleeding|heavy menstrual bleeding
666736|NCT00386308|Menorrhagia|menorrhagia
666737|NCT00386282|Mifepristone|mifepristone
666738|NCT00386282|Misoprostol|misoprostol
666739|NCT00386282|Buccal administration|buccal administration
666740|NCT00386269|codeine phosphate analgesia|codeine phosphate analgesia
666741|NCT00386256|telehealth|telehealth
666742|NCT00386256|telerehabilitation|telerehabilitation
666743|NCT00386256|deconditioning|deconditioning
666744|NCT00386256|exercise|exercise
666745|NCT00386243|analgesia|analgesia
666746|NCT00386243|analgesics|analgesics
666747|NCT00386243|cognitive behavioral therapy|cognitive behavioral therapy
666748|NCT00386243|Pain|pain
666749|NCT00386243|self-management|self-management
666750|NCT00386243|stepped care|stepped care
666751|NCT00386243|musculoskeletal pain|musculoskeletal pain
666752|NCT00386230|transmission|transmission
666753|NCT00386230|infant|infant
666754|NCT00386230|HIV|hiv
666755|NCT00386230|pregnancy|pregnancy
666756|NCT00386230|HIV-1 infection|hiv-1 infection
666757|NCT00386230|HIV Seronegativity|hiv seronegativity
666758|NCT00386217|Cervical Cancer|cervical cancer
666759|NCT00386217|Breast Cancer|breast cancer
666760|NCT00386217|Hodgkin's Disease|hodgkin's disease
666761|NCT00386217|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
666762|NCT00386217|Female Infertility|female infertility
666763|NCT00386217|Telephone Survey|telephone survey
666764|NCT00386204|Q-switched Ruby laser|q-switched ruby laser
666765|NCT00386191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
666766|NCT00386191|Ischemic cerebrovascular disease|ischemic cerebrovascular disease
666767|NCT00386178|vitamin E|vitamin e
666768|NCT00386178|gamma tocopherol|gamma tocopherol
666769|NCT00386178|moderate to severe asthma|moderate to severe asthma
666770|NCT00386178|healthy subjects|healthy subjects
666771|NCT00386165|larazotide acetate|larazotide acetate
666772|NCT00386152|Anemia|anemia
666773|NCT00386152|Cancer|cancer
666774|NCT00386152|Chemotherapy-Induced Anemia|chemotherapy-induced anemia
666775|NCT00386152|Epoetin alfa|epoetin alfa
666776|NCT00386152|Darbepoetin alfa|darbepoetin alfa
666777|NCT00386139|Diastolic|diastolic
666778|NCT00386139|systolic|systolic
666779|NCT00386139|hypertension|hypertension
666780|NCT00386139|aliskiren|aliskiren
666781|NCT00386139|blood pressure|blood pressure
666782|NCT00386139|hydrochlorothiazide, HCTZ|hydrochlorothiazide, hctz
666783|NCT00386126|Heart Failure|heart failure
666784|NCT00386126|Anemia|anemia
666785|NCT00386126|Treatment|treatment
666786|NCT00386113|Influenza|influenza
666787|NCT00386113|improved vaccine|improved vaccine
666788|NCT00386113|elderly|elderly
666789|NCT00386100|Fasting Plasma Glucose|fasting plasma glucose
666790|NCT00386100|Dual energy X ray absorptiometry (DXA)|dual energy x ray absorptiometry (dxa)
666791|NCT00386100|Drug-naive|drug-naive
666792|NCT00386100|Type 2 diabetes mellitus|type 2 diabetes mellitus
666793|NCT00386100|Bone Mineral Density|bone mineral density
666794|NCT00386100|Hyperglycemia|hyperglycemia
666795|NCT00386100|HbA1c|hba1c
666796|NCT00386087|Breast Cancer|breast cancer
666797|NCT00386087|Cancer of the Breast|cancer of the breast
666799|NCT00386074|electrolytic iron|electrolytic iron
666800|NCT00386074|efficacy|efficacy
666801|NCT00386074|whole maize flour|whole maize flour
666802|NCT00386074|phytate|phytate
666803|NCT00386074|school-age children|school-age children
666804|NCT00386074|controlled trial|controlled trial
666805|NCT00386074|Africa|africa
666806|NCT00386061|Obesity|obesity
666807|NCT00386061|risk factors|risk factors
666808|NCT00386048|Cognitive Behavioral Therapy|cognitive behavioral therapy
666809|NCT00386048|Pediatric Sickle Cell Disease|pediatric sickle cell disease
666810|NCT00386048|Pain Management|pain management
666811|NCT00386035|Treatment Experienced|treatment experienced
666812|NCT00386022|Gonadotropin-releasing hormone|gonadotropin-releasing hormone
666813|NCT00386022|Estrogens|estrogens
666814|NCT00386022|postmenopausal women|postmenopausal women
666815|NCT00386022|Pituitary hormones|pituitary hormones
666816|NCT00386009|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
666817|NCT00386009|Benign Prostatic Hypertrophy|benign prostatic hypertrophy
666818|NCT00385996|Carcinoma,non-small cell lung|carcinoma,non-small cell lung
666819|NCT00385996|preoperative|preoperative
666820|NCT00385996|Tarceva|tarceva
666821|NCT00385996|Response rate|response rate
666822|NCT00385983|thyroidectomy|thyroidectomy
666823|NCT00385983|thyroid neoplasm|thyroid neoplasm
666824|NCT00385983|postoperative complications|postoperative complications
666825|NCT00385983|cost effectiveness|cost effectiveness
666826|NCT00385957|Treatment Naive|treatment naive
666827|NCT00385931|Hypertension|hypertension
666828|NCT00385931|high cholesterol|high cholesterol
666829|NCT00385931|valsartan|valsartan
666830|NCT00385931|simvastatin|simvastatin
666831|NCT00385918|Cardiovascular Fitness|cardiovascular fitness
666832|NCT00385918|Exercise|exercise
666833|NCT00385918|Gait|gait
666834|NCT00385918|Spinal Cord Injury|spinal cord injury
666835|NCT00385918|Treadmill Training|treadmill training
666836|NCT00385892|Healthy volonteers|healthy volonteers
666837|NCT00385892|Abdominal binder|abdominal binder
666838|NCT00385892|IAP|iap
666839|NCT00385892|MAP|map
666840|NCT00385892|APP|app
666841|NCT00385866|Patient Navigator|patient navigator
666842|NCT00385866|Community health|community health
666843|NCT00385866|Communication|communication
666844|NCT00385853|PTK|ptk
666845|NCT00385853|temozolomide|temozolomide
666846|NCT00385853|glioblastoma|glioblastoma
666847|NCT00385840|Influenza vaccine|influenza vaccine
666848|NCT00385840|Influenza|influenza
666849|NCT00385827|Cancer|cancer
666850|NCT00385827|Prostate|prostate
666851|NCT00385827|IL-6|il-6
666852|NCT00385827|Mitoxantrone|mitoxantrone
666853|NCT00385827|Metastatic prostate cancer|metastatic prostate cancer
666854|NCT00385801|cocaine|cocaine
666855|NCT00385801|dependence|dependence
666856|NCT00385801|risperidal|risperidal
666857|NCT00385801|MRI|mri
666858|NCT00385788|Hodgkin's Disease|hodgkin's disease
666859|NCT00385788|Stem Cell Transplantation|stem cell transplantation
666860|NCT00385788|Antithymocyte Globulin|antithymocyte globulin
666861|NCT00385788|Gemcitabine|gemcitabine
666862|NCT00385788|Gemzar|gemzar
666863|NCT00385788|Fludarabine|fludarabine
666864|NCT00385788|Fludarabine Phosphate|fludarabine phosphate
666865|NCT00385788|Melphalan|melphalan
666866|NCT00385788|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
666867|NCT00385788|AST|ast
666868|NCT00385788|SCT|sct
666869|NCT00385788|ATG|atg
666870|NCT00385788|Thymoglobulin|thymoglobulin
666871|NCT00385775|Cancer|cancer
666872|NCT00385775|solid tumours|solid tumours
666873|NCT00385775|refractory|refractory
666874|NCT00385775|antisense|antisense
666875|NCT00385775|oligonucleotide|oligonucleotide
666876|NCT00385762|Human volunteers|human volunteers
666877|NCT00385749|Implanted cardioverter defibrillator|implanted cardioverter defibrillator
666878|NCT00385749|congestive heart failure|congestive heart failure
666879|NCT00385749|right ventricular lead placement|right ventricular lead placement
666880|NCT00385749|select site pacing|select site pacing
666881|NCT00385736|Moderate to Severe Ulcerative Colitis|moderate to severe ulcerative colitis
666882|NCT00385736|Double-blind|double-blind
666883|NCT00385736|Adalimumab|adalimumab
666884|NCT00385736|Induction of Clinical Remission|induction of clinical remission
666885|NCT00385723|affect|affect
666886|NCT00385723|inflammation|inflammation
666887|NCT00385710|Progressive supranuclear palsy (PSP)|progressive supranuclear palsy (psp)
666888|NCT00385697|Randomized|randomized
666889|NCT00385697|Double Blind|double blind
666890|NCT00385697|Parallel Group|parallel group
666891|NCT00385697|Controlled Clinical Trial|controlled clinical trial
666892|NCT00385684|Agitation|agitation
666893|NCT00385684|Alzheimer Disease|alzheimer disease
666894|NCT00385684|Analgesics|analgesics
666895|NCT00385684|Dementia|dementia
666896|NCT00385684|Narcotics|narcotics
666897|NCT00385684|Opioid|opioid
666898|NCT00385684|Pain|pain
666899|NCT00385684|Palliative Care|palliative care
666900|NCT00385684|Psychomotor|psychomotor
666901|NCT00385684|Suffering, Physical|suffering, physical
666902|NCT00385658|Dyslipidemia|dyslipidemia
666903|NCT00385658|metabolic syndrome|metabolic syndrome
666904|NCT00385658|fluvastatin|fluvastatin
666905|NCT00385658|fenofibrate|fenofibrate
666906|NCT00385658|simvastatin|simvastatin
666907|NCT00385658|ezetimibe|ezetimibe
666908|NCT00385645|HIV seronegativity|hiv seronegativity
666909|NCT00385632|Treatment Experienced|treatment experienced
666910|NCT00385606|prolonged continuous infusion|prolonged continuous infusion
666911|NCT00385606|Cox-2 inhibitors|cox-2 inhibitors
666912|NCT00385567|AIDS|aids
666913|NCT00385567|Treatment Experienced|treatment experienced
666914|NCT00385554|Microbicide|microbicide
666915|NCT00385554|HIV prevention|hiv prevention
666916|NCT00385554|Botswana|botswana
666917|NCT00385554|Preventing acquisition of HIV infection|preventing acquisition of hiv infection
666918|NCT00385554|HIV Seronegativity|hiv seronegativity
666919|NCT00385541|pain|pain
666920|NCT00385541|morphine|morphine
666921|NCT00385541|hydromorphone|hydromorphone
666922|NCT00385541|nausea|nausea
666923|NCT00385541|vomiting|vomiting
666924|NCT00385541|pruritis|pruritis
666925|NCT00385528|Case complexity|case complexity
666926|NCT00385528|INTERMED|intermed
666927|NCT00385528|Consultation liaison psychiatry|consultation liaison psychiatry
666928|NCT00385528|depression|depression
666929|NCT00385502|toenail|toenail
666930|NCT00385502|fungus|fungus
666931|NCT00385502|onychomycosis|onychomycosis
666932|NCT00385502|antifungal|antifungal
666933|NCT00385502|anti-fungal|anti-fungal
666934|NCT00385502|nail|nail
666935|NCT00385476|Advanced Cancer|advanced cancer
666936|NCT00385476|Medication Knowledge|medication knowledge
666937|NCT00385476|Emergency Center|emergency center
666938|NCT00385476|Questionnaire|questionnaire
666939|NCT00385476|Survey|survey
666940|NCT00385463|Asthma|asthma
666941|NCT00385463|Rhinitis|rhinitis
666942|NCT00385463|Allergic Asthma|allergic asthma
666943|NCT00385437|Driving safety|driving safety
666944|NCT00385437|maintenance of wakefulness test|maintenance of wakefulness test
666945|NCT00385437|major depressive disorder|major depressive disorder
666946|NCT00385437|mirtazapine|mirtazapine
666947|NCT00385398|tumors metastatic to brain|tumors metastatic to brain
666948|NCT00385398|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
666949|NCT00385372|low pseudoallergen diet|low pseudoallergen diet
666950|NCT00385372|elimination diet|elimination diet
666951|NCT00385372|provocation diet|provocation diet
666952|NCT00385372|oral provocation|oral provocation
666953|NCT00385372|natural food ingredients|natural food ingredients
666954|NCT00385372|food additives|food additives
666955|NCT00385372|flavours|flavours
666956|NCT00385346|Expressive writing|expressive writing
666957|NCT00385346|Male infertility|male infertility
666958|NCT00385333|Mitochondrion|mitochondrion
666959|NCT00385333|Retina|retina
666960|NCT00385333|Mitochondria|mitochondria
666961|NCT00385333|Metabolism|metabolism
666962|NCT00385333|In Vivo Imaging|in vivo imaging
666963|NCT00385333|Age-Related Macular Degeneration|age-related macular degeneration
666964|NCT00385333|AMD|amd
666965|NCT00385333|Diabetic Retinopathy|diabetic retinopathy
666966|NCT00385333|DR|dr
666967|NCT00385333|Hippel-Lindau Disease|hippel-lindau disease
666968|NCT00385333|VHL|vhl
666969|NCT00385307|Depression|depression
666970|NCT00385307|Clinical Trials|clinical trials
666971|NCT00385307|Major Depressive Disorder|major depressive disorder
666972|NCT00385294|Genetic|genetic
666973|NCT00385294|pain|pain
666974|NCT00385294|obstetrical|obstetrical
666975|NCT00385281|proteomic profiling, influenza, vaccine, FluMist|proteomic profiling, influenza, vaccine, flumist
666976|NCT00385268|cocaine|cocaine
666977|NCT00385255|Immunogenicity,|immunogenicity,
666978|NCT00385255|Influenza|influenza
666979|NCT00385255|Co-administration,|co-administration,
666980|NCT00385255|Tdap,|tdap,
666981|NCT00385242|coronary artery disease|coronary artery disease
666982|NCT00385242|left ventricular dysfunction|left ventricular dysfunction
666983|NCT00385242|positron emission tomography|positron emission tomography
666984|NCT00385242|viable myocardium|viable myocardium
666985|NCT00385242|revascularization|revascularization
666986|NCT00385242|cost effectiveness|cost effectiveness
666987|NCT00385229|Asphyxia neonatorum|asphyxia neonatorum
666988|NCT00385229|Birth Injury|birth injury
666989|NCT00385229|Meconium Aspiration Syndrome|meconium aspiration syndrome
666990|NCT00385216|Third Molar|third molar
666991|NCT00385216|Pain|pain
666992|NCT00385203|cancer|cancer
666993|NCT00385203|tumour|tumour
666994|NCT00385203|advanced cancer|advanced cancer
666995|NCT00385203|Metastatic Gastro-Intestinal Stromal Tumours|metastatic gastro-intestinal stromal tumours
666996|NCT00385203|gastro-intestinal cancer|gastro-intestinal cancer
666997|NCT00385203|RECENTIN|recentin
666998|NCT00385190|SAD|sad
666999|NCT00385164|lung neoplasms|lung neoplasms
667000|NCT00385164|positron emissions tomography|positron emissions tomography
667001|NCT00385164|radiotherapy planning|radiotherapy planning
667002|NCT00385151|Post conditioning|post conditioning
667003|NCT00385138|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
667004|NCT00385138|ACS|acs
667005|NCT00385125|relapsed|relapsed
667006|NCT00385125|refractory|refractory
667007|NCT00385125|CD 20 positive|cd 20 positive
667008|NCT00385112|Cardiology|cardiology
667009|NCT00385112|Echocardiograms|echocardiograms
667010|NCT00385112|Surgery|surgery
667011|NCT00385112|Valve Disease|valve disease
667012|NCT00385112|Heart Valve Disease|heart valve disease
667013|NCT00385099|IBS|ibs
667014|NCT00385099|stress|stress
667015|NCT00385099|CRF1|crf1
667016|NCT00385086|Sciatica|sciatica
667017|NCT00385086|Pain|pain
667018|NCT00385086|TNF-alpha|tnf-alpha
667019|NCT00385086|Discectomy|discectomy
667020|NCT00385086|Fibrosis|fibrosis
667021|NCT00385086|Spine|spine
667022|NCT00385047|malaria|malaria
667023|NCT00385047|vaccine|vaccine
667024|NCT00385047|AMA-1 (apical membrane antigen-1)|ama-1 (apical membrane antigen-1)
667025|NCT00385047|efficacy|efficacy
667026|NCT00385034|randomized controlled trial|randomized controlled trial
667027|NCT00385034|RCT|rct
667028|NCT00385034|partner violence|partner violence
667029|NCT00385034|IPV|ipv
667030|NCT00385034|screening|screening
667031|NCT00385034|family practice|family practice
667032|NCT00385034|computer|computer
667033|NCT00385021|Advanced|advanced
667034|NCT00385021|metastatic|metastatic
667035|NCT00385021|colorectal|colorectal
667036|NCT00385021|cancer|cancer
667037|NCT00385021|Avastin|avastin
667038|NCT00385008|Combination product, sumatriptan succinate, naproxen sodium, absorption, pharmacokinetics, disintegration, gastric transit, gastric scintigraphy|combination product, sumatriptan succinate, naproxen sodium, absorption, pharmacokinetics, disintegration, gastric transit, gastric scintigraphy
667039|NCT00384995|Contrast Induced Nephropathy|contrast induced nephropathy
667040|NCT00384995|Chronic Kidney Disease|chronic kidney disease
667041|NCT00384995|Acute Renal Failure|acute renal failure
667042|NCT00384995|End-stage Renal Disease|end-stage renal disease
667043|NCT00384995|Cardiovascular diseases|cardiovascular diseases
667044|NCT00384995|Coronary catheterization|coronary catheterization
667045|NCT00384995|Percutaneous coronary intervention|percutaneous coronary intervention
667046|NCT00384995|Intra-arterial angiography|intra-arterial angiography
667047|NCT00384995|Bicarbonate|bicarbonate
667048|NCT00384995|Saline|saline
667049|NCT00384982|Bone marrow-derived stem cells|bone marrow-derived stem cells
667050|NCT00384982|Acute myocardial infarction|acute myocardial infarction
667051|NCT00384969|RAD001|rad001
667052|NCT00384969|Sorafenib|sorafenib
667053|NCT00384969|Renal Cell Carcinoma|renal cell carcinoma
667054|NCT00384969|Metastatic|metastatic
667055|NCT00384956|MDS either de novo or secondary, fitting any of the WHO classifications.|mds either de novo or secondary, fitting any of the who classifications.
667056|NCT00384943|postpartum depression|postpartum depression
667057|NCT00384943|exercise|exercise
667058|NCT00384891|Superficial urothelial cell carcinoma of bladder|superficial urothelial cell carcinoma of bladder
667059|NCT00384891|NMIBC|nmibc
667060|NCT00384891|Non Muscle Invasive Bladder Cancer|non muscle invasive bladder cancer
667061|NCT00384891|Hyperthermia|hyperthermia
667062|NCT00384891|Bladder instillation|bladder instillation
667063|NCT00384891|Mitomycin C|mitomycin c
667064|NCT00384891|RITE|rite
667065|NCT00384891|SHTC|shtc
667066|NCT00384891|Intravesical|intravesical
667067|NCT00384865|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
667068|NCT00384852|Fracture|fracture
667069|NCT00384852|Humerus|humerus
667070|NCT00384826|Adenocarcinoma, Bronchiolo-Alveolar|adenocarcinoma, bronchiolo-alveolar
667071|NCT00384787|HIV Seronegativity|hiv seronegativity
667072|NCT00384787|Adenoviral Vector Vaccine|adenoviral vector vaccine
667073|NCT00384787|DNA Plasmid Vaccine|dna plasmid vaccine
667074|NCT00384787|HIV Preventive Vaccine|hiv preventive vaccine
667075|NCT00384774|Migraine|migraine
667076|NCT00384748|Cerebrovascular Accident|cerebrovascular accident
667077|NCT00384748|Rehabilitation|rehabilitation
667078|NCT00384748|Telemedicine|telemedicine
667079|NCT00384735|bone tumor|bone tumor
667080|NCT00384735|soft tissue tumor|soft tissue tumor
667081|NCT00384722|Left ventricular lead|left ventricular lead
667082|NCT00384722|Pacing|pacing
667083|NCT00384722|Heart Failure|heart failure
667084|NCT00384709|Elderly|elderly
667085|NCT00384709|Hospitalization|hospitalization
667086|NCT00384709|Geriatrics|geriatrics
667087|NCT00384709|Mortality|mortality
667088|NCT00384709|Readmission|readmission
667089|NCT00384709|Length of Stay|length of stay
667090|NCT00384696|Risk Perception|risk perception
667091|NCT00384696|Smoking Cessation|smoking cessation
667092|NCT00384696|Nicotine Replacement Therapy|nicotine replacement therapy
667093|NCT00384696|Questionnaire|questionnaire
667094|NCT00384696|Nicotine|nicotine
667095|NCT00384683|Endothelial Dysfunction|endothelial dysfunction
667096|NCT00384683|Endothelial Cells|endothelial cells
667097|NCT00384683|Perioperative Outcome|perioperative outcome
667098|NCT00384683|Blood Sample|blood sample
667099|NCT00384670|dengue|dengue
667100|NCT00384670|vaccine|vaccine
667101|NCT00384657|chronic heart failure|chronic heart failure
667102|NCT00384657|chronic kidney disease|chronic kidney disease
667103|NCT00384657|anemia|anemia
667104|NCT00384657|intravenous iron|intravenous iron
667105|NCT00384644|heart failure|heart failure
667106|NCT00384644|sepsis|sepsis
667107|NCT00384644|septic shock|septic shock
667108|NCT00384644|cardiogenic shock|cardiogenic shock
667109|NCT00384631|Neovascular|neovascular
667110|NCT00384631|Glaucoma|glaucoma
667111|NCT00384631|Bevacizumab|bevacizumab
667112|NCT00384631|Avastin|avastin
667113|NCT00384631|Intravitreal|intravitreal
667114|NCT00384631|IOP|iop
667115|NCT00384618|Kidney, Antioxidants, Statin, Carotid IMT|kidney, antioxidants, statin, carotid imt
667116|NCT00384592|heartburn|heartburn
667117|NCT00384592|reflux|reflux
667118|NCT00384592|proton pump inhibitor|proton pump inhibitor
667119|NCT00384592|GERD|gerd
667120|NCT00384592|GORD|gord
667121|NCT00384579|back|back
667122|NCT00384579|pain|pain
667123|NCT00384540|-Heart Transplant, Allograft Vasculopathy, Dobutamine Stress Echocardiography, Brain Natriuretic Peptide|-heart transplant, allograft vasculopathy, dobutamine stress echocardiography, brain natriuretic peptide
667124|NCT00384540|Vasculopathy|vasculopathy
667125|NCT00384527|Clostridium difficile|clostridium difficile
667126|NCT00384514|Coronary Artery disease with chronic stable angina|coronary artery disease with chronic stable angina
667127|NCT00384501|keratoconus|keratoconus
667128|NCT00384501|Intacs|intacs
667129|NCT00384488|Diabetes mellitus|diabetes mellitus
667130|NCT00384488|Weight control|weight control
667131|NCT00384488|Healthy eating|healthy eating
667132|NCT00384488|Physical Activity|physical activity
667133|NCT00384475|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
667134|NCT00384475|Ciclesonide|ciclesonide
667135|NCT00384475|Hay Fever|hay fever
667136|NCT00384475|SAR|sar
667137|NCT00384462|Premature infants (32-35 weeks GA) <6 months of age at the start of the RSV season who are not receiving palivizumab and do not have CLD of prematurity|premature infants (32-35 weeks ga) <6 months of age at the start of the rsv season who are not receiving palivizumab and do not have cld of prematurity
667138|NCT00384462|Respiratory Syncytial Viruses|respiratory syncytial viruses
667139|NCT00384449|Eales|eales
667140|NCT00384436|Major Depressive Disorder|major depressive disorder
667141|NCT00384423|Alzheimer's Disease|alzheimer's disease
667142|NCT00384423|AD|ad
667143|NCT00384423|PRX-03140|prx-03140
667144|NCT00384423|Dementia|dementia
667145|NCT00384423|Epix|epix
667146|NCT00384423|Predix|predix
667147|NCT00384423|Cognition enhancing|cognition enhancing
667148|NCT00384410|Pain|pain
667149|NCT00384410|Insomnia|insomnia
667150|NCT00384410|Nabilone|nabilone
667151|NCT00384397|Menactra vaccine|menactra vaccine
667152|NCT00384397|Meningococcal meningitis|meningococcal meningitis
667153|NCT00384397|Measles|measles
667154|NCT00384397|Mumps|mumps
667155|NCT00384397|Rubella|rubella
667156|NCT00384397|Varicella virus|varicella virus
667157|NCT00384397|Haemophilus influenzae type b|haemophilus influenzae type b
667158|NCT00384397|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
667159|NCT00384384|Dialysis|dialysis
667160|NCT00384384|Serum potassium|serum potassium
667161|NCT00384384|18b glycyrrhetinic acid|18b glycyrrhetinic acid
667162|NCT00384384|insulin sensitivity|insulin sensitivity
667163|NCT00384371|back|back
667164|NCT00384371|pain|pain
667165|NCT00384358|Fractures|fractures
667166|NCT00384345|bright light treatment|bright light treatment
667167|NCT00384345|exercise|exercise
667168|NCT00384345|body fat index|body fat index
667169|NCT00384345|mood|mood
667170|NCT00384345|sleep|sleep
667171|NCT00384345|fatigue|fatigue
667172|NCT00384332|Bipolar Depression|bipolar depression
667173|NCT00384332|Weight gain bipolar medicine|weight gain bipolar medicine
667174|NCT00384332|side effects olanzapine|side effects olanzapine
667175|NCT00384332|gastrointestinal hormones bipolar medicine|gastrointestinal hormones bipolar medicine
667176|NCT00384319|resuscitation|resuscitation
667177|NCT00384319|hypothermia|hypothermia
667178|NCT00384306|COPD|copd
667179|NCT00384306|prednisolone|prednisolone
667180|NCT00384306|bone biopsy|bone biopsy
667181|NCT00384306|tetracycline labelling|tetracycline labelling
667182|NCT00384267|malaria, infants, preterm babies, neonates, Mali|malaria, infants, preterm babies, neonates, mali
667183|NCT00384254|Tobacco.|tobacco.
667184|NCT00384254|Cessation.|cessation.
667185|NCT00384254|Dental patients.|dental patients.
667186|NCT00384254|Dentists.|dentists.
667187|NCT00384254|Hygienists.|hygienists.
667188|NCT00384254|Dental assistants.|dental assistants.
667189|NCT00384254|Health care providers.|health care providers.
667190|NCT00384254|Behavioral intervention.|behavioral intervention.
667191|NCT00384254|Tobacco intervention.|tobacco intervention.
667192|NCT00384254|Cigarettes.|cigarettes.
667193|NCT00384254|Smokeless tobacco.|smokeless tobacco.
667194|NCT00384254|Smoking intervention.|smoking intervention.
667195|NCT00384241|Blood Pressure, High|blood pressure, high
667196|NCT00384241|Stress|stress
667197|NCT00384241|Inflammation|inflammation
667198|NCT00384228|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
667199|NCT00384228|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
667200|NCT00384202|Tacrolimus|tacrolimus
667201|NCT00384202|Liver Transplantation|liver transplantation
667202|NCT00384189|Asthma|asthma
667203|NCT00384189|Ciclesonide|ciclesonide
667204|NCT00384189|children|children
667205|NCT00384176|Metastatic Colorectal Cancer|metastatic colorectal cancer
667206|NCT00384176|RECENTIN|recentin
667207|NCT00384163|cardiac|cardiac
667208|NCT00384163|adult|adult
667209|NCT00384163|PVR|pvr
667210|NCT00384150|galiximab|galiximab
667211|NCT00384150|antibody|antibody
667212|NCT00384150|refractory|refractory
667213|NCT00384150|follicular|follicular
667214|NCT00384150|relapsed|relapsed
667215|NCT00384150|NHL|nhl
667216|NCT00384150|rituximab|rituximab
667217|NCT00384150|retreatment|retreatment
667218|NCT00384137|Tacrolimus|tacrolimus
667219|NCT00384137|Kidney Transplantation|kidney transplantation
667220|NCT00384124|Bowens disease|bowens disease
667221|NCT00384124|Squamous cell carcinoma in situ of the skin|squamous cell carcinoma in situ of the skin
667222|NCT00384124|imiquimod|imiquimod
667223|NCT00384098|Psoriasis|psoriasis
667224|NCT00384072|postmenopausal|postmenopausal
667225|NCT00384072|women|women
667226|NCT00384072|SERM|serm
667227|NCT00384072|osteoporosis|osteoporosis
667228|NCT00384033|MDD|mdd
667229|NCT00384033|Major Depressive Disorder|major depressive disorder
667230|NCT00384033|Depression|depression
667231|NCT00384020|Major Depression Disorder|major depression disorder
667232|NCT00384020|Antidepressant|antidepressant
667233|NCT00384020|Pharmacogenomics|pharmacogenomics
667234|NCT00384020|Cytochrome P450|cytochrome p450
667235|NCT00384020|Serotonin Transporter|serotonin transporter
667236|NCT00384007|back pain|back pain
667237|NCT00384007|herniated disc|herniated disc
667238|NCT00384007|leg pain|leg pain
667239|NCT00384007|pinched nerves|pinched nerves
667240|NCT00384007|sciatica|sciatica
667241|NCT00384007|radiculopathy|radiculopathy
667242|NCT00383994|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
667243|NCT00383994|CLL|cll
667244|NCT00383994|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
667245|NCT00383994|B-Cell Lymphoma|b-cell lymphoma
667246|NCT00383994|Lymphoma|lymphoma
667247|NCT00383994|granulocyte-macrophage colony-stimulating factor|granulocyte-macrophage colony-stimulating factor
667248|NCT00383994|Leukemia|leukemia
667249|NCT00383994|NK Cells|nk cells
667250|NCT00383994|Rituximab|rituximab
667251|NCT00383994|GM-CSF|gm-csf
667252|NCT00383994|Non-myeloablative Allogeneic Stem Cell Transplantation|non-myeloablative allogeneic stem cell transplantation
667253|NCT00383994|Stem Cell Transplant|stem cell transplant
667254|NCT00383981|malondialdehyde optoelectronic vitamin complex|malondialdehyde optoelectronic vitamin complex
667255|NCT00383942|Pregnancy|pregnancy
667256|NCT00383942|Extra amniotic saline infusion|extra amniotic saline infusion
667257|NCT00383942|Misoprostol|misoprostol
667258|NCT00383942|Labor induction|labor induction
667259|NCT00383929|Blood pressure reduction|blood pressure reduction
667260|NCT00383929|combination therapy|combination therapy
667261|NCT00383929|candesartan cilexetil|candesartan cilexetil
667262|NCT00383929|hydrochlorothiazide|hydrochlorothiazide
667263|NCT00383916|healthy|healthy
667264|NCT00383890|American Society of Anesthesiologists (ASA)|american society of anesthesiologists (asa)
667265|NCT00383890|Mallampati Score|mallampati score
667266|NCT00383890|Ramsay Sedation Scale (RSS)|ramsay sedation scale (rss)
667267|NCT00383864|liver fibrosis|liver fibrosis
667268|NCT00383864|portal pressure|portal pressure
667269|NCT00383864|antiviral therapy|antiviral therapy
667270|NCT00383851|ATN-224|atn-224
667271|NCT00383851|Temozolomide|temozolomide
667272|NCT00383851|Combination|combination
667273|NCT00383851|Sequential|sequential
667274|NCT00383851|Anti-angiogenic|anti-angiogenic
667275|NCT00383851|Copper|copper
667276|NCT00383838|brief motivational intervention; teens; substance use|brief motivational intervention; teens; substance use
667277|NCT00383825|conjunctival autografts|conjunctival autografts
667278|NCT00383825|amniotic membrane|amniotic membrane
667279|NCT00383825|indocyanine green angiography|indocyanine green angiography
667280|NCT00383825|pterygium surgery|pterygium surgery
667281|NCT00383812|Polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
667282|NCT00383812|Intravitreal Bevacizumab|intravitreal bevacizumab
667283|NCT00383799|Ventricular tachycardia|ventricular tachycardia
667284|NCT00383786|PTSD|ptsd
667285|NCT00383786|Substance P|substance p
667286|NCT00383786|Treatment Study|treatment study
667287|NCT00383786|Placebo|placebo
667288|NCT00383786|Controlled|controlled
667289|NCT00383786|Post Traumatic Stress Disorder|post traumatic stress disorder
667290|NCT00383773|retinal vein occlusion|retinal vein occlusion
667291|NCT00383773|rTPA|rtpa
667292|NCT00383747|cognition|cognition
667293|NCT00383747|nicotine|nicotine
667294|NCT00383747|schizophrenia|schizophrenia
667295|NCT00383734|HIV-Associated Lipodystrophy Syndrome|hiv-associated lipodystrophy syndrome
667296|NCT00383734|polylactic acid|polylactic acid
667297|NCT00383734|polyacrylamide gels|polyacrylamide gels
667298|NCT00383695|adenocarcinoma of the rectum|adenocarcinoma of the rectum
667299|NCT00383695|stage I rectal cancer|stage i rectal cancer
667300|NCT00383695|stage II rectal cancer|stage ii rectal cancer
667301|NCT00383695|stage III rectal cancer|stage iii rectal cancer
667302|NCT00383682|postamputation pain|postamputation pain
667303|NCT00383682|phantom pain|phantom pain
667304|NCT00383682|stump pain|stump pain
667305|NCT00383682|neuroma pain|neuroma pain
667306|NCT00383682|opioid|opioid
667307|NCT00383682|mexiletine|mexiletine
667308|NCT00383669|HIV|hiv
667309|NCT00383669|AIDS|aids
667310|NCT00383669|Disease Progression|disease progression
667311|NCT00383669|Multivitamins|multivitamins
667312|NCT00383669|Anti-Retroviral Therapy|anti-retroviral therapy
667313|NCT00383669|HAART|haart
667314|NCT00383669|Tanzania|tanzania
667315|NCT00383669|Africa|africa
667316|NCT00383656|gonadotropin releasing hormone|gonadotropin releasing hormone
667317|NCT00383656|GnRH deficiency|gnrh deficiency
667318|NCT00383656|hypothalamic amenorrhea|hypothalamic amenorrhea
667319|NCT00383656|hypogonadotropic hypogonadism|hypogonadotropic hypogonadism
667320|NCT00383656|Kallman's syndrome|kallman's syndrome
667321|NCT00383656|infertility|infertility
667322|NCT00383630|End Stage Heart Failure|end stage heart failure
667323|NCT00383630|LVAD|lvad
667324|NCT00383630|Bone Marrow Transplantation|bone marrow transplantation
667325|NCT00383630|Stem Cell Transplantation|stem cell transplantation
667326|NCT00383617|pre-radiographic|pre-radiographic
667327|NCT00383617|screening|screening
667328|NCT00383617|early diagnosis|early diagnosis
667329|NCT00383578|Type 2 diabetes|type 2 diabetes
667330|NCT00383578|vildagliptin|vildagliptin
667331|NCT00383578|hemoglobin A1c|hemoglobin a1c
667332|NCT00383578|metformin|metformin
667333|NCT00383539|Influenza|influenza
667334|NCT00383539|Orthomyxoviruses|orthomyxoviruses
667335|NCT00383539|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
667336|NCT00383539|Adults|adults
667337|NCT00383526|Influenza|influenza
667338|NCT00383526|Orthomyxoviruses|orthomyxoviruses
667339|NCT00383526|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
667340|NCT00383526|elderly|elderly
667341|NCT00383513|Lupus|lupus
667342|NCT00383513|Antibody|antibody
667343|NCT00383513|B-Cell Immunotherapy|b-cell immunotherapy
667344|NCT00383461|tobacco use disorder|tobacco use disorder
667345|NCT00383448|Stem cell transplantation|stem cell transplantation
667346|NCT00383448|Inborn errors of metabolism|inborn errors of metabolism
667347|NCT00383448|Adrenoleukodystrophy (ALD)|adrenoleukodystrophy (ald)
667348|NCT00383448|Metachromatic leukodystrophy (MLD)|metachromatic leukodystrophy (mld)
667349|NCT00383448|Globoid cell leukodystrophy (GLD or Krabbe)|globoid cell leukodystrophy (gld or krabbe)
667350|NCT00383448|Tay Sachs|tay sachs
667351|NCT00383448|Sandhoff|sandhoff
667352|NCT00383448|Sanfilippo syndrome|sanfilippo syndrome
667353|NCT00383448|Mucopolysaccharidosis III (MPS-III)|mucopolysaccharidosis iii (mps-iii)
667354|NCT00383448|GM1 gangliosidosis|gm1 gangliosidosis
667355|NCT00383448|I-cell|i-cell
667356|NCT00383448|mucolipidosis|mucolipidosis
667357|NCT00383409|breast|breast
667358|NCT00383409|cancer|cancer
667359|NCT00383409|fatigue|fatigue
667360|NCT00383409|multivitamins|multivitamins
667361|NCT00383357|Performance|performance
667362|NCT00383357|Gait stability|gait stability
667363|NCT00383357|sedative|sedative
667364|NCT00383357|hypnotic|hypnotic
667365|NCT00383357|quality of life|quality of life
667366|NCT00383357|sleep disorder|sleep disorder
667367|NCT00383357|wakefulness|wakefulness
667368|NCT00383357|sleeping pills|sleeping pills
667369|NCT00383357|Cognitive function|cognitive function
667370|NCT00383344|Crohn Disease|crohn disease
667371|NCT00383344|Positron Emission Tomography|positron emission tomography
667372|NCT00383344|Colonoscopy|colonoscopy
667373|NCT00383318|Neonate|neonate
667374|NCT00383318|Hyperbilirubinemia|hyperbilirubinemia
667375|NCT00383318|Jaundice|jaundice
667376|NCT00383318|G6PD Deficiency|g6pd deficiency
667377|NCT00383318|Gilbert's Syndrome|gilbert's syndrome
667378|NCT00383305|neonatal|neonatal
667379|NCT00383305|hypoxic|hypoxic
667380|NCT00383305|ischemic|ischemic
667381|NCT00383305|encephalopathy|encephalopathy
667382|NCT00383305|HIE|hie
667383|NCT00383305|birth asphyxia|birth asphyxia
667384|NCT00383305|neonatal encephalopathy|neonatal encephalopathy
667385|NCT00383305|Asphyxia Neonatorum|asphyxia neonatorum
667386|NCT00383305|hypothermia, therapeutic|hypothermia, therapeutic
667387|NCT00383305|brain cooling|brain cooling
667388|NCT00383305|selective head cooling|selective head cooling
667389|NCT00383279|recurrent cervical cancer|recurrent cervical cancer
667390|NCT00383279|stage 0 cervical cancer|stage 0 cervical cancer
667391|NCT00383279|stage IA cervical cancer|stage ia cervical cancer
667392|NCT00383279|stage IB cervical cancer|stage ib cervical cancer
667393|NCT00383279|stage IIA cervical cancer|stage iia cervical cancer
667394|NCT00383279|stage IIB cervical cancer|stage iib cervical cancer
667395|NCT00383279|stage III cervical cancer|stage iii cervical cancer
667396|NCT00383279|stage IVA cervical cancer|stage iva cervical cancer
667397|NCT00383279|stage IVB cervical cancer|stage ivb cervical cancer
667398|NCT00383279|recurrent uterine sarcoma|recurrent uterine sarcoma
667399|NCT00383279|stage I uterine sarcoma|stage i uterine sarcoma
667400|NCT00383279|stage II uterine sarcoma|stage ii uterine sarcoma
667401|NCT00383279|stage III uterine sarcoma|stage iii uterine sarcoma
668981|NCT00377858|type 2|type 2
667402|NCT00383279|stage IV uterine sarcoma|stage iv uterine sarcoma
667403|NCT00383279|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
667404|NCT00383279|ovarian sarcoma|ovarian sarcoma
667405|NCT00383279|ovarian stromal cancer|ovarian stromal cancer
667406|NCT00383279|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
667407|NCT00383279|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
667408|NCT00383279|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
667409|NCT00383279|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
667410|NCT00383279|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
667411|NCT00383279|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
667412|NCT00383279|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
667413|NCT00383279|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
667414|NCT00383279|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
667415|NCT00383279|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
667416|NCT00383214|Lupus,|lupus,
667417|NCT00383214|antibody,|antibody,
667418|NCT00383214|B-cell immunotherapy|b-cell immunotherapy
667419|NCT00383201|Contact Lens Care|contact lens care
667420|NCT00383188|Arthritis, Rheumatoid|arthritis, rheumatoid
667421|NCT00383175|Ocular Accommodation|ocular accommodation
667422|NCT00383175|Reading|reading
667423|NCT00383162|Combination Product|combination product
667424|NCT00383162|naproxen sodium|naproxen sodium
667425|NCT00383162|sumatriptan succinate|sumatriptan succinate
667426|NCT00383162|short acting triptan|short acting triptan
667427|NCT00383162|migraine, acute|migraine, acute
667428|NCT00383162|Poor response|poor response
667429|NCT00383136|STEMI|stemi
667430|NCT00383136|Primary Angioplasty|primary angioplasty
667431|NCT00383136|Abciximab|abciximab
667432|NCT00383136|Tirofiban|tirofiban
667433|NCT00383123|Fluarix|fluarix
667434|NCT00383123|Influenza|influenza
667435|NCT00383110|Diabetes|diabetes
667436|NCT00383110|Health Outcomes|health outcomes
667437|NCT00383110|Racial Preference|racial preference
667438|NCT00383110|Clinical Trial|clinical trial
667439|NCT00383110|Ethnic Differences|ethnic differences
667440|NCT00383097|CTLs|ctls
667441|NCT00383097|LMP1|lmp1
667442|NCT00383097|LMP2|lmp2
667443|NCT00383097|CYTOTOXIC T-LYMPHOCYTES|cytotoxic t-lymphocytes
667444|NCT00383097|CD45|cd45
667445|NCT00383097|ANTIBODY|antibody
667446|NCT00383097|EBV-POSITIVE HODGKIN'S|ebv-positive hodgkin's
667447|NCT00383097|NON-HODGKIN'S LYMPHOMA|non-hodgkin's lymphoma
667448|NCT00383084|Pain|pain
667449|NCT00383084|Physical Activity|physical activity
667450|NCT00383084|Fatigue|fatigue
667451|NCT00383084|Lifestyle Activity|lifestyle activity
667452|NCT00383071|Apheresis|apheresis
667453|NCT00383071|Avian Flu|avian flu
667454|NCT00383071|Healthy Volunteers|healthy volunteers
667455|NCT00383071|Infectious Diseases|infectious diseases
667456|NCT00383071|IVIG|ivig
667457|NCT00383071|Healthy Volunteer|healthy volunteer
667458|NCT00383071|HV|hv
667459|NCT00383058|obesity|obesity
667460|NCT00383058|green tea|green tea
667461|NCT00383045|Buprenorphine|buprenorphine
667462|NCT00383045|Naltrexone|naltrexone
667463|NCT00383045|HIV risk reduction behavior|hiv risk reduction behavior
667464|NCT00383045|Counseling|counseling
667465|NCT00383006|Psychotherapy, Group|psychotherapy, group
667466|NCT00383006|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
667467|NCT00383006|Ambulatory Care|ambulatory care
667468|NCT00382993|migraine with or without aura|migraine with or without aura
667469|NCT00382993|naproxen sodium|naproxen sodium
667470|NCT00382993|combination product|combination product
667471|NCT00382993|sumatriptan succinate|sumatriptan succinate
667472|NCT00382993|poor response|poor response
667473|NCT00382993|short acting triptan|short acting triptan
667474|NCT00382993|migraine, acute|migraine, acute
667475|NCT00382980|influenza, vaccine, A/H5N1, aluminum hydroxide, Vero cell|influenza, vaccine, a/h5n1, aluminum hydroxide, vero cell
667476|NCT00382967|Parkinsonian Syndromes, Parkinsonism, DaTSCAN, SPECT, clinical management, quality of life, movement disorder|parkinsonian syndromes, parkinsonism, datscan, spect, clinical management, quality of life, movement disorder
667477|NCT00382967|Clinically uncertain Parkinsonian Syndromes|clinically uncertain parkinsonian syndromes
667478|NCT00382954|Acute Myelogenous Leukemia|acute myelogenous leukemia
667479|NCT00382954|AML|aml
667480|NCT00382954|Relapse|relapse
667481|NCT00382954|Elderly|elderly
667482|NCT00382954|Velcade|velcade
667483|NCT00382954|Idarubicin|idarubicin
667484|NCT00382954|Bortezomib|bortezomib
667485|NCT00382928|Randomized Controlled Trials|randomized controlled trials
667486|NCT00382928|Defibrillators|defibrillators
667487|NCT00382928|Medical Devices|medical devices
667488|NCT00382915|Smoking|smoking
667489|NCT00382915|Topography|topography
667490|NCT00382915|Nicotine|nicotine
667491|NCT00382902|Contact Lens Care|contact lens care
667492|NCT00382889|Anti-Asthmatic Agents|anti-asthmatic agents
667493|NCT00382889|corticosteroids|corticosteroids
667494|NCT00382889|symptom-driven|symptom-driven
667495|NCT00382889|beclomethasone|beclomethasone
667496|NCT00382889|salbutamol|salbutamol
667599|NCT00382551|Endothelial function|endothelial function
667497|NCT00382876|apnea, hypoxia, car seat, car bed|apnea, hypoxia, car seat, car bed
667498|NCT00382863|heart failure|heart failure
667499|NCT00382863|cardiac support|cardiac support
667500|NCT00382863|Paracor|paracor
667501|NCT00382863|HeartNet|heartnet
667502|NCT00382863|PEERLESS-HF|peerless-hf
667503|NCT00382850|Nissen fundoplication|nissen fundoplication
667504|NCT00382850|gastroesophageal reflux|gastroesophageal reflux
667505|NCT00382837|Lupus,|lupus,
667506|NCT00382837|Antibody,|antibody,
667507|NCT00382837|B-Cell immunotherapy|b-cell immunotherapy
667508|NCT00382824|Progressive Supranuclear Palsy|progressive supranuclear palsy
667509|NCT00382824|Atypical Parkinsonism|atypical parkinsonism
667510|NCT00382824|CoQ10|coq10
667511|NCT00382811|Recurrent Ovarian Epithelial Cancer|recurrent ovarian epithelial cancer
667512|NCT00382811|Stage IV Ovarian Epithelial Cancer|stage iv ovarian epithelial cancer
667513|NCT00382811|Peritoneal Cavity Cancer|peritoneal cavity cancer
667514|NCT00382811|Stage III Ovarian Epithelial Cancer|stage iii ovarian epithelial cancer
667515|NCT00382785|online|online
667516|NCT00382785|support|support
667517|NCT00382785|breast cancer|breast cancer
667518|NCT00382772|HRV vaccine|hrv vaccine
667519|NCT00382772|Diarrhoea|diarrhoea
667520|NCT00382772|Rotavirus|rotavirus
667521|NCT00382746|Congestive|congestive
667522|NCT00382746|Heart|heart
667523|NCT00382746|Failure|failure
667524|NCT00382746|CHF|chf
667525|NCT00382733|Solid Tumors|solid tumors
667526|NCT00382707|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
667527|NCT00382707|low frequency|low frequency
667528|NCT00382707|frontal lobe epilepsy|frontal lobe epilepsy
667529|NCT00382707|brain excitability|brain excitability
667530|NCT00382707|electromyography|electromyography
667531|NCT00382694|Myeloma|myeloma
667532|NCT00382694|Induction therapy|induction therapy
667533|NCT00382694|High-dose melphalan|high-dose melphalan
667534|NCT00382694|Autologous stem cell support|autologous stem cell support
667535|NCT00382694|Fludarabine|fludarabine
667536|NCT00382694|Cyclophosphamide|cyclophosphamide
667537|NCT00382694|Dexamethasone|dexamethasone
667538|NCT00382694|Safety|safety
667539|NCT00382694|Toxicity|toxicity
667540|NCT00382681|Contact Lens Care|contact lens care
667541|NCT00382668|hepatically impaired|hepatically impaired
667542|NCT00382655|Prevention|prevention
667543|NCT00382655|Emergency Medical Services|emergency medical services
667544|NCT00382655|Emergency Medical Technicians|emergency medical technicians
667545|NCT00382642|alcoholism, alcohol disorder, drinking,alcohol|alcoholism, alcohol disorder, drinking,alcohol
667546|NCT00382629|Multiple sclerosis|multiple sclerosis
667547|NCT00382629|MS|ms
667548|NCT00382629|Bayhill|bayhill
667549|NCT00382629|BHT-3009|bht-3009
667550|NCT00382629|immunotherapy|immunotherapy
667551|NCT00382616|behavioral problems|behavioral problems
667552|NCT00382616|learning problems|learning problems
667553|NCT00382616|inattentive|inattentive
667554|NCT00382616|impulsive|impulsive
667555|NCT00382616|hyperactive|hyperactive
667556|NCT00382616|children|children
667557|NCT00382616|phosphatidylserine|phosphatidylserine
667558|NCT00382616|long-chain polyunsaturated fatty acid|long-chain polyunsaturated fatty acid
667559|NCT00382616|eicosapentaenoic acid|eicosapentaenoic acid
667560|NCT00382616|docosahexaenoic acid|docosahexaenoic acid
667561|NCT00382616|omega3:omega6 ratio|omega3:omega6 ratio
667562|NCT00382616|eicosapentaenoic acid:arachidonic acid ratio|eicosapentaenoic acid:arachidonic acid ratio
667563|NCT00382616|Test of Variables of Attention|test of variables of attention
667564|NCT00382616|ADHD index scores|adhd index scores
667565|NCT00382603|Contact Lens Care|contact lens care
667566|NCT00382590|Acute Myelogenous Leukemia|acute myelogenous leukemia
667567|NCT00382590|AML|aml
667568|NCT00382590|Myelodysplastic Syndrome|myelodysplastic syndrome
667569|NCT00382590|Leukemia|leukemia
667570|NCT00382590|MDS|mds
667571|NCT00382590|Azacytidine|azacytidine
667572|NCT00382590|5-Azacytidine|5-azacytidine
667573|NCT00382590|5-aza|5-aza
667574|NCT00382590|Vidaza|vidaza
667575|NCT00382590|5-AZC|5-azc
667576|NCT00382590|AZA-CR|aza-cr
667577|NCT00382590|Ladakamycin|ladakamycin
667578|NCT00382590|Ara-C|ara-c
667579|NCT00382590|Cytarabine|cytarabine
667580|NCT00382590|Cytosar|cytosar
667581|NCT00382590|DepoCyt|depocyt
667582|NCT00382590|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
667583|NCT00382590|Valproic Acid|valproic acid
667584|NCT00382590|VPA|vpa
667585|NCT00382590|Depakene|depakene
667586|NCT00382564|Imaging|imaging
667587|NCT00382564|Arteriosclerosis|arteriosclerosis
667588|NCT00382564|Hardening of the arteries|hardening of the arteries
667589|NCT00382564|MRA|mra
667590|NCT00382564|Narrowing of Vessels|narrowing of vessels
667591|NCT00382564|Noninvasive Plaque Imaging|noninvasive plaque imaging
667592|NCT00382564|Atherosclerotic Disease|atherosclerotic disease
667593|NCT00382564|Plaque|plaque
667594|NCT00382564|Arteries|arteries
667595|NCT00382564|Diabetes|diabetes
667596|NCT00382564|Hypertension|hypertension
667597|NCT00382551|Alcohol|alcohol
667598|NCT00382551|Red wine|red wine
668308|NCT00379574|CHOP|chop
667600|NCT00382551|Flow-mediated vasodilation|flow-mediated vasodilation
667601|NCT00382551|Cardiovascular disease|cardiovascular disease
667602|NCT00382538|mifepristone|mifepristone
667603|NCT00382538|induction|induction
667604|NCT00382538|abortion|abortion
667605|NCT00382538|injection, intra-amniotic|injection, intra-amniotic
667606|NCT00382525|Bradyarrhythmia|bradyarrhythmia
667607|NCT00382525|Atrial Fibrillation|atrial fibrillation
667608|NCT00382525|Ventricular Tachycardia|ventricular tachycardia
667609|NCT00382525|Ventricular Fibrillation|ventricular fibrillation
667610|NCT00382525|Heart Failure|heart failure
667611|NCT00382525|Pacemaker|pacemaker
667612|NCT00382525|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
667613|NCT00382525|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
667614|NCT00382525|Loop recorder|loop recorder
667615|NCT00382525|Registry|registry
667616|NCT00382512|Moderate Plaque Psoriasis|moderate plaque psoriasis
667617|NCT00382499|Intravenous Lidocaine|intravenous lidocaine
667618|NCT00382499|Lidocaine Infusion|lidocaine infusion
667619|NCT00382499|Total Abdominal Hysterectomy|total abdominal hysterectomy
667620|NCT00382499|Analgesia|analgesia
667621|NCT00382499|Anesthesia|anesthesia
667622|NCT00382499|Adjunct|adjunct
667623|NCT00382486|Intestinal transplant|intestinal transplant
667624|NCT00382486|Bone marrow|bone marrow
667625|NCT00382486|Irradiation of allograft|irradiation of allograft
667626|NCT00382473|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
667627|NCT00382473|Overweight|overweight
667628|NCT00382473|Fatty acid oxidation|fatty acid oxidation
667629|NCT00382473|Mitochondria|mitochondria
667630|NCT00382473|Exercise|exercise
667631|NCT00382447|breath actuated nebulizer|breath actuated nebulizer
667632|NCT00382447|nebulizer|nebulizer
667633|NCT00382434|emergency pharmacist|emergency pharmacist
667634|NCT00382434|emergency medicine|emergency medicine
667635|NCT00382434|emergency department|emergency department
667636|NCT00382434|medical error|medical error
667637|NCT00382434|adverse event|adverse event
667638|NCT00382434|pharmacist|pharmacist
667639|NCT00382434|patient safety|patient safety
667640|NCT00382421|Myocardial Ischemia|myocardial ischemia
667641|NCT00382421|Randomized Controlled Trials|randomized controlled trials
667642|NCT00382421|Drug Therapy|drug therapy
667643|NCT00382408|Acute respiratory disease prevention|acute respiratory disease prevention
667644|NCT00382408|Adenovirus|adenovirus
667645|NCT00382395|Glaucoma shunt|glaucoma shunt
667646|NCT00382395|Ocular implant|ocular implant
667647|NCT00382395|Gold|gold
667648|NCT00382395|trabeculectomy|trabeculectomy
667649|NCT00382382|Autism|autism
667650|NCT00382382|Asperger Syndrome|asperger syndrome
667651|NCT00382382|Restricted repetitive behavior|restricted repetitive behavior
667652|NCT00382382|Stereotyped patterns of behavior|stereotyped patterns of behavior
667653|NCT00382382|Typically Developing children|typically developing children
667654|NCT00382382|Human Volunteers|human volunteers
667655|NCT00382369|familial vocal cord paralysis|familial vocal cord paralysis
667656|NCT00382369|genetic screening|genetic screening
667657|NCT00382356|Benign Prostatic Enlargement|benign prostatic enlargement
667658|NCT00382356|Benign Prostatic Hypertrophy|benign prostatic hypertrophy
667659|NCT00382356|Dutasteride|dutasteride
667660|NCT00382356|5-alpha reductase inhibitors|5-alpha reductase inhibitors
667661|NCT00382356|Hormonal therapy|hormonal therapy
667662|NCT00382343|Prevention|prevention
667663|NCT00382343|Pyelonephritis|pyelonephritis
667664|NCT00382343|Renal scars|renal scars
667665|NCT00382343|Vesico-ureteral reflux|vesico-ureteral reflux
667666|NCT00382343|Dimercaptosuccinic acid renal scan (DMSA)|dimercaptosuccinic acid renal scan (dmsa)
667667|NCT00382330|Vulva|vulva
667668|NCT00382317|MSCT indications|msct indications
667669|NCT00382304|Clostridium difficile-associated diarrhea|clostridium difficile-associated diarrhea
667670|NCT00382304|C. difficile|c. difficile
667671|NCT00382304|CDAD|cdad
667672|NCT00382304|Clostridium difficile|clostridium difficile
667673|NCT00382304|Clostridium difficile Disease|clostridium difficile disease
667674|NCT00382304|Clostridium Enterocolitis|clostridium enterocolitis
667675|NCT00382304|Antibiotic-Associated Colitis|antibiotic-associated colitis
667676|NCT00382304|Infectious diarrhea|infectious diarrhea
667677|NCT00382291|OCD|ocd
667678|NCT00382291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation
667679|NCT00382291|Placebos|placebos
667680|NCT00382291|Cognitive Behavior Therapy|cognitive behavior therapy
667681|NCT00382291|Child Psychiatry|child psychiatry
667682|NCT00382291|Activation Syndrome|activation syndrome
667683|NCT00382291|Psychometrics|psychometrics
667684|NCT00382278|Stem cell|stem cell
667685|NCT00382278|Liver cirrhosis|liver cirrhosis
667686|NCT00382278|Cellular therapy|cellular therapy
667687|NCT00382278|Autologous|autologous
667688|NCT00382278|Bone marrow|bone marrow
667689|NCT00382265|urolithiasis|urolithiasis
667690|NCT00382265|renal colic|renal colic
667691|NCT00382265|kidney stones|kidney stones
667692|NCT00382265|urinary stone disease|urinary stone disease
667693|NCT00382252|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
668309|NCT00379574|Lenograstim|lenograstim
667694|NCT00382252|lung metastases|lung metastases
667695|NCT00382239|diabetes|diabetes
667696|NCT00382239|exenatide|exenatide
667697|NCT00382239|LY2148568|ly2148568
667698|NCT00382239|Lilly|lilly
667699|NCT00382239|Amylin|amylin
667700|NCT00382239|Japan|japan
667701|NCT00382226|Glaucoma|glaucoma
667702|NCT00382200|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
667703|NCT00382200|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
667704|NCT00382187|influenza|influenza
667705|NCT00382187|pandemic influenza|pandemic influenza
667706|NCT00382187|influenza vaccine|influenza vaccine
667707|NCT00382187|adjuvanted influenza vaccine|adjuvanted influenza vaccine
667708|NCT00382187|H5N1 influenza antigen|h5n1 influenza antigen
667709|NCT00382187|MF59|mf59
667710|NCT00382187|Pandemic influenza disease|pandemic influenza disease
667711|NCT00382174|pressure ulcers|pressure ulcers
667712|NCT00382174|cutaneous wound- healing|cutaneous wound- healing
667713|NCT00382174|chronic wound-healing|chronic wound-healing
667714|NCT00382174|Thymosin Beta 4|thymosin beta 4
667715|NCT00382174|laminin-5|laminin-5
667716|NCT00382161|impotence|impotence
667717|NCT00382161|erectile dysfunction|erectile dysfunction
667718|NCT00382161|cardiovascular risk factor|cardiovascular risk factor
667719|NCT00382161|statin|statin
667720|NCT00382148|TOPS|tops
667721|NCT00382148|Peanut allergy|peanut allergy
667722|NCT00382148|Peanut-induced allergy|peanut-induced allergy
667723|NCT00382148|Allergy|allergy
667724|NCT00382135|Impotence|impotence
667725|NCT00382135|erectile dysfunction|erectile dysfunction
667726|NCT00382135|semen|semen
667727|NCT00382135|sperm|sperm
667728|NCT00382135|Healthy male volunteers|healthy male volunteers
667729|NCT00382135|men with mild erectile dysfunction|men with mild erectile dysfunction
667730|NCT00382122|Glaucoma|glaucoma
667731|NCT00382122|Ocular hypertension|ocular hypertension
667732|NCT00382122|Dry eye|dry eye
667733|NCT00382122|Ocular surface disease|ocular surface disease
667734|NCT00382096|Type 2 diabetes|type 2 diabetes
667735|NCT00382096|vildagliptin|vildagliptin
667736|NCT00382096|metformin|metformin
667737|NCT00382096|hemoglobin A1c|hemoglobin a1c
667738|NCT00382083|Mammogram|mammogram
667739|NCT00382083|Pain|pain
667740|NCT00382083|Discomfort|discomfort
667741|NCT00382083|Breast|breast
667742|NCT00382083|Pre-medication|pre-medication
667743|NCT00382070|stage I breast cancer|stage i breast cancer
667744|NCT00382070|stage II breast cancer|stage ii breast cancer
667745|NCT00382070|stage IIIA breast cancer|stage iiia breast cancer
667746|NCT00382057|Testosterone|testosterone
667747|NCT00382057|Insulin resistance|insulin resistance
667748|NCT00382057|Insulin sensitivity|insulin sensitivity
667749|NCT00382057|Metabolic disorders|metabolic disorders
667750|NCT00382044|Kidney Failure, Chronic|kidney failure, chronic
667751|NCT00382044|Dialysis|dialysis
667752|NCT00382044|Anemia|anemia
667753|NCT00382044|epoetin|epoetin
667754|NCT00382018|recurrent breast cancer|recurrent breast cancer
667755|NCT00382018|stage IV breast cancer|stage iv breast cancer
667756|NCT00381992|sexual risk behavior|sexual risk behavior
667757|NCT00381992|diabetes mellitus|diabetes mellitus
667758|NCT00381992|hypertension|hypertension
667759|NCT00381992|obesity|obesity
667760|NCT00381992|human immunodeficiency virus|human immunodeficiency virus
667761|NCT00381992|hyperlipidemia|hyperlipidemia
667762|NCT00381992|chlamydia|chlamydia
667763|NCT00381979|Depression|depression
667764|NCT00381979|Anxiety|anxiety
667765|NCT00381979|Adolescents|adolescents
667766|NCT00381979|Treatment|treatment
667767|NCT00381979|Supportive Expressive Therapy|supportive expressive therapy
667768|NCT00381966|Prostate Cancer|prostate cancer
667769|NCT00381966|Brachytherapy|brachytherapy
667770|NCT00381927|Breast Cancer Risk|breast cancer risk
667771|NCT00381927|Counseling|counseling
667772|NCT00381927|Prevention|prevention
667773|NCT00381927|Anxiety|anxiety
667774|NCT00381927|BRCA1 mutation|brca1 mutation
667775|NCT00381927|BRCA2 mutation|brca2 mutation
667776|NCT00381927|Tamoxifen|tamoxifen
667777|NCT00381914|Infants|infants
667778|NCT00381914|Vitamin D|vitamin d
667779|NCT00381914|Dose-response|dose-response
667780|NCT00381901|stage II breast cancer|stage ii breast cancer
667781|NCT00381901|stage IIIA breast cancer|stage iiia breast cancer
667782|NCT00381901|stage IIIB breast cancer|stage iiib breast cancer
667783|NCT00381901|stage IA breast cancer|stage ia breast cancer
667784|NCT00381901|stage IB breast cancer|stage ib breast cancer
667785|NCT00381901|recurrent breast cancer|recurrent breast cancer
667786|NCT00381901|stage IIIC breast cancer|stage iiic breast cancer
667787|NCT00381888|thromboembolism|thromboembolism
667788|NCT00381888|cervical cancer|cervical cancer
667789|NCT00381888|endometrial cancer|endometrial cancer
667790|NCT00381888|ovarian epithelial cancer|ovarian epithelial cancer
667791|NCT00381888|ovarian germ cell tumor|ovarian germ cell tumor
667792|NCT00381888|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
667793|NCT00381888|ovarian sarcoma|ovarian sarcoma
667794|NCT00381888|ovarian stromal cancer|ovarian stromal cancer
668505|NCT00378820|Casein|casein
667795|NCT00381888|uterine sarcoma|uterine sarcoma
667796|NCT00381888|vaginal cancer|vaginal cancer
667797|NCT00381888|vulvar cancer|vulvar cancer
667798|NCT00381888|fallopian tube cancer|fallopian tube cancer
667799|NCT00381875|HIV infection|hiv infection
667800|NCT00381862|nausea and vomiting|nausea and vomiting
667801|NCT00381862|recurrent colon cancer|recurrent colon cancer
667802|NCT00381862|stage IV colon cancer|stage iv colon cancer
667803|NCT00381862|recurrent rectal cancer|recurrent rectal cancer
667804|NCT00381862|stage IV rectal cancer|stage iv rectal cancer
667805|NCT00381849|Cystone|cystone
667806|NCT00381849|Uricare|uricare
667807|NCT00381849|Computerized tomography|computerized tomography
667808|NCT00381849|Kidney calculi|kidney calculi
667809|NCT00381849|Supersaturation|supersaturation
667810|NCT00381849|Nephrolithiasis|nephrolithiasis
667811|NCT00381849|Quantitative CT|quantitative ct
667812|NCT00381836|Prostate Cancer|prostate cancer
667813|NCT00381836|Anemia|anemia
667814|NCT00381836|Blood transfusion|blood transfusion
667815|NCT00381836|Cancer|cancer
667816|NCT00381836|Critical illness|critical illness
667817|NCT00381836|Drug efficacy|drug efficacy
667818|NCT00381836|Drug safety|drug safety
667819|NCT00381836|Drug tolerability|drug tolerability
667820|NCT00381836|Erythropoietin|erythropoietin
667821|NCT00381836|Fatigue|fatigue
667822|NCT00381836|Hemoglobin|hemoglobin
667823|NCT00381836|Human|human
667824|NCT00381836|Male|male
667825|NCT00381836|Multicenter study|multicenter study
667826|NCT00381836|Quality of life|quality of life
667827|NCT00381836|Questionnaire|questionnaire
667828|NCT00381836|Randomized controlled trial|randomized controlled trial
667829|NCT00381836|Recombinant erythropoietin|recombinant erythropoietin
667830|NCT00381823|Pregnant women|pregnant women
667831|NCT00381823|Intervention Studies|intervention studies
667832|NCT00381823|African Americans|african americans
667833|NCT00381823|Infant Mortality|infant mortality
667834|NCT00381823|Environmental Tobacco Smoke Pollution|environmental tobacco smoke pollution
667835|NCT00381823|Depression|depression
667836|NCT00381823|Partner Abuse|partner abuse
667837|NCT00381823|Tobacco Smoke|tobacco smoke
667838|NCT00381810|Rituxan|rituxan
667839|NCT00381810|SLE|sle
667840|NCT00381810|Lupus|lupus
667841|NCT00381784|YMSM|ymsm
667842|NCT00381784|HIV/AIDS|hiv/aids
667843|NCT00381784|Condom use|condom use
667844|NCT00381784|Drug users|drug users
667845|NCT00381784|Minority women|minority women
667846|NCT00381771|Globus Pharyngeus|globus pharyngeus
667847|NCT00381771|Xerostomia|xerostomia
667848|NCT00381771|Salivary Hypofunction|salivary hypofunction
667849|NCT00381771|Pharyngoxerosis|pharyngoxerosis
667850|NCT00381758|ADHD|adhd
667851|NCT00381758|Methylphenidate|methylphenidate
667852|NCT00381758|Metadate CD|metadate cd
667853|NCT00381758|Concerta|concerta
667854|NCT00381758|COMACS|comacs
667855|NCT00381758|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
667856|NCT00381732|Impotence|impotence
667857|NCT00381732|erectile dysfunction|erectile dysfunction
667858|NCT00381706|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
667859|NCT00381706|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
667860|NCT00381706|stage IV esophageal cancer|stage iv esophageal cancer
667861|NCT00381706|recurrent esophageal cancer|recurrent esophageal cancer
667862|NCT00381693|primary myelofibrosis|primary myelofibrosis
667863|NCT00381693|polycythemia vera|polycythemia vera
667864|NCT00381693|essential thrombocythemia|essential thrombocythemia
667865|NCT00381693|secondary myelofibrosis|secondary myelofibrosis
667866|NCT00381667|safety|safety
667867|NCT00381667|GW642444M|gw642444m
667868|NCT00381667|Single Dose|single dose
667869|NCT00381667|pharmacodynamics|pharmacodynamics
667870|NCT00381667|pharmacokinetics|pharmacokinetics
667871|NCT00381667|GW642444H|gw642444h
667872|NCT00381667|tolerability|tolerability
667873|NCT00381654|Solid Tumors|solid tumors
667874|NCT00381654|Tyrosine Kinases|tyrosine kinases
667875|NCT00381628|Anatomy|anatomy
667876|NCT00381628|cells|cells
667877|NCT00381628|epithelial cells|epithelial cells
667878|NCT00381628|blood cells|blood cells
667879|NCT00381628|cystic fibrosis|cystic fibrosis
667880|NCT00381628|equipment and supplies|equipment and supplies
667881|NCT00381628|disposable equipment|disposable equipment
667882|NCT00381628|reagent kits|reagent kits
667883|NCT00381615|Meningococcal disease|meningococcal disease
667884|NCT00381615|prevention|prevention
667885|NCT00381615|vaccination|vaccination
667886|NCT00381602|End stage renal disease|end stage renal disease
667887|NCT00381602|Hemodialysis|hemodialysis
667888|NCT00381602|Malnutrition|malnutrition
667889|NCT00381602|End stage renal disease (ESRD)|end stage renal disease (esrd)
667890|NCT00381589|clozapine-induced hypersalivation|clozapine-induced hypersalivation
667891|NCT00381576|Resistance training|resistance training
667892|NCT00381576|Strength training|strength training
667893|NCT00381576|Training adaptations|training adaptations
667894|NCT00381576|CNS|cns
667895|NCT00381563|Bracing|bracing
667896|NCT00381563|Patellofemoral|patellofemoral
667897|NCT00381563|Osteoarthritis|osteoarthritis
667898|NCT00381537|childhood epilepsy|childhood epilepsy
667899|NCT00381537|Active childhood epilepsy|active childhood epilepsy
667900|NCT00381524|human immunodeficiency virus|human immunodeficiency virus
667901|NCT00381524|behavior change|behavior change
667902|NCT00381511|pulmonary embolism,|pulmonary embolism,
667903|NCT00381511|deferred diagnosis,|deferred diagnosis,
667904|NCT00381511|protective anticoagulation|protective anticoagulation
667905|NCT00381511|anticoagulants|anticoagulants
667906|NCT00381472|Parkinson's Disease|parkinson's disease
667907|NCT00381472|Dyskinesia|dyskinesia
667908|NCT00381472|Adjunctive Therapy with L-dopa|adjunctive therapy with l-dopa
667909|NCT00381446|corneal staining|corneal staining
667910|NCT00381446|contact lens care|contact lens care
667911|NCT00381446|multipurpose solution|multipurpose solution
667912|NCT00381433|HCV|hcv
667913|NCT00381433|Hepatitis C virus|hepatitis c virus
667914|NCT00381407|ADHD|adhd
667915|NCT00381407|Organizational Skills|organizational skills
667916|NCT00381407|Contingency Management|contingency management
667917|NCT00381394|amphotericin B|amphotericin b
667918|NCT00381394|safety|safety
667919|NCT00381394|tolerability and pharmacokinetics of oral sitamaquine|tolerability and pharmacokinetics of oral sitamaquine
667920|NCT00381394|Visceral leishmaniasis|visceral leishmaniasis
667921|NCT00381381|Alzheimer's disease|alzheimer's disease
667922|NCT00381368|breast cancer|breast cancer
667923|NCT00381368|skeletal metastases|skeletal metastases
667924|NCT00381368|bisphosphonate therapy|bisphosphonate therapy
667925|NCT00381368|Breast cancer with painful skeletal metastases|breast cancer with painful skeletal metastases
667926|NCT00381355|asthma|asthma
667927|NCT00381355|children|children
667928|NCT00381355|written action plan|written action plan
667929|NCT00381355|education|education
667930|NCT00381355|guided self-management|guided self-management
667931|NCT00381355|efficacy|efficacy
667932|NCT00381355|compliance|compliance
667933|NCT00381355|b2-agonists|b2-agonists
667934|NCT00381355|inhaled corticosteroids|inhaled corticosteroids
667935|NCT00381355|oral steroids|oral steroids
667936|NCT00381355|relapse|relapse
667937|NCT00381355|randomised controlled trial|randomised controlled trial
667938|NCT00381355|emergency department|emergency department
667939|NCT00381342|diabetes|diabetes
667940|NCT00381342|exenatide|exenatide
667941|NCT00381342|Amylin|amylin
667942|NCT00381342|Lilly|lilly
667943|NCT00381342|monotherapy|monotherapy
667944|NCT00381329|Motivational Interviewing|motivational interviewing
667945|NCT00381329|Structured Brief Advice|structured brief advice
667946|NCT00381329|Adolescent Smoking|adolescent smoking
667947|NCT00381329|Behavioral Intervention|behavioral intervention
667948|NCT00381329|Smoking|smoking
667949|NCT00381329|Primary Care|primary care
667950|NCT00381329|Tobacco|tobacco
667951|NCT00381303|HIV|hiv
667952|NCT00381303|AIDS|aids
667953|NCT00381303|Immunodeficiency Virus, Human|immunodeficiency virus, human
667954|NCT00381303|Females|females
667955|NCT00381303|Women|women
667956|NCT00381303|PREZISTA|prezista
667957|NCT00381303|darunavir|darunavir
667958|NCT00381303|TMC114|tmc114
667959|NCT00381303|Protease Inhibitor|protease inhibitor
667960|NCT00381290|Arthritis|arthritis
667961|NCT00381290|Arthritis, Degenerative|arthritis, degenerative
667962|NCT00381290|Knee Health|knee health
667963|NCT00381290|Obesity|obesity
667964|NCT00381290|Overweight|overweight
667965|NCT00381290|Osteoarthritis|osteoarthritis
667966|NCT00381290|Weight Loss|weight loss
667967|NCT00381290|Diet|diet
667968|NCT00381290|Exercise|exercise
667969|NCT00381290|Knee Pain|knee pain
667970|NCT00381277|nephrolithiasis|nephrolithiasis
667971|NCT00381277|citrate|citrate
667972|NCT00381277|oxalate|oxalate
667973|NCT00381251|vaginal atrophy|vaginal atrophy
667974|NCT00381251|postmenopausal osteoporosis|postmenopausal osteoporosis
667975|NCT00381251|menopause|menopause
667976|NCT00381251|hot flashes|hot flashes
667977|NCT00381238|Alzheimer's Disease|alzheimer's disease
667978|NCT00381238|Rosiglitazone|rosiglitazone
667979|NCT00381225|Radio-frequency ablation; Head and Neck neoplasia.|radio-frequency ablation; head and neck neoplasia.
667980|NCT00381212|Immunotherapeutic injection|immunotherapeutic injection
667981|NCT00381199|fibromyalgia|fibromyalgia
667982|NCT00381199|cannabinoid|cannabinoid
667983|NCT00381199|chronic pain|chronic pain
667984|NCT00381199|sleep|sleep
667985|NCT00381199|insomnia|insomnia
667986|NCT00381199|diffuse widespread pain|diffuse widespread pain
667987|NCT00381199|antidepressant|antidepressant
667988|NCT00381186|impaired glucose tolerance|impaired glucose tolerance
667989|NCT00381186|type 2 diabetes|type 2 diabetes
667990|NCT00381173|MGI PHARMA|mgi pharma
667991|NCT00381173|ZYC3-002|zyc3-002
667992|NCT00381173|ZYC300|zyc300
667993|NCT00381173|plasmid DNA|plasmid dna
667994|NCT00381173|cyclophosphamide|cyclophosphamide
667995|NCT00381173|Cytoxan|cytoxan
667996|NCT00381173|advanced breast cancer|advanced breast cancer
667997|NCT00381173|advanced ovarian cancer|advanced ovarian cancer
667998|NCT00381173|hormone refractory prostate cancer|hormone refractory prostate cancer
667999|NCT00381173|advanced colon cancer|advanced colon cancer
668780|NCT00378638|bevacizumab|bevacizumab
668000|NCT00381173|advanced renal cancer|advanced renal cancer
668001|NCT00381173|advanced stage malignancies|advanced stage malignancies
668002|NCT00381173|immune therapy|immune therapy
668003|NCT00381173|gene therapy|gene therapy
668004|NCT00381173|biologic therapy|biologic therapy
668005|NCT00381173|T-regulatory cells|t-regulatory cells
668006|NCT00381173|cancer vaccine|cancer vaccine
668007|NCT00381173|vaccine|vaccine
668008|NCT00381173|Advanced stage malignancies-ovary, breast, colon, prostate|advanced stage malignancies-ovary, breast, colon, prostate
668009|NCT00381160|weight loss|weight loss
668010|NCT00381160|obesity|obesity
668011|NCT00381160|sugar-sweetened beverages|sugar-sweetened beverages
668012|NCT00381160|diet|diet
668013|NCT00381160|adolescence|adolescence
668014|NCT00381134|double-blind|double-blind
668015|NCT00381134|placebo-controlled|placebo-controlled
668016|NCT00381134|nephropathy|nephropathy
668017|NCT00381134|blood pressure|blood pressure
668018|NCT00381134|urine albumin to creatinine ratio|urine albumin to creatinine ratio
668019|NCT00381134|placebo|placebo
668020|NCT00381121|Tissue Biobank|tissue biobank
668021|NCT00381121|molecular markers|molecular markers
668022|NCT00381121|molecular pathways|molecular pathways
668023|NCT00381108|BPH|bph
668024|NCT00381082|Pediculus|pediculus
668025|NCT00381082|capitis|capitis
668026|NCT00381082|lice|lice
668027|NCT00381069|Recreation Centers|recreation centers
668028|NCT00381069|Families|families
668029|NCT00381069|Obesity Prevention|obesity prevention
668030|NCT00381056|labor and delivery care|labor and delivery care
668031|NCT00381056|teamwork training|teamwork training
668032|NCT00381056|crew resource management|crew resource management
668033|NCT00381056|cluster-randomized trial|cluster-randomized trial
668034|NCT00381043|Alcohol Dependence|alcohol dependence
668035|NCT00381043|Family Medicine Setting|family medicine setting
668036|NCT00381043|University of North Carolina at Chapel Hill|university of north carolina at chapel hill
668037|NCT00381030|beta-Adrenergic Blockers|beta-adrenergic blockers
668038|NCT00381030|Disease Management|disease management
668039|NCT00381004|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
668040|NCT00381004|Leukemia|leukemia
668041|NCT00381004|Cyclophosphamide|cyclophosphamide
668042|NCT00381004|Fludarabine|fludarabine
668043|NCT00381004|Sargramostim|sargramostim
668044|NCT00381004|Rituximab|rituximab
668045|NCT00381004|GM-CSF|gm-csf
668046|NCT00381004|FCR|fcr
668047|NCT00380978|labor pain|labor pain
668048|NCT00380978|cesarean section|cesarean section
668049|NCT00380978|epidural analgesia|epidural analgesia
668050|NCT00380978|opioid analgesics|opioid analgesics
668051|NCT00380978|local anesthetics|local anesthetics
668052|NCT00380978|labor induced|labor induced
668053|NCT00380965|Chemotherapy-induced|chemotherapy-induced
668054|NCT00380965|neuropathy|neuropathy
668055|NCT00380965|cancer|cancer
668056|NCT00380952|IDC|idc
668057|NCT00380952|DCIS|dcis
668058|NCT00380952|ILC|ilc
668059|NCT00380926|polyunsatturated fatty acids|polyunsatturated fatty acids
668060|NCT00380926|nutrition|nutrition
668061|NCT00380926|low-dose allergen challenge|low-dose allergen challenge
668062|NCT00380926|exhaled nitric oxide|exhaled nitric oxide
668063|NCT00380887|bioavailability|bioavailability
668064|NCT00380887|bioequivalence|bioequivalence
668065|NCT00380887|marketed product|marketed product
668066|NCT00380887|Premarin|premarin
668067|NCT00380887|Medroxyprogesterone acetate|medroxyprogesterone acetate
668068|NCT00380887|MPA|mpa
668069|NCT00380887|Postmenopausal|postmenopausal
668070|NCT00380887|vasomotor symptoms|vasomotor symptoms
668071|NCT00380874|Pain|pain
668072|NCT00380874|chemotherapy|chemotherapy
668073|NCT00380861|Total Knee Replacement|total knee replacement
668074|NCT00380861|Flexion|flexion
668075|NCT00380861|Range of Motion|range of motion
668076|NCT00380861|Activities of Daily Living|activities of daily living
668077|NCT00380861|Implant design|implant design
668078|NCT00380861|Subject Satisfaction|subject satisfaction
668079|NCT00380861|Non-inflammatory arthritis|non-inflammatory arthritis
668080|NCT00380848|sleep apnea|sleep apnea
668081|NCT00380848|end stage renal disease|end stage renal disease
668082|NCT00380848|hemodiafiltration|hemodiafiltration
668083|NCT00380835|metastatic breast cancer|metastatic breast cancer
668084|NCT00380835|amrubicin|amrubicin
668085|NCT00380822|alpa-glucosidase inhibitor|alpa-glucosidase inhibitor
668086|NCT00380796|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
668087|NCT00380796|COPD|copd
668088|NCT00380770|HIV|hiv
668089|NCT00380770|AIDS|aids
668090|NCT00380770|Kaposi's sarcoma|kaposi's sarcoma
668091|NCT00380770|Human herpesvirus 8|human herpesvirus 8
668092|NCT00380757|cardiac arrest|cardiac arrest
668093|NCT00380757|CPR|cpr
668094|NCT00380757|resuscitation|resuscitation
668095|NCT00380757|fatigue|fatigue
668096|NCT00380757|quality|quality
668097|NCT00380731|Social Anxiety Disorder|social anxiety disorder
668098|NCT00380731|Magnetic Resonance Imaging|magnetic resonance imaging
668099|NCT00380731|Cognitive Behavior Therapy|cognitive behavior therapy
668100|NCT00380640|Pediatrics|pediatrics
668101|NCT00380640|Epidermolysis Bullosa|epidermolysis bullosa
668102|NCT00380640|Trimethoprim|trimethoprim
668103|NCT00380640|Wound Healing|wound healing
668104|NCT00380614|Acute Hepatitis B, Lamivudine|acute hepatitis b, lamivudine
668105|NCT00380575|hyponatremia|hyponatremia
668106|NCT00380575|hypervolemic|hypervolemic
668107|NCT00380575|euvolemic|euvolemic
668108|NCT00380575|vasopressins|vasopressins
668109|NCT00380575|YM087|ym087
668110|NCT00380562|Quality of life|quality of life
668111|NCT00380562|Cognitive Functioning|cognitive functioning
668112|NCT00380562|Activities of Daily Living|activities of daily living
668113|NCT00380562|Disability prevention|disability prevention
668114|NCT00380549|osteoarthritis, hip replacement|osteoarthritis, hip replacement
668115|NCT00380536|Peer-led Education|peer-led education
668116|NCT00380510|Family Physicians|family physicians
668117|NCT00380510|Adolescents|adolescents
668118|NCT00380510|Preventive Care|preventive care
668119|NCT00380510|Health Behavior|health behavior
668120|NCT00380497|Pediatrics|pediatrics
668121|NCT00380497|Colonoscopy|colonoscopy
668122|NCT00380497|Bowel cleanout|bowel cleanout
668123|NCT00380497|Poly-Ethylene Glycol|poly-ethylene glycol
668124|NCT00380497|Pico-Salax|pico-salax
668125|NCT00380471|bath PUVA|bath puva
668126|NCT00380458|Obstructive|obstructive
668127|NCT00380458|Sleep|sleep
668128|NCT00380458|Apnea|apnea
668129|NCT00380458|Pain|pain
668130|NCT00380458|UPPP|uppp
668131|NCT00380458|Tonsillectomy|tonsillectomy
668132|NCT00380458|Narcotics|narcotics
668133|NCT00380445|Vildagliptin, Type 2 diabetes|vildagliptin, type 2 diabetes
668134|NCT00380419|Pregnancy|pregnancy
668135|NCT00380419|Postpartum Depression|postpartum depression
668136|NCT00380406|Gonadotropin releasing hormone agonist|gonadotropin releasing hormone agonist
668137|NCT00380406|GnRH|gnrh
668138|NCT00380406|Fertility|fertility
668139|NCT00380406|Fertility preservation|fertility preservation
668140|NCT00380406|Oncology|oncology
668141|NCT00380406|Cancer|cancer
668142|NCT00380406|Chemotherapy|chemotherapy
668143|NCT00380393|Malaria|malaria
668144|NCT00380393|Plasmodium|plasmodium
668145|NCT00380393|RTS|rts
668146|NCT00380393|S/AS01|s/as01
668147|NCT00380393|Falciparum|falciparum
668148|NCT00380380|Vildagliptin, type 2 diabetes, gastric emptying|vildagliptin, type 2 diabetes, gastric emptying
668149|NCT00380354|allergen|allergen
668150|NCT00380354|methacholine|methacholine
668151|NCT00380354|GSK256066|gsk256066
668152|NCT00380354|mild asthmatics|mild asthmatics
668153|NCT00380354|repeat dose|repeat dose
668154|NCT00380354|challenge|challenge
668155|NCT00380354|late asthmatic response|late asthmatic response
668156|NCT00380328|Pharmacokinetic|pharmacokinetic
668157|NCT00380328|healthy subjects|healthy subjects
668158|NCT00380315|Cough|cough
668159|NCT00380315|Chronic bronchitis|chronic bronchitis
668160|NCT00380315|PNDs|pnds
668161|NCT00380315|Post Nasal Drip syndrome|post nasal drip syndrome
668162|NCT00380315|GERD|gerd
668163|NCT00380315|gastroesophageal reflux disease|gastroesophageal reflux disease
668164|NCT00380315|bronchiectasis|bronchiectasis
668165|NCT00380302|Alzheimer's disease|alzheimer's disease
668166|NCT00380302|symptomatic|symptomatic
668167|NCT00380302|cognition|cognition
668168|NCT00380289|Essential hypertension|essential hypertension
668169|NCT00380289|Glucose metabolism|glucose metabolism
668170|NCT00380289|Thiazides|thiazides
668171|NCT00380289|Beta blockers|beta blockers
668172|NCT00380276|Alzheimer's|alzheimer's
668173|NCT00380276|Dementia|dementia
668174|NCT00380276|Dementia of Alzheimer Type|dementia of alzheimer type
668175|NCT00380237|Bird Flu|bird flu
668176|NCT00380237|Avian Flu|avian flu
668177|NCT00380224|schizophrenia|schizophrenia
668178|NCT00380211|Thimerosal reduced content|thimerosal reduced content
668179|NCT00380211|Immunogenicity, safety, reactogenicity|immunogenicity, safety, reactogenicity
668180|NCT00380211|Young and elderly adults|young and elderly adults
668181|NCT00380211|Influenza vaccine|influenza vaccine
668182|NCT00380185|Peripheral Arterial Disease|peripheral arterial disease
668183|NCT00380185|Atherosclerosis|atherosclerosis
668184|NCT00380172|AMD|amd
668185|NCT00380172|Macular Degeneration|macular degeneration
668186|NCT00380172|Retinal Degeneration|retinal degeneration
668187|NCT00380159|Extension study to ACH443-014A|extension study to ach443-014a
668188|NCT00380146|Malaria|malaria
668189|NCT00380146|Intermittent presumptive treatment|intermittent presumptive treatment
668190|NCT00380146|IPT|ipt
668191|NCT00380146|Pharmacokinetic|pharmacokinetic
668192|NCT00380146|Efficacy|efficacy
668193|NCT00380146|Gametocyte|gametocyte
668194|NCT00380146|Molecular markers|molecular markers
668195|NCT00380133|COPD SB-681323 prednisolone biomarkers|copd sb-681323 prednisolone biomarkers
668196|NCT00380107|Minor surgery|minor surgery
668197|NCT00380107|Volume optimization|volume optimization
668198|NCT00380107|Volume deficit|volume deficit
668199|NCT00380107|Epidural anesthesia|epidural anesthesia
668200|NCT00380094|ACS|acs
668201|NCT00380094|NSTEMI|nstemi
668202|NCT00380094|Myeloperoxidase|myeloperoxidase
668203|NCT00380094|nonST segment elevation myocardial infarction|nonst segment elevation myocardial infarction
668204|NCT00380081|Insomnia|insomnia
668205|NCT00380055|Cancer Screening|cancer screening
668206|NCT00380055|Navigators|navigators
668207|NCT00380055|Community Outreach|community outreach
668208|NCT00380055|Behavioral Change|behavioral change
668209|NCT00380055|Access|access
668210|NCT00380042|Cortical Electrical Stimulation|cortical electrical stimulation
668211|NCT00380042|Treatment Resistant Depression|treatment resistant depression
668212|NCT00380042|Major Depressive Disorder|major depressive disorder
668213|NCT00380029|stage II bladder cancer|stage ii bladder cancer
668214|NCT00380029|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
668215|NCT00380016|Angioplasty|angioplasty
668216|NCT00380016|Stent|stent
668217|NCT00380016|Coronary Artery Disease|coronary artery disease
668218|NCT00380016|Peripheral Artery Disease|peripheral artery disease
668219|NCT00380016|Percutaneous Coronary Intervention|percutaneous coronary intervention
668220|NCT00380016|CAD|cad
668221|NCT00380016|PAD|pad
668222|NCT00380016|Cardiovascular Disease|cardiovascular disease
668223|NCT00379990|iNOS|inos
668224|NCT00379990|Exhaled NO|exhaled no
668225|NCT00379990|Rheumatoid arthritis|rheumatoid arthritis
668226|NCT00379938|Parvovirus B-19, Parvoviridae, vaccine|parvovirus b-19, parvoviridae, vaccine
668227|NCT00379925|Physical Activity|physical activity
668228|NCT00379925|Exercise|exercise
668229|NCT00379925|Dietary Habits|dietary habits
668230|NCT00379899|calcification|calcification
668231|NCT00379899|vascular calcification|vascular calcification
668232|NCT00379899|coronary vascular calcification|coronary vascular calcification
668233|NCT00379899|chronic kidney disease|chronic kidney disease
668234|NCT00379899|end stage renal disease|end stage renal disease
668235|NCT00379899|dialysis|dialysis
668236|NCT00379886|ECT|ect
668237|NCT00379886|Depression|depression
668238|NCT00379886|Anesthiticum|anesthiticum
668239|NCT00379886|Propofol|propofol
668240|NCT00379886|Thiopental|thiopental
668241|NCT00379847|hyponatremia|hyponatremia
668242|NCT00379847|hypervolemic|hypervolemic
668243|NCT00379847|euvolemic|euvolemic
668244|NCT00379847|treatment outcomes|treatment outcomes
668245|NCT00379847|YM087|ym087
668246|NCT00379834|glaucoma|glaucoma
668247|NCT00379834|diurnal|diurnal
668248|NCT00379834|intraocular pressure|intraocular pressure
668249|NCT00379821|chloroquine, malaria, Plasmodium falciparum, Malawi, children|chloroquine, malaria, plasmodium falciparum, malawi, children
668250|NCT00379808|coronary heart disease|coronary heart disease
668251|NCT00379808|montelukast|montelukast
668252|NCT00379808|inflammation|inflammation
668253|NCT00379795|CNV|cnv
668254|NCT00379795|Lucentis|lucentis
668255|NCT00379795|AMD|amd
668256|NCT00379795|Age-related macular degeneration|age-related macular degeneration
668257|NCT00379795|RVO|rvo
668258|NCT00379769|diabetes|diabetes
668259|NCT00379769|CV outcomes|cv outcomes
668260|NCT00379769|rosiglitazone|rosiglitazone
668261|NCT00379769|Type II diabetes|type ii diabetes
668262|NCT00379769|sulfonylurea|sulfonylurea
668263|NCT00379769|RECORD|record
668264|NCT00379769|metformin|metformin
668265|NCT00379756|Erectile dysfunction, impotence|erectile dysfunction, impotence
668266|NCT00379730|CT scan|ct scan
668267|NCT00379730|breathing tests|breathing tests
668268|NCT00379730|lung function tests|lung function tests
668269|NCT00379730|biomarkers|biomarkers
668270|NCT00379730|prednisolone|prednisolone
668271|NCT00379730|IOS|ios
668272|NCT00379730|COPD|copd
668273|NCT00379730|clinical outcomes|clinical outcomes
668274|NCT00379717|helical tomotherapy|helical tomotherapy
668275|NCT00379717|dose escalation|dose escalation
668276|NCT00379717|chemotherapy|chemotherapy
668277|NCT00379704|Tissue factor|tissue factor
668278|NCT00379704|Obesity|obesity
668279|NCT00379704|Adipose tissue|adipose tissue
668280|NCT00379704|Microparticles|microparticles
668281|NCT00379691|spinal|spinal
668282|NCT00379691|Cesarean section|cesarean section
668283|NCT00379691|hypotension|hypotension
668284|NCT00379691|nausea|nausea
668285|NCT00379691|vomiting|vomiting
668286|NCT00379691|phenylephrine|phenylephrine
668287|NCT00379678|atopic dermatitis|atopic dermatitis
668288|NCT00379665|Lung|lung
668289|NCT00379665|Chemotherapy|chemotherapy
668290|NCT00379665|Cisplatin|cisplatin
668291|NCT00379665|Intratumoral|intratumoral
668292|NCT00379665|Bronchoscope|bronchoscope
668293|NCT00379665|Brachytherapy|brachytherapy
668294|NCT00379652|Community Health Centers|community health centers
668295|NCT00379652|Diabetes|diabetes
668296|NCT00379652|Blood Pressure, High|blood pressure, high
668297|NCT00379639|Pancreatic cancer|pancreatic cancer
668298|NCT00379639|advanced solid tumors|advanced solid tumors
668299|NCT00379626|Paraphilia|paraphilia
668300|NCT00379626|Hormonal treatment|hormonal treatment
668301|NCT00379626|Cognitive treatment|cognitive treatment
668302|NCT00379600|Anti-inflammatory treatment|anti-inflammatory treatment
668303|NCT00379600|Rheumatoid Arthritis|rheumatoid arthritis
668304|NCT00379587|Rituximab|rituximab
668305|NCT00379587|Chronic GVHD|chronic gvhd
668306|NCT00379574|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
668307|NCT00379574|Bortezomib|bortezomib
668310|NCT00379561|Prostate Cancer|prostate cancer
668311|NCT00379561|Recurrent Prostate Cancer|recurrent prostate cancer
668312|NCT00379561|Non-Metastatic prostate cancer|non-metastatic prostate cancer
668313|NCT00379561|Recurrent Localized Prostate Cancer with Biochemical Failure|recurrent localized prostate cancer with biochemical failure
668314|NCT00379535|pregnancy , lack of iodine|pregnancy , lack of iodine
668315|NCT00379535|lack of iodine during pregnancy|lack of iodine during pregnancy
668316|NCT00379522|hemorrhagic|hemorrhagic
668317|NCT00379522|shock|shock
668318|NCT00379522|traumatic|traumatic
668319|NCT00379522|shock treatment|shock treatment
668320|NCT00379522|vasopressin|vasopressin
668321|NCT00379522|Circulatory Collapse|circulatory collapse
668322|NCT00379522|Hypovolemic Shock|hypovolemic shock
668323|NCT00379509|recurrent breast cancer|recurrent breast cancer
668324|NCT00379509|stage IIIA breast cancer|stage iiia breast cancer
668325|NCT00379509|stage IIIB breast cancer|stage iiib breast cancer
668326|NCT00379509|stage IIIC breast cancer|stage iiic breast cancer
668327|NCT00379509|stage IV breast cancer|stage iv breast cancer
668328|NCT00379509|male breast cancer|male breast cancer
668329|NCT00379496|Fibromyalgia|fibromyalgia
668330|NCT00379496|Acupuncture|acupuncture
668331|NCT00379496|Randomized study|randomized study
668332|NCT00379483|Transfusional iron overload|transfusional iron overload
668333|NCT00379483|Deferasirox|deferasirox
668334|NCT00379470|Brain tumor|brain tumor
668335|NCT00379470|Treatment|treatment
668336|NCT00379470|Minimal toxicity|minimal toxicity
668337|NCT00379470|GBM|gbm
668338|NCT00379470|Glioblastoma|glioblastoma
668339|NCT00379470|Recurrent|recurrent
668340|NCT00379470|TTFields|ttfields
668341|NCT00379457|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
668342|NCT00379457|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
668343|NCT00379457|childhood malignant mesenchymoma|childhood malignant mesenchymoma
668344|NCT00379457|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
668345|NCT00379457|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
668346|NCT00379457|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
668347|NCT00379444|tobacco, intervention, tobacco cessation, ALaska Natives,|tobacco, intervention, tobacco cessation, alaska natives,
668348|NCT00379444|Native Americans, pregnancy, women|native americans, pregnancy, women
668349|NCT00379405|Saquinavir/ritonavir|saquinavir/ritonavir
668350|NCT00379405|Single therapy|single therapy
668351|NCT00379405|Virological efficacy|virological efficacy
668352|NCT00379405|Safety|safety
668353|NCT00379405|HIV-1|hiv-1
668354|NCT00379392|Stroke|stroke
668355|NCT00379392|Mental Imagery|mental imagery
668356|NCT00379392|Constraint Induced Therapy|constraint induced therapy
668357|NCT00379379|electroacupuncture, plasma glucose, plasma insulin|electroacupuncture, plasma glucose, plasma insulin
668358|NCT00379366|Randomized Controlled Trials|randomized controlled trials
668359|NCT00379366|Renal Dialysis|renal dialysis
668360|NCT00379366|Graft Occlusion, Vascular|graft occlusion, vascular
668361|NCT00379366|Angioplasty|angioplasty
668362|NCT00379366|Vascular Patency|vascular patency
668363|NCT00379366|Radiation, Ionizing|radiation, ionizing
668364|NCT00379353|Advanced Cancers|advanced cancers
668365|NCT00379353|Anorexia|anorexia
668366|NCT00379353|Fatigue|fatigue
668367|NCT00379353|Thalidomide|thalidomide
668368|NCT00379353|Placebo|placebo
668369|NCT00379327|Pregnancy|pregnancy
668370|NCT00379327|Acupuncture|acupuncture
668371|NCT00379327|Pregnancy Outcome|pregnancy outcome
668372|NCT00379327|Randomized Controlled Trial|randomized controlled trial
668373|NCT00379327|Double-Blind Method|double-blind method
668374|NCT00379314|Incontinence|incontinence
668375|NCT00379314|Urinary|urinary
668376|NCT00379314|Female|female
668377|NCT00379314|Surgery|surgery
668378|NCT00379314|Complications|complications
668379|NCT00379301|Atrial Fibrillation|atrial fibrillation
668380|NCT00379301|A-Fib|a-fib
668381|NCT00379301|AF|af
668382|NCT00379301|Persistent|persistent
668383|NCT00379301|Permanent|permanent
668384|NCT00379301|Pulmonary Vein Isolation|pulmonary vein isolation
668385|NCT00379301|Ablation|ablation
668386|NCT00379275|Sarcoidosis|sarcoidosis
668387|NCT00379275|Uveitis|uveitis
668388|NCT00379275|Pulmonary Sarcoidosis|pulmonary sarcoidosis
668389|NCT00379275|HLA-Typing|hla-typing
668390|NCT00379275|Cytokines|cytokines
668391|NCT00379275|Serum Markers|serum markers
668392|NCT00379262|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
668393|NCT00379262|Chemoradiotherapy|chemoradiotherapy
668394|NCT00379262|Accelerated Fractionation|accelerated fractionation
668395|NCT00379249|hypercholesterolemia|hypercholesterolemia
668396|NCT00379249|statin|statin
668397|NCT00379249|compliance|compliance
668398|NCT00379236|osteoarthritis|osteoarthritis
668399|NCT00379236|knee|knee
668400|NCT00379223|retinal vein occlusion|retinal vein occlusion
668401|NCT00379223|vitrectomy|vitrectomy
668402|NCT00379223|surgery|surgery
668403|NCT00379223|retinal disorders|retinal disorders
668404|NCT00379223|vascular diseases|vascular diseases
668405|NCT00379210|Attention|attention
668406|NCT00379210|ERP|erp
668407|NCT00379210|event-related potentials|event-related potentials
668408|NCT00379210|fMRI|fmri
668409|NCT00379210|functional magnetic resonance imaging|functional magnetic resonance imaging
668410|NCT00379210|MBSR|mbsr
668411|NCT00379210|Mindfulness Based Stress Reduction|mindfulness based stress reduction
668412|NCT00379210|Mindfulness Meditation Training|mindfulness meditation training
668413|NCT00379210|MMT|mmt
668414|NCT00379197|stage IV breast cancer, estrogen receptor positive|stage iv breast cancer, estrogen receptor positive
668415|NCT00379197|recurrent breast cancer|recurrent breast cancer
668416|NCT00379197|hormone-refractory, metastatic breast cancer|hormone-refractory, metastatic breast cancer
668417|NCT00379184|arthritis|arthritis
668418|NCT00379171|Children|children
668419|NCT00379171|Complementary feeding|complementary feeding
668420|NCT00379171|Breast feeding|breast feeding
668421|NCT00379171|Cow's milk|cow's milk
668422|NCT00379171|Formula|formula
668423|NCT00379171|Protein|protein
668424|NCT00379171|LCPUFA|lcpufa
668425|NCT00379171|Fish oil|fish oil
668426|NCT00379171|Lipid profile|lipid profile
668427|NCT00379171|Intestinal inflammation|intestinal inflammation
668428|NCT00379171|Intestinal microbiota|intestinal microbiota
668429|NCT00379158|multiple micronutrient supplements|multiple micronutrient supplements
668430|NCT00379158|home-fortification|home-fortification
668431|NCT00379158|complementary foods|complementary foods
668432|NCT00379158|infants|infants
668433|NCT00379158|Ghana|ghana
668434|NCT00379145|uterine leiomyosarcoma|uterine leiomyosarcoma
668435|NCT00379145|recurrent uterine sarcoma|recurrent uterine sarcoma
668436|NCT00379145|stage III uterine sarcoma|stage iii uterine sarcoma
668437|NCT00379145|stage IV uterine sarcoma|stage iv uterine sarcoma
668438|NCT00379132|Glioma|glioma
668439|NCT00379132|prostatic|prostatic
668440|NCT00379132|breast|breast
668441|NCT00379132|non-small cell lung|non-small cell lung
668442|NCT00379132|melanoma|melanoma
668443|NCT00379132|colorectal|colorectal
668444|NCT00379132|pancreatic|pancreatic
668445|NCT00379119|adenocarcinoma of the prostate|adenocarcinoma of the prostate
668446|NCT00379119|recurrent prostate cancer|recurrent prostate cancer
668447|NCT00379119|stage I prostate cancer|stage i prostate cancer
668448|NCT00379119|stage IIB prostate cancer|stage iib prostate cancer
668449|NCT00379119|stage IIA prostate cancer|stage iia prostate cancer
668450|NCT00379119|stage III prostate cancer|stage iii prostate cancer
668451|NCT00379106|Supportive|supportive
668452|NCT00379106|Mastectomy|mastectomy
668453|NCT00379106|Quality of Life|quality of life
668454|NCT00379106|Arm Function|arm function
668455|NCT00379093|Alcohol|alcohol
668456|NCT00379093|Comorbidity|comorbidity
668457|NCT00379093|Aging|aging
668458|NCT00379093|Brief Advice|brief advice
668459|NCT00379093|Randomized Trial|randomized trial
668460|NCT00379067|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
668461|NCT00379067|Nocturia|nocturia
668462|NCT00379067|Actigraphy|actigraphy
668463|NCT00379067|Tamsulosin|tamsulosin
668464|NCT00379054|social support, smoking, smoking cessation, intervention,|social support, smoking, smoking cessation, intervention,
668465|NCT00379054|telephone counseling|telephone counseling
668466|NCT00379041|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
668467|NCT00379041|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
668468|NCT00379028|COPD|copd
668469|NCT00379015|stage IIIB breast cancer|stage iiib breast cancer
668470|NCT00379015|stage IIIC breast cancer|stage iiic breast cancer
668471|NCT00379015|stage IV breast cancer|stage iv breast cancer
668472|NCT00379002|Interstitial Cystitis|interstitial cystitis
668473|NCT00379002|Sexual Dysfunction|sexual dysfunction
668474|NCT00379002|Vulvodynia|vulvodynia
668475|NCT00379002|Pelvic Pain|pelvic pain
668476|NCT00379002|incontinence|incontinence
668477|NCT00378976|HIV infection|hiv infection
668478|NCT00378976|HIV shedding|hiv shedding
668479|NCT00378976|HSV suppression|hsv suppression
668480|NCT00378976|Co-infected|co-infected
668481|NCT00378976|MSM|msm
668482|NCT00378976|Reactivation|reactivation
668483|NCT00378976|Valacyclovir|valacyclovir
668484|NCT00378950|Congestive Heart Failure|congestive heart failure
668485|NCT00378937|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
668486|NCT00378937|pain|pain
668487|NCT00378885|HIV-prevention|hiv-prevention
668488|NCT00378885|Internet Prevention intervention|internet prevention intervention
668489|NCT00378885|Online randomized controlled trial|online randomized controlled trial
668490|NCT00378885|Effect evaluation|effect evaluation
668491|NCT00378885|MSM|msm
668492|NCT00378885|Steady relationships|steady relationships
668493|NCT00378859|Children|children
668494|NCT00378859|Milk|milk
668495|NCT00378859|Meat|meat
668496|NCT00378859|Animal Protein|animal protein
668497|NCT00378859|Growth Factors|growth factors
668498|NCT00378859|IGF-I|igf-i
668499|NCT00378859|IGFBP-3|igfbp-3
668500|NCT00378859|Insulin|insulin
668501|NCT00378846|fever, sweats, and hot flashes|fever, sweats, and hot flashes
668502|NCT00378833|Primary Hypercholesterolemia or Mixed Hyperlipidemia|primary hypercholesterolemia or mixed hyperlipidemia
668503|NCT00378820|Children|children
668504|NCT00378820|Whey|whey
668506|NCT00378820|Milk minerals|milk minerals
668507|NCT00378820|Growth factors|growth factors
668508|NCT00378820|IGF-I|igf-i
668509|NCT00378820|Insulin|insulin
668510|NCT00378781|infection|infection
668511|NCT00378781|poor vascular access|poor vascular access
668512|NCT00378781|thromboembolism|thromboembolism
668513|NCT00378781|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
668514|NCT00378781|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
668515|NCT00378781|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
668516|NCT00378781|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
668517|NCT00378781|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
668518|NCT00378781|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
668519|NCT00378781|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
668520|NCT00378781|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
668521|NCT00378781|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
668522|NCT00378781|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
668523|NCT00378781|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
668524|NCT00378781|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
668525|NCT00378781|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
668526|NCT00378781|chronic eosinophilic leukemia|chronic eosinophilic leukemia
668527|NCT00378781|primary myelofibrosis|primary myelofibrosis
668528|NCT00378781|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
668529|NCT00378781|chronic neutrophilic leukemia|chronic neutrophilic leukemia
668530|NCT00378781|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
668531|NCT00378781|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
668532|NCT00378781|disseminated neuroblastoma|disseminated neuroblastoma
668533|NCT00378781|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
668534|NCT00378781|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
668535|NCT00378781|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
668536|NCT00378781|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
668537|NCT00378781|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
668538|NCT00378781|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
668539|NCT00378781|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
668540|NCT00378781|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
668541|NCT00378781|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
668542|NCT00378781|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
668543|NCT00378781|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
668544|NCT00378781|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
668545|NCT00378781|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
668546|NCT00378781|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
668547|NCT00378781|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
668548|NCT00378781|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
668549|NCT00378781|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
668550|NCT00378781|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
668551|NCT00378781|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
668552|NCT00378781|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
668553|NCT00378781|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
668554|NCT00378781|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
668555|NCT00378781|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
668556|NCT00378781|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
668557|NCT00378781|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
668558|NCT00378781|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
668559|NCT00378781|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
668560|NCT00378781|recurrent breast cancer|recurrent breast cancer
668561|NCT00378781|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
668562|NCT00378781|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
668563|NCT00378781|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
668564|NCT00378781|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
668565|NCT00378781|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
668566|NCT00378781|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
668567|NCT00378781|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
668568|NCT00378781|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
668569|NCT00378781|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
668570|NCT00378781|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
668571|NCT00378781|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
668572|NCT00378781|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
668573|NCT00378781|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
668574|NCT00378781|recurrent neuroblastoma|recurrent neuroblastoma
668575|NCT00378781|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
668576|NCT00378781|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
668577|NCT00378781|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
668578|NCT00378781|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
668579|NCT00378781|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
668580|NCT00378781|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
668581|NCT00378781|refractory hairy cell leukemia|refractory hairy cell leukemia
668582|NCT00378781|refractory multiple myeloma|refractory multiple myeloma
668583|NCT00378781|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
668584|NCT00378781|secondary acute myeloid leukemia|secondary acute myeloid leukemia
668585|NCT00378781|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
668586|NCT00378781|splenic marginal zone lymphoma|splenic marginal zone lymphoma
668587|NCT00378781|stage I multiple myeloma|stage i multiple myeloma
668588|NCT00378781|stage II multiple myeloma|stage ii multiple myeloma
668589|NCT00378781|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
668590|NCT00378781|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
668591|NCT00378781|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
668592|NCT00378781|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
668593|NCT00378781|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
668594|NCT00378781|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
668595|NCT00378781|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
668596|NCT00378781|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
668597|NCT00378781|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
668598|NCT00378781|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
668599|NCT00378781|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
668600|NCT00378781|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
668601|NCT00378781|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
668602|NCT00378781|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
668603|NCT00378781|stage III multiple myeloma|stage iii multiple myeloma
668604|NCT00378781|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
668605|NCT00378781|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
668606|NCT00378781|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
668607|NCT00378781|stage IIIA breast cancer|stage iiia breast cancer
668608|NCT00378781|stage IIIB breast cancer|stage iiib breast cancer
668609|NCT00378781|stage IIIC breast cancer|stage iiic breast cancer
668610|NCT00378781|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
668611|NCT00378781|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
668612|NCT00378781|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
668613|NCT00378781|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
668614|NCT00378781|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
668615|NCT00378781|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
668616|NCT00378781|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
668617|NCT00378781|stage IV breast cancer|stage iv breast cancer
668618|NCT00378781|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
668619|NCT00378781|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
668620|NCT00378781|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
668621|NCT00378781|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
668622|NCT00378781|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
668623|NCT00378781|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
668624|NCT00378781|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
668625|NCT00378781|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
668626|NCT00378781|acute undifferentiated leukemia|acute undifferentiated leukemia
668627|NCT00378781|mast cell leukemia|mast cell leukemia
668628|NCT00378781|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
668629|NCT00378781|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
668630|NCT00378781|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
668631|NCT00378781|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
668632|NCT00378781|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
668633|NCT00378781|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
668634|NCT00378781|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
668635|NCT00378781|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
668636|NCT00378781|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
668637|NCT00378781|prolymphocytic leukemia|prolymphocytic leukemia
668638|NCT00378781|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
668639|NCT00378781|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
668640|NCT00378781|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
668641|NCT00378781|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
668642|NCT00378781|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
668643|NCT00378781|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
668644|NCT00378781|anaplastic large cell lymphoma|anaplastic large cell lymphoma
668645|NCT00378781|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
668646|NCT00378781|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
668647|NCT00378781|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
668648|NCT00378781|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
668649|NCT00378781|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
668650|NCT00378781|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
668651|NCT00378781|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
668652|NCT00378781|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
668653|NCT00378781|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
668654|NCT00378781|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
668655|NCT00378781|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
668656|NCT00378781|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
668657|NCT00378781|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
668658|NCT00378781|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
668659|NCT00378781|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
668660|NCT00378781|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
668661|NCT00378781|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
668662|NCT00378781|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
668663|NCT00378781|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
668664|NCT00378781|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
668665|NCT00378781|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
668666|NCT00378781|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
668667|NCT00378781|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
668668|NCT00378781|stage I mantle cell lymphoma|stage i mantle cell lymphoma
668669|NCT00378781|stage I marginal zone lymphoma|stage i marginal zone lymphoma
668670|NCT00378781|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
668671|NCT00378781|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
668672|NCT00378781|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
668673|NCT00378781|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
668674|NCT00378781|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
668675|NCT00378781|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
668676|NCT00378781|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
668677|NCT00378781|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
668785|NCT00378547|Tonsillectomy|tonsillectomy
668678|NCT00378781|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
668679|NCT00378781|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
668680|NCT00378781|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
668681|NCT00378781|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
668682|NCT00378781|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
668683|NCT00378781|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
668684|NCT00378781|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
668685|NCT00378781|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
668686|NCT00378781|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
668687|NCT00378781|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
668688|NCT00378781|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
668689|NCT00378781|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
668690|NCT00378781|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
668691|NCT00378781|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
668692|NCT00378781|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
668693|NCT00378781|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
668694|NCT00378781|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
668695|NCT00378781|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
668696|NCT00378781|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
668697|NCT00378781|intraocular lymphoma|intraocular lymphoma
668698|NCT00378781|stage I melanoma|stage i melanoma
668699|NCT00378781|stage II melanoma|stage ii melanoma
668700|NCT00378781|stage III melanoma|stage iii melanoma
668701|NCT00378781|stage IV melanoma|stage iv melanoma
668702|NCT00378781|recurrent melanoma|recurrent melanoma
668703|NCT00378781|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
668704|NCT00378781|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
668705|NCT00378781|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
668706|NCT00378781|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
668707|NCT00378781|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
668708|NCT00378781|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
668709|NCT00378781|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
668710|NCT00378781|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
668711|NCT00378781|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
668712|NCT00378781|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
668713|NCT00378781|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
668714|NCT00378781|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
668715|NCT00378781|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
668716|NCT00378781|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
668717|NCT00378781|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
668718|NCT00378781|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
668719|NCT00378781|recurrent uterine sarcoma|recurrent uterine sarcoma
668720|NCT00378781|stage I uterine sarcoma|stage i uterine sarcoma
668721|NCT00378781|stage II uterine sarcoma|stage ii uterine sarcoma
668722|NCT00378781|stage III uterine sarcoma|stage iii uterine sarcoma
668723|NCT00378781|stage IV uterine sarcoma|stage iv uterine sarcoma
668724|NCT00378781|localized osteosarcoma|localized osteosarcoma
668725|NCT00378781|metastatic osteosarcoma|metastatic osteosarcoma
668726|NCT00378781|recurrent osteosarcoma|recurrent osteosarcoma
668727|NCT00378781|chondrosarcoma|chondrosarcoma
668728|NCT00378781|small intestine leiomyosarcoma|small intestine leiomyosarcoma
668729|NCT00378781|recurrent small intestine cancer|recurrent small intestine cancer
668730|NCT00378781|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
668731|NCT00378768|stage I multiple myeloma|stage i multiple myeloma
668732|NCT00378768|stage II multiple myeloma|stage ii multiple myeloma
668733|NCT00378768|stage III multiple myeloma|stage iii multiple myeloma
668734|NCT00378768|refractory multiple myeloma|refractory multiple myeloma
668735|NCT00378755|velcade|velcade
668736|NCT00378755|myeloma|myeloma
668737|NCT00378755|VAD regimen|vad regimen
668738|NCT00378755|Transplantation, Autologous|transplantation, autologous
668739|NCT00378742|Glaucoma|glaucoma
668740|NCT00378742|Gene|gene
668741|NCT00378742|Phenotype-Genotype correlation|phenotype-genotype correlation
668742|NCT00378742|Molecular Diagnosis|molecular diagnosis
668743|NCT00378742|Retinal Degeneration|retinal degeneration
668744|NCT00378742|Inherited Eye Disease|inherited eye disease
668745|NCT00378742|Retinitis Pigmentosa|retinitis pigmentosa
668746|NCT00378742|Macular Dystrophy|macular dystrophy
668747|NCT00378742|Congenital Glaucoma|congenital glaucoma
668748|NCT00378729|PCOS|pcos
668749|NCT00378729|FERTILOSCOPY|fertiloscopy
668750|NCT00378729|Ovarian hyperstimulation|ovarian hyperstimulation
668751|NCT00378729|Multiple pregnancies|multiple pregnancies
668752|NCT00378729|Patient with PCOS (Rotterdam criteria)|patient with pcos (rotterdam criteria)
668753|NCT00378729|Failure of treatment with Clomiphene Citrate|failure of treatment with clomiphene citrate
668754|NCT00378729|Age between 18 and 36 years old|age between 18 and 36 years old
668755|NCT00378729|Spermogram must be normal|spermogram must be normal
668756|NCT00378729|Permeability of Fallopian tubes|permeability of fallopian tubes
668757|NCT00378716|stage II colon cancer|stage ii colon cancer
668758|NCT00378716|stage III colon cancer|stage iii colon cancer
668759|NCT00378716|adenocarcinoma of the colon|adenocarcinoma of the colon
668760|NCT00378690|Prostate Cancer|prostate cancer
668761|NCT00378690|Prostate Specific Antigen|prostate specific antigen
668762|NCT00378677|Powder inhalation|powder inhalation
668763|NCT00378677|Side effects|side effects
668764|NCT00378677|Nephrotoxicity|nephrotoxicity
668765|NCT00378677|Calcineurin inhibitor|calcineurin inhibitor
668766|NCT00378677|Bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
668767|NCT00378677|Forced Expiratory Volume|forced expiratory volume
668768|NCT00378664|urinary incontinence|urinary incontinence
668769|NCT00378664|spinal cord injury|spinal cord injury
668770|NCT00378664|spina bifida|spina bifida
668771|NCT00378651|Intubation, Endotracheal|intubation, endotracheal
668772|NCT00378651|Anesthesia, General|anesthesia, general
668773|NCT00378638|lymph|lymph
668774|NCT00378638|node|node
668775|NCT00378638|positive|positive
668776|NCT00378638|breast|breast
668777|NCT00378638|cancer|cancer
668778|NCT00378638|metastases|metastases
668779|NCT00378638|angiogenesis|angiogenesis
668781|NCT00378638|chemotherapy|chemotherapy
668782|NCT00378612|trials|trials
668783|NCT00378612|stents|stents
668784|NCT00378612|coronary occlusions|coronary occlusions
668786|NCT00378547|pregabalin|pregabalin
668787|NCT00378547|dexamethasone|dexamethasone
668788|NCT00378547|multimodal postoperative analgesia|multimodal postoperative analgesia
668789|NCT00378534|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
668790|NCT00378534|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
668791|NCT00378534|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
668792|NCT00378534|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
668793|NCT00378534|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
668794|NCT00378534|Leukemia|leukemia
668795|NCT00378534|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
668796|NCT00378534|CML|cml
668797|NCT00378534|Acute Myeloid Leukemia|acute myeloid leukemia
668798|NCT00378534|AML|aml
668799|NCT00378534|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
668800|NCT00378534|CLL|cll
668801|NCT00378534|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
668802|NCT00378534|ALL|all
668803|NCT00378534|Myelodysplasia Syndrome|myelodysplasia syndrome
668804|NCT00378521|Raynaud's|raynaud's
668805|NCT00378521|Nitroglycerin|nitroglycerin
668806|NCT00378521|topical gel|topical gel
668807|NCT00378521|cold hands|cold hands
668808|NCT00378521|painful hands|painful hands
668809|NCT00378521|scleroderma|scleroderma
668810|NCT00378508|immune therapy|immune therapy
668811|NCT00378508|autoimmunity|autoimmunity
668812|NCT00378508|insulin secretion|insulin secretion
668813|NCT00378508|diabetes mellitus|diabetes mellitus
668814|NCT00378495|miltefosine|miltefosine
668815|NCT00378495|kala azar|kala azar
668816|NCT00378495|Brazil|brazil
668817|NCT00378482|Melanoma and other tumors|melanoma and other tumors
668818|NCT00378469|Hepcidin|hepcidin
668819|NCT00378469|Hemojuvelin|hemojuvelin
668820|NCT00378469|Iron|iron
668821|NCT00378469|Healthy volunteers|healthy volunteers
668822|NCT00378417|Otitis Media|otitis media
668823|NCT00378417|Pneumococcal Infections|pneumococcal infections
668824|NCT00378417|Pneumococcal Vaccines|pneumococcal vaccines
668825|NCT00378417|Proportional Hazards Models|proportional hazards models
668826|NCT00378417|Prospective Studies|prospective studies
668827|NCT00378417|Streptococcus pneumoniae|streptococcus pneumoniae
668828|NCT00378417|Vaccines, Conjugate|vaccines, conjugate
668829|NCT00378404|NSCLC|nsclc
668830|NCT00378404|Non-Small Cell Lung Cancer|non-small cell lung cancer
668831|NCT00378404|Non-Small Cell|non-small cell
668832|NCT00378404|Lung Cancer|lung cancer
668833|NCT00378404|Docetaxel|docetaxel
668834|NCT00378404|Radiation|radiation
668835|NCT00378404|Metastatic|metastatic
668836|NCT00378404|Recurrent|recurrent
668837|NCT00378391|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
668838|NCT00378391|upstream abciximab|upstream abciximab
668839|NCT00378391|guideline adherence|guideline adherence
668840|NCT00378391|hospital networking|hospital networking
668841|NCT00378365|Acute promyelocytic leukaemia|acute promyelocytic leukaemia
668842|NCT00378365|ATRA|atra
668843|NCT00378365|Idarubicin|idarubicin
668844|NCT00378365|Arsenic trioxide|arsenic trioxide
668845|NCT00378365|Patient with a newly acute promyelocytic leukaemia (APL)|patient with a newly acute promyelocytic leukaemia (apl)
668846|NCT00378365|Unmapped MeSH term|unmapped mesh term
668847|NCT00378352|Acute Myocardial Infarction|acute myocardial infarction
668848|NCT00378352|Left Ventricular Remodeling|left ventricular remodeling
668849|NCT00378352|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
668850|NCT00378352|Endothelial Progenitor Cells|endothelial progenitor cells
668851|NCT00378352|Infarct Size|infarct size
668852|NCT00378339|arthrosis|arthrosis
668853|NCT00378339|gold|gold
668854|NCT00378326|paraneoplastic syndrome|paraneoplastic syndrome
668855|NCT00378313|NSABP|nsabp
668856|NCT00378313|gemcitabine|gemcitabine
668857|NCT00378313|epirubicin|epirubicin
668858|NCT00378313|paclitaxel|paclitaxel
668859|NCT00378313|Taxol|taxol
668860|NCT00378313|breast cancer|breast cancer
668861|NCT00378313|neoadjuvant chemotherapy|neoadjuvant chemotherapy
668862|NCT00378313|primary chemotherapy|primary chemotherapy
668863|NCT00378300|Atopic Dermatitis|atopic dermatitis
668864|NCT00378300|Probiotics|probiotics
668865|NCT00378300|T Regulatory Cells|t regulatory cells
668866|NCT00378287|Acid Reflux|acid reflux
668867|NCT00378287|Proton Pump Inhibitor|proton pump inhibitor
668868|NCT00378287|GERD|gerd
668869|NCT00378274|Neuropathic pain|neuropathic pain
668870|NCT00378274|Chronic pain|chronic pain
668871|NCT00378274|Depression|depression
668872|NCT00378274|Anxiety|anxiety
668873|NCT00378261|Rheumatoid Arthritis|rheumatoid arthritis
668874|NCT00378248|Personality disorders,|personality disorders,
668875|NCT00378248|Day treatment,|day treatment,
668876|NCT00378248|Group psychotherapy,|group psychotherapy,
668877|NCT00378248|Combined psychotherapy,|combined psychotherapy,
668878|NCT00378248|Outcome,|outcome,
668879|NCT00378248|Attachment pattern|attachment pattern
668880|NCT00378235|neurosurgery, craniotomy|neurosurgery, craniotomy
668881|NCT00378235|convection-enhanced delivery|convection-enhanced delivery
668882|NCT00378235|CNS interstitial infusion|cns interstitial infusion
668883|NCT00378235|recombinant toxins|recombinant toxins
668884|NCT00378235|malignant glioma, recurrent|malignant glioma, recurrent
668885|NCT00378235|catheter,|catheter,
668886|NCT00378235|intratumoral therapy|intratumoral therapy
668887|NCT00378235|positive pressure microinfusion|positive pressure microinfusion
668888|NCT00378222|Myeloma previously untreated|myeloma previously untreated
668889|NCT00378222|Single autologous transplantation|single autologous transplantation
668890|NCT00378222|Double autologous transplantation|double autologous transplantation
668891|NCT00378222|Complete response|complete response
668892|NCT00378209|relapsed multiple myeloma|relapsed multiple myeloma
668893|NCT00378209|refractory multiple myeloma|refractory multiple myeloma
668894|NCT00378196|Idiopathic Parafoveal Telangiectasia (IPT)|idiopathic parafoveal telangiectasia (ipt)
668895|NCT00378196|Also Known As Idiopathic Juxtafoveal Telangiectasia (IJFT)|also known as idiopathic juxtafoveal telangiectasia (ijft)
668896|NCT00378183|weight loss|weight loss
668897|NCT00378183|behavioral therapy|behavioral therapy
668898|NCT00378183|risperidone|risperidone
668899|NCT00378183|switching antipsychotics|switching antipsychotics
668900|NCT00378183|schizoaffective disorder|schizoaffective disorder
668901|NCT00378183|Risperdal|risperdal
668902|NCT00378183|schizophrenia|schizophrenia
668903|NCT00378183|olanzapine|olanzapine
668904|NCT00378183|Zyprexa|zyprexa
668905|NCT00378170|intubation|intubation
668906|NCT00378170|difficulty|difficulty
668907|NCT00378170|Macintosh|macintosh
668908|NCT00378170|dental damage|dental damage
668909|NCT00378170|complications|complications
668910|NCT00378157|autism|autism
668911|NCT00378157|joint attention|joint attention
668912|NCT00378157|intervention|intervention
668913|NCT00378157|joint engagement|joint engagement
668914|NCT00378157|language|language
668915|NCT00378118|HIV-1|hiv-1
668916|NCT00378118|HIV-2|hiv-2
668917|NCT00378105|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
668918|NCT00378092|Schizophrenia|schizophrenia
668919|NCT00378092|Risperidone|risperidone
668920|NCT00378092|Risperdal consta|risperdal consta
668921|NCT00378053|Radiation|radiation
668922|NCT00378053|Exposure|exposure
668923|NCT00378053|Hand|hand
668924|NCT00378053|Orthopaedic|orthopaedic
668925|NCT00378053|Surgeons|surgeons
668926|NCT00378027|Pulmonary Embolism|pulmonary embolism
668927|NCT00378027|PE|pe
668928|NCT00378027|Outpatient|outpatient
668929|NCT00378027|Anticoagulation|anticoagulation
668930|NCT00378014|Liver transplantation, everolimus, CNI|liver transplantation, everolimus, cni
668931|NCT00378001|Infertility, FSH, IVF, Ovarian stimulation|infertility, fsh, ivf, ovarian stimulation
668932|NCT00377988|Contraception|contraception
668933|NCT00377988|Hormonal contraception|hormonal contraception
668934|NCT00377988|Oral contraception|oral contraception
668935|NCT00377988|Ethinyl estradiol|ethinyl estradiol
668936|NCT00377988|Progestin|progestin
668937|NCT00377988|Transdermal|transdermal
668938|NCT00377988|Thrombosis|thrombosis
668939|NCT00377988|Venous thromboembolism|venous thromboembolism
668940|NCT00377975|UCP-1|ucp-1
668941|NCT00377975|ephedrine|ephedrine
668942|NCT00377975|caffeine|caffeine
668943|NCT00377975|pioglitazone|pioglitazone
668944|NCT00377962|thoracic transplant recipients|thoracic transplant recipients
668945|NCT00377962|everolimus|everolimus
668946|NCT00377962|immunosuppressants|immunosuppressants
668947|NCT00377949|Systemic Sclerosis|systemic sclerosis
668948|NCT00377949|Scleroderma|scleroderma
668949|NCT00377949|Pulmonary Hypertension|pulmonary hypertension
668950|NCT00377949|PHAROS|pharos
668951|NCT00377949|PHROS|phros
668952|NCT00377949|Exercise Echocardiogram|exercise echocardiogram
668953|NCT00377949|Pulmonary Functional Tests|pulmonary functional tests
668954|NCT00377949|Six minute walk tests|six minute walk tests
668955|NCT00377949|6 minute walk tests|6 minute walk tests
668956|NCT00377949|Right heart catheterization|right heart catheterization
668957|NCT00377936|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
668958|NCT00377936|Locally advanced|locally advanced
668959|NCT00377936|Metastatic|metastatic
668960|NCT00377923|pharmacodynamic and pharmacokinetic study|pharmacodynamic and pharmacokinetic study
668961|NCT00377923|Progesterone|progesterone
668962|NCT00377923|healthy volunteers|healthy volunteers
668963|NCT00377923|Endometrial decidualisation|endometrial decidualisation
668964|NCT00377910|Chronic Achilles tendinopathy|chronic achilles tendinopathy
668965|NCT00377910|Polidocanol|polidocanol
668966|NCT00377910|Ultrasound|ultrasound
668967|NCT00377910|Efficacy|efficacy
668968|NCT00377910|RCT|rct
668969|NCT00377897|critical leg ischemia|critical leg ischemia
668970|NCT00377897|PAD|pad
668971|NCT00377897|cell therapy|cell therapy
668972|NCT00377884|THA|tha
668973|NCT00377871|Stentless|stentless
668974|NCT00377871|Biological|biological
668975|NCT00377871|aortic|aortic
668976|NCT00377871|heart|heart
668977|NCT00377871|valve|valve
668978|NCT00377871|prosthesis|prosthesis
668979|NCT00377871|artificial|artificial
668980|NCT00377858|diabetes|diabetes
668982|NCT00377845|self test|self test
668983|NCT00377845|PAP smear|pap smear
668984|NCT00377845|tampon test|tampon test
668985|NCT00377845|cervical dysplasia|cervical dysplasia
668986|NCT00377832|Fetal tachycardia|fetal tachycardia
668987|NCT00377832|Fever in labor|fever in labor
668988|NCT00377832|Acetaminophen|acetaminophen
668989|NCT00377832|Non reassuring fetal status|non reassuring fetal status
668990|NCT00377819|RANKL|rankl
668991|NCT00377819|RANK|rank
668992|NCT00377819|denosumab|denosumab
668993|NCT00377819|AMG 162|amg 162
668994|NCT00377819|osteoporosis|osteoporosis
668995|NCT00377819|bone turnover|bone turnover
668996|NCT00377819|bone mineral density|bone mineral density
668997|NCT00377819|clinical trial|clinical trial
668998|NCT00377819|postmenopausal osteoporosis|postmenopausal osteoporosis
668999|NCT00377819|alendronate|alendronate
669000|NCT00377819|total hip bone mineral density|total hip bone mineral density
669001|NCT00377806|Superficial thrombophlebitis, diclofenac gel, non steroidal antiinflammatory drugs|superficial thrombophlebitis, diclofenac gel, non steroidal antiinflammatory drugs
669002|NCT00377780|Breast cancer|breast cancer
669003|NCT00377780|metastatic|metastatic
669004|NCT00377780|cardiotoxicity|cardiotoxicity
669005|NCT00377780|liposomal|liposomal
669006|NCT00377780|doxorubicin|doxorubicin
669007|NCT00377780|trastuzumab|trastuzumab
669008|NCT00377780|docetaxel|docetaxel
669009|NCT00377780|HER2/neu positive metastatic breast cancer|her2/neu positive metastatic breast cancer
669010|NCT00377767|Chronic Care Model|chronic care model
669011|NCT00377767|Obesity|obesity
669012|NCT00377767|Overweight|overweight
669013|NCT00377767|Children|children
669014|NCT00377767|Body Mass Index|body mass index
669015|NCT00377767|Primary Care|primary care
669016|NCT00377754|dengue virus, immunity, hemorrhagic fever, Philippines|dengue virus, immunity, hemorrhagic fever, philippines
669017|NCT00377728|Seasonal Allergic Rhinitis Inflammation Vienna CHallenge Chamber|seasonal allergic rhinitis inflammation vienna challenge chamber
669018|NCT00377715|Dimebon, Alzheimer's Disease, Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-cog)|dimebon, alzheimer's disease, alzheimer's disease assessment scale-cognitive subscale (adas-cog)
669019|NCT00377702|Coronary Heart Disease|coronary heart disease
669020|NCT00377702|Risk Factors|risk factors
669021|NCT00377702|Heart Failure|heart failure
669022|NCT00377689|Accidental falls|accidental falls
669023|NCT00377689|Cerebrovascular accident|cerebrovascular accident
669024|NCT00377689|Balance|balance
669025|NCT00377689|ADL|adl
669026|NCT00377689|Self efficacy|self efficacy
669027|NCT00377689|Quality of Life|quality of life
669028|NCT00377689|Gait parameters|gait parameters
669029|NCT00377676|diabetes|diabetes
669030|NCT00377676|diabetes mellitus|diabetes mellitus
669031|NCT00377611|Influenza vaccine|influenza vaccine
669032|NCT00377598|Herpes Zoster|herpes zoster
669033|NCT00377598|Neuralgia|neuralgia
669034|NCT00377598|Drug Therapy|drug therapy
669035|NCT00377585|Elderly|elderly
669036|NCT00377585|Improved vaccine|improved vaccine
669037|NCT00377585|Influenza|influenza
669038|NCT00377585|Influenza disease|influenza disease
669039|NCT00377572|Immunoglobulins|immunoglobulins
669040|NCT00377572|Immunoglobulin E|immunoglobulin e
669041|NCT00377572|omalizumab|omalizumab
669042|NCT00377572|anti-IgE|anti-ige
669043|NCT00377559|Breast cancer|breast cancer
669044|NCT00377559|metastatic|metastatic
669045|NCT00377559|cardiotoxicity|cardiotoxicity
669046|NCT00377559|liposomal|liposomal
669047|NCT00377559|doxorubicin|doxorubicin
669048|NCT00377559|docetaxel|docetaxel
669049|NCT00377559|HER2/neu negative metastatic breast cancer|her2/neu negative metastatic breast cancer
669050|NCT00377546|Retinal Surgery|retinal surgery
669051|NCT00377533|wheelchairs|wheelchairs
669052|NCT00377533|caregivers|caregivers
669053|NCT00377533|skills|skills
669054|NCT00377507|catechin|catechin
669055|NCT00377507|elderly|elderly
669056|NCT00377507|mouth washing|mouth washing
669057|NCT00377507|disabled|disabled
669058|NCT00377507|colonized|colonized
669059|NCT00377494|malaria, Plasmodium falciparum, vaccine, Ghana|malaria, plasmodium falciparum, vaccine, ghana
669060|NCT00377468|THC|thc
669061|NCT00377468|CRPS|crps
669062|NCT00377468|Pain|pain
669063|NCT00377468|Complex Regional Pain Syndrome|complex regional pain syndrome
669064|NCT00377468|Neuropathic Pain|neuropathic pain
669065|NCT00377468|Chronic|chronic
669066|NCT00377468|Prevention|prevention
669067|NCT00377455|scleroderma|scleroderma
669068|NCT00377455|systemic sclerosis|systemic sclerosis
669069|NCT00377455|bosentan|bosentan
669070|NCT00377455|pulmonary hypertension|pulmonary hypertension
669071|NCT00377455|PHAROS|pharos
669072|NCT00377455|PHROS|phros
669073|NCT00377455|exercise echocardiogram|exercise echocardiogram
669074|NCT00377429|Epithelial Cancer|epithelial cancer
669075|NCT00377429|Epithelial Carcinoma|epithelial carcinoma
669076|NCT00377429|Epithelial Ovarian Cancer|epithelial ovarian cancer
669077|NCT00377429|Epithelial Ovarian Carcinoma|epithelial ovarian carcinoma
669078|NCT00377429|Fallopian Tube Cancer|fallopian tube cancer
669079|NCT00377429|Fallopian Tube Carcinoma|fallopian tube carcinoma
669080|NCT00377429|Ovarian Cancer|ovarian cancer
669081|NCT00377429|Ovarian Carcinoma|ovarian carcinoma
669082|NCT00377429|Ovarian Epithelial Cancer|ovarian epithelial cancer
669083|NCT00377429|Ovarian Epithelial Carcinoma|ovarian epithelial carcinoma
669084|NCT00377429|Peritoneal Cancer|peritoneal cancer
669085|NCT00377429|Peritoneal Carcinoma|peritoneal carcinoma
669086|NCT00377429|Advanced Epithelial Ovarian Cancer|advanced epithelial ovarian cancer
669087|NCT00377416|Gene Transfer Techniques|gene transfer techniques
669088|NCT00377416|Gene Therapy|gene therapy
669089|NCT00377403|rhinosinusitis, sinusitis, amoxicillin|rhinosinusitis, sinusitis, amoxicillin
669090|NCT00377390|Immunoglobulin|immunoglobulin
669091|NCT00377390|IgE|ige
669092|NCT00377390|Omalizumab|omalizumab
669093|NCT00377377|GH release|gh release
669094|NCT00377377|Pharmacokinetics|pharmacokinetics
669095|NCT00377377|Safety|safety
669096|NCT00377364|Acetaminophen|acetaminophen
669097|NCT00377364|corticosteroids|corticosteroids
669098|NCT00377364|prednisone|prednisone
669099|NCT00377351|Public Health|public health
669100|NCT00377351|Elderly Population|elderly population
669101|NCT00377351|Neurodegenerative Diseases|neurodegenerative diseases
669102|NCT00377351|Exposure|exposure
669103|NCT00377351|Lifestyle|lifestyle
669104|NCT00377338|Bronchoscopy|bronchoscopy
669105|NCT00377338|Diagnostic imaging|diagnostic imaging
669106|NCT00377338|Laser scanning confocal microscopy|laser scanning confocal microscopy
669107|NCT00377338|Pulmonary Alveoli|pulmonary alveoli
669108|NCT00377338|Healthy volunteers|healthy volunteers
669109|NCT00377338|Diffuse peripheral lung disease|diffuse peripheral lung disease
669110|NCT00377338|Focal peripheral lung disease|focal peripheral lung disease
669111|NCT00377312|Endocrine System Diseases|endocrine system diseases
669112|NCT00377312|MusculoSkeletal System Disease|musculoskeletal system disease
669113|NCT00377312|Hormone|hormone
669114|NCT00377312|Physiologic Properties|physiologic properties
669115|NCT00377299|Amphetamine Abuse|amphetamine abuse
669116|NCT00377299|Amphetamine Dependence|amphetamine dependence
669117|NCT00377299|Bipolar Disorder|bipolar disorder
669118|NCT00377299|Major Depressive Disorder|major depressive disorder
669119|NCT00377299|Citicoline|citicoline
669120|NCT00377286|Osteoarthritis|osteoarthritis
669121|NCT00377286|Knee Pain|knee pain
669122|NCT00377286|Glucosamine|glucosamine
669123|NCT00377286|MRI|mri
669124|NCT00377286|CTX-II|ctx-ii
669125|NCT00377286|Biomarkers|biomarkers
669126|NCT00377286|Skin quality|skin quality
669127|NCT00377260|acute otitis media, infants, children|acute otitis media, infants, children
669128|NCT00377247|Carcinoma|carcinoma
669129|NCT00377247|Head|head
669130|NCT00377247|Neck|neck
669131|NCT00377247|Oral Cavity|oral cavity
669132|NCT00377247|Oropharynx|oropharynx
669133|NCT00377247|Mouth|mouth
669134|NCT00377208|Blood Pressure, High|blood pressure, high
669135|NCT00377195|Marginal Zone Lymphoma|marginal zone lymphoma
669136|NCT00377195|Involved field radiotherapy|involved field radiotherapy
669137|NCT00377195|H. pylori|h. pylori
669138|NCT00377169|Treatment Experienced|treatment experienced
669139|NCT00377156|cognitive/functional effects|cognitive/functional effects
669140|NCT00377156|tumors metastatic to brain|tumors metastatic to brain
669141|NCT00377156|stage IV breast cancer|stage iv breast cancer
669142|NCT00377156|stage IV prostate cancer|stage iv prostate cancer
669143|NCT00377156|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
669144|NCT00377156|male breast cancer|male breast cancer
669145|NCT00377156|recurrent breast cancer|recurrent breast cancer
669146|NCT00377156|recurrent prostate cancer|recurrent prostate cancer
669147|NCT00377156|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
669148|NCT00377143|warfarin|warfarin
669149|NCT00377143|pharmacogenomic|pharmacogenomic
669150|NCT00377143|CYP2C9|cyp2c9
669151|NCT00377143|VKORC1|vkorc1
669152|NCT00377143|polymorphism, single nucleotide|polymorphism, single nucleotide
669153|NCT00377130|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
669154|NCT00377130|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
669155|NCT00377091|pulmonary embolism|pulmonary embolism
669156|NCT00377091|venous thromboembolism|venous thromboembolism
669157|NCT00377091|pharmacoeconomic|pharmacoeconomic
669159|NCT00377091|unfractionated heparin|unfractionated heparin
669160|NCT00377091|fondaparinux|fondaparinux
669161|NCT00377091|length of stay|length of stay
669162|NCT00377091|costs|costs
669163|NCT00377091|bleeding|bleeding
669164|NCT00377091|thrombosis|thrombosis
669165|NCT00377078|recombinant human lactoferrin|recombinant human lactoferrin
669166|NCT00377052|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
669167|NCT00377039|ACR 1990 Fibromyalgia|acr 1990 fibromyalgia
669168|NCT00377039|Fibromyalgia Impact Questionnaire|fibromyalgia impact questionnaire
669169|NCT00377026|weight loss|weight loss
669170|NCT00377026|postpartum|postpartum
669171|NCT00377026|weight retention|weight retention
669172|NCT00376987|renal cell carcinoma|renal cell carcinoma
669173|NCT00376987|bladder cancer|bladder cancer
669174|NCT00376987|cervical cancer|cervical cancer
669175|NCT00376987|esophageal cancer|esophageal cancer
669176|NCT00376987|gastric cancer|gastric cancer
669177|NCT00376987|adult acute myeloid leukemia|adult acute myeloid leukemia
669178|NCT00376987|pancreatic cancer|pancreatic cancer
669179|NCT00376987|hypopharyngeal cancer|hypopharyngeal cancer
669180|NCT00376987|lip and oral cavity cancer|lip and oral cavity cancer
669181|NCT00376987|laryngeal cancer|laryngeal cancer
669182|NCT00376987|nasopharyngeal cancer|nasopharyngeal cancer
669183|NCT00376987|oropharyngeal cancer|oropharyngeal cancer
669184|NCT00376987|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
669185|NCT00376987|non-small cell lung cancer|non-small cell lung cancer
669186|NCT00376987|small cell lung cancer|small cell lung cancer
669187|NCT00376987|adult primary liver cancer|adult primary liver cancer
669188|NCT00376987|tongue cancer|tongue cancer
669189|NCT00376987|tobacco use disorder|tobacco use disorder
669190|NCT00376974|glaucoma|glaucoma
669191|NCT00376974|compliance|compliance
669192|NCT00376974|intraocular pressure|intraocular pressure
669193|NCT00376974|video|video
669194|NCT00376961|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
669195|NCT00376961|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
669196|NCT00376961|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
669197|NCT00376961|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
669198|NCT00376948|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
669199|NCT00376948|stage III pancreatic cancer|stage iii pancreatic cancer
669200|NCT00376948|stage IV pancreatic cancer|stage iv pancreatic cancer
669201|NCT00376948|recurrent pancreatic cancer|recurrent pancreatic cancer
669202|NCT00376935|Treatment Experienced|treatment experienced
669203|NCT00376922|pain|pain
669204|NCT00376922|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
669205|NCT00376922|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
669206|NCT00376922|acute undifferentiated leukemia|acute undifferentiated leukemia
669207|NCT00376922|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
669208|NCT00376922|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
669209|NCT00376922|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
669210|NCT00376922|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
669211|NCT00376922|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
669212|NCT00376922|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
669213|NCT00376922|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
669214|NCT00376922|chronic eosinophilic leukemia|chronic eosinophilic leukemia
669215|NCT00376922|primary myelofibrosis|primary myelofibrosis
669216|NCT00376922|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
669217|NCT00376922|chronic neutrophilic leukemia|chronic neutrophilic leukemia
669218|NCT00376922|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
669219|NCT00376922|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
669220|NCT00376922|essential thrombocythemia|essential thrombocythemia
669221|NCT00376922|extramedullary plasmacytoma|extramedullary plasmacytoma
669222|NCT00376922|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
669223|NCT00376922|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
669224|NCT00376922|polycythemia vera|polycythemia vera
669225|NCT00376922|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
669226|NCT00376922|primary systemic amyloidosis|primary systemic amyloidosis
669227|NCT00376922|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
669228|NCT00376922|prolymphocytic leukemia|prolymphocytic leukemia
669229|NCT00376922|secondary acute myeloid leukemia|secondary acute myeloid leukemia
669230|NCT00376922|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
669231|NCT00376922|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
669232|NCT00376922|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
669233|NCT00376922|stage III multiple myeloma|stage iii multiple myeloma
669234|NCT00376922|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
669235|NCT00376922|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
669236|NCT00376922|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
669237|NCT00376922|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
669238|NCT00376922|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
669239|NCT00376922|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
669240|NCT00376922|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
669241|NCT00376922|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
669242|NCT00376922|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
669243|NCT00376922|mast cell leukemia|mast cell leukemia
669244|NCT00376922|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
669245|NCT00376922|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
669246|NCT00376922|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
669247|NCT00376922|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
670155|NCT00374153|College|college
669248|NCT00376922|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
669249|NCT00376922|refractory hairy cell leukemia|refractory hairy cell leukemia
669250|NCT00376922|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
669251|NCT00376922|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
669252|NCT00376922|untreated hairy cell leukemia|untreated hairy cell leukemia
669253|NCT00376922|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
669254|NCT00376922|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
669255|NCT00376922|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
669256|NCT00376922|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
669257|NCT00376922|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
669258|NCT00376922|anaplastic large cell lymphoma|anaplastic large cell lymphoma
669259|NCT00376922|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
669260|NCT00376922|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
669261|NCT00376922|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
669262|NCT00376922|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
669263|NCT00376922|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
669264|NCT00376922|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
669265|NCT00376922|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
669266|NCT00376922|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
669267|NCT00376922|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
669268|NCT00376922|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
669269|NCT00376922|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
669270|NCT00376922|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
669271|NCT00376922|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
669272|NCT00376922|Waldenström macroglobulinemia|waldenström macroglobulinemia
669273|NCT00376922|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
669274|NCT00376922|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
669275|NCT00376922|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
669276|NCT00376922|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
669277|NCT00376922|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
669278|NCT00376922|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
669279|NCT00376922|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
669280|NCT00376922|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
669281|NCT00376922|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
669282|NCT00376922|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
669283|NCT00376922|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
669284|NCT00376922|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
669285|NCT00376922|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
669286|NCT00376922|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
669287|NCT00376922|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
669288|NCT00376922|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
669289|NCT00376922|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
669290|NCT00376922|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
669291|NCT00376922|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
669292|NCT00376922|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
669293|NCT00376922|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
669294|NCT00376922|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
669295|NCT00376922|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
669296|NCT00376922|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
669297|NCT00376922|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
669298|NCT00376922|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
669299|NCT00376922|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
669300|NCT00376922|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
669301|NCT00376922|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
669302|NCT00376922|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
669303|NCT00376922|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
669304|NCT00376922|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
669305|NCT00376922|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
669306|NCT00376922|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
669307|NCT00376922|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
670356|NCT00373412|antibodies|antibodies
669308|NCT00376922|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
669309|NCT00376922|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
669310|NCT00376922|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
669311|NCT00376922|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
669312|NCT00376922|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
669313|NCT00376922|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
669314|NCT00376922|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
669315|NCT00376922|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
669316|NCT00376922|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
669317|NCT00376922|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
669318|NCT00376922|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
669319|NCT00376922|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
669320|NCT00376922|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
669321|NCT00376922|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
669322|NCT00376922|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
669323|NCT00376922|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
669324|NCT00376922|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
669325|NCT00376922|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
669326|NCT00376922|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
669327|NCT00376922|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
669328|NCT00376922|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
669329|NCT00376922|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
669330|NCT00376922|stage I mantle cell lymphoma|stage i mantle cell lymphoma
669331|NCT00376922|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
669332|NCT00376922|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
669333|NCT00376922|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
669334|NCT00376922|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
669335|NCT00376922|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
669336|NCT00376922|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
669337|NCT00376922|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
669338|NCT00376922|splenic marginal zone lymphoma|splenic marginal zone lymphoma
669339|NCT00376922|stage I marginal zone lymphoma|stage i marginal zone lymphoma
669340|NCT00376922|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
669341|NCT00376922|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
669342|NCT00376922|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
669343|NCT00376922|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
669344|NCT00376922|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
669345|NCT00376922|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
669346|NCT00376922|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
669347|NCT00376922|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
669348|NCT00376922|isolated plasmacytoma of bone|isolated plasmacytoma of bone
669349|NCT00376922|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
669350|NCT00376922|refractory multiple myeloma|refractory multiple myeloma
669351|NCT00376922|stage I multiple myeloma|stage i multiple myeloma
669352|NCT00376922|stage II multiple myeloma|stage ii multiple myeloma
669353|NCT00376922|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
669354|NCT00376922|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
669355|NCT00376909|breast cancer|breast cancer
669356|NCT00376909|cervical cancer|cervical cancer
669357|NCT00376909|colon cancer|colon cancer
669358|NCT00376909|rectal cancer|rectal cancer
669359|NCT00376896|IBS fMRI|ibs fmri
669360|NCT00376883|multiple myeloma|multiple myeloma
669361|NCT00376883|pamidronate prophylaxis|pamidronate prophylaxis
669362|NCT00376883|dose comparison|dose comparison
669363|NCT00376883|quality of life|quality of life
669364|NCT00376883|skeletal event|skeletal event
669365|NCT00376883|response|response
669366|NCT00376883|survival|survival
669367|NCT00376870|PCI|pci
669368|NCT00376870|STENT|stent
669369|NCT00376870|Coronary|coronary
669370|NCT00376870|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
669371|NCT00376857|Indocyanine green, toxicity, epiretinal membrane, visual field defect|indocyanine green, toxicity, epiretinal membrane, visual field defect
669372|NCT00376844|stage I endometrial carcinoma|stage i endometrial carcinoma
669373|NCT00376831|colonoscopy|colonoscopy
669374|NCT00376831|conscious sedation|conscious sedation
669375|NCT00376831|midazolam|midazolam
669376|NCT00376831|ketamine|ketamine
669377|NCT00376831|fentanyl|fentanyl
669378|NCT00376818|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
669379|NCT00376818|adult anaplastic astrocytoma|adult anaplastic astrocytoma
669380|NCT00376818|adult anaplastic ependymoma|adult anaplastic ependymoma
669381|NCT00376818|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
669382|NCT00376818|adult giant cell glioblastoma|adult giant cell glioblastoma
669383|NCT00376818|adult gliosarcoma|adult gliosarcoma
669384|NCT00376818|adult medulloblastoma|adult medulloblastoma
669385|NCT00376818|adult anaplastic meningioma|adult anaplastic meningioma
669386|NCT00376818|adult papillary meningioma|adult papillary meningioma
669387|NCT00376818|adult mixed glioma|adult mixed glioma
669388|NCT00376818|recurrent adult brain tumor|recurrent adult brain tumor
669389|NCT00376818|adult glioblastoma|adult glioblastoma
669390|NCT00376818|adult grade III meningioma|adult grade iii meningioma
669391|NCT00376805|stage IV breast cancer|stage iv breast cancer
669392|NCT00376805|male breast cancer|male breast cancer
669393|NCT00376805|recurrent breast cancer|recurrent breast cancer
669394|NCT00376792|stage IIB prostate cancer|stage iib prostate cancer
669395|NCT00376792|stage IIA prostate cancer|stage iia prostate cancer
669396|NCT00376792|stage III prostate cancer|stage iii prostate cancer
669397|NCT00376792|adenocarcinoma of the prostate|adenocarcinoma of the prostate
669398|NCT00376779|Haemophilus influenzae type b|haemophilus influenzae type b
669399|NCT00376779|Double-blind|double-blind
669400|NCT00376779|Finland|finland
669401|NCT00376779|randomized|randomized
669402|NCT00376779|phase 2|phase 2
669403|NCT00376779|GSK Biologicals|gsk biologicals
669404|NCT00376779|DTPa-HBV-IPV/Hib|dtpa-hbv-ipv/hib
669405|NCT00376766|Cluster seizure|cluster seizure
669406|NCT00376766|seizure clustering|seizure clustering
669407|NCT00376766|repetitive seizure|repetitive seizure
669408|NCT00376766|Drug resistant epilepsy|drug resistant epilepsy
669409|NCT00376766|Levetiracetam|levetiracetam
669410|NCT00376766|keppra|keppra
669411|NCT00376753|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
669412|NCT00376753|Writer's Cramp|writer's cramp
669413|NCT00376753|Electromyogram|electromyogram
669414|NCT00376753|Focal Hand Dystonia|focal hand dystonia
669415|NCT00376753|FHD|fhd
669416|NCT00376753|Healthy Volunteer|healthy volunteer
669417|NCT00376753|HV|hv
669418|NCT00376740|breast cancer, postmenopausal, letrozole, zoledronic acid, adjuvant,bone mineral density|breast cancer, postmenopausal, letrozole, zoledronic acid, adjuvant,bone mineral density
669419|NCT00376727|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
669420|NCT00376714|plethysmography|plethysmography
669421|NCT00376714|muscarinic receptor antagonist|muscarinic receptor antagonist
669422|NCT00376714|COPD|copd
669423|NCT00376714|repeat dosing|repeat dosing
669424|NCT00376701|Choroidal Neovascularization|choroidal neovascularization
669425|NCT00376701|Photodynamic Therapy|photodynamic therapy
669426|NCT00376701|Age Related Macular Degeneration|age related macular degeneration
669427|NCT00376701|Triamcinolone Acetonide|triamcinolone acetonide
669428|NCT00376701|Avastin|avastin
669429|NCT00376701|Visudyne|visudyne
669430|NCT00376675|fatigue|fatigue
669431|NCT00376675|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
669432|NCT00376662|HRT|hrt
669433|NCT00376662|Etidronate|etidronate
669434|NCT00376662|Fractures|fractures
669435|NCT00376662|Osteoporosis|osteoporosis
669436|NCT00376662|Asthma|asthma
669437|NCT00376662|Glucocorticoids|glucocorticoids
669438|NCT00376649|crohns|crohns
669439|NCT00376649|quality of life|quality of life
669440|NCT00376649|lifestyle changing|lifestyle changing
669441|NCT00376649|remmision|remmision
669442|NCT00376597|lymphedema|lymphedema
669443|NCT00376597|stage IA breast cancer|stage ia breast cancer
669444|NCT00376597|stage IB breast cancer|stage ib breast cancer
669445|NCT00376597|stage II breast cancer|stage ii breast cancer
669446|NCT00376597|stage IIIA breast cancer|stage iiia breast cancer
669447|NCT00376597|stage IIIB breast cancer|stage iiib breast cancer
669448|NCT00376597|stage IIIC breast cancer|stage iiic breast cancer
669449|NCT00376584|Primary Hypercholesteremia|primary hypercholesteremia
669450|NCT00376584|Mixed Hyperlipidemia|mixed hyperlipidemia
669451|NCT00376571|PCI|pci
669452|NCT00376571|Bifurcation lesion|bifurcation lesion
669453|NCT00376558|cocaine dependence|cocaine dependence
669454|NCT00376545|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
669455|NCT00376545|Visuomotor|visuomotor
669456|NCT00376545|Occipital Cortex|occipital cortex
669457|NCT00376545|Prefrontal Cortex|prefrontal cortex
669458|NCT00376545|Healthy Volunteer|healthy volunteer
669459|NCT00376545|HV|hv
669460|NCT00376532|Cardiac Ischemia|cardiac ischemia
669461|NCT00376532|Cardiac Arrhythmia|cardiac arrhythmia
669462|NCT00376532|Defibrillator|defibrillator
669463|NCT00376532|Matrix Metalloproteinase|matrix metalloproteinase
669464|NCT00376532|Genetic Polymorphism|genetic polymorphism
669465|NCT00376519|graft versus host disease|graft versus host disease
669466|NCT00376519|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
669467|NCT00376519|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
669468|NCT00376519|secondary acute myeloid leukemia|secondary acute myeloid leukemia
669469|NCT00376519|refractory anemia with excess blasts|refractory anemia with excess blasts
669470|NCT00376519|myelodysplastic syndromes|myelodysplastic syndromes
669471|NCT00376519|chronic myelogenous leukemia|chronic myelogenous leukemia
669472|NCT00376519|refractory anemia|refractory anemia
669473|NCT00376519|prolymphocytic leukemia|prolymphocytic leukemia
669474|NCT00376519|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
669475|NCT00376519|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
669476|NCT00376519|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
669477|NCT00376519|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
669478|NCT00376519|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
669479|NCT00376519|follicular lymphoma|follicular lymphoma
669480|NCT00376519|mantle cell lymphoma|mantle cell lymphoma
669481|NCT00376519|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
669482|NCT00376519|secondary myelofibrosis|secondary myelofibrosis
669483|NCT00376519|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
669484|NCT00376519|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
669485|NCT00376519|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
669486|NCT00376519|marginal zone lymphoma|marginal zone lymphoma
669487|NCT00376519|diffuse large cell lymphoma|diffuse large cell lymphoma
669488|NCT00376519|anaplastic large cell lymphoma|anaplastic large cell lymphoma
669489|NCT00376519|lymphoblastic lymphoma|lymphoblastic lymphoma
669490|NCT00376519|immunoblastic large cell lymphoma|immunoblastic large cell lymphoma
669491|NCT00376519|multiple myeloma|multiple myeloma
669492|NCT00376506|Aspiration|aspiration
669493|NCT00376506|Rehabilitation|rehabilitation
669494|NCT00376506|Swallowing Disorders|swallowing disorders
669495|NCT00376506|Stroke|stroke
669496|NCT00376506|Parkinson's Disease|parkinson's disease
669497|NCT00376506|Dysphagia|dysphagia
669498|NCT00376506|Parkinson Disease|parkinson disease
669499|NCT00376506|PD|pd
669500|NCT00376493|Abortion|abortion
669501|NCT00376493|Infection|infection
669502|NCT00376493|Antibiotics|antibiotics
669503|NCT00376493|Treatment|treatment
669504|NCT00376493|Pregnancy complications|pregnancy complications
669505|NCT00376480|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
669506|NCT00376480|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
669507|NCT00376480|refractory anemia with excess blasts|refractory anemia with excess blasts
669508|NCT00376480|refractory anemia|refractory anemia
669509|NCT00376480|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
669510|NCT00376480|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
669511|NCT00376480|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
669512|NCT00376480|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
669513|NCT00376480|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
669514|NCT00376480|secondary acute myeloid leukemia|secondary acute myeloid leukemia
669515|NCT00376480|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
669516|NCT00376480|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
669517|NCT00376480|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
669518|NCT00376480|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
669519|NCT00376480|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
669520|NCT00376480|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
669521|NCT00376480|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
669522|NCT00376467|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
669523|NCT00376467|Philadelphia positive|philadelphia positive
669524|NCT00376467|Adult|adult
669525|NCT00376467|Elderly|elderly
669526|NCT00376467|Imatinib|imatinib
669527|NCT00376454|neuropathic pain|neuropathic pain
669528|NCT00376441|vaginal|vaginal
669529|NCT00376441|incontinence|incontinence
669530|NCT00376441|sexual function|sexual function
669531|NCT00376428|Cystic Fibrosis Transmembrane Conductance Regulator|cystic fibrosis transmembrane conductance regulator
669532|NCT00376428|Premature termination codon|premature termination codon
669533|NCT00376428|Gentamicin-induced readthrough|gentamicin-induced readthrough
669534|NCT00376415|Lessertia frutescens|lessertia frutescens
669535|NCT00376415|Sutherlandia frutescens|sutherlandia frutescens
669536|NCT00376415|Phase 1 clinical trial|phase 1 clinical trial
669537|NCT00376415|Human safety study|human safety study
669538|NCT00376402|Pandemic|pandemic
669539|NCT00376402|Influenza|influenza
669540|NCT00376402|Prevention|prevention
669541|NCT00376402|Vaccine|vaccine
669542|NCT00376402|Prevention of Pandemic Influenza|prevention of pandemic influenza
669543|NCT00376376|levofloxacin|levofloxacin
669544|NCT00376376|pharmacodynamic|pharmacodynamic
669545|NCT00376376|bactericidal|bactericidal
669546|NCT00376363|glaucoma|glaucoma
669547|NCT00376363|Ahmed implant|ahmed implant
669548|NCT00376363|Baerveldt implant|baerveldt implant
669549|NCT00376350|Low Back Pain|low back pain
669550|NCT00376350|Chronic|chronic
669551|NCT00376350|Manipulation|manipulation
669552|NCT00376350|Chiropractic|chiropractic
669553|NCT00376350|Massage|massage
669554|NCT00376337|Invasive Aspergillosis|invasive aspergillosis
669555|NCT00376337|Salvage Therapy|salvage therapy
669556|NCT00376337|Micafungin|micafungin
669557|NCT00376324|pharmacokinetics|pharmacokinetics
669558|NCT00376324|human bone|human bone
669559|NCT00376311|Lequesne's algo-functional score|lequesne's algo-functional score
669560|NCT00376311|Biomarkers of joint metabolism|biomarkers of joint metabolism
669561|NCT00376298|incontinence|incontinence
669562|NCT00376298|prostate cancer|prostate cancer
669563|NCT00376298|interstitial cystitis|interstitial cystitis
669564|NCT00376272|atrial fibrillation,atrial remodeling,dysrhythmias,valsartan|atrial fibrillation,atrial remodeling,dysrhythmias,valsartan
669565|NCT00376259|lamivudine resistance|lamivudine resistance
669566|NCT00376259|Hepatitis B virus|hepatitis b virus
669567|NCT00376233|Schizophrenia,|schizophrenia,
669568|NCT00376233|Cannabinoids,|cannabinoids,
669569|NCT00376233|Arachidonic Acid,|arachidonic acid,
669570|NCT00376233|Niacin,|niacin,
669571|NCT00376233|Prostaglandins|prostaglandins
669572|NCT00376220|Bipolar|bipolar
669573|NCT00376220|Depression|depression
669574|NCT00376207|Cerebral infarct|cerebral infarct
669575|NCT00376207|physical exercise|physical exercise
669576|NCT00376207|insulin sensitivity|insulin sensitivity
669577|NCT00376207|low grade chronic inflammation|low grade chronic inflammation
669578|NCT00376207|intervention|intervention
669579|NCT00376207|HOMA|homa
669580|NCT00376207|PASE|pase
669581|NCT00376194|Pervasive Developmental Disorder|pervasive developmental disorder
669582|NCT00376194|Alternative Therapy|alternative therapy
669583|NCT00376194|Autism|autism
669584|NCT00376194|Asperger's Disorder|asperger's disorder
669585|NCT00376194|Clinical Trial|clinical trial
669586|NCT00376194|Autism Spectrum Disorder|autism spectrum disorder
669587|NCT00376194|ASD|asd
669588|NCT00376194|Asperger Disorder|asperger disorder
669589|NCT00376181|type 2 diabetes|type 2 diabetes
669590|NCT00376181|hypertension|hypertension
669591|NCT00376181|blood pressure|blood pressure
669592|NCT00376181|diastolic blood pressure|diastolic blood pressure
669593|NCT00376155|malaria|malaria
669594|NCT00376155|prevention|prevention
669595|NCT00376155|intermittent|intermittent
669596|NCT00376155|drugs|drugs
669597|NCT00376142|Intention|intention
669598|NCT00376142|Behaviour|behaviour
669599|NCT00376142|Evidence-based practice|evidence-based practice
669600|NCT00376142|Intervention|intervention
669601|NCT00376116|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
669602|NCT00376116|Pacemaker|pacemaker
669603|NCT00376116|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
669604|NCT00376116|Heart failure|heart failure
669605|NCT00376116|Predictor|predictor
669606|NCT00376116|Mortality|mortality
669607|NCT00376116|Rehospitalization|rehospitalization
669608|NCT00376116|Telemedicine|telemedicine
669609|NCT00376116|Home Monitoring|home monitoring
669610|NCT00376103|Brain Tumor|brain tumor
669611|NCT00376103|GBM|gbm
669612|NCT00376103|Glioblastoma Multiforme|glioblastoma multiforme
669613|NCT00376103|Glioblastoma|glioblastoma
669614|NCT00376103|Brachytherapy|brachytherapy
669615|NCT00376103|Temozolomide|temozolomide
669616|NCT00376103|Temodar|temodar
669617|NCT00376090|MVA vector|mva vector
669618|NCT00376090|Immunogenicity|immunogenicity
669619|NCT00376090|HIV vaccine|hiv vaccine
669620|NCT00376090|HIV preventative vaccine|hiv preventative vaccine
669621|NCT00376077|Thrombocytopenia|thrombocytopenia
669622|NCT00376077|pediatric|pediatric
669623|NCT00376077|methylprednisolone|methylprednisolone
669624|NCT00376077|intracranial hemorrhage|intracranial hemorrhage
669625|NCT00376077|intravenous immune globulin|intravenous immune globulin
669626|NCT00376064|Growth hormone (GH)|growth hormone (gh)
669627|NCT00376064|IGF-1|igf-1
669628|NCT00376064|Acromegaly|acromegaly
669629|NCT00376064|Pituitary adenoma|pituitary adenoma
669630|NCT00376064|Brain tumor|brain tumor
669631|NCT00376064|Brain cancer|brain cancer
669632|NCT00376064|Octreotide acetate|octreotide acetate
669633|NCT00376051|frontotemporal lobar degeneration|frontotemporal lobar degeneration
669634|NCT00376051|frontotemporal dementia|frontotemporal dementia
669635|NCT00376051|serotonin|serotonin
669636|NCT00376051|dementia|dementia
669637|NCT00376051|behavioural disturbances|behavioural disturbances
669638|NCT00376038|GSK189074|gsk189074
669639|NCT00376038|T2DM|t2dm
669640|NCT00376038|GSK189075|gsk189075
669641|NCT00376038|Glucophage|glucophage
669642|NCT00376038|Obesity|obesity
669643|NCT00376038|Diabetes|diabetes
669644|NCT00376038|Metformin|metformin
669645|NCT00376038|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
669646|NCT00376038|Drug Interaction|drug interaction
669647|NCT00376025|Kashin-Beck Disease|kashin-beck disease
669648|NCT00376025|Kashin-Beck Osteoarthropathy|kashin-beck osteoarthropathy
669649|NCT00376012|Chemotherapy for TB in HIV infection|chemotherapy for tb in hiv infection
669650|NCT00375986|Cesarean delivery|cesarean delivery
669651|NCT00375986|Placental removal|placental removal
669652|NCT00375986|Blood loss|blood loss
669653|NCT00375973|Fatigue|fatigue
669654|NCT00375973|Fatigue syndrome, chronic|fatigue syndrome, chronic
669655|NCT00375973|Chronic fatigue syndrome|chronic fatigue syndrome
669656|NCT00375973|CFS|cfs
669657|NCT00375973|Fibromyalgia|fibromyalgia
669658|NCT00375960|Pain associated with diabetes Type I or Type II|pain associated with diabetes type i or type ii
669659|NCT00375960|Neuropathic Pain due to diabetes|neuropathic pain due to diabetes
669660|NCT00375960|Diabetic peripheral neuropathic pain|diabetic peripheral neuropathic pain
669661|NCT00375960|Pain|pain
669662|NCT00375960|Diabetes with burning sensation in the arms and/or legs|diabetes with burning sensation in the arms and/or legs
669663|NCT00375960|Diabetes with tingling sensation in the arms and/or legs|diabetes with tingling sensation in the arms and/or legs
669664|NCT00375960|Neuropathic Pain Due to Diabetes Type I or Type II|neuropathic pain due to diabetes type i or type ii
669665|NCT00375947|exercise|exercise
669666|NCT00375947|hand disability|hand disability
669667|NCT00375947|arthritis|arthritis
669668|NCT00375947|AUSCAN|auscan
669669|NCT00375934|Bunionectomy|bunionectomy
669670|NCT00375934|Bunion surgery|bunion surgery
669671|NCT00375934|Post-operative pain|post-operative pain
669672|NCT00375921|diet|diet
669673|NCT00375921|food|food
669674|NCT00375921|taste|taste
669675|NCT00375921|smell|smell
669676|NCT00375921|head and neck|head and neck
669677|NCT00375921|radiation|radiation
669678|NCT00375921|chemotherapy|chemotherapy
669679|NCT00375908|Neonatal Encephalopathy|neonatal encephalopathy
669680|NCT00375908|Hypoxic-Ischemic Brain Injury|hypoxic-ischemic brain injury
669681|NCT00375908|Umbilical Cord Blood|umbilical cord blood
669682|NCT00375908|Proteomics|proteomics
669683|NCT00375895|Cyclosporin|cyclosporin
669684|NCT00375895|Peginterferon|peginterferon
669685|NCT00375895|Ribavirin|ribavirin
669686|NCT00375895|Chronic hepatitis C|chronic hepatitis c
669687|NCT00375895|Liver transplantation|liver transplantation
669688|NCT00375869|Neuroprotection|neuroprotection
669689|NCT00375869|neuron specific enolase|neuron specific enolase
669690|NCT00375869|CSF glutamate levels|csf glutamate levels
669691|NCT00375869|Darbepoetin Alfa|darbepoetin alfa
669692|NCT00375856|arthroplasty|arthroplasty
669693|NCT00375856|knee|knee
669694|NCT00375856|computer-assist|computer-assist
669695|NCT00375856|gait|gait
669696|NCT00375856|Total knee arthroplasty|total knee arthroplasty
669697|NCT00375856|knee prostheses|knee prostheses
669698|NCT00375804|Endometrial Cancer|endometrial cancer
669699|NCT00375791|Relapsed Multiple Myeloma|relapsed multiple myeloma
669700|NCT00375791|Refractory Multiple Myeloma|refractory multiple myeloma
669701|NCT00375778|Parkinson's Disease|parkinson's disease
669702|NCT00375778|Positron Emission Tomography|positron emission tomography
669703|NCT00375778|Memantine|memantine
669704|NCT00375778|NMDA antagonists|nmda antagonists
669705|NCT00375778|Cerebral Blood Flow|cerebral blood flow
669706|NCT00375778|Cerebral Metabolic Rate of Oxygen|cerebral metabolic rate of oxygen
669707|NCT00375765|Dutasteride|dutasteride
669708|NCT00375765|BPH|bph
669709|NCT00375765|Prostate cancer|prostate cancer
669710|NCT00375765|Gene expression|gene expression
669711|NCT00375765|PSA|psa
669712|NCT00375752|Breast cancer|breast cancer
669713|NCT00375752|Anti tumor potential|anti tumor potential
669714|NCT00375752|Letrozole|letrozole
669715|NCT00375752|Zoledronic acid|zoledronic acid
669716|NCT00375752|Neoadjuvant treatment|neoadjuvant treatment
669717|NCT00375752|Hormone responsive breast cancer|hormone responsive breast cancer
669718|NCT00375739|Actinic Keratosis|actinic keratosis
669719|NCT00375739|Topical|topical
669720|NCT00375739|Solar Keratosis|solar keratosis
669721|NCT00375739|Sun Spots|sun spots
669722|NCT00375739|Dermatology|dermatology
669723|NCT00375726|Dengue Fever|dengue fever
669724|NCT00375726|Dengue Vaccine|dengue vaccine
669725|NCT00375726|Dengue Virus|dengue virus
669726|NCT00375726|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
669727|NCT00375726|Dengue Shock Syndrome|dengue shock syndrome
669728|NCT00375713|Dermatitis|dermatitis
669729|NCT00375713|Eczema|eczema
669730|NCT00375713|Pruritus|pruritus
669731|NCT00375713|Xyzal|xyzal
669732|NCT00375713|Zyrtec|zyrtec
669733|NCT00375713|Levocetirizine|levocetirizine
669734|NCT00375713|Cetirizine|cetirizine
669735|NCT00375700|food|food
669736|NCT00375700|diet|diet
669737|NCT00375700|oral supplement|oral supplement
669738|NCT00375700|head and neck cancer|head and neck cancer
669739|NCT00375700|radiation|radiation
669740|NCT00375687|Prostate cancer|prostate cancer
669741|NCT00375661|hepatocellular carcinoma|hepatocellular carcinoma
669742|NCT00375648|Prostate|prostate
669743|NCT00375648|Cancer|cancer
669744|NCT00375648|Bone metastases|bone metastases
669745|NCT00375648|Zoledronic acid|zoledronic acid
669746|NCT00375648|Bone metastases-related pain|bone metastases-related pain
669747|NCT00375648|Prostate cancer|prostate cancer
669748|NCT00375635|mFPSA|mfpsa
669749|NCT00375635|Uremic toxins|uremic toxins
669750|NCT00375635|Protein bound toxins|protein bound toxins
669751|NCT00375635|Uremia|uremia
669752|NCT00375635|Chronic hemodialysis|chronic hemodialysis
669753|NCT00375622|HHT|hht
669754|NCT00375622|Epistaxis|epistaxis
669755|NCT00375622|Tamoxifen|tamoxifen
669756|NCT00375622|Hemoglobin|hemoglobin
669757|NCT00375609|Prevention of Venous Thromboembolism|prevention of venous thromboembolism
669758|NCT00375583|Lymphatic Filariasis|lymphatic filariasis
669759|NCT00375583|Diethylcarbamazine|diethylcarbamazine
669760|NCT00375583|Microfilariae|microfilariae
669761|NCT00375583|Helminths|helminths
669762|NCT00375583|Nematode|nematode
669763|NCT00375544|Laser Therapy, Low-Level|laser therapy, low-level
669764|NCT00375544|Osteoarthritis|osteoarthritis
669765|NCT00375544|Phototherapy|phototherapy
669766|NCT00375544|Osteoarthritis, knee|osteoarthritis, knee
669767|NCT00375544|Light-emitting diode|light-emitting diode
669768|NCT00375531|Post Traumatic Stress Disorder|post traumatic stress disorder
669769|NCT00375531|Mindfulness Meditation|mindfulness meditation
669770|NCT00375518|Thoracic Surgery|thoracic surgery
669771|NCT00375518|Cardiopulmonary complications|cardiopulmonary complications
669772|NCT00375518|Atorvastatin|atorvastatin
669773|NCT00375505|Breast Cancer|breast cancer
669774|NCT00375505|Premenopausal|premenopausal
669775|NCT00375505|Bone mineral density|bone mineral density
669776|NCT00375505|Cancer therapy induced bone loss|cancer therapy induced bone loss
669777|NCT00375505|zoledronic acid|zoledronic acid
669778|NCT00375492|diabetes|diabetes
669779|NCT00375492|overweight|overweight
669780|NCT00375492|obesity|obesity
669781|NCT00375492|weight loss|weight loss
669782|NCT00375492|exenatide|exenatide
669783|NCT00375492|Amylin|amylin
669784|NCT00375492|Lilly|lilly
669785|NCT00375466|Hemorrhage|hemorrhage
669786|NCT00375466|Transfusion|transfusion
669787|NCT00375466|Blood components|blood components
669788|NCT00375466|Fibrinolysis|fibrinolysis
669789|NCT00375466|Platelet activation|platelet activation
669790|NCT00375453|Paclitaxel|paclitaxel
669791|NCT00375453|Advanced Solid Tumors|advanced solid tumors
669792|NCT00375440|Tranexamic Acid|tranexamic acid
669793|NCT00375440|Revision Total Hip Replacement|revision total hip replacement
669794|NCT00375440|Reduction in Blood Loss|reduction in blood loss
669795|NCT00375427|Breast cancer|breast cancer
669796|NCT00375427|Zoledronic acid|zoledronic acid
669797|NCT00375427|Skeletal related events (SRE)|skeletal related events (sre)
669798|NCT00375414|Enteral tube feeding,|enteral tube feeding,
669799|NCT00375414|endoscopic gastropexy,|endoscopic gastropexy,
669800|NCT00375414|percutaneous endoscopic gastrostomy,|percutaneous endoscopic gastrostomy,
669801|NCT00375414|PEG|peg
669802|NCT00375388|Type 2 diabetes mellitus|type 2 diabetes mellitus
669803|NCT00375388|Metformin on top of insulin therapy|metformin on top of insulin therapy
669804|NCT00375388|Randomized placebo-controlled trial|randomized placebo-controlled trial
669805|NCT00375388|Diabetes regulation|diabetes regulation
669806|NCT00375388|Daily dose of insulin|daily dose of insulin
669807|NCT00375388|Body Weight|body weight
669808|NCT00375388|Patients with type 2 diabetes|patients with type 2 diabetes
669809|NCT00375388|Intensive insulin therapy|intensive insulin therapy
669810|NCT00375388|Age: 30-80 years|age: 30-80 years
669811|NCT00375388|Body mass index|body mass index
669812|NCT00375388|Lipids|lipids
669813|NCT00375388|Blood Pressure|blood pressure
669814|NCT00375388|Endothelial function|endothelial function
669815|NCT00375388|Low grade inflammation|low grade inflammation
669816|NCT00375388|Fibrinolysis|fibrinolysis
669817|NCT00375388|Microvascular complications|microvascular complications
669818|NCT00375388|Macrovascular complications|macrovascular complications
669819|NCT00375375|Minimal hepatic encephalopathy|minimal hepatic encephalopathy
669820|NCT00375375|Hepatic encephalopathy|hepatic encephalopathy
669821|NCT00375375|Subclinical hepatic encephalopathy|subclinical hepatic encephalopathy
669822|NCT00375375|Health related quality of life|health related quality of life
669823|NCT00375362|nitroglycerin|nitroglycerin
669824|NCT00375362|morphine|morphine
669825|NCT00375362|patient controlled analgesia|patient controlled analgesia
669826|NCT00375362|total knee arthroplasty|total knee arthroplasty
669827|NCT00375349|fatty liver|fatty liver
669828|NCT00375349|statin|statin
669829|NCT00375349|non-alcoholic|non-alcoholic
669830|NCT00375336|Aortic valve|aortic valve
669831|NCT00375336|Calcification|calcification
669832|NCT00375336|Endothelial dysfunction|endothelial dysfunction
669833|NCT00375336|Calcium metabolism|calcium metabolism
669834|NCT00375336|Coronary artery disease|coronary artery disease
669835|NCT00375323|factor VIII inhibitor|factor viii inhibitor
669836|NCT00375310|Phase I|phase i
669837|NCT00375310|Pancreas Cancer|pancreas cancer
669838|NCT00375310|Chemo-radiotherapy|chemo-radiotherapy
669839|NCT00375297|antidepressants|antidepressants
669840|NCT00375297|sexual dysfunction|sexual dysfunction
669841|NCT00375297|women|women
669842|NCT00375297|sildenafil|sildenafil
669843|NCT00375297|PDE5 inhibitors|pde5 inhibitors
669844|NCT00375297|serotonin reuptake inhibitor antidepressants|serotonin reuptake inhibitor antidepressants
669845|NCT00375271|Monitoring, Intraoperative|monitoring, intraoperative
669846|NCT00375271|Hemodynamic Processes|hemodynamic processes
669847|NCT00375271|Treatment Protocols|treatment protocols
669848|NCT00375258|Adult trauma patients with ongoing significant haemorrhage or at risk of significant haemorrhage|adult trauma patients with ongoing significant haemorrhage or at risk of significant haemorrhage
669849|NCT00375245|phase I|phase i
669850|NCT00375245|metastatic|metastatic
669851|NCT00375245|advanced cancer|advanced cancer
669852|NCT00375245|lung cancer|lung cancer
669853|NCT00375245|renal cancer|renal cancer
669854|NCT00375245|kidney cancer|kidney cancer
669855|NCT00375245|head and neck cancer|head and neck cancer
669856|NCT00375245|bladder cancer|bladder cancer
669857|NCT00375245|breast cancer|breast cancer
669858|NCT00375245|colorectal cancer|colorectal cancer
669859|NCT00375245|esophagus|esophagus
669860|NCT00375245|GIST|gist
669861|NCT00375245|liver cancer|liver cancer
669862|NCT00375245|melanoma|melanoma
669863|NCT00375245|mesothelioma|mesothelioma
669864|NCT00375245|lymphoma|lymphoma
669865|NCT00375245|ovary cancer|ovary cancer
669866|NCT00375245|ovarian cancer|ovarian cancer
669867|NCT00375245|pancreas cancer|pancreas cancer
669868|NCT00375245|pancreatic cancer|pancreatic cancer
669869|NCT00375245|prostate cancer|prostate cancer
669870|NCT00375245|stomach cancer|stomach cancer
669871|NCT00375245|thyroid cancer|thyroid cancer
669872|NCT00375245|Metastatic solid tumor|metastatic solid tumor
669873|NCT00375232|Exercise-Induced Bronchospasm|exercise-induced bronchospasm
669874|NCT00375232|Asthma|asthma
669875|NCT00375232|Cardiopulmonary Stress Test|cardiopulmonary stress test
669876|NCT00375232|Eucapnic Voluntary Hyperventilation|eucapnic voluntary hyperventilation
669877|NCT00375232|Induced sputum|induced sputum
669878|NCT00375219|Chronic Myeloid Leukemia|chronic myeloid leukemia
669880|NCT00375219|HHT|hht
669881|NCT00375219|Homoharringtonine|homoharringtonine
669882|NCT00375219|Omacetaxine|omacetaxine
669883|NCT00375219|T315i|t315i
669884|NCT00375219|ChemGenex|chemgenex
669885|NCT00375219|ChemGenex Pharmaceuticals|chemgenex pharmaceuticals
669886|NCT00375206|PowderMed, DNA vaccine, influenza|powdermed, dna vaccine, influenza
669887|NCT00375193|small cell lung cancer|small cell lung cancer
669888|NCT00375193|amrubicin|amrubicin
669889|NCT00375180|food|food
669890|NCT00375180|diet|diet
669891|NCT00375180|mucositis|mucositis
669892|NCT00375180|xerostomia|xerostomia
669893|NCT00375180|dysphagia|dysphagia
669894|NCT00375180|taste|taste
669895|NCT00375180|smell|smell
669896|NCT00375180|head and neck|head and neck
669897|NCT00375180|radiation|radiation
669898|NCT00375180|chemotherapy|chemotherapy
669899|NCT00375167|Recovery, Hope, Empowerment, Randomized Control Trial|recovery, hope, empowerment, randomized control trial
669900|NCT00375154|Acute respiratory failure|acute respiratory failure
669901|NCT00375154|Prehospital care|prehospital care
669902|NCT00375154|Noninvasive ventilation|noninvasive ventilation
669903|NCT00375154|Emergency|emergency
669904|NCT00375128|Malaria|malaria
669905|NCT00375128|Vaccine|vaccine
669906|NCT00375128|Prime-boost|prime-boost
669907|NCT00375128|Challenge|challenge
669908|NCT00375102|acupuncture|acupuncture
669909|NCT00375102|relaxation response|relaxation response
669910|NCT00375102|homeless|homeless
669911|NCT00375102|veterans|veterans
669912|NCT00375102|randomized trials|randomized trials
669913|NCT00375089|Early-onset Morbid Obesity|early-onset morbid obesity
669914|NCT00375063|left main stenosis|left main stenosis
669915|NCT00375063|Percutaneous Coronary Intervention|percutaneous coronary intervention
669916|NCT00375063|Coronary Artery Bypass Grafting|coronary artery bypass grafting
669917|NCT00375037|hand washing|hand washing
669918|NCT00375037|cluster randomized trial|cluster randomized trial
669919|NCT00375037|performance feedback|performance feedback
669920|NCT00375037|healthcare workers|healthcare workers
669921|NCT00375037|Hand hygiene|hand hygiene
669922|NCT00375037|hand washing adherence|hand washing adherence
669923|NCT00375024|Patient navigation|patient navigation
669924|NCT00375024|Breast cancer|breast cancer
669925|NCT00375024|Colon cancer|colon cancer
669926|NCT00375024|Questionnaire|questionnaire
669927|NCT00375011|MELD-Model of End Stage Liver Disease score|meld-model of end stage liver disease score
669928|NCT00375011|CTP-Child-Turcotte-Pugh score|ctp-child-turcotte-pugh score
669929|NCT00375011|MEGX-monoethylglycinexylidide-resultant of metabolism of lidocaine|megx-monoethylglycinexylidide-resultant of metabolism of lidocaine
669930|NCT00375011|HCC-Hepatocellular carcinoma|hcc-hepatocellular carcinoma
669931|NCT00375011|HCV-Hepatitis C virus|hcv-hepatitis c virus
669932|NCT00375011|NASH-Non-alcoholic Steatohepatitis|nash-non-alcoholic steatohepatitis
669933|NCT00374998|Malaria|malaria
669934|NCT00374998|Vaccine|vaccine
669935|NCT00374998|Prime-boost|prime-boost
669936|NCT00374985|chemoradiation|chemoradiation
669937|NCT00374985|docetaxel|docetaxel
669938|NCT00374985|oxaliplatin|oxaliplatin
669939|NCT00374985|gastric|gastric
669940|NCT00374985|neoadjuvant|neoadjuvant
669941|NCT00374985|radiochemotherapy|radiochemotherapy
669942|NCT00374959|Prevention of pneumonia|prevention of pneumonia
669943|NCT00374959|ceftriaxone|ceftriaxone
669944|NCT00374959|continuous aspiration|continuous aspiration
669945|NCT00374959|subglottic secretions|subglottic secretions
669946|NCT00374959|Mechanical ventilation with Endotracheal intubation.|mechanical ventilation with endotracheal intubation.
669947|NCT00374959|Absence of infection|absence of infection
669948|NCT00374933|AML|aml
669949|NCT00374933|ALL|all
669950|NCT00374933|MDS|mds
669951|NCT00374933|Allogeneic transplant|allogeneic transplant
669952|NCT00374933|Acute Myelogenous Leukemia|acute myelogenous leukemia
669953|NCT00374933|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
669954|NCT00374933|Myelodysplastic Syndrome|myelodysplastic syndrome
669955|NCT00374933|Adoptive cell therapy|adoptive cell therapy
669956|NCT00374933|Non-myeloablative|non-myeloablative
669957|NCT00374920|bipolar|bipolar
669958|NCT00374920|mania|mania
669959|NCT00374920|mixed|mixed
669960|NCT00374894|2,3-dimercaptosuccinic acid|2,3-dimercaptosuccinic acid
669961|NCT00374894|Blood Lead Levels|blood lead levels
669962|NCT00374894|children|children
669963|NCT00374894|multi-nutrients|multi-nutrients
669964|NCT00374842|Influenza vaccine|influenza vaccine
669965|NCT00374842|Prophylaxis Influenza vaccine|prophylaxis influenza vaccine
669966|NCT00374829|randomised prospective trial|randomised prospective trial
669967|NCT00374829|medication refill compliance|medication refill compliance
669968|NCT00374829|hypertension|hypertension
669969|NCT00374829|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
669970|NCT00374829|information technology based patient support system|information technology based patient support system
669971|NCT00374829|process of care, quality of life, pharmacoeconomics|process of care, quality of life, pharmacoeconomics
669972|NCT00374829|multidisciplinary patient management|multidisciplinary patient management
669973|NCT00374803|Kidney|kidney
669974|NCT00374803|Transplant|transplant
669975|NCT00374803|Corticosteroid|corticosteroid
669976|NCT00374803|Myfortic|myfortic
669977|NCT00374790|Lead toxicity|lead toxicity
669978|NCT00374777|Insomnia|insomnia
669979|NCT00374777|schizophrenia|schizophrenia
669980|NCT00374777|manic-depressive psychosis|manic-depressive psychosis
669981|NCT00374777|zolpidem|zolpidem
669982|NCT00374764|Autism, Applied Behavioral Analysis, Risperidone|autism, applied behavioral analysis, risperidone
669983|NCT00374751|Samarium|samarium
669984|NCT00374751|Kyphoplasty|kyphoplasty
669985|NCT00374751|Pain management|pain management
669986|NCT00374751|Bone metastases|bone metastases
669987|NCT00374751|Histologically proven malignancy in the primary site|histologically proven malignancy in the primary site
669988|NCT00374751|Radiographic evidence of bone metastasis|radiographic evidence of bone metastasis
669989|NCT00374751|Significant pain equal or more than score 5|significant pain equal or more than score 5
669990|NCT00374751|Karnofsky Performance status >40|karnofsky performance status >40
669991|NCT00374751|The patient must sign a study specific informed consent|the patient must sign a study specific informed consent
669992|NCT00374738|Guided Imagery for Trauma (GIFT)|guided imagery for trauma (gift)
669993|NCT00374738|Posttraumatic Stress Disorder (PTSD)|posttraumatic stress disorder (ptsd)
669994|NCT00374738|Military Sexual Trauma (MST)|military sexual trauma (mst)
669995|NCT00374738|Military Sexual Trauma - related PTSD|military sexual trauma - related ptsd
669996|NCT00374725|Ulcerative Colitis|ulcerative colitis
669997|NCT00374725|Probiotic|probiotic
669998|NCT00374725|Placebo controlled trial|placebo controlled trial
669999|NCT00374725|Lactobacillus rhamnosus|lactobacillus rhamnosus
670000|NCT00374725|Lactobacillus acidophilus|lactobacillus acidophilus
670001|NCT00374712|Phosphate|phosphate
670002|NCT00374712|Dialysis|dialysis
670003|NCT00374712|Klotho|klotho
670004|NCT00374712|Hemodialysis|hemodialysis
670005|NCT00374699|Velcade|velcade
670006|NCT00374699|Bortezomib|bortezomib
670007|NCT00374699|CHOP|chop
670008|NCT00374699|Peripheral T-cell lymphomas(PTCLs)|peripheral t-cell lymphomas(ptcls)
670009|NCT00374699|natural killer (NK)-cell lymphomas|natural killer (nk)-cell lymphomas
670010|NCT00374686|cytomegalovirus|cytomegalovirus
670011|NCT00374686|kidney|kidney
670012|NCT00374686|transplantation|transplantation
670013|NCT00374686|valganciclovir|valganciclovir
670014|NCT00374686|preemptive|preemptive
670015|NCT00374673|TMS|tms
670016|NCT00374673|chronic pain|chronic pain
670017|NCT00374673|fibromyalgia|fibromyalgia
670018|NCT00374673|IBS|ibs
670019|NCT00374673|burning mouth syndrome|burning mouth syndrome
670020|NCT00374673|predictive factors|predictive factors
670021|NCT00374660|Irofulven|irofulven
670022|NCT00374660|Oxaliplatin|oxaliplatin
670023|NCT00374647|Renal|renal
670024|NCT00374647|Kidney|kidney
670025|NCT00374647|Transplant|transplant
670026|NCT00374608|pediatric|pediatric
670027|NCT00374608|congenital complete heart block|congenital complete heart block
670028|NCT00374608|dual chamber pacemaker|dual chamber pacemaker
670029|NCT00374595|Kidney Transplant|kidney transplant
670030|NCT00374595|Vascular Risk|vascular risk
670031|NCT00374595|inflammation|inflammation
670032|NCT00374595|Diabetes|diabetes
670033|NCT00374595|Insulin resistance|insulin resistance
670034|NCT00374595|Chronic kidney disease|chronic kidney disease
670035|NCT00374582|Bioelectric impedance analysis|bioelectric impedance analysis
670036|NCT00374582|BIA|bia
670037|NCT00374582|ESLD|esld
670038|NCT00374582|LVP|lvp
670039|NCT00374582|Large volume paracentesis|large volume paracentesis
670040|NCT00374582|Ascites|ascites
670041|NCT00374582|Liver|liver
670042|NCT00374582|Hepatic|hepatic
670043|NCT00374569|Gymnastics, Computerized Dynamic Posturography, Balance|gymnastics, computerized dynamic posturography, balance
670044|NCT00374556|eszopiclone|eszopiclone
670045|NCT00374556|insomnia|insomnia
670046|NCT00374543|Bipolar Disorder|bipolar disorder
670047|NCT00374543|Generalized Anxiety Disorder|generalized anxiety disorder
670048|NCT00374543|Double-blind|double-blind
670049|NCT00374543|Placebo-controlled|placebo-controlled
670050|NCT00374543|Ziprasidone|ziprasidone
670051|NCT00374517|Mycobacterium Tuberculosis|mycobacterium tuberculosis
670052|NCT00374517|Pimonidazole Hydrochloride|pimonidazole hydrochloride
670053|NCT00374517|Recurrent Tuberculosis|recurrent tuberculosis
670054|NCT00374517|Hypoxyprobe|hypoxyprobe
670055|NCT00374517|mRNA Expression|mrna expression
670056|NCT00374517|Pulmonary Tuberculosis|pulmonary tuberculosis
670057|NCT00374491|ACL|acl
670058|NCT00374491|Bone Screw|bone screw
670059|NCT00374491|Knee|knee
670060|NCT00374478|Scopolamine|scopolamine
670061|NCT00374478|Antiemetic|antiemetic
670062|NCT00374478|Task performance and analysis|task performance and analysis
670063|NCT00374478|Psychomotor vigilance test|psychomotor vigilance test
670064|NCT00374465|Dilated Cardiomyopathy|dilated cardiomyopathy
670065|NCT00374465|Heart Failure|heart failure
670066|NCT00374452|hypertension|hypertension
670067|NCT00374452|practice guidelines|practice guidelines
670068|NCT00374452|quality of health care|quality of health care
670069|NCT00374452|decision support systems|decision support systems
670070|NCT00374452|evidence-based medicine|evidence-based medicine
670071|NCT00374452|medical informatics|medical informatics
670072|NCT00374439|depression|depression
670073|NCT00374439|adolescents|adolescents
670074|NCT00374439|prevention|prevention
670075|NCT00374439|schools|schools
670076|NCT00374426|depression|depression
670077|NCT00374426|diabetes mellitus|diabetes mellitus
670078|NCT00374426|depression recurrence|depression recurrence
670079|NCT00374413|DDD|ddd
670080|NCT00374413|artificial disc|artificial disc
670081|NCT00374400|Kidney|kidney
670082|NCT00374400|Transplant|transplant
670083|NCT00374400|Paired donation|paired donation
670084|NCT00374400|Living donor|living donor
670085|NCT00374387|Healthy women|healthy women
670086|NCT00374374|probiotic|probiotic
670087|NCT00374361|insulin sensitivity|insulin sensitivity
670088|NCT00374361|endothelial function|endothelial function
670089|NCT00374361|adolescence|adolescence
670090|NCT00374361|lipids|lipids
670091|NCT00374361|puberty|puberty
670092|NCT00374348|Schizophrenia with OCD|schizophrenia with ocd
670093|NCT00374348|Schizophrenia with-comorbid symptoms of Obsessive Compulsive Disorder(OCD)|schizophrenia with-comorbid symptoms of obsessive compulsive disorder(ocd)
670094|NCT00374335|prospective cohort study|prospective cohort study
670095|NCT00374322|Breast Cancer|breast cancer
670096|NCT00374322|ErbB2-overexpressing|erbb2-overexpressing
670097|NCT00374322|early-stage breast cancer|early-stage breast cancer
670098|NCT00374322|adjuvant|adjuvant
670099|NCT00374309|Hemorrhagic Fever|hemorrhagic fever
670100|NCT00374309|Healthy|healthy
670101|NCT00374309|Immunity|immunity
670102|NCT00374309|T -Cells|t -cells
670103|NCT00374309|Filovirus|filovirus
670104|NCT00374309|Healthy Volunteer|healthy volunteer
670105|NCT00374309|HV|hv
670106|NCT00374296|Leukemia|leukemia
670107|NCT00374296|MDS|mds
670108|NCT00374296|Phase II|phase ii
670109|NCT00374296|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
670110|NCT00374296|High Risk Myelodysplastic Syndromes (MDS)|high risk myelodysplastic syndromes (mds)
670111|NCT00374283|Monitoring|monitoring
670112|NCT00374283|Polyomavirus|polyomavirus
670113|NCT00374283|Kidney|kidney
670114|NCT00374283|Pancreas|pancreas
670115|NCT00374283|Transplant|transplant
670116|NCT00374270|Diabetes (type I and type II)|diabetes (type i and type ii)
670117|NCT00374257|NB-UVB|nb-uvb
670118|NCT00374257|cGVHD|cgvhd
670119|NCT00374244|schizophrenia|schizophrenia
670120|NCT00374244|pimozide|pimozide
670121|NCT00374244|clozapine|clozapine
670122|NCT00374231|Liver|liver
670123|NCT00374231|Transplant|transplant
670124|NCT00374231|Corticosteroid withdrawal|corticosteroid withdrawal
670125|NCT00374231|Tacrolimus|tacrolimus
670126|NCT00374231|CellCept|cellcept
670127|NCT00374231|MMF|mmf
670128|NCT00374231|Mycophenolate mofetil|mycophenolate mofetil
670129|NCT00374218|Carbohydrate|carbohydrate
670130|NCT00374218|Glycemic index|glycemic index
670131|NCT00374218|Randomized|randomized
670132|NCT00374218|Double-blind|double-blind
670133|NCT00374218|Glucose|glucose
670134|NCT00374218|Insulin|insulin
670135|NCT00374218|C-reactive protein|c-reactive protein
670136|NCT00374205|Ghana|ghana
670137|NCT00374205|Effectiveness|effectiveness
670138|NCT00374205|Safety|safety
670139|NCT00374205|Drug-Resistance|drug-resistance
670140|NCT00374205|ACT|act
670141|NCT00374205|Coartem|coartem
670142|NCT00374205|Arsucam|arsucam
670143|NCT00374192|Menopause|menopause
670144|NCT00374192|Insomnia|insomnia
670145|NCT00374192|Depression|depression
670146|NCT00374192|Anxiety|anxiety
670147|NCT00374192|Sleep|sleep
670148|NCT00374192|Lunesta|lunesta
670149|NCT00374192|Quality of Life|quality of life
670150|NCT00374166|Anti-anxiety agents|anti-anxiety agents
670151|NCT00374166|antidepressive agents|antidepressive agents
670152|NCT00374166|controlled clinical trial|controlled clinical trial
670153|NCT00374153|Alcohol|alcohol
670154|NCT00374153|Drinking|drinking
670156|NCT00374153|Motivational|motivational
670157|NCT00374153|Feedback|feedback
670158|NCT00374153|Assessment|assessment
670159|NCT00374140|small cell|small cell
670160|NCT00374140|lung|lung
670161|NCT00374127|Marijuana|marijuana
670162|NCT00374127|Comparison between joints and blunts|comparison between joints and blunts
670163|NCT00374127|Pharmacokinetic effects|pharmacokinetic effects
670164|NCT00374114|cervical|cervical
670165|NCT00374114|dysplasia|dysplasia
670166|NCT00374101|PPIs,|ppis,
670167|NCT00374101|endoscopic therapy,|endoscopic therapy,
670168|NCT00374101|peptic ulcers,|peptic ulcers,
670169|NCT00374101|upper gastrointestinal bleeding,|upper gastrointestinal bleeding,
670170|NCT00374101|non-variceal upper gastrointestinal bleeding|non-variceal upper gastrointestinal bleeding
670171|NCT00374088|N-acetylcysteine|n-acetylcysteine
670172|NCT00374088|Myocardial dysfunction|myocardial dysfunction
670173|NCT00374088|Transposition of the Great Arteries|transposition of the great arteries
670174|NCT00374075|Spinal Muscular Atrophy (SMA)|spinal muscular atrophy (sma)
670175|NCT00374075|Valproic Acid|valproic acid
670176|NCT00374062|Mohs Surgery|mohs surgery
670177|NCT00374049|Prostate|prostate
670178|NCT00374049|vaccine|vaccine
670179|NCT00374049|immunosuppression|immunosuppression
670180|NCT00374049|dendritic cells|dendritic cells
670181|NCT00374036|chemotherapy|chemotherapy
670182|NCT00374036|stomach cancer metastatic|stomach cancer metastatic
670183|NCT00374036|Capecitabine|capecitabine
670184|NCT00374036|Irinotecan|irinotecan
670185|NCT00374023|Zinc|zinc
670186|NCT00374023|vitamin A|vitamin a
670187|NCT00374023|immunity|immunity
670188|NCT00374023|morbidity|morbidity
670189|NCT00374023|height gain|height gain
670190|NCT00374023|weight gain|weight gain
670191|NCT00374023|Children aged between 1 and 3 years|children aged between 1 and 3 years
670192|NCT00374023|Weight for age between 70% and 61% of NCHS standard|weight for age between 70% and 61% of nchs standard
670193|NCT00374023|Acute diarrhoeal Patients|acute diarrhoeal patients
670194|NCT00374023|No signs of vitamin A deficiency|no signs of vitamin a deficiency
670195|NCT00374023|Who has not received measles vaccine|who has not received measles vaccine
670196|NCT00374010|end-of-life decision making|end-of-life decision making
670197|NCT00374010|advance care planning|advance care planning
670198|NCT00373984|shoulder|shoulder
670199|NCT00373984|thoracotomy|thoracotomy
670200|NCT00373971|Activities of daily living|activities of daily living
670201|NCT00373971|Elderly|elderly
670202|NCT00373971|Nutrition|nutrition
670203|NCT00373971|Postoperative|postoperative
670204|NCT00373971|Hip fractures|hip fractures
670205|NCT00373971|Hip replacement|hip replacement
670206|NCT00373971|Knee replacement|knee replacement
670207|NCT00373945|HLA-B*5701|hla-b*5701
670208|NCT00373945|pharmacogenetic marker|pharmacogenetic marker
670209|NCT00373945|hypersensitivity to abacavir,|hypersensitivity to abacavir,
670210|NCT00373945|retrospective analysis|retrospective analysis
670211|NCT00373932|Exercise|exercise
670212|NCT00373932|Physical Activity|physical activity
670213|NCT00373932|Adherence|adherence
670214|NCT00373906|MALT Lymphoma, Bortezomib|malt lymphoma, bortezomib
670215|NCT00373893|Pain|pain
670216|NCT00373893|Hyperalgesia|hyperalgesia
670217|NCT00373893|capsaicin|capsaicin
670218|NCT00373880|Aripiprazole|aripiprazole
670219|NCT00373880|Cocaine abuse|cocaine abuse
670220|NCT00373867|Secondary prevention|secondary prevention
670221|NCT00373867|Physical therapy|physical therapy
670222|NCT00373867|Fear-avoidance beliefs|fear-avoidance beliefs
670223|NCT00373867|Disability|disability
670224|NCT00373854|Hypoglycemia|hypoglycemia
670225|NCT00373854|Endothelial function|endothelial function
670226|NCT00373841|Lung|lung
670227|NCT00373841|Fibrosis|fibrosis
670228|NCT00373841|Idiopathic|idiopathic
670229|NCT00373841|Biomarkers|biomarkers
670230|NCT00373841|Genomics|genomics
670231|NCT00373841|Longitudinal|longitudinal
670232|NCT00373828|Chest Pain|chest pain
670233|NCT00373828|Chest Wall|chest wall
670234|NCT00373828|Angina Pectoris|angina pectoris
670235|NCT00373828|Atypical Chest Pain|atypical chest pain
670236|NCT00373828|Physical Examination|physical examination
670237|NCT00373828|Myocardial Perfusion Imaging|myocardial perfusion imaging
670238|NCT00373828|Observational Study|observational study
670239|NCT00373828|Non-Cardiac Chest Pain|non-cardiac chest pain
670240|NCT00373828|Ischemic Heart Disease|ischemic heart disease
670241|NCT00373815|acute GVHD|acute gvhd
670242|NCT00373815|Immunosuppression|immunosuppression
670243|NCT00373789|Botulinum Toxin A|botulinum toxin a
670244|NCT00373789|Urinary Incontinence|urinary incontinence
670245|NCT00373789|Detrusor Overactivity|detrusor overactivity
670246|NCT00373776|mucosal|mucosal
670247|NCT00373776|leishmaniasis|leishmaniasis
670248|NCT00373776|miltefosine|miltefosine
670249|NCT00373763|Congenital diaphragmatic hernia|congenital diaphragmatic hernia
670250|NCT00373763|tracheal occlusion|tracheal occlusion
670251|NCT00373763|fetus|fetus
670252|NCT00373763|fetal surgery|fetal surgery
670253|NCT00373763|fetoscopy|fetoscopy
670254|NCT00373750|Native American health|native american health
670255|NCT00373750|Teen pregnancy|teen pregnancy
670256|NCT00373750|Family strengthening|family strengthening
670257|NCT00373750|Substance abuse prevention|substance abuse prevention
670258|NCT00373750|Injury prevention|injury prevention
670259|NCT00373724|sacroiliac joint|sacroiliac joint
670260|NCT00373724|low back pain|low back pain
670261|NCT00373724|radiofrequency|radiofrequency
670262|NCT00373698|Stress Disorders, Posttraumatic|stress disorders, posttraumatic
670263|NCT00373698|Delivery of Health Care, Integrated|delivery of health care, integrated
670264|NCT00373698|Primary Health Care|primary health care
670265|NCT00373698|Veterans|veterans
670266|NCT00373698|Depression|depression
670267|NCT00373685|GI events in patients with moderate GI risk treated with NSAIDS|gi events in patients with moderate gi risk treated with nsaids
670268|NCT00373672|schizophrenia|schizophrenia
670269|NCT00373672|cognition|cognition
670270|NCT00373659|Neovascularization|neovascularization
670271|NCT00373659|Age-related macular degeneration|age-related macular degeneration
670272|NCT00373659|Ranibizumab (Lucentis)|ranibizumab (lucentis)
670273|NCT00373659|Optical coherence tomography|optical coherence tomography
670274|NCT00373659|Intravitreal injection|intravitreal injection
670275|NCT00373646|MALT Lymphoma|malt lymphoma
670276|NCT00373646|thalidomide|thalidomide
670277|NCT00373646|disseminated MALT Lymphoma or at relapse following HP-eradication|disseminated malt lymphoma or at relapse following hp-eradication
670278|NCT00373646|or chemotherapy or radiation|or chemotherapy or radiation
670279|NCT00373633|THoracic Surgery|thoracic surgery
670280|NCT00373633|thoracic epidural|thoracic epidural
670281|NCT00373633|epidural|epidural
670282|NCT00373633|thoracotomy|thoracotomy
670283|NCT00373633|intercostal nerve block|intercostal nerve block
670284|NCT00373633|intercostal|intercostal
670285|NCT00373633|nerve block|nerve block
670286|NCT00373620|endometrial cancer|endometrial cancer
670287|NCT00373620|high risk|high risk
670288|NCT00373620|weekly paclitaxel|weekly paclitaxel
670289|NCT00373620|Cuncurrent chemoradiation|cuncurrent chemoradiation
670290|NCT00373607|Non complicated malaria|non complicated malaria
670291|NCT00373607|Microscopy|microscopy
670292|NCT00373607|Adult|adult
670293|NCT00373607|Children|children
670294|NCT00373594|Cold agglutinin disease|cold agglutinin disease
670295|NCT00373594|Hemolytic|hemolytic
670296|NCT00373594|Anemia|anemia
670297|NCT00373594|Lymphoproliferative disease|lymphoproliferative disease
670298|NCT00373594|Monoclonal antibodies|monoclonal antibodies
670299|NCT00373594|Rituximab|rituximab
670300|NCT00373594|Fludarabine|fludarabine
670301|NCT00373581|Vigabatrin|vigabatrin
670302|NCT00373581|GABA levels|gaba levels
670303|NCT00373581|Smoked cocaine|smoked cocaine
670304|NCT00373568|mucosal|mucosal
670305|NCT00373568|miltefosine|miltefosine
670306|NCT00373555|Sarcoidosis|sarcoidosis
670307|NCT00373555|mediastinal adenopathy|mediastinal adenopathy
670308|NCT00373555|bronchoscopy|bronchoscopy
670309|NCT00373555|Transbronchial needle aspiration|transbronchial needle aspiration
670310|NCT00373555|endobronchial ultrasonography|endobronchial ultrasonography
670311|NCT00373542|Restless Legs Syndrome|restless legs syndrome
670312|NCT00373542|ropinirole|ropinirole
670313|NCT00373542|polysomnography|polysomnography
670314|NCT00373542|RLS|rls
670315|NCT00373542|PSG|psg
670316|NCT00373529|Acute myelogenous leukemia|acute myelogenous leukemia
670317|NCT00373529|Acute myeloid leukemia|acute myeloid leukemia
670318|NCT00373529|newly Diagnosed AML|newly diagnosed aml
670319|NCT00373529|Clofarabine|clofarabine
670320|NCT00373529|CLASSIC II|classic ii
670321|NCT00373529|CLO243|clo243
670322|NCT00373516|psoriasis|psoriasis
670323|NCT00373516|topical therapy|topical therapy
670324|NCT00373503|Lofexidine|lofexidine
670325|NCT00373503|Oral THC|oral thc
670326|NCT00373503|Cannabinoids|cannabinoids
670327|NCT00373477|Depression|depression
670328|NCT00373477|Primary Care|primary care
670329|NCT00373477|Care Manager|care manager
670330|NCT00373464|Postoperative pain|postoperative pain
670331|NCT00373464|Opioid|opioid
670332|NCT00373464|Etoricoxib|etoricoxib
670333|NCT00373464|Ketorolac|ketorolac
670334|NCT00373464|Laparoscopic Surgery|laparoscopic surgery
670335|NCT00373464|Surgical Procedures, Gynecologic|surgical procedures, gynecologic
670336|NCT00373451|NSTEMI|nstemi
670337|NCT00373438|Congenital diaphragmatic hernia|congenital diaphragmatic hernia
670338|NCT00373438|tracheal occlusion|tracheal occlusion
670339|NCT00373438|fetus|fetus
670340|NCT00373438|fetal surgery|fetal surgery
670341|NCT00373438|fetoscopy|fetoscopy
670343|NCT00373425|Adjuvant Non-small Cell Lung Cancer|adjuvant non-small cell lung cancer
670344|NCT00373425|Tarceva|tarceva
670345|NCT00373425|Early-stage Lung Cancer|early-stage lung cancer
670346|NCT00373425|Adjuvant|adjuvant
670347|NCT00373425|RADIANT|radiant
670348|NCT00373425|NSCLC|nsclc
670349|NCT00373425|EGFR-positive tumor|egfr-positive tumor
670350|NCT00373425|Stage IB Non-small Cell Lung Cancer|stage ib non-small cell lung cancer
670351|NCT00373425|Stage II Non-small Cell Lung Cancer|stage ii non-small cell lung cancer
670352|NCT00373425|Stage IIIA Non-small Cell Lung Cancer|stage iiia non-small cell lung cancer
670353|NCT00373412|cytomegalovirus|cytomegalovirus
670354|NCT00373412|vaccine|vaccine
670355|NCT00373412|T cell|t cell
670357|NCT00373399|Cannabinoids|cannabinoids
670358|NCT00373399|Risk taking|risk taking
670359|NCT00373399|Decision making|decision making
670360|NCT00373386|growth hormone|growth hormone
670361|NCT00373386|endothelial function|endothelial function
670362|NCT00373373|Sorafenib|sorafenib
670363|NCT00373373|Acute Myeloid Leukemia|acute myeloid leukemia
670364|NCT00373373|Flt3|flt3
670365|NCT00373373|AML|aml
670366|NCT00373373|Kinase Inhibitor|kinase inhibitor
670367|NCT00373360|pulmonary hypertension|pulmonary hypertension
670368|NCT00373360|PAH|pah
670369|NCT00373360|Remodulin|remodulin
670370|NCT00373360|treprostinil|treprostinil
670371|NCT00373360|Quality of Life|quality of life
670372|NCT00373360|Rapid Switch|rapid switch
670373|NCT00373334|gastroesophageal reflux disease|gastroesophageal reflux disease
670374|NCT00373334|GERD|gerd
670375|NCT00373334|heartburn|heartburn
670376|NCT00373308|Quality of Life|quality of life
670377|NCT00373295|Baclofen|baclofen
670378|NCT00373295|Marijuana Dependence|marijuana dependence
670379|NCT00373295|Marijuana Withdrawal|marijuana withdrawal
670380|NCT00373282|PVR|pvr
670381|NCT00373282|Retinal detachment|retinal detachment
670382|NCT00373282|Silicone oil|silicone oil
670383|NCT00373282|Triamcinolone|triamcinolone
670384|NCT00373269|Acute ischemic stroke|acute ischemic stroke
670385|NCT00373269|Stroke|stroke
670386|NCT00373269|Hyperglycemia|hyperglycemia
670387|NCT00373269|Procoagulation|procoagulation
670388|NCT00373269|Diabetes|diabetes
670389|NCT00373269|Blood coagulation|blood coagulation
670390|NCT00373256|Breast cancer|breast cancer
670391|NCT00373256|advanced|advanced
670392|NCT00373256|sunitinib|sunitinib
670393|NCT00373256|bevacizumab|bevacizumab
670394|NCT00373256|paclitaxel|paclitaxel
670395|NCT00373256|Phase 3|phase 3
670396|NCT00373243|hepatic impairment pharmacokinetics|hepatic impairment pharmacokinetics
670397|NCT00373230|weight loss|weight loss
670398|NCT00373230|telemedicine|telemedicine
670399|NCT00373230|african-american|african-american
670400|NCT00373230|rural|rural
670401|NCT00373217|fallopian tube cancer|fallopian tube cancer
670402|NCT00373217|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
670403|NCT00373217|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
670404|NCT00373217|primary peritoneal cavity cancer|primary peritoneal cavity cancer
670405|NCT00373204|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
670406|NCT00373204|Non-small cell lung cancer|non-small cell lung cancer
670407|NCT00373204|Lung cancer|lung cancer
670408|NCT00373204|Metastatic lung cancer|metastatic lung cancer
670409|NCT00373204|Second line treatment for advanced lung cancer|second line treatment for advanced lung cancer
670410|NCT00373204|Cancer|cancer
670411|NCT00373204|Advanced lung cancer|advanced lung cancer
670412|NCT00373191|stage I breast cancer|stage i breast cancer
670413|NCT00373191|stage II breast cancer|stage ii breast cancer
670414|NCT00373191|stage IIIA breast cancer|stage iiia breast cancer
670415|NCT00373191|stage IIIB breast cancer|stage iiib breast cancer
670416|NCT00373191|stage IIIC breast cancer|stage iiic breast cancer
670417|NCT00373191|ductal breast carcinoma in situ|ductal breast carcinoma in situ
670418|NCT00373178|rosiglitazone|rosiglitazone
670419|NCT00373178|metformin|metformin
670420|NCT00373165|Renal Transplantation|renal transplantation
670421|NCT00373165|CMV|cmv
670422|NCT00373165|Ganciclovir|ganciclovir
670423|NCT00373165|Prophylaxis|prophylaxis
670424|NCT00373165|Preemptive Therapy|preemptive therapy
670425|NCT00373165|Graft Survival|graft survival
670426|NCT00373165|Proteomics|proteomics
670427|NCT00373152|stage I breast cancer|stage i breast cancer
670428|NCT00373152|stage II breast cancer|stage ii breast cancer
670429|NCT00373152|stage IIIA breast cancer|stage iiia breast cancer
670430|NCT00373152|stage IIIC breast cancer|stage iiic breast cancer
670431|NCT00373152|stage IV breast cancer|stage iv breast cancer
670432|NCT00373139|Pregnancy,|pregnancy,
670433|NCT00373139|Screening,|screening,
670434|NCT00373139|Whole Blood|whole blood
670435|NCT00373126|nicotine|nicotine
670436|NCT00373126|schizophrenia|schizophrenia
670437|NCT00373126|reward|reward
670438|NCT00373126|withdrawal|withdrawal
670439|NCT00373113|advanced breast cancer|advanced breast cancer
670440|NCT00373113|metastatic breast cancer|metastatic breast cancer
670441|NCT00373113|treatment resistant|treatment resistant
670442|NCT00373113|treatment failure|treatment failure
670443|NCT00373100|Zinc|zinc
670444|NCT00373100|placebo|placebo
670445|NCT00373100|severe pneumonia|severe pneumonia
670446|NCT00373100|children|children
670447|NCT00373087|Parkinson's disease|parkinson's disease
670448|NCT00373087|Catechol O-methyltransferase|catechol o-methyltransferase
670449|NCT00373087|Entacapone|entacapone
670450|NCT00373087|pharmacogenetic|pharmacogenetic
670451|NCT00373074|Spinal Puncture Headache|spinal puncture headache
670452|NCT00373048|HIV-1 malaria Clinical Trial|hiv-1 malaria clinical trial
670453|NCT00373035|prostate cancer|prostate cancer
670454|NCT00373022|depression|depression
670455|NCT00373022|anxiety disorder|anxiety disorder
670456|NCT00373022|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
670457|NCT00373022|stage II colon cancer|stage ii colon cancer
670458|NCT00373022|stage III colon cancer|stage iii colon cancer
670459|NCT00373022|stage II rectal cancer|stage ii rectal cancer
670460|NCT00373022|stage III rectal cancer|stage iii rectal cancer
670461|NCT00373009|Low back pain|low back pain
670462|NCT00373009|Primary prevention|primary prevention
670463|NCT00373009|Secondary prevention|secondary prevention
670464|NCT00373009|Lumbar stabilization|lumbar stabilization
670465|NCT00373009|Psychosocial education|psychosocial education
670466|NCT00372983|chronic HCV|chronic hcv
670467|NCT00372983|Failed treatment|failed treatment
670468|NCT00372983|genotype 1|genotype 1
670469|NCT00372983|failed treatment with pegylated interferon plus ribavirin|failed treatment with pegylated interferon plus ribavirin
670470|NCT00372970|gastroparesis|gastroparesis
670471|NCT00372970|vomiting|vomiting
670472|NCT00372970|nausea|nausea
670473|NCT00372970|bloating|bloating
670474|NCT00372970|dyspepsia|dyspepsia
670475|NCT00372957|pharmacodynamics|pharmacodynamics
670476|NCT00372957|Diabetes|diabetes
670477|NCT00372957|pharmacokinetics|pharmacokinetics
670478|NCT00372944|advanced pancreatic cancer|advanced pancreatic cancer
670479|NCT00372944|metastatic pancreatic cancer|metastatic pancreatic cancer
670480|NCT00372944|AZD6244|azd6244
670481|NCT00372905|follicular lymphoma|follicular lymphoma
670482|NCT00372892|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
670483|NCT00372892|Rituximab|rituximab
670484|NCT00372892|Feasibility study|feasibility study
670485|NCT00372879|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
670486|NCT00372879|vitamin E|vitamin e
670487|NCT00372879|muscle cramp|muscle cramp
670488|NCT00372840|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
670489|NCT00372840|stage I breast cancer|stage i breast cancer
670490|NCT00372840|stage II breast cancer|stage ii breast cancer
670491|NCT00372840|stage IIIA breast cancer|stage iiia breast cancer
670492|NCT00372840|stage IIIA colon cancer|stage iiia colon cancer
670493|NCT00372840|stage I prostate cancer|stage i prostate cancer
670494|NCT00372840|stage IIB prostate cancer|stage iib prostate cancer
670495|NCT00372840|stage IIA prostate cancer|stage iia prostate cancer
670496|NCT00372840|stage III prostate cancer|stage iii prostate cancer
670497|NCT00372840|stage I non-small cell lung cancer|stage i non-small cell lung cancer
670498|NCT00372840|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
670499|NCT00372840|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
670500|NCT00372840|limited stage small cell lung cancer|limited stage small cell lung cancer
670501|NCT00372840|stage I rectal cancer|stage i rectal cancer
670502|NCT00372840|stage IIA rectal cancer|stage iia rectal cancer
670503|NCT00372840|stage IIB rectal cancer|stage iib rectal cancer
670504|NCT00372840|stage IIC rectal cancer|stage iic rectal cancer
670505|NCT00372840|stage IIIA rectal cancer|stage iiia rectal cancer
670506|NCT00372840|pulmonary carcinoid tumor|pulmonary carcinoid tumor
670507|NCT00372840|stage I thymoma|stage i thymoma
670508|NCT00372840|stage II thymoma|stage ii thymoma
670509|NCT00372840|stage III thymoma|stage iii thymoma
670510|NCT00372840|stage I colon cancer|stage i colon cancer
670511|NCT00372840|stage IIA colon cancer|stage iia colon cancer
670512|NCT00372840|stage IIB colon cancer|stage iib colon cancer
670513|NCT00372840|stage IIC colon cancer|stage iic colon cancer
670514|NCT00372840|stage IA malignant mesothelioma|stage ia malignant mesothelioma
670515|NCT00372840|stage IB malignant mesothelioma|stage ib malignant mesothelioma
670516|NCT00372840|stage II malignant mesothelioma|stage ii malignant mesothelioma
670517|NCT00372840|stage III malignant mesothelioma|stage iii malignant mesothelioma
670518|NCT00372814|diabetes|diabetes
670519|NCT00372814|regimen adherence|regimen adherence
670520|NCT00372814|metabolic control|metabolic control
670521|NCT00372814|adolescents|adolescents
670522|NCT00372814|family therapy|family therapy
670523|NCT00372801|Osteoarthritis|osteoarthritis
670524|NCT00372801|Ibuprofen|ibuprofen
670525|NCT00372801|COX2|cox2
670526|NCT00372801|VAS|vas
670527|NCT00372801|knee|knee
670528|NCT00372801|single dose|single dose
670529|NCT00372788|NSCLC|nsclc
670530|NCT00372788|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
670531|NCT00372788|AZD6244|azd6244
670532|NCT00372775|brain metastases|brain metastases
670533|NCT00372775|Sunitinib|sunitinib
670534|NCT00372775|Phase 2|phase 2
670535|NCT00372762|Insulin resistance|insulin resistance
670536|NCT00372762|heart failure|heart failure
670537|NCT00372762|diuretic therapy|diuretic therapy
670538|NCT00372749|Alcohol dependence|alcohol dependence
670539|NCT00372749|Craving|craving
670540|NCT00372749|Disulfiram|disulfiram
670541|NCT00372749|Cue exposure|cue exposure
670542|NCT00372736|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
670543|NCT00372723|toxic epidermal necrlysis|toxic epidermal necrlysis
670544|NCT00372723|ten|ten
670545|NCT00372710|Breast cancer|breast cancer
670546|NCT00372710|Palliation|palliation
670547|NCT00372710|Bone metastasis|bone metastasis
670548|NCT00372710|Zoledronic acid|zoledronic acid
670549|NCT00372697|acromegaly|acromegaly
670550|NCT00372697|octreotide acetate|octreotide acetate
670551|NCT00372697|partial responder patients|partial responder patients
670552|NCT00372684|Plasmodium falciparum|plasmodium falciparum
670553|NCT00372684|Malaria|malaria
670554|NCT00372684|Imported malaria|imported malaria
670555|NCT00372684|Severe malaria|severe malaria
670556|NCT00372684|Uncomplicated malaria|uncomplicated malaria
670557|NCT00372684|Intensive Care Units|intensive care units
670558|NCT00372684|Polymorphism, Genetic|polymorphism, genetic
670559|NCT00372684|Parasitic Sensitivity Tests|parasitic sensitivity tests
670560|NCT00372684|Inflammation Mediators|inflammation mediators
670561|NCT00372671|Cardiac Rehabilitation|cardiac rehabilitation
670562|NCT00372671|Improving Cardiac Rehabilitation Participation|improving cardiac rehabilitation participation
670563|NCT00372658|hysterosalpingogram|hysterosalpingogram
670564|NCT00372658|intracervical local anesthesia|intracervical local anesthesia
670565|NCT00372658|pain perception|pain perception
670566|NCT00372658|visual analogue scale|visual analogue scale
670567|NCT00372645|Healthy|healthy
670568|NCT00372632|Pregnancy malaria prevention|pregnancy malaria prevention
670569|NCT00372619|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
670570|NCT00372619|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
670571|NCT00372619|acute undifferentiated leukemia|acute undifferentiated leukemia
670572|NCT00372619|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
670573|NCT00372619|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
670574|NCT00372619|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
670575|NCT00372619|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
670576|NCT00372619|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
670577|NCT00372619|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
670578|NCT00372619|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
670579|NCT00372619|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
670580|NCT00372619|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
670581|NCT00372619|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
670582|NCT00372619|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
670583|NCT00372619|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
670584|NCT00372619|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
670585|NCT00372619|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
670586|NCT00372619|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
670587|NCT00372619|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
670588|NCT00372619|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
670589|NCT00372619|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
670590|NCT00372619|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
670591|NCT00372606|Obesity|obesity
670592|NCT00372606|Overweight|overweight
670593|NCT00372606|Hispanics|hispanics
670594|NCT00372606|Online|online
670595|NCT00372606|Weight Loss|weight loss
670596|NCT00372593|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
670597|NCT00372593|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
670598|NCT00372593|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
670599|NCT00372593|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
670600|NCT00372593|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
670601|NCT00372593|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
670602|NCT00372593|adult acute basophilic leukemia|adult acute basophilic leukemia
670603|NCT00372593|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
670604|NCT00372593|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
670605|NCT00372593|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
670606|NCT00372593|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
670607|NCT00372593|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
670608|NCT00372593|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
670609|NCT00372593|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
670610|NCT00372593|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
670611|NCT00372593|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
670612|NCT00372593|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
670613|NCT00372593|childhood acute basophilic leukemia|childhood acute basophilic leukemia
670614|NCT00372593|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
670615|NCT00372593|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
670616|NCT00372593|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
670617|NCT00372593|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
670618|NCT00372593|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
670619|NCT00372593|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
670620|NCT00372593|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
670621|NCT00372593|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
670622|NCT00372593|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
670623|NCT00372541|ceftriaxone|ceftriaxone
670624|NCT00372541|chloramphenicol|chloramphenicol
670625|NCT00372541|severe pneumonia|severe pneumonia
670626|NCT00372541|children|children
670627|NCT00372515|epidermal growth factor|epidermal growth factor
670628|NCT00372515|EGFR|egfr
670629|NCT00372515|lung cancer|lung cancer
670630|NCT00372515|Iressa|iressa
670631|NCT00372515|Gefitinib|gefitinib
670632|NCT00372502|sepsis|sepsis
670633|NCT00372502|shock|shock
670634|NCT00372502|emergency department|emergency department
670635|NCT00372502|resuscitation|resuscitation
670636|NCT00372489|anemia|anemia
670637|NCT00372489|chronic kidney disease|chronic kidney disease
670638|NCT00372489|CKD|ckd
670639|NCT00372489|chronic renal failure|chronic renal failure
670640|NCT00372489|CRF|crf
670641|NCT00372489|dialysis|dialysis
670642|NCT00372489|erythropoietin|erythropoietin
670643|NCT00372489|EPO|epo
670644|NCT00372489|erythropoiesis stimulating agent|erythropoiesis stimulating agent
670645|NCT00372489|ESA|esa
670646|NCT00372489|Hematide™|hematide™
670647|NCT00372489|hemodialysis|hemodialysis
670648|NCT00372489|hemoglobin|hemoglobin
670649|NCT00372489|Hb|hb
670650|NCT00372489|Hgb|hgb
670651|NCT00372489|Omontys|omontys
670652|NCT00372489|peginesatide|peginesatide
670653|NCT00372489|red blood cell|red blood cell
670654|NCT00372489|red blood cell production|red blood cell production
670655|NCT00372476|Breast cancer|breast cancer
670656|NCT00372476|Tyrosine inhibitor|tyrosine inhibitor
670657|NCT00372476|Chemotherapy|chemotherapy
670658|NCT00372476|Imatinib|imatinib
670659|NCT00372463|diabetes|diabetes
670660|NCT00372463|type 2 diabetes|type 2 diabetes
670661|NCT00372463|type II diabetes|type ii diabetes
670662|NCT00372463|diabetes mellitus|diabetes mellitus
670663|NCT00372463|diabetes type 2|diabetes type 2
670664|NCT00372463|diabetes type II|diabetes type ii
670665|NCT00372463|diabetes education|diabetes education
670666|NCT00372463|patient education|patient education
670667|NCT00372463|workshop|workshop
670668|NCT00372463|class|class
670669|NCT00372463|education|education
670670|NCT00372463|online|online
670671|NCT00372463|on-line|on-line
670672|NCT00372463|internet|internet
670673|NCT00372463|web|web
670674|NCT00372450|recurrent esophageal cancer|recurrent esophageal cancer
670675|NCT00372450|stage III esophageal cancer|stage iii esophageal cancer
670676|NCT00372450|stage IV esophageal cancer|stage iv esophageal cancer
670677|NCT00372450|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
670678|NCT00372450|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
670679|NCT00372450|gastrointestinal complications|gastrointestinal complications
670680|NCT00372437|Refractory solid tumors|refractory solid tumors
670681|NCT00372437|Phase I/II|phase i/ii
670682|NCT00372437|Refractory and solid tumors|refractory and solid tumors
670683|NCT00372424|Breast cancer over-expressing HER2. First-line treatment with sunitinib/docetaxel/trastuzumab.|breast cancer over-expressing her2. first-line treatment with sunitinib/docetaxel/trastuzumab.
670684|NCT00372411|Stroke|stroke
670685|NCT00372411|Rehabilitation|rehabilitation
670686|NCT00372411|Single-blind|single-blind
670687|NCT00372411|Clinical Trial|clinical trial
670688|NCT00372411|Randomized controlled trial|randomized controlled trial
670689|NCT00372411|Upper extremity|upper extremity
670690|NCT00372411|Robotics|robotics
670691|NCT00372398|scleroderma|scleroderma
670692|NCT00372398|sclerosis|sclerosis
670693|NCT00372398|atherosclerosis|atherosclerosis
670694|NCT00372372|corticosteroids, bone mineral, risedronate, bisphosphonate|corticosteroids, bone mineral, risedronate, bisphosphonate
670695|NCT00372359|Attention Deficit Disorder|attention deficit disorder
670696|NCT00372359|Hyperactivity|hyperactivity
670697|NCT00372359|Methylphenidate|methylphenidate
670698|NCT00372333|musculoskeletal pain; soft tissue inflammation; IDEA-033|musculoskeletal pain; soft tissue inflammation; idea-033
670699|NCT00372320|Adenovirus|adenovirus
670700|NCT00372320|Aquaporin-1|aquaporin-1
670701|NCT00372320|Gene Transfer|gene transfer
670702|NCT00372320|Radiation-Induced Salivary Hypofunction|radiation-induced salivary hypofunction
670703|NCT00372320|Salivary Gland|salivary gland
670704|NCT00372320|Xerostomia|xerostomia
670705|NCT00372320|Salivary Dysfunction|salivary dysfunction
670706|NCT00372320|Hyposalivation|hyposalivation
670707|NCT00372320|Dry mouth|dry mouth
670708|NCT00372320|head and neck cancer|head and neck cancer
670709|NCT00372320|side effects radiation damage|side effects radiation damage
670710|NCT00372294|Toxoplasmosis|toxoplasmosis
670711|NCT00372294|Chorioretinitis|chorioretinitis
670712|NCT00372294|Intravitreal Clindamycin|intravitreal clindamycin
670713|NCT00372294|Dexamethasone in chorioretinitis|dexamethasone in chorioretinitis
670714|NCT00372294|Toxoplasmic|toxoplasmic
670715|NCT00372281|MRI, CLIAVIST, MACROPHAGE, INFECTION, SPINE|mri, cliavist, macrophage, infection, spine
670716|NCT00372268|Comparison of four conditionings of the insufflated gas during laparoscopy and their consequences on the core temperature and the post-operative pain.|comparison of four conditionings of the insufflated gas during laparoscopy and their consequences on the core temperature and the post-operative pain.
670717|NCT00372268|Women with womb pathology needing laparoscopic surgery|women with womb pathology needing laparoscopic surgery
670718|NCT00372268|No emergency|no emergency
670719|NCT00372268|Aged over 18 years|aged over 18 years
670720|NCT00372242|Mal-nutrition|mal-nutrition
670721|NCT00372242|Morbidity|morbidity
670722|NCT00372242|Nutrition Education|nutrition education
670723|NCT00372242|Complementary Feeding|complementary feeding
670724|NCT00372242|Weight gain|weight gain
670725|NCT00372242|Height|height
670726|NCT00372216|myocardial infarction|myocardial infarction
670727|NCT00372216|Clopidogrel|clopidogrel
670728|NCT00372216|primary PCI|primary pci
670729|NCT00372216|TIMI-flow|timi-flow
670730|NCT00372216|STEMI within 6 hrs.|stemi within 6 hrs.
670731|NCT00372203|Non-small cell lung cancer|non-small cell lung cancer
670732|NCT00372203|NSCLC|nsclc
670733|NCT00372203|EBUS|ebus
670734|NCT00372203|Endobronchial ultrasound|endobronchial ultrasound
670735|NCT00372203|mediastinoscopy|mediastinoscopy
670736|NCT00372190|Pelvic organ prolapse|pelvic organ prolapse
670737|NCT00372190|recurrence|recurrence
670738|NCT00372190|mesh|mesh
670739|NCT00372190|complications|complications
670740|NCT00372190|treatment|treatment
670741|NCT00372177|monoclonal antibody|monoclonal antibody
670742|NCT00372177|diagnostics|diagnostics
670743|NCT00372177|RA|ra
670744|NCT00372177|Immunoglobulins|immunoglobulins
670745|NCT00372177|molecular target|molecular target
670746|NCT00372177|Tc99m-pertechnetate|tc99m-pertechnetate
670747|NCT00372177|Fab-fragment of Anti-human CD4|fab-fragment of anti-human cd4
670748|NCT00372177|Radiopharmaceutical|radiopharmaceutical
670749|NCT00372177|chronic inflammatory diseases|chronic inflammatory diseases
670750|NCT00372177|active Rheumatoid Arthritis|active rheumatoid arthritis
670751|NCT00372164|ASIPP|asipp
670752|NCT00372164|Guidelines|guidelines
670753|NCT00372151|Schizophrenia|schizophrenia
670754|NCT00372151|Schizoaffective disorders|schizoaffective disorders
670755|NCT00372151|Theonine|theonine
670756|NCT00372151|Augmentation|augmentation
670757|NCT00372138|Abdominal aortic aneurysms|abdominal aortic aneurysms
670758|NCT00372138|Endoleaks|endoleaks
670759|NCT00372138|Prevention|prevention
670760|NCT00372125|Prader-Willi syndrome|prader-willi syndrome
670761|NCT00372125|Growth hormone|growth hormone
670762|NCT00372125|Body composition|body composition
670763|NCT00372112|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
670764|NCT00372112|COPD|copd
670765|NCT00372099|Postmenopausal women|postmenopausal women
670766|NCT00372099|bone microarchitecture|bone microarchitecture
670767|NCT00372099|peripheral quantitative micro-CT|peripheral quantitative micro-ct
670768|NCT00372099|salmon calcitonin|salmon calcitonin
670769|NCT00372034|contact lenses|contact lenses
670770|NCT00372034|intolerance|intolerance
670771|NCT00372034|punctal plugs|punctal plugs
670772|NCT00372034|tear volume|tear volume
670773|NCT00372034|Intolerance to contact lens wear due to dryness symptoms|intolerance to contact lens wear due to dryness symptoms
670774|NCT00372021|non arthritic ischemic optic neuropathy|non arthritic ischemic optic neuropathy
670775|NCT00372021|anterior ischemic optic neuropathy|anterior ischemic optic neuropathy
670776|NCT00372021|Optic nerve Neurotomy|optic nerve neurotomy
670777|NCT00371995|Visceral leishmaniasis|visceral leishmaniasis
670778|NCT00371995|kala-azar|kala-azar
670779|NCT00371995|miltefosine|miltefosine
670780|NCT00371995|AmBisome|ambisome
670781|NCT00371982|Fish oil|fish oil
670782|NCT00371982|Type 2 diabetic women|type 2 diabetic women
670783|NCT00371982|adiposity|adiposity
670784|NCT00371982|adipose tissue inflammation|adipose tissue inflammation
670785|NCT00371982|PAI-1|pai-1
670786|NCT00371982|Insulin sensitivity|insulin sensitivity
670787|NCT00371969|Unsafe drinking|unsafe drinking
670788|NCT00371969|Human Immunodeficiency Virus|human immunodeficiency virus
670789|NCT00371969|Motivational Interviewing|motivational interviewing
670790|NCT00371956|raloxifene|raloxifene
670791|NCT00371956|estrogen|estrogen
670792|NCT00371956|receptor|receptor
670793|NCT00371956|modulation|modulation
670794|NCT00371956|osteoporosis|osteoporosis
670795|NCT00371956|steroid|steroid
670796|NCT00371956|Steroids|steroids
670797|NCT00371943|variceal bleeding,band ligation, beta-blocker|variceal bleeding,band ligation, beta-blocker
670798|NCT00371943|had history of esophageal variceal bleeding|had history of esophageal variceal bleeding
670799|NCT00371904|Rituximab|rituximab
670800|NCT00371904|donor|donor
670801|NCT00371904|sensitised|sensitised
670802|NCT00371904|antibody|antibody
670803|NCT00371904|rejection|rejection
670804|NCT00371878|Vaccine|vaccine
670805|NCT00371878|Lung|lung
670806|NCT00371878|Bronchoalveolar lavage|bronchoalveolar lavage
670807|NCT00371878|Lymphocyte|lymphocyte
670808|NCT00371878|Immunoglobulin|immunoglobulin
670809|NCT00371878|HIV|hiv
671005|NCT00371020|5-FU|5-fu
670810|NCT00371878|Streptococcus pneumoniae|streptococcus pneumoniae
670811|NCT00371878|Conjugate vaccine|conjugate vaccine
670812|NCT00371865|Behavior therapy|behavior therapy
670813|NCT00371865|Chronic pain|chronic pain
670814|NCT00371865|Cognitive therapy|cognitive therapy
670815|NCT00371865|Meditation|meditation
670816|NCT00371865|Mindfulness|mindfulness
670817|NCT00371865|Psychotherapy|psychotherapy
670818|NCT00371839|Hearing Loss|hearing loss
670819|NCT00371839|Hearing Aids|hearing aids
670820|NCT00371839|Rehabilitation of hearing impaired|rehabilitation of hearing impaired
670821|NCT00371826|Renal transplantation|renal transplantation
670822|NCT00371826|everolimus|everolimus
670823|NCT00371826|Immunosuppressants|immunosuppressants
670824|NCT00371800|Cinnamon|cinnamon
670825|NCT00371800|Type 1 Diabetes|type 1 diabetes
670826|NCT00371800|Adolescent|adolescent
670827|NCT00371800|HbA1c|hba1c
670828|NCT00371774|Psoriasis|psoriasis
670829|NCT00371774|Plaque Psoriasis|plaque psoriasis
670830|NCT00371774|Amevive®|amevive®
670831|NCT00371774|alefacept|alefacept
670832|NCT00371761|Hepatitis B virus|hepatitis b virus
670833|NCT00371761|Pegylated interferon alfa-2b (PegIntron)|pegylated interferon alfa-2b (pegintron)
670834|NCT00371735|Malaria CDA LAPDAP Africa|malaria cda lapdap africa
670835|NCT00371722|Cesarean section|cesarean section
670836|NCT00371722|Appendectomy|appendectomy
670837|NCT00371683|Prevention of deep vein thrombosis and pulmonary embolism after total knee replacement surgery|prevention of deep vein thrombosis and pulmonary embolism after total knee replacement surgery
670838|NCT00371670|Knee, osteoarthritis, pain, disease modifying|knee, osteoarthritis, pain, disease modifying
670839|NCT00371657|obesity|obesity
670840|NCT00371657|small for gestation age|small for gestation age
670841|NCT00371657|intrauterine growth restriction|intrauterine growth restriction
670842|NCT00371644|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
670843|NCT00371644|Cognitive Processing Therapy|cognitive processing therapy
670844|NCT00371644|Military sexual trauma|military sexual trauma
670845|NCT00371644|Psychology, Military|psychology, military
670846|NCT00371644|Veterans|veterans
670847|NCT00371644|Rape|rape
670848|NCT00371644|Veterans, psychology|veterans, psychology
670849|NCT00371644|Healthcare utilization|healthcare utilization
670850|NCT00371631|biofilm|biofilm
670851|NCT00371631|clinical trial|clinical trial
670852|NCT00371631|Escherichia coli|escherichia coli
670853|NCT00371631|urinary catheter|urinary catheter
670854|NCT00371618|Fluoroscopy|fluoroscopy
670855|NCT00371618|Interventional Pain Management Procedures|interventional pain management procedures
670856|NCT00371605|Voriconazole|voriconazole
670857|NCT00371605|Liver Transplant|liver transplant
670858|NCT00371605|Fungal Infection|fungal infection
670859|NCT00371592|Treatment Naive|treatment naive
670860|NCT00371579|rosuvastatin|rosuvastatin
670861|NCT00371579|hepatitis C|hepatitis c
670862|NCT00371579|geranylgeranylation|geranylgeranylation
670863|NCT00371579|HCV-RNA load|hcv-rna load
670864|NCT00371566|squamous cell carcinoma of head and neck|squamous cell carcinoma of head and neck
670865|NCT00371566|lapatinib|lapatinib
670866|NCT00371566|ErbB1/ErbB2 inhibitor|erbb1/erbb2 inhibitor
670867|NCT00371566|apoptosis|apoptosis
670868|NCT00371553|relapsed or cisplatin-refractory germ cell cancer|relapsed or cisplatin-refractory germ cell cancer
670869|NCT00371553|germ cell cancer|germ cell cancer
670870|NCT00371553|SU011248 (Sunitinib)|su011248 (sunitinib)
670871|NCT00371540|Africa|africa
670872|NCT00371540|Antiretrovirals|antiretrovirals
670873|NCT00371527|Bronchitis|bronchitis
670874|NCT00371527|Acute bronchitis|acute bronchitis
670875|NCT00371527|Ipratropium|ipratropium
670876|NCT00371527|Cough|cough
670877|NCT00371527|Metered dose inhaler|metered dose inhaler
670878|NCT00371527|Antibiotic prescriptions|antibiotic prescriptions
670879|NCT00371527|Sputum production|sputum production
670880|NCT00371501|lupus|lupus
670881|NCT00371501|atherosclerosis|atherosclerosis
670882|NCT00371501|thrombosis|thrombosis
670883|NCT00371501|statin|statin
670884|NCT00371501|lipid|lipid
670885|NCT00371488|ErbB2|erbb2
670886|NCT00371488|Stage IV breast cancer|stage iv breast cancer
670887|NCT00371488|ErbB1|erbb1
670888|NCT00371488|breast cancer|breast cancer
670889|NCT00371488|lapatinib|lapatinib
670890|NCT00371488|Herceptin|herceptin
670891|NCT00371488|trastuzumab|trastuzumab
670892|NCT00371462|intervention study|intervention study
670893|NCT00371462|technology|technology
670894|NCT00371462|weight loss|weight loss
670895|NCT00371449|hearing loss|hearing loss
670896|NCT00371449|hearing aids|hearing aids
670897|NCT00371436|Counseling|counseling
670898|NCT00371436|Education|education
670899|NCT00371436|Evaluation studies|evaluation studies
670900|NCT00371436|Quality of health care|quality of health care
670901|NCT00371436|Rehabilitation of hearing impaired|rehabilitation of hearing impaired
670902|NCT00371436|Triage|triage
670903|NCT00371410|Vitrectomy|vitrectomy
670904|NCT00371410|Intravitreal triamcinolone acetonide|intravitreal triamcinolone acetonide
670905|NCT00371410|Macular focal laser photocoagulation|macular focal laser photocoagulation
670906|NCT00371410|Best-corrected visual acuity|best-corrected visual acuity
670907|NCT00371410|Central macular thickness|central macular thickness
670908|NCT00371397|yoga|yoga
670909|NCT00371397|immune function|immune function
670910|NCT00371397|stress|stress
670911|NCT00371397|health|health
670912|NCT00371397|mood|mood
670913|NCT00371397|skin barrier repair|skin barrier repair
670914|NCT00371384|massage|massage
670915|NCT00371384|back pain|back pain
670916|NCT00371384|effectiveness|effectiveness
670917|NCT00371371|clinical trial|clinical trial
670918|NCT00371371|chronic critical limb ischemia|chronic critical limb ischemia
670919|NCT00371371|leg pain|leg pain
670920|NCT00371371|cell therapy|cell therapy
670921|NCT00371371|bone marrow|bone marrow
670922|NCT00371371|mononuclear|mononuclear
670923|NCT00371371|progenitor cell|progenitor cell
670924|NCT00371371|stem cell|stem cell
670925|NCT00371371|critical limb ischemia|critical limb ischemia
670926|NCT00371371|nonhealing leg ulcer|nonhealing leg ulcer
670927|NCT00371345|Recurrent, locally-advanced, or metastatic breast cancer|recurrent, locally-advanced, or metastatic breast cancer
670928|NCT00371332|chronic periodontitis, mouth|chronic periodontitis, mouth
670929|NCT00371332|Moderate to advanced chronic periodontitis|moderate to advanced chronic periodontitis
670930|NCT00371319|lupus|lupus
670931|NCT00371319|nephritis|nephritis
670932|NCT00371319|tacrolimus|tacrolimus
670933|NCT00371319|mycophenolate mofetil|mycophenolate mofetil
670934|NCT00371306|Diabetes|diabetes
670935|NCT00371306|Pregnancy|pregnancy
670936|NCT00371293|Sleep Apnea|sleep apnea
670937|NCT00371293|C-Reactive Protein|c-reactive protein
670938|NCT00371293|Obesity|obesity
670939|NCT00371293|Insulin Resistance|insulin resistance
670940|NCT00371293|Arterial stiffness|arterial stiffness
670941|NCT00371280|hydroxyapatite|hydroxyapatite
670942|NCT00371280|peg|peg
670943|NCT00371280|prosthetic motility|prosthetic motility
670944|NCT00371280|orbital implant|orbital implant
670945|NCT00371267|cognitive behavioral therapy|cognitive behavioral therapy
670946|NCT00371267|pain|pain
670947|NCT00371254|Recurrent, locally-advanced, or 'triple negative' metastatic breast cancer|recurrent, locally-advanced, or 'triple negative' metastatic breast cancer
670948|NCT00371241|ECMO|ecmo
670949|NCT00371241|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
670950|NCT00371241|cytokines|cytokines
670951|NCT00371241|chemokines|chemokines
670952|NCT00371228|cord clamping|cord clamping
670953|NCT00371228|hematocrit|hematocrit
670954|NCT00371228|hemoglobin|hemoglobin
670955|NCT00371228|timing|timing
670956|NCT00371215|hemostasis|hemostasis
670957|NCT00371215|grafting, skin|grafting, skin
670958|NCT00371215|hemostatics|hemostatics
670959|NCT00371215|phase 2|phase 2
670960|NCT00371202|keratoconus, penetrating keratoplasty,|keratoconus, penetrating keratoplasty,
670961|NCT00371202|deep lamellar keratoplasty|deep lamellar keratoplasty
670962|NCT00371202|big bubble technique|big bubble technique
670963|NCT00371189|circumsporozoite, malaria, vaccine|circumsporozoite, malaria, vaccine
670964|NCT00371176|Cognitive Behavior Therapy|cognitive behavior therapy
670965|NCT00371176|Cognitive enhancers|cognitive enhancers
670966|NCT00371176|Combat Disorders|combat disorders
670967|NCT00371176|D-Cycloserine|d-cycloserine
670968|NCT00371176|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
670969|NCT00371163|Identification of genes by microarray analyses.|identification of genes by microarray analyses.
670970|NCT00371137|FMS|fms
670971|NCT00371137|Fibro|fibro
670972|NCT00371137|pain|pain
670973|NCT00371137|Body pain|body pain
670974|NCT00371137|tenderness|tenderness
670975|NCT00371137|joint pain|joint pain
670976|NCT00371137|stiffness|stiffness
670977|NCT00371137|muscular pain|muscular pain
670978|NCT00371124|Myopia treatment|myopia treatment
670979|NCT00371124|Atropine|atropine
670980|NCT00371111|Resistant uveitic cystoid macular edema|resistant uveitic cystoid macular edema
670981|NCT00371111|intravitreal triamcinolone|intravitreal triamcinolone
670982|NCT00371111|intravitreal bevacizumab|intravitreal bevacizumab
670983|NCT00371098|influenza vaccination|influenza vaccination
670984|NCT00371098|coronary artery disease|coronary artery disease
670985|NCT00371098|prevention|prevention
670986|NCT00371098|acute coronary syndromes|acute coronary syndromes
670987|NCT00371085|heart failure|heart failure
670988|NCT00371085|quality improvement|quality improvement
670989|NCT00371085|patient education|patient education
670990|NCT00371085|health care economics|health care economics
670991|NCT00371072|Aphakic Glaucoma|aphakic glaucoma
670992|NCT00371072|trabeculectomy with mitomycin- C|trabeculectomy with mitomycin- c
670993|NCT00371072|Ahmed glaucoma implant|ahmed glaucoma implant
670994|NCT00371059|Agitation|agitation
670995|NCT00371059|Dementia|dementia
670996|NCT00371059|Alzheimer's|alzheimer's
670997|NCT00371046|preterm labor|preterm labor
670998|NCT00371046|transvaginal ultrasound cervical length|transvaginal ultrasound cervical length
670999|NCT00371046|fetal fibronectin|fetal fibronectin
671000|NCT00371046|preterm birth|preterm birth
671001|NCT00371020|silicone oil|silicone oil
671002|NCT00371020|PVR|pvr
671003|NCT00371020|retinal redetachment|retinal redetachment
671004|NCT00371020|low molecular weight heparin|low molecular weight heparin
671006|NCT00370994|post-lumbar surgery syndrome|post-lumbar surgery syndrome
671007|NCT00370994|percutaneous lumbar epidural adhesiolysis|percutaneous lumbar epidural adhesiolysis
671008|NCT00370994|hypertonic saline neurolysis|hypertonic saline neurolysis
671009|NCT00370981|investigational drug|investigational drug
671010|NCT00370981|ejaculation|ejaculation
671011|NCT00370968|Children|children
671012|NCT00370968|India|india
671013|NCT00370968|Hospital|hospital
671014|NCT00370968|Zinc|zinc
671015|NCT00370968|Malnutrition|malnutrition
671016|NCT00370968|Treatment|treatment
671017|NCT00370955|Phacoemulsification|phacoemulsification
671018|NCT00370955|Corneal endothelial cell loss|corneal endothelial cell loss
671019|NCT00370955|Hydrodynamic parameters|hydrodynamic parameters
671020|NCT00370955|Total ultrasound energy|total ultrasound energy
671021|NCT00370955|Total infused fluids|total infused fluids
671022|NCT00370942|GW823093C|gw823093c
671023|NCT00370942|diabetes|diabetes
671024|NCT00370942|type 2 diabetes mellitus|type 2 diabetes mellitus
671025|NCT00370942|DPP-IV inhibitor|dpp-iv inhibitor
671026|NCT00370916|Clinical Decision Support Systems|clinical decision support systems
671027|NCT00370916|Continuity of Patient Care|continuity of patient care
671028|NCT00370916|Medication Errors|medication errors
671029|NCT00370916|Drug Adverse Effects|drug adverse effects
671030|NCT00370903|cesarean|cesarean
671031|NCT00370903|planned|planned
671032|NCT00370903|emergent|emergent
671033|NCT00370903|postpartum depression|postpartum depression
671034|NCT00370890|nasopharyngeal cancer|nasopharyngeal cancer
671035|NCT00370890|adjuvant chemotherapy|adjuvant chemotherapy
671036|NCT00370890|EBV DNA|ebv dna
671037|NCT00370890|PET CT scan|pet ct scan
671038|NCT00370877|Post-partum hemorrhage|post-partum hemorrhage
671039|NCT00370877|Arterial embolization|arterial embolization
671040|NCT00370877|Surgery|surgery
671041|NCT00370877|Hysterectomy|hysterectomy
671042|NCT00370877|Activated recombinant human factor VII|activated recombinant human factor vii
671043|NCT00370864|Pandemic|pandemic
671044|NCT00370864|Influenza|influenza
671045|NCT00370864|Prevention|prevention
671046|NCT00370864|Vaccine|vaccine
671047|NCT00370864|Prevention of Pandemic Influenza|prevention of pandemic influenza
671048|NCT00370851|intravitreal Avastin|intravitreal avastin
671049|NCT00370851|BRVO|brvo
671050|NCT00370851|Macular edema|macular edema
671051|NCT00370838|Tics|tics
671052|NCT00370838|Tourette syndrome|tourette syndrome
671053|NCT00370838|levetiracetam|levetiracetam
671054|NCT00370838|clonidine|clonidine
671055|NCT00370825|Visceral leishmaniasis|visceral leishmaniasis
671056|NCT00370825|miltefosine|miltefosine
671057|NCT00370825|AmBisome|ambisome
671058|NCT00370825|Combination|combination
671059|NCT00370812|amniotic membrane transplantation|amniotic membrane transplantation
671060|NCT00370812|ocular chemical burns|ocular chemical burns
671061|NCT00370799|Caudal Epidural injections|caudal epidural injections
671062|NCT00370799|lumbar disc herniation|lumbar disc herniation
671063|NCT00370799|spinal stenosis|spinal stenosis
671064|NCT00370799|discogenic pain|discogenic pain
671065|NCT00370799|post-lumbar laminectomy syndrome|post-lumbar laminectomy syndrome
671066|NCT00370786|Choroidal neovascularization (CNV)|choroidal neovascularization (cnv)
671067|NCT00370786|Bevacizumab|bevacizumab
671068|NCT00370786|Non AMD|non amd
671069|NCT00370786|High myopia|high myopia
671070|NCT00370786|angioid streaks|angioid streaks
671071|NCT00370786|Ocular histoplasmosis|ocular histoplasmosis
671072|NCT00370786|Idiopathic|idiopathic
671073|NCT00370773|Failed Back Surgery Syndrome|failed back surgery syndrome
671074|NCT00370773|Back Pain|back pain
671075|NCT00370773|Chronic Pain|chronic pain
671076|NCT00370773|Spinal Cord Stimulation|spinal cord stimulation
671077|NCT00370760|PVR|pvr
671078|NCT00370760|Oral colchicine|oral colchicine
671079|NCT00370760|Dexamethasone|dexamethasone
671080|NCT00370760|low molecular weight heparin|low molecular weight heparin
671081|NCT00370760|5-FU|5-fu
671082|NCT00370734|botulinum toxin|botulinum toxin
671083|NCT00370734|thyroid eye disease|thyroid eye disease
671084|NCT00370734|lid retraction|lid retraction
671085|NCT00370721|Proliferative diabetic retinopathy(PDR)|proliferative diabetic retinopathy(pdr)
671086|NCT00370721|Pan retinal photocoagulation (PRP)|pan retinal photocoagulation (prp)
671087|NCT00370721|Vitreous hemorrhage|vitreous hemorrhage
671088|NCT00370721|Traction retinal detachment|traction retinal detachment
671089|NCT00370721|Neovascularization on disc (NVD)|neovascularization on disc (nvd)
671090|NCT00370721|Neovascularization elsewhere (NVE)|neovascularization elsewhere (nve)
671091|NCT00370721|Fibrous proliferation on disc (FPD)|fibrous proliferation on disc (fpd)
671092|NCT00370721|Fibrous proliferaiton elsewhere (FPE)|fibrous proliferaiton elsewhere (fpe)
671093|NCT00370708|Cesarean|cesarean
671094|NCT00370708|Oral|oral
671095|NCT00370708|Intake|intake
671096|NCT00370695|Chronic back pain|chronic back pain
671097|NCT00370695|Intractable neuropathic back pain|intractable neuropathic back pain
671098|NCT00370695|Lumbar radiculopathy|lumbar radiculopathy
671099|NCT00370695|Spinal cord stimulation|spinal cord stimulation
671100|NCT00370669|Bevacizumab|bevacizumab
671101|NCT00370669|CSME|csme
671102|NCT00370669|MPC|mpc
671103|NCT00370669|Triamcinolone acetonide|triamcinolone acetonide
671104|NCT00370656|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
671105|NCT00370643|hyperglycaemia|hyperglycaemia
671106|NCT00370643|open heart surgery|open heart surgery
671107|NCT00370643|intensive care unit|intensive care unit
671108|NCT00370630|CRVO|crvo
671109|NCT00370630|Intravitreal Avastin|intravitreal avastin
671110|NCT00370630|Intravitreal triamcinolone|intravitreal triamcinolone
671111|NCT00370617|chronic hepatitis C|chronic hepatitis c
671112|NCT00370617|insulin resistance|insulin resistance
671113|NCT00370617|therapy|therapy
671114|NCT00370604|Parturient|parturient
671115|NCT00370604|Obstetrics|obstetrics
671116|NCT00370604|Pregnancy|pregnancy
671117|NCT00370604|Labour|labour
671118|NCT00370604|Labor|labor
671119|NCT00370604|Headache|headache
671120|NCT00370604|Epidural|epidural
671121|NCT00370604|Analgesia|analgesia
671122|NCT00370604|Anesthesia|anesthesia
671123|NCT00370604|Anaesthesia|anaesthesia
671124|NCT00370591|Inhaled corticosteroids|inhaled corticosteroids
671125|NCT00370591|Asthma|asthma
671126|NCT00370578|STEMI, THROMBUS, ASPIRATION DEVICE, NO REFLOW|stemi, thrombus, aspiration device, no reflow
671127|NCT00370539|Photodynamic therapy,|photodynamic therapy,
671128|NCT00370539|Bevacizumab,|bevacizumab,
671129|NCT00370539|Triamcinolone,|triamcinolone,
671130|NCT00370539|Age-related macular degeneration,|age-related macular degeneration,
671131|NCT00370539|Choroidal neovascular membrane|choroidal neovascular membrane
671132|NCT00370526|heart failure|heart failure
671133|NCT00370526|resynchronization|resynchronization
671134|NCT00370526|CRT|crt
671135|NCT00370526|Bi-V pacemaker|bi-v pacemaker
671136|NCT00370526|LV lead placement|lv lead placement
671137|NCT00370526|hemodynamic assessment|hemodynamic assessment
671138|NCT00370526|CRT Outcomes|crt outcomes
671139|NCT00370513|pazopanib|pazopanib
671140|NCT00370513|liver cancer|liver cancer
671141|NCT00370513|hepatocellular cancer|hepatocellular cancer
671142|NCT00370500|Schizophrenia|schizophrenia
671143|NCT00370500|Dopamine transporter gene|dopamine transporter gene
671144|NCT00370500|DNA methylation|dna methylation
671145|NCT00370500|Epigenetics|epigenetics
671146|NCT00370487|Abortion|abortion
671147|NCT00370487|Midlevel providers|midlevel providers
671148|NCT00370487|South Africa|south africa
671149|NCT00370487|Viet Nam|viet nam
671150|NCT00370474|Bi-V lead|bi-v lead
671151|NCT00370474|Magnetic Navigation|magnetic navigation
671152|NCT00370474|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
671153|NCT00370461|Basic Cardiac Life Support|basic cardiac life support
671154|NCT00370461|Termination of Resuscitation|termination of resuscitation
671155|NCT00370461|Emergency Medical Services|emergency medical services
671156|NCT00370461|Primary Care Paramedics|primary care paramedics
671157|NCT00370461|Out of Hospital Cardiac Arrest|out of hospital cardiac arrest
671158|NCT00370435|rheumatoid arthritis|rheumatoid arthritis
671159|NCT00370435|safety|safety
671160|NCT00370435|GW274150|gw274150
671161|NCT00370435|pharmacokinetics|pharmacokinetics
671162|NCT00370435|tolerability|tolerability
671163|NCT00370422|Cystoid macular edema|cystoid macular edema
671164|NCT00370422|Diabetic macular edema|diabetic macular edema
671165|NCT00370422|Hard exudates|hard exudates
671166|NCT00370422|Intravitreal bevacizumab|intravitreal bevacizumab
671167|NCT00370422|Intravitreal triamcinolone|intravitreal triamcinolone
671168|NCT00370422|Macular thickness|macular thickness
671169|NCT00370409|Rebleeding|rebleeding
671170|NCT00370409|Diabetic vitreous hemorrhage|diabetic vitreous hemorrhage
671171|NCT00370409|Cryotherapy|cryotherapy
671172|NCT00370396|Streptococcus pneumonia, pneumococcal conjugate vaccine|streptococcus pneumonia, pneumococcal conjugate vaccine
671173|NCT00370383|Non Small Cell Lung Cancer|non small cell lung cancer
671174|NCT00370383|PATIENTS ≥ 70 YEARS WITH UNRESECTABLE STAGE 3 OR 4 NSCLC|patients ≥ 70 years with unresectable stage 3 or 4 nsclc
671175|NCT00370370|Bevacizumab,|bevacizumab,
671176|NCT00370370|Triamcinolone|triamcinolone
671177|NCT00370370|Age-related macular degeneration|age-related macular degeneration
671178|NCT00370370|Choroidal neovascular membrane|choroidal neovascular membrane
671179|NCT00370357|Microbicide|microbicide
671180|NCT00370357|SPL7013|spl7013
671181|NCT00370357|VivaGel|vivagel
671182|NCT00370344|Gallbladder diseases|gallbladder diseases
671183|NCT00370344|gallstones|gallstones
671184|NCT00370344|cholecystectomy|cholecystectomy
671185|NCT00370344|minilaparotomy|minilaparotomy
671186|NCT00370344|laparoscopy|laparoscopy
671187|NCT00370331|ITP|itp
671188|NCT00370331|idiopathic|idiopathic
671189|NCT00370331|platelets|platelets
671190|NCT00370331|purpura|purpura
671191|NCT00370331|thrombocytopenia|thrombocytopenia
671192|NCT00370331|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
671193|NCT00370331|thrombocytopenic|thrombocytopenic
671194|NCT00370318|Pneumococcal Disease|pneumococcal disease
671195|NCT00370305|11ß-hydroxysteroid dehydrogenase|11ß-hydroxysteroid dehydrogenase
671196|NCT00370305|rosiglitazone|rosiglitazone
671197|NCT00370305|insulin sensitivity|insulin sensitivity
671198|NCT00370305|Impaired glucose tolerance|impaired glucose tolerance
671199|NCT00370279|Pseudophakic retinal detachment,|pseudophakic retinal detachment,
671200|NCT00370279|Aphakic retinal detachment,|aphakic retinal detachment,
671201|NCT00370279|Scleral buckling,|scleral buckling,
671202|NCT00370279|Primary vitrectomy,|primary vitrectomy,
671203|NCT00370279|Proliferative vitreoretinopathy|proliferative vitreoretinopathy
671204|NCT00370266|Macular edema|macular edema
671205|NCT00370266|Branch retinal vein occlusion|branch retinal vein occlusion
671206|NCT00370266|Intravitreal triamcinolone|intravitreal triamcinolone
671207|NCT00370266|Macular thickness|macular thickness
671208|NCT00370266|Retinal neovascularization|retinal neovascularization
671209|NCT00370253|hepatorenal syndrome|hepatorenal syndrome
671210|NCT00370253|ascites|ascites
671211|NCT00370253|portal hypertension|portal hypertension
671212|NCT00370253|cirrhosis|cirrhosis
671213|NCT00370240|Female|female
671214|NCT00370240|Anesthetics,local|anesthetics,local
671215|NCT00370227|Streptococcus pneumonia, pneumococcal conjugate vaccine|streptococcus pneumonia, pneumococcal conjugate vaccine
671216|NCT00370214|Pulmonary arterial hypertension|pulmonary arterial hypertension
671217|NCT00370214|Lung diseases|lung diseases
671218|NCT00370214|Heart diseases|heart diseases
671219|NCT00370214|Pulmonary circulation|pulmonary circulation
671220|NCT00370214|Vascular resistance|vascular resistance
671221|NCT00370214|PAH|pah
671222|NCT00370214|Hypertension|hypertension
671223|NCT00370201|retinal detachment|retinal detachment
671224|NCT00370201|proliferative vitreoretinopathy|proliferative vitreoretinopathy
671225|NCT00370188|problem gambling|problem gambling
671226|NCT00370188|topiramate|topiramate
671227|NCT00370123|endometriosis|endometriosis
671228|NCT00370123|apoptosis|apoptosis
671229|NCT00370123|regulatory T cells|regulatory t cells
671230|NCT00370097|Asthma infants FLOVENT spacer|asthma infants flovent spacer
671231|NCT00370071|MS|ms
671232|NCT00370058|ect|ect
671233|NCT00370058|depression|depression
671234|NCT00370058|homocysteine|homocysteine
671235|NCT00370058|mthfr genotype|mthfr genotype
671236|NCT00370032|mucosal blood flow d-IBS|mucosal blood flow d-ibs
671237|NCT00370019|Premature Ovarian Failure|premature ovarian failure
671238|NCT00370019|Ovulation|ovulation
671239|NCT00370019|Fertility|fertility
671240|NCT00370019|Estrogen Replacement|estrogen replacement
671241|NCT00370019|Follicle Function|follicle function
671242|NCT00370019|Premature Menopause|premature menopause
671243|NCT00370019|POF|pof
671244|NCT00370006|cytomegalovirus|cytomegalovirus
671245|NCT00370006|vaccine|vaccine
671246|NCT00370006|T cell|t cell
671247|NCT00370006|antibodies|antibodies
671248|NCT00369993|asthma|asthma
671249|NCT00369993|spacer|spacer
671250|NCT00369967|Contraception|contraception
671251|NCT00369967|Adolescents|adolescents
671252|NCT00369967|Contraceptive vaginal ring|contraceptive vaginal ring
671253|NCT00369967|Quick start|quick start
671254|NCT00369954|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
671255|NCT00369954|fallopian tube cancer|fallopian tube cancer
671256|NCT00369954|peritoneal cavity cancer|peritoneal cavity cancer
671257|NCT00369915|Cholinergic|cholinergic
671258|NCT00369915|Unipolar|unipolar
671259|NCT00369915|Bipolar|bipolar
671260|NCT00369915|Depression|depression
671261|NCT00369915|Muscarinic|muscarinic
671262|NCT00369915|Scopolamine|scopolamine
671263|NCT00369915|Major Depressive Disorder|major depressive disorder
671264|NCT00369915|MDD|mdd
671265|NCT00369915|Bipolar Disorder|bipolar disorder
671266|NCT00369915|BP|bp
671267|NCT00369902|pain|pain
671268|NCT00369902|acupuncture|acupuncture
671269|NCT00369889|Thymoma|thymoma
671270|NCT00369889|Thymic Cancer|thymic cancer
671271|NCT00369876|Burns|burns
671272|NCT00369876|Anorexia|anorexia
671273|NCT00369876|Neuropeptide|neuropeptide
671274|NCT00369876|Leptin|leptin
671275|NCT00369876|Adiponectin|adiponectin
671276|NCT00369876|Gherlin|gherlin
671277|NCT00369863|Cystoid macular edema|cystoid macular edema
671278|NCT00369863|Diabetic macular edema|diabetic macular edema
671279|NCT00369863|Hard exudates|hard exudates
671280|NCT00369863|Intravitreal triamcinolone|intravitreal triamcinolone
671281|NCT00369863|Macular thickness|macular thickness
671282|NCT00369850|osteoporosis|osteoporosis
671283|NCT00369850|stage I breast cancer|stage i breast cancer
671284|NCT00369850|stage II breast cancer|stage ii breast cancer
671285|NCT00369850|stage IIIA breast cancer|stage iiia breast cancer
671286|NCT00369824|HPV|hpv
671287|NCT00369824|HPV, diptheria, pertussis, tetanus, meningitis|hpv, diptheria, pertussis, tetanus, meningitis
671288|NCT00369811|Cholecystectomy, postoperative|cholecystectomy, postoperative
671289|NCT00369798|Unipolar Depression|unipolar depression
671290|NCT00369798|Phosphorylation|phosphorylation
671291|NCT00369798|Affinity States|affinity states
671292|NCT00369798|Compartment Analysis|compartment analysis
671293|NCT00369798|(R)-(11)C Rolipram|(r)-(11)c rolipram
671294|NCT00369798|Depression|depression
671295|NCT00369798|Major Depressive Disorder|major depressive disorder
671296|NCT00369798|MDD|mdd
671297|NCT00369798|Healthy Volunteer|healthy volunteer
671298|NCT00369798|HV|hv
671299|NCT00369785|cognitive/functional effects|cognitive/functional effects
671300|NCT00369785|fatigue|fatigue
671567|NCT00368940|Geriatric Depression|geriatric depression
671301|NCT00369785|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
671302|NCT00369785|radiation toxicity|radiation toxicity
671303|NCT00369785|tumors metastatic to brain|tumors metastatic to brain
671304|NCT00369785|adult brain stem glioma|adult brain stem glioma
671305|NCT00369785|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
671306|NCT00369785|adult choroid plexus tumor|adult choroid plexus tumor
671307|NCT00369785|adult craniopharyngioma|adult craniopharyngioma
671308|NCT00369785|adult mixed glioma|adult mixed glioma
671309|NCT00369785|adult anaplastic meningioma|adult anaplastic meningioma
671310|NCT00369785|meningeal melanocytoma|meningeal melanocytoma
671311|NCT00369785|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
671312|NCT00369785|adult grade I meningioma|adult grade i meningioma
671313|NCT00369785|adult grade II meningioma|adult grade ii meningioma
671314|NCT00369785|adult grade III meningioma|adult grade iii meningioma
671315|NCT00369785|adult papillary meningioma|adult papillary meningioma
671316|NCT00369785|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
671317|NCT00369785|adult oligodendroglioma|adult oligodendroglioma
671318|NCT00369785|adult pineoblastoma|adult pineoblastoma
671319|NCT00369785|adult pineocytoma|adult pineocytoma
671320|NCT00369785|adult anaplastic astrocytoma|adult anaplastic astrocytoma
671321|NCT00369785|adult diffuse astrocytoma|adult diffuse astrocytoma
671322|NCT00369785|adult glioblastoma|adult glioblastoma
671323|NCT00369785|adult giant cell glioblastoma|adult giant cell glioblastoma
671324|NCT00369785|adult gliosarcoma|adult gliosarcoma
671325|NCT00369785|adult pilocytic astrocytoma|adult pilocytic astrocytoma
671326|NCT00369785|adult ependymoblastoma|adult ependymoblastoma
671327|NCT00369785|adult medulloblastoma|adult medulloblastoma
671328|NCT00369785|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
671329|NCT00369785|adult anaplastic ependymoma|adult anaplastic ependymoma
671330|NCT00369785|adult ependymoma|adult ependymoma
671331|NCT00369785|adult myxopapillary ependymoma|adult myxopapillary ependymoma
671332|NCT00369785|adult subependymoma|adult subependymoma
671333|NCT00369772|Aranesp|aranesp
671334|NCT00369772|Anemia|anemia
671335|NCT00369772|Kidney Disease|kidney disease
671336|NCT00369772|Hemoglobin|hemoglobin
671337|NCT00369772|darbepoetin alfa|darbepoetin alfa
671338|NCT00369772|QoL|qol
671339|NCT00369759|Acute Lower Respiratory Infection|acute lower respiratory infection
671340|NCT00369759|Retractions|retractions
671341|NCT00369759|Bronchiolitis or pneumonia|bronchiolitis or pneumonia
671342|NCT00369759|Wheezing|wheezing
671343|NCT00369759|Rales|rales
671344|NCT00369759|Crackles|crackles
671345|NCT00369746|Depression|depression
671346|NCT00369746|Alcohol Abuse|alcohol abuse
671347|NCT00369746|Alcohol Dependence|alcohol dependence
671348|NCT00369733|Aranesp|aranesp
671349|NCT00369733|Anemia|anemia
671350|NCT00369733|Kidney Disease|kidney disease
671351|NCT00369733|Hemoglobin|hemoglobin
671352|NCT00369733|darbepoetin alfa|darbepoetin alfa
671353|NCT00369733|QoL|qol
671354|NCT00369720|Prematurity|prematurity
671355|NCT00369720|Resuscitation|resuscitation
671356|NCT00369720|Room Air|room air
671357|NCT00369707|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
671358|NCT00369694|Esophageal varices|esophageal varices
671359|NCT00369694|Portal Hypertension|portal hypertension
671360|NCT00369694|Melena|melena
671361|NCT00369694|Hematemesis|hematemesis
671362|NCT00369694|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
671363|NCT00369694|Terlipressin|terlipressin
671364|NCT00369694|Efficacy|efficacy
671365|NCT00369694|Safety|safety
671366|NCT00369681|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
671367|NCT00369681|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
671368|NCT00369681|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
671369|NCT00369681|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
671370|NCT00369681|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
671371|NCT00369681|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
671372|NCT00369668|Rehabilitation|rehabilitation
671373|NCT00369668|Physical Therapy Techniques|physical therapy techniques
671374|NCT00369668|Occupational Therapy|occupational therapy
671375|NCT00369668|Upper Extremity; Motor skills|upper extremity; motor skills
671376|NCT00369642|Cognitive-behavioral therapy|cognitive-behavioral therapy
671377|NCT00369642|Children|children
671378|NCT00369642|Obsessive-compulsive disorder|obsessive-compulsive disorder
671379|NCT00369642|Intensive Cognitive-behavioral therapy|intensive cognitive-behavioral therapy
671380|NCT00369642|Weekly Cognitive-behavioral therapy|weekly cognitive-behavioral therapy
671381|NCT00369629|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
671382|NCT00369629|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
671383|NCT00369629|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
671384|NCT00369629|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
671385|NCT00369629|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
671386|NCT00369629|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
672354|NCT00365599|Tamoxifen|tamoxifen
671387|NCT00369629|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
671388|NCT00369629|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
671389|NCT00369629|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
671390|NCT00369629|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
671391|NCT00369603|Alzheimer's Disease|alzheimer's disease
671392|NCT00369603|fMRI|fmri
671393|NCT00369603|Functional Neuroimaging|functional neuroimaging
671394|NCT00369603|Allosteric Nicotinic Receptor Modulation|allosteric nicotinic receptor modulation
671395|NCT00369603|Acetylcholinesterase Inhibition|acetylcholinesterase inhibition
671396|NCT00369603|Head to head|head to head
671397|NCT00369603|Dose escalation|dose escalation
671398|NCT00369603|Biomarker|biomarker
671399|NCT00369577|Agitation|agitation
671400|NCT00369577|Schizophrenia|schizophrenia
671401|NCT00369564|neurotoxicity|neurotoxicity
671402|NCT00369564|peripheral neuropathy|peripheral neuropathy
671403|NCT00369564|stage I Wilms tumor|stage i wilms tumor
671404|NCT00369564|stage II Wilms tumor|stage ii wilms tumor
671405|NCT00369564|stage III Wilms tumor|stage iii wilms tumor
671406|NCT00369564|stage IV Wilms tumor|stage iv wilms tumor
671407|NCT00369564|stage V Wilms tumor|stage v wilms tumor
671408|NCT00369564|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
671409|NCT00369564|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
671410|NCT00369564|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
671411|NCT00369564|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
671412|NCT00369564|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
671413|NCT00369564|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
671414|NCT00369564|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
671415|NCT00369564|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
671416|NCT00369564|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
671417|NCT00369564|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
671418|NCT00369564|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
671419|NCT00369564|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
671420|NCT00369564|childhood Burkitt lymphoma|childhood burkitt lymphoma
671421|NCT00369564|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
671422|NCT00369564|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
671423|NCT00369564|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
671424|NCT00369564|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
671425|NCT00369564|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
671426|NCT00369538|Podocyte - podocyturia - microparticles - angiotensin receptor antagonist - glomerulosclerosis|podocyte - podocyturia - microparticles - angiotensin receptor antagonist - glomerulosclerosis
671427|NCT00369538|Patients presenting with stable glomerular nephropathy with proteinuria, normal or slightly altered renal function, with hypertension|patients presenting with stable glomerular nephropathy with proteinuria, normal or slightly altered renal function, with hypertension
671428|NCT00369512|Phase II|phase ii
671429|NCT00369512|Erlotinib|erlotinib
671430|NCT00369512|Radiotherapy|radiotherapy
671431|NCT00369512|Squamous Cell Carcinomas|squamous cell carcinomas
671432|NCT00369512|Cutaneous|cutaneous
671433|NCT00369512|Stage III|stage iii
671434|NCT00369486|diabetic|diabetic
671435|NCT00369486|macular|macular
671436|NCT00369486|edema|edema
671437|NCT00369486|peribulbar|peribulbar
671438|NCT00369486|triamcinolone|triamcinolone
671439|NCT00369486|acetonide|acetonide
671440|NCT00369486|laser|laser
671441|NCT00369486|photocoagulation|photocoagulation
671442|NCT00369486|intraocular|intraocular
671443|NCT00369486|DME|dme
671444|NCT00369473|rheumatoid arthritis|rheumatoid arthritis
671445|NCT00369460|recurrent pancreatic cancer|recurrent pancreatic cancer
671446|NCT00369460|stage III pancreatic cancer|stage iii pancreatic cancer
671447|NCT00369460|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
671448|NCT00369460|stage IV pancreatic cancer|stage iv pancreatic cancer
671449|NCT00369447|Non small cell lung cancer|non small cell lung cancer
671450|NCT00369447|NSCLC|nsclc
671451|NCT00369447|Nimotuzumab|nimotuzumab
671452|NCT00369447|TheraCIM|theracim
671453|NCT00369447|h-R3|h-r3
671454|NCT00369447|YM BioSciences|ym biosciences
671455|NCT00369447|Radiation|radiation
671456|NCT00369447|Non small cell lung cancer, Stage IIb, III and IV|non small cell lung cancer, stage iib, iii and iv
671457|NCT00369421|Dietary Therapy|dietary therapy
671458|NCT00369421|Biochemical Defects|biochemical defects
671459|NCT00369421|Enzyme Defects|enzyme defects
671460|NCT00369421|Transport|transport
671461|NCT00369421|Rare Diseases|rare diseases
671462|NCT00369421|Varied Disorders|varied disorders
671463|NCT00369421|Screening|screening
671464|NCT00369421|Relatives|relatives
671465|NCT00369408|Randomized Trial|randomized trial
671466|NCT00369408|Medication for Heavy Drinking|medication for heavy drinking
671467|NCT00369408|Naltrexone Treatment|naltrexone treatment
671468|NCT00369408|Daily vs. Targeted Administration|daily vs. targeted administration
671469|NCT00369395|melanoma|melanoma
671470|NCT00369395|antibody|antibody
671471|NCT00369395|angiogenesis|angiogenesis
671472|NCT00369395|volociximab|volociximab
671473|NCT00369382|Heart Transplant|heart transplant
671474|NCT00369382|Kidney Failure|kidney failure
671475|NCT00369343|Major Depressive Disorder|major depressive disorder
671476|NCT00369343|vasomotor symptoms|vasomotor symptoms
671477|NCT00369343|menopause|menopause
671478|NCT00369343|diabetic neuropathy|diabetic neuropathy
671479|NCT00369343|fibromyalgia|fibromyalgia
671480|NCT00369330|atrial fibrillation|atrial fibrillation
671481|NCT00369330|early cardioversion|early cardioversion
671482|NCT00369330|electrical cardioversion|electrical cardioversion
671483|NCT00369304|Health|health
671484|NCT00369278|Renal transplantation, mycophenolate|renal transplantation, mycophenolate
671485|NCT00369265|Gastroesophageal reflux|gastroesophageal reflux
671486|NCT00369265|Laryngitis|laryngitis
671487|NCT00369265|Hoarseness|hoarseness
671488|NCT00369265|Dysphonia|dysphonia
671489|NCT00369265|Proton pump inhibitor|proton pump inhibitor
671490|NCT00369252|Nimotuzumab|nimotuzumab
671491|NCT00369252|TheraCIM|theracim
671492|NCT00369252|H-R3|h-r3
671493|NCT00369252|Solid tumours|solid tumours
671494|NCT00369252|EGFR|egfr
671495|NCT00369252|Monoclonal antibody|monoclonal antibody
671496|NCT00369239|Early psychosis|early psychosis
671497|NCT00369239|premorbid functioning|premorbid functioning
671498|NCT00369239|Scale for Assessment of Insight|scale for assessment of insight
671499|NCT00369239|Risperdal Consta|risperdal consta
671500|NCT00369239|risperidone long acting injectable|risperidone long acting injectable
671501|NCT00369226|Velcade|velcade
671502|NCT00369226|Bortezomib|bortezomib
671503|NCT00369226|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
671504|NCT00369226|GVHD|gvhd
671505|NCT00369213|Crossover trial|crossover trial
671506|NCT00369213|condom failure|condom failure
671507|NCT00369213|additional spermicidal lubricant|additional spermicidal lubricant
671508|NCT00369148|glinides|glinides
671509|NCT00369148|premixed insulin|premixed insulin
671510|NCT00369148|combination therapy|combination therapy
671511|NCT00369148|glycemic control|glycemic control
671512|NCT00369135|work|work
671513|NCT00369135|Musculoskeletal Disorders|musculoskeletal disorders
671514|NCT00369109|recurrent colon cancer|recurrent colon cancer
671515|NCT00369109|stage III colon cancer|stage iii colon cancer
671516|NCT00369109|stage IV colon cancer|stage iv colon cancer
671517|NCT00369109|recurrent rectal cancer|recurrent rectal cancer
671518|NCT00369109|stage III rectal cancer|stage iii rectal cancer
671519|NCT00369109|stage IV rectal cancer|stage iv rectal cancer
671520|NCT00369109|recurrent pancreatic cancer|recurrent pancreatic cancer
671521|NCT00369109|stage II pancreatic cancer|stage ii pancreatic cancer
671522|NCT00369109|stage III pancreatic cancer|stage iii pancreatic cancer
671523|NCT00369109|stage IV pancreatic cancer|stage iv pancreatic cancer
671524|NCT00369109|recurrent breast cancer|recurrent breast cancer
671525|NCT00369109|stage IIIA breast cancer|stage iiia breast cancer
671526|NCT00369109|stage IIIB breast cancer|stage iiib breast cancer
671527|NCT00369109|stage IIIC breast cancer|stage iiic breast cancer
671528|NCT00369109|stage IV breast cancer|stage iv breast cancer
671529|NCT00369096|Peritoneal Dialysis|peritoneal dialysis
671530|NCT00369096|Bemiparin|bemiparin
671531|NCT00369096|Icodextrin|icodextrin
671532|NCT00369096|Peritoneal Transport Disorders|peritoneal transport disorders
671533|NCT00369083|Frail elderly|frail elderly
671534|NCT00369083|Hospital at home|hospital at home
671535|NCT00369070|AMG 706|amg 706
671536|NCT00369070|Bevacizumab|bevacizumab
671537|NCT00369070|Paclitaxel and Carboplatin|paclitaxel and carboplatin
671538|NCT00369070|Randomized|randomized
671539|NCT00369070|Non-Small Cell Lung Cancer|non-small cell lung cancer
671540|NCT00369057|Intraocular pressure|intraocular pressure
671541|NCT00369057|Prostatectomy|prostatectomy
671542|NCT00369057|Robotic|robotic
671543|NCT00369057|Glaucoma|glaucoma
671544|NCT00369057|Carbon dioxide|carbon dioxide
671545|NCT00369044|decompensated heart failure|decompensated heart failure
671546|NCT00369044|prednisone|prednisone
671547|NCT00369044|diuretics|diuretics
671548|NCT00369044|diuresis|diuresis
671549|NCT00369031|HIV|hiv
671550|NCT00369031|vaccine|vaccine
671551|NCT00369031|nasal immunization|nasal immunization
671552|NCT00369018|photodynamic therapy|photodynamic therapy
671553|NCT00369018|methyl aminolevulinate|methyl aminolevulinate
671554|NCT00369018|hexaminolevulinate|hexaminolevulinate
671555|NCT00369018|dose-finding|dose-finding
671556|NCT00369018|cervical dysplasia|cervical dysplasia
671557|NCT00369005|Transfusions|transfusions
671558|NCT00369005|Erythrocyte|erythrocyte
671559|NCT00369005|Anemia|anemia
671560|NCT00369005|Brain|brain
671561|NCT00369005|Infant, Premature|infant, premature
671562|NCT00368979|Benign Prostatic Hyperplasia BPH dutasteride|benign prostatic hyperplasia bph dutasteride
671563|NCT00368966|Pneumococcal|pneumococcal
671564|NCT00368966|Pediatric|pediatric
671565|NCT00368966|Vaccine|vaccine
671566|NCT00368940|Memory Deficits|memory deficits
671568|NCT00368940|Cognitive Impairment|cognitive impairment
671569|NCT00368940|Executive Dysfunction|executive dysfunction
671570|NCT00368940|Disability|disability
671571|NCT00368940|Problem Solving Therapy|problem solving therapy
671572|NCT00368914|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
671573|NCT00368901|Aranesp|aranesp
671574|NCT00368901|Anemia|anemia
671575|NCT00368901|Kidney Disease|kidney disease
671576|NCT00368901|Hemoglobin|hemoglobin
671577|NCT00368901|darbepoetin alfa|darbepoetin alfa
671578|NCT00368901|QoL|qol
671579|NCT00368862|Alcoholism|alcoholism
671580|NCT00368862|Depression|depression
671581|NCT00368862|Efficacy study|efficacy study
671582|NCT00368862|Memantine|memantine
671583|NCT00368862|Escitalopram|escitalopram
671584|NCT00368849|Huntington Disease|huntington disease
671585|NCT00368849|Chorea|chorea
671586|NCT00368849|Attention|attention
671587|NCT00368849|ADHD|adhd
671588|NCT00368849|ADD|add
671589|NCT00368849|Strattera|strattera
671590|NCT00368849|Atomoxetine|atomoxetine
671591|NCT00368836|Capnography|capnography
671592|NCT00368836|Thromboembolism|thromboembolism
671593|NCT00368836|Arthroplasty|arthroplasty
671594|NCT00368836|D-dimer|d-dimer
671595|NCT00368823|point of care|point of care
671596|NCT00368823|evidence based medicine|evidence based medicine
671597|NCT00368810|Children|children
671598|NCT00368810|Cross-Sectional|cross-sectional
671599|NCT00368810|Glycosylphosphatidylinositol|glycosylphosphatidylinositol
671600|NCT00368810|Cytokines|cytokines
671601|NCT00368810|Peripheral Blood Mononuclear Cells|peripheral blood mononuclear cells
671602|NCT00368810|Malaria|malaria
671603|NCT00368797|Gene Therapy|gene therapy
671604|NCT00368797|PAOD|paod
671605|NCT00368797|CLI|cli
671606|NCT00368771|Irritable Bowel Syndrome|irritable bowel syndrome
671607|NCT00368771|Abdominal Pain|abdominal pain
671608|NCT00368771|Abdominal Discomfort|abdominal discomfort
671609|NCT00368771|Diarrhea|diarrhea
671610|NCT00368771|Constipation|constipation
671611|NCT00368771|IBS|ibs
671612|NCT00368758|Meteorism|meteorism
671613|NCT00368758|Bloating|bloating
671614|NCT00368758|Irritable bowel syndrome (IBS)|irritable bowel syndrome (ibs)
671615|NCT00368758|Probiotics|probiotics
671616|NCT00368758|Bowel gas|bowel gas
671617|NCT00368732|Congenital Heart Defects|congenital heart defects
671618|NCT00368706|solifenacin|solifenacin
671619|NCT00368706|Overactive bladder|overactive bladder
671620|NCT00368706|Urinary incontinence|urinary incontinence
671621|NCT00368706|Treatment outcomes|treatment outcomes
671622|NCT00368706|VESIcare|vesicare
671623|NCT00368680|Respiratory Distress Syndrome|respiratory distress syndrome
671624|NCT00368680|Early Bubble CPAP|early bubble cpap
671625|NCT00368680|Mechanical Ventilation|mechanical ventilation
671626|NCT00368680|Surfactant|surfactant
671627|NCT00368667|Anorexia Nervosa|anorexia nervosa
671628|NCT00368667|Body Composition|body composition
671629|NCT00368667|Metabolic Rate|metabolic rate
671630|NCT00368628|acute ischemic stroke|acute ischemic stroke
671631|NCT00368628|sleep apnea|sleep apnea
671632|NCT00368628|continuous positive airway pressure|continuous positive airway pressure
671633|NCT00368615|melanoma|melanoma
671634|NCT00368615|malignant melanoma|malignant melanoma
671635|NCT00368589|atherosclerotic plaque|atherosclerotic plaque
671636|NCT00368589|USPIO|uspio
671637|NCT00368589|Atheroma|atheroma
671638|NCT00368589|thrombo-embolic stroke|thrombo-embolic stroke
671639|NCT00368589|magnetic resonance imaging|magnetic resonance imaging
671640|NCT00368589|Ultra small Super-Paramagnetic Iron Oxide|ultra small super-paramagnetic iron oxide
671641|NCT00368576|SB-480848|sb-480848
671642|NCT00368576|methacholine challenge|methacholine challenge
671643|NCT00368576|asthma|asthma
671644|NCT00368576|inhaled steroid|inhaled steroid
671645|NCT00368550|Alcohol Drinking|alcohol drinking
671646|NCT00368550|Alcohol Dependence|alcohol dependence
671647|NCT00368550|Sertraline Pharmacotherapy|sertraline pharmacotherapy
671648|NCT00368550|Alcoholism Subtypes|alcoholism subtypes
671649|NCT00368550|Early- versus Late-Onset Alcoholism|early- versus late-onset alcoholism
671650|NCT00368537|skin infection|skin infection
671651|NCT00368537|antibiotics|antibiotics
671652|NCT00368524|cocaine dependence|cocaine dependence
671653|NCT00368524|mental disorder|mental disorder
671654|NCT00368524|dual diagnoses|dual diagnoses
671655|NCT00368524|homelessness|homelessness
671656|NCT00368511|Fall Prevention|fall prevention
671657|NCT00368511|Dynamic Posturography|dynamic posturography
671658|NCT00368511|Nolwenn Effect|nolwenn effect
671659|NCT00368511|Music Listening|music listening
671660|NCT00368498|teicoplanin|teicoplanin
671661|NCT00368485|diaphragm electrical activity|diaphragm electrical activity
671662|NCT00368485|non invasive ventilation|non invasive ventilation
671663|NCT00368485|patient ventilator interaction|patient ventilator interaction
671664|NCT00368472|Refractory|refractory
671665|NCT00368472|Partial|partial
671666|NCT00368472|Seizures|seizures
671667|NCT00368459|raloxifene, women|raloxifene, women
671668|NCT00368446|Nontuberculous Mycobacterial Infection|nontuberculous mycobacterial infection
672894|NCT00363909|hot flashes|hot flashes
671669|NCT00368446|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
671670|NCT00368446|Cystic Fibrosis|cystic fibrosis
671671|NCT00368446|Pseudohypoaldosteronism|pseudohypoaldosteronism
671672|NCT00368446|Chronic Granulomatous Disease|chronic granulomatous disease
671673|NCT00368446|Mycobacterial Infection|mycobacterial infection
671674|NCT00368446|PCD|pcd
671675|NCT00368446|CF|cf
671676|NCT00368446|PHA|pha
671677|NCT00368446|Healthy Volunteer|healthy volunteer
671678|NCT00368446|HV|hv
671679|NCT00368433|Sensory Processing|sensory processing
671680|NCT00368433|Electromyogram|electromyogram
671681|NCT00368433|Tic Disorder|tic disorder
671682|NCT00368433|Tourette Syndrome|tourette syndrome
671683|NCT00368433|Tourette's Syndrome|tourette's syndrome
671684|NCT00368433|Healthy Volunteer|healthy volunteer
671685|NCT00368433|HV|hv
671686|NCT00368420|ovarian cancer|ovarian cancer
671687|NCT00368420|recurrence|recurrence
671688|NCT00368420|surgery|surgery
671689|NCT00368407|308-nm excimer laser|308-nm excimer laser
671690|NCT00368407|vitiligo|vitiligo
671691|NCT00368394|Insulin glulisine|insulin glulisine
671692|NCT00368394|Euglycaemic clamp|euglycaemic clamp
671693|NCT00368394|Diabetes mellitus Type 1|diabetes mellitus type 1
671694|NCT00368381|sepsis|sepsis
671695|NCT00368381|septicemia|septicemia
671696|NCT00368381|sepsis syndrome|sepsis syndrome
671697|NCT00368381|adrenal insufficiency|adrenal insufficiency
671698|NCT00368381|adrenal cortex hormones|adrenal cortex hormones
671699|NCT00368381|hydrocortisone|hydrocortisone
671700|NCT00368381|fludrocortisone|fludrocortisone
671701|NCT00368355|haploidenticalstem cell transplant|haploidenticalstem cell transplant
671702|NCT00368355|acute lymphoblastic leukemia|acute lymphoblastic leukemia
671703|NCT00368355|Non Hodgkins Lymphoma|non hodgkins lymphoma
671704|NCT00368355|Myelodysplastic Syndrome|myelodysplastic syndrome
671705|NCT00368355|Acute myeloid leukemia|acute myeloid leukemia
671706|NCT00368355|Chronic myelogenous leukemia|chronic myelogenous leukemia
671707|NCT00368355|Hemophagocytic lymphohistiocytosis (HLH)|hemophagocytic lymphohistiocytosis (hlh)
671708|NCT00368355|Familial hemophagocytic lymphohistiocytosis (FLH)|familial hemophagocytic lymphohistiocytosis (flh)
671709|NCT00368355|Viral-associated hemophagocytic syndrome (VAHS)|viral-associated hemophagocytic syndrome (vahs)
671710|NCT00368355|X-linked lymphoproliferative disease (XLP)|x-linked lymphoproliferative disease (xlp)
671711|NCT00368316|Dysentery|dysentery
671712|NCT00368316|S. sonnei|s. sonnei
671713|NCT00368316|Antibody Response|antibody response
671714|NCT00368316|Protection|protection
671715|NCT00368303|Major Depression|major depression
671716|NCT00368303|paroxetine controlled release (CR)|paroxetine controlled release (cr)
671717|NCT00368303|paroxetine immediate release (IR)|paroxetine immediate release (ir)
671718|NCT00368290|cocaine dependence|cocaine dependence
671719|NCT00368290|hiv prevention|hiv prevention
671720|NCT00368277|Systolic hypertension|systolic hypertension
671721|NCT00368277|hypertension|hypertension
671722|NCT00368277|aliskiren|aliskiren
671723|NCT00368277|blood pressure|blood pressure
671724|NCT00368277|ramipril|ramipril
671725|NCT00368277|HTN|htn
671726|NCT00368264|lupus|lupus
671727|NCT00368264|nephritis|nephritis
671728|NCT00368264|membraneous|membraneous
671729|NCT00368264|proteinuria|proteinuria
671730|NCT00368264|TNF|tnf
671731|NCT00368264|infliximab|infliximab
671732|NCT00368264|azathioprine|azathioprine
671733|NCT00368264|autoantibodies|autoantibodies
671734|NCT00368251|Unverricht-Lundborg Disease|unverricht-lundborg disease
671735|NCT00368251|Baltic Myoclonus|baltic myoclonus
671736|NCT00368251|Progressive Myoclonic Epilepsies|progressive myoclonic epilepsies
671737|NCT00368251|Myoclonus|myoclonus
671738|NCT00368251|Brivaracetam|brivaracetam
671739|NCT00368238|Platelet function tests|platelet function tests
671740|NCT00368238|Erythropoietin|erythropoietin
671741|NCT00368238|Aspirin|aspirin
671742|NCT00368238|Clopidogrel|clopidogrel
671743|NCT00368225|Viral Hepatitis|viral hepatitis
671744|NCT00368225|Hepatitis C|hepatitis c
671745|NCT00368225|HCV|hcv
671746|NCT00368225|Liver Transplant|liver transplant
671747|NCT00368225|Renal Transplant|renal transplant
671748|NCT00368225|Kidney Transplant|kidney transplant
671749|NCT00368212|Somatization|somatization
671750|NCT00368212|Refractory Symptoms|refractory symptoms
671751|NCT00368199|single photon emission computer tomography (SPECT)|single photon emission computer tomography (spect)
671752|NCT00368199|transcranial sonography|transcranial sonography
671753|NCT00368199|transcranial duplex scanning|transcranial duplex scanning
671754|NCT00368199|parkinson's disease|parkinson's disease
671755|NCT00368199|atypical parkinson syndromes|atypical parkinson syndromes
671756|NCT00368199|parkinsonism|parkinsonism
671757|NCT00368199|parkinsonian|parkinsonian
671758|NCT00368199|diagnostic|diagnostic
671759|NCT00368199|progressive supranuclear paralysis|progressive supranuclear paralysis
671760|NCT00368160|Next day driving|next day driving
671761|NCT00368147|Hemodialysis|hemodialysis
671762|NCT00368147|Arteriovenous Fistula|arteriovenous fistula
671763|NCT00368147|Arteriovenous Graft|arteriovenous graft
671764|NCT00368147|Left Ventricular Hypertrophy|left ventricular hypertrophy
671765|NCT00368147|Brain Natriuretic Peptide|brain natriuretic peptide
671766|NCT00368134|Type 2 Diabetes|type 2 diabetes
671767|NCT00368134|Vildagliptin|vildagliptin
671768|NCT00368134|HbA1c|hba1c
671769|NCT00368121|Multiple Myeloma|multiple myeloma
671770|NCT00368121|Cetuximab|cetuximab
671771|NCT00368095|DM|dm
671772|NCT00368095|HT|ht
671773|NCT00368095|Dyslipidemia|dyslipidemia
671774|NCT00368095|Obesity|obesity
671775|NCT00368095|Cardiovascular disease|cardiovascular disease
671776|NCT00368095|Cerebrovascular disease|cerebrovascular disease
671777|NCT00368095|Myocardial infarction|myocardial infarction
671778|NCT00368095|stroke|stroke
671779|NCT00368095|Metabolic syndrome|metabolic syndrome
671780|NCT00368095|CVD-CAD|cvd-cad
671781|NCT00368082|EBV-Positive Lymphoma|ebv-positive lymphoma
671782|NCT00368082|Hodgkin´s Disease (HD)|hodgkin´s disease (hd)
671783|NCT00368082|Non-Hodgkin's lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
671784|NCT00368082|relapsed Hodgkin's disease|relapsed hodgkin's disease
671785|NCT00368082|relapsed non-Hodgkin's disease|relapsed non-hodgkin's disease
671786|NCT00368082|lymphoma|lymphoma
671787|NCT00368082|TGFbeta resistant LMP-specific CTLs|tgfbeta resistant lmp-specific ctls
671788|NCT00368082|cytotoxic T cells|cytotoxic t cells
671789|NCT00368069|Epilepsy|epilepsy
671790|NCT00368069|Keppra® XR|keppra® xr
671791|NCT00368069|Levetiracetam XR|levetiracetam xr
671792|NCT00368069|Extended release|extended release
671793|NCT00368043|Pituitary|pituitary
671794|NCT00368043|Adrenal|adrenal
671795|NCT00368043|Growth|growth
671796|NCT00368043|Cortisol|cortisol
671797|NCT00368043|Stress Response|stress response
671798|NCT00368043|Adoption|adoption
671799|NCT00368043|Thyroid Hormone|thyroid hormone
671800|NCT00368043|Psychosocial Adjustment|psychosocial adjustment
671801|NCT00368043|Healthy Volunteer|healthy volunteer
671802|NCT00368043|HV|hv
671803|NCT00368030|Insomnia related to major depressive disorder.|insomnia related to major depressive disorder.
671804|NCT00368004|Coloboma|coloboma
671805|NCT00368004|Genetics|genetics
671806|NCT00368004|Optic Nerve Coloboma|optic nerve coloboma
671807|NCT00368004|Chorioretinal Coloboma|chorioretinal coloboma
671808|NCT00368004|Iris Coloboma|iris coloboma
671809|NCT00368004|Uveal Coloboma|uveal coloboma
671810|NCT00367991|Platelet function tests|platelet function tests
671811|NCT00367991|Erythropoietin|erythropoietin
671812|NCT00367991|Myocardial infarction|myocardial infarction
671813|NCT00367978|Hypertension, diabetes, African-American, amlodipine/benazepril|hypertension, diabetes, african-american, amlodipine/benazepril
671814|NCT00367965|Insomnia related to rheumatoid arthritis (RA)|insomnia related to rheumatoid arthritis (ra)
671815|NCT00367952|HIV|hiv
671816|NCT00367952|apricitabine|apricitabine
671817|NCT00367952|drug resistance|drug resistance
671818|NCT00367952|reverse transcriptase|reverse transcriptase
671819|NCT00367952|lamivudine|lamivudine
671820|NCT00367939|Hypertension|hypertension
671821|NCT00367926|ginseng|ginseng
671822|NCT00367926|polysaccharides|polysaccharides
671823|NCT00367926|postprandial glycemia|postprandial glycemia
671824|NCT00367926|area under the glucose curve|area under the glucose curve
671825|NCT00367926|peak incremental glucose|peak incremental glucose
671826|NCT00367913|pulmonary disease|pulmonary disease
671827|NCT00367913|Treatment of Opportunist Mycobacteria|treatment of opportunist mycobacteria
671828|NCT00367913|Clarithromycin|clarithromycin
671829|NCT00367913|Ciprofloxacin|ciprofloxacin
671830|NCT00367913|M.vaccae|m.vaccae
671831|NCT00367913|Pulmonary diseases caused by Opportunist Mycobacteria|pulmonary diseases caused by opportunist mycobacteria
671832|NCT00367900|Diet|diet
671833|NCT00367900|Lifestyle|lifestyle
671834|NCT00367900|Neurodegenerative Diseases|neurodegenerative diseases
671835|NCT00367900|Elderly Population|elderly population
671836|NCT00367900|Public Health|public health
671837|NCT00367900|Parkinson Disease|parkinson disease
671838|NCT00367900|Environment|environment
671839|NCT00367887|Hepatitis C|hepatitis c
671840|NCT00367874|Opiate dependence|opiate dependence
671841|NCT00367874|Benzodiazepine dependence|benzodiazepine dependence
671842|NCT00367874|Polydrug Abuse|polydrug abuse
671843|NCT00367874|Detoxification|detoxification
671844|NCT00367874|Withdrawal Treatment|withdrawal treatment
671845|NCT00367861|GIST|gist
671846|NCT00367861|Glivec®|glivec®
671847|NCT00367861|randomized|randomized
671848|NCT00367861|phase III|phase iii
671849|NCT00367848|suspected fractures in the ankle and wrist|suspected fractures in the ankle and wrist
671850|NCT00367822|Restless Legs Syndrome|restless legs syndrome
671851|NCT00367822|dopamine agonist|dopamine agonist
671852|NCT00367822|lisuride|lisuride
671853|NCT00367822|ropinirole|ropinirole
671854|NCT00367809|Meditation|meditation
671855|NCT00367809|Mindfulness|mindfulness
671856|NCT00367809|Organ Transplant|organ transplant
671857|NCT00367809|Transplantation|transplantation
671858|NCT00367809|Minnesota|minnesota
671859|NCT00367809|Immune suppressive therapy|immune suppressive therapy
671860|NCT00367796|Craniosynostosis|craniosynostosis
671861|NCT00367796|Philadelphia Type|philadelphia type
671862|NCT00367770|bosentan|bosentan
671863|NCT00367770|PAH related to Eisenmenger physiology|pah related to eisenmenger physiology
671864|NCT00367770|Tracleer|tracleer
671865|NCT00367757|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
671866|NCT00367757|persistent atrial fibrillation|persistent atrial fibrillation
671867|NCT00367757|high burden of atrial fibrillation|high burden of atrial fibrillation
671868|NCT00367757|atrial fibrillation ablation|atrial fibrillation ablation
671869|NCT00367757|Pulmonary vein isolation|pulmonary vein isolation
671870|NCT00367757|AF trigger|af trigger
671871|NCT00367757|complex fractionated electrograms|complex fractionated electrograms
671872|NCT00367757|CFE|cfe
671873|NCT00367757|CFAE|cfae
671874|NCT00367757|complex fractionated atrial electrograms|complex fractionated atrial electrograms
671875|NCT00367757|refractory antiarrhythmic medication|refractory antiarrhythmic medication
671876|NCT00367757|PVAI|pvai
671877|NCT00367757|Ensite NavX|ensite navx
671878|NCT00367757|NavX|navx
671879|NCT00367757|CoolPath catheter|coolpath catheter
671880|NCT00367757|irrigated ablation catheter|irrigated ablation catheter
671881|NCT00367757|high burden of paroxysmal or persistent atrial fibrillation|high burden of paroxysmal or persistent atrial fibrillation
671882|NCT00367757|candidates for AF ablation|candidates for af ablation
671883|NCT00367757|symptomatic AF|symptomatic af
671884|NCT00367757|AF is refractory to at least one antiarrhythmic medication|af is refractory to at least one antiarrhythmic medication
671885|NCT00367744|mitochondria|mitochondria
671886|NCT00367744|HIV|hiv
671887|NCT00367744|lipoatrophy|lipoatrophy
671888|NCT00367731|HIV|hiv
671889|NCT00367731|AIDS|aids
671890|NCT00367731|Neurological complications|neurological complications
671891|NCT00367731|HAART|haart
671892|NCT00367692|Scleritis|scleritis
671893|NCT00367679|pazopanib|pazopanib
671894|NCT00367679|I-ELCAP|i-elcap
671895|NCT00367679|non-small cell lung cancer|non-small cell lung cancer
671896|NCT00367679|antiangiogenesis|antiangiogenesis
671897|NCT00367679|NSCLC|nsclc
671898|NCT00367679|GW786034|gw786034
671899|NCT00367640|Sublingual immunotherapy|sublingual immunotherapy
671900|NCT00367640|Grass pollen tablet|grass pollen tablet
671901|NCT00367640|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
671902|NCT00367627|Children|children
671903|NCT00367627|Malnutrition|malnutrition
671904|NCT00367627|Ascaris Lumbricoides|ascaris lumbricoides
671905|NCT00367627|Trichuris trichiura Morbidity|trichuris trichiura morbidity
671906|NCT00367627|Helminthiasis|helminthiasis
671907|NCT00367627|Children 2-5 years|children 2-5 years
671908|NCT00367627|Stool RME +ve for helminthiasis|stool rme +ve for helminthiasis
671909|NCT00367614|Adolescents|adolescents
671910|NCT00367614|GERD|gerd
671911|NCT00367588|chemotherapy|chemotherapy
671912|NCT00367588|diet|diet
671913|NCT00367588|hematological malignancy|hematological malignancy
671914|NCT00367588|infection prevention|infection prevention
671915|NCT00367588|protective isolation|protective isolation
671916|NCT00367588|Patients with cytopenia due to intensive chemotherapy for hematological malignancy|patients with cytopenia due to intensive chemotherapy for hematological malignancy
671917|NCT00367575|alcoholism|alcoholism
671918|NCT00367575|drinking|drinking
671919|NCT00367575|randomized|randomized
671920|NCT00367575|internet personalized alcohol feedback|internet personalized alcohol feedback
671921|NCT00367562|IGA NEPHROPATHY|iga nephropathy
671922|NCT00367562|STEROIDS|steroids
671923|NCT00367562|ENALAPRIL|enalapril
671924|NCT00367562|VALSARTAN|valsartan
671925|NCT00367562|PROTEINURIA|proteinuria
671926|NCT00367562|IMMUNOGLOBULIN A NEPHROPATHY (IGA NEPHROPATHY)|immunoglobulin a nephropathy (iga nephropathy)
671927|NCT00367549|Labor|labor
671928|NCT00367549|instrumental delivery|instrumental delivery
671929|NCT00367549|nutrition|nutrition
671930|NCT00367549|epidural anesthesia|epidural anesthesia
671931|NCT00367549|oxytocin|oxytocin
671932|NCT00367536|Health|health
671933|NCT00367523|Echocardiogram|echocardiogram
671934|NCT00367523|Nigeria|nigeria
671935|NCT00367523|Screening|screening
671936|NCT00367523|Sickle Cell Disease|sickle cell disease
671937|NCT00367523|Genetics|genetics
671938|NCT00367497|aggressive non-Hodgkin's lymphoma|aggressive non-hodgkin's lymphoma
671939|NCT00367497|salvage chemotherapy|salvage chemotherapy
671940|NCT00367497|rituximab|rituximab
671941|NCT00367471|metastatic|metastatic
671942|NCT00367471|paclitaxel|paclitaxel
671943|NCT00367471|lapatinib|lapatinib
671944|NCT00367471|trastuzumab|trastuzumab
671945|NCT00367471|carboplatin|carboplatin
671946|NCT00367471|breast cancer|breast cancer
671947|NCT00367458|Viremia|viremia
671948|NCT00367458|Statin|statin
671949|NCT00367458|HIV Replication|hiv replication
671950|NCT00367458|Cholesterol|cholesterol
671951|NCT00367458|Lipid Raft|lipid raft
671952|NCT00367458|HIV Infection|hiv infection
671953|NCT00367458|HIV Positive|hiv positive
671954|NCT00367432|Epilepsies|epilepsies
671955|NCT00367432|Partial|partial
671956|NCT00367432|Keppra|keppra
671957|NCT00367432|levetiracetam|levetiracetam
671958|NCT00367393|Pimecrolimus, skin atrophy, dermoscopy, atopic dermatitis, eczema|pimecrolimus, skin atrophy, dermoscopy, atopic dermatitis, eczema
671959|NCT00367380|Malaria|malaria
671960|NCT00367380|Sporozoite|sporozoite
671961|NCT00367380|Challenge Model|challenge model
671962|NCT00367380|Plasmodium vivax|plasmodium vivax
671963|NCT00367380|Human Volunteers|human volunteers
671964|NCT00367367|embryo transfer|embryo transfer
671965|NCT00367367|hysteroscopy|hysteroscopy
671966|NCT00367367|curettage|curettage
671967|NCT00367367|iv-vitro fertilization|iv-vitro fertilization
671968|NCT00367367|molecular markers|molecular markers
671969|NCT00367367|endometrial receptivity|endometrial receptivity
671970|NCT00367367|endometrial dating|endometrial dating
671971|NCT00367354|Imaging Technology|imaging technology
671972|NCT00367354|Cardiology|cardiology
671973|NCT00367341|Depression, Treatment, Imaging|depression, treatment, imaging
671974|NCT00367328|Hidradenitis Supperativa|hidradenitis supperativa
671975|NCT00367315|Osteoarthritis, lumiracoxib, celecoxib, cyclooxygenase-2 inhibitors|osteoarthritis, lumiracoxib, celecoxib, cyclooxygenase-2 inhibitors
671976|NCT00367302|addiction|addiction
671977|NCT00367302|jail|jail
671978|NCT00367302|opiates|opiates
671979|NCT00367302|buprenorphine|buprenorphine
671980|NCT00367302|clinical trial|clinical trial
671981|NCT00367276|Females requiring contraceptives|females requiring contraceptives
671982|NCT00367263|Asthma|asthma
671983|NCT00367224|vitiligo|vitiligo
671984|NCT00367224|tolerance|tolerance
671985|NCT00367224|ultraviolet B.|ultraviolet b.
671986|NCT00367211|Gastric Ulcers|gastric ulcers
671987|NCT00367211|NSAID|nsaid
671988|NCT00367211|Arthritis|arthritis
671989|NCT00367185|Multiple myeloma|multiple myeloma
671990|NCT00367185|Elderly patients|elderly patients
671991|NCT00367185|Thalidomide|thalidomide
671992|NCT00367185|Autologous transplantation|autologous transplantation
671993|NCT00367172|human immunodeficiency virus|human immunodeficiency virus
671994|NCT00367172|acquired immunodeficiency syndrome|acquired immunodeficiency syndrome
671995|NCT00367172|substance abuse|substance abuse
671996|NCT00367172|directly administered antiretroviral therapy|directly administered antiretroviral therapy
671997|NCT00367172|adherence, directly observed therapy|adherence, directly observed therapy
671998|NCT00367159|Vesico-ureteral reflux, autologous adipocytes, adipocytes graft|vesico-ureteral reflux, autologous adipocytes, adipocytes graft
671999|NCT00367146|liver transplantation|liver transplantation
672000|NCT00367146|children|children
672001|NCT00367146|immunosuppression|immunosuppression
672002|NCT00367146|mycophenolatmofetil|mycophenolatmofetil
672003|NCT00367146|calcineurin inhibitor|calcineurin inhibitor
672004|NCT00367146|kidney disease|kidney disease
672005|NCT00367133|diabetic|diabetic
672006|NCT00367133|macular|macular
672007|NCT00367133|edema|edema
672008|NCT00367133|intravitreal|intravitreal
672009|NCT00367133|triamcinolone|triamcinolone
672010|NCT00367133|laser|laser
672011|NCT00367133|photocoagulation|photocoagulation
672012|NCT00367133|DME|dme
672013|NCT00367107|Autism spectrum disorders|autism spectrum disorders
672014|NCT00367107|long-term outcomes|long-term outcomes
672015|NCT00367107|caregiver burden|caregiver burden
672016|NCT00367107|birth cohort|birth cohort
672017|NCT00367107|nested case-control study|nested case-control study
672018|NCT00367094|Hypertension, benazepril, hydrochlorothiazide, fixed combination|hypertension, benazepril, hydrochlorothiazide, fixed combination
672019|NCT00367081|Toxoplasmic Encephalitis|toxoplasmic encephalitis
672020|NCT00367081|AIDS|aids
672021|NCT00367068|Cerebral palsy|cerebral palsy
672022|NCT00367068|Spasticity|spasticity
672023|NCT00367068|Child|child
672024|NCT00367068|Baclofen|baclofen
672025|NCT00367068|Intrathecal injection|intrathecal injection
672026|NCT00367055|Beta cell function|beta cell function
672027|NCT00367055|Type 2 diabetes|type 2 diabetes
672028|NCT00367055|Combination treatment|combination treatment
672029|NCT00367029|Physical Activity|physical activity
672030|NCT00367003|Depression, Unipolar, Bipolar-II, DBS, Imaging|depression, unipolar, bipolar-ii, dbs, imaging
672031|NCT00366990|Arterial Stiffening|arterial stiffening
672032|NCT00366977|Cessation|cessation
672033|NCT00366977|Smoking|smoking
672034|NCT00366977|Quitline|quitline
672035|NCT00366977|Policies|policies
672036|NCT00366977|Counseling|counseling
672037|NCT00366951|Cervical Ripening|cervical ripening
672038|NCT00366951|Labor, Induced|labor, induced
672039|NCT00366951|Balloon Dilation|balloon dilation
672040|NCT00366951|Oxytocin|oxytocin
672041|NCT00366938|Osteoarthritis, lumiracoxib, celecoxib, Cox-2|osteoarthritis, lumiracoxib, celecoxib, cox-2
672042|NCT00366912|work of breathing|work of breathing
672043|NCT00366912|pressure time product|pressure time product
672044|NCT00366912|muscle pressures|muscle pressures
672045|NCT00366899|Vaccine|vaccine
672046|NCT00366899|Infants|infants
672047|NCT00366886|cardiac|cardiac
672048|NCT00366886|pediatric|pediatric
672049|NCT00366886|surgery|surgery
672050|NCT00366886|blood markers|blood markers
672051|NCT00366873|Infant|infant
672052|NCT00366873|Term|term
672053|NCT00366860|soy|soy
672054|NCT00366860|isoflavones|isoflavones
672055|NCT00366860|bone resorption|bone resorption
672056|NCT00366860|osteogenesis|osteogenesis
672057|NCT00366860|diet|diet
672058|NCT00366860|hyperlipidemia|hyperlipidemia
672059|NCT00366847|cardiac|cardiac
672060|NCT00366847|MRI|mri
672061|NCT00366847|pediatrics|pediatrics
672062|NCT00366834|Anthracycline|anthracycline
672063|NCT00366834|Cyclophosphamide|cyclophosphamide
672064|NCT00366834|Moderately|moderately
672065|NCT00366834|Nausea|nausea
672066|NCT00366834|Emetogenic|emetogenic
672067|NCT00366834|Vomiting|vomiting
672068|NCT00366821|cardiac|cardiac
672069|NCT00366821|pediatric|pediatric
672070|NCT00366821|genetic|genetic
672071|NCT00366782|Respiratory Tract Disease|respiratory tract disease
672072|NCT00366782|Bovine|bovine
672073|NCT00366782|Chimeric Vaccine|chimeric vaccine
672074|NCT00366756|Vision|vision
672075|NCT00366756|Visual Acuity|visual acuity
672076|NCT00366730|Amebiasis|amebiasis
672077|NCT00366730|Entamoeba histolytica|entamoeba histolytica
672078|NCT00366717|Cancer under chemotherapy|cancer under chemotherapy
672079|NCT00366704|Schizophrenia|schizophrenia
672080|NCT00366691|cataract|cataract
672081|NCT00366678|Safety|safety
672082|NCT00366678|Vaccine|vaccine
672083|NCT00366652|Healthy|healthy
672084|NCT00366639|Heart failure, congestive|heart failure, congestive
672085|NCT00366639|Heart decompensation|heart decompensation
672086|NCT00366626|Alcohol dependence|alcohol dependence
672087|NCT00366626|Alcoholism|alcoholism
672088|NCT00366626|Craving|craving
672089|NCT00366626|Genetic|genetic
672090|NCT00366613|Cataract|cataract
672091|NCT00366613|Cataract Extraction|cataract extraction
672092|NCT00366600|Breast Cancer|breast cancer
672093|NCT00366600|Health|health
672094|NCT00366600|Pharmacokinetics|pharmacokinetics
672095|NCT00366600|healthy subjects|healthy subjects
672096|NCT00366561|neonates|neonates
672097|NCT00366561|neurological complications|neurological complications
672098|NCT00366561|surgery|surgery
672099|NCT00366548|Vaccine|vaccine
672100|NCT00366548|Infant|infant
672101|NCT00366535|Muscle Pain|muscle pain
672102|NCT00366535|Fibrositis Allodynia|fibrositis allodynia
672103|NCT00366535|Stiffness|stiffness
672104|NCT00366535|Tender Points|tender points
672105|NCT00366535|Fibromyalgia|fibromyalgia
672106|NCT00366522|Safety|safety
672107|NCT00366522|Healthy|healthy
672108|NCT00366522|healthy subjects|healthy subjects
672109|NCT00366509|Vac A Toxin|vac a toxin
672110|NCT00366509|Lung|lung
672111|NCT00366509|Bronchoscopy|bronchoscopy
672112|NCT00366509|Endoscopy|endoscopy
672113|NCT00366509|Cytotoxin|cytotoxin
672114|NCT00366509|Pulmonary Disease|pulmonary disease
672115|NCT00366509|Lung Disease|lung disease
672116|NCT00366509|Genetic Disease|genetic disease
672117|NCT00366509|Oropharyngeal Disease|oropharyngeal disease
672118|NCT00366509|Pulmonary Fibrosis|pulmonary fibrosis
672119|NCT00366509|Asthma|asthma
672120|NCT00366483|healthy young volunteers|healthy young volunteers
672121|NCT00366483|healthy elderly volunteers|healthy elderly volunteers
672122|NCT00366483|Alzheimer's disease|alzheimer's disease
672123|NCT00366483|5HT1A antagonist|5ht1a antagonist
672124|NCT00366483|Health|health
672125|NCT00366483|Pharmacokinetics|pharmacokinetics
672126|NCT00366444|Bunionectomy|bunionectomy
672127|NCT00366444|Bunion surgery|bunion surgery
672128|NCT00366444|Post-operative pain|post-operative pain
672129|NCT00366431|OIBD|oibd
672130|NCT00366431|OIC|oic
672131|NCT00366431|Opioid|opioid
672132|NCT00366431|Constipation|constipation
672133|NCT00366431|Laxative|laxative
672134|NCT00366418|CLL|cll
672135|NCT00366418|Monoclonal Antibody Therapy|monoclonal antibody therapy
672136|NCT00366418|Anti CD20|anti cd20
672137|NCT00366418|Biologic Response Modifier Therapy|biologic response modifier therapy
672138|NCT00366418|Fractionated-Dose|fractionated-dose
672139|NCT00366418|Low-Dose|low-dose
672140|NCT00366418|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
672141|NCT00366405|cataract|cataract
672142|NCT00366392|Low Vision|low vision
672143|NCT00366392|Optical Aids|optical aids
672144|NCT00366353|Mechanical Ventilation|mechanical ventilation
672145|NCT00366353|Spontaneous Breathing Trial|spontaneous breathing trial
672146|NCT00366353|Sedation|sedation
672147|NCT00366340|safety|safety
672148|NCT00366340|Vaccine|vaccine
672149|NCT00366327|Schizophrenia|schizophrenia
672150|NCT00366314|Blood samples|blood samples
672151|NCT00366314|Medication administration|medication administration
672152|NCT00366314|CICU|cicu
672153|NCT00366314|PICU|picu
672154|NCT00366314|NICU|nicu
672155|NCT00366301|type 2 diabetes|type 2 diabetes
672156|NCT00366301|insulin|insulin
672157|NCT00366301|insulin injection|insulin injection
672158|NCT00366301|metformin|metformin
672159|NCT00366301|C-reactive protein|c-reactive protein
672160|NCT00366301|insulin sensitivity|insulin sensitivity
672161|NCT00366301|glycemic control|glycemic control
672162|NCT00366301|inflammation|inflammation
672163|NCT00366288|Healthy|healthy
672164|NCT00366288|Safety|safety
672165|NCT00366275|follicular lymphoma|follicular lymphoma
672166|NCT00366275|rituximab|rituximab
672167|NCT00366275|immunochemotherapy|immunochemotherapy
672168|NCT00366275|peripheral blood stem cells (PBSC) mobilization|peripheral blood stem cells (pbsc) mobilization
672169|NCT00366275|in vivo purging|in vivo purging
672170|NCT00366275|autotransplant|autotransplant
672171|NCT00366275|bcl-2 rearrangement|bcl-2 rearrangement
672172|NCT00366275|molecular response|molecular response
672173|NCT00366262|Health|health
672174|NCT00366249|Diabetic foot infection|diabetic foot infection
672175|NCT00366249|Osteomyelitis|osteomyelitis
672176|NCT00366249|Diabetes Complications|diabetes complications
672177|NCT00366249|Foot ulcer|foot ulcer
672178|NCT00366249|Skin infection|skin infection
672179|NCT00366236|Amebiasis|amebiasis
672180|NCT00366236|Entamoeba histolytica|entamoeba histolytica
672181|NCT00366223|infection|infection
672182|NCT00366223|candida|candida
672183|NCT00366210|stroke|stroke
672184|NCT00366210|rehabilitation|rehabilitation
672185|NCT00366210|physical therapy|physical therapy
672186|NCT00366210|occupational therapy|occupational therapy
672187|NCT00366210|arm|arm
672188|NCT00366197|Rapid Shallow Breathing Index|rapid shallow breathing index
672189|NCT00366197|Mechanical Ventilation|mechanical ventilation
672190|NCT00366184|Neuromodulation|neuromodulation
672191|NCT00366184|Stroke|stroke
672192|NCT00366184|Motor Cortex|motor cortex
672193|NCT00366184|Motor Learning|motor learning
672194|NCT00366184|L-Dopa|l-dopa
672195|NCT00366184|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
672196|NCT00366184|Levodopa|levodopa
672197|NCT00366184|Healthy Volunteer|healthy volunteer
672198|NCT00366184|HV|hv
672199|NCT00366171|Schizophrenia|schizophrenia
672200|NCT00366158|Patients with intact AV conduction|patients with intact av conduction
672201|NCT00366145|acute GVHD|acute gvhd
672202|NCT00366145|steroid refractory GVHD|steroid refractory gvhd
672203|NCT00366145|severe steroid refractory acute GVHD|severe steroid refractory acute gvhd
672204|NCT00366145|steroid refractory|steroid refractory
672205|NCT00366145|Steroid Refractory Acute Graft Versus Host Disease|steroid refractory acute graft versus host disease
672206|NCT00366132|Diabetic|diabetic
672207|NCT00366132|Foot Ulcers|foot ulcers
672208|NCT00366132|TRT|trt
672209|NCT00366132|DermaGold|dermagold
672210|NCT00366132|Shockwave|shockwave
672211|NCT00366132|ESWT|eswt
672212|NCT00366132|Diabetes Mellitus|diabetes mellitus
672213|NCT00366119|hypertension|hypertension
672214|NCT00366119|ramipril|ramipril
672215|NCT00366119|blood pressure|blood pressure
672216|NCT00366119|artery stiffness|artery stiffness
672217|NCT00366119|BNP|bnp
672218|NCT00366119|CRP|crp
672219|NCT00366106|Relapsed Multiple Myeloma|relapsed multiple myeloma
672220|NCT00366106|Refractory Multiple Myeloma|refractory multiple myeloma
672221|NCT00366093|Menopause|menopause
672222|NCT00366093|Perimenopause|perimenopause
672223|NCT00366080|GSK189254 H3 Histamine Narcolepsy|gsk189254 h3 histamine narcolepsy
672224|NCT00366067|Bronchial asthma|bronchial asthma
672225|NCT00366067|Phenytoin|phenytoin
672226|NCT00366067|Antiepileptic drugs|antiepileptic drugs
672227|NCT00366067|Efficacy|efficacy
672228|NCT00366028|Organization Innovation|organization innovation
672229|NCT00366028|Diffusion of Innovation|diffusion of innovation
672230|NCT00366028|Evidence-based Medicine|evidence-based medicine
672231|NCT00366028|Infection Control|infection control
672232|NCT00366015|Coronary Artery Disease|coronary artery disease
672233|NCT00366015|PCI|pci
672234|NCT00366015|Drug eluting stents|drug eluting stents
672235|NCT00366015|Coronary Hybrid Revascularization|coronary hybrid revascularization
672236|NCT00366015|Robotic CABG|robotic cabg
672237|NCT00366002|Darifenacin,Overactive Bladder,antimuscarinic,M3 muscarinic receptor antagonist|darifenacin,overactive bladder,antimuscarinic,m3 muscarinic receptor antagonist
672238|NCT00365989|Fibroids|fibroids
672239|NCT00365989|leiomyoma|leiomyoma
672240|NCT00365989|neoplasm|neoplasm
672241|NCT00365989|benign tumors|benign tumors
672242|NCT00365976|Insomnia|insomnia
672243|NCT00365976|Low Back Pain|low back pain
672244|NCT00365976|Hypnotics|hypnotics
672245|NCT00365976|Eszopiclone|eszopiclone
672246|NCT00365976|Pain|pain
672247|NCT00365976|Disability|disability
672248|NCT00365963|lung cancer, caregivers, support, resources, education|lung cancer, caregivers, support, resources, education
672249|NCT00365950|Duration of anticoagulation|duration of anticoagulation
672250|NCT00365950|Deep vein thrombosis and/or pulmonary embolism|deep vein thrombosis and/or pulmonary embolism
672251|NCT00365937|immunotherapy|immunotherapy
672252|NCT00365937|adjuvants|adjuvants
672253|NCT00365937|IMP321|imp321
672254|NCT00365937|Montanide ISA51 VG|montanide isa51 vg
672255|NCT00365937|tumor-specific peptides|tumor-specific peptides
672256|NCT00365924|12 month therapy with postmenopausal women with osteoporosis to examine changes in bone quality parameters|12 month therapy with postmenopausal women with osteoporosis to examine changes in bone quality parameters
672257|NCT00365911|No specific condition|no specific condition
672258|NCT00365898|Chronic non-malignant pain, opioid|chronic non-malignant pain, opioid
672259|NCT00365885|Medical Informatics|medical informatics
672260|NCT00365885|Decision Support Systems, Clinical|decision support systems, clinical
672261|NCT00365885|Community Health Services|community health services
672262|NCT00365885|Costs and Cost analysis|costs and cost analysis
672263|NCT00365872|Sarcoma|sarcoma
672264|NCT00365872|Intratumoral injection|intratumoral injection
672265|NCT00365872|Dendritic cells|dendritic cells
672266|NCT00365872|Neo-adjuvant treatment|neo-adjuvant treatment
672267|NCT00365872|Immunotherapy|immunotherapy
672268|NCT00365872|Pheresis|pheresis
672269|NCT00365872|Radiation|radiation
672270|NCT00365859|Serious behavioral problems in children and adolescents with AD|serious behavioral problems in children and adolescents with ad
672271|NCT00365859|behavioral problems|behavioral problems
672272|NCT00365846|prevent kidney rejection|prevent kidney rejection
672273|NCT00365833|Transplantation|transplantation
672274|NCT00365833|Cardiovascular|cardiovascular
672275|NCT00365833|Renal|renal
672276|NCT00365820|Opioid, constipation, tegaserod|opioid, constipation, tegaserod
672277|NCT00365820|Opioid-induced constipation|opioid-induced constipation
672278|NCT00365807|Obesity|obesity
672279|NCT00365807|Overweight|overweight
672280|NCT00365807|Behavioral treatment|behavioral treatment
672281|NCT00365807|Family involvement|family involvement
672282|NCT00365794|Aging|aging
672283|NCT00365794|Older men|older men
672284|NCT00365794|Abdominal obesity|abdominal obesity
672285|NCT00365794|Central obesity|central obesity
672286|NCT00365794|Insulin resistance|insulin resistance
672287|NCT00365794|Low testosterone|low testosterone
672288|NCT00365781|Injection Site Reaction|injection site reaction
672289|NCT00365781|Subcutaneous administration|subcutaneous administration
672290|NCT00365781|Dermatological effects|dermatological effects
672291|NCT00365781|Antisense|antisense
672292|NCT00365768|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
672293|NCT00365768|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
672294|NCT00365768|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
672295|NCT00365768|stage I Wilms tumor|stage i wilms tumor
672296|NCT00365768|stage II Wilms tumor|stage ii wilms tumor
672297|NCT00365768|stage III Wilms tumor|stage iii wilms tumor
672298|NCT00365768|stage IV Wilms tumor|stage iv wilms tumor
672299|NCT00365768|stage V Wilms tumor|stage v wilms tumor
672300|NCT00365768|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
672301|NCT00365768|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
672302|NCT00365768|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
672303|NCT00365768|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
672304|NCT00365768|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
672305|NCT00365768|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
672306|NCT00365768|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
672307|NCT00365768|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
672308|NCT00365768|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
672309|NCT00365768|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
672310|NCT00365768|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
672311|NCT00365768|childhood Burkitt lymphoma|childhood burkitt lymphoma
672312|NCT00365768|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
672313|NCT00365768|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
672314|NCT00365768|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
672315|NCT00365768|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
672316|NCT00365768|localized Ewing sarcoma/PNET|localized ewing sarcoma/pnet
672317|NCT00365768|metastatic Ewing sarcoma/PNET|metastatic ewing sarcoma/pnet
672318|NCT00365768|neurotoxicity|neurotoxicity
672319|NCT00365768|peripheral neuropathy|peripheral neuropathy
672320|NCT00365755|disseminated neuroblastoma|disseminated neuroblastoma
672321|NCT00365742|red yeast rice|red yeast rice
672322|NCT00365742|pharmaceutical grade fish oil|pharmaceutical grade fish oil
672323|NCT00365742|simvastatin|simvastatin
672324|NCT00365742|primary prevention|primary prevention
672325|NCT00365729|genitoanal HPV infection|genitoanal hpv infection
672326|NCT00365729|HIV infection|hiv infection
672327|NCT00365716|HPV 6/11/16/18 infection and related genital disease|hpv 6/11/16/18 infection and related genital disease
672328|NCT00365703|Infant, Premature|infant, premature
672329|NCT00365703|Tube feeding|tube feeding
672330|NCT00365690|AIDS|aids
672331|NCT00365690|Older Adults|older adults
672332|NCT00365690|Telephone|telephone
672333|NCT00365690|Telemedicine|telemedicine
672334|NCT00365651|obesity|obesity
672335|NCT00365651|overweight|overweight
672336|NCT00365638|PCOS|pcos
672337|NCT00365638|statin|statin
672338|NCT00365638|testosterone|testosterone
672339|NCT00365638|lipids|lipids
672340|NCT00365625|Psoriasis|psoriasis
672341|NCT00365625|JAM3 protein, human|jam3 protein, human
672342|NCT00365625|Cell Adhesion Molecules|cell adhesion molecules
672343|NCT00365625|Skin|skin
672344|NCT00365625|Inflammation|inflammation
672345|NCT00365625|Lymphocytes|lymphocytes
672346|NCT00365612|HIV|hiv
672347|NCT00365612|HIV-1|hiv-1
672348|NCT00365612|AIDS|aids
672349|NCT00365612|Human Immunodeficiency Virus|human immunodeficiency virus
672350|NCT00365612|HIV-1 Infection|hiv-1 infection
672351|NCT00365599|Breast cancer|breast cancer
672352|NCT00365599|Suberoylanilide hydroxamic acid (SAHA)|suberoylanilide hydroxamic acid (saha)
672353|NCT00365599|Vorinostat|vorinostat
672355|NCT00365599|Anti-hormonal therapy|anti-hormonal therapy
672356|NCT00365599|Estrogen receptor positive|estrogen receptor positive
672357|NCT00365599|Progesterone receptor positive|progesterone receptor positive
672358|NCT00365599|Metastatic disease|metastatic disease
672359|NCT00365599|Aromatase inhibitors (Ais)|aromatase inhibitors (ais)
672360|NCT00365599|Histone deacetylase (HDAC) inhibitors|histone deacetylase (hdac) inhibitors
672361|NCT00365599|Selective estrogen receptor modulators(SERMS)|selective estrogen receptor modulators(serms)
672362|NCT00365586|Pain|pain
672363|NCT00365586|Osteoarthritis|osteoarthritis
672364|NCT00365586|Knee|knee
672365|NCT00365586|NSAID|nsaid
672366|NCT00365547|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
672367|NCT00365547|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
672368|NCT00365547|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
672369|NCT00365547|adenocarcinoma of the lung|adenocarcinoma of the lung
672370|NCT00365547|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
672371|NCT00365547|large cell lung cancer|large cell lung cancer
672372|NCT00365534|First colonoscopy examination|first colonoscopy examination
672373|NCT00365521|Organ transplant patients receiving immunosuppressive therapy|organ transplant patients receiving immunosuppressive therapy
672374|NCT00365508|bladder cancer|bladder cancer
672375|NCT00365508|cervical cancer|cervical cancer
672376|NCT00365508|esophageal cancer|esophageal cancer
672377|NCT00365508|gastric cancer|gastric cancer
672378|NCT00365508|renal cell carcinoma|renal cell carcinoma
672379|NCT00365508|adult primary liver cancer|adult primary liver cancer
672380|NCT00365508|non-small cell lung cancer|non-small cell lung cancer
672381|NCT00365508|small cell lung cancer|small cell lung cancer
672382|NCT00365508|pancreatic cancer|pancreatic cancer
672383|NCT00365508|hypopharyngeal cancer|hypopharyngeal cancer
672384|NCT00365508|laryngeal cancer|laryngeal cancer
672385|NCT00365508|lip and oral cavity cancer|lip and oral cavity cancer
672386|NCT00365508|nasopharyngeal cancer|nasopharyngeal cancer
672387|NCT00365508|oropharyngeal cancer|oropharyngeal cancer
672388|NCT00365508|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
672389|NCT00365508|adult acute myeloid leukemia|adult acute myeloid leukemia
672390|NCT00365508|tongue cancer|tongue cancer
672391|NCT00365508|tobacco use disorder|tobacco use disorder
672392|NCT00365495|Type 2 diabetes|type 2 diabetes
672393|NCT00365495|physical training|physical training
672394|NCT00365495|mitochondrial function|mitochondrial function
672395|NCT00365482|Epilepsy|epilepsy
672396|NCT00365482|Bipolar Disorder|bipolar disorder
672397|NCT00365469|Probiotics|probiotics
672398|NCT00365469|Eczema|eczema
672399|NCT00365469|Asthma|asthma
672400|NCT00365469|Allergic Rhinitis|allergic rhinitis
672401|NCT00365469|Prevention|prevention
672402|NCT00365469|Immunological responses|immunological responses
672403|NCT00365456|Lumbar Spine Bone Mineral Density (BMD)|lumbar spine bone mineral density (bmd)
672404|NCT00365443|anogenital warts|anogenital warts
672405|NCT00365443|premalignancy|premalignancy
672406|NCT00365443|HPV|hpv
672407|NCT00365443|Human papillomavirus|human papillomavirus
672408|NCT00365430|Patient safety|patient safety
672409|NCT00365430|Adverse event|adverse event
672410|NCT00365430|Prevention|prevention
672411|NCT00365430|Knowledge|knowledge
672412|NCT00365430|Inpatient|inpatient
672413|NCT00365430|Hospital|hospital
672414|NCT00365430|Nursing home|nursing home
672415|NCT00365430|Long term care|long term care
672416|NCT00365430|Nurse|nurse
672417|NCT00365417|NSABP|nsabp
672418|NCT00365417|Doxorubicin|doxorubicin
672419|NCT00365417|Cyclophosphamide|cyclophosphamide
672420|NCT00365417|Bevacizumab|bevacizumab
672421|NCT00365417|Capecitabine|capecitabine
672422|NCT00365417|Docetaxel|docetaxel
672423|NCT00365417|Breast cancer|breast cancer
672424|NCT00365417|Locally advanced|locally advanced
672425|NCT00365417|Neoadjuvant|neoadjuvant
672426|NCT00365417|Locally advanced breast cancer|locally advanced breast cancer
672427|NCT00365404|Behavioral change|behavioral change
672428|NCT00365404|Weight management|weight management
672429|NCT00365404|Physical activity|physical activity
672431|NCT00365339|Protease Inhibitor|protease inhibitor
672432|NCT00365326|AC133|ac133
672433|NCT00365326|coronary|coronary
672434|NCT00365326|bone marrow|bone marrow
672435|NCT00365326|autologous|autologous
672436|NCT00365326|coronary artery disease|coronary artery disease
672437|NCT00365313|celecoxib|celecoxib
672438|NCT00365313|oesomeprazole|oesomeprazole
672439|NCT00365313|arthritis|arthritis
672440|NCT00365313|ulcer bleeding|ulcer bleeding
672441|NCT00365300|GERD|gerd
672442|NCT00365300|Infants|infants
672443|NCT00365300|Gastroesophageal Reflux|gastroesophageal reflux
672444|NCT00365287|stage IV breast cancer|stage iv breast cancer
672445|NCT00365287|recurrent renal cell cancer|recurrent renal cell cancer
672446|NCT00365287|stage III renal cell cancer|stage iii renal cell cancer
672447|NCT00365287|stage IV renal cell cancer|stage iv renal cell cancer
672448|NCT00365287|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
672449|NCT00365287|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
672450|NCT00365287|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
672451|NCT00365287|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
672452|NCT00365287|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
672453|NCT00365287|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
672454|NCT00365287|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
672455|NCT00365287|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
672456|NCT00365287|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
672457|NCT00365287|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
672458|NCT00365287|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
672459|NCT00365287|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
672460|NCT00365287|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
672461|NCT00365287|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
672462|NCT00365287|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
672463|NCT00365287|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
672464|NCT00365287|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
672465|NCT00365287|stage I multiple myeloma|stage i multiple myeloma
672466|NCT00365287|stage II multiple myeloma|stage ii multiple myeloma
672467|NCT00365287|stage III multiple myeloma|stage iii multiple myeloma
672468|NCT00365287|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
672469|NCT00365287|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
672470|NCT00365287|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
672471|NCT00365287|refractory anemia|refractory anemia
672472|NCT00365287|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
672473|NCT00365287|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
672474|NCT00365287|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
672475|NCT00365287|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
672476|NCT00365287|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
672477|NCT00365287|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
672478|NCT00365287|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
672479|NCT00365287|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
672480|NCT00365287|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
672481|NCT00365287|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
672482|NCT00365287|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
672483|NCT00365287|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
672484|NCT00365287|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
672485|NCT00365287|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
672486|NCT00365287|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
672487|NCT00365287|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
672488|NCT00365287|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
672489|NCT00365287|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
672490|NCT00365287|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
672491|NCT00365287|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
672492|NCT00365287|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
672493|NCT00365287|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
672494|NCT00365287|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
672495|NCT00365287|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
672496|NCT00365287|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
672497|NCT00365287|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
672498|NCT00365287|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
672499|NCT00365287|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
672500|NCT00365287|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
672501|NCT00365287|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
672502|NCT00365287|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
672503|NCT00365287|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
672504|NCT00365287|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
672505|NCT00365287|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
672506|NCT00365287|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
672507|NCT00365287|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
672508|NCT00365287|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
672509|NCT00365287|refractory multiple myeloma|refractory multiple myeloma
672510|NCT00365287|secondary acute myeloid leukemia|secondary acute myeloid leukemia
672511|NCT00365287|splenic marginal zone lymphoma|splenic marginal zone lymphoma
672512|NCT00365287|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
672513|NCT00365287|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
672514|NCT00365287|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
672515|NCT00365287|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
672516|NCT00365287|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
672517|NCT00365287|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
672518|NCT00365287|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
672519|NCT00365287|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
672520|NCT00365287|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
672521|NCT00365287|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
672522|NCT00365287|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
672523|NCT00365287|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
672524|NCT00365287|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
672525|NCT00365287|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
672526|NCT00365287|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
672527|NCT00365287|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
672528|NCT00365287|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
672529|NCT00365287|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
672530|NCT00365287|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
672531|NCT00365287|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
672532|NCT00365287|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
672533|NCT00365287|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
672534|NCT00365287|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
672535|NCT00365287|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
672536|NCT00365287|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
672537|NCT00365287|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
672538|NCT00365287|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
672539|NCT00365287|refractory anemia with excess blasts|refractory anemia with excess blasts
672540|NCT00365287|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
672541|NCT00365274|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
672542|NCT00365274|NHL|nhl
672543|NCT00365274|murine monoclonal antibody|murine monoclonal antibody
672544|NCT00365274|mAb|mab
672545|NCT00365274|SGN-30|sgn-30
672546|NCT00365274|CHOP|chop
672547|NCT00365274|Cyclophosphamide|cyclophosphamide
672548|NCT00365274|Doxorubicin Hydrochloride|doxorubicin hydrochloride
672549|NCT00365274|Vincristine|vincristine
672550|NCT00365274|Prednisone|prednisone
672551|NCT00365274|anaplastic large cell lymphoma|anaplastic large cell lymphoma
672552|NCT00365274|Lymphoma|lymphoma
672553|NCT00365274|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
672554|NCT00365274|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
672555|NCT00365274|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
672556|NCT00365274|Neoplasms by Histologic Type|neoplasms by histologic type
672557|NCT00365274|Neoplasms|neoplasms
672558|NCT00365274|Lymphoproliferative Disorders|lymphoproliferative disorders
672559|NCT00365274|Lymphatic Diseases|lymphatic diseases
672560|NCT00365274|Immunoproliferative Disorders|immunoproliferative disorders
672561|NCT00365274|Immune System Diseases|immune system diseases
672562|NCT00365274|Lymphoma, B-Cell|lymphoma, b-cell
672563|NCT00365274|Lymphoma, T-Cell|lymphoma, t-cell
672564|NCT00365274|Antibodies|antibodies
672565|NCT00365274|Antibodies, Monoclonal|antibodies, monoclonal
672566|NCT00365274|Immunologic Factors|immunologic factors
672567|NCT00365274|Physiological Effects of Drugs|physiological effects of drugs
672568|NCT00365274|Pharmacologic Actions|pharmacologic actions
672569|NCT00365274|Immunosuppressive Agents|immunosuppressive agents
672570|NCT00365274|Antirheumatic Agents|antirheumatic agents
672571|NCT00365274|Therapeutic Uses|therapeutic uses
672572|NCT00365274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
672573|NCT00365274|Alkylating Agents|alkylating agents
672574|NCT00365274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
672575|NCT00365274|Antineoplastic Agents|antineoplastic agents
672576|NCT00365274|Myeloablative Agonists|myeloablative agonists
672577|NCT00365274|Antibiotics|antibiotics
672578|NCT00365274|Antineoplastic|antineoplastic
672579|NCT00365261|pain|pain
672580|NCT00365261|fatigue|fatigue
672581|NCT00365261|sleep|sleep
672582|NCT00365261|bone marrow transplant|bone marrow transplant
672583|NCT00365261|cancer|cancer
672584|NCT00365248|Surgical resection of the liver with or without segmental transplantation|surgical resection of the liver with or without segmental transplantation
672585|NCT00365222|Temozolomide|temozolomide
672586|NCT00365222|Temodar|temodar
672587|NCT00365222|Glioblastoma|glioblastoma
672588|NCT00365222|Gliosarcoma|gliosarcoma
672589|NCT00365222|Brain Tumor|brain tumor
672590|NCT00365222|Quality of Life|quality of life
672591|NCT00365222|Neurological|neurological
672592|NCT00365196|Autonomic Nervous System|autonomic nervous system
672593|NCT00365183|Non Small Cell Lung Cancer|non small cell lung cancer
672594|NCT00365183|Lung Cancer|lung cancer
672595|NCT00365183|Metastatic Lung Cancer|metastatic lung cancer
672596|NCT00365183|Inoperable Lung Cancer|inoperable lung cancer
672597|NCT00365183|Advanced Lung Cancer|advanced lung cancer
672598|NCT00365183|Large Cell Lung Cancer|large cell lung cancer
672599|NCT00365183|Adenocarcinoma, lung|adenocarcinoma, lung
672600|NCT00365183|Squamous Cell Carcinoma, lung|squamous cell carcinoma, lung
672601|NCT00365183|Squamous Cell Lung Cancer|squamous cell lung cancer
672602|NCT00365183|Large Cell Carcinoma, lung|large cell carcinoma, lung
672603|NCT00365183|Cancer of the Lung|cancer of the lung
672604|NCT00365183|Carcinoma|carcinoma
672605|NCT00365183|Bronchogenic|bronchogenic
672606|NCT00365144|stage IV pancreatic cancer|stage iv pancreatic cancer
672607|NCT00365144|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
672608|NCT00365144|recurrent pancreatic cancer|recurrent pancreatic cancer
672609|NCT00365131|Type I Gaucher disease|type i gaucher disease
672610|NCT00365131|Glucocerebrosidase Deficiency Disease|glucocerebrosidase deficiency disease
672611|NCT00365118|Port wine stains|port wine stains
672612|NCT00365118|naevus flammeus|naevus flammeus
672613|NCT00365105|pain|pain
672614|NCT00365105|bone metastases|bone metastases
672615|NCT00365105|extensive stage small cell lung cancer|extensive stage small cell lung cancer
672616|NCT00365105|recurrent breast cancer|recurrent breast cancer
672617|NCT00365105|stage IV breast cancer|stage iv breast cancer
672618|NCT00365105|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
672619|NCT00365105|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
672620|NCT00365105|recurrent prostate cancer|recurrent prostate cancer
672621|NCT00365105|stage IV prostate cancer|stage iv prostate cancer
672622|NCT00365092|Insertion of tympanostomy tubes|insertion of tympanostomy tubes
672623|NCT00365092|Otitis media with effusion|otitis media with effusion
672624|NCT00365092|Child development|child development
672625|NCT00365092|Literacy|literacy
672626|NCT00365092|Attention|attention
672627|NCT00365092|Middle-ear effusion|middle-ear effusion
672628|NCT00365092|Educational status|educational status
672629|NCT00365092|Behavior|behavior
672630|NCT00365092|Social behavior|social behavior
672631|NCT00365092|Achievement|achievement
672632|NCT00365040|myopia|myopia
672633|NCT00365040|excimer laser|excimer laser
672634|NCT00365027|GNRH agonist|gnrh agonist
672635|NCT00365027|ovarian hyperstimulation syndrome|ovarian hyperstimulation syndrome
672636|NCT00365027|Embryo cryopreservation|embryo cryopreservation
672637|NCT00365014|aplastic anemia|aplastic anemia
672638|NCT00365014|myelodysplastic syndromes|myelodysplastic syndromes
672639|NCT00365014|cytopenias|cytopenias
672640|NCT00365014|acute myeloid leukemia|acute myeloid leukemia
672641|NCT00365014|myelodysplastic/myeloproliferative diseases|myelodysplastic/myeloproliferative diseases
672642|NCT00365014|benzene poisoning|benzene poisoning
672643|NCT00364988|pioglitazone|pioglitazone
672644|NCT00364988|losartan|losartan
672645|NCT00364988|proteinuria|proteinuria
672646|NCT00364988|end stage renal disease (ESRD)|end stage renal disease (esrd)
672647|NCT00364975|gourmet healthy cooking|gourmet healthy cooking
672648|NCT00364975|quality of life|quality of life
672649|NCT00364975|adjuvant chemotherapy|adjuvant chemotherapy
672650|NCT00364975|weight|weight
672651|NCT00364975|breast cancer|breast cancer
672652|NCT00364962|NPC|npc
672653|NCT00364962|Nasopharyngectomy|nasopharyngectomy
672654|NCT00364962|KTP laser|ktp laser
672655|NCT00364962|recurrence|recurrence
672656|NCT00364949|Polycystic Ovary Syndrome|polycystic ovary syndrome
672657|NCT00364949|PCOS|pcos
672658|NCT00364949|Pregnant|pregnant
672659|NCT00364949|Cord Blood|cord blood
672660|NCT00364936|palliative care|palliative care
672661|NCT00364936|hospice|hospice
672662|NCT00364936|end-of-life|end-of-life
672663|NCT00364936|symptom control|symptom control
672664|NCT00364936|evaluation|evaluation
672665|NCT00364936|effectiveness|effectiveness
672666|NCT00364923|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
672667|NCT00364923|T-cell Lymphoma|t-cell lymphoma
672668|NCT00364923|Lymphoma|lymphoma
672669|NCT00364923|PDX|pdx
672670|NCT00364923|Pralatrexate|pralatrexate
672671|NCT00364923|Vitamin B12|vitamin b12
672672|NCT00364923|Folic acid|folic acid
672673|NCT00364910|Myocardial Infarction (MI)|myocardial infarction (mi)
672674|NCT00364910|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
672675|NCT00364910|Adherence|adherence
672676|NCT00364910|Depression|depression
672677|NCT00364884|chronic kidney disease|chronic kidney disease
672678|NCT00364871|Obesity|obesity
672679|NCT00364858|Type 1 Gaucher Disease|type 1 gaucher disease
672680|NCT00364858|Glucocerebrosidase Deficiency Disease|glucocerebrosidase deficiency disease
672681|NCT00364845|Quality of Life|quality of life
672682|NCT00364845|Chronic Kidney Disease|chronic kidney disease
672683|NCT00364845|Anemia|anemia
672684|NCT00364819|Primary Biliary Cirrhosis|primary biliary cirrhosis
672685|NCT00364806|Migraine|migraine
672686|NCT00364806|Headache|headache
672687|NCT00364793|HIV, Pediatric|hiv, pediatric
672688|NCT00364767|Moderate alcohol consumption|moderate alcohol consumption
672689|NCT00364767|Fat and carbohydrate oxidative capacity|fat and carbohydrate oxidative capacity
672690|NCT00364767|Postprandial glycemic response|postprandial glycemic response
672691|NCT00364754|Tesmilifene|tesmilifene
672692|NCT00364754|DPPE|dppe
672693|NCT00364754|Breast cancer|breast cancer
672694|NCT00364754|Cyclophosphamide|cyclophosphamide
672695|NCT00364754|Epirubicin|epirubicin
672696|NCT00364754|Pharmacokinetic|pharmacokinetic
672697|NCT00364715|Nuclear localization, annexin A1, oral SCC|nuclear localization, annexin a1, oral scc
672698|NCT00364702|Virtual Reality|virtual reality
672699|NCT00364702|ADHD|adhd
672700|NCT00364702|Methylphenidate|methylphenidate
672701|NCT00364689|Encephalopathy, Hepatic|encephalopathy, hepatic
672702|NCT00364689|Portosystemic Encephalopathy|portosystemic encephalopathy
672703|NCT00364689|Encephalopathy, Hepatocerebral|encephalopathy, hepatocerebral
672704|NCT00364689|Encephalopathy, Portal-Systemic|encephalopathy, portal-systemic
672705|NCT00364689|Encephalopathy, Portosystemic|encephalopathy, portosystemic
672706|NCT00364689|Hepatic Coma|hepatic coma
672707|NCT00364689|Hepatic Stupor|hepatic stupor
672708|NCT00364689|Hepatocerebral Encephalopathy|hepatocerebral encephalopathy
672709|NCT00364689|Portal-Systemic Encephalopathy|portal-systemic encephalopathy
672710|NCT00364676|Vinorelbine|vinorelbine
672711|NCT00364676|solid tumors|solid tumors
672712|NCT00364676|Hodgkins|hodgkins
672713|NCT00364676|Non hodgkins|non hodgkins
672714|NCT00364676|Lymphoma|lymphoma
672715|NCT00364676|Advanced solid tumors|advanced solid tumors
672716|NCT00364663|NSCLC|nsclc
672717|NCT00364663|staging|staging
672718|NCT00364663|18F-FDG PET|18f-fdg pet
672719|NCT00364663|decision tree model|decision tree model
672720|NCT00364663|cost-effectiveness|cost-effectiveness
672721|NCT00364650|Renal transplantation|renal transplantation
672722|NCT00364650|Diarrhea|diarrhea
672723|NCT00364650|Immunosuppression|immunosuppression
672724|NCT00364650|Probiotics|probiotics
672725|NCT00364637|Sevoflurane|sevoflurane
672726|NCT00364637|Anesthesia|anesthesia
672727|NCT00364637|Troponin|troponin
672728|NCT00364637|Myocardial Preconditioning|myocardial preconditioning
672729|NCT00364637|Surgery, Cardiac|surgery, cardiac
672730|NCT00364637|Stents|stents
672731|NCT00364637|Non-cardiac Surgery|non-cardiac surgery
672732|NCT00364637|Surgery|surgery
672733|NCT00364624|lung cancer|lung cancer
672734|NCT00364624|adrenal insufficiency|adrenal insufficiency
672735|NCT00364598|Anginera|anginera
672736|NCT00364598|LVAD|lvad
672737|NCT00364598|Transplant|transplant
672738|NCT00364598|Histology|histology
672739|NCT00364598|LVAD implantation as a bridge to transplant|lvad implantation as a bridge to transplant
672740|NCT00364572|sciatica|sciatica
672741|NCT00364572|low back pain|low back pain
672742|NCT00364572|epidural|epidural
672743|NCT00364572|tumor necrosis factor|tumor necrosis factor
672744|NCT00364559|intracerebral hemorrhage|intracerebral hemorrhage
672745|NCT00364559|statins|statins
672746|NCT00364559|rosuvastatin|rosuvastatin
672747|NCT00364559|stroke|stroke
672748|NCT00364546|Osteoarthritis|osteoarthritis
672749|NCT00364546|Pain|pain
672750|NCT00364546|Low Back Pain|low back pain
672751|NCT00364546|Hip Pain|hip pain
672752|NCT00364546|Knee Pain|knee pain
672753|NCT00364546|Backache|backache
672754|NCT00364546|tapentadol|tapentadol
672755|NCT00364533|Arthralgia|arthralgia
672756|NCT00364533|Pain|pain
672757|NCT00364533|Pain Assessment|pain assessment
672758|NCT00364533|Hip Replacement|hip replacement
672759|NCT00364533|Tapentadol|tapentadol
672760|NCT00364520|Hematologic Diseases|hematologic diseases
672761|NCT00364520|Benzene|benzene
672762|NCT00364520|Genetic Polymorphisms|genetic polymorphisms
672763|NCT00364494|Hematocrit|hematocrit
672764|NCT00364494|Hemodilution|hemodilution
672765|NCT00364494|Blood Transfusion|blood transfusion
672766|NCT00364494|Cardiopulmonary Bypass|cardiopulmonary bypass
672767|NCT00364494|Multiple Organ Failure|multiple organ failure
672768|NCT00364494|Surgery, Cardiac|surgery, cardiac
672769|NCT00364494|Kidney Failure|kidney failure
672770|NCT00364494|Cardiac Surgical Procedures|cardiac surgical procedures
672771|NCT00364481|apnea|apnea
672772|NCT00364481|tongue|tongue
672773|NCT00364481|exercises|exercises
672774|NCT00364481|reflux|reflux
672775|NCT00364481|airway|airway
672776|NCT00364481|upper|upper
672777|NCT00364481|fatigue|fatigue
672778|NCT00364468|pegfilgrastim|pegfilgrastim
672779|NCT00364468|neutropenia|neutropenia
672780|NCT00364468|cancer patients|cancer patients
672781|NCT00364468|lymphoma|lymphoma
672782|NCT00364455|Hormone refractory prostate cancer|hormone refractory prostate cancer
672783|NCT00364455|Anemia|anemia
672784|NCT00364455|Quality-of-life|quality-of-life
672785|NCT00364442|asthma|asthma
672786|NCT00364429|schizophrenic patients|schizophrenic patients
672787|NCT00364429|SPET|spet
672788|NCT00364429|NMDA receptor|nmda receptor
672789|NCT00364429|ligand [123]I-CNS 1261|ligand [123]i-cns 1261
672790|NCT00364416|Heart Failure, congestive|heart failure, congestive
672791|NCT00364416|Heart decompensation|heart decompensation
672792|NCT00364403|Glycemic index|glycemic index
672793|NCT00364403|Glycemic load|glycemic load
672794|NCT00364403|Low fat|low fat
672795|NCT00364403|Impaired glucose tolerance|impaired glucose tolerance
672796|NCT00364403|Large for gestational age infant|large for gestational age infant
672797|NCT00364403|Excessive body weight|excessive body weight
672798|NCT00364390|CABG|cabg
672799|NCT00364390|Anginera|anginera
672801|NCT00364351|Non Small Cell Lung Cancer|non small cell lung cancer
672802|NCT00364351|NSCLC|nsclc
672803|NCT00364338|gourmet healthy cooking|gourmet healthy cooking
672804|NCT00364338|quality of life|quality of life
672805|NCT00364338|preimenopause|preimenopause
672806|NCT00364338|weight|weight
672807|NCT00364338|lipids|lipids
672808|NCT00364325|Heart failure, congestive|heart failure, congestive
672809|NCT00364325|Heart decompensation|heart decompensation
672810|NCT00364312|behavior therapy|behavior therapy
672811|NCT00364312|dietary control|dietary control
672812|NCT00364312|exercise|exercise
672813|NCT00364312|diabetes mellitus|diabetes mellitus
672814|NCT00364312|behavior modification|behavior modification
672815|NCT00364312|blood glucose|blood glucose
672816|NCT00364312|clinical trial|clinical trial
672817|NCT00364312|diabetes education|diabetes education
672818|NCT00364312|health behavior|health behavior
672819|NCT00364312|health care service utilization|health care service utilization
672820|NCT00364312|obesity|obesity
672821|NCT00364312|quality of life|quality of life
672822|NCT00364299|Ventilator-associated pneumonia|ventilator-associated pneumonia
672823|NCT00364299|Mechanical ventilation|mechanical ventilation
672824|NCT00364299|Tracheal tube cuff pressure|tracheal tube cuff pressure
672825|NCT00364286|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
672826|NCT00364286|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
672827|NCT00364286|Prolymphocytic Leukemia|prolymphocytic leukemia
672828|NCT00364286|Leukemia|leukemia
672829|NCT00364286|Lymphoma|lymphoma
672830|NCT00364286|Dasatinib|dasatinib
672831|NCT00364286|BMS-354825|bms-354825
672832|NCT00364273|Asthma|asthma
672833|NCT00364260|Anemia|anemia
672834|NCT00364260|epoetin alfa|epoetin alfa
672835|NCT00364247|Acute pain|acute pain
672836|NCT00364247|bunionectomy|bunionectomy
672837|NCT00364234|Renal Osteodystrophy|renal osteodystrophy
672838|NCT00364195|Metastatic breast cancer|metastatic breast cancer
672839|NCT00364195|Tesmilifene|tesmilifene
672840|NCT00364195|DPPE|dppe
672841|NCT00364182|Hemophilia B|hemophilia b
672842|NCT00364182|BeneFIX|benefix
672843|NCT00364169|constipation|constipation
672844|NCT00364169|cancer|cancer
672845|NCT00364169|surgery|surgery
672846|NCT00364169|intervention|intervention
672847|NCT00364169|nursing|nursing
672848|NCT00364169|postoperative|postoperative
672849|NCT00364143|Cancer|cancer
672850|NCT00364143|Advanced Solid Tumor|advanced solid tumor
672851|NCT00364143|Oncology|oncology
672852|NCT00364117|150 discharges|150 discharges
672853|NCT00364117|adults|adults
672854|NCT00364117|Internal Medicine|internal medicine
672855|NCT00364104|Iron deficiency|iron deficiency
672856|NCT00364104|Helicobacter infection|helicobacter infection
672857|NCT00364104|Epidemiology|epidemiology
672858|NCT00364091|allergic conjunctivitis, ophthalmology, multicenter, controlled|allergic conjunctivitis, ophthalmology, multicenter, controlled
672859|NCT00364078|Cross-sectional correlational study|cross-sectional correlational study
672860|NCT00364078|Uncertainty|uncertainty
672861|NCT00364078|Locus of Control|locus of control
672862|NCT00364078|Quality of life|quality of life
672863|NCT00364078|Transitoriness|transitoriness
672864|NCT00364078|Cancer care|cancer care
672865|NCT00364052|Valganciclovir, Oral Ganciclovir, Liver transplant|valganciclovir, oral ganciclovir, liver transplant
672866|NCT00364013|Oncology|oncology
672867|NCT00364013|Cancer|cancer
672868|NCT00364013|metastatic colorectal cancer|metastatic colorectal cancer
672869|NCT00364013|EGFr|egfr
672870|NCT00364013|Panitumumab|panitumumab
672871|NCT00364013|Clinical Trail|clinical trail
672872|NCT00364013|Amgen|amgen
672873|NCT00364000|haemodialysis|haemodialysis
672874|NCT00364000|hyperphosphatemia|hyperphosphatemia
672875|NCT00364000|sevelamer|sevelamer
672876|NCT00364000|calcium acetate|calcium acetate
672877|NCT00363987|nephropathy with type 2 diabetes|nephropathy with type 2 diabetes
672878|NCT00363974|AML|aml
672879|NCT00363974|leukemia|leukemia
672880|NCT00363974|relapse|relapse
672881|NCT00363974|refractory|refractory
672882|NCT00363974|antisense|antisense
672883|NCT00363974|oligonucleotide|oligonucleotide
672884|NCT00363961|End stage renal disease|end stage renal disease
672885|NCT00363961|Maintenance dialysis|maintenance dialysis
672886|NCT00363961|Resistance exercise|resistance exercise
672887|NCT00363961|Muscle wasting|muscle wasting
672888|NCT00363961|Disability|disability
672889|NCT00363948|MK-0431|mk-0431
672890|NCT00363948|ONO-5435|ono-5435
672891|NCT00363948|Type 2 diabetes mellitus|type 2 diabetes mellitus
672892|NCT00363922|Coronary Artery Bypass [E04.100.376.719.332]|coronary artery bypass [e04.100.376.719.332]
672893|NCT00363909|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
672895|NCT00363909|breast cancer|breast cancer
672896|NCT00363896|COPD|copd
672897|NCT00363896|Lung function|lung function
672898|NCT00363896|Exacerbations|exacerbations
672899|NCT00363896|Quality of Life|quality of life
672900|NCT00363870|Influenza vaccine|influenza vaccine
672901|NCT00363870|Prophylaxis Influenza vaccine|prophylaxis influenza vaccine
672902|NCT00363857|fatigue|fatigue
672903|NCT00363857|sleep|sleep
672904|NCT00363857|sleep disorder|sleep disorder
672905|NCT00363857|Legs|legs
672906|NCT00363857|RLS|rls
672907|NCT00363857|Restless Legs Syndrome|restless legs syndrome
672908|NCT00363857|Ropinirole|ropinirole
672909|NCT00363844|MK-0431|mk-0431
672910|NCT00363844|ONO-5435|ono-5435
672911|NCT00363844|Type 2 diabetes mellitus|type 2 diabetes mellitus
672912|NCT00363818|Endothelial function|endothelial function
672913|NCT00363818|Platelet function|platelet function
672914|NCT00363818|Coronary artery disease|coronary artery disease
672915|NCT00363818|Thrombosis|thrombosis
672916|NCT00363818|Aggregation|aggregation
672917|NCT00363805|lung cancer|lung cancer
672918|NCT00363805|prevention|prevention
672919|NCT00363805|green tea|green tea
672920|NCT00363805|former smokers|former smokers
672921|NCT00363792|Healthy subjects|healthy subjects
672922|NCT00363779|Large Granular Lymphocyte (LGL)|large granular lymphocyte (lgl)
672923|NCT00363779|LGL|lgl
672924|NCT00363779|Leukemia|leukemia
672925|NCT00363779|Cyclosporine|cyclosporine
672926|NCT00363779|Microarray|microarray
672927|NCT00363779|Gene Expression|gene expression
672928|NCT00363779|Cyclosporin|cyclosporin
672929|NCT00363779|Large Granular Lymphocyte Leukemia|large granular lymphocyte leukemia
672930|NCT00363779|LGL Leukemia|lgl leukemia
672931|NCT00363753|Transient ischemic attack|transient ischemic attack
672932|NCT00363753|Stroke|stroke
672933|NCT00363753|Aspirin|aspirin
672934|NCT00363753|Clopidogrel|clopidogrel
672935|NCT00363740|GW685698X|gw685698x
672936|NCT00363740|allergic rhinitis|allergic rhinitis
672937|NCT00363740|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
672938|NCT00363727|dyskinesia|dyskinesia
672939|NCT00363727|SINEMET|sinemet
672940|NCT00363727|Parkinson's disease|parkinson's disease
672941|NCT00363727|controlled release ropinirole|controlled release ropinirole
672942|NCT00363701|Protonpumpinhibitors|protonpumpinhibitors
672943|NCT00363701|withdrawal|withdrawal
672944|NCT00363701|longterm treatment|longterm treatment
672945|NCT00363701|dyspepsia|dyspepsia
672946|NCT00363701|functional dyspepsia|functional dyspepsia
672947|NCT00363701|gastrooesophageal reflux|gastrooesophageal reflux
672948|NCT00363701|upper endoscopy|upper endoscopy
672949|NCT00363688|Non life threatening allergic reaction|non life threatening allergic reaction
672950|NCT00363688|oral challenge|oral challenge
672951|NCT00363688|penicillin|penicillin
672952|NCT00363688|skin testing|skin testing
672953|NCT00363675|Hand Burns|hand burns
672954|NCT00363675|Pediatrics|pediatrics
672955|NCT00363649|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
672956|NCT00363649|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
672957|NCT00363636|relapsed|relapsed
672958|NCT00363636|NHL|nhl
672959|NCT00363636|pharmacokinetics|pharmacokinetics
672960|NCT00363636|antibody|antibody
672961|NCT00363636|safety|safety
672962|NCT00363636|galiximab|galiximab
672963|NCT00363636|efficacy|efficacy
672964|NCT00363636|rituximab|rituximab
672965|NCT00363636|refractory|refractory
672966|NCT00363610|Advanced and/or Metastatic Solid Tumors and Lymphoma|advanced and/or metastatic solid tumors and lymphoma
672967|NCT00363597|dyspepsia|dyspepsia
672968|NCT00363597|gastrointestinal disease|gastrointestinal disease
672969|NCT00363597|indigestion|indigestion
672970|NCT00363584|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
672971|NCT00363584|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
672972|NCT00363584|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
672973|NCT00363584|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
672974|NCT00363584|adenocarcinoma with squamous metaplasia of the gallbladder|adenocarcinoma with squamous metaplasia of the gallbladder
672975|NCT00363584|anaplastic carcinoma of the gallbladder|anaplastic carcinoma of the gallbladder
672976|NCT00363584|localized gallbladder cancer|localized gallbladder cancer
672977|NCT00363584|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
672978|NCT00363584|squamous cell carcinoma of the gallbladder|squamous cell carcinoma of the gallbladder
672979|NCT00363584|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
672980|NCT00363558|skin graft|skin graft
672981|NCT00363558|fixation|fixation
672982|NCT00363558|cyanoacrylate glue|cyanoacrylate glue
672983|NCT00363558|skin staples|skin staples
672984|NCT00363545|Prophylaxis against gastroenteritis caused by Rotavirus|prophylaxis against gastroenteritis caused by rotavirus
672985|NCT00363532|migraine with out aura|migraine with out aura
672986|NCT00363519|MK-0431|mk-0431
672987|NCT00363519|ONO-5435|ono-5435
672988|NCT00363519|Type 2 diabetes mellitus|type 2 diabetes mellitus
672989|NCT00363506|nutritional|nutritional
673916|NCT00360048|sepsis|sepsis
672990|NCT00363506|C10.228.140.546.399.750|c10.228.140.546.399.750
672991|NCT00363480|Asthma|asthma
672992|NCT00363480|Asthma Control Test|asthma control test
672993|NCT00363480|SERETIDE|seretide
672994|NCT00363467|Busulfan|busulfan
672995|NCT00363467|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
672996|NCT00363467|Hematopoietic Stem Cell Transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
672997|NCT00363467|Dendritic cells|dendritic cells
672998|NCT00363467|Bone marrow transplantation|bone marrow transplantation
672999|NCT00363467|PBSC mobilization|pbsc mobilization
673000|NCT00363467|Autologous stem cells|autologous stem cells
673002|NCT00363454|Pharmacokinetics|pharmacokinetics
673003|NCT00363454|TCN-PM|tcn-pm
673004|NCT00363454|VD-0002|vd-0002
673005|NCT00363454|Immunohistochemistry|immunohistochemistry
673006|NCT00363454|Serum tumor marker|serum tumor marker
673007|NCT00363454|Akt phosphorylation|akt phosphorylation
673008|NCT00363454|Ex vivo testing|ex vivo testing
673009|NCT00363454|metastatic|metastatic
673010|NCT00363441|head and neck neoplasms|head and neck neoplasms
673011|NCT00363441|squamous cell cancer|squamous cell cancer
673012|NCT00363441|intensity modulated radiotherapy|intensity modulated radiotherapy
673013|NCT00363428|pulmonary complications|pulmonary complications
673014|NCT00363428|perioperative/postoperative complications|perioperative/postoperative complications
673015|NCT00363428|tobacco use disorder|tobacco use disorder
673016|NCT00363428|non-small cell lung cancer|non-small cell lung cancer
673017|NCT00363428|small cell lung cancer|small cell lung cancer
673018|NCT00363402|Cystic Fibrosis|cystic fibrosis
673019|NCT00363389|Hysteroscopy|hysteroscopy
673020|NCT00363389|Misoprostol|misoprostol
673021|NCT00363389|Uterine hemorrhage|uterine hemorrhage
673022|NCT00363389|Uterine cervix|uterine cervix
673023|NCT00363389|Dilatation|dilatation
673024|NCT00363376|olanzapine|olanzapine
673025|NCT00363376|zonisamide|zonisamide
673026|NCT00363376|weight gain|weight gain
673027|NCT00363376|bipolar disorder|bipolar disorder
673028|NCT00363376|psychotic disorders|psychotic disorders
673029|NCT00363363|Pediatrics|pediatrics
673030|NCT00363363|Fontan Procedure|fontan procedure
673031|NCT00363363|Physical Activity|physical activity
673032|NCT00363363|Physical Fitness|physical fitness
673033|NCT00363363|Congenital Heart Defects|congenital heart defects
673034|NCT00363363|exercise rehabilitation|exercise rehabilitation
673035|NCT00363337|Adults|adults
673036|NCT00363337|Bipolar Depression|bipolar depression
673037|NCT00363337|Bipolar Disorder|bipolar disorder
673038|NCT00363337|Bipolar I|bipolar i
673039|NCT00363337|Bipolar II|bipolar ii
673040|NCT00363337|Depression|depression
673041|NCT00363324|stem cell|stem cell
673042|NCT00363324|acute myocardial infarction|acute myocardial infarction
673043|NCT00363311|Dutasteride Prostate Cancer Expectant management REDEEM|dutasteride prostate cancer expectant management redeem
673044|NCT00363298|D-amphetamine, dextro-amphetamine, stimulant drug|d-amphetamine, dextro-amphetamine, stimulant drug
673045|NCT00363285|adenocarcinoma of the prostate|adenocarcinoma of the prostate
673046|NCT00363285|stage III prostate cancer|stage iii prostate cancer
673047|NCT00363285|stage IV prostate cancer|stage iv prostate cancer
673048|NCT00363246|Elderly|elderly
673049|NCT00363246|Fall risk|fall risk
673050|NCT00363246|Veterans|veterans
673051|NCT00363246|WheelChairs|wheelchairs
673052|NCT00363246|Injury|injury
673053|NCT00363233|type 2 diabetes|type 2 diabetes
673054|NCT00363233|lignans|lignans
673055|NCT00363233|flaxseed|flaxseed
673056|NCT00363233|cholesterol|cholesterol
673057|NCT00363220|Infection|infection
673058|NCT00363220|E coli|e coli
673059|NCT00363220|Klebsiella|klebsiella
673060|NCT00363220|ESBL|esbl
673061|NCT00363207|behavior|behavior
673062|NCT00363207|local anesthesia|local anesthesia
673063|NCT00363207|behavior after dental local anesthesia|behavior after dental local anesthesia
673064|NCT00363194|Pazopanib GW786034 Advanced cancer Metastatic cancer|pazopanib gw786034 advanced cancer metastatic cancer
673065|NCT00363181|Insulin resistance|insulin resistance
673066|NCT00363181|Metabolic problems|metabolic problems
673067|NCT00363181|Weight gain|weight gain
673068|NCT00363181|Mental health problems|mental health problems
673069|NCT00363181|Mental disorders|mental disorders
673070|NCT00363181|Antipsychotic medication|antipsychotic medication
673071|NCT00363181|Olanzapine|olanzapine
673072|NCT00363168|Hemorrhagic Choroidal Neovascularization|hemorrhagic choroidal neovascularization
673073|NCT00363155|chronic|chronic
673074|NCT00363155|hepatitis b|hepatitis b
673075|NCT00363142|HIV-1 LEXIVA Ritonavir Once-daily|hiv-1 lexiva ritonavir once-daily
673076|NCT00363129|neurotoxicity|neurotoxicity
673077|NCT00363129|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
673078|NCT00363116|Kidney transplant|kidney transplant
673079|NCT00363116|Pancreas transplant|pancreas transplant
673080|NCT00363116|Daclizumab|daclizumab
673081|NCT00363116|Tacrolimus|tacrolimus
673082|NCT00363116|Mycophenolate mofetil|mycophenolate mofetil
673083|NCT00363116|Steroids|steroids
673084|NCT00363116|Immunosuppression|immunosuppression
673085|NCT00363116|Acute allograft rejection|acute allograft rejection
673171|NCT00362765|Type 2 Diabetes|type 2 diabetes
673086|NCT00363090|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
673087|NCT00363090|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
673088|NCT00363090|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
673089|NCT00363090|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
673090|NCT00363090|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
673091|NCT00363090|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
673092|NCT00363090|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
673093|NCT00363090|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
673094|NCT00363090|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
673095|NCT00363090|anaplastic large cell lymphoma|anaplastic large cell lymphoma
673096|NCT00363090|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
673097|NCT00363090|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
673098|NCT00363090|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
673099|NCT00363077|Influenza vaccine|influenza vaccine
673100|NCT00363077|Prophylaxis Influenza vaccine|prophylaxis influenza vaccine
673101|NCT00363051|Pancreatic|pancreatic
673102|NCT00363051|Tumor|tumor
673103|NCT00363051|Islet Cell|islet cell
673104|NCT00363051|Carcinoma|carcinoma
673105|NCT00363051|Neuroendocrine|neuroendocrine
673106|NCT00363051|Endocrine|endocrine
673107|NCT00363051|Atypical Carcinoid|atypical carcinoid
673108|NCT00363051|RADIANT1|radiant1
673109|NCT00363051|RADIANT-1|radiant-1
673110|NCT00363038|Bruising|bruising
673111|NCT00363038|Topical 20% arnica|topical 20% arnica
673112|NCT00363025|Acute myeloid leukemia|acute myeloid leukemia
673113|NCT00363025|Older patients|older patients
673114|NCT00363025|Patient aged 65 years or more|patient aged 65 years or more
673115|NCT00363012|stage IIIA breast cancer|stage iiia breast cancer
673116|NCT00363012|stage IIIB breast cancer|stage iiib breast cancer
673117|NCT00363012|stage IIIC breast cancer|stage iiic breast cancer
673118|NCT00363012|stage IV breast cancer|stage iv breast cancer
673119|NCT00363012|male breast cancer|male breast cancer
673120|NCT00362999|Allergic|allergic
673121|NCT00362999|Rhinitis|rhinitis
673122|NCT00362999|Pharmacogenetics|pharmacogenetics
673123|NCT00362999|Histamine|histamine
673124|NCT00362986|dermatologic complications|dermatologic complications
673125|NCT00362986|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
673126|NCT00362973|male breast cancer|male breast cancer
673127|NCT00362973|recurrent breast cancer|recurrent breast cancer
673128|NCT00362973|stage I breast cancer|stage i breast cancer
673129|NCT00362973|stage II breast cancer|stage ii breast cancer
673130|NCT00362973|stage IIIA breast cancer|stage iiia breast cancer
673131|NCT00362973|stage IIIB breast cancer|stage iiib breast cancer
673132|NCT00362973|stage IIIC breast cancer|stage iiic breast cancer
673133|NCT00362973|stage IV breast cancer|stage iv breast cancer
673134|NCT00362960|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
673135|NCT00362960|Diabetic Nephropathy|diabetic nephropathy
673136|NCT00362960|Inflammatory Markers|inflammatory markers
673137|NCT00362960|Proteinuria|proteinuria
673138|NCT00362960|Renal Disease|renal disease
673139|NCT00362947|Superficial vein thrombosis|superficial vein thrombosis
673140|NCT00362947|thrombophlebitis|thrombophlebitis
673141|NCT00362947|LMWH|lmwh
673142|NCT00362947|parnaparin|parnaparin
673143|NCT00362934|Hyperlipidemia Combined|hyperlipidemia combined
673144|NCT00362934|efficacy combination fenofibrate simvastatin versus atorvastatin|efficacy combination fenofibrate simvastatin versus atorvastatin
673145|NCT00362921|adult glioblastoma multiforme|adult glioblastoma multiforme
673146|NCT00362921|adult gliosarcoma|adult gliosarcoma
673147|NCT00362921|recurrent adult brain tumor|recurrent adult brain tumor
673148|NCT00362908|Obesity|obesity
673149|NCT00362908|Hypertension|hypertension
673150|NCT00362908|Insulin Resistance|insulin resistance
673151|NCT00362869|Enteroaggregative Escherichia coli, diarrhea, challenge|enteroaggregative escherichia coli, diarrhea, challenge
673152|NCT00362856|larazotide acetate|larazotide acetate
673153|NCT00362843|11C-Leucine|11c-leucine
673154|NCT00362843|Positron Emission Tomography (PET)|positron emission tomography (pet)
673155|NCT00362843|Cerebral Protein Synthesis|cerebral protein synthesis
673156|NCT00362843|Propofol|propofol
673157|NCT00362843|Fragile X|fragile x
673158|NCT00362843|Fragile X Syndrome|fragile x syndrome
673159|NCT00362817|Recurrent|recurrent
673160|NCT00362817|Symptomatic|symptomatic
673161|NCT00362804|tetrabenazine|tetrabenazine
673162|NCT00362804|partial response|partial response
673163|NCT00362804|psychosis|psychosis
673164|NCT00362804|schizophrenia|schizophrenia
673165|NCT00362804|schizoaffective disorder|schizoaffective disorder
673166|NCT00362804|partial response to antipsychotics|partial response to antipsychotics
673167|NCT00362791|voluntary counseling and testing|voluntary counseling and testing
673168|NCT00362791|HIV/STD prevention counseling|hiv/std prevention counseling
673169|NCT00362791|HIV/STD prevention intervention|hiv/std prevention intervention
673170|NCT00362791|counseling efficacy|counseling efficacy
673172|NCT00362765|Dyslipidemia|dyslipidemia
673173|NCT00362765|Hyperinsulinemic|hyperinsulinemic
673174|NCT00362765|Clamp|clamp
673175|NCT00362765|Metformin|metformin
673176|NCT00362765|Fenofibrate|fenofibrate
673177|NCT00362752|norfloxacin|norfloxacin
673178|NCT00362752|hepatopulmonary syndrome|hepatopulmonary syndrome
673179|NCT00362726|HIV|hiv
673180|NCT00362687|HIV, HAART|hiv, haart
673181|NCT00362661|PTSD|ptsd
673182|NCT00362661|cortisol|cortisol
673183|NCT00362661|memory|memory
673184|NCT00362661|treatment|treatment
673185|NCT00362622|Travalert|travalert
673186|NCT00362622|open angle glaucoma|open angle glaucoma
673187|NCT00362609|Safety|safety
673188|NCT00362596|Acyclovir|acyclovir
673189|NCT00362596|HIV|hiv
673190|NCT00362596|HSV|hsv
673191|NCT00362583|Cancer pain with breakthrough pain episodes|cancer pain with breakthrough pain episodes
673192|NCT00362570|Newly diagnosed|newly diagnosed
673193|NCT00362544|antifungal prophylaxis|antifungal prophylaxis
673194|NCT00362544|allogeneic stem-cell transplantation|allogeneic stem-cell transplantation
673195|NCT00362544|acute leukaemia|acute leukaemia
673196|NCT00362544|antifungal prophylaxis treatment of allogeneic stem-cell transplantation and acute leukaemia|antifungal prophylaxis treatment of allogeneic stem-cell transplantation and acute leukaemia
673197|NCT00362518|atherosclerosis|atherosclerosis
673198|NCT00362518|vitamin C|vitamin c
673199|NCT00362518|vitamin E|vitamin e
673200|NCT00362492|TKR|tkr
673201|NCT00362492|Ultrasonography|ultrasonography
673202|NCT00362492|asymptomatic deep venous thrombosis|asymptomatic deep venous thrombosis
673203|NCT00362492|extended duration prophylaxis|extended duration prophylaxis
673204|NCT00362492|short duration prophylaxis|short duration prophylaxis
673205|NCT00362479|pregnancy prevention|pregnancy prevention
673206|NCT00362479|oral contraceptives|oral contraceptives
673207|NCT00362466|Leukemia (chronic myeloid leukemia - chronic phase)|leukemia (chronic myeloid leukemia - chronic phase)
673208|NCT00362440|HIV lipodystrophy|hiv lipodystrophy
673209|NCT00362440|Leptin|leptin
673210|NCT00362440|Fat wasting|fat wasting
673211|NCT00362440|Pioglitazone|pioglitazone
673212|NCT00362440|Insulin resistance|insulin resistance
673213|NCT00362427|Hepatitis B|hepatitis b
673214|NCT00362427|Pertussis|pertussis
673215|NCT00362427|Diphtheria|diphtheria
673216|NCT00362427|Tetanus|tetanus
673217|NCT00362427|H. influenzae type b|h. influenzae type b
673218|NCT00362427|Polio|polio
673219|NCT00362414|Stroke|stroke
673220|NCT00362401|Psychoacoustics|psychoacoustics
673221|NCT00362401|Quality of Life|quality of life
673222|NCT00362401|Heart Valve Prosthesis|heart valve prosthesis
673223|NCT00362388|Coronary artery disease|coronary artery disease
673224|NCT00362388|Ischemic heart disease|ischemic heart disease
673225|NCT00362388|Angiogenesis|angiogenesis
673226|NCT00362388|Cells|cells
673227|NCT00362388|Cardiac surgery|cardiac surgery
673228|NCT00362375|Adult|adult
673229|NCT00362375|*HIV Infections/pc [Prevention & Control]|*hiv infections/pc [prevention & control]
673230|NCT00362375|Female|female
673231|NCT00362375|Humans|humans
673232|NCT00362375|Risk-Taking|risk-taking
673233|NCT00362375|Safe Sex|safe sex
673234|NCT00362375|Sexual Behavior|sexual behavior
673235|NCT00362375|HIV Testing|hiv testing
673236|NCT00362362|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
673237|NCT00362362|Primary Lateral Sclerosis|primary lateral sclerosis
673238|NCT00362362|Genetics|genetics
673239|NCT00362362|Blood Sample|blood sample
673240|NCT00362362|PLS|pls
673241|NCT00362362|ALS|als
673242|NCT00362349|ITP|itp
673243|NCT00362349|IVIg|ivig
673244|NCT00362349|Platelet count|platelet count
673245|NCT00362349|Bleeding|bleeding
673246|NCT00362336|Hepatitis B|hepatitis b
673247|NCT00362336|Polio|polio
673248|NCT00362336|Diphtheria|diphtheria
673249|NCT00362336|Pertussis|pertussis
673250|NCT00362336|H. influenzae type b|h. influenzae type b
673251|NCT00362323|Treatment of Dyslipidemia and of Type 2 Diabetes Mellitus|treatment of dyslipidemia and of type 2 diabetes mellitus
673252|NCT00362310|classical kaposi's sarcoma|classical kaposi's sarcoma
673253|NCT00362310|treatment|treatment
673254|NCT00362310|HIV protease inhibitor indinavir|hiv protease inhibitor indinavir
673255|NCT00362284|Alzheimer's disease|alzheimer's disease
673256|NCT00362284|coping|coping
673257|NCT00362284|quality of life|quality of life
673258|NCT00362284|caregiving|caregiving
673259|NCT00362271|Healthy Subjects|healthy subjects
673260|NCT00362245|Amikacin|amikacin
673261|NCT00362245|Pharmacokinetics|pharmacokinetics
673262|NCT00362245|Pharmacodynamics|pharmacodynamics
673263|NCT00362245|Intra-Thecal injection|intra-thecal injection
673264|NCT00362232|Prevention of venous thromboembolism|prevention of venous thromboembolism
673265|NCT00362219|topical|topical
673266|NCT00362219|morphine|morphine
673267|NCT00362219|pain|pain
673268|NCT00362219|skin-wound|skin-wound
673269|NCT00362219|skin-graft|skin-graft
673270|NCT00362219|peripheral analgesia|peripheral analgesia
673271|NCT00362219|burn|burn
673272|NCT00362206|Hyperlipidemia Combined, efficacy combination fenofibrate simvastatin versus pravastatin|hyperlipidemia combined, efficacy combination fenofibrate simvastatin versus pravastatin
673273|NCT00362206|Hyperlipidemia Combined|hyperlipidemia combined
673274|NCT00362193|Diabetes|diabetes
673275|NCT00362193|Chronic disease management|chronic disease management
673276|NCT00362193|Relapse|relapse
673277|NCT00362180|LDL-cholesterol|ldl-cholesterol
673278|NCT00362180|apoB-100|apob-100
673279|NCT00362180|apoB-48|apob-48
673280|NCT00362180|triglyceride|triglyceride
673281|NCT00362180|HeFH|hefh
673282|NCT00362180|FHBL|fhbl
673283|NCT00362167|Clinical Experience|clinical experience
673284|NCT00362167|Educational Training|educational training
673285|NCT00362167|Pain Syndromes|pain syndromes
673286|NCT00362167|Analgesia|analgesia
673287|NCT00362167|Pain Medicine|pain medicine
673288|NCT00362167|Therapy|therapy
673289|NCT00362167|Neuropathic|neuropathic
673290|NCT00362167|Chronic Pain|chronic pain
673291|NCT00362167|Acute Pain|acute pain
673292|NCT00362167|Analgesics|analgesics
673293|NCT00362167|Medication|medication
673294|NCT00362167|Evaluation|evaluation
673295|NCT00362141|levetiracetam|levetiracetam
673296|NCT00362141|status|status
673297|NCT00362141|epilepticus|epilepticus
673298|NCT00362128|Blood Pressure, High|blood pressure, high
673299|NCT00362128|Obesity|obesity
673300|NCT00362128|Tobacco Use Disorder|tobacco use disorder
673301|NCT00362115|hypertension|hypertension
673302|NCT00362115|blood pressure|blood pressure
673303|NCT00362115|diastolic blood pressure|diastolic blood pressure
673304|NCT00362115|drug therapy|drug therapy
673305|NCT00362102|EGFR-detectable metastatic colorectal carcinoma with documented progressive disease to irinotecan-based chemotherapy and failure|egfr-detectable metastatic colorectal carcinoma with documented progressive disease to irinotecan-based chemotherapy and failure
673306|NCT00362089|n-3 fatty acids|n-3 fatty acids
673307|NCT00362089|n-6 fatty acids|n-6 fatty acids
673308|NCT00362089|long chain polyunsaturated fatty acids|long chain polyunsaturated fatty acids
673309|NCT00362089|pregnancy|pregnancy
673310|NCT00362089|lactation|lactation
673311|NCT00362089|breast feeding|breast feeding
673312|NCT00362089|breast milk|breast milk
673313|NCT00362089|adipose tissue|adipose tissue
673314|NCT00362089|newborn|newborn
673315|NCT00362089|fetal development|fetal development
673316|NCT00362076|Perception|perception
673317|NCT00362076|Development|development
673318|NCT00362076|Cognition|cognition
673319|NCT00362076|Vision|vision
673320|NCT00362076|Infants|infants
673321|NCT00362076|Autonomic Function|autonomic function
673322|NCT00362076|Cardiac Vagal Tone|cardiac vagal tone
673323|NCT00362076|Categorization|categorization
673324|NCT00362076|Habituation|habituation
673325|NCT00362076|Motion-Carried Information|motion-carried information
673326|NCT00362063|growth hormone|growth hormone
673327|NCT00362050|malaria, falciparum|malaria, falciparum
673328|NCT00362050|uncomplicated Plasmodium falciparum malaria|uncomplicated plasmodium falciparum malaria
673329|NCT00361998|Uncomplicated Cystitis|uncomplicated cystitis
673330|NCT00361998|Nitrofurantoin Macrocrystals|nitrofurantoin macrocrystals
673331|NCT00361985|Gastric bypass|gastric bypass
673332|NCT00361985|Anastomotic stricture|anastomotic stricture
673333|NCT00361985|Morbid obesity|morbid obesity
673334|NCT00361985|Bariatric surgery|bariatric surgery
673335|NCT00361985|Omeprazole|omeprazole
673336|NCT00361959|fluticasone propionate/salmeterol combination|fluticasone propionate/salmeterol combination
673337|NCT00361959|tiotropium|tiotropium
673338|NCT00361959|SERETIDE|seretide
673339|NCT00361959|COPD exacerbation|copd exacerbation
673340|NCT00361946|Type 2 diabetes|type 2 diabetes
673341|NCT00361946|Lean|lean
673342|NCT00361946|Obese|obese
673343|NCT00361920|steroid resistant asthma|steroid resistant asthma
673344|NCT00361907|Pulsatile intravenous insulin|pulsatile intravenous insulin
673345|NCT00361907|Oral carbohydrate loading|oral carbohydrate loading
673346|NCT00361907|Respiratory Quotients|respiratory quotients
673347|NCT00361907|Hypoglycemia|hypoglycemia
673348|NCT00361907|Diabetic Complications|diabetic complications
673349|NCT00361907|Circulating vascular and inflammatory markers|circulating vascular and inflammatory markers
673350|NCT00361868|Treatment of Dyslipidemia and of Type 2 Diabetes Mellitus|treatment of dyslipidemia and of type 2 diabetes mellitus
673351|NCT00361855|MI|mi
673352|NCT00361842|Colorectal cancer|colorectal cancer
673353|NCT00361842|Colorectal carcinoma|colorectal carcinoma
673354|NCT00361842|Colonic cancer|colonic cancer
673355|NCT00361842|Rectal cancer|rectal cancer
673356|NCT00361829|Development|development
673357|NCT00361829|Childhood Growth|childhood growth
673358|NCT00361816|Maternal Effect Gene|maternal effect gene
673359|NCT00361816|Embryonic Development|embryonic development
673360|NCT00361816|Infertility|infertility
673361|NCT00361803|chemotherapy|chemotherapy
673362|NCT00361803|recurrent|recurrent
673363|NCT00361803|refractory|refractory
673364|NCT00361803|research|research
673365|NCT00361803|cancer|cancer
673366|NCT00361803|pharmacokinetics|pharmacokinetics
673367|NCT00361790|Healthy Subjects|healthy subjects
673368|NCT00361777|Obesity|obesity
673369|NCT00361777|Pseudo-Cushing State|pseudo-cushing state
673370|NCT00361777|Hypercortisolism|hypercortisolism
673371|NCT00361777|Cushing's Syndrome|cushing's syndrome
673372|NCT00361777|Cushing Syndrome|cushing syndrome
673373|NCT00361751|Glucose metabolism|glucose metabolism
673374|NCT00361751|Fat Metabolism|fat metabolism
673375|NCT00361751|Insulin Resistance|insulin resistance
673376|NCT00361751|Protein Metabolism|protein metabolism
673377|NCT00361751|Tracer Methodology|tracer methodology
673378|NCT00361738|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
673379|NCT00361725|severe sepsis|severe sepsis
673380|NCT00361725|organ failure|organ failure
673381|NCT00361725|activated protein C|activated protein c
673382|NCT00361725|thrombomodulin|thrombomodulin
673383|NCT00361725|EPCR|epcr
673384|NCT00361712|Epidural|epidural
673385|NCT00361712|analgesia|analgesia
673386|NCT00361712|labor|labor
673387|NCT00361712|cytokines|cytokines
673388|NCT00361699|stroke|stroke
673389|NCT00361699|brain ischemia|brain ischemia
673390|NCT00361699|cerebrovascular accident|cerebrovascular accident
673391|NCT00361699|statin|statin
673392|NCT00361699|hydroxymethylglutaryl-CoA reductase inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
673393|NCT00361699|cholesterol|cholesterol
673394|NCT00361699|hypercholesterolemia|hypercholesterolemia
673395|NCT00361699|hyperlipidemia|hyperlipidemia
673396|NCT00361699|multicenter studies|multicenter studies
673397|NCT00361699|prospective studies|prospective studies
673398|NCT00361699|endpoint determination|endpoint determination
673399|NCT00361699|randomized controlled trials|randomized controlled trials
673400|NCT00361699|recurrence|recurrence
673401|NCT00361699|pravastatin|pravastatin
673402|NCT00361699|c-reactive Protein|c-reactive protein
673403|NCT00361686|tramadol|tramadol
673404|NCT00361686|remifentanyl|remifentanyl
673405|NCT00361686|patient controlled analgesia|patient controlled analgesia
673406|NCT00361686|abortion|abortion
673407|NCT00361673|Health Disparities|health disparities
673408|NCT00361673|Built Environments|built environments
673409|NCT00361660|Motor skills|motor skills
673410|NCT00361660|Occupational Therapy|occupational therapy
673411|NCT00361660|Physical Therapy Techniques|physical therapy techniques
673412|NCT00361660|Rehabilitation|rehabilitation
673413|NCT00361660|Upper Extremity|upper extremity
673414|NCT00361660|Stroke|stroke
673415|NCT00361634|Etanercept|etanercept
673416|NCT00361634|Enbrel|enbrel
673417|NCT00361634|DCE-MRI|dce-mri
673418|NCT00361634|RA|ra
673419|NCT00361621|VELCADE|velcade
673420|NCT00361608|diabetes|diabetes
673421|NCT00361608|hypoglycemia|hypoglycemia
673422|NCT00361608|monitor|monitor
673423|NCT00361608|children with Type I Diabetes|children with type i diabetes
673424|NCT00361595|osteoporosis|osteoporosis
673425|NCT00361595|zoledronic acid|zoledronic acid
673426|NCT00361595|forteo|forteo
673427|NCT00361582|Osteoarthritis|osteoarthritis
673428|NCT00361582|tapentadol|tapentadol
673429|NCT00361582|knee-replacement|knee-replacement
673430|NCT00361582|hip replacement|hip replacement
673431|NCT00361582|pain|pain
673432|NCT00361569|vaginal atrophy|vaginal atrophy
673433|NCT00361569|vaginal dryness|vaginal dryness
673434|NCT00361569|vaginal itching|vaginal itching
673435|NCT00361569|vaginal pain|vaginal pain
673436|NCT00361556|low back pain|low back pain
673437|NCT00361556|disability|disability
673438|NCT00361556|health education|health education
673439|NCT00361556|primary care|primary care
673440|NCT00361543|Schizophrenia|schizophrenia
673441|NCT00361543|Mental Illness|mental illness
673442|NCT00361543|SERM|serm
673443|NCT00361543|Raloxifene|raloxifene
673444|NCT00361543|Cognition|cognition
673445|NCT00361530|stroke|stroke
673446|NCT00361530|brain ischemia|brain ischemia
673447|NCT00361530|cerebrovascular accident|cerebrovascular accident
673448|NCT00361530|statin|statin
673449|NCT00361530|hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
673450|NCT00361530|cholesterol|cholesterol
673451|NCT00361530|hypercholesterolemia|hypercholesterolemia
673452|NCT00361530|hyperlipidemia|hyperlipidemia
673453|NCT00361530|multicenter studies|multicenter studies
673454|NCT00361530|prospective studies|prospective studies
673455|NCT00361530|endpoint determination|endpoint determination
673456|NCT00361530|randomized controlled trials|randomized controlled trials
673457|NCT00361530|recurrence|recurrence
673458|NCT00361530|pravastatin|pravastatin
673459|NCT00361530|plaque|plaque
673460|NCT00361530|tunica intima|tunica intima
673461|NCT00361530|tunica media|tunica media
673462|NCT00361530|ultrasonography|ultrasonography
673463|NCT00361530|carotid arteries|carotid arteries
673464|NCT00361517|GM monitoring|gm monitoring
673465|NCT00361517|Immunocompromised|immunocompromised
673466|NCT00361517|hematological disorder|hematological disorder
673467|NCT00361517|Allogenic HSCT recipients|allogenic hsct recipients
673468|NCT00361517|Aspergillus PCR assay|aspergillus pcr assay
673469|NCT00361504|Osteoarthritis|osteoarthritis
673470|NCT00361504|Pain|pain
673471|NCT00361504|Low Back Pain|low back pain
673472|NCT00361504|Hip Pain|hip pain
673473|NCT00361504|Knee Pain|knee pain
673474|NCT00361504|Backache|backache
673475|NCT00361504|Tapentadol|tapentadol
673476|NCT00361491|Depression|depression
673477|NCT00361491|antidepressive disorders|antidepressive disorders
673478|NCT00361491|controlled clinical trial|controlled clinical trial
673479|NCT00361478|exercise|exercise
673480|NCT00361478|postnatal depression|postnatal depression
673481|NCT00361478|psychological health|psychological health
673482|NCT00361478|well-being|well-being
673483|NCT00361426|COPD|copd
673484|NCT00361426|Respiration Rate|respiration rate
673485|NCT00361426|Monitoring|monitoring
673486|NCT00361413|Stem cell transplantation|stem cell transplantation
673487|NCT00361413|GVHD|gvhd
673488|NCT00361413|Graft Versus Host Disease|graft versus host disease
673489|NCT00361400|pregnancy|pregnancy
673490|NCT00361400|hormonal contraception|hormonal contraception
673491|NCT00361387|Sarcoidosis|sarcoidosis
673492|NCT00361387|Sarcoid|sarcoid
673493|NCT00361374|Depression|depression
673494|NCT00361374|Omega-3|omega-3
673495|NCT00361374|Boston|boston
673496|NCT00361348|Palifermin|palifermin
673497|NCT00361348|drug interaction|drug interaction
673498|NCT00361335|Rheumatoid arthritis|rheumatoid arthritis
673499|NCT00361335|Golimumab|golimumab
673500|NCT00361335|Methotrexate|methotrexate
673501|NCT00361335|Tumor Necrosis Factor-alpha|tumor necrosis factor-alpha
673502|NCT00361335|Immunology|immunology
673503|NCT00361309|liver cancer|liver cancer
673504|NCT00361309|HCC|hcc
673505|NCT00361296|refractory anemia with excess blasts|refractory anemia with excess blasts
673506|NCT00361296|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
673507|NCT00361296|refractory anemia|refractory anemia
673508|NCT00361296|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
673509|NCT00361296|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
673510|NCT00361296|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
673511|NCT00361296|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
673512|NCT00361270|Biofeedback|biofeedback
673513|NCT00361270|Hypnosis|hypnosis
673514|NCT00361270|Low Back Pain, Recurrent|low back pain, recurrent
673515|NCT00361270|Pain beliefs|pain beliefs
673516|NCT00361270|Pain coping strategies|pain coping strategies
673517|NCT00361270|Pain intensity|pain intensity
673518|NCT00361270|Pain interference|pain interference
673519|NCT00361270|Pain quality|pain quality
673520|NCT00361270|Self-help treatment|self-help treatment
673521|NCT00361270|Sleep dysfunction|sleep dysfunction
673522|NCT00361257|Treatment Experienced|treatment experienced
673523|NCT00361244|Sutent|sutent
673524|NCT00361231|Avastin|avastin
673525|NCT00361231|GEMOX|gemox
673526|NCT00361218|depression|depression
673527|NCT00361218|biology|biology
673528|NCT00361205|Parkinson's Disease, pharmacology, compliance, dopaminergic|parkinson's disease, pharmacology, compliance, dopaminergic
673529|NCT00361192|temporal arteritis|temporal arteritis
673530|NCT00361192|duplex of temporal artery|duplex of temporal artery
673531|NCT00361192|biopsy of temporal artery|biopsy of temporal artery
673532|NCT00361179|Observation|observation
673533|NCT00361179|Post-treatment|post-treatment
673534|NCT00361166|Schizophrenia|schizophrenia
673535|NCT00361166|psychosis|psychosis
673536|NCT00361166|delusions|delusions
673537|NCT00361166|hallucination|hallucination
673538|NCT00361140|Busulfan|busulfan
673539|NCT00361140|Fludarabine|fludarabine
673540|NCT00361140|Chimerism|chimerism
673541|NCT00361140|Allogeneic stem cell transplantation (HCT)|allogeneic stem cell transplantation (hct)
673542|NCT00361140|Myelodysplastic Syndromes|myelodysplastic syndromes
673543|NCT00361140|Leukemia Myeloproliferative disorders (MPD)|leukemia myeloproliferative disorders (mpd)
673544|NCT00361140|Leukemia, Lymphocytic|leukemia, lymphocytic
673545|NCT00361140|Myeloma|myeloma
673546|NCT00361140|Lymphoma|lymphoma
673547|NCT00361140|AUC|auc
673548|NCT00361140|Hematologic malignancies|hematologic malignancies
673549|NCT00361127|Heart failure|heart failure
673550|NCT00361127|pulmonary edema|pulmonary edema
673551|NCT00361127|ACE-inhibitors|ace-inhibitors
673552|NCT00361127|lung diffusion|lung diffusion
673553|NCT00361127|exercise capacity|exercise capacity
673554|NCT00361127|Chronic heart failure|chronic heart failure
673555|NCT00361101|HIV|hiv
673556|NCT00361101|X4 tropic virus|x4 tropic virus
673557|NCT00361088|Velcade (PS-341)|velcade (ps-341)
673558|NCT00361088|Bortezomib|bortezomib
673559|NCT00361088|Zarnestra (R115777)|zarnestra (r115777)
673560|NCT00361088|Tipifarnib|tipifarnib
673561|NCT00361075|Perimenopause|perimenopause
673562|NCT00361075|Abdominal adipose tissue|abdominal adipose tissue
673563|NCT00361075|Women's health|women's health
673564|NCT00361075|Cholesterol|cholesterol
673565|NCT00361075|Lipid Metabolism|lipid metabolism
673566|NCT00361062|aggressive|aggressive
673567|NCT00361062|SSRI's|ssri's
673568|NCT00361062|simulation|simulation
673569|NCT00361062|behavioral|behavioral
673570|NCT00361062|Side Effects, Psychological|side effects, psychological
673571|NCT00361062|adverse effects|adverse effects
673572|NCT00361062|Serotonin Reuptake Inhibitors|serotonin reuptake inhibitors
673573|NCT00361062|aggressive behavior|aggressive behavior
673574|NCT00361062|computer simulation|computer simulation
673917|NCT00360048|lps|lps
673575|NCT00361049|graft versus host disease|graft versus host disease
673576|NCT00361049|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
673577|NCT00361049|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
673578|NCT00361049|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
673579|NCT00361049|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
673580|NCT00361049|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
673581|NCT00361049|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
673582|NCT00361049|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
673583|NCT00361049|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
673584|NCT00361049|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
673585|NCT00361049|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
673586|NCT00361049|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
673587|NCT00361049|chronic eosinophilic leukemia|chronic eosinophilic leukemia
673588|NCT00361049|primary myelofibrosis|primary myelofibrosis
673589|NCT00361049|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
673590|NCT00361049|chronic neutrophilic leukemia|chronic neutrophilic leukemia
673591|NCT00361049|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
673592|NCT00361049|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
673593|NCT00361049|disseminated neuroblastoma|disseminated neuroblastoma
673594|NCT00361049|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
673595|NCT00361049|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
673596|NCT00361049|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
673597|NCT00361049|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
673598|NCT00361049|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
673599|NCT00361049|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
673600|NCT00361049|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
673601|NCT00361049|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
673602|NCT00361049|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
673603|NCT00361049|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
673604|NCT00361049|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
673605|NCT00361049|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
673606|NCT00361049|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
673607|NCT00361049|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
673608|NCT00361049|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
673609|NCT00361049|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
673610|NCT00361049|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
673611|NCT00361049|secondary acute myeloid leukemia|secondary acute myeloid leukemia
673612|NCT00361049|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
673613|NCT00361049|splenic marginal zone lymphoma|splenic marginal zone lymphoma
673614|NCT00361049|stage I multiple myeloma|stage i multiple myeloma
673615|NCT00361049|stage II multiple myeloma|stage ii multiple myeloma
673616|NCT00361049|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
673617|NCT00361049|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
673618|NCT00361049|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
673619|NCT00361049|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
673620|NCT00361049|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
673621|NCT00361049|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
673622|NCT00361049|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
673623|NCT00361049|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
673624|NCT00361049|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
673625|NCT00361049|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
673626|NCT00361049|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
673627|NCT00361049|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
673628|NCT00361049|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
673629|NCT00361049|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
673630|NCT00361049|stage III multiple myeloma|stage iii multiple myeloma
673631|NCT00361049|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
673632|NCT00361049|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
673633|NCT00361049|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
673634|NCT00361049|stage IIIA breast cancer|stage iiia breast cancer
673635|NCT00361049|stage IIIB breast cancer|stage iiib breast cancer
673636|NCT00361049|stage IIIC breast cancer|stage iiic breast cancer
673637|NCT00361049|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
673638|NCT00361049|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
673639|NCT00361049|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
673640|NCT00361049|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
673641|NCT00361049|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
673642|NCT00361049|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
673643|NCT00361049|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
673644|NCT00361049|stage IV breast cancer|stage iv breast cancer
673645|NCT00361049|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
673646|NCT00361049|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
673647|NCT00361049|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
673648|NCT00361049|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
673649|NCT00361049|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
673650|NCT00361049|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
673651|NCT00361049|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
673652|NCT00361049|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
673653|NCT00361036|Leiomyoma|leiomyoma
673654|NCT00361036|Leiomyomatosis|leiomyomatosis
673655|NCT00361036|Uterine Neoplasms|uterine neoplasms
673656|NCT00361036|BeadBlock|beadblock
673657|NCT00361036|Embsophere|embsophere
673658|NCT00361036|Embolization|embolization
673659|NCT00361036|Uterine fibroid embolization|uterine fibroid embolization
673660|NCT00361023|Angiotensin type 1 receptor blocker (ARB)|angiotensin type 1 receptor blocker (arb)
673661|NCT00361023|losartan|losartan
673662|NCT00361023|type 2 diabetes|type 2 diabetes
673663|NCT00361023|insulin sensitivity and secretion|insulin sensitivity and secretion
673664|NCT00361023|glucose metabolism|glucose metabolism
673665|NCT00361010|Keppra|keppra
673666|NCT00361010|Epilepsy|epilepsy
673667|NCT00361010|Childhood Absence Epilepsy|childhood absence epilepsy
673668|NCT00361010|Seizures|seizures
673669|NCT00360997|Stroke rehabilitation|stroke rehabilitation
673670|NCT00360997|Physical therapy|physical therapy
673671|NCT00360984|CSII|csii
673672|NCT00360984|insulin analog|insulin analog
673673|NCT00360984|severe hypoglycaemia|severe hypoglycaemia
673674|NCT00360984|altered hypoglycaemia awareness|altered hypoglycaemia awareness
673675|NCT00360984|diabetes quality of life|diabetes quality of life
673676|NCT00360984|CGMS|cgms
673677|NCT00360971|mucositis|mucositis
673678|NCT00360971|pain|pain
673679|NCT00360971|radiation toxicity|radiation toxicity
673680|NCT00360971|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
673681|NCT00360971|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
673682|NCT00360971|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
673683|NCT00360971|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
673684|NCT00360971|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
673685|NCT00360971|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
673686|NCT00360971|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
673687|NCT00360971|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
673688|NCT00360958|ultrafiltration|ultrafiltration
673689|NCT00360958|heart failure|heart failure
673690|NCT00360958|fluid overload|fluid overload
673691|NCT00360945|childhood oligodendroglioma|childhood oligodendroglioma
673692|NCT00360945|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
673693|NCT00360945|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
673694|NCT00360945|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
673695|NCT00360945|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
673696|NCT00360945|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
673697|NCT00360945|recurrent childhood brain tumor|recurrent childhood brain tumor
673698|NCT00360932|facial lipoatrophy|facial lipoatrophy
673699|NCT00360932|HIV/AIDs|hiv/aids
673700|NCT00360919|casomorphin|casomorphin
673701|NCT00360919|cheese|cheese
673702|NCT00360919|craving|craving
673703|NCT00360919|casein|casein
673704|NCT00360919|milk|milk
673705|NCT00360906|RRMS|rrms
673706|NCT00360906|Omega-3|omega-3
673707|NCT00360906|Treatment|treatment
673708|NCT00360867|Extension study|extension study
673709|NCT00360867|solid tumors|solid tumors
673710|NCT00360854|untreated childhood brain stem glioma|untreated childhood brain stem glioma
673711|NCT00360854|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
673712|NCT00360854|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
673713|NCT00360854|recurrent childhood ependymoma|recurrent childhood ependymoma
673714|NCT00360854|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
673715|NCT00360854|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
673807|NCT00360568|severe motor fluctuations|severe motor fluctuations
673716|NCT00360854|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
673717|NCT00360854|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
673718|NCT00360854|childhood choroid plexus tumor|childhood choroid plexus tumor
673719|NCT00360854|childhood craniopharyngioma|childhood craniopharyngioma
673720|NCT00360854|childhood grade I meningioma|childhood grade i meningioma
673721|NCT00360854|childhood grade II meningioma|childhood grade ii meningioma
673722|NCT00360854|childhood grade III meningioma|childhood grade iii meningioma
673723|NCT00360854|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
673724|NCT00360854|childhood infratentorial ependymoma|childhood infratentorial ependymoma
673725|NCT00360854|childhood supratentorial ependymoma|childhood supratentorial ependymoma
673726|NCT00360854|recurrent childhood brain tumor|recurrent childhood brain tumor
673727|NCT00360854|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
673728|NCT00360854|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
673729|NCT00360841|auricular|auricular
673730|NCT00360841|acupuncture|acupuncture
673731|NCT00360828|Recurrent Anaplastic Astrocytoma|recurrent anaplastic astrocytoma
673732|NCT00360828|Mixed Malignant Glioma|mixed malignant glioma
673733|NCT00360828|Oligodendroglioma|oligodendroglioma
673734|NCT00360828|Irinotecan|irinotecan
673735|NCT00360828|Brain tumor|brain tumor
673736|NCT00360828|Nitrosoureas|nitrosoureas
673737|NCT00360828|Brain and nervous system|brain and nervous system
673738|NCT00360802|chronic low back pain|chronic low back pain
673739|NCT00360802|cognitive-behavioral therapy|cognitive-behavioral therapy
673740|NCT00360802|Mindful Based Stress Reduction|mindful based stress reduction
673741|NCT00360802|pain clinics|pain clinics
673742|NCT00360802|anxiety|anxiety
673743|NCT00360802|quality of life|quality of life
673744|NCT00360802|chronic pain|chronic pain
673745|NCT00360789|STROKE REHABILITATION|stroke rehabilitation
673746|NCT00360789|pHYSICAL THERAPY|physical therapy
673747|NCT00360750|intraocular retinoblastoma|intraocular retinoblastoma
673748|NCT00360750|extraocular retinoblastoma|extraocular retinoblastoma
673749|NCT00360737|Clinical Trials|clinical trials
673750|NCT00360737|Investigational Drug|investigational drug
673751|NCT00360737|Healthy Volunteers|healthy volunteers
673752|NCT00360737|Botulinum Antitoxin|botulinum antitoxin
673753|NCT00360737|Phoenix, Arizona|phoenix, arizona
673754|NCT00360724|dysthymia|dysthymia
673755|NCT00360724|dysthymic disorder|dysthymic disorder
673756|NCT00360724|chronic depression|chronic depression
673757|NCT00360724|chronic low-grade depression|chronic low-grade depression
673758|NCT00360724|atypical depression|atypical depression
673759|NCT00360724|minor depression|minor depression
673760|NCT00360724|depression NOS|depression nos
673761|NCT00360724|depression|depression
673762|NCT00360724|depressive disorder|depressive disorder
673763|NCT00360724|mood disorder|mood disorder
673764|NCT00360724|unipolar depression|unipolar depression
673765|NCT00360724|low-grade depression|low-grade depression
673766|NCT00360711|Moral Distress|moral distress
673767|NCT00360711|Nondirectiveness|nondirectiveness
673768|NCT00360711|Ethical Dilemma|ethical dilemma
673769|NCT00360685|Tacrolimus|tacrolimus
673770|NCT00360685|Methotrexate|methotrexate
673771|NCT00360685|Mycophenolate mofetil|mycophenolate mofetil
673772|NCT00360685|Mucositis|mucositis
673773|NCT00360685|Acute graft-versus-host disease (aGVHD)|acute graft-versus-host disease (agvhd)
673774|NCT00360685|Engraftment|engraftment
673775|NCT00360685|hemolytic/uremic syndrome (HUS)|hemolytic/uremic syndrome (hus)
673776|NCT00360685|Thrombotic thrombocytopenic purpura (TTP)|thrombotic thrombocytopenic purpura (ttp)
673777|NCT00360672|Acute Myelogenous Leukemia|acute myelogenous leukemia
673778|NCT00360672|Myelodysplastic Syndrome|myelodysplastic syndrome
673779|NCT00360659|Obstructive sleep Apnea|obstructive sleep apnea
673780|NCT00360659|Hypertension|hypertension
673781|NCT00360659|Vasoactive hormones|vasoactive hormones
673782|NCT00360646|LIVER DIS|liver dis
673783|NCT00360646|CHEM IND|chem ind
673784|NCT00360646|Drugs|drugs
673785|NCT00360646|Drug induced liver injury|drug induced liver injury
673786|NCT00360646|phenotype|phenotype
673787|NCT00360646|cholestatic liver injury|cholestatic liver injury
673788|NCT00360646|hepatocellular liver injury|hepatocellular liver injury
673789|NCT00360646|mixed liver injury|mixed liver injury
673790|NCT00360646|genotype|genotype
673791|NCT00360633|Parkinson's Disease|parkinson's disease
673792|NCT00360633|Impulse control disorder|impulse control disorder
673793|NCT00360633|Dopamine agonist withdrawal syndrome|dopamine agonist withdrawal syndrome
673794|NCT00360633|Anxiety|anxiety
673795|NCT00360633|Depression|depression
673796|NCT00360633|Healthcare Utilization|healthcare utilization
673797|NCT00360633|Disability|disability
673798|NCT00360633|Quality of life|quality of life
673799|NCT00360633|Cognitive function|cognitive function
673800|NCT00360633|Psychosis|psychosis
673801|NCT00360633|Apathy|apathy
673802|NCT00360633|Dyskinesias|dyskinesias
673803|NCT00360633|Wearing off|wearing off
673804|NCT00360594|alcoholism|alcoholism
673805|NCT00360581|Smoking abstinence|smoking abstinence
673806|NCT00360568|carbidopa|carbidopa
673915|NCT00360048|tnf|tnf
673808|NCT00360568|intestinal gel|intestinal gel
673809|NCT00360568|levodopa|levodopa
673810|NCT00360568|efficacy|efficacy
673811|NCT00360568|levodopa carbidopa intestinal gel|levodopa carbidopa intestinal gel
673812|NCT00360568|dyskinesia|dyskinesia
673813|NCT00360568|Parkinson's Disease|parkinson's disease
673814|NCT00360568|Duodopa|duodopa
673815|NCT00360568|levodopa-carbidopa|levodopa-carbidopa
673816|NCT00360568|DUOPA|duopa
673817|NCT00360516|healthy volunteers|healthy volunteers
673818|NCT00360503|Cystic fibrosis|cystic fibrosis
673819|NCT00360503|Antibiotic resistance|antibiotic resistance
673820|NCT00360503|Microbiology|microbiology
673821|NCT00360490|Idiopathic Menorrhagia|idiopathic menorrhagia
673822|NCT00360477|Kidney stone removal surgery|kidney stone removal surgery
673823|NCT00360451|Prevention|prevention
673824|NCT00360451|Child|child
673825|NCT00360451|Adolescent|adolescent
673826|NCT00360451|Parent|parent
673827|NCT00360438|Leukemia|leukemia
673828|NCT00360438|Lymphoma|lymphoma
673829|NCT00360438|Tumor Lysis Syndrome|tumor lysis syndrome
673830|NCT00360438|TLS|tls
673831|NCT00360438|Rasburicase|rasburicase
673832|NCT00360438|Elitek|elitek
673833|NCT00360425|anemia|anemia
673834|NCT00360425|intravenous iron|intravenous iron
673835|NCT00360425|pharmacokinetics|pharmacokinetics
673836|NCT00360425|QTc|qtc
673837|NCT00360399|Escitalopram|escitalopram
673838|NCT00360399|Duloxetine|duloxetine
673839|NCT00360399|Cognitive Behavioral Therapy|cognitive behavioral therapy
673840|NCT00360399|PET|pet
673841|NCT00360399|fMRI|fmri
673842|NCT00360373|bariatric|bariatric
673843|NCT00360373|obesity|obesity
673844|NCT00360373|insulin resistance|insulin resistance
673845|NCT00360373|gastric bypass|gastric bypass
673846|NCT00360373|adolescent|adolescent
673847|NCT00360360|Neoplasm, Unknown Primary|neoplasm, unknown primary
673848|NCT00360334|diabetes|diabetes
673849|NCT00360334|exenatide|exenatide
673850|NCT00360334|insulin glargine|insulin glargine
673851|NCT00360334|Lilly|lilly
673852|NCT00360334|Amylin|amylin
673853|NCT00360282|Migraine|migraine
673854|NCT00360282|Triptans|triptans
673855|NCT00360282|Motion Sickness|motion sickness
673856|NCT00360256|Depression|depression
673857|NCT00360256|Amplichip P450 tests|amplichip p450 tests
673858|NCT00360256|Antidepressants|antidepressants
673859|NCT00360230|Vaccine|vaccine
673860|NCT00360230|Prophylaxis Plasmodium falciparum malaria|prophylaxis plasmodium falciparum malaria
673861|NCT00360230|Plasmodium falciparum|plasmodium falciparum
673862|NCT00360230|Malaria|malaria
673863|NCT00360217|Omega-3|omega-3
673864|NCT00360217|Triglyceride|triglyceride
673865|NCT00360217|Hyperlipidemia|hyperlipidemia
673866|NCT00360217|Coronary Artery Disease|coronary artery disease
673867|NCT00360217|Fatty Acids|fatty acids
673868|NCT00360217|Safety|safety
673869|NCT00360217|Fish Oil|fish oil
673870|NCT00360217|Docosohexanoic Acid|docosohexanoic acid
673871|NCT00360204|Infant health|infant health
673872|NCT00360204|parenting competence|parenting competence
673873|NCT00360204|Home nurse visit|home nurse visit
673874|NCT00360204|maternal post-partum care|maternal post-partum care
673875|NCT00360204|postpartum health utilization|postpartum health utilization
673876|NCT00360204|Breastfeeding|breastfeeding
673877|NCT00360178|hypertension|hypertension
673878|NCT00360178|valsartan|valsartan
673879|NCT00360178|amlodipine|amlodipine
673880|NCT00360178|hydrochlorothiazide|hydrochlorothiazide
673881|NCT00360152|Breast Cancer|breast cancer
673882|NCT00360152|Axilla|axilla
673883|NCT00360152|Ultrasound|ultrasound
673884|NCT00360152|FNA|fna
673885|NCT00360152|Molecular Analysis|molecular analysis
673886|NCT00360139|Sculptra|sculptra
673887|NCT00360139|lipoatrophy|lipoatrophy
673888|NCT00360139|emaciation|emaciation
673889|NCT00360139|facial|facial
673890|NCT00360139|dermal filler|dermal filler
673891|NCT00360139|poly-L-lactic acid|poly-l-lactic acid
673892|NCT00360139|Dermik|dermik
673893|NCT00360139|SpaMD|spamd
673894|NCT00360139|Sanofi|sanofi
673895|NCT00360139|Facial lipoatrophy|facial lipoatrophy
673896|NCT00360139|Facial emaciation|facial emaciation
673897|NCT00360126|Lamictal|lamictal
673898|NCT00360126|lamotrigine|lamotrigine
673899|NCT00360126|Open-Label Extension Study|open-label extension study
673900|NCT00360126|Bipolar Disorder|bipolar disorder
673901|NCT00360087|Treatment Study|treatment study
673902|NCT00360087|Sickle Cell Anemia|sickle cell anemia
673903|NCT00360087|6-Minute Walk|6-minute walk
673904|NCT00360087|Right Heart Catheterization|right heart catheterization
673905|NCT00360087|Tracleer|tracleer
673906|NCT00360087|Sickle Cell|sickle cell
673907|NCT00360087|SCD|scd
673908|NCT00360074|secondary hypothyroidism|secondary hypothyroidism
673909|NCT00360074|body weight adjusted thyroxin dose|body weight adjusted thyroxin dose
673910|NCT00360074|triiodothyronine supplementation|triiodothyronine supplementation
673911|NCT00360061|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
673912|NCT00360061|Adolescents|adolescents
673913|NCT00360061|Cognitive Behaviour Therapy|cognitive behaviour therapy
673914|NCT00360048|oxytocin|oxytocin
673918|NCT00360009|Parkinson's disease|parkinson's disease
673919|NCT00360009|Parkinson disease|parkinson disease
673920|NCT00360009|PD|pd
673921|NCT00360009|deep brain stimulation|deep brain stimulation
673922|NCT00360009|DBS|dbs
673923|NCT00360009|subthalamic nucleus|subthalamic nucleus
673924|NCT00360009|STN|stn
673925|NCT00360009|globus pallidus interna|globus pallidus interna
673926|NCT00360009|GPi|gpi
673927|NCT00360009|mood|mood
673928|NCT00360009|motor symptoms|motor symptoms
673929|NCT00360009|cognition|cognition
673930|NCT00360009|emotion|emotion
673931|NCT00360009|memory|memory
673932|NCT00360009|attention|attention
673933|NCT00360009|tremor|tremor
673934|NCT00360009|rigidity|rigidity
673935|NCT00360009|bradykinesia|bradykinesia
673936|NCT00359996|diabetes|diabetes
673937|NCT00359996|quality improvement|quality improvement
673938|NCT00359996|community health center|community health center
673939|NCT00359996|health disparities|health disparities
673940|NCT00359983|Humans|humans
673941|NCT00359983|Meningococcal vaccines|meningococcal vaccines
673942|NCT00359983|Immunogenicity|immunogenicity
673943|NCT00359983|Vaccines|vaccines
673944|NCT00359983|H. influenzae type b vaccine|h. influenzae type b vaccine
673945|NCT00359983|Conjugate|conjugate
673946|NCT00359983|Toddlers|toddlers
673947|NCT00359983|Comparative study|comparative study
673948|NCT00359983|Neisseria meningitidis|neisseria meningitidis
673949|NCT00359970|Diarrhea|diarrhea
673950|NCT00359970|Travel|travel
673951|NCT00359970|Travelers' diarrhea|travelers' diarrhea
673952|NCT00359970|Azithromycin|azithromycin
673953|NCT00359970|Loperamide|loperamide
673954|NCT00359970|Treatment|treatment
673955|NCT00359970|Antibiotic|antibiotic
673956|NCT00359957|Pediatric obesity|pediatric obesity
673957|NCT00359957|Physical activity|physical activity
673958|NCT00359957|Visceral fat|visceral fat
673959|NCT00359957|Weight|weight
673960|NCT00359944|Alzheimer|alzheimer
673961|NCT00359944|Dementia|dementia
673962|NCT00359931|Neural Networks|neural networks
673963|NCT00359931|Mathematical Modeling|mathematical modeling
673964|NCT00359931|Auditory Processing|auditory processing
673965|NCT00359931|Tinnitis|tinnitis
673966|NCT00359931|Hearing Loss|hearing loss
673967|NCT00359918|infarction|infarction
673968|NCT00359918|facilitated PCI|facilitated pci
673969|NCT00359918|primary PCI|primary pci
673970|NCT00359918|infarct size|infarct size
673971|NCT00359918|fibrinolysis|fibrinolysis
673972|NCT00359918|ST-elevation myocardial infarction (STEMI)|st-elevation myocardial infarction (stemi)
673973|NCT00359905|Benign prostatic hyperplasia|benign prostatic hyperplasia
673974|NCT00359905|alpha-blockers|alpha-blockers
673975|NCT00359879|diabetes|diabetes
673976|NCT00359879|exenatide|exenatide
673977|NCT00359879|Lilly|lilly
673978|NCT00359879|Amylin|amylin
673979|NCT00359853|Norfloxacin, primary prophylaxis, SBP|norfloxacin, primary prophylaxis, sbp
673980|NCT00359840|darbepoetin alfa|darbepoetin alfa
673981|NCT00359840|anemia|anemia
673982|NCT00359840|cancer patients|cancer patients
673983|NCT00359840|chemotherapy|chemotherapy
673984|NCT00359814|Cyclosporine|cyclosporine
673985|NCT00359814|renal insufficiency, chronic|renal insufficiency, chronic
673986|NCT00359814|long-term care|long-term care
673987|NCT00359801|Large Simple Trial|large simple trial
673988|NCT00359775|Coping|coping
673989|NCT00359775|psychosocial|psychosocial
673990|NCT00359775|Quality of Life|quality of life
673991|NCT00359775|problem solving|problem solving
673992|NCT00359762|exenatide|exenatide
673993|NCT00359762|diabetes|diabetes
673994|NCT00359762|Amylin|amylin
673995|NCT00359762|Lilly|lilly
673996|NCT00359762|glimepiride|glimepiride
673997|NCT00359736|alveolitis, fibrosing|alveolitis, fibrosing
673998|NCT00359736|exercise, aerobic|exercise, aerobic
673999|NCT00359736|fibrosis, pulmonary|fibrosis, pulmonary
674000|NCT00359736|hypertension, pulmonary|hypertension, pulmonary
674001|NCT00359723|Parkinson's disease|parkinson's disease
674002|NCT00359723|PD|pd
674003|NCT00359723|methylphenidate|methylphenidate
674004|NCT00359723|Ritalin|ritalin
674005|NCT00359723|MPD|mpd
674006|NCT00359710|Multiracial Populations|multiracial populations
674007|NCT00359710|Human Genetic Variation|human genetic variation
674008|NCT00359710|Family History|family history
674009|NCT00359710|Admixture|admixture
674010|NCT00359710|Physician-Patient Communication|physician-patient communication
674011|NCT00359710|Ancestry|ancestry
674012|NCT00359710|Self-Identified Multiracial Adults|self-identified multiracial adults
674013|NCT00359710|Interview|interview
674014|NCT00359684|Cystinosis|cystinosis
674015|NCT00359684|Cystine|cystine
674016|NCT00359684|Lysomal Storage Disease|lysomal storage disease
674017|NCT00359684|Mutation Analysis|mutation analysis
674018|NCT00359684|Metabolic Disease|metabolic disease
674019|NCT00359658|Cyclosporine|cyclosporine
674020|NCT00359658|Glucocorticoids|glucocorticoids
674021|NCT00359658|renal insufficiency, chronic|renal insufficiency, chronic
674022|NCT00359658|long-term care|long-term care
674023|NCT00359645|Screening|screening
674121|NCT00359307|Genetic|genetic
674024|NCT00359645|Upper aerodigestive tract cancer|upper aerodigestive tract cancer
674025|NCT00359645|Alcohol|alcohol
674026|NCT00359645|Tobacco|tobacco
674027|NCT00359645|Randomized trial|randomized trial
674028|NCT00359632|Optic neuropathy following long-term linezolid use|optic neuropathy following long-term linezolid use
674029|NCT00359619|HPV vaccine|hpv vaccine
674030|NCT00359606|DNA Methylation|dna methylation
674031|NCT00359606|Advanced Cancer|advanced cancer
674032|NCT00359606|Methyltransferase Inhibitor|methyltransferase inhibitor
674033|NCT00359606|Epigenetics|epigenetics
674034|NCT00359606|Gene Re-Expression|gene re-expression
674035|NCT00359593|Stroke|stroke
674036|NCT00359593|Rehabilitation|rehabilitation
674037|NCT00359593|Knowledge translation|knowledge translation
674038|NCT00359593|Evidence based practice|evidence based practice
674039|NCT00359593|Outcomes|outcomes
674040|NCT00359580|Ancestry|ancestry
674041|NCT00359567|nausea and vomiting|nausea and vomiting
674042|NCT00359554|Influenza|influenza
674043|NCT00359541|CYP2C9|cyp2c9
674044|NCT00359541|CYP2C19|cyp2c19
674045|NCT00359541|Pharmacology|pharmacology
674046|NCT00359541|Genotype|genotype
674047|NCT00359541|Metabolism|metabolism
674048|NCT00359515|Archived Samples|archived samples
674049|NCT00359515|Mutation Screening|mutation screening
674050|NCT00359515|Genotype-Phenotype Correlation|genotype-phenotype correlation
674051|NCT00359515|Pediatric Developmental Disorder|pediatric developmental disorder
674052|NCT00359515|Cataracts|cataracts
674053|NCT00359515|Mutation Detection|mutation detection
674054|NCT00359515|Lowe Syndrome|lowe syndrome
674055|NCT00359515|Genotype|genotype
674056|NCT00359476|Locally advanced/metastatic gastric adenocarcinoma|locally advanced/metastatic gastric adenocarcinoma
674057|NCT00359476|adenocarcinoma-gastroesophageal junction|adenocarcinoma-gastroesophageal junction
674058|NCT00359476|Gastric Adenocarcinoma|gastric adenocarcinoma
674059|NCT00359463|hepatitis C-associated thrombocytopenia|hepatitis c-associated thrombocytopenia
674060|NCT00359463|chemotherapy induced thrombocytopenia|chemotherapy induced thrombocytopenia
674061|NCT00359463|thrombocytopenia|thrombocytopenia
674062|NCT00359463|hepatic impairment|hepatic impairment
674063|NCT00359463|chronic immune thrombocytopenia purpura|chronic immune thrombocytopenia purpura
674064|NCT00359450|Locally advanced or metastatic non-small cell lung cancer|locally advanced or metastatic non-small cell lung cancer
674065|NCT00359424|acute ischemic stroke|acute ischemic stroke
674066|NCT00359424|rt-PA|rt-pa
674067|NCT00359424|thrombolytic|thrombolytic
674068|NCT00359424|recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
674069|NCT00359424|recanalization|recanalization
674070|NCT00359424|blood clot|blood clot
674071|NCT00359424|stroke|stroke
674072|NCT00359424|clot-dissolving|clot-dissolving
674073|NCT00359424|Activase®|activase®
674074|NCT00359424|Actilyse®|actilyse®
674075|NCT00359424|Concentric Merci® Retriever|concentric merci® retriever
674076|NCT00359424|EKOS® Micro-Infusion catheter (MicroLysus)|ekos® micro-infusion catheter (microlysus)
674077|NCT00359424|The Penumbra System™|the penumbra system™
674078|NCT00359424|Standard microcatheter|standard microcatheter
674079|NCT00359411|Epstein-Barr Virus|epstein-barr virus
674080|NCT00359411|B-Cell Lymphoma|b-cell lymphoma
674081|NCT00359411|Herpes Virus|herpes virus
674082|NCT00359411|Infectious Mononucleosis|infectious mononucleosis
674083|NCT00359398|Cardiopulmonary bypass|cardiopulmonary bypass
674084|NCT00359398|Blood component removal|blood component removal
674085|NCT00359385|primary hyperparathyroidism|primary hyperparathyroidism
674086|NCT00359385|hyperparathyroidism|hyperparathyroidism
674087|NCT00359385|PHPT|phpt
674088|NCT00359385|PTH|pth
674089|NCT00359385|hypercalcemia|hypercalcemia
674090|NCT00359385|bone density|bone density
674091|NCT00359385|osteoporosis|osteoporosis
674092|NCT00359385|bone turnover|bone turnover
674093|NCT00359385|DXA|dxa
674094|NCT00359385|pQCT|pqct
674095|NCT00359385|cQCT|cqct
674096|NCT00359385|alendronate|alendronate
674097|NCT00359385|Fosamax|fosamax
674098|NCT00359385|parathyroid hormone|parathyroid hormone
674099|NCT00359385|parathyroid surgery|parathyroid surgery
674100|NCT00359385|parathyroidectomy|parathyroidectomy
674101|NCT00359385|Silverberg|silverberg
674102|NCT00359385|Rubin|rubin
674103|NCT00359385|Bilezikian|bilezikian
674104|NCT00359385|treatment|treatment
674105|NCT00359372|Chronic Heart Failure|chronic heart failure
674106|NCT00359372|Cardiac Resynchronization|cardiac resynchronization
674107|NCT00359372|Magnetic Resonance Imaging|magnetic resonance imaging
674108|NCT00359372|Biventricular Pacing|biventricular pacing
674109|NCT00359372|Heart Function|heart function
674110|NCT00359372|CRT|crt
674111|NCT00359359|Small Cell Lung Cancer|small cell lung cancer
674112|NCT00359346|Plasmapheresis|plasmapheresis
674113|NCT00359346|Auto-antibodies|auto-antibodies
674114|NCT00359346|Autonomic Nervous System|autonomic nervous system
674115|NCT00359346|Dysautonomia|dysautonomia
674116|NCT00359346|Sympathetic Nervous System|sympathetic nervous system
674117|NCT00359346|Autonomic Failure|autonomic failure
674118|NCT00359320|Pancreaticoduodenectomy|pancreaticoduodenectomy
674119|NCT00359320|Pancreaticojejunostomy|pancreaticojejunostomy
674120|NCT00359320|Pancreatic Cancer|pancreatic cancer
674122|NCT00359307|Longitudinal|longitudinal
674123|NCT00359307|Prospective|prospective
674124|NCT00359307|Epidemiology|epidemiology
674125|NCT00359307|Heart Attack|heart attack
674126|NCT00359294|Tumor|tumor
674127|NCT00359294|Lymphoma|lymphoma
674128|NCT00359294|Zalypsis|zalypsis
674129|NCT00359294|PharmaMar|pharmamar
674130|NCT00359294|PM00104|pm00104
674131|NCT00359281|healthy volunteers|healthy volunteers
674132|NCT00359268|Polymerase Chain Reaction|polymerase chain reaction
674133|NCT00359268|Random Priming|random priming
674134|NCT00359268|Nucleic Acid|nucleic acid
674135|NCT00359268|Viral Genome|viral genome
674136|NCT00359268|Virus|virus
674137|NCT00359268|Identification|identification
674138|NCT00359255|Exercise|exercise
674139|NCT00359255|rehabilitation|rehabilitation
674140|NCT00359255|upper limb|upper limb
674141|NCT00359255|inpatient|inpatient
674142|NCT00359255|RCT|rct
674143|NCT00359255|activities of daily living|activities of daily living
674144|NCT00359242|Infant Sleep|infant sleep
674145|NCT00359242|Infant Diet|infant diet
674146|NCT00359242|Infant Temperament|infant temperament
674147|NCT00359242|Rapid Infant weight gain|rapid infant weight gain
674148|NCT00359242|Infant Development|infant development
674149|NCT00359242|Parenting Competence|parenting competence
674150|NCT00359242|infant weight gain|infant weight gain
674151|NCT00359216|Hypopnea Syndrome|hypopnea syndrome
674152|NCT00359203|syncope|syncope
674153|NCT00359203|implantable loop recorder|implantable loop recorder
674154|NCT00359190|lapatinib|lapatinib
674155|NCT00359190|breast cancer|breast cancer
674156|NCT00359190|treatment-naive|treatment-naive
674157|NCT00359177|emesis liver problems hepatic impairment GW679769|emesis liver problems hepatic impairment gw679769
674158|NCT00359164|AMD|amd
674159|NCT00359164|Avastin|avastin
674160|NCT00359164|Visudyne|visudyne
674161|NCT00359164|Medical condition being studied AMD|medical condition being studied amd
674162|NCT00359151|Perioperative care of total arthroplasty assessing opioid consumption|perioperative care of total arthroplasty assessing opioid consumption
674163|NCT00359138|Histamine H1 Antagonists|histamine h1 antagonists
674164|NCT00359138|Anti-Allergic Agents|anti-allergic agents
674165|NCT00359125|bipolar|bipolar
674166|NCT00359125|RU-486|ru-486
674167|NCT00359125|mifepristone|mifepristone
674168|NCT00359125|neurocognition|neurocognition
674169|NCT00359125|mood|mood
674170|NCT00359125|cortisol|cortisol
674171|NCT00359125|HPA axis|hpa axis
674172|NCT00359112|Type 2 diabetes|type 2 diabetes
674173|NCT00359112|overweight|overweight
674174|NCT00359112|AVANDAMET|avandamet
674175|NCT00359112|metformin|metformin
674176|NCT00359112|sulphonylurea|sulphonylurea
674177|NCT00359099|Hepatic Medicine|hepatic medicine
674178|NCT00359099|Surgery|surgery
674179|NCT00359086|Relapsed and Refractory Lymphoma|relapsed and refractory lymphoma
674180|NCT00359086|Phase II|phase ii
674181|NCT00359073|asthma|asthma
674182|NCT00359073|leukotrienes|leukotrienes
674183|NCT00359073|rhinovirus|rhinovirus
674184|NCT00359060|Physical activity|physical activity
674185|NCT00359060|Sex steroid hormones|sex steroid hormones
674186|NCT00359060|Breast cancer risk|breast cancer risk
674187|NCT00359060|Intervention study|intervention study
674188|NCT00359060|Postmenopausal women|postmenopausal women
674189|NCT00359047|Osteoporosis|osteoporosis
674190|NCT00359047|Fragility fracture|fragility fracture
674191|NCT00359047|Women|women
674192|NCT00359047|Randomised control trial|randomised control trial
674193|NCT00359047|Patient education|patient education
674194|NCT00359047|Diagnosis|diagnosis
674195|NCT00359047|Treatment|treatment
674196|NCT00359034|Doppler ultrasound|doppler ultrasound
674197|NCT00359034|pulsewave velocity|pulsewave velocity
674198|NCT00359034|intrauterine growth restriction|intrauterine growth restriction
674199|NCT00359034|Fetal Pulsewave Velocity|fetal pulsewave velocity
674200|NCT00359021|HIV-1|hiv-1
674201|NCT00359021|treatment experienced|treatment experienced
674202|NCT00359021|virologic failure|virologic failure
674203|NCT00359008|AMD|amd
674204|NCT00359008|CNV|cnv
674205|NCT00359008|PHP|php
674206|NCT00358995|Cognitive Behavioral Therapy|cognitive behavioral therapy
674207|NCT00358995|Primary Obsessions|primary obsessions
674208|NCT00358995|Obsessive Compulsive Disorder|obsessive compulsive disorder
674209|NCT00358995|Compulsive Disorder|compulsive disorder
674210|NCT00358982|Relapsed or Refractory Hodgkin's Lymphoma|relapsed or refractory hodgkin's lymphoma
674211|NCT00358982|Phase II|phase ii
674212|NCT00358969|borderline personality disorder|borderline personality disorder
674213|NCT00358969|guanfacine|guanfacine
674214|NCT00358969|impulsivity|impulsivity
674215|NCT00358969|aggression|aggression
674216|NCT00358969|affective instability|affective instability
674217|NCT00358956|medullary thyroid cancer|medullary thyroid cancer
674219|NCT00358956|hereditary medullary thyroid cancer|hereditary medullary thyroid cancer
674220|NCT00358956|thyroid cancer|thyroid cancer
674221|NCT00358943|Gaucher Disease|gaucher disease
674222|NCT00358943|Glucocerebrosidase Deficiency Disease|glucocerebrosidase deficiency disease
674324|NCT00358566|Unresesctable|unresesctable
674223|NCT00358930|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
674224|NCT00358904|Hill Sachs|hill sachs
674225|NCT00358904|Weber osteotomy|weber osteotomy
674226|NCT00358904|shoulder dislocation|shoulder dislocation
674227|NCT00358891|Prematurity|prematurity
674228|NCT00358891|Chronic Lung Disease|chronic lung disease
674229|NCT00358891|Respiratory Health|respiratory health
674230|NCT00358891|Neurodevelopment|neurodevelopment
674231|NCT00358891|Preschool|preschool
674232|NCT00358891|Influencing Factors|influencing factors
674233|NCT00358878|Ascites|ascites
674234|NCT00358878|Liver Cirrhosis|liver cirrhosis
674235|NCT00358865|Virtual Reality|virtual reality
674236|NCT00358865|ABI|abi
674237|NCT00358865|Projected system|projected system
674238|NCT00358852|Schizophrenia|schizophrenia
674239|NCT00358852|Mental disorder|mental disorder
674240|NCT00358852|Schizoaffective disorder|schizoaffective disorder
674241|NCT00358852|Schizophreniform disorder|schizophreniform disorder
674242|NCT00358852|Epidemiological study|epidemiological study
674243|NCT00358852|Scale validation|scale validation
674244|NCT00358852|Relapse|relapse
674245|NCT00358852|Short Term Hospitalization|short term hospitalization
674246|NCT00358852|PRE-COG|pre-cog
674247|NCT00358852|RISSCH4075|rissch4075
674248|NCT00358839|Familial hemiplegic migraine type 1 and 2|familial hemiplegic migraine type 1 and 2
674249|NCT00358839|CGRP|cgrp
674250|NCT00358839|middle cerebral artery|middle cerebral artery
674251|NCT00358839|superficial temporal artery|superficial temporal artery
674252|NCT00358839|headache|headache
674253|NCT00358839|genotype|genotype
674254|NCT00358839|Healthy Volunteers|healthy volunteers
674255|NCT00358813|emesis|emesis
674256|NCT00358813|renal impairment|renal impairment
674257|NCT00358813|GW679769|gw679769
674258|NCT00358813|kidney problems|kidney problems
674259|NCT00358800|OSAHS and REMStar Auto with C-Flex|osahs and remstar auto with c-flex
674260|NCT00358787|Supracondylar fracture|supracondylar fracture
674261|NCT00358787|humerus|humerus
674262|NCT00358787|ulnar nerve injury|ulnar nerve injury
674263|NCT00358787|Baumann's angle|baumann's angle
674264|NCT00358787|Supracondylar fracture of the humerus|supracondylar fracture of the humerus
674265|NCT00358774|homeopathic|homeopathic
674266|NCT00358774|common cold|common cold
674267|NCT00358774|Research Subjects|research subjects
674268|NCT00358761|Lone Star Tick|lone star tick
674269|NCT00358761|Borrelia|borrelia
674270|NCT00358761|Skin Biopsy|skin biopsy
674271|NCT00358761|Spirochete|spirochete
674272|NCT00358761|Erythema Migrans|erythema migrans
674273|NCT00358761|Southern Tick-Assoicated Rash Illness|southern tick-assoicated rash illness
674274|NCT00358761|STARI|stari
674275|NCT00358748|Preterm|preterm
674276|NCT00358748|hypotension|hypotension
674277|NCT00358748|steroids|steroids
674278|NCT00358748|hydrocortisone|hydrocortisone
674279|NCT00358735|SAFE|safe
674280|NCT00358735|CECT|cect
674281|NCT00358735|SFT|sft
674282|NCT00358735|ActiveCare|activecare
674283|NCT00358735|ActiveCare+SFT|activecare+sft
674284|NCT00358735|Deep Vein Thrombosis prevention|deep vein thrombosis prevention
674285|NCT00358735|Total Hip Replacement|total hip replacement
674286|NCT00358735|Total Hip Arthroplasty|total hip arthroplasty
674287|NCT00358735|Low Molecular Weight Heparin|low molecular weight heparin
674288|NCT00358735|MCS|mcs
674289|NCT00358709|Cognitive-behavioral therapy|cognitive-behavioral therapy
674290|NCT00358709|symptom management|symptom management
674291|NCT00358709|first psychotic episode|first psychotic episode
674292|NCT00358696|tenofovir|tenofovir
674293|NCT00358696|didanosine|didanosine
674294|NCT00358696|hiv|hiv
674295|NCT00358696|hepatitis c virus infection|hepatitis c virus infection
674296|NCT00358696|treatment|treatment
674297|NCT00358683|certolizunab pegol|certolizunab pegol
674298|NCT00358683|long term safety follow-up|long term safety follow-up
674299|NCT00358683|Chrohn's disease|chrohn's disease
674300|NCT00358683|infliximab failures patients|infliximab failures patients
674301|NCT00358683|Greek population|greek population
674302|NCT00358644|Acute Myeloid Leukemia|acute myeloid leukemia
674303|NCT00358644|AML|aml
674304|NCT00358644|Decitabine|decitabine
674305|NCT00358644|Dacogen|dacogen
674306|NCT00358644|MGI PHARMA, INC.|mgi pharma, inc.
674307|NCT00358631|depression|depression
674308|NCT00358631|antidepressive agents|antidepressive agents
674309|NCT00358631|controlled clinical trial|controlled clinical trial
674310|NCT00358618|Randomized|randomized
674311|NCT00358618|double-blind|double-blind
674312|NCT00358618|3-group clinical interventional study|3-group clinical interventional study
674313|NCT00358605|OSAHS|osahs
674314|NCT00358605|Oral Appliance|oral appliance
674315|NCT00358605|Hypopnoea Syndrome|hypopnoea syndrome
674316|NCT00358592|surgical instruments|surgical instruments
674317|NCT00358592|cesarean section|cesarean section
674318|NCT00358592|obesity|obesity
674319|NCT00358579|Vasopressin|vasopressin
674320|NCT00358579|Adrenaline|adrenaline
674321|NCT00358579|Survival|survival
674322|NCT00358579|Return of spontaneous of circulation|return of spontaneous of circulation
674323|NCT00358566|Advanced|advanced
674325|NCT00358566|Adenocarcinoma|adenocarcinoma
674326|NCT00358566|Pancreatic cancer|pancreatic cancer
674327|NCT00358553|Human Volunteers|human volunteers
674328|NCT00358540|sarcoma|sarcoma
674329|NCT00358540|eltrombopag|eltrombopag
674330|NCT00358540|thrombopoiesis|thrombopoiesis
674331|NCT00358540|thrombocytopenia|thrombocytopenia
674332|NCT00358514|Tibia|tibia
674333|NCT00358514|fracture|fracture
674334|NCT00358514|compartment syndrome|compartment syndrome
674335|NCT00358514|fasciotomy|fasciotomy
674336|NCT00358501|Defibrotide|defibrotide
674337|NCT00358501|Severe veno occlusive disease|severe veno occlusive disease
674338|NCT00358501|Multi organ failure|multi organ failure
674339|NCT00358501|Stem cell transplant|stem cell transplant
674341|NCT00358501|Regimen related toxicity|regimen related toxicity
674342|NCT00358501|Day 100 survival|day 100 survival
674343|NCT00358488|Safety|safety
674344|NCT00358488|Asthmatic patients|asthmatic patients
674345|NCT00358488|GSK159797|gsk159797
674346|NCT00358488|Efficacy|efficacy
674347|NCT00358475|perennial allergic rhinitis|perennial allergic rhinitis
674348|NCT00358462|NGU, M genitalium, Ureaplasma, azithromycin, doxycycline|ngu, m genitalium, ureaplasma, azithromycin, doxycycline
674349|NCT00358449|eosinophilic|eosinophilic
674350|NCT00358449|mepolizumab|mepolizumab
674351|NCT00358449|esophagitis|esophagitis
674352|NCT00358436|COPD|copd
674353|NCT00358436|Lung function|lung function
674354|NCT00358436|Exacerbations|exacerbations
674355|NCT00358436|Quality of Life|quality of life
674356|NCT00358423|CME|cme
674357|NCT00358423|Pegaptanib|pegaptanib
674358|NCT00358423|Post-Surgical Ocular Inflammation|post-surgical ocular inflammation
674359|NCT00358410|Functional Dyspepsia|functional dyspepsia
674360|NCT00358410|Barostat|barostat
674361|NCT00358410|Stomach|stomach
674362|NCT00358397|Solid Tumor|solid tumor
674363|NCT00358397|Clostridial|clostridial
674364|NCT00358397|Spore-forming bacteria|spore-forming bacteria
674365|NCT00358397|hypoxia|hypoxia
674366|NCT00358397|anaerobes|anaerobes
674367|NCT00358397|Clostridium novyi|clostridium novyi
674368|NCT00358397|Bacteria|bacteria
674369|NCT00358397|Bacteriolytic|bacteriolytic
674370|NCT00358397|Tumor lysis|tumor lysis
674371|NCT00358397|Necrosis|necrosis
674372|NCT00358397|Colon Cancer|colon cancer
674373|NCT00358397|Lung Cancer|lung cancer
674374|NCT00358397|Sarcoma|sarcoma
674375|NCT00358397|Bladder Cancer|bladder cancer
674376|NCT00358397|Rectal Cancer|rectal cancer
674377|NCT00358397|Gastric Cancer|gastric cancer
674378|NCT00358397|Pancreatic Cancer|pancreatic cancer
674379|NCT00358397|Experimental Therapy|experimental therapy
674380|NCT00358397|Solid Tumors|solid tumors
674381|NCT00358384|tolerability|tolerability
674382|NCT00358384|safety|safety
674383|NCT00358384|angiogenesis|angiogenesis
674384|NCT00358384|vascular endothelial growth factor|vascular endothelial growth factor
674385|NCT00358384|pharmacodynamics|pharmacodynamics
674386|NCT00358384|pharmacokinetics|pharmacokinetics
674387|NCT00358384|microplaque|microplaque
674388|NCT00358384|VEGF|vegf
674389|NCT00358384|GW786034|gw786034
674390|NCT00358371|bioavailability flucloxacillin|bioavailability flucloxacillin
674391|NCT00358358|COPD|copd
674392|NCT00358358|Impulse Oscillometry System|impulse oscillometry system
674393|NCT00358358|Computerized Tomography|computerized tomography
674394|NCT00358345|AMD|amd
674395|NCT00358332|malaria, vaccine, Mali, children|malaria, vaccine, mali, children
674396|NCT00358319|Valproic Acid (VPA)|valproic acid (vpa)
674397|NCT00358319|Karenitecin|karenitecin
674398|NCT00358319|Malignant Melanoma|malignant melanoma
674399|NCT00358319|Histone deacetylases (HDAC)inhibitors|histone deacetylases (hdac)inhibitors
674400|NCT00358319|Topoisomerase I inhibitor|topoisomerase i inhibitor
674401|NCT00358319|metastatic|metastatic
674402|NCT00358306|Endothelium|endothelium
674403|NCT00358306|Chronic Kidney Disease|chronic kidney disease
674404|NCT00358306|Acute Kidney Injury|acute kidney injury
674405|NCT00358306|Hemolytic-uremic syndrome (HUS)|hemolytic-uremic syndrome (hus)
674406|NCT00358293|Multiple Sclerosis|multiple sclerosis
674407|NCT00358293|Spasticity|spasticity
674408|NCT00358293|Sublingual Tizanidine|sublingual tizanidine
674409|NCT00358293|Ashworth Scores|ashworth scores
674410|NCT00358293|Spasticity in Multiple Sclerosis Patients|spasticity in multiple sclerosis patients
674411|NCT00358280|Patients ASA category I ～ II|patients asa category i ～ ii
674412|NCT00358280|Unilateral Lower limb surgery|unilateral lower limb surgery
674413|NCT00358280|Spinal Anesthesia|spinal anesthesia
674414|NCT00358267|Inferior Turbinate Reduction|inferior turbinate reduction
674415|NCT00358267|Partial Resection of Inferior Turbinates (PRIT)|partial resection of inferior turbinates (prit)
674416|NCT00358267|Radiofrequency Ablation (RFA)|radiofrequency ablation (rfa)
674417|NCT00358267|NOSE scale|nose scale
674418|NCT00358267|Nasal Obstruction|nasal obstruction
674419|NCT00358241|Nerve block, postoperative pain, analgesia|nerve block, postoperative pain, analgesia
674420|NCT00358228|Smoking cessation|smoking cessation
674421|NCT00358228|Abstinence|abstinence
674422|NCT00358215|Survival study|survival study
674423|NCT00358215|morbidity and mortality|morbidity and mortality
674603|NCT00357513|Gene Chip|gene chip
674424|NCT00358215|heart failure hospitalization|heart failure hospitalization
674425|NCT00358215|all-cause death|all-cause death
674426|NCT00358215|patient-reported outcomes|patient-reported outcomes
674427|NCT00358215|Kansas City Cardiomyopathy questionnaire|kansas city cardiomyopathy questionnaire
674428|NCT00358215|anemia treatment|anemia treatment
674429|NCT00358202|intramuscular antibiotics|intramuscular antibiotics
674430|NCT00358202|nursing home acquired pneumonia|nursing home acquired pneumonia
674431|NCT00358202|nhap|nhap
674432|NCT00358202|pharmacoeconomics|pharmacoeconomics
674433|NCT00358202|cefepime|cefepime
674434|NCT00358202|ceftriaxone|ceftriaxone
674435|NCT00358189|deep brain stimulation|deep brain stimulation
674436|NCT00358189|gait|gait
674437|NCT00358189|manual dexterity|manual dexterity
674438|NCT00358189|parkinson's disease|parkinson's disease
674439|NCT00358176|Treatment osteoporosis postmenopausal|treatment osteoporosis postmenopausal
674440|NCT00358163|angiogenesis|angiogenesis
674441|NCT00358163|taxane|taxane
674442|NCT00358163|tyrosine kinase|tyrosine kinase
674443|NCT00358163|pharmacokinetics|pharmacokinetics
674444|NCT00358163|Vatalanib|vatalanib
674445|NCT00358163|Taxol|taxol
674446|NCT00358150|Type 1 Gaucher Disease|type 1 gaucher disease
674447|NCT00358150|Glucocerebrosidase Deficiency Disease|glucocerebrosidase deficiency disease
674448|NCT00358137|Blood Pressure, High|blood pressure, high
674449|NCT00358111|high-grade disease|high-grade disease
674450|NCT00358111|Cervical examination|cervical examination
674451|NCT00358111|targeting biopsies|targeting biopsies
674452|NCT00358111|dysplasia|dysplasia
674453|NCT00358111|cancer|cancer
674454|NCT00358098|PET|pet
674455|NCT00358098|hormone positive breast cancer|hormone positive breast cancer
674456|NCT00358085|Endovascular|endovascular
674457|NCT00358085|Vascular Surgical Procedures|vascular surgical procedures
674458|NCT00358085|Aneurysm|aneurysm
674459|NCT00358085|Expertise Based Methodology|expertise based methodology
674460|NCT00358072|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
674461|NCT00358072|Adult patients|adult patients
674462|NCT00358072|Minimal residual disease|minimal residual disease
674463|NCT00358072|Risk-oriented therapy|risk-oriented therapy
674464|NCT00358059|diabetes mellitus|diabetes mellitus
674465|NCT00358059|adolescence|adolescence
674466|NCT00358059|adherence|adherence
674467|NCT00358059|glycemic control|glycemic control
674468|NCT00358059|adaptation|adaptation
674469|NCT00358059|communication|communication
674470|NCT00358046|Hyperphosphatemia|hyperphosphatemia
674471|NCT00358046|Chronic kidney disease|chronic kidney disease
674472|NCT00358046|Dialysis|dialysis
674473|NCT00358046|Hyperphosphatemia in CKD patients on dialysis|hyperphosphatemia in ckd patients on dialysis
674474|NCT00358020|MYELOMA, THALIDOMIDE, BORTEZOMIB|myeloma, thalidomide, bortezomib
674475|NCT00358007|Kilovoltage Imaging|kilovoltage imaging
674476|NCT00358007|Cone-beam CT|cone-beam ct
674477|NCT00358007|CBCT|cbct
674478|NCT00358007|radiation therapy|radiation therapy
674479|NCT00358007|head and neck neoplasms|head and neck neoplasms
674480|NCT00357994|carbidopa|carbidopa
674481|NCT00357994|levodopa-carbidopa|levodopa-carbidopa
674482|NCT00357994|levodopa|levodopa
674483|NCT00357994|levodopa/carbidopa suspension|levodopa/carbidopa suspension
674484|NCT00357994|dyskinesia|dyskinesia
674485|NCT00357994|Duodopa|duodopa
674486|NCT00357994|levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
674487|NCT00357994|Severe Motor Fluctuations|severe motor fluctuations
674488|NCT00357994|DUOPA|duopa
674489|NCT00357981|Contraceptive patch|contraceptive patch
674490|NCT00357981|menstruation|menstruation
674491|NCT00357981|economics|economics
674492|NCT00357942|Morphine|morphine
674493|NCT00357942|Mouthwash|mouthwash
674494|NCT00357942|Mucositis|mucositis
674495|NCT00357942|Pain|pain
674496|NCT00357942|Cancer|cancer
674497|NCT00357942|Child|child
674498|NCT00357942|Adolescent|adolescent
674499|NCT00357929|permissive hypercarbia|permissive hypercarbia
674500|NCT00357929|weaning from mechanical ventilation|weaning from mechanical ventilation
674501|NCT00357916|PEP005|pep005
674502|NCT00357916|Safety|safety
674503|NCT00357903|Rheumatoid Arthritis, Etanercept, Long-term Safety, Enbrel|rheumatoid arthritis, etanercept, long-term safety, enbrel
674504|NCT00357890|type 1 diabetes|type 1 diabetes
674505|NCT00357890|diabetes|diabetes
674506|NCT00357890|new onset|new onset
674507|NCT00357890|CSII|csii
674508|NCT00357890|insulin glargine|insulin glargine
674509|NCT00357890|insulin sensitivity|insulin sensitivity
674510|NCT00357890|beta cell function|beta cell function
674511|NCT00357890|beta cell preservation|beta cell preservation
674512|NCT00357851|pancreatitis, blood loss|pancreatitis, blood loss
674513|NCT00357838|normal healthy women|normal healthy women
674514|NCT00357812|Herpes Simplex Virus Type 1|herpes simplex virus type 1
674515|NCT00357812|Herpes Simplex Keratitis|herpes simplex keratitis
674516|NCT00357812|Cornea|cornea
674517|NCT00357812|Dendretic Ulcer|dendretic ulcer
674518|NCT00357812|In vivo Confocal Microscopy|in vivo confocal microscopy
674519|NCT00357812|Nested Multi-plex PCR|nested multi-plex pcr
674520|NCT00357812|Monoclonal Antibody|monoclonal antibody
674521|NCT00357812|Glycoprotein D|glycoprotein d
674522|NCT00357812|Glycoprotein C|glycoprotein c
674523|NCT00357799|Venipuncture|venipuncture
674524|NCT00357799|Randomized Controlled Trial|randomized controlled trial
674525|NCT00357799|Intravenous Access|intravenous access
674526|NCT00357799|Children|children
674527|NCT00357799|Emergency Department Nursing|emergency department nursing
674528|NCT00357799|VeinViewer|veinviewer
674529|NCT00357799|Pediatrics|pediatrics
674530|NCT00357799|Emergency Nursing|emergency nursing
674531|NCT00357786|Lysosomal Disease|lysosomal disease
674532|NCT00357786|Glycolipid|glycolipid
674533|NCT00357786|Stroke|stroke
674534|NCT00357786|Peripheral Neuropathy|peripheral neuropathy
674535|NCT00357786|Storage Disorder|storage disorder
674536|NCT00357760|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
674537|NCT00357760|VEGF Trap|vegf trap
674538|NCT00357747|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
674539|NCT00357734|lung cancer|lung cancer
674540|NCT00357734|breast cancer|breast cancer
674541|NCT00357695|Praxis|praxis
674542|NCT00357695|Grasping|grasping
674543|NCT00357695|Premotor Cortex|premotor cortex
674544|NCT00357695|Visuo-Motor Integration|visuo-motor integration
674545|NCT00357695|Motor Imagination|motor imagination
674546|NCT00357682|esophageal cancer|esophageal cancer
674547|NCT00357682|Barrett's esophagus|barrett's esophagus
674548|NCT00357669|Unverricht-Lundborg disease|unverricht-lundborg disease
674549|NCT00357669|Baltic myoclonus|baltic myoclonus
674550|NCT00357669|progressive myoclonic epilepsies|progressive myoclonic epilepsies
674551|NCT00357669|myoclonus|myoclonus
674552|NCT00357669|brivaracetam|brivaracetam
674553|NCT00357656|Hemophilia A (severe or moderately severe)|hemophilia a (severe or moderately severe)
674554|NCT00357643|calcium|calcium
674555|NCT00357643|vitamin D|vitamin d
674556|NCT00357643|bone loss|bone loss
674557|NCT00357630|adenocarcinoma of unknown primary|adenocarcinoma of unknown primary
674558|NCT00357630|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
674559|NCT00357630|undifferentiated carcinoma of unknown primary|undifferentiated carcinoma of unknown primary
674560|NCT00357630|pain|pain
674561|NCT00357617|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
674562|NCT00357617|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
674563|NCT00357617|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
674564|NCT00357617|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
674565|NCT00357617|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
674566|NCT00357617|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
674567|NCT00357617|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
674568|NCT00357617|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
674569|NCT00357617|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
674570|NCT00357617|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
674571|NCT00357617|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
674572|NCT00357617|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
674573|NCT00357617|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
674574|NCT00357617|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
674575|NCT00357617|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
674576|NCT00357617|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
674577|NCT00357617|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
674578|NCT00357617|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
674579|NCT00357617|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
674580|NCT00357617|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
674582|NCT00357604|Protease Inhibitor|protease inhibitor
674583|NCT00357591|Heart Failure|heart failure
674584|NCT00357591|Acute Decompensation|acute decompensation
674585|NCT00357591|Chronic Heart Failure|chronic heart failure
674586|NCT00357578|Macrophages|macrophages
674587|NCT00357578|Biopsy|biopsy
674588|NCT00357578|Genetic Analysis|genetic analysis
674589|NCT00357578|Geographic Atrophy|geographic atrophy
674590|NCT00357578|Choroidal Neovascularization|choroidal neovascularization
674591|NCT00357578|Fibroblast|fibroblast
674592|NCT00357578|Disciform|disciform
674593|NCT00357578|Age-Related Macular Degeneration|age-related macular degeneration
674594|NCT00357565|MDS|mds
674595|NCT00357565|AML|aml
674596|NCT00357552|Treatment Experienced|treatment experienced
674597|NCT00357526|vaginal ring|vaginal ring
674598|NCT00357526|Oral contraceptive pills|oral contraceptive pills
674599|NCT00357526|Teenagers|teenagers
674600|NCT00357526|Young women|young women
674601|NCT00357526|Patient satisfaction|patient satisfaction
674602|NCT00357513|Cerebrovascular Disease|cerebrovascular disease
674604|NCT00357513|Inflammation|inflammation
674605|NCT00357513|Pathophysiology Stroke|pathophysiology stroke
674606|NCT00357513|Stroke Genomics|stroke genomics
674607|NCT00357513|Stroke Subtypes|stroke subtypes
674608|NCT00357513|Neuroimaging|neuroimaging
674609|NCT00357513|Clinical Outcome Measures|clinical outcome measures
674610|NCT00357513|Stroke|stroke
674611|NCT00357513|CVA|cva
674612|NCT00357513|Healthy Volunteer|healthy volunteer
674613|NCT00357513|HV|hv
674614|NCT00357513|Normal Control|normal control
674615|NCT00357500|Metronomic|metronomic
674616|NCT00357500|antiangiogenic|antiangiogenic
674617|NCT00357487|Sentinel lymph node|sentinel lymph node
674618|NCT00357487|Breast cancer|breast cancer
674619|NCT00357487|Lymphoscintigraphy|lymphoscintigraphy
674620|NCT00357487|Probe|probe
674621|NCT00357487|Operative gamma camera|operative gamma camera
674622|NCT00357487|Breast cancer and sentinel lymph node biopsy|breast cancer and sentinel lymph node biopsy
674623|NCT00357487|Use of lymphoscintigraphy|use of lymphoscintigraphy
674624|NCT00357487|Use of intraoperative gamma camera|use of intraoperative gamma camera
674625|NCT00357487|Use of intraoperative probe|use of intraoperative probe
674626|NCT00357474|HCC, TACE, PEIT|hcc, tace, peit
674627|NCT00357461|stage IV melanoma|stage iv melanoma
674628|NCT00357461|recurrent melanoma|recurrent melanoma
674629|NCT00357435|Cornea|cornea
674630|NCT00357435|Genetics|genetics
674631|NCT00357435|Dystrophy|dystrophy
674632|NCT00357435|Gene|gene
674633|NCT00357435|Mapping|mapping
674634|NCT00357435|Molecular|molecular
674635|NCT00357435|Bietti|bietti
674636|NCT00357435|Fleck|fleck
674637|NCT00357435|Positional Cloning|positional cloning
674638|NCT00357435|Linkage|linkage
674639|NCT00357422|HCC, operation, percutaneous ethanol injection|hcc, operation, percutaneous ethanol injection
674640|NCT00357409|GABA|gaba
674641|NCT00357409|Occipital|occipital
674642|NCT00357409|Vision|vision
674643|NCT00357409|Plasticity|plasticity
674644|NCT00357409|MRS|mrs
674645|NCT00357409|Blind|blind
674646|NCT00357396|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
674647|NCT00357396|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
674648|NCT00357357|Alzheimer's disease|alzheimer's disease
674649|NCT00357344|Obesity|obesity
674650|NCT00357344|Gray Matter|gray matter
674651|NCT00357344|Eating Behavior|eating behavior
674652|NCT00357344|Brain MRI|brain mri
674653|NCT00357344|Body Weight Regulation|body weight regulation
674654|NCT00357331|postmenopausal osteopenia|postmenopausal osteopenia
674655|NCT00357331|treatment|treatment
674656|NCT00357331|bone loss|bone loss
674657|NCT00357266|Uveitis|uveitis
674658|NCT00357266|Interleukin 2|interleukin 2
674659|NCT00357266|Interleukin 2 Receptor|interleukin 2 receptor
674660|NCT00357266|Microarrays|microarrays
674661|NCT00357266|Genetic Expression|genetic expression
674662|NCT00357266|Daclizumab|daclizumab
674663|NCT00357266|HAT|hat
674664|NCT00357266|Zenapax|zenapax
674665|NCT00357266|Proteins|proteins
674666|NCT00357266|RNA|rna
674667|NCT00357266|Ocular Inflammatory Disease|ocular inflammatory disease
674668|NCT00357253|untreated childhood brain stem glioma|untreated childhood brain stem glioma
674669|NCT00357253|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
674670|NCT00357253|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
674671|NCT00357240|Protease inhibitor|protease inhibitor
674672|NCT00357227|Atrial fibrillation|atrial fibrillation
674673|NCT00357227|Stroke|stroke
674674|NCT00357227|Vascular Dementia|vascular dementia
674675|NCT00357227|Mild Cognitive Impairment|mild cognitive impairment
674676|NCT00357214|bone turnover|bone turnover
674677|NCT00357214|calcium excretion|calcium excretion
674678|NCT00357214|nitrogen excretion|nitrogen excretion
674679|NCT00357214|potassium bicarbonate|potassium bicarbonate
674680|NCT00357214|muscle loss|muscle loss
674681|NCT00357214|muscle atrophy|muscle atrophy
674682|NCT00357214|bone loss|bone loss
674683|NCT00357123|abdominal sepsis|abdominal sepsis
674684|NCT00357123|sepsis|sepsis
674685|NCT00357123|rosuvastatin|rosuvastatin
674686|NCT00357110|Breast neoplasms|breast neoplasms
674687|NCT00357110|breast cancer|breast cancer
674688|NCT00357110|early breast cancer|early breast cancer
674689|NCT00357110|oncology|oncology
674690|NCT00357110|cancer|cancer
674691|NCT00357110|breast cancer micrometastasis|breast cancer micrometastasis
674692|NCT00357110|fulvestrant|fulvestrant
674693|NCT00357097|randomised|randomised
674694|NCT00357097|ropinirole|ropinirole
674695|NCT00357097|depression|depression
674696|NCT00357097|RLS|rls
674697|NCT00357097|placebo|placebo
674698|NCT00357097|mood|mood
674699|NCT00357097|double-blind|double-blind
674700|NCT00357097|restless legs syndrome|restless legs syndrome
674701|NCT00357097|germany|germany
674702|NCT00357084|graft versus host disease|graft versus host disease
674703|NCT00357084|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
674763|NCT00357084|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
674704|NCT00357084|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
674705|NCT00357084|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
674706|NCT00357084|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
674707|NCT00357084|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
674708|NCT00357084|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
674709|NCT00357084|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
674710|NCT00357084|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
674711|NCT00357084|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
674712|NCT00357084|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
674713|NCT00357084|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
674714|NCT00357084|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
674715|NCT00357084|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
674716|NCT00357084|chronic eosinophilic leukemia|chronic eosinophilic leukemia
674717|NCT00357084|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
674718|NCT00357084|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
674719|NCT00357084|chronic neutrophilic leukemia|chronic neutrophilic leukemia
674720|NCT00357084|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
674721|NCT00357084|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
674722|NCT00357084|disseminated neuroblastoma|disseminated neuroblastoma
674723|NCT00357084|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
674724|NCT00357084|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
674725|NCT00357084|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
674726|NCT00357084|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
674727|NCT00357084|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
674728|NCT00357084|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
674729|NCT00357084|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
674730|NCT00357084|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
674731|NCT00357084|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
674732|NCT00357084|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
674733|NCT00357084|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
674734|NCT00357084|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
674735|NCT00357084|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
674736|NCT00357084|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
674737|NCT00357084|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
674738|NCT00357084|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
674739|NCT00357084|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
674740|NCT00357084|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
674741|NCT00357084|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
674742|NCT00357084|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
674743|NCT00357084|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
674744|NCT00357084|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
674745|NCT00357084|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
674746|NCT00357084|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
674747|NCT00357084|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
674748|NCT00357084|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
674749|NCT00357084|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
674750|NCT00357084|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
674751|NCT00357084|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
674752|NCT00357084|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
674753|NCT00357084|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
674754|NCT00357084|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
674755|NCT00357084|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
674756|NCT00357084|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
674757|NCT00357084|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
674758|NCT00357084|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
674759|NCT00357084|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
674760|NCT00357084|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
674761|NCT00357084|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
674762|NCT00357084|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
675142|NCT00355693|Anxiety|anxiety
674764|NCT00357084|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
674765|NCT00357084|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
674766|NCT00357084|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
674767|NCT00357084|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
674768|NCT00357084|refractory hairy cell leukemia|refractory hairy cell leukemia
674769|NCT00357084|refractory multiple myeloma|refractory multiple myeloma
674770|NCT00357084|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
674771|NCT00357084|secondary acute myeloid leukemia|secondary acute myeloid leukemia
674772|NCT00357084|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
674773|NCT00357084|splenic marginal zone lymphoma|splenic marginal zone lymphoma
674774|NCT00357084|stage I multiple myeloma|stage i multiple myeloma
674775|NCT00357084|stage II multiple myeloma|stage ii multiple myeloma
674776|NCT00357084|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
674777|NCT00357084|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
674778|NCT00357084|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
674779|NCT00357084|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
674780|NCT00357084|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
674781|NCT00357084|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
674782|NCT00357084|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
674783|NCT00357084|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
674784|NCT00357084|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
674785|NCT00357084|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
674786|NCT00357084|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
674787|NCT00357084|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
674788|NCT00357084|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
674789|NCT00357084|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
674790|NCT00357084|stage III multiple myeloma|stage iii multiple myeloma
674791|NCT00357084|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
674792|NCT00357084|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
674793|NCT00357084|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
674794|NCT00357084|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
674795|NCT00357084|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
674796|NCT00357084|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
674797|NCT00357084|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
674798|NCT00357084|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
674799|NCT00357084|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
674800|NCT00357084|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
674801|NCT00357084|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
674802|NCT00357084|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
674803|NCT00357084|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
674804|NCT00357084|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
674805|NCT00357084|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
674806|NCT00357084|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
674807|NCT00357084|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
674808|NCT00357084|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
674809|NCT00357071|Autoimmunity|autoimmunity
674810|NCT00357071|Cell Mediated Immunity|cell mediated immunity
674811|NCT00357071|S Antigen|s antigen
674812|NCT00357071|Cell Proliferation|cell proliferation
674813|NCT00357071|Uveitis|uveitis
674814|NCT00357071|Cell Proliferation Assays|cell proliferation assays
674815|NCT00357071|Auto-Antibody|auto-antibody
674816|NCT00357071|Auto-Antigens|auto-antigens
674817|NCT00357058|Deafferentiation-Induced Plasticity|deafferentiation-induced plasticity
674818|NCT00357058|fMRI|fmri
674819|NCT00357058|Cortical Reorganization|cortical reorganization
674820|NCT00357058|Tactile Performance|tactile performance
674821|NCT00357058|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
674822|NCT00357058|Tactile Discrimination|tactile discrimination
674823|NCT00357058|Plasticity|plasticity
674824|NCT00357058|Healthy Volunteer|healthy volunteer
674826|NCT00357058|Normal Control|normal control
674827|NCT00357006|Schizophrenia|schizophrenia
674828|NCT00357006|Estrogen|estrogen
674829|NCT00357006|Psychosis|psychosis
674830|NCT00356993|nicotine replacement therapy|nicotine replacement therapy
674831|NCT00356993|smoking cessation|smoking cessation
674832|NCT00356980|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
674833|NCT00356967|smoking|smoking
674834|NCT00356967|cessation|cessation
674835|NCT00356967|tobacco|tobacco
674836|NCT00356967|smoking cessation|smoking cessation
674837|NCT00356967|tobacco use cessation|tobacco use cessation
674838|NCT00356954|Kidney failure|kidney failure
674839|NCT00356954|Contrast media|contrast media
674840|NCT00356954|Antioxidant|antioxidant
674841|NCT00356954|Prevention|prevention
675143|NCT00355693|Dental|dental
674842|NCT00356941|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
674843|NCT00356941|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
674844|NCT00356941|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
674845|NCT00356941|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
674846|NCT00356928|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
674847|NCT00356928|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
674848|NCT00356928|secondary acute myeloid leukemia|secondary acute myeloid leukemia
674849|NCT00356928|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
674850|NCT00356928|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
674851|NCT00356915|Nail fungus|nail fungus
674852|NCT00356915|Onychomycosis|onychomycosis
674853|NCT00356915|Itraconazole|itraconazole
674854|NCT00356915|Toenail|toenail
674855|NCT00356863|Intervention|intervention
674856|NCT00356863|Awareness|awareness
674857|NCT00356863|Cardiac Rehabilitation (CR)|cardiac rehabilitation (cr)
674858|NCT00356863|Coronary Artery Patients|coronary artery patients
674859|NCT00356863|Coronary Artery Bypass Grafting Surgery (CABG)|coronary artery bypass grafting surgery (cabg)
674860|NCT00356824|Child|child
674861|NCT00356811|Lapatinib|lapatinib
674862|NCT00356811|Metastatic breast cancer|metastatic breast cancer
674863|NCT00356811|Paclitaxel|paclitaxel
674864|NCT00356811|ErbB2-amplification|erbb2-amplification
674865|NCT00356811|GW572016|gw572016
674866|NCT00356798|pandemic|pandemic
674867|NCT00356798|influenza|influenza
674868|NCT00356798|H5N1|h5n1
674869|NCT00356798|vaccine|vaccine
674870|NCT00356785|lifestyle|lifestyle
674871|NCT00356785|diet|diet
674872|NCT00356785|exercise|exercise
674873|NCT00356785|physical activity|physical activity
674874|NCT00356785|obesity|obesity
674875|NCT00356759|warfarin|warfarin
674876|NCT00356759|prothrombin time|prothrombin time
674877|NCT00356759|monitoring|monitoring
674878|NCT00356746|Perioperative inflammatory response|perioperative inflammatory response
674879|NCT00356746|General anesthesia|general anesthesia
674880|NCT00356746|Toll-Like Receptors|toll-like receptors
674881|NCT00356733|cardiorenal syndrome|cardiorenal syndrome
674882|NCT00356733|erythropoietin|erythropoietin
674883|NCT00356733|Heart Failure, Congestive|heart failure, congestive
674884|NCT00356733|Renal Insufficiency, Chronic|renal insufficiency, chronic
674885|NCT00356707|Body Mass Index|body mass index
674886|NCT00356681|AMG 706|amg 706
674887|NCT00356681|Paclitaxel|paclitaxel
674888|NCT00356681|Metastatic Breast Cancer|metastatic breast cancer
674889|NCT00356681|Antiangiogenic|antiangiogenic
674890|NCT00356681|Bevacizumab|bevacizumab
674891|NCT00356668|HFNC|hfnc
674892|NCT00356668|NCPAP|ncpap
674893|NCT00356668|nasal continuous positive airway pressure|nasal continuous positive airway pressure
674894|NCT00356668|humidified high flow nasal cannula|humidified high flow nasal cannula
674895|NCT00356668|esophageal pressure|esophageal pressure
674896|NCT00356668|gas flow|gas flow
674897|NCT00356655|Depressive disorder|depressive disorder
674898|NCT00356655|Patient compliance|patient compliance
674899|NCT00356655|Antidepressive Agents|antidepressive agents
674900|NCT00356655|Patient education|patient education
674901|NCT00356655|Community pharmacy services|community pharmacy services
674902|NCT00356655|Counseling|counseling
674903|NCT00356642|PK|pk
674904|NCT00356642|GW842470X|gw842470x
674905|NCT00356642|safety|safety
674906|NCT00356642|tolerability|tolerability
674907|NCT00356642|PD|pd
674908|NCT00356642|Atopic Dermatitis|atopic dermatitis
674909|NCT00356629|bronchopulmonary ignition|bronchopulmonary ignition
674910|NCT00356629|condensate of exhaled air|condensate of exhaled air
674911|NCT00356629|Mucoviscidosis|mucoviscidosis
674912|NCT00356629|Asthma|asthma
674913|NCT00356616|Antiretroviral treatment|antiretroviral treatment
674914|NCT00356616|virological failure|virological failure
674915|NCT00356616|HIV|hiv
674916|NCT00356603|Migraine|migraine
674917|NCT00356603|Sumatriptan Succinate Injection Kit|sumatriptan succinate injection kit
674918|NCT00356603|Cluster Headache|cluster headache
674919|NCT00356603|self-injection|self-injection
674920|NCT00356590|Rheumatoid Arthritis|rheumatoid arthritis
674921|NCT00356590|Etanercept|etanercept
674922|NCT00356590|Long-term Safety|long-term safety
674923|NCT00356590|Enbrel|enbrel
674924|NCT00356564|Prophylaxis for hepatitis B disease|prophylaxis for hepatitis b disease
674925|NCT00356551|Teen pregnancy|teen pregnancy
674926|NCT00356551|Family strengthening|family strengthening
674927|NCT00356551|Substance abuse prevention|substance abuse prevention
674928|NCT00356551|Depression prevention|depression prevention
674929|NCT00356551|Parent involvement|parent involvement
674930|NCT00356512|Phosphate|phosphate
674931|NCT00356512|Vitamin D|vitamin d
674932|NCT00356512|Hypoparathyroidism|hypoparathyroidism
674933|NCT00356512|Phosphatonin|phosphatonin
674934|NCT00356512|Clamp|clamp
674935|NCT00356486|Chronic Hepatitis C|chronic hepatitis c
674936|NCT00356486|Co-infection|co-infection
674937|NCT00356486|Induction dose|induction dose
674938|NCT00356486|HIV|hiv
674939|NCT00356486|HIV Infections|hiv infections
674940|NCT00356473|Rheumatoid arthritis|rheumatoid arthritis
674941|NCT00356473|Atherosclerosis|atherosclerosis
674942|NCT00356473|High density lipoprotein (HDL) cholesterol|high density lipoprotein (hdl) cholesterol
674943|NCT00356473|Statins|statins
674944|NCT00356473|HDL anti-inflammatory properties|hdl anti-inflammatory properties
674945|NCT00356473|Atorvastatin|atorvastatin
674946|NCT00356434|deep vein thrombosis|deep vein thrombosis
674947|NCT00356434|thrombophilia|thrombophilia
674948|NCT00356434|pregnancy|pregnancy
674949|NCT00356434|thromboprophylaxis|thromboprophylaxis
674950|NCT00356434|decreased mobility|decreased mobility
674951|NCT00356434|hospitalization|hospitalization
674952|NCT00356408|CDP870|cdp870
674953|NCT00356408|certolizumab pegol|certolizumab pegol
674954|NCT00356408|Crohn's Disease|crohn's disease
674955|NCT00356395|endothelial function, insulin resistance, adipocytokines|endothelial function, insulin resistance, adipocytokines
674956|NCT00356382|probiotic|probiotic
674957|NCT00356382|Lactobacillus (L.) casei|lactobacillus (l.) casei
674958|NCT00356382|cultured dairy drink|cultured dairy drink
674959|NCT00356382|Health|health
674960|NCT00356369|Immunogenicity|immunogenicity
674961|NCT00356369|Healthy|healthy
674962|NCT00356369|Persistence|persistence
674963|NCT00356369|Meningococcal vaccine|meningococcal vaccine
674964|NCT00356369|Non-inferiority|non-inferiority
674965|NCT00356369|Meningococcal A C W Y Diseases|meningococcal a c w y diseases
674966|NCT00356369|meningococcal serogroups A, C, W & Y diseases|meningococcal serogroups a, c, w & y diseases
674967|NCT00356343|NMES|nmes
674968|NCT00356343|Cerebral Palsy|cerebral palsy
674969|NCT00356343|Spastic Diplegia|spastic diplegia
674970|NCT00356343|Electrical Stimulation|electrical stimulation
674971|NCT00356343|Children|children
674972|NCT00356330|pacemaker|pacemaker
674973|NCT00356330|magnetic resonance imaging|magnetic resonance imaging
674974|NCT00356330|safety|safety
674975|NCT00356317|Culture|culture
674976|NCT00356317|Family|family
674977|NCT00356317|Therapy|therapy
674978|NCT00356304|Dysthymia|dysthymia
674979|NCT00356304|Major Depression|major depression
674980|NCT00356304|Hispanics|hispanics
674981|NCT00356304|Latinos|latinos
674982|NCT00356304|Motivational Interviewing|motivational interviewing
674983|NCT00356304|Adherence|adherence
674984|NCT00356291|HIV|hiv
674985|NCT00356291|AIDS|aids
674986|NCT00356291|Prevention|prevention
674987|NCT00356291|Serious Mental Illness|serious mental illness
674988|NCT00356278|D-Cycloserine|d-cycloserine
674989|NCT00356278|Virtual Reality|virtual reality
674990|NCT00356278|Exposure Therapy|exposure therapy
674991|NCT00356278|Veterans|veterans
674992|NCT00356278|Cognitive Behavior Therapy|cognitive behavior therapy
674993|NCT00356278|Translational Research|translational research
674994|NCT00356265|Blood Pressure Nitric Oxide|blood pressure nitric oxide
674995|NCT00356265|L-NMMA|l-nmma
674996|NCT00356265|Phenylephrine|phenylephrine
674997|NCT00356265|Vasoreactivity|vasoreactivity
674998|NCT00356265|Blood Pressure|blood pressure
674999|NCT00356239|Defibrillators, Implantable|defibrillators, implantable
675000|NCT00356239|Heart Failure, Congestive|heart failure, congestive
675001|NCT00356239|Magnetic Resonance Imaging|magnetic resonance imaging
675002|NCT00356226|norepinephrine|norepinephrine
675003|NCT00356226|renin|renin
675004|NCT00356226|aldosterone|aldosterone
675005|NCT00356226|hemodynamics|hemodynamics
675006|NCT00356226|spironolactone|spironolactone
675007|NCT00356213|morbid obesity|morbid obesity
675008|NCT00356213|bariatric surgery|bariatric surgery
675009|NCT00356213|sleeve-gastrectomy|sleeve-gastrectomy
675010|NCT00356213|Roux-Y-gastric bypass|roux-y-gastric bypass
675011|NCT00356213|outcome|outcome
675012|NCT00356213|weight loss|weight loss
675013|NCT00356174|Food Allergy|food allergy
675014|NCT00356161|colorectal neoplasms|colorectal neoplasms
675015|NCT00356161|hepatocellular carcinoma|hepatocellular carcinoma
675016|NCT00356161|gallbladder cancer|gallbladder cancer
675017|NCT00356161|bile duct cancer|bile duct cancer
675018|NCT00356161|hepatic arterial infusion|hepatic arterial infusion
675019|NCT00356148|breast cancer|breast cancer
675020|NCT00356148|breast surgery|breast surgery
675021|NCT00356148|clean wound|clean wound
675022|NCT00356148|overweight|overweight
675023|NCT00356148|prophylaxis|prophylaxis
675024|NCT00356148|antibiotics|antibiotics
675025|NCT00356122|Lung|lung
675026|NCT00356122|non-small cell|non-small cell
675027|NCT00356122|chemotherapy|chemotherapy
675028|NCT00356122|tumor|tumor
675029|NCT00356122|advanced|advanced
675030|NCT00356122|recurrent|recurrent
675031|NCT00356122|metastatic|metastatic
675032|NCT00356122|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
675033|NCT00356070|Attention Deficit Hyperactivity Disorder, treatment,|attention deficit hyperactivity disorder, treatment,
675034|NCT00356070|Strattera,|strattera,
675035|NCT00356070|rehabilitation|rehabilitation
675036|NCT00356057|atrial fibrillation|atrial fibrillation
675037|NCT00356057|AV node ablation|av node ablation
675038|NCT00356057|pacemaker|pacemaker
675039|NCT00356057|congestive heart failure|congestive heart failure
675040|NCT00356044|Transradial access|transradial access
675041|NCT00356044|Femoral access|femoral access
675042|NCT00356044|Femoral vs radial access|femoral vs radial access
675043|NCT00356031|Avastin|avastin
675044|NCT00356018|Epilepsy|epilepsy
675045|NCT00356018|Compliance|compliance
675046|NCT00356005|falciparum malaria|falciparum malaria
675047|NCT00356005|therapy|therapy
675048|NCT00356005|azithromycin|azithromycin
675049|NCT00356005|artesunate|artesunate
675050|NCT00356005|Coartem|coartem
675051|NCT00356005|Bangladesh|bangladesh
675052|NCT00355992|Myocardial Ischemia|myocardial ischemia
675053|NCT00355992|Chest pain|chest pain
675054|NCT00355992|Ischemia Modified Albumin|ischemia modified albumin
675055|NCT00355992|Acute Coronary Syndrome|acute coronary syndrome
675056|NCT00355979|Obesity, intragastric balloon, Pharmacotherapy|obesity, intragastric balloon, pharmacotherapy
675057|NCT00355966|Premature rupture of membranes|premature rupture of membranes
675058|NCT00355966|Induction of labour with Misoprostol|induction of labour with misoprostol
675059|NCT00355966|Induction of labour with PGE2 gel|induction of labour with pge2 gel
675060|NCT00355953|Post-Menopausal Women|post-menopausal women
675061|NCT00355953|Osteoporosis|osteoporosis
675062|NCT00355953|Phytoestrogen|phytoestrogen
675063|NCT00355953|Genistein|genistein
675064|NCT00355940|endovascular|endovascular
675065|NCT00355940|aortic|aortic
675066|NCT00355940|repair|repair
675067|NCT00355940|navigation|navigation
675068|NCT00355940|DynaCT|dynact
675069|NCT00355940|position|position
675070|NCT00355940|sensor|sensor
675071|NCT00355927|Deep brain stimulation|deep brain stimulation
675072|NCT00355927|Microelectrode recordings|microelectrode recordings
675073|NCT00355927|Basal Ganglia|basal ganglia
675074|NCT00355927|Sedation|sedation
675075|NCT00355927|Propofol|propofol
675076|NCT00355914|Lumbar Facet Joint Nerve Block|lumbar facet joint nerve block
675077|NCT00355901|Ulcerative Colitis|ulcerative colitis
675078|NCT00355901|Colitis|colitis
675079|NCT00355901|Steroid-Refractory|steroid-refractory
675080|NCT00355901|Visilizumab|visilizumab
675081|NCT00355901|Intravenous Steroid-Refractory Ulcerative Colitis (IVSR-UC)|intravenous steroid-refractory ulcerative colitis (ivsr-uc)
675082|NCT00355888|Cancer|cancer
675083|NCT00355888|Advanced or Metastatic Solid Tumor|advanced or metastatic solid tumor
675084|NCT00355875|newborn|newborn
675085|NCT00355875|preterm|preterm
675086|NCT00355875|resuscitation|resuscitation
675087|NCT00355875|oxidative injury|oxidative injury
675088|NCT00355875|protein carbonyl|protein carbonyl
675089|NCT00355862|Sirolimus|sirolimus
675090|NCT00355862|mTOR|mtor
675091|NCT00355862|HCC-recurrence free survival|hcc-recurrence free survival
675092|NCT00355862|Liver transplant recipients|liver transplant recipients
675093|NCT00355862|HCC recurrence free survival|hcc recurrence free survival
675094|NCT00355836|Motor Imagery|motor imagery
675095|NCT00355836|Stroke|stroke
675096|NCT00355836|Neuro-rehabilitation|neuro-rehabilitation
675097|NCT00355836|health psychology|health psychology
675098|NCT00355836|neuroscience|neuroscience
675099|NCT00355836|randomised controlled trial|randomised controlled trial
675100|NCT00355823|electric field|electric field
675101|NCT00355823|wound current|wound current
675102|NCT00355823|wound healing|wound healing
675103|NCT00355823|bioelectric field|bioelectric field
675104|NCT00355823|chronic ulcer|chronic ulcer
675105|NCT00355823|diabetic|diabetic
675106|NCT00355823|Diabetes|diabetes
675107|NCT00355823|aging|aging
675108|NCT00355810|Probiotics|probiotics
675109|NCT00355797|Bradycardia|bradycardia
675110|NCT00355797|Sinus Node Dysfunction|sinus node dysfunction
675111|NCT00355797|Chronotropic incompetence|chronotropic incompetence
675112|NCT00355797|Pacemaker|pacemaker
675113|NCT00355797|Rate adaptive|rate adaptive
675114|NCT00355784|growth hormone|growth hormone
675115|NCT00355784|overfeeding|overfeeding
675116|NCT00355784|energy expenditure|energy expenditure
675117|NCT00355784|protein metabolism|protein metabolism
675118|NCT00355784|lipid metabolism|lipid metabolism
675119|NCT00355771|allergic rhinitis|allergic rhinitis
675120|NCT00355771|histamine antagonist|histamine antagonist
675121|NCT00355771|sleep disorder|sleep disorder
675122|NCT00355758|Prostate Cancer Detection by Serum Proteomic Profiling|prostate cancer detection by serum proteomic profiling
675123|NCT00355745|Breast|breast
675124|NCT00355745|tumor|tumor
675125|NCT00355745|ultrasound|ultrasound
675126|NCT00355745|biopsy|biopsy
675127|NCT00355745|Breast mammographic or ultrasound findings|breast mammographic or ultrasound findings
675128|NCT00355732|Respiration|respiration
675129|NCT00355732|COPD|copd
675130|NCT00355732|Mechanical Ventilation|mechanical ventilation
675131|NCT00355732|Ventilator Weaning|ventilator weaning
675132|NCT00355732|Respiratory Failure|respiratory failure
675133|NCT00355732|ICU|icu
675134|NCT00355732|Pressure Support Ventilation|pressure support ventilation
675135|NCT00355719|Nevirapine|nevirapine
675136|NCT00355719|Atazanavir|atazanavir
675137|NCT00355719|Pharmacokinetics|pharmacokinetics
675138|NCT00355719|Interactions|interactions
675139|NCT00355706|chronic low back pain|chronic low back pain
675140|NCT00355706|thoracic facet joint|thoracic facet joint
675141|NCT00355706|nerve block|nerve block
675144|NCT00355693|Oral|oral
675145|NCT00355693|Surgery|surgery
675146|NCT00355693|Colonoscopy|colonoscopy
675147|NCT00355693|Propofol|propofol
675148|NCT00355693|Sedation|sedation
675149|NCT00355693|Effect|effect
675150|NCT00355693|Reaction|reaction
675151|NCT00355680|Retina|retina
675152|NCT00355680|Retinal Diseases|retinal diseases
675153|NCT00355680|Retinal Vessels|retinal vessels
675154|NCT00355680|Laser Coagulation|laser coagulation
675155|NCT00355667|diuretics|diuretics
675156|NCT00355667|furosemide|furosemide
675157|NCT00355667|azosemide|azosemide
675158|NCT00355667|congestive heart failure|congestive heart failure
675159|NCT00355654|Diphtheria|diphtheria
675160|NCT00355654|Tetanus|tetanus
675161|NCT00355654|Pertussis|pertussis
675162|NCT00355654|Poliomyelitis|poliomyelitis
675163|NCT00355654|Haemophilus influenzae type b|haemophilus influenzae type b
675164|NCT00355654|Hepatitis B|hepatitis b
675165|NCT00355641|Ropinirole|ropinirole
675166|NCT00355641|Restless Legs Syndrome|restless legs syndrome
675167|NCT00355641|RLS|rls
675168|NCT00355628|Pain|pain
675169|NCT00355628|Cancer|cancer
675170|NCT00355628|Neoplasm|neoplasm
675171|NCT00355628|Continual Reassessment Method|continual reassessment method
675172|NCT00355628|Pain Associated with Cancer/Neoplasms|pain associated with cancer/neoplasms
675173|NCT00355615|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
675174|NCT00355602|Antibiotics|antibiotics
675175|NCT00355602|Controlled Clinical Trial|controlled clinical trial
675176|NCT00355589|Hypertension|hypertension
675177|NCT00355589|High Blood Pressure|high blood pressure
675178|NCT00355589|Diuretic|diuretic
675179|NCT00355589|Angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
675180|NCT00355589|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
675181|NCT00355576|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
675182|NCT00355576|Celecoxib|celecoxib
675183|NCT00355576|Creatine|creatine
675184|NCT00355576|Minocycline|minocycline
675185|NCT00355576|Combination|combination
675186|NCT00355576|Selection|selection
675187|NCT00355576|ALS|als
675188|NCT00355576|Motor Neuron Disease|motor neuron disease
675189|NCT00355550|Mild Cognitive Impairment|mild cognitive impairment
675190|NCT00355550|Cognition disorders|cognition disorders
675191|NCT00355550|nutritional supplement|nutritional supplement
675192|NCT00355550|dietary supplement|dietary supplement
675193|NCT00355524|HIV-1|hiv-1
675194|NCT00355524|Darunavir|darunavir
675195|NCT00355524|Ritonavir|ritonavir
675196|NCT00355524|TMC114|tmc114
675197|NCT00355511|heart failure, congestive|heart failure, congestive
675198|NCT00355511|patient care team|patient care team
675199|NCT00355511|randomized controlled trial|randomized controlled trial
675200|NCT00355511|disease management|disease management
675201|NCT00355511|drug therapy|drug therapy
675202|NCT00355511|diet therapy|diet therapy
675203|NCT00355511|hospitalization|hospitalization
675204|NCT00355511|mortality|mortality
675205|NCT00355498|functional magnetic resonance imaging|functional magnetic resonance imaging
675206|NCT00355498|positron emission tomography|positron emission tomography
675207|NCT00355498|beta-amyloid|beta-amyloid
675208|NCT00355498|tau|tau
675209|NCT00355485|Acne|acne
675210|NCT00355485|Microdermabrasion|microdermabrasion
675211|NCT00355472|Adult T-Cell Leukemia|adult t-cell leukemia
675212|NCT00355472|ATL|atl
675213|NCT00355472|Adult Peripheral T-Cell Lymphoma|adult peripheral t-cell lymphoma
675214|NCT00355472|PTCL|ptcl
675215|NCT00355459|Meibomian Gland Dystrophy|meibomian gland dystrophy
675216|NCT00355446|Cataract|cataract
675217|NCT00355446|Human Aqueous|human aqueous
675218|NCT00355433|urinary incontinence|urinary incontinence
675219|NCT00355433|urodynamics|urodynamics
675220|NCT00355433|temperature|temperature
675221|NCT00355407|Aranesp|aranesp
675222|NCT00355407|allogeneic stem cell transplant|allogeneic stem cell transplant
675223|NCT00355381|Information Services|information services
675224|NCT00355381|Randomized Controlled Trials|randomized controlled trials
675225|NCT00355381|Medical Records Systems, Computerized|medical records systems, computerized
675226|NCT00355381|Internet|internet
675227|NCT00355381|Librarians|librarians
675228|NCT00355381|Breast Neoplasms|breast neoplasms
675229|NCT00355381|Patient Satisfaction|patient satisfaction
675230|NCT00355381|Health Personnel|health personnel
675231|NCT00355381|Costs and Cost Analysis|costs and cost analysis
675232|NCT00355381|Premature Birth|premature birth
675233|NCT00355368|intubation|intubation
675234|NCT00355368|intensive care|intensive care
675235|NCT00355368|neuromuscular depolarizing agents|neuromuscular depolarizing agents
675236|NCT00355368|neuromuscular nondepolarizing agents|neuromuscular nondepolarizing agents
675237|NCT00355368|neuromuscular blocking agents|neuromuscular blocking agents
675238|NCT00355355|Hepatocellular carcinoma|hepatocellular carcinoma
675239|NCT00355355|HCC|hcc
675240|NCT00355355|Liver Neoplasms|liver neoplasms
675241|NCT00355355|Talaporfin Sodium (LS11)|talaporfin sodium (ls11)
675242|NCT00355355|Light emitting diodes (LEDs)|light emitting diodes (leds)
675243|NCT00355355|Light activation|light activation
675244|NCT00355342|Osteoporosis|osteoporosis
675245|NCT00355342|Bone Mineral Density|bone mineral density
675246|NCT00355342|Osteopenia|osteopenia
675247|NCT00355342|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
675248|NCT00355342|COPD|copd
675249|NCT00355329|Traditional Chinese Medicine (TCM)|traditional chinese medicine (tcm)
675250|NCT00355329|Autism|autism
675251|NCT00355329|Autistic Spectrum Disorder|autistic spectrum disorder
675252|NCT00355329|Tongue Acupuncture (TAC)|tongue acupuncture (tac)
675253|NCT00355329|18F-fluorodeoxyglucose Positron Emission Tomography (PET)|18f-fluorodeoxyglucose positron emission tomography (pet)
675254|NCT00355329|children|children
675255|NCT00355316|Breast Cancer|breast cancer
675256|NCT00355316|Peripheral|peripheral
675257|NCT00355316|Blood|blood
675258|NCT00355303|Premature rupture of membranes at term|premature rupture of membranes at term
675259|NCT00355303|Induction of labour|induction of labour
675260|NCT00355303|Misoprostol|misoprostol
675261|NCT00355303|PGE2 gel|pge2 gel
675262|NCT00355303|Immediate induction with PGE2 gel|immediate induction with pge2 gel
675263|NCT00355303|Immediate induction with Misoprostol|immediate induction with misoprostol
675264|NCT00355290|Chronic Oral Anticoagulation|chronic oral anticoagulation
675265|NCT00355277|Tricyclic antidepressants|tricyclic antidepressants
675266|NCT00355277|Neuropathic pain|neuropathic pain
675267|NCT00355277|Local anaesthesia|local anaesthesia
675268|NCT00355277|Transcutaneous|transcutaneous
675269|NCT00355251|Atorvastatin|atorvastatin
675270|NCT00355251|Viral replication|viral replication
675271|NCT00355251|HIV-1|hiv-1
675272|NCT00355251|plasma cholesterol|plasma cholesterol
675273|NCT00355251|Cell membrane cholesterol|cell membrane cholesterol
675274|NCT00355225|insecticide-treated bednets|insecticide-treated bednets
675275|NCT00355225|malaria|malaria
675276|NCT00355225|africa|africa
675277|NCT00355225|social marketing|social marketing
675278|NCT00355225|ante-natal care|ante-natal care
675279|NCT00355225|ITN coverage|itn coverage
675280|NCT00355225|ITn use|itn use
675281|NCT00355212|percutaneous ethanol injection|percutaneous ethanol injection
675282|NCT00355212|radiofrequency|radiofrequency
675283|NCT00355212|liver cirrhosis|liver cirrhosis
675284|NCT00355212|carcinoma, hepatocellular|carcinoma, hepatocellular
675285|NCT00355199|DLBCL|dlbcl
675286|NCT00355199|R-HDS|r-hds
675287|NCT00355199|R-CHOP14|r-chop14
675288|NCT00355186|acute myocardial infarction|acute myocardial infarction
675289|NCT00355186|MRI|mri
675290|NCT00355186|bone marrow cells|bone marrow cells
675291|NCT00355186|stem cells|stem cells
675292|NCT00355186|remodeling|remodeling
675293|NCT00355160|Headache|headache
675294|NCT00355160|Sinusitis|sinusitis
675295|NCT00355160|Rhinitis|rhinitis
675296|NCT00355160|Facial Pain|facial pain
675297|NCT00355147|Ischemic stroke|ischemic stroke
675298|NCT00355147|Preventive medicine|preventive medicine
675299|NCT00355147|Transient Ischemic Attack|transient ischemic attack
675300|NCT00355147|Neurology|neurology
675301|NCT00355147|Risk management|risk management
675302|NCT00355134|fingolimod|fingolimod
675303|NCT00355134|FTY720|fty720
675304|NCT00355134|relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
675305|NCT00355134|MS|ms
675306|NCT00355134|RRMS|rrms
675307|NCT00355121|Meningococcal meningitis|meningococcal meningitis
675308|NCT00355121|Tetanus|tetanus
675309|NCT00355121|Diphtheria|diphtheria
675310|NCT00355121|Pertussis|pertussis
675311|NCT00355121|Poliomyelitis|poliomyelitis
675312|NCT00355121|Neisseria meningitidis|neisseria meningitidis
675313|NCT00355108|Rendu Osler syndrome|rendu osler syndrome
675314|NCT00355108|Epistaxis|epistaxis
675315|NCT00355108|Tranexamic acid|tranexamic acid
675316|NCT00355108|clinical trial|clinical trial
675317|NCT00355095|multiple sclerosis|multiple sclerosis
675318|NCT00355095|add-on Therapy|add-on therapy
675319|NCT00355095|erythropoietin|erythropoietin
675320|NCT00355095|methylprednisolone|methylprednisolone
675321|NCT00355095|autoimmune optic neuritis|autoimmune optic neuritis
675322|NCT00355082|epilepsy|epilepsy
675323|NCT00355082|lamotrigine|lamotrigine
675324|NCT00355082|Lamictal|lamictal
675325|NCT00355082|monotherapy|monotherapy
675326|NCT00355069|pediatric|pediatric
675327|NCT00355069|asthma|asthma
675328|NCT00355069|translational research|translational research
675329|NCT00355069|health information technology|health information technology
675330|NCT00355056|Migraine|migraine
675331|NCT00355056|PFO|pfo
675332|NCT00355056|Migraine Headache|migraine headache
675333|NCT00355056|patent foramen ovale|patent foramen ovale
675334|NCT00355043|Zinc treatment|zinc treatment
675335|NCT00355043|Bronchiolitis|bronchiolitis
675336|NCT00355043|Wheezing|wheezing
675337|NCT00355043|Children aged 2 months to 23 months|children aged 2 months to 23 months
675338|NCT00355043|Diagnosed case of acute bronchiolitis|diagnosed case of acute bronchiolitis
675339|NCT00355004|colon cancer|colon cancer
675340|NCT00355004|rectal cancer|rectal cancer
675341|NCT00354978|Colorectal Cancer|colorectal cancer
675342|NCT00354978|FOLFIRI|folfiri
675343|NCT00354978|Irinotecan|irinotecan
675344|NCT00354978|CPT-11|cpt-11
675345|NCT00354978|Leucovorin|leucovorin
675346|NCT00354978|LV|lv
675347|NCT00354978|Folinic Acid|folinic acid
675348|NCT00354978|Fluorouracil|fluorouracil
675349|NCT00354978|5-FU|5-fu
675350|NCT00354978|Adrucil|adrucil
675351|NCT00354978|Efudex|efudex
675352|NCT00354978|Bevacizumab|bevacizumab
675353|NCT00354978|Avastin|avastin
675354|NCT00354978|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
675355|NCT00354978|rhuMAb-VEGF|rhumab-vegf
675356|NCT00354965|ABS|abs
675357|NCT00354965|Acute Bacterial|acute bacterial
675358|NCT00354965|Sinusitis|sinusitis
675359|NCT00354965|Bacterial Sinusitis|bacterial sinusitis
675360|NCT00354952|Healthy volunteers|healthy volunteers
675361|NCT00354952|Antibiotic exposure|antibiotic exposure
675362|NCT00354952|Resistance selection|resistance selection
675363|NCT00354926|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
675364|NCT00354926|rituximab|rituximab
675365|NCT00354926|humanized monoclonal antibody|humanized monoclonal antibody
675366|NCT00354926|anti-CD20 monoclonal antibody|anti-cd20 monoclonal antibody
675367|NCT00354913|adult grade I meningioma|adult grade i meningioma
675368|NCT00354913|adult grade II meningioma|adult grade ii meningioma
675369|NCT00354913|adult grade III meningioma|adult grade iii meningioma
675370|NCT00354913|adult papillary meningioma|adult papillary meningioma
675371|NCT00354913|adult anaplastic meningioma|adult anaplastic meningioma
675372|NCT00354913|recurrent adult brain tumor|recurrent adult brain tumor
675373|NCT00354913|glioblastoma multiforme (GBM)|glioblastoma multiforme (gbm)
675374|NCT00354913|Imatinib|imatinib
675375|NCT00354913|Imatinib mesylate|imatinib mesylate
675376|NCT00354913|Hydroxyurea|hydroxyurea
675377|NCT00354913|Droxia|droxia
675378|NCT00354913|Hydrea|hydrea
675379|NCT00354913|Hydroxycarbamide|hydroxycarbamide
675380|NCT00354913|Gleevec|gleevec
675381|NCT00354913|Meningioma|meningioma
675382|NCT00354900|breast cancer|breast cancer
675383|NCT00354900|fibrinolysis|fibrinolysis
675384|NCT00354900|urokinase-type plasminogen activator|urokinase-type plasminogen activator
675385|NCT00354900|plasminogen activator inhibitor|plasminogen activator inhibitor
675386|NCT00354900|aprotinin|aprotinin
675387|NCT00354900|plasmin/alpha-2-antiplasmin complex|plasmin/alpha-2-antiplasmin complex
675388|NCT00354887|Gastrointestinal Cancer|gastrointestinal cancer
675389|NCT00354887|Small Bowel Cancer|small bowel cancer
675390|NCT00354887|Ampulla of Vater|ampulla of vater
675391|NCT00354887|Capecitabine|capecitabine
675392|NCT00354887|Xeloda|xeloda
675393|NCT00354887|Oxaliplatin|oxaliplatin
675394|NCT00354887|Eloxatin|eloxatin
675395|NCT00354874|GW642444 asthmatic subjects safety tolerability PD and PK|gw642444 asthmatic subjects safety tolerability pd and pk
675396|NCT00354861|Healthy volunteers|healthy volunteers
675397|NCT00354861|IMP321|imp321
675398|NCT00354861|Adjuvant|adjuvant
675399|NCT00354861|Pharmacodynamics|pharmacodynamics
675400|NCT00354822|Zevalin|zevalin
675401|NCT00354822|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
675402|NCT00354809|cognition|cognition
675403|NCT00354809|Primary Insomnia|primary insomnia
675404|NCT00354809|sleep|sleep
675405|NCT00354809|polysomnography|polysomnography
675406|NCT00354796|bleeding|bleeding
675407|NCT00354796|anticoagulation|anticoagulation
675408|NCT00354796|LMWH|lmwh
675409|NCT00354796|Enoxaparin|enoxaparin
675410|NCT00354783|Very low birth weight premature infants|very low birth weight premature infants
675411|NCT00354783|Kicking|kicking
675412|NCT00354783|Stepping|stepping
675413|NCT00354783|Walking|walking
675414|NCT00354783|Motor development|motor development
675415|NCT00354783|Kinematics|kinematics
675416|NCT00354770|Trichotillomania|trichotillomania
675417|NCT00354770|Hair-pulling|hair-pulling
675418|NCT00354757|gastroesophageal reflux disease, proton-pump inhibitor test|gastroesophageal reflux disease, proton-pump inhibitor test
675419|NCT00354744|adult rhabdomyosarcoma|adult rhabdomyosarcoma
675420|NCT00354744|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
675421|NCT00354744|adult malignant mesenchymoma|adult malignant mesenchymoma
675422|NCT00354744|childhood malignant mesenchymoma|childhood malignant mesenchymoma
675423|NCT00354744|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
675424|NCT00354744|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
675425|NCT00354731|nephrotic syndrome, pentoxifylline, corticosteroid|nephrotic syndrome, pentoxifylline, corticosteroid
675426|NCT00354705|Colon Cancer|colon cancer
675427|NCT00354705|Adenocarcinoma of the Colon|adenocarcinoma of the colon
675428|NCT00354705|Cancer Recurrence|cancer recurrence
675429|NCT00354705|Survey|survey
675430|NCT00354705|Chemotherapy|chemotherapy
675431|NCT00354705|Surgery|surgery
675432|NCT00354679|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
675433|NCT00354679|recurrent esophageal cancer|recurrent esophageal cancer
675434|NCT00354679|stage III esophageal cancer|stage iii esophageal cancer
675435|NCT00354679|stage II esophageal cancer|stage ii esophageal cancer
675436|NCT00354666|inhaled|inhaled
675437|NCT00354666|asthmatic subjects|asthmatic subjects
675438|NCT00354666|GSK159797|gsk159797
675439|NCT00354666|safety and tolerability|safety and tolerability
675440|NCT00354666|efficacy|efficacy
675441|NCT00354666|dry powder|dry powder
675442|NCT00354653|HBeAg|hbeag
675443|NCT00354653|HBV|hbv
675444|NCT00354653|CHRONIC HEPATITIS|chronic hepatitis
675445|NCT00354653|lamivudine|lamivudine
675446|NCT00354640|breast cancer|breast cancer
675447|NCT00354640|breast cancer in situ|breast cancer in situ
675448|NCT00354640|ductal breast carcinoma in situ|ductal breast carcinoma in situ
675449|NCT00354640|stage I breast cancer|stage i breast cancer
675450|NCT00354640|stage II breast cancer|stage ii breast cancer
675451|NCT00354640|stage IIIA breast cancer|stage iiia breast cancer
675452|NCT00354640|stage IIIB breast cancer|stage iiib breast cancer
675453|NCT00354640|stage IIIC breast cancer|stage iiic breast cancer
675454|NCT00354627|HIV-1|hiv-1
675455|NCT00354627|Early Access Program (EAP)|early access program (eap)
675456|NCT00354627|TMC125|tmc125
675457|NCT00354627|treatment-experienced|treatment-experienced
675458|NCT00354627|failing multiple antiretroviral (ARV) regimens|failing multiple antiretroviral (arv) regimens
675459|NCT00354627|limited to no treatment options|limited to no treatment options
675460|NCT00354601|fallopian tube cancer|fallopian tube cancer
675461|NCT00354601|peritoneal cavity cancer|peritoneal cavity cancer
675462|NCT00354601|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
675463|NCT00354601|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
675464|NCT00354601|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
675465|NCT00354601|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
675466|NCT00354601|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
675467|NCT00354601|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
675468|NCT00354588|chronic renal failure|chronic renal failure
675469|NCT00354588|arterial stiffness|arterial stiffness
675470|NCT00354588|arterial wave reflections|arterial wave reflections
675471|NCT00354575|Constipation;|constipation;
675472|NCT00354575|Chinese herb;|chinese herb;
675473|NCT00354575|Long-term care;|long-term care;
675474|NCT00354575|Integrative Chinese Medicine and Western Medicine;|integrative chinese medicine and western medicine;
675475|NCT00354562|Lung Cancer|lung cancer
675476|NCT00354562|Non-Small Cell Lung Cancer|non-small cell lung cancer
675477|NCT00354562|NSCLC|nsclc
675478|NCT00354562|ABT-751|abt-751
675479|NCT00354562|docetaxel|docetaxel
675480|NCT00354562|Taxotere|taxotere
675481|NCT00354549|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
675482|NCT00354549|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
675483|NCT00354549|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
675484|NCT00354549|adenocarcinoma of the lung|adenocarcinoma of the lung
675485|NCT00354549|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
675486|NCT00354549|large cell lung cancer|large cell lung cancer
675487|NCT00354536|GSK716155|gsk716155
675488|NCT00354536|albiglutide|albiglutide
675489|NCT00354536|pharmacodynamics|pharmacodynamics
675490|NCT00354536|pharmacokinetics|pharmacokinetics
675491|NCT00354523|Solid Tumor|solid tumor
675492|NCT00354523|Thyroid Cancer|thyroid cancer
675493|NCT00354523|Medullary Thyroid Cancer|medullary thyroid cancer
675494|NCT00354523|MTC|mtc
675495|NCT00354523|Advanced Metastatic Medullary Thyroid Carcinoma|advanced metastatic medullary thyroid carcinoma
675496|NCT00354523|Capecitabine|capecitabine
675497|NCT00354523|Dacarbazine|dacarbazine
675498|NCT00354523|Imatinib|imatinib
675499|NCT00354523|Gleevec|gleevec
675500|NCT00354523|Imatinib Mesylate|imatinib mesylate
675501|NCT00354523|DTIC-Dome|dtic-dome
675502|NCT00354523|Xeloda|xeloda
675503|NCT00354510|atopic dermatitis|atopic dermatitis
675504|NCT00354510|GW842470X|gw842470x
675505|NCT00354510|PDE4 inhibitor|pde4 inhibitor
675506|NCT00354497|prostate cancer|prostate cancer
675507|NCT00354484|anemia|anemia
675508|NCT00354484|postpartum|postpartum
675509|NCT00354458|heart failure|heart failure
675510|NCT00354458|diuretic|diuretic
675511|NCT00354458|renal impairment|renal impairment
675512|NCT00354458|renal function|renal function
675513|NCT00354445|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
675514|NCT00354445|pegaptanib sodium|pegaptanib sodium
675515|NCT00354445|subfoveal CNV|subfoveal cnv
675516|NCT00354445|macugen|macugen
675517|NCT00354432|recurrent prostate cancer|recurrent prostate cancer
675518|NCT00354432|stage I prostate cancer|stage i prostate cancer
675519|NCT00354432|stage IIB prostate cancer|stage iib prostate cancer
675520|NCT00354432|stage IIA prostate cancer|stage iia prostate cancer
675521|NCT00354432|stage III prostate cancer|stage iii prostate cancer
675522|NCT00354432|stage IV prostate cancer|stage iv prostate cancer
675523|NCT00354432|hot flashes|hot flashes
675524|NCT00354406|Abciximab|abciximab
675525|NCT00354406|Magnetic Resonance Imaging|magnetic resonance imaging
675526|NCT00354406|Percutaneous Transluminal Coronary Angioplasty|percutaneous transluminal coronary angioplasty
675527|NCT00354393|localized malignant mesothelioma|localized malignant mesothelioma
675528|NCT00354393|sarcomatous mesothelioma|sarcomatous mesothelioma
675529|NCT00354393|advanced malignant mesothelioma|advanced malignant mesothelioma
675530|NCT00354393|epithelial mesothelioma|epithelial mesothelioma
675531|NCT00354380|Malaria|malaria
675532|NCT00354380|Africa|africa
675533|NCT00354380|Methalyne-blue|methalyne-blue
675534|NCT00354380|Artesunate|artesunate
675535|NCT00354380|Amodiaquine|amodiaquine
675536|NCT00354367|Crohn Disease|crohn disease
675537|NCT00354367|Certolizumab pegol|certolizumab pegol
675538|NCT00354367|Fistula|fistula
675539|NCT00354354|COPD|copd
675540|NCT00354354|Combivent|combivent
675541|NCT00354354|Exercise|exercise
675542|NCT00354354|Bronchodilator|bronchodilator
675543|NCT00354354|Kinetics|kinetics
675544|NCT00354328|HCM|hcm
675545|NCT00354328|Echocardiography|echocardiography
675546|NCT00354328|Diastolic Dysfunction|diastolic dysfunction
675547|NCT00354328|Enalapril|enalapril
675548|NCT00354315|Shared decision making|shared decision making
675549|NCT00354315|Optimal drug prescription|optimal drug prescription
675550|NCT00354302|osteoporosis|osteoporosis
675551|NCT00354302|stage I breast cancer|stage i breast cancer
675552|NCT00354302|stage II breast cancer|stage ii breast cancer
675553|NCT00354302|stage IIIA breast cancer|stage iiia breast cancer
675554|NCT00354276|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
675555|NCT00354276|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
675556|NCT00354276|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
675557|NCT00354276|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
675558|NCT00354276|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
675559|NCT00354276|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
675560|NCT00354276|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
675561|NCT00354276|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
675562|NCT00354276|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
675563|NCT00354276|adult acute basophilic leukemia|adult acute basophilic leukemia
675564|NCT00354276|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
675565|NCT00354276|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
675566|NCT00354276|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
675567|NCT00354276|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
675568|NCT00354263|Healthy male volunteers|healthy male volunteers
675569|NCT00354263|IMP321|imp321
675570|NCT00354263|Adjuvant|adjuvant
675571|NCT00354263|Monotherapy|monotherapy
675572|NCT00354263|Pharmacokinetics/Pharmacodynamics|pharmacokinetics/pharmacodynamics
675573|NCT00354237|diabetes mellitus|diabetes mellitus
675574|NCT00354237|cardiac rehabilitation|cardiac rehabilitation
675575|NCT00354237|insulin|insulin
675576|NCT00354224|recurrent gastric cancer|recurrent gastric cancer
675577|NCT00354224|stage III gastric cancer|stage iii gastric cancer
675578|NCT00354224|stage IV gastric cancer|stage iv gastric cancer
675579|NCT00354211|Cardiac Output|cardiac output
675580|NCT00354211|Hemodynamic Phenomena|hemodynamic phenomena
675581|NCT00354198|rapidly progressive glomerulonephritis|rapidly progressive glomerulonephritis
675582|NCT00354198|pentoxifylline|pentoxifylline
675583|NCT00354172|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
675584|NCT00354172|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
675585|NCT00354172|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
675586|NCT00354172|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
675587|NCT00354172|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
675588|NCT00354172|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
675589|NCT00354172|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
675590|NCT00354172|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
675591|NCT00354172|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
675592|NCT00354172|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
675593|NCT00354172|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
675594|NCT00354172|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
675595|NCT00354172|secondary acute myeloid leukemia|secondary acute myeloid leukemia
675596|NCT00354172|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
675597|NCT00354172|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
675598|NCT00354159|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
675599|NCT00354159|Intracardiac pressures|intracardiac pressures
675600|NCT00354146|Farnesyl transferase inhibitor|farnesyl transferase inhibitor
675601|NCT00354146|relapsed or refractory acute myeloid leukemia|relapsed or refractory acute myeloid leukemia
675602|NCT00354133|Parkinson Disease|parkinson disease
675603|NCT00354133|Deep Brain Stimulation|deep brain stimulation
675604|NCT00354133|PDQ-39|pdq-39
675605|NCT00354081|Coronary Artery Disease|coronary artery disease
675606|NCT00354081|Myocardial Infarction|myocardial infarction
675607|NCT00354081|Cerebrovascular Stroke|cerebrovascular stroke
675608|NCT00354081|Homocysteine|homocysteine
675609|NCT00354081|Folic Acid|folic acid
675610|NCT00354081|Vitamin B 12|vitamin b 12
675611|NCT00354081|Vitamin B 6|vitamin b 6
675612|NCT00354068|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
675816|NCT00353327|HIV|hiv
675613|NCT00354068|adult giant cell glioblastoma|adult giant cell glioblastoma
675614|NCT00354068|adult gliosarcoma|adult gliosarcoma
675615|NCT00354068|adult mixed glioma|adult mixed glioma
675616|NCT00354068|adult anaplastic astrocytoma|adult anaplastic astrocytoma
675617|NCT00354068|recurrent adult brain tumor|recurrent adult brain tumor
675618|NCT00354068|adult glioblastoma|adult glioblastoma
675619|NCT00354042|GW597901X|gw597901x
675620|NCT00354042|Asthma|asthma
675621|NCT00354042|Crossover|crossover
675622|NCT00354042|dose ascending|dose ascending
675623|NCT00354042|repeat dose|repeat dose
675624|NCT00354042|inhaled|inhaled
675625|NCT00354029|hemorrhoids|hemorrhoids
675626|NCT00354029|hemorrhoidectomy|hemorrhoidectomy
675627|NCT00354029|S (+) ketamine|s (+) ketamine
675628|NCT00354029|pain|pain
675629|NCT00354016|influenza|influenza
675630|NCT00354016|vaccine|vaccine
675631|NCT00354003|Parkinson|parkinson
675632|NCT00354003|Imaging|imaging
675633|NCT00353990|insulin|insulin
675634|NCT00353990|bioavailability|bioavailability
675635|NCT00353990|duodenum|duodenum
675636|NCT00353990|infusion|infusion
675637|NCT00353990|healthy|healthy
675638|NCT00353990|diabetes|diabetes
675639|NCT00353990|absorption|absorption
675640|NCT00353977|Cytomegalovirus|cytomegalovirus
675641|NCT00353977|Vaccine|vaccine
675642|NCT00353977|CMV|cmv
675643|NCT00353977|Immunization|immunization
675644|NCT00353977|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
675645|NCT00353977|Stem Cell Allotransplant|stem cell allotransplant
675646|NCT00353951|primary care|primary care
675647|NCT00353951|lower respiratory tract infection|lower respiratory tract infection
675648|NCT00353951|antibiotics|antibiotics
675649|NCT00353951|cough|cough
675650|NCT00353938|PTSD, MDMA, psychotherapy, Switzerland|ptsd, mdma, psychotherapy, switzerland
675651|NCT00353925|Hypertrophy|hypertrophy
675652|NCT00353925|LVH|lvh
675653|NCT00353925|Cardiac|cardiac
675654|NCT00353925|Blood Pressure|blood pressure
675655|NCT00353925|Papillary Muscle|papillary muscle
675656|NCT00353912|Blood|blood
675657|NCT00353912|Venous|venous
675658|NCT00353912|Systolic|systolic
675659|NCT00353912|Diastolic|diastolic
675660|NCT00353912|Pulse|pulse
675661|NCT00353912|Pressure|pressure
675662|NCT00353899|Magnetic Resonance Imaging|magnetic resonance imaging
675663|NCT00353899|Pediatric|pediatric
675664|NCT00353899|Normal Volunteer|normal volunteer
675665|NCT00353899|Electrocardiogram|electrocardiogram
675666|NCT00353899|Cardiac|cardiac
675667|NCT00353899|Healthy Volunteer|healthy volunteer
675668|NCT00353899|HV|hv
675669|NCT00353886|Retrospective|retrospective
675670|NCT00353886|Epilepsy|epilepsy
675671|NCT00353886|Antiepileptic Drugs|antiepileptic drugs
675672|NCT00353886|Behavioral Development|behavioral development
675673|NCT00353886|Intellectual Development|intellectual development
675674|NCT00353873|FLIXOTIDE|flixotide
675675|NCT00353873|asthmatics children 4-11 years|asthmatics children 4-11 years
675676|NCT00353873|SERETIDE|seretide
675677|NCT00353873|asthma-control|asthma-control
675678|NCT00353860|Leukemia|leukemia
675679|NCT00353860|Transplant - Mortality|transplant - mortality
675680|NCT00353860|Immunosuppression|immunosuppression
675681|NCT00353860|Radiation|radiation
675682|NCT00353860|Cure|cure
675683|NCT00353860|Peripheral Blood Stem Cells|peripheral blood stem cells
675684|NCT00353860|Graft-Versus Leukemia/Myeloma|graft-versus leukemia/myeloma
675685|NCT00353860|Graft-Versus-Host Disease|graft-versus-host disease
675686|NCT00353860|Cyclosporine|cyclosporine
675687|NCT00353860|Fludarabine|fludarabine
675688|NCT00353847|acupuncture, RCTs, chronic LBP|acupuncture, rcts, chronic lbp
675689|NCT00353834|endothelial dysfunction|endothelial dysfunction
675690|NCT00353834|subclinical inflammation|subclinical inflammation
675691|NCT00353834|flow mediated brachial artery dilation|flow mediated brachial artery dilation
675692|NCT00353834|pulse wave analysis|pulse wave analysis
675693|NCT00353834|glucagon like polypeptide mimetics|glucagon like polypeptide mimetics
675694|NCT00353834|type 2 diabetes mellitus|type 2 diabetes mellitus
675695|NCT00353821|Tumor Necrosis Factor Alpha (TNF-Alpha)|tumor necrosis factor alpha (tnf-alpha)
675696|NCT00353821|Interferon-Gamma (IFN-Gamma)|interferon-gamma (ifn-gamma)
675697|NCT00353821|Interleukin-10 (IL-10)|interleukin-10 (il-10)
675698|NCT00353821|Interleukin-6 (IL-6)|interleukin-6 (il-6)
675699|NCT00353821|Interleukin-1 (IL-1 Ra)|interleukin-1 (il-1 ra)
675700|NCT00353821|Interleukin-1 Receptor Antagonist (IL-1 Ra)|interleukin-1 receptor antagonist (il-1 ra)
675701|NCT00353821|Vitamin D Receptor (VitD R)|vitamin d receptor (vitd r)
675702|NCT00353795|MESA|mesa
675703|NCT00353795|MRI|mri
675704|NCT00353795|Cardiovascular|cardiovascular
675705|NCT00353795|Cardiac|cardiac
675706|NCT00353795|Coronary|coronary
675707|NCT00353795|Atherosclerosis|atherosclerosis
675708|NCT00353782|Dyslipidemia|dyslipidemia
675709|NCT00353782|Hypertriglyceridemia|hypertriglyceridemia
675710|NCT00353782|Hyperalphalipoproteinemia|hyperalphalipoproteinemia
675711|NCT00353782|Atheroembolism|atheroembolism
675712|NCT00353782|Atherosclerosis|atherosclerosis
675713|NCT00353782|Dyslipoproteinemia|dyslipoproteinemia
676285|NCT00351988|Behavioral|behavioral
675714|NCT00353782|Hypercholesterolemia|hypercholesterolemia
675715|NCT00353782|hypoalphalipoproteinemia|hypoalphalipoproteinemia
675716|NCT00353769|scalp laceration|scalp laceration
675717|NCT00353769|tissue adhesive|tissue adhesive
675718|NCT00353769|wound care|wound care
675719|NCT00353769|cost effectiveness|cost effectiveness
675720|NCT00353743|infected abortion|infected abortion
675721|NCT00353743|treatment period|treatment period
675722|NCT00353743|doxycycline|doxycycline
675723|NCT00353743|metronidazole|metronidazole
675724|NCT00353743|placebo|placebo
675725|NCT00353730|Serial Analysis of Gene Expression|serial analysis of gene expression
675726|NCT00353730|Carotid Artery Plaque|carotid artery plaque
675727|NCT00353730|Atherosclerosis|atherosclerosis
675728|NCT00353717|breast|breast
675729|NCT00353717|basal like|basal like
675730|NCT00353717|carcinoma|carcinoma
675731|NCT00353717|metastatic|metastatic
675732|NCT00353717|EGFR|egfr
675733|NCT00353704|Intervertebral disk displacement|intervertebral disk displacement
675734|NCT00353704|disk prolapse|disk prolapse
675735|NCT00353704|pregabalin|pregabalin
675736|NCT00353678|Hip replacement|hip replacement
675737|NCT00353678|Arthroplasty|arthroplasty
675738|NCT00353678|Prevention|prevention
675739|NCT00353678|Thromboembolism|thromboembolism
675740|NCT00353678|Treatment outcomes|treatment outcomes
675741|NCT00353678|Arthroplasty, replacement, hip|arthroplasty, replacement, hip
675742|NCT00353665|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
675743|NCT00353665|motor neuron disease|motor neuron disease
675744|NCT00353665|memantine|memantine
675745|NCT00353665|clinical trial|clinical trial
675746|NCT00353652|Blood Pressure, High|blood pressure, high
675747|NCT00353639|Ulcera|ulcera
675748|NCT00353639|Telomerase|telomerase
675749|NCT00353639|TERT|tert
675750|NCT00353639|TERC|terc
675751|NCT00353639|SBDS|sbds
675752|NCT00353639|DNA Helicase|dna helicase
675753|NCT00353639|Inflammatory Bowel Disease|inflammatory bowel disease
675754|NCT00353639|IBD|ibd
675755|NCT00353626|Amputation|amputation
675756|NCT00353626|trans tibial|trans tibial
675757|NCT00353626|prosthesis|prosthesis
675758|NCT00353626|motion analysis|motion analysis
675759|NCT00353613|Antibiotic prophylaxis|antibiotic prophylaxis
675760|NCT00353600|Proteinuria|proteinuria
675761|NCT00353600|Renal Failure|renal failure
675762|NCT00353600|Angiotension Converting Enzyme Inhibitor|angiotension converting enzyme inhibitor
675763|NCT00353600|Glomerular Filtration Rate|glomerular filtration rate
675764|NCT00353587|insulin sensitizer|insulin sensitizer
675765|NCT00353587|type 2 diabetes|type 2 diabetes
675766|NCT00353587|diabetes|diabetes
675767|NCT00353587|glucose control|glucose control
675768|NCT00353574|Resistant Hypertension|resistant hypertension
675769|NCT00353548|Bulimia Nervosa|bulimia nervosa
675770|NCT00353548|Binge Eating Disorder|binge eating disorder
675771|NCT00353548|Obesity|obesity
675772|NCT00353548|Anorexia Nervosa|anorexia nervosa
675773|NCT00353535|glomerulosclerosis, focal|glomerulosclerosis, focal
675774|NCT00353535|pretransplant immunosuppression|pretransplant immunosuppression
675775|NCT00353535|total lymphoid irradiation|total lymphoid irradiation
675776|NCT00353535|renal transplant|renal transplant
675777|NCT00353535|recurrence|recurrence
675778|NCT00353496|Non functioning entero-pancreatic tumours|non functioning entero-pancreatic tumours
675779|NCT00353483|Breast Cancer|breast cancer
675780|NCT00353483|Neoadjuvant|neoadjuvant
675781|NCT00353470|PD|pd
675782|NCT00353470|CBT|cbt
675783|NCT00353470|PFPP|pfpp
675784|NCT00353457|Adjuvant therapy|adjuvant therapy
675785|NCT00353457|Rectal cancer|rectal cancer
675786|NCT00353457|Capecitabine|capecitabine
675787|NCT00353457|Oxaliplatin|oxaliplatin
675788|NCT00353457|Cetuximab|cetuximab
675789|NCT00353457|Erbitux|erbitux
675790|NCT00353444|head injury|head injury
675791|NCT00353444|transcranial Doppler|transcranial doppler
675792|NCT00353444|pulsatility index|pulsatility index
675793|NCT00353444|vasospasm in head injury|vasospasm in head injury
675794|NCT00353431|Hyperglycaemia|hyperglycaemia
675795|NCT00353431|algorithm|algorithm
675796|NCT00353431|emergency|emergency
675797|NCT00353431|s.c. insulin therapy|s.c. insulin therapy
675798|NCT00353431|Emergency patient|emergency patient
675799|NCT00353405|Adolescents|adolescents
675800|NCT00353405|Sexually Transmitted Infections|sexually transmitted infections
675801|NCT00353405|Gonorrhea|gonorrhea
675802|NCT00353405|Chlamydia Infections|chlamydia infections
675803|NCT00353366|safety|safety
675804|NCT00353366|Post-marketing surveillance (PMS)|post-marketing surveillance (pms)
675805|NCT00353366|Rotarix|rotarix
675806|NCT00353366|oral|oral
675807|NCT00353366|Filipino|filipino
675808|NCT00353366|Rotavirus|rotavirus
675809|NCT00353366|Gastroenteritis|gastroenteritis
675810|NCT00353366|Human Rotavirus (HRV) vaccine|human rotavirus (hrv) vaccine
675811|NCT00353353|no specific conditions|no specific conditions
675812|NCT00353340|sodium bicarbonate,|sodium bicarbonate,
675813|NCT00353340|n-acetylcisteine,|n-acetylcisteine,
675814|NCT00353340|contrast nephropathy,|contrast nephropathy,
675815|NCT00353340|cardiac catheterisation|cardiac catheterisation
675817|NCT00353327|Passive immunotherapy|passive immunotherapy
675818|NCT00353301|Carcinoma, Renal Cell|carcinoma, renal cell
675819|NCT00353301|Receptor, Epidermal Growth Factor|receptor, epidermal growth factor
675820|NCT00353301|mTOR protein|mtor protein
675821|NCT00353301|Sirolimus|sirolimus
675822|NCT00353301|Erlotinib|erlotinib
675823|NCT00353275|Strict glycemic control|strict glycemic control
675824|NCT00353249|Cognitive Behavioral Therapy|cognitive behavioral therapy
675825|NCT00353249|CBT|cbt
675826|NCT00353249|Homeless Women|homeless women
675827|NCT00353236|delivery of preterm infant and/or twins|delivery of preterm infant and/or twins
675828|NCT00353223|Heart Failure|heart failure
675829|NCT00353223|Functional Impairment|functional impairment
675830|NCT00353223|Health-Related Quality of Life|health-related quality of life
675831|NCT00353223|Telemedicine|telemedicine
675832|NCT00353210|IVF|ivf
675833|NCT00353210|embryos|embryos
675834|NCT00353210|research|research
675835|NCT00353210|donation|donation
675836|NCT00353210|surplus|surplus
675837|NCT00353210|stem cells|stem cells
675838|NCT00353210|abnormal embryo|abnormal embryo
675839|NCT00353210|screening|screening
675840|NCT00353197|IVF|ivf
675841|NCT00353197|embryos|embryos
675842|NCT00353197|research|research
675843|NCT00353197|donation|donation
675844|NCT00353197|surplus|surplus
675845|NCT00353197|stem cells|stem cells
675846|NCT00353184|Acute|acute
675847|NCT00353184|Asthma|asthma
675848|NCT00353184|Child|child
675849|NCT00353184|Pediatric|pediatric
675850|NCT00353184|Emergency|emergency
675851|NCT00353184|Oral|oral
675852|NCT00353184|Montelukast|montelukast
675853|NCT00353184|Forced Expiratory Volume in One Second|forced expiratory volume in one second
675854|NCT00353184|FEV1|fev1
675855|NCT00353171|Smoking|smoking
675856|NCT00353171|PCB|pcb
675857|NCT00353171|DDE|dde
675858|NCT00353171|Menstrual Cycle|menstrual cycle
675859|NCT00353171|NC Infant Feeding Study|nc infant feeding study
675860|NCT00353158|Phototesting|phototesting
675861|NCT00353158|UVR/UVA|uvr/uva
675862|NCT00353158|Sunburn|sunburn
675863|NCT00353158|Doxycycline|doxycycline
675864|NCT00353158|Voriconazole|voriconazole
675865|NCT00353158|Phototoxicity|phototoxicity
675866|NCT00353158|Healthy Volunteer|healthy volunteer
675867|NCT00353158|HV|hv
675868|NCT00353145|Unknown Primary Neoplasms|unknown primary neoplasms
675869|NCT00353145|UPC|upc
675870|NCT00353145|Unknown Primary Cancer|unknown primary cancer
675871|NCT00353145|Questionnaire|questionnaire
675872|NCT00353145|Gemcitabine|gemcitabine
675873|NCT00353145|Gemcitabine Hydrochloride|gemcitabine hydrochloride
675874|NCT00353145|Gemzar|gemzar
675875|NCT00353145|Oxaliplatin|oxaliplatin
675876|NCT00353145|Eloxatin|eloxatin
675877|NCT00353145|Gemox|gemox
675878|NCT00353119|Palmoplantar pustulosis|palmoplantar pustulosis
675879|NCT00353119|Psoriasis|psoriasis
675880|NCT00353119|Etanercept|etanercept
675881|NCT00353106|Graft-Versus-Host Disease|graft-versus-host disease
675882|NCT00353106|GVHD|gvhd
675883|NCT00353106|Chronic Graft-Versus-Host Disease|chronic graft-versus-host disease
675884|NCT00353106|cGVHD|cgvhd
675885|NCT00353106|Interview|interview
675886|NCT00353106|Questionnaire|questionnaire
675887|NCT00353106|Survey|survey
675888|NCT00353106|Caregiver|caregiver
675889|NCT00353093|deep vein thrombosis,D-dimer,ultrasonography|deep vein thrombosis,d-dimer,ultrasonography
675890|NCT00353080|Prevention of postmenopausal osteoporosis|prevention of postmenopausal osteoporosis
675891|NCT00353067|unstable angina|unstable angina
675892|NCT00353067|myocardial infarction|myocardial infarction
675893|NCT00353067|coronary thrombosis|coronary thrombosis
675894|NCT00353067|coronary atherosclerosis|coronary atherosclerosis
675895|NCT00353054|Caltrate|caltrate
675896|NCT00353054|Lipoproteins|lipoproteins
675897|NCT00353054|Glucose|glucose
675898|NCT00353054|Insulin|insulin
675899|NCT00353054|Blood pressure|blood pressure
675900|NCT00353054|Body fat|body fat
675901|NCT00353054|Body weight|body weight
675902|NCT00353054|Women|women
675903|NCT00353054|Diet|diet
675904|NCT00353054|Macronutrients|macronutrients
675905|NCT00353041|topical|topical
675906|NCT00353041|anesthetic|anesthetic
675907|NCT00353041|pain|pain
675908|NCT00353028|Fluvoxamine Maleate|fluvoxamine maleate
675909|NCT00353028|Depression|depression
675910|NCT00353028|Children and Adolescents|children and adolescents
675911|NCT00353015|Gastrointestinal cancer|gastrointestinal cancer
675912|NCT00353015|high grade gastrointestinal neuroendocrine carcinoma|high grade gastrointestinal neuroendocrine carcinoma
675913|NCT00353015|High grade neuroendocrine carcinoma of unknown primary site|high grade neuroendocrine carcinoma of unknown primary site
675914|NCT00353015|Cisplatin|cisplatin
675915|NCT00353015|Platinol-AQ|platinol-aq
675916|NCT00353015|Platinol|platinol
675917|NCT00353015|CDDP|cddp
675918|NCT00353015|CPT-11|cpt-11
675919|NCT00353015|Irinotecan|irinotecan
675920|NCT00353002|Pain|pain
675921|NCT00353002|Ametop|ametop
675922|NCT00353002|Liposomal Lidocaine|liposomal lidocaine
675923|NCT00353002|Venous cannulation|venous cannulation
675924|NCT00352976|Bone Marrow transplant|bone marrow transplant
675925|NCT00352976|stem cell transplant|stem cell transplant
675926|NCT00352976|cord blood transplant|cord blood transplant
675927|NCT00352976|total body irradiation|total body irradiation
675928|NCT00352976|thymic shielding|thymic shielding
675929|NCT00352963|Open, phase 3, Infanrix hexa™, Hib-MenC, co-administered|open, phase 3, infanrix hexa™, hib-menc, co-administered
675930|NCT00352950|NSCLC, Lung cancer|nsclc, lung cancer
675931|NCT00352950|Panitumumab|panitumumab
675932|NCT00352950|Sirolimus|sirolimus
675933|NCT00352950|mTOR|mtor
675934|NCT00352950|Monoclonal antibody|monoclonal antibody
675935|NCT00352937|Coronary Arteriosclerosis|coronary arteriosclerosis
675936|NCT00352937|Tomography, X-Ray Computed|tomography, x-ray computed
675937|NCT00352937|Tomography, Emission-Computed, Single-Photon|tomography, emission-computed, single-photon
675938|NCT00352924|Cancer|cancer
675939|NCT00352924|Pesticides|pesticides
675940|NCT00352924|Agriculture|agriculture
675941|NCT00352911|HIV-1|hiv-1
675942|NCT00352885|Cancer|cancer
675943|NCT00352885|IL-2 therapy|il-2 therapy
675944|NCT00352885|Antidepressant|antidepressant
675945|NCT00352885|Immune system|immune system
675946|NCT00352885|Neuroendocrine response|neuroendocrine response
675947|NCT00352872|Pharmacogenetics|pharmacogenetics
675948|NCT00352872|Toxicity|toxicity
675949|NCT00352872|Pre-Menopausal|pre-menopausal
675950|NCT00352872|Women|women
675951|NCT00352872|Doxorubicin|doxorubicin
675952|NCT00352872|Cyclophosphamide|cyclophosphamide
675953|NCT00352872|Breast Cancer|breast cancer
675954|NCT00352872|Chemotherapy|chemotherapy
675955|NCT00352859|Cancer|cancer
675956|NCT00352859|Renal Cell Cancer|renal cell cancer
675957|NCT00352859|RCC|rcc
675958|NCT00352846|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
675959|NCT00352846|Lymphoma|lymphoma
675960|NCT00352846|Zoledronic Acid|zoledronic acid
675961|NCT00352846|Zoledronate|zoledronate
675962|NCT00352846|Zometa|zometa
675963|NCT00352846|Vitamin D|vitamin d
675964|NCT00352846|Calcium Carbonate|calcium carbonate
675965|NCT00352846|Bone Loss|bone loss
675966|NCT00352833|gastric cancer|gastric cancer
675967|NCT00352833|investigational drug|investigational drug
675968|NCT00352833|adjuvant therapy|adjuvant therapy
675969|NCT00352833|intraoperative|intraoperative
675970|NCT00352833|intraperitoneal|intraperitoneal
675971|NCT00352833|EpCAM-positive tumor|epcam-positive tumor
675972|NCT00352820|Caregiver|caregiver
675973|NCT00352820|Brain cancer|brain cancer
675974|NCT00352820|Glioma|glioma
675975|NCT00352820|Questionnaire|questionnaire
675976|NCT00352820|Survey|survey
675977|NCT00352820|Interview|interview
675978|NCT00352807|Cataract|cataract
675979|NCT00352794|Combination chemotherapy|combination chemotherapy
675980|NCT00352794|Myelofibrosis (MF)|myelofibrosis (mf)
675981|NCT00352781|nicotine replacement therapy|nicotine replacement therapy
675982|NCT00352781|smoking cessation|smoking cessation
675983|NCT00352768|Fluvoxamine Maleate|fluvoxamine maleate
675984|NCT00352768|OCD|ocd
675985|NCT00352768|Children and Adolescents|children and adolescents
675986|NCT00352742|Multiple myeloma|multiple myeloma
675987|NCT00352742|bortezomib|bortezomib
675988|NCT00352742|ATN-224|atn-224
675989|NCT00352742|refractory|refractory
675990|NCT00352742|relapsed|relapsed
675991|NCT00352742|antiangiogenic|antiangiogenic
675992|NCT00352729|Burns|burns
675993|NCT00352729|ACell|acell
675994|NCT00352729|Donor Site|donor site
675995|NCT00352703|Oral mucositis|oral mucositis
675996|NCT00352703|Non-Hodgkin's lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
675997|NCT00352703|conditioning chemotherapy|conditioning chemotherapy
675998|NCT00352703|autologous PBSCT|autologous pbsct
675999|NCT00352703|multiple myeloma (MM)|multiple myeloma (mm)
676000|NCT00352703|Melphalan|melphalan
676001|NCT00352664|Advanced Cancer|advanced cancer
676002|NCT00352664|Cancer Pain|cancer pain
676003|NCT00352664|Donepezil|donepezil
676004|NCT00352664|Sedation|sedation
676005|NCT00352664|Placebo|placebo
676006|NCT00352651|Acute Herpes Zoster (AHZ)|acute herpes zoster (ahz)
676007|NCT00352651|Postherpetic Neuralgia (PHN)|postherpetic neuralgia (phn)
676008|NCT00352651|Pregabalin|pregabalin
676009|NCT00352651|Lyrica|lyrica
676010|NCT00352651|Pain|pain
676011|NCT00352638|colon cancer|colon cancer
676012|NCT00352638|rectal cancer|rectal cancer
676013|NCT00352625|Tendonitis|tendonitis
676014|NCT00352625|Bursitis|bursitis
676015|NCT00352625|Pain|pain
676016|NCT00352625|Shoulder Pain|shoulder pain
676017|NCT00352625|Elbow Pain|elbow pain
676018|NCT00352625|Knee Pain|knee pain
676019|NCT00352625|Tendon Injury|tendon injury
676020|NCT00352625|Muscle, Bone and Cartilage Disorders|muscle, bone and cartilage disorders
676021|NCT00352612|clinical trial|clinical trial
676022|NCT00352612|randomized|randomized
676023|NCT00352612|blinded|blinded
676024|NCT00352612|controlled|controlled
676025|NCT00352599|Neurofibromatosis Type 1|neurofibromatosis type 1
676026|NCT00352599|NF1|nf1
676027|NCT00352599|Lovastatin|lovastatin
676028|NCT00352599|statin|statin
676286|NCT00351988|Caregiver|caregiver
676029|NCT00352586|Classical Conditioning|classical conditioning
676030|NCT00352586|Learning|learning
676031|NCT00352586|NMDA|nmda
676032|NCT00352586|Startle|startle
676033|NCT00352586|Eyeblink|eyeblink
676034|NCT00352586|Anxiety|anxiety
676035|NCT00352586|Fear Conditioning|fear conditioning
676036|NCT00352586|Fear Potentiated Startle|fear potentiated startle
676037|NCT00352586|Extinction|extinction
676038|NCT00352586|D-cycloserine|d-cycloserine
676039|NCT00352586|Healthy Volunteer|healthy volunteer
676040|NCT00352586|HV|hv
676041|NCT00352586|Normal Control|normal control
676042|NCT00352573|Ethics, Clinical|ethics, clinical
676043|NCT00352573|Physician's Role|physician's role
676044|NCT00352573|Health Care Rationing|health care rationing
676045|NCT00352573|Knowledge, Attitudes, Practices|knowledge, attitudes, practices
676046|NCT00352573|Questionnaires|questionnaires
676047|NCT00352573|Survey|survey
676048|NCT00352573|Ethics|ethics
676049|NCT00352560|Patients with Paroxysmal Atrial Fibrillation (PAF)|patients with paroxysmal atrial fibrillation (paf)
676050|NCT00352547|Immunosuppresant|immunosuppresant
676051|NCT00352547|Genetic Polymorphism|genetic polymorphism
676052|NCT00352547|Drug Metabolism|drug metabolism
676053|NCT00352547|Pharmacogenetics|pharmacogenetics
676054|NCT00352547|Rapamycin|rapamycin
676055|NCT00352521|adult anaplastic astrocytoma|adult anaplastic astrocytoma
676056|NCT00352521|adult mixed glioma|adult mixed glioma
676057|NCT00352521|adult giant cell glioblastoma|adult giant cell glioblastoma
676058|NCT00352521|adult gliosarcoma|adult gliosarcoma
676059|NCT00352521|recurrent adult brain tumor|recurrent adult brain tumor
676060|NCT00352521|adult glioblastoma|adult glioblastoma
676061|NCT00352521|adult anaplastic ependymoma|adult anaplastic ependymoma
676062|NCT00352521|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
676063|NCT00352521|adult pineal gland astrocytoma|adult pineal gland astrocytoma
676064|NCT00352508|Internet, dietary advice, saturated fat|internet, dietary advice, saturated fat
676065|NCT00352495|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
676066|NCT00352495|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
676067|NCT00352495|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
676068|NCT00352495|childhood oligodendroglioma|childhood oligodendroglioma
676069|NCT00352495|neurofibromatosis type 1|neurofibromatosis type 1
676070|NCT00352495|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
676071|NCT00352495|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
676072|NCT00352482|Pulmonary Hypertension|pulmonary hypertension
676073|NCT00352482|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
676074|NCT00352469|Alcoholism|alcoholism
676075|NCT00352469|Anxiety|anxiety
676076|NCT00352469|GAD|gad
676077|NCT00352469|PTSD|ptsd
676078|NCT00352469|Panic Disorder|panic disorder
676079|NCT00352469|OCD|ocd
676080|NCT00352456|Amygdala|amygdala
676081|NCT00352456|Facial Affect|facial affect
676082|NCT00352456|Instrumental Learning|instrumental learning
676083|NCT00352456|Psychopathy|psychopathy
676084|NCT00352456|Emotion|emotion
676085|NCT00352456|Orbitofrontal Cortex|orbitofrontal cortex
676086|NCT00352456|Healthy Volunteer|healthy volunteer
676087|NCT00352456|HV|hv
676088|NCT00352443|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
676089|NCT00352443|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
676090|NCT00352443|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
676091|NCT00352443|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
676092|NCT00352443|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
676093|NCT00352443|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
676094|NCT00352443|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
676095|NCT00352443|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
676096|NCT00352443|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
676097|NCT00352443|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
676098|NCT00352443|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
676099|NCT00352443|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
676100|NCT00352443|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
676101|NCT00352443|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
676102|NCT00352443|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
676103|NCT00352443|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
676104|NCT00352443|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
676105|NCT00352443|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
676106|NCT00352443|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
676107|NCT00352443|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
676108|NCT00352443|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
676109|NCT00352443|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
676110|NCT00352443|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
676111|NCT00352443|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
676112|NCT00352443|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
676113|NCT00352443|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
676114|NCT00352443|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
676115|NCT00352443|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
676116|NCT00352443|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
676117|NCT00352443|splenic marginal zone lymphoma|splenic marginal zone lymphoma
676118|NCT00352443|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
676119|NCT00352443|anaplastic large cell lymphoma|anaplastic large cell lymphoma
676120|NCT00352443|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
676121|NCT00352443|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
676122|NCT00352430|Nitric Oxide|nitric oxide
676123|NCT00352430|PDE Inhibitors|pde inhibitors
676124|NCT00352430|Pulmonary Hypertension|pulmonary hypertension
676125|NCT00352430|Sickle Cell|sickle cell
676126|NCT00352430|Thalassemia|thalassemia
676127|NCT00352430|Sickle Cell Anemia|sickle cell anemia
676128|NCT00352404|Endomicroscopy|endomicroscopy
676129|NCT00352404|Chromoendoscopy|chromoendoscopy
676130|NCT00352404|Chromoscopy|chromoscopy
676131|NCT00352404|Ulcerative Colitis|ulcerative colitis
676132|NCT00352404|Intraepithelial Neoplasia|intraepithelial neoplasia
676133|NCT00352391|Non-Small Cell Lung Cancer|non-small cell lung cancer
676134|NCT00352391|Head And Neck Cancer|head and neck cancer
676135|NCT00352391|Lung Cancer|lung cancer
676136|NCT00352391|Bronchoscopy|bronchoscopy
676137|NCT00352391|Laryngoscopy|laryngoscopy
676138|NCT00352391|NSCLC|nsclc
676139|NCT00352391|Disease Free Survival|disease free survival
676140|NCT00352391|Current Smoker|current smoker
676141|NCT00352391|Former Smoker|former smoker
676142|NCT00352378|Primary|primary
676143|NCT00352352|Traditional Chinese Medicine (TCM)|traditional chinese medicine (tcm)
676144|NCT00352352|Alternative Medicine (AM)|alternative medicine (am)
676145|NCT00352352|Tongue Acupuncture (TAC)|tongue acupuncture (tac)
676146|NCT00352352|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
676148|NCT00352352|Children|children
676149|NCT00352339|Schizophrenia|schizophrenia
676150|NCT00352339|Switching|switching
676151|NCT00352339|Early stage|early stage
676152|NCT00352339|Risperidone|risperidone
676153|NCT00352339|Aripirazole|aripirazole
676154|NCT00352313|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
676155|NCT00352313|adult gliosarcoma|adult gliosarcoma
676156|NCT00352313|adult mixed glioma|adult mixed glioma
676157|NCT00352313|adult anaplastic astrocytoma|adult anaplastic astrocytoma
676158|NCT00352313|recurrent adult brain tumor|recurrent adult brain tumor
676159|NCT00352313|adult glioblastoma|adult glioblastoma
676160|NCT00352313|adult giant cell glioblastoma|adult giant cell glioblastoma
676161|NCT00352287|Visceral fat|visceral fat
676162|NCT00352287|Impaired glucose tolerance|impaired glucose tolerance
676163|NCT00352287|Insulin resistance|insulin resistance
676164|NCT00352287|Growth hormone|growth hormone
676165|NCT00352287|Thiazolidinedione|thiazolidinedione
676166|NCT00352261|Barrett's Esophagus|barrett's esophagus
676167|NCT00352248|Alternative Medicine (AM)|alternative medicine (am)
676168|NCT00352248|Traditional Chinese Medicine|traditional chinese medicine
676169|NCT00352248|Tongue Acupuncture|tongue acupuncture
676170|NCT00352248|Autistic Spectrum Disorder|autistic spectrum disorder
676171|NCT00352248|Autism|autism
676172|NCT00352248|Children|children
676173|NCT00352235|Chronic hepatitis C|chronic hepatitis c
676174|NCT00352235|KRN7000|krn7000
676175|NCT00352235|a-GalCer|a-galcer
676176|NCT00352235|immunotherapy|immunotherapy
676177|NCT00352235|Natural Killer T cells|natural killer t cells
676178|NCT00352235|interferon|interferon
676179|NCT00352222|iliac arteries|iliac arteries
676180|NCT00352222|implantation|implantation
676181|NCT00352222|treatment of atherosclerotic disease|treatment of atherosclerotic disease
676182|NCT00352222|stenosed|stenosed
676183|NCT00352222|occlusive|occlusive
676184|NCT00352209|Cyclophosphamide|cyclophosphamide
676185|NCT00352209|Preparative Regimens|preparative regimens
676186|NCT00352209|Risk Factors|risk factors
676187|NCT00352209|Chart Review|chart review
676188|NCT00352209|Incidence|incidence
676189|NCT00352196|Asperger's Disorder|asperger's disorder
676190|NCT00352196|Risperidone|risperidone
676191|NCT00352196|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
676192|NCT00352196|Social Skills|social skills
676193|NCT00352183|Hyperlipidemia Combined|hyperlipidemia combined
676194|NCT00352183|Combination of fenofibrate and simvastatin|combination of fenofibrate and simvastatin
676195|NCT00352170|calcium|calcium
676196|NCT00352170|vitamin D|vitamin d
676197|NCT00352170|secondary hyperparathyroidism|secondary hyperparathyroidism
676198|NCT00352170|osteoporotic fractures|osteoporotic fractures
676199|NCT00352157|Soy|soy
676200|NCT00352157|Dermatology|dermatology
676201|NCT00352157|Skin|skin
676202|NCT00352157|Hair|hair
676203|NCT00352157|Finger Nails|finger nails
676204|NCT00352157|Weight Loss|weight loss
676205|NCT00352157|Body Mass Index|body mass index
676206|NCT00352157|Photoaging of Skin|photoaging of skin
676207|NCT00352157|Skin Wrinkling|skin wrinkling
676208|NCT00352131|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
676209|NCT00352131|stage II pancreatic cancer|stage ii pancreatic cancer
676210|NCT00352131|stage III pancreatic cancer|stage iii pancreatic cancer
676211|NCT00352131|stage IV pancreatic cancer|stage iv pancreatic cancer
676212|NCT00352131|recurrent pancreatic cancer|recurrent pancreatic cancer
676213|NCT00352118|oral complications of radiation therapy|oral complications of radiation therapy
676214|NCT00352118|oral complications of chemotherapy|oral complications of chemotherapy
676215|NCT00352118|mucositis|mucositis
676216|NCT00352118|xerostomia|xerostomia
676217|NCT00352118|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
676218|NCT00352118|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
676219|NCT00352118|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
676220|NCT00352118|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
676221|NCT00352118|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
676222|NCT00352118|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
676223|NCT00352118|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
676224|NCT00352118|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
676225|NCT00352105|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
676226|NCT00352105|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
676227|NCT00352105|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
676228|NCT00352105|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
676229|NCT00352105|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
676230|NCT00352105|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
676231|NCT00352105|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
676232|NCT00352105|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
676233|NCT00352092|Kidney disease|kidney disease
676234|NCT00352092|Renal transplant|renal transplant
676235|NCT00352092|HLA Identical|hla identical
676236|NCT00352092|Living Donor|living donor
676237|NCT00352092|Corticosteroid free|corticosteroid free
676238|NCT00352092|Calcineurin sparing|calcineurin sparing
676239|NCT00352092|Adults|adults
676240|NCT00352079|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
676241|NCT00352079|stage 0 bladder cancer|stage 0 bladder cancer
676242|NCT00352079|stage I bladder cancer|stage i bladder cancer
676243|NCT00352079|recurrent bladder cancer|recurrent bladder cancer
676244|NCT00352066|Human Immunodeficiency Virus|human immunodeficiency virus
676245|NCT00352066|anti-retroviral therapy|anti-retroviral therapy
676246|NCT00352066|nucleoside analogue|nucleoside analogue
676247|NCT00352066|reverse transcriptase|reverse transcriptase
676248|NCT00352066|apricitabine|apricitabine
676249|NCT00352066|tipranavir|tipranavir
676250|NCT00352066|bioequivalence|bioequivalence
676251|NCT00352066|drug-drug interaction|drug-drug interaction
676252|NCT00352066|pharmacokinetics|pharmacokinetics
676253|NCT00352053|Phase 3|phase 3
676254|NCT00352053|Randomized, Double-Blind|randomized, double-blind
676255|NCT00352053|Control|control
676256|NCT00352053|Treatment-Experienced|treatment-experienced
676257|NCT00352053|OBR|obr
676258|NCT00352053|Optimized background regimen|optimized background regimen
676259|NCT00352053|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
676260|NCT00352053|HAART|haart
676261|NCT00352053|HIV|hiv
676262|NCT00352053|HIV-1|hiv-1
676263|NCT00352053|AIDS Virus|aids virus
676264|NCT00352053|Human Immunodeficiency Virus|human immunodeficiency virus
676265|NCT00352053|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
676266|NCT00352053|Virus|virus
676267|NCT00352053|Human Immunodeficiency|human immunodeficiency
676268|NCT00352053|Pediatrics|pediatrics
676269|NCT00352027|Hodgkin's Disease|hodgkin's disease
676270|NCT00352014|Monitoring of antiplatelet therapy|monitoring of antiplatelet therapy
676271|NCT00352014|antiplatelet therapy|antiplatelet therapy
676272|NCT00352014|platelet function assays|platelet function assays
676273|NCT00352014|Aspirin|aspirin
676274|NCT00352014|Clopidogrel|clopidogrel
676275|NCT00352014|elective PCI|elective pci
676276|NCT00352001|refractory anemia with excess blasts|refractory anemia with excess blasts
676277|NCT00352001|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
676278|NCT00352001|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
676279|NCT00352001|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
676280|NCT00352001|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
676281|NCT00351988|Lung Cancer|lung cancer
676282|NCT00351988|Non-Small Cell Lung Cancer|non-small cell lung cancer
676283|NCT00351988|Breast Cancer|breast cancer
676284|NCT00351988|Psychosocial|psychosocial
676287|NCT00351988|Interview|interview
676288|NCT00351988|Questionnaire|questionnaire
676289|NCT00351988|Minority Caregiver|minority caregiver
676290|NCT00351988|Non-Minority Caregiver|non-minority caregiver
676291|NCT00351988|Survey|survey
676292|NCT00351962|lung neoplasms|lung neoplasms
676293|NCT00351962|metastatic lung cancer|metastatic lung cancer
676294|NCT00351962|stereotactic radiation|stereotactic radiation
676295|NCT00351949|Advanced or metastatic renal cell carcinoma|advanced or metastatic renal cell carcinoma
676296|NCT00351949|IMP321|imp321
676297|NCT00351949|Monotherapy|monotherapy
676298|NCT00351949|LAG-3|lag-3
676299|NCT00351949|CD223|cd223
676300|NCT00351936|Schizophrenia|schizophrenia
676301|NCT00351936|Diabetes|diabetes
676302|NCT00351936|Obesity|obesity
676303|NCT00351936|Olanzapine|olanzapine
676304|NCT00351936|Insulin Resistance|insulin resistance
676305|NCT00351910|Major Depressive Disorder|major depressive disorder
676306|NCT00351910|MDD|mdd
676307|NCT00351884|Type 2 diabetes|type 2 diabetes
676308|NCT00351884|vildagliptin|vildagliptin
676309|NCT00351884|Hemoglobin A1c|hemoglobin a1c
676310|NCT00351871|HCV|hcv
676311|NCT00351858|Breast Cancer|breast cancer
676312|NCT00351858|investigational drug|investigational drug
676313|NCT00351858|drug therapy|drug therapy
676314|NCT00351858|Antineoplastic Protocols|antineoplastic protocols
676315|NCT00351858|Immunotherapy|immunotherapy
676316|NCT00351858|Metastatic breast cancer|metastatic breast cancer
676317|NCT00351858|Advanced breast cancer|advanced breast cancer
676318|NCT00351858|Stage III to IV breast cancer|stage iii to iv breast cancer
676319|NCT00351858|Hormonal therapy refractory|hormonal therapy refractory
676320|NCT00351858|Failure of hormonal therapy|failure of hormonal therapy
676321|NCT00351858|Her-2/neu expressing breast cancer|her-2/neu expressing breast cancer
676322|NCT00351858|low to moderate Her-2/neu expression|low to moderate her-2/neu expression
676323|NCT00351832|Type 2 diabetes|type 2 diabetes
676324|NCT00351832|Vildagliptin|vildagliptin
676325|NCT00351832|Hemoglobin A1c|hemoglobin a1c
676326|NCT00351819|Testosterone|testosterone
676327|NCT00351819|Pain|pain
676328|NCT00351819|Opioid|opioid
676329|NCT00351819|Hypogonadism|hypogonadism
676330|NCT00351806|acute intracerebral infarction|acute intracerebral infarction
676331|NCT00351780|fractional flow reserve|fractional flow reserve
676332|NCT00351780|bifurcation|bifurcation
676333|NCT00351780|stent|stent
676334|NCT00351767|Diabetes|diabetes
676335|NCT00351767|Dabetic Feet|dabetic feet
676336|NCT00351741|Burns|burns
676337|NCT00351715|Sublingual Methadone|sublingual methadone
676338|NCT00351715|Cancer related breakthrough pain|cancer related breakthrough pain
676339|NCT00351715|feasibility study|feasibility study
676340|NCT00351715|Phase II/open label|phase ii/open label
676341|NCT00351715|Outpatients|outpatients
676342|NCT00351715|Safety/ efficacy|safety/ efficacy
676343|NCT00351715|previously receiving opioids|previously receiving opioids
676344|NCT00351715|speak English|speak english
676345|NCT00351702|Preventive therapy|preventive therapy
676346|NCT00351689|Probiotic bacteria|probiotic bacteria
676347|NCT00351689|cutaneous immune homeostasis|cutaneous immune homeostasis
676348|NCT00351689|UV radiation|uv radiation
676349|NCT00351689|dietary supplement|dietary supplement
676350|NCT00351676|Drug Therapy|drug therapy
676351|NCT00351676|Hospitals, Teaching|hospitals, teaching
676352|NCT00351676|Hospitals, Community|hospitals, community
676353|NCT00351676|Interprofessional relations|interprofessional relations
676354|NCT00351676|Patient Care Team|patient care team
676355|NCT00351676|Pharmacists|pharmacists
676356|NCT00351676|Pharmacy Service, Hospital|pharmacy service, hospital
676357|NCT00351676|Comparative Study|comparative study
676358|NCT00351676|Hospitalization|hospitalization
676359|NCT00351663|Venous Thrombosis|venous thrombosis
676360|NCT00351663|Critical Illness|critical illness
676361|NCT00351663|Blood Coagulation|blood coagulation
676362|NCT00351663|Factor Xa|factor xa
676363|NCT00351650|Imaging|imaging
676364|NCT00351650|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
676365|NCT00351650|Islet|islet
676366|NCT00351650|B Cell Mass|b cell mass
676367|NCT00351650|Pet Scan|pet scan
676368|NCT00351650|Type 1 Diabetes|type 1 diabetes
676369|NCT00351650|T1DM|t1dm
676370|NCT00351650|Pancreas|pancreas
676371|NCT00351650|Healthy Volunteer|healthy volunteer
676372|NCT00351650|HV|hv
676373|NCT00351637|Sublingual methadone|sublingual methadone
676374|NCT00351637|iatrogenic|iatrogenic
676375|NCT00351637|treatment related incident breakthrough pain|treatment related incident breakthrough pain
676376|NCT00351637|feasibility study|feasibility study
676377|NCT00351637|Phase II/open-label|phase ii/open-label
676378|NCT00351637|inpatients|inpatients
676379|NCT00351637|Safety/efficacy|safety/efficacy
676380|NCT00351637|Cancer related breakthrough pain|cancer related breakthrough pain
676381|NCT00351637|previously receiving opioids|previously receiving opioids
676382|NCT00351637|speak English|speak english
676383|NCT00351624|DHA supplementation|dha supplementation
676384|NCT00351624|Cognitive function|cognitive function
676385|NCT00351624|Preschool children|preschool children
676488|NCT00351247|MRI|mri
676386|NCT00351624|Attention and behavior|attention and behavior
676387|NCT00351624|Healthy Children|healthy children
676388|NCT00351611|epilepsy partial seizure treatment with pregabalin or placebo|epilepsy partial seizure treatment with pregabalin or placebo
676389|NCT00351611|vision testing|vision testing
676390|NCT00351598|Tumour Volume|tumour volume
676391|NCT00351598|Prognostic value|prognostic value
676392|NCT00351585|Vildagliptin|vildagliptin
676393|NCT00351585|Type 2 diabetes|type 2 diabetes
676394|NCT00351585|Insulin secretion|insulin secretion
676395|NCT00351585|Beta cell|beta cell
676396|NCT00351572|colon cancer|colon cancer
676397|NCT00351559|allograft|allograft
676398|NCT00351559|rejection|rejection
676399|NCT00351559|biopsy|biopsy
676400|NCT00351559|gene|gene
676401|NCT00351559|expression|expression
676402|NCT00351559|cardiac|cardiac
676403|NCT00351559|heart|heart
676404|NCT00351559|transplant|transplant
676405|NCT00351546|Vildagliptin|vildagliptin
676406|NCT00351546|Type 2 diabetes|type 2 diabetes
676407|NCT00351546|Insulin sensitivity|insulin sensitivity
676408|NCT00351546|Insulin action|insulin action
676409|NCT00351533|Respiratory distress syndrome, adult|respiratory distress syndrome, adult
676410|NCT00351533|Acute lung injury|acute lung injury
676411|NCT00351533|Acute respiratory distress syndrome|acute respiratory distress syndrome
676412|NCT00351533|ARDS, human|ards, human
676413|NCT00351533|Fish oils|fish oils
676414|NCT00351533|Fatty Acids, Omega-3|fatty acids, omega-3
676415|NCT00351533|Docosahexaenoic Acids|docosahexaenoic acids
676416|NCT00351533|Eicosapentaenoic Acid|eicosapentaenoic acid
676417|NCT00351520|Anthoponotic Cutaneous leishmaniasis|anthoponotic cutaneous leishmaniasis
676418|NCT00351520|Glucantime|glucantime
676419|NCT00351520|Miltefosine|miltefosine
676420|NCT00351507|Vildagliptin|vildagliptin
676421|NCT00351507|Type 2 diabetes|type 2 diabetes
676422|NCT00351494|embolization|embolization
676423|NCT00351494|contrast enhanced ultrasound|contrast enhanced ultrasound
676424|NCT00351494|myoma|myoma
676425|NCT00351494|uterine artery|uterine artery
676426|NCT00351494|microvascularisation|microvascularisation
676427|NCT00351481|IVF|ivf
676428|NCT00351481|endometrial receptivity|endometrial receptivity
676429|NCT00351481|embryo implantation|embryo implantation
676430|NCT00351481|recurrent implantation failure|recurrent implantation failure
676431|NCT00351468|eltrombopag olamine|eltrombopag olamine
676432|NCT00351468|SB-497115-GR|sb-497115-gr
676433|NCT00351468|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
676434|NCT00351468|thrombocytopenia|thrombocytopenia
676435|NCT00351468|ITP|itp
676436|NCT00351468|platelets|platelets
676437|NCT00351455|hernia|hernia
676438|NCT00351455|incisional hernia|incisional hernia
676439|NCT00351455|ventral hernia|ventral hernia
676440|NCT00351455|umbilical hernia|umbilical hernia
676441|NCT00351442|Host Resistance|host resistance
676442|NCT00351429|Glaucoma|glaucoma
676443|NCT00351429|Trabeculectomy|trabeculectomy
676444|NCT00351429|Sutures|sutures
676445|NCT00351416|GnRH deficiency|gnrh deficiency
676446|NCT00351416|GnRH antagonist|gnrh antagonist
676447|NCT00351416|Letrozole|letrozole
676448|NCT00351416|GnRH|gnrh
676449|NCT00351416|FSH|fsh
676450|NCT00351416|LH|lh
676451|NCT00351416|Inhibins|inhibins
676452|NCT00351403|Chronic HCV infection|chronic hcv infection
676453|NCT00351403|Genotype 1|genotype 1
676454|NCT00351403|Individually adapted therapy|individually adapted therapy
676455|NCT00351403|Peginterferon alfa-2b|peginterferon alfa-2b
676456|NCT00351403|Ribavirin|ribavirin
676457|NCT00351403|Sustained viral response (SVR)|sustained viral response (svr)
676458|NCT00351390|congestive heart failure treatment|congestive heart failure treatment
676459|NCT00351390|congestive heart failure, prognosis|congestive heart failure, prognosis
676460|NCT00351390|NT-proBNP testing|nt-probnp testing
676461|NCT00351377|Autoimmune disease, mycophenolate, GI problems|autoimmune disease, mycophenolate, gi problems
676462|NCT00351364|atherosclerosis|atherosclerosis
676463|NCT00351364|inflammation|inflammation
676464|NCT00351364|leukotriene blockade|leukotriene blockade
676465|NCT00351364|endothelial function|endothelial function
676466|NCT00351351|Kidney Stones|kidney stones
676467|NCT00351351|Renal Calculi|renal calculi
676468|NCT00351312|Pressure ulcers|pressure ulcers
676469|NCT00351312|socks|socks
676470|NCT00351312|foot pressure|foot pressure
676471|NCT00351299|Delirium|delirium
676472|NCT00351299|Agitation|agitation
676473|NCT00351299|Sedation|sedation
676474|NCT00351299|Dexmedetomidine|dexmedetomidine
676475|NCT00351299|Surgical|surgical
676476|NCT00351286|peripheral arterial disease|peripheral arterial disease
676477|NCT00351286|peripheral vascular disease|peripheral vascular disease
676478|NCT00351286|claudication|claudication
676479|NCT00351273|Chlamydia|chlamydia
676480|NCT00351260|Bifurcation|bifurcation
676481|NCT00351260|Coronary|coronary
676482|NCT00351260|Stenosis|stenosis
676483|NCT00351260|Stent|stent
676484|NCT00351260|drug elution|drug elution
676485|NCT00351247|Myocardial Infarction|myocardial infarction
676486|NCT00351247|Primary PCI|primary pci
676487|NCT00351247|Postconditioning|postconditioning
676489|NCT00351234|Diabetes Mellitus Type I,|diabetes mellitus type i,
676490|NCT00351234|Hypoglycemia,|hypoglycemia,
676491|NCT00351234|Carnitine|carnitine
676492|NCT00351208|Spinal cord stimulation|spinal cord stimulation
676493|NCT00351208|Spinal cord stimulation efficacy|spinal cord stimulation efficacy
676494|NCT00351208|Spinal cord stimulators|spinal cord stimulators
676495|NCT00351208|Stimulation frequencies|stimulation frequencies
676496|NCT00351208|Stimulation pulse-widths|stimulation pulse-widths
676497|NCT00351208|Varying settings|varying settings
676498|NCT00351195|Hepatocellular carcinoma|hepatocellular carcinoma
676499|NCT00351195|Etoposide|etoposide
676500|NCT00351195|Oxaliplatin|oxaliplatin
676501|NCT00351195|Capecitabine|capecitabine
676502|NCT00351182|Scrub typhus|scrub typhus
676503|NCT00351182|Telithromycin|telithromycin
676504|NCT00351182|Doxycycline|doxycycline
676505|NCT00351182|5 day Course of Telithromycin versus Doxycycline for the Treatment of Mild to Moderate Scrub Typhus|5 day course of telithromycin versus doxycycline for the treatment of mild to moderate scrub typhus
676506|NCT00351169|Major Depressive Disorder|major depressive disorder
676507|NCT00351169|MDD|mdd
676508|NCT00351156|Gaucher Disease|gaucher disease
676509|NCT00351156|Gaucher Disease, Type 1|gaucher disease, type 1
676510|NCT00351156|Gaucher Disease, Type 2|gaucher disease, type 2
676511|NCT00351156|Gaucher Disease, Type 3|gaucher disease, type 3
676512|NCT00351156|Neuronopathic Gaucher Disease|neuronopathic gaucher disease
676513|NCT00351156|Non-Neuronopathic Gaucher Disease|non-neuronopathic gaucher disease
676514|NCT00351156|Lysosomal Storage Disease|lysosomal storage disease
676515|NCT00351156|Metabolism, Inborn Errors|metabolism, inborn errors
676516|NCT00351156|Metabolic Diseases|metabolic diseases
676517|NCT00351156|Sphingolipidoses|sphingolipidoses
676518|NCT00351156|Genetic Diseases, Inborn|genetic diseases, inborn
676519|NCT00351143|QoL|qol
676520|NCT00351143|Asthma|asthma
676521|NCT00351143|asthma compliance enhancement|asthma compliance enhancement
676522|NCT00351143|Salmeterol/fluticasone|salmeterol/fluticasone
676523|NCT00351143|Total control|total control
676524|NCT00351143|SERETIDE|seretide
676525|NCT00351143|FEV1|fev1
676526|NCT00351130|Hypertension,|hypertension,
676527|NCT00351130|stage 1 hypertension,|stage 1 hypertension,
676528|NCT00351130|stage 2 hypertension,|stage 2 hypertension,
676529|NCT00351130|valsartan,|valsartan,
676530|NCT00351130|amlodipine,|amlodipine,
676531|NCT00351117|St. John's Wort|st. john's wort
676532|NCT00351117|Selective Serotonin Receptor Inhibitor|selective serotonin receptor inhibitor
676533|NCT00351117|Microvasculature|microvasculature
676534|NCT00351117|Natural Health Products|natural health products
676535|NCT00351104|Sprain|sprain
676536|NCT00351104|Strain|strain
676537|NCT00351104|Pain|pain
676538|NCT00351104|Ankle Pain|ankle pain
676539|NCT00351104|Muscle, Bone and Cartilage Disorders|muscle, bone and cartilage disorders
676540|NCT00351078|Cystic fibrosis|cystic fibrosis
676541|NCT00351078|Nonsense mutation|nonsense mutation
676542|NCT00351078|Premature stop codon|premature stop codon
676543|NCT00351078|CF|cf
676544|NCT00351078|PTC124|ptc124
676545|NCT00351065|erectile dysfunction, PDE-5 inhibitor|erectile dysfunction, pde-5 inhibitor
676546|NCT00351052|Pimecrolimus, Atopic Dermatitis, Eczema, Pediatric|pimecrolimus, atopic dermatitis, eczema, pediatric
676547|NCT00351026|opioid dependence|opioid dependence
676548|NCT00351026|methadone|methadone
676549|NCT00351026|HIV|hiv
676550|NCT00351013|malaria|malaria
676551|NCT00351013|Plasmodium falciparum|plasmodium falciparum
676552|NCT00351013|Tropica Nosode|tropica nosode
676553|NCT00351013|Homeopathy|homeopathy
676554|NCT00351000|Schizophrenia|schizophrenia
676555|NCT00351000|Ziprasidone|ziprasidone
676556|NCT00351000|Diabetes|diabetes
676557|NCT00351000|Insulin Resistance|insulin resistance
676558|NCT00350987|Procalcitonin, guidelines, LRTI, non-inferiority|procalcitonin, guidelines, lrti, non-inferiority
676559|NCT00350987|COLD|cold
676560|NCT00350961|Cholangiocarcinoma|cholangiocarcinoma
676561|NCT00350961|Fixed dose rate|fixed dose rate
676562|NCT00350961|Gemcitabine|gemcitabine
676563|NCT00350961|Oxaliplatin|oxaliplatin
676564|NCT00350961|Capecitabine|capecitabine
676565|NCT00350948|Ovary|ovary
676566|NCT00350935|fMRI|fmri
676567|NCT00350935|Visual perception|visual perception
676568|NCT00350935|Attention|attention
676569|NCT00350909|drug abuse|drug abuse
676570|NCT00350896|trapezotrapezoidial|trapezotrapezoidial
676571|NCT00350896|scaphotrapezial|scaphotrapezial
676572|NCT00350896|thumb|thumb
676573|NCT00350896|pain|pain
676574|NCT00350896|orthoses|orthoses
676575|NCT00350896|Osteoarthritis in the BTOA concerns the trapezometacarpal joint|osteoarthritis in the btoa concerns the trapezometacarpal joint
676576|NCT00350883|Cognitive Therapy|cognitive therapy
676577|NCT00350883|Negative Symptoms|negative symptoms
676578|NCT00350883|Functional Outcomes|functional outcomes
676579|NCT00350883|Schizophrenia|schizophrenia
676580|NCT00350883|Schizoaffective Disorder|schizoaffective disorder
676581|NCT00350870|disulfiram|disulfiram
676582|NCT00350870|cognitive behavioral therapy|cognitive behavioral therapy
676583|NCT00350870|contingency management|contingency management
676584|NCT00350870|drug abuse therapy|drug abuse therapy
676585|NCT00350870|educational/resource design/development|educational/resource design/development
676586|NCT00350844|Sickle Cell Disease|sickle cell disease
676587|NCT00350844|Pulmonary Hypertension|pulmonary hypertension
676588|NCT00350831|Solid tumor|solid tumor
676589|NCT00350818|Acute Myelogenous Leukemia|acute myelogenous leukemia
676590|NCT00350818|Myelodysplastic Syndrome|myelodysplastic syndrome
676591|NCT00350818|Allogeneic Transplantation|allogeneic transplantation
676592|NCT00350818|Leukemia|leukemia
676593|NCT00350818|Azacitidine|azacitidine
676594|NCT00350818|Vidaza|vidaza
676595|NCT00350805|Schizophrenia|schizophrenia
676596|NCT00350805|Time perception|time perception
676597|NCT00350805|Cortical synchronization|cortical synchronization
676598|NCT00350805|Electroencephalography|electroencephalography
676599|NCT00350779|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
676600|NCT00350766|Myocardial Infarction|myocardial infarction
676601|NCT00350766|Myocardial Ischemia|myocardial ischemia
676602|NCT00350766|Ventricular Remodeling|ventricular remodeling
676603|NCT00350766|Bone Marrow Cell Transplantation|bone marrow cell transplantation
676604|NCT00350766|Stem cells|stem cells
676605|NCT00350753|Cholangiocarcinoma|cholangiocarcinoma
676606|NCT00350727|relapsed|relapsed
676607|NCT00350727|lapatinib|lapatinib
676608|NCT00350727|Pazopanib|pazopanib
676609|NCT00350727|glioblastoma|glioblastoma
676610|NCT00350714|HCV (Hepatitis C Virus)|hcv (hepatitis c virus)
676611|NCT00350714|MBT (Methacetin Breath Test)|mbt (methacetin breath test)
676612|NCT00350714|Hepatitis C Virus Patients|hepatitis c virus patients
676613|NCT00350701|DM type 2|dm type 2
676614|NCT00350701|Hypogonadism|hypogonadism
676615|NCT00350701|Testosterone|testosterone
676616|NCT00350701|AndroGel|androgel
676617|NCT00350688|Bladder,|bladder,
676618|NCT00350688|Cancer,|cancer,
676619|NCT00350688|Chemoradiation,|chemoradiation,
676620|NCT00350688|IMRT,|imrt,
676621|NCT00350688|tomotherapy|tomotherapy
676622|NCT00350662|Deferiprone|deferiprone
676623|NCT00350662|L1|l1
676624|NCT00350662|Desferrioxamine|desferrioxamine
676625|NCT00350662|Hemochromatosis|hemochromatosis
676626|NCT00350662|Iron overload|iron overload
676627|NCT00350662|Thalassemia|thalassemia
676628|NCT00350649|behavior modification|behavior modification
676629|NCT00350649|cognitive behavioral therapy|cognitive behavioral therapy
676630|NCT00350649|combination therapy|combination therapy
676631|NCT00350649|drug abuse therapy|drug abuse therapy
676632|NCT00350649|drug addition|drug addition
676633|NCT00350649|human therapy evaluation|human therapy evaluation
676634|NCT00350649|psychotherapy|psychotherapy
676635|NCT00350649|clinical trial phase II|clinical trial phase ii
676636|NCT00350649|coping|coping
676637|NCT00350649|drug and alcohol abstinence|drug and alcohol abstinence
676638|NCT00350649|longitudinal human study|longitudinal human study
676639|NCT00350649|outcomes research|outcomes research
676640|NCT00350649|outpatient care|outpatient care
676641|NCT00350649|psychological reinforcement|psychological reinforcement
676642|NCT00350649|therapy compliance|therapy compliance
676643|NCT00350649|behavior and social research tag|behavior and social research tag
676644|NCT00350649|human subjects|human subjects
676645|NCT00350649|neuropsychological test|neuropsychological test
676646|NCT00350649|patient oriented research|patient oriented research
676647|NCT00350636|OAB, anticholineric, oxybutynin, urge urinary incontinence|oab, anticholineric, oxybutynin, urge urinary incontinence
676648|NCT00350623|AIDS|aids
676649|NCT00350610|cognitive behavior therapy|cognitive behavior therapy
676650|NCT00350610|computer assisted instruction|computer assisted instruction
676651|NCT00350610|drug abuse therapy|drug abuse therapy
676652|NCT00350610|educational resource design and development|educational resource design and development
676653|NCT00350597|Malignant Melanoma|malignant melanoma
676654|NCT00350597|Adjuvant Therapy|adjuvant therapy
676655|NCT00350597|Cytokine Therapy|cytokine therapy
676656|NCT00350597|Immunologic Testing|immunologic testing
676657|NCT00350584|Mindfulness|mindfulness
676658|NCT00350584|Psychoeducation|psychoeducation
676659|NCT00350584|Telehealth Intervention|telehealth intervention
676660|NCT00350571|behavior therapy|behavior therapy
676661|NCT00350571|counseling|counseling
676662|NCT00350571|drug abuse therapy|drug abuse therapy
676663|NCT00350571|outpatient care|outpatient care
676664|NCT00350571|therapy compliance|therapy compliance
676665|NCT00350571|clinical trial phase I|clinical trial phase i
676666|NCT00350571|coping|coping
676667|NCT00350571|outcomes research|outcomes research
676668|NCT00350571|satisfaction|satisfaction
676669|NCT00350571|social psychology|social psychology
676670|NCT00350571|patient oriented research|patient oriented research
676671|NCT00350532|pain, chronic pain|pain, chronic pain
676672|NCT00350532|acetylcholine|acetylcholine
676673|NCT00350532|clonidine|clonidine
676674|NCT00350532|a2-adrenergic agonists|a2-adrenergic agonists
676675|NCT00350532|alpha2-adrenergic agonists|alpha2-adrenergic agonists
676676|NCT00350519|Hemostasis, Surgical|hemostasis, surgical
676677|NCT00350519|Epoetin alfa|epoetin alfa
676678|NCT00350519|Surgery|surgery
676679|NCT00350519|Abdomen|abdomen
676680|NCT00350519|Pelvis|pelvis
676681|NCT00350519|PROCRIT|procrit
676682|NCT00350519|pRBC|prbc
676683|NCT00350519|Blood transfusion|blood transfusion
676684|NCT00350519|Packed red blood cell transfusion|packed red blood cell transfusion
676685|NCT00350480|acute uterine bleeding|acute uterine bleeding
676686|NCT00350467|Schizophrenia|schizophrenia
676687|NCT00350467|DSM-IV|dsm-iv
676688|NCT00350467|PANSS|panss
676689|NCT00350467|informed consent|informed consent
676690|NCT00350441|Sildenafil Citrate|sildenafil citrate
676691|NCT00350441|Cardiopulmonary bypass|cardiopulmonary bypass
676692|NCT00350441|Open heart surgery|open heart surgery
676693|NCT00350428|Acute primary angle closure|acute primary angle closure
676694|NCT00350428|Laser preipheral iridotomy|laser preipheral iridotomy
676695|NCT00350428|Phacoemulsification|phacoemulsification
676696|NCT00350415|ulcerative colitis, inflammatory bowel disease|ulcerative colitis, inflammatory bowel disease
676697|NCT00350402|Parkinson's disease|parkinson's disease
676698|NCT00350402|PD|pd
676699|NCT00350402|masked faces|masked faces
676700|NCT00350402|diminished facial expressivity|diminished facial expressivity
676701|NCT00350402|diminished facial expression|diminished facial expression
676702|NCT00350402|high intensity respiratory muscle strength training|high intensity respiratory muscle strength training
676703|NCT00350402|MST|mst
676704|NCT00350389|Falls, Older persons|falls, older persons
676705|NCT00350376|asthma|asthma
676706|NCT00350376|allergies|allergies
676707|NCT00350376|Xolair|xolair
676708|NCT00350376|Advair|advair
676709|NCT00350350|XEROSTOMIA|xerostomia
676710|NCT00350350|MOUTH DRYNESS|mouth dryness
676711|NCT00350350|ELDERLY|elderly
676712|NCT00350350|ORAL LUBRICANT|oral lubricant
676713|NCT00350298|Monoclonal antibody,|monoclonal antibody,
676714|NCT00350298|Clostridium difficile Associated Diarrhea|clostridium difficile associated diarrhea
676715|NCT00350285|cannabis|cannabis
676716|NCT00350285|marijuana|marijuana
676717|NCT00350272|HIV-1 treatment naive|hiv-1 treatment naive
676718|NCT00350233|Bone Tumors|bone tumors
676719|NCT00350233|Bone Cancer|bone cancer
676720|NCT00350233|Prostate Cancer|prostate cancer
676721|NCT00350233|lung cancer|lung cancer
676722|NCT00350220|Single ventricle|single ventricle
676723|NCT00350220|Bidirectional Glenn|bidirectional glenn
676724|NCT00350220|Fontan|fontan
676725|NCT00350220|Congenital cardiac disease|congenital cardiac disease
676726|NCT00350220|Red blood cell transfusion|red blood cell transfusion
676727|NCT00350220|oxygen utilization|oxygen utilization
676728|NCT00350220|lactate level|lactate level
676729|NCT00350220|hemoglobin level|hemoglobin level
676730|NCT00350194|Fatty Acids, Omega-3|fatty acids, omega-3
676731|NCT00350168|Blood pressure|blood pressure
676732|NCT00350168|Venous pressure|venous pressure
676733|NCT00350168|Systolic pressure|systolic pressure
676734|NCT00350168|Diastolic pressure|diastolic pressure
676735|NCT00350168|Pulse pressure|pulse pressure
676736|NCT00350155|Video capsule endoscopy, healthy volunteers, naproxen, omeprazole, lumiracoxib, small bowel|video capsule endoscopy, healthy volunteers, naproxen, omeprazole, lumiracoxib, small bowel
676737|NCT00350142|Stereotactic Body Radiotherapy (SBRT)|stereotactic body radiotherapy (sbrt)
676738|NCT00350142|pancreas cancer|pancreas cancer
676739|NCT00350142|locally advanced|locally advanced
676740|NCT00350142|local control|local control
676741|NCT00350142|Gemcitabine|gemcitabine
676742|NCT00350129|glucose|glucose
676743|NCT00350129|vasospasm|vasospasm
676744|NCT00350129|RVA|rva
676745|NCT00350129|LDF|ldf
676746|NCT00350129|vasospastic subjects|vasospastic subjects
676747|NCT00350129|non-vasospastic subjects|non-vasospastic subjects
676748|NCT00350116|plaque psoriasis|plaque psoriasis
676749|NCT00350116|Vitamin B12|vitamin b12
676750|NCT00350090|Anemia|anemia
676751|NCT00350090|Neoplasms|neoplasms
676752|NCT00350090|Hemoglobin values|hemoglobin values
676753|NCT00350077|Burns|burns
676754|NCT00350064|Metabolic Syndrome|metabolic syndrome
676755|NCT00350064|Obesity|obesity
676756|NCT00350064|Exercise|exercise
676757|NCT00350064|Diabetes|diabetes
676758|NCT00350064|Physical Activity|physical activity
676759|NCT00350051|Prostate cancer|prostate cancer
676760|NCT00350051|Metastatic androgen-independent prostate cancer|metastatic androgen-independent prostate cancer
676761|NCT00350025|urothelial|urothelial
676762|NCT00350025|urologic|urologic
676763|NCT00350025|neoplasm|neoplasm
676764|NCT00350025|advanced|advanced
676765|NCT00350025|metastatic|metastatic
676766|NCT00350012|stroke|stroke
676767|NCT00350012|visual|visual
676768|NCT00350012|spatial neglect|spatial neglect
676769|NCT00349999|Vibrio cholerae, Cholera, Bangladesh, esophagogastroduodenoscopy, sub-study|vibrio cholerae, cholera, bangladesh, esophagogastroduodenoscopy, sub-study
676770|NCT00349973|Schizophrenia|schizophrenia
676771|NCT00349973|Positive symptoms|positive symptoms
676772|NCT00349973|Negative symptoms|negative symptoms
676773|NCT00349973|Cognitive deficits|cognitive deficits
676774|NCT00349960|Erythropoiesis stimulating agent|erythropoiesis stimulating agent
676775|NCT00349960|Dosing frequency|dosing frequency
676776|NCT00349960|Hemodialysis|hemodialysis
676777|NCT00349960|Therapeutic equivalence|therapeutic equivalence
676778|NCT00349934|Metastatic breast cancer|metastatic breast cancer
676779|NCT00349934|IMP321|imp321
676780|NCT00349934|hLAG-3Ig|hlag-3ig
676781|NCT00349934|LAG-3|lag-3
676782|NCT00349934|CD223|cd223
676783|NCT00349934|Chemotherapy|chemotherapy
676784|NCT00349934|Paclitaxel|paclitaxel
676785|NCT00349934|Combination therapy|combination therapy
676786|NCT00349921|pain|pain
676787|NCT00349921|chronic pain|chronic pain
676788|NCT00349921|clonidine|clonidine
676789|NCT00349921|adenosine|adenosine
676790|NCT00349921|complex regional pain syndrome|complex regional pain syndrome
676791|NCT00349921|CRPS|crps
676792|NCT00349921|a2-adrenergic agonists|a2-adrenergic agonists
676793|NCT00349921|alpha2-adrenergic agonists|alpha2-adrenergic agonists
676794|NCT00349908|Atherosclerosis,Wide Neck Aneurysm|atherosclerosis,wide neck aneurysm
676795|NCT00349895|Percutaneous Transluminal Coronary Angioplasty|percutaneous transluminal coronary angioplasty
676796|NCT00349895|Stent implantation|stent implantation
676797|NCT00349869|inflammatory arthritis|inflammatory arthritis
676798|NCT00349869|rheumatoid arthritis|rheumatoid arthritis
676799|NCT00349869|knee osteoarthritis|knee osteoarthritis
676800|NCT00349869|arthritis|arthritis
676801|NCT00349869|yoga|yoga
676802|NCT00349804|temperature|temperature
676803|NCT00349804|Temperature Homeostasis|temperature homeostasis
676804|NCT00349791|Natural Menopause|natural menopause
676805|NCT00349765|cardiovascular disease|cardiovascular disease
676806|NCT00349765|saturated fat|saturated fat
676807|NCT00349765|trans fat|trans fat
676808|NCT00349765|polyunsaturated fat|polyunsaturated fat
676809|NCT00349765|diet|diet
676810|NCT00349765|intramyocellular lipid|intramyocellular lipid
676811|NCT00349752|certolizumab pegol|certolizumab pegol
676812|NCT00349752|Cimzia|cimzia
676813|NCT00349752|Crohn's Disease|crohn's disease
676814|NCT00349752|Inflammatory Bowel Disease|inflammatory bowel disease
676815|NCT00349739|age related macular degeneration|age related macular degeneration
676816|NCT00349726|NICHD Neonatal Research Network|nichd neonatal research network
676817|NCT00349726|Pharmacokinetics|pharmacokinetics
676818|NCT00349726|Inositol|inositol
676819|NCT00349726|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
676820|NCT00349726|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
676821|NCT00349726|Prematurity|prematurity
676822|NCT00349713|Plasmodium falciparum Malaria, Mali, adjuvant|plasmodium falciparum malaria, mali, adjuvant
676823|NCT00349700|healing|healing
676824|NCT00349700|skin|skin
676825|NCT00349700|infection|infection
676826|NCT00349700|wound therapy|wound therapy
676827|NCT00349674|Wegener's granulomatosis,|wegener's granulomatosis,
676828|NCT00349674|microscopic polyangiitis,|microscopic polyangiitis,
676829|NCT00349674|ANCA-associated vasculitis,|anca-associated vasculitis,
676830|NCT00349674|methotrexate,|methotrexate,
676831|NCT00349674|azathioprine|azathioprine
676832|NCT00349661|clopidogrel|clopidogrel
676833|NCT00349661|omeprazole|omeprazole
676834|NCT00349648|subacromial|subacromial
676835|NCT00349648|impingement|impingement
676836|NCT00349648|acromioplasty|acromioplasty
676837|NCT00349648|physiotherapy|physiotherapy
676838|NCT00349635|Weight loss and diet.|weight loss and diet.
676839|NCT00349622|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
676840|NCT00349622|ALS|als
676841|NCT00349622|ceftriaxone|ceftriaxone
676842|NCT00349622|cephalosporin antibiotic|cephalosporin antibiotic
676843|NCT00349622|motor neurons|motor neurons
676844|NCT00349596|Hypomethylating agent|hypomethylating agent
676845|NCT00349596|Chemotherapy|chemotherapy
676846|NCT00349596|Relapsed or refractory ALL|relapsed or refractory all
676847|NCT00349596|Acute Lymphocytic Leukemia (ALL)|acute lymphocytic leukemia (all)
676848|NCT00349570|thrombus|thrombus
676849|NCT00349570|aspiration catheter|aspiration catheter
676850|NCT00349557|Prostate Cancer|prostate cancer
676851|NCT00349557|High-Risk Prostate Cancer|high-risk prostate cancer
676852|NCT00349557|1st line therapy|1st line therapy
676853|NCT00349544|Neck pain|neck pain
676854|NCT00349544|Cervicalgia|cervicalgia
676855|NCT00349544|Quality of life|quality of life
676856|NCT00349544|Disability|disability
676857|NCT00349518|Chronic and Advanced Phase CML and|chronic and advanced phase cml and
676858|NCT00349518|Philadelphia Chromosome Positive ALL with imatinib intolerance or resistance|philadelphia chromosome positive all with imatinib intolerance or resistance
676859|NCT00349505|previous treatment surgery + 6 cycles of platinum based chemotherapy|previous treatment surgery + 6 cycles of platinum based chemotherapy
676860|NCT00349492|Small Cell Lung Cancer|small cell lung cancer
676861|NCT00349492|Extensive Disease|extensive disease
676862|NCT00349492|Chemotherapy|chemotherapy
676863|NCT00349492|Randomisation|randomisation
676864|NCT00349479|stroke|stroke
676865|NCT00349479|tissue plasminogen activator|tissue plasminogen activator
676866|NCT00349479|t-PA|t-pa
676867|NCT00349479|barrier assessment and interactive educational intervention|barrier assessment and interactive educational intervention
676868|NCT00349479|BA-IEI|ba-iei
676869|NCT00349466|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
676870|NCT00349466|KCS|kcs
676871|NCT00349466|Dry Eye|dry eye
676872|NCT00349453|Deferiprone|deferiprone
676873|NCT00349453|L1|l1
676874|NCT00349453|Desferrioxamine|desferrioxamine
676875|NCT00349453|Hemochromatosis|hemochromatosis
676876|NCT00349453|Iron overload|iron overload
676877|NCT00349453|Thalassemia|thalassemia
676878|NCT00349440|Dry eye|dry eye
676879|NCT00349427|Insulin|insulin
676880|NCT00349427|BRL49653 /rosiglitazone|brl49653 /rosiglitazone
676881|NCT00349427|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
676882|NCT00349414|Advanced glaucoma|advanced glaucoma
676883|NCT00349414|Refractory glaucoma|refractory glaucoma
676884|NCT00349414|Cyclophotocoagulation|cyclophotocoagulation
676885|NCT00349414|Transscleral cyclophotocoagulation|transscleral cyclophotocoagulation
676886|NCT00349414|Micropulse transscleral cyclophotocoagulation|micropulse transscleral cyclophotocoagulation
676887|NCT00349401|pain|pain
676888|NCT00349401|chronic pain|chronic pain
676889|NCT00349401|morphine|morphine
676890|NCT00349401|ketorolac|ketorolac
676891|NCT00349388|Mesalamine|mesalamine
676892|NCT00349388|Ulcerative Colitis|ulcerative colitis
676893|NCT00349375|Hyperlipidemia Combined, efficacy combination fenofibrate simvastatin|hyperlipidemia combined, efficacy combination fenofibrate simvastatin
676894|NCT00349323|Community directed treatment,|community directed treatment,
676895|NCT00349323|soil-transmitted helminth infections,|soil-transmitted helminth infections,
676896|NCT00349323|treatment coverage,|treatment coverage,
676897|NCT00349323|Zambia|zambia
676898|NCT00349284|Hyperlipidemia Combined and features of the metabolic syndrome, efficacy combination fenofibrate ezetimibe|hyperlipidemia combined and features of the metabolic syndrome, efficacy combination fenofibrate ezetimibe
676899|NCT00349271|Chagas Cardiomyopathy|chagas cardiomyopathy
676900|NCT00349271|Dilated Cardiomyopathy|dilated cardiomyopathy
676901|NCT00349271|stem cells|stem cells
676902|NCT00349271|Therapeutics|therapeutics
676903|NCT00349271|Randomized Controlled Trials|randomized controlled trials
676904|NCT00349258|OHSS|ohss
676905|NCT00349258|PCOS|pcos
676906|NCT00349258|Previous high response|previous high response
676907|NCT00349258|GnRH antagonist|gnrh antagonist
676908|NCT00349258|GnRH agonist|gnrh agonist
676909|NCT00349258|IVF|ivf
676910|NCT00349245|Endotracheal|endotracheal
676911|NCT00349245|Awake fiberoptic intubation|awake fiberoptic intubation
676912|NCT00349245|Dexmedetomidine|dexmedetomidine
676913|NCT00349245|Remifentanil|remifentanil
676914|NCT00349232|childhood obesity|childhood obesity
676915|NCT00349232|lifestyle intervention|lifestyle intervention
676916|NCT00349232|school health program|school health program
676917|NCT00349232|special primary education|special primary education
676918|NCT00349219|first-line|first-line
676919|NCT00349219|second-line|second-line
676920|NCT00349219|targeted therapy|targeted therapy
676921|NCT00349193|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
676922|NCT00349180|Total Hip Replacement|total hip replacement
676923|NCT00349180|Enoxaparin|enoxaparin
676924|NCT00349167|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
676925|NCT00349141|Pandemic influenza|pandemic influenza
676926|NCT00349128|Treatment of Dyslipidemia and of Type 2 Diabetes Mellitus|treatment of dyslipidemia and of type 2 diabetes mellitus
676927|NCT00349102|Non-small-cell lung cancer|non-small-cell lung cancer
676928|NCT00349102|Breath-hold|breath-hold
676929|NCT00349102|Radiation pneumonitis|radiation pneumonitis
676930|NCT00349102|Serum cytokines|serum cytokines
676931|NCT00349102|LENT-SOMA scale|lent-soma scale
676932|NCT00349102|Non-metastatic non-small-cell lung cancer|non-metastatic non-small-cell lung cancer
676933|NCT00349089|Non-small cell lung cancer|non-small cell lung cancer
676934|NCT00349089|adjuvant therapy|adjuvant therapy
676935|NCT00349089|clinical feasibility rate|clinical feasibility rate
676936|NCT00349050|trigeminal neuralgia|trigeminal neuralgia
676937|NCT00349050|neuropathic pain|neuropathic pain
676938|NCT00349050|complex regional pain syndrome|complex regional pain syndrome
676939|NCT00349050|reflex sympathetic dystrophy|reflex sympathetic dystrophy
676940|NCT00349050|pain|pain
676941|NCT00349050|chronic pain|chronic pain
676942|NCT00349050|transcranial magnetic stimulation|transcranial magnetic stimulation
676943|NCT00349050|TMS|tms
676944|NCT00349050|laboratory pain assessment|laboratory pain assessment
676945|NCT00349037|DNA vaccine|dna vaccine
676946|NCT00349037|influenza|influenza
676947|NCT00349037|immunogenicity|immunogenicity
676948|NCT00349037|tolerability|tolerability
676949|NCT00349037|PMED|pmed
676950|NCT00349037|efficacy|efficacy
676951|NCT00349037|challenge virus|challenge virus
676952|NCT00349024|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
676953|NCT00349024|pain|pain
676954|NCT00349024|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
676955|NCT00349024|childhood Hodgkin lymphoma|childhood hodgkin lymphoma
676956|NCT00349024|chondrosarcoma|chondrosarcoma
676957|NCT00349024|osteosarcoma|osteosarcoma
676958|NCT00349024|childhood soft tissue sarcoma|childhood soft tissue sarcoma
676959|NCT00349024|Wilms tumor and other childhood kidney tumors|wilms tumor and other childhood kidney tumors
676960|NCT00349024|neuroblastoma|neuroblastoma
676961|NCT00349024|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
676962|NCT00349024|childhood large cell lymphoma|childhood large cell lymphoma
676963|NCT00349024|childhood lymphoblastic lymphoma|childhood lymphoblastic lymphoma
676964|NCT00349024|childhood small noncleaved cell lymphoma|childhood small noncleaved cell lymphoma
676965|NCT00349024|childhood rhabdomyosarcoma|childhood rhabdomyosarcoma
676966|NCT00349024|childhood brain stem glioma|childhood brain stem glioma
676967|NCT00349024|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
676968|NCT00349024|childhood cerebellar astrocytoma|childhood cerebellar astrocytoma
676969|NCT00349024|childhood cerebral astrocytoma/malignant glioma|childhood cerebral astrocytoma/malignant glioma
676970|NCT00349024|childhood choroid plexus tumor|childhood choroid plexus tumor
676971|NCT00349024|childhood craniopharyngioma|childhood craniopharyngioma
676972|NCT00349024|childhood ependymoma|childhood ependymoma
676973|NCT00349024|childhood medulloblastoma|childhood medulloblastoma
676974|NCT00349024|childhood meningioma|childhood meningioma
676975|NCT00349024|childhood oligodendroglioma|childhood oligodendroglioma
676976|NCT00349024|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
676977|NCT00349024|childhood spinal cord neoplasm|childhood spinal cord neoplasm
676978|NCT00349024|childhood supratentorial primitive neuroectodermal tumor|childhood supratentorial primitive neuroectodermal tumor
676979|NCT00349024|childhood visual pathway and hypothalamic glioma|childhood visual pathway and hypothalamic glioma
676980|NCT00349024|chordoma|chordoma
676981|NCT00349024|mucositis|mucositis
676982|NCT00349024|Ewing sarcoma/peripheral primitive neuroectodermal tumor (PNET)|ewing sarcoma/peripheral primitive neuroectodermal tumor (pnet)
676983|NCT00349011|menopause|menopause
676984|NCT00349011|genetic counseling|genetic counseling
676985|NCT00349011|breast cancer|breast cancer
676986|NCT00349011|tamoxifen|tamoxifen
676987|NCT00349011|chemoprevention|chemoprevention
676988|NCT00348998|adenocarcinoma of the prostate|adenocarcinoma of the prostate
676989|NCT00348998|stage IIB prostate cancer|stage iib prostate cancer
676990|NCT00348998|stage IIA prostate cancer|stage iia prostate cancer
676991|NCT00348998|stage III prostate cancer|stage iii prostate cancer
676992|NCT00348998|stage IV prostate cancer|stage iv prostate cancer
676993|NCT00348972|Glargine|glargine
676994|NCT00348972|prediabetes|prediabetes
676995|NCT00348972|impaired glucose tolerance|impaired glucose tolerance
676996|NCT00348972|impaired fasting glucose|impaired fasting glucose
676997|NCT00348959|Haematological Malignancies|haematological malignancies
676998|NCT00348959|Autologous Stem Cell Transplantation|autologous stem cell transplantation
676999|NCT00348959|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
677000|NCT00348959|Quality of Life|quality of life
677001|NCT00348959|Life Threatening Illness|life threatening illness
677002|NCT00348959|Art in Health Care|art in health care
677003|NCT00348959|Randomised Controlled Trial|randomised controlled trial
677004|NCT00348959|Mixed Methods Research|mixed methods research
677005|NCT00348946|Klinefelter syndrome|klinefelter syndrome
677006|NCT00348946|androgen|androgen
677007|NCT00348946|androgen oxandrolone|androgen oxandrolone
677008|NCT00348933|Developmental Delay|developmental delay
677009|NCT00348933|Mental Retardation|mental retardation
677011|NCT00348933|Microcephaly|microcephaly
677012|NCT00348933|Seizures|seizures
677013|NCT00348920|Aortic Valve|aortic valve
677014|NCT00348920|Aortic Stenosis|aortic stenosis
677015|NCT00348920|High Spinal Anesthesia|high spinal anesthesia
677016|NCT00348920|Total Spinal Anesthesia|total spinal anesthesia
677017|NCT00348920|Stress Response|stress response
677018|NCT00348920|Inflammatory Mediators|inflammatory mediators
677019|NCT00348920|Renal Function|renal function
677020|NCT00348920|Hemodynamic Stability|hemodynamic stability
677021|NCT00348907|doppler|doppler
677022|NCT00348907|CIVIQ quality of life|civiq quality of life
677023|NCT00348907|Hydrotherapy|hydrotherapy
677024|NCT00348907|anticoagulants|anticoagulants
677025|NCT00348881|Diphtheria|diphtheria
677026|NCT00348881|Tetanus|tetanus
677027|NCT00348881|Pertussis|pertussis
677028|NCT00348881|Hepatitis B Hansenula (HB)|hepatitis b hansenula (hb)
677029|NCT00348881|Haemophilus influenzae type b|haemophilus influenzae type b
677030|NCT00348868|HIV Infection|hiv infection
677031|NCT00348868|Opioid dependence|opioid dependence
677032|NCT00348868|DSM-IV criteria for opioid dependence|dsm-iv criteria for opioid dependence
677033|NCT00348855|High Blood Pressure|high blood pressure
677034|NCT00348855|High cardiovascular risk|high cardiovascular risk
677035|NCT00348855|Type 2 diabetes|type 2 diabetes
677036|NCT00348855|Reaching goals|reaching goals
677037|NCT00348842|Immunotherapy|immunotherapy
677038|NCT00348829|CHF|chf
677039|NCT00348829|mitral insufficiency|mitral insufficiency
677040|NCT00348829|conductance catheter|conductance catheter
677041|NCT00348829|mitral valve repair|mitral valve repair
677042|NCT00348816|stage I prostate cancer|stage i prostate cancer
677043|NCT00348816|stage IIB prostate cancer|stage iib prostate cancer
677044|NCT00348816|stage IIA prostate cancer|stage iia prostate cancer
677045|NCT00348816|stage III prostate cancer|stage iii prostate cancer
677046|NCT00348816|stage IV prostate cancer|stage iv prostate cancer
677047|NCT00348790|adult grade I meningioma|adult grade i meningioma
677048|NCT00348790|adult grade II meningioma|adult grade ii meningioma
677049|NCT00348790|adult grade III meningioma|adult grade iii meningioma
677050|NCT00348790|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
677051|NCT00348790|adult anaplastic meningioma|adult anaplastic meningioma
677052|NCT00348790|adult papillary meningioma|adult papillary meningioma
677053|NCT00348790|adult melanocytic lesion|adult melanocytic lesion
677054|NCT00348790|recurrent adult brain tumor|recurrent adult brain tumor
677055|NCT00348777|Visual analogic Scale of pain|visual analogic scale of pain
677056|NCT00348777|Womac indice|womac indice
677057|NCT00348777|SF-36 quality of life|sf-36 quality of life
677058|NCT00348777|Hydrotherapy|hydrotherapy
677059|NCT00348764|lauromacrogol|lauromacrogol
677060|NCT00348764|Sclerotherapy|sclerotherapy
677061|NCT00348738|radiotherapy|radiotherapy
677062|NCT00348738|clinical trial|clinical trial
677063|NCT00348738|erythropoietin|erythropoietin
677064|NCT00348738|cervix cancer|cervix cancer
677065|NCT00348738|Phase III|phase iii
677066|NCT00348738|2 Arms|2 arms
677067|NCT00348725|Treatment of Dyslipidemia and of Type 2 Diabetes Mellitus|treatment of dyslipidemia and of type 2 diabetes mellitus
677068|NCT00348686|LVH|lvh
677069|NCT00348660|Screening for Hepatitis C in Pregnancy|screening for hepatitis c in pregnancy
677070|NCT00348647|Prevention|prevention
677071|NCT00348647|Exercise|exercise
677072|NCT00348647|Overuse|overuse
677073|NCT00348647|Anterior knee pain syndrome|anterior knee pain syndrome
677074|NCT00348647|Exertional lower leg pain|exertional lower leg pain
677075|NCT00348647|Prospective|prospective
677076|NCT00348647|Risk factors|risk factors
677077|NCT00348647|Hip|hip
677078|NCT00348634|Constipation, Tegaserod, orocecal transit, colonic transit, gastric emptying|constipation, tegaserod, orocecal transit, colonic transit, gastric emptying
677079|NCT00348621|cataract surgery|cataract surgery
677080|NCT00348621|refractive correction|refractive correction
677081|NCT00348621|low vision services|low vision services
677082|NCT00348621|nursing home|nursing home
677083|NCT00348621|visual impairment|visual impairment
677084|NCT00348608|Coronary|coronary
677085|NCT00348608|Angiography|angiography
677086|NCT00348608|X-ray|x-ray
677087|NCT00348608|CAD|cad
677088|NCT00348595|Prostate Cancer|prostate cancer
677089|NCT00348569|CT|ct
677090|NCT00348569|Coronary|coronary
677091|NCT00348569|Cardiac|cardiac
677092|NCT00348569|Angiography|angiography
677093|NCT00348569|X-ray|x-ray
677094|NCT00348569|CAD|cad
677095|NCT00348569|Chest pain|chest pain
677096|NCT00348543|age-related macula degeneration|age-related macula degeneration
677097|NCT00348543|prophylactic laser treatment|prophylactic laser treatment
677098|NCT00348543|exudative complication|exudative complication
677099|NCT00348530|Systolic heart failure; Therapy; Cardiomyopathy|systolic heart failure; therapy; cardiomyopathy
677100|NCT00348491|Dental surgery|dental surgery
677101|NCT00348491|acute pain|acute pain
677102|NCT00348491|lumiracoxib|lumiracoxib
677103|NCT00348491|celecoxib|celecoxib
677104|NCT00348491|Moderate to severe pain following dental surgery|moderate to severe pain following dental surgery
677105|NCT00348478|trachoma|trachoma
677106|NCT00348478|chlamydia trachomatis|chlamydia trachomatis
677107|NCT00348478|water|water
677108|NCT00348478|health education|health education
677109|NCT00348478|face washing|face washing
677110|NCT00348465|Brachytherapy|brachytherapy
677111|NCT00348465|Prostate volume|prostate volume
677112|NCT00348452|osteoarthritis pain; knee; hip; extended release analgesia; opioid|osteoarthritis pain; knee; hip; extended release analgesia; opioid
677113|NCT00348426|Food Borne Botulism|food borne botulism
677114|NCT00348413|Graves ophthalmopathy/therapy|graves ophthalmopathy/therapy
677115|NCT00348413|Randomized controlled trial|randomized controlled trial
677116|NCT00348413|Methylprednisolone|methylprednisolone
677117|NCT00348413|Methotrexate|methotrexate
677118|NCT00348387|Imovax polio|imovax polio
677119|NCT00348387|poliomyelitis|poliomyelitis
677120|NCT00348374|type two diabetes, insulin, HbA1c|type two diabetes, insulin, hba1c
677121|NCT00348361|Hay fever|hay fever
677122|NCT00348361|biomarkers|biomarkers
677123|NCT00348309|apolipoprotein E|apolipoprotein e
677124|NCT00348309|Alzheimer's disease|alzheimer's disease
677125|NCT00348309|cognition|cognition
677126|NCT00348309|rosiglitazone|rosiglitazone
677127|NCT00348309|adjunctive therapy|adjunctive therapy
677128|NCT00348296|Scleroderma, Systemic|scleroderma, systemic
677129|NCT00348270|Cataract|cataract
677130|NCT00348270|Intraocular lens|intraocular lens
677131|NCT00348270|Aberration|aberration
677132|NCT00348270|Wavefront|wavefront
677133|NCT00348231|diabetes mellitus, biphasic insulin analogue|diabetes mellitus, biphasic insulin analogue
677134|NCT00348218|Neurovision|neurovision
677135|NCT00348218|Myopia Therapy|myopia therapy
677136|NCT00348192|Alzheimer's Disease|alzheimer's disease
677137|NCT00348192|cognition global functioning|cognition global functioning
677138|NCT00348192|symptomatic|symptomatic
677139|NCT00348192|SB-742457|sb-742457
677140|NCT00348179|Vascular abnormalities|vascular abnormalities
677141|NCT00348179|Type 1 diabetes|type 1 diabetes
677142|NCT00348179|Healthy control subjects|healthy control subjects
677143|NCT00348153|Uveitis|uveitis
677144|NCT00348153|Adalimumab|adalimumab
677145|NCT00348153|TNF alpha|tnf alpha
677146|NCT00348140|adjunctive therapy|adjunctive therapy
677147|NCT00348140|moderate|moderate
677148|NCT00348140|Alzheimer's disease|alzheimer's disease
677149|NCT00348140|apolipoprotein E|apolipoprotein e
677150|NCT00348140|mild|mild
677151|NCT00348140|rosiglitazone|rosiglitazone
677152|NCT00348140|cognition|cognition
677153|NCT00348127|Neurovision|neurovision
677154|NCT00348127|Myopia Therapy|myopia therapy
677155|NCT00348114|autologous|autologous
677156|NCT00348114|transplantation ex-vivo expanded limbal epithelium|transplantation ex-vivo expanded limbal epithelium
677157|NCT00348114|limbal deficiency|limbal deficiency
677158|NCT00348101|Patients undergoing major vascular surgery having documented CAD or risk factors for CAD|patients undergoing major vascular surgery having documented cad or risk factors for cad
677159|NCT00348088|Metastatic|metastatic
677160|NCT00348088|Melanoma|melanoma
677161|NCT00348088|Untreated|untreated
677162|NCT00348088|Biomarker|biomarker
677163|NCT00348075|Neurovision|neurovision
677164|NCT00348075|Adult myopia|adult myopia
677165|NCT00348075|Therapy|therapy
677166|NCT00348049|LASIK|lasik
677168|NCT00348049|Myopia|myopia
677169|NCT00348036|Major Depression|major depression
677170|NCT00348036|Trauma|trauma
677171|NCT00348036|Primary Care|primary care
677172|NCT00348036|Low-Income Patients|low-income patients
677173|NCT00348010|osteoarthritis|osteoarthritis
677174|NCT00348010|knee pain|knee pain
677175|NCT00348010|extended release analgesia|extended release analgesia
677176|NCT00348010|opioid|opioid
677177|NCT00347971|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
677178|NCT00347971|interleukin-21|interleukin-21
677179|NCT00347971|rituximab|rituximab
677180|NCT00347971|Immunotherapy|immunotherapy
677181|NCT00347958|Tetanus,|tetanus,
677182|NCT00347958|Diphtheria,|diphtheria,
677183|NCT00347958|Pertussis|pertussis
677184|NCT00347945|convergence insufficiency, vision therapy, orthoptics|convergence insufficiency, vision therapy, orthoptics
677185|NCT00347919|GW786034|gw786034
677186|NCT00347919|Quality of Life|quality of life
677187|NCT00347919|GW572016|gw572016
677188|NCT00347919|Lapatinib|lapatinib
677189|NCT00347919|Pazopanib|pazopanib
677190|NCT00347919|Metastatic|metastatic
677191|NCT00347919|Breast cancer|breast cancer
677192|NCT00347919|Genetics|genetics
677193|NCT00347919|FISH|fish
677194|NCT00347919|Advanced|advanced
677195|NCT00347893|Primary open angle glaucoma|primary open angle glaucoma
677196|NCT00347893|Ocular hypertension|ocular hypertension
677197|NCT00347893|Pseudo-exfoliative glaucoma|pseudo-exfoliative glaucoma
677198|NCT00347893|Pigment Dispersion glaucoma|pigment dispersion glaucoma
677199|NCT00347893|selective laser trabeculoplasty|selective laser trabeculoplasty
677200|NCT00347893|intraocular pressure|intraocular pressure
677201|NCT00347880|Bronchiolitis|bronchiolitis
677202|NCT00347880|ANP|anp
677203|NCT00347880|BNP|bnp
677204|NCT00347880|Atrial Natriuretic Peptide|atrial natriuretic peptide
677205|NCT00347880|Brain Natriuretic Peptide|brain natriuretic peptide
677206|NCT00347880|Vasopressin|vasopressin
677207|NCT00347880|ADH|adh
677208|NCT00347880|Pediatric|pediatric
677209|NCT00347880|Respiratory Distress|respiratory distress
677210|NCT00347880|Fluid Balance|fluid balance
677211|NCT00347867|IUGR|iugr
677212|NCT00347867|PET|pet
677213|NCT00347867|Pregnancy|pregnancy
677214|NCT00347867|Viagra|viagra
677215|NCT00347867|Sildenafil citrate|sildenafil citrate
677216|NCT00347854|Normal, healthy eyes (other than correction for visual acuity)|normal, healthy eyes (other than correction for visual acuity)
677217|NCT00347828|Antibiotic prophylaxis|antibiotic prophylaxis
677218|NCT00347828|Vigamox|vigamox
677219|NCT00347828|Moxifloxacin|moxifloxacin
677220|NCT00347828|Zymar|zymar
677221|NCT00347828|Gatifloxacin|gatifloxacin
677222|NCT00347828|Preoperative antibiotic|preoperative antibiotic
677223|NCT00347828|Eye infection|eye infection
677224|NCT00347789|glaucoma|glaucoma
677225|NCT00347789|trabeculectomy|trabeculectomy
677226|NCT00347789|filtering bleb revision|filtering bleb revision
677227|NCT00347789|intraocular pressure|intraocular pressure
677228|NCT00347789|needling procedure|needling procedure
677229|NCT00347789|mitomycin C|mitomycin c
677230|NCT00347776|trichiasis|trichiasis
677231|NCT00347776|azithromycin|azithromycin
677232|NCT00347776|trichiasis surgery|trichiasis surgery
677233|NCT00347776|topical tetracycline|topical tetracycline
677234|NCT00347763|trachoma|trachoma
677235|NCT00347763|chlamydia|chlamydia
677236|NCT00347763|flies|flies
677237|NCT00347763|permethrin|permethrin
677238|NCT00347750|Lopinavir|lopinavir
677239|NCT00347750|Pharmacokinetic|pharmacokinetic
677240|NCT00347750|Pharmacodynamic|pharmacodynamic
677241|NCT00347750|Ethiopian population|ethiopian population
677242|NCT00347750|Caucasian population|caucasian population
677243|NCT00347724|chronic low back pain; chronic pain; low back pain; extended-release analgesia; opioid|chronic low back pain; chronic pain; low back pain; extended-release analgesia; opioid
677244|NCT00347698|diabetic retinopathy|diabetic retinopathy
677245|NCT00347698|bevacizumab|bevacizumab
677246|NCT00347698|photocoagulation|photocoagulation
677247|NCT00347685|chronic non-malignant pain; chronic pain; non-malignant|chronic non-malignant pain; chronic pain; non-malignant
677248|NCT00347685|pain; moderate pain; severe pain|pain; moderate pain; severe pain
677249|NCT00347672|Bird Flu|bird flu
677250|NCT00347659|Lung volume reduction|lung volume reduction
677251|NCT00347659|Bronchoscopy|bronchoscopy
677252|NCT00347659|Emphysema|emphysema
677253|NCT00347659|COPD|copd
677254|NCT00347659|NETT|nett
677255|NCT00347659|Lung disease|lung disease
677256|NCT00347659|COLD|cold
677257|NCT00347659|BLVR|blvr
677258|NCT00347607|trachoma|trachoma
677259|NCT00347607|chlamydia trachomatis|chlamydia trachomatis
677260|NCT00347607|surveillance|surveillance
677261|NCT00347607|azithromycin|azithromycin
677262|NCT00347594|Corneal surface topography|corneal surface topography
677263|NCT00347594|Ocular aberrations|ocular aberrations
677264|NCT00347581|convergence insufficiency|convergence insufficiency
677265|NCT00347581|base-in prism|base-in prism
677266|NCT00347581|orthoptics|orthoptics
677267|NCT00347581|vision therapy|vision therapy
677268|NCT00347568|decision aids|decision aids
677269|NCT00347568|high risk|high risk
677270|NCT00347568|breast cancer|breast cancer
677271|NCT00347568|breast cancer prevention|breast cancer prevention
677272|NCT00347555|malaria, falciparum, Plasmodium falciparum malaria, vaccine|malaria, falciparum, plasmodium falciparum malaria, vaccine
677273|NCT00347542|Vitamin D|vitamin d
677274|NCT00347542|Diabetes|diabetes
677275|NCT00347542|Insulin sensitivity|insulin sensitivity
677276|NCT00347542|Obesity|obesity
677277|NCT00347529|DNA vaccine, influenza, immunogenicity, tolerability, PMED, pandemic|dna vaccine, influenza, immunogenicity, tolerability, pmed, pandemic
677278|NCT00347516|IOL formula|iol formula
677279|NCT00347516|High myopia|high myopia
677280|NCT00347516|axial length|axial length
677281|NCT00347477|cardiac arrest|cardiac arrest
677282|NCT00347477|hypothermia|hypothermia
677283|NCT00347477|neurologic outcome|neurologic outcome
677284|NCT00347477|edema|edema
677285|NCT00347464|Kleinfelter|kleinfelter
677286|NCT00347451|myopia|myopia
677287|NCT00347451|optical coherence tomography|optical coherence tomography
677288|NCT00347438|breast cancer|breast cancer
677289|NCT00347438|neoadjuvant|neoadjuvant
677290|NCT00347438|locally advanced|locally advanced
677291|NCT00347425|Switch Study|switch study
677292|NCT00347425|Schizophrenia|schizophrenia
677293|NCT00347425|Atypical Antipsychotics|atypical antipsychotics
677294|NCT00347412|NSCLC|nsclc
677295|NCT00347412|Stage IIIb|stage iiib
677296|NCT00347412|Stage IV|stage iv
677297|NCT00347412|Non Small Cell Lung Cancer (NSCLC)|non small cell lung cancer (nsclc)
677298|NCT00347412|NSCLC Stage IIIb with malignant pleural/pericardial effusion|nsclc stage iiib with malignant pleural/pericardial effusion
677299|NCT00347412|NSCLC Stage IV|nsclc stage iv
677300|NCT00347399|macular degeneration|macular degeneration
677301|NCT00347399|antibodies|antibodies
677302|NCT00347399|angiogenesis inhibitor|angiogenesis inhibitor
677303|NCT00347386|Infants|infants
677304|NCT00347386|India|india
677305|NCT00347386|Zinc|zinc
677306|NCT00347386|Bacterial illness|bacterial illness
677307|NCT00347386|Treatment|treatment
677308|NCT00347373|conjugated linoleic acid|conjugated linoleic acid
677309|NCT00347373|obesity|obesity
677310|NCT00347373|body composition|body composition
677311|NCT00347373|body fat mass|body fat mass
677312|NCT00347373|lean body mass|lean body mass
677313|NCT00347360|carvedilol|carvedilol
677314|NCT00347360|hypertension|hypertension
677315|NCT00347360|lisinopril|lisinopril
677316|NCT00347360|factorial|factorial
677317|NCT00347334|Torticollis|torticollis
677318|NCT00347334|infant home positioning|infant home positioning
677319|NCT00347334|head control|head control
677320|NCT00347321|Percutaneous tracheostomy|percutaneous tracheostomy
677321|NCT00347321|Endotracheal intubation|endotracheal intubation
677322|NCT00347321|Mechanical ventilation|mechanical ventilation
677323|NCT00347321|Cardiac surgery|cardiac surgery
677324|NCT00347321|Ventilator-free days|ventilator-free days
677325|NCT00347308|brow ptosis, facial aesthetics, browlift, facelift|brow ptosis, facial aesthetics, browlift, facelift
677326|NCT00347282|Post enucleation socket syndrome|post enucleation socket syndrome
677327|NCT00347282|Multi-slice computed tomography scan|multi-slice computed tomography scan
677328|NCT00347282|Prospective studies|prospective studies
677329|NCT00347282|Tomography, X Ray Computed|tomography, x ray computed
677330|NCT00347269|Anxiety Disorders|anxiety disorders
677331|NCT00347269|Post-traumatic Stress Disorder|post-traumatic stress disorder
677332|NCT00347269|Generalized Anxiety Disorder|generalized anxiety disorder
677333|NCT00347269|Panic Disorder|panic disorder
677334|NCT00347269|Social Anxiety Disorder|social anxiety disorder
677335|NCT00347269|Stress|stress
677336|NCT00347269|Stress Disorders, Traumatic|stress disorders, traumatic
677337|NCT00347269|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
677338|NCT00347269|Mental Health Disorders|mental health disorders
677339|NCT00347230|Intacs ring segments|intacs ring segments
677340|NCT00347230|Keratoconus|keratoconus
677341|NCT00347217|Cholesterol|cholesterol
677342|NCT00347217|rosuvastatin|rosuvastatin
677343|NCT00347217|LDL-C goal|ldl-c goal
677344|NCT00347217|observational study|observational study
677345|NCT00347217|primary prevention|primary prevention
677346|NCT00347217|secondary prevention|secondary prevention
677347|NCT00347204|PRK|prk
677348|NCT00347204|laser vision correction|laser vision correction
677349|NCT00347204|surface ablation|surface ablation
677350|NCT00347204|pain|pain
677351|NCT00347204|wound healing|wound healing
677352|NCT00347204|corneal haze|corneal haze
677353|NCT00347191|Corneal thickness|corneal thickness
677354|NCT00347191|Intraocular pressure|intraocular pressure
677355|NCT00347191|Instrumentation|instrumentation
677356|NCT00347191|Glaucoma|glaucoma
677357|NCT00347191|Keratoconus|keratoconus
677358|NCT00347178|Asymptomatic Narrow Angles|asymptomatic narrow angles
677359|NCT00347178|Primary Angle Closure Suspects|primary angle closure suspects
677360|NCT00347178|Laser Peripheral Iridotomy|laser peripheral iridotomy
677361|NCT00347178|Randomised Controlled Trial|randomised controlled trial
677362|NCT00347165|macular degeneration|macular degeneration
677363|NCT00347165|angiogenesis|angiogenesis
677364|NCT00347165|antibodies|antibodies
677365|NCT00347152|Intellectual disabilities|intellectual disabilities
677366|NCT00347152|development disabilities|development disabilities
677367|NCT00347152|behavior disorders|behavior disorders
677368|NCT00347152|stable epilepsy|stable epilepsy
677369|NCT00347139|Tolerability|tolerability
677370|NCT00347139|Pharmacodynamics|pharmacodynamics
677371|NCT00347139|Safety|safety
677372|NCT00347139|Pharmacokinetics|pharmacokinetics
677373|NCT00347139|GW642444|gw642444
677374|NCT00347139|Asthmatic patients|asthmatic patients
677375|NCT00347139|Efficacy|efficacy
677376|NCT00347126|Glaucoma|glaucoma
677377|NCT00347126|Latanoprost|latanoprost
677378|NCT00347126|Travoprost|travoprost
677379|NCT00347126|Intraocular pressure|intraocular pressure
677380|NCT00347126|Hyperemia|hyperemia
677381|NCT00347113|P. falciparum|p. falciparum
677382|NCT00347113|malaria|malaria
677383|NCT00347113|schistosome infections|schistosome infections
677384|NCT00347113|soil-transmitted helminths infection|soil-transmitted helminths infection
677385|NCT00347113|anaemia|anaemia
677386|NCT00347113|immune response|immune response
677387|NCT00347113|Tanzania|tanzania
677388|NCT00347087|Insulin sensitivity|insulin sensitivity
677389|NCT00347087|chronic heart failure|chronic heart failure
677390|NCT00347087|metabolism|metabolism
677391|NCT00347074|Keratoconus, corneal topography, ocular aberrometry, visual outcome, contact lens wear, quality of life|keratoconus, corneal topography, ocular aberrometry, visual outcome, contact lens wear, quality of life
677392|NCT00347061|Benign Prostatic Hyperplasiam|benign prostatic hyperplasiam
677393|NCT00347061|Adrenergic alpha-antagonist|adrenergic alpha-antagonist
677394|NCT00347048|Ulcerative colitis|ulcerative colitis
677395|NCT00347048|tacrolimus|tacrolimus
677396|NCT00347048|FK506|fk506
677397|NCT00347048|treatment outcome|treatment outcome
677398|NCT00347022|Multislice computed tomography (MSCT)indications|multislice computed tomography (msct)indications
677399|NCT00347009|Cirrhosis|cirrhosis
677400|NCT00347009|Advanced Fibrosis|advanced fibrosis
677401|NCT00347009|Chronic Hepatitis B|chronic hepatitis b
677402|NCT00347009|Adefovir Dipivoxil|adefovir dipivoxil
677403|NCT00346996|diabetes|diabetes
677404|NCT00346996|insulin|insulin
677405|NCT00346996|insulin analogues|insulin analogues
677406|NCT00346996|hypoglycaemia|hypoglycaemia
677407|NCT00346996|severe hypoglycaemia|severe hypoglycaemia
677408|NCT00346970|Metabolic Syndrome|metabolic syndrome
677409|NCT00346970|High Density Lipoprotein|high density lipoprotein
677410|NCT00346970|Extended-Release Niacin|extended-release niacin
677411|NCT00346970|Endothelial Function|endothelial function
677412|NCT00346970|Endothelial Progenitor Cells|endothelial progenitor cells
677413|NCT00346931|glaucoma|glaucoma
677414|NCT00346931|cataract|cataract
677415|NCT00346931|surgery|surgery
677416|NCT00346931|intraocular pressure|intraocular pressure
677417|NCT00346931|phacoemulsification|phacoemulsification
677418|NCT00346931|trabeculotomy|trabeculotomy
677419|NCT00346918|ADPKD|adpkd
677420|NCT00346918|autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
677421|NCT00346918|Sirolimus|sirolimus
677422|NCT00346918|volumetry|volumetry
677423|NCT00346905|GERD|gerd
677424|NCT00346905|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
677425|NCT00346905|Reflux|reflux
677426|NCT00346905|Enteryx|enteryx
677427|NCT00346892|Prophylaxis rotavirus|prophylaxis rotavirus
677428|NCT00346879|fondaparinux for prevention of blood clots|fondaparinux for prevention of blood clots
677429|NCT00346853|Dark adaptation inhibition|dark adaptation inhibition
677430|NCT00346853|Stargardt macular dystrophy|stargardt macular dystrophy
677431|NCT00346853|4-Methylpyrazole (4-MP)|4-methylpyrazole (4-mp)
677432|NCT00346853|Antizol|antizol
677433|NCT00346853|Fomepizole|fomepizole
677434|NCT00346840|Labor induction|labor induction
677435|NCT00346840|cervical ripening|cervical ripening
677436|NCT00346840|misoprostol|misoprostol
677437|NCT00346840|vaginal insert|vaginal insert
677438|NCT00346814|Retinopathy of prematurity|retinopathy of prematurity
677439|NCT00346814|antiangiogenic therapy|antiangiogenic therapy
677440|NCT00346801|Non-Small Cell Lung Cancer|non-small cell lung cancer
677441|NCT00346801|Lung Cancer|lung cancer
677442|NCT00346801|Celecoxib|celecoxib
677443|NCT00346801|Cisplatin|cisplatin
677444|NCT00346801|Platinol|platinol
677445|NCT00346801|CPT-11|cpt-11
677446|NCT00346801|Irinotecan|irinotecan
677447|NCT00346801|SC-58635|sc-58635
677448|NCT00346801|Celebrex|celebrex
677449|NCT00346801|Radiation Therapy|radiation therapy
677450|NCT00346775|questionnaire|questionnaire
677451|NCT00346775|nasal spray|nasal spray
677452|NCT00346775|Seasonal allergic rhinitis|seasonal allergic rhinitis
677453|NCT00346775|nasal spray questionnaire|nasal spray questionnaire
677454|NCT00346775|allergic rhinitis|allergic rhinitis
677455|NCT00346762|Former Plasma Donors|former plasma donors
677456|NCT00346762|Commercial Plasma Donors|commercial plasma donors
677457|NCT00346762|Long-Term Nonprogressors|long-term nonprogressors
677458|NCT00346762|Host Factors|host factors
677459|NCT00346762|Viral Factors|viral factors
677460|NCT00346762|HIV|hiv
677461|NCT00346749|Inflammation|inflammation
677462|NCT00346749|FEV1|fev1
677463|NCT00346749|Sputum|sputum
677464|NCT00346736|Alternative medicine|alternative medicine
677465|NCT00346736|Traditional Chinese medicine|traditional chinese medicine
677466|NCT00346736|Acupuncture|acupuncture
677467|NCT00346736|Autistic Spectrum Disorder|autistic spectrum disorder
677468|NCT00346736|Autism|autism
677469|NCT00346736|Children|children
677470|NCT00346723|Influenza, Vaccine, CHMP criteria|influenza, vaccine, chmp criteria
677471|NCT00346710|communication|communication
677472|NCT00346710|patient experience|patient experience
677473|NCT00346710|fellowship training|fellowship training
677474|NCT00346697|AIDS|aids
677475|NCT00346697|HIV|hiv
677476|NCT00346697|HAART|haart
677477|NCT00346697|Lipids|lipids
677478|NCT00346697|Triglycerides|triglycerides
677479|NCT00346697|Cholesterol|cholesterol
677480|NCT00346697|omega-3 fatty acids|omega-3 fatty acids
677481|NCT00346697|bone turnover|bone turnover
677482|NCT00346697|inflammation|inflammation
677483|NCT00346697|insulin resistance|insulin resistance
677484|NCT00346684|Lymphoma|lymphoma
677485|NCT00346684|LPHD|lphd
677486|NCT00346684|Rituximab|rituximab
677487|NCT00346671|Reiki|reiki
677488|NCT00346671|Stress|stress
677489|NCT00346671|CAM|cam
677490|NCT00346658|Osteoporosis|osteoporosis
677491|NCT00346658|bone density|bone density
677492|NCT00346658|magnesium|magnesium
677493|NCT00346658|vitamin D|vitamin d
677494|NCT00346645|NON-SMALL CELL LUNG CANCER METASTATIC|non-small cell lung cancer metastatic
677495|NCT00346632|AML|aml
677496|NCT00346632|ALL|all
677497|NCT00346632|MDS|mds
677498|NCT00346632|CML|cml
677499|NCT00346632|Kinase Inhibitor|kinase inhibitor
677500|NCT00346606|Chronic Idiopathic Urticaria|chronic idiopathic urticaria
677501|NCT00346606|Desloratadine|desloratadine
677502|NCT00346606|Denosin|denosin
677503|NCT00346606|Levocetirizine|levocetirizine
677504|NCT00346567|mother-to-child-transmission|mother-to-child-transmission
677505|NCT00346567|PMTCT|pmtct
677506|NCT00346567|HIV|hiv
677507|NCT00346567|resistance|resistance
677508|NCT00346567|NNRTI|nnrti
677509|NCT00346554|COPD|copd
677510|NCT00346554|Sleep disorders|sleep disorders
677511|NCT00346554|pulmonary rehabilitation|pulmonary rehabilitation
677512|NCT00346541|glaucoma|glaucoma
677513|NCT00346541|polymorphism, genetic|polymorphism, genetic
677514|NCT00346515|carotid artery|carotid artery
677515|NCT00346515|carotid stenosis|carotid stenosis
677516|NCT00346515|carotid stenting|carotid stenting
677517|NCT00346515|embolic protection|embolic protection
677518|NCT00346489|Trabeculectomy|trabeculectomy
677519|NCT00346489|5-fluorouracil|5-fluorouracil
677520|NCT00346489|Mitomycin C|mitomycin c
677521|NCT00346476|TB|tb
677522|NCT00346476|Transmission|transmission
677523|NCT00346476|Genetic Diversity|genetic diversity
677524|NCT00346476|Genetic Testing|genetic testing
677525|NCT00346476|RFLP|rflp
677526|NCT00346463|Allopurinol|allopurinol
677527|NCT00346463|Fetal Growth Retardation|fetal growth retardation
677528|NCT00346463|Oxidative Stress|oxidative stress
677529|NCT00346463|Placental Insufficiency|placental insufficiency
677530|NCT00346450|Culture|culture
677531|NCT00346450|Conjunctiva|conjunctiva
677532|NCT00346450|transplantation|transplantation
677533|NCT00346450|pterygium|pterygium
677534|NCT00346450|ocular surface|ocular surface
677535|NCT00346437|angina|angina
677536|NCT00346437|FGF-4|fgf-4
677537|NCT00346437|angiogenesis|angiogenesis
677538|NCT00346437|adenovector|adenovector
677539|NCT00346437|growth factor|growth factor
677540|NCT00346437|myocardial ischemia|myocardial ischemia
677541|NCT00346437|revascularization|revascularization
677542|NCT00346424|occluded central catheter|occluded central catheter
677543|NCT00346424|central venous access devices dysfunction|central venous access devices dysfunction
677544|NCT00346424|withdrawal occlusion|withdrawal occlusion
677545|NCT00346424|Thrombosis|thrombosis
677546|NCT00346424|Venous thrombosis|venous thrombosis
677547|NCT00346411|rheumatoid arthritis|rheumatoid arthritis
677548|NCT00346411|mood|mood
677549|NCT00346411|adherence|adherence
677550|NCT00346411|medication|medication
677551|NCT00346398|asthma|asthma
677552|NCT00346398|allergen|allergen
677553|NCT00346398|allergic disease|allergic disease
677554|NCT00346398|allergen immunotherapy|allergen immunotherapy
677555|NCT00346398|allergic sensitization|allergic sensitization
677556|NCT00346398|atopic dermatitis|atopic dermatitis
677557|NCT00346398|eczema|eczema
677558|NCT00346398|food allergy|food allergy
677559|NCT00346398|oral mucosal immunoprophylaxis (OMIP)|oral mucosal immunoprophylaxis (omip)
677560|NCT00346385|recurrent small cell lung cancer|recurrent small cell lung cancer
677561|NCT00346385|merkel cell carcinoma|merkel cell carcinoma
677562|NCT00346385|ovarian cancer|ovarian cancer
677563|NCT00346372|Ocular Melanoma|ocular melanoma
677564|NCT00346372|Optical Coherence Tomography|optical coherence tomography
677565|NCT00346372|Eye Tumor|eye tumor
677566|NCT00346372|Choroidal Melanoma|choroidal melanoma
677567|NCT00346372|Uveal Melanoma|uveal melanoma
677568|NCT00346359|graft versus host disease|graft versus host disease
677569|NCT00346359|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
677570|NCT00346359|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
677571|NCT00346359|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
677572|NCT00346359|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
677573|NCT00346359|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
677574|NCT00346359|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
677575|NCT00346359|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
677576|NCT00346359|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
677577|NCT00346359|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
677578|NCT00346359|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
677579|NCT00346359|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
677580|NCT00346359|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
677581|NCT00346359|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
677582|NCT00346359|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
677583|NCT00346359|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
677584|NCT00346359|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
677585|NCT00346359|secondary acute myeloid leukemia|secondary acute myeloid leukemia
677586|NCT00346359|chronic eosinophilic leukemia|chronic eosinophilic leukemia
677587|NCT00346359|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
677588|NCT00346359|chronic neutrophilic leukemia|chronic neutrophilic leukemia
677589|NCT00346359|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
677590|NCT00346359|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
677591|NCT00346359|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
677592|NCT00346359|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
677593|NCT00346359|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
677594|NCT00346359|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
677595|NCT00346346|Immunity|immunity
677596|NCT00346346|Memory|memory
677597|NCT00346346|ELISPOT|elispot
677598|NCT00346346|Malaria|malaria
677599|NCT00346346|Prospective|prospective
677600|NCT00346333|Retinitis Pigmentosa, Inherited Retinal Degeneration|retinitis pigmentosa, inherited retinal degeneration
677601|NCT00346320|stage I non-small cell lung cancer|stage i non-small cell lung cancer
677602|NCT00346320|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
677603|NCT00346320|adenocarcinoma of the lung|adenocarcinoma of the lung
677604|NCT00346320|adenosquamous cell lung cancer|adenosquamous cell lung cancer
677605|NCT00346320|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
677606|NCT00346320|large cell lung cancer|large cell lung cancer
677607|NCT00346320|squamous cell lung cancer|squamous cell lung cancer
677608|NCT00346294|Rheumatoid Arthritis|rheumatoid arthritis
677609|NCT00346294|Device|device
677610|NCT00346294|Auto-injector|auto-injector
677611|NCT00346294|SureClick|sureclick
677612|NCT00346294|Enbrel|enbrel
677613|NCT00346294|Etanercept|etanercept
677614|NCT00346281|unresectable pancreatic cancer|unresectable pancreatic cancer
677615|NCT00346281|brachytherapy|brachytherapy
677616|NCT00346281|32P|32p
677617|NCT00346281|BioSilicon|biosilicon
677618|NCT00346281|locally advanced|locally advanced
677619|NCT00346281|gemcitabine|gemcitabine
677620|NCT00346281|intratumourally|intratumourally
677621|NCT00346281|unresectable|unresectable
677622|NCT00346255|stage I multiple myeloma|stage i multiple myeloma
677623|NCT00346255|stage II multiple myeloma|stage ii multiple myeloma
677624|NCT00346255|stage III multiple myeloma|stage iii multiple myeloma
677625|NCT00346242|thalassemia|thalassemia
677626|NCT00346242|zoledronic acid|zoledronic acid
677627|NCT00346242|skeletal events|skeletal events
677628|NCT00346229|stage III B breast cancer|stage iii b breast cancer
677629|NCT00346229|stage III C breast cancer|stage iii c breast cancer
677630|NCT00346229|stage IV breast cancer|stage iv breast cancer
677631|NCT00346229|inflammatory breast cancer|inflammatory breast cancer
677632|NCT00346229|recurrent breast cancer|recurrent breast cancer
677633|NCT00346177|heart|heart
677634|NCT00346177|stem Cells|stem cells
677635|NCT00346177|low EF|low ef
677636|NCT00346177|heart attack|heart attack
677637|NCT00346177|cardiomyopathy|cardiomyopathy
677638|NCT00346177|congestive heart failure|congestive heart failure
677639|NCT00346177|cardiovascular disease|cardiovascular disease
677640|NCT00346177|Heart Failure|heart failure
677641|NCT00346177|Low Ejection Fraction|low ejection fraction
677642|NCT00346151|renal transplantation|renal transplantation
677643|NCT00346151|kidney transplantation|kidney transplantation
677644|NCT00346151|renal allograft recipient|renal allograft recipient
677645|NCT00346151|anti-rejection drugs|anti-rejection drugs
677646|NCT00346151|immunosuppression protocol|immunosuppression protocol
677647|NCT00346151|immunosuppression withdrawal|immunosuppression withdrawal
677648|NCT00346125|soft tissue sarcoma|soft tissue sarcoma
677649|NCT00346125|Malignant fibrous histiocytoma|malignant fibrous histiocytoma
677650|NCT00346125|Liposarcoma|liposarcoma
677651|NCT00346125|Fibrosarcoma|fibrosarcoma
677652|NCT00346125|Leiomyosarcoma|leiomyosarcoma
677653|NCT00346125|Synovial sarcoma|synovial sarcoma
677654|NCT00346125|Malignant peripheral nerve sheath tumor (MPNST)|malignant peripheral nerve sheath tumor (mpnst)
677655|NCT00346125|Epithelioid sarcoma|epithelioid sarcoma
677656|NCT00346112|ICD|icd
677657|NCT00346112|distress|distress
677658|NCT00346112|anxiety|anxiety
677659|NCT00346112|quality-of-life|quality-of-life
677660|NCT00346099|NSABP|nsabp
677661|NCT00346099|panitumumab|panitumumab
677662|NCT00346099|rectal cancer|rectal cancer
677663|NCT00346099|colorectal cancer|colorectal cancer
677664|NCT00346099|oxaliplatin|oxaliplatin
677665|NCT00346099|capecitabine|capecitabine
677666|NCT00346099|combined modality therapy|combined modality therapy
677667|NCT00346099|combined pelvic radiation therapy|combined pelvic radiation therapy
677668|NCT00346099|Rectal cancer with or without metastasis|rectal cancer with or without metastasis
677669|NCT00346086|CpG oligonucleotide vaccine|cpg oligonucleotide vaccine
677670|NCT00346086|ragweed immunotherapy|ragweed immunotherapy
677671|NCT00346073|Prophylaxis for diphtheria, tetanus, pertussis|prophylaxis for diphtheria, tetanus, pertussis
677672|NCT00346073|Immunogenicity, booster, dTpa|immunogenicity, booster, dtpa
677673|NCT00346060|Dry age related macular degeneration.|dry age related macular degeneration.
677674|NCT00346060|Retinal Transplant|retinal transplant
677675|NCT00346060|Fetal Tissue|fetal tissue
677676|NCT00346060|Early treatment diabetic retinopathy study|early treatment diabetic retinopathy study
677677|NCT00346060|20/200 or worse.|20/200 or worse.
677678|NCT00346021|Children's behavior towards hat use|children's behavior towards hat use
677679|NCT00346008|melanoma|melanoma
677680|NCT00346008|recurrent melanoma|recurrent melanoma
677681|NCT00346008|stage I melanoma|stage i melanoma
677682|NCT00346008|stage II melanoma|stage ii melanoma
677683|NCT00346008|stage III melanoma|stage iii melanoma
677684|NCT00346008|stage IV melanoma|stage iv melanoma
677685|NCT00345982|Schizophrenia|schizophrenia
677686|NCT00345982|Treatment-resistant|treatment-resistant
677687|NCT00345982|sertindole|sertindole
677688|NCT00345982|clozapine|clozapine
677689|NCT00345969|Testosterone Replacement Therapy|testosterone replacement therapy
677690|NCT00345969|Physical Frailty|physical frailty
677691|NCT00345969|Hip Fracture|hip fracture
677692|NCT00345956|Prophylaxis against gastroenteritis caused by Rotavirus|prophylaxis against gastroenteritis caused by rotavirus
677693|NCT00345943|Eating Disorders|eating disorders
677694|NCT00345943|Bulimia Nervosa|bulimia nervosa
677695|NCT00345943|Bulimia|bulimia
677696|NCT00345943|fMRI|fmri
677697|NCT00345943|Magnetic Resonance Imaging|magnetic resonance imaging
677698|NCT00345930|Complementary and alternative medicine|complementary and alternative medicine
677699|NCT00345930|Complementary therapies|complementary therapies
677700|NCT00345930|Alternative therapies|alternative therapies
677701|NCT00345930|Prescription Drugs|prescription drugs
677702|NCT00345930|Non prescription Drugs|non prescription drugs
677703|NCT00345930|Liver Disease|liver disease
677704|NCT00345930|Chemical Ind|chemical ind
677705|NCT00345930|Phenotype|phenotype
677706|NCT00345930|Proteomics|proteomics
677707|NCT00345930|Metabolomics|metabolomics
677708|NCT00345930|Cholestatic Liver Injury|cholestatic liver injury
677709|NCT00345930|Hepatocellular Liver Injury|hepatocellular liver injury
677710|NCT00345930|Mixed Liver Injury|mixed liver injury
677711|NCT00345930|Matched Case Control Studies|matched case control studies
677712|NCT00345930|Genotype|genotype
677713|NCT00345930|Liver Dis|liver dis
677714|NCT00345930|Chem Ind|chem ind
677715|NCT00345917|Retinitis Pigmentosa|retinitis pigmentosa
677716|NCT00345917|Retinal Transplant|retinal transplant
677717|NCT00345917|Fetal Tissue|fetal tissue
677718|NCT00345917|Early treatment diabetic retinopathy study|early treatment diabetic retinopathy study
677719|NCT00345917|20/200 or worse.|20/200 or worse.
677720|NCT00345904|influenza, vaccine|influenza, vaccine
677721|NCT00345904|prophylaxis of influenza|prophylaxis of influenza
677722|NCT00345891|Lung neoplasms|lung neoplasms
677723|NCT00345891|Family|family
677724|NCT00345891|Stress|stress
677725|NCT00345878|HPV-16/18 L1 VLP AS04|hpv-16/18 l1 vlp as04
677726|NCT00345878|Cervical neoplasia|cervical neoplasia
677727|NCT00345878|Cervical cancer|cervical cancer
677728|NCT00345878|Human Papillomavirus (HPV)|human papillomavirus (hpv)
677729|NCT00345878|Double-blind|double-blind
677730|NCT00345878|AS04|as04
677731|NCT00345865|Hodgkin lymphoma|hodgkin lymphoma
677732|NCT00345865|non-Hodgkin lymphoma|non-hodgkin lymphoma
677733|NCT00345865|HIV-associated lymphoma|hiv-associated lymphoma
677734|NCT00345852|twin to twin transfusion syndrome|twin to twin transfusion syndrome
677735|NCT00345852|fetoscopic selective laser photocoagulation|fetoscopic selective laser photocoagulation
677736|NCT00345852|amnioreduction|amnioreduction
677737|NCT00345839|Cinacalcet HCl|cinacalcet hcl
677738|NCT00345839|Cinacalcet|cinacalcet
677739|NCT00345839|AMG 073|amg 073
677740|NCT00345839|Sensipar|sensipar
677741|NCT00345839|Mimpara|mimpara
677742|NCT00345839|Calcimimetic|calcimimetic
677743|NCT00345839|Hemodialysis|hemodialysis
677745|NCT00345839|Secondary hyperparathyroidism (HPT)|secondary hyperparathyroidism (hpt)
677746|NCT00345826|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
677747|NCT00345826|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
677748|NCT00345826|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
677749|NCT00345826|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
677750|NCT00345826|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
677751|NCT00345826|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
677752|NCT00345813|adenocarcinoma of the prostate|adenocarcinoma of the prostate
677753|NCT00345813|stage I prostate cancer|stage i prostate cancer
677754|NCT00345813|stage IIB prostate cancer|stage iib prostate cancer
677755|NCT00345813|stage IIA prostate cancer|stage iia prostate cancer
677756|NCT00345813|stage III prostate cancer|stage iii prostate cancer
677757|NCT00345813|stage IV prostate cancer|stage iv prostate cancer
677758|NCT00345800|Endocrine Evaluation cataplexy|endocrine evaluation cataplexy
677759|NCT00345800|sodium oxybate (xyrem)|sodium oxybate (xyrem)
677760|NCT00345787|Osteoarthritic Pain|osteoarthritic pain
677761|NCT00345774|Pulmonary Hypertension|pulmonary hypertension
677762|NCT00345774|PH|ph
677763|NCT00345774|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
677764|NCT00345774|PAH|pah
677765|NCT00345774|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
677766|NCT00345774|COPD|copd
677767|NCT00345774|PRX-08066|prx-08066
677768|NCT00345774|Predix|predix
677769|NCT00345761|Advanced and/or metastatic colorectal cancer|advanced and/or metastatic colorectal cancer
677770|NCT00345735|Cancer pain with breakthrough pain episodes|cancer pain with breakthrough pain episodes
677771|NCT00345722|Strawberry|strawberry
677772|NCT00345722|Almond|almond
677773|NCT00345722|Soy protein|soy protein
677774|NCT00345722|viscous dietary fibre|viscous dietary fibre
677775|NCT00345722|plant sterols|plant sterols
677776|NCT00345722|portfolio diet|portfolio diet
677777|NCT00345722|blood lipids|blood lipids
677778|NCT00345722|compliance|compliance
677779|NCT00345722|blood pressure|blood pressure
677780|NCT00345709|Ovarian Cancer|ovarian cancer
677781|NCT00345709|Peritoneal Cancer|peritoneal cancer
677782|NCT00345709|Fallopian Tube Cancer|fallopian tube cancer
677783|NCT00345709|Elizabeth Registry|elizabeth registry
677784|NCT00345709|Questionnaire|questionnaire
677785|NCT00345709|Registry|registry
677786|NCT00345709|Survey|survey
677787|NCT00345696|Capecitabine|capecitabine
677788|NCT00345696|Oxaliplatin|oxaliplatin
677789|NCT00345696|Bevacizumab|bevacizumab
677790|NCT00345696|First line|first line
677791|NCT00345683|H. influenzae type B vaccine|h. influenzae type b vaccine
677792|NCT00345683|Infants|infants
677793|NCT00345683|Neisseria meningitidis|neisseria meningitidis
677794|NCT00345683|Vaccines, conjugate|vaccines, conjugate
677795|NCT00345683|Meningococcal vaccines|meningococcal vaccines
677796|NCT00345683|Prophylaxis|prophylaxis
677797|NCT00345683|Comparative study|comparative study
677798|NCT00345683|Safety|safety
677799|NCT00345683|Humans|humans
677800|NCT00345670|Lower respiratory tract illness|lower respiratory tract illness
677801|NCT00345670|RSV and PIV3 infection|rsv and piv3 infection
677802|NCT00345657|Hyperlipidemia|hyperlipidemia
677803|NCT00345657|Dyslipidemia|dyslipidemia
677804|NCT00345657|Niacin|niacin
677805|NCT00345657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
677806|NCT00345657|Combination lipid therapy|combination lipid therapy
677807|NCT00345657|Lovastatin|lovastatin
677808|NCT00345644|Postmenopausal|postmenopausal
677809|NCT00345631|Closure Device|closure device
677810|NCT00345631|Angiography|angiography
677811|NCT00345631|Angioplasty|angioplasty
677812|NCT00345631|Hemostasis|hemostasis
677813|NCT00345631|Heart Catheterization|heart catheterization
677814|NCT00345631|Peripheral Angiography|peripheral angiography
677815|NCT00345631|Femoral Closure|femoral closure
677816|NCT00345631|Vascular Closure|vascular closure
677817|NCT00345631|Coronary Angiography|coronary angiography
677818|NCT00345618|Deep venous thrombosis|deep venous thrombosis
677819|NCT00345618|pulmonary embolism|pulmonary embolism
677820|NCT00345618|anticoagulant drugs|anticoagulant drugs
677821|NCT00345605|Argininosuccinic Acid Lyase Deficiency|argininosuccinic acid lyase deficiency
677822|NCT00345605|ASA|asa
677823|NCT00345579|Prophylaxis|prophylaxis
677824|NCT00345579|Neisseria meningitidis Vaccines, conjugate|neisseria meningitidis vaccines, conjugate
677825|NCT00345579|Infants|infants
677826|NCT00345579|Meningococcal vaccines|meningococcal vaccines
677827|NCT00345579|H. influenzae type B vaccine|h. influenzae type b vaccine
677828|NCT00345579|Humans|humans
677829|NCT00345579|Safety|safety
677830|NCT00345566|cerebral palsy|cerebral palsy
677831|NCT00345566|protein composition|protein composition
677832|NCT00345566|gastric emptying rate|gastric emptying rate
677833|NCT00345566|tube feeding|tube feeding
677834|NCT00345553|Biliary Atresia|biliary atresia
677835|NCT00345553|Cholestasis|cholestasis
677836|NCT00345540|Platinum Resistant Tumors of Ovarian Origin|platinum resistant tumors of ovarian origin
677837|NCT00345527|Problem gambling|problem gambling
677838|NCT00345527|Clinically significant anger|clinically significant anger
677839|NCT00345514|Children|children
677840|NCT00345514|Self-efficacy|self-efficacy
677841|NCT00345514|Organization|organization
677842|NCT00345514|Process of care|process of care
677843|NCT00345501|contrast media|contrast media
677844|NCT00345501|contrast nephropathy|contrast nephropathy
677845|NCT00345475|Birth Defects|birth defects
677846|NCT00345475|Epilepsy|epilepsy
677847|NCT00345475|High Risk Pregnancy|high risk pregnancy
677848|NCT00345462|Influenza, Vaccine, CHMP criteria|influenza, vaccine, chmp criteria
677849|NCT00345449|cystic fibrosis,|cystic fibrosis,
677850|NCT00345449|lung disease,|lung disease,
677851|NCT00345449|lung transplantation,|lung transplantation,
677852|NCT00345449|decision aid|decision aid
677853|NCT00345436|Insulin Sensitivity|insulin sensitivity
677854|NCT00345436|Moderate intensity|moderate intensity
677855|NCT00345436|Insulin Resistance|insulin resistance
677856|NCT00345436|Exercise Intervention|exercise intervention
677857|NCT00345410|obesity and dyslipidemia|obesity and dyslipidemia
677858|NCT00345397|cecostomy|cecostomy
677859|NCT00345397|colonoscopy|colonoscopy
677860|NCT00345397|colostomy|colostomy
677861|NCT00345397|constipation|constipation
677862|NCT00345397|endoscopy, gastrointestinal|endoscopy, gastrointestinal
677863|NCT00345397|fecal incontinence|fecal incontinence
677864|NCT00345397|percutaneous|percutaneous
677865|NCT00345397|quality of life|quality of life
677866|NCT00345397|spinal cord injury|spinal cord injury
677867|NCT00345384|Dexmedetomidine|dexmedetomidine
677868|NCT00345384|Sedation|sedation
677869|NCT00345384|Opioid|opioid
677870|NCT00345384|Respiratory depression|respiratory depression
677871|NCT00345371|methamphetamine addiction|methamphetamine addiction
677872|NCT00345358|Booster vaccination|booster vaccination
677873|NCT00345358|Catch-up vaccination|catch-up vaccination
677874|NCT00345358|Pneumococcal vaccine|pneumococcal vaccine
677875|NCT00345358|Immunogenicity|immunogenicity
677876|NCT00345358|Safety|safety
677877|NCT00345358|Pneumococcal disease|pneumococcal disease
677878|NCT00345345|Neutropenia|neutropenia
677879|NCT00345345|Monoclonal Antibody Therapy|monoclonal antibody therapy
677880|NCT00345345|Anti-CD52|anti-cd52
677881|NCT00345345|T-LGL Leukemia|t-lgl leukemia
677882|NCT00345345|LGL Leukemia|lgl leukemia
677883|NCT00345345|Anemia|anemia
677884|NCT00345345|Immunosuppression|immunosuppression
677885|NCT00345345|Chronic T Cell Lymphocytosis with Neutropenia|chronic t cell lymphocytosis with neutropenia
677886|NCT00345345|Leukemia|leukemia
677887|NCT00345319|rabies|rabies
677888|NCT00345319|vaccine|vaccine
677889|NCT00345319|post-exposure prophylaxis|post-exposure prophylaxis
677890|NCT00345306|endometrial preparation|endometrial preparation
677891|NCT00345306|Utrogestan|utrogestan
677892|NCT00345306|Endometrin|endometrin
677893|NCT00345293|Prostate Cancer|prostate cancer
677894|NCT00345280|Cystic fibrosis|cystic fibrosis
677895|NCT00345280|eye|eye
677896|NCT00345280|inflammation|inflammation
677897|NCT00345280|apoptosis|apoptosis
677898|NCT00345280|C11+|c11+
677899|NCT00345267|Asthma|asthma
677900|NCT00345267|Children|children
677901|NCT00345267|Integrated Care Pathway|integrated care pathway
677902|NCT00345267|Evidence based medicine|evidence based medicine
677903|NCT00345267|Prescribing errors|prescribing errors
677904|NCT00345241|Blepharitis|blepharitis
677905|NCT00345228|High myopia|high myopia
677906|NCT00345228|Choroidal neovascularisation|choroidal neovascularisation
677907|NCT00345228|Lacquer crack|lacquer crack
677908|NCT00345228|Fundus fluorescein angiography|fundus fluorescein angiography
677909|NCT00345228|Indocyanine green angiography|indocyanine green angiography
677910|NCT00345228|Axial length|axial length
677911|NCT00345215|Urinary Aquaporin 2|urinary aquaporin 2
677912|NCT00345215|High/low Sodium Diet|high/low sodium diet
677913|NCT00345215|Fractional Sodium Excretion|fractional sodium excretion
677914|NCT00345202|HMG-COA reductase inhibition|hmg-coa reductase inhibition
677915|NCT00345202|GFR|gfr
677916|NCT00345202|RPF|rpf
677917|NCT00345202|FE|fe
677918|NCT00345202|CL|cl
677919|NCT00345189|Hsp90 inhibitor|hsp90 inhibitor
677920|NCT00345189|CNF2024|cnf2024
677921|NCT00345189|Advanced Solid Tumors|advanced solid tumors
677922|NCT00345176|age-related macular degeneration|age-related macular degeneration
677923|NCT00345176|AMD|amd
677924|NCT00345176|lutein|lutein
677925|NCT00345176|zeaxanthin|zeaxanthin
677926|NCT00345176|docosahexaenoic acid|docosahexaenoic acid
677927|NCT00345176|eicosapentaenoic acid|eicosapentaenoic acid
677928|NCT00345163|Glioblastoma Multiforme|glioblastoma multiforme
677929|NCT00345163|Avastin|avastin
677930|NCT00345163|Brain Cancer|brain cancer
677931|NCT00345163|GBM|gbm
677932|NCT00345150|hypertension|hypertension
677933|NCT00345150|nitric oxide|nitric oxide
677934|NCT00345150|renal hemodynamics|renal hemodynamics
677935|NCT00345137|Renal hemodynamics|renal hemodynamics
677936|NCT00345137|Nitric oxide|nitric oxide
677937|NCT00345124|urinary aquaporin-2|urinary aquaporin-2
677938|NCT00345124|ENaC|enac
677939|NCT00345124|fractional sodium excretion|fractional sodium excretion
677940|NCT00345124|High/low sodium diet|high/low sodium diet
677941|NCT00345111|Restor IOL versus Conventional IOL|restor iol versus conventional iol
677942|NCT00345098|Depression, Antidepressive agents|depression, antidepressive agents
677943|NCT00345098|Clinical Trial|clinical trial
677944|NCT00345098|Phase III|phase iii
677945|NCT00345098|Multicenter study|multicenter study
677946|NCT00345072|Menopause|menopause
677947|NCT00345072|Decision aids|decision aids
677948|NCT00345072|Internet|internet
677949|NCT00345072|Hormone Replacement Therapy|hormone replacement therapy
677950|NCT00345072|Breast Cancer|breast cancer
677951|NCT00345072|Cardiovascular Disease|cardiovascular disease
677952|NCT00345072|Osteoporosis|osteoporosis
677953|NCT00345059|second line|second line
677954|NCT00345059|monochemotherapy|monochemotherapy
677955|NCT00345059|combination chemotherapy|combination chemotherapy
677956|NCT00345059|platinum refractory|platinum refractory
677957|NCT00345059|previously treated|previously treated
677958|NCT00345046|Glaucoma|glaucoma
677959|NCT00345046|Cataract|cataract
677960|NCT00345033|Glucose Metabolism|glucose metabolism
677961|NCT00345020|Deep Lamellar Endotheliam Keratoplasty|deep lamellar endotheliam keratoplasty
677962|NCT00345007|Retinal detachment|retinal detachment
677963|NCT00345007|Macular function|macular function
677964|NCT00345007|Multifocal electrophysiology|multifocal electrophysiology
677965|NCT00344994|Restless Legs Syndrome|restless legs syndrome
677966|NCT00344994|Mirapex (pramipexole)|mirapex (pramipexole)
677967|NCT00344994|Requip(Ropinirole)|requip(ropinirole)
677968|NCT00344994|Dopamine Agonist|dopamine agonist
677969|NCT00344981|Cell Cycle Agents|cell cycle agents
677970|NCT00344955|HMG-COA reductase inhibition|hmg-coa reductase inhibition
677971|NCT00344955|GFR|gfr
677972|NCT00344955|RPF|rpf
677973|NCT00344955|FE|fe
677974|NCT00344955|CL|cl
677975|NCT00344916|Renal hemodynamics|renal hemodynamics
677976|NCT00344916|Nitric oxide|nitric oxide
677977|NCT00344903|Atherosclerosis|atherosclerosis
677978|NCT00344903|Heart Failure|heart failure
677979|NCT00344903|Ventricular Hypertrophy|ventricular hypertrophy
677980|NCT00344903|Myocardial Infarction|myocardial infarction
677981|NCT00344903|Screening|screening
677982|NCT00344903|Hypertension|hypertension
677983|NCT00344903|Diabetes|diabetes
677984|NCT00344903|Obesity|obesity
677985|NCT00344903|Metabolic Syndrome|metabolic syndrome
677986|NCT00344890|Cervical fusion|cervical fusion
677987|NCT00344890|Anterior Cervical Discectomy and Fusion|anterior cervical discectomy and fusion
677988|NCT00344890|ACDF|acdf
677989|NCT00344877|Epilepsy|epilepsy
677990|NCT00344877|Temporal Lobe Epilepsy|temporal lobe epilepsy
677991|NCT00344877|Cortical Excitability|cortical excitability
677992|NCT00344877|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
677993|NCT00344877|Memory Testing|memory testing
677994|NCT00344877|Seizures|seizures
677995|NCT00344877|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
677996|NCT00344877|Memory|memory
677997|NCT00344877|Plasticity|plasticity
677998|NCT00344864|Contact Lenses Higher Order Aberrations|contact lenses higher order aberrations
677999|NCT00344851|menstrual cyclicity|menstrual cyclicity
678000|NCT00344851|insulin resistance|insulin resistance
678001|NCT00344851|body fat distribution|body fat distribution
678002|NCT00344851|pancreatic ß-cell function|pancreatic ß-cell function
678003|NCT00344851|inflammatory markers|inflammatory markers
678004|NCT00344851|liver function tests|liver function tests
678005|NCT00344838|LADARWave™|ladarwave™
678006|NCT00344838|WaveScan Wavefront™ Systems|wavescan wavefront™ systems
678007|NCT00344825|B- Chronic Lymphocytic Leukemia|b- chronic lymphocytic leukemia
678008|NCT00344799|Choroidal Melanoma|choroidal melanoma
678009|NCT00344799|Choroidal Malignant Melanoma|choroidal malignant melanoma
678010|NCT00344799|Ocular Melanoma|ocular melanoma
678011|NCT00344799|Uveal Melanoma|uveal melanoma
678012|NCT00344786|CLL|cll
678013|NCT00344786|CNF2024|cnf2024
678014|NCT00344786|Hsp90 inhibitor|hsp90 inhibitor
678015|NCT00344773|Locally advanced (IIIB) pulmonary adenocarcinoma with EGFR mutation|locally advanced (iiib) pulmonary adenocarcinoma with egfr mutation
678016|NCT00344773|Metastatic (IV) pulmonary adenocarcinoma with EGFR mutation|metastatic (iv) pulmonary adenocarcinoma with egfr mutation
678017|NCT00344773|Recurrent pulmonary adenocarcinoma with EGFR mutation|recurrent pulmonary adenocarcinoma with egfr mutation
678018|NCT00344747|intervention program|intervention program
678019|NCT00344747|diet|diet
678020|NCT00344747|physical activity|physical activity
678021|NCT00344747|adolescents|adolescents
678022|NCT00344747|obesity|obesity
678023|NCT00344734|Nitric oxide|nitric oxide
678024|NCT00344734|Renal hemodynamics|renal hemodynamics
678025|NCT00344721|Meibomian Gland Syndrome|meibomian gland syndrome
678026|NCT00344721|Blepharitis|blepharitis
678027|NCT00344708|Tissue-Cultured Human Amniotic Epithelial Cells onto damaged corneal surface|tissue-cultured human amniotic epithelial cells onto damaged corneal surface
678028|NCT00344682|memantine|memantine
678029|NCT00344682|Namenda|namenda
678030|NCT00344682|augmentation|augmentation
678031|NCT00344682|add-on|add-on
678032|NCT00344682|depression|depression
678033|NCT00344682|MDD (major depressive disorder)|mdd (major depressive disorder)
678034|NCT00344682|unipolar depression|unipolar depression
678035|NCT00344682|NMDA|nmda
678036|NCT00344682|ketamine|ketamine
678037|NCT00344682|uncompetitive NMDA receptor antagonist|uncompetitive nmda receptor antagonist
678038|NCT00344669|underweight|underweight
678039|NCT00344669|preschool|preschool
678040|NCT00344669|mass deworming|mass deworming
678041|NCT00344656|Eating Disorders|eating disorders
678042|NCT00344656|Anorexia Nervosa|anorexia nervosa
678043|NCT00344643|Comparison of Daily wear versus Extended wear in bacterial binding and corneal epithelial thickness|comparison of daily wear versus extended wear in bacterial binding and corneal epithelial thickness
678044|NCT00344617|Choroidal neovascularisation|choroidal neovascularisation
678045|NCT00344617|Polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
678046|NCT00344617|Intravitreal injection|intravitreal injection
678047|NCT00344617|Avastin|avastin
678048|NCT00344604|Patients who have undergone routine LASIK as a primary refractive procedure for myopia, hyperopia, or astigmatism.|patients who have undergone routine lasik as a primary refractive procedure for myopia, hyperopia, or astigmatism.
678049|NCT00344591|HIV|hiv
678050|NCT00344591|AIDS|aids
678051|NCT00344578|Higher Order Abberations|higher order abberations
678052|NCT00344539|asexual blood stage vaccine, Plasmodium falciparum malaria|asexual blood stage vaccine, plasmodium falciparum malaria
678053|NCT00344526|AL amyloidosis|al amyloidosis
678054|NCT00344526|Autologous stem cell transplantation|autologous stem cell transplantation
678055|NCT00344526|Melphalan|melphalan
678056|NCT00344526|Dexamethasone|dexamethasone
678057|NCT00344513|registry|registry
678058|NCT00344513|OPTIMIZE|optimize
678059|NCT00344513|Heart failure|heart failure
678060|NCT00344513|OPTIMIZE-HF|optimize-hf
678061|NCT00344500|Antipsychotic|antipsychotic
678062|NCT00344500|Bipolar|bipolar
678063|NCT00344500|Diabetes|diabetes
678064|NCT00344500|Mental Illness|mental illness
678065|NCT00344500|Nutrition|nutrition
678066|NCT00344500|Obesity|obesity
678067|NCT00344500|Schizoaffective|schizoaffective
678068|NCT00344500|Schizophrenia|schizophrenia
678069|NCT00344500|Weight Gain|weight gain
678070|NCT00344500|Weight Loss|weight loss
678071|NCT00344474|Prevention|prevention
678072|NCT00344474|Addiction|addiction
678073|NCT00344474|Personality|personality
678074|NCT00344474|Adolescents|adolescents
678075|NCT00344474|Binge Drinking|binge drinking
678076|NCT00344474|Alcohol Abuse|alcohol abuse
678077|NCT00344474|Comorbidity|comorbidity
678078|NCT00344474|Depression|depression
678079|NCT00344474|Anxiety|anxiety
678080|NCT00344474|Antisocial Behaviour|antisocial behaviour
678081|NCT00344448|Adhesion Molecule|adhesion molecule
678082|NCT00344448|Interventional Study|interventional study
678083|NCT00344448|Immunomodulation|immunomodulation
678084|NCT00344448|Autoimmunity|autoimmunity
678085|NCT00344448|Sjogren Syndrome|sjogren syndrome
678086|NCT00344448|SS|ss
678087|NCT00344435|Hemophilia|hemophilia
678088|NCT00344435|Antibody|antibody
678089|NCT00344435|Mutations|mutations
678090|NCT00344435|SNP|snp
678091|NCT00344435|clotting|clotting
678092|NCT00344422|Anthracyclines|anthracyclines
678093|NCT00344422|Liposomes|liposomes
678094|NCT00344422|Liposomal|liposomal
678095|NCT00344422|Vincristine|vincristine
678096|NCT00344422|Doxorubicin|doxorubicin
678097|NCT00344422|Dexamethasone|dexamethasone
678098|NCT00344422|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
678099|NCT00344422|DOXIL|doxil
678100|NCT00344422|drug resistant myeloma|drug resistant myeloma
678101|NCT00344409|darbepoetin alfa|darbepoetin alfa
678102|NCT00344409|anemia|anemia
678103|NCT00344409|cancer patients|cancer patients
678104|NCT00344409|platinum containing chemotherapy|platinum containing chemotherapy
678105|NCT00344383|oral contraceptive|oral contraceptive
678106|NCT00344383|breakthrough bleeding|breakthrough bleeding
678107|NCT00344383|spotting|spotting
678108|NCT00344370|Pitavastatin|pitavastatin
678109|NCT00344370|Type II Diabetes Mellitus|type ii diabetes mellitus
678110|NCT00344370|Combined Dyslipidemia|combined dyslipidemia
678111|NCT00344344|Asthma|asthma
678112|NCT00344344|Cockroach|cockroach
678113|NCT00344344|Dust Mite|dust mite
678114|NCT00344344|Extermination|extermination
678115|NCT00344344|Targeted Cleaning|targeted cleaning
678116|NCT00344344|Allergy|allergy
678117|NCT00344344|Prevention|prevention
678118|NCT00344331|Lysosomal Storage|lysosomal storage
678119|NCT00344331|Biomarkers|biomarkers
678120|NCT00344331|Longitudinal|longitudinal
678121|NCT00344331|Niemann Pick Type C|niemann pick type c
678122|NCT00344331|NPC|npc
678123|NCT00344331|Lysosomal Storage Disorder|lysosomal storage disorder
678124|NCT00344318|Immunogenicity|immunogenicity
678125|NCT00344318|Safety|safety
678126|NCT00344318|Pneumococcal vaccine|pneumococcal vaccine
678127|NCT00344318|Pneumococcal disease|pneumococcal disease
678128|NCT00344305|children, FluMist, shedding,|children, flumist, shedding,
678129|NCT00344292|Polymorphism, Genetic|polymorphism, genetic
678130|NCT00344292|Coronary Artery Disease|coronary artery disease
678131|NCT00344292|Coronary Arteriosclerosis|coronary arteriosclerosis
678132|NCT00344292|Polymorphism, Single Nucleotide|polymorphism, single nucleotide
678133|NCT00344292|SNPs|snps
678134|NCT00344279|Coinfection|coinfection
678135|NCT00344279|AIDS|aids
678136|NCT00344279|Lymphatic Filariasis|lymphatic filariasis
678137|NCT00344279|Diethylcarbamazine (DEC)|diethylcarbamazine (dec)
678138|NCT00344279|Albendazole|albendazole
678139|NCT00344266|Obesity|obesity
678140|NCT00344266|Adipose Tissue|adipose tissue
678141|NCT00344266|Microarrays|microarrays
678142|NCT00344266|Cytokines|cytokines
678143|NCT00344266|Eicosanoids|eicosanoids
678144|NCT00344266|Gene Expression|gene expression
678145|NCT00344266|Adipokines|adipokines
678146|NCT00344266|Inflammation|inflammation
678147|NCT00344266|Weight Loss|weight loss
678148|NCT00344266|Lipid Products|lipid products
678149|NCT00344253|Uveitis|uveitis
678150|NCT00344253|Macular Edema|macular edema
678151|NCT00344253|Interferon|interferon
678152|NCT00344253|Multiple Sclerosis|multiple sclerosis
678153|NCT00344253|Encephalomyelitis disseminata (ED)|encephalomyelitis disseminata (ed)
678154|NCT00344240|type 2 diabetes|type 2 diabetes
678155|NCT00344240|exercise|exercise
678156|NCT00344240|activity guidance|activity guidance
678157|NCT00344240|health education|health education
678158|NCT00344227|neovascularization|neovascularization
678159|NCT00344227|age-related macular degeneration|age-related macular degeneration
678160|NCT00344227|vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
678161|NCT00344227|antigen-binding fragment (Fab)|antigen-binding fragment (fab)
678162|NCT00344227|antiangiogenesis|antiangiogenesis
678163|NCT00344227|optical coherence tomography (OCT)|optical coherence tomography (oct)
678164|NCT00344214|HIV|hiv
678165|NCT00344214|STDs|stds
678166|NCT00344214|Methamphetamine|methamphetamine
678167|NCT00344201|Pterygium|pterygium
678168|NCT00344201|Fibrin adhesive|fibrin adhesive
678169|NCT00344201|Conjunctival graft|conjunctival graft
678170|NCT00344201|Ocular surface reconstruction|ocular surface reconstruction
678171|NCT00344188|Cutaneous|cutaneous
678172|NCT00344188|Visceral|visceral
678173|NCT00344188|PCR|pcr
678174|NCT00344188|Mucocutaneous|mucocutaneous
678175|NCT00344188|Biopsy|biopsy
678176|NCT00344188|Leishmanial Infection|leishmanial infection
678177|NCT00344188|Leishmaniasis|leishmaniasis
678178|NCT00344175|hypercholesterolemia|hypercholesterolemia
678179|NCT00344175|dyslipidemia|dyslipidemia
678180|NCT00344175|CHD|chd
678181|NCT00344175|pitavastatin|pitavastatin
678182|NCT00344175|simvastatin|simvastatin
678183|NCT00344175|2 or more risk factors for coronary heart disease|2 or more risk factors for coronary heart disease
678184|NCT00344175|combined dyslipidemia|combined dyslipidemia
678185|NCT00344162|Epidemiology|epidemiology
678186|NCT00344162|Population|population
678187|NCT00344162|Pregnancy|pregnancy
678188|NCT00344162|Preeclampsia|preeclampsia
678189|NCT00344149|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
678190|NCT00344149|Rituximab|rituximab
678191|NCT00344149|Splenectomy|splenectomy
678192|NCT00344149|Response|response
678193|NCT00344149|Treatment|treatment
678194|NCT00344149|treatment of Idiopathic Thrombocytopenic Purpura|treatment of idiopathic thrombocytopenic purpura
678195|NCT00344136|Blood Pressure, High|blood pressure, high
678196|NCT00344136|Stroke|stroke
678197|NCT00344136|Hypertension|hypertension
678198|NCT00344136|Diabetes Mellitus|diabetes mellitus
678199|NCT00344136|Obesity|obesity
678200|NCT00344136|Cerebrovascular Accident|cerebrovascular accident
678201|NCT00344136|Atherosclerosis|atherosclerosis
678202|NCT00344123|HIV|hiv
678203|NCT00344110|Hypertension, aliskiren, blood pressure, renin|hypertension, aliskiren, blood pressure, renin
678204|NCT00344097|soy protein|soy protein
678205|NCT00344097|pain|pain
678206|NCT00344097|thoracotomy|thoracotomy
678207|NCT00344084|Leishmania Major|leishmania major
678208|NCT00344084|Phlebotomus Duboscqi|phlebotomus duboscqi
678209|NCT00344084|Dermatology|dermatology
678210|NCT00344084|Vector-Transmitted Disease|vector-transmitted disease
678211|NCT00344084|Africa|africa
678212|NCT00344084|Cutaneous Leishmaniasis|cutaneous leishmaniasis
678213|NCT00344084|CL|cl
678214|NCT00344071|Clinical|clinical
678215|NCT00344071|Tissue|tissue
678216|NCT00344071|Photographs|photographs
678217|NCT00344071|Women|women
678218|NCT00344071|Case-Control|case-control
678219|NCT00344058|pregnancy|pregnancy
678220|NCT00344058|preeclampsia|preeclampsia
678221|NCT00344058|treatment|treatment
678222|NCT00344045|Subjects with postoperative pain after Total Hip Arthroplasty|subjects with postoperative pain after total hip arthroplasty
678223|NCT00344032|Double-blind|double-blind
678224|NCT00344032|Human Papillomavirus|human papillomavirus
678225|NCT00344032|Phase IIIb|phase iiib
678226|NCT00344032|Controlled|controlled
678227|NCT00344032|Randomized|randomized
678228|NCT00344032|India|india
678229|NCT00344019|Acute coronary syndrome|acute coronary syndrome
678230|NCT00344019|Percutaneous coronary intervention|percutaneous coronary intervention
678231|NCT00344019|Peri-procedure myocardial infarction|peri-procedure myocardial infarction
678232|NCT00344006|Malaria CDA COARTEM Africa pediatrics children|malaria cda coartem africa pediatrics children
678233|NCT00343993|noninvasive positive pressure ventilation|noninvasive positive pressure ventilation
678234|NCT00343993|acute lung injury|acute lung injury
678235|NCT00343993|acute respiratory distress syndrome|acute respiratory distress syndrome
678236|NCT00343954|sickle cell disease|sickle cell disease
678237|NCT00343941|HIV-1 infection|hiv-1 infection
678238|NCT00343941|Tucaresol|tucaresol
678239|NCT00343941|Viral suppression|viral suppression
678240|NCT00343915|Persistence|persistence
678241|NCT00343915|Hepatitis B vaccine|hepatitis b vaccine
678242|NCT00343902|Hawthorn|hawthorn
678243|NCT00343902|Crataegus|crataegus
678244|NCT00343902|Herbs|herbs
678245|NCT00343889|Diphtheria|diphtheria
678246|NCT00343889|Tetanus|tetanus
678247|NCT00343889|Pertussis|pertussis
678248|NCT00343889|Hepatitis B Hansenula (HB)|hepatitis b hansenula (hb)
678249|NCT00343889|Haemophilus influenzae type b|haemophilus influenzae type b
678250|NCT00343889|Haemophilus Influenzae|haemophilus influenzae
678251|NCT00343876|hs-CRP|hs-crp
678252|NCT00343876|aspirin|aspirin
678253|NCT00343876|clopidogrel|clopidogrel
678254|NCT00343850|idiopathic chronic inflammatory disease of large intestine|idiopathic chronic inflammatory disease of large intestine
678255|NCT00343850|ulcerative colitis|ulcerative colitis
678256|NCT00343850|inactive ulcerative colitis|inactive ulcerative colitis
678257|NCT00343850|chronic disease of large intestine|chronic disease of large intestine
678258|NCT00343850|medication adherence|medication adherence
678259|NCT00343850|Asacol|asacol
678260|NCT00343850|mesalamine|mesalamine
678261|NCT00343824|Burn wounds - Silver Dressings - Bacterial Control|burn wounds - silver dressings - bacterial control
678262|NCT00343811|Attention-Deficit/Hyper Activity Disorder|attention-deficit/hyper activity disorder
678263|NCT00343811|ADHD|adhd
678264|NCT00343759|Breast cancer|breast cancer
678265|NCT00343759|Tyrosine kinase inhibitors|tyrosine kinase inhibitors
678266|NCT00343759|Lapatinib|lapatinib
678267|NCT00343759|Biologic response modifiers|biologic response modifiers
678268|NCT00343759|Magnetic resonance imaging|magnetic resonance imaging
678269|NCT00343759|Treatment-naive, operable|treatment-naive, operable
678270|NCT00343733|diabetic peripheral neuropathy|diabetic peripheral neuropathy
678271|NCT00343733|postherpetic neuralgia|postherpetic neuralgia
678272|NCT00343733|traumatic injury|traumatic injury
678273|NCT00343733|complex regional pain syndrome|complex regional pain syndrome
678274|NCT00343733|back pain|back pain
678275|NCT00343733|neck pain|neck pain
678276|NCT00343733|fibromyalgia|fibromyalgia
678277|NCT00343733|chronic pancreatitis|chronic pancreatitis
678278|NCT00343733|osteoarthritis|osteoarthritis
678279|NCT00343720|VELCADE|velcade
678280|NCT00343720|Alimta|alimta
678281|NCT00343720|locally advanced|locally advanced
678282|NCT00343720|metastatic|metastatic
678283|NCT00343720|non-small cell lung cancer|non-small cell lung cancer
678284|NCT00343720|complete response|complete response
678285|NCT00343720|partial response|partial response
678286|NCT00343720|Locally Advanced or Metastatic Non-Small Cell Lung Cancer|locally advanced or metastatic non-small cell lung cancer
678287|NCT00343707|Social Anxiety Disorder|social anxiety disorder
678288|NCT00343707|brain imaging|brain imaging
678289|NCT00343707|Positron Emission Tomography|positron emission tomography
678290|NCT00343707|antidepressant|antidepressant
678291|NCT00343681|Influenza|influenza
678292|NCT00343681|Orthomyxoviridae Infections|orthomyxoviridae infections
678293|NCT00343681|Orthomyxoviruses|orthomyxoviruses
678294|NCT00343681|Split-virion influenza vaccine|split-virion influenza vaccine
678295|NCT00343668|advanced gastric cancer|advanced gastric cancer
678296|NCT00343668|First-line therapy|first-line therapy
678297|NCT00343668|S-1|s-1
678298|NCT00343668|irinotecan|irinotecan
678299|NCT00343655|Hypercholesterolemia|hypercholesterolemia
678300|NCT00343642|Crohn's disease|crohn's disease
678301|NCT00343642|Fructooligosaccharide|fructooligosaccharide
678302|NCT00343642|Inulin|inulin
678303|NCT00343642|Diet|diet
678304|NCT00343642|Treatment|treatment
678305|NCT00343642|Bacterial flora|bacterial flora
678306|NCT00343642|Oxidative stress|oxidative stress
678307|NCT00343629|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
678308|NCT00343616|cognitive/functional effects|cognitive/functional effects
678309|NCT00343616|fatigue|fatigue
678310|NCT00343616|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
678311|NCT00343616|stage I breast cancer|stage i breast cancer
678312|NCT00343616|stage II breast cancer|stage ii breast cancer
678313|NCT00343616|stage IIIA breast cancer|stage iiia breast cancer
678314|NCT00343603|maculopathy|maculopathy
678315|NCT00343577|proteinuria|proteinuria
678316|NCT00343577|ARBs|arbs
678317|NCT00343577|agalsidase-beta|agalsidase-beta
678318|NCT00343577|MDRD estimated GFR|mdrd estimated gfr
678319|NCT00343577|Chronic kidney disease|chronic kidney disease
678320|NCT00343551|Hypertension, ambulatory blood pressure, missed dose, aliskiren|hypertension, ambulatory blood pressure, missed dose, aliskiren
678321|NCT00343525|HCV|hcv
678322|NCT00343525|monoclonal antibody|monoclonal antibody
678323|NCT00343525|phase 1|phase 1
678324|NCT00343512|inflammatory breast cancer|inflammatory breast cancer
678325|NCT00343512|stage II breast cancer|stage ii breast cancer
678326|NCT00343512|stage IIIA breast cancer|stage iiia breast cancer
678327|NCT00343512|stage IIIB breast cancer|stage iiib breast cancer
678328|NCT00343512|stage IIIC breast cancer|stage iiic breast cancer
678329|NCT00343499|atrial fibrillation|atrial fibrillation
678330|NCT00343499|valsartan|valsartan
678331|NCT00343499|sinus rhythm|sinus rhythm
678332|NCT00343499|persistent atrial fibrillation undergoing electrical cardioversion to restore normal sinus rhythm|persistent atrial fibrillation undergoing electrical cardioversion to restore normal sinus rhythm
678333|NCT00343486|Overactive Bladder|overactive bladder
678334|NCT00343473|Fuch's dystrophy|fuch's dystrophy
678335|NCT00343473|corneal disorders|corneal disorders
678336|NCT00343473|cornea|cornea
678337|NCT00343473|lasik|lasik
678338|NCT00343473|refractive surgery|refractive surgery
678339|NCT00343460|nausea and vomiting|nausea and vomiting
678340|NCT00343460|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
678341|NCT00343447|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
678342|NCT00343447|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
678343|NCT00343447|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
678344|NCT00343447|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
678345|NCT00343434|stage I breast cancer|stage i breast cancer
678346|NCT00343434|stage II breast cancer|stage ii breast cancer
678347|NCT00343434|stage IIIA breast cancer|stage iiia breast cancer
678348|NCT00343434|stage IIIB breast cancer|stage iiib breast cancer
678349|NCT00343434|stage IIIC breast cancer|stage iiic breast cancer
678350|NCT00343434|obesity|obesity
678351|NCT00343421|Diphtheria|diphtheria
678352|NCT00343421|Tetanus|tetanus
678353|NCT00343421|Pertussis|pertussis
678354|NCT00343421|Poliomyelitis|poliomyelitis
678355|NCT00343421|Haemophilus influenzae type b|haemophilus influenzae type b
678356|NCT00343421|Pneumococcal infections|pneumococcal infections
678357|NCT00343408|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
678358|NCT00343408|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
678359|NCT00343408|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
678360|NCT00343408|recurrent colon cancer|recurrent colon cancer
678361|NCT00343408|stage III colon cancer|stage iii colon cancer
678362|NCT00343408|stage IV colon cancer|stage iv colon cancer
678363|NCT00343408|recurrent rectal cancer|recurrent rectal cancer
678364|NCT00343408|stage III rectal cancer|stage iii rectal cancer
678365|NCT00343408|stage IV rectal cancer|stage iv rectal cancer
678366|NCT00343395|rosiglitazone|rosiglitazone
678367|NCT00343395|metformin|metformin
678368|NCT00343395|hs-CRP|hs-crp
678369|NCT00343395|inflammation|inflammation
678370|NCT00343382|sexuality and reproductive issues|sexuality and reproductive issues
678371|NCT00343382|sexual dysfunction|sexual dysfunction
678372|NCT00343382|recurrent breast cancer|recurrent breast cancer
678373|NCT00343382|stage I breast cancer|stage i breast cancer
678374|NCT00343382|stage II breast cancer|stage ii breast cancer
678375|NCT00343382|stage IIIA breast cancer|stage iiia breast cancer
678376|NCT00343382|stage IIIB breast cancer|stage iiib breast cancer
678377|NCT00343382|stage IIIC breast cancer|stage iiic breast cancer
678378|NCT00343382|stage IV breast cancer|stage iv breast cancer
678379|NCT00343369|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
678380|NCT00343369|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
678381|NCT00343369|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
678382|NCT00343369|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
678383|NCT00343356|Bladder neoplasm;|bladder neoplasm;
678384|NCT00343356|Carcinoma;|carcinoma;
678385|NCT00343356|Epirubicin;|epirubicin;
678386|NCT00343356|BCG;|bcg;
678387|NCT00343356|Perfusion|perfusion
678388|NCT00343317|puerperal sepsis|puerperal sepsis
678389|NCT00343317|HIV infection|hiv infection
678390|NCT00343317|prophylactic antibiotics|prophylactic antibiotics
678391|NCT00343304|Stroke.Robot.Ergometer.Group OT|stroke.robot.ergometer.group ot
678392|NCT00343291|Non-Small Cell Lung Cancer|non-small cell lung cancer
678393|NCT00343291|Malignant pleural effusions|malignant pleural effusions
678394|NCT00343278|Valaciclovir Hydrochloride|valaciclovir hydrochloride
678395|NCT00343278|hemodialysis patient|hemodialysis patient
678396|NCT00343278|ALDH|aldh
678397|NCT00343278|pharmacokinetics|pharmacokinetics
678398|NCT00343278|Japanese|japanese
678399|NCT00343265|Preterm birth|preterm birth
678400|NCT00343265|Multiple pregnancy|multiple pregnancy
678401|NCT00343265|Vaginal progesterone|vaginal progesterone
678402|NCT00343265|Preterm birth in multiple pregnancy|preterm birth in multiple pregnancy
678403|NCT00343226|Basiliximab, transplantation, liver, renal function|basiliximab, transplantation, liver, renal function
678404|NCT00343213|Prognostic value of p16INK4a|prognostic value of p16ink4a
678405|NCT00343213|CIN 1|cin 1
678406|NCT00343213|LSIL|lsil
678407|NCT00343213|HPV|hpv
678408|NCT00343187|Tarceva|tarceva
678409|NCT00343187|Rash|rash
678410|NCT00343187|EGFR-1 Rash|egfr-1 rash
678411|NCT00343187|erlotinib|erlotinib
678412|NCT00343187|Aczone|aczone
678413|NCT00343187|Dapsone|dapsone
678414|NCT00343187|Non-small Cell Lung Cancer|non-small cell lung cancer
678415|NCT00343187|subjects treated with Tarceva for non-small cell lung cancer (NSCLC) who subsequently develop a rash suspected to be related to Tarceva|subjects treated with tarceva for non-small cell lung cancer (nsclc) who subsequently develop a rash suspected to be related to tarceva
678416|NCT00343174|stroke|stroke
678417|NCT00343174|vascular diseases|vascular diseases
678418|NCT00343161|Nexium|nexium
678419|NCT00343135|Skin|skin
678420|NCT00343135|AUGMENTIN|augmentin
678421|NCT00343135|1gm|1gm
678422|NCT00343135|Soft|soft
678423|NCT00343135|tissue|tissue
678424|NCT00343135|Infections|infections
678425|NCT00343122|liver|liver
678426|NCT00343122|cirrhosis|cirrhosis
678427|NCT00343122|hepatopulmonary syndrome|hepatopulmonary syndrome
678428|NCT00343096|intranasal|intranasal
678429|NCT00343096|buccal|buccal
678430|NCT00343096|lorazepam|lorazepam
678431|NCT00343096|paediatric|paediatric
678432|NCT00343096|convulsions|convulsions
678433|NCT00343083|Head and Neck Neoplasms|head and neck neoplasms
678434|NCT00343044|platinum resistant ovarian cancer|platinum resistant ovarian cancer
678435|NCT00343044|recurrent ovarian cancer|recurrent ovarian cancer
678436|NCT00343044|platinum resistant cancer|platinum resistant cancer
678437|NCT00343031|Insecticides|insecticides
678438|NCT00343031|Children|children
678439|NCT00343031|Women|women
678440|NCT00343031|Infection|infection
678441|NCT00343031|DDT|ddt
678442|NCT00343031|Contaminant|contaminant
678443|NCT00343018|Preschoolers|preschoolers
678444|NCT00343018|Young Children|young children
678445|NCT00343018|Eyewitness|eyewitness
678446|NCT00343018|Memory|memory
678447|NCT00343005|Blood-Stage|blood-stage
678448|NCT00343005|Investigational|investigational
678449|NCT00343005|Endemic|endemic
678450|NCT00343005|Malaria|malaria
678451|NCT00343005|Vaccine|vaccine
678452|NCT00342992|Vitamin E|vitamin e
678453|NCT00342992|Micronutrients|micronutrients
678454|NCT00342992|Genetics|genetics
678455|NCT00342992|Smoking|smoking
678456|NCT00342992|Biomarkers|biomarkers
678457|NCT00342966|Metabolism|metabolism
678458|NCT00342966|Tracer Studies|tracer studies
678459|NCT00342966|Chemoprevention|chemoprevention
678460|NCT00342966|Selenomethionine|selenomethionine
678461|NCT00342966|Plasma Selenoproteins|plasma selenoproteins
678462|NCT00342953|saline|saline
678463|NCT00342953|silicone|silicone
678464|NCT00342953|Breast Implants|breast implants
678465|NCT00342953|augmentation mammoplasty|augmentation mammoplasty
678466|NCT00342953|visk|visk
678467|NCT00342940|influenza|influenza
678468|NCT00342940|influenza vaccine|influenza vaccine
678469|NCT00342940|flu|flu
678470|NCT00342940|vaccination|vaccination
678471|NCT00342940|immunogenicity|immunogenicity
678472|NCT00342927|American Indians|american indians
678473|NCT00342927|Complications|complications
678474|NCT00342927|Genetics|genetics
678475|NCT00342927|Linkage|linkage
678476|NCT00342927|Type 2 Diabetes|type 2 diabetes
678477|NCT00342927|Diabetic Kidney Disease|diabetic kidney disease
678478|NCT00342888|Childhood Cancer|childhood cancer
678479|NCT00342888|Pesticides|pesticides
678480|NCT00342888|Polychlorinated Biphenyls|polychlorinated biphenyls
678481|NCT00342888|Organochlorines|organochlorines
678482|NCT00342888|Polybrominated Diphenyl Ethers|polybrominated diphenyl ethers
678483|NCT00342875|Bladder Cancer|bladder cancer
678484|NCT00342875|Exposure|exposure
678485|NCT00342875|Drinking Water|drinking water
678486|NCT00342862|Pregnancy|pregnancy
678487|NCT00342862|Amevive|amevive
678488|NCT00342862|alefacept|alefacept
678489|NCT00342862|Registry|registry
678490|NCT00342862|Psoriasis|psoriasis
678491|NCT00342849|Clinical Trial|clinical trial
678492|NCT00342849|Low-level Lead Poisoning|low-level lead poisoning
678493|NCT00342849|Chelation|chelation
678494|NCT00342849|Developmental Assessment|developmental assessment
678495|NCT00342849|Succimer|succimer
678496|NCT00342836|Akt|akt
678497|NCT00342836|Immunohistochemistry|immunohistochemistry
678498|NCT00342836|Myoinositol|myoinositol
678499|NCT00342836|Bronchial Specimens|bronchial specimens
678500|NCT00342836|Phosphorylation|phosphorylation
678501|NCT00342823|Linkage Analysis|linkage analysis
678502|NCT00342823|Canidate Gene Analysis|canidate gene analysis
678503|NCT00342823|Genome Scan|genome scan
678504|NCT00342823|L. Chagasi|l. chagasi
678505|NCT00342823|Visceral Leishmania|visceral leishmania
678506|NCT00342810|Eye Diseases|eye diseases
678507|NCT00342797|second primary cancer|second primary cancer
678508|NCT00342797|retinoblastoma|retinoblastoma
678619|NCT00342433|Tissue|tissue
678509|NCT00342797|RB1 germline mutation|rb1 germline mutation
678510|NCT00342784|Mutation|mutation
678511|NCT00342784|Cancer Genetics|cancer genetics
678512|NCT00342771|Tobacco Use|tobacco use
678513|NCT00342771|Tumor Biology|tumor biology
678514|NCT00342771|Biomarker|biomarker
678515|NCT00342771|Risk Factor|risk factor
678516|NCT00342771|Health Disparity|health disparity
678517|NCT00342758|Asthma|asthma
678518|NCT00342758|Wheeze|wheeze
678519|NCT00342758|Environment|environment
678520|NCT00342758|Diet|diet
678521|NCT00342758|Infection|infection
678522|NCT00342732|Genetics|genetics
678523|NCT00342732|Fat Intake|fat intake
678524|NCT00342732|Pima Indians|pima indians
678525|NCT00342732|Weight Control|weight control
678526|NCT00342732|Appetite Control|appetite control
678527|NCT00342706|Teen Pregnancy|teen pregnancy
678528|NCT00342706|Short Inter-Pregnancy Intervals|short inter-pregnancy intervals
678529|NCT00342693|Radiation|radiation
678530|NCT00342693|Screening|screening
678531|NCT00342693|Cancer|cancer
678532|NCT00342693|Nodules|nodules
678533|NCT00342693|Nuclear|nuclear
678534|NCT00342693|Thyroid Screening|thyroid screening
678535|NCT00342693|Thyroid Gland|thyroid gland
678536|NCT00342667|Preterm Birth|preterm birth
678537|NCT00342667|Predictors of Outcome|predictors of outcome
678538|NCT00342667|Neonatal/Infant Complications|neonatal/infant complications
678539|NCT00342667|Neurologic Development|neurologic development
678540|NCT00342667|(SqrRoot) mniotic Fluid|(sqrroot) mniotic fluid
678541|NCT00342667|Cerebral Palsy|cerebral palsy
678542|NCT00342667|Risk Factors|risk factors
678543|NCT00342654|Epidemiology|epidemiology
678544|NCT00342654|Cancer|cancer
678545|NCT00342654|Environment|environment
678546|NCT00342654|Genetics|genetics
678547|NCT00342654|Nutrition|nutrition
678548|NCT00342641|Lymphoma|lymphoma
678549|NCT00342641|Multiple Myeloma|multiple myeloma
678550|NCT00342641|Thyroiditis|thyroiditis
678551|NCT00342641|Cohort Study|cohort study
678552|NCT00342641|Record linkage study|record linkage study
678553|NCT00342641|Hepatitis C|hepatitis c
678554|NCT00342628|Antibody|antibody
678555|NCT00342628|Reactions|reactions
678556|NCT00342628|Vaccine|vaccine
678557|NCT00342628|Conjugate Vaccine|conjugate vaccine
678558|NCT00342628|Typhoid Fever|typhoid fever
678559|NCT00342628|Trial|trial
678560|NCT00342628|Safety|safety
678561|NCT00342628|Immunogenicity|immunogenicity
678562|NCT00342628|Comparability|comparability
678563|NCT00342628|DTP|dtp
678564|NCT00342602|JC Virus|jc virus
678565|NCT00342602|Opportunistic Infection|opportunistic infection
678566|NCT00342602|Single Nucleotide Polymorphism|single nucleotide polymorphism
678567|NCT00342602|Genotype|genotype
678568|NCT00342602|Sequencing|sequencing
678569|NCT00342589|Pneumocystis|pneumocystis
678570|NCT00342589|HIV|hiv
678571|NCT00342589|Oral Wash|oral wash
678572|NCT00342589|PCR|pcr
678573|NCT00342589|Drug Resistance|drug resistance
678574|NCT00342576|Filarial Parasites|filarial parasites
678575|NCT00342576|Wuchereria Bancrofti|wuchereria bancrofti
678576|NCT00342576|Brugia Malayi|brugia malayi
678577|NCT00342576|Diethylcarbamazine (DEC)|diethylcarbamazine (dec)
678578|NCT00342576|Ivermectin|ivermectin
678579|NCT00342563|mecamylamine|mecamylamine
678580|NCT00342563|treatment|treatment
678581|NCT00342563|alcohol dependence|alcohol dependence
678582|NCT00342563|smoking|smoking
678583|NCT00342550|Pregnancy|pregnancy
678584|NCT00342550|Preterm Birth|preterm birth
678585|NCT00342550|Pregnancy Complications|pregnancy complications
678586|NCT00342537|Pathology|pathology
678587|NCT00342537|Genetics|genetics
678588|NCT00342537|Testicular Cancer|testicular cancer
678589|NCT00342537|Familial|familial
678590|NCT00342537|Cancer Epidemiology|cancer epidemiology
678591|NCT00342524|IVIG|ivig
678592|NCT00342524|Plasmapheresis|plasmapheresis
678593|NCT00342524|Blood Collection|blood collection
678594|NCT00342524|Immune Globulin|immune globulin
678595|NCT00342524|Severe Acute Respiratory Syndrome|severe acute respiratory syndrome
678596|NCT00342524|SARS|sars
678597|NCT00342511|Pap|pap
678598|NCT00342511|Hybrid Capture 2|hybrid capture 2
678599|NCT00342511|HSIL|hsil
678600|NCT00342511|Colposcopy|colposcopy
678601|NCT00342511|CIN|cin
678602|NCT00342511|Specimen Collection|specimen collection
678603|NCT00342498|DNA|dna
678604|NCT00342498|Hormone|hormone
678605|NCT00342498|Resistance|resistance
678606|NCT00342498|Skeleton|skeleton
678607|NCT00342485|Cellular Immunity|cellular immunity
678608|NCT00342485|HIV-infected|hiv-infected
678609|NCT00342485|Immune Deficiency|immune deficiency
678610|NCT00342485|Cancer|cancer
678611|NCT00342485|Transplantation|transplantation
678612|NCT00342472|Esophageal Cancer|esophageal cancer
678613|NCT00342472|Polycyclic Aromatic Hydrocarbons|polycyclic aromatic hydrocarbons
678614|NCT00342446|GONADOTROPIN|gonadotropin
678615|NCT00342446|CLOMIPHENE|clomiphene
678616|NCT00342446|Ovulation-Stimulating Drugs|ovulation-stimulating drugs
678617|NCT00342433|Androgens|androgens
678618|NCT00342433|Serum|serum
678620|NCT00342407|Cancer Risk|cancer risk
678621|NCT00342407|Cosmic Radiation|cosmic radiation
678622|NCT00342407|Airlines|airlines
678623|NCT00342407|Flight Attendants|flight attendants
678624|NCT00342407|Circadian Rhythm|circadian rhythm
678625|NCT00342394|Biological Monitoring|biological monitoring
678626|NCT00342394|Exposure Determinants|exposure determinants
678627|NCT00342394|Exposure Validation|exposure validation
678628|NCT00342394|Occupational Exposure|occupational exposure
678629|NCT00342394|Pesticides|pesticides
678630|NCT00342394|Agriculture|agriculture
678631|NCT00342381|Motor fatigue|motor fatigue
678632|NCT00342381|Cognitive fatigue|cognitive fatigue
678633|NCT00342368|CPAP|cpap
678634|NCT00342368|ARDS|ards
678635|NCT00342368|ALI|ali
678636|NCT00342368|Hypoxemia|hypoxemia
678637|NCT00342368|Intubation|intubation
678638|NCT00342355|Protease Inhibitors|protease inhibitors
678639|NCT00342355|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
678640|NCT00342355|AIDS|aids
678641|NCT00342355|Opportunistic Infections|opportunistic infections
678642|NCT00342355|Resource-Poor|resource-poor
678643|NCT00342342|Genetics|genetics
678644|NCT00342329|Case-Control|case-control
678645|NCT00342329|Hydrocarbons|hydrocarbons
678646|NCT00342329|Metals|metals
678647|NCT00342329|Silica|silica
678648|NCT00342329|Tobacco Smoke|tobacco smoke
678649|NCT00342329|Lupus Nephritis|lupus nephritis
678650|NCT00342329|Environmental Exposures|environmental exposures
678651|NCT00342329|Occupational Exposures|occupational exposures
678652|NCT00342316|Acute Myeloid Leukemia|acute myeloid leukemia
678653|NCT00342316|Stem Cell Transplantation|stem cell transplantation
678654|NCT00342316|Reduced Intensity Conditioning|reduced intensity conditioning
678655|NCT00342316|Survival|survival
678656|NCT00342316|Relapse|relapse
678657|NCT00342303|Premature Infants|premature infants
678658|NCT00342303|Fatty Acid Metabolism|fatty acid metabolism
678659|NCT00342303|Polyunsaturated Fatty Acids|polyunsaturated fatty acids
678660|NCT00342303|Infant Formula|infant formula
678661|NCT00342303|Gas-chromatography|gas-chromatography
678662|NCT00342303|Mass Spectrometry|mass spectrometry
678663|NCT00342290|Pathophysiological Volume Measurement|pathophysiological volume measurement
678664|NCT00342290|Power Doppler Ultrasound|power doppler ultrasound
678665|NCT00342290|Prediction of Adverse Pregnancy Outcome|prediction of adverse pregnancy outcome
678666|NCT00342290|Subchorionic Hemorrhage|subchorionic hemorrhage
678667|NCT00342277|Premature Rupture of Membranes|premature rupture of membranes
678668|NCT00342277|Genetic Risk Factors|genetic risk factors
678669|NCT00342277|Tissue Specific Expression|tissue specific expression
678670|NCT00342277|Quantitative Real Time PCR|quantitative real time pcr
678671|NCT00342277|Preterm Birth|preterm birth
678672|NCT00342277|Expression Profiling|expression profiling
678673|NCT00342277|Microarrays|microarrays
678674|NCT00342264|Lung Cancer|lung cancer
678675|NCT00342264|Smoking|smoking
678676|NCT00342264|Diesel Exhaust|diesel exhaust
678677|NCT00342251|Macular Degeneration|macular degeneration
678678|NCT00342251|Retinal Images|retinal images
678679|NCT00342251|Risk Factors|risk factors
678680|NCT00342251|Linkage Analysis|linkage analysis
678681|NCT00342251|Gene|gene
678682|NCT00342251|Mutation|mutation
678683|NCT00342225|Observation|observation
678684|NCT00342225|Mothers|mothers
678685|NCT00342225|Description|description
678686|NCT00342212|Walking|walking
678687|NCT00342212|Jogging|jogging
678688|NCT00342212|Bridging Study|bridging study
678689|NCT00342212|Data Comparability|data comparability
678690|NCT00342212|Healthy Adults|healthy adults
678691|NCT00342212|Healthy Volunteer|healthy volunteer
678692|NCT00342212|HV|hv
678693|NCT00342199|Incidence|incidence
678694|NCT00342199|Prevalence|prevalence
678695|NCT00342199|Immunity|immunity
678696|NCT00342199|Bacteriology|bacteriology
678697|NCT00342199|Pathogenesis|pathogenesis
678698|NCT00342186|China|china
678699|NCT00342186|Cancer|cancer
678700|NCT00342186|Hepatitis B|hepatitis b
678701|NCT00342186|Genetics|genetics
678702|NCT00342186|Liver Disease|liver disease
678703|NCT00342186|HBV|hbv
678704|NCT00342173|Cervix|cervix
678705|NCT00342173|Natural History|natural history
678706|NCT00342173|Neoplasia|neoplasia
678707|NCT00342173|HPV|hpv
678708|NCT00342173|Costa Rica|costa rica
678709|NCT00342160|AIDS|aids
678710|NCT00342160|HIV Infectiousness|hiv infectiousness
678711|NCT00342160|Immunity|immunity
678712|NCT00342160|CTL|ctl
678713|NCT00342160|Epidemiology|epidemiology
678714|NCT00342147|EBV|ebv
678715|NCT00342147|NPC|npc
678716|NCT00342134|Demyelination|demyelination
678717|NCT00342134|Inflammation|inflammation
678718|NCT00342134|Immunosuppression|immunosuppression
678719|NCT00342134|Autoimmunity|autoimmunity
678720|NCT00342134|Bone Marrow|bone marrow
678721|NCT00342134|Multiple Sclerosis|multiple sclerosis
678722|NCT00342121|Cancer|cancer
678723|NCT00342121|NHL|nhl
678724|NCT00342121|Pesticides|pesticides
678725|NCT00342121|Atrazine|atrazine
678726|NCT00342121|Organophosphates|organophosphates
678727|NCT00342121|Cancer Risk|cancer risk
678728|NCT00342121|Normal Control|normal control
678729|NCT00342095|Autoimmune Diseases|autoimmune diseases
678730|NCT00342095|Estrogen|estrogen
678731|NCT00342095|Silica|silica
678732|NCT00342095|Pesticides|pesticides
678733|NCT00342095|Major Histocompatibility Complex|major histocompatibility complex
678734|NCT00342095|Genetic Susceptibility|genetic susceptibility
678735|NCT00342082|Zidovudine|zidovudine
678736|NCT00342082|HIV|hiv
678737|NCT00342082|Cord Blood|cord blood
678738|NCT00342069|Decision Making|decision making
678739|NCT00342069|Genetic Counseling|genetic counseling
678740|NCT00342069|Pregnancy Options|pregnancy options
678741|NCT00342069|Attitudes Toward Reproductive Options|attitudes toward reproductive options
678742|NCT00342069|Beliefs About Down Syndrome Risk|beliefs about down syndrome risk
678743|NCT00342069|Down Syndrome Risk|down syndrome risk
678744|NCT00342069|Pregnancy|pregnancy
678745|NCT00342056|Pharmacogenetics|pharmacogenetics
678746|NCT00342056|Transporter Proteins|transporter proteins
678747|NCT00342056|Drug Exposure|drug exposure
678748|NCT00342056|Imatinib|imatinib
678749|NCT00342056|Retrospective|retrospective
678750|NCT00342056|Cancer|cancer
678751|NCT00342043|Sickle Trait|sickle trait
678752|NCT00342043|Fetal Hemoglobin|fetal hemoglobin
678753|NCT00342043|Hemoglobin C|hemoglobin c
678754|NCT00342043|Beta-Thalassemia|beta-thalassemia
678755|NCT00342043|Artesunate-Amodiaquine|artesunate-amodiaquine
678756|NCT00342030|Respiratory|respiratory
678757|NCT00342030|Polymorphism|polymorphism
678758|NCT00342030|Fruit|fruit
678759|NCT00342030|COPD|copd
678760|NCT00342030|Prospective|prospective
678761|NCT00342030|Diet|diet
678762|NCT00342017|Filarial Infections|filarial infections
678763|NCT00342017|Helminths|helminths
678764|NCT00342017|Tuberculosis|tuberculosis
678765|NCT00342017|Filarial Infection|filarial infection
678766|NCT00342004|Shanghai|shanghai
678767|NCT00342004|Residential History|residential history
678768|NCT00342004|Exposure Assessment|exposure assessment
678769|NCT00342004|Cohort Study|cohort study
678770|NCT00342004|Molecular Epidemiology|molecular epidemiology
678771|NCT00341991|DNA Repair|dna repair
678772|NCT00341991|Genes|genes
678773|NCT00341991|Pigmentation|pigmentation
678774|NCT00341991|Skin Cancer|skin cancer
678775|NCT00341991|Sun Exposure|sun exposure
678776|NCT00341965|DDT|ddt
678777|NCT00341965|DDE|dde
678778|NCT00341965|Androgen Levels|androgen levels
678779|NCT00341965|Farming|farming
678780|NCT00341965|Antiandrogen|antiandrogen
678781|NCT00341952|Case-Control Study|case-control study
678782|NCT00341952|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
678783|NCT00341939|Drug Therapy|drug therapy
678784|NCT00341939|Pharmacogenetics|pharmacogenetics
678785|NCT00341939|Cancer|cancer
678786|NCT00341939|Pharmacodynamics|pharmacodynamics
678787|NCT00341939|Parmacokinetics|parmacokinetics
678788|NCT00341913|Research|research
678789|NCT00341913|Repository|repository
678790|NCT00341913|Registry|registry
678791|NCT00341913|Surveillance|surveillance
678792|NCT00341913|Databases|databases
678793|NCT00341900|Chromosome Translocations|chromosome translocations
678794|NCT00341900|Cosmic Radiation|cosmic radiation
678795|NCT00341900|Airline Flight Crew|airline flight crew
678796|NCT00341900|Airlines|airlines
678797|NCT00341900|Flight Crew|flight crew
678798|NCT00341900|Occupational Exposure|occupational exposure
678799|NCT00341887|Screening|screening
678800|NCT00341887|AIDS|aids
678801|NCT00341887|Antiretrovirals|antiretrovirals
678802|NCT00341887|Military|military
678803|NCT00341887|Force readiness|force readiness
678804|NCT00341874|DNA Mutations|dna mutations
678805|NCT00341874|Genetic Variation|genetic variation
678806|NCT00341874|GENETIC LINKAGE|genetic linkage
678807|NCT00341874|Gene Expression Patterns|gene expression patterns
678808|NCT00341874|Hereditary Hearing Disorder|hereditary hearing disorder
678809|NCT00341861|Bladder Cancer|bladder cancer
678810|NCT00341861|Occupational and Environmental Risks|occupational and environmental risks
678811|NCT00341861|Lifestyle Factors|lifestyle factors
678812|NCT00341861|Epidemiology|epidemiology
678813|NCT00341861|Genetic Susceptibility|genetic susceptibility
678814|NCT00341848|Apoptosis|apoptosis
678815|NCT00341848|Environment|environment
678816|NCT00341848|Infection|infection
678817|NCT00341848|Inflammation|inflammation
678818|NCT00341848|Leiomyoma|leiomyoma
678819|NCT00341848|Uterine Leiomyoma|uterine leiomyoma
678820|NCT00341848|Uterus|uterus
678821|NCT00341835|Linkage Analysis|linkage analysis
678822|NCT00341835|Cancer Susceptibility Alleles|cancer susceptibility alleles
678823|NCT00341835|Cancer Genetics|cancer genetics
678824|NCT00341835|Linkage Mapping|linkage mapping
678825|NCT00341835|Linkage Disequilibrium|linkage disequilibrium
678826|NCT00341822|Amniocentesis|amniocentesis
678827|NCT00341822|Chorionic Villus Sampling|chorionic villus sampling
678828|NCT00341822|Fertility|fertility
678829|NCT00341822|Genetic Counseling|genetic counseling
678830|NCT00341822|Decisional Conflict|decisional conflict
678831|NCT00341822|Prenatal Testing|prenatal testing
678832|NCT00341822|Questionnaire|questionnaire
678833|NCT00341809|Natural Killer Cells|natural killer cells
678834|NCT00341809|Autoimmune Disease|autoimmune disease
678835|NCT00341809|Chronic Inflammation|chronic inflammation
678836|NCT00341809|Two-Locus Interaction|two-locus interaction
678837|NCT00341809|Allele/Haplotype Analysis|allele/haplotype analysis
678838|NCT00341796|AIDS|aids
678839|NCT00341796|HIV|hiv
678840|NCT00341796|Perinatal|perinatal
678841|NCT00341796|Transmission|transmission
678842|NCT00341796|Antiretroviral|antiretroviral
678843|NCT00341796|Outcomes|outcomes
678844|NCT00341783|Plasmodium|plasmodium
678845|NCT00341783|Falciparum|falciparum
678846|NCT00341783|Screening|screening
678847|NCT00341783|Malaria|malaria
678848|NCT00341757|Family Reports|family reports
678849|NCT00341757|Cancer|cancer
678850|NCT00341757|Questionnaire|questionnaire
678851|NCT00341757|Validity|validity
678852|NCT00341757|Surveillance|surveillance
678853|NCT00341744|Vision|vision
678854|NCT00341744|Aids|aids
678855|NCT00341731|Cystic Ovaries|cystic ovaries
678856|NCT00341731|Environmental Factors|environmental factors
678857|NCT00341731|Heritability|heritability
678858|NCT00341731|Hyperandrogenism|hyperandrogenism
678859|NCT00341731|Twin Study|twin study
678860|NCT00341718|Interview|interview
678861|NCT00341718|Genetics|genetics
678862|NCT00341705|AIDS|aids
678864|NCT00341705|Hepatitis C Virus|hepatitis c virus
678865|NCT00341705|HIV|hiv
678866|NCT00341705|Natural History|natural history
678867|NCT00341705|Hemophilia|hemophilia
678868|NCT00341705|Hepatitis C|hepatitis c
678869|NCT00341692|Mammary|mammary
678870|NCT00341692|Development|development
678871|NCT00341692|Cancer|cancer
678872|NCT00341692|Risk|risk
678873|NCT00341692|Genes|genes
678874|NCT00341679|Autoimmune Diseases|autoimmune diseases
678875|NCT00341679|Genetic Risk Factors|genetic risk factors
678876|NCT00341679|Polymyositis|polymyositis
678877|NCT00341679|Dermatomyositis|dermatomyositis
678878|NCT00341679|Connective Tissue Disorders|connective tissue disorders
678879|NCT00341679|Idiopathic Inflammatory Myopathies|idiopathic inflammatory myopathies
678880|NCT00341679|Inclusion Body Myositis|inclusion body myositis
678881|NCT00341679|Pathogenesis|pathogenesis
678882|NCT00341679|Environmental Risk Factor|environmental risk factor
678883|NCT00341679|IIM|iim
678884|NCT00341666|Immune Regulation|immune regulation
678885|NCT00341666|Co-Infection|co-infection
678886|NCT00341666|Filariasis|filariasis
678887|NCT00341666|Immunology|immunology
678888|NCT00341666|Filarial Infection|filarial infection
678889|NCT00341653|Asthma|asthma
678890|NCT00341653|Pulmonary Function|pulmonary function
678891|NCT00341653|Air Pollution|air pollution
678892|NCT00341653|Genetic Polymorphism|genetic polymorphism
678893|NCT00341653|Environmental Tobacco Agents|environmental tobacco agents
678894|NCT00341640|Teen Pregnancy|teen pregnancy
678895|NCT00341627|Bone Tumor|bone tumor
678896|NCT00341627|Familial Chordoma|familial chordoma
678897|NCT00341627|Gene Mapping|gene mapping
678898|NCT00341627|Genetics|genetics
678899|NCT00341627|Sporadic Chordoma|sporadic chordoma
678900|NCT00341614|Exercise|exercise
678901|NCT00341614|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
678902|NCT00341614|Postmenopause|postmenopause
678903|NCT00341614|Diet|diet
678904|NCT00341601|Mycobacterium Tuberculosis|mycobacterium tuberculosis
678905|NCT00341601|TLR-2|tlr-2
678906|NCT00341601|Recurrent Tuberculosis|recurrent tuberculosis
678907|NCT00341601|Phenolic Glycolipid|phenolic glycolipid
678908|NCT00341601|mRNA Expression Profiles|mrna expression profiles
678909|NCT00341588|Testicular Cancer|testicular cancer
678910|NCT00341588|Epidemiology|epidemiology
678911|NCT00341588|Testicular Germ Cell Cancer|testicular germ cell cancer
678912|NCT00341588|TGCT|tgct
678913|NCT00341588|Healthy Volunteer|healthy volunteer
678914|NCT00341575|Family Systems|family systems
678915|NCT00341575|Communication|communication
678916|NCT00341575|Information Diffusion|information diffusion
678917|NCT00341575|Social Networks|social networks
678918|NCT00341575|Family Dynamics|family dynamics
678919|NCT00341562|Gene Expression Profiling|gene expression profiling
678920|NCT00341562|Vascular Disease|vascular disease
678921|NCT00341549|Linkage|linkage
678922|NCT00341549|Genetics|genetics
678923|NCT00341549|Mapping|mapping
678924|NCT00341549|Gene|gene
678925|NCT00341549|Susceptibility|susceptibility
678926|NCT00341549|Myopia|myopia
678927|NCT00341549|Nearsightedness|nearsightedness
678928|NCT00341549|Refraction|refraction
678929|NCT00341549|Eye|eye
678930|NCT00341536|Diet|diet
678931|NCT00341536|Pilot|pilot
678932|NCT00341536|Cohort|cohort
678933|NCT00341536|Environmental|environmental
678934|NCT00341536|Chronic Disease|chronic disease
678935|NCT00341523|Cytology|cytology
678936|NCT00341523|Endoscopy|endoscopy
678937|NCT00341523|Esophageal Cancer|esophageal cancer
678938|NCT00341523|Early Detection|early detection
678939|NCT00341523|Treatment|treatment
678940|NCT00341510|Risk Behavior|risk behavior
678941|NCT00341510|Health Status|health status
678942|NCT00341510|Adolescence|adolescence
678943|NCT00341510|Positive Health Behaviors|positive health behaviors
678944|NCT00341510|Social Support|social support
678945|NCT00341510|Health Behavior|health behavior
678946|NCT00341510|Survey|survey
678947|NCT00341497|Leukoplakia|leukoplakia
678948|NCT00341497|Oral Mucosa|oral mucosa
678949|NCT00341497|Biomarkers|biomarkers
678950|NCT00341484|Genetics|genetics
678951|NCT00341484|Liver Cancer|liver cancer
678952|NCT00341484|HIV|hiv
678953|NCT00341471|School|school
678954|NCT00341471|Sixth Grade|sixth grade
678955|NCT00341471|Curricular|curricular
678956|NCT00341471|Howard University|howard university
678957|NCT00341471|D.C.|d.c.
678958|NCT00341471|Adolescent Pregnancy|adolescent pregnancy
678959|NCT00341471|Intervention|intervention
678960|NCT00341458|Breast Cancer|breast cancer
678961|NCT00341458|Environment|environment
678962|NCT00341458|Genetics|genetics
678963|NCT00341458|Epidemiology|epidemiology
678964|NCT00341445|Environmental Intervention|environmental intervention
678965|NCT00341445|Indoor Allergens|indoor allergens
678966|NCT00341445|Environment|environment
678967|NCT00341432|NRT Study|nrt study
678968|NCT00341432|Smoking Cessation|smoking cessation
678969|NCT00341419|ABC Transporter|abc transporter
678970|NCT00341419|ABCC6|abcc6
678971|NCT00341419|Slkin Laxity|slkin laxity
678972|NCT00341419|Genetic Association|genetic association
678973|NCT00341419|Angiod Streaks|angiod streaks
678974|NCT00341419|Pseudoxanthoma Elasticum|pseudoxanthoma elasticum
678975|NCT00341419|PXE|pxe
678976|NCT00341406|Obesity|obesity
678977|NCT00341406|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
678978|NCT00341406|Adipose Cell Turn Over|adipose cell turn over
678979|NCT00341393|HIV Infection|hiv infection
678980|NCT00341393|AIDS|aids
678981|NCT00341393|Viral Load|viral load
678982|NCT00341393|Retroviral Treatment|retroviral treatment
678983|NCT00341393|Uganda|uganda
678984|NCT00341380|Cancer|cancer
678985|NCT00341380|Lung Cancer|lung cancer
678986|NCT00341380|Surgical Resection|surgical resection
678987|NCT00341380|Non-Small Cell Lung Cancer|non-small cell lung cancer
678988|NCT00341380|NSCLC|nsclc
678989|NCT00341367|Analgesic|analgesic
678990|NCT00341367|Back Pain|back pain
678991|NCT00341367|Lumbar Disc|lumbar disc
678992|NCT00341367|Nerve|nerve
678993|NCT00341367|Radiculopathy|radiculopathy
678994|NCT00341354|Pneumonia|pneumonia
678995|NCT00341354|Bacterial Infection|bacterial infection
678996|NCT00341354|Nosocomial Infection|nosocomial infection
678997|NCT00341354|Trachea|trachea
678998|NCT00341354|Biofilm|biofilm
678999|NCT00341354|Mucus Shaver|mucus shaver
679000|NCT00341341|Smoking|smoking
679001|NCT00341341|Smoking Cessation|smoking cessation
679002|NCT00341341|GSTM1|gstm1
679003|NCT00341341|Glutathione S. Transferase|glutathione s. transferase
679004|NCT00341341|Lung Cancer|lung cancer
679005|NCT00341341|Smokers|smokers
679006|NCT00341341|Genetic Risk Communication|genetic risk communication
679007|NCT00341328|India|india
679008|NCT00341328|Pulmonary Tuberculosis|pulmonary tuberculosis
679009|NCT00341328|Category-I Pulmonary Tuberculosis|category-i pulmonary tuberculosis
679010|NCT00341328|Immunomodulator|immunomodulator
679011|NCT00341328|Mycobacterium w|mycobacterium w
679012|NCT00341315|Epidemiology|epidemiology
679013|NCT00341315|DDT|ddt
679014|NCT00341315|BMI|bmi
679015|NCT00341315|Serum|serum
679016|NCT00341315|Case-Control Study|case-control study
679017|NCT00341302|HIV|hiv
679018|NCT00341302|AIDS|aids
679019|NCT00341302|Perinatal|perinatal
679020|NCT00341302|Transmission|transmission
679021|NCT00341302|Antiretroviral|antiretroviral
679022|NCT00341302|Outcomes|outcomes
679023|NCT00341289|Submersion|submersion
679024|NCT00341289|Epidemiology|epidemiology
679025|NCT00341289|Fatal|fatal
679026|NCT00341289|Child|child
679027|NCT00341289|Swim|swim
679028|NCT00341289|Drowning|drowning
679029|NCT00341289|Survey|survey
679030|NCT00341276|Esophageal Cancer|esophageal cancer
679031|NCT00341276|Genetics|genetics
679032|NCT00341276|Polymorphism|polymorphism
679033|NCT00341276|Susceptibility Genes|susceptibility genes
679034|NCT00341276|Tumor|tumor
679035|NCT00341263|Twins|twins
679036|NCT00341263|Clinical Research|clinical research
679037|NCT00341263|Endocrinology|endocrinology
679038|NCT00341263|Breast Cancer|breast cancer
679039|NCT00341263|Biochemical Epidemiology|biochemical epidemiology
679040|NCT00341250|Blood Stage|blood stage
679041|NCT00341250|Investigational|investigational
679042|NCT00341250|Endemic|endemic
679043|NCT00341250|Malaria|malaria
679044|NCT00341237|Polymorphism|polymorphism
679045|NCT00341237|Genotype|genotype
679046|NCT00341237|Phenotype|phenotype
679047|NCT00341237|Environmental Factor|environmental factor
679048|NCT00341237|Single Nucleotide Polymorphism|single nucleotide polymorphism
679049|NCT00341224|Aggression|aggression
679050|NCT00341224|Violence|violence
679051|NCT00341224|Adolescents|adolescents
679052|NCT00341224|Randomized Trial|randomized trial
679053|NCT00341224|Behavioral Intervention|behavioral intervention
679054|NCT00341211|AIDS|aids
679055|NCT00341211|Cancer|cancer
679056|NCT00341211|Epidemiology|epidemiology
679057|NCT00341211|Immunology|immunology
679058|NCT00341211|Virology|virology
679059|NCT00341198|Rheumatoid Arthritis|rheumatoid arthritis
679060|NCT00341198|Lupus|lupus
679061|NCT00341198|Scleroderma|scleroderma
679062|NCT00341198|Sjogren's Syndrome|sjogren's syndrome
679063|NCT00341198|Farming|farming
679064|NCT00341198|Autoimmune Disease|autoimmune disease
679065|NCT00341198|Exposure|exposure
679066|NCT00341185|Biodosimetry|biodosimetry
679067|NCT00341185|Dose Reconstruction|dose reconstruction
679068|NCT00341185|Radioactive Fallout|radioactive fallout
679069|NCT00341185|Thyroid Screening|thyroid screening
679070|NCT00341185|Ultrasound|ultrasound
679071|NCT00341172|Retinitis|retinitis
679072|NCT00341172|Cytomegalovirus|cytomegalovirus
679073|NCT00341172|HIV-1|hiv-1
679074|NCT00341172|Polymorphisms|polymorphisms
679075|NCT00341172|HAART|haart
679076|NCT00341159|Breast|breast
679077|NCT00341159|BRCA1|brca1
679078|NCT00341159|BRCA2|brca2
679079|NCT00341159|Inherited|inherited
679080|NCT00341159|Association|association
679081|NCT00341159|Breast Cancer|breast cancer
679082|NCT00341159|Population-Based|population-based
679083|NCT00341159|Cancer Susceptibility Alleles|cancer susceptibility alleles
679084|NCT00341146|Cancer|cancer
679085|NCT00341146|Catonese Chinese|catonese chinese
679086|NCT00341146|Genetic Predisposition|genetic predisposition
679087|NCT00341146|Genotyping|genotyping
679088|NCT00341146|Triad analysis|triad analysis
679089|NCT00341146|Nasopharyngeal Cancer|nasopharyngeal cancer
679090|NCT00341146|NPC|npc
679091|NCT00341133|Laterality|laterality
679092|NCT00341133|Heterotaxy|heterotaxy
679093|NCT00341133|Holoprosencephaly|holoprosencephaly
679094|NCT00341133|Genetic Testing|genetic testing
679095|NCT00341133|Congential Cardiac Malformations|congential cardiac malformations
679096|NCT00341133|Disturbed Internal Organ Positioning|disturbed internal organ positioning
679097|NCT00341120|Genotypes|genotypes
679098|NCT00341120|Mutation|mutation
679099|NCT00341120|Folate|folate
679100|NCT00341120|Male Infertility|male infertility
679101|NCT00341120|Nutrition|nutrition
679102|NCT00341107|Cancer|cancer
679103|NCT00341107|Genes|genes
679104|NCT00341107|Screening|screening
679105|NCT00341107|Primary Care|primary care
679106|NCT00341107|Inherited Susceptibility|inherited susceptibility
679107|NCT00341094|Cohort|cohort
679108|NCT00341094|Radiation|radiation
679109|NCT00341094|In Utero|in utero
679110|NCT00341094|Genomic|genomic
679111|NCT00341081|Short Tandem Repeat|short tandem repeat
679112|NCT00341081|Molecular Epidemiology|molecular epidemiology
679113|NCT00341081|Viral Infection|viral infection
679114|NCT00341081|Mixture Detection|mixture detection
679115|NCT00341081|Intervention & Education|intervention & education
679116|NCT00341081|Intervention|intervention
679117|NCT00341081|Education|education
679118|NCT00341068|Birth Defects|birth defects
679119|NCT00341068|Genetics|genetics
679120|NCT00341068|Folic Acid|folic acid
679121|NCT00341068|Gene-Environment Interactions|gene-environment interactions
679122|NCT00341068|Neural Tube Defects|neural tube defects
679123|NCT00341068|Cleft Lip|cleft lip
679124|NCT00341068|Cleft Palate|cleft palate
679125|NCT00341068|Mutations|mutations
679126|NCT00341055|Anemia|anemia
679127|NCT00341055|Hemoglobin|hemoglobin
679128|NCT00341055|Chemotherapy|chemotherapy
679129|NCT00341055|Epoetin alfa|epoetin alfa
679130|NCT00341042|Normal Values|normal values
679131|NCT00341042|Complete Blood Count|complete blood count
679132|NCT00341042|HIV|hiv
679133|NCT00341042|Tuberculosis|tuberculosis
679134|NCT00341042|Flow Cytometry|flow cytometry
679135|NCT00341029|Longitudinal Study|longitudinal study
679136|NCT00341029|Chromosomal Effects|chromosomal effects
679137|NCT00341029|Sister Chromatid Exchanges|sister chromatid exchanges
679138|NCT00341029|Micronuclei|micronuclei
679139|NCT00341029|Stimulants|stimulants
679140|NCT00341029|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
679141|NCT00341029|ADHD|adhd
679142|NCT00341016|Radiation|radiation
679143|NCT00341003|Plasmodium Falciparum|plasmodium falciparum
679144|NCT00341003|Hemoglobin E|hemoglobin e
679145|NCT00341003|Mefloquine|mefloquine
679146|NCT00341003|Artemisinin|artemisinin
679147|NCT00341003|Piperaquine|piperaquine
679148|NCT00341003|Malaria|malaria
679149|NCT00340990|Tuberculosis|tuberculosis
679150|NCT00340990|HIV|hiv
679151|NCT00340990|CD4+ T Cell|cd4+ t cell
679152|NCT00340990|Interferon-Gamma|interferon-gamma
679153|NCT00340990|Lymphocyte Proliferation|lymphocyte proliferation
679154|NCT00340977|Birth Defects|birth defects
679155|NCT00340977|Case-Control Studies|case-control studies
679156|NCT00340977|Genetic Susceptibility|genetic susceptibility
679157|NCT00340964|Photography|photography
679158|NCT00340964|Self-Esteem|self-esteem
679584|NCT00339690|Behaviors|behaviors
679159|NCT00340964|Perceived Social Stigma|perceived social stigma
679160|NCT00340964|Hopefulness|hopefulness
679161|NCT00340964|Cleft Lip and Palate|cleft lip and palate
679162|NCT00340964|Hemifacial Microsomia|hemifacial microsomia
679163|NCT00340964|Treacher Collins Syndrome|treacher collins syndrome
679164|NCT00340964|Mobius Syndrome|mobius syndrome
679165|NCT00340964|Apert Syndrome|apert syndrome
679166|NCT00340964|Videography|videography
679167|NCT00340964|Craniofacial Differences|craniofacial differences
679168|NCT00340964|Self -Esteem|self -esteem
679169|NCT00340951|Regulatory T Cells|regulatory t cells
679170|NCT00340951|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
679171|NCT00340951|Genetic Polymorphism|genetic polymorphism
679172|NCT00340951|Innate Immunity|innate immunity
679173|NCT00340951|Transplantation|transplantation
679174|NCT00340951|Lung Transplantation|lung transplantation
679175|NCT00340938|Adherence|adherence
679176|NCT00340938|Education|education
679177|NCT00340938|Problem Solving|problem solving
679178|NCT00340938|Motivation|motivation
679179|NCT00340938|Locus of Responsibility|locus of responsibility
679180|NCT00340912|Skin Biopsy|skin biopsy
679181|NCT00340899|Perinatal Mortality|perinatal mortality
679182|NCT00340899|Perinatal Morbidity|perinatal morbidity
679183|NCT00340899|Preterm Birth|preterm birth
679184|NCT00340899|Pregnancy Complications|pregnancy complications
679185|NCT00340899|Pregnancy|pregnancy
679186|NCT00340886|Genetic Susceptibility|genetic susceptibility
679187|NCT00340886|Single Nucleotide Polymorphism|single nucleotide polymorphism
679188|NCT00340886|Environmental Risk Factor|environmental risk factor
679189|NCT00340886|Allelic Variants|allelic variants
679190|NCT00340886|Ascertainment by Genotype|ascertainment by genotype
679191|NCT00340873|Molecular Epidemiology|molecular epidemiology
679192|NCT00340873|Cross-Sectional|cross-sectional
679193|NCT00340873|Gene-Enviroment Interaction|gene-enviroment interaction
679194|NCT00340860|Ultrasound|ultrasound
679195|NCT00340860|Biobank|biobank
679196|NCT00340860|Urine|urine
679197|NCT00340860|Blood|blood
679198|NCT00340860|Exposure|exposure
679199|NCT00340860|Norway Mother and Child Study|norway mother and child study
679200|NCT00340847|Molecular Profiling|molecular profiling
679201|NCT00340847|In Situ Hybridization|in situ hybridization
679202|NCT00340847|SAGE|sage
679203|NCT00340847|Tumor Markers|tumor markers
679204|NCT00340847|IHC|ihc
679205|NCT00340847|Lung Cancer|lung cancer
679206|NCT00340847|Genetics|genetics
679207|NCT00340834|FTY720|fty720
679208|NCT00340834|Interferon|interferon
679209|NCT00340834|RRMS|rrms
679210|NCT00340834|Multiple Sclerosis|multiple sclerosis
679211|NCT00340834|Efficacy|efficacy
679212|NCT00340821|HTLV-I|htlv-i
679213|NCT00340808|Endometrial Cancer|endometrial cancer
679214|NCT00340808|Epidemiology|epidemiology
679215|NCT00340808|Questionnaire|questionnaire
679216|NCT00340808|Etiology|etiology
679217|NCT00340808|Biomarkers|biomarkers
679218|NCT00340795|Media Analysis|media analysis
679219|NCT00340795|Nutrition|nutrition
679220|NCT00340795|Physical Activity|physical activity
679221|NCT00340795|After-School|after-school
679222|NCT00340795|Exercise|exercise
679223|NCT00340782|Menstrual Cycles|menstrual cycles
679224|NCT00340782|Early Pregnancy|early pregnancy
679225|NCT00340782|Reproductive Hormones|reproductive hormones
679226|NCT00340782|Stress|stress
679227|NCT00340782|Adrenal Function|adrenal function
679228|NCT00340769|Cytokines|cytokines
679229|NCT00340769|Inflammation|inflammation
679230|NCT00340769|mRNA Stability|mrna stability
679231|NCT00340769|Pygmy|pygmy
679232|NCT00340769|Zinc Finger Proteins|zinc finger proteins
679233|NCT00340769|Ethnic Group|ethnic group
679234|NCT00340756|GCMS|gcms
679235|NCT00340756|LCMS-MS|lcms-ms
679236|NCT00340743|Heterocyclic Aminos|heterocyclic aminos
679237|NCT00340743|Cruciferous Vegetables|cruciferous vegetables
679238|NCT00340743|Yogurt|yogurt
679239|NCT00340743|Chlorophyllin|chlorophyllin
679240|NCT00340743|Comet Assay|comet assay
679241|NCT00340743|Diet|diet
679242|NCT00340743|Healthy Volunteer|healthy volunteer
679243|NCT00340730|Health Education|health education
679244|NCT00340730|Mentoring|mentoring
679245|NCT00340730|Parenting|parenting
679246|NCT00340730|Social Skills Training|social skills training
679247|NCT00340730|Violence|violence
679248|NCT00340730|Intervention|intervention
679249|NCT00340730|Youth Injury|youth injury
679250|NCT00340717|Methylation|methylation
679251|NCT00340717|Genes|genes
679252|NCT00340717|Screening|screening
679253|NCT00340717|Prospective|prospective
679254|NCT00340717|Diagnosis|diagnosis
679255|NCT00340704|tamsulosin|tamsulosin
679256|NCT00340704|pediatric|pediatric
679257|NCT00340704|neurogenic bladder|neurogenic bladder
679258|NCT00340691|Parasite|parasite
679259|NCT00340691|Chemotherapy|chemotherapy
679260|NCT00340691|Wuchereria Bancrofti|wuchereria bancrofti
679261|NCT00340678|Angiotensin II Receptor Antagonist|angiotensin ii receptor antagonist
679262|NCT00340678|Therapeutic Trial|therapeutic trial
679263|NCT00340678|Glomerular Filtration Rate|glomerular filtration rate
679264|NCT00340678|Kidney Biopsy|kidney biopsy
679265|NCT00340678|Non-Insulin Dependent Diabetes Mellitus|non-insulin dependent diabetes mellitus
679266|NCT00340665|Soy|soy
679267|NCT00340665|Infant Formula|infant formula
679268|NCT00340665|Sexual Development|sexual development
679269|NCT00340665|Hormone|hormone
679270|NCT00340665|Isoflavones|isoflavones
679271|NCT00340652|Soy|soy
679272|NCT00340652|Isoflavones|isoflavones
679273|NCT00340652|Infant Formula|infant formula
679274|NCT00340652|Sexual Development|sexual development
679275|NCT00340652|Hormone|hormone
679276|NCT00340639|Adherence|adherence
679277|NCT00340639|Chronic Illness|chronic illness
679278|NCT00340639|Adolescent|adolescent
679279|NCT00340639|Family|family
679280|NCT00340639|Self-Regulation|self-regulation
679281|NCT00340626|Whole Genome Sequencing|whole genome sequencing
679282|NCT00340626|Cleft Palate|cleft palate
679283|NCT00340613|Type 1 Diabetes|type 1 diabetes
679284|NCT00340613|Poorly controlled glucose|poorly controlled glucose
679285|NCT00340613|adolescents|adolescents
679286|NCT00340600|Cancer|cancer
679287|NCT00340600|DES|des
679288|NCT00340600|Endocrine Disrupting Chemicals|endocrine disrupting chemicals
679289|NCT00340600|In Utero|in utero
679290|NCT00340587|Zona Pellucida|zona pellucida
679291|NCT00340587|Human Eggs|human eggs
679292|NCT00340587|ZP1, ZP2, ZP3|zp1, zp2, zp3
679293|NCT00340587|Fertilization|fertilization
679294|NCT00340574|Human|human
679295|NCT00340574|Clinical Trial|clinical trial
679296|NCT00340574|Mosquito|mosquito
679297|NCT00340574|Healthy Volunteer|healthy volunteer
679298|NCT00340574|HV|hv
679299|NCT00340561|Test Track|test track
679300|NCT00340561|Distraction|distraction
679301|NCT00340561|Motor Vehicle|motor vehicle
679302|NCT00340561|Learning|learning
679303|NCT00340561|Inexperience|inexperience
679304|NCT00340548|Genotyping|genotyping
679305|NCT00340548|Polymorphisms|polymorphisms
679306|NCT00340548|Co-Infection|co-infection
679307|NCT00340548|Chemokines|chemokines
679308|NCT00340548|Associations|associations
679309|NCT00340548|HIV|hiv
679310|NCT00340548|HCV|hcv
679311|NCT00340548|Hepatitis C|hepatitis c
679312|NCT00340548|Hemophilia|hemophilia
679313|NCT00340535|Disinfection byproducts|disinfection byproducts
679314|NCT00340535|Genetic Variation|genetic variation
679315|NCT00340535|Trihalomethanes|trihalomethanes
679316|NCT00340522|Sarcoma|sarcoma
679317|NCT00340522|Brain Tumor|brain tumor
679318|NCT00340522|Embryonal Tumor|embryonal tumor
679319|NCT00340522|Tumor Array|tumor array
679320|NCT00340522|Childhood Cancer|childhood cancer
679321|NCT00340522|Plexiform Neurofibromas|plexiform neurofibromas
679322|NCT00340522|Drug Screening|drug screening
679323|NCT00340522|Immunohistochemistry|immunohistochemistry
679324|NCT00340509|Genetics|genetics
679325|NCT00340509|Population|population
679326|NCT00340509|CHD Risk|chd risk
679327|NCT00340509|Epidemiology|epidemiology
679328|NCT00340509|Gene Mapping|gene mapping
679329|NCT00340496|Schwannoma|schwannoma
679330|NCT00340496|Meningioma|meningioma
679331|NCT00340496|Follow-Up|follow-up
679332|NCT00340496|Radiation Therapy|radiation therapy
679333|NCT00340496|Cohort|cohort
679334|NCT00340483|Smoking Cessation|smoking cessation
679335|NCT00340483|Young Adults|young adults
679336|NCT00340483|Quit Smoking|quit smoking
679337|NCT00340483|Email|email
679338|NCT00340483|Social Marketing|social marketing
679339|NCT00340470|Injury|injury
679340|NCT00340470|Motor Vehicle|motor vehicle
679341|NCT00340470|Parenting|parenting
679342|NCT00340470|Randomized Trial|randomized trial
679343|NCT00340470|Behavioral Intervention|behavioral intervention
679344|NCT00340457|Case-Control Study|case-control study
679345|NCT00340457|Renal Cell Carcinoma|renal cell carcinoma
679346|NCT00340457|Kidney Cancer|kidney cancer
679347|NCT00340457|Diet|diet
679348|NCT00340457|Occupation|occupation
679349|NCT00340444|Linkage|linkage
679350|NCT00340444|Covariates|covariates
679351|NCT00340444|Association|association
679352|NCT00340444|Fine Mapping|fine mapping
679353|NCT00340444|Inflammatory Bowel Disease|inflammatory bowel disease
679354|NCT00340444|Ulcerative Colitis|ulcerative colitis
679355|NCT00340444|Crohn's Disease|crohn's disease
679356|NCT00340431|Human|human
679357|NCT00340431|Clinical Trial|clinical trial
679358|NCT00340431|Mosquito|mosquito
679359|NCT00340418|Bronchoalveolar Lavage|bronchoalveolar lavage
679360|NCT00340418|Acute Rejection|acute rejection
679361|NCT00340418|Chronic Rejection|chronic rejection
679362|NCT00340418|Genetic Polymorphisms|genetic polymorphisms
679363|NCT00340418|Innate Immunity|innate immunity
679364|NCT00340418|Lung Transplantation|lung transplantation
679365|NCT00340418|Lung Allograft Rejection|lung allograft rejection
679366|NCT00340405|Blood|blood
679367|NCT00340405|Lung Cancer|lung cancer
679368|NCT00340405|Occupational Exposure|occupational exposure
679369|NCT00340405|Radon|radon
679370|NCT00340405|Arsenic|arsenic
679371|NCT00340392|Mammary Stem Cells|mammary stem cells
679372|NCT00340392|Breast Cancer|breast cancer
679373|NCT00340392|Cancer Stem Cells|cancer stem cells
679374|NCT00340392|Gene Expression Profiling|gene expression profiling
679375|NCT00340379|Psychotic|psychotic
679376|NCT00340366|Homocysteine|homocysteine
679377|NCT00340366|Vitamin B12|vitamin b12
679378|NCT00340366|Birth Defects|birth defects
679379|NCT00340366|Pregnancy|pregnancy
679380|NCT00340366|Folate|folate
679381|NCT00340366|Irish Individuals|irish individuals
679382|NCT00340353|Gene Expression|gene expression
679383|NCT00340353|Drug Sensitivity|drug sensitivity
679384|NCT00340353|TFE3|tfe3
679385|NCT00340353|ASPL-TFE3|aspl-tfe3
679386|NCT00340353|NOD-SCID Mice|nod-scid mice
679387|NCT00340353|Sarcoma|sarcoma
679388|NCT00340353|Alveolar Soft Part Sarcoma|alveolar soft part sarcoma
679389|NCT00340353|ASPS|asps
679390|NCT00340340|Population-Based Case Control Study|population-based case control study
679391|NCT00340340|Lung Cancer|lung cancer
679392|NCT00340340|Epidemiology|epidemiology
679393|NCT00340340|Smoking|smoking
679394|NCT00340340|Smokers|smokers
679395|NCT00340340|Genetics|genetics
679396|NCT00340327|healthy subjects|healthy subjects
679397|NCT00340314|symptomatic|symptomatic
679398|NCT00340314|paroxysmal|paroxysmal
679399|NCT00340314|atrial fibrillation|atrial fibrillation
679400|NCT00340301|Polymorphism|polymorphism
679401|NCT00340301|Neurodegenerative Diseases|neurodegenerative diseases
679402|NCT00340301|ALS|als
679403|NCT00340288|Fibroids|fibroids
679404|NCT00340288|Life Style/Endrocrinology|life style/endrocrinology
679405|NCT00340288|Magnetic Resonance Imaging|magnetic resonance imaging
679406|NCT00340288|Molecular Characterization|molecular characterization
679407|NCT00340288|Symptoms/Clinical Outcome|symptoms/clinical outcome
679408|NCT00340288|Uterine Fibroids|uterine fibroids
679409|NCT00340275|Bacterial Vaginosis|bacterial vaginosis
679410|NCT00340275|Vaginal Infection|vaginal infection
679411|NCT00340275|Vaginitis|vaginitis
679412|NCT00340275|Cohort Study|cohort study
679413|NCT00340275|Sexually Transmitted Disease|sexually transmitted disease
679414|NCT00340262|Supplemental Hormone Use|supplemental hormone use
679415|NCT00340262|Osteoporosis|osteoporosis
679416|NCT00340262|Endogenous Sex Hormones|endogenous sex hormones
679417|NCT00340249|Premature Rupture of the Membranes (PROM)|premature rupture of the membranes (prom)
679418|NCT00340249|Preterm Delivery|preterm delivery
679419|NCT00340249|In-Utero Fetal Demise|in-utero fetal demise
679420|NCT00340249|Chorioamnionitis|chorioamnionitis
679421|NCT00340249|Spontaneous Abortion|spontaneous abortion
679422|NCT00340223|Immunity|immunity
679423|NCT00340223|Mutations|mutations
679424|NCT00340223|Viral Selection|viral selection
679425|NCT00340223|Disease Progression|disease progression
679426|NCT00340223|RNA|rna
679427|NCT00340210|Biomarkers|biomarkers
679428|NCT00340210|Breast Cancer|breast cancer
679429|NCT00340210|Etiology|etiology
679430|NCT00340210|Hormones|hormones
679431|NCT00340210|Prospective Study|prospective study
679432|NCT00340184|concurrent|concurrent
679433|NCT00340184|chemoradiation|chemoradiation
679434|NCT00340184|paclitaxel|paclitaxel
679435|NCT00340184|carboplatin|carboplatin
679436|NCT00340171|Intrauterine Growth Retardation|intrauterine growth retardation
679437|NCT00340171|Macrosomia|macrosomia
679438|NCT00340171|Fetal Volume|fetal volume
679439|NCT00340171|Fetal Anatomy|fetal anatomy
679440|NCT00340171|Prediction of Birthweight|prediction of birthweight
679441|NCT00340171|3D Ultrasonography|3d ultrasonography
679442|NCT00340171|Fetus|fetus
679443|NCT00340171|Prenatal Diagnosis|prenatal diagnosis
679444|NCT00340158|Mammary|mammary
679445|NCT00340158|Diagnosis|diagnosis
679446|NCT00340158|Aggressive|aggressive
679447|NCT00340158|Pathology|pathology
679448|NCT00340158|Epidemiology|epidemiology
679449|NCT00340132|Non-Insulin Dependent Diabetes|non-insulin dependent diabetes
679450|NCT00340132|Insulin Resistance|insulin resistance
679451|NCT00340132|Insulin Secretion|insulin secretion
679452|NCT00340132|Glucose Tolerance|glucose tolerance
679453|NCT00340132|Adipose Tissue|adipose tissue
679454|NCT00340132|Preadipocytes|preadipocytes
679455|NCT00340119|CHOICE Cohort|choice cohort
679456|NCT00340119|End Stage Renal Disease|end stage renal disease
679457|NCT00340119|Epidemiology|epidemiology
679458|NCT00340119|Prevention|prevention
679459|NCT00340119|Single Nucleotide Polymorphisms|single nucleotide polymorphisms
679460|NCT00340119|ESRD|esrd
679461|NCT00340106|Infant Health Study|infant health study
679462|NCT00340106|Environmental Tobacco Smoke|environmental tobacco smoke
679463|NCT00340106|Infant Health|infant health
679464|NCT00340093|Adherence|adherence
679465|NCT00340093|Behavioral Intervention|behavioral intervention
679466|NCT00340093|Adolescence|adolescence
679467|NCT00340093|Self-Regulation|self-regulation
679468|NCT00340093|Behavioral Medicine|behavioral medicine
679469|NCT00340093|Diabetes|diabetes
679470|NCT00340080|Abacavir|abacavir
679471|NCT00340080|Pharmacogenetics|pharmacogenetics
679472|NCT00340080|hypersensitivity|hypersensitivity
679473|NCT00340080|HLA-B*5701|hla-b*5701
679474|NCT00340054|brain tumor|brain tumor
679475|NCT00340028|Ovulation|ovulation
679476|NCT00340028|Diary Record|diary record
679585|NCT00339690|Test-Kit|test-kit
679477|NCT00340028|Urine Collection|urine collection
679478|NCT00340028|Leutinizing Hormone|leutinizing hormone
679479|NCT00340028|Blood Collection|blood collection
679480|NCT00340028|Pregnancy|pregnancy
679481|NCT00340015|Cancer|cancer
679482|NCT00340015|Mortality|mortality
679483|NCT00340015|Lifestyle Factors|lifestyle factors
679484|NCT00340015|Cohort|cohort
679485|NCT00340002|Fetal Anatomy|fetal anatomy
679486|NCT00340002|Pregnancy|pregnancy
679487|NCT00340002|Prenatal Diagnosis|prenatal diagnosis
679488|NCT00339989|Molecular Markers|molecular markers
679489|NCT00339989|Human Papillomavirus|human papillomavirus
679490|NCT00339989|Cervix|cervix
679491|NCT00339989|Cancer|cancer
679492|NCT00339989|Microarray|microarray
679493|NCT00339976|Case-Control Study|case-control study
679494|NCT00339976|Death Certificates|death certificates
679495|NCT00339976|National Death Index|national death index
679496|NCT00339976|Cause of Death Information|cause of death information
679497|NCT00339976|Lead Exposure|lead exposure
679498|NCT00339976|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
679499|NCT00339976|ALS|als
679500|NCT00339963|Microarray|microarray
679501|NCT00339963|Lymphoma|lymphoma
679502|NCT00339963|Gene Expression|gene expression
679503|NCT00339963|Molecular Diagnosis|molecular diagnosis
679504|NCT00339963|Prognosis|prognosis
679505|NCT00339963|Leukemia|leukemia
679506|NCT00339963|Myeloma|myeloma
679507|NCT00339963|Lymphoid Malignancy|lymphoid malignancy
679508|NCT00339950|Colorectal adenoma|colorectal adenoma
679509|NCT00339950|Screening|screening
679510|NCT00339950|Polyp|polyp
679511|NCT00339950|Diet|diet
679512|NCT00339950|Nutrition|nutrition
679513|NCT00339950|Polymorphism|polymorphism
679514|NCT00339950|Cooking|cooking
679515|NCT00339950|Risk Factors|risk factors
679516|NCT00339937|Human Herpes virus 8 (HHV8)|human herpes virus 8 (hhv8)
679517|NCT00339937|Kaposi sarcoma (KS)|kaposi sarcoma (ks)
679518|NCT00339924|Clinical Decision-Making|clinical decision-making
679519|NCT00339924|Physician Bias|physician bias
679520|NCT00339924|Genetics|genetics
679521|NCT00339924|Race|race
679522|NCT00339924|Ethnicity|ethnicity
679523|NCT00339924|Human Genetic Variation|human genetic variation
679524|NCT00339911|Repository|repository
679525|NCT00339911|Phlebotomy|phlebotomy
679526|NCT00339911|Venipuncture|venipuncture
679527|NCT00339911|Anemia|anemia
679528|NCT00339911|Occupational Health Services|occupational health services
679529|NCT00339898|Minimal Residual Disease|minimal residual disease
679530|NCT00339898|Ewings Sarcoma|ewings sarcoma
679531|NCT00339885|Type 2 Diabetes|type 2 diabetes
679532|NCT00339872|healthy subjects|healthy subjects
679533|NCT00339859|Molecular Epidemiology of Lung Cancer|molecular epidemiology of lung cancer
679534|NCT00339859|Health Disparities|health disparities
679535|NCT00339846|Craniosynostosis|craniosynostosis
679536|NCT00339846|Craniofrontonasal Syndrome|craniofrontonasal syndrome
679537|NCT00339846|CFNS|cfns
679538|NCT00339833|Salsalate|salsalate
679539|NCT00339833|Insulin Resistance|insulin resistance
679540|NCT00339833|Diabetes Mellitus|diabetes mellitus
679541|NCT00339833|Inflammation|inflammation
679542|NCT00339833|Diabetes|diabetes
679543|NCT00339833|HCV|hcv
679544|NCT00339807|Retrovirus|retrovirus
679545|NCT00339807|Caribbean|caribbean
679546|NCT00339807|Transmission|transmission
679547|NCT00339807|Genetic|genetic
679548|NCT00339807|Viral Markers|viral markers
679549|NCT00339807|HTLV-1|htlv-1
679550|NCT00339794|Racial Profiling|racial profiling
679551|NCT00339794|Genomics|genomics
679552|NCT00339794|Genetic Testing|genetic testing
679553|NCT00339794|Family History|family history
679554|NCT00339794|Family Physician|family physician
679555|NCT00339781|Fetomaternal Microchimerism|fetomaternal microchimerism
679556|NCT00339781|Cell Trafficking|cell trafficking
679557|NCT00339781|Discordant Twins|discordant twins
679558|NCT00339781|Maternofetal Microchimerism|maternofetal microchimerism
679559|NCT00339781|Diabetes Type I|diabetes type i
679560|NCT00339781|Twins|twins
679561|NCT00339768|Helicobacter Pylori|helicobacter pylori
679562|NCT00339768|Gastric Cancer Prevention|gastric cancer prevention
679563|NCT00339768|Precancerous Gastric Lesions|precancerous gastric lesions
679564|NCT00339742|Esophageal Cancer|esophageal cancer
679565|NCT00339742|Case-Control Study|case-control study
679566|NCT00339742|Environmental Risk Factors|environmental risk factors
679567|NCT00339742|Genetic Risk Factors|genetic risk factors
679568|NCT00339729|Children|children
679569|NCT00339729|Behavior|behavior
679570|NCT00339729|Epidemiology|epidemiology
679571|NCT00339729|Lead|lead
679572|NCT00339729|Learning Disorder|learning disorder
679573|NCT00339716|Cohort|cohort
679574|NCT00339716|Radiation|radiation
679575|NCT00339716|In Utero|in utero
679576|NCT00339703|Resistin|resistin
679577|NCT00339703|Asthma|asthma
679578|NCT00339703|CRP|crp
679579|NCT00339703|Diabetes|diabetes
679580|NCT00339703|FIZZ|fizz
679581|NCT00339690|Asthma|asthma
679582|NCT00339690|Allergy|allergy
679583|NCT00339690|Intervention|intervention
679586|NCT00339690|Dust Mites Allergen|dust mites allergen
679587|NCT00339677|Measurement Error|measurement error
679588|NCT00339677|Dietary Assessment|dietary assessment
679589|NCT00339677|Dietary Intake|dietary intake
679590|NCT00339677|Energy|energy
679591|NCT00339677|Protein|protein
679592|NCT00339664|Pharmacokinetics|pharmacokinetics
679593|NCT00339664|Quantify|quantify
679594|NCT00339664|HPLC|hplc
679595|NCT00339664|LC/MS|lc/ms
679596|NCT00339664|Pharmacodynamics|pharmacodynamics
679597|NCT00339651|Precursors|precursors
679598|NCT00339651|Endometrial Cancer|endometrial cancer
679599|NCT00339651|Hyperplasia|hyperplasia
679600|NCT00339651|Progression|progression
679601|NCT00339638|Epidemiology|epidemiology
679602|NCT00339638|Risk Prediction|risk prediction
679603|NCT00339638|Biomarkers|biomarkers
679604|NCT00339638|Nested Case Control|nested case control
679605|NCT00339625|Intervention|intervention
679606|NCT00339625|Diet|diet
679607|NCT00339625|Colon|colon
679608|NCT00339612|Perinatal|perinatal
679609|NCT00339612|HIV|hiv
679610|NCT00339612|AIDS|aids
679611|NCT00339599|Atherosclerosis|atherosclerosis
679612|NCT00339599|Single Nucleotide Polymorphisms|single nucleotide polymorphisms
679613|NCT00339599|Monocyte Chemotactic Protein-1|monocyte chemotactic protein-1
679614|NCT00339599|Inflammation|inflammation
679615|NCT00339599|Eotaxin|eotaxin
679616|NCT00339586|Non-small cell lung cancer|non-small cell lung cancer
679617|NCT00339586|tyrosine kinase inhibition|tyrosine kinase inhibition
679618|NCT00339586|first-line treatment|first-line treatment
679619|NCT00339586|mutant EGFR-gene|mutant egfr-gene
679620|NCT00339573|Asthma|asthma
679621|NCT00339573|Dust Mite|dust mite
679622|NCT00339573|Cockroach|cockroach
679623|NCT00339573|Lead Toxicity|lead toxicity
679624|NCT00339573|Allergy|allergy
679625|NCT00339560|Ampulla of Vater|ampulla of vater
679626|NCT00339560|Gallbaldder|gallbaldder
679627|NCT00339560|Cancer|cancer
679628|NCT00339560|Extrahepatic Bile Duct|extrahepatic bile duct
679629|NCT00339547|Leiomyomas|leiomyomas
679630|NCT00339547|Ultrasound|ultrasound
679631|NCT00339547|Hysterectomy|hysterectomy
679632|NCT00339547|Epidemiology|epidemiology
679633|NCT00339547|Hyperinsulinemia|hyperinsulinemia
679634|NCT00339534|African Men|african men
679635|NCT00339534|Case-Control Study|case-control study
679636|NCT00339534|Prostate Cancer|prostate cancer
679637|NCT00339534|Cancer|cancer
679638|NCT00339521|Asthma|asthma
679639|NCT00339521|Mexico|mexico
679640|NCT00339521|Candidate Genes|candidate genes
679641|NCT00339521|Triads|triads
679642|NCT00339521|Polymorphism|polymorphism
679643|NCT00339508|Linkage Analysis|linkage analysis
679644|NCT00339508|Cancer Genetics|cancer genetics
679645|NCT00339508|Software|software
679646|NCT00339508|Bug Reports|bug reports
679647|NCT00339508|Computer Programs|computer programs
679648|NCT00339508|Data Analysis|data analysis
679649|NCT00339495|Prostate|prostate
679650|NCT00339495|Screening Trail|screening trail
679651|NCT00339495|Ovarian|ovarian
679652|NCT00339495|Lung|lung
679653|NCT00339495|Colorectal|colorectal
679654|NCT00339482|Epidemiology|epidemiology
679655|NCT00339482|Type 2 Diabetes|type 2 diabetes
679656|NCT00339482|Vascular Complications|vascular complications
679657|NCT00339482|Retinopathy|retinopathy
679658|NCT00339482|Nephropathy|nephropathy
679659|NCT00339482|Genetics|genetics
679660|NCT00339469|Prevention|prevention
679661|NCT00339469|Colorectal Neoplasms|colorectal neoplasms
679662|NCT00339469|Insulin Resistance|insulin resistance
679663|NCT00339469|Inflammation Obesity|inflammation obesity
679664|NCT00339469|Adenoma|adenoma
679665|NCT00339456|Therapy|therapy
679666|NCT00339456|Africa|africa
679667|NCT00339456|Structured|structured
679668|NCT00339456|Interruption|interruption
679669|NCT00339456|Antiretroviral|antiretroviral
679670|NCT00339456|HIV|hiv
679671|NCT00339443|Buccal Cells|buccal cells
679672|NCT00339443|Concordance|concordance
679673|NCT00339443|DNA Yields|dna yields
679674|NCT00339443|pH Meter|ph meter
679675|NCT00339443|Urine pH|urine ph
679676|NCT00339443|Calibration|calibration
679677|NCT00339430|Genotyping|genotyping
679678|NCT00339430|HIV|hiv
679679|NCT00339430|HPV|hpv
679680|NCT00339430|HCV|hcv
679681|NCT00339430|HBV|hbv
679682|NCT00339417|Lymphatic Filariasis|lymphatic filariasis
679683|NCT00339417|Chemotherapy|chemotherapy
679684|NCT00339404|Genotyping|genotyping
679685|NCT00339404|Linkage Analysis|linkage analysis
679686|NCT00339404|Cancer|cancer
679687|NCT00339404|Hereditary Melanoma|hereditary melanoma
679688|NCT00339391|Adjustment|adjustment
679689|NCT00339391|Environmental Complexity|environmental complexity
679690|NCT00339391|Mental Illness|mental illness
679691|NCT00339391|Non-literate|non-literate
679692|NCT00339391|West Africa|west africa
679693|NCT00339391|Stress|stress
679694|NCT00339391|Knowledge|knowledge
679695|NCT00339391|Mental Health|mental health
679696|NCT00339391|AIDS|aids
679697|NCT00339378|Record Linkage|record linkage
679698|NCT00339378|Retrospective|retrospective
679699|NCT00339378|Cohort|cohort
679700|NCT00339378|Registries|registries
679701|NCT00339378|Agricultural|agricultural
679702|NCT00339365|Infants|infants
679703|NCT00339365|Toddlers|toddlers
679704|NCT00339365|Attachment|attachment
679705|NCT00339365|Maltreatment|maltreatment
679706|NCT00339365|Foster Care|foster care
679707|NCT00339352|Brain|brain
679708|NCT00339352|Exposures|exposures
679709|NCT00339352|Genetics|genetics
679710|NCT00339352|Glioma|glioma
679711|NCT00339352|Occupations|occupations
679712|NCT00339339|Dental Materials|dental materials
679713|NCT00339339|Resins|resins
679714|NCT00339339|BisDMA|bisdma
679715|NCT00339339|Absorption|absorption
679716|NCT00339339|Systemic|systemic
679717|NCT00339326|Human Herpes virus 8 (HHV8)|human herpes virus 8 (hhv8)
679718|NCT00339326|Kaposis sarcoma (KS)|kaposis sarcoma (ks)
679719|NCT00339326|Kaposi Sarcoma|kaposi sarcoma
679720|NCT00339326|Karposi Sarcoma-Associated Herpesvirus|karposi sarcoma-associated herpesvirus
679721|NCT00339326|KSHV|kshv
679722|NCT00339326|KS|ks
679723|NCT00339313|Obesity|obesity
679724|NCT00339313|Etiology|etiology
679725|NCT00339313|Macronutrient Selection|macronutrient selection
679726|NCT00339313|Taste Preference|taste preference
679727|NCT00339313|Mixed Meal Test|mixed meal test
679728|NCT00339300|Etiology|etiology
679729|NCT00339300|Brain Cancer|brain cancer
679730|NCT00339300|Epidemiology|epidemiology
679731|NCT00339300|Brain Tumors|brain tumors
679732|NCT00339300|Glioma|glioma
679733|NCT00339287|Inflammation|inflammation
679734|NCT00339287|Innate Immunity|innate immunity
679735|NCT00339287|Macrophages|macrophages
679736|NCT00339287|Neutrophils|neutrophils
679737|NCT00339287|Pathogenesis|pathogenesis
679738|NCT00339274|Repositories|repositories
679739|NCT00339274|Pathology|pathology
679740|NCT00339274|Belarus|belarus
679741|NCT00339274|Russia|russia
679742|NCT00339274|Ukraine|ukraine
679743|NCT00339261|Cardiovascular|cardiovascular
679744|NCT00339261|Renal|renal
679745|NCT00339261|Autoimmune Disease|autoimmune disease
679746|NCT00339261|Genetics|genetics
679747|NCT00339261|Mortality|mortality
679748|NCT00339248|Hyperplasia|hyperplasia
679749|NCT00339248|Atypia|atypia
679750|NCT00339248|Polymorphism|polymorphism
679751|NCT00339248|Progression|progression
679752|NCT00339248|Epidemiology|epidemiology
679753|NCT00339235|Preterm Birth Prevention|preterm birth prevention
679754|NCT00339235|Preterm Birth|preterm birth
679755|NCT00339235|Pregnancy|pregnancy
679756|NCT00339235|Pregnancy Complications|pregnancy complications
679757|NCT00339222|Genetics|genetics
679758|NCT00339222|Kindreds|kindreds
679759|NCT00339222|Mediterranean Population|mediterranean population
679760|NCT00339222|Nevi|nevi
679761|NCT00339222|Pigmentation|pigmentation
679762|NCT00339222|Melanoma-Prone Families|melanoma-prone families
679763|NCT00339222|Sun Exposure|sun exposure
679764|NCT00339222|Melanoma|melanoma
679765|NCT00339209|Genetic Polymorphisms|genetic polymorphisms
679766|NCT00339209|Acute Rejection|acute rejection
679767|NCT00339209|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
679768|NCT00339209|Transplant Rejection|transplant rejection
679769|NCT00339209|Innate Immunity|innate immunity
679770|NCT00339209|Lung Transplantation Rejection|lung transplantation rejection
679771|NCT00339196|AML|aml
679772|NCT00339196|MDS High risk|mds high risk
679773|NCT00339196|Demethylating agents|demethylating agents
679774|NCT00339196|HDAC Inhibitors|hdac inhibitors
679775|NCT00339183|Oncology|oncology
679776|NCT00339183|Cancer|cancer
679777|NCT00339183|Metastatic Colorectal Cancer|metastatic colorectal cancer
679778|NCT00339183|EGFr|egfr
679779|NCT00339183|Panitumumab|panitumumab
679780|NCT00339183|Clinical Trial|clinical trial
679781|NCT00339183|Amgen|amgen
679782|NCT00339170|Schizoaffective Disorder|schizoaffective disorder
679783|NCT00339170|Schizophrenic Disorders|schizophrenic disorders
679784|NCT00339170|Psychotic Disorders|psychotic disorders
679785|NCT00339170|Cognition|cognition
679786|NCT00339157|IDIOPATHIC JUVENILE ARTHRITIS|idiopathic juvenile arthritis
679787|NCT00339157|PEDIATRICS|pediatrics
679788|NCT00339157|ORPHAN DISEASE|orphan disease
679789|NCT00339157|INTERLEUKIN - 1|interleukin - 1
679790|NCT00339157|RECEPTORS , INTERLEUKINS|receptors , interleukins
679791|NCT00339157|ANTAGONISTS|antagonists
679792|NCT00339144|Solid tumors (including relapsed disease) that are refractory to standard therapies or for which no effective standard therapy exists|solid tumors (including relapsed disease) that are refractory to standard therapies or for which no effective standard therapy exists
679793|NCT00339131|radiopharmaceutical|radiopharmaceutical
679794|NCT00339131|radiation dosimetry|radiation dosimetry
679795|NCT00339131|iodine|iodine
679796|NCT00339131|MIBG|mibg
679797|NCT00339131|iobenguane|iobenguane
679798|NCT00339131|Ultratrace|ultratrace
679799|NCT00339131|neuroendocrine tumors|neuroendocrine tumors
679800|NCT00339105|Acute|acute
679801|NCT00339105|Coronary|coronary
679802|NCT00339105|Syndrome|syndrome
679803|NCT00339105|HyperQ|hyperq
679804|NCT00339105|High|high
679805|NCT00339105|Frequency|frequency
679806|NCT00339105|ECG|ecg
679807|NCT00339105|chest|chest
679808|NCT00339105|pain|pain
679809|NCT00339092|HIV|hiv
679810|NCT00339092|ART|art
679811|NCT00339066|Late-Life Depression|late-life depression
679812|NCT00339053|thoracic aortic aneurysm|thoracic aortic aneurysm
679813|NCT00339053|immunonutrition|immunonutrition
679814|NCT00339053|respiratory failure|respiratory failure
679815|NCT00339053|lenght of stay ICU|lenght of stay icu
679816|NCT00339040|HPV|hpv
679817|NCT00339027|child care centers|child care centers
679818|NCT00339027|community based research|community based research
679819|NCT00339027|behavioral health|behavioral health
679820|NCT00339027|health literacy|health literacy
679821|NCT00339027|unmet healthcare needs|unmet healthcare needs
679822|NCT00339001|Erythropoietin|erythropoietin
679823|NCT00339001|Iron|iron
679824|NCT00339001|Retinopathy of prematurity|retinopathy of prematurity
679825|NCT00338988|Gastrointestinal|gastrointestinal
679826|NCT00338988|Capecitabine|capecitabine
679827|NCT00338988|Oxaliplatin|oxaliplatin
679828|NCT00338988|Carcinoma of the Gallbladder|carcinoma of the gallbladder
679829|NCT00338988|Carcinoma of the Intrahepatic or Extrahepatic Biliary Tract|carcinoma of the intrahepatic or extrahepatic biliary tract
679830|NCT00338988|Xeloda|xeloda
679831|NCT00338988|Eloxatin|eloxatin
679832|NCT00338975|Psychotic Disorders|psychotic disorders
679833|NCT00338975|Schizoaffective Disorder|schizoaffective disorder
679834|NCT00338975|Cognitive Behavioral Therapy|cognitive behavioral therapy
679835|NCT00338975|Social Skills Training|social skills training
679836|NCT00338962|SSRI|ssri
679837|NCT00338962|treatment|treatment
679838|NCT00338962|naltrexone|naltrexone
679839|NCT00338962|alcohol dependence|alcohol dependence
679840|NCT00338962|Desipramine|desipramine
679841|NCT00338962|depression|depression
679842|NCT00338962|PTSD|ptsd
679843|NCT00338949|Ziprasidone|ziprasidone
679844|NCT00338949|Olanzapine|olanzapine
679845|NCT00338949|Risperidone|risperidone
679846|NCT00338949|Schizoaffective Disorder|schizoaffective disorder
679847|NCT00338949|Insulin Sensitivity|insulin sensitivity
679848|NCT00338949|Visceral Adiposity|visceral adiposity
679849|NCT00338949|Metabolic Syndrome|metabolic syndrome
679850|NCT00338936|Hypertension|hypertension
679851|NCT00338936|Valsartan|valsartan
679852|NCT00338936|Hydrochlorothiazide|hydrochlorothiazide
679853|NCT00338910|healthy volunteers|healthy volunteers
679854|NCT00338897|Venous Thromboembolism|venous thromboembolism
679855|NCT00338897|Prevention|prevention
679856|NCT00338897|Arthroplasty|arthroplasty
679857|NCT00338897|Replacement|replacement
679858|NCT00338897|Hip|hip
679859|NCT00338897|orthopedic surgery|orthopedic surgery
679860|NCT00338845|STDs|stds
679861|NCT00338832|Lifestyle Intervention|lifestyle intervention
679862|NCT00338832|Schizoaffective Disorder|schizoaffective disorder
679863|NCT00338819|DVT prevention|dvt prevention
679864|NCT00338819|Hemodynamic study|hemodynamic study
679865|NCT00338819|IPC|ipc
679866|NCT00338819|CECT|cect
679867|NCT00338806|Prevention|prevention
679868|NCT00338806|Mood Disorders|mood disorders
679869|NCT00338806|Unipolar Depression|unipolar depression
679870|NCT00338793|Tuberculosis;|tuberculosis;
679871|NCT00338793|Pleural effusion;|pleural effusion;
679872|NCT00338793|Corticosteroids.|corticosteroids.
679873|NCT00338780|Chronic Hepatitis B|chronic hepatitis b
679874|NCT00338780|Lamivudine|lamivudine
679875|NCT00338780|HBeAg negative|hbeag negative
679876|NCT00338767|AIDS|aids
679877|NCT00338767|DOT|dot
679878|NCT00338767|Directly Observed Therapy|directly observed therapy
679879|NCT00338728|Breast Cancer|breast cancer
679880|NCT00338728|Letrozole|letrozole
679881|NCT00338728|Imatinib Mesylate|imatinib mesylate
679882|NCT00338728|Gleevec|gleevec
679883|NCT00338728|Femara|femara
679884|NCT00338715|Effectiveness|effectiveness
679885|NCT00338715|Pulmonary Vein Isolation Procedure|pulmonary vein isolation procedure
679886|NCT00338715|Coronary Artery Bypass Surgery|coronary artery bypass surgery
679887|NCT00338715|Atrial Fibrillation|atrial fibrillation
679888|NCT00338702|Diabetic|diabetic
679889|NCT00338702|Foot|foot
679890|NCT00338702|Ulcer|ulcer
679891|NCT00338702|Autologous|autologous
679892|NCT00338702|Platelet|platelet
679893|NCT00338702|Gel|gel
679894|NCT00338689|infant formula|infant formula
679895|NCT00338689|protein content|protein content
679896|NCT00338689|growth|growth
679897|NCT00338689|obesity|obesity
679898|NCT00338689|breast feeding|breast feeding
679899|NCT00338676|Aortic stenosis|aortic stenosis
679900|NCT00338676|Elderly|elderly
679901|NCT00338663|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
679902|NCT00338663|knee immobilization|knee immobilization
679903|NCT00338663|postoperative pain|postoperative pain
679904|NCT00338624|lower urinary tract symptoms|lower urinary tract symptoms
679905|NCT00338624|DITROPAN XL|ditropan xl
679906|NCT00338624|oxybutynin extended release tablets|oxybutynin extended release tablets
679907|NCT00338611|vision therapy|vision therapy
679908|NCT00338611|orthoptics|orthoptics
679909|NCT00338611|pencil push-up therapy|pencil push-up therapy
679910|NCT00338598|glycine|glycine
679911|NCT00338598|treatment|treatment
679912|NCT00338598|alcohol dependence|alcohol dependence
679913|NCT00338598|schizophrenia|schizophrenia
679915|NCT00338585|acute peripheral arterial occlusion|acute peripheral arterial occlusion
679916|NCT00338585|thrombolysis|thrombolysis
679917|NCT00338585|blood clot|blood clot
679918|NCT00338585|leg attack|leg attack
679919|NCT00338585|alfimeprase|alfimeprase
679920|NCT00338585|thrombus|thrombus
679921|NCT00338585|embolism|embolism
679922|NCT00338585|thromboembolism|thromboembolism
679923|NCT00338585|claudication|claudication
679924|NCT00338585|thrombolytic|thrombolytic
679925|NCT00338585|thrombosis|thrombosis
679926|NCT00338585|plasminogen activator|plasminogen activator
679927|NCT00338585|arterial flow|arterial flow
679928|NCT00338572|Inflammation|inflammation
679929|NCT00338572|Blood Pressure, High|blood pressure, high
679930|NCT00338559|Strabismus|strabismus
679931|NCT00338559|LMA|lma
679932|NCT00338559|ET Tube|et tube
679933|NCT00338559|POV|pov
679934|NCT00338546|Cocaine|cocaine
679935|NCT00338546|Sympathetic nerve activity|sympathetic nerve activity
679936|NCT00338546|Blood pressure|blood pressure
679937|NCT00338546|Cutaneous vasoconstriction|cutaneous vasoconstriction
679938|NCT00338546|Coronary vasoconstriction|coronary vasoconstriction
679939|NCT00338533|childhood glaucoma|childhood glaucoma
679940|NCT00338520|Cerebral malaria, phenylalanine, Tanzania|cerebral malaria, phenylalanine, tanzania
679941|NCT00338507|Chronic Bronchitis|chronic bronchitis
679942|NCT00338507|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
679943|NCT00338468|Anemia|anemia
679944|NCT00338468|Elderly|elderly
679945|NCT00338468|Hemoglobin level|hemoglobin level
679946|NCT00338468|Chronic Kidney Disease|chronic kidney disease
679947|NCT00338455|Congestive heart failure|congestive heart failure
679948|NCT00338455|cardiac transplantation|cardiac transplantation
679949|NCT00338455|renal insufficiency|renal insufficiency
679950|NCT00338455|renal failure|renal failure
679951|NCT00338455|dialysis|dialysis
679952|NCT00338455|ultrafiltration|ultrafiltration
679953|NCT00338455|vasodilator|vasodilator
679954|NCT00338455|Natrecor (nesiritide)|natrecor (nesiritide)
679955|NCT00338442|Immune compromised|immune compromised
679956|NCT00338442|Varicella Zoster Virus ( VZV) Infection|varicella zoster virus ( vzv) infection
679957|NCT00338442|Pediatric|pediatric
679958|NCT00338429|sleep onset latency|sleep onset latency
679959|NCT00338429|bedtime resistance|bedtime resistance
679960|NCT00338416|Chemotherapy Induced Anemia|chemotherapy induced anemia
679961|NCT00338416|PROCRIT (Epoetin alfa)|procrit (epoetin alfa)
679962|NCT00338416|Chemotherapy|chemotherapy
679963|NCT00338416|Epoetin alfa|epoetin alfa
679964|NCT00338403|CPAP pressure of -5cm/water during cold, dry air exposure|cpap pressure of -5cm/water during cold, dry air exposure
679965|NCT00338403|CPAP pressure of 0cm/water during cold, dry air exposure|cpap pressure of 0cm/water during cold, dry air exposure
679966|NCT00338403|CPAP pressure of 5cm/water during cold, dry air exposure|cpap pressure of 5cm/water during cold, dry air exposure
679967|NCT00338403|CPAP pressure of 10cm/water during cold, dry air exposure|cpap pressure of 10cm/water during cold, dry air exposure
679968|NCT00338390|Antiretrovirals|antiretrovirals
679969|NCT00338390|CD4 cell count|cd4 cell count
679970|NCT00338390|toxicity|toxicity
679971|NCT00338377|Melanoma|melanoma
679972|NCT00338377|Regional nodal disease|regional nodal disease
679973|NCT00338377|Dendritic Cell Immunization|dendritic cell immunization
679974|NCT00338377|Lymphodepletion|lymphodepletion
679975|NCT00338377|Adoptive Cell Transfer|adoptive cell transfer
679976|NCT00338377|T Cells|t cells
679977|NCT00338377|Vaccine|vaccine
679978|NCT00338377|Cyclosphosphamide|cyclosphosphamide
679979|NCT00338377|Cytoxan|cytoxan
679980|NCT00338377|Neosar|neosar
679981|NCT00338377|Dendritic Cells|dendritic cells
679982|NCT00338377|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
679983|NCT00338377|TIL Cells|til cells
679984|NCT00338377|MART Peptide|mart peptide
679985|NCT00338377|Fludarabine|fludarabine
679986|NCT00338377|Fludarabine Phosphate|fludarabine phosphate
679987|NCT00338377|Fludara|fludara
679988|NCT00338377|Proleukin|proleukin
679989|NCT00338377|IL-2|il-2
679990|NCT00338377|Interleukin-2|interleukin-2
679991|NCT00338377|Leptomeningeal disease|leptomeningeal disease
679992|NCT00338364|Pediatric pain|pediatric pain
679993|NCT00338364|Pediatric anxiety|pediatric anxiety
679994|NCT00338364|Painful procedures|painful procedures
679995|NCT00338338|essential hypertension|essential hypertension
679996|NCT00338338|Amlodipine|amlodipine
679997|NCT00338338|blood pressure|blood pressure
679998|NCT00338338|lacidipine|lacidipine
679999|NCT00338325|Pediatric Anxiety|pediatric anxiety
680000|NCT00338325|Pediatric Pain|pediatric pain
680001|NCT00338312|Natural Menopause|natural menopause
680002|NCT00338312|HSDD|hsdd
680003|NCT00338299|Anemia|anemia
680004|NCT00338299|hemoglobin|hemoglobin
680005|NCT00338299|chemotherapy|chemotherapy
680006|NCT00338299|subcutaneous injection|subcutaneous injection
680007|NCT00338299|Epoetin alfa|epoetin alfa
680008|NCT00338286|anemia|anemia
680009|NCT00338286|metastatic breast cancer|metastatic breast cancer
680010|NCT00338286|Hemoglobin|hemoglobin
680011|NCT00338286|progression-free survival (PFS)|progression-free survival (pfs)
680012|NCT00338286|erythropoiesis-stimulating agents (ESA)|erythropoiesis-stimulating agents (esa)
680013|NCT00338273|Bipolar I disorder with major depressive episode|bipolar i disorder with major depressive episode
680014|NCT00338247|advanced|advanced
680015|NCT00338247|TYKERB|tykerb
680016|NCT00338247|HER2 positive|her2 positive
680017|NCT00338247|Stage IIIc|stage iiic
680018|NCT00338247|ErbB2 positive|erbb2 positive
680019|NCT00338247|GW572016|gw572016
680020|NCT00338247|metastatic|metastatic
680021|NCT00338247|Stage IIIb|stage iiib
680022|NCT00338247|breast cancer|breast cancer
680023|NCT00338234|anemia|anemia
680024|NCT00338234|intensive care|intensive care
680025|NCT00338234|cardiac surgery|cardiac surgery
680026|NCT00338234|iron metabolism|iron metabolism
680027|NCT00338234|hepcidin|hepcidin
680028|NCT00338221|Diarrhea, Malnutrition, Brazil|diarrhea, malnutrition, brazil
680029|NCT00338208|low vision|low vision
680030|NCT00338208|glaucoma|glaucoma
680031|NCT00338195|Caffeine dependence|caffeine dependence
680032|NCT00338195|Caffeine withdrawal|caffeine withdrawal
680033|NCT00338182|Solid tumor|solid tumor
680034|NCT00338156|Left Ventricle Remodelling|left ventricle remodelling
680035|NCT00338156|Collagen markers|collagen markers
680036|NCT00338156|Neurohormones|neurohormones
680037|NCT00338156|Cardiac MRI|cardiac mri
680038|NCT00338143|Plaque psoriasis|plaque psoriasis
680039|NCT00338143|Antipsoriatic|antipsoriatic
680040|NCT00338130|Melanoma|melanoma
680041|NCT00338130|Phase II|phase ii
680042|NCT00338130|AZD6244|azd6244
680043|NCT00338130|temozolomide|temozolomide
680044|NCT00338117|Dementia|dementia
680045|NCT00338117|neurodegenerative disorder|neurodegenerative disorder
680046|NCT00338117|impairment of memory|impairment of memory
680047|NCT00338117|galantamine|galantamine
680048|NCT00338117|galanthamine|galanthamine
680049|NCT00338117|acetylcholinesterase inhibitor|acetylcholinesterase inhibitor
680050|NCT00338117|Mini Mental State Examination score|mini mental state examination score
680051|NCT00338104|insulin|insulin
680052|NCT00338104|glargine|glargine
680053|NCT00338104|intravenous|intravenous
680054|NCT00338104|subcutaneous|subcutaneous
680055|NCT00338104|hospital|hospital
680056|NCT00338104|diabetes|diabetes
680057|NCT00338104|glucose|glucose
680058|NCT00338104|inpatient|inpatient
680059|NCT00338091|Renal Insufficiency,Chronic|renal insufficiency,chronic
680060|NCT00338091|Disease Progression|disease progression
680061|NCT00338091|Proteinuria|proteinuria
680062|NCT00338091|Dose-Response Relationship,Drug|dose-response relationship,drug
680063|NCT00338091|Benazepril|benazepril
680064|NCT00338091|Losartan|losartan
680065|NCT00338065|Intraocular Pressure|intraocular pressure
680066|NCT00338052|Contraception|contraception
680067|NCT00338039|Pancreatic Cancer|pancreatic cancer
680068|NCT00338039|Cetuximab|cetuximab
680069|NCT00338039|C225|c225
680070|NCT00338039|Erbitux|erbitux
680071|NCT00338039|Gemcitabine|gemcitabine
680072|NCT00338039|Oxaliplatin|oxaliplatin
680073|NCT00338039|Eloxatin|eloxatin
680074|NCT00338039|Capecitabine|capecitabine
680075|NCT00338039|Xeloda|xeloda
680076|NCT00338026|Solid Tumors|solid tumors
680077|NCT00338026|Thallion|thallion
680078|NCT00338026|TLN-4601|tln-4601
680079|NCT00338026|Ecopia|ecopia
680080|NCT00338026|ECO-4601|eco-4601
680081|NCT00338026|Patients with histologically confirmed solid tumors:|patients with histologically confirmed solid tumors:
680082|NCT00338026|High Grade Glioma|high grade glioma
680083|NCT00338026|Colorectal|colorectal
680084|NCT00338026|Lung|lung
680085|NCT00338026|Breast|breast
680086|NCT00338026|Ovarian|ovarian
680087|NCT00338026|Pancreatic|pancreatic
680088|NCT00338026|Prostate|prostate
680089|NCT00338013|sleep|sleep
680090|NCT00338000|Chronic renal failure|chronic renal failure
680091|NCT00338000|left ventricular hypertrophy|left ventricular hypertrophy
680092|NCT00338000|epoetin alfa|epoetin alfa
680093|NCT00337974|cognitive enhancement|cognitive enhancement
680094|NCT00337974|memory|memory
680095|NCT00337974|auditory memory|auditory memory
680096|NCT00337974|speech|speech
680097|NCT00337974|computerized|computerized
680098|NCT00337961|Optic Nerve Sheath Fenestration|optic nerve sheath fenestration
680099|NCT00337948|Anemia|anemia
680100|NCT00337948|Epoetin Alfa|epoetin alfa
680101|NCT00337948|Chemotherapy|chemotherapy
680102|NCT00337948|Anemia due to Cancer|anemia due to cancer
680103|NCT00337935|Long Term Care Facilities|long term care facilities
680104|NCT00337935|subcutaneous injections|subcutaneous injections
680105|NCT00337935|PROCRIT|procrit
680106|NCT00337935|Epoetin alfa|epoetin alfa
680107|NCT00337935|Anemia|anemia
680108|NCT00337922|EPZICOM|epzicom
680109|NCT00337922|Lamivudine|lamivudine
680110|NCT00337922|Abacavir|abacavir
680111|NCT00337922|pharmacokinetics|pharmacokinetics
680112|NCT00337922|Japanese|japanese
680113|NCT00337909|cognitive enhancement|cognitive enhancement
680114|NCT00337909|memory|memory
680115|NCT00337909|auditory memory|auditory memory
680116|NCT00337909|speech|speech
680117|NCT00337909|computerized|computerized
680118|NCT00337896|vaccine, influenza, A/H5N1, CMI, sub-study|vaccine, influenza, a/h5n1, cmi, sub-study
680119|NCT00337883|Glioblastoma Multiforme|glioblastoma multiforme
680120|NCT00337883|glioma|glioma
680121|NCT00337883|Grade IV glioma|grade iv glioma
680122|NCT00337870|Pediatric Anxiety|pediatric anxiety
680123|NCT00337870|Pediatric Pain|pediatric pain
680124|NCT00337870|Emergency room procedures|emergency room procedures
680125|NCT00337818|Non-inferiority|non-inferiority
680126|NCT00337818|Immunogenicity|immunogenicity
680127|NCT00337818|HPV Vaccine Consistency|hpv vaccine consistency
680128|NCT00337805|colloid|colloid
680129|NCT00337805|crystalloid|crystalloid
680130|NCT00337805|hemodynamics|hemodynamics
680131|NCT00337805|flow-directed|flow-directed
680132|NCT00337805|resuscitation|resuscitation
680133|NCT00337766|Blood Loss|blood loss
680134|NCT00337766|Postoperative Blood loss|postoperative blood loss
680135|NCT00337753|Gambling|gambling
680136|NCT00337714|Central venous catheter,|central venous catheter,
680137|NCT00337714|bloodstream infections,|bloodstream infections,
680138|NCT00337714|intensive care unit|intensive care unit
680139|NCT00337688|Cerebral Palsy|cerebral palsy
680140|NCT00337688|Spasticity|spasticity
680141|NCT00337688|Joystick|joystick
680142|NCT00337688|Wheelchair|wheelchair
680143|NCT00337688|rehabilitation|rehabilitation
680144|NCT00337636|NCL|ncl
680145|NCT00337636|INCL|incl
680146|NCT00337636|LINCL|lincl
680147|NCT00337636|Batten disease|batten disease
680148|NCT00337636|Infantile Neuronal Ceroid Lipofuscinosis (INCL)|infantile neuronal ceroid lipofuscinosis (incl)
680149|NCT00337636|Late Infantile Neuronal Ceroid Lipofuscinosis (LINCL)|late infantile neuronal ceroid lipofuscinosis (lincl)
680150|NCT00337623|Cataracts|cataracts
680151|NCT00337623|Corticosteroids|corticosteroids
680152|NCT00337623|Scheimpflug|scheimpflug
680153|NCT00337623|Lens autofluorescence|lens autofluorescence
680154|NCT00337597|Normal saline|normal saline
680155|NCT00337597|Dextrose 5% in water|dextrose 5% in water
680156|NCT00337597|neurostimulation|neurostimulation
680157|NCT00337597|Continuous regional analgesia after total knee arthroplasty|continuous regional analgesia after total knee arthroplasty
680158|NCT00337584|out patient surgery|out patient surgery
680159|NCT00337584|quality improvement|quality improvement
680160|NCT00337571|Serious behavioral problems in children and adolescents with AD|serious behavioral problems in children and adolescents with ad
680161|NCT00337558|treatment outcomes|treatment outcomes
680162|NCT00337558|Overactive bladder|overactive bladder
680163|NCT00337558|Solifenacin succinate|solifenacin succinate
680164|NCT00337558|urinary incontinence|urinary incontinence
680165|NCT00337558|urge incontinence|urge incontinence
680166|NCT00337558|frequency|frequency
680167|NCT00337545|Metastatic|metastatic
680168|NCT00337545|Refractory|refractory
680169|NCT00337519|chronic lymphocytic leukemia|chronic lymphocytic leukemia
680170|NCT00337519|reduced intensity conditioning|reduced intensity conditioning
680171|NCT00337519|alemtuzumab|alemtuzumab
680172|NCT00337519|allogeneic stem cell transplantation|allogeneic stem cell transplantation
680173|NCT00337506|the efficacy and safety of Velcade plus dexamethasone|the efficacy and safety of velcade plus dexamethasone
680174|NCT00337506|Multiple Myeloma|multiple myeloma
680175|NCT00337480|acute coronary syndrome|acute coronary syndrome
680176|NCT00337480|cardiovascular risk factors|cardiovascular risk factors
680177|NCT00337480|smoking habits|smoking habits
680178|NCT00337480|obesity|obesity
680179|NCT00337480|sedentary lifestyle|sedentary lifestyle
680180|NCT00337480|overweight|overweight
680181|NCT00337480|education|education
680182|NCT00337480|follow up after hospitalization|follow up after hospitalization
680183|NCT00337467|HIV-Infected Patients Evidencing Virologic Suppression|hiv-infected patients evidencing virologic suppression
680184|NCT00337454|Imatinib resistant or intolerant CML|imatinib resistant or intolerant cml
680185|NCT00337454|Treatment resistant or intolerant Ph+ALL|treatment resistant or intolerant ph+all
680186|NCT00337441|Chronic Anemia|chronic anemia
680187|NCT00337441|Anemia|anemia
680188|NCT00337441|Chronic Diseases|chronic diseases
680189|NCT00337441|Elderly|elderly
680190|NCT00337441|Epoetin alfa|epoetin alfa
680191|NCT00337441|Fatigue|fatigue
680192|NCT00337441|Quality of life|quality of life
680193|NCT00337441|Mobility|mobility
680194|NCT00337402|Gastrostomy|gastrostomy
680195|NCT00337402|Quality of life|quality of life
680196|NCT00337389|Metastatic|metastatic
680197|NCT00337389|Colorectal|colorectal
680198|NCT00337389|Cancer|cancer
680199|NCT00337389|CoFactor|cofactor
680200|NCT00337389|Stage IV|stage iv
680201|NCT00337350|Schizophrenia|schizophrenia
680202|NCT00337350|Glucose Metabolism|glucose metabolism
680203|NCT00337350|Insulin Resistance|insulin resistance
680204|NCT00337337|Diabetes|diabetes
680205|NCT00337337|rice|rice
680206|NCT00337337|fiber|fiber
680207|NCT00337324|Diabetic neuropathy|diabetic neuropathy
680208|NCT00337324|Complications of diabetes|complications of diabetes
680209|NCT00337324|Neuropathies|neuropathies
680210|NCT00337324|Electromagnetic stimulation|electromagnetic stimulation
680211|NCT00337324|Neuropathic pain|neuropathic pain
680212|NCT00337298|Diabetes|diabetes
680213|NCT00337298|Retinopathy|retinopathy
680214|NCT00337298|Blood Pressure|blood pressure
680215|NCT00337298|Amlodipine|amlodipine
680216|NCT00337298|Lisinopril|lisinopril
680217|NCT00337285|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
680218|NCT00337285|Attention Deficit Disorders with Hyperactivity|attention deficit disorders with hyperactivity
680219|NCT00337285|Attention Deficit Hyperactivity Disorders|attention deficit hyperactivity disorders
680220|NCT00337272|chronic insomnia|chronic insomnia
680221|NCT00337259|marginal zone lymphoma|marginal zone lymphoma
680222|NCT00337259|gemcitabine|gemcitabine
680223|NCT00337246|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
680224|NCT00337246|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
680225|NCT00337246|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
680226|NCT00337246|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
680227|NCT00337246|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
680228|NCT00337233|fatigue|fatigue
680229|NCT00337233|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
680230|NCT00337233|recurrent breast cancer|recurrent breast cancer
680231|NCT00337233|stage I breast cancer|stage i breast cancer
680232|NCT00337233|stage II breast cancer|stage ii breast cancer
680233|NCT00337233|stage IIIA breast cancer|stage iiia breast cancer
680234|NCT00337233|stage IIIB breast cancer|stage iiib breast cancer
680235|NCT00337233|stage IIIC breast cancer|stage iiic breast cancer
680236|NCT00337233|stage IV breast cancer|stage iv breast cancer
680237|NCT00337233|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
680238|NCT00337233|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
680239|NCT00337233|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
680240|NCT00337233|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
680241|NCT00337233|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
680242|NCT00337233|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
680243|NCT00337233|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
680244|NCT00337233|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
680245|NCT00337233|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
680246|NCT00337233|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
680247|NCT00337220|allograft|allograft
680248|NCT00337220|graft|graft
680249|NCT00337207|adult glioblastoma|adult glioblastoma
680250|NCT00337207|adult gliosarcoma|adult gliosarcoma
680251|NCT00337207|recurrent adult brain tumor|recurrent adult brain tumor
680252|NCT00337207|adult anaplastic astrocytoma|adult anaplastic astrocytoma
680253|NCT00337207|adult giant cell glioblastoma|adult giant cell glioblastoma
680254|NCT00337181|HIV-1|hiv-1
680255|NCT00337181|Natural History|natural history
680256|NCT00337181|HIV vaccine|hiv vaccine
680257|NCT00337181|Thailand|thailand
680258|NCT00337168|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
680259|NCT00337168|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
680260|NCT00337168|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
680261|NCT00337168|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
680262|NCT00337168|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
680263|NCT00337155|Recurrent Prostate Cancer|recurrent prostate cancer
680264|NCT00337155|metastatic Cancer|metastatic cancer
680265|NCT00337142|gestational diabetes|gestational diabetes
680266|NCT00337142|newborn|newborn
680267|NCT00337142|hypoglycemia|hypoglycemia
680268|NCT00337129|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
680269|NCT00337129|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
680270|NCT00337129|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
680271|NCT00337129|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
680272|NCT00337129|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
680273|NCT00337129|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
680274|NCT00337129|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
680275|NCT00337129|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
680276|NCT00337129|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
680388|NCT00336596|Patients receiving iv thrombolytic therapy (t-PA)|patients receiving iv thrombolytic therapy (t-pa)
680277|NCT00337129|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
680278|NCT00337129|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
680279|NCT00337129|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
680280|NCT00337129|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
680281|NCT00337129|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
680366|NCT00336700|Pancreatic|pancreatic
680282|NCT00337090|Over Active Bladder|over active bladder
680283|NCT00337090|Urinary incontinence|urinary incontinence
680284|NCT00337090|YM178|ym178
680285|NCT00337090|Symptomatic Over Active Bladder|symptomatic over active bladder
680286|NCT00337077|Eribulin Mesylate|eribulin mesylate
680287|NCT00337077|metastatic hormone refractory prostate cancer|metastatic hormone refractory prostate cancer
680288|NCT00337077|Halichondrin B Analog|halichondrin b analog
680289|NCT00337064|Breast cancer treatment|breast cancer treatment
680290|NCT00337064|Partial breast radiation|partial breast radiation
680291|NCT00337064|Radiation Therapy|radiation therapy
680292|NCT00337064|Adjuvant Treatment|adjuvant treatment
680293|NCT00337051|Renal transplantation|renal transplantation
680294|NCT00337051|renal allograft|renal allograft
680295|NCT00337051|end-stage renal disease|end-stage renal disease
680296|NCT00337051|renal failure|renal failure
680297|NCT00337051|general anaesthesia|general anaesthesia
680298|NCT00337051|inhaled anaesthetic|inhaled anaesthetic
680299|NCT00337051|Sevoflurane|sevoflurane
680300|NCT00337051|ischemia|ischemia
680301|NCT00337051|reperfusion|reperfusion
680302|NCT00337051|ischemic lesions|ischemic lesions
680303|NCT00336973|Plaque Psoriasis|plaque psoriasis
680304|NCT00336973|Raptiva|raptiva
680305|NCT00336973|Anti-TNF|anti-tnf
680306|NCT00336960|stage II rectal cancer|stage ii rectal cancer
680307|NCT00336960|stage III rectal cancer|stage iii rectal cancer
680308|NCT00336960|adenocarcinoma of the rectum|adenocarcinoma of the rectum
680309|NCT00336947|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
680310|NCT00336947|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
680311|NCT00336947|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
680312|NCT00336947|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
680313|NCT00336947|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
680314|NCT00336947|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
680315|NCT00336947|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
680316|NCT00336947|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
680317|NCT00336947|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
680318|NCT00336947|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
680319|NCT00336934|adenocarcinoma of the prostate|adenocarcinoma of the prostate
680320|NCT00336934|recurrent prostate cancer|recurrent prostate cancer
680321|NCT00336934|stage I prostate cancer|stage i prostate cancer
680322|NCT00336934|stage II prostate cancer|stage ii prostate cancer
680323|NCT00336934|stage III prostate cancer|stage iii prostate cancer
680324|NCT00336934|stage IV prostate cancer|stage iv prostate cancer
680325|NCT00336908|Intensive Care,Neonatal|intensive care,neonatal
680326|NCT00336908|Parenteral nutrition|parenteral nutrition
680327|NCT00336908|Fat emulsions,Intravenous|fat emulsions,intravenous
680328|NCT00336895|Liver transplantation|liver transplantation
680329|NCT00336895|mycophenolate mofetil|mycophenolate mofetil
680330|NCT00336895|gastrointestinal|gastrointestinal
680331|NCT00336895|adverse effects|adverse effects
680332|NCT00336882|traumatic brain injury|traumatic brain injury
680333|NCT00336882|propofol|propofol
680334|NCT00336882|oxidative stress|oxidative stress
680335|NCT00336882|microdialysis|microdialysis
680336|NCT00336856|Colon Cancer|colon cancer
680337|NCT00336843|Zevalin|zevalin
680338|NCT00336843|B-cell non-Hodgkin's lymphoma|b-cell non-hodgkin's lymphoma
680339|NCT00336843|autologous stem cell transplantation|autologous stem cell transplantation
680340|NCT00336843|BuCyE regimen|bucye regimen
680341|NCT00336830|Cardiac Rehabilitation|cardiac rehabilitation
680342|NCT00336830|Improving Cardiac Rehabilitation Participation|improving cardiac rehabilitation participation
680343|NCT00336830|coronary angioplasty|coronary angioplasty
680344|NCT00336830|coronary artery bypass surgery|coronary artery bypass surgery
680345|NCT00336817|Liver transplantation|liver transplantation
680346|NCT00336817|mycophenolate mofetil|mycophenolate mofetil
680347|NCT00336817|gastrointestinal|gastrointestinal
680348|NCT00336817|adverse effects|adverse effects
680349|NCT00336791|Breast Cancer|breast cancer
680350|NCT00336791|Gene Expression|gene expression
680351|NCT00336791|Fluorouracil|fluorouracil
680352|NCT00336791|Cyclophosphamide|cyclophosphamide
680353|NCT00336791|Doxorubicin|doxorubicin
680354|NCT00336791|Paclitaxel|paclitaxel
680355|NCT00336765|solid tumors|solid tumors
680356|NCT00336752|undisplaced ,unstable wEBER B ankle fractures|undisplaced ,unstable weber b ankle fractures
680357|NCT00336752|operative intervention|operative intervention
680358|NCT00336752|non operative intervention|non operative intervention
680359|NCT00336739|Gastric acidity determination|gastric acidity determination
680360|NCT00336739|Calcium sensing receptor|calcium sensing receptor
680361|NCT00336713|depression|depression
680362|NCT00336713|antidepressive agents|antidepressive agents
680363|NCT00336713|controlled clinical trial|controlled clinical trial
680364|NCT00336700|Pancreas|pancreas
680365|NCT00336700|Cancer|cancer
680367|NCT00336687|Thrombopenia|thrombopenia
680368|NCT00336687|Reanimation|reanimation
680369|NCT00336687|Thrombopenia in reanimation|thrombopenia in reanimation
680370|NCT00336674|Type 1 diabetes|type 1 diabetes
680371|NCT00336661|Periodontitis|periodontitis
680372|NCT00336661|Chronic Periodontitis|chronic periodontitis
680373|NCT00336661|Gingivitis|gingivitis
680374|NCT00336661|PERIOWAVE|periowave
680375|NCT00336661|Photodynamic Disinfection|photodynamic disinfection
680376|NCT00336648|Pancreatic Neoplasms|pancreatic neoplasms
680377|NCT00336648|Bevacizumab|bevacizumab
680378|NCT00336648|Gemcitabine|gemcitabine
680379|NCT00336648|Radiation Therapy|radiation therapy
680380|NCT00336648|adenocarcinoma of the pancreatic head|adenocarcinoma of the pancreatic head
680381|NCT00336648|adenocarcinoma of the uncinate process|adenocarcinoma of the uncinate process
680382|NCT00336635|smallpox, vaccine, immunity|smallpox, vaccine, immunity
680383|NCT00336622|Carpal Tunnel Syndrome|carpal tunnel syndrome
680384|NCT00336622|Splints|splints
680385|NCT00336596|middle cerebral artery occlusion|middle cerebral artery occlusion
680386|NCT00336596|intracranial embolism and thrombosis|intracranial embolism and thrombosis
680387|NCT00336596|ultrasound enhanced thrombolysis|ultrasound enhanced thrombolysis
680389|NCT00336583|oxaliplatin|oxaliplatin
680390|NCT00336583|ESHAOX|eshaox
680391|NCT00336583|refractory|refractory
680392|NCT00336583|relapsed|relapsed
680393|NCT00336583|non-hodgkin's lymphoma|non-hodgkin's lymphoma
680394|NCT00336570|Oxidative Stress|oxidative stress
680395|NCT00336570|Endothelial Function|endothelial function
680396|NCT00336570|Flow Mediated Dilation|flow mediated dilation
680397|NCT00336557|High-Dose Interferon|high-dose interferon
680398|NCT00336557|Neutralizing Antibodies|neutralizing antibodies
680399|NCT00336544|Pneumonia|pneumonia
680400|NCT00336544|Respiratory|respiratory
680401|NCT00336544|Infection|infection
680402|NCT00336544|Infectious|infectious
680403|NCT00336544|Advanced|advanced
680404|NCT00336544|Life|life
680405|NCT00336544|Sciences|sciences
680406|NCT00336544|Lung|lung
680407|NCT00336544|Pulmonary|pulmonary
680408|NCT00336544|Cethromycin|cethromycin
680409|NCT00336544|Clarithromycin|clarithromycin
680410|NCT00336544|Biaxin|biaxin
680411|NCT00336531|prophylactic itraconazole|prophylactic itraconazole
680412|NCT00336531|Relapsed pediatric solid tumors|relapsed pediatric solid tumors
680413|NCT00336531|Embryonal brain tumor|embryonal brain tumor
680414|NCT00336505|Pneumonia|pneumonia
680415|NCT00336505|Respiratory|respiratory
680416|NCT00336505|Infection|infection
680417|NCT00336505|Infectious|infectious
680418|NCT00336505|Advanced|advanced
680419|NCT00336505|Life|life
680420|NCT00336505|Sciences|sciences
680421|NCT00336505|Lung|lung
680422|NCT00336505|Pulmonary|pulmonary
680423|NCT00336505|Cethromycin|cethromycin
680424|NCT00336505|Restanza|restanza
680425|NCT00336505|Clarithromycin|clarithromycin
680426|NCT00336505|Biaxin|biaxin
680427|NCT00336492|Ulcerative colitis|ulcerative colitis
680428|NCT00336492|inflammatory bowel disease|inflammatory bowel disease
680429|NCT00336492|children|children
680430|NCT00336466|Cardiac bypass surgery|cardiac bypass surgery
680431|NCT00336453|Influenza|influenza
680432|NCT00336427|MRSA|mrsa
680433|NCT00336427|Colonization|colonization
680434|NCT00336427|Pregnancy|pregnancy
680435|NCT00336427|Neonates|neonates
680436|NCT00336414|Juvenile Systemic Lupus Erythematosus nephritis|juvenile systemic lupus erythematosus nephritis
680437|NCT00336414|randomised actively controlled clinical trial|randomised actively controlled clinical trial
680438|NCT00336414|cyclophosphamide|cyclophosphamide
680439|NCT00336414|prednisone|prednisone
680440|NCT00336414|azathioprine|azathioprine
680441|NCT00336414|methylprednisolone|methylprednisolone
680442|NCT00336401|anesthesia|anesthesia
680443|NCT00336401|non cardiac surgery|non cardiac surgery
680444|NCT00336401|cardiac outcomes|cardiac outcomes
680445|NCT00336388|Malaria|malaria
680446|NCT00336362|Beta Thalassemia Major|beta thalassemia major
680447|NCT00336362|Hematopoietic Stem Cell Mobilization|hematopoietic stem cell mobilization
680448|NCT00336362|Gene Transfer Techniques|gene transfer techniques
680449|NCT00336349|diabetes mellitus|diabetes mellitus
680450|NCT00336349|neuropathic pain|neuropathic pain
680451|NCT00336323|diabetic|diabetic
680452|NCT00336323|macular|macular
680453|NCT00336323|edema|edema
680454|NCT00336323|avastin|avastin
680455|NCT00336323|bevacizumab|bevacizumab
680456|NCT00336323|anti-VEGF|anti-vegf
680457|NCT00336323|retinal thickness|retinal thickness
680458|NCT00336323|visual acuity|visual acuity
680459|NCT00336323|DME|dme
680460|NCT00336310|Diabetes Mellitus|diabetes mellitus
680461|NCT00336310|Treatment|treatment
680462|NCT00336310|Repaglinide|repaglinide
680463|NCT00336297|screening|screening
680464|NCT00336297|screening methods|screening methods
680465|NCT00336297|intimate partner violence|intimate partner violence
680466|NCT00336284|Telemonitoring|telemonitoring
680467|NCT00336284|ICD|icd
680468|NCT00336284|Reduction of office follow-ups|reduction of office follow-ups
680469|NCT00336271|coffee|coffee
680470|NCT00336271|caffeine|caffeine
680471|NCT00336271|healthy subjects|healthy subjects
680472|NCT00336258|Deep Vein Thrombosis|deep vein thrombosis
680473|NCT00336258|Cancer|cancer
680474|NCT00336258|US- Doppler|us- doppler
680475|NCT00336258|Procoagulant Microparticles|procoagulant microparticles
680476|NCT00336258|Asymptomatic|asymptomatic
680477|NCT00336245|Contraception|contraception
680478|NCT00336245|Women|women
680479|NCT00336245|HIV/AIDS|hiv/aids
680480|NCT00336245|IUD|iud
680481|NCT00336245|IUCD|iucd
680482|NCT00336232|Vitamin K metabolism|vitamin k metabolism
680483|NCT00336232|Bone health|bone health
680484|NCT00336232|Metabolism|metabolism
680485|NCT00336219|GERD|gerd
680486|NCT00336219|Pantoprazole|pantoprazole
680487|NCT00336206|Low dose Alemtuzumab|low dose alemtuzumab
680488|NCT00336206|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
680489|NCT00336206|B-Cell|b-cell
680490|NCT00336193|home visitation|home visitation
680491|NCT00336193|family outcomes|family outcomes
680492|NCT00336193|competency training|competency training
680493|NCT00336180|Adolescent|adolescent
680494|NCT00336180|Adolescent behavior|adolescent behavior
680495|NCT00336180|Adolescent development|adolescent development
680496|NCT00336180|Drinking behavior|drinking behavior
680497|NCT00336180|Health behavior|health behavior
680498|NCT00336180|Reproductive Behavior|reproductive behavior
680499|NCT00336180|Sexual Behavior|sexual behavior
680500|NCT00336180|South Africa|south africa
680501|NCT00336167|carnitine palmitoyl transferase 2 deficiency|carnitine palmitoyl transferase 2 deficiency
680502|NCT00336167|Fatty acid oxidation|fatty acid oxidation
680503|NCT00336167|Mitochondria|mitochondria
680504|NCT00336128|infant|infant
680505|NCT00336128|kindergarten|kindergarten
680506|NCT00336128|obesity|obesity
680507|NCT00336128|adiposity|adiposity
680508|NCT00336115|pertussis|pertussis
680509|NCT00336115|bone marrow transplant|bone marrow transplant
680510|NCT00336102|fatigue|fatigue
680511|NCT00336102|hypothyroidism|hypothyroidism
680512|NCT00336102|stage I breast cancer|stage i breast cancer
680513|NCT00336102|stage II breast cancer|stage ii breast cancer
680514|NCT00336102|stage IIIA breast cancer|stage iiia breast cancer
680515|NCT00336102|stage IIIB breast cancer|stage iiib breast cancer
680516|NCT00336089|fatigue|fatigue
680517|NCT00336089|pain|pain
680518|NCT00336089|cancer survivor|cancer survivor
680519|NCT00336089|breast cancer in situ|breast cancer in situ
680520|NCT00336089|inflammatory breast cancer|inflammatory breast cancer
680521|NCT00336089|stage IA breast cancer|stage ia breast cancer
680522|NCT00336089|stage IB breast cancer|stage ib breast cancer
680523|NCT00336089|stage II breast cancer|stage ii breast cancer
680524|NCT00336089|stage IIIA breast cancer|stage iiia breast cancer
680525|NCT00336089|stage IIIB breast cancer|stage iiib breast cancer
680526|NCT00336089|stage IIIC breast cancer|stage iiic breast cancer
680527|NCT00336089|stage IV breast cancer|stage iv breast cancer
680528|NCT00336089|recurrent breast cancer|recurrent breast cancer
680529|NCT00336076|Mast cell disease|mast cell disease
680530|NCT00336076|Anaphylaxis|anaphylaxis
680531|NCT00336076|c-kit|c-kit
680532|NCT00336076|Mutation|mutation
680533|NCT00336076|Mastocytosis (suspected or proven)|mastocytosis (suspected or proven)
680534|NCT00336050|Air Pollution|air pollution
680535|NCT00336050|Pulmonary Function|pulmonary function
680536|NCT00336011|pacemaker|pacemaker
680537|NCT00336011|magnetic resonance imaging|magnetic resonance imaging
680538|NCT00336011|safety|safety
680539|NCT00335985|polymyositis, dermatomyositis|polymyositis, dermatomyositis
680540|NCT00335985|High-dose intravenous immunoglobulin|high-dose intravenous immunoglobulin
680541|NCT00335985|Venoglobulin-IH|venoglobulin-ih
680542|NCT00335985|Steroid-resistant polymyositis(PM) and dermatomyositis(DM)|steroid-resistant polymyositis(pm) and dermatomyositis(dm)
680543|NCT00335972|Carotid Endarterectomy patients|carotid endarterectomy patients
680544|NCT00335959|adenocarcinoma of the stomach|adenocarcinoma of the stomach
680545|NCT00335959|stage I gastric cancer|stage i gastric cancer
680546|NCT00335959|stage II gastric cancer|stage ii gastric cancer
680547|NCT00335959|stage III gastric cancer|stage iii gastric cancer
680548|NCT00335933|Postherpetic Neuralgia (PHN)|postherpetic neuralgia (phn)
680549|NCT00335920|Sudden Hearing Loss|sudden hearing loss
680550|NCT00335920|intratympanic|intratympanic
680551|NCT00335920|steroids|steroids
680552|NCT00335907|Clinical trial|clinical trial
680553|NCT00335907|Controlled clinical trial|controlled clinical trial
680554|NCT00335907|Shock, Septic|shock, septic
680555|NCT00335894|Infertility|infertility
680556|NCT00335894|IVF|ivf
680557|NCT00335894|ART|art
680558|NCT00335894|hMG|hmg
680559|NCT00335881|Prophylaxis for hepatitis B disease|prophylaxis for hepatitis b disease
680560|NCT00335868|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
680561|NCT00335868|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
680562|NCT00335868|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
680563|NCT00335868|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
680564|NCT00335855|Device, influenza|device, influenza
680565|NCT00335829|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
680566|NCT00335829|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
680567|NCT00335829|advanced adult primary liver cancer|advanced adult primary liver cancer
680568|NCT00335829|recurrent adult primary liver cancer|recurrent adult primary liver cancer
680569|NCT00335816|stage II rectal cancer|stage ii rectal cancer
680570|NCT00335816|stage III rectal cancer|stage iii rectal cancer
680571|NCT00335816|adenocarcinoma of the rectum|adenocarcinoma of the rectum
680572|NCT00335751|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
680573|NCT00335751|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
680574|NCT00335751|localized osteosarcoma|localized osteosarcoma
680575|NCT00335751|metastatic osteosarcoma|metastatic osteosarcoma
680576|NCT00335751|recurrent osteosarcoma|recurrent osteosarcoma
680577|NCT00335751|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
680578|NCT00335751|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
680579|NCT00335751|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
680580|NCT00335725|Ovarian stimulation|ovarian stimulation
680581|NCT00335725|Infertility|infertility
680582|NCT00335725|ICSI|icsi
680583|NCT00335725|FSH|fsh
680584|NCT00335712|ONO-5129|ono-5129
680585|NCT00335712|type 2 diabetes mellitus|type 2 diabetes mellitus
680586|NCT00335699|Hypercholesterolemia with nondiabetic metabolic syndrome|hypercholesterolemia with nondiabetic metabolic syndrome
680587|NCT00335686|Mitochondrial toxicity|mitochondrial toxicity
680588|NCT00335686|Lopinavir-rtv|lopinavir-rtv
680589|NCT00335686|Nevirapine|nevirapine
680590|NCT00335686|DNA mitochondrial/DNA nuclear|dna mitochondrial/dna nuclear
680591|NCT00335660|Idiopathic Detrusor Overactivity|idiopathic detrusor overactivity
680592|NCT00335660|NK-1 Receptor Antagonist|nk-1 receptor antagonist
680593|NCT00335660|Neurokinin|neurokinin
680594|NCT00335660|Urge Incontinence|urge incontinence
680595|NCT00335647|stage III multiple myeloma|stage iii multiple myeloma
680596|NCT00335647|refractory multiple myeloma|refractory multiple myeloma
680597|NCT00335647|stage II multiple myeloma|stage ii multiple myeloma
680598|NCT00335634|Prostate Cancer|prostate cancer
680599|NCT00335634|Radical Prostatectomy|radical prostatectomy
680600|NCT00335634|Sexual Dysfunction|sexual dysfunction
680601|NCT00335634|Intimacy|intimacy
680602|NCT00335634|Adaptation|adaptation
680603|NCT00335634|Psychosocial Oncology|psychosocial oncology
680604|NCT00335621|COPD|copd
680605|NCT00335621|ipratropium|ipratropium
680606|NCT00335621|tiotropium|tiotropium
680607|NCT00335595|colorectal cancer|colorectal cancer
680608|NCT00335595|Bevacizumab|bevacizumab
680609|NCT00335595|capecitabine|capecitabine
680610|NCT00335595|oxaliplatin|oxaliplatin
680611|NCT00335582|alpha 2 agonists|alpha 2 agonists
680612|NCT00335582|cardiac events|cardiac events
680613|NCT00335582|non cardiac surgery|non cardiac surgery
680614|NCT00335569|Infertility, sterility, hCG, IVF|infertility, sterility, hcg, ivf
680615|NCT00335543|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
680616|NCT00335543|stage I pancreatic cancer|stage i pancreatic cancer
680617|NCT00335543|stage II pancreatic cancer|stage ii pancreatic cancer
680618|NCT00335543|stage III pancreatic cancer|stage iii pancreatic cancer
680619|NCT00335517|Lumbar surgery|lumbar surgery
680620|NCT00335517|Surgery L3-S1|surgery l3-s1
680621|NCT00335517|DepoDur|depodur
680622|NCT00335517|Post-operative pain|post-operative pain
680623|NCT00335517|Pain control|pain control
680624|NCT00335517|Pain relief|pain relief
680625|NCT00335491|small cell lung cancer|small cell lung cancer
680626|NCT00335491|non-small cell lung cancer|non-small cell lung cancer
680627|NCT00335491|colon cancer|colon cancer
680628|NCT00335491|prostate cancer|prostate cancer
680629|NCT00335491|breast cancer|breast cancer
680630|NCT00335491|male breast cancer|male breast cancer
680631|NCT00335491|fatigue|fatigue
680632|NCT00335491|lymphoma|lymphoma
680633|NCT00335491|ovarian epithelial cancer|ovarian epithelial cancer
680634|NCT00335491|bladder cancer|bladder cancer
680635|NCT00335491|esophageal cancer|esophageal cancer
680636|NCT00335478|neutropenia|neutropenia
680637|NCT00335478|infection|infection
680638|NCT00335478|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
680639|NCT00335478|fever, sweats, and hot flashes|fever, sweats, and hot flashes
680640|NCT00335452|platelet aggregation inhibitors|platelet aggregation inhibitors
680641|NCT00335452|acute coronary disease|acute coronary disease
680642|NCT00335452|percutaneous coronary|percutaneous coronary
680643|NCT00335413|Renal autoregulation|renal autoregulation
680644|NCT00335413|Glomerular filtration rate|glomerular filtration rate
680645|NCT00335413|Type 1 diabetes|type 1 diabetes
680646|NCT00335374|Parkinson's disease|parkinson's disease
680647|NCT00335361|Male Contraceptive Devices|male contraceptive devices
680648|NCT00335361|Intra Vas Device (IVD)|intra vas device (ivd)
680649|NCT00335361|Male Sterilization|male sterilization
680650|NCT00335361|Vasectomy|vasectomy
680651|NCT00335361|Intra Vas Deferens Occlusion|intra vas deferens occlusion
680652|NCT00335361|Vas Occlusion|vas occlusion
680653|NCT00335348|Multiple Myeloma|multiple myeloma
680654|NCT00335348|Relapse|relapse
680655|NCT00335348|Bortezomib|bortezomib
680656|NCT00335348|Dexamethasone|dexamethasone
680657|NCT00335348|Maintenance|maintenance
680658|NCT00335335|Coronary|coronary
680659|NCT00335335|Angiography|angiography
680660|NCT00335335|X-ray|x-ray
680661|NCT00335335|CAD|cad
680662|NCT00335322|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
680663|NCT00335309|chronic rhinosinusitis|chronic rhinosinusitis
680664|NCT00335309|sinus irrigation|sinus irrigation
680665|NCT00335296|PFO|pfo
680666|NCT00335296|Migraine|migraine
680667|NCT00335296|Stroke|stroke
680668|NCT00335296|TIA (transient ischemic attack)|tia (transient ischemic attack)
680669|NCT00335296|Decompression Illness|decompression illness
680670|NCT00335270|HIV Type 1|hiv type 1
680671|NCT00335257|Drospirenone|drospirenone
680672|NCT00335257|Safety|safety
680673|NCT00335257|INAS|inas
680674|NCT00335231|Post-cataract surgery endophthalmitis|post-cataract surgery endophthalmitis
680675|NCT00335218|Early postmenopausal state|early postmenopausal state
680676|NCT00335218|Climacteric symptoms|climacteric symptoms
680677|NCT00335218|Hormone replacement therapy|hormone replacement therapy
680678|NCT00335205|ropinirole|ropinirole
680679|NCT00335205|dopamine|dopamine
680680|NCT00335205|D2|d2
680681|NCT00335205|depression|depression
680682|NCT00335205|bipolar|bipolar
680683|NCT00335192|Intracellular concentrations|intracellular concentrations
680684|NCT00335192|Plasma concentration|plasma concentration
680685|NCT00335192|Abacavir|abacavir
680686|NCT00335192|Tenofovir|tenofovir
680687|NCT00335192|Lamivudine (3TC)|lamivudine (3tc)
680688|NCT00335192|Pharmacokinetic interactions|pharmacokinetic interactions
680689|NCT00335179|Actinic keratosis|actinic keratosis
680690|NCT00335179|AK|ak
680691|NCT00335179|imiquimod|imiquimod
680692|NCT00335179|confocal microscopy|confocal microscopy
680693|NCT00335179|gene microarray|gene microarray
680694|NCT00335166|Parkinson Disease|parkinson disease
680695|NCT00335153|severe motor fluctuations|severe motor fluctuations
680696|NCT00335153|levodopa|levodopa
680697|NCT00335153|levodopa/carbidopa intestinal gel|levodopa/carbidopa intestinal gel
680698|NCT00335153|efficacy|efficacy
680699|NCT00335153|dyskinesia|dyskinesia
680700|NCT00335153|Parkinson's Disease|parkinson's disease
680701|NCT00335153|carbidopa|carbidopa
680702|NCT00335153|DUOPA|duopa
680703|NCT00335140|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
680704|NCT00335114|cyclosporine, dry eye syndrome, contact lens|cyclosporine, dry eye syndrome, contact lens
680705|NCT00335101|Coronary Artery Disease (CAD), Renal Impairment, Serum creatinine (SCr), Iodixanol, Ioversol, Iopromide, Contrast Induced Nephropathy (CIN)|coronary artery disease (cad), renal impairment, serum creatinine (scr), iodixanol, ioversol, iopromide, contrast induced nephropathy (cin)
680706|NCT00335088|Prophylaxis,|prophylaxis,
680707|NCT00335088|Intraocular surgery|intraocular surgery
680708|NCT00335088|Lacrimal sac|lacrimal sac
680709|NCT00335088|Eye lid|eye lid
680710|NCT00335088|No conditions|no conditions
680711|NCT00335062|Autoimmune thyroid disease|autoimmune thyroid disease
680712|NCT00335062|Children and Adolescents|children and adolescents
680713|NCT00335062|TSH Receptor Antibodies|tsh receptor antibodies
680714|NCT00335049|myopia progression|myopia progression
680715|NCT00335049|bifocal|bifocal
680716|NCT00335036|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
680717|NCT00335036|Ventricular Arrhythmia|ventricular arrhythmia
680718|NCT00335036|Sudden Cardiac Death|sudden cardiac death
680719|NCT00335036|Congenital Heart Disease|congenital heart disease
680720|NCT00335036|Pediatric Electrophysiology|pediatric electrophysiology
680721|NCT00335023|postpartum hemorrhage|postpartum hemorrhage
680722|NCT00335023|red blood cell transfusion|red blood cell transfusion
680723|NCT00335023|health related quality of life|health related quality of life
680724|NCT00335010|Nitroglycerine|nitroglycerine
680725|NCT00335010|gastroesophageal anastomosis|gastroesophageal anastomosis
680726|NCT00335010|microvascular bloodflow|microvascular bloodflow
680727|NCT00335010|microvascular hemoglobinsaturation|microvascular hemoglobinsaturation
680728|NCT00334997|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
680729|NCT00334997|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
680730|NCT00334997|stage 0 laryngeal cancer|stage 0 laryngeal cancer
680731|NCT00334984|childhood fibrosarcoma|childhood fibrosarcoma
680732|NCT00334984|childhood neurofibrosarcoma|childhood neurofibrosarcoma
680733|NCT00334984|childhood synovial sarcoma|childhood synovial sarcoma
680734|NCT00334984|chondrosarcoma|chondrosarcoma
680735|NCT00334984|localized osteosarcoma|localized osteosarcoma
680736|NCT00334984|metastatic osteosarcoma|metastatic osteosarcoma
680737|NCT00334984|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
680738|NCT00334984|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
680739|NCT00334984|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
680740|NCT00334984|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
680741|NCT00334984|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
680742|NCT00334984|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
680743|NCT00334984|childhood alveolar soft-part sarcoma|childhood alveolar soft-part sarcoma
680744|NCT00334984|childhood angiosarcoma|childhood angiosarcoma
680745|NCT00334984|childhood epithelioid sarcoma|childhood epithelioid sarcoma
680746|NCT00334984|childhood leiomyosarcoma|childhood leiomyosarcoma
680747|NCT00334984|childhood liposarcoma|childhood liposarcoma
680748|NCT00334984|localized childhood malignant fibrous histiocytoma of bone|localized childhood malignant fibrous histiocytoma of bone
680749|NCT00334984|metastatic childhood malignant fibrous histiocytoma of bone|metastatic childhood malignant fibrous histiocytoma of bone
680750|NCT00334984|childhood malignant mesenchymoma|childhood malignant mesenchymoma
680751|NCT00334984|dermatofibrosarcoma protuberans|dermatofibrosarcoma protuberans
680752|NCT00334984|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
680753|NCT00334971|African-American|african-american
680754|NCT00334971|estradiol|estradiol
680755|NCT00334971|luteinizing hormone|luteinizing hormone
680756|NCT00334971|follicle stimulating hormone|follicle stimulating hormone
680757|NCT00334971|androstenedione|androstenedione
680758|NCT00334971|aromatase|aromatase
680759|NCT00334971|inhibins|inhibins
680760|NCT00334971|ovarian|ovarian
680761|NCT00334971|Healthy volunteers|healthy volunteers
680762|NCT00334971|Fragile X|fragile x
680763|NCT00334945|Fibroblast Growth Factors|fibroblast growth factors
680764|NCT00334945|Bone development|bone development
680765|NCT00334932|refractory multiple myeloma|refractory multiple myeloma
680766|NCT00334932|stage I multiple myeloma|stage i multiple myeloma
680767|NCT00334932|stage II multiple myeloma|stage ii multiple myeloma
680768|NCT00334932|stage III multiple myeloma|stage iii multiple myeloma
680769|NCT00334919|Diabetes|diabetes
680770|NCT00334919|Pre-Diabetes|pre-diabetes
680771|NCT00334919|Anti-Inflammatory Diet|anti-inflammatory diet
680772|NCT00334919|Diet Study|diet study
680773|NCT00334919|Inflammation|inflammation
680774|NCT00334919|Diabetic Diet|diabetic diet
680775|NCT00334906|memantine|memantine
680776|NCT00334906|Alzheimer's disease|alzheimer's disease
680777|NCT00334906|MRI|mri
680778|NCT00334906|moderate Alzheimer's disease|moderate alzheimer's disease
680779|NCT00334880|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
680780|NCT00334880|Attention Deficit Disorders with Hyperactivity|attention deficit disorders with hyperactivity
680781|NCT00334880|Attention Deficit Hyperactivity Disorders|attention deficit hyperactivity disorders
680782|NCT00334867|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
680783|NCT00334854|childhood synovial sarcoma|childhood synovial sarcoma
680784|NCT00334854|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
680785|NCT00334854|childhood alveolar soft-part sarcoma|childhood alveolar soft-part sarcoma
680786|NCT00334854|childhood angiosarcoma|childhood angiosarcoma
680787|NCT00334854|childhood epithelioid sarcoma|childhood epithelioid sarcoma
680788|NCT00334854|childhood fibrosarcoma|childhood fibrosarcoma
680789|NCT00334854|childhood leiomyosarcoma|childhood leiomyosarcoma
680790|NCT00334854|childhood liposarcoma|childhood liposarcoma
680791|NCT00334854|childhood neurofibrosarcoma|childhood neurofibrosarcoma
680792|NCT00334854|localized childhood malignant fibrous histiocytoma of bone|localized childhood malignant fibrous histiocytoma of bone
680793|NCT00334854|childhood malignant hemangiopericytoma|childhood malignant hemangiopericytoma
680794|NCT00334854|dermatofibrosarcoma protuberans|dermatofibrosarcoma protuberans
680795|NCT00334854|chondrosarcoma|chondrosarcoma
680796|NCT00334828|Severe sepsis|severe sepsis
680797|NCT00334828|septic shock|septic shock
680798|NCT00334828|sepsis|sepsis
680799|NCT00334776|recurrent melanoma|recurrent melanoma
680800|NCT00334776|stage IV melanoma|stage iv melanoma
680801|NCT00334776|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
680802|NCT00334776|iris melanoma|iris melanoma
680803|NCT00334776|recurrent intraocular melanoma|recurrent intraocular melanoma
680804|NCT00334776|extraocular extension melanoma|extraocular extension melanoma
680805|NCT00334763|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
680806|NCT00334763|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
680807|NCT00334763|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
680808|NCT00334763|squamous cell lung cancer|squamous cell lung cancer
680809|NCT00334750|Glaucoma, Open-Angle Ocular Hypertension Risk factors Canadian|glaucoma, open-angle ocular hypertension risk factors canadian
680810|NCT00334737|erythropoietin|erythropoietin
680811|NCT00334737|darbepoetin|darbepoetin
680812|NCT00334737|transfusions|transfusions
680813|NCT00334737|neonates|neonates
680814|NCT00334737|outcomes|outcomes
680815|NCT00334737|neurodevelopment|neurodevelopment
680816|NCT00334724|Cardiovascular disease|cardiovascular disease
680817|NCT00334724|Vascular disease|vascular disease
680818|NCT00334724|Hypertension|hypertension
680819|NCT00334724|Home blood pressure measurement|home blood pressure measurement
680820|NCT00334711|Permanent Neonatal Diabetes|permanent neonatal diabetes
680821|NCT00334711|Kir6.2|kir6.2
680822|NCT00334711|KCNJ11|kcnj11
680823|NCT00334711|Infancy onset diabetes|infancy onset diabetes
680824|NCT00334711|Sulfonylurea|sulfonylurea
680825|NCT00334672|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
680826|NCT00334659|HIV-1 Infection|hiv-1 infection
680827|NCT00334646|cyclophosphamide|cyclophosphamide
680828|NCT00334646|CINV|cinv
680829|NCT00334646|Chemotherapy induced nausea and vomiting|chemotherapy induced nausea and vomiting
680830|NCT00334633|bacterial vaginosis|bacterial vaginosis
680831|NCT00334633|tinidazole|tinidazole
680832|NCT00334620|randomised double-blinded trial|randomised double-blinded trial
680833|NCT00334620|rehabilitation|rehabilitation
680834|NCT00334620|radon spa therapy|radon spa therapy
680835|NCT00334620|long-term effectiveness|long-term effectiveness
680836|NCT00334607|HRV vaccine|hrv vaccine
680837|NCT00334607|diarrhoea|diarrhoea
680838|NCT00334607|rotavirus|rotavirus
680839|NCT00334594|epithelial mesothelioma|epithelial mesothelioma
680840|NCT00334594|sarcomatous mesothelioma|sarcomatous mesothelioma
680841|NCT00334594|stage IA malignant mesothelioma|stage ia malignant mesothelioma
680842|NCT00334594|stage IB malignant mesothelioma|stage ib malignant mesothelioma
680843|NCT00334594|stage II malignant mesothelioma|stage ii malignant mesothelioma
680844|NCT00334594|stage III malignant mesothelioma|stage iii malignant mesothelioma
680845|NCT00334568|AVANDIA|avandia
680846|NCT00334568|Alzheimers Disease|alzheimers disease
680847|NCT00334555|trichomoniasis|trichomoniasis
680848|NCT00334555|partner notification|partner notification
680849|NCT00334542|breast cancer|breast cancer
680850|NCT00334542|ductal breast carcinoma in situ|ductal breast carcinoma in situ
680851|NCT00334542|breast cancer in situ|breast cancer in situ
680852|NCT00334542|stage I breast cancer|stage i breast cancer
680853|NCT00334542|stage II breast cancer|stage ii breast cancer
680854|NCT00334542|stage IIIA breast cancer|stage iiia breast cancer
680855|NCT00334542|stage IIIB breast cancer|stage iiib breast cancer
680856|NCT00334542|stage IIIC breast cancer|stage iiic breast cancer
680857|NCT00334529|Tamiflu|tamiflu
680858|NCT00334529|Flu|flu
680859|NCT00334529|Antiviral|antiviral
680860|NCT00334529|Neuraminidase Inhibitor|neuraminidase inhibitor
680861|NCT00334529|Pharmacokinetic Trial|pharmacokinetic trial
680862|NCT00334529|Healthy Volunteer|healthy volunteer
680863|NCT00334529|HV|hv
680864|NCT00334516|Motor Neuron Disease|motor neuron disease
680865|NCT00334516|Cognitive Testing|cognitive testing
680866|NCT00334516|Movement-Related Potential|movement-related potential
680867|NCT00334516|MRI|mri
680868|NCT00334516|Neuropsychologic Testing|neuropsychologic testing
680869|NCT00334516|Primary Lateral Sclerosis|primary lateral sclerosis
680870|NCT00334516|PLS|pls
680871|NCT00334516|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
680872|NCT00334516|ALS|als
680873|NCT00334516|Healthy Volunteer|healthy volunteer
680874|NCT00334516|HV|hv
680875|NCT00334503|alpa-glucosidase inhibitor,Biguanide|alpa-glucosidase inhibitor,biguanide
680876|NCT00334490|Pulmonary Hypertension|pulmonary hypertension
680877|NCT00334490|Sildenafil|sildenafil
680878|NCT00334490|Viagra|viagra
680879|NCT00334490|Cardiac Surgery|cardiac surgery
680880|NCT00334490|Cardiopulmonary Bypass|cardiopulmonary bypass
680881|NCT00334477|erectile dysfunction|erectile dysfunction
680882|NCT00334477|chronic renal dysfunction|chronic renal dysfunction
680883|NCT00334477|tadalafil|tadalafil
680884|NCT00334464|warfarin metabolism|warfarin metabolism
680885|NCT00334464|CYP2C0|cyp2c0
680886|NCT00334464|anticoagulation|anticoagulation
680887|NCT00334464|genotyping|genotyping
680888|NCT00334464|DVT|dvt
680889|NCT00334464|PE|pe
680890|NCT00334451|Heart Failure|heart failure
680891|NCT00334451|Remote Monitoring|remote monitoring
680892|NCT00334451|Implantable Device|implantable device
680893|NCT00334438|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
680894|NCT00334438|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
680895|NCT00334438|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
680896|NCT00334438|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
680897|NCT00334438|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
680898|NCT00334399|alpa-glucosidase inhibitor,Biguanide|alpa-glucosidase inhibitor,biguanide
680899|NCT00334386|Hypertension|hypertension
680900|NCT00334386|Anti-hypertensive effect|anti-hypertensive effect
680901|NCT00334386|Diuretic|diuretic
680902|NCT00334373|Myocardial infarction|myocardial infarction
680903|NCT00334373|Magnetic Resonance Imaging|magnetic resonance imaging
680904|NCT00334373|Coronary Angioplasty|coronary angioplasty
680905|NCT00334334|Streptococcus pneumonia, vaccine|streptococcus pneumonia, vaccine
680906|NCT00334321|IMRT|imrt
680907|NCT00334321|Tomotherapy|tomotherapy
680908|NCT00334321|Post-Hysterectomy|post-hysterectomy
680909|NCT00334321|Endometrial Cancer|endometrial cancer
680910|NCT00334295|Recurrent or metastatic endometrial carcinoma|recurrent or metastatic endometrial carcinoma
680911|NCT00334282|Metastatic|metastatic
680912|NCT00334282|Anti-angiogenesis|anti-angiogenesis
680913|NCT00334282|GW786034|gw786034
680914|NCT00334282|Pazopanib|pazopanib
680915|NCT00334269|obesity|obesity
680916|NCT00334269|physical activity|physical activity
680917|NCT00334269|daily energy intake|daily energy intake
680918|NCT00334269|nutrition|nutrition
680919|NCT00334269|healthy lifestyle|healthy lifestyle
680920|NCT00334269|Aboriginal|aboriginal
680921|NCT00334269|body fat|body fat
680922|NCT00334269|exercise|exercise
680923|NCT00334269|education|education
680924|NCT00334269|family|family
680925|NCT00334269|body mass index|body mass index
680926|NCT00334269|knowledge|knowledge
680927|NCT00334269|randomized controlled trial|randomized controlled trial
680928|NCT00334269|community|community
680929|NCT00334269|intervention|intervention
680930|NCT00334269|Six Nations Indian Reserve|six nations indian reserve
680931|NCT00334269|household|household
680932|NCT00334269|health counselling|health counselling
680933|NCT00334256|PMTCT|pmtct
680934|NCT00334256|Resistance|resistance
680935|NCT00334256|HIV infection|hiv infection
680936|NCT00334256|Pregnancy|pregnancy
680937|NCT00334243|in vitro fertilization|in vitro fertilization
680938|NCT00334243|infertile|infertile
680939|NCT00334243|infertility|infertility
680940|NCT00334243|pregnancy|pregnancy
680941|NCT00334243|pregnancy rates|pregnancy rates
680942|NCT00334243|microflare protocol|microflare protocol
680943|NCT00334243|antagonist protocol|antagonist protocol
680944|NCT00334243|demi-halt protocol|demi-halt protocol
680945|NCT00334243|poor responders|poor responders
680946|NCT00334243|low antral follicle count|low antral follicle count
680947|NCT00334243|Infertile Patients undergoing in vitro fertilization (IVF)|infertile patients undergoing in vitro fertilization (ivf)
680948|NCT00334243|Patients with a previous poor response to ovarian stimulation|patients with a previous poor response to ovarian stimulation
680949|NCT00334243|Patients with an antral follicle count of less than 10|patients with an antral follicle count of less than 10
680950|NCT00334230|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
680951|NCT00334230|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
680952|NCT00334230|Locomotion|locomotion
680953|NCT00334230|Cortical Reorganization|cortical reorganization
680954|NCT00334230|Rehabilitation|rehabilitation
680955|NCT00334230|fMRI|fmri
680956|NCT00334230|Stroke|stroke
680957|NCT00334230|Healthy Volunteer|healthy volunteer
680958|NCT00334230|HV|hv
680959|NCT00334217|Psychology: cognitive aspects|psychology: cognitive aspects
680960|NCT00334217|Substance-Related Disorders|substance-related disorders
680961|NCT00334217|treatment efficacy|treatment efficacy
680962|NCT00334204|Platelet Function Analyser-100 (PFA-100)|platelet function analyser-100 (pfa-100)
680963|NCT00334204|renal failure|renal failure
680964|NCT00334204|kidney biopsy|kidney biopsy
680965|NCT00334204|bleeding|bleeding
680966|NCT00334204|hematoma|hematoma
680967|NCT00334191|Cardiac surgery,|cardiac surgery,
680968|NCT00334191|Cardiopulmonary bypass,|cardiopulmonary bypass,
680969|NCT00334191|Oxidative stress,|oxidative stress,
680970|NCT00334191|Acute renal dysfunction,|acute renal dysfunction,
680971|NCT00334191|Sodium Bicarbonate|sodium bicarbonate
680972|NCT00334178|Migraine|migraine
680973|NCT00334178|Migraine prophylaxis|migraine prophylaxis
680974|NCT00334152|NK-1|nk-1
680975|NCT00334152|antiemetics|antiemetics
680976|NCT00334152|casopitant mesylate|casopitant mesylate
680977|NCT00334152|postoperative nausea and vomiting|postoperative nausea and vomiting
680978|NCT00334152|ondansetron hydrochloride|ondansetron hydrochloride
680979|NCT00334152|5HT3|5ht3
680980|NCT00334152|ZOFRAN|zofran
680981|NCT00334152|PONV|ponv
680982|NCT00334139|serum bone markers|serum bone markers
680983|NCT00334139|bone metastasis|bone metastasis
680984|NCT00334139|prostate cancer|prostate cancer
680985|NCT00334139|breast cancer|breast cancer
680986|NCT00334139|quality of life|quality of life
680987|NCT00334139|bisphosphonates|bisphosphonates
680988|NCT00334126|Schizophrenia|schizophrenia
680989|NCT00334126|Antipsychotic|antipsychotic
680990|NCT00334126|paliperidone|paliperidone
680991|NCT00334126|quetiapine|quetiapine
680992|NCT00334126|Seroquel|seroquel
680993|NCT00334126|placebo|placebo
680994|NCT00334113|Diabetes Mellitus|diabetes mellitus
680995|NCT00334113|Exercise|exercise
680996|NCT00334113|Obesity|obesity
680997|NCT00334113|Telemedicine|telemedicine
680998|NCT00334100|Exercise|exercise
680999|NCT00334100|multiple sclerosis|multiple sclerosis
681000|NCT00334100|treadmill|treadmill
681001|NCT00334087|primary dental prevention|primary dental prevention
681002|NCT00334087|early childhood caries|early childhood caries
681003|NCT00334087|prenatal oral care|prenatal oral care
681004|NCT00334074|AML|aml
681005|NCT00334074|MDS|mds
681006|NCT00334074|CML|cml
681007|NCT00334074|Relapsed|relapsed
681008|NCT00334074|Refractory|refractory
681009|NCT00334074|Chemo treatment|chemo treatment
681010|NCT00334074|Clofarabine|clofarabine
681011|NCT00334074|Cytarabine|cytarabine
681012|NCT00334074|standard or poor cytogenetic risk AML|standard or poor cytogenetic risk aml
681013|NCT00334074|untreated high-risk (>10% blasts) MDS|untreated high-risk (>10% blasts) mds
681014|NCT00334074|CML in accelerated phase or blast crisis|cml in accelerated phase or blast crisis
681015|NCT00334074|Elderly AML patients with risk of anthracycline toxicity|elderly aml patients with risk of anthracycline toxicity
681016|NCT00334061|Penumbra|penumbra
681017|NCT00334061|Ischemic|ischemic
681018|NCT00334061|Stroke|stroke
681019|NCT00334061|Intervention|intervention
681020|NCT00334061|Neurovascular|neurovascular
681021|NCT00334061|Thrombus|thrombus
681022|NCT00334061|Embolectomy|embolectomy
681023|NCT00334061|Ischemic stroke|ischemic stroke
681024|NCT00334048|Medication-induced sexual dysfunction|medication-induced sexual dysfunction
681025|NCT00334048|SSRI-induced sexual dysfunction|ssri-induced sexual dysfunction
681026|NCT00334048|Anorgasmia|anorgasmia
681027|NCT00334048|Delayed ejaculation|delayed ejaculation
681028|NCT00334048|Sexual dysfunction|sexual dysfunction
681029|NCT00334048|Antidepressant-induced sexual dysfunction|antidepressant-induced sexual dysfunction
681030|NCT00334048|Requip|requip
681031|NCT00334048|Ropinirole|ropinirole
681032|NCT00334048|Dopamine agonist|dopamine agonist
681033|NCT00334048|Serotonin reuptake inhibitor|serotonin reuptake inhibitor
681034|NCT00334048|Sexual dysfunction, physiological, medication-induced|sexual dysfunction, physiological, medication-induced
681035|NCT00334022|Fuzeon|fuzeon
681036|NCT00334022|Viral Decay|viral decay
681037|NCT00334009|Cardiac Surgery|cardiac surgery
681038|NCT00334009|Cardiopulmonary Bypass|cardiopulmonary bypass
681039|NCT00334009|COMT-Polymorphism|comt-polymorphism
681040|NCT00334009|Vasoplegia|vasoplegia
681041|NCT00334009|Catecholamines|catecholamines
681042|NCT00334009|Acute Renal Failure|acute renal failure
681043|NCT00333970|cognition|cognition
681044|NCT00333970|neuropsychology|neuropsychology
681045|NCT00333970|Rehabilitation|rehabilitation
681046|NCT00333970|treatment efficacy|treatment efficacy
681047|NCT00333970|cognitive remediation|cognitive remediation
681048|NCT00333957|capsule endoscopy|capsule endoscopy
681049|NCT00333944|Organophosphorus poisoning|organophosphorus poisoning
681050|NCT00333944|Atropine|atropine
681051|NCT00333944|Pralidoxime|pralidoxime
681052|NCT00333944|Intermediate syndrome.|intermediate syndrome.
681053|NCT00333931|Impulsive Aggression|impulsive aggression
681054|NCT00333931|Posttraumatic Stress Disorder|posttraumatic stress disorder
681055|NCT00333918|Cataract Extraction|cataract extraction
681056|NCT00333918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
681057|NCT00333905|Exercise|exercise
681058|NCT00333905|Exercise Therapy|exercise therapy
681059|NCT00333892|primary HIV infection|primary hiv infection
681060|NCT00333892|chronic HIV infection|chronic hiv infection
681061|NCT00333879|Rehabilitation|rehabilitation
681062|NCT00333879|Sensory Aid|sensory aid
681063|NCT00333840|CML|cml
681064|NCT00333840|STI571|sti571
681065|NCT00333840|imatinib|imatinib
681066|NCT00333840|interferon|interferon
681067|NCT00333840|interferon alpha|interferon alpha
681068|NCT00333840|cytosine arabinoside|cytosine arabinoside
681069|NCT00333840|chronic myeloid leukemia|chronic myeloid leukemia
681070|NCT00333840|Philadelphia chromosome positive|philadelphia chromosome positive
681071|NCT00333827|Dilated Cardiomyopathy|dilated cardiomyopathy
681072|NCT00333827|stem cells|stem cells
681073|NCT00333827|Therapeutics|therapeutics
681074|NCT00333827|Randomized Controlled Trials|randomized controlled trials
681075|NCT00333801|Posttraumatic Stress Disorder|posttraumatic stress disorder
681076|NCT00333801|Veterans|veterans
681077|NCT00333801|Vocational Rehabilitation|vocational rehabilitation
681078|NCT00333801|Supported Employment|supported employment
681079|NCT00333801|Individual Placement and Support|individual placement and support
681080|NCT00333788|Crohn's Disease|crohn's disease
681081|NCT00333788|Certolizumab pegol|certolizumab pegol
681082|NCT00333788|CDP870|cdp870
681083|NCT00333788|Cimzia|cimzia
681084|NCT00333762|aging|aging
681085|NCT00333762|blindness|blindness
681086|NCT00333762|wheelchairs|wheelchairs
681087|NCT00333762|spinal cord injury|spinal cord injury
681088|NCT00333749|children|children
681089|NCT00333736|Injection site reactions|injection site reactions
681090|NCT00333736|enfuvirtide administration|enfuvirtide administration
681091|NCT00333723|Rosiglitazone|rosiglitazone
681092|NCT00333723|Glyburide|glyburide
681093|NCT00333723|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
681094|NCT00333723|African American|african american
681095|NCT00333723|Hispanic|hispanic
681096|NCT00333710|Rehabilitation|rehabilitation
681097|NCT00333710|Telecommunication|telecommunication
681098|NCT00333697|Deep vein thrombosis|deep vein thrombosis
681099|NCT00333697|Duplex ultrasound|duplex ultrasound
681100|NCT00333697|Pulmonary embolism|pulmonary embolism
681101|NCT00333671|Macular oedema|macular oedema
681102|NCT00333671|Diabetes|diabetes
681103|NCT00333671|Pathogenesis|pathogenesis
681104|NCT00333671|Osmolality|osmolality
681105|NCT00333671|Retinal thickness|retinal thickness
681106|NCT00333658|psychotherapy, group|psychotherapy, group
681107|NCT00333658|rehabilitation, vocational|rehabilitation, vocational
681108|NCT00333658|treatment outcome|treatment outcome
681109|NCT00333645|Liver transplantation|liver transplantation
681110|NCT00333645|Invasive fungal infection|invasive fungal infection
681111|NCT00333645|Invasive aspergillosis|invasive aspergillosis
681112|NCT00333645|Prophylaxis|prophylaxis
681113|NCT00333645|Caspofungin|caspofungin
681115|NCT00333632|Dexmedetomidine|dexmedetomidine
681116|NCT00333632|Postoperative care|postoperative care
681117|NCT00333632|Sedation|sedation
681118|NCT00333619|sleep disorders|sleep disorders
681119|NCT00333619|rehabilitation|rehabilitation
681120|NCT00333619|rehabilitation outcomes|rehabilitation outcomes
681121|NCT00333593|Dialysis|dialysis
681122|NCT00333593|Large pore dialyser|large pore dialyser
681123|NCT00333593|Cytokines|cytokines
681124|NCT00333593|Noradrenaline|noradrenaline
681125|NCT00333580|Ethnography|ethnography
681126|NCT00333580|Psychometrics|psychometrics
681127|NCT00333580|Qualitative Research|qualitative research
681128|NCT00333567|arthroscopic knee surgery|arthroscopic knee surgery
681129|NCT00333567|cyclooxygenase-2 inhibitors|cyclooxygenase-2 inhibitors
681130|NCT00333567|lumiracoxib|lumiracoxib
681131|NCT00333567|COX189|cox189
681132|NCT00333567|Ambulatory arthroscopic knee surgery|ambulatory arthroscopic knee surgery
681133|NCT00333554|DHA|dha
681134|NCT00333554|docosahexaenoic acid|docosahexaenoic acid
681135|NCT00333554|omega-3 fatty acid|omega-3 fatty acid
681136|NCT00333554|fish oil|fish oil
681137|NCT00333554|pregnancy|pregnancy
681138|NCT00333554|infancy|infancy
681139|NCT00333554|prevention|prevention
681140|NCT00333554|"at risk for developing type 1 diabetes"|"at risk for developing type 1 diabetes"
681141|NCT00333554|juvenile diabetes|juvenile diabetes
681142|NCT00333554|T1D|t1d
681143|NCT00333554|diabetes mellitus|diabetes mellitus
681144|NCT00333554|Type 1 diabetes TrialNet|type 1 diabetes trialnet
681145|NCT00333554|TrialNet|trialnet
681146|NCT00333554|dietary supplementation|dietary supplementation
681147|NCT00333554|nutrition|nutrition
681148|NCT00333541|Contraceptive behavior|contraceptive behavior
681149|NCT00333541|Internet Use|internet use
681150|NCT00333541|Adolescent pregnancy|adolescent pregnancy
681151|NCT00333541|Unintended pregnancy|unintended pregnancy
681152|NCT00333528|Chemical Warfare Agents|chemical warfare agents
681153|NCT00333528|Chemical Nerve Agent Intoxication|chemical nerve agent intoxication
681154|NCT00333528|Chemical Terrorism|chemical terrorism
681155|NCT00333515|Chemical nerve agent intoxication|chemical nerve agent intoxication
681156|NCT00333502|Cancer, Neoplasms, Solid Tumor, Ovarian Cancer, Lung Cancer,|cancer, neoplasms, solid tumor, ovarian cancer, lung cancer,
681157|NCT00333502|Non Small Cell Lung Cancer, Pancreatic Cancer,|non small cell lung cancer, pancreatic cancer,
681158|NCT00333502|Breast Cancer, Colon Cancer, Endometrial Cancer,|breast cancer, colon cancer, endometrial cancer,
681159|NCT00333502|Kidney (Renal Cell) Cancer, Melanoma, Prostate Cancer,|kidney (renal cell) cancer, melanoma, prostate cancer,
681160|NCT00333502|Skin Cancer, Thyroid Cancer,|skin cancer, thyroid cancer,
681161|NCT00333502|Solid Malignancies|solid malignancies
681162|NCT00333489|valsartan|valsartan
681163|NCT00333489|amlodipine|amlodipine
681164|NCT00333489|hypertension|hypertension
681165|NCT00333437|Scleroderma, Systemic|scleroderma, systemic
681166|NCT00333424|HIV|hiv
681167|NCT00333424|Human Immunodeficiency Virus|human immunodeficiency virus
681168|NCT00333424|Prophylactic vaccine|prophylactic vaccine
681169|NCT00333398|CSL Influenza Vaccine, influenza, vaccine, immunogenicity|csl influenza vaccine, influenza, vaccine, immunogenicity
681170|NCT00333385|Ceftazidime|ceftazidime
681171|NCT00333385|Continuous infusion|continuous infusion
681172|NCT00333385|Antibiotic course|antibiotic course
681173|NCT00333333|Thrombocytopenia|thrombocytopenia
681174|NCT00333333|Small for Gestational Age (SGA)|small for gestational age (sga)
681175|NCT00333333|Preeclampsia|preeclampsia
681176|NCT00333320|acute myocardial infarction|acute myocardial infarction
681177|NCT00333320|postconditioning|postconditioning
681178|NCT00333320|coronary reserve|coronary reserve
681179|NCT00333320|ejection fraction|ejection fraction
681180|NCT00333307|relaxin|relaxin
681181|NCT00333307|preeclampsia|preeclampsia
681182|NCT00333281|Healthy Volunteers|healthy volunteers
681183|NCT00333242|Pain|pain
681184|NCT00333242|opioid|opioid
681185|NCT00333242|hyperalgesia|hyperalgesia
681186|NCT00333242|methadone|methadone
681187|NCT00333229|Breast Cancer|breast cancer
681188|NCT00333229|premenopausal|premenopausal
681189|NCT00333229|Bone Mineral density|bone mineral density
681190|NCT00333229|Cancer therapy induced bone loss|cancer therapy induced bone loss
681191|NCT00333229|zoledronic acid|zoledronic acid
681192|NCT00333203|epimacular membrane|epimacular membrane
681193|NCT00333190|stem cell transplant|stem cell transplant
681194|NCT00333190|graft versus host disease|graft versus host disease
681195|NCT00333190|GVHD|gvhd
681196|NCT00333190|CD+8 T cell depletion|cd+8 t cell depletion
681197|NCT00333177|Schizoaffective Disorder, Depressed Type|schizoaffective disorder, depressed type
681198|NCT00333177|Schizophreniform Disorder|schizophreniform disorder
681199|NCT00333177|First-Episode Schizophrenia|first-episode schizophrenia
681200|NCT00333177|Supported Employment|supported employment
681201|NCT00333177|Cognitive Remediation|cognitive remediation
681202|NCT00333177|Health Behavior Training|health behavior training
681203|NCT00333177|Antipsychotic Medication|antipsychotic medication
681204|NCT00333164|intracranial arteriosclerosis|intracranial arteriosclerosis
681205|NCT00333164|cilostazol|cilostazol
681206|NCT00333164|Platelete aggrigation inhibitors dual antiplatelet therapy|platelete aggrigation inhibitors dual antiplatelet therapy
681207|NCT00333164|Drug therapy, combination|drug therapy, combination
681208|NCT00333164|Clinical trials|clinical trials
681209|NCT00333138|FTY720|fty720
681210|NCT00333138|MS|ms
681211|NCT00333138|Multiple Sclerosis|multiple sclerosis
681212|NCT00333138|RRMS|rrms
681213|NCT00333112|Treatment Outcome|treatment outcome
681214|NCT00333112|Urology|urology
681215|NCT00333112|Solifenacin succinate|solifenacin succinate
681216|NCT00333112|Urinary Incontinence|urinary incontinence
681217|NCT00333099|Enteral nutrition|enteral nutrition
681218|NCT00333099|immunonutrients|immunonutrients
681219|NCT00333099|head and neck cancer|head and neck cancer
681220|NCT00333099|esophageal cancer|esophageal cancer
681221|NCT00333099|chemoradiotherapy|chemoradiotherapy
681222|NCT00333099|H&N or esophageal cancer patients with a chemoradiotherapy treatment.|h&n or esophageal cancer patients with a chemoradiotherapy treatment.
681223|NCT00333086|Endometrial Cancer|endometrial cancer
681224|NCT00333086|Aromatase inhibitor|aromatase inhibitor
681225|NCT00333086|Letrozole|letrozole
681226|NCT00333073|urinary incontinence|urinary incontinence
681227|NCT00333073|Bulkamid|bulkamid
681228|NCT00333047|Metastatic breast cancer|metastatic breast cancer
681229|NCT00333047|Aromatase inhibitor|aromatase inhibitor
681230|NCT00333047|Letrozole|letrozole
681231|NCT00333034|Psoriasis|psoriasis
681232|NCT00333021|Fondaparinux Abdominal surgery Japanese VTE|fondaparinux abdominal surgery japanese vte
681233|NCT00333008|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
681234|NCT00333008|CDOP|cdop
681235|NCT00333008|Dose Dense|dose dense
681236|NCT00333008|Anne Arbor Stage I-IV|anne arbor stage i-iv
681237|NCT00333008|Any IPI score|any ipi score
681238|NCT00332995|HIV Seronegativity|hiv seronegativity
681239|NCT00332982|best practices, performance improvement, intensive care, measurement|best practices, performance improvement, intensive care, measurement
681240|NCT00332969|Open label|open label
681241|NCT00332969|phase II|phase ii
681242|NCT00332969|disease|disease
681243|NCT00332969|clinical trial|clinical trial
681244|NCT00332969|Octreotide|octreotide
681245|NCT00332969|thymoma|thymoma
681246|NCT00332969|cancer|cancer
681247|NCT00332969|tumor|tumor
681248|NCT00332943|colorectal polyps|colorectal polyps
681249|NCT00332943|colorectal cancer|colorectal cancer
681250|NCT00332943|Virtual colonoscopy|virtual colonoscopy
681251|NCT00332943|Fecal tagging|fecal tagging
681252|NCT00332943|MR colonography|mr colonography
681253|NCT00332930|HIV|hiv
681254|NCT00332930|Therapeutic vaccine|therapeutic vaccine
681255|NCT00332917|Parkinson's disease|parkinson's disease
681256|NCT00332904|betablocker|betablocker
681257|NCT00332904|aldosterone antagonist|aldosterone antagonist
681258|NCT00332904|peripheral haemodynamics|peripheral haemodynamics
681259|NCT00332904|cardiac haemodynamics|cardiac haemodynamics
681260|NCT00332904|oxygenation|oxygenation
681261|NCT00332891|Anxiety|anxiety
681262|NCT00332891|Anti-Anxiety Agents|anti-anxiety agents
681263|NCT00332891|controlled Clinical Trials|controlled clinical trials
681264|NCT00332878|Behavioral Intervention|behavioral intervention
681265|NCT00332878|HIV|hiv
681266|NCT00332878|HSV2|hsv2
681267|NCT00332865|Head and neck cancer|head and neck cancer
681268|NCT00332865|Radiotherapy|radiotherapy
681269|NCT00332865|Dysphagia|dysphagia
681270|NCT00332865|Exercise|exercise
681271|NCT00332865|Deglutition|deglutition
681272|NCT00332865|Randomized controlled trial|randomized controlled trial
681273|NCT00332865|Quality of life|quality of life
681274|NCT00332865|Tube feeding|tube feeding
681275|NCT00332852|Postive breast cancer|postive breast cancer
681276|NCT00332852|postmenopausal|postmenopausal
681277|NCT00332852|disease free survival|disease free survival
681278|NCT00332852|letrozole|letrozole
681279|NCT00332852|early adjuvant treatment|early adjuvant treatment
681280|NCT00332852|primary hormone receptor|primary hormone receptor
681281|NCT00332839|enteric-coated mycophenolate sodium, everolimus, CNI-free regimen|enteric-coated mycophenolate sodium, everolimus, cni-free regimen
681282|NCT00332826|Inhaled insulin|inhaled insulin
681283|NCT00332826|Diabetes Type I and II with Asthma|diabetes type i and ii with asthma
681284|NCT00332813|HIV Risk Behavior|hiv risk behavior
681285|NCT00332813|Pregnancy|pregnancy
681286|NCT00332813|Drug Abuse|drug abuse
681287|NCT00332800|Stroke-Nutritional Supplementation-Functional Recovery|stroke-nutritional supplementation-functional recovery
681288|NCT00332787|Major Depressive Disorder|major depressive disorder
681289|NCT00332735|spinal|spinal
681290|NCT00332735|anesthesia|anesthesia
681291|NCT00332735|articaine|articaine
681292|NCT00332735|bupivacaine|bupivacaine
681293|NCT00332735|outpatient|outpatient
681294|NCT00332735|surgery|surgery
681295|NCT00332735|limbs|limbs
681296|NCT00332709|Breast cancer|breast cancer
681297|NCT00332709|postmenopausal|postmenopausal
681298|NCT00332709|bone mineral density|bone mineral density
681299|NCT00332709|Zoledronic acid|zoledronic acid
681300|NCT00332709|Letrozole|letrozole
681301|NCT00332709|extended adjuvant treatment.|extended adjuvant treatment.
681302|NCT00332709|Postmenopausal women with primary hormone receptor positive breast cancer|postmenopausal women with primary hormone receptor positive breast cancer
681303|NCT00332696|bowel obstruction,|bowel obstruction,
681304|NCT00332696|peritoneal carcinomatosis|peritoneal carcinomatosis
681305|NCT00332696|Octreotide|octreotide
681306|NCT00332696|inoperable|inoperable
681307|NCT00332683|Dysphagia|dysphagia
681308|NCT00332683|spine surgery|spine surgery
681309|NCT00332683|cuff pressure|cuff pressure
681310|NCT00332670|(Non-seasonal) Depression|(non-seasonal) depression
681311|NCT00332670|bright light therapy|bright light therapy
681312|NCT00332670|randomized controlled trial|randomized controlled trial
681313|NCT00332670|suprachiasmatic nucleus|suprachiasmatic nucleus
681314|NCT00332670|HPA-axis|hpa-axis
681315|NCT00332670|DHEA|dhea
681316|NCT00332670|melatonin|melatonin
681317|NCT00332670|actigraphy|actigraphy
681318|NCT00332670|elderly|elderly
681319|NCT00332670|self-efficacy|self-efficacy
681320|NCT00332670|social support|social support
681321|NCT00332631|Cardiac surgery,|cardiac surgery,
681322|NCT00332631|Cardiopulmonary bypass,|cardiopulmonary bypass,
681323|NCT00332631|Oxidative stress,|oxidative stress,
681324|NCT00332631|Acute renal dysfunction,|acute renal dysfunction,
681325|NCT00332631|N-acetylcysteine|n-acetylcysteine
681326|NCT00332618|MULTICENTER|multicenter
681327|NCT00332618|CONTROLLED|controlled
681328|NCT00332618|PARALLEL GROUPS|parallel groups
681329|NCT00332605|Methamphetamine Dependence|methamphetamine dependence
681330|NCT00332592|Necrotizing Enterocolitis|necrotizing enterocolitis
681331|NCT00332592|Intragastric microdialysis|intragastric microdialysis
681332|NCT00332592|Peritoneal microdialysis|peritoneal microdialysis
681333|NCT00332592|Infants|infants
681334|NCT00332579|Compulsive Shoplifting|compulsive shoplifting
681335|NCT00332579|Kleptomania|kleptomania
681336|NCT00332579|Compulsive Stealing|compulsive stealing
681337|NCT00332514|pharmacist intervention|pharmacist intervention
681338|NCT00332514|post-discharge telephone call|post-discharge telephone call
681339|NCT00332514|black hole|black hole
681340|NCT00332462|Liver transplantation, Cyclosporine|liver transplantation, cyclosporine
681341|NCT00332449|early breast feeding|early breast feeding
681342|NCT00332449|hypoglycemia|hypoglycemia
681343|NCT00332449|newborn|newborn
681344|NCT00332410|Voriconazole|voriconazole
681345|NCT00332410|renal transplant|renal transplant
681346|NCT00332410|kidney function|kidney function
681347|NCT00332410|kidneys|kidneys
681348|NCT00332371|Intensive Care|intensive care
681349|NCT00332371|Shock, Septic|shock, septic
681350|NCT00332371|Adsorption|adsorption
681351|NCT00332371|Sorption Detoxification|sorption detoxification
681352|NCT00332332|Phase IV|phase iv
681353|NCT00332332|Psoriasis|psoriasis
681354|NCT00332332|Inflammation|inflammation
681355|NCT00332319|spinal cord injury|spinal cord injury
681356|NCT00332319|urgency|urgency
681357|NCT00332319|Overactive bladder|overactive bladder
681358|NCT00332319|neurogenic|neurogenic
681359|NCT00332319|neurometry|neurometry
681360|NCT00332319|frequency|frequency
681361|NCT00332319|urge incontinence|urge incontinence
681362|NCT00332306|Once daily antiretroviral treatment|once daily antiretroviral treatment
681363|NCT00332306|Concomitant antituberculosis treatment|concomitant antituberculosis treatment
681364|NCT00332306|HIV Infections|hiv infections
681365|NCT00332280|solid tumors|solid tumors
681366|NCT00332280|clinical benefit|clinical benefit
681367|NCT00332280|quality of life|quality of life
681368|NCT00332280|esophageal cancer|esophageal cancer
681369|NCT00332280|colon cancer|colon cancer
681370|NCT00332280|pancreatic cancer|pancreatic cancer
681371|NCT00332280|gastric cancer|gastric cancer
681372|NCT00332280|liver cancer|liver cancer
681373|NCT00332280|gall bladder cancer|gall bladder cancer
681374|NCT00332280|prostate cancer|prostate cancer
681375|NCT00332280|gynecological cancer|gynecological cancer
681376|NCT00332280|lung cancer|lung cancer
681377|NCT00332280|Tumors of GI tract, prostate and gynaecological|tumors of gi tract, prostate and gynaecological
681378|NCT00332267|Sepsis|sepsis
681379|NCT00332267|Hypoxia|hypoxia
681380|NCT00332267|Altitude Sickness|altitude sickness
681381|NCT00332267|Endotoxin|endotoxin
681382|NCT00332267|Cytokines|cytokines
681383|NCT00332267|Cerebral blood flow|cerebral blood flow
681384|NCT00332267|Cerebral metabolism|cerebral metabolism
681385|NCT00332267|Reactive oxygen species|reactive oxygen species
681386|NCT00332254|Anterior cruciate ligament tear|anterior cruciate ligament tear
681387|NCT00332254|Meniscus tear|meniscus tear
681388|NCT00332254|Chondral injury|chondral injury
681389|NCT00332241|Serious behavioral problems in children and adolescents with AD|serious behavioral problems in children and adolescents with ad
681390|NCT00332241|Behavioral Problems|behavioral problems
681391|NCT00332228|opiate dependence|opiate dependence
681392|NCT00332228|heroin dependence|heroin dependence
681393|NCT00332228|naltrexone|naltrexone
681394|NCT00332228|cognitive behavioral therapy|cognitive behavioral therapy
681395|NCT00332215|Cystic Fibrosis|cystic fibrosis
681396|NCT00332215|Antioxidants|antioxidants
681397|NCT00332215|Inhalational therapy|inhalational therapy
681398|NCT00332215|Induced sputum|induced sputum
681399|NCT00332215|Airway inflammation|airway inflammation
681400|NCT00332189|PKU|pku
681401|NCT00332176|Hepatitis C|hepatitis c
681402|NCT00332176|Celgosivir|celgosivir
681403|NCT00332176|HCV|hcv
681404|NCT00332176|Genotype 1|genotype 1
681405|NCT00332176|Treatment-naive|treatment-naive
681406|NCT00332176|Early viral kinetics|early viral kinetics
681407|NCT00332163|STEPP|stepp
681408|NCT00332163|STEP|step
681409|NCT00332163|STEEP|steep
681410|NCT00332163|mCRC|mcrc
681411|NCT00332163|Skin Toxicities|skin toxicities
681412|NCT00332163|Skin Rash|skin rash
681413|NCT00332163|Metastatic Colorectal Cancer|metastatic colorectal cancer
681414|NCT00332163|Anti-EGFr Skin Rash|anti-egfr skin rash
681415|NCT00332163|colon cancer|colon cancer
681416|NCT00332163|colorectal cancer|colorectal cancer
681417|NCT00332163|rectal cancer|rectal cancer
681418|NCT00332150|parents|parents
681419|NCT00332150|newborn|newborn
681420|NCT00332150|clinical trials|clinical trials
681421|NCT00332111|transplant|transplant
681422|NCT00332111|pancreas|pancreas
681423|NCT00332098|Childhood Mood Disorders|childhood mood disorders
681424|NCT00332098|Family Treatment|family treatment
681425|NCT00332098|Psychoeducation|psychoeducation
681426|NCT00332098|Pharmacotherapy|pharmacotherapy
681427|NCT00332098|Family Functioning|family functioning
681428|NCT00332098|Psychosocial Intervention|psychosocial intervention
681429|NCT00332046|fMRI placebo GW679769 Social Anxiety Disorder SAD|fmri placebo gw679769 social anxiety disorder sad
681430|NCT00332033|Fibroids|fibroids
681431|NCT00332033|Leiomyoma|leiomyoma
681432|NCT00332033|Pirfenidone|pirfenidone
681433|NCT00332033|Misoprostol|misoprostol
681434|NCT00332033|Non-Surgical|non-surgical
681435|NCT00332033|Collagen|collagen
681436|NCT00332033|Uterus|uterus
681437|NCT00332033|Uterine Fibroids|uterine fibroids
681438|NCT00332033|Uterine Leiomyoma|uterine leiomyoma
681439|NCT00331942|Breast|breast
681440|NCT00331942|Cancer|cancer
681441|NCT00331942|Associated|associated
681442|NCT00331942|Antibodies|antibodies
681443|NCT00331929|Asthma|asthma
681444|NCT00331929|Allergy|allergy
681445|NCT00331929|Respiratory|respiratory
681446|NCT00331929|Pollution|pollution
681447|NCT00331929|Children|children
681448|NCT00331929|Air pollution|air pollution
681449|NCT00331890|Neuroprotection|neuroprotection
681450|NCT00331890|Acute ischemic stroke|acute ischemic stroke
681451|NCT00331890|Cerebral infarction|cerebral infarction
681452|NCT00331877|family|family
681453|NCT00331877|end-of-life|end-of-life
681454|NCT00331877|intensive care unit|intensive care unit
681455|NCT00331864|AMD, ranibizumab|amd, ranibizumab
681456|NCT00331838|Prevention|prevention
681457|NCT00331838|Venous Thrombosis|venous thrombosis
681458|NCT00331838|Orthopedic Surgery|orthopedic surgery
681459|NCT00331825|Schizophrenia, EPS, risperidone, olanzapine|schizophrenia, eps, risperidone, olanzapine
681460|NCT00331812|Hypermetabolism|hypermetabolism
681461|NCT00331812|Mitochondrial abnormalities|mitochondrial abnormalities
681462|NCT00331812|Oxidant/antioxidant status|oxidant/antioxidant status
681463|NCT00331799|Depression|depression
681464|NCT00331799|Pharmacotherapy|pharmacotherapy
681465|NCT00331799|Duloxetine|duloxetine
681466|NCT00331786|colon cancer|colon cancer
681467|NCT00331786|rectal cancer|rectal cancer
681468|NCT00331773|adenocarcinoma of the prostate|adenocarcinoma of the prostate
681469|NCT00331773|stage IIB prostate cancer|stage iib prostate cancer
681470|NCT00331773|stage IIA prostate cancer|stage iia prostate cancer
681471|NCT00331760|stage I endometrial carcinoma|stage i endometrial carcinoma
681472|NCT00331760|stage II endometrial carcinoma|stage ii endometrial carcinoma
681473|NCT00331760|stage III endometrial carcinoma|stage iii endometrial carcinoma
681474|NCT00331760|endometrial adenoacanthoma|endometrial adenoacanthoma
681475|NCT00331760|endometrial adenocarcinoma|endometrial adenocarcinoma
681476|NCT00331760|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
681477|NCT00331760|stage IB cervical cancer|stage ib cervical cancer
681478|NCT00331760|stage IIA cervical cancer|stage iia cervical cancer
681479|NCT00331760|stage IIB cervical cancer|stage iib cervical cancer
681480|NCT00331760|cervical adenocarcinoma|cervical adenocarcinoma
681481|NCT00331760|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
681603|NCT00331214|Surgical menopause|surgical menopause
681482|NCT00331760|cervical squamous cell carcinoma|cervical squamous cell carcinoma
681483|NCT00331721|Acute Ischemic Stroke|acute ischemic stroke
681484|NCT00331708|Malaria|malaria
681485|NCT00331708|Efficacy|efficacy
681486|NCT00331708|Pharmacokinetic|pharmacokinetic
681487|NCT00331708|Gametocyte|gametocyte
681488|NCT00331708|Molecular markers|molecular markers
681489|NCT00331708|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
681490|NCT00331708|Artesunate|artesunate
681491|NCT00331708|Artemisinin|artemisinin
681492|NCT00331695|Progesterone|progesterone
681493|NCT00331695|Preterm delivery|preterm delivery
681494|NCT00331695|Preterm labor|preterm labor
681495|NCT00331695|Cervical length|cervical length
681496|NCT00331695|ultrasonography|ultrasonography
681497|NCT00331669|deep brain stimulation|deep brain stimulation
681498|NCT00331669|pallidum|pallidum
681499|NCT00331669|tardive dystonia|tardive dystonia
681500|NCT00331669|randomized|randomized
681501|NCT00331669|double blind|double blind
681502|NCT00331669|multicenter|multicenter
681503|NCT00331656|noninvasive|noninvasive
681504|NCT00331656|positive|positive
681505|NCT00331656|cuirass|cuirass
681506|NCT00331656|ventilation|ventilation
681507|NCT00331656|respiratory|respiratory
681508|NCT00331656|failure|failure
681509|NCT00331630|stage I breast cancer|stage i breast cancer
681510|NCT00331630|stage II breast cancer|stage ii breast cancer
681511|NCT00331630|stage IIIA breast cancer|stage iiia breast cancer
681512|NCT00331630|stage IIIB breast cancer|stage iiib breast cancer
681513|NCT00331630|stage IIIC breast cancer|stage iiic breast cancer
681514|NCT00331565|Bariatric surgery|bariatric surgery
681515|NCT00331565|Bioavailability|bioavailability
681516|NCT00331565|Bioequivalence|bioequivalence
681517|NCT00331565|Atorvastatin|atorvastatin
681518|NCT00331565|CYP's|cyp's
681519|NCT00331565|P-gp|p-gp
681520|NCT00331565|OATP|oatp
681521|NCT00331539|Cochlear implant|cochlear implant
681522|NCT00331539|threshold (T) measurement|threshold (t) measurement
681523|NCT00331539|comfort (C) level|comfort (c) level
681524|NCT00331539|profound hearing loss|profound hearing loss
681525|NCT00331539|auditory stimuli|auditory stimuli
681526|NCT00331539|profound hearing loss patients eligible for the study should be capable of providing reliable|profound hearing loss patients eligible for the study should be capable of providing reliable
681527|NCT00331539|subjective counted thresholds and has good NRT recordings, implanted with|subjective counted thresholds and has good nrt recordings, implanted with
681528|NCT00331539|the Nucleus Freedom system|the nucleus freedom system
681529|NCT00331526|adult glioblastoma|adult glioblastoma
681530|NCT00331526|adult gliosarcoma|adult gliosarcoma
681531|NCT00331526|adult giant cell glioblastoma|adult giant cell glioblastoma
681532|NCT00331487|Glucose Metabolism Disorder|glucose metabolism disorder
681533|NCT00331487|Dysmetabolic Syndrome|dysmetabolic syndrome
681534|NCT00331487|Type II Diabetes|type ii diabetes
681535|NCT00331487|Diabetes Mellitus|diabetes mellitus
681536|NCT00331487|Lipoatrophic|lipoatrophic
681537|NCT00331487|Dyslipidemia|dyslipidemia
681538|NCT00331487|Drug Therapy|drug therapy
681539|NCT00331474|BCG|bcg
681540|NCT00331474|HIV|hiv
681541|NCT00331474|Immune responses|immune responses
681542|NCT00331474|Delayed vaccination|delayed vaccination
681543|NCT00331474|Infant morbidity|infant morbidity
681544|NCT00331474|Nutritional status|nutritional status
681545|NCT00331474|Morbidity|morbidity
681546|NCT00331474|Mortality|mortality
681547|NCT00331448|Treatment Experienced|treatment experienced
681548|NCT00331448|Lipoatrophy|lipoatrophy
681549|NCT00331448|Lipohypertrophy|lipohypertrophy
681550|NCT00331448|Glucose|glucose
681551|NCT00331448|Cholesterol|cholesterol
681552|NCT00331448|Triglycerides|triglycerides
681553|NCT00331448|MRI|mri
681554|NCT00331448|DXA|dxa
681555|NCT00331448|Carotid IMT|carotid imt
681556|NCT00331448|LDL|ldl
681557|NCT00331448|HDL|hdl
681558|NCT00331435|AMD|amd
681559|NCT00331435|PCV|pcv
681560|NCT00331435|PDT|pdt
681561|NCT00331422|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
681562|NCT00331422|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
681563|NCT00331422|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
681564|NCT00331422|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
681565|NCT00331422|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
681566|NCT00331422|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
681567|NCT00331422|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
681568|NCT00331422|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
681569|NCT00331422|peritoneal cavity cancer|peritoneal cavity cancer
681570|NCT00331422|fallopian tube cancer|fallopian tube cancer
681571|NCT00331422|Brenner tumor|brenner tumor
681572|NCT00331409|stage III renal cell cancer|stage iii renal cell cancer
681573|NCT00331409|stage IV renal cell cancer|stage iv renal cell cancer
681574|NCT00331409|clear cell renal cell carcinoma|clear cell renal cell carcinoma
681575|NCT00331409|recurrent renal cell cancer|recurrent renal cell cancer
681576|NCT00331357|acute idiopathic thrombocytopenic purpura|acute idiopathic thrombocytopenic purpura
681577|NCT00331357|paediatric|paediatric
681578|NCT00331357|quality of life|quality of life
681579|NCT00331331|Uveitis|uveitis
681580|NCT00331331|Intermediate Uveitis|intermediate uveitis
681581|NCT00331331|Pars Planitis|pars planitis
681582|NCT00331331|Macular Edema|macular edema
681583|NCT00331331|Vasculitis|vasculitis
681584|NCT00331331|Ocular Inflammatory Disease|ocular inflammatory disease
681585|NCT00331318|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
681586|NCT00331318|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
681587|NCT00331318|Motor Learning|motor learning
681588|NCT00331318|Brain Plasticity|brain plasticity
681589|NCT00331318|Healthy Volunteer|healthy volunteer
681590|NCT00331318|HV|hv
681591|NCT00331305|Exercise|exercise
681592|NCT00331292|Asthma bronchoscopy|asthma bronchoscopy
681593|NCT00331279|polycystic ovary syndrome|polycystic ovary syndrome
681594|NCT00331279|insulin resistance|insulin resistance
681595|NCT00331279|cinnamon|cinnamon
681596|NCT00331253|Indocyanine Green-Mediated Photothrombosis|indocyanine green-mediated photothrombosis
681597|NCT00331253|Neovascular|neovascular
681598|NCT00331253|Age-Related Macular Degeneration|age-related macular degeneration
681599|NCT00331227|flavonoids|flavonoids
681600|NCT00331227|food supplements|food supplements
681601|NCT00331227|endothelial function|endothelial function
681703|NCT00330759|advanced cancer|advanced cancer
681602|NCT00331227|no conditions allowed, healthy volunteers only|no conditions allowed, healthy volunteers only
681604|NCT00331214|HSDD|hsdd
681606|NCT00331188|Esophageal Variceal Bleeding|esophageal variceal bleeding
681607|NCT00331188|Portal Hypertension|portal hypertension
681608|NCT00331188|Hepatic Cirrhosis|hepatic cirrhosis
681609|NCT00331188|Cirrhosis|cirrhosis
681610|NCT00331188|Liver Cirrhosis|liver cirrhosis
681611|NCT00331188|Somatostatin Analog|somatostatin analog
681612|NCT00331188|Vapreotide|vapreotide
681613|NCT00331188|Acute Esophageal Variceal Bleeding|acute esophageal variceal bleeding
681614|NCT00331162|Renal Transplantation|renal transplantation
681615|NCT00331162|Pancreas Transplantation|pancreas transplantation
681616|NCT00331162|Graft Rejection|graft rejection
681617|NCT00331162|Immunosuppression|immunosuppression
681618|NCT00331162|Kidney failure, chronic|kidney failure, chronic
681619|NCT00331162|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
681620|NCT00331162|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
681621|NCT00331149|safety|safety
681622|NCT00331149|efficacy|efficacy
681623|NCT00331149|L-dopa|l-dopa
681624|NCT00331149|ropinirole PR|ropinirole pr
681625|NCT00331149|Parkinson's disease|parkinson's disease
681626|NCT00331149|ropinirole IR|ropinirole ir
681627|NCT00331149|adjunctive therapy|adjunctive therapy
681628|NCT00331149|superiority|superiority
681629|NCT00331149|REQUIP|requip
681630|NCT00331149|health outcomes|health outcomes
681631|NCT00331136|malaria|malaria
681632|NCT00331136|pyronaridine|pyronaridine
681633|NCT00331136|artesunate|artesunate
681634|NCT00331136|falciparum|falciparum
681635|NCT00331136|ACT|act
681636|NCT00331123|Surgical menopause|surgical menopause
681637|NCT00331123|HSDD|hsdd
681638|NCT00331097|elderly|elderly
681639|NCT00331097|adjuvant therapy|adjuvant therapy
681640|NCT00331097|intermediate risk|intermediate risk
681641|NCT00331097|high risk|high risk
681642|NCT00331084|prevention of post inflammation in cataract surgery|prevention of post inflammation in cataract surgery
681643|NCT00331071|Contraception|contraception
681644|NCT00331071|Hormonal contraception|hormonal contraception
681645|NCT00331071|Oral contraception|oral contraception
681646|NCT00331071|Ethinyl estradiol, Progestin, Contraception|ethinyl estradiol, progestin, contraception
681647|NCT00331071|Transdermal|transdermal
681648|NCT00331058|Severe Asthma bronchoscopy|severe asthma bronchoscopy
681649|NCT00331045|Opioids|opioids
681650|NCT00331045|cancer|cancer
681651|NCT00331045|constipation|constipation
681652|NCT00331032|VivaGel™, sexually transmitted, microbicide, herpes simplex|vivagel™, sexually transmitted, microbicide, herpes simplex
681653|NCT00331019|Streptococcus Group B|streptococcus group b
681654|NCT00331019|Pregnancy|pregnancy
681655|NCT00331006|Blood Coagulation Factor Inhibitors|blood coagulation factor inhibitors
681656|NCT00330993|mifepristone|mifepristone
681657|NCT00330993|misoprostol|misoprostol
681658|NCT00330993|medical abortion|medical abortion
681659|NCT00330993|buccal administration|buccal administration
681660|NCT00330980|Cognition|cognition
681661|NCT00330980|Statins|statins
681662|NCT00330980|Serotonin|serotonin
681663|NCT00330980|Cholesterol|cholesterol
681664|NCT00330967|Fat Emulsions, Intravenous|fat emulsions, intravenous
681665|NCT00330967|Free Fatty Acids|free fatty acids
681666|NCT00330967|Glucose Clamp Technique|glucose clamp technique
681667|NCT00330967|Inflammation|inflammation
681668|NCT00330967|Insulin Resistance|insulin resistance
681669|NCT00330967|Muscle, Skeletal|muscle, skeletal
681670|NCT00330967|NF-Kappa B|nf-kappa b
681671|NCT00330954|viral response genes|viral response genes
681672|NCT00330902|malaria|malaria
681673|NCT00330902|subpatent parasitaemia|subpatent parasitaemia
681674|NCT00330902|dry season|dry season
681675|NCT00330902|primaquine|primaquine
681676|NCT00330902|Plasmodium falciparum infection detected by PCR|plasmodium falciparum infection detected by pcr
681677|NCT00330889|Rheumatoid Arthritis|rheumatoid arthritis
681678|NCT00330876|pitavastatin|pitavastatin
681679|NCT00330876|hypercholesterolemia|hypercholesterolemia
681680|NCT00330876|combined dyslipidemia|combined dyslipidemia
681681|NCT00330863|Relapse|relapse
681682|NCT00330863|Prevention|prevention
681683|NCT00330863|Schizophrenia|schizophrenia
681684|NCT00330863|Injectable Medication|injectable medication
681685|NCT00330850|Migraine|migraine
681686|NCT00330850|Photophobia|photophobia
681687|NCT00330850|Phonophobia|phonophobia
681688|NCT00330850|Aura|aura
681689|NCT00330824|prevention of post inflammation in LASIK surgery|prevention of post inflammation in lasik surgery
681690|NCT00330811|Pediatrics|pediatrics
681691|NCT00330811|Non-cardiac Illness|non-cardiac illness
681692|NCT00330811|B-type Natriuretic Peptide (BNP)|b-type natriuretic peptide (bnp)
681693|NCT00330798|Photorefractive Keratectomy|photorefractive keratectomy
681694|NCT00330772|Cardiac Surger|cardiac surger
681695|NCT00330772|Coronary Artery Bypass Grafting|coronary artery bypass grafting
681696|NCT00330772|Graft patency|graft patency
681697|NCT00330772|Aspirin|aspirin
681698|NCT00330772|Clopidogrel|clopidogrel
681699|NCT00330772|Hemorrhage|hemorrhage
681700|NCT00330772|Transfusion|transfusion
681701|NCT00330759|Bone metastases|bone metastases
681702|NCT00330759|lytic bone lesions|lytic bone lesions
681704|NCT00330759|multiple myeloma|multiple myeloma
681705|NCT00330759|lymphoma|lymphoma
681706|NCT00330759|solid tumors|solid tumors
681707|NCT00330759|skeletal related events|skeletal related events
681708|NCT00330759|skeletal fractures|skeletal fractures
681709|NCT00330759|spinal cord compressions, radiation to bone|spinal cord compressions, radiation to bone
681710|NCT00330759|surgery to bone, bisphosphonates|surgery to bone, bisphosphonates
681711|NCT00330759|denosumab|denosumab
681712|NCT00330746|elderly|elderly
681713|NCT00330746|chemotherapy|chemotherapy
681714|NCT00330746|targeted therapy|targeted therapy
681715|NCT00330746|combination therapy|combination therapy
681716|NCT00330746|sequential therapy|sequential therapy
681717|NCT00330746|randomized phase II|randomized phase ii
681718|NCT00330746|one year survival|one year survival
681719|NCT00330733|Cardiovascular Disease|cardiovascular disease
681720|NCT00330733|Inflammation|inflammation
681721|NCT00330733|Insulin Resistance|insulin resistance
681722|NCT00330733|Type 2 DM|type 2 dm
681723|NCT00330720|Personal Emergency Response System|personal emergency response system
681724|NCT00330720|Anxiety|anxiety
681725|NCT00330720|Fear of Falling|fear of falling
681726|NCT00330720|RCT|rct
681727|NCT00330707|bladder cancer|bladder cancer
681728|NCT00330707|BCG|bcg
681729|NCT00330707|interferon alpha|interferon alpha
681730|NCT00330694|Physical Therapy|physical therapy
681731|NCT00330694|Organisation of care|organisation of care
681732|NCT00330681|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
681733|NCT00330681|free radical scavenger|free radical scavenger
681734|NCT00330668|Insulin-like Growth Factor Deficiency|insulin-like growth factor deficiency
681735|NCT00330668|IGF-1|igf-1
681736|NCT00330668|Short Stature|short stature
681737|NCT00330655|Binge eating|binge eating
681738|NCT00330655|Obesity|obesity
681739|NCT00330655|Eating disorder|eating disorder
681740|NCT00330642|Streptococcus Group B|streptococcus group b
681741|NCT00330642|Pregnancy|pregnancy
681742|NCT00330616|WELLBUTRIN|wellbutrin
681743|NCT00330616|elderly|elderly
681744|NCT00330616|depression|depression
681745|NCT00330616|Pharmacokinetics|pharmacokinetics
681746|NCT00330603|Cough|cough
681747|NCT00330603|Gastroesophageal Reflux|gastroesophageal reflux
681748|NCT00330590|Central Venous|central venous
681749|NCT00330590|Ultrasonography|ultrasonography
681750|NCT00330590|Catheterization|catheterization
681751|NCT00330564|VHL Syndrome|vhl syndrome
681752|NCT00330564|Von Hippel-Lindau Syndrome|von hippel-lindau syndrome
681753|NCT00330564|VHL Disease|vhl disease
681754|NCT00330564|Kidney|kidney
681755|NCT00330564|Retina|retina
681756|NCT00330564|Brain|brain
681757|NCT00330564|Spinal cord|spinal cord
681758|NCT00330564|Pancreas|pancreas
681759|NCT00330564|Inner ear|inner ear
681760|NCT00330564|Cysts|cysts
681761|NCT00330564|Tumors|tumors
681762|NCT00330564|Sunitinib Malate|sunitinib malate
681763|NCT00330564|SU011248|su011248
681764|NCT00330564|Sutent|sutent
681766|NCT00330564|Sunitinib|sunitinib
681767|NCT00330564|Renal cell carcinoma|renal cell carcinoma
681768|NCT00330564|Hemangioblastoma|hemangioblastoma
681769|NCT00330564|Endothelium|endothelium
681770|NCT00330551|Schizoaffective Disorder, Depressed Type|schizoaffective disorder, depressed type
681771|NCT00330551|Schizophreniform Disorder|schizophreniform disorder
681772|NCT00330551|First-episode Schizophrenia|first-episode schizophrenia
681773|NCT00330551|Injectable Risperidone|injectable risperidone
681774|NCT00330538|Osteoporosis|osteoporosis
681775|NCT00330538|Childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
681776|NCT00330512|regional anestesia|regional anestesia
681777|NCT00330512|cesarean section|cesarean section
681778|NCT00330512|hypotention|hypotention
681779|NCT00330512|newborn|newborn
681780|NCT00330499|Locally invasive|locally invasive
681781|NCT00330499|Bladder cancer|bladder cancer
681782|NCT00330499|Chemoradiotherapy|chemoradiotherapy
681783|NCT00330499|Efficacy|efficacy
681784|NCT00330499|Organ conservation|organ conservation
681785|NCT00330486|Acamprosate|acamprosate
681786|NCT00330486|Addiction|addiction
681787|NCT00330486|Alcoholism|alcoholism
681788|NCT00330486|Alcohol dependence|alcohol dependence
681789|NCT00330486|Bipolar disorder|bipolar disorder
681790|NCT00330486|Depression|depression
681791|NCT00330486|Impulsivity|impulsivity
681792|NCT00330486|Mania|mania
681793|NCT00330486|Substance abuse|substance abuse
681794|NCT00330460|Osteoporosis|osteoporosis
681795|NCT00330460|Osteopenia|osteopenia
681796|NCT00330460|AMG 162|amg 162
681797|NCT00330460|Fracture - hip|fracture - hip
681798|NCT00330460|Postmenopausal|postmenopausal
681799|NCT00330447|pregnancy|pregnancy
681800|NCT00330447|in utero|in utero
681801|NCT00330447|chemotherapy|chemotherapy
681802|NCT00330447|radiotherapy|radiotherapy
681803|NCT00330447|cancer|cancer
681804|NCT00330447|offspring|offspring
681805|NCT00330447|neonatal|neonatal
681806|NCT00330447|long term|long term
681807|NCT00330447|follow up|follow up
681808|NCT00330447|cancer during pregnancy|cancer during pregnancy
683016|NCT00325767|inhalation|inhalation
681809|NCT00330447|chemotherapy and radiotherapy during pregnancy|chemotherapy and radiotherapy during pregnancy
681810|NCT00330447|long term follow up of children|long term follow up of children
681811|NCT00330434|Alcohol|alcohol
681812|NCT00330434|Bupropion|bupropion
681813|NCT00330434|Chlorzoxazone|chlorzoxazone
681814|NCT00330434|Interaction|interaction
681815|NCT00330434|Induction|induction
681816|NCT00330434|Depression|depression
681817|NCT00330434|Smoking|smoking
681818|NCT00330434|Drinking|drinking
681819|NCT00330434|Cytochrome P450 Enzyme|cytochrome p450 enzyme
681820|NCT00330434|CYP2B6|cyp2b6
681821|NCT00330434|CYP2E1|cyp2e1
681822|NCT00330434|Pharmacogenetics|pharmacogenetics
681823|NCT00330434|Pharmacokinetics|pharmacokinetics
681824|NCT00330434|Pharmacodynamics|pharmacodynamics
681825|NCT00330434|Boston|boston
681826|NCT00330434|Tufts University|tufts university
681827|NCT00330408|Adherence|adherence
681828|NCT00330408|GP training|gp training
681829|NCT00330408|Medication Event Monitoring System(MEMS)|medication event monitoring system(mems)
681830|NCT00330408|Antihypertensive Medication|antihypertensive medication
681831|NCT00330408|Hypertension|hypertension
681832|NCT00330356|Dietary Salt|dietary salt
681833|NCT00330356|Blood Pressure|blood pressure
681834|NCT00330356|Normotensives|normotensives
681835|NCT00330343|morphine|morphine
681836|NCT00330343|naloxone|naloxone
681837|NCT00330343|pediatrics|pediatrics
681838|NCT00330343|adverse effects|adverse effects
681839|NCT00330343|pain|pain
681840|NCT00330330|Fasting plasma glucose|fasting plasma glucose
681841|NCT00330330|HbA1c|hba1c
681842|NCT00330317|Letrozole|letrozole
681843|NCT00330317|Breast Conserving Surgery|breast conserving surgery
681844|NCT00330317|NeoAdjuvant|neoadjuvant
681845|NCT00330317|Early Breast Cancer|early breast cancer
681846|NCT00330304|Tuberculosis|tuberculosis
681847|NCT00330304|Child|child
681848|NCT00330304|HIV|hiv
681849|NCT00330304|prophylaxis|prophylaxis
681850|NCT00330304|mortality|mortality
681851|NCT00330291|PTSD|ptsd
681852|NCT00330291|Xyrem|xyrem
681853|NCT00330291|Sleep problems|sleep problems
681854|NCT00330278|Cesarean section|cesarean section
681855|NCT00330278|Antibiotic prophylaxis|antibiotic prophylaxis
681856|NCT00330278|Cefazolin|cefazolin
681857|NCT00330252|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
681858|NCT00330252|Relapsed Chronic Lymphocytic Leukemia|relapsed chronic lymphocytic leukemia
681859|NCT00330252|Alemtuzumab|alemtuzumab
681860|NCT00330252|Campath|campath
681861|NCT00330252|Rituximab|rituximab
681862|NCT00330252|Rituxan|rituxan
681863|NCT00330239|Substance Abuse|substance abuse
681864|NCT00330239|Trauma|trauma
681865|NCT00330239|Dependence|dependence
681866|NCT00330226|schizophrenia|schizophrenia
681867|NCT00330226|bipolar disorder|bipolar disorder
681868|NCT00330226|atypical antipsychotics|atypical antipsychotics
681869|NCT00330226|mood stabilizers|mood stabilizers
681870|NCT00330226|biological markers|biological markers
681871|NCT00330213|transthoracic|transthoracic
681872|NCT00330213|echocardiography|echocardiography
681873|NCT00330213|red wine|red wine
681874|NCT00330213|cognac|cognac
681875|NCT00330213|coronary reactivity|coronary reactivity
681876|NCT00330200|Fasting plasma glucose|fasting plasma glucose
681877|NCT00330200|HbA1c|hba1c
681878|NCT00330200|Metabolism|metabolism
681879|NCT00330187|nicotine dependence|nicotine dependence
681880|NCT00330187|bupropion SR|bupropion sr
681881|NCT00330187|smoking cessation|smoking cessation
681882|NCT00330187|adolescents|adolescents
681883|NCT00330187|contingency management|contingency management
681884|NCT00330174|Alcoholism|alcoholism
681885|NCT00330174|Mood|mood
681886|NCT00330174|Anxiety|anxiety
681887|NCT00330174|Acamprosate|acamprosate
681888|NCT00330148|trypanosomiasis|trypanosomiasis
681889|NCT00330148|gambiense|gambiense
681890|NCT00330148|combination drug therapy|combination drug therapy
681891|NCT00330148|sleeping sickness|sleeping sickness
681892|NCT00330148|Uganda|uganda
681893|NCT00330135|hip osteoarthritis|hip osteoarthritis
681894|NCT00330135|Hyaluronic acid|hyaluronic acid
681895|NCT00330135|Viscosupplementation|viscosupplementation
681896|NCT00330135|intra-articular injections|intra-articular injections
681897|NCT00330122|radius articular displaced fractures|radius articular displaced fractures
681898|NCT00330122|fore locked plate|fore locked plate
681899|NCT00330122|external radiocarpal fixer|external radiocarpal fixer
681900|NCT00330109|glioma|glioma
681901|NCT00330109|machine learning|machine learning
681902|NCT00330109|advanced diagnostic imaging|advanced diagnostic imaging
681903|NCT00330096|bone loss, osteoporosis, prevention, hesperidin|bone loss, osteoporosis, prevention, hesperidin
681904|NCT00330070|8-week treatment|8-week treatment
681905|NCT00330070|oral tablets|oral tablets
681906|NCT00330070|persistent moderate to severe asthma|persistent moderate to severe asthma
681907|NCT00330070|AQLQ|aqlq
681908|NCT00330070|asthma control|asthma control
681909|NCT00330070|quality of life|quality of life
681910|NCT00330018|BMT|bmt
681911|NCT00330018|CMV|cmv
681912|NCT00330018|GVHD|gvhd
683017|NCT00325767|aerosol|aerosol
681913|NCT00330005|psychotherapy|psychotherapy
681914|NCT00330005|bipolar disorder|bipolar disorder
681915|NCT00330005|psychodynamic|psychodynamic
681916|NCT00330005|psychoeducation|psychoeducation
681917|NCT00330005|illness management|illness management
681918|NCT00330005|controlled trial|controlled trial
681919|NCT00330005|pilot study|pilot study
681920|NCT00329979|aortic stenosis|aortic stenosis
681921|NCT00329979|radial|radial
681922|NCT00329979|femoral|femoral
681923|NCT00329979|vascular access site|vascular access site
681924|NCT00329979|embolism|embolism
681925|NCT00329979|cerebral|cerebral
681926|NCT00329979|MRI|mri
681927|NCT00329979|stroke|stroke
681928|NCT00329966|Influenza|influenza
681929|NCT00329966|adult|adult
681930|NCT00329966|elderly|elderly
681931|NCT00329966|vaccine|vaccine
681932|NCT00329940|Letrozole|letrozole
681933|NCT00329940|breast cancer|breast cancer
681934|NCT00329940|critical musculoskeletal|critical musculoskeletal
681935|NCT00329940|postmenopausal|postmenopausal
681936|NCT00329940|rheumatologic tolerance|rheumatologic tolerance
681937|NCT00329927|Adjuvanted Influenza Vaccine|adjuvanted influenza vaccine
681938|NCT00329914|Preterm delivery|preterm delivery
681939|NCT00329914|Prevention|prevention
681940|NCT00329914|Twins|twins
681941|NCT00329914|Progesterone|progesterone
681942|NCT00329901|Meningitis|meningitis
681943|NCT00329901|healthy subject|healthy subject
681944|NCT00329901|vaccine|vaccine
681945|NCT00329888|Endoscopic papillary balloon dilatation|endoscopic papillary balloon dilatation
681946|NCT00329888|Endoscopic sphincterotomy|endoscopic sphincterotomy
681947|NCT00329862|Laparoscopic Adjustable Gastric Banding|laparoscopic adjustable gastric banding
681948|NCT00329862|Truncal Vagotomy|truncal vagotomy
681949|NCT00329862|Lap Band|lap band
681950|NCT00329862|Lap Banding|lap banding
681951|NCT00329862|Obesity Surgery|obesity surgery
681952|NCT00329862|Bariatric surgery|bariatric surgery
681953|NCT00329862|Weight Loss Surgery|weight loss surgery
681954|NCT00329849|Meningitis|meningitis
681955|NCT00329849|children|children
681956|NCT00329849|vaccine|vaccine
681957|NCT00329849|safety|safety
681958|NCT00329849|efficacy|efficacy
681959|NCT00329823|Hidradenitis suppurativa, etanercept|hidradenitis suppurativa, etanercept
681960|NCT00329797|osteoporosis|osteoporosis
681961|NCT00329797|adenocarcinoma of the prostate|adenocarcinoma of the prostate
681962|NCT00329797|stage IIB prostate cancer|stage iib prostate cancer
681963|NCT00329797|stage IIA prostate cancer|stage iia prostate cancer
681964|NCT00329797|stage III prostate cancer|stage iii prostate cancer
681965|NCT00329797|stage IV prostate cancer|stage iv prostate cancer
681966|NCT00329784|peanut allergy|peanut allergy
681967|NCT00329784|egg allergy|egg allergy
681968|NCT00329784|eczema|eczema
681969|NCT00329784|peanut|peanut
681970|NCT00329784|allergy|allergy
681971|NCT00329784|allergies|allergies
681972|NCT00329784|allergic reaction|allergic reaction
681973|NCT00329784|anaphylaxis|anaphylaxis
681974|NCT00329784|infants|infants
681975|NCT00329784|children|children
681976|NCT00329758|moderate head injury|moderate head injury
681977|NCT00329758|rosuvastatin|rosuvastatin
681978|NCT00329758|statin|statin
681979|NCT00329758|amnesia|amnesia
681980|NCT00329758|orientation|orientation
681981|NCT00329745|Rotavirus Gastroenteritis|rotavirus gastroenteritis
681982|NCT00329745|Human rotavirus vaccine, efficacy, infants|human rotavirus vaccine, efficacy, infants
681983|NCT00329706|mild cognitive impairment|mild cognitive impairment
681984|NCT00329706|Alzheimer's disease|alzheimer's disease
681985|NCT00329706|dementia|dementia
681986|NCT00329706|FDG|fdg
681987|NCT00329706|PET|pet
681988|NCT00329680|Sepsis|sepsis
681989|NCT00329680|Severe Sepsis|severe sepsis
681990|NCT00329680|Septic Shock|septic shock
681991|NCT00329680|Enteral Nutrition|enteral nutrition
681992|NCT00329680|Antioxidants|antioxidants
681993|NCT00329680|EPA|epa
681994|NCT00329680|GLA|gla
681995|NCT00329680|Nutrition|nutrition
681996|NCT00329680|Intensive Care|intensive care
681997|NCT00329680|ICU|icu
681998|NCT00329667|heart valve|heart valve
681999|NCT00329667|mitral|mitral
682000|NCT00329667|aortic|aortic
682001|NCT00329667|valvular disease|valvular disease
682002|NCT00329654|Burn wounds, light therapy|burn wounds, light therapy
682003|NCT00329628|Prevention|prevention
682004|NCT00329628|Thromboembolism|thromboembolism
682005|NCT00329615|Cancer cachexia|cancer cachexia
682006|NCT00329615|Tumor host metabolism|tumor host metabolism
682007|NCT00329602|Moderate|moderate
682008|NCT00329602|Restless Legs Syndrome|restless legs syndrome
682009|NCT00329602|Severe|severe
682010|NCT00329602|ropinirole|ropinirole
682011|NCT00329589|Malignancies of the central nervous system, head and neck area|malignancies of the central nervous system, head and neck area
682012|NCT00329589|and cervix|and cervix
682013|NCT00329563|Cardiac Arrest|cardiac arrest
682014|NCT00329563|Hypothermia|hypothermia
682015|NCT00329550|Certolizumab pegol|certolizumab pegol
682016|NCT00329550|Cimzia|cimzia
682017|NCT00329550|CZP|czp
682018|NCT00329537|Crohn's Disease|crohn's disease
682019|NCT00329537|Sargramostim|sargramostim
682020|NCT00329537|CDAI|cdai
682021|NCT00329537|Moderately to severely active Crohn's Disease|moderately to severely active crohn's disease
682022|NCT00329524|Tinnitus|tinnitus
682023|NCT00329524|TMS|tms
682024|NCT00329524|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
682025|NCT00329511|pregnancy|pregnancy
682026|NCT00329511|hypertension|hypertension
682027|NCT00329511|compliance|compliance
682028|NCT00329511|clonidine patch|clonidine patch
682029|NCT00329511|methyldopa|methyldopa
682030|NCT00329498|ascorbic acid|ascorbic acid
682031|NCT00329485|Elevated BNP Levels in CHF patients|elevated bnp levels in chf patients
682032|NCT00329459|menstrual migraine|menstrual migraine
682033|NCT00329459|headache|headache
682034|NCT00329459|early intervention|early intervention
682035|NCT00329459|dysmenorrhea|dysmenorrhea
682036|NCT00329446|GAD|gad
682037|NCT00329446|anxiety|anxiety
682038|NCT00329433|Deep venous thrombosis|deep venous thrombosis
682039|NCT00329433|DVT|dvt
682040|NCT00329433|Heparin induced thrombocytopenia|heparin induced thrombocytopenia
682041|NCT00329433|HIT|hit
682042|NCT00329433|Direct thrombin inhibitor|direct thrombin inhibitor
682043|NCT00329420|Crohn's Disease|crohn's disease
682044|NCT00329420|CDP870|cdp870
682045|NCT00329420|Certolizumab pegol|certolizumab pegol
682046|NCT00329420|CZP|czp
682047|NCT00329407|Alcoholism|alcoholism
682048|NCT00329407|Heavy Drinking|heavy drinking
682049|NCT00329407|Alcohol Dependence|alcohol dependence
682050|NCT00329394|Ketamine|ketamine
682051|NCT00329394|Analgesia|analgesia
682052|NCT00329394|Alcool-dependent|alcool-dependent
682053|NCT00329394|carcinological surgery|carcinological surgery
682054|NCT00329381|Allergic|allergic
682055|NCT00329381|Asthma|asthma
682056|NCT00329381|Immunotherapy|immunotherapy
682057|NCT00329368|Cancer|cancer
682058|NCT00329368|Vaccine|vaccine
682059|NCT00329368|Phase I|phase i
682060|NCT00329368|FolateImmune|folateimmune
682061|NCT00329368|Recurrent|recurrent
682062|NCT00329368|Refractory|refractory
682063|NCT00329368|Experimental|experimental
682064|NCT00329355|menstrual migraine|menstrual migraine
682065|NCT00329355|headache|headache
682066|NCT00329355|early intervention|early intervention
682067|NCT00329355|dysmenorrhea|dysmenorrhea
682068|NCT00329342|Low back pain;|low back pain;
682069|NCT00329342|Return to work;|return to work;
682070|NCT00329342|Posture|posture
682071|NCT00329329|Advanced solid malignancies|advanced solid malignancies
682072|NCT00329316|Pre-term labor|pre-term labor
682073|NCT00329316|progesterone|progesterone
682074|NCT00329303|Moderate to severe chronic plaque psoriasis|moderate to severe chronic plaque psoriasis
682075|NCT00329303|anti TNF α|anti tnf α
682076|NCT00329303|CDP 870|cdp 870
682077|NCT00329303|Cimzia®|cimzia®
682078|NCT00329303|certolizumab pegol|certolizumab pegol
682079|NCT00329303|retreatment|retreatment
682080|NCT00329290|pregnancy|pregnancy
682081|NCT00329290|anticoagulation|anticoagulation
682082|NCT00329290|enoxaparin|enoxaparin
682083|NCT00329290|prosthetic heart valves|prosthetic heart valves
682084|NCT00329277|age-related macular degeneration|age-related macular degeneration
682085|NCT00329277|preferred retinal locus|preferred retinal locus
682086|NCT00329277|macular perimetry|macular perimetry
682087|NCT00329264|GAD|gad
682088|NCT00329264|anxiety|anxiety
682089|NCT00329251|HIV|hiv
682090|NCT00329251|Viral load|viral load
682091|NCT00329251|Vaccines|vaccines
682092|NCT00329251|Immunotherapy|immunotherapy
682093|NCT00329225|Type 2 Diabetes Mellitus Thiazolidinediones Insulin|type 2 diabetes mellitus thiazolidinediones insulin
682094|NCT00329212|Pharmacokinetics|pharmacokinetics
682095|NCT00329212|Bioavailability|bioavailability
682096|NCT00329212|Therapeutic Equivalency|therapeutic equivalency
682097|NCT00329199|Depression|depression
682098|NCT00329199|Adolescents|adolescents
682099|NCT00329199|Family Therapy|family therapy
682100|NCT00329199|Primary Care|primary care
682101|NCT00329199|Family Conflict|family conflict
682102|NCT00329186|Healthy Subjects|healthy subjects
682103|NCT00329186|Major Depressive Disorder|major depressive disorder
682104|NCT00329186|Depression|depression
682105|NCT00329186|Cytochrome P-450 CYP2D6|cytochrome p-450 cyp2d6
682106|NCT00329186|Pharmacokinetics|pharmacokinetics
682107|NCT00329186|Health|health
682108|NCT00329147|Healthy Subjects|healthy subjects
682109|NCT00329147|Major Depressive Disorder|major depressive disorder
682110|NCT00329147|Depression|depression
682111|NCT00329121|SCCIS|sccis
682112|NCT00329121|Bowens disease|bowens disease
682113|NCT00329121|PEP005|pep005
682114|NCT00329121|Topical|topical
682115|NCT00329121|Dermatology|dermatology
682116|NCT00329121|Cutaneous Squamous Cell Carcinoma in situ|cutaneous squamous cell carcinoma in situ
682117|NCT00329095|Glaucoma|glaucoma
682118|NCT00329095|Compliance|compliance
682119|NCT00329069|statin|statin
682120|NCT00329069|atorvastatin|atorvastatin
682121|NCT00329069|hypercholesterolemia|hypercholesterolemia
682122|NCT00329069|coronary artery disease|coronary artery disease
682123|NCT00329069|monocyte|monocyte
683510|NCT00324246|in-vitro|in-vitro
682124|NCT00329069|collateral formation|collateral formation
682125|NCT00329069|arteriogenesis|arteriogenesis
682126|NCT00329069|chemotaxis|chemotaxis
682127|NCT00329069|migration|migration
682128|NCT00329069|growth factors|growth factors
682129|NCT00329069|vascular endothelial growth factor A|vascular endothelial growth factor a
682130|NCT00329069|placenta growth factor 1|placenta growth factor 1
682131|NCT00329069|hepatocyte growth factor|hepatocyte growth factor
682132|NCT00329069|monocyte chemotactic protein 1|monocyte chemotactic protein 1
682133|NCT00329056|Parkinson's disease|parkinson's disease
682134|NCT00329056|MitoQ|mitoq
682135|NCT00329056|UPDRS|updrs
682136|NCT00329043|Prostate Cancer|prostate cancer
682137|NCT00329043|Adenocarcinoma of the Prostate|adenocarcinoma of the prostate
682138|NCT00329043|Ductal Adenocarcinoma of the Prostate|ductal adenocarcinoma of the prostate
682139|NCT00329043|Hormonal Ablation|hormonal ablation
682140|NCT00329043|Radical Prostatectomy|radical prostatectomy
682141|NCT00329043|LHRH Agonist|lhrh agonist
682142|NCT00329043|Lupron|lupron
682143|NCT00329043|Leuprolide|leuprolide
682144|NCT00329043|Sunitinib Malate|sunitinib malate
682145|NCT00329043|SU011248|su011248
682146|NCT00329030|Large B-Cell Lymphoma|large b-cell lymphoma
682147|NCT00329030|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
682148|NCT00329017|SNPs|snps
682149|NCT00329017|single nucleotide polymorphism|single nucleotide polymorphism
682150|NCT00329017|breast atypia|breast atypia
682151|NCT00329017|breast epithelial hyperplasia|breast epithelial hyperplasia
682152|NCT00329017|high risk for breast cancer|high risk for breast cancer
682153|NCT00329004|Solid Tumors|solid tumors
682154|NCT00328991|wart|wart
682155|NCT00328991|common wart|common wart
682156|NCT00328991|verruca vulgaris|verruca vulgaris
682157|NCT00328991|verruca plantaris|verruca plantaris
682158|NCT00328991|plantar wart|plantar wart
682159|NCT00328991|duct tape|duct tape
682160|NCT00328991|occlusion therapy|occlusion therapy
682161|NCT00328978|schizophrenia|schizophrenia
682162|NCT00328978|schizoaffective disorders|schizoaffective disorders
682163|NCT00328965|Korean patients|korean patients
682164|NCT00328965|Type 2 diabetes|type 2 diabetes
682165|NCT00328965|Endothelial function|endothelial function
682166|NCT00328965|lacidipine|lacidipine
682167|NCT00328965|Essential hypertension|essential hypertension
682168|NCT00328952|schizophrenia|schizophrenia
682169|NCT00328952|auditory verbal hallucination|auditory verbal hallucination
682170|NCT00328952|antipsychotic treatment|antipsychotic treatment
682171|NCT00328939|ARIXTRA|arixtra
682172|NCT00328939|prevention of DVT|prevention of dvt
682173|NCT00328926|Hypogonadotropic Hypogonadism (LH <1.2 IU/L)|hypogonadotropic hypogonadism (lh <1.2 iu/l)
682174|NCT00328926|Placebo|placebo
682175|NCT00328926|Luveris® 75 IU|luveris® 75 iu
682176|NCT00328926|Luveris® 25 IU|luveris® 25 iu
682177|NCT00328926|Recombinant human chorionic gonadotropin (r-hCG)|recombinant human chorionic gonadotropin (r-hcg)
682178|NCT00328913|satiety|satiety
682179|NCT00328913|food intake|food intake
682180|NCT00328913|mood|mood
682181|NCT00328913|wellness|wellness
682182|NCT00328913|weight management|weight management
682183|NCT00328900|Galvanic skin response|galvanic skin response
682184|NCT00328900|Anesthesia|anesthesia
682185|NCT00328900|Atropine|atropine
682186|NCT00328887|Esophageal Neoplasms|esophageal neoplasms
682187|NCT00328874|Progressive Supranuclear Palsy|progressive supranuclear palsy
682188|NCT00328874|Coenzyme Q10|coenzyme q10
682189|NCT00328861|Adoptive Cell Therapy|adoptive cell therapy
682190|NCT00328861|Cutaneous Melanoma|cutaneous melanoma
682191|NCT00328861|Clinical Response|clinical response
682192|NCT00328861|Rate of Repopulation|rate of repopulation
682193|NCT00328861|Toxicity Profile|toxicity profile
682194|NCT00328861|Metastatic Melanoma|metastatic melanoma
682195|NCT00328861|Metastatic Kidney Cancer|metastatic kidney cancer
682196|NCT00328848|patient care management|patient care management
682197|NCT00328848|chronic disease|chronic disease
682198|NCT00328835|Optic Nerve|optic nerve
682199|NCT00328835|Glaucoma|glaucoma
682200|NCT00328822|Primary insomnia|primary insomnia
682201|NCT00328822|Quetiapine|quetiapine
682202|NCT00328822|Randomized controlled trial|randomized controlled trial
682203|NCT00328822|Double blind|double blind
682204|NCT00328796|Perineal|perineal
682205|NCT00328796|repair|repair
682206|NCT00328796|episiotomies|episiotomies
682207|NCT00328796|midwives|midwives
682208|NCT00328796|pain relief|pain relief
682209|NCT00328796|Episiotomy|episiotomy
682210|NCT00328783|Breast cancer|breast cancer
682211|NCT00328783|Active Breathing Control|active breathing control
682212|NCT00328783|Active Breathing Coordinator|active breathing coordinator
682213|NCT00328783|ABC|abc
682214|NCT00328770|liver transplant|liver transplant
682215|NCT00328770|hepatocellular carcinoma|hepatocellular carcinoma
682216|NCT00328770|sirolimus|sirolimus
682217|NCT00328757|gynecologic cancer|gynecologic cancer
682218|NCT00328757|cervical cancer|cervical cancer
682219|NCT00328757|ovarian cancer|ovarian cancer
682220|NCT00328757|endometrial cancer|endometrial cancer
682221|NCT00328757|radical abdominal hysterectomy|radical abdominal hysterectomy
682222|NCT00328757|pelvic lymphadenectomy|pelvic lymphadenectomy
682223|NCT00328757|surgical staging|surgical staging
682224|NCT00328757|postoperative feeding|postoperative feeding
682225|NCT00328757|Early-stage gynecologic cancer patients|early-stage gynecologic cancer patients
682226|NCT00328744|Weight|weight
682227|NCT00328744|Dietary intake|dietary intake
682228|NCT00328744|Energy|energy
682229|NCT00328744|Hedonics|hedonics
682230|NCT00328744|Behavioral|behavioral
682231|NCT00328744|Sensory-specific satiety|sensory-specific satiety
682232|NCT00328744|Monotony|monotony
682233|NCT00328731|Allergy|allergy
682234|NCT00328731|NAET|naet
682235|NCT00328718|Persistent Asthma|persistent asthma
682236|NCT00328718|pediatric asthmatic|pediatric asthmatic
682237|NCT00328718|asthma control|asthma control
682238|NCT00328705|Sensing|sensing
682239|NCT00328705|Capture Management|capture management
682240|NCT00328705|Heart Failure|heart failure
682241|NCT00328705|ICD Indication|icd indication
682242|NCT00328692|heart failure|heart failure
682243|NCT00328692|diuretic|diuretic
682244|NCT00328692|renal impairment|renal impairment
682245|NCT00328692|renal function|renal function
682246|NCT00328679|abdominal|abdominal
682247|NCT00328679|stomach|stomach
682248|NCT00328679|dyspepsia|dyspepsia
682249|NCT00328679|food allergy|food allergy
682250|NCT00328653|vernal keratoconjunctivitis (VKC), eye, allergy, cyclosporin|vernal keratoconjunctivitis (vkc), eye, allergy, cyclosporin
682251|NCT00328640|CVA|cva
682252|NCT00328640|Ischemic stroke|ischemic stroke
682253|NCT00328627|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
682254|NCT00328627|Drug Therapy|drug therapy
682255|NCT00328627|Diabetes Mellitus, Non Insulin Dependent|diabetes mellitus, non insulin dependent
682256|NCT00328627|Glucose Intolerance|glucose intolerance
682257|NCT00328627|Hyperglycemia|hyperglycemia
682258|NCT00328614|Locally advanced prostate cancer|locally advanced prostate cancer
682259|NCT00328614|positive lymph nodes|positive lymph nodes
682260|NCT00328588|Treatment Efficacy|treatment efficacy
682261|NCT00328588|Treatment Effectiveness|treatment effectiveness
682262|NCT00328588|Disease Management|disease management
682263|NCT00328588|Treatment|treatment
682264|NCT00328588|Safety|safety
682265|NCT00328575|Brain metastases|brain metastases
682266|NCT00328575|Parenchymal|parenchymal
682267|NCT00328575|Neoplasm|neoplasm
682268|NCT00328575|IMRT|imrt
682269|NCT00328575|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
682270|NCT00328562|Advanced NSCLC|advanced nsclc
682271|NCT00328562|Non-Small Cell Lung Carcinoma|non-small cell lung carcinoma
682272|NCT00328562|Stage IV NSCLC|stage iv nsclc
682273|NCT00328549|Natural History,|natural history,
682274|NCT00328549|Hepatitis C Infection|hepatitis c infection
682275|NCT00328549|Ribavirin|ribavirin
682276|NCT00328549|Pegylated Interferon|pegylated interferon
682277|NCT00328549|Interferon|interferon
682278|NCT00328536|flow-mediated vasodilatation|flow-mediated vasodilatation
682279|NCT00328536|endothelial dysfunction|endothelial dysfunction
682280|NCT00328536|omega-3 fatty acids|omega-3 fatty acids
682281|NCT00328536|type 2 diabetes mellitus|type 2 diabetes mellitus
682282|NCT00328536|postprandial state|postprandial state
682283|NCT00328510|Stereotactic radiotherapy|stereotactic radiotherapy
682284|NCT00328484|COPD|copd
682285|NCT00328484|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
682286|NCT00328484|Exercise|exercise
682287|NCT00328484|Emphysema|emphysema
682288|NCT00328484|Chronic Bronchitis|chronic bronchitis
682289|NCT00328471|patient care management|patient care management
682290|NCT00328471|cerebrovascular accident|cerebrovascular accident
682291|NCT00328458|CNS and head and neck cancers|cns and head and neck cancers
682292|NCT00328458|Histologically confirmed CNS malignancy head and neck|histologically confirmed cns malignancy head and neck
682293|NCT00328458|there is on standard therapy or|there is on standard therapy or
682294|NCT00328458|have failed standard therapy|have failed standard therapy
682295|NCT00328445|Curriculum|curriculum
682296|NCT00328445|Classroom management|classroom management
682297|NCT00328445|School-wide climate|school-wide climate
682298|NCT00328445|Parent involvement|parent involvement
682299|NCT00328432|early breast cancer|early breast cancer
682300|NCT00328432|double-blind randomized placebo-controlled|double-blind randomized placebo-controlled
682301|NCT00328432|RCT|rct
682302|NCT00328432|pre-surgical model|pre-surgical model
682303|NCT00328432|DCIS model|dcis model
682304|NCT00328432|COX-2 inhibitor|cox-2 inhibitor
682305|NCT00328432|celecoxib|celecoxib
682306|NCT00328432|Ki-67 placebo|ki-67 placebo
682307|NCT00328419|Photoprotection,|photoprotection,
682308|NCT00328419|Parenteral nutrition|parenteral nutrition
682309|NCT00328419|Oxidant stress|oxidant stress
682310|NCT00328419|Infant, Premature|infant, premature
682311|NCT00328393|Hypertension|hypertension
682312|NCT00328380|Travelers' Diarrhea|travelers' diarrhea
682313|NCT00328380|Xifaxan|xifaxan
682314|NCT00328380|Rifaximin|rifaximin
682315|NCT00328380|Escherichia coli|escherichia coli
682316|NCT00328380|E coli|e coli
682317|NCT00328380|EAEC|eaec
682318|NCT00328380|Enteroaggregative E coli|enteroaggregative e coli
682319|NCT00328380|ETEC|etec
682320|NCT00328380|Enterotoxigenic E coli|enterotoxigenic e coli
682321|NCT00328367|schizophrenia|schizophrenia
682322|NCT00328367|aripiprazole|aripiprazole
682323|NCT00328367|clozapine|clozapine
682324|NCT00328341|traumatic brain injury|traumatic brain injury
682325|NCT00328341|hemorrhagic shock|hemorrhagic shock
682326|NCT00328341|multisystem trauma|multisystem trauma
682327|NCT00328341|under resuscitation|under resuscitation
682328|NCT00328341|tissue oxygen monitoring|tissue oxygen monitoring
682329|NCT00328315|Myocardial Perfusion SPECT|myocardial perfusion spect
682330|NCT00328302|Diabetes|diabetes
682331|NCT00328302|Kidney function|kidney function
682332|NCT00328302|24 ambulatory blood pressure|24 ambulatory blood pressure
682333|NCT00328302|Kidney biopsy|kidney biopsy
682334|NCT00328289|Dialysis associated hypotension|dialysis associated hypotension
682335|NCT00328289|Urea removal|urea removal
682336|NCT00328263|Bio-K+CL1285|bio-k+cl1285
682337|NCT00328263|Probiotics|probiotics
682338|NCT00328263|Antibiotics-associated diarrhea|antibiotics-associated diarrhea
682339|NCT00328263|Clostridium difficile-associated diarrhea|clostridium difficile-associated diarrhea
682340|NCT00328263|Lactobacillus acidophilus|lactobacillus acidophilus
682341|NCT00328263|Clostridium Difficile|clostridium difficile
682342|NCT00328250|Internet|internet
682343|NCT00328250|CBT|cbt
682344|NCT00328250|Insomnia|insomnia
682345|NCT00328250|Sleep|sleep
682346|NCT00328237|Cord Blood Transplant|cord blood transplant
682347|NCT00328237|Umbilical cord blood transplant|umbilical cord blood transplant
682348|NCT00328237|Transplant|transplant
682349|NCT00328237|Fludarabine|fludarabine
682350|NCT00328237|Total Body Irradiation|total body irradiation
682351|NCT00328237|Cyclophosphamide|cyclophosphamide
682352|NCT00328224|ritalin|ritalin
682353|NCT00328224|ADHA|adha
682354|NCT00328224|dental status|dental status
682355|NCT00328224|periodontal status|periodontal status
682356|NCT00328224|Attention-Deficit Hyperactivity Disorder|attention-deficit hyperactivity disorder
682357|NCT00328224|Dental trauma|dental trauma
682358|NCT00328198|CAMPATH|campath
682359|NCT00328198|Alemtuzumab|alemtuzumab
682360|NCT00328198|Leukemia|leukemia
682361|NCT00328198|MabCampath|mabcampath
682362|NCT00328198|Chronic|chronic
682363|NCT00328198|Subcutaneous|subcutaneous
682364|NCT00328198|CLL|cll
682365|NCT00328198|C-CLL|c-cll
682366|NCT00328198|Relapsed|relapsed
682367|NCT00328198|Refractory|refractory
682368|NCT00328198|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
682369|NCT00328185|pediatric|pediatric
682370|NCT00328185|heart disease|heart disease
682371|NCT00328185|orthotopic heart transplantation|orthotopic heart transplantation
682372|NCT00328185|allograft fibrosis|allograft fibrosis
682373|NCT00328159|FAO disorders|fao disorders
682374|NCT00328159|long-chain FAO enzyme defects|long-chain fao enzyme defects
682375|NCT00328159|inborn errors of metabolism|inborn errors of metabolism
682376|NCT00328159|carnitine palmitoyltransferase 1 (CPT1),|carnitine palmitoyltransferase 1 (cpt1),
682377|NCT00328159|carnitine-acylcarnitine translocase (CAT),|carnitine-acylcarnitine translocase (cat),
682378|NCT00328159|carnitine palmitoyltransferase 2 (CPT2),|carnitine palmitoyltransferase 2 (cpt2),
682379|NCT00328159|very-long chain acyl-CoA dehydrogenase (VLCAD),|very-long chain acyl-coa dehydrogenase (vlcad),
682380|NCT00328159|L-3-hydroxy-acyl-CoA dehydrogenase (LCHAD)|l-3-hydroxy-acyl-coa dehydrogenase (lchad)
682381|NCT00328159|or trifunctional protein (MTP).|or trifunctional protein (mtp).
682382|NCT00328146|pediatric|pediatric
682383|NCT00328146|cardiac|cardiac
682384|NCT00328146|re-operative surgery|re-operative surgery
682385|NCT00328133|recombinant Factor VIIa|recombinant factor viia
682386|NCT00328133|traumatic hemorrhage|traumatic hemorrhage
682387|NCT00328133|hemorrhagic shock|hemorrhagic shock
682388|NCT00328133|coagulopathy|coagulopathy
682389|NCT00328120|Advanced breast cancer|advanced breast cancer
682390|NCT00328120|Faslodex|faslodex
682391|NCT00328107|Influenza|influenza
682392|NCT00328094|Tight|tight
682393|NCT00328094|Glycemic|glycemic
682394|NCT00328094|control|control
682395|NCT00328094|outcomes|outcomes
682396|NCT00328094|peripheral vascular disease|peripheral vascular disease
682397|NCT00328094|infection|infection
682398|NCT00328094|cardiovascular|cardiovascular
682399|NCT00328094|morbidity|morbidity
682400|NCT00328094|mortality|mortality
682401|NCT00328081|Obesity|obesity
682402|NCT00328081|Weight gain|weight gain
682403|NCT00328081|Anti-obesity medication|anti-obesity medication
682404|NCT00328081|Anti-obesity management strategies|anti-obesity management strategies
682405|NCT00328081|Body Weight|body weight
682406|NCT00328068|ASAS classification|asas classification
682407|NCT00328068|ASAS diagnostic criteria|asas diagnostic criteria
682408|NCT00328068|spondyloarthritis|spondyloarthritis
682409|NCT00328068|spondyloarthropathy|spondyloarthropathy
682410|NCT00328068|spondylitis, ankylosing|spondylitis, ankylosing
682411|NCT00328068|modified New York criteria for AS|modified new york criteria for as
682412|NCT00328068|ESSG criteria for SpA|essg criteria for spa
682413|NCT00328068|Amor criteria for SpA|amor criteria for spa
682414|NCT00328068|arthritis|arthritis
682415|NCT00328068|enthesitis|enthesitis
682416|NCT00328068|magnetic resonance imaging|magnetic resonance imaging
682417|NCT00328055|functional ability|functional ability
682418|NCT00328055|patient care management|patient care management
682419|NCT00328055|communication|communication
682420|NCT00328055|literacy|literacy
682421|NCT00328042|Self-care|self-care
682422|NCT00328042|Quality of Life|quality of life
682423|NCT00328042|Chronic disease|chronic disease
682424|NCT00328029|Busulfan|busulfan
682425|NCT00328029|pharmacokinetic|pharmacokinetic
682426|NCT00328029|respiratory function assessment|respiratory function assessment
682427|NCT00328029|Busulfan pharmacokinetic and respiratory function tests|busulfan pharmacokinetic and respiratory function tests
682428|NCT00328016|hypertension|hypertension
682429|NCT00328016|high blood pressure|high blood pressure
682430|NCT00328016|meditation|meditation
682431|NCT00327990|ibandronate|ibandronate
682432|NCT00327990|osteoporosis|osteoporosis
682433|NCT00327990|preference|preference
682434|NCT00327990|case-finding|case-finding
682435|NCT00327990|post-menopausal|post-menopausal
682436|NCT00327990|alendronate|alendronate
682437|NCT00327977|hypoxemia|hypoxemia
682438|NCT00327977|palliative neonatal surgery|palliative neonatal surgery
682439|NCT00327964|malaria|malaria
682440|NCT00327964|fever|fever
682441|NCT00327964|Uganda|uganda
682442|NCT00327964|children|children
682443|NCT00327964|rapid diagnostic tests|rapid diagnostic tests
682444|NCT00327964|RDTs|rdts
682445|NCT00327964|Africa|africa
682446|NCT00327951|pediatric|pediatric
682447|NCT00327951|cardiac|cardiac
682448|NCT00327951|weight gain pre-operative|weight gain pre-operative
682449|NCT00327951|trisomy 21|trisomy 21
682450|NCT00327951|complete atrioventricular canal|complete atrioventricular canal
682451|NCT00327938|Remifentanil|remifentanil
682452|NCT00327938|Skin Conductance|skin conductance
682453|NCT00327938|Anesthesia|anesthesia
682454|NCT00327938|Analgesics, Opioid|analgesics, opioid
682455|NCT00327925|Ovarian|ovarian
682456|NCT00327925|Cancer|cancer
682457|NCT00327925|Antibodies|antibodies
682458|NCT00327925|Ovarian Cancer Associated Antibodies|ovarian cancer associated antibodies
682459|NCT00327912|Obesity|obesity
682460|NCT00327912|Surgery|surgery
682461|NCT00327912|Gastric bypass|gastric bypass
682462|NCT00327912|Biliopancreatic diversion with Duodenal switch|biliopancreatic diversion with duodenal switch
682463|NCT00327912|Laparoscopy|laparoscopy
682464|NCT00327899|pediatric|pediatric
682465|NCT00327899|congestive heart failure|congestive heart failure
682466|NCT00327899|inotropes|inotropes
682467|NCT00327886|pediatric|pediatric
682468|NCT00327886|Glenn operation|glenn operation
682469|NCT00327886|Cyanosis|cyanosis
682470|NCT00327873|breathlessness|breathlessness
682471|NCT00327873|shortness of breath|shortness of breath
682472|NCT00327873|end-of-life care|end-of-life care
682473|NCT00327873|hospice|hospice
682474|NCT00327808|Smokers|smokers
682475|NCT00327808|Adults|adults
682476|NCT00327808|Inflammatory markers|inflammatory markers
682477|NCT00327795|congenital heart disease|congenital heart disease
682478|NCT00327795|pediatric|pediatric
682479|NCT00327795|surgical outcomes|surgical outcomes
682480|NCT00327782|pediatric|pediatric
682481|NCT00327782|palliative care|palliative care
682482|NCT00327782|end stage heart failure|end stage heart failure
682483|NCT00327769|Advanced breast cancer|advanced breast cancer
682484|NCT00327769|fulvestrant|fulvestrant
682485|NCT00327769|anastrozole|anastrozole
682486|NCT00327756|Depression|depression
682487|NCT00327756|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
682488|NCT00327756|Mitochondrial Enhancer|mitochondrial enhancer
682489|NCT00327756|Manic Depressive|manic depressive
682490|NCT00327756|Bioenergetics|bioenergetics
682491|NCT00327756|Bipolar Disorder|bipolar disorder
682492|NCT00327756|Manic Depression|manic depression
682493|NCT00327743|Cancer Alternative Therapies|cancer alternative therapies
682494|NCT00327743|Metastatic Breast Cancer|metastatic breast cancer
682495|NCT00327730|Muscle|muscle
682496|NCT00327730|Spasm|spasm
682497|NCT00327730|Back|back
682498|NCT00327730|Pain|pain
682499|NCT00327717|Epilepsy|epilepsy
682500|NCT00327717|Partial seizures|partial seizures
682501|NCT00327704|Septic Shock|septic shock
682502|NCT00327691|Major cardiovascular event|major cardiovascular event
682503|NCT00327691|Major Coronary event|major coronary event
682504|NCT00327691|Revascularization|revascularization
682505|NCT00327678|ALL,|all,
682506|NCT00327678|young patients,|young patients,
682507|NCT00327678|chemotherapy,|chemotherapy,
682508|NCT00327678|Mabtera,|mabtera,
682509|NCT00327678|Imatinib,|imatinib,
682510|NCT00327678|allogeneic transplant|allogeneic transplant
682511|NCT00327665|pneumonia|pneumonia
682512|NCT00327665|pneumococcal vaccine|pneumococcal vaccine
682513|NCT00327665|elderly subjects|elderly subjects
682514|NCT00327665|invasive pneumococcal diseases|invasive pneumococcal diseases
682515|NCT00327665|Prophylaxis|prophylaxis
682516|NCT00327652|carcinoma|carcinoma
682517|NCT00327652|liver|liver
682518|NCT00327652|hepatic|hepatic
682519|NCT00327652|metastasis|metastasis
682520|NCT00327652|Listeria|listeria
683903|NCT00322400|Oral|oral
682521|NCT00327626|Fasting plasma glucose|fasting plasma glucose
682522|NCT00327626|HbA1c|hba1c
682523|NCT00327626|Oral antidiabetic agent(s)|oral antidiabetic agent(s)
682524|NCT00327613|PEX|pex
682525|NCT00327613|glaucoma|glaucoma
682526|NCT00327613|MMP|mmp
682527|NCT00327613|DNA degradation|dna degradation
682528|NCT00327613|POAG|poag
682529|NCT00327613|Healthy subjects|healthy subjects
682530|NCT00327587|hypertension|hypertension
682531|NCT00327587|valsartan|valsartan
682532|NCT00327587|amlodipine|amlodipine
682533|NCT00327587|HCTZ|hctz
682534|NCT00327561|Inflammation|inflammation
682535|NCT00327561|Periodontitis|periodontitis
682536|NCT00327561|Endothelial function|endothelial function
682537|NCT00327561|Atherosclerosis|atherosclerosis
682538|NCT00327561|Controlled trial|controlled trial
682539|NCT00327509|mRNA|mrna
682540|NCT00327509|glaucoma|glaucoma
682541|NCT00327483|Transplant|transplant
682542|NCT00327483|Medication error|medication error
682543|NCT00327483|Patient Safety|patient safety
682544|NCT00327483|Information technology|information technology
682545|NCT00327470|neovascular age related macular degeneration|neovascular age related macular degeneration
682546|NCT00327470|choroidal neovascularization|choroidal neovascularization
682547|NCT00327457|colorectal cancer screening|colorectal cancer screening
682548|NCT00327457|sigmoidoscopy|sigmoidoscopy
682549|NCT00327457|colonoscopy|colonoscopy
682550|NCT00327444|Ovarian neoplasm|ovarian neoplasm
682551|NCT00327444|Ascites|ascites
682552|NCT00327444|Angiogenesis inhibitor|angiogenesis inhibitor
682553|NCT00327444|Vascular Endothelial Growth Factor A|vascular endothelial growth factor a
682554|NCT00327444|Recombinant fusion protein|recombinant fusion protein
682555|NCT00327431|Hypertension|hypertension
682556|NCT00327431|Blood Pressure|blood pressure
682557|NCT00327431|Psychosocial Factors|psychosocial factors
682558|NCT00327405|POAG|poag
682559|NCT00327405|Primary Open Angle Glaucoma|primary open angle glaucoma
682560|NCT00327405|Trabeculectomy|trabeculectomy
682561|NCT00327405|Combined Phacotrabeculectomy|combined phacotrabeculectomy
682562|NCT00327405|Combined Glaucoma Cataract Surgery|combined glaucoma cataract surgery
682563|NCT00327405|Releasable Suture|releasable suture
682564|NCT00327405|Ocular Compresssion|ocular compresssion
682565|NCT00327392|Arthroscopy|arthroscopy
682566|NCT00327392|AV Shunt|av shunt
682567|NCT00327392|Bunion|bunion
682568|NCT00327392|Dilatation and Curettage|dilatation and curettage
682569|NCT00327392|Esophagogastroduodenoscopy|esophagogastroduodenoscopy
682570|NCT00327392|Hysteroscopy|hysteroscopy
682571|NCT00327392|Lithotripsy|lithotripsy
682572|NCT00327392|Rotator Cuff/ Shoulder|rotator cuff/ shoulder
682573|NCT00327392|Transesophageal Echocardiography|transesophageal echocardiography
682574|NCT00327392|Ureteroscopy|ureteroscopy
682575|NCT00327392|AQUAVAN|aquavan
682576|NCT00327392|Sedation|sedation
682577|NCT00327379|Bloodloss|bloodloss
682578|NCT00327379|Transfusion Requirements in Patients Undergoing Elective Spinal Fusion Surgery|transfusion requirements in patients undergoing elective spinal fusion surgery
682579|NCT00327366|Menstrual Cycle|menstrual cycle
682580|NCT00327366|Light Therapy|light therapy
682581|NCT00327366|Sex Hormones|sex hormones
682582|NCT00327366|Ovulation|ovulation
682583|NCT00327353|Asthma|asthma
682584|NCT00327353|Salmeterol|salmeterol
682585|NCT00327353|Formoterol|formoterol
682586|NCT00327353|Airway resistance|airway resistance
682587|NCT00327340|Metastatic hormone refractory prostate cancer (HRPC)|metastatic hormone refractory prostate cancer (hrpc)
682588|NCT00327301|POAG|poag
682589|NCT00327301|Parkinson's disease|parkinson's disease
682590|NCT00327301|cellular proteome|cellular proteome
682591|NCT00327301|human leucocytes|human leucocytes
682592|NCT00327301|vasospasm|vasospasm
682593|NCT00327301|POAG patients|poag patients
682594|NCT00327301|Patients with Parkinson's disease|patients with parkinson's disease
682595|NCT00327301|Healthy subjects|healthy subjects
682596|NCT00327288|Hormone refractory prostate cancer|hormone refractory prostate cancer
682597|NCT00327262|chronic myeloid leukemia|chronic myeloid leukemia
682598|NCT00327262|Ph+|ph+
682599|NCT00327262|bcr/abl+|bcr/abl+
682600|NCT00327262|imatinib|imatinib
682601|NCT00327236|Paraneoplastic Neurologic Syndromes|paraneoplastic neurologic syndromes
682602|NCT00327223|Metastatic cancer|metastatic cancer
682603|NCT00327223|Disseminated malignant disease|disseminated malignant disease
682604|NCT00327210|BGAT|bgat
682605|NCT00327210|Blood Glucose Awareness Training|blood glucose awareness training
682606|NCT00327210|Diabetes|diabetes
682607|NCT00327210|T1DM|t1dm
682608|NCT00327210|Internet|internet
682609|NCT00327210|Web|web
682610|NCT00327210|Intervention|intervention
682611|NCT00327210|Treatment|treatment
682612|NCT00327210|Behavior|behavior
682613|NCT00327210|Education|education
682614|NCT00327210|Awareness|awareness
682615|NCT00327197|bronchoscopy|bronchoscopy
682616|NCT00327197|Sputum induction|sputum induction
682617|NCT00327197|Prednisolone|prednisolone
682618|NCT00327197|Asthma|asthma
682619|NCT00327197|biomarkers|biomarkers
682620|NCT00327171|ovarian cancer|ovarian cancer
682621|NCT00327171|angiogenesis|angiogenesis
682622|NCT00327171|angiogenesis inhibition|angiogenesis inhibition
682623|NCT00327171|VEGF-Trap fusion recombinant protein|vegf-trap fusion recombinant protein
682624|NCT00327171|Cancer and other neoplasms|cancer and other neoplasms
682625|NCT00327158|Reaming|reaming
682626|NCT00327158|fracture|fracture
682627|NCT00327158|emboli|emboli
682628|NCT00327145|HCTZ|hctz
682629|NCT00327145|hypertension|hypertension
682630|NCT00327145|valsartan|valsartan
682631|NCT00327145|amlodipine|amlodipine
682632|NCT00327132|Early-stage Lg/Hg Gastric MALT Lymphoma|early-stage lg/hg gastric malt lymphoma
682633|NCT00327132|Eradication of Helicobacter pylori (Hp)|eradication of helicobacter pylori (hp)
682634|NCT00327119|EGFR|egfr
682635|NCT00327119|Fully human|fully human
682636|NCT00327119|Monoclonal antibody|monoclonal antibody
682637|NCT00327119|Panitumumab|panitumumab
682638|NCT00327119|ABX-EGF|abx-egf
682639|NCT00327119|AMG954|amg954
682640|NCT00327119|Colorectal Cancer|colorectal cancer
682641|NCT00327119|Japan|japan
682642|NCT00327106|hip fracture|hip fracture
682643|NCT00327106|transfusion|transfusion
682644|NCT00327106|tranexamic acid|tranexamic acid
682645|NCT00327106|fondaparinux|fondaparinux
682646|NCT00327093|Colorectal cancer,|colorectal cancer,
682647|NCT00327093|immunohistochemistry,|immunohistochemistry,
682648|NCT00327093|monoclonal antibodies,|monoclonal antibodies,
682649|NCT00327093|predictive model,|predictive model,
682650|NCT00327093|antiangiogenic agents,|antiangiogenic agents,
682651|NCT00327093|medical imaging|medical imaging
682652|NCT00327093|Colorectal cancer with liver metastases|colorectal cancer with liver metastases
682653|NCT00327080|HIV|hiv
682654|NCT00327080|AIDS|aids
682655|NCT00327080|Pulmonary Hypertension|pulmonary hypertension
682656|NCT00327080|Blood Flow Studies|blood flow studies
682657|NCT00327080|Right Heart Catheterization|right heart catheterization
682658|NCT00327080|HIV Infection|hiv infection
682659|NCT00327080|HIV Associated Pulmonary Hypertension|hiv associated pulmonary hypertension
682660|NCT00327080|Healthy Volunteer|healthy volunteer
682661|NCT00327080|HV|hv
682662|NCT00327067|Hemoglobin|hemoglobin
682663|NCT00327067|Iron Supplementation|iron supplementation
682664|NCT00327067|Donor Retention|donor retention
682665|NCT00327067|Iron Stores|iron stores
682666|NCT00327067|Ferritin|ferritin
682667|NCT00327067|Transferrin Saturation|transferrin saturation
682668|NCT00327067|Healthy Volunteer|healthy volunteer
682669|NCT00327067|HV|hv
682670|NCT00327067|Blood Donors|blood donors
682671|NCT00327054|Dyslipidaemia|dyslipidaemia
682672|NCT00327054|Herbal medicine|herbal medicine
682673|NCT00327054|Home remedy|home remedy
682674|NCT00327054|Alternative medicine|alternative medicine
682675|NCT00327054|Metabolic syndrome|metabolic syndrome
682676|NCT00327041|Aspirin|aspirin
682677|NCT00327041|Clopidogrel|clopidogrel
682678|NCT00327041|Balloon Angioplasty|balloon angioplasty
682679|NCT00327041|Coronary Thrombosis|coronary thrombosis
682680|NCT00327028|Bronchial asthma|bronchial asthma
682681|NCT00327028|Phenytoin, Diphenine|phenytoin, diphenine
682682|NCT00327028|Antiepileptic drugs|antiepileptic drugs
682683|NCT00327028|Efficacy|efficacy
682684|NCT00327002|Low HDL|low hdl
682685|NCT00327002|Metabolic syndrome|metabolic syndrome
682686|NCT00327002|low HDL Cholesterol in setting of metabolic syndrome|low hdl cholesterol in setting of metabolic syndrome
682687|NCT00326989|Extracorporal shock wave therapy|extracorporal shock wave therapy
682688|NCT00326989|Cell therapy|cell therapy
682689|NCT00326976|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
682690|NCT00326976|Myocardial Revascularization|myocardial revascularization
682691|NCT00326950|Cancer|cancer
682692|NCT00326950|Tumors|tumors
682693|NCT00326950|Phase I|phase i
682694|NCT00326950|E7389|e7389
682695|NCT00326924|Transfusion|transfusion
682696|NCT00326898|Sorafenib|sorafenib
682697|NCT00326898|Sunitinib|sunitinib
682698|NCT00326898|Renal Carcinoma|renal carcinoma
682699|NCT00326885|Ascites|ascites
682700|NCT00326885|Epithelial Cancer|epithelial cancer
682701|NCT00326885|Epithelial Carcinoma|epithelial carcinoma
682702|NCT00326885|Epithelial Ovarian Cancer|epithelial ovarian cancer
682703|NCT00326885|Epithelial Ovarian Carcinoma|epithelial ovarian carcinoma
682704|NCT00326885|Fallopian Tube Cancer|fallopian tube cancer
682705|NCT00326885|Fallopian Tube Carcinoma|fallopian tube carcinoma
682706|NCT00326885|Malignant Ascites|malignant ascites
682707|NCT00326885|Ovarian Cancer|ovarian cancer
682708|NCT00326885|Ovarian Carcinoma|ovarian carcinoma
682709|NCT00326885|Ovarian Epithelial Cancer|ovarian epithelial cancer
682710|NCT00326885|Ovarian Epithelial Carcinoma|ovarian epithelial carcinoma
682711|NCT00326885|Peritoneal Cancer|peritoneal cancer
682712|NCT00326885|Peritoneal Carcinoma|peritoneal carcinoma
682713|NCT00326885|Recurrent Ascites|recurrent ascites
682714|NCT00326885|Recurrent Malignant Ascites|recurrent malignant ascites
682715|NCT00326885|Recurrent Symptomatic Malignant Ascites|recurrent symptomatic malignant ascites
682716|NCT00326885|Symptomatic Malignant Ascites|symptomatic malignant ascites
682717|NCT00326885|Symptomatic Ascites|symptomatic ascites
682718|NCT00326885|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
682719|NCT00326885|Ovarian Neoplasms|ovarian neoplasms
682720|NCT00326885|Fallopian Tube Neoplasms|fallopian tube neoplasms
682721|NCT00326885|Peritoneal Neoplasms|peritoneal neoplasms
682722|NCT00326859|analgesia strategies|analgesia strategies
682723|NCT00326859|pain|pain
682724|NCT00326859|extensive dressing change|extensive dressing change
682725|NCT00326833|Vitamin B12 deficiency|vitamin b12 deficiency
682726|NCT00326833|Vitamin B12 absorption|vitamin b12 absorption
682727|NCT00326833|Holotranscobalamin|holotranscobalamin
682728|NCT00326820|hypercalcemia of malignancy|hypercalcemia of malignancy
682729|NCT00326820|stage IV breast cancer|stage iv breast cancer
682730|NCT00326820|bone metastases|bone metastases
682731|NCT00326820|recurrent breast cancer|recurrent breast cancer
682732|NCT00326820|male breast cancer|male breast cancer
682733|NCT00326807|naltrexone|naltrexone
682734|NCT00326807|alcohol|alcohol
682735|NCT00326807|gambling|gambling
682736|NCT00326807|concurrent|concurrent
682737|NCT00326794|Nonsurgical proximal humerus fracture|nonsurgical proximal humerus fracture
682738|NCT00326794|Rehabilitation|rehabilitation
682739|NCT00326794|Physiotherapy|physiotherapy
682740|NCT00326794|randomised controlled trial|randomised controlled trial
682741|NCT00326781|Nicotine nasal spray + counseling|nicotine nasal spray + counseling
682742|NCT00326781|Transdermal nicotine + counseling|transdermal nicotine + counseling
682743|NCT00326742|Alcoholism|alcoholism
682744|NCT00326742|Risk factors|risk factors
682745|NCT00326742|Adolescence|adolescence
682746|NCT00326742|Stress test|stress test
682747|NCT00326742|HPA system|hpa system
682748|NCT00326742|Family adversity|family adversity
682749|NCT00326742|Candidate genes|candidate genes
682750|NCT00326742|Cortisol|cortisol
682751|NCT00326742|Adrenocorticotrophin|adrenocorticotrophin
682752|NCT00326729|burns|burns
682753|NCT00326729|thermal injury|thermal injury
682754|NCT00326729|hemodynamics|hemodynamics
682755|NCT00326729|microcirculation|microcirculation
682756|NCT00326716|HIV-1 infected pregnant women, either treatment naive or on ATV/RTV combined with ZDV/3TC|hiv-1 infected pregnant women, either treatment naive or on atv/rtv combined with zdv/3tc
682757|NCT00326703|hypoxia|hypoxia
682758|NCT00326703|hypobaric|hypobaric
682759|NCT00326703|altitude|altitude
682760|NCT00326690|Congestive Heart Failure|congestive heart failure
682761|NCT00326690|Coronary Artery Disease|coronary artery disease
682762|NCT00326690|Ischemic Cardiomyopathy|ischemic cardiomyopathy
682763|NCT00326690|Idiopathic Cardiomyopathy|idiopathic cardiomyopathy
682764|NCT00326677|Depression Prevention|depression prevention
682765|NCT00326677|Prevention of Depression|prevention of depression
682766|NCT00326677|Depression in the Elderly|depression in the elderly
682767|NCT00326677|Late Life Depression|late life depression
682768|NCT00326677|Depression in Old Age|depression in old age
682769|NCT00326677|Treatment of Depression in Primary Care Patients|treatment of depression in primary care patients
682770|NCT00326677|Sub syndromal depression|sub syndromal depression
682771|NCT00326677|Minor Depression|minor depression
682772|NCT00326651|infertility|infertility
682773|NCT00326651|pregnancy|pregnancy
682774|NCT00326651|conception|conception
682775|NCT00326651|conceive|conceive
682776|NCT00326651|conceiving|conceiving
682777|NCT00326651|trying to conceive|trying to conceive
682778|NCT00326651|get pregnant|get pregnant
682779|NCT00326651|conception kit|conception kit
682780|NCT00326651|conception cap|conception cap
682781|NCT00326651|fertility|fertility
682782|NCT00326651|Women who are actively trying to become pregnant|women who are actively trying to become pregnant
682783|NCT00326638|prostate, IMRT, tomotherapy, radiation, cancer|prostate, imrt, tomotherapy, radiation, cancer
682784|NCT00326612|Seizures|seizures
682785|NCT00326599|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
682786|NCT00326599|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
682787|NCT00326599|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
682788|NCT00326599|squamous cell lung cancer|squamous cell lung cancer
682789|NCT00326573|Diabetes|diabetes
682790|NCT00326573|Teenagers|teenagers
682791|NCT00326573|Motivational Interviewing|motivational interviewing
682792|NCT00326560|Pterygium excision|pterygium excision
682793|NCT00326560|Cut and paste|cut and paste
682794|NCT00326560|Tisseel fibrin glue|tisseel fibrin glue
682795|NCT00326560|Conjunctival autograft|conjunctival autograft
682796|NCT00326534|Sarcoidosis|sarcoidosis
682797|NCT00326534|Rickettsia|rickettsia
682798|NCT00326534|Serological reactions|serological reactions
682799|NCT00326534|Polymerase chain reaction|polymerase chain reaction
682800|NCT00326521|Pregnant Women|pregnant women
682801|NCT00326521|Epidural Anesthesia|epidural anesthesia
682802|NCT00326521|Fever|fever
682803|NCT00326521|Chorioamnionitis|chorioamnionitis
682804|NCT00326521|Intrauterine pressure catheter|intrauterine pressure catheter
682805|NCT00326521|Pregnancy|pregnancy
682806|NCT00326508|T Lymphocytes|t lymphocytes
682807|NCT00326508|IL-2 Conjugate|il-2 conjugate
682808|NCT00326508|CD25|cd25
682809|NCT00326508|T Regulatory Cells|t regulatory cells
682810|NCT00326508|Autoimmunity|autoimmunity
682811|NCT00326508|Uveitis|uveitis
682812|NCT00326508|Daclizumab|daclizumab
682813|NCT00326508|Denileukin Diftitox|denileukin diftitox
682814|NCT00326508|Immune Tolerance|immune tolerance
682815|NCT00326508|T Cell|t cell
682816|NCT00326495|Sorafenib|sorafenib
682817|NCT00326495|Cetuximab|cetuximab
682818|NCT00326495|Advanced Cancer|advanced cancer
682819|NCT00326495|Phase II|phase ii
682820|NCT00326495|Colorectal Cancer|colorectal cancer
682821|NCT00326495|Colon Cancer|colon cancer
682822|NCT00326495|Rectal Cancer|rectal cancer
682823|NCT00326495|CRC|crc
682824|NCT00326495|Metastatic Colorectal Cancer|metastatic colorectal cancer
682825|NCT00326482|Drug Toxicity|drug toxicity
682826|NCT00326482|Steatohepatitis|steatohepatitis
682827|NCT00326482|Hepatotoxicity|hepatotoxicity
682828|NCT00326482|Liver Biopsy|liver biopsy
682829|NCT00326482|Elevated transaminases|elevated transaminases
682830|NCT00326482|HIV|hiv
682831|NCT00326482|Liver Fibrosis|liver fibrosis
682832|NCT00326456|ovarian cancer|ovarian cancer
682833|NCT00326456|chemotherapy|chemotherapy
682834|NCT00326456|first-line|first-line
682835|NCT00326443|Salmonella, vaccine, typhoid fever, S. Typhi|salmonella, vaccine, typhoid fever, s. typhi
682836|NCT00326430|Social Phobia|social phobia
682837|NCT00326430|Cognitive Therapy|cognitive therapy
682838|NCT00326430|Interpersonal Therapy|interpersonal therapy
682839|NCT00326430|Efficacy|efficacy
682840|NCT00326430|Process-Outcome|process-outcome
682841|NCT00326417|Severe Aplastic Anemia|severe aplastic anemia
682842|NCT00326404|Oral Contraceptives|oral contraceptives
682843|NCT00326404|Adolescents|adolescents
682844|NCT00326404|Compliance|compliance
682845|NCT00326391|Attention Deficit Disorder with Hyperactivity, ADHD, Attention Deficit Disorder Adult|attention deficit disorder with hyperactivity, adhd, attention deficit disorder adult
682846|NCT00326365|mechanical ventilation|mechanical ventilation
682847|NCT00326365|secretions|secretions
682848|NCT00326365|viscosity|viscosity
682849|NCT00326365|homeopathy|homeopathy
682850|NCT00326365|kalium bichromate|kalium bichromate
682851|NCT00326365|extubation|extubation
682852|NCT00326352|Sedation|sedation
682853|NCT00326352|Propofol|propofol
682854|NCT00326352|Remifentanil|remifentanil
682855|NCT00326352|recovery|recovery
682856|NCT00326339|R935788|r935788
682857|NCT00326339|Rheumatoid Arthritis|rheumatoid arthritis
682858|NCT00326339|Syk Kinase|syk kinase
682859|NCT00326313|Group B streptococci|group b streptococci
682860|NCT00326313|virulent|virulent
682861|NCT00326313|morbidity|morbidity
682862|NCT00326313|mortality|mortality
682863|NCT00326300|Attention Deficit Hyperactivity Disorder, ADHD, Attention Deficit Disorder Adult|attention deficit hyperactivity disorder, adhd, attention deficit disorder adult
682864|NCT00326287|Community-Acquired Pneumonia|community-acquired pneumonia
682865|NCT00326287|Cephalosporins|cephalosporins
682866|NCT00326287|Methicillin-Resistant Staphylococcus Aureus|methicillin-resistant staphylococcus aureus
682867|NCT00326248|postoperative nausea and vomiting PONV antiemetics NK-1 5HT3 casopitant mesylate ZOFRAN ondansetron hydrochloride|postoperative nausea and vomiting ponv antiemetics nk-1 5ht3 casopitant mesylate zofran ondansetron hydrochloride
682868|NCT00326235|Opioid withdrawal|opioid withdrawal
682869|NCT00326235|Buspirone|buspirone
682870|NCT00326235|Methadone taper|methadone taper
682871|NCT00326222|Patient Education as a Topic|patient education as a topic
682872|NCT00326222|Self-Management Program|self-management program
682873|NCT00326222|Health promotion|health promotion
682874|NCT00326222|Self Efficacy|self efficacy
682875|NCT00326222|Quality of life|quality of life
682877|NCT00326209|Ulcerative colitis|ulcerative colitis
682878|NCT00326209|Inflammatory bowel disease|inflammatory bowel disease
682879|NCT00326209|IBD|ibd
682880|NCT00326196|CABG|cabg
682881|NCT00326196|Coronary Disease|coronary disease
682882|NCT00326196|Diabetes|diabetes
682883|NCT00326196|PCI|pci
682884|NCT00326170|Combination Chemotherapy|combination chemotherapy
682885|NCT00326170|MDS|mds
682886|NCT00326170|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
682887|NCT00326170|AML|aml
682888|NCT00326170|Acute myelogenous leukemia|acute myelogenous leukemia
682889|NCT00326170|valproic acid|valproic acid
682890|NCT00326170|VPA|vpa
682891|NCT00326170|Depakene|depakene
682892|NCT00326170|5-azacytidine|5-azacytidine
682893|NCT00326170|5-aza|5-aza
682894|NCT00326170|Azacitidine|azacitidine
682895|NCT00326170|5-AZC|5-azc
682896|NCT00326170|Vidaza|vidaza
682897|NCT00326170|AZA-CR|aza-cr
682898|NCT00326170|Ladakamycin|ladakamycin
682899|NCT00326170|NSC-102816|nsc-102816
682900|NCT00326170|All-trans retinoic acid|all-trans retinoic acid
682901|NCT00326170|ATRA|atra
682902|NCT00326170|Tretinoin|tretinoin
682903|NCT00326170|Vesanoid|vesanoid
682904|NCT00326157|antifungal primary prophylaxis treatment|antifungal primary prophylaxis treatment
682905|NCT00326157|allogeneic stem-cell transplantation|allogeneic stem-cell transplantation
682906|NCT00326157|antifungal primary prophylaxis treatment of high risk patients undergoing allogeneic stem-cell transplantation|antifungal primary prophylaxis treatment of high risk patients undergoing allogeneic stem-cell transplantation
682907|NCT00326144|MDD|mdd
682908|NCT00326144|Depression|depression
682909|NCT00326118|Meningococcal serogroup C diseases|meningococcal serogroup c diseases
682910|NCT00326118|H.influenzae type b diseases|h.influenzae type b diseases
682911|NCT00326105|MDD|mdd
682912|NCT00326105|Depression|depression
682913|NCT00326079|Open angle|open angle
682914|NCT00326079|Glaucoma|glaucoma
682915|NCT00326079|Surgery|surgery
682916|NCT00326066|Open angle|open angle
682917|NCT00326066|Glaucoma|glaucoma
682918|NCT00326066|Surgery|surgery
682919|NCT00326066|Cataract|cataract
682920|NCT00326053|Asthma Reoccurrence|asthma reoccurrence
682921|NCT00326053|Acute Asthma|acute asthma
682922|NCT00326053|Patient Discharge|patient discharge
682923|NCT00326053|Emergency Service, Hospital|emergency service, hospital
682924|NCT00326053|Asthma Exacerbation|asthma exacerbation
682925|NCT00326053|Asthma Relapse|asthma relapse
682926|NCT00326040|Open angle|open angle
682927|NCT00326040|Glaucoma|glaucoma
682928|NCT00326040|Refractory|refractory
682929|NCT00326040|Surgery|surgery
682930|NCT00326027|GERD|gerd
682931|NCT00326027|Pantoprazole|pantoprazole
682932|NCT00326027|NERD|nerd
682933|NCT00326014|Open angle|open angle
682934|NCT00326014|Glaucoma|glaucoma
682935|NCT00326014|Cataract|cataract
682936|NCT00326014|Surgery|surgery
682937|NCT00326001|Transvenous Catheter Ablation|transvenous catheter ablation
682938|NCT00326001|Radiofrequency Catheter Ablation|radiofrequency catheter ablation
682939|NCT00326001|Atrial flutter|atrial flutter
682940|NCT00326001|Catheter Ablation|catheter ablation
682941|NCT00325988|Neuroimmunology|neuroimmunology
682942|NCT00325988|Demyelinating Disease|demyelinating disease
682943|NCT00325988|Genetics|genetics
682944|NCT00325988|Proteins|proteins
682945|NCT00325975|Smallpox|smallpox
682946|NCT00325975|Variola|variola
682947|NCT00325975|Orthopoxvirus|orthopoxvirus
682948|NCT00325975|Virus|virus
682949|NCT00325975|Immunogenicity|immunogenicity
682950|NCT00325975|Smallpox Vaccine|smallpox vaccine
682951|NCT00325962|Hypertension|hypertension
682952|NCT00325962|Type 2 Diabetes|type 2 diabetes
682953|NCT00325962|6R-BH4|6r-bh4
682954|NCT00325962|BH4|bh4
682955|NCT00325962|BH4 deficiency|bh4 deficiency
682956|NCT00325962|sapropterin dihydrochloride|sapropterin dihydrochloride
682957|NCT00325962|endothelial dysfunction|endothelial dysfunction
682958|NCT00325962|NO|no
682959|NCT00325962|Nitric Oxide|nitric oxide
682960|NCT00325936|metabolic syndrome|metabolic syndrome
682961|NCT00325936|Hypertension|hypertension
682962|NCT00325936|CCB|ccb
682963|NCT00325936|cilnidipine|cilnidipine
682964|NCT00325923|Decision making|decision making
682965|NCT00325923|Decision support|decision support
682966|NCT00325923|Decisional conflict|decisional conflict
682967|NCT00325923|Menopause|menopause
682968|NCT00325923|Natural health products|natural health products
682969|NCT00325923|Herbs|herbs
682970|NCT00325923|Complementary medicine|complementary medicine
682971|NCT00325923|Complementary therapies|complementary therapies
682972|NCT00325910|Diabetes|diabetes
682973|NCT00325910|Heart Failure|heart failure
682974|NCT00325910|Mortality|mortality
682975|NCT00325910|Hospitalization|hospitalization
682976|NCT00325910|Feasability|feasability
682977|NCT00325884|coronary artery disease|coronary artery disease
682978|NCT00325884|bifurcation lesions|bifurcation lesions
682979|NCT00325884|percutaneous interventions|percutaneous interventions
682980|NCT00325884|stenting|stenting
682981|NCT00325884|outcomes|outcomes
682982|NCT00325884|death|death
682983|NCT00325884|myocardial infarction|myocardial infarction
682984|NCT00325858|osteoarthritis pain|osteoarthritis pain
682985|NCT00325858|knee|knee
682986|NCT00325858|hip|hip
682987|NCT00325858|extended-release analgesia|extended-release analgesia
682988|NCT00325858|opioid|opioid
682989|NCT00325845|Investigational|investigational
682990|NCT00325845|Therapeutic|therapeutic
682991|NCT00325845|Efficacy|efficacy
682992|NCT00325845|Safety|safety
682993|NCT00325845|Outcomes|outcomes
682994|NCT00325845|Lumbar facet joint arthrosis|lumbar facet joint arthrosis
682995|NCT00325845|Lumbar facet joint arthropathy|lumbar facet joint arthropathy
682996|NCT00325832|Hypertension|hypertension
682997|NCT00325832|Blood Pressure|blood pressure
682998|NCT00325832|Systolic Pressure|systolic pressure
682999|NCT00325832|Diastolic Pressure|diastolic pressure
683000|NCT00325832|Blood Pressure Monitoring, Ambulatory|blood pressure monitoring, ambulatory
683001|NCT00325819|Acetaminophen|acetaminophen
683002|NCT00325819|Vaccination|vaccination
683003|NCT00325819|Immunization|immunization
683004|NCT00325793|nicardipine|nicardipine
683005|NCT00325793|hypertension|hypertension
683006|NCT00325793|intracerebral hemorrhage|intracerebral hemorrhage
683007|NCT00325793|ischemic stroke|ischemic stroke
683008|NCT00325780|Kowa|kowa
683009|NCT00325780|Hypercholesterolemia|hypercholesterolemia
683010|NCT00325780|dyslipidemia|dyslipidemia
683011|NCT00325780|pitavastatin|pitavastatin
683012|NCT00325780|NK-104|nk-104
683013|NCT00325780|Hypercholesterolemia or combined dyslipidemia|hypercholesterolemia or combined dyslipidemia
683014|NCT00325767|mucociliary clearance|mucociliary clearance
683015|NCT00325767|beta-adrenergic drugs|beta-adrenergic drugs
683018|NCT00325754|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
683019|NCT00325754|COPD|copd
683020|NCT00325741|Lupus|lupus
683021|NCT00325741|Systemic Lupus Erythematosus|systemic lupus erythematosus
683022|NCT00325741|Blood Stem Cell Transplantation|blood stem cell transplantation
683023|NCT00325728|Chronic Insomnia|chronic insomnia
683024|NCT00325728|Sleep Initiation and Maintenance Disorder|sleep initiation and maintenance disorder
683025|NCT00325728|Drug Therapy|drug therapy
683026|NCT00325728|Alzheimer disease|alzheimer disease
683027|NCT00325702|HIV|hiv
683028|NCT00325702|prevention|prevention
683029|NCT00325676|GERD|gerd
683030|NCT00325676|Pantoprazole|pantoprazole
683031|NCT00325676|Complete Remission|complete remission
683032|NCT00325663|acupuncture|acupuncture
683033|NCT00325663|double-blind|double-blind
683034|NCT00325663|sham control|sham control
683035|NCT00325663|osteoarthritis|osteoarthritis
683036|NCT00325663|pain|pain
683037|NCT00325650|Prediabetic state|prediabetic state
683038|NCT00325650|Impaired fasting glucose|impaired fasting glucose
683039|NCT00325650|Impaired glucose Tolerance|impaired glucose tolerance
683040|NCT00325637|CHERISH|cherish
683041|NCT00325637|Ischemic Stroke|ischemic stroke
683042|NCT00325624|Blood Pressure|blood pressure
683043|NCT00325624|Diabetes mellitus|diabetes mellitus
683044|NCT00325624|Hypertension|hypertension
683045|NCT00325624|Home Care|home care
683046|NCT00325624|Glucometer|glucometer
683047|NCT00325611|Palliative care|palliative care
683048|NCT00325611|End of life care|end of life care
683049|NCT00325585|Human Immunodeficiency Viruses|human immunodeficiency viruses
683050|NCT00325585|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
683051|NCT00325585|Substance Abuse|substance abuse
683052|NCT00325585|Sexually Transmitted Disease, Viral|sexually transmitted disease, viral
683053|NCT00325585|Intervention Studies|intervention studies
683054|NCT00325585|Women's Health|women's health
683055|NCT00325546|Obesity|obesity
683056|NCT00325533|Blood Pressure, High|blood pressure, high
683057|NCT00325533|Blacks|blacks
683058|NCT00325533|African Americans|african americans
683059|NCT00325507|Renal cell cancer|renal cell cancer
683060|NCT00325507|requiring IL-2 treatment|requiring il-2 treatment
683061|NCT00325507|Locally advanced or metastatic renal cell carcinoma|locally advanced or metastatic renal cell carcinoma
683062|NCT00325494|Pancreatic Cancer|pancreatic cancer
683063|NCT00325494|Mesothelioma|mesothelioma
683064|NCT00325494|Ovarian Cancer|ovarian cancer
683065|NCT00325494|Non-Small Cell Lung Cancer|non-small cell lung cancer
683066|NCT00325494|Mesothelin|mesothelin
683067|NCT00325468|bone loss|bone loss
683068|NCT00325468|osteoporosis|osteoporosis
683069|NCT00325442|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
683070|NCT00325429|Type 2 diabetes|type 2 diabetes
683071|NCT00325429|Vildagliptin|vildagliptin
683072|NCT00325429|HbA1c|hba1c
683073|NCT00325416|melphalan|melphalan
683074|NCT00325416|topotecan|topotecan
683075|NCT00325416|topoisomerase|topoisomerase
683076|NCT00325416|bone marrow transplant|bone marrow transplant
683077|NCT00325416|drug sequence|drug sequence
683078|NCT00325403|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
683079|NCT00325390|SR25990C|sr25990c
683080|NCT00325390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
683081|NCT00325390|NSTEACS|nsteacs
683082|NCT00325377|low back pain|low back pain
683083|NCT00325377|pain|pain
683084|NCT00325377|magnetism|magnetism
683085|NCT00325377|electromagnetic fields|electromagnetic fields
683086|NCT00325377|visual analogue pain scale|visual analogue pain scale
683087|NCT00325351|Ovarian cancer|ovarian cancer
683088|NCT00325351|Ovarian neoplasms, epithelium|ovarian neoplasms, epithelium
683089|NCT00325338|Allergy|allergy
683090|NCT00325338|Specific Immunotherapy|specific immunotherapy
683091|NCT00325338|Ragweed|ragweed
683092|NCT00325338|Environmental Exposure Chamber|environmental exposure chamber
683093|NCT00325325|Kidney Transplantation|kidney transplantation
683094|NCT00325312|Neck Pain|neck pain
683095|NCT00325312|Complementary Therapies|complementary therapies
683096|NCT00325312|Subcutaneous Carbon Dioxide Insufflations|subcutaneous carbon dioxide insufflations
683097|NCT00325312|Acute Treatment|acute treatment
683098|NCT00325273|Lactobacillus rhamnosus|lactobacillus rhamnosus
683099|NCT00325273|Atopic dermatitis|atopic dermatitis
683100|NCT00325273|Allergic rhinitis|allergic rhinitis
683101|NCT00325273|Asthma|asthma
683102|NCT00325273|Infant|infant
683103|NCT00325273|Pregnancy|pregnancy
683104|NCT00325260|influenza|influenza
683105|NCT00325260|non-inferiority|non-inferiority
683106|NCT00325260|Influvac|influvac
683107|NCT00325260|Agrippal|agrippal
683108|NCT00325260|healthy subjects|healthy subjects
683109|NCT00325247|ZINC SUPPLEMENTATION|zinc supplementation
683110|NCT00325247|ACUTE DIARRHOEA|acute diarrhoea
683111|NCT00325247|UNDER FIVE CHILDREN|under five children
683112|NCT00325247|RURAL BANGLADESH|rural bangladesh
683113|NCT00325221|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
683114|NCT00325221|telemedicine|telemedicine
683115|NCT00325221|Home Monitoring|home monitoring
683116|NCT00325221|psychosomatic|psychosomatic
683117|NCT00325221|ventricular tachyarrhythmia|ventricular tachyarrhythmia
683118|NCT00325221|quality of life|quality of life
683119|NCT00325221|Electric Countershock|electric countershock
683120|NCT00325182|Alcoholism|alcoholism
683121|NCT00325169|Cross-over|cross-over
683122|NCT00325169|Tiotropium|tiotropium
683123|NCT00325169|Triple|triple
683124|NCT00325169|COPD|copd
683125|NCT00325169|SERETIDE 50/500|seretide 50/500
683126|NCT00325169|Dyspnoea|dyspnoea
683127|NCT00325169|Impulse oscillometry|impulse oscillometry
683128|NCT00325169|Plethysmography|plethysmography
683129|NCT00325117|Type 2 diabetes|type 2 diabetes
683130|NCT00325117|Vildagliptin|vildagliptin
683131|NCT00325117|HbA1c|hba1c
683132|NCT00325104|Multiple Endocrine Neoplasia|multiple endocrine neoplasia
683133|NCT00325104|Gastrinoma|gastrinoma
683134|NCT00325104|Prolacinoma|prolacinoma
683135|NCT00325104|Medullary Thyroid Cancer|medullary thyroid cancer
683136|NCT00325104|Insulinoma|insulinoma
683137|NCT00325104|MEN1|men1
683138|NCT00325104|MEN2A|men2a
683139|NCT00325104|Familial Primary Hyperparathytoidism|familial primary hyperparathytoidism
683140|NCT00325091|Writer's Cramp|writer's cramp
683141|NCT00325091|Electroencephalogram (EEG)|electroencephalogram (eeg)
683142|NCT00325091|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
683143|NCT00325091|Fine Motor Skills|fine motor skills
683144|NCT00325091|Focal Hand Dystonia|focal hand dystonia
683145|NCT00325091|Writer Cramp|writer cramp
683146|NCT00325091|Healthy Volunteer|healthy volunteer
683147|NCT00325091|HV|hv
683148|NCT00325078|Remicade|remicade
683149|NCT00325078|Crohn's Disease|crohn's disease
683150|NCT00325078|IBD|ibd
683151|NCT00325078|CGD Infection|cgd infection
683152|NCT00325078|Infliximab|infliximab
683153|NCT00325078|Chorionic Granulomatous Disease|chorionic granulomatous disease
683154|NCT00325078|CGD|cgd
683155|NCT00325078|Inflammatory Bowel Disease|inflammatory bowel disease
683156|NCT00325065|Amygdala|amygdala
683157|NCT00325065|Emotion|emotion
683158|NCT00325065|Memory|memory
683159|NCT00325065|Threat|threat
683160|NCT00325065|Peptides|peptides
683161|NCT00325065|Neuropeptides|neuropeptides
683162|NCT00325065|Oxytocin|oxytocin
683163|NCT00325065|Vasopressin|vasopressin
683164|NCT00325065|Mood Disorder|mood disorder
683165|NCT00325039|Urinary Incontinence, Stress|urinary incontinence, stress
683166|NCT00325039|Surgery|surgery
683167|NCT00325026|Preterm gestation|preterm gestation
683168|NCT00325026|Cervical ripening|cervical ripening
683169|NCT00325026|Labor induction|labor induction
683170|NCT00325026|Misoprostol|misoprostol
683171|NCT00325026|Foley bulb|foley bulb
683172|NCT00325013|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
683173|NCT00325013|PSC|psc
683174|NCT00325013|DHA|dha
683175|NCT00325013|Docosahexaenoic Acid|docosahexaenoic acid
683176|NCT00324974|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
683177|NCT00324974|infant|infant
683178|NCT00324974|lansoprazole oral suspension|lansoprazole oral suspension
683179|NCT00324974|PPI|ppi
683180|NCT00324961|adefovir dipivoxil|adefovir dipivoxil
683181|NCT00324961|e Antigen negative|e antigen negative
683182|NCT00324961|chronic hepatitis B|chronic hepatitis b
683183|NCT00324961|Chinese|chinese
683184|NCT00324948|Female sexual arousal disorder|female sexual arousal disorder
683185|NCT00324948|Female sexual dysfunction|female sexual dysfunction
683186|NCT00324922|Vancomycin|vancomycin
683187|NCT00324922|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
683188|NCT00324896|Parkinson's|parkinson's
683189|NCT00324896|insomnia|insomnia
683190|NCT00324896|drug|drug
683191|NCT00324896|eszopiclone|eszopiclone
683192|NCT00324896|placebo|placebo
683193|NCT00324883|sodium intake|sodium intake
683194|NCT00324883|sodium excretion|sodium excretion
683195|NCT00324883|chloride excretion|chloride excretion
683196|NCT00324883|creatinine|creatinine
683197|NCT00324883|hypertension|hypertension
683198|NCT00324857|Osteoarthritis, Knee|osteoarthritis, knee
683199|NCT00324857|race|race
683200|NCT00324857|ethnicity|ethnicity
683201|NCT00324857|knee replacement|knee replacement
683202|NCT00324831|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
683203|NCT00324831|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
683204|NCT00324831|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
683205|NCT00324831|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
683206|NCT00324818|bacterial vaginosis|bacterial vaginosis
683207|NCT00324818|treatment|treatment
683208|NCT00324805|AJCC v6|ajcc v6
683209|NCT00324779|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
683210|NCT00324779|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
683211|NCT00324779|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
683212|NCT00324779|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
683213|NCT00324779|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
683214|NCT00324779|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
683215|NCT00324779|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
683216|NCT00324779|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
683217|NCT00324779|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
683218|NCT00324779|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
683219|NCT00324779|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
683220|NCT00324779|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
683221|NCT00324779|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
683222|NCT00324779|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
683223|NCT00324753|cancer|cancer
683224|NCT00324753|screening|screening
683225|NCT00324753|communication|communication
683226|NCT00324753|prevention|prevention
683227|NCT00324727|liver metastases|liver metastases
683228|NCT00324727|extraocular extension melanoma|extraocular extension melanoma
683229|NCT00324727|stage IV melanoma|stage iv melanoma
683230|NCT00324727|recurrent melanoma|recurrent melanoma
683231|NCT00324727|recurrent intraocular melanoma|recurrent intraocular melanoma
683232|NCT00324727|metastatic intraocular melanoma|metastatic intraocular melanoma
683233|NCT00324727|iris melanoma|iris melanoma
683234|NCT00324727|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
683235|NCT00324714|osteoporosis|osteoporosis
683236|NCT00324714|ductal breast carcinoma in situ|ductal breast carcinoma in situ
683237|NCT00324714|breast cancer in situ|breast cancer in situ
683238|NCT00324701|Mental Health|mental health
683239|NCT00324701|Geriatric Medicine|geriatric medicine
683240|NCT00324701|Depression|depression
683241|NCT00324701|Health Service Delivery|health service delivery
683242|NCT00324701|Aged|aged
683243|NCT00324688|HIV-1|hiv-1
683244|NCT00324688|Methadone|methadone
683245|NCT00324688|HIV-1 infection|hiv-1 infection
683246|NCT00324675|type 2 diabetes,|type 2 diabetes,
683247|NCT00324675|glomerular filtration rate,|glomerular filtration rate,
683248|NCT00324675|renal plasma flow,|renal plasma flow,
683249|NCT00324675|endothelial dysfunction,|endothelial dysfunction,
683250|NCT00324675|proteinuria,|proteinuria,
683251|NCT00324675|diabetic nephropathy|diabetic nephropathy
683252|NCT00324662|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
683253|NCT00324662|Ventricular tachyarrhythmia|ventricular tachyarrhythmia
683254|NCT00324662|Supraventricular tachyarrhythmia|supraventricular tachyarrhythmia
683255|NCT00324662|Electric Countershock|electric countershock
683256|NCT00324649|HIV-1|hiv-1
683257|NCT00324623|stage IV melanoma|stage iv melanoma
683258|NCT00324623|recurrent melanoma|recurrent melanoma
683259|NCT00324610|fluoropyrimidines|fluoropyrimidines
683260|NCT00324610|metastases|metastases
683261|NCT00324610|pharmacokinetics|pharmacokinetics
683262|NCT00324610|phase 1-2 study|phase 1-2 study
683263|NCT00324597|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
683264|NCT00324597|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
683265|NCT00324597|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
683266|NCT00324597|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
683267|NCT00324597|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
683268|NCT00324597|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
683269|NCT00324597|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
683270|NCT00324597|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
683271|NCT00324597|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
683272|NCT00324597|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
683273|NCT00324597|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
683274|NCT00324597|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
683275|NCT00324597|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
683276|NCT00324597|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
683277|NCT00324597|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
683278|NCT00324597|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
683279|NCT00324597|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
683280|NCT00324597|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
683281|NCT00324597|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
683282|NCT00324597|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
683283|NCT00324597|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
683284|NCT00324597|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
683285|NCT00324597|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
683286|NCT00324597|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
683287|NCT00324597|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
683288|NCT00324597|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
683289|NCT00324597|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
683290|NCT00324597|splenic marginal zone lymphoma|splenic marginal zone lymphoma
684604|NCT00319683|Neoplasms|neoplasms
683291|NCT00324597|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
683292|NCT00324597|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
683293|NCT00324597|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
683294|NCT00324597|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
683295|NCT00324597|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
683296|NCT00324597|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
683297|NCT00324597|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
683298|NCT00324597|Waldenström macroglobulinemia|waldenström macroglobulinemia
683299|NCT00324597|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
683300|NCT00324597|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
683301|NCT00324597|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
683302|NCT00324597|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
683303|NCT00324597|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
683304|NCT00324597|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
683305|NCT00324597|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
683306|NCT00324597|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
683307|NCT00324597|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
683308|NCT00324597|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
683309|NCT00324597|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
683310|NCT00324597|adenocarcinoma of the lung|adenocarcinoma of the lung
683311|NCT00324597|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
683312|NCT00324597|large cell lung cancer|large cell lung cancer
683313|NCT00324597|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
683314|NCT00324597|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
683315|NCT00324597|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
683316|NCT00324597|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
683317|NCT00324597|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
683318|NCT00324597|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
683319|NCT00324597|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
683320|NCT00324597|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
683321|NCT00324597|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
683322|NCT00324597|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
683323|NCT00324597|anaplastic large cell lymphoma|anaplastic large cell lymphoma
683324|NCT00324597|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
683325|NCT00324597|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
683326|NCT00324597|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
683327|NCT00324584|type 1 diabetes mellitus|type 1 diabetes mellitus
683328|NCT00324584|telecare|telecare
683329|NCT00324584|telemedicine|telemedicine
683330|NCT00324584|insulin pump therapy|insulin pump therapy
683331|NCT00324558|Bemiparin|bemiparin
683332|NCT00324558|small cell lung carcinoma|small cell lung carcinoma
683333|NCT00324545|Obesity|obesity
683334|NCT00324545|Diets|diets
683335|NCT00324545|Heart Disease|heart disease
683336|NCT00324545|Randomized controlled trial|randomized controlled trial
683337|NCT00324545|Ischemia.|ischemia.
683338|NCT00324519|second trimester|second trimester
683339|NCT00324519|pregnancy termination|pregnancy termination
683340|NCT00324519|misoprostol|misoprostol
683341|NCT00324519|foley bulb|foley bulb
683342|NCT00324493|Severe Hemophilia|severe hemophilia
683343|NCT00324493|Musculoskeletal Function|musculoskeletal function
683344|NCT00324493|Factor Replacement|factor replacement
683345|NCT00324467|NON-HODGKIN'S LYMPHOMA|non-hodgkin's lymphoma
683346|NCT00324467|POSITRON EMISSION TOMOGRAPHY|positron emission tomography
683348|NCT00324467|DLBCL|dlbcl
683349|NCT00324467|R-CHOP|r-chop
683350|NCT00324467|R-ICE|r-ice
683351|NCT00324454|motor neuron disease|motor neuron disease
683352|NCT00324454|amyotrophic lateral sclerosis primary lateral|amyotrophic lateral sclerosis primary lateral
683353|NCT00324454|sclerosis; progressive muscular atrophy|sclerosis; progressive muscular atrophy
683354|NCT00324454|cramps|cramps
683355|NCT00324454|spasticity|spasticity
683356|NCT00324441|Fibromyalgia|fibromyalgia
683357|NCT00324441|Rehabilitation|rehabilitation
683358|NCT00324441|Physical Medicine|physical medicine
683359|NCT00324441|Whole-Body Hyperthermia|whole-body hyperthermia
683360|NCT00324441|Water-Filtered Near Infrared|water-filtered near infrared
683361|NCT00324428|TMS|tms
683362|NCT00324428|Visceral Pain|visceral pain
683363|NCT00324428|Analgesia|analgesia
683364|NCT00324428|Pancreatic Cancer|pancreatic cancer
683365|NCT00324428|Cancer|cancer
683366|NCT00324428|Electric stimulation therapy|electric stimulation therapy
683367|NCT00324428|Electric stimulation|electric stimulation
683368|NCT00324428|Pain|pain
683369|NCT00324428|Safety|safety
683370|NCT00324415|stage I anal cancer|stage i anal cancer
683371|NCT00324415|stage II anal cancer|stage ii anal cancer
683372|NCT00324415|stage IIIA anal cancer|stage iiia anal cancer
683373|NCT00324415|stage IIIB anal cancer|stage iiib anal cancer
683374|NCT00324415|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
683375|NCT00324415|basaloid carcinoma of the anus|basaloid carcinoma of the anus
683376|NCT00324415|cloacogenic carcinoma of the anus|cloacogenic carcinoma of the anus
683377|NCT00324402|brain natriuretic peptide|brain natriuretic peptide
683378|NCT00324402|pregnancy|pregnancy
683379|NCT00324402|biomarker|biomarker
683380|NCT00324389|Interferon, Gene Expression in Liver, Lymphocytes, High Density Oligonucleotide Microarray Expression Analysis, African American, Hepatitis C|interferon, gene expression in liver, lymphocytes, high density oligonucleotide microarray expression analysis, african american, hepatitis c
683381|NCT00324363|exenatide|exenatide
683382|NCT00324363|diabetes|diabetes
683383|NCT00324363|Amylin|amylin
683384|NCT00324363|Lilly|lilly
683385|NCT00324363|China|china
683386|NCT00324350|Diabetes Mellitus|diabetes mellitus
683387|NCT00324350|Fracture|fracture
683388|NCT00324350|Falls|falls
683389|NCT00324350|Height Loss|height loss
683390|NCT00324324|infection|infection
683391|NCT00324324|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
683392|NCT00324324|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
683393|NCT00324324|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
683394|NCT00324324|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
683395|NCT00324324|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
683396|NCT00324324|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
683397|NCT00324324|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
683398|NCT00324324|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
683399|NCT00324324|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
683400|NCT00324324|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
683401|NCT00324324|chronic eosinophilic leukemia|chronic eosinophilic leukemia
683402|NCT00324324|primary myelofibrosis|primary myelofibrosis
683403|NCT00324324|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
683404|NCT00324324|chronic neutrophilic leukemia|chronic neutrophilic leukemia
683405|NCT00324324|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
683406|NCT00324324|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
683407|NCT00324324|disseminated neuroblastoma|disseminated neuroblastoma
683408|NCT00324324|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
683409|NCT00324324|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
683410|NCT00324324|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
683411|NCT00324324|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
683412|NCT00324324|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
683413|NCT00324324|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
683414|NCT00324324|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
683415|NCT00324324|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
683416|NCT00324324|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
683417|NCT00324324|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
683418|NCT00324324|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
683419|NCT00324324|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
683420|NCT00324324|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
683421|NCT00324324|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
683422|NCT00324324|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
683423|NCT00324324|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
683424|NCT00324324|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
683425|NCT00324324|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
683426|NCT00324324|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
683427|NCT00324324|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
683428|NCT00324324|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
683429|NCT00324324|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
683430|NCT00324324|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
683431|NCT00324324|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
683432|NCT00324324|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
683433|NCT00324324|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
683434|NCT00324324|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
683435|NCT00324324|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
683436|NCT00324324|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
683437|NCT00324324|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
683438|NCT00324324|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
683439|NCT00324324|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
683440|NCT00324324|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
683441|NCT00324324|recurrent neuroblastoma|recurrent neuroblastoma
683442|NCT00324324|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
683443|NCT00324324|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
683444|NCT00324324|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
683445|NCT00324324|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
683446|NCT00324324|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
683447|NCT00324324|refractory hairy cell leukemia|refractory hairy cell leukemia
683448|NCT00324324|refractory multiple myeloma|refractory multiple myeloma
683449|NCT00324324|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
683450|NCT00324324|secondary acute myeloid leukemia|secondary acute myeloid leukemia
683451|NCT00324324|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
683452|NCT00324324|splenic marginal zone lymphoma|splenic marginal zone lymphoma
683453|NCT00324324|stage I multiple myeloma|stage i multiple myeloma
683454|NCT00324324|stage II multiple myeloma|stage ii multiple myeloma
683455|NCT00324324|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
683456|NCT00324324|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
683457|NCT00324324|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
683458|NCT00324324|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
683459|NCT00324324|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
683460|NCT00324324|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
683461|NCT00324324|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
683462|NCT00324324|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
683463|NCT00324324|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
683464|NCT00324324|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
683465|NCT00324324|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
683466|NCT00324324|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
683467|NCT00324324|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
683468|NCT00324324|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
683469|NCT00324324|stage III multiple myeloma|stage iii multiple myeloma
683470|NCT00324324|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
683471|NCT00324324|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
683472|NCT00324324|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
683473|NCT00324324|stage IIIA breast cancer|stage iiia breast cancer
683474|NCT00324324|stage IIIB breast cancer|stage iiib breast cancer
683475|NCT00324324|stage IIIC breast cancer|stage iiic breast cancer
683476|NCT00324324|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
683477|NCT00324324|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
683478|NCT00324324|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
683479|NCT00324324|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
683480|NCT00324324|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
683481|NCT00324324|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
683482|NCT00324324|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
683483|NCT00324324|stage IV breast cancer|stage iv breast cancer
683484|NCT00324324|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
683485|NCT00324324|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
683486|NCT00324324|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
683487|NCT00324324|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
683488|NCT00324324|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
683489|NCT00324324|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
683490|NCT00324324|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
683491|NCT00324324|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
683492|NCT00324298|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
683493|NCT00324298|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
683494|NCT00324285|Diarrhoea|diarrhoea
683495|NCT00324285|severe malnutrition|severe malnutrition
683496|NCT00324285|amylase resistant starch|amylase resistant starch
683497|NCT00324285|ORS|ors
683498|NCT00324272|Groin dissection|groin dissection
683499|NCT00324272|Axilla (or axillary) dissection|axilla (or axillary) dissection
683500|NCT00324272|Lymph node dissection|lymph node dissection
683501|NCT00324272|Lymphadenectomy|lymphadenectomy
683502|NCT00324272|Seroma|seroma
683503|NCT00324272|Wound drainage|wound drainage
683504|NCT00324272|Fibrin sealant|fibrin sealant
683505|NCT00324272|Malignant melanoma|malignant melanoma
683506|NCT00324272|Squamous cell carcinoma|squamous cell carcinoma
683507|NCT00324246|vaginal infection|vaginal infection
683508|NCT00324246|color appearance|color appearance
683509|NCT00324246|new developed indicator strips (NEW NORMA-SENSE)|new developed indicator strips (new norma-sense)
683511|NCT00324246|vaginal secretion|vaginal secretion
683512|NCT00324246|elevated pH|elevated ph
683513|NCT00324233|Residual urine|residual urine
683514|NCT00324233|Hematuria|hematuria
683515|NCT00324233|Ultra sound|ultra sound
683516|NCT00324220|Phase I/II|phase i/ii
683517|NCT00324207|Type 1 diabetes mellitus|type 1 diabetes mellitus
683518|NCT00324207|Insulin mRNA|insulin mrna
683519|NCT00324194|Leukemia|leukemia
683520|NCT00324194|Myelodysplastic Syndromes|myelodysplastic syndromes
683521|NCT00324194|Phase I|phase i
683522|NCT00324181|normal-tension glaucoma|normal-tension glaucoma
683523|NCT00324181|psychopathology|psychopathology
683524|NCT00324181|Hong Kong|hong kong
683525|NCT00324168|Bacterial Infections|bacterial infections
683526|NCT00324168|Eye Diseases|eye diseases
683527|NCT00324168|Bacterial Keratitis|bacterial keratitis
683528|NCT00324168|Visual Acuity|visual acuity
683529|NCT00324155|Stage IIIc N3 (unresectable)|stage iiic n3 (unresectable)
683530|NCT00324155|Stage IV melanoma|stage iv melanoma
683531|NCT00324142|Bacterial vaginosis|bacterial vaginosis
683532|NCT00324142|Tinidazole|tinidazole
683533|NCT00324142|Vaginitis|vaginitis
683534|NCT00324129|Leukemia|leukemia
683535|NCT00324129|Myelodysplastic Syndromes|myelodysplastic syndromes
683536|NCT00324129|Phase I|phase i
683537|NCT00324103|HIV|hiv
683538|NCT00324103|Chronic Infection|chronic infection
683539|NCT00324103|Clinical Trial|clinical trial
683540|NCT00324103|Structured Treatment Interruption|structured treatment interruption
683541|NCT00324077|Chronic phase chronic myelogenous leukemia (CML)|chronic phase chronic myelogenous leukemia (cml)
683542|NCT00324064|Growth hormone deficiency|growth hormone deficiency
683543|NCT00324038|OA|oa
683544|NCT00324038|Elderly|elderly
683545|NCT00324038|Pain|pain
683546|NCT00324038|OA of the hips and/or knees|oa of the hips and/or knees
683547|NCT00324025|Cryptococcal meningitis|cryptococcal meningitis
683548|NCT00324012|Adrenocortical Carcinoma|adrenocortical carcinoma
683549|NCT00324012|cisplatin|cisplatin
683550|NCT00324012|taxotere|taxotere
683551|NCT00323999|Hysteroscopic resection|hysteroscopic resection
683552|NCT00323999|Menorrhagia|menorrhagia
683553|NCT00323999|fibroids|fibroids
683554|NCT00323999|polyps|polyps
683555|NCT00323986|COPD|copd
683556|NCT00323986|tracheotomy|tracheotomy
683557|NCT00323986|azithromycin|azithromycin
683558|NCT00323986|exacerbation|exacerbation
683559|NCT00323986|hospitalisation|hospitalisation
683560|NCT00323986|exhaled breath condensate|exhaled breath condensate
683561|NCT00323973|Chagas, Heart failure, Cardiomiopathy|chagas, heart failure, cardiomiopathy
683562|NCT00323960|Juvenile dermatomyositis|juvenile dermatomyositis
683563|NCT00323960|randomised actively controlled clinical trial|randomised actively controlled clinical trial
683564|NCT00323960|prednisone|prednisone
683565|NCT00323960|cyclosporine|cyclosporine
683566|NCT00323960|methotrexate|methotrexate
683567|NCT00323960|effectiveness|effectiveness
683568|NCT00323947|ADHD|adhd
683569|NCT00323947|Seizures|seizures
683570|NCT00323947|Methylphenidate|methylphenidate
683571|NCT00323947|Stimulant|stimulant
683572|NCT00323934|metastatic solid tumor|metastatic solid tumor
683573|NCT00323934|aggressive non Hodgkin's Lymphoma|aggressive non hodgkin's lymphoma
683574|NCT00323934|Phase I|phase i
683575|NCT00323934|Advanced Solid Tumors|advanced solid tumors
683576|NCT00323908|Breast Cancer|breast cancer
683577|NCT00323908|prevention|prevention
683578|NCT00323908|tissue sampling|tissue sampling
683579|NCT00323908|polymorphisms|polymorphisms
683580|NCT00323908|steroid and carcinogen metabolism|steroid and carcinogen metabolism
683581|NCT00323882|Prostate Cancer|prostate cancer
683582|NCT00323882|Oncology|oncology
683583|NCT00323882|Prostate|prostate
683584|NCT00323882|Cancer|cancer
683585|NCT00323882|Metastatic|metastatic
683586|NCT00323882|Hormone|hormone
683588|NCT00323882|Metastatic Hormone-Refractory Prostate Cancer (HRPC)|metastatic hormone-refractory prostate cancer (hrpc)
683589|NCT00323856|Hemophilia A|hemophilia a
683590|NCT00323856|Plasma-derived treatment|plasma-derived treatment
683591|NCT00323856|Factor VIII|factor viii
683592|NCT00323856|Inhibitor|inhibitor
683593|NCT00323843|Kidney stone|kidney stone
683594|NCT00323843|ureteropyeloscopy|ureteropyeloscopy
683595|NCT00323843|renal pelvic pressure|renal pelvic pressure
683596|NCT00323830|gastric cancer|gastric cancer
683597|NCT00323830|radiotherapy|radiotherapy
683598|NCT00323830|postoperative therapy|postoperative therapy
683599|NCT00323830|chemotherapy|chemotherapy
683600|NCT00323804|Maintenance therapy|maintenance therapy
683601|NCT00323804|Non-responder patients|non-responder patients
683602|NCT00323804|Ribavirin/peginterferon combination therapy|ribavirin/peginterferon combination therapy
683603|NCT00323804|Hepatitis C, Chronic|hepatitis c, chronic
683604|NCT00323791|recurrent renal cell cancer|recurrent renal cell cancer
683605|NCT00323791|clear cell renal cell carcinoma|clear cell renal cell carcinoma
683606|NCT00323791|papillary renal cell carcinoma|papillary renal cell carcinoma
683607|NCT00323791|stage IV renal cell cancer|stage iv renal cell cancer
683608|NCT00323778|hyalgan|hyalgan
683609|NCT00323778|knee|knee
683610|NCT00323778|osteoarthritis|osteoarthritis
683611|NCT00323778|MRI|mri
683612|NCT00323765|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
683613|NCT00323765|Cervical Dystonia|cervical dystonia
683614|NCT00323765|Plasticity|plasticity
683615|NCT00323765|Healthy Volunteer|healthy volunteer
683616|NCT00323765|HV|hv
683617|NCT00323752|Blood loss, Erythropoetin|blood loss, erythropoetin
683618|NCT00323739|kidney cancer|kidney cancer
683619|NCT00323739|bevacizumab|bevacizumab
683620|NCT00323713|Chronic renal insufficiency|chronic renal insufficiency
683621|NCT00323713|CKD stage 4|ckd stage 4
683622|NCT00323713|CKD stage 5|ckd stage 5
683623|NCT00323713|Protein intake|protein intake
683624|NCT00323713|Low protein diet|low protein diet
683625|NCT00323713|Very low protein diet|very low protein diet
683626|NCT00323713|Ketoanalogs|ketoanalogs
683627|NCT00323713|Renal death|renal death
683628|NCT00323700|ADHD|adhd
683629|NCT00323700|Effectiveness|effectiveness
683630|NCT00323700|ODD|odd
683631|NCT00323687|HIV-1 Infection|hiv-1 infection
683632|NCT00323674|Hernia Inguinalis|hernia inguinalis
683633|NCT00323661|Pacing|pacing
683634|NCT00323661|Rate-adaptive|rate-adaptive
683635|NCT00323661|Quality of life|quality of life
683636|NCT00323661|Cognitive performance|cognitive performance
683637|NCT00323661|Atrial fibrillation|atrial fibrillation
683638|NCT00323661|Pacemaker sensor|pacemaker sensor
683639|NCT00323635|nocturia|nocturia
683640|NCT00323635|urinary incontinence|urinary incontinence
683641|NCT00323635|overactive bladder|overactive bladder
683642|NCT00323635|tolterodine|tolterodine
683643|NCT00323635|sleep|sleep
683644|NCT00323635|sleep disorder|sleep disorder
683645|NCT00323635|menopause|menopause
683646|NCT00323635|midlife women|midlife women
683647|NCT00323635|psychological tests|psychological tests
683648|NCT00323609|Kyphoplasty|kyphoplasty
683649|NCT00323609|Vertebroplasty|vertebroplasty
683650|NCT00323609|Balloon Kyphoplasty|balloon kyphoplasty
683651|NCT00323609|Inflatable Bone Tamp|inflatable bone tamp
683652|NCT00323609|Spine|spine
683653|NCT00323609|Back Pain|back pain
683654|NCT00323609|Vertebral Compression Fracture|vertebral compression fracture
683655|NCT00323609|Vertebral Body Compression Fracture|vertebral body compression fracture
683656|NCT00323583|Cancer|cancer
683657|NCT00323583|Pancreatic Cancer|pancreatic cancer
683658|NCT00323583|Cancer Alternative Therapies|cancer alternative therapies
683659|NCT00323583|Living with Cancer|living with cancer
683660|NCT00323557|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
683661|NCT00323557|Leukemia|leukemia
683662|NCT00323557|Sargramostim|sargramostim
683663|NCT00323557|Pneumococcal Pneumonia|pneumococcal pneumonia
683664|NCT00323557|Pneumococcal Vaccine|pneumococcal vaccine
683665|NCT00323557|Prevnar|prevnar
683666|NCT00323557|GM-CSF|gm-csf
683667|NCT00323557|CLL|cll
683668|NCT00323544|HIV 1|hiv 1
683669|NCT00323544|HIV 1 infection|hiv 1 infection
683670|NCT00323531|thoracoscopy|thoracoscopy
683671|NCT00323531|fibrinolysis|fibrinolysis
683672|NCT00323531|empyema|empyema
683673|NCT00323531|children|children
683674|NCT00323518|oral mucositis|oral mucositis
683675|NCT00323518|hematologic|hematologic
683676|NCT00323518|autologous stem cell transplant|autologous stem cell transplant
683677|NCT00323518|velafermin|velafermin
683678|NCT00323518|stomatitis|stomatitis
683679|NCT00323518|oncology - supportive care|oncology - supportive care
683680|NCT00323518|mouth diseases|mouth diseases
683681|NCT00323492|HIV 1 Infection|hiv 1 infection
683682|NCT00323479|breast cancer treatment|breast cancer treatment
683683|NCT00323479|joint disorders|joint disorders
683684|NCT00323453|Appendectomy|appendectomy
683685|NCT00323453|Surgery|surgery
683686|NCT00323453|Infection|infection
683687|NCT00323440|Familial Mediterranean fever|familial mediterranean fever
683688|NCT00323440|Inflammation|inflammation
683689|NCT00323440|Attacks|attacks
683690|NCT00323440|Remission|remission
683691|NCT00323440|RNA|rna
683692|NCT00323440|Cytokines|cytokines
683693|NCT00323440|Inflammatory proteins|inflammatory proteins
683694|NCT00323440|MEFV|mefv
683695|NCT00323440|mutations|mutations
683696|NCT00323440|Colchicine|colchicine
683697|NCT00323440|Treatment|treatment
683698|NCT00323440|microarray RNA analysis|microarray rna analysis
683699|NCT00323427|Audiology|audiology
683700|NCT00323427|Coping behaviors|coping behaviors
683701|NCT00323427|Counseling|counseling
683702|NCT00323427|Hearing aids|hearing aids
683703|NCT00323427|Hearing impairment|hearing impairment
683704|NCT00323427|Patient-centered care|patient-centered care
683705|NCT00323427|Psychological adaptation|psychological adaptation
683706|NCT00323427|Psychological adjustment|psychological adjustment
683707|NCT00323427|Rehabilitation|rehabilitation
683708|NCT00323427|Social adjustment|social adjustment
683709|NCT00323427|Aural Rehabilitation|aural rehabilitation
683710|NCT00323414|PUFA|pufa
683711|NCT00323414|NASH|nash
683712|NCT00323414|Fatty Liver|fatty liver
683713|NCT00323414|Insulin resistance|insulin resistance
683714|NCT00323414|Metabolic syndrome|metabolic syndrome
683715|NCT00323414|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
684698|NCT00319267|children|children
683716|NCT00323414|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
683717|NCT00323414|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
683718|NCT00323401|Pregnancy|pregnancy
683719|NCT00323401|Parturition|parturition
683720|NCT00323401|Depression|depression
683721|NCT00323401|Randomized|randomized
683722|NCT00323401|Antenatal classes|antenatal classes
683723|NCT00323375|Malaria|malaria
683724|NCT00323375|Aminoquinolines|aminoquinolines
683725|NCT00323375|Drug Resistance|drug resistance
683726|NCT00323375|Chloroquine Resistance|chloroquine resistance
683727|NCT00323362|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
683728|NCT00323362|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
683729|NCT00323349|Glucose Tolerance Test|glucose tolerance test
683730|NCT00323349|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
683731|NCT00323349|Motivation|motivation
683732|NCT00323349|Communication|communication
683733|NCT00323349|Health Behavior|health behavior
683734|NCT00323323|Untreated|untreated
683735|NCT00323323|CD-20 Negative|cd-20 negative
683736|NCT00323323|Large B-Cell Lymphomas|large b-cell lymphomas
683737|NCT00323310|disease of the central nervous system (brain or spine)|disease of the central nervous system (brain or spine)
683738|NCT00323284|Open angle|open angle
683739|NCT00323284|Glaucoma|glaucoma
683740|NCT00323284|Cataract|cataract
683741|NCT00323284|Surgery|surgery
683742|NCT00323271|Chronic pain|chronic pain
683743|NCT00323271|Cognitive behavioral therapy|cognitive behavioral therapy
683744|NCT00323271|Multiple sclerosis|multiple sclerosis
683745|NCT00323271|Randomized controlled trial|randomized controlled trial
683746|NCT00323258|Heart disease|heart disease
683747|NCT00323258|Coronary disease|coronary disease
683748|NCT00323258|Patient compliance|patient compliance
683749|NCT00323258|Treatment refusal|treatment refusal
683750|NCT00323258|Pharmacists|pharmacists
683751|NCT00323258|Continuity of patient care|continuity of patient care
683752|NCT00323258|Evidence-based medicine|evidence-based medicine
683753|NCT00323258|Patient education|patient education
683754|NCT00323258|Adherence|adherence
683755|NCT00323245|Randomized clinical trial|randomized clinical trial
683756|NCT00323245|osteoporosis|osteoporosis
683757|NCT00323245|urinary incontinence|urinary incontinence
683758|NCT00323245|physiotherapy|physiotherapy
683759|NCT00323245|education|education
683760|NCT00323232|DHS, Intertrochanteric|dhs, intertrochanteric
683761|NCT00323219|Cellulitis, RCT, emergency Department, Double-blind, Equivalence trial, Moxifloxacin, Cefazolin, Probenecid.|cellulitis, rct, emergency department, double-blind, equivalence trial, moxifloxacin, cefazolin, probenecid.
683762|NCT00323206|melanoma|melanoma
683763|NCT00323206|electroporation|electroporation
683764|NCT00323206|IL-12|il-12
683765|NCT00323206|gene therapy|gene therapy
683766|NCT00323206|gene transfer|gene transfer
683767|NCT00323193|Behavioral interventions|behavioral interventions
683768|NCT00323193|Mental Illness|mental illness
683769|NCT00323193|Obesity|obesity
683770|NCT00323193|Psycho-educational interventions|psycho-educational interventions
683771|NCT00323193|Weight management|weight management
683772|NCT00323167|Variant Cystic Fibrosis|variant cystic fibrosis
683773|NCT00323167|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
683774|NCT00323154|Morphine, analgesia|morphine, analgesia
683775|NCT00323141|Hernia umbilicalis|hernia umbilicalis
683776|NCT00323115|immunotherapy|immunotherapy
683777|NCT00323115|cancer vaccine|cancer vaccine
683778|NCT00323115|glioblastoma multiforme|glioblastoma multiforme
683779|NCT00323089|microcoil|microcoil
683780|NCT00323089|subcentimetre nodules|subcentimetre nodules
683781|NCT00323063|recurrent breast cancer|recurrent breast cancer
683782|NCT00323063|stage IV breast cancer|stage iv breast cancer
683783|NCT00323063|male breast cancer|male breast cancer
683784|NCT00323063|stage IIIA breast cancer|stage iiia breast cancer
683785|NCT00323063|stage IIIB breast cancer|stage iiib breast cancer
683786|NCT00323063|stage IIIC breast cancer|stage iiic breast cancer
683787|NCT00323037|heart failure|heart failure
683788|NCT00323024|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
683789|NCT00323024|Pulmonary Hypertension|pulmonary hypertension
683790|NCT00323024|Idiopathic PAH|idiopathic pah
683791|NCT00323024|PH associated with connective tissue disease (CTD)|ph associated with connective tissue disease (ctd)
683792|NCT00323024|PH associated with interstitial lung disease (ILD)|ph associated with interstitial lung disease (ild)
683793|NCT00323024|PH associated with congestive heart failure (CHF)|ph associated with congestive heart failure (chf)
683794|NCT00323024|PH associated with chronic obstructive pulmonary disease (COPD)|ph associated with chronic obstructive pulmonary disease (copd)
683795|NCT00322985|T-cell lymphoma|t-cell lymphoma
683796|NCT00322985|lenalidomide|lenalidomide
683797|NCT00322972|Bacterial Infections|bacterial infections
683798|NCT00322972|Chlamydia Infections|chlamydia infections
683799|NCT00322972|Eye Diseases|eye diseases
683800|NCT00322959|dendritic cells|dendritic cells
683801|NCT00322959|Tai-Chi-Chuan|tai-chi-chuan
683802|NCT00322946|Dengue Fever|dengue fever
683803|NCT00322946|Dengue Vaccine|dengue vaccine
683804|NCT00322946|Dengue Virus|dengue virus
683805|NCT00322946|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
683806|NCT00322946|Dengue Shock Syndrome|dengue shock syndrome
683807|NCT00322933|intermittent renal replacement therapy|intermittent renal replacement therapy
683808|NCT00322933|continuous renal replacement therapy|continuous renal replacement therapy
683809|NCT00322933|acute renal failure|acute renal failure
683810|NCT00322933|renal recovery|renal recovery
683811|NCT00322933|mortality|mortality
683812|NCT00322920|cervical cancer|cervical cancer
683813|NCT00322920|topotecan|topotecan
683814|NCT00322920|Stage IVB cervical cancer|stage ivb cervical cancer
683815|NCT00322920|Persistent or recurrent cervical cancer|persistent or recurrent cervical cancer
683816|NCT00322907|malaria|malaria
683817|NCT00322907|treatment|treatment
683818|NCT00322907|cotrifazid|cotrifazid
683819|NCT00322907|clinical trial|clinical trial
683820|NCT00322907|efficacy|efficacy
683821|NCT00322894|Breast cancer|breast cancer
683822|NCT00322894|Risk factors|risk factors
683823|NCT00322894|Treatment|treatment
683824|NCT00322894|Clinico-pathologic|clinico-pathologic
683825|NCT00322894|Outcomes|outcomes
683826|NCT00322894|Tissue repository|tissue repository
683827|NCT00322894|Registry|registry
683828|NCT00322881|carboplatin|carboplatin
683829|NCT00322881|paclitaxel|paclitaxel
683830|NCT00322881|elderly women|elderly women
683831|NCT00322868|Prescription drugs|prescription drugs
683832|NCT00322868|Administration, oral|administration, oral
683833|NCT00322868|Durable medical equipment|durable medical equipment
683834|NCT00322868|Kinetics|kinetics
683835|NCT00322842|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
683836|NCT00322842|Multiple Myeloma|multiple myeloma
683837|NCT00322842|Stem cell mobilization|stem cell mobilization
683838|NCT00322829|Group B Streptococcus, Strepotococcus agalactiae, detection|group b streptococcus, strepotococcus agalactiae, detection
683839|NCT00322816|Malaria, Plasmodium falciparum, Gambia, larvicides|malaria, plasmodium falciparum, gambia, larvicides
683840|NCT00322803|panic disorder|panic disorder
683841|NCT00322803|proof of concept|proof of concept
683842|NCT00322777|Major depression|major depression
683843|NCT00322777|Spirituality|spirituality
683844|NCT00322777|Randomized clinical trial|randomized clinical trial
683845|NCT00322764|manic depression|manic depression
683846|NCT00322764|bipolar disorder|bipolar disorder
683847|NCT00322764|depression|depression
683848|NCT00322764|uridine|uridine
683849|NCT00322764|RG2417|rg2417
683850|NCT00322738|malaria, Plasmodium falciparum, Gambia, larvicides, vector|malaria, plasmodium falciparum, gambia, larvicides, vector
683851|NCT00322699|Bladder Cancer|bladder cancer
683852|NCT00322699|Photodynamic Therapy|photodynamic therapy
683853|NCT00322699|Photofrin|photofrin
683854|NCT00322699|Photosensitization|photosensitization
683855|NCT00322699|Photoradiation|photoradiation
683856|NCT00322686|oglemilast|oglemilast
683857|NCT00322686|asthma|asthma
683858|NCT00322686|allergen|allergen
683859|NCT00322686|prevention|prevention
683860|NCT00322686|prophylaxis|prophylaxis
683861|NCT00322686|Allergen-Induced Asthma|allergen-induced asthma
683862|NCT00322673|acute myeloid leukemia|acute myeloid leukemia
683864|NCT00322608|Solid Tumors|solid tumors
683865|NCT00322608|Lymphomas|lymphomas
683866|NCT00322595|Anxiety|anxiety
683867|NCT00322595|GAD|gad
683868|NCT00322582|familial cardiomyopathy|familial cardiomyopathy
683869|NCT00322582|genetics analysis|genetics analysis
683870|NCT00322569|Percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
683871|NCT00322569|Drug eluting stent (DES)|drug eluting stent (des)
683872|NCT00322556|Immunoglobulin Intravenous|immunoglobulin intravenous
683873|NCT00322556|Agammaglobulinemia|agammaglobulinemia
683874|NCT00322556|Hypogammaglobulinemia|hypogammaglobulinemia
683875|NCT00322556|Common variable immunodeficiency|common variable immunodeficiency
683876|NCT00322556|Immunoglobulin G|immunoglobulin g
683877|NCT00322556|Children|children
683878|NCT00322543|Percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
683879|NCT00322543|Drug eluting stent (DES)|drug eluting stent (des)
683880|NCT00322491|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
683881|NCT00322491|Multiple Myeloma|multiple myeloma
683882|NCT00322491|Stem cell mobilization|stem cell mobilization
683883|NCT00322465|non-gonococcal urethritis, doxycycline, azithromycin, sexually transmitted, tinidazole|non-gonococcal urethritis, doxycycline, azithromycin, sexually transmitted, tinidazole
683884|NCT00322452|NSCLC|nsclc
683885|NCT00322452|Gefitinib|gefitinib
683886|NCT00322439|plaque Psoriasis patients|plaque psoriasis patients
683887|NCT00322439|TNF-inhibitor naïve|tnf-inhibitor naïve
683888|NCT00322426|Freezing of Gait|freezing of gait
683889|NCT00322426|Parkinson's Disease|parkinson's disease
683890|NCT00322426|Sensory Cues|sensory cues
683891|NCT00322413|Epoetin alfa|epoetin alfa
683892|NCT00322413|Epoetin omega|epoetin omega
683893|NCT00322413|Comparative efficacy trial|comparative efficacy trial
683894|NCT00322413|Renal anemia|renal anemia
683895|NCT00322400|Clinical trial|clinical trial
683896|NCT00322400|AMG 706|amg 706
683897|NCT00322400|Anti-angiogenesis|anti-angiogenesis
683898|NCT00322400|Locally Recurrent|locally recurrent
683899|NCT00322400|Metastatic|metastatic
683900|NCT00322400|Breast Cancer|breast cancer
683901|NCT00322400|VEGF|vegf
683902|NCT00322400|Angiogenesis Inhibitor|angiogenesis inhibitor
683904|NCT00322400|Multi-kinase Inhibitor|multi-kinase inhibitor
683905|NCT00322400|Anti-tumor|anti-tumor
683906|NCT00322400|PDGF receptor|pdgf receptor
683907|NCT00322400|Paclitaxel|paclitaxel
683908|NCT00322400|Docetaxel|docetaxel
683909|NCT00322400|Targeted Therapy|targeted therapy
683910|NCT00322400|Oncology|oncology
683911|NCT00322400|Amgen|amgen
683912|NCT00322400|c-Kit|c-kit
683913|NCT00322387|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
683914|NCT00322387|Multiple Myeloma|multiple myeloma
683915|NCT00322387|Stem cell mobilization|stem cell mobilization
683916|NCT00322348|oncology|oncology
683917|NCT00322348|cancer|cancer
683918|NCT00322348|breast cancer|breast cancer
683919|NCT00322335|H.influenzae type b Disease|h.influenzae type b disease
683920|NCT00322322|L-carnitine supplementation|l-carnitine supplementation
683921|NCT00322322|Hemodialysis|hemodialysis
683922|NCT00322322|Anaemia|anaemia
683923|NCT00322322|Erythropoietin responsiveness|erythropoietin responsiveness
683924|NCT00322309|Cocaine|cocaine
683925|NCT00322309|Substance Abuse|substance abuse
683926|NCT00322296|Parapsoriasis|parapsoriasis
683927|NCT00322296|Cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
683928|NCT00322296|Mycosis fungoides|mycosis fungoides
683929|NCT00322296|Bexarotene|bexarotene
683930|NCT00322296|Retinoids|retinoids
683931|NCT00322283|oglemilast|oglemilast
683932|NCT00322283|asthma|asthma
683933|NCT00322283|exercise|exercise
683934|NCT00322283|prevention|prevention
683935|NCT00322283|prophylaxis|prophylaxis
683936|NCT00322270|Occluded Central Venous Access Devices|occluded central venous access devices
683937|NCT00322270|Occluded Catheters|occluded catheters
683938|NCT00322270|Thrombosis|thrombosis
683939|NCT00322270|thrombosis, catheter|thrombosis, catheter
683940|NCT00322270|alfimeprase|alfimeprase
683941|NCT00322270|thrombotic occlusion|thrombotic occlusion
683942|NCT00322270|thrombosis, CVAD|thrombosis, cvad
683943|NCT00322270|thrombosis, catheters|thrombosis, catheters
683944|NCT00322244|Osteoarthritis|osteoarthritis
683945|NCT00322244|Massage therapy|massage therapy
683946|NCT00322192|Stroke rehabilitation|stroke rehabilitation
683947|NCT00322192|Physical Therapy|physical therapy
683948|NCT00322179|Microarray Analysis|microarray analysis
683949|NCT00322179|Obesity|obesity
683950|NCT00322179|Chronic Hepatitis C|chronic hepatitis c
683951|NCT00322166|accidental falls|accidental falls
683952|NCT00322166|vitamin D|vitamin d
683953|NCT00322166|parathyroid hormone|parathyroid hormone
683954|NCT00322166|osteoporosis|osteoporosis
683955|NCT00322153|memantine|memantine
683956|NCT00322153|Alzheimer's disease|alzheimer's disease
683957|NCT00322153|moderate to severe Alzheimer's disease|moderate to severe alzheimer's disease
683958|NCT00322140|Metastatic|metastatic
683959|NCT00322140|Triterpenoids|triterpenoids
683960|NCT00322140|2-Cyano-3,12-Dioxooleana-1,9(11)Dien-28oic Acid|2-cyano-3,12-dioxooleana-1,9(11)dien-28oic acid
683961|NCT00322140|Dose-Limiting|dose-limiting
683962|NCT00322140|Pharmacokinetic|pharmacokinetic
683963|NCT00322140|Solid Tumor|solid tumor
683964|NCT00322140|Lymphoma|lymphoma
683965|NCT00322127|Hematopoietic Stem Cells|hematopoietic stem cells
683966|NCT00322127|Stem Cell Mobilization|stem cell mobilization
683967|NCT00322127|CXCR4|cxcr4
683968|NCT00322127|SDF-1|sdf-1
683969|NCT00322127|Healthy Volunteer|healthy volunteer
683970|NCT00322127|HV|hv
683971|NCT00322114|prostate cancer|prostate cancer
683972|NCT00322062|Colon cleansing|colon cleansing
683973|NCT00322049|Dengue, Vaccine, Thailand|dengue, vaccine, thailand
683974|NCT00322036|Alzheimer Disease|alzheimer disease
683975|NCT00322036|Dementia|dementia
683976|NCT00322023|Negative symptoms|negative symptoms
683977|NCT00322023|NMDA|nmda
683978|NCT00322023|Glutamate|glutamate
683979|NCT00322023|Glycine|glycine
683980|NCT00322010|mechanical ventilation|mechanical ventilation
683981|NCT00322010|physical therapy|physical therapy
683982|NCT00322010|occupational therapy|occupational therapy
683983|NCT00322010|mobilization|mobilization
683984|NCT00322010|clinical protocols|clinical protocols
683985|NCT00322010|ICU acquired weakness|icu acquired weakness
683986|NCT00322010|critical illness myopathy|critical illness myopathy
683987|NCT00322010|muscle atrophy|muscle atrophy
683988|NCT00322010|intensive care unit|intensive care unit
683989|NCT00322010|randomized controlled trial|randomized controlled trial
683990|NCT00321997|AMD|amd
683991|NCT00321997|Age-Related Macular Degeneration|age-related macular degeneration
683992|NCT00321997|Macular Degeneration|macular degeneration
683993|NCT00321997|Macugen|macugen
683994|NCT00321997|pegaptanib sodium|pegaptanib sodium
683995|NCT00321984|Gastroesophageal Reflux Disease(GERD)|gastroesophageal reflux disease(gerd)
683996|NCT00321984|Heartburn|heartburn
683997|NCT00321971|Anxiety|anxiety
683998|NCT00321971|Mild Cognitive Impairment|mild cognitive impairment
683999|NCT00321971|MCI|mci
684000|NCT00321971|Cognitive Impairment|cognitive impairment
684001|NCT00321971|Alzheimer's Disease|alzheimer's disease
684002|NCT00321971|Caregiver Burden|caregiver burden
684003|NCT00321971|Caregiver Stress|caregiver stress
684004|NCT00321971|Family Dementia Caregiving|family dementia caregiving
685446|NCT00316537|diabetes|diabetes
684005|NCT00321971|Spousal Dementia Caregiving|spousal dementia caregiving
684006|NCT00321958|Barrett Esophagus|barrett esophagus
684007|NCT00321958|Esophageal Neoplasm|esophageal neoplasm
684008|NCT00321958|Deglutition disorders|deglutition disorders
684009|NCT00321958|Cryotherapy|cryotherapy
684010|NCT00321958|Cryosurgery|cryosurgery
684011|NCT00321958|GERD|gerd
684012|NCT00321958|Neoplasm|neoplasm
684013|NCT00321958|Esophagus|esophagus
684014|NCT00321958|Endoscopy, Digestive System|endoscopy, digestive system
684015|NCT00321945|Atrial Fibrillation|atrial fibrillation
684016|NCT00321945|Atrial Flutter|atrial flutter
684017|NCT00321945|Angiotensin Converting Enzyme Inhibitor|angiotensin converting enzyme inhibitor
684018|NCT00321945|Angiotensin Receptor Blocker|angiotensin receptor blocker
684019|NCT00321906|Rejection in lung transplant|rejection in lung transplant
684020|NCT00321893|Small cell lung cancer|small cell lung cancer
684021|NCT00321893|Non-small cell lung cancer|non-small cell lung cancer
684022|NCT00321893|Budesonide|budesonide
684023|NCT00321893|Entocort EC|entocort ec
684024|NCT00321893|Pulmicort Respules|pulmicort respules
684025|NCT00321893|Rhinocort aqua|rhinocort aqua
684026|NCT00321893|Aerosol budesonide treatment|aerosol budesonide treatment
684027|NCT00321893|Smoking|smoking
684028|NCT00321880|fatigue|fatigue
684029|NCT00321880|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
684030|NCT00321880|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
684031|NCT00321880|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
684032|NCT00321880|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
684033|NCT00321880|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
684034|NCT00321880|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
684035|NCT00321880|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
684036|NCT00321880|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
684037|NCT00321880|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
684038|NCT00321880|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
684039|NCT00321867|rectocele|rectocele
684040|NCT00321867|pelvic prolapse|pelvic prolapse
684041|NCT00321867|graft|graft
684042|NCT00321867|surgical repair|surgical repair
684043|NCT00321828|adenocarcinoma of the colon|adenocarcinoma of the colon
684044|NCT00321828|stage IV colon cancer|stage iv colon cancer
684045|NCT00321815|advanced carcinoma non-small cell lung EGFR positive Erlotinib Tarceva PF-3512676 Phase II immunotherapy immune modulator|advanced carcinoma non-small cell lung egfr positive erlotinib tarceva pf-3512676 phase ii immunotherapy immune modulator
684046|NCT00321802|atrial fibrillation|atrial fibrillation
684047|NCT00321802|statin therapy|statin therapy
684048|NCT00321802|CRP levels|crp levels
684049|NCT00321802|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
684050|NCT00321789|self care|self care
684051|NCT00321789|social support|social support
684052|NCT00321763|Influenza|influenza
684053|NCT00321763|Influenza vaccine|influenza vaccine
684054|NCT00321750|Oral erosive lichen planus|oral erosive lichen planus
684055|NCT00321750|pimecrolimus cream|pimecrolimus cream
684056|NCT00321737|Erosive Esophagitis|erosive esophagitis
684058|NCT00321711|Myelodysplastic Syndromes|myelodysplastic syndromes
684059|NCT00321711|Refractory Cytopenias|refractory cytopenias
684060|NCT00321711|Thrombocytopenia|thrombocytopenia
684061|NCT00321698|adenocarcinoma of the prostate|adenocarcinoma of the prostate
684062|NCT00321698|stage II prostate cancer|stage ii prostate cancer
684063|NCT00321698|stage III prostate cancer|stage iii prostate cancer
684064|NCT00321672|Analgesics|analgesics
684065|NCT00321672|Capsaicin|capsaicin
684066|NCT00321672|Neuropathic pain|neuropathic pain
684067|NCT00321672|Neuropathy|neuropathy
684068|NCT00321672|Distal sensory polyneuropathy|distal sensory polyneuropathy
684069|NCT00321672|Peripheral neuropathy|peripheral neuropathy
684070|NCT00321672|Dermal assessment|dermal assessment
684071|NCT00321672|Pain measurement|pain measurement
684072|NCT00321659|fibromyalgia|fibromyalgia
684073|NCT00321659|self-management|self-management
684074|NCT00321659|exercise|exercise
684075|NCT00321659|patient education|patient education
684076|NCT00321646|prostate cancer|prostate cancer
684077|NCT00321646|bevacizumab|bevacizumab
684078|NCT00321646|docetaxel|docetaxel
684079|NCT00321646|radical prostatectomy|radical prostatectomy
684080|NCT00321633|stage IV breast cancer|stage iv breast cancer
684081|NCT00321633|recurrent breast cancer|recurrent breast cancer
684082|NCT00321633|hereditary breast/ovarian cancer (BRCA1, BRCA2)|hereditary breast/ovarian cancer (brca1, brca2)
684083|NCT00321633|BRCA1 mutation carrier|brca1 mutation carrier
684084|NCT00321633|BRCA2 mutation carrier|brca2 mutation carrier
684085|NCT00321620|Bone metastases|bone metastases
684086|NCT00321620|Hormone-refractory prostate cancer|hormone-refractory prostate cancer
684087|NCT00321620|Skeletal|skeletal
684088|NCT00321620|Fractures|fractures
684089|NCT00321620|Compressions|compressions
684090|NCT00321620|Bisphosphonates|bisphosphonates
684091|NCT00321581|VEGFR2|vegfr2
684092|NCT00321581|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
685447|NCT00316537|foot ulcers|foot ulcers
684093|NCT00321581|Antiangiogenesis|antiangiogenesis
684094|NCT00321581|Solid Tumors|solid tumors
684095|NCT00321581|Childhood Cancer|childhood cancer
684096|NCT00321581|Solid Tumor|solid tumor
684097|NCT00321581|Recurrent Solid Tumor|recurrent solid tumor
684098|NCT00321581|Treatment Resistant Solid Tumor|treatment resistant solid tumor
684099|NCT00321581|Acute Myelogenous Leukemia|acute myelogenous leukemia
684100|NCT00321581|AML|aml
684101|NCT00321568|Multiple Sclerosis|multiple sclerosis
684102|NCT00321568|Magnetic Resonance|magnetic resonance
684103|NCT00321568|MRI|mri
684104|NCT00321568|Magnetic Field|magnetic field
684105|NCT00321568|MS|ms
684106|NCT00321555|Biologic Therapy|biologic therapy
684107|NCT00321555|Monoclonal Antibody|monoclonal antibody
684108|NCT00321555|Immunotherapy|immunotherapy
684109|NCT00321555|Pseudomonas Exotoxin|pseudomonas exotoxin
684110|NCT00321555|Targeted Therapy|targeted therapy
684111|NCT00321555|Hairy Cell Leukemia|hairy cell leukemia
684112|NCT00321555|HCL|hcl
684113|NCT00321542|Computed tomography|computed tomography
684114|NCT00321542|Diabetes mellitus|diabetes mellitus
684115|NCT00321542|Coronary atherosclerosis|coronary atherosclerosis
684116|NCT00321542|Non-invasive imaging|non-invasive imaging
684117|NCT00321529|Cervical spine instability|cervical spine instability
684118|NCT00321529|Penning Study|penning study
684119|NCT00321516|Bipolar type I Disorder|bipolar type i disorder
684120|NCT00321503|acid reflux|acid reflux
684121|NCT00321503|LPR|lpr
684122|NCT00321503|gastroesophageal reflux|gastroesophageal reflux
684123|NCT00321503|GERD|gerd
684124|NCT00321503|pH probe|ph probe
684125|NCT00321503|proton pump inhibitor|proton pump inhibitor
684126|NCT00321503|PPI|ppi
684127|NCT00321490|MDD|mdd
684128|NCT00321490|Quetiapine fumarate, sustained release|quetiapine fumarate, sustained release
684129|NCT00321490|Depression|depression
684130|NCT00321477|Overactive Bladder|overactive bladder
684131|NCT00321464|Fractures|fractures
684132|NCT00321464|Compressions|compressions
684133|NCT00321464|Bisphosphonates|bisphosphonates
684134|NCT00321464|Bone metastases|bone metastases
684135|NCT00321464|Breast cancer|breast cancer
684136|NCT00321464|Skeletal|skeletal
684137|NCT00321464|Radiation|radiation
684138|NCT00321464|Surgery to Bone|surgery to bone
684139|NCT00321451|insomnia|insomnia
684140|NCT00321451|cognitive behavior therapy|cognitive behavior therapy
684141|NCT00321438|HIV-1|hiv-1
684142|NCT00321438|GW873140|gw873140
684143|NCT00321438|CCR5 antagonist|ccr5 antagonist
684144|NCT00321438|experienced|experienced
684145|NCT00321438|treatment experienced|treatment experienced
684146|NCT00321412|Crohn's disease|crohn's disease
684147|NCT00321412|IBD|ibd
684148|NCT00321412|Inflammatory Bowel Disease|inflammatory bowel disease
684149|NCT00321412|Fistula|fistula
684150|NCT00321399|CORONARY ANATOMY|coronary anatomy
684151|NCT00321399|Coronary Artery Disease|coronary artery disease
684152|NCT00321399|SPECT|spect
684153|NCT00321399|PET|pet
684154|NCT00321399|PET/CT|pet/ct
684155|NCT00321399|CTA|cta
684156|NCT00321386|Glaucoma|glaucoma
684157|NCT00321386|Open Angle|open angle
684158|NCT00321386|Normal Tension|normal tension
684159|NCT00321373|Influenza|influenza
684160|NCT00321373|Influenza vaccine|influenza vaccine
684161|NCT00321360|propofol|propofol
684162|NCT00321360|sedation|sedation
684163|NCT00321347|Cancer|cancer
684164|NCT00321347|Pain|pain
684165|NCT00321347|Lidocaine|lidocaine
684166|NCT00321334|non-small cell lung cancer|non-small cell lung cancer
684167|NCT00321334|Chemotherapy|chemotherapy
684168|NCT00321334|surgery|surgery
684169|NCT00321334|neo-adjuvant|neo-adjuvant
684170|NCT00321334|adjuvant|adjuvant
684171|NCT00321334|RCT|rct
684172|NCT00321321|Type 2 diabetes mellitus|type 2 diabetes mellitus
684173|NCT00321321|Glucose dependent insulinotropic polypeptide|glucose dependent insulinotropic polypeptide
684174|NCT00321321|Sulfonylurea compounds|sulfonylurea compounds
684175|NCT00321321|insulin secretion|insulin secretion
684176|NCT00321321|Sulfonylurea receptor subunit-SUR1|sulfonylurea receptor subunit-sur1
684177|NCT00321321|Impaired incretin effect|impaired incretin effect
684178|NCT00321308|advanced carcinoma, non-small cell lung cancer, phase II, pemetrexed, Alimta, PF-3512676, immunotherapy, immunomodulator|advanced carcinoma, non-small cell lung cancer, phase ii, pemetrexed, alimta, pf-3512676, immunotherapy, immunomodulator
684179|NCT00321295|Bi-ventricular pacing|bi-ventricular pacing
684180|NCT00321295|Cardiac Surgery|cardiac surgery
684181|NCT00321295|Cardiomyopahty|cardiomyopahty
684182|NCT00321295|Heart Failure|heart failure
684183|NCT00321282|Atrial Fibrillation|atrial fibrillation
684184|NCT00321282|Coronary Artery Bypass Graft|coronary artery bypass graft
684185|NCT00321282|Risk Stratification|risk stratification
684186|NCT00321269|Home Monitoring|home monitoring
684187|NCT00321269|Heart Failure|heart failure
684188|NCT00321269|Depression|depression
684189|NCT00321256|islet transplantation|islet transplantation
684190|NCT00321256|brittle diabetes|brittle diabetes
684191|NCT00321256|severe hypoglycemia|severe hypoglycemia
684192|NCT00321256|type 1 diabetes mellitus|type 1 diabetes mellitus
684193|NCT00321243|triage|triage
684194|NCT00321230|Colon cleansing|colon cleansing
684195|NCT00321217|rheumatoid arthritis|rheumatoid arthritis
684196|NCT00321217|pharmacogenetics|pharmacogenetics
684197|NCT00321217|anti-TNF|anti-tnf
684198|NCT00321217|high throughput genotyping|high throughput genotyping
684199|NCT00321204|Atrial Fibrillation|atrial fibrillation
684200|NCT00321204|Atrial Flutter|atrial flutter
684201|NCT00321204|Cardiac Surgery|cardiac surgery
684202|NCT00321204|Thiazolidinediones|thiazolidinediones
684203|NCT00321178|Mycobacterium ulcerans|mycobacterium ulcerans
684204|NCT00321178|Buruli ulcer|buruli ulcer
684205|NCT00321178|Ghana|ghana
684206|NCT00321178|randomized comparison|randomized comparison
684207|NCT00321178|streptomycin|streptomycin
684208|NCT00321178|rifampicin|rifampicin
684209|NCT00321178|clarithromycin|clarithromycin
684210|NCT00321165|nutrition|nutrition
684211|NCT00321165|parenteral|parenteral
684212|NCT00321165|infection|infection
684213|NCT00321165|katheter|katheter
684214|NCT00321165|taurolidine|taurolidine
684215|NCT00321165|acridine orange|acridine orange
684216|NCT00321165|prevention|prevention
684217|NCT00321139|biomarkers|biomarkers
684218|NCT00321139|oxidative stress|oxidative stress
684219|NCT00321139|intravascular ultrasound|intravascular ultrasound
684220|NCT00321126|Zinc|zinc
684221|NCT00321126|Shigella|shigella
684222|NCT00321126|Children|children
684223|NCT00321126|Bangladesh|bangladesh
684224|NCT00321113|MARGINAL KIDNEY|marginal kidney
684225|NCT00321113|TACROLIMUS|tacrolimus
684226|NCT00321113|IMMUNOSUPPRESSION|immunosuppression
684227|NCT00321113|ELDERLY RECEPIENTS|elderly recepients
684228|NCT00321100|metastatic|metastatic
684229|NCT00321100|colorectal|colorectal
684230|NCT00321100|cancer|cancer
684231|NCT00321100|initial therapy|initial therapy
684232|NCT00321087|Movement Disorder|movement disorder
684233|NCT00321074|IMMUNOSUPPRESSION|immunosuppression
684234|NCT00321074|TACROLIMUS|tacrolimus
684235|NCT00321074|MARGINAL LIVERS|marginal livers
684236|NCT00321074|PHARMACOKINETICS|pharmacokinetics
684237|NCT00321061|HIV Negative|hiv negative
684238|NCT00321061|Healthy|healthy
684239|NCT00321061|Immunity|immunity
684240|NCT00321061|Preventive|preventive
684241|NCT00321061|Virus|virus
684242|NCT00321061|Healthy Volunteer|healthy volunteer
684243|NCT00321061|HV|hv
684244|NCT00321048|breast cancer|breast cancer
684245|NCT00321048|SPECT|spect
684246|NCT00321048|ABC device|abc device
684247|NCT00321048|Invasive adenocarcinoma of the left breast|invasive adenocarcinoma of the left breast
684248|NCT00321048|Ductal Carcinoma In Situ of the left breast|ductal carcinoma in situ of the left breast
684249|NCT00321035|Glaucoma|glaucoma
684250|NCT00321035|Pterygium|pterygium
684251|NCT00321035|collagen matrix|collagen matrix
684252|NCT00321035|oculusgen|oculusgen
684253|NCT00321035|ologen|ologen
684254|NCT00321035|trabeculectomy|trabeculectomy
684255|NCT00321035|anti scarring|anti scarring
684256|NCT00321035|prevent recurrence|prevent recurrence
684257|NCT00321035|tissue engineering|tissue engineering
684258|NCT00321035|Aeon Astron|aeon astron
684259|NCT00321022|Transient Ischemic Attack (TIA)|transient ischemic attack (tia)
684260|NCT00321022|Diagnostic Protocol|diagnostic protocol
684261|NCT00321022|Observational Medicine|observational medicine
684262|NCT00321022|Emergency Department Observational Unit|emergency department observational unit
684263|NCT00321009|Myocardial Infarction|myocardial infarction
684264|NCT00321009|Left Ventricular Mural Thrombus|left ventricular mural thrombus
684265|NCT00321009|Low Molecular Weight Heparin|low molecular weight heparin
684266|NCT00321009|Enoxaparin|enoxaparin
684267|NCT00321009|Warfarin|warfarin
684268|NCT00321009|Echocardiograms|echocardiograms
684269|NCT00320996|Pelvic mass|pelvic mass
684270|NCT00320983|Cancer|cancer
684271|NCT00320983|Cervix|cervix
684272|NCT00320970|TGF-Beta 1|tgf-beta 1
684273|NCT00320970|Angiotensin II|angiotensin ii
684274|NCT00320970|Advanced glycation end products|advanced glycation end products
684275|NCT00320957|Glaucoma|glaucoma
684276|NCT00320957|Pterygium|pterygium
684277|NCT00320957|collagen matrix|collagen matrix
684278|NCT00320957|OculusGen|oculusgen
684279|NCT00320957|trabeculectomy|trabeculectomy
684280|NCT00320957|Anti scarring|anti scarring
684281|NCT00320957|pterygium recurrence|pterygium recurrence
684282|NCT00320957|tissue engineering|tissue engineering
684283|NCT00320957|Aeon Astron|aeon astron
684284|NCT00320957|ologen|ologen
684285|NCT00320931|Coronary artery disease|coronary artery disease
684286|NCT00320931|PET CT scan|pet ct scan
684287|NCT00320931|Stress test|stress test
684288|NCT00320931|Rubudium|rubudium
684289|NCT00320918|Unresectable/metastatic cholangiocarcinoma|unresectable/metastatic cholangiocarcinoma
684290|NCT00320918|Cancer|cancer
684291|NCT00320918|Chart Review|chart review
684292|NCT00320905|Cardiac Rehabilitation|cardiac rehabilitation
684293|NCT00320905|Cognitive functioning|cognitive functioning
684294|NCT00320905|Cardiovascular disease|cardiovascular disease
684295|NCT00320892|Death Rattle|death rattle
684296|NCT00320892|Noise level|noise level
684297|NCT00320892|Primary Care|primary care
684298|NCT00320879|diabetes|diabetes
684299|NCT00320879|microalbuminuria|microalbuminuria
684300|NCT00320879|angiotensin II receptor blockade|angiotensin ii receptor blockade
684301|NCT00320879|irbesartan|irbesartan
684302|NCT00320879|dose-response|dose-response
684303|NCT00320879|randomized|randomized
684304|NCT00320879|double-blind|double-blind
684305|NCT00320879|renin-angiotensin-aldosterone system|renin-angiotensin-aldosterone system
684306|NCT00320879|clinical|clinical
684307|NCT00320879|hypertension|hypertension
684308|NCT00320866|Hypodermoclysis|hypodermoclysis
684309|NCT00320866|Evaluation of Symptoms|evaluation of symptoms
684310|NCT00320853|Diabetes|diabetes
684311|NCT00320853|Vitamin D|vitamin d
684312|NCT00320853|Insulin sensitivity|insulin sensitivity
684313|NCT00320853|Insulin secretion|insulin secretion
684314|NCT00320840|preterm infants|preterm infants
684315|NCT00320840|twins|twins
684316|NCT00320840|motherhood|motherhood
684317|NCT00320840|internal resources|internal resources
684318|NCT00320840|familial resources|familial resources
684319|NCT00320827|Apoptosis|apoptosis
684320|NCT00320827|Death receptor 5|death receptor 5
684321|NCT00320827|Cancer|cancer
684322|NCT00320827|Advanced solid malignancies and lymphomas (without leukemic component)|advanced solid malignancies and lymphomas (without leukemic component)
684323|NCT00320801|Chronic pain|chronic pain
684324|NCT00320801|osteoarthritis|osteoarthritis
684325|NCT00320801|transdermal|transdermal
684326|NCT00320788|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
684327|NCT00320775|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
684328|NCT00320762|Glaucoma|glaucoma
684329|NCT00320762|Pterygium|pterygium
684330|NCT00320762|collagen matrix|collagen matrix
684331|NCT00320762|OculusGen|oculusgen
684332|NCT00320762|trabeculectomy|trabeculectomy
684333|NCT00320762|Anti scarring|anti scarring
684334|NCT00320762|pterygium recurrence|pterygium recurrence
684335|NCT00320762|tissue engineering|tissue engineering
684336|NCT00320762|Aeon Astron|aeon astron
684337|NCT00320749|Advanced Pancreatic Cancer|advanced pancreatic cancer
684338|NCT00320736|schizophrenia|schizophrenia
684339|NCT00320736|cognitive function|cognitive function
684340|NCT00320736|cholinergic medication|cholinergic medication
684341|NCT00320736|nicotinic receptor agonist|nicotinic receptor agonist
684342|NCT00320723|schizophrenia|schizophrenia
684343|NCT00320723|smoking cessation|smoking cessation
684344|NCT00320723|nicotine|nicotine
684345|NCT00320723|patch|patch
684346|NCT00320723|bupropion|bupropion
684347|NCT00320723|nicotine replacement therapy|nicotine replacement therapy
684348|NCT00320723|cognitive behavioral therapy|cognitive behavioral therapy
684349|NCT00320710|Breast cancer|breast cancer
684350|NCT00320710|zoledronic acid|zoledronic acid
684351|NCT00320710|bone metastases|bone metastases
684352|NCT00320697|schizophrenia|schizophrenia
684353|NCT00320697|smoking cessation|smoking cessation
684354|NCT00320697|relapse prevention|relapse prevention
684355|NCT00320697|nicotine|nicotine
684356|NCT00320697|bupropion|bupropion
684357|NCT00320697|cognitive behavioral therapy|cognitive behavioral therapy
684358|NCT00320697|nicotine replacement therapy|nicotine replacement therapy
684359|NCT00320684|Serotonin Transporter|serotonin transporter
684360|NCT00320684|Positron-Emission Tomography|positron-emission tomography
684361|NCT00320671|First-episode|first-episode
684362|NCT00320671|Schizoaffective Disorder|schizoaffective disorder
684363|NCT00320671|Schizophreniform Disorder|schizophreniform disorder
684364|NCT00320671|Psychotic Disorder Not Otherwise Specified NOS|psychotic disorder not otherwise specified nos
684365|NCT00320671|Aripiprazole|aripiprazole
684366|NCT00320671|Clozapine|clozapine
684367|NCT00320671|Risperidone|risperidone
684368|NCT00320658|Plasmodium falciparum|plasmodium falciparum
684369|NCT00320632|Major Depressive Disorder|major depressive disorder
684370|NCT00320632|MDD|mdd
684371|NCT00320619|Aminocaproic Acids|aminocaproic acids
684372|NCT00320619|Blood Transfusion|blood transfusion
684373|NCT00320606|allograft function|allograft function
684374|NCT00320606|anti-rejection|anti-rejection
684375|NCT00320606|immunosuppression withdrawal|immunosuppression withdrawal
684376|NCT00320606|liver transplant|liver transplant
684377|NCT00320606|liver transplantation|liver transplantation
684378|NCT00320606|living donor transplant|living donor transplant
684379|NCT00320593|Myopia|myopia
684380|NCT00320593|Progressive Addition Lenses (PALs)|progressive addition lenses (pals)
684381|NCT00320593|Single Vision Lenses (SVLs)|single vision lenses (svls)
684382|NCT00320593|Accommodative lags|accommodative lags
684383|NCT00320593|Near esophoria|near esophoria
684384|NCT00320593|Refractive error|refractive error
684385|NCT00320580|Metrorrhagia|metrorrhagia
684386|NCT00320580|oral contraception|oral contraception
684387|NCT00320580|breakthrough bleeding|breakthrough bleeding
684388|NCT00320580|spotting|spotting
684389|NCT00320567|osteoporosis|osteoporosis
684390|NCT00320567|anorexia nervosa|anorexia nervosa
684391|NCT00320567|pediatric|pediatric
684392|NCT00320541|Breast Cancer|breast cancer
684393|NCT00320541|Cancer of Breast|cancer of breast
684394|NCT00320541|Cancer of the breast|cancer of the breast
684395|NCT00320541|Breast Neoplasms|breast neoplasms
684396|NCT00320476|Multiple myeloma|multiple myeloma
684397|NCT00320450|SB-681323|sb-681323
684398|NCT00320450|CRP|crp
684399|NCT00320450|Rheumatoid Arthritis SB-681323 CRP RA|rheumatoid arthritis sb-681323 crp ra
684400|NCT00320450|Rheumatoid Arthritis|rheumatoid arthritis
684401|NCT00320450|RA|ra
684402|NCT00320437|trauma|trauma
684403|NCT00320437|anxiety|anxiety
684404|NCT00320437|antenatal|antenatal
684405|NCT00320437|mothers|mothers
684406|NCT00320437|children|children
684407|NCT00320437|Gene x Environment Interaction|gene x environment interaction
684408|NCT00320424|Xa factor|xa factor
684409|NCT00320424|VTE|vte
684410|NCT00320424|MOSLL|mosll
684411|NCT00320424|pentasaccharide|pentasaccharide
684412|NCT00320411|Stage IV breast cancer|stage iv breast cancer
684413|NCT00320411|Herceptin|herceptin
684414|NCT00320411|metastatic breast cancer|metastatic breast cancer
684415|NCT00320411|ErbB1|erbb1
684416|NCT00320411|ErbB2|erbb2
684417|NCT00320411|trastuzumab|trastuzumab
684418|NCT00320411|lapatinib|lapatinib
684419|NCT00320398|Fondaparinux|fondaparinux
684420|NCT00320398|Hip Replacement Arthroplasty|hip replacement arthroplasty
684421|NCT00320398|VTE|vte
684422|NCT00320398|THR|thr
684423|NCT00320398|MOSLL|mosll
684424|NCT00320398|pentasaccharide|pentasaccharide
684425|NCT00320398|Xa factor|xa factor
684426|NCT00320385|lapatinib|lapatinib
684427|NCT00320385|GW572016|gw572016
684428|NCT00320385|ErbB2|erbb2
684429|NCT00320385|EGFR|egfr
684430|NCT00320385|ErbB1|erbb1
684431|NCT00320385|MBC|mbc
684432|NCT00320385|FISH amplification|fish amplification
684433|NCT00320385|Metastatic Breast Cancer|metastatic breast cancer
684434|NCT00320385|dual tyrosine kinase inhibitor|dual tyrosine kinase inhibitor
684435|NCT00320385|Her-2/neu|her-2/neu
684436|NCT00320372|Major Depressive Disorder|major depressive disorder
684437|NCT00320372|Treatment-resistant Depression|treatment-resistant depression
684438|NCT00320359|First-line Cisplatin|first-line cisplatin
684439|NCT00320359|Small Cell Lung Cancer|small cell lung cancer
684440|NCT00320359|topotecan|topotecan
684441|NCT00320359|etoposide|etoposide
684442|NCT00320359|Extensive Disease|extensive disease
684443|NCT00320346|Pandemic|pandemic
684444|NCT00320346|Influenza|influenza
684445|NCT00320346|Prevention|prevention
684446|NCT00320346|Vaccine|vaccine
684447|NCT00320346|Prevention of Pandemic Influenza|prevention of pandemic influenza
684448|NCT00320333|COPD|copd
684449|NCT00320333|rehabilitation|rehabilitation
684450|NCT00320333|health services research|health services research
684451|NCT00320320|No prior chemotherapy|no prior chemotherapy
684452|NCT00320307|Human Immunodeficiency Virus|human immunodeficiency virus
684453|NCT00320307|HIV|hiv
684454|NCT00320307|Abacavir regime|abacavir regime
684455|NCT00320307|ABC|abc
684456|NCT00320281|Botox|botox
684457|NCT00320268|MDD|mdd
684458|NCT00320268|Quetiapine fumarate, sustained release|quetiapine fumarate, sustained release
684459|NCT00320268|Depression|depression
684460|NCT00320255|anticoagulant|anticoagulant
684461|NCT00320242|Parkinson's disease|parkinson's disease
684462|NCT00320242|laser cane|laser cane
684463|NCT00320242|freezing of gait|freezing of gait
684464|NCT00320242|visual cues|visual cues
684465|NCT00320229|angioplasty|angioplasty
684466|NCT00320229|stent|stent
684467|NCT00320229|abciximab|abciximab
684468|NCT00320229|Platelet Glycoprotein GPIIb-IIIa Complex|platelet glycoprotein gpiib-iiia complex
684469|NCT00320229|myocardial infarction|myocardial infarction
684470|NCT00320216|Psoriasis|psoriasis
684471|NCT00320216|CNTO 1275|cnto 1275
684472|NCT00320216|Ustekinumab|ustekinumab
684473|NCT00320216|Stelara|stelara
684474|NCT00320216|Interleukin-12|interleukin-12
684475|NCT00320216|IL-12|il-12
684476|NCT00320216|Interleukin-23|interleukin-23
684477|NCT00320216|IL-23|il-23
684478|NCT00320203|open-angle|open-angle
684479|NCT00320203|glaucoma|glaucoma
684480|NCT00320190|Chronic phase CML, with a suboptimal response after treatment with imatinib|chronic phase cml, with a suboptimal response after treatment with imatinib
684481|NCT00320177|Binge Eating|binge eating
684482|NCT00320177|Food Intake|food intake
684483|NCT00320177|Obesity|obesity
684484|NCT00320177|Melanocortin-4 Receptor Gene|melanocortin-4 receptor gene
684485|NCT00320177|Child|child
684486|NCT00320177|Macronutrient Composition|macronutrient composition
684487|NCT00320164|Healthy Volunteers|healthy volunteers
684488|NCT00320151|chronic lung disease|chronic lung disease
684489|NCT00320138|PTSD|ptsd
684490|NCT00320138|Posttraumatic Stress|posttraumatic stress
684491|NCT00320138|Acupuncture|acupuncture
684492|NCT00320138|Randomized Controlled Trial|randomized controlled trial
684493|NCT00320138|Complementary medicine|complementary medicine
684494|NCT00320138|Alternative medicine|alternative medicine
684495|NCT00320138|Chinese medicine|chinese medicine
684496|NCT00320138|military healthcare|military healthcare
684497|NCT00320125|Dairy|dairy
684498|NCT00320125|Calcium|calcium
684499|NCT00320125|Pregnancy|pregnancy
684500|NCT00320125|Fetus|fetus
684501|NCT00320125|Bone mineralization|bone mineralization
684502|NCT00320112|telemedicine|telemedicine
684503|NCT00320112|case management|case management
684504|NCT00320112|insulin|insulin
684505|NCT00320112|self-care|self-care
684506|NCT00320099|septic shock|septic shock
684507|NCT00320099|adrenal insufficiency|adrenal insufficiency
684508|NCT00320099|glucose control|glucose control
684509|NCT00320099|mineralocorticoids|mineralocorticoids
684510|NCT00320073|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
684511|NCT00320060|Diabetic nephropathy|diabetic nephropathy
684512|NCT00320060|Advanced Glycation Endproduct Inhibitor|advanced glycation endproduct inhibitor
684513|NCT00320060|Pyridorin|pyridorin
684514|NCT00320060|Pyridoxamine|pyridoxamine
684515|NCT00320047|Binge Eating Disorder|binge eating disorder
684516|NCT00320034|levalbuterol|levalbuterol
684517|NCT00320034|asthma|asthma
684518|NCT00320034|allergen provocation|allergen provocation
684519|NCT00320034|airway inflammation|airway inflammation
684520|NCT00320034|clinical trial|clinical trial
684521|NCT00320021|Diabetic nephropathy|diabetic nephropathy
684522|NCT00320021|Advanced Glycation Endproduct Inhibitor|advanced glycation endproduct inhibitor
684523|NCT00320021|Pyridorin|pyridorin
684524|NCT00320021|Pyridoxamine|pyridoxamine
684525|NCT00319982|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
684526|NCT00319982|Left ventricular hypertrophy|left ventricular hypertrophy
684527|NCT00319982|Diltiazem|diltiazem
684528|NCT00319969|small cell lung cancer|small cell lung cancer
684529|NCT00319969|amrubicin|amrubicin
684530|NCT00319956|premature infant|premature infant
684531|NCT00319956|respiratory distress syndrome|respiratory distress syndrome
684532|NCT00319956|mechanical ventilation|mechanical ventilation
684533|NCT00319943|Cognitive remediation|cognitive remediation
684534|NCT00319943|Cognitive impairment|cognitive impairment
684535|NCT00319943|computer|computer
684536|NCT00319943|training|training
684537|NCT00319930|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
684538|NCT00319930|CLL|cll
684539|NCT00319930|ZAP-70|zap-70
684540|NCT00319930|Hsp90 inhibitor|hsp90 inhibitor
684541|NCT00319917|Tacrolimus|tacrolimus
684542|NCT00319917|Rheumatoid Arthritis|rheumatoid arthritis
684543|NCT00319917|Tacrolimus anhydrous|tacrolimus anhydrous
684544|NCT00319904|Schizophrenia|schizophrenia
684545|NCT00319904|DNA|dna
684546|NCT00319891|Alzheimer's|alzheimer's
684547|NCT00319891|AD|ad
684548|NCT00319891|Mild Cognitive Impairment|mild cognitive impairment
684549|NCT00319891|Dementia|dementia
684550|NCT00319891|Cognitive remediation|cognitive remediation
684551|NCT00319891|computer-based training|computer-based training
684552|NCT00319865|Multiple Myeloma Relapsed|multiple myeloma relapsed
684553|NCT00319852|Diphteria;|diphteria;
684554|NCT00319852|Tetanus;|tetanus;
684555|NCT00319852|Pertussis;|pertussis;
684556|NCT00319852|Poliomyelitis;|poliomyelitis;
684557|NCT00319852|acellular|acellular
684558|NCT00319839|Head cancer|head cancer
684559|NCT00319839|Neck cancer|neck cancer
684560|NCT00319839|cetuximab|cetuximab
684561|NCT00319839|abraxane|abraxane
684562|NCT00319839|erbitux|erbitux
684563|NCT00319839|IMC-225|imc-225
684564|NCT00319839|NSC-714692|nsc-714692
684565|NCT00319826|Staphylococcus aureus, S. aureus, bacteremia, sepsis|staphylococcus aureus, s. aureus, bacteremia, sepsis
684566|NCT00319774|End-stage renal disease|end-stage renal disease
684567|NCT00319774|Hemodialysis|hemodialysis
684568|NCT00319774|Hypertension|hypertension
684569|NCT00319774|Hypotension|hypotension
684570|NCT00319774|Blood volume|blood volume
684571|NCT00319774|Hypervolemia|hypervolemia
684572|NCT00319774|Quality of life|quality of life
684573|NCT00319774|Biofeedback system|biofeedback system
684574|NCT00319761|glomerulonephritis|glomerulonephritis
684575|NCT00319761|proteinuria|proteinuria
684576|NCT00319761|chronic kidney diseases|chronic kidney diseases
684577|NCT00319748|Breast|breast
684578|NCT00319748|Ovarian|ovarian
684579|NCT00319748|Endometrial|endometrial
684580|NCT00319748|Cervical|cervical
684581|NCT00319748|Metastatic|metastatic
684582|NCT00319748|852A|852a
684583|NCT00319748|IRM|irm
684584|NCT00319748|Oncology|oncology
684585|NCT00319748|Metastatic Cervical Cancer|metastatic cervical cancer
684586|NCT00319748|Metastatic Ovarian Cancer|metastatic ovarian cancer
684587|NCT00319748|Metastatic Breast Cancer|metastatic breast cancer
684588|NCT00319748|Metastatic Endometrial Cancer|metastatic endometrial cancer
684589|NCT00319722|autism|autism
684590|NCT00319722|pervasive developmental disorder|pervasive developmental disorder
684591|NCT00319722|evoked potentials|evoked potentials
684592|NCT00319722|EEG|eeg
684593|NCT00319722|Coherence|coherence
684594|NCT00319709|depression|depression
684595|NCT00319709|antidepressive agents|antidepressive agents
684596|NCT00319709|controlled clinical trial|controlled clinical trial
684597|NCT00319696|systemic sclerosis|systemic sclerosis
684598|NCT00319696|digital ulcers|digital ulcers
684599|NCT00319696|bosentan|bosentan
684600|NCT00319696|open label|open label
684601|NCT00319696|finger ulcers|finger ulcers
684602|NCT00319683|Cancer|cancer
684603|NCT00319683|Tumors|tumors
684605|NCT00319683|Anticarcinogenic Agents|anticarcinogenic agents
684606|NCT00319683|Antineoplastic Agents|antineoplastic agents
684607|NCT00319683|Dihydrouracil Dehydrogenase (NADP)|dihydrouracil dehydrogenase (nadp)
684608|NCT00319670|constipation|constipation
684609|NCT00319670|pediatric|pediatric
684610|NCT00319657|Kidney Transplantation|kidney transplantation
684611|NCT00319657|Blood Stem Cell Transplantation|blood stem cell transplantation
684612|NCT00319631|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
684613|NCT00319605|Cross sectional study|cross sectional study
684614|NCT00319605|acceptability|acceptability
684615|NCT00319605|levetiracetam|levetiracetam
684616|NCT00319605|oral solution|oral solution
684617|NCT00319605|Keppra|keppra
684618|NCT00319592|Japanese encephalitis|japanese encephalitis
684619|NCT00319592|ChimeriVax™-JE|chimerivax™-je
684620|NCT00319592|JE-VAX®|je-vax®
684621|NCT00319579|living kidney donors|living kidney donors
684622|NCT00319579|prospective|prospective
684623|NCT00319579|medical|medical
684624|NCT00319579|psychosocial|psychosocial
684625|NCT00319566|Coronary Heart Disease|coronary heart disease
684626|NCT00319566|Hormone replacement therapy|hormone replacement therapy
684627|NCT00319566|Estrogen|estrogen
684628|NCT00319566|Postmenopausal women|postmenopausal women
684629|NCT00319553|Tetanus|tetanus
684630|NCT00319553|diphtheria|diphtheria
684631|NCT00319553|acellular pertussis|acellular pertussis
684632|NCT00319540|Depression|depression
684633|NCT00319540|psychoeducation|psychoeducation
684634|NCT00319540|RCT|rct
684635|NCT00319540|primary health services|primary health services
684636|NCT00319527|long term outcome|long term outcome
684637|NCT00319527|living kidney donor|living kidney donor
684638|NCT00319501|Acute Repetitive Seizures|acute repetitive seizures
684639|NCT00319501|ARS|ars
684640|NCT00319501|Diazepam|diazepam
684641|NCT00319501|Cluster Seizures|cluster seizures
684642|NCT00319488|Wheezing|wheezing
684643|NCT00319488|Respiratory Tract Illness|respiratory tract illness
684644|NCT00319462|point A, cervical cancer, radiotherapy|point a, cervical cancer, radiotherapy
684645|NCT00319436|parenting intervention|parenting intervention
684646|NCT00319436|family intervention|family intervention
684647|NCT00319436|maternal substance abuse|maternal substance abuse
684648|NCT00319436|mother-child relations|mother-child relations
684649|NCT00319436|parent-child relations|parent-child relations
684650|NCT00319423|Hip Osteoarthritis, Exercise therapy, Patient Education|hip osteoarthritis, exercise therapy, patient education
684651|NCT00319410|Menorrhagia|menorrhagia
684652|NCT00319410|intrauterine diagnosis|intrauterine diagnosis
684653|NCT00319410|visual analogue scale|visual analogue scale
684654|NCT00319397|vascular resistance|vascular resistance
684655|NCT00319397|vasomotion|vasomotion
684656|NCT00319397|coronary disorder|coronary disorder
684657|NCT00319397|hemodynamics|hemodynamics
684658|NCT00319397|physical fitness|physical fitness
684659|NCT00319384|congestive heart failure|congestive heart failure
684660|NCT00319384|heart failure|heart failure
684661|NCT00319384|ultrafiltration therapy|ultrafiltration therapy
684662|NCT00319384|fluid overload|fluid overload
684663|NCT00319371|vasospasm|vasospasm
684664|NCT00319371|circadian|circadian
684665|NCT00319371|sleep-disorders|sleep-disorders
684666|NCT00319358|chronic pancreatitis|chronic pancreatitis
684667|NCT00319358|antioxidant supplementation|antioxidant supplementation
684668|NCT00319358|oxidative stress|oxidative stress
684669|NCT00319345|Traumatic brain injury|traumatic brain injury
684670|NCT00319345|Intracranial pressure|intracranial pressure
684671|NCT00319345|Osmotherapy|osmotherapy
684672|NCT00319345|Glasgow outcome score|glasgow outcome score
684673|NCT00319345|Mannitol|mannitol
684674|NCT00319345|Sodium-Lactate|sodium-lactate
684675|NCT00319332|non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
684676|NCT00319332|follicular lymphoma|follicular lymphoma
684677|NCT00319332|BEXXAR|bexxar
684678|NCT00319332|ZEVALIN|zevalin
684798|NCT00318812|Ferritin|ferritin
684679|NCT00319332|Iodine I 131 Tositumomab|iodine i 131 tositumomab
684680|NCT00319332|Ibritumomab Tiuxetan|ibritumomab tiuxetan
684681|NCT00319332|Follicular, mixed small-cleaved and large-cell|follicular, mixed small-cleaved and large-cell
684682|NCT00319332|Diffuse large cell non-Hodgkin's lymphoma following or concurrent with a diagnosis of follicular lymphoma|diffuse large cell non-hodgkin's lymphoma following or concurrent with a diagnosis of follicular lymphoma
684683|NCT00319319|major depressive disorder,|major depressive disorder,
684684|NCT00319319|serotonin selective reuptake inhibitor,|serotonin selective reuptake inhibitor,
684685|NCT00319319|mecamylamine,|mecamylamine,
684686|NCT00319319|controlled trial,|controlled trial,
684687|NCT00319319|cigarette smoking|cigarette smoking
684688|NCT00319306|Respiratory Tract Diseases|respiratory tract diseases
684689|NCT00319306|Bronchial Diseases|bronchial diseases
684690|NCT00319306|Anti-asthmatic agents|anti-asthmatic agents
684691|NCT00319306|Anti-asthmatic drugs|anti-asthmatic drugs
684692|NCT00319306|Bronchodilators|bronchodilators
684693|NCT00319280|Osteoarthritis, Knee|osteoarthritis, knee
684694|NCT00319280|Osteotomy|osteotomy
684695|NCT00319280|Healing|healing
684696|NCT00319280|Roentgen Stereometric Analysis|roentgen stereometric analysis
684697|NCT00319267|bosentan|bosentan
684699|NCT00319267|pharmacokinetics|pharmacokinetics
684700|NCT00319267|pulmonary arterial hypertension|pulmonary arterial hypertension
684701|NCT00319254|Advanced Breast Cancer|advanced breast cancer
684702|NCT00319241|parenting intervention|parenting intervention
684703|NCT00319241|substance abuse treatment|substance abuse treatment
684704|NCT00319241|mother-child relations|mother-child relations
684705|NCT00319241|parent-child relations|parent-child relations
684706|NCT00319241|child abuse and neglect|child abuse and neglect
684707|NCT00319228|AT-III deficiency|at-iii deficiency
684708|NCT00319228|AT-III concentrate|at-iii concentrate
684709|NCT00319228|Bleeding disorders|bleeding disorders
684710|NCT00319228|Blood disorders|blood disorders
684711|NCT00319215|ramelteon|ramelteon
684712|NCT00319215|zopiclone|zopiclone
684713|NCT00319215|driving|driving
684714|NCT00319215|memory|memory
684715|NCT00319215|balance|balance
684716|NCT00319215|psychomotor|psychomotor
684717|NCT00319202|Impaired fasting glucose|impaired fasting glucose
684718|NCT00319202|Abdominal obesity|abdominal obesity
684719|NCT00319202|HOMA|homa
684720|NCT00319202|Angiotensin-receptor blocker|angiotensin-receptor blocker
684721|NCT00319189|Nateglinide|nateglinide
684722|NCT00319189|Renal|renal
684723|NCT00319189|Kidney|kidney
684724|NCT00319189|Transplantation|transplantation
684725|NCT00319189|Diabets|diabets
684726|NCT00319189|Glucose|glucose
684727|NCT00319176|Pregnancy|pregnancy
684728|NCT00319176|Enoxaparin|enoxaparin
684729|NCT00319176|Anticoagulation|anticoagulation
684730|NCT00319163|oral contraceptive|oral contraceptive
684731|NCT00319163|therapeutic equivalency|therapeutic equivalency
684732|NCT00319163|contraceptives, oral, combined|contraceptives, oral, combined
684733|NCT00319150|Erythropoetin resistance|erythropoetin resistance
684734|NCT00319150|End Stage Renal Disease on hemodialysis|end stage renal disease on hemodialysis
684735|NCT00319137|GW274150|gw274150
684736|NCT00319137|Nitric Oxide|nitric oxide
684737|NCT00319137|acute migraine|acute migraine
684738|NCT00319124|Hip Osteoarthritis, muscle strength, range of motion, aerobic capacity, functional capacity, health-related quality of life|hip osteoarthritis, muscle strength, range of motion, aerobic capacity, functional capacity, health-related quality of life
684739|NCT00319111|pulmonary hypertension|pulmonary hypertension
684740|NCT00319111|bosentan|bosentan
684741|NCT00319111|BENEFIT|benefit
684742|NCT00319111|CTEPH|cteph
684743|NCT00319111|inoperable chronic thromboembolic pulmonary hypertension (CTEPH)|inoperable chronic thromboembolic pulmonary hypertension (cteph)
684744|NCT00319098|Adjuvanted pandemic influenza candidate vaccine|adjuvanted pandemic influenza candidate vaccine
684745|NCT00319098|Influenza|influenza
684746|NCT00319085|Arthroplasty,|arthroplasty,
684747|NCT00319085|Hip,|hip,
684748|NCT00319085|Pre-heating,|pre-heating,
684749|NCT00319085|Radiostereometric analysis,|radiostereometric analysis,
684750|NCT00319085|Dual-Energy Radiographic Absorptiometry,|dual-energy radiographic absorptiometry,
684751|NCT00319046|Type 1 Gaucher Disease|type 1 gaucher disease
684752|NCT00319046|miglustat|miglustat
684753|NCT00319046|enzyme replacement therapy|enzyme replacement therapy
684754|NCT00319033|interstitial lung disease|interstitial lung disease
684755|NCT00319033|scleroderma|scleroderma
684756|NCT00319033|bosentan|bosentan
684757|NCT00319020|bosentan|bosentan
684758|NCT00319020|pulmonary arterial hypertension|pulmonary arterial hypertension
684759|NCT00319020|children|children
684760|NCT00319020|FUTURE 1|future 1
684761|NCT00318981|Medication trial|medication trial
684762|NCT00318981|ADHD|adhd
684763|NCT00318981|Concerta|concerta
684764|NCT00318981|Efficacy trial|efficacy trial
684765|NCT00318968|Acid Reflux|acid reflux
684766|NCT00318968|Nexium|nexium
684767|NCT00318968|Esomeprazole|esomeprazole
684768|NCT00318955|Dexmedetomidine, Sedation, Extubation, Phase 4|dexmedetomidine, sedation, extubation, phase 4
684769|NCT00318942|Sepsis|sepsis
684770|NCT00318942|Multiple Trauma|multiple trauma
684771|NCT00318942|Hypovolemic Shock|hypovolemic shock
684772|NCT00318929|Treatment Efficacy|treatment efficacy
684773|NCT00318929|pharmacokinetics|pharmacokinetics
684774|NCT00318903|Chemotherapy for cancer of the esophagus|chemotherapy for cancer of the esophagus
684775|NCT00318903|Radiotherapy for cancer of the esophagus|radiotherapy for cancer of the esophagus
684776|NCT00318903|Surgery for cancer of the esophagus|surgery for cancer of the esophagus
684777|NCT00318903|Chemotherapy, radiotherapy, surgery for esophageal cancer|chemotherapy, radiotherapy, surgery for esophageal cancer
684778|NCT00318890|Chemotherapy and Radiotherapy for Head and Neck Cancer|chemotherapy and radiotherapy for head and neck cancer
684779|NCT00318890|Chemotherapy, Radiotherapy Squamous Cell Carcinoma Head Neck|chemotherapy, radiotherapy squamous cell carcinoma head neck
684780|NCT00318877|Obesity|obesity
684781|NCT00318877|Physical activity|physical activity
684782|NCT00318864|depression|depression
684783|NCT00318864|cardiovascular risk|cardiovascular risk
684784|NCT00318864|mechanisms|mechanisms
684785|NCT00318851|Carotid Artery stenting|carotid artery stenting
684786|NCT00318851|Stroke|stroke
684787|NCT00318825|Pain|pain
684788|NCT00318825|Colonoscopy|colonoscopy
684789|NCT00318825|Sedation|sedation
684790|NCT00318812|Randomized controlled trial (RCT)|randomized controlled trial (rct)
684791|NCT00318812|Prospective Studies|prospective studies
684792|NCT00318812|ferric oxide, saccharated|ferric oxide, saccharated
684793|NCT00318812|Peptides|peptides
684794|NCT00318812|Heme|heme
684795|NCT00318812|Iron|iron
684796|NCT00318812|Erythropoietin,|erythropoietin,
684797|NCT00318812|Recombinant|recombinant
684799|NCT00318812|Transferrin|transferrin
684800|NCT00318812|Treatment Outcome|treatment outcome
684801|NCT00318799|prevention of unintended pregnancies|prevention of unintended pregnancies
684802|NCT00318773|PMS|pms
684803|NCT00318773|PMDD|pmdd
684804|NCT00318773|sertraline|sertraline
684805|NCT00318773|antidepressant|antidepressant
684806|NCT00318773|extended treatment|extended treatment
684807|NCT00318773|relapse|relapse
684808|NCT00318760|Drug Cue|drug cue
684809|NCT00318760|Relapse|relapse
684810|NCT00318760|Stress|stress
684811|NCT00318760|Craving|craving
684812|NCT00318747|Amb a 1-Immunostimulatory Oligodeoxyribonucleotide Conjugate|amb a 1-immunostimulatory oligodeoxyribonucleotide conjugate
684813|NCT00318747|AIC|aic
684814|NCT00318747|Amb a I Protein|amb a i protein
684815|NCT00318747|Ragweed Allergy|ragweed allergy
684816|NCT00318747|Hay Fever|hay fever
684817|NCT00318747|Wheeze|wheeze
684818|NCT00318747|Immunotherapy|immunotherapy
684819|NCT00318747|Tolerance|tolerance
684820|NCT00318747|Immunostimulatory|immunostimulatory
684821|NCT00318747|Ragweed Season|ragweed season
684822|NCT00318747|Asthma|asthma
684823|NCT00318747|Asthmatics|asthmatics
684824|NCT00318747|Asthmatic|asthmatic
684825|NCT00318721|Leishmania donovani|leishmania donovani
684826|NCT00318721|cluster-randomised control trial|cluster-randomised control trial
684827|NCT00318721|Long Lasting Impregnated Nets|long lasting impregnated nets
684828|NCT00318721|Bednets|bednets
684829|NCT00318721|Sandflies|sandflies
684830|NCT00318695|Probiotics|probiotics
684831|NCT00318695|Eczema|eczema
684832|NCT00318695|Asthma|asthma
684833|NCT00318695|Allergic Rhinitis|allergic rhinitis
684834|NCT00318695|Prevention|prevention
684835|NCT00318695|Immunological responses|immunological responses
684836|NCT00318682|biopsy|biopsy
684837|NCT00318682|FIBROSCAN|fibroscan
684838|NCT00318669|Anxiety|anxiety
684839|NCT00318669|SAD|sad
684840|NCT00318669|Social|social
684841|NCT00318669|Disorder|disorder
684842|NCT00318656|type 2 diabetes|type 2 diabetes
684843|NCT00318656|rosiglitazone|rosiglitazone
684844|NCT00318656|metformin|metformin
684845|NCT00318656|glimepiride|glimepiride
684846|NCT00318656|glycemia|glycemia
684847|NCT00318643|Non-invasive bladder cancer|non-invasive bladder cancer
684848|NCT00318643|Chemophase|chemophase
684849|NCT00318643|Intravesical administration|intravesical administration
684850|NCT00318643|Superficial Bladder Cancer|superficial bladder cancer
684851|NCT00318630|Asthma AVANDIA Inflammation|asthma avandia inflammation
684852|NCT00318617|peroxisome proliferator activated receptors,|peroxisome proliferator activated receptors,
684853|NCT00318617|PPARs,|ppars,
684854|NCT00318617|Heart Failure,|heart failure,
684855|NCT00318617|cardiac energetics,|cardiac energetics,
684856|NCT00318617|MRI,|mri,
684857|NCT00318617|GW501516X|gw501516x
684858|NCT00318617|fatty acid metabolism,|fatty acid metabolism,
684859|NCT00318604|plasma circulating DNA|plasma circulating dna
684860|NCT00318604|hean and neck cancers|hean and neck cancers
684861|NCT00318604|esophageal cancer|esophageal cancer
684862|NCT00318604|localized head and neck cancers|localized head and neck cancers
684863|NCT00318604|localized esophageal cancer|localized esophageal cancer
684864|NCT00318578|convulsive status epilepticus|convulsive status epilepticus
684865|NCT00318578|outcome|outcome
684866|NCT00318578|prognosis factors|prognosis factors
684867|NCT00318578|seizure duration|seizure duration
684868|NCT00318578|adult|adult
684869|NCT00318578|electroencephalogram|electroencephalogram
684870|NCT00318578|intensive care unit|intensive care unit
684871|NCT00318565|Heart Disease|heart disease
684872|NCT00318565|Atrial Flutter|atrial flutter
684873|NCT00318565|Typical Atrial Flutter|typical atrial flutter
684874|NCT00318552|Antibiotic Therapy|antibiotic therapy
684875|NCT00318552|sepsis treatment|sepsis treatment
684876|NCT00318552|Meropenem|meropenem
684877|NCT00318539|Obsessive Compulsive Disorder|obsessive compulsive disorder
684878|NCT00318513|breast cancer|breast cancer
684879|NCT00318513|lymphedema|lymphedema
684880|NCT00318513|extremity|extremity
684881|NCT00318513|women|women
684882|NCT00318500|Endometriosis|endometriosis
684883|NCT00318500|Dysmenorrhea|dysmenorrhea
684884|NCT00318500|Pelvic pain|pelvic pain
684885|NCT00318500|Dyspareunia|dyspareunia
684886|NCT00318487|Dental implants|dental implants
684887|NCT00318474|Proteinuria|proteinuria
684888|NCT00318474|Immunoglobulin A|immunoglobulin a
684889|NCT00318448|Child Psychology|child psychology
684890|NCT00318448|Pediatric Psychology|pediatric psychology
684891|NCT00318448|Insomnia|insomnia
684892|NCT00318448|Sleeplessness|sleeplessness
684893|NCT00318409|Methamphetamine|methamphetamine
684894|NCT00318409|HIV|hiv
684895|NCT00318396|THA|tha
684896|NCT00318383|Vaccine|vaccine
684897|NCT00318383|Immunogenicity|immunogenicity
684898|NCT00318383|Randomized Controlled Trial|randomized controlled trial
684899|NCT00318370|Ovarian Cancer|ovarian cancer
684900|NCT00318370|Primary Fallopian Tube Cancer|primary fallopian tube cancer
684901|NCT00318370|Peritoneal Cancer|peritoneal cancer
684902|NCT00318357|Cardiac Resynchronization therapy (CRT)|cardiac resynchronization therapy (crt)
684903|NCT00318357|All-cause mortality|all-cause mortality
684904|NCT00318357|Long-term follow-up|long-term follow-up
684905|NCT00318331|Glutamine|glutamine
684906|NCT00318331|Critical Illness|critical illness
684907|NCT00318331|Enteral Feeding|enteral feeding
684908|NCT00318331|Blood Volume Analysis|blood volume analysis
684909|NCT00318318|Premarin,|premarin,
684910|NCT00318318|HRT,|hrt,
684911|NCT00318318|RNA,|rna,
684912|NCT00318318|Gene Expression.|gene expression.
684913|NCT00318318|Postmenopausal Women|postmenopausal women
684914|NCT00318292|preemptive analgesia|preemptive analgesia
684915|NCT00318292|paracervical block|paracervical block
684916|NCT00318292|vaginal hysterectomy|vaginal hysterectomy
684917|NCT00318279|Surgical education|surgical education
684918|NCT00318279|Vascular anastomosis|vascular anastomosis
684919|NCT00318279|Simulator|simulator
684920|NCT00318279|Randomized controlled trial|randomized controlled trial
684921|NCT00318266|Detection of Bladder Cancer using NMP22 Urine Test Kit|detection of bladder cancer using nmp22 urine test kit
684922|NCT00318253|Cranberry juice|cranberry juice
684923|NCT00318253|Antiadhesion|antiadhesion
684924|NCT00318253|Urinary tract infection|urinary tract infection
684925|NCT00318253|vaginosis|vaginosis
684926|NCT00318240|High Intensity Focused Ultrasound|high intensity focused ultrasound
684927|NCT00318240|Men|men
684928|NCT00318240|Locally recurrent prostate cancer.|locally recurrent prostate cancer.
684929|NCT00318227|Postoperative care|postoperative care
684930|NCT00318227|Cardiac Surgery|cardiac surgery
684931|NCT00318227|Blood Transfusion|blood transfusion
684932|NCT00318214|toe ulcer|toe ulcer
684933|NCT00318214|heel ulcer|heel ulcer
684934|NCT00318214|foot ulcer|foot ulcer
684935|NCT00318214|diabetic feet|diabetic feet
684936|NCT00318214|diabetic foot|diabetic foot
684937|NCT00318214|complications of diabetes|complications of diabetes
684938|NCT00318201|Healthy Subjects|healthy subjects
684939|NCT00318188|scleroderma|scleroderma
684940|NCT00318188|HAQ|haq
684941|NCT00318188|Intensive care reeducation, readaptation|intensive care reeducation, readaptation
684942|NCT00318175|Systemic Scleroderma|systemic scleroderma
684943|NCT00318175|Dermal Sclerosis|dermal sclerosis
684944|NCT00318175|Bosentan|bosentan
684945|NCT00318175|Endothelin Receptor Antagonist|endothelin receptor antagonist
684946|NCT00318175|Rodnan Skin Score|rodnan skin score
684947|NCT00318162|autism|autism
684948|NCT00318162|PDD|pdd
684949|NCT00318162|LDN|ldn
684950|NCT00318162|naltrexone|naltrexone
684951|NCT00318136|BRIDGE|bridge
684952|NCT00318136|NSCLC|nsclc
684953|NCT00318136|Lung Cancer|lung cancer
684954|NCT00318136|Avastin|avastin
684955|NCT00318123|Simplification therapy|simplification therapy
684956|NCT00318123|Efficacy|efficacy
684957|NCT00318123|Safety|safety
684958|NCT00318123|Virological effectiveness|virological effectiveness
684959|NCT00318123|Immunological effectiveness|immunological effectiveness
684960|NCT00318123|HIV|hiv
684961|NCT00318110|Metastatic|metastatic
684962|NCT00318110|Renal|renal
684963|NCT00318110|Cell|cell
684964|NCT00318110|Carcinoma|carcinoma
684965|NCT00318110|Unrelated|unrelated
684966|NCT00318110|Donor|donor
684967|NCT00318110|Transplant|transplant
684968|NCT00318110|stage IV|stage iv
684969|NCT00318110|clear cell|clear cell
684970|NCT00318097|McCune Albright Syndrome|mccune albright syndrome
684971|NCT00318097|Histamine regulation|histamine regulation
684972|NCT00318084|Gastroesophageal reflux disease|gastroesophageal reflux disease
684973|NCT00318084|Heartburn|heartburn
684974|NCT00318084|Acid-related diseases|acid-related diseases
684975|NCT00318084|Acid reflux disease|acid reflux disease
684976|NCT00318084|Nexium|nexium
684977|NCT00318071|Stroke|stroke
684978|NCT00318071|Ischemic|ischemic
684979|NCT00318071|Thrombus|thrombus
684980|NCT00318071|Embolectomy|embolectomy
684981|NCT00318071|Thrombectomy|thrombectomy
684982|NCT00318071|Merci|merci
684983|NCT00318071|Concentric|concentric
684984|NCT00318071|Embolus|embolus
684985|NCT00318071|Embolism|embolism
684986|NCT00318071|Mechanical|mechanical
684987|NCT00318045|Refractive error|refractive error
684988|NCT00318045|Asthenopia|asthenopia
684989|NCT00318032|Randomised control trial|randomised control trial
684990|NCT00318032|Screening|screening
684991|NCT00318032|Intensive management|intensive management
684992|NCT00318032|Diabetes mellitus|diabetes mellitus
684993|NCT00318032|Type 2 diabetes|type 2 diabetes
684994|NCT00318019|Energy|energy
684995|NCT00318019|Energy Level|energy level
684996|NCT00318006|chronic|chronic
684997|NCT00318006|nasal|nasal
684998|NCT00318006|sinus|sinus
684999|NCT00318006|symptoms|symptoms
685000|NCT00317980|Cutaneous leishmaniasis|cutaneous leishmaniasis
685001|NCT00317980|Leishmania braziliensis|leishmania braziliensis
685002|NCT00317980|Pentavalent antimony|pentavalent antimony
685003|NCT00317980|Meglumine antimoniate|meglumine antimoniate
685004|NCT00317967|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
685005|NCT00317967|Statin therapy|statin therapy
685006|NCT00317967|Regression|regression
685007|NCT00317967|Heart failure|heart failure
685008|NCT00317967|Arrhythmias|arrhythmias
685009|NCT00317967|Sudden cardiac death|sudden cardiac death
685010|NCT00317954|Diabetic nephropathy|diabetic nephropathy
685011|NCT00317954|Spironolactone|spironolactone
685012|NCT00317954|Aldosterone antagonism|aldosterone antagonism
685013|NCT00317954|Renoprotection|renoprotection
685014|NCT00317941|Multiple Sclerosis|multiple sclerosis
685015|NCT00317941|RRMS|rrms
685016|NCT00317928|Polycystic Ovary Syndrome|polycystic ovary syndrome
685017|NCT00317928|Metformin|metformin
685018|NCT00317928|Metabolic Syndrome|metabolic syndrome
685019|NCT00317928|Hyperandrogenism|hyperandrogenism
685020|NCT00317928|Ovulation|ovulation
685021|NCT00317902|Anemia|anemia
685022|NCT00317902|erythropoetin|erythropoetin
685023|NCT00317902|Epoetin alfa|epoetin alfa
685024|NCT00317902|erythropoetin recombinant|erythropoetin recombinant
685025|NCT00317902|HIV, AIDS|hiv, aids
685026|NCT00317889|THA|tha
685027|NCT00317876|Fanconi anemia|fanconi anemia
685028|NCT00317837|Fracture of Femoral Neck|fracture of femoral neck
685029|NCT00317811|stage I multiple myeloma|stage i multiple myeloma
685030|NCT00317811|stage II multiple myeloma|stage ii multiple myeloma
685031|NCT00317811|stage III multiple myeloma|stage iii multiple myeloma
685032|NCT00317798|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
685033|NCT00317798|stage I multiple myeloma|stage i multiple myeloma
685034|NCT00317798|stage II multiple myeloma|stage ii multiple myeloma
685035|NCT00317798|stage III multiple myeloma|stage iii multiple myeloma
685036|NCT00317798|refractory multiple myeloma|refractory multiple myeloma
685037|NCT00317785|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
685038|NCT00317785|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
685039|NCT00317785|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
685040|NCT00317785|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
685041|NCT00317785|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
685042|NCT00317785|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
685043|NCT00317785|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
685044|NCT00317785|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
685045|NCT00317785|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
685046|NCT00317785|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
685047|NCT00317785|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
685048|NCT00317785|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
685049|NCT00317785|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
685050|NCT00317785|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
685051|NCT00317785|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
685052|NCT00317785|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
685053|NCT00317785|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
685054|NCT00317785|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
685055|NCT00317785|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
685056|NCT00317785|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
685057|NCT00317785|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
685058|NCT00317785|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
685059|NCT00317785|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
685060|NCT00317785|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
685061|NCT00317785|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
685062|NCT00317785|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
685063|NCT00317785|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
685064|NCT00317785|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
685065|NCT00317785|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
685066|NCT00317785|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
685067|NCT00317785|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
685068|NCT00317785|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
685069|NCT00317785|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
685070|NCT00317785|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
685071|NCT00317785|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
685072|NCT00317785|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
685073|NCT00317785|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
685074|NCT00317785|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
685075|NCT00317785|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
685076|NCT00317785|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
685077|NCT00317785|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
685078|NCT00317785|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
685079|NCT00317785|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
685080|NCT00317785|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
685081|NCT00317785|secondary acute myeloid leukemia|secondary acute myeloid leukemia
685082|NCT00317785|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
685083|NCT00317785|splenic marginal zone lymphoma|splenic marginal zone lymphoma
685084|NCT00317785|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
685085|NCT00317785|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
685086|NCT00317785|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
685087|NCT00317785|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
685088|NCT00317785|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
685089|NCT00317785|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
685090|NCT00317785|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
685091|NCT00317785|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
685092|NCT00317785|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
685093|NCT00317785|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
685094|NCT00317785|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
685095|NCT00317785|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
685096|NCT00317785|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
685097|NCT00317785|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
685098|NCT00317785|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
685099|NCT00317785|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
685100|NCT00317785|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
685101|NCT00317785|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
685102|NCT00317785|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
685103|NCT00317785|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
685104|NCT00317785|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
685105|NCT00317785|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
685106|NCT00317785|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
685107|NCT00317785|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
685108|NCT00317785|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
685109|NCT00317785|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
685110|NCT00317772|Epithelial Ovarian Cancer|epithelial ovarian cancer
685111|NCT00317772|Peritoneal Cancer|peritoneal cancer
685112|NCT00317772|Fallopian Tube Cancer|fallopian tube cancer
685113|NCT00317772|Epidermal Growth Factor|epidermal growth factor
685114|NCT00317772|Platinum Hypersensitivity|platinum hypersensitivity
685115|NCT00317772|Hycamtin|hycamtin
685116|NCT00317772|Gefitinib|gefitinib
685117|NCT00317772|Iressa|iressa
685118|NCT00317772|Topotecan|topotecan
685119|NCT00317772|EGFR|egfr
685120|NCT00317759|stage IV melanoma|stage iv melanoma
685121|NCT00317759|recurrent melanoma|recurrent melanoma
685122|NCT00317746|HIV/HCV Co-infection|hiv/hcv co-infection
685123|NCT00317746|Depression|depression
685124|NCT00317746|Citalopram|citalopram
685125|NCT00317733|Ketoprofen|ketoprofen
685126|NCT00317733|Transfersome|transfersome
685127|NCT00317733|Osteoarthritis, Knee|osteoarthritis, knee
685128|NCT00317720|Breast Cancer|breast cancer
685129|NCT00317720|Metastatic Breast Cancer|metastatic breast cancer
685130|NCT00317720|Trastuzumab|trastuzumab
685131|NCT00317720|RAD001|rad001
685132|NCT00317720|Herceptin|herceptin
685133|NCT00317707|cardiovascular risk|cardiovascular risk
685134|NCT00317707|cardiovascular diseases|cardiovascular diseases
685135|NCT00317707|cardiovascular prevention|cardiovascular prevention
685136|NCT00317707|polyunsaturated fatty acids|polyunsaturated fatty acids
685137|NCT00317707|diabetes|diabetes
685138|NCT00317707|hypertension|hypertension
685139|NCT00317707|hypercholesterolemia|hypercholesterolemia
685140|NCT00317707|obesity|obesity
685141|NCT00317694|Hyperphosphatemia|hyperphosphatemia
685142|NCT00317694|Phosphate binder|phosphate binder
685143|NCT00317681|Cutaneous lupus erythematosus|cutaneous lupus erythematosus
685144|NCT00317681|Tacrolimus ointment|tacrolimus ointment
685145|NCT00317681|Topical treatment|topical treatment
685146|NCT00317681|Skin lesions|skin lesions
685147|NCT00317655|back pain|back pain
685148|NCT00317642|acute myelogenous leukemia|acute myelogenous leukemia
685149|NCT00317642|acute myeloid leukemia|acute myeloid leukemia
685150|NCT00317642|relapsed AML|relapsed aml
685151|NCT00317642|refractory AML|refractory aml
685152|NCT00317642|clofarabine|clofarabine
685153|NCT00317642|cytarabine|cytarabine
685154|NCT00317642|CLO341|clo341
685155|NCT00317642|clolar|clolar
685156|NCT00317629|leishmaniasis|leishmaniasis
685157|NCT00317629|nitric oxide|nitric oxide
685158|NCT00317629|treatment|treatment
685159|NCT00317629|donor|donor
685160|NCT00317629|controlled trial|controlled trial
685161|NCT00317616|FALS|fals
685162|NCT00317616|SOD1|sod1
685163|NCT00317616|familial|familial
685164|NCT00317616|genetic testing|genetic testing
685165|NCT00317616|genetic counseling|genetic counseling
685166|NCT00317616|ALS|als
685167|NCT00317616|C9ORF72|c9orf72
685168|NCT00317616|TARDBP|tardbp
685169|NCT00317616|VCP|vcp
685170|NCT00317616|FUS|fus
685171|NCT00317616|PFN1|pfn1
685172|NCT00317603|autologous vaccination|autologous vaccination
685173|NCT00317603|GM-CSF|gm-csf
685174|NCT00317603|adenoviral mediated gene transfer|adenoviral mediated gene transfer
685175|NCT00317603|Stage IV breast cancer|stage iv breast cancer
685176|NCT00317590|Diagnosis|diagnosis
685177|NCT00317590|Rapid Diagnostic Test|rapid diagnostic test
685178|NCT00317590|Management|management
685179|NCT00317590|Attributable Fraction|attributable fraction
685180|NCT00317590|Threshold|threshold
685181|NCT00317577|Low-pressure glaucoma|low-pressure glaucoma
685182|NCT00317577|Normal tension glaucoma|normal tension glaucoma
685183|NCT00317577|Neuroprotection|neuroprotection
685184|NCT00317577|Brimonidine|brimonidine
685185|NCT00317577|Visual field progression|visual field progression
685186|NCT00317564|Birth Defects|birth defects
685187|NCT00317564|High Risk Pregnancy|high risk pregnancy
685188|NCT00317564|Multiple Sclerosis|multiple sclerosis
685189|NCT00317551|Aberration control|aberration control
685190|NCT00317551|Accommodative facility|accommodative facility
685191|NCT00317551|Accommodative response|accommodative response
685192|NCT00317551|Peripheral refraction|peripheral refraction
685193|NCT00317551|Accommodative convergence to accommodation ratio|accommodative convergence to accommodation ratio
685194|NCT00317538|Rheumatoid Arthritis|rheumatoid arthritis
685195|NCT00317538|Switching|switching
685196|NCT00317538|Structural Damage|structural damage
685197|NCT00317538|MRI|mri
685198|NCT00317525|Refractive error|refractive error
685199|NCT00317525|Asthenopia|asthenopia
685200|NCT00317512|Hemoglobin Based Oxygen carrier|hemoglobin based oxygen carrier
685201|NCT00317512|HBOC 201|hboc 201
685202|NCT00317512|Percutaneous Revascularization|percutaneous revascularization
685203|NCT00317512|Percutaneous Coronary Intervention|percutaneous coronary intervention
685204|NCT00317512|Non ST-segment Elevation Myocardial Infarction|non st-segment elevation myocardial infarction
685205|NCT00317512|Tissue Oxygenation|tissue oxygenation
685206|NCT00317512|Transluminal Percutaneous Coronary Angioplasty|transluminal percutaneous coronary angioplasty
685207|NCT00317486|pulmonary arterial hypertension|pulmonary arterial hypertension
685208|NCT00317486|Eisenmenger physiology|eisenmenger physiology
685209|NCT00317486|bosentan|bosentan
685210|NCT00317473|Vaccine|vaccine
685211|NCT00317473|Phase 1|phase 1
685212|NCT00317473|Plasmodium falciparum|plasmodium falciparum
685213|NCT00317473|Malaria|malaria
685214|NCT00317473|Merozoite surface protein-1|merozoite surface protein-1
685215|NCT00317473|MSP-1|msp-1
685216|NCT00317473|Falciparum malaria protein 1|falciparum malaria protein 1
685217|NCT00317473|FMP-1|fmp-1
685218|NCT00317473|AS02A|as02a
685219|NCT00317460|Drug Abuse|drug abuse
685220|NCT00317460|Drug Addiction|drug addiction
685221|NCT00317460|Drug Dependence|drug dependence
685222|NCT00317460|Drug Use Disorders|drug use disorders
685223|NCT00317460|Drug Use Disorder|drug use disorder
685224|NCT00317460|Substance Abuse|substance abuse
685225|NCT00317460|Substance Use Disorder|substance use disorder
685226|NCT00317460|Buprenorphine|buprenorphine
685227|NCT00317460|Opiate Addiction|opiate addiction
685228|NCT00317447|Sciatica|sciatica
685229|NCT00317447|Lower back pain|lower back pain
685230|NCT00317447|Prednisone|prednisone
685231|NCT00317447|Randomized, controlled clinical trial|randomized, controlled clinical trial
685232|NCT00317434|ovarian cancer|ovarian cancer
685233|NCT00317421|Phosphodiesterase 5|phosphodiesterase 5
685234|NCT00317421|Sildenafil|sildenafil
685235|NCT00317421|Hypertension|hypertension
685236|NCT00317421|Blood pressure|blood pressure
685237|NCT00317421|Arterial stiffness|arterial stiffness
685238|NCT00317421|Endothelial function|endothelial function
685239|NCT00317408|anaplastic large cell lymphoma|anaplastic large cell lymphoma
685240|NCT00317408|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
685241|NCT00317408|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
685242|NCT00317408|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
685243|NCT00317395|Non ST elevation Acute Coronary Syndrome|non st elevation acute coronary syndrome
685244|NCT00317395|Early invasive strategy|early invasive strategy
685245|NCT00317395|Percutaneous Coronary Intervention|percutaneous coronary intervention
685246|NCT00317382|lumbar puncture|lumbar puncture
685247|NCT00317382|headache|headache
685248|NCT00317382|traumatic tap|traumatic tap
685249|NCT00317369|OPC-6535|opc-6535
685250|NCT00317369|Crohn's disease|crohn's disease
685251|NCT00317356|OPC-6535|opc-6535
685252|NCT00317356|ulcerative colitis|ulcerative colitis
685349|NCT00316940|refractory multiple myeloma|refractory multiple myeloma
685253|NCT00317343|Patients candidate to a PCI with a planned anticoagulation regime other than unfractionated heparin in monotherapy|patients candidate to a pci with a planned anticoagulation regime other than unfractionated heparin in monotherapy
685254|NCT00317317|IVF|ivf
685255|NCT00317317|Acupuncture|acupuncture
685256|NCT00317317|Pregnant|pregnant
685257|NCT00317304|Hot flashes|hot flashes
685258|NCT00317304|vasomotor symptoms|vasomotor symptoms
685259|NCT00317304|menopause|menopause
685260|NCT00317304|mindfulness based stress reduction|mindfulness based stress reduction
685261|NCT00317304|meditation|meditation
685262|NCT00317291|Acupuncture|acupuncture
685263|NCT00317291|HIV|hiv
685264|NCT00317291|AIDS|aids
685265|NCT00317291|Symptom management|symptom management
685266|NCT00317291|Non-invasive|non-invasive
685267|NCT00317291|Complementary Therapies|complementary therapies
685268|NCT00317291|Treatment Experienced|treatment experienced
685269|NCT00317278|Massage|massage
685270|NCT00317278|immune system|immune system
685271|NCT00317278|preterm infants|preterm infants
685272|NCT00317265|coronary artery disease|coronary artery disease
685273|NCT00317265|coronary bypass surgery|coronary bypass surgery
685274|NCT00317265|complete arterial coronary surgery|complete arterial coronary surgery
685275|NCT00317265|internal mammary artery|internal mammary artery
685276|NCT00317252|contrast induced nephropathy|contrast induced nephropathy
685277|NCT00317252|contrast nephropathy|contrast nephropathy
685278|NCT00317252|contrast media|contrast media
685279|NCT00317252|kidney diseases|kidney diseases
685280|NCT00317252|angiotensin converting enzyme inhibitors|angiotensin converting enzyme inhibitors
685281|NCT00317239|Anemia|anemia
685282|NCT00317239|Chronic Kidney Disease|chronic kidney disease
685283|NCT00317239|Iron|iron
685284|NCT00317226|Anemia|anemia
685285|NCT00317226|CKD|ckd
685286|NCT00317226|Chronic Kidney Disease|chronic kidney disease
685287|NCT00317226|Iron|iron
685288|NCT00317226|Maintenance Dose|maintenance dose
685289|NCT00317213|Smoking|smoking
685290|NCT00317213|Nicotine|nicotine
685291|NCT00317213|Withdrawal|withdrawal
685292|NCT00317213|Phospholipids|phospholipids
685293|NCT00317213|Cell membrane fluidity|cell membrane fluidity
685294|NCT00317213|Smoking cessation|smoking cessation
685295|NCT00317148|Hot Flashes|hot flashes
685296|NCT00317148|Menopause|menopause
685297|NCT00317148|Quality of Life|quality of life
685298|NCT00317148|Hot flushes|hot flushes
685299|NCT00317109|meningococcal serogroups A and C diseases|meningococcal serogroups a and c diseases
685300|NCT00317109|tetanus|tetanus
685301|NCT00317109|hepatitis B|hepatitis b
685302|NCT00317109|pertussis|pertussis
685303|NCT00317109|Haemophilus influenzae type b|haemophilus influenzae type b
685304|NCT00317109|meningococcal vaccine|meningococcal vaccine
685305|NCT00317109|Prophylaxis diphtheria|prophylaxis diphtheria
685306|NCT00317096|Drug Therapy|drug therapy
685307|NCT00317096|Maintenance|maintenance
685308|NCT00317096|rituximab|rituximab
685309|NCT00317083|Cough Reflex|cough reflex
685310|NCT00317083|Citric acid|citric acid
685311|NCT00317083|Obesity|obesity
685312|NCT00317083|Sleep apnea syndrome|sleep apnea syndrome
685313|NCT00317070|PBS/IC|pbs/ic
685314|NCT00317070|Painful bladder syndrome including Interstitial cystitis|painful bladder syndrome including interstitial cystitis
685315|NCT00317057|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
685316|NCT00317057|Outpatient management|outpatient management
685317|NCT00317057|nurse-lead patient education|nurse-lead patient education
685318|NCT00317044|Moderate to severe Asthma|moderate to severe asthma
685319|NCT00317044|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
685320|NCT00317044|esomeprazole|esomeprazole
685321|NCT00317044|GERD|gerd
685322|NCT00317031|Alcoholism|alcoholism
685323|NCT00317031|Drug Therapy|drug therapy
685324|NCT00317018|depression|depression
685325|NCT00317018|quality improvement|quality improvement
685326|NCT00317018|implementation|implementation
685327|NCT00317018|translation|translation
685328|NCT00317018|evidence-based practice|evidence-based practice
685329|NCT00317018|collaborative care|collaborative care
685330|NCT00317018|adoption|adoption
685331|NCT00317018|sustainability|sustainability
685332|NCT00317018|cost-effectiveness|cost-effectiveness
685333|NCT00317018|rural|rural
685334|NCT00317005|hemodialysis|hemodialysis
685335|NCT00317005|chronic uremia|chronic uremia
685336|NCT00317005|hyperhomocysteinemia|hyperhomocysteinemia
685337|NCT00317005|folate|folate
685338|NCT00316992|Insomnia|insomnia
685339|NCT00316992|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
685340|NCT00316992|Drug Therapy|drug therapy
685341|NCT00316979|migraine|migraine
685342|NCT00316979|transcranial magnetic stimulation|transcranial magnetic stimulation
685343|NCT00316979|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
685344|NCT00316979|rTMS|rtms
685345|NCT00316966|Nutritional status, dietary intervention, health care use, costs|nutritional status, dietary intervention, health care use, costs
685346|NCT00316940|stage I multiple myeloma|stage i multiple myeloma
685347|NCT00316940|stage II multiple myeloma|stage ii multiple myeloma
685348|NCT00316940|stage III multiple myeloma|stage iii multiple myeloma
685350|NCT00316927|adenocarcinoma of the prostate|adenocarcinoma of the prostate
685351|NCT00316927|stage III prostate cancer|stage iii prostate cancer
685352|NCT00316927|stage IV prostate cancer|stage iv prostate cancer
685353|NCT00316914|neurotoxicity|neurotoxicity
685354|NCT00316914|stage II colon cancer|stage ii colon cancer
685355|NCT00316914|stage III colon cancer|stage iii colon cancer
685356|NCT00316914|adenocarcinoma of the colon|adenocarcinoma of the colon
685357|NCT00316914|stage II rectal cancer|stage ii rectal cancer
685358|NCT00316914|stage III rectal cancer|stage iii rectal cancer
685359|NCT00316914|stage IV rectal cancer|stage iv rectal cancer
685360|NCT00316914|stage IV colon cancer|stage iv colon cancer
685361|NCT00316914|adenocarcinoma of the rectum|adenocarcinoma of the rectum
685362|NCT00316901|stage IV renal cell cancer|stage iv renal cell cancer
685363|NCT00316901|stage IV melanoma|stage iv melanoma
685364|NCT00316901|recurrent melanoma|recurrent melanoma
685365|NCT00316901|recurrent renal cell cancer|recurrent renal cell cancer
685366|NCT00316888|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
685367|NCT00316888|stage I anal cancer|stage i anal cancer
685368|NCT00316888|stage II anal cancer|stage ii anal cancer
685369|NCT00316888|stage IIIA anal cancer|stage iiia anal cancer
685370|NCT00316888|stage IIIB anal cancer|stage iiib anal cancer
685371|NCT00316888|basaloid carcinoma of the anus|basaloid carcinoma of the anus
685372|NCT00316888|cloacogenic carcinoma of the anus|cloacogenic carcinoma of the anus
685373|NCT00316875|stage IV breast cancer|stage iv breast cancer
685374|NCT00316875|recurrent breast cancer|recurrent breast cancer
685375|NCT00316875|male breast cancer|male breast cancer
685376|NCT00316862|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
685377|NCT00316862|stage II esophageal cancer|stage ii esophageal cancer
685378|NCT00316862|stage III esophageal cancer|stage iii esophageal cancer
685379|NCT00316836|stage I breast cancer|stage i breast cancer
685380|NCT00316836|stage II breast cancer|stage ii breast cancer
685381|NCT00316836|stage IIIA breast cancer|stage iiia breast cancer
685382|NCT00316823|thyroid cancer|thyroid cancer
685383|NCT00316810|Campath 1H|campath 1h
685384|NCT00316810|Alemtuzumab|alemtuzumab
685385|NCT00316810|Tacrolimus|tacrolimus
685386|NCT00316810|Pancreas-kidney transplantation|pancreas-kidney transplantation
685387|NCT00316810|immunosuppression|immunosuppression
685388|NCT00316810|prevention of acute rejection|prevention of acute rejection
685389|NCT00316797|SPECT|spect
685390|NCT00316797|Nuclear Medicine|nuclear medicine
685391|NCT00316784|osteoarthritis; knee; IDEA-033|osteoarthritis; knee; idea-033
685392|NCT00316745|irinotecan|irinotecan
685393|NCT00316745|S-1|s-1
685394|NCT00316745|Oxaliplatin|oxaliplatin
685395|NCT00316745|l-leucovorin|l-leucovorin
685396|NCT00316745|Fluorouracil|fluorouracil
685397|NCT00316745|Metastatic colorectal cancer|metastatic colorectal cancer
685398|NCT00316745|phase III|phase iii
685399|NCT00316732|Avodart|avodart
685400|NCT00316732|IPSS|ipss
685401|NCT00316732|BPH|bph
685402|NCT00316732|dutasteride|dutasteride
685403|NCT00316732|EQ-5D|eq-5d
685404|NCT00316732|Observational|observational
685405|NCT00316719|treatment naive|treatment naive
685406|NCT00316719|CHB|chb
685407|NCT00316719|adefovir|adefovir
685408|NCT00316719|monotherapy|monotherapy
685409|NCT00316706|Prophylaxis HPV-16/18 infections and cervical neoplasia|prophylaxis hpv-16/18 infections and cervical neoplasia
685410|NCT00316693|HPV Vaccine Efficacy|hpv vaccine efficacy
685411|NCT00316667|epidemiology|epidemiology
685412|NCT00316667|risk factors|risk factors
685413|NCT00316654|Prevention of Meningococcal Meningitis|prevention of meningococcal meningitis
685414|NCT00316654|vaccines, conjugate|vaccines, conjugate
685415|NCT00316654|immunology|immunology
685416|NCT00316654|child|child
685417|NCT00316654|antibody persistence|antibody persistence
685418|NCT00316628|influenza|influenza
685419|NCT00316628|elderly|elderly
685420|NCT00316628|vaccine|vaccine
685421|NCT00316615|influenza|influenza
685422|NCT00316615|non elderly adult and elderly|non elderly adult and elderly
685423|NCT00316615|vaccine|vaccine
685424|NCT00316602|Atopic dermatitis|atopic dermatitis
685425|NCT00316602|Smallpox|smallpox
685426|NCT00316602|Vaccination|vaccination
685427|NCT00316589|HIV|hiv
685428|NCT00316589|treatment experienced|treatment experienced
685429|NCT00316589|treatment vaccinia naive|treatment vaccinia naive
685430|NCT00316576|Kidney failure, Acute|kidney failure, acute
685431|NCT00316576|Genetic Polymorphism|genetic polymorphism
685432|NCT00316576|Angiotensin-converting enzyme|angiotensin-converting enzyme
685433|NCT00316563|cannabinoids|cannabinoids
685434|NCT00316563|taste disorders|taste disorders
685435|NCT00316563|olfaction disorders|olfaction disorders
685436|NCT00316563|cancer|cancer
685437|NCT00316563|palliative medicine|palliative medicine
685438|NCT00316563|caloric intake|caloric intake
685439|NCT00316563|appetite|appetite
685440|NCT00316563|reward|reward
685441|NCT00316563|tetrahydrocannabinol/therapeutic use|tetrahydrocannabinol/therapeutic use
685442|NCT00316563|anorexia/drug therapy|anorexia/drug therapy
685443|NCT00316563|quality of life|quality of life
685444|NCT00316563|chemosensory changes/drug therapy|chemosensory changes/drug therapy
685445|NCT00316550|Irritable Bowel Syndrome (IBS)|irritable bowel syndrome (ibs)
685448|NCT00316537|nicotine gel|nicotine gel
685449|NCT00316537|wound healing|wound healing
685450|NCT00316524|Smallpox|smallpox
685451|NCT00316524|Vaccination|vaccination
685452|NCT00316524|Prevention|prevention
685453|NCT00316511|advanced solid malignancies|advanced solid malignancies
685454|NCT00316511|B-cell lymphoma|b-cell lymphoma
685455|NCT00316511|Aroplatin|aroplatin
685456|NCT00316511|L-NDDP|l-nddp
685457|NCT00316511|MTD|mtd
685458|NCT00316511|advanced solid malignancies or B-cell lymphoma|advanced solid malignancies or b-cell lymphoma
685459|NCT00316498|Eye Movement|eye movement
685460|NCT00316498|Niemann Pick C|niemann pick c
685461|NCT00316485|Bone|bone
685462|NCT00316485|Microbiology|microbiology
685463|NCT00316485|Dental Pulp Stem Cell|dental pulp stem cell
685464|NCT00316485|Wisdom Teeth|wisdom teeth
685465|NCT00316485|Biopsy|biopsy
685466|NCT00316485|Third Molar Extraction|third molar extraction
685467|NCT00316472|Hyperphosphatemia|hyperphosphatemia
685468|NCT00316472|End Stage Renal Disease|end stage renal disease
685469|NCT00316472|Renal Osteodystrophy|renal osteodystrophy
685470|NCT00316459|Healthy|healthy
685471|NCT00316459|Cardiac|cardiac
685472|NCT00316459|Pharmacokinetics|pharmacokinetics
685473|NCT00316394|Preventive Health Care|preventive health care
685474|NCT00316394|Annual Health Check-up|annual health check-up
685475|NCT00316394|Primary Care|primary care
685476|NCT00316394|Reminders|reminders
685477|NCT00316381|stem cells|stem cells
685478|NCT00316381|acute myocardial infarction|acute myocardial infarction
685479|NCT00316381|regeneration|regeneration
685480|NCT00316381|left ventricular ejection fraction|left ventricular ejection fraction
685481|NCT00316368|Bi-Ventricular pacing post coronary artery bypass graft|bi-ventricular pacing post coronary artery bypass graft
685482|NCT00316368|coronary artery bypass graft|coronary artery bypass graft
685483|NCT00316355|Anxiety|anxiety
685484|NCT00316355|Behavior therapy|behavior therapy
685485|NCT00316355|Cognitive-behavioral therapy|cognitive-behavioral therapy
685486|NCT00316355|Stepped care|stepped care
685487|NCT00316355|Cost-effectiveness|cost-effectiveness
685488|NCT00316342|Low back pain|low back pain
685489|NCT00316342|Industrial workers|industrial workers
685490|NCT00316342|Recurrent back pain|recurrent back pain
685491|NCT00316342|Back supports|back supports
685492|NCT00316342|Back health education|back health education
685493|NCT00316342|Rehabilitation|rehabilitation
685494|NCT00316316|OCD|ocd
685495|NCT00316303|Serious Mental Illness|serious mental illness
685496|NCT00316303|Dual Diagnosis|dual diagnosis
685497|NCT00316303|Mental Disorders|mental disorders
685498|NCT00316303|Substance-Related Disorders|substance-related disorders
685499|NCT00316290|ADHD|adhd
685500|NCT00316290|Cognitive Behavioral Therapy|cognitive behavioral therapy
685501|NCT00316290|Parent Training|parent training
685502|NCT00316277|Opiate Analgesic Dependence|opiate analgesic dependence
685503|NCT00316264|Respiratory Syncytial Virus|respiratory syncytial virus
685504|NCT00316264|Premature and under 6 mos. of age|premature and under 6 mos. of age
685505|NCT00316264|Chronic Lung Disease over 6 mos. of age|chronic lung disease over 6 mos. of age
685506|NCT00316264|palivizumab|palivizumab
685507|NCT00316264|motavizumab|motavizumab
685508|NCT00316264|RSV|rsv
685509|NCT00316251|Somatosensory dysfunction|somatosensory dysfunction
685510|NCT00316212|Coronary Artery Bypass Graft Surgery involving Cardiopulmonary Bypass|coronary artery bypass graft surgery involving cardiopulmonary bypass
685511|NCT00316186|chemonaive|chemonaive
685512|NCT00316186|small cell lung cancer|small cell lung cancer
685513|NCT00316186|untreated|untreated
685514|NCT00316186|Lung cancer|lung cancer
685515|NCT00316186|HYCAMTIN|hycamtin
685516|NCT00316186|first-line|first-line
685517|NCT00316186|extensive disease|extensive disease
685518|NCT00316173|HYCAMTIN|hycamtin
685519|NCT00316173|ovarian cancer|ovarian cancer
685520|NCT00316173|recurrent|recurrent
685521|NCT00316173|relapsed|relapsed
685522|NCT00316173|carboplatin|carboplatin
685523|NCT00316173|topotecan|topotecan
685524|NCT00316173|potentially platinum-sensitive|potentially platinum-sensitive
685525|NCT00316160|sexual dysfunction|sexual dysfunction
685526|NCT00316160|Depression|depression
685527|NCT00316160|MDD|mdd
685528|NCT00316147|diphtheria|diphtheria
685529|NCT00316147|tetanus|tetanus
685530|NCT00316147|poliomyelitis|poliomyelitis
685531|NCT00316147|pertussis|pertussis
685532|NCT00316147|hepatitis B|hepatitis b
685533|NCT00316147|Prophylaxis|prophylaxis
685534|NCT00316147|Haemophilus influenza type b diseases|haemophilus influenza type b diseases
685535|NCT00316134|Pleural Diseases|pleural diseases
685536|NCT00316134|Pleural Effusion|pleural effusion
685537|NCT00316134|Pleural Effusion, Malignant|pleural effusion, malignant
685538|NCT00316134|Pleural Neoplasms|pleural neoplasms
685539|NCT00316134|Neoplasms, Pleural|neoplasms, pleural
685540|NCT00316121|One or Two Level Degenerative Disc Disease|one or two level degenerative disc disease
685541|NCT00316108|Carotid|carotid
685542|NCT00316108|Carotid Artery Stenting|carotid artery stenting
685543|NCT00316108|Stent|stent
685544|NCT00316108|Carotid Endarterectomy|carotid endarterectomy
685545|NCT00316108|Stroke|stroke
685546|NCT00316108|Transient Ischemic Attack|transient ischemic attack
685547|NCT00316108|Stenosis|stenosis
685548|NCT00316108|Atherosclerotic Disease|atherosclerotic disease
685549|NCT00001675|Brain Imaging|brain imaging
685550|NCT00001675|Affect|affect
685551|NCT00001675|Limbic System|limbic system
685552|NCT00001675|Cerebral Blood Volume|cerebral blood volume
685553|NCT00001675|Alcoholism|alcoholism
685554|NCT00001675|Emotion|emotion
685555|NCT00001675|Brain|brain
685556|NCT00001675|Operant|operant
685557|NCT00001675|Autonomic|autonomic
685558|NCT00001675|Relapse|relapse
685559|NCT00001675|Normal Volunteer|normal volunteer
685560|NCT00001673|Alcoholics|alcoholics
685561|NCT00001673|Screening|screening
685562|NCT00001673|Healthy Volunteers|healthy volunteers
685563|NCT00001673|Violent Abusers|violent abusers
685564|NCT00001673|Illicit Drug Testing|illicit drug testing
685565|NCT00001673|Blood Tests|blood tests
685566|NCT00001673|Normal Volunteer|normal volunteer
685567|NCT00316069|Erythropoiesis|erythropoiesis
685568|NCT00316069|Leukapheresis|leukapheresis
685569|NCT00316069|G-CSF|g-csf
685570|NCT00316069|Mobilization|mobilization
685571|NCT00316069|Stem Cells|stem cells
685572|NCT00316069|Apheresis|apheresis
685573|NCT00316069|Blood Donation|blood donation
685574|NCT00316069|Healthy Volunteer|healthy volunteer
685575|NCT00316069|HV|hv
685576|NCT00316056|Genetic Literacy|genetic literacy
685577|NCT00316056|Learning|learning
685578|NCT00316056|Genetic Knowledge|genetic knowledge
685579|NCT00316056|Public Understanding of Science|public understanding of science
685580|NCT00316056|Science Education|science education
685581|NCT00316056|Healthy Volunteer|healthy volunteer
685582|NCT00316056|HV|hv
685583|NCT00316043|Urinary tract infections|urinary tract infections
685584|NCT00316043|Renal failure|renal failure
685585|NCT00316043|Renal scarring|renal scarring
685586|NCT00316043|Prevention|prevention
685587|NCT00316043|Primary Care|primary care
685588|NCT00316043|General Practice|general practice
685589|NCT00316043|Intervention Studies|intervention studies
685590|NCT00316043|Children|children
685591|NCT00316030|AML|aml
685592|NCT00316030|Acute Myeloid Leukemia|acute myeloid leukemia
685593|NCT00316030|Bexarotene|bexarotene
685594|NCT00316030|Leukemia|leukemia
685595|NCT00316017|Trauma|trauma
685596|NCT00316017|Shock|shock
685597|NCT00316004|Traumatic|traumatic
685598|NCT00316004|Brain injury|brain injury
685599|NCT00315991|BG perception|bg perception
685600|NCT00315991|hypoglycemic awareness|hypoglycemic awareness
685601|NCT00315991|pediatric T1DM|pediatric t1dm
685602|NCT00315978|Risk Assessment|risk assessment
685603|NCT00315978|Decision Support Technique|decision support technique
685604|NCT00315978|Physician-Patient Relations|physician-patient relations
685605|NCT00315978|Prevention and Control|prevention and control
685606|NCT00315965|Diffusion|diffusion
685607|NCT00315965|Membrane diffusing capacity|membrane diffusing capacity
685608|NCT00315965|Alveolar capillary gas diffusion|alveolar capillary gas diffusion
685609|NCT00315965|Transfer factor|transfer factor
685610|NCT00315965|Nitric oxide diffusion|nitric oxide diffusion
685611|NCT00315952|type 1 diabetes mellitus|type 1 diabetes mellitus
685612|NCT00315952|inhaled insulin|inhaled insulin
685613|NCT00315952|Positron Emission Tomography|positron emission tomography
685614|NCT00315939|Diabetes|diabetes
685615|NCT00315939|hypoglycemic episodes|hypoglycemic episodes
685616|NCT00315926|Cardiac morbidity|cardiac morbidity
685617|NCT00315926|Melatonin|melatonin
685618|NCT00315926|Surgery|surgery
685619|NCT00315926|Postoperative|postoperative
685620|NCT00315913|Labor|labor
685621|NCT00315913|Dysfunctional Labor|dysfunctional labor
685622|NCT00315913|Labor Arrest|labor arrest
685623|NCT00315913|Primary Cesarean Section Prevention|primary cesarean section prevention
685624|NCT00315900|Seroquel|seroquel
685625|NCT00315900|Depakote ER|depakote er
685626|NCT00315900|Nursing Home|nursing home
685627|NCT00315900|Quetiapine|quetiapine
685628|NCT00315900|Divalproex ER|divalproex er
685629|NCT00315900|Agitation|agitation
685630|NCT00315887|low back pain|low back pain
685631|NCT00315887|opioid|opioid
685632|NCT00315887|transdermal|transdermal
685633|NCT00315874|chronic back pain|chronic back pain
685634|NCT00315874|opioid|opioid
685635|NCT00315874|transdermal|transdermal
685636|NCT00315861|ovarian carcinoma|ovarian carcinoma
685637|NCT00315861|endometrial carcinoma|endometrial carcinoma
685638|NCT00315861|cervical carcinoma|cervical carcinoma
685639|NCT00315861|lung carcinoma|lung carcinoma
685640|NCT00315848|chronic pain|chronic pain
685641|NCT00315848|osteoarthritis|osteoarthritis
685642|NCT00315848|opioid|opioid
685643|NCT00315848|transdermal|transdermal
685644|NCT00315835|postoperative pain|postoperative pain
685645|NCT00315835|opioid|opioid
685646|NCT00315835|transdermal|transdermal
685647|NCT00315822|Surgery|surgery
685648|NCT00315822|colon|colon
685649|NCT00315809|leprosy, Philippines|leprosy, philippines
685650|NCT00315796|Mind-Body Intervention|mind-body intervention
685651|NCT00315796|Distraction|distraction
685652|NCT00315796|Biophilic|biophilic
685653|NCT00315796|Cancer|cancer
685654|NCT00315796|pain|pain
685655|NCT00315796|Bedscapes|bedscapes
685656|NCT00315796|procedures|procedures
685657|NCT00315796|bone marrow aspirate|bone marrow aspirate
685658|NCT00315796|bone marrow biopsy|bone marrow biopsy
685659|NCT00315783|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
685660|NCT00315783|echocardiography|echocardiography
685661|NCT00315783|magnetic resonance imaging|magnetic resonance imaging
685662|NCT00315770|overweight|overweight
685663|NCT00315770|Metabolic syndrome|metabolic syndrome
685664|NCT00315744|moderate asthma|moderate asthma
685665|NCT00315744|fluticasone|fluticasone
685666|NCT00315744|children|children
685667|NCT00315744|salmeterol|salmeterol
685668|NCT00315744|steroid-sparing|steroid-sparing
685669|NCT00315744|Asthma|asthma
685670|NCT00315731|Bexxar|bexxar
685671|NCT00315731|tositumomab and iodine I 131 tositumomab therapeutic regiment|tositumomab and iodine i 131 tositumomab therapeutic regiment
685672|NCT00315731|fission|fission
685673|NCT00315731|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
685674|NCT00315731|Iodine I 131 Tositumomab|iodine i 131 tositumomab
685675|NCT00315731|pharmacokinetics|pharmacokinetics
685676|NCT00315731|tellurium|tellurium
685677|NCT00315718|Hintonia latiflora extract|hintonia latiflora extract
685678|NCT00315718|Diabetes mellitus type 2|diabetes mellitus type 2
685679|NCT00315718|HbA1c|hba1c
685680|NCT00315718|Safety|safety
685681|NCT00315718|Liver function tests|liver function tests
685682|NCT00315705|clofarabine|clofarabine
685683|NCT00315705|acute leukemia|acute leukemia
685684|NCT00315705|ALL|all
685685|NCT00315705|AML|aml
685686|NCT00315705|clolar|clolar
685687|NCT00315705|CLO218|clo218
685688|NCT00315692|Ovarian Neoplasms|ovarian neoplasms
685689|NCT00315679|recurrent aphthous stomatitis|recurrent aphthous stomatitis
685690|NCT00315679|recurrent mouth ulcers|recurrent mouth ulcers
685691|NCT00315679|pentoxifylline|pentoxifylline
685692|NCT00315679|clinical trial|clinical trial
685693|NCT00315679|double blind|double blind
685694|NCT00315679|placebo controlled|placebo controlled
685695|NCT00315679|randomized|randomized
685696|NCT00315666|Chronic tension-type headache|chronic tension-type headache
685697|NCT00315653|Bladder Cancer|bladder cancer
685698|NCT00315653|Cancer of Bladder|cancer of bladder
685699|NCT00315653|Bladder Tumors|bladder tumors
685700|NCT00315653|Cancer of the Bladder|cancer of the bladder
685701|NCT00315653|Neoplasms, Bladder|neoplasms, bladder
685702|NCT00315640|Elevated IOP due to intravitreal triamcinolone therapy|elevated iop due to intravitreal triamcinolone therapy
685703|NCT00315627|Islet Transplantation|islet transplantation
685704|NCT00315614|Islet Transplantation|islet transplantation
685705|NCT00315601|Telithromycin (drug)|telithromycin (drug)
685706|NCT00315601|Azithromycin (drug)|azithromycin (drug)
685707|NCT00315601|Bronchoalveolar lavage (procedure)|bronchoalveolar lavage (procedure)
685708|NCT00315601|Pharmacokinetics|pharmacokinetics
685709|NCT00315588|Islet Transplantation|islet transplantation
685710|NCT00315575|Dementia|dementia
685711|NCT00315575|brain circulation|brain circulation
685712|NCT00315575|disease /disorder proneness /risk|disease /disorder proneness /risk
685713|NCT00315575|neuropathology|neuropathology
685714|NCT00315575|neurophysiology|neurophysiology
685715|NCT00315575|aging|aging
685716|NCT00315575|apolipoprotein E|apolipoprotein e
685717|NCT00315575|genotype|genotype
685718|NCT00315575|hemodynamics|hemodynamics
685719|NCT00315575|memory|memory
685720|NCT00315575|temporal lobe /cortex|temporal lobe /cortex
685721|NCT00315562|stroke|stroke
685722|NCT00315562|carotid stenosis|carotid stenosis
685723|NCT00315562|carotid endarterectomy|carotid endarterectomy
685724|NCT00315562|timing|timing
685725|NCT00315549|Tonsillitis|tonsillitis
685726|NCT00315549|pharyngitis|pharyngitis
685727|NCT00315549|penicillin|penicillin
685728|NCT00315549|telithromycin|telithromycin
685729|NCT00315549|ketolides|ketolides
685730|NCT00315549|clinical trials|clinical trials
685731|NCT00315523|Levocetirizine|levocetirizine
685732|NCT00315523|Xyzal|xyzal
685733|NCT00315523|Rhinitis|rhinitis
685734|NCT00315523|Allergic|allergic
685735|NCT00315523|Seasonal|seasonal
685736|NCT00315523|Ragweed|ragweed
685737|NCT00315510|Ischemia-reperfusion|ischemia-reperfusion
685738|NCT00315510|Annexin A5|annexin a5
685739|NCT00315497|Giant Cell Arteritis|giant cell arteritis
685740|NCT00315484|Anemia|anemia
685741|NCT00315484|chemotherapy|chemotherapy
685742|NCT00315484|hemoglobin level|hemoglobin level
685743|NCT00315484|recombinant human erythropoietin|recombinant human erythropoietin
685744|NCT00315484|epoetin alfa|epoetin alfa
685745|NCT00315484|darbepoetin alfa|darbepoetin alfa
685746|NCT00315471|Vasculitis|vasculitis
685747|NCT00315458|osteoarthritis|osteoarthritis
685748|NCT00315458|opioid|opioid
685749|NCT00315458|transdermal|transdermal
685750|NCT00315445|chronic back pain|chronic back pain
685751|NCT00315445|opioid|opioid
685752|NCT00315445|transdermal|transdermal
685753|NCT00315432|Natural History, Hepatitis C Infection, HIV Infection, HCV/HIV co-infection Ribavirin, Pegylated Interferon, Interferon|natural history, hepatitis c infection, hiv infection, hcv/hiv co-infection ribavirin, pegylated interferon, interferon
685754|NCT00315419|Large Granular Lymphocyte Leukemia|large granular lymphocyte leukemia
685755|NCT00315419|Amegakaryocytic Thrombocytopenic Purpura|amegakaryocytic thrombocytopenic purpura
685756|NCT00315419|Idiopathic Pure Red Cell Aplasia|idiopathic pure red cell aplasia
685757|NCT00315419|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
685758|NCT00315406|PAN|pan
685759|NCT00315406|Periarteritis Nodosa|periarteritis nodosa
685760|NCT00315393|GPA|gpa
685761|NCT00315393|MPA|mpa
685762|NCT00315393|WG|wg
685763|NCT00315380|EGPA|egpa
685764|NCT00315380|CSS|css
685765|NCT00315367|Multiple Sclerosis|multiple sclerosis
685766|NCT00315367|Memory impairment|memory impairment
685767|NCT00315354|obesity|obesity
685768|NCT00315354|nutrition|nutrition
685769|NCT00315328|Amblyopia|amblyopia
685770|NCT00315328|Atropine|atropine
685771|NCT00315328|Patching|patching
685772|NCT00315315|Nasolacrimal duct obstruction|nasolacrimal duct obstruction
685773|NCT00315315|Balloon catheter nasolacrimal duct dilation|balloon catheter nasolacrimal duct dilation
685774|NCT00315315|Nasolacrimal intubation|nasolacrimal intubation
685775|NCT00315315|Simple Nasolacrimal duct probing|simple nasolacrimal duct probing
685776|NCT00315302|Amblyopia|amblyopia
685777|NCT00315302|Atropine|atropine
685778|NCT00315302|Plano lens|plano lens
685779|NCT00315289|Nasolacrimal duct obstruction|nasolacrimal duct obstruction
685780|NCT00315289|Simple probing|simple probing
685781|NCT00315289|Balloon catheter dilation|balloon catheter dilation
685782|NCT00315289|Nasolacrimal intubation|nasolacrimal intubation
685783|NCT00315276|ADHD|adhd
685784|NCT00315263|DNA|dna
685785|NCT00315263|Genomics|genomics
685786|NCT00315263|SNPs|snps
685787|NCT00315263|Neonatology|neonatology
685788|NCT00315263|Chronic Lung Disease|chronic lung disease
685789|NCT00315263|Periventricular Brain Injury|periventricular brain injury
685790|NCT00315263|Hypoxic Respiratory Failure|hypoxic respiratory failure
685791|NCT00315250|Parkinson|parkinson
685792|NCT00315224|Isolated systolic Hypertension|isolated systolic hypertension
685793|NCT00315224|exercise|exercise
685794|NCT00315224|pulse pressure|pulse pressure
685795|NCT00315224|endothelium|endothelium
685796|NCT00315211|Small Cell Lung Cancer Recurrent|small cell lung cancer recurrent
685797|NCT00315198|amblyopia|amblyopia
685798|NCT00315198|patching|patching
685799|NCT00315198|visual activities|visual activities
685800|NCT00315185|Advanced Non-small Cell Lung Cancer|advanced non-small cell lung cancer
685801|NCT00315185|First Line Treatment|first line treatment
685802|NCT00315172|Adipose Tissue|adipose tissue
685803|NCT00315172|Weight Gain|weight gain
685804|NCT00315172|Pediatric|pediatric
685805|NCT00315172|Body Composition|body composition
685806|NCT00315172|Thermogenesis|thermogenesis
685807|NCT00315172|Exercise|exercise
685808|NCT00315172|Healthy Volunteer|healthy volunteer
685809|NCT00315172|HV|hv
685810|NCT00315159|Squamous|squamous
685811|NCT00315159|Cell|cell
685812|NCT00315159|Carcinoma|carcinoma
685813|NCT00315159|Vulva|vulva
685814|NCT00315159|Sentinel Node|sentinel node
685815|NCT00315146|Body Composition|body composition
685816|NCT00315146|Sarcopenia|sarcopenia
685817|NCT00315146|Weight loss trials|weight loss trials
685818|NCT00315146|Intervention studies|intervention studies
685819|NCT00315146|Elderly|elderly
685820|NCT00315133|Diabetes mellitus|diabetes mellitus
685821|NCT00315133|Stem cells|stem cells
685822|NCT00315133|Autologous stem cell transplantation|autologous stem cell transplantation
685823|NCT00315133|Autoimmune diseases|autoimmune diseases
685824|NCT00315120|Randomized controlled trial|randomized controlled trial
685825|NCT00315120|Low back pain|low back pain
685826|NCT00315120|Spinal manipulative therapy|spinal manipulative therapy
685827|NCT00315120|Spinal manipulation|spinal manipulation
685828|NCT00315120|Osteopathic manipulation|osteopathic manipulation
685829|NCT00315120|Osteopathic medicine|osteopathic medicine
685830|NCT00315120|Physical therapy modalities|physical therapy modalities
685831|NCT00315094|home parenteral nutrition|home parenteral nutrition
685832|NCT00315081|Schizophrenia|schizophrenia
685833|NCT00315081|Hyperprolactinemia|hyperprolactinemia
685834|NCT00315081|Risperidone|risperidone
685835|NCT00315081|Bromocriptin|bromocriptin
685836|NCT00315068|arrythmia|arrythmia
685837|NCT00315068|atrial fibrillation|atrial fibrillation
685838|NCT00315068|proteins|proteins
685839|NCT00315055|Hepatitis B|hepatitis b
685840|NCT00315055|Polio|polio
685841|NCT00315055|Diphtheria|diphtheria
685842|NCT00315055|Pertussis|pertussis
685843|NCT00315055|H influenzae type b|h influenzae type b
685844|NCT00315042|Tonsillitis|tonsillitis
685845|NCT00315042|pharyngitis|pharyngitis
685846|NCT00315042|penicillin|penicillin
685847|NCT00315042|telithromycin|telithromycin
685848|NCT00315042|ketolides|ketolides
685849|NCT00315042|clinical trials|clinical trials
685850|NCT00315029|Implementation|implementation
685851|NCT00315029|Single embryo transfer|single embryo transfer
685852|NCT00315029|ICSI|icsi
685853|NCT00315029|IVF|ivf
685854|NCT00315029|prevention|prevention
685855|NCT00315016|albuminuria|albuminuria
685856|NCT00315016|eplerenone|eplerenone
685857|NCT00315016|ACE inhibition|ace inhibition
685858|NCT00315016|renal function|renal function
685859|NCT00315016|endothelial function|endothelial function
685860|NCT00315003|Otitis Media|otitis media
685861|NCT00315003|Suppurative|suppurative
685862|NCT00315003|Purulent|purulent
685863|NCT00315003|Ketolide|ketolide
685864|NCT00315003|Azithromycin|azithromycin
685865|NCT00315003|Telithromycin|telithromycin
685866|NCT00315003|Controlled Clinical Trials|controlled clinical trials
685867|NCT00314990|Venous thrombosis|venous thrombosis
685868|NCT00314990|Deep-vein thrombosis|deep-vein thrombosis
685869|NCT00314990|Pulmonary embolism|pulmonary embolism
685870|NCT00314990|Homocysteine|homocysteine
685871|NCT00314990|B-vitamins|b-vitamins
685872|NCT00314990|Folate|folate
685873|NCT00314990|Vitamin B12|vitamin b12
685874|NCT00314990|Vitamin B6|vitamin b6
685875|NCT00314977|Large resectable breast cancer|large resectable breast cancer
685876|NCT00314977|Locally advanced breast cancer|locally advanced breast cancer
685877|NCT00314977|Neoadjuvant therapy|neoadjuvant therapy
685878|NCT00314951|CDAD, Clostridium difficile, diarrhea|cdad, clostridium difficile, diarrhea
685879|NCT00314951|Clostridium difficile-Associated Diarrhea|clostridium difficile-associated diarrhea
685880|NCT00314925|advanced carcinoma|advanced carcinoma
685881|NCT00314925|carcinoid|carcinoid
685882|NCT00314925|neuroendocrine features|neuroendocrine features
685883|NCT00314925|oncolytic virus|oncolytic virus
685884|NCT00314925|phase I study|phase i study
685885|NCT00314925|dose escalation study|dose escalation study
685886|NCT00314925|rhabdomyosarcoma|rhabdomyosarcoma
685887|NCT00314925|alveolar rhabdomyosarcoma|alveolar rhabdomyosarcoma
685888|NCT00314925|medulloblastoma|medulloblastoma
685889|NCT00314925|rhabdoid|rhabdoid
685890|NCT00314925|glioblastoma|glioblastoma
685891|NCT00314925|ewing's sarcoma|ewing's sarcoma
685892|NCT00314925|pediatric oncologies|pediatric oncologies
685893|NCT00314925|neuroblastoma|neuroblastoma
685894|NCT00314925|wilms' tumor|wilms' tumor
685895|NCT00314925|retinoblastoma|retinoblastoma
685896|NCT00314925|Large cell lung cancer|large cell lung cancer
685897|NCT00314899|Malaria, Plasmodium falciparum, Kenya, immunity|malaria, plasmodium falciparum, kenya, immunity
685898|NCT00314886|Diet|diet
685899|NCT00314886|Fiber|fiber
685900|NCT00314886|Irritable Bowel Syndrome|irritable bowel syndrome
685901|NCT00314886|Colonic Flora|colonic flora
685902|NCT00314873|Thymic malignancy|thymic malignancy
685903|NCT00314873|Thymic Carcinoma|thymic carcinoma
685904|NCT00314860|Restless Legs Syndrome|restless legs syndrome
685905|NCT00314847|Myocardial infarction|myocardial infarction
685906|NCT00314847|Cardiogenic shock|cardiogenic shock
685907|NCT00314847|Extracorporeal Life Support-Impella|extracorporeal life support-impella
685908|NCT00314834|hemodialysis|hemodialysis
685909|NCT00314834|intradialytic parenteral nutrition|intradialytic parenteral nutrition
685910|NCT00314834|oral supplementation|oral supplementation
685911|NCT00314834|survival|survival
685912|NCT00314834|hospitalization|hospitalization
685913|NCT00314834|serum albumin|serum albumin
685914|NCT00314834|prealbumin|prealbumin
685915|NCT00314834|transthyretin|transthyretin
685916|NCT00314821|bipolar disorder, ropinirole, depression|bipolar disorder, ropinirole, depression
685917|NCT00314808|primary gliomas|primary gliomas
685918|NCT00314808|brain tumors|brain tumors
685919|NCT00314808|vomiting|vomiting
685920|NCT00314808|appetite suppression|appetite suppression
685921|NCT00314808|appetite|appetite
685922|NCT00314795|pure red cell aplasia|pure red cell aplasia
685923|NCT00314795|PRCA|prca
685924|NCT00314795|chronic kidney disease|chronic kidney disease
685925|NCT00314795|CKD|ckd
685926|NCT00314795|chronic renal failure|chronic renal failure
685927|NCT00314795|CRF|crf
685928|NCT00314795|anemia|anemia
685929|NCT00314795|erythropoietin|erythropoietin
685930|NCT00314795|EPO|epo
685931|NCT00314795|erythropoiesis stimulating agent|erythropoiesis stimulating agent
685932|NCT00314795|ESA|esa
685933|NCT00314795|hemoglobin|hemoglobin
685934|NCT00314795|Hb|hb
685935|NCT00314795|Hgb|hgb
685936|NCT00314795|red blood cell|red blood cell
685937|NCT00314795|red blood cell production|red blood cell production
685938|NCT00314782|metastatic hormone-refractory prostate cancer (HRPC)|metastatic hormone-refractory prostate cancer (hrpc)
685939|NCT00314769|Transcranial Direct Current Stimulation (TDCS)|transcranial direct current stimulation (tdcs)
685940|NCT00314769|Motor Learning|motor learning
685941|NCT00314769|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
685942|NCT00314769|Cortical Re-Organization|cortical re-organization
685943|NCT00314769|Neuroplasticity|neuroplasticity
685944|NCT00314769|Neurorehabilitation|neurorehabilitation
685945|NCT00314769|TBI|tbi
685946|NCT00314769|Stroke|stroke
685947|NCT00314769|Healthy Volunteer|healthy volunteer
685948|NCT00314769|HV|hv
685949|NCT00314756|imiquimod cream|imiquimod cream
685950|NCT00314756|nodular basal cell carcinoma|nodular basal cell carcinoma
685951|NCT00314756|curettage|curettage
685952|NCT00314743|Patients with Non-Hodgkins Lymphoma or Multiple Myeloma|patients with non-hodgkins lymphoma or multiple myeloma
685953|NCT00314704|shock|shock
685954|NCT00314704|hypotension|hypotension
685955|NCT00314704|circulatory failure|circulatory failure
685956|NCT00314704|septic shock|septic shock
685957|NCT00314704|cardiogenic shock|cardiogenic shock
685958|NCT00314691|fetal DNA|fetal dna
685959|NCT00314691|prenatal diagnosis|prenatal diagnosis
685960|NCT00314691|maternal plasma|maternal plasma
685961|NCT00314691|Diagnostic potential of cell-free fetal DNA circulating in maternal blood|diagnostic potential of cell-free fetal dna circulating in maternal blood
685962|NCT00314678|Ovarian|ovarian
685963|NCT00314678|Peritoneal|peritoneal
685964|NCT00314665|Sarcoidosis|sarcoidosis
685965|NCT00314665|Chronic Uveitis|chronic uveitis
685966|NCT00314665|Uveitis|uveitis
685967|NCT00314665|Thalidomide|thalidomide
685968|NCT00314652|Osteoarthritis|osteoarthritis
685969|NCT00314652|chronic pain|chronic pain
685970|NCT00314652|opioid|opioid
685971|NCT00314652|transdermal|transdermal
685972|NCT00314626|Antiviral efficacy|antiviral efficacy
685973|NCT00314626|Tolerability|tolerability
685974|NCT00314626|Immunologic response|immunologic response
685975|NCT00314626|Virologic response|virologic response
685976|NCT00314626|HIV|hiv
685977|NCT00314613|Schizophreniform; Schizophrenia; Schizoaffective Disorders|schizophreniform; schizophrenia; schizoaffective disorders
685978|NCT00314600|Fracture|fracture
685979|NCT00314600|Forearm|forearm
685980|NCT00314600|Midshaft|midshaft
685981|NCT00314600|Child|child
685982|NCT00314600|Cast|cast
685983|NCT00314587|fracture|fracture
685984|NCT00314587|forearm|forearm
685985|NCT00314587|midshaft|midshaft
685986|NCT00314587|child|child
685987|NCT00314587|treatment|treatment
685988|NCT00314574|Persistent Asthma|persistent asthma
685989|NCT00314574|EXTRA|extra
685990|NCT00314574|Xolair|xolair
685991|NCT00314574|Difficult Breathing|difficult breathing
685992|NCT00314561|Rosiglitazone|rosiglitazone
685993|NCT00314561|Pioglitazone|pioglitazone
685994|NCT00314561|FMD|fmd
685995|NCT00314561|PWV|pwv
685996|NCT00314561|atherosclerosis|atherosclerosis
685997|NCT00314548|ARDS|ards
685998|NCT00314548|pulmonary hypertension|pulmonary hypertension
685999|NCT00314548|prostacyclins|prostacyclins
686000|NCT00314509|Asthma|asthma
686001|NCT00314509|Ciclesonide|ciclesonide
686002|NCT00314509|Formoterol Fumarate|formoterol fumarate
686003|NCT00314509|Long-acting beta2-agonists|long-acting beta2-agonists
686004|NCT00314509|LABA|laba
686005|NCT00314509|Steroids|steroids
686006|NCT00314483|Mesenchymal stem cells|mesenchymal stem cells
686007|NCT00314483|GVHD|gvhd
686008|NCT00314483|Treatment|treatment
686009|NCT00314483|Steroid refractory GVHD|steroid refractory gvhd
686010|NCT00314457|pain control|pain control
686011|NCT00314457|intra-articular pain control device|intra-articular pain control device
686012|NCT00314457|ACL repair|acl repair
686013|NCT00314457|Bankart Repair|bankart repair
686014|NCT00314444|Psychogenic|psychogenic
686015|NCT00314444|Psychogenic Movement Disorders|psychogenic movement disorders
686016|NCT00314431|neonatal chronic lung disease|neonatal chronic lung disease
686017|NCT00314431|bronchopulmonary dysplasia|bronchopulmonary dysplasia
686018|NCT00314431|prematurity|prematurity
686019|NCT00314431|telephone follow up|telephone follow up
686020|NCT00314431|care coordination|care coordination
686021|NCT00314431|children with special health care needs|children with special health care needs
686022|NCT00314418|Colonoscopy|colonoscopy
686023|NCT00314418|technique|technique
686024|NCT00314418|time|time
686025|NCT00314418|duration|duration
686026|NCT00314418|position|position
686027|NCT00314418|abdominal pressure|abdominal pressure
686028|NCT00314405|sentinel lymph node|sentinel lymph node
686029|NCT00314405|SLN|sln
686030|NCT00314405|probe|probe
686031|NCT00314405|breast cancer|breast cancer
686032|NCT00314405|lymphoscintigraphy|lymphoscintigraphy
686033|NCT00314405|methylene blue dye|methylene blue dye
686034|NCT00314392|Experimental pain|experimental pain
686035|NCT00314392|Placebo analgesia|placebo analgesia
686036|NCT00314392|Heart rate variability|heart rate variability
686037|NCT00314392|Skin conductance|skin conductance
686038|NCT00314379|Diabetes|diabetes
686039|NCT00314379|Endothelial Function|endothelial function
686040|NCT00314379|Haptoglobin|haptoglobin
686041|NCT00314366|stem cell|stem cell
686042|NCT00314366|autologous|autologous
686043|NCT00314366|ischemia|ischemia
686044|NCT00314353|NSABP|nsabp
686045|NCT00314353|bevacizumab|bevacizumab
686046|NCT00314353|capecitabine|capecitabine
686047|NCT00314353|oxaliplatin|oxaliplatin
686048|NCT00314353|irinotecan|irinotecan
686049|NCT00314353|rectal cancer|rectal cancer
686050|NCT00314353|colon cancer|colon cancer
686051|NCT00314353|colorectal cancer|colorectal cancer
686052|NCT00314340|Chronic Pain|chronic pain
686053|NCT00314340|Opioids|opioids
686054|NCT00314327|first episode|first episode
686055|NCT00314327|schizophrenia|schizophrenia
686056|NCT00314327|risperidone|risperidone
686057|NCT00314314|Bipolar Disorder, memory, executive functioning|bipolar disorder, memory, executive functioning
686058|NCT00314301|cerebral palsy|cerebral palsy
686059|NCT00314301|resistance|resistance
686060|NCT00314301|movement|movement
686061|NCT00314301|biomechanics|biomechanics
686062|NCT00314288|Parkinson's Disease|parkinson's disease
686063|NCT00314288|Dyskinesia|dyskinesia
686064|NCT00314288|L-dopa-induced dyskinesia|l-dopa-induced dyskinesia
686065|NCT00314275|Pharmacokinetics|pharmacokinetics
686066|NCT00314275|Coronary Artery Disease|coronary artery disease
686067|NCT00314275|PCI|pci
686068|NCT00314275|Drug Eluting Stent|drug eluting stent
686069|NCT00314262|Skin Lesions|skin lesions
686070|NCT00314262|Premalignant Lesion|premalignant lesion
686071|NCT00314249|Fibromyalgia|fibromyalgia
686072|NCT00314236|Cartilage repair|cartilage repair
686073|NCT00314236|Cartilage|cartilage
686074|NCT00314236|Knee|knee
686075|NCT00314236|Knee Pain|knee pain
686076|NCT00314236|Microfracture|microfracture
686077|NCT00314236|arthroscopy|arthroscopy
686078|NCT00314236|bone marrow stimulation|bone marrow stimulation
686079|NCT00314236|Chondrogenesis|chondrogenesis
686080|NCT00314236|Scaffold|scaffold
686081|NCT00314236|Chitosan|chitosan
686082|NCT00314236|A02.165.165|a02.165.165
686083|NCT00314236|A10.165.382.332|a10.165.382.332
686084|NCT00314236|G07.574.500.325.377.625.180|g07.574.500.325.377.625.180
686085|NCT00314236|A10.165.382.400|a10.165.382.400
686086|NCT00314236|Articular Cartilage Repair|articular cartilage repair
686087|NCT00314210|Generalised Anxiety Disorder|generalised anxiety disorder
686088|NCT00314197|automated counseling system|automated counseling system
686089|NCT00314197|telephone-based intervention|telephone-based intervention
686090|NCT00314197|behavior change|behavior change
686091|NCT00314184|Bipolar I disorder.|bipolar i disorder.
686092|NCT00314171|open-angle glaucoma|open-angle glaucoma
686093|NCT00314171|ocular hypertension|ocular hypertension
686094|NCT00314132|Japanese Encephalitis|japanese encephalitis
686095|NCT00314132|Encephalitis virus|encephalitis virus
686096|NCT00314132|ChimeriVax™-JE Vaccine|chimerivax™-je vaccine
686097|NCT00314119|Tumor Imaging|tumor imaging
686098|NCT00314119|NF1|nf1
686099|NCT00314119|Neurofibromatosis|neurofibromatosis
686100|NCT00314106|Clinical Response|clinical response
686101|NCT00314106|Stage IV Melanoma|stage iv melanoma
686102|NCT00314106|Adoptive Cell Therapy|adoptive cell therapy
686103|NCT00314106|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
686104|NCT00314106|Immunologic Response|immunologic response
686105|NCT00314106|Metastatic Melanoma|metastatic melanoma
686106|NCT00314093|Clinical Response|clinical response
686107|NCT00314093|Stage IV Melanoma|stage iv melanoma
686108|NCT00314093|Immunotoxin|immunotoxin
686109|NCT00314093|T Regulatory Cells|t regulatory cells
686110|NCT00314093|CD25+ Cells|cd25+ cells
686111|NCT00314093|Metastatic Melanoma|metastatic melanoma
686112|NCT00314080|Botulism|botulism
686113|NCT00314080|Botulinum anti-toxin|botulinum anti-toxin
686114|NCT00314080|Repetitive nerve stimulation|repetitive nerve stimulation
686115|NCT00314080|Respiratory failure|respiratory failure
686116|NCT00314067|Quality of Health Care|quality of health care
686117|NCT00314067|Primary Health Care|primary health care
686118|NCT00314067|Education|education
686119|NCT00314067|E-Learning|e-learning
686120|NCT00314067|Alcohol-related Disorders|alcohol-related disorders
686121|NCT00314054|Hepatitis C|hepatitis c
686122|NCT00314054|Hepatic Impairment|hepatic impairment
686123|NCT00314054|Healthy Volunteer|healthy volunteer
686124|NCT00314054|Phase 1|phase 1
686125|NCT00314054|Hepacivirus|hepacivirus
686126|NCT00314041|Infant|infant
686127|NCT00314041|Conjugate vaccine|conjugate vaccine
686128|NCT00314041|Meningococcal|meningococcal
686129|NCT00314041|Antibody|antibody
686130|NCT00314041|Immune memory|immune memory
686131|NCT00314041|Health|health
686132|NCT00314041|Meningococcal Vaccines|meningococcal vaccines
686133|NCT00314028|African American|african american
686134|NCT00314028|Men|men
686135|NCT00314028|Sexually Transmitted Diseases|sexually transmitted diseases
686136|NCT00314028|Condoms|condoms
686137|NCT00314002|Massive pulmonary embolism|massive pulmonary embolism
686138|NCT00314002|Catheter thrombectomy|catheter thrombectomy
686139|NCT00313976|Multiple Sclerosis|multiple sclerosis
686140|NCT00313976|Early secondary progressive Multiple Sclerosis|early secondary progressive multiple sclerosis
686141|NCT00313963|Anemia, Sickle Cell|anemia, sickle cell
686142|NCT00313963|Magnesium Sulfate|magnesium sulfate
686143|NCT00313963|pediatric|pediatric
686144|NCT00313950|measles|measles
686145|NCT00313950|rubella|rubella
686146|NCT00313950|mumps|mumps
686147|NCT00313950|hepatitis A|hepatitis a
686148|NCT00313924|URGENCY FREQUENCY SYNDROME|urgency frequency syndrome
686149|NCT00313924|URGE INCONTINENCE|urge incontinence
686150|NCT00313911|Diphtheria|diphtheria
686151|NCT00313911|Tetanus|tetanus
686152|NCT00313911|Pertussis|pertussis
686153|NCT00313911|Recombinant Hepatitis B|recombinant hepatitis b
686154|NCT00313911|Poliomyelitis|poliomyelitis
686155|NCT00313911|Haemophilus influenzae type b|haemophilus influenzae type b
686156|NCT00313911|Tetanus protein|tetanus protein
686157|NCT00313898|quality of sexual life, Mild erectile dysfunction|quality of sexual life, mild erectile dysfunction
686158|NCT00313872|gastric cancer|gastric cancer
686159|NCT00313872|chemotherapy|chemotherapy
686160|NCT00313872|irinotecan|irinotecan
686161|NCT00313872|docetaxel|docetaxel
686162|NCT00313859|colorectal cancer|colorectal cancer
686163|NCT00313859|metastatic|metastatic
686164|NCT00313846|Chronic pain|chronic pain
686166|NCT00313846|transdermal|transdermal
686167|NCT00313846|osteoarthritis|osteoarthritis
686168|NCT00313833|Chronic pain|chronic pain
686169|NCT00313833|elderly|elderly
686170|NCT00313833|supervised living|supervised living
686171|NCT00313833|opioid|opioid
686172|NCT00313833|transdermal|transdermal
686173|NCT00313820|Post-stroke pain, pregabalin|post-stroke pain, pregabalin
686174|NCT00313807|contrast nephropathy|contrast nephropathy
686175|NCT00313807|renal failure|renal failure
686176|NCT00313807|Travasol|travasol
686177|NCT00313781|randomized|randomized
686178|NCT00313781|non-comparative|non-comparative
686179|NCT00313781|efficacy|efficacy
686180|NCT00313768|advanced carcinoma, non-small cell lung, Phase II, paclitaxel, Taxol, carboplatin, Paraplatin, bevacizumab, Avastin, PF-3512676, immunotherapy, immunomodulator|advanced carcinoma, non-small cell lung, phase ii, paclitaxel, taxol, carboplatin, paraplatin, bevacizumab, avastin, pf-3512676, immunotherapy, immunomodulator
686181|NCT00313755|colonoscopy, narrow band imaging,|colonoscopy, narrow band imaging,
686182|NCT00313755|high definition endoscopy|high definition endoscopy
686183|NCT00313755|colorectal cancer|colorectal cancer
686184|NCT00313755|dysplasia|dysplasia
686185|NCT00313755|hereditary non-polyposis colorectal cancer|hereditary non-polyposis colorectal cancer
686186|NCT00313755|Lynch Syndrome|lynch syndrome
686187|NCT00313755|HNPCC|hnpcc
686188|NCT00313729|adult oligodendroglioma|adult oligodendroglioma
686189|NCT00313729|adult mixed glioma|adult mixed glioma
686190|NCT00313729|adult diffuse astrocytoma|adult diffuse astrocytoma
686191|NCT00313729|adult pilocytic astrocytoma|adult pilocytic astrocytoma
686192|NCT00313729|adult pineal gland astrocytoma|adult pineal gland astrocytoma
686193|NCT00313716|anemia|anemia
686194|NCT00313716|traumatic brain injury|traumatic brain injury
686195|NCT00313716|recombinant human erythropoietin|recombinant human erythropoietin
686196|NCT00313716|rhEpo|rhepo
686197|NCT00313716|erythropoietin|erythropoietin
686198|NCT00313716|TBI|tbi
686199|NCT00313716|Epo|epo
686200|NCT00313703|headache|headache
686201|NCT00313703|emergency department|emergency department
686202|NCT00313703|migraine|migraine
686203|NCT00313703|recurrent headache|recurrent headache
686204|NCT00313690|Lung Cancer|lung cancer
686205|NCT00313677|muscular dystrophy|muscular dystrophy
686206|NCT00313677|MD|md
686207|NCT00313677|fukutin-related protein gene|fukutin-related protein gene
686208|NCT00313677|limb girdle|limb girdle
686209|NCT00313677|FKRP gene|fkrp gene
686210|NCT00313677|congenital muscular dystrophy|congenital muscular dystrophy
686211|NCT00313677|childhood onset LGMD|childhood onset lgmd
686212|NCT00313677|adult onset LGMD|adult onset lgmd
686213|NCT00313677|POMT1|pomt1
686214|NCT00313677|POMT2|pomt2
686215|NCT00313677|POMGnT|pomgnt
686216|NCT00313677|LARGE|large
686217|NCT00313677|alpha dystroglycan|alpha dystroglycan
686218|NCT00313677|dystroglycanopathy|dystroglycanopathy
686219|NCT00313677|ISPD|ispd
686220|NCT00313677|DPM|dpm
686221|NCT00313677|GMPPB|gmppb
686222|NCT00313677|B3GNT1|b3gnt1
686223|NCT00313677|B3GALNT2|b3galnt2
686224|NCT00313677|GTDC2|gtdc2
686225|NCT00313677|TMEM5|tmem5
686226|NCT00313677|Fukutin|fukutin
686227|NCT00313677|DAG1|dag1
686228|NCT00313677|POMK|pomk
686229|NCT00313625|stage I multiple myeloma|stage i multiple myeloma
686230|NCT00313625|stage II multiple myeloma|stage ii multiple myeloma
686231|NCT00313625|stage III multiple myeloma|stage iii multiple myeloma
686232|NCT00313625|refractory multiple myeloma|refractory multiple myeloma
686233|NCT00313599|recurrent breast cancer|recurrent breast cancer
686234|NCT00313599|stage IV breast cancer|stage iv breast cancer
686235|NCT00313599|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
686236|NCT00313599|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
686237|NCT00313599|recurrent prostate cancer|recurrent prostate cancer
686238|NCT00313599|stage IV prostate cancer|stage iv prostate cancer
686239|NCT00313599|recurrent bladder cancer|recurrent bladder cancer
686240|NCT00313599|stage IV bladder cancer|stage iv bladder cancer
686241|NCT00313599|recurrent gastric cancer|recurrent gastric cancer
686242|NCT00313599|stage IV gastric cancer|stage iv gastric cancer
686243|NCT00313599|recurrent esophageal cancer|recurrent esophageal cancer
686244|NCT00313599|stage IV esophageal cancer|stage iv esophageal cancer
686245|NCT00313599|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
686246|NCT00313599|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
686247|NCT00313599|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
686248|NCT00313599|ovarian choriocarcinoma|ovarian choriocarcinoma
686249|NCT00313599|ovarian dysgerminoma|ovarian dysgerminoma
686250|NCT00313599|ovarian embryonal carcinoma|ovarian embryonal carcinoma
686251|NCT00313599|ovarian yolk sac tumor|ovarian yolk sac tumor
686252|NCT00313599|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
686253|NCT00313599|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
686254|NCT00313599|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
686346|NCT00313170|cancer|cancer
686255|NCT00313599|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
686256|NCT00313599|recurrent extragonadal seminoma|recurrent extragonadal seminoma
686257|NCT00313599|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
686258|NCT00313599|stage IV extragonadal seminoma|stage iv extragonadal seminoma
686259|NCT00313599|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
686260|NCT00313573|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
686261|NCT00313573|pain|pain
686262|NCT00313573|depression|depression
686263|NCT00313560|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
686264|NCT00313560|stage I pancreatic cancer|stage i pancreatic cancer
686265|NCT00313560|stage II pancreatic cancer|stage ii pancreatic cancer
686266|NCT00313547|Blood pressure|blood pressure
686267|NCT00313547|Hypertension|hypertension
686268|NCT00313547|Renin|renin
686269|NCT00313547|Aldosterone|aldosterone
686270|NCT00313547|Heart rate variability|heart rate variability
686271|NCT00313534|recurrent prostate cancer|recurrent prostate cancer
686272|NCT00313534|stage IIB prostate cancer|stage iib prostate cancer
686273|NCT00313534|stage IIA prostate cancer|stage iia prostate cancer
686274|NCT00313534|stage III prostate cancer|stage iii prostate cancer
686275|NCT00313534|stage I prostate cancer|stage i prostate cancer
686276|NCT00313521|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
686277|NCT00313521|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
686278|NCT00313508|stage IV melanoma|stage iv melanoma
686279|NCT00313508|recurrent melanoma|recurrent melanoma
686280|NCT00313508|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
686281|NCT00313508|recurrent intraocular melanoma|recurrent intraocular melanoma
686282|NCT00313508|metastatic intraocular melanoma|metastatic intraocular melanoma
686283|NCT00313508|extraocular extension melanoma|extraocular extension melanoma
686284|NCT00313508|iris melanoma|iris melanoma
686285|NCT00313495|Huntington disease, observational, family members, biomarker|huntington disease, observational, family members, biomarker
686286|NCT00313469|Pharmacokinetics/Pharmacodynamics|pharmacokinetics/pharmacodynamics
686287|NCT00313469|Elderly|elderly
686288|NCT00313469|Anticoagulants|anticoagulants
686289|NCT00313443|Anti-Arrhythmia Agents|anti-arrhythmia agents
686290|NCT00313443|Amiodarone, chronic treatment|amiodarone, chronic treatment
686291|NCT00313443|Amiodarone, adverse effects|amiodarone, adverse effects
686292|NCT00313443|Biopsy, Fine-Needle, Adipose tissue|biopsy, fine-needle, adipose tissue
686293|NCT00313443|Drug concentrations in tissues|drug concentrations in tissues
686294|NCT00313443|Drug accumulation in tissues|drug accumulation in tissues
686295|NCT00313430|Urine concentration ability|urine concentration ability
686296|NCT00313430|chronic renal insufficiency|chronic renal insufficiency
686297|NCT00313430|hypertension|hypertension
686298|NCT00313430|aquaporin2|aquaporin2
686299|NCT00313430|Patients with chronic renal insufficiency|patients with chronic renal insufficiency
686300|NCT00313430|Patients with hypertension|patients with hypertension
686301|NCT00313430|Healthy volunteers|healthy volunteers
686302|NCT00313417|Creatine|creatine
686303|NCT00313417|major depressive disorders|major depressive disorders
686304|NCT00313404|Norovirus|norovirus
686305|NCT00313404|Gastroenteritis|gastroenteritis
686306|NCT00313404|Clinical Trial|clinical trial
686307|NCT00313404|Stomach flu|stomach flu
686308|NCT00313378|Thoracotomy|thoracotomy
686309|NCT00313378|Neuropathic pain|neuropathic pain
686310|NCT00313378|Nerve trauma|nerve trauma
686311|NCT00313378|Ketamine|ketamine
686312|NCT00313378|NMDA receptors|nmda receptors
686313|NCT00313352|adult|adult
686314|NCT00313352|cardiac|cardiac
686315|NCT00313352|transposition of great arteries|transposition of great arteries
686316|NCT00313352|beta-adrenergic blockers|beta-adrenergic blockers
686317|NCT00313339|myocardial infarction|myocardial infarction
686318|NCT00313339|bone marrow|bone marrow
686319|NCT00313339|cd34+|cd34+
686320|NCT00313339|stem cells|stem cells
686321|NCT00313326|Adaptive Support ventilation|adaptive support ventilation
686322|NCT00313326|Weaning|weaning
686323|NCT00313248|Breast Cancer|breast cancer
686324|NCT00313248|Metastatic Breast Cancer|metastatic breast cancer
686325|NCT00313235|Dendritic Vaccine|dendritic vaccine
686326|NCT00313235|Melanoma|melanoma
686327|NCT00313235|Cyclophosphamide (CPA)|cyclophosphamide (cpa)
686328|NCT00313222|CTEPH|cteph
686329|NCT00313222|bosentan|bosentan
686330|NCT00313209|Roflumilast|roflumilast
686331|NCT00313209|Salmeterol|salmeterol
686332|NCT00313209|COPD|copd
686333|NCT00313209|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
686334|NCT00313196|Pulmonary Hypertension|pulmonary hypertension
686335|NCT00313196|Sickle Cell Disease|sickle cell disease
686336|NCT00313196|Sickle cell anemia|sickle cell anemia
686337|NCT00313196|bosentan|bosentan
686338|NCT00313196|ASSET|asset
686339|NCT00313196|ASSET-2|asset-2
686340|NCT00313183|Type 1 Diabetes|type 1 diabetes
686341|NCT00313183|pediatric|pediatric
686342|NCT00313183|pramlintide|pramlintide
686343|NCT00313183|Symlin|symlin
686344|NCT00313183|Amylin|amylin
686345|NCT00313170|oncology|oncology
686347|NCT00313170|breast cancer|breast cancer
686348|NCT00313157|Atrial fibrillation|atrial fibrillation
686349|NCT00313131|bacterial vaginosis|bacterial vaginosis
686350|NCT00313131|vaginal candidiasis|vaginal candidiasis
686351|NCT00313131|trichomoniasis|trichomoniasis
686352|NCT00313131|vaginitis|vaginitis
686353|NCT00313131|Ghana|ghana
686354|NCT00313131|Togo|togo
686355|NCT00313131|Mali|mali
686356|NCT00313131|Guinea|guinea
686357|NCT00313118|oxidative stress parameters|oxidative stress parameters
686358|NCT00313105|smoking cessation|smoking cessation
686359|NCT00313105|smokeless tobacco|smokeless tobacco
686360|NCT00313105|nicotine patch|nicotine patch
686361|NCT00313105|nicotine buccal tablets|nicotine buccal tablets
686362|NCT00313105|retreatment|retreatment
686363|NCT00313105|adherence|adherence
686364|NCT00313092|OSAS|osas
686365|NCT00313092|glaucoma|glaucoma
686366|NCT00313092|MMP|mmp
686367|NCT00313066|CTGF|ctgf
686368|NCT00313066|fibrogenic cytokine|fibrogenic cytokine
686369|NCT00313066|FGF|fgf
686370|NCT00313066|pleural fibrosis|pleural fibrosis
686371|NCT00313040|physical activity|physical activity
686372|NCT00313040|sedentary|sedentary
686373|NCT00313040|behavioral medicine|behavioral medicine
686374|NCT00313040|motivational interviewing|motivational interviewing
686375|NCT00313014|Low back pain|low back pain
686376|NCT00313014|opioid|opioid
686377|NCT00313014|transdermal|transdermal
686378|NCT00313014|Butrans|butrans
686379|NCT00312988|Ovarian cancer|ovarian cancer
686380|NCT00312962|Schizoaffective Disorder|schizoaffective disorder
686381|NCT00312962|Cognitive Remediation|cognitive remediation
686382|NCT00312962|fMRI|fmri
686383|NCT00312949|Patient participation|patient participation
686384|NCT00312949|Patient education|patient education
686385|NCT00312949|Consumer involvement|consumer involvement
686386|NCT00312936|Medication adherence|medication adherence
686387|NCT00312936|Medication compliance|medication compliance
686388|NCT00312936|Quality of Life|quality of life
686389|NCT00312936|Stress reduction|stress reduction
686390|NCT00312936|mindfulness based stress reduction|mindfulness based stress reduction
686391|NCT00312936|HIV/AIDS|hiv/aids
686392|NCT00312936|treatment experienced|treatment experienced
686393|NCT00312923|HIV|hiv
686394|NCT00312923|lipids|lipids
686395|NCT00312923|dyslipidemia|dyslipidemia
686396|NCT00312923|policosanol|policosanol
686397|NCT00312923|treatment experienced|treatment experienced
686398|NCT00312910|Cirrhosis|cirrhosis
686399|NCT00312910|Probiotics|probiotics
686400|NCT00312910|Hepatic encephalopathy|hepatic encephalopathy
686401|NCT00312910|Ammonia|ammonia
686402|NCT00312897|Adolescents|adolescents
686403|NCT00312897|Depression|depression
686404|NCT00312897|Fish Oil|fish oil
686405|NCT00312897|Omega-3 Fatty Acids|omega-3 fatty acids
686406|NCT00312897|Psychiatry|psychiatry
686407|NCT00312884|telemonitoring|telemonitoring
686408|NCT00312884|heart failure|heart failure
686409|NCT00312884|randomised|randomised
686410|NCT00312884|hospitalisation|hospitalisation
686411|NCT00312884|HomMed|hommed
686412|NCT00312871|Chronic renal failure|chronic renal failure
686413|NCT00312871|Anemia|anemia
686414|NCT00312871|Renal replacement therapy|renal replacement therapy
686415|NCT00312871|Epoetin|epoetin
686416|NCT00312871|Epoetin alfa|epoetin alfa
686417|NCT00312871|erythropoietin|erythropoietin
686418|NCT00312871|Chronic kidney failure|chronic kidney failure
686419|NCT00312871|end-stage renal disease|end-stage renal disease
686420|NCT00312858|Hepatitis A Virus|hepatitis a virus
686421|NCT00312845|B-cell Non-Hodgkin's Lymphoma|b-cell non-hodgkin's lymphoma
686423|NCT00312832|d4T|d4t
686424|NCT00312832|TDF|tdf
686425|NCT00312832|lipoatrophy|lipoatrophy
686426|NCT00312832|treatment experienced|treatment experienced
686427|NCT00312832|HIV-infection|hiv-infection
686428|NCT00312819|Non-small cel lung cancer|non-small cel lung cancer
686429|NCT00312819|chemotherapy|chemotherapy
686430|NCT00312819|randomized phaseII|randomized phaseii
686431|NCT00312819|disulfiram|disulfiram
686432|NCT00312819|antiangiogenesis|antiangiogenesis
686433|NCT00312819|placebo|placebo
686434|NCT00312806|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
686435|NCT00312806|GERD|gerd
686436|NCT00312806|Pantoprazole|pantoprazole
686437|NCT00312806|ReQuestTM|requesttm
686438|NCT00312793|Anterior Cruciate Ligament reconstruction surgery|anterior cruciate ligament reconstruction surgery
686439|NCT00312780|albuminuria|albuminuria
686440|NCT00312780|diabetic nephropathy|diabetic nephropathy
686441|NCT00312780|diabetes|diabetes
686442|NCT00312767|Agalsidase beta|agalsidase beta
686443|NCT00312767|alpha Galactosidase A|alpha galactosidase a
686444|NCT00312767|aGAL|agal
686445|NCT00312767|rh aGAL|rh agal
686446|NCT00312767|Fabry|fabry
686447|NCT00312767|GL3|gl3
686448|NCT00312767|Fabrazyme|fabrazyme
686449|NCT00312767|dialysis|dialysis
686450|NCT00312767|hemodialysis|hemodialysis
686451|NCT00312741|community-acquired pneumonia|community-acquired pneumonia
686452|NCT00312741|microbiological tests|microbiological tests
686453|NCT00312741|urinary antigen|urinary antigen
686454|NCT00312741|selection of antibiotic treatment|selection of antibiotic treatment
686455|NCT00312728|Brain Cancer|brain cancer
686456|NCT00312728|Brain Metastases|brain metastases
686457|NCT00312728|Avastin|avastin
686458|NCT00312728|NSCLC|nsclc
686459|NCT00312728|Lung Cancer|lung cancer
686460|NCT00312728|PASSPORT|passport
686461|NCT00312715|Deiodinase|deiodinase
686462|NCT00312715|Levothyroxine|levothyroxine
686463|NCT00312715|Liothyronine|liothyronine
686464|NCT00312715|Lipid Metabolism|lipid metabolism
686465|NCT00312715|Healthy Volunteer|healthy volunteer
686466|NCT00312715|HV|hv
686467|NCT00312702|Vaccine|vaccine
686468|NCT00312702|Malaria|malaria
686469|NCT00312702|Liver Stage Antigen-1|liver stage antigen-1
686470|NCT00312702|Falciparum Malaria Protein-11|falciparum malaria protein-11
686471|NCT00312702|AS02A|as02a
686472|NCT00312702|adjuvant|adjuvant
686473|NCT00312689|congenital|congenital
686474|NCT00312689|lacrimal|lacrimal
686475|NCT00312689|stenosis|stenosis
686476|NCT00312689|bacteria|bacteria
686477|NCT00312689|microbiological|microbiological
686478|NCT00312676|Tolerability|tolerability
686479|NCT00312676|Depakote DR|depakote dr
686480|NCT00312676|Depakote ER|depakote er
686481|NCT00312676|Elderly|elderly
686482|NCT00312676|Conversion|conversion
686483|NCT00312663|Vaccine|vaccine
686484|NCT00312663|Phase I/II|phase i/ii
686485|NCT00312663|Malaria|malaria
686486|NCT00312663|Liver Stage Antigen -1|liver stage antigen -1
686487|NCT00312663|Falciparum Malaria Protein -11|falciparum malaria protein -11
686488|NCT00312663|AS01B|as01b
686489|NCT00312663|adjuvant|adjuvant
686490|NCT00312650|ovarian cancer|ovarian cancer
686491|NCT00312650|recurrent|recurrent
686492|NCT00312650|progressive|progressive
686493|NCT00312637|Breast Cancer Staging|breast cancer staging
686494|NCT00312624|ICD implantation|icd implantation
686495|NCT00312624|cardiac MRI|cardiac mri
686496|NCT00312624|cardiomyopathy|cardiomyopathy
686497|NCT00312624|ventricular arrhythmias|ventricular arrhythmias
686498|NCT00312624|LVEF 35% or less|lvef 35% or less
686499|NCT00312624|indication for ICD implantation as part of standard of care|indication for icd implantation as part of standard of care
686500|NCT00312611|Gastric pacing device|gastric pacing device
686501|NCT00312611|Obesity|obesity
686502|NCT00312598|schizophrenia|schizophrenia
686503|NCT00312598|BMI|bmi
686504|NCT00312598|weight|weight
686505|NCT00312598|aripiprazole|aripiprazole
686506|NCT00312598|antipsychotic|antipsychotic
686507|NCT00312598|Mood Disorders with psychotic features|mood disorders with psychotic features
686508|NCT00312585|pregnancy|pregnancy
686509|NCT00312585|acupuncture|acupuncture
686510|NCT00312572|Osteoarthritis, opioid, transdermal|osteoarthritis, opioid, transdermal
686511|NCT00312559|Parkinson's Disease|parkinson's disease
686512|NCT00312546|Virus Latency|virus latency
686513|NCT00312546|Valproic Acid|valproic acid
686514|NCT00312546|Histone Deacetylase|histone deacetylase
686515|NCT00312533|knee|knee
686516|NCT00312533|injection|injection
686517|NCT00312533|function|function
686518|NCT00312533|osteoarthritis|osteoarthritis
686519|NCT00312507|Meconium Aspiration Syndrome|meconium aspiration syndrome
686520|NCT00312507|Surfactant|surfactant
686521|NCT00312507|Bronchoalveolar Lavage|bronchoalveolar lavage
686522|NCT00312507|newborns|newborns
686523|NCT00312468|AIDS|aids
686524|NCT00312455|Substance abuse|substance abuse
686525|NCT00312455|Depression|depression
686526|NCT00312455|Aggression|aggression
686527|NCT00312442|Prostate cancer after radiation therapy|prostate cancer after radiation therapy
686528|NCT00312429|Hematological Malignancies|hematological malignancies
686529|NCT00312429|Leukemia|leukemia
686530|NCT00312429|Lymphoma|lymphoma
686531|NCT00312429|Myelodysplasia|myelodysplasia
686532|NCT00312429|Multiple Myeloma|multiple myeloma
686533|NCT00312416|Choroidal blood flow|choroidal blood flow
686534|NCT00312416|Clonidin|clonidin
686535|NCT00312416|Brimonidin|brimonidin
686536|NCT00312403|Glaucoma|glaucoma
686537|NCT00312403|Gene Polymorphism|gene polymorphism
686538|NCT00312403|Metalloproteinase|metalloproteinase
686539|NCT00312390|Amblyopia|amblyopia
686540|NCT00312390|Retinal vessel diameters|retinal vessel diameters
686541|NCT00312390|Retinal blood flow|retinal blood flow
686542|NCT00312390|Flicker|flicker
686543|NCT00312377|Non-small cell lung cancer|non-small cell lung cancer
686544|NCT00312377|NSCLC|nsclc
686545|NCT00312364|toe ulcer|toe ulcer
686546|NCT00312364|heel ulcer|heel ulcer
686547|NCT00312364|foot ulcer|foot ulcer
686548|NCT00312364|diabetic feet|diabetic feet
686549|NCT00312364|diabetic foot|diabetic foot
686550|NCT00312364|complications of diabetes|complications of diabetes
686552|NCT00312351|Age-Related Macular Degeneration|age-related macular degeneration
686553|NCT00312351|Macular Degeneration|macular degeneration
686554|NCT00312351|Macugen|macugen
686555|NCT00312351|pegaptanib sodium|pegaptanib sodium
686556|NCT00312351|ERG|erg
686557|NCT00312351|specular microscopy|specular microscopy
686558|NCT00312351|Age-Related Mcular Degeneration (AMD)|age-related mcular degeneration (amd)
686757|NCT00311428|Influenza|influenza
686559|NCT00312325|Optic nerve head blood flow|optic nerve head blood flow
686560|NCT00312325|Choroidal blood flow|choroidal blood flow
686561|NCT00312325|Prednisolone|prednisolone
686562|NCT00312325|Graves´ Ophthalmopathy|graves´ ophthalmopathy
686563|NCT00312325|optic neuritis|optic neuritis
686564|NCT00312312|Asthma|asthma
686565|NCT00312312|Allergic rhinitis|allergic rhinitis
686566|NCT00312312|Atopy|atopy
686567|NCT00312312|Exhaled nitric oxide|exhaled nitric oxide
686568|NCT00312312|Specific immunotherapy|specific immunotherapy
686569|NCT00312312|Atopic diseases|atopic diseases
686570|NCT00312299|Double-Blind Method|double-blind method
686571|NCT00312299|Clinical Trials, Randomized|clinical trials, randomized
686572|NCT00312299|Lenses, Intraocular|lenses, intraocular
686573|NCT00312299|Prospective Studies|prospective studies
686574|NCT00312299|PMMA|pmma
686575|NCT00312299|Visual acuity|visual acuity
686576|NCT00312286|Cervical Neoplasms|cervical neoplasms
686577|NCT00312286|Drug Therapy|drug therapy
686578|NCT00312286|Human Papillomavirus|human papillomavirus
686579|NCT00312286|Cervical Human Papillomavirus|cervical human papillomavirus
686580|NCT00312286|Cervical Dysplasia|cervical dysplasia
686581|NCT00312286|Chemoprevention|chemoprevention
686582|NCT00312286|High Risk Cervical Human Papillomavirus|high risk cervical human papillomavirus
686583|NCT00312286|Atypical Squamous Cells of Undetermined Significance|atypical squamous cells of undetermined significance
686584|NCT00312286|Low Grade Intraepithelial Lesions|low grade intraepithelial lesions
686585|NCT00312273|Heart Arrest|heart arrest
686586|NCT00312273|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
686587|NCT00312273|Aminophylline|aminophylline
686588|NCT00312273|Bradycardia|bradycardia
686589|NCT00312273|Humans|humans
686590|NCT00312273|Emergency Medical Services|emergency medical services
686591|NCT00312260|Pain|pain
686592|NCT00312260|Analgesia|analgesia
686593|NCT00312260|Gabapentin|gabapentin
686594|NCT00312260|Amitriptyline|amitriptyline
686595|NCT00312260|Pediatrics|pediatrics
686596|NCT00312247|Walking|walking
686597|NCT00312247|Muscle Strength|muscle strength
686598|NCT00312247|Energy Cost|energy cost
686599|NCT00312247|Quality of Life|quality of life
686600|NCT00312234|Muscular Disease|muscular disease
686601|NCT00312234|Fibromyalgia|fibromyalgia
686602|NCT00312234|Exercise Therapy|exercise therapy
686603|NCT00312234|Qigong|qigong
686604|NCT00312234|Aerobic Exercise|aerobic exercise
686605|NCT00312234|pediatrics|pediatrics
686606|NCT00312221|Osteoarthritis, opioid, transdermal|osteoarthritis, opioid, transdermal
686607|NCT00312195|Chronic pain|chronic pain
686608|NCT00312195|opioid|opioid
686609|NCT00312195|transdermal|transdermal
686610|NCT00312195|Butrans™ [BTDS]|butrans™ [btds]
686611|NCT00312169|HIV|hiv
686612|NCT00312169|NNRTI|nnrti
686613|NCT00312169|Incomplete virologic suppression|incomplete virologic suppression
686614|NCT00312169|treatment experienced|treatment experienced
686615|NCT00312143|De novo Kidney Transplant recipients, enteric-coated mycophenolate sodium|de novo kidney transplant recipients, enteric-coated mycophenolate sodium
686616|NCT00312130|Vildaglptin|vildaglptin
686617|NCT00312130|Pre-diabetes|pre-diabetes
686618|NCT00312117|contrast induced nephropathy|contrast induced nephropathy
686619|NCT00312117|sodium bicarbonate|sodium bicarbonate
686620|NCT00312117|cardiac catheterization|cardiac catheterization
686621|NCT00312091|Pharmacokinetics|pharmacokinetics
686622|NCT00312091|Treatment Experienced|treatment experienced
686623|NCT00312078|Minimal Hepatic Encephalopathy|minimal hepatic encephalopathy
686624|NCT00312078|Cirrhosis|cirrhosis
686625|NCT00312065|servocontrolled|servocontrolled
686626|NCT00312065|radiant warmer|radiant warmer
686627|NCT00312065|thermistor|thermistor
686628|NCT00312065|heat shield|heat shield
686629|NCT00312052|Coronary Artery Disease|coronary artery disease
686630|NCT00312039|HIV-1|hiv-1
686631|NCT00312039|treatment experienced|treatment experienced
686632|NCT00312026|Plaque Psoriasis|plaque psoriasis
686633|NCT00312026|Hands|hands
686634|NCT00312026|Feet|feet
686635|NCT00312026|Hand|hand
686636|NCT00312013|low molecular weight heparin|low molecular weight heparin
686637|NCT00312013|nadroparin|nadroparin
686638|NCT00312013|non-small cell lung cancer|non-small cell lung cancer
686639|NCT00312013|cancer survival|cancer survival
686640|NCT00312013|prostate cancer|prostate cancer
686641|NCT00312013|pancreatic cancer|pancreatic cancer
686642|NCT00312000|colorectal|colorectal
686643|NCT00312000|cancer|cancer
686644|NCT00312000|capecitabine|capecitabine
686645|NCT00312000|irinotecan|irinotecan
686646|NCT00312000|oxaliplatin|oxaliplatin
686647|NCT00311987|Hypercholesterolemia|hypercholesterolemia
686648|NCT00311987|Thyroid hormone|thyroid hormone
686649|NCT00311987|Diiodothyropropionic acid|diiodothyropropionic acid
686650|NCT00311987|Therapy|therapy
686651|NCT00311974|Dihydralazine|dihydralazine
686652|NCT00311974|Sympathetic activation|sympathetic activation
686653|NCT00311974|Fractional sodium excretion|fractional sodium excretion
686654|NCT00311961|COPD|copd
686655|NCT00311961|Exacerbations|exacerbations
686656|NCT00311961|Corticosteroids|corticosteroids
686657|NCT00311961|Oral|oral
686658|NCT00311961|Intravenous|intravenous
686659|NCT00311961|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
686660|NCT00311948|Teen smokers|teen smokers
686661|NCT00311948|Quithelper|quithelper
686662|NCT00311948|Tobacco|tobacco
686663|NCT00311948|Tobacco Website|tobacco website
686664|NCT00311948|Website Intervention|website intervention
686665|NCT00311948|Tobacco counseling|tobacco counseling
686666|NCT00311948|Tobacco abstinence|tobacco abstinence
686667|NCT00311935|Hernia|hernia
686668|NCT00311935|Inguinal|inguinal
686669|NCT00311935|Groin|groin
686670|NCT00311935|Laparoscopic|laparoscopic
686671|NCT00311935|Open|open
686672|NCT00311935|Abdominal wall|abdominal wall
686673|NCT00311922|Diabetes|diabetes
686674|NCT00311922|Education|education
686675|NCT00311922|Health Literacy|health literacy
686676|NCT00311909|Tourette Syndrome|tourette syndrome
686677|NCT00311909|Deep Brain Stimulation|deep brain stimulation
686678|NCT00311909|Video assessment|video assessment
686679|NCT00311909|YGTSS|ygtss
686680|NCT00311909|TSSL|tssl
686681|NCT00311896|Cancer|cancer
686682|NCT00311896|Thrombosis|thrombosis
686683|NCT00311896|Catheter|catheter
686684|NCT00311896|Bemiparin|bemiparin
686685|NCT00311896|Prophylaxis|prophylaxis
686686|NCT00311883|Cystic Fibrosis|cystic fibrosis
686687|NCT00311883|Induced sputum|induced sputum
686688|NCT00311883|Lung inflammation|lung inflammation
686689|NCT00311857|Cetuximab|cetuximab
686690|NCT00311831|Pediatrics|pediatrics
686691|NCT00311831|Gastroenteritis|gastroenteritis
686692|NCT00311831|Education|education
686693|NCT00311792|training|training
686694|NCT00311792|teaching|teaching
686695|NCT00311792|curriculum|curriculum
686696|NCT00311779|Pediculosis capitis|pediculosis capitis
686697|NCT00311779|Head Lice|head lice
686698|NCT00311779|Crawlers|crawlers
686699|NCT00311779|Ova|ova
686700|NCT00311766|Epidermolysis Bullosa|epidermolysis bullosa
686701|NCT00311766|cutaneous wound-healing|cutaneous wound-healing
686702|NCT00311766|chronic wound-healing|chronic wound-healing
686703|NCT00311766|Thymosin Beta 4|thymosin beta 4
686704|NCT00311766|laminin-5|laminin-5
686705|NCT00311753|heparin, thromboprophylaxis, medical patients, acutely ill|heparin, thromboprophylaxis, medical patients, acutely ill
686706|NCT00311753|Acutely ill non surgical patients|acutely ill non surgical patients
686707|NCT00311753|Immobilization|immobilization
686708|NCT00311740|Hypertension,|hypertension,
686709|NCT00311740|Valsartan,|valsartan,
686710|NCT00311740|Hydrochlorothiazide|hydrochlorothiazide
686711|NCT00311727|Cell-Mediated Immune Responses, Influenza, A/H5N1, Vaccine, sub-study|cell-mediated immune responses, influenza, a/h5n1, vaccine, sub-study
686712|NCT00311714|Influenza, United Kingdom|influenza, united kingdom
686713|NCT00311701|Influenza, pediatric|influenza, pediatric
686714|NCT00311688|IL-2|il-2
686715|NCT00311688|Immunomodulatory Therapies|immunomodulatory therapies
686716|NCT00311675|influenza, A/H5N1, vaccine|influenza, a/h5n1, vaccine
686717|NCT00311649|H5N1, Influenza|h5n1, influenza
686718|NCT00311636|stage I breast cancer|stage i breast cancer
686719|NCT00311636|stage II breast cancer|stage ii breast cancer
686720|NCT00311636|stage IIIA breast cancer|stage iiia breast cancer
686721|NCT00311636|stage IIIB breast cancer|stage iiib breast cancer
686722|NCT00311636|stage IIIC breast cancer|stage iiic breast cancer
686723|NCT00311623|stage III prostate cancer|stage iii prostate cancer
686724|NCT00311623|stage I prostate cancer|stage i prostate cancer
686725|NCT00311623|stage IIB prostate cancer|stage iib prostate cancer
686726|NCT00311623|stage IIA prostate cancer|stage iia prostate cancer
686727|NCT00311623|adenocarcinoma of the prostate|adenocarcinoma of the prostate
686728|NCT00311610|recurrent colon cancer|recurrent colon cancer
686729|NCT00311610|stage IV colon cancer|stage iv colon cancer
686730|NCT00311610|recurrent rectal cancer|recurrent rectal cancer
686731|NCT00311610|stage IV rectal cancer|stage iv rectal cancer
686732|NCT00311597|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
686733|NCT00311584|recurrent neuroblastoma|recurrent neuroblastoma
686734|NCT00311571|bedrest|bedrest
686735|NCT00311571|spaceflight|spaceflight
686736|NCT00311571|Weightlessness|weightlessness
686737|NCT00311571|Countermeasure|countermeasure
686738|NCT00311558|stage IV melanoma|stage iv melanoma
686739|NCT00311558|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
686740|NCT00311558|recurrent melanoma|recurrent melanoma
686741|NCT00311545|recurrent renal cell cancer|recurrent renal cell cancer
686742|NCT00311545|stage IV renal cell cancer|stage iv renal cell cancer
686743|NCT00311545|stage III renal cell cancer|stage iii renal cell cancer
686744|NCT00311519|Subcutaneous hydration|subcutaneous hydration
686745|NCT00311519|Hylenex|hylenex
686746|NCT00311519|Hyaluronidase|hyaluronidase
686747|NCT00311506|Pulmozyme|pulmozyme
686748|NCT00311493|TBE|tbe
686749|NCT00311493|vaccine|vaccine
686750|NCT00311493|adults|adults
686751|NCT00311480|influenza|influenza
686752|NCT00311480|pandemic influenza|pandemic influenza
686753|NCT00311480|influenza vaccine|influenza vaccine
686754|NCT00311480|adjuvanted influenza vaccine|adjuvanted influenza vaccine
686755|NCT00311467|renal cell cancer|renal cell cancer
686756|NCT00311441|TBE, children, vaccine|tbe, children, vaccine
686758|NCT00311428|Children|children
686759|NCT00311428|Vaccine|vaccine
686760|NCT00311415|Prevention of Meningococcal Meningitis|prevention of meningococcal meningitis
686761|NCT00311415|meningococcal vaccines|meningococcal vaccines
686762|NCT00311415|conjugate|conjugate
686763|NCT00311415|immunology|immunology
686764|NCT00311415|infant|infant
686765|NCT00311415|antibody persistence|antibody persistence
686766|NCT00311389|Glaucoma|glaucoma
686767|NCT00311389|POAG|poag
686768|NCT00311389|OAG|oag
686769|NCT00311389|OHT|oht
686770|NCT00311350|Safety|safety
686771|NCT00311350|Health|health
686772|NCT00311350|Pharmacokinetics|pharmacokinetics
686773|NCT00311350|ileus|ileus
686774|NCT00311337|VELCADE|velcade
686775|NCT00311337|bortezomib|bortezomib
686776|NCT00311337|maintenance treatment|maintenance treatment
686777|NCT00311337|multiple myeloma|multiple myeloma
686778|NCT00311337|primary disease|primary disease
686779|NCT00311324|behavioral intervention|behavioral intervention
686780|NCT00311311|Kidney transplant|kidney transplant
686781|NCT00311311|Renal transplant|renal transplant
686782|NCT00311311|Immunosuppression|immunosuppression
686783|NCT00311311|Atherosclerosis|atherosclerosis
686784|NCT00311311|Graft Rejection|graft rejection
686785|NCT00311298|tuberculosis|tuberculosis
686787|NCT00311298|diabetes|diabetes
686788|NCT00311298|protein-energy|protein-energy
686789|NCT00311298|micronutrients|micronutrients
686790|NCT00311285|Electromyography|electromyography
686791|NCT00311285|Glucocorticoids|glucocorticoids
686792|NCT00311285|Heart Rate|heart rate
686793|NCT00311285|Physical workload|physical workload
686794|NCT00311285|Mental workload|mental workload
686795|NCT00311285|Ergonomics|ergonomics
686796|NCT00311285|Laparoscopy|laparoscopy
686797|NCT00311285|Workload|workload
686798|NCT00311285|Biomechanics|biomechanics
686799|NCT00311272|dendritic cells|dendritic cells
686800|NCT00311272|antigens, neoplasm|antigens, neoplasm
686801|NCT00311246|Sarcoidosis|sarcoidosis
686802|NCT00311246|Humira|humira
686803|NCT00311246|Adalimumab|adalimumab
686804|NCT00311246|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors
686805|NCT00311233|child|child
686806|NCT00311233|psychosocial|psychosocial
686807|NCT00311233|predictors|predictors
686808|NCT00311233|cohort|cohort
686809|NCT00311233|recurrent|recurrent
686810|NCT00311220|tuberculosis|tuberculosis
686811|NCT00311220|latent tuberculosis|latent tuberculosis
686812|NCT00311220|tuberculin skin test|tuberculin skin test
686813|NCT00311220|quantiferon TB-RD1|quantiferon tb-rd1
686814|NCT00311220|contact screening|contact screening
686815|NCT00311220|elderly|elderly
686816|NCT00311207|diagnostic kit|diagnostic kit
686817|NCT00311207|immunochromatography test|immunochromatography test
686818|NCT00311207|PCR detection kit|pcr detection kit
686819|NCT00311207|luminex|luminex
686820|NCT00311194|Heart failure|heart failure
686821|NCT00311194|Education|education
686822|NCT00311194|CD-ROM|cd-rom
686823|NCT00311194|Randomization|randomization
686824|NCT00311194|Hospitalization|hospitalization
686825|NCT00311194|Readmission|readmission
686826|NCT00311194|Death|death
686827|NCT00311194|Knowledge|knowledge
686828|NCT00311181|ICD|icd
686829|NCT00311181|Defibrillation|defibrillation
686830|NCT00311181|ULV|ulv
686831|NCT00311181|Tuned|tuned
686832|NCT00311155|Olmesartan medoxomil|olmesartan medoxomil
686833|NCT00311155|Hypertension|hypertension
686834|NCT00311142|Sleep pattern|sleep pattern
686835|NCT00311142|newborn|newborn
686836|NCT00311142|actigraphy|actigraphy
686837|NCT00311142|delivery mode|delivery mode
686838|NCT00311142|Parents' approval|parents' approval
686839|NCT00311116|Vitamin E|vitamin e
686840|NCT00311116|Cancer|cancer
686841|NCT00311116|pediatrics|pediatrics
686842|NCT00311116|supportive care|supportive care
686843|NCT00311116|oral mucositis|oral mucositis
686844|NCT00311116|Bayesian analysis|bayesian analysis
686845|NCT00311116|N-of-1 trial|n-of-1 trial
686846|NCT00311116|prophylaxis|prophylaxis
686847|NCT00311103|Elderly|elderly
686848|NCT00311103|Disability|disability
686849|NCT00311103|Musculoskeletal diseases|musculoskeletal diseases
686850|NCT00311090|Deep Venous Thrombosis|deep venous thrombosis
686851|NCT00311051|Asthma|asthma
686852|NCT00311051|Allergens|allergens
686853|NCT00311051|house dust mites|house dust mites
686854|NCT00311051|Ramatroban|ramatroban
686855|NCT00311051|Montelukast|montelukast
686856|NCT00311051|Bronchial Provocation Tests|bronchial provocation tests
686857|NCT00311038|ONO-1101|ono-1101
686858|NCT00311038|Landiolol Hydrochloride|landiolol hydrochloride
686859|NCT00311038|Multi-slice CT|multi-slice ct
686860|NCT00311038|Coronary Artery Disease|coronary artery disease
686861|NCT00311025|stroke|stroke
686862|NCT00311025|physical therapy|physical therapy
686863|NCT00311025|rehabilitation|rehabilitation
686864|NCT00311025|exercise|exercise
686865|NCT00311025|longterm follow-up|longterm follow-up
686866|NCT00311012|Hypertension, Aliskiren|hypertension, aliskiren
686867|NCT00310999|Cervical Vertebrae|cervical vertebrae
686868|NCT00310999|Intubation, Intratracheal|intubation, intratracheal
686869|NCT00310999|Laryngoscopes|laryngoscopes
686870|NCT00310999|Fluoroscopy|fluoroscopy
686871|NCT00310986|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
686872|NCT00310986|meditation|meditation
686873|NCT00310986|breathing meditation|breathing meditation
686874|NCT00310986|Anapanasathi|anapanasathi
686875|NCT00310986|randomized controlled trial|randomized controlled trial
686876|NCT00310986|nonpharmacologic treatment|nonpharmacologic treatment
686877|NCT00310986|complementary and alternative medicine|complementary and alternative medicine
686878|NCT00310973|HIV|hiv
686879|NCT00310973|Prevention|prevention
686880|NCT00310973|Risk Behavior Reduction|risk behavior reduction
686881|NCT00310973|Roma|roma
686882|NCT00310973|Bulgaria|bulgaria
686883|NCT00310973|HIV seronegativity|hiv seronegativity
686884|NCT00310960|infantile esotropia|infantile esotropia
686885|NCT00310960|acquired non-accommodative esotropia|acquired non-accommodative esotropia
686886|NCT00310960|acquired partially accommodative esotropia|acquired partially accommodative esotropia
686887|NCT00310947|Coronary artery disease|coronary artery disease
686888|NCT00310947|Coronary flow reserve|coronary flow reserve
686889|NCT00310947|Heart failure|heart failure
686890|NCT00310947|prospective randomised|prospective randomised
686891|NCT00310934|heroin dependence|heroin dependence
686892|NCT00310934|methadone|methadone
686893|NCT00310934|buprenorphine|buprenorphine
686894|NCT00310934|contingency management|contingency management
686895|NCT00310934|relapse prevention|relapse prevention
686896|NCT00310908|Renal|renal
686897|NCT00310908|Colic|colic
686898|NCT00310908|Calculi|calculi
686899|NCT00310908|Treatment|treatment
686900|NCT00310895|Refractory|refractory
686901|NCT00310895|Relapsed|relapsed
686902|NCT00310882|breast cancer|breast cancer
686903|NCT00310882|digitalis like compounds|digitalis like compounds
686904|NCT00310882|prognostic factor|prognostic factor
686905|NCT00310869|Preterm Birth|preterm birth
686906|NCT00310869|Prematurity|prematurity
686907|NCT00310869|NIDCAP|nidcap
686908|NCT00310869|Adolescence|adolescence
686909|NCT00310869|Developmental Care|developmental care
686910|NCT00310869|Follow-up|follow-up
686911|NCT00310869|Neurobehavior|neurobehavior
686912|NCT00310856|meningitis|meningitis
686913|NCT00310856|children|children
686914|NCT00310856|vaccine|vaccine
686915|NCT00310830|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
686916|NCT00310830|Pulmonary hypertension|pulmonary hypertension
686917|NCT00310830|Sickle Cell Disease|sickle cell disease
686918|NCT00310830|Sickle cell anemia|sickle cell anemia
686919|NCT00310830|ASSET|asset
686920|NCT00310830|ASSET-1|asset-1
686921|NCT00310817|meningitis|meningitis
686922|NCT00310817|children|children
686923|NCT00310817|vaccine|vaccine
686924|NCT00310804|Influenza|influenza
686925|NCT00310804|Flu|flu
686926|NCT00310804|Cell-Derived|cell-derived
686927|NCT00310804|Egg-Derived|egg-derived
686928|NCT00310804|Healthy Adults|healthy adults
686929|NCT00310804|Safety|safety
686930|NCT00310804|Immunogenicity|immunogenicity
686931|NCT00310804|Vaccination|vaccination
686932|NCT00310791|anorexia nervosa|anorexia nervosa
686933|NCT00310791|adolescents|adolescents
686934|NCT00310791|dual-energy x-ray absorptiometry|dual-energy x-ray absorptiometry
686935|NCT00310791|dehydroepiandrosterone (DHEA)|dehydroepiandrosterone (dhea)
686936|NCT00310791|osteoporosis|osteoporosis
686937|NCT00310778|High sodium diet|high sodium diet
686938|NCT00310778|Low sodium diet|low sodium diet
686939|NCT00310778|Renin-angiotensin system blockers|renin-angiotensin system blockers
686940|NCT00310778|AT1 receptor (AT1R) antagonist|at1 receptor (at1r) antagonist
686941|NCT00310778|ACE inhibition|ace inhibition
686942|NCT00310765|abdominal pain|abdominal pain
686943|NCT00310765|surgical adhesions|surgical adhesions
686944|NCT00310726|Mother to Child Transmission of HIV|mother to child transmission of hiv
686945|NCT00310726|Postnatal HIV transmission|postnatal hiv transmission
686946|NCT00310726|HIV|hiv
686947|NCT00310726|Breastfeeding|breastfeeding
686948|NCT00310726|Perinatal HIV Transmission|perinatal hiv transmission
686949|NCT00310726|HIV Seronegativity|hiv seronegativity
686950|NCT00310713|Prevention of Meningococcal Meningitis|prevention of meningococcal meningitis
686951|NCT00310713|vaccines|vaccines
686952|NCT00310713|conjugate|conjugate
686953|NCT00310713|immunology|immunology
686954|NCT00310713|children|children
686955|NCT00310713|antibody persistence|antibody persistence
686956|NCT00310700|Prevention of Meningococcal Meningitis|prevention of meningococcal meningitis
686957|NCT00310700|vaccines, conjugate|vaccines, conjugate
686958|NCT00310700|immunology|immunology
686959|NCT00310700|infant|infant
686960|NCT00310700|antibody persistence|antibody persistence
686961|NCT00310687|Prevention of Meningococcal Meningitis|prevention of meningococcal meningitis
686962|NCT00310687|vaccines|vaccines
686963|NCT00310687|conjugate|conjugate
686964|NCT00310687|immunology|immunology
686965|NCT00310687|antibody persistence|antibody persistence
686966|NCT00310674|Prevention of Meningococcal Meningitis|prevention of meningococcal meningitis
687603|NCT00308048|Genotype 2|genotype 2
686967|NCT00310674|meningococcal vaccines|meningococcal vaccines
686968|NCT00310674|conjugate|conjugate
686969|NCT00310674|Immunology|immunology
686970|NCT00310674|infant|infant
686971|NCT00310661|sarizotan|sarizotan
686972|NCT00310661|neuroleptic-induced tardive dyskinesia|neuroleptic-induced tardive dyskinesia
686973|NCT00310648|Influenza, elderly, vaccine|influenza, elderly, vaccine
686974|NCT00310635|Prevention of meningococcal infection|prevention of meningococcal infection
686975|NCT00310622|HyperQ|hyperq
686976|NCT00310622|Ischemia|ischemia
686977|NCT00310622|dobutamine|dobutamine
686978|NCT00310609|Structural abnormalities of the aortic arch and cerebral branches|structural abnormalities of the aortic arch and cerebral branches
686979|NCT00310596|ECG safety|ecg safety
686980|NCT00310583|tactile hyperalgesia|tactile hyperalgesia
686981|NCT00310583|neuropathic pain|neuropathic pain
686982|NCT00310583|enriched design|enriched design
686983|NCT00310583|peripheral nerve lesion|peripheral nerve lesion
686984|NCT00310583|plexus lesion|plexus lesion
686985|NCT00310583|radicular lesion|radicular lesion
686986|NCT00310583|spinal lesion|spinal lesion
686987|NCT00310583|polyneuropathy|polyneuropathy
686988|NCT00310583|postzosteric neuralgia|postzosteric neuralgia
686989|NCT00310570|distal|distal
686990|NCT00310570|interphalangeal|interphalangeal
686991|NCT00310570|extensor tendon|extensor tendon
686992|NCT00310570|avulsion|avulsion
686993|NCT00310505|visceral leishmaniasis|visceral leishmaniasis
686994|NCT00310505|amphotericin B|amphotericin b
686995|NCT00310505|Kala-azar|kala-azar
686996|NCT00310479|Magnetic Resonance Imaging|magnetic resonance imaging
686997|NCT00310479|prostate cancer imaging|prostate cancer imaging
686998|NCT00310479|3T MRS|3t mrs
686999|NCT00310479|functional imaging|functional imaging
687000|NCT00310440|Degenerative disc disease|degenerative disc disease
687001|NCT00310440|P-15 Bone Putty|p-15 bone putty
687002|NCT00310440|Bone graft|bone graft
687003|NCT00310440|Cervical discectomy|cervical discectomy
687004|NCT00310440|Cervical spine|cervical spine
687005|NCT00310427|Anxiety|anxiety
687006|NCT00310427|Alcohol Dependence|alcohol dependence
687007|NCT00310427|Alcoholism|alcoholism
687008|NCT00310414|Imaging Studies|imaging studies
687009|NCT00310414|Botulinum Toxin|botulinum toxin
687010|NCT00310414|Writer's Cramp|writer's cramp
687011|NCT00310414|Focal Hand Dystonia|focal hand dystonia
687012|NCT00310414|FHD|fhd
687013|NCT00310414|Writer Cramp|writer cramp
687014|NCT00310414|Healthy Volunteer|healthy volunteer
687015|NCT00310414|HV|hv
687016|NCT00310401|brain death|brain death
687017|NCT00310401|organ donor|organ donor
687018|NCT00310401|pulmonary edema|pulmonary edema
687019|NCT00310401|albuterol|albuterol
687020|NCT00310401|hypoxia|hypoxia
687021|NCT00310401|lung transplantation|lung transplantation
687022|NCT00310401|infiltrates|infiltrates
687023|NCT00310388|Partial Seizures|partial seizures
687024|NCT00310388|Epilepsy|epilepsy
687025|NCT00310388|RTG115097|rtg115097
687026|NCT00310388|Complex Partial Seizures|complex partial seizures
687027|NCT00310388|Anticonvulsant|anticonvulsant
687028|NCT00310388|Potassium Channels|potassium channels
687029|NCT00310388|Epilepsies, Partial|epilepsies, partial
687030|NCT00310375|Epilepsy|epilepsy
687031|NCT00310375|Partial Seizures|partial seizures
687032|NCT00310375|Potassium Channels|potassium channels
687033|NCT00310375|Anticonvulsant|anticonvulsant
687034|NCT00310375|Complex Partial Seizures|complex partial seizures
687035|NCT00310375|Epilepsies, Partial|epilepsies, partial
687036|NCT00310375|RTG115098|rtg115098
687037|NCT00310362|telephone|telephone
687038|NCT00310362|telemedicine|telemedicine
687039|NCT00310362|mass screening|mass screening
687040|NCT00310362|patient education|patient education
687041|NCT00310362|Patient compliance|patient compliance
687042|NCT00310349|pneumococcal vaccine|pneumococcal vaccine
687043|NCT00310349|clinical trial|clinical trial
687044|NCT00310349|Indigenous|indigenous
687045|NCT00310349|Maternal|maternal
687046|NCT00310349|Streptococcus pneumoniae|streptococcus pneumoniae
687047|NCT00310323|sleep apnea|sleep apnea
687048|NCT00310323|phenotyping|phenotyping
687049|NCT00310323|cytochrome P450|cytochrome p450
687050|NCT00310323|drug metabolism|drug metabolism
687051|NCT00310323|child|child
687052|NCT00310310|Continuous positive airway pressure|continuous positive airway pressure
687053|NCT00310310|Patient compliance|patient compliance
687054|NCT00310310|Self-care|self-care
687055|NCT00310284|Insomnia|insomnia
687056|NCT00310284|Sleep|sleep
687057|NCT00310271|DNA vaccine, immunotherapy, HSV-2, PMED|dna vaccine, immunotherapy, hsv-2, pmed
687058|NCT00310245|CD4-guided STI|cd4-guided sti
687059|NCT00310245|Keywords:|keywords:
687060|NCT00310245|HAART|haart
687061|NCT00310245|Clinical outcome|clinical outcome
687062|NCT00310245|Resistance|resistance
687063|NCT00310245|Costs|costs
687064|NCT00310245|Prognostic factors|prognostic factors
687065|NCT00310245|pulse therapy|pulse therapy
687066|NCT00310245|treatment experienced|treatment experienced
687067|NCT00310245|treatment interruption|treatment interruption
687068|NCT00310232|Quality of Life|quality of life
687069|NCT00310232|Blood transfusion|blood transfusion
687070|NCT00310219|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
687071|NCT00310219|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
687072|NCT00310219|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
687073|NCT00310219|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
687074|NCT00310206|Influenza, pandemic, H5N1, vaccine|influenza, pandemic, h5n1, vaccine
687075|NCT00310167|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
687076|NCT00310167|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
687077|NCT00310167|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
687078|NCT00310167|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
687079|NCT00310167|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
687080|NCT00310167|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
687081|NCT00310167|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
687082|NCT00310167|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
687083|NCT00310167|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
687084|NCT00310167|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
687085|NCT00310167|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
687086|NCT00310167|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
687087|NCT00310167|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
687088|NCT00310167|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
687089|NCT00310167|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
687090|NCT00310167|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
687091|NCT00310167|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
687092|NCT00310167|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
687093|NCT00310167|Marginal zone lymphoma|marginal zone lymphoma
687094|NCT00310154|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
687095|NCT00310154|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
687096|NCT00310154|adenosquamous cell lung cancer|adenosquamous cell lung cancer
687097|NCT00310154|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
687098|NCT00310154|large cell lung cancer|large cell lung cancer
687099|NCT00310154|squamous cell lung cancer|squamous cell lung cancer
687100|NCT00310154|adenocarcinoma of the lung|adenocarcinoma of the lung
687101|NCT00310141|non-small cell lung cancer|non-small cell lung cancer
687102|NCT00310141|small cell lung cancer|small cell lung cancer
687103|NCT00310128|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
687104|NCT00310128|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
687105|NCT00310128|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
687106|NCT00310128|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
687107|NCT00310128|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
687108|NCT00310128|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
687109|NCT00310128|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
687110|NCT00310128|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
687111|NCT00310128|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
687112|NCT00310128|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
687113|NCT00310128|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
687114|NCT00310128|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
687115|NCT00310128|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
687116|NCT00310128|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
687117|NCT00310128|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
687118|NCT00310128|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
687119|NCT00310128|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
687120|NCT00310128|contiguous stage II adult Burkitt's lymphoma|contiguous stage ii adult burkitt's lymphoma
687121|NCT00310128|noncontiguous stage II adult Burkitt's lymphoma|noncontiguous stage ii adult burkitt's lymphoma
687122|NCT00310128|recurrent adult Burkitt's lymphoma|recurrent adult burkitt's lymphoma
687123|NCT00310128|stage I adult Burkitt's lymphoma|stage i adult burkitt's lymphoma
687124|NCT00310128|stage III adult Burkitt's lymphoma|stage iii adult burkitt's lymphoma
687125|NCT00310128|stage IV adult Burkitt's lymphoma|stage iv adult burkitt's lymphoma
687126|NCT00310128|anaplastic large cell lymphoma|anaplastic large cell lymphoma
687127|NCT00310128|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
687128|NCT00310128|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
687129|NCT00310128|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
687130|NCT00310128|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
687131|NCT00310128|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
687132|NCT00310128|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
687133|NCT00310128|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
687207|NCT00309920|stage IIIC breast cancer|stage iiic breast cancer
687134|NCT00310128|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
687135|NCT00310128|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
687136|NCT00310128|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
687137|NCT00310128|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
687138|NCT00310128|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
687139|NCT00310128|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
687140|NCT00310128|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
687370|NCT00309218|Mycophenolate Mofetil|mycophenolate mofetil
687141|NCT00310128|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
687142|NCT00310128|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
687143|NCT00310128|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
687144|NCT00310128|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
687145|NCT00310115|non-small cell lung cancer|non-small cell lung cancer
687146|NCT00310115|small cell lung cancer|small cell lung cancer
687147|NCT00310115|bladder cancer|bladder cancer
687148|NCT00310115|cervical cancer|cervical cancer
687149|NCT00310115|esophageal cancer|esophageal cancer
687150|NCT00310115|gastric cancer|gastric cancer
687151|NCT00310115|renal cell carcinoma|renal cell carcinoma
687152|NCT00310115|adult primary liver cancer|adult primary liver cancer
687153|NCT00310115|pancreatic cancer|pancreatic cancer
687154|NCT00310115|hypopharyngeal cancer|hypopharyngeal cancer
687155|NCT00310115|lip and oral cavity cancer|lip and oral cavity cancer
687156|NCT00310115|laryngeal cancer|laryngeal cancer
687157|NCT00310115|nasopharyngeal cancer|nasopharyngeal cancer
687158|NCT00310115|oropharyngeal cancer|oropharyngeal cancer
687159|NCT00310115|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
687160|NCT00310115|adult acute myeloid leukemia|adult acute myeloid leukemia
687161|NCT00310115|tobacco use disorder|tobacco use disorder
687162|NCT00310089|stage IIIA breast cancer|stage iiia breast cancer
687163|NCT00310089|stage IIIB breast cancer|stage iiib breast cancer
687164|NCT00310089|stage IIIC breast cancer|stage iiic breast cancer
687165|NCT00310089|inflammatory breast cancer|inflammatory breast cancer
687166|NCT00310076|carcinoma of the appendix|carcinoma of the appendix
687167|NCT00310076|stage II colon cancer|stage ii colon cancer
687168|NCT00310076|stage III colon cancer|stage iii colon cancer
687169|NCT00310076|stage IV colon cancer|stage iv colon cancer
687170|NCT00310076|recurrent colon cancer|recurrent colon cancer
687171|NCT00310076|stage II rectal cancer|stage ii rectal cancer
687172|NCT00310076|stage III rectal cancer|stage iii rectal cancer
687173|NCT00310076|stage IV rectal cancer|stage iv rectal cancer
687174|NCT00310076|recurrent rectal cancer|recurrent rectal cancer
687175|NCT00310063|nausea and vomiting|nausea and vomiting
687176|NCT00310063|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
687177|NCT00310050|stage II pancreatic cancer|stage ii pancreatic cancer
687178|NCT00310050|stage III pancreatic cancer|stage iii pancreatic cancer
687179|NCT00310050|stage IV pancreatic cancer|stage iv pancreatic cancer
687180|NCT00310011|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
687181|NCT00310011|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
687182|NCT00310011|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
687183|NCT00310011|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
687184|NCT00310011|stage IV bladder cancer|stage iv bladder cancer
687185|NCT00310011|recurrent bladder cancer|recurrent bladder cancer
687186|NCT00309998|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
687187|NCT00309998|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
687188|NCT00309998|adenocarcinoma of the lung|adenocarcinoma of the lung
687189|NCT00309998|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
687190|NCT00309998|large cell lung cancer|large cell lung cancer
687191|NCT00309998|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
687192|NCT00309985|metastatic hormone-sensitive prostate cancer|metastatic hormone-sensitive prostate cancer
687193|NCT00309985|docetaxel|docetaxel
687194|NCT00309972|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
687195|NCT00309972|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
687196|NCT00309933|cognitive/functional effects|cognitive/functional effects
687197|NCT00309933|spiritual concerns|spiritual concerns
687198|NCT00309933|sexuality and reproductive issues|sexuality and reproductive issues
687199|NCT00309933|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
687200|NCT00309933|cancer survivor|cancer survivor
687201|NCT00309933|stage I breast cancer|stage i breast cancer
687202|NCT00309933|stage II breast cancer|stage ii breast cancer
687203|NCT00309933|stage IIIA breast cancer|stage iiia breast cancer
687204|NCT00309933|stage IIIB breast cancer|stage iiib breast cancer
687205|NCT00309933|stage IIIC breast cancer|stage iiic breast cancer
687206|NCT00309920|stage IIIA breast cancer|stage iiia breast cancer
687208|NCT00309894|adenocarcinoma of the prostate|adenocarcinoma of the prostate
687209|NCT00309894|recurrent prostate cancer|recurrent prostate cancer
687210|NCT00309881|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
687211|NCT00309881|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
687212|NCT00309881|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
687213|NCT00309881|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
687214|NCT00309881|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
687215|NCT00309868|heart catheterization|heart catheterization
687216|NCT00309868|echocardiogram|echocardiogram
687217|NCT00309868|nesiritide|nesiritide
687218|NCT00309842|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
687219|NCT00309842|primary myelofibrosis|primary myelofibrosis
687220|NCT00309842|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
687221|NCT00309842|myelodysplastic syndromes|myelodysplastic syndromes
687222|NCT00309842|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
687223|NCT00309842|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
687224|NCT00309842|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
687225|NCT00309842|recurrent lymphoblastic lymphoma|recurrent lymphoblastic lymphoma
687226|NCT00309842|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
687227|NCT00309842|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
687228|NCT00309842|recurrent follicular lymphoma|recurrent follicular lymphoma
687229|NCT00309842|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
687230|NCT00309842|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
687231|NCT00309842|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
687232|NCT00309842|refractory multiple myeloma|refractory multiple myeloma
687233|NCT00309842|chronic myelogenous leukemia|chronic myelogenous leukemia
687234|NCT00309842|secondary acute myeloid leukemia|secondary acute myeloid leukemia
687235|NCT00309842|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
687236|NCT00309842|multiple myeloma|multiple myeloma
687237|NCT00309842|adult lymphoblastic lymphoma|adult lymphoblastic lymphoma
687238|NCT00309842|refractory anemia with excess blasts|refractory anemia with excess blasts
687239|NCT00309842|refractory anemia|refractory anemia
687240|NCT00309842|Burkitt lymphoma|burkitt lymphoma
687241|NCT00309842|childhood large cell lymphoma|childhood large cell lymphoma
687242|NCT00309842|adult Burkitt lymphoma|adult burkitt lymphoma
687243|NCT00309842|mantle cell lymphoma|mantle cell lymphoma
687244|NCT00309842|childhood lymphoblastic lymphoma|childhood lymphoblastic lymphoma
687371|NCT00309218|Cyclosporine A|cyclosporine a
687245|NCT00309842|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
687246|NCT00309816|Exercise stress test|exercise stress test
687247|NCT00309803|Carotid artery|carotid artery
687248|NCT00309803|distal protection device|distal protection device
687249|NCT00309790|exercise stress test|exercise stress test
687250|NCT00309777|hypercholesterolemia|hypercholesterolemia
687251|NCT00309777|kowa|kowa
687252|NCT00309777|dyslipidemia|dyslipidemia
687253|NCT00309777|pitavastatin|pitavastatin
687254|NCT00309777|NK-104|nk-104
687255|NCT00309777|Primary Hypercholesterolemia or Combined Dyslipidemia|primary hypercholesterolemia or combined dyslipidemia
687256|NCT00309751|Kowa|kowa
687257|NCT00309751|Type II Diabetes Mellitus|type ii diabetes mellitus
687258|NCT00309751|Combined Dyslipidemia|combined dyslipidemia
687259|NCT00309751|pitavastatin|pitavastatin
687260|NCT00309751|NK-104|nk-104
687261|NCT00309751|Atorvastatin|atorvastatin
687262|NCT00309738|Kowa|kowa
687263|NCT00309738|KRE|kre
687264|NCT00309738|Hypercholesterolemia|hypercholesterolemia
687265|NCT00309738|combined dyslipidemia|combined dyslipidemia
687266|NCT00309738|dyslipidemia|dyslipidemia
687267|NCT00309738|pitavastatin|pitavastatin
687268|NCT00309738|NK-104|nk-104
687269|NCT00309738|simvastatin|simvastatin
687270|NCT00309725|Alzheimer's Disease|alzheimer's disease
687271|NCT00309725|cardiac arrhythmias|cardiac arrhythmias
687272|NCT00309712|diabetes|diabetes
687273|NCT00309712|combination lipid treatment|combination lipid treatment
687274|NCT00309712|statin|statin
687275|NCT00309712|fibrate|fibrate
687276|NCT00309712|hypercholesteremia|hypercholesteremia
687277|NCT00309712|mixed dyslipidemia|mixed dyslipidemia
687278|NCT00309699|Affective psychosis|affective psychosis
687279|NCT00309699|mixed-state|mixed-state
687280|NCT00309699|bipolar disorder|bipolar disorder
687281|NCT00309699|manic disorder|manic disorder
687282|NCT00309699|manic-depressive psychosis|manic-depressive psychosis
687283|NCT00309699|mania|mania
687284|NCT00309699|manic state|manic state
687285|NCT00309699|paliperidone|paliperidone
687286|NCT00309699|paliperidone ER.|paliperidone er.
687287|NCT00309686|Affective psychosis|affective psychosis
687288|NCT00309686|bipolar disorder|bipolar disorder
687289|NCT00309686|manic disorder|manic disorder
687290|NCT00309686|manic-depressive psychosis|manic-depressive psychosis
687291|NCT00309686|mania|mania
687292|NCT00309686|manic state|manic state
687293|NCT00309686|paliperidone|paliperidone
687294|NCT00309686|paliperidone ER|paliperidone er
687295|NCT00309686|adjunctive therapy|adjunctive therapy
687296|NCT00309673|tuberculosis, tuberculin, childhood, pain|tuberculosis, tuberculin, childhood, pain
687297|NCT00309660|PPARgamma ligand|ppargamma ligand
687298|NCT00309660|Rosiglitazone|rosiglitazone
687299|NCT00309660|Enema|enema
687300|NCT00309647|prophylaxis of pandemic influenza|prophylaxis of pandemic influenza
687301|NCT00309634|prophylaxis of pandemic influenza|prophylaxis of pandemic influenza
687302|NCT00309621|Hand Dermatoses,|hand dermatoses,
687303|NCT00309621|hand dermatitis|hand dermatitis
687304|NCT00309621|hand eczema|hand eczema
687305|NCT00309621|chronic hand dermatitis|chronic hand dermatitis
687306|NCT00309621|retinoid|retinoid
687307|NCT00309569|Cyclophosphamide|cyclophosphamide
687308|NCT00309569|Methotrexate|methotrexate
687309|NCT00309569|Fluorouracil|fluorouracil
687310|NCT00309569|Epirubicine|epirubicine
687311|NCT00309569|Breast Cancer|breast cancer
687312|NCT00309556|Epirubicin|epirubicin
687313|NCT00309556|Docetaxel|docetaxel
687314|NCT00309556|Capecitabine|capecitabine
687315|NCT00309556|Herceptin|herceptin
687316|NCT00309556|Breast cancer|breast cancer
687317|NCT00309543|Fluorouracil|fluorouracil
687318|NCT00309543|Leucovorin|leucovorin
687319|NCT00309543|Colon cancer|colon cancer
687320|NCT00309530|Fluorouracil|fluorouracil
687321|NCT00309530|Levamisol|levamisol
687322|NCT00309530|Interferon|interferon
687323|NCT00309530|Colon cancer|colon cancer
687324|NCT00309517|Fluorouracil|fluorouracil
687325|NCT00309517|Leucovorin|leucovorin
687326|NCT00309517|MAb 17-1A|mab 17-1a
687327|NCT00309517|Rectal cancer|rectal cancer
687328|NCT00309504|magnetic resonance imaging|magnetic resonance imaging
687329|NCT00309504|magnetic resonance spectroscopy|magnetic resonance spectroscopy
687330|NCT00309491|Tamoxifen|tamoxifen
687331|NCT00309491|Aminoglutethimide|aminoglutethimide
687332|NCT00309491|Breast cancer|breast cancer
687333|NCT00309478|Cyclophosphamide|cyclophosphamide
687334|NCT00309478|Methotrexate|methotrexate
687335|NCT00309478|Fluorouracil|fluorouracil
687336|NCT00309478|Goserelin|goserelin
687337|NCT00309478|Tamoxifen|tamoxifen
687338|NCT00309478|Breast cancer|breast cancer
687339|NCT00309465|Diabetes|diabetes
687340|NCT00309465|Insulin Glargine|insulin glargine
687341|NCT00309465|Surgery|surgery
687342|NCT00309452|First episode psychosis|first episode psychosis
687343|NCT00309452|Specialized care|specialized care
687344|NCT00309452|Phase-specific treatment|phase-specific treatment
687345|NCT00309452|Schizophrenia|schizophrenia
687346|NCT00309452|Disorders with psychotic features|disorders with psychotic features
687347|NCT00309426|atherosclerosis|atherosclerosis
687348|NCT00309413|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
687349|NCT00309400|History|history
687350|NCT00309400|Phenylketonuria|phenylketonuria
687351|NCT00309400|Galactosemia|galactosemia
687352|NCT00309400|Screening|screening
687353|NCT00309400|Treatment|treatment
687354|NCT00309387|Cataract|cataract
687355|NCT00309387|Nutritional supplements|nutritional supplements
687356|NCT00309374|LPS|lps
687357|NCT00309374|Statins|statins
687358|NCT00309374|leukocyte mRNA expression profiles|leukocyte mrna expression profiles
687359|NCT00309361|Soft Tissue Anesthesia (Numbness)|soft tissue anesthesia (numbness)
687360|NCT00309335|Soft Tissue Anesthesia (Numbness)|soft tissue anesthesia (numbness)
687361|NCT00309322|Soft Tissue Anesthesia (Numbness)|soft tissue anesthesia (numbness)
687362|NCT00309296|smoking cessation|smoking cessation
687363|NCT00309296|smoking reduction|smoking reduction
687364|NCT00309296|nicotine replacement therapy|nicotine replacement therapy
687365|NCT00309270|Campath-1H, low-dose immunosuppression, T regulatives cells|campath-1h, low-dose immunosuppression, t regulatives cells
687366|NCT00309231|diabetes mellitus|diabetes mellitus
687367|NCT00309231|islet transplantation|islet transplantation
687368|NCT00309218|Pediatric renal transplantation|pediatric renal transplantation
687369|NCT00309218|Steroid withdrawal|steroid withdrawal
687372|NCT00309218|Stable graft function|stable graft function
687373|NCT00309218|children|children
687374|NCT00309218|renal transplantation|renal transplantation
687375|NCT00309205|HIV seronegativity|hiv seronegativity
687376|NCT00309192|Diabetes, Macular Edema, Triamcinolone|diabetes, macular edema, triamcinolone
687377|NCT00309179|Advanced colorectal cancer|advanced colorectal cancer
687378|NCT00309127|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
687379|NCT00309127|DM Nephropathy|dm nephropathy
687380|NCT00309127|Structured care|structured care
687381|NCT00309114|UTI|uti
687382|NCT00309114|SCI|sci
687383|NCT00309114|E coli|e coli
687384|NCT00309114|Prevention|prevention
687385|NCT00309101|Tacrolimus|tacrolimus
687386|NCT00309101|Myasthenia Gravis|myasthenia gravis
687387|NCT00309088|Tacrolimus|tacrolimus
687388|NCT00309088|Myasthenia Gravis|myasthenia gravis
687389|NCT00309075|Stenosis of the calf and/or pedal arteries|stenosis of the calf and/or pedal arteries
687390|NCT00309062|Allergy|allergy
687391|NCT00309062|Birch pollen|birch pollen
687392|NCT00309062|Recombinant|recombinant
687393|NCT00309036|Allergy|allergy
687394|NCT00309036|Grass pollen|grass pollen
687395|NCT00309036|Recombinant|recombinant
687396|NCT00309023|Advanced Solid Tumors|advanced solid tumors
687397|NCT00309010|Focal Hand Dystonia|focal hand dystonia
687398|NCT00309010|Motor Planning|motor planning
687399|NCT00309010|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
687400|NCT00309010|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
687401|NCT00309010|FHD|fhd
687402|NCT00309010|Writer's Cramp|writer's cramp
687403|NCT00309010|Healthy Volunteer|healthy volunteer
687404|NCT00309010|HV|hv
687405|NCT00308997|Auditory Hallucinations|auditory hallucinations
687406|NCT00308997|Schizophrenia|schizophrenia
687407|NCT00308997|Schizoaffective Disorder|schizoaffective disorder
687408|NCT00308997|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
687409|NCT00308997|Wernicke's Area|wernicke's area
687410|NCT00308997|Superior Temporal Gyrus|superior temporal gyrus
687411|NCT00308984|Pediatrics|pediatrics
687412|NCT00308984|Intraoperative Awareness|intraoperative awareness
687413|NCT00308984|Pediatric Anesthesia|pediatric anesthesia
687414|NCT00308958|cystic fibrosis|cystic fibrosis
687415|NCT00308958|chest physiotherapy|chest physiotherapy
687416|NCT00308958|airway clearance|airway clearance
687417|NCT00308958|bronchiectasis|bronchiectasis
687418|NCT00308945|Glaucoma|glaucoma
687419|NCT00308945|Blood flow|blood flow
687420|NCT00308945|Choroid|choroid
687421|NCT00308945|Retina|retina
687422|NCT00308945|Prostaglandin analogues|prostaglandin analogues
687423|NCT00308932|fluticasone|fluticasone
687424|NCT00308932|asthma therapy|asthma therapy
687425|NCT00308932|spacer inhaler|spacer inhaler
687426|NCT00308932|HFA-134a|hfa-134a
687427|NCT00308906|infection|infection
687428|NCT00308906|renal dysfunction|renal dysfunction
687429|NCT00308906|aminoglycoside|aminoglycoside
687430|NCT00308906|protein|protein
687431|NCT00308906|child|child
687432|NCT00308893|Antidepressants|antidepressants
687433|NCT00308893|escitalopram|escitalopram
687434|NCT00308893|Genetic polymorphism|genetic polymorphism
687435|NCT00308880|Tranexamic acid|tranexamic acid
687436|NCT00308880|head neck surgery|head neck surgery
687437|NCT00308867|PDT|pdt
687438|NCT00308867|AK|ak
687439|NCT00308867|Cryosurgery|cryosurgery
687440|NCT00308854|AK|ak
687441|NCT00308854|PDT|pdt
687442|NCT00308841|"Objective: To evaluate the efficacy of intrauterine lidocaine instillation in reducing patient discomfort during the removal of a lost IUD"|"objective: to evaluate the efficacy of intrauterine lidocaine instillation in reducing patient discomfort during the removal of a lost iud"
687443|NCT00308815|Resuscitation|resuscitation
687444|NCT00308815|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
687445|NCT00308815|cardiac arrest|cardiac arrest
687446|NCT00308815|CPR|cpr
687447|NCT00308802|Kidney|kidney
687448|NCT00308802|Transplant|transplant
687449|NCT00308802|Rejection|rejection
687450|NCT00308802|Kidney Disease|kidney disease
687451|NCT00308802|Kidney Failure|kidney failure
687452|NCT00308802|End Stage Renal Disease|end stage renal disease
687453|NCT00308789|Continuous Positive Airway Pressure|continuous positive airway pressure
687454|NCT00308789|Infant,newborn|infant,newborn
687455|NCT00308789|Artificial respiration|artificial respiration
687456|NCT00308763|Smoking Cessation|smoking cessation
687457|NCT00308763|Nicotine Dependence|nicotine dependence
687458|NCT00308724|Generalized Anxiety Disorder|generalized anxiety disorder
687459|NCT00308724|Geriatric|geriatric
687460|NCT00308711|Cervical ripening|cervical ripening
687461|NCT00308711|Induction of labor|induction of labor
687462|NCT00308711|Dinoprostone vaginal insert|dinoprostone vaginal insert
687463|NCT00308711|Cervidil|cervidil
687464|NCT00308711|Misoprostol vaginal insert|misoprostol vaginal insert
687465|NCT00308711|Modified Bishop's Score|modified bishop's score
687466|NCT00308711|PGE2|pge2
687467|NCT00308711|PGE1|pge1
687468|NCT00308711|Uterine Hyperstimulation|uterine hyperstimulation
687469|NCT00308711|Cesarean section|cesarean section
687470|NCT00308698|recombinant human erythropoietin|recombinant human erythropoietin
687471|NCT00308698|adiponectin|adiponectin
687472|NCT00308698|mortality|mortality
687473|NCT00308685|Asthma|asthma
687474|NCT00308685|Pediatric asthma|pediatric asthma
687475|NCT00308633|Cardiac Rehabilitation|cardiac rehabilitation
687476|NCT00308633|Apoptosis|apoptosis
687477|NCT00308633|Gene Expression|gene expression
687478|NCT00308633|Nitric Oxide|nitric oxide
687479|NCT00308633|Reactive Oxygen Species|reactive oxygen species
687480|NCT00308633|Coronary Artery Disease|coronary artery disease
687481|NCT00308633|CAD|cad
687482|NCT00308620|HIV|hiv
687483|NCT00308620|chloroquine|chloroquine
687484|NCT00308620|disease progression|disease progression
687485|NCT00308620|inflammation|inflammation
687486|NCT00308620|treatment naive|treatment naive
687487|NCT00308607|melanoma|melanoma
687488|NCT00308607|metastatic|metastatic
687489|NCT00308607|bevacizumab|bevacizumab
687490|NCT00308594|cervical radiculopathy|cervical radiculopathy
687491|NCT00308594|dexamethasone|dexamethasone
687492|NCT00308594|corticosteroid|corticosteroid
687493|NCT00308594|oral|oral
687494|NCT00308581|Crohn's Disease|crohn's disease
687495|NCT00308581|Certolizumab pegol|certolizumab pegol
687602|NCT00308048|Hepatitis C|hepatitis c
687496|NCT00308568|screening colonoscopy|screening colonoscopy
687497|NCT00308568|adherence|adherence
687498|NCT00308555|Cannabis|cannabis
687499|NCT00308555|Morphine|morphine
687500|NCT00308555|Oxycodone|oxycodone
687501|NCT00308555|Marijuana|marijuana
687502|NCT00308555|chronic pain|chronic pain
687503|NCT00308542|eye diseases|eye diseases
687504|NCT00308542|diabetic eye problems|diabetic eye problems
687505|NCT00308529|Carcinoma Small Cell Lung|carcinoma small cell lung
687506|NCT00308529|Lung Cancer|lung cancer
687507|NCT00308516|Rectal Cancer|rectal cancer
687508|NCT00308516|Cancer of the Rectum|cancer of the rectum
687509|NCT00308516|Colorectal Cancer|colorectal cancer
687510|NCT00308516|Bevacizumab|bevacizumab
687511|NCT00308503|Primary Insomnia|primary insomnia
687512|NCT00308503|Sleep Maintenance Insomnia|sleep maintenance insomnia
687513|NCT00308503|Awakening|awakening
687514|NCT00308477|eye diseases|eye diseases
687515|NCT00308451|chromium|chromium
687516|NCT00308451|chromium picolinate|chromium picolinate
687517|NCT00308451|type 2 diabetes mellitus|type 2 diabetes mellitus
687518|NCT00308451|fructosamine|fructosamine
687519|NCT00308451|glycemic control|glycemic control
687520|NCT00308451|OGTT|ogtt
687521|NCT00308438|Crohn Disease|crohn disease
687522|NCT00308438|Crohn's Disease|crohn's disease
687523|NCT00308425|Renal transplantation, EC-MPS|renal transplantation, ec-mps
687524|NCT00308412|Respiratory Tract Infection|respiratory tract infection
687525|NCT00308386|Nurse Case Management|nurse case management
687526|NCT00308386|Diabetes|diabetes
687527|NCT00308386|Hypertension|hypertension
687528|NCT00308386|Hyperlipidemia|hyperlipidemia
687529|NCT00308386|Behavior therapy|behavior therapy
687530|NCT00308386|Motivational interviewing|motivational interviewing
687531|NCT00308360|Hostility|hostility
687532|NCT00308360|Impulsivity|impulsivity
687533|NCT00308360|Aggression|aggression
687534|NCT00308334|Domperidone|domperidone
687535|NCT00308334|breast milk|breast milk
687536|NCT00308334|breast milk composition|breast milk composition
687537|NCT00308334|preterm infant|preterm infant
687538|NCT00308334|neonate|neonate
687539|NCT00308334|nutrition|nutrition
687540|NCT00308269|Cancer|cancer
687541|NCT00308269|Phase I|phase i
687542|NCT00308269|EC145|ec145
687543|NCT00308269|Recurrent|recurrent
687544|NCT00308269|Refractory|refractory
687545|NCT00308269|Solid Tumors|solid tumors
687546|NCT00308269|Experimental|experimental
687547|NCT00308256|Type1 diabetes;|type1 diabetes;
687548|NCT00308256|nurse-counselling;|nurse-counselling;
687549|NCT00308256|adolescent|adolescent
687550|NCT00308243|Cystic Fibrosis|cystic fibrosis
687551|NCT00308243|Sodium Pyruvate|sodium pyruvate
687552|NCT00308243|Reactive Oxygen Species|reactive oxygen species
687553|NCT00308243|Inflammation of Lung|inflammation of lung
687554|NCT00308230|Congenital, BNP|congenital, bnp
687555|NCT00308217|Heart Disease, Congenital|heart disease, congenital
687556|NCT00308217|Single Ventricle|single ventricle
687557|NCT00308217|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
687558|NCT00308204|discoid lupus|discoid lupus
687559|NCT00308204|lupus|lupus
687560|NCT00308204|discoid lupus erythematosus|discoid lupus erythematosus
687561|NCT00308204|lupus of the scalp|lupus of the scalp
687562|NCT00308191|COPD|copd
687563|NCT00308191|Formoterol|formoterol
687564|NCT00308191|Tiotropium|tiotropium
687565|NCT00308178|Abraxane|abraxane
687566|NCT00308178|dose-dense chemotherapy|dose-dense chemotherapy
687567|NCT00308178|taxol|taxol
687568|NCT00308165|Recurrent Primary Malignant Brain Tumors|recurrent primary malignant brain tumors
687569|NCT00308165|Brain Tumors|brain tumors
687570|NCT00308165|Neoplasms, Brain|neoplasms, brain
687571|NCT00308165|Brain Cancer|brain cancer
687572|NCT00308165|Brain cancer treatment|brain cancer treatment
687573|NCT00308165|Topotecan|topotecan
687574|NCT00308152|Colonoscopy|colonoscopy
687575|NCT00308152|Rehydration|rehydration
687576|NCT00308152|Sedation|sedation
687577|NCT00308139|diabetes|diabetes
687578|NCT00308139|exenatide|exenatide
687579|NCT00308139|long acting release|long acting release
687580|NCT00308139|LAR|lar
687581|NCT00308139|Amylin|amylin
687582|NCT00308139|Lilly|lilly
687583|NCT00308126|Abdominal operation|abdominal operation
687584|NCT00308113|Muscular dystrophy|muscular dystrophy
687585|NCT00308113|Duchenne|duchenne
687586|NCT00308113|CoQ10|coq10
687587|NCT00308113|prednisone|prednisone
687588|NCT00308100|Liver Transplantation|liver transplantation
687589|NCT00308087|Sargramostim|sargramostim
687590|NCT00308087|Leukine|leukine
687591|NCT00308087|NHL|nhl
687592|NCT00308074|behavioral problems|behavioral problems
687593|NCT00308074|aggression|aggression
687594|NCT00308074|autism|autism
687595|NCT00308074|aripiprazole|aripiprazole
687596|NCT00308061|Plasmodium falciparum|plasmodium falciparum
687597|NCT00308061|malaria|malaria
687598|NCT00308061|merozoite surface protein-1|merozoite surface protein-1
687599|NCT00308048|Interferon|interferon
687600|NCT00308048|Pegylated interferon|pegylated interferon
687601|NCT00308048|Pegylated interferon alfa 2b|pegylated interferon alfa 2b
687604|NCT00308048|Genotype 3|genotype 3
687605|NCT00308048|Rapid virological response|rapid virological response
687606|NCT00308048|Short treatment|short treatment
687607|NCT00308048|14 weeks treatment|14 weeks treatment
687608|NCT00308048|health related quality of life|health related quality of life
687609|NCT00308048|sick leave|sick leave
687610|NCT00308048|Injecting drug use|injecting drug use
687611|NCT00308022|Acute Lung Injury|acute lung injury
687612|NCT00308022|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
687613|NCT00308022|High Frequency Percussive Ventilation|high frequency percussive ventilation
687614|NCT00308022|Ventilator Associated Pneumonia|ventilator associated pneumonia
687615|NCT00308009|Pelvic Organ Prolapse|pelvic organ prolapse
687616|NCT00308009|Urinary stress incontinence|urinary stress incontinence
687617|NCT00308009|Surgery|surgery
687618|NCT00307996|CoQ10|coq10
687619|NCT00307996|hemodialysis|hemodialysis
687620|NCT00307996|oxidative marker|oxidative marker
687621|NCT00307996|antioxidant|antioxidant
687622|NCT00307970|fluticasone|fluticasone
687623|NCT00307970|asthma therapy|asthma therapy
687624|NCT00307970|spacer inhaler|spacer inhaler
687625|NCT00307970|HFA-134a|hfa-134a
687626|NCT00307957|Obstructive Sleep Apnea|obstructive sleep apnea
687627|NCT00307957|Daytime Sleepiness|daytime sleepiness
687628|NCT00307957|Pillar Palatal Implants|pillar palatal implants
687629|NCT00307944|Acid Reflux|acid reflux
687630|NCT00307944|Obstructive Sleep Apnea|obstructive sleep apnea
687631|NCT00307944|Daytime Sleepiness|daytime sleepiness
687632|NCT00307931|Certolizumab pegol|certolizumab pegol
687633|NCT00307931|Cimzia|cimzia
687634|NCT00307931|Crohn's disease|crohn's disease
687635|NCT00307931|Greek patients|greek patients
687636|NCT00307918|acupuncture, intraocular pressure, glaucoma|acupuncture, intraocular pressure, glaucoma
687637|NCT00307905|homeopathy|homeopathy
687638|NCT00307905|pain|pain
687639|NCT00307905|traumeel s|traumeel s
687640|NCT00307905|Fracture of neck of femur|fracture of neck of femur
687641|NCT00307905|Surgical correction of fracture of neck of hip|surgical correction of fracture of neck of hip
687642|NCT00307892|Homeopathy|homeopathy
687643|NCT00307892|Traumeel S|traumeel s
687644|NCT00307892|Arthroscopy|arthroscopy
687645|NCT00307892|Pain management|pain management
687646|NCT00307892|Post-operative pain following arthroscopy|post-operative pain following arthroscopy
687647|NCT00307879|Myocardial infarction|myocardial infarction
687648|NCT00307879|revascularization|revascularization
687649|NCT00307879|granulocyte colony stimulating factor (G-CSF)|granulocyte colony stimulating factor (g-csf)
687650|NCT00307866|Known or suspected focal liver lesions detected by spiral CT|known or suspected focal liver lesions detected by spiral ct
687651|NCT00307853|homeopathy|homeopathy
687652|NCT00307853|pain|pain
687653|NCT00307853|traumeel s|traumeel s
687654|NCT00307853|total knee arthroplasty|total knee arthroplasty
687655|NCT00307853|total hip arthroplasty|total hip arthroplasty
687656|NCT00307840|hemodialysis; secondary hyperparathyroidism; hypercalcemia; hyperphosphatemia; vitamin D|hemodialysis; secondary hyperparathyroidism; hypercalcemia; hyperphosphatemia; vitamin d
687657|NCT00307827|Steroid-Refractory|steroid-refractory
687658|NCT00307827|IVSR-UC|ivsr-uc
687659|NCT00307827|Ulcerative Colitis|ulcerative colitis
687660|NCT00307814|Anemia|anemia
687661|NCT00307814|Low Blood Count|low blood count
687662|NCT00307814|Chronic Kidney Failure|chronic kidney failure
687663|NCT00307814|Chronic Kidney Disease|chronic kidney disease
687664|NCT00307814|epoetin alfa|epoetin alfa
687665|NCT00307814|recombinant human erythropoietin|recombinant human erythropoietin
687666|NCT00307801|Dysfunctional uterine bleeding|dysfunctional uterine bleeding
687667|NCT00307788|Psychiatric Comorbidity|psychiatric comorbidity
687668|NCT00307788|Acupuncture|acupuncture
687669|NCT00307788|expectancy|expectancy
687670|NCT00307775|oestradiol, faecal incontinence, post menopausal|oestradiol, faecal incontinence, post menopausal
687671|NCT00307775|post menopausal women with faecal incontinence|post menopausal women with faecal incontinence
687672|NCT00307762|Stroke|stroke
687673|NCT00307762|Physiotherapy|physiotherapy
687674|NCT00307762|Effectiveness|effectiveness
687675|NCT00307762|Gait trainer|gait trainer
687676|NCT00307749|Neuropathy|neuropathy
687677|NCT00307749|Nerve Conduction|nerve conduction
687678|NCT00307736|Fluorouracil|fluorouracil
687679|NCT00307736|bevacizumab|bevacizumab
687680|NCT00307736|erlotinib|erlotinib
687681|NCT00307736|external beam radiation therapy|external beam radiation therapy
687682|NCT00307736|EBRT|ebrt
687683|NCT00307723|EBRT|ebrt
687684|NCT00307723|advanced pancreatic cancer|advanced pancreatic cancer
687685|NCT00307710|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
687686|NCT00307710|Influenza Vaccination|influenza vaccination
687687|NCT00307710|Trivalent Baculovirus-Expressed Influenza HA vaccine|trivalent baculovirus-expressed influenza ha vaccine
687688|NCT00307710|Antineoplastic Therapy|antineoplastic therapy
687689|NCT00307697|Letter intervention|letter intervention
687690|NCT00307697|Depression|depression
687691|NCT00307697|Anxiety|anxiety
687692|NCT00307697|Primary health care|primary health care
687693|NCT00307684|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
687694|NCT00307684|Adult|adult
687695|NCT00307684|Long term safety|long term safety
687696|NCT00307684|Efficacy|efficacy
687697|NCT00307684|Quality of life|quality of life
687698|NCT00307671|Systemic necrotizing vasculitides|systemic necrotizing vasculitides
687699|NCT00307671|corticosteroids; azathioprine; mycophenolate mofetil;|corticosteroids; azathioprine; mycophenolate mofetil;
687700|NCT00307671|cyclophosphamide|cyclophosphamide
687701|NCT00307671|Elderly patients|elderly patients
687702|NCT00307671|Randomized controlled trial|randomized controlled trial
687703|NCT00307658|ANCA associated Vasculitides|anca associated vasculitides
687704|NCT00307658|Relapse|relapse
687705|NCT00307658|intravenous Immunoglobulins|intravenous immunoglobulins
687706|NCT00307658|Corticosteroid|corticosteroid
687707|NCT00307658|Immunosuppressant|immunosuppressant
687708|NCT00307645|ANCA associated systemic vasculitis|anca associated systemic vasculitis
687709|NCT00307645|Maintenance therapy|maintenance therapy
687710|NCT00307645|Azathioprine|azathioprine
687711|NCT00307645|Mycophenolate mofetil|mycophenolate mofetil
687712|NCT00307632|Contraception|contraception
687713|NCT00307632|Hormonal patch|hormonal patch
687714|NCT00307632|Norelgestromine|norelgestromine
687715|NCT00307632|Ethinyl estradiol|ethinyl estradiol
687716|NCT00307619|Binge-Eating Disorder|binge-eating disorder
687717|NCT00307606|Mastectomy|mastectomy
687718|NCT00307606|Seroma|seroma
687719|NCT00307606|Breast cancer|breast cancer
687720|NCT00307606|Glucocorticoid|glucocorticoid
687721|NCT00307593|Systemic ANCA+ vascularizes|systemic anca+ vascularizes
687722|NCT00307593|Relapse|relapse
687723|NCT00307593|Corticosteroids|corticosteroids
687724|NCT00307593|Immunosuppressant|immunosuppressant
687725|NCT00307593|Infliximab/rituximab|infliximab/rituximab
687726|NCT00307593|Patients with relapsing or refractory forms of ANCA|patients with relapsing or refractory forms of anca
687727|NCT00307593|associated vasculitides Microscopic polyangiitis|associated vasculitides microscopic polyangiitis
687728|NCT00307580|CVADS|cvads
687729|NCT00307502|protease inhibitors|protease inhibitors
687730|NCT00307502|non-nucleoside analog reverse transcriptase inhibitors|non-nucleoside analog reverse transcriptase inhibitors
687731|NCT00307502|pharmacokinetic models|pharmacokinetic models
687732|NCT00307502|treatment experienced|treatment experienced
687734|NCT00307476|Fecal Incontinence|fecal incontinence
687735|NCT00307476|Fecal Containment Devices|fecal containment devices
687736|NCT00307476|Skin Integrity|skin integrity
687737|NCT00307463|end-stage renal disease|end-stage renal disease
687738|NCT00307463|hemodialysis|hemodialysis
687739|NCT00307463|volume control|volume control
687740|NCT00307463|ultrafiltration|ultrafiltration
687741|NCT00307463|inflammation|inflammation
687742|NCT00307463|cardiovascular disease|cardiovascular disease
687743|NCT00307463|left ventricular hypertrophy|left ventricular hypertrophy
687744|NCT00307463|dietary salt restriction|dietary salt restriction
687745|NCT00307450|Dyskinesias|dyskinesias
687746|NCT00307450|Parkinson's disease|parkinson's disease
687747|NCT00307450|Levetiracetam|levetiracetam
687748|NCT00307450|Treatment|treatment
687749|NCT00307437|Moderate to Severe Plaque-Type Psoriasis|moderate to severe plaque-type psoriasis
687750|NCT00307437|interleukin 23|interleukin 23
687751|NCT00307437|IL-12|il-12
687752|NCT00307437|interleukin-12|interleukin-12
687753|NCT00307437|interleukin-23|interleukin-23
687754|NCT00307437|CNTO1275|cnto1275
687755|NCT00307437|biologic|biologic
687756|NCT00307437|Psoriasis|psoriasis
687757|NCT00307437|CNTO 1275|cnto 1275
687758|NCT00307437|IL23|il23
687759|NCT00307437|interleukin 12|interleukin 12
687760|NCT00307437|IL-23|il-23
687761|NCT00307437|IL12|il12
687762|NCT00307437|ustekinumab|ustekinumab
687763|NCT00307411|Metabolic syndrome|metabolic syndrome
687765|NCT00307398|Dry AMD|dry amd
687766|NCT00307398|Drusen|drusen
687767|NCT00307398|CNV|cnv
687768|NCT00307385|Motor Recovery|motor recovery
687769|NCT00307385|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
687770|NCT00307385|Homeostatic Plasticity|homeostatic plasticity
687771|NCT00307385|Ipsilesional Primary Motor Cortex|ipsilesional primary motor cortex
687772|NCT00307385|Paretic Fingers Motor Sequence|paretic fingers motor sequence
687773|NCT00307385|Motor Cortex|motor cortex
687774|NCT00307385|Motor Function|motor function
687775|NCT00307385|Motor Learning|motor learning
687776|NCT00307385|Premotor Cortex|premotor cortex
687777|NCT00307385|Primary Motor Cortex|primary motor cortex
687778|NCT00307385|Stroke|stroke
687779|NCT00307385|Healthy Volunteer|healthy volunteer
687780|NCT00307385|HV|hv
687781|NCT00307346|Movement-Related Potential|movement-related potential
687782|NCT00307346|Electroencephalogram|electroencephalogram
687783|NCT00307346|Psychogenic Movement Disorders|psychogenic movement disorders
687784|NCT00307346|Psychogenic Movement Disorder|psychogenic movement disorder
687785|NCT00307346|Healthy Volunteer|healthy volunteer
687786|NCT00307346|HV|hv
687787|NCT00307333|very low birth weight infants|very low birth weight infants
687788|NCT00307333|heart rate characteristics|heart rate characteristics
687789|NCT00307320|pregnancy|pregnancy
687790|NCT00307320|stress|stress
687791|NCT00307320|anxiety|anxiety
687792|NCT00307307|atherosclerosis|atherosclerosis
687793|NCT00307307|HDL cholesterol|hdl cholesterol
687794|NCT00307307|niacin|niacin
687795|NCT00307307|MR imaging|mr imaging
687796|NCT00307294|Prostate|prostate
687797|NCT00307294|Androgen|androgen
687798|NCT00307294|AIPC|aipc
687799|NCT00307294|Doxil|doxil
687800|NCT00307268|ADHD Effectiveness|adhd effectiveness
687801|NCT00307255|unspecified adult solid tumor|unspecified adult solid tumor
687802|NCT00307255|protocol specific|protocol specific
687803|NCT00307255|Paclitaxel|paclitaxel
687804|NCT00307255|Abraxane|abraxane
687805|NCT00307255|Gemcitabine|gemcitabine
687806|NCT00307255|Gemzar|gemzar
687807|NCT00307255|Phase I|phase i
687808|NCT00307255|Lineberger|lineberger
687809|NCT00307242|Adefovir Dipivoxil|adefovir dipivoxil
687810|NCT00307242|Lamivudine|lamivudine
687811|NCT00307242|Hepatitis B|hepatitis b
687812|NCT00307229|metastatic breast cancer|metastatic breast cancer
687813|NCT00307229|recurrent breast cancer|recurrent breast cancer
687814|NCT00307216|First Episode Psychosis|first episode psychosis
687815|NCT00307216|Early Psychosis|early psychosis
687816|NCT00307216|Psychosocial Intervention|psychosocial intervention
687817|NCT00307203|Bupropion|bupropion
687818|NCT00307203|Zyban|zyban
687819|NCT00307203|Wellbutrin|wellbutrin
687820|NCT00307203|Smoking cessation|smoking cessation
687821|NCT00307203|Schizophrenia|schizophrenia
687822|NCT00307203|Schizoaffective disorder|schizoaffective disorder
687823|NCT00307203|Cognitive Behavioral Therapy|cognitive behavioral therapy
687824|NCT00307190|BED|bed
687825|NCT00307177|influenza vaccine, baculovirus, immunogenicity, lymphoma|influenza vaccine, baculovirus, immunogenicity, lymphoma
687826|NCT00307164|Treatment Experienced|treatment experienced
687827|NCT00307164|Uridine|uridine
687828|NCT00307151|Treatment Naive|treatment naive
687829|NCT00307151|Mother-To-Child Transmission|mother-to-child transmission
687830|NCT00307151|MTCT|mtct
687831|NCT00307151|Pediatrics|pediatrics
687832|NCT00307151|Viral resistance|viral resistance
687833|NCT00307138|Coronary artery bypass, Off-pump|coronary artery bypass, off-pump
687834|NCT00307138|Hetastarch|hetastarch
687835|NCT00307138|Plasma substitutes|plasma substitutes
687836|NCT00307138|Equivalence|equivalence
687837|NCT00307125|Organ Transplantation|organ transplantation
687838|NCT00307125|Graft function/survival|graft function/survival
687839|NCT00307125|Immunosuppression|immunosuppression
687840|NCT00307125|anti-CD20 (rituximab)|anti-cd20 (rituximab)
687841|NCT00307112|Group A streptococcus, Nicaragua, Rheumatic Heart Disease|group a streptococcus, nicaragua, rheumatic heart disease
687842|NCT00307099|bacterial diseases|bacterial diseases
687843|NCT00307073|Pacemaker|pacemaker
687844|NCT00307073|Managed Ventricular Pacing|managed ventricular pacing
687845|NCT00307073|Ventricular Pacing|ventricular pacing
687846|NCT00307047|Stents|stents
687847|NCT00307047|Angioplasty|angioplasty
687848|NCT00307047|Total coronary occlusion|total coronary occlusion
687849|NCT00307047|coronary restenosis|coronary restenosis
687850|NCT00307047|stent thrombosis|stent thrombosis
687851|NCT00307034|Primary vaccination|primary vaccination
687852|NCT00307034|Pneumococcal disease|pneumococcal disease
687853|NCT00307034|Safety|safety
687854|NCT00307034|Booster vaccination|booster vaccination
687855|NCT00307034|Immunogenicity|immunogenicity
687856|NCT00307034|Pneumococcal vaccine|pneumococcal vaccine
687857|NCT00307034|Dose comparison|dose comparison
687858|NCT00307021|Parasitic Diseases|parasitic diseases
687859|NCT00307021|Malaria, Falciparum|malaria, falciparum
687860|NCT00307021|Malaria|malaria
687861|NCT00307021|Coccidiosis|coccidiosis
687862|NCT00307008|Prophylaxis Invasive pneumococcal diseases and pneumonia|prophylaxis invasive pneumococcal diseases and pneumonia
687863|NCT00306995|prophylaxis of pandemic influenza|prophylaxis of pandemic influenza
687864|NCT00306982|Prophylaxis Influenza vaccine|prophylaxis influenza vaccine
687865|NCT00306969|mycosis fungoides, Sézary Syndrome|mycosis fungoides, sézary syndrome
687866|NCT00306956|Infant|infant
687867|NCT00306956|Newborn|newborn
687868|NCT00306956|pacifier|pacifier
687869|NCT00306956|dummies|dummies
687870|NCT00306956|breastfeeding|breastfeeding
687871|NCT00306956|Sudden Infant Death|sudden infant death
687872|NCT00306956|SIDS|sids
687873|NCT00306956|Pacifiers|pacifiers
687874|NCT00306930|Total Hip Replacement|total hip replacement
687875|NCT00306930|post-traumatic arthritis|post-traumatic arthritis
687876|NCT00306917|Total Hip Replacement|total hip replacement
687877|NCT00306904|Macular|macular
687878|NCT00306904|Edema|edema
687879|NCT00306904|Diabetic|diabetic
687880|NCT00306904|Retinopathy|retinopathy
687881|NCT00306891|Advanced solid tumours|advanced solid tumours
687882|NCT00306891|Advanced cancer|advanced cancer
687883|NCT00306891|tumor|tumor
687884|NCT00306891|tumour|tumour
687885|NCT00306891|RECENTIN|recentin
687886|NCT00306865|Neurotransmitter|neurotransmitter
687887|NCT00306865|Neuroimaging|neuroimaging
687888|NCT00306865|Movement Disorder|movement disorder
687889|NCT00306865|Focal Hand Dystonia|focal hand dystonia
687890|NCT00306865|FHD|fhd
687891|NCT00306865|HV|hv
687892|NCT00306852|Glaucoma|glaucoma
687893|NCT00306852|Trabeculectomy|trabeculectomy
687894|NCT00306852|Tube shunt surgery|tube shunt surgery
687895|NCT00306839|Tissucol|tissucol
687896|NCT00306839|Tisseel|tisseel
687897|NCT00306839|Lichtenstein|lichtenstein
687898|NCT00306839|hernia|hernia
687899|NCT00306839|inguinal|inguinal
687900|NCT00306826|Impaired glucose tolerance|impaired glucose tolerance
687901|NCT00306813|refractory or relapsed multiple myeloma|refractory or relapsed multiple myeloma
687902|NCT00306813|CC-5013|cc-5013
687903|NCT00306813|Revlimid|revlimid
687904|NCT00306813|lenalidomide|lenalidomide
687905|NCT00306813|RAD|rad
687906|NCT00306800|Methyl aminolevulinate|methyl aminolevulinate
687907|NCT00306800|Photodynamic therapy|photodynamic therapy
687908|NCT00306800|Aktilite CL128 LED light source|aktilite cl128 led light source
687909|NCT00306800|Multiple Actinic Keratosis|multiple actinic keratosis
687910|NCT00306787|Herpes simplex|herpes simplex
687911|NCT00306787|genital herpes|genital herpes
687912|NCT00306787|famciclovir|famciclovir
687913|NCT00306787|valacyclovir|valacyclovir
687914|NCT00306787|Recurrent genital herpes|recurrent genital herpes
687915|NCT00306774|osteoarthritis|osteoarthritis
687916|NCT00306774|vitamin D|vitamin d
687917|NCT00306774|knee pain|knee pain
687918|NCT00306774|cartilage loss|cartilage loss
687919|NCT00306774|WOMAC|womac
687920|NCT00306774|MRI|mri
687921|NCT00306774|cartilage volume|cartilage volume
687922|NCT00306774|OA|oa
687923|NCT00306774|physical function|physical function
687924|NCT00306774|web-based|web-based
687925|NCT00306774|internet-based|internet-based
687926|NCT00306748|Chronic Constipation|chronic constipation
687927|NCT00306748|Chronic Idiopathic Constipation|chronic idiopathic constipation
687928|NCT00306748|Constipation|constipation
687929|NCT00306748|CIC|cic
687930|NCT00306748|CC|cc
687931|NCT00306748|MD-1100|md-1100
687932|NCT00306748|MD-1100 Acetate|md-1100 acetate
687933|NCT00306748|Microbia|microbia
687934|NCT00306748|Microbia, Inc.|microbia, inc.
687935|NCT00306748|linaclotide|linaclotide
687936|NCT00306748|linaclotide acetate|linaclotide acetate
687937|NCT00306735|Multiple Myeloma|multiple myeloma
687938|NCT00306735|Stem Cell Transplantation|stem cell transplantation
687939|NCT00306735|CINV|cinv
687940|NCT00306722|Bronchoscopy|bronchoscopy
687941|NCT00306722|Sedation|sedation
687942|NCT00306722|AQUAVAN|aquavan
687943|NCT00306722|fospropofol disodium|fospropofol disodium
687944|NCT00306722|Flexible bronchoscopy|flexible bronchoscopy
687945|NCT00306709|obesity|obesity
687946|NCT00306709|behavior change|behavior change
687947|NCT00306709|cultural adaptations|cultural adaptations
687948|NCT00306709|weight loss|weight loss
687949|NCT00306696|rosiglitazone|rosiglitazone
687950|NCT00306696|fluid retention|fluid retention
687951|NCT00306696|Type 2 diabetes|type 2 diabetes
687952|NCT00306696|diuretics|diuretics
687953|NCT00306683|Hypothalamic-pituitary lesions|hypothalamic-pituitary lesions
687954|NCT00306683|Craniopharyngioma|craniopharyngioma
687955|NCT00306683|Obesity|obesity
687956|NCT00306683|Diazoxide|diazoxide
687957|NCT00306683|Hyperinsulinemia|hyperinsulinemia
687958|NCT00306683|Pediatric neurosurgery|pediatric neurosurgery
687959|NCT00306683|Oncology|oncology
687960|NCT00306683|Pituitary|pituitary
687961|NCT00306683|Hypothalamus|hypothalamus
687962|NCT00306670|Acquired Hemophilia A|acquired hemophilia a
687963|NCT00306670|Anti-Factor VIII antibodies|anti-factor viii antibodies
687964|NCT00306670|Anti-Factor VIII inhibitors|anti-factor viii inhibitors
687965|NCT00306670|Hemophilia A|hemophilia a
687966|NCT00306670|Factor VIII inhibitors|factor viii inhibitors
687967|NCT00306657|Glaucoma Open-Angle|glaucoma open-angle
687968|NCT00306657|Normal tension glaucoma progressive|normal tension glaucoma progressive
687969|NCT00306657|chronic open angle glaucoma progressive|chronic open angle glaucoma progressive
687970|NCT00306657|optic nerve sheath fenestration|optic nerve sheath fenestration
687971|NCT00306657|cerebrospinal fluid|cerebrospinal fluid
687972|NCT00306657|Beta-Trace Protein|beta-trace protein
687973|NCT00306644|rosiglitazone|rosiglitazone
687974|NCT00306644|Type 2 diabetes|type 2 diabetes
687975|NCT00306644|intima media thickness|intima media thickness
687976|NCT00306644|Insulin resistance|insulin resistance
687977|NCT00306631|Advanced and Metastatic Breast Cancer|advanced and metastatic breast cancer
687978|NCT00306605|Emotional experiences|emotional experiences
687979|NCT00306605|fathers|fathers
687980|NCT00306605|stress|stress
687981|NCT00306605|depressive symptomatology|depressive symptomatology
687982|NCT00306605|NICU|nicu
687983|NCT00306605|preterm birth|preterm birth
687984|NCT00306592|Multiple Sclerosis|multiple sclerosis
687985|NCT00306592|MS|ms
687986|NCT00306579|Ischemic Stroke|ischemic stroke
687987|NCT00306579|Myocardial ischemia|myocardial ischemia
687988|NCT00306579|Myocardial necrosis|myocardial necrosis
687989|NCT00306527|Influenza|influenza
687990|NCT00306527|adult/elderly|adult/elderly
687991|NCT00306527|flu cell culture|flu cell culture
687992|NCT00306527|vaccine|vaccine
687993|NCT00306514|metastatic malignant melanoma of the skin|metastatic malignant melanoma of the skin
687994|NCT00306501|Training|training
687995|NCT00306501|Cortical Stimulation|cortical stimulation
687996|NCT00306501|Sensory Stimulation|sensory stimulation
687997|NCT00306501|Brain Imaging|brain imaging
688408|NCT00305357|Post-Herpetic Neuralgia|post-herpetic neuralgia
687998|NCT00306501|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
687999|NCT00306501|Swallowing|swallowing
688000|NCT00306501|Dysphagia|dysphagia
688001|NCT00306501|Stroke|stroke
688002|NCT00306501|CVA|cva
688003|NCT00306501|Cerebral Vascular Accident|cerebral vascular accident
688004|NCT00306501|Healthy Volunteer|healthy volunteer
688005|NCT00306501|HV|hv
688006|NCT00306488|Retinal Pigment Epithelium|retinal pigment epithelium
688007|NCT00306488|Dynamic Light Scattering (DLS)|dynamic light scattering (dls)
688008|NCT00306488|Visual Acuity Decrease|visual acuity decrease
688009|NCT00306488|Intra-ocular Pressure|intra-ocular pressure
688010|NCT00306488|Autofluorescence of Retina|autofluorescence of retina
688011|NCT00306488|Age-Related Macular Degeneration|age-related macular degeneration
688012|NCT00306488|AMD|amd
688013|NCT00306475|schizophrenia, cognition, mood stabilizer|schizophrenia, cognition, mood stabilizer
688014|NCT00306462|Premature Labor|premature labor
688015|NCT00306462|Premature Birth|premature birth
688016|NCT00306462|Magnesium sulfate|magnesium sulfate
688017|NCT00306462|Nifedipine|nifedipine
688018|NCT00306449|Weight gain|weight gain
688019|NCT00306449|obesity|obesity
688020|NCT00306449|overweight|overweight
688021|NCT00306449|young adults|young adults
688022|NCT00306449|lipid disorders|lipid disorders
688023|NCT00306449|insulin resistance|insulin resistance
688024|NCT00306449|randomized controled study|randomized controled study
688025|NCT00306436|Diabetes|diabetes
688026|NCT00306436|renal deficiency|renal deficiency
688027|NCT00306436|hypertension|hypertension
688028|NCT00306423|exercise|exercise
688029|NCT00306410|Vitamin D deficiency|vitamin d deficiency
688030|NCT00306410|HIV/AIDS|hiv/aids
688031|NCT00306410|HAART|haart
688032|NCT00306410|T-Lymphocytes, Regulatory|t-lymphocytes, regulatory
688033|NCT00306410|insulin resistance|insulin resistance
688034|NCT00306410|bone density|bone density
688035|NCT00306397|Kidney transplantation|kidney transplantation
688036|NCT00306397|Steroid free|steroid free
688037|NCT00306397|Calcineurin inhibitor free|calcineurin inhibitor free
688038|NCT00306397|Tacrolimus|tacrolimus
688039|NCT00306397|Sirolimus|sirolimus
688040|NCT00306384|Glucose Metabolism Disorder|glucose metabolism disorder
688041|NCT00306384|Dysmetabolic Syndrome|dysmetabolic syndrome
688042|NCT00306384|Type II Diabetes|type ii diabetes
688043|NCT00306384|Diabetes Mellitus,|diabetes mellitus,
688044|NCT00306384|Lipoatrophic|lipoatrophic
688045|NCT00306384|Dyslipidemia|dyslipidemia
688046|NCT00306384|Drug Therapy|drug therapy
688047|NCT00306371|diode|diode
688048|NCT00306371|laser|laser
688049|NCT00306371|acne|acne
688050|NCT00306371|acne scar|acne scar
688051|NCT00306358|absorption test|absorption test
688052|NCT00306358|cobalamin|cobalamin
688053|NCT00306358|holotranscobalamin|holotranscobalamin
688054|NCT00306358|vitamin B12|vitamin b12
688055|NCT00306345|Outreach|outreach
688056|NCT00306345|Major general surgery|major general surgery
688057|NCT00306345|Intensive care|intensive care
688058|NCT00306345|Serious adverse events|serious adverse events
688059|NCT00306332|Allogeneic Stem cell transplantation|allogeneic stem cell transplantation
688060|NCT00306332|T-cell depletion|t-cell depletion
688061|NCT00306332|B-cell depletion|b-cell depletion
688062|NCT00306332|Immunomagnetic selection|immunomagnetic selection
688063|NCT00306319|Tuberculosis|tuberculosis
688064|NCT00306293|Recurrent Genital Herpes|recurrent genital herpes
688065|NCT00306280|Helicobacter pylori|helicobacter pylori
688066|NCT00306280|phototherapy|phototherapy
688067|NCT00306280|peptic ulcer|peptic ulcer
688068|NCT00306280|gastric cancer|gastric cancer
688069|NCT00306267|Anemia|anemia
688070|NCT00306267|non-chemotherapy-induced|non-chemotherapy-induced
688071|NCT00306267|non-radiation therapy-induced|non-radiation therapy-induced
688072|NCT00306267|cancer|cancer
688073|NCT00306267|non-myeloid|non-myeloid
688074|NCT00306241|Cervical neoplasia|cervical neoplasia
688075|NCT00306241|Cervical cancer|cervical cancer
688076|NCT00306241|Double-blind|double-blind
688077|NCT00306241|HPV-16/18 L1 VLP AS04|hpv-16/18 l1 vlp as04
688078|NCT00306241|HPV|hpv
688079|NCT00306241|AS04|as04
688080|NCT00306228|ST elevation acute myocardial infarction|st elevation acute myocardial infarction
688081|NCT00306228|Thrombolysis|thrombolysis
688082|NCT00306228|Early routine percutaneous coronary intervention|early routine percutaneous coronary intervention
688083|NCT00306228|tirofiban|tirofiban
688084|NCT00306228|paclitaxel|paclitaxel
688085|NCT00306215|double-blind|double-blind
688086|NCT00306215|placebo-controlled|placebo-controlled
688087|NCT00306215|multicenter|multicenter
688088|NCT00306215|efficacy|efficacy
688089|NCT00306215|safety|safety
688090|NCT00306202|Relapsed and Refractory Leukemia|relapsed and refractory leukemia
688091|NCT00306189|RANKL|rankl
688092|NCT00306189|RANK|rank
688093|NCT00306189|denosumab|denosumab
688094|NCT00306189|AMG 162|amg 162
688095|NCT00306189|osteoporosis|osteoporosis
688096|NCT00306189|bone turnover|bone turnover
688097|NCT00306189|bone mineral density|bone mineral density
688098|NCT00306189|Japanese|japanese
688099|NCT00306176|rosiglitazone,exercise,cardiovascular risk factors|rosiglitazone,exercise,cardiovascular risk factors
688100|NCT00306163|Asthma|asthma
688101|NCT00306163|AMP|amp
688102|NCT00306163|Ciclesonide|ciclesonide
688103|NCT00306163|Fluticasone propionate|fluticasone propionate
688104|NCT00306150|Prevention of blood loss|prevention of blood loss
688105|NCT00306150|Blood Loss, Surgical|blood loss, surgical
688106|NCT00306150|Blood Loss, Postoperative|blood loss, postoperative
688107|NCT00306124|Dementia|dementia
688108|NCT00306124|Mild Cognitive Impairment|mild cognitive impairment
688109|NCT00306124|MCI|mci
688110|NCT00306124|levodopa|levodopa
688111|NCT00306124|learning|learning
688112|NCT00306124|enhancement|enhancement
688113|NCT00306111|stem cell transplantation|stem cell transplantation
688114|NCT00306111|stem cell mobilization|stem cell mobilization
688115|NCT00306111|high-dose therapy|high-dose therapy
688116|NCT00306098|Transplantation, Islets of Langerhans|transplantation, islets of langerhans
688117|NCT00306085|Peripheral arterial disease,|peripheral arterial disease,
688118|NCT00306085|blood marrow cells,|blood marrow cells,
688119|NCT00306085|therapeutic angiogenesis.|therapeutic angiogenesis.
688120|NCT00306046|PETScan|petscan
688121|NCT00306046|Positron-Emission Tomography|positron-emission tomography
688122|NCT00306046|Bisphosphonate|bisphosphonate
688123|NCT00306046|Biochemical Markers|biochemical markers
688124|NCT00306046|Paget's Disease of Bone (monostotic and polyostotic)|paget's disease of bone (monostotic and polyostotic)
688125|NCT00306033|myasthenia gravis|myasthenia gravis
688126|NCT00306033|immunoglobulin|immunoglobulin
688127|NCT00306033|intravenous immunoglobulin|intravenous immunoglobulin
688128|NCT00306033|treatment|treatment
688129|NCT00306020|Skin ulcers|skin ulcers
688130|NCT00306020|Topical morphine|topical morphine
688131|NCT00306020|Chronic pain|chronic pain
688132|NCT00306020|Cancer|cancer
688133|NCT00306007|Pregnancy|pregnancy
688134|NCT00306007|Unplanned pregnancy|unplanned pregnancy
688135|NCT00306007|Psychosocial|psychosocial
688136|NCT00306007|Measure|measure
688137|NCT00305968|Quality of life|quality of life
688138|NCT00305968|Gastrointestinal symptoms|gastrointestinal symptoms
688139|NCT00305968|Health related costs|health related costs
688140|NCT00305955|amblyopia|amblyopia
688141|NCT00305955|bilateral amblyopia|bilateral amblyopia
688142|NCT00305955|refractive error|refractive error
688143|NCT00305942|Lung Cancer|lung cancer
688144|NCT00305942|Carcinoma, Small Cell|carcinoma, small cell
688145|NCT00305929|Treatment of localized prostate cancer|treatment of localized prostate cancer
688146|NCT00305929|Localized prostate cancer|localized prostate cancer
688147|NCT00305916|MSCT|msct
688148|NCT00305916|Idiopathic Cardiomyopathy|idiopathic cardiomyopathy
688149|NCT00305916|Sinus rhythm|sinus rhythm
688150|NCT00305903|Dementia,|dementia,
688151|NCT00305903|Alzheimer's,|alzheimer's,
688152|NCT00305903|Rivastigmine,|rivastigmine,
688153|NCT00305903|Memantine|memantine
688154|NCT00305851|fatigue|fatigue
688155|NCT00305851|pain|pain
688156|NCT00305851|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
688157|NCT00305851|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
688158|NCT00305851|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
688159|NCT00305851|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
688160|NCT00305851|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
688161|NCT00305851|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
688162|NCT00305851|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
688163|NCT00305851|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
688164|NCT00305851|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
688165|NCT00305851|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
688166|NCT00305851|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
688167|NCT00305851|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
688168|NCT00305851|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
688169|NCT00305851|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
688170|NCT00305851|chronic eosinophilic leukemia|chronic eosinophilic leukemia
688171|NCT00305851|primary myelofibrosis|primary myelofibrosis
688172|NCT00305851|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
688173|NCT00305851|chronic neutrophilic leukemia|chronic neutrophilic leukemia
688174|NCT00305851|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
688175|NCT00305851|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
688176|NCT00305851|disseminated neuroblastoma|disseminated neuroblastoma
688177|NCT00305851|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
688178|NCT00305851|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
688179|NCT00305851|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
688180|NCT00305851|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
688181|NCT00305851|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
688182|NCT00305851|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
688183|NCT00305851|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
688184|NCT00305851|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
688185|NCT00305851|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
688186|NCT00305851|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
688187|NCT00305851|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
688188|NCT00305851|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
688189|NCT00305851|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
688190|NCT00305851|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
688191|NCT00305851|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
688192|NCT00305851|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
688193|NCT00305851|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
688194|NCT00305851|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
688195|NCT00305851|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
688196|NCT00305851|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
688197|NCT00305851|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
688198|NCT00305851|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
688199|NCT00305851|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
688200|NCT00305851|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
688201|NCT00305851|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
688202|NCT00305851|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
688203|NCT00305851|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
688204|NCT00305851|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
688205|NCT00305851|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
688206|NCT00305851|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
688207|NCT00305851|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
688208|NCT00305851|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
688209|NCT00305851|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
688210|NCT00305851|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
688211|NCT00305851|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
688212|NCT00305851|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
688213|NCT00305851|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
688214|NCT00305851|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
688215|NCT00305851|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
688216|NCT00305851|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
688217|NCT00305851|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
688218|NCT00305851|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
688219|NCT00305851|recurrent neuroblastoma|recurrent neuroblastoma
688220|NCT00305851|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
688221|NCT00305851|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
688222|NCT00305851|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
688223|NCT00305851|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
688572|NCT00304889|Clostridium difficile|clostridium difficile
688224|NCT00305851|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
688225|NCT00305851|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
688226|NCT00305851|refractory hairy cell leukemia|refractory hairy cell leukemia
688227|NCT00305851|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
688228|NCT00305851|secondary acute myeloid leukemia|secondary acute myeloid leukemia
688229|NCT00305851|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
688230|NCT00305851|splenic marginal zone lymphoma|splenic marginal zone lymphoma
688231|NCT00305851|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
688232|NCT00305851|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
688233|NCT00305851|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
688234|NCT00305851|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
688235|NCT00305851|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
688236|NCT00305851|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
688237|NCT00305851|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
688238|NCT00305851|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
688239|NCT00305851|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
688240|NCT00305851|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
688777|NCT00303979|Outcomes|outcomes
688241|NCT00305851|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
688242|NCT00305851|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
688243|NCT00305851|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
688244|NCT00305851|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
688245|NCT00305851|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
688246|NCT00305851|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
688247|NCT00305851|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
688248|NCT00305851|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
688249|NCT00305851|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
688250|NCT00305851|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
688251|NCT00305851|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
688252|NCT00305851|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
688253|NCT00305851|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
688254|NCT00305851|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
688255|NCT00305851|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
688256|NCT00305851|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
688257|NCT00305851|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
688258|NCT00305851|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
688259|NCT00305851|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
688260|NCT00305851|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
688261|NCT00305851|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
688262|NCT00305851|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
688263|NCT00305851|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
688264|NCT00305851|Ewing sarcoma|ewing sarcoma
688265|NCT00305851|childhood brain tumor|childhood brain tumor
688266|NCT00305851|adult brain tumor|adult brain tumor
688267|NCT00305851|osteosarcoma|osteosarcoma
688268|NCT00305838|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
688269|NCT00305838|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
688270|NCT00305838|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
688271|NCT00305838|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
688272|NCT00305838|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
688273|NCT00305838|recurrent fallopian tube cancer|recurrent fallopian tube cancer
688274|NCT00305838|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
688275|NCT00305838|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
688276|NCT00305838|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
688277|NCT00305838|stage IV fallopian tube cancer|stage iv fallopian tube cancer
688278|NCT00305838|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
688279|NCT00305838|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
688280|NCT00305838|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
688281|NCT00305838|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
688282|NCT00305838|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
688283|NCT00305825|recurrent breast cancer|recurrent breast cancer
688284|NCT00305825|stage IIIA breast cancer|stage iiia breast cancer
688285|NCT00305825|stage IIIB breast cancer|stage iiib breast cancer
688286|NCT00305825|stage IIIC breast cancer|stage iiic breast cancer
688287|NCT00305825|stage IV breast cancer|stage iv breast cancer
688288|NCT00305812|stage I multiple myeloma|stage i multiple myeloma
688289|NCT00305812|stage II multiple myeloma|stage ii multiple myeloma
688290|NCT00305812|stage III multiple myeloma|stage iii multiple myeloma
688291|NCT00305799|neurotoxicity|neurotoxicity
688292|NCT00305799|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
688293|NCT00305786|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
688294|NCT00305786|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
688295|NCT00305786|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
688296|NCT00305760|stage III pancreatic cancer|stage iii pancreatic cancer
688297|NCT00305760|recurrent pancreatic cancer|recurrent pancreatic cancer
688298|NCT00305760|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
688299|NCT00305760|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
688300|NCT00305760|stage IV pancreatic cancer|stage iv pancreatic cancer
688301|NCT00305747|recurrent prostate cancer|recurrent prostate cancer
688302|NCT00305747|stage I prostate cancer|stage i prostate cancer
688303|NCT00305747|stage II prostate cancer|stage ii prostate cancer
688304|NCT00305747|stage III prostate cancer|stage iii prostate cancer
688305|NCT00305747|adenocarcinoma of the prostate|adenocarcinoma of the prostate
688306|NCT00305747|stage IV prostate cancer|stage iv prostate cancer
688307|NCT00305708|thrombocytopenia|thrombocytopenia
688308|NCT00305708|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
688309|NCT00305708|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
688310|NCT00305708|Diamond-Blackfan anemia|diamond-blackfan anemia
688311|NCT00305708|congenital amegakaryocytic thrombocytopenia|congenital amegakaryocytic thrombocytopenia
688312|NCT00305708|Fanconi anemia|fanconi anemia
688313|NCT00305708|severe congenital neutropenia|severe congenital neutropenia
688314|NCT00305708|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
688315|NCT00305669|adenocarcinoma of the prostate|adenocarcinoma of the prostate
688316|NCT00305669|stage I prostate cancer|stage i prostate cancer
688317|NCT00305669|stage IIB prostate cancer|stage iib prostate cancer
688318|NCT00305669|stage IIA prostate cancer|stage iia prostate cancer
688319|NCT00305669|stage III prostate cancer|stage iii prostate cancer
688320|NCT00305643|Hand-Foot Syndrome|hand-foot syndrome
688321|NCT00305643|cancer-related problem/condition|cancer-related problem/condition
688322|NCT00305643|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
688324|NCT00305643|palmar-plantar erythrodysesthesia|palmar-plantar erythrodysesthesia
688325|NCT00305643|stage IV breast cancer|stage iv breast cancer
688326|NCT00305643|male breast cancer|male breast cancer
688327|NCT00305643|recurrent breast cancer|recurrent breast cancer
688328|NCT00305643|stage IV colon cancer|stage iv colon cancer
688329|NCT00305643|stage IV rectal cancer|stage iv rectal cancer
688330|NCT00305643|recurrent colon cancer|recurrent colon cancer
688331|NCT00305643|recurrent rectal cancer|recurrent rectal cancer
688332|NCT00305643|Celecoxib|celecoxib
688333|NCT00305643|Celebrex|celebrex
688334|NCT00305643|Capecitabine|capecitabine
688335|NCT00305643|Xeloda|xeloda
688336|NCT00305630|Corticosteroids|corticosteroids
688337|NCT00305630|Triamcinolone|triamcinolone
688338|NCT00305630|Photodynamic therapy|photodynamic therapy
688339|NCT00305630|Choroidal neovascularization|choroidal neovascularization
688340|NCT00305630|Age-related macular degeneration|age-related macular degeneration
688341|NCT00305617|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
688342|NCT00305617|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
688343|NCT00305591|magnetic resonance imaging|magnetic resonance imaging
688344|NCT00305591|magnetic resonance spectroscopy|magnetic resonance spectroscopy
688345|NCT00305591|functional magnetic resonance imaging|functional magnetic resonance imaging
688346|NCT00305591|cirrhosis|cirrhosis
688347|NCT00305591|hepatic encephalopathy|hepatic encephalopathy
688348|NCT00305591|l-ornithine l-aspartate|l-ornithine l-aspartate
688349|NCT00305578|Bipolar|bipolar
688350|NCT00305578|Depression|depression
688351|NCT00305578|Incomplete Response|incomplete response
688352|NCT00305565|Depression|depression
688353|NCT00305565|Chronic Depression|chronic depression
688354|NCT00305565|Bipolar Disorder|bipolar disorder
688355|NCT00305552|Randomized controlled trial|randomized controlled trial
688356|NCT00305552|Thalidomide vs placebo|thalidomide vs placebo
688357|NCT00305552|skin sarcoidosis|skin sarcoidosis
688358|NCT00305552|Thalidomide|thalidomide
688359|NCT00305539|Giant Cell Arteritis|giant cell arteritis
688360|NCT00305539|Placebo|placebo
688361|NCT00305539|Anti-TNF|anti-tnf
688362|NCT00305539|Multicenter-randomized-trial|multicenter-randomized-trial
688363|NCT00305539|Proved GCA according to ACR criteria (HUNDER et al 1990)|proved gca according to acr criteria (hunder et al 1990)
688364|NCT00305513|right hemispheric CVA|right hemispheric cva
688365|NCT00305513|neglect|neglect
688366|NCT00305513|phasic alert treatment|phasic alert treatment
688367|NCT00305513|PET scan|pet scan
688368|NCT00305513|patients post right hemispheric CVA (stroke)|patients post right hemispheric cva (stroke)
688369|NCT00305500|OCD|ocd
688370|NCT00305500|Escitalopram|escitalopram
688371|NCT00305487|Hay Fever|hay fever
688372|NCT00305487|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
688373|NCT00305487|Nasal spray|nasal spray
688374|NCT00305487|Ciclesonide|ciclesonide
688375|NCT00305487|Allergic Rhinitis|allergic rhinitis
688376|NCT00305474|Negative symptoms|negative symptoms
688377|NCT00305474|neuropsychological deficits|neuropsychological deficits
688378|NCT00305474|Cognitive function|cognitive function
688379|NCT00305474|diagnostic|diagnostic
688380|NCT00305474|prevention|prevention
688381|NCT00305461|Asthma|asthma
688382|NCT00305461|Quality of Life|quality of life
688383|NCT00305461|Ciclesonide|ciclesonide
688384|NCT00305448|oncology|oncology
688385|NCT00305448|cancer|cancer
688386|NCT00305448|breast cancer|breast cancer
688387|NCT00305435|AMG 531, ITP, Phase 2, Japanese|amg 531, itp, phase 2, japanese
688388|NCT00305409|Crohn's|crohn's
688389|NCT00305409|TNF-alpha|tnf-alpha
688390|NCT00305409|Synbiotic|synbiotic
688391|NCT00305409|Probiotic|probiotic
688392|NCT00305396|Kidney transplantation|kidney transplantation
688393|NCT00305396|immunosuppression|immunosuppression
688394|NCT00305396|sirolimus|sirolimus
688395|NCT00305396|Thymoglobulin|thymoglobulin
688396|NCT00305383|Viramidine|viramidine
688397|NCT00305383|Peginterferon alfa-2b|peginterferon alfa-2b
688398|NCT00305383|Valeant|valeant
688399|NCT00305383|Hepatitis C|hepatitis c
688400|NCT00305383|Rapid virologic response|rapid virologic response
688401|NCT00305383|HCV RNA|hcv rna
688402|NCT00305370|clinical trial|clinical trial
688403|NCT00305370|aripiprazole|aripiprazole
688404|NCT00305370|methylphenidate|methylphenidate
688405|NCT00305370|Bipolar Disorder|bipolar disorder
688406|NCT00305370|Attention-Deficit Hyperactivity Disorder|attention-deficit hyperactivity disorder
688407|NCT00305370|ADHD|adhd
689335|NCT00302107|Veterans|veterans
688409|NCT00305357|Acute Herpes Zoster|acute herpes zoster
688410|NCT00305344|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
688411|NCT00305344|Umbilical Cord|umbilical cord
688412|NCT00305344|Regeneration|regeneration
688413|NCT00305344|Insulin|insulin
688414|NCT00305344|Islets of Langerhans|islets of langerhans
688415|NCT00305331|Parkinson's disease|parkinson's disease
688416|NCT00305331|Domperidone|domperidone
688417|NCT00305331|Peripheral edema|peripheral edema
688418|NCT00305331|Pramipexole|pramipexole
688419|NCT00305331|Ropinirole|ropinirole
688420|NCT00305305|Agenesis Corpus Callosum|agenesis corpus callosum
688421|NCT00305305|Polymicrogyria|polymicrogyria
688422|NCT00305305|Dandy-Walker|dandy-walker
688423|NCT00305305|Brain Malformation|brain malformation
688424|NCT00305305|Autism|autism
688425|NCT00305305|Epilepsy|epilepsy
688426|NCT00305305|Mental Retardation|mental retardation
688427|NCT00305305|MRI|mri
688428|NCT00305305|Agenesis of the Corpus Callosum (complete or partial)|agenesis of the corpus callosum (complete or partial)
688429|NCT00305305|Confirmed by a brain MRI.|confirmed by a brain mri.
688430|NCT00305305|Aicardi Syndrome.|aicardi syndrome.
688431|NCT00305266|CIDP|cidp
688432|NCT00305266|IVIG|ivig
688433|NCT00305266|gammaglobulin|gammaglobulin
688434|NCT00305266|Chronic Inflammatory Demyelinating Polyradiculoneuropathy|chronic inflammatory demyelinating polyradiculoneuropathy
688435|NCT00305253|maternal mortality|maternal mortality
688436|NCT00305253|obstetric hemorrhage|obstetric hemorrhage
688437|NCT00305240|Myocardial Infarction|myocardial infarction
688438|NCT00305240|Microvolt T Wave Alternans Test|microvolt t wave alternans test
688439|NCT00305240|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
688440|NCT00305240|Ventricular Arrythmias|ventricular arrythmias
688441|NCT00305227|urinary tract infection|urinary tract infection
688442|NCT00305227|cystitis|cystitis
688443|NCT00305227|Lactobacillus|lactobacillus
688444|NCT00305227|probiotic|probiotic
688445|NCT00305227|prevention|prevention
688446|NCT00305214|Myocardial Infarction|myocardial infarction
688447|NCT00305214|Microvolt T Wave Alternans Test|microvolt t wave alternans test
688448|NCT00305214|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
688449|NCT00305214|Ventricular Arrhythmia|ventricular arrhythmia
688450|NCT00305201|Mucocutaneous Lymph Node Syndrome|mucocutaneous lymph node syndrome
688451|NCT00305201|Kawasaki disease|kawasaki disease
688452|NCT00305201|Endothelial dysfunction|endothelial dysfunction
688453|NCT00305201|Pravastatin|pravastatin
688454|NCT00305201|Statin therapy|statin therapy
688455|NCT00305188|Neurotoxicity syndromes|neurotoxicity syndromes
688456|NCT00305188|Paresthesia|paresthesia
688457|NCT00305188|Oxaliplatin|oxaliplatin
688458|NCT00305188|Xaliproden|xaliproden
688459|NCT00305175|Hydroxyurea|hydroxyurea
688460|NCT00305175|Sickle Cell Anemia|sickle cell anemia
688461|NCT00305162|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
688462|NCT00305162|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
688463|NCT00305162|non-ST-segment elevation myocardial infarction (NSTEMI)|non-st-segment elevation myocardial infarction (nstemi)
688464|NCT00305162|ST-segment elevation myocardial infarction (STEMI)|st-segment elevation myocardial infarction (stemi)
688465|NCT00305149|Hodgkin Lymphoma|hodgkin lymphoma
688466|NCT00305149|BEACOPP|beacopp
688467|NCT00305149|PET|pet
688468|NCT00305149|Gallium|gallium
688469|NCT00305149|Tailored therapy|tailored therapy
688470|NCT00305136|thoracotomy|thoracotomy
688471|NCT00305136|post-operative pain|post-operative pain
688472|NCT00305136|chronic pain|chronic pain
688473|NCT00305136|endogenous analgesia|endogenous analgesia
688474|NCT00305136|temporal summation|temporal summation
688475|NCT00305136|central sensitization|central sensitization
688476|NCT00305136|prediction|prediction
688477|NCT00305136|Patients Who Should Undergo Thoracotomy|patients who should undergo thoracotomy
688478|NCT00305123|Pharyngitis, Mali, Group A Streptococcus, Children|pharyngitis, mali, group a streptococcus, children
688479|NCT00305110|Pain|pain
688480|NCT00305110|Acute|acute
688481|NCT00305110|Emergency Department|emergency department
688482|NCT00305110|Severe|severe
688483|NCT00305110|Hydromorphone|hydromorphone
688484|NCT00305110|Dilaudid|dilaudid
688485|NCT00305110|Adult|adult
688486|NCT00305097|coffee|coffee
688487|NCT00305097|caffeine|caffeine
688488|NCT00305097|glucose tolerance|glucose tolerance
688489|NCT00305097|body weight|body weight
688490|NCT00305097|insulin sensitivity|insulin sensitivity
688491|NCT00305097|randomized controlled trial|randomized controlled trial
688492|NCT00305084|NGR-hTNF|ngr-htnf
688493|NCT00305084|doxorubicin|doxorubicin
688494|NCT00305084|solid tumors|solid tumors
688495|NCT00305071|pyuria|pyuria
688496|NCT00305071|urinary tract infections|urinary tract infections
688497|NCT00305071|Vaccinium macrocarpon|vaccinium macrocarpon
688498|NCT00305058|Elderly|elderly
688499|NCT00305058|Hydromorphone|hydromorphone
688500|NCT00305058|Morphine|morphine
688501|NCT00305058|Pain|pain
688502|NCT00305058|Acute|acute
688503|NCT00305058|Emergency Department|emergency department
688504|NCT00305045|Major Depressive Disorder|major depressive disorder
689615|NCT00301522|stent|stent
688505|NCT00305045|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
688506|NCT00305045|Treatment resistance|treatment resistance
688507|NCT00305006|cerebral palsy|cerebral palsy
688508|NCT00305006|constraint-induced therapy|constraint-induced therapy
688509|NCT00305006|constraint-induced movement therapy|constraint-induced movement therapy
688510|NCT00305006|CP|cp
688511|NCT00305006|hemiplegia|hemiplegia
688512|NCT00305006|hand|hand
688513|NCT00305006|forced use|forced use
688514|NCT00305006|motor control|motor control
688515|NCT00305006|children|children
688516|NCT00305006|HABIT|habit
688517|NCT00305006|Hand-arm bimanual intensive therapy|hand-arm bimanual intensive therapy
688518|NCT00305006|Bilateral training|bilateral training
688519|NCT00305006|Bimanual training|bimanual training
688520|NCT00305006|functional therapy|functional therapy
688521|NCT00305006|physical therapy|physical therapy
688522|NCT00305006|occupational therapy|occupational therapy
688523|NCT00305006|intensive|intensive
688524|NCT00305006|pediatric|pediatric
688525|NCT00305006|development|development
688526|NCT00305006|upper extremity|upper extremity
688527|NCT00305006|hemiplegic|hemiplegic
688528|NCT00304993|fenofibrate|fenofibrate
688529|NCT00304993|niacin|niacin
688530|NCT00304993|rosiglitazone|rosiglitazone
688531|NCT00304993|LDL phenotype pattern B|ldl phenotype pattern b
688532|NCT00304993|small, dense LDL|small, dense ldl
688533|NCT00304993|insulin resistance|insulin resistance
688534|NCT00304993|Metabolic Syndrome|metabolic syndrome
688535|NCT00304967|Cataract|cataract
688536|NCT00304967|Normal Lenses|normal lenses
688537|NCT00304967|Lens Crystallines|lens crystallines
688538|NCT00304967|Dynamic or Quasielastic Light Scattering (DLS)|dynamic or quasielastic light scattering (dls)
688539|NCT00304967|Eye Examinations|eye examinations
688540|NCT00304967|Healthy Volunteer|healthy volunteer
688541|NCT00304967|HV|hv
688542|NCT00304967|Eye Examination|eye examination
688543|NCT00304954|Age-Related Macular Degeneration|age-related macular degeneration
688544|NCT00304954|Rapamycin|rapamycin
688545|NCT00304954|Remicade|remicade
688546|NCT00304954|Daclizumab|daclizumab
688547|NCT00304954|Immunosuppression|immunosuppression
688548|NCT00304954|Infliximab|infliximab
688549|NCT00304954|Choroidal Neovascularization|choroidal neovascularization
688550|NCT00304954|Sirolimus|sirolimus
688551|NCT00304954|AMD|amd
688552|NCT00304954|Ocular Inflammation|ocular inflammation
688553|NCT00304941|Breast Cancer|breast cancer
688554|NCT00304941|Family History|family history
688555|NCT00304941|Pre/Post Menopausal|pre/post menopausal
688556|NCT00304941|Prevention|prevention
688557|NCT00304941|Risk-Factor|risk-factor
688558|NCT00304941|Body-Mass-Index|body-mass-index
688559|NCT00304941|BRCA1|brca1
688560|NCT00304941|Insulin|insulin
688561|NCT00304941|Genetic Counseling|genetic counseling
688562|NCT00304941|Penetrance|penetrance
688563|NCT00304941|Risk Assessment|risk assessment
688564|NCT00304941|Healthy Volunteer|healthy volunteer
688565|NCT00304941|HV|hv
688566|NCT00304915|HIV, depression|hiv, depression
688567|NCT00304915|patient care management|patient care management
688568|NCT00304915|patient care team|patient care team
688569|NCT00304902|MRSA|mrsa
688570|NCT00304902|Methicillin Resistant Staphylococcus aureus|methicillin resistant staphylococcus aureus
688571|NCT00304902|Staphylococcus aureus Bacteremia|staphylococcus aureus bacteremia
688573|NCT00304876|Clostridium difficile associated diarrhea|clostridium difficile associated diarrhea
688574|NCT00304863|CDAD|cdad
688575|NCT00304863|Clostridium difficile Associated Diarrhea|clostridium difficile associated diarrhea
688576|NCT00304850|polyamines|polyamines
688577|NCT00304850|pain|pain
688578|NCT00304850|breast cancer|breast cancer
688579|NCT00304850|mastectomy|mastectomy
688580|NCT00304850|post operative pain|post operative pain
688581|NCT00304837|Nonhealing leg ulcers|nonhealing leg ulcers
688582|NCT00304837|Ischemic rest pain|ischemic rest pain
688583|NCT00304824|Glaucoma|glaucoma
688584|NCT00304824|Olfactory functions|olfactory functions
688585|NCT00304824|Sniffing Sticks Test|sniffing sticks test
688586|NCT00304811|MRSA|mrsa
688587|NCT00304811|Methicillin Resistant Staphylococcus aureus|methicillin resistant staphylococcus aureus
688588|NCT00304798|Transient Ischemic Attack (TIA).|transient ischemic attack (tia).
688589|NCT00304798|Stroke.|stroke.
688590|NCT00304798|Hospital admission.|hospital admission.
688591|NCT00304772|Candida|candida
688592|NCT00304772|bloodstream infection|bloodstream infection
688593|NCT00304772|fluconazole|fluconazole
688594|NCT00304772|micafungin|micafungin
688595|NCT00304772|randomized controlled trial|randomized controlled trial
688596|NCT00304759|prostate cancer|prostate cancer
688597|NCT00304759|localized prostate cancer|localized prostate cancer
688598|NCT00304759|intermediate risk|intermediate risk
688599|NCT00304759|prostate specific antigen|prostate specific antigen
688600|NCT00304759|PSA|psa
688601|NCT00304759|radiation fractionation|radiation fractionation
688602|NCT00304759|shorter schedule|shorter schedule
688603|NCT00304759|quality of life|quality of life
688703|NCT00304213|hypogonadism|hypogonadism
688704|NCT00304213|testosterone|testosterone
688604|NCT00304733|neuropathic foot ulcerations - total contact cast - custom -made footwear - off-loading|neuropathic foot ulcerations - total contact cast - custom -made footwear - off-loading
688605|NCT00304720|Lymphoma|lymphoma
688606|NCT00304720|Leukemia|leukemia
688607|NCT00304694|NPC|npc
688608|NCT00304694|Induction chemotherapy|induction chemotherapy
688609|NCT00304694|Therapeutic response|therapeutic response
688610|NCT00304694|18F-FDG PET|18f-fdg pet
688611|NCT00304681|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
688612|NCT00304681|OROS* Methylphenidate|oros* methylphenidate
688613|NCT00304668|HIV-1|hiv-1
688614|NCT00304668|HIV Seronegativity|hiv seronegativity
688615|NCT00304655|Schizophrenia|schizophrenia
688616|NCT00304655|Schizoaffective disorder|schizoaffective disorder
688617|NCT00304655|Aripiprazole|aripiprazole
688618|NCT00304642|HIV-1|hiv-1
688619|NCT00304642|HIV Seronegativity|hiv seronegativity
688620|NCT00304629|Alzheimer's disease|alzheimer's disease
688621|NCT00304629|cholinesterase inhibitors|cholinesterase inhibitors
688622|NCT00304629|galantamine|galantamine
688623|NCT00304616|Schizophrenia|schizophrenia
688624|NCT00304616|Aripiprazole|aripiprazole
688625|NCT00304603|Obesity|obesity
688626|NCT00304603|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
688627|NCT00304603|Topiramate|topiramate
688628|NCT00304603|Pharmacogenomics|pharmacogenomics
688629|NCT00304603|DNA Polymorphism|dna polymorphism
688630|NCT00304577|Strabismus|strabismus
688631|NCT00304577|Esotropia|esotropia
688632|NCT00304577|Surgical techniques|surgical techniques
688633|NCT00304564|Posturography, Fall Prevention, Geriatrics, Nolwenn Effect|posturography, fall prevention, geriatrics, nolwenn effect
688634|NCT00304551|CHC with compensated LC|chc with compensated lc
688635|NCT00304538|diabetes|diabetes
688636|NCT00304525|Anti-angiogenesis therapy|anti-angiogenesis therapy
688637|NCT00304525|Kinase inhibitor therapy|kinase inhibitor therapy
688638|NCT00304525|Raf inhibitor|raf inhibitor
688639|NCT00304525|Locally Advanced Melanoma|locally advanced melanoma
688640|NCT00304512|Amicus Therapeutics|amicus therapeutics
688641|NCT00304512|AT1001|at1001
688642|NCT00304512|Migalastat|migalastat
688643|NCT00304512|Pharmacokinetics|pharmacokinetics
688644|NCT00304512|Substrate|substrate
688645|NCT00304499|OROS®|oros®
688646|NCT00304499|middle age|middle age
688647|NCT00304499|elderly|elderly
688648|NCT00304499|oxybutynin|oxybutynin
688649|NCT00304499|urinary incontinenence|urinary incontinenence
688650|NCT00304499|women|women
688651|NCT00304473|Schizophrenia|schizophrenia
688652|NCT00304460|Serum Protein Levels|serum protein levels
688653|NCT00304460|Lymphocyte Phenotypes|lymphocyte phenotypes
688654|NCT00304460|Predictive Analysis|predictive analysis
688655|NCT00304460|Serum Cytokines|serum cytokines
688656|NCT00304460|Kidney Cancer|kidney cancer
688657|NCT00304460|Renal Cell Cancer|renal cell cancer
688658|NCT00304460|Melanoma|melanoma
688659|NCT00304460|Metastatic Melanoma|metastatic melanoma
688660|NCT00304447|Leukemia|leukemia
688661|NCT00304447|Mylotarg|mylotarg
688662|NCT00304447|Safety|safety
688663|NCT00304447|Adverse Events|adverse events
688664|NCT00304434|Adverse effects|adverse effects
688665|NCT00304434|Antiviral|antiviral
688666|NCT00304434|Clinical trial|clinical trial
688667|NCT00304434|Oseltamivir|oseltamivir
688668|NCT00304434|Pharmacokinetics|pharmacokinetics
688669|NCT00304434|Probenecid|probenecid
688670|NCT00304421|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
688671|NCT00304421|Proton Pump Inhibitors|proton pump inhibitors
688672|NCT00304421|Gastric pH|gastric ph
688673|NCT00304421|Gastric Acid Secretion|gastric acid secretion
688674|NCT00304408|Clostridium difficile|clostridium difficile
688675|NCT00304395|Community Acquired Pneumonia|community acquired pneumonia
688676|NCT00304395|CAP|cap
688677|NCT00304382|Pneumococcus|pneumococcus
688678|NCT00304382|Pneumococcal pneumonia|pneumococcal pneumonia
688679|NCT00304369|Clostridium difficile|clostridium difficile
688680|NCT00304356|Clostridium difficile Associated Diarrhea|clostridium difficile associated diarrhea
688681|NCT00304330|gram negative infection|gram negative infection
688682|NCT00304317|calculi|calculi
688683|NCT00304317|ureteral calculi|ureteral calculi
688684|NCT00304317|ureter|ureter
688685|NCT00304304|child care centers|child care centers
688686|NCT00304304|asthma triggers|asthma triggers
688687|NCT00304304|community-based research|community-based research
688688|NCT00304291|Novantrone|novantrone
688689|NCT00304278|Head and Neck Cancer|head and neck cancer
688690|NCT00304278|Erlotinib|erlotinib
688691|NCT00304278|RADPLAT|radplat
688692|NCT00304265|Pertussis,|pertussis,
688693|NCT00304265|Diphtheria,|diphtheria,
688694|NCT00304265|Tetanus,|tetanus,
688695|NCT00304265|Poliomyelitis|poliomyelitis
688696|NCT00304239|Methyl aminolevulinate|methyl aminolevulinate
688697|NCT00304239|Photodynamic therapy|photodynamic therapy
688698|NCT00304239|Aktilite CL128 LED light source|aktilite cl128 led light source
688699|NCT00304239|Multiple Actinic Keratosis|multiple actinic keratosis
688700|NCT00304226|Valsartan,|valsartan,
688701|NCT00304226|amlodipine,|amlodipine,
688702|NCT00304226|hydrochlorothiazide|hydrochlorothiazide
688705|NCT00304213|aging|aging
688706|NCT00304213|Total testosterone < 300 ng/dL|total testosterone < 300 ng/dl
688707|NCT00304213|Bioavailable testosterone < 70 ng/dL|bioavailable testosterone < 70 ng/dl
688708|NCT00304200|Metastatic Malignant Melanoma|metastatic malignant melanoma
688709|NCT00304187|Binge-Eating Disorder|binge-eating disorder
688710|NCT00304161|Depression|depression
688711|NCT00304161|Parkinson's Disease|parkinson's disease
688712|NCT00304161|Atomoxetine|atomoxetine
688713|NCT00304148|Renal Insufficiency Chronic|renal insufficiency chronic
688714|NCT00304135|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
688715|NCT00304135|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
688716|NCT00304135|unresectable gallbladder cancer|unresectable gallbladder cancer
688717|NCT00304096|recurrent breast cancer|recurrent breast cancer
688718|NCT00304096|stage IIIA breast cancer|stage iiia breast cancer
688719|NCT00304096|stage IIIB breast cancer|stage iiib breast cancer
688720|NCT00304096|stage IIIC breast cancer|stage iiic breast cancer
688721|NCT00304096|stage IV breast cancer|stage iv breast cancer
688722|NCT00304096|male breast cancer|male breast cancer
688723|NCT00304096|invasive lobular breast carcinoma|invasive lobular breast carcinoma
688724|NCT00304083|adult neurofibrosarcoma|adult neurofibrosarcoma
688725|NCT00304083|childhood neurofibrosarcoma|childhood neurofibrosarcoma
688726|NCT00304083|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
688727|NCT00304083|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
688728|NCT00304083|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
688729|NCT00304083|neurofibromatosis type 1|neurofibromatosis type 1
688730|NCT00304031|adult glioblastoma|adult glioblastoma
688731|NCT00304031|adult giant cell glioblastoma|adult giant cell glioblastoma
688732|NCT00304031|adult gliosarcoma|adult gliosarcoma
688733|NCT00304018|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
688734|NCT00304018|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
688735|NCT00304018|secondary acute myeloid leukemia|secondary acute myeloid leukemia
688736|NCT00304018|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
688737|NCT00304018|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
688738|NCT00304018|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
688739|NCT00304018|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
688740|NCT00304018|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
688741|NCT00304018|refractory multiple myeloma|refractory multiple myeloma
688742|NCT00304018|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
688743|NCT00304018|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
688744|NCT00304018|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
688745|NCT00304018|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
688746|NCT00304018|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
688747|NCT00304018|stage II multiple myeloma|stage ii multiple myeloma
688748|NCT00304018|stage III multiple myeloma|stage iii multiple myeloma
688749|NCT00304018|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
688750|NCT00304018|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
688751|NCT00304018|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
688752|NCT00304018|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
688753|NCT00304018|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
688754|NCT00304018|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
688755|NCT00304018|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
688756|NCT00304018|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
688757|NCT00304018|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
688758|NCT00304018|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
688759|NCT00304018|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
688760|NCT00304018|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
688761|NCT00304018|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
688762|NCT00304018|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
688763|NCT00304018|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
688764|NCT00304018|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
688765|NCT00304018|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
688766|NCT00304018|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
688767|NCT00304018|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
688768|NCT00304018|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
688769|NCT00304018|stage I multiple myeloma|stage i multiple myeloma
688770|NCT00304005|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
688771|NCT00304005|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
688772|NCT00304005|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
688773|NCT00303992|stage IV breast cancer|stage iv breast cancer
688774|NCT00303992|recurrent breast cancer|recurrent breast cancer
688775|NCT00303979|Systolic Heart Failure|systolic heart failure
688776|NCT00303979|Quality of Care|quality of care
688778|NCT00303979|Evidence-based Guidelines|evidence-based guidelines
688779|NCT00303979|Recommended Therapies|recommended therapies
688780|NCT00303940|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
688781|NCT00303940|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
688782|NCT00303940|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
688783|NCT00303940|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
688784|NCT00303940|recurrent osteosarcoma|recurrent osteosarcoma
688785|NCT00303940|recurrent neuroblastoma|recurrent neuroblastoma
688786|NCT00303940|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
688787|NCT00303940|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
688788|NCT00303940|recurrent childhood liver cancer|recurrent childhood liver cancer
688789|NCT00303940|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
688790|NCT00303940|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
688791|NCT00303940|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
688792|NCT00303940|recurrent childhood ependymoma|recurrent childhood ependymoma
688793|NCT00303940|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
688794|NCT00303940|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
688795|NCT00303940|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
688796|NCT00303940|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
688797|NCT00303940|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
688798|NCT00303940|childhood choroid plexus tumor|childhood choroid plexus tumor
688799|NCT00303940|childhood craniopharyngioma|childhood craniopharyngioma
688800|NCT00303940|childhood infratentorial ependymoma|childhood infratentorial ependymoma
688801|NCT00303940|childhood supratentorial ependymoma|childhood supratentorial ependymoma
688802|NCT00303940|childhood oligodendroglioma|childhood oligodendroglioma
688803|NCT00303940|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
688804|NCT00303940|recurrent childhood brain tumor|recurrent childhood brain tumor
688805|NCT00303940|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
688806|NCT00303940|childhood grade I meningioma|childhood grade i meningioma
688807|NCT00303940|childhood grade II meningioma|childhood grade ii meningioma
688808|NCT00303940|childhood grade III meningioma|childhood grade iii meningioma
688809|NCT00303940|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
688810|NCT00303940|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
688811|NCT00303940|childhood teratoma|childhood teratoma
688812|NCT00303927|recurrent pancreatic cancer|recurrent pancreatic cancer
688813|NCT00303927|stage IV pancreatic cancer|stage iv pancreatic cancer
688814|NCT00303914|pain|pain
688815|NCT00303914|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
688816|NCT00303914|cognitive/functional effects|cognitive/functional effects
688817|NCT00303914|recurrent breast cancer|recurrent breast cancer
688818|NCT00303914|stage I breast cancer|stage i breast cancer
688819|NCT00303914|stage II breast cancer|stage ii breast cancer
688820|NCT00303914|stage IIIA breast cancer|stage iiia breast cancer
688821|NCT00303914|stage IIIB breast cancer|stage iiib breast cancer
688822|NCT00303914|stage IIIC breast cancer|stage iiic breast cancer
688823|NCT00303914|stage IV breast cancer|stage iv breast cancer
688824|NCT00303914|recurrent colon cancer|recurrent colon cancer
688825|NCT00303914|stage I colon cancer|stage i colon cancer
688826|NCT00303914|stage II colon cancer|stage ii colon cancer
688827|NCT00303914|stage III colon cancer|stage iii colon cancer
688828|NCT00303914|stage IV colon cancer|stage iv colon cancer
688829|NCT00303914|recurrent rectal cancer|recurrent rectal cancer
688830|NCT00303914|stage I rectal cancer|stage i rectal cancer
688831|NCT00303914|stage II rectal cancer|stage ii rectal cancer
688832|NCT00303914|stage III rectal cancer|stage iii rectal cancer
688833|NCT00303914|stage IV rectal cancer|stage iv rectal cancer
688834|NCT00303914|extensive stage small cell lung cancer|extensive stage small cell lung cancer
688835|NCT00303914|limited stage small cell lung cancer|limited stage small cell lung cancer
688836|NCT00303914|recurrent small cell lung cancer|recurrent small cell lung cancer
688837|NCT00303914|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
688838|NCT00303914|stage I non-small cell lung cancer|stage i non-small cell lung cancer
688839|NCT00303914|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
688840|NCT00303914|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
688841|NCT00303914|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
688842|NCT00303914|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
688843|NCT00303914|recurrent prostate cancer|recurrent prostate cancer
688844|NCT00303914|stage I prostate cancer|stage i prostate cancer
688845|NCT00303914|stage IIB prostate cancer|stage iib prostate cancer
688846|NCT00303914|stage IIA prostate cancer|stage iia prostate cancer
688847|NCT00303914|stage III prostate cancer|stage iii prostate cancer
688848|NCT00303914|stage IV prostate cancer|stage iv prostate cancer
688849|NCT00303914|male breast cancer|male breast cancer
688850|NCT00303914|pulmonary carcinoid tumor|pulmonary carcinoid tumor
688851|NCT00303901|lung metastases|lung metastases
688852|NCT00303901|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
688853|NCT00303901|recurrent small cell lung cancer|recurrent small cell lung cancer
688854|NCT00303901|stage I non-small cell lung cancer|stage i non-small cell lung cancer
688855|NCT00303901|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
688856|NCT00303901|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
688857|NCT00303901|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
688858|NCT00303901|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
688859|NCT00303901|extensive stage small cell lung cancer|extensive stage small cell lung cancer
688860|NCT00303901|limited stage small cell lung cancer|limited stage small cell lung cancer
688861|NCT00303901|pulmonary carcinoid tumor|pulmonary carcinoid tumor
688862|NCT00303888|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
688863|NCT00303888|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
688864|NCT00303888|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
688865|NCT00303888|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
688866|NCT00303888|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
688867|NCT00303888|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
688868|NCT00303888|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
688869|NCT00303888|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
688870|NCT00303888|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
688871|NCT00303888|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
688872|NCT00303888|recurrent fallopian tube cancer|recurrent fallopian tube cancer
688873|NCT00303888|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
688874|NCT00303888|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
688875|NCT00303888|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
688876|NCT00303888|stage IV fallopian tube cancer|stage iv fallopian tube cancer
688877|NCT00303875|recurrent prostate cancer|recurrent prostate cancer
688878|NCT00303875|stage I prostate cancer|stage i prostate cancer
688879|NCT00303875|stage IIB prostate cancer|stage iib prostate cancer
688880|NCT00303875|stage IIA prostate cancer|stage iia prostate cancer
688881|NCT00303875|stage III prostate cancer|stage iii prostate cancer
688882|NCT00303875|stage IV prostate cancer|stage iv prostate cancer
688883|NCT00303875|recurrent breast cancer|recurrent breast cancer
688884|NCT00303875|stage I breast cancer|stage i breast cancer
688885|NCT00303875|stage II breast cancer|stage ii breast cancer
688886|NCT00303875|stage IIIA breast cancer|stage iiia breast cancer
688887|NCT00303875|stage IIIB breast cancer|stage iiib breast cancer
688888|NCT00303875|stage IIIC breast cancer|stage iiic breast cancer
688889|NCT00303875|stage IV breast cancer|stage iv breast cancer
688890|NCT00303875|recurrent colon cancer|recurrent colon cancer
688891|NCT00303875|stage I colon cancer|stage i colon cancer
688892|NCT00303875|stage II colon cancer|stage ii colon cancer
688893|NCT00303875|stage III colon cancer|stage iii colon cancer
688894|NCT00303875|stage IV colon cancer|stage iv colon cancer
688895|NCT00303875|recurrent rectal cancer|recurrent rectal cancer
688896|NCT00303875|stage I rectal cancer|stage i rectal cancer
688897|NCT00303875|stage II rectal cancer|stage ii rectal cancer
688898|NCT00303875|stage III rectal cancer|stage iii rectal cancer
688899|NCT00303875|stage IV rectal cancer|stage iv rectal cancer
688900|NCT00303810|childhood infratentorial ependymoma|childhood infratentorial ependymoma
688901|NCT00303810|childhood supratentorial ependymoma|childhood supratentorial ependymoma
688902|NCT00303810|untreated childhood medulloblastoma|untreated childhood medulloblastoma
688903|NCT00303810|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
688904|NCT00303810|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
688905|NCT00303784|hot flashes|hot flashes
688906|NCT00303784|anemia|anemia
688907|NCT00303784|osteoporosis|osteoporosis
688908|NCT00303784|cardiovascular complications|cardiovascular complications
688909|NCT00303784|recurrent prostate cancer|recurrent prostate cancer
688910|NCT00303784|stage III prostate cancer|stage iii prostate cancer
688911|NCT00303784|stage IV prostate cancer|stage iv prostate cancer
688912|NCT00303784|adenocarcinoma of the prostate|adenocarcinoma of the prostate
688913|NCT00303771|adenocarcinoma of the rectum|adenocarcinoma of the rectum
688914|NCT00303771|stage IV rectal cancer|stage iv rectal cancer
688915|NCT00303771|stage IV colon cancer|stage iv colon cancer
688916|NCT00303771|adenocarcinoma of the colon|adenocarcinoma of the colon
688917|NCT00303771|recurrent colon cancer|recurrent colon cancer
688918|NCT00303771|recurrent rectal cancer|recurrent rectal cancer
688919|NCT00303758|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
688920|NCT00303758|recurrent pancreatic cancer|recurrent pancreatic cancer
688921|NCT00303758|stage IV pancreatic cancer|stage iv pancreatic cancer
688922|NCT00303745|adenocarcinoma of the colon|adenocarcinoma of the colon
688923|NCT00303745|recurrent colon cancer|recurrent colon cancer
688924|NCT00303745|stage IV colon cancer|stage iv colon cancer
688925|NCT00303745|adenocarcinoma of the rectum|adenocarcinoma of the rectum
688926|NCT00303745|recurrent rectal cancer|recurrent rectal cancer
688927|NCT00303745|stage IV rectal cancer|stage iv rectal cancer
689616|NCT00301522|restenosis|restenosis
688928|NCT00303732|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
688929|NCT00303732|recurrent renal cell cancer|recurrent renal cell cancer
688930|NCT00303732|stage IV renal cell cancer|stage iv renal cell cancer
688931|NCT00303719|leukemia|leukemia
688932|NCT00303719|lymphoma|lymphoma
688933|NCT00303719|myeloma|myeloma
688934|NCT00303706|CABG, Endoscopic, Radial Artery|cabg, endoscopic, radial artery
688935|NCT00303706|Radial Artery Conduit|radial artery conduit
688936|NCT00303706|Coronary Artery Bypass Surgery|coronary artery bypass surgery
688937|NCT00303706|Endoscopic technique|endoscopic technique
688938|NCT00303667|NK cells|nk cells
688939|NCT00303667|natural killer cells|natural killer cells
688940|NCT00303667|immunotherapy|immunotherapy
688941|NCT00303667|hematopoietic cell transplant|hematopoietic cell transplant
688942|NCT00303667|acute myelogenous leukemia|acute myelogenous leukemia
688943|NCT00303654|recurrent bladder cancer|recurrent bladder cancer
688944|NCT00303654|stage I bladder cancer|stage i bladder cancer
688945|NCT00303654|stage II bladder cancer|stage ii bladder cancer
688946|NCT00303654|stage III bladder cancer|stage iii bladder cancer
688947|NCT00303654|stage IV bladder cancer|stage iv bladder cancer
688948|NCT00303641|Cardiopulmonary bypass|cardiopulmonary bypass
688949|NCT00303641|Inflammatory reaction|inflammatory reaction
688950|NCT00303628|Rectal cancer|rectal cancer
688951|NCT00303628|Bevacizumab|bevacizumab
688952|NCT00303615|ER (-) and PR (-)|er (-) and pr (-)
688953|NCT00303576|HIV-1|hiv-1
688954|NCT00303576|HIV Seronegativity|hiv seronegativity
688955|NCT00303550|skin infection|skin infection
688956|NCT00303550|complicated skin infection|complicated skin infection
688957|NCT00303550|skin structure infection|skin structure infection
688958|NCT00303550|Complicated Skin and Skin Structure Infection|complicated skin and skin structure infection
688959|NCT00303537|hepatitis|hepatitis
688960|NCT00303537|metformin|metformin
688961|NCT00303537|non-alcoholic fatty liver (NAFLD)|non-alcoholic fatty liver (nafld)
688962|NCT00303537|non-alcoholic steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
688963|NCT00303537|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
688964|NCT00303511|adult|adult
688965|NCT00303511|pacemaker|pacemaker
688966|NCT00303511|bradycardia|bradycardia
688967|NCT00303511|tachycardia|tachycardia
688968|NCT00303511|heart failure|heart failure
688969|NCT00303472|MDS|mds
688970|NCT00303472|Myelodysplastic Syndromes|myelodysplastic syndromes
688971|NCT00303472|Refractory Cytopenias|refractory cytopenias
688972|NCT00303472|Thrombocytopenia|thrombocytopenia
688973|NCT00303459|sildenafil|sildenafil
688974|NCT00303459|Combination Drug Therapy|combination drug therapy
688975|NCT00303459|bosentan|bosentan
688976|NCT00303459|Pulmonary Hypertension|pulmonary hypertension
688977|NCT00303459|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
688978|NCT00303459|Multicenter Study|multicenter study
688979|NCT00303459|Antihypertensive Agents|antihypertensive agents
688980|NCT00303459|Tracleer|tracleer
688981|NCT00303459|endothelin receptor antagonist|endothelin receptor antagonist
688982|NCT00303459|Randomized Controlled Trial|randomized controlled trial
688983|NCT00303459|Phosphodiesterase type 5 inhibitor (PDE5i)|phosphodiesterase type 5 inhibitor (pde5i)
688984|NCT00303459|Outcome Assessment|outcome assessment
688985|NCT00303446|Motor Neuron|motor neuron
688986|NCT00303446|Androgen Receptor|androgen receptor
688987|NCT00303446|Polyglutamine|polyglutamine
688988|NCT00303446|X-Linked|x-linked
688989|NCT00303446|Ligand Dependency|ligand dependency
688990|NCT00303446|Spinal and Bulbar Muscular Atrophy|spinal and bulbar muscular atrophy
688991|NCT00303446|SBMA|sbma
688992|NCT00303446|Kennedy Disease|kennedy disease
688993|NCT00303433|Prevention|prevention
688994|NCT00303433|Post-Operative tates|post-operative tates
688995|NCT00303433|Delirium|delirium
688996|NCT00303433|Namenda|namenda
688997|NCT00303420|catheter|catheter
688998|NCT00303420|hemodialysis|hemodialysis
688999|NCT00303420|dysfunction|dysfunction
689000|NCT00303420|thrombolytic|thrombolytic
689001|NCT00303420|alteplase|alteplase
689002|NCT00303394|Type 2 Diabetes, IL-1, inflammation, glucotoxicity, insulin|type 2 diabetes, il-1, inflammation, glucotoxicity, insulin
689003|NCT00303368|Neurofibromatosis (NF1)|neurofibromatosis (nf1)
689004|NCT00303368|Tibial Dysplasia (TD)|tibial dysplasia (td)
689005|NCT00303355|jugular venous pulse|jugular venous pulse
689006|NCT00303342|sleep|sleep
689007|NCT00303342|arousal|arousal
689008|NCT00303342|stress|stress
689009|NCT00303342|cortisol|cortisol
689010|NCT00303342|catecholamines|catecholamines
689011|NCT00303329|β-thalassemia|β-thalassemia
689012|NCT00303329|rare chronic anemia|rare chronic anemia
689013|NCT00303329|iron overload|iron overload
689014|NCT00303329|deferasirox|deferasirox
689015|NCT00303329|chronic anemias|chronic anemias
689016|NCT00303329|transfusional hemosiderosis|transfusional hemosiderosis
689017|NCT00303316|Diphtheria|diphtheria
689018|NCT00303316|Tetanus|tetanus
689019|NCT00303316|Pertussis|pertussis
689020|NCT00303316|whooping cough|whooping cough
689021|NCT00303316|Haemophilus influenzae type b|haemophilus influenzae type b
689022|NCT00303316|Hepatitis B|hepatitis b
689023|NCT00303316|Poliomyelitis|poliomyelitis
689024|NCT00303303|Snake envenomation|snake envenomation
689025|NCT00303303|Antivenins|antivenins
689026|NCT00303303|Disability evaluation|disability evaluation
689027|NCT00303303|Activities of daily living|activities of daily living
689028|NCT00303290|Early Chronic Phase CML|early chronic phase cml
689029|NCT00303290|Peg Interferon Alpha 2b|peg interferon alpha 2b
689030|NCT00303290|Peg Intron|peg intron
689031|NCT00303290|Ara-C|ara-c
689032|NCT00303290|Cytosine Arabinoside|cytosine arabinoside
689033|NCT00303277|Alzheimer's disease|alzheimer's disease
689034|NCT00303277|beta-amyloid|beta-amyloid
689035|NCT00303277|statins|statins
689036|NCT00303264|functional dyspepsia|functional dyspepsia
689037|NCT00303264|cholecystokinin|cholecystokinin
689039|NCT00303264|gastrointestinal|gastrointestinal
689040|NCT00303264|intestinal transit|intestinal transit
689041|NCT00303264|GI motility|gi motility
689042|NCT00303264|bloating|bloating
689043|NCT00303264|upper GI discomfort|upper gi discomfort
689044|NCT00303264|upper GI|upper gi
689045|NCT00303264|early satiety|early satiety
689046|NCT00303264|nausea|nausea
689047|NCT00303264|belching|belching
689048|NCT00303264|retching|retching
689049|NCT00303264|vomiting|vomiting
689050|NCT00303264|GERD|gerd
689051|NCT00303251|Locally Advanced or Metastatic Melanoma|locally advanced or metastatic melanoma
689052|NCT00303238|Inflammation|inflammation
689053|NCT00303238|Interleukin-1|interleukin-1
689054|NCT00303238|C-reactive protein|c-reactive protein
689055|NCT00303238|Genotype|genotype
689056|NCT00303238|Rose Hips|rose hips
689057|NCT00303238|Blueberry|blueberry
689058|NCT00303238|Blackberry|blackberry
689059|NCT00303238|Aframomum melegueta|aframomum melegueta
689060|NCT00303238|Resveravine|resveravine
689061|NCT00303225|Biodefense|biodefense
689062|NCT00303225|Smallpox|smallpox
689063|NCT00303225|Monkeypox|monkeypox
689064|NCT00303225|Vaccinia|vaccinia
689065|NCT00303225|Prophylaxis|prophylaxis
689066|NCT00303225|Healthy Volunteer|healthy volunteer
689067|NCT00303225|HV|hv
689068|NCT00303212|heart failure|heart failure
689069|NCT00303212|CHF|chf
689070|NCT00303212|telemedicine|telemedicine
689071|NCT00303212|disease management|disease management
689072|NCT00303199|Multiple Myeloma|multiple myeloma
689073|NCT00303199|Arsenic|arsenic
689074|NCT00303199|Cancer study|cancer study
689075|NCT00303199|Failed treatment|failed treatment
689076|NCT00303186|Rheumatoid Arthritis|rheumatoid arthritis
689077|NCT00303173|Pre-eclampsia|pre-eclampsia
689078|NCT00303173|hypertension|hypertension
689079|NCT00303173|blood pressure|blood pressure
689080|NCT00303173|pregnancy|pregnancy
689081|NCT00303173|randomized clinical trial|randomized clinical trial
689082|NCT00303173|guided imagery|guided imagery
689083|NCT00303173|relaxation|relaxation
689084|NCT00303173|psychophysiology|psychophysiology
689085|NCT00303173|mind-body|mind-body
689086|NCT00303160|heliobacter pylori infection|heliobacter pylori infection
689087|NCT00303160|reactive oxygen species|reactive oxygen species
689088|NCT00303160|antioxidants|antioxidants
689089|NCT00303147|Expressive Writing|expressive writing
689090|NCT00303147|Written Emotional Expression|written emotional expression
689091|NCT00303147|Caregiver Stress|caregiver stress
689092|NCT00303147|Cognition|cognition
689093|NCT00303134|islet cell|islet cell
689094|NCT00303134|diabetes|diabetes
689095|NCT00303134|transplant|transplant
689096|NCT00303134|immunosuppression|immunosuppression
689097|NCT00303134|autoimmunity|autoimmunity
689098|NCT00303134|alloimmunity|alloimmunity
689099|NCT00303121|Glaucoma|glaucoma
689100|NCT00303121|Compliance|compliance
689101|NCT00303121|Therapy|therapy
689102|NCT00303121|Administration technique|administration technique
689103|NCT00303082|Probiotics|probiotics
689104|NCT00303082|Bacterial Vaginosis|bacterial vaginosis
689105|NCT00303082|Premature birth|premature birth
689106|NCT00303082|Intra-uterine Infection|intra-uterine infection
689107|NCT00303082|Periventricular leukomalacia|periventricular leukomalacia
689108|NCT00303069|S. aureus;|s. aureus;
689109|NCT00303069|Vaccine|vaccine
689110|NCT00303069|FIM|fim
689111|NCT00303056|Osteoarthritis|osteoarthritis
689112|NCT00303056|knee|knee
689113|NCT00303043|Hemodynamic monitoring|hemodynamic monitoring
689114|NCT00303043|Mixed venous saturation|mixed venous saturation
689115|NCT00303043|Critically ill patients|critically ill patients
689116|NCT00303030|Fecal incontinence|fecal incontinence
689117|NCT00303030|Biofeedback|biofeedback
689118|NCT00303030|Patient Satisfaction|patient satisfaction
689119|NCT00303030|Quality of LifeTreatment Outcome|quality of lifetreatment outcome
689120|NCT00303030|Injections|injections
689121|NCT00302991|Observational|observational
689122|NCT00302991|cross-sectional|cross-sectional
689123|NCT00302991|health-related quality of life|health-related quality of life
689124|NCT00302991|adverse effects|adverse effects
689125|NCT00302991|Baker´s AEP scale validation|baker´s aep scale validation
689126|NCT00302991|epilepsy|epilepsy
689127|NCT00302978|Height phobia|height phobia
689128|NCT00302978|fear of heights|fear of heights
690927|NCT00296309|Tacrolimus|tacrolimus
689129|NCT00302978|specific phobia|specific phobia
689130|NCT00302965|Plasma|plasma
689131|NCT00302965|Trauma|trauma
689132|NCT00302965|Critical Care|critical care
689133|NCT00302952|Arthritis, Rheumatoid|arthritis, rheumatoid
689134|NCT00302939|Aging|aging
689135|NCT00302926|Weight loss|weight loss
689136|NCT00302926|obesity|obesity
689137|NCT00302926|energy restriction|energy restriction
689138|NCT00302913|Clopidogrel|clopidogrel
689139|NCT00302913|Coronary Artery Disease|coronary artery disease
689140|NCT00302913|Dose-Response Relationship, Drug|dose-response relationship, drug
689141|NCT00302913|Drug Resistance|drug resistance
689142|NCT00302913|PCI|pci
689143|NCT00302900|Blood Donation|blood donation
689144|NCT00302900|Syncope|syncope
689145|NCT00302900|Vasovagal Reactions|vasovagal reactions
689146|NCT00302887|fibromyalgia|fibromyalgia
689147|NCT00302887|connective tissue manipulation|connective tissue manipulation
689148|NCT00302887|ultrasound therapy|ultrasound therapy
689149|NCT00302887|high voltage pulsed galvanic stimulation|high voltage pulsed galvanic stimulation
689150|NCT00302874|diabetes|diabetes
689151|NCT00302874|hyperglycemia|hyperglycemia
689152|NCT00302874|hospital|hospital
689153|NCT00302874|medicine ward|medicine ward
689154|NCT00302861|B-Cll|b-cll
689155|NCT00302848|Venous thromboembolism|venous thromboembolism
689156|NCT00302848|Drospirenone|drospirenone
689157|NCT00302835|Analgesics|analgesics
689158|NCT00302835|Chronic Kidney Failure|chronic kidney failure
689159|NCT00302822|HIV infections|hiv infections
689160|NCT00302822|Fuzeon|fuzeon
689161|NCT00302822|Truvada|truvada
689162|NCT00302822|AIDS|aids
689163|NCT00302822|Treatment Naive|treatment naive
689164|NCT00302809|Flavonoids|flavonoids
689165|NCT00302809|Arterial stiffness|arterial stiffness
689166|NCT00302809|Blood pressure|blood pressure
689167|NCT00302809|Endothelium|endothelium
689168|NCT00302809|Inflammation|inflammation
689169|NCT00302796|Low Back Pain,|low back pain,
689170|NCT00302783|Education, Medical|education, medical
689171|NCT00302783|Education, Competency-Based|education, competency-based
689172|NCT00302783|Multi-Source Feedback|multi-source feedback
689173|NCT00302783|Communication|communication
689174|NCT00302783|Professionalism|professionalism
689175|NCT00302770|Patients with SAD|patients with sad
689176|NCT00302757|NHL|nhl
689177|NCT00302757|low and high grade non-Hodgkin lymphoma|low and high grade non-hodgkin lymphoma
689178|NCT00302744|Anxiety|anxiety
689179|NCT00302744|Depression|depression
689180|NCT00302744|Mood|mood
689181|NCT00302744|Cancer|cancer
689182|NCT00302744|Quality of Life|quality of life
689183|NCT00302744|Psychiatric|psychiatric
689184|NCT00302744|Psilocybin|psilocybin
689185|NCT00302744|Alternative|alternative
689186|NCT00302744|Los Angeles|los angeles
689187|NCT00302718|Physician Incentive Plan|physician incentive plan
689188|NCT00302718|Quality of Health Care|quality of health care
689189|NCT00302718|Reimbursement, Incentive|reimbursement, incentive
689190|NCT00302718|Randomized Controlled Trial|randomized controlled trial
689191|NCT00302718|Physicians|physicians
689192|NCT00302718|Reward|reward
689193|NCT00302705|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
689194|NCT00302705|Valsartan|valsartan
689195|NCT00302705|Enalapril|enalapril
689196|NCT00302705|Missing dose|missing dose
689197|NCT00302679|Colonoscopy|colonoscopy
689198|NCT00302679|Sigmoidoscopy|sigmoidoscopy
689199|NCT00302679|Colon cancer screening|colon cancer screening
689200|NCT00302679|Pain|pain
689201|NCT00302679|Screening|screening
689202|NCT00302666|Contraception, Bleeding pattern|contraception, bleeding pattern
689203|NCT00302627|bisphosphonates|bisphosphonates
689204|NCT00302627|vitamin D|vitamin d
689205|NCT00302627|calcium supplement|calcium supplement
689206|NCT00302627|corticosteroid therapy|corticosteroid therapy
689207|NCT00302627|fractures|fractures
689208|NCT00302614|obstructive sleep apnea|obstructive sleep apnea
689209|NCT00302614|snoring|snoring
689210|NCT00302614|collapsibility|collapsibility
689211|NCT00302614|upper airway|upper airway
689212|NCT00302601|Pulmonary embolism|pulmonary embolism
689213|NCT00302601|Right heart strain|right heart strain
689214|NCT00302601|Lung scintigraphy|lung scintigraphy
689215|NCT00302601|Pulmonary angiography|pulmonary angiography
689216|NCT00302588|metastatic carcinoma|metastatic carcinoma
689217|NCT00302588|cervical lymph nodes|cervical lymph nodes
689218|NCT00302588|unknown primary|unknown primary
689219|NCT00302588|diagnosis|diagnosis
689220|NCT00302588|result|result
689221|NCT00302575|Substance-Related Disorders|substance-related disorders
689222|NCT00302575|Prisoners|prisoners
689223|NCT00302562|laryngeal cancer|laryngeal cancer
689224|NCT00302562|hypopharyngeal cancer|hypopharyngeal cancer
689225|NCT00302562|CXCR4|cxcr4
689226|NCT00302562|CXCL12|cxcl12
689227|NCT00302562|matrix metalloproteinases(MMPs)|matrix metalloproteinases(mmps)
689228|NCT00302562|metastasis|metastasis
689229|NCT00302549|Tacrolimus|tacrolimus
689230|NCT00302549|Cyclophosphamide|cyclophosphamide
689231|NCT00302549|Treatment|treatment
689232|NCT00302549|Lupus Nephritis|lupus nephritis
691780|NCT00293904|Allergy|allergy
689233|NCT00302536|Idiopathic Focal Segmental Glomerulosclerosis|idiopathic focal segmental glomerulosclerosis
689234|NCT00302536|Treatment|treatment
689235|NCT00302536|Steroids|steroids
689236|NCT00302523|Idiopathic Membranous Nephropathy|idiopathic membranous nephropathy
689237|NCT00302523|Treatment|treatment
689238|NCT00302523|Tacrolimus|tacrolimus
689239|NCT00302523|Cyclophosphamide|cyclophosphamide
689240|NCT00302510|lipoprotein glomerulopathy|lipoprotein glomerulopathy
689241|NCT00302510|treatment|treatment
689242|NCT00302510|immunoadsorption|immunoadsorption
689243|NCT00302510|apolipoprotein E|apolipoprotein e
689244|NCT00302458|healthy volunteers|healthy volunteers
689245|NCT00302432|smoking reduction|smoking reduction
689246|NCT00302432|group therapy|group therapy
689247|NCT00302432|cigarette holders|cigarette holders
689248|NCT00302432|"Flowers Menthol"|"flowers menthol"
689249|NCT00302419|Acute myocardial infarction|acute myocardial infarction
689250|NCT00302419|primary angioplasty|primary angioplasty
689251|NCT00302419|streptokinase|streptokinase
689252|NCT00302419|microvasculature|microvasculature
689253|NCT00302393|healthy volunteers|healthy volunteers
689254|NCT00302341|Pulmonary disease|pulmonary disease
689255|NCT00302341|Dyspnea|dyspnea
689256|NCT00302341|Hypoxemia|hypoxemia
689257|NCT00302341|AIDS|aids
689258|NCT00302341|Pneumocystis jiroveci|pneumocystis jiroveci
689259|NCT00302315|postcesarean physiotherapy|postcesarean physiotherapy
689260|NCT00302315|incisional pain|incisional pain
689261|NCT00302315|functional activity|functional activity
689262|NCT00302315|connective tissue manipulation|connective tissue manipulation
689263|NCT00302315|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
689264|NCT00302302|Blood glucose|blood glucose
689265|NCT00302302|Insulin|insulin
689266|NCT00302302|Triglyceride|triglyceride
689267|NCT00302302|GIP|gip
689268|NCT00302302|GLP-1|glp-1
689269|NCT00302302|L-arabinose|l-arabinose
689270|NCT00302302|Appetite|appetite
689271|NCT00302302|Energy intake|energy intake
689272|NCT00302289|green tea|green tea
689273|NCT00302289|caffeine|caffeine
689274|NCT00302289|tyrosine|tyrosine
689275|NCT00302289|energy expenditure|energy expenditure
689276|NCT00302289|energy intake|energy intake
689277|NCT00302276|Body fat loss|body fat loss
689278|NCT00302276|energy expenditure|energy expenditure
689279|NCT00302276|capsaicin|capsaicin
689280|NCT00302276|caffeine|caffeine
689281|NCT00302276|green tea|green tea
689282|NCT00302276|calcium|calcium
689283|NCT00302276|fecal fat|fecal fat
689284|NCT00302276|fecal energy|fecal energy
689285|NCT00302263|Green tea|green tea
689286|NCT00302263|capsaicin|capsaicin
689287|NCT00302263|tyrosine|tyrosine
689288|NCT00302263|caffeine|caffeine
689289|NCT00302263|energy expenditure|energy expenditure
689290|NCT00302263|catecholamines|catecholamines
689291|NCT00302250|Cardiovascular|cardiovascular
689292|NCT00302250|Flow-mediated vasodilation (FMD)|flow-mediated vasodilation (fmd)
689293|NCT00302250|Pulse perfusion-mediated vasodilation (PPMV)|pulse perfusion-mediated vasodilation (ppmv)
689294|NCT00302250|Endothelial function|endothelial function
689295|NCT00302250|Heart failure|heart failure
689296|NCT00302237|carotid, stenting, angioplasty|carotid, stenting, angioplasty
689297|NCT00302224|safety|safety
689298|NCT00302224|type 2 diabetes|type 2 diabetes
689299|NCT00302211|PAH|pah
689300|NCT00302211|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
689301|NCT00302198|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
689302|NCT00302185|Palliative Care|palliative care
689303|NCT00302185|Acupuncture|acupuncture
689304|NCT00302185|Symptom Management|symptom management
689305|NCT00302185|Quality of Life|quality of life
689306|NCT00302172|Cancer|cancer
689307|NCT00302172|solid tumor|solid tumor
689308|NCT00302172|metastatic|metastatic
689309|NCT00302172|primary tumor|primary tumor
689310|NCT00302159|Chemotherapy|chemotherapy
689311|NCT00302159|Radiation|radiation
689312|NCT00302159|Brain Tumor|brain tumor
689313|NCT00302159|GBM|gbm
689314|NCT00302159|Radiosensitizer|radiosensitizer
689315|NCT00302159|Glioblastoma|glioblastoma
689316|NCT00302159|Glioblastoma Multiforme|glioblastoma multiforme
689317|NCT00302146|Lysosomal Storage Disorder|lysosomal storage disorder
689318|NCT00302146|Carrier|carrier
689319|NCT00302146|L-Dopa Uptake|l-dopa uptake
689320|NCT00302146|Glucocerebrosidase|glucocerebrosidase
689321|NCT00302146|Pathogenesis|pathogenesis
689322|NCT00302146|Carbidopa|carbidopa
689323|NCT00302146|Gaucher Disease|gaucher disease
689324|NCT00302146|Parkinson Disease|parkinson disease
689325|NCT00302146|[O-15]-Water|[o-15]-water
689326|NCT00302146|6-[F-18]Fluoro-L-dopa|6-[f-18]fluoro-l-dopa
689327|NCT00302146|Healthy Volunteer|healthy volunteer
689328|NCT00302146|HV|hv
689329|NCT00302133|Alcoholism Bipolar Disorder Pharmacotherapy Naltrexone|alcoholism bipolar disorder pharmacotherapy naltrexone
689330|NCT00302120|Magnetic Resonance Imaging|magnetic resonance imaging
689331|NCT00302120|Breast Neoplasms|breast neoplasms
689332|NCT00302120|Diagnostic Trial|diagnostic trial
689333|NCT00302107|Mirtazapine|mirtazapine
689334|NCT00302107|PTSD|ptsd
689336|NCT00302107|antidepressant|antidepressant
689337|NCT00302081|Hepatitis C, Chronic|hepatitis c, chronic
689338|NCT00302081|Genotype 2 and Genotype 3|genotype 2 and genotype 3
689339|NCT00302068|Exercise|exercise
689340|NCT00302029|Cytomegalovirus, risk factors, seroprevalence|cytomegalovirus, risk factors, seroprevalence
689341|NCT00302016|Chronic myeloid leukemia|chronic myeloid leukemia
689342|NCT00302016|AMN 107|amn 107
689343|NCT00302016|Imatinib resistant or intolerant|imatinib resistant or intolerant
689344|NCT00302016|nilotinib|nilotinib
689345|NCT00302016|enact|enact
689346|NCT00301990|stage IV renal cell cancer|stage iv renal cell cancer
689347|NCT00301990|recurrent renal cell cancer|recurrent renal cell cancer
689348|NCT00301990|clear cell renal cell carcinoma|clear cell renal cell carcinoma
689349|NCT00301951|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
689350|NCT00301951|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
689351|NCT00301951|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
689352|NCT00301951|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
689353|NCT00301951|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
689354|NCT00301951|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
689355|NCT00301951|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
689356|NCT00301951|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
689357|NCT00301951|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
689358|NCT00301951|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
689359|NCT00301951|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
689360|NCT00301951|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
689361|NCT00301951|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
689362|NCT00301951|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
689363|NCT00301951|anaplastic large cell lymphoma|anaplastic large cell lymphoma
689364|NCT00301951|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
689365|NCT00301951|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
689366|NCT00301951|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
689367|NCT00301951|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
689368|NCT00301951|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
689369|NCT00301951|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
689370|NCT00301951|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
689371|NCT00301951|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
689372|NCT00301951|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
689373|NCT00301951|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
689374|NCT00301951|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
689375|NCT00301951|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
689376|NCT00301951|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
689377|NCT00301951|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
689378|NCT00301951|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
689379|NCT00301951|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
689380|NCT00301951|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
689381|NCT00301951|refractory multiple myeloma|refractory multiple myeloma
689382|NCT00301951|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
689383|NCT00301951|secondary acute myeloid leukemia|secondary acute myeloid leukemia
689384|NCT00301951|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
689385|NCT00301951|splenic marginal zone lymphoma|splenic marginal zone lymphoma
689386|NCT00301951|stage I multiple myeloma|stage i multiple myeloma
689387|NCT00301951|stage II multiple myeloma|stage ii multiple myeloma
689388|NCT00301951|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
689389|NCT00301951|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
689390|NCT00301951|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
689391|NCT00301951|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
689392|NCT00301951|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
689393|NCT00301951|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
689394|NCT00301951|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
689395|NCT00301951|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
689396|NCT00301951|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
689397|NCT00301951|stage III multiple myeloma|stage iii multiple myeloma
689398|NCT00301951|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
689399|NCT00301951|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
689400|NCT00301951|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
689401|NCT00301951|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
689402|NCT00301951|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
689403|NCT00301951|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
689404|NCT00301951|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
689405|NCT00301951|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
689406|NCT00301951|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
689407|NCT00301951|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
689408|NCT00301925|stage I breast cancer|stage i breast cancer
689409|NCT00301925|stage II breast cancer|stage ii breast cancer
689410|NCT00301925|stage IIIA breast cancer|stage iiia breast cancer
689411|NCT00301925|male breast cancer|male breast cancer
689412|NCT00301912|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
689413|NCT00301912|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
689414|NCT00301912|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
689415|NCT00301912|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
689416|NCT00301912|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
689417|NCT00301912|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
689418|NCT00301912|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
689419|NCT00301912|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
689420|NCT00301912|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
689421|NCT00301912|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
689422|NCT00301912|secondary acute myeloid leukemia|secondary acute myeloid leukemia
689423|NCT00301912|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
689424|NCT00301912|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
689425|NCT00301912|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
689426|NCT00301912|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
689427|NCT00301912|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
689428|NCT00301912|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
689429|NCT00301912|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
689430|NCT00301912|anemia|anemia
689431|NCT00301912|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
689432|NCT00301912|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
689433|NCT00301912|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
689434|NCT00301912|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
689435|NCT00301912|stage II multiple myeloma|stage ii multiple myeloma
689436|NCT00301912|stage III multiple myeloma|stage iii multiple myeloma
689437|NCT00301912|refractory multiple myeloma|refractory multiple myeloma
689438|NCT00301912|polycythemia vera|polycythemia vera
689439|NCT00301912|essential thrombocythemia|essential thrombocythemia
689440|NCT00301912|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
689441|NCT00301912|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
689442|NCT00301912|splenic marginal zone lymphoma|splenic marginal zone lymphoma
689443|NCT00301912|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
689444|NCT00301912|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
689445|NCT00301912|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
689446|NCT00301912|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
689447|NCT00301912|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
689448|NCT00301912|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
689449|NCT00301912|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
689450|NCT00301912|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
689451|NCT00301912|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
689452|NCT00301912|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
689453|NCT00301912|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
689454|NCT00301912|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
689455|NCT00301912|chronic eosinophilic leukemia|chronic eosinophilic leukemia
689456|NCT00301912|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
689457|NCT00301912|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
689458|NCT00301912|chronic neutrophilic leukemia|chronic neutrophilic leukemia
689459|NCT00301912|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
689460|NCT00301912|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
689461|NCT00301912|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
689462|NCT00301912|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
689463|NCT00301912|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
689464|NCT00301912|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
689465|NCT00301912|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
689466|NCT00301912|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
689467|NCT00301912|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
692984|NCT00290433|Vincristine|vincristine
689468|NCT00301912|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
689469|NCT00301912|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
689470|NCT00301912|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
689471|NCT00301912|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
689472|NCT00301912|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
689473|NCT00301912|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
689474|NCT00301912|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
689475|NCT00301912|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
689476|NCT00301912|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
689477|NCT00301912|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
689478|NCT00301912|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
689479|NCT00301912|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
689480|NCT00301912|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
689481|NCT00301912|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
689482|NCT00301912|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
689483|NCT00301912|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
689583|NCT00301626|nicotine|nicotine
689484|NCT00301912|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
689485|NCT00301912|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
689486|NCT00301912|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
689487|NCT00301912|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
689488|NCT00301912|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
689489|NCT00301912|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
689490|NCT00301912|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
689491|NCT00301912|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
689492|NCT00301912|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
689493|NCT00301912|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
689494|NCT00301912|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
689495|NCT00301912|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
689496|NCT00301912|stage I multiple myeloma|stage i multiple myeloma
689497|NCT00301912|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
689498|NCT00301899|recurrent breast cancer|recurrent breast cancer
689499|NCT00301899|male breast cancer|male breast cancer
689500|NCT00301899|stage IIIA breast cancer|stage iiia breast cancer
689501|NCT00301899|stage IIIB breast cancer|stage iiib breast cancer
689502|NCT00301899|stage IIIC breast cancer|stage iiic breast cancer
689503|NCT00301899|stage IV breast cancer|stage iv breast cancer
689504|NCT00301886|pain|pain
689505|NCT00301886|hypercalcemia of malignancy|hypercalcemia of malignancy
689506|NCT00301886|stage IV breast cancer|stage iv breast cancer
689507|NCT00301886|bone metastases|bone metastases
689508|NCT00301886|recurrent breast cancer|recurrent breast cancer
689509|NCT00301873|osteoporosis|osteoporosis
689510|NCT00301873|adult anaplastic astrocytoma|adult anaplastic astrocytoma
689511|NCT00301873|adult giant cell glioblastoma|adult giant cell glioblastoma
689512|NCT00301873|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
689513|NCT00301873|adult gliosarcoma|adult gliosarcoma
689514|NCT00301873|adult mixed glioma|adult mixed glioma
689515|NCT00301873|recurrent adult brain tumor|recurrent adult brain tumor
689516|NCT00301873|adult glioblastoma|adult glioblastoma
689517|NCT00301860|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
689518|NCT00301860|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
689519|NCT00301860|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
689520|NCT00301860|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
689521|NCT00301860|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
689522|NCT00301860|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
689523|NCT00301860|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
689524|NCT00301860|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
689525|NCT00301860|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
689526|NCT00301860|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
689527|NCT00301860|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
689528|NCT00301860|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
689529|NCT00301860|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
689530|NCT00301847|tumors metastatic to brain|tumors metastatic to brain
689531|NCT00301847|recurrent renal cell cancer|recurrent renal cell cancer
689532|NCT00301847|stage IV renal cell cancer|stage iv renal cell cancer
689533|NCT00301834|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
689534|NCT00301834|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
689535|NCT00301834|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
689536|NCT00301834|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
689537|NCT00301834|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
689538|NCT00301834|congenital amegakaryocytic thrombocytopenia|congenital amegakaryocytic thrombocytopenia
689539|NCT00301834|Diamond-Blackfan anemia|diamond-blackfan anemia
689540|NCT00301834|severe congenital neutropenia|severe congenital neutropenia
689541|NCT00301834|secondary acute myeloid leukemia|secondary acute myeloid leukemia
689542|NCT00301834|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
689543|NCT00301834|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
689544|NCT00301821|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
689545|NCT00301821|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
689546|NCT00301821|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
689547|NCT00301821|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
689548|NCT00301808|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
689549|NCT00301808|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
689550|NCT00301782|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
689551|NCT00301782|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
689552|NCT00301782|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
689553|NCT00301782|testicular choriocarcinoma|testicular choriocarcinoma
689554|NCT00301782|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
689555|NCT00301782|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
689556|NCT00301782|testicular embryonal carcinoma|testicular embryonal carcinoma
689557|NCT00301782|testicular yolk sac tumor|testicular yolk sac tumor
689558|NCT00301782|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
689559|NCT00301782|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
689560|NCT00301782|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
689561|NCT00301782|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
689562|NCT00301782|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
689563|NCT00301782|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
689564|NCT00301782|stage I extragonadal non-seminomatous germ cell tumor|stage i extragonadal non-seminomatous germ cell tumor
689565|NCT00301782|stage II extragonadal non-seminomatous germ cell tumor|stage ii extragonadal non-seminomatous germ cell tumor
689566|NCT00301782|stage III extragonadal non-seminomatous germ cell tumor|stage iii extragonadal non-seminomatous germ cell tumor
689567|NCT00301782|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
689568|NCT00301782|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
689569|NCT00301782|testicular immature teratoma|testicular immature teratoma
689570|NCT00301782|testicular mature teratoma|testicular mature teratoma
689571|NCT00301782|adult teratoma|adult teratoma
689572|NCT00301730|lung metastases|lung metastases
689573|NCT00301730|stage IV breast cancer|stage iv breast cancer
689574|NCT00301730|recurrent breast cancer|recurrent breast cancer
689575|NCT00301691|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
689576|NCT00301678|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
689577|NCT00301652|ANCA|anca
689578|NCT00301652|vasculitis|vasculitis
689579|NCT00301652|mycophenolate mofetil|mycophenolate mofetil
689580|NCT00301652|cyclophosphamide|cyclophosphamide
689581|NCT00301652|treatment|treatment
689582|NCT00301626|tobacco|tobacco
689584|NCT00301626|smoking reduction|smoking reduction
689585|NCT00301613|Henoch-Schonlein purpura nephritis Mycophenolate mofetil|henoch-schonlein purpura nephritis mycophenolate mofetil
689586|NCT00301613|Cyclophosphamide|cyclophosphamide
689587|NCT00301613|treatment|treatment
689588|NCT00301600|Crescentic IgA nephropathy|crescentic iga nephropathy
689589|NCT00301600|Mycophenolate mofetil|mycophenolate mofetil
689590|NCT00301600|Cyclophosphamide|cyclophosphamide
689591|NCT00301600|treatment|treatment
689592|NCT00301587|spina bifida|spina bifida
689593|NCT00301587|birth defects|birth defects
689594|NCT00301587|folic acid|folic acid
689595|NCT00301587|nervous system diseases|nervous system diseases
689596|NCT00301587|folate|folate
689597|NCT00301587|Vitamin B|vitamin b
689598|NCT00301574|Alzheimer's disease|alzheimer's disease
689599|NCT00301574|Cognitive dysfunction|cognitive dysfunction
689600|NCT00301561|Antiretroviral treatment|antiretroviral treatment
689601|NCT00301561|Expanded access|expanded access
689602|NCT00301561|Africa|africa
689603|NCT00301561|Treatment Naive|treatment naive
689604|NCT00301548|antineoplastic protocols|antineoplastic protocols
689605|NCT00301548|neoadjuvant therapy|neoadjuvant therapy
689606|NCT00301548|perioperative chemotherapy|perioperative chemotherapy
689607|NCT00301548|fluorouracil|fluorouracil
689608|NCT00301535|Coronary Artery Bypass Graft|coronary artery bypass graft
689609|NCT00301535|memory loss after cardiac surgery|memory loss after cardiac surgery
689610|NCT00301535|side effects of bypass|side effects of bypass
689611|NCT00301522|Coronary|coronary
689612|NCT00301522|Artery|artery
689613|NCT00301522|Stenosis|stenosis
689614|NCT00301522|Drug-eluting|drug-eluting
689617|NCT00301522|revascularization|revascularization
689618|NCT00301483|multiple trauma|multiple trauma
689619|NCT00301483|bleeding injuries|bleeding injuries
689620|NCT00301483|gunshot wounds|gunshot wounds
689621|NCT00301483|stab wounds|stab wounds
689622|NCT00301483|penetrating injuries|penetrating injuries
689623|NCT00301483|blunt trauma|blunt trauma
689624|NCT00301483|multiple wounds|multiple wounds
689625|NCT00301470|Ureter, obstruction|ureter, obstruction
689626|NCT00301470|Diagnostic techniques, urological|diagnostic techniques, urological
689627|NCT00301470|MRI, functional|mri, functional
689628|NCT00301457|Hormone Sensitive Primary Breast Cancer|hormone sensitive primary breast cancer
689629|NCT00301457|Adjuvant Treatment|adjuvant treatment
689630|NCT00301457|Aromatase Inhibitor|aromatase inhibitor
689631|NCT00301444|phantom limb pain|phantom limb pain
689632|NCT00301444|limb amputation|limb amputation
689633|NCT00301431|Fibromyalgia|fibromyalgia
689634|NCT00301431|Adults|adults
689635|NCT00301431|Outpatients|outpatients
689636|NCT00301431|Adult|adult
689637|NCT00301431|Double-Blind Method|double-blind method
689638|NCT00301418|Glioblastoma Multiforme|glioblastoma multiforme
689639|NCT00301418|Anaplastic Astrocytoma|anaplastic astrocytoma
689640|NCT00301418|High Grade Glial Neoplasms|high grade glial neoplasms
689641|NCT00301418|Brain Tumor|brain tumor
689642|NCT00301405|prostatitis|prostatitis
689643|NCT00301405|pelvic pain|pelvic pain
689644|NCT00301392|Glucose intolerance|glucose intolerance
689645|NCT00301392|Diabetes mellitus|diabetes mellitus
689646|NCT00301392|Statins,HMG-CoA|statins,hmg-coa
689647|NCT00301379|Cholangiocarcinoma|cholangiocarcinoma
689648|NCT00301379|Observational|observational
689649|NCT00301366|alpha 1-Antitrypsin Deficiency|alpha 1-antitrypsin deficiency
689650|NCT00301366|alpha 1-Antitrypsin|alpha 1-antitrypsin
689651|NCT00301366|pulmonary emphysema|pulmonary emphysema
689652|NCT00301353|early menopause|early menopause
689653|NCT00301353|isoflavones/phyto-estrogens|isoflavones/phyto-estrogens
689654|NCT00301353|bone metabolism|bone metabolism
689655|NCT00301353|bone mineral density|bone mineral density
689656|NCT00301353|hormones|hormones
689657|NCT00301249|Diabetes|diabetes
689658|NCT00301249|Nephropathy|nephropathy
689659|NCT00301249|Diabetic Nephropathy|diabetic nephropathy
689660|NCT00301249|Genome Scan|genome scan
689661|NCT00301249|Genetic Research|genetic research
689662|NCT00301236|ADHD, children, CADS-T, Dexmethylphenidate-HCl, extended release|adhd, children, cads-t, dexmethylphenidate-hcl, extended release
689663|NCT00301197|Childhood obesity|childhood obesity
689664|NCT00301197|intervention|intervention
689665|NCT00301197|obesity|obesity
689666|NCT00301197|weight loss|weight loss
689667|NCT00301197|behavior therapy|behavior therapy
689668|NCT00301197|peer group|peer group
689669|NCT00301197|social support network|social support network
689670|NCT00301197|child|child
689671|NCT00301197|clinical research|clinical research
689672|NCT00301197|human subject|human subject
689673|NCT00301184|HIV Seronegativity|hiv seronegativity
689674|NCT00301184|HIV Preventive Vaccine|hiv preventive vaccine
689675|NCT00301184|HIV DNA Vaccine|hiv dna vaccine
689676|NCT00301184|Modified Vaccinia Ankara Vaccine|modified vaccinia ankara vaccine
689677|NCT00301171|Wheezing|wheezing
689678|NCT00301158|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
689679|NCT00301145|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
689680|NCT00301119|small cell lung cancer|small cell lung cancer
689681|NCT00301119|non-small cell lung cancer|non-small cell lung cancer
689682|NCT00301119|smoker lung cancer screening|smoker lung cancer screening
689683|NCT00301119|low dose spiral CT screening|low dose spiral ct screening
689684|NCT00301106|stage IV breast cancer|stage iv breast cancer
689685|NCT00301106|liver metastases|liver metastases
689686|NCT00301093|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
689687|NCT00301093|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
689688|NCT00301080|pain|pain
689689|NCT00301080|neurotoxicity|neurotoxicity
689690|NCT00301080|breast cancer|breast cancer
689691|NCT00301067|stage IV melanoma|stage iv melanoma
689692|NCT00301067|recurrent melanoma|recurrent melanoma
689693|NCT00301054|Anaemia|anaemia
689694|NCT00301054|Malaria|malaria
689695|NCT00301054|Rural Area in Ghana|rural area in ghana
689696|NCT00301041|invasive ductal breast carcinoma|invasive ductal breast carcinoma
689697|NCT00301041|invasive lobular breast carcinoma|invasive lobular breast carcinoma
689698|NCT00301041|stage I breast cancer|stage i breast cancer
689699|NCT00301041|stage II breast cancer|stage ii breast cancer
689700|NCT00301041|stage IIIA breast cancer|stage iiia breast cancer
689701|NCT00301028|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
689702|NCT00301028|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
689703|NCT00301028|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
689704|NCT00301028|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
689705|NCT00301028|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
689706|NCT00301002|safety|safety
689707|NCT00301002|effectiveness|effectiveness
689708|NCT00301002|Alefacept|alefacept
689709|NCT00301002|Palmar|palmar
689710|NCT00301002|Plantar|plantar
689711|NCT00301002|Pustulosis|pustulosis
689712|NCT00300976|Blood glucose|blood glucose
689713|NCT00300976|Blood pressure|blood pressure
689714|NCT00300976|Lipids|lipids
689715|NCT00300963|psychosis|psychosis
689716|NCT00300963|cognition|cognition
689717|NCT00300950|Pancreas Cancer|pancreas cancer
689718|NCT00300950|resected pancreas cancer|resected pancreas cancer
689719|NCT00300950|non-metastatic pancreas cancer|non-metastatic pancreas cancer
689720|NCT00300911|Natriuretic Peptide, Brain|natriuretic peptide, brain
689721|NCT00300911|Heart Failure, Congestive|heart failure, congestive
689722|NCT00300898|contained lumbar herniated disc|contained lumbar herniated disc
689723|NCT00300898|nucleoplasty|nucleoplasty
689724|NCT00300898|percutaneous decompression|percutaneous decompression
689725|NCT00300898|Dekompressor|dekompressor
689726|NCT00300898|intervertebral electrothermal disc decompression|intervertebral electrothermal disc decompression
689727|NCT00300898|IDET|idet
689728|NCT00300885|Non-Small Cell Lung Cancer|non-small cell lung cancer
689729|NCT00300885|NSCLC|nsclc
689730|NCT00300820|Bipolar Disorder|bipolar disorder
689731|NCT00300820|Affected Adults and Adult Siblings|affected adults and adult siblings
689732|NCT00300820|Interest in Genetic Counseling|interest in genetic counseling
689733|NCT00300820|Bipolar|bipolar
689734|NCT00300820|Genes|genes
689735|NCT00300820|Familial|familial
689736|NCT00300820|Education|education
689737|NCT00300820|Testing|testing
689739|NCT00300820|Adult Siblings|adult siblings
689740|NCT00300807|Hepatitis C|hepatitis c
689741|NCT00300807|Monoclonal Antibody|monoclonal antibody
689742|NCT00300807|failed IFN/RBV treatment|failed ifn/rbv treatment
689743|NCT00300781|phase 2|phase 2
689744|NCT00300781|HER2+ breast cancer|her2+ breast cancer
689745|NCT00300781|monotherapy neratinib|monotherapy neratinib
689746|NCT00300781|HKI-272|hki-272
689747|NCT00300781|Neratinib|neratinib
689748|NCT00300781|Nerlynx|nerlynx
689749|NCT00300781|PB-272|pb-272
689750|NCT00300768|onchocerciasis|onchocerciasis
689751|NCT00300768|onchocerca volvulus|onchocerca volvulus
689752|NCT00300768|river blindness|river blindness
689753|NCT00300768|ivermectin|ivermectin
689754|NCT00300768|moxidectin|moxidectin
689755|NCT00300755|GERD|gerd
689756|NCT00300755|Children|children
689757|NCT00300755|Child|child
689758|NCT00300755|Child, Preschool|child, preschool
689759|NCT00300742|drinking|drinking
689760|NCT00300742|eating|eating
689761|NCT00300742|obesity|obesity
689762|NCT00300742|alcohol|alcohol
689763|NCT00300742|binge eating|binge eating
689764|NCT00300729|Cyclooxygenase-2 inhibitors|cyclooxygenase-2 inhibitors
689765|NCT00300729|Celecoxib|celecoxib
689766|NCT00300729|Carcinoma, non-small-cell lung|carcinoma, non-small-cell lung
689767|NCT00300729|Antineoplastic agents|antineoplastic agents
689768|NCT00300729|Therapy, palliative|therapy, palliative
689769|NCT00300729|Survival|survival
689770|NCT00300716|Multiple Sclerosis|multiple sclerosis
689771|NCT00300716|Cognitive impairment|cognitive impairment
689772|NCT00300716|Memantine|memantine
689773|NCT00300716|Placebo|placebo
689774|NCT00300716|Neuropsychological tests|neuropsychological tests
689775|NCT00300716|Quality of life|quality of life
689776|NCT00300716|Fatigue|fatigue
689777|NCT00300703|Cardiac Arrest|cardiac arrest
689778|NCT00300690|Lower extremity bypass surgery|lower extremity bypass surgery
689779|NCT00300690|femoro-popliteal bypass|femoro-popliteal bypass
689780|NCT00300690|Dacron material|dacron material
689781|NCT00300690|PTFE material|ptfe material
689782|NCT00300677|Pharmacokinetics|pharmacokinetics
689783|NCT00300677|Voriconazole|voriconazole
689784|NCT00300677|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
689785|NCT00300651|Cognitive Behavioral Therapy|cognitive behavioral therapy
689786|NCT00300651|Schizophrenia|schizophrenia
689787|NCT00300651|Cognitive Biases|cognitive biases
689788|NCT00300651|Efficacy|efficacy
689789|NCT00300638|Alcoholism|alcoholism
689790|NCT00300638|Emotion|emotion
689791|NCT00300638|Cognition|cognition
689792|NCT00300638|Brain scans|brain scans
689793|NCT00300625|Syncope|syncope
689794|NCT00300625|Near syncope|near syncope
689795|NCT00300625|San Francisco Syncope rule|san francisco syncope rule
689796|NCT00300586|Non-small cell lung cancer ;|non-small cell lung cancer ;
689797|NCT00300586|metastatic ;|metastatic ;
689798|NCT00300586|chemotherapy ;|chemotherapy ;
689799|NCT00300586|erlotinib|erlotinib
689800|NCT00300573|dexelvucitabine|dexelvucitabine
689801|NCT00300573|DFC|dfc
689802|NCT00300573|Treatment Experienced|treatment experienced
689803|NCT00300573|HIV-1|hiv-1
689804|NCT00300560|ESBL-producing E.coli Infections|esbl-producing e.coli infections
689805|NCT00300560|ESBL-producing Klebsiella pneumoniae Infections|esbl-producing klebsiella pneumoniae infections
689806|NCT00300560|Colistin|colistin
689807|NCT00300547|colorectal cancer|colorectal cancer
689808|NCT00300547|polyps|polyps
689809|NCT00300547|Virtual colonoscopy|virtual colonoscopy
689810|NCT00300547|synchronous carcinoma|synchronous carcinoma
689811|NCT00300547|MR colonography|mr colonography
689812|NCT00300534|Diagnosis|diagnosis
689813|NCT00300521|hepatocellular carcinoma|hepatocellular carcinoma
689814|NCT00300521|liver transplantation|liver transplantation
689815|NCT00300521|adenovirus-thymidine kinase enzyme|adenovirus-thymidine kinase enzyme
689816|NCT00300521|gene therapy|gene therapy
689817|NCT00300521|immunosuppression|immunosuppression
689818|NCT00300508|Hormone receptor positive breast cancer|hormone receptor positive breast cancer
689819|NCT00300495|Atrial fibrillation|atrial fibrillation
689820|NCT00300495|Lung cancer|lung cancer
689821|NCT00300495|Pulmonary resection|pulmonary resection
689822|NCT00300495|Post-operative complications|post-operative complications
689823|NCT00300482|Dyslipidemia|dyslipidemia
689824|NCT00300482|Coronary Heart Disease|coronary heart disease
689825|NCT00300482|Mixed Dyslipidemia|mixed dyslipidemia
689826|NCT00300469|Mixed Dyslipidemia|mixed dyslipidemia
689827|NCT00300469|Coronary Heart Disease|coronary heart disease
689828|NCT00300469|Dyslipidemia|dyslipidemia
689829|NCT00300456|Dyslipidemia|dyslipidemia
689830|NCT00300456|Coronary Heart Disease|coronary heart disease
689831|NCT00300456|Mixed Dyslipidemia|mixed dyslipidemia
689832|NCT00300417|Flavivirus|flavivirus
689833|NCT00300417|Mosquito|mosquito
689834|NCT00300417|Immunity|immunity
689835|NCT00300417|Preventive|preventive
689836|NCT00300417|West Nile Fever|west nile fever
689837|NCT00300417|West Nile Virus|west nile virus
689838|NCT00300417|Vaccine|vaccine
689839|NCT00300417|Healthy Volunteer|healthy volunteer
689840|NCT00300417|HV|hv
689841|NCT00300404|Schizophrenia|schizophrenia
689842|NCT00300404|Psychosis|psychosis
689843|NCT00300404|Depression|depression
689844|NCT00300404|Affective Disorder|affective disorder
689845|NCT00300391|Delirium|delirium
689846|NCT00300391|Mechanical ventilation|mechanical ventilation
689847|NCT00300391|Intensive care|intensive care
689848|NCT00300391|Haloperidol|haloperidol
689849|NCT00300378|Depression|depression
689850|NCT00300378|Adult|adult
689851|NCT00300378|Outpatients|outpatients
689852|NCT00300365|HDL cholesterol|hdl cholesterol
689853|NCT00300365|Metabolic syndrome|metabolic syndrome
689854|NCT00300352|Coronary artery disease|coronary artery disease
689855|NCT00300352|Folic acid|folic acid
689856|NCT00300352|Endothelial function|endothelial function
689857|NCT00300300|ACL computer-assisted surgery graft|acl computer-assisted surgery graft
689858|NCT00300287|Type 2 diabetes|type 2 diabetes
689859|NCT00300287|Vildagliptin|vildagliptin
689860|NCT00300274|Everolimus|everolimus
689861|NCT00300274|heart transplant|heart transplant
689862|NCT00300274|heart disease|heart disease
689863|NCT00300274|transplantation|transplantation
689864|NCT00300274|heart IVUS assessment at 12 months|heart ivus assessment at 12 months
689865|NCT00300274|rate of graft loss|rate of graft loss
689866|NCT00300274|acute rejection episodes|acute rejection episodes
689867|NCT00300274|survival|survival
689868|NCT00300261|Heart Failure|heart failure
689869|NCT00300248|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
689870|NCT00300248|Acute Lung Injury|acute lung injury
689871|NCT00300248|Respiratory Failure|respiratory failure
689872|NCT00300248|ARDS, Human|ards, human
689873|NCT00300235|Sickle Cell Anemia|sickle cell anemia
689874|NCT00300222|dermal assessment|dermal assessment
689875|NCT00300222|pain measurement|pain measurement
689876|NCT00300222|diary|diary
689877|NCT00300222|PHN|phn
689878|NCT00300222|shingles|shingles
689879|NCT00300222|neuropathy|neuropathy
689880|NCT00300222|analgesics|analgesics
689881|NCT00300222|capsaicin|capsaicin
689882|NCT00300222|postherpetic neuralgia|postherpetic neuralgia
689883|NCT00300196|Stroke|stroke
689884|NCT00300196|Fibrinogen|fibrinogen
689885|NCT00300196|Reperfusion|reperfusion
689886|NCT00300196|Thrombolysis|thrombolysis
689887|NCT00300183|HIV|hiv
689888|NCT00300183|health services accessibility|health services accessibility
689889|NCT00300183|health services research|health services research
689890|NCT00300183|homeless|homeless
689891|NCT00300183|social support|social support
689892|NCT00300183|AIDS|aids
689893|NCT00300183|substance abuse|substance abuse
689894|NCT00300183|mental health|mental health
689895|NCT00300183|quality of life|quality of life
689896|NCT00300183|outreach|outreach
689897|NCT00300183|harm reduction|harm reduction
689898|NCT00300170|HIV|hiv
689899|NCT00300170|race|race
689900|NCT00300170|unstable housing|unstable housing
689901|NCT00300170|health services accessibility|health services accessibility
689902|NCT00300170|health services utilization|health services utilization
689903|NCT00300170|substance abuse|substance abuse
689904|NCT00300170|AIDS|aids
689905|NCT00300170|health services research|health services research
689906|NCT00300170|social support|social support
689907|NCT00300170|depression|depression
689908|NCT00300170|trust|trust
689909|NCT00300170|discrimination|discrimination
689910|NCT00300157|Left main coronary artery stenosis, stent, Taxus|left main coronary artery stenosis, stent, taxus
689911|NCT00300157|Unprotected left main coronary artery disease|unprotected left main coronary artery disease
692985|NCT00290433|G-CSF|g-csf
689912|NCT00300157|Percutaneous coronary intervention with Taxus stent|percutaneous coronary intervention with taxus stent
689913|NCT00300131|Bioabsorbable|bioabsorbable
689914|NCT00300131|Coronary Stent|coronary stent
689915|NCT00300131|Everolimus|everolimus
689916|NCT00300131|drug eluting stents|drug eluting stents
689917|NCT00300131|stents|stents
689918|NCT00300131|angioplasty|angioplasty
689919|NCT00300131|coronary artery disease|coronary artery disease
689920|NCT00300131|total coronary occlusion|total coronary occlusion
689921|NCT00300131|coronary artery restenosis|coronary artery restenosis
689922|NCT00300131|stent thrombosis|stent thrombosis
689923|NCT00300131|vascular disease|vascular disease
689924|NCT00300131|myocardial ischemia|myocardial ischemia
689925|NCT00300131|coronary artery stenosis|coronary artery stenosis
689926|NCT00300105|Patients diagnosed with type 2 diabetes who have participated in and completed the randomized, double-blind, parallel-group, multi-center study GALLANT 4|patients diagnosed with type 2 diabetes who have participated in and completed the randomized, double-blind, parallel-group, multi-center study gallant 4
689927|NCT00300079|Ocular Hypertension Patients|ocular hypertension patients
689928|NCT00300066|Glomerular Filtration Rate|glomerular filtration rate
689929|NCT00300066|Serum Cystatin C|serum cystatin c
689930|NCT00300066|Body Composition|body composition
689931|NCT00300066|bioelectrical impedance spectroscopy|bioelectrical impedance spectroscopy
689932|NCT00300053|angina|angina
689933|NCT00300040|Amputation|amputation
689934|NCT00300040|Lower limb|lower limb
689935|NCT00300040|Critical Limb Ischemia|critical limb ischemia
689936|NCT00300040|residual limb|residual limb
689937|NCT00300040|Peripheral Vascular Disease|peripheral vascular disease
689938|NCT00300040|re-amputation|re-amputation
689939|NCT00300040|Lower Limb Ischemia|lower limb ischemia
689940|NCT00300040|PVD|pvd
689941|NCT00300027|Advanced Gastrointestinal Malignancies|advanced gastrointestinal malignancies
689942|NCT00300014|Post vitrectomy|post vitrectomy
689943|NCT00300014|Recurrent diabetic vitreous hemorrhage|recurrent diabetic vitreous hemorrhage
689944|NCT00300014|Intravitreal triamcinolone injection|intravitreal triamcinolone injection
689945|NCT00300001|Cancer|cancer
689946|NCT00300001|Symptom Management|symptom management
689947|NCT00300001|Supportive Symptom Interventions|supportive symptom interventions
689948|NCT00300001|Symptom Severity|symptom severity
689949|NCT00300001|quality of life|quality of life
689950|NCT00300001|Home-based symptom monitoring|home-based symptom monitoring
689951|NCT00299988|Immunotherapy|immunotherapy
689952|NCT00299988|Amyloid beta protein|amyloid beta protein
689953|NCT00299988|Antibodies|antibodies
689954|NCT00299988|Alzheimer's|alzheimer's
689955|NCT00299988|Dementia|dementia
689956|NCT00299975|Randomized Controlled Trials|randomized controlled trials
689957|NCT00299975|Medicine, Chinese Traditional|medicine, chinese traditional
689958|NCT00299975|Medicine, Herbal|medicine, herbal
689959|NCT00299975|Constipation|constipation
689960|NCT00299962|gene therapy|gene therapy
689961|NCT00299962|immunotherapy|immunotherapy
689962|NCT00299936|hepatitis C|hepatitis c
689963|NCT00299936|chronic hepatitis C|chronic hepatitis c
689964|NCT00299936|ribavirin|ribavirin
689965|NCT00299936|WIN-R|win-r
689966|NCT00299923|drug therapy|drug therapy
689967|NCT00299923|Interferon|interferon
689968|NCT00299897|HIV|hiv
689969|NCT00299897|AIDS|aids
689970|NCT00299897|Treatment Resistance|treatment resistance
689971|NCT00299897|Treatment Failure|treatment failure
689972|NCT00299897|Mutations|mutations
689973|NCT00299897|GP120|gp120
689974|NCT00299897|Entry Inhibitors|entry inhibitors
689975|NCT00299897|HAART|haart
689976|NCT00299897|antiretroviral|antiretroviral
689977|NCT00299897|antiviral|antiviral
689978|NCT00299897|ARV|arv
689979|NCT00299897|CCR5|ccr5
689980|NCT00299897|CXCR4|cxcr4
689981|NCT00299897|receptors|receptors
689982|NCT00299897|intracellular fluid|intracellular fluid
689983|NCT00299897|lipid rafts|lipid rafts
689984|NCT00299897|cholesterol|cholesterol
689985|NCT00299897|chemokine|chemokine
689986|NCT00299897|Treatment Experienced|treatment experienced
689987|NCT00299884|Randomized|randomized
689988|NCT00299884|non-blinded|non-blinded
689989|NCT00299884|prospective|prospective
689990|NCT00299884|open-label|open-label
689991|NCT00299884|LDL-C|ldl-c
689992|NCT00299884|HDL-C|hdl-c
689993|NCT00299871|Type 2 diabetes|type 2 diabetes
689994|NCT00299858|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
689995|NCT00299858|Theophylline|theophylline
689996|NCT00299858|Exercise testing|exercise testing
689997|NCT00299845|gastroesophageal reflux|gastroesophageal reflux
689998|NCT00299845|children|children
689999|NCT00299845|lansoprazole|lansoprazole
690000|NCT00299845|cytochrome P450 2C19 (CYP2C19)|cytochrome p450 2c19 (cyp2c19)
690001|NCT00299845|pharmacogenomics|pharmacogenomics
690002|NCT00299845|genetic polymorphisms|genetic polymorphisms
690003|NCT00299845|individualized medicine|individualized medicine
690004|NCT00299845|pharmacokinetics/dynamics|pharmacokinetics/dynamics
690005|NCT00299832|Hypertension, aliskiren, blood pressure, rennin|hypertension, aliskiren, blood pressure, rennin
690006|NCT00299819|Lupus|lupus
690109|NCT00299507|exudative AMD|exudative amd
690007|NCT00299806|Hypertension, aliskiren, blood pressure, rennin|hypertension, aliskiren, blood pressure, rennin
690008|NCT00299793|Epilepsy|epilepsy
690009|NCT00299793|Quality of life|quality of life
690010|NCT00299780|Mobilization|mobilization
690011|NCT00299780|Stem Cell|stem cell
690012|NCT00299780|Parathyroid Hormone|parathyroid hormone
690013|NCT00299754|Low dose misoprostol|low dose misoprostol
690014|NCT00299754|dinoprostone|dinoprostone
690015|NCT00299754|cervical priming|cervical priming
690016|NCT00299741|Sutent|sutent
690017|NCT00299741|Sunitinib|sunitinib
690018|NCT00299741|Bone|bone
690019|NCT00299741|Metastatic|metastatic
690020|NCT00299741|Hormone-refractory|hormone-refractory
690021|NCT00299741|Biomarkers|biomarkers
690022|NCT00299728|NY-ESO-1|ny-eso-1
690023|NCT00299728|Vaccine|vaccine
690024|NCT00299728|Adjuvant or metastatic setting|adjuvant or metastatic setting
690025|NCT00299728|Several tumor types eligible|several tumor types eligible
690026|NCT00299715|Affective psychosis|affective psychosis
690027|NCT00299715|mixed-state|mixed-state
690028|NCT00299715|bipolar disorder|bipolar disorder
690029|NCT00299715|manic disorder|manic disorder
690030|NCT00299715|manic-depressive|manic-depressive
690031|NCT00299715|psychosis|psychosis
690032|NCT00299715|mania|mania
690033|NCT00299715|manic state|manic state
690034|NCT00299715|paliperidone|paliperidone
690035|NCT00299715|paliperidone ER.|paliperidone er.
690036|NCT00299702|Schizophrenia|schizophrenia
690037|NCT00299702|Relapse|relapse
690038|NCT00299702|Remission|remission
690039|NCT00299702|Treatment Outcome|treatment outcome
690040|NCT00299702|long-acting injectable|long-acting injectable
690041|NCT00299689|Melanoma|melanoma
690042|NCT00299689|Metastatic|metastatic
690043|NCT00299689|Stage IV|stage iv
690044|NCT00299689|Ontak|ontak
690045|NCT00299676|Alzheimer's Disease|alzheimer's disease
690046|NCT00299676|Dementia|dementia
690047|NCT00299676|Post Marketing|post marketing
690048|NCT00299676|Prospective Studies|prospective studies
690049|NCT00299676|Longitudinal Studies|longitudinal studies
690050|NCT00299676|New Zealand|new zealand
690051|NCT00299676|Cholinesterase Inhibitors|cholinesterase inhibitors
690052|NCT00299676|Observational|observational
690053|NCT00299676|Outcomes|outcomes
690054|NCT00299663|group A streptococcal infection|group a streptococcal infection
690055|NCT00299663|genital tract|genital tract
690056|NCT00299663|CARRIER|carrier
690057|NCT00299663|patients with GAS isolation|patients with gas isolation
690058|NCT00299663|Streptococcus Group A|streptococcus group a
690059|NCT00299650|ARDS|ards
690060|NCT00299650|mortality|mortality
690061|NCT00299650|mechanical ventilation|mechanical ventilation
690062|NCT00299650|pneumonia|pneumonia
690063|NCT00299650|muscle relaxants|muscle relaxants
690064|NCT00299624|venous thromboembolism risk,|venous thromboembolism risk,
690065|NCT00299624|elderly,|elderly,
690066|NCT00299624|hypercoagulability|hypercoagulability
690067|NCT00299624|fibrinolysis|fibrinolysis
690068|NCT00299624|microparticles|microparticles
690069|NCT00299611|OCD|ocd
690070|NCT00299611|Anxiety|anxiety
690071|NCT00299611|Pharmacotherapy|pharmacotherapy
690072|NCT00299611|Sertraline|sertraline
690073|NCT00299611|Levetiracetam|levetiracetam
690074|NCT00299598|antibacterial|antibacterial
690075|NCT00299598|composite|composite
690076|NCT00299598|polyethylenimine|polyethylenimine
690077|NCT00299598|nanoparticle|nanoparticle
690078|NCT00299585|dental implant|dental implant
690079|NCT00299585|dental implantation|dental implantation
690080|NCT00299585|osseointegration|osseointegration
690081|NCT00299585|bone cement|bone cement
690082|NCT00299585|osteoconductivity|osteoconductivity
690083|NCT00299585|brushite|brushite
690084|NCT00299585|calcium phosphate|calcium phosphate
690085|NCT00299585|bone augmentation|bone augmentation
690086|NCT00299585|primary stability|primary stability
690087|NCT00299585|immediate implantation|immediate implantation
690088|NCT00299585|Mandibular Ridge Augmentation|mandibular ridge augmentation
690089|NCT00299585|Maxillary Ridge Augmentation|maxillary ridge augmentation
690090|NCT00299585|synthetic implants for rebuilding the alveolar ridge|synthetic implants for rebuilding the alveolar ridge
690091|NCT00299572|alendronate|alendronate
690092|NCT00299572|peritoneal dialysis|peritoneal dialysis
690093|NCT00299572|vascular calcification|vascular calcification
690094|NCT00299572|bone mineral density|bone mineral density
690095|NCT00299559|common cold|common cold
690096|NCT00299559|organic chemicals|organic chemicals
690097|NCT00299559|menthol|menthol
690098|NCT00299559|cineole|cineole
690099|NCT00299559|camphor|camphor
690100|NCT00299559|etheric oils|etheric oils
690101|NCT00299559|alternative medicine|alternative medicine
690102|NCT00299559|smart textiles|smart textiles
690103|NCT00299546|Rheumatoid Arthritis|rheumatoid arthritis
690104|NCT00299546|Anti-TNFa agents|anti-tnfa agents
690105|NCT00299546|subcutaneous injection|subcutaneous injection
690106|NCT00299520|skin infection|skin infection
690107|NCT00299520|complicated skin infection|complicated skin infection
690108|NCT00299520|skin structure infection|skin structure infection
690110|NCT00299507|age-related macular degeneration (AMD)|age-related macular degeneration (amd)
690111|NCT00299494|Lymphoma|lymphoma
690112|NCT00299494|NHL|nhl
690113|NCT00299481|Tissue Bank|tissue bank
690114|NCT00299481|Endometrial neoplasm|endometrial neoplasm
690115|NCT00299481|uterine cervical neoplasm|uterine cervical neoplasm
690116|NCT00299481|ovarian neoplasm|ovarian neoplasm
690117|NCT00299481|leiomyoma|leiomyoma
690118|NCT00299481|DNA|dna
690119|NCT00299481|RNA|rna
690120|NCT00299481|Protein|protein
690121|NCT00299481|Serum|serum
690122|NCT00299468|hypertension|hypertension
690123|NCT00299468|home care|home care
690124|NCT00299468|patient activation|patient activation
690125|NCT00299468|stages-of-change|stages-of-change
690126|NCT00299442|behavior|behavior
690127|NCT00299442|conduct|conduct
690128|NCT00299442|child|child
690129|NCT00299442|parenting|parenting
690130|NCT00299442|self-help|self-help
690131|NCT00299442|media-based|media-based
690132|NCT00299429|Stent|stent
690133|NCT00299429|drug-eluting stent|drug-eluting stent
690134|NCT00299429|Minimally invasive bypass surgery|minimally invasive bypass surgery
690135|NCT00299429|left anterior descending|left anterior descending
690136|NCT00299416|Stroke|stroke
690137|NCT00299416|Nonhemorrhagic|nonhemorrhagic
690138|NCT00299416|hypothermia|hypothermia
690139|NCT00299403|Depressive disorder,|depressive disorder,
690140|NCT00299403|Antidepressant effect,|antidepressant effect,
690141|NCT00299403|rTMS,|rtms,
690142|NCT00299403|ECT,|ect,
690143|NCT00299403|cognition,|cognition,
690144|NCT00299403|Saliva cortisol|saliva cortisol
690145|NCT00299403|noninferiority trial|noninferiority trial
690146|NCT00299390|Sagopilone|sagopilone
690147|NCT00299390|Epothilone|epothilone
690148|NCT00299390|SCLC|sclc
690149|NCT00299390|Small Cell Lung Cancer|small cell lung cancer
690150|NCT00299390|Lung Cancer|lung cancer
690151|NCT00299377|STEMI|stemi
690152|NCT00299377|infarct size|infarct size
690153|NCT00299377|primary PCI|primary pci
690154|NCT00299377|no-reflow|no-reflow
690155|NCT00299377|ST-elevation myocardial infarction|st-elevation myocardial infarction
690156|NCT00299364|Climacteric symptoms|climacteric symptoms
690157|NCT00299364|Black Cohosh|black cohosh
690158|NCT00299364|Efficacy|efficacy
690159|NCT00299364|Safety|safety
690160|NCT00299338|HIV|hiv
690161|NCT00299338|AIDS|aids
690162|NCT00299338|CD4|cd4
690163|NCT00299338|HAART|haart
690164|NCT00299338|antiretroviral|antiretroviral
690165|NCT00299338|treatment failure|treatment failure
690166|NCT00299338|resistance|resistance
690167|NCT00299338|CCR4|ccr4
690168|NCT00299338|CXCR5|cxcr5
690169|NCT00299338|gp120|gp120
690170|NCT00299338|gp41|gp41
690171|NCT00299338|cholesterol|cholesterol
690172|NCT00299338|lipid rafts|lipid rafts
690173|NCT00299338|intracellular fluid|intracellular fluid
690174|NCT00299338|receptors|receptors
690175|NCT00299338|chemokine|chemokine
690176|NCT00299338|antigens|antigens
690177|NCT00299338|Treatment Experienced|treatment experienced
690178|NCT00299312|Loss of Purposeful Hand Use Syndrome|loss of purposeful hand use syndrome
690179|NCT00299312|Loss of Communication|loss of communication
690180|NCT00299312|Stereotypic Hand Movements|stereotypic hand movements
690181|NCT00299312|MECP2 mutation|mecp2 mutation
690182|NCT00299312|MECP2 duplication|mecp2 duplication
690183|NCT00299312|CDKL5 mutation|cdkl5 mutation
690184|NCT00299312|FOXG1 mutation|foxg1 mutation
690185|NCT00299286|Ki67|ki67
690186|NCT00299286|Molecular|molecular
690187|NCT00299286|antiproliferative|antiproliferative
690188|NCT00299273|Obesity;|obesity;
690189|NCT00299273|Low calorie high fat/protein diet;|low calorie high fat/protein diet;
690190|NCT00299273|Low-carbohydrate diet|low-carbohydrate diet
690191|NCT00299273|Weight Loss|weight loss
690192|NCT00299260|cytomegalovirus, glycoprotein B vaccine, allograft|cytomegalovirus, glycoprotein b vaccine, allograft
690193|NCT00299247|Malaria, Plasmodium falciparum, drug resistance, Colombia|malaria, plasmodium falciparum, drug resistance, colombia
690194|NCT00299234|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
690195|NCT00299221|immunosuppression|immunosuppression
690196|NCT00299221|steroid withdrawal|steroid withdrawal
690197|NCT00299221|rejection|rejection
690198|NCT00299221|coronary disease|coronary disease
690199|NCT00299221|cytomegalovirus infection|cytomegalovirus infection
690200|NCT00299208|Malaria|malaria
690201|NCT00299195|Oral Leukoplakia|oral leukoplakia
690202|NCT00299195|Benign Neoplasms|benign neoplasms
690203|NCT00299195|Chemoprevention|chemoprevention
690204|NCT00299195|Pan-cyclooxygenase (COX) inhibitor|pan-cyclooxygenase (cox) inhibitor
690205|NCT00299195|sulindac|sulindac
690206|NCT00299195|04-099|04-099
690207|NCT00299182|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
690208|NCT00299182|Lymphoma|lymphoma
690209|NCT00299182|Mantle Cell Lymphoma|mantle cell lymphoma
690210|NCT00299182|AMG 531|amg 531
690211|NCT00299182|Romiplostim|romiplostim
690212|NCT00299182|Placebo|placebo
690213|NCT00299182|R-HyperCVAD|r-hypercvad
690214|NCT00299182|R-Ara-C/MTX|r-ara-c/mtx
690215|NCT00299182|Cyclophosphamide|cyclophosphamide
690216|NCT00299182|Cytarabine|cytarabine
690217|NCT00299182|Dexamethasone|dexamethasone
690218|NCT00299182|Doxorubicin|doxorubicin
690219|NCT00299182|Methotrexate|methotrexate
690220|NCT00299182|Rituximab|rituximab
690221|NCT00299182|Vincristine|vincristine
690222|NCT00299182|Decadron|decadron
690223|NCT00299182|Neosar|neosar
690224|NCT00299182|AD|ad
690225|NCT00299182|Hydroxydaunomycin hydrocholoride|hydroxydaunomycin hydrocholoride
690226|NCT00299182|Ara-C|ara-c
690227|NCT00299182|Cytosar|cytosar
690228|NCT00299182|DepoCyt|depocyt
690229|NCT00299182|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
690230|NCT00299169|N of 1 trial|n of 1 trial
690231|NCT00299169|diabetes mellitus|diabetes mellitus
690232|NCT00299169|HMG CoA Reductase Inhibitors|hmg coa reductase inhibitors
690233|NCT00299169|cardiovascular disease|cardiovascular disease
690234|NCT00299156|Myelodysplastic Syndrome|myelodysplastic syndrome
690235|NCT00299156|MDS|mds
690236|NCT00299156|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
690237|NCT00299156|CMML|cmml
690238|NCT00299156|Clofarabine|clofarabine
690239|NCT00299156|Clofarex|clofarex
690240|NCT00299156|Clolar|clolar
690241|NCT00299156|Chemotherapy|chemotherapy
690242|NCT00299143|SIPA|sipa
690243|NCT00299143|acute coronary syndrome|acute coronary syndrome
690244|NCT00299130|RA|ra
690245|NCT00299130|Rituxan|rituxan
690246|NCT00299130|SERENE|serene
690247|NCT00299117|Smoking cessation|smoking cessation
690248|NCT00299117|Stress|stress
690249|NCT00299117|Nicotine dependence|nicotine dependence
690250|NCT00299117|Complication, postoperative|complication, postoperative
690251|NCT00299104|Rituxan|rituxan
690252|NCT00299104|MTX|mtx
690253|NCT00299104|RA|ra
690254|NCT00299104|IMAGE|image
690255|NCT00299104|WA17047|wa17047
690256|NCT00299091|Therapeutic drug monitoring|therapeutic drug monitoring
690257|NCT00299091|Treatment Naive|treatment naive
690258|NCT00299091|Treatment Experienced|treatment experienced
690259|NCT00299091|HIV|hiv
690260|NCT00299065|Asthma, bronchial|asthma, bronchial
690261|NCT00299065|Asthma, exercise-induced|asthma, exercise-induced
690262|NCT00299065|Anti-asthmatic agents|anti-asthmatic agents
690263|NCT00299052|Tibia|tibia
690264|NCT00299052|Fracture|fracture
690265|NCT00299052|DBM|dbm
690266|NCT00299039|Randomized controlled trial|randomized controlled trial
690267|NCT00299039|Clinical trial|clinical trial
690268|NCT00299039|Breast tumor surgery|breast tumor surgery
690269|NCT00299039|Outpatient surgery|outpatient surgery
690270|NCT00299039|Analgesia|analgesia
690271|NCT00299039|Outpatient analgesia|outpatient analgesia
690272|NCT00299039|Post surgical analgesia|post surgical analgesia
690273|NCT00299039|≥ 18 and ≤ 70 years of age|≥ 18 and ≤ 70 years of age
690274|NCT00299039|Elective outpatient breast surgery for:|elective outpatient breast surgery for:
690275|NCT00299039|lumpectomy/quadrantectomy +/- Sentinel Lymph Node Biopsy|lumpectomy/quadrantectomy +/- sentinel lymph node biopsy
690276|NCT00299039|lumpectomy/quadrantectomy with Axillary Node Dissection|lumpectomy/quadrantectomy with axillary node dissection
690277|NCT00299039|simple mastectomy +/- Sentinel Lymph Node Biopsy|simple mastectomy +/- sentinel lymph node biopsy
690278|NCT00299039|Modified Radical mastectomy|modified radical mastectomy
690279|NCT00299026|Coronary Artery Disease|coronary artery disease
690280|NCT00299026|Percutaneous Coronary Intervention|percutaneous coronary intervention
690281|NCT00299026|Stent Implant|stent implant
690282|NCT00299026|Drug-coated Stent|drug-coated stent
690283|NCT00299013|Ulcerative colitis|ulcerative colitis
690284|NCT00298987|Chronic Myeloid Leukemia Accelerated and Blast Phase|chronic myeloid leukemia accelerated and blast phase
690285|NCT00298987|Leukemia, Acute, Philadelphia-Positive|leukemia, acute, philadelphia-positive
690286|NCT00298974|Osteoarthritis of the hip or knee|osteoarthritis of the hip or knee
690287|NCT00298935|Randomized Controlled Trial|randomized controlled trial
690288|NCT00298935|Pregnant Women|pregnant women
690289|NCT00298922|Cystic Fibrosis|cystic fibrosis
690290|NCT00298922|Burkholderia cepacia complex|burkholderia cepacia complex
690291|NCT00298896|Lung|lung
690292|NCT00298896|Squamous Cell|squamous cell
690293|NCT00298896|Small Cell|small cell
690294|NCT00298896|Carcinoma|carcinoma
690295|NCT00298896|Cancer|cancer
690296|NCT00298896|Small Cell Lung Cancer|small cell lung cancer
690297|NCT00298883|Renal|renal
690298|NCT00298883|Transplant|transplant
690299|NCT00298883|PRA|pra
690300|NCT00298870|pulmonary tuberculosis|pulmonary tuberculosis
690301|NCT00298870|isoniazid|isoniazid
690302|NCT00298870|arylamine N-acetyltransferase 2|arylamine n-acetyltransferase 2
690303|NCT00298870|pharmacogenomics|pharmacogenomics
690304|NCT00298870|genetic polymorphisms|genetic polymorphisms
690305|NCT00298870|individualized medicine|individualized medicine
690306|NCT00298870|drug-induced hepatotoxity|drug-induced hepatotoxity
690307|NCT00298857|Healthy|healthy
690308|NCT00298857|Obesity|obesity
690309|NCT00298857|Pharmacokinetics|pharmacokinetics
690310|NCT00298844|Type 2 diabetes mellitus|type 2 diabetes mellitus
690311|NCT00298844|Macrovascular disease|macrovascular disease
690312|NCT00298844|Diastolic dysfunction|diastolic dysfunction
690313|NCT00298844|Intima media thickness|intima media thickness
690314|NCT00298844|Single- photon emission computed tomography (SPECT)|single- photon emission computed tomography (spect)
690315|NCT00298818|Epilepsy|epilepsy
690316|NCT00298818|Mental Retardation|mental retardation
690317|NCT00298818|Developmental Disabilities|developmental disabilities
690318|NCT00298805|Migraine|migraine
690319|NCT00298805|Headache|headache
690320|NCT00298805|Depression|depression
690321|NCT00298805|Quality of Life|quality of life
690322|NCT00298792|Cognitive Behavioral Treatment|cognitive behavioral treatment
690323|NCT00298792|Alcohol Dependence|alcohol dependence
690324|NCT00298792|Functional Analysis|functional analysis
690325|NCT00298792|Experience Sampling|experience sampling
690326|NCT00298792|Interactive Voice Response|interactive voice response
690327|NCT00298779|patients with advanced solid tumors or Non-Hodgkins's Lymphoma|patients with advanced solid tumors or non-hodgkins's lymphoma
690328|NCT00298727|Knowledge transfer|knowledge transfer
690329|NCT00298727|Clinical decision-making|clinical decision-making
690330|NCT00298727|Outcome measures|outcome measures
690331|NCT00298714|Hepatitis C, Chronic|hepatitis c, chronic
690332|NCT00298701|Allergy|allergy
690333|NCT00298662|Multiple Sclerosis|multiple sclerosis
690334|NCT00298662|Betaseron-Prograf|betaseron-prograf
690335|NCT00298662|patients of Multiple Sclerosis|patients of multiple sclerosis
690336|NCT00298662|Secondary Progressive type|secondary progressive type
690337|NCT00298662|Relapsing-Remitting type|relapsing-remitting type
690338|NCT00298649|pesticide safety|pesticide safety
690339|NCT00298649|migrant and seasonal farmworkers|migrant and seasonal farmworkers
690340|NCT00298649|Latino/Hispanic|latino/hispanic
690341|NCT00298649|agricultural health|agricultural health
690342|NCT00298649|occupational health|occupational health
690343|NCT00298610|Uncomplicated Malaria|uncomplicated malaria
690344|NCT00298610|GMP artesunate|gmp artesunate
690345|NCT00298584|Diagnostic techniques, urological|diagnostic techniques, urological
690346|NCT00298584|urinary catheterization|urinary catheterization
690347|NCT00298584|Aspiration|aspiration
690348|NCT00298584|Neonates|neonates
690349|NCT00298584|Neonatal Intensive Care Unit|neonatal intensive care unit
690350|NCT00298584|Infant, Newborn|infant, newborn
690351|NCT00298584|Infant, Premature|infant, premature
690352|NCT00298584|Infant, Low-birth weight|infant, low-birth weight
690353|NCT00298571|Cesarean Delivery|cesarean delivery
690354|NCT00298571|Post-operative|post-operative
690355|NCT00298571|Pain|pain
690356|NCT00298571|Local Anesthetic|local anesthetic
690357|NCT00298558|cognition disorder|cognition disorder
690358|NCT00298558|cognitive behavior therapy|cognitive behavior therapy
690359|NCT00298558|functional ability|functional ability
690360|NCT00298532|Pediatrics|pediatrics
690361|NCT00298532|Seizure|seizure
690362|NCT00298532|Trauma|trauma
690363|NCT00298532|Respiratory|respiratory
690364|NCT00298532|Cardiac|cardiac
690365|NCT00298532|Arrest|arrest
690366|NCT00298506|Tacrolimus|tacrolimus
690367|NCT00298506|Mycophenolate mofetil|mycophenolate mofetil
690368|NCT00298506|Cyclophosphamide|cyclophosphamide
690369|NCT00298506|Lupus nephritis|lupus nephritis
690370|NCT00298506|Treatment|treatment
690371|NCT00298493|ICU|icu
690372|NCT00298493|Sedation strategies|sedation strategies
690373|NCT00298493|Daily sedative interruption|daily sedative interruption
690374|NCT00298493|Sedation protocols|sedation protocols
690375|NCT00298480|preterm labor|preterm labor
690376|NCT00298480|transvaginal ultrasound|transvaginal ultrasound
690377|NCT00298480|dynamic cervical change|dynamic cervical change
690378|NCT00298467|ALCL|alcl
690379|NCT00298467|csALCL|csalcl
690380|NCT00298467|pcALCL|pcalcl
690381|NCT00298467|Lymphoma|lymphoma
690382|NCT00298467|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
690383|NCT00298467|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
690384|NCT00298467|classic systemci Anaplastic Large Cell Lymphoma (csALCL)|classic systemci anaplastic large cell lymphoma (csalcl)
690385|NCT00298467|primary cutaneous Anaplastic Large Cell Lymphoma (pcALCL)|primary cutaneous anaplastic large cell lymphoma (pcalcl)
690386|NCT00298454|renal failure|renal failure
690387|NCT00298454|oliguric|oliguric
690388|NCT00298454|critically ill|critically ill
690389|NCT00298454|furosemide|furosemide
690390|NCT00298441|intravenous iron administration|intravenous iron administration
690391|NCT00298428|stent|stent
690392|NCT00298428|percutaneous coronary intervention|percutaneous coronary intervention
690393|NCT00298428|platelet aggregation|platelet aggregation
690394|NCT00298428|clopidogrel|clopidogrel
690395|NCT00298428|shear|shear
690396|NCT00298428|metabolic syndrome|metabolic syndrome
690397|NCT00298415|2-years survival|2-years survival
690398|NCT00298402|macrophage|macrophage
690399|NCT00298402|MMP|mmp
690400|NCT00298402|CT scan|ct scan
690401|NCT00298389|macrophage|macrophage
690402|NCT00298389|phagocytosis|phagocytosis
690403|NCT00298389|exacerbation|exacerbation
690404|NCT00298376|Cow’s milk allergy,|cow’s milk allergy,
690405|NCT00298376|food allergy|food allergy
690406|NCT00298376|oral tolerance,|oral tolerance,
690407|NCT00298376|infant,|infant,
690408|NCT00298376|regulatory T cells,|regulatory t cells,
690409|NCT00298376|intestinal microflora|intestinal microflora
690410|NCT00298363|Hepatitis; Hepatitis B virus; Tenofovir|hepatitis; hepatitis b virus; tenofovir
690411|NCT00298350|Phase 2|phase 2
690412|NCT00298350|Phase II|phase ii
690413|NCT00298350|Randomized|randomized
690414|NCT00298350|Controlled|controlled
690415|NCT00298350|Comparator|comparator
690416|NCT00298350|Partially Blind|partially blind
690417|NCT00298350|Protease Inhibitors|protease inhibitors
690418|NCT00298350|Integrase Inhibitors|integrase inhibitors
690419|NCT00298350|Antiviral Agents|antiviral agents
690420|NCT00298350|Antiretroviral Agents|antiretroviral agents
690421|NCT00298350|ART|art
690422|NCT00298350|ARV|arv
690423|NCT00298350|Highly Activity Antiretroviral Therapy|highly activity antiretroviral therapy
690424|NCT00298350|HAART|haart
690425|NCT00298350|Treatment Experienced|treatment experienced
690426|NCT00298324|GvHD|gvhd
690427|NCT00298324|graft versus host disease|graft versus host disease
690428|NCT00298324|extensive|extensive
690429|NCT00298324|myfortic|myfortic
690430|NCT00298298|lung cancer|lung cancer
690431|NCT00298298|non-small cell lung cancere|non-small cell lung cancere
690432|NCT00298298|vaccine|vaccine
690433|NCT00298298|immunotherapy|immunotherapy
690434|NCT00298285|mechanical valve replacement|mechanical valve replacement
690435|NCT00298285|warfarin|warfarin
690436|NCT00298246|Neurodevelopmental Disorders|neurodevelopmental disorders
690437|NCT00298246|Neurological Disorder|neurological disorder
690438|NCT00298246|Children- Onset|children- onset
690439|NCT00298246|Children|children
690440|NCT00298246|Pervasive Developmental Disorder|pervasive developmental disorder
690441|NCT00298246|PDD|pdd
690442|NCT00298246|Autism|autism
690443|NCT00298246|Healthy Volunteer|healthy volunteer
690444|NCT00298246|HV|hv
690445|NCT00298233|Antibody Response|antibody response
690446|NCT00298233|Antiviral Efficacy|antiviral efficacy
690447|NCT00298233|Bird Flu|bird flu
690448|NCT00298233|Severe Respiratory Distress|severe respiratory distress
690449|NCT00298233|Viral Replication and Shedding|viral replication and shedding
690450|NCT00298220|Family Practice|family practice
690451|NCT00298220|Intervention Studies|intervention studies
690452|NCT00298220|Prevention and Control|prevention and control
690453|NCT00298207|high blood pressure|high blood pressure
690454|NCT00298207|hypertension|hypertension
690455|NCT00298207|adult|adult
690456|NCT00298207|African Americans|african americans
690457|NCT00298207|Walking|walking
690458|NCT00298168|Delayed Graft Function|delayed graft function
690459|NCT00298142|Cervicogenic Headache|cervicogenic headache
690460|NCT00298142|Migraine|migraine
690461|NCT00298142|Tension Type Headache|tension type headache
690462|NCT00298103|Antibiotic resistant|antibiotic resistant
690463|NCT00298103|Infection|infection
690464|NCT00298090|Oxygenation|oxygenation
690465|NCT00298077|Infection|infection
690466|NCT00298077|transplant recipients|transplant recipients
690467|NCT00298064|Cervical cancer|cervical cancer
690468|NCT00298064|EGFR|egfr
690469|NCT00298064|cervical|cervical
690470|NCT00298064|genomic|genomic
690471|NCT00298064|DNA|dna
690472|NCT00298064|markers|markers
690473|NCT00298064|prognostic|prognostic
690474|NCT00298064|gene|gene
690475|NCT00298064|epidermal growth factor|epidermal growth factor
690476|NCT00298051|Iron-deficiency anemia|iron-deficiency anemia
690477|NCT00298051|Umbilical cord clamping|umbilical cord clamping
690478|NCT00298051|Infant|infant
690479|NCT00298025|Infertility|infertility
690480|NCT00298025|Cetrotide|cetrotide
690481|NCT00298025|Antagon|antagon
690482|NCT00298025|Recombinant human follicle stimulating hormone (r-hFSH)|recombinant human follicle stimulating hormone (r-hfsh)
690483|NCT00298025|Human Menopausal Gonadotropin (hMG)|human menopausal gonadotropin (hmg)
690484|NCT00298025|Recombinant Human Choriogonadotropin (r-hCG)|recombinant human choriogonadotropin (r-hcg)
690485|NCT00298012|Methotrexate|methotrexate
690486|NCT00298012|Magnetic Resonance Imaging|magnetic resonance imaging
690487|NCT00298012|Anterior uveitis|anterior uveitis
690488|NCT00297947|schizophrenia|schizophrenia
690489|NCT00297947|quetiapine|quetiapine
690490|NCT00297947|schizoaffective disorder|schizoaffective disorder
690491|NCT00297934|dual-task|dual-task
690492|NCT00297934|postural control|postural control
690493|NCT00297934|cognitive|cognitive
690494|NCT00297908|Ethanol levels|ethanol levels
690495|NCT00297908|Dermal absorbtion|dermal absorbtion
690496|NCT00297895|sentinel lymph node dissection|sentinel lymph node dissection
690497|NCT00297895|complete lymph node dissection|complete lymph node dissection
690498|NCT00297895|surgical|surgical
690499|NCT00297882|Efficacy|efficacy
690500|NCT00297882|Safety|safety
690501|NCT00297882|Children|children
690502|NCT00297882|Cameroon|cameroon
690503|NCT00297856|Boostrix|boostrix
690504|NCT00297830|Heart Transplantation|heart transplantation
690505|NCT00297830|Liver Transplantation|liver transplantation
690506|NCT00297830|Immunosuppression|immunosuppression
690507|NCT00297830|Bone Density/drug effects|bone density/drug effects
690508|NCT00297830|Alendronate|alendronate
690509|NCT00297830|Zoledronic acid|zoledronic acid
690510|NCT00297830|Comparative study|comparative study
690511|NCT00297830|Humans|humans
690512|NCT00297817|Meningococcal Disease; Meningococcal Meningitis; Vaccine|meningococcal disease; meningococcal meningitis; vaccine
690513|NCT00297804|Coronary Artery Disease|coronary artery disease
690514|NCT00297804|Percutaneous Coronary Intervention|percutaneous coronary intervention
690515|NCT00297804|Stent Implant|stent implant
690516|NCT00297804|Drug-coated Stent|drug-coated stent
690517|NCT00297791|rectal cancer|rectal cancer
690518|NCT00297791|laparoscopic technique|laparoscopic technique
690519|NCT00297791|open technique|open technique
690520|NCT00297791|clinical trial|clinical trial
690521|NCT00297791|multicenter study|multicenter study
690522|NCT00297791|randomized controlled trial|randomized controlled trial
690523|NCT00297791|Tumor Below 15cm|tumor below 15cm
690524|NCT00297791|curative surgical resection|curative surgical resection
690525|NCT00297791|no evidence for distant metastases|no evidence for distant metastases
690526|NCT00297765|Renal Transplantation|renal transplantation
690527|NCT00297765|Therapeutics|therapeutics
690528|NCT00297765|Treatment Outcome|treatment outcome
690529|NCT00297765|Safety|safety
690530|NCT00297752|facial burns|facial burns
690531|NCT00297752|cerium flammazine|cerium flammazine
690532|NCT00297752|quality of life|quality of life
690533|NCT00297752|randomised clinical trial|randomised clinical trial
690534|NCT00297739|Aggression|aggression
690535|NCT00297739|ADHD|adhd
690536|NCT00297739|Antipsychotic|antipsychotic
690537|NCT00297726|Osteoarthritis, Knee|osteoarthritis, knee
690538|NCT00297726|Osteoarthritis, Hip|osteoarthritis, hip
690539|NCT00297726|Osteoarthritis, Ankle|osteoarthritis, ankle
690540|NCT00297726|Arthritis|arthritis
690541|NCT00297726|Self-Management|self-management
690542|NCT00297700|Smoking|smoking
690543|NCT00297700|Dental|dental
690544|NCT00297700|Cessation|cessation
690545|NCT00297700|Prevention|prevention
690546|NCT00297700|Control|control
690547|NCT00297700|Quitline|quitline
690548|NCT00297700|5A-Model|5a-model
690549|NCT00297700|Cost-effective|cost-effective
690550|NCT00297687|Vaccines|vaccines
690551|NCT00297687|Healthy Adults|healthy adults
690552|NCT00297687|Health|health
690553|NCT00297687|Adult|adult
690554|NCT00297687|Meningococcal Vaccines|meningococcal vaccines
690555|NCT00297674|clarithromycin|clarithromycin
690556|NCT00297674|sepsis|sepsis
690557|NCT00297674|immunomodulation|immunomodulation
690558|NCT00297661|Coronary Revascularization|coronary revascularization
690559|NCT00297661|Sirolimus-eluting stents|sirolimus-eluting stents
690560|NCT00297661|Paclitaxel-eluting stents|paclitaxel-eluting stents
690561|NCT00297648|Certolizumab pegol|certolizumab pegol
690562|NCT00297648|Crohn's disease|crohn's disease
690563|NCT00297648|Mucosal healing|mucosal healing
690564|NCT00297635|Hyperglycemia|hyperglycemia
690565|NCT00297635|Insulin Infusion Systems|insulin infusion systems
690566|NCT00297635|Blood Glucose Self-Monitoring|blood glucose self-monitoring
690567|NCT00297609|Resuscitation medication errors|resuscitation medication errors
690568|NCT00297609|critical care|critical care
690569|NCT00297609|pediatrics|pediatrics
690570|NCT00297609|clinical decision support systems|clinical decision support systems
690571|NCT00297609|computerized physician order entry|computerized physician order entry
690572|NCT00297596|Metastatic|metastatic
690573|NCT00297596|HER2/neu+|her2/neu+
690574|NCT00297570|CML|cml
690575|NCT00297570|Imatinib|imatinib
690576|NCT00297570|Pegylated Interferon|pegylated interferon
690577|NCT00297570|Philadelphia Positive CML|philadelphia positive cml
690578|NCT00297544|impotence|impotence
690579|NCT00297544|endothelial function|endothelial function
690580|NCT00297544|autonomic nervous system|autonomic nervous system
690581|NCT00297531|Chronic Periodontitis|chronic periodontitis
690582|NCT00297531|Periodontitis|periodontitis
690583|NCT00297531|Photodynamic disinfection|photodynamic disinfection
690584|NCT00297531|PDD|pdd
690585|NCT00297531|PDT|pdt
690586|NCT00297531|Periowave|periowave
690587|NCT00297531|Scaling and Root Planing|scaling and root planing
690588|NCT00297531|SRP|srp
690589|NCT00297518|Adult Periodontitis|adult periodontitis
690590|NCT00297518|Chronic Periodontitis|chronic periodontitis
690591|NCT00297518|PDD|pdd
690592|NCT00297518|PDT|pdt
690593|NCT00297518|Photodynamic Disinfection|photodynamic disinfection
690594|NCT00297518|SRP|srp
690595|NCT00297518|Scaling and Root Planing|scaling and root planing
690596|NCT00297505|Cocaine; citalopram; impulsivity; serotonin|cocaine; citalopram; impulsivity; serotonin
690597|NCT00297492|Smoking Cessation|smoking cessation
690598|NCT00297492|Tobacco|tobacco
690599|NCT00297479|Tobacco Cessation|tobacco cessation
690600|NCT00297479|Smoking Cessation|smoking cessation
690601|NCT00297466|tobacco use|tobacco use
690602|NCT00297466|smoking cessation|smoking cessation
690603|NCT00297466|emergency department|emergency department
690604|NCT00297440|Smoking|smoking
690605|NCT00297440|Exercise|exercise
690606|NCT00297440|Adolescent|adolescent
690607|NCT00297440|Girls|girls
690608|NCT00297427|urinary incontinence|urinary incontinence
690609|NCT00297414|Mild Cognitive Impairment|mild cognitive impairment
690610|NCT00297414|Dementia|dementia
690611|NCT00297414|Galantamine|galantamine
690612|NCT00297414|Memory disorders|memory disorders
690613|NCT00297414|Isolated memory impairment|isolated memory impairment
690614|NCT00297414|Alzheimer's disease|alzheimer's disease
690615|NCT00297388|schizophrenia|schizophrenia
690616|NCT00297388|schizoaffective disorder|schizoaffective disorder
690617|NCT00297388|long-acting risperidone|long-acting risperidone
690618|NCT00297388|intramuscular injection risperidone|intramuscular injection risperidone
690619|NCT00297388|risperidone|risperidone
690620|NCT00297375|treatment|treatment
690621|NCT00297375|Pain|pain
690622|NCT00297375|acute|acute
690623|NCT00297375|migraine|migraine
690624|NCT00297375|headache|headache
690625|NCT00297362|Alzheimer Disease|alzheimer disease
690626|NCT00297362|Dementia|dementia
690627|NCT00297362|Brain Disease|brain disease
690628|NCT00297362|Memory Loss|memory loss
690629|NCT00297362|Caregiver|caregiver
690630|NCT00297362|Galantamine hydrobromide|galantamine hydrobromide
690631|NCT00297362|Nervous System Diseases|nervous system diseases
690632|NCT00297362|Mental Disorders|mental disorders
690633|NCT00297349|Seizures|seizures
690634|NCT00297349|Epilepsy|epilepsy
690635|NCT00297349|Tonic-clonic|tonic-clonic
690636|NCT00297349|Lennox-Gastaut Syndrome|lennox-gastaut syndrome
690637|NCT00297349|Focal Epilepsy|focal epilepsy
690638|NCT00297349|Topiramate|topiramate
690639|NCT00297349|Epilepsy in Children|epilepsy in children
690640|NCT00297336|Topiramate|topiramate
690641|NCT00297336|Migraine|migraine
690642|NCT00297336|Headache|headache
690643|NCT00297336|Chronic headache|chronic headache
690644|NCT00297336|Chronic migraine|chronic migraine
690645|NCT00297323|Seizures|seizures
690646|NCT00297323|Epilepsy|epilepsy
690647|NCT00297323|Topiramate|topiramate
690648|NCT00297323|Epilepsy in Children|epilepsy in children
690649|NCT00297310|Tacrolimus|tacrolimus
690650|NCT00297310|Kidney transplantation|kidney transplantation
690651|NCT00297310|Transplantation|transplantation
690652|NCT00297310|Kidney failure|kidney failure
690653|NCT00297310|chronic|chronic
690654|NCT00297310|P-Glycoprotein|p-glycoprotein
690655|NCT00297297|Solitary solid and scintigraphically cold thyroid nodules|solitary solid and scintigraphically cold thyroid nodules
690656|NCT00297284|systemic lupus erythematosus|systemic lupus erythematosus
690657|NCT00297284|cognitive efficiency|cognitive efficiency
690658|NCT00297284|cognitive dysfunction|cognitive dysfunction
690659|NCT00297284|cognition|cognition
690660|NCT00297284|memory|memory
690661|NCT00297284|attention|attention
690662|NCT00297284|modafinil|modafinil
690663|NCT00297284|provigil|provigil
690664|NCT00297271|Dementia|dementia
690665|NCT00297271|Mild Cognitive Impairment|mild cognitive impairment
690666|NCT00297271|Patient Registries|patient registries
690667|NCT00297271|Prospective Studies|prospective studies
690668|NCT00297271|Longitudinal Studies|longitudinal studies
690669|NCT00297271|Australia|australia
690670|NCT00297271|Cholinesterase Inhibitors|cholinesterase inhibitors
690671|NCT00297271|Observational|observational
690672|NCT00297271|Non-randomized|non-randomized
690673|NCT00297258|Sarcoma|sarcoma
690674|NCT00297258|Synovial sarcoma|synovial sarcoma
690675|NCT00297258|Pazopanib(GW786034)|pazopanib(gw786034)
690676|NCT00297258|Adipocytic tumors|adipocytic tumors
690677|NCT00297258|Leiomyosarcoma|leiomyosarcoma
690678|NCT00297258|Phase II|phase ii
690679|NCT00297245|gastrodin|gastrodin
690680|NCT00297232|Multiple Sclerosis|multiple sclerosis
690681|NCT00297232|MS|ms
690682|NCT00297219|Hemodialysis|hemodialysis
690683|NCT00297219|Coronary artery calcification|coronary artery calcification
690684|NCT00297219|Adynamic bone disease|adynamic bone disease
690685|NCT00297219|Dialysate calcium|dialysate calcium
690686|NCT00297219|Bone mineral density|bone mineral density
690687|NCT00297219|Bone histomorphometry|bone histomorphometry
690688|NCT00297206|pharmacokinetics herpes varicella herpes labialis Epstein-Barr virus|pharmacokinetics herpes varicella herpes labialis epstein-barr virus
690689|NCT00297193|Crohn's Disease|crohn's disease
690690|NCT00297193|HSCT|hsct
690691|NCT00297193|Autologous|autologous
690692|NCT00297193|EBMT|ebmt
690693|NCT00297193|ECCO|ecco
690694|NCT00297180|hunger|hunger
690695|NCT00297180|obesity|obesity
690696|NCT00297180|sodium-dependent glucose transporter|sodium-dependent glucose transporter
690697|NCT00297180|GW869682|gw869682
690698|NCT00297180|body composition|body composition
690699|NCT00297180|SGLT2 inhibitor|sglt2 inhibitor
690700|NCT00297180|weight loss|weight loss
690701|NCT00297167|CF|cf
690702|NCT00297167|Cystic Fibrosis|cystic fibrosis
690703|NCT00297167|EPI|epi
690704|NCT00297167|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
690705|NCT00297167|Pancreatic|pancreatic
690706|NCT00297167|Enzyme|enzyme
690707|NCT00297167|PEP|pep
690708|NCT00297154|Heart failure, congestive|heart failure, congestive
690709|NCT00297154|Metabolic Syndrome X|metabolic syndrome x
690710|NCT00297154|Obesity|obesity
690711|NCT00297141|Preoperative|preoperative
690712|NCT00297141|Radiochemotherapy|radiochemotherapy
690713|NCT00297141|Newly Diagnosed|newly diagnosed
690822|NCT00296777|ERP|erp
690714|NCT00297141|Primary Operable|primary operable
690715|NCT00297141|Locally Advanced|locally advanced
690716|NCT00297141|Rectal Carcinoma|rectal carcinoma
690717|NCT00297141|T3|t3
690718|NCT00297141|Lower Rectum|lower rectum
690719|NCT00297141|Middle Rectum|middle rectum
690720|NCT00297141|ABCSG|abcsg
690721|NCT00297141|TAKO|tako
690722|NCT00297141|95|95
690723|NCT00297141|05|05
690724|NCT00297128|pilot study|pilot study
690725|NCT00297128|rectal|rectal
690726|NCT00297128|cancer|cancer
690727|NCT00297128|phase II|phase ii
690728|NCT00297128|preoperative|preoperative
690729|NCT00297128|chemoradiation|chemoradiation
690730|NCT00297128|capecitabine|capecitabine
690731|NCT00297128|cetuximab|cetuximab
690732|NCT00297128|operable|operable
690733|NCT00297128|T4|t4
690734|NCT00297128|ABCSG|abcsg
690735|NCT00297128|TAKO|tako
690736|NCT00297128|R03|r03
690737|NCT00297128|96|96
690738|NCT00297128|06|06
690739|NCT00297115|Roflumilast|roflumilast
690740|NCT00297115|COPD|copd
690741|NCT00297115|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
690742|NCT00297102|Roflumilast|roflumilast
690743|NCT00297102|COPD|copd
690744|NCT00297102|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
690745|NCT00297089|Lung Cancer|lung cancer
690746|NCT00297089|ABT-751|abt-751
690747|NCT00297089|NSCLC|nsclc
690748|NCT00297089|Alimta|alimta
690749|NCT00297089|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
690750|NCT00297089|pemetrexed|pemetrexed
690751|NCT00297076|HIV-1|hiv-1
690752|NCT00297076|GW873140|gw873140
690753|NCT00297076|CCR5 antagonist|ccr5 antagonist
690754|NCT00297076|experienced|experienced
690755|NCT00297076|Treatment Experienced|treatment experienced
690756|NCT00297063|rosiglitazone|rosiglitazone
690757|NCT00297063|vandia|vandia
690758|NCT00297063|Type 2 diabetes mellitus|type 2 diabetes mellitus
690759|NCT00297063|diabetes;|diabetes;
690760|NCT00297050|Influenza Virus|influenza virus
690761|NCT00297050|Avian Influenza|avian influenza
690762|NCT00297050|Normal Volunteers|normal volunteers
690763|NCT00297050|Neuraminidase Inhibitor|neuraminidase inhibitor
690764|NCT00297050|Viral Disease|viral disease
690765|NCT00297050|Healthy Volunteer|healthy volunteer
690766|NCT00297050|HV|hv
690767|NCT00297037|oral lichen planus, pimecrolimus 1% cream|oral lichen planus, pimecrolimus 1% cream
690768|NCT00296985|Cardiac surgery|cardiac surgery
690769|NCT00296985|Cellsaver|cellsaver
690770|NCT00296985|Neurocognitive Function|neurocognitive function
690771|NCT00296985|Neuronal Protection|neuronal protection
690772|NCT00296985|Quality of Life|quality of life
690773|NCT00296972|peg interferon|peg interferon
690774|NCT00296972|ribavirin|ribavirin
690775|NCT00296972|HAART|haart
690776|NCT00296972|HIV|hiv
690777|NCT00296972|Chronic Hepatitis C|chronic hepatitis c
690778|NCT00296972|Treatment Experienced|treatment experienced
690779|NCT00296959|Dyskinesia|dyskinesia
690780|NCT00296959|AMPA receptor antagonists|ampa receptor antagonists
690781|NCT00296946|Sialorrhoea|sialorrhoea
690782|NCT00296933|Major Depression|major depression
690783|NCT00296933|Antidepressant|antidepressant
690784|NCT00296933|Pharmacotherapy|pharmacotherapy
690785|NCT00296933|Memory functioning|memory functioning
690786|NCT00296933|Memory Impairment|memory impairment
690787|NCT00296920|Deep Brain Stimulation|deep brain stimulation
690788|NCT00296920|Treatment failure|treatment failure
690789|NCT00296907|cancer|cancer
690790|NCT00296907|siblings|siblings
690791|NCT00296907|behavior|behavior
690792|NCT00296907|psychological adaptation|psychological adaptation
690793|NCT00296907|intervention|intervention
690794|NCT00296881|Periodontitis|periodontitis
690795|NCT00296881|Photodynamic Disinfection|photodynamic disinfection
690796|NCT00296881|PERIOWAVE|periowave
690797|NCT00296881|Scaling and Root Planing|scaling and root planing
690798|NCT00296881|SRP|srp
690799|NCT00296868|reflex sympathetic dystrophy|reflex sympathetic dystrophy
690800|NCT00296868|ascorbic acid|ascorbic acid
690801|NCT00296868|primary prevention|primary prevention
690802|NCT00296868|radius fractures|radius fractures
690803|NCT00296855|Peripheral artery disease|peripheral artery disease
690804|NCT00296842|posttraumatic stress disorder|posttraumatic stress disorder
690805|NCT00296842|children|children
690806|NCT00296842|injury|injury
690807|NCT00296842|road traffic accident|road traffic accident
690808|NCT00296829|Influenza;|influenza;
690809|NCT00296829|Orthomyxoviruses;|orthomyxoviruses;
690810|NCT00296829|Inactivated Split-virion influenza vaccine;|inactivated split-virion influenza vaccine;
690811|NCT00296829|Elderly.|elderly.
690812|NCT00296803|metabolic syndrome|metabolic syndrome
690813|NCT00296777|Major Depression|major depression
690814|NCT00296777|Dysthymia|dysthymia
690815|NCT00296777|f-MRI|f-mri
690816|NCT00296777|Escitalopram|escitalopram
690817|NCT00296777|Bupropion|bupropion
690818|NCT00296777|Imipramine|imipramine
690819|NCT00296777|Neuropsychologic test|neuropsychologic test
690820|NCT00296777|Dichotic listening|dichotic listening
690821|NCT00296777|EEG|eeg
690823|NCT00296764|Happy Puppet Syndrome|happy puppet syndrome
690824|NCT00296764|Developmental Disorders|developmental disorders
690825|NCT00296725|Major Depression|major depression
690826|NCT00296725|Dysthymia|dysthymia
690827|NCT00296725|Depression NOS|depression nos
690828|NCT00296725|Dichotic Listening|dichotic listening
690829|NCT00296725|Fluoxetine|fluoxetine
690830|NCT00296725|Imipramine|imipramine
690831|NCT00296725|Placebo|placebo
690832|NCT00296725|Predictors|predictors
690833|NCT00296712|Major Depression|major depression
690834|NCT00296712|Dysthymia|dysthymia
690835|NCT00296712|Depression NOS|depression nos
690836|NCT00296712|Escitalopram|escitalopram
690837|NCT00296712|Bupropion|bupropion
690838|NCT00296712|Dual Therapy|dual therapy
690839|NCT00296712|Combination Therapy|combination therapy
690840|NCT00296699|Atypical Depression|atypical depression
690841|NCT00296699|Major Depressive Disorder|major depressive disorder
690842|NCT00296699|Dysthymic Disorder|dysthymic disorder
690843|NCT00296699|Atypical Features|atypical features
690844|NCT00296699|Duloxetine|duloxetine
690845|NCT00296686|Major Depression|major depression
690846|NCT00296686|Refractory Depression|refractory depression
690847|NCT00296686|Tranylcypromine|tranylcypromine
690848|NCT00296686|Dextroamphetamine|dextroamphetamine
690849|NCT00296686|Triiodothyronine|triiodothyronine
690850|NCT00296673|Rehabilitation, Side Bridge test, Muscular endurance|rehabilitation, side bridge test, muscular endurance
690851|NCT00296660|Acute Infection|acute infection
690852|NCT00296634|H5N1, Influenza, vaccine|h5n1, influenza, vaccine
690853|NCT00296621|glutamine|glutamine
690854|NCT00296621|nutrition|nutrition
690855|NCT00296621|children|children
690856|NCT00296621|pediatrics|pediatrics
690857|NCT00296621|randomized controlled clinical trial|randomized controlled clinical trial
690858|NCT00296621|therapy|therapy
690859|NCT00296621|supplement|supplement
690860|NCT00296621|oral administration|oral administration
690861|NCT00296621|handicap|handicap
690862|NCT00296608|stage II rectal cancer|stage ii rectal cancer
690863|NCT00296608|stage III rectal cancer|stage iii rectal cancer
690864|NCT00296608|adenocarcinoma of the rectum|adenocarcinoma of the rectum
690865|NCT00296556|Ulcerative colitis|ulcerative colitis
690866|NCT00296556|EP4 agonist|ep4 agonist
690867|NCT00296556|PGE2|pge2
690868|NCT00296543|hemodialysis|hemodialysis
690869|NCT00296543|sudden cardiac death|sudden cardiac death
690870|NCT00296530|Asthma|asthma
690871|NCT00296530|Allergic Rhinitis|allergic rhinitis
690872|NCT00296517|depression|depression
690873|NCT00296517|double-blind|double-blind
690874|NCT00296517|placebo-controlled|placebo-controlled
690875|NCT00296517|bupropion hydrochloride|bupropion hydrochloride
690876|NCT00296517|SSRI|ssri
690877|NCT00296517|comparative study|comparative study
690878|NCT00296517|non-responder|non-responder
690879|NCT00296504|antiretroviral therapy naive subjects|antiretroviral therapy naive subjects
690880|NCT00296504|fosamprenavir|fosamprenavir
690881|NCT00296504|HIV-1|hiv-1
690882|NCT00296504|protease inhibitor|protease inhibitor
690883|NCT00296504|pro-drug|pro-drug
690884|NCT00296504|antiretroviral therapy|antiretroviral therapy
690885|NCT00296504|LEXIVA|lexiva
690886|NCT00296504|AGENERASE|agenerase
690887|NCT00296504|GW433908|gw433908
690888|NCT00296504|amprenavir|amprenavir
690889|NCT00296491|Allergic Rhinitis|allergic rhinitis
690890|NCT00296491|Asthma|asthma
690891|NCT00296452|cancer|cancer
690892|NCT00296452|nutrition|nutrition
690893|NCT00296426|Adverse Drug Event|adverse drug event
690894|NCT00296426|Inpatients|inpatients
690895|NCT00296426|Outcome assessment|outcome assessment
690896|NCT00296413|epilepsy|epilepsy
690897|NCT00296413|menstrual cycle|menstrual cycle
690898|NCT00296413|valproate|valproate
690899|NCT00296413|lamotrigine|lamotrigine
690900|NCT00296413|oral contraceptive|oral contraceptive
690901|NCT00296400|Hyperlipidemia|hyperlipidemia
690902|NCT00296400|Proteinuria|proteinuria
690903|NCT00296400|Diabetes Mellitus|diabetes mellitus
690904|NCT00296374|Hyperlipidemia|hyperlipidemia
690905|NCT00296374|Proteinuria|proteinuria
690906|NCT00296374|Diabetes Mellitus|diabetes mellitus
690907|NCT00296361|Tacrolimus|tacrolimus
690908|NCT00296361|Kidney Transplantation|kidney transplantation
690909|NCT00296361|Immunosuppression|immunosuppression
690910|NCT00296361|Adult|adult
690911|NCT00296361|Treatment Outcomes|treatment outcomes
690912|NCT00296348|Tacrolimus|tacrolimus
690913|NCT00296348|Kidney Transplantation|kidney transplantation
690914|NCT00296348|Child|child
690915|NCT00296348|Treatment Outcome|treatment outcome
690916|NCT00296348|Immunosuppression|immunosuppression
690917|NCT00296335|Stomach cancer|stomach cancer
690918|NCT00296335|Adjuvant chemotherapy|adjuvant chemotherapy
690919|NCT00296335|Mitomycin|mitomycin
690920|NCT00296335|Cisplatin|cisplatin
690921|NCT00296335|Doxifluridine|doxifluridine
690922|NCT00296322|stomach cancer|stomach cancer
690923|NCT00296322|adjuvant chemotherapy|adjuvant chemotherapy
690924|NCT00296322|mitomycin|mitomycin
690925|NCT00296322|cisplatin|cisplatin
690926|NCT00296322|doxifluridine|doxifluridine
690928|NCT00296309|Kidney Transplantation|kidney transplantation
690929|NCT00296309|Immunosuppression|immunosuppression
690930|NCT00296309|Adult|adult
690931|NCT00296309|Treatment Outcomes|treatment outcomes
690932|NCT00296296|kidney Transplant|kidney transplant
690933|NCT00296296|Type II Diabetes|type ii diabetes
690934|NCT00296296|Diabetic Nephropathy|diabetic nephropathy
690935|NCT00296296|Immunosuppression|immunosuppression
690936|NCT00296296|Cyclosporin|cyclosporin
690937|NCT00296296|Tacrolimus|tacrolimus
690938|NCT00296283|Relatives|relatives
690939|NCT00296283|Bipolar Disorder|bipolar disorder
690940|NCT00296283|Psychoeducation|psychoeducation
690941|NCT00296244|steroid-free immunosuppression|steroid-free immunosuppression
690942|NCT00296244|liver transplantation|liver transplantation
690943|NCT00296231|premature infants|premature infants
690944|NCT00296231|very low birthweight infants|very low birthweight infants
690945|NCT00296231|high frequency ventilation|high frequency ventilation
690946|NCT00296231|nasal ventilation|nasal ventilation
690947|NCT00296205|Multiple Sclerosis|multiple sclerosis
690948|NCT00296205|Cyclophosphamide|cyclophosphamide
690949|NCT00296205|autoimmune|autoimmune
690950|NCT00296192|Rotigotine|rotigotine
690951|NCT00296192|Rotigotine nasal spray|rotigotine nasal spray
690952|NCT00296192|Efficacy, safety and tolerability|efficacy, safety and tolerability
690953|NCT00296192|Parkinson's disease|parkinson's disease
690954|NCT00296166|Atrial fibrillation|atrial fibrillation
690955|NCT00296166|Permanent Atrial fibrillation|permanent atrial fibrillation
690956|NCT00296166|catheter ablation|catheter ablation
690957|NCT00296166|thoracoscopy|thoracoscopy
690958|NCT00296166|Arrhythmia|arrhythmia
690959|NCT00296166|Heart|heart
690960|NCT00296153|Human immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
690961|NCT00296153|Highly Active Antiviral Therapy (HAART)|highly active antiviral therapy (haart)
690962|NCT00296153|Ischemic Heart Disease|ischemic heart disease
690963|NCT00296153|OMACOR|omacor
690964|NCT00296153|Triglycerides|triglycerides
690965|NCT00296153|Endothelial function|endothelial function
690966|NCT00296153|Treatment Experienced|treatment experienced
690967|NCT00296140|post-stroke depression|post-stroke depression
690968|NCT00296140|clinical reminder|clinical reminder
690969|NCT00296140|self-management|self-management
690970|NCT00296114|Cancer|cancer
690971|NCT00296114|Pancreas|pancreas
690972|NCT00296101|Physical Inactivity|physical inactivity
690973|NCT00296088|Mechanical Ventilation|mechanical ventilation
690974|NCT00296088|Critical Care|critical care
690975|NCT00296088|Respiratory Failure|respiratory failure
690976|NCT00296062|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
690977|NCT00296062|stage III colon cancer|stage iii colon cancer
690978|NCT00296062|stage IV colon cancer|stage iv colon cancer
690979|NCT00296062|stage III rectal cancer|stage iii rectal cancer
690980|NCT00296062|stage IV rectal cancer|stage iv rectal cancer
690981|NCT00296062|recurrent colon cancer|recurrent colon cancer
690982|NCT00296062|recurrent rectal cancer|recurrent rectal cancer
690983|NCT00296049|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
690984|NCT00296049|infection|infection
690985|NCT00296049|neutropenia|neutropenia
690986|NCT00296049|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
690987|NCT00296036|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
690988|NCT00296036|stage I breast cancer|stage i breast cancer
690989|NCT00296036|stage II breast cancer|stage ii breast cancer
690990|NCT00296036|stage IIIA breast cancer|stage iiia breast cancer
690991|NCT00296036|stage IIIB breast cancer|stage iiib breast cancer
690992|NCT00296036|stage IIIC breast cancer|stage iiic breast cancer
690993|NCT00296036|stage IV breast cancer|stage iv breast cancer
690994|NCT00296036|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
690995|NCT00296023|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
690996|NCT00296023|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
690997|NCT00296023|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
690998|NCT00296023|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
690999|NCT00296023|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
691000|NCT00296023|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
691001|NCT00296023|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
691002|NCT00296023|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
691003|NCT00296023|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
691004|NCT00296023|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
691005|NCT00296023|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
691006|NCT00296023|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
691007|NCT00296023|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
691008|NCT00296023|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
691009|NCT00296023|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
691010|NCT00296023|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
691011|NCT00296023|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
691012|NCT00296023|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
691013|NCT00296023|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
691014|NCT00296023|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
691015|NCT00296023|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
691016|NCT00296023|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
691017|NCT00296023|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
691018|NCT00296023|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
691019|NCT00296023|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
691020|NCT00296023|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
691021|NCT00296023|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
691022|NCT00296023|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
691023|NCT00296023|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
691024|NCT00296023|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
691025|NCT00296023|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
691026|NCT00296023|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
691027|NCT00296023|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
691028|NCT00296023|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
691029|NCT00296023|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
691030|NCT00296023|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
691031|NCT00296023|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
691032|NCT00296023|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
691033|NCT00296023|splenic marginal zone lymphoma|splenic marginal zone lymphoma
691034|NCT00296023|stage II multiple myeloma|stage ii multiple myeloma
691035|NCT00296023|stage III multiple myeloma|stage iii multiple myeloma
691036|NCT00296023|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
691037|NCT00296023|primary myelofibrosis|primary myelofibrosis
691038|NCT00296023|polycythemia vera|polycythemia vera
691039|NCT00296023|prolymphocytic leukemia|prolymphocytic leukemia
691040|NCT00296023|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
691041|NCT00296023|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
691042|NCT00296023|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
691043|NCT00296023|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
691044|NCT00296023|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
691045|NCT00296023|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
691046|NCT00296023|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
691047|NCT00296023|refractory anemia with excess blasts|refractory anemia with excess blasts
691048|NCT00296023|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
691049|NCT00296023|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
691050|NCT00296023|secondary acute myeloid leukemia|secondary acute myeloid leukemia
691051|NCT00296023|Waldenström macroglobulinemia|waldenström macroglobulinemia
691052|NCT00296023|essential thrombocythemia|essential thrombocythemia
691053|NCT00296023|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
691054|NCT00296023|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
691055|NCT00296023|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
691056|NCT00296023|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
691057|NCT00296023|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
691058|NCT00296023|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
691059|NCT00296023|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
691060|NCT00296023|stage I multiple myeloma|stage i multiple myeloma
691061|NCT00296010|stage I breast cancer|stage i breast cancer
691062|NCT00296010|stage II breast cancer|stage ii breast cancer
691063|NCT00296010|stage IIIA breast cancer|stage iiia breast cancer
691064|NCT00295997|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
691065|NCT00295997|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
691066|NCT00295997|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
691067|NCT00295997|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
691068|NCT00295997|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
691069|NCT00295997|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
691070|NCT00295997|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
691071|NCT00295997|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
691072|NCT00295997|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
691139|NCT00295958|recurrent melanoma|recurrent melanoma
691073|NCT00295997|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
691074|NCT00295997|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
691075|NCT00295997|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
691076|NCT00295997|chronic eosinophilic leukemia|chronic eosinophilic leukemia
691077|NCT00295997|primary myelofibrosis|primary myelofibrosis
691078|NCT00295997|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
691079|NCT00295997|chronic neutrophilic leukemia|chronic neutrophilic leukemia
691080|NCT00295997|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
691081|NCT00295997|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
691082|NCT00295997|essential thrombocythemia|essential thrombocythemia
691083|NCT00295997|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
691084|NCT00295997|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
691085|NCT00295997|polycythemia vera|polycythemia vera
691086|NCT00295997|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
691087|NCT00295997|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
691088|NCT00295997|prolymphocytic leukemia|prolymphocytic leukemia
691089|NCT00295997|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
691090|NCT00295997|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
691091|NCT00295997|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
691092|NCT00295997|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
691093|NCT00295997|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
691094|NCT00295997|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
691095|NCT00295997|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
691096|NCT00295997|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
691097|NCT00295997|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
691098|NCT00295997|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
691099|NCT00295997|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
691100|NCT00295997|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
691101|NCT00295997|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
691102|NCT00295997|refractory multiple myeloma|refractory multiple myeloma
691103|NCT00295997|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
691104|NCT00295997|secondary acute myeloid leukemia|secondary acute myeloid leukemia
691105|NCT00295997|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
691106|NCT00295997|stage II multiple myeloma|stage ii multiple myeloma
691107|NCT00295997|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
691108|NCT00295997|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
691109|NCT00295997|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
691110|NCT00295997|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
691111|NCT00295997|stage III multiple myeloma|stage iii multiple myeloma
691112|NCT00295997|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
691113|NCT00295997|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
691114|NCT00295997|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
691115|NCT00295997|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
691116|NCT00295997|recurrent renal cell cancer|recurrent renal cell cancer
691117|NCT00295997|stage IV renal cell cancer|stage iv renal cell cancer
691118|NCT00295997|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
691119|NCT00295997|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
691120|NCT00295997|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
691121|NCT00295997|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
691122|NCT00295997|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
691123|NCT00295984|classic Kaposi sarcoma|classic kaposi sarcoma
691124|NCT00295984|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
691125|NCT00295971|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
691126|NCT00295971|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
691127|NCT00295971|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
691128|NCT00295971|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
691129|NCT00295971|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
691130|NCT00295971|secondary acute myeloid leukemia|secondary acute myeloid leukemia
691131|NCT00295971|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
691132|NCT00295971|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
691133|NCT00295971|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
691134|NCT00295971|refractory anemia with excess blasts|refractory anemia with excess blasts
691135|NCT00295971|severe congenital neutropenia|severe congenital neutropenia
691136|NCT00295971|congenital amegakaryocytic thrombocytopenia|congenital amegakaryocytic thrombocytopenia
691137|NCT00295971|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
691138|NCT00295971|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
691475|NCT00295100|Tamoxifen|tamoxifen
691140|NCT00295958|stage IV melanoma|stage iv melanoma
691141|NCT00295958|skin cancer|skin cancer
691142|NCT00295945|pain|pain
691143|NCT00295945|perioperative/postoperative complications|perioperative/postoperative complications
691144|NCT00295945|stage III cervical cancer|stage iii cervical cancer
691145|NCT00295945|recurrent cervical cancer|recurrent cervical cancer
691146|NCT00295945|stage IB cervical cancer|stage ib cervical cancer
691147|NCT00295945|stage IIB cervical cancer|stage iib cervical cancer
691148|NCT00295945|stage IVB cervical cancer|stage ivb cervical cancer
691149|NCT00295945|stage IA cervical cancer|stage ia cervical cancer
691150|NCT00295945|stage IIA cervical cancer|stage iia cervical cancer
691151|NCT00295945|stage IVA cervical cancer|stage iva cervical cancer
691152|NCT00295945|stage I endometrial carcinoma|stage i endometrial carcinoma
691153|NCT00295945|stage II endometrial carcinoma|stage ii endometrial carcinoma
691154|NCT00295945|stage III endometrial carcinoma|stage iii endometrial carcinoma
691155|NCT00295945|stage IV endometrial carcinoma|stage iv endometrial carcinoma
691156|NCT00295945|recurrent endometrial carcinoma|recurrent endometrial carcinoma
691157|NCT00295945|stage I uterine sarcoma|stage i uterine sarcoma
691158|NCT00295945|stage II uterine sarcoma|stage ii uterine sarcoma
691159|NCT00295945|stage III uterine sarcoma|stage iii uterine sarcoma
691160|NCT00295945|stage IV uterine sarcoma|stage iv uterine sarcoma
691161|NCT00295945|recurrent uterine sarcoma|recurrent uterine sarcoma
691162|NCT00295945|ovarian sarcoma|ovarian sarcoma
691163|NCT00295945|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
691164|NCT00295945|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
691165|NCT00295945|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
691166|NCT00295945|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
691167|NCT00295945|ovarian stromal cancer|ovarian stromal cancer
691168|NCT00295945|recurrent fallopian tube cancer|recurrent fallopian tube cancer
691169|NCT00295945|stage IA fallopian tube cancer|stage ia fallopian tube cancer
691170|NCT00295945|stage IB fallopian tube cancer|stage ib fallopian tube cancer
691171|NCT00295945|stage IC fallopian tube cancer|stage ic fallopian tube cancer
691172|NCT00295945|stage IIA fallopian tube cancer|stage iia fallopian tube cancer
691173|NCT00295945|stage IIB fallopian tube cancer|stage iib fallopian tube cancer
691174|NCT00295945|stage IIC fallopian tube cancer|stage iic fallopian tube cancer
691175|NCT00295945|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
691176|NCT00295945|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
691177|NCT00295945|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
691178|NCT00295945|stage IV fallopian tube cancer|stage iv fallopian tube cancer
691179|NCT00295945|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
691180|NCT00295945|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
691181|NCT00295945|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
691182|NCT00295945|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
691183|NCT00295945|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
691184|NCT00295945|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
691185|NCT00295945|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
691186|NCT00295945|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
691187|NCT00295945|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
691188|NCT00295945|stage IA ovarian germ cell tumor|stage ia ovarian germ cell tumor
691189|NCT00295945|stage IB ovarian germ cell tumor|stage ib ovarian germ cell tumor
691190|NCT00295945|stage IC ovarian germ cell tumor|stage ic ovarian germ cell tumor
691191|NCT00295945|stage IIA ovarian germ cell tumor|stage iia ovarian germ cell tumor
691192|NCT00295945|stage IIB ovarian germ cell tumor|stage iib ovarian germ cell tumor
691193|NCT00295945|stage IIC ovarian germ cell tumor|stage iic ovarian germ cell tumor
691194|NCT00295945|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
691195|NCT00295945|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
691196|NCT00295945|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
691197|NCT00295932|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
691198|NCT00295932|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
691199|NCT00295932|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
691200|NCT00295932|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
691201|NCT00295932|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
691202|NCT00295932|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
691203|NCT00295932|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
691204|NCT00295932|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
691205|NCT00295932|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
691206|NCT00295932|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
691207|NCT00295932|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
691208|NCT00295932|splenic marginal zone lymphoma|splenic marginal zone lymphoma
691209|NCT00295919|recurrent neuroblastoma|recurrent neuroblastoma
691210|NCT00295906|melanoma|melanoma
691211|NCT00295906|skin cancer|skin cancer
691212|NCT00295893|inflammatory breast cancer|inflammatory breast cancer
691213|NCT00295893|stage II breast cancer|stage ii breast cancer
691214|NCT00295893|stage IIIA breast cancer|stage iiia breast cancer
691215|NCT00295893|stage IIIB breast cancer|stage iiib breast cancer
691216|NCT00295893|stage IIIC breast cancer|stage iiic breast cancer
691217|NCT00295893|male breast cancer|male breast cancer
691218|NCT00295893|Paget disease of the breast with invasive ductal carcinoma|paget disease of the breast with invasive ductal carcinoma
691219|NCT00295893|invasive ductal breast carcinoma with predominant intraductal component|invasive ductal breast carcinoma with predominant intraductal component
691220|NCT00295893|invasive ductal breast carcinoma|invasive ductal breast carcinoma
691221|NCT00295893|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
691222|NCT00295893|comedo ductal breast carcinoma|comedo ductal breast carcinoma
691223|NCT00295893|invasive lobular breast carcinoma with predominant in situ component|invasive lobular breast carcinoma with predominant in situ component
691224|NCT00295893|invasive lobular breast carcinoma|invasive lobular breast carcinoma
691225|NCT00295893|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
691226|NCT00295893|papillary ductal breast carcinoma|papillary ductal breast carcinoma
691227|NCT00295893|tubular ductal breast carcinoma|tubular ductal breast carcinoma
691228|NCT00295880|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
691229|NCT00295880|adult acute myeloid leukemia|adult acute myeloid leukemia
691230|NCT00295880|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
691231|NCT00295880|secondary acute myeloid leukemia|secondary acute myeloid leukemia
691232|NCT00295880|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
691233|NCT00295880|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
691234|NCT00295880|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
691235|NCT00295880|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
691236|NCT00295880|refractory anemia with excess blasts|refractory anemia with excess blasts
691237|NCT00295880|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
691238|NCT00295880|myelodysplastic syndromes|myelodysplastic syndromes
691239|NCT00295880|adult diffuse large cell lymphoma|adult diffuse large cell lymphoma
691240|NCT00295880|adult diffuse mixed cell lymphoma|adult diffuse mixed cell lymphoma
691241|NCT00295880|adult diffuse small cleaved cell lymphoma|adult diffuse small cleaved cell lymphoma
691242|NCT00295880|adult lymphoblastic lymphoma|adult lymphoblastic lymphoma
691243|NCT00295880|grade 3 follicular lymphoma|grade 3 follicular lymphoma
691244|NCT00295880|mantle cell lymphoma|mantle cell lymphoma
691245|NCT00295880|childhood large cell lymphoma|childhood large cell lymphoma
691246|NCT00295880|childhood lymphoblastic lymphoma|childhood lymphoblastic lymphoma
691247|NCT00295880|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
691248|NCT00295880|acute lymphoblastic leukemia|acute lymphoblastic leukemia
691249|NCT00295880|refractory anemia|refractory anemia
691250|NCT00295880|refractory cytopenia|refractory cytopenia
691251|NCT00295880|childhood acute myeloid leukemia|childhood acute myeloid leukemia
691252|NCT00295880|adult immunoblastic large cell lymphoma|adult immunoblastic large cell lymphoma
691253|NCT00295880|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
691254|NCT00295880|chronic eosinophilic leukemia|chronic eosinophilic leukemia
691255|NCT00295880|chronic neutrophilic leukemia|chronic neutrophilic leukemia
691256|NCT00295880|childhood small noncleaved cell lymphoma|childhood small noncleaved cell lymphoma
691257|NCT00295880|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
691258|NCT00295867|stage I breast cancer|stage i breast cancer
691259|NCT00295867|stage II breast cancer|stage ii breast cancer
691260|NCT00295867|stage IIIA breast cancer|stage iiia breast cancer
691261|NCT00295867|stage IIIB breast cancer|stage iiib breast cancer
691262|NCT00295867|stage IIIC breast cancer|stage iiic breast cancer
691263|NCT00295854|Interstitial Cystitis|interstitial cystitis
691264|NCT00295854|urgency|urgency
691265|NCT00295854|frequency|frequency
691266|NCT00295854|MN-001|mn-001
691267|NCT00295854|Global Response Assessment|global response assessment
691268|NCT00295854|bladder pain/urgency|bladder pain/urgency
691269|NCT00295854|O'Leary Sant IC Symptom and Problem Index|o'leary sant ic symptom and problem index
691270|NCT00295841|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
691271|NCT00295841|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
691272|NCT00295841|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
691273|NCT00295841|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
691274|NCT00295841|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
691275|NCT00295841|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
691276|NCT00295841|adult acute basophilic leukemia|adult acute basophilic leukemia
691277|NCT00295841|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
691278|NCT00295841|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
691279|NCT00295841|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
691280|NCT00295841|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
691281|NCT00295841|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
691282|NCT00295841|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
691283|NCT00295841|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
691476|NCT00295100|Prevention|prevention
691284|NCT00295841|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
691285|NCT00295841|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
691286|NCT00295841|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
691287|NCT00295828|VEGF|vegf
691288|NCT00295828|iris neovascularization|iris neovascularization
691289|NCT00295828|diabetic retinopathy|diabetic retinopathy
691290|NCT00295828|Macugen|macugen
691291|NCT00295802|Prostate Cancer|prostate cancer
691292|NCT00295802|HIFU|hifu
691293|NCT00295802|EDAP|edap
691294|NCT00295802|Low Risk, Localized Prostate Cancer|low risk, localized prostate cancer
691295|NCT00295789|cervical cancer|cervical cancer
691296|NCT00295789|palliative chemotherapy|palliative chemotherapy
691297|NCT00295789|recurrent|recurrent
691298|NCT00295789|persistent|persistent
691299|NCT00295789|stageⅣb|stageⅳb
691300|NCT00295789|cisplatin|cisplatin
691301|NCT00295789|carboplatin|carboplatin
691302|NCT00295789|paclitaxel|paclitaxel
691303|NCT00295776|Inclusion Criteria:Minimum of 4 on the Likert Pain Scale.If currently taking TCA and/or Gabapentin, need to have been on stable dose for minimum of 4 weeks.|inclusion criteria:minimum of 4 on the likert pain scale.if currently taking tca and/or gabapentin, need to have been on stable dose for minimum of 4 weeks.
691304|NCT00295776|Exclusion Criteria:|exclusion criteria:
691305|NCT00295776|Currently on any antiepilepic drugs (AED), except for Gabapentin.|currently on any antiepilepic drugs (aed), except for gabapentin.
691306|NCT00295776|Currently taking opioid or unwilling to washout prior to the study,|currently taking opioid or unwilling to washout prior to the study,
691307|NCT00295776|Pregnant and lactating,|pregnant and lactating,
691308|NCT00295776|Have active severe systemic disease,|have active severe systemic disease,
691309|NCT00295776|History of Stevens-Johnson syndrome or TEN,|history of stevens-johnson syndrome or ten,
691310|NCT00295763|papillary thyroid cancer|papillary thyroid cancer
691311|NCT00295763|follicular thyroid cancer|follicular thyroid cancer
691312|NCT00295763|recombinant human TSH|recombinant human tsh
691313|NCT00295763|Thyrogen|thyrogen
691314|NCT00295763|thyroid stimulating hormone|thyroid stimulating hormone
691315|NCT00295763|thyroid remnant ablation|thyroid remnant ablation
691316|NCT00295763|radioiodine|radioiodine
691317|NCT00295750|Prostate Cancer|prostate cancer
691318|NCT00295737|allergic rhinitis|allergic rhinitis
691319|NCT00295724|bicifadine|bicifadine
691320|NCT00295724|chronic low back pain|chronic low back pain
691321|NCT00295711|bicifadine|bicifadine
691322|NCT00295711|chronic low back pain|chronic low back pain
691323|NCT00295698|HIV|hiv
691324|NCT00295698|Lymphatic filariasis|lymphatic filariasis
691325|NCT00295698|Diethylcarbamazine|diethylcarbamazine
691326|NCT00295698|Interaction|interaction
691327|NCT00295698|Tanzania|tanzania
691328|NCT00295685|Reflux|reflux
691329|NCT00295685|GERD|gerd
691330|NCT00295672|Non-Small-Cell Lung,radiotherapy, Chemotherapy, vinorelbine|non-small-cell lung,radiotherapy, chemotherapy, vinorelbine
691331|NCT00295659|Gestational Diabetes|gestational diabetes
691332|NCT00295659|Screening|screening
691333|NCT00295659|Cost-effectiveness|cost-effectiveness
691334|NCT00295659|obstetrical outcomes|obstetrical outcomes
691335|NCT00295646|ABCSG|abcsg
691336|NCT00295646|12|12
691337|NCT00295646|Phase 3|phase 3
691338|NCT00295646|breast cancer|breast cancer
691339|NCT00295646|anastrozole|anastrozole
691340|NCT00295646|tamoxifen|tamoxifen
691341|NCT00295646|zoledronic acid|zoledronic acid
691342|NCT00295646|premenopausal|premenopausal
691343|NCT00295646|hormone receptor-positive|hormone receptor-positive
691344|NCT00295646|Stage I|stage i
691345|NCT00295646|Stage II|stage ii
691346|NCT00295646|bone mineral density|bone mineral density
691347|NCT00295646|BMD|bmd
691348|NCT00295646|bisphosphonate|bisphosphonate
691349|NCT00295646|zoledronate|zoledronate
691350|NCT00295620|Hormone receptor positive breast cancer|hormone receptor positive breast cancer
691351|NCT00295607|Tacrolimus|tacrolimus
691352|NCT00295607|Liver Transplantation|liver transplantation
691353|NCT00295607|Immunosuppression|immunosuppression
691354|NCT00295607|Adult|adult
691355|NCT00295607|Treatment Outcome|treatment outcome
691356|NCT00295594|Tacrolimus|tacrolimus
691357|NCT00295594|Liver Transplantation|liver transplantation
691358|NCT00295594|Treatment Outcome|treatment outcome
691359|NCT00295594|Immunosuppression|immunosuppression
691360|NCT00295581|Human|human
691361|NCT00295581|Clinical Trial|clinical trial
691362|NCT00295581|Mosquito|mosquito
691363|NCT00295581|Healthy Volunteer|healthy volunteer
691364|NCT00295581|HV|hv
691365|NCT00295568|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
691366|NCT00295568|Motor Learning|motor learning
691367|NCT00295568|Accuracy|accuracy
691368|NCT00295568|Tracking Motor Task|tracking motor task
691369|NCT00295568|Healthy Volunteer|healthy volunteer
691370|NCT00295568|HV|hv
691371|NCT00295555|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
691372|NCT00295555|doxazosin|doxazosin
691373|NCT00295555|alpha1-adrenergic antagonists|alpha1-adrenergic antagonists
691374|NCT00295555|sympathetic nervous activity|sympathetic nervous activity
691375|NCT00295555|diabetic nephropathy|diabetic nephropathy
691376|NCT00295555|essential hypertension|essential hypertension
691377|NCT00295555|power spectral analysis|power spectral analysis
691378|NCT00295555|morning surge|morning surge
691505|NCT00294918|Serostim®|serostim®
691379|NCT00295542|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
691380|NCT00295542|cardiovascular risk|cardiovascular risk
691381|NCT00295542|chronotherapy|chronotherapy
691382|NCT00295542|circadian pattern|circadian pattern
691383|NCT00295529|Primary health care|primary health care
691384|NCT00295529|Breast neoplasm|breast neoplasm
691385|NCT00295529|Education|education
691386|NCT00295516|Rhesus|rhesus
691387|NCT00295516|Isoimmunization|isoimmunization
691388|NCT00295516|Red Cell Alloimmunization|red cell alloimmunization
691389|NCT00295516|Fetal Hemolytic Anemia|fetal hemolytic anemia
691390|NCT00295516|Erythroblastosis fetalis|erythroblastosis fetalis
691391|NCT00295503|mesothelioma|mesothelioma
691392|NCT00295503|bevacizumab|bevacizumab
691393|NCT00295503|chemotherapy|chemotherapy
691394|NCT00295490|double blind randomised controlled trial|double blind randomised controlled trial
691395|NCT00295490|phase II|phase ii
691396|NCT00295490|Devil's Claw|devil's claw
691397|NCT00295490|osteoarthritis of the knee|osteoarthritis of the knee
691398|NCT00295490|osteoarthritis of the hip|osteoarthritis of the hip
691399|NCT00295477|HIV|hiv
691400|NCT00295477|Treatment Experienced|treatment experienced
691401|NCT00295464|Antenatal glucocorticoid|antenatal glucocorticoid
691402|NCT00295464|Premature birth|premature birth
691403|NCT00295438|robot-based tele-echography|robot-based tele-echography
691404|NCT00295438|tele-medicine|tele-medicine
691405|NCT00295425|psoriasis|psoriasis
691406|NCT00295425|randomized clinical trial|randomized clinical trial
691407|NCT00295425|cyclosporine A|cyclosporine a
691408|NCT00295425|mycophenolate mofetil|mycophenolate mofetil
691409|NCT00295425|immunosuppression|immunosuppression
691410|NCT00295399|cerebrovascular accident|cerebrovascular accident
691411|NCT00295399|traumatic brain injury|traumatic brain injury
691412|NCT00295399|stroke|stroke
691413|NCT00295399|telerehabilitation|telerehabilitation
691414|NCT00295373|Hypercholesterolemia|hypercholesterolemia
691415|NCT00295373|Exercise|exercise
691416|NCT00295373|Statin|statin
691417|NCT00295373|Rosuvastatin|rosuvastatin
691418|NCT00295373|TLR4|tlr4
691419|NCT00295373|Inflammation|inflammation
691420|NCT00295360|cholestasis|cholestasis
691421|NCT00295360|BCRP|bcrp
691422|NCT00295360|multidrug resistance|multidrug resistance
691423|NCT00295360|duodenum|duodenum
691424|NCT00295360|bile acids|bile acids
691425|NCT00295360|ABCG2|abcg2
691426|NCT00295334|adherence|adherence
691427|NCT00295334|glycemic control|glycemic control
691428|NCT00295308|Opioid Dependence|opioid dependence
691429|NCT00295308|Clonidine|clonidine
691430|NCT00295308|Buprenorphine|buprenorphine
691431|NCT00295308|Opioid Abstinence|opioid abstinence
691432|NCT00295308|Relapse|relapse
691433|NCT00295295|vibration|vibration
691434|NCT00295295|bone density|bone density
691435|NCT00295282|Ulcerative Colitis|ulcerative colitis
691436|NCT00295282|UC|uc
691437|NCT00295282|Colitis|colitis
691438|NCT00295256|randomized trial|randomized trial
691439|NCT00295256|diabetes|diabetes
691440|NCT00295256|pregnancy|pregnancy
691441|NCT00295230|respiratory distress syndrome|respiratory distress syndrome
691442|NCT00295230|very low birth weight infant|very low birth weight infant
691443|NCT00295230|mechanical ventilation|mechanical ventilation
691444|NCT00295217|Fibroids|fibroids
691445|NCT00295217|Uterine Leiomyomas|uterine leiomyomas
691446|NCT00295217|ExAblate|exablate
691447|NCT00295217|MrgFUS|mrgfus
691448|NCT00295204|Syncope|syncope
691449|NCT00295204|pre-syncope|pre-syncope
691450|NCT00295204|palpitations|palpitations
691451|NCT00295191|end-stage renal disease|end-stage renal disease
691452|NCT00295191|hemodialysis|hemodialysis
691453|NCT00295191|cardiovascular morbidity and mortality|cardiovascular morbidity and mortality
691454|NCT00295191|high flux dialyser|high flux dialyser
691455|NCT00295191|ultrapure dialysate|ultrapure dialysate
691456|NCT00295191|coronary vascular calcifications|coronary vascular calcifications
691457|NCT00295191|carotid intima-media thickness|carotid intima-media thickness
691458|NCT00295191|atherosclerosis|atherosclerosis
691459|NCT00295152|elderly/aged|elderly/aged
691460|NCT00295152|occupational therapy|occupational therapy
691461|NCT00295152|daily activities|daily activities
691462|NCT00295152|caregivers|caregivers
691463|NCT00295152|sense of competence|sense of competence
691464|NCT00295139|treatment|treatment
691465|NCT00295139|dual diagnosis|dual diagnosis
691466|NCT00295126|Edentulous|edentulous
691467|NCT00295126|Tooth Loss|tooth loss
691468|NCT00295126|APC|apc
691469|NCT00295126|Autologous platelet concentrate|autologous platelet concentrate
691470|NCT00295113|Pulmonary arterial pressure|pulmonary arterial pressure
691471|NCT00295113|COPD|copd
691472|NCT00295113|Cardiac output|cardiac output
691473|NCT00295113|pulmonary and cardiac functions|pulmonary and cardiac functions
691474|NCT00295113|pulmonary arterial pressure measurements|pulmonary arterial pressure measurements
691477|NCT00295100|Breast Cancer|breast cancer
691478|NCT00295100|MRI|mri
691479|NCT00295087|Premature Ovarian Failure|premature ovarian failure
691480|NCT00295087|X-Chromosome Inactivation|x-chromosome inactivation
691481|NCT00295074|traumatic brain injury|traumatic brain injury
691482|NCT00295074|head injury|head injury
691483|NCT00295074|concussion|concussion
691484|NCT00295074|neuropsychologic test|neuropsychologic test
691485|NCT00295061|alpha 1-Antitrypsin Deficiency|alpha 1-antitrypsin deficiency
691486|NCT00295061|alpha 1-Antitrypsin|alpha 1-antitrypsin
691487|NCT00295061|pulmonary emphysema|pulmonary emphysema
691488|NCT00295048|treatment|treatment
691489|NCT00295048|cognition|cognition
691490|NCT00295048|schizophrenia|schizophrenia
691491|NCT00295022|Levocetirizine|levocetirizine
691492|NCT00295022|Xyzal|xyzal
691493|NCT00295022|Rhinitis|rhinitis
691494|NCT00295022|Allergic|allergic
691495|NCT00295022|Seasonal|seasonal
691496|NCT00295022|Ragweed|ragweed
691497|NCT00294996|Metastatic Her2+ Breast cancer|metastatic her2+ breast cancer
691498|NCT00294996|Myocet|myocet
691499|NCT00294996|liposomal doxorubicin|liposomal doxorubicin
691500|NCT00294996|trastuzumab|trastuzumab
691501|NCT00294931|Lung Cancer, Small Cell|lung cancer, small cell
691502|NCT00294931|Extensive|extensive
691503|NCT00294918|Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)|human immunodeficiency virus-associated adipose redistribution syndrome (hars)
691504|NCT00294918|Human Immunodeficiency Virus Infections|human immunodeficiency virus infections
691506|NCT00294918|recombinant human growth hormone (r-hGH)|recombinant human growth hormone (r-hgh)
691507|NCT00294905|COPD|copd
691508|NCT00294905|smoking cessation|smoking cessation
691509|NCT00294905|implementation|implementation
691510|NCT00294905|patient counseling|patient counseling
691511|NCT00294905|general practice|general practice
691512|NCT00294892|HIV|hiv
691513|NCT00294892|mother to child transmission; MTCT|mother to child transmission; mtct
691514|NCT00294892|nevirapine resistance|nevirapine resistance
691515|NCT00294892|pharmacokinetics|pharmacokinetics
691516|NCT00294892|Treatment Naive|treatment naive
691517|NCT00294866|End Stage Renal Disease|end stage renal disease
691518|NCT00294866|Inflammation|inflammation
691519|NCT00294853|Coronary calcium score|coronary calcium score
691520|NCT00294853|Coronary artery disease|coronary artery disease
691521|NCT00294853|Cardiac transplantation|cardiac transplantation
691522|NCT00294853|Coronary calcium score in heart transplanted patients|coronary calcium score in heart transplanted patients
691523|NCT00294853|Coronary artery disease in heart transplanted patients|coronary artery disease in heart transplanted patients
691524|NCT00294827|Liver transplantation|liver transplantation
691525|NCT00294814|Cardiac Surgery|cardiac surgery
691526|NCT00294814|CABG|cabg
691527|NCT00294814|Microemboli|microemboli
691528|NCT00294814|Transcranial Doppler|transcranial doppler
691529|NCT00294814|Cognitive Decline|cognitive decline
691530|NCT00294814|Anastomotic Device|anastomotic device
691531|NCT00294814|Proximal Anastomosis|proximal anastomosis
691532|NCT00294814|Coronary Artery Bypass Graft (CABG)|coronary artery bypass graft (cabg)
691533|NCT00294801|knee osteoarthritis|knee osteoarthritis
691534|NCT00294788|Influenza|influenza
691535|NCT00294788|bioadjuvant|bioadjuvant
691536|NCT00294788|probiotic|probiotic
691537|NCT00294788|HAI|hai
691538|NCT00294788|immunity|immunity
691539|NCT00294788|vaccine|vaccine
691540|NCT00294788|Immune response to influenza vaccine|immune response to influenza vaccine
691541|NCT00294775|diastolic dysfunction|diastolic dysfunction
691542|NCT00294775|Reverse Remodelling|reverse remodelling
691543|NCT00294762|NSCLC|nsclc
691544|NCT00294762|Erlotinib|erlotinib
691545|NCT00294762|Tarceva|tarceva
691546|NCT00294762|Lung Cancer|lung cancer
691547|NCT00294749|Prostate,|prostate,
691548|NCT00294749|Infection,|infection,
691549|NCT00294749|Biopsy,|biopsy,
691550|NCT00294749|Antibiotic,|antibiotic,
691551|NCT00294749|Prophylaxis|prophylaxis
691552|NCT00294736|lung cancer|lung cancer
691553|NCT00294736|erlotinib|erlotinib
691554|NCT00294736|NSCLC|nsclc
691555|NCT00294736|smokers|smokers
691556|NCT00294710|Hypertension, aliskiren, hydrochlorothiazide, amlodipine|hypertension, aliskiren, hydrochlorothiazide, amlodipine
691557|NCT00294697|polymorphisms|polymorphisms
691558|NCT00294697|innate immune response|innate immune response
691559|NCT00294697|immunomonitoring|immunomonitoring
691560|NCT00294697|immuno paralysis|immuno paralysis
691561|NCT00294684|biliary atresia|biliary atresia
691562|NCT00294684|hepatoportoenterostomy|hepatoportoenterostomy
691563|NCT00294684|corticosteroids|corticosteroids
691564|NCT00294671|familial amyloid polyneuropathy|familial amyloid polyneuropathy
691565|NCT00294671|familial amyloidosis|familial amyloidosis
691566|NCT00294671|diflunisal|diflunisal
691567|NCT00294671|amyloidosis|amyloidosis
691568|NCT00294671|transthyretin|transthyretin
691569|NCT00294671|peripheral neuropathy|peripheral neuropathy
691570|NCT00294671|autonomic neuropathy|autonomic neuropathy
691571|NCT00294671|amyloid cardiomyopathy|amyloid cardiomyopathy
691572|NCT00294658|myasthenia gravis|myasthenia gravis
691573|NCT00294658|thymectomy|thymectomy
691574|NCT00294658|prednisone|prednisone
691575|NCT00294658|corticosteroid|corticosteroid
691576|NCT00294658|extended transsternal thymectomy|extended transsternal thymectomy
691577|NCT00294658|ETTX|ettx
691578|NCT00294658|MG|mg
691579|NCT00294658|thymus|thymus
691580|NCT00294658|thymoma|thymoma
691581|NCT00294645|Remote Follow Up|remote follow up
691582|NCT00294645|Diagnostic|diagnostic
691583|NCT00294645|Bradycardia|bradycardia
691584|NCT00294632|Mantle Cell Lymphoma|mantle cell lymphoma
691585|NCT00294632|B-Cell Non-Hodgkin's Lymphoma|b-cell non-hodgkin's lymphoma
691586|NCT00294632|Transformed Large Cell Lymphoma|transformed large cell lymphoma
691587|NCT00294632|Follicular Lymphoma|follicular lymphoma
691588|NCT00294632|Lymphoma|lymphoma
691589|NCT00294632|MCL|mcl
691590|NCT00294632|Lenalidomide|lenalidomide
691591|NCT00294632|CC-5013|cc-5013
691592|NCT00294632|Revlimid™|revlimid™
691593|NCT00294632|Rituximab|rituximab
691594|NCT00294632|Rituxan|rituxan
691595|NCT00294619|Growth hormone deficiency|growth hormone deficiency
691596|NCT00294606|vasopressor agents|vasopressor agents
691597|NCT00294606|carotid endarterectomy|carotid endarterectomy
691598|NCT00294606|cardiac function|cardiac function
691599|NCT00294606|transesophageal echocardiography|transesophageal echocardiography
691600|NCT00294606|wall motion abnormalities|wall motion abnormalities
691601|NCT00294593|Down syndrome|down syndrome
691602|NCT00294593|folinic acid therapy|folinic acid therapy
691603|NCT00294593|cognitive functions|cognitive functions
691604|NCT00294580|Malaria|malaria
691605|NCT00294580|Cognition|cognition
691606|NCT00294580|Prevention & control|prevention & control
691607|NCT00294580|Anemia|anemia
691608|NCT00294580|Chemoprophylaxis|chemoprophylaxis
691609|NCT00294580|Mortality|mortality
691610|NCT00294580|Children|children
691611|NCT00294580|Randomized controlled trial|randomized controlled trial
691612|NCT00294580|Education|education
691613|NCT00294580|Long-term effects|long-term effects
691614|NCT00294580|The Gambia|the gambia
691615|NCT00294580|Africa, West|africa, west
691616|NCT00294567|Hypertension|hypertension
691617|NCT00294567|PCI|pci
691618|NCT00294567|Calcium Channel Blockers|calcium channel blockers
691619|NCT00294567|IVUS|ivus
691620|NCT00294567|Plaque|plaque
691621|NCT00294554|Parkinson's Disease|parkinson's disease
691622|NCT00294554|Cognitive Impairment|cognitive impairment
691623|NCT00294554|Dementia|dementia
691624|NCT00294554|Memory|memory
691625|NCT00294541|sickle cell disease|sickle cell disease
691626|NCT00294541|sickle cell anemia|sickle cell anemia
691627|NCT00294528|osteoarthritis, knee|osteoarthritis, knee
691628|NCT00294528|total knee arthroplasty|total knee arthroplasty
691629|NCT00294528|range of motion|range of motion
691630|NCT00294528|satisfaction|satisfaction
691631|NCT00294489|HCV|hcv
691632|NCT00294489|Fibrosis|fibrosis
691633|NCT00294489|Breath test|breath test
691634|NCT00294476|IVIg|ivig
691635|NCT00294476|Cancer|cancer
691636|NCT00294476|Melanoma|melanoma
691637|NCT00294463|postmenopause|postmenopause
691638|NCT00294463|endometrium|endometrium
691639|NCT00294463|Gene Expression Profiling|gene expression profiling
691640|NCT00294463|Histology, Comparative|histology, comparative
691641|NCT00294463|Hormone Replacement Therapy|hormone replacement therapy
691642|NCT00294463|Hormones|hormones
691643|NCT00294437|Prostate Cancer|prostate cancer
691644|NCT00294437|Zometa|zometa
691645|NCT00294424|Waiting time|waiting time
691646|NCT00294424|Total hip replacement|total hip replacement
691647|NCT00294424|Total knee replacement|total knee replacement
691648|NCT00294424|Quality of life|quality of life
691649|NCT00294424|The15D|the15d
691650|NCT00294424|Harris Hip Score|harris hip score
691651|NCT00294424|Knee Score|knee score
691652|NCT00294424|Pain measurement|pain measurement
691653|NCT00294424|Cost-effectiveness|cost-effectiveness
691654|NCT00294424|Medication|medication
691655|NCT00294424|Health services|health services
691656|NCT00294424|Social services|social services
691657|NCT00294424|Randomized Controlled Trial|randomized controlled trial
691658|NCT00294398|Asthma, Controller Medications|asthma, controller medications
691659|NCT00294385|Breast Cancer|breast cancer
691660|NCT00294385|Docetaxel|docetaxel
691661|NCT00294359|colorectal neoplasm|colorectal neoplasm
691662|NCT00294346|Social Anxiety Disorder|social anxiety disorder
691663|NCT00294346|Social Phobia|social phobia
691664|NCT00294320|Aldara|aldara
691665|NCT00294320|Actinic Keratosis|actinic keratosis
691666|NCT00294307|Nursing Models of Care|nursing models of care
691667|NCT00294307|Collaborative Care|collaborative care
691668|NCT00294307|Care Management|care management
691669|NCT00294307|Transitional Care|transitional care
691670|NCT00294307|Advanced Practice Nurse Care Interventions|advanced practice nurse care interventions
691671|NCT00294307|Cognitive Impairment|cognitive impairment
691672|NCT00294307|Dementia|dementia
691673|NCT00294307|Delirium|delirium
691674|NCT00294294|vaccine|vaccine
691675|NCT00294294|infant|infant
691676|NCT00294281|Pain|pain
691677|NCT00294281|Tenderness|tenderness
691678|NCT00294281|Depression|depression
691679|NCT00294281|Work Disability|work disability
691680|NCT00294281|Physical Function|physical function
691681|NCT00294281|Quality of Life|quality of life
691682|NCT00294281|Chronic Pain|chronic pain
691683|NCT00294268|obesity|obesity
691684|NCT00294268|CBT|cbt
691685|NCT00294268|motivational enhancement therapy|motivational enhancement therapy
691686|NCT00294268|weight loss maintenance|weight loss maintenance
691687|NCT00294255|mixed mania|mixed mania
691688|NCT00294255|depression|depression
691689|NCT00294255|irritability|irritability
691690|NCT00294242|pregnancy|pregnancy
691691|NCT00294242|membranes sweeping|membranes sweeping
691692|NCT00294242|prelabor rupture of membranes|prelabor rupture of membranes
691693|NCT00294229|Low back pain|low back pain
691694|NCT00294229|Spinal manipulative therapy|spinal manipulative therapy
691695|NCT00294229|Randomised controlled trial|randomised controlled trial
691696|NCT00294216|Omacor|omacor
691697|NCT00294216|Omega-3 PUFA|omega-3 pufa
691698|NCT00294216|Endarterectomy|endarterectomy
691699|NCT00294216|Carotid Plaque stability|carotid plaque stability
691700|NCT00294216|Structural changes|structural changes
691701|NCT00294216|inflammation|inflammation
691702|NCT00294203|Digestive System Surgical Procedures|digestive system surgical procedures
691703|NCT00294203|Post-Operative Care|post-operative care
691704|NCT00294203|Fatigue|fatigue
691705|NCT00294203|Quality of Life|quality of life
691706|NCT00294203|Erythrocyte Transfusion|erythrocyte transfusion
691707|NCT00294203|Esophagectomy|esophagectomy
691708|NCT00294203|Gastric Cancer|gastric cancer
691709|NCT00294203|Hepatectomy|hepatectomy
691710|NCT00294203|Pancreatic Cancer|pancreatic cancer
691711|NCT00294203|Rectum|rectum
691712|NCT00294190|Lung Cancer|lung cancer
691713|NCT00294190|Extensive stage|extensive stage
691714|NCT00294190|Small Cell Lung Cancer|small cell lung cancer
691715|NCT00294177|Trophoblastic Neoplasms|trophoblastic neoplasms
691716|NCT00294177|Chorionic Gonadotropin|chorionic gonadotropin
691717|NCT00294177|Molecular Conformation|molecular conformation
691718|NCT00294164|Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)|human immunodeficiency virus-associated adipose redistribution syndrome (hars)
691719|NCT00294164|Human Immunodeficiency Virus Infections|human immunodeficiency virus infections
691720|NCT00294164|recombinant human growth hormone (r-hGH)|recombinant human growth hormone (r-hgh)
691721|NCT00294164|Serostim®|serostim®
691722|NCT00294164|Placebo|placebo
691723|NCT00294151|breast cancer|breast cancer
691724|NCT00294151|prostate cancer|prostate cancer
691725|NCT00294151|vertebral metastasis|vertebral metastasis
691726|NCT00294151|vertebroplasty|vertebroplasty
691727|NCT00294151|vertebral metastasis from breast cancer|vertebral metastasis from breast cancer
691728|NCT00294151|vertebral metastasis from prostate cancer|vertebral metastasis from prostate cancer
691729|NCT00294125|Medical Food|medical food
691730|NCT00294125|Botanicals|botanicals
691731|NCT00294125|Phytochemicals|phytochemicals
691732|NCT00294112|mesenchymal stem cells|mesenchymal stem cells
691733|NCT00294099|A/H5N1, Influenza, Vaccine|a/h5n1, influenza, vaccine
691734|NCT00294086|valsartan,|valsartan,
691735|NCT00294086|chronic heart failure,|chronic heart failure,
691736|NCT00294073|femoral block|femoral block
691737|NCT00294073|fascia iliaca block|fascia iliaca block
691738|NCT00294073|ACL repair|acl repair
691739|NCT00294073|post-operative analgesia|post-operative analgesia
691740|NCT00294073|knee surgery|knee surgery
691741|NCT00294073|ACL damage|acl damage
691742|NCT00294073|knee damage|knee damage
691743|NCT00294060|Pacemaker|pacemaker
691744|NCT00294060|Bradycardia|bradycardia
691745|NCT00294047|Vaccine|vaccine
691746|NCT00294047|Human papillomavirus|human papillomavirus
691747|NCT00294047|Cervical Cancer|cervical cancer
691748|NCT00294047|Cervical Infection|cervical infection
691749|NCT00294034|Registry|registry
691750|NCT00294034|Pacemaker|pacemaker
691751|NCT00294034|Diagnostics|diagnostics
691752|NCT00294008|Schizophrenia|schizophrenia
691753|NCT00294008|Treatment adherence|treatment adherence
691754|NCT00294008|Antipsychotic agents|antipsychotic agents
691755|NCT00294008|Risperidone|risperidone
691756|NCT00294008|Long-acting injectable|long-acting injectable
691757|NCT00294008|Risperdal tablet|risperdal tablet
691758|NCT00294008|Risperidal Consta|risperidal consta
691759|NCT00293982|Patient satisfaction|patient satisfaction
691760|NCT00293982|Patient expectations|patient expectations
691761|NCT00293982|Pediatric emergency department|pediatric emergency department
691762|NCT00293969|Pain|pain
691763|NCT00293969|Morphine|morphine
691764|NCT00293956|hypothyroxinemia|hypothyroxinemia
691765|NCT00293956|full term infants|full term infants
691766|NCT00293956|near term infants|near term infants
691767|NCT00293956|respiratory distress|respiratory distress
691768|NCT00293956|thyroid disease|thyroid disease
691769|NCT00293943|Atrial fibrillation|atrial fibrillation
691770|NCT00293943|Pulmonary vein ablation|pulmonary vein ablation
691771|NCT00293943|Linear lesions|linear lesions
691772|NCT00293930|Treatment Outcome|treatment outcome
691773|NCT00293930|Tacrolimus|tacrolimus
691774|NCT00293930|Safety|safety
691775|NCT00293930|Psoriasis|psoriasis
691776|NCT00293917|Treatment Outcome|treatment outcome
691777|NCT00293917|Tacrolimus|tacrolimus
691778|NCT00293917|Safety|safety
691779|NCT00293917|Psoriasis|psoriasis
691781|NCT00293904|Grass Pollen|grass pollen
691782|NCT00293904|Systemic Immunotherapy|systemic immunotherapy
691783|NCT00293891|Treatment Outcome|treatment outcome
691784|NCT00293891|Tacrolimus|tacrolimus
691785|NCT00293891|Safety|safety
691786|NCT00293891|Psoriasis|psoriasis
691787|NCT00293865|Breast infiltrative cancer|breast infiltrative cancer
691788|NCT00293852|Heart failure, Congestive|heart failure, congestive
691789|NCT00293852|Metabolic Syndrome X|metabolic syndrome x
691790|NCT00293852|Ambulatory Care|ambulatory care
691791|NCT00293852|Health behavior|health behavior
691792|NCT00293839|bladder|bladder
691793|NCT00293839|overactive|overactive
691794|NCT00293826|ACR criteria|acr criteria
691795|NCT00293826|methotrexate|methotrexate
691796|NCT00293826|DMARDs|dmards
691797|NCT00293826|patient reported outcomes|patient reported outcomes
691798|NCT00293826|joint assessment|joint assessment
691799|NCT00293813|Post Menopausal|post menopausal
691800|NCT00293813|Osteoporosis|osteoporosis
691801|NCT00293813|MicroCT|microct
691802|NCT00293813|Amgen|amgen
691803|NCT00293813|denosumab|denosumab
691804|NCT00293813|Extreme CT|extreme ct
691805|NCT00293813|XCT|xct
691806|NCT00293813|Fosamax|fosamax
691807|NCT00293813|Alendronate|alendronate
691808|NCT00293800|Open-angle|open-angle
691809|NCT00293800|glaucoma|glaucoma
691810|NCT00293800|ocular|ocular
691811|NCT00293800|hypertension|hypertension
691812|NCT00293787|Open-angle|open-angle
691813|NCT00293787|glaucoma|glaucoma
691814|NCT00293787|ocular|ocular
691815|NCT00293787|hypertension|hypertension
691816|NCT00293774|Prospective|prospective
691817|NCT00293774|Conventional therapy|conventional therapy
691818|NCT00293774|Registry|registry
691819|NCT00293774|Metal-on-metal|metal-on-metal
691820|NCT00293774|Ceramic-on-ceramic|ceramic-on-ceramic
691821|NCT00293774|Hip Arthroplasty|hip arthroplasty
691822|NCT00293761|open-angle|open-angle
691823|NCT00293761|glaucoma|glaucoma
691824|NCT00293761|ocular|ocular
691825|NCT00293761|hypertension|hypertension
691826|NCT00293748|Genomics|genomics
691827|NCT00293748|Statins|statins
691828|NCT00293748|Coronary Heart Disease|coronary heart disease
691829|NCT00293748|Stroke|stroke
691830|NCT00293748|Inflammation|inflammation
691831|NCT00293748|Gene Expression|gene expression
691832|NCT00293748|Vascular Risk|vascular risk
691833|NCT00293748|Peripheral Blood Mononuclear Cells|peripheral blood mononuclear cells
691834|NCT00293748|Atorvastatin|atorvastatin
691835|NCT00293748|Vascular Disease|vascular disease
691836|NCT00293748|Vascular Disease Risk|vascular disease risk
691837|NCT00293735|Preeclampsia|preeclampsia
691838|NCT00293735|Pregnancy|pregnancy
691839|NCT00293735|Hypertension|hypertension
691840|NCT00293735|Eclampsia|eclampsia
691841|NCT00293735|HELLP Syndrome|hellp syndrome
691842|NCT00293735|Seizures|seizures
691843|NCT00293735|Prevention|prevention
691844|NCT00293722|Arthritis|arthritis
691845|NCT00293709|Arthritis|arthritis
691846|NCT00293696|biomarker study|biomarker study
691847|NCT00293696|Patients with clinically localised prostate cancer|patients with clinically localised prostate cancer
691848|NCT00293683|cesarean|cesarean
691849|NCT00293683|closure|closure
691850|NCT00293683|skin|skin
691851|NCT00293683|staple|staple
691852|NCT00293683|absorbable|absorbable
691853|NCT00293683|metal|metal
691854|NCT00293644|Pregnancy Complications|pregnancy complications
691855|NCT00293644|Hyperemesis Gravidarum|hyperemesis gravidarum
691856|NCT00293644|Diclectin|diclectin
691857|NCT00293644|doxylamine succinate|doxylamine succinate
691858|NCT00293644|pyridoxine hydrochloride|pyridoxine hydrochloride
691859|NCT00293618|Implementation of prediction rules|implementation of prediction rules
691860|NCT00293618|Decision Support Systems, Clinical|decision support systems, clinical
691861|NCT00293618|PONV|ponv
691862|NCT00293618|Emesis|emesis
691863|NCT00293618|Nausea|nausea
691864|NCT00293618|Vomiting|vomiting
691865|NCT00293618|Postoperative|postoperative
691866|NCT00293618|Implementation|implementation
691867|NCT00293618|prediction rule|prediction rule
691868|NCT00293618|impact study|impact study
691869|NCT00293618|decision support|decision support
691870|NCT00293618|clinical decision support|clinical decision support
691871|NCT00293605|aseptic loosening|aseptic loosening
691872|NCT00293605|femoral stem design|femoral stem design
691873|NCT00293592|Heart surgery|heart surgery
691874|NCT00293592|Cardiopulmonary bypass|cardiopulmonary bypass
691875|NCT00293592|Systemic Inflammatory Response Syndrome (SIRS)|systemic inflammatory response syndrome (sirs)
691876|NCT00293579|head and neck cancer|head and neck cancer
691877|NCT00293540|metastatic|metastatic
691878|NCT00293540|secondary|secondary
691879|NCT00293540|Hormone Receptor-Positive Breast Cancer|hormone receptor-positive breast cancer
691880|NCT00293527|Metastatic|metastatic
691881|NCT00293514|standard surgical treatment for air leakage in pulmonary lobectomy|standard surgical treatment for air leakage in pulmonary lobectomy
691882|NCT00293501|clear cell renal cell carcinoma|clear cell renal cell carcinoma
691883|NCT00293501|stage IV renal cell cancer|stage iv renal cell cancer
692986|NCT00290433|Filgrastim|filgrastim
691884|NCT00293501|recurrent renal cell cancer|recurrent renal cell cancer
691885|NCT00293488|anaplastic large cell lymphoma|anaplastic large cell lymphoma
691886|NCT00293488|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
691887|NCT00293488|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
691888|NCT00293488|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
691889|NCT00293488|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
691890|NCT00293488|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
691891|NCT00293488|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
691892|NCT00293488|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
691893|NCT00293488|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
691894|NCT00293488|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
691895|NCT00293488|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
691896|NCT00293488|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
691897|NCT00293488|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
691898|NCT00293488|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
691899|NCT00293488|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
691900|NCT00293488|splenic marginal zone lymphoma|splenic marginal zone lymphoma
691901|NCT00293462|mucositis|mucositis
691902|NCT00293462|radiation toxicity|radiation toxicity
691903|NCT00293462|recurrent squamous and basal cell carcinoma of the hypopharynx,larynx,lip,nasopharynx|recurrent squamous and basal cell carcinoma of the hypopharynx,larynx,lip,nasopharynx
691904|NCT00293462|oropharynx, paranasal sinus and nasal cavity|oropharynx, paranasal sinus and nasal cavity
691905|NCT00293462|stage I-IV lymphoepithelioma of the nasopharynx|stage i-iv lymphoepithelioma of the nasopharynx
691906|NCT00293462|stage I-IV lymphoepithelioma of the oropharynx|stage i-iv lymphoepithelioma of the oropharynx
691907|NCT00293462|Recurrent and stage I-IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent and stage i-iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
691908|NCT00293462|Recurrent and stage I-IV inverted papilloma of the paranasal sinus and nasal cavity|recurrent and stage i-iv inverted papilloma of the paranasal sinus and nasal cavity
691909|NCT00293462|Recurrent and stage I-IV midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent and stage i-iv midline lethal granuloma of the paranasal sinus and nasal cavity
691910|NCT00293462|untreated, current,metastatic squamous neck cancer with occult primary|untreated, current,metastatic squamous neck cancer with occult primary
691911|NCT00293462|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
691912|NCT00293462|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
691913|NCT00293462|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
691914|NCT00293462|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
691915|NCT00293462|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
691916|NCT00293462|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
691917|NCT00293462|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
691918|NCT00293462|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
691919|NCT00293462|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
691920|NCT00293462|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
691921|NCT00293462|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
691922|NCT00293462|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
691923|NCT00293462|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
691924|NCT00293462|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
691925|NCT00293462|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
691926|NCT00293462|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
691927|NCT00293462|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
691928|NCT00293462|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
691929|NCT00293462|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
691930|NCT00293462|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
691931|NCT00293462|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
691932|NCT00293462|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
691933|NCT00293462|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
691934|NCT00293462|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
691935|NCT00293462|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
691936|NCT00293462|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
691937|NCT00293462|tongue cancer|tongue cancer
691938|NCT00293436|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
691939|NCT00293436|advanced adult primary liver cancer|advanced adult primary liver cancer
691940|NCT00293436|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
691941|NCT00293423|adult glioblastoma|adult glioblastoma
691942|NCT00293423|recurrent adult brain tumor|recurrent adult brain tumor
691943|NCT00293410|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
691944|NCT00293410|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
691945|NCT00293410|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
691946|NCT00293410|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
691947|NCT00293410|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
691948|NCT00293410|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
691949|NCT00293410|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
691950|NCT00293410|secondary acute myeloid leukemia|secondary acute myeloid leukemia
691951|NCT00293410|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
691952|NCT00293410|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
691953|NCT00293410|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
691954|NCT00293410|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
691955|NCT00293410|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
691956|NCT00293410|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
691957|NCT00293410|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
691958|NCT00293410|acute undifferentiated leukemia|acute undifferentiated leukemia
691959|NCT00293410|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
691960|NCT00293410|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
691961|NCT00293410|adult acute basophilic leukemia|adult acute basophilic leukemia
691962|NCT00293410|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
691963|NCT00293410|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
691964|NCT00293410|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
691965|NCT00293410|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
691966|NCT00293410|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
691967|NCT00293410|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
691968|NCT00293410|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
691969|NCT00293410|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
691970|NCT00293410|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
691971|NCT00293410|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
691972|NCT00293410|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
691973|NCT00293410|childhood acute basophilic leukemia|childhood acute basophilic leukemia
691974|NCT00293410|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
691975|NCT00293410|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
691976|NCT00293410|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
691977|NCT00293410|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
691978|NCT00293410|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
691979|NCT00293410|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
691980|NCT00293410|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
691981|NCT00293410|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
691982|NCT00293410|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
691983|NCT00293410|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
691984|NCT00293397|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
691985|NCT00293397|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
691986|NCT00293384|nausea and vomiting|nausea and vomiting
691987|NCT00293384|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
691988|NCT00293384|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
691989|NCT00293384|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
691990|NCT00293384|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
691991|NCT00293384|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
691992|NCT00293384|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
691993|NCT00293384|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
691994|NCT00293384|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
691995|NCT00293384|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
691996|NCT00293384|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
691997|NCT00293384|chronic eosinophilic leukemia|chronic eosinophilic leukemia
691998|NCT00293384|primary myelofibrosis|primary myelofibrosis
691999|NCT00293384|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
692000|NCT00293384|chronic neutrophilic leukemia|chronic neutrophilic leukemia
692001|NCT00293384|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
692142|NCT00293098|Iron induced heart disease|iron induced heart disease
692002|NCT00293384|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
692003|NCT00293384|disseminated neuroblastoma|disseminated neuroblastoma
692004|NCT00293384|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
692005|NCT00293384|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
692006|NCT00293384|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
692007|NCT00293384|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
692008|NCT00293384|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
692009|NCT00293384|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
692010|NCT00293384|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
692011|NCT00293384|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
692012|NCT00293384|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
692013|NCT00293384|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
692014|NCT00293384|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
692015|NCT00293384|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
692016|NCT00293384|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
692017|NCT00293384|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
692018|NCT00293384|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
692019|NCT00293384|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
692020|NCT00293384|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
692021|NCT00293384|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
692022|NCT00293384|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
692023|NCT00293384|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
692024|NCT00293384|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
692025|NCT00293384|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
692026|NCT00293384|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
692027|NCT00293384|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
692028|NCT00293384|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
692029|NCT00293384|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
692030|NCT00293384|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
692031|NCT00293384|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
692032|NCT00293384|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
692033|NCT00293384|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
692034|NCT00293384|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
692035|NCT00293384|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
692036|NCT00293384|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
692037|NCT00293384|recurrent neuroblastoma|recurrent neuroblastoma
692038|NCT00293384|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
692039|NCT00293384|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
692040|NCT00293384|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
692041|NCT00293384|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
692042|NCT00293384|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
692043|NCT00293384|refractory hairy cell leukemia|refractory hairy cell leukemia
692044|NCT00293384|refractory multiple myeloma|refractory multiple myeloma
692045|NCT00293384|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
692046|NCT00293384|secondary acute myeloid leukemia|secondary acute myeloid leukemia
692047|NCT00293384|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
692048|NCT00293384|splenic marginal zone lymphoma|splenic marginal zone lymphoma
692049|NCT00293384|stage I multiple myeloma|stage i multiple myeloma
692050|NCT00293384|stage II multiple myeloma|stage ii multiple myeloma
692051|NCT00293384|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
692052|NCT00293384|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
692053|NCT00293384|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
692054|NCT00293384|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
692055|NCT00293384|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
692056|NCT00293384|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
692057|NCT00293384|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
692058|NCT00293384|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
692059|NCT00293384|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
692060|NCT00293384|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
692061|NCT00293384|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
692062|NCT00293384|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
692063|NCT00293384|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
692064|NCT00293384|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
692065|NCT00293384|stage III multiple myeloma|stage iii multiple myeloma
692066|NCT00293384|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
692067|NCT00293384|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
692068|NCT00293384|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
692069|NCT00293384|stage IIIA breast cancer|stage iiia breast cancer
692070|NCT00293384|stage IIIB breast cancer|stage iiib breast cancer
692071|NCT00293384|stage IIIC breast cancer|stage iiic breast cancer
692072|NCT00293384|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
692073|NCT00293384|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
692074|NCT00293384|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
692075|NCT00293384|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
692076|NCT00293384|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
692077|NCT00293384|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
692078|NCT00293384|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
692079|NCT00293384|stage IV breast cancer|stage iv breast cancer
692080|NCT00293384|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
692081|NCT00293384|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
692082|NCT00293384|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
692083|NCT00293384|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
692084|NCT00293384|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
692085|NCT00293384|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
692086|NCT00293384|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
692087|NCT00293384|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
692088|NCT00293371|adenocarcinoma of the prostate|adenocarcinoma of the prostate
692089|NCT00293371|recurrent prostate cancer|recurrent prostate cancer
692090|NCT00293371|stage IV prostate cancer|stage iv prostate cancer
692091|NCT00293358|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
692092|NCT00293358|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
692093|NCT00293358|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
692094|NCT00293358|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
692095|NCT00293358|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
692096|NCT00293332|stage I non-small cell lung cancer|stage i non-small cell lung cancer
692097|NCT00293332|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
692098|NCT00293332|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
692099|NCT00293319|recurrent neuroblastoma|recurrent neuroblastoma
692100|NCT00293293|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
692101|NCT00293293|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
692102|NCT00293293|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
692103|NCT00293293|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
692104|NCT00293293|peritoneal cavity cancer|peritoneal cavity cancer
692105|NCT00293280|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
692106|NCT00293280|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
692107|NCT00293280|adenocarcinoma of the lung|adenocarcinoma of the lung
692108|NCT00293280|adenosquamous cell lung cancer|adenosquamous cell lung cancer
692109|NCT00293280|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
692110|NCT00293280|large cell lung cancer|large cell lung cancer
692111|NCT00293280|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
692112|NCT00293280|squamous cell lung cancer|squamous cell lung cancer
692113|NCT00293267|Treatment Experienced|treatment experienced
692114|NCT00293254|Treatment Experienced|treatment experienced
692115|NCT00293241|Pacemaker or ICD replacement|pacemaker or icd replacement
692116|NCT00293228|Latent tuberculosis|latent tuberculosis
692117|NCT00293228|biomarkers|biomarkers
692118|NCT00293228|isoniazid|isoniazid
692119|NCT00293228|ELISPOT|elispot
692120|NCT00293228|PPD positive individuals|ppd positive individuals
692121|NCT00293202|etanercept|etanercept
692122|NCT00293202|malnutrition|malnutrition
692123|NCT00293202|inflammation|inflammation
692124|NCT00293202|hemodialysis|hemodialysis
692125|NCT00293189|hip fracture|hip fracture
692126|NCT00293189|epidemiology|epidemiology
692127|NCT00293189|genetics|genetics
692128|NCT00293189|p2x7|p2x7
692129|NCT00293176|Cognitive impairment|cognitive impairment
692130|NCT00293176|Memory Loss|memory loss
692131|NCT00293150|diastolic heart failure|diastolic heart failure
692132|NCT00293150|heart failure|heart failure
692133|NCT00293137|Chronic systolic heart failure|chronic systolic heart failure
692134|NCT00293137|Heart Failure|heart failure
692135|NCT00293124|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
692136|NCT00293124|Glivec|glivec
692137|NCT00293111|Multiple Myeloma|multiple myeloma
692138|NCT00293111|Relapsed Multiple Myeloma|relapsed multiple myeloma
692139|NCT00293111|Refractory Multiple Myeloma|refractory multiple myeloma
692140|NCT00293098|Iron overload|iron overload
692141|NCT00293098|Thalassemia|thalassemia
692143|NCT00293098|deferoxamine (Desferal)|deferoxamine (desferal)
692144|NCT00293098|Deferiprone|deferiprone
692145|NCT00293085|NSCLC|nsclc
692146|NCT00293085|Docetaxel|docetaxel
692147|NCT00293072|Rituximab, ANCA, vasculitis, lupus,|rituximab, anca, vasculitis, lupus,
692148|NCT00293059|Dysfunctional Uterine Bleeding|dysfunctional uterine bleeding
692149|NCT00293046|Allergy|allergy
692150|NCT00293033|Breakthrough Pain in Cancer Patients|breakthrough pain in cancer patients
692151|NCT00293020|Breakthrough Pain in Cancer Patients|breakthrough pain in cancer patients
692152|NCT00292994|Metabolic Syndrome|metabolic syndrome
692153|NCT00292994|Hyperlipidemia|hyperlipidemia
692154|NCT00292994|Type 2 diabetes mellitus|type 2 diabetes mellitus
692155|NCT00292994|Insulin resistance|insulin resistance
692156|NCT00292994|Weight loss|weight loss
692157|NCT00292994|Obesity|obesity
692158|NCT00292994|Exercise|exercise
692159|NCT00292994|Hypertension|hypertension
692160|NCT00292981|C1 Inhibitor|c1 inhibitor
692161|NCT00292981|Hereditary angioedema|hereditary angioedema
692162|NCT00292981|Acute HAE attack|acute hae attack
692163|NCT00292968|Health Behavior|health behavior
692164|NCT00292968|Prevention|prevention
692165|NCT00292968|Informatics|informatics
692166|NCT00292968|Electronic Health Record|electronic health record
692167|NCT00292955|Cervical Cancer, Cetuximab, Phase II Clinical Trials|cervical cancer, cetuximab, phase ii clinical trials
692168|NCT00292955|Stage IB2-IVB Carcinoma of the Cervix|stage ib2-ivb carcinoma of the cervix
692169|NCT00292942|artesunate|artesunate
692170|NCT00292942|artemisinin|artemisinin
692171|NCT00292942|falciparum|falciparum
692172|NCT00292929|artesunate|artesunate
692173|NCT00292929|artemisinin|artemisinin
692174|NCT00292929|falciparum|falciparum
692175|NCT00292916|whole body vibration|whole body vibration
692176|NCT00292916|exercise|exercise
692177|NCT00292916|elderly woman|elderly woman
692178|NCT00292916|Bone Mineral Density|bone mineral density
692179|NCT00292916|falls|falls
692180|NCT00292916|higher age|higher age
692181|NCT00292903|Perinatal Depression|perinatal depression
692182|NCT00292903|Interpersonal Psychotherapy|interpersonal psychotherapy
692183|NCT00292890|injection devices|injection devices
692184|NCT00292890|injection technique|injection technique
692185|NCT00292890|insulin needles|insulin needles
692186|NCT00292890|insulin administration|insulin administration
692187|NCT00292877|1. Eosinophilic bronchitis, 2. Asthma, 3. Steroid dependent asthma, 4. Sputum eosinophils, 5. SB-240563 (Mepolizumab)|1. eosinophilic bronchitis, 2. asthma, 3. steroid dependent asthma, 4. sputum eosinophils, 5. sb-240563 (mepolizumab)
692188|NCT00292864|Cancer|cancer
692189|NCT00292864|Carcinoma|carcinoma
692190|NCT00292864|Adenocarcinoma|adenocarcinoma
692191|NCT00292864|Tumor|tumor
692192|NCT00292864|Advanced solid tumors|advanced solid tumors
692193|NCT00292838|Eosinophilic bronchitis with asthma|eosinophilic bronchitis with asthma
692194|NCT00292838|Eosinophilic bronchitis without asthma|eosinophilic bronchitis without asthma
692195|NCT00292825|vasovagal syncope|vasovagal syncope
692196|NCT00292825|syncope|syncope
692197|NCT00292825|cardioinhibitory syncope|cardioinhibitory syncope
692198|NCT00292825|neurocardiogenic syncope|neurocardiogenic syncope
692199|NCT00292825|pacing|pacing
692200|NCT00292825|closed loop pacing|closed loop pacing
692201|NCT00292825|tilt table|tilt table
692202|NCT00292812|Infant nutrition|infant nutrition
692203|NCT00292812|Nucleotides|nucleotides
692204|NCT00292812|Infant formula|infant formula
692205|NCT00292799|Polycystic ovary syndrome|polycystic ovary syndrome
692206|NCT00292799|Obesity|obesity
692207|NCT00292799|metformin|metformin
692208|NCT00292799|orlistat|orlistat
692209|NCT00292786|Functional Electrical Stimulation|functional electrical stimulation
692210|NCT00292786|FES|fes
692211|NCT00292786|Walking|walking
692212|NCT00292786|Practice|practice
692213|NCT00292786|Coordination|coordination
692214|NCT00292786|Posture|posture
692215|NCT00292773|Anovulation|anovulation
692216|NCT00292773|Obesity|obesity
692217|NCT00292773|bariatric surgery|bariatric surgery
692218|NCT00292708|Antibiotics|antibiotics
692219|NCT00292708|Prophylaxis|prophylaxis
692220|NCT00292708|Surgical wound infection|surgical wound infection
692221|NCT00292656|Allergy|allergy
692222|NCT00292591|vitamin D|vitamin d
692223|NCT00292591|cholecalciferol|cholecalciferol
692224|NCT00292591|pregnancy|pregnancy
692225|NCT00292591|bone mineral density|bone mineral density
692226|NCT00292578|Allergy|allergy
692227|NCT00292578|Sugar Intolerance|sugar intolerance
692228|NCT00292578|Fatigue|fatigue
692229|NCT00292552|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
692230|NCT00292552|longitudinal|longitudinal
692231|NCT00292552|eclipse|eclipse
692232|NCT00292539|Pacemaker|pacemaker
692233|NCT00292539|NYHA class|nyha class
692234|NCT00292539|Ejection fraction|ejection fraction
692235|NCT00292539|Heart Failure|heart failure
692236|NCT00292526|Chemotherapy induced cardiotoxicity|chemotherapy induced cardiotoxicity
692237|NCT00292526|Troponin|troponin
692238|NCT00292526|Heart failure|heart failure
692239|NCT00292500|CABG, anastomotic device; myocardial revascularization|cabg, anastomotic device; myocardial revascularization
692240|NCT00292474|coronary artery disease|coronary artery disease
692241|NCT00292474|percutaneous coronary interventions|percutaneous coronary interventions
692242|NCT00292474|stent implant|stent implant
692243|NCT00292474|drug-coated stent|drug-coated stent
692244|NCT00292461|Epilepsy|epilepsy
692245|NCT00292461|seizures|seizures
692246|NCT00292422|Arthritis, Rheumatoid|arthritis, rheumatoid
692247|NCT00292422|Methotrexate|methotrexate
692248|NCT00292422|Antirheumatic Agents|antirheumatic agents
692249|NCT00292383|Cardiac Pacing, artificial|cardiac pacing, artificial
692250|NCT00292383|Atrial Fibrillation|atrial fibrillation
692251|NCT00292383|Heart failure|heart failure
692252|NCT00292383|Pacemaker leads|pacemaker leads
692253|NCT00292383|Lead position|lead position
692254|NCT00292383|Higher degree AV-Block|higher degree av-block
692255|NCT00292370|Atypical Antipsychotics|atypical antipsychotics
692256|NCT00292370|Controlled Trial|controlled trial
692257|NCT00292370|Paroxetine|paroxetine
692258|NCT00292370|Quetiapine|quetiapine
692259|NCT00292370|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
692260|NCT00292370|Treatment refractory|treatment refractory
692261|NCT00292370|Treatment resistant|treatment resistant
692262|NCT00292344|Travelers' diarrhea|travelers' diarrhea
692263|NCT00292344|rifaximin|rifaximin
692264|NCT00292344|loperamide|loperamide
692265|NCT00292344|enterotoxigenic E. coli|enterotoxigenic e. coli
692266|NCT00292331|gastric varices|gastric varices
692267|NCT00292331|liver cirrhosis|liver cirrhosis
692268|NCT00292331|hepatocelluar carcinoma|hepatocelluar carcinoma
692269|NCT00292331|rebleeding|rebleeding
692270|NCT00292331|long-term|long-term
692271|NCT00292318|adequate relief|adequate relief
692272|NCT00292318|anorectal manometry|anorectal manometry
692273|NCT00292318|biofeedback therapy|biofeedback therapy
692274|NCT00292318|fecal incontinence|fecal incontinence
692275|NCT00292305|PCI|pci
692276|NCT00292305|Bifurcation lesion|bifurcation lesion
692277|NCT00292279|Impact of Omega 3 fatty acid on outcome|impact of omega 3 fatty acid on outcome
692278|NCT00292279|Omega-3 fatty acid|omega-3 fatty acid
692279|NCT00292279|Carcinoma surgery|carcinoma surgery
692280|NCT00292279|Digestive System|digestive system
692281|NCT00292279|Parenteral Nutrition|parenteral nutrition
692282|NCT00292279|Fat Emulsions, Intravenous|fat emulsions, intravenous
692283|NCT00292279|Clinical outcome|clinical outcome
692284|NCT00292279|SIRS|sirs
692285|NCT00292279|Infectious complication|infectious complication
692286|NCT00292279|Postoperative hospital stay|postoperative hospital stay
692287|NCT00292279|Cost of postoperative period|cost of postoperative period
692288|NCT00292279|Post-operative nutritional cost & total treatment cost|post-operative nutritional cost & total treatment cost
692289|NCT00292266|Relapsing-remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
692290|NCT00292266|Rebif®|rebif®
692291|NCT00292266|Avonex®|avonex®
692292|NCT00292266|interferon-beta-1a|interferon-beta-1a
692293|NCT00292253|MS|ms
692294|NCT00292240|brief motivational intervention; teens; substance use|brief motivational intervention; teens; substance use
692295|NCT00292227|advanced-stage idiopathic Parkinson's disease|advanced-stage idiopathic parkinson's disease
692296|NCT00292214|paracetamol|paracetamol
692297|NCT00292214|acetaminophen|acetaminophen
692298|NCT00292214|pharmacokinetic|pharmacokinetic
692299|NCT00292214|intravenous|intravenous
692300|NCT00292214|oral|oral
692301|NCT00292214|analgesia|analgesia
692302|NCT00292214|pain|pain
692303|NCT00292214|opioid|opioid
692304|NCT00292201|Asthma|asthma
692305|NCT00292201|Statin|statin
692306|NCT00292188|Phase 4, post-traumatic neuropathic pain, neuropathic pain, Nep, post surgical pain, nerve injury, phantom limb pain, international|phase 4, post-traumatic neuropathic pain, neuropathic pain, nep, post surgical pain, nerve injury, phantom limb pain, international
692307|NCT00292175|colonoscopy, narrow band imaging (NBI), ulcerative colitis|colonoscopy, narrow band imaging (nbi), ulcerative colitis
692308|NCT00292162|Chronic Heart Failure|chronic heart failure
692309|NCT00292162|Atrial Fibrillation|atrial fibrillation
692310|NCT00292162|Radiofrequency Ablation|radiofrequency ablation
692311|NCT00292136|Cocaine Dependence|cocaine dependence
692312|NCT00292136|Drug Relapse|drug relapse
692313|NCT00292136|Pharmacokinetics|pharmacokinetics
692314|NCT00292136|EMA|ema
692315|NCT00292136|Polydrug Abuse|polydrug abuse
692316|NCT00292110|HIV|hiv
692317|NCT00292110|Opiate Substitution|opiate substitution
692318|NCT00292110|Pharmacokinetics|pharmacokinetics
692319|NCT00292110|ECG|ecg
692320|NCT00292110|Polydrug Abuse|polydrug abuse
692321|NCT00292097|Respiratory failure|respiratory failure
692322|NCT00292097|Tracheostomy|tracheostomy
692323|NCT00292097|Percutaneous dilatation tracheostomy|percutaneous dilatation tracheostomy
692324|NCT00292097|Endotracheal Conversion|endotracheal conversion
692325|NCT00292097|Traumatic brain injury|traumatic brain injury
692326|NCT00292084|Hepatitis C|hepatitis c
692327|NCT00292084|Celgosivir|celgosivir
692328|NCT00292084|HCV|hcv
692329|NCT00292084|Genotype 1|genotype 1
692330|NCT00292084|Non-responders|non-responders
692331|NCT00292084|End of Treatment Response|end of treatment response
692332|NCT00292084|Sustained Viral Response|sustained viral response
692333|NCT00292058|Telepsychiatry|telepsychiatry
692334|NCT00292058|Videoconference|videoconference
692335|NCT00292058|Psychiatric consultation|psychiatric consultation
692336|NCT00292058|Equivalence trial|equivalence trial
692337|NCT00292045|NY-ESO-1 protein, immunization, advanced prostate cancer|ny-eso-1 protein, immunization, advanced prostate cancer
692338|NCT00292032|cardiac arrest|cardiac arrest
692339|NCT00292032|diagnosis|diagnosis
692340|NCT00292032|genetics|genetics
692341|NCT00292032|testing|testing
692342|NCT00292006|clinical scaphoid fracture|clinical scaphoid fracture
692343|NCT00292006|pediatric|pediatric
692344|NCT00291993|Obstructive sleep apnea|obstructive sleep apnea
692345|NCT00291993|Vasoactive hormones|vasoactive hormones
692346|NCT00291993|Blood pressure|blood pressure
692347|NCT00291980|Dialysis|dialysis
692348|NCT00291980|Pre-dialysis|pre-dialysis
692349|NCT00291980|Hepatitis B vaccine|hepatitis b vaccine
692350|NCT00291980|Prophylaxis hepatitis B infection|prophylaxis hepatitis b infection
692351|NCT00291954|Dialysis|dialysis
692352|NCT00291954|Pre-dialysis|pre-dialysis
692353|NCT00291954|Hepatitis B vaccine|hepatitis b vaccine
692354|NCT00291954|Prophylaxis hepatitis B infection|prophylaxis hepatitis b infection
692355|NCT00291941|Dialysis|dialysis
692356|NCT00291941|Pre-dialysis|pre-dialysis
692357|NCT00291941|Hepatitis B vaccine|hepatitis b vaccine
692358|NCT00291941|Prophylaxis|prophylaxis
692359|NCT00291915|early arthritis, methotrexate, adalimumab|early arthritis, methotrexate, adalimumab
692360|NCT00291902|CHD|chd
692361|NCT00291902|coronary heart disease|coronary heart disease
692362|NCT00291902|atherosclerosis|atherosclerosis
692363|NCT00291902|inflammation|inflammation
692364|NCT00291876|HAVRIX™|havrix™
692365|NCT00291876|Hepatitis A|hepatitis a
692366|NCT00291863|end stage renal failure|end stage renal failure
692367|NCT00291863|peritoneal dialysis|peritoneal dialysis
692368|NCT00291863|simvastatin|simvastatin
692369|NCT00291863|endothelium|endothelium
692370|NCT00291863|vasodilation|vasodilation
692371|NCT00291850|NSCLC|nsclc
692372|NCT00291837|ovarian|ovarian
692373|NCT00291837|CT-2106|ct-2106
692374|NCT00291824|Cardiovascular risks|cardiovascular risks
692375|NCT00291824|Motivational interviewing|motivational interviewing
692376|NCT00291824|Behavior change|behavior change
692377|NCT00291824|Primary care setting|primary care setting
692378|NCT00291811|AMD3100|amd3100
692379|NCT00291811|G-CSF|g-csf
692380|NCT00291798|pilot study|pilot study
692381|NCT00291798|exemestane|exemestane
692382|NCT00291798|endocrinotherapy|endocrinotherapy
692383|NCT00291798|mamma carcinoma|mamma carcinoma
692384|NCT00291798|neoadjuvant|neoadjuvant
692385|NCT00291798|ABCSG|abcsg
692386|NCT00291798|17|17
692387|NCT00291785|colorectal cancer|colorectal cancer
692388|NCT00291785|camptothecin|camptothecin
692389|NCT00291772|Type 1 Diabetes|type 1 diabetes
692390|NCT00291772|hypoglycemia|hypoglycemia
692391|NCT00291772|hyperglycemia|hyperglycemia
692392|NCT00291746|GERD|gerd
692393|NCT00291733|Levetiracetam|levetiracetam
692394|NCT00291733|Levodopa-induced dyskinesias|levodopa-induced dyskinesias
692395|NCT00291733|Parkinson's|parkinson's
692396|NCT00291720|Aldosterone|aldosterone
692397|NCT00291720|Spironolactone|spironolactone
692398|NCT00291720|Chronic Kidney Disease|chronic kidney disease
692399|NCT00291720|Arterial Stiffness|arterial stiffness
692400|NCT00291707|head|head
692401|NCT00291707|neck|neck
692402|NCT00291707|Cetuximab|cetuximab
692403|NCT00291707|Pemetrexed|pemetrexed
692404|NCT00291694|breast atypia|breast atypia
692405|NCT00291694|double-blind randomized clinical trial|double-blind randomized clinical trial
692406|NCT00291694|RCT|rct
692407|NCT00291694|celecoxib|celecoxib
692408|NCT00291694|COX-2 inhibitor|cox-2 inhibitor
692409|NCT00291694|placebo|placebo
692410|NCT00291694|high risk for breast cancer|high risk for breast cancer
692411|NCT00291694|breast epithelial hyperplasia|breast epithelial hyperplasia
692412|NCT00291694|ki-67|ki-67
692413|NCT00291694|chemoprevention|chemoprevention
692414|NCT00291681|Inflammatory Bowel Disease|inflammatory bowel disease
692415|NCT00291681|B cell selection|b cell selection
692416|NCT00291668|Crohn's Disease|crohn's disease
692417|NCT00291668|CDP870, Certolizumab pegol|cdp870, certolizumab pegol
692418|NCT00291655|NEWLY DIAGNOSED EPILEPSY|newly diagnosed epilepsy
692419|NCT00291655|LEVETIRACETAM|levetiracetam
692420|NCT00291655|KEPPRA|keppra
692421|NCT00291655|N01175 (NCT00175903)|n01175 (nct00175903)
692422|NCT00291642|Levocetirizine, Xyzal, Rhinitis, Allergic, Seasonal, Ragweed|levocetirizine, xyzal, rhinitis, allergic, seasonal, ragweed
692423|NCT00291629|Myocardial infarction|myocardial infarction
692424|NCT00291629|revascularization|revascularization
692425|NCT00291629|drug eluting stents|drug eluting stents
692426|NCT00291616|chronic hepatitis B, pegylated interferon, thymosin alpha|chronic hepatitis b, pegylated interferon, thymosin alpha
692427|NCT00291603|dialysis|dialysis
692428|NCT00291603|Renal Dialysis|renal dialysis
692429|NCT00291603|inflammation|inflammation
692430|NCT00291603|quality of life|quality of life
692431|NCT00291603|End Stage Kidney Failure|end stage kidney failure
692432|NCT00291590|diabetes|diabetes
692433|NCT00291590|behavioral change|behavioral change
692434|NCT00291590|chronic care model|chronic care model
692435|NCT00291590|stage of change|stage of change
692436|NCT00291590|Medicaid|medicaid
692437|NCT00291590|Dual eligible|dual eligible
692438|NCT00291590|ethnic|ethnic
692439|NCT00291590|self-care|self-care
692440|NCT00291577|advanced|advanced
692441|NCT00291577|sunitinib (Sutent)|sunitinib (sutent)
692442|NCT00291577|docetaxel|docetaxel
692443|NCT00291577|Phase 1B|phase 1b
692444|NCT00291564|Observational|observational
692445|NCT00291564|Heart Failure|heart failure
692446|NCT00291564|Continuous Cardiac Resynchronization Therapy|continuous cardiac resynchronization therapy
692447|NCT00291525|valve|valve
692448|NCT00291525|prosthesis|prosthesis
692449|NCT00291525|antithrombotics|antithrombotics
692450|NCT00291525|randomized|randomized
692451|NCT00291512|HIV|hiv
692452|NCT00291512|STDs|stds
692453|NCT00291512|Methamphetamine abuse|methamphetamine abuse
692454|NCT00291512|MSM|msm
692455|NCT00291499|symptomatic OA of the hand|symptomatic oa of the hand
692456|NCT00291460|COPD|copd
692457|NCT00291460|respiratory failure|respiratory failure
692458|NCT00291460|inspiratory muscle training|inspiratory muscle training
692459|NCT00291434|Head and neck cancer|head and neck cancer
692460|NCT00291434|Fractionation|fractionation
692461|NCT00291434|Radiotherapy|radiotherapy
692462|NCT00291434|Conventional fractionation|conventional fractionation
692463|NCT00291434|Hyperfractionation|hyperfractionation
692464|NCT00291434|Accelerated fractionation|accelerated fractionation
692465|NCT00291421|Alzheimer's Disease|alzheimer's disease
692466|NCT00291421|Dementia|dementia
692467|NCT00291421|Brain Disease|brain disease
692468|NCT00291421|Memory Loss|memory loss
692469|NCT00291421|Caregiver|caregiver
692470|NCT00291421|Primary Caregiver|primary caregiver
692471|NCT00291421|Observation|observation
692472|NCT00291421|galantamine|galantamine
692473|NCT00291421|donepezil|donepezil
692474|NCT00291421|rivastigmine|rivastigmine
692475|NCT00291421|Quality of life|quality of life
692476|NCT00291382|Total asthma control|total asthma control
692477|NCT00291382|airway hyper-responsiveness|airway hyper-responsiveness
692478|NCT00291382|adult|adult
692479|NCT00291382|Asthma|asthma
692480|NCT00291369|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
692481|NCT00291369|Interleukin-2|interleukin-2
692482|NCT00291369|Interferon alfa|interferon alfa
692483|NCT00291369|Cytokines|cytokines
692484|NCT00291369|Survival|survival
692485|NCT00291356|Diabetes|diabetes
692486|NCT00291356|sodium dependent glucose transporter|sodium dependent glucose transporter
692487|NCT00291356|SGLT2|sglt2
692488|NCT00291356|GSK189075|gsk189075
692489|NCT00291356|GSK189074|gsk189074
692490|NCT00291356|SGLT1|sglt1
692491|NCT00291356|GW869683|gw869683
692492|NCT00291343|hepatitis B|hepatitis b
692493|NCT00291343|meningococcal vaccine|meningococcal vaccine
692494|NCT00291343|pertussis|pertussis
692495|NCT00291343|Prophylaxis diphtheria|prophylaxis diphtheria
692496|NCT00291343|meningococcal serogroups A and C diseases|meningococcal serogroups a and c diseases
692497|NCT00291343|tetanus|tetanus
692498|NCT00291343|Haemophilus influenzae type b|haemophilus influenzae type b
692499|NCT00291317|pediatric spinal cord injury|pediatric spinal cord injury
692500|NCT00291317|FES cycling|fes cycling
692501|NCT00291317|bone mineral density|bone mineral density
692502|NCT00291317|quality of life|quality of life
692503|NCT00291304|Magnetic Resonance Imaging|magnetic resonance imaging
692504|NCT00291304|Pathology|pathology
692505|NCT00291278|Endometriosis|endometriosis
692506|NCT00291278|Bone Mineral Density|bone mineral density
692507|NCT00291278|Osteopenia|osteopenia
692508|NCT00291278|Osteoporosis|osteoporosis
692509|NCT00291278|DEXA Scan|dexa scan
692510|NCT00291278|Menopause|menopause
692511|NCT00291278|Screening|screening
692512|NCT00291278|Healthy Volunteer|healthy volunteer
692513|NCT00291278|HV|hv
692514|NCT00291265|Bradykinesia|bradykinesia
692515|NCT00291265|Tremor|tremor
692516|NCT00291265|Speech|speech
692517|NCT00291265|Rigidity|rigidity
692518|NCT00291265|Neurodegeneration|neurodegeneration
692519|NCT00291265|Parkinson Disease|parkinson disease
692520|NCT00291265|PD|pd
692521|NCT00291226|schizophrenia prodrome|schizophrenia prodrome
692522|NCT00291200|Psychosis|psychosis
692523|NCT00291200|Basic Symptoms|basic symptoms
692524|NCT00291174|Ventricular Arrhythmia|ventricular arrhythmia
692525|NCT00291174|Myocardial Infarction|myocardial infarction
692526|NCT00291174|Ventricular Dysfunction|ventricular dysfunction
692527|NCT00291174|Coronary Artery Disease|coronary artery disease
692528|NCT00291174|Structural Heart Disease|structural heart disease
692529|NCT00291174|Arrhythmia|arrhythmia
692530|NCT00291174|Cardiomyopathies|cardiomyopathies
692531|NCT00291161|Delivery of Health Care, Integrated|delivery of health care, integrated
692532|NCT00291161|United States Department of Veterans Affairs|united states department of veterans affairs
692533|NCT00291161|Dementia|dementia
692534|NCT00291161|Patient Care Management|patient care management
692535|NCT00291148|Neuropathic pain|neuropathic pain
692536|NCT00291148|Multiple Sclerosis|multiple sclerosis
692537|NCT00291148|pregabalin|pregabalin
692538|NCT00291148|paroxetine|paroxetine
692539|NCT00291135|breast atypia|breast atypia
692540|NCT00291135|open label pilot study|open label pilot study
692541|NCT00291135|letrozole|letrozole
692542|NCT00291135|fine needle aspiration|fine needle aspiration
692543|NCT00291135|high risk for breast cancer|high risk for breast cancer
692544|NCT00291135|breast epithelial hyperplasia|breast epithelial hyperplasia
692545|NCT00291135|Ki-67|ki-67
692546|NCT00291135|hormones plus chemoprevention|hormones plus chemoprevention
692547|NCT00291135|chemoprevention|chemoprevention
692548|NCT00291122|breast atypia|breast atypia
692549|NCT00291122|breast epithelial hyperplasia|breast epithelial hyperplasia
692550|NCT00291122|ki-67|ki-67
692551|NCT00291122|RTPCR|rtpcr
692552|NCT00291122|microdissection|microdissection
692553|NCT00291109|breast atypia|breast atypia
692554|NCT00291109|breast epithelial hyperplasia|breast epithelial hyperplasia
692555|NCT00291109|Ki-67|ki-67
692556|NCT00291109|RTPCR|rtpcr
692557|NCT00291109|microdissection|microdissection
692558|NCT00291096|breast atypia|breast atypia
692559|NCT00291096|fine needle aspiration|fine needle aspiration
692560|NCT00291096|high risk for breast cancer|high risk for breast cancer
692561|NCT00291096|breast epithelial hyperplasia|breast epithelial hyperplasia
692562|NCT00291083|NAF|naf
692563|NCT00291083|nipple aspirate fluid|nipple aspirate fluid
692564|NCT00291083|breast atypia|breast atypia
692565|NCT00291083|high risk for breast cancer|high risk for breast cancer
692566|NCT00291083|breast epithelial hyperplasia|breast epithelial hyperplasia
692567|NCT00291083|Ki-67|ki-67
692568|NCT00291083|hormones plus chemoprevention|hormones plus chemoprevention
692569|NCT00291083|chemoprevention|chemoprevention
692570|NCT00291070|ADHD|adhd
692571|NCT00291070|attention|attention
692572|NCT00291070|insomnia|insomnia
692573|NCT00291070|hyperactivity|hyperactivity
692574|NCT00291070|anxiety|anxiety
692575|NCT00291057|Pediculosis|pediculosis
692576|NCT00291057|Head Lice|head lice
692577|NCT00291044|pregnancy, genital herpes|pregnancy, genital herpes
692578|NCT00291031|nightmare|nightmare
692579|NCT00291031|sleep disorder|sleep disorder
692580|NCT00291031|sleep|sleep
692581|NCT00291031|imagery rehearsal|imagery rehearsal
692582|NCT00291031|anxiety disorders|anxiety disorders
692583|NCT00291031|mood disorders|mood disorders
692584|NCT00291031|personality disorders|personality disorders
692585|NCT00291018|ProDisc|prodisc
692586|NCT00291018|ProDisc-C|prodisc-c
692587|NCT00291018|Spinal Fusion|spinal fusion
692588|NCT00291018|Anterior cervical diskectomy|anterior cervical diskectomy
692589|NCT00291018|Cervical spine|cervical spine
692590|NCT00291018|Disc disease|disc disease
692591|NCT00291018|Implant|implant
692592|NCT00291018|Degenerative disc disease|degenerative disc disease
692593|NCT00291018|Intervertebral disc|intervertebral disc
692594|NCT00291005|Prostate cancer|prostate cancer
692595|NCT00291005|HRPC|hrpc
692596|NCT00291005|AIPC|aipc
692597|NCT00291005|Hormone refractory|hormone refractory
692598|NCT00291005|Androgen independent|androgen independent
692599|NCT00291005|Docetaxel|docetaxel
692600|NCT00291005|Taxotere|taxotere
692601|NCT00291005|prednisolone|prednisolone
692602|NCT00290992|urate oxidase, hyperuricemia, lymphoma, leukemia|urate oxidase, hyperuricemia, lymphoma, leukemia
692603|NCT00290979|HMR1964, insulin glulisine, Diabetes Mellitus, Type 1|hmr1964, insulin glulisine, diabetes mellitus, type 1
692604|NCT00290966|docetaxel|docetaxel
692605|NCT00290966|stomach neoplasm|stomach neoplasm
692606|NCT00290953|Metastases|metastases
692607|NCT00290940|Diabetes mellitus, Type 2|diabetes mellitus, type 2
692608|NCT00290940|High blood sugar|high blood sugar
692609|NCT00290940|Hyperglycemia|hyperglycemia
692610|NCT00290940|Antihyperglycemic agents|antihyperglycemic agents
692611|NCT00290940|CS-917|cs-917
692612|NCT00290927|HMR1964, insulin glulisine, Diabetes Mellitus, Type 2|hmr1964, insulin glulisine, diabetes mellitus, type 2
692613|NCT00290888|Rotator Cuff Tear|rotator cuff tear
692614|NCT00290888|Tendon Repair|tendon repair
692615|NCT00290888|Acromioplasty|acromioplasty
692616|NCT00290888|Arthroscopy|arthroscopy
692617|NCT00290888|Orthopedic Surgery|orthopedic surgery
692618|NCT00290875|cspine injury|cspine injury
692619|NCT00290875|radiography|radiography
692620|NCT00290875|clinical impact|clinical impact
692621|NCT00290875|dissemination|dissemination
692622|NCT00290862|Osteoporosis|osteoporosis
692623|NCT00290862|Spine fracture|spine fracture
692624|NCT00290862|Back Pain|back pain
692625|NCT00290862|Vertebroplasty|vertebroplasty
692626|NCT00290862|Vertebral compression fractures related to osteoporosis|vertebral compression fractures related to osteoporosis
692627|NCT00290823|Taenia|taenia
692628|NCT00290823|Seizures|seizures
692629|NCT00290823|Tapeworm|tapeworm
692630|NCT00290823|Parasite|parasite
692631|NCT00290771|imatinib mesylate|imatinib mesylate
692632|NCT00290771|hydroxyurea|hydroxyurea
692633|NCT00290771|protein tyrosine kinases|protein tyrosine kinases
692634|NCT00290771|glioma|glioma
692635|NCT00290771|glioblastoma multiforme|glioblastoma multiforme
692636|NCT00290771|recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
692637|NCT00290771|GBM|gbm
692638|NCT00290771|MacDonald criteria|macdonald criteria
692639|NCT00290745|breast cancer in situ|breast cancer in situ
692640|NCT00290745|ductal breast carcinoma in situ|ductal breast carcinoma in situ
692641|NCT00290732|stage I breast cancer|stage i breast cancer
692642|NCT00290732|stage II breast cancer|stage ii breast cancer
692643|NCT00290732|stage IIIA breast cancer|stage iiia breast cancer
692644|NCT00290732|stage IIIC breast cancer|stage iiic breast cancer
692645|NCT00290732|stage IV breast cancer|stage iv breast cancer
692646|NCT00290732|breast cancer in situ|breast cancer in situ
692647|NCT00290732|ductal breast carcinoma in situ|ductal breast carcinoma in situ
692648|NCT00290719|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
692649|NCT00290719|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
692650|NCT00290719|stage II esophageal cancer|stage ii esophageal cancer
692651|NCT00290719|stage III esophageal cancer|stage iii esophageal cancer
692652|NCT00290706|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
692653|NCT00290706|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
692654|NCT00290706|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
692655|NCT00290706|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
692656|NCT00290706|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
692657|NCT00290706|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
692658|NCT00290706|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
692659|NCT00290693|recurrent pancreatic cancer|recurrent pancreatic cancer
692660|NCT00290693|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
692661|NCT00290693|stage IV pancreatic cancer|stage iv pancreatic cancer
692662|NCT00290680|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
692663|NCT00290667|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
692664|NCT00290667|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
692665|NCT00290667|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
692666|NCT00290667|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
692667|NCT00290667|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
692668|NCT00290667|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
692669|NCT00290667|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
692670|NCT00290667|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
692671|NCT00290667|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
692672|NCT00290667|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
692673|NCT00290667|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
692674|NCT00290667|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
692675|NCT00290667|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
692676|NCT00290667|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
692677|NCT00290667|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
692678|NCT00290667|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
692679|NCT00290667|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
692680|NCT00290667|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
692681|NCT00290667|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
692682|NCT00290667|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
692683|NCT00290667|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
692684|NCT00290667|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
692685|NCT00290667|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
692686|NCT00290667|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
692687|NCT00290667|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
692688|NCT00290667|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
692689|NCT00290667|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
692690|NCT00290667|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
692691|NCT00290667|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
692692|NCT00290667|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
692693|NCT00290667|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
692694|NCT00290667|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
692695|NCT00290667|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
692696|NCT00290667|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
692697|NCT00290667|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
692698|NCT00290667|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
692699|NCT00290667|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
692700|NCT00290667|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
692701|NCT00290667|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
692987|NCT00290433|Neupogen|neupogen
692702|NCT00290667|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
692703|NCT00290654|ductal breast carcinoma in situ|ductal breast carcinoma in situ
692704|NCT00290654|breast cancer in situ|breast cancer in situ
692705|NCT00290641|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
692706|NCT00290641|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
692707|NCT00290641|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
692708|NCT00290641|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
692709|NCT00290641|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
692710|NCT00290641|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
692711|NCT00290641|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
692712|NCT00290641|secondary acute myeloid leukemia|secondary acute myeloid leukemia
692713|NCT00290641|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
692714|NCT00290641|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
692715|NCT00290641|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
692716|NCT00290641|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
692717|NCT00290641|refractory anemia with excess blasts|refractory anemia with excess blasts
692718|NCT00290641|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
692719|NCT00290641|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
692720|NCT00290641|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
692721|NCT00290641|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
692722|NCT00290641|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
692723|NCT00290641|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
692724|NCT00290641|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
692725|NCT00290641|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
692726|NCT00290641|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
692727|NCT00290641|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
692728|NCT00290641|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
692729|NCT00290641|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
692730|NCT00290641|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
692731|NCT00290641|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
692732|NCT00290641|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
692733|NCT00290641|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
692734|NCT00290641|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
692735|NCT00290641|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
692736|NCT00290641|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
692737|NCT00290641|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
692738|NCT00290641|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
692739|NCT00290641|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
692740|NCT00290641|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
692741|NCT00290641|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
692742|NCT00290641|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
692743|NCT00290641|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
692744|NCT00290641|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
692745|NCT00290641|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
692746|NCT00290641|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
692747|NCT00290641|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
692748|NCT00290641|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
692749|NCT00290641|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
692750|NCT00290641|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
692751|NCT00290641|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
692752|NCT00290641|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
692753|NCT00290641|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
692754|NCT00290641|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
692755|NCT00290641|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
692756|NCT00290641|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
693206|NCT00289484|Mood disorder|mood disorder
692757|NCT00290641|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
692758|NCT00290641|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
692759|NCT00290641|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
692760|NCT00290641|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
692882|NCT00290628|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
692761|NCT00290641|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
692762|NCT00290641|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
692763|NCT00290641|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
692764|NCT00290641|chronic eosinophilic leukemia|chronic eosinophilic leukemia
692765|NCT00290641|chronic neutrophilic leukemia|chronic neutrophilic leukemia
692766|NCT00290641|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
692767|NCT00290641|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
692768|NCT00290641|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
692769|NCT00290641|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
692770|NCT00290641|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
692771|NCT00290641|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
692772|NCT00290641|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
692773|NCT00290641|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
692774|NCT00290641|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
692775|NCT00290641|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
692776|NCT00290641|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
692777|NCT00290641|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
692778|NCT00290641|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
692779|NCT00290641|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
692780|NCT00290641|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
692781|NCT00290641|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
692782|NCT00290641|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
692783|NCT00290641|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
692784|NCT00290641|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
692785|NCT00290641|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
692786|NCT00290641|stage I mantle cell lymphoma|stage i mantle cell lymphoma
692787|NCT00290641|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
692788|NCT00290641|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
692789|NCT00290641|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
692790|NCT00290641|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
692791|NCT00290641|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
692792|NCT00290641|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
692793|NCT00290641|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
692794|NCT00290641|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
692795|NCT00290628|graft versus host disease|graft versus host disease
692796|NCT00290628|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
692797|NCT00290628|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
692798|NCT00290628|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
692799|NCT00290628|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
692800|NCT00290628|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
692801|NCT00290628|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
692802|NCT00290628|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
692803|NCT00290628|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
692804|NCT00290628|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
692805|NCT00290628|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
692806|NCT00290628|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
692807|NCT00290628|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
692808|NCT00290628|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
692809|NCT00290628|chronic eosinophilic leukemia|chronic eosinophilic leukemia
692810|NCT00290628|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
692811|NCT00290628|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
692812|NCT00290628|chronic neutrophilic leukemia|chronic neutrophilic leukemia
692813|NCT00290628|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
692814|NCT00290628|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
692815|NCT00290628|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
692816|NCT00290628|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
692817|NCT00290628|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
692818|NCT00290628|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
692819|NCT00290628|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
692820|NCT00290628|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
692982|NCT00290433|Mesna|mesna
692821|NCT00290628|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
692822|NCT00290628|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
692823|NCT00290628|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
692824|NCT00290628|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
692825|NCT00290628|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
692826|NCT00290628|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
692827|NCT00290628|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
692828|NCT00290628|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
692829|NCT00290628|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
692830|NCT00290628|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
692831|NCT00290628|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
692832|NCT00290628|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
692833|NCT00290628|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
692834|NCT00290628|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
692835|NCT00290628|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
692836|NCT00290628|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
692837|NCT00290628|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
692838|NCT00290628|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
692839|NCT00290628|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
692840|NCT00290628|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
692841|NCT00290628|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
692842|NCT00290628|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
692843|NCT00290628|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
693332|NCT00288834|stroke|stroke
692844|NCT00290628|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
692845|NCT00290628|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
692846|NCT00290628|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
692847|NCT00290628|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
692848|NCT00290628|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
692849|NCT00290628|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
692850|NCT00290628|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
692851|NCT00290628|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
692852|NCT00290628|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
692853|NCT00290628|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
692854|NCT00290628|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
692855|NCT00290628|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
692856|NCT00290628|refractory hairy cell leukemia|refractory hairy cell leukemia
692857|NCT00290628|refractory multiple myeloma|refractory multiple myeloma
692858|NCT00290628|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
692859|NCT00290628|secondary acute myeloid leukemia|secondary acute myeloid leukemia
692860|NCT00290628|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
692861|NCT00290628|splenic marginal zone lymphoma|splenic marginal zone lymphoma
692862|NCT00290628|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
692863|NCT00290628|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
692864|NCT00290628|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
692865|NCT00290628|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
692866|NCT00290628|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
692867|NCT00290628|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
692868|NCT00290628|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
692869|NCT00290628|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
692870|NCT00290628|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
692871|NCT00290628|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
692872|NCT00290628|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
692873|NCT00290628|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
692874|NCT00290628|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
692875|NCT00290628|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
692876|NCT00290628|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
692877|NCT00290628|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
692878|NCT00290628|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
692879|NCT00290628|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
692880|NCT00290628|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
692881|NCT00290628|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
692983|NCT00290433|Methotrexate|methotrexate
692883|NCT00290628|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
692884|NCT00290628|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
692885|NCT00290628|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
692886|NCT00290628|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
692887|NCT00290628|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
692888|NCT00290628|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
692889|NCT00290628|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
692890|NCT00290628|Diamond-Blackfan anemia|diamond-blackfan anemia
692891|NCT00290628|Fanconi anemia|fanconi anemia
692892|NCT00290628|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
692893|NCT00290615|adenocarcinoma of the colon|adenocarcinoma of the colon
692894|NCT00290615|recurrent colon cancer|recurrent colon cancer
692895|NCT00290615|stage IV colon cancer|stage iv colon cancer
692896|NCT00290615|adenocarcinoma of the rectum|adenocarcinoma of the rectum
692897|NCT00290615|recurrent rectal cancer|recurrent rectal cancer
692898|NCT00290615|stage IV rectal cancer|stage iv rectal cancer
692899|NCT00290602|Acute respiratory distress syndrome|acute respiratory distress syndrome
692900|NCT00290602|corticosteroids|corticosteroids
692901|NCT00290602|postoperative complications|postoperative complications
692902|NCT00290602|cytokines|cytokines
692903|NCT00290589|low back pain|low back pain
692904|NCT00290589|emergency department|emergency department
692905|NCT00290589|corticosteroids|corticosteroids
692906|NCT00290576|Digestive and Nutritional Effects|digestive and nutritional effects
692907|NCT00290576|Safety and Growth|safety and growth
692908|NCT00290576|Feeding Tolerance|feeding tolerance
692909|NCT00290550|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
692910|NCT00290550|NSCLC|nsclc
692911|NCT00290537|Non-Small Cell Lung Cancer|non-small cell lung cancer
692912|NCT00290537|Lung Cancer|lung cancer
692913|NCT00290537|Carboplatin|carboplatin
692914|NCT00290537|Paclitaxel|paclitaxel
692915|NCT00290537|ZD6474|zd6474
692916|NCT00290537|NSCLC|nsclc
692917|NCT00290524|Oral alimentation following colorectal surgery|oral alimentation following colorectal surgery
692918|NCT00290524|anastomosis|anastomosis
692919|NCT00290524|laparoscopy|laparoscopy
692920|NCT00290524|hospitalization stay|hospitalization stay
692921|NCT00290511|Follicular Lymphoma|follicular lymphoma
692922|NCT00290511|Zevalin|zevalin
692923|NCT00290511|Ibritumomab Tiuxetan|ibritumomab tiuxetan
692924|NCT00290511|IDEC-Y2B8|idec-y2b8
692925|NCT00290511|Fludarabine|fludarabine
692926|NCT00290511|Fludara|fludara
692927|NCT00290511|Dexamethasone|dexamethasone
692928|NCT00290511|Mitoxantrone|mitoxantrone
692929|NCT00290511|Rituximab|rituximab
692930|NCT00290511|Rituxan|rituxan
692931|NCT00290511|R-FND|r-fnd
692932|NCT00290511|Fludarabine Phosphate|fludarabine phosphate
692933|NCT00290511|Decadron|decadron
692934|NCT00290498|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
692935|NCT00290498|B-Cell Non-Hodgkin's Lymphoma|b-cell non-hodgkin's lymphoma
692936|NCT00290498|Lymphoma|lymphoma
692937|NCT00290498|Cyclophosphamide|cyclophosphamide
692938|NCT00290498|Cytarabine|cytarabine
692939|NCT00290498|Doxorubicin|doxorubicin
692940|NCT00290498|Hyper-CVAD|hyper-cvad
692941|NCT00290498|Methotrexate|methotrexate
692942|NCT00290498|Prednisone|prednisone
692943|NCT00290498|Rituximab|rituximab
692944|NCT00290498|Vincristine|vincristine
692945|NCT00290498|R-CHOP|r-chop
692946|NCT00290498|R-HCVAD|r-hcvad
692947|NCT00290498|Dexamethasone|dexamethasone
692948|NCT00290498|Decadron|decadron
692949|NCT00290498|Leucovorin|leucovorin
692950|NCT00290498|Ara-C|ara-c
692951|NCT00290498|Cytosar|cytosar
692952|NCT00290498|Cytoxan|cytoxan
692953|NCT00290498|DepoCyt|depocyt
692954|NCT00290498|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
692955|NCT00290498|AD|ad
692956|NCT00290498|Hydroxydaunomycin hydrochloride|hydroxydaunomycin hydrochloride
692957|NCT00290498|Neosar|neosar
692958|NCT00290485|non-resectable tumor|non-resectable tumor
692959|NCT00290485|high-risk tumor|high-risk tumor
692960|NCT00290485|metastasis|metastasis
692961|NCT00290485|Response Evaluation Criteria in Solid Tumors (RECIST)|response evaluation criteria in solid tumors (recist)
692962|NCT00290485|Gleevec|gleevec
692963|NCT00290485|Imatinib mesylate|imatinib mesylate
692964|NCT00290459|Gynecologic Disease|gynecologic disease
692965|NCT00290459|Gynecologic Cancer|gynecologic cancer
692966|NCT00290459|Prognostic Markers|prognostic markers
692967|NCT00290433|Lymphoma|lymphoma
692968|NCT00290433|Peripheral T Cell|peripheral t cell
692969|NCT00290433|HCVIDDOXIL Regimen|hcviddoxil regimen
692970|NCT00290433|ARA-C|ara-c
692971|NCT00290433|Cytosar|cytosar
692972|NCT00290433|DepoCyt|depocyt
692973|NCT00290433|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
692974|NCT00290433|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
692975|NCT00290433|Doxorubicin hydrochloride|doxorubicin hydrochloride
692976|NCT00290433|Doxil|doxil
692977|NCT00290433|Cyclophosphamide|cyclophosphamide
692978|NCT00290433|Cytoxan|cytoxan
692979|NCT00290433|Neosar|neosar
692980|NCT00290433|Dexamethasone|dexamethasone
692981|NCT00290433|Decadron|decadron
692988|NCT00290420|malaria|malaria
692989|NCT00290420|Plasmodium vivax|plasmodium vivax
692990|NCT00290420|pregnancy|pregnancy
692991|NCT00290420|chemoprophylaxis|chemoprophylaxis
692992|NCT00290407|chronic lymphocytic leukemia|chronic lymphocytic leukemia
692993|NCT00290407|small lymphocytic lymphoma|small lymphocytic lymphoma
692994|NCT00290407|rituximab|rituximab
692995|NCT00290407|beta-glucan|beta-glucan
692996|NCT00290394|Blood Pressure,|blood pressure,
692997|NCT00290394|rosiglitazone,Diabetes Mellitus, Type 2,|rosiglitazone,diabetes mellitus, type 2,
692998|NCT00290381|Allergic rhinitis|allergic rhinitis
692999|NCT00290368|Nasal allergen challenge|nasal allergen challenge
693000|NCT00290368|Allergic rhinitis|allergic rhinitis
693001|NCT00290368|Timothy grass pollen|timothy grass pollen
693002|NCT00290368|inflammatory mediators|inflammatory mediators
693003|NCT00290329|Safety|safety
693004|NCT00290329|Meningococcal disease|meningococcal disease
693005|NCT00290329|Meningitidis serogroups A, C,W & Y diseases|meningitidis serogroups a, c,w & y diseases
693006|NCT00290329|Meningococcal vaccine|meningococcal vaccine
693007|NCT00290316|Hepatocellular carcinoma|hepatocellular carcinoma
693008|NCT00290316|Cholangiocarcinoma|cholangiocarcinoma
693009|NCT00290316|Metastasis|metastasis
693010|NCT00290316|Liver neoplasm|liver neoplasm
693011|NCT00290290|Prevention|prevention
693012|NCT00290290|Antiseptic Preoperative Scrub|antiseptic preoperative scrub
693013|NCT00290290|Postoperative Wound Infection|postoperative wound infection
693014|NCT00290251|Endometrium|endometrium
693015|NCT00290251|Progesterone|progesterone
693016|NCT00290251|Estrogen|estrogen
693017|NCT00290251|Fibroid|fibroid
693018|NCT00290251|Hysterectomy|hysterectomy
693019|NCT00290251|Leiomyoma|leiomyoma
693020|NCT00290251|Uterine Fibroids|uterine fibroids
693021|NCT00290251|Fibroids|fibroids
693022|NCT00290238|Chronic Low Back Pain|chronic low back pain
693023|NCT00290238|Lower Extremity Pain|lower extremity pain
693024|NCT00290238|Central Sensitization|central sensitization
693025|NCT00290238|Percutaneous Neuromodulation Therapy|percutaneous neuromodulation therapy
693026|NCT00290225|Posttraumatic stress disorder|posttraumatic stress disorder
693027|NCT00290225|depression|depression
693028|NCT00290225|disaster mental health|disaster mental health
693029|NCT00290225|yoga|yoga
693030|NCT00290225|Breathwork|breathwork
693031|NCT00290225|exposure treatments|exposure treatments
693032|NCT00290212|Women|women
693033|NCT00290212|Bone density|bone density
693034|NCT00290212|Menopause|menopause
693035|NCT00290212|Dietary Supplements|dietary supplements
693036|NCT00290212|Vitamin K2|vitamin k2
693037|NCT00290199|Fetal Membranes, Premature Rupture|fetal membranes, premature rupture
693038|NCT00290199|Labor, Induced|labor, induced
693039|NCT00290199|Foley Catheter|foley catheter
693040|NCT00290186|Cerebral Palsy|cerebral palsy
693041|NCT00290186|Spastic Cerebral Palsy|spastic cerebral palsy
693042|NCT00290186|CP|cp
693043|NCT00290186|Hyperbaric|hyperbaric
693044|NCT00290186|HBOT|hbot
693045|NCT00290173|pre term labor|pre term labor
693046|NCT00290173|therapy|therapy
693047|NCT00290173|maintenance|maintenance
693048|NCT00290160|Hyperkalemia|hyperkalemia
693049|NCT00290160|Protein|protein
693050|NCT00290160|Hyperglycemia|hyperglycemia
693051|NCT00290160|ELBW|elbw
693052|NCT00290147|Dengue|dengue
693053|NCT00290147|DNA vaccine|dna vaccine
693054|NCT00290134|Hypogonadism|hypogonadism
693055|NCT00290134|Testosterone|testosterone
693056|NCT00290121|Schizophrenia|schizophrenia
693057|NCT00290121|Atypical antipsychotics|atypical antipsychotics
693058|NCT00290121|Weight gain|weight gain
693059|NCT00290121|Appetite|appetite
693060|NCT00290121|fMRI|fmri
693061|NCT00290108|BIS|bis
693062|NCT00290108|Propofol|propofol
693063|NCT00290108|hemodynamic|hemodynamic
693064|NCT00290108|pharmacokinetic|pharmacokinetic
693065|NCT00290095|Multiple Myeloma|multiple myeloma
693066|NCT00290095|Quality of Life|quality of life
693067|NCT00290095|Response Shift|response shift
693068|NCT00290095|Clinically Important Difference|clinically important difference
693069|NCT00290082|sedation|sedation
693070|NCT00290082|midazolam|midazolam
693071|NCT00290082|loxapine|loxapine
693072|NCT00290082|agitation|agitation
693073|NCT00290082|emergency department|emergency department
693074|NCT00290082|toxicological analysis|toxicological analysis
693075|NCT00290069|Renal function|renal function
693076|NCT00290069|Serum creatinine|serum creatinine
693077|NCT00290069|Immunosuppression|immunosuppression
693078|NCT00290069|Rejection|rejection
693079|NCT00290056|CHD|chd
693080|NCT00290056|Arrhythmia|arrhythmia
693081|NCT00290056|ICD|icd
693082|NCT00290056|Omega-3 PUFA|omega-3 pufa
693083|NCT00290056|Nutrition|nutrition
693084|NCT00290043|Insulin glulisine|insulin glulisine
693085|NCT00290043|Diabetes mellitus Type 1|diabetes mellitus type 1
693086|NCT00290043|Postprandial Period|postprandial period
693087|NCT00290043|Pharmacokinetics|pharmacokinetics
693088|NCT00290043|Glucodynamics|glucodynamics
693089|NCT00290030|acute urinary retention|acute urinary retention
693279|NCT00289068|phacoemulsification sleeve|phacoemulsification sleeve
693090|NCT00290030|International Prostate Symptom Score (IPSS)|international prostate symptom score (ipss)
693091|NCT00290004|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
693092|NCT00290004|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
693093|NCT00290004|Leukemia|leukemia
693094|NCT00290004|Lymphoma|lymphoma
693095|NCT00290004|Motexafin Gadolinium|motexafin gadolinium
693096|NCT00290004|Relapsed Chronic Lymphocytic Leukemia|relapsed chronic lymphocytic leukemia
693097|NCT00290004|Relapsed Small Lymphocytic Lymphoma|relapsed small lymphocytic lymphoma
693098|NCT00290004|Refractory Chronic Lymphocytic Leukemia|refractory chronic lymphocytic leukemia
693099|NCT00290004|Refractory Small Lymphocytic Lymphoma|refractory small lymphocytic lymphoma
693100|NCT00289978|Multiple Sclerosis|multiple sclerosis
693101|NCT00289978|FTY720|fty720
693102|NCT00289978|Fingolimod|fingolimod
693103|NCT00289965|Alcohol Abuse|alcohol abuse
693104|NCT00289965|Alcohol Drinking|alcohol drinking
693105|NCT00289965|Intervention Studies|intervention studies
693106|NCT00289965|Computer-Assisted Instruction|computer-assisted instruction
693107|NCT00289965|College Students|college students
693108|NCT00289952|HIV infections|hiv infections
693109|NCT00289952|Histone deacetylase Inhibitor|histone deacetylase inhibitor
693110|NCT00289952|HIV Reservoirs|hiv reservoirs
693111|NCT00289952|Peripheral Blood Mononuclear Cells|peripheral blood mononuclear cells
693112|NCT00289952|Valproic Acid|valproic acid
693113|NCT00289952|Treatment Experienced|treatment experienced
693114|NCT00289939|women|women
693115|NCT00289939|women's health|women's health
693116|NCT00289939|HIV|hiv
693117|NCT00289939|risk factors|risk factors
693118|NCT00289939|risk behaviors|risk behaviors
693119|NCT00289939|prevention|prevention
693120|NCT00289939|motivational interviewing|motivational interviewing
693121|NCT00289939|domestic violence|domestic violence
693122|NCT00289939|partner violence|partner violence
693123|NCT00289939|behavioral trial|behavioral trial
693124|NCT00289939|community justice|community justice
693125|NCT00289939|criminal justice|criminal justice
693126|NCT00289926|low libido|low libido
693127|NCT00289926|lack of wellbeing|lack of wellbeing
693128|NCT00289913|Hepatitis A virus|hepatitis a virus
693129|NCT00289861|Schizophrenia|schizophrenia
693130|NCT00289861|risperidone|risperidone
693131|NCT00289861|prolactin|prolactin
693132|NCT00289861|clozapine|clozapine
693133|NCT00289835|Coronary Artery Bypass Grafting|coronary artery bypass grafting
693134|NCT00289835|Drug Eluting Stent|drug eluting stent
693135|NCT00289835|Saphenous Vein Graft|saphenous vein graft
693136|NCT00289822|chronic heart failure|chronic heart failure
693137|NCT00289822|myocardial infarction|myocardial infarction
693138|NCT00289783|Primary and booster vaccination|primary and booster vaccination
693139|NCT00289783|Neisseria meningitidis|neisseria meningitidis
693140|NCT00289783|Hib disease|hib disease
693141|NCT00289783|Meningococcal vaccine|meningococcal vaccine
693142|NCT00289783|Meningococcal disease|meningococcal disease
693143|NCT00289783|Children|children
693144|NCT00289783|Immunogenicity|immunogenicity
693145|NCT00289783|Safety|safety
693146|NCT00289783|Infants|infants
693147|NCT00289770|TWINRIX™ ADULT|twinrix™ adult
693148|NCT00289770|Hepatitis A|hepatitis a
693149|NCT00289770|Hepatitis B|hepatitis b
693150|NCT00289757|Havrix™|havrix™
693151|NCT00289757|Hepatitis A|hepatitis a
693152|NCT00289744|Hepatitis B|hepatitis b
693153|NCT00289744|TWINRIX™ ADULT|twinrix™ adult
693154|NCT00289744|Hepatitis A|hepatitis a
693155|NCT00289731|Combined hepatitis A and hepatitis B vaccine|combined hepatitis a and hepatitis b vaccine
693156|NCT00289731|Hepatitis B|hepatitis b
693157|NCT00289731|Hepatitis A|hepatitis a
693158|NCT00289731|Monovalent hepatitis A and hepatitis B vaccines|monovalent hepatitis a and hepatitis b vaccines
693159|NCT00289718|Combined Hepatitis A and B vaccine|combined hepatitis a and b vaccine
693160|NCT00289718|Hepatitis A|hepatitis a
693161|NCT00289718|Hepatitis B|hepatitis b
693162|NCT00289705|Obesity|obesity
693163|NCT00289705|Surgery|surgery
693164|NCT00289705|Adolescent|adolescent
693165|NCT00289705|Roux-en-Y gastric bypass|roux-en-y gastric bypass
693166|NCT00289705|Laparoscopic|laparoscopic
693167|NCT00289666|Sleep Disorder|sleep disorder
693168|NCT00289666|CPAP|cpap
693169|NCT00289653|nicotine dependence,|nicotine dependence,
693170|NCT00289653|transdermal nicotine patch,|transdermal nicotine patch,
693171|NCT00289653|smoking while receiving nicotine replacement,|smoking while receiving nicotine replacement,
693172|NCT00289653|comorbidities|comorbidities
693173|NCT00289640|Stage III (unresectable)|stage iii (unresectable)
693174|NCT00289640|Stage IV melanoma|stage iv melanoma
693175|NCT00289627|Previously treated melanoma|previously treated melanoma
693176|NCT00289627|Unresectable Stage III|unresectable stage iii
693177|NCT00289627|Stage IV|stage iv
693178|NCT00289614|contrast induced nephropathy|contrast induced nephropathy
693179|NCT00289601|aspirin|aspirin
693180|NCT00289601|clopidogrel|clopidogrel
693181|NCT00289601|resistance|resistance
693182|NCT00289601|angioplasty|angioplasty
693183|NCT00289601|percutaneous coronary intervention|percutaneous coronary intervention
693184|NCT00289601|myocardial infarction|myocardial infarction
693475|NCT00288106|stage IV prostate cancer|stage iv prostate cancer
693185|NCT00289588|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
693186|NCT00289588|Staphylococcus aureus|staphylococcus aureus
693187|NCT00289588|MRSA|mrsa
693188|NCT00289588|CA-MRSA|ca-mrsa
693189|NCT00289575|Femur head aseptic osteonecrosis|femur head aseptic osteonecrosis
693190|NCT00289575|Bone reconstruction|bone reconstruction
693191|NCT00289575|Macroporous biphasic calcium phosphate granules|macroporous biphasic calcium phosphate granules
693192|NCT00289562|B-cell|b-cell
693193|NCT00289562|leukemia|leukemia
693194|NCT00289562|B-lymphoblastic leukemia|b-lymphoblastic leukemia
693195|NCT00289562|lymphoma|lymphoma
693196|NCT00289562|B-All|b-all
693197|NCT00289549|CLL|cll
693198|NCT00289549|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
693199|NCT00289549|leukemia|leukemia
693200|NCT00289549|Advanced, fludarabine-refractory CLL|advanced, fludarabine-refractory cll
693201|NCT00289523|Major Depressive Disorder, Depressive Disorder, Unipolar Depression, Antidepressants, Electroencephalography|major depressive disorder, depressive disorder, unipolar depression, antidepressants, electroencephalography
693202|NCT00289497|Charcot|charcot
693203|NCT00289497|foot|foot
693204|NCT00289497|ulceration|ulceration
693205|NCT00289497|neuropathy|neuropathy
693207|NCT00289471|Sensitivity and specificity|sensitivity and specificity
693208|NCT00289471|Physician's practice patterns|physician's practice patterns
693209|NCT00289471|Health Care costs|health care costs
693210|NCT00289471|Quality of Health Care|quality of health care
693211|NCT00289458|older adults, falls, arthritis, aquatic, exercise|older adults, falls, arthritis, aquatic, exercise
693212|NCT00289419|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
693213|NCT00289419|Anesthetics, Local|anesthetics, local
693214|NCT00289419|Pain, Postoperative|pain, postoperative
693215|NCT00289406|hypertension|hypertension
693216|NCT00289380|Nutritional Risk Screening(NRS)|nutritional risk screening(nrs)
693217|NCT00289380|Malnutrition|malnutrition
693218|NCT00289380|Overweight|overweight
693219|NCT00289380|Obesity|obesity
693220|NCT00289380|Clinical nutritional support|clinical nutritional support
693221|NCT00289380|Clinical outcome|clinical outcome
693222|NCT00289380|Cost effectiveness|cost effectiveness
693223|NCT00289380|Complication|complication
693224|NCT00289380|Infective complications|infective complications
693225|NCT00289354|chromium|chromium
693226|NCT00289354|chromium picolinate|chromium picolinate
693227|NCT00289354|type 2 diabetes mellitus|type 2 diabetes mellitus
693228|NCT00289354|HbA1c|hba1c
693229|NCT00289354|hyperglycemia|hyperglycemia
693230|NCT00289354|cholesterol|cholesterol
693231|NCT00289302|Heart Failure|heart failure
693232|NCT00289302|Cardiac pacing|cardiac pacing
693233|NCT00289302|Cardiac resynchronization therapy|cardiac resynchronization therapy
693234|NCT00289302|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
693235|NCT00289289|Atrial Fibrillation|atrial fibrillation
693236|NCT00289289|Atrial Tachyarrhythmia|atrial tachyarrhythmia
693237|NCT00289289|Arrhythmia|arrhythmia
693238|NCT00289289|Bradycardia|bradycardia
693239|NCT00289289|Cardiac Pacemaker|cardiac pacemaker
693240|NCT00289289|IPG Indication|ipg indication
693241|NCT00289289|Pacing|pacing
693242|NCT00289276|Cardiomyopathy|cardiomyopathy
693243|NCT00289276|Ventricular Ejection Fraction|ventricular ejection fraction
693244|NCT00289276|Congestive Heart Failure|congestive heart failure
693245|NCT00289276|Impedance|impedance
693246|NCT00289263|metastatic breast cancer|metastatic breast cancer
693247|NCT00289263|maintenance chemotherapy|maintenance chemotherapy
693248|NCT00289250|Malaria|malaria
693249|NCT00289250|Gametocytes|gametocytes
693250|NCT00289250|Asymptomatic carriers|asymptomatic carriers
693251|NCT00289237|Lifestyle intervention|lifestyle intervention
693252|NCT00289237|Behavioural changes|behavioural changes
693253|NCT00289237|CHD|chd
693254|NCT00289237|Type 2 diabetes|type 2 diabetes
693255|NCT00289224|bivalent killed whole cell oral cholera vaccine|bivalent killed whole cell oral cholera vaccine
693256|NCT00289224|double blind randomized clinical trial|double blind randomized clinical trial
693257|NCT00289211|Hereditary angioedema|hereditary angioedema
693258|NCT00289211|HAE|hae
693259|NCT00289211|C1 esterase inhibitor (human)|c1 esterase inhibitor (human)
693260|NCT00289211|C1INH-nf|c1inh-nf
693261|NCT00289198|GW685698X|gw685698x
693262|NCT00289198|perennial allergic rhinitis|perennial allergic rhinitis
693263|NCT00289198|allergic rhinitis|allergic rhinitis
693264|NCT00289185|Coccidiosis|coccidiosis
693265|NCT00289185|Parasitic Diseases|parasitic diseases
693266|NCT00289185|Malaria, Falciparum|malaria, falciparum
693267|NCT00289185|Malaria|malaria
693268|NCT00289159|aged 18-50|aged 18-50
693269|NCT00289159|remitting evolution|remitting evolution
693270|NCT00289159|less than two years of evolution|less than two years of evolution
693271|NCT00289159|MS patients|ms patients
693272|NCT00289146|kidney cancer, immunology|kidney cancer, immunology
693273|NCT00289133|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
693274|NCT00289120|urolithiasis, cola|urolithiasis, cola
693275|NCT00289107|Total Knee Replacement|total knee replacement
693276|NCT00289107|Knee Prosthesis|knee prosthesis
693277|NCT00289081|Total Knee Replacement|total knee replacement
693278|NCT00289068|cataract surgery|cataract surgery
693280|NCT00289055|Peripheral Artery Occlusive Disease|peripheral artery occlusive disease
693281|NCT00289042|atrial fibrillation|atrial fibrillation
693282|NCT00289042|atrial thrombus|atrial thrombus
693283|NCT00289042|cardioversion|cardioversion
693284|NCT00289042|enoxaparin|enoxaparin
693285|NCT00289042|low molecular weight heparin|low molecular weight heparin
693286|NCT00289042|transesophageal echocardiography|transesophageal echocardiography
693287|NCT00289016|gene transfer|gene transfer
693288|NCT00289016|gene therapy|gene therapy
693289|NCT00289016|oncolytic virus|oncolytic virus
693290|NCT00289016|GM-CSF|gm-csf
693291|NCT00289016|melanoma|melanoma
693292|NCT00288990|MS|ms
693293|NCT00288977|Diabetes|diabetes
693294|NCT00288977|Islet Transplantation|islet transplantation
693295|NCT00288964|balloon|balloon
693296|NCT00288964|fiber|fiber
693297|NCT00288964|respiratory|respiratory
693298|NCT00288964|oxygenator|oxygenator
693299|NCT00288964|Heart Failure|heart failure
693300|NCT00288964|ARDS|ards
693301|NCT00288964|COPD|copd
693302|NCT00288938|Suspicious mole|suspicious mole
693303|NCT00288938|Congenital Nevus|congenital nevus
693304|NCT00288938|Skin Cancer|skin cancer
693305|NCT00288938|Moles|moles
693306|NCT00288938|Pigmented lesion|pigmented lesion
693307|NCT00288938|LCMN|lcmn
693308|NCT00288912|Self-Care|self-care
693309|NCT00288912|Telemedicine|telemedicine
693310|NCT00288912|Pain|pain
693311|NCT00288912|Veterans|veterans
693312|NCT00288899|Informed Consent|informed consent
693313|NCT00288899|Medical Record Systems, computerized|medical record systems, computerized
693314|NCT00288899|Comprehension|comprehension
693315|NCT00288899|Anxiety|anxiety
693316|NCT00288899|Personal Satisfactin|personal satisfactin
693317|NCT00288886|Compliance|compliance
693318|NCT00288886|Aftercare|aftercare
693319|NCT00288886|Reinforcement, social|reinforcement, social
693320|NCT00288886|Alcoholics Anonymous|alcoholics anonymous
693321|NCT00288886|Support Groups|support groups
693322|NCT00288886|Treatment Outcome|treatment outcome
693323|NCT00288873|Vitamin D deficiency|vitamin d deficiency
693324|NCT00288873|Secondary hyperparathyroidism|secondary hyperparathyroidism
693325|NCT00288873|Obesity|obesity
693326|NCT00288860|telemedicine|telemedicine
693327|NCT00288860|treatment compliance|treatment compliance
693328|NCT00288860|mental health|mental health
693329|NCT00288847|Patella Dislocation|patella dislocation
693330|NCT00288847|Surface EMG|surface emg
693331|NCT00288847|Gender difference|gender difference
693333|NCT00288834|dysphagia|dysphagia
693334|NCT00288834|rehabilitation|rehabilitation
693335|NCT00288834|biofeedback|biofeedback
693336|NCT00288821|Gynaecological malignancy|gynaecological malignancy
693337|NCT00288821|Diagnostic Accuracy|diagnostic accuracy
693338|NCT00288821|DWIBS|dwibs
693339|NCT00288821|Lymph Nodes|lymph nodes
693340|NCT00288821|Metastasis|metastasis
693341|NCT00288808|Blood|blood
693342|NCT00288808|Coagulation|coagulation
693343|NCT00288808|PT/InR|pt/inr
693344|NCT00288808|Warfarin|warfarin
693345|NCT00288808|Mechanical Valve|mechanical valve
693346|NCT00288795|Fatigue|fatigue
693347|NCT00288795|Polarity|polarity
693348|NCT00288795|Massage|massage
693349|NCT00288782|Mirtazapine|mirtazapine
693350|NCT00288782|Antidepressant|antidepressant
693351|NCT00288782|Positron Emission Tomography|positron emission tomography
693352|NCT00288769|Recurrent aphthous stomatitis|recurrent aphthous stomatitis
693353|NCT00288769|vitamin B12|vitamin b12
693354|NCT00288756|arrythmias|arrythmias
693355|NCT00288730|Heart Failure|heart failure
693356|NCT00288730|Renal Dysfunction|renal dysfunction
693357|NCT00288730|Cardiomyopathy|cardiomyopathy
693358|NCT00288730|Heart Decompensation|heart decompensation
693359|NCT00288730|Dyspnea Paroxysmal|dyspnea paroxysmal
693360|NCT00288704|Familial Cold Autoinflammatory Syndrome (FCAS)|familial cold autoinflammatory syndrome (fcas)
693361|NCT00288704|Muckle-Wells Syndrome (MWS)|muckle-wells syndrome (mws)
693362|NCT00288704|CIAS1|cias1
693363|NCT00288704|NLRP-3|nlrp-3
693364|NCT00288704|PYPAF1|pypaf1
693365|NCT00288704|Cryopyrin|cryopyrin
693366|NCT00288704|CAPS|caps
693367|NCT00288704|Interleukin-1|interleukin-1
693368|NCT00288691|Treatment-resistant menorrhagia|treatment-resistant menorrhagia
693369|NCT00288678|Diabetic shared care|diabetic shared care
693370|NCT00288678|Health manager|health manager
693371|NCT00288678|Prospective Study|prospective study
693372|NCT00288678|Health Care Quality, Access, and Evaluation|health care quality, access, and evaluation
693373|NCT00288665|Myocardial infarction|myocardial infarction
693374|NCT00288665|aspiration|aspiration
693375|NCT00288665|thrombectomy|thrombectomy
693376|NCT00288665|ventricular remodeling|ventricular remodeling
693377|NCT00288639|Pregabalin for partial seizures|pregabalin for partial seizures
693378|NCT00288626|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
693379|NCT00288626|HCT- autologous hematopoietic cell transplant|hct- autologous hematopoietic cell transplant
693380|NCT00288626|HDIT-high-dose immunosuppressive therapy|hdit-high-dose immunosuppressive therapy
693476|NCT00288080|stage III prostate cancer|stage iii prostate cancer
693858|NCT00286598|foot ulcer|foot ulcer
693381|NCT00288626|BEAM -Carmustine (BCNU), Etoposide (VP-16), Cytarabine (ara-C), and Melphalan|beam -carmustine (bcnu), etoposide (vp-16), cytarabine (ara-c), and melphalan
693382|NCT00288613|ESRD|esrd
693383|NCT00288613|Daily Hemodialysis|daily hemodialysis
693384|NCT00288613|Hemodialysis|hemodialysis
693385|NCT00288613|Kidney Failure|kidney failure
693386|NCT00288613|Kidney Disease|kidney disease
693387|NCT00288600|Immunoglobulins, Intravenous|immunoglobulins, intravenous
693388|NCT00288600|Hyperbilirubinemia|hyperbilirubinemia
693389|NCT00288600|Erythroblastosis, Fetal|erythroblastosis, fetal
693390|NCT00288600|Exchange Transfusion, Whole Blood|exchange transfusion, whole blood
693391|NCT00288587|Heart Failure|heart failure
693392|NCT00288587|Congestive Heart Failure|congestive heart failure
693393|NCT00288587|CHF|chf
693394|NCT00288574|Depression|depression
693395|NCT00288561|ARMD, ranibizumab, verteporfin|armd, ranibizumab, verteporfin
693396|NCT00288535|coronary bifurcation ; PCI; modified T-Stenting; sirolimus stent|coronary bifurcation ; pci; modified t-stenting; sirolimus stent
693397|NCT00288496|mechanical bowel preparation, colorectal surgery, anastomotic dehiscence|mechanical bowel preparation, colorectal surgery, anastomotic dehiscence
693398|NCT00288444|Advanced malignancies.|advanced malignancies.
693399|NCT00288431|cancer|cancer
693400|NCT00288431|sarcoma|sarcoma
693401|NCT00288418|Colonization of the catheter|colonization of the catheter
693402|NCT00288418|Catheter related bloodstream infection|catheter related bloodstream infection
693403|NCT00288405|Intracranial|intracranial
693404|NCT00288405|Wide-neck|wide-neck
693405|NCT00288405|Saccular|saccular
693406|NCT00288405|Aneurysms|aneurysms
693407|NCT00288379|Asthma|asthma
693408|NCT00288379|allergen challenge|allergen challenge
693409|NCT00288379|airway responsiveness|airway responsiveness
693410|NCT00288379|airway inflammation|airway inflammation
693411|NCT00288379|Symbicort®|symbicort®
693412|NCT00288366|schizophrenia|schizophrenia
693413|NCT00288366|schizoaffective disorder|schizoaffective disorder
693414|NCT00288366|bipolar disorder|bipolar disorder
693415|NCT00288366|metabolic syndrome|metabolic syndrome
693416|NCT00288353|schizophrenia|schizophrenia
693417|NCT00288353|schizoaffective disorder|schizoaffective disorder
693418|NCT00288353|bipolar disorder|bipolar disorder
693419|NCT00288353|metabolic syndrome|metabolic syndrome
693420|NCT00288340|psychotic disorders|psychotic disorders
693421|NCT00288340|auditory hallucinations|auditory hallucinations
693422|NCT00288340|brain structure|brain structure
693423|NCT00288340|psychiatric disorder with auditory hallucinations (at least one every 20 minutes)|psychiatric disorder with auditory hallucinations (at least one every 20 minutes)
693424|NCT00288340|schizophrenia/schizoaffective disorder without auditory hallucinations|schizophrenia/schizoaffective disorder without auditory hallucinations
693425|NCT00288327|diet|diet
693426|NCT00288327|physical activity|physical activity
693427|NCT00288327|smoking cessation|smoking cessation
693428|NCT00288314|PTSD|ptsd
693429|NCT00288314|MRI, Functional|mri, functional
693430|NCT00288314|Anxiety|anxiety
693431|NCT00288314|Working Memory|working memory
693432|NCT00288314|Processing speed|processing speed
693433|NCT00288301|diet|diet
693434|NCT00288301|physical activity|physical activity
693435|NCT00288301|weight management|weight management
693436|NCT00288275|Ovarian Cancer|ovarian cancer
693437|NCT00288275|Fallopian Tube Cancer|fallopian tube cancer
693438|NCT00288275|Peritoneal Cancer|peritoneal cancer
693439|NCT00288275|Assay|assay
693440|NCT00288275|Chemotherapy|chemotherapy
693441|NCT00288275|Recurrent|recurrent
693442|NCT00288275|Refractory|refractory
693443|NCT00288275|Persistent|persistent
693444|NCT00288275|Chemoresponse|chemoresponse
693445|NCT00288275|Sensitivity|sensitivity
693446|NCT00288275|Precision Therapeutics|precision therapeutics
693447|NCT00288262|hot flashes|hot flashes
693448|NCT00288262|melatonin|melatonin
693449|NCT00288262|depression|depression
693450|NCT00288262|sleep|sleep
693451|NCT00288262|luteinizing hormone|luteinizing hormone
693452|NCT00288262|postmenopause|postmenopause
693453|NCT00288249|Breast Cancer|breast cancer
693454|NCT00288249|Breast Neoplasms|breast neoplasms
693455|NCT00288236|Type 2 diabetes mellitus|type 2 diabetes mellitus
693456|NCT00288210|Myocardial Infarction|myocardial infarction
693457|NCT00288210|Stents|stents
693458|NCT00288210|Sirolimus|sirolimus
693459|NCT00288210|abciximab|abciximab
693460|NCT00288145|worksite|worksite
693461|NCT00288145|weight gain prevention (among adults)|weight gain prevention (among adults)
693462|NCT00288145|obesity (among adults)|obesity (among adults)
693463|NCT00288145|physical activity|physical activity
693464|NCT00288145|nutrition|nutrition
693465|NCT00288132|Diabetes|diabetes
693466|NCT00288132|self-management|self-management
693467|NCT00288132|telemedicine|telemedicine
693468|NCT00288132|retinal|retinal
693469|NCT00288132|screening|screening
693470|NCT00288119|Barrett's Esophagus|barrett's esophagus
693471|NCT00288106|recurrent prostate cancer|recurrent prostate cancer
693472|NCT00288106|stage I prostate cancer|stage i prostate cancer
693473|NCT00288106|stage II prostate cancer|stage ii prostate cancer
693474|NCT00288106|stage III prostate cancer|stage iii prostate cancer
693857|NCT00286611|Amifostine|amifostine
693477|NCT00288080|stage IIB prostate cancer|stage iib prostate cancer
693478|NCT00288080|stage IIA prostate cancer|stage iia prostate cancer
693479|NCT00288080|stage IV prostate cancer|stage iv prostate cancer
693480|NCT00288054|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
693481|NCT00288054|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
693482|NCT00288054|adenocarcinoma of the lung|adenocarcinoma of the lung
693483|NCT00288054|large cell lung cancer|large cell lung cancer
693484|NCT00288054|squamous cell lung cancer|squamous cell lung cancer
693485|NCT00288028|stage I multiple myeloma|stage i multiple myeloma
693486|NCT00288028|stage II multiple myeloma|stage ii multiple myeloma
693487|NCT00288028|stage III multiple myeloma|stage iii multiple myeloma
693488|NCT00288028|refractory multiple myeloma|refractory multiple myeloma
693489|NCT00288015|adult angiosarcoma|adult angiosarcoma
693490|NCT00288015|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
693491|NCT00288015|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
693492|NCT00288015|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
693493|NCT00288015|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
693494|NCT00288015|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
693495|NCT00288002|inflammatory breast cancer|inflammatory breast cancer
693496|NCT00288002|stage II breast cancer|stage ii breast cancer
693497|NCT00288002|stage IIIA breast cancer|stage iiia breast cancer
693498|NCT00288002|stage IIIB breast cancer|stage iiib breast cancer
693499|NCT00288002|stage IIIC breast cancer|stage iiic breast cancer
693500|NCT00288002|stage IA breast cancer|stage ia breast cancer
693501|NCT00288002|stage IB breast cancer|stage ib breast cancer
693502|NCT00288002|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
693503|NCT00288002|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
693504|NCT00288002|HER2-negative breast cancer|her2-negative breast cancer
693505|NCT00288002|HER2-positive breast cancer|her2-positive breast cancer
693506|NCT00287989|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
693507|NCT00287989|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
693508|NCT00287989|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
693509|NCT00287976|childhood hepatoblastoma|childhood hepatoblastoma
693510|NCT00287976|recurrent childhood liver cancer|recurrent childhood liver cancer
693511|NCT00287963|adenocarcinoma of the lung|adenocarcinoma of the lung
693512|NCT00287963|adenosquamous cell lung cancer|adenosquamous cell lung cancer
693513|NCT00287963|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
693514|NCT00287963|combined type small cell lung cancer|combined type small cell lung cancer
693515|NCT00287963|intermediate type small cell lung cancer|intermediate type small cell lung cancer
693516|NCT00287963|large cell lung cancer|large cell lung cancer
693517|NCT00287963|lymphocyte-like type small cell lung cancer|lymphocyte-like type small cell lung cancer
693518|NCT00287963|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
693519|NCT00287963|recurrent small cell lung cancer|recurrent small cell lung cancer
693520|NCT00287963|squamous cell lung cancer|squamous cell lung cancer
693521|NCT00287950|disseminated neuroblastoma|disseminated neuroblastoma
693522|NCT00287950|localized resectable neuroblastoma|localized resectable neuroblastoma
693523|NCT00287950|localized unresectable neuroblastoma|localized unresectable neuroblastoma
693524|NCT00287950|regional neuroblastoma|regional neuroblastoma
693525|NCT00287950|stage 4S neuroblastoma|stage 4s neuroblastoma
693526|NCT00287924|childhood infratentorial ependymoma|childhood infratentorial ependymoma
693527|NCT00287924|childhood supratentorial ependymoma|childhood supratentorial ependymoma
693528|NCT00287924|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
693529|NCT00287911|cervical adenocarcinoma|cervical adenocarcinoma
693530|NCT00287911|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
693531|NCT00287911|cervical squamous cell carcinoma|cervical squamous cell carcinoma
693532|NCT00287911|stage IB cervical cancer|stage ib cervical cancer
693533|NCT00287911|stage IIA cervical cancer|stage iia cervical cancer
693534|NCT00287911|stage IIB cervical cancer|stage iib cervical cancer
693535|NCT00287911|stage III cervical cancer|stage iii cervical cancer
693536|NCT00287911|stage IVA cervical cancer|stage iva cervical cancer
693537|NCT00287898|breast cancer|breast cancer
693538|NCT00287885|recurrent cervical cancer|recurrent cervical cancer
693539|NCT00287885|stage III cervical cancer|stage iii cervical cancer
693540|NCT00287885|stage IVA cervical cancer|stage iva cervical cancer
693541|NCT00287885|stage IVB cervical cancer|stage ivb cervical cancer
693542|NCT00287885|stage III endometrial carcinoma|stage iii endometrial carcinoma
693543|NCT00287885|recurrent endometrial carcinoma|recurrent endometrial carcinoma
693544|NCT00287885|stage IV endometrial carcinoma|stage iv endometrial carcinoma
693545|NCT00287885|fallopian tube cancer|fallopian tube cancer
693546|NCT00287885|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
693547|NCT00287885|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
693548|NCT00287885|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
693549|NCT00287885|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
693550|NCT00287885|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
693551|NCT00287885|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
693552|NCT00287885|recurrent uterine sarcoma|recurrent uterine sarcoma
693553|NCT00287885|stage III uterine sarcoma|stage iii uterine sarcoma
693554|NCT00287885|stage IV uterine sarcoma|stage iv uterine sarcoma
693555|NCT00287885|stage III vaginal cancer|stage iii vaginal cancer
693556|NCT00287885|recurrent vaginal cancer|recurrent vaginal cancer
693557|NCT00287885|stage IVA vaginal cancer|stage iva vaginal cancer
693558|NCT00287885|stage IVB vaginal cancer|stage ivb vaginal cancer
693559|NCT00287885|stage III vulvar cancer|stage iii vulvar cancer
693560|NCT00287885|recurrent vulvar cancer|recurrent vulvar cancer
693561|NCT00287885|stage IV vulvar cancer|stage iv vulvar cancer
693562|NCT00287885|ovarian sarcoma|ovarian sarcoma
693563|NCT00287885|ovarian stromal cancer|ovarian stromal cancer
693564|NCT00287885|peritoneal cavity cancer|peritoneal cavity cancer
693565|NCT00287872|stage II multiple myeloma|stage ii multiple myeloma
693566|NCT00287872|stage III multiple myeloma|stage iii multiple myeloma
693567|NCT00287859|fallopian tube cancer|fallopian tube cancer
693568|NCT00287859|peritoneal cavity cancer|peritoneal cavity cancer
693569|NCT00287859|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
693570|NCT00287846|desmoid tumor|desmoid tumor
693571|NCT00287820|schizophrenia|schizophrenia
693572|NCT00287820|diabetes|diabetes
693573|NCT00287820|metabolic syndrome|metabolic syndrome
693574|NCT00287820|hyperglycemia|hyperglycemia
693575|NCT00287820|glucose|glucose
693576|NCT00287820|insulin|insulin
693577|NCT00287820|lipids|lipids
693578|NCT00287820|IL-6|il-6
693579|NCT00287820|prolactin|prolactin
693580|NCT00287807|Diabetes mellitus, type 2|diabetes mellitus, type 2
693581|NCT00287807|Blood Glucose Self-Monitoring|blood glucose self-monitoring
693582|NCT00287807|life style|life style
693583|NCT00287794|rheumatoid arthritis|rheumatoid arthritis
693584|NCT00287794|sleep disturbance|sleep disturbance
693585|NCT00287781|Migraine|migraine
693586|NCT00287781|Lidocaine|lidocaine
693587|NCT00287781|Headache|headache
693588|NCT00287768|gastric cancer|gastric cancer
693589|NCT00287768|advanced gastric cancer|advanced gastric cancer
693590|NCT00287768|S-1|s-1
693591|NCT00287768|docetaxel|docetaxel
693592|NCT00287768|phase III study|phase iii study
693593|NCT00287755|gastric cancer|gastric cancer
693594|NCT00287755|S-1|s-1
693595|NCT00287755|chemosensitivity|chemosensitivity
693596|NCT00287755|adjuvant|adjuvant
693597|NCT00287742|risperidone|risperidone
693598|NCT00287742|antipsychotic agents|antipsychotic agents
693599|NCT00287742|Alzheimer's disease|alzheimer's disease
693600|NCT00287742|dementia|dementia
693601|NCT00287742|psychosis|psychosis
693602|NCT00287729|Idiopathic|idiopathic
693603|NCT00287729|Pulmonary|pulmonary
693604|NCT00287729|Fibrosis|fibrosis
693605|NCT00287729|Lung|lung
693606|NCT00287729|Pirfenidone|pirfenidone
693607|NCT00287729|InterMune|intermune
693608|NCT00287716|Idiopathic|idiopathic
693609|NCT00287716|Pulmonary|pulmonary
693610|NCT00287716|Fibrosis|fibrosis
693611|NCT00287716|Lung|lung
693612|NCT00287716|Pirfenidone|pirfenidone
693613|NCT00287716|InterMune|intermune
693614|NCT00287703|Major depression|major depression
693615|NCT00287703|Treatment resistant|treatment resistant
693616|NCT00287703|PEMF|pemf
693617|NCT00287703|AQT|aqt
693618|NCT00287703|Hamilton|hamilton
693619|NCT00287690|arteries|arteries
693620|NCT00287690|blood flow|blood flow
693621|NCT00287690|coronary artery disease|coronary artery disease
693622|NCT00287690|diet|diet
693623|NCT00287677|Growth Hormone|growth hormone
693624|NCT00287677|HIV-1|hiv-1
693625|NCT00287677|Vaccination|vaccination
693626|NCT00287677|Thymopoiesis|thymopoiesis
693627|NCT00287677|HIV-specific responses|hiv-specific responses
693628|NCT00287677|Treatment Experienced|treatment experienced
693629|NCT00287664|hepatorenal syndrome|hepatorenal syndrome
693630|NCT00287664|terlipressin|terlipressin
693631|NCT00287664|albumin|albumin
693632|NCT00287664|cirrhosis|cirrhosis
693633|NCT00287651|Pulsatile intravenous insulin|pulsatile intravenous insulin
693634|NCT00287651|Oral carbohydrate loading|oral carbohydrate loading
693635|NCT00287651|Respiratory Quotients|respiratory quotients
693636|NCT00287651|Hypoglycemia|hypoglycemia
693637|NCT00287638|Obstructive sleep apnea|obstructive sleep apnea
693638|NCT00287625|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
693639|NCT00287625|Pulmonary rehabilitation|pulmonary rehabilitation
693640|NCT00287612|GERD|gerd
693641|NCT00287612|Hiatal Hernia|hiatal hernia
693642|NCT00287612|Recurrence|recurrence
693643|NCT00287599|Surgical wound infections|surgical wound infections
693644|NCT00287599|Real-time PCR|real-time pcr
693645|NCT00287599|Rapid identification of bacteria|rapid identification of bacteria
693646|NCT00287599|Cloning|cloning
693647|NCT00287599|16S rRNA sequencing|16s rrna sequencing
693648|NCT00287586|Testosterone Replacement|testosterone replacement
693649|NCT00287586|Heart Disease|heart disease
693650|NCT00287586|Vascular Disease|vascular disease
693651|NCT00287586|Risk Factors for Cardiovascular Disease|risk factors for cardiovascular disease
693652|NCT00287586|Cholesterol|cholesterol
693653|NCT00287586|Obesity|obesity
693654|NCT00287586|Blood pressure|blood pressure
693655|NCT00287586|Quality of Life|quality of life
693656|NCT00287534|Early Breast Cancer|early breast cancer
693657|NCT00287521|open|open
693658|NCT00287521|angle|angle
693659|NCT00287521|glaucoma|glaucoma
693660|NCT00287521|ocular|ocular
693661|NCT00287521|hypertension|hypertension
693662|NCT00287508|Carotid stenting|carotid stenting
693663|NCT00287508|Carotid endarterectomy|carotid endarterectomy
693664|NCT00287508|Carotid artery disease with severe narrowing of the artery|carotid artery disease with severe narrowing of the artery
693665|NCT00287508|Stroke prevention|stroke prevention
693666|NCT00287508|cerebral infarction|cerebral infarction
693667|NCT00287495|AIDS|aids
693668|NCT00287495|HIV|hiv
693669|NCT00287495|Antiangiogenesis|antiangiogenesis
693670|NCT00287495|VEGF|vegf
693671|NCT00287495|AIDS Malignancy|aids malignancy
693672|NCT00287495|Kaposi Sarcoma|kaposi sarcoma
693673|NCT00287495|KS|ks
693674|NCT00287482|Treatment side effects|treatment side effects
693675|NCT00287482|Quality of Life|quality of life
693676|NCT00287482|Transition|transition
693677|NCT00287482|Survivorship|survivorship
693678|NCT00287469|Hepatitis E|hepatitis e
693679|NCT00287469|clinical hepatitis|clinical hepatitis
693680|NCT00287469|vaccine|vaccine
693681|NCT00287469|efficacy|efficacy
693682|NCT00287469|Nepal|nepal
693683|NCT00287417|Nucal translucency|nucal translucency
693684|NCT00287417|Down syndrome|down syndrome
693685|NCT00287417|MSS|mss
693686|NCT00287417|Risk assessment|risk assessment
693687|NCT00287404|type 2 diabetes|type 2 diabetes
693688|NCT00287404|hyperlipidemia|hyperlipidemia
693689|NCT00287404|dyslipidemia|dyslipidemia
693690|NCT00287404|fasting lipids|fasting lipids
693691|NCT00287404|postprandial lipids|postprandial lipids
693692|NCT00287404|Non-HDL cholesterol|non-hdl cholesterol
693693|NCT00287404|NMR lipoanalysis|nmr lipoanalysis
693694|NCT00287404|ATP III guidelines|atp iii guidelines
693695|NCT00287391|Insomnia|insomnia
693696|NCT00287391|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
693697|NCT00287391|Sleep Disturbance|sleep disturbance
693698|NCT00287352|First episode psychosis|first episode psychosis
693699|NCT00287339|Cough|cough
693700|NCT00287339|GERD|gerd
693701|NCT00287326|Epidural|epidural
693702|NCT00287326|Bupivacaine|bupivacaine
693703|NCT00287326|Clonidine|clonidine
693704|NCT00287313|Unstable INRs|unstable inrs
693705|NCT00287313|Warfarin|warfarin
693706|NCT00287313|Vitamin K|vitamin k
693707|NCT00287300|Malaria|malaria
693708|NCT00287300|Pregnancy|pregnancy
693709|NCT00287300|Efficacy|efficacy
693710|NCT00287300|Azithromycin|azithromycin
693711|NCT00287300|Artesunate|artesunate
693712|NCT00287287|Lenalidomide|lenalidomide
693713|NCT00287287|Clinical Trials phase II|clinical trials phase ii
693714|NCT00287287|Carcinomas, thyroid|carcinomas, thyroid
693715|NCT00287287|Radioiodine-Unresponsive Papillary & Follicular Thyroid Carcinomas|radioiodine-unresponsive papillary & follicular thyroid carcinomas
693716|NCT00287261|myelofibrosis|myelofibrosis
693717|NCT00287261|D009191|d009191
693718|NCT00287248|Alzheimer|alzheimer
693719|NCT00287248|Alzheimer disease|alzheimer disease
693720|NCT00287248|Alzheimer disease (AD)|alzheimer disease (ad)
693721|NCT00287235|Hepatic Encephalopathy|hepatic encephalopathy
693722|NCT00287235|End Stage Liver Disease|end stage liver disease
693723|NCT00287235|Cirrhosis|cirrhosis
693724|NCT00287235|MARS|mars
693725|NCT00287235|Albumin Dialysis|albumin dialysis
693726|NCT00287222|Inoperable and Metastatic Hepatocellular Carcinoma|inoperable and metastatic hepatocellular carcinoma
693727|NCT00287209|RASCABG 1 - study|rascabg 1 - study
693728|NCT00287209|Postoperative atrial fibrillation|postoperative atrial fibrillation
693729|NCT00287209|Randomized, controlled trial|randomized, controlled trial
693730|NCT00287209|Amiodarone|amiodarone
693731|NCT00287196|Melanoma|melanoma
693732|NCT00287196|Lymph node disease|lymph node disease
693733|NCT00287196|Adjuvant radiotherapy|adjuvant radiotherapy
693734|NCT00287196|Lymphoedema|lymphoedema
693735|NCT00287170|Crohn's Disease|crohn's disease
693736|NCT00287170|Local Ileal Delivery|local ileal delivery
693737|NCT00287170|Delayed-Release Formulations|delayed-release formulations
693738|NCT00287170|6-Mercaptopurine|6-mercaptopurine
693739|NCT00287170|Calcitriol|calcitriol
693740|NCT00287157|Traumatic Brain Injury|traumatic brain injury
693741|NCT00287157|Actigraphy|actigraphy
693742|NCT00287157|Spasticity, Cognition and Functioning|spasticity, cognition and functioning
693743|NCT00287144|Hypothyroidism|hypothyroidism
693744|NCT00287131|melanoma|melanoma
693745|NCT00287131|metastatic melanoma|metastatic melanoma
693746|NCT00287131|adoptive immunotherapy|adoptive immunotherapy
693747|NCT00287131|IL-2|il-2
693748|NCT00287105|Chemotherapy|chemotherapy
693749|NCT00287105|Leukemia|leukemia
693750|NCT00287105|Children|children
693751|NCT00287105|Philadelphia chromosome|philadelphia chromosome
693752|NCT00287105|Protein-tyrosine kinase inhibitor|protein-tyrosine kinase inhibitor
693753|NCT00287092|Haemophilus influenzae type b;|haemophilus influenzae type b;
693754|NCT00287092|Corynebacterium diphtheriae;|corynebacterium diphtheriae;
693755|NCT00287092|Clostridium tetani;|clostridium tetani;
693756|NCT00287092|Bordetella pertussis;|bordetella pertussis;
693757|NCT00287092|poliovirus types 1, 2 and 3;|poliovirus types 1, 2 and 3;
693758|NCT00287092|Vero cell;|vero cell;
693759|NCT00287092|Influenza;|influenza;
693760|NCT00287092|Diphtheria|diphtheria
693761|NCT00287053|divalproex sodium|divalproex sodium
693762|NCT00287053|valproic acid|valproic acid
693763|NCT00287053|food intake|food intake
693764|NCT00287053|energy expenditure|energy expenditure
693765|NCT00287053|posture allocation|posture allocation
693766|NCT00287053|None, the population of study is healthy|none, the population of study is healthy
693767|NCT00287040|Breast Cancer|breast cancer
693768|NCT00287040|Mammography|mammography
693769|NCT00287027|psychotic disorders|psychotic disorders
693770|NCT00287027|family burden|family burden
693771|NCT00287027|long acting injectible antipsychotic medication|long acting injectible antipsychotic medication
693772|NCT00287014|Rift valley fever, Kenya|rift valley fever, kenya
693773|NCT00287001|Acquired bilateral nevus of Ota-like macules|acquired bilateral nevus of ota-like macules
693774|NCT00287001|Postinflammatory hyperpigmentation|postinflammatory hyperpigmentation
693775|NCT00287001|Cold air cooling|cold air cooling
693776|NCT00286988|Preventative|preventative
693777|NCT00286988|Open-Label|open-label
693778|NCT00286988|Safety/Efficacy|safety/efficacy
693779|NCT00286975|Leadership skills|leadership skills
693780|NCT00286975|Management skills|management skills
693781|NCT00286975|Postgraduate medical education|postgraduate medical education
693782|NCT00286962|Diabetes mellitus, type 1|diabetes mellitus, type 1
693783|NCT00286962|insulin infusion systems|insulin infusion systems
693784|NCT00286962|continuous intraperitoneal insulin infusion|continuous intraperitoneal insulin infusion
693785|NCT00286962|cross-over studies|cross-over studies
693786|NCT00286949|Parkinson's disease|parkinson's disease
693787|NCT00286949|executive dysfunction|executive dysfunction
693788|NCT00286949|impairment|impairment
693789|NCT00286949|motor skills|motor skills
693790|NCT00286949|cognitive|cognitive
693791|NCT00286936|Hip fracture|hip fracture
693792|NCT00286936|delirium|delirium
693793|NCT00286936|sleep disturbance|sleep disturbance
693794|NCT00286936|hypnotic|hypnotic
693795|NCT00286923|migraine|migraine
693796|NCT00286923|chronic headache|chronic headache
693797|NCT00286923|hyperexcitability|hyperexcitability
693798|NCT00286923|Magnetic stimulation|magnetic stimulation
693799|NCT00286910|AQP-2|aqp-2
693800|NCT00286910|NPHS2-gene|nphs2-gene
693801|NCT00286845|Chemosensitivity|chemosensitivity
693802|NCT00286845|Acute Myeloid Leukemia|acute myeloid leukemia
693803|NCT00286845|Apoptosis|apoptosis
693804|NCT00286845|MiCK Assay|mick assay
693805|NCT00286832|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
693806|NCT00286832|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
693807|NCT00286832|PET|pet
693808|NCT00286832|Prognosis|prognosis
693809|NCT00286819|early breast cancer,|early breast cancer,
693810|NCT00286819|Fluorouracil|fluorouracil
693811|NCT00286793|at-101|at-101
693812|NCT00286793|at101|at101
693813|NCT00286793|cancer|cancer
693814|NCT00286793|hormone refractory|hormone refractory
693815|NCT00286793|prostate|prostate
693816|NCT00286793|docetaxel|docetaxel
693817|NCT00286793|prednisone|prednisone
693818|NCT00286780|AT101|at101
693819|NCT00286780|AT-101|at-101
693820|NCT00286780|cancer|cancer
693821|NCT00286780|lymphoctic|lymphoctic
693822|NCT00286780|lukemia|lukemia
693823|NCT00286780|Rituximab|rituximab
693824|NCT00286767|Opportunistic Infections|opportunistic infections
693825|NCT00286767|Immune Restoration Disease|immune restoration disease
693826|NCT00286767|Mycobacterial Infections|mycobacterial infections
693827|NCT00286767|HIV-1 Infection|hiv-1 infection
693828|NCT00286767|HIV|hiv
693829|NCT00286767|ART Naive|art naive
693830|NCT00286754|Hypertension|hypertension
693831|NCT00286754|Behavior modification|behavior modification
693832|NCT00286754|Randomized controlled trial|randomized controlled trial
693833|NCT00286754|Treatment effectiveness|treatment effectiveness
693834|NCT00286754|Telemedicine|telemedicine
693835|NCT00286754|Prevention|prevention
693836|NCT00286741|Diabetes|diabetes
693837|NCT00286741|Hypertension|hypertension
693838|NCT00286741|Randomized controlled trials|randomized controlled trials
693839|NCT00286741|cost-effectiveness|cost-effectiveness
693840|NCT00286741|health services|health services
693841|NCT00286728|self-help groups|self-help groups
693842|NCT00286728|referral and consultation|referral and consultation
693843|NCT00286702|splints|splints
693844|NCT00286702|Occupational Therapy|occupational therapy
693845|NCT00286663|AIH, Autoimmune Hepatitis|aih, autoimmune hepatitis
693846|NCT00286650|Paracetamol|paracetamol
693847|NCT00286637|OCT|oct
693848|NCT00286637|CSLO|cslo
693849|NCT00286637|SLP|slp
693850|NCT00286637|Perimetry|perimetry
693851|NCT00286637|electrophysiology|electrophysiology
693852|NCT00286637|glaucoma|glaucoma
693853|NCT00286637|macular degeneration|macular degeneration
693854|NCT00286637|retinopathy|retinopathy
693855|NCT00286637|diabetes|diabetes
693856|NCT00286637|macular hole|macular hole
693859|NCT00286598|diabetes mellitus|diabetes mellitus
693860|NCT00286598|motor activity|motor activity
693861|NCT00286598|randomized controlled trial|randomized controlled trial
693862|NCT00286598|prevention|prevention
693863|NCT00286585|preconditioning|preconditioning
693864|NCT00286585|cardiac protection|cardiac protection
693865|NCT00286585|morbidity|morbidity
693866|NCT00286585|mortality|mortality
693867|NCT00286585|major non-cardiac surgery|major non-cardiac surgery
693868|NCT00286585|cardiac mortality and morbidity|cardiac mortality and morbidity
693869|NCT00286585|high cardiac perioperative risk|high cardiac perioperative risk
693870|NCT00286572|insulin-dependent diabetes mellitus|insulin-dependent diabetes mellitus
693871|NCT00286572|non-insulin-dependent diabetes mellitus|non-insulin-dependent diabetes mellitus
693872|NCT00286572|coronary artery disease|coronary artery disease
693873|NCT00286572|long-term mortality|long-term mortality
693874|NCT00286559|Coronary artery disease|coronary artery disease
693875|NCT00286559|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
693876|NCT00286559|SPECT|spect
693877|NCT00286559|Adenosin|adenosin
693878|NCT00286546|Testosterone|testosterone
693879|NCT00286546|Major Depression|major depression
693880|NCT00286546|Men|men
693881|NCT00286533|Implant|implant
693882|NCT00286520|Constipation|constipation
693883|NCT00286520|Fecal incontinence|fecal incontinence
693884|NCT00286520|Spinal cord injury|spinal cord injury
693885|NCT00286520|transanal irrigation|transanal irrigation
693886|NCT00286520|quality of life|quality of life
693887|NCT00286507|Full thickness macular hole|full thickness macular hole
693888|NCT00286507|Internal limiting membrane (ILM)|internal limiting membrane (ilm)
693889|NCT00286507|Vitreo retinal surgery|vitreo retinal surgery
693890|NCT00286507|Vitrectomy|vitrectomy
693891|NCT00286494|Glucose Metabolism Disorder|glucose metabolism disorder
693892|NCT00286494|Dysmetabolic Syndrome|dysmetabolic syndrome
693893|NCT00286494|Type II Diabetes|type ii diabetes
693894|NCT00286494|Diabetes Mellitus|diabetes mellitus
693895|NCT00286494|Lipoatrophic|lipoatrophic
693896|NCT00286494|Dyslipidemia|dyslipidemia
693897|NCT00286494|Drug Therapy|drug therapy
693898|NCT00286481|Hyperlipidemia|hyperlipidemia
693899|NCT00286481|Drug Therapy|drug therapy
693900|NCT00286468|Glucose Metabolism Disorder|glucose metabolism disorder
693901|NCT00286468|Dysmetabolic Syndrome|dysmetabolic syndrome
693902|NCT00286468|Type II Diabetes|type ii diabetes
693903|NCT00286468|Diabetes Mellitus|diabetes mellitus
693904|NCT00286468|Lipoatrophic|lipoatrophic
693905|NCT00286468|Dyslipidemia|dyslipidemia
693906|NCT00286468|Drug Therapy|drug therapy
693907|NCT00286455|Glucose Metabolism Disorder|glucose metabolism disorder
693908|NCT00286455|Dysmetabolic Syndrome|dysmetabolic syndrome
693909|NCT00286455|Type II Diabetes; Diabetes Mellitus|type ii diabetes; diabetes mellitus
693910|NCT00286455|Lipoatrophic|lipoatrophic
693911|NCT00286455|Dyslipidemia|dyslipidemia
693912|NCT00286455|Drug Therapy|drug therapy
693913|NCT00286442|Glucose Metabolism Disorder|glucose metabolism disorder
693914|NCT00286442|Dysmetabolic Syndrome|dysmetabolic syndrome
693915|NCT00286442|Type II Diabetes|type ii diabetes
693916|NCT00286442|Diabetes Mellitus|diabetes mellitus
693917|NCT00286442|Lipoatrophic|lipoatrophic
693918|NCT00286442|Dyslipidemia|dyslipidemia
693919|NCT00286442|Drug Therapy|drug therapy
693920|NCT00286429|Glucose Metabolism Disorder|glucose metabolism disorder
693921|NCT00286429|Dysmetabolic Syndrome|dysmetabolic syndrome
693922|NCT00286429|Type II Diabetes|type ii diabetes
693923|NCT00286429|Diabetes Mellitus|diabetes mellitus
693924|NCT00286429|Lipoatrophic|lipoatrophic
693925|NCT00286429|Dyslipidemia|dyslipidemia
693926|NCT00286429|Drug Therapy|drug therapy
693927|NCT00286416|AERD|aerd
693928|NCT00286416|aspirin|aspirin
693929|NCT00286416|allergy|allergy
693930|NCT00286416|omalizumab|omalizumab
693931|NCT00286403|Acute Tubular Necrosis|acute tubular necrosis
693932|NCT00286403|antioxidants|antioxidants
693933|NCT00286403|Fenoldopam|fenoldopam
693934|NCT00286338|Fluid therapy|fluid therapy
693935|NCT00286338|Monitoring|monitoring
693936|NCT00286312|Acute myocardial infarction|acute myocardial infarction
693937|NCT00286312|Primary angioplasty|primary angioplasty
693938|NCT00286312|Reperfusion damage|reperfusion damage
693939|NCT00286312|Atorvastatin|atorvastatin
693940|NCT00286312|Placebo|placebo
693941|NCT00286312|Early left ventricular remodelling|early left ventricular remodelling
693942|NCT00286312|Late left ventricular remodelling|late left ventricular remodelling
693943|NCT00286312|Cardiac MRI|cardiac mri
693944|NCT00286312|Statin|statin
693945|NCT00286312|Transluminal, Percutaneous Coronary|transluminal, percutaneous coronary
693946|NCT00286312|Angioplasty|angioplasty
693947|NCT00286299|Schizophrenia|schizophrenia
693948|NCT00286299|Cardiovascular disease|cardiovascular disease
693949|NCT00286299|Aerobic capacity|aerobic capacity
693950|NCT00286299|Mortality|mortality
693951|NCT00286299|Exercise|exercise
693952|NCT00286286|Laparoscopy|laparoscopy
693953|NCT00286286|Laparoscopic Surgical Procedures|laparoscopic surgical procedures
693954|NCT00286286|Laparoscopic Surgery|laparoscopic surgery
693955|NCT00286286|Gastric Bypass|gastric bypass
693956|NCT00286286|Drug Delivery Systems|drug delivery systems
693957|NCT00286286|Pain Measurement|pain measurement
693958|NCT00286273|kidney failure, acute|kidney failure, acute
693959|NCT00286273|venovenous hemofiltration|venovenous hemofiltration
693960|NCT00286273|hemorrhage|hemorrhage
693961|NCT00286273|heparin, low-molecular-weight|heparin, low-molecular-weight
693962|NCT00286273|nadroparin|nadroparin
693963|NCT00286273|citrates|citrates
693964|NCT00286260|polyneuropathy|polyneuropathy
693965|NCT00286260|neuropathic pain|neuropathic pain
693966|NCT00286260|levetiracetam|levetiracetam
693967|NCT00286234|triglycerides|triglycerides
693968|NCT00286234|HDL-cholesterol|hdl-cholesterol
693969|NCT00286234|insulin resistance|insulin resistance
693970|NCT00286234|omega-3 fatty acids|omega-3 fatty acids
693971|NCT00286234|niacin|niacin
693972|NCT00286208|Medical abortion|medical abortion
693973|NCT00286208|mifepristone|mifepristone
693974|NCT00286208|misoprostol|misoprostol
693975|NCT00286182|Heart Failure|heart failure
693976|NCT00286182|Elderly|elderly
693977|NCT00286182|Diastolic Dysfunction|diastolic dysfunction
693978|NCT00286182|Anemia|anemia
693979|NCT00286182|Ventricular End Diastolic Volume|ventricular end diastolic volume
693980|NCT00286182|Aged|aged
693981|NCT00286169|Extensive-disease small-cell lung cancer (ED-SCLC)|extensive-disease small-cell lung cancer (ed-sclc)
693982|NCT00286156|ADPKD|adpkd
693983|NCT00286130|metastatic colorectal cancer|metastatic colorectal cancer
693984|NCT00286130|FOLFOX 6|folfox 6
693985|NCT00286130|FOLFIRI|folfiri
693986|NCT00286117|Breast Cancer|breast cancer
693987|NCT00286104|Ventriculitis|ventriculitis
693988|NCT00286104|External ventricular catheter|external ventricular catheter
693989|NCT00286104|Antibiotic-impregnated|antibiotic-impregnated
693990|NCT00286091|Hormone refractory prostate cancer|hormone refractory prostate cancer
693991|NCT00286091|androgen independent|androgen independent
693992|NCT00286091|ADT|adt
693993|NCT00286091|bone metastasis|bone metastasis
693994|NCT00286078|Headache|headache
693995|NCT00286078|Migraine|migraine
693996|NCT00286078|Refractory|refractory
693997|NCT00286078|Chronic|chronic
693998|NCT00286078|Pain|pain
693999|NCT00286065|Pain|pain
694000|NCT00286065|Fentanyl|fentanyl
694001|NCT00286065|Analgesics|analgesics
694002|NCT00286065|Opioid|opioid
694003|NCT00286065|Inhalation|inhalation
694004|NCT00286026|Chlamydia trachomatis|chlamydia trachomatis
694005|NCT00285961|Fractures of the wrist, forearm, elbow, ankle, foot|fractures of the wrist, forearm, elbow, ankle, foot
694006|NCT00285961|Distortions of the wrist, elbow, ankle|distortions of the wrist, elbow, ankle
694007|NCT00285961|Wounds without tendon injuries|wounds without tendon injuries
694008|NCT00285935|Major Depressive Disorder|major depressive disorder
694009|NCT00285935|MDD|mdd
694010|NCT00285935|Neurobiology|neurobiology
694011|NCT00285935|Selective Serotonin Reuptake Inhibitor|selective serotonin reuptake inhibitor
694012|NCT00285935|SSRI|ssri
694013|NCT00285935|Depression|depression
694014|NCT00285922|myocardial infarction|myocardial infarction
694015|NCT00285922|electrocardiography|electrocardiography
694016|NCT00285922|myocardial ischemia|myocardial ischemia
694017|NCT00285922|emergency medicine|emergency medicine
694018|NCT00285922|monitoring, physiologic|monitoring, physiologic
694019|NCT00285909|Moderate alcohol consumption|moderate alcohol consumption
694020|NCT00285909|Alcohol dehydrogenase 1c polymorphism|alcohol dehydrogenase 1c polymorphism
694021|NCT00285909|PPAR-gamma activated gene expression|ppar-gamma activated gene expression
694022|NCT00285896|GLP-1|glp-1
694023|NCT00285896|fasting|fasting
694024|NCT00285896|hypoglycaemia|hypoglycaemia
694025|NCT00285883|Invirase|invirase
694026|NCT00285883|HIV|hiv
694027|NCT00285883|DOT|dot
694028|NCT00285883|Treatment Experienced|treatment experienced
694029|NCT00285857|duct cytology|duct cytology
694030|NCT00285844|obesity|obesity
694031|NCT00285844|insulin resistance|insulin resistance
694032|NCT00285844|thiazolidinedione|thiazolidinedione
694033|NCT00285844|weight loss|weight loss
694034|NCT00285844|adipose tissue|adipose tissue
694035|NCT00285844|metabolic syndrome|metabolic syndrome
694036|NCT00285844|diabetes prevention|diabetes prevention
694037|NCT00285844|cardiovascular disease prevention|cardiovascular disease prevention
694038|NCT00285805|Rosiglitazone|rosiglitazone
694039|NCT00285805|Furosemide|furosemide
694040|NCT00285805|Amiloride|amiloride
694041|NCT00285805|Epithelial sodium channel|epithelial sodium channel
694042|NCT00285805|Sodium excretion|sodium excretion
694043|NCT00285792|Preschool, Physical Activity|preschool, physical activity
694044|NCT00285766|Depression|depression
694045|NCT00285753|psychosocial intervention|psychosocial intervention
694046|NCT00285753|mild cognitive impairment|mild cognitive impairment
694047|NCT00285753|support group|support group
694048|NCT00285753|caregivers|caregivers
694049|NCT00285753|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
694050|NCT00285753|Cognitive Impairment No Dementia (CIND)|cognitive impairment no dementia (cind)
694051|NCT00285714|3D computer assisted imaging|3d computer assisted imaging
694052|NCT00285714|maxillofacial surgery|maxillofacial surgery
694053|NCT00285714|cephalometry|cephalometry
694054|NCT00285714|normative value|normative value
694055|NCT00285688|H. Pylori, Clarithromycin resistant, gene|h. pylori, clarithromycin resistant, gene
694056|NCT00285675|Calcitriol, DN-101, Androgen Independent Prostate Cancer (AIPC), Prostate Cancer, Non Small Cell Lung Cancer (NSCLC)|calcitriol, dn-101, androgen independent prostate cancer (aipc), prostate cancer, non small cell lung cancer (nsclc)
694057|NCT00285662|IPTi|ipti
694058|NCT00285662|Malaria|malaria
694059|NCT00285662|Anemia|anemia
694060|NCT00285662|Prevention|prevention
694061|NCT00285662|Infant|infant
694062|NCT00285662|Artesunate|artesunate
694063|NCT00285662|SP|sp
694064|NCT00285662|Amodiaquine|amodiaquine
694065|NCT00285662|Papua New Guinea|papua new guinea
694066|NCT00285649|Spinal Manipulation|spinal manipulation
694067|NCT00285636|Long Term Follow-Up|long term follow-up
694068|NCT00285623|Collection of all thromboembolic events,|collection of all thromboembolic events,
694069|NCT00285623|immunological events and drug interactions leading to thromboembolic events or major|immunological events and drug interactions leading to thromboembolic events or major
694070|NCT00285623|bleeding after exposure to TachoSil®.|bleeding after exposure to tachosil®.
694071|NCT00285584|HIV infection|hiv infection
694072|NCT00285584|Depression|depression
694073|NCT00285584|Men who have sex with men|men who have sex with men
694074|NCT00285584|Drug abuse|drug abuse
694075|NCT00285558|obesity|obesity
694076|NCT00285558|adolescent|adolescent
694077|NCT00285558|weight loss|weight loss
694078|NCT00285558|body mass index|body mass index
694079|NCT00285558|evaluation studies|evaluation studies
694080|NCT00285558|peer group|peer group
694081|NCT00285558|behavior therapy|behavior therapy
694082|NCT00285558|diet|diet
694083|NCT00285558|exercise|exercise
694084|NCT00285558|self efficacy|self efficacy
694085|NCT00285558|parents|parents
694086|NCT00285545|Blood Supply|blood supply
694087|NCT00285545|Mesentery|mesentery
694088|NCT00285532|Blood Lead|blood lead
694089|NCT00285532|Pesticides|pesticides
694090|NCT00285532|Community-based|community-based
694091|NCT00285532|Sampling Kits|sampling kits
694092|NCT00285519|Morning hypertension|morning hypertension
694093|NCT00285506|Healthy Volunteers|healthy volunteers
694094|NCT00285493|low back pain|low back pain
694095|NCT00285467|kidney, parathyroid hormone, vitamin d|kidney, parathyroid hormone, vitamin d
694097|NCT00285428|treatment|treatment
694098|NCT00285428|NHL|nhl
694099|NCT00285428|CD20+ B-cell NHL|cd20+ b-cell nhl
694100|NCT00285428|Lymphoma|lymphoma
694101|NCT00285415|Advanced endometrial adenocarcinoma, stage III A, B, C|advanced endometrial adenocarcinoma, stage iii a, b, c
694102|NCT00285402|Migraine|migraine
694103|NCT00285402|Migraine prophylaxis|migraine prophylaxis
694104|NCT00285402|Migraine prevention|migraine prevention
694105|NCT00285402|Chronic migraine treatment|chronic migraine treatment
694106|NCT00285389|Mantle cell lymphoma|mantle cell lymphoma
694107|NCT00285389|Chemotherapy|chemotherapy
694108|NCT00285389|Autologous PBSCT|autologous pbsct
694109|NCT00285389|Molecular evaluation|molecular evaluation
694110|NCT00285376|Depression. Genetics, Pharmacogenetics|depression. genetics, pharmacogenetics
694111|NCT00285363|cancer|cancer
694112|NCT00285363|quality of life|quality of life
694113|NCT00285363|adolescents|adolescents
694114|NCT00285350|myasthenia gravis|myasthenia gravis
694115|NCT00285337|Myelopathy|myelopathy
694116|NCT00285337|Laminectomy|laminectomy
694117|NCT00285337|Laminoplasty|laminoplasty
694118|NCT00285337|Decompression of Spinal Cord|decompression of spinal cord
694119|NCT00285337|Cervical Spondylosis|cervical spondylosis
694120|NCT00285324|Glioma|glioma
694121|NCT00285324|Glioblastoma Multiforme|glioblastoma multiforme
694122|NCT00285324|Brain Cancer|brain cancer
694123|NCT00285324|Diffusion-Weighted Magnetic Resonance Imaging|diffusion-weighted magnetic resonance imaging
694124|NCT00285324|Brain Tumor|brain tumor
694125|NCT00285298|proteinuria|proteinuria
694126|NCT00285298|Kidney failure, chronic|kidney failure, chronic
694127|NCT00285285|Point-of-care Testing|point-of-care testing
694128|NCT00285285|Pediatric Emergency Department|pediatric emergency department
694129|NCT00285285|Length of Stay|length of stay
694130|NCT00285285|Efficiency|efficiency
694131|NCT00285259|cytomegalovirus infection|cytomegalovirus infection
694132|NCT00285259|infectious disease|infectious disease
694133|NCT00285259|viremia|viremia
694134|NCT00285259|cytomegalovirus disease|cytomegalovirus disease
694135|NCT00285259|stem cell transplant|stem cell transplant
694136|NCT00285259|allogeneic|allogeneic
694137|NCT00285259|bone marrow transplant|bone marrow transplant
694138|NCT00285259|hematopoietic cell transplant|hematopoietic cell transplant
694139|NCT00285259|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
694140|NCT00285259|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
694141|NCT00285259|Acute Myelogenous Leukemia|acute myelogenous leukemia
694142|NCT00285259|Hodgkin's Lymphoma|hodgkin's lymphoma
694143|NCT00285259|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
694144|NCT00285259|Myelodysplastic Syndrome|myelodysplastic syndrome
694145|NCT00285246|combat disorders|combat disorders
694146|NCT00285246|stress, psychological|stress, psychological
694147|NCT00285246|somatoform disorders|somatoform disorders
694148|NCT00285246|life change events|life change events
694149|NCT00285246|utilization|utilization
694150|NCT00285207|Cervical Intraepithelial Neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
694151|NCT00285207|High-grade Cervical Intraepithelial Neoplasia|high-grade cervical intraepithelial neoplasia
694152|NCT00285207|High-grade Squamous Intraepithelial Lesions (HSIL)|high-grade squamous intraepithelial lesions (hsil)
694153|NCT00285207|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
694154|NCT00285207|High-Grade Cervical Intraepithelial Lesions (CIN 2/3)|high-grade cervical intraepithelial lesions (cin 2/3)
694155|NCT00285181|persons|persons
694156|NCT00285168|Osteoporosis|osteoporosis
694157|NCT00285168|Fractures, Bone|fractures, bone
694158|NCT00285168|Bone Mineral Density|bone mineral density
694159|NCT00285155|bupropion|bupropion
694160|NCT00285155|repeated dose|repeated dose
694161|NCT00285155|healthy volunteers|healthy volunteers
694162|NCT00285155|cognitive function|cognitive function
694163|NCT00285155|behaviour|behaviour
694164|NCT00285155|tolerance|tolerance
694165|NCT00285155|Persons|persons
694166|NCT00285142|rosiglitazone|rosiglitazone
694167|NCT00285142|insulin secretion|insulin secretion
694168|NCT00285142|clinical trial|clinical trial
694169|NCT00285142|healthy|healthy
694170|NCT00285142|persons|persons
694171|NCT00285103|Antisense, mRNA antagonist, Bcl-2, CLL|antisense, mrna antagonist, bcl-2, cll
694172|NCT00285090|Burn Injury|burn injury
694173|NCT00285090|Calcium|calcium
694174|NCT00285090|Vitamin D|vitamin d
694175|NCT00285090|Bone Mineral Density|bone mineral density
694176|NCT00285077|Alzheimer disease|alzheimer disease
694177|NCT00285077|nerve growth factors|nerve growth factors
694178|NCT00285077|Clinical Trial|clinical trial
694179|NCT00285064|MDCT|mdct
694180|NCT00285064|viability|viability
694181|NCT00285051|emesis, nausea,|emesis, nausea,
694182|NCT00285038|Deep vein thrombosis|deep vein thrombosis
694183|NCT00285038|Gynecological cancer|gynecological cancer
694184|NCT00285025|Alzheimer disease|alzheimer disease
694185|NCT00285025|nerve growth factors|nerve growth factors
694186|NCT00285025|Clinical Trial|clinical trial
694187|NCT00285012|smoking cessation|smoking cessation
694188|NCT00285012|smoking cessation in COPD|smoking cessation in copd
694189|NCT00284986|GVHD|gvhd
694190|NCT00284986|Graft vs Host Disease|graft vs host disease
694191|NCT00284986|Graft versus Host Disease|graft versus host disease
694192|NCT00284973|malaria|malaria
694193|NCT00284960|erectile dysfunction|erectile dysfunction
694194|NCT00284960|metabolic syndrome|metabolic syndrome
694195|NCT00284960|insulin resistance|insulin resistance
694196|NCT00284960|etiology|etiology
694197|NCT00284947|Side effects|side effects
694198|NCT00284947|calcineurin inhibitors|calcineurin inhibitors
694199|NCT00284947|maintenance|maintenance
694200|NCT00284947|basiliximab|basiliximab
694201|NCT00284947|Kidney maintenance transplant|kidney maintenance transplant
694202|NCT00284934|Dose optimization|dose optimization
694203|NCT00284934|immune suppressive regimen|immune suppressive regimen
694204|NCT00284934|enteric-coated mycophenolate sodium|enteric-coated mycophenolate sodium
694205|NCT00284934|EC-MPS|ec-mps
694206|NCT00284934|renal transplantation|renal transplantation
694207|NCT00284934|kidney|kidney
694208|NCT00284934|transplant|transplant
694209|NCT00284934|maintenance patients|maintenance patients
694210|NCT00284934|Renal transplantation in maintenance|renal transplantation in maintenance
694211|NCT00284921|kidney transplant, hepatitis C, enteric-coated mycophenolate sodium|kidney transplant, hepatitis c, enteric-coated mycophenolate sodium
694212|NCT00284908|S-Tenatoprazole-Na|s-tenatoprazole-na
694213|NCT00284908|Pharmacokinetic|pharmacokinetic
694214|NCT00284908|intragastric pH recording|intragastric ph recording
694215|NCT00284908|dose-response|dose-response
694216|NCT00284895|Obesity|obesity
694217|NCT00284895|Bariatric Surgery|bariatric surgery
694218|NCT00284895|Weight Loss Surgery|weight loss surgery
694219|NCT00284895|Asthma|asthma
694220|NCT00284882|Streptococcus, Fiji, pyoderma, pharyngitis, scabies|streptococcus, fiji, pyoderma, pharyngitis, scabies
694221|NCT00284869|LPS|lps
694222|NCT00284869|ethnicity|ethnicity
694223|NCT00284869|neutrophils|neutrophils
694224|NCT00284869|TNF|tnf
694225|NCT00284843|Streptococcus, Fiji, pyoderma, scabies, rheumatic disease|streptococcus, fiji, pyoderma, scabies, rheumatic disease
694226|NCT00284830|Right Ventricular Pacing|right ventricular pacing
694227|NCT00284830|Persistent Atrial Fibrillation|persistent atrial fibrillation
694228|NCT00284830|Atrioventricular Conduction|atrioventricular conduction
694229|NCT00284830|Heart Failure Hospitalization|heart failure hospitalization
694230|NCT00284830|Cardiovascular Health Care Utilization|cardiovascular health care utilization
694231|NCT00284830|Sinus-node Disease|sinus-node disease
694232|NCT00284830|Minimized Ventricular Pacing|minimized ventricular pacing
694233|NCT00284804|relapsed or refractory Hodgkin's Disease|relapsed or refractory hodgkin's disease
694234|NCT00284778|lung cancer|lung cancer
694235|NCT00284778|second line treatment|second line treatment
694236|NCT00284778|cost-minimization trial|cost-minimization trial
694237|NCT00284778|Pharmaco-economic study|pharmaco-economic study
694238|NCT00284778|docetaxel|docetaxel
694239|NCT00284778|pemetrexed|pemetrexed
694240|NCT00284752|Prostate|prostate
694241|NCT00284752|Cancer|cancer
694242|NCT00284752|Metastatic|metastatic
694243|NCT00284726|Cytokines in lung transplantation|cytokines in lung transplantation
694244|NCT00284726|Cold storage solutions|cold storage solutions
694245|NCT00284726|Ischemic reperfusion injury|ischemic reperfusion injury
694246|NCT00284700|Helicobacter pylori|helicobacter pylori
694247|NCT00284700|Iron deficiency anemia|iron deficiency anemia
694248|NCT00284700|children|children
694249|NCT00284687|bone marrow transplantation|bone marrow transplantation
694250|NCT00284687|CMV disease|cmv disease
694251|NCT00284661|Meniscal repair|meniscal repair
694252|NCT00284661|Meniscal suturing|meniscal suturing
694253|NCT00284661|Meniscal tear|meniscal tear
694254|NCT00284648|Achilles tendon|achilles tendon
694255|NCT00284648|Rupture|rupture
694256|NCT00284648|Non-operative|non-operative
694257|NCT00284648|Operative|operative
694258|NCT00284622|HTO|hto
694259|NCT00284622|Arthroscopy|arthroscopy
694260|NCT00284622|Osteoarthritis|osteoarthritis
694261|NCT00284622|Alignement|alignement
694262|NCT00284622|Varus gonarthrosis|varus gonarthrosis
694263|NCT00284609|Type 2 diabetes,|type 2 diabetes,
694264|NCT00284609|rehabilitation,|rehabilitation,
694265|NCT00284609|quality of life,|quality of life,
694266|NCT00284609|glycaemic control,|glycaemic control,
694267|NCT00284609|lifestyle intervention,|lifestyle intervention,
694268|NCT00284609|patient education,|patient education,
694269|NCT00284609|physical training,|physical training,
694270|NCT00284609|group visits,|group visits,
694271|NCT00284609|reminders|reminders
694272|NCT00284596|Opening wedge high tibial osteotomy|opening wedge high tibial osteotomy
694273|NCT00284596|Radio Sterometric Analysis|radio sterometric analysis
694274|NCT00284596|Locking screw fixation|locking screw fixation
694275|NCT00284583|Morton's Neuroma|morton's neuroma
694276|NCT00284583|Alcohol|alcohol
694277|NCT00284583|Steroid|steroid
694278|NCT00284570|pediatrics|pediatrics
694279|NCT00284570|congenital heart disease|congenital heart disease
694280|NCT00284570|cardiac|cardiac
694281|NCT00284570|cardiopulmonary bypass|cardiopulmonary bypass
694282|NCT00284570|infection|infection
694283|NCT00284570|sepsis|sepsis
694284|NCT00284570|postoperative|postoperative
694285|NCT00284570|marker for infection|marker for infection
694286|NCT00284570|inflammation|inflammation
694287|NCT00284570|cardiac surgery|cardiac surgery
694288|NCT00284557|Behavioral/Social|behavioral/social
694289|NCT00284557|Obesity|obesity
694290|NCT00284557|Pediatrics|pediatrics
694291|NCT00284557|Preventive Medicine|preventive medicine
694292|NCT00284531|cardiac transplantation|cardiac transplantation
694293|NCT00284531|allograft rejection|allograft rejection
694294|NCT00284531|anti-CD25|anti-cd25
694295|NCT00284505|cytokine|cytokine
694296|NCT00284505|arachnoiditis|arachnoiditis
694297|NCT00284505|neuropathic pain|neuropathic pain
694298|NCT00284505|tumor necrosis factor|tumor necrosis factor
694299|NCT00284492|Women|women
694300|NCT00284492|Acupuncture|acupuncture
694301|NCT00284492|Menopause|menopause
694302|NCT00284492|Hot flashes|hot flashes
694303|NCT00284492|Health related quality of life|health related quality of life
694304|NCT00284479|walking intervention|walking intervention
694305|NCT00284479|cardiovascular risk|cardiovascular risk
694306|NCT00284479|inflammatory markers|inflammatory markers
694307|NCT00284479|aerobic fitness|aerobic fitness
694308|NCT00284479|fatness|fatness
694309|NCT00284466|coronary artery disease|coronary artery disease
694310|NCT00284466|cardiac catheterization|cardiac catheterization
694311|NCT00284466|CT coronary angiography|ct coronary angiography
694312|NCT00284466|coronary angiography|coronary angiography
694313|NCT00284453|ventricular|ventricular
694314|NCT00284453|arrhythmias|arrhythmias
694315|NCT00284453|ICD|icd
694316|NCT00284453|VT storm|vt storm
694317|NCT00284453|ICD patients with VT storm|icd patients with vt storm
694318|NCT00284440|Visual field progression|visual field progression
694319|NCT00284440|Choroidal blood flow|choroidal blood flow
694320|NCT00284401|Reversed prosthesis|reversed prosthesis
694321|NCT00284336|breast cancer|breast cancer
694322|NCT00284336|elderly|elderly
694323|NCT00284336|adjuvant chemotherapy|adjuvant chemotherapy
694324|NCT00284336|Caelyx|caelyx
694325|NCT00284323|Acute Myocardial Infarction|acute myocardial infarction
694326|NCT00284323|PCI|pci
694327|NCT00284323|Adenosine|adenosine
694328|NCT00284323|Postconditioning|postconditioning
694329|NCT00284310|Wrist surgery: 4-corner arthrodesis or proximal row carpectomy|wrist surgery: 4-corner arthrodesis or proximal row carpectomy
694330|NCT00284271|Hodgkin´s Lymphoma|hodgkin´s lymphoma
694331|NCT00284271|eldery patients|eldery patients
694332|NCT00284271|primary diagnosis|primary diagnosis
694333|NCT00284258|Colorectal Cancer|colorectal cancer
694334|NCT00284245|Chronic Pain|chronic pain
694335|NCT00284245|Pain|pain
694336|NCT00284245|Computer Analysis|computer analysis
694337|NCT00284245|Pain Diagrams|pain diagrams
694338|NCT00284232|HbA1c|hba1c
694339|NCT00284232|Self-monitoring blood glucose (SMBG)|self-monitoring blood glucose (smbg)
694340|NCT00284232|Diabetes treatment|diabetes treatment
694341|NCT00284232|quality of care|quality of care
694342|NCT00284219|rTMS, smoking, dopamine, acotinine|rtms, smoking, dopamine, acotinine
695337|NCT00281307|Intranasal|intranasal
694343|NCT00284206|methamphetamine, cognition, outpatient, risperidone|methamphetamine, cognition, outpatient, risperidone
694344|NCT00284180|Breast Neoplasms|breast neoplasms
694345|NCT00284180|Breast Cancer|breast cancer
694346|NCT00284180|Vinflunine|vinflunine
694347|NCT00284180|Vinca Alkaloid|vinca alkaloid
694348|NCT00284180|Javlor|javlor
694349|NCT00284167|tailored|tailored
694350|NCT00284167|web-based|web-based
694351|NCT00284167|weight management|weight management
694352|NCT00284167|obesity|obesity
694353|NCT00284167|efficacy|efficacy
694354|NCT00284154|Extensive stage|extensive stage
694355|NCT00284154|Relapsed|relapsed
694356|NCT00284141|lung|lung
694357|NCT00284141|cancer|cancer
694358|NCT00284141|non-small-cell lung cancer|non-small-cell lung cancer
694359|NCT00284141|metastatic|metastatic
694360|NCT00284141|carcinoma|carcinoma
694361|NCT00284141|lung neoplasm|lung neoplasm
694362|NCT00284141|lung diseases|lung diseases
694363|NCT00284141|angiogenesis|angiogenesis
694364|NCT00284141|anti-angiogenesis|anti-angiogenesis
694365|NCT00284141|anti-angiogenesis inhibitors|anti-angiogenesis inhibitors
694366|NCT00284141|cancer and other neoplasms|cancer and other neoplasms
694367|NCT00284141|respiratory tract|respiratory tract
694368|NCT00284141|(lung and bronchial) diseases|(lung and bronchial) diseases
694369|NCT00284128|Cardiovascular Disease C14|cardiovascular disease c14
694370|NCT00284128|vascular disease C14.907|vascular disease c14.907
694371|NCT00284128|hypertension C14.907.489|hypertension c14.907.489
694372|NCT00284115|Gait trainer|gait trainer
694373|NCT00284115|Hemiplegia|hemiplegia
694374|NCT00284115|Rehabilitation|rehabilitation
694375|NCT00284115|Stroke|stroke
694376|NCT00284102|gas exchange|gas exchange
694377|NCT00284102|dead space|dead space
694378|NCT00284102|respiratory failure|respiratory failure
694379|NCT00284102|ALI/ARDS patients|ali/ards patients
694380|NCT00284089|Subfoveal CNV, AMD, ranibizumab|subfoveal cnv, amd, ranibizumab
694381|NCT00284063|spinal manipulation, zygapophysial joints|spinal manipulation, zygapophysial joints
694382|NCT00284050|DME|dme
694383|NCT00284050|Diabetic macular edema|diabetic macular edema
694384|NCT00284050|ranibizumab|ranibizumab
694385|NCT00284050|Diabetic macular edema with center involvement|diabetic macular edema with center involvement
694386|NCT00284037|obstructive sleep apnea,|obstructive sleep apnea,
694387|NCT00284037|baroreceptors|baroreceptors
694388|NCT00284024|breastfeeding|breastfeeding
694389|NCT00284024|domperidone|domperidone
694390|NCT00284024|efficacy|efficacy
694391|NCT00284024|randomized controlled trial|randomized controlled trial
694392|NCT00284024|compliance|compliance
694393|NCT00284011|SAMe|same
694394|NCT00284011|AdoMet|adomet
694395|NCT00284011|Methylation|methylation
694396|NCT00284011|Homocysteine|homocysteine
694397|NCT00284011|Dietary Supplement|dietary supplement
694398|NCT00284011|S-Adenosyl-L-Methionine|s-adenosyl-l-methionine
694399|NCT00283998|Odontoid|odontoid
694400|NCT00283998|Type II fractures|type ii fractures
694401|NCT00283998|Elderly patients|elderly patients
694402|NCT00283998|Surgical vs. conservative treatment|surgical vs. conservative treatment
694403|NCT00283985|NK/T-cell lymphoma|nk/t-cell lymphoma
694404|NCT00283985|Lymphoma|lymphoma
694405|NCT00283985|L-asparaginase|l-asparaginase
694406|NCT00283985|Nasal NK-cell lymphoma|nasal nk-cell lymphoma
694407|NCT00283985|Nasal-type NK-cell Lymphoma|nasal-type nk-cell lymphoma
694408|NCT00283972|Health Outcome Study|health outcome study
694409|NCT00283946|zolpidem|zolpidem
694410|NCT00283946|sleep initiation and maintenance disorders Hypnotics and sedatives|sleep initiation and maintenance disorders hypnotics and sedatives
694411|NCT00283946|double-blind study|double-blind study
694412|NCT00283946|comparative study|comparative study
694413|NCT00283933|Amicus Therapeutics|amicus therapeutics
694414|NCT00283933|AT1001|at1001
694415|NCT00283933|Migalastat|migalastat
694416|NCT00283933|Pharmacokinetics|pharmacokinetics
694417|NCT00283933|Substrate|substrate
694418|NCT00283920|Pharmacokinetics|pharmacokinetics
694419|NCT00283920|Compartmental Analysis|compartmental analysis
694420|NCT00283920|Distribution Volume|distribution volume
694421|NCT00283920|Identitiability|identitiability
694422|NCT00283920|Healthy Volunteer|healthy volunteer
694423|NCT00283920|HV|hv
694424|NCT00283907|Electroencephalogram (EEG)|electroencephalogram (eeg)
694425|NCT00283907|Sense of Agency|sense of agency
694426|NCT00283907|Coherence|coherence
694427|NCT00283907|Voluntary Movement|voluntary movement
694428|NCT00283907|Self-Agency|self-agency
694429|NCT00283907|Healthy Volunteer|healthy volunteer
694430|NCT00283907|HV|hv
694431|NCT00283894|Obesity|obesity
694432|NCT00283894|Leptin|leptin
694433|NCT00283894|Sleep Attacks|sleep attacks
694434|NCT00283894|Energy Metabolism|energy metabolism
694435|NCT00283894|Healthy Control|healthy control
694436|NCT00283894|Narcolepsy|narcolepsy
694437|NCT00283894|Healthy Volunteer|healthy volunteer
694438|NCT00283894|HV|hv
694439|NCT00283881|Haptic Skills|haptic skills
694440|NCT00283881|Implicit Tactile Learning|implicit tactile learning
694441|NCT00283881|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
695536|NCT00280280|spasticity|spasticity
694442|NCT00283881|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
694443|NCT00283881|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
694444|NCT00283881|Stroke|stroke
694445|NCT00283881|Healthy Volunteer|healthy volunteer
694446|NCT00283881|HV|hv
694447|NCT00283868|stroke|stroke
694448|NCT00283868|digital video|digital video
694449|NCT00283868|SPOTRIAS|spotrias
694450|NCT00283855|Rheumatoid Arthritis|rheumatoid arthritis
694451|NCT00283855|Self-Management|self-management
694452|NCT00283855|Internet|internet
694453|NCT00283842|neuropathic pain|neuropathic pain
694454|NCT00283842|diabetic peripheral neuropathy|diabetic peripheral neuropathy
694455|NCT00283829|Immunotherapy|immunotherapy
694456|NCT00283816|Polycystic Ovary Syndrome|polycystic ovary syndrome
694457|NCT00283816|Overweight Adolescent Girls|overweight adolescent girls
694458|NCT00283816|Irregular Menstrual Cycles|irregular menstrual cycles
694459|NCT00283777|insulin|insulin
694460|NCT00283777|glucose|glucose
694461|NCT00283777|body weight|body weight
694462|NCT00283777|chromium|chromium
694463|NCT00283738|migraine|migraine
694464|NCT00283738|aura|aura
694465|NCT00283738|Patent Foramen Ovale (PFO)|patent foramen ovale (pfo)
694466|NCT00283738|cardiac defects|cardiac defects
694467|NCT00283738|Heart Septal Defects, Atrial|heart septal defects, atrial
694468|NCT00283738|Cephalalgia|cephalalgia
694469|NCT00283725|Dementia|dementia
694470|NCT00283725|Alzheimer's Disease|alzheimer's disease
694471|NCT00283725|Acetylcholinesterase inhibitor|acetylcholinesterase inhibitor
694472|NCT00283725|Galantamine|galantamine
694473|NCT00283725|Nursing Home Admission|nursing home admission
694474|NCT00283712|Skin Diseases|skin diseases
694475|NCT00283712|Autoimmune Diseases|autoimmune diseases
694476|NCT00283699|neurocysticercosis|neurocysticercosis
694477|NCT00283699|albendazole|albendazole
694478|NCT00283699|tape worm|tape worm
694479|NCT00283686|polycystic kidney disease|polycystic kidney disease
694480|NCT00283686|polycystic|polycystic
694481|NCT00283686|kidney|kidney
694482|NCT00283686|disease|disease
694483|NCT00283686|adpkd|adpkd
694484|NCT00283686|halt|halt
694485|NCT00283686|pkd|pkd
694486|NCT00283686|blood pressure|blood pressure
694487|NCT00283686|bp|bp
694488|NCT00283686|hypertension|hypertension
694489|NCT00283686|renal|renal
694490|NCT00283686|renin-angiotensin-aldosterone-system|renin-angiotensin-aldosterone-system
694491|NCT00283686|RAAS|raas
694492|NCT00283660|Zinc|zinc
694493|NCT00283660|Dietary Supplements|dietary supplements
694494|NCT00283660|Nutritional Supplements|nutritional supplements
694495|NCT00283660|Child|child
694496|NCT00283660|Mental Health|mental health
694497|NCT00283660|School|school
694498|NCT00283660|Guatemala|guatemala
694499|NCT00283647|lead exposure|lead exposure
694500|NCT00283647|magnetic resonance imaging|magnetic resonance imaging
694501|NCT00283647|magnetic resonance spectroscopy|magnetic resonance spectroscopy
694502|NCT00283647|functional magnetic resonance|functional magnetic resonance
694503|NCT00283647|brain development|brain development
694504|NCT00283621|Aranesp|aranesp
694505|NCT00283621|Darbepoetin Alfa|darbepoetin alfa
694506|NCT00283621|Pegfilgrastim|pegfilgrastim
694507|NCT00283621|Neulasta|neulasta
694508|NCT00283621|Sarcoma|sarcoma
694509|NCT00283621|Adriamycin|adriamycin
694510|NCT00283621|Doxorubicin Hydrocholoride|doxorubicin hydrocholoride
694511|NCT00283621|Adriamycin PFS|adriamycin pfs
694512|NCT00283621|Adriamycin RDF|adriamycin rdf
694513|NCT00283621|Ifosfamide|ifosfamide
694514|NCT00283608|stage I breast cancer|stage i breast cancer
694515|NCT00283608|stage II breast cancer|stage ii breast cancer
694516|NCT00283608|stage IIIA breast cancer|stage iiia breast cancer
694517|NCT00283608|stage IIIB breast cancer|stage iiib breast cancer
694518|NCT00283608|stage IIIC breast cancer|stage iiic breast cancer
694519|NCT00283595|Anorexia Nervosa|anorexia nervosa
694520|NCT00283595|Eating disorder|eating disorder
694521|NCT00283595|Bone|bone
694522|NCT00283595|Growth hormone|growth hormone
694523|NCT00283595|Osteopenia|osteopenia
694524|NCT00283595|Osteoporosis|osteoporosis
694525|NCT00283569|Glioma|glioma
694526|NCT00283556|High Dose Irinotecan|high dose irinotecan
694527|NCT00283556|CPT-11|cpt-11
694528|NCT00283556|Camptosar|camptosar
694529|NCT00283556|Malignant Glioma|malignant glioma
694530|NCT00283556|Unresectable|unresectable
694531|NCT00283543|Glioma|glioma
694532|NCT00283543|Gliadel Wafer|gliadel wafer
694533|NCT00283530|Cancer|cancer
694534|NCT00283530|Cancer receiving chemotherapy|cancer receiving chemotherapy
694535|NCT00283530|Tumor biopsy|tumor biopsy
694536|NCT00283517|Risperidone long-acting injection|risperidone long-acting injection
694537|NCT00283517|Antipsychotic medication|antipsychotic medication
694538|NCT00283517|Schizophrenia|schizophrenia
694539|NCT00283517|Treatment retention|treatment retention
694540|NCT00283517|Observational study|observational study
694541|NCT00283491|Iron absorption|iron absorption
694542|NCT00283491|Organic acids|organic acids
694543|NCT00283491|Lactobacillus|lactobacillus
694544|NCT00283491|Probiotic|probiotic
694545|NCT00283478|Advanced stage|advanced stage
694546|NCT00283478|Lung cancer|lung cancer
694547|NCT00283465|Anemia|anemia
694548|NCT00283465|cancer|cancer
694549|NCT00283465|neoplasm|neoplasm
694550|NCT00283465|transfusion|transfusion
694551|NCT00283465|quality of life|quality of life
694552|NCT00283465|tumor response|tumor response
694553|NCT00283465|survival|survival
694554|NCT00283465|chemotherapy|chemotherapy
694555|NCT00283465|hemoglobin|hemoglobin
694556|NCT00283465|standard care|standard care
694557|NCT00283465|epoetin alfa|epoetin alfa
694558|NCT00283465|epoetin|epoetin
694559|NCT00283465|erythropoietin|erythropoietin
694560|NCT00283452|Physical activity maintenance|physical activity maintenance
694561|NCT00283452|Interactive phone and mail-based intervention|interactive phone and mail-based intervention
694562|NCT00283452|Older adults|older adults
694563|NCT00283439|NHL|nhl
694564|NCT00283439|chemotherapy induced thrombocytopenia|chemotherapy induced thrombocytopenia
694565|NCT00283439|CIT|cit
694566|NCT00283439|ICE|ice
694567|NCT00283439|RICE|rice
694568|NCT00283439|Hodgkin's Lymphoma|hodgkin's lymphoma
694569|NCT00283439|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
694570|NCT00283439|CHOP|chop
694571|NCT00283439|ESHAP|eshap
694572|NCT00283439|DHAP|dhap
694573|NCT00283439|R-CHOP|r-chop
694574|NCT00283439|R-ESHAP|r-eshap
694575|NCT00283439|R-DHAP|r-dhap
694576|NCT00283413|Covered Stent System|covered stent system
694577|NCT00283413|Saphenous Vein Graft|saphenous vein graft
694578|NCT00283413|Coronary Artery Bypass[MeSH]|coronary artery bypass[mesh]
694579|NCT00283413|Stents[MeSH]|stents[mesh]
694580|NCT00283400|subarachnoid hemorrhage|subarachnoid hemorrhage
694581|NCT00283400|SAH|sah
694582|NCT00283400|human albumin|human albumin
694583|NCT00283400|HA|ha
694584|NCT00283400|cerebral vasospasm|cerebral vasospasm
694585|NCT00283400|aneurysm|aneurysm
694586|NCT00283400|neuroprotective|neuroprotective
694587|NCT00283387|Primary Hyperoxaluria|primary hyperoxaluria
694588|NCT00283374|Metabolic Syndrome|metabolic syndrome
694589|NCT00283374|Obesity|obesity
694590|NCT00283374|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
694591|NCT00283374|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
694592|NCT00283374|Bariatric Surgery|bariatric surgery
694593|NCT00283348|Renal Transplantation|renal transplantation
694594|NCT00283348|Immunosuppression|immunosuppression
694595|NCT00283348|Chronic Rejection|chronic rejection
694596|NCT00283322|Heparin Induced Thrombocytopenia|heparin induced thrombocytopenia
694597|NCT00283322|HIT|hit
694598|NCT00283322|HITT|hitt
694599|NCT00283322|Thrombosis|thrombosis
694600|NCT00283322|Thromboembolism|thromboembolism
694601|NCT00283309|Corticosteroids|corticosteroids
694602|NCT00283309|Riluzole|riluzole
694603|NCT00283309|Memantine|memantine
694604|NCT00283309|Memory|memory
694605|NCT00283296|manual wheelchair|manual wheelchair
694606|NCT00283296|assistive technology|assistive technology
694607|NCT00283296|travel wheelchair|travel wheelchair
694608|NCT00283283|Influenza|influenza
694609|NCT00283270|Mental health|mental health
694610|NCT00283270|Screening|screening
694611|NCT00283270|Elderly|elderly
694612|NCT00283270|Chinese|chinese
694613|NCT00283270|Problem-solving counselling|problem-solving counselling
694614|NCT00283257|Problem solving|problem solving
694615|NCT00283257|psychosocial support|psychosocial support
694616|NCT00283244|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
694617|NCT00283244|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
694618|NCT00283231|Hot Flashes|hot flashes
694619|NCT00283231|Menopausal Symptoms|menopausal symptoms
694620|NCT00283231|Paced respiration|paced respiration
694621|NCT00283231|RESPeRATE|resperate
694622|NCT00283205|Menopausal Symptoms|menopausal symptoms
694623|NCT00283205|Hot Flashes|hot flashes
694624|NCT00283205|Yoga|yoga
694625|NCT00283192|Menopausal Symptoms|menopausal symptoms
694626|NCT00283192|Hot flashes|hot flashes
694627|NCT00283179|Aripiprazole|aripiprazole
694628|NCT00283179|Risperidone|risperidone
694629|NCT00283179|Schizophrenia|schizophrenia
694630|NCT00283179|Schizoaffective disorder|schizoaffective disorder
694631|NCT00283166|Palliative Care|palliative care
694632|NCT00283153|Traumatic Brain Injury|traumatic brain injury
694633|NCT00283153|Stroke|stroke
694634|NCT00283153|Emotion Recognition|emotion recognition
694635|NCT00283153|Affect|affect
694636|NCT00283153|Interventions|interventions
694637|NCT00283127|Chlamydia trachomatis|chlamydia trachomatis
694638|NCT00283127|Mass screening|mass screening
694639|NCT00283127|Home sampling|home sampling
694640|NCT00283127|Urine test|urine test
694641|NCT00283114|Lintuzumab|lintuzumab
694642|NCT00283114|Antigens, CD33|antigens, cd33
694643|NCT00283114|Antibodies, Monoclonal|antibodies, monoclonal
694644|NCT00283114|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
694645|NCT00283114|Myelodysplastic Syndromes|myelodysplastic syndromes
694646|NCT00283114|Hematologic Diseases|hematologic diseases
694647|NCT00283114|Myeloproliferative Disorders|myeloproliferative disorders
694648|NCT00283114|Leukemia|leukemia
694649|NCT00283101|Antigens, CD40|antigens, cd40
694650|NCT00283101|Antibody, Monoclonal|antibody, monoclonal
694651|NCT00283101|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
694652|NCT00283101|Hematologic Diseases|hematologic diseases
694653|NCT00283101|Immunoproliferatic Disorders|immunoproliferatic disorders
694654|NCT00283101|Lymphatic Diseases|lymphatic diseases
694655|NCT00283101|Lymphoproliferative Disorders|lymphoproliferative disorders
694656|NCT00283101|Leukemia|leukemia
694657|NCT00283088|stroke|stroke
694658|NCT00283088|hypothermia|hypothermia
694659|NCT00283088|cooling|cooling
694660|NCT00283088|tissue plasminogen activator|tissue plasminogen activator
694661|NCT00283088|tPA|tpa
694662|NCT00283088|thrombolysis|thrombolysis
694663|NCT00283075|intraabdominal cancer (carcinomas)|intraabdominal cancer (carcinomas)
694664|NCT00283075|agarose macrobeads|agarose macrobeads
694665|NCT00283075|mouse kidney cancer cells|mouse kidney cancer cells
694666|NCT00283075|cancer cell growth inhibition|cancer cell growth inhibition
694667|NCT00283023|All selective craniotomy|all selective craniotomy
694668|NCT00283010|cognitive enhancement|cognitive enhancement
694669|NCT00283010|memory|memory
694670|NCT00283010|auditory memory|auditory memory
694671|NCT00283010|speech|speech
694672|NCT00283010|computerized|computerized
694673|NCT00283010|cognitive decline|cognitive decline
694674|NCT00282971|Type 2 diabetes melllitus|type 2 diabetes melllitus
694675|NCT00282893|aneurysm|aneurysm
694676|NCT00282893|vasospasm|vasospasm
694677|NCT00282893|subarachnoid hemorrhage|subarachnoid hemorrhage
694678|NCT00282893|transluminal ballooning|transluminal ballooning
694679|NCT00282867|stroke|stroke
694680|NCT00282867|acute ischemic stroke|acute ischemic stroke
694681|NCT00282867|hyperglycemia|hyperglycemia
694682|NCT00282867|glucose|glucose
694683|NCT00282867|insulin|insulin
694684|NCT00282867|insulin and potassium therapy|insulin and potassium therapy
694685|NCT00282867|GIK|gik
694686|NCT00282854|epilepsy|epilepsy
694687|NCT00282854|Rolandic epilepsy|rolandic epilepsy
694688|NCT00282841|stroke|stroke
694689|NCT00282841|ultrasound|ultrasound
694690|NCT00282841|occlusion|occlusion
694691|NCT00282841|blockage|blockage
694692|NCT00282841|contrast solution|contrast solution
694693|NCT00282828|Social Anxiety Disorder|social anxiety disorder
694694|NCT00282828|Pharmacotherapy|pharmacotherapy
694695|NCT00282828|Genetics|genetics
694696|NCT00282828|Treatment Refractory|treatment refractory
694697|NCT00282815|obstructive sleep apnea|obstructive sleep apnea
694698|NCT00282815|stroke|stroke
694699|NCT00282815|OSA|osa
694700|NCT00282815|CPAP|cpap
694701|NCT00282815|continuous positive airway pressure|continuous positive airway pressure
694702|NCT00282802|Parkinson's Disease|parkinson's disease
694703|NCT00282802|twins|twins
694704|NCT00282802|SPECT|spect
694705|NCT00282802|National Academy of Sciences/National Resource Council (NAS/NRC) World War II Veteran Twins Cohort Registry|national academy of sciences/national resource council (nas/nrc) world war ii veteran twins cohort registry
694706|NCT00282802|NAS/NRC|nas/nrc
694707|NCT00282802|World War II Veteran Twins|world war ii veteran twins
694708|NCT00282776|Postpartum Depression|postpartum depression
694709|NCT00282776|Telephone Care Management|telephone care management
694710|NCT00282776|Screening for Postpartum Depression|screening for postpartum depression
694711|NCT00282750|"Surgery[MeSH]"|"surgery[mesh]"
694712|NCT00282750|"Surgical Sponges[MeSH]"|"surgical sponges[mesh]"
694713|NCT00282750|"Automatic Data Processing[MeSH]"|"automatic data processing[mesh]"
694714|NCT00282724|Lamellar ichthyosis|lamellar ichthyosis
694715|NCT00282724|Liarozole|liarozole
694716|NCT00282724|Investigator's Global Assessment|investigator's global assessment
694717|NCT00282724|Scaling|scaling
694718|NCT00282711|Diagnostic Techniques, Radioisotope|diagnostic techniques, radioisotope
694719|NCT00282711|Radionuclide Imaging|radionuclide imaging
694720|NCT00282711|Diagnostic Techniques, Cardiovascular|diagnostic techniques, cardiovascular
694721|NCT00282711|Heart Function tests|heart function tests
694722|NCT00282685|Patients with symmetric peripheral diabetic neuropathy|patients with symmetric peripheral diabetic neuropathy
694723|NCT00282672|Barrett's Esophagus|barrett's esophagus
694724|NCT00282672|Dysplasia|dysplasia
694725|NCT00282672|Radiofrequency Ablation|radiofrequency ablation
694726|NCT00282659|Hemodynamics|hemodynamics
694727|NCT00282659|Hypertension|hypertension
694728|NCT00282659|Dyslipidemia|dyslipidemia
694729|NCT00282659|Diabetes|diabetes
694730|NCT00282659|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
694731|NCT00282659|Blood Pressure|blood pressure
694732|NCT00282646|critical limb ischemia|critical limb ischemia
694733|NCT00282646|peripheral arterial occlusive disease|peripheral arterial occlusive disease
694734|NCT00282646|[C14.907.137]|[c14.907.137]
694735|NCT00282633|Cesarean Delivery|cesarean delivery
694736|NCT00282633|Wound closure|wound closure
694737|NCT00282633|Suture|suture
694738|NCT00282633|Alternative therapy|alternative therapy
694739|NCT00282633|Surgery|surgery
694740|NCT00282620|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
694741|NCT00282620|Magnesium|magnesium
694742|NCT00282620|Electrocardiogram|electrocardiogram
694743|NCT00282620|Ventricular Arrhythmia|ventricular arrhythmia
694744|NCT00282607|Erectile Dysfunction|erectile dysfunction
694745|NCT00282594|Intensive Insulin Therapy|intensive insulin therapy
694746|NCT00282594|General Surgical|general surgical
694747|NCT00282594|Vascular Surgical|vascular surgical
694748|NCT00282594|Tight Glycemic Control|tight glycemic control
694749|NCT00282581|HIV|hiv
694750|NCT00282581|Smallpox|smallpox
694751|NCT00282581|MVA|mva
694752|NCT00282568|Pharmacokinetics|pharmacokinetics
694753|NCT00282568|Therapy|therapy
694754|NCT00282568|Immunosuppression|immunosuppression
694755|NCT00282568|Drugs, Investigational|drugs, investigational
694756|NCT00282568|Adult|adult
694757|NCT00282555|Esophagitis, Reflux|esophagitis, reflux
694758|NCT00282555|S-Tenatoprazole-Na|s-tenatoprazole-na
694759|NCT00282555|Heartburn|heartburn
694760|NCT00282555|Esophageal endoscopy|esophageal endoscopy
694761|NCT00282542|Hepatocytes|hepatocytes
694762|NCT00282529|lymphedema, screening, treatment|lymphedema, screening, treatment
694763|NCT00282516|asthma|asthma
694764|NCT00282516|telemedicine|telemedicine
694765|NCT00282516|case management|case management
694766|NCT00282516|clinic|clinic
694767|NCT00282516|children|children
694768|NCT00282516|pediatric|pediatric
694769|NCT00282503|aGvHD|agvhd
694770|NCT00282490|Overactive bladder|overactive bladder
694771|NCT00282490|Children|children
694772|NCT00282490|Nerve stimulation|nerve stimulation
694773|NCT00282490|TENS|tens
694774|NCT00282477|cyclist|cyclist
694775|NCT00282464|Bipolar I Depression|bipolar i depression
694776|NCT00282399|Myelodysplastic Syndrome|myelodysplastic syndrome
694777|NCT00282399|MGI Pharma|mgi pharma
694778|NCT00282399|Decitabine|decitabine
694779|NCT00282399|Dacogen|dacogen
694780|NCT00282360|coronary artery disease|coronary artery disease
694781|NCT00282360|diabetes mellitus|diabetes mellitus
694782|NCT00282347|Class IV LN|class iv ln
694783|NCT00282347|Lupus|lupus
694784|NCT00282347|LUNAR|lunar
694785|NCT00282347|LN|ln
694786|NCT00282334|Telemedicine|telemedicine
694787|NCT00282334|Blood pressure|blood pressure
694788|NCT00282334|Quality of life|quality of life
694789|NCT00282334|Cost-effectiveness|cost-effectiveness
694790|NCT00282308|RA|ra
694791|NCT00282308|Rituxan|rituxan
694792|NCT00282308|SIERRA|sierra
694793|NCT00282295|tetanus|tetanus
694794|NCT00282295|pertussis|pertussis
694795|NCT00282295|Prophylaxis|prophylaxis
694796|NCT00282295|meningococcus|meningococcus
694797|NCT00282295|diptheria|diptheria
694798|NCT00282282|non-myeloablative peripheral blood stem cell|non-myeloablative peripheral blood stem cell
694799|NCT00282282|PBSCT|pbsct
694800|NCT00282282|tacrolimus|tacrolimus
694801|NCT00282282|sirolimus|sirolimus
694802|NCT00282269|Traumatic Brain Injury|traumatic brain injury
694803|NCT00282269|Children|children
694804|NCT00282269|Hypothermia|hypothermia
694805|NCT00282269|Outcome|outcome
694806|NCT00282269|Intensive Care|intensive care
694807|NCT00282269|Magnetic resonance Imaging|magnetic resonance imaging
694808|NCT00282256|Child|child
694809|NCT00282256|Pharmacokinetics|pharmacokinetics
694810|NCT00282256|Immunosuppression Drugs|immunosuppression drugs
694811|NCT00282256|Hepatic transplant|hepatic transplant
694812|NCT00282256|Liver Transplantation|liver transplantation
694813|NCT00282243|Pharmacokinetics|pharmacokinetics
694814|NCT00282243|Therapy|therapy
694815|NCT00282243|Immunosuppression|immunosuppression
694816|NCT00282243|Drugs, Investigational|drugs, investigational
694817|NCT00282243|Adult|adult
694818|NCT00282230|Malononitrilamide|malononitrilamide
694819|NCT00282230|immunosuppression|immunosuppression
694820|NCT00282230|treatment efficacy|treatment efficacy
694821|NCT00282230|treatment outcome|treatment outcome
694822|NCT00282217|Kidney Failure|kidney failure
694823|NCT00282217|Kidney Transplant|kidney transplant
694824|NCT00282217|Graft Rejection|graft rejection
694825|NCT00282217|Kidney Transplantation|kidney transplantation
694826|NCT00282204|Hypnosis|hypnosis
694827|NCT00282204|Hypnotherapy|hypnotherapy
694828|NCT00282204|Childbirth|childbirth
694829|NCT00282204|Analgesia|analgesia
694830|NCT00282191|spasticity|spasticity
694831|NCT00282191|mental retardation|mental retardation
694832|NCT00282178|Metabolic|metabolic
694833|NCT00282178|Hypertension|hypertension
694834|NCT00282178|Abdominal obesity|abdominal obesity
694835|NCT00282178|Insulin sensitivity|insulin sensitivity
694836|NCT00282178|Hyperinsulinemic euglycemic clamp|hyperinsulinemic euglycemic clamp
694837|NCT00282152|Early Stage Parkinson's Disease|early stage parkinson's disease
694838|NCT00282152|Parkinson's Disease|parkinson's disease
694839|NCT00282152|Deep Brain Stimulation|deep brain stimulation
694840|NCT00282152|PD|pd
694841|NCT00282152|DBS|dbs
694842|NCT00282126|Calcium balance|calcium balance
694843|NCT00282113|Probiotic|probiotic
694844|NCT00282113|Prebiotic|prebiotic
694845|NCT00282113|NEC|nec
694846|NCT00282113|Premature infants|premature infants
694847|NCT00282113|commensal flora|commensal flora
694848|NCT00282087|early stage|early stage
694849|NCT00282087|high grade|high grade
694850|NCT00282087|uterine leiomyosarcoma|uterine leiomyosarcoma
694851|NCT00282087|adjuvant treatment|adjuvant treatment
694852|NCT00282061|3 conditions in a within-subject design:|3 conditions in a within-subject design:
694853|NCT00282061|1-ad-lib sleep wake|1-ad-lib sleep wake
694854|NCT00282061|2-forced morning wake-up|2-forced morning wake-up
694855|NCT00282061|3- ad-lib sleep wake after treatment with melatonin|3- ad-lib sleep wake after treatment with melatonin
694856|NCT00282035|breast cancer|breast cancer
694857|NCT00282035|breast tumour|breast tumour
694858|NCT00282035|DCIS|dcis
694859|NCT00282035|female|female
694860|NCT00282035|breast conserving surgery|breast conserving surgery
694861|NCT00282035|irradiation|irradiation
694862|NCT00282035|whole breast irradiation|whole breast irradiation
694863|NCT00282035|3D CRT accelerated partial breast irradiation|3d crt accelerated partial breast irradiation
694864|NCT00282035|cosmetic outcome|cosmetic outcome
694865|NCT00282035|quality of life|quality of life
694866|NCT00282022|recurrent small cell lung cancer|recurrent small cell lung cancer
694867|NCT00282022|extensive stage small cell lung cancer|extensive stage small cell lung cancer
694868|NCT00282022|limited stage small cell lung cancer|limited stage small cell lung cancer
694869|NCT00282009|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
694870|NCT00281996|recurrent pancreatic cancer|recurrent pancreatic cancer
694871|NCT00281996|stage III pancreatic cancer|stage iii pancreatic cancer
694872|NCT00281996|stage IV pancreatic cancer|stage iv pancreatic cancer
694873|NCT00281983|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
694874|NCT00281983|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
694875|NCT00281983|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
694876|NCT00281983|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
694877|NCT00281983|Waldenström macroglobulinemia|waldenström macroglobulinemia
694878|NCT00281970|stage I non-small cell lung cancer|stage i non-small cell lung cancer
694879|NCT00281970|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
694880|NCT00281970|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
694881|NCT00281970|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
694882|NCT00281931|prolymphocytic leukemia|prolymphocytic leukemia
694883|NCT00281918|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
694884|NCT00281918|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
694885|NCT00281918|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
694886|NCT00281918|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
694887|NCT00281918|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
694888|NCT00281905|untreated childhood brain stem glioma|untreated childhood brain stem glioma
694889|NCT00281905|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
694890|NCT00281905|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
694891|NCT00281905|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
694892|NCT00281905|childhood choroid plexus tumor|childhood choroid plexus tumor
694893|NCT00281905|childhood infratentorial ependymoma|childhood infratentorial ependymoma
694894|NCT00281905|childhood supratentorial ependymoma|childhood supratentorial ependymoma
694895|NCT00281905|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
694896|NCT00281905|untreated childhood medulloblastoma|untreated childhood medulloblastoma
694897|NCT00281905|childhood oligodendroglioma|childhood oligodendroglioma
694898|NCT00281905|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
694899|NCT00281905|disseminated neuroblastoma|disseminated neuroblastoma
694900|NCT00281905|localized resectable neuroblastoma|localized resectable neuroblastoma
694901|NCT00281905|localized unresectable neuroblastoma|localized unresectable neuroblastoma
694902|NCT00281905|regional neuroblastoma|regional neuroblastoma
694903|NCT00281905|stage 4S neuroblastoma|stage 4s neuroblastoma
694904|NCT00281892|anemia|anemia
694905|NCT00281892|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
694906|NCT00281892|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
694907|NCT00281892|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
694908|NCT00281892|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
694909|NCT00281892|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
694910|NCT00281892|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
694911|NCT00281879|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
694912|NCT00281879|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
694913|NCT00281879|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
694914|NCT00281879|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
694915|NCT00281879|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
694916|NCT00281879|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
694917|NCT00281879|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
694918|NCT00281879|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
694919|NCT00281879|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
694920|NCT00281879|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
694921|NCT00281879|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
694922|NCT00281879|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
694923|NCT00281879|L3 childhood acute lymphoblastic leukemia|l3 childhood acute lymphoblastic leukemia
694924|NCT00281879|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
694925|NCT00281879|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
695685|NCT00279643|Laser Hair Removal|laser hair removal
694926|NCT00281879|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
694927|NCT00281879|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
694928|NCT00281879|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
694929|NCT00281879|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
694930|NCT00281879|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
694931|NCT00281879|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
694932|NCT00281879|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
694933|NCT00281879|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
694934|NCT00281879|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
694935|NCT00281879|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
694936|NCT00281879|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
694937|NCT00281879|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
694938|NCT00281879|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
694939|NCT00281879|secondary acute myeloid leukemia|secondary acute myeloid leukemia
694940|NCT00281879|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
694941|NCT00281879|refractory anemia with excess blasts|refractory anemia with excess blasts
694942|NCT00281879|refractory anemia|refractory anemia
694943|NCT00281879|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
694944|NCT00281879|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
694945|NCT00281879|chronic eosinophilic leukemia|chronic eosinophilic leukemia
694946|NCT00281879|primary myelofibrosis|primary myelofibrosis
694947|NCT00281879|chronic neutrophilic leukemia|chronic neutrophilic leukemia
694948|NCT00281879|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
694949|NCT00281879|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
694950|NCT00281879|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
694951|NCT00281879|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
694952|NCT00281879|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
694953|NCT00281879|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
694954|NCT00281879|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
694955|NCT00281879|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
694956|NCT00281879|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
694957|NCT00281879|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
694958|NCT00281879|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
694959|NCT00281879|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
694960|NCT00281879|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
694961|NCT00281879|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
694962|NCT00281879|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
694963|NCT00281879|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
694964|NCT00281879|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
694965|NCT00281879|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
694966|NCT00281879|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
694967|NCT00281879|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
694968|NCT00281879|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
694969|NCT00281879|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
694970|NCT00281879|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
694971|NCT00281879|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
694972|NCT00281879|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
694973|NCT00281879|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
694974|NCT00281879|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
694975|NCT00281879|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
694976|NCT00281879|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
694977|NCT00281879|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
694978|NCT00281879|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
694979|NCT00281879|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
694980|NCT00281879|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
694981|NCT00281879|refractory hairy cell leukemia|refractory hairy cell leukemia
695537|NCT00280280|Botox|botox
694982|NCT00281879|refractory multiple myeloma|refractory multiple myeloma
694983|NCT00281879|splenic marginal zone lymphoma|splenic marginal zone lymphoma
694984|NCT00281879|stage I multiple myeloma|stage i multiple myeloma
694985|NCT00281879|stage II multiple myeloma|stage ii multiple myeloma
694986|NCT00281879|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
694987|NCT00281879|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
694988|NCT00281879|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
694989|NCT00281879|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
694990|NCT00281879|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
694991|NCT00281879|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
694992|NCT00281879|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
694993|NCT00281879|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
694994|NCT00281879|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
694995|NCT00281879|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
694996|NCT00281879|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
694997|NCT00281879|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
694998|NCT00281879|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
694999|NCT00281879|stage III multiple myeloma|stage iii multiple myeloma
695000|NCT00281879|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
695001|NCT00281879|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
695002|NCT00281879|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
695003|NCT00281879|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
695004|NCT00281879|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
695005|NCT00281879|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
695006|NCT00281879|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
695007|NCT00281879|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
695008|NCT00281879|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
695009|NCT00281879|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
695010|NCT00281879|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
695011|NCT00281879|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
695012|NCT00281879|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
695013|NCT00281879|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
695014|NCT00281879|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
695015|NCT00281879|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
695016|NCT00281879|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
695017|NCT00281879|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
695018|NCT00281879|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
695019|NCT00281879|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
695020|NCT00281879|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
695021|NCT00281879|unusual cancers of childhood|unusual cancers of childhood
695022|NCT00281879|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
695023|NCT00281866|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
695024|NCT00281866|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
695025|NCT00281866|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
695026|NCT00281866|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
695027|NCT00281866|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
695028|NCT00281866|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
695029|NCT00281866|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
695030|NCT00281866|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
695031|NCT00281866|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
695032|NCT00281866|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
695033|NCT00281866|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
695034|NCT00281866|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
695035|NCT00281866|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
695036|NCT00281866|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
695037|NCT00281853|neurotoxicity|neurotoxicity
695038|NCT00281853|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
695039|NCT00281840|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
695040|NCT00281840|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
695041|NCT00281840|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
695042|NCT00281840|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
695043|NCT00281840|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
695044|NCT00281840|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
695045|NCT00281840|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
695046|NCT00281840|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
695047|NCT00281840|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
695048|NCT00281840|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
695049|NCT00281827|adenocarcinoma of the lung|adenocarcinoma of the lung
695050|NCT00281827|squamous cell lung cancer|squamous cell lung cancer
695051|NCT00281827|large cell lung cancer|large cell lung cancer
695052|NCT00281827|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
695053|NCT00281827|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
695054|NCT00281814|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
695055|NCT00281814|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
695056|NCT00281814|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
695057|NCT00281814|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
695058|NCT00281814|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
695059|NCT00281814|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
695060|NCT00281814|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
695061|NCT00281814|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
695062|NCT00281814|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
695063|NCT00281814|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
695064|NCT00281814|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
695065|NCT00281814|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
695066|NCT00281814|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
695067|NCT00281814|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
695068|NCT00281814|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
695069|NCT00281814|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
695070|NCT00281814|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
695071|NCT00281814|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
695072|NCT00281814|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
695073|NCT00281814|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
695074|NCT00281814|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
695075|NCT00281814|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
695076|NCT00281814|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
695077|NCT00281814|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
695078|NCT00281814|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
695079|NCT00281814|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
695080|NCT00281814|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
695081|NCT00281814|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
695082|NCT00281814|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
695083|NCT00281814|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
695084|NCT00281814|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
695085|NCT00281814|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
695086|NCT00281814|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
695087|NCT00281814|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
695088|NCT00281814|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
695089|NCT00281814|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
695090|NCT00281814|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
695091|NCT00281814|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
695092|NCT00281814|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
695093|NCT00281814|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
695094|NCT00281814|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
695095|NCT00281814|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
695096|NCT00281814|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
695097|NCT00281814|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
695098|NCT00281814|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
695099|NCT00281814|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
695100|NCT00281814|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
695101|NCT00281814|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
695102|NCT00281814|refractory hairy cell leukemia|refractory hairy cell leukemia
695103|NCT00281814|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
695104|NCT00281814|secondary acute myeloid leukemia|secondary acute myeloid leukemia
695105|NCT00281814|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
695106|NCT00281814|splenic marginal zone lymphoma|splenic marginal zone lymphoma
695107|NCT00281814|stage I multiple myeloma|stage i multiple myeloma
695108|NCT00281814|stage II multiple myeloma|stage ii multiple myeloma
695109|NCT00281814|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
695110|NCT00281814|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
695111|NCT00281814|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
695112|NCT00281814|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
695113|NCT00281814|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
695114|NCT00281814|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
695115|NCT00281814|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
695116|NCT00281814|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
695117|NCT00281814|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
695118|NCT00281814|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
695119|NCT00281814|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
695120|NCT00281814|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
695121|NCT00281814|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
695122|NCT00281814|stage III multiple myeloma|stage iii multiple myeloma
695123|NCT00281814|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
695124|NCT00281814|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
695125|NCT00281814|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
695126|NCT00281814|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
695127|NCT00281814|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
695128|NCT00281814|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
695129|NCT00281814|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
695130|NCT00281814|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
695131|NCT00281814|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
695132|NCT00281814|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
695133|NCT00281814|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
695134|NCT00281814|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
695135|NCT00281814|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
695136|NCT00281814|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
695137|NCT00281814|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
695138|NCT00281801|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
695139|NCT00281801|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
695140|NCT00281801|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
695141|NCT00281801|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
695142|NCT00281801|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
695143|NCT00281801|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
695144|NCT00281801|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
695145|NCT00281801|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
695146|NCT00281801|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
695147|NCT00281801|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
695148|NCT00281801|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
695149|NCT00281801|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
695150|NCT00281801|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
695151|NCT00281801|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
695152|NCT00281801|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
695153|NCT00281801|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
695154|NCT00281801|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
695155|NCT00281801|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
695156|NCT00281801|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
695157|NCT00281801|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
695158|NCT00281801|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
695159|NCT00281801|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
695160|NCT00281801|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
695161|NCT00281801|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
695162|NCT00281801|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
695163|NCT00281801|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
695164|NCT00281801|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
695165|NCT00281801|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
695166|NCT00281801|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
695167|NCT00281801|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
695168|NCT00281801|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
695169|NCT00281801|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
695170|NCT00281801|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
695171|NCT00281801|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
695172|NCT00281801|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
695173|NCT00281801|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
695174|NCT00281801|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
695175|NCT00281801|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
695176|NCT00281801|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
695177|NCT00281801|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
695178|NCT00281801|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
695179|NCT00281801|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
695180|NCT00281801|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
695181|NCT00281801|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
695182|NCT00281801|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
695183|NCT00281801|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
695184|NCT00281801|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
695185|NCT00281801|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
695186|NCT00281801|refractory hairy cell leukemia|refractory hairy cell leukemia
695187|NCT00281801|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
695188|NCT00281801|secondary acute myeloid leukemia|secondary acute myeloid leukemia
695189|NCT00281801|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
695190|NCT00281801|splenic marginal zone lymphoma|splenic marginal zone lymphoma
695191|NCT00281801|stage I multiple myeloma|stage i multiple myeloma
695192|NCT00281801|stage II multiple myeloma|stage ii multiple myeloma
695193|NCT00281801|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
695194|NCT00281801|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
695195|NCT00281801|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
695196|NCT00281801|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
695197|NCT00281801|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
695198|NCT00281801|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
695199|NCT00281801|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
695200|NCT00281801|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
695201|NCT00281801|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
695202|NCT00281801|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
695203|NCT00281801|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
695204|NCT00281801|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
695205|NCT00281801|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
695206|NCT00281801|stage III multiple myeloma|stage iii multiple myeloma
695207|NCT00281801|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
695208|NCT00281801|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
695209|NCT00281801|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
695210|NCT00281801|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
695211|NCT00281801|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
695212|NCT00281801|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
695213|NCT00281801|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
695214|NCT00281801|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
695215|NCT00281801|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
695216|NCT00281801|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
695217|NCT00281801|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
695218|NCT00281801|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
695219|NCT00281801|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
695220|NCT00281801|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
695221|NCT00281801|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
695222|NCT00281788|stage I esophageal cancer|stage i esophageal cancer
695223|NCT00281788|stage II esophageal cancer|stage ii esophageal cancer
695224|NCT00281788|stage III esophageal cancer|stage iii esophageal cancer
695225|NCT00281762|AQP-2|aqp-2
695226|NCT00281762|NSAID|nsaid
695227|NCT00281762|Urinary concentrating ability|urinary concentrating ability
695228|NCT00281749|ALZHEIMER'S D-SE|alzheimer's d-se
695229|NCT00281749|PARKINSON'S D-SE|parkinson's d-se
695230|NCT00281749|FRAILTY|frailty
695231|NCT00281736|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
695538|NCT00280280|baclofen|baclofen
695232|NCT00281736|recurrent esophageal cancer|recurrent esophageal cancer
695233|NCT00281736|stage 0 esophageal cancer|stage 0 esophageal cancer
695234|NCT00281736|stage I esophageal cancer|stage i esophageal cancer
695235|NCT00281736|precancerous condition|precancerous condition
695236|NCT00281723|Aphthous|aphthous
695237|NCT00281723|oral|oral
695238|NCT00281710|AQP-2|aqp-2
695239|NCT00281710|Methylprednisolone|methylprednisolone
695240|NCT00281710|Urinary concentrating ability|urinary concentrating ability
695241|NCT00281697|Ribbon 2|ribbon 2
695242|NCT00281697|Avastin|avastin
695244|NCT00281697|Breast cancer|breast cancer
695245|NCT00281684|Acute Pain|acute pain
695246|NCT00281684|Dental Pain|dental pain
695247|NCT00281684|Vanilloid|vanilloid
695248|NCT00281684|VR1|vr1
695249|NCT00281684|TRPV1|trpv1
695250|NCT00281684|Inflammation|inflammation
695251|NCT00281671|Nesiritide|nesiritide
695252|NCT00281671|Natriuretic Peptide, Brain|natriuretic peptide, brain
695253|NCT00281671|Heart Defects, Congenital|heart defects, congenital
695254|NCT00281671|Cardiopulmonary Bypass|cardiopulmonary bypass
695255|NCT00281671|Diuretics|diuretics
695256|NCT00281658|ErbB2 positive|erbb2 positive
695257|NCT00281658|Her2+|her2+
695258|NCT00281658|metastatic breast cancer|metastatic breast cancer
695259|NCT00281658|FISH positive|fish positive
695260|NCT00281658|Stage IV|stage iv
695261|NCT00281632|Pazopanib|pazopanib
695262|NCT00281632|Fallopian tube cancer|fallopian tube cancer
695263|NCT00281632|Ovarian epithelial cancer|ovarian epithelial cancer
695264|NCT00281632|Peritoneal cancer|peritoneal cancer
695265|NCT00281619|Pediatric Kidney Transplant|pediatric kidney transplant
695266|NCT00281619|Kidney Transplant|kidney transplant
695267|NCT00281619|CellCept|cellcept
695268|NCT00281619|Mycophenolate mofetil|mycophenolate mofetil
695269|NCT00281619|Mycophenolic Acid|mycophenolic acid
695270|NCT00281619|MPA|mpa
695271|NCT00281606|Lopinavir|lopinavir
695272|NCT00281606|antiretroviral therapy|antiretroviral therapy
695273|NCT00281606|cross-over|cross-over
695274|NCT00281606|tolerability|tolerability
695275|NCT00281554|Investigational Therapies|investigational therapies
695276|NCT00281554|Atrial Fibrillation|atrial fibrillation
695277|NCT00281554|Treatment Efficacy|treatment efficacy
695278|NCT00281554|Treatment Effectiveness|treatment effectiveness
695279|NCT00281554|Safety|safety
695280|NCT00281554|RSD1235|rsd1235
695281|NCT00281541|Treatment Efficacy|treatment efficacy
695282|NCT00281541|Treatment Effectiveness|treatment effectiveness
695283|NCT00281541|Disease Management|disease management
695284|NCT00281541|Treatment|treatment
695285|NCT00281541|Safety|safety
695286|NCT00281541|Malignant Melanoma|malignant melanoma
695287|NCT00281528|First Line Metastatic Breast Cancer|first line metastatic breast cancer
695288|NCT00281502|Hepatic Encephalopathy|hepatic encephalopathy
695289|NCT00281502|Hepatitis C|hepatitis c
695290|NCT00281502|Liver Cirrhosis|liver cirrhosis
695291|NCT00281502|Bacterial Overgrowth|bacterial overgrowth
695292|NCT00281489|Recall|recall
695293|NCT00281489|Awareness|awareness
695294|NCT00281489|BIS|bis
695295|NCT00281489|Anesthesia|anesthesia
695296|NCT00281489|Explicit Recall|explicit recall
695297|NCT00281476|multiple myeloma|multiple myeloma
695298|NCT00281476|statins|statins
695299|NCT00281476|bone|bone
695300|NCT00281463|wheelchair|wheelchair
695301|NCT00281463|spinal cord injury|spinal cord injury
695302|NCT00281463|rehabilitation|rehabilitation
695303|NCT00281437|exercise|exercise
695304|NCT00281437|adherence|adherence
695305|NCT00281437|lifestyle|lifestyle
695306|NCT00281437|choice|choice
695307|NCT00281437|autonomy|autonomy
695308|NCT00281424|exercise adherence|exercise adherence
695309|NCT00281424|cardiac patients|cardiac patients
695310|NCT00281424|walking|walking
695311|NCT00281411|Blood Vessel Prosthesis Implantation|blood vessel prosthesis implantation
695312|NCT00281411|Endovascular aneurysm repair|endovascular aneurysm repair
695313|NCT00281411|Magnetic Resonance Angiography|magnetic resonance angiography
695314|NCT00281411|Computed Tomography Angiography|computed tomography angiography
695315|NCT00281411|Endoleak|endoleak
695316|NCT00281398|homelessness|homelessness
695317|NCT00281398|Attitudes of medical trainees towards the homeless|attitudes of medical trainees towards the homeless
695318|NCT00281385|adherence|adherence
695319|NCT00281385|lifestyle|lifestyle
695320|NCT00281385|exercise|exercise
695321|NCT00281385|pedometer|pedometer
695322|NCT00281385|training|training
695323|NCT00281372|sexual dysfunction|sexual dysfunction
695324|NCT00281372|male|male
695325|NCT00281372|female|female
695326|NCT00281372|dental care|dental care
695327|NCT00281372|need of control|need of control
695328|NCT00281359|cerebral palsy|cerebral palsy
695329|NCT00281359|dynamic splinting|dynamic splinting
695330|NCT00281359|contractures|contractures
695331|NCT00281359|heat therapy|heat therapy
695332|NCT00281346|Doppler echocardiography|doppler echocardiography
695333|NCT00281346|coronary stenosis|coronary stenosis
695334|NCT00281346|Coronary angiography|coronary angiography
695335|NCT00281307|Rhinitis|rhinitis
695336|NCT00281307|Vitamin E|vitamin e
695338|NCT00281294|Arthritis, Rheumatoid|arthritis, rheumatoid
695339|NCT00281281|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
695340|NCT00281281|vancomycin|vancomycin
695341|NCT00281242|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
695342|NCT00281242|COPD|copd
695343|NCT00281229|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
695344|NCT00281229|COPD|copd
695345|NCT00281216|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
695346|NCT00281216|COPD|copd
695347|NCT00281203|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
695348|NCT00281203|COPD|copd
695349|NCT00281190|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
695350|NCT00281190|COPD|copd
695351|NCT00281125|Non-Small Cell Lung Cancer|non-small cell lung cancer
695352|NCT00281125|Pleural Mesothelioma|pleural mesothelioma
695353|NCT00281099|ICD|icd
695354|NCT00281099|Pacing|pacing
695355|NCT00281099|Heart Failure|heart failure
695356|NCT00281073|Intra-Cardiac Echocardiography|intra-cardiac echocardiography
695357|NCT00281073|Cardioversion|cardioversion
695358|NCT00281060|endovascular|endovascular
695359|NCT00281060|balloon angioplasty|balloon angioplasty
695360|NCT00281060|stents|stents
695361|NCT00281047|Helicobacter pylori (H. pylori)|helicobacter pylori (h. pylori)
695362|NCT00281047|FP-10|fp-10
695363|NCT00281047|amoxicillin|amoxicillin
695364|NCT00281047|clarithromycin|clarithromycin
695365|NCT00281047|lansoprazole|lansoprazole
695366|NCT00281034|brain infarction|brain infarction
695367|NCT00281034|SF-36|sf-36
695368|NCT00281034|HRQOL|hrqol
695369|NCT00281034|Japan|japan
695370|NCT00281034|Post-stroke syndrome|post-stroke syndrome
695371|NCT00281021|non-small cell lung cancer|non-small cell lung cancer
695372|NCT00281021|Erlotinib|erlotinib
695373|NCT00281021|Digoxin|digoxin
695374|NCT00281008|LDL-cholesterol|ldl-cholesterol
695375|NCT00281008|apoB-100|apob-100
695376|NCT00281008|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
695377|NCT00280995|LDL-cholesterol|ldl-cholesterol
695378|NCT00280995|apoB-100|apob-100
695379|NCT00280995|Homozygous Familial Hypercholesterolemia|homozygous familial hypercholesterolemia
695380|NCT00280982|dendritic cells, immunotherapy, vaccination, mesothelioma|dendritic cells, immunotherapy, vaccination, mesothelioma
695381|NCT00280969|HIV infection|hiv infection
695382|NCT00280969|treatment|treatment
695383|NCT00280969|efavirenz|efavirenz
695384|NCT00280969|atazanavir|atazanavir
695385|NCT00280969|ritonavir|ritonavir
695386|NCT00280943|All NC LTC facilities having ten residents with a hip fracture or osteoporosis on the MDS will be invited to participate in the trial|all nc ltc facilities having ten residents with a hip fracture or osteoporosis on the mds will be invited to participate in the trial
695387|NCT00280930|letrozole|letrozole
695388|NCT00280930|breast cancer|breast cancer
695389|NCT00280930|menopause|menopause
695390|NCT00280917|Rheumatoid Arthritis|rheumatoid arthritis
695391|NCT00280917|RA|ra
695392|NCT00280904|Hydrocephalus|hydrocephalus
695393|NCT00280904|Shunt|shunt
695394|NCT00280891|head and neck|head and neck
695395|NCT00280891|cancer|cancer
695396|NCT00280891|palliation|palliation
695397|NCT00280891|radiotherapy|radiotherapy
695398|NCT00280878|Lymphoma|lymphoma
695399|NCT00280878|CD20+|cd20+
695400|NCT00280865|Tesaglitazar|tesaglitazar
695401|NCT00280865|type 2 diabetes|type 2 diabetes
695402|NCT00280852|anaplastic thyroid cancer|anaplastic thyroid cancer
695403|NCT00280852|chemotherapy|chemotherapy
695404|NCT00280852|radiotherapy|radiotherapy
695405|NCT00280826|OCT|oct
695406|NCT00280826|Retinal Disease|retinal disease
695407|NCT00280826|Adhesion Molecule|adhesion molecule
695408|NCT00280826|Ocular Inflammation|ocular inflammation
695409|NCT00280826|Raptiva|raptiva
695410|NCT00280826|Macular Edema|macular edema
695411|NCT00280826|Uveitis|uveitis
695412|NCT00280826|Immunosuppression|immunosuppression
695413|NCT00280813|treatment|treatment
695414|NCT00280813|dual diagnosis|dual diagnosis
695415|NCT00280800|randomized|randomized
695416|NCT00280800|controlled|controlled
695417|NCT00280800|double blind|double blind
695418|NCT00280800|effectiveness|effectiveness
695419|NCT00280800|auto CPAP|auto cpap
695420|NCT00280800|treatment|treatment
695421|NCT00280800|sleep apnea|sleep apnea
695422|NCT00280787|unresectable|unresectable
695423|NCT00280787|induction|induction
695424|NCT00280787|radiotherapy|radiotherapy
695425|NCT00280787|ZD1839|zd1839
695426|NCT00280774|corticosteroid|corticosteroid
695427|NCT00280774|prednisone|prednisone
695428|NCT00280774|memantine|memantine
695429|NCT00280774|Patients who are taking a corticosteroid for a|patients who are taking a corticosteroid for a
695430|NCT00280774|pulmonary illness|pulmonary illness
695431|NCT00280774|rheumatic illness|rheumatic illness
695432|NCT00280774|kidney transplant|kidney transplant
695433|NCT00280761|adenocarcinoma of the rectum|adenocarcinoma of the rectum
695434|NCT00280761|recurrent rectal cancer|recurrent rectal cancer
695435|NCT00280761|stage II rectal cancer|stage ii rectal cancer
695436|NCT00280761|stage III rectal cancer|stage iii rectal cancer
695437|NCT00280761|stage IV rectal cancer|stage iv rectal cancer
695438|NCT00280748|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
695439|NCT00280748|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
695440|NCT00280748|tumors metastatic to brain|tumors metastatic to brain
695441|NCT00280735|stage I non-small cell lung cancer|stage i non-small cell lung cancer
695442|NCT00280735|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
695443|NCT00280735|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
695444|NCT00280722|Randomised|randomised
695445|NCT00280722|Intervention|intervention
695446|NCT00280722|Leaflet|leaflet
695447|NCT00280722|Information|information
695448|NCT00280722|Awareness|awareness
695449|NCT00280722|Behaviour|behaviour
695450|NCT00280722|Research|research
695451|NCT00280709|Bile duct|bile duct
695452|NCT00280709|Bile duct obstruction|bile duct obstruction
695453|NCT00280709|Biliary stent|biliary stent
695454|NCT00280709|Metal stent|metal stent
695455|NCT00280709|ERCP|ercp
695456|NCT00280709|Patency|patency
695457|NCT00280709|Complication|complication
695458|NCT00280709|Stent occlusion|stent occlusion
695459|NCT00280696|Epilepsies, Partial,|epilepsies, partial,
695460|NCT00280696|Keppra, levetiracetam|keppra, levetiracetam
695461|NCT00280683|Airway Inflammation|airway inflammation
695462|NCT00280683|Moderate persistent asthma|moderate persistent asthma
695463|NCT00280683|Severe Persistent Asthma|severe persistent asthma
695464|NCT00280657|Acne papulopustulosa|acne papulopustulosa
695465|NCT00280592|Prophylaxis|prophylaxis
695466|NCT00280592|Cranberry|cranberry
695467|NCT00280592|Neurogenic bladder|neurogenic bladder
695468|NCT00280553|analgesia|analgesia
695469|NCT00280553|laparoscopic surgical procedures|laparoscopic surgical procedures
695470|NCT00280553|length of stay|length of stay
695471|NCT00280540|Hypertension|hypertension
695472|NCT00280540|High blood pressure|high blood pressure
695473|NCT00280540|Blood pressure control|blood pressure control
695474|NCT00280540|Blood pressure reduction|blood pressure reduction
695475|NCT00280540|Valsartan|valsartan
695476|NCT00280527|NAFLD|nafld
695477|NCT00280527|NASH|nash
695478|NCT00280527|Obesity|obesity
695479|NCT00280527|Bariatric Surgery|bariatric surgery
695480|NCT00280527|Weight Reduction|weight reduction
695481|NCT00280514|abscess|abscess
695482|NCT00280514|penetration|penetration
695483|NCT00280514|antibiotics|antibiotics
695484|NCT00280514|cefpirome|cefpirome
695485|NCT00280514|moxifloxacin|moxifloxacin
695486|NCT00280514|abdominal cyst|abdominal cyst
695487|NCT00280501|Sulpiride|sulpiride
695488|NCT00280501|Quetiapine|quetiapine
695489|NCT00280501|Light/dark transition|light/dark transition
695490|NCT00280501|Choroidal blood flow|choroidal blood flow
695491|NCT00280488|Motivational Interviewing|motivational interviewing
695492|NCT00280488|Alcohol Abuse|alcohol abuse
695493|NCT00280488|Alcohol Dependence|alcohol dependence
695494|NCT00280488|Emergency Care Setting|emergency care setting
695495|NCT00280475|Randomized Controlled Trials|randomized controlled trials
695496|NCT00280475|Brain Neoplasms/Secondary|brain neoplasms/secondary
695497|NCT00280475|Brain Neoplasms/Radiotherapy|brain neoplasms/radiotherapy
695498|NCT00280475|Radiosurgery|radiosurgery
695499|NCT00280462|Nifedipine|nifedipine
695500|NCT00280462|Choroidal blood flow|choroidal blood flow
695501|NCT00280462|Choroidal autoregulation|choroidal autoregulation
695502|NCT00280462|Isometric exercise|isometric exercise
695503|NCT00280449|people living with HIV|people living with hiv
695504|NCT00280449|quality of life|quality of life
695505|NCT00280436|Polysomnography|polysomnography
695506|NCT00280436|Electroencephalography|electroencephalography
695507|NCT00280436|Primary Insomnia|primary insomnia
695508|NCT00280436|Cognition|cognition
695509|NCT00280436|Sleep|sleep
695510|NCT00280423|Cognition|cognition
695511|NCT00280423|Polysomnography|polysomnography
695512|NCT00280423|Primary Insomnia|primary insomnia
695513|NCT00280423|Electroencephalography|electroencephalography
695514|NCT00280423|Sleep|sleep
695515|NCT00280397|Cancer, solid tumors|cancer, solid tumors
695516|NCT00280371|COPD|copd
695517|NCT00280371|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
695518|NCT00280371|formoterol|formoterol
695519|NCT00280358|Fluticasone|fluticasone
695520|NCT00280358|Formoterol|formoterol
695521|NCT00280358|PK Study|pk study
695522|NCT00280358|Pharmacokinetics|pharmacokinetics
695523|NCT00280345|pigmentary glaucoma|pigmentary glaucoma
695524|NCT00280345|primary open angle glaucoma|primary open angle glaucoma
695525|NCT00280345|cataract|cataract
695526|NCT00280345|trabeculectomy|trabeculectomy
695527|NCT00280345|cataract surgery|cataract surgery
695528|NCT00280332|colonic adenoma, colonic advanced neoplasm|colonic adenoma, colonic advanced neoplasm
695529|NCT00280319|randomized controlled trial|randomized controlled trial
695530|NCT00280319|depression|depression
695531|NCT00280319|Uganda|uganda
695532|NCT00280319|adolescents|adolescents
695533|NCT00280293|Bipolar Disorder|bipolar disorder
695534|NCT00280293|Cocaine Dependence|cocaine dependence
695535|NCT00280293|Dual Diagnosis|dual diagnosis
695539|NCT00280267|hip fracture|hip fracture
695540|NCT00280267|testosterone|testosterone
695541|NCT00280267|muscle weakness|muscle weakness
695542|NCT00280267|frail elderly|frail elderly
695543|NCT00280267|aging|aging
695544|NCT00280254|Heart Failure|heart failure
695545|NCT00280254|Hemodynamics|hemodynamics
695546|NCT00280254|Echocardiography|echocardiography
695547|NCT00280241|Chronic|chronic
695548|NCT00280241|Lymphocytic|lymphocytic
695549|NCT00280241|Leukemia|leukemia
695550|NCT00280241|Fludarabine|fludarabine
695551|NCT00280241|Cyclophosphamide|cyclophosphamide
695552|NCT00280241|Rituximab|rituximab
695553|NCT00280228|ADHD|adhd
695554|NCT00280228|Oppositional Defiant Disorder|oppositional defiant disorder
695555|NCT00280228|Conduct Disorder|conduct disorder
695556|NCT00280228|Substance Use|substance use
695557|NCT00280228|Drug and Alcohol Use|drug and alcohol use
695558|NCT00280215|Primary Hyperoxaluria|primary hyperoxaluria
695559|NCT00280202|Non-small cell lung cancer|non-small cell lung cancer
695560|NCT00280202|Carcinogenesis|carcinogenesis
695561|NCT00280202|Genomic changes leading to malignant phenotypes in NSCLC.|genomic changes leading to malignant phenotypes in nsclc.
695562|NCT00280202|Simultaneous mutagenesis of epithelial cells.|simultaneous mutagenesis of epithelial cells.
695563|NCT00280202|Chromosomal abnormalities/mutations in bronchial tissues.|chromosomal abnormalities/mutations in bronchial tissues.
695564|NCT00280202|Detect micrometastases in histologically neg. lymph nodes|detect micrometastases in histologically neg. lymph nodes
695565|NCT00280189|Radiofrequency ablation|radiofrequency ablation
695566|NCT00280189|Pulmonary malignancies|pulmonary malignancies
695567|NCT00280189|Primary lung cancer|primary lung cancer
695568|NCT00280189|Pulmonary metastasis|pulmonary metastasis
695569|NCT00280189|Primary lung tumors|primary lung tumors
695570|NCT00280189|Secondary lung tumors|secondary lung tumors
695571|NCT00280189|Coagulation necrosis of soft tissue tumors|coagulation necrosis of soft tissue tumors
695572|NCT00280176|recurrent rectal cancer|recurrent rectal cancer
695573|NCT00280176|stage II rectal cancer|stage ii rectal cancer
695574|NCT00280176|stage III rectal cancer|stage iii rectal cancer
695575|NCT00280176|stage IV rectal cancer|stage iv rectal cancer
695576|NCT00280176|adenocarcinoma of the rectum|adenocarcinoma of the rectum
695577|NCT00280163|Genomics, cardiac surgery|genomics, cardiac surgery
695578|NCT00280150|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
695579|NCT00280150|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
695580|NCT00280150|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
695581|NCT00280150|squamous cell lung cancer|squamous cell lung cancer
695582|NCT00280137|Quality of Life|quality of life
695583|NCT00280137|Pediatric Systemic Lupus Erythematosus|pediatric systemic lupus erythematosus
695584|NCT00280111|rotavirus|rotavirus
695585|NCT00280111|vaccine|vaccine
695586|NCT00280111|safety|safety
695587|NCT00280111|immunogenicity|immunogenicity
695588|NCT00280111|infants|infants
695589|NCT00280072|Renal Failure, Acute|renal failure, acute
695590|NCT00280072|Acute Kidney Failure|acute kidney failure
695591|NCT00280072|Acute Renal Failure|acute renal failure
695592|NCT00280072|Acute Tubular Necrosis|acute tubular necrosis
695593|NCT00280072|Anuria|anuria
695594|NCT00280072|Renal Dialysis|renal dialysis
695595|NCT00280072|Acute Kidney Injury|acute kidney injury
695596|NCT00280059|Epilepsy|epilepsy
695597|NCT00280059|partial seizures|partial seizures
695598|NCT00280059|pregabalin monotherapy|pregabalin monotherapy
695599|NCT00280059|lamotrigine comparator|lamotrigine comparator
695600|NCT00280059|double-blind and randomized trial|double-blind and randomized trial
695601|NCT00280033|H5N1, Influenza, vaccine, parent protocol|h5n1, influenza, vaccine, parent protocol
695602|NCT00280020|sleep disorders|sleep disorders
695603|NCT00280020|meditation|meditation
695604|NCT00280020|cognitive behavior therapy|cognitive behavior therapy
695605|NCT00280007|hepatocellular carcinoma|hepatocellular carcinoma
695606|NCT00280007|TACE|tace
695607|NCT00280007|transarterial chemoembolisation|transarterial chemoembolisation
695608|NCT00280007|portal hypertension|portal hypertension
695609|NCT00280007|angiogenesis|angiogenesis
695610|NCT00280007|VEGF|vegf
695611|NCT00280007|bevacizumab|bevacizumab
695612|NCT00279994|Intermittent claudication|intermittent claudication
695613|NCT00279994|Exercise therapy|exercise therapy
695614|NCT00279994|Therapy feedback|therapy feedback
695615|NCT00279994|Accelerometer|accelerometer
695616|NCT00279994|Physiotherapy|physiotherapy
695617|NCT00279994|PAD;|pad;
695618|NCT00279994|peripheral arterial disease according to Fontaine stage II)|peripheral arterial disease according to fontaine stage ii)
695619|NCT00279981|Atrial fibrillation|atrial fibrillation
695620|NCT00279981|Stroke|stroke
695621|NCT00279981|Pacemaker|pacemaker
695622|NCT00279981|Implantable Cardiac Defibrillator|implantable cardiac defibrillator
695623|NCT00279981|Resynchronization systems|resynchronization systems
695624|NCT00279968|ICD|icd
695625|NCT00279968|Registry|registry
695626|NCT00279968|Ventricular tachycardia|ventricular tachycardia
695627|NCT00279968|Ventricular Fibrillation|ventricular fibrillation
695628|NCT00279955|Heart Failure, Congestive|heart failure, congestive
695629|NCT00279955|Implantable Cardioverter-Defibrillators|implantable cardioverter-defibrillators
695630|NCT00279942|Fibromyalgia|fibromyalgia
695631|NCT00279942|Dietary Supplements|dietary supplements
695632|NCT00279942|Rheumatologic Diseases|rheumatologic diseases
695633|NCT00279942|Complementary and Alternative Medicine|complementary and alternative medicine
695634|NCT00279851|idiopathic seizure|idiopathic seizure
695635|NCT00279851|hypoglycemia|hypoglycemia
695636|NCT00279851|hyperammonemia/hyperinsulinism syndrome|hyperammonemia/hyperinsulinism syndrome
695637|NCT00279812|Immune response|immune response
695638|NCT00279812|Selenomethionine|selenomethionine
695639|NCT00279812|Selenium enriched foods|selenium enriched foods
695640|NCT00279812|Selenium status|selenium status
695641|NCT00279812|Selenium biomarkers|selenium biomarkers
695642|NCT00279799|Sexually Transmitted Diseases, HIV, condom use, adolescents|sexually transmitted diseases, hiv, condom use, adolescents
695643|NCT00279786|pediatric|pediatric
695644|NCT00279773|Acute|acute
695645|NCT00279773|Myeloid|myeloid
695646|NCT00279773|Leukemia|leukemia
695647|NCT00279734|Rheumatoid Arthritis|rheumatoid arthritis
695648|NCT00279721|thyroid neoplasms|thyroid neoplasms
695649|NCT00279721|intensity modulated radiation|intensity modulated radiation
695650|NCT00279721|radiotherapy|radiotherapy
695651|NCT00279708|Granulomatous Inflammation|granulomatous inflammation
695652|NCT00279708|Steroid-Sparing|steroid-sparing
695653|NCT00279708|Pulmonary Function|pulmonary function
695654|NCT00279708|Sarcoidosis, Pulmonary|sarcoidosis, pulmonary
695655|NCT00279708|Statins (Atorvastatin)|statins (atorvastatin)
695656|NCT00279708|Biomarkers|biomarkers
695657|NCT00279708|Nitric Oxide|nitric oxide
695658|NCT00279708|Disease Activity|disease activity
695659|NCT00279708|Quality of Life|quality of life
695660|NCT00279708|Corticosteroids|corticosteroids
695661|NCT00279708|Pulmonary Sarcoidosis|pulmonary sarcoidosis
695662|NCT00279708|Sarcoidosis|sarcoidosis
695663|NCT00279695|Glaucoma|glaucoma
695664|NCT00279695|Accommodation|accommodation
695665|NCT00279695|Ocular Tumors|ocular tumors
695666|NCT00279695|Age-Related Macular Degeneration|age-related macular degeneration
695667|NCT00279695|Ultrasound|ultrasound
695668|NCT00279695|Eye|eye
695669|NCT00279682|depression|depression
695670|NCT00279682|suicide|suicide
695671|NCT00279682|geriatric|geriatric
695672|NCT00279682|elderly|elderly
695673|NCT00279682|primary care|primary care
695674|NCT00279669|Retinopathy of Prematurity|retinopathy of prematurity
695675|NCT00279669|Ultrasound|ultrasound
695676|NCT00279669|Eye|eye
695677|NCT00279656|Frail elderly|frail elderly
695678|NCT00279656|Pharmaceutical services|pharmaceutical services
695679|NCT00279656|Drug therapy|drug therapy
695680|NCT00279656|Geriatrics|geriatrics
695681|NCT00279656|Randomized controlled trial|randomized controlled trial
695682|NCT00279656|Hospitals, teaching|hospitals, teaching
695683|NCT00279643|Laser|laser
695684|NCT00279643|immunohistochemical staining|immunohistochemical staining
695686|NCT00279643|follicular stem cells|follicular stem cells
695687|NCT00279643|keratin 15|keratin 15
695688|NCT00279630|Tibialis Posterior Tendinopathy|tibialis posterior tendinopathy
695689|NCT00279578|haemophilia A|haemophilia a
695690|NCT00279578|thrombelastography|thrombelastography
695691|NCT00279578|recombinant factor VIII|recombinant factor viii
695692|NCT00279578|thrombin generation|thrombin generation
695693|NCT00279565|buprenorphine|buprenorphine
695694|NCT00279565|methadone|methadone
695695|NCT00279565|Peg-Intron|peg-intron
695696|NCT00279565|Rebetol|rebetol
695697|NCT00279552|Vitamin B12 deficiency|vitamin b12 deficiency
695698|NCT00279552|Vitamin B12 malabsorption|vitamin b12 malabsorption
695699|NCT00279552|Intrinsic factor|intrinsic factor
695700|NCT00279552|Holotranscobalamin|holotranscobalamin
695701|NCT00279539|Cardiovascular|cardiovascular
695702|NCT00279539|Gene Therapy|gene therapy
695703|NCT00279539|DNA|dna
695704|NCT00279539|Stem Cells|stem cells
695705|NCT00279539|Congestive Heart Failure|congestive heart failure
695706|NCT00279539|Coronary Artery Disease|coronary artery disease
695707|NCT00279539|CHF|chf
695708|NCT00279539|Cardiomyopathy|cardiomyopathy
695709|NCT00279526|Depression|depression
695710|NCT00279526|Health services utilization|health services utilization
695711|NCT00279526|Elderly|elderly
695712|NCT00279526|Primary Care|primary care
695713|NCT00279513|homeopathy|homeopathy
695714|NCT00279513|hallux valgus|hallux valgus
695715|NCT00279513|pain|pain
695716|NCT00279513|traumeel s|traumeel s
695717|NCT00279487|Patients undergoing total knee replacement who received pain management by the following modality:|patients undergoing total knee replacement who received pain management by the following modality:
695718|NCT00279487|IV PCA opioid|iv pca opioid
695719|NCT00279487|Local femoral nerve block with 1.5% Mepivacaine & 0.5% Ropivacaine|local femoral nerve block with 1.5% mepivacaine & 0.5% ropivacaine
695720|NCT00279474|cancer patients|cancer patients
695721|NCT00279474|family|family
695722|NCT00279474|cognitive behavior|cognitive behavior
695723|NCT00279474|distress|distress
695724|NCT00279461|Rheumatoid Arthritis|rheumatoid arthritis
695725|NCT00279461|Vitamin D|vitamin d
695726|NCT00279435|Intravenous, Steroid-Refractory, Ulcerative Colitis|intravenous, steroid-refractory, ulcerative colitis
695727|NCT00279422|Intravenous, Steroid-Refractory, Ulcerative Colitis|intravenous, steroid-refractory, ulcerative colitis
695728|NCT00279409|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
695729|NCT00279409|ADHD|adhd
695730|NCT00279409|Treatment resistant|treatment resistant
695731|NCT00279409|Partial responder|partial responder
695732|NCT00279409|Non-responder|non-responder
695733|NCT00279409|Atypical Antipsychotic|atypical antipsychotic
695734|NCT00279383|Intra-operatively treated patients with hemostatic supporting agents/techniques in addition to the standard surgical procedures|intra-operatively treated patients with hemostatic supporting agents/techniques in addition to the standard surgical procedures
695735|NCT00279370|SSRI Exposure|ssri exposure
695736|NCT00279370|Pregnancy|pregnancy
695737|NCT00279370|Infant Development|infant development
695738|NCT00279357|NBI|nbi
695739|NCT00279357|high risk group for adenomas|high risk group for adenomas
695740|NCT00279331|HIV Seronegativity|hiv seronegativity
695741|NCT00279331|Men who have Sex with Men|men who have sex with men
695742|NCT00279331|MSM|msm
695743|NCT00279331|Peru|peru
695744|NCT00279331|Ecuador|ecuador
695745|NCT00279331|Incidence|incidence
695746|NCT00279331|Prevalence|prevalence
695747|NCT00279331|Drug resistance, viral|drug resistance, viral
695748|NCT00279318|Environment|environment
695749|NCT00279318|Exposures|exposures
695750|NCT00279318|Diet|diet
695751|NCT00279318|Toxins|toxins
695752|NCT00279318|Psychosocial|psychosocial
695753|NCT00279318|Infectious Agents|infectious agents
695754|NCT00279318|Bacterial|bacterial
695755|NCT00279318|Viral|viral
695756|NCT00279318|Immunizations|immunizations
695757|NCT00279318|Autoantibody|autoantibody
695758|NCT00279305|Newly diagnosed type 1 diabetes|newly diagnosed type 1 diabetes
695759|NCT00279305|New Onset type 1 diabetes|new onset type 1 diabetes
695760|NCT00279305|Preservation of insulin secretion|preservation of insulin secretion
695761|NCT00279305|Type 1 diabetes|type 1 diabetes
695762|NCT00279305|Juvenile Onset Diabetes|juvenile onset diabetes
695763|NCT00279305|Insulin Dependent Diabetes|insulin dependent diabetes
695764|NCT00279305|T1D|t1d
695765|NCT00279292|Pancreatic neoplasm|pancreatic neoplasm
695766|NCT00279279|Implantable cardioverter defibrillator (ICD)|implantable cardioverter defibrillator (icd)
695767|NCT00279279|Sudden Cardiac Death|sudden cardiac death
695768|NCT00279279|Primary Prevention|primary prevention
695769|NCT00279266|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
695770|NCT00279266|Peripheral Neuropathy|peripheral neuropathy
695771|NCT00279266|Diabetes Mellitus|diabetes mellitus
695772|NCT00279253|clonidine|clonidine
695773|NCT00279253|glaucoma|glaucoma
695774|NCT00279240|Impaired glucose tolerance|impaired glucose tolerance
695775|NCT00279240|Intervention|intervention
695776|NCT00279240|Prevention|prevention
695777|NCT00279227|coronary artery disease|coronary artery disease
695778|NCT00279227|epicardial adipose tissue|epicardial adipose tissue
695779|NCT00279227|epicardial fat|epicardial fat
695780|NCT00279227|obesity|obesity
695781|NCT00279201|diabetes|diabetes
695782|NCT00279201|type 2|type 2
695783|NCT00279188|Bronchial hyperresponsiveness|bronchial hyperresponsiveness
695784|NCT00279188|Atopy|atopy
695785|NCT00279188|Inhaled steroids|inhaled steroids
695786|NCT00279188|Exacerbations|exacerbations
695787|NCT00279188|Lung function decline|lung function decline
695788|NCT00279188|Prognosis|prognosis
695789|NCT00279175|Acute myocardial infarction|acute myocardial infarction
695790|NCT00279149|Telemedicine|telemedicine
695791|NCT00279149|TELESTROKE|telestroke
695792|NCT00279149|symptoms of ischemic stroke since less than 3 hours|symptoms of ischemic stroke since less than 3 hours
695793|NCT00279136|Bronchial hyperresponsiveness,|bronchial hyperresponsiveness,
695794|NCT00279136|lung function,|lung function,
695795|NCT00279136|airway inflammation,|airway inflammation,
695796|NCT00279136|deep inspiration,|deep inspiration,
695797|NCT00279136|bronchial biopsies|bronchial biopsies
695798|NCT00279136|airway smooth muscle|airway smooth muscle
695799|NCT00279110|HIV|hiv
695800|NCT00279110|Antiretroviral therapy|antiretroviral therapy
695801|NCT00279110|Heroin dependence|heroin dependence
695802|NCT00279110|Methadone|methadone
695803|NCT00279110|Buprenorphine|buprenorphine
695804|NCT00279097|Intracranial pressure|intracranial pressure
695805|NCT00279097|High Frequency Chest Wall Oscillation|high frequency chest wall oscillation
695806|NCT00279097|Neurosurgery|neurosurgery
695807|NCT00279084|Anaemia|anaemia
695808|NCT00279084|Chronic kidney disease|chronic kidney disease
695809|NCT00279084|Type 2 diabetes|type 2 diabetes
695810|NCT00279084|Randomized trial|randomized trial
695811|NCT00279071|dystocia|dystocia
695812|NCT00279071|stimulation|stimulation
695813|NCT00279071|acupuncture|acupuncture
695814|NCT00279071|oxytocin|oxytocin
695815|NCT00279045|type 2 diabetes monotherapy treatment naive|type 2 diabetes monotherapy treatment naive
695816|NCT00279032|GW406381|gw406381
695817|NCT00279032|peripheral nerve injury|peripheral nerve injury
695818|NCT00279032|patients|patients
695819|NCT00279032|allodynia|allodynia
695820|NCT00279032|hyperalgesia|hyperalgesia
695821|NCT00279032|randomised|randomised
695822|NCT00279032|placebo-controlled|placebo-controlled
695823|NCT00279019|GSK233705|gsk233705
695920|NCT00278460|squamous cell lung cancer|squamous cell lung cancer
695824|NCT00279019|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
695825|NCT00279019|COPD|copd
695826|NCT00279006|DES (drug eluting stents)|des (drug eluting stents)
695827|NCT00279006|CAD (cornary artery disease)|cad (cornary artery disease)
695828|NCT00279006|stent retrieval|stent retrieval
695829|NCT00278993|Prostate cancer|prostate cancer
695830|NCT00278993|metastatic disease|metastatic disease
695831|NCT00278967|colonoscopy|colonoscopy
695832|NCT00278967|preparation|preparation
695833|NCT00278954|Primary Antibody Deficiency|primary antibody deficiency
695834|NCT00278954|Common variable hypogammaglobulinemia|common variable hypogammaglobulinemia
695835|NCT00278954|X-linked hypogammaglobulinemia|x-linked hypogammaglobulinemia
695836|NCT00278954|Hypogammaglobulinemia|hypogammaglobulinemia
695837|NCT00278954|Immunodeficiency with hyper-IgM|immunodeficiency with hyper-igm
695838|NCT00278954|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
695839|NCT00278941|Seroquel SR™|seroquel sr™
695840|NCT00278941|Major Depressive Disorder|major depressive disorder
695841|NCT00278928|Hypertriglyceridemia|hypertriglyceridemia
695842|NCT00278928|Infant, Premature|infant, premature
695843|NCT00278915|Progressive Precocious Puberty|progressive precocious puberty
695844|NCT00278915|PPP|ppp
695845|NCT00278915|McCune-Albright Syndrome|mccune-albright syndrome
695846|NCT00278915|MAS|mas
695847|NCT00278902|ErbB2+ Breast Cancer|erbb2+ breast cancer
695848|NCT00278902|HER2+ Breast Cancer|her2+ breast cancer
695849|NCT00278889|Colorectal Cancer|colorectal cancer
695850|NCT00278889|phase II|phase ii
695851|NCT00278889|metastatic colorectal cancer|metastatic colorectal cancer
695852|NCT00278889|AZD2171|azd2171
695853|NCT00278889|RECENTIN|recentin
695854|NCT00278876|GIST|gist
695855|NCT00278876|Imatinib|imatinib
695856|NCT00278876|Adjuvant therapy|adjuvant therapy
695857|NCT00278876|Kit mutation|kit mutation
695858|NCT00278863|Stomach cancer|stomach cancer
695859|NCT00278863|Palliative chemotherapy|palliative chemotherapy
695860|NCT00278863|Capecitabine|capecitabine
695861|NCT00278863|S-1|s-1
695862|NCT00278850|Vulvar vestibulitis|vulvar vestibulitis
695863|NCT00278850|Treatment|treatment
695864|NCT00278850|Education|education
695865|NCT00278837|Meditation|meditation
695866|NCT00278837|Stress-reduction|stress-reduction
695867|NCT00278837|Cognitive-affective behavior learning|cognitive-affective behavior learning
695868|NCT00278824|Chronic Pain|chronic pain
695869|NCT00278824|Pain|pain
695870|NCT00278811|Mental Health Services|mental health services
695871|NCT00278811|Suicide|suicide
695872|NCT00278811|Suicide ideation|suicide ideation
695873|NCT00278798|tracehelectomy|tracehelectomy
695874|NCT00278798|radical hysterectomy|radical hysterectomy
695875|NCT00278785|interviews|interviews
695876|NCT00278785|brief intervention|brief intervention
695877|NCT00278785|drinking|drinking
695878|NCT00278785|alcohol|alcohol
695879|NCT00278785|injuries|injuries
695880|NCT00278785|wounds|wounds
695881|NCT00278785|intervention studies|intervention studies
695882|NCT00278759|rapid viral diagnosis|rapid viral diagnosis
695883|NCT00278759|respiratory infection|respiratory infection
695884|NCT00278759|pediatric emergency department|pediatric emergency department
695885|NCT00278759|febrile respiratory infection|febrile respiratory infection
695886|NCT00278746|zinc|zinc
695887|NCT00278746|diarrhea|diarrhea
695888|NCT00278746|cluster randomization|cluster randomization
695889|NCT00278746|hospitalization|hospitalization
695890|NCT00278733|Randomized controlled trial|randomized controlled trial
695891|NCT00278733|brief intervention|brief intervention
695892|NCT00278733|university students|university students
695893|NCT00278733|physician advice|physician advice
695894|NCT00278733|high risk drinking|high risk drinking
695895|NCT00278707|Canavan Disease|canavan disease
695896|NCT00278707|Aspartoacylase Deficiency|aspartoacylase deficiency
695897|NCT00278707|NAA|naa
695898|NCT00278707|Acetate|acetate
695899|NCT00278707|Glyceryltriacetate|glyceryltriacetate
695900|NCT00278694|Oxaliplatin, radiation|oxaliplatin, radiation
695901|NCT00278681|zinc|zinc
695902|NCT00278681|diarrhea|diarrhea
695903|NCT00278681|hospitalization|hospitalization
695904|NCT00278681|programme|programme
695905|NCT00278538|Stem cell, Autoimmune disease, Systemic Lupus Erythematosus|stem cell, autoimmune disease, systemic lupus erythematosus
695906|NCT00278473|Primarily Inattentive|primarily inattentive
695907|NCT00278473|Hyperactive Impulsive Type|hyperactive impulsive type
695908|NCT00278473|Combined Type|combined type
695909|NCT00278473|ADHD|adhd
695910|NCT00278473|Adults|adults
695911|NCT00278473|Psychological|psychological
695912|NCT00278473|Cognitive Behavioral Therapy|cognitive behavioral therapy
695913|NCT00278473|CBT|cbt
695914|NCT00278460|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
695915|NCT00278460|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
695916|NCT00278460|adenocarcinoma of the lung|adenocarcinoma of the lung
695917|NCT00278460|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
695918|NCT00278460|large cell lung cancer|large cell lung cancer
695919|NCT00278460|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
695921|NCT00278447|Alcohol|alcohol
695922|NCT00278447|Alcohol use|alcohol use
695923|NCT00278447|Alcohol dependence|alcohol dependence
695924|NCT00278447|Drug|drug
695925|NCT00278447|Drug use|drug use
695926|NCT00278447|Drug dependence|drug dependence
695927|NCT00278447|Utilization|utilization
695928|NCT00278447|Hospitalization|hospitalization
695929|NCT00278447|Primary care|primary care
695930|NCT00278447|Chronic disease management|chronic disease management
695931|NCT00278447|Care management|care management
695932|NCT00278447|Comorbidity|comorbidity
695933|NCT00278434|cervical cancer|cervical cancer
695934|NCT00278434|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
695935|NCT00278434|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
695936|NCT00278421|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
695937|NCT00278421|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
695938|NCT00278421|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
695939|NCT00278421|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
695940|NCT00278421|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
695941|NCT00278421|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
695942|NCT00278421|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
695943|NCT00278421|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
695944|NCT00278421|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
695945|NCT00278421|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
695946|NCT00278421|anaplastic large cell lymphoma|anaplastic large cell lymphoma
695947|NCT00278421|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
695948|NCT00278421|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
695949|NCT00278421|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
695950|NCT00278421|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
695951|NCT00278421|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
695952|NCT00278421|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
695953|NCT00278421|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
695954|NCT00278421|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
695955|NCT00278421|stage I mantle cell lymphoma|stage i mantle cell lymphoma
695956|NCT00278421|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
695957|NCT00278421|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
695958|NCT00278421|stage I marginal zone lymphoma|stage i marginal zone lymphoma
695959|NCT00278421|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
695960|NCT00278421|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
695961|NCT00278421|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
695962|NCT00278421|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
695963|NCT00278421|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
695964|NCT00278421|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
695965|NCT00278421|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
695966|NCT00278421|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
695967|NCT00278421|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
695968|NCT00278421|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
695969|NCT00278421|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
695970|NCT00278421|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
695971|NCT00278421|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
695972|NCT00278421|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
695973|NCT00278408|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
695974|NCT00278408|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
695975|NCT00278408|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
695976|NCT00278408|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
695977|NCT00278408|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
695978|NCT00278408|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
695979|NCT00278408|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
695980|NCT00278408|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
695981|NCT00278408|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
695982|NCT00278408|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
695983|NCT00278408|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
695984|NCT00278408|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
695985|NCT00278408|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
695986|NCT00278408|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
695987|NCT00278408|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
695988|NCT00278408|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
695989|NCT00278408|anaplastic large cell lymphoma|anaplastic large cell lymphoma
695990|NCT00278408|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
695991|NCT00278408|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
695992|NCT00278408|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
695993|NCT00278408|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
695994|NCT00278408|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
695995|NCT00278408|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
695996|NCT00278408|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
695997|NCT00278408|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
695998|NCT00278408|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
695999|NCT00278408|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
696000|NCT00278408|stage I mantle cell lymphoma|stage i mantle cell lymphoma
696001|NCT00278408|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
696002|NCT00278408|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
696003|NCT00278408|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
696004|NCT00278408|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
696005|NCT00278408|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
696006|NCT00278408|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
696007|NCT00278408|stage I marginal zone lymphoma|stage i marginal zone lymphoma
696008|NCT00278408|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
696009|NCT00278408|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
696010|NCT00278369|recurrent renal cell cancer|recurrent renal cell cancer
696011|NCT00278369|stage IV renal cell cancer|stage iv renal cell cancer
696012|NCT00278369|clear cell renal cell carcinoma|clear cell renal cell carcinoma
696013|NCT00278304|cervical adenocarcinoma|cervical adenocarcinoma
696014|NCT00278304|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
696015|NCT00278304|cervical squamous cell carcinoma|cervical squamous cell carcinoma
696016|NCT00278304|stage IB cervical cancer|stage ib cervical cancer
696017|NCT00278304|stage IIA cervical cancer|stage iia cervical cancer
696018|NCT00278304|stage IIB cervical cancer|stage iib cervical cancer
696019|NCT00278304|stage III cervical cancer|stage iii cervical cancer
696020|NCT00278304|stage IVA cervical cancer|stage iva cervical cancer
696021|NCT00278304|stage IVB cervical cancer|stage ivb cervical cancer
696022|NCT00278278|untreated childhood brain stem glioma|untreated childhood brain stem glioma
696023|NCT00278278|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
696024|NCT00278278|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
696128|NCT00278005|pediatric|pediatric
696025|NCT00278278|childhood spinal cord neoplasm|childhood spinal cord neoplasm
696026|NCT00278265|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
696027|NCT00278265|anemia|anemia
696028|NCT00278265|neutropenia|neutropenia
696029|NCT00278252|recurrent childhood ependymoma|recurrent childhood ependymoma
696030|NCT00278252|childhood infratentorial ependymoma|childhood infratentorial ependymoma
696031|NCT00278252|childhood supratentorial ependymoma|childhood supratentorial ependymoma
696032|NCT00278239|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
696033|NCT00278239|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
696034|NCT00278239|cognitive/functional effects|cognitive/functional effects
696035|NCT00278239|childhood supratentorial primitive neuroectodermal tumor|childhood supratentorial primitive neuroectodermal tumor
696036|NCT00278226|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
696037|NCT00278213|prolymphocytic leukemia|prolymphocytic leukemia
696038|NCT00278213|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
696039|NCT00278213|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
696040|NCT00278213|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
696041|NCT00278213|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
696042|NCT00278213|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
696043|NCT00278213|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
696044|NCT00278200|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
696045|NCT00278187|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
696046|NCT00278187|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
696047|NCT00278187|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
696048|NCT00278174|stage IV renal cell cancer|stage iv renal cell cancer
696049|NCT00278174|recurrent renal cell cancer|recurrent renal cell cancer
696050|NCT00278174|clear cell renal cell carcinoma|clear cell renal cell carcinoma
696051|NCT00278161|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
696052|NCT00278161|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
696053|NCT00278161|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
696054|NCT00278161|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
696676|NCT00275210|Oxaliplatin|oxaliplatin
696055|NCT00278161|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
696056|NCT00278161|small lymphocytic lymphoma|small lymphocytic lymphoma
696057|NCT00278161|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
696058|NCT00278161|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
696059|NCT00278161|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
696060|NCT00278161|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
696061|NCT00278161|splenic marginal zone lymphoma|splenic marginal zone lymphoma
696062|NCT00278161|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
696063|NCT00278161|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
696064|NCT00278161|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
696065|NCT00278161|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
696066|NCT00278161|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
696067|NCT00278161|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
696068|NCT00278161|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
696069|NCT00278161|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
696070|NCT00278161|stage I mantle cell lymphoma|stage i mantle cell lymphoma
696071|NCT00278161|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
696072|NCT00278161|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
696073|NCT00278161|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
696074|NCT00278161|prolymphocytic leukemia|prolymphocytic leukemia
696075|NCT00278161|stage I marginal zone lymphoma|stage i marginal zone lymphoma
696076|NCT00278161|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
696077|NCT00278161|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
696078|NCT00278161|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
696079|NCT00278161|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
696080|NCT00278161|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
696081|NCT00278161|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
696082|NCT00278161|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
696083|NCT00278161|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
696084|NCT00278161|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
696085|NCT00278161|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
696086|NCT00278161|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
696087|NCT00278161|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
696088|NCT00278161|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
696089|NCT00278161|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
696090|NCT00278161|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
696091|NCT00278161|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
696092|NCT00278161|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
696093|NCT00278161|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
696094|NCT00278161|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
696095|NCT00278161|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
696096|NCT00278148|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
696097|NCT00278148|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
696098|NCT00278135|Cognition|cognition
696099|NCT00278135|Memory|memory
696100|NCT00278135|Nutrition|nutrition
696101|NCT00278135|Omega-3|omega-3
696102|NCT00278135|DHA|dha
696103|NCT00278122|stage III melanoma|stage iii melanoma
696104|NCT00278122|stage IV melanoma|stage iv melanoma
696105|NCT00278122|recurrent melanoma|recurrent melanoma
696106|NCT00278109|stage I breast cancer|stage i breast cancer
696107|NCT00278109|stage II breast cancer|stage ii breast cancer
696108|NCT00278096|disability|disability
696109|NCT00278096|occupational therapy|occupational therapy
696110|NCT00278083|Pharmacology|pharmacology
696111|NCT00278083|Asthma|asthma
696112|NCT00278083|TNF-alpha|tnf-alpha
696113|NCT00278070|Metronomic-therapy|metronomic-therapy
696114|NCT00278070|vinorelbine|vinorelbine
696115|NCT00278070|Recurrent Breast Cancer|recurrent breast cancer
696116|NCT00278070|Recurrent Non Small Cell Lung Cancer|recurrent non small cell lung cancer
696117|NCT00278070|Metastatic prostate cancer|metastatic prostate cancer
696118|NCT00278057|Blood pressure;|blood pressure;
696119|NCT00278057|chronic renal failure;|chronic renal failure;
696120|NCT00278057|diabetes mellitus;|diabetes mellitus;
696121|NCT00278057|dialysis fluid; glucose;|dialysis fluid; glucose;
696122|NCT00278057|hemodialysis;|hemodialysis;
696123|NCT00278057|hypertension;|hypertension;
696124|NCT00278057|uremia.|uremia.
696125|NCT00278044|Search as text words in Annotation & Scope Note|search as text words in annotation & scope note
696126|NCT00278031|Retinoblastoma|retinoblastoma
696127|NCT00278031|Quality of life|quality of life
696129|NCT00278005|DiGeorge Syndrome|digeorge syndrome
696130|NCT00278005|Congenital heart defects|congenital heart defects
696131|NCT00278005|Infections|infections
696132|NCT00278005|Cardiac surgery|cardiac surgery
696133|NCT00277992|Pediatric|pediatric
696134|NCT00277992|Cardiac|cardiac
696135|NCT00277992|Norwood operation modification|norwood operation modification
696136|NCT00277992|GT/Nissen operation|gt/nissen operation
696137|NCT00277992|Po feed|po feed
696138|NCT00277992|GT fed|gt fed
696139|NCT00277979|pediatric|pediatric
696140|NCT00277979|cardiac|cardiac
696141|NCT00277979|Infantile Pompe's Disease|infantile pompe's disease
696142|NCT00277979|3D Echocardiography|3d echocardiography
696143|NCT00277966|Pediatric|pediatric
696144|NCT00277966|Cardiac Catheterization|cardiac catheterization
696145|NCT00277966|Fluoroscopy time|fluoroscopy time
696146|NCT00277953|Pediatric|pediatric
696147|NCT00277953|Cardiac|cardiac
696148|NCT00277953|Tracheal Dimensions|tracheal dimensions
696149|NCT00277953|MRI|mri
696150|NCT00277940|Pediatric|pediatric
696151|NCT00277940|Cardiac|cardiac
696152|NCT00277940|Neoaortic Elastic Properties|neoaortic elastic properties
696153|NCT00277940|Aortic Arch Reconstruction|aortic arch reconstruction
696154|NCT00277927|Pediatric|pediatric
696155|NCT00277927|Cardiac|cardiac
696156|NCT00277927|Valvar Pulmonary Stenosis|valvar pulmonary stenosis
696157|NCT00277901|cardiac|cardiac
696158|NCT00277901|pediatric|pediatric
696159|NCT00277901|MRI|mri
696160|NCT00277901|Tetralogy of Fallot TOF|tetralogy of fallot tof
696161|NCT00277901|Aortic Coarctation|aortic coarctation
696162|NCT00277888|Dialysis|dialysis
696163|NCT00277888|Hemodialysis|hemodialysis
696164|NCT00277888|Catheterization|catheterization
696165|NCT00277875|Cardiovascular|cardiovascular
696166|NCT00277875|Flow-Mediated Vasodilation (FMD)|flow-mediated vasodilation (fmd)
696167|NCT00277875|Pulse Perfusion-Mediated Vasodilation (PPMV)|pulse perfusion-mediated vasodilation (ppmv)
696168|NCT00277875|Endothelial Function|endothelial function
696169|NCT00277875|Heart Failure|heart failure
696170|NCT00277875|Local Distensibility|local distensibility
696171|NCT00277875|Arterial Stiffening|arterial stiffening
696172|NCT00277875|Augmentation Index (AI)|augmentation index (ai)
696173|NCT00277875|Aging|aging
696174|NCT00277875|Isolated Systolic Hypertension|isolated systolic hypertension
696175|NCT00277875|Advanced Glycation Endproducts|advanced glycation endproducts
696176|NCT00277875|Vascular Stiffness|vascular stiffness
696177|NCT00277862|chronic hepatitis C;|chronic hepatitis c;
696178|NCT00277862|peg-interferon alfa-2b;|peg-interferon alfa-2b;
696179|NCT00277862|ribavirin,|ribavirin,
696180|NCT00277862|rapid virologic response,|rapid virologic response,
696181|NCT00277862|sustained virological response|sustained virological response
696182|NCT00277849|Sickle|sickle
696183|NCT00277849|Hemoglobinopathy|hemoglobinopathy
696184|NCT00277849|Thalassemia|thalassemia
696185|NCT00277849|G6PD|g6pd
696186|NCT00277849|Plasmodium|plasmodium
696187|NCT00277849|Erythrocyte Variant|erythrocyte variant
696188|NCT00277849|Hemoglobin Variant|hemoglobin variant
696189|NCT00277849|Healthy Volunteer|healthy volunteer
696190|NCT00277849|HV|hv
696191|NCT00277836|malignant tumor|malignant tumor
696192|NCT00277823|Depression|depression
696193|NCT00277823|Adult|adult
696194|NCT00277823|Outpatients|outpatients
696195|NCT00277810|Alzheimer's Disease|alzheimer's disease
696196|NCT00277810|Cholinesterase Inhibitors|cholinesterase inhibitors
696197|NCT00277810|Outpatients|outpatients
696198|NCT00277797|Low Back Pain|low back pain
696199|NCT00277784|Age Related Macular Degeneration|age related macular degeneration
696200|NCT00277784|Ultrasound|ultrasound
696201|NCT00277784|OCT|oct
696202|NCT00277784|Eye|eye
696203|NCT00277771|technology in weight loss|technology in weight loss
696204|NCT00277771|standard behavioral therapy for obesity|standard behavioral therapy for obesity
696205|NCT00277758|Interleukin-2|interleukin-2
696206|NCT00277745|periodontitis|periodontitis
696207|NCT00277745|microfluidics|microfluidics
696208|NCT00277745|saliva diagnostics|saliva diagnostics
696209|NCT00277706|periodontitis|periodontitis
696210|NCT00277706|bone regeneration|bone regeneration
696211|NCT00277706|Parathyroid Hormone|parathyroid hormone
696212|NCT00277706|moderate to advanced periodontitis|moderate to advanced periodontitis
696213|NCT00277693|hemodialysis|hemodialysis
696214|NCT00277693|aldosterone|aldosterone
696215|NCT00277693|heart failure|heart failure
696216|NCT00277693|spironolactone|spironolactone
696217|NCT00277680|uterine fibroids|uterine fibroids
696218|NCT00277680|leiomyoma|leiomyoma
696219|NCT00277680|laparoscopy|laparoscopy
696220|NCT00277680|menorrhagia|menorrhagia
696221|NCT00277667|currently experiencing hypomania or mild mania|currently experiencing hypomania or mild mania
696222|NCT00277654|Bipolar Disorder with Concurrent Moderately Severe Anxiety and Lifetime Panic or Generalized Anxiety Disorder|bipolar disorder with concurrent moderately severe anxiety and lifetime panic or generalized anxiety disorder
696223|NCT00277641|Binge Eating Disorder Associated with Obesity|binge eating disorder associated with obesity
696224|NCT00277615|Children|children
696225|NCT00277615|Bladder volume|bladder volume
696226|NCT00277615|Ultrasound|ultrasound
696227|NCT00277576|DNA vaccine|dna vaccine
696228|NCT00277576|immunotherapy|immunotherapy
696229|NCT00277576|Hepatitis B Virus|hepatitis b virus
696409|NCT00276770|adult glioblastoma|adult glioblastoma
696230|NCT00277576|Particle Mediated Epidermal Delivery|particle mediated epidermal delivery
696231|NCT00277563|Carpal Tunnel Syndrome|carpal tunnel syndrome
696232|NCT00277563|Neuropathic Pain|neuropathic pain
696233|NCT00277563|Neuromodulation|neuromodulation
696234|NCT00277563|PEMF|pemf
696235|NCT00277563|Magnetic Field Therapy|magnetic field therapy
696236|NCT00277563|Magnetotherapy|magnetotherapy
696237|NCT00277550|Constipation, Tegaserod, Dyspepsia|constipation, tegaserod, dyspepsia
696238|NCT00277537|Mannitol|mannitol
696239|NCT00277524|Pacemaker|pacemaker
696240|NCT00277524|Defibrillator|defibrillator
696241|NCT00277524|Cardiac Resynchronization|cardiac resynchronization
696242|NCT00277524|Dysynchrony|dysynchrony
696243|NCT00277524|Heart failure|heart failure
696244|NCT00277524|Arrhythmia|arrhythmia
696245|NCT00277524|Tachycardia|tachycardia
696246|NCT00277524|Bradycardia|bradycardia
696247|NCT00277472|Hypertension|hypertension
696248|NCT00277472|High blood pressure|high blood pressure
696249|NCT00277472|diuretics|diuretics
696250|NCT00277472|valsartan|valsartan
696251|NCT00277446|Asthma|asthma
696252|NCT00277446|Soy isoflavones|soy isoflavones
696253|NCT00277446|Eosinophils|eosinophils
696254|NCT00277446|Exhaled nitric oxide|exhaled nitric oxide
696255|NCT00277433|Atopic Dermatitis|atopic dermatitis
696256|NCT00277433|Eczema|eczema
696257|NCT00277433|Genetics|genetics
696258|NCT00277433|Histamine|histamine
696259|NCT00277407|NAET|naet
696260|NCT00277407|Chiropractic procedures|chiropractic procedures
696261|NCT00277407|Acupuncture/acupressure|acupuncture/acupressure
696262|NCT00277407|Treatment of Autism by holistic procedures|treatment of autism by holistic procedures
696263|NCT00277407|Food and Vaccination allergy|food and vaccination allergy
696264|NCT00277394|Acute, symptomatic and objectively confirmed DVT|acute, symptomatic and objectively confirmed dvt
696265|NCT00277381|Adherence|adherence
696266|NCT00277381|Hypertension|hypertension
696267|NCT00277381|Telemedicine|telemedicine
696268|NCT00277368|Epilepsy|epilepsy
696269|NCT00277368|Headache|headache
696270|NCT00277368|Seizure|seizure
696271|NCT00277355|Study of Minocycline in Huntington's Disease|study of minocycline in huntington's disease
696272|NCT00277342|lipid induced hepatic insulin resistance|lipid induced hepatic insulin resistance
696273|NCT00277342|polymorphisms liver fatty-acid-binding-protein|polymorphisms liver fatty-acid-binding-protein
696274|NCT00277342|gluconeogenesis|gluconeogenesis
696275|NCT00277342|glycogenolysis|glycogenolysis
696276|NCT00277342|endogenous glucose production|endogenous glucose production
696277|NCT00277316|Kidney cancer|kidney cancer
696278|NCT00277316|Metastatic|metastatic
696279|NCT00277303|Colon Cancer|colon cancer
696280|NCT00277290|Cancer|cancer
696281|NCT00277290|Recurrent|recurrent
696282|NCT00277290|Platinum-resistant|platinum-resistant
696283|NCT00277290|Platinum-sensitive|platinum-sensitive
696284|NCT00277277|Telemedicine|telemedicine
696285|NCT00277277|Biobehavioral weight loss program|biobehavioral weight loss program
696286|NCT00277277|Body Mass Index|body mass index
696287|NCT00277277|Blood Glucose|blood glucose
696288|NCT00277277|Diabetes Management|diabetes management
696289|NCT00277251|Crohn's disease|crohn's disease
696290|NCT00277251|systemic-onset juvenile rheumatoid arthritis|systemic-onset juvenile rheumatoid arthritis
696291|NCT00277251|juvenile dermatomyositis|juvenile dermatomyositis
696292|NCT00277251|systemic lupus erythematosus (SLE)|systemic lupus erythematosus (sle)
696293|NCT00277251|Mixed connective tissue disease (MCTD)|mixed connective tissue disease (mctd)
696294|NCT00277251|vasculitis|vasculitis
696295|NCT00277238|HCV|hcv
696296|NCT00277238|Hepatitis c virus|hepatitis c virus
696297|NCT00277238|Virus diseases|virus diseases
696298|NCT00277238|Interferon-alpha|interferon-alpha
696299|NCT00277238|Interferons|interferons
696300|NCT00277238|Liver diseases|liver diseases
696301|NCT00277212|Bipolar I Disorder with a recent manic or mixed episode|bipolar i disorder with a recent manic or mixed episode
696302|NCT00277186|Arthroplasty|arthroplasty
696303|NCT00277186|Health services research|health services research
696304|NCT00277186|Intent to treat|intent to treat
696305|NCT00277186|Randomized|randomized
696306|NCT00277186|Controlled|controlled
696307|NCT00277173|Medication Safety|medication safety
696308|NCT00277173|Adverse Drug Events|adverse drug events
696309|NCT00277173|Preventable Adverse Drug Events|preventable adverse drug events
696310|NCT00277173|Culture of Safety|culture of safety
696311|NCT00277173|Failure Modes and Effects Analysis|failure modes and effects analysis
696312|NCT00277173|Teambuilding|teambuilding
696313|NCT00277147|Typhoid Fever|typhoid fever
696314|NCT00277147|Immunogenicity|immunogenicity
696315|NCT00277147|Safety|safety
696316|NCT00277147|Vaccine|vaccine
696317|NCT00277147|Conjugate|conjugate
696318|NCT00277147|Healthy Volunteer|healthy volunteer
696319|NCT00277121|Lipid disorder|lipid disorder
696320|NCT00277121|Gene mutation|gene mutation
696321|NCT00277108|postpartum depression|postpartum depression
696322|NCT00277108|postnatal depression|postnatal depression
696323|NCT00277108|PPD|ppd
696324|NCT00277095|Urinary Incontinence|urinary incontinence
696325|NCT00277082|Metastatic or Recurrent Cancer of the Endometrium or the Lung (NSCLC)|metastatic or recurrent cancer of the endometrium or the lung (nsclc)
696326|NCT00277082|Aerosolized Liposomal 9-Nitro 20|aerosolized liposomal 9-nitro 20
696327|NCT00277082|Camptothecin (L9NC)|camptothecin (l9nc)
696328|NCT00277069|Breast metastatic|breast metastatic
696329|NCT00277056|leukemia|leukemia
696330|NCT00277043|Taxane|taxane
696331|NCT00277043|Test Dose|test dose
696332|NCT00277030|Respiratory Distress Syndrome|respiratory distress syndrome
696333|NCT00277030|Surfactant|surfactant
696334|NCT00277030|Nasal CPAP|nasal cpap
696335|NCT00277017|Combination Therapy|combination therapy
696336|NCT00277017|5-Fluorouracil|5-fluorouracil
696337|NCT00277017|Interferon-a Interleukin-2|interferon-a interleukin-2
696338|NCT00277017|Thalidomide|thalidomide
696339|NCT00277017|Renal Cell Carcinoma|renal cell carcinoma
696340|NCT00276991|Prolonged Viral Suppression|prolonged viral suppression
696341|NCT00276991|HIV Infections|hiv infections
696342|NCT00276978|Therapy-resistant Depression|therapy-resistant depression
696343|NCT00276978|add-on therapy depression|add-on therapy depression
696344|NCT00276965|Bipolar II Depression|bipolar ii depression
696345|NCT00276952|Gonyautoxins|gonyautoxins
696346|NCT00276952|Tension-type Headache|tension-type headache
696347|NCT00276952|Human Treatment|human treatment
696348|NCT00276939|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
696349|NCT00276939|Diet, Vegetarian|diet, vegetarian
696350|NCT00276939|Diet, Fat-Restricted|diet, fat-restricted
696351|NCT00276939|Glycemic Index|glycemic index
696352|NCT00276926|Hypereosinophilic Syndrome|hypereosinophilic syndrome
696353|NCT00276926|Eosinophilic leukemias|eosinophilic leukemias
696354|NCT00276926|STI571 (Gleevec)|sti571 (gleevec)
696355|NCT00276926|PDGF receptor alpha|pdgf receptor alpha
696356|NCT00276926|Familiar hypereosinophilia|familiar hypereosinophilia
696357|NCT00276926|Myeloproliferative disorder (MPD) with eosinophilia|myeloproliferative disorder (mpd) with eosinophilia
696358|NCT00276926|myeloproliferative disorders/myelodysplastic syndromes|myeloproliferative disorders/myelodysplastic syndromes
696359|NCT00276900|Postpartum Depression|postpartum depression
696360|NCT00276900|Recurrent Depression|recurrent depression
696361|NCT00276887|Somatization Disorder|somatization disorder
696362|NCT00276887|Multiple Medically Unexplained Symptoms|multiple medically unexplained symptoms
696363|NCT00276887|Cognitive Behavior Therapy|cognitive behavior therapy
696364|NCT00276887|Mental Health|mental health
696365|NCT00276874|Cocaine Addiction|cocaine addiction
696366|NCT00276874|Cocaine Dependence|cocaine dependence
696367|NCT00276861|adenocarcinoma of the colon|adenocarcinoma of the colon
696368|NCT00276861|recurrent colon cancer|recurrent colon cancer
696369|NCT00276861|stage IV colon cancer|stage iv colon cancer
696370|NCT00276848|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
696371|NCT00276848|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
696372|NCT00276835|recurrent renal cell cancer|recurrent renal cell cancer
696373|NCT00276835|clear cell renal cell carcinoma|clear cell renal cell carcinoma
696374|NCT00276835|stage IV renal cell cancer|stage iv renal cell cancer
696375|NCT00276835|recurrent melanoma|recurrent melanoma
696376|NCT00276835|stage IV melanoma|stage iv melanoma
696377|NCT00276822|stage I breast cancer|stage i breast cancer
696378|NCT00276822|stage II breast cancer|stage ii breast cancer
696379|NCT00276822|stage IIIA breast cancer|stage iiia breast cancer
696380|NCT00276822|stage IIIB breast cancer|stage iiib breast cancer
696381|NCT00276822|stage IIIC breast cancer|stage iiic breast cancer
696382|NCT00276822|stage IV breast cancer|stage iv breast cancer
696383|NCT00276809|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
696384|NCT00276809|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
696385|NCT00276809|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
696386|NCT00276809|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
696387|NCT00276809|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
696388|NCT00276796|cervical squamous cell carcinoma|cervical squamous cell carcinoma
696389|NCT00276796|stage III cervical cancer|stage iii cervical cancer
696390|NCT00276796|recurrent cervical cancer|recurrent cervical cancer
696391|NCT00276796|cervical adenocarcinoma|cervical adenocarcinoma
696392|NCT00276796|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
696393|NCT00276796|cervical small cell carcinoma|cervical small cell carcinoma
696394|NCT00276796|stage IVA cervical cancer|stage iva cervical cancer
696395|NCT00276796|stage IVB cervical cancer|stage ivb cervical cancer
696396|NCT00276783|primary central nervous system lymphoma|primary central nervous system lymphoma
696397|NCT00276783|tumors metastatic to brain|tumors metastatic to brain
696398|NCT00276783|recurrent adult brain tumor|recurrent adult brain tumor
696399|NCT00276783|adult giant cell glioblastoma|adult giant cell glioblastoma
696400|NCT00276783|adult gliosarcoma|adult gliosarcoma
696401|NCT00276783|adult mixed glioma|adult mixed glioma
696402|NCT00276783|adult anaplastic astrocytoma|adult anaplastic astrocytoma
696403|NCT00276783|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
696404|NCT00276783|adult glioblastoma|adult glioblastoma
696405|NCT00276770|adult anaplastic astrocytoma|adult anaplastic astrocytoma
696406|NCT00276770|adult anaplastic ependymoma|adult anaplastic ependymoma
696407|NCT00276770|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
696408|NCT00276770|adult diffuse astrocytoma|adult diffuse astrocytoma
696569|NCT00276003|Phase II|phase ii
696410|NCT00276770|adult giant cell glioblastoma|adult giant cell glioblastoma
696411|NCT00276770|adult gliosarcoma|adult gliosarcoma
696412|NCT00276770|adult ependymoma|adult ependymoma
696413|NCT00276770|adult oligodendroglioma|adult oligodendroglioma
696414|NCT00276770|recurrent adult brain tumor|recurrent adult brain tumor
696415|NCT00276770|adult mixed glioma|adult mixed glioma
696416|NCT00276757|childhood Langerhans cell histiocytosis|childhood langerhans cell histiocytosis
696417|NCT00276744|recurrent pancreatic cancer|recurrent pancreatic cancer
696418|NCT00276744|stage III pancreatic cancer|stage iii pancreatic cancer
696419|NCT00276744|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
696420|NCT00276744|stage I pancreatic cancer|stage i pancreatic cancer
696421|NCT00276744|stage II pancreatic cancer|stage ii pancreatic cancer
696422|NCT00276731|localized resectable neuroblastoma|localized resectable neuroblastoma
696423|NCT00276731|localized unresectable neuroblastoma|localized unresectable neuroblastoma
696424|NCT00276731|regional neuroblastoma|regional neuroblastoma
696425|NCT00276718|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
696426|NCT00276718|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
696427|NCT00276718|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
696428|NCT00276718|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
696429|NCT00276718|childhood teratoma|childhood teratoma
696430|NCT00276705|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
696431|NCT00276705|childhood hepatocellular carcinoma|childhood hepatocellular carcinoma
696432|NCT00276705|advanced adult primary liver cancer|advanced adult primary liver cancer
696433|NCT00276705|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
696434|NCT00276705|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
696435|NCT00276705|stage I childhood liver cancer|stage i childhood liver cancer
696436|NCT00276705|stage II childhood liver cancer|stage ii childhood liver cancer
696437|NCT00276705|stage III childhood liver cancer|stage iii childhood liver cancer
696438|NCT00276705|stage IV childhood liver cancer|stage iv childhood liver cancer
696439|NCT00276692|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
696440|NCT00276679|recurrent neuroblastoma|recurrent neuroblastoma
696441|NCT00276679|disseminated neuroblastoma|disseminated neuroblastoma
696442|NCT00276679|localized unresectable neuroblastoma|localized unresectable neuroblastoma
696443|NCT00276666|untreated childhood medulloblastoma|untreated childhood medulloblastoma
696444|NCT00276640|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
696445|NCT00276640|untreated childhood brain stem glioma|untreated childhood brain stem glioma
696446|NCT00276640|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
696447|NCT00276640|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
696448|NCT00276640|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
696449|NCT00276640|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
696450|NCT00276640|childhood oligodendroglioma|childhood oligodendroglioma
696451|NCT00276640|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
696452|NCT00276640|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
696453|NCT00276640|childhood spinal cord neoplasm|childhood spinal cord neoplasm
696454|NCT00276627|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
696455|NCT00276614|stage IV renal cell cancer|stage iv renal cell cancer
696456|NCT00276614|recurrent renal cell cancer|recurrent renal cell cancer
696457|NCT00276614|papillary renal cell carcinoma|papillary renal cell carcinoma
696458|NCT00276601|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
696459|NCT00276601|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
696460|NCT00276601|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
696461|NCT00276601|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
696462|NCT00276601|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
696463|NCT00276588|adenocarcinoma of the lung|adenocarcinoma of the lung
696464|NCT00276588|adenosquamous cell lung cancer|adenosquamous cell lung cancer
696465|NCT00276588|large cell lung cancer|large cell lung cancer
696466|NCT00276588|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
696467|NCT00276588|squamous cell lung cancer|squamous cell lung cancer
696468|NCT00276588|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
696469|NCT00276588|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
696470|NCT00276575|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
696471|NCT00276549|adenocarcinoma of the prostate|adenocarcinoma of the prostate
696472|NCT00276549|stage IV prostate cancer|stage iv prostate cancer
696473|NCT00276536|stage IV melanoma|stage iv melanoma
696474|NCT00276536|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
696475|NCT00276523|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
696476|NCT00276523|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
696570|NCT00276003|Gemcitabine|gemcitabine
696571|NCT00276003|Irinotecan|irinotecan
696477|NCT00276523|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
696478|NCT00276523|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
696479|NCT00276523|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
696480|NCT00276523|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
696481|NCT00276523|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
696482|NCT00276523|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
696483|NCT00276523|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
696484|NCT00276523|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
696485|NCT00276523|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
696486|NCT00276523|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
696487|NCT00276523|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
696488|NCT00276523|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
696489|NCT00276523|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
696490|NCT00276523|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
696491|NCT00276497|Impaired glucose tolerance|impaired glucose tolerance
696492|NCT00276497|Intervention|intervention
696493|NCT00276497|Prevention|prevention
696494|NCT00276445|allergy|allergy
696495|NCT00276445|Allergy conjunctivitis|allergy conjunctivitis
696496|NCT00276445|beta-1-3glucan|beta-1-3glucan
696497|NCT00276445|Th1/Th2|th1/th2
696498|NCT00276341|cognitive impairment|cognitive impairment
696499|NCT00276289|nephrolithiasis|nephrolithiasis
696500|NCT00276289|hypercalciuria|hypercalciuria
696501|NCT00276289|hypokalemia|hypokalemia
696502|NCT00276289|thiazide diuretics|thiazide diuretics
696503|NCT00276276|relapsed|relapsed
696504|NCT00276276|lung cancer|lung cancer
696505|NCT00276276|resistant|resistant
696506|NCT00276276|small cel|small cel
696507|NCT00276276|topotecan (HYCAMTIN)|topotecan (hycamtin)
696508|NCT00276263|Schizophrenia prodrome|schizophrenia prodrome
696509|NCT00276263|Sarcosine|sarcosine
696510|NCT00276263|Psychosis|psychosis
696511|NCT00276263|NMDA receptor|nmda receptor
696512|NCT00276263|Prevention|prevention
696513|NCT00276237|Congenital Heart Disease|congenital heart disease
696514|NCT00276237|Pulmonary Valve Replacement|pulmonary valve replacement
696515|NCT00276224|iron deficiency schistosomiasis soil transmitted helminths|iron deficiency schistosomiasis soil transmitted helminths
696516|NCT00276211|MRI diffusion mamma cancer|mri diffusion mamma cancer
696517|NCT00276198|Clinical trial, controlled|clinical trial, controlled
696518|NCT00276198|Micronutrients|micronutrients
696519|NCT00276198|Dietary Supplementation|dietary supplementation
696520|NCT00276198|Infants|infants
696521|NCT00276185|spasticity ;|spasticity ;
696522|NCT00276185|Botulinum toxin ;|botulinum toxin ;
696523|NCT00276185|Upper limb ;|upper limb ;
696524|NCT00276185|motor function.|motor function.
696525|NCT00276185|spastic hemiplegia after stoke|spastic hemiplegia after stoke
696526|NCT00276159|Leukemia|leukemia
696527|NCT00276159|Lymphoma|lymphoma
696528|NCT00276159|Myeloma|myeloma
696529|NCT00276159|Hematology|hematology
696530|NCT00276159|852A|852a
696531|NCT00276159|IRM|irm
696532|NCT00276159|Oncology|oncology
696533|NCT00276146|dipyridamole|dipyridamole
696534|NCT00276146|magnesium|magnesium
696535|NCT00276146|sickle cell|sickle cell
696536|NCT00276146|anemia|anemia
696537|NCT00276146|red blood cells|red blood cells
696538|NCT00276133|small dense LDL|small dense ldl
696539|NCT00276120|Breast|breast
696540|NCT00276120|Cancer|cancer
696541|NCT00276120|Young|young
696542|NCT00276120|Women|women
696543|NCT00276107|Vaccine|vaccine
696544|NCT00276107|Healthy Infants|healthy infants
696545|NCT00276094|Urogenital atrophy|urogenital atrophy
696546|NCT00276094|Vaginal atrophy|vaginal atrophy
696547|NCT00276094|Vulvar and vaginal atrophy in postmenopausal women|vulvar and vaginal atrophy in postmenopausal women
696548|NCT00276094|Menopausal symptoms|menopausal symptoms
696549|NCT00276081|Hot flashes|hot flashes
696550|NCT00276081|postmenopausal|postmenopausal
696551|NCT00276081|climacteric symptoms|climacteric symptoms
696552|NCT00276081|hormone replacement therapy|hormone replacement therapy
696553|NCT00276081|gabapentin|gabapentin
696554|NCT00276068|Vulvar vestibulitis|vulvar vestibulitis
696555|NCT00276068|Vulvodynia|vulvodynia
696556|NCT00276068|Desipramine|desipramine
696557|NCT00276068|Lidocaine|lidocaine
696558|NCT00276068|Genetics|genetics
696559|NCT00276055|Soft Tissue Sarcoma|soft tissue sarcoma
696560|NCT00276055|Phase I|phase i
696561|NCT00276055|Gemcitabine|gemcitabine
696562|NCT00276055|Docetaxel|docetaxel
696563|NCT00276055|Bevacizumab|bevacizumab
696564|NCT00276055|vascular endothelial growth factor|vascular endothelial growth factor
696565|NCT00276042|AOM|aom
696566|NCT00276029|Asthma|asthma
696567|NCT00276029|Refractory|refractory
696568|NCT00276003|Lymphoma-Non Hodgkins|lymphoma-non hodgkins
696572|NCT00275990|coronary thrombectomy|coronary thrombectomy
696573|NCT00275990|thrombectomy for acute myocardial infarction|thrombectomy for acute myocardial infarction
696574|NCT00275990|C14.280.647.500|c14.280.647.500
696575|NCT00275990|C14.907.553.355.500|c14.907.553.355.500
696576|NCT00275977|"Stem cell"|"stem cell"
696577|NCT00275977|"autologous bone marrow transplantation"|"autologous bone marrow transplantation"
696578|NCT00275977|"Myocardial infarction"|"myocardial infarction"
696579|NCT00275951|Combination|combination
696580|NCT00275951|Chemotherapy|chemotherapy
696581|NCT00275951|Gastric cancer|gastric cancer
696582|NCT00275938|hepatitis B virus|hepatitis b virus
696583|NCT00275938|e antigen|e antigen
696584|NCT00275938|interferon|interferon
696585|NCT00275938|ribavirin|ribavirin
696586|NCT00275925|partial epilepsy, oxcarbazepine, adults|partial epilepsy, oxcarbazepine, adults
696587|NCT00275834|obesity treatment|obesity treatment
696588|NCT00275834|weight loss|weight loss
696589|NCT00275834|antiobesity drugs|antiobesity drugs
696590|NCT00275834|zonisamide|zonisamide
696591|NCT00275821|Age-related macular degeneration, ranibizumab|age-related macular degeneration, ranibizumab
696592|NCT00275795|NST-NAET testing|nst-naet testing
696593|NCT00275795|Food Ssensitivities|food ssensitivities
696594|NCT00275795|Eczema|eczema
696595|NCT00275795|Acne|acne
696596|NCT00275795|Indigestion|indigestion
696597|NCT00275769|Arrhythmia|arrhythmia
696598|NCT00275769|Bradycardia|bradycardia
696599|NCT00275769|Cardiac Pacemaker Artificial|cardiac pacemaker artificial
696600|NCT00275756|Ocular Physiology|ocular physiology
696601|NCT00275756|Brimonidine|brimonidine
696602|NCT00275756|Timoptic|timoptic
696603|NCT00275756|Dorzolamide|dorzolamide
696604|NCT00275756|ocular blood flow|ocular blood flow
696605|NCT00275756|Regional Blood Flow|regional blood flow
696606|NCT00275730|indometacine|indometacine
696607|NCT00275730|retinal blood flow|retinal blood flow
696608|NCT00275730|choroidal blood flow|choroidal blood flow
696609|NCT00275561|Eosinophilic Esophagitis|eosinophilic esophagitis
696610|NCT00275561|Fluticasone|fluticasone
696611|NCT00275561|Dysphagia|dysphagia
696612|NCT00275535|kidney transplantation|kidney transplantation
696613|NCT00275535|immunosuppression|immunosuppression
696614|NCT00275535|calcineurin inhibitor|calcineurin inhibitor
696615|NCT00275535|sirolimus|sirolimus
696616|NCT00275535|chronic allograft nephropathy|chronic allograft nephropathy
696617|NCT00275509|kidney|kidney
696618|NCT00275509|transplantation|transplantation
696619|NCT00275509|positive crossmatch|positive crossmatch
696620|NCT00275509|antibody mediated rejection|antibody mediated rejection
696621|NCT00275509|rejection|rejection
696622|NCT00275509|induction|induction
696623|NCT00275509|therapy|therapy
696624|NCT00275509|trial|trial
696625|NCT00275496|SLND|slnd
696626|NCT00275496|Sentinel|sentinel
696627|NCT00275496|Melanoma|melanoma
696628|NCT00275496|Surgical|surgical
696629|NCT00275431|cancer|cancer
696630|NCT00275431|AT-101|at-101
696631|NCT00275431|AT101|at101
696632|NCT00275431|B-cell malignancies|b-cell malignancies
696633|NCT00275431|Non-Hodgkin|non-hodgkin
696634|NCT00275431|lymphoma|lymphoma
696635|NCT00275431|lukemia|lukemia
696636|NCT00275418|Crohn's disease|crohn's disease
696637|NCT00275418|remission|remission
696638|NCT00275418|beta carotene|beta carotene
696639|NCT00275405|Effects of Garlic|effects of garlic
696640|NCT00275392|Dizziness|dizziness
696641|NCT00275392|Geriatrics|geriatrics
696642|NCT00275392|Rehabilitation|rehabilitation
696643|NCT00275392|Vestibular rehabilitation|vestibular rehabilitation
696644|NCT00275379|Cystitis|cystitis
696645|NCT00275366|cuff, rotator|cuff, rotator
696646|NCT00275366|Rotator cuff|rotator cuff
696647|NCT00275340|Pain|pain
696648|NCT00275340|Depressive Symptoms|depressive symptoms
696649|NCT00275340|Coronary Artery Bypass|coronary artery bypass
696650|NCT00275340|Convalescence|convalescence
696651|NCT00275340|Quality of Life|quality of life
696652|NCT00275340|Human Activities|human activities
696653|NCT00275327|antibiotics|antibiotics
696654|NCT00275314|transplantation|transplantation
696655|NCT00275301|Borderline Personality Disorder|borderline personality disorder
696656|NCT00275301|BPD|bpd
696657|NCT00275301|PET|pet
696658|NCT00275301|olanzapine|olanzapine
696659|NCT00275301|brain|brain
696660|NCT00275288|Borderline Personality Disorder|borderline personality disorder
696661|NCT00275288|BPD|bpd
696662|NCT00275288|amygdala|amygdala
696663|NCT00275288|facial expression response|facial expression response
696664|NCT00275288|MRI|mri
696665|NCT00275275|PD|pd
696666|NCT00275275|Parkinson's|parkinson's
696667|NCT00275262|Bone marrow transplantation|bone marrow transplantation
696668|NCT00275262|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
696669|NCT00275262|Hodgkin's disease|hodgkin's disease
696670|NCT00275262|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
696671|NCT00275262|multiple myeloma|multiple myeloma
696672|NCT00275249|Chronic Pain|chronic pain
696673|NCT00275236|Idiopthic Restless Legs Syndrome|idiopthic restless legs syndrome
696674|NCT00275223|adipose tissue|adipose tissue
696675|NCT00275223|adipocytokines|adipocytokines
696677|NCT00275210|Chemotherapy,adjuvant|chemotherapy,adjuvant
696678|NCT00275210|Colonic Neoplasms|colonic neoplasms
696679|NCT00275184|Bowel preparation|bowel preparation
696680|NCT00275184|capsule endoscopy|capsule endoscopy
696681|NCT00275184|randomised|randomised
696682|NCT00275184|Citramag|citramag
696683|NCT00275184|Senna|senna
696684|NCT00275184|Metoclopramide|metoclopramide
696685|NCT00275184|Patients referred for Capsule endoscopy|patients referred for capsule endoscopy
696686|NCT00275184|occult/overt gastrointestinal bleeding|occult/overt gastrointestinal bleeding
696687|NCT00275184|other suspected small bowel pathology|other suspected small bowel pathology
696688|NCT00275171|Nontoxic nodular goiter|nontoxic nodular goiter
696689|NCT00275171|131I therapy|131i therapy
696690|NCT00275171|thyroid radioiodine uptake|thyroid radioiodine uptake
696691|NCT00275171|optimal time-interval|optimal time-interval
696692|NCT00275171|reduced 131I activity|reduced 131i activity
696693|NCT00275171|goiter reduction|goiter reduction
696694|NCT00275158|Pre-Eclampsia|pre-eclampsia
696695|NCT00275158|Glomerular Filtration Rate (GFR)|glomerular filtration rate (gfr)
696696|NCT00275158|Inulin clearance|inulin clearance
696697|NCT00275158|Hypertension|hypertension
696698|NCT00275158|L-Arginine|l-arginine
696699|NCT00275158|Nitric Oxide|nitric oxide
696700|NCT00275158|cGMP|cgmp
696701|NCT00275158|Endothelin|endothelin
696702|NCT00275158|ADMA|adma
696703|NCT00275132|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
696704|NCT00275132|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
696705|NCT00275119|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
696706|NCT00275119|stage II pancreatic cancer|stage ii pancreatic cancer
696707|NCT00275119|stage III pancreatic cancer|stage iii pancreatic cancer
696708|NCT00275119|recurrent pancreatic cancer|recurrent pancreatic cancer
696709|NCT00275106|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
696710|NCT00275106|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
696711|NCT00275106|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
696712|NCT00275106|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
696713|NCT00275067|adult anaplastic astrocytoma|adult anaplastic astrocytoma
696714|NCT00275067|adult gliosarcoma|adult gliosarcoma
696715|NCT00275067|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
696716|NCT00275067|adult mixed glioma|adult mixed glioma
696717|NCT00275067|adult glioblastoma|adult glioblastoma
696718|NCT00275067|adult giant cell glioblastoma|adult giant cell glioblastoma
696719|NCT00275067|recurrent adult brain tumor|recurrent adult brain tumor
696720|NCT00275054|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
696721|NCT00275054|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
696722|NCT00275054|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
696723|NCT00275054|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
696724|NCT00275041|recurrent breast cancer|recurrent breast cancer
696725|NCT00275041|stage IV breast cancer|stage iv breast cancer
696726|NCT00275041|male breast cancer|male breast cancer
696727|NCT00275015|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
696728|NCT00275015|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
696729|NCT00275015|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
696730|NCT00275015|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
696731|NCT00275015|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
696732|NCT00275015|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
696733|NCT00275002|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
696734|NCT00275002|recurrent childhood brain tumor|recurrent childhood brain tumor
696735|NCT00274989|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
696736|NCT00274989|relapsed refractory chronic lymphocytic leukemia|relapsed refractory chronic lymphocytic leukemia
696737|NCT00274989|previously untreated chronic lymphocytic leukemia|previously untreated chronic lymphocytic leukemia
696738|NCT00274976|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
696739|NCT00274976|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
696740|NCT00274976|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
696741|NCT00274963|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
696742|NCT00274963|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
696743|NCT00274950|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
696744|NCT00274950|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
696745|NCT00274950|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
696746|NCT00274950|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
696747|NCT00274950|childhood teratoma|childhood teratoma
696748|NCT00274950|childhood extracranial germ cell tumor|childhood extracranial germ cell tumor
696749|NCT00274924|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
696750|NCT00274924|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
696751|NCT00274924|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
696752|NCT00274924|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
696753|NCT00274911|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
696754|NCT00274898|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
696755|NCT00274898|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
696756|NCT00274898|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
696757|NCT00274898|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
696758|NCT00274885|neurotoxicity|neurotoxicity
696759|NCT00274885|carcinoma of the appendix|carcinoma of the appendix
696760|NCT00274885|recurrent anal cancer|recurrent anal cancer
696761|NCT00274885|stage I anal cancer|stage i anal cancer
696762|NCT00274885|stage II anal cancer|stage ii anal cancer
696763|NCT00274885|stage IIIA anal cancer|stage iiia anal cancer
696764|NCT00274885|stage IIIB anal cancer|stage iiib anal cancer
696765|NCT00274885|stage IV anal cancer|stage iv anal cancer
696766|NCT00274885|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
696767|NCT00274885|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
696768|NCT00274885|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
696769|NCT00274885|localized gallbladder cancer|localized gallbladder cancer
696770|NCT00274885|recurrent gallbladder cancer|recurrent gallbladder cancer
696771|NCT00274885|unresectable gallbladder cancer|unresectable gallbladder cancer
696772|NCT00274885|recurrent gastric cancer|recurrent gastric cancer
696773|NCT00274885|stage IV gastric cancer|stage iv gastric cancer
696774|NCT00274885|recurrent colon cancer|recurrent colon cancer
696775|NCT00274885|recurrent rectal cancer|recurrent rectal cancer
696776|NCT00274885|recurrent esophageal cancer|recurrent esophageal cancer
696777|NCT00274885|localized gastrointestinal carcinoid tumor|localized gastrointestinal carcinoid tumor
696778|NCT00274885|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
696779|NCT00274885|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
696780|NCT00274885|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
696781|NCT00274885|gastrointestinal stromal tumor|gastrointestinal stromal tumor
696782|NCT00274885|advanced adult primary liver cancer|advanced adult primary liver cancer
696783|NCT00274885|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
696784|NCT00274885|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
696785|NCT00274885|recurrent adult primary liver cancer|recurrent adult primary liver cancer
696786|NCT00274885|recurrent pancreatic cancer|recurrent pancreatic cancer
696787|NCT00274885|stage I pancreatic cancer|stage i pancreatic cancer
696788|NCT00274885|stage II pancreatic cancer|stage ii pancreatic cancer
696789|NCT00274885|stage III pancreatic cancer|stage iii pancreatic cancer
696790|NCT00274885|recurrent small intestine cancer|recurrent small intestine cancer
696791|NCT00274885|small intestine adenocarcinoma|small intestine adenocarcinoma
696792|NCT00274885|small intestine leiomyosarcoma|small intestine leiomyosarcoma
696793|NCT00274885|small intestine lymphoma|small intestine lymphoma
696794|NCT00274885|stage IV pancreatic cancer|stage iv pancreatic cancer
696795|NCT00274885|metastatic extrahepatic bile duct cancer|metastatic extrahepatic bile duct cancer
696796|NCT00274885|metastatic gallbladder cancer|metastatic gallbladder cancer
696797|NCT00274885|stage IA gastric cancer|stage ia gastric cancer
696798|NCT00274885|stage IB gastric cancer|stage ib gastric cancer
696799|NCT00274885|stage IIA gastric cancer|stage iia gastric cancer
696800|NCT00274885|stage IIB gastric cancer|stage iib gastric cancer
696801|NCT00274885|stage IIIA gastric cancer|stage iiia gastric cancer
696802|NCT00274885|stage IIIB gastric cancer|stage iiib gastric cancer
696803|NCT00274885|stage IIIC gastric cancer|stage iiic gastric cancer
696804|NCT00274885|stage I colon cancer|stage i colon cancer
696805|NCT00274885|stage IIA colon cancer|stage iia colon cancer
696806|NCT00274885|stage IIB colon cancer|stage iib colon cancer
696807|NCT00274885|stage IIIA colon cancer|stage iiia colon cancer
696808|NCT00274885|stage IIIB colon cancer|stage iiib colon cancer
696809|NCT00274885|stage IIIC colon cancer|stage iiic colon cancer
696810|NCT00274885|stage IVA colon cancer|stage iva colon cancer
696811|NCT00274885|stage IVB colon cancer|stage ivb colon cancer
696812|NCT00274885|stage I rectal cancer|stage i rectal cancer
696813|NCT00274885|stage IIA rectal cancer|stage iia rectal cancer
696814|NCT00274885|stage IIB rectal cancer|stage iib rectal cancer
696815|NCT00274885|stage IIC rectal cancer|stage iic rectal cancer
696816|NCT00274885|stage IIIA rectal cancer|stage iiia rectal cancer
696817|NCT00274885|stage IIIB rectal cancer|stage iiib rectal cancer
696818|NCT00274885|stage IIIC rectal cancer|stage iiic rectal cancer
696819|NCT00274885|stage IVA rectal cancer|stage iva rectal cancer
696820|NCT00274885|stage IVB rectal cancer|stage ivb rectal cancer
696821|NCT00274885|stage IA esophageal cancer|stage ia esophageal cancer
696822|NCT00274885|stage IB esophageal cancer|stage ib esophageal cancer
696823|NCT00274885|stage IIA esophageal cancer|stage iia esophageal cancer
696824|NCT00274885|stage IIB esophageal cancer|stage iib esophageal cancer
696825|NCT00274885|stage IIIA esophageal cancer|stage iiia esophageal cancer
696826|NCT00274885|stage IIIB esophageal cancer|stage iiib esophageal cancer
696827|NCT00274885|stage IIIC esophageal cancer|stage iiic esophageal cancer
696828|NCT00274885|stage IV esophageal cancer|stage iv esophageal cancer
696829|NCT00274872|recurrent rectal cancer|recurrent rectal cancer
697368|NCT00272610|Skin Aging|skin aging
696830|NCT00274872|stage IV rectal cancer|stage iv rectal cancer
696831|NCT00274872|recurrent colon cancer|recurrent colon cancer
696832|NCT00274872|stage IV colon cancer|stage iv colon cancer
696833|NCT00274872|adenocarcinoma of the colon|adenocarcinoma of the colon
696834|NCT00274872|adenocarcinoma of the rectum|adenocarcinoma of the rectum
696835|NCT00274859|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
696836|NCT00274846|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
696837|NCT00274846|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
696838|NCT00274846|secondary acute myeloid leukemia|secondary acute myeloid leukemia
696839|NCT00274846|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
696840|NCT00274846|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
696841|NCT00274846|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
696842|NCT00274846|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
696843|NCT00274846|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
696844|NCT00274833|adult glioblastoma|adult glioblastoma
696845|NCT00274833|adult giant cell glioblastoma|adult giant cell glioblastoma
696846|NCT00274833|adult gliosarcoma|adult gliosarcoma
696847|NCT00274820|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
696848|NCT00274820|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
696849|NCT00274820|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
696850|NCT00274820|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
696851|NCT00274820|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
696852|NCT00274820|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
696853|NCT00274820|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
696854|NCT00274807|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
696855|NCT00274807|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
696856|NCT00274807|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
696857|NCT00274807|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
696858|NCT00274807|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
696859|NCT00274807|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
696860|NCT00274794|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
696861|NCT00274794|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
696862|NCT00274794|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
696863|NCT00274794|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
696864|NCT00274794|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
696865|NCT00274794|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
696866|NCT00274794|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
696867|NCT00274794|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
696868|NCT00274794|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
696869|NCT00274794|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
696870|NCT00274794|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
696871|NCT00274794|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
696872|NCT00274794|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
696873|NCT00274794|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
696874|NCT00274794|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
696875|NCT00274794|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
696876|NCT00274794|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
696877|NCT00274794|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
696878|NCT00274794|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
696879|NCT00274794|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
696880|NCT00274794|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
696881|NCT00274794|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
696882|NCT00274794|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
696883|NCT00274794|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
696884|NCT00274794|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
696885|NCT00274794|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
696886|NCT00274794|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
696887|NCT00274794|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
696888|NCT00274794|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
696889|NCT00274794|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
697074|NCT00273832|Spiral computed tomography|spiral computed tomography
696890|NCT00274794|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
696891|NCT00274794|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
696892|NCT00274794|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
696893|NCT00274794|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
696894|NCT00274794|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
696895|NCT00274794|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
696896|NCT00274794|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
696897|NCT00274794|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
696898|NCT00274794|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
696899|NCT00274794|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
696900|NCT00274794|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
696901|NCT00274794|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
696902|NCT00274794|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
696903|NCT00274794|splenic marginal zone lymphoma|splenic marginal zone lymphoma
696904|NCT00274794|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
696905|NCT00274794|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
696906|NCT00274794|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
696907|NCT00274794|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
696908|NCT00274794|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
696909|NCT00274794|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
696910|NCT00274781|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
696911|NCT00274781|refractory anemia with excess blasts|refractory anemia with excess blasts
696912|NCT00274781|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
696913|NCT00274781|secondary acute myeloid leukemia|secondary acute myeloid leukemia
696914|NCT00274781|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
696915|NCT00274781|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
696916|NCT00274781|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
696917|NCT00274768|stage IV breast cancer|stage iv breast cancer
696918|NCT00274768|male breast cancer|male breast cancer
696919|NCT00274768|recurrent breast cancer|recurrent breast cancer
696920|NCT00274755|adult anaplastic astrocytoma|adult anaplastic astrocytoma
696921|NCT00274755|adult diffuse astrocytoma|adult diffuse astrocytoma
696922|NCT00274755|adult glioblastoma|adult glioblastoma
696923|NCT00274755|adult giant cell glioblastoma|adult giant cell glioblastoma
696924|NCT00274755|adult gliosarcoma|adult gliosarcoma
696925|NCT00274755|adult pilocytic astrocytoma|adult pilocytic astrocytoma
696926|NCT00274755|adult anaplastic ependymoma|adult anaplastic ependymoma
696927|NCT00274755|adult ependymoma|adult ependymoma
696928|NCT00274755|adult myxopapillary ependymoma|adult myxopapillary ependymoma
696929|NCT00274755|adult subependymoma|adult subependymoma
696930|NCT00274755|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
696931|NCT00274755|adult oligodendroglioma|adult oligodendroglioma
696932|NCT00274755|adult mixed glioma|adult mixed glioma
696933|NCT00274742|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
696934|NCT00274742|Cancer immunotherapy|cancer immunotherapy
696935|NCT00274742|Monoclonal antibody|monoclonal antibody
696936|NCT00274742|anti-CD19|anti-cd19
696937|NCT00274742|anti-CD3|anti-cd3
696938|NCT00274742|BiTE|bite
696939|NCT00274742|Blinatumomab|blinatumomab
696940|NCT00274729|Dietary intervention|dietary intervention
696941|NCT00274729|High-carbohydrate diet|high-carbohydrate diet
696942|NCT00274729|High-fat diet|high-fat diet
696943|NCT00274729|Moderate-fat diet|moderate-fat diet
696944|NCT00274729|Obesity|obesity
696945|NCT00274729|Weight maintenance|weight maintenance
696946|NCT00274729|Body composition|body composition
696947|NCT00274729|Glucose metabolism|glucose metabolism
696948|NCT00274729|Cardiovascular disease|cardiovascular disease
696949|NCT00274729|Appetite regulation|appetite regulation
696950|NCT00274729|Energy expenditure|energy expenditure
696951|NCT00274703|anti IL-5|anti il-5
696952|NCT00274703|oesophagitis|oesophagitis
696953|NCT00274703|eosinophils|eosinophils
696954|NCT00274703|mepolizumab|mepolizumab
696955|NCT00274703|adults|adults
696956|NCT00274690|Neurokinin-1 Receptor Antagonist|neurokinin-1 receptor antagonist
696957|NCT00274690|GW679769|gw679769
696958|NCT00274690|Post-operative Nausea|post-operative nausea
696959|NCT00274690|NK-1 Receptor Antagonist|nk-1 receptor antagonist
696960|NCT00274690|PONV|ponv
696961|NCT00274690|Post-discharge Nausea and Vomiting|post-discharge nausea and vomiting
696962|NCT00274690|PDNV|pdnv
696963|NCT00274690|Vomiting|vomiting
696964|NCT00274677|Bipolar Disorder|bipolar disorder
696965|NCT00274664|Amblyopia|amblyopia
696966|NCT00274664|Occlusion dose monitoring|occlusion dose monitoring
696967|NCT00274664|Refractive adaptation|refractive adaptation
696968|NCT00274664|Dose-response|dose-response
696969|NCT00274651|CTCL|ctcl
696970|NCT00274651|PTCL|ptcl
696971|NCT00274651|lymphoma|lymphoma
696972|NCT00274651|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
696973|NCT00274651|Cutaneous T-Cell Lymphomas (CTCL)|cutaneous t-cell lymphomas (ctcl)
696974|NCT00274651|Peripheral T-Cell Lymphomas (PTCL)|peripheral t-cell lymphomas (ptcl)
696975|NCT00274651|Other Types of Non-Hodgkin's Lymphoma|other types of non-hodgkin's lymphoma
696976|NCT00274651|belinostat|belinostat
696977|NCT00274625|Biomaterials|biomaterials
696978|NCT00274625|Bariatric Surgery|bariatric surgery
696979|NCT00274625|Hernia, Prevention of|hernia, prevention of
696980|NCT00274625|Obesity|obesity
696981|NCT00274625|Bypass Surgery|bypass surgery
696982|NCT00274625|Incisional Hernia|incisional hernia
696983|NCT00274625|Ventral Hernia|ventral hernia
696984|NCT00274495|Genotype 1|genotype 1
696985|NCT00274495|Metabolic syndrome|metabolic syndrome
696986|NCT00274495|Insulin resistance|insulin resistance
696987|NCT00274469|oncology|oncology
696988|NCT00274469|cancer|cancer
696989|NCT00274469|breast cancer|breast cancer
696990|NCT00274456|Metastatic breast cancer, nab paclitaxel, docetaxel,|metastatic breast cancer, nab paclitaxel, docetaxel,
696991|NCT00274404|infectious mononucleosis|infectious mononucleosis
696992|NCT00274404|Epstein-Barr virus|epstein-barr virus
696993|NCT00274404|valacyclovir|valacyclovir
696994|NCT00274404|quantitative PCR|quantitative pcr
696995|NCT00274378|radius fracture|radius fracture
696996|NCT00274378|fracture fixation|fracture fixation
696997|NCT00274378|homologous bone transplantation|homologous bone transplantation
696998|NCT00274365|general practitioners, psychiatry, videoconference|general practitioners, psychiatry, videoconference
696999|NCT00274352|sarcoidosis|sarcoidosis
697000|NCT00274352|adalimumab|adalimumab
697001|NCT00274352|skin diseases|skin diseases
697002|NCT00274339|Laryngopharyngeal Reflux|laryngopharyngeal reflux
697003|NCT00274339|Prevacid|prevacid
697004|NCT00274339|Lifestyle changes|lifestyle changes
697005|NCT00274339|Reflux Finding Score|reflux finding score
697006|NCT00274339|Reflux Symptom Index|reflux symptom index
697007|NCT00274339|Laryngoscopy|laryngoscopy
697008|NCT00274326|Hyponatremia|hyponatremia
697009|NCT00274313|Cystic Fibrosis|cystic fibrosis
697010|NCT00274300|DNA vaccine|dna vaccine
697011|NCT00274300|immunotherapy|immunotherapy
697012|NCT00274300|Herpes Simplex Virus Type 2 (HSV2)|herpes simplex virus type 2 (hsv2)
697013|NCT00274300|Particle Mediated Epidermal Delivery|particle mediated epidermal delivery
697014|NCT00274261|contraception|contraception
697015|NCT00274235|Malaria|malaria
697016|NCT00274235|Prevention|prevention
697017|NCT00274235|Pregnancy|pregnancy
697018|NCT00274235|Low birthweight|low birthweight
697019|NCT00274235|Anemia|anemia
697020|NCT00274235|Africa|africa
697021|NCT00274222|COPD, nebulized budesonide, systemic corticosteroids|copd, nebulized budesonide, systemic corticosteroids
697022|NCT00274209|Ulcerative colitis|ulcerative colitis
697023|NCT00274209|Crohn's disease|crohn's disease
697024|NCT00274209|Chromoendoscopy|chromoendoscopy
697025|NCT00274209|Dysplasia|dysplasia
697026|NCT00274209|Neoplasia|neoplasia
697027|NCT00274196|fractures, occult|fractures, occult
697028|NCT00274196|hip|hip
697029|NCT00274196|ultrasound examination|ultrasound examination
697030|NCT00274196|MRI|mri
697031|NCT00274196|sensitivity|sensitivity
697032|NCT00274196|specificity|specificity
697033|NCT00274170|Migraine|migraine
697034|NCT00274170|Octreotide|octreotide
697035|NCT00274170|Prochlorperazine|prochlorperazine
697036|NCT00274157|Peripheral Vascular Disease|peripheral vascular disease
697037|NCT00274157|Intermittent Claudication|intermittent claudication
697038|NCT00274157|Catheter-based Arterial Revascularization|catheter-based arterial revascularization
697039|NCT00274157|Peripheral angioplasty|peripheral angioplasty
697040|NCT00274157|Peripheral stenting|peripheral stenting
697041|NCT00274157|Functional capacity|functional capacity
697042|NCT00274157|Quality of life|quality of life
697043|NCT00273949|Lactulose|lactulose
697044|NCT00273949|Prebiotics|prebiotics
697045|NCT00273949|Nosocomial infection|nosocomial infection
697046|NCT00273949|children|children
697047|NCT00273949|infants|infants
697048|NCT00273910|Disease Free Survival|disease free survival
697049|NCT00273910|gp 100:209-217 (210m)|gp 100:209-217 (210m)
697050|NCT00273910|Immunologic Response|immunologic response
697051|NCT00273910|Adjuvant Therapy|adjuvant therapy
697052|NCT00273910|Cutaneous Melanoma|cutaneous melanoma
697053|NCT00273910|Melanoma|melanoma
697054|NCT00273897|Dementia Treatment|dementia treatment
697055|NCT00273897|Hand Function|hand function
697056|NCT00273897|Clinical Trials|clinical trials
697057|NCT00273897|Dementia|dementia
697058|NCT00273897|Cortical Syndrome|cortical syndrome
697059|NCT00273897|CBS|cbs
697060|NCT00273897|Apraxia|apraxia
697061|NCT00273884|AML|aml
697062|NCT00273884|Secondary AML|secondary aml
697063|NCT00273884|Leukemia|leukemia
697064|NCT00273871|kidney transplant|kidney transplant
697065|NCT00273858|Rheumatoid Arthritis|rheumatoid arthritis
697066|NCT00273858|Ankylosing Spondylitis|ankylosing spondylitis
697067|NCT00273858|Psoriatic Arthritis|psoriatic arthritis
697068|NCT00273845|case management|case management
697069|NCT00273845|substance abuse treatment|substance abuse treatment
697070|NCT00273845|linkage|linkage
697071|NCT00273832|Chest pain|chest pain
697072|NCT00273832|Angina pectoris|angina pectoris
697073|NCT00273832|Emergency medicine|emergency medicine
697075|NCT00273832|Length of stay|length of stay
697076|NCT00273832|Cost analysis|cost analysis
697077|NCT00273819|Congestive heart failure, LV dysfunction|congestive heart failure, lv dysfunction
697078|NCT00273806|Behavioral risk factors|behavioral risk factors
697079|NCT00273806|Primary Care|primary care
697080|NCT00273806|Health services research|health services research
697081|NCT00273780|Patient compliance|patient compliance
697082|NCT00273767|troponin T|troponin t
697083|NCT00273767|CK-MB|ck-mb
697084|NCT00273767|protein S-100|protein s-100
697085|NCT00273767|Cardiopulmonary Bypass|cardiopulmonary bypass
697086|NCT00273767|Erythropoietin|erythropoietin
697087|NCT00273754|Obstructive Sleep Apnea (OSA)|obstructive sleep apnea (osa)
697088|NCT00273754|Tonsillectomy and Adenoidectomy (T&A)|tonsillectomy and adenoidectomy (t&a)
697089|NCT00273754|Postoperative Complications|postoperative complications
697090|NCT00273754|Recovery|recovery
697091|NCT00273741|palliative care|palliative care
697092|NCT00273741|methylphenidate|methylphenidate
697093|NCT00273728|Hydroxyethyl Starch|hydroxyethyl starch
697094|NCT00273728|shock, septic|shock, septic
697095|NCT00273728|infusion, intravenous|infusion, intravenous
697096|NCT00273728|mortality|mortality
697097|NCT00273715|Comparative|comparative
697098|NCT00273715|Randomized|randomized
697099|NCT00273715|Suture|suture
697100|NCT00273715|Staples, surgical|staples, surgical
697101|NCT00273715|Skin|skin
697102|NCT00273715|Surgical procedures, operative|surgical procedures, operative
697103|NCT00273715|Orthopedics|orthopedics
697104|NCT00273715|Joint, hip|joint, hip
697105|NCT00273715|Surgical procedures of Hip, Operative|surgical procedures of hip, operative
697106|NCT00273702|Gambling|gambling
697107|NCT00273702|Gambler|gambler
697108|NCT00273702|Gamble|gamble
697109|NCT00273702|Pathological|pathological
697110|NCT00273676|Community-acquired pneumonia|community-acquired pneumonia
697111|NCT00273676|Treatment|treatment
697112|NCT00273676|Antibiotics|antibiotics
697113|NCT00273663|cerebral blood flow|cerebral blood flow
697114|NCT00273663|electrical stimulation|electrical stimulation
697115|NCT00273663|Computed Tomography Scanner, X-Ray|computed tomography scanner, x-ray
697116|NCT00273663|Brain Mapping|brain mapping
697117|NCT00273650|Autism|autism
697118|NCT00273650|Placebo|placebo
697119|NCT00273650|B12|b12
697120|NCT00273650|Controlled|controlled
697121|NCT00273650|Complementary Alternative Medicine|complementary alternative medicine
697122|NCT00273650|Vitamin Supplement|vitamin supplement
697123|NCT00273637|heart failure|heart failure
697124|NCT00273637|peripartum cardiomyopathy|peripartum cardiomyopathy
697125|NCT00273637|pregnancy-associated cardiomyopathy|pregnancy-associated cardiomyopathy
697126|NCT00273637|pregnancy complications|pregnancy complications
697127|NCT00273637|nonischemic cardiomyopathy|nonischemic cardiomyopathy
697128|NCT00273624|Therapy-resistant depression|therapy-resistant depression
697129|NCT00273624|add-on therapy depression|add-on therapy depression
697130|NCT00273611|vitamin D deficiency|vitamin d deficiency
697131|NCT00273611|geriatric patients|geriatric patients
697132|NCT00273598|Scoliosis|scoliosis
697133|NCT00273598|spinal disease|spinal disease
697134|NCT00273598|pediatrics|pediatrics
697135|NCT00273598|Adolescents|adolescents
697136|NCT00273598|Universal Spinal Instrumentation System|universal spinal instrumentation system
697137|NCT00273598|Moss Miami Spinal Instrumentation System|moss miami spinal instrumentation system
697138|NCT00273598|Orthopedic Surgery|orthopedic surgery
697139|NCT00273585|Fecal occult blood testing|fecal occult blood testing
697140|NCT00273585|Flexible sigmoidoscopy|flexible sigmoidoscopy
697141|NCT00273585|Colonoscopy|colonoscopy
697142|NCT00273585|Self-efficacy|self-efficacy
697143|NCT00273572|Obesity|obesity
697144|NCT00273572|Women|women
697145|NCT00273572|Arab|arab
697146|NCT00273572|Metabolic syndrome|metabolic syndrome
697147|NCT00273572|Lifestyle intervention|lifestyle intervention
697148|NCT00273572|Quality of life|quality of life
697149|NCT00273559|Renal Transplantation|renal transplantation
697150|NCT00273546|Head and Neck Cancer|head and neck cancer
697151|NCT00273546|Induction|induction
697152|NCT00273546|Chemotherapy|chemotherapy
697153|NCT00273546|Chemoradiotherapy|chemoradiotherapy
697154|NCT00273507|Non-small cell lung cancer|non-small cell lung cancer
697155|NCT00273507|neoadjuvant|neoadjuvant
697156|NCT00273507|resection|resection
697157|NCT00273494|N2 disease|n2 disease
697158|NCT00273494|Non-small cell lung cancer|non-small cell lung cancer
697159|NCT00273494|Surgery|surgery
697160|NCT00273494|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
697161|NCT00273403|HIV|hiv
697162|NCT00273403|Minority Groups|minority groups
697163|NCT00273403|Health Services Accessibility|health services accessibility
697164|NCT00273403|Quality of Life|quality of life
697165|NCT00273377|Anesthesia|anesthesia
697166|NCT00273377|Oxygen|oxygen
697167|NCT00273377|Carbon dioxide|carbon dioxide
697168|NCT00273377|Hypercapnia|hypercapnia
697169|NCT00273377|Hypercarbia|hypercarbia
697170|NCT00273377|Dexamethasone|dexamethasone
697171|NCT00273377|Steroid|steroid
697172|NCT00273377|Postoperative nausea and vomiting (PONV)|postoperative nausea and vomiting (ponv)
697268|NCT00272922|Laparoscopy|laparoscopy
697173|NCT00273364|stem cell, autoimmune disease, multiple sclerosis|stem cell, autoimmune disease, multiple sclerosis
697174|NCT00273351|Parkinson|parkinson
697175|NCT00273351|family history|family history
697176|NCT00273351|diagnosis|diagnosis
697177|NCT00273338|Androgen-independent Prostate Cancer (AIPC)|androgen-independent prostate cancer (aipc)
697178|NCT00273338|Prostate Cancer|prostate cancer
697179|NCT00273338|DN-101|dn-101
697180|NCT00273338|calcitriol|calcitriol
697181|NCT00273338|Taxotere|taxotere
697182|NCT00273338|docetaxel|docetaxel
697183|NCT00273325|NICHD Neonatal Research Network|nichd neonatal research network
697184|NCT00273325|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
697185|NCT00273325|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
697186|NCT00273325|Prematurity|prematurity
697187|NCT00273325|Pneumococcal Vaccines|pneumococcal vaccines
697188|NCT00273325|Vaccines, Conjugate|vaccines, conjugate
697189|NCT00273325|Immunogenicity|immunogenicity
697190|NCT00273325|Vaccine Response|vaccine response
697191|NCT00273325|Heptavalent pneumococcal conjugate vaccine (PCV-7)|heptavalent pneumococcal conjugate vaccine (pcv-7)
697192|NCT00273325|pneumococcal polysaccharide, type 6B|pneumococcal polysaccharide, type 6b
697193|NCT00273325|Pneumococcal polysaccharide, type 14|pneumococcal polysaccharide, type 14
697194|NCT00273325|Pneumococcal polysaccharide, type 19F,|pneumococcal polysaccharide, type 19f,
697195|NCT00273325|Pneumococcal polysaccharide, 23F|pneumococcal polysaccharide, 23f
697196|NCT00273325|Pneumococcal polysaccharide, 18C|pneumococcal polysaccharide, 18c
697197|NCT00273325|Pneumococcal polysaccharide, 4|pneumococcal polysaccharide, 4
697198|NCT00273325|Pneumococcal polysaccharide, 9V|pneumococcal polysaccharide, 9v
697199|NCT00273312|Advanced unresectable metastatic hepatocellular carcinoma|advanced unresectable metastatic hepatocellular carcinoma
697200|NCT00273312|Liver cancer|liver cancer
697201|NCT00273299|hypertension|hypertension
697202|NCT00273299|high blood pressure|high blood pressure
697203|NCT00273299|valsartan/hydrochlorozide|valsartan/hydrochlorozide
697204|NCT00273299|severe hypertension|severe hypertension
697205|NCT00273286|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
697206|NCT00273286|Diabetes Mellitus, Juvenile-Onset|diabetes mellitus, juvenile-onset
697207|NCT00273286|IDDM|iddm
697208|NCT00273286|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
697209|NCT00273273|HIV|hiv
697210|NCT00273273|Atazanavir|atazanavir
697211|NCT00273273|ritonavir|ritonavir
697212|NCT00273273|tenofovir|tenofovir
697213|NCT00273273|Adolescent|adolescent
697214|NCT00273273|Treatment Experienced|treatment experienced
697215|NCT00273234|Venous|venous
697216|NCT00273234|Ulcer|ulcer
697217|NCT00273234|autologous|autologous
697218|NCT00273234|platelet|platelet
697219|NCT00273234|healing|healing
697220|NCT00273221|Glaucoma|glaucoma
697221|NCT00273221|Cataract|cataract
697222|NCT00273208|breast cancer|breast cancer
697223|NCT00273208|fatigue|fatigue
697224|NCT00273195|Implantable Cardioverter Defibrillator, Anti-tachycardia pacing (ATP)|implantable cardioverter defibrillator, anti-tachycardia pacing (atp)
697225|NCT00273182|Heart Failure|heart failure
697226|NCT00273182|Cardiomyopathy|cardiomyopathy
697227|NCT00273182|Cardiac pacing|cardiac pacing
697228|NCT00273182|Cardiac resynchronization therapy|cardiac resynchronization therapy
697229|NCT00273130|transnasal gastroscopy, stress response, ischaemia|transnasal gastroscopy, stress response, ischaemia
697230|NCT00273117|transnasal gastroscopy|transnasal gastroscopy
697231|NCT00273117|tachycardia|tachycardia
697232|NCT00273117|hypoxemia|hypoxemia
697233|NCT00273078|Speech,|speech,
697234|NCT00273078|tongue,|tongue,
697235|NCT00273078|pressure,|pressure,
697236|NCT00273078|transducer,|transducer,
697237|NCT00273078|complete denture|complete denture
697238|NCT00273065|Local Anesthetic|local anesthetic
697239|NCT00273065|Neosaxitoxin|neosaxitoxin
697240|NCT00273052|hypertension|hypertension
697241|NCT00273039|Social Anxiety Disorder|social anxiety disorder
697242|NCT00273039|Anxiety|anxiety
697243|NCT00273039|Psychiatry|psychiatry
697244|NCT00273026|Asthma Advair|asthma advair
697245|NCT00273013|asthma|asthma
697246|NCT00273013|allergen challenge|allergen challenge
697247|NCT00272987|trastuzumab|trastuzumab
697248|NCT00272987|ErbB2|erbb2
697249|NCT00272987|paclitaxel|paclitaxel
697250|NCT00272987|Herceptin|herceptin
697251|NCT00272987|Taxol|taxol
697252|NCT00272987|ErbB1|erbb1
697253|NCT00272987|metastatic breast cancer|metastatic breast cancer
697254|NCT00272987|Stage IV breast cancer|stage iv breast cancer
697255|NCT00272987|lapatinib|lapatinib
697256|NCT00272974|AE adverse event|ae adverse event
697257|NCT00272974|DCF data collection forms|dcf data collection forms
697258|NCT00272974|IRB Institutional Review Board|irb institutional review board
697259|NCT00272974|SAE serious adverse event|sae serious adverse event
697260|NCT00272948|Venoocclusive disease|venoocclusive disease
697261|NCT00272948|Pediatric|pediatric
697262|NCT00272948|myeloablative conditioning|myeloablative conditioning
697263|NCT00272948|stem cell transplant|stem cell transplant
697264|NCT00272935|menopause|menopause
697265|NCT00272935|vasomotor symptoms|vasomotor symptoms
697266|NCT00272922|Biomaterials|biomaterials
697267|NCT00272922|Paraesophageal Hernia|paraesophageal hernia
697269|NCT00272909|Acute Ischemic Stroke|acute ischemic stroke
697270|NCT00272909|9-Hour window MRI|9-hour window mri
697271|NCT00272909|Serotonin receptor agonist|serotonin receptor agonist
697272|NCT00272896|Migraine|migraine
697273|NCT00272896|VIP|vip
697274|NCT00272896|Transcranial Doppler|transcranial doppler
697275|NCT00272896|Headache|headache
697276|NCT00272883|central core|central core
697277|NCT00272883|centronuclear|centronuclear
697278|NCT00272883|multiminicore|multiminicore
697279|NCT00272883|multicore|multicore
697280|NCT00272883|minicore|minicore
697281|NCT00272883|congenital fiber type disproportion|congenital fiber type disproportion
697282|NCT00272883|myotubular|myotubular
697283|NCT00272883|nemaline|nemaline
697284|NCT00272883|congenital myopathy|congenital myopathy
697285|NCT00272883|neuromuscular|neuromuscular
697286|NCT00272883|rigid spine|rigid spine
697287|NCT00272844|cholesterol|cholesterol
697288|NCT00272844|Smith-Lemli-Opitz syndrome|smith-lemli-opitz syndrome
697289|NCT00272844|mental retardation|mental retardation
697290|NCT00272844|sterols|sterols
697291|NCT00272844|congenital anomalies|congenital anomalies
697292|NCT00272831|Diabetic nephropathy|diabetic nephropathy
697293|NCT00272831|Macroalbuminuria|macroalbuminuria
697294|NCT00272831|Pletaal|pletaal
697295|NCT00272818|Colitis|colitis
697296|NCT00272818|Esophagitis|esophagitis
697297|NCT00272818|CD23|cd23
697298|NCT00272805|chronic heart failure|chronic heart failure
697299|NCT00272805|left ventricular systolic dysfunction|left ventricular systolic dysfunction
697300|NCT00272779|HIV|hiv
697301|NCT00272779|Treatment Naive|treatment naive
697302|NCT00272766|Ocular histoplasmosis|ocular histoplasmosis
697303|NCT00272766|Macugen|macugen
697304|NCT00272766|Photodynamic therapy with Visudyne|photodynamic therapy with visudyne
697305|NCT00272766|Best-corrected visual acuity scores between 20/40-20/200|best-corrected visual acuity scores between 20/40-20/200
697306|NCT00272766|classic or occult choroidal neovascularization|classic or occult choroidal neovascularization
697307|NCT00272740|breast cancer|breast cancer
697308|NCT00272740|fulvestrant|fulvestrant
697309|NCT00272740|Faslodex|faslodex
697310|NCT00272740|hormonotherapy|hormonotherapy
697311|NCT00272740|aromatase inhibitor failure|aromatase inhibitor failure
697312|NCT00272740|Advanced breast cancer|advanced breast cancer
697313|NCT00272727|Asthma|asthma
697314|NCT00272727|dialog tool|dialog tool
697315|NCT00272727|compliance|compliance
697316|NCT00272714|breast pain, tenderness, benign breast conditions|breast pain, tenderness, benign breast conditions
697317|NCT00272675|Nosocomial infection,|nosocomial infection,
697318|NCT00272675|Decontamination,|decontamination,
697319|NCT00272675|Randomized placebo-controlled trial,|randomized placebo-controlled trial,
697320|NCT00272675|Cardiac surgery,|cardiac surgery,
697321|NCT00272675|Chlorhexidine,|chlorhexidine,
697322|NCT00272675|Prevention|prevention
697323|NCT00272662|anemia|anemia
697324|NCT00272662|cancer|cancer
697325|NCT00272662|chemotherapy|chemotherapy
697326|NCT00272662|chemotherapy induced anemia|chemotherapy induced anemia
697327|NCT00272662|CIA|cia
697328|NCT00272662|hemoglobin|hemoglobin
697329|NCT00272662|Hb|hb
697330|NCT00272662|Hgb|hgb
697331|NCT00272662|erythropoietin|erythropoietin
697332|NCT00272662|EPO|epo
697333|NCT00272662|erythropoiesis stimulating agent|erythropoiesis stimulating agent
697334|NCT00272662|ESA|esa
697335|NCT00272662|Hematide|hematide
697336|NCT00272662|Omontys|omontys
697337|NCT00272662|peginesatide|peginesatide
697338|NCT00272662|red blood cell|red blood cell
697339|NCT00272662|red blood cell production|red blood cell production
697340|NCT00272649|Kidney cancer|kidney cancer
697341|NCT00272649|Renal cancer|renal cancer
697342|NCT00272636|atrial fibrillation|atrial fibrillation
697343|NCT00272636|catheter ablation|catheter ablation
697344|NCT00272636|amiodarone|amiodarone
697345|NCT00272636|cardioversion|cardioversion
697346|NCT00272623|Catheter, Indwelling|catheter, indwelling
697347|NCT00272623|Indwelling Catheter|indwelling catheter
697348|NCT00272623|Indwelling Catheters|indwelling catheters
697349|NCT00272623|Implantable Catheters|implantable catheters
697350|NCT00272623|Catheter, Implantable|catheter, implantable
697351|NCT00272623|Catheters, Implantable|catheters, implantable
697352|NCT00272623|Implantable Catheter|implantable catheter
697353|NCT00272623|In-Dwelling Catheters|in-dwelling catheters
697354|NCT00272623|Catheter, In-Dwelling|catheter, in-dwelling
697355|NCT00272623|Catheters, In-Dwelling|catheters, in-dwelling
697356|NCT00272623|In Dwelling Catheters|in dwelling catheters
697357|NCT00272623|In-Dwelling Catheter|in-dwelling catheter
697358|NCT00272623|Venous Reservoirs|venous reservoirs
697359|NCT00272623|Reservoir, Venous|reservoir, venous
697360|NCT00272623|Reservoirs, Venous|reservoirs, venous
697361|NCT00272623|Venous Reservoir|venous reservoir
697362|NCT00272623|Vascular Access Ports|vascular access ports
697363|NCT00272623|Access Port, Vascular|access port, vascular
697364|NCT00272623|Access Ports, Vascular|access ports, vascular
697365|NCT00272623|Port, Vascular Access|port, vascular access
697366|NCT00272623|Ports, Vascular Access|ports, vascular access
697367|NCT00272623|Vascular Access Port|vascular access port
697369|NCT00272610|Bateman's Purpura|bateman's purpura
697370|NCT00272597|Psychosis|psychosis
697371|NCT00272597|schizophrenia|schizophrenia
697372|NCT00272597|schizoaffective|schizoaffective
697373|NCT00272597|risperidone|risperidone
697374|NCT00272584|Psychosis, schizophrenia, schizoaffective, clozapine, risperidone|psychosis, schizophrenia, schizoaffective, clozapine, risperidone
697375|NCT00272571|ECPT, endothelial progenitor cells|ecpt, endothelial progenitor cells
697376|NCT00272558|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
697377|NCT00272558|Chemotherapy|chemotherapy
697378|NCT00272545|Anorexia Nervosa|anorexia nervosa
697379|NCT00272545|Bulimia Nervosa|bulimia nervosa
697380|NCT00272545|Cognitive Behavioral Therapy|cognitive behavioral therapy
697381|NCT00272519|HIV|hiv
697382|NCT00272519|AIDS|aids
697383|NCT00272519|Adolescent|adolescent
697384|NCT00272519|HIV Positive|hiv positive
697385|NCT00272493|Treatment Experienced|treatment experienced
697386|NCT00272493|Treatment Naive|treatment naive
697387|NCT00272480|HAM/TSP|ham/tsp
697388|NCT00272480|HTLV-I-associated myelopathy|htlv-i-associated myelopathy
697389|NCT00272480|zidovudine|zidovudine
697390|NCT00272480|lamivudine|lamivudine
697391|NCT00272480|antiretroviral therapy|antiretroviral therapy
697392|NCT00272467|Helicobacter pylori|helicobacter pylori
697393|NCT00272467|Stomach ulcer|stomach ulcer
697394|NCT00272467|Rebamipide|rebamipide
697395|NCT00272467|Omeprazole|omeprazole
697396|NCT00272454|cilostazol|cilostazol
697397|NCT00272454|aspirin|aspirin
697398|NCT00272454|cerebral infarction|cerebral infarction
697399|NCT00272428|Prevention trial|prevention trial
697400|NCT00272428|Antioxydant vitamins and minerals|antioxydant vitamins and minerals
697401|NCT00272428|Cancer|cancer
697402|NCT00272428|Ischemic disease|ischemic disease
697403|NCT00272428|Mortality|mortality
697404|NCT00272428|Health related quality of life|health related quality of life
697405|NCT00272415|INO4136g|ino4136g
697406|NCT00272415|inotek|inotek
697407|NCT00272415|Parp|parp
697408|NCT00272415|Temodar|temodar
697409|NCT00272402|physician decision support|physician decision support
697410|NCT00272402|diabetes mellitus|diabetes mellitus
697411|NCT00272402|electronic medical records|electronic medical records
697412|NCT00272402|office systems redesign|office systems redesign
697413|NCT00272376|Myopia|myopia
697414|NCT00272376|Nearsightedness|nearsightedness
697415|NCT00272363|Glaucoma|glaucoma
697416|NCT00272350|Brain|brain
697417|NCT00272350|Tumor|tumor
697418|NCT00272350|Therapy|therapy
697419|NCT00272350|Progression|progression
697420|NCT00272350|Antiangiogenesis|antiangiogenesis
697421|NCT00272350|Brain Tumor|brain tumor
697422|NCT00272350|Malignant Glioma|malignant glioma
697423|NCT00272337|Cardiovascular diseases|cardiovascular diseases
697424|NCT00272337|Aspirin|aspirin
697425|NCT00272337|Atherosclerosis|atherosclerosis
697426|NCT00272337|Myocardial Infarction|myocardial infarction
697427|NCT00272324|Colorectal neoplasms|colorectal neoplasms
697428|NCT00272324|Adenomatous polyps|adenomatous polyps
697429|NCT00272311|Primary prevention|primary prevention
697430|NCT00272311|Cardiovascular diseases|cardiovascular diseases
697431|NCT00272311|Aspirin|aspirin
697432|NCT00272311|Metabolic Syndrome X|metabolic syndrome x
697433|NCT00272311|Atherosclerosis|atherosclerosis
697434|NCT00272285|Serotonin antagonists|serotonin antagonists
697435|NCT00272285|Randomized controlled trial|randomized controlled trial
697436|NCT00272285|Combination drug therapy|combination drug therapy
697437|NCT00272285|Double-blind method|double-blind method
697438|NCT00272272|Fall Prevention, Music Therapy, Geriatric, Nursing Home|fall prevention, music therapy, geriatric, nursing home
697439|NCT00272246|dystonia|dystonia
697440|NCT00272233|Inflammation Mediators [D23.469]|inflammation mediators [d23.469]
697441|NCT00272233|Cardiovascular Physiologic Phenomena [G09.330.553]|cardiovascular physiologic phenomena [g09.330.553]
697442|NCT00272220|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
697443|NCT00272220|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
697444|NCT00272220|Randomized Controlled Trials|randomized controlled trials
697445|NCT00272220|Africa|africa
697446|NCT00272220|Adherence|adherence
697447|NCT00272220|Treatment Naive|treatment naive
697448|NCT00272207|Fibromyalgia|fibromyalgia
697449|NCT00272207|Cannabinoids|cannabinoids
697450|NCT00272207|Nabilone|nabilone
697451|NCT00272207|Cesamet|cesamet
697452|NCT00272207|Pain|pain
697453|NCT00272194|Endotracheal Intubation|endotracheal intubation
697454|NCT00272194|Supraglottic Airway|supraglottic airway
697455|NCT00272168|Cognitive behavioral therapy|cognitive behavioral therapy
697456|NCT00272168|Social Skills training|social skills training
697457|NCT00272168|Vocational Rehabilitation|vocational rehabilitation
697458|NCT00272142|mortality|mortality
697459|NCT00272142|hospitalization|hospitalization
697460|NCT00272142|diarrhea|diarrhea
697461|NCT00272142|respiratory infection|respiratory infection
697462|NCT00272142|low birth weight|low birth weight
697463|NCT00272142|morbidity|morbidity
697464|NCT00272116|zinc|zinc
697465|NCT00272116|diarrhea|diarrhea
697466|NCT00272116|severe diarrhea|severe diarrhea
697467|NCT00272116|recurrent diarrhea|recurrent diarrhea
697468|NCT00272116|acute lower respiratory infection|acute lower respiratory infection
697469|NCT00272116|pneumonia|pneumonia
697470|NCT00272103|functional dyspepsia|functional dyspepsia
697471|NCT00272103|non ulcer dyspepsia|non ulcer dyspepsia
697472|NCT00272103|drug treatment|drug treatment
697473|NCT00272051|Neurotoxicity syndromes|neurotoxicity syndromes
697474|NCT00272051|Paresthesia|paresthesia
697475|NCT00272051|Oxaliplatin|oxaliplatin
697476|NCT00272051|Xaliproden|xaliproden
697477|NCT00272025|Bipolar Depression|bipolar depression
697478|NCT00272025|Escitalopram|escitalopram
697479|NCT00272025|Mood Stabilizer|mood stabilizer
697480|NCT00272025|Atypical Antipsychotic|atypical antipsychotic
697481|NCT00271999|randomized controlled clinical trial|randomized controlled clinical trial
697482|NCT00271999|hemodialysis|hemodialysis
697483|NCT00271999|End Stage Renal Disease|end stage renal disease
697484|NCT00271986|Peritoneal microdialysis|peritoneal microdialysis
697485|NCT00271986|Low anterior resection|low anterior resection
697486|NCT00271986|Recto-sigmoid cancer|recto-sigmoid cancer
697487|NCT00271986|Anastomotic leakage|anastomotic leakage
697488|NCT00271960|Pregnancy|pregnancy
697489|NCT00271960|Birth Weight|birth weight
697490|NCT00271960|Gestational Age|gestational age
697491|NCT00271960|Preterm Delivery|preterm delivery
697492|NCT00271960|HIV Seronegativity|hiv seronegativity
697493|NCT00271921|eating disorders|eating disorders
697494|NCT00271921|anorexia nervosa|anorexia nervosa
697495|NCT00271921|body fat distribution|body fat distribution
697496|NCT00271921|metabolic syndrome|metabolic syndrome
697497|NCT00271921|visceral adipose tissue|visceral adipose tissue
697498|NCT00271908|HIV|hiv
697499|NCT00271908|AIDS|aids
697500|NCT00271908|Adolescent|adolescent
697501|NCT00271908|Community|community
697502|NCT00271908|Structural Changes|structural changes
697503|NCT00271908|HIV Seronegativity|hiv seronegativity
697504|NCT00271882|Adolescent Females|adolescent females
697505|NCT00271882|HIV positive|hiv positive
697506|NCT00271882|PTSD|ptsd
697507|NCT00271882|Sexual Abuse|sexual abuse
697508|NCT00271869|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
697509|NCT00271869|graft-versus-host disease|graft-versus-host disease
697510|NCT00271869|treatment|treatment
697511|NCT00271856|HIV|hiv
697512|NCT00271856|Meditation|meditation
697513|NCT00271856|Stress|stress
697514|NCT00271856|Randomized Controlled Trial|randomized controlled trial
697515|NCT00271856|Complementary Therapies|complementary therapies
697516|NCT00271856|MBSR|mbsr
697517|NCT00271856|Not on ART medications|not on art medications
697518|NCT00271830|renal|renal
697519|NCT00271830|transplant|transplant
697520|NCT00271830|sexual dysfunction|sexual dysfunction
697521|NCT00271830|male|male
697522|NCT00271830|dialysis free|dialysis free
697523|NCT00271804|Myelodysplastic syndrome|myelodysplastic syndrome
697524|NCT00271804|Myelodysplasia|myelodysplasia
697525|NCT00271804|MDS|mds
697526|NCT00271804|Velcade|velcade
697527|NCT00271804|Thalidomide|thalidomide
697528|NCT00271804|Bortezomib|bortezomib
697529|NCT00271791|Vestibular Neuronitis|vestibular neuronitis
697530|NCT00271791|Vestibular Function Tests|vestibular function tests
697531|NCT00271791|Vestibular Adaptation|vestibular adaptation
697532|NCT00271791|Steroids|steroids
697533|NCT00271778|Otitis media suppurative|otitis media suppurative
697534|NCT00271778|surgery ear|surgery ear
697535|NCT00271765|Myocardial infarction|myocardial infarction
697536|NCT00271765|Coronary angioplasty|coronary angioplasty
697537|NCT00271765|PARP inhibitor|parp inhibitor
697538|NCT00271765|PARP inhibition|parp inhibition
697539|NCT00271765|Heart Attack|heart attack
697540|NCT00271752|Procalcitonin|procalcitonin
697541|NCT00271752|Sepsis|sepsis
697542|NCT00271752|Intensive Care Unit|intensive care unit
697543|NCT00271752|Sepsis and Complications|sepsis and complications
697544|NCT00271752|Organ Failure|organ failure
697545|NCT00271739|Telemedicine|telemedicine
697546|NCT00271739|Diabetes Mellitus|diabetes mellitus
697547|NCT00271726|distal radius fracture|distal radius fracture
697548|NCT00271726|extraarticular Colles fracture|extraarticular colles fracture
697549|NCT00271713|bone structure|bone structure
697550|NCT00271713|ibandronate|ibandronate
697551|NCT00271700|Diabetes Mellitus|diabetes mellitus
697552|NCT00271700|Outcome Assessment (Healthcare)|outcome assessment (healthcare)
697553|NCT00271700|Inpatients|inpatients
697554|NCT00271700|Hospital Information Systems|hospital information systems
697555|NCT00271700|Education|education
697556|NCT00271687|exercise|exercise
697557|NCT00271687|exercise therapy|exercise therapy
697558|NCT00271687|activities of daily living|activities of daily living
697559|NCT00271687|quality of life|quality of life
697560|NCT00271661|presbyopia; breast cancer survivors|presbyopia; breast cancer survivors
697561|NCT00271635|Charcot-Marie-Tooth Disease|charcot-marie-tooth disease
697562|NCT00271635|Hereditary Motor and Sensory Neuropathies|hereditary motor and sensory neuropathies
697563|NCT00271635|Ascorbic Acid|ascorbic acid
697564|NCT00271635|Vitamin C|vitamin c
697565|NCT00271622|Screening|screening
697566|NCT00271622|Pediatric|pediatric
697674|NCT00271245|liver disease|liver disease
697567|NCT00271622|Pervasive Developmental Disorder|pervasive developmental disorder
697568|NCT00271622|Early Development|early development
697569|NCT00271622|Children|children
697570|NCT00271622|Autism Spectrum Disorders|autism spectrum disorders
697571|NCT00271622|Healthy Volunteer|healthy volunteer
697572|NCT00271622|HV|hv
697573|NCT00271609|AVASTIN|avastin
697574|NCT00271609|Recurrence|recurrence
697575|NCT00271609|Chemotherapy|chemotherapy
697576|NCT00271609|Anti-Angiogenesis|anti-angiogenesis
697577|NCT00271609|Radiotherapy|radiotherapy
697578|NCT00271609|Brain Tumor|brain tumor
697579|NCT00271609|Malignant Glioma|malignant glioma
697580|NCT00271596|Huntington Disease|huntington disease
697581|NCT00271596|Citalopram|citalopram
697582|NCT00271596|Celexa|celexa
697583|NCT00271596|Chorea|chorea
697584|NCT00271596|Focus|focus
697585|NCT00271596|ADD|add
697586|NCT00271596|ADHD|adhd
697587|NCT00271596|HD|hd
697588|NCT00271596|SSRI|ssri
697589|NCT00271583|emergency contraception|emergency contraception
697590|NCT00271583|antiprogestin|antiprogestin
697591|NCT00271557|Heart Failure|heart failure
697592|NCT00271557|Renal Dysfunction|renal dysfunction
697593|NCT00271557|Cardiomyopathy|cardiomyopathy
697594|NCT00271557|Heart Decompensation|heart decompensation
697595|NCT00271557|Dyspnea Paroxysmal.|dyspnea paroxysmal.
697596|NCT00271544|heart failure|heart failure
697597|NCT00271544|cardiac pacing|cardiac pacing
697598|NCT00271544|left ventricular lead|left ventricular lead
697599|NCT00271544|cardiac resynchronization therapy|cardiac resynchronization therapy
697600|NCT00271531|bacterial infection, pneumonia, ventilation, children|bacterial infection, pneumonia, ventilation, children
697601|NCT00271505|Non-Small Cell Lung Cancer|non-small cell lung cancer
697602|NCT00271505|Lung Cancer|lung cancer
697603|NCT00271505|Bevacizumab|bevacizumab
697604|NCT00271505|Carboplatin|carboplatin
697605|NCT00271505|Docetaxel|docetaxel
697606|NCT00271505|Avastin|avastin
697607|NCT00271505|NSCLC|nsclc
697608|NCT00271505|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
697609|NCT00271505|rhuMAb-VEGF|rhumab-vegf
697610|NCT00271505|Paraplatin®|paraplatin®
697611|NCT00271505|Taxotere|taxotere
697612|NCT00271479|Meningitis|meningitis
697613|NCT00271479|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
697614|NCT00271479|Neisseria meningitidis|neisseria meningitidis
697615|NCT00271479|Outbreaks|outbreaks
697616|NCT00271479|Vaccine|vaccine
697617|NCT00271479|Africa|africa
697618|NCT00271479|Uganda|uganda
697619|NCT00271479|Prevention of Neisseria meningitidis infections|prevention of neisseria meningitidis infections
697620|NCT00271479|In outbreak contexts in developing countries|in outbreak contexts in developing countries
697621|NCT00271466|opioid|opioid
697622|NCT00271466|fentanyl|fentanyl
697623|NCT00271466|Duragesic|duragesic
697624|NCT00271466|transdermal|transdermal
697625|NCT00271466|chronic pain|chronic pain
697626|NCT00271466|morphine|morphine
697627|NCT00271453|chronic pain|chronic pain
697628|NCT00271453|opioid|opioid
697629|NCT00271453|fentanyl|fentanyl
697630|NCT00271453|transdermal|transdermal
697631|NCT00271453|Durogesic|durogesic
697632|NCT00271453|morphine|morphine
697633|NCT00271440|chlorhexidine|chlorhexidine
697634|NCT00271440|neonatal|neonatal
697635|NCT00271440|skin flora|skin flora
697636|NCT00271440|skin cleansing|skin cleansing
697637|NCT00271440|bacterial colonization|bacterial colonization
697638|NCT00271427|Thyroiditis|thyroiditis
697639|NCT00271427|Autoimmune|autoimmune
697640|NCT00271427|Hashimoto's|hashimoto's
697641|NCT00271427|TPOAb|tpoab
697642|NCT00271427|Selenium|selenium
697643|NCT00271414|chronic pain|chronic pain
697644|NCT00271414|opioid|opioid
697645|NCT00271414|fentanyl|fentanyl
697646|NCT00271414|transdermal|transdermal
697647|NCT00271414|Duragesic|duragesic
697648|NCT00271414|morphine|morphine
697649|NCT00271401|Stents|stents
697650|NCT00271401|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
697651|NCT00271388|Galvanic Vestibular Stimulation|galvanic vestibular stimulation
697652|NCT00271388|Hemispatial Neglect|hemispatial neglect
697653|NCT00271388|Stroke|stroke
697654|NCT00271375|Age|age
697655|NCT00271375|Caregivers|caregivers
697656|NCT00271375|Family|family
697657|NCT00271375|Intervention Studies|intervention studies
697658|NCT00271362|Exercise|exercise
697659|NCT00271362|Physical function|physical function
697660|NCT00271362|Prosthetic mobility|prosthetic mobility
697661|NCT00271362|Rehabilitation|rehabilitation
697662|NCT00271349|Eosinophilic Esophagitis|eosinophilic esophagitis
697663|NCT00271349|Budesonide|budesonide
697664|NCT00271336|NEC|nec
697665|NCT00271336|Premature Infants|premature infants
697666|NCT00271336|TNF|tnf
697667|NCT00271336|Pentoxifylline|pentoxifylline
697668|NCT00271297|pelvic floor|pelvic floor
697669|NCT00271297|exercise therapy|exercise therapy
697670|NCT00271297|prevention|prevention
697671|NCT00271297|ultrasonography|ultrasonography
697672|NCT00271297|risk factors|risk factors
697673|NCT00271245|cirrhosis|cirrhosis
697675|NCT00271245|selenium|selenium
697676|NCT00271245|selenoproteins|selenoproteins
697677|NCT00271245|selenoprotein P|selenoprotein p
697678|NCT00271245|biomarkers|biomarkers
697679|NCT00271232|Heart Failure, Cardiac Resynchronization|heart failure, cardiac resynchronization
697680|NCT00271219|opiate addiction|opiate addiction
697681|NCT00271219|opiate dependence|opiate dependence
697682|NCT00271219|substance abuse|substance abuse
697683|NCT00271219|addiction|addiction
697684|NCT00271219|substance addiction|substance addiction
697685|NCT00271219|pregnancy|pregnancy
697686|NCT00271219|buprenorphine|buprenorphine
697687|NCT00271219|methadone|methadone
697688|NCT00271219|fetal|fetal
697689|NCT00271219|neonatal|neonatal
697690|NCT00271219|post-partum|post-partum
697691|NCT00271206|Nicotine Dependence|nicotine dependence
697692|NCT00271206|Tobacco Dependence|tobacco dependence
697693|NCT00271180|Cardiac Pacing|cardiac pacing
697694|NCT00271180|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
697695|NCT00271180|pacemaker|pacemaker
697696|NCT00271180|Sinus Bradycardia|sinus bradycardia
697697|NCT00271167|Cardiac surgery|cardiac surgery
697698|NCT00271167|PARP inhibitor|parp inhibitor
697699|NCT00271167|PARP inhibition|parp inhibition
697700|NCT00271167|Bypass surgery|bypass surgery
697701|NCT00271167|CPB surgery|cpb surgery
697702|NCT00271167|Cardiopulmonary bypass|cardiopulmonary bypass
697703|NCT00271167|Coronary revascularization|coronary revascularization
697704|NCT00271167|Cardiac valve replacement|cardiac valve replacement
697705|NCT00271154|Heart Failure|heart failure
697706|NCT00271154|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
697707|NCT00271154|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
697708|NCT00271141|Parkinson's disease|parkinson's disease
697709|NCT00271141|Oxidative stress|oxidative stress
697710|NCT00271141|Marker|marker
697711|NCT00271128|NT-proBNP|nt-probnp
697712|NCT00271128|Heart failure|heart failure
697713|NCT00271128|Dyspnea|dyspnea
697714|NCT00271115|Kangaroo holding|kangaroo holding
697715|NCT00271115|Kangaroo care|kangaroo care
697716|NCT00271115|Maternal stress levels|maternal stress levels
697717|NCT00271115|Premature birth|premature birth
697718|NCT00271102|Cystocele, prolapse, anterior repair, colporrhaphy|cystocele, prolapse, anterior repair, colporrhaphy
697719|NCT00271076|CAD|cad
697720|NCT00271076|CEA|cea
697721|NCT00271076|CAS|cas
697722|NCT00271076|IVUS|ivus
697723|NCT00271076|symptomatic|symptomatic
697724|NCT00271076|asymptomatic|asymptomatic
697725|NCT00271076|Cerebral Protection Device|cerebral protection device
697726|NCT00271076|TIA|tia
697727|NCT00271076|Stroke|stroke
697728|NCT00271076|plaque morphology|plaque morphology
697729|NCT00271063|Refractory or Relapsed Acute Lymphocytic Leukemia|refractory or relapsed acute lymphocytic leukemia
697730|NCT00271050|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
697731|NCT00271050|external beam radiotherapy (EBRT)|external beam radiotherapy (ebrt)
697732|NCT00271050|radio-immunotherapy (RIT)|radio-immunotherapy (rit)
697733|NCT00271050|Zevalin|zevalin
697734|NCT00271037|Pelvic organ prolapse|pelvic organ prolapse
697735|NCT00271037|Stress urinary incontinence|stress urinary incontinence
697736|NCT00271037|Surgery|surgery
697737|NCT00271037|Colpocleisis|colpocleisis
697738|NCT00271037|Urinary retention|urinary retention
697739|NCT00271024|Smoking|smoking
697740|NCT00271024|Smoking Cessation|smoking cessation
697741|NCT00270998|Stress urinary incontinence|stress urinary incontinence
697742|NCT00270985|almonds|almonds
697743|NCT00270985|pre-diabetes|pre-diabetes
697744|NCT00270985|inflammatory|inflammatory
697745|NCT00270985|CRP|crp
697746|NCT00270972|Venous leg ulcer|venous leg ulcer
697747|NCT00270972|Venous insufficiency|venous insufficiency
697748|NCT00270972|OrCel|orcel
697749|NCT00270959|PTSD|ptsd
697750|NCT00270946|Venous leg ulcer|venous leg ulcer
697751|NCT00270946|OrCel|orcel
697752|NCT00270946|Compression therapy|compression therapy
697753|NCT00270933|defibrillators|defibrillators
697754|NCT00270933|LLECG|llecg
697755|NCT00270933|ventricular tachycardia|ventricular tachycardia
697756|NCT00270933|ventricular fibrillation|ventricular fibrillation
697757|NCT00270920|Initiation, Maintenance, Breastfeeding|initiation, maintenance, breastfeeding
697758|NCT00270907|Metastatic Breast Cancer|metastatic breast cancer
697759|NCT00270907|Breast Cancer|breast cancer
697760|NCT00270907|CT-2103|ct-2103
697761|NCT00270907|Gemcitabine|gemcitabine
697762|NCT00270907|Xyotax|xyotax
697763|NCT00270907|Gemzar|gemzar
697764|NCT00270894|neoadjuvant chemotherapy|neoadjuvant chemotherapy
697765|NCT00270894|HER2 positive breast cancer|her2 positive breast cancer
697766|NCT00270894|stage II - III breast cancer|stage ii - iii breast cancer
697767|NCT00270881|cord blood transplantation|cord blood transplantation
697768|NCT00270881|myeloablative regimen|myeloablative regimen
697769|NCT00270881|hematologic malignancies|hematologic malignancies
697770|NCT00270868|Double guide wire technique|double guide wire technique
697771|NCT00270868|Difficult selective biliary cannulation|difficult selective biliary cannulation
697772|NCT00270868|ERCP|ercp
697773|NCT00270868|Attempts of cannulation|attempts of cannulation
698290|NCT00269126|Emphysema|emphysema
697774|NCT00270868|Post-ERCP complications.|post-ercp complications.
697775|NCT00270855|Body Composition|body composition
697776|NCT00270855|Exercise|exercise
697777|NCT00270855|Glucose Tolerance|glucose tolerance
697778|NCT00270855|Insulin Sensitivity|insulin sensitivity
697779|NCT00270855|Functional Electric Stimulation|functional electric stimulation
697780|NCT00270842|Education|education
697781|NCT00270842|Exercise|exercise
697782|NCT00270842|Gait|gait
697783|NCT00270842|Peripheral Nervous System|peripheral nervous system
697784|NCT00270842|Postural Balance|postural balance
697785|NCT00270842|Self Efficacy|self efficacy
697786|NCT00270842|Tai Chi Chuan|tai chi chuan
697787|NCT00270829|renal function|renal function
697788|NCT00270816|Multiple Sclerosis|multiple sclerosis
697789|NCT00270816|Interferon-ß-1b|interferon-ß-1b
697790|NCT00270816|Therapy|therapy
697791|NCT00270803|Marijuana, FDG, PET, maze, THC, motor coordination.|marijuana, fdg, pet, maze, thc, motor coordination.
697792|NCT00270790|Head and Neck cancer|head and neck cancer
697793|NCT00270777|Controlled trial|controlled trial
697794|NCT00270777|Snake bite|snake bite
697795|NCT00270777|Safety|safety
697796|NCT00270777|Antivenom|antivenom
697797|NCT00270764|HIV/AIDS|hiv/aids
697798|NCT00270764|Antiretroviral therapy|antiretroviral therapy
697799|NCT00270764|Quality of life|quality of life
697800|NCT00270764|South Africa|south africa
697801|NCT00270764|Treatment Naive|treatment naive
697802|NCT00270751|Video-Assisted Thoracoscopic Surgery|video-assisted thoracoscopic surgery
697803|NCT00270751|Spontaneous pneumothorax|spontaneous pneumothorax
697804|NCT00270751|Pleurectomy|pleurectomy
697805|NCT00270751|Pleural abrasion|pleural abrasion
697806|NCT00270751|Minocycline|minocycline
697807|NCT00270738|urinary incontinence|urinary incontinence
697808|NCT00270738|transversus abdominis|transversus abdominis
697809|NCT00270738|pelvic floor muscles|pelvic floor muscles
697810|NCT00270738|randomized controlled trial|randomized controlled trial
697811|NCT00270725|HIV|hiv
697812|NCT00270725|AIDS|aids
697813|NCT00270725|Labor productivity|labor productivity
697814|NCT00270725|Antiretroviral therapy|antiretroviral therapy
697815|NCT00270725|South Africa|south africa
697816|NCT00270712|kidney|kidney
697817|NCT00270712|transplant|transplant
697818|NCT00270712|dysfunction|dysfunction
697819|NCT00270712|chronic|chronic
697820|NCT00270712|deterioration|deterioration
697821|NCT00270712|loss of function|loss of function
697822|NCT00270699|Dengue Vaccine|dengue vaccine
697823|NCT00270699|Dengue Virus|dengue virus
697824|NCT00270699|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
697825|NCT00270699|Dengue Shock Syndrome|dengue shock syndrome
697826|NCT00270686|Ehlers-Danlos Syndrome|ehlers-danlos syndrome
697827|NCT00270686|Stickler Syndrome|stickler syndrome
697828|NCT00270686|Marfan Syndrome|marfan syndrome
697829|NCT00270686|Genetics|genetics
697830|NCT00270686|Aneurysm|aneurysm
697831|NCT00270673|Lactate|lactate
697832|NCT00270673|Tissue hypoxia|tissue hypoxia
697833|NCT00270673|Intensive care|intensive care
697834|NCT00270673|Goal- directed therapy|goal- directed therapy
697835|NCT00270660|retraction pockets ear|retraction pockets ear
697836|NCT00270660|unsafe otitis media|unsafe otitis media
697837|NCT00270660|otitis media complications|otitis media complications
697838|NCT00270647|cancer|cancer
697839|NCT00270647|prostate cancer|prostate cancer
697840|NCT00270647|colorectal cancer|colorectal cancer
697841|NCT00270647|cardiovascular disease|cardiovascular disease
697842|NCT00270647|eye disease|eye disease
697843|NCT00270647|cognitive decline|cognitive decline
697844|NCT00270634|Randomized Controlled Trials|randomized controlled trials
697845|NCT00270634|Immunosuppression|immunosuppression
697846|NCT00270634|Adult|adult
697847|NCT00270634|Kidney Transplantation|kidney transplantation
697848|NCT00270634|Treatment Outcome|treatment outcome
697849|NCT00270608|Hypertension|hypertension
697850|NCT00270608|Peripheral vascular disease|peripheral vascular disease
697851|NCT00270608|Diabetes|diabetes
697852|NCT00270608|Total body fat percentage|total body fat percentage
697853|NCT00270556|Treatment Experienced|treatment experienced
697854|NCT00270543|Stomach Neoplasms|stomach neoplasms
697855|NCT00270530|Malaria|malaria
697856|NCT00270530|Placental diseases|placental diseases
697857|NCT00270530|Birth complications|birth complications
697858|NCT00270530|Plasmodium falciparum|plasmodium falciparum
697859|NCT00270530|Zambia|zambia
697860|NCT00270530|HIV-seropositive|hiv-seropositive
697861|NCT00270530|HIV|hiv
697862|NCT00270504|Memokath|memokath
697863|NCT00270504|Urethral stricture|urethral stricture
697864|NCT00270504|urethral stent|urethral stent
697865|NCT00270504|Bulbar urethral stricture|bulbar urethral stricture
697866|NCT00270478|Erythropoietin Therapy|erythropoietin therapy
697867|NCT00270478|Fetal Hemoglobin Induction|fetal hemoglobin induction
697868|NCT00270478|Sickle Cell Disease|sickle cell disease
697869|NCT00270478|Pulmonary Hypertension|pulmonary hypertension
697870|NCT00270478|Chronic Kidney Disease|chronic kidney disease
697871|NCT00270478|SCD|scd
697872|NCT00270465|HIV-positive|hiv-positive
697873|NCT00270465|Treatment Interruption|treatment interruption
697874|NCT00270465|Therapeutic Vaccine|therapeutic vaccine
697875|NCT00270465|HIV/AIDS|hiv/aids
697876|NCT00270465|Virologic Response|virologic response
697877|NCT00270465|HIV Positive|hiv positive
697878|NCT00270452|Myelodyplastic Syndrome (MDS)|myelodyplastic syndrome (mds)
697879|NCT00270452|Wilm's tumor-1|wilm's tumor-1
697880|NCT00270452|Proteinase-3|proteinase-3
697881|NCT00270452|Vaccine Therapy|vaccine therapy
697882|NCT00270452|Acute Myeloid Leukemia|acute myeloid leukemia
697883|NCT00270452|Chronic Myeloid Leukemias|chronic myeloid leukemias
697884|NCT00270452|Myelodysplastic Syndrome|myelodysplastic syndrome
697885|NCT00270452|MDS|mds
697886|NCT00270439|Obesity|obesity
697887|NCT00270439|Omentectomy|omentectomy
697888|NCT00270439|Diabetes Mellitus Type 2|diabetes mellitus type 2
697889|NCT00270439|Laparoscopic|laparoscopic
697890|NCT00270439|Dyslipidemia|dyslipidemia
697891|NCT00270426|Advanced Chronic Renal Insufficiency|advanced chronic renal insufficiency
697892|NCT00270426|Benazepril|benazepril
697893|NCT00270413|breast cancer|breast cancer
697894|NCT00270413|metastatic|metastatic
697895|NCT00270413|taxanes|taxanes
697896|NCT00270413|SU11248|su11248
697897|NCT00270400|Heart Failure|heart failure
697898|NCT00270400|Renal Dysfunction|renal dysfunction
697899|NCT00270400|Cardiomyopathy|cardiomyopathy
697900|NCT00270400|Heart Decompensation|heart decompensation
697901|NCT00270400|Dyspnea Paroxsymal.|dyspnea paroxsymal.
697902|NCT00270387|Acutely Decompensated Congestive Heart Failure|acutely decompensated congestive heart failure
697903|NCT00270387|Heart Failure|heart failure
697904|NCT00270387|Renal Impairment|renal impairment
697905|NCT00270387|Kidney Failure|kidney failure
697906|NCT00270387|Myocardial Infarction.|myocardial infarction.
697907|NCT00270374|Congestive heart failure|congestive heart failure
697908|NCT00270374|CHF|chf
697909|NCT00270374|Left-sided heart failure|left-sided heart failure
697910|NCT00270374|Right-sided heart failure|right-sided heart failure
697911|NCT00270374|Systolic Heart Failure|systolic heart failure
697912|NCT00270361|Heart Failure|heart failure
697913|NCT00270361|Renal Dysfunction|renal dysfunction
697914|NCT00270361|Cardiomyopathy|cardiomyopathy
697915|NCT00270361|Heart Decompensation|heart decompensation
697916|NCT00270361|Dyspnea Paroxsymal|dyspnea paroxsymal
697917|NCT00270361|Outpatient Therapy.|outpatient therapy.
697918|NCT00270348|Asthma|asthma
697919|NCT00270348|Safety|safety
697920|NCT00270348|Pediatrics|pediatrics
697921|NCT00270322|total knee replacement|total knee replacement
697922|NCT00270322|orthopedic surgery|orthopedic surgery
697923|NCT00270322|post operative analgesia|post operative analgesia
697924|NCT00270322|continuous epidural|continuous epidural
697925|NCT00270322|patients controlled analgesia|patients controlled analgesia
697926|NCT00270322|morphine|morphine
697927|NCT00270322|combined spinal epidural anesthesia|combined spinal epidural anesthesia
697928|NCT00270322|anesthesia|anesthesia
697929|NCT00270322|analgesia|analgesia
697930|NCT00270322|epidural marcaine|epidural marcaine
697931|NCT00270322|epidural fentanyl|epidural fentanyl
697932|NCT00270322|pain|pain
697933|NCT00270309|lower urinary tract symptoms, self-management|lower urinary tract symptoms, self-management
697934|NCT00270296|Treatment Naive|treatment naive
697935|NCT00270296|MTCT|mtct
697936|NCT00270296|HIV Seronegativity|hiv seronegativity
697937|NCT00270283|Anemia|anemia
697938|NCT00270283|AIDS|aids
697939|NCT00270283|erythropoietin|erythropoietin
697940|NCT00270283|epoetin alfa|epoetin alfa
697941|NCT00270283|Quality of Life|quality of life
697942|NCT00270283|Zidovudine|zidovudine
697943|NCT00270283|HIV|hiv
697944|NCT00270270|erythropoietin|erythropoietin
697945|NCT00270270|Anemia|anemia
697946|NCT00270270|Quality of Life|quality of life
697947|NCT00270270|epoetin alfa|epoetin alfa
697948|NCT00270270|HIV|hiv
697949|NCT00270270|Zidovudine|zidovudine
697950|NCT00270270|AIDS|aids
697951|NCT00270257|HIV Seronegativity|hiv seronegativity
697952|NCT00270257|Opiate Addiction|opiate addiction
697953|NCT00270257|Opiate Dependence|opiate dependence
697954|NCT00270244|Major Depression|major depression
697955|NCT00270244|Dysthymic Disorder|dysthymic disorder
697956|NCT00270244|Adjustment Disorder With Depressed Mood|adjustment disorder with depressed mood
697957|NCT00270244|Depressive Disorder Not Otherwise Specified|depressive disorder not otherwise specified
697958|NCT00270244|Adolescent|adolescent
697959|NCT00270244|Psychotherapy|psychotherapy
697960|NCT00270231|within-subjects, crossover, laboratory study|within-subjects, crossover, laboratory study
697961|NCT00270231|Naltrexone vs. Placebo|naltrexone vs. placebo
697962|NCT00270218|HIV Seronegativity|hiv seronegativity
697963|NCT00270218|Adenoviral Vector Vaccine|adenoviral vector vaccine
697964|NCT00270218|DNA Plasmid Vaccine|dna plasmid vaccine
697965|NCT00270205|Treatment Experienced|treatment experienced
697966|NCT00270205|HIV Therapeutic Vaccine|hiv therapeutic vaccine
697967|NCT00270192|Breastfeeding|breastfeeding
697968|NCT00270192|exclusive|exclusive
697969|NCT00270192|education|education
697970|NCT00270192|counseling|counseling
697971|NCT00270179|Anemia|anemia
697972|NCT00270179|blood transfusion|blood transfusion
697973|NCT00270179|epoetin alfa|epoetin alfa
697974|NCT00270179|erythropoietin|erythropoietin
697975|NCT00270179|surgery|surgery
697976|NCT00270179|self-blood donation|self-blood donation
697977|NCT00270166|cancer|cancer
697978|NCT00270166|malignancy|malignancy
697979|NCT00270166|red cell transfusion|red cell transfusion
697980|NCT00270166|epoetin alfa|epoetin alfa
697981|NCT00270166|epoetin|epoetin
697982|NCT00270166|erythropoietin|erythropoietin
697983|NCT00270166|red blood cells|red blood cells
697984|NCT00270153|renal transplant, ACE inhibitor|renal transplant, ace inhibitor
697985|NCT00270140|anemia|anemia
697986|NCT00270140|blood transfusion|blood transfusion
697987|NCT00270140|epoetin alfa|epoetin alfa
697988|NCT00270140|erythropoietin|erythropoietin
697989|NCT00270140|surgery|surgery
697990|NCT00270140|blood donation|blood donation
697991|NCT00270140|blood|blood
697992|NCT00270127|Anemia|anemia
697993|NCT00270127|cancer|cancer
697994|NCT00270127|quality of life|quality of life
697995|NCT00270127|chemotherapy|chemotherapy
697996|NCT00270127|hemoglobin|hemoglobin
697997|NCT00270127|transfusion|transfusion
697998|NCT00270127|epoetin alfa|epoetin alfa
697999|NCT00270127|epoetin|epoetin
698000|NCT00270127|erythropoietin|erythropoietin
698001|NCT00270114|Anemia|anemia
698002|NCT00270114|blood transfusion, autologous|blood transfusion, autologous
698003|NCT00270114|epoetin alfa|epoetin alfa
698004|NCT00270114|epogen|epogen
698005|NCT00270114|erythropoietin|erythropoietin
698006|NCT00270114|orthopedic procedures|orthopedic procedures
698007|NCT00270114|orthopedic surgery|orthopedic surgery
698008|NCT00270101|anemia|anemia
698009|NCT00270101|cancer|cancer
698010|NCT00270101|quality of life|quality of life
698011|NCT00270101|chemotherapy|chemotherapy
698012|NCT00270101|hemoglobin|hemoglobin
698013|NCT00270101|multiple myeloma|multiple myeloma
698014|NCT00270101|transfusion|transfusion
698015|NCT00270101|epoetin alfa|epoetin alfa
698016|NCT00270101|epoetin|epoetin
698017|NCT00270101|erythropoietin|erythropoietin
698018|NCT00270088|Anemia|anemia
698019|NCT00270088|blood transfusion|blood transfusion
698020|NCT00270088|epoetin alfa|epoetin alfa
698021|NCT00270088|epogen|epogen
698022|NCT00270088|erythropoietin|erythropoietin
698023|NCT00270088|orthopedic procedures|orthopedic procedures
698024|NCT00270088|orthopedic surgery|orthopedic surgery
698025|NCT00270075|epogen|epogen
698026|NCT00270075|erythropoietin|erythropoietin
698027|NCT00270075|orthopedic procedures|orthopedic procedures
698028|NCT00270075|orthopedic surgery|orthopedic surgery
698029|NCT00270075|cardiovascular surgical procedures|cardiovascular surgical procedures
698030|NCT00270075|Blood transfusion|blood transfusion
698031|NCT00270075|epoetin alfa|epoetin alfa
698032|NCT00270062|anemia|anemia
698033|NCT00270062|blood transfusion|blood transfusion
698034|NCT00270062|epoetin alfa|epoetin alfa
698035|NCT00270062|erythropoietin|erythropoietin
698036|NCT00270062|surgery|surgery
698037|NCT00270062|blood donation|blood donation
698038|NCT00270062|blood|blood
698039|NCT00270049|Anemia|anemia
698040|NCT00270049|cancer|cancer
698041|NCT00270049|leukemia|leukemia
698042|NCT00270049|chronic lymphocytic leukemia|chronic lymphocytic leukemia
698043|NCT00270049|lymphocytic leukemia|lymphocytic leukemia
698044|NCT00270049|epoetin alfa|epoetin alfa
698045|NCT00270049|erythropoietin|erythropoietin
698046|NCT00270049|red blood cells|red blood cells
698047|NCT00270049|transfusions|transfusions
698048|NCT00270049|quality of life|quality of life
698049|NCT00270036|Blood transfusion|blood transfusion
698050|NCT00270036|epoetin alfa|epoetin alfa
698051|NCT00270036|epogen|epogen
698052|NCT00270036|erythropoietin|erythropoietin
698053|NCT00270036|orthopedic procedures|orthopedic procedures
698054|NCT00270036|orthopedic surgery|orthopedic surgery
698055|NCT00270023|Blood transfusion|blood transfusion
698056|NCT00270023|epoetin alfa|epoetin alfa
698057|NCT00270023|epogen|epogen
698058|NCT00270023|erythropoietin|erythropoietin
698059|NCT00270023|orthopedic procedures|orthopedic procedures
698060|NCT00270023|orthopedic surgery|orthopedic surgery
698061|NCT00270023|cardiovascular surgical procedures|cardiovascular surgical procedures
698062|NCT00270023|breast reduction|breast reduction
698063|NCT00270010|Anemia|anemia
698064|NCT00270010|AIDS|aids
698065|NCT00270010|HIV|hiv
698066|NCT00270010|Zidovudine|zidovudine
698067|NCT00270010|Quality of Life|quality of life
698068|NCT00270010|erythropoietin|erythropoietin
698069|NCT00270010|epoetin alfa|epoetin alfa
698070|NCT00269997|Anemia|anemia
698071|NCT00269997|chemotherapy|chemotherapy
698072|NCT00269997|epoetin alfa|epoetin alfa
698073|NCT00269997|epogen|epogen
698074|NCT00269997|erythropoietin|erythropoietin
698075|NCT00269997|neoplasms|neoplasms
698076|NCT00269997|cancer|cancer
698077|NCT00269984|Anemia|anemia
698078|NCT00269984|Blood transfusion|blood transfusion
698079|NCT00269984|Epoetin alfa|epoetin alfa
698080|NCT00269984|Erythropoietin|erythropoietin
698081|NCT00269984|Neoplasm|neoplasm
698082|NCT00269984|Epogen|epogen
698083|NCT00269984|Cancer|cancer
698084|NCT00269971|hip replacement|hip replacement
698085|NCT00269971|hip replacement surgery|hip replacement surgery
698086|NCT00269971|surgery|surgery
698087|NCT00269971|anemia|anemia
698088|NCT00269971|transfusions|transfusions
698089|NCT00269971|blood|blood
698090|NCT00269971|blood transfusions|blood transfusions
698091|NCT00269958|hip replacement|hip replacement
698092|NCT00269958|hip replacement surgery|hip replacement surgery
698093|NCT00269958|surgery|surgery
698094|NCT00269958|anemia|anemia
698095|NCT00269958|transfusions|transfusions
698096|NCT00269958|blood transfusions|blood transfusions
698097|NCT00269945|Anemia|anemia
698098|NCT00269945|AIDS|aids
698099|NCT00269945|HIV|hiv
698100|NCT00269945|Zidovudine|zidovudine
698101|NCT00269945|Quality of Life|quality of life
698102|NCT00269945|erythropoietin|erythropoietin
698103|NCT00269945|epoetin alfa|epoetin alfa
698104|NCT00269932|Bronchitis|bronchitis
698105|NCT00269932|chronic bronchitis|chronic bronchitis
698106|NCT00269932|lung diseases|lung diseases
698107|NCT00269932|respiratory tract infections|respiratory tract infections
698108|NCT00269932|bronchial diseases|bronchial diseases
698109|NCT00269932|antibacterial agents|antibacterial agents
698110|NCT00269932|quinolones|quinolones
698111|NCT00269932|levofloxacin|levofloxacin
698112|NCT00269919|Schizophrenia|schizophrenia
698113|NCT00269919|Risperidone|risperidone
698114|NCT00269919|Risperidal Consta|risperidal consta
698115|NCT00269906|Angina, unstable|angina, unstable
698116|NCT00269906|Angioplasty, transluminal, percutaneous coronary|angioplasty, transluminal, percutaneous coronary
698117|NCT00269906|Abciximab|abciximab
698118|NCT00269893|Abciximab|abciximab
698119|NCT00269893|Angina, unstable|angina, unstable
698120|NCT00269893|Angioplasty, transluminal, Percutaneous coronary|angioplasty, transluminal, percutaneous coronary
698121|NCT00269880|Angioplasty, Transluminal, Percutaneous coronary|angioplasty, transluminal, percutaneous coronary
698122|NCT00269867|Rheumatoid Arthritis|rheumatoid arthritis
698123|NCT00269867|infliximab|infliximab
698124|NCT00269867|methotrexate|methotrexate
698125|NCT00269854|Crohn's Disease|crohn's disease
698126|NCT00269841|fistulae|fistulae
698127|NCT00269841|Crohn's Disease|crohn's disease
698128|NCT00269828|Non-small cell lung cancer|non-small cell lung cancer
698129|NCT00269828|NSCLC|nsclc
698130|NCT00269828|PS 2|ps 2
698131|NCT00269828|female|female
698132|NCT00269828|chemotherapy|chemotherapy
698133|NCT00269815|ADHD|adhd
698134|NCT00269815|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
698135|NCT00269815|OROS®|oros®
698136|NCT00269815|children|children
698137|NCT00269815|methylphenidate|methylphenidate
698138|NCT00269802|ADHD|adhd
698139|NCT00269802|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
698140|NCT00269802|OROS®|oros®
698141|NCT00269802|Ritalin®|ritalin®
698142|NCT00269802|children|children
698143|NCT00269802|methylphenidate|methylphenidate
698144|NCT00269789|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
698145|NCT00269789|OROS®|oros®
698146|NCT00269789|Ritalin®|ritalin®
698147|NCT00269789|children|children
698148|NCT00269789|methylphenidate|methylphenidate
698149|NCT00269789|ADHD|adhd
698150|NCT00269776|ADHD|adhd
698151|NCT00269776|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
698152|NCT00269776|OROS|oros
698153|NCT00269776|children|children
698154|NCT00269776|methylphenidate|methylphenidate
698155|NCT00269776|Ritalin|ritalin
698156|NCT00269763|patch|patch
698157|NCT00269763|pain|pain
698158|NCT00269763|fentanyl|fentanyl
698159|NCT00269763|narcotic|narcotic
698160|NCT00269763|Cancer|cancer
698161|NCT00269750|Ditropan®|ditropan®
698162|NCT00269750|OROS®|oros®
698163|NCT00269750|urge|urge
698164|NCT00269750|oxybutynin|oxybutynin
698165|NCT00269750|mixed urinary incontinence|mixed urinary incontinence
698166|NCT00269737|fentanyl|fentanyl
698167|NCT00269737|pain|pain
698168|NCT00269737|Cancer|cancer
698169|NCT00269737|patch|patch
698170|NCT00269724|urinary incontinence|urinary incontinence
698171|NCT00269724|oxybutynin|oxybutynin
698172|NCT00269724|OROS®|oros®
698173|NCT00269685|Septic shock|septic shock
698174|NCT00269685|catecholamine|catecholamine
698175|NCT00269685|vasopressin|vasopressin
698176|NCT00269685|tonometria|tonometria
698177|NCT00269685|lactate|lactate
698178|NCT00269672|vaccine|vaccine
698179|NCT00269659|Left Bundle Branch Block|left bundle branch block
698180|NCT00269659|Regional cardiac function|regional cardiac function
698181|NCT00269659|Global cardiac function|global cardiac function
698182|NCT00269659|Mechanical asynchrony|mechanical asynchrony
698183|NCT00269659|Echocardiography|echocardiography
698184|NCT00269659|2D echocardiography|2d echocardiography
698185|NCT00269659|Tissue Doppler Imaging|tissue doppler imaging
698186|NCT00269659|Real-time 3D echocardiography|real-time 3d echocardiography
698187|NCT00269659|Cardiovascular Magnetic Resonance Imaging-tagging|cardiovascular magnetic resonance imaging-tagging
698188|NCT00269646|Diet|diet
698189|NCT00269646|Low-carbohydrate|low-carbohydrate
698190|NCT00269646|Insulin|insulin
698191|NCT00269646|Dietary fiber|dietary fiber
698192|NCT00269646|Diabetes|diabetes
698193|NCT00269646|Cardiovascular disease|cardiovascular disease
698194|NCT00269633|Seasonal Affective Disorder|seasonal affective disorder
698195|NCT00269620|contraceptive vaginal ring|contraceptive vaginal ring
698196|NCT00269620|contraceptive patch|contraceptive patch
698197|NCT00269620|oral contraceptives|oral contraceptives
698198|NCT00269620|acceptability|acceptability
698199|NCT00269607|Substance abuse|substance abuse
698200|NCT00269607|Treatment|treatment
698201|NCT00269607|Relapse prevention|relapse prevention
698202|NCT00269607|opioid antagonist|opioid antagonist
698203|NCT00269594|Skin|skin
698204|NCT00269594|Picking|picking
698205|NCT00269594|Pick|pick
698206|NCT00269594|Neurotic Excoriation|neurotic excoriation
698207|NCT00269581|migraine|migraine
698208|NCT00269581|tension headaches|tension headaches
698209|NCT00269581|chronic daily headaches|chronic daily headaches
698210|NCT00269568|medical abortion|medical abortion
698211|NCT00269568|mifepristone|mifepristone
698212|NCT00269568|misoprostol|misoprostol
698213|NCT00269555|Prostate|prostate
698214|NCT00269555|Cancer|cancer
698215|NCT00269555|Prostate Specific Antigen|prostate specific antigen
698216|NCT00269555|C04.588.945.440.770|c04.588.945.440.770
698217|NCT00269542|zinc supplementation|zinc supplementation
698218|NCT00269542|hospitalisations|hospitalisations
698219|NCT00269542|children|children
698220|NCT00269542|mortality|mortality
698221|NCT00269542|iron folic acid|iron folic acid
698222|NCT00269529|postoperative pain|postoperative pain
698223|NCT00269529|knee arthroplasty|knee arthroplasty
698224|NCT00269529|analgesia|analgesia
698225|NCT00269529|infiltration|infiltration
698226|NCT00269529|femoral nerve block|femoral nerve block
698227|NCT00269516|Parkinson's disease|parkinson's disease
698228|NCT00269490|Post-Traumatic Stress Disorder|post-traumatic stress disorder
698229|NCT00269490|Yoga Nidra|yoga nidra
698230|NCT00269477|Meningitis|meningitis
698231|NCT00269477|Meningococcal infection|meningococcal infection
698232|NCT00269477|Neisseria meningitidis|neisseria meningitidis
698233|NCT00269477|Menactra®|menactra®
698234|NCT00269477|Menomune®|menomune®
698235|NCT00269425|Cardiovascular disease|cardiovascular disease
698236|NCT00269425|Nutrition|nutrition
698237|NCT00269425|Mediterranean diet|mediterranean diet
698238|NCT00269425|Low fat diet|low fat diet
698239|NCT00269425|American Heart Association diet|american heart association diet
698240|NCT00269425|Monounsaturated fats|monounsaturated fats
698241|NCT00269425|Omega-3 fats|omega-3 fats
698242|NCT00269425|Outcomes|outcomes
698243|NCT00269412|Irritable bowel syndrome|irritable bowel syndrome
698244|NCT00269399|Clostridium difficile-associated Diarrhea (CDAD)|clostridium difficile-associated diarrhea (cdad)
698245|NCT00269399|CDAD|cdad
698246|NCT00269399|C diff|c diff
698247|NCT00269386|Clarithromycin|clarithromycin
698248|NCT00269386|Crohn's|crohn's
698249|NCT00269373|Unknown primary tumor|unknown primary tumor
698250|NCT00269373|PET-CT|pet-ct
698251|NCT00269360|Chiropractic|chiropractic
698252|NCT00269360|Manual Therapies|manual therapies
698253|NCT00269360|Exercise|exercise
698254|NCT00269360|Randomized|randomized
698255|NCT00269360|Clinical Trial|clinical trial
698256|NCT00269360|Neck Pain|neck pain
698257|NCT00269347|Chiropractic|chiropractic
698258|NCT00269347|Manual Therapy|manual therapy
698259|NCT00269347|Exercise|exercise
698260|NCT00269347|Randomized|randomized
698261|NCT00269347|Clinical Trial|clinical trial
698262|NCT00269347|Back Pain|back pain
698263|NCT00269334|antidepressant,major depression,CYP2D6,CYP2C19,SSRI|antidepressant,major depression,cyp2d6,cyp2c19,ssri
698264|NCT00269321|Randomized|randomized
698265|NCT00269321|Clinical Trial|clinical trial
698266|NCT00269321|Low Back Pain|low back pain
698267|NCT00269321|Chiropractic|chiropractic
698268|NCT00269321|Manual Therapies|manual therapies
698269|NCT00269321|Exercise|exercise
698270|NCT00269308|Randomized|randomized
698271|NCT00269308|Clinical Trial|clinical trial
698272|NCT00269308|Neck Pain|neck pain
698273|NCT00269308|Chiropractic|chiropractic
698274|NCT00269308|Manual Therapies|manual therapies
698275|NCT00269308|Exercise|exercise
698276|NCT00269295|Typhoid fever, S typhi, vaccine|typhoid fever, s typhi, vaccine
698277|NCT00269230|cardiac resynchronization therapy, left ventricular Lead, Heart Failure|cardiac resynchronization therapy, left ventricular lead, heart failure
698278|NCT00269191|Arcoxia|arcoxia
698279|NCT00269178|malaria|malaria
698280|NCT00269178|knowledge attitudes and practice (KAP)|knowledge attitudes and practice (kap)
698281|NCT00269178|bednets|bednets
698282|NCT00269178|peer health education|peer health education
698283|NCT00269139|Behavioral crisis|behavioral crisis
698284|NCT00269139|Perception of social crisis|perception of social crisis
698285|NCT00269139|Repetition compulsion|repetition compulsion
698286|NCT00269139|Intrusive mental events|intrusive mental events
698287|NCT00269139|Uncontrollable urges|uncontrollable urges
698288|NCT00269126|COPD|copd
698289|NCT00269126|Chronic Bronchitis|chronic bronchitis
698291|NCT00269100|Debridement|debridement
698292|NCT00269087|Chronic Bronchitis|chronic bronchitis
698293|NCT00269087|COPD|copd
698294|NCT00269087|Emphysema|emphysema
698295|NCT00269061|pioglitazone|pioglitazone
698296|NCT00269061|diabetes|diabetes
698297|NCT00269061|fluid|fluid
698298|NCT00269048|CHD|chd
698299|NCT00269048|Lp-PLA2|lp-pla2
698300|NCT00269048|SB-480848|sb-480848
698301|NCT00269035|SB-773812|sb-773812
698302|NCT00269035|SPECT|spect
698303|NCT00269035|D2 RO|d2 ro
698304|NCT00269035|pharmacokinetics|pharmacokinetics
698305|NCT00269035|schizophrenic patients|schizophrenic patients
698306|NCT00269035|5HT2A RO|5ht2a ro
698307|NCT00269022|SB-705498 acute migraine single dose TRPV1 combination inpatient outpatient study|sb-705498 acute migraine single dose trpv1 combination inpatient outpatient study
698308|NCT00269009|Tobacco use|tobacco use
698309|NCT00268996|Coronary artery disease|coronary artery disease
698310|NCT00268996|Lipoprotein-associated Phospholipase A2|lipoprotein-associated phospholipase a2
698311|NCT00268996|palpography|palpography
698312|NCT00268996|hs-CRP|hs-crp
698313|NCT00268996|endothelial function|endothelial function
698314|NCT00268996|intravascular ultrasound|intravascular ultrasound
698315|NCT00268983|rituximab|rituximab
698316|NCT00268983|tositumomab and iodine I 131 tositumomab|tositumomab and iodine i 131 tositumomab
698317|NCT00268983|non-Hodgkins lymphoma|non-hodgkins lymphoma
698318|NCT00268983|radioimmunotherapy|radioimmunotherapy
698319|NCT00268983|anti-B1 antibody|anti-b1 antibody
698320|NCT00268983|Bexxar|bexxar
698321|NCT00268983|NHL|nhl
698322|NCT00268983|Tositumomab|tositumomab
698323|NCT00268970|Advanced non-small cell lung cancer (NSCLC)|advanced non-small cell lung cancer (nsclc)
698324|NCT00268957|Chronic|chronic
698325|NCT00268957|Hemodialysis|hemodialysis
698326|NCT00268957|Kidney|kidney
698327|NCT00268957|Hyperphosphatemia|hyperphosphatemia
698328|NCT00268957|Chronic kidney disease|chronic kidney disease
698329|NCT00268957|Chronic Renal Insufficiency|chronic renal insufficiency
698330|NCT00268944|Glycogen Storage Disease Type II|glycogen storage disease type ii
698331|NCT00268944|GSD-II|gsd-ii
698332|NCT00268944|Pompe Disease|pompe disease
698333|NCT00268931|premature birth|premature birth
698334|NCT00268931|motor skills|motor skills
698335|NCT00268931|learning|learning
698336|NCT00268931|reaching|reaching
698337|NCT00268918|PTK787|ptk787
698338|NCT00268918|Metastatic breast cancer|metastatic breast cancer
698339|NCT00268918|Refractory gynecological cancer|refractory gynecological cancer
698340|NCT00268892|Prostate Cancer|prostate cancer
698341|NCT00268892|Androgen ablation therapy|androgen ablation therapy
698342|NCT00268879|Irritable bowel syndrome|irritable bowel syndrome
698343|NCT00268879|Constipation-predominant irritable bowel syndrome|constipation-predominant irritable bowel syndrome
698344|NCT00268853|lymphoma|lymphoma
698345|NCT00268853|NHL|nhl
698346|NCT00268853|large cell|large cell
698347|NCT00268853|phase II|phase ii
698348|NCT00268853|CHOP R|chop r
698349|NCT00268853|CPOP R|cpop r
698350|NCT00268853|non Hodgkins|non hodgkins
698351|NCT00268840|Pancreas or biliary cancer|pancreas or biliary cancer
698352|NCT00268827|Kaletra|kaletra
698353|NCT00268827|Comparison|comparison
698354|NCT00268827|Quality of Life|quality of life
698355|NCT00268827|African American|african american
698356|NCT00268788|multifocal motor neuropathy|multifocal motor neuropathy
698357|NCT00268788|subcutaneous|subcutaneous
698358|NCT00268788|IVIG|ivig
698359|NCT00268788|gammaglobulin|gammaglobulin
698360|NCT00268775|community pharmacy services|community pharmacy services
698361|NCT00268775|patient care|patient care
698362|NCT00268775|outcome assessment|outcome assessment
698363|NCT00268775|benzodiazepines therapeutic use|benzodiazepines therapeutic use
698364|NCT00268762|stroke|stroke
698365|NCT00268762|thrombin inhibition|thrombin inhibition
698366|NCT00268762|thrombolysis|thrombolysis
698367|NCT00268762|bleeding|bleeding
698368|NCT00268762|outcome|outcome
698369|NCT00268697|Hyperlipidemia|hyperlipidemia
698370|NCT00268697|Drug Therapy|drug therapy
698371|NCT00268658|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
698372|NCT00268658|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
698373|NCT00268658|Arthroscopy|arthroscopy
698374|NCT00268606|fibromyalgia|fibromyalgia
698375|NCT00268606|cognitive-behavioral therapy|cognitive-behavioral therapy
698376|NCT00268606|tailored treatment|tailored treatment
698377|NCT00268593|heparanase|heparanase
698378|NCT00268593|angiogenesis|angiogenesis
698379|NCT00268580|Asthma|asthma
698380|NCT00268580|Care map|care map
698381|NCT00268580|Clinical pathway|clinical pathway
698382|NCT00268580|Education|education
698383|NCT00268580|Emergency department|emergency department
698384|NCT00268554|adenosine|adenosine
698385|NCT00268554|caffeine|caffeine
698386|NCT00268554|dipyridamole|dipyridamole
698387|NCT00268541|exercise|exercise
698388|NCT00268541|physical activity|physical activity
698389|NCT00268541|insulin resistance|insulin resistance
698390|NCT00268541|adipose tissue|adipose tissue
698391|NCT00268541|gene expression|gene expression
698392|NCT00268502|fatigue|fatigue
698393|NCT00268502|depression|depression
698394|NCT00268502|spiritual concerns|spiritual concerns
698395|NCT00268502|sexual dysfunction|sexual dysfunction
698396|NCT00268502|sleep disorders|sleep disorders
698397|NCT00268502|cancer survivor|cancer survivor
698398|NCT00268502|stage IA breast cancer|stage ia breast cancer
698399|NCT00268502|stage IB breast cancer|stage ib breast cancer
698400|NCT00268502|stage II breast cancer|stage ii breast cancer
698401|NCT00268502|stage IIIA breast cancer|stage iiia breast cancer
698402|NCT00268502|stage IIIB breast cancer|stage iiib breast cancer
698403|NCT00268502|stage IIIC breast cancer|stage iiic breast cancer
698404|NCT00268489|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
698405|NCT00268489|squamous cell lung cancer|squamous cell lung cancer
698406|NCT00268489|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
698407|NCT00268489|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
698408|NCT00268476|Stage III Prostate Cancer|stage iii prostate cancer
698409|NCT00268476|Stage IV Prostate Cancer|stage iv prostate cancer
698410|NCT00268476|Recurrent Prostate Cancer|recurrent prostate cancer
698411|NCT00268476|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
698412|NCT00268463|liver metastases|liver metastases
698413|NCT00268463|stage IV colon cancer|stage iv colon cancer
698414|NCT00268463|stage IV rectal cancer|stage iv rectal cancer
698415|NCT00268463|adenocarcinoma of the colon|adenocarcinoma of the colon
698416|NCT00268463|adenocarcinoma of the rectum|adenocarcinoma of the rectum
698417|NCT00268450|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
698418|NCT00268450|stage III bladder cancer|stage iii bladder cancer
698419|NCT00268450|stage II bladder cancer|stage ii bladder cancer
698420|NCT00268450|recurrent bladder cancer|recurrent bladder cancer
698421|NCT00268437|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
698422|NCT00268437|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
698423|NCT00268437|stage III esophageal cancer|stage iii esophageal cancer
698424|NCT00268437|stage II esophageal cancer|stage ii esophageal cancer
698425|NCT00268411|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
698426|NCT00268411|stage IV pancreatic cancer|stage iv pancreatic cancer
698427|NCT00268398|adenocarcinoma of the colon|adenocarcinoma of the colon
698428|NCT00268398|stage IV colon cancer|stage iv colon cancer
698429|NCT00268398|adenocarcinoma of the rectum|adenocarcinoma of the rectum
698430|NCT00268398|stage IV rectal cancer|stage iv rectal cancer
698431|NCT00268398|resectable metastases|resectable metastases
698432|NCT00268372|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
698433|NCT00268372|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
698434|NCT00268359|adult anaplastic astrocytoma|adult anaplastic astrocytoma
698435|NCT00268359|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
698436|NCT00268359|adult glioblastoma|adult glioblastoma
698437|NCT00268359|adult gliosarcoma|adult gliosarcoma
698438|NCT00268359|recurrent adult brain tumor|recurrent adult brain tumor
698439|NCT00268359|adult giant cell glioblastoma|adult giant cell glioblastoma
698440|NCT00268346|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
698441|NCT00268346|recurrent esophageal cancer|recurrent esophageal cancer
698442|NCT00268346|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
698443|NCT00268346|stage IV esophageal cancer|stage iv esophageal cancer
698444|NCT00268333|adenocarcinoma of the colon|adenocarcinoma of the colon
698445|NCT00268333|adenocarcinoma of the rectum|adenocarcinoma of the rectum
698446|NCT00268333|stage IV colon cancer|stage iv colon cancer
698447|NCT00268333|stage III colon cancer|stage iii colon cancer
698448|NCT00268333|stage III rectal cancer|stage iii rectal cancer
698449|NCT00268333|stage IV rectal cancer|stage iv rectal cancer
698450|NCT00268320|congestive heart failure, atrial arrhythmia, cardiac resynchronization therapy, implantable cardioverter defibrillator|congestive heart failure, atrial arrhythmia, cardiac resynchronization therapy, implantable cardioverter defibrillator
698451|NCT00268307|Cell therapy|cell therapy
698452|NCT00268294|cardiac resynchronization therapy, atrial arrhythmia|cardiac resynchronization therapy, atrial arrhythmia
698453|NCT00268281|cardiac resynchronization therapy|cardiac resynchronization therapy
698454|NCT00268255|stage I non-small cell lung cancer|stage i non-small cell lung cancer
698455|NCT00268255|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
698456|NCT00268255|adenosquamous cell lung cancer|adenosquamous cell lung cancer
698457|NCT00268255|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
698458|NCT00268255|large cell lung cancer|large cell lung cancer
698459|NCT00268255|squamous cell lung cancer|squamous cell lung cancer
698460|NCT00268255|adenocarcinoma of the lung|adenocarcinoma of the lung
698461|NCT00268242|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
698462|NCT00268242|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
698463|NCT00268242|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
698464|NCT00268242|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
698465|NCT00268242|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
698466|NCT00268242|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
698653|NCT00267553|Letrozole|letrozole
698467|NCT00268242|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
698468|NCT00268242|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
698469|NCT00268242|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
698470|NCT00268242|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
698471|NCT00268242|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
698472|NCT00268242|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
698473|NCT00268242|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
698474|NCT00268242|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
698475|NCT00268229|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
698476|NCT00268229|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
698477|NCT00268229|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
698478|NCT00268229|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
698479|NCT00268229|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
698480|NCT00268229|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
698481|NCT00268229|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
698482|NCT00268229|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
698483|NCT00268229|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
698484|NCT00268229|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
698485|NCT00268229|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
698486|NCT00268229|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
698487|NCT00268229|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
698488|NCT00268229|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
698489|NCT00268216|mortality|mortality
698490|NCT00268216|TORCH|torch
698491|NCT00268216|SERETIDE|seretide
698492|NCT00268216|ADVAIR|advair
698493|NCT00268216|COPD|copd
698494|NCT00268203|expanded access study|expanded access study
698495|NCT00268203|refractory low-grade non-Hodgkin's Lymphoma|refractory low-grade non-hodgkin's lymphoma
698496|NCT00268203|Bexxar®|bexxar®
698497|NCT00268203|Iodine I 131 Tositumomab|iodine i 131 tositumomab
698498|NCT00268203|EAP|eap
698499|NCT00268203|relapsed low-grade non-Hodgkin's lymphoma|relapsed low-grade non-hodgkin's lymphoma
698500|NCT00268177|Airways|airways
698501|NCT00268177|Pulmonary|pulmonary
698502|NCT00268177|Obstructive|obstructive
698503|NCT00268177|Chronic|chronic
698504|NCT00268177|inflammation|inflammation
698505|NCT00268177|salmeterol/fluticasone propionate|salmeterol/fluticasone propionate
698506|NCT00268151|non-small cell lung cancer|non-small cell lung cancer
698507|NCT00268151|oxaliplatin|oxaliplatin
698508|NCT00268151|capecitabine|capecitabine
698509|NCT00268151|XELOX-RT|xelox-rt
698510|NCT00268138|amine fluoride|amine fluoride
698511|NCT00268138|white spot lesions|white spot lesions
698512|NCT00268138|qlf|qlf
698513|NCT00268125|Breast Neoplasm|breast neoplasm
698514|NCT00268125|FEC100|fec100
698515|NCT00268125|Chemotherapy|chemotherapy
698516|NCT00268125|acupression|acupression
698517|NCT00268125|bracelet|bracelet
698518|NCT00268125|nausea|nausea
698519|NCT00268125|vomiting|vomiting
698520|NCT00268112|pediatric|pediatric
698521|NCT00268112|cardiac|cardiac
698522|NCT00268112|ALCAPA|alcapa
698523|NCT00268112|Tissue Doppler Imaging|tissue doppler imaging
698524|NCT00268099|pediatric|pediatric
698525|NCT00268099|cardiac|cardiac
698526|NCT00268099|repair of right to left shunt lesions|repair of right to left shunt lesions
698527|NCT00268099|Tetralogy of Fallot defects|tetralogy of fallot defects
698528|NCT00268086|constrictive pericarditis|constrictive pericarditis
698529|NCT00268086|adult congenital patients|adult congenital patients
698530|NCT00268086|pulmonary insufficiency|pulmonary insufficiency
698531|NCT00268073|Pediatric|pediatric
698532|NCT00268073|cardiac|cardiac
698533|NCT00268073|neo-aortic insufficience|neo-aortic insufficience
698534|NCT00268073|Norwood standard Stage I procedure|norwood standard stage i procedure
698535|NCT00268073|Norwood Sano procedure|norwood sano procedure
698536|NCT00268060|pediatric|pediatric
698537|NCT00268060|cardiac|cardiac
698538|NCT00268060|Long QT Syndrome|long qt syndrome
698539|NCT00268060|Pacemaker|pacemaker
698540|NCT00268060|Herg mutation|herg mutation
698541|NCT00268047|pediatric|pediatric
698542|NCT00268047|cardiac|cardiac
698543|NCT00268047|surgery|surgery
698544|NCT00268047|transplantation|transplantation
698545|NCT00268047|pulmonary vascular resistance in Fontan patients|pulmonary vascular resistance in fontan patients
698546|NCT00268034|pediatric|pediatric
698547|NCT00268034|cardiac|cardiac
698548|NCT00268034|aneurysms|aneurysms
698549|NCT00268034|left ventricular aneurysms|left ventricular aneurysms
698550|NCT00268034|surgical repair for LV aneurysms|surgical repair for lv aneurysms
698551|NCT00268021|pediatric|pediatric
698552|NCT00268021|biventricular pacemaker|biventricular pacemaker
698654|NCT00267553|Lobular breast carcinoma|lobular breast carcinoma
698553|NCT00268021|automated implantable cardioverter defibrillator|automated implantable cardioverter defibrillator
698554|NCT00268021|AICD|aicd
698555|NCT00268008|aortic valve replacement|aortic valve replacement
698556|NCT00268008|mitral valve replacement|mitral valve replacement
698557|NCT00268008|valvular stenosis|valvular stenosis
698558|NCT00268008|Ross procedure|ross procedure
698559|NCT00268008|Homograft valves|homograft valves
698560|NCT00268008|Bio-prosthetic valves|bio-prosthetic valves
698561|NCT00268008|Mechanical valves|mechanical valves
698562|NCT00267995|Pediatric|pediatric
698563|NCT00267995|cardiac|cardiac
698564|NCT00267995|Ross procedure|ross procedure
698565|NCT00267995|Aortic valve replacement|aortic valve replacement
698566|NCT00267995|Proximal buttressing technique|proximal buttressing technique
698567|NCT00267982|pediatric|pediatric
698568|NCT00267982|cardiac|cardiac
698569|NCT00267982|Radiofrequency Ablation|radiofrequency ablation
698570|NCT00267982|Ectopic Atrial Tachycardia|ectopic atrial tachycardia
698571|NCT00267969|Ustekinumab|ustekinumab
698572|NCT00267969|CNTO1275|cnto1275
698573|NCT00267969|Plaque type Psoriasis|plaque type psoriasis
698574|NCT00267969|Interleukin-23|interleukin-23
698575|NCT00267969|IL-23|il-23
698576|NCT00267969|Psoriasis|psoriasis
698577|NCT00267969|Interleukin 12|interleukin 12
698578|NCT00267969|IL-12|il-12
698579|NCT00267956|Psoriatic arthritis|psoriatic arthritis
698580|NCT00267956|CNTO 1275|cnto 1275
698581|NCT00267956|Ustekinumab|ustekinumab
698582|NCT00267956|Interleukin-23, IL-12, IL-23|interleukin-23, il-12, il-23
698583|NCT00267956|Monoclonal antibodies|monoclonal antibodies
698584|NCT00267930|AFib|afib
698585|NCT00267930|AF|af
698586|NCT00267904|Normal Physiology|normal physiology
698587|NCT00267904|Catecholamines|catecholamines
698588|NCT00267904|Catechols|catechols
698589|NCT00267904|Healthy Volunteer|healthy volunteer
698590|NCT00267904|HV|hv
698591|NCT00267891|Healthy Control Subjects|healthy control subjects
698592|NCT00267891|Aggression|aggression
698593|NCT00267891|Prefrontal Cortex Function|prefrontal cortex function
698594|NCT00267891|Children and Adolescents|children and adolescents
698595|NCT00267891|Healthy Volunteer|healthy volunteer
698596|NCT00267891|HV|hv
698597|NCT00267865|HIV|hiv
698598|NCT00267865|AIDS-Related-Primary Central Nervous System Lymphoma|aids-related-primary central nervous system lymphoma
698599|NCT00267865|High Dose Methotrexate|high dose methotrexate
698600|NCT00267865|Rituximab|rituximab
698601|NCT00267865|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
698602|NCT00267865|AIDS Related-Primary Central Nervous System Lymphoma|aids related-primary central nervous system lymphoma
698603|NCT00267865|AR-PCNSL|ar-pcnsl
698604|NCT00267852|Arthritis|arthritis
698605|NCT00267839|exercise|exercise
698606|NCT00267839|intervention|intervention
698607|NCT00267839|elderly woman|elderly woman
698608|NCT00267839|risk factors|risk factors
698609|NCT00267839|health costs|health costs
698610|NCT00267839|Osteoporosis|osteoporosis
698611|NCT00267839|cardiovascular diseases|cardiovascular diseases
698612|NCT00267839|diabetes|diabetes
698613|NCT00267839|Higher Age|higher age
698614|NCT00267826|Anti-CD20 antibody treatment|anti-cd20 antibody treatment
698615|NCT00267826|Atopic dermatitis|atopic dermatitis
698616|NCT00267826|B cells|b cells
698617|NCT00267826|Cytokines|cytokines
698618|NCT00267826|Immunopathology|immunopathology
698619|NCT00267813|craving|craving
698620|NCT00267813|nicotine|nicotine
698621|NCT00267813|imaging|imaging
698622|NCT00267813|FDG|fdg
698623|NCT00267813|PET|pet
698624|NCT00267813|smoking|smoking
698625|NCT00267813|Bupropion|bupropion
698626|NCT00267800|Lung disease, Interstitial|lung disease, interstitial
698627|NCT00267800|Sarcoidosis|sarcoidosis
698628|NCT00267800|Pulmonary fibrosis|pulmonary fibrosis
698629|NCT00267735|pregnancy|pregnancy
698630|NCT00267735|repeat cesarean|repeat cesarean
698631|NCT00267735|vaginal birth after cesarean|vaginal birth after cesarean
698632|NCT00267696|ovarian cancer|ovarian cancer
698633|NCT00267696|platinum sensitive cancer|platinum sensitive cancer
698634|NCT00267696|fallopian tube cancer|fallopian tube cancer
698635|NCT00267696|peritoneal cancer|peritoneal cancer
698636|NCT00267670|Fatty Liver Disease|fatty liver disease
698637|NCT00267670|Liver|liver
698638|NCT00267670|NASH|nash
698639|NCT00267670|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
698640|NCT00267670|Nonalcoholic Fatty Liver Disease (NAFLD)|nonalcoholic fatty liver disease (nafld)
698641|NCT00267670|Pentoxifylline|pentoxifylline
698642|NCT00267644|Children, dehydration, Ultrasound|children, dehydration, ultrasound
698643|NCT00267631|children, obesity, emergency medicine|children, obesity, emergency medicine
698644|NCT00267553|Atamestane|atamestane
698645|NCT00267553|Breast neoplasms|breast neoplasms
698646|NCT00267553|Combined hormonal therapy|combined hormonal therapy
698647|NCT00267553|Complete estrogen blockade|complete estrogen blockade
698648|NCT00267553|Ductal breast carcinoma|ductal breast carcinoma
698649|NCT00267553|Estrogen blocker|estrogen blocker
698650|NCT00267553|Fareston®|fareston®
698651|NCT00267553|Femara®|femara®
698652|NCT00267553|First line therapy|first line therapy
698655|NCT00267553|Locally advanced breast cancer|locally advanced breast cancer
698656|NCT00267553|Locally recurrent breast cancer|locally recurrent breast cancer
698657|NCT00267553|Maximal estrogen inhibition|maximal estrogen inhibition
698658|NCT00267553|Metastatic breast cancer|metastatic breast cancer
698659|NCT00267553|Neoplasms, Hormone-dependent|neoplasms, hormone-dependent
698660|NCT00267553|Receptor-positive|receptor-positive
698661|NCT00267553|Stage IIIA breast cancer|stage iiia breast cancer
698662|NCT00267553|Stage IIIB breast cancer|stage iiib breast cancer
698663|NCT00267553|Stage IV breast cancer|stage iv breast cancer
698664|NCT00267553|Toremifene|toremifene
698665|NCT00267540|Vitamin D|vitamin d
698666|NCT00267540|adolescent girls|adolescent girls
698667|NCT00267540|bone accretion|bone accretion
698668|NCT00267540|bone turn over|bone turn over
698669|NCT00267540|vitamin D status|vitamin d status
698670|NCT00267540|Vitamin D insufficiency in young girls|vitamin d insufficiency in young girls
698671|NCT00267527|Treatment Experienced|treatment experienced
698672|NCT00267527|HIV Visceral Obesity|hiv visceral obesity
698673|NCT00267514|Hemodialysis|hemodialysis
698674|NCT00267501|Eosinophilic Disorders|eosinophilic disorders
698675|NCT00267488|Hycamtin|hycamtin
698676|NCT00267488|endometrial cancer|endometrial cancer
698677|NCT00267488|topotecan|topotecan
698678|NCT00267475|eosinophilic esophagitis|eosinophilic esophagitis
698679|NCT00267475|eosinophilic gastritis|eosinophilic gastritis
698680|NCT00267475|eosinophilic enteritis|eosinophilic enteritis
698681|NCT00267475|eosinophilic colitis|eosinophilic colitis
698682|NCT00267475|eosinophilic gastroenteritis|eosinophilic gastroenteritis
698683|NCT00267462|pediatric|pediatric
698684|NCT00267462|cardiac|cardiac
698685|NCT00267462|hypertrophic Myopathy|hypertrophic myopathy
698686|NCT00267449|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
698687|NCT00267449|Mammography|mammography
698688|NCT00267449|Breast Cancer|breast cancer
698689|NCT00267436|adaptation|adaptation
698690|NCT00267436|HIV prevention|hiv prevention
698691|NCT00267436|HIV positive|hiv positive
698692|NCT00267436|evidence based interventions|evidence based interventions
698693|NCT00267436|HIV Seronegativity|hiv seronegativity
698694|NCT00267423|pediatric|pediatric
698695|NCT00267423|cardiac|cardiac
698696|NCT00267423|electrophysiology|electrophysiology
698697|NCT00267423|epicardial biventricular pacing|epicardial biventricular pacing
698698|NCT00267410|HIV|hiv
698699|NCT00267410|Adaptation|adaptation
698700|NCT00267410|Behavioral interventions|behavioral interventions
698701|NCT00267410|Seropositive|seropositive
698702|NCT00267410|MSM|msm
698703|NCT00267410|HIV Seronegativity|hiv seronegativity
698704|NCT00267397|infant|infant
698705|NCT00267397|prenatal|prenatal
698706|NCT00267397|birth defects|birth defects
698707|NCT00267397|22Q11 deletion|22q11 deletion
698708|NCT00267384|Aminoglycosides|aminoglycosides
698709|NCT00267371|Migraine headache|migraine headache
698710|NCT00267371|Patent Foramen Ovale|patent foramen ovale
698711|NCT00267371|Patent Foramen Ovale Closure|patent foramen ovale closure
698712|NCT00267332|Sedation|sedation
698713|NCT00267332|Pain|pain
698714|NCT00267332|modafinil|modafinil
698715|NCT00267332|opioids|opioids
698716|NCT00267293|fever treatment|fever treatment
698717|NCT00267293|children|children
698718|NCT00267241|ARDS|ards
698719|NCT00267241|ALI|ali
698720|NCT00267241|respiratory mechanics|respiratory mechanics
698721|NCT00267241|gas exchange|gas exchange
698722|NCT00267241|assisted ventilation|assisted ventilation
698723|NCT00267228|Anorexia Nervosa|anorexia nervosa
698724|NCT00267228|Eating disorder|eating disorder
698725|NCT00267228|Quality of life|quality of life
698726|NCT00267215|Lumiracoxib|lumiracoxib
698727|NCT00267215|osteoarthritis|osteoarthritis
698728|NCT00267202|Allergic Asthma, IgE, immunotherapy, omalizumab|allergic asthma, ige, immunotherapy, omalizumab
698729|NCT00267189|Liver transplantation, everolimus, calcineurin inhibitor, renal function|liver transplantation, everolimus, calcineurin inhibitor, renal function
698730|NCT00267176|Osteoarthritis,|osteoarthritis,
698731|NCT00267176|hypertension,|hypertension,
698732|NCT00267176|lumiracoxib,|lumiracoxib,
698733|NCT00267176|ibuprofen,|ibuprofen,
698734|NCT00267176|24-hour blood pressure profile|24-hour blood pressure profile
698735|NCT00267163|Alzheimer's disease|alzheimer's disease
698736|NCT00267163|Mild Cognitive Impairment|mild cognitive impairment
698737|NCT00267150|Simultaneous Pancreas-Kidney Transplantation|simultaneous pancreas-kidney transplantation
698738|NCT00267150|mycophenolate|mycophenolate
698739|NCT00267150|GI problems|gi problems
698740|NCT00267137|Pacemaker, Atrial Fibrillation/Therapy|pacemaker, atrial fibrillation/therapy
698741|NCT00267124|cognitive decline|cognitive decline
698742|NCT00267124|dementia|dementia
698743|NCT00267124|neuroimaging|neuroimaging
698744|NCT00267111|Infant,newborn|infant,newborn
698745|NCT00267111|Topical anesthesia|topical anesthesia
698746|NCT00267111|Intramuscular injection|intramuscular injection
698747|NCT00267098|Atrioventricular block|atrioventricular block
698748|NCT00267098|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
698749|NCT00267098|Pacemaker|pacemaker
698750|NCT00267098|Defibrillator|defibrillator
698751|NCT00267098|NYHA Class I, II or III Heart failure|nyha class i, ii or iii heart failure
698752|NCT00267085|Chronic Myeloid Leukemia|chronic myeloid leukemia
698753|NCT00267085|Minimal Residual Disease|minimal residual disease
698754|NCT00267085|Peptide Vaccine|peptide vaccine
698755|NCT00267072|Ovarian Cancer|ovarian cancer
698756|NCT00267059|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
698757|NCT00267059|Lenalidomide|lenalidomide
698758|NCT00267059|Revlimid|revlimid
698759|NCT00267059|CLL|cll
698760|NCT00267046|Sarcoma|sarcoma
698761|NCT00267046|Soft Tissue Sarcoma|soft tissue sarcoma
698762|NCT00267046|Oral Mucositis|oral mucositis
698763|NCT00267046|Doxorubicin|doxorubicin
698764|NCT00267046|Adriamycin|adriamycin
698765|NCT00267046|Ifosfamide|ifosfamide
698766|NCT00267046|Palifermin|palifermin
698767|NCT00267046|Vincristine|vincristine
698768|NCT00267046|Cisplatin|cisplatin
698769|NCT00267046|Placebo|placebo
698770|NCT00267033|Neoplasm Metastasis|neoplasm metastasis
698771|NCT00267033|Bone Neoplasms|bone neoplasms
698772|NCT00267033|Pain|pain
698773|NCT00267033|Radiotherapy|radiotherapy
698774|NCT00267033|Vertebroplasty|vertebroplasty
698775|NCT00267033|Combined modality therapy|combined modality therapy
698776|NCT00267007|Peripheral neuropathy|peripheral neuropathy
698777|NCT00267007|Chemotherapy-induced|chemotherapy-induced
698778|NCT00267007|Hemoglobin level|hemoglobin level
698779|NCT00267007|Cancer|cancer
698780|NCT00267007|Taxane|taxane
698781|NCT00267007|Platinum-based chemotherapy|platinum-based chemotherapy
698782|NCT00266994|Thrombosis|thrombosis
698783|NCT00266968|pediatric|pediatric
698784|NCT00266968|cardiac|cardiac
698785|NCT00266968|single ventricle|single ventricle
698786|NCT00266955|pediatric|pediatric
698787|NCT00266955|cardiac|cardiac
698788|NCT00266955|ADHD|adhd
698789|NCT00266955|Adderall|adderall
698790|NCT00266955|Straterra|straterra
698791|NCT00266942|Fontan procedure|fontan procedure
698792|NCT00266942|single ventricle physiology|single ventricle physiology
698793|NCT00266942|intra-atrial|intra-atrial
698794|NCT00266942|extracardiac technique|extracardiac technique
698795|NCT00266929|odontoid fx|odontoid fx
698796|NCT00266929|surgical intervention|surgical intervention
698797|NCT00266929|conservative treatment|conservative treatment
698798|NCT00266929|nonunion|nonunion
698799|NCT00266929|odontoid fractures|odontoid fractures
698800|NCT00266929|surgical treatment|surgical treatment
698801|NCT00266916|adult|adult
698802|NCT00266916|congenital heart disease|congenital heart disease
698803|NCT00266916|percutaneous occlusion|percutaneous occlusion
698804|NCT00266916|percutaneous balloon valvotomy|percutaneous balloon valvotomy
698805|NCT00266916|balloon angioplasty|balloon angioplasty
698806|NCT00266916|complex cyanotic congenital heart defects (CCHD)|complex cyanotic congenital heart defects (cchd)
698807|NCT00266903|adult|adult
698808|NCT00266903|congenital heart disease|congenital heart disease
698809|NCT00266903|Eisenmenger's Syndrome|eisenmenger's syndrome
698810|NCT00266903|Bosentan|bosentan
698811|NCT00266903|Sitaxsetan|sitaxsetan
698812|NCT00266903|Sildenafil|sildenafil
698813|NCT00266877|Lung Cancer|lung cancer
698814|NCT00266877|HKI-272|hki-272
698815|NCT00266877|Neratinib|neratinib
698816|NCT00266877|Nerlynx|nerlynx
698817|NCT00266864|Spinal Cord Injury|spinal cord injury
698818|NCT00266864|Testosterone Replacement Therapy|testosterone replacement therapy
698819|NCT00266864|Dual Energy X ray Absorptiometry|dual energy x ray absorptiometry
698820|NCT00266864|Lean Tissue Mass|lean tissue mass
698821|NCT00266851|Randomized clinical trial|randomized clinical trial
698822|NCT00266851|Asthma|asthma
698823|NCT00266851|Adults|adults
698824|NCT00266851|Azithromycin|azithromycin
698825|NCT00266838|Lacrimal Obstruction|lacrimal obstruction
698826|NCT00266838|Epiphora|epiphora
698827|NCT00266812|temozolomide|temozolomide
698828|NCT00266812|radiotherapy|radiotherapy
698829|NCT00266773|Chronic Pain|chronic pain
698830|NCT00266773|Cognitive Therapy|cognitive therapy
698831|NCT00266773|Cognitive Behavioral Therapy|cognitive behavioral therapy
698832|NCT00266773|Recurrence|recurrence
698833|NCT00266773|Relapse Prevention|relapse prevention
698834|NCT00266773|Educational Technology|educational technology
698836|NCT00266773|CST|cst
698837|NCT00266773|IVR|ivr
698838|NCT00266773|TIVR|tivr
698839|NCT00266747|Anxiety|anxiety
698840|NCT00266747|Anti-Anxiety Agents|anti-anxiety agents
698841|NCT00266747|Controlled Clinical Trial|controlled clinical trial
698842|NCT00266734|Adenoviral conjunctivitis|adenoviral conjunctivitis
698843|NCT00266734|Viral conjunctivitis|viral conjunctivitis
698844|NCT00266734|conjunctivitis|conjunctivitis
698845|NCT00266721|Pancrelipase|pancrelipase
698846|NCT00266721|Abdominal bloating|abdominal bloating
698847|NCT00266721|Abdominal pain|abdominal pain
698848|NCT00266721|Eructation|eructation
698849|NCT00266708|renal transplant|renal transplant
698850|NCT00266708|post-transplant osteoporosis|post-transplant osteoporosis
698851|NCT00266682|Bradycardia|bradycardia
698852|NCT00266669|Raynaud's Phenomenon|raynaud's phenomenon
698853|NCT00266669|Raynaud's Disease|raynaud's disease
698854|NCT00266669|Scleroderma|scleroderma
698855|NCT00266669|Raynaud's Disease Secondary to Scleroderma|raynaud's disease secondary to scleroderma
698856|NCT00266669|Raynaud's Disease Secondary to Other Autoimmune Disease|raynaud's disease secondary to other autoimmune disease
698857|NCT00266617|Anemia|anemia
698858|NCT00266617|chemotherapy|chemotherapy
698859|NCT00266617|epoetin alfa|epoetin alfa
698860|NCT00266617|epogen|epogen
698861|NCT00266617|erythropoietin|erythropoietin
698862|NCT00266617|neoplasms|neoplasms
698863|NCT00266617|cancer|cancer
698864|NCT00266604|Epilepsy|epilepsy
698865|NCT00266604|seizures|seizures
698866|NCT00266604|new-onset epilepsy|new-onset epilepsy
698867|NCT00266604|epilepsy relapse|epilepsy relapse
698868|NCT00266604|epilepsy monotherapy|epilepsy monotherapy
698869|NCT00266591|Epilepsy|epilepsy
698870|NCT00266591|Seizures|seizures
698871|NCT00266591|Topiramate|topiramate
698872|NCT00266591|Prophylaxis|prophylaxis
698873|NCT00266591|Antiepileptic|antiepileptic
698874|NCT00266591|Epileptic seizures|epileptic seizures
698875|NCT00266591|Partial seizure disorder|partial seizure disorder
698876|NCT00266591|Brain disease|brain disease
698877|NCT00266578|Eosinophilic Esophagitis|eosinophilic esophagitis
698878|NCT00266552|conduct disorder|conduct disorder
698879|NCT00266552|oppositional defiant disorder|oppositional defiant disorder
698880|NCT00266552|disruptive behavior disorder not otherwise specified|disruptive behavior disorder not otherwise specified
698881|NCT00266552|ADHD|adhd
698882|NCT00266552|risperidone|risperidone
698883|NCT00266552|antipsychotropic agents|antipsychotropic agents
698884|NCT00266552|children|children
698885|NCT00266539|Postoperative pain|postoperative pain
698886|NCT00266539|patient-controlled analgesia|patient-controlled analgesia
698887|NCT00266526|Allergy|allergy
698888|NCT00266526|Birch pollen|birch pollen
698889|NCT00266526|Recombinant|recombinant
698890|NCT00266513|CD40 Ligand|cd40 ligand
698891|NCT00266513|Nemo|nemo
698892|NCT00266513|Genetics|genetics
698893|NCT00266513|Hyper-IGM|hyper-igm
698894|NCT00266513|Ectodermal Dysplasia|ectodermal dysplasia
698895|NCT00266513|CVID|cvid
698896|NCT00266513|Hyper-IgM Syndrome|hyper-igm syndrome
698897|NCT00266513|Primary Immune Deficiency Disorders|primary immune deficiency disorders
698898|NCT00266513|Common Variable Immune Deficiency|common variable immune deficiency
698899|NCT00266500|Adipose Tissue|adipose tissue
698900|NCT00266500|Weight Gain|weight gain
698901|NCT00266500|Overweight|overweight
698902|NCT00266500|Thermogenesis|thermogenesis
698903|NCT00266500|Deep Body Temperature|deep body temperature
698904|NCT00266500|Adult|adult
698905|NCT00266500|Exercise|exercise
698906|NCT00266487|Homocysteine|homocysteine
698907|NCT00266487|B vitamins|b vitamins
698908|NCT00266487|Folic acid|folic acid
698909|NCT00266487|Randomized trial|randomized trial
698910|NCT00266487|Secondary prevention|secondary prevention
698911|NCT00266474|Cystic Fibrosis with Chronic Rhinosinusitis|cystic fibrosis with chronic rhinosinusitis
698912|NCT00266461|Postoperative Ileus|postoperative ileus
698913|NCT00266448|MRSA|mrsa
698914|NCT00266448|eradication|eradication
698915|NCT00266448|chlorhexidine|chlorhexidine
698916|NCT00266435|Asymptomatic subjects|asymptomatic subjects
698917|NCT00266435|Moderate to high risk for cardiovascular event|moderate to high risk for cardiovascular event
698918|NCT00266396|Total Hip Arthroplasty|total hip arthroplasty
698919|NCT00266396|THA|tha
698920|NCT00266396|Total Knee Arthroplasty|total knee arthroplasty
698921|NCT00266396|TKA|tka
698922|NCT00266396|Total Hip Replacement|total hip replacement
698923|NCT00266396|THR|thr
698924|NCT00266396|Total Knee Replacement|total knee replacement
698925|NCT00266396|TKR|tkr
698926|NCT00266331|Breast cancer|breast cancer
698927|NCT00266331|Radiation skin protection|radiation skin protection
698928|NCT00266318|Hepatitis C Nonresponder|hepatitis c nonresponder
698929|NCT00266318|Genotype 1|genotype 1
698930|NCT00266318|Interferon Alfacon-1|interferon alfacon-1
698931|NCT00266318|Consensus Interferon|consensus interferon
698932|NCT00266318|CIFN|cifn
698933|NCT00266318|Infergen|infergen
698934|NCT00266318|Ribavirin|ribavirin
698935|NCT00266305|n-3 LCPUFA|n-3 lcpufa
698936|NCT00266305|Infant development|infant development
698937|NCT00266305|Visual acuity|visual acuity
698938|NCT00266305|Immune function|immune function
698939|NCT00266305|Breast milk|breast milk
698940|NCT00266292|Fish oil|fish oil
698941|NCT00266292|Polyunsaturated fatty acid|polyunsaturated fatty acid
698942|NCT00266292|Immune function|immune function
698943|NCT00266292|Endothelial function|endothelial function
698944|NCT00266292|Cardiovascular risk factors|cardiovascular risk factors
698945|NCT00266266|Human Papilloma Virus|human papilloma virus
698946|NCT00266214|lidocaine patch 5%|lidocaine patch 5%
698947|NCT00266214|Lidoderm|lidoderm
698948|NCT00266214|carpal tunnel syndrome|carpal tunnel syndrome
698949|NCT00266214|pain|pain
698950|NCT00266214|nerve compression injury|nerve compression injury
698951|NCT00266214|topical analgesic|topical analgesic
698952|NCT00266201|Heart Defects, Congenital|heart defects, congenital
698953|NCT00266201|Right Ventricular Dysfunction|right ventricular dysfunction
698954|NCT00266201|Low Cardiac Output|low cardiac output
698955|NCT00266201|Biochemical markers|biochemical markers
698956|NCT00266201|Neurohumoral activity|neurohumoral activity
698957|NCT00266188|Heart Defects, Congenital|heart defects, congenital
698958|NCT00266188|Tetralogy of Fallot|tetralogy of fallot
698959|NCT00266188|Heart Septal Defects, Ventricular|heart septal defects, ventricular
698960|NCT00266188|Pulmonary Valve Diseases|pulmonary valve diseases
698961|NCT00266188|Magnetic Resonance Imaging|magnetic resonance imaging
698962|NCT00266188|Heart Catheterization|heart catheterization
698963|NCT00266188|Echocardiography|echocardiography
698964|NCT00266175|Pulmonary heart disease|pulmonary heart disease
698965|NCT00266175|Pulmonary hypertension|pulmonary hypertension
698966|NCT00266175|Stent implantation|stent implantation
698967|NCT00266175|Balloon dilatation|balloon dilatation
698968|NCT00266175|Surgery|surgery
698969|NCT00266162|Heart Defects, Congenital|heart defects, congenital
698970|NCT00266162|Eisenmenger Complex|eisenmenger complex
698971|NCT00266162|Hypertension, Pulmonary|hypertension, pulmonary
698972|NCT00266162|Pulmonary Heart Disease|pulmonary heart disease
698973|NCT00266162|Pulmonary Circulation|pulmonary circulation
698974|NCT00266162|Vascular Resistance|vascular resistance
698975|NCT00266149|Pharmacokinetics|pharmacokinetics
698976|NCT00266149|Lamotrigine|lamotrigine
698977|NCT00266149|Oral Contraceptives|oral contraceptives
698978|NCT00266149|UGT|ugt
698979|NCT00266149|Glucuronidation.|glucuronidation.
698980|NCT00266136|AML treatment, de-novo, secondary, high-risk MDS, chemotherapy, autologous SCT, adult|aml treatment, de-novo, secondary, high-risk mds, chemotherapy, autologous sct, adult
698981|NCT00266123|Kidney Failure|kidney failure
698982|NCT00266123|Kidney Transplant|kidney transplant
698983|NCT00266110|stage IV breast cancer|stage iv breast cancer
698984|NCT00266110|recurrent breast cancer|recurrent breast cancer
698985|NCT00266097|stage III pancreatic cancer|stage iii pancreatic cancer
698986|NCT00266097|stage IV pancreatic cancer|stage iv pancreatic cancer
698987|NCT00266097|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
698988|NCT00266097|unresectable gallbladder cancer|unresectable gallbladder cancer
698989|NCT00266097|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
698990|NCT00266097|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
698991|NCT00266097|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
698992|NCT00266097|recurrent pancreatic cancer|recurrent pancreatic cancer
698993|NCT00266097|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
698994|NCT00266097|recurrent gallbladder cancer|recurrent gallbladder cancer
698995|NCT00266084|Cervix|cervix
698996|NCT00266084|Uterus|uterus
698997|NCT00266084|Dysplasia|dysplasia
698998|NCT00266084|Cancer|cancer
698999|NCT00266084|Collector|collector
699000|NCT00266071|skin|skin
699001|NCT00266071|pressure|pressure
699002|NCT00266071|age|age
699003|NCT00266058|healthy|healthy
699004|NCT00266058|controls|controls
699005|NCT00266058|research|research
699006|NCT00266058|clinical|clinical
699007|NCT00266058|study|study
699008|NCT00266058|pharmacokinetic|pharmacokinetic
699009|NCT00266058|PK|pk
699010|NCT00266058|HIV|hiv
699011|NCT00266058|malaria|malaria
699012|NCT00266045|Deep Vein Thrombosis|deep vein thrombosis
699013|NCT00266045|Pulmonary Embolism|pulmonary embolism
699014|NCT00266045|D-dimer|d-dimer
699015|NCT00266045|Recurrence|recurrence
699016|NCT00266045|Duration of Anticoagulation|duration of anticoagulation
699017|NCT00266045|Vitamin K Antagonists|vitamin k antagonists
699018|NCT00266019|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
699019|NCT00266019|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
699020|NCT00266019|Fatty liver|fatty liver
699021|NCT00266019|Cirrhosis|cirrhosis
699022|NCT00266019|Obesity|obesity
699023|NCT00266019|Weight Reduction|weight reduction
699024|NCT00266019|Weight Management|weight management
699025|NCT00265980|Leptin|leptin
699026|NCT00265980|Obesity|obesity
699027|NCT00265980|Energy|energy
699028|NCT00265980|Autonomics|autonomics
699029|NCT00265980|Neuroendocrine|neuroendocrine
699030|NCT00265941|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
699031|NCT00265941|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
699032|NCT00265941|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
699033|NCT00265941|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
699034|NCT00265941|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
699035|NCT00265941|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
699036|NCT00265928|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
699037|NCT00265928|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
699038|NCT00265928|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
699039|NCT00265928|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
699040|NCT00265928|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
699041|NCT00265928|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
699042|NCT00265928|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
699043|NCT00265928|splenic marginal zone lymphoma|splenic marginal zone lymphoma
699044|NCT00265928|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
699045|NCT00265928|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
699046|NCT00265928|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
699047|NCT00265915|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
699048|NCT00265915|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
699049|NCT00265915|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
699050|NCT00265915|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
699051|NCT00265915|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
699052|NCT00265915|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
699053|NCT00265915|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
699054|NCT00265902|Kaposi sarcoma|kaposi sarcoma
699055|NCT00265889|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
699056|NCT00265889|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
699057|NCT00265889|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
699058|NCT00265876|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
699059|NCT00265876|stage III pancreatic cancer|stage iii pancreatic cancer
699060|NCT00265876|recurrent pancreatic cancer|recurrent pancreatic cancer
699061|NCT00265876|stage IV pancreatic cancer|stage iv pancreatic cancer
699062|NCT00265863|malignant ascites|malignant ascites
699063|NCT00265850|recurrent colon cancer|recurrent colon cancer
699064|NCT00265850|stage III colon cancer|stage iii colon cancer
699065|NCT00265850|stage III rectal cancer|stage iii rectal cancer
699066|NCT00265850|stage IV colon cancer|stage iv colon cancer
699067|NCT00265850|recurrent rectal cancer|recurrent rectal cancer
699068|NCT00265850|stage IV rectal cancer|stage iv rectal cancer
699069|NCT00265850|adenocarcinoma of the colon|adenocarcinoma of the colon
699070|NCT00265850|adenocarcinoma of the rectum|adenocarcinoma of the rectum
699071|NCT00265837|graft versus host disease|graft versus host disease
699072|NCT00265837|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
699073|NCT00265837|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
699074|NCT00265837|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
699075|NCT00265837|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
699076|NCT00265837|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
699077|NCT00265837|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
699078|NCT00265837|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
699079|NCT00265837|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
699080|NCT00265837|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
699081|NCT00265837|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
699082|NCT00265837|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
699083|NCT00265837|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
699084|NCT00265837|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
699085|NCT00265837|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
699086|NCT00265837|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
699087|NCT00265837|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
699088|NCT00265837|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
699089|NCT00265837|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
699090|NCT00265837|secondary acute myeloid leukemia|secondary acute myeloid leukemia
699091|NCT00265837|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
699092|NCT00265837|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
699093|NCT00265837|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
699094|NCT00265837|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
699095|NCT00265837|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
699096|NCT00265837|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
699097|NCT00265837|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
699098|NCT00265837|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
699099|NCT00265837|stage I multiple myeloma|stage i multiple myeloma
699100|NCT00265837|stage II multiple myeloma|stage ii multiple myeloma
699101|NCT00265837|stage III multiple myeloma|stage iii multiple myeloma
699102|NCT00265837|refractory multiple myeloma|refractory multiple myeloma
699103|NCT00265837|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
699104|NCT00265837|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
699105|NCT00265837|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
699106|NCT00265837|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
699107|NCT00265837|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
699108|NCT00265837|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
699109|NCT00265837|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
699110|NCT00265837|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
699111|NCT00265837|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
699112|NCT00265837|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
699113|NCT00265837|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
699114|NCT00265837|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
699115|NCT00265837|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
699116|NCT00265837|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
699117|NCT00265837|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
699118|NCT00265837|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
699119|NCT00265837|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
699120|NCT00265837|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
699121|NCT00265837|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
699232|NCT00265499|Flow|flow
699122|NCT00265837|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
699123|NCT00265837|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
699124|NCT00265837|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
699125|NCT00265837|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
699126|NCT00265837|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
699127|NCT00265837|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
699128|NCT00265837|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
699129|NCT00265837|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
699130|NCT00265837|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
699131|NCT00265837|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
699132|NCT00265837|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
699133|NCT00265837|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
699134|NCT00265837|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
699135|NCT00265837|splenic marginal zone lymphoma|splenic marginal zone lymphoma
699136|NCT00265837|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
699137|NCT00265837|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
699138|NCT00265837|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
699139|NCT00265837|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
699140|NCT00265837|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
699141|NCT00265837|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
699142|NCT00265837|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
699143|NCT00265837|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
699144|NCT00265837|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
699145|NCT00265837|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
699146|NCT00265837|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
699147|NCT00265837|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
699148|NCT00265837|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
699149|NCT00265837|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
699150|NCT00265837|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
699151|NCT00265837|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
699152|NCT00265837|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
699153|NCT00265837|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
699154|NCT00265837|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
699155|NCT00265837|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
699156|NCT00265837|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
699157|NCT00265837|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
699158|NCT00265837|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
699159|NCT00265837|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
699160|NCT00265824|stage IV colon cancer|stage iv colon cancer
699161|NCT00265824|stage IV rectal cancer|stage iv rectal cancer
699162|NCT00265824|adenocarcinoma of the colon|adenocarcinoma of the colon
699163|NCT00265824|adenocarcinoma of the rectum|adenocarcinoma of the rectum
699164|NCT00265824|chemotherapy|chemotherapy
699165|NCT00265811|stage III colon cancer|stage iii colon cancer
699166|NCT00265811|adenocarcinoma of the colon|adenocarcinoma of the colon
699167|NCT00265785|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
699168|NCT00265785|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
699169|NCT00265785|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
699170|NCT00265785|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
699171|NCT00265772|enteral nutrition|enteral nutrition
699172|NCT00265772|steroids|steroids
699173|NCT00265772|mucosal healing|mucosal healing
699562|NCT00264004|phase II|phase ii
699174|NCT00265759|stage II breast cancer|stage ii breast cancer
699175|NCT00265759|stage IIIA breast cancer|stage iiia breast cancer
699176|NCT00265759|stage IIIB breast cancer|stage iiib breast cancer
699177|NCT00265759|stage IIIC breast cancer|stage iiic breast cancer
699178|NCT00265759|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
699179|NCT00265746|metformin|metformin
699180|NCT00265746|gestational diabetes|gestational diabetes
699181|NCT00265746|lifestyle|lifestyle
699182|NCT00265733|male breast cancer|male breast cancer
699183|NCT00265733|recurrent breast cancer|recurrent breast cancer
699184|NCT00265733|stage IV breast cancer|stage iv breast cancer
699185|NCT00265720|African Americans|african americans
699186|NCT00265720|Colorectal Cancer Screening|colorectal cancer screening
699187|NCT00265720|Colorectal Cancer|colorectal cancer
699188|NCT00265720|Colorectal Cancer and African Americans|colorectal cancer and african americans
699189|NCT00265720|Cancer Disparities|cancer disparities
699190|NCT00265707|Hypertension|hypertension
699191|NCT00265707|Hypotension|hypotension
699192|NCT00265681|smokeless tobacco cessation|smokeless tobacco cessation
699193|NCT00265681|chewing tobacco|chewing tobacco
699194|NCT00265681|oral tobacco|oral tobacco
699195|NCT00265681|smokeless tobacco|smokeless tobacco
699196|NCT00265681|telephone|telephone
699197|NCT00265681|counseling|counseling
699198|NCT00265642|Hepatitis C, Chronic|hepatitis c, chronic
699199|NCT00265642|irbesartan|irbesartan
699200|NCT00265629|Atrial fibrillation|atrial fibrillation
699201|NCT00265616|Refractory status epilepticus,|refractory status epilepticus,
699202|NCT00265616|coma-induction,|coma-induction,
699203|NCT00265616|treatment,|treatment,
699204|NCT00265616|propofol,|propofol,
699205|NCT00265616|barbiturates,|barbiturates,
699206|NCT00265616|efficacy,|efficacy,
699207|NCT00265616|safety.|safety.
699208|NCT00265590|Aniridia|aniridia
699209|NCT00265590|PAX6|pax6
699210|NCT00265590|Keratopathy|keratopathy
699211|NCT00265590|Limbal Stem Cell Deficiency|limbal stem cell deficiency
699212|NCT00265590|Molecular Genetics|molecular genetics
699213|NCT00265564|outcomes assessment|outcomes assessment
699214|NCT00265564|substance use disorders|substance use disorders
699215|NCT00265564|stress disorders, post-traumatic|stress disorders, post-traumatic
699216|NCT00265564|screening|screening
699217|NCT00265551|Schizophrenia|schizophrenia
699218|NCT00265538|Hypertension|hypertension
699219|NCT00265538|Diuretics|diuretics
699220|NCT00265538|Drug Therapy|drug therapy
699221|NCT00265538|Anti-Hypertensive Agents|anti-hypertensive agents
699222|NCT00265538|Patient Intervention|patient intervention
699223|NCT00265525|Randomized Control Trial|randomized control trial
699224|NCT00265525|Exercise Intervention|exercise intervention
699225|NCT00265525|Prevention|prevention
699226|NCT00265525|Rehabilitation|rehabilitation
699227|NCT00265512|Telemedicine|telemedicine
699228|NCT00265512|Aftercare|aftercare
699229|NCT00265499|Coronary Artery Bypass|coronary artery bypass
699230|NCT00265499|Skeletonization|skeletonization
699231|NCT00265499|Internal Thoracic Artery|internal thoracic artery
699234|NCT00265499|Pain|pain
699235|NCT00265486|Divers|divers
699236|NCT00265486|Brain|brain
699237|NCT00265486|Flow|flow
699238|NCT00265486|Blood|blood
699239|NCT00265486|EPO|epo
699240|NCT00265486|Dive|dive
699241|NCT00265486|reflex|reflex
699242|NCT00265460|smoking cessation,|smoking cessation,
699243|NCT00265460|nicotine,|nicotine,
699244|NCT00265460|smokeless tobacco,|smokeless tobacco,
699245|NCT00265460|cigarettes|cigarettes
699246|NCT00265447|knee osteoarthritis|knee osteoarthritis
699247|NCT00265447|exercise|exercise
699248|NCT00265447|aerobic exercise|aerobic exercise
699249|NCT00265447|strengthening exercise|strengthening exercise
699250|NCT00265447|exercise prescription|exercise prescription
699251|NCT00265447|rehabilitation|rehabilitation
699252|NCT00265447|physical disability|physical disability
699253|NCT00265447|physical function|physical function
699254|NCT00265447|physical activity|physical activity
699255|NCT00265447|physical fitness|physical fitness
699256|NCT00265421|Suture Techniques|suture techniques
699257|NCT00265408|Cervicocephalic Arterial Dissection|cervicocephalic arterial dissection
699258|NCT00265382|Adolescent Subjects|adolescent subjects
699259|NCT00265356|Positron Emission Tomography (PET)|positron emission tomography (pet)
699260|NCT00265356|Diagnostic Investigation|diagnostic investigation
699261|NCT00265356|Colorectal cancer|colorectal cancer
699262|NCT00265356|Liver metastases|liver metastases
699263|NCT00265356|Liver surgery|liver surgery
699264|NCT00265330|Children And Adolescents With Bipolar I Disorder (Manic Or Mixed)|children and adolescents with bipolar i disorder (manic or mixed)
699265|NCT00265317|Non-small cell lung cancer|non-small cell lung cancer
699266|NCT00265317|sunitinib|sunitinib
699267|NCT00265317|erlotinib|erlotinib
699268|NCT00265317|Phase 2|phase 2
699269|NCT00265304|Osteoarthritis|osteoarthritis
699270|NCT00265291|Depression|depression
699271|NCT00265291|mood disorders|mood disorders
699272|NCT00265291|affective disorders|affective disorders
699273|NCT00265291|pharmacogenetics|pharmacogenetics
699274|NCT00265291|pharmacogenomics|pharmacogenomics
699275|NCT00265265|Cocaine Dependence|cocaine dependence
699276|NCT00265252|osteonecrosis|osteonecrosis
699277|NCT00265252|total hip replacement|total hip replacement
699278|NCT00265239|Edaravone|edaravone
699279|NCT00265239|Randomized Control Trial|randomized control trial
699280|NCT00265239|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
699281|NCT00265239|Coronary Angioplasty|coronary angioplasty
699282|NCT00265226|India|india
699283|NCT00265226|Pulmonary Tuberculosis|pulmonary tuberculosis
699284|NCT00265226|Category-II tuberculosis|category-ii tuberculosis
699285|NCT00265226|Immunomodulator|immunomodulator
699286|NCT00265226|Mycobacterium w|mycobacterium w
699287|NCT00265226|Revised National Tuberculosis Control Programme|revised national tuberculosis control programme
699288|NCT00265226|Category-II Pulmonary Tuberculosis|category-ii pulmonary tuberculosis
699289|NCT00265213|breast conservative surgery|breast conservative surgery
699290|NCT00265213|shoulder functional outcome questionnaire|shoulder functional outcome questionnaire
699291|NCT00265213|disability questionnaire|disability questionnaire
699292|NCT00265200|Zometa|zometa
699293|NCT00265200|bone metastasis|bone metastasis
699294|NCT00265200|lung cancer|lung cancer
699295|NCT00265200|non-small cell lung cancer|non-small cell lung cancer
699296|NCT00265200|small cell lung cancer|small cell lung cancer
699297|NCT00265200|bone metabolic markers|bone metabolic markers
699298|NCT00265200|tartrate resistant acid phosphatase|tartrate resistant acid phosphatase
699299|NCT00265187|child, bronchiolitis,|child, bronchiolitis,
699300|NCT00265174|SERUM DNA|serum dna
699301|NCT00265174|LOH|loh
699302|NCT00265174|METHYLATION|methylation
699303|NCT00265174|GLIOMA|glioma
699304|NCT00265174|MGMT|mgmt
699305|NCT00265161|influenza vaccine|influenza vaccine
699306|NCT00265161|effectiveness|effectiveness
699307|NCT00265161|health care worker|health care worker
699308|NCT00265161|OBSERVATIONAL STUDY|observational study
699309|NCT00265148|rosiglitazone|rosiglitazone
699310|NCT00265148|cognition|cognition
699311|NCT00265148|cerebral glucose metabolism|cerebral glucose metabolism
699312|NCT00265148|positron emission tomography (PET)|positron emission tomography (pet)
699313|NCT00265148|Alzheimer's Disease|alzheimer's disease
699314|NCT00265135|Renal cell carcinoma|renal cell carcinoma
699315|NCT00265135|CNTO 328|cnto 328
699316|NCT00265135|Infusions|infusions
699317|NCT00265135|Renal cell cancer|renal cell cancer
699318|NCT00265122|Crohn Disease|crohn disease
699319|NCT00265122|Biologic|biologic
699320|NCT00265122|Infusion|infusion
699321|NCT00265122|Injection|injection
699322|NCT00265122|CNTO 1275|cnto 1275
699323|NCT00265122|Ustekinumab|ustekinumab
699324|NCT00265122|C01275|c01275
699325|NCT00265122|IL-12p40|il-12p40
699326|NCT00265109|body dysmorphic disorder|body dysmorphic disorder
699327|NCT00265109|levetiracetam|levetiracetam
699328|NCT00265096|Psoriatic Arthritis|psoriatic arthritis
699329|NCT00265096|Spondyloarthritis|spondyloarthritis
699330|NCT00265096|Spondyloarthropathy|spondyloarthropathy
699331|NCT00265096|subcutaneous injection|subcutaneous injection
699332|NCT00265083|Spondylitis|spondylitis
699333|NCT00265083|subcutaneous injection|subcutaneous injection
699334|NCT00265083|Bechterew's Disease|bechterew's disease
699335|NCT00265083|Spondyloarthritis|spondyloarthritis
699336|NCT00265083|Spondyloarthropathy|spondyloarthropathy
699337|NCT00265057|Cancer;|cancer;
699338|NCT00265057|Tumors;|tumors;
699339|NCT00265057|Neoplasms;|neoplasms;
699340|NCT00265057|Anticarcinogenic Agents;|anticarcinogenic agents;
699341|NCT00265057|Antineoplastic Agents;|antineoplastic agents;
699342|NCT00265057|Cadherins;|cadherins;
699343|NCT00265057|Non-Small-Cell Lung Carcinoma;|non-small-cell lung carcinoma;
699344|NCT00265057|Ovarian Cancer|ovarian cancer
699345|NCT00265044|Behavior Change|behavior change
699346|NCT00265044|patient Education|patient education
699347|NCT00265031|Hodgkin´s Lymphoma|hodgkin´s lymphoma
699348|NCT00265031|advanced stages|advanced stages
699349|NCT00265018|Hodgkin´s lymphoma|hodgkin´s lymphoma
699350|NCT00265018|early stages|early stages
699351|NCT00265005|alteplase|alteplase
699352|NCT00265005|occluded central venous catheter|occluded central venous catheter
699353|NCT00265005|occluded arterial catheter|occluded arterial catheter
699354|NCT00265005|occluded PICC|occluded picc
699355|NCT00265005|neonates|neonates
699356|NCT00265005|infants|infants
699357|NCT00264992|embryo implantation, in vitro fertilization,|embryo implantation, in vitro fertilization,
699358|NCT00264992|cytokine expression|cytokine expression
699359|NCT00264979|Colorectal cancer|colorectal cancer
699360|NCT00264979|Sequential or simultaneous surgery|sequential or simultaneous surgery
699361|NCT00264979|Synchronous hepatic metastases|synchronous hepatic metastases
699362|NCT00264966|Mild asthma|mild asthma
699363|NCT00264953|Hodgkin´s lymphoma|hodgkin´s lymphoma
699364|NCT00264953|intermediate stages|intermediate stages
699365|NCT00264927|Inappropriate ADH Syndrome|inappropriate adh syndrome
699366|NCT00264927|Hyponatremia|hyponatremia
699367|NCT00264914|Inappropriate ADH Syndrome|inappropriate adh syndrome
699368|NCT00264914|Hyponatremia|hyponatremia
699369|NCT00264888|Duchenne muscular dystrophy|duchenne muscular dystrophy
699370|NCT00264888|Nonsense mutation|nonsense mutation
699566|NCT00263978|VOD|vod
699371|NCT00264888|Premature stop codon|premature stop codon
699372|NCT00264849|Asthma|asthma
699373|NCT00264849|omalizumab|omalizumab
699374|NCT00264849|Severe persistent allergic asthma|severe persistent allergic asthma
699375|NCT00264823|HIV|hiv
699376|NCT00264823|Mental Illness|mental illness
699377|NCT00264810|Responsive Stimulation|responsive stimulation
699378|NCT00264810|Brain Stimulator|brain stimulator
699379|NCT00264810|Epilepsy|epilepsy
699380|NCT00264810|Seizures|seizures
699381|NCT00264784|Streptococcus, Group A, Fiji, epidemiology|streptococcus, group a, fiji, epidemiology
699382|NCT00264771|Fiji, Group A streptococcus, rheumatic, glomerulonephritis|fiji, group a streptococcus, rheumatic, glomerulonephritis
699383|NCT00264758|randomized controlled clinical trial|randomized controlled clinical trial
699384|NCT00264758|hemodialysis|hemodialysis
699385|NCT00264758|end stage renal disease|end stage renal disease
699386|NCT00264745|Caregiver|caregiver
699387|NCT00264745|Stroke|stroke
699388|NCT00264732|cervical lesions|cervical lesions
699389|NCT00264732|cervical dysplasia|cervical dysplasia
699390|NCT00264732|Human papilloma virus|human papilloma virus
699391|NCT00264732|abnormal Pap|abnormal pap
699392|NCT00264732|High-grade cervical intraepithelial lesions (CIN 2/3)|high-grade cervical intraepithelial lesions (cin 2/3)
699393|NCT00264719|A drug is administered to initiate breastfeeding|a drug is administered to initiate breastfeeding
699394|NCT00264680|quality of life|quality of life
699395|NCT00264680|qolie-10|qolie-10
699396|NCT00264680|epilepsy|epilepsy
699397|NCT00264680|lamotrigine|lamotrigine
699398|NCT00264680|Validation of questionnaire|validation of questionnaire
699399|NCT00264667|Dyslipidaemia|dyslipidaemia
699400|NCT00264654|Social|social
699401|NCT00264654|(SAD)|(sad)
699402|NCT00264654|Anxiety|anxiety
699403|NCT00264654|Disorder|disorder
699404|NCT00264641|Hypoglycemia|hypoglycemia
699405|NCT00264641|Cognitive impairment|cognitive impairment
699406|NCT00264641|PET|pet
699407|NCT00264641|CalCAP|calcap
699408|NCT00264628|NK1-antagonist|nk1-antagonist
699409|NCT00264628|Depression|depression
699410|NCT00264628|Fibromyalgia|fibromyalgia
699411|NCT00264628|GW679769|gw679769
699412|NCT00264628|Outpatient|outpatient
699413|NCT00264615|once daily dosing|once daily dosing
699414|NCT00264615|seizure|seizure
699415|NCT00264615|pharmacokinetics|pharmacokinetics
699416|NCT00264615|epilepsy|epilepsy
699417|NCT00264602|Lymphatic mapping|lymphatic mapping
699418|NCT00264602|nodal targeting|nodal targeting
699419|NCT00264602|indocyanine green|indocyanine green
699420|NCT00264602|near infrared imaging|near infrared imaging
699421|NCT00264589|vascular function|vascular function
699422|NCT00264589|cardiac function|cardiac function
699423|NCT00264589|individualized training|individualized training
699424|NCT00264589|ultrasonography|ultrasonography
699425|NCT00264589|body composition|body composition
699426|NCT00264576|influenza|influenza
699427|NCT00264576|flu|flu
699428|NCT00264550|Rheumatoid Arthritis|rheumatoid arthritis
699429|NCT00264550|Golimumab|golimumab
699430|NCT00264550|Methotrexate|methotrexate
699431|NCT00264550|Fully Human anti-TNFa monoclonal antibody|fully human anti-tnfa monoclonal antibody
699432|NCT00264550|Simpony|simpony
699433|NCT00264537|Rheumatoid Arthritis|rheumatoid arthritis
699434|NCT00264537|Methotrexate Naïve|methotrexate naïve
699435|NCT00264537|subcutaneous injection|subcutaneous injection
699436|NCT00264524|Rheumatic heart disease, HLA, Genetics, Taiwan|rheumatic heart disease, hla, genetics, taiwan
699437|NCT00264511|Hyperbaric oxygen|hyperbaric oxygen
699438|NCT00264511|Crush injury|crush injury
699439|NCT00264511|Tibial fracture|tibial fracture
699440|NCT00264511|Gustillo 3|gustillo 3
699441|NCT00264511|soft tissue injury|soft tissue injury
699442|NCT00264511|complications|complications
699443|NCT00264511|outcomes|outcomes
699444|NCT00264511|randomised controlled trial|randomised controlled trial
699445|NCT00264498|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
699446|NCT00264498|NSCLC|nsclc
699447|NCT00264498|Lung Cancer|lung cancer
699448|NCT00264485|Postoperative pain|postoperative pain
699449|NCT00264485|patient-controlled analgesia|patient-controlled analgesia
699450|NCT00264472|Cancer|cancer
699451|NCT00264472|Tumors|tumors
699452|NCT00264472|Neoplasms|neoplasms
699453|NCT00264472|Anticarcinogenic Agents|anticarcinogenic agents
699454|NCT00264472|Antineoplastic Agents|antineoplastic agents
699455|NCT00264472|Dihydrouracil Dehydrogenase (NADP)|dihydrouracil dehydrogenase (nadp)
699456|NCT00264459|Sublingual immunotherapy|sublingual immunotherapy
699457|NCT00264459|Rhinoconjunctivitis|rhinoconjunctivitis
699458|NCT00264459|Rhinitis|rhinitis
699459|NCT00264459|Asthma|asthma
699460|NCT00264446|Cancer; Tumors; Neoplasms; Anticarcinogenic Agents; Antineoplastic Agents;|cancer; tumors; neoplasms; anticarcinogenic agents; antineoplastic agents;
699461|NCT00264446|Dihydrouracil dehydrogenase (NADP); Colorectal Carcinoma; Liver Cancer|dihydrouracil dehydrogenase (nadp); colorectal carcinoma; liver cancer
699462|NCT00264433|Cancer; Tumors; Neoplasms; Anticarcinogenic Agents; Antineoplastic Agents|cancer; tumors; neoplasms; anticarcinogenic agents; antineoplastic agents
699563|NCT00264004|Hypertension|hypertension
699564|NCT00264004|RECENTIN|recentin
699565|NCT00263978|Venous occlusive disease|venous occlusive disease
699463|NCT00264433|Cadherins; Non-Small-Cell Lung Carcinoma; Esophageal Cancer; Gastric Cancer; Renal Cell Carcinoma; Hepatocellular Carcinoma; Adrenocortical Carcinoma|cadherins; non-small-cell lung carcinoma; esophageal cancer; gastric cancer; renal cell carcinoma; hepatocellular carcinoma; adrenocortical carcinoma
699464|NCT00264420|bone metastases|bone metastases
699465|NCT00264420|breast cancer|breast cancer
699466|NCT00264420|lung cancer|lung cancer
699467|NCT00264420|prostate cancer|prostate cancer
699468|NCT00264420|zoledronic acid|zoledronic acid
699469|NCT00264420|radiation therapy|radiation therapy
699470|NCT00264407|Hearing Loss, Central|hearing loss, central
699471|NCT00264407|Presbycusis|presbycusis
699472|NCT00264407|Hearing Loss, Sensorineural|hearing loss, sensorineural
699473|NCT00264407|Hearing Loss, Cochlear|hearing loss, cochlear
699474|NCT00264407|Hearing Loss, Bilateral|hearing loss, bilateral
699475|NCT00264407|Sex Steroid Hormones|sex steroid hormones
699476|NCT00264407|Estradiol|estradiol
699477|NCT00264394|Computer generated reminder system|computer generated reminder system
699478|NCT00264394|quality control|quality control
699479|NCT00264394|dyslipidemia|dyslipidemia
699480|NCT00264394|antiretroviral therapy|antiretroviral therapy
699481|NCT00264394|HIV infection|hiv infection
699482|NCT00264381|Superficial Thrombophlebitis|superficial thrombophlebitis
699483|NCT00264381|STP|stp
699484|NCT00264381|Fragmin|fragmin
699485|NCT00264381|Ibuprofen|ibuprofen
699486|NCT00264381|Superficial Thrombus|superficial thrombus
699487|NCT00264381|Superficial Phlebitis|superficial phlebitis
699488|NCT00264381|phlebitis|phlebitis
699489|NCT00264368|Renal replacement therapy|renal replacement therapy
699490|NCT00264368|CMV disease|cmv disease
699491|NCT00264355|cyclosporine|cyclosporine
699492|NCT00264355|metabolites|metabolites
699493|NCT00264355|metabolic pattern|metabolic pattern
699494|NCT00264355|genotypes|genotypes
699495|NCT00264342|Smoking|smoking
699496|NCT00264342|Tobacco|tobacco
699497|NCT00264342|Nicotine|nicotine
699498|NCT00264316|bone marrow cell transfer|bone marrow cell transfer
699499|NCT00264316|acute myocardial infarction|acute myocardial infarction
699500|NCT00264316|left ventricular function|left ventricular function
699501|NCT00264303|Chronic Idiopathic Urticaria|chronic idiopathic urticaria
699502|NCT00264303|CUTE Levocetirizine Xyzal®|cute levocetirizine xyzal®
699503|NCT00264290|HIV|hiv
699504|NCT00264290|CMV|cmv
699505|NCT00264290|T Cell activation|t cell activation
699506|NCT00264290|Valganciclovir|valganciclovir
699507|NCT00264277|D-dimer|d-dimer
699508|NCT00264277|Recurrence|recurrence
699509|NCT00264277|Venous Thromboembolism|venous thromboembolism
699510|NCT00264277|Anticoagulation|anticoagulation
699511|NCT00264277|Duration|duration
699512|NCT00264264|Closure device|closure device
699513|NCT00264264|Stenting|stenting
699514|NCT00264264|Percutaneous coronary intervention|percutaneous coronary intervention
699515|NCT00264251|HIV|hiv
699516|NCT00264251|Body composition|body composition
699517|NCT00264251|Weight reduction|weight reduction
699518|NCT00264251|Insulin resistance/sensitivity|insulin resistance/sensitivity
699519|NCT00264251|Exercise|exercise
699520|NCT00264251|Diet|diet
699521|NCT00264251|Visceral adiposity|visceral adiposity
699522|NCT00264225|osteoarthritis, pain|osteoarthritis, pain
699523|NCT00264199|Chronic Congestive heart failure|chronic congestive heart failure
699524|NCT00264199|Ischemic heart disease|ischemic heart disease
699525|NCT00264199|insulin resistance|insulin resistance
699526|NCT00264160|AMN107|amn107
699527|NCT00264160|CML|cml
699528|NCT00264160|Bcr Abl|bcr abl
699529|NCT00264160|cytogenetic response|cytogenetic response
699530|NCT00264160|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
699531|NCT00264160|imatinib mesylate|imatinib mesylate
699532|NCT00264147|Arcoxia|arcoxia
699533|NCT00264134|Non-Small Cell Lung Cancer|non-small cell lung cancer
699534|NCT00264121|congenital, high scrotal|congenital, high scrotal
699535|NCT00264108|Antineoplastic agents|antineoplastic agents
699536|NCT00264108|Chemotherapy|chemotherapy
699537|NCT00264108|Cost-effectiveness|cost-effectiveness
699538|NCT00264108|Epoetin alfa|epoetin alfa
699539|NCT00264108|Darbepoetin alfa|darbepoetin alfa
699540|NCT00264095|Anemia|anemia
699541|NCT00264095|Blood loss|blood loss
699542|NCT00264095|Transfusion|transfusion
699543|NCT00264095|Blood transfusion|blood transfusion
699544|NCT00264095|Erythropoietin|erythropoietin
699545|NCT00264095|Surgery|surgery
699546|NCT00264095|Surgical blood loss|surgical blood loss
699547|NCT00264095|Tumor|tumor
699548|NCT00264095|Cancer|cancer
699549|NCT00264095|Surgical resection|surgical resection
699550|NCT00264095|Tumor resection|tumor resection
699551|NCT00264069|Adherence|adherence
699552|NCT00264069|Compliance|compliance
699553|NCT00264069|Schizophrenia|schizophrenia
699554|NCT00264069|Bipolar Disorder|bipolar disorder
699555|NCT00264069|Depression|depression
699556|NCT00264069|Personality Disorders|personality disorders
699557|NCT00264069|Registry|registry
699558|NCT00264056|malignant melanoma|malignant melanoma
699559|NCT00264056|hyperthermia|hyperthermia
699560|NCT00264056|chemotherapy|chemotherapy
699561|NCT00264004|Advanced Solid Tumours|advanced solid tumours
699567|NCT00263952|Bee venom allergy|bee venom allergy
699568|NCT00263952|Specific immunotherapy|specific immunotherapy
699569|NCT00263939|chronic disease|chronic disease
699570|NCT00263939|patient education|patient education
699571|NCT00263939|self-efficacy|self-efficacy
699572|NCT00263939|self-management|self-management
699573|NCT00263926|Wasp venom allergy,|wasp venom allergy,
699574|NCT00263926|specific immunotherapy|specific immunotherapy
699575|NCT00263900|Influenza A|influenza a
699576|NCT00263900|Influenza B|influenza b
699577|NCT00263900|RSV|rsv
699578|NCT00263887|alpha 1 proteinase inhibitor|alpha 1 proteinase inhibitor
699579|NCT00263887|alpha1 proteinase inhibitor|alpha1 proteinase inhibitor
699580|NCT00263887|congenital emphysema|congenital emphysema
699581|NCT00263887|replacement therapy|replacement therapy
699582|NCT00263861|neurotoxicity|neurotoxicity
699583|NCT00263861|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
699584|NCT00263822|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
699585|NCT00263822|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
699586|NCT00263822|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
699587|NCT00263822|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
699588|NCT00263822|primary peritoneal cavity cancer|primary peritoneal cavity cancer
699589|NCT00263822|fallopian tube cancer|fallopian tube cancer
699590|NCT00263731|lung cancer|lung cancer
699591|NCT00263731|non-small cell lung cancer|non-small cell lung cancer
699592|NCT00263731|small cell lung cancer|small cell lung cancer
699593|NCT00263731|cancer metabolism|cancer metabolism
699594|NCT00263640|House dust mite|house dust mite
699595|NCT00263640|Bronchial Asthma|bronchial asthma
699596|NCT00263640|Allergy|allergy
699597|NCT00263640|House Dust Mite Allergy|house dust mite allergy
699598|NCT00263627|specific immunotherapy|specific immunotherapy
699599|NCT00263627|birch pollen allergy|birch pollen allergy
699600|NCT00263627|Allergovit|allergovit
699601|NCT00263601|Allergovit|allergovit
699602|NCT00263601|Grass pollen allergy|grass pollen allergy
699603|NCT00263588|breast cancer brain metastases ErbB2 positive HER2 positive|breast cancer brain metastases erbb2 positive her2 positive
699604|NCT00263575|EN3267|en3267
699605|NCT00263575|Breakthrough Pain|breakthrough pain
699606|NCT00263575|Safety Study|safety study
699607|NCT00263575|Fentanyl Tablets|fentanyl tablets
699608|NCT00263562|Sickle cell disease|sickle cell disease
699609|NCT00263562|vaso-occlusive crisis|vaso-occlusive crisis
699610|NCT00263562|steroid treatment|steroid treatment
699611|NCT00263549|House dust mite,|house dust mite,
699612|NCT00263549|Allergy|allergy
699613|NCT00263536|Obesity|obesity
699614|NCT00263536|Adiposity|adiposity
699615|NCT00263536|Binge Eating|binge eating
699616|NCT00263536|Social Functioning|social functioning
699617|NCT00263536|Eating Disorders|eating disorders
699618|NCT00263536|Prevention|prevention
699619|NCT00263536|Adolescence|adolescence
699620|NCT00263536|Adolescent Weight Gain|adolescent weight gain
699621|NCT00263536|Overweight|overweight
699622|NCT00263523|Serotonin|serotonin
699623|NCT00263523|Positron Emission Tomograhy|positron emission tomograhy
699624|NCT00263523|Brain|brain
699625|NCT00263523|Neurochemistry|neurochemistry
699626|NCT00263523|Neurotransmitter|neurotransmitter
699627|NCT00263523|Healthy Volunteer|healthy volunteer
699628|NCT00263523|HV|hv
699629|NCT00263497|Postinjury chronic pain|postinjury chronic pain
699630|NCT00263497|Transtibial amputation|transtibial amputation
699631|NCT00263497|Physical rehabilitation|physical rehabilitation
699632|NCT00263497|Immediate temporary prosthesis|immediate temporary prosthesis
699633|NCT00263484|Steroids, Fluorinated|steroids, fluorinated
699634|NCT00263484|Thalidomide|thalidomide
699635|NCT00263484|Bisphosphonates|bisphosphonates
699636|NCT00263458|HIV|hiv
699637|NCT00263458|acquired immunodeficiency syndrome|acquired immunodeficiency syndrome
699638|NCT00263458|buprenorphine|buprenorphine
699639|NCT00263458|opioid dependence|opioid dependence
699640|NCT00263458|opioid-related disorders|opioid-related disorders
699641|NCT00263458|integrated care|integrated care
699642|NCT00263458|primary care|primary care
699643|NCT00263445|Growth hormone dosing|growth hormone dosing
699644|NCT00263445|IGF-I|igf-i
699645|NCT00263419|Diabetes Type 2|diabetes type 2
699646|NCT00263419|Late Complications|late complications
699647|NCT00263419|Stress relief management|stress relief management
699648|NCT00263419|psychosocial stress|psychosocial stress
699649|NCT00263393|Myocardial Infarction|myocardial infarction
699650|NCT00263393|Angina Pectoris|angina pectoris
699651|NCT00263393|Cerebrovascular Accident|cerebrovascular accident
699652|NCT00263393|Diabetes Mellitus|diabetes mellitus
699653|NCT00263393|Cluster randomized design|cluster randomized design
699654|NCT00263393|Community-based intervention trial|community-based intervention trial
699655|NCT00263393|Primary Healthcare intervention|primary healthcare intervention
699656|NCT00263393|Lifestyle advice|lifestyle advice
699657|NCT00263380|COPD|copd
699658|NCT00263380|cytokines|cytokines
699659|NCT00263380|corticosteroids|corticosteroids
699660|NCT00263380|beta agonists|beta agonists
699661|NCT00263380|synergistic effect|synergistic effect
699662|NCT00263367|Autism|autism
699663|NCT00263367|Oxidative Stress|oxidative stress
699664|NCT00263367|Hyperbaric Oxygen|hyperbaric oxygen
699665|NCT00263367|Reduced Glutathione|reduced glutathione
699666|NCT00263367|Lipid Peroxides|lipid peroxides
699667|NCT00263341|Contraceptive agents|contraceptive agents
699668|NCT00263341|Female contraception|female contraception
699669|NCT00263341|Progestins|progestins
699670|NCT00263328|immunosuppression|immunosuppression
699671|NCT00263328|JAK3 inhibitor|jak3 inhibitor
699672|NCT00263328|kidney transplant|kidney transplant
699673|NCT00263328|tofacitinib|tofacitinib
699674|NCT00263328|Xeljanz|xeljanz
699675|NCT00263328|CP-690|cp-690
699676|NCT00263328|550|550
699677|NCT00263328|tacromilus|tacromilus
699678|NCT00263328|mycophenolate mofetil|mycophenolate mofetil
699679|NCT00263315|aspergillosis|aspergillosis
699680|NCT00263315|mycosis|mycosis
699681|NCT00263315|neutropenia|neutropenia
699682|NCT00263315|primary prevention|primary prevention
699683|NCT00263315|hematologic diseases|hematologic diseases
699684|NCT00263315|amphotericin B|amphotericin b
699685|NCT00263315|AmBisome|ambisome
699686|NCT00263315|liposomal amphotericin B|liposomal amphotericin b
699687|NCT00263302|dexamethasone, diuretic, congestive heart failure|dexamethasone, diuretic, congestive heart failure
699688|NCT00263250|inguinal hernia|inguinal hernia
699689|NCT00263250|asymptomatic|asymptomatic
699690|NCT00263250|watchful waiting|watchful waiting
699691|NCT00263250|tension-free hernia repair|tension-free hernia repair
699692|NCT00263237|T Cell|t cell
699693|NCT00263237|Lymphocyte|lymphocyte
699694|NCT00263237|Lamina Propria|lamina propria
699695|NCT00263237|Malabsorption|malabsorption
699696|NCT00263237|Colonoscopy|colonoscopy
699697|NCT00263237|Common Variable Immunodeficiency|common variable immunodeficiency
699698|NCT00263237|CVID|cvid
699699|NCT00263237|Gastrointestinal Inflammation|gastrointestinal inflammation
699700|NCT00263211|Breast Cancer|breast cancer
699701|NCT00263211|Metastatic|metastatic
699702|NCT00263211|Platelet|platelet
699703|NCT00263172|internet|internet
699704|NCT00263172|weight management|weight management
699705|NCT00263172|behavior therapy|behavior therapy
699706|NCT00263172|self-help|self-help
699707|NCT00263172|commercial program|commercial program
699708|NCT00263172|obesity|obesity
699709|NCT00263133|Depression|depression
699710|NCT00263133|SSRI|ssri
699711|NCT00263133|Sertraline|sertraline
699712|NCT00263133|synaptic plasticity|synaptic plasticity
699713|NCT00263133|visually evoked potentials|visually evoked potentials
699714|NCT00263107|telerounding|telerounding
699715|NCT00263107|minimally invasive surgery|minimally invasive surgery
699716|NCT00263094|Fasting|fasting
699717|NCT00263094|Headache|headache
699718|NCT00263094|Cox 2 Inhibitors|cox 2 inhibitors
699719|NCT00263094|Pain|pain
699720|NCT00263094|Prophylaxis|prophylaxis
699721|NCT00263081|Hyperlipidemia|hyperlipidemia
699722|NCT00263081|Dyslipidemia|dyslipidemia
699723|NCT00263081|Drug Therapy|drug therapy
699724|NCT00263068|IDIOPATHIC RESTLESS LEGS SYNDROME|idiopathic restless legs syndrome
699725|NCT00263042|Myocardial infarction|myocardial infarction
699726|NCT00263042|cerebrovascular accident|cerebrovascular accident
699727|NCT00263042|obesity|obesity
699728|NCT00262990|Epithelial ovarian cancer|epithelial ovarian cancer
699729|NCT00262990|fallopian tube cancer|fallopian tube cancer
699730|NCT00262990|peritoneal cancer|peritoneal cancer
699731|NCT00262990|primary cancer|primary cancer
699732|NCT00262990|recurrent cancer|recurrent cancer
699733|NCT00262990|doxorubicin|doxorubicin
699734|NCT00262990|taxane chemotherapy|taxane chemotherapy
699735|NCT00262990|platinum chemotherapy|platinum chemotherapy
699736|NCT00262990|Patupilone|patupilone
699737|NCT00262990|taxane platinum resistant|taxane platinum resistant
699738|NCT00262977|diabetes mellitus|diabetes mellitus
699739|NCT00262977|cardiovascular diseases|cardiovascular diseases
699740|NCT00262977|aspirin|aspirin
699741|NCT00262977|quality of healthcare|quality of healthcare
699742|NCT00262964|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
699743|NCT00262964|obesity|obesity
699744|NCT00262964|fatty liver disease|fatty liver disease
699745|NCT00262951|stage I pancreatic cancer|stage i pancreatic cancer
699746|NCT00262951|stage II pancreatic cancer|stage ii pancreatic cancer
699747|NCT00262951|stage III pancreatic cancer|stage iii pancreatic cancer
699748|NCT00262951|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
699749|NCT00262938|stage I endometrial carcinoma|stage i endometrial carcinoma
699750|NCT00262938|stage II endometrial carcinoma|stage ii endometrial carcinoma
699751|NCT00262938|weight changes|weight changes
699752|NCT00262925|MOAD|moad
699753|NCT00262925|Methotrexate|methotrexate
699754|NCT00262925|Vincristine|vincristine
699755|NCT00262925|L-asparaginase|l-asparaginase
699756|NCT00262925|Dexamethasone|dexamethasone
699757|NCT00262925|Subcutaneous Campath|subcutaneous campath
699758|NCT00262899|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
699759|NCT00262899|ductal breast carcinoma in situ|ductal breast carcinoma in situ
699760|NCT00262899|breast cancer in situ|breast cancer in situ
699761|NCT00262899|stage IA breast cancer|stage ia breast cancer
699762|NCT00262899|stage IB breast cancer|stage ib breast cancer
699763|NCT00262899|stage II breast cancer|stage ii breast cancer
699764|NCT00262899|stage IIIA breast cancer|stage iiia breast cancer
699765|NCT00262886|recurrent renal cell cancer|recurrent renal cell cancer
699766|NCT00262886|stage IV renal cell cancer|stage iv renal cell cancer
699767|NCT00262873|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
699768|NCT00262873|refractory anemia with excess blasts|refractory anemia with excess blasts
699769|NCT00262873|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
699770|NCT00262873|refractory anemia|refractory anemia
699771|NCT00262873|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
699772|NCT00262873|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
699773|NCT00262860|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
699774|NCT00262808|stage II colon cancer|stage ii colon cancer
699775|NCT00262808|stage III colon cancer|stage iii colon cancer
699776|NCT00262808|adenocarcinoma of the colon|adenocarcinoma of the colon
699777|NCT00262795|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
699778|NCT00262795|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
699779|NCT00262795|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
699780|NCT00262795|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
699781|NCT00262795|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
699782|NCT00262782|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
699783|NCT00262782|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
699784|NCT00262782|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
699785|NCT00262782|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
699786|NCT00262769|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
699787|NCT00262769|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
699788|NCT00262769|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
699789|NCT00262769|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
699790|NCT00262769|recurrent gallbladder cancer|recurrent gallbladder cancer
699791|NCT00262769|unresectable gallbladder cancer|unresectable gallbladder cancer
699792|NCT00262769|metastatic extrahepatic bile duct cancer|metastatic extrahepatic bile duct cancer
699793|NCT00262769|metastatic gallbladder cancer|metastatic gallbladder cancer
699794|NCT00262743|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
699795|NCT00262743|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
699796|NCT00262743|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
699797|NCT00262743|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
699798|NCT00262730|adult glioblastoma|adult glioblastoma
699799|NCT00262730|adult giant cell glioblastoma|adult giant cell glioblastoma
699800|NCT00262730|adult gliosarcoma|adult gliosarcoma
699801|NCT00262717|HIV drug resistance testing|hiv drug resistance testing
699802|NCT00262717|Treatment Experienced|treatment experienced
699803|NCT00262704|physician intervention|physician intervention
699804|NCT00262704|diabetes mellitus|diabetes mellitus
699805|NCT00262704|primary care|primary care
699806|NCT00262704|quality improvement|quality improvement
699807|NCT00262704|disease management|disease management
699808|NCT00262652|sodium pyruvate|sodium pyruvate
699809|NCT00262652|anti-inflammatory|anti-inflammatory
699810|NCT00262652|bronchodilation|bronchodilation
699811|NCT00262652|asthma|asthma
699812|NCT00262652|asthmatics|asthmatics
699813|NCT00262639|Alcoholism|alcoholism
699814|NCT00262639|Alcohol Dependence|alcohol dependence
699815|NCT00262639|Alcohol Withdrawal|alcohol withdrawal
699816|NCT00262639|Treatment|treatment
699817|NCT00262639|Pharmacotherapy|pharmacotherapy
699818|NCT00262613|Sodium Pyruvate|sodium pyruvate
699819|NCT00262613|COPD|copd
699820|NCT00262613|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
699821|NCT00262587|Sport|sport
699822|NCT00262587|Asthma|asthma
699823|NCT00262587|Treatment|treatment
699824|NCT00262587|Airway inflammation|airway inflammation
699825|NCT00262574|endothelial disfunction|endothelial disfunction
699827|NCT00262574|PCI|pci
699828|NCT00262574|coronary artery disease|coronary artery disease
699829|NCT00262561|Intermittent Claudication|intermittent claudication
699830|NCT00262561|Aspirin resistance|aspirin resistance
699831|NCT00262561|Clopidogrel resistance|clopidogrel resistance
699832|NCT00262548|Obesity|obesity
699833|NCT00262548|Menopause|menopause
699834|NCT00262522|Human Immunodeficiency Virus Infections|human immunodeficiency virus infections
699835|NCT00262509|Rehabilitation|rehabilitation
699836|NCT00262509|Sensory Aid|sensory aid
699837|NCT00262496|Botox|botox
699838|NCT00262496|Overactive bladder|overactive bladder
699839|NCT00262496|Incontinence|incontinence
699840|NCT00262496|Spinal Cord Injury|spinal cord injury
699841|NCT00262470|tachycardia|tachycardia
699842|NCT00262470|sinus tachycardia|sinus tachycardia
699843|NCT00262470|postural tachycardia syndrome (POTS)|postural tachycardia syndrome (pots)
699844|NCT00262457|electrical stimulation|electrical stimulation
699845|NCT00262457|Pressure Ulcers|pressure ulcers
699846|NCT00262457|Spinal Cord Injury|spinal cord injury
699847|NCT00262431|Tracheostomy|tracheostomy
699848|NCT00262431|Tracheostomy timing|tracheostomy timing
699849|NCT00262431|Ventilator associated pneumonia|ventilator associated pneumonia
699850|NCT00262431|Mechanical ventilation|mechanical ventilation
699851|NCT00262392|heterotopic ossification,|heterotopic ossification,
699852|NCT00262392|prevention,|prevention,
699853|NCT00262392|high risk,|high risk,
699854|NCT00262392|bisphosphonates,|bisphosphonates,
699855|NCT00262392|radiotherapy|radiotherapy
699856|NCT00262379|Chronic hepatitis C|chronic hepatitis c
699857|NCT00262379|peginterferon|peginterferon
699858|NCT00262379|ribavirin|ribavirin
699859|NCT00262379|epoetin beta|epoetin beta
699860|NCT00262340|Asthma|asthma
699861|NCT00262340|Pediatrics|pediatrics
699862|NCT00262340|Airway|airway
699863|NCT00262340|Inflammation|inflammation
699864|NCT00262327|antiangiogenesis|antiangiogenesis
699865|NCT00262327|endostatin|endostatin
699866|NCT00262327|adenovirus|adenovirus
699867|NCT00262327|gene therapy|gene therapy
699868|NCT00262327|cancer|cancer
699869|NCT00262236|Hypertension, Aliskiren, Atenolol, Blood Pressure|hypertension, aliskiren, atenolol, blood pressure
699870|NCT00262223|Co-morbid alcohol dependence and PTSD|co-morbid alcohol dependence and ptsd
699871|NCT00262223|Alcohol and other drug use disorders|alcohol and other drug use disorders
699872|NCT00262223|Treatment outcome|treatment outcome
699873|NCT00262197|Diabetes mellitus|diabetes mellitus
699874|NCT00262197|Medical error rates|medical error rates
699875|NCT00262197|Pharmacotherapy|pharmacotherapy
699876|NCT00262184|Post-Menopausal osteopenia|post-menopausal osteopenia
699877|NCT00262158|smoking status|smoking status
699878|NCT00262158|cigarette consumption|cigarette consumption
699879|NCT00262145|glucose|glucose
699880|NCT00262145|lipid|lipid
699881|NCT00262145|diabetes|diabetes
699882|NCT00262145|overweight|overweight
699883|NCT00262119|Physiological pacing|physiological pacing
699884|NCT00262119|Antitachycardia pacing therapies|antitachycardia pacing therapies
699885|NCT00262106|Administration, intravaginal|administration, intravaginal
699886|NCT00262106|Anti-infective agents|anti-infective agents
699887|NCT00262106|Double blind method|double blind method
699888|NCT00262106|Drug evaluation|drug evaluation
699889|NCT00262106|Female|female
699890|NCT00262106|Gels|gels
699891|NCT00262106|HIV infections/prevention and control|hiv infections/prevention and control
699892|NCT00262106|Microbicide|microbicide
699893|NCT00262106|Naphthalenesulfonates/administration and dosage|naphthalenesulfonates/administration and dosage
699894|NCT00262106|Polymers/administration and dosage|polymers/administration and dosage
699895|NCT00262106|Sexual behavior|sexual behavior
699896|NCT00262106|Vaginal creams, foams and jellies|vaginal creams, foams and jellies
699897|NCT00262106|HIV Seronegativity|hiv seronegativity
699898|NCT00262106|Genital Herpes Infections|genital herpes infections
699899|NCT00262093|preeclampsia|preeclampsia
699900|NCT00262093|sFlt1|sflt1
699901|NCT00262093|PlGF|plgf
699902|NCT00262093|parity|parity
699903|NCT00262093|angiogenesis|angiogenesis
699904|NCT00262054|coronary disease|coronary disease
699905|NCT00261989|pulse oximetry readings|pulse oximetry readings
699906|NCT00261989|pediatrics|pediatrics
699907|NCT00261989|cardiac|cardiac
699908|NCT00261989|congenital heart disease|congenital heart disease
699909|NCT00261976|Rheumatoid arthritis|rheumatoid arthritis
699910|NCT00261976|Crohn's disease|crohn's disease
699911|NCT00261976|Psoriasis|psoriasis
699912|NCT00261950|Cinacalcet HCl, Cinacalcet, Amgen (AMG) 073, Sensipar, Mimpara, Calcimimetic|cinacalcet hcl, cinacalcet, amgen (amg) 073, sensipar, mimpara, calcimimetic
699913|NCT00261924|Thrombocytopenic patients|thrombocytopenic patients
699914|NCT00261911|Meridia|meridia
699915|NCT00261911|Sibutramine|sibutramine
699916|NCT00261911|Obesity|obesity
699917|NCT00261911|Adolescent|adolescent
699918|NCT00261911|BMI|bmi
699919|NCT00261898|Sleep Deprivation|sleep deprivation
699920|NCT00261898|Obesity|obesity
699921|NCT00261898|Metabolic Syndrome|metabolic syndrome
699922|NCT00261898|Hormones|hormones
699923|NCT00261898|Public Health|public health
699924|NCT00261898|Overweight|overweight
699925|NCT00261898|Sleep|sleep
699926|NCT00261872|Alcoholism|alcoholism
699927|NCT00261872|Attention Deficit Disorder|attention deficit disorder
699928|NCT00261872|ADHD|adhd
699929|NCT00261859|hazardous drinking|hazardous drinking
699930|NCT00261846|Leukemia|leukemia
699931|NCT00261846|tyrosine kinase inhibitor|tyrosine kinase inhibitor
699932|NCT00261846|philadelphia chromosome|philadelphia chromosome
699933|NCT00261846|Myeloid|myeloid
699934|NCT00261846|Philadelphia Positive|philadelphia positive
699935|NCT00261833|Alpha1-proteinase inhibitor deficiency|alpha1-proteinase inhibitor deficiency
699936|NCT00261833|Emphysema|emphysema
699937|NCT00261833|Chronic augmentation and maintenance therapy|chronic augmentation and maintenance therapy
699938|NCT00261820|Kidney Transplant|kidney transplant
699939|NCT00261807|severe|severe
699940|NCT00261807|skin|skin
699941|NCT00261807|infections|infections
699942|NCT00261794|cognition|cognition
699943|NCT00261794|schizophrenia|schizophrenia
699944|NCT00261794|treatment|treatment
699945|NCT00261781|Treadmill|treadmill
699946|NCT00261781|Walking|walking
699947|NCT00261781|Exercise|exercise
699948|NCT00261781|Automaticity|automaticity
699949|NCT00261781|Quality of Life|quality of life
699950|NCT00261768|Aging|aging
699951|NCT00261768|hearing aids|hearing aids
699952|NCT00261768|hearing loss, sensorineural|hearing loss, sensorineural
699953|NCT00261768|speech recognition|speech recognition
699954|NCT00261755|Acupuncture|acupuncture
699955|NCT00261755|pain relief|pain relief
699956|NCT00261755|labour|labour
699957|NCT00261755|randomized controlled trial|randomized controlled trial
699958|NCT00261755|TENS|tens
699959|NCT00261742|perianal|perianal
699960|NCT00261742|dermatitis|dermatitis
699961|NCT00261742|streptococcus pyogenes|streptococcus pyogenes
699962|NCT00261729|Paroxetine|paroxetine
699963|NCT00261729|Prazosin|prazosin
699964|NCT00261729|Sleep Disorders|sleep disorders
699965|NCT00261729|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
699966|NCT00261716|clinical trial|clinical trial
699967|NCT00261716|employment|employment
699968|NCT00261716|schizoaffective disorder|schizoaffective disorder
699969|NCT00261716|schizophrenia|schizophrenia
699970|NCT00261690|Virtual Reality Distraction|virtual reality distraction
699971|NCT00261677|Anemia|anemia
699972|NCT00261677|cancer|cancer
699973|NCT00261677|solid tumor|solid tumor
699974|NCT00261677|Hodgkin's Disease|hodgkin's disease
699975|NCT00261677|Acute Lymphocytic Leukemia (ALL)|acute lymphocytic leukemia (all)
699976|NCT00261677|Non-Hodgkin's Lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
699977|NCT00261677|Quality of Life|quality of life
699978|NCT00261677|hemoglobin|hemoglobin
699979|NCT00261677|Epoetin alfa|epoetin alfa
699980|NCT00261638|Mental Health Promotion|mental health promotion
699981|NCT00261638|Mental Health Index|mental health index
699982|NCT00261638|Taiwan Mental Health Index scale|taiwan mental health index scale
699983|NCT00261638|psychophysical health|psychophysical health
699984|NCT00261638|education years over 9 years|education years over 9 years
699985|NCT00261638|normal people, especially joining Mental Health Foundation Promotions|normal people, especially joining mental health foundation promotions
699986|NCT00261625|peritoneal dialysis|peritoneal dialysis
699987|NCT00261625|artery calcification|artery calcification
699988|NCT00261625|bone mineral density|bone mineral density
699989|NCT00261612|relapsed or chemotherapy-refractory disease|relapsed or chemotherapy-refractory disease
699990|NCT00261599|Colonoscopy|colonoscopy
699991|NCT00261599|Sedation|sedation
699992|NCT00261599|AQUAVAN|aquavan
699993|NCT00261599|Fospropofol disodium|fospropofol disodium
699994|NCT00261599|Colon polyps|colon polyps
699995|NCT00261599|Endoscopic outcomes|endoscopic outcomes
699996|NCT00261599|Endoscopic sedation|endoscopic sedation
699997|NCT00261599|Endoscopy|endoscopy
699998|NCT00261586|aspirin|aspirin
699999|NCT00261586|analgesics|analgesics
700000|NCT00261586|cyclooxygenase activity|cyclooxygenase activity
700001|NCT00261586|non-steroidal antiinflammatory drugs|non-steroidal antiinflammatory drugs
700002|NCT00261573|"Alzheimer's disease with cerebrovascular disease (mixed dementia)"|"alzheimer's disease with cerebrovascular disease (mixed dementia)"
700003|NCT00261573|probable vascular dementia|probable vascular dementia
700004|NCT00261573|galantamine|galantamine
700005|NCT00261560|ankle sprain|ankle sprain
700006|NCT00261560|acetaminophen extended release, ibuprofen|acetaminophen extended release, ibuprofen
700007|NCT00261547|Kidney transplantation|kidney transplantation
700008|NCT00261547|HLA|hla
700009|NCT00261534|Chemotherapy|chemotherapy
700010|NCT00261521|Kidney failure, Chronic|kidney failure, chronic
700011|NCT00261521|End-stage renal disease|end-stage renal disease
700012|NCT00261521|Kidney failure|kidney failure
700013|NCT00261521|Anemia|anemia
700014|NCT00261521|Dialysis|dialysis
700015|NCT00261521|Epoetin|epoetin
700016|NCT00261521|Erythropoetin|erythropoetin
700017|NCT00261521|Epoetin alfa|epoetin alfa
700018|NCT00261508|Risperidone|risperidone
700019|NCT00261508|child development disorders|child development disorders
700020|NCT00261508|pervasive development disorders|pervasive development disorders
700021|NCT00261508|autistic disorder|autistic disorder
700022|NCT00261508|autism|autism
700023|NCT00261508|developmental disabilities|developmental disabilities
700024|NCT00261508|antipsychotropic agents|antipsychotropic agents
700025|NCT00261495|chronic noncancer pain|chronic noncancer pain
700026|NCT00261495|pain|pain
700027|NCT00261495|analgesia|analgesia
700028|NCT00261495|analgesic opioid|analgesic opioid
700029|NCT00261495|oxycodone|oxycodone
700030|NCT00261495|hydromorphone|hydromorphone
700031|NCT00261482|contraception|contraception
700032|NCT00261482|female contraception|female contraception
700033|NCT00261482|hormonal contraception|hormonal contraception
700034|NCT00261482|transdermal contraception|transdermal contraception
700035|NCT00261482|EVRA|evra
700036|NCT00261482|estrogen|estrogen
700037|NCT00261482|progestin|progestin
700038|NCT00261482|ethinyl estradiol|ethinyl estradiol
700039|NCT00261482|norelgestromin|norelgestromin
700040|NCT00261469|Migraine|migraine
700041|NCT00261469|Headache|headache
700042|NCT00261456|Prostate cancer|prostate cancer
700043|NCT00261456|BRCA1|brca1
700044|NCT00261456|BRCA2|brca2
700334|NCT00260338|stem cell|stem cell
700045|NCT00261456|prostate screening|prostate screening
700046|NCT00261456|PSA|psa
700047|NCT00261456|prostate biopsy|prostate biopsy
700048|NCT00261443|Bipolar I Disorder with a recent manic or mixed episode|bipolar i disorder with a recent manic or mixed episode
700049|NCT00261430|Schizophrenia|schizophrenia
700050|NCT00261430|acceptance|acceptance
700051|NCT00261430|motivational enhancement therapy|motivational enhancement therapy
700052|NCT00261430|long-acting risperidone|long-acting risperidone
700053|NCT00261430|intramuscular injection|intramuscular injection
700054|NCT00261430|Treatment Guidebook|treatment guidebook
700055|NCT00261430|GAIN Acceptance Approach|gain acceptance approach
700056|NCT00261391|Arteriovenous Malformation|arteriovenous malformation
700057|NCT00261391|Lymphatic Malformation|lymphatic malformation
700058|NCT00261391|Gorham|gorham
700059|NCT00261378|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
700060|NCT00261339|Gastroesophageal Reflux|gastroesophageal reflux
700061|NCT00261339|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
700062|NCT00261339|Pantoprazole|pantoprazole
700063|NCT00261326|Simvastatin|simvastatin
700064|NCT00261326|Optic Neuritis|optic neuritis
700065|NCT00261326|Multiple Sclerosis|multiple sclerosis
700066|NCT00261313|Breast cancer|breast cancer
700067|NCT00261313|Doses dense chemotherapy|doses dense chemotherapy
700068|NCT00261313|Growth factor support|growth factor support
700069|NCT00261313|Adjuvant Breast Cancer|adjuvant breast cancer
700070|NCT00261300|Gastric acid|gastric acid
700071|NCT00261300|GERD|gerd
700072|NCT00261300|Gastroesophageal reflux disease|gastroesophageal reflux disease
700073|NCT00261300|Pantoprazole|pantoprazole
700074|NCT00261300|Proton pump inhibitor|proton pump inhibitor
700075|NCT00261287|Hay Fever|hay fever
700076|NCT00261287|Allergic Rhinitis|allergic rhinitis
700077|NCT00261287|Perennial Allergic Rhinitis|perennial allergic rhinitis
700078|NCT00261287|Ciclesonide|ciclesonide
700079|NCT00261274|transfusion; red blood cells|transfusion; red blood cells
700080|NCT00261261|children|children
700081|NCT00261261|anxiety|anxiety
700082|NCT00261261|behavioral preparation|behavioral preparation
700083|NCT00261261|family|family
700084|NCT00261261|surgery|surgery
700085|NCT00261261|parents|parents
700086|NCT00261248|Phase 2|phase 2
700087|NCT00261248|Vaccine|vaccine
700088|NCT00261248|Urinary Tract Infection|urinary tract infection
700089|NCT00261248|Vaginal Mucosal|vaginal mucosal
700090|NCT00261235|Rehabilitation, Vocational|rehabilitation, vocational
700091|NCT00261235|Virtues|virtues
700092|NCT00261235|Employment, supported|employment, supported
700093|NCT00261235|veterans|veterans
700094|NCT00261235|Mentally Ill Persons|mentally ill persons
700095|NCT00261222|Amodiaquine|amodiaquine
700096|NCT00261222|Efficacy|efficacy
700097|NCT00261222|Malaria|malaria
700098|NCT00261222|Burkina Faso|burkina faso
700099|NCT00261209|Flexor Tendon Adhesions|flexor tendon adhesions
700100|NCT00261209|Zone II of the Hand|zone ii of the hand
700101|NCT00261196|Frozen Shoulder|frozen shoulder
700102|NCT00261170|smoking|smoking
700103|NCT00261157|nephrectomy|nephrectomy
700104|NCT00261157|Safety|safety
700105|NCT00261157|Laparoscopy|laparoscopy
700106|NCT00261157|telerounding|telerounding
700107|NCT00261157|prostatectomy|prostatectomy
700108|NCT00261131|cerebral palsy|cerebral palsy
700109|NCT00261131|spasticity|spasticity
700110|NCT00261131|diplegia|diplegia
700111|NCT00261118|colitis|colitis
700112|NCT00261118|rituximab|rituximab
700113|NCT00261066|Functional outcome|functional outcome
700114|NCT00261066|Orthopaedic surgery|orthopaedic surgery
700115|NCT00261040|Osteoarthritis|osteoarthritis
700116|NCT00261040|Total Hip Arthroplasty|total hip arthroplasty
700117|NCT00261040|Minimally Invasive Surgery|minimally invasive surgery
700118|NCT00261027|ovarian cancer|ovarian cancer
700119|NCT00261014|Recurrent|recurrent
700120|NCT00261014|Idiopathic|idiopathic
700121|NCT00261014|Deep Vein Thrombosis|deep vein thrombosis
700122|NCT00261014|Pulmonary Embolism|pulmonary embolism
700123|NCT00261014|Clinical Prediction Rule|clinical prediction rule
700124|NCT00261014|Venous Thromboembolism|venous thromboembolism
700125|NCT00261014|Risk Factors|risk factors
700126|NCT00261001|Transcutaneous|transcutaneous
700127|NCT00261001|Vaccination|vaccination
700128|NCT00261001|Safety|safety
700129|NCT00261001|Immunogenicity|immunogenicity
700131|NCT00261001|Treatment Experienced|treatment experienced
700132|NCT00260988|Prophylaxis|prophylaxis
700133|NCT00260988|Thromboembolic disease|thromboembolic disease
700134|NCT00260988|End stage renal disease|end stage renal disease
700135|NCT00260988|Hemodialysis|hemodialysis
700136|NCT00260988|Pharmacokinetics|pharmacokinetics
700137|NCT00260988|Low Molecular Weight Heparin|low molecular weight heparin
700138|NCT00260988|Innohep|innohep
700139|NCT00260988|Tinzaparin|tinzaparin
700140|NCT00260988|Fragmin|fragmin
700141|NCT00260988|Dalteparin|dalteparin
700142|NCT00260988|Anti Xa|anti xa
700143|NCT00260988|INR|inr
700144|NCT00260988|Oral anticoagulation|oral anticoagulation
700145|NCT00260988|warfarin|warfarin
700146|NCT00260988|Coumadin|coumadin
700147|NCT00260975|breast cancer|breast cancer
700148|NCT00260975|chemotherapy|chemotherapy
700149|NCT00260975|hormonal therapy|hormonal therapy
700150|NCT00260975|cognitive function|cognitive function
700151|NCT00260975|chemo fog|chemo fog
700152|NCT00260962|Pilot Project,|pilot project,
700153|NCT00260962|Clinical Trial,|clinical trial,
700154|NCT00260962|Treatment Outcome,|treatment outcome,
700155|NCT00260962|Psychopharmacology|psychopharmacology
700156|NCT00260949|rotator cuff tear|rotator cuff tear
700157|NCT00260949|arthroscopic repair|arthroscopic repair
700158|NCT00260936|HIV|hiv
700159|NCT00260936|AIDS|aids
700160|NCT00260936|Adolescent Males|adolescent males
700161|NCT00260936|HIV positive|hiv positive
700162|NCT00260936|Treatment Naive|treatment naive
700163|NCT00260936|Treatment Experienced|treatment experienced
700164|NCT00260923|hypertension|hypertension
700165|NCT00260923|aliskiren|aliskiren
700166|NCT00260923|blood pressure|blood pressure
700167|NCT00260897|avascular necrosis of the femoral head|avascular necrosis of the femoral head
700168|NCT00260897|genotyping|genotyping
700169|NCT00260897|linkage analysis|linkage analysis
700170|NCT00260897|pathogenesis|pathogenesis
700171|NCT00260897|therapy|therapy
700172|NCT00260871|lung adenocarcinoma|lung adenocarcinoma
700173|NCT00260871|genetic epidemiology|genetic epidemiology
700174|NCT00260871|environmental factors|environmental factors
700175|NCT00260871|genetic map|genetic map
700176|NCT00260871|coordination center|coordination center
700177|NCT00260858|Glycemic index|glycemic index
700178|NCT00260858|Nutrition|nutrition
700179|NCT00260858|Carbohydrates|carbohydrates
700180|NCT00260858|Glycemic responses|glycemic responses
700181|NCT00260858|Methodology|methodology
700182|NCT00260858|Healthy human subjects|healthy human subjects
700183|NCT00260832|Acute Myeloid Leukemia|acute myeloid leukemia
700184|NCT00260832|Dacogen|dacogen
700185|NCT00260832|Decitabine|decitabine
700186|NCT00260832|Poor or intermediate-risk cytogenetics|poor or intermediate-risk cytogenetics
700187|NCT00260819|Hypoxia-induced pulmonary artery hypertension|hypoxia-induced pulmonary artery hypertension
700188|NCT00260819|High-altitude pulmonary oedema|high-altitude pulmonary oedema
700189|NCT00260819|ETA receptor antagonist|eta receptor antagonist
700190|NCT00260793|Ropinirole|ropinirole
700191|NCT00260793|Parkinson's disease|parkinson's disease
700192|NCT00260793|dopamine agonist|dopamine agonist
700193|NCT00260780|sexually transmitted diseases|sexually transmitted diseases
700194|NCT00260780|Risk Behavior|risk behavior
700195|NCT00260754|Risk behavior|risk behavior
700196|NCT00260754|Sexually transmitted diseases|sexually transmitted diseases
700197|NCT00260741|cannabis|cannabis
700198|NCT00260741|marijuana|marijuana
700199|NCT00260741|Multiple Sclerosis|multiple sclerosis
700200|NCT00260741|Spasticity|spasticity
700201|NCT00260728|vascular access|vascular access
700202|NCT00260728|hemodialysis|hemodialysis
700203|NCT00260715|Risk behavior|risk behavior
700204|NCT00260715|Sexually Transmitted Diseases|sexually transmitted diseases
700205|NCT00260702|Phenotype|phenotype
700206|NCT00260702|Monoclonal|monoclonal
700207|NCT00260702|Immunoglobulin|immunoglobulin
700208|NCT00260702|Immunodeficiency|immunodeficiency
700209|NCT00260702|Dermatitis|dermatitis
700210|NCT00260702|Job's Syndrome|job's syndrome
700211|NCT00260702|Hyper-IgE Syndrome|hyper-ige syndrome
700212|NCT00260702|HIES|hies
700213|NCT00260689|Immunosuppression|immunosuppression
700214|NCT00260689|T-cells|t-cells
700215|NCT00260689|Hematopoiesis|hematopoiesis
700216|NCT00260689|Autoimmunity|autoimmunity
700217|NCT00260689|Thrombocytopenia|thrombocytopenia
700218|NCT00260689|Severe Aplastic Anemia|severe aplastic anemia
700219|NCT00260689|SAA|saa
700220|NCT00260676|brain death|brain death
700221|NCT00260676|lung transplantation|lung transplantation
700222|NCT00260676|organ donors|organ donors
700223|NCT00260676|potential organ donors|potential organ donors
700224|NCT00260663|Hearing Impaired Rehabilitation|hearing impaired rehabilitation
700225|NCT00260663|Hearing Aids|hearing aids
700226|NCT00260663|Randomized Controlled Trials|randomized controlled trials
700227|NCT00260663|Cost Effectiveness|cost effectiveness
700228|NCT00260663|Quality of life|quality of life
700229|NCT00260663|Patient Compliance|patient compliance
700230|NCT00260650|heart failure, congestive|heart failure, congestive
700231|NCT00260650|self-care|self-care
700232|NCT00260650|quality of life|quality of life
700233|NCT00260650|health behavior|health behavior
700234|NCT00260637|Prostatitis|prostatitis
700235|NCT00260624|agitation|agitation
700236|NCT00260624|dementia|dementia
700237|NCT00260624|Alzheimer's Disease|alzheimer's disease
700238|NCT00260611|prostate|prostate
700239|NCT00260598|Non-small cell lung cancer|non-small cell lung cancer
700240|NCT00260598|Head and neck squamous cell cancer|head and neck squamous cell cancer
700241|NCT00260598|White light bronchoscopy|white light bronchoscopy
700242|NCT00260598|Imaging Elastic Scattering Spectroscopy (IESS)|imaging elastic scattering spectroscopy (iess)
700243|NCT00260598|Fluorescence Bronchoscopy|fluorescence bronchoscopy
700245|NCT00260598|Helium-Cadmium Laser Bronchoscopy|helium-cadmium laser bronchoscopy
700246|NCT00260598|Autofluorescence spectra of dysplasia & cancer in situ (CIS)|autofluorescence spectra of dysplasia & cancer in situ (cis)
700335|NCT00260338|mesenchymal|mesenchymal
700247|NCT00260598|Severe Chronic Obstructive Pulmonary Disorders(COPD)|severe chronic obstructive pulmonary disorders(copd)
700248|NCT00260585|gastroesophageal reflux disease|gastroesophageal reflux disease
700249|NCT00260585|GERD|gerd
700250|NCT00260585|hiatal hernia|hiatal hernia
700251|NCT00260585|achalasia|achalasia
700252|NCT00260585|Barrett's metaplasia|barrett's metaplasia
700253|NCT00260585|Anti-Reflux Surgery|anti-reflux surgery
700254|NCT00260585|Known/suspected esophageal/gastroesophageal junction tumor|known/suspected esophageal/gastroesophageal junction tumor
700255|NCT00260585|Esophageal disorders such as Barrett's metaplasia|esophageal disorders such as barrett's metaplasia
700256|NCT00260585|Symptomatic gastroesophageal reflux disease|symptomatic gastroesophageal reflux disease
700257|NCT00260572|GERD|gerd
700258|NCT00260572|nissen|nissen
700259|NCT00260572|fundoplication|fundoplication
700260|NCT00260572|reflux|reflux
700261|NCT00260572|toupet|toupet
700262|NCT00260572|QOL|qol
700263|NCT00260572|dyspepsia|dyspepsia
700264|NCT00260572|heartburn|heartburn
700265|NCT00260572|Patients with reflux symptoms for at least 6 months|patients with reflux symptoms for at least 6 months
700266|NCT00260572|Patients scheduled for lap nissen or toupet fundoplication|patients scheduled for lap nissen or toupet fundoplication
700267|NCT00260572|Reflux diagnosed by either endoscopy, upper GI, or 24hr. pH (numeric scale used to specify the acidity of gastric contents)|reflux diagnosed by either endoscopy, upper gi, or 24hr. ph (numeric scale used to specify the acidity of gastric contents)
700268|NCT00260572|On or starting treatment with PPI or pro-motility agents|on or starting treatment with ppi or pro-motility agents
700269|NCT00260559|Esophagectomy|esophagectomy
700270|NCT00260559|Esophageal Cancer|esophageal cancer
700271|NCT00260559|Quality of Life|quality of life
700272|NCT00260559|Minimally Invasive Esophagectomy|minimally invasive esophagectomy
700273|NCT00260559|Laparoscopic Transhiatal Esophagectomy|laparoscopic transhiatal esophagectomy
700274|NCT00260559|Open Esophagectomy|open esophagectomy
700275|NCT00260559|Karnofsky Score|karnofsky score
700276|NCT00260559|Dysphagia score|dysphagia score
700277|NCT00260559|Heartburn Scale|heartburn scale
700278|NCT00260559|Nutrition Score|nutrition score
700279|NCT00260546|Ventricular dyssynchrony|ventricular dyssynchrony
700280|NCT00260520|Low molecular weight heparin|low molecular weight heparin
700281|NCT00260520|Preeclampsia|preeclampsia
700282|NCT00260520|Fetal Growth Restriction|fetal growth restriction
700283|NCT00260520|Thrombophilia|thrombophilia
700284|NCT00260520|Factor V Leiden|factor v leiden
700285|NCT00260520|G20210A prothrombin gene mutation|g20210a prothrombin gene mutation
700286|NCT00260494|Cardiac Surgical Procedures|cardiac surgical procedures
700287|NCT00260494|open saphenous vein graft harvest wounds|open saphenous vein graft harvest wounds
700288|NCT00260494|Postoperative Complications|postoperative complications
700289|NCT00260494|Surgical Wound Infection|surgical wound infection
700290|NCT00260494|Surgical Wound Dehiscence|surgical wound dehiscence
700291|NCT00260481|Methamphetamine Dependence|methamphetamine dependence
700292|NCT00260481|Pharmacotherapy|pharmacotherapy
700293|NCT00260468|Major depression|major depression
700294|NCT00260468|Magnetic resonance imaging|magnetic resonance imaging
700295|NCT00260468|White matter lesions|white matter lesions
700296|NCT00260468|Perfusion|perfusion
700297|NCT00260468|Diffusion|diffusion
700298|NCT00260468|Magnetization transfer|magnetization transfer
700299|NCT00260468|Vascular risk factors|vascular risk factors
700300|NCT00260442|sarcopenia|sarcopenia
700301|NCT00260442|resistance training|resistance training
700302|NCT00260442|strength training|strength training
700303|NCT00260442|skeletal muscle|skeletal muscle
700304|NCT00260442|elderly|elderly
700305|NCT00260442|cholesterol|cholesterol
700306|NCT00260442|aging|aging
700307|NCT00260442|cardiovascular disease|cardiovascular disease
700308|NCT00260442|nutrition|nutrition
700309|NCT00260442|inflammation|inflammation
700310|NCT00260442|lipids|lipids
700311|NCT00260429|Dupuytren's contracture|dupuytren's contracture
700312|NCT00260429|fixed flexion contracture|fixed flexion contracture
700313|NCT00260416|Acute myocardial infarction|acute myocardial infarction
700314|NCT00260416|Symptom duration|symptom duration
700315|NCT00260416|Primary angioplasty|primary angioplasty
700316|NCT00260416|Infarct size|infarct size
700317|NCT00260416|Myocardial scintigraphy|myocardial scintigraphy
700318|NCT00260390|Dysthymic Disorder|dysthymic disorder
700319|NCT00260390|HPG hypofunctioning|hpg hypofunctioning
700320|NCT00260390|Testosterone replacement|testosterone replacement
700321|NCT00260377|Aspirin treatment|aspirin treatment
700322|NCT00260377|Aspirin resistance|aspirin resistance
700323|NCT00260377|Coronary bypass surgery|coronary bypass surgery
700324|NCT00260364|Recurrent carcinoma of the pancreas|recurrent carcinoma of the pancreas
700325|NCT00260364|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
700326|NCT00260364|Stage II carcinoma of the pancreas|stage ii carcinoma of the pancreas
700327|NCT00260364|Stage III carcinoma of the pancreas|stage iii carcinoma of the pancreas
700328|NCT00260364|Stage IVA carcinoma of the pancreas|stage iva carcinoma of the pancreas
700329|NCT00260364|Stage IVB carcinoma of the pancreas|stage ivb carcinoma of the pancreas
700330|NCT00260351|rabies;|rabies;
700331|NCT00260351|rabies post-exposure;|rabies post-exposure;
700332|NCT00260351|category III|category iii
700333|NCT00260338|myocardial ischemia|myocardial ischemia
700336|NCT00260338|myocardial perfusion|myocardial perfusion
700337|NCT00260325|pretreatment|pretreatment
700338|NCT00260325|healthy volunteers|healthy volunteers
700339|NCT00260312|inactived|inactived
700340|NCT00260312|polio|polio
700341|NCT00260312|vaccine|vaccine
700342|NCT00260312|cuba|cuba
700343|NCT00260312|trial|trial
700344|NCT00260312|randomized|randomized
700345|NCT00260312|eradication|eradication
700346|NCT00260299|cholesterol defects|cholesterol defects
700347|NCT00260299|Mevalonic Aciduria|mevalonic aciduria
700348|NCT00260299|Mevalonate Kinase Deficiency|mevalonate kinase deficiency
700349|NCT00260299|HIDS|hids
700350|NCT00260299|Hyperimmunoglobulinemia with periodic fever syndrome|hyperimmunoglobulinemia with periodic fever syndrome
700351|NCT00260299|MKD|mkd
700352|NCT00260299|Lipid Metabolism, Inborn Errors|lipid metabolism, inborn errors
700353|NCT00260299|Periodic Fever Syndromes, hereditary|periodic fever syndromes, hereditary
700354|NCT00260299|mevalonic acid|mevalonic acid
700355|NCT00260299|mevalonate kinase|mevalonate kinase
700356|NCT00260299|cholesterol, dietary|cholesterol, dietary
700357|NCT00260299|Hyper IgD|hyper igd
700358|NCT00260299|Multiple malformations|multiple malformations
700359|NCT00260299|Fever|fever
700360|NCT00260286|LH pulsatility|lh pulsatility
700361|NCT00260286|energy availability|energy availability
700362|NCT00260286|exercise|exercise
700363|NCT00260286|diet|diet
700364|NCT00260286|gynecological age|gynecological age
700365|NCT00260273|Preventive Therapy|preventive therapy
700366|NCT00260273|Psychoses|psychoses
700367|NCT00260273|Cognitive Behaviour Therapy|cognitive behaviour therapy
700368|NCT00260247|CYP3A4|cyp3a4
700369|NCT00260247|Induction|induction
700370|NCT00260247|Oxcarbazepine|oxcarbazepine
700371|NCT00260247|Carbamazepine|carbamazepine
700372|NCT00260247|Quinidine|quinidine
700373|NCT00260247|Human|human
700374|NCT00260247|In vivo|in vivo
700375|NCT00260234|Transplantation, Pancreatic Islets|transplantation, pancreatic islets
700376|NCT00260234|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
700377|NCT00260234|Insulin Dependent|insulin dependent
700378|NCT00260234|Islet Transplant|islet transplant
700379|NCT00260221|Virtual Reality Hypnosis|virtual reality hypnosis
700380|NCT00260208|Liver transplant, adults, hepatitis C, liver fibrosis, cyclosporine microemulsion, tacrolimus|liver transplant, adults, hepatitis c, liver fibrosis, cyclosporine microemulsion, tacrolimus
700381|NCT00260195|Trauma|trauma
700382|NCT00260195|Violence|violence
700383|NCT00260195|Adolescent|adolescent
700384|NCT00260195|Schools|schools
700385|NCT00260195|Cognitive behavioral therapy|cognitive behavioral therapy
700386|NCT00260182|Depressive Disorder|depressive disorder
700387|NCT00260182|Family|family
700388|NCT00260182|Genetics|genetics
700389|NCT00260169|Treatment Preferences|treatment preferences
700390|NCT00260169|Public sector|public sector
700391|NCT00260169|Latino|latino
700392|NCT00260156|Type 2 diabetes|type 2 diabetes
700393|NCT00260156|vildagliptin|vildagliptin
700394|NCT00260143|HIV+ men|hiv+ men
700395|NCT00260143|Treatment Experienced|treatment experienced
700396|NCT00260130|obesity|obesity
700397|NCT00260130|food intake|food intake
700398|NCT00260130|human|human
700399|NCT00260130|energy balance|energy balance
700400|NCT00260130|beverage|beverage
700401|NCT00260117|Exercise|exercise
700402|NCT00260117|Physical activity|physical activity
700403|NCT00260117|walking|walking
700404|NCT00260117|running|running
700405|NCT00260091|Infertility|infertility
700406|NCT00260091|Advanced maternal age|advanced maternal age
700407|NCT00260091|Pregnancy|pregnancy
700408|NCT00260091|Reproductive health|reproductive health
700409|NCT00260091|Fertility treatment|fertility treatment
700410|NCT00260091|Reproduction|reproduction
700411|NCT00260078|Treatment Experienced|treatment experienced
700412|NCT00260078|Pharmacokinetics|pharmacokinetics
700413|NCT00260078|PK|pk
700414|NCT00260065|Myelodysplastic Syndrome|myelodysplastic syndrome
700415|NCT00260065|Decitabine|decitabine
700416|NCT00260065|Dacogen|dacogen
700417|NCT00260065|MGI Pharma|mgi pharma
700418|NCT00260052|traumatic brain injury|traumatic brain injury
700419|NCT00260026|Lung Cancer|lung cancer
700420|NCT00260013|chronic mental illness|chronic mental illness
700421|NCT00260000|mild PKU|mild pku
700422|NCT00260000|Y414C|y414c
700423|NCT00260000|5,6,7,8-tetrahydrobiopterin, BH4|5,6,7,8-tetrahydrobiopterin, bh4
700424|NCT00260000|treatment without protein restriction|treatment without protein restriction
700425|NCT00259987|relapsed adenocarcinoma|relapsed adenocarcinoma
700426|NCT00259987|esophagus|esophagus
700427|NCT00259987|tumors|tumors
700428|NCT00259987|GE junction|ge junction
700429|NCT00259987|cancer|cancer
700430|NCT00259987|lapatinib|lapatinib
700431|NCT00259987|gastric cardia|gastric cardia
700432|NCT00259974|Anti-MAG monoclonal gammopathy|anti-mag monoclonal gammopathy
700433|NCT00259974|Polyneuropathy|polyneuropathy
700434|NCT00259974|Rituximab|rituximab
700435|NCT00259948|HR variability, CVA, Myocardial infarction, aerobic exercise training|hr variability, cva, myocardial infarction, aerobic exercise training
700436|NCT00259935|Any Solid Tumor|any solid tumor
700894|NCT00258193|IBS-C|ibs-c
700437|NCT00259922|constipation|constipation
700438|NCT00259922|gastrointestinal|gastrointestinal
700439|NCT00259922|opioids|opioids
700440|NCT00259922|pain|pain
700441|NCT00259922|non-cancer pain|non-cancer pain
700442|NCT00259922|opioid-induced|opioid-induced
700443|NCT00259922|bowel dysfunction|bowel dysfunction
700444|NCT00259909|Patient reported outcomes|patient reported outcomes
700445|NCT00259909|COPD|copd
700446|NCT00259909|acute exacerbation of chronic obstructive pulmonary disease (AECOPD)|acute exacerbation of chronic obstructive pulmonary disease (aecopd)
700447|NCT00259896|exenatide|exenatide
700448|NCT00259896|pharmacokinetics|pharmacokinetics
700449|NCT00259896|pharmacodynamics|pharmacodynamics
700450|NCT00259883|depressive episodes|depressive episodes
700451|NCT00259883|paroxetine|paroxetine
700452|NCT00259883|PAXIL|paxil
700453|NCT00259883|depression|depression
700454|NCT00259883|benzodiazepine|benzodiazepine
700455|NCT00259883|combination|combination
700456|NCT00259870|Schizophrenia|schizophrenia
700457|NCT00259870|PANSS|panss
700458|NCT00259870|Acute|acute
700459|NCT00259870|Cognition|cognition
700460|NCT00259857|Fracture|fracture
700461|NCT00259857|Bone Mineral Density|bone mineral density
700462|NCT00259857|DXA|dxa
700463|NCT00259844|Colorectal|colorectal
700464|NCT00259844|Liver Metastases|liver metastases
700465|NCT00259844|Vaccine|vaccine
700466|NCT00259844|Colorectal Liver Metastases|colorectal liver metastases
700467|NCT00259831|cold|cold
700468|NCT00259831|influenza|influenza
700469|NCT00259818|Refractory|refractory
700470|NCT00259818|Solid Tumors|solid tumors
700471|NCT00259805|encephalitis|encephalitis
700472|NCT00259805|epilepsy|epilepsy
700473|NCT00259805|Rasmussens|rasmussens
700474|NCT00259805|rituximab|rituximab
700475|NCT00259805|autoimmune|autoimmune
700476|NCT00259779|COPD|copd
700477|NCT00259753|Wet Age-Related Macular Degeneration|wet age-related macular degeneration
700478|NCT00259740|Multiple Myeloma, Relapsed, Plateau-Phase|multiple myeloma, relapsed, plateau-phase
700479|NCT00259727|Amprenavir|amprenavir
700480|NCT00259727|Glucagon|glucagon
700481|NCT00259727|HIV Protease inhibitors|hiv protease inhibitors
700482|NCT00259727|Indinavir|indinavir
700483|NCT00259727|Lopinavir|lopinavir
700484|NCT00259727|Ritonavir|ritonavir
700485|NCT00259714|hypertension|hypertension
700486|NCT00259714|hemodialysis|hemodialysis
700487|NCT00259714|sodium|sodium
700488|NCT00259714|dialysate|dialysate
700489|NCT00259714|hemodynamics|hemodynamics
700490|NCT00259701|endothelium|endothelium
700491|NCT00259701|iontophoresis|iontophoresis
700492|NCT00259701|acetylcholine|acetylcholine
700493|NCT00259701|nitroglycerin|nitroglycerin
700494|NCT00259701|vasodilation|vasodilation
700495|NCT00259688|Preeclampsia|preeclampsia
700496|NCT00259688|Sleep Apnea|sleep apnea
700497|NCT00259688|CPAP|cpap
700498|NCT00259662|cancer--ovarian|cancer--ovarian
700499|NCT00259662|cancer--endometria|cancer--endometria
700500|NCT00259662|deep vein thrombosis|deep vein thrombosis
700501|NCT00259662|statin therapy in perioperative period|statin therapy in perioperative period
700502|NCT00259623|Cardiac surgery|cardiac surgery
700503|NCT00259623|Radiofrequency ablation|radiofrequency ablation
700504|NCT00259623|Atrial fibrillation|atrial fibrillation
700505|NCT00259610|RA|ra
700506|NCT00259610|painful joints|painful joints
700507|NCT00259610|swollen joints|swollen joints
700508|NCT00259597|nuclear morphology|nuclear morphology
700509|NCT00259597|image analysis|image analysis
700510|NCT00259597|lipid peroxidation|lipid peroxidation
700511|NCT00259597|diet|diet
700512|NCT00259597|proliferative breast disease|proliferative breast disease
700513|NCT00259571|remission|remission
700514|NCT00259571|mesalazin|mesalazin
700515|NCT00259571|non-inferiority study|non-inferiority study
700516|NCT00259571|relapse|relapse
700517|NCT00259558|Ulcerative Colitis|ulcerative colitis
700518|NCT00259558|Dose Finding|dose finding
700519|NCT00259558|Phosphatidylcholine|phosphatidylcholine
700520|NCT00259545|retarded phosphatidylcholine|retarded phosphatidylcholine
700521|NCT00259545|chronic active|chronic active
700522|NCT00259545|steroid|steroid
700523|NCT00259519|premature or preterm birth|premature or preterm birth
700524|NCT00259519|chorioamnionitis|chorioamnionitis
700525|NCT00259519|neonatal sepsis|neonatal sepsis
700526|NCT00259519|labour|labour
700527|NCT00259519|Cesarean Section|cesarean section
700528|NCT00259519|delivery|delivery
700529|NCT00259519|length of stay|length of stay
700530|NCT00259519|pregnancy|pregnancy
700531|NCT00259506|Recurrent depression|recurrent depression
700532|NCT00259506|Mental Health|mental health
700533|NCT00259493|Coronary Artery Disease|coronary artery disease
700534|NCT00259493|Coronary Artery Bypass Graft Surgery|coronary artery bypass graft surgery
700535|NCT00259493|Off-pump CABG|off-pump cabg
700536|NCT00259493|Cardiac CT|cardiac ct
700537|NCT00259493|Bypass Graft CT angiography|bypass graft ct angiography
700538|NCT00259467|Activity, Dementia, Caregiving|activity, dementia, caregiving
700539|NCT00259454|Caregivers|caregivers
700540|NCT00259454|in-home care occupational therapy|in-home care occupational therapy
700541|NCT00259441|Kidney failure|kidney failure
700542|NCT00259441|Contrast media|contrast media
700543|NCT00259441|Prevention|prevention
700544|NCT00259441|Simvastatin|simvastatin
700545|NCT00259428|Atrial Fibrillation|atrial fibrillation
700546|NCT00259428|Atrial Flutter|atrial flutter
700547|NCT00259428|Arrhythmia|arrhythmia
700548|NCT00259428|Anti-Arrhythmia agents|anti-arrhythmia agents
700549|NCT00259415|Support groups|support groups
700550|NCT00259415|Alzheimer's Disease|alzheimer's disease
700551|NCT00259389|Treatment Experienced|treatment experienced
700552|NCT00259389|Adherence|adherence
700553|NCT00259389|Compliance|compliance
700554|NCT00259389|Directly Observed Therapy|directly observed therapy
700555|NCT00259389|DOT|dot
700556|NCT00259389|Treatment Naive|treatment naive
700557|NCT00259376|Atrial Fibrillation|atrial fibrillation
700558|NCT00259376|Atrial Flutter|atrial flutter
700559|NCT00259376|Arrhythmia|arrhythmia
700560|NCT00259376|Anti-Arrhythmia agents|anti-arrhythmia agents
700561|NCT00259350|Central venous catheter|central venous catheter
700562|NCT00259350|Skin disinfection|skin disinfection
700563|NCT00259350|Antisepsis|antisepsis
700564|NCT00259350|Nosocomial infection|nosocomial infection
700565|NCT00259350|Catheter infection|catheter infection
700566|NCT00259337|Diphteria|diphteria
700567|NCT00259337|Tetanus|tetanus
700568|NCT00259337|Polio|polio
700569|NCT00259337|Acellular Pertussis|acellular pertussis
700570|NCT00259337|Hib|hib
700571|NCT00259337|Haemophilus influenzae type B|haemophilus influenzae type b
700572|NCT00259259|Appetite regulation|appetite regulation
700573|NCT00259259|Hormones|hormones
700574|NCT00259259|Energy intake|energy intake
700575|NCT00259220|Bleeding|bleeding
700576|NCT00259220|Endoscopy|endoscopy
700577|NCT00259220|Gastric tube|gastric tube
700578|NCT00259220|Erythromycin|erythromycin
700579|NCT00259220|Randomized|randomized
700580|NCT00259207|Pulmonary valve regurgitation|pulmonary valve regurgitation
700581|NCT00259207|Valve replacement|valve replacement
700582|NCT00259207|Hybrid procedure|hybrid procedure
700583|NCT00259194|Coronary angiography|coronary angiography
700584|NCT00259194|Complications|complications
700585|NCT00259194|Observation|observation
700586|NCT00259181|chlorhexidine gluconate|chlorhexidine gluconate
700587|NCT00259181|polymethylmethacrylate|polymethylmethacrylate
700588|NCT00259181|Anti-Bacterial Agents|anti-bacterial agents
700589|NCT00259168|Postprandial endothelial function|postprandial endothelial function
700590|NCT00259155|Irritable bowel syndrome, Bacterial overgrowth|irritable bowel syndrome, bacterial overgrowth
700715|NCT00258713|Dermatologic Agents|dermatologic agents
700591|NCT00259142|home management of fever, malaria, Uganda|home management of fever, malaria, uganda
700592|NCT00259116|Congestive heart failure|congestive heart failure
700593|NCT00259116|Relaxin|relaxin
700594|NCT00259116|Cardiac hemodynamics|cardiac hemodynamics
700595|NCT00259103|relaxin|relaxin
700596|NCT00259103|pregnancy|pregnancy
700597|NCT00259103|cervical ripening|cervical ripening
700598|NCT00259103|normal pregnancy at least at 40 weeks of gestation|normal pregnancy at least at 40 weeks of gestation
700599|NCT00259038|Carperitide|carperitide
700600|NCT00259038|Atrial Natriuretic Peptide|atrial natriuretic peptide
700601|NCT00259038|Treatment efficacy|treatment efficacy
700602|NCT00259038|Safety|safety
700603|NCT00259038|Heart failure, Congestive|heart failure, congestive
700604|NCT00259038|Pulmonary Artery Catheterization|pulmonary artery catheterization
700605|NCT00259025|Renal failure, chronic|renal failure, chronic
700606|NCT00259025|Death, sudden, cardiac|death, sudden, cardiac
700607|NCT00259025|Heart rate variability|heart rate variability
700608|NCT00259025|Tachycardia, ventricular|tachycardia, ventricular
700609|NCT00259025|Ventricular premature complexes|ventricular premature complexes
700610|NCT00259025|Ventricular repolarization|ventricular repolarization
700611|NCT00259025|Eicosapentaenoic acid|eicosapentaenoic acid
700612|NCT00259025|Docosahexaenoic acid|docosahexaenoic acid
700613|NCT00259012|GERD|gerd
700614|NCT00259012|Infant|infant
700615|NCT00258999|Skin Cholesterol|skin cholesterol
700616|NCT00258999|Carotid Plaque|carotid plaque
700617|NCT00258999|Carotid Intima-Media Thickness|carotid intima-media thickness
700618|NCT00258986|Living donors|living donors
700619|NCT00258986|Nephrectomy|nephrectomy
700620|NCT00258986|Kidney transplantation|kidney transplantation
700621|NCT00258986|Randomized Controlled Trial|randomized controlled trial
700622|NCT00258986|Laparoscopy|laparoscopy
700623|NCT00258973|Hand held Ultrasound|hand held ultrasound
700624|NCT00258973|Office practice|office practice
700625|NCT00258973|Atherosclerosis prevention|atherosclerosis prevention
700626|NCT00258973|Ultrasound training|ultrasound training
700627|NCT00258960|HER2 positive breast cancer|her2 positive breast cancer
700628|NCT00258960|Metastatic breast cancer|metastatic breast cancer
700629|NCT00258947|Smallpox|smallpox
700630|NCT00258947|Orthopoxvirus|orthopoxvirus
700631|NCT00258947|Poxvirus|poxvirus
700632|NCT00258947|Vaccina Virus|vaccina virus
700633|NCT00258947|LISTER Strain|lister strain
700634|NCT00258947|Bioterrorism|bioterrorism
700635|NCT00258934|Influenza|influenza
700636|NCT00258934|Orthomyxoviruses|orthomyxoviruses
700637|NCT00258934|Inactivated|inactivated
700638|NCT00258934|Split-virion influenza vaccine|split-virion influenza vaccine
700639|NCT00258934|adults|adults
700640|NCT00258934|Myxovirus Infection|myxovirus infection
700641|NCT00258934|Orthomyxovirus Infection|orthomyxovirus infection
700642|NCT00258908|ADACEL™|adacel™
700643|NCT00258908|Tetanus|tetanus
700644|NCT00258908|Diphteria|diphteria
700645|NCT00258908|Acellular pertussis|acellular pertussis
700646|NCT00258895|DAPTACEL®|daptacel®
700647|NCT00258895|Pentacel™|pentacel™
700648|NCT00258895|Diphtheria|diphtheria
700649|NCT00258895|Tetanus|tetanus
700650|NCT00258895|Pertussis|pertussis
700651|NCT00258895|Whooping cough|whooping cough
700652|NCT00258895|Acellular Pertussis Vaccine Adsorbed|acellular pertussis vaccine adsorbed
700653|NCT00258882|Tetanus Toxoid,|tetanus toxoid,
700654|NCT00258882|acellular pertussis,|acellular pertussis,
700655|NCT00258882|diphtheria toxoid|diphtheria toxoid
700656|NCT00258869|prospective studies|prospective studies
700657|NCT00258869|biological assay|biological assay
700658|NCT00258869|body weights and measures|body weights and measures
700659|NCT00258869|chemistry, analytical|chemistry, analytical
700660|NCT00258869|microchip analytical procedures|microchip analytical procedures
700661|NCT00258869|spectrum analysis, mass|spectrum analysis, mass
700662|NCT00258869|molecular diagnostic techniques|molecular diagnostic techniques
700663|NCT00258869|microbiological techniques|microbiological techniques
700664|NCT00258869|drug administration schedule|drug administration schedule
700665|NCT00258869|data collection|data collection
700666|NCT00258869|statistics|statistics
700667|NCT00258869|gene expression profiling|gene expression profiling
700668|NCT00258869|sequence analysis|sequence analysis
700669|NCT00258869|human experimentation|human experimentation
700670|NCT00258869|immunoassay|immunoassay
700671|NCT00258869|Trauma severity indices|trauma severity indices
700672|NCT00258869|Glasgow Coma score|glasgow coma score
700673|NCT00258869|Outcome assessment|outcome assessment
700674|NCT00258869|mortality|mortality
700675|NCT00258869|computer models|computer models
700676|NCT00258869|decision modeling|decision modeling
700677|NCT00258869|linear models|linear models
700678|NCT00258869|logistic models|logistic models
700679|NCT00258869|immunologic model|immunologic model
700680|NCT00258869|mathematical model|mathematical model
700681|NCT00258869|non-linear models|non-linear models
700682|NCT00258869|early diagnosis|early diagnosis
700683|NCT00258869|diagnosis, computer assisted|diagnosis, computer assisted
700684|NCT00258869|medical informatics|medical informatics
700685|NCT00258869|prognosis|prognosis
700686|NCT00258869|registries|registries
700687|NCT00258869|computational biology|computational biology
700688|NCT00258869|systems biology|systems biology
700689|NCT00258856|Meningitis|meningitis
700690|NCT00258856|Meningococcal infection|meningococcal infection
700691|NCT00258856|Neisseria meningitidis|neisseria meningitidis
700692|NCT00258856|Menactra®|menactra®
700693|NCT00258856|Menomune®|menomune®
700694|NCT00258843|IMOVAX;|imovax;
700695|NCT00258843|poliomyelitis|poliomyelitis
700696|NCT00258830|Influenza vaccine|influenza vaccine
700697|NCT00258817|Fluzone®|fluzone®
700698|NCT00258817|Influenza Virus Vaccine|influenza virus vaccine
700699|NCT00258791|Psychiatric disorders|psychiatric disorders
700700|NCT00258791|ECT|ect
700701|NCT00258791|Headache|headache
700702|NCT00258791|Ibuprofen|ibuprofen
700703|NCT00258765|zoledronic acid|zoledronic acid
700704|NCT00258765|prostate cancer|prostate cancer
700705|NCT00258765|high risk|high risk
700706|NCT00258765|PSA|psa
700707|NCT00258765|docetaxel|docetaxel
700708|NCT00258752|Prevention|prevention
700709|NCT00258752|Adolescent|adolescent
700710|NCT00258726|Measels, Mumps, Varicella, Rubella, vaccine, children|measels, mumps, varicella, rubella, vaccine, children
700711|NCT00258713|Randomized Controlled Trials|randomized controlled trials
700712|NCT00258713|Immunosuppression|immunosuppression
700713|NCT00258713|Adult|adult
700714|NCT00258713|Chronic Disease|chronic disease
700716|NCT00258713|Female|female
700717|NCT00258713|Humans|humans
700718|NCT00258713|Male|male
700719|NCT00258713|Middle Aged|middle aged
700720|NCT00258713|Severity of Illness Index|severity of illness index
700721|NCT00258713|Treatment Outcome|treatment outcome
700722|NCT00258713|Quality of Life|quality of life
700723|NCT00258713|Double-Blind Method|double-blind method
700724|NCT00258687|GVAX|gvax
700725|NCT00258687|GM-CSF|gm-csf
700726|NCT00258687|Adenoviral mediated gene transfer|adenoviral mediated gene transfer
700727|NCT00258687|Pediatric Melanoma|pediatric melanoma
700728|NCT00258674|Diabetes|diabetes
700729|NCT00258674|Care coordination|care coordination
700730|NCT00258674|Case management|case management
700731|NCT00258674|Physician profiling|physician profiling
700732|NCT00258661|Pneumonia|pneumonia
700733|NCT00258661|Osteopathic|osteopathic
700734|NCT00258661|Manipulation|manipulation
700735|NCT00258661|Multi-center|multi-center
700736|NCT00258661|Elderly|elderly
700737|NCT00258635|Allergy|allergy
700738|NCT00258635|Specific Immunotherapy|specific immunotherapy
700739|NCT00258622|Peripheral neuropathic pain|peripheral neuropathic pain
700740|NCT00258622|Neuropathic pain|neuropathic pain
700741|NCT00258622|Chronic pain|chronic pain
700742|NCT00258609|Botulinum toxin type A,|botulinum toxin type a,
700743|NCT00258609|Dysport®,Dysport|dysport®,dysport
700744|NCT00258609|Migraine without aura,|migraine without aura,
700745|NCT00258609|Migraine prophylaxis.|migraine prophylaxis.
700746|NCT00258596|drug-eluting stent|drug-eluting stent
700747|NCT00258596|chronic total occlusion|chronic total occlusion
700748|NCT00258596|sirolimus-eluting stent|sirolimus-eluting stent
700749|NCT00258596|zotarolimus-eluting stent|zotarolimus-eluting stent
700750|NCT00258596|QCA|qca
700751|NCT00258583|"Lung[A04.400]"|"lung[a04.400]"
700752|NCT00258570|"Lung[A04.400]"|"lung[a04.400]"
700753|NCT00258557|HIV|hiv
700754|NCT00258557|Anti-Retroviral agents|anti-retroviral agents
700755|NCT00258557|HIV-1|hiv-1
700756|NCT00258557|TMC114/r|tmc114/r
700757|NCT00258557|Treatment naïve patients|treatment naïve patients
700758|NCT00258544|Lung|lung
700759|NCT00258544|Fibrosis|fibrosis
700760|NCT00258544|Idiopathic|idiopathic
700761|NCT00258544|Microarray|microarray
700762|NCT00258544|Tissue|tissue
700763|NCT00258544|Biopsy|biopsy
700764|NCT00258518|Critically ill patients|critically ill patients
700765|NCT00258505|Spreading depression|spreading depression
700766|NCT00258505|Seizures|seizures
700767|NCT00258505|Blood-brain barrier|blood-brain barrier
700768|NCT00258492|Restless legs syndrome|restless legs syndrome
700769|NCT00258492|Insomnia|insomnia
700770|NCT00258492|Daytime sleepiness|daytime sleepiness
700771|NCT00258492|Exercise|exercise
700772|NCT00258479|Nicotine Dependence|nicotine dependence
700773|NCT00258479|Nicotine Use Disorder|nicotine use disorder
700774|NCT00258479|Tobacco Dependence|tobacco dependence
700775|NCT00258466|adenocarcinoma of the prostate|adenocarcinoma of the prostate
700776|NCT00258466|stage I prostate cancer|stage i prostate cancer
700777|NCT00258466|stage II prostate cancer|stage ii prostate cancer
700778|NCT00258466|stage III prostate cancer|stage iii prostate cancer
700779|NCT00258453|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
700780|NCT00258453|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
700781|NCT00258453|perioperative/postoperative complications|perioperative/postoperative complications
700782|NCT00258453|weight changes|weight changes
700783|NCT00258453|childhood craniopharyngioma|childhood craniopharyngioma
700784|NCT00258440|fatigue|fatigue
700785|NCT00258440|anemia|anemia
700786|NCT00258440|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
700787|NCT00258427|Fanconi anemia|fanconi anemia
700788|NCT00258401|diarrhea|diarrhea
700789|NCT00258401|radiation toxicity|radiation toxicity
700790|NCT00258401|recurrent uterine sarcoma|recurrent uterine sarcoma
700791|NCT00258401|stage I uterine sarcoma|stage i uterine sarcoma
700792|NCT00258401|stage II uterine sarcoma|stage ii uterine sarcoma
700793|NCT00258401|stage III uterine sarcoma|stage iii uterine sarcoma
700794|NCT00258401|stage IV uterine sarcoma|stage iv uterine sarcoma
700795|NCT00258401|recurrent prostate cancer|recurrent prostate cancer
700796|NCT00258401|stage I prostate cancer|stage i prostate cancer
700797|NCT00258401|stage II prostate cancer|stage ii prostate cancer
700798|NCT00258401|stage III prostate cancer|stage iii prostate cancer
700799|NCT00258401|stage IV prostate cancer|stage iv prostate cancer
700800|NCT00258401|recurrent cervical cancer|recurrent cervical cancer
700801|NCT00258401|stage 0 cervical cancer|stage 0 cervical cancer
700802|NCT00258401|stage IA cervical cancer|stage ia cervical cancer
700803|NCT00258401|stage IB cervical cancer|stage ib cervical cancer
700804|NCT00258401|stage IIA cervical cancer|stage iia cervical cancer
700805|NCT00258401|stage IIB cervical cancer|stage iib cervical cancer
700806|NCT00258401|stage III cervical cancer|stage iii cervical cancer
700807|NCT00258401|stage IVA cervical cancer|stage iva cervical cancer
700808|NCT00258401|stage IVB cervical cancer|stage ivb cervical cancer
700809|NCT00258388|adenocarcinoma of the prostate|adenocarcinoma of the prostate
700810|NCT00258388|recurrent prostate cancer|recurrent prostate cancer
700811|NCT00258388|stage IV prostate cancer|stage iv prostate cancer
700812|NCT00258375|stage IIIA breast cancer|stage iiia breast cancer
700813|NCT00258375|stage IIIB breast cancer|stage iiib breast cancer
700814|NCT00258375|stage IIIC breast cancer|stage iiic breast cancer
700815|NCT00258375|stage IV breast cancer|stage iv breast cancer
700816|NCT00258375|recurrent breast cancer|recurrent breast cancer
700817|NCT00258362|recurrent endometrial carcinoma|recurrent endometrial carcinoma
700818|NCT00258362|stage III endometrial carcinoma|stage iii endometrial carcinoma
700819|NCT00258362|stage IV endometrial carcinoma|stage iv endometrial carcinoma
700820|NCT00258336|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
700821|NCT00258336|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
700822|NCT00258336|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
700823|NCT00258336|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
700824|NCT00258336|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
700825|NCT00258336|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
700826|NCT00258336|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
700892|NCT00258206|refractory multiple myeloma|refractory multiple myeloma
700827|NCT00258336|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
700828|NCT00258336|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
700829|NCT00258336|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
700830|NCT00258336|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
700831|NCT00258336|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
700832|NCT00258323|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
700833|NCT00258323|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
700834|NCT00258323|stage II esophageal cancer|stage ii esophageal cancer
700835|NCT00258323|stage III esophageal cancer|stage iii esophageal cancer
700836|NCT00258323|stage IV esophageal cancer|stage iv esophageal cancer
700837|NCT00258310|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
700838|NCT00258310|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
700839|NCT00258310|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
700840|NCT00258310|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
700841|NCT00258310|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
700842|NCT00258310|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
700843|NCT00258310|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
700844|NCT00258310|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
700845|NCT00258310|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
700846|NCT00258310|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
700847|NCT00258310|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
700848|NCT00258310|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
700849|NCT00258310|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
700850|NCT00258310|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
700851|NCT00258310|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
700852|NCT00258310|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
700853|NCT00258310|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
700854|NCT00258310|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
700855|NCT00258310|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
700856|NCT00258310|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
700857|NCT00258297|stage I esophageal cancer|stage i esophageal cancer
700858|NCT00258297|stage II esophageal cancer|stage ii esophageal cancer
700859|NCT00258297|stage III esophageal cancer|stage iii esophageal cancer
700860|NCT00258297|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
700861|NCT00258297|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
700862|NCT00258284|recurrent prostate cancer|recurrent prostate cancer
700863|NCT00258284|stage IV prostate cancer|stage iv prostate cancer
700864|NCT00258284|adenocarcinoma of the prostate|adenocarcinoma of the prostate
700865|NCT00258271|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
700866|NCT00258271|adult acute basophilic leukemia|adult acute basophilic leukemia
700867|NCT00258271|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
700868|NCT00258271|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
700869|NCT00258271|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
700870|NCT00258271|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
700871|NCT00258271|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
700872|NCT00258271|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
700873|NCT00258271|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
700874|NCT00258271|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
700875|NCT00258271|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
700876|NCT00258271|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
700877|NCT00258271|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
700878|NCT00258258|refractory multiple myeloma|refractory multiple myeloma
700879|NCT00258245|stage II multiple myeloma|stage ii multiple myeloma
700880|NCT00258245|stage III multiple myeloma|stage iii multiple myeloma
700881|NCT00258245|refractory multiple myeloma|refractory multiple myeloma
700882|NCT00258245|stage I multiple myeloma|stage i multiple myeloma
700883|NCT00258232|adenocarcinoma of the colon|adenocarcinoma of the colon
700884|NCT00258232|adenocarcinoma of the rectum|adenocarcinoma of the rectum
700885|NCT00258232|recurrent colon cancer|recurrent colon cancer
700886|NCT00258232|recurrent rectal cancer|recurrent rectal cancer
700887|NCT00258232|stage IV colon cancer|stage iv colon cancer
700888|NCT00258232|stage IV rectal cancer|stage iv rectal cancer
700889|NCT00258206|stage I multiple myeloma|stage i multiple myeloma
700890|NCT00258206|stage II multiple myeloma|stage ii multiple myeloma
700891|NCT00258206|stage III multiple myeloma|stage iii multiple myeloma
700893|NCT00258193|C-IBS|c-ibs
700895|NCT00258193|Constipation-predominant Irritable Bowel Syndrome|constipation-predominant irritable bowel syndrome
700896|NCT00258193|Constipation Predominant Irritable Bowel Syndrome|constipation predominant irritable bowel syndrome
700897|NCT00258193|Irritable Bowel Syndrome|irritable bowel syndrome
700898|NCT00258193|IBS|ibs
700899|NCT00258193|Transit|transit
700900|NCT00258193|Scintigraphy|scintigraphy
700901|NCT00258193|Gastroenterology|gastroenterology
700902|NCT00258193|Gastrointestinal|gastrointestinal
700903|NCT00258193|GC|gc
700904|NCT00258193|MD-1100 Acetate|md-1100 acetate
700905|NCT00258193|MD-1100|md-1100
700906|NCT00258193|linaclotide|linaclotide
700907|NCT00258193|linaclotide acetate|linaclotide acetate
700908|NCT00258180|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
700909|NCT00258180|gastrointestinal complications|gastrointestinal complications
700910|NCT00258180|diarrhea|diarrhea
700911|NCT00258167|Family members|family members
700912|NCT00258167|Illness burden|illness burden
700913|NCT00258167|Mental Disorders|mental disorders
700914|NCT00258167|Family intervention|family intervention
700915|NCT00258115|Obesity|obesity
700916|NCT00258115|Metabolic Syndrome|metabolic syndrome
700917|NCT00258115|Diabetes|diabetes
700918|NCT00258115|Inflammation|inflammation
700919|NCT00258102|levofloxacin|levofloxacin
700920|NCT00258102|urinary tract infections|urinary tract infections
700921|NCT00258102|bacterial infections|bacterial infections
700922|NCT00258102|bacteriuria|bacteriuria
700923|NCT00258102|urinary anti-infective agents|urinary anti-infective agents
700924|NCT00258102|urinary infections|urinary infections
700925|NCT00258102|quinolones|quinolones
700926|NCT00258089|levofloxacin|levofloxacin
700927|NCT00258089|urinary tract infections|urinary tract infections
700928|NCT00258089|bacterial infections|bacterial infections
700929|NCT00258089|bacteriuria|bacteriuria
700930|NCT00258089|urinary anti-infective agents|urinary anti-infective agents
700931|NCT00258089|urinary infections|urinary infections
700932|NCT00258089|quinolones|quinolones
700933|NCT00258076|Transdermal contraception|transdermal contraception
700934|NCT00258076|contraceptive|contraceptive
700935|NCT00258076|hormonal, steroid contraception|hormonal, steroid contraception
700936|NCT00258076|ethinyl estradiol|ethinyl estradiol
700937|NCT00258076|progesterone|progesterone
700938|NCT00258076|EVRA|evra
700939|NCT00258063|Transdermal contraception|transdermal contraception
700940|NCT00258063|contraceptive|contraceptive
700941|NCT00258063|hormonal, steroid contraception|hormonal, steroid contraception
700942|NCT00258063|ethinyl estradiol|ethinyl estradiol
700943|NCT00258063|progesterone|progesterone
700944|NCT00258063|EVRA|evra
700945|NCT00258063|CILEST|cilest
700946|NCT00258063|ORTHO EVRA|ortho evra
700947|NCT00258050|midazolam|midazolam
700948|NCT00258050|pharmacokinetics|pharmacokinetics
700949|NCT00258050|lapatinib|lapatinib
700950|NCT00258037|Physiotherapy|physiotherapy
700951|NCT00258037|Stroke|stroke
700952|NCT00258037|Urinary Incontinence|urinary incontinence
700953|NCT00258037|quality of Life|quality of life
700954|NCT00258024|IPT-SP, pregnancy, malaria,Ghana|ipt-sp, pregnancy, malaria,ghana
700955|NCT00258011|MPS I Disease|mps i disease
700956|NCT00257985|Familial hemiplegic migraine type 1 and 2|familial hemiplegic migraine type 1 and 2
700957|NCT00257985|GTN|gtn
700958|NCT00257985|middle cerebral artery|middle cerebral artery
700959|NCT00257985|superficial temporal artery|superficial temporal artery
700960|NCT00257985|headache|headache
700961|NCT00257985|genotype|genotype
700962|NCT00257972|Bipolar Mania|bipolar mania
700963|NCT00257946|Diaphragm|diaphragm
700964|NCT00257946|Hernia|hernia
700965|NCT00257946|Congenital|congenital
700966|NCT00257933|Corticosteroids|corticosteroids
700967|NCT00257933|Treatment|treatment
700968|NCT00257933|Pediatric|pediatric
700969|NCT00257920|Stage 5 Chronic Kidney Disease (CKD)|stage 5 chronic kidney disease (ckd)
700970|NCT00257907|Latent Tuberculosis|latent tuberculosis
700971|NCT00257907|PPD|ppd
700972|NCT00257907|Antigen Specific T-Cells|antigen specific t-cells
700973|NCT00257907|Lymphocyte Proliferation Assay|lymphocyte proliferation assay
700974|NCT00257907|HIV|hiv
700975|NCT00257907|LPA|lpa
700976|NCT00257894|Baclofen|baclofen
700977|NCT00257894|Conditioning, Classical|conditioning, classical
700978|NCT00257894|Nicotine|nicotine
700979|NCT00257894|Smoking|smoking
700980|NCT00257881|Tumor|tumor
700981|NCT00257855|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
700982|NCT00257855|Neuroprotection|neuroprotection
700983|NCT00257855|Axonal loss|axonal loss
700984|NCT00257855|Brain atrophy|brain atrophy
700985|NCT00257855|MRI|mri
700986|NCT00257855|Lamotrigine|lamotrigine
700987|NCT00257855|Sodium Channel Blockers|sodium channel blockers
700988|NCT00257829|Cervical Cancer|cervical cancer
700989|NCT00257816|Cervical Cancer|cervical cancer
700990|NCT00257816|Topotecan|topotecan
700991|NCT00257816|Cisplatin|cisplatin
700992|NCT00257803|Oxytocin, bolus, postpartum hemorrhage|oxytocin, bolus, postpartum hemorrhage
700993|NCT00257790|Fever|fever
700994|NCT00257790|Neutropenia|neutropenia
700995|NCT00257790|Tobramycin|tobramycin
700996|NCT00257790|Aminoglycoside|aminoglycoside
700997|NCT00257790|Penicillin|penicillin
700998|NCT00257764|Swallowing disorder|swallowing disorder
700999|NCT00257764|Stroke|stroke
701000|NCT00257764|Standardized swallowing therapy|standardized swallowing therapy
701001|NCT00257764|Randomized controlled trial|randomized controlled trial
701002|NCT00257725|ADHD|adhd
701003|NCT00257725|Attention-deficit/hyperactivity disorder (ADHD)|attention-deficit/hyperactivity disorder (adhd)
701004|NCT00257712|Alzheimer's disease|alzheimer's disease
701005|NCT00257712|cognition disorders|cognition disorders
701006|NCT00257699|Crohn's Disease|crohn's disease
701007|NCT00257699|Randomized|randomized
701008|NCT00257699|Ciprofloxacin|ciprofloxacin
701009|NCT00257699|Metronidazole|metronidazole
701010|NCT00257699|Antibiotic|antibiotic
701011|NCT00257686|Kowa|kowa
701012|NCT00257686|Hypercholesterolemia|hypercholesterolemia
701013|NCT00257686|combined|combined
701014|NCT00257686|dyslipidemia|dyslipidemia
701015|NCT00257686|elderly|elderly
701016|NCT00257686|pitavastatin|pitavastatin
701017|NCT00257686|NK-104|nk-104
701018|NCT00257673|Cognition|cognition
701019|NCT00257673|Alzheimer's|alzheimer's
701020|NCT00257673|Cognitive impairment|cognitive impairment
701021|NCT00257634|lateral epicondylitis|lateral epicondylitis
701022|NCT00257634|iontophoresis|iontophoresis
701023|NCT00257634|dexamethasone|dexamethasone
701024|NCT00257621|HIV-1 protease inhibitor GW640385 ritonavir RTV|hiv-1 protease inhibitor gw640385 ritonavir rtv
701025|NCT00257608|NSCLC|nsclc
701026|NCT00257608|Lung Cancer|lung cancer
701027|NCT00257608|ATLAS|atlas
701028|NCT00257608|Avastin|avastin
701029|NCT00257608|Tarceva|tarceva
701030|NCT00257595|Perennial Allergic Rhinitis pediatric|perennial allergic rhinitis pediatric
701031|NCT00257582|cetirizine|cetirizine
701032|NCT00257582|various type of cutaneous disease accompanied with Pruritus|various type of cutaneous disease accompanied with pruritus
701033|NCT00257582|pediatrics|pediatrics
701034|NCT00257569|Atopic|atopic
701035|NCT00257569|Pediatric|pediatric
701036|NCT00257569|Dermatitis|dermatitis
701037|NCT00257543|sickle cell disease|sickle cell disease
701038|NCT00257543|bone marrow transplant|bone marrow transplant
701039|NCT00257517|Congenital heart disease|congenital heart disease
701040|NCT00257517|Single ventricle|single ventricle
701041|NCT00257517|Infant feeding|infant feeding
701042|NCT00257478|Treatment Efficacy|treatment efficacy
701043|NCT00257478|Treatment Effectiveness|treatment effectiveness
701044|NCT00257478|Disease Management|disease management
701045|NCT00257478|Treatment|treatment
701046|NCT00257478|Safety|safety
701047|NCT00257465|melanoma|melanoma
701048|NCT00257465|metastatic|metastatic
701049|NCT00257465|vaccine|vaccine
701050|NCT00257465|immunotherapy|immunotherapy
701051|NCT00257465|autologous|autologous
701052|NCT00257439|Vitamin B12|vitamin b12
701053|NCT00257439|Folic Acid|folic acid
701054|NCT00257426|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
701055|NCT00257426|advanced adult primary liver cancer|advanced adult primary liver cancer
701056|NCT00257426|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
701057|NCT00257426|recurrent adult primary liver cancer|recurrent adult primary liver cancer
701058|NCT00257400|major depressive disorder|major depressive disorder
701059|NCT00257400|psychotherapy|psychotherapy
701060|NCT00257400|childhood sexual abuse|childhood sexual abuse
701061|NCT00257400|trauma|trauma
701062|NCT00257387|Kidney|kidney
701063|NCT00257387|Kidney Transplant|kidney transplant
701064|NCT00257348|Advanced Cervical Carcinoma|advanced cervical carcinoma
701065|NCT00257348|Recurrent Cervical Carcinoma|recurrent cervical carcinoma
701066|NCT00257335|Carcinoma of the head and neck|carcinoma of the head and neck
701067|NCT00257322|Metastatic colon cancer|metastatic colon cancer
701068|NCT00257322|Metastatic rectal cancer|metastatic rectal cancer
701069|NCT00257309|Acute myocardial infarction|acute myocardial infarction
701070|NCT00257309|Elderly|elderly
701071|NCT00257309|Thrombolysis|thrombolysis
701072|NCT00257309|Primary angioplasty|primary angioplasty
701073|NCT00257309|Randomized trial|randomized trial
701074|NCT00257309|Efficacy|efficacy
701075|NCT00257309|Safety|safety
701076|NCT00257283|Chronic renal failure|chronic renal failure
701077|NCT00257283|Hemodialysis|hemodialysis
701078|NCT00257283|OMACOR (omega-3-acid ethyl ester 90)|omacor (omega-3-acid ethyl ester 90)
701079|NCT00257283|intervention study|intervention study
701080|NCT00257283|cardiovascular events|cardiovascular events
701081|NCT00257283|mortality|mortality
701082|NCT00257270|Chronic|chronic
701083|NCT00257270|Tinnitus|tinnitus
701084|NCT00257270|Acoustic trauma|acoustic trauma
701085|NCT00257270|Psychophysics|psychophysics
701086|NCT00257270|Loudness match|loudness match
701087|NCT00257270|gabapentin|gabapentin
701088|NCT00257257|Type 2 diabetes mellitus|type 2 diabetes mellitus
701089|NCT00257244|Immunity, innate|immunity, innate
701090|NCT00257244|Inflammation|inflammation
701091|NCT00257244|Genomics|genomics
701092|NCT00257244|Proteomics|proteomics
701093|NCT00257231|Immunity, innate|immunity, innate
701094|NCT00257231|Inflammation|inflammation
701095|NCT00257231|Genomics|genomics
701096|NCT00257231|Proteomics|proteomics
701097|NCT00257192|Adolescent Subjects With Schizophrenia|adolescent subjects with schizophrenia
701098|NCT00257179|Tissue factor|tissue factor
701099|NCT00257179|Lung cancer|lung cancer
701100|NCT00257179|Tissue factor protein inhibitor|tissue factor protein inhibitor
701101|NCT00257179|Factor VII|factor vii
701102|NCT00257179|Factor X|factor x
701103|NCT00257153|Acute myocardial infarction|acute myocardial infarction
701104|NCT00257153|primary angioplasty|primary angioplasty
701105|NCT00257153|myocardial reperfusion|myocardial reperfusion
701106|NCT00257153|thrombus aspiration|thrombus aspiration
701107|NCT00257140|Bronchitis|bronchitis
701108|NCT00257140|chronic bronchitis|chronic bronchitis
701109|NCT00257140|lung diseases|lung diseases
701110|NCT00257140|respiratory tract infections|respiratory tract infections
701111|NCT00257140|bronchial diseases|bronchial diseases
701112|NCT00257140|antibacterial agents|antibacterial agents
701113|NCT00257140|quinolones|quinolones
701114|NCT00257140|levofloxacin|levofloxacin
701115|NCT00257127|Vaccination|vaccination
701116|NCT00257114|Multiple Myeloma|multiple myeloma
701117|NCT00257114|Retreatment|retreatment
701118|NCT00257114|VELCADE|velcade
701119|NCT00257088|development|development
701120|NCT00257088|epidemiology|epidemiology
701121|NCT00257088|risk factors|risk factors
701122|NCT00257088|randomized field trials|randomized field trials
701123|NCT00257075|risperidone|risperidone
701124|NCT00257075|antipsychotic agents|antipsychotic agents
701125|NCT00257075|bipolar disorders|bipolar disorders
701126|NCT00257075|manic episode|manic episode
701127|NCT00257062|Infectious skin diseases|infectious skin diseases
701128|NCT00257062|skin diseases|skin diseases
701129|NCT00257062|bacterial skin diseases|bacterial skin diseases
701130|NCT00257062|antibacterial agents|antibacterial agents
701131|NCT00257062|quinolones|quinolones
701132|NCT00257062|levofloxacin|levofloxacin
701133|NCT00257049|Pneumonia|pneumonia
701134|NCT00257049|lung inflammation|lung inflammation
701135|NCT00257049|bacterial pneumonia|bacterial pneumonia
701136|NCT00257049|lung diseases|lung diseases
701137|NCT00257049|respiratory tract infections|respiratory tract infections
701138|NCT00257049|antibacterial agents|antibacterial agents
701139|NCT00257049|quinolones|quinolones
701140|NCT00257049|levofloxacin|levofloxacin
701141|NCT00257036|Infectious skin diseases|infectious skin diseases
701142|NCT00257036|skin diseases|skin diseases
701143|NCT00257036|bacterial skin diseases|bacterial skin diseases
701144|NCT00257036|cellulitis|cellulitis
701145|NCT00257036|quinolones|quinolones
701146|NCT00257036|levofloxacin|levofloxacin
701147|NCT00257023|Schizophrenia|schizophrenia
701148|NCT00257023|Risperidone|risperidone
701149|NCT00257023|Positive and Negative Syndrome Scale (PANSS)|positive and negative syndrome scale (panss)
701150|NCT00257023|Clinical Global Impression (CGI)|clinical global impression (cgi)
701151|NCT00257023|Positron Emission Tomography (PET)|positron emission tomography (pet)
701152|NCT00257010|Migraine|migraine
701153|NCT00257010|Almotriptan Malate|almotriptan malate
701154|NCT00257010|Headache|headache
701155|NCT00257010|Triptan|triptan
701156|NCT00256997|Schizophrenia|schizophrenia
701157|NCT00256997|Risperidone|risperidone
701158|NCT00256997|Risperdal Consta|risperdal consta
701159|NCT00256984|Obstructive Defecation Syndrome|obstructive defecation syndrome
701160|NCT00256984|Colorectal Surgery|colorectal surgery
701161|NCT00256984|Defecography|defecography
701162|NCT00256984|Constipation|constipation
701163|NCT00256984|Rectocele|rectocele
701164|NCT00256984|Intussusception|intussusception
701165|NCT00256984|Quality of Life|quality of life
701166|NCT00256945|biofilm formation|biofilm formation
701167|NCT00256945|dental plaque|dental plaque
701168|NCT00256945|surface roughness|surface roughness
701169|NCT00256945|dental restoration|dental restoration
701170|NCT00256945|dental materials|dental materials
701171|NCT00256932|bowel dysfunction|bowel dysfunction
701172|NCT00256932|constipation|constipation
701173|NCT00256932|gastrointestinal|gastrointestinal
701174|NCT00256932|opioids|opioids
701175|NCT00256932|pain|pain
701176|NCT00256932|non-cancer pain|non-cancer pain
701177|NCT00256932|Opioid-induced|opioid-induced
701178|NCT00256919|GW856553|gw856553
701179|NCT00256919|biomarkers|biomarkers
701180|NCT00256919|CRP|crp
701181|NCT00256919|rheumatoid arthritis|rheumatoid arthritis
701182|NCT00256906|lateral ventricles|lateral ventricles
701183|NCT00256906|fetal ventriculomegaly|fetal ventriculomegaly
701184|NCT00256893|pain intensity|pain intensity
701185|NCT00256893|numerical rating scale|numerical rating scale
701186|NCT00256893|fibromyalgia|fibromyalgia
701187|NCT00256880|Pazopanib(GW786034)|pazopanib(gw786034)
701188|NCT00256880|Solid Tumors|solid tumors
701189|NCT00256880|Myeloma|myeloma
701190|NCT00256867|Type 2 diabetes Type II|type 2 diabetes type ii
701191|NCT00256854|RLS|rls
701192|NCT00256854|Ropinirole|ropinirole
701193|NCT00256854|Restless Legs Syndrome|restless legs syndrome
701194|NCT00256841|Hypofractionated Chest Radiation|hypofractionated chest radiation
701195|NCT00256841|Taxotere|taxotere
701196|NCT00256841|5-FU|5-fu
701197|NCT00256828|HIV infection|hiv infection
701198|NCT00256828|Highly active antiretroviral therapy|highly active antiretroviral therapy
701199|NCT00256828|Treatment Naive|treatment naive
701200|NCT00256815|Hypofractionated chest radiation|hypofractionated chest radiation
701201|NCT00256815|Oral Navelbine|oral navelbine
701202|NCT00256802|Headache|headache
701203|NCT00256802|migraine|migraine
701204|NCT00256802|MR-angiography|mr-angiography
701205|NCT00256802|healthy volunteers|healthy volunteers
701206|NCT00256802|GTN|gtn
701207|NCT00256802|Middle cerebral artery|middle cerebral artery
701208|NCT00256789|NSCLC, Non-Small Cell Lung Cancer,Weekly Radiation, Taxotere|nsclc, non-small cell lung cancer,weekly radiation, taxotere
701209|NCT00256776|Multiple Myeloma|multiple myeloma
701210|NCT00256776|Velcade|velcade
701211|NCT00256776|Autologous transplantation|autologous transplantation
701212|NCT00256776|Relapse|relapse
701213|NCT00256776|Disease progress|disease progress
701214|NCT00256737|Maintenance of healed erosive esophagitis|maintenance of healed erosive esophagitis
701215|NCT00256724|hypotension|hypotension
701216|NCT00256724|hypovolemia|hypovolemia
701217|NCT00256724|dehydration|dehydration
701218|NCT00256724|sepsis|sepsis
701219|NCT00256724|blood loss|blood loss
701220|NCT00256711|Locally advanced or metastatic NSCLC.|locally advanced or metastatic nsclc.
701221|NCT00256711|Stage IIIb or Stage IV lung cancer|stage iiib or stage iv lung cancer
701222|NCT00256698|Hormone|hormone
701223|NCT00256698|receptor|receptor
701224|NCT00256698|positive|positive
701225|NCT00256698|breast|breast
701226|NCT00256698|cancer|cancer
701227|NCT00256698|first|first
701228|NCT00256698|relapse|relapse
701229|NCT00256685|Menopause|menopause
701230|NCT00256672|Spinal Cord Injury|spinal cord injury
701231|NCT00256672|TLSO brace|tlso brace
701232|NCT00256672|Spine curvature|spine curvature
701233|NCT00256672|Child|child
701234|NCT00256672|Effectiveness of bracing|effectiveness of bracing
701235|NCT00256659|Medical inpatients|medical inpatients
701236|NCT00256659|Social Work|social work
701237|NCT00256659|Physical therapy|physical therapy
701238|NCT00256659|Occupational therapy|occupational therapy
701239|NCT00256659|Psychiatry|psychiatry
701240|NCT00256659|Early intervention|early intervention
701241|NCT00256659|Iatrogenic complications|iatrogenic complications
701242|NCT00256620|Cardiopulmonary bypass|cardiopulmonary bypass
701243|NCT00256620|Coronary artery disease|coronary artery disease
701244|NCT00256620|Cardiac morbidity|cardiac morbidity
701245|NCT00256620|Neurologic morbidity|neurologic morbidity
701246|NCT00256620|Neurocognitive function|neurocognitive function
701247|NCT00256620|Autoregulation|autoregulation
701248|NCT00256594|Medical Errors|medical errors
701249|NCT00256594|Medication Errors|medication errors
701250|NCT00256594|Prescriptions, Drug|prescriptions, drug
701251|NCT00256581|myocardial perfusion|myocardial perfusion
701252|NCT00256581|Imaging|imaging
701253|NCT00256568|Medical Errors|medical errors
701254|NCT00256568|Medication Errors|medication errors
701255|NCT00256568|Prescriptions, Drug|prescriptions, drug
701256|NCT00256568|Pharmacies|pharmacies
701257|NCT00256568|Ambulatory Care Facilities|ambulatory care facilities
701258|NCT00256542|interstitial cystitis|interstitial cystitis
701259|NCT00256542|pelvic pain|pelvic pain
701260|NCT00256542|urgency|urgency
701261|NCT00256542|frequency|frequency
701262|NCT00256542|Pelvic Pain and/or Urgency of Bladder Origin|pelvic pain and/or urgency of bladder origin
701263|NCT00256529|dysphagia|dysphagia
701264|NCT00256529|eosinophilic esophagitis|eosinophilic esophagitis
701265|NCT00256516|Diet Therapy|diet therapy
701266|NCT00256503|Primary Insomnia|primary insomnia
701267|NCT00256503|Insomnia|insomnia
701268|NCT00256503|Sleep|sleep
701269|NCT00256490|Diffuse large B cells lymphoma|diffuse large b cells lymphoma
701270|NCT00256490|PET/CT|pet/ct
701271|NCT00256490|FDG|fdg
701272|NCT00256464|PTSD|ptsd
701273|NCT00256451|Naltrexone|naltrexone
701274|NCT00256451|Endophenotype|endophenotype
701275|NCT00256438|Depression|depression
701276|NCT00256438|Transcranial Direct Current Stimulation|transcranial direct current stimulation
701277|NCT00256425|glioma|glioma
701278|NCT00256425|brain tumor|brain tumor
701279|NCT00256425|cognit|cognit
701280|NCT00256425|neuropsycholog|neuropsycholog
701281|NCT00256425|attention|attention
701282|NCT00256425|memory|memory
701283|NCT00256425|executive function|executive function
701284|NCT00256425|rehabilitation|rehabilitation
701285|NCT00256425|remediation|remediation
701286|NCT00256425|training|training
701287|NCT00256386|Baseline|baseline
701288|NCT00256386|Laboratory|laboratory
701289|NCT00256386|Drug|drug
701290|NCT00256373|Low Back Pain|low back pain
701291|NCT00256373|Dynamic Back-Muscle exercise Treatment|dynamic back-muscle exercise treatment
701292|NCT00256373|Interdisciplinary Treatment|interdisciplinary treatment
701293|NCT00256373|Roland Morris Disability Questionnaire|roland morris disability questionnaire
701294|NCT00256373|SF-36|sf-36
701295|NCT00256373|Low Back Pain Rating Scale|low back pain rating scale
701296|NCT00256360|breast cancer|breast cancer
701297|NCT00256360|adjuvant|adjuvant
701298|NCT00256360|dose dense|dose dense
701299|NCT00256360|docetaxel|docetaxel
701300|NCT00256360|pegfilgrastim|pegfilgrastim
701301|NCT00256334|Colon Cancer|colon cancer
701302|NCT00256334|Resveratrol|resveratrol
701303|NCT00256334|Clinical Trial|clinical trial
701304|NCT00256334|WnT signaling|wnt signaling
701305|NCT00256334|Grapes|grapes
701306|NCT00256334|Cancer prevention|cancer prevention
701307|NCT00256321|Gastric Carcinoma|gastric carcinoma
701308|NCT00256321|Gastroesophageal junction Carcinoma|gastroesophageal junction carcinoma
701309|NCT00256308|Head and Neck Cancer|head and neck cancer
701310|NCT00256308|oxaliplatin|oxaliplatin
701311|NCT00256308|resected squamous cell carcinoma|resected squamous cell carcinoma
701312|NCT00256308|Eloxatin™|eloxatin™
701313|NCT00256295|Cancer of the Head and Neck|cancer of the head and neck
701314|NCT00256282|Metastatic Melanoma|metastatic melanoma
701315|NCT00256269|Esophageal Cancer|esophageal cancer
701705|NCT00255580|marijuana|marijuana
701316|NCT00256269|Gastroesophageal junction cancer|gastroesophageal junction cancer
701317|NCT00256269|Oxaliplatin|oxaliplatin
701318|NCT00256269|Irinotecan|irinotecan
701319|NCT00256256|type 2 diabetes|type 2 diabetes
701320|NCT00256256|GLP-1|glp-1
701321|NCT00256256|PET|pet
701322|NCT00256256|brain|brain
701323|NCT00256256|heart|heart
701324|NCT00256204|Parkinson's|parkinson's
701325|NCT00256204|Rasagiline Mesylate|rasagiline mesylate
701326|NCT00256191|taxanes|taxanes
701327|NCT00256191|multidrug resistance|multidrug resistance
701328|NCT00256191|mutant tubulin binding|mutant tubulin binding
701329|NCT00256191|Hodgkin's or Non-Hodgkin's Lymphoma|hodgkin's or non-hodgkin's lymphoma
701330|NCT00256178|Hyperlipidemia|hyperlipidemia
701331|NCT00256178|Drug Therapy|drug therapy
701332|NCT00256165|Aortic valve replacement|aortic valve replacement
701333|NCT00256152|Atrial fibrillation|atrial fibrillation
701334|NCT00256152|Pacemaker|pacemaker
701335|NCT00256152|AF suppression pacing|af suppression pacing
701336|NCT00256152|Indications for Pacemaker Implantation due to sinus node or atrio-ventricular node disease|indications for pacemaker implantation due to sinus node or atrio-ventricular node disease
701337|NCT00256113|depression|depression
701338|NCT00256113|antidepressive agents|antidepressive agents
701339|NCT00256113|controlled clinical trial|controlled clinical trial
701340|NCT00256087|Nosocomial rates in critically ill patients|nosocomial rates in critically ill patients
701341|NCT00256009|Late abortion|late abortion
701342|NCT00255983|bronchitis|bronchitis
701343|NCT00255983|AECB|aecb
701344|NCT00255970|Periodontal Treatment of Intraosseous Vertical Defects|periodontal treatment of intraosseous vertical defects
701345|NCT00255957|Stroke, HES, Coagulation, Kinetics, Hemorehology|stroke, hes, coagulation, kinetics, hemorehology
701346|NCT00255944|HIV Prevention|hiv prevention
701347|NCT00255944|Internet Intervention|internet intervention
701348|NCT00255944|STDs|stds
701349|NCT00255931|Heart Failure|heart failure
701350|NCT00255931|Biofeedback-Relaxation|biofeedback-relaxation
701351|NCT00255931|Cognitive Behavioral Therapy|cognitive behavioral therapy
701352|NCT00255918|Evoked Potentials|evoked potentials
701353|NCT00255918|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine
701354|NCT00255918|DMXB-A|dmxb-a
701355|NCT00255918|Receptors, Nicotinic|receptors, nicotinic
701356|NCT00255905|Depression|depression
701357|NCT00255905|Insomnia|insomnia
701358|NCT00255892|HIV|hiv
701359|NCT00255879|Schizophrenia|schizophrenia
701360|NCT00255879|Neuroleptic|neuroleptic
701361|NCT00255879|Tardive dyskinesia|tardive dyskinesia
701362|NCT00255866|Assisted Living Facilities|assisted living facilities
701363|NCT00255866|Aged|aged
701364|NCT00255866|Elderly|elderly
701365|NCT00255866|Caregivers|caregivers
701366|NCT00255840|Treatment Naive|treatment naive
701367|NCT00255814|liver metastases|liver metastases
701368|NCT00255801|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
701369|NCT00255801|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
701370|NCT00255801|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
701371|NCT00255801|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
701372|NCT00255801|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
701373|NCT00255801|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
701374|NCT00255801|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
701375|NCT00255801|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
701376|NCT00255801|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
701377|NCT00255801|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
701378|NCT00255788|recurrent breast cancer|recurrent breast cancer
701379|NCT00255788|stage IV breast cancer|stage iv breast cancer
701380|NCT00255788|male breast cancer|male breast cancer
701381|NCT00255775|non-small cell lung cancer|non-small cell lung cancer
701382|NCT00255775|small cell lung cancer|small cell lung cancer
701383|NCT00255749|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
701384|NCT00255749|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
701385|NCT00255749|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
701386|NCT00255749|anemia|anemia
701387|NCT00255749|extramedullary plasmacytoma|extramedullary plasmacytoma
701388|NCT00255749|isolated plasmacytoma of bone|isolated plasmacytoma of bone
701389|NCT00255749|refractory multiple myeloma|refractory multiple myeloma
701390|NCT00255749|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
701391|NCT00255749|primary systemic amyloidosis|primary systemic amyloidosis
701392|NCT00255749|stage I multiple myeloma|stage i multiple myeloma
701393|NCT00255749|stage II multiple myeloma|stage ii multiple myeloma
701394|NCT00255749|stage III multiple myeloma|stage iii multiple myeloma
701395|NCT00255749|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
701396|NCT00255749|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
701397|NCT00255749|anaplastic large cell lymphoma|anaplastic large cell lymphoma
701398|NCT00255749|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
701399|NCT00255749|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
701400|NCT00255749|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
701401|NCT00255749|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
701402|NCT00255749|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
701403|NCT00255749|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
701404|NCT00255749|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
701405|NCT00255749|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
701406|NCT00255749|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
701407|NCT00255749|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
701408|NCT00255749|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
701409|NCT00255749|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
701410|NCT00255749|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
701411|NCT00255749|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
701412|NCT00255749|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
701413|NCT00255749|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
701414|NCT00255749|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
701415|NCT00255749|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
701416|NCT00255749|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
701417|NCT00255749|splenic marginal zone lymphoma|splenic marginal zone lymphoma
701418|NCT00255749|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
701419|NCT00255749|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
701420|NCT00255749|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
701421|NCT00255749|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
701422|NCT00255749|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
701423|NCT00255749|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
701424|NCT00255749|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
701425|NCT00255749|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
701426|NCT00255749|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
701427|NCT00255749|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
701428|NCT00255749|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
701429|NCT00255749|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
701430|NCT00255749|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
701431|NCT00255749|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
701432|NCT00255749|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
701433|NCT00255749|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
701434|NCT00255749|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
701435|NCT00255749|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
701436|NCT00255749|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
701437|NCT00255749|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
701438|NCT00255749|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
701439|NCT00255749|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
701440|NCT00255749|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
701441|NCT00255749|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
701442|NCT00255749|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
701443|NCT00255749|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
701444|NCT00255749|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
701445|NCT00255749|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
701446|NCT00255749|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
701447|NCT00255749|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
701448|NCT00255749|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
701449|NCT00255749|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
701450|NCT00255749|Waldenström macroglobulinemia|waldenström macroglobulinemia
701451|NCT00255749|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
701452|NCT00255749|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
701453|NCT00255749|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
701454|NCT00255749|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
701455|NCT00255749|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
701456|NCT00255749|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
701457|NCT00255749|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
701458|NCT00255749|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
701459|NCT00255749|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
701460|NCT00255749|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
701461|NCT00255749|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
701462|NCT00255749|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
701463|NCT00255749|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
701464|NCT00255749|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
701465|NCT00255749|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
701466|NCT00255749|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
701467|NCT00255749|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
701468|NCT00255749|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
701469|NCT00255749|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
701470|NCT00255749|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
701471|NCT00255749|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
701472|NCT00255749|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
701473|NCT00255749|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
701474|NCT00255749|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
701475|NCT00255749|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
701476|NCT00255749|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
701477|NCT00255749|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
701478|NCT00255749|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
701479|NCT00255749|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
701480|NCT00255749|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
701481|NCT00255749|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
701482|NCT00255749|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
701483|NCT00255749|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
701484|NCT00255749|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
701485|NCT00255749|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
701486|NCT00255749|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
701487|NCT00255749|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
701488|NCT00255749|stage I mantle cell lymphoma|stage i mantle cell lymphoma
701489|NCT00255749|stage I marginal zone lymphoma|stage i marginal zone lymphoma
701490|NCT00255749|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
701491|NCT00255749|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
701492|NCT00255749|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
701493|NCT00255749|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
701494|NCT00255749|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
701495|NCT00255749|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
701496|NCT00255749|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
701497|NCT00255749|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
701498|NCT00255749|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
701499|NCT00255749|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
701500|NCT00255749|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
701501|NCT00255749|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
701502|NCT00255749|refractory hairy cell leukemia|refractory hairy cell leukemia
701503|NCT00255749|prolymphocytic leukemia|prolymphocytic leukemia
701504|NCT00255749|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
701505|NCT00255749|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
701506|NCT00255723|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
701507|NCT00255723|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
701508|NCT00255723|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
701509|NCT00255723|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
701510|NCT00255710|graft versus host disease|graft versus host disease
701511|NCT00255710|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
701916|NCT00254527|Risk Factor|risk factor
701512|NCT00255710|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
701706|NCT00255580|HIV|hiv
701513|NCT00255710|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
701514|NCT00255710|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
701515|NCT00255710|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
701516|NCT00255710|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
701517|NCT00255710|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
701518|NCT00255710|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
701519|NCT00255710|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
701520|NCT00255710|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
701521|NCT00255710|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
701522|NCT00255710|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
701523|NCT00255710|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
701524|NCT00255710|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
701525|NCT00255710|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
701526|NCT00255710|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
701527|NCT00255710|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
701528|NCT00255710|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
701529|NCT00255710|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
701530|NCT00255710|stage II multiple myeloma|stage ii multiple myeloma
701531|NCT00255710|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
701532|NCT00255710|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
701533|NCT00255710|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
701534|NCT00255710|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
701535|NCT00255710|stage III multiple myeloma|stage iii multiple myeloma
701536|NCT00255710|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
701537|NCT00255710|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
701538|NCT00255710|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
701539|NCT00255710|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
701540|NCT00255710|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
701541|NCT00255710|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
701542|NCT00255710|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
701543|NCT00255710|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
701544|NCT00255710|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
701545|NCT00255710|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
701546|NCT00255710|refractory anemia with excess blasts|refractory anemia with excess blasts
701547|NCT00255710|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
701548|NCT00255710|primary systemic amyloidosis|primary systemic amyloidosis
701549|NCT00255710|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
701550|NCT00255710|secondary acute myeloid leukemia|secondary acute myeloid leukemia
701551|NCT00255710|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
701552|NCT00255710|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
701553|NCT00255697|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
701554|NCT00255697|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
701555|NCT00255684|graft versus host disease|graft versus host disease
701556|NCT00255684|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
701557|NCT00255684|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
701558|NCT00255684|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
701559|NCT00255684|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
701560|NCT00255684|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
701561|NCT00255684|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
701562|NCT00255684|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
701563|NCT00255684|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
701564|NCT00255684|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
701565|NCT00255684|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
701566|NCT00255684|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
701567|NCT00255684|acute undifferentiated leukemia|acute undifferentiated leukemia
701568|NCT00255684|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
701569|NCT00255684|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
701570|NCT00255684|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
701571|NCT00255684|refractory anemia with excess blasts|refractory anemia with excess blasts
701572|NCT00255684|refractory anemia|refractory anemia
701573|NCT00255684|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
701719|NCT00255411|Conversion Disorder|conversion disorder
701574|NCT00255684|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
701575|NCT00255684|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
701576|NCT00255684|primary myelofibrosis|primary myelofibrosis
701577|NCT00255684|refractory hairy cell leukemia|refractory hairy cell leukemia
701578|NCT00255684|stage I multiple myeloma|stage i multiple myeloma
701579|NCT00255684|stage II multiple myeloma|stage ii multiple myeloma
701580|NCT00255684|stage III multiple myeloma|stage iii multiple myeloma
701581|NCT00255684|refractory multiple myeloma|refractory multiple myeloma
701582|NCT00255684|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
701583|NCT00255684|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
701584|NCT00255684|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
701585|NCT00255684|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
701586|NCT00255684|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
701587|NCT00255684|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
701588|NCT00255684|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
701589|NCT00255684|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
701590|NCT00255684|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
701591|NCT00255684|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
701592|NCT00255684|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
701593|NCT00255684|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
701594|NCT00255684|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
701595|NCT00255684|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
701596|NCT00255684|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
701597|NCT00255684|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
701598|NCT00255684|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
701599|NCT00255684|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
701600|NCT00255684|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
701601|NCT00255684|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
701602|NCT00255684|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
701603|NCT00255684|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
701604|NCT00255684|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
701605|NCT00255684|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
701606|NCT00255684|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
701607|NCT00255684|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
701608|NCT00255684|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
701609|NCT00255684|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
701610|NCT00255684|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
701611|NCT00255684|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
701612|NCT00255684|splenic marginal zone lymphoma|splenic marginal zone lymphoma
701613|NCT00255684|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
701614|NCT00255684|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
701615|NCT00255684|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
701616|NCT00255684|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
701617|NCT00255684|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
701618|NCT00255684|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
701619|NCT00255684|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
701620|NCT00255684|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
701621|NCT00255684|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
701622|NCT00255684|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
701623|NCT00255684|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
701624|NCT00255684|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
701625|NCT00255684|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
701626|NCT00255684|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
701627|NCT00255684|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
701628|NCT00255684|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
701629|NCT00255684|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
701630|NCT00255684|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
701631|NCT00255684|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
701632|NCT00255684|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
701633|NCT00255684|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
701634|NCT00255684|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
701635|NCT00255684|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
701636|NCT00255684|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
701637|NCT00255684|secondary acute myeloid leukemia|secondary acute myeloid leukemia
701823|NCT00254956|Diseases|diseases
701638|NCT00255684|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
701639|NCT00255684|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
701640|NCT00255684|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
701641|NCT00255684|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
701642|NCT00255684|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
701643|NCT00255684|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
701644|NCT00255684|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
701645|NCT00255684|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
701646|NCT00255684|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
701647|NCT00255684|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
701648|NCT00255684|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
701649|NCT00255684|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
701650|NCT00255684|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
701651|NCT00255684|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
701652|NCT00255671|radiation toxicity|radiation toxicity
701653|NCT00255671|tumors metastatic to brain|tumors metastatic to brain
701654|NCT00255671|adult anaplastic astrocytoma|adult anaplastic astrocytoma
701655|NCT00255671|adult anaplastic ependymoma|adult anaplastic ependymoma
701656|NCT00255671|adult anaplastic meningioma|adult anaplastic meningioma
701657|NCT00255671|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
701658|NCT00255671|adult brain stem glioma|adult brain stem glioma
701659|NCT00255671|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
701660|NCT00255671|adult choroid plexus tumor|adult choroid plexus tumor
701661|NCT00255671|adult craniopharyngioma|adult craniopharyngioma
701662|NCT00255671|adult diffuse astrocytoma|adult diffuse astrocytoma
701663|NCT00255671|adult ependymoblastoma|adult ependymoblastoma
701664|NCT00255671|adult ependymoma|adult ependymoma
701665|NCT00255671|adult giant cell glioblastoma|adult giant cell glioblastoma
701666|NCT00255671|adult gliosarcoma|adult gliosarcoma
701667|NCT00255671|adult medulloblastoma|adult medulloblastoma
701668|NCT00255671|adult melanocytic lesion|adult melanocytic lesion
701669|NCT00255671|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
701670|NCT00255671|adult meningioma|adult meningioma
701671|NCT00255671|adult myxopapillary ependymoma|adult myxopapillary ependymoma
701672|NCT00255671|adult oligodendroglioma|adult oligodendroglioma
701673|NCT00255671|adult papillary meningioma|adult papillary meningioma
701674|NCT00255671|adult pineoblastoma|adult pineoblastoma
701675|NCT00255671|adult pineocytoma|adult pineocytoma
701676|NCT00255671|adult subependymoma|adult subependymoma
701677|NCT00255671|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
701678|NCT00255671|adult grade I meningioma|adult grade i meningioma
701679|NCT00255671|adult grade II meningioma|adult grade ii meningioma
701680|NCT00255671|adult grade III meningioma|adult grade iii meningioma
701681|NCT00255671|adult mixed glioma|adult mixed glioma
701682|NCT00255671|recurrent adult brain tumor|recurrent adult brain tumor
701683|NCT00255671|adult pilocytic astrocytoma|adult pilocytic astrocytoma
701684|NCT00255671|adult glioblastoma|adult glioblastoma
701685|NCT00255671|ACTH-producing pituitary tumor|acth-producing pituitary tumor
701686|NCT00255671|growth hormone-producing pituitary tumor|growth hormone-producing pituitary tumor
701687|NCT00255671|nonfunctioning pituitary tumor|nonfunctioning pituitary tumor
701688|NCT00255671|prolactin-producing pituitary tumor|prolactin-producing pituitary tumor
701689|NCT00255671|recurrent pituitary tumor|recurrent pituitary tumor
701690|NCT00255671|TSH producing pituitary tumor|tsh producing pituitary tumor
701691|NCT00255619|Continuous ambulatory peritoneal dialysis (CAPD)|continuous ambulatory peritoneal dialysis (capd)
701692|NCT00255619|Peritonitis|peritonitis
701693|NCT00255619|ANDY-disc® (Fresenius Medical care)|andy-disc® (fresenius medical care)
701694|NCT00255619|Ultra® (Baxter)|ultra® (baxter)
701695|NCT00255619|Twin bag System|twin bag system
701696|NCT00255606|adenocarcinoma of the prostate|adenocarcinoma of the prostate
701697|NCT00255606|stage IV prostate cancer|stage iv prostate cancer
701698|NCT00255606|recurrent prostate cancer|recurrent prostate cancer
701699|NCT00255593|Kidney|kidney
701700|NCT00255593|Transplantation|transplantation
701701|NCT00255593|Immunosuppression|immunosuppression
701702|NCT00255593|Rituximab|rituximab
701703|NCT00255580|neuropathy|neuropathy
701704|NCT00255580|cannabis|cannabis
701707|NCT00255580|DSPN|dspn
701708|NCT00255567|Visceral Leishmaniasis|visceral leishmaniasis
701709|NCT00255567|Combination|combination
701710|NCT00255554|Borderline Personality Disorder|borderline personality disorder
701711|NCT00255554|BPD|bpd
701712|NCT00255554|Dialectical Behavior Therapy|dialectical behavior therapy
701713|NCT00255554|DBT|dbt
701714|NCT00255554|Escitalopram|escitalopram
701715|NCT00255554|Lexapro|lexapro
701716|NCT00255528|Pediatric hypertension|pediatric hypertension
701717|NCT00255502|Pediatric hypertension|pediatric hypertension
701718|NCT00255450|anemia|anemia
701720|NCT00255411|Somatoform Disorder|somatoform disorder
701721|NCT00255411|Involuntary Movement|involuntary movement
701722|NCT00255411|Childhood Abuse|childhood abuse
701723|NCT00255411|Depression|depression
701724|NCT00255411|Psychogenic Movement Disorder|psychogenic movement disorder
701725|NCT00255411|PMD|pmd
701726|NCT00255411|Non-Epileptic Seizure|non-epileptic seizure
701727|NCT00255411|NES|nes
701728|NCT00255411|Healthy Volunteer|healthy volunteer
701729|NCT00255411|HV|hv
701730|NCT00255398|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
701731|NCT00255398|Minimal Change Disease|minimal change disease
701732|NCT00255398|Diabetic Nephropathy|diabetic nephropathy
701733|NCT00255398|Mass Spectrometry|mass spectrometry
701734|NCT00255398|Proteinuria|proteinuria
701735|NCT00255398|Idiopathic Nephrotic Syndrome|idiopathic nephrotic syndrome
701736|NCT00255398|Glomerular Disease|glomerular disease
701737|NCT00255398|FSG|fsg
701738|NCT00255398|Kidney Disease|kidney disease
701739|NCT00255385|Zinc|zinc
701740|NCT00255385|Iron|iron
701741|NCT00255385|Probiotics|probiotics
701742|NCT00255385|Prebiotics|prebiotics
701743|NCT00255385|Child health|child health
701744|NCT00255385|Milk fortification|milk fortification
701745|NCT00255385|Randomized controlled trial|randomized controlled trial
701746|NCT00255346|targeted therapy|targeted therapy
701747|NCT00255346|leukemia|leukemia
701748|NCT00255346|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
701749|NCT00255346|Myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
701750|NCT00255346|Agnogenic myeloid metaplasia - myelofibrosis (MMM)|agnogenic myeloid metaplasia - myelofibrosis (mmm)
701751|NCT00255346|Hypereosinophilic syndrome (HES)|hypereosinophilic syndrome (hes)
701752|NCT00255346|Polycythemia vera (PV)|polycythemia vera (pv)
701753|NCT00255346|Mastocytosis|mastocytosis
701754|NCT00255346|CMML|cmml
701755|NCT00255320|healthy volunteers, headache, migraine, hemodynamics, VIP, SPECT, ultrasound|healthy volunteers, headache, migraine, hemodynamics, vip, spect, ultrasound
701756|NCT00255307|cold|cold
701757|NCT00255307|flu|flu
701758|NCT00255307|respiratory tract infection|respiratory tract infection
701759|NCT00255255|Asthma|asthma
701760|NCT00255242|Cystic Fibrosis|cystic fibrosis
701761|NCT00255242|Airway Inflammation|airway inflammation
701762|NCT00255242|Cytokines|cytokines
701763|NCT00255242|Simvastatin|simvastatin
701764|NCT00255242|HMG-CoA reductase inhibitors|hmg-coa reductase inhibitors
701765|NCT00255242|Rho GTP-ase|rho gtp-ase
701766|NCT00255229|irinotecan|irinotecan
701767|NCT00255229|5FU|5fu
701768|NCT00255229|amino acids|amino acids
701769|NCT00255229|heat shock protein|heat shock protein
701770|NCT00255190|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
701771|NCT00255177|Hepatitis C|hepatitis c
701772|NCT00255164|Erosive Esophagitis|erosive esophagitis
701773|NCT00255151|Erosive Esophagitis|erosive esophagitis
701774|NCT00255138|Cancer|cancer
701775|NCT00255138|Cognitive Late Effects|cognitive late effects
701776|NCT00255138|Stimulants|stimulants
701777|NCT00255138|Atomoxetine|atomoxetine
701778|NCT00255138|Attention|attention
701779|NCT00255138|Children|children
701780|NCT00255125|Estrogen Receptor|estrogen receptor
701781|NCT00255125|Isoflavones|isoflavones
701782|NCT00255125|Prostate Neoplasm|prostate neoplasm
701783|NCT00255125|Soy Supplementation|soy supplementation
701784|NCT00255112|SAD|sad
701785|NCT00255112|treatment|treatment
701786|NCT00255112|cognitive behavior therapy|cognitive behavior therapy
701787|NCT00255112|family|family
701788|NCT00255112|children|children
701789|NCT00255112|anxiety|anxiety
701790|NCT00255099|HIV|hiv
701791|NCT00255099|HIV-1|hiv-1
701792|NCT00255099|TMC125|tmc125
701793|NCT00255047|Pertussis|pertussis
701794|NCT00255047|Whooping cough|whooping cough
701795|NCT00255047|Filamentous Haemagglutinin|filamentous haemagglutinin
701796|NCT00255047|Fimbriae Types 2 and 3;|fimbriae types 2 and 3;
701797|NCT00255047|Pertactin|pertactin
701798|NCT00255047|Diphtheria|diphtheria
701799|NCT00255047|Tetanus|tetanus
701800|NCT00255047|Poliovirus Types 1, 2, and 3.|poliovirus types 1, 2, and 3.
701801|NCT00255034|chronic hepatitis C|chronic hepatitis c
701802|NCT00255034|pegylated interferon alfa-2b|pegylated interferon alfa-2b
701803|NCT00255034|ribavirin|ribavirin
701804|NCT00255034|Australia|australia
701805|NCT00255021|Diphteria|diphteria
701806|NCT00255021|Tetanus|tetanus
701807|NCT00255021|Pertussis|pertussis
701808|NCT00255021|Poliomyelitis|poliomyelitis
701809|NCT00255021|Haemophilus influenzae type b|haemophilus influenzae type b
701810|NCT00255021|acellular|acellular
701811|NCT00255008|chronic hepatitis C|chronic hepatitis c
701812|NCT00255008|pegylated interferon alfa-2b|pegylated interferon alfa-2b
701813|NCT00255008|ribavirin|ribavirin
701814|NCT00255008|Asia|asia
701815|NCT00254995|Meningitis|meningitis
701816|NCT00254995|Meningococcal disease|meningococcal disease
701817|NCT00254995|Menactra vaccine|menactra vaccine
701818|NCT00254969|Diphteria|diphteria
701819|NCT00254969|tetanus|tetanus
701820|NCT00254969|haemophilus influenzae type b|haemophilus influenzae type b
701821|NCT00254969|poliomyelitis|poliomyelitis
701822|NCT00254969|pertussis|pertussis
701824|NCT00254956|respiratory tract diseases|respiratory tract diseases
701825|NCT00254956|respiratory hypersensitivity|respiratory hypersensitivity
701826|NCT00254956|asthma|asthma
701827|NCT00254930|learning disorder|learning disorder
701828|NCT00254930|children|children
701829|NCT00254930|behaviour disorder|behaviour disorder
701830|NCT00254930|risperidone|risperidone
701831|NCT00254917|Pentaxim|pentaxim
701832|NCT00254904|advanced carcinoma, non-small cell lung, Phase III, Gemcitabine, Gemzar, Cisplatin, Platinol, PF-3512676, immunotherapy, immune modulator|advanced carcinoma, non-small cell lung, phase iii, gemcitabine, gemzar, cisplatin, platinol, pf-3512676, immunotherapy, immune modulator
701833|NCT00254891|advanced carcinoma, non-small cell lung, Phase III, Paclitaxel, Taxol, Carboplatin, Paraplatin, PF-3512676, immunotherapy, immune modulator|advanced carcinoma, non-small cell lung, phase iii, paclitaxel, taxol, carboplatin, paraplatin, pf-3512676, immunotherapy, immune modulator
701834|NCT00254878|ADHD, Methylphenidate hydrochloride, modified-release|adhd, methylphenidate hydrochloride, modified-release
701835|NCT00254865|Transdermal contraception|transdermal contraception
701836|NCT00254865|contraceptive|contraceptive
701837|NCT00254865|hormonal, steroid contraception|hormonal, steroid contraception
701838|NCT00254865|ethinyl estradiol|ethinyl estradiol
701839|NCT00254865|progesterone|progesterone
701840|NCT00254865|EVRA|evra
701841|NCT00254865|CILEST|cilest
701842|NCT00254852|Primary lumbar fusion|primary lumbar fusion
701843|NCT00254852|Demineralized Bone Matrix|demineralized bone matrix
701844|NCT00254852|DBM|dbm
701845|NCT00254852|Optecure|optecure
701846|NCT00254852|Allograft|allograft
701847|NCT00254852|Autograft|autograft
701848|NCT00254852|Lumbar fusion|lumbar fusion
701849|NCT00254852|Interbody fusion|interbody fusion
701850|NCT00254852|Instrumented fusion|instrumented fusion
701851|NCT00254852|Non-instrumented fusion|non-instrumented fusion
701852|NCT00254852|Exactech|exactech
701853|NCT00254852|Spinal fusion|spinal fusion
701854|NCT00254839|Oral malodor|oral malodor
701855|NCT00254839|Dental implants|dental implants
701856|NCT00254826|Yellow Fever Virus Vaccination|yellow fever virus vaccination
701857|NCT00254813|Schizophrenia|schizophrenia
701858|NCT00254813|Schizoaffective disorder|schizoaffective disorder
701859|NCT00254800|diabetes|diabetes
701860|NCT00254800|exenatide|exenatide
701861|NCT00254800|Amylin|amylin
701862|NCT00254800|Lilly|lilly
701863|NCT00254787|Schizophrenia|schizophrenia
701864|NCT00254774|Bipolar Disorder I or II with Rapid Cycling|bipolar disorder i or ii with rapid cycling
701865|NCT00254761|cannabis|cannabis
701866|NCT00254761|marijuana|marijuana
701867|NCT00254761|neuropathy|neuropathy
701868|NCT00254761|antinociception|antinociception
701869|NCT00254761|mood|mood
701870|NCT00254761|cognition|cognition
701871|NCT00254748|Borderline personality disorder|borderline personality disorder
701872|NCT00254735|Obsessive Compulsive Disorder (OCD)|obsessive compulsive disorder (ocd)
701873|NCT00254722|Traumatic Brain Injury|traumatic brain injury
701874|NCT00254722|Stem Cell|stem cell
701875|NCT00254709|kidney transplant|kidney transplant
701876|NCT00254709|elderly|elderly
701877|NCT00254696|bacterial infection|bacterial infection
701878|NCT00254683|Rectal Cancer|rectal cancer
701879|NCT00254683|Positron Emission Tomography|positron emission tomography
701880|NCT00254683|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
701881|NCT00254683|Computed Tomography|computed tomography
701882|NCT00254683|Neoadjuvant Therapy|neoadjuvant therapy
701883|NCT00254683|Chemotherapy|chemotherapy
701884|NCT00254683|Radiotherapy|radiotherapy
701885|NCT00254670|Alcohol|alcohol
701886|NCT00254670|Naltrexone|naltrexone
701887|NCT00254657|Fibromyalgia|fibromyalgia
701888|NCT00254657|Fibro|fibro
701889|NCT00254657|Keppra|keppra
701890|NCT00254657|Levetiracetam|levetiracetam
701891|NCT00254644|phonological treatment|phonological treatment
701892|NCT00254644|language|language
701893|NCT00254644|fMRI|fmri
701894|NCT00254631|long bone fracture|long bone fracture
701895|NCT00254631|open fractures|open fractures
701896|NCT00254631|closed fractures|closed fractures
701897|NCT00254631|trauma|trauma
701898|NCT00254618|ulcerative colitis; pharmacokinetics; pediatrics|ulcerative colitis; pharmacokinetics; pediatrics
701899|NCT00254605|imaging|imaging
701900|NCT00254605|adaptive optics scanning laser ophthalmoscope|adaptive optics scanning laser ophthalmoscope
701901|NCT00254605|optical coherence tomography|optical coherence tomography
701902|NCT00254605|electroretinography|electroretinography
701903|NCT00254592|Inflammatory|inflammatory
701904|NCT00254592|Breast Cancer|breast cancer
701905|NCT00254592|Female|female
701906|NCT00254592|Neo-adjuvant|neo-adjuvant
701907|NCT00254592|HER-2 positive|her-2 positive
701908|NCT00254592|Hormone receptor|hormone receptor
701909|NCT00254579|refractory melanoma|refractory melanoma
701910|NCT00254579|malignant melanoma|malignant melanoma
701911|NCT00254566|Azithromycin SR; Moxifloxacin; Acute exacerbation of chronic bronchitis (AECB)|azithromycin sr; moxifloxacin; acute exacerbation of chronic bronchitis (aecb)
701912|NCT00254540|Ph2, RCC, SU011248, SUNITINIB|ph2, rcc, su011248, sunitinib
701913|NCT00254527|Methicillin Resistant Staphylococcus aureus|methicillin resistant staphylococcus aureus
701914|NCT00254527|Children|children
701915|NCT00254527|Colonization|colonization
701917|NCT00254501|diabetes|diabetes
701918|NCT00254475|Valsartan|valsartan
701919|NCT00254475|simvastatin|simvastatin
701920|NCT00254475|hypertension|hypertension
701921|NCT00254475|hypercholesterolemia|hypercholesterolemia
701922|NCT00254475|angiotensin II receptor blocker|angiotensin ii receptor blocker
701923|NCT00254462|ADHD|adhd
701924|NCT00254462|Atomoxetine|atomoxetine
701925|NCT00254436|Epoetin Alfa|epoetin alfa
701926|NCT00254436|Epogen|epogen
701927|NCT00254436|Erythropoietin|erythropoietin
701928|NCT00254423|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
701929|NCT00254423|CML|cml
701930|NCT00254423|Dasatinib|dasatinib
701931|NCT00254423|BMS-354825|bms-354825
701932|NCT00254410|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
701933|NCT00254410|Untreated|untreated
701934|NCT00254410|Fludarabine|fludarabine
701935|NCT00254410|Fludara|fludara
701936|NCT00254410|Cyclophosphamide|cyclophosphamide
701937|NCT00254410|Cytoxan|cytoxan
701938|NCT00254410|Mitoxantrone|mitoxantrone
701939|NCT00254410|Novantrone|novantrone
701940|NCT00254410|Rituximab|rituximab
701941|NCT00254410|Rituxan|rituxan
701942|NCT00254410|Pegylated Filgrastim|pegylated filgrastim
701943|NCT00254410|Neupogen|neupogen
701944|NCT00254397|Melanoma|melanoma
701945|NCT00254397|Uveal Melanoma|uveal melanoma
701946|NCT00254397|Peptide Vaccine|peptide vaccine
701947|NCT00254397|LHRH-agonist|lhrh-agonist
701948|NCT00254397|Leuprolide|leuprolide
701949|NCT00254397|Lupron|lupron
701950|NCT00254397|MAGE-3 Peptide|mage-3 peptide
701951|NCT00254397|MAGE-3|mage-3
701952|NCT00254397|GP100 Peptide|gp100 peptide
701953|NCT00254397|Melanoma vaccines|melanoma vaccines
701954|NCT00254397|Tumor fighting immune cells|tumor fighting immune cells
701955|NCT00254397|T cells|t cells
701956|NCT00254397|Skin Cancer|skin cancer
701957|NCT00254397|Eye Cancer|eye cancer
701958|NCT00254384|Non-Small Cell Lung Cancer|non-small cell lung cancer
701959|NCT00254384|Lung Cancer|lung cancer
701960|NCT00254384|Cisplatin|cisplatin
701961|NCT00254384|Platinol|platinol
701962|NCT00254384|Platinol-AQ|platinol-aq
701963|NCT00254384|CDDP|cddp
701964|NCT00254384|Docetaxel|docetaxel
701965|NCT00254384|Taxotere|taxotere
701966|NCT00254384|Erlotinib|erlotinib
701967|NCT00254384|Tarceva|tarceva
701968|NCT00254384|OSI-774|osi-774
701969|NCT00254384|NSCLC|nsclc
701970|NCT00254358|Nicotine|nicotine
701971|NCT00254358|Dopamine|dopamine
701972|NCT00254358|IBZM|ibzm
701973|NCT00254345|biofilm|biofilm
701974|NCT00254345|adhesion|adhesion
701975|NCT00254345|liquid polish|liquid polish
701976|NCT00254345|bonding resin|bonding resin
701977|NCT00254345|PMMA Polymethylmetacrylate|pmma polymethylmetacrylate
701978|NCT00254345|provisional crown|provisional crown
701979|NCT00254345|no antibiotics treatment three months prior to experiment|no antibiotics treatment three months prior to experiment
701980|NCT00254345|no mouth rinse with oral solutions one month prior to experiment|no mouth rinse with oral solutions one month prior to experiment
701981|NCT00254332|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
701982|NCT00254332|Sezary Syndrome|sezary syndrome
701983|NCT00254332|Mycosis Fungoides|mycosis fungoides
701984|NCT00254332|Denileukin Diftitox|denileukin diftitox
701985|NCT00254306|Ecstasy|ecstasy
701986|NCT00254306|D2 Dopamine Receptor|d2 dopamine receptor
701987|NCT00254306|IBZM|ibzm
701988|NCT00254306|MDMA|mdma
701989|NCT00254280|Warts|warts
701990|NCT00254280|Intense pulsed light|intense pulsed light
701991|NCT00254280|RCT|rct
701992|NCT00254280|Recalcitrant hand and foot warts|recalcitrant hand and foot warts
701993|NCT00254267|Gastrointestinal Stromal Tumor, Imatinib Mesylate Resistance, Phase2 study, AMG 706|gastrointestinal stromal tumor, imatinib mesylate resistance, phase2 study, amg 706
701994|NCT00254254|diabetes|diabetes
701995|NCT00254254|adolescents|adolescents
701996|NCT00254254|exenatide|exenatide
701997|NCT00254254|Amylin|amylin
701998|NCT00254254|Lilly|lilly
701999|NCT00254241|Schizophrenia|schizophrenia
702000|NCT00254228|Balance|balance
702001|NCT00254228|Vestibular|vestibular
702002|NCT00254228|Electrotactile|electrotactile
702003|NCT00254228|BrainPort|brainport
702004|NCT00254228|Sensory substitution|sensory substitution
702005|NCT00254228|Tongue|tongue
702006|NCT00254215|overweight|overweight
702007|NCT00254215|obesity|obesity
702008|NCT00254215|glycemic index|glycemic index
702009|NCT00254215|glycemic load|glycemic load
702010|NCT00254215|high protein diet|high protein diet
702011|NCT00254215|blood cholesterol|blood cholesterol
702012|NCT00254202|Schizophrenia|schizophrenia
702013|NCT00254202|Atypical antipsychotic|atypical antipsychotic
702014|NCT00254202|psychosis|psychosis
702015|NCT00254189|Ovulation|ovulation
702016|NCT00254189|Oral Contraceptive|oral contraceptive
702017|NCT00254176|Neonate|neonate
702018|NCT00254176|Glutathione|glutathione
702019|NCT00254176|Cysteine|cysteine
702020|NCT00254176|Sepsis|sepsis
702021|NCT00254176|Stable Isotope|stable isotope
702022|NCT00254137|capecitabine|capecitabine
702023|NCT00254137|irinotecan|irinotecan
702024|NCT00254137|cetuximab|cetuximab
702025|NCT00254137|oxaliplatin|oxaliplatin
702026|NCT00254137|colorectal cancer|colorectal cancer
702027|NCT00254124|obesity|obesity
702028|NCT00254124|type 2 diabetes mellitus|type 2 diabetes mellitus
702029|NCT00254124|portion control|portion control
702030|NCT00254111|osteoarthritis|osteoarthritis
702031|NCT00254111|hand|hand
702032|NCT00254111|laser|laser
702033|NCT00254111|device|device
702034|NCT00254111|hand pain|hand pain
702035|NCT00254111|stiffness|stiffness
702036|NCT00254085|Type 2 diabtes|type 2 diabtes
702037|NCT00254085|Postprandial hyperglycemia|postprandial hyperglycemia
702038|NCT00254085|Insulin treatment|insulin treatment
702039|NCT00254072|Morbid Obesity|morbid obesity
702040|NCT00254072|Laparoscopic Gastric Bypass|laparoscopic gastric bypass
702041|NCT00254072|Staple Line Hemorrhage|staple line hemorrhage
702042|NCT00254059|OSAHS, OSA, CPAP, polysomnography, overnight oximetry, Obstructive sleep apnea, apnea hypopnea index, AHI, Obstructive Sleep Apnea Hypopnea Syndrome|osahs, osa, cpap, polysomnography, overnight oximetry, obstructive sleep apnea, apnea hypopnea index, ahi, obstructive sleep apnea hypopnea syndrome
702043|NCT00254046|HIV|hiv
702044|NCT00254046|HIV-1|hiv-1
702045|NCT00254046|TMC125|tmc125
702046|NCT00254033|Alzheimer's Disease|alzheimer's disease
702047|NCT00254033|Apathy|apathy
702048|NCT00254033|Brain Reward System|brain reward system
702049|NCT00254033|Dopamine|dopamine
702050|NCT00254033|Dextroamphetamine Challenge|dextroamphetamine challenge
702051|NCT00254033|Methylphenidate|methylphenidate
702052|NCT00254020|stroke|stroke
702053|NCT00254020|depression|depression
702054|NCT00254020|cytokines|cytokines
702055|NCT00254020|serotonin|serotonin
702056|NCT00254020|citalopram|citalopram
702057|NCT00254007|depression|depression
702058|NCT00254007|traumatic brain injury|traumatic brain injury
702059|NCT00254007|serotonin transporter|serotonin transporter
702060|NCT00254007|genetic polymorphisms|genetic polymorphisms
702061|NCT00254007|citalopram|citalopram
702062|NCT00253981|Pain, Intractable|pain, intractable
702063|NCT00253981|Infrared Rays|infrared rays
702064|NCT00253981|Leg|leg
702065|NCT00253968|Primary Insomnia|primary insomnia
702066|NCT00253968|Sleeplessness|sleeplessness
702067|NCT00253968|Early Awakening|early awakening
702068|NCT00253968|Chronic Insomnia|chronic insomnia
702069|NCT00253929|adenosine|adenosine
702070|NCT00253929|polymorphisms|polymorphisms
702071|NCT00253929|blood flow|blood flow
702072|NCT00253929|adenosine A2a receptor|adenosine a2a receptor
702073|NCT00253929|AMP deaminase|amp deaminase
702074|NCT00253903|Primary Insomnia|primary insomnia
702075|NCT00253903|Sleeplessness|sleeplessness
702076|NCT00253903|Early Awakening|early awakening
702077|NCT00253903|Chronic Insomnia|chronic insomnia
702078|NCT00253890|sleep quality|sleep quality
702079|NCT00253890|methadone|methadone
702080|NCT00253890|substance use|substance use
702081|NCT00253877|osteoarthritis|osteoarthritis
702082|NCT00253877|hip resurfacing|hip resurfacing
702083|NCT00253864|shoulder surgery|shoulder surgery
702084|NCT00253864|prospective database|prospective database
702085|NCT00253864|long term outcome|long term outcome
702086|NCT00253851|DVT|dvt
702087|NCT00253851|Osteoarthritis|osteoarthritis
702088|NCT00253851|Total Knee Arthroplasty|total knee arthroplasty
702089|NCT00253838|revision hip arthroplasty|revision hip arthroplasty
702090|NCT00253838|bone mineral density|bone mineral density
702091|NCT00253812|colonoscopy, sigmoidoscopy, chromoendoscopy, autofluorescence, narrow band imaging, colorectal cancer, polyp, adenoma,rectal remnant, FAP|colonoscopy, sigmoidoscopy, chromoendoscopy, autofluorescence, narrow band imaging, colorectal cancer, polyp, adenoma,rectal remnant, fap
702092|NCT00253786|diabetes|diabetes
702093|NCT00253786|nephropathy|nephropathy
702094|NCT00253773|sulfer amino acids|sulfer amino acids
702095|NCT00253773|redox status|redox status
702096|NCT00253760|redox|redox
702097|NCT00253760|sulfur amino acids|sulfur amino acids
702098|NCT00253760|glutathione|glutathione
702099|NCT00253760|aging|aging
702100|NCT00253734|Influenza|influenza
702101|NCT00253721|adult anaplastic astrocytoma|adult anaplastic astrocytoma
702102|NCT00253721|adult brain stem glioma|adult brain stem glioma
702103|NCT00253721|adult diffuse astrocytoma|adult diffuse astrocytoma
702104|NCT00253721|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
702105|NCT00253721|adult medulloblastoma|adult medulloblastoma
702106|NCT00253721|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
702107|NCT00253721|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
702108|NCT00253721|adult oligodendroglioma|adult oligodendroglioma
702109|NCT00253721|adult pineoblastoma|adult pineoblastoma
702110|NCT00253721|tumors metastatic to brain|tumors metastatic to brain
702111|NCT00253721|adult mixed glioma|adult mixed glioma
702112|NCT00253721|recurrent adult brain tumor|recurrent adult brain tumor
702113|NCT00253721|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
702114|NCT00253708|depression|depression
702115|NCT00253708|nausea and vomiting|nausea and vomiting
702116|NCT00253708|pain|pain
702117|NCT00253708|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
702118|NCT00253708|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
702119|NCT00253708|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
702120|NCT00253708|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
702121|NCT00253708|extensive stage small cell lung cancer|extensive stage small cell lung cancer
702122|NCT00253708|stage III gastric cancer|stage iii gastric cancer
702123|NCT00253708|stage III esophageal cancer|stage iii esophageal cancer
702124|NCT00253708|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
702125|NCT00253708|stage III colon cancer|stage iii colon cancer
702126|NCT00253708|stage IV renal cell cancer|stage iv renal cell cancer
702127|NCT00253708|stage IV bladder cancer|stage iv bladder cancer
702128|NCT00253708|stage IV prostate cancer|stage iv prostate cancer
702129|NCT00253708|stage IV breast cancer|stage iv breast cancer
702130|NCT00253708|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
702131|NCT00253708|advanced adult primary liver cancer|advanced adult primary liver cancer
702132|NCT00253708|stage IV melanoma|stage iv melanoma
702133|NCT00253708|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
702134|NCT00253708|ovarian sarcoma|ovarian sarcoma
702135|NCT00253708|ovarian stromal cancer|ovarian stromal cancer
702136|NCT00253708|recurrent small cell lung cancer|recurrent small cell lung cancer
702137|NCT00253708|recurrent adult primary liver cancer|recurrent adult primary liver cancer
702138|NCT00253708|recurrent colon cancer|recurrent colon cancer
702139|NCT00253708|recurrent esophageal cancer|recurrent esophageal cancer
702140|NCT00253708|recurrent gastric cancer|recurrent gastric cancer
702141|NCT00253708|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
702142|NCT00253708|recurrent bladder cancer|recurrent bladder cancer
702143|NCT00253708|recurrent breast cancer|recurrent breast cancer
702144|NCT00253708|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
702145|NCT00253708|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
702146|NCT00253708|recurrent prostate cancer|recurrent prostate cancer
702147|NCT00253708|recurrent renal cell cancer|recurrent renal cell cancer
702148|NCT00253708|recurrent melanoma|recurrent melanoma
702149|NCT00253669|thromboembolism|thromboembolism
702150|NCT00253669|adult anaplastic astrocytoma|adult anaplastic astrocytoma
702151|NCT00253669|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
702152|NCT00253669|adult glioblastoma|adult glioblastoma
702153|NCT00253669|adult giant cell glioblastoma|adult giant cell glioblastoma
702154|NCT00253669|adult gliosarcoma|adult gliosarcoma
702155|NCT00253643|prostate cancer|prostate cancer
702156|NCT00253643|precancerous condition|precancerous condition
702157|NCT00253591|stage I non-small cell lung cancer|stage i non-small cell lung cancer
702158|NCT00253591|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
702159|NCT00253591|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
702160|NCT00253591|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
702161|NCT00253565|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
702162|NCT00253552|graft versus host disease|graft versus host disease
702163|NCT00253552|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
702164|NCT00253552|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
702165|NCT00253552|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
702166|NCT00253552|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
702167|NCT00253552|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
702168|NCT00253552|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
702169|NCT00253552|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
702170|NCT00253552|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
702171|NCT00253552|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
702172|NCT00253552|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
702173|NCT00253552|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
702174|NCT00253552|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
702175|NCT00253552|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
702176|NCT00253552|chronic eosinophilic leukemia|chronic eosinophilic leukemia
702177|NCT00253552|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
702178|NCT00253552|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
702179|NCT00253552|chronic neutrophilic leukemia|chronic neutrophilic leukemia
702180|NCT00253552|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
702181|NCT00253552|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
702182|NCT00253552|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
702183|NCT00253552|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
702184|NCT00253552|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
702185|NCT00253552|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
702186|NCT00253552|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
702187|NCT00253552|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
702188|NCT00253552|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
702189|NCT00253552|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
702190|NCT00253552|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
702191|NCT00253552|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
702192|NCT00253552|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
702193|NCT00253552|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
702194|NCT00253552|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
702195|NCT00253552|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
702196|NCT00253552|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
702197|NCT00253552|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
702198|NCT00253552|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
702199|NCT00253552|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
702200|NCT00253552|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
702201|NCT00253552|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
702202|NCT00253552|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
702203|NCT00253552|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
702204|NCT00253552|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
702205|NCT00253552|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
702206|NCT00253552|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
702207|NCT00253552|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
702208|NCT00253552|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
702209|NCT00253552|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
702210|NCT00253552|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
702211|NCT00253552|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
702212|NCT00253552|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
702213|NCT00253552|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
702214|NCT00253552|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
702215|NCT00253552|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
702216|NCT00253552|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
702217|NCT00253552|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
702218|NCT00253552|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
702219|NCT00253552|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
702220|NCT00253552|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
702221|NCT00253552|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
702222|NCT00253552|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
702223|NCT00253552|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
702224|NCT00253552|refractory hairy cell leukemia|refractory hairy cell leukemia
702225|NCT00253552|refractory multiple myeloma|refractory multiple myeloma
702226|NCT00253552|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
702227|NCT00253552|secondary acute myeloid leukemia|secondary acute myeloid leukemia
702228|NCT00253552|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
702229|NCT00253552|splenic marginal zone lymphoma|splenic marginal zone lymphoma
702230|NCT00253552|stage I multiple myeloma|stage i multiple myeloma
702231|NCT00253552|stage II multiple myeloma|stage ii multiple myeloma
702232|NCT00253552|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
702233|NCT00253552|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
702234|NCT00253552|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
702235|NCT00253552|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
702236|NCT00253552|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
702237|NCT00253552|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
702238|NCT00253552|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
702239|NCT00253552|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
702240|NCT00253552|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
702241|NCT00253552|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
702242|NCT00253552|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
702243|NCT00253552|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
702244|NCT00253552|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
702245|NCT00253552|stage III multiple myeloma|stage iii multiple myeloma
702246|NCT00253552|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
702247|NCT00253552|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
702248|NCT00253552|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
702249|NCT00253552|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
702250|NCT00253552|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
702251|NCT00253552|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
702252|NCT00253552|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
702253|NCT00253552|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
702254|NCT00253552|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
702255|NCT00253552|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
702256|NCT00253552|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
702257|NCT00253552|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
702258|NCT00253552|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
702259|NCT00253552|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
702260|NCT00253552|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
702261|NCT00253552|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
702262|NCT00253539|hereditary breast/ovarian cancer (BRCA1, BRCA2)|hereditary breast/ovarian cancer (brca1, brca2)
702263|NCT00253539|breast cancer|breast cancer
702264|NCT00253513|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
702265|NCT00253513|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
702266|NCT00253513|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
702267|NCT00253513|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
702268|NCT00253513|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
702269|NCT00253513|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
702270|NCT00253513|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
702271|NCT00253513|secondary acute myeloid leukemia|secondary acute myeloid leukemia
702272|NCT00253513|myelodysplastic syndromes|myelodysplastic syndromes
702273|NCT00253513|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
702274|NCT00253500|stage II breast cancer|stage ii breast cancer
702275|NCT00253500|stage I breast cancer|stage i breast cancer
702276|NCT00253500|stage IIIA breast cancer|stage iiia breast cancer
702277|NCT00253500|stage IIIB breast cancer|stage iiib breast cancer
702278|NCT00253487|adult glioblastoma|adult glioblastoma
702279|NCT00253487|adult anaplastic astrocytoma|adult anaplastic astrocytoma
702280|NCT00253487|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
702281|NCT00253487|adult giant cell glioblastoma|adult giant cell glioblastoma
702282|NCT00253487|adult gliosarcoma|adult gliosarcoma
702283|NCT00253474|neoplasm of uncertain malignant potential|neoplasm of uncertain malignant potential
702284|NCT00253474|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
702285|NCT00253461|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
702286|NCT00253461|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
702287|NCT00253461|extensive stage small cell lung cancer|extensive stage small cell lung cancer
702288|NCT00253461|recurrent small cell lung cancer|recurrent small cell lung cancer
702289|NCT00253461|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
702290|NCT00253461|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
702291|NCT00253461|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
702292|NCT00253461|tumors metastatic to brain|tumors metastatic to brain
702293|NCT00253448|adult glioblastoma|adult glioblastoma
702294|NCT00253448|adult giant cell glioblastoma|adult giant cell glioblastoma
702295|NCT00253448|adult gliosarcoma|adult gliosarcoma
702296|NCT00253435|recurrent neuroblastoma|recurrent neuroblastoma
702297|NCT00253422|recurrent breast cancer|recurrent breast cancer
702298|NCT00253422|stage IV breast cancer|stage iv breast cancer
702299|NCT00253422|stage IIIB breast cancer|stage iiib breast cancer
702300|NCT00253422|stage IIIC breast cancer|stage iiic breast cancer
702301|NCT00253409|localized malignant mesothelioma|localized malignant mesothelioma
702302|NCT00253396|warfarin|warfarin
702303|NCT00253396|clinical trial|clinical trial
702304|NCT00253396|pain measurement|pain measurement
702305|NCT00253396|heparin|heparin
702306|NCT00253396|heparin, low-molecular-weight|heparin, low-molecular-weight
702307|NCT00253396|Anticoagulants|anticoagulants
702308|NCT00253383|transitional care planning|transitional care planning
702309|NCT00253383|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
702310|NCT00253383|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
702311|NCT00253383|extensive stage small cell lung cancer|extensive stage small cell lung cancer
702312|NCT00253383|stage IV breast cancer|stage iv breast cancer
702313|NCT00253383|recurrent breast cancer|recurrent breast cancer
702314|NCT00253383|male breast cancer|male breast cancer
702315|NCT00253383|stage IIIB anal cancer|stage iiib anal cancer
702316|NCT00253383|stage IV anal cancer|stage iv anal cancer
702317|NCT00253383|carcinoma of the appendix|carcinoma of the appendix
702318|NCT00253383|stage III colon cancer|stage iii colon cancer
702319|NCT00253383|stage IV colon cancer|stage iv colon cancer
702320|NCT00253383|stage III rectal cancer|stage iii rectal cancer
702321|NCT00253383|stage IV rectal cancer|stage iv rectal cancer
702322|NCT00253383|stage III esophageal cancer|stage iii esophageal cancer
702323|NCT00253383|stage IV esophageal cancer|stage iv esophageal cancer
702324|NCT00253383|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
702514|NCT00252681|controlled|controlled
702325|NCT00253383|unresectable gallbladder cancer|unresectable gallbladder cancer
702326|NCT00253383|stage III gastric cancer|stage iii gastric cancer
702327|NCT00253383|stage IV gastric cancer|stage iv gastric cancer
702328|NCT00253383|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
702329|NCT00253383|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
702330|NCT00253383|gastrointestinal stromal tumor|gastrointestinal stromal tumor
702331|NCT00253383|advanced adult primary liver cancer|advanced adult primary liver cancer
702332|NCT00253383|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
702333|NCT00253383|stage III pancreatic cancer|stage iii pancreatic cancer
702334|NCT00253383|recurrent small intestine cancer|recurrent small intestine cancer
702335|NCT00253383|small intestine adenocarcinoma|small intestine adenocarcinoma
702336|NCT00253383|small intestine leiomyosarcoma|small intestine leiomyosarcoma
702337|NCT00253383|small intestine lymphoma|small intestine lymphoma
702338|NCT00253383|stage IV bladder cancer|stage iv bladder cancer
702339|NCT00253383|stage IV renal cell cancer|stage iv renal cell cancer
702340|NCT00253383|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
702341|NCT00253383|peripheral primitive neuroectodermal tumor of the kidney|peripheral primitive neuroectodermal tumor of the kidney
702342|NCT00253383|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
702343|NCT00253383|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
702344|NCT00253383|anterior urethral cancer|anterior urethral cancer
702345|NCT00253383|posterior urethral cancer|posterior urethral cancer
702346|NCT00253383|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
702347|NCT00253383|stage IV penile cancer|stage iv penile cancer
702348|NCT00253383|stage IV prostate cancer|stage iv prostate cancer
702349|NCT00253383|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
702350|NCT00253383|stage IV endometrial carcinoma|stage iv endometrial carcinoma
702351|NCT00253383|fallopian tube cancer|fallopian tube cancer
702352|NCT00253383|ovarian sarcoma|ovarian sarcoma
702353|NCT00253383|ovarian stromal cancer|ovarian stromal cancer
702354|NCT00253383|stage IV pancreatic cancer|stage iv pancreatic cancer
702355|NCT00253370|Sorafenib|sorafenib
702356|NCT00253370|Docetaxel|docetaxel
702357|NCT00253370|Cisplatin|cisplatin
702358|NCT00253370|gastric cancer|gastric cancer
702359|NCT00253370|gastroesophageal junction adenocarcinoma|gastroesophageal junction adenocarcinoma
702360|NCT00253357|Heart Failure|heart failure
702361|NCT00253357|Congestive Heart Failure|congestive heart failure
702362|NCT00253357|Fluid overload|fluid overload
702363|NCT00253357|Left sided heart failure|left sided heart failure
702364|NCT00253357|Pacemaker|pacemaker
702365|NCT00253357|Defibrillator|defibrillator
702366|NCT00253344|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
702367|NCT00253331|Raynaud's|raynaud's
702368|NCT00253331|sclerderma|sclerderma
702369|NCT00253331|systemic sclerosis|systemic sclerosis
702370|NCT00253331|autoimmune disease|autoimmune disease
702371|NCT00253318|Neoplasm Metastasis|neoplasm metastasis
702372|NCT00253318|Breast Cancer|breast cancer
702373|NCT00253318|Docetaxel|docetaxel
702374|NCT00253318|RAD001|rad001
702375|NCT00253318|Taxotere|taxotere
702376|NCT00253305|tinea unguium|tinea unguium
702377|NCT00253305|onychomycosis|onychomycosis
702378|NCT00253292|Burns|burns
702379|NCT00253292|Trauma|trauma
702380|NCT00253292|Outcomes|outcomes
702381|NCT00253292|Quality of Life|quality of life
702382|NCT00253279|Protein Synthesis Rate|protein synthesis rate
702383|NCT00253279|Burn Injury|burn injury
702384|NCT00253279|PET Scan|pet scan
702385|NCT00253266|Treatment resistant depression|treatment resistant depression
702386|NCT00253266|Augmentation|augmentation
702387|NCT00253266|Pharmacogenetics|pharmacogenetics
702388|NCT00253253|orchidopexy, long-term outcome, congenital|orchidopexy, long-term outcome, congenital
702389|NCT00253227|Alzheimer's disease|alzheimer's disease
702390|NCT00253227|dementia|dementia
702391|NCT00253227|brain disease|brain disease
702392|NCT00253227|memory loss|memory loss
702393|NCT00253227|galantamine|galantamine
702394|NCT00253227|placebo|placebo
702395|NCT00253214|Alzheimer's disease|alzheimer's disease
702396|NCT00253214|dementia|dementia
702397|NCT00253214|galantamine hydrobromide|galantamine hydrobromide
702398|NCT00253214|controlled-release|controlled-release
702399|NCT00253214|once-daily dosing|once-daily dosing
702400|NCT00253201|Alzheimer's disease|alzheimer's disease
702401|NCT00253201|dementia|dementia
702402|NCT00253201|brain disease|brain disease
702403|NCT00253201|memory loss|memory loss
702404|NCT00253201|galantamine|galantamine
702405|NCT00253201|placebo|placebo
702406|NCT00253201|caregiver|caregiver
702407|NCT00253201|quality of life|quality of life
702408|NCT00253201|resource utilization|resource utilization
702409|NCT00253188|Alzheimer's disease|alzheimer's disease
702410|NCT00253188|dementia|dementia
702411|NCT00253188|brain disease|brain disease
702412|NCT00253188|memory loss|memory loss
702413|NCT00253188|galantamine|galantamine
702414|NCT00253188|placebo|placebo
702415|NCT00253188|caregiver|caregiver
702416|NCT00253188|quality of life|quality of life
702417|NCT00253188|resource utilization|resource utilization
702418|NCT00253175|topiramate|topiramate
702419|NCT00253175|migraine headache|migraine headache
702420|NCT00253175|migraine prevention|migraine prevention
702421|NCT00253175|migraine|migraine
702422|NCT00253162|risperidone|risperidone
702423|NCT00253162|antipsychotic agents|antipsychotic agents
702424|NCT00253162|bipolar disorders|bipolar disorders
702425|NCT00253162|manic episode|manic episode
702426|NCT00253149|risperidone|risperidone
702427|NCT00253149|antipsychotic agents|antipsychotic agents
702428|NCT00253149|bipolar disorders|bipolar disorders
702429|NCT00253149|manic episode|manic episode
702430|NCT00253136|schizophrenia|schizophrenia
702431|NCT00253136|schizoaffective disorder|schizoaffective disorder
702432|NCT00253136|psychotic disorder|psychotic disorder
702433|NCT00253136|risperidone|risperidone
702434|NCT00253136|long-acting injectable|long-acting injectable
702435|NCT00253136|intramuscular injection|intramuscular injection
702436|NCT00253136|antipsychotic agents|antipsychotic agents
702437|NCT00253123|Dementia|dementia
702438|NCT00253123|Alzheimer's disease|alzheimer's disease
702439|NCT00253123|vascular dementia|vascular dementia
702440|NCT00253123|mixed dementia|mixed dementia
702441|NCT00253123|risperidone|risperidone
702442|NCT00253123|nursing home|nursing home
702443|NCT00253110|Schizophrenia, Psychotic Disorders|schizophrenia, psychotic disorders
702444|NCT00253110|Haloperidol|haloperidol
702445|NCT00253110|Risperidone|risperidone
702446|NCT00253110|Schizoaffective disorder|schizoaffective disorder
702447|NCT00253097|stroke recurrence|stroke recurrence
702448|NCT00253097|risk factors|risk factors
702449|NCT00253097|health behavior|health behavior
702450|NCT00253097|intervention|intervention
702451|NCT00253097|tertiary prevention|tertiary prevention
702452|NCT00253071|Prophylactic treatment|prophylactic treatment
702453|NCT00253071|Pharmacological treatment|pharmacological treatment
702454|NCT00253071|Psychological treatment|psychological treatment
702455|NCT00253058|Allergic|allergic
702456|NCT00253058|pediatric|pediatric
702457|NCT00253058|Rhinitis|rhinitis
702458|NCT00253058|Perennial|perennial
702459|NCT00253045|Motivational Interviewing|motivational interviewing
702460|NCT00253045|antiretroviral therapy|antiretroviral therapy
702461|NCT00253045|medication adherence|medication adherence
702462|NCT00253045|risk reduction behaviors|risk reduction behaviors
702463|NCT00253045|women|women
702464|NCT00253045|HIV|hiv
702465|NCT00253045|AIDS|aids
702466|NCT00253019|birth control|birth control
702467|NCT00253019|continuation|continuation
702468|NCT00253019|abortion|abortion
702469|NCT00253019|contraception|contraception
702470|NCT00253006|NO|no
702471|NCT00253006|mRNA-expression|mrna-expression
702472|NCT00253006|pathophysiology|pathophysiology
702473|NCT00253006|painful bladder syndrome|painful bladder syndrome
702474|NCT00252993|Nausea|nausea
702475|NCT00252993|Vomiting|vomiting
702476|NCT00252993|Chronic Functional Vomiting|chronic functional vomiting
702477|NCT00252993|Functional Vomiting|functional vomiting
702478|NCT00252993|Cyclic Vomiting|cyclic vomiting
702479|NCT00252980|Cannabis|cannabis
702480|NCT00252980|Dependence|dependence
702481|NCT00252980|Marijuana|marijuana
702482|NCT00252980|Substance Abuse Treatment|substance abuse treatment
702483|NCT00252980|Psychotherapy,|psychotherapy,
702484|NCT00252967|Reactive Oxgen Speers|reactive oxgen speers
702485|NCT00252967|Atrial Fibrillation|atrial fibrillation
702486|NCT00252967|Oxidative Stress|oxidative stress
702487|NCT00252967|Inflammation|inflammation
702488|NCT00252954|Spinal cord injury|spinal cord injury
702489|NCT00252954|Neuropathic pain|neuropathic pain
702490|NCT00252954|Spasms|spasms
702491|NCT00252941|prostate cancer|prostate cancer
702492|NCT00252941|brachytherapy|brachytherapy
702493|NCT00252941|urethral stenting|urethral stenting
702494|NCT00252928|sodium dichloroisocyanurate|sodium dichloroisocyanurate
702495|NCT00252928|water purification|water purification
702496|NCT00252928|disinfection|disinfection
702497|NCT00252928|Ghana|ghana
702498|NCT00252902|tobacco; emergency department; motivation; counseling|tobacco; emergency department; motivation; counseling
702499|NCT00252889|Metastatic cancer|metastatic cancer
702500|NCT00252889|Metastatic gastric and esophagus adenocarcinoma|metastatic gastric and esophagus adenocarcinoma
702501|NCT00252889|Unresectable pancreatic cancer|unresectable pancreatic cancer
702502|NCT00252889|Unresectable head and neck cancer|unresectable head and neck cancer
702503|NCT00252889|Cancer of undetermined primary|cancer of undetermined primary
702504|NCT00252850|Parkinson's Disease|parkinson's disease
702505|NCT00252850|Gene Transfer|gene transfer
702506|NCT00252798|Non Small Cell Lung Cancer|non small cell lung cancer
702507|NCT00252785|Asthma|asthma
702508|NCT00252746|NSCLC|nsclc
702509|NCT00252746|Non Small Cell Lung Cancer|non small cell lung cancer
702510|NCT00252733|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
702511|NCT00252720|Diabetes mellitus type 1|diabetes mellitus type 1
702512|NCT00252694|Diabetes mellitus type 2|diabetes mellitus type 2
702513|NCT00252681|randomized|randomized
702515|NCT00252681|trial|trial
702516|NCT00252681|necrotizing|necrotizing
702517|NCT00252681|enterocolitis|enterocolitis
702518|NCT00252681|premature|premature
702519|NCT00252681|infants|infants
702520|NCT00252681|laparotomy|laparotomy
702521|NCT00252681|peritoneal|peritoneal
702522|NCT00252681|drainage|drainage
702523|NCT00252668|Rheumatoid Arthritis|rheumatoid arthritis
702524|NCT00252642|Hepatitis C|hepatitis c
702525|NCT00252642|Interferon|interferon
702526|NCT00252642|Cirrhosis|cirrhosis
702527|NCT00252642|Liver Disease|liver disease
702528|NCT00252642|Portal Hypertension|portal hypertension
702529|NCT00252642|Portal Pressure|portal pressure
702530|NCT00252629|Fatigue|fatigue
702531|NCT00252629|Functional Somatic Syndrome|functional somatic syndrome
702532|NCT00252629|Gulf War Syndrome|gulf war syndrome
702533|NCT00252629|Sleep apnea|sleep apnea
702534|NCT00252629|Upper Airway Resistance Syndrome|upper airway resistance syndrome
702535|NCT00252616|Mechanical ventilation|mechanical ventilation
702536|NCT00252616|acute respiratory failure|acute respiratory failure
702537|NCT00252616|early nutrition|early nutrition
702538|NCT00252603|Autism|autism
702539|NCT00252603|Childhood Autism|childhood autism
702540|NCT00252590|Psychotherapy motivational intervention|psychotherapy motivational intervention
702541|NCT00252577|Lithium|lithium
702542|NCT00252577|Pharmacogenetics|pharmacogenetics
702543|NCT00252551|spondylolisthesis, decompressive surgery, osteosynthesis|spondylolisthesis, decompressive surgery, osteosynthesis
702544|NCT00252538|Cortisol|cortisol
702545|NCT00252538|Depression|depression
702546|NCT00252538|Hepatitis C|hepatitis c
702547|NCT00252538|Interferon|interferon
702548|NCT00252538|Polymorphism|polymorphism
702549|NCT00252538|Serotonin|serotonin
702550|NCT00252538|Tryptophan|tryptophan
702551|NCT00252512|Contingency management interventions|contingency management interventions
702552|NCT00252512|Substance use disorders treatment|substance use disorders treatment
702553|NCT00252512|Treatment effectiveness|treatment effectiveness
702554|NCT00252512|Randomized clinical trial|randomized clinical trial
702555|NCT00252512|Behavioral research|behavioral research
702556|NCT00252499|beta cell function|beta cell function
702557|NCT00252499|fenofibrate|fenofibrate
702558|NCT00252499|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
702559|NCT00252499|rosiglitazone|rosiglitazone
702560|NCT00252499|insulin sensitivity|insulin sensitivity
702561|NCT00252486|Bipolar|bipolar
702562|NCT00252486|Omega-3 Fatty acids|omega-3 fatty acids
702563|NCT00252434|high-risk sexual behavior|high-risk sexual behavior
702564|NCT00252434|methamphetamine use|methamphetamine use
702565|NCT00252434|drug craving|drug craving
702566|NCT00252434|addiction behaviors|addiction behaviors
702567|NCT00252421|osteoporosis|osteoporosis
702568|NCT00252421|bone mineral density|bone mineral density
702569|NCT00252421|nitrates|nitrates
702570|NCT00252408|Fracture|fracture
702571|NCT00252408|Osteoporosis|osteoporosis
702572|NCT00252408|Bone mineral density|bone mineral density
702573|NCT00252408|Hormone replacement therapy|hormone replacement therapy
702574|NCT00252408|Estrogen|estrogen
702575|NCT00252408|Breast cancer|breast cancer
702576|NCT00252395|medication error|medication error
702577|NCT00252395|electronic prescribing|electronic prescribing
702578|NCT00252395|patient safety|patient safety
702579|NCT00252382|Lung|lung
702580|NCT00252382|Squamous Cell|squamous cell
702581|NCT00252382|Large Cell|large cell
702582|NCT00252382|Adenocarcinoma|adenocarcinoma
702583|NCT00252382|Carcinoma|carcinoma
702584|NCT00252382|Cancer|cancer
702585|NCT00252356|major depressive disorder|major depressive disorder
702586|NCT00252356|depression|depression
702587|NCT00252356|major depressive episode|major depressive episode
702588|NCT00252356|antidepressive agents|antidepressive agents
702589|NCT00252343|anxiety disorder|anxiety disorder
702590|NCT00252330|major depressive disorder|major depressive disorder
702591|NCT00252330|depression|depression
702592|NCT00252330|major depressive episode|major depressive episode
702593|NCT00252330|antidepressive agents|antidepressive agents
702594|NCT00252317|Aortic stenosis|aortic stenosis
702595|NCT00252317|ACE-inhibitores|ace-inhibitores
702596|NCT00252304|Child, severe pneumonia, Zinc, Nepal, therapeutic|child, severe pneumonia, zinc, nepal, therapeutic
702597|NCT00252291|bronchial|bronchial
702598|NCT00252291|hyperresponsiveness|hyperresponsiveness
702599|NCT00252239|stroke|stroke
702600|NCT00252239|tenecteplase|tenecteplase
702601|NCT00252239|TNK|tnk
702602|NCT00252239|ischemic|ischemic
702603|NCT00252239|tissue plasminogen activator|tissue plasminogen activator
702604|NCT00252239|tPA|tpa
702605|NCT00252226|Quetiapine|quetiapine
702606|NCT00252226|bipolar spectrum disorders|bipolar spectrum disorders
702607|NCT00252187|Heart failure|heart failure
702608|NCT00252187|Natriuretic peptides|natriuretic peptides
702609|NCT00252187|B-type natriuretic peptide|b-type natriuretic peptide
702610|NCT00252187|Kidney|kidney
702611|NCT00252187|Nesiritide|nesiritide
702612|NCT00252187|Natrecor|natrecor
702613|NCT00252187|CHF|chf
702614|NCT00252174|MDMA|mdma
702615|NCT00252174|cancer|cancer
702616|NCT00252174|anxiety|anxiety
702617|NCT00252174|psychotherapy|psychotherapy
702618|NCT00252174|quality of life|quality of life
702619|NCT00252161|Neoadjuvant Therapy|neoadjuvant therapy
702620|NCT00252161|Stomach Neoplasms|stomach neoplasms
702621|NCT00252161|Cisplatin|cisplatin
702622|NCT00252161|S-1(combination)|s-1(combination)
702623|NCT00252148|HIV Preventive Vaccine|hiv preventive vaccine
702624|NCT00252135|Moderate to severe asthma|moderate to severe asthma
702625|NCT00252109|HIV|hiv
702626|NCT00252109|Seropositive|seropositive
702627|NCT00252109|MSM|msm
702628|NCT00252109|African American|african american
702629|NCT00252109|Popular Opinion Leader|popular opinion leader
702630|NCT00252096|Diagnosis|diagnosis
702631|NCT00252096|Chlamydia trachomatis|chlamydia trachomatis
702632|NCT00252096|Neisseria gonorrhoeae|neisseria gonorrhoeae
702633|NCT00252096|Nucleic acid amplification test|nucleic acid amplification test
702634|NCT00252096|Rectum|rectum
702635|NCT00252096|Pharynx|pharynx
702636|NCT00252083|Seropositive|seropositive
702637|NCT00252083|MSM|msm
702638|NCT00252083|Hispanic|hispanic
702639|NCT00252083|Popular Opinion Leader|popular opinion leader
702640|NCT00252083|HIV|hiv
702641|NCT00252070|arthritis|arthritis
702642|NCT00252070|exercise|exercise
702643|NCT00252070|function|function
702644|NCT00252070|pain|pain
702645|NCT00252057|rehospitalization|rehospitalization
702646|NCT00252057|readmission|readmission
702647|NCT00252057|adverse events|adverse events
702648|NCT00252057|discharge|discharge
702649|NCT00252031|Borderline Personality Disorder|borderline personality disorder
702650|NCT00252031|BPD|bpd
702651|NCT00252031|Dialectical Behavior Therapy|dialectical behavior therapy
702652|NCT00252031|DBT|dbt
702653|NCT00252018|Nutritional supplement|nutritional supplement
702654|NCT00252018|Prevention|prevention
702655|NCT00252018|Endothelial function|endothelial function
702656|NCT00252018|Flow mediated dilation|flow mediated dilation
702657|NCT00251966|Prevention of gastroduodenal lesions|prevention of gastroduodenal lesions
702658|NCT00251966|erosive oesophagitis|erosive oesophagitis
702659|NCT00251966|upper GI symptoms|upper gi symptoms
702660|NCT00251927|Acid reflux disease|acid reflux disease
702661|NCT00251927|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
702662|NCT00251901|Gastroesophageal reflux disease|gastroesophageal reflux disease
702663|NCT00251901|GERD|gerd
702664|NCT00251888|cervix cancer|cervix cancer
702665|NCT00251888|advanced cervix cancer|advanced cervix cancer
702666|NCT00251888|radiochemotherapy|radiochemotherapy
702667|NCT00251888|pelvic radiotherapy|pelvic radiotherapy
702668|NCT00251888|campto|campto
702669|NCT00251888|cisplatin|cisplatin
702670|NCT00251888|irinotecan|irinotecan
702671|NCT00251888|cisplatyl|cisplatyl
702672|NCT00251888|maximum dose search|maximum dose search
702673|NCT00251875|patient portals|patient portals
702674|NCT00251875|electronic health records|electronic health records
702675|NCT00251875|family history|family history
702676|NCT00251875|health maintenance|health maintenance
702677|NCT00251875|medications|medications
702678|NCT00251875|diabetes|diabetes
702679|NCT00251862|Colorectal cancer screening|colorectal cancer screening
702680|NCT00251862|Shared decision-making|shared decision-making
702681|NCT00251862|Decision aid|decision aid
702682|NCT00251849|Intermittent Claudication|intermittent claudication
702683|NCT00251836|Kidney donation|kidney donation
702684|NCT00251836|Organ Donation|organ donation
702685|NCT00251836|Vascular anatomy|vascular anatomy
702686|NCT00251836|Adrenal Insufficiency|adrenal insufficiency
702687|NCT00251823|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
702688|NCT00251810|general anaesthesia|general anaesthesia
702689|NCT00251810|depth of hypnosis|depth of hypnosis
702690|NCT00251810|Cerebral State Monitor|cerebral state monitor
702691|NCT00251810|CSM|csm
702692|NCT00251810|Bispectral Index|bispectral index
702693|NCT00251810|BIS|bis
702694|NCT00251797|Phase I|phase i
702695|NCT00251797|Brain cancer|brain cancer
702696|NCT00251797|Recurrent CNS tumors|recurrent cns tumors
702697|NCT00251771|Thrombolytic therapy|thrombolytic therapy
702698|NCT00251771|Postphlebitic syndrome|postphlebitic syndrome
702699|NCT00251771|Venous thrombosis|venous thrombosis
702700|NCT00251758|Non-Erosive Gastroesophageal Reflux Disease(GERD),heartburn|non-erosive gastroesophageal reflux disease(gerd),heartburn
702701|NCT00251745|Non-Erosive Gastroesophageal Reflux Disease (GERD)|non-erosive gastroesophageal reflux disease (gerd)
702702|NCT00251745|Heartburn|heartburn
702703|NCT00251732|acid reflux studies|acid reflux studies
702704|NCT00251732|efficacy of PPI therapy|efficacy of ppi therapy
702705|NCT00251732|failing PPI therapy|failing ppi therapy
702706|NCT00251732|GERD|gerd
702707|NCT00251732|Acid Reflux Disease|acid reflux disease
702708|NCT00251719|Erosive Esophagitis|erosive esophagitis
702709|NCT00251706|atrial fibrillation|atrial fibrillation
702710|NCT00251706|atrial flutter|atrial flutter
702711|NCT00251706|amiodarone|amiodarone
702712|NCT00251706|post-operative|post-operative
702713|NCT00251706|coronary artery bypass surgery|coronary artery bypass surgery
702714|NCT00251706|valve replacement or repair|valve replacement or repair
702715|NCT00251693|Erosive Esophagitis|erosive esophagitis
702914|NCT00250835|Cancer|cancer
702716|NCT00251680|Hyperlipidemia|hyperlipidemia
702717|NCT00251680|Drug Therapy|drug therapy
702718|NCT00251654|complications|complications
702719|NCT00251654|adverse events|adverse events
702720|NCT00251654|regional anesthesia|regional anesthesia
702721|NCT00251654|adverse effects|adverse effects
702722|NCT00251628|Tonsils|tonsils
702723|NCT00251628|Tonsillectomy|tonsillectomy
702724|NCT00251615|vascular surgery|vascular surgery
702725|NCT00251615|vascular aging|vascular aging
702726|NCT00251615|arterial aging|arterial aging
702727|NCT00251615|surgical tissue|surgical tissue
702728|NCT00251615|Aging|aging
702729|NCT00251602|heart rate variability|heart rate variability
702730|NCT00251602|gene response|gene response
702731|NCT00251589|Relapsed Non-Small-Cell Lung Cancer|relapsed non-small-cell lung cancer
702732|NCT00251589|Refractory Non-Small-Cell Lung Cancer|refractory non-small-cell lung cancer
702733|NCT00251563|Cancer,Risk factors|cancer,risk factors
702734|NCT00251537|Pilot study|pilot study
702735|NCT00251537|Randomized|randomized
702736|NCT00251537|Placebo-controlled|placebo-controlled
702737|NCT00251537|Double-blind|double-blind
702738|NCT00251537|Effect on viral load|effect on viral load
702739|NCT00251537|LTB4|ltb4
702740|NCT00251537|HIV-1 infection|hiv-1 infection
702741|NCT00251498|Metastatic 1st line NSCLC|metastatic 1st line nsclc
702742|NCT00251485|Metastatic 1st line colorectal cancer|metastatic 1st line colorectal cancer
702743|NCT00251459|SAILOR|sailor
702744|NCT00251459|CNV|cnv
702745|NCT00251459|AMD|amd
702746|NCT00251459|CNV secondary to AMD|cnv secondary to amd
702747|NCT00251433|ErbB1|erbb1
702748|NCT00251433|ErbB2|erbb2
702749|NCT00251433|trastuzumab (Herceptin)|trastuzumab (herceptin)
702750|NCT00251433|lapatinib|lapatinib
702751|NCT00251433|Stage IV breast cancer|stage iv breast cancer
702752|NCT00251433|metastatic breast cancer|metastatic breast cancer
702753|NCT00251433|overexpression of ErbB2 receptors|overexpression of erbb2 receptors
702754|NCT00251433|docetaxel (Taxotere)|docetaxel (taxotere)
702755|NCT00251420|copd|copd
702756|NCT00251420|asthma|asthma
702757|NCT00251420|QoL|qol
702758|NCT00251420|Perceived health status|perceived health status
702759|NCT00251420|Trait anxiety|trait anxiety
702760|NCT00251407|Advanced solid tumor malignancy|advanced solid tumor malignancy
702761|NCT00251407|cisplatin|cisplatin
702762|NCT00251407|CPT-11|cpt-11
702763|NCT00251407|taxotere|taxotere
702764|NCT00251394|B-Cell follicular non-Hodgkin's lymphoma|b-cell follicular non-hodgkin's lymphoma
702765|NCT00251394|Rituxan|rituxan
702766|NCT00251394|Rituximab|rituximab
702767|NCT00251394|1018 ISS|1018 iss
702768|NCT00251394|CD 20 +|cd 20 +
702769|NCT00251381|Oropharyngeal Neoplasms|oropharyngeal neoplasms
702770|NCT00251381|Cetuximab|cetuximab
702771|NCT00251381|Concomitant-boost accelerated radiotherapy|concomitant-boost accelerated radiotherapy
702772|NCT00251368|leukemia|leukemia
702773|NCT00251368|9-Aminocamptothecin|9-aminocamptothecin
702774|NCT00251368|AML|aml
702775|NCT00251368|ALL|all
702776|NCT00251368|refractory leukemia|refractory leukemia
702777|NCT00251368|relapsed leukemia|relapsed leukemia
702778|NCT00251355|gemcitabine|gemcitabine
702779|NCT00251355|5-fluorouracil|5-fluorouracil
702780|NCT00251355|5-FU|5-fu
702781|NCT00251355|unresectable pancreatic cancer|unresectable pancreatic cancer
702782|NCT00251355|non-metastatic pancreatic cancer|non-metastatic pancreatic cancer
702783|NCT00251342|Postnatal depression|postnatal depression
702784|NCT00251342|Randomized controlled trial|randomized controlled trial
702785|NCT00251342|Screening|screening
702786|NCT00251342|Outcome|outcome
702787|NCT00251342|Edinburgh Postnatal Depression Scale|edinburgh postnatal depression scale
702788|NCT00251329|Neoadjuvant|neoadjuvant
702789|NCT00251329|Breast Cancer|breast cancer
702790|NCT00251329|pCR|pcr
702791|NCT00251329|Capecitabine|capecitabine
702792|NCT00251329|Carboplatin|carboplatin
702793|NCT00251329|Docetaxel|docetaxel
702794|NCT00251316|Thyroid Neoplasm|thyroid neoplasm
702795|NCT00251316|I-131|i-131
702796|NCT00251316|Radiation Dose|radiation dose
702797|NCT00251316|Radiation Effect|radiation effect
702798|NCT00251316|Pharmaceutical Adjuvant|pharmaceutical adjuvant
702799|NCT00251316|Thyroid Cancer|thyroid cancer
702800|NCT00251303|Clinical Trial|clinical trial
702801|NCT00251303|Glutamate Antagonist|glutamate antagonist
702802|NCT00251303|Pediatrics|pediatrics
702803|NCT00251303|Basal Ganglia|basal ganglia
702804|NCT00251303|Neuropsychological|neuropsychological
702805|NCT00251303|Obsessive Compulsive Disorder|obsessive compulsive disorder
702806|NCT00251303|OCD|ocd
702807|NCT00251303|Riluzole|riluzole
702808|NCT00251303|Rilutek|rilutek
702809|NCT00251290|transient ischemic attack|transient ischemic attack
702810|NCT00251290|sleep apnea|sleep apnea
702811|NCT00251277|Thrombotic Thrombocytopenic Purpura|thrombotic thrombocytopenic purpura
702812|NCT00251277|TTP|ttp
702813|NCT00251277|Hematology|hematology
702814|NCT00251264|Shoulder instability|shoulder instability
702815|NCT00251264|Traumatic|traumatic
702816|NCT00251264|Anterior|anterior
702817|NCT00251264|Unidirectional|unidirectional
702818|NCT00251264|Open stabilization|open stabilization
702819|NCT00251264|Arthroscopic|arthroscopic
702820|NCT00251264|Bankart repair|bankart repair
702821|NCT00251264|Shoulder instability, traumatic|shoulder instability, traumatic
702822|NCT00251264|Anterior, unidirectional instability|anterior, unidirectional instability
702823|NCT00251264|Bankart|bankart
702824|NCT00251251|Congestive heart failure|congestive heart failure
702825|NCT00251251|Multicentre randomized controlled trial|multicentre randomized controlled trial
702826|NCT00251251|Defibrillator|defibrillator
702827|NCT00251251|Cardiac resynchronization|cardiac resynchronization
702828|NCT00251251|Sudden death/mortality|sudden death/mortality
702829|NCT00251251|Hospitalization|hospitalization
702830|NCT00251251|ICD indication|icd indication
702831|NCT00251251|NYHA Class II|nyha class ii
702832|NCT00251251|LVEF </equal to 30%|lvef </equal to 30%
702833|NCT00251251|QRS >/equal to 120 ms|qrs >/equal to 120 ms
702834|NCT00251238|Raynaud´s phenomenon|raynaud´s phenomenon
702835|NCT00251238|Vasospastic attacks|vasospastic attacks
702836|NCT00251238|Ginkgo biloba|ginkgo biloba
702837|NCT00251225|prostate|prostate
702838|NCT00251212|Alcohol|alcohol
702839|NCT00251212|Violence|violence
702840|NCT00251212|Alcohol consumption|alcohol consumption
702841|NCT00251212|Alcohol, drinking|alcohol, drinking
702842|NCT00251160|Multi-directional instability|multi-directional instability
702843|NCT00251160|MDI|mdi
702844|NCT00251160|Ligamentous laxity|ligamentous laxity
702845|NCT00251160|Multi-directional laxity|multi-directional laxity
702846|NCT00251160|MDL-AII|mdl-aii
702847|NCT00251160|Shoulder instability|shoulder instability
702848|NCT00251160|electrothermal capsulorrhaphy, ETAC|electrothermal capsulorrhaphy, etac
702849|NCT00251160|inferior capsular shift, ICS|inferior capsular shift, ics
702850|NCT00251160|capsular redundancy|capsular redundancy
702851|NCT00251147|rotator cuff|rotator cuff
702852|NCT00251147|open|open
702853|NCT00251147|arthroscopic|arthroscopic
702854|NCT00251147|mini-open|mini-open
702855|NCT00251147|acromioplasty|acromioplasty
702856|NCT00251147|quality of life|quality of life
702857|NCT00251147|shoulder|shoulder
702858|NCT00251134|myocardial infarction|myocardial infarction
702859|NCT00251134|omega 3-fatty acids|omega 3-fatty acids
702860|NCT00251121|Electrophysiological study|electrophysiological study
702861|NCT00251121|paroxysmal tachycardia|paroxysmal tachycardia
702862|NCT00251108|'traumatic brain injury'|'traumatic brain injury'
702863|NCT00251108|'head injury'|'head injury'
702864|NCT00251108|'brain injuries'|'brain injuries'
702865|NCT00251108|'exercise therapy'|'exercise therapy'
702866|NCT00251108|'physical fitness'|'physical fitness'
702867|NCT00251095|Metastatic Breast Cancer|metastatic breast cancer
702868|NCT00251082|hormone replacement|hormone replacement
702869|NCT00251082|vasomotoric symptoms|vasomotoric symptoms
702870|NCT00251082|bleeding pattern|bleeding pattern
702871|NCT00251069|glucosamine sulphate, osteoarthritis, cholesterol,|glucosamine sulphate, osteoarthritis, cholesterol,
702872|NCT00251043|Pregnancy|pregnancy
702873|NCT00251043|Antepartum Depression|antepartum depression
702874|NCT00251043|Major Depression|major depression
702875|NCT00251017|single nucleotide polymorphisms (SNPs)|single nucleotide polymorphisms (snps)
702876|NCT00251017|personalized medicines|personalized medicines
702877|NCT00251017|Subjects 16 years of age or older, of either sex.|subjects 16 years of age or older, of either sex.
702878|NCT00251017|Subjects have a medication including vancomycin|subjects have a medication including vancomycin
702879|NCT00251004|Renal transplantation, kidney, and organ transplant|renal transplantation, kidney, and organ transplant
702880|NCT00251004|Renal transplant rejection|renal transplant rejection
702881|NCT00250991|stroke|stroke
702882|NCT00250991|integrilin|integrilin
702883|NCT00250991|eptifibatide|eptifibatide
702884|NCT00250991|activase|activase
702885|NCT00250991|recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
702886|NCT00250991|rt-PA|rt-pa
702887|NCT00250991|recombinant t-PA|recombinant t-pa
702888|NCT00250991|SPOTRIAS|spotrias
702889|NCT00250978|Advanced Non Small Cell Lung Cancer|advanced non small cell lung cancer
702890|NCT00250952|Clinical Practice Variations|clinical practice variations
702891|NCT00250939|Glycogen Storage Disease Type II|glycogen storage disease type ii
702892|NCT00250939|GSD-II|gsd-ii
702893|NCT00250939|Pompe Disease|pompe disease
702894|NCT00250926|bortezomib|bortezomib
702895|NCT00250926|dexamethasone|dexamethasone
702896|NCT00250926|rituximab|rituximab
702897|NCT00250913|motor activity|motor activity
702898|NCT00250913|determinants|determinants
702899|NCT00250913|psychology|psychology
702900|NCT00250913|health care costs|health care costs
702901|NCT00250913|quality of life|quality of life
702902|NCT00250913|Angioplasty|angioplasty
702903|NCT00250900|Otitis|otitis
702904|NCT00250900|Antibiotic|antibiotic
702905|NCT00250900|Prescription|prescription
702906|NCT00250887|recurrent Glioblastoma, Gefitinib|recurrent glioblastoma, gefitinib
702907|NCT00250848|Lung Diseases|lung diseases
702908|NCT00250848|Cancer|cancer
702909|NCT00250835|Resectable Rectal Cancer|resectable rectal cancer
702910|NCT00250835|Radiation|radiation
702911|NCT00250835|Neoadjuvant|neoadjuvant
702912|NCT00250835|Rectum|rectum
702913|NCT00250835|GI - Colorectal Neoadjuvant|gi - colorectal neoadjuvant
702915|NCT00250822|Liver|liver
702916|NCT00250822|hepatocellular|hepatocellular
702917|NCT00250822|Gem-Ox|gem-ox
702918|NCT00250822|Cancer|cancer
702919|NCT00250796|Phase II|phase ii
702920|NCT00250796|Hepatocellular carcinoma|hepatocellular carcinoma
702921|NCT00250783|Corpus Uteri|corpus uteri
702922|NCT00250783|Endometrium|endometrium
702923|NCT00250783|Cancer|cancer
702924|NCT00250770|Corpus Uteri|corpus uteri
702925|NCT00250770|Endometrium|endometrium
702926|NCT00250770|Cancer|cancer
702927|NCT00250757|prostate|prostate
702928|NCT00250757|NMR Spectroscopy|nmr spectroscopy
702929|NCT00250744|delayed nausea and vomiting|delayed nausea and vomiting
702930|NCT00250744|Emetogenic Chemotherapy|emetogenic chemotherapy
702931|NCT00250744|Pilot Trial|pilot trial
702932|NCT00250731|diabetes|diabetes
702933|NCT00250731|relationship|relationship
702934|NCT00250731|social support|social support
702935|NCT00250731|behavior change|behavior change
702936|NCT00250731|telemedicine|telemedicine
702937|NCT00250718|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
702938|NCT00250718|Phase II|phase ii
702939|NCT00250718|Lymphoid malignancies|lymphoid malignancies
702940|NCT00250705|Aripiprazole|aripiprazole
702941|NCT00250679|COPD|copd
702942|NCT00250679|chronic bronchitis|chronic bronchitis
702943|NCT00250679|emphysema|emphysema
702944|NCT00250666|Biological Markers|biological markers
702945|NCT00250666|Procalcitonin|procalcitonin
702946|NCT00250666|Critical Care|critical care
702947|NCT00250666|Diagnosis, Differential|diagnosis, differential
702948|NCT00250666|Prospective Study|prospective study
702949|NCT00250666|Sepsis|sepsis
702950|NCT00250666|Antibiotic stewardship|antibiotic stewardship
702951|NCT00250666|Antimicrobial resistance|antimicrobial resistance
702952|NCT00250653|depression|depression
702953|NCT00250653|antidepressive agents|antidepressive agents
702954|NCT00250653|clinical trial|clinical trial
702955|NCT00250640|Primary Pulmonary hypertension|primary pulmonary hypertension
702956|NCT00250627|depression|depression
702957|NCT00250627|antidepressive agents|antidepressive agents
702958|NCT00250627|controlled clinical trial|controlled clinical trial
702959|NCT00250614|depression|depression
702960|NCT00250614|antidepressive agents|antidepressive agents
702961|NCT00250614|controlled clinical trial|controlled clinical trial
702962|NCT00250601|depression|depression
702963|NCT00250601|antidepressive agents|antidepressive agents
702964|NCT00250601|controlled clinical trial|controlled clinical trial
702965|NCT00250588|Asthma|asthma
702966|NCT00250588|Child|child
702967|NCT00250588|Problem-solving|problem-solving
702968|NCT00250588|Quality of Life|quality of life
702969|NCT00250588|Barriers to Care|barriers to care
702970|NCT00250575|Schizophrenia, treatment-resistant, clozapine|schizophrenia, treatment-resistant, clozapine
702971|NCT00250562|Hypertension|hypertension
702972|NCT00250562|Angiotensin II receptor blocker|angiotensin ii receptor blocker
702973|NCT00250562|fixed combination|fixed combination
702974|NCT00250562|diuretics|diuretics
702975|NCT00250549|HIV|hiv
702976|NCT00250549|Prevention|prevention
702977|NCT00250549|Rapid HIV testing|rapid hiv testing
702978|NCT00250523|trauma|trauma
702979|NCT00250523|critical illness|critical illness
702980|NCT00250523|injury|injury
702981|NCT00250510|Obesity treatment|obesity treatment
702982|NCT00250510|Insurance reimbursement|insurance reimbursement
702983|NCT00250510|Health care utilization|health care utilization
702984|NCT00250510|Health care costs|health care costs
702985|NCT00250497|Adolescent|adolescent
702986|NCT00250497|Girls|girls
702987|NCT00250497|Physical Activity|physical activity
702988|NCT00250497|Exercise|exercise
702989|NCT00250497|Diet|diet
702990|NCT00250497|Body image|body image
702991|NCT00250484|analgesia|analgesia
702992|NCT00250484|electric stimulation therapy|electric stimulation therapy
702993|NCT00250484|electric stimulation|electric stimulation
702994|NCT00250484|pain|pain
702995|NCT00250484|safety|safety
702996|NCT00250471|GP IIb/IIIa inhibitors|gp iib/iiia inhibitors
702997|NCT00250471|eptifibatide|eptifibatide
702998|NCT00250471|Anti-thrombotic agents|anti-thrombotic agents
702999|NCT00250445|Arcoxia|arcoxia
703000|NCT00250406|urolithiasis|urolithiasis
703001|NCT00250406|ureteral stent|ureteral stent
703002|NCT00250406|triclosan|triclosan
703003|NCT00250406|drug eluting|drug eluting
703004|NCT00250393|Parkinson's disease|parkinson's disease
703005|NCT00250393|monotherapy|monotherapy
703006|NCT00250380|Aspirin|aspirin
703007|NCT00250380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
703008|NCT00250367|risperidone|risperidone
703009|NCT00250367|antipsychotic agents|antipsychotic agents
703010|NCT00250367|bipolar disorders|bipolar disorders
703011|NCT00250367|manic episode|manic episode
703012|NCT00250354|conduct disorder|conduct disorder
703013|NCT00250354|oppositional deficit disorder|oppositional deficit disorder
703014|NCT00250354|disruptive behavior disorder not otherwise specified|disruptive behavior disorder not otherwise specified
703015|NCT00250354|ADHD|adhd
703016|NCT00250354|risperidone|risperidone
703017|NCT00250354|antipsychotropic agents|antipsychotropic agents
703018|NCT00250354|children|children
703019|NCT00250289|malodor|malodor
703020|NCT00250289|halitosis|halitosis
703021|NCT00250289|herbal formulation|herbal formulation
703022|NCT00250289|natural medicinals|natural medicinals
703023|NCT00250289|slow release delivery system|slow release delivery system
703024|NCT00250263|rhinitis|rhinitis
703025|NCT00250263|asthma|asthma
703026|NCT00250263|atopy|atopy
703027|NCT00250263|house dust mite|house dust mite
703028|NCT00250263|immunotherapy|immunotherapy
703029|NCT00250263|SLIT|slit
703030|NCT00250237|Post-operative delirium|post-operative delirium
703031|NCT00250237|hip fracture|hip fracture
703032|NCT00250224|Radiotherapy|radiotherapy
703033|NCT00250224|image guided|image guided
703034|NCT00250224|marker|marker
703035|NCT00250211|magnetic resonance imaging, functional|magnetic resonance imaging, functional
703036|NCT00250211|radiation therapy|radiation therapy
703037|NCT00250211|temozolomide|temozolomide
703038|NCT00250211|functional imaging|functional imaging
703039|NCT00250211|concurrent chemoradiation|concurrent chemoradiation
703040|NCT00250198|T Cell|t cell
703041|NCT00250198|Lymphocyte|lymphocyte
703042|NCT00250198|Lamina Propria|lamina propria
703043|NCT00250198|Colonoscopy|colonoscopy
703044|NCT00250198|Placebo|placebo
703045|NCT00250198|Crohn's Disease|crohn's disease
703046|NCT00250198|Crohns Disease|crohns disease
703047|NCT00250185|Ischemia Tolerance|ischemia tolerance
703048|NCT00250185|Endothelial Function|endothelial function
703049|NCT00250185|Forearm Blood Flow|forearm blood flow
703050|NCT00250185|Muscle Recovery|muscle recovery
703051|NCT00250185|Inflammation|inflammation
703052|NCT00250185|Healthy Volunteer|healthy volunteer
703053|NCT00250185|HV|hv
703054|NCT00250172|Dosimetry|dosimetry
703055|NCT00250172|Pharmacokinetics|pharmacokinetics
703056|NCT00250172|Compartment Analysis|compartment analysis
703057|NCT00250172|Reproducibility|reproducibility
703058|NCT00250172|Healthy Volunteer|healthy volunteer
703059|NCT00250172|HV|hv
703060|NCT00250159|Congenital Adrenal Hyperplasia (CAH)|congenital adrenal hyperplasia (cah)
703061|NCT00250159|Familial Male Precocious Puberty (FMPP)|familial male precocious puberty (fmpp)
703062|NCT00250159|21-hydroxylast deficiency|21-hydroxylast deficiency
703063|NCT00250159|Congenital Adrenal Hyperplasia|congenital adrenal hyperplasia
703064|NCT00250159|CAH|cah
703065|NCT00250159|Familial Male Precocious Puberty|familial male precocious puberty
703066|NCT00250159|FMPP|fmpp
703067|NCT00250146|Celiac Disease|celiac disease
703068|NCT00250146|Gluten|gluten
703069|NCT00250146|Toxicity|toxicity
703070|NCT00250146|Small bowel morphometry|small bowel morphometry
703071|NCT00250133|selective decontamination of the digestive tract|selective decontamination of the digestive tract
703072|NCT00250120|NSCLC|nsclc
703073|NCT00250120|L9NC|l9nc
703074|NCT00250120|Aerosolized Liposomal 9-Nitro-20 (S)-Camptothecin|aerosolized liposomal 9-nitro-20 (s)-camptothecin
703075|NCT00250094|Phase I|phase i
703076|NCT00250094|Ovarian Cancer|ovarian cancer
703077|NCT00250094|Ovary|ovary
703078|NCT00250094|Cancer|cancer
703079|NCT00250081|Cerebral Palsy|cerebral palsy
703080|NCT00250081|Tendon Transfer|tendon transfer
703081|NCT00250081|Botulinum Toxin Type A|botulinum toxin type a
703082|NCT00250081|Occupational Therapy|occupational therapy
703083|NCT00250081|Child|child
703084|NCT00250068|Phase II|phase ii
703085|NCT00250068|Aerosol Delivery|aerosol delivery
703086|NCT00250068|NSCLC|nsclc
703087|NCT00250068|9-Nitrocamptothecin|9-nitrocamptothecin
703088|NCT00250055|NIH|nih
703089|NCT00250055|Non-Invasive diagnosis of cervical tissue|non-invasive diagnosis of cervical tissue
703090|NCT00250055|Los Alamos/NIH|los alamos/nih
703091|NCT00250029|Colorectal Cancer|colorectal cancer
703092|NCT00250029|Pilot Study|pilot study
703093|NCT00250029|Oxaliplatin|oxaliplatin
703094|NCT00250016|Endometrium|endometrium
703095|NCT00250016|Tissue|tissue
703096|NCT00250016|L9NC|l9nc
703097|NCT00250003|Elderly|elderly
703098|NCT00250003|Preventive home visits|preventive home visits
703099|NCT00249990|Uterus|uterus
703100|NCT00249990|Recurrent disease|recurrent disease
703101|NCT00249990|Treatment|treatment
703102|NCT00249990|9-Nitrocamptothecin|9-nitrocamptothecin
703103|NCT00249990|Endometrium|endometrium
703104|NCT00249977|Phase I|phase i
703105|NCT00249977|solid tumors|solid tumors
703106|NCT00249977|DNA repair|dna repair
703107|NCT00249964|Extensive or recurrent small cell lung cancer Phase I|extensive or recurrent small cell lung cancer phase i
703108|NCT00249964|Paclitaxel, Carboplatin, Temozolomide|paclitaxel, carboplatin, temozolomide
703109|NCT00249951|nephrocalcinosis|nephrocalcinosis
703110|NCT00249951|premature infants|premature infants
703111|NCT00249951|hypocitraturia|hypocitraturia
703112|NCT00249951|alcaline citrate therapy|alcaline citrate therapy
703113|NCT00249951|Nephrocalcinosis in premature infants|nephrocalcinosis in premature infants
703114|NCT00249938|Antilipemic agents|antilipemic agents
703115|NCT00249938|hyperlipidemia|hyperlipidemia
703116|NCT00249925|Home modification|home modification
703117|NCT00249925|Occupational Therapy|occupational therapy
703118|NCT00249925|Physical Therapy|physical therapy
703119|NCT00249925|Home care|home care
703120|NCT00249912|Hyperlipidemia|hyperlipidemia
703121|NCT00249912|Drug Therapy|drug therapy
703122|NCT00249899|Hyperlipidemia|hyperlipidemia
703123|NCT00249899|Drug Therapy|drug therapy
703124|NCT00249873|Atrial fibrillation|atrial fibrillation
703125|NCT00249873|Anticoagulant therapy|anticoagulant therapy
703126|NCT00249873|Thromboembolic prevention|thromboembolic prevention
703127|NCT00249860|Subjects with chronic hepatitis C who have never previously received interferon therapy.|subjects with chronic hepatitis c who have never previously received interferon therapy.
703128|NCT00249847|Hot flashes, vasomotor symptoms, estrogen, paroxetine|hot flashes, vasomotor symptoms, estrogen, paroxetine
703129|NCT00249834|Assisted Reproductive Technology (ART)|assisted reproductive technology (art)
703130|NCT00249834|Infertility|infertility
703131|NCT00249834|Ovarian stimulation|ovarian stimulation
703132|NCT00249808|Candidates for systemic therapy for psoriasis|candidates for systemic therapy for psoriasis
703133|NCT00249795|Atrial fibrillation|atrial fibrillation
703134|NCT00249795|Cardiovascular disease|cardiovascular disease
703135|NCT00249795|angiotensin II blocker|angiotensin ii blocker
703136|NCT00249782|rosacea, Papulopustular Rosacea,erythema, dapsone|rosacea, papulopustular rosacea,erythema, dapsone
703137|NCT00249769|Japanese Encephalitis|japanese encephalitis
703138|NCT00249769|Japanese B Encephalitis|japanese b encephalitis
703139|NCT00249769|Japanese B Viral Encephalitis|japanese b viral encephalitis
703140|NCT00249769|Viral Encephalitis, Japanese B|viral encephalitis, japanese b
703141|NCT00249756|Criminal Justice|criminal justice
703142|NCT00249743|fall prevention|fall prevention
703143|NCT00249743|fall risk management|fall risk management
703144|NCT00249743|RCT|rct
703145|NCT00249743|cost|cost
703146|NCT00249717|Contingency management|contingency management
703147|NCT00249717|Substance abuse treatment|substance abuse treatment
703148|NCT00249691|cocaine addiction|cocaine addiction
703149|NCT00249691|cocaine dependence|cocaine dependence
703150|NCT00249678|Behavior Therapy|behavior therapy
703151|NCT00249678|methamphetamine|methamphetamine
703152|NCT00249652|End stage liver disease|end stage liver disease
703153|NCT00249652|End stage renal disease|end stage renal disease
703154|NCT00249652|Substance-Related Disorders|substance-related disorders
703155|NCT00249639|Contingency Management|contingency management
703156|NCT00249639|Substance Abuse Treatment|substance abuse treatment
703157|NCT00249626|Contingency management|contingency management
703158|NCT00249626|substance abuse treatment|substance abuse treatment
703159|NCT00249613|gender-responsive substance abuse treatment|gender-responsive substance abuse treatment
703160|NCT00249600|contingency management|contingency management
703161|NCT00249600|substance abuse|substance abuse
703162|NCT00249574|heroin addiction|heroin addiction
703163|NCT00249548|contingency management|contingency management
703164|NCT00249548|substance abuse|substance abuse
703165|NCT00249535|Substance Abuse|substance abuse
703166|NCT00249535|Contingency Management|contingency management
703167|NCT00249522|contingency management|contingency management
703168|NCT00249522|substance abuse treatment|substance abuse treatment
703169|NCT00249509|marijuana dependence|marijuana dependence
703170|NCT00249496|cocaine|cocaine
703171|NCT00249496|opioids|opioids
703172|NCT00249496|contingency management|contingency management
703173|NCT00249496|sexual risk|sexual risk
703175|NCT00249483|Cocaine Addiction|cocaine addiction
703176|NCT00249483|Cocaine Dependence|cocaine dependence
703177|NCT00249470|HIV|hiv
703178|NCT00249470|HIV risk behaviors|hiv risk behaviors
703179|NCT00249470|Heroin|heroin
703180|NCT00249470|Cocaine|cocaine
703181|NCT00249470|Methadone|methadone
703182|NCT00249470|Opioid Dependence|opioid dependence
703183|NCT00249470|Cocaine Abuse|cocaine abuse
703184|NCT00249470|Contingency management|contingency management
703185|NCT00249470|alcohol & drug use|alcohol & drug use
703186|NCT00249470|sexual risk behaviors|sexual risk behaviors
703187|NCT00249457|Behavior Therapy|behavior therapy
703188|NCT00249457|Cocaine Abuse|cocaine abuse
703189|NCT00249457|Cocaine Dependence|cocaine dependence
703190|NCT00249457|Contingency Management|contingency management
703191|NCT00249457|Heroin Dependence|heroin dependence
703192|NCT00249457|Methadone|methadone
703193|NCT00249457|Opioid Dependence|opioid dependence
703194|NCT00249444|cocaine dependence|cocaine dependence
703195|NCT00249444|mirtazipine|mirtazipine
703196|NCT00249431|Gambling|gambling
703197|NCT00249431|Alcohol|alcohol
703198|NCT00249418|Contingency Management|contingency management
703199|NCT00249418|Substance Abuse Treatment|substance abuse treatment
703200|NCT00249405|Clinical trial|clinical trial
703201|NCT00249405|Alcoholism|alcoholism
703202|NCT00249405|Alcohol|alcohol
703203|NCT00249405|Pharmacogenetics|pharmacogenetics
703204|NCT00249405|Citalopram|citalopram
703205|NCT00249405|Genotype|genotype
703206|NCT00249405|Therapy compliance|therapy compliance
703207|NCT00249405|Serotonin inhibitor|serotonin inhibitor
703208|NCT00249405|Alcoholism/alcohol abuse therapy|alcoholism/alcohol abuse therapy
703209|NCT00249392|ocular diseases|ocular diseases
703210|NCT00249392|risk factors|risk factors
703211|NCT00249392|genetic factors|genetic factors
703212|NCT00249379|Alcohol dependence|alcohol dependence
703213|NCT00249379|Acamprosate(drug)|acamprosate(drug)
703214|NCT00249379|Drug Court|drug court
703215|NCT00249379|Probation|probation
703216|NCT00249379|Parole|parole
703217|NCT00249379|Criminal justice|criminal justice
703218|NCT00249366|Alcohol withdrawal|alcohol withdrawal
703219|NCT00249366|Symptom-triggered therapy|symptom-triggered therapy
703220|NCT00249366|Fixed-schedule therapy|fixed-schedule therapy
703221|NCT00249366|CIWA-Ar|ciwa-ar
703222|NCT00249366|Lorazepam (drug)|lorazepam (drug)
703223|NCT00249353|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
703224|NCT00249353|ADHD|adhd
703225|NCT00249353|Concerta|concerta
703226|NCT00249340|behavioral weight loss treatment|behavioral weight loss treatment
703227|NCT00249340|brief behavioral treatment|brief behavioral treatment
703228|NCT00249340|commercial weight loss programs|commercial weight loss programs
703229|NCT00249340|Weight Watchers|weight watchers
703230|NCT00249327|HIV testing|hiv testing
703231|NCT00249327|HIV disclosure|hiv disclosure
703232|NCT00249327|HIV Seronegativity|hiv seronegativity
703233|NCT00249314|South Asians|south asians
703234|NCT00249314|European Caucasians|european caucasians
703235|NCT00249314|ethnic differences|ethnic differences
703236|NCT00249314|body composition|body composition
703237|NCT00249314|body fat distribution|body fat distribution
703238|NCT00249314|adipose tissue|adipose tissue
703239|NCT00249314|visceral fat|visceral fat
703240|NCT00249314|myocellular lipids|myocellular lipids
703241|NCT00249314|skeletal muscle|skeletal muscle
703242|NCT00249301|Breast Cancer|breast cancer
703243|NCT00249301|Colon Cancer|colon cancer
703244|NCT00249301|Pancreatic Cancer|pancreatic cancer
703245|NCT00249301|Bladder Cancer|bladder cancer
703246|NCT00249288|Schizophrenia|schizophrenia
703247|NCT00249288|Negative Symptoms|negative symptoms
703248|NCT00249288|Folate|folate
703249|NCT00249275|significant refractive errors|significant refractive errors
703250|NCT00249275|children|children
703251|NCT00249275|spectacles|spectacles
703252|NCT00249275|Africa|africa
703253|NCT00249249|hypercholesterolemia|hypercholesterolemia
703254|NCT00249249|dyslipidemia|dyslipidemia
703255|NCT00249249|kowa|kowa
703256|NCT00249249|KRE|kre
703257|NCT00249249|pitavastatin|pitavastatin
703258|NCT00249249|NK-104|nk-104
703259|NCT00249236|risperidone|risperidone
703260|NCT00249236|antipsychotic agents|antipsychotic agents
703261|NCT00249236|bipolar disorders|bipolar disorders
703262|NCT00249236|manic episode|manic episode
703263|NCT00249223|chronic schizophrenia, psychotic disorder, risperidone, long-acting injectable, intramuscular injection, antipsychotic agents|chronic schizophrenia, psychotic disorder, risperidone, long-acting injectable, intramuscular injection, antipsychotic agents
703264|NCT00249210|Sinusitis|sinusitis
703265|NCT00249210|respiratory tract diseases|respiratory tract diseases
703266|NCT00249210|nose diseases|nose diseases
703267|NCT00249210|respiratory tract infections|respiratory tract infections
703268|NCT00249210|paranasal sinus diseases|paranasal sinus diseases
703269|NCT00249210|antibacterial agents|antibacterial agents
703270|NCT00249210|quinolones|quinolones
703271|NCT00249210|levofloxacin|levofloxacin
703272|NCT00249197|skin infection|skin infection
703273|NCT00249197|bacterial infection|bacterial infection
703274|NCT00249197|levofloxacin|levofloxacin
703275|NCT00249197|quinolones|quinolones
703277|NCT00249197|infection|infection
703278|NCT00249171|acute schizophrenia|acute schizophrenia
703279|NCT00249171|psychosis|psychosis
703280|NCT00249171|risperidone|risperidone
703281|NCT00249171|lorazepam, antipsychotic agents|lorazepam, antipsychotic agents
703282|NCT00249171|emergency treatment|emergency treatment
703283|NCT00249158|Dementia|dementia
703284|NCT00249158|Alzheimer's Disease|alzheimer's disease
703285|NCT00249158|vascular dementia|vascular dementia
703286|NCT00249158|mixed dementia|mixed dementia
703287|NCT00249158|risperidone|risperidone
703288|NCT00249158|nursing home|nursing home
703289|NCT00249145|Dementia|dementia
703290|NCT00249145|Alzheimer's Disease|alzheimer's disease
703291|NCT00249145|vascular dementia|vascular dementia
703292|NCT00249145|mixed dementia, risperidone|mixed dementia, risperidone
703293|NCT00249145|nursing home|nursing home
703294|NCT00249132|chronic schizophrenia|chronic schizophrenia
703295|NCT00249132|psychotic disorder|psychotic disorder
703296|NCT00249132|risperidone|risperidone
703297|NCT00249132|antipsychotic agents|antipsychotic agents
703298|NCT00249119|chronic schizophrenia|chronic schizophrenia
703299|NCT00249119|psychotic disorders|psychotic disorders
703300|NCT00249119|risperidone|risperidone
703301|NCT00249119|antipsychotic agents|antipsychotic agents
703302|NCT00249080|3T MRI|3t mri
703303|NCT00249080|neurodegenerative disease|neurodegenerative disease
703304|NCT00249080|Alzheimer's disease|alzheimer's disease
703305|NCT00249080|spectroscopy|spectroscopy
703306|NCT00249080|Normal, healthy subject without memory complaint|normal, healthy subject without memory complaint
703307|NCT00249080|Not pregnant|not pregnant
703308|NCT00249080|MR compatible|mr compatible
703309|NCT00249067|Congestive Heart Failure, Left-to-Right Shunt|congestive heart failure, left-to-right shunt
703310|NCT00249041|Rheumatoid Arthritis, Enbrel liquid, antibodies|rheumatoid arthritis, enbrel liquid, antibodies
703311|NCT00249015|aerobic exercise|aerobic exercise
703312|NCT00249015|resistance exercise|resistance exercise
703313|NCT00249015|physical fitness|physical fitness
703314|NCT00249015|body composition|body composition
703315|NCT00249015|quality of life|quality of life
703316|NCT00249015|rehabilitation|rehabilitation
703317|NCT00249015|psychosocial oncology|psychosocial oncology
703318|NCT00249015|adherence|adherence
703319|NCT00249002|Vascular Access Graft Failure|vascular access graft failure
703320|NCT00249002|Venous Neointimal Hyperplasia(VNH)|venous neointimal hyperplasia(vnh)
703321|NCT00249002|Hemodialysis|hemodialysis
703322|NCT00248989|Skin aging|skin aging
703323|NCT00248989|Menopausal symptoms|menopausal symptoms
703324|NCT00248976|Angioplasty|angioplasty
703325|NCT00248976|Motivating behavior change|motivating behavior change
703326|NCT00248976|Reducing risk factors|reducing risk factors
703327|NCT00248976|Enhancing quality of life|enhancing quality of life
703328|NCT00248976|Improving treatment outcomes|improving treatment outcomes
703329|NCT00248963|Oral Contraceptive|oral contraceptive
703330|NCT00248950|Angioplasty|angioplasty
703331|NCT00248950|Behavior Change|behavior change
703332|NCT00248937|African-American|african-american
703333|NCT00248937|Hypertension|hypertension
703334|NCT00248937|Medication adherence|medication adherence
703335|NCT00248937|Risk reduction|risk reduction
703336|NCT00248924|Social service intervention|social service intervention
703337|NCT00248924|Social support|social support
703338|NCT00248924|Elderly|elderly
703339|NCT00248924|Homebound|homebound
703340|NCT00248924|Quality of life|quality of life
703341|NCT00248911|Breast cancer|breast cancer
703342|NCT00248911|Gynecologic cancers|gynecologic cancers
703343|NCT00248911|Meditation|meditation
703344|NCT00248911|Stress-reduction|stress-reduction
703345|NCT00248911|Cognitive-affective behavioral learning|cognitive-affective behavioral learning
703346|NCT00248898|nonagenarians|nonagenarians
703347|NCT00248898|quality of life|quality of life
703348|NCT00248898|cardiothoracic surgery|cardiothoracic surgery
703349|NCT00248898|long term survival|long term survival
703350|NCT00248885|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
703351|NCT00248885|Perioperative complications|perioperative complications
703352|NCT00248885|Neurocognitive function|neurocognitive function
703353|NCT00248885|Quality of life|quality of life
703354|NCT00248885|Blood pressure|blood pressure
703355|NCT00248872|African-American|african-american
703356|NCT00248872|Hypertension|hypertension
703357|NCT00248872|Medication adherence|medication adherence
703358|NCT00248872|Risk reduction|risk reduction
703359|NCT00248859|Coronary artery disease|coronary artery disease
703360|NCT00248859|Depressive symptoms|depressive symptoms
703361|NCT00248859|Latino American|latino american
703362|NCT00248846|Angioplasty patients|angioplasty patients
703363|NCT00248846|Behavior change|behavior change
703364|NCT00248846|Physical activity|physical activity
703365|NCT00248846|Risk reduction|risk reduction
703366|NCT00248820|Contrast-enhanced Ultrasound|contrast-enhanced ultrasound
703367|NCT00248820|Ultrasound Contrast agent, microbubbles|ultrasound contrast agent, microbubbles
703368|NCT00248820|Ovarian tumor|ovarian tumor
703369|NCT00248820|vascularization|vascularization
703370|NCT00248807|Blood Pressure, Low|blood pressure, low
703371|NCT00248807|Hypotension, Postural|hypotension, postural
703372|NCT00248807|Injuries, Spinal Cord|injuries, spinal cord
703373|NCT00248807|Spinal Cord Transection|spinal cord transection
703374|NCT00248807|Spinal Cord Trauma|spinal cord trauma
703375|NCT00248794|Cognitive Impairment|cognitive impairment
703376|NCT00248794|Rehabilitation|rehabilitation
703377|NCT00248781|Activities of daily living|activities of daily living
703378|NCT00248781|Aging|aging
703379|NCT00248781|Exercise|exercise
703380|NCT00248781|Weight lifting|weight lifting
703381|NCT00248768|Depression|depression
703382|NCT00248768|Parkinson Disease|parkinson disease
703383|NCT00248768|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
703384|NCT00248755|cystic fibrosis|cystic fibrosis
703385|NCT00248755|mucociliary clearance|mucociliary clearance
703386|NCT00248755|nuclear medicine|nuclear medicine
703387|NCT00248742|IBD, psychological, stress management|ibd, psychological, stress management
703388|NCT00248703|Disseminating tumor cells,breast cancer,docetaxel,adjuvant|disseminating tumor cells,breast cancer,docetaxel,adjuvant
703389|NCT00248690|Subarachnoid hemorrhage|subarachnoid hemorrhage
703390|NCT00248690|Intracranial hypertension|intracranial hypertension
703391|NCT00248690|Intracranial pressure|intracranial pressure
703392|NCT00248690|Diagnostic techniques and procedures|diagnostic techniques and procedures
703393|NCT00248690|Compliance|compliance
703394|NCT00248690|Treatment outcome|treatment outcome
703395|NCT00248690|Intensive care, surgical|intensive care, surgical
703396|NCT00248664|Cystitis, Interstitial|cystitis, interstitial
703397|NCT00248664|Case-Control Studies|case-control studies
703398|NCT00248664|Risk Factors|risk factors
703399|NCT00248651|Bloating|bloating
703400|NCT00248651|Early Fullness|early fullness
703401|NCT00248651|Nausea|nausea
703402|NCT00248651|Upper Abdominal Discomfort|upper abdominal discomfort
703403|NCT00248651|dyspepsia|dyspepsia
703404|NCT00248651|stomach pain|stomach pain
703405|NCT00248651|stomach discomfort|stomach discomfort
703406|NCT00248625|acute liver failure|acute liver failure
703407|NCT00248625|hepatic encephalopathy|hepatic encephalopathy
703408|NCT00248625|acetaminophen toxicity|acetaminophen toxicity
703409|NCT00248625|N-acetylcysteine|n-acetylcysteine
703410|NCT00248612|Venlafaxine|venlafaxine
703411|NCT00248612|Alcoholism|alcoholism
703412|NCT00248612|Anxiety Disorders|anxiety disorders
703413|NCT00248612|Alcohol-Use Disorders|alcohol-use disorders
703414|NCT00248612|Alcohol Abuse|alcohol abuse
703415|NCT00248612|Alcohol Dependence|alcohol dependence
703416|NCT00248612|Cognitive Behavioral Treatment|cognitive behavioral treatment
703417|NCT00248560|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
703418|NCT00248560|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
703419|NCT00248560|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
703420|NCT00248560|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
703421|NCT00248560|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
703422|NCT00248560|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
703423|NCT00248560|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
703424|NCT00248560|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
703425|NCT00248560|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
703426|NCT00248560|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
703427|NCT00248560|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
703428|NCT00248560|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
703429|NCT00248560|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
703430|NCT00248560|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
703431|NCT00248547|nausea and vomiting|nausea and vomiting
703432|NCT00248547|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
703433|NCT00248547|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
703434|NCT00248547|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
703435|NCT00248547|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
703436|NCT00248547|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
703437|NCT00248547|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
703438|NCT00248547|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
703439|NCT00248547|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
703440|NCT00248547|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
703441|NCT00248547|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
703442|NCT00248547|chronic eosinophilic leukemia|chronic eosinophilic leukemia
703443|NCT00248547|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
703444|NCT00248547|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
703445|NCT00248547|chronic neutrophilic leukemia|chronic neutrophilic leukemia
703446|NCT00248547|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
703447|NCT00248547|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
703448|NCT00248547|disseminated neuroblastoma|disseminated neuroblastoma
703449|NCT00248547|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
703450|NCT00248547|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
703451|NCT00248547|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
703452|NCT00248547|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
703453|NCT00248547|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
703454|NCT00248547|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
703455|NCT00248547|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
703456|NCT00248547|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
703457|NCT00248547|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
703458|NCT00248547|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
703459|NCT00248547|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
703460|NCT00248547|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
703461|NCT00248547|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
703462|NCT00248547|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
703463|NCT00248547|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
703464|NCT00248547|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
703708|NCT00247884|HCV|hcv
703465|NCT00248547|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
703466|NCT00248547|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
703467|NCT00248547|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
703468|NCT00248547|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
703469|NCT00248547|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
703470|NCT00248547|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
703471|NCT00248547|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
703472|NCT00248547|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
703473|NCT00248547|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
703474|NCT00248547|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
703475|NCT00248547|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
703476|NCT00248547|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
703477|NCT00248547|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
703478|NCT00248547|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
703479|NCT00248547|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
703480|NCT00248547|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
703481|NCT00248547|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
703482|NCT00248547|recurrent neuroblastoma|recurrent neuroblastoma
703483|NCT00248547|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
703484|NCT00248547|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
703485|NCT00248547|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
703486|NCT00248547|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
703487|NCT00248547|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
703488|NCT00248547|refractory hairy cell leukemia|refractory hairy cell leukemia
703489|NCT00248547|refractory multiple myeloma|refractory multiple myeloma
703490|NCT00248547|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
703491|NCT00248547|secondary acute myeloid leukemia|secondary acute myeloid leukemia
703492|NCT00248547|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
703493|NCT00248547|splenic marginal zone lymphoma|splenic marginal zone lymphoma
703494|NCT00248547|stage I multiple myeloma|stage i multiple myeloma
703495|NCT00248547|stage II multiple myeloma|stage ii multiple myeloma
703496|NCT00248547|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
703497|NCT00248547|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
703498|NCT00248547|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
703499|NCT00248547|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
703500|NCT00248547|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
703501|NCT00248547|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
703502|NCT00248547|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
703503|NCT00248547|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
703504|NCT00248547|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
703505|NCT00248547|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
703506|NCT00248547|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
703507|NCT00248547|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
703508|NCT00248547|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
703509|NCT00248547|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
703510|NCT00248547|stage III multiple myeloma|stage iii multiple myeloma
703511|NCT00248547|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
703512|NCT00248547|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
703513|NCT00248547|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
703514|NCT00248547|stage IIIA breast cancer|stage iiia breast cancer
703515|NCT00248547|stage IIIB breast cancer|stage iiib breast cancer
703516|NCT00248547|stage IIIC breast cancer|stage iiic breast cancer
703517|NCT00248547|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
703518|NCT00248547|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
703519|NCT00248547|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
703520|NCT00248547|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
703521|NCT00248547|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
703522|NCT00248547|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
703523|NCT00248547|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
703524|NCT00248547|stage IV breast cancer|stage iv breast cancer
703525|NCT00248547|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
703526|NCT00248547|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
703527|NCT00248547|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
703528|NCT00248547|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
703529|NCT00248547|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
703530|NCT00248547|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
703531|NCT00248547|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
703532|NCT00248547|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
703533|NCT00248547|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
703534|NCT00248534|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
703535|NCT00248521|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
703536|NCT00248495|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
703537|NCT00248495|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
703538|NCT00248495|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
703539|NCT00248495|stage I non-small cell lung cancer|stage i non-small cell lung cancer
703540|NCT00248482|extensive stage small cell lung cancer|extensive stage small cell lung cancer
703541|NCT00248482|recurrent small cell lung cancer|recurrent small cell lung cancer
703542|NCT00248469|Community randomised trial|community randomised trial
703543|NCT00248469|Sexual behavior|sexual behavior
703544|NCT00248469|Intervention|intervention
703545|NCT00248469|Evaluation|evaluation
703546|NCT00248469|Sexual health education|sexual health education
703547|NCT00248469|Youth-friendly health services|youth-friendly health services
703548|NCT00248469|Adolescents|adolescents
703549|NCT00248469|Behavior change|behavior change
703550|NCT00248469|HIV Seronegativity|hiv seronegativity
703552|NCT00248443|Haematology and cancer patients|haematology and cancer patients
703553|NCT00248443|Acute respiratory failure|acute respiratory failure
703554|NCT00248443|Bronchoalveolar lavage|bronchoalveolar lavage
703555|NCT00248443|Non invasive diagnostic tools|non invasive diagnostic tools
703556|NCT00248443|Mechanical ventilation|mechanical ventilation
703557|NCT00248443|Intensive Care|intensive care
703558|NCT00248430|graft versus host disease|graft versus host disease
703559|NCT00248430|stage II multiple myeloma|stage ii multiple myeloma
703560|NCT00248430|stage III multiple myeloma|stage iii multiple myeloma
703561|NCT00248430|refractory multiple myeloma|refractory multiple myeloma
703562|NCT00248430|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
703563|NCT00248430|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
703564|NCT00248430|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
703565|NCT00248430|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
703566|NCT00248430|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
703567|NCT00248430|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
703568|NCT00248430|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
703569|NCT00248430|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
703570|NCT00248430|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
703571|NCT00248430|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
703572|NCT00248430|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
703573|NCT00248430|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
703574|NCT00248430|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
703575|NCT00248430|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
703576|NCT00248430|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
703577|NCT00248430|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
703578|NCT00248430|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
703579|NCT00248430|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
703580|NCT00248404|colorectal cancer|colorectal cancer
703581|NCT00248404|ovarian cancer|ovarian cancer
703582|NCT00248404|lung cancer|lung cancer
703583|NCT00248404|breast cancer|breast cancer
703584|NCT00248404|small bowel cancer|small bowel cancer
703585|NCT00248404|Advanced, recurrent, or metastatic solid tumors of any type|advanced, recurrent, or metastatic solid tumors of any type
703586|NCT00248404|TS overexpression confirmed by fresh biopsy (RTPCR)|ts overexpression confirmed by fresh biopsy (rtpcr)
703587|NCT00248404|Suitable for experimental monotherapy|suitable for experimental monotherapy
703588|NCT00248391|adenoid hypertrophy|adenoid hypertrophy
703589|NCT00248391|feeding position|feeding position
703591|NCT00248391|upright|upright
703592|NCT00248391|pneumonia|pneumonia
703593|NCT00248391|wheezing|wheezing
703594|NCT00248391|otitis|otitis
703595|NCT00248391|adenoid|adenoid
703596|NCT00248391|tonsil|tonsil
703597|NCT00248391|caries|caries
703598|NCT00248378|Multiple Sclerosis|multiple sclerosis
703599|NCT00248378|Cannabis|cannabis
703600|NCT00248378|Spasticity|spasticity
703601|NCT00248378|Tolerability|tolerability
703602|NCT00248365|Chronic GvHD|chronic gvhd
703603|NCT00248365|Extensive chronic GvHD|extensive chronic gvhd
703604|NCT00248365|Resistant chronic GvHD|resistant chronic gvhd
703605|NCT00248352|Coronary Artery Disease|coronary artery disease
703606|NCT00248352|Diabetes Mellitus|diabetes mellitus
703607|NCT00248352|Type 2|type 2
703608|NCT00248352|Chronic Disease|chronic disease
703609|NCT00248339|Hepatitis C|hepatitis c
703610|NCT00248339|Peginterferon|peginterferon
703611|NCT00248339|Ribavirin|ribavirin
703612|NCT00248339|Procrit|procrit
703613|NCT00248339|Epoetin-alpha|epoetin-alpha
703614|NCT00248326|atrial fibrillation|atrial fibrillation
703615|NCT00248326|genetics|genetics
703616|NCT00248326|genetic polymorphisms|genetic polymorphisms
703617|NCT00248313|Kidney Disease|kidney disease
703618|NCT00248300|ventilator-associated pneumonia|ventilator-associated pneumonia
703619|NCT00248300|hospital acquired pneumonia|hospital acquired pneumonia
703620|NCT00248274|atrial fibrillation|atrial fibrillation
703621|NCT00248274|genetics|genetics
703622|NCT00248261|ziprasidone, sertraline, PTSD|ziprasidone, sertraline, ptsd
703623|NCT00248248|Consolidation|consolidation
703624|NCT00248248|Ovarian cancer|ovarian cancer
703625|NCT00248248|DOXIL|doxil
703626|NCT00248248|Hand-foot syndrome|hand-foot syndrome
703627|NCT00248235|exercise|exercise
703628|NCT00248235|rehabilitation|rehabilitation
703629|NCT00248235|head and neck neoplasms|head and neck neoplasms
703630|NCT00248222|Exercise|exercise
703631|NCT00248222|Rehabilitation|rehabilitation
703632|NCT00248222|Aerobic training|aerobic training
703633|NCT00248209|Female Orgasmic Disorder|female orgasmic disorder
703634|NCT00248209|Female Sexual Dysfunction|female sexual dysfunction
703635|NCT00248170|Breast cancer|breast cancer
703636|NCT00248170|letrozole|letrozole
703637|NCT00248170|anastrozole|anastrozole
703638|NCT00248170|adjuvant|adjuvant
703639|NCT00248170|postmenopausal|postmenopausal
703640|NCT00248170|FACE|face
703641|NCT00248157|Diabetic retinopathy|diabetic retinopathy
703642|NCT00248157|Octreotide acetate in microspheres|octreotide acetate in microspheres
703643|NCT00248144|Herpes labialis|herpes labialis
703644|NCT00248131|Diabetic retinopathy, octreotide acetate in microspheres|diabetic retinopathy, octreotide acetate in microspheres
703645|NCT00248118|Randomized|randomized
703646|NCT00248118|Double-blind|double-blind
703647|NCT00248118|Placebo-controlled|placebo-controlled
703648|NCT00248105|Arthritis|arthritis
703649|NCT00248105|Physical Activity|physical activity
703650|NCT00248092|d-Amphetamine|d-amphetamine
703651|NCT00248092|Diethylpropion|diethylpropion
703652|NCT00248092|Diethylpropion Hydrochloride|diethylpropion hydrochloride
703653|NCT00248092|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
703654|NCT00248092|Attention Deficit Disorders with Hyperactivity|attention deficit disorders with hyperactivity
703655|NCT00248092|Attention Deficit Hyperactivity Disorders|attention deficit hyperactivity disorders
703656|NCT00248092|Amphetamine Abuse|amphetamine abuse
703657|NCT00248092|Amphetamine Dependence|amphetamine dependence
703658|NCT00248092|Amphetamine Addiction|amphetamine addiction
703659|NCT00248092|Amphetamine Users|amphetamine users
703660|NCT00248092|Drug Abuse|drug abuse
703661|NCT00248092|Drug Addiction|drug addiction
703662|NCT00248092|Drug Dependence|drug dependence
703663|NCT00248092|Drug Habituation|drug habituation
703664|NCT00248092|Drug Use Disorders|drug use disorders
703665|NCT00248092|Substance Abuse|substance abuse
703666|NCT00248092|Substance Dependence|substance dependence
703667|NCT00248092|Substance Use Disorders|substance use disorders
703668|NCT00248092|Drug Usage|drug usage
703669|NCT00248092|Substance Addiction|substance addiction
703670|NCT00248079|Coronary Disease|coronary disease
703671|NCT00248066|Coronary artery disease|coronary artery disease
703672|NCT00248066|Restenosis|restenosis
703673|NCT00248066|Coronary stent restenosis|coronary stent restenosis
703674|NCT00248053|Familial adenomatous polyposis patient with 5 or more adenomatous polyps in the colon or ileoanal pouch|familial adenomatous polyposis patient with 5 or more adenomatous polyps in the colon or ileoanal pouch
703675|NCT00248040|Kidney transplantation|kidney transplantation
703676|NCT00248040|Reperfusion Injury|reperfusion injury
703677|NCT00248040|Survival|survival
703678|NCT00248027|early intervention,program evaluation|early intervention,program evaluation
703679|NCT00248014|CLASS II|class ii
703680|NCT00248014|FUNCTIONAL APPLIANCE|functional appliance
703681|NCT00248014|MANDIBULAR ADVANCEMENT STABILITY|mandibular advancement stability
703682|NCT00247988|Ovarian|ovarian
703683|NCT00247988|Relapsed|relapsed
703684|NCT00247975|L-carnitine|l-carnitine
703685|NCT00247975|Breast cancer|breast cancer
703686|NCT00247975|Anthracycline Cardiotoxicity|anthracycline cardiotoxicity
703687|NCT00247975|Primary prevention|primary prevention
703688|NCT00247975|Anthracycline induced cardiotoxicity|anthracycline induced cardiotoxicity
703689|NCT00247975|Left Ventricular Ejection Fraction|left ventricular ejection fraction
703690|NCT00247962|Ankylosing Spondylitis (AS)|ankylosing spondylitis (as)
703691|NCT00247949|carbon dioxide|carbon dioxide
703692|NCT00247949|monitoring|monitoring
703693|NCT00247949|major surgery|major surgery
703694|NCT00247949|repeated blood gas testing|repeated blood gas testing
703695|NCT00247949|carbon dioxide monitoring|carbon dioxide monitoring
703696|NCT00247936|Adenocarcinoma, Esophagectomy|adenocarcinoma, esophagectomy
703697|NCT00247923|Endometrial polyps.|endometrial polyps.
703698|NCT00247923|Angiogenesis.|angiogenesis.
703699|NCT00247923|Asymptomatic.|asymptomatic.
703700|NCT00247923|Symptoms.|symptoms.
703701|NCT00247923|Malignancy.|malignancy.
703702|NCT00247923|Treatment efficiency.|treatment efficiency.
703703|NCT00247923|Vaginal bleeding.|vaginal bleeding.
703704|NCT00247910|hypertension, ambulatory BP, office resting BP, hydrochlorothiazide, stress reduction, self-help, psychotherapy, efficacy|hypertension, ambulatory bp, office resting bp, hydrochlorothiazide, stress reduction, self-help, psychotherapy, efficacy
703705|NCT00247884|Injection drug users|injection drug users
703706|NCT00247884|pegylated interferon|pegylated interferon
703707|NCT00247884|ribavirin,|ribavirin,
703709|NCT00247871|MRSA, USA300, CMRSA-10, CMRSA-6, soft tissue abscesses|mrsa, usa300, cmrsa-10, cmrsa-6, soft tissue abscesses
703710|NCT00247858|MRSA, USA300, CMRSA-10, CMRSA-6, soft tissue abscesses|mrsa, usa300, cmrsa-10, cmrsa-6, soft tissue abscesses
703711|NCT00247845|HIV|hiv
703712|NCT00247845|Atazanavir|atazanavir
703713|NCT00247845|quality of life|quality of life
703714|NCT00247845|Treatment Experienced|treatment experienced
703715|NCT00247832|Monitoring, early mobilization, motivation modality, visitation rate, step rates, anxiety, pain|monitoring, early mobilization, motivation modality, visitation rate, step rates, anxiety, pain
703716|NCT00247832|Elective lobectomy|elective lobectomy
703717|NCT00247819|Substance abuse|substance abuse
703718|NCT00247806|Pilot, pediatric, stem cell transplant, lactose intolerance|pilot, pediatric, stem cell transplant, lactose intolerance
703719|NCT00247793|immunonutrition|immunonutrition
703720|NCT00247793|preoperative optimization|preoperative optimization
703721|NCT00247793|preoperative enteral nutritional supplement|preoperative enteral nutritional supplement
703722|NCT00247793|high risk|high risk
703723|NCT00247793|cardiac surgery|cardiac surgery
703724|NCT00247793|arginine|arginine
703725|NCT00247793|omega-3 polyunsaturated fatty acids|omega-3 polyunsaturated fatty acids
703726|NCT00247793|nucleotides|nucleotides
703727|NCT00247793|glycine|glycine
703728|NCT00247793|immune enhancing nutritional supplement|immune enhancing nutritional supplement
703729|NCT00247793|immune enhancing formula|immune enhancing formula
703730|NCT00247780|Atrial fibrillation|atrial fibrillation
703731|NCT00247780|Pulmonary vein isolation|pulmonary vein isolation
703732|NCT00247780|Tissue Doppler echocardiography|tissue doppler echocardiography
703733|NCT00247754|Anxiety|anxiety
703734|NCT00247754|Therapy|therapy
703735|NCT00247754|Behaviour|behaviour
703736|NCT00247741|spinal anesthesia|spinal anesthesia
703737|NCT00247741|lidocaine|lidocaine
703738|NCT00247741|articaine|articaine
703739|NCT00247741|intrathecal|intrathecal
703740|NCT00247728|PI-88|pi-88
703741|NCT00247728|post resection hepatoma|post resection hepatoma
703742|NCT00247728|adjuvant therapy|adjuvant therapy
703743|NCT00247728|hepatectomy|hepatectomy
703744|NCT00247728|hepatoma|hepatoma
703745|NCT00247715|uninvestigated dyspepsia|uninvestigated dyspepsia
703746|NCT00247715|cost effectiveness|cost effectiveness
703747|NCT00247715|acid suppressive medicine|acid suppressive medicine
703748|NCT00247715|primary care|primary care
703749|NCT00247715|gastrointestinal complaints|gastrointestinal complaints
703750|NCT00247715|Gastrointestinal drugs|gastrointestinal drugs
703751|NCT00247702|CYP2C9|cyp2c9
703752|NCT00247702|VKORC1|vkorc1
703753|NCT00247702|polymorphism|polymorphism
703754|NCT00247702|warfarin|warfarin
703755|NCT00247689|Ritalin|ritalin
703756|NCT00247689|Substance Abuse|substance abuse
703757|NCT00247689|Allelic Variants|allelic variants
703758|NCT00247689|Genotype|genotype
703759|NCT00247689|Addiction-Associated Human Gene Variants|addiction-associated human gene variants
703760|NCT00247689|Methylphenidate|methylphenidate
703761|NCT00247676|Liver neoplasms, sunitinib, Phase 2|liver neoplasms, sunitinib, phase 2
703762|NCT00247663|Aromatase inhibitor|aromatase inhibitor
703763|NCT00247663|letrozole|letrozole
703764|NCT00247663|breast cancer|breast cancer
703765|NCT00247650|neoadjuvant, postmenopausal women, breast cancer, hormonal therapy, bisphosphonate|neoadjuvant, postmenopausal women, breast cancer, hormonal therapy, bisphosphonate
703766|NCT00247637|Mental Health|mental health
703767|NCT00247637|Psychosis|psychosis
703768|NCT00247637|Genetics|genetics
703769|NCT00247637|Heredity|heredity
703770|NCT00247624|Depression|depression
703771|NCT00247624|Hypnotics|hypnotics
703772|NCT00247624|Sleep|sleep
703773|NCT00247624|Quality of Life|quality of life
703774|NCT00247624|Insomnia|insomnia
703775|NCT00247624|Suicide|suicide
703776|NCT00247611|HIV|hiv
703777|NCT00247611|AIDS|aids
703778|NCT00247611|Antiretroviral Medication Adherence|antiretroviral medication adherence
703779|NCT00247585|Alcohol|alcohol
703780|NCT00247585|Alcohol abuse|alcohol abuse
703781|NCT00247585|Alcohol consumption|alcohol consumption
703782|NCT00247585|Unhealthy alcohol use|unhealthy alcohol use
703783|NCT00247585|Residual effects|residual effects
703784|NCT00247585|Sleep Stages|sleep stages
703785|NCT00247585|Respiratory Physiology|respiratory physiology
703786|NCT00247572|d-Amphetamine|d-amphetamine
703787|NCT00247572|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
703788|NCT00247572|Attention Deficit Disorders with Hyperactivity|attention deficit disorders with hyperactivity
703789|NCT00247572|Attention Deficit Hyperactivity Disorders|attention deficit hyperactivity disorders
703790|NCT00247572|Amphetamine Abuse|amphetamine abuse
703791|NCT00247572|Amphetamine Dependence|amphetamine dependence
703792|NCT00247572|Amphetamine Addiction|amphetamine addiction
703793|NCT00247572|Amphetamine Users|amphetamine users
703794|NCT00247572|Drug Abuse|drug abuse
703795|NCT00247572|Drug Addiction|drug addiction
703796|NCT00247572|Drug Dependence|drug dependence
703797|NCT00247572|Drug Habituation|drug habituation
703798|NCT00247572|Drug Use Disorders|drug use disorders
703799|NCT00247572|Substance Abuse|substance abuse
703800|NCT00247572|Substance Dependence|substance dependence
703801|NCT00247572|Substance Use Disorders|substance use disorders
703802|NCT00247572|Drug Usage|drug usage
703803|NCT00247572|Substance Addiction|substance addiction
703804|NCT00247572|Drug Abuse, Intravenous|drug abuse, intravenous
703805|NCT00247572|Intravenous Drug Abuse|intravenous drug abuse
703806|NCT00247559|crow's feet|crow's feet
703807|NCT00247559|cosmesis|cosmesis
703808|NCT00247559|ageing|ageing
703809|NCT00247546|Falls|falls
703810|NCT00247546|Accidental falls|accidental falls
703811|NCT00247546|Prevention|prevention
703812|NCT00247546|Aged|aged
703813|NCT00247546|Multifactorial trial|multifactorial trial
703814|NCT00247533|coronary disease|coronary disease
703815|NCT00247533|cerebrovascular disorders|cerebrovascular disorders
703816|NCT00247533|angiography|angiography
703817|NCT00247533|cerebral ischemia|cerebral ischemia
703818|NCT00247533|intracranial atherosclerosis|intracranial atherosclerosis
703819|NCT00247533|Coronary artery disease|coronary artery disease
703820|NCT00247533|cerebral artery stenosis|cerebral artery stenosis
703821|NCT00247533|percutaneous coronary balloon angioplasty|percutaneous coronary balloon angioplasty
703822|NCT00247533|coronary artery bypass surgery|coronary artery bypass surgery
703823|NCT00247533|ischemic stroke|ischemic stroke
703824|NCT00247533|electrocardiograph|electrocardiograph
703825|NCT00247533|electroencephalograph|electroencephalograph
703826|NCT00247533|Nuclear brain scan|nuclear brain scan
703827|NCT00247533|cognition decline|cognition decline
703828|NCT00247533|atrial fibrillation|atrial fibrillation
703956|NCT00247091|children|children
703829|NCT00247533|undetermined ischemic stroke|undetermined ischemic stroke
703830|NCT00247520|Seasonal allergic rhinitis (SAR), rhinoconjunctivitis, allergy|seasonal allergic rhinitis (sar), rhinoconjunctivitis, allergy
703831|NCT00247507|Anemia|anemia
703832|NCT00247507|atherosclerosis|atherosclerosis
703833|NCT00247507|End-stage renal disease|end-stage renal disease
703834|NCT00247507|Erythropoietin|erythropoietin
703835|NCT00247507|Hemodialysis|hemodialysis
703836|NCT00247507|Oxidative stress|oxidative stress
703837|NCT00247507|Pro-inflammation|pro-inflammation
703838|NCT00247494|HIV-1|hiv-1
703839|NCT00247494|atherosclerosis|atherosclerosis
703840|NCT00247494|immunomodulation|immunomodulation
703841|NCT00247481|Metastatic Breast Cancer|metastatic breast cancer
703842|NCT00247455|Human nutrition|human nutrition
703843|NCT00247455|Dietary fibre|dietary fibre
703844|NCT00247455|Insulin resistance|insulin resistance
703845|NCT00247455|Obesity|obesity
703846|NCT00247455|Glucose|glucose
703847|NCT00247455|Colonic fermentation|colonic fermentation
703848|NCT00247455|Short chain fatty acids|short chain fatty acids
703849|NCT00247455|GLP-1|glp-1
703850|NCT00247455|Appetite|appetite
703851|NCT00247455|Abdominal fat|abdominal fat
703852|NCT00247442|Mammography screening|mammography screening
703853|NCT00247442|Breast cancer screening|breast cancer screening
703854|NCT00247442|Screening outcomes|screening outcomes
703855|NCT00247442|Decision aid|decision aid
703856|NCT00247442|Decision support tool|decision support tool
703857|NCT00247442|Informed choice|informed choice
703858|NCT00247429|depression|depression
703859|NCT00247429|anxiety|anxiety
703860|NCT00247429|elderly|elderly
703861|NCT00247416|Untreated|untreated
703862|NCT00247416|Lung|lung
703863|NCT00247416|Cancer|cancer
703864|NCT00247416|non-small cell|non-small cell
703865|NCT00247416|gemcitabine|gemcitabine
703866|NCT00247416|gemzar|gemzar
703867|NCT00247416|carboplatin|carboplatin
703868|NCT00247416|dexamethasone|dexamethasone
703869|NCT00247403|Intracranial cancer|intracranial cancer
703870|NCT00247403|Cancer|cancer
703871|NCT00247403|2DG|2dg
703872|NCT00247403|2-deoxyglucose|2-deoxyglucose
703873|NCT00247403|Intracranial metastatic cancer|intracranial metastatic cancer
703874|NCT00247390|Chronic Insomnia|chronic insomnia
703875|NCT00247390|Sleep Initiation and Maintenance Disorder|sleep initiation and maintenance disorder
703876|NCT00247390|Drug Therapy|drug therapy
703877|NCT00247377|Morbid Obesity|morbid obesity
703878|NCT00247377|Laparoscopic Gastric Bypass|laparoscopic gastric bypass
703879|NCT00247377|Laparoscopic Gastric Banding|laparoscopic gastric banding
703880|NCT00247364|RLS|rls
703881|NCT00247338|parenteral nutrition|parenteral nutrition
703882|NCT00247338|low calorie|low calorie
703883|NCT00247338|low nitrogen|low nitrogen
703884|NCT00247338|gastrointestinal neoplasms|gastrointestinal neoplasms
703885|NCT00247338|gastrointestinal diseases|gastrointestinal diseases
703886|NCT00247338|gastrectomy|gastrectomy
703887|NCT00247338|colectomy|colectomy
703888|NCT00247338|rectectomy|rectectomy
703889|NCT00247338|operations|operations
703890|NCT00247325|Kidney failure|kidney failure
703891|NCT00247325|Contrast media|contrast media
703892|NCT00247325|Iodixanol|iodixanol
703893|NCT00247325|Ioxaglate|ioxaglate
703894|NCT00247312|Prostate cancer|prostate cancer
703895|NCT00247312|brachytherapy|brachytherapy
703896|NCT00247312|palladium 103|palladium 103
703897|NCT00247312|I-125|i-125
703898|NCT00247299|Vascular lesions|vascular lesions
703899|NCT00247299|Intense pulse light|intense pulse light
703900|NCT00247299|phototermolysis|phototermolysis
703901|NCT00247299|wavelength|wavelength
703902|NCT00247299|filters|filters
703903|NCT00247299|non coherent|non coherent
703904|NCT00247286|urodynamic stress incontinence|urodynamic stress incontinence
703905|NCT00247286|weighted vaginal cones|weighted vaginal cones
703906|NCT00247286|pelvic floor biofeedback|pelvic floor biofeedback
703907|NCT00247286|randomized controlled trial|randomized controlled trial
703908|NCT00247273|randomized controlled trial, osteoporosis, risedronate|randomized controlled trial, osteoporosis, risedronate
703909|NCT00247260|HCC|hcc
703910|NCT00247260|Primary Liver Cancer|primary liver cancer
703911|NCT00247221|Alcohol|alcohol
703912|NCT00247221|Substance abuse|substance abuse
703913|NCT00247221|Adolescent|adolescent
703914|NCT00247221|Family functioning|family functioning
703915|NCT00247208|Coronary artery bypass|coronary artery bypass
703916|NCT00247208|Stents|stents
703917|NCT00247208|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
703918|NCT00247208|Coronary Restenosis|coronary restenosis
703919|NCT00247208|Paclitaxel|paclitaxel
703920|NCT00247195|Major Depression|major depression
703921|NCT00247195|MDD|mdd
703922|NCT00247195|Hispanic|hispanic
703923|NCT00247195|Primary Care|primary care
703924|NCT00247195|Cultural Congruence|cultural congruence
703925|NCT00247182|Stepped Care|stepped care
703926|NCT00247182|Brief Motivational Intervention|brief motivational intervention
703927|NCT00247182|Minimal Intervention|minimal intervention
703928|NCT00247182|Treatment response|treatment response
703929|NCT00247182|College Students|college students
703930|NCT00247169|cervical intraepithelial neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
703931|NCT00247169|progesterone|progesterone
703932|NCT00247156|Autism|autism
703933|NCT00247156|eye contact|eye contact
703934|NCT00247156|Noncommunicable|noncommunicable
703935|NCT00247143|Protease Inhibitor|protease inhibitor
703936|NCT00247143|Antiretroviral Agents|antiretroviral agents
703937|NCT00247143|Treatment Experienced|treatment experienced
703938|NCT00247130|Omeprazole|omeprazole
703939|NCT00247130|Ranitidine|ranitidine
703940|NCT00247130|Endoscopic treatment|endoscopic treatment
703941|NCT00247130|Hemostasis|hemostasis
703942|NCT00247130|Peptic ulcer|peptic ulcer
703943|NCT00247117|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
703944|NCT00247117|insulin resistance|insulin resistance
703945|NCT00247117|metformin|metformin
703946|NCT00247104|Urinary tract infection|urinary tract infection
703947|NCT00247104|Endometritis|endometritis
703948|NCT00247104|Respiratory Distress Syndrome|respiratory distress syndrome
703949|NCT00247104|Necrotizing enterocolitis|necrotizing enterocolitis
703950|NCT00247104|Intraventricular hemorrhage|intraventricular hemorrhage
703951|NCT00247104|Latent period|latent period
703952|NCT00247104|Neonatal infection|neonatal infection
703953|NCT00247091|HIV|hiv
703954|NCT00247091|measles|measles
703955|NCT00247091|measles vaccine|measles vaccine
703957|NCT00247091|Zambia|zambia
703958|NCT00247078|black|black
703959|NCT00247078|widow|widow
703960|NCT00247078|spider|spider
703961|NCT00247078|antivenom|antivenom
703962|NCT00247052|post operative pericardial effusion|post operative pericardial effusion
703963|NCT00247052|NSAID|nsaid
703964|NCT00247039|neutropenia|neutropenia
703965|NCT00247039|fever|fever
703966|NCT00247039|garlic|garlic
703967|NCT00247039|infection|infection
703968|NCT00247026|myelodysplasia|myelodysplasia
703969|NCT00247026|curcumin|curcumin
703970|NCT00247026|coenzyme Q10|coenzyme q10
703971|NCT00247026|cytopenia|cytopenia
703972|NCT00247013|automated telephone system|automated telephone system
703973|NCT00247013|breast cancer|breast cancer
703974|NCT00247013|cancer prevention|cancer prevention
703975|NCT00247013|intervention|intervention
703976|NCT00247013|mammography|mammography
703977|NCT00247013|screening|screening
703978|NCT00247000|Cardiovascular Diseases|cardiovascular diseases
703979|NCT00247000|Heart Disease|heart disease
703980|NCT00247000|Heart Failure,Congestive|heart failure,congestive
703981|NCT00247000|Health Outcomes|health outcomes
703982|NCT00247000|Disease Management|disease management
703983|NCT00247000|Telehomecare|telehomecare
703984|NCT00247000|Home Telehealth|home telehealth
703985|NCT00246974|bladder cancer|bladder cancer
703986|NCT00246974|Transitionel cell cancer of the urothelium|transitionel cell cancer of the urothelium
703987|NCT00246961|Adjuvant|adjuvant
703988|NCT00246948|Physical therapy|physical therapy
703989|NCT00246935|COPD|copd
703990|NCT00246935|Phosphodiesterase 4 inhibitor|phosphodiesterase 4 inhibitor
703991|NCT00246935|Roflumilast|roflumilast
703992|NCT00246922|Asthma|asthma
703993|NCT00246922|Roflumilast|roflumilast
703994|NCT00246922|phosphodiesterase 4 inhibitor|phosphodiesterase 4 inhibitor
703995|NCT00246909|Gastroesophageal Reflux|gastroesophageal reflux
703996|NCT00246909|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
703997|NCT00246909|Pantoprazole|pantoprazole
703998|NCT00246883|Endothelial Progenitor Cells|endothelial progenitor cells
703999|NCT00246883|Nitric Oxide|nitric oxide
704000|NCT00246883|Brachial Artery Reactivity|brachial artery reactivity
704001|NCT00246883|Physical Fitness|physical fitness
704002|NCT00246883|C-reactive Protein|c-reactive protein
704003|NCT00246883|Exercise|exercise
704004|NCT00246883|Vascular Function|vascular function
704005|NCT00246870|Seizures|seizures
704006|NCT00246870|Development|development
704007|NCT00246870|Pediatric|pediatric
704008|NCT00246870|Benzodiazepine Receptors|benzodiazepine receptors
704009|NCT00246870|Neurotransmission|neurotransmission
704010|NCT00246870|Succinic Semialdehyde Dehydrogenase|succinic semialdehyde dehydrogenase
704011|NCT00246870|Deficiency|deficiency
704012|NCT00246870|SSADH Deficiency|ssadh deficiency
704013|NCT00246870|Healthy Volunteer|healthy volunteer
704014|NCT00246870|HV|hv
704015|NCT00246857|Apoptosis|apoptosis
704016|NCT00246857|T-cell|t-cell
704017|NCT00246857|Autoimmunity|autoimmunity
704018|NCT00246857|Immunodeficiency|immunodeficiency
704019|NCT00246857|B-Cell|b-cell
704020|NCT00246857|Inherited Lymphhocyte Homeostasis|inherited lymphhocyte homeostasis
704021|NCT00246857|Genetic Disease|genetic disease
704022|NCT00246844|Transplant|transplant
704023|NCT00246844|Diabetes|diabetes
704024|NCT00246844|C-Peptide|c-peptide
704025|NCT00246844|B Cell|b cell
704026|NCT00246844|Immunosuppression|immunosuppression
704027|NCT00246844|Type 1 Diabetes|type 1 diabetes
704028|NCT00246844|Pancreas Transplant|pancreas transplant
704029|NCT00246831|fMRI|fmri
704030|NCT00246831|Self-Agency|self-agency
704031|NCT00246831|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
704032|NCT00246831|Voluntary Movement|voluntary movement
704033|NCT00246831|Healthy Volunteer|healthy volunteer
704034|NCT00246831|HV|hv
704035|NCT00246818|Mind-Body|mind-body
704036|NCT00246818|Stress Reduction|stress reduction
704037|NCT00246818|Complementary Medicine|complementary medicine
704038|NCT00246818|Quality of Life|quality of life
704039|NCT00246818|Well-being|well-being
704040|NCT00246818|Psychoneuroimmunology|psychoneuroimmunology
704041|NCT00246818|Tai Chi|tai chi
704042|NCT00246818|Aerobic Exercise|aerobic exercise
704043|NCT00246818|Cancer Survivor|cancer survivor
704044|NCT00246805|Permanent atrial fibrillation|permanent atrial fibrillation
704045|NCT00246805|VVI(R) pacing|vvi(r) pacing
704046|NCT00246805|rate regularization|rate regularization
704047|NCT00246792|School-based intervention|school-based intervention
704048|NCT00246792|Learning disabilities|learning disabilities
704049|NCT00246792|ecological intervention|ecological intervention
704050|NCT00246779|transfusion|transfusion
704051|NCT00246779|cardiac surgery|cardiac surgery
704052|NCT00246779|modified ultrafiltration|modified ultrafiltration
704053|NCT00246779|Cardiopulmonary bypass|cardiopulmonary bypass
704054|NCT00246766|Maternal's movements recorded by a specific sensor|maternal's movements recorded by a specific sensor
704055|NCT00246766|Parameters of fetal distress (umbilical and cerebral Doppler) and new-born parameters.|parameters of fetal distress (umbilical and cerebral doppler) and new-born parameters.
704056|NCT00246753|adenocarcinoma of the prostate|adenocarcinoma of the prostate
704057|NCT00246753|recurrent prostate cancer|recurrent prostate cancer
704058|NCT00246753|stage I prostate cancer|stage i prostate cancer
704059|NCT00246753|stage II prostate cancer|stage ii prostate cancer
704060|NCT00246753|stage III prostate cancer|stage iii prostate cancer
704061|NCT00246753|stage IV prostate cancer|stage iv prostate cancer
704062|NCT00246740|Doxycycline|doxycycline
704063|NCT00246740|coronary artery bypass grafting|coronary artery bypass grafting
704064|NCT00246714|endotoxin tolerance|endotoxin tolerance
704065|NCT00246714|humans|humans
704066|NCT00246714|cross-tolerance|cross-tolerance
704067|NCT00246714|pro and anti-inflammatory cytokines|pro and anti-inflammatory cytokines
704068|NCT00246701|omega-3-acid ethyl esters|omega-3-acid ethyl esters
704069|NCT00246701|simvastatin|simvastatin
704070|NCT00246701|Lovaza|lovaza
704071|NCT00246701|High triglycerides|high triglycerides
704072|NCT00246662|Leukemia|leukemia
704073|NCT00246662|Hematologic|hematologic
704074|NCT00246662|Blood|blood
704075|NCT00246662|Cancer|cancer
704076|NCT00246662|Malignancy|malignancy
704077|NCT00246662|Myelodysplastic Syndromes|myelodysplastic syndromes
704078|NCT00246636|Very high triglycerides|very high triglycerides
704079|NCT00246636|omega-3-acid ethyl esters|omega-3-acid ethyl esters
704080|NCT00246636|fenofibrate|fenofibrate
704081|NCT00246636|Lovaza|lovaza
704082|NCT00246610|Non-randomized open-label single-arm study of Nelfinavir plus Combivir in pregnant females infected with HIV-1 virus.|non-randomized open-label single-arm study of nelfinavir plus combivir in pregnant females infected with hiv-1 virus.
704083|NCT00246597|Anemia|anemia
704084|NCT00246597|Breast cancer|breast cancer
704085|NCT00246597|Hemoglobin|hemoglobin
704086|NCT00246597|Quality of Life|quality of life
704087|NCT00246597|Adjuvant Chemotherapy|adjuvant chemotherapy
704088|NCT00246597|Pure red cell aplasia (PRCA)|pure red cell aplasia (prca)
704089|NCT00246597|Cognitive and executive function|cognitive and executive function
704090|NCT00246584|Hypertension|hypertension
704091|NCT00246584|angiotensin|angiotensin
704092|NCT00246584|renin|renin
704093|NCT00246584|aliskiren|aliskiren
704094|NCT00246558|Tight Achilles Tendon|tight achilles tendon
704095|NCT00246558|Hyperpronation of the foot|hyperpronation of the foot
704096|NCT00246519|hypertension|hypertension
704097|NCT00246519|pharmacogenetics|pharmacogenetics
704098|NCT00246519|pharmacogenomics|pharmacogenomics
704099|NCT00246519|beta-blocker|beta-blocker
704100|NCT00246519|atenolol|atenolol
704101|NCT00246519|diuretic|diuretic
704102|NCT00246519|hydrochlorothiazide|hydrochlorothiazide
704103|NCT00246519|blood pressure|blood pressure
704104|NCT00246519|metabolic adverse effects|metabolic adverse effects
704105|NCT00246506|Infertility|infertility
704106|NCT00246506|Fertility|fertility
704107|NCT00246506|Reproduction|reproduction
704108|NCT00246506|Advanced Maternal Age|advanced maternal age
704109|NCT00246506|Reproductive Medicine|reproductive medicine
704110|NCT00246506|Reproductive Techniques|reproductive techniques
704111|NCT00246506|Pregnancy|pregnancy
704112|NCT00246493|Coronary|coronary
704113|NCT00246493|Endothelial|endothelial
704114|NCT00246493|Vascular|vascular
704115|NCT00246493|Atherosclerosis|atherosclerosis
704116|NCT00246493|Arterial|arterial
704117|NCT00246480|Respiratory Syncytial Virus Infections, RSV, elderly|respiratory syncytial virus infections, rsv, elderly
704118|NCT00246467|plague|plague
704119|NCT00246454|circadian|circadian
704120|NCT00246454|advanced sleep phase|advanced sleep phase
704121|NCT00246454|delayed sleep phase|delayed sleep phase
704122|NCT00246441|Pharmacotherapy|pharmacotherapy
704123|NCT00246441|Self medication|self medication
704124|NCT00246428|Motivational Interviewing|motivational interviewing
704125|NCT00246428|Alcohol Abuse|alcohol abuse
704126|NCT00246428|Alcohol Dependence|alcohol dependence
704127|NCT00246428|Emergency Care Setting|emergency care setting
704128|NCT00246415|Alcohol Dependence|alcohol dependence
704129|NCT00246415|Alcohol Abuse|alcohol abuse
704130|NCT00246415|Memantine|memantine
704131|NCT00246415|Alcohol Treatment|alcohol treatment
704132|NCT00246389|muscle spasm|muscle spasm
704133|NCT00246389|cyclobenzaprine hydrochloride|cyclobenzaprine hydrochloride
704134|NCT00246363|HIV|hiv
704135|NCT00246363|Hepatitis C|hepatitis c
704136|NCT00246350|Headaches|headaches
704137|NCT00246350|Spinal manipulation|spinal manipulation
704138|NCT00246350|Massage|massage
704139|NCT00246350|chiropractic|chiropractic
704140|NCT00246298|Anemia|anemia
704141|NCT00246298|erythropoetin|erythropoetin
704142|NCT00246298|Epoetin alfa|epoetin alfa
704143|NCT00246298|erythropoietin recombinant|erythropoietin recombinant
704144|NCT00246298|HIV infection|hiv infection
704145|NCT00246298|HIV|hiv
704146|NCT00246298|AIDS|aids
704147|NCT00246285|schizophrenia|schizophrenia
704148|NCT00246285|antipsychotic agents|antipsychotic agents
704149|NCT00246285|risperidone|risperidone
704150|NCT00246285|adolescents|adolescents
704151|NCT00246272|risperidone|risperidone
704152|NCT00246272|schizophrenia|schizophrenia
704153|NCT00246272|rapidly-dissolving|rapidly-dissolving
704154|NCT00246259|Schizophrenia|schizophrenia
704155|NCT00246259|Schizoaffective disorder|schizoaffective disorder
704156|NCT00246259|Schizophreniform disorder|schizophreniform disorder
704157|NCT00246259|Risperidone|risperidone
704158|NCT00246259|Risperdal Consta|risperdal consta
704159|NCT00246246|risperidone|risperidone
704160|NCT00246246|long-acting injectable|long-acting injectable
704161|NCT00246246|bipolar disorder|bipolar disorder
704162|NCT00246246|intramuscular injection|intramuscular injection
704163|NCT00246233|methylphenidate hydrochloride|methylphenidate hydrochloride
704164|NCT00246233|oral tablets|oral tablets
704165|NCT00246233|Major Depressive Disorder|major depressive disorder
704166|NCT00246220|Attention deficit/hyperactivity disorder|attention deficit/hyperactivity disorder
704167|NCT00246220|methylphenidate|methylphenidate
704168|NCT00246220|central nervous system stimulants|central nervous system stimulants
704169|NCT00246207|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
704170|NCT00246207|once-day oral tablets|once-day oral tablets
704171|NCT00246194|Schizophrenia|schizophrenia
704172|NCT00246194|Mental disorder|mental disorder
704173|NCT00246194|DSM-IV|dsm-iv
704174|NCT00246194|RISPERDAL CONSTA|risperdal consta
704175|NCT00246194|Risperidone|risperidone
704176|NCT00246194|Long-acting risperidone|long-acting risperidone
704177|NCT00246194|Disorganized|disorganized
704178|NCT00246194|Catatonic|catatonic
704179|NCT00246194|Paranoid|paranoid
704180|NCT00246181|Lung cancer|lung cancer
704181|NCT00246181|stereotactic body radiotherapy|stereotactic body radiotherapy
704182|NCT00246168|Rheumatoid arthritis|rheumatoid arthritis
704183|NCT00246168|NSAID add-on therapy|nsaid add-on therapy
704184|NCT00246168|tramadol|tramadol
704185|NCT00246168|acetaminophen|acetaminophen
704186|NCT00246155|chronic|chronic
704187|NCT00246155|muscular|muscular
704188|NCT00246129|Kidney Transplantation|kidney transplantation
704189|NCT00246129|Kidney Disease|kidney disease
704190|NCT00246129|Kidney Failure|kidney failure
704191|NCT00246129|Graft Rejection|graft rejection
704192|NCT00246116|Lung Cancer|lung cancer
704193|NCT00246116|Radiation Oncology|radiation oncology
704194|NCT00246116|Treated with Stereostatic Body Radiation|treated with stereostatic body radiation
704195|NCT00246103|Valproic Acid|valproic acid
704196|NCT00246103|Epirubicin|epirubicin
704197|NCT00246103|Solid Tumor|solid tumor
704198|NCT00246103|Malignancies|malignancies
704199|NCT00246077|chronic transfusion therapy|chronic transfusion therapy
704200|NCT00246077|quality of life|quality of life
704201|NCT00246064|Rheumatoid Arthritis|rheumatoid arthritis
704202|NCT00246064|Infliximab infusions|infliximab infusions
704203|NCT00246064|Methotrexate|methotrexate
704204|NCT00246064|Remicade|remicade
704205|NCT00246051|Police|police
704206|NCT00246051|Sleep|sleep
704208|NCT00246051|Work Hours|work hours
704209|NCT00246051|Sleep disorder|sleep disorder
704210|NCT00246051|Performance|performance
704211|NCT00246038|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
704212|NCT00246038|Aortic Aneurysm|aortic aneurysm
704213|NCT00246038|AAA|aaa
704214|NCT00246038|Endovascular|endovascular
704215|NCT00246038|Stent Graft|stent graft
704216|NCT00246038|Endograft|endograft
704217|NCT00246038|Vascular Prostheses|vascular prostheses
704218|NCT00246012|Melanoma|melanoma
704219|NCT00246012|Neoplasm|neoplasm
704220|NCT00246012|CNTO 95|cnto 95
704221|NCT00246012|Dacarbazine|dacarbazine
704222|NCT00246012|Intetumumab|intetumumab
704223|NCT00245986|Pharmacokinetics|pharmacokinetics
704224|NCT00245986|Cytochrome P450|cytochrome p450
704225|NCT00245986|HIV Resistance|hiv resistance
704226|NCT00245986|Drug Interaction|drug interaction
704227|NCT00245986|Non-Nucleoside Reverse Transcriptase Inhibitors|non-nucleoside reverse transcriptase inhibitors
704228|NCT00245986|HIV Positive|hiv positive
704229|NCT00245986|Healthy Volunteer|healthy volunteer
704230|NCT00245986|HV|hv
704231|NCT00245960|Psoriatic Arthritis|psoriatic arthritis
704232|NCT00245960|Skin Disease|skin disease
704233|NCT00245960|Joint Disease|joint disease
704234|NCT00245947|Crohn's Disease|crohn's disease
704235|NCT00245947|Inflammation|inflammation
704236|NCT00245934|Rheumatoid Arthritis|rheumatoid arthritis
704237|NCT00245921|contraception|contraception
704238|NCT00245908|Asthma|asthma
704239|NCT00245908|Chlamydia pneumoniae|chlamydia pneumoniae
704240|NCT00245908|Chlamydophila pneumoniae|chlamydophila pneumoniae
704241|NCT00245908|Azithromycin|azithromycin
704242|NCT00245895|Anemia,|anemia,
704243|NCT00245895|Prostate Cancer|prostate cancer
704244|NCT00245882|Telehealth|telehealth
704245|NCT00245882|Veterans|veterans
704246|NCT00245882|Glycemic control|glycemic control
704247|NCT00245882|Active care management|active care management
704248|NCT00245882|Care coordination|care coordination
704249|NCT00245869|Contrast-enhanced Ultrasound|contrast-enhanced ultrasound
704250|NCT00245869|Ultrasound Contrast agents, microbubbles|ultrasound contrast agents, microbubbles
704251|NCT00245869|breast cancer|breast cancer
704252|NCT00245869|chemotherapy|chemotherapy
704253|NCT00245869|vascularization|vascularization
704254|NCT00245856|Upper Extremity Deep-Vein Thrombosis|upper extremity deep-vein thrombosis
704255|NCT00245856|DVT|dvt
704256|NCT00245856|Fragmin|fragmin
704257|NCT00245856|Deep-Vein Thrombosis|deep-vein thrombosis
704258|NCT00245856|Thrombosis|thrombosis
704259|NCT00245843|Premature birth|premature birth
704260|NCT00245843|moderate preterm|moderate preterm
704261|NCT00245843|late preterm|late preterm
704262|NCT00245843|Joint attention|joint attention
704263|NCT00245843|Social interaction|social interaction
704264|NCT00245843|Child development|child development
704265|NCT00245843|Parent|parent
704266|NCT00245843|infant|infant
704267|NCT00245830|Ischemia/reperfusion of the liver|ischemia/reperfusion of the liver
704268|NCT00245830|Ischemic Preconditioning|ischemic preconditioning
704269|NCT00245830|Cadaver organ donor|cadaver organ donor
704270|NCT00245817|Anxiety. Depression. HRQOL. Psycho-educative intervention|anxiety. depression. hrqol. psycho-educative intervention
704271|NCT00245791|Complicated Urinary Infection|complicated urinary infection
704272|NCT00245765|chronic plaque psoriasis, anti TNFα|chronic plaque psoriasis, anti tnfα
704273|NCT00245765|CDP870, Cimzia|cdp870, cimzia
704274|NCT00245752|post term pregnancy|post term pregnancy
704275|NCT00245752|acupuncture|acupuncture
704276|NCT00245752|induction|induction
704277|NCT00245739|HIV infections|hiv infections
704278|NCT00245739|HIV-1|hiv-1
704279|NCT00245739|TMC114|tmc114
704280|NCT00245739|Early access|early access
704281|NCT00245739|Highly antiretroviral treatment experienced patients|highly antiretroviral treatment experienced patients
704282|NCT00245739|Anti-retroviral agents|anti-retroviral agents
704283|NCT00245713|Levetiracetam, adult, partial-onset epilepsy, antiepileptic|levetiracetam, adult, partial-onset epilepsy, antiepileptic
704284|NCT00245687|feeding tube, nutrition, gastric, jejunal|feeding tube, nutrition, gastric, jejunal
704285|NCT00245661|COPD|copd
704286|NCT00245661|respiratory|respiratory
704287|NCT00245661|sleep quality|sleep quality
704288|NCT00245661|temazepam|temazepam
704289|NCT00245661|dyspnea|dyspnea
704290|NCT00245635|Body Dysmorphic Disorder|body dysmorphic disorder
704291|NCT00245635|BDD|bdd
704292|NCT00245635|BDD treatment|bdd treatment
704293|NCT00245635|delusionality variant|delusionality variant
704294|NCT00245635|OCD|ocd
704295|NCT00245622|Phase 2b Tovaxin|phase 2b tovaxin
704296|NCT00245622|Clinically Isolated Syndrome (CIS)|clinically isolated syndrome (cis)
704297|NCT00245622|Relapse-Remitting Multiple Sclerosis (RR-MS)|relapse-remitting multiple sclerosis (rr-ms)
704679|NCT00244647|restenosis|restenosis
704298|NCT00245583|Pathological Gambling|pathological gambling
704299|NCT00245583|Compulsive Gambling|compulsive gambling
704300|NCT00245583|Gambling|gambling
704301|NCT00245583|topiramate|topiramate
704302|NCT00245557|Depression|depression
704303|NCT00245557|Geriatric|geriatric
704304|NCT00245557|MRI|mri
704305|NCT00245557|Sertraline|sertraline
704306|NCT00245531|endocrine abnormalities|endocrine abnormalities
704307|NCT00245531|cognitive performance|cognitive performance
704308|NCT00245518|prostate cancer|prostate cancer
704309|NCT00245518|soy|soy
704310|NCT00245518|androgen deprivation|androgen deprivation
704311|NCT00245518|quality of life|quality of life
704312|NCT00245518|isoflavones|isoflavones
704313|NCT00245492|Colonoscopy|colonoscopy
704314|NCT00245492|Chromoscopy|chromoscopy
704315|NCT00245492|Prevention|prevention
704316|NCT00245479|Primary nocturnal enuresis|primary nocturnal enuresis
704317|NCT00245466|Prostate Cancer|prostate cancer
704318|NCT00245466|Androgen ablation therapy|androgen ablation therapy
704319|NCT00245453|pneumonia|pneumonia
704320|NCT00245453|Spneumoniae|spneumoniae
704321|NCT00245453|bronchitis|bronchitis
704322|NCT00245453|telithromycin|telithromycin
704323|NCT00245453|azithromycin|azithromycin
704324|NCT00245440|S.pneumonia|s.pneumonia
704325|NCT00245440|sinusitis|sinusitis
704326|NCT00245440|ams|ams
704327|NCT00245440|azithromycin|azithromycin
704328|NCT00245427|beta-lactam|beta-lactam
704329|NCT00245427|macrolide|macrolide
704330|NCT00245427|antibiotics|antibiotics
704331|NCT00245388|Mixed Dyslipidemia|mixed dyslipidemia
704332|NCT00245375|Outpatient Surgery for:|outpatient surgery for:
704333|NCT00245375|inguinal hernia repair|inguinal hernia repair
704334|NCT00245375|abdominal hernia repair|abdominal hernia repair
704335|NCT00245375|umbilical hernia repair|umbilical hernia repair
704336|NCT00245362|cancer vaccine|cancer vaccine
704337|NCT00245362|pancreatic cancer|pancreatic cancer
704338|NCT00245362|metastatic pancreatic cancer|metastatic pancreatic cancer
704339|NCT00245362|unresectable pancreatic cancer|unresectable pancreatic cancer
704340|NCT00245362|immunotherapy|immunotherapy
704341|NCT00245349|Head and Neck cancer|head and neck cancer
704342|NCT00245349|Squamous cell carcinoma|squamous cell carcinoma
704344|NCT00245349|Fluorothymidine|fluorothymidine
704345|NCT00245349|F-18|f-18
704346|NCT00245336|hemostasis|hemostasis
704347|NCT00245336|surgery|surgery
704348|NCT00245336|hemostatics|hemostatics
704349|NCT00245336|randomized controlled trial|randomized controlled trial
704350|NCT00245336|phase 3|phase 3
704351|NCT00245323|smoking|smoking
704352|NCT00245310|ICG clearance|icg clearance
704353|NCT00245310|liver cirrhosis|liver cirrhosis
704354|NCT00245310|acute liver failure|acute liver failure
704355|NCT00245310|prognosis|prognosis
704356|NCT00245297|Bleeding disorder|bleeding disorder
704357|NCT00245297|severe Haemophilia A|severe haemophilia a
704358|NCT00245297|Prophylaxis|prophylaxis
704359|NCT00245271|Knee|knee
704360|NCT00245271|Musculoskeletal System|musculoskeletal system
704361|NCT00245271|Ligament|ligament
704362|NCT00245271|ACL reconstruction|acl reconstruction
704363|NCT00245245|hemophilia A|hemophilia a
704364|NCT00245245|inhibitor|inhibitor
704365|NCT00245245|treatment|treatment
704366|NCT00245232|PTSD|ptsd
704367|NCT00245232|Cognitive therapy|cognitive therapy
704368|NCT00245232|Rape|rape
704369|NCT00245206|Antipsychotic|antipsychotic
704370|NCT00245206|Diabetes|diabetes
704371|NCT00245206|Hyperlipidemia|hyperlipidemia
704372|NCT00245206|Stroke|stroke
704373|NCT00245193|Major Depression|major depression
704374|NCT00245154|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
704375|NCT00245154|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
704376|NCT00245141|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
704377|NCT00245141|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
704378|NCT00245141|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
704379|NCT00245128|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
704380|NCT00245128|polycythemia vera|polycythemia vera
704381|NCT00245128|essential thrombocythemia|essential thrombocythemia
704382|NCT00245115|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
704383|NCT00245115|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
704384|NCT00245115|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
704385|NCT00245115|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
704386|NCT00245115|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
704387|NCT00245115|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
704388|NCT00245115|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
704389|NCT00245115|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
704390|NCT00245115|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
704391|NCT00245115|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
704680|NCT00244647|in-stent restenosis|in-stent restenosis
704392|NCT00245115|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
704393|NCT00245115|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
704394|NCT00245115|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
704395|NCT00245115|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
704396|NCT00245115|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
704397|NCT00245115|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
704398|NCT00245115|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
704399|NCT00245115|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
704400|NCT00245115|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
704401|NCT00245115|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
704402|NCT00245115|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
704403|NCT00245115|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
704404|NCT00245115|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
704405|NCT00245115|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
704406|NCT00245115|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
704407|NCT00245115|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
704408|NCT00245115|secondary acute myeloid leukemia|secondary acute myeloid leukemia
704409|NCT00245089|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
704410|NCT00245089|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
704411|NCT00245089|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
704412|NCT00245076|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
704413|NCT00245050|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
704414|NCT00245050|fallopian tube cancer|fallopian tube cancer
704415|NCT00245050|peritoneal cavity cancer|peritoneal cavity cancer
704416|NCT00245050|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
704417|NCT00245050|recurrent endometrial carcinoma|recurrent endometrial carcinoma
704418|NCT00245050|stage III endometrial carcinoma|stage iii endometrial carcinoma
704419|NCT00245050|stage IV endometrial carcinoma|stage iv endometrial carcinoma
704420|NCT00245050|stage IV breast cancer|stage iv breast cancer
704421|NCT00245050|male breast cancer|male breast cancer
704422|NCT00245050|recurrent breast cancer|recurrent breast cancer
704423|NCT00245037|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
704424|NCT00245037|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
704425|NCT00245037|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
704426|NCT00245037|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
704427|NCT00245037|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
704428|NCT00245037|atypical chronic myeloid leukemia, breakpoint cluster region-Abelson (BCR-ABL) negative|atypical chronic myeloid leukemia, breakpoint cluster region-abelson (bcr-abl) negative
704429|NCT00245037|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
704430|NCT00245037|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
704431|NCT00245037|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
704432|NCT00245037|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
704433|NCT00245037|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
704434|NCT00245037|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
704435|NCT00245037|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
704436|NCT00245037|stage II multiple myeloma|stage ii multiple myeloma
704437|NCT00245037|stage III multiple myeloma|stage iii multiple myeloma
704438|NCT00245037|primary systemic amyloidosis|primary systemic amyloidosis
704439|NCT00245037|refractory multiple myeloma|refractory multiple myeloma
704440|NCT00245037|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
704441|NCT00245037|chronic eosinophilic leukemia|chronic eosinophilic leukemia
704442|NCT00245037|primary myelofibrosis|primary myelofibrosis
704443|NCT00245037|chronic neutrophilic leukemia|chronic neutrophilic leukemia
704444|NCT00245037|essential thrombocythemia|essential thrombocythemia
704445|NCT00245037|polycythemia vera|polycythemia vera
704446|NCT00245037|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
704447|NCT00245037|acute undifferentiated leukemia|acute undifferentiated leukemia
704448|NCT00245037|extramedullary plasmacytoma|extramedullary plasmacytoma
704449|NCT00245037|isolated plasmacytoma of bone|isolated plasmacytoma of bone
704450|NCT00245037|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
704451|NCT00245037|stage I multiple myeloma|stage i multiple myeloma
704452|NCT00245037|secondary acute myeloid leukemia|secondary acute myeloid leukemia
704453|NCT00245037|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
704454|NCT00245037|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
704455|NCT00245037|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
704456|NCT00245037|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
705253|NCT00242099|HHV-6|hhv-6
704457|NCT00245037|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
704458|NCT00245037|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
704459|NCT00245037|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
704460|NCT00245037|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
704461|NCT00245037|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
704462|NCT00245037|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
704463|NCT00245037|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
704464|NCT00245037|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
704465|NCT00245037|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
704466|NCT00245037|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
704467|NCT00245037|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
704468|NCT00245037|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
704469|NCT00245037|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
704470|NCT00245037|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
704471|NCT00245037|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
704472|NCT00245037|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
704473|NCT00245037|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
704474|NCT00245037|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
704475|NCT00245037|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
704476|NCT00245037|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
704477|NCT00245037|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
704478|NCT00245037|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
704479|NCT00245037|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
704480|NCT00245037|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
704481|NCT00245037|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
704482|NCT00245037|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
704483|NCT00245037|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
704484|NCT00245037|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
704485|NCT00245037|splenic marginal zone lymphoma|splenic marginal zone lymphoma
704486|NCT00245037|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
704487|NCT00245037|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
704488|NCT00245037|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
704489|NCT00245037|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
704490|NCT00245037|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
704491|NCT00245037|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
704492|NCT00245037|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
704493|NCT00245037|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
704494|NCT00245037|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
704495|NCT00245037|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
704496|NCT00245037|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
704497|NCT00245037|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
704498|NCT00245037|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
704499|NCT00245037|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
704500|NCT00245037|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
704501|NCT00245037|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
704502|NCT00245037|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
704503|NCT00245037|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
704504|NCT00245037|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
704505|NCT00245037|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
704506|NCT00245037|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
704507|NCT00245037|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
704508|NCT00245037|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
704509|NCT00245037|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
704510|NCT00245037|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
704511|NCT00245037|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
704512|NCT00245037|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
704513|NCT00245024|breast cancer|breast cancer
704514|NCT00245024|ductal breast carcinoma in situ|ductal breast carcinoma in situ
704515|NCT00245024|lobular breast carcinoma in situ|lobular breast carcinoma in situ
704516|NCT00245024|breast cancer in situ|breast cancer in situ
704517|NCT00245011|recurrent osteosarcoma|recurrent osteosarcoma
704518|NCT00245011|metastatic osteosarcoma|metastatic osteosarcoma
704519|NCT00245011|localized osteosarcoma|localized osteosarcoma
705254|NCT00242099|HHV-7|hhv-7
704520|NCT00244998|adenocarcinoma of the prostate|adenocarcinoma of the prostate
704521|NCT00244998|stage III prostate cancer|stage iii prostate cancer
704522|NCT00244998|stage IV prostate cancer|stage iv prostate cancer
704523|NCT00244985|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
704524|NCT00244985|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
704525|NCT00244985|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
704526|NCT00244985|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
704527|NCT00244985|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
704528|NCT00244985|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
704529|NCT00244985|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
704530|NCT00244985|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
704531|NCT00244985|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
704532|NCT00244985|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
704533|NCT00244985|splenic marginal zone lymphoma|splenic marginal zone lymphoma
704534|NCT00244959|stage I breast cancer|stage i breast cancer
704535|NCT00244959|stage II breast cancer|stage ii breast cancer
704536|NCT00244959|stage IIIA breast cancer|stage iiia breast cancer
704537|NCT00244959|stage IIIB breast cancer|stage iiib breast cancer
704538|NCT00244959|stage IIIC breast cancer|stage iiic breast cancer
704539|NCT00244959|ductal breast carcinoma in situ|ductal breast carcinoma in situ
704540|NCT00244959|breast cancer in situ|breast cancer in situ
704541|NCT00244946|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
704542|NCT00244946|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
704543|NCT00244946|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
704544|NCT00244946|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
704545|NCT00244946|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
704546|NCT00244946|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
704547|NCT00244946|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
704548|NCT00244946|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
704549|NCT00244946|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
704550|NCT00244946|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
704551|NCT00244946|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
704552|NCT00244946|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
704553|NCT00244946|splenic marginal zone lymphoma|splenic marginal zone lymphoma
704554|NCT00244946|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
704555|NCT00244946|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
704556|NCT00244946|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
704557|NCT00244946|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
704558|NCT00244946|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
704559|NCT00244946|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
704560|NCT00244946|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
704561|NCT00244946|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
704562|NCT00244946|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
704563|NCT00244946|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
704564|NCT00244946|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
704565|NCT00244946|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
704566|NCT00244946|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
704567|NCT00244946|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
704568|NCT00244946|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
704569|NCT00244946|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
704570|NCT00244946|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
704571|NCT00244946|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
704572|NCT00244946|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
704573|NCT00244946|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
704574|NCT00244946|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
704575|NCT00244946|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
704576|NCT00244946|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
704577|NCT00244946|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
704578|NCT00244946|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
704579|NCT00244946|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
704580|NCT00244946|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
704581|NCT00244946|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
704582|NCT00244946|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
704583|NCT00244946|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
704584|NCT00244946|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
704585|NCT00244946|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
704586|NCT00244946|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
704587|NCT00244946|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
704588|NCT00244946|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
704589|NCT00244946|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
704590|NCT00244946|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
704591|NCT00244933|stage IV breast cancer|stage iv breast cancer
704592|NCT00244933|recurrent breast cancer|recurrent breast cancer
704593|NCT00244920|adenocarcinoma of the prostate|adenocarcinoma of the prostate
704594|NCT00244920|stage III prostate cancer|stage iii prostate cancer
704595|NCT00244907|Bone Resorption|bone resorption
704596|NCT00244907|Phytoestrogens|phytoestrogens
704597|NCT00244907|Calcium|calcium
704598|NCT00244907|Genistein|genistein
704599|NCT00244907|Equol|equol
704600|NCT00244894|fatigue|fatigue
704601|NCT00244894|recurrent prostate cancer|recurrent prostate cancer
704602|NCT00244894|stage II prostate cancer|stage ii prostate cancer
704603|NCT00244894|stage III prostate cancer|stage iii prostate cancer
704604|NCT00244894|stage IV prostate cancer|stage iv prostate cancer
704605|NCT00244894|hot flashes|hot flashes
704606|NCT00244868|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
704607|NCT00244868|metastatic cancer|metastatic cancer
704608|NCT00244842|Randomized Controlled Trials|randomized controlled trials
704609|NCT00244842|Immunosuppression|immunosuppression
704610|NCT00244842|Adult|adult
704611|NCT00244842|Chronic Disease|chronic disease
704612|NCT00244842|Dermatologic Agents|dermatologic agents
704613|NCT00244842|Female|female
704614|NCT00244842|Humans|humans
704615|NCT00244842|Male|male
704616|NCT00244842|Middle Aged|middle aged
704617|NCT00244842|Severity of Illness Index|severity of illness index
704618|NCT00244842|Treatment Outcome|treatment outcome
704619|NCT00244842|Quality of Life|quality of life
704620|NCT00244842|Double-Blind Method|double-blind method
704621|NCT00244829|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
704622|NCT00244829|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
704623|NCT00244829|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
704624|NCT00244829|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
704625|NCT00244829|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
704626|NCT00244829|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
704627|NCT00244829|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
704628|NCT00244803|Human Immunodeficiency Virus|human immunodeficiency virus
704629|NCT00244803|FRAM 1|fram 1
704630|NCT00244790|glomerular hyperfiltration|glomerular hyperfiltration
704631|NCT00244790|proteinuria|proteinuria
704632|NCT00244777|Seizure|seizure
704633|NCT00244777|Altered consciousness|altered consciousness
704634|NCT00244777|Hyponatraemia|hyponatraemia
704635|NCT00244777|Diarrhoea|diarrhoea
704636|NCT00244777|Hypo osmolar ORS|hypo osmolar ors
704637|NCT00244764|Angiogenesis|angiogenesis
704638|NCT00244764|Renal Cell Carcinoma|renal cell carcinoma
704639|NCT00244764|Solid tumors|solid tumors
704640|NCT00244764|Pazopanib(GW786034)|pazopanib(gw786034)
704641|NCT00244751|Hepatitis C liver fibrosis|hepatitis c liver fibrosis
704642|NCT00244738|pregnancy|pregnancy
704643|NCT00244738|post-date|post-date
704644|NCT00244738|induction of labor|induction of labor
704645|NCT00244738|castor oil|castor oil
704646|NCT00244725|deep vein thrombosis|deep vein thrombosis
704647|NCT00244725|total knee replacement|total knee replacement
704648|NCT00244725|PE|pe
704649|NCT00244725|Venous thromboembolism|venous thromboembolism
704650|NCT00244725|DVT|dvt
704651|NCT00244725|pulmonary embolism|pulmonary embolism
704652|NCT00244725|VTE|vte
704653|NCT00244712|HEAT|heat
704654|NCT00244712|Antiretroviral-naive|antiretroviral-naive
704655|NCT00244712|HIV|hiv
704656|NCT00244712|EPZICOM|epzicom
704657|NCT00244712|TRUVADA|truvada
704658|NCT00244712|KALETRA|kaletra
704659|NCT00244712|once-daily|once-daily
704660|NCT00244699|youth|youth
704661|NCT00244699|drug addiction|drug addiction
704662|NCT00244699|substance abuse|substance abuse
704663|NCT00244699|mindfulness|mindfulness
704664|NCT00244699|motivational interviewing|motivational interviewing
704665|NCT00244699|brief treatment|brief treatment
704666|NCT00244699|skills training|skills training
704667|NCT00244699|group therapy|group therapy
704668|NCT00244699|emotion regulation|emotion regulation
704669|NCT00244686|Hypereosinophilic Syndrome|hypereosinophilic syndrome
704670|NCT00244686|Mepo|mepo
704671|NCT00244686|HES|hes
704672|NCT00244686|Compassionate Use|compassionate use
704673|NCT00244686|Mepolizumab|mepolizumab
704674|NCT00244673|Vaccination|vaccination
704675|NCT00244673|DTP|dtp
704676|NCT00244673|Child mortality|child mortality
704677|NCT00244673|Sex|sex
704678|NCT00244673|Non-specific effects|non-specific effects
704681|NCT00244621|Pediatric hypertension|pediatric hypertension
704682|NCT00244595|Pediatric hypertension|pediatric hypertension
704683|NCT00244595|Hypertension in children|hypertension in children
704684|NCT00244582|Central Nervous System|central nervous system
704685|NCT00244582|Enzyme Replacement Therapy|enzyme replacement therapy
704686|NCT00244582|Convection|convection
704687|NCT00244582|Gaucher Disease|gaucher disease
704688|NCT00244582|Neuronopathic Gaucher Disease|neuronopathic gaucher disease
704689|NCT00244582|Type 2 Gaucher Disease|type 2 gaucher disease
704690|NCT00244569|Nonalcoholic Fatty Liver Disease|nonalcoholic fatty liver disease
704691|NCT00244569|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
704692|NCT00244569|Liver Function|liver function
704693|NCT00244569|Metabolism|metabolism
704694|NCT00244569|Cirrhosis|cirrhosis
704695|NCT00244569|Fibrosis|fibrosis
704696|NCT00244569|Liver|liver
704697|NCT00244556|Rheumatoid Arthritis|rheumatoid arthritis
704698|NCT00244543|ocular, allergic conjunctivitis, ophthalmic|ocular, allergic conjunctivitis, ophthalmic
704699|NCT00244530|Preventive Therapy|preventive therapy
704700|NCT00244530|Calcium Channel Blockers|calcium channel blockers
704701|NCT00244530|Kidney Failure, Chronic|kidney failure, chronic
704702|NCT00244530|Coronary Artery Bypass|coronary artery bypass
704703|NCT00244530|Heart Valve Prosthesis Implantation|heart valve prosthesis implantation
704704|NCT00244517|ventricular function|ventricular function
704705|NCT00244517|diastolic function|diastolic function
704706|NCT00244517|inhalative anaesthetics|inhalative anaesthetics
704707|NCT00244491|care transitions|care transitions
704708|NCT00244491|geriatric|geriatric
704709|NCT00244491|care coordination|care coordination
704710|NCT00244491|self-management|self-management
704711|NCT00244491|chronic illness|chronic illness
704712|NCT00244491|patient-centered care|patient-centered care
704713|NCT00244465|Narcolepsy|narcolepsy
704714|NCT00244465|Cataplexy|cataplexy
704715|NCT00244465|Oxybate|oxybate
704716|NCT00244465|Xyrem|xyrem
704717|NCT00244465|Misuse|misuse
704718|NCT00244465|Safety|safety
704719|NCT00244452|Endometriosis|endometriosis
704720|NCT00244452|Cetrorelix|cetrorelix
704721|NCT00244452|Hormone|hormone
704722|NCT00244452|Symptoms relief|symptoms relief
704723|NCT00244452|Safety|safety
704724|NCT00244452|Tolerability|tolerability
704725|NCT00244452|Pharmacodynamic|pharmacodynamic
704726|NCT00244452|Pharmacokinetic|pharmacokinetic
704727|NCT00244439|Head Lice|head lice
704728|NCT00244439|Pediculosis capitis|pediculosis capitis
704729|NCT00244426|Prevention of thromboembolic events in patients with non valvular atrial fibrillation|prevention of thromboembolic events in patients with non valvular atrial fibrillation
704730|NCT00244413|Myotonia|myotonia
704731|NCT00244413|Paramyotonia Congenita|paramyotonia congenita
704732|NCT00244413|Thomsen's Disease|thomsen's disease
704733|NCT00244400|Femur Head Necrosis|femur head necrosis
704734|NCT00244400|CYP3A|cyp3a
704735|NCT00244387|advanced stage idiopathic Parkinson's disease|advanced stage idiopathic parkinson's disease
704736|NCT00244361|opsoclonus|opsoclonus
704737|NCT00244361|myoclonus|myoclonus
704738|NCT00244348|hepatic artery infusion|hepatic artery infusion
704739|NCT00244348|colorectal cancer|colorectal cancer
704740|NCT00244348|liver metastasis|liver metastasis
704741|NCT00244348|oxaliplatin|oxaliplatin
704742|NCT00244348|5 fluorouracil|5 fluorouracil
704743|NCT00244335|Post-Traumatic Stress Disorders|post-traumatic stress disorders
704744|NCT00244335|PTSD|ptsd
704745|NCT00244309|brachytherapy|brachytherapy
704746|NCT00244309|urinary symptoms|urinary symptoms
704747|NCT00244283|Myocardial preconditioning|myocardial preconditioning
704748|NCT00244283|anesthetics|anesthetics
704749|NCT00244283|epidural anesthesia|epidural anesthesia
704750|NCT00244283|sevoflurane|sevoflurane
704751|NCT00244283|NT proBNP|nt probnp
704752|NCT00244270|totally implantable vascular access devices|totally implantable vascular access devices
704753|NCT00244270|thromboembolism|thromboembolism
704754|NCT00244270|genetic susceptibility to venous thrombosis.|genetic susceptibility to venous thrombosis.
704755|NCT00244257|idiopathic thrombocytopenia purpura|idiopathic thrombocytopenia purpura
704756|NCT00244231|Niacin|niacin
704757|NCT00244231|Hyperlipidemia|hyperlipidemia
704758|NCT00244218|phenylketonuria|phenylketonuria
704759|NCT00244218|hyperphenylalaninemia|hyperphenylalaninemia
704760|NCT00244192|COPD|copd
704761|NCT00244192|infliximab|infliximab
704762|NCT00244192|Remicade|remicade
704763|NCT00244192|inflammation|inflammation
704764|NCT00244192|cachexia|cachexia
704765|NCT00244192|fat-free mass|fat-free mass
704766|NCT00244192|health status|health status
704767|NCT00244192|exercise capacity|exercise capacity
704768|NCT00244179|reactive arthritis|reactive arthritis
704769|NCT00244179|trial|trial
704770|NCT00244179|interferon-gamma|interferon-gamma
704771|NCT00244179|infliximab|infliximab
704772|NCT00244179|chronic|chronic
704773|NCT00244179|tnf-blocker|tnf-blocker
704774|NCT00244166|treatment|treatment
704775|NCT00244166|ankylosing spondylitis|ankylosing spondylitis
704776|NCT00244166|prednisolone|prednisolone
704777|NCT00244166|trial|trial
704778|NCT00244166|steroid|steroid
704875|NCT00243685|Chemosensitivity|chemosensitivity
704779|NCT00244153|intraarticular morphine, steroids, arthroscopy|intraarticular morphine, steroids, arthroscopy
704780|NCT00244140|Ultravist 370|ultravist 370
704781|NCT00244140|CECT|cect
704782|NCT00244140|CT Scan|ct scan
704783|NCT00244114|Hemophilia B|hemophilia b
704784|NCT00244114|Allergic Reaction|allergic reaction
704785|NCT00244101|Prematurity|prematurity
704786|NCT00244101|respiratory distress syndrome|respiratory distress syndrome
704787|NCT00244101|surfactant|surfactant
704788|NCT00244101|nasal continuous positive airway pressure|nasal continuous positive airway pressure
704789|NCT00244088|Abdominal infection|abdominal infection
704790|NCT00244023|Erectile Dysfunction|erectile dysfunction
704791|NCT00244023|Testosterone|testosterone
704792|NCT00244023|Testosterone Therapy|testosterone therapy
704793|NCT00244023|PDE V Inhibitor|pde v inhibitor
704794|NCT00244023|Tadalafil|tadalafil
704795|NCT00244010|Aplastic anemia|aplastic anemia
704796|NCT00244010|Amegakaryocytic thrombocytopenia|amegakaryocytic thrombocytopenia
704797|NCT00244010|Diamond-Blackfan Anemia|diamond-blackfan anemia
704798|NCT00244010|Kostmann syndrome|kostmann syndrome
704799|NCT00244010|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
704800|NCT00244010|Haploidentical stem cell transplant|haploidentical stem cell transplant
704801|NCT00244010|T-cell depletion|t-cell depletion
704802|NCT00244010|Partially matched family member donor transplant|partially matched family member donor transplant
704803|NCT00244010|Refractory cytopenia|refractory cytopenia
704804|NCT00243997|parents|parents
704805|NCT00243997|fathers|fathers
704806|NCT00243997|mothers|mothers
704807|NCT00243984|metabolic syndrome|metabolic syndrome
704808|NCT00243984|type 2 diabetes|type 2 diabetes
704809|NCT00243984|topiramate|topiramate
704810|NCT00243984|weight loss|weight loss
704811|NCT00243971|EARLY-STAGE, IDIOPATHIC PARKINSON'S DISEASE|early-stage, idiopathic parkinson's disease
704812|NCT00243932|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
704813|NCT00243932|ALS|als
704814|NCT00243932|Lou Gehrig's disease|lou gehrig's disease
704815|NCT00243932|CoQ10|coq10
704816|NCT00243932|coenzyme Q10|coenzyme q10
704817|NCT00243932|antioxidants|antioxidants
704818|NCT00243932|free radicals|free radicals
704819|NCT00243932|mitochondrial dysfunction|mitochondrial dysfunction
704820|NCT00243919|stroke|stroke
704821|NCT00243919|locomotor|locomotor
704822|NCT00243919|exercise|exercise
704823|NCT00243919|walking|walking
704824|NCT00243919|training program|training program
704825|NCT00243919|body weight support training|body weight support training
704826|NCT00243919|physical therapy|physical therapy
704827|NCT00243906|acute ischemic stroke|acute ischemic stroke
704828|NCT00243906|stroke|stroke
704829|NCT00243906|rt-PA|rt-pa
704830|NCT00243906|thrombolytic|thrombolytic
704831|NCT00243906|recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
704832|NCT00243893|giant aneurysms|giant aneurysms
704833|NCT00243893|arteriovenous malformations|arteriovenous malformations
704834|NCT00243893|minocycline|minocycline
704835|NCT00243893|doxycycline|doxycycline
704836|NCT00243893|BAVM|bavm
704837|NCT00243880|acute ischemic stroke|acute ischemic stroke
704838|NCT00243880|lovastatin|lovastatin
704839|NCT00243880|statin|statin
704840|NCT00243880|neuroprotection|neuroprotection
704841|NCT00243880|SPOTRIAS|spotrias
704842|NCT00243867|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
704843|NCT00243854|Pancreatic Cancer|pancreatic cancer
704844|NCT00243854|Resectable Pancreatic Cancer|resectable pancreatic cancer
704845|NCT00243854|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
704846|NCT00243828|Noninvasive Mechanical Ventilation|noninvasive mechanical ventilation
704847|NCT00243828|Acute Respiratory Failure|acute respiratory failure
704848|NCT00243828|Intubation|intubation
704849|NCT00243815|randomized controlled trial|randomized controlled trial
704850|NCT00243815|prophylactic nonsteroidal antiflammatory drug|prophylactic nonsteroidal antiflammatory drug
704851|NCT00243815|IUD removal|iud removal
704852|NCT00243802|Atrial Fibrillation|atrial fibrillation
704853|NCT00243802|Oxidative Stress|oxidative stress
704854|NCT00243802|Atrial Flutter|atrial flutter
704855|NCT00243789|Duchenne|duchenne
704856|NCT00243789|Genetic|genetic
704857|NCT00243789|Muscular Dystrophy|muscular dystrophy
704858|NCT00243789|DMD|dmd
704859|NCT00243763|Refractory Multiple Myeloma or|refractory multiple myeloma or
704860|NCT00243763|Relapsed Multiple Myeloma|relapsed multiple myeloma
704861|NCT00243750|ankylosing spondylitis|ankylosing spondylitis
704862|NCT00243750|trial|trial
704863|NCT00243750|methotrexate|methotrexate
704864|NCT00243737|Malaria|malaria
704865|NCT00243737|falciparum|falciparum
704866|NCT00243737|Mefloquine|mefloquine
704867|NCT00243737|Artesunate|artesunate
704868|NCT00243737|Artemisinin|artemisinin
704869|NCT00243724|immunohistochemical|immunohistochemical
704870|NCT00243724|erosive esophagitis|erosive esophagitis
704871|NCT00243724|Acid reflux disease|acid reflux disease
704872|NCT00243698|Contrast-enhanced Ultrasound Sonography|contrast-enhanced ultrasound sonography
704873|NCT00243698|Ultrasound Contrast agents, microbubbles|ultrasound contrast agents, microbubbles
704874|NCT00243698|Breast tumors|breast tumors
705151|NCT00242606|Lamotrigine|lamotrigine
704876|NCT00243685|Chemotherapy|chemotherapy
704877|NCT00243685|Lung cancer|lung cancer
704878|NCT00243685|Ovarian Cancer|ovarian cancer
704879|NCT00243685|Breast Cancer|breast cancer
704880|NCT00243685|Sarcoma|sarcoma
704881|NCT00243685|Apoptosis|apoptosis
704882|NCT00243685|MiCK Assay|mick assay
704883|NCT00243685|New Technology|new technology
704884|NCT00243685|Patients with pathological diagnoses of breast, lung, and ovarian adenocarcinomas and soft tissue sarcoma|patients with pathological diagnoses of breast, lung, and ovarian adenocarcinomas and soft tissue sarcoma
704885|NCT00243659|Hemophilia A|hemophilia a
704886|NCT00243659|bleeding disorder|bleeding disorder
704887|NCT00243646|Radiation therapy|radiation therapy
704888|NCT00243646|Brachytherapy|brachytherapy
704889|NCT00243646|Prostatic neoplasm|prostatic neoplasm
704890|NCT00243633|focal liver lesions|focal liver lesions
704891|NCT00243633|contrast-enhanced ultrasound sonography|contrast-enhanced ultrasound sonography
704892|NCT00243633|cirrhosis|cirrhosis
704893|NCT00243633|suspected liver metastases|suspected liver metastases
704894|NCT00243633|suspected liver cirrhosis|suspected liver cirrhosis
704895|NCT00243620|Chronic leg ulcers; wound healing; wound care; Vacuum Assisted Closure; topical negative Pressure|chronic leg ulcers; wound healing; wound care; vacuum assisted closure; topical negative pressure
704896|NCT00243607|climacteric symptoms|climacteric symptoms
704897|NCT00243607|breast cancer|breast cancer
704898|NCT00243607|hydrotherapy|hydrotherapy
704899|NCT00243594|Dendritic cells|dendritic cells
704900|NCT00243594|Immunotherapy|immunotherapy
704901|NCT00243594|Vaccination|vaccination
704902|NCT00243594|Melanoma|melanoma
704903|NCT00243594|Peptides|peptides
704904|NCT00243594|MRI|mri
704905|NCT00243594|Scintigraphy|scintigraphy
704906|NCT00243594|Immune response|immune response
704907|NCT00243568|HIV Infections|hiv infections
704908|NCT00243568|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
704909|NCT00243568|CCR5/CXCR4 mixed tropism|ccr5/cxcr4 mixed tropism
704910|NCT00243568|R5/X4 mixed tropism|r5/x4 mixed tropism
704911|NCT00243568|CCR5 inhibitor|ccr5 inhibitor
704912|NCT00243568|vicriviroc|vicriviroc
704913|NCT00243568|treatment-experienced|treatment-experienced
704914|NCT00243555|peanut hypersensitivity|peanut hypersensitivity
704915|NCT00243555|chemokines|chemokines
704916|NCT00243555|cytokines|cytokines
704917|NCT00243555|RNA,messenger|rna,messenger
704918|NCT00243555|monocytes|monocytes
704919|NCT00243542|Acne, G6PD deficiency, Dapsone|acne, g6pd deficiency, dapsone
704920|NCT00243529|Dendritic cells|dendritic cells
704921|NCT00243529|Melanoma|melanoma
704922|NCT00243529|Vaccine|vaccine
704923|NCT00243529|Immunotherapy|immunotherapy
704924|NCT00243529|RNA|rna
704925|NCT00243529|Peptides|peptides
704926|NCT00243516|Acute Coronary Syndrome|acute coronary syndrome
704927|NCT00243516|Emergency Department|emergency department
704928|NCT00243516|Chest Pain Evaluation Unit|chest pain evaluation unit
704929|NCT00243516|Overtesting|overtesting
704930|NCT00243516|Chest Pain Protocol|chest pain protocol
704931|NCT00243516|Myocardial Infarction|myocardial infarction
704932|NCT00243516|Medical Malpractice|medical malpractice
704933|NCT00243503|Breast Cancer Metastatic|breast cancer metastatic
704934|NCT00243490|Photodynamic therapy|photodynamic therapy
704935|NCT00243490|Malignant glioma|malignant glioma
704936|NCT00243490|Photosan|photosan
704937|NCT00243477|Coronary Artery Bypass|coronary artery bypass
704938|NCT00243477|Surgery|surgery
704939|NCT00243425|Major Depressive Disorder;|major depressive disorder;
704940|NCT00243425|African Americans;|african americans;
704941|NCT00243425|Disparities;|disparities;
704942|NCT00243425|Quality Improvement;|quality improvement;
704943|NCT00243425|Patient Centered Care;|patient centered care;
704944|NCT00243425|Primary Care;|primary care;
704945|NCT00243425|Patient-Physician Relationship;|patient-physician relationship;
704946|NCT00243412|Rituxan|rituxan
704947|NCT00243412|RA|ra
704948|NCT00243399|Fanconi anemia|fanconi anemia
704949|NCT00243399|FA|fa
704950|NCT00243373|Patient safety|patient safety
704951|NCT00243373|Medication safety|medication safety
704952|NCT00243373|Barcode technology|barcode technology
704953|NCT00243360|Urinary tract infections,|urinary tract infections,
704954|NCT00243360|antibiotic use,|antibiotic use,
704955|NCT00243360|long term care facilities|long term care facilities
704956|NCT00243347|RECENTIN|recentin
704957|NCT00243334|Ambulatory Care Information Systems|ambulatory care information systems
704958|NCT00243334|Clinical Decision Support Systems|clinical decision support systems
704959|NCT00243334|Medication Systems|medication systems
704960|NCT00243334|Medication Errors|medication errors
704961|NCT00243334|Reminder Systems|reminder systems
704962|NCT00243334|Drug Monitoring|drug monitoring
704963|NCT00243334|Preventive Health Services|preventive health services
704964|NCT00243334|Time and Motion Studies|time and motion studies
704965|NCT00243334|Efficiency|efficiency
704966|NCT00243334|Cost-Benefit Analysis|cost-benefit analysis
704967|NCT00243321|brachytherapy|brachytherapy
704968|NCT00243321|intensity-modulated radiation therapy|intensity-modulated radiation therapy
704969|NCT00243321|prostate specific antigen|prostate specific antigen
704970|NCT00243308|Anti-inflammatory agents|anti-inflammatory agents
704971|NCT00243308|unstable plaque|unstable plaque
704972|NCT00243308|acute coronary syndrome|acute coronary syndrome
704973|NCT00243295|osteoarthritis|osteoarthritis
704974|NCT00243295|deformity of knee|deformity of knee
704975|NCT00243282|Complementary Therapies|complementary therapies
704976|NCT00243282|Dyspnea|dyspnea
704977|NCT00243282|Palliative Care|palliative care
704978|NCT00243282|Meditation|meditation
704979|NCT00243282|Quality of Life|quality of life
704980|NCT00243269|nausea, acupressure bands, relaxation|nausea, acupressure bands, relaxation
704981|NCT00243243|Burns|burns
704982|NCT00243204|Stage IIIb/IV non-small cell lung cancer|stage iiib/iv non-small cell lung cancer
704983|NCT00243204|NSCLC|nsclc
704984|NCT00243204|Lung Cancer|lung cancer
704985|NCT00243191|newly diagnosed or recurrent|newly diagnosed or recurrent
704986|NCT00243178|Atrial fibrillation|atrial fibrillation
704987|NCT00243178|Anticoagulant therapy|anticoagulant therapy
704988|NCT00243178|Thromboembolic prevention|thromboembolic prevention
704989|NCT00243165|breast cancer|breast cancer
704990|NCT00243165|honey|honey
704991|NCT00243165|myelosuppression|myelosuppression
704992|NCT00243165|chemotherapy|chemotherapy
704993|NCT00243152|pain|pain
704994|NCT00243152|neuropathic|neuropathic
704995|NCT00243152|face|face
704996|NCT00243152|trigeminal|trigeminal
704997|NCT00243139|Oral appliances|oral appliances
704998|NCT00243139|Obstructive sleep apnea|obstructive sleep apnea
704999|NCT00243139|Epworth Sleepiness Scale|epworth sleepiness scale
705000|NCT00243139|SF-36|sf-36
705001|NCT00243126|HIV prevention|hiv prevention
705002|NCT00243126|HIV Seronegativity|hiv seronegativity
705003|NCT00243126|HIV negative|hiv negative
705004|NCT00243113|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
705005|NCT00243113|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
705006|NCT00243113|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
705007|NCT00243113|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
705008|NCT00243087|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
705009|NCT00243087|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
705010|NCT00243087|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
705011|NCT00243087|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
705012|NCT00243087|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
705013|NCT00243087|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
705014|NCT00243087|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
705015|NCT00243087|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
705016|NCT00243087|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
705017|NCT00243087|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
705018|NCT00243087|anaplastic large cell lymphoma|anaplastic large cell lymphoma
705019|NCT00243087|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
705020|NCT00243087|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
705021|NCT00243087|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
705022|NCT00243087|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
705023|NCT00243087|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
705024|NCT00243087|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
705025|NCT00243087|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
705026|NCT00243087|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
705027|NCT00243048|stage I prostate cancer|stage i prostate cancer
705028|NCT00243048|stage II prostate cancer|stage ii prostate cancer
705029|NCT00243022|cerebral edema|cerebral edema
705030|NCT00243022|adult glioblastoma|adult glioblastoma
705031|NCT00243022|adult giant cell glioblastoma|adult giant cell glioblastoma
705032|NCT00243022|adult gliosarcoma|adult gliosarcoma
705033|NCT00243022|adult anaplastic astrocytoma|adult anaplastic astrocytoma
705034|NCT00243022|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
705035|NCT00243009|recurrent renal cell cancer|recurrent renal cell cancer
705036|NCT00243009|stage IV renal cell cancer|stage iv renal cell cancer
705037|NCT00243009|clear cell renal cell carcinoma|clear cell renal cell carcinoma
705038|NCT00242996|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
705039|NCT00242983|adenocarcinoma of the lung|adenocarcinoma of the lung
705040|NCT00242983|large cell lung cancer|large cell lung cancer
705041|NCT00242983|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
705042|NCT00242983|squamous cell lung cancer|squamous cell lung cancer
705043|NCT00242983|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
705044|NCT00242983|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
705045|NCT00242957|HIV/AIDS|hiv/aids
705046|NCT00242957|Gender Based Violence|gender based violence
705047|NCT00242957|Structural Interventions|structural interventions
705048|NCT00242957|South Africa|south africa
705049|NCT00242957|HIV Seronegativity|hiv seronegativity
705050|NCT00242944|Acute coronary syndrome|acute coronary syndrome
705051|NCT00242944|Hypercholesterolemia|hypercholesterolemia
705152|NCT00242593|cognition disorders|cognition disorders
705052|NCT00242944|Primary coronary intervention|primary coronary intervention
705053|NCT00242944|Hydroxymethylglutaryl-CoA reductase inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
705054|NCT00242944|coronary plaque|coronary plaque
705055|NCT00242944|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
705056|NCT00242944|Ultrasonography, Interventional|ultrasonography, interventional
705057|NCT00242931|adenocarcinoma of the prostate|adenocarcinoma of the prostate
705058|NCT00242931|recurrent prostate cancer|recurrent prostate cancer
705059|NCT00242931|stage IV prostate cancer|stage iv prostate cancer
705060|NCT00242918|High risk|high risk
705061|NCT00242918|adenocarcinoma|adenocarcinoma
705062|NCT00242918|prostate cancer|prostate cancer
705063|NCT00242918|neoadjuvant|neoadjuvant
705064|NCT00242905|Memory|memory
705065|NCT00242905|Epilepsy|epilepsy
705066|NCT00242905|Children|children
705067|NCT00242905|Magnetic resonance imaging|magnetic resonance imaging
705068|NCT00242905|Functional magnetic resonance imaging|functional magnetic resonance imaging
705069|NCT00242892|Deployment stent optimisation|deployment stent optimisation
705070|NCT00242892|Fractional Flow Reserve|fractional flow reserve
705071|NCT00242892|Stent|stent
705072|NCT00242892|Restenosis|restenosis
705073|NCT00242892|Coronary|coronary
705074|NCT00242879|treatment-experienced|treatment-experienced
705075|NCT00242879|RTV|rtv
705076|NCT00242879|protease inhibitor|protease inhibitor
705077|NCT00242879|ritonavir|ritonavir
705078|NCT00242879|GW640385|gw640385
705079|NCT00242879|HIV-1|hiv-1
705080|NCT00242866|Productivity|productivity
705081|NCT00242866|Efficacy|efficacy
705082|NCT00242866|without aura|without aura
705083|NCT00242866|iNOS|inos
705084|NCT00242866|Safety|safety
705085|NCT00242866|Nitric Oxide|nitric oxide
705086|NCT00242866|Pharmacokinetics|pharmacokinetics
705087|NCT00242866|GW274150|gw274150
705088|NCT00242866|with aura|with aura
705089|NCT00242866|Migraine|migraine
705090|NCT00242866|Prophylaxis|prophylaxis
705091|NCT00242866|Quality of Life|quality of life
705092|NCT00242853|iNOS|inos
705093|NCT00242853|Rheumatoid arthritis|rheumatoid arthritis
705094|NCT00242853|Exhaled NO|exhaled no
705095|NCT00242840|protease inhibitor|protease inhibitor
705096|NCT00242840|ritonavir|ritonavir
705097|NCT00242840|GW433908|gw433908
705098|NCT00242840|HIV-1|hiv-1
705099|NCT00242840|fosamprenavir|fosamprenavir
705100|NCT00242788|Colorectal Cancer|colorectal cancer
705101|NCT00242775|Asthma|asthma
705102|NCT00242762|Head and Neck Neoplasms|head and neck neoplasms
705103|NCT00242762|Cancer of Head and Neck|cancer of head and neck
705104|NCT00242762|Head and Neck Cancer|head and neck cancer
705105|NCT00242762|Head Cancer|head cancer
705106|NCT00242762|Neck Cancer|neck cancer
705107|NCT00242749|Head and Neck Cancer Disease|head and neck cancer disease
705108|NCT00242749|Head Cancer|head cancer
705109|NCT00242749|Neck Cancer|neck cancer
705110|NCT00242749|Cancer of Head|cancer of head
705111|NCT00242749|Cancer of Neck|cancer of neck
705112|NCT00242749|Cancer of the Head|cancer of the head
705113|NCT00242749|Cancer of the Head and Neck|cancer of the head and neck
705114|NCT00242749|Cancer of the Neck|cancer of the neck
705115|NCT00242749|Neoplasms, Head and Neck|neoplasms, head and neck
705116|NCT00242723|Lung Cancers|lung cancers
705117|NCT00242723|Esophageal Cancer|esophageal cancer
705118|NCT00242723|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
705119|NCT00242723|Biopsy|biopsy
705120|NCT00242723|Staging Studies|staging studies
705121|NCT00242723|Lung Cancer|lung cancer
705122|NCT00242710|Endometrium|endometrium
705123|NCT00242710|Uterus|uterus
705124|NCT00242710|Menopause|menopause
705125|NCT00242697|coronary artery bypass surgery|coronary artery bypass surgery
705126|NCT00242697|anesthesia, general|anesthesia, general
705127|NCT00242697|anesthesia, spinal|anesthesia, spinal
705128|NCT00242697|heart-lung machine|heart-lung machine
705129|NCT00242684|Aging|aging
705130|NCT00242684|Undernutrition|undernutrition
705131|NCT00242684|Inflammation|inflammation
705132|NCT00242684|Frail Elderly|frail elderly
705133|NCT00242671|general anesthesia, hyperventilation, carbon dioxide, isocapnic hyperponea|general anesthesia, hyperventilation, carbon dioxide, isocapnic hyperponea
705134|NCT00242658|Physical Activity|physical activity
705135|NCT00242658|Wellness Programs|wellness programs
705136|NCT00242658|Health Promotion|health promotion
705137|NCT00242658|Blood Pressure, High|blood pressure, high
705138|NCT00242645|Doctor-Patient relation|doctor-patient relation
705139|NCT00242645|Physician-Patient relation|physician-patient relation
705140|NCT00242645|Diabetes|diabetes
705141|NCT00242645|Office visits|office visits
705142|NCT00242645|Comparative Study|comparative study
705143|NCT00242645|Health behavior|health behavior
705144|NCT00242645|Randomized controlled trials|randomized controlled trials
705145|NCT00242645|Health Promotion|health promotion
705146|NCT00242645|Health Education|health education
705147|NCT00242645|Computer-tailor information|computer-tailor information
705148|NCT00242606|Newly diagnosed epilepsy|newly diagnosed epilepsy
705149|NCT00242606|Initial monotherapy|initial monotherapy
705150|NCT00242606|Levetiracetam|levetiracetam
705153|NCT00242593|Alzheimer's disease|alzheimer's disease
705154|NCT00242593|memory|memory
705155|NCT00242580|AMD|amd
705156|NCT00242580|age-related macular degeneration|age-related macular degeneration
705157|NCT00242580|choroidal neovascularization|choroidal neovascularization
705158|NCT00242567|zoledronic acid|zoledronic acid
705159|NCT00242567|bone metastases|bone metastases
705160|NCT00242567|prostate cancer|prostate cancer
705161|NCT00242567|hormone-sensitive|hormone-sensitive
705162|NCT00242554|Prostate Cancer|prostate cancer
705163|NCT00242554|Bone Metastases|bone metastases
705164|NCT00242554|Zoledronic acid|zoledronic acid
705165|NCT00242541|microadenoma|microadenoma
705166|NCT00242541|macroadenoma|macroadenoma
705167|NCT00242528|Bone Lesions|bone lesions
705168|NCT00242528|Multiple Myeloma|multiple myeloma
705169|NCT00242528|zoledronic acid|zoledronic acid
705170|NCT00242515|High risk Myelodysplastic Syndrome (MDS)|high risk myelodysplastic syndrome (mds)
705171|NCT00242502|Hepatocellular Carcinoma|hepatocellular carcinoma
705172|NCT00242502|Liver Cancer|liver cancer
705173|NCT00242502|Bevacizumab|bevacizumab
705174|NCT00242502|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
705175|NCT00242502|rhuMAb-VEGF|rhumab-vegf
705176|NCT00242502|Erlotinib Hydrochloride|erlotinib hydrochloride
705177|NCT00242502|OSI-774|osi-774
705178|NCT00242502|Tarceva|tarceva
705179|NCT00242502|Erlotinib|erlotinib
705180|NCT00242502|Avastin|avastin
705181|NCT00242489|Arcoxia|arcoxia
705182|NCT00242463|malnutrition|malnutrition
705183|NCT00242463|anabolic steroids|anabolic steroids
705184|NCT00242463|intensive care unit|intensive care unit
705185|NCT00242463|rehabilitation|rehabilitation
705186|NCT00242450|metoclopramide|metoclopramide
705187|NCT00242450|feeding|feeding
705188|NCT00242450|very low birthweightnewborn|very low birthweightnewborn
705189|NCT00242424|influenza vaccine|influenza vaccine
705190|NCT00242424|infants|infants
705191|NCT00242424|safety|safety
705192|NCT00242424|immunogenicity|immunogenicity
705193|NCT00242398|Intensive care unit|intensive care unit
705194|NCT00242398|Patients with bleeding high risk|patients with bleeding high risk
705195|NCT00242398|Intermittent hemodialysis without anticoagulation|intermittent hemodialysis without anticoagulation
705196|NCT00242398|Blood lost|blood lost
705197|NCT00242385|Severe congenital Alpha1-Proteinase Inhibitor (Alpha1-PI) deficiency|severe congenital alpha1-proteinase inhibitor (alpha1-pi) deficiency
705198|NCT00242372|Insulin dependent Type 2 diabetes|insulin dependent type 2 diabetes
705199|NCT00242346|Hypertension|hypertension
705200|NCT00242333|COPD|copd
705201|NCT00242333|COAD|coad
705202|NCT00242333|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
705203|NCT00242333|emphysema|emphysema
705204|NCT00242333|chronic bronchitis|chronic bronchitis
705205|NCT00242320|COPD|copd
705206|NCT00242320|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
705207|NCT00242320|Roflumilast|roflumilast
705208|NCT00242307|Asthma|asthma
705209|NCT00242307|Roflumilast|roflumilast
705210|NCT00242307|phosphodiesterase 4 inhibitor|phosphodiesterase 4 inhibitor
705211|NCT00242294|COPD|copd
705212|NCT00242294|Phosphodiesterase 4 inhibitor|phosphodiesterase 4 inhibitor
705213|NCT00242294|Roflumilast|roflumilast
705214|NCT00242281|Sore Throat|sore throat
705215|NCT00242281|Pharyngitis|pharyngitis
705216|NCT00242281|Tonsillitis|tonsillitis
705217|NCT00242255|Histone|histone
705218|NCT00242255|Chromatin|chromatin
705219|NCT00242255|Epigenome|epigenome
705220|NCT00242255|Senescence|senescence
705221|NCT00242255|Acetylation|acetylation
705222|NCT00242255|Aging|aging
705223|NCT00242255|Tissue Sample|tissue sample
705224|NCT00242242|Stroke|stroke
705225|NCT00242242|BCI|bci
705226|NCT00242242|Healthy Volunteer|healthy volunteer
705227|NCT00242242|HV|hv
705228|NCT00242229|Depression|depression
705229|NCT00242216|HIV-1 infected people|hiv-1 infected people
705230|NCT00242216|Antiretroviral treatment-naïve|antiretroviral treatment-naïve
705231|NCT00242216|Atazanavir|atazanavir
705232|NCT00242216|Fosamprenavir|fosamprenavir
705233|NCT00242216|ARV Treatment Naive|arv treatment naive
705234|NCT00242203|Breast Cancer|breast cancer
705235|NCT00242203|Neoadjuvant|neoadjuvant
705236|NCT00242203|Micrometastasis|micrometastasis
705237|NCT00242190|drug therapy|drug therapy
705238|NCT00242190|radiotherapy|radiotherapy
705239|NCT00242190|clinical trial|clinical trial
705240|NCT00242177|Multiple Sclerosis|multiple sclerosis
705241|NCT00242177|Relapsing, Remitting|relapsing, remitting
705242|NCT00242177|Autoimmune disease|autoimmune disease
705243|NCT00242164|Hemodialysis|hemodialysis
705244|NCT00242164|Magnesium|magnesium
705245|NCT00242164|Arrhythmia|arrhythmia
705246|NCT00242164|QTc interval|qtc interval
705247|NCT00242164|QT dispersion|qt dispersion
705248|NCT00242151|Delirium, Confusion, Cardiac Surgery, Organic Brain Injury, Diffusion Weighted Magnetic Resonance Imaging (DW-MRI)|delirium, confusion, cardiac surgery, organic brain injury, diffusion weighted magnetic resonance imaging (dw-mri)
705249|NCT00242125|Primary biliary Cirrhosis|primary biliary cirrhosis
705250|NCT00242125|genes|genes
705251|NCT00242125|DNA|dna
705252|NCT00242099|liver transplant|liver transplant
705255|NCT00242099|Human Herpesvirus-6|human herpesvirus-6
705256|NCT00242099|Human Herpesvirus-7|human herpesvirus-7
705257|NCT00242047|Tuberculosis.|tuberculosis.
705258|NCT00242047|Children.|children.
705259|NCT00242047|Vaccine.|vaccine.
705260|NCT00242047|BCG.|bcg.
705261|NCT00242021|Satiety, ad libitum food intake, fatty acids, hormones|satiety, ad libitum food intake, fatty acids, hormones
705262|NCT00242008|IDIOPATHIC PARKINSON'S DISEASE|idiopathic parkinson's disease
705263|NCT00241982|rheumatoid arthritis|rheumatoid arthritis
705264|NCT00241982|long circulating liposomes|long circulating liposomes
705265|NCT00241969|nutrition therapy|nutrition therapy
705266|NCT00241969|preschool children|preschool children
705267|NCT00241969|cystic fibrosis|cystic fibrosis
705268|NCT00241943|Hepatitis C|hepatitis c
705269|NCT00241943|Heroin|heroin
705270|NCT00241943|Populations at risk|populations at risk
705271|NCT00241943|testing|testing
705272|NCT00241943|vaccination|vaccination
705273|NCT00241930|Heroin|heroin
705274|NCT00241930|HIV|hiv
705275|NCT00241930|buprenorphine|buprenorphine
705276|NCT00241930|integration|integration
705277|NCT00241930|drug treatment|drug treatment
705278|NCT00241917|hepatitis C|hepatitis c
705279|NCT00241917|heroin|heroin
705280|NCT00241917|populations at risk|populations at risk
705281|NCT00241917|testing|testing
705282|NCT00241917|vaccination|vaccination
705283|NCT00241722|bowel dysfunction|bowel dysfunction
705284|NCT00241722|constipation|constipation
705285|NCT00241722|gastrointestinal|gastrointestinal
705286|NCT00241722|opioids|opioids
705287|NCT00241722|pain|pain
705288|NCT00241722|non-cancer pain|non-cancer pain
705289|NCT00241722|opioid-induced|opioid-induced
705290|NCT00241644|Rotavirus gastroenteritis|rotavirus gastroenteritis
705291|NCT00241644|HRV vaccine|hrv vaccine
705292|NCT00241618|Clinical trial|clinical trial
705293|NCT00241618|Randomized|randomized
705294|NCT00241618|Treatment|treatment
705295|NCT00241618|Prospective|prospective
705296|NCT00241618|Parallel Assignment|parallel assignment
705297|NCT00241618|Efficacy Safety Study|efficacy safety study
705298|NCT00241605|Metformin|metformin
705299|NCT00241605|AVANDAMET|avandamet
705300|NCT00241605|Type 2 diabetes|type 2 diabetes
705301|NCT00241592|Cannabis|cannabis
705302|NCT00241592|Marijuana|marijuana
705303|NCT00241592|Vaporization|vaporization
705304|NCT00241592|Volcano|volcano
705305|NCT00241592|THC|thc
705306|NCT00241579|Pain|pain
705307|NCT00241579|Cannabis|cannabis
705308|NCT00241579|Analgesic|analgesic
705309|NCT00241566|Neuropathic pain|neuropathic pain
705310|NCT00241566|Electric cortical stimulation|electric cortical stimulation
705311|NCT00241566|Economic Medical evaluation|economic medical evaluation
705312|NCT00241540|NSAIDs|nsaids
705313|NCT00241540|Upper GI symptoms|upper gi symptoms
705314|NCT00241514|NSAIDs|nsaids
705315|NCT00241514|Upper GI symptoms|upper gi symptoms
705316|NCT00241475|Cancer of the Prostate|cancer of the prostate
705317|NCT00241462|Advanced Breast Cancer|advanced breast cancer
705318|NCT00241449|Locally advanced breast cancer or metastatic breast cancer|locally advanced breast cancer or metastatic breast cancer
705319|NCT00241423|exenatide|exenatide
705320|NCT00241423|diabetes|diabetes
705321|NCT00241423|Amylin|amylin
705322|NCT00241423|Lilly|lilly
705323|NCT00241410|Allergy|allergy
705324|NCT00241410|Specific Immunotherapy|specific immunotherapy
705325|NCT00241410|Sublingual Immunotherapy|sublingual immunotherapy
705326|NCT00241397|pain|pain
705327|NCT00241397|depression|depression
705328|NCT00241397|anxiety disorder|anxiety disorder
705329|NCT00241384|Prostatic Cancer|prostatic cancer
705330|NCT00241384|Brachytherapy|brachytherapy
705331|NCT00241384|Prostatic neoplasm|prostatic neoplasm
705332|NCT00241384|Radiation therapy|radiation therapy
705333|NCT00241371|Multiple Myeloma|multiple myeloma
705334|NCT00241358|Plerixafor|plerixafor
705335|NCT00241358|Stem cell transplantation|stem cell transplantation
705336|NCT00241358|Stem cells|stem cells
705337|NCT00241358|Mobilization|mobilization
705338|NCT00241345|post transplant|post transplant
705339|NCT00241345|Any patient receiving an allogeneic bone marrow or peripheral blood stem cell transplant at Washington University Medical Center|any patient receiving an allogeneic bone marrow or peripheral blood stem cell transplant at washington university medical center
705340|NCT00241332|pain|pain
705341|NCT00241332|hyperalgesia|hyperalgesia
705342|NCT00241332|drug tolerance|drug tolerance
705343|NCT00241332|remifentanil|remifentanil
705344|NCT00241332|fentanyl|fentanyl
705345|NCT00241332|Anterior Cruciate Ligament|anterior cruciate ligament
705346|NCT00241332|Posterior Cruciate Ligament|posterior cruciate ligament
705347|NCT00241332|Medial Collateral Ligament, Knee|medial collateral ligament, knee
705348|NCT00241319|ocular, allergic conjunctivitis, ophthalmic|ocular, allergic conjunctivitis, ophthalmic
705349|NCT00241306|aging|aging
705350|NCT00241306|language|language
705351|NCT00241306|gender|gender
705352|NCT00241293|language|language
705353|NCT00241267|Pulmonary|pulmonary
705354|NCT00241267|Neoplasms|neoplasms
705355|NCT00241267|Endobronchial|endobronchial
705356|NCT00241267|Ultrasonography|ultrasonography
705357|NCT00241267|Primary|primary
705358|NCT00241254|Multiple Sclerosis, Chronic Progressive|multiple sclerosis, chronic progressive
705359|NCT00241254|Cyclophosphamide|cyclophosphamide
705360|NCT00241254|Methylprednisolone|methylprednisolone
705361|NCT00241254|Randomized Controlled Trials|randomized controlled trials
705362|NCT00241254|Double-Blind Study|double-blind study
705363|NCT00241241|myeloproliferative disorder|myeloproliferative disorder
705364|NCT00241241|polycythemia vera|polycythemia vera
705365|NCT00241241|interferon|interferon
705366|NCT00241228|Shock, Septic|shock, septic
705367|NCT00241228|Renal Failure, Acute|renal failure, acute
705368|NCT00241228|Venovenous Hemofiltration|venovenous hemofiltration
705369|NCT00241228|Randomized Controlled Trial|randomized controlled trial
705370|NCT00241228|Multicenter Study|multicenter study
705371|NCT00241228|Mortality|mortality
705372|NCT00241215|Botulinum toxin serotype A|botulinum toxin serotype a
705373|NCT00241215|Cervicobrachial syndrome|cervicobrachial syndrome
705374|NCT00241215|Myofascial pain|myofascial pain
705375|NCT00241215|Cervicothoracic myofascial pain|cervicothoracic myofascial pain
705376|NCT00241215|Propulsion|propulsion
705377|NCT00241215|Postural abnormality|postural abnormality
705378|NCT00241202|signs and symptoms|signs and symptoms
705379|NCT00241202|self care|self care
705380|NCT00241202|patient compliance|patient compliance
705381|NCT00241202|quality of life|quality of life
705382|NCT00241189|Systemic sclerosis|systemic sclerosis
705383|NCT00241189|Scleroderma|scleroderma
705384|NCT00241189|Rapamycin|rapamycin
705385|NCT00241189|Methotrexate|methotrexate
705386|NCT00241176|Psychiatric|psychiatric
705387|NCT00241176|Clinical Trial|clinical trial
705388|NCT00241176|Pediatrics|pediatrics
705389|NCT00241176|Tourette's Disorder|tourette's disorder
705390|NCT00241176|Tic Disorder|tic disorder
705391|NCT00241150|valsartan|valsartan
705392|NCT00241150|hypertension|hypertension
705393|NCT00241150|metabolic syndrome|metabolic syndrome
705394|NCT00241150|endothelial function|endothelial function
705395|NCT00241137|hypertension|hypertension
705396|NCT00241137|valsartan|valsartan
705397|NCT00241124|hypertension|hypertension
705398|NCT00241124|valsartan|valsartan
705399|NCT00241124|morning/evening dosing|morning/evening dosing
705400|NCT00241124|lisinopril|lisinopril
705401|NCT00241111|Prostate|prostate
705402|NCT00241111|cancer|cancer
705403|NCT00241111|bone metastasis|bone metastasis
705404|NCT00241111|zoledronic acid|zoledronic acid
705405|NCT00241098|HYPERTENSION|hypertension
705406|NCT00241098|HEART FAILURE|heart failure
705407|NCT00241098|PEPTIDE|peptide
705408|NCT00241098|valsartan|valsartan
705409|NCT00241085|proteinuria|proteinuria
705410|NCT00241085|hypertension|hypertension
705411|NCT00241085|valsartan|valsartan
705412|NCT00241085|type 2 diabetes|type 2 diabetes
705413|NCT00241059|Renal transplantation, maintenance patients, tolerability, EC-MPS|renal transplantation, maintenance patients, tolerability, ec-mps
705414|NCT00241046|Breast cancer|breast cancer
705415|NCT00241046|Machine learning techniques|machine learning techniques
705416|NCT00241046|Aromatase inhibitors|aromatase inhibitors
705417|NCT00241046|1st line treatment|1st line treatment
705418|NCT00241046|2nd line treatment|2nd line treatment
705419|NCT00241020|hepatocellular carcinoma|hepatocellular carcinoma
705420|NCT00241020|Octreotide|octreotide
705421|NCT00241007|HYPERTENSION, VALSARTAN|hypertension, valsartan
705422|NCT00240994|End stage renal disease|end stage renal disease
705423|NCT00240994|Kidney transplantation|kidney transplantation
705424|NCT00240994|Renal transplantation|renal transplantation
705425|NCT00240994|Kidney failure|kidney failure
705426|NCT00240994|Pediatric renal transplant recipients|pediatric renal transplant recipients
705427|NCT00240994|Alemtuzumab|alemtuzumab
705428|NCT00240994|Campath|campath
705429|NCT00240994|Mycophenolate mofetil|mycophenolate mofetil
705430|NCT00240994|MMF|mmf
705431|NCT00240994|CellCept|cellcept
705432|NCT00240994|Tacrolimus|tacrolimus
705433|NCT00240994|Prograf|prograf
705434|NCT00240994|Sirolimus|sirolimus
705435|NCT00240994|Rapamycin|rapamycin
705436|NCT00240981|Andropause|andropause
705437|NCT00240981|frailty|frailty
705438|NCT00240981|hormone replacement therapy|hormone replacement therapy
705439|NCT00240981|Aging|aging
705440|NCT00240968|Avian influenza, vaccine, A/H5N1, sub-study|avian influenza, vaccine, a/h5n1, sub-study
705441|NCT00240955|Renal/Kidney, Transplantation, steroids, EC-MPS|renal/kidney, transplantation, steroids, ec-mps
705442|NCT00240942|Endometriosis|endometriosis
705443|NCT00240942|GnRH analog|gnrh analog
705444|NCT00240942|Aromataseinhibitor|aromataseinhibitor
705445|NCT00240942|Letrozole|letrozole
705446|NCT00240903|revaccination, vaccination, influenza, H5N1 vaccine|revaccination, vaccination, influenza, h5n1 vaccine
705447|NCT00240864|postoperative dental pain|postoperative dental pain
705448|NCT00240864|acetaminophen|acetaminophen
705449|NCT00240864|ibuprofen|ibuprofen
705450|NCT00240851|muscle ache|muscle ache
705451|NCT00240851|pain|pain
705452|NCT00240851|soreness|soreness
705453|NCT00240851|acetaminophen|acetaminophen
705454|NCT00240838|muscle soreness|muscle soreness
705455|NCT00240838|pain, acetaminophen|pain, acetaminophen
705456|NCT00240838|ibuprofen|ibuprofen
705457|NCT00240825|postoperative dental pain|postoperative dental pain
705458|NCT00240825|acetaminophen|acetaminophen
705459|NCT00240825|ibuprofen|ibuprofen
705460|NCT00240812|nocturnal enuresis|nocturnal enuresis
705461|NCT00240812|bedwetting|bedwetting
705462|NCT00240812|ibuprofen|ibuprofen
705463|NCT00240799|osteoarthritis hip|osteoarthritis hip
705464|NCT00240799|osteoarthritis knee|osteoarthritis knee
705465|NCT00240799|acetaminophen|acetaminophen
705466|NCT00240786|osteoarthritis hip|osteoarthritis hip
705467|NCT00240786|osteoarthritis knee|osteoarthritis knee
705468|NCT00240786|acetaminophen|acetaminophen
705469|NCT00240773|osteoarthritis hip|osteoarthritis hip
705470|NCT00240773|osteoarthritis knee|osteoarthritis knee
705471|NCT00240773|acetaminophen, naproxen|acetaminophen, naproxen
705472|NCT00240760|Memantine|memantine
705473|NCT00240760|Down syndrome|down syndrome
705474|NCT00240760|Dementia|dementia
705475|NCT00240760|learning Disability|learning disability
705476|NCT00240760|Treatment of Dementia|treatment of dementia
705477|NCT00240734|Anemia|anemia
705478|NCT00240734|Chronic renal failure|chronic renal failure
705479|NCT00240734|pre-dialysis|pre-dialysis
705480|NCT00240734|diabetic|diabetic
705481|NCT00240721|topiramate|topiramate
705482|NCT00240721|bipolar disorders|bipolar disorders
705483|NCT00240721|mood disorders|mood disorders
705484|NCT00240721|manic state|manic state
705485|NCT00240721|depression|depression
705486|NCT00240721|manic-depressive psychoses|manic-depressive psychoses
705487|NCT00240708|Schizophrenia|schizophrenia
705488|NCT00240708|intramuscular injection|intramuscular injection
705489|NCT00240708|antipsychotic agents|antipsychotic agents
705490|NCT00240708|risperidone|risperidone
705491|NCT00240708|long-acting injectable|long-acting injectable
705492|NCT00240695|Alzheimer's disease|alzheimer's disease
705493|NCT00240695|Dementia|dementia
705494|NCT00240695|Brain Disease|brain disease
705495|NCT00240695|Memory Loss|memory loss
705496|NCT00240695|galantamine|galantamine
705497|NCT00240695|Nervous System Diseases|nervous system diseases
705498|NCT00240695|open-label|open-label
705499|NCT00240695|elderly|elderly
705500|NCT00240682|Carcinoma, Squamous Cell|carcinoma, squamous cell
705502|NCT00240682|cetuximab|cetuximab
705503|NCT00240682|epidermal growth factor receptor|epidermal growth factor receptor
705504|NCT00240669|Maxillo facial surgery,|maxillo facial surgery,
705505|NCT00240669|osteosynthesis,|osteosynthesis,
705506|NCT00240669|resorbable device|resorbable device
705507|NCT00240656|aldosterone antagonists, spironolactone, captopril carvedilol|aldosterone antagonists, spironolactone, captopril carvedilol
705508|NCT00240643|non valvular atrial fibrillation|non valvular atrial fibrillation
705509|NCT00240643|stroke|stroke
705510|NCT00240643|aspirin|aspirin
705511|NCT00240630|acute migraine|acute migraine
705512|NCT00240630|consistency of response|consistency of response
705513|NCT00240630|satisfaction|satisfaction
705514|NCT00240630|migraine|migraine
705515|NCT00240630|early intervention|early intervention
705516|NCT00240617|consistency of response|consistency of response
705517|NCT00240617|migraine|migraine
705518|NCT00240617|satisfaction|satisfaction
705519|NCT00240617|early intervention|early intervention
705520|NCT00240604|corticosteroid treatment|corticosteroid treatment
705521|NCT00240604|inflammatory diseases|inflammatory diseases
705522|NCT00240591|BEXXAR|bexxar
705523|NCT00240591|Tositumomab|tositumomab
705524|NCT00240591|Iodine I 131 Tositumomab|iodine i 131 tositumomab
705525|NCT00240591|low-grade follicular lymphomas|low-grade follicular lymphomas
705526|NCT00240578|Long-Term Follow-up|long-term follow-up
705527|NCT00240578|BEXXAR|bexxar
705528|NCT00240578|Iodine I 131 Tositumomab|iodine i 131 tositumomab
705529|NCT00240578|Low-grade lymphoma|low-grade lymphoma
705530|NCT00240565|BEXXAR|bexxar
705531|NCT00240565|non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
705532|NCT00240565|tositumomab|tositumomab
705533|NCT00240565|I-131|i-131
705534|NCT00240552|protease inhibitor|protease inhibitor
705535|NCT00240552|Treatment Experienced|treatment experienced
705536|NCT00240552|amprenavir|amprenavir
705537|NCT00240552|fosamprenavir|fosamprenavir
705538|NCT00240552|GW433908|gw433908
705539|NCT00240552|HIV|hiv
705540|NCT00240552|pro drug|pro drug
705541|NCT00240539|Hepatitis B|hepatitis b
705542|NCT00240526|Hepatitis B immunoglobulin|hepatitis b immunoglobulin
705543|NCT00240526|Hepatitis B antibody persistence|hepatitis b antibody persistence
705544|NCT00240513|Acne|acne
705545|NCT00240500|Long-term follow-up|long-term follow-up
705546|NCT00240500|Hepatitis B antibody persistence|hepatitis b antibody persistence
705547|NCT00240487|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
705548|NCT00240487|ARDS|ards
705549|NCT00240487|Nitric Oxide|nitric oxide
705550|NCT00240461|respiratory|respiratory
705551|NCT00240461|infection|infection
705552|NCT00240461|influenza|influenza
705553|NCT00240396|fracture|fracture
705554|NCT00240396|Tibia|tibia
705555|NCT00240396|femur|femur
705556|NCT00240396|humerus|humerus
705557|NCT00240396|narcotics|narcotics
705558|NCT00240396|bimodal|bimodal
705559|NCT00240396|analgesia|analgesia
705560|NCT00240396|long-bone|long-bone
705561|NCT00240396|NSAIDS|nsaids
705562|NCT00240344|High risk patients|high risk patients
705563|NCT00240344|Crestor|crestor
705564|NCT00240344|Rosuvastatin|rosuvastatin
705565|NCT00240344|LDL cholesterol|ldl cholesterol
705566|NCT00240344|observational|observational
705567|NCT00240331|End Stage Renal Failure|end stage renal failure
705568|NCT00240318|Coronary Artery Disease|coronary artery disease
705569|NCT00240305|Metabolic Syndrome|metabolic syndrome
705570|NCT00240305|Dyslipidaemia|dyslipidaemia
705571|NCT00240292|Ischaemic or non-ischaemic systolic congestive heart failure|ischaemic or non-ischaemic systolic congestive heart failure
705572|NCT00240279|high blood cholesterol levels|high blood cholesterol levels
705573|NCT00240266|Metabolic Syndrome|metabolic syndrome
705574|NCT00240266|Dyslipaemia|dyslipaemia
705575|NCT00240253|diabetes|diabetes
705576|NCT00240253|Amylin|amylin
705577|NCT00240253|Symlin|symlin
705578|NCT00240253|pramlintide|pramlintide
705579|NCT00240253|insulin glargine|insulin glargine
705580|NCT00240227|Alcoholism|alcoholism
705581|NCT00240227|Cocaine Dependence|cocaine dependence
705582|NCT00240227|Prazosin|prazosin
705583|NCT00240227|Substance use disorders|substance use disorders
705584|NCT00240214|Kidney transplants|kidney transplants
705585|NCT00240188|Hernia|hernia
705586|NCT00240188|Incisional|incisional
705587|NCT00240188|Laparoscopic|laparoscopic
705588|NCT00240188|Mesh|mesh
705589|NCT00240188|Repair|repair
705590|NCT00240188|Ventral|ventral
705591|NCT00240162|Myeloma|myeloma
705592|NCT00240162|PTK|ptk
705593|NCT00240136|Early, severe|early, severe
705594|NCT00240123|ERCP|ercp
705595|NCT00240123|EUS|eus
705596|NCT00240110|Bipolar|bipolar
705597|NCT00240110|Cocaine|cocaine
705598|NCT00240110|Comorbidity|comorbidity
705599|NCT00240071|Breast cancer|breast cancer
705600|NCT00240071|Metastatic breast cancer|metastatic breast cancer
705601|NCT00240071|Hormonal therapy|hormonal therapy
705602|NCT00240071|Bevacizumab|bevacizumab
705603|NCT00240058|Blood Pressure|blood pressure
705604|NCT00240058|Nitric Oxide|nitric oxide
705605|NCT00240058|L-NMMA|l-nmma
705606|NCT00240058|Phenylephrine|phenylephrine
705607|NCT00240058|Nitroprusside|nitroprusside
705608|NCT00240058|Vasoreactivity|vasoreactivity
705609|NCT00240045|Hepatorenal syndrome|hepatorenal syndrome
705610|NCT00240045|Refractory ascites|refractory ascites
705611|NCT00240045|Midodrine|midodrine
705612|NCT00240045|Octreotide|octreotide
705613|NCT00240045|Albumin|albumin
705614|NCT00240045|Cirrhosis|cirrhosis
705615|NCT00240006|Multiple Sclerosis|multiple sclerosis
705616|NCT00240006|Copaxone®|copaxone®
705617|NCT00240006|Shared Solutions®|shared solutions®
705618|NCT00239980|antineoplastic agent|antineoplastic agent
705619|NCT00239980|ovarian cancer|ovarian cancer
705620|NCT00239980|fragmin|fragmin
705621|NCT00239980|dalteparin|dalteparin
705622|NCT00239967|dyslipidemia|dyslipidemia
705623|NCT00239967|obesity|obesity
705624|NCT00239928|Long-Term Study For Pegaptanib Sodium In Patients With Subfoveal Choroidal Neovascularization Secondary To Age-Related Macular Degeneration|long-term study for pegaptanib sodium in patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration
705625|NCT00239902|Transplantation, kidney, and organ transplantation|transplantation, kidney, and organ transplantation
705626|NCT00239889|Forearm fracture|forearm fracture
705627|NCT00239889|Postmenopausal women|postmenopausal women
705629|NCT00239889|Grip strength|grip strength
705630|NCT00239889|Salmon calcitonin|salmon calcitonin
705631|NCT00239876|Transplantation, kidney, and organ transplant|transplantation, kidney, and organ transplant
705632|NCT00239863|Transplantation, kidney,organ transplant|transplantation, kidney,organ transplant
705633|NCT00239850|obesity|obesity
705634|NCT00239850|lifestyle|lifestyle
705635|NCT00239850|treatment|treatment
705636|NCT00239850|Complications|complications
705637|NCT00239850|endocrine changes|endocrine changes
705638|NCT00239850|Lipids|lipids
705639|NCT00239850|C18.654.726.500.495|c18.654.726.500.495
705640|NCT00239837|Adolescent|adolescent
705641|NCT00239837|Foster Care|foster care
705642|NCT00239837|Female|female
705643|NCT00239824|urinary incontinence|urinary incontinence
705644|NCT00239824|pelvic floor muscle training|pelvic floor muscle training
705645|NCT00239824|radical prostatectomy|radical prostatectomy
705646|NCT00239824|physiotherapy|physiotherapy
705647|NCT00239811|Transplantation, kidney, and organ transplant.|transplantation, kidney, and organ transplant.
705648|NCT00239798|Transplantation, kidney, organ transplant|transplantation, kidney, organ transplant
705649|NCT00239785|Transplantation, kidney, and organ transplant.|transplantation, kidney, and organ transplant.
705650|NCT00239772|Cognitive Therapy|cognitive therapy
705651|NCT00239772|PTSD|ptsd
705652|NCT00239772|Females|females
705653|NCT00239772|Rape|rape
705654|NCT00239772|Trauma|trauma
705655|NCT00239759|Epidemiological study|epidemiological study
705656|NCT00239746|Nonsteroidal Anti-inflammatories|nonsteroidal anti-inflammatories
705657|NCT00239746|NSAIDS|nsaids
705658|NCT00239733|HIV|hiv
705659|NCT00239733|HCV|hcv
705660|NCT00239733|Hepatitis C|hepatitis c
706225|NCT00237549|Screening|screening
705661|NCT00239733|Thrombocytopenia|thrombocytopenia
705662|NCT00239720|Psoriatic Arthritis|psoriatic arthritis
705663|NCT00239720|Arthritis|arthritis
705664|NCT00239720|Psoriasis|psoriasis
705665|NCT00239720|Psoriatic|psoriatic
705666|NCT00239720|PsA|psa
705667|NCT00239707|insulin sensitivity|insulin sensitivity
705668|NCT00239707|blood sugar|blood sugar
705669|NCT00239694|Immune response|immune response
705670|NCT00239694|Antibody response|antibody response
705671|NCT00239681|Primary prevention|primary prevention
705672|NCT00239681|Cardiovascular disease|cardiovascular disease
705673|NCT00239681|Statin therapy|statin therapy
705674|NCT00239681|C-reactive protein|c-reactive protein
705675|NCT00239668|Burns|burns
705676|NCT00239668|Functional|functional
705677|NCT00239668|Psychosocial|psychosocial
705678|NCT00239668|Recovery|recovery
705679|NCT00239668|Long-term|long-term
705680|NCT00239668|Pediatric|pediatric
705681|NCT00239668|Surgical|surgical
705682|NCT00239668|Outcomes|outcomes
705683|NCT00239668|Benchmarking|benchmarking
705684|NCT00239642|Iron|iron
705685|NCT00239642|Anemia|anemia
705686|NCT00239642|CKD|ckd
705687|NCT00239616|Anemia|anemia
705688|NCT00239616|Pharmacokinetics|pharmacokinetics
705689|NCT00239603|OV-Watch|ov-watch
705690|NCT00239603|fertility monitor|fertility monitor
705691|NCT00239603|ovulation induction|ovulation induction
705692|NCT00239603|clomiphene citrate|clomiphene citrate
705693|NCT00239603|anovulation|anovulation
705694|NCT00239603|infertility|infertility
705695|NCT00239577|Dengue infection|dengue infection
705696|NCT00239564|IPX054|ipx054
705697|NCT00239564|Parkinson disease|parkinson disease
705698|NCT00239564|Levodopa|levodopa
705699|NCT00239551|gastric stress ulcer|gastric stress ulcer
705700|NCT00239551|Prevacid|prevacid
705701|NCT00239551|Prostaglandin|prostaglandin
705702|NCT00239525|Cerebrovascular Accident|cerebrovascular accident
705703|NCT00239525|Intracranial Hypertension|intracranial hypertension
705704|NCT00239512|PDA|pda
705705|NCT00239512|VLBW infants|vlbw infants
705706|NCT00239512|Indomethacin|indomethacin
705707|NCT00239512|Ibuprofen|ibuprofen
705708|NCT00239330|high blood cholesterol levels|high blood cholesterol levels
705709|NCT00239317|tamsulosin|tamsulosin
705710|NCT00239317|urinary tract diseases|urinary tract diseases
705711|NCT00239317|male|male
705712|NCT00239304|Stage III Head and Neck Cancer|stage iii head and neck cancer
705713|NCT00239304|Stage IV Head and Neck Cancer|stage iv head and neck cancer
705714|NCT00239265|tamsulosin|tamsulosin
705715|NCT00239265|urinary tract diseases|urinary tract diseases
705716|NCT00239265|female|female
705717|NCT00239252|Interferon alfacon-1|interferon alfacon-1
705718|NCT00239252|Virus disease|virus disease
705719|NCT00239252|Hepatitis C|hepatitis c
705720|NCT00239239|Non-myeloid malignancy|non-myeloid malignancy
705721|NCT00239239|Chemotherapy-induced anemia|chemotherapy-induced anemia
705722|NCT00239239|Oncology|oncology
705723|NCT00239239|Clinical Trials|clinical trials
705724|NCT00239239|Pharmacokinetics|pharmacokinetics
705725|NCT00239239|Darbepoetin alfa|darbepoetin alfa
705726|NCT00239239|Aranesp|aranesp
705727|NCT00239239|Amgen|amgen
705728|NCT00239226|atrial fibrillation|atrial fibrillation
705729|NCT00239226|interatrial septum|interatrial septum
705730|NCT00239226|atrial pacing|atrial pacing
705731|NCT00239226|symptomatic sinus node dysfunction,|symptomatic sinus node dysfunction,
705732|NCT00239226|pacemaker indication class I|pacemaker indication class i
705733|NCT00239213|catechins|catechins
705734|NCT00239213|gargling|gargling
705735|NCT00239213|healthy volunteers|healthy volunteers
705736|NCT00239187|Type 2 diabetes|type 2 diabetes
705737|NCT00239174|obesity|obesity
705738|NCT00239161|Pyelonephritis|pyelonephritis
705739|NCT00239148|Type 1 diabetes|type 1 diabetes
705740|NCT00239135|Actinic Keratosis|actinic keratosis
705741|NCT00239135|Topical|topical
705742|NCT00239135|Maximum Tolerated Dose|maximum tolerated dose
705743|NCT00239135|Solar Keratosis|solar keratosis
705744|NCT00239135|Sun Spots|sun spots
705745|NCT00239135|Dermatology|dermatology
705746|NCT00239122|Cognitive Therapy|cognitive therapy
705747|NCT00239122|Psychotic Disorders|psychotic disorders
705748|NCT00239122|Treatment Outcome|treatment outcome
705749|NCT00239096|alcoholic liver cirrhosis|alcoholic liver cirrhosis
705750|NCT00239096|ascites|ascites
705751|NCT00239096|sodium retention|sodium retention
705752|NCT00239083|MYFORMS, Kidney Transplantation, Enteric-Coated Mycophenolate Sodium (EC-MPS), Cyclosporine microemulsion (CsA-ME)|myforms, kidney transplantation, enteric-coated mycophenolate sodium (ec-mps), cyclosporine microemulsion (csa-me)
705753|NCT00239070|EC-MPS, renal transplantation, de novo patients|ec-mps, renal transplantation, de novo patients
705754|NCT00239057|Renal transplantation, EC-MPS|renal transplantation, ec-mps
705755|NCT00239044|Kidney transplant recipients; Enteric-coated Mycophenolate sodium (EC-MPS)|kidney transplant recipients; enteric-coated mycophenolate sodium (ec-mps)
705756|NCT00239031|Renal transplantation, EC-MPS|renal transplantation, ec-mps
705757|NCT00239018|Enteric-Coated Mycophenolate Sodium (EC-MPS), de novo, kidney transplantation, long-term safety.|enteric-coated mycophenolate sodium (ec-mps), de novo, kidney transplantation, long-term safety.
705758|NCT00239005|QoL|qol
705759|NCT00239005|GI Side Effects|gi side effects
705760|NCT00239005|MPA|mpa
705761|NCT00238992|Kidney, de novo transplant, steroid withdrawal, adults, EC-MPS and cyclosporine|kidney, de novo transplant, steroid withdrawal, adults, ec-mps and cyclosporine
705762|NCT00238979|Renal transplantation, Enteric-coated mycophenolate sodium|renal transplantation, enteric-coated mycophenolate sodium
705763|NCT00238966|Renal transplantation, Enteric-Coated Mycophenolate Sodium (EC-MPS)|renal transplantation, enteric-coated mycophenolate sodium (ec-mps)
705764|NCT00238953|Kidney transplantation|kidney transplantation
705765|NCT00238953|enteric-coated mycophenolate sodium|enteric-coated mycophenolate sodium
705766|NCT00238940|Renal transplantation, Enteric-Coated Mycophenolate Sodium (EC-MPS)|renal transplantation, enteric-coated mycophenolate sodium (ec-mps)
705767|NCT00238927|asthma|asthma
705768|NCT00238927|preschool|preschool
705769|NCT00238927|viral|viral
705770|NCT00238927|upper respiratory track infection|upper respiratory track infection
705771|NCT00238927|fluticasone|fluticasone
705772|NCT00238927|inhaled corticosteroids|inhaled corticosteroids
705773|NCT00238927|placebo|placebo
705774|NCT00238927|exacerbations|exacerbations
705775|NCT00238927|severity|severity
705776|NCT00238927|safety|safety
705777|NCT00238927|growth|growth
705778|NCT00238927|bone mineral density|bone mineral density
705779|NCT00238927|adrenal function|adrenal function
705780|NCT00238927|rescue beta2-agonists|rescue beta2-agonists
705781|NCT00238901|Liver transplant, HCV+, steroid free|liver transplant, hcv+, steroid free
705782|NCT00238888|asthma|asthma
705783|NCT00238888|children|children
705784|NCT00238888|adolescent|adolescent
705785|NCT00238888|education|education
705786|NCT00238888|medical review|medical review
705787|NCT00238888|asthma control|asthma control
705788|NCT00238888|questionnaire|questionnaire
705789|NCT00238888|quality of life|quality of life
705790|NCT00238888|emergency department visit|emergency department visit
705791|NCT00238888|use of medication|use of medication
705792|NCT00238888|adherence to treatment|adherence to treatment
705793|NCT00238875|stereotactic body radiation therapy|stereotactic body radiation therapy
705794|NCT00238875|T1N0M0 non-small cell lung cancer|t1n0m0 non-small cell lung cancer
705795|NCT00238875|radiotherapy|radiotherapy
705796|NCT00238862|Diabetes|diabetes
705797|NCT00238862|Corneal transplant|corneal transplant
705798|NCT00238862|Neurotrophic keratitis|neurotrophic keratitis
705799|NCT00238862|Post-bacterial keratitis|post-bacterial keratitis
705800|NCT00238862|Metaherpetic keratitis|metaherpetic keratitis
705801|NCT00238849|Non-small cell lung cancer|non-small cell lung cancer
705802|NCT00238823|cryoablation|cryoablation
705803|NCT00238823|radiofrequency ablation|radiofrequency ablation
705804|NCT00238823|pediatrics|pediatrics
705805|NCT00238823|cardiology|cardiology
705806|NCT00238810|BNP|bnp
705807|NCT00238810|Pediatrics|pediatrics
705808|NCT00238810|Congenital heart disease|congenital heart disease
705809|NCT00238810|b-type natriuretic peptide|b-type natriuretic peptide
705810|NCT00238797|Glioblastoma multiforme|glioblastoma multiforme
705811|NCT00238797|Brain tumour|brain tumour
705812|NCT00238758|Mood Disorder|mood disorder
705813|NCT00238745|Postmenopausal Osteoporosis|postmenopausal osteoporosis
705814|NCT00238732|Vaginal Atrophy|vaginal atrophy
705815|NCT00238732|Postmenopause|postmenopause
705816|NCT00238719|Social Anxiety|social anxiety
705817|NCT00238719|Children Disorders|children disorders
705818|NCT00238706|Radiofrequency catheter ablation|radiofrequency catheter ablation
705819|NCT00238706|Atrial fibrillation|atrial fibrillation
705820|NCT00238706|Randomized trial|randomized trial
705821|NCT00238693|transplant|transplant
705822|NCT00238693|transplantation of liver, kidney, pancreas|transplantation of liver, kidney, pancreas
705823|NCT00238680|Overactive bladder|overactive bladder
705824|NCT00238680|Children|children
705825|NCT00238680|Bladder rehabilitation|bladder rehabilitation
705826|NCT00238667|Extracranial carotid artery dissection|extracranial carotid artery dissection
705827|NCT00238667|Dissection and stroke|dissection and stroke
705828|NCT00238550|Diabetes|diabetes
705829|NCT00238550|Pain|pain
705830|NCT00238550|Peripheral neuropathy|peripheral neuropathy
705831|NCT00238537|Stroke|stroke
705832|NCT00238537|Thrombolysis|thrombolysis
705833|NCT00238537|MRI|mri
705834|NCT00238537|Echoplanar|echoplanar
705835|NCT00238537|Penumbra|penumbra
705836|NCT00238524|painful distal diabetic neuropathy|painful distal diabetic neuropathy
705837|NCT00238498|Type 2 diabetes|type 2 diabetes
705838|NCT00238498|vildagliptin|vildagliptin
705839|NCT00238498|HbA1c|hba1c
705840|NCT00238485|Bipolar I Disorder|bipolar i disorder
705841|NCT00238472|Type 2 diabetes|type 2 diabetes
705842|NCT00238472|nateglinide|nateglinide
705843|NCT00238459|Immunity to HIV|immunity to hiv
705844|NCT00238459|Acute Infection|acute infection
705845|NCT00238459|Treatment Naive|treatment naive
705846|NCT00238459|Treatment Interruption|treatment interruption
705847|NCT00238459|Structured Treatment Interruption|structured treatment interruption
705848|NCT00238459|STI|sti
705849|NCT00238446|Enteric-coated mycophenolate sodium, heart transplant recipients, long term safety|enteric-coated mycophenolate sodium, heart transplant recipients, long term safety
705850|NCT00238433|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
706426|NCT00236808|antibiotic|antibiotic
705851|NCT00238433|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
705852|NCT00238433|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
705853|NCT00238433|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
705854|NCT00238433|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
705855|NCT00238433|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
705856|NCT00238433|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
705857|NCT00238433|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
705858|NCT00238433|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
705859|NCT00238433|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
705860|NCT00238433|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
705861|NCT00238433|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
705862|NCT00238433|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
705863|NCT00238433|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
705864|NCT00238433|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
705865|NCT00238433|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
705866|NCT00238433|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
705867|NCT00238433|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
705868|NCT00238433|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
705869|NCT00238433|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
705870|NCT00238433|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
705871|NCT00238433|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
705872|NCT00238433|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
705873|NCT00238433|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
705874|NCT00238433|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
705875|NCT00238433|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
705876|NCT00238433|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
705877|NCT00238433|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
705878|NCT00238433|splenic marginal zone lymphoma|splenic marginal zone lymphoma
705879|NCT00238433|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
705880|NCT00238433|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
705881|NCT00238433|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
705882|NCT00238433|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
705883|NCT00238433|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
705884|NCT00238433|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
705885|NCT00238433|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
705886|NCT00238433|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
705887|NCT00238433|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
705888|NCT00238433|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
705889|NCT00238433|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
705890|NCT00238433|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
705891|NCT00238433|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
705892|NCT00238433|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
705893|NCT00238433|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
705894|NCT00238433|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
705895|NCT00238433|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
705896|NCT00238433|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
705897|NCT00238433|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
705898|NCT00238433|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
705899|NCT00238433|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
705900|NCT00238433|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
705901|NCT00238407|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
705902|NCT00238407|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
705903|NCT00238407|stage III esophageal cancer|stage iii esophageal cancer
705904|NCT00238407|stage IV esophageal cancer|stage iv esophageal cancer
705905|NCT00238381|adenocarcinoma of the rectum|adenocarcinoma of the rectum
705906|NCT00238381|stage 0 rectal cancer|stage 0 rectal cancer
705907|NCT00238381|stage I rectal cancer|stage i rectal cancer
705908|NCT00238381|stage II rectal cancer|stage ii rectal cancer
705909|NCT00238381|stage III rectal cancer|stage iii rectal cancer
705910|NCT00238381|stage IV rectal cancer|stage iv rectal cancer
705911|NCT00238381|recurrent rectal cancer|recurrent rectal cancer
705912|NCT00238368|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
705913|NCT00238368|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
705914|NCT00238368|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
705915|NCT00238368|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
705916|NCT00238368|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
705917|NCT00238368|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
705918|NCT00238368|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
705919|NCT00238368|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
705920|NCT00238368|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
705921|NCT00238368|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
705922|NCT00238368|anaplastic large cell lymphoma|anaplastic large cell lymphoma
705923|NCT00238368|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
705924|NCT00238368|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
705925|NCT00238368|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
705926|NCT00238368|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
705927|NCT00238355|infection|infection
705928|NCT00238355|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
705929|NCT00238342|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
705930|NCT00238342|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
705931|NCT00238342|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
705932|NCT00238342|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
705933|NCT00238342|fallopian tube cancer|fallopian tube cancer
705934|NCT00238342|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
705935|NCT00238342|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
705936|NCT00238342|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
705937|NCT00238342|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
705938|NCT00238342|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
705939|NCT00238329|recurrent melanoma|recurrent melanoma
705940|NCT00238329|stage IV melanoma|stage iv melanoma
705941|NCT00238329|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
705942|NCT00238329|extraocular extension melanoma|extraocular extension melanoma
705943|NCT00238329|iris melanoma|iris melanoma
705944|NCT00238329|recurrent intraocular melanoma|recurrent intraocular melanoma
705945|NCT00238316|breast cancer|breast cancer
705946|NCT00238290|recurrent breast cancer|recurrent breast cancer
705947|NCT00238290|stage IIIA breast cancer|stage iiia breast cancer
705948|NCT00238290|stage IIIB breast cancer|stage iiib breast cancer
705949|NCT00238290|stage IIIC breast cancer|stage iiic breast cancer
705950|NCT00238290|stage IV breast cancer|stage iv breast cancer
705951|NCT00238277|adult glioblastoma|adult glioblastoma
705952|NCT00238277|adult giant cell glioblastoma|adult giant cell glioblastoma
705953|NCT00238277|adult gliosarcoma|adult gliosarcoma
705954|NCT00238264|childhood oligodendroglioma|childhood oligodendroglioma
705955|NCT00238264|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
705956|NCT00238264|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
705957|NCT00238264|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
705958|NCT00238264|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
705959|NCT00238264|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
705960|NCT00238264|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
705961|NCT00238251|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
705962|NCT00238251|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
705963|NCT00238251|tumors metastatic to brain|tumors metastatic to brain
705964|NCT00238238|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
705965|NCT00238238|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
705966|NCT00238238|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
705967|NCT00238225|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
705968|NCT00238199|stage III pancreatic cancer|stage iii pancreatic cancer
705969|NCT00238199|stage IV pancreatic cancer|stage iv pancreatic cancer
705970|NCT00238173|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
705971|NCT00238173|bone marrow suppression|bone marrow suppression
705972|NCT00238173|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
705973|NCT00238173|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
705974|NCT00238173|untreated childhood brain stem glioma|untreated childhood brain stem glioma
705975|NCT00238173|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
705976|NCT00238173|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
705977|NCT00238173|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
705978|NCT00238173|recurrent childhood brain tumor|recurrent childhood brain tumor
705979|NCT00238173|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
705980|NCT00238173|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
705981|NCT00238173|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
705982|NCT00238173|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
705983|NCT00238173|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
705984|NCT00238173|childhood oligodendroglioma|childhood oligodendroglioma
705985|NCT00238173|childhood infratentorial ependymoma|childhood infratentorial ependymoma
705986|NCT00238173|childhood supratentorial ependymoma|childhood supratentorial ependymoma
705987|NCT00238173|recurrent childhood ependymoma|recurrent childhood ependymoma
705988|NCT00238173|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
705989|NCT00238173|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
705990|NCT00238173|childhood central nervous system germinoma|childhood central nervous system germinoma
705991|NCT00238173|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
705992|NCT00238173|childhood central nervous system teratoma|childhood central nervous system teratoma
705993|NCT00238173|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
705994|NCT00238173|recurrent childhood central nervous system embryonal tumor|recurrent childhood central nervous system embryonal tumor
705995|NCT00238147|stage II esophageal cancer|stage ii esophageal cancer
705996|NCT00238147|stage III esophageal cancer|stage iii esophageal cancer
705997|NCT00238108|Sleep disorders|sleep disorders
705998|NCT00238108|High blood pressure|high blood pressure
705999|NCT00238082|COPD|copd
706000|NCT00238082|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
706001|NCT00238082|Emphysema|emphysema
706002|NCT00238082|Chronic Bronchitis|chronic bronchitis
706003|NCT00238069|Asthma|asthma
706004|NCT00238069|Sleep Apnea|sleep apnea
706005|NCT00238069|Obesity|obesity
706006|NCT00238069|CPAP|cpap
706007|NCT00238056|Domperidone, QT, prematurity|domperidone, qt, prematurity
706008|NCT00238043|Biogeneric Epoetin treatment|biogeneric epoetin treatment
706009|NCT00238043|Renal anaemia|renal anaemia
706010|NCT00238043|Chronic Kidney Disease|chronic kidney disease
706011|NCT00238043|Pure Red Blood Cell Aplasia|pure red blood cell aplasia
706012|NCT00238043|Hemodialysis|hemodialysis
706013|NCT00238030|organ donation|organ donation
706014|NCT00238030|thyroid replacement|thyroid replacement
706015|NCT00238017|malaria, amodiaquine, artesunate, safety, efficacy|malaria, amodiaquine, artesunate, safety, efficacy
706016|NCT00238004|Niacin|niacin
706017|NCT00237965|Skin Self Examination|skin self examination
706018|NCT00237965|Mole Mapping Diagram|mole mapping diagram
706019|NCT00237965|Melanoma|melanoma
706020|NCT00237926|Sleep|sleep
706021|NCT00237926|Fatigue|fatigue
706022|NCT00237926|Exercise tolerance|exercise tolerance
706023|NCT00237926|Quality of life|quality of life
706024|NCT00237926|Health status|health status
706025|NCT00237887|Psoriasis|psoriasis
706026|NCT00237887|adalimumab|adalimumab
706027|NCT00237874|prodrome|prodrome
706028|NCT00237874|ultra high risk|ultra high risk
706029|NCT00237874|aripiprazole|aripiprazole
706030|NCT00237822|Treatment Adherence|treatment adherence
706031|NCT00237822|Co-Occurring Disorders|co-occurring disorders
706032|NCT00237822|Motivational Enhancement Therapy|motivational enhancement therapy
706033|NCT00237822|Contingency Management|contingency management
706034|NCT00237822|MEMS Caps|mems caps
706035|NCT00237796|Behavioral|behavioral
706036|NCT00237796|Cognitive|cognitive
706037|NCT00237796|Functioning|functioning
706038|NCT00237796|Older|older
706039|NCT00237796|CBT|cbt
706040|NCT00237796|Rehabilitation|rehabilitation
706041|NCT00237796|Schizophrenia|schizophrenia
706042|NCT00237796|Skills|skills
706043|NCT00237796|Social|social
706044|NCT00237796|Training|training
706045|NCT00237783|Renal dialysis|renal dialysis
706046|NCT00237783|Hypotension|hypotension
706047|NCT00237783|Dialysis solutions|dialysis solutions
706048|NCT00237770|Blood Pressure|blood pressure
706049|NCT00237770|Cardiovascular Autonomic Control|cardiovascular autonomic control
706050|NCT00237770|Nitric Oxide|nitric oxide
706051|NCT00237770|NOS Inhibitor|nos inhibitor
706052|NCT00237770|Orthostatic Hypotension|orthostatic hypotension
706053|NCT00237770|Spinal Cord Injury|spinal cord injury
706054|NCT00237770|Tetraplegia|tetraplegia
706055|NCT00237757|Patient Care Team|patient care team
706056|NCT00237757|Rehabilitation outcomes|rehabilitation outcomes
706057|NCT00237757|Treatment outcomes|treatment outcomes
706058|NCT00237744|Motor Learning|motor learning
706059|NCT00237744|Rehabilitation|rehabilitation
706060|NCT00237744|Robotics|robotics
706061|NCT00237744|Therapeutic Electric Stimulation|therapeutic electric stimulation
706062|NCT00237731|Acute pain|acute pain
706063|NCT00237731|Morphine titration|morphine titration
706064|NCT00237731|Analgesia|analgesia
706065|NCT00237731|Pre-hospital care|pre-hospital care
706066|NCT00237705|Headache|headache
706067|NCT00237705|Concussion|concussion
706068|NCT00237705|Post concussive syndrome|post concussive syndrome
706069|NCT00237705|Head trauma|head trauma
706070|NCT00237692|Telemedicine|telemedicine
706071|NCT00237692|Adherence|adherence
706072|NCT00237692|Tailored Nurse Intervention|tailored nurse intervention
706073|NCT00237692|Home Blood Pressure Monitoring|home blood pressure monitoring
706074|NCT00237692|cardiovascular disease|cardiovascular disease
706075|NCT00237679|behavior therapy|behavior therapy
706076|NCT00237679|combination therapy|combination therapy
706077|NCT00237679|gastrointestinal disorder chemotherapy|gastrointestinal disorder chemotherapy
706078|NCT00237679|human therapy evaluation|human therapy evaluation
706079|NCT00237679|larynx disorder|larynx disorder
706080|NCT00237679|middle childhood (6-11)|middle childhood (6-11)
706081|NCT00237679|lansoprazole|lansoprazole
706082|NCT00237679|reflux esophagitis|reflux esophagitis
706083|NCT00237679|quality of life|quality of life
706084|NCT00237679|clinical research|clinical research
706085|NCT00237679|human subject|human subject
706086|NCT00237679|laryngoscopy|laryngoscopy
706087|NCT00237679|patient oriented research|patient oriented research
706088|NCT00237679|questionnaire|questionnaire
706089|NCT00237666|Bipolar II Disorder|bipolar ii disorder
706090|NCT00237666|Major Depressive Episode|major depressive episode
706091|NCT00237653|Valganciclovir|valganciclovir
706092|NCT00237653|Cytomegalovirus|cytomegalovirus
706093|NCT00237653|Cryptogenic inflammatory bowel diseases|cryptogenic inflammatory bowel diseases
706094|NCT00237653|Crohn Disease|crohn disease
706095|NCT00237653|colitis, ulcerative|colitis, ulcerative
706096|NCT00237640|Cinnamon|cinnamon
706097|NCT00237640|Diabetes mellitus|diabetes mellitus
706098|NCT00237640|Hyperlipidemia|hyperlipidemia
706099|NCT00237640|Insulin Resistance|insulin resistance
706100|NCT00237627|stage IIIA breast cancer|stage iiia breast cancer
706101|NCT00237627|stage IIIB breast cancer|stage iiib breast cancer
706102|NCT00237627|stage IIIC breast cancer|stage iiic breast cancer
706103|NCT00237627|stage IV breast cancer|stage iv breast cancer
706104|NCT00237627|male breast cancer|male breast cancer
706105|NCT00237627|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
706106|NCT00237627|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
706107|NCT00237627|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
706108|NCT00237627|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
706109|NCT00237627|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
706110|NCT00237627|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
706111|NCT00237627|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
706112|NCT00237627|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
706113|NCT00237627|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
706114|NCT00237627|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
706115|NCT00237627|secondary acute myeloid leukemia|secondary acute myeloid leukemia
706116|NCT00237627|mast cell leukemia|mast cell leukemia
706117|NCT00237627|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
706118|NCT00237627|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
706119|NCT00237627|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
706120|NCT00237627|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
706121|NCT00237627|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
706122|NCT00237627|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
706123|NCT00237627|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
706124|NCT00237627|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
706125|NCT00237627|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
706126|NCT00237627|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
706127|NCT00237627|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
706128|NCT00237627|refractory hairy cell leukemia|refractory hairy cell leukemia
706129|NCT00237627|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
706130|NCT00237627|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
706131|NCT00237627|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
706132|NCT00237627|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
706133|NCT00237627|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
706134|NCT00237627|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
706135|NCT00237627|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
706136|NCT00237627|anaplastic large cell lymphoma|anaplastic large cell lymphoma
706137|NCT00237627|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
706138|NCT00237627|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
706139|NCT00237627|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
706140|NCT00237627|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
706141|NCT00237627|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
706142|NCT00237627|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
706143|NCT00237627|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
706144|NCT00237627|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
706145|NCT00237627|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
706146|NCT00237627|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
706147|NCT00237627|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
706148|NCT00237627|splenic marginal zone lymphoma|splenic marginal zone lymphoma
706149|NCT00237627|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
706150|NCT00237627|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
706151|NCT00237627|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
706152|NCT00237627|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
706153|NCT00237627|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
706154|NCT00237627|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
706155|NCT00237627|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
706156|NCT00237627|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
706157|NCT00237627|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
706158|NCT00237627|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
706159|NCT00237627|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
706160|NCT00237627|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
706161|NCT00237627|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
706162|NCT00237627|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
706163|NCT00237627|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
706164|NCT00237627|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
706165|NCT00237627|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
706166|NCT00237627|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
706167|NCT00237627|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
706168|NCT00237627|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
706169|NCT00237627|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
706170|NCT00237627|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
706171|NCT00237627|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
706172|NCT00237627|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
706173|NCT00237627|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
706174|NCT00237627|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
706175|NCT00237627|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
706176|NCT00237627|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
706177|NCT00237627|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
706178|NCT00237627|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
706179|NCT00237627|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
706180|NCT00237627|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
706181|NCT00237627|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
706182|NCT00237627|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
706183|NCT00237627|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
706184|NCT00237627|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
706185|NCT00237627|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
706186|NCT00237627|intraocular lymphoma|intraocular lymphoma
706187|NCT00237627|primary central nervous system lymphoma|primary central nervous system lymphoma
706188|NCT00237627|stage III multiple myeloma|stage iii multiple myeloma
706189|NCT00237627|stage II multiple myeloma|stage ii multiple myeloma
706190|NCT00237627|refractory multiple myeloma|refractory multiple myeloma
706191|NCT00237627|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
706192|NCT00237627|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
706193|NCT00237627|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
706194|NCT00237627|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
706195|NCT00237627|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
706196|NCT00237627|recurrent breast cancer|recurrent breast cancer
706197|NCT00237627|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
706198|NCT00237614|Contrast-induced nephropathy|contrast-induced nephropathy
706199|NCT00237614|Acute myocardial infarction|acute myocardial infarction
706200|NCT00237614|Primary coronary angioplasty|primary coronary angioplasty
706201|NCT00237601|Home birth|home birth
706202|NCT00237601|Hospital birth|hospital birth
706203|NCT00237601|Midwifery|midwifery
706204|NCT00237601|Effectivity|effectivity
706205|NCT00237601|Efficiency|efficiency
706206|NCT00237588|Angiotensin II Type I Receptor Blockers|angiotensin ii type i receptor blockers
706207|NCT00237588|Amlodipine|amlodipine
706208|NCT00237588|Calcium Channel Blockers|calcium channel blockers
706209|NCT00237588|Diabetes Mellitus|diabetes mellitus
706210|NCT00237588|Hypertension|hypertension
706211|NCT00237588|Insulin Resistance|insulin resistance
706212|NCT00237588|Losartan|losartan
706213|NCT00237575|urothelial|urothelial
706214|NCT00237575|bladder|bladder
706215|NCT00237575|gemcitabine|gemcitabine
706216|NCT00237575|cisplatin|cisplatin
706217|NCT00237575|leukine|leukine
706218|NCT00237575|neupogen|neupogen
706219|NCT00237575|filgrastim|filgrastim
706220|NCT00237575|sargramostim|sargramostim
706221|NCT00237575|metastatic|metastatic
706222|NCT00237575|Regionally Advanced|regionally advanced
706223|NCT00237575|Advanced|advanced
706224|NCT00237549|Type 2 diabetes|type 2 diabetes
706226|NCT00237549|Intensive treatment|intensive treatment
706227|NCT00237549|Polypharmacy|polypharmacy
706228|NCT00237549|Primary care|primary care
706229|NCT00237536|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
706230|NCT00237536|BPH|bph
706231|NCT00237536|Enlarged Prostate|enlarged prostate
706232|NCT00237523|Breast pain|breast pain
706233|NCT00237523|Mastalgia|mastalgia
706234|NCT00237523|Cyclic mastalgia|cyclic mastalgia
706235|NCT00237523|Periodic mastalgia|periodic mastalgia
706236|NCT00237523|Non-cyclic mastalgia|non-cyclic mastalgia
706237|NCT00237523|Fibrosis|fibrosis
706238|NCT00237523|Nodularity|nodularity
706239|NCT00237523|Cysts|cysts
706240|NCT00237523|Fibrocystic breast disease|fibrocystic breast disease
706241|NCT00237523|Fibrocystic breast condition|fibrocystic breast condition
706242|NCT00237523|Fibocystic breast syndrome|fibocystic breast syndrome
706243|NCT00237510|Antidepressant induced excessive sweating|antidepressant induced excessive sweating
706244|NCT00237497|Insomnia|insomnia
706245|NCT00237497|Center of Pressure|center of pressure
706246|NCT00237497|Postural Sway|postural sway
706247|NCT00237497|Drug Therapy|drug therapy
706248|NCT00237497|Balance and Stability|balance and stability
706249|NCT00237484|pegylated interferon alfa-2b|pegylated interferon alfa-2b
706250|NCT00237484|ribavirin|ribavirin
706251|NCT00237484|infliximab|infliximab
706252|NCT00237484|chronic hepatitis C|chronic hepatitis c
706253|NCT00237471|Acute Myocardial Infarction|acute myocardial infarction
706254|NCT00237471|Hyperglycaemia|hyperglycaemia
706255|NCT00237471|Insulin Infusion|insulin infusion
706256|NCT00237419|Ankylosing spondylitis|ankylosing spondylitis
706257|NCT00237419|Long-term therapy with infliximab|long-term therapy with infliximab
706258|NCT00237419|Radiographic progression|radiographic progression
706259|NCT00237406|IVR, methadone|ivr, methadone
706260|NCT00237406|methadone maintenance|methadone maintenance
706261|NCT00237393|PTSD|ptsd
706262|NCT00237393|Posttraumatic stress disorder|posttraumatic stress disorder
706263|NCT00237393|Treatment|treatment
706264|NCT00237393|Quetiapine|quetiapine
706265|NCT00237380|Cystic fibrosis|cystic fibrosis
706266|NCT00237380|Nonsense mutation|nonsense mutation
706267|NCT00237380|Premature stop codon|premature stop codon
706268|NCT00237367|Gastroesophageal Reflux|gastroesophageal reflux
706269|NCT00237367|GERD|gerd
706270|NCT00237367|Nighttime heartburn|nighttime heartburn
706271|NCT00237367|heartburn|heartburn
706272|NCT00237367|esophagus|esophagus
706273|NCT00237367|esophageal acid exposure|esophageal acid exposure
706274|NCT00237367|EAE|eae
706275|NCT00237367|Aciphex|aciphex
706276|NCT00237367|Pariet|pariet
706277|NCT00237367|rabeprazole|rabeprazole
706278|NCT00237367|Protonix|protonix
706279|NCT00237367|pantoprazole|pantoprazole
706280|NCT00237354|Recurrent soft tissue breast carcinoma|recurrent soft tissue breast carcinoma
706281|NCT00237341|chronic low back pain|chronic low back pain
706282|NCT00237341|opioid|opioid
706283|NCT00237341|fentanyl|fentanyl
706284|NCT00237328|Heparin resistance|heparin resistance
706285|NCT00237328|Blood clotting|blood clotting
706286|NCT00237328|Heart surgery|heart surgery
706287|NCT00237328|Cardiopulmonary bypass|cardiopulmonary bypass
706288|NCT00237315|Urea|urea
706289|NCT00237315|Inherited metabolic disorders|inherited metabolic disorders
706290|NCT00237302|pediatric migraine|pediatric migraine
706291|NCT00237302|migraine headache|migraine headache
706292|NCT00237302|migraine prophylaxis|migraine prophylaxis
706293|NCT00237302|migraine prevention|migraine prevention
706294|NCT00237302|migraine|migraine
706295|NCT00237289|Manic depression|manic depression
706296|NCT00237289|Mania|mania
706297|NCT00237289|Depression|depression
706298|NCT00237289|Bipolar disorder|bipolar disorder
706299|NCT00237289|Psychosis|psychosis
706300|NCT00237276|colonoscopy, chromoendoscopy, autoflurescence, narrow band imaging, high definition endoscopy, colorectal cancer, colitis, polyp, DALM, adenoma, video|colonoscopy, chromoendoscopy, autoflurescence, narrow band imaging, high definition endoscopy, colorectal cancer, colitis, polyp, dalm, adenoma, video
706301|NCT00237263|Parkinson's disease, end-of -dose wearing-off, entacapone|parkinson's disease, end-of -dose wearing-off, entacapone
706302|NCT00237250|Pre-diabetes|pre-diabetes
706303|NCT00237250|vildagliptin|vildagliptin
706304|NCT00237250|IGT|igt
706305|NCT00237237|Type 2 diabetes|type 2 diabetes
706306|NCT00237237|vildagliptin|vildagliptin
706307|NCT00237224|Breast Cancer, ER and/or PgR positive, Letrozole|breast cancer, er and/or pgr positive, letrozole
706308|NCT00237211|Aromatase inhibitor|aromatase inhibitor
706309|NCT00237211|letrozole|letrozole
706310|NCT00237211|breast cancer|breast cancer
706311|NCT00237198|Aromatase inhibitor|aromatase inhibitor
706312|NCT00237198|letrozole|letrozole
706313|NCT00237198|breast cancer|breast cancer
706314|NCT00237185|GIST|gist
706315|NCT00237185|c-kit|c-kit
706316|NCT00237185|imatinib mesylate|imatinib mesylate
706317|NCT00237172|GIST|gist
706318|NCT00237172|Imatinib|imatinib
706319|NCT00237172|STI571|sti571
706320|NCT00237172|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
706321|NCT00237159|Prostate cancer|prostate cancer
706322|NCT00237159|Bone metastasis|bone metastasis
706323|NCT00237159|Skeletal related event|skeletal related event
706324|NCT00237146|Prostate cancer|prostate cancer
706325|NCT00237146|Zoledronic acid|zoledronic acid
706326|NCT00237146|Bone metastasis|bone metastasis
706327|NCT00237133|Breast cancer,|breast cancer,
706328|NCT00237133|Letrozole,|letrozole,
706329|NCT00237133|Hormonal receptors|hormonal receptors
706330|NCT00237120|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
706331|NCT00237120|Imatinib|imatinib
706332|NCT00237120|CML|cml
706333|NCT00237107|Cytoreduction Surgical Procedures|cytoreduction surgical procedures
706334|NCT00237107|Curretage|curretage
706335|NCT00237107|Photochemotherapy|photochemotherapy
706336|NCT00237094|Diabetes|diabetes
706337|NCT00237094|Self Management|self management
706338|NCT00237094|Interdisciplinary team|interdisciplinary team
706339|NCT00237081|Interstitial Cystitis|interstitial cystitis
706340|NCT00237081|Painful Bladder Syndrome|painful bladder syndrome
706341|NCT00237081|Genetics|genetics
706342|NCT00237081|Risk factors|risk factors
706343|NCT00237081|Family history|family history
706344|NCT00237068|Gastroesophageal Reflux|gastroesophageal reflux
706345|NCT00237055|Children|children
706346|NCT00237055|Crohn's disease|crohn's disease
706347|NCT00237055|Inflammatory bowel disease|inflammatory bowel disease
706348|NCT00237055|Infectious agents|infectious agents
706349|NCT00237055|Colonoscopy|colonoscopy
706350|NCT00237042|Temporomandibular Disorders|temporomandibular disorders
706351|NCT00237042|TMJ Disorders|tmj disorders
706352|NCT00237003|women|women
706353|NCT00237003|incarceration|incarceration
706354|NCT00237003|alcohol use|alcohol use
706355|NCT00237003|motivational interviewing|motivational interviewing
706356|NCT00236990|prostatitis|prostatitis
706357|NCT00236990|Elmiron|elmiron
706358|NCT00236990|pentosan polysulfate sodium|pentosan polysulfate sodium
706359|NCT00236977|CKD|ckd
706360|NCT00236977|iron|iron
706361|NCT00236977|anemia|anemia
706362|NCT00236964|Anemia|anemia
706363|NCT00236964|Chronic Kidney Disease|chronic kidney disease
706364|NCT00236951|Anemia|anemia
706365|NCT00236951|Cancer|cancer
706366|NCT00236951|Chemotherapy|chemotherapy
706367|NCT00236938|iron|iron
706368|NCT00236938|peritoneal dialysis|peritoneal dialysis
706369|NCT00236938|anemia|anemia
706370|NCT00236925|Fibromyalgia|fibromyalgia
706371|NCT00236925|Cortisol|cortisol
706372|NCT00236925|Hydrocortisone|hydrocortisone
706373|NCT00236925|Stress|stress
706374|NCT00236912|complicated appendicitis|complicated appendicitis
706375|NCT00236912|antibiotics|antibiotics
706376|NCT00236912|appendicitis|appendicitis
706377|NCT00236912|infection|infection
706378|NCT00236886|Epilepsy|epilepsy
706379|NCT00236886|Partial Epilepsy|partial epilepsy
706380|NCT00236886|Secondary Generalized Epilepsy|secondary generalized epilepsy
706381|NCT00236886|Primary Generalized Epilepsy|primary generalized epilepsy
706382|NCT00236886|Tonic-Clonic Seizures|tonic-clonic seizures
706383|NCT00236886|Topiramate|topiramate
706384|NCT00236886|Weight Loss|weight loss
706385|NCT00236873|topiramate|topiramate
706386|NCT00236873|epilepsy|epilepsy
706387|NCT00236873|partial epilepsies|partial epilepsies
706388|NCT00236873|partial epilepsy|partial epilepsy
706389|NCT00236873|seizures|seizures
706390|NCT00236873|epileptic seizures|epileptic seizures
706391|NCT00236873|partial seizure disorder|partial seizure disorder
706392|NCT00236873|brain diseases|brain diseases
706393|NCT00236860|partial seizure disorder|partial seizure disorder
706394|NCT00236860|brain diseases|brain diseases
706395|NCT00236860|topiramate|topiramate
706396|NCT00236860|epilepsy|epilepsy
706397|NCT00236860|partial epilepsies|partial epilepsies
706398|NCT00236860|partial epilepsy|partial epilepsy
706399|NCT00236860|seizures|seizures
706400|NCT00236860|epileptic seizures|epileptic seizures
706401|NCT00236847|topiramate|topiramate
706402|NCT00236847|epilepsy|epilepsy
706403|NCT00236847|partial epilepsy|partial epilepsy
706404|NCT00236847|seizures|seizures
706405|NCT00236847|epileptic seizures|epileptic seizures
706406|NCT00236847|partial seizure disorder|partial seizure disorder
706407|NCT00236847|brain diseases|brain diseases
706408|NCT00236834|respiratory tract diseases|respiratory tract diseases
706409|NCT00236834|levofloxacin|levofloxacin
706410|NCT00236834|pneumonia|pneumonia
706411|NCT00236834|quinolones, hospital-acquired pneumonia|quinolones, hospital-acquired pneumonia
706412|NCT00236834|lung diseases|lung diseases
706413|NCT00236821|respiratory tract diseases|respiratory tract diseases
706414|NCT00236821|pneumonia|pneumonia
706415|NCT00236821|levofloxacin|levofloxacin
706416|NCT00236821|community-acquired pneumonia|community-acquired pneumonia
706417|NCT00236821|lung diseases|lung diseases
706418|NCT00236821|quinolones|quinolones
706419|NCT00236808|quinolones, ciprofloxacin|quinolones, ciprofloxacin
706420|NCT00236808|levofloxacin|levofloxacin
706421|NCT00236808|chronic bacterial prostatitis|chronic bacterial prostatitis
706422|NCT00236808|inflammation|inflammation
706423|NCT00236808|chronic prostatitis|chronic prostatitis
706424|NCT00236808|prostatitis|prostatitis
706425|NCT00236808|prostate|prostate
706427|NCT00236795|contraception|contraception
706428|NCT00236795|hormonal contraception|hormonal contraception
706429|NCT00236795|oral contraception|oral contraception
706430|NCT00236795|steroid, ethinyl estradiol, horgestimate, levonorgestrel contraception|steroid, ethinyl estradiol, horgestimate, levonorgestrel contraception
706431|NCT00236795|transdermal.|transdermal.
706432|NCT00236782|contraception|contraception
706433|NCT00236782|hormonal contraception|hormonal contraception
706434|NCT00236782|oral contraception|oral contraception
706435|NCT00236782|steroid, ethinyl estradiol, progestin contraception|steroid, ethinyl estradiol, progestin contraception
706436|NCT00236782|transdermal.|transdermal.
706437|NCT00236769|contraception|contraception
706438|NCT00236769|transdermal contraception|transdermal contraception
706439|NCT00236769|hormonal, steroidal contraception|hormonal, steroidal contraception
706440|NCT00236769|ethinyl estradiol|ethinyl estradiol
706441|NCT00236769|progesterone|progesterone
706442|NCT00236756|Epilepsy|epilepsy
706443|NCT00236756|Seizures|seizures
706444|NCT00236756|Topiramate|topiramate
706445|NCT00236756|Prophylaxis|prophylaxis
706446|NCT00236756|Antiepileptic|antiepileptic
706447|NCT00236756|Lennox-Gastaut syndrome|lennox-gastaut syndrome
706448|NCT00236756|Seizures, tonic|seizures, tonic
706449|NCT00236743|topiramate|topiramate
706450|NCT00236743|epilepsy|epilepsy
706451|NCT00236743|partial epilepsies|partial epilepsies
706452|NCT00236743|partial epilepsy|partial epilepsy
706453|NCT00236743|seizures|seizures
706454|NCT00236743|epileptic seizures|epileptic seizures
706455|NCT00236743|partial seizure disorder|partial seizure disorder
706456|NCT00236743|children|children
706457|NCT00236743|pediatric|pediatric
706458|NCT00236730|topiramate|topiramate
706459|NCT00236730|epilepsy|epilepsy
706460|NCT00236730|partial epilepsies|partial epilepsies
706461|NCT00236730|partial epilepsy|partial epilepsy
706462|NCT00236730|seizures|seizures
706463|NCT00236730|epileptic seizures|epileptic seizures
706464|NCT00236730|partial seizure disorder|partial seizure disorder
706465|NCT00236730|brain diseases|brain diseases
706466|NCT00236717|Epilepsy|epilepsy
706467|NCT00236717|Seizures|seizures
706468|NCT00236717|Topiramate|topiramate
706469|NCT00236717|Prophylaxis|prophylaxis
706470|NCT00236717|Antiepileptic|antiepileptic
706471|NCT00236704|Epilepsy|epilepsy
706472|NCT00236704|Seizures|seizures
706473|NCT00236704|Topiramate|topiramate
706474|NCT00236704|Prophylaxis|prophylaxis
706475|NCT00236704|Antiepileptic|antiepileptic
706476|NCT00236704|Tonic-clonic seizures|tonic-clonic seizures
706477|NCT00236704|Grand mal seizures|grand mal seizures
706478|NCT00236691|topiramate|topiramate
706479|NCT00236691|epilepsy|epilepsy
706480|NCT00236691|partial epilepsies|partial epilepsies
706481|NCT00236691|partial epilepsy|partial epilepsy
706482|NCT00236691|seizures|seizures
706483|NCT00236691|epileptic seizures|epileptic seizures
706484|NCT00236691|partial seizure disorder|partial seizure disorder
706485|NCT00236691|brain diseases|brain diseases
706486|NCT00236678|Anemia|anemia
706487|NCT00236678|Rheumatoid arthritis|rheumatoid arthritis
706488|NCT00236678|Hemoglobin level|hemoglobin level
706489|NCT00236665|Obesity|obesity
706490|NCT00236665|Essential Hypertension|essential hypertension
706491|NCT00236665|Mild Hypertension|mild hypertension
706492|NCT00236665|Moderate Hypertension|moderate hypertension
706493|NCT00236665|High Blood Pressure|high blood pressure
706494|NCT00236652|Maxillary Sinusitis|maxillary sinusitis
706495|NCT00236652|Infection|infection
706496|NCT00236639|Obesity|obesity
706497|NCT00236639|Hypertension|hypertension
706498|NCT00236639|Hyperlipidemia|hyperlipidemia
706499|NCT00236639|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
706500|NCT00236639|Body Mass Index|body mass index
706501|NCT00236626|Type 2 Diabetes|type 2 diabetes
706502|NCT00236626|Obesity|obesity
706503|NCT00236626|Insulin Resistance|insulin resistance
706504|NCT00236626|Body Mass Index|body mass index
706505|NCT00236626|Hypertension|hypertension
706506|NCT00236626|Hyperlipidemia|hyperlipidemia
706507|NCT00236626|Sulfonylurea|sulfonylurea
706508|NCT00236626|Topiramate|topiramate
706509|NCT00236626|Adult-Onset Diabetes Mellitus|adult-onset diabetes mellitus
706510|NCT00236626|Metabolic Syndrome|metabolic syndrome
706511|NCT00236613|Obesity|obesity
706512|NCT00236613|Hypertension|hypertension
706513|NCT00236613|Hyperlipidemia|hyperlipidemia
706514|NCT00236613|Body Mass Index|body mass index
706515|NCT00236600|Obesity|obesity
706516|NCT00236600|Hypertension|hypertension
706517|NCT00236600|Hyperlipidemia|hyperlipidemia
706518|NCT00236600|Type 2 Diabetes|type 2 diabetes
706519|NCT00236600|Life style modification|life style modification
706520|NCT00236587|Schizophrenia|schizophrenia
706521|NCT00236587|Intramuscular injection|intramuscular injection
706522|NCT00236587|Antipsychotic agents|antipsychotic agents
706523|NCT00236587|Long-acting risperidone|long-acting risperidone
706524|NCT00236574|Dementia|dementia
706525|NCT00236574|Alzheimer disease|alzheimer disease
706526|NCT00236574|Mild cognitive impairment|mild cognitive impairment
706527|NCT00236574|Galantamine hydrobromide|galantamine hydrobromide
706528|NCT00236574|Memory disorder|memory disorder
706529|NCT00236561|Migraine|migraine
706530|NCT00236561|Common Migraine|common migraine
706531|NCT00236561|Classic Migraine|classic migraine
706532|NCT00236561|Headache|headache
706533|NCT00236561|Topiramate|topiramate
706534|NCT00236561|Propranolol|propranolol
706535|NCT00236561|Prophylaxis|prophylaxis
706536|NCT00236561|Prevention|prevention
706537|NCT00236548|Schizophrenia|schizophrenia
706538|NCT00236548|schizoaffective disorder|schizoaffective disorder
706539|NCT00236548|patient compliance|patient compliance
706540|NCT00236548|long-acting risperidone|long-acting risperidone
706541|NCT00236548|intramuscular injection|intramuscular injection
706542|NCT00236548|Treatment Guidebook|treatment guidebook
706543|NCT00236535|musculoskeletal|musculoskeletal
706544|NCT00236535|Pain|pain
706545|NCT00236535|sprained ankle|sprained ankle
706546|NCT00236535|ligament|ligament
706547|NCT00236535|sprain|sprain
706548|NCT00236535|ankle|ankle
706549|NCT00236522|sinus infection|sinus infection
706550|NCT00236522|acute bacterial sinusitis|acute bacterial sinusitis
706551|NCT00236522|sinusitis|sinusitis
706552|NCT00236522|bacterial sinus infection|bacterial sinus infection
706553|NCT00236509|Migraine|migraine
706554|NCT00236509|Common Migraine|common migraine
706555|NCT00236509|Classic Migraine|classic migraine
706556|NCT00236509|Headache|headache
706557|NCT00236509|Topiramate|topiramate
706558|NCT00236509|Prophylaxis|prophylaxis
706559|NCT00236496|tremor|tremor
706560|NCT00236496|essential tremor|essential tremor
706561|NCT00236483|Oral Surgery|oral surgery
706562|NCT00236483|Analgesics|analgesics
706563|NCT00236483|Postoperative Pain|postoperative pain
706564|NCT00236483|dental|dental
706565|NCT00236470|Disruptive behavior disorder|disruptive behavior disorder
706566|NCT00236470|risperidone|risperidone
706567|NCT00236470|antipsychotropic agents|antipsychotropic agents
706568|NCT00236470|child|child
706569|NCT00236470|adolescent|adolescent
706570|NCT00236457|Schizophrenia|schizophrenia
706571|NCT00236457|Intramuscular injection|intramuscular injection
706572|NCT00236457|Antipsychotic agents|antipsychotic agents
706573|NCT00236457|Long-acting risperidone|long-acting risperidone
706574|NCT00236457|Olanzapine|olanzapine
706575|NCT00236444|Child|child
706576|NCT00236444|adolescent|adolescent
706577|NCT00236444|disruptive behavior disorders|disruptive behavior disorders
706578|NCT00236444|risperidone|risperidone
706579|NCT00236444|antipsychotropic agents|antipsychotropic agents
706580|NCT00236431|Mild cognitive impairment|mild cognitive impairment
706581|NCT00236431|Galantamine hydrobromide|galantamine hydrobromide
706582|NCT00236431|Memory disorders|memory disorders
706583|NCT00236418|Epilepsy|epilepsy
706584|NCT00236418|Seizures|seizures
706585|NCT00236418|Topiramate|topiramate
706586|NCT00236418|Prophylaxis|prophylaxis
706587|NCT00236418|Antiepileptic|antiepileptic
706588|NCT00236418|Tonic-clonic seizures|tonic-clonic seizures
706589|NCT00236418|Grand mal seizures|grand mal seizures
706590|NCT00236405|Anemia|anemia
706591|NCT00236405|erythropoetin|erythropoetin
706592|NCT00236405|quality-of-life outcomes|quality-of-life outcomes
706593|NCT00236392|Gastroesophageal reflux|gastroesophageal reflux
706594|NCT00236392|Heartburn|heartburn
706595|NCT00236392|Rabeprazole|rabeprazole
706596|NCT00236392|Anti-ulcer agents|anti-ulcer agents
706597|NCT00236392|GERD|gerd
706598|NCT00236392|Proton pump inhibitor|proton pump inhibitor
706599|NCT00236392|GORD|gord
706600|NCT00236392|Non-Erosive Reflux Disease|non-erosive reflux disease
706601|NCT00236392|NERD|nerd
706602|NCT00236379|schizophrenia|schizophrenia
706603|NCT00236379|blood glucose|blood glucose
706604|NCT00236379|glucose metabolism|glucose metabolism
706605|NCT00236379|diabetes mellitus|diabetes mellitus
706606|NCT00236379|risperidone|risperidone
706607|NCT00236379|olanzapine|olanzapine
706608|NCT00236366|Fentanyl|fentanyl
706609|NCT00236366|opioid analgesics|opioid analgesics
706610|NCT00236366|osteoarthritis|osteoarthritis
706611|NCT00236366|arthritis|arthritis
706612|NCT00236366|transdermal administration|transdermal administration
706613|NCT00236353|schizophrenia|schizophrenia
706614|NCT00236353|schizoaffective disorder|schizoaffective disorder
706615|NCT00236353|long-acting risperidone|long-acting risperidone
706616|NCT00236353|intramuscular injection|intramuscular injection
706617|NCT00236340|Amniodrainage|amniodrainage
706618|NCT00236340|Pregnancy|pregnancy
706619|NCT00236340|Amniocentesis|amniocentesis
706620|NCT00236327|Fentanyl|fentanyl
706621|NCT00236327|Analgesia|analgesia
706622|NCT00236327|Pain|pain
706623|NCT00236327|Cancer pain|cancer pain
706624|NCT00236327|Opioid analgesia|opioid analgesia
706625|NCT00236327|Transdermal fentanyl|transdermal fentanyl
706626|NCT00236327|Patient-controlled analgesia|patient-controlled analgesia
706627|NCT00236301|Hormone|hormone
706628|NCT00236301|Menopause|menopause
706629|NCT00236301|Inflammation|inflammation
706630|NCT00236301|Dose effects|dose effects
706631|NCT00236301|Apoptosis|apoptosis
706632|NCT00236288|Cancer treatment and tobacco abuse|cancer treatment and tobacco abuse
706633|NCT00236275|Comparison of imaging modalities|comparison of imaging modalities
706634|NCT00236275|predict the effectiveness of neoadjuvant chemotherapy|predict the effectiveness of neoadjuvant chemotherapy
706635|NCT00236262|SDRA|sdra
706636|NCT00236262|Distress|distress
706637|NCT00236262|Expiratory|expiratory
706638|NCT00236262|Pressure|pressure
706639|NCT00236262|Ventilatory|ventilatory
706640|NCT00236249|Double blind method|double blind method
706641|NCT00236249|Prospective study|prospective study
706642|NCT00236249|Lidocaine/administration and dosage/therapeutic use|lidocaine/administration and dosage/therapeutic use
706643|NCT00236249|Anaesthetics local/administration and dosage|anaesthetics local/administration and dosage
706644|NCT00236249|Opioids/administration and dosage|opioids/administration and dosage
706645|NCT00236249|Pain, postoperative|pain, postoperative
706646|NCT00236249|Perioperative care|perioperative care
706647|NCT00236249|Postoperative care|postoperative care
706648|NCT00236249|Analgesia, Patient-controlled|analgesia, patient-controlled
706649|NCT00236249|Length of stay|length of stay
706650|NCT00236249|Survival analysis|survival analysis
706651|NCT00236249|Patient satisfaction|patient satisfaction
706652|NCT00236249|Surgery|surgery
706653|NCT00236249|Middle age|middle age
706654|NCT00236249|Adult|adult
706655|NCT00236249|Aged|aged
706656|NCT00236223|Primary hip replacement|primary hip replacement
706657|NCT00236223|Gabapentin|gabapentin
706658|NCT00236223|Dexamethasone|dexamethasone
706659|NCT00236223|Ketamine|ketamine
706660|NCT00236223|Multimodal postoperative analgesia.|multimodal postoperative analgesia.
706661|NCT00236210|Vascular Intervention Program|vascular intervention program
706662|NCT00236210|Vascular Disease|vascular disease
706663|NCT00236210|Coronary Artery Disease|coronary artery disease
706664|NCT00236210|Diabetes|diabetes
706665|NCT00236210|Lifestyle Modification|lifestyle modification
706666|NCT00236210|Modifiable Risk Factors|modifiable risk factors
706667|NCT00236197|Heartburn|heartburn
706668|NCT00236197|Rabeprazole|rabeprazole
706669|NCT00236171|topical therapy|topical therapy
706670|NCT00236171|Psoriasis Plaque Test|psoriasis plaque test
706671|NCT00236145|BTP|btp
706672|NCT00236145|Break through pain|break through pain
706673|NCT00236145|breakthrough pain|breakthrough pain
706674|NCT00236093|Sickle Cell|sickle cell
706675|NCT00236041|Breakthrough Pain|breakthrough pain
706677|NCT00236041|Sickle Cell|sickle cell
706678|NCT00236041|Severe Burns|severe burns
706679|NCT00236041|Children|children
706680|NCT00236041|Adolescents|adolescents
706681|NCT00236041|Analgesia|analgesia
706682|NCT00236041|Sickle Cell Disease|sickle cell disease
706683|NCT00236041|Non-Cancer|non-cancer
706684|NCT00236028|Early Rheumatoid Arthritis|early rheumatoid arthritis
706685|NCT00235989|Relapsing multiple sclerosis|relapsing multiple sclerosis
706686|NCT00235989|interferon beta 1b|interferon beta 1b
706687|NCT00235989|Betaferon|betaferon
706688|NCT00235989|Betaseron|betaseron
706689|NCT00235976|Neuromuscular Blocking Agent|neuromuscular blocking agent
706690|NCT00235976|Anesthesia|anesthesia
706691|NCT00235976|Succinylcholine|succinylcholine
706692|NCT00235976|Tracheal Intubation|tracheal intubation
706693|NCT00235976|Adjunct for tracheal intubation|adjunct for tracheal intubation
706694|NCT00235950|Coronary Heart Disease|coronary heart disease
706695|NCT00235950|Percutaeous Coronary Intervention (PCI)|percutaeous coronary intervention (pci)
706696|NCT00235937|Premenopausal|premenopausal
706697|NCT00235937|Advanced Breast Cancer|advanced breast cancer
706698|NCT00235937|Metastatic Breast Cancer|metastatic breast cancer
706699|NCT00235924|menopause|menopause
706700|NCT00235924|isoflavone|isoflavone
706701|NCT00235924|endometrial safety|endometrial safety
706702|NCT00235924|breast innocuity assessment|breast innocuity assessment
706703|NCT00235924|hot flushes|hot flushes
706704|NCT00235885|Psoriatic Arthritis|psoriatic arthritis
706705|NCT00235885|adalimumab|adalimumab
706706|NCT00235872|Rheumatoid arthritis|rheumatoid arthritis
706707|NCT00235859|Rheumatoid Arthritis|rheumatoid arthritis
706708|NCT00235859|adalimumab|adalimumab
706709|NCT00235846|Endoscopic vein harvesting|endoscopic vein harvesting
706710|NCT00235846|Saphenous vein|saphenous vein
706711|NCT00235833|Rheumatoid Arthritis|rheumatoid arthritis
706712|NCT00235820|Psoriasis|psoriasis
706713|NCT00235820|adalimumab|adalimumab
706714|NCT00235807|Audiology|audiology
706715|NCT00235807|Rehabilitation|rehabilitation
706716|NCT00235807|Tinnitus|tinnitus
706717|NCT00235781|Kidney Transplantation|kidney transplantation
706718|NCT00235781|Antilymphocyte Serum|antilymphocyte serum
706719|NCT00235781|Induction|induction
706720|NCT00235781|Graft Rejection|graft rejection
706721|NCT00235768|Ecstasy|ecstasy
706722|NCT00235768|MDMA|mdma
706723|NCT00235768|Cognition|cognition
706724|NCT00235768|Brain function|brain function
706725|NCT00235768|Neuroimaging|neuroimaging
706726|NCT00235755|Partial Seizures|partial seizures
706727|NCT00235755|Complex Partial Seizures|complex partial seizures
706728|NCT00235755|Epilepsy|epilepsy
706729|NCT00235755|Potassium Channels|potassium channels
706730|NCT00235755|Anticonvulsant|anticonvulsant
706731|NCT00235729|Opiate addiction|opiate addiction
707034|NCT00234182|hepatectomy|hepatectomy
706732|NCT00235729|Opiate dependence|opiate dependence
706733|NCT00235729|Withdrawal symptoms|withdrawal symptoms
706734|NCT00235716|Alzheimer's Disease|alzheimer's disease
706735|NCT00235716|clinical trial|clinical trial
706736|NCT00235716|randomized controlled trial|randomized controlled trial
706737|NCT00235716|alpha-tocopherol|alpha-tocopherol
706738|NCT00235716|vitamin E|vitamin e
706739|NCT00235716|Namenda|namenda
706740|NCT00235716|memantine|memantine
706741|NCT00235677|Endoscopic antireflux treatment|endoscopic antireflux treatment
706742|NCT00235677|GERD|gerd
706743|NCT00235677|Sham-controlled|sham-controlled
706744|NCT00235677|Endocinch|endocinch
706745|NCT00235664|liver transplant recipients|liver transplant recipients
706746|NCT00235664|intestinal transplant recipients|intestinal transplant recipients
706747|NCT00235664|multivisceral transplant recipients|multivisceral transplant recipients
706748|NCT00235651|Lung transplant recipient|lung transplant recipient
706749|NCT00235625|Alternative Medicine|alternative medicine
706750|NCT00235625|Psoriasis|psoriasis
706751|NCT00235625|Turmeric|turmeric
706752|NCT00235625|Curcumin|curcumin
706753|NCT00235625|Dermatology|dermatology
706754|NCT00235599|Growth|growth
706755|NCT00235599|Hormone|hormone
706756|NCT00235599|Deficiency|deficiency
706757|NCT00235586|vitamin D deficiency postmenopausal women|vitamin d deficiency postmenopausal women
706758|NCT00235573|Vitamin B12 absorption|vitamin b12 absorption
706759|NCT00235573|Holo-transcobalamin|holo-transcobalamin
706760|NCT00235560|AML|aml
706761|NCT00235560|Rapamycin|rapamycin
706762|NCT00235560|Elderly|elderly
706763|NCT00235560|Elderly patients not eligible for intensive chemotherapy|elderly patients not eligible for intensive chemotherapy
706764|NCT00235547|abortion|abortion
706765|NCT00235547|randomized|randomized
706766|NCT00235547|contraception|contraception
706767|NCT00235547|pregnancy|pregnancy
706768|NCT00235547|compliance|compliance
706769|NCT00235547|continuation|continuation
706770|NCT00235547|contraceptive patch|contraceptive patch
706771|NCT00235547|transdermal hormonal contraception|transdermal hormonal contraception
706772|NCT00235534|abortion|abortion
706773|NCT00235534|randomized|randomized
706774|NCT00235534|contraception|contraception
706775|NCT00235534|pregnancy|pregnancy
706776|NCT00235534|compliance|compliance
706777|NCT00235534|continuation|continuation
706778|NCT00235534|oral contraceptive pills|oral contraceptive pills
706779|NCT00235521|Pulmonary hypertension|pulmonary hypertension
706780|NCT00235521|Cardiac Surgery|cardiac surgery
706781|NCT00235521|Children|children
706782|NCT00235521|Pediatric Patients|pediatric patients
706783|NCT00235521|Iloprost|iloprost
706784|NCT00235521|NO|no
706785|NCT00235521|nitric oxide|nitric oxide
706786|NCT00235521|Pulmonary hypertension after cardiac surgery in pediatric patients, 0 - 2 years old|pulmonary hypertension after cardiac surgery in pediatric patients, 0 - 2 years old
706787|NCT00235508|Insomnia|insomnia
706788|NCT00235508|Anxiety|anxiety
706789|NCT00235508|Generalized Anxiety Disorder|generalized anxiety disorder
706790|NCT00235495|stroke|stroke
706791|NCT00235469|PAINFUL DISTAL DIABETIC NEUROPATHY|painful distal diabetic neuropathy
706792|NCT00235456|oxygen|oxygen
706793|NCT00235456|surgical complications|surgical complications
706794|NCT00235456|colo-rectal resections|colo-rectal resections
706795|NCT00235443|Painful Distal Diabetic Neuropathy|painful distal diabetic neuropathy
706796|NCT00235417|Bone Marrow Transplantation|bone marrow transplantation
706797|NCT00235404|Treatment of elderly.|treatment of elderly.
706798|NCT00235404|Nursing home.|nursing home.
706799|NCT00235404|Rehabilitation.|rehabilitation.
706800|NCT00235404|Readmissions.|readmissions.
706801|NCT00235391|Deferasirox|deferasirox
706802|NCT00235391|Congenital Anemias|congenital anemias
706803|NCT00235391|Anemias|anemias
706804|NCT00235391|Red Blood Cell Disorders|red blood cell disorders
706805|NCT00235391|Chronic Iron Overload|chronic iron overload
706806|NCT00235391|Transfusional Iron Overload|transfusional iron overload
706807|NCT00235391|Iron Chelators|iron chelators
706808|NCT00235391|Oral Iron Chelators|oral iron chelators
706809|NCT00235391|Thalassemia|thalassemia
706810|NCT00235391|Sickle Cell Disease|sickle cell disease
706811|NCT00235391|Diamond Blackfan Anemia|diamond blackfan anemia
706812|NCT00235391|Myelofibrosis|myelofibrosis
706813|NCT00235391|ICL670A|icl670a
706814|NCT00235378|Lupus|lupus
706815|NCT00235378|SLE|sle
706816|NCT00235352|Schizphrenia|schizphrenia
706817|NCT00235352|Cognition|cognition
706818|NCT00235352|Negative Symptoms|negative symptoms
706819|NCT00235339|Oxygen Consumption|oxygen consumption
706820|NCT00235339|Exercise|exercise
706821|NCT00235339|Rehabilitation|rehabilitation
706822|NCT00235326|residents of Walkerton ontario at outbreak|residents of walkerton ontario at outbreak
706823|NCT00235313|Nicotine replacement therapies|nicotine replacement therapies
706824|NCT00235313|Smoking|smoking
706825|NCT00235313|Smoking related diseases|smoking related diseases
706826|NCT00235313|Saliva cotinine|saliva cotinine
706827|NCT00235313|Dose adjustment|dose adjustment
706828|NCT00235313|Smoker; patients with smoking related disease conditions|smoker; patients with smoking related disease conditions
706829|NCT00235300|Anti-T cells antibodies|anti-t cells antibodies
706830|NCT00235300|Cadaveric Donor Renal Transplantation|cadaveric donor renal transplantation
706831|NCT00235300|Acute Renal Allograft Rejection|acute renal allograft rejection
706832|NCT00235300|Induction Therapy|induction therapy
706833|NCT00235287|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors
706834|NCT00235287|type 1 angiotensin receptor antagonists|type 1 angiotensin receptor antagonists
706835|NCT00235287|blood pressure|blood pressure
706836|NCT00235274|Schizophrenia|schizophrenia
706837|NCT00235274|Secretin|secretin
706838|NCT00235261|Total hip replacement|total hip replacement
706839|NCT00235261|Pregablin|pregablin
706840|NCT00235261|Dexamethasone|dexamethasone
706841|NCT00235261|Multimodal postoperative analgesia.|multimodal postoperative analgesia.
706842|NCT00235248|TIA/Brain infarct|tia/brain infarct
706843|NCT00235248|and plaque>4mm in the aortic arch|and plaque>4mm in the aortic arch
706844|NCT00235248|Or peripheral embolism|or peripheral embolism
706845|NCT00235248|and plaque>4 mm in the thoracic aorta|and plaque>4 mm in the thoracic aorta
706846|NCT00235222|Stavudine|stavudine
706847|NCT00235222|Reduced dose of stavudine|reduced dose of stavudine
706848|NCT00235222|Viral load|viral load
706849|NCT00235222|Peripheral neuropathy|peripheral neuropathy
706850|NCT00235222|Treatment Experienced|treatment experienced
706851|NCT00235183|plasma|plasma
706852|NCT00235183|bleeding|bleeding
706853|NCT00235183|liver transplantation|liver transplantation
706854|NCT00235131|Peripheral Artery Occlusive Disease|peripheral artery occlusive disease
706855|NCT00235105|early ankylosing spondylitis|early ankylosing spondylitis
706856|NCT00235105|spondyloarthritis|spondyloarthritis
706857|NCT00235105|trial|trial
706858|NCT00235105|adalimumab|adalimumab
706859|NCT00235079|Pericarditis|pericarditis
706860|NCT00235079|Recurrence|recurrence
706861|NCT00235079|Therapeutics|therapeutics
706862|NCT00235079|Prevention|prevention
706863|NCT00235079|Colchicine|colchicine
706864|NCT00235053|asthma|asthma
706865|NCT00235053|candidiasis, oral|candidiasis, oral
706866|NCT00235053|voice disorders|voice disorders
706867|NCT00235040|Upper Respiratory Infections|upper respiratory infections
706868|NCT00235040|Respiratory Tract Infections|respiratory tract infections
706869|NCT00235040|Tree Number C01.539.739|tree number c01.539.739
706870|NCT00235040|Tree Number C08.730|tree number c08.730
706871|NCT00235040|Unique ID D012141|unique id d012141
706872|NCT00235014|hypertension|hypertension
706873|NCT00235014|diabetes|diabetes
706874|NCT00235014|trandolapril|trandolapril
706875|NCT00235014|verapamil|verapamil
706876|NCT00235014|albuminuria|albuminuria
706877|NCT00235001|Hypertension|hypertension
706878|NCT00235001|Tarka|tarka
706879|NCT00234988|Sibutramine|sibutramine
706880|NCT00234988|Obesity|obesity
706881|NCT00234975|Lopinavir|lopinavir
706882|NCT00234975|Ritonavir|ritonavir
706883|NCT00234975|Phase 4|phase 4
706884|NCT00234975|HIV|hiv
706885|NCT00234962|HIV Infection|hiv infection
706886|NCT00234962|HAART|haart
706887|NCT00234962|Lopinavir|lopinavir
706888|NCT00234962|Ritonavir|ritonavir
706889|NCT00234962|Treatment Experienced|treatment experienced
706890|NCT00234962|Treatment Naive|treatment naive
706891|NCT00234949|Cefdinir|cefdinir
706892|NCT00234949|Cephalexin|cephalexin
706893|NCT00234949|Skin Infection|skin infection
706894|NCT00234936|rheumatoid arthritis|rheumatoid arthritis
706895|NCT00234936|adalimumab|adalimumab
706896|NCT00234936|quality of life|quality of life
706897|NCT00234923|HIV Infection|hiv infection
706898|NCT00234923|Kaletra|kaletra
706899|NCT00234923|Lopinavir|lopinavir
706900|NCT00234923|Ritonavir|ritonavir
706901|NCT00234923|Treatment Naive|treatment naive
706902|NCT00234910|Lopinavir|lopinavir
706903|NCT00234910|Ritonavir|ritonavir
706904|NCT00234910|Kaletra|kaletra
706905|NCT00234910|Tenofovir|tenofovir
706906|NCT00234910|HIV infection|hiv infection
706907|NCT00234910|Treatment Naive|treatment naive
706908|NCT00234897|adalimumab|adalimumab
706909|NCT00234897|rheumatoid arthritis|rheumatoid arthritis
706910|NCT00234884|rheumatoid arthritis|rheumatoid arthritis
706911|NCT00234884|adalimumab|adalimumab
706912|NCT00234871|Hypertension|hypertension
706913|NCT00234871|Diabetes|diabetes
706914|NCT00234871|Proteinuria|proteinuria
706915|NCT00234871|Tarka|tarka
706916|NCT00234871|Lotrel|lotrel
706917|NCT00234858|Hypertension|hypertension
706918|NCT00234858|Metabolic Syndrome|metabolic syndrome
706919|NCT00234858|Tarka|tarka
706920|NCT00234858|Hyzaar|hyzaar
706921|NCT00234832|Obesity|obesity
706922|NCT00234832|Sibutramine|sibutramine
706923|NCT00234819|Menopause|menopause
706924|NCT00234806|telehealth|telehealth
706925|NCT00234806|telemedicine|telemedicine
706926|NCT00234793|childhood cancer|childhood cancer
706927|NCT00234793|intervention|intervention
706928|NCT00234793|maternal coping|maternal coping
706929|NCT00234793|problem solving skills|problem solving skills
706930|NCT00234793|anxiety|anxiety
706931|NCT00234793|cope|cope
706932|NCT00234793|problem solving|problem solving
706933|NCT00234780|acute home care|acute home care
707035|NCT00234182|survival|survival
706934|NCT00234767|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
706935|NCT00234767|ARDS|ards
706936|NCT00234767|Acute Lung Injury|acute lung injury
706937|NCT00234767|ALI|ali
706938|NCT00234767|Cost-effectiveness|cost-effectiveness
706939|NCT00234767|Pharmacoeconomics|pharmacoeconomics
706940|NCT00234767|Long-term follow-up|long-term follow-up
706941|NCT00234754|Incontinence|incontinence
706942|NCT00234754|Surgery|surgery
706943|NCT00234754|Trans-vaginal tape|trans-vaginal tape
706944|NCT00234754|Trans-obturator tape|trans-obturator tape
706945|NCT00234728|psoriasis|psoriasis
706946|NCT00234728|hydrogel|hydrogel
706947|NCT00234728|occlusive dressing|occlusive dressing
706948|NCT00234728|occlusion|occlusion
706949|NCT00234728|hydrocortisone|hydrocortisone
706950|NCT00234728|tacrolimus|tacrolimus
706951|NCT00234728|Protopic|protopic
706952|NCT00234728|triamcinolone|triamcinolone
706953|NCT00234728|calcipotriene|calcipotriene
706954|NCT00234728|Dovonex|dovonex
706955|NCT00234728|halobetasol|halobetasol
706956|NCT00234728|Ultravate|ultravate
706957|NCT00234715|Breast Cancer|breast cancer
706958|NCT00234715|Breast Cancer Risk|breast cancer risk
706959|NCT00234715|Breast Cancer Risk Assessment|breast cancer risk assessment
706960|NCT00234715|Psychosocial|psychosocial
706961|NCT00234715|Acceptance|acceptance
706962|NCT00234676|Parkinson disease|parkinson disease
706963|NCT00234676|women|women
706964|NCT00234676|postmenopause|postmenopause
706965|NCT00234676|estrogen replacement therapy|estrogen replacement therapy
706966|NCT00234676|clinical trials|clinical trials
706967|NCT00234663|Cystic fibrosis|cystic fibrosis
706968|NCT00234663|Nonsense mutation|nonsense mutation
706969|NCT00234663|Premature stop codon|premature stop codon
706970|NCT00234650|position change|position change
706971|NCT00234650|adenoma|adenoma
706972|NCT00234650|colonoscopy|colonoscopy
706973|NCT00234637|Alzheimer's disease,|alzheimer's disease,
706974|NCT00234637|switch,|switch,
706975|NCT00234637|rivastigmine,|rivastigmine,
706976|NCT00234637|memantine|memantine
706977|NCT00234598|Pneumonia|pneumonia
706978|NCT00234598|Dental Health|dental health
706979|NCT00234598|Critical Care|critical care
706980|NCT00234559|Angiogenesis|angiogenesis
706981|NCT00234559|Post surgical dehisced wounds of the lower extremity|post surgical dehisced wounds of the lower extremity
706982|NCT00234533|growth|growth
706983|NCT00234533|child development|child development
706984|NCT00234533|growth hormone|growth hormone
706985|NCT00234533|inadequate growth hormone secretion|inadequate growth hormone secretion
706986|NCT00234533|growth failure|growth failure
706987|NCT00234468|Locally Advanced Non Small Cell Lung Cancer (Stage IIIA and IIIB)|locally advanced non small cell lung cancer (stage iiia and iiib)
706988|NCT00234442|Non symptomatic brain metastases|non symptomatic brain metastases
706989|NCT00234442|Iressa|iressa
706990|NCT00234429|Colorectal carcinoma advanced disease|colorectal carcinoma advanced disease
706991|NCT00234416|Pancreatic Cancer|pancreatic cancer
706992|NCT00234416|EGF-R|egf-r
706993|NCT00234403|Advanced breast cancer|advanced breast cancer
706994|NCT00234403|Metastatic breast cancer|metastatic breast cancer
706995|NCT00234403|ER positive breast cancer|er positive breast cancer
706996|NCT00234403|PR positive breast cancer|pr positive breast cancer
706997|NCT00234377|Schizophrenia|schizophrenia
706998|NCT00234364|Pergolide|pergolide
706999|NCT00234364|Ergotamine derivates|ergotamine derivates
707000|NCT00234364|Valvular heart disease|valvular heart disease
707001|NCT00234338|Children|children
707002|NCT00234338|Vaccine|vaccine
707003|NCT00234338|Prevenar|prevenar
707004|NCT00234312|Depressive Disorders|depressive disorders
707005|NCT00234299|Cancer|cancer
707006|NCT00234299|Prostate|prostate
707007|NCT00234299|Preventive Therapy|preventive therapy
707008|NCT00234286|Palliative Care|palliative care
707009|NCT00234286|Terminal Care|terminal care
707010|NCT00234286|Hospice Care|hospice care
707011|NCT00234286|Patient Care Planning|patient care planning
707012|NCT00234286|Nursing Care Plans|nursing care plans
707013|NCT00234286|Quality of Health Care|quality of health care
707014|NCT00234286|Inpatients|inpatients
707015|NCT00234286|Professional education|professional education
707016|NCT00234286|Resuscitation orders|resuscitation orders
707017|NCT00234286|Pastoral Care|pastoral care
707018|NCT00234273|Adapted Physical Activity|adapted physical activity
707019|NCT00234273|Quality of life|quality of life
707020|NCT00234273|cardiovascular risk|cardiovascular risk
707021|NCT00234273|teaching|teaching
707022|NCT00234273|Directly Observed Therapy|directly observed therapy
707023|NCT00234273|Physical activity|physical activity
707024|NCT00234260|Genetics|genetics
707025|NCT00234234|Biologics|biologics
707026|NCT00234208|Complicated parapneumonic effusion|complicated parapneumonic effusion
707027|NCT00234208|Pleural empyema|pleural empyema
707028|NCT00234208|Intervention|intervention
707029|NCT00234208|Medical thoracoscopy|medical thoracoscopy
707030|NCT00234208|Chest tube drainage|chest tube drainage
707031|NCT00234195|Breast Cancer|breast cancer
707032|NCT00234195|Major Depressive Disorder|major depressive disorder
707033|NCT00234182|liver cancer|liver cancer
707036|NCT00234182|recurrence|recurrence
707037|NCT00234169|Multiple Myeloma|multiple myeloma
707038|NCT00234169|Lymphoma|lymphoma
707039|NCT00234156|Fructose|fructose
707040|NCT00234156|Lipogenesis|lipogenesis
707041|NCT00234156|Triglycerides|triglycerides
707042|NCT00234156|Dialysis|dialysis
707043|NCT00234143|MDS|mds
707044|NCT00234143|EPO|epo
707045|NCT00234143|G-CSF|g-csf
707046|NCT00234143|REGiM|regim
707047|NCT00234130|Dialysis|dialysis
707048|NCT00234130|Cytokines|cytokines
707049|NCT00234130|Triglycerides|triglycerides
707050|NCT00234130|Insulin|insulin
707051|NCT00234104|OPC-41061|opc-41061
707052|NCT00234104|Tolvaptan|tolvaptan
707053|NCT00234104|Heart Failure|heart failure
707054|NCT00234104|Edema|edema
707055|NCT00234104|Extracellular volume expansion|extracellular volume expansion
707056|NCT00234091|Treatment Naive|treatment naive
707057|NCT00234091|Treatment Initiation|treatment initiation
707058|NCT00234091|Infant|infant
707059|NCT00234091|Preschool Child|preschool child
707060|NCT00234091|Child|child
707061|NCT00234091|Zidovudine|zidovudine
707062|NCT00234091|AZT|azt
707063|NCT00234091|Retrovir|retrovir
707064|NCT00234091|3TC|3tc
707065|NCT00234091|Lamivudine|lamivudine
707066|NCT00234091|Epivir|epivir
707067|NCT00234091|Nevirapine|nevirapine
707068|NCT00234091|NVP|nvp
707069|NCT00234091|Viramune|viramune
707070|NCT00234091|Efavirenz|efavirenz
707071|NCT00234091|EFV|efv
707072|NCT00234091|Sustiva|sustiva
707073|NCT00234091|Lopinavir/Ritonavir|lopinavir/ritonavir
707074|NCT00234091|LPV/r|lpv/r
707075|NCT00234091|Kaletra|kaletra
707076|NCT00234091|Nelfinavir|nelfinavir
707077|NCT00234091|NFV|nfv
707078|NCT00234091|Viracept|viracept
707079|NCT00234091|ABC|abc
707080|NCT00234091|Abacavir|abacavir
707081|NCT00234091|Ziagen|ziagen
707082|NCT00234078|OPC-12759|opc-12759
707083|NCT00234078|Dry eye syndromes|dry eye syndromes
707084|NCT00234052|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
707085|NCT00234052|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
707086|NCT00234052|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
707087|NCT00234052|adenocarcinoma of the lung|adenocarcinoma of the lung
707088|NCT00234052|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
707089|NCT00234052|large cell lung cancer|large cell lung cancer
707090|NCT00234039|recurrent bladder cancer|recurrent bladder cancer
707091|NCT00234039|stage 0 bladder cancer|stage 0 bladder cancer
707092|NCT00234039|stage I bladder cancer|stage i bladder cancer
707093|NCT00234039|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
707094|NCT00234026|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
707095|NCT00234026|stage I mantle cell lymphoma|stage i mantle cell lymphoma
707096|NCT00234026|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
707097|NCT00234026|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
707098|NCT00234026|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
707099|NCT00234026|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
707100|NCT00234000|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
707101|NCT00234000|refractory anemia with excess blasts|refractory anemia with excess blasts
707102|NCT00234000|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
707103|NCT00234000|refractory anemia|refractory anemia
707104|NCT00234000|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
707105|NCT00234000|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
707106|NCT00234000|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
707107|NCT00234000|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
707108|NCT00233987|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
707109|NCT00233974|stage IIIA breast cancer|stage iiia breast cancer
707110|NCT00233974|stage IIIB breast cancer|stage iiib breast cancer
707111|NCT00233974|stage IIIC breast cancer|stage iiic breast cancer
707112|NCT00233974|stage IV breast cancer|stage iv breast cancer
707113|NCT00233961|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
707114|NCT00233922|orbit|orbit
707115|NCT00233922|orbital|orbital
707116|NCT00233922|trauma|trauma
707117|NCT00233922|fractures|fractures
707118|NCT00233922|facial|facial
707119|NCT00233909|Leukemia, Myeloid|leukemia, myeloid
707120|NCT00233909|Relapse|relapse
707121|NCT00233909|Chemotherapy|chemotherapy
707122|NCT00233909|Zosuquidar|zosuquidar
707123|NCT00233909|gemtuzumab ozogamicin (GO)|gemtuzumab ozogamicin (go)
707124|NCT00233896|Hematopoietic cell transplant|hematopoietic cell transplant
707125|NCT00233896|Acute graft-vs.-host disease|acute graft-vs.-host disease
707126|NCT00233896|Gastrointestinal tract|gastrointestinal tract
707127|NCT00233896|Randomized trial|randomized trial
707128|NCT00233896|Topical corticosteroid|topical corticosteroid
707129|NCT00233896|Beclomethasone dipropionate|beclomethasone dipropionate
707130|NCT00233896|Prednisone|prednisone
707131|NCT00233896|Survival|survival
707132|NCT00233857|Acute pain|acute pain
707133|NCT00233857|postoperative pain|postoperative pain
707134|NCT00233857|auricular acupuncture|auricular acupuncture
707135|NCT00233844|Acute pain|acute pain
707136|NCT00233844|pain on venipuncture|pain on venipuncture
707137|NCT00233844|"cough-trick"|"cough-trick"
707138|NCT00233844|distraction|distraction
707139|NCT00233831|Postoperative pain|postoperative pain
707140|NCT00233831|analgesia|analgesia
707141|NCT00233831|total knee arthroplasty|total knee arthroplasty
707142|NCT00233753|Intracranial|intracranial
707143|NCT00233753|Wide-neck|wide-neck
707144|NCT00233753|Saccular|saccular
707145|NCT00233753|Aneurysms|aneurysms
707146|NCT00233727|cervical cancer|cervical cancer
707147|NCT00233727|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
707148|NCT00233727|prevention|prevention
707149|NCT00233727|cryotherapy|cryotherapy
707150|NCT00233727|HPV testing|hpv testing
707151|NCT00233727|cytology|cytology
707152|NCT00233701|NPH|nph
707153|NCT00233701|Hydrocephalus|hydrocephalus
707154|NCT00233636|Squamous Cell Carcinoma of Head and Neck|squamous cell carcinoma of head and neck
707155|NCT00233636|Inoperable locally advanced Squamous Cell Carcinoma of Head and Neck|inoperable locally advanced squamous cell carcinoma of head and neck
707156|NCT00233623|Metastatic Colorectal Cancer|metastatic colorectal cancer
707157|NCT00233610|Casodex monotherapy|casodex monotherapy
707158|NCT00233597|anemia|anemia
707159|NCT00233597|iron|iron
707160|NCT00233584|Children of asthmatic mothers|children of asthmatic mothers
707161|NCT00233545|cutaneous|cutaneous
707162|NCT00233545|leishmaniasis|leishmaniasis
707163|NCT00233545|drug|drug
707164|NCT00233545|miltefosine|miltefosine
707165|NCT00233532|Hypertension|hypertension
707166|NCT00233532|Trandolapril|trandolapril
707167|NCT00233506|CpG 7909|cpg 7909
707168|NCT00233506|CLL|cll
707169|NCT00233493|dermatophytes|dermatophytes
707170|NCT00233480|Randomized Controlled Trial|randomized controlled trial
707171|NCT00233480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
707172|NCT00233480|Sympathetic Nervous System|sympathetic nervous system
707173|NCT00233480|Ventricular Remodeling|ventricular remodeling
707174|NCT00233480|Chemokines|chemokines
707175|NCT00233467|antipsychotics|antipsychotics
707176|NCT00233467|PTSD|ptsd
707177|NCT00233467|posttraumatic stress disorder|posttraumatic stress disorder
707178|NCT00233441|Atrial Fibrillation|atrial fibrillation
707179|NCT00233441|Atrial Flutter|atrial flutter
707180|NCT00233441|Arrhythmia|arrhythmia
707181|NCT00233441|Anti-Arrhythmia Agents|anti-arrhythmia agents
707182|NCT00233428|Healthy volunteers|healthy volunteers
707183|NCT00233402|Bladder Cancer|bladder cancer
707184|NCT00233402|Hexvix|hexvix
707185|NCT00233402|Fluorescence|fluorescence
707186|NCT00233402|Cystoscopy|cystoscopy
707187|NCT00233376|Decision support system|decision support system
707188|NCT00233376|Causal probabilistic network|causal probabilistic network
707189|NCT00233376|Antibiotics|antibiotics
707190|NCT00233376|Antibiotic resistance|antibiotic resistance
707191|NCT00233376|Community-acquired infections|community-acquired infections
707192|NCT00233376|Cross-infections|cross-infections
707193|NCT00233350|Neuronavigation|neuronavigation
707194|NCT00233350|Ultrasound|ultrasound
707195|NCT00233350|Brain tumour surgery|brain tumour surgery
707196|NCT00233350|Biopsy|biopsy
707197|NCT00233350|Histopathology|histopathology
707198|NCT00233350|Intraoperative imaging|intraoperative imaging
707199|NCT00233350|3D ultrasound imaging|3d ultrasound imaging
707200|NCT00233337|Malaria, non-immune travelers|malaria, non-immune travelers
707201|NCT00233324|NICHD Neonatal Research Network|nichd neonatal research network
707202|NCT00233324|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
707203|NCT00233324|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
707204|NCT00233324|Prematurity|prematurity
707205|NCT00233324|Mechanical ventilation|mechanical ventilation
707206|NCT00233324|Surfactant|surfactant
707207|NCT00233324|Intubation|intubation
707208|NCT00233324|Neurodevelopmental impairment|neurodevelopmental impairment
707209|NCT00233324|Pulse oximetry|pulse oximetry
707210|NCT00233324|Oxygen saturation|oxygen saturation
707211|NCT00233324|Positive-Pressure Respiration|positive-pressure respiration
707212|NCT00233311|high fat diet|high fat diet
707213|NCT00233311|inflammation|inflammation
707214|NCT00233311|inflammatory markers|inflammatory markers
707215|NCT00233311|C-reactive protein|c-reactive protein
707216|NCT00233311|Aging|aging
707217|NCT00233298|Hypoglycemia|hypoglycemia
707218|NCT00233298|Blood Sugar|blood sugar
707219|NCT00233298|Blood Glucose Level|blood glucose level
707220|NCT00233298|Insulin Sensitivity|insulin sensitivity
707221|NCT00233298|Metabolism|metabolism
707222|NCT00233298|Type 2 Diabetes|type 2 diabetes
707223|NCT00233298|Healthy|healthy
707224|NCT00233272|Frailty|frailty
707225|NCT00233272|Disease Processes|disease processes
707226|NCT00233155|Analgesics|analgesics
707227|NCT00233155|Capsaicin|capsaicin
707228|NCT00233155|Neuropathic pain|neuropathic pain
707229|NCT00233155|Neuropathy|neuropathy
707230|NCT00233155|PHN|phn
707231|NCT00233155|Shingles|shingles
707232|NCT00233142|Diabetes|diabetes
707233|NCT00233142|Emotions|emotions
707234|NCT00233142|Blood glucose|blood glucose
707235|NCT00233142|Expressive Writing|expressive writing
707236|NCT00233129|Day treatment|day treatment
707237|NCT00233129|executive function|executive function
707238|NCT00233129|problem solving|problem solving
707239|NCT00233129|attention|attention
707240|NCT00233129|participation|participation
707241|NCT00233129|TBI|tbi
707242|NCT00233129|brain injury|brain injury
707243|NCT00233129|traumatic brain injury|traumatic brain injury
707244|NCT00233103|Sertraline|sertraline
707245|NCT00233103|TBI|tbi
707246|NCT00233103|depression|depression
707247|NCT00233103|SSRI|ssri
707248|NCT00233103|brain injury|brain injury
707249|NCT00233090|Fatigue|fatigue
707250|NCT00233090|TBI|tbi
707251|NCT00233090|brain injury|brain injury
707252|NCT00233090|Modafinil|modafinil
707253|NCT00233090|traumatic brain injury|traumatic brain injury
707254|NCT00233077|breast cancer|breast cancer
707255|NCT00233077|adjuvant treatment|adjuvant treatment
707256|NCT00233077|racial disparities|racial disparities
707257|NCT00233051|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
707258|NCT00233051|Emphysema|emphysema
707259|NCT00233051|Chronic Bronchitis|chronic bronchitis
707260|NCT00233051|Inhaled Steroid|inhaled steroid
707261|NCT00233051|Salmeterol|salmeterol
707262|NCT00233038|Pancreatic cancer|pancreatic cancer
707263|NCT00233038|Pancreatic adenoma|pancreatic adenoma
707264|NCT00233038|Ethanol|ethanol
707265|NCT00233038|Endoscopic ultrasound|endoscopic ultrasound
707266|NCT00233038|Cyst ablation|cyst ablation
707267|NCT00233012|Refractory partial-onset seizures|refractory partial-onset seizures
707268|NCT00233012|Infants aged 1-24 months|infants aged 1-24 months
707269|NCT00233012|Pharmacokinetics|pharmacokinetics
707270|NCT00233012|Topiramate|topiramate
707271|NCT00232999|Allergic asthma|allergic asthma
707272|NCT00232999|Allergen challenge|allergen challenge
707273|NCT00232999|Bronchial hyperresponsiveness|bronchial hyperresponsiveness
707274|NCT00232960|oral and oropharynx carcinoma|oral and oropharynx carcinoma
707275|NCT00232960|surgery|surgery
707276|NCT00232960|postoperative radiotherapy|postoperative radiotherapy
707277|NCT00232960|molecular analysis|molecular analysis
707278|NCT00232960|microsatellite instability|microsatellite instability
707279|NCT00232947|vaccine|vaccine
707280|NCT00232947|elderly|elderly
707281|NCT00232947|immunogenicity|immunogenicity
707282|NCT00232947|safety|safety
707283|NCT00232934|Myeloma|myeloma
707284|NCT00232934|Thalidomide|thalidomide
707285|NCT00232934|Diagnosis|diagnosis
707286|NCT00232934|Elderly patients|elderly patients
707287|NCT00232882|Hypertension|hypertension
707288|NCT00232882|Blood pressure|blood pressure
707289|NCT00232882|Antihypertensive drugs|antihypertensive drugs
707290|NCT00232882|Clinical Pharmacology|clinical pharmacology
707291|NCT00232882|Autonomic nervous system|autonomic nervous system
707292|NCT00232882|Renin angiotensin system|renin angiotensin system
707293|NCT00232882|Oxidative stress|oxidative stress
707294|NCT00232882|Inflammatory markers|inflammatory markers
707295|NCT00232843|Peripheral Artery Occlusive Disease|peripheral artery occlusive disease
707296|NCT00232817|Postoperative pain|postoperative pain
707297|NCT00232726|Malignant melanoma|malignant melanoma
707298|NCT00232726|CP-4055|cp-4055
707299|NCT00232726|Chemotherapy-naïve patients|chemotherapy-naïve patients
707300|NCT00232726|Phase II|phase ii
707301|NCT00232726|Chemotherapy-naive patients|chemotherapy-naive patients
707302|NCT00232726|Metastatic malignant melanoma|metastatic malignant melanoma
707303|NCT00232713|Birth Defects|birth defects
707304|NCT00232713|Pregnancy|pregnancy
707305|NCT00232713|Uterine Fibroids|uterine fibroids
707306|NCT00232713|Fibroids|fibroids
707307|NCT00232700|Major depressive disorder|major depressive disorder
707308|NCT00232700|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
707309|NCT00232674|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
707310|NCT00232635|RSV|rsv
707311|NCT00232635|HSCT|hsct
707312|NCT00232635|HEMATOPOIETIC STEM CELL TRANSPL|hematopoietic stem cell transpl
707313|NCT00232622|Prosthetic valve thrombosis|prosthetic valve thrombosis
707314|NCT00232622|Fibrinolysis|fibrinolysis
707315|NCT00232622|Streptokinase|streptokinase
707316|NCT00232609|Wheelchair|wheelchair
707317|NCT00232609|Exercise|exercise
707318|NCT00232609|Cardiovascular Disease|cardiovascular disease
707319|NCT00232596|Partial Seizures|partial seizures
707320|NCT00232596|Anticonvulsant|anticonvulsant
707321|NCT00232596|Complex Partial Seizures|complex partial seizures
707322|NCT00232596|Potassium Channels|potassium channels
707323|NCT00232596|Epilepsy|epilepsy
707324|NCT00232583|TYpe 2 diabetes mellitus|type 2 diabetes mellitus
707325|NCT00232583|Newly diagnosed|newly diagnosed
707326|NCT00232583|Beta-cell function|beta-cell function
707327|NCT00232570|sleep disturbance|sleep disturbance
707328|NCT00232570|dementia|dementia
707329|NCT00232557|Asthma|asthma
707330|NCT00232557|Disease Management|disease management
707331|NCT00232557|Telecommunications|telecommunications
707332|NCT00232557|Health Services|health services
707333|NCT00232557|Quality of Life|quality of life
707334|NCT00232557|Patient Compliance|patient compliance
707335|NCT00232544|sleep apnea, obstructive|sleep apnea, obstructive
707336|NCT00232544|Quality of Life|quality of life
707337|NCT00232544|Depression|depression
707338|NCT00232544|Patient Compliance|patient compliance
707339|NCT00232518|immune system|immune system
707340|NCT00232518|infection|infection
707341|NCT00232518|allergic rhinitis|allergic rhinitis
707342|NCT00232505|recurrent breast cancer|recurrent breast cancer
707343|NCT00232505|stage IV breast cancer|stage iv breast cancer
707344|NCT00232492|Wisdom|wisdom
707345|NCT00232492|Tooth|tooth
707346|NCT00232492|Teeth|teeth
707347|NCT00232492|Third|third
707348|NCT00232492|Molar|molar
707349|NCT00232466|Vertebroplasty|vertebroplasty
707350|NCT00232466|Vertebral fracture|vertebral fracture
707351|NCT00232466|Actonel|actonel
707352|NCT00232466|Osteoporotic|osteoporotic
707353|NCT00232466|vertebral|vertebral
707354|NCT00232466|fractures|fractures
707355|NCT00232427|Liver cirrhosis|liver cirrhosis
707356|NCT00232427|Hemodynamics|hemodynamics
707357|NCT00232427|Fluid balance|fluid balance
707358|NCT00232414|bipolar|bipolar
707359|NCT00232414|with acute depressive episode|with acute depressive episode
707360|NCT00232401|urine|urine
707361|NCT00232401|circadian rhythm|circadian rhythm
707362|NCT00232388|Ejection Fraction <35%|ejection fraction <35%
707363|NCT00232375|SPIDDM|spiddm
707364|NCT00232375|LADA|lada
707365|NCT00232375|GAD antibody|gad antibody
707366|NCT00232375|Beta cell function|beta cell function
707367|NCT00232375|Insulin|insulin
707368|NCT00232349|schizophrenia|schizophrenia
707369|NCT00232349|galantamine|galantamine
707370|NCT00232349|cholinesterase inhibitors|cholinesterase inhibitors
707371|NCT00232349|quality of life|quality of life
707372|NCT00232349|cognition|cognition
707373|NCT00232336|cocaine|cocaine
707374|NCT00232336|drug|drug
707375|NCT00232336|substance|substance
707376|NCT00232336|abuse|abuse
707377|NCT00232336|addiction|addiction
707378|NCT00232336|dependence|dependence
707379|NCT00232336|quetiapine|quetiapine
707380|NCT00232336|antipsychotic|antipsychotic
707381|NCT00232336|treatment|treatment
707382|NCT00232323|intensive care|intensive care
707383|NCT00232323|stress|stress
707384|NCT00232323|education|education
707385|NCT00232323|simulation|simulation
707386|NCT00232310|Atrial Fibrillation|atrial fibrillation
707387|NCT00232310|Atrial Flutter|atrial flutter
707388|NCT00232310|Electric Countershock|electric countershock
707389|NCT00232297|Tachycardia, Ventricular|tachycardia, ventricular
707390|NCT00232297|Ventricular Fibrillation|ventricular fibrillation
707391|NCT00232297|Defibrillators Implantable|defibrillators implantable
707392|NCT00232297|Arrhythmia|arrhythmia
707393|NCT00232297|Anti-arrhythmia agents|anti-arrhythmia agents
707394|NCT00232258|NK1 Antagonist|nk1 antagonist
707395|NCT00232258|Inflammatory Bowel Disease|inflammatory bowel disease
707396|NCT00232258|Mesalamine|mesalamine
707397|NCT00232232|Atrial mechanical stunning and|atrial mechanical stunning and
707398|NCT00232232|atrial electrical remodeling|atrial electrical remodeling
707399|NCT00232206|NSCLC|nsclc
707400|NCT00232206|Lung|lung
707401|NCT00232206|Cancer|cancer
707402|NCT00232206|Metastatic|metastatic
707403|NCT00232206|Neoadjuvant|neoadjuvant
707404|NCT00232206|Stage IB Non-Small Cell Lung Cancer (NSCLC)|stage ib non-small cell lung cancer (nsclc)
707405|NCT00232206|IIA Non-Small Cell Lung Cancer (NSCLC)|iia non-small cell lung cancer (nsclc)
707406|NCT00232206|IIB Non-Small Cell Lung Cancer (NSCLC)|iib non-small cell lung cancer (nsclc)
707407|NCT00232206|Some IIIA Non-Small Cell Lung Cancer (NSCLC)|some iiia non-small cell lung cancer (nsclc)
707408|NCT00232193|Multiple Sclerosis|multiple sclerosis
707409|NCT00232193|Interferon Beta 1-a|interferon beta 1-a
707410|NCT00232193|Pulsed steroids|pulsed steroids
707411|NCT00232180|Open-label|open-label
707412|NCT00232180|single arm mortality/morbidity trial eplerenone chronic systolic heart failure|single arm mortality/morbidity trial eplerenone chronic systolic heart failure
707413|NCT00232115|Perioral Dermatitis, pimecrolimus cream|perioral dermatitis, pimecrolimus cream
707414|NCT00232102|Dyspepsia, gastrointestinal, tegaserod|dyspepsia, gastrointestinal, tegaserod
707415|NCT00232089|Dyspepsia, gastrointestinal, tegaserod|dyspepsia, gastrointestinal, tegaserod
707416|NCT00232076|Atopic Dermatitis, Ciclosporin,|atopic dermatitis, ciclosporin,
707417|NCT00232063|Atopic Dermatitis, Ciclosporin,|atopic dermatitis, ciclosporin,
707418|NCT00232050|Asthma, IgE, Omalizumab|asthma, ige, omalizumab
707419|NCT00232037|Dyspepsia, gastrointestinal, tegaserod|dyspepsia, gastrointestinal, tegaserod
707420|NCT00232024|Dyspepsia, gastrointestinal, tegaserod|dyspepsia, gastrointestinal, tegaserod
707421|NCT00232011|Atopic dermatitis, ASM981, pimecrolimus|atopic dermatitis, asm981, pimecrolimus
707422|NCT00231998|Atopic dermatitis, ASM981, pimecrolimus|atopic dermatitis, asm981, pimecrolimus
707423|NCT00231985|Habit-reversal Therapy|habit-reversal therapy
707424|NCT00231985|Behavior Therapy|behavior therapy
707425|NCT00231985|Supportive Therapy|supportive therapy
707426|NCT00231972|HIV|hiv
707427|NCT00231972|MSM|msm
707428|NCT00231959|Depression, Treatment-Resistant|depression, treatment-resistant
707429|NCT00231946|gonadotropins|gonadotropins
707430|NCT00231946|hormone therapy|hormone therapy
707431|NCT00231946|HRT|hrt
707432|NCT00231946|Antigonadotropin|antigonadotropin
707433|NCT00231946|Leuprolide|leuprolide
707434|NCT00231933|Person-centered Care|person-centered care
707435|NCT00231933|Recovery|recovery
707436|NCT00231933|Disparities|disparities
707437|NCT00231933|Culturally Responsive Care|culturally responsive care
707438|NCT00231933|Psychosis|psychosis
707439|NCT00231920|Influenza, Vaccine, Infants|influenza, vaccine, infants
707440|NCT00231907|influenza, vaccine, TIV, LAIV, booster, children|influenza, vaccine, tiv, laiv, booster, children
707441|NCT00231894|atypical antipsychotics|atypical antipsychotics
707442|NCT00231894|hyperglycemia|hyperglycemia
707443|NCT00231894|triglycerides|triglycerides
707444|NCT00231894|HDL|hdl
707445|NCT00231894|cholesterol|cholesterol
707446|NCT00231894|insulin resistance|insulin resistance
707447|NCT00231894|schizophrenia|schizophrenia
707448|NCT00231894|verbal memory|verbal memory
707449|NCT00231881|GORD – Oesophageal sensitivity- Oesophageal permeability|gord – oesophageal sensitivity- oesophageal permeability
707450|NCT00231868|Uterine Papillary Serous Carcinoma|uterine papillary serous carcinoma
707451|NCT00231868|UPSC|upsc
707452|NCT00231868|Radiation Therapy|radiation therapy
707453|NCT00231868|Chemotherapy|chemotherapy
707454|NCT00231855|Epithelial Ovarian Cancer|epithelial ovarian cancer
707455|NCT00231855|Uterine Cancer|uterine cancer
707456|NCT00231855|Prior Therapy|prior therapy
707457|NCT00231855|Chemotherapy|chemotherapy
707458|NCT00231855|Recurrence|recurrence
707459|NCT00231842|Mixed Mesodermal Tumor|mixed mesodermal tumor
707460|NCT00231842|MMT|mmt
707461|NCT00231842|Uterine Cancer|uterine cancer
707462|NCT00231842|Radiation Therapy|radiation therapy
707463|NCT00231842|Chemotherapy|chemotherapy
707464|NCT00231829|Treatment|treatment
707465|NCT00231829|Uterine Papillary Serous Carcinoma|uterine papillary serous carcinoma
707466|NCT00231829|Clear Cell Carcinoma|clear cell carcinoma
707467|NCT00231829|COX-2 Inhibitors|cox-2 inhibitors
707468|NCT00231816|Prevention of Herpes Zoster|prevention of herpes zoster
707469|NCT00231764|Renal transplantation|renal transplantation
707470|NCT00231764|Immunosuppression|immunosuppression
707471|NCT00231764|Daclizumab|daclizumab
707472|NCT00231764|GFR|gfr
707473|NCT00231751|Hemophilia A|hemophilia a
707474|NCT00231751|Inhibitors|inhibitors
707475|NCT00231738|Eicosapentaenoic acid|eicosapentaenoic acid
707476|NCT00231738|Coronary artery disease|coronary artery disease
707477|NCT00231712|prospective analysis of immune function,|prospective analysis of immune function,
707478|NCT00231712|spectratype|spectratype
707479|NCT00231712|immunoscope|immunoscope
707480|NCT00231712|TREC analysis|trec analysis
707481|NCT00231712|solid tumor|solid tumor
707482|NCT00231699|Prevention of Hypothermia|prevention of hypothermia
707483|NCT00231699|Pediatric Patient|pediatric patient
707484|NCT00231699|Cotton|cotton
707485|NCT00231699|Plastic wrap|plastic wrap
707486|NCT00231686|Lung function test|lung function test
707487|NCT00231686|Physical conditioning, human|physical conditioning, human
707488|NCT00231686|Physical fitness|physical fitness
707489|NCT00231686|Quality of life|quality of life
707490|NCT00231673|Diabetic peripheral polyneuropathy|diabetic peripheral polyneuropathy
707491|NCT00231673|Electrophysiology|electrophysiology
707492|NCT00231673|Nerve Conduction Study|nerve conduction study
707493|NCT00231673|Neurological Examination|neurological examination
707494|NCT00231673|Quantitative Sensory Testing|quantitative sensory testing
707495|NCT00231673|Topiramate|topiramate
707496|NCT00231660|Type 2 Diabetes|type 2 diabetes
707497|NCT00231660|Obesity|obesity
707498|NCT00231660|Metformin|metformin
707499|NCT00231660|Hemoglobin A1c|hemoglobin a1c
707500|NCT00231660|Adult-Onset Diabetes Mellitus (AODM)|adult-onset diabetes mellitus (aodm)
707501|NCT00231647|Obesity|obesity
707502|NCT00231647|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
707503|NCT00231647|Metformin|metformin
707504|NCT00231647|Diabetic Diet|diabetic diet
707505|NCT00231647|Topiramate|topiramate
707506|NCT00231647|Adult-Onset Diabetes Mellitus (AODM)|adult-onset diabetes mellitus (aodm)
707507|NCT00231634|Obesity|obesity
707508|NCT00231634|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
707509|NCT00231634|HbA1c|hba1c
707510|NCT00231634|Sulfonylurea|sulfonylurea
707511|NCT00231634|Topiramate|topiramate
707512|NCT00231634|Adult-Onset Diabetes Mellitus (AODM)|adult-onset diabetes mellitus (aodm)
707513|NCT00231621|Obesity|obesity
707514|NCT00231621|Dyslipidemia|dyslipidemia
707515|NCT00231621|Hyperlipidemia|hyperlipidemia
707516|NCT00231621|Triglyceride|triglyceride
707517|NCT00231621|HDL|hdl
707518|NCT00231621|LDL|ldl
707519|NCT00231621|Diabetes|diabetes
707520|NCT00231608|Obesity|obesity
707521|NCT00231608|Abdominal Obesity|abdominal obesity
707522|NCT00231608|Visceral Fat|visceral fat
707523|NCT00231608|Subcutaneous Fat|subcutaneous fat
707524|NCT00231608|Dislipidemia|dislipidemia
707525|NCT00231608|Hypertension|hypertension
707526|NCT00231608|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
707527|NCT00231595|Migraine|migraine
707528|NCT00231595|Common Migraine|common migraine
707529|NCT00231595|Classic Migraine|classic migraine
707530|NCT00231595|Headache|headache
707531|NCT00231595|Topiramate|topiramate
707532|NCT00231595|Prophylaxis|prophylaxis
707533|NCT00231595|Prevention|prevention
707534|NCT00231582|High-dose with autologous germ-cell tumors|high-dose with autologous germ-cell tumors
707535|NCT00231569|LDL-cholesterol|ldl-cholesterol
707536|NCT00231569|apoB-100|apob-100
707537|NCT00231569|apoB-48|apob-48
707538|NCT00231556|Epilepsy|epilepsy
707539|NCT00231556|Seizures|seizures
707540|NCT00231556|Parital Epilepsies|parital epilepsies
707541|NCT00231556|Generalized Epilepsy|generalized epilepsy
707542|NCT00231556|Tonic-Clonic Epilepsy|tonic-clonic epilepsy
707543|NCT00231556|Topiramate|topiramate
707544|NCT00231530|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
707545|NCT00231530|Obesity|obesity
707546|NCT00231530|Diabetic Diet|diabetic diet
707547|NCT00231530|Hypertension|hypertension
707548|NCT00231530|Hyperlipidemia|hyperlipidemia
707549|NCT00231530|Adult-Onset Diabetes Mellitus(AODM)|adult-onset diabetes mellitus(aodm)
707550|NCT00231504|Polymorphism P1|polymorphism p1
707551|NCT00231504|Polymorphism P2|polymorphism p2
707552|NCT00231504|FSH Receptor|fsh receptor
707553|NCT00231504|Antral follicle count|antral follicle count
707554|NCT00231504|FSH receptor polymorphism|fsh receptor polymorphism
707555|NCT00231491|Overactive bladder|overactive bladder
707556|NCT00231491|Urgency|urgency
707557|NCT00231491|Urge incontinence|urge incontinence
707558|NCT00231491|Botulinum toxin A|botulinum toxin a
707559|NCT00231491|Quality of life|quality of life
707560|NCT00231465|elderly|elderly
707561|NCT00231465|malignant pleural effusion|malignant pleural effusion
707562|NCT00231452|natural acquired immunity,|natural acquired immunity,
707563|NCT00231452|clinical malaria,|clinical malaria,
707564|NCT00231452|P. falciparum,|p. falciparum,
707565|NCT00231452|age,|age,
707566|NCT00231452|exposure,|exposure,
707567|NCT00231452|neonatal immunology,|neonatal immunology,
707568|NCT00231452|infants|infants
707569|NCT00231439|Post-polio syndrome|post-polio syndrome
707570|NCT00231439|IvIg|ivig
707571|NCT00231400|Glycogen Storage Disease Type II (GSD-II)|glycogen storage disease type ii (gsd-ii)
707572|NCT00231400|GSD-II|gsd-ii
707573|NCT00231400|Pompe Disease|pompe disease
707574|NCT00231400|Pompe Disease (late-onset)|pompe disease (late-onset)
707575|NCT00231400|Acid Maltase Deficiency Disease|acid maltase deficiency disease
707576|NCT00231400|Glycogenosis II|glycogenosis ii
707577|NCT00231387|diabetes rosiglitazone plaque|diabetes rosiglitazone plaque
707578|NCT00231374|cerebrospinal fluid|cerebrospinal fluid
707579|NCT00231374|pain in cervical spine|pain in cervical spine
707580|NCT00231374|pain in lumbar spine|pain in lumbar spine
707581|NCT00231374|myelogram|myelogram
707582|NCT00231348|Social anxiety disorder|social anxiety disorder
707583|NCT00231348|social phobia|social phobia
707584|NCT00231348|positron emission tomography (PET|positron emission tomography (pet
707585|NCT00231348|regional cerebral blood flow (rCBF)|regional cerebral blood flow (rcbf)
707586|NCT00231348|nefazodone|nefazodone
707587|NCT00231348|amygdala|amygdala
707588|NCT00231335|schizophrenia|schizophrenia
707589|NCT00231335|depression|depression
707590|NCT00231335|anxiety|anxiety
707591|NCT00231335|negative symptoms|negative symptoms
707592|NCT00231322|Schistosoma haematobium|schistosoma haematobium
707593|NCT00231322|haematuria|haematuria
707594|NCT00231322|ultrasonography|ultrasonography
707595|NCT00231322|Uganda|uganda
707596|NCT00231322|Vesical polyps|vesical polyps
707597|NCT00231309|G-CSF|g-csf
707598|NCT00231309|Bone Marrow|bone marrow
707599|NCT00231309|Hematologic malignancies|hematologic malignancies
707600|NCT00231309|Non-malignancies|non-malignancies
707601|NCT00231309|Matched sibling donor|matched sibling donor
707602|NCT00231309|Allogeneic BMT|allogeneic bmt
707603|NCT00231296|cryoablation|cryoablation
707604|NCT00231296|atrial fibrillation|atrial fibrillation
707605|NCT00231218|vitamin c|vitamin c
707606|NCT00231218|echinacea|echinacea
707607|NCT00231218|propolis|propolis
707608|NCT00231218|upper respiratory tract infection|upper respiratory tract infection
707609|NCT00231218|common cold|common cold
707610|NCT00231218|gastroenteritis|gastroenteritis
707611|NCT00231218|dietary supplement|dietary supplement
707612|NCT00231218|herbal remedy|herbal remedy
707613|NCT00231205|viability|viability
707614|NCT00231205|myocardium|myocardium
707615|NCT00231205|preejection velocity|preejection velocity
707616|NCT00231205|CAD|cad
707617|NCT00231205|echocardiography|echocardiography
707618|NCT00231205|tissue Doppler|tissue doppler
707619|NCT00231192|Diabetes|diabetes
707620|NCT00231192|Adolescents|adolescents
707621|NCT00231192|Cystic Fibrosis|cystic fibrosis
707622|NCT00231192|Insulin|insulin
707623|NCT00231192|Repaglinide|repaglinide
707624|NCT00231179|child, preschool|child, preschool
707625|NCT00231179|intelligence|intelligence
707626|NCT00231179|environment|environment
707627|NCT00231179|home visiting|home visiting
707628|NCT00231166|dose-finding|dose-finding
707629|NCT00231166|monoclonal antibody|monoclonal antibody
707630|NCT00231166|Multiple Myeloma|multiple myeloma
707631|NCT00231153|catheter site infection|catheter site infection
707632|NCT00231153|catheter colonization|catheter colonization
707633|NCT00231153|catheter related blood stream infection|catheter related blood stream infection
707634|NCT00231153|patients with central venous catheters|patients with central venous catheters
707635|NCT00231140|ALS, motor neuron disease|als, motor neuron disease
707636|NCT00231127|COPD|copd
707637|NCT00231127|Osteoporosis|osteoporosis
707638|NCT00231127|Osteopenia|osteopenia
707639|NCT00231127|Glucocorticoids|glucocorticoids
707640|NCT00231127|GOLD|gold
707641|NCT00231127|BODE|bode
707642|NCT00231114|Asthma|asthma
707643|NCT00231101|Smoking|smoking
707644|NCT00231101|Schizophrenia|schizophrenia
707645|NCT00231075|Epithelial ovary cancer F.I.G.O. stages III or IV|epithelial ovary cancer f.i.g.o. stages iii or iv
707646|NCT00231075|70 years or older|70 years or older
707647|NCT00231062|sinusitis|sinusitis
707648|NCT00231062|rhinitis|rhinitis
707649|NCT00231062|sinus surgery|sinus surgery
707650|NCT00231062|maxillary|maxillary
707651|NCT00231062|ethmoid|ethmoid
707652|NCT00231062|sphenoid|sphenoid
707653|NCT00231062|frontal|frontal
707654|NCT00231062|FESS|fess
707655|NCT00231062|sinuplasty|sinuplasty
707656|NCT00231049|Genital Herpes|genital herpes
707657|NCT00231049|HSV-2 Seropositive|hsv-2 seropositive
707658|NCT00231049|Vaccine|vaccine
707659|NCT00231023|Anterior Subtenon|anterior subtenon
707660|NCT00231023|Posterior Peribulbar|posterior peribulbar
707661|NCT00231023|Laser Photocoagulation|laser photocoagulation
707662|NCT00231023|Diabetes|diabetes
707663|NCT00231023|Diabetic Retinopathy|diabetic retinopathy
707664|NCT00231023|Diabetic Macular Edema|diabetic macular edema
707665|NCT00231023|DME|dme
707666|NCT00231010|Retnitis Pigmentosa|retnitis pigmentosa
707667|NCT00231010|Retinal Degeneration|retinal degeneration
707668|NCT00231010|Retinitis Pigmentosa|retinitis pigmentosa
707669|NCT00231010|RP|rp
707670|NCT00231010|Usher Syndrome|usher syndrome
707671|NCT00231010|USH|ush
707672|NCT00231010|Bietti Crystalline Dystrophy|bietti crystalline dystrophy
707673|NCT00231010|BCD|bcd
707674|NCT00230997|Galantamine|galantamine
707675|NCT00230997|Dementia with Lewy Bodies|dementia with lewy bodies
707676|NCT00230997|Treatment|treatment
707677|NCT00230984|Chronic Respiratory Failure|chronic respiratory failure
707678|NCT00230984|Pulmonary Rehabilitation|pulmonary rehabilitation
707679|NCT00230984|Nutritional Depletion|nutritional depletion
707680|NCT00230984|Home|home
707681|NCT00230984|COPD|copd
707682|NCT00230984|Oral Dietary Supplements|oral dietary supplements
707683|NCT00230984|Therapeutic Education|therapeutic education
707684|NCT00230984|Androgens|androgens
707685|NCT00230984|Exacerbation|exacerbation
707686|NCT00230984|Survival|survival
707687|NCT00230971|Intra-Abdominal Infections|intra-abdominal infections
707688|NCT00230971|Abscess|abscess
707689|NCT00230958|Viramidine|viramidine
707690|NCT00230958|Ribavirin|ribavirin
707691|NCT00230958|Valeant|valeant
707692|NCT00230958|Hepatitis C|hepatitis c
707693|NCT00230958|Pegylated interferon alfa-2b|pegylated interferon alfa-2b
707694|NCT00230932|Veterans|veterans
707695|NCT00230932|Pain|pain
707696|NCT00230932|Palliative Care|palliative care
707697|NCT00230932|Cardiology|cardiology
707698|NCT00230932|Reproducibility of Results|reproducibility of results
707699|NCT00230932|Health Personnel|health personnel
707700|NCT00230932|Heart Failure, Congestive|heart failure, congestive
707701|NCT00230919|Obesity,|obesity,
707702|NCT00230919|weight loss,|weight loss,
707703|NCT00230919|diet counseling|diet counseling
707704|NCT00230919|low-glycemic load|low-glycemic load
707705|NCT00230893|Antipsychotics|antipsychotics
707706|NCT00230893|PTSD|ptsd
707707|NCT00230893|Post Traumatic Stress Disorder|post traumatic stress disorder
707708|NCT00230893|monotherapy|monotherapy
707709|NCT00230893|adjunct therapy|adjunct therapy
707710|NCT00230880|Contraception behavior|contraception behavior
707711|NCT00230880|Condoms|condoms
707712|NCT00230880|Unsafe sex|unsafe sex
707713|NCT00230880|Pregnancy unwanted|pregnancy unwanted
707714|NCT00230880|Adolescent pregnancy|adolescent pregnancy
707715|NCT00230880|Condom use|condom use
707716|NCT00230880|Unprotected sex|unprotected sex
707717|NCT00230880|Unintended pregnancy|unintended pregnancy
707718|NCT00230867|herpes labialis|herpes labialis
707719|NCT00230867|cold sore|cold sore
707720|NCT00230867|acyclovir|acyclovir
707721|NCT00230867|iontophoresis|iontophoresis
707722|NCT00230867|topical|topical
707723|NCT00230854|hepatitis C|hepatitis c
707724|NCT00230854|genotype 1|genotype 1
707725|NCT00230854|non-responders|non-responders
707726|NCT00230854|viral hepatitis|viral hepatitis
707727|NCT00230841|croup|croup
707728|NCT00230841|humidity therapy|humidity therapy
707729|NCT00230841|pediatrics|pediatrics
707730|NCT00230815|Oligoanovulatory infertility|oligoanovulatory infertility
707731|NCT00230815|Follitropin alfa|follitropin alfa
707732|NCT00230815|Pen device|pen device
707733|NCT00230815|Gonal-f®|gonal-f®
707734|NCT00230815|Recombinant Human Choriogonadotropin (r-hCG)|recombinant human choriogonadotropin (r-hcg)
707735|NCT00230815|Ovidrel®|ovidrel®
707736|NCT00230802|pregnancy|pregnancy
707737|NCT00230802|hypothyroidism|hypothyroidism
707738|NCT00230802|levothyroxine|levothyroxine
707739|NCT00230750|influenza, elderly, vaccine, H5N1, parent protocol|influenza, elderly, vaccine, h5n1, parent protocol
707740|NCT00230737|Aged|aged
707741|NCT00230737|Sleep|sleep
707742|NCT00230737|Insomnia|insomnia
707743|NCT00230737|Melatonin|melatonin
707744|NCT00230737|Neurobehavioral Manifestations|neurobehavioral manifestations
707745|NCT00230737|Circadian Rhythms|circadian rhythms
707746|NCT00230737|Human|human
707747|NCT00230737|Polysomnography|polysomnography
707748|NCT00230737|Elderly|elderly
707749|NCT00230724|Exercise maintenance|exercise maintenance
707750|NCT00230711|Physical activity|physical activity
707751|NCT00230711|Cancer follow-up care|cancer follow-up care
707752|NCT00230698|Epilepsy|epilepsy
707753|NCT00230698|Partial Epilepsies|partial epilepsies
707754|NCT00230698|Seizures|seizures
707755|NCT00230698|Topiramate|topiramate
707756|NCT00230685|Pulmonary arteriovenous malformations|pulmonary arteriovenous malformations
707757|NCT00230646|cancer recovery|cancer recovery
707758|NCT00230646|physical activity|physical activity
707759|NCT00230607|alpha Galactosidase A|alpha galactosidase a
707760|NCT00230607|aGAL|agal
707761|NCT00230607|rh aGAL|rh agal
707762|NCT00230607|Fabry|fabry
707764|NCT00230607|Fabrazyme|fabrazyme
707765|NCT00230607|Lysosomal Storage Disorder|lysosomal storage disorder
707766|NCT00230607|Enzyme Replacement Therapy (ERT)|enzyme replacement therapy (ert)
707767|NCT00230581|IBS-d, IBS|ibs-d, ibs
707768|NCT00230568|Mild to Moderate Alzheimer's Disease|mild to moderate alzheimer's disease
707769|NCT00230568|Hispanic|hispanic
707770|NCT00230568|Latino|latino
707771|NCT00230568|Spanish-speaking|spanish-speaking
707772|NCT00230555|child, preschool|child, preschool
707773|NCT00230555|environment|environment
707774|NCT00230555|intelligence|intelligence
707775|NCT00230542|platinum-sensitive recurrence|platinum-sensitive recurrence
707776|NCT00230542|carboplatin|carboplatin
707777|NCT00230542|pemetrexed|pemetrexed
707778|NCT00230529|Plaque-type Psoriasis|plaque-type psoriasis
707779|NCT00230529|infliximab|infliximab
707780|NCT00230529|Remicade|remicade
707781|NCT00230529|biologics|biologics
707782|NCT00230516|N/A this study is being conducted with healthy volunteers|n/a this study is being conducted with healthy volunteers
707783|NCT00230503|Hepatitis B, Chronic|hepatitis b, chronic
707784|NCT00230503|Hepatitis B Virus|hepatitis b virus
707785|NCT00230503|Pradefovir Mesylate|pradefovir mesylate
707786|NCT00230503|Adefovir Dipivoxyl|adefovir dipivoxyl
707787|NCT00230490|Hepatitis B, Chronic|hepatitis b, chronic
707788|NCT00230490|Hepatitis B Virus|hepatitis b virus
707789|NCT00230490|Pradefovir Mesylate|pradefovir mesylate
707790|NCT00230490|Adefovir Dipivoxyl|adefovir dipivoxyl
707791|NCT00230477|Hepatitis B|hepatitis b
707792|NCT00230464|diabetes|diabetes
707793|NCT00230464|rate of appearance of glucose|rate of appearance of glucose
707794|NCT00230464|insulin secretion|insulin secretion
707795|NCT00230464|glucagon|glucagon
707796|NCT00230425|Alcohol Abuse|alcohol abuse
707797|NCT00230425|Anxiety Disorders|anxiety disorders
707798|NCT00230425|Mood Disorders|mood disorders
707799|NCT00230412|Kidney Failure, Acute|kidney failure, acute
707800|NCT00230412|Acute Renal Failure|acute renal failure
707801|NCT00230412|Kidney Failure|kidney failure
707802|NCT00230412|Heat-Shock Proteins|heat-shock proteins
707803|NCT00230412|Children|children
707804|NCT00230373|Localized scleroderma|localized scleroderma
707805|NCT00230360|constipation|constipation
707806|NCT00230360|fecal incontinence|fecal incontinence
707807|NCT00230360|diagnosis|diagnosis
707808|NCT00230360|children|children
707809|NCT00230308|Head and Neck Cancer|head and neck cancer
707810|NCT00230243|Aspergillosis|aspergillosis
707811|NCT00230243|CandidiasisMucormycosis|candidiasismucormycosis
707812|NCT00230243|FusariosisCryptococcosis|fusariosiscryptococcosis
707813|NCT00230243|Endemic Fungal infections|endemic fungal infections
707814|NCT00230243|Phaeohyphomycosis|phaeohyphomycosis
707815|NCT00230217|Relapse|relapse
707816|NCT00230217|Refracturing|refracturing
707817|NCT00230217|Leukemia|leukemia
707818|NCT00230217|Lymphoma|lymphoma
707819|NCT00230217|Solid Tumor|solid tumor
707820|NCT00230204|Multiple sclerosis|multiple sclerosis
707821|NCT00230204|Antibodies|antibodies
707822|NCT00230204|Serum|serum
707823|NCT00230204|Infectious agents|infectious agents
707824|NCT00230204|Immunoglobulin G|immunoglobulin g
707825|NCT00230204|Immunoglobulin M|immunoglobulin m
707826|NCT00230191|Oral|oral
707827|NCT00230191|Mucositis|mucositis
707828|NCT00230191|Stomatitis|stomatitis
707829|NCT00230191|Head and Neck Cancer|head and neck cancer
707830|NCT00230178|Hyperuricemia|hyperuricemia
707831|NCT00230178|Tumor lysis syndrome|tumor lysis syndrome
707832|NCT00230178|Leukemia|leukemia
707833|NCT00230178|Lymphoma|lymphoma
707834|NCT00230178|Myelodysplastic Syndromes|myelodysplastic syndromes
707835|NCT00230178|Solid tumor cancers|solid tumor cancers
707836|NCT00230178|Solid Tumor cancers with hyperuricemia Hyperuricemia (cancer patients only)|solid tumor cancers with hyperuricemia hyperuricemia (cancer patients only)
707837|NCT00230178|Tumor lysis syndrome (cancer patients only)|tumor lysis syndrome (cancer patients only)
707838|NCT00230165|Platelets|platelets
707839|NCT00230165|Erythrocytes|erythrocytes
707840|NCT00230165|Leukocytes|leukocytes
707841|NCT00230165|Coagulation|coagulation
707842|NCT00230165|Thrombosis|thrombosis
707843|NCT00230126|African Americans|african americans
707844|NCT00230113|NAFLD|nafld
707845|NCT00230113|NASH|nash
707846|NCT00230113|Fatty Liver Disease|fatty liver disease
707847|NCT00230113|Omega-3 Fatty Acid|omega-3 fatty acid
707848|NCT00230113|Fish oil|fish oil
707849|NCT00230100|Gender differences|gender differences
707850|NCT00230100|Women|women
707851|NCT00230100|Substance use disorders|substance use disorders
707852|NCT00230100|Alcohol use disorders|alcohol use disorders
707853|NCT00230100|Treatment outcomes|treatment outcomes
707854|NCT00230100|Group therapy|group therapy
707855|NCT00230087|diabetes|diabetes
707856|NCT00230087|nafld|nafld
707857|NCT00230087|nash|nash
707858|NCT00230087|phlebotomy|phlebotomy
707859|NCT00230074|Amyotrophic Lateral Sclerosis; ALS|amyotrophic lateral sclerosis; als
707861|NCT00230009|child abuse, child neglect, substance use, violence exposure, brief intervention|child abuse, child neglect, substance use, violence exposure, brief intervention
707862|NCT00229996|endometriosis|endometriosis
707863|NCT00229996|pelvic pain|pelvic pain
707864|NCT00229996|treatment|treatment
707865|NCT00229983|Substance use disorders|substance use disorders
707866|NCT00229983|Substance abuse|substance abuse
707867|NCT00229983|Alcohol abuse|alcohol abuse
707868|NCT00229983|Drug abuse|drug abuse
707869|NCT00229957|Occupational therapy|occupational therapy
707870|NCT00229957|Physical therapy techniques|physical therapy techniques
707871|NCT00229957|Primary health care|primary health care
707872|NCT00229957|Chronic disease|chronic disease
707873|NCT00229957|Rehabilitation|rehabilitation
707874|NCT00229957|Disease management|disease management
707875|NCT00229957|Self care|self care
707876|NCT00229944|Azithromycin|azithromycin
707877|NCT00229944|V. cholerae O1 / O139|v. cholerae o1 / o139
707878|NCT00229944|adults|adults
707879|NCT00229944|Bangladesh|bangladesh
707880|NCT00229944|Clinical trial|clinical trial
707881|NCT00229931|CATARACT EXTRACTION|cataract extraction
707882|NCT00229931|MACULAR EDEMA|macular edema
707883|NCT00229931|DIABETES|diabetes
707884|NCT00229931|FOCAL LASER|focal laser
707885|NCT00229931|TRIAMCINOLONE|triamcinolone
707886|NCT00229918|Diabetic macular edema|diabetic macular edema
707887|NCT00229918|Clinically significant macular edema|clinically significant macular edema
707888|NCT00229905|pediatric health|pediatric health
707889|NCT00229905|children|children
707890|NCT00229905|single case study|single case study
707891|NCT00229892|pediatric health|pediatric health
707892|NCT00229892|cardiac|cardiac
707893|NCT00229892|small incisions|small incisions
707894|NCT00229892|operations|operations
707895|NCT00229892|minimally invasive|minimally invasive
707896|NCT00229879|pediatric health|pediatric health
707897|NCT00229879|rare tumor|rare tumor
707898|NCT00229879|children|children
707899|NCT00229879|cardiac|cardiac
707900|NCT00229866|newborn|newborn
707901|NCT00229866|pediatric health|pediatric health
707902|NCT00229866|Feeding difficulty|feeding difficulty
707903|NCT00229866|discharge with a NG tube|discharge with a ng tube
707904|NCT00229866|G-tube placement|g-tube placement
707905|NCT00229866|Nissen fundoplication|nissen fundoplication
707906|NCT00229853|Children's Healthcare of Atlanta|children's healthcare of atlanta
707907|NCT00229853|pediatric|pediatric
707908|NCT00229853|Thoracoscopic Vascular ring|thoracoscopic vascular ring
707909|NCT00229853|diverticulopexy|diverticulopexy
707910|NCT00229853|Vascular Ring Division|vascular ring division
707911|NCT00229840|MRI, fMRI, Epilepsy, Pediatric|mri, fmri, epilepsy, pediatric
707912|NCT00229827|pediatric health|pediatric health
707913|NCT00229827|cardiac|cardiac
707914|NCT00229827|pediatric population|pediatric population
707915|NCT00229827|congenital heart surgery|congenital heart surgery
707916|NCT00229827|left to right shunt lesions|left to right shunt lesions
707917|NCT00229827|heart surgery|heart surgery
707918|NCT00229827|Atrioventricular canal defects|atrioventricular canal defects
707919|NCT00229814|Tectal Plate Glioma|tectal plate glioma
707920|NCT00229814|Tumor|tumor
707921|NCT00229814|Brain|brain
707922|NCT00229814|MRI|mri
707923|NCT00229814|Spectroscopy|spectroscopy
707924|NCT00229801|Renal Function, MRI|renal function, mri
707925|NCT00229788|orthotopic heart transplantation|orthotopic heart transplantation
707926|NCT00229775|Plasmodium falciparum malaria|plasmodium falciparum malaria
707927|NCT00229775|malaria|malaria
707928|NCT00229775|artemether lumafantrine|artemether lumafantrine
707929|NCT00229775|chloroquine|chloroquine
707930|NCT00229775|sulfadoxine pyrimethamine|sulfadoxine pyrimethamine
707931|NCT00229775|Coartem|coartem
707932|NCT00229762|pneumococcal vaccination coverage with no disease or efficacy outcomes recorded|pneumococcal vaccination coverage with no disease or efficacy outcomes recorded
707933|NCT00229749|HCV|hcv
707934|NCT00229723|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
707935|NCT00229723|Head and Neck Squamous Cell Cancer|head and neck squamous cell cancer
707936|NCT00229723|Squamous Cell Carcinoma|squamous cell carcinoma
707937|NCT00229723|Squamous Cell Cancer|squamous cell cancer
707938|NCT00229710|Diabetes Mellitus, Type II|diabetes mellitus, type ii
707939|NCT00229710|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
707940|NCT00229697|Breast cancer|breast cancer
707941|NCT00229697|metastatic breast cancer|metastatic breast cancer
707942|NCT00229684|Type 2 Diabetes|type 2 diabetes
707943|NCT00229658|diabetes|diabetes
707944|NCT00229658|pramlintide|pramlintide
707945|NCT00229658|Symlin|symlin
707946|NCT00229658|Amylin|amylin
707947|NCT00229658|phase 4|phase 4
707948|NCT00229645|Major Depression|major depression
707949|NCT00229645|Anxiety|anxiety
707950|NCT00229632|Friedreich's Ataxia|friedreich's ataxia
707951|NCT00229632|Idebenone|idebenone
707952|NCT00229632|Ataxia|ataxia
707953|NCT00229632|Drug Trial|drug trial
707954|NCT00229632|Randomized Trial|randomized trial
707955|NCT00229632|Friedreich Ataxia|friedreich ataxia
707956|NCT00229632|FA|fa
707957|NCT00229619|rituxan|rituxan
707958|NCT00229619|Immunosuppression|immunosuppression
707959|NCT00229619|Bone Marrow Failure|bone marrow failure
707960|NCT00229619|Monoclonal Antibody Therapy|monoclonal antibody therapy
707961|NCT00229619|Diamond Blackfan Anemia (DBA)|diamond blackfan anemia (dba)
707962|NCT00229619|T -Cells|t -cells
707963|NCT00229619|B-Cells|b-cells
707964|NCT00229619|Hematopoiesis|hematopoiesis
707965|NCT00229619|Moderate Aplastic Anemia (MAA)|moderate aplastic anemia (maa)
707966|NCT00229619|Diamond-Blackfan Anemia|diamond-blackfan anemia
707967|NCT00229619|DBA|dba
707968|NCT00229619|Pure Red Cell Aplasia|pure red cell aplasia
707969|NCT00229619|PRCA|prca
707970|NCT00229593|Male contraception|male contraception
707971|NCT00229593|Androgen|androgen
707972|NCT00229593|Progestin|progestin
707973|NCT00229593|Spermatogenesis|spermatogenesis
707974|NCT00229593|Gonadotropin suppression|gonadotropin suppression
707975|NCT00229593|Testosterone|testosterone
707976|NCT00229593|Nestorone|nestorone
707977|NCT00229580|Brief Intervention|brief intervention
707978|NCT00229580|Motivational Interviewing|motivational interviewing
707979|NCT00229580|Health Psychology|health psychology
707980|NCT00229580|Alcohol|alcohol
707981|NCT00229580|Hepatitis C|hepatitis c
707982|NCT00229580|Patient Education|patient education
707983|NCT00229567|ketamine|ketamine
707984|NCT00229567|lidocaine|lidocaine
707985|NCT00229567|postoperative ileus|postoperative ileus
707986|NCT00229567|randomized controlled trial|randomized controlled trial
707987|NCT00229567|acute postoperative pain|acute postoperative pain
707988|NCT00229554|health surveys|health surveys
707989|NCT00229554|questionnaires|questionnaires
707990|NCT00229541|Medical in-patient rehabilitation|medical in-patient rehabilitation
707991|NCT00229541|Gainfully employed|gainfully employed
707992|NCT00229541|Work incapacity|work incapacity
707993|NCT00229515|Myocardial infarction|myocardial infarction
707994|NCT00229515|Revascularization|revascularization
707995|NCT00229515|Stent|stent
707996|NCT00229515|ST segment elevation|st segment elevation
707997|NCT00229476|Depression|depression
707998|NCT00229476|EEG|eeg
707999|NCT00229476|QEEG|qeeg
708000|NCT00229476|cordance|cordance
708001|NCT00229476|Zoloft|zoloft
708002|NCT00229476|sertraline|sertraline
708003|NCT00229476|placebo|placebo
708004|NCT00229476|electroencephalogram|electroencephalogram
708005|NCT00229476|brain|brain
708006|NCT00229476|antidepressants|antidepressants
708007|NCT00229463|Depression|depression
708008|NCT00229463|genetic|genetic
708009|NCT00229463|gene|gene
708010|NCT00229463|antidepressant|antidepressant
708011|NCT00229463|research|research
708012|NCT00229450|depression|depression
708013|NCT00229450|menopause|menopause
708014|NCT00229450|perimenopause|perimenopause
708015|NCT00229450|mood|mood
708016|NCT00229450|memory|memory
708017|NCT00229450|perimenopausal|perimenopausal
708018|NCT00229450|antidepressant|antidepressant
708019|NCT00229450|estrogen|estrogen
708020|NCT00229437|Diabetic Mononeuropathy|diabetic mononeuropathy
708021|NCT00229437|Diabetic Neuralgia|diabetic neuralgia
708022|NCT00229437|Mononeuropathy, Diabetic|mononeuropathy, diabetic
708023|NCT00229437|Neuralgia, Diabetic|neuralgia, diabetic
708024|NCT00229437|Diabetic Polyneuropathy|diabetic polyneuropathy
708025|NCT00229437|Drug Therapy|drug therapy
708026|NCT00229424|lafutidine|lafutidine
708027|NCT00229424|reflux oesophagitis|reflux oesophagitis
708028|NCT00229424|Gastroesophageal Reflux|gastroesophageal reflux
708029|NCT00229424|famotidine|famotidine
708030|NCT00229424|Double Blind|double blind
708031|NCT00229424|Controlled Study|controlled study
708032|NCT00229424|H2 receptor antagonist|h2 receptor antagonist
708033|NCT00229424|H2-blocker|h2-blocker
708034|NCT00229411|intensive care|intensive care
708035|NCT00229411|teamwork|teamwork
708036|NCT00229411|medical errors|medical errors
708037|NCT00229411|education|education
708038|NCT00229411|simulation|simulation
708039|NCT00229333|Escitalopram|escitalopram
708040|NCT00229333|Depression|depression
708041|NCT00229333|Dementia|dementia
708042|NCT00229333|Treatment|treatment
708608|NCT00226421|oxymorphone|oxymorphone
708043|NCT00229333|Depressive Syndrome in Alzheimer’s Disease|depressive syndrome in alzheimer’s disease
708044|NCT00229333|Depressive Syndrome in Vascular Dementia|depressive syndrome in vascular dementia
708045|NCT00229333|Depressive Syndrome in Mixed Vascular and Alzheimer’s Dementia|depressive syndrome in mixed vascular and alzheimer’s dementia
708046|NCT00229307|Post traumatic stress disorder|post traumatic stress disorder
708047|NCT00229268|Healthy Volunteers|healthy volunteers
708048|NCT00229255|Non-Alcoholic hepatic steatosis|non-alcoholic hepatic steatosis
708049|NCT00229242|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
708050|NCT00229242|Echocardiography|echocardiography
708051|NCT00229242|Diastolic function|diastolic function
708052|NCT00229242|Left ventricular mass regression|left ventricular mass regression
708053|NCT00229229|Obesity|obesity
708054|NCT00229229|Cardiovascular Disease|cardiovascular disease
708055|NCT00229229|Metabolic Syndrome|metabolic syndrome
708056|NCT00229229|Canada Food Guide|canada food guide
708057|NCT00229229|Glycemic Index|glycemic index
708058|NCT00229229|Glycemic Load|glycemic load
708059|NCT00229203|Myeloma|myeloma
708060|NCT00229203|Aplidin|aplidin
708061|NCT00229203|Plitidepsin|plitidepsin
708062|NCT00229203|PharmaMar|pharmamar
708063|NCT00229190|Nasal lavage fluid|nasal lavage fluid
708064|NCT00229190|Eosinophils|eosinophils
708065|NCT00229190|Reproducibility of results|reproducibility of results
708066|NCT00229177|ONO-2506|ono-2506
708067|NCT00229177|stroke|stroke
708068|NCT00229177|Acute ischemic stroke|acute ischemic stroke
708069|NCT00229164|Primary Dysmenorrhea,|primary dysmenorrhea,
708070|NCT00229164|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
708071|NCT00229138|De novo kidney recipients,|de novo kidney recipients,
708072|NCT00229138|EC-MPS,|ec-mps,
708073|NCT00229138|tacrolimus,|tacrolimus,
708074|NCT00229138|efficacy,|efficacy,
708075|NCT00229138|safety,|safety,
708076|NCT00229138|glomerular filtration rate|glomerular filtration rate
708077|NCT00229138|Treatment in de novo kidney recipients|treatment in de novo kidney recipients
708078|NCT00229125|Alcohol Withdrawal Syndrome|alcohol withdrawal syndrome
708079|NCT00229125|CIWA-Ar|ciwa-ar
708080|NCT00229125|Acoustic Startle Procedure|acoustic startle procedure
708081|NCT00229125|Rebound Effect|rebound effect
708082|NCT00229073|dapoxetine|dapoxetine
708083|NCT00229073|premature ejaculation|premature ejaculation
708084|NCT00229073|ejaculation|ejaculation
708085|NCT00229073|sexual dysfunction|sexual dysfunction
708086|NCT00229073|orgasmic disorder|orgasmic disorder
708087|NCT00229073|sexual intercourse|sexual intercourse
708088|NCT00229060|Complicated Intra-Abdominal Infections|complicated intra-abdominal infections
708089|NCT00229060|Appendicitis|appendicitis
708090|NCT00229060|Cholecystitis|cholecystitis
708091|NCT00229060|Peritonitis|peritonitis
708092|NCT00229047|Ischemic Preconditioning|ischemic preconditioning
708093|NCT00229047|Microvascular Perfusion|microvascular perfusion
708094|NCT00229047|Inflammation|inflammation
708095|NCT00229047|Ischemia and Reperfusion|ischemia and reperfusion
708096|NCT00229047|Chronic Limb Ischemia|chronic limb ischemia
708097|NCT00229034|Systemic Inflammation|systemic inflammation
708098|NCT00229034|Microvascular Perfusion|microvascular perfusion
708099|NCT00229034|Septic Shock|septic shock
708100|NCT00229021|Complicated Urinary Tract Infection|complicated urinary tract infection
708101|NCT00229021|Pyelonephritis|pyelonephritis
708102|NCT00229008|Ceftobiprole medocaril|ceftobiprole medocaril
708103|NCT00229008|Nosocomial Pneumonia|nosocomial pneumonia
708104|NCT00229008|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
708105|NCT00229008|Cephalosporins|cephalosporins
708106|NCT00229008|Methicillin-Resistant Staphylococcus Aureus|methicillin-resistant staphylococcus aureus
708107|NCT00228995|Anemia|anemia
708108|NCT00228995|Subcutaneous injection|subcutaneous injection
708109|NCT00228995|PROCRIT|procrit
708110|NCT00228995|Erythropoietin|erythropoietin
708111|NCT00228995|Epoetin Alfa|epoetin alfa
708112|NCT00228995|Hemoglobin Level|hemoglobin level
708113|NCT00228995|Elderly|elderly
708114|NCT00228982|Complicated Skin Infections|complicated skin infections
708115|NCT00228982|Infectious Skin Diseases|infectious skin diseases
708116|NCT00228982|Bacterial Skin Diseases|bacterial skin diseases
708117|NCT00228982|Staphylococcal Skin Infections|staphylococcal skin infections
708118|NCT00228982|Cephalosporin|cephalosporin
708119|NCT00228956|Breast Cancer|breast cancer
708120|NCT00228956|Aromatase Inhibitor|aromatase inhibitor
708121|NCT00228956|Letrozole|letrozole
708122|NCT00228956|Exemestane|exemestane
708123|NCT00228943|Breast cancer survivorship|breast cancer survivorship
708124|NCT00228943|Hot Flashes|hot flashes
708125|NCT00228943|Serotonin|serotonin
708126|NCT00228930|Breast Cancer|breast cancer
708127|NCT00228930|Tamoxifen|tamoxifen
708128|NCT00228930|Prevention|prevention
708129|NCT00228917|Hib & Neisseria meningitidis serogroups A & C diseases|hib & neisseria meningitidis serogroups a & c diseases
708130|NCT00228904|Pulsatile intravenous insulin|pulsatile intravenous insulin
708131|NCT00228904|Oral carbohydrate loading|oral carbohydrate loading
708132|NCT00228904|Respiratory Quotients|respiratory quotients
708133|NCT00228904|Hypoglycemia|hypoglycemia
708134|NCT00228904|Diabetic Neuropathy|diabetic neuropathy
709202|NCT00223795|Obesity|obesity
708135|NCT00228904|Diabetes Mellitus, with complications|diabetes mellitus, with complications
708136|NCT00228891|Pulsatile intravenous insulin|pulsatile intravenous insulin
708137|NCT00228891|Oral carbohydrate loading|oral carbohydrate loading
708138|NCT00228891|Respiratory Quotients|respiratory quotients
708139|NCT00228891|Hypoglycemia|hypoglycemia
708140|NCT00228891|Diabetic Neuropathy|diabetic neuropathy
708141|NCT00228878|Diabetes|diabetes
708142|NCT00228878|Pulsatile intravenous insulin|pulsatile intravenous insulin
708143|NCT00228878|Oral carbohydrate loading|oral carbohydrate loading
708144|NCT00228878|Respiratory Quotients|respiratory quotients
708145|NCT00228878|Hypoglycemia|hypoglycemia
708146|NCT00228878|Diabetes Mellitus, with complications|diabetes mellitus, with complications
708147|NCT00228865|Pulsatile intravenous insulin|pulsatile intravenous insulin
708148|NCT00228865|Oral carbohydrate loading|oral carbohydrate loading
708149|NCT00228865|Mindstream testing|mindstream testing
708150|NCT00228865|Wechsler Memory Scale II|wechsler memory scale ii
708151|NCT00228865|Respiratory Quotients|respiratory quotients
708152|NCT00228865|Hypoglycemia|hypoglycemia
708153|NCT00228865|Diabetes Mellitus with cognitive impairment|diabetes mellitus with cognitive impairment
708154|NCT00228865|Diabetes Mellitus with complications|diabetes mellitus with complications
708155|NCT00228852|Patients with severe T-cell immune deficiency diseases|patients with severe t-cell immune deficiency diseases
708156|NCT00228839|Recipients of an allogeneic hematopoietic stem cell transplant who have acute GVHD|recipients of an allogeneic hematopoietic stem cell transplant who have acute gvhd
708157|NCT00228696|late effects|late effects
708158|NCT00228670|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
708159|NCT00228670|herpesvirus|herpesvirus
708160|NCT00228670|lung biopsy|lung biopsy
708161|NCT00228670|Having diagnosed lung disease|having diagnosed lung disease
708162|NCT00228670|Scheduled to have a lung biopsy as part of the evaluation for your lung disease|scheduled to have a lung biopsy as part of the evaluation for your lung disease
708163|NCT00228644|oxidative stress|oxidative stress
708164|NCT00228644|amino acids|amino acids
708165|NCT00228644|acetaminophen|acetaminophen
708166|NCT00228644|dietary requirements|dietary requirements
708167|NCT00228631|sickle|sickle
708168|NCT00228631|cell|cell
708169|NCT00228618|oxidative stress|oxidative stress
708170|NCT00228618|amino acids|amino acids
708171|NCT00228618|dietary requirements|dietary requirements
708172|NCT00228605|Pain|pain
708173|NCT00228605|Sudden Pain|sudden pain
708174|NCT00228605|Flares|flares
708175|NCT00228605|noncancer|noncancer
708176|NCT00228605|low back pain|low back pain
708177|NCT00228605|neuropathic pain|neuropathic pain
708178|NCT00228605|osteoarthritis pain|osteoarthritis pain
708179|NCT00228605|migraine|migraine
708180|NCT00228605|chronic headache|chronic headache
708181|NCT00228605|diabetic peripheral neuropathy|diabetic peripheral neuropathy
708182|NCT00228579|diabetes|diabetes
708183|NCT00228579|insulin resistance|insulin resistance
708184|NCT00228488|advanced non-nasopharyngeal head and neck carcinoma|advanced non-nasopharyngeal head and neck carcinoma
708185|NCT00228462|Schizophrenia|schizophrenia
708186|NCT00228449|anemia|anemia
708187|NCT00228449|chronic kidney disease|chronic kidney disease
708188|NCT00228449|CKD|ckd
708189|NCT00228449|chronic renal failure|chronic renal failure
708190|NCT00228449|CRF|crf
708191|NCT00228449|dialysis|dialysis
708192|NCT00228449|erythropoietin|erythropoietin
708193|NCT00228449|EPO|epo
708194|NCT00228449|erythropoiesis stimulating agent|erythropoiesis stimulating agent
708195|NCT00228449|ESA|esa
708196|NCT00228449|Hematide™|hematide™
708197|NCT00228449|hemodialysis|hemodialysis
708198|NCT00228449|hemoglobin|hemoglobin
708199|NCT00228449|Hb|hb
708200|NCT00228449|Hgb|hgb
708201|NCT00228449|Omontys|omontys
708202|NCT00228449|peginesatide|peginesatide
708203|NCT00228449|red blood cell|red blood cell
708204|NCT00228449|red blood cell production|red blood cell production
708205|NCT00228436|anemia|anemia
708206|NCT00228436|chronic kidney disease|chronic kidney disease
708207|NCT00228436|CKD|ckd
708208|NCT00228436|chronic renal failure|chronic renal failure
708209|NCT00228436|CRF|crf
708210|NCT00228436|dialysis|dialysis
708211|NCT00228436|erythropoietin|erythropoietin
708212|NCT00228436|EPO|epo
708213|NCT00228436|erythropoiesis stimulating agent|erythropoiesis stimulating agent
708214|NCT00228436|ESA|esa
708215|NCT00228436|Hematide™|hematide™
708216|NCT00228436|hemoglobin|hemoglobin
708217|NCT00228436|Hb|hb
708218|NCT00228436|Hgb|hgb
708219|NCT00228436|Omontys|omontys
708220|NCT00228436|peginesatide|peginesatide
708221|NCT00228436|red blood cell|red blood cell
708222|NCT00228436|red blood cell production|red blood cell production
708223|NCT00228423|Saphenous vein|saphenous vein
708224|NCT00228423|Intimal hyperplasia|intimal hyperplasia
708225|NCT00228423|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
708226|NCT00228423|Antiplatelet therapy|antiplatelet therapy
708227|NCT00228423|Clopidogrel|clopidogrel
708228|NCT00228423|Saphenous vein graft disease|saphenous vein graft disease
708229|NCT00228410|Skin Infections|skin infections
708230|NCT00228410|Skin Disease|skin disease
709691|NCT00221715|arteritis|arteritis
708231|NCT00228397|Multiple Sclerosis|multiple sclerosis
708232|NCT00228371|Epilepsy|epilepsy
708233|NCT00228371|deep brain stimulation|deep brain stimulation
708234|NCT00228371|Subthalamic nucleus|subthalamic nucleus
708235|NCT00228371|Drug resistant epilepsy|drug resistant epilepsy
708236|NCT00228345|Idiopathic Axonal Polyneuropathy|idiopathic axonal polyneuropathy
708237|NCT00228345|abnormal OGTT|abnormal ogtt
708238|NCT00228293|cardiac arrest|cardiac arrest
708239|NCT00228293|CPR|cpr
708240|NCT00228280|Apicoectomy|apicoectomy
708241|NCT00228280|Retrograde|retrograde
708242|NCT00228280|MTA|mta
708243|NCT00228267|Chronic Headache|chronic headache
708244|NCT00228267|Analgesic Rebound Headache|analgesic rebound headache
708245|NCT00228267|Chronic Daily Headache|chronic daily headache
708246|NCT00228267|Headache, Intractable|headache, intractable
708247|NCT00228267|Randomised controlled trial|randomised controlled trial
708248|NCT00228267|Propofol|propofol
708249|NCT00228254|acute respiratory infection|acute respiratory infection
708250|NCT00228254|acute lower respiratory infection|acute lower respiratory infection
708251|NCT00228254|diarrhea|diarrhea
708252|NCT00228241|Sick sinus syndrome|sick sinus syndrome
708253|NCT00228241|AV-block|av-block
708254|NCT00228228|Multiple Sclerosis|multiple sclerosis
708255|NCT00228228|T-cell vaccination|t-cell vaccination
708256|NCT00228228|Autoreactive T cells|autoreactive t cells
708257|NCT00228215|sleep|sleep
708258|NCT00228215|neonates|neonates
708259|NCT00228215|mothers|mothers
708260|NCT00228215|behavioural intervention|behavioural intervention
708261|NCT00228202|cytomegalovirus|cytomegalovirus
708262|NCT00228202|CMV|cmv
708263|NCT00228202|pregnancy|pregnancy
708264|NCT00228202|amniotic fluid|amniotic fluid
708265|NCT00228202|bone marrow|bone marrow
708266|NCT00228202|transplantation|transplantation
708267|NCT00228202|viral load|viral load
708268|NCT00228202|glycoprotein B|glycoprotein b
708269|NCT00228202|genotyping|genotyping
708270|NCT00228202|PCR|pcr
708271|NCT00228202|real-time PCR|real-time pcr
708272|NCT00228202|CMV disease|cmv disease
708273|NCT00228202|Congenital CMV infection|congenital cmv infection
708274|NCT00228189|Dendritic cells|dendritic cells
708275|NCT00228189|Colorectal cancer|colorectal cancer
708276|NCT00228189|Carcinoembryonic antigen|carcinoembryonic antigen
708277|NCT00228189|Vaccine|vaccine
708278|NCT00228189|Immunotherapy|immunotherapy
708279|NCT00228176|Metabolic syndrome|metabolic syndrome
708280|NCT00228176|Carotid Atherosclerosis|carotid atherosclerosis
708281|NCT00228163|Multiple Sclerosis Relapsing Remitting|multiple sclerosis relapsing remitting
708282|NCT00228163|Secondary Progressive|secondary progressive
708283|NCT00228163|Progressive Relapsing|progressive relapsing
708284|NCT00228150|Parkinson Disease|parkinson disease
708285|NCT00228150|levodopa|levodopa
708286|NCT00228150|dopamine agonists|dopamine agonists
708287|NCT00228124|Prostate cancer|prostate cancer
708288|NCT00228124|Continuous androgen suppression|continuous androgen suppression
708289|NCT00228124|Intermittent androgen suppression|intermittent androgen suppression
708290|NCT00228124|Bone loss|bone loss
708291|NCT00228124|Osteoporosis|osteoporosis
708292|NCT00228111|Computed tomography|computed tomography
708293|NCT00228111|wounds and injuries,non penetrating|wounds and injuries,non penetrating
708294|NCT00228111|algorithms|algorithms
708295|NCT00228111|Blunt trauma of the thorax and abdomen|blunt trauma of the thorax and abdomen
708296|NCT00228072|Hyperhidrosis|hyperhidrosis
708297|NCT00228072|Axillary|axillary
708298|NCT00228072|Excision|excision
708299|NCT00228072|Suction-curettage|suction-curettage
708300|NCT00228072|Outcome|outcome
708301|NCT00228059|Bipolar disorder, manic episode/treatment/licarbazepine|bipolar disorder, manic episode/treatment/licarbazepine
708302|NCT00228046|ADHD|adhd
708303|NCT00228046|ODD|odd
708304|NCT00228046|Conduct Disorder|conduct disorder
708305|NCT00228046|CD|cd
708306|NCT00228033|Calcium|calcium
708307|NCT00228033|Pregnancy|pregnancy
708308|NCT00228033|Postpartum Depression|postpartum depression
708309|NCT00228033|Depression|depression
708310|NCT00228020|pediatric, kidney transplantation, basiliximab|pediatric, kidney transplantation, basiliximab
708311|NCT00228007|Injection Drug Use|injection drug use
708312|NCT00228007|HIV Risk Behavior|hiv risk behavior
708313|NCT00228007|HIV Seronegativity|hiv seronegativity
708314|NCT00227994|Cholinesterase Inhibitors|cholinesterase inhibitors
708315|NCT00227994|Elderly|elderly
708316|NCT00227994|Stroke|stroke
708317|NCT00227994|Cognition|cognition
708318|NCT00227981|Depression Relapse|depression relapse
708319|NCT00227981|Maintenance Therapy|maintenance therapy
708320|NCT00227968|Manic-depressive psychosis|manic-depressive psychosis
708321|NCT00227968|Depression, bipolar|depression, bipolar
708322|NCT00227955|Major depression|major depression
708323|NCT00227942|Women|women
708324|NCT00227942|Menopause|menopause
708325|NCT00227942|Depression|depression
708326|NCT00227942|Hot flash|hot flash
708327|NCT00227942|Insomnia|insomnia
708328|NCT00227942|Sleep Disruption|sleep disruption
708329|NCT00227942|Estrogen Replacement Therapy|estrogen replacement therapy
708330|NCT00227929|Major Depressive Disorder|major depressive disorder
708331|NCT00227929|MDD|mdd
708332|NCT00227916|alcohol, marijuana|alcohol, marijuana
708333|NCT00227890|substance abuse|substance abuse
708334|NCT00227877|alcohol abuse|alcohol abuse
708335|NCT00227877|substance abuse|substance abuse
708336|NCT00227877|substance related disorders|substance related disorders
708337|NCT00227864|marijuana|marijuana
708338|NCT00227864|sexual risk|sexual risk
708339|NCT00227838|substance abuse|substance abuse
708340|NCT00227825|Behavioral Intervention|behavioral intervention
708341|NCT00227812|cocaine dependence|cocaine dependence
708342|NCT00227786|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
708343|NCT00227786|tobacco use disorder|tobacco use disorder
708344|NCT00227773|localized gastrointestinal carcinoid tumor|localized gastrointestinal carcinoid tumor
708345|NCT00227773|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
708346|NCT00227773|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
708347|NCT00227773|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
708348|NCT00227773|recurrent islet cell carcinoma|recurrent islet cell carcinoma
708349|NCT00227773|gastrinoma|gastrinoma
708350|NCT00227773|insulinoma|insulinoma
708351|NCT00227773|WDHA syndrome|wdha syndrome
708352|NCT00227773|glucagonoma|glucagonoma
708353|NCT00227773|pancreatic polypeptide tumor|pancreatic polypeptide tumor
708354|NCT00227773|somatostatinoma|somatostatinoma
708355|NCT00227747|adenocarcinoma of the rectum|adenocarcinoma of the rectum
708356|NCT00227747|stage II rectal cancer|stage ii rectal cancer
708357|NCT00227747|stage III rectal cancer|stage iii rectal cancer
708358|NCT00227734|stage IV colon cancer|stage iv colon cancer
708359|NCT00227734|stage IV rectal cancer|stage iv rectal cancer
708360|NCT00227734|recurrent colon cancer|recurrent colon cancer
708361|NCT00227734|recurrent rectal cancer|recurrent rectal cancer
708362|NCT00227721|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
708363|NCT00227721|peritoneal cavity cancer|peritoneal cavity cancer
708364|NCT00227708|adenocarcinoma of the lung|adenocarcinoma of the lung
708365|NCT00227708|adenosquamous cell lung cancer|adenosquamous cell lung cancer
708366|NCT00227708|large cell lung cancer|large cell lung cancer
708367|NCT00227708|squamous cell lung cancer|squamous cell lung cancer
708368|NCT00227708|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
708369|NCT00227708|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
708370|NCT00227708|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
708371|NCT00227695|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
708372|NCT00227695|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
708373|NCT00227695|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
708374|NCT00227695|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
708375|NCT00227695|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
708376|NCT00227695|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
708377|NCT00227695|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
708378|NCT00227695|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
708379|NCT00227695|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
708380|NCT00227695|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
708381|NCT00227695|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
708382|NCT00227695|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
708383|NCT00227695|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
708384|NCT00227695|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
708385|NCT00227695|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
708386|NCT00227695|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
708387|NCT00227695|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
708388|NCT00227695|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
708389|NCT00227682|refractory multiple myeloma|refractory multiple myeloma
708390|NCT00227669|uterine leiomyosarcoma|uterine leiomyosarcoma
708391|NCT00227669|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
708392|NCT00227669|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
708393|NCT00227669|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
708394|NCT00227669|stage III uterine sarcoma|stage iii uterine sarcoma
708395|NCT00227669|stage IV uterine sarcoma|stage iv uterine sarcoma
708396|NCT00227669|recurrent uterine sarcoma|recurrent uterine sarcoma
708397|NCT00227669|adult leiomyosarcoma|adult leiomyosarcoma
708398|NCT00227656|stage IV breast cancer|stage iv breast cancer
708399|NCT00227656|recurrent breast cancer|recurrent breast cancer
708400|NCT00227656|male breast cancer|male breast cancer
708401|NCT00227656|tumors metastatic to brain|tumors metastatic to brain
708402|NCT00227630|epithelial mesothelioma|epithelial mesothelioma
708403|NCT00227630|sarcomatous mesothelioma|sarcomatous mesothelioma
708404|NCT00227630|localized malignant mesothelioma|localized malignant mesothelioma
708405|NCT00227630|recurrent malignant mesothelioma|recurrent malignant mesothelioma
708406|NCT00227617|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
708407|NCT00227617|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
710372|NCT00218166|cocaine|cocaine
708408|NCT00227617|pulmonary carcinoid tumor|pulmonary carcinoid tumor
708409|NCT00227617|gastrinoma|gastrinoma
708410|NCT00227617|insulinoma|insulinoma
708411|NCT00227617|WDHA syndrome|wdha syndrome
708412|NCT00227617|glucagonoma|glucagonoma
708413|NCT00227617|pancreatic polypeptide tumor|pancreatic polypeptide tumor
708414|NCT00227617|somatostatinoma|somatostatinoma
708415|NCT00227617|recurrent islet cell carcinoma|recurrent islet cell carcinoma
708416|NCT00227617|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
708417|NCT00227565|extensive stage small cell lung cancer|extensive stage small cell lung cancer
708418|NCT00227539|stage I non-small cell lung cancer|stage i non-small cell lung cancer
708419|NCT00227539|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
708420|NCT00227539|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
708421|NCT00227539|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
708422|NCT00227526|Colon|colon
708423|NCT00227526|Surgery|surgery
708424|NCT00227526|Prehabilitation|prehabilitation
708425|NCT00227526|Exercise|exercise
708426|NCT00227500|Hyperlipidaemia|hyperlipidaemia
708427|NCT00227500|Lipid metabolism|lipid metabolism
708428|NCT00227500|Glucose metabolism|glucose metabolism
708429|NCT00227500|HMG CoA reductase inhibitors|hmg coa reductase inhibitors
708430|NCT00227500|Lipodystrophy|lipodystrophy
708431|NCT00227500|Cardiovascular disease|cardiovascular disease
708432|NCT00227500|Treatment Experienced|treatment experienced
708433|NCT00227500|HIV|hiv
708434|NCT00227487|autism|autism
708435|NCT00227487|intestine|intestine
708436|NCT00227487|disaccharidases|disaccharidases
708437|NCT00227487|inflammation|inflammation
708438|NCT00227487|permeability|permeability
708439|NCT00227474|stage IIIB breast cancer|stage iiib breast cancer
708440|NCT00227474|stage IIIC breast cancer|stage iiic breast cancer
708441|NCT00227474|stage IV breast cancer|stage iv breast cancer
708442|NCT00227461|Aphasia|aphasia
708443|NCT00227461|Stroke|stroke
708444|NCT00227448|Ischemic|ischemic
708445|NCT00227448|Stroke|stroke
708446|NCT00227422|Neisseria meningitidis serogroups A & C diseases|neisseria meningitidis serogroups a & c diseases
708447|NCT00227422|Hib diseases|hib diseases
708448|NCT00227409|Repeated chelation therapy|repeated chelation therapy
708449|NCT00227409|Progressive renal insufficiency|progressive renal insufficiency
708450|NCT00227409|Body lead burden|body lead burden
708451|NCT00227409|Long-term outcome|long-term outcome
708452|NCT00227409|Glomerular filtration rate|glomerular filtration rate
708453|NCT00227383|Diabetes|diabetes
708454|NCT00227383|gastroparesis|gastroparesis
708455|NCT00227383|electroacupuncture|electroacupuncture
708456|NCT00227370|Acute rejection|acute rejection
708457|NCT00227370|Non-CMV infections|non-cmv infections
708458|NCT00227370|Resistance|resistance
708459|NCT00227357|HIV|hiv
708460|NCT00227357|AIDS|aids
708461|NCT00227357|Buprenorphine|buprenorphine
708462|NCT00227357|Methadone|methadone
708463|NCT00227357|Primary care|primary care
708464|NCT00227357|dual diagnosis|dual diagnosis
708465|NCT00227357|ptsd|ptsd
708466|NCT00227331|Pneumonia|pneumonia
708467|NCT00227305|Schizophrenia|schizophrenia
708468|NCT00227305|Bipolar I Disorder|bipolar i disorder
708469|NCT00227292|Low back pain|low back pain
708470|NCT00227292|Depression|depression
708471|NCT00227279|Grass pollen allergy|grass pollen allergy
708472|NCT00227279|Hayfever|hayfever
708473|NCT00227279|Allergen immunotherapy|allergen immunotherapy
708474|NCT00227279|Specific immunotherapy|specific immunotherapy
708475|NCT00227266|Spinal Muscular Atrophy (SMA)|spinal muscular atrophy (sma)
708476|NCT00227266|SMA Type 2|sma type 2
708477|NCT00227266|SMA Type 3|sma type 3
708478|NCT00227253|Phenotype|phenotype
708479|NCT00227253|Growth|growth
708480|NCT00227253|Genotype|genotype
708481|NCT00227253|Chromosome 18|chromosome 18
708482|NCT00227201|African-American|african-american
708483|NCT00227201|Hypertension|hypertension
708484|NCT00227201|Complementary medicine|complementary medicine
708485|NCT00227201|Medication adherence|medication adherence
708486|NCT00227175|African American|african american
708487|NCT00227175|Hypertension|hypertension
708488|NCT00227175|Medication adherence|medication adherence
708489|NCT00227175|Risk reduction|risk reduction
708490|NCT00227162|Asthma|asthma
708491|NCT00227162|Behavior change|behavior change
708492|NCT00227162|Physical activity|physical activity
708493|NCT00227162|Risk reduction|risk reduction
708494|NCT00227149|C06.552.380.705.440|c06.552.380.705.440
708495|NCT00227136|5Hydroxytryptamine|5hydroxytryptamine
708496|NCT00227136|Chromogranin A|chromogranin a
708497|NCT00227136|5HIAA|5hiaa
708498|NCT00227136|carcinoid|carcinoid
708499|NCT00227123|Bipolar, cocaine, methamphetamine,quetiapine,risperidone|bipolar, cocaine, methamphetamine,quetiapine,risperidone
708500|NCT00227110|NASH, IGT, T2DM|nash, igt, t2dm
708501|NCT00227097|therapeutic education|therapeutic education
708502|NCT00227097|thrombi embolic disease|thrombi embolic disease
708503|NCT00227084|Mammary glands|mammary glands
708504|NCT00227084|hemostasis|hemostasis
708505|NCT00227084|Mammaplasty|mammaplasty
708506|NCT00227071|accidental falls|accidental falls
708507|NCT00227071|osteoporosis|osteoporosis
708508|NCT00227071|risk factors|risk factors
708509|NCT00227058|allergic rhinitis|allergic rhinitis
708510|NCT00227045|Kidney Transplantation|kidney transplantation
708511|NCT00227032|adult giant cell glioblastoma|adult giant cell glioblastoma
708512|NCT00227032|adult gliosarcoma|adult gliosarcoma
708513|NCT00227032|adult glioblastoma|adult glioblastoma
708514|NCT00227032|recurrent adult brain tumor|recurrent adult brain tumor
708515|NCT00226915|ovarian neoplasms|ovarian neoplasms
708516|NCT00226915|randomized controlled trial|randomized controlled trial
708517|NCT00226915|paclitaxel|paclitaxel
708518|NCT00226915|carboplatin|carboplatin
708519|NCT00226902|Diabetes|diabetes
708520|NCT00226902|Hemoglobin|hemoglobin
708521|NCT00226902|Dialysis|dialysis
708522|NCT00226902|Vascular reactivity|vascular reactivity
708523|NCT00226889|Scleroderma|scleroderma
708524|NCT00226889|Fibrosis|fibrosis
708525|NCT00226889|Therapy|therapy
708526|NCT00226889|Bosentan|bosentan
708527|NCT00226889|Endothelin-1|endothelin-1
708528|NCT00226876|dreaming|dreaming
708529|NCT00226876|anaesthesia|anaesthesia
708530|NCT00226876|electroencephalography|electroencephalography
708531|NCT00226876|bispectral index|bispectral index
708532|NCT00226876|awareness|awareness
708533|NCT00226824|Tourette's disorder|tourette's disorder
708534|NCT00226824|tic|tic
708535|NCT00226772|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
708536|NCT00226772|ACL reconstruction|acl reconstruction
708537|NCT00226759|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
708538|NCT00226759|ACL reconstruction|acl reconstruction
708539|NCT00226746|Pancreatic Cancer|pancreatic cancer
708540|NCT00226746|Hyperfractionated Radiation Therapy|hyperfractionated radiation therapy
708541|NCT00226746|Gemcitabine|gemcitabine
708542|NCT00226746|Paclitaxel|paclitaxel
708543|NCT00226746|Carcinoma, Pancreatic Ductal|carcinoma, pancreatic ductal
708544|NCT00226733|Coronary Artery Bypass (E04.928.220.520.220)|coronary artery bypass (e04.928.220.520.220)
708545|NCT00226733|Exercise Test [E01.370.370.380.250]|exercise test [e01.370.370.380.250]
708546|NCT00226733|Echocardiography [E01.370.370.380.220]|echocardiography [e01.370.370.380.220]
708547|NCT00226733|Quality of Life [K01.752.400.750]|quality of life [k01.752.400.750]
708548|NCT00226720|alcoholism|alcoholism
708549|NCT00226720|Alcohol dependence|alcohol dependence
708550|NCT00226720|Detoxification|detoxification
708551|NCT00226720|Abstinence maintain|abstinence maintain
708552|NCT00226720|Efficacy|efficacy
708553|NCT00226720|Ambulatory detoxification|ambulatory detoxification
708554|NCT00226707|Chronic hand dermatitis, pimecrolimus, dermatitis|chronic hand dermatitis, pimecrolimus, dermatitis
708555|NCT00226694|Alcoholism|alcoholism
708557|NCT00226694|Gender Differences|gender differences
708558|NCT00226694|Addiction|addiction
708559|NCT00226694|Alcohol Dependence|alcohol dependence
708560|NCT00226668|peritumoral brain edema|peritumoral brain edema
708561|NCT00226668|edema|edema
708562|NCT00226668|malignant brain tumor|malignant brain tumor
708563|NCT00226668|astrocytoma|astrocytoma
708564|NCT00226668|brain tumor|brain tumor
708565|NCT00226668|dexamethasone|dexamethasone
708566|NCT00226668|Decadron|decadron
708567|NCT00226655|peritumoral brain edema|peritumoral brain edema
708568|NCT00226655|edema|edema
708569|NCT00226655|malignant brain tumor|malignant brain tumor
708570|NCT00226655|astrocytoma|astrocytoma
708571|NCT00226655|brain tumor|brain tumor
708572|NCT00226655|dexamethasone|dexamethasone
708573|NCT00226655|Decadron|decadron
708574|NCT00226642|depression|depression
708575|NCT00226642|primary care|primary care
708576|NCT00226616|Zinc|zinc
708577|NCT00226616|cholera|cholera
708578|NCT00226616|children|children
708579|NCT00226616|Bangladesh|bangladesh
708580|NCT00226603|groin injury|groin injury
708581|NCT00226603|football|football
708582|NCT00226603|prevention|prevention
708583|NCT00226603|traing programme|traing programme
708584|NCT00226603|cluster randomized study|cluster randomized study
708585|NCT00226590|non-small cell lung cancer|non-small cell lung cancer
708586|NCT00226590|carcinoma|carcinoma
708587|NCT00226590|unresectable|unresectable
708588|NCT00226590|Stage IIIA|stage iiia
708589|NCT00226590|Stage IIIB|stage iiib
708590|NCT00226590|thoracic radiation|thoracic radiation
708591|NCT00226577|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
708592|NCT00226577|resectable|resectable
708593|NCT00226577|NSCLC|nsclc
708594|NCT00226525|Restenosis, skin metal allergy|restenosis, skin metal allergy
708595|NCT00226473|malignant Melanoma|malignant melanoma
708596|NCT00226473|Chemotherapy|chemotherapy
708597|NCT00226473|Metastasis|metastasis
708598|NCT00226473|standard palliative care|standard palliative care
708599|NCT00226473|best supportive care|best supportive care
708600|NCT00226447|Chronic Hepatitis B|chronic hepatitis b
708601|NCT00226447|Pegylated Interferon|pegylated interferon
708602|NCT00226447|Lamivudine|lamivudine
708603|NCT00226434|HIV infection|hiv infection
708604|NCT00226434|Tuberculosis|tuberculosis
708605|NCT00226434|Paradoxical reaction|paradoxical reaction
708606|NCT00226434|Treatment Naive|treatment naive
708607|NCT00226421|opioid|opioid
708609|NCT00226421|chronic pain|chronic pain
708610|NCT00226421|randomized, double-blind trial|randomized, double-blind trial
708611|NCT00226421|low back pain|low back pain
708612|NCT00226408|melanoma,adjuvant therapy,stageIII Interferon|melanoma,adjuvant therapy,stageiii interferon
708613|NCT00226408|high dose|high dose
708614|NCT00226395|oxymorphone|oxymorphone
708615|NCT00226395|acute pain|acute pain
708616|NCT00226395|abdominal surgery|abdominal surgery
708617|NCT00226395|opioids|opioids
708618|NCT00226382|Chronic Hepatitis B|chronic hepatitis b
708619|NCT00226382|Pegylated Interferon-alfa-2a|pegylated interferon-alfa-2a
708620|NCT00226382|Pegasys|pegasys
708621|NCT00226369|Pediatric|pediatric
708622|NCT00226369|Cardiopulmonary bypass|cardiopulmonary bypass
708623|NCT00226369|Congenital heart disease|congenital heart disease
708624|NCT00226369|Reperfusion injury|reperfusion injury
708625|NCT00226330|Patients diagnosed with type 2 diabetes who have participated in and completed the randomized, double-blind, parallel-group, multi-center study GALLANT 6.|patients diagnosed with type 2 diabetes who have participated in and completed the randomized, double-blind, parallel-group, multi-center study gallant 6.
708626|NCT00226304|Focal Brain Lesions|focal brain lesions
708627|NCT00226304|AIDS|aids
708628|NCT00226304|Lymphoma|lymphoma
708629|NCT00226304|EBV|ebv
708630|NCT00226304|FDG-PET|fdg-pet
708631|NCT00226304|HIV Infection|hiv infection
708632|NCT00226304|Brain Lesion|brain lesion
708633|NCT00226291|EBM|ebm
708634|NCT00226291|evidence based medicine|evidence based medicine
708635|NCT00226291|informationist|informationist
708636|NCT00226291|clinical medical librarian|clinical medical librarian
708637|NCT00226265|Cardiac surgery patients|cardiac surgery patients
708638|NCT00226265|Quality of Life|quality of life
708639|NCT00226265|Recall bias|recall bias
708640|NCT00226265|Aortic valve replacement|aortic valve replacement
708641|NCT00226265|Mitral valve replacement|mitral valve replacement
708642|NCT00226265|Tricuspid valve replacement|tricuspid valve replacement
708643|NCT00226265|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
708644|NCT00226252|Wheelchair|wheelchair
708645|NCT00226252|Propulsion|propulsion
708646|NCT00226252|Biomechanics|biomechanics
708647|NCT00226239|head|head
708648|NCT00226239|neck|neck
708649|NCT00226200|Allergic|allergic
708650|NCT00226200|Non allergic|non allergic
708651|NCT00226187|Fatty acids|fatty acids
708652|NCT00226187|Human milk|human milk
708653|NCT00226187|Infant development|infant development
708654|NCT00226187|Very low birthweight infants|very low birthweight infants
708655|NCT00226174|Curcuminoids|curcuminoids
708656|NCT00226174|Oral Lichen Planus|oral lichen planus
708657|NCT00226148|Implant|implant
708658|NCT00226148|Immediate placement|immediate placement
708659|NCT00226148|Molar tooth|molar tooth
708660|NCT00226135|Bipolar disorder|bipolar disorder
708661|NCT00226135|Treatment|treatment
708662|NCT00226135|Long-term|long-term
708663|NCT00226135|Lithium|lithium
708664|NCT00226135|Lamotrigine|lamotrigine
708665|NCT00226135|Randomised Clinical Trial|randomised clinical trial
708666|NCT00226122|Enuresis|enuresis
708667|NCT00226122|Nocturnal|nocturnal
708668|NCT00226122|Monosymptomatic|monosymptomatic
708669|NCT00226122|DDAVP|ddavp
708670|NCT00226122|Indomethacin|indomethacin
708671|NCT00226122|Randomized|randomized
708672|NCT00226109|Alcoholism|alcoholism
708673|NCT00226109|cardiomyopathy|cardiomyopathy
708674|NCT00226109|skeletal muscle|skeletal muscle
708675|NCT00226109|spironolactone|spironolactone
708676|NCT00226109|Na,K-pumps|na,k-pumps
708677|NCT00226109|Magnesium|magnesium
708678|NCT00226096|Clinical Trial|clinical trial
708679|NCT00226096|Blood Pressure|blood pressure
708680|NCT00226096|CVA (Cerebrovascular Accident)|cva (cerebrovascular accident)
708681|NCT00226070|selfrated health,|selfrated health,
708682|NCT00226070|SF-36,|sf-36,
708683|NCT00226070|rehabilitation,|rehabilitation,
708684|NCT00226070|total hip replacement,|total hip replacement,
708685|NCT00226070|patients above 65|patients above 65
708686|NCT00226057|Atopic dermatitis|atopic dermatitis
708687|NCT00226057|Raptiva|raptiva
708688|NCT00226044|Omeprazole, suppository, infants|omeprazole, suppository, infants
708689|NCT00226031|Osteoporosis|osteoporosis
708690|NCT00226031|Wrist fractures|wrist fractures
708691|NCT00226031|Knowledge translation|knowledge translation
708692|NCT00226031|Implementation|implementation
708693|NCT00226031|Educational reminder|educational reminder
708694|NCT00226005|pancreas|pancreas
708695|NCT00226005|adenocarcinoma|adenocarcinoma
708696|NCT00226005|cancer|cancer
708697|NCT00226005|metastatic|metastatic
708698|NCT00226005|advanced cancer|advanced cancer
708699|NCT00226005|Phase II|phase ii
708700|NCT00226005|growth factor|growth factor
708701|NCT00226005|VEGF|vegf
708702|NCT00226005|angiogenesis|angiogenesis
708703|NCT00225979|Acromegaly|acromegaly
708704|NCT00225979|Untreated|untreated
708705|NCT00225979|Newly diagnosed|newly diagnosed
708706|NCT00225979|Octreotide LAR|octreotide lar
708707|NCT00225979|Pituitary surgery|pituitary surgery
708708|NCT00225966|Urinary urgency-frequency|urinary urgency-frequency
708709|NCT00225927|invasive breast cancer|invasive breast cancer
708710|NCT00225927|in situ breast cancer|in situ breast cancer
708711|NCT00225927|radioguided seed localization|radioguided seed localization
708712|NCT00225927|nonpalpable tumour|nonpalpable tumour
708713|NCT00225927|needle localization|needle localization
708714|NCT00225927|margin status|margin status
708715|NCT00225914|Menopause|menopause
708716|NCT00225914|Hormone Therapy|hormone therapy
708717|NCT00225914|Paxil|paxil
708718|NCT00225914|Hot Flash|hot flash
708719|NCT00225914|Sleep Disturbance|sleep disturbance
708720|NCT00225914|Night Sweats|night sweats
708721|NCT00225914|Antidepressants|antidepressants
708722|NCT00225888|Diabetes|diabetes
708723|NCT00225888|Nutrition|nutrition
708724|NCT00225888|Digital photography|digital photography
708725|NCT00225888|Self-management|self-management
708726|NCT00225875|Autoimmune thrombocytopenic purpura|autoimmune thrombocytopenic purpura
708727|NCT00225875|Rituximab|rituximab
708728|NCT00225862|RLS|rls
708729|NCT00225862|Restless Legs Syndrome|restless legs syndrome
708730|NCT00225849|Aspirin|aspirin
708731|NCT00225849|Primary prevention|primary prevention
708732|NCT00225836|Dysmenorrhoea|dysmenorrhoea
708733|NCT00225836|Women|women
708734|NCT00225836|Pain|pain
708735|NCT00225836|TENS|tens
708736|NCT00225823|Seasonal Allergic Rhinitis Intranasal Corticosteroid|seasonal allergic rhinitis intranasal corticosteroid
708737|NCT00225797|chronic pain|chronic pain
708738|NCT00225797|lower back|lower back
708739|NCT00225797|opioid|opioid
708740|NCT00225797|efficacy|efficacy
708741|NCT00225797|safety|safety
708742|NCT00225784|Stage I, II, III pancreatic adenocarcinoma|stage i, ii, iii pancreatic adenocarcinoma
708743|NCT00225784|Radiographically measurable disease|radiographically measurable disease
708744|NCT00225758|breast cancer|breast cancer
708745|NCT00225758|endocrine therapy|endocrine therapy
708746|NCT00225758|drug resistance|drug resistance
708747|NCT00225758|lapatinib|lapatinib
708748|NCT00225758|epidermal growth factor receptor|epidermal growth factor receptor
708749|NCT00225745|Ghrelin|ghrelin
708750|NCT00225693|coronary artery|coronary artery
708751|NCT00225693|restenosis|restenosis
708752|NCT00225693|patency|patency
708753|NCT00225693|drug eluting|drug eluting
708754|NCT00225693|stent|stent
708755|NCT00225680|coronary artery|coronary artery
708756|NCT00225680|stent|stent
708757|NCT00225680|drug eluting|drug eluting
708758|NCT00225680|patency|patency
708759|NCT00225680|restenosis|restenosis
708760|NCT00225667|Atrial Fibrillation|atrial fibrillation
708761|NCT00225667|Arrhythmia|arrhythmia
708762|NCT00225667|Pacemaker, Artificial|pacemaker, artificial
708763|NCT00225667|Atrial High Rate Episodes|atrial high rate episodes
708764|NCT00225667|Electrophysiology|electrophysiology
708765|NCT00225667|Renin-Angiotensin System|renin-angiotensin system
708766|NCT00225667|Hypertension|hypertension
708767|NCT00225667|Cardiac Remodeling|cardiac remodeling
708768|NCT00225654|coronary artery|coronary artery
708769|NCT00225654|stent|stent
708770|NCT00225654|drug eluting|drug eluting
708771|NCT00225654|patency|patency
708772|NCT00225654|restenosis|restenosis
708773|NCT00225641|Follow-up|follow-up
708774|NCT00225628|Computerized clinical decision support|computerized clinical decision support
708775|NCT00225628|Patient Safety|patient safety
708776|NCT00225628|Quality of Care|quality of care
708777|NCT00225628|Electronic Medical Records|electronic medical records
708778|NCT00225628|Chronic Disease Management|chronic disease management
708779|NCT00225628|Drug Monitoring|drug monitoring
708780|NCT00225628|Guideline Adherence|guideline adherence
708781|NCT00225628|Reminder Systems|reminder systems
708782|NCT00225615|Phenylalanine Hydroxylase|phenylalanine hydroxylase
708783|NCT00225602|Schizophrenia|schizophrenia
708784|NCT00225602|Assertive community treatment|assertive community treatment
708785|NCT00225589|Hypercholesteremia|hypercholesteremia
708786|NCT00225576|medication errors|medication errors
708787|NCT00225576|adverse drug events|adverse drug events
708788|NCT00225576|electronic health records|electronic health records
708789|NCT00225563|Electronic medical records|electronic medical records
708790|NCT00225563|Electronic prescribing|electronic prescribing
708791|NCT00225563|Quality measures|quality measures
708792|NCT00225550|Cancer;|cancer;
708793|NCT00225550|Tumors;|tumors;
708794|NCT00225550|Neoplasms;|neoplasms;
708795|NCT00225550|Anticarcinogenic Agents;|anticarcinogenic agents;
708796|NCT00225550|Antineoplastic Agents;|antineoplastic agents;
708797|NCT00225550|Cadherins|cadherins
708798|NCT00225537|hcv|hcv
708799|NCT00225537|hbv|hbv
708800|NCT00225537|methylumbelliferone|methylumbelliferone
708801|NCT00225537|liver|liver
708802|NCT00225537|hepatitis|hepatitis
708803|NCT00225537|viral|viral
708804|NCT00225537|heparvit|heparvit
708805|NCT00225537|hiv|hiv
708806|NCT00225537|aids|aids
708807|NCT00225524|Depression|depression
708808|NCT00225511|Depression|depression
708809|NCT00225485|Depression|depression
708810|NCT00225459|Religious psychology|religious psychology
708811|NCT00225459|Anxiety disorder|anxiety disorder
708812|NCT00225459|Mood disorder|mood disorder
708813|NCT00225459|Suicide|suicide
708814|NCT00225446|Orthognathic surgery.|orthognathic surgery.
708815|NCT00225446|optic repositioning system.|optic repositioning system.
708816|NCT00225433|infertility|infertility
708817|NCT00225433|in vitro fertilization|in vitro fertilization
708818|NCT00225420|adenocarcinoma of the prostate|adenocarcinoma of the prostate
708819|NCT00225420|stage I prostate cancer|stage i prostate cancer
708820|NCT00225420|stage II prostate cancer|stage ii prostate cancer
708821|NCT00225420|stage III prostate cancer|stage iii prostate cancer
708822|NCT00225420|stage IV prostate cancer|stage iv prostate cancer
708823|NCT00225407|Cannabis|cannabis
708824|NCT00225407|Tetrahydrocannabinol|tetrahydrocannabinol
708825|NCT00225407|Pharmacokinetics|pharmacokinetics
708826|NCT00225407|Psychomotor tests|psychomotor tests
708827|NCT00225407|Event related potentials|event related potentials
708828|NCT00225394|CMV|cmv
708829|NCT00225394|Kidney Transplant|kidney transplant
708830|NCT00225394|Pancreas Transplant|pancreas transplant
708831|NCT00225394|Ganciclovir-resistance|ganciclovir-resistance
708832|NCT00225394|Valganciclovir|valganciclovir
708833|NCT00225394|CMV Disease|cmv disease
708834|NCT00225381|Oxygen consumption|oxygen consumption
708835|NCT00225381|CO2 production|co2 production
708836|NCT00225381|Indirect calorimetry|indirect calorimetry
708837|NCT00225381|Non steady state|non steady state
708838|NCT00225381|Anesthesia monitoring|anesthesia monitoring
708839|NCT00225381|Critical events during anesthesia|critical events during anesthesia
708840|NCT00225381|Acid base balance|acid base balance
708841|NCT00225381|Metabolism during anesthesia|metabolism during anesthesia
708842|NCT00225368|Malaria|malaria
708843|NCT00225368|All-cause mortality|all-cause mortality
708844|NCT00225368|Africa|africa
708845|NCT00225368|Burkina Faso|burkina faso
708846|NCT00225355|Angina pectoris|angina pectoris
708847|NCT00225355|Metabolic syndrome|metabolic syndrome
708848|NCT00225355|Ischaemic heart disease|ischaemic heart disease
708849|NCT00225342|Angina|angina
708850|NCT00225342|Ischaemic heart disease|ischaemic heart disease
708851|NCT00225342|Diabetes|diabetes
708852|NCT00225329|RCT|rct
708853|NCT00225329|intervention study|intervention study
708854|NCT00225329|labour management|labour management
708855|NCT00225329|assessment|assessment
708856|NCT00225316|RCT|rct
708857|NCT00225316|intervention study|intervention study
708858|NCT00225316|addiction|addiction
708859|NCT00225316|substance use|substance use
708860|NCT00225316|pregnancy|pregnancy
708861|NCT00225303|HIV infection|hiv infection
708862|NCT00225303|TMC125|tmc125
708863|NCT00225303|Non-Nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
708864|NCT00225303|Protease inhibitor|protease inhibitor
708865|NCT00225303|TMC125-C227|tmc125-c227
708866|NCT00225290|Phase III|phase iii
708867|NCT00225290|Hepatocellular Carcinoma|hepatocellular carcinoma
708868|NCT00225277|Glucose Metabolism Disorder|glucose metabolism disorder
708869|NCT00225277|Dysmetabolic Syndrome|dysmetabolic syndrome
708870|NCT00225277|Type II Diabetes|type ii diabetes
708871|NCT00225277|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
708872|NCT00225277|Dyslipidemia|dyslipidemia
708873|NCT00225277|Drug Therapy|drug therapy
708874|NCT00225277|Atherosclerosis|atherosclerosis
708875|NCT00225264|Glucose Metabolism Disorder|glucose metabolism disorder
708876|NCT00225264|Dysmetabolic Syndrome|dysmetabolic syndrome
708877|NCT00225264|Type II Diabetes|type ii diabetes
708878|NCT00225264|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
708879|NCT00225264|Dyslipidemia|dyslipidemia
708880|NCT00225264|Drug Therapy|drug therapy
708881|NCT00225251|Dysthymic Disorder|dysthymic disorder
708882|NCT00225251|Dysthymia|dysthymia
708883|NCT00225251|Depression|depression
708884|NCT00225251|Chronic Depression|chronic depression
708885|NCT00225251|Wellbutrin XL|wellbutrin xl
708886|NCT00225238|colonoscopy prep|colonoscopy prep
708887|NCT00225212|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
708888|NCT00225212|diffuse large cell lymphoma|diffuse large cell lymphoma
708889|NCT00225212|mantle cell lymphoma|mantle cell lymphoma
708890|NCT00225212|transformed lymphoma|transformed lymphoma
708891|NCT00225212|other subtypes of B cell lymphoma|other subtypes of b cell lymphoma
708892|NCT00225212|recurrent lymphoma|recurrent lymphoma
708893|NCT00225173|nodular sclerosis|nodular sclerosis
708894|NCT00225173|lymphocyte rich|lymphocyte rich
708895|NCT00225173|lymphocyte depleted|lymphocyte depleted
708896|NCT00225173|mixed cellularity|mixed cellularity
708897|NCT00225160|HIV|hiv
708898|NCT00225160|poly neuropathy|poly neuropathy
708899|NCT00225160|acetyl L-carnitine|acetyl l-carnitine
708900|NCT00225160|treatment naïve|treatment naïve
708901|NCT00225160|combination antiretroviral therapy|combination antiretroviral therapy
708902|NCT00225160|Lipid abnormalities|lipid abnormalities
708903|NCT00225108|Deep vein thrombosis|deep vein thrombosis
708904|NCT00225108|bleeding|bleeding
708905|NCT00225095|meniscectomy|meniscectomy
708906|NCT00225095|Chondrogen|chondrogen
708907|NCT00225095|Mesenchymal Stem Cells|mesenchymal stem cells
708908|NCT00225095|Osiris|osiris
708909|NCT00225082|Lipoatrophy|lipoatrophy
708910|NCT00225082|Mitochondrial function|mitochondrial function
710373|NCT00218166|tiagabine|tiagabine
708911|NCT00225082|Nucleoside analogue switch|nucleoside analogue switch
708912|NCT00225082|Treatment Experienced|treatment experienced
708913|NCT00225069|Facial blushing|facial blushing
708914|NCT00225069|Sympathectomy|sympathectomy
708915|NCT00225017|Atazanavir|atazanavir
708916|NCT00225017|Endothelial function|endothelial function
708917|NCT00225017|Treatment Experienced|treatment experienced
708918|NCT00225004|Colles Fracture|colles fracture
708919|NCT00225004|Osteoporosis|osteoporosis
708920|NCT00225004|BMD|bmd
708921|NCT00225004|Quality assurance|quality assurance
708922|NCT00224991|osteoporosis|osteoporosis
708923|NCT00224991|fall frequency|fall frequency
708924|NCT00224991|medical treatment|medical treatment
708925|NCT00224991|compliance|compliance
708926|NCT00224991|quality of life|quality of life
708927|NCT00224991|systematic education|systematic education
708928|NCT00224965|nicotine dependence|nicotine dependence
708929|NCT00224952|seizures|seizures
708930|NCT00224952|Epilepsy|epilepsy
708931|NCT00224926|Tinea Capitis|tinea capitis
708932|NCT00224913|osteoarthritis|osteoarthritis
708933|NCT00224913|quadriceps|quadriceps
708934|NCT00224913|inhibition|inhibition
708935|NCT00224913|functional outcome|functional outcome
708936|NCT00224913|electrical stimulation|electrical stimulation
708937|NCT00224900|Perinatally-acquired HIV infection|perinatally-acquired hiv infection
708938|NCT00224900|Life Skills|life skills
708939|NCT00224900|Focus Group|focus group
708940|NCT00224900|Young adolescents|young adolescents
708941|NCT00224900|Caregivers|caregivers
708942|NCT00224874|Acute Graft vs Host Disease|acute graft vs host disease
708943|NCT00224874|GVHD|gvhd
708944|NCT00224822|Psychiatry|psychiatry
708945|NCT00224822|Antipsychotic|antipsychotic
708946|NCT00224822|Psychopharmacology|psychopharmacology
708947|NCT00224822|Clinical Trial|clinical trial
708948|NCT00224822|Open Label|open label
708949|NCT00224822|Schizophrenia|schizophrenia
708950|NCT00224822|Schizoaffective Disorder|schizoaffective disorder
708951|NCT00224822|Bipolar Disorder|bipolar disorder
708952|NCT00224822|Metabolic Syndrome|metabolic syndrome
708953|NCT00224796|Wound closure|wound closure
708954|NCT00224796|Foot salvage|foot salvage
708955|NCT00224796|Accelerated healing|accelerated healing
708956|NCT00224796|Amputation Wounds of the Diabetic Foot|amputation wounds of the diabetic foot
708957|NCT00224757|Echocardiography|echocardiography
708958|NCT00224744|Vulvar Neoplasms|vulvar neoplasms
708959|NCT00224744|Skin Neoplasms|skin neoplasms
708960|NCT00224744|Ultracision|ultracision
708961|NCT00224744|Lymphadenectomy|lymphadenectomy
708962|NCT00224731|Attention disorder with hyperactivity|attention disorder with hyperactivity
708963|NCT00224731|sleep|sleep
708964|NCT00224731|stimulants|stimulants
708965|NCT00224731|actigraphy|actigraphy
708966|NCT00224718|Abdominal aortic aneurysm|abdominal aortic aneurysm
708967|NCT00224718|Endograft|endograft
708968|NCT00224718|Open repair|open repair
708969|NCT00224718|Endovascular repair|endovascular repair
708970|NCT00224718|AAA|aaa
708971|NCT00224705|Albumin dialysis|albumin dialysis
708972|NCT00224705|MARS system|mars system
708973|NCT00224705|Extracorporeal artificial liver support|extracorporeal artificial liver support
708974|NCT00224705|Fulminant hepatitis|fulminant hepatitis
708975|NCT00224705|Subfulminant hepatitis|subfulminant hepatitis
708976|NCT00224705|Acute liver failure|acute liver failure
708977|NCT00224692|Mucositis|mucositis
708978|NCT00224692|Pain|pain
708979|NCT00224692|Morphine|morphine
708980|NCT00224692|Ketamine|ketamine
708981|NCT00224679|Colon cancer|colon cancer
708982|NCT00224679|Aspirin|aspirin
708983|NCT00224679|Adenomas|adenomas
708984|NCT00224679|Prevention|prevention
708985|NCT00224666|Cortex stimulation ,Rebel neuropathic pains|cortex stimulation ,rebel neuropathic pains
708986|NCT00224653|Obesity.|obesity.
708987|NCT00224653|Respiration. Respiration, artificial.|respiration. respiration, artificial.
708988|NCT00224653|Ventilation. Pressure controlled. Volume controlled.|ventilation. pressure controlled. volume controlled.
708989|NCT00224640|Iron-chelating treatment|iron-chelating treatment
708990|NCT00224627|Randomized study|randomized study
708991|NCT00224627|Capsule endoscopy|capsule endoscopy
708992|NCT00224627|Push enteroscopy|push enteroscopy
708993|NCT00224627|Occult gastrointestinal bleeding|occult gastrointestinal bleeding
708994|NCT00224627|Endoscopy|endoscopy
708995|NCT00224614|stem cell transplantation|stem cell transplantation
708996|NCT00224614|reduced-intensity conditioning regimen|reduced-intensity conditioning regimen
708997|NCT00224614|acute myeloid leukemia|acute myeloid leukemia
708998|NCT00224601|Colorectal cancer|colorectal cancer
708999|NCT00224601|HNPCC|hnpcc
709000|NCT00224601|Diagnosis|diagnosis
709001|NCT00224601|Coloscopy|coloscopy
709002|NCT00224601|Chromoscopy|chromoscopy
709003|NCT00224601|Indigo carmine|indigo carmine
709004|NCT00224601|Colorectal Neoplasms|colorectal neoplasms
709005|NCT00224601|Hereditary Nonpolyposis|hereditary nonpolyposis
709006|NCT00224588|Ketamine|ketamine
709007|NCT00224588|Chronic post thoracotomy pain|chronic post thoracotomy pain
709008|NCT00224588|NMDA|nmda
709009|NCT00224588|Post operative|post operative
709010|NCT00224575|Veterans|veterans
709011|NCT00224562|TNF alpha antagonists|tnf alpha antagonists
709012|NCT00224562|infections|infections
709013|NCT00224562|lymphoma|lymphoma
709014|NCT00224562|safety|safety
709015|NCT00224549|Resistant hypertension|resistant hypertension
709016|NCT00224549|Combined diuretic therapy|combined diuretic therapy
709017|NCT00224549|Combined RAS blockers|combined ras blockers
709018|NCT00224536|Myocardial infarction|myocardial infarction
709019|NCT00224536|Bone marrow cells|bone marrow cells
709020|NCT00224536|Intracoronary|intracoronary
709021|NCT00224523|perennial allergic rhinitis|perennial allergic rhinitis
709022|NCT00224523|nasal biopsy|nasal biopsy
709023|NCT00224523|GW685698X|gw685698x
709024|NCT00224510|bipolar disorder bipolar depression lamotrigine|bipolar disorder bipolar depression lamotrigine
709025|NCT00224497|Alzheimer's disease|alzheimer's disease
709026|NCT00224497|cognition global functioning|cognition global functioning
709027|NCT00224497|symptomatic|symptomatic
709028|NCT00224497|B-742457|b-742457
709029|NCT00224484|Herpes Simplex vaccine|herpes simplex vaccine
709030|NCT00224484|Safety|safety
709031|NCT00224484|Adolescents|adolescents
709032|NCT00224484|Immunogenicity|immunogenicity
709033|NCT00224471|Adolescents|adolescents
709034|NCT00224471|Immunogenicity|immunogenicity
709035|NCT00224471|Safety|safety
709036|NCT00224471|Herpes Simplex vaccine|herpes simplex vaccine
709037|NCT00224458|Treatment Experienced|treatment experienced
709038|NCT00224458|HIV-1|hiv-1
709039|NCT00224445|Treatment Naive|treatment naive
709040|NCT00224445|HIV-1|hiv-1
709041|NCT00224432|Atopic Dermatitis|atopic dermatitis
709042|NCT00224432|SCORAD|scorad
709043|NCT00224432|probiotics|probiotics
709044|NCT00224432|cytokines|cytokines
709045|NCT00224432|Infant|infant
709046|NCT00224419|Smoking cessation|smoking cessation
709047|NCT00224419|Pregnancy|pregnancy
709048|NCT00224419|Nicotine replacement therapy|nicotine replacement therapy
709049|NCT00224419|Motivational interviewing|motivational interviewing
709050|NCT00224406|Lung transplantation|lung transplantation
709051|NCT00224406|Reperfusion Injury|reperfusion injury
709052|NCT00224406|Survival|survival
709053|NCT00224393|Amyloidosis|amyloidosis
709054|NCT00224393|Enbrel|enbrel
709055|NCT00224380|Serious mental illness|serious mental illness
709056|NCT00224380|medication adherence|medication adherence
709057|NCT00224367|fracture|fracture
709058|NCT00224367|hip|hip
709059|NCT00224367|ambulation|ambulation
709060|NCT00224354|LYMPHOCYTIC|lymphocytic
709061|NCT00224354|B-LEUKEMIA|b-leukemia
709062|NCT00224354|B-CLL|b-cll
709063|NCT00224341|Pacemaker|pacemaker
709064|NCT00224341|Atrial Fibrillation|atrial fibrillation
709065|NCT00224341|Prevention pacing|prevention pacing
709066|NCT00224341|Algorithms|algorithms
709067|NCT00224341|Sick sinus syndrome + Atrial Fibrillation|sick sinus syndrome + atrial fibrillation
709068|NCT00224328|Tissue Oxygen Saturation|tissue oxygen saturation
709069|NCT00224328|Peripheral Arterial Disease|peripheral arterial disease
709070|NCT00224328|Critical Limb Ischemia|critical limb ischemia
709071|NCT00224328|Near-infrared Spectroscopy|near-infrared spectroscopy
709072|NCT00224315|Schizophrenia,|schizophrenia,
709073|NCT00224315|schizoaffective disorder,|schizoaffective disorder,
709074|NCT00224315|treatment resistancy|treatment resistancy
709075|NCT00224315|clozapine,|clozapine,
709076|NCT00224315|ziprasidone|ziprasidone
709077|NCT00224315|risperidone|risperidone
709078|NCT00224315|combination|combination
709079|NCT00224302|Schizophrenia,|schizophrenia,
709080|NCT00224302|schizoaffective disorder,|schizoaffective disorder,
709081|NCT00224302|major depressive episode,|major depressive episode,
709082|NCT00224302|combination,|combination,
709083|NCT00224302|duloxetine|duloxetine
709084|NCT00224289|Latanoprost|latanoprost
709085|NCT00224289|Glaucoma|glaucoma
709086|NCT00224289|Intraocular pressure|intraocular pressure
709087|NCT00224263|Traditional Chinese Medicine|traditional chinese medicine
709088|NCT00224263|Lingzhi|lingzhi
709089|NCT00224237|Latino patients|latino patients
709090|NCT00224237|Health practices|health practices
709091|NCT00224237|Culture influences|culture influences
709092|NCT00224224|Clinical performance|clinical performance
709093|NCT00224224|Continuity of care|continuity of care
709094|NCT00224224|Utilization of resources|utilization of resources
709095|NCT00224185|Healthy individuals|healthy individuals
709096|NCT00224185|smokers|smokers
709097|NCT00224185|ex-smokers|ex-smokers
709098|NCT00224185|non-smokers|non-smokers
709099|NCT00224172|Pre-hospitalization characteristics|pre-hospitalization characteristics
709100|NCT00224172|Post-hospitalization characteristics|post-hospitalization characteristics
709101|NCT00224172|Psychosocial measures|psychosocial measures
709102|NCT00224172|Predict re-hospitalization|predict re-hospitalization
709103|NCT00224159|Statin therapy|statin therapy
709104|NCT00224159|Dietary behavior|dietary behavior
709105|NCT00224159|Attitudes and beliefs|attitudes and beliefs
709106|NCT00224159|Self efficacy|self efficacy
709107|NCT00224146|Oxytrol(r)|oxytrol(r)
709108|NCT00224146|transdermal oxybutynin|transdermal oxybutynin
709109|NCT00224146|overactive bladder|overactive bladder
709203|NCT00223795|Osteoarthritis|osteoarthritis
709110|NCT00224133|benign prostatic hyperplasia, alpha blocker|benign prostatic hyperplasia, alpha blocker
709111|NCT00224120|Benign prostatic hyperplasia, alpha blocker|benign prostatic hyperplasia, alpha blocker
709112|NCT00224107|Benign prostatic hyperplasia, BPH, alpha blocker|benign prostatic hyperplasia, bph, alpha blocker
709113|NCT00224094|Menopause|menopause
709114|NCT00224094|Testosterone|testosterone
709115|NCT00224094|Androgens|androgens
709116|NCT00224094|Sex Hormone Binding Globulin|sex hormone binding globulin
709117|NCT00224094|Thyroid function|thyroid function
709118|NCT00224094|Cortisol|cortisol
709119|NCT00224081|iron deficiency anemia|iron deficiency anemia
709120|NCT00224081|ferritin|ferritin
709121|NCT00224081|hemodialysis|hemodialysis
709122|NCT00224081|sodium ferric gluconate|sodium ferric gluconate
709123|NCT00224081|epoetin alfa|epoetin alfa
709124|NCT00224068|Iron deficiency|iron deficiency
709125|NCT00224068|Sodium ferric gluconate|sodium ferric gluconate
709126|NCT00224068|anemia|anemia
709127|NCT00224068|cancer chemotherapy|cancer chemotherapy
709128|NCT00224068|epoetin alfa|epoetin alfa
709129|NCT00224068|Anemia/drug therapy|anemia/drug therapy
709130|NCT00224068|Anemia, Iron-Deficiency/drug therapy/etiology|anemia, iron-deficiency/drug therapy/etiology
709131|NCT00224068|Hematinics/administration & dosage/pharmacology|hematinics/administration & dosage/pharmacology
709132|NCT00224068|Antineoplastic Agents/adverse effects|antineoplastic agents/adverse effects
709133|NCT00224068|Erythropoietin, Recombinant/therapeutic use/adverse effects|erythropoietin, recombinant/therapeutic use/adverse effects
709134|NCT00224055|Iron deficiency|iron deficiency
709135|NCT00224055|Anemia|anemia
709136|NCT00224055|Chronic kidney disease|chronic kidney disease
709137|NCT00224055|Sodium Ferric Gluconate|sodium ferric gluconate
709138|NCT00224055|Anemia, Iron-Deficiency/drug therapy/etiology|anemia, iron-deficiency/drug therapy/etiology
709139|NCT00224055|Kidney Failure, Chronic/blood/complications/therapy|kidney failure, chronic/blood/complications/therapy
709140|NCT00224042|Iron deficiency|iron deficiency
709141|NCT00224042|Anemia|anemia
709142|NCT00224042|Chronic kidney disease|chronic kidney disease
709143|NCT00224042|Erythropoietic agents|erythropoietic agents
709144|NCT00224042|Sodium Ferric Gluconate|sodium ferric gluconate
709145|NCT00224042|Anemia, Iron-Deficiency/drug therapy/etiology|anemia, iron-deficiency/drug therapy/etiology
709146|NCT00224042|Kidney Failure, Chronic/blood/complications/therapy|kidney failure, chronic/blood/complications/therapy
709147|NCT00224042|Erythropoietin, Recombinant/adverse effects/therapeutic use|erythropoietin, recombinant/adverse effects/therapeutic use
709148|NCT00224003|Anemia|anemia
709149|NCT00223990|Plasmodium|plasmodium
709150|NCT00223990|falciparum|falciparum
709151|NCT00223990|malaria|malaria
709152|NCT00223990|vaccine|vaccine
709153|NCT00223990|AS02A adjuvant|as02a adjuvant
709154|NCT00223990|FMP1|fmp1
709155|NCT00223990|Merozoite surface protein-1|merozoite surface protein-1
709156|NCT00223977|Anemia.|anemia.
709157|NCT00223964|Iron Deficiency|iron deficiency
709158|NCT00223964|Anemia in Pediatric Hemodialysis|anemia in pediatric hemodialysis
709159|NCT00223951|Healthy volunteers, safety, ocular, allergic conjunctivitis, ophthalmic|healthy volunteers, safety, ocular, allergic conjunctivitis, ophthalmic
709160|NCT00223925|Stem cell transplantation|stem cell transplantation
709161|NCT00223925|Allogeneic transplantation|allogeneic transplantation
709162|NCT00223912|Cardiovascular Disease|cardiovascular disease
709163|NCT00223912|Exercise|exercise
709164|NCT00223912|Functional electrical stimulation|functional electrical stimulation
709165|NCT00223912|hemostasis|hemostasis
709166|NCT00223912|Spinal cord injury|spinal cord injury
709167|NCT00223899|Melanoma|melanoma
709168|NCT00223899|Electroporation|electroporation
709169|NCT00223899|IL-2|il-2
709170|NCT00223873|Penile Vibratory Stimulation|penile vibratory stimulation
709171|NCT00223873|Muscles Spasticity|muscles spasticity
709172|NCT00223873|Spasms|spasms
709173|NCT00223873|Ferti Care Vibrator|ferti care vibrator
709174|NCT00223873|Antispasmotic treatment|antispasmotic treatment
709175|NCT00223860|Hypogonadal|hypogonadal
709176|NCT00223860|Hypothalamus|hypothalamus
709177|NCT00223860|Pituitary|pituitary
709178|NCT00223860|Spinal Cord Injury|spinal cord injury
709179|NCT00223860|Testes|testes
709180|NCT00223860|Testosterone|testosterone
709181|NCT00223847|Aphasia rehabilitation|aphasia rehabilitation
709182|NCT00223847|Aphasia therapy|aphasia therapy
709183|NCT00223847|Constraint therapy|constraint therapy
709184|NCT00223847|Language therapy|language therapy
709185|NCT00223834|Counseling|counseling
709186|NCT00223834|Motivation|motivation
709187|NCT00223834|Psychotherapy, brief|psychotherapy, brief
709188|NCT00223821|Behavior Therapy|behavior therapy
709189|NCT00223821|Behavioral Medicine|behavioral medicine
709190|NCT00223821|Behavioral Research|behavioral research
709191|NCT00223821|Behavioral Sciences|behavioral sciences
709192|NCT00223821|Combined Modality Therapy|combined modality therapy
709193|NCT00223821|Drug Therapy|drug therapy
709194|NCT00223821|Overactive bladder|overactive bladder
709195|NCT00223821|Treatment Outcome|treatment outcome
709196|NCT00223821|Urge incontinence|urge incontinence
709197|NCT00223821|Urinary incontinence|urinary incontinence
709198|NCT00223808|Rehabilitation|rehabilitation
709199|NCT00223808|Robotics|robotics
709200|NCT00223795|Cane|cane
709201|NCT00223795|Gait|gait
709204|NCT00223795|Walking Aids|walking aids
709205|NCT00223782|Diabetes|diabetes
709206|NCT00223782|Peripheral Neuropathy|peripheral neuropathy
709207|NCT00223782|Walking|walking
709208|NCT00223769|oxandrolone|oxandrolone
709209|NCT00223769|oxandrin|oxandrin
709210|NCT00223769|lean body mass|lean body mass
709211|NCT00223769|functional recovery|functional recovery
709212|NCT00223769|resistance training|resistance training
709213|NCT00223756|Vision, Low|vision, low
709214|NCT00223743|essential tremor|essential tremor
709215|NCT00223743|zonisamide|zonisamide
709216|NCT00223743|clinical trial|clinical trial
709217|NCT00223730|Peripheral Blood Stem Cell Transplant|peripheral blood stem cell transplant
709218|NCT00223730|Bone Marrow Transplant|bone marrow transplant
709219|NCT00223730|Citrulline|citrulline
709220|NCT00223730|Urea Cycle|urea cycle
709221|NCT00223730|Hepatic Injury|hepatic injury
709222|NCT00223730|Allogeneic PBSCT|allogeneic pbsct
709223|NCT00223730|Matched-Unrelated PBSCT|matched-unrelated pbsct
709224|NCT00223717|Supine Hypertension|supine hypertension
709225|NCT00223717|Hypertension|hypertension
709226|NCT00223717|Treatment|treatment
709227|NCT00223717|Autonomic failure|autonomic failure
709228|NCT00223717|Pure autonomic failure|pure autonomic failure
709229|NCT00223717|Multiple System Atrophy|multiple system atrophy
709230|NCT00223717|Shy-Drager Syndrome|shy-drager syndrome
709231|NCT00223704|Coronary Artery Bypass|coronary artery bypass
709232|NCT00223704|Blood Transfusion|blood transfusion
709233|NCT00223704|Bradykinin Receptor Antagonism|bradykinin receptor antagonism
709234|NCT00223704|Anti-Inflammatory Agents|anti-inflammatory agents
709235|NCT00223704|Antifibrinolytic Agents|antifibrinolytic agents
709236|NCT00223691|orthostatic hypotension|orthostatic hypotension
709237|NCT00223691|autonomic failure|autonomic failure
709238|NCT00223665|Intermittent Hormone Therapy|intermittent hormone therapy
709239|NCT00223665|Intermittent Androgen Suppression|intermittent androgen suppression
709240|NCT00223665|Biochemical Relapsed Prostate Cancer|biochemical relapsed prostate cancer
709241|NCT00223665|Androgen Deprivation Therapy|androgen deprivation therapy
709242|NCT00223665|Localized Prostate Cancer|localized prostate cancer
709243|NCT00223652|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
709244|NCT00223652|Telephone psychotherapy|telephone psychotherapy
709245|NCT00223652|Clinical Trial|clinical trial
709246|NCT00223652|Primary Care Clinic|primary care clinic
709247|NCT00223652|Treatment for Depression|treatment for depression
709248|NCT00223639|alcoholism /alcohol abuse|alcoholism /alcohol abuse
709249|NCT00223639|alcoholism antagonist|alcoholism antagonist
709250|NCT00223639|anticonvulsant|anticonvulsant
709251|NCT00223639|cognition|cognition
709252|NCT00223639|neuropharmacology|neuropharmacology
709253|NCT00223639|substance abuse related behavior|substance abuse related behavior
709254|NCT00223639|craving|craving
709255|NCT00223639|euphoria|euphoria
709256|NCT00223639|relapse /recurrence|relapse /recurrence
709257|NCT00223639|patient oriented research|patient oriented research
709258|NCT00223626|Cocaine Addiction|cocaine addiction
709259|NCT00223626|Cocaine Dependence|cocaine dependence
709260|NCT00223613|diabetes|diabetes
709261|NCT00223613|juvenile diabetes|juvenile diabetes
709262|NCT00223613|insulin deficiency|insulin deficiency
709263|NCT00223600|lipids|lipids
709264|NCT00223600|lipoproproteins|lipoproproteins
709265|NCT00223600|growth|growth
709266|NCT00223600|neurological development|neurological development
709267|NCT00223600|vascular wall|vascular wall
709268|NCT00223600|blood pressure|blood pressure
709269|NCT00223600|nutrient intake|nutrient intake
709270|NCT00223587|driving|driving
709271|NCT00223587|memory|memory
709272|NCT00223561|adult|adult
709273|NCT00223548|prophylaxis|prophylaxis
709274|NCT00223548|contrast-induced nephropathy|contrast-induced nephropathy
709275|NCT00223548|mesna|mesna
709276|NCT00223548|acute renal failure|acute renal failure
709277|NCT00223535|Schizophrenia|schizophrenia
709278|NCT00223535|Cognitive Remediation|cognitive remediation
709279|NCT00223535|Social Skills Training|social skills training
709280|NCT00223535|Psychosocial|psychosocial
709281|NCT00223522|Schizophrenia|schizophrenia
709282|NCT00223522|Schizoaffective|schizoaffective
709283|NCT00223522|MEMS|mems
709284|NCT00223522|adherence to antipsychotic medication|adherence to antipsychotic medication
709285|NCT00223509|mixed mania|mixed mania
709286|NCT00223509|lamotrigine|lamotrigine
709287|NCT00223496|Bipolar Depression|bipolar depression
709288|NCT00223496|Refractory|refractory
709289|NCT00223483|Hematologic Diseases|hematologic diseases
709290|NCT00223483|Genomics|genomics
709291|NCT00223483|Cytokines|cytokines
709292|NCT00223483|Chemokines|chemokines
709293|NCT00223483|Receptors|receptors
709294|NCT00223470|pain|pain
709295|NCT00223457|multiple sclerosis|multiple sclerosis
709296|NCT00223457|compliance|compliance
709297|NCT00223457|adherence|adherence
709298|NCT00223457|disease modifying therapy|disease modifying therapy
709299|NCT00223457|depression|depression
709300|NCT00223457|hope|hope
709301|NCT00223457|quality of life|quality of life
709302|NCT00223444|alcohol|alcohol
709303|NCT00223444|GABA|gaba
709304|NCT00223444|genetic variation|genetic variation
709305|NCT00223418|aripiprazole|aripiprazole
709306|NCT00223418|olanzapine|olanzapine
709307|NCT00223418|vocational|vocational
709308|NCT00223418|learning|learning
709309|NCT00223418|cognition|cognition
709310|NCT00223418|cognitive|cognitive
709311|NCT00223405|enamel wear against ceramic crowns|enamel wear against ceramic crowns
709312|NCT00223379|Apical Periodontitis, Root Canal Therapy, Apical Preparation|apical periodontitis, root canal therapy, apical preparation
709313|NCT00223366|Pain in teeth|pain in teeth
709314|NCT00223353|Biomechanics|biomechanics
709315|NCT00223353|Gait|gait
709316|NCT00223353|Balance|balance
709317|NCT00223340|patient activation|patient activation
709318|NCT00223340|primary care|primary care
709319|NCT00223340|diabetes|diabetes
709320|NCT00223340|cardiovascular risk|cardiovascular risk
709321|NCT00223327|pain|pain
709322|NCT00223327|Normal pulp and normal periodontal status|normal pulp and normal periodontal status
709323|NCT00223327|Chronic apical periodontitis of pulpal origin|chronic apical periodontitis of pulpal origin
709324|NCT00223314|HIV|hiv
709325|NCT00223314|Sexually Transmitted Diseases|sexually transmitted diseases
709326|NCT00223314|Pregnancy|pregnancy
709327|NCT00223314|HIV Seronegativity|hiv seronegativity
709328|NCT00223275|Bipolar Disorder|bipolar disorder
709329|NCT00223275|Alcohol Dependence|alcohol dependence
709330|NCT00223275|Dual Diagnosis|dual diagnosis
709331|NCT00223275|Naltrexone|naltrexone
709332|NCT00223210|bipolar disorder|bipolar disorder
709333|NCT00223210|cocaine dependence|cocaine dependence
709334|NCT00223210|quetiapine|quetiapine
709335|NCT00223197|Bipolar with depression|bipolar with depression
709336|NCT00223197|Recurrent major depressive disorder|recurrent major depressive disorder
709337|NCT00223197|substance abuse dependence|substance abuse dependence
709338|NCT00223171|Stage T3 T4|stage t3 t4
709339|NCT00223171|PSA > 20|psa > 20
709340|NCT00223171|Gleason Score > 7|gleason score > 7
709341|NCT00223158|Thyroid cancer|thyroid cancer
709342|NCT00223158|Hypothyroidism|hypothyroidism
709343|NCT00223158|Whole Body Scintigraphy|whole body scintigraphy
709344|NCT00223158|Liothyronine|liothyronine
709345|NCT00223158|TSH elevation|tsh elevation
709346|NCT00223145|Prostate adenocarcinoma|prostate adenocarcinoma
709347|NCT00223145|Gleason score <= 6 and PSA 10-20|gleason score <= 6 and psa 10-20
709348|NCT00223145|Gleason score = 7 and PSA <=20|gleason score = 7 and psa <=20
709349|NCT00223132|bariatric surgery|bariatric surgery
709350|NCT00223132|body contouring|body contouring
709351|NCT00223132|skin laxity|skin laxity
709352|NCT00223132|plastic surgery|plastic surgery
709353|NCT00223132|suture granuloma|suture granuloma
709354|NCT00223132|absorbable sutures|absorbable sutures
709355|NCT00223119|perineal trauma|perineal trauma
709356|NCT00223119|perineal laceration|perineal laceration
709357|NCT00223119|persistent perineal pain|persistent perineal pain
709358|NCT00223106|urge incontinence|urge incontinence
709359|NCT00223106|urinary incontinence|urinary incontinence
709360|NCT00223106|vault prolapse|vault prolapse
709361|NCT00223106|stess incontinence|stess incontinence
709362|NCT00223106|mixed incontinence|mixed incontinence
709363|NCT00223106|urine leakage|urine leakage
709364|NCT00223106|enterocele|enterocele
709365|NCT00223106|rectocele|rectocele
709366|NCT00223106|cystocele|cystocele
709367|NCT00223093|renal transplantation, TAIZ-moncytes|renal transplantation, taiz-moncytes
709368|NCT00223080|HIV Seronegativity|hiv seronegativity
709369|NCT00223067|renal transplantation|renal transplantation
709370|NCT00223067|TAIZ|taiz
709371|NCT00223054|cyclosporin A|cyclosporin a
709372|NCT00223054|Tacrolimus|tacrolimus
709373|NCT00223054|Everolimus|everolimus
709374|NCT00223054|Sirolimus|sirolimus
709375|NCT00223054|Fluvastatin|fluvastatin
709376|NCT00223041|renal transplantation|renal transplantation
709377|NCT00223041|cardiovasculary disease|cardiovasculary disease
709378|NCT00223041|statin|statin
709379|NCT00223028|fluvastain|fluvastain
709380|NCT00223028|sirolimus|sirolimus
709381|NCT00223028|mycophenolat mofetil|mycophenolat mofetil
709382|NCT00223028|renal transplantation|renal transplantation
709383|NCT00223015|renal transplantation|renal transplantation
709384|NCT00223015|pharmacokinetics|pharmacokinetics
709385|NCT00223015|Fluvastatin|fluvastatin
709386|NCT00223015|Mycophenolat mofetil|mycophenolat mofetil
709387|NCT00223015|tacrolimus|tacrolimus
709388|NCT00222989|GERD|gerd
709389|NCT00222989|PPI|ppi
709390|NCT00222989|Functional heartburn|functional heartburn
709391|NCT00222963|Obesity|obesity
709392|NCT00222963|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
709393|NCT00222963|Children|children
709394|NCT00222963|Adolescents|adolescents
709395|NCT00222963|Adenotonsillectomy|adenotonsillectomy
709396|NCT00222950|plant sterols, serum, aortic valve cusps|plant sterols, serum, aortic valve cusps
709397|NCT00222937|Voice Problems|voice problems
709398|NCT00222937|Voice Disorders|voice disorders
709399|NCT00222924|Mitochondria|mitochondria
709400|NCT00222911|plantar fasciitis|plantar fasciitis
709401|NCT00222911|heel pain|heel pain
709402|NCT00222911|heel spur|heel spur
709403|NCT00222911|night splint|night splint
709404|NCT00222911|arch support|arch support
709405|NCT00222911|foot orthosis|foot orthosis
709406|NCT00222911|physical therapy|physical therapy
709407|NCT00222898|Pancreatic Cyst|pancreatic cyst
709408|NCT00222898|PANDA Study|panda study
709409|NCT00222885|PET imaging|pet imaging
709410|NCT00222885|Skeletal muscle|skeletal muscle
709411|NCT00222885|In vivo insulin-stimulated tissue perfusion|in vivo insulin-stimulated tissue perfusion
709412|NCT00222885|Glucose transport|glucose transport
709413|NCT00222885|Glucose phosphorylation|glucose phosphorylation
709414|NCT00222872|Endocrine System Diseases|endocrine system diseases
709415|NCT00222872|MusculoSkeletal System Diseases|musculoskeletal system diseases
709416|NCT00222872|Hormone|hormone
709417|NCT00222872|Postmenopausal Women|postmenopausal women
709418|NCT00222859|HIV|hiv
709419|NCT00222859|HCV|hcv
709420|NCT00222846|Clinical trial|clinical trial
709421|NCT00222846|Behavioral research|behavioral research
709422|NCT00222846|Patient compliance|patient compliance
709423|NCT00222833|Schizophrenia|schizophrenia
709424|NCT00222833|Schizoaffective disorder|schizoaffective disorder
709425|NCT00222833|Aripiprazole|aripiprazole
709426|NCT00222833|Obese|obese
709427|NCT00222833|Overweight|overweight
709428|NCT00222833|Heart Health|heart health
709429|NCT00222833|Antipsychotic|antipsychotic
709430|NCT00222833|Heart Health Factors|heart health factors
709431|NCT00222833|Cardiovascular Health Indices|cardiovascular health indices
709432|NCT00222833|Cardiovascular health|cardiovascular health
709433|NCT00222807|schizophrenia, psychosis, type 2 diabetes mellitus|schizophrenia, psychosis, type 2 diabetes mellitus
709434|NCT00222794|Schizophrenia|schizophrenia
709435|NCT00222794|Schizo-Affective Disorder|schizo-affective disorder
709436|NCT00222794|Negative Symptoms|negative symptoms
709437|NCT00222794|Atomoxetine|atomoxetine
709438|NCT00222794|Strattera|strattera
709439|NCT00222781|Skeletal muscle|skeletal muscle
709440|NCT00222781|Triple-tracer PET imaging|triple-tracer pet imaging
709441|NCT00222768|Adipose tissue|adipose tissue
709442|NCT00222768|PET imaging|pet imaging
709443|NCT00222755|Mood disorders-bipolar|mood disorders-bipolar
709444|NCT00222755|Disease management|disease management
709445|NCT00222755|Quality of care|quality of care
709446|NCT00222742|hypothermia|hypothermia
709447|NCT00222742|pediatric TBI|pediatric tbi
709448|NCT00222729|head|head
709449|NCT00222729|neck|neck
709450|NCT00222716|Treatment adherence|treatment adherence
709451|NCT00222716|HIV|hiv
709452|NCT00222716|Self-efficacy|self-efficacy
709453|NCT00222716|Treatment Experienced|treatment experienced
709454|NCT00222703|nicotine addiction|nicotine addiction
709455|NCT00222703|relapse|relapse
709456|NCT00222703|smoking|smoking
709457|NCT00222703|chronic disorders|chronic disorders
709458|NCT00222703|randomized controlled trial|randomized controlled trial
709459|NCT00222703|intervention|intervention
709460|NCT00222690|qualitative interview|qualitative interview
709461|NCT00222690|symptom triggers|symptom triggers
709462|NCT00222690|activity and participation|activity and participation
709463|NCT00222677|venous thromboembolism|venous thromboembolism
709464|NCT00222677|deep vein thrombosis|deep vein thrombosis
709465|NCT00222677|pulmonary embolism|pulmonary embolism
709466|NCT00222677|antithrombotic agents|antithrombotic agents
709467|NCT00222664|hepatitis B|hepatitis b
709468|NCT00222664|hepatocellular carcinoma|hepatocellular carcinoma
709469|NCT00222664|prevention|prevention
709470|NCT00222664|vaccination|vaccination
709471|NCT00222651|pulmonary embolism|pulmonary embolism
709472|NCT00222651|right ventricular dysfunction|right ventricular dysfunction
709473|NCT00222651|thrombolysis|thrombolysis
709474|NCT00222651|echocardiography|echocardiography
709475|NCT00222638|Oral anticoagulants|oral anticoagulants
709476|NCT00222638|Influenza virus|influenza virus
709477|NCT00222638|Influenza vaccine|influenza vaccine
709478|NCT00222638|Pharmacological interference|pharmacological interference
709479|NCT00222625|Intracerebral Hemorrhage|intracerebral hemorrhage
709480|NCT00222625|Oral Anticoagulants|oral anticoagulants
709481|NCT00222625|Antiplatelet Agents|antiplatelet agents
709482|NCT00222625|Recombinant Activated Factor VII|recombinant activated factor vii
709483|NCT00222573|clopidogrel|clopidogrel
709484|NCT00222573|metoprolol|metoprolol
709485|NCT00222573|myocardial infarction|myocardial infarction
709486|NCT00222573|randomised trial|randomised trial
709487|NCT00222560|physical activity counselling|physical activity counselling
709488|NCT00222560|physical activity behavior change intervention|physical activity behavior change intervention
709489|NCT00222560|prevention|prevention
709490|NCT00222560|collaborative health care|collaborative health care
709491|NCT00222560|physical inactivity|physical inactivity
709492|NCT00222560|motivation|motivation
709493|NCT00222560|fitness|fitness
709494|NCT00222560|randomized controlled trial|randomized controlled trial
709495|NCT00222534|Respiratory Insufficiency|respiratory insufficiency
709496|NCT00222534|Alkalosis|alkalosis
709497|NCT00222521|Cystic Fibrosis|cystic fibrosis
709498|NCT00222521|Diabetes|diabetes
709499|NCT00222508|Cystic Fibrosis|cystic fibrosis
709500|NCT00222508|Diabetes|diabetes
709501|NCT00222508|Complications|complications
709502|NCT00222495|Psychotic Disorders in adolescents|psychotic disorders in adolescents
709503|NCT00222495|Schizophrenia in adolescents|schizophrenia in adolescents
709504|NCT00222495|Schizophreniform Disorders in adolescents|schizophreniform disorders in adolescents
709505|NCT00222495|Schizoaffective Disorders in adolescents|schizoaffective disorders in adolescents
709506|NCT00222482|Borderline Personality Disorder|borderline personality disorder
709507|NCT00222469|pancreatic cancer|pancreatic cancer
709508|NCT00222469|unresectable pancreatic cancer|unresectable pancreatic cancer
709509|NCT00222469|metastatic pancreatic cancer|metastatic pancreatic cancer
709510|NCT00222469|bevacizumab|bevacizumab
709511|NCT00222469|oxaliplatin|oxaliplatin
709512|NCT00222469|gemcitabine|gemcitabine
709513|NCT00222469|1st line treatment|1st line treatment
709514|NCT00222469|first line treatment|first line treatment
709515|NCT00222469|locally advanced (unresectable) pancreatic cancer|locally advanced (unresectable) pancreatic cancer
709516|NCT00222456|preterm infants|preterm infants
709517|NCT00222456|early intervention|early intervention
709518|NCT00222456|outcome|outcome
709519|NCT00222456|behavioral problems|behavioral problems
709520|NCT00222456|parenting stress|parenting stress
709521|NCT00222443|Recurrent solid tumors|recurrent solid tumors
709522|NCT00222443|recurrent lymphomas|recurrent lymphomas
709523|NCT00222443|Pediatrics|pediatrics
709524|NCT00222443|Adolescents|adolescents
709525|NCT00222430|Fluoroscopy|fluoroscopy
709526|NCT00222430|Femoral Artery|femoral artery
709527|NCT00222430|Arterial Vascular Access|arterial vascular access
709528|NCT00222404|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
709529|NCT00222404|Pharmacogenomic|pharmacogenomic
709530|NCT00222378|Crohn's disease|crohn's disease
709531|NCT00222378|ulcerative colitis|ulcerative colitis
709532|NCT00222378|cytomegalovirus|cytomegalovirus
709533|NCT00222378|Epstein Bar Virus|epstein bar virus
709534|NCT00222378|Human Herpes virus 6|human herpes virus 6
709535|NCT00222365|homeopathy|homeopathy
709536|NCT00222365|assessment|assessment
709537|NCT00222365|pain|pain
709538|NCT00222365|ligamentoplasty|ligamentoplasty
709539|NCT00222352|Unstable Angina|unstable angina
709540|NCT00222352|Non-ST-segment Myocardial Infarction|non-st-segment myocardial infarction
709541|NCT00222352|Myocardial Necrosis|myocardial necrosis
709542|NCT00222352|Troponin I|troponin i
709543|NCT00222339|Stroke|stroke
709544|NCT00222339|Hand function|hand function
709545|NCT00222339|Task-specific training|task-specific training
709546|NCT00222326|Hysterectomy,|hysterectomy,
709547|NCT00222326|Prolapse,|prolapse,
709548|NCT00222326|Pelvic floor muscles,|pelvic floor muscles,
709549|NCT00222326|Bladder,|bladder,
709550|NCT00222326|Bowel.|bowel.
709551|NCT00222300|Total hip replacement|total hip replacement
709552|NCT00222300|Strength training|strength training
709553|NCT00222300|Gait analysis|gait analysis
709554|NCT00222287|Feldenkrais Method|feldenkrais method
709555|NCT00222287|movement class|movement class
709556|NCT00222287|balance|balance
709557|NCT00222287|Four square step test|four square step test
709558|NCT00222287|Activities Specific Balance Confidence Scale|activities specific balance confidence scale
709559|NCT00222287|systems theory|systems theory
709560|NCT00222274|fibromyalgia|fibromyalgia
709561|NCT00222274|pain|pain
709562|NCT00222274|biofeedback|biofeedback
709563|NCT00222274|heart rate variability|heart rate variability
709564|NCT00222261|antiplatelet therapy|antiplatelet therapy
709565|NCT00222261|aspirin non-responders|aspirin non-responders
709566|NCT00222261|aspirin resistance|aspirin resistance
709567|NCT00222261|clopidogrel|clopidogrel
709568|NCT00222261|coronary heart disease|coronary heart disease
709569|NCT00222261|stable angina pectoris|stable angina pectoris
709570|NCT00222248|Stress urinary incontinence|stress urinary incontinence
709571|NCT00222248|Pelvic floor muscle training|pelvic floor muscle training
709572|NCT00222248|Bladder training|bladder training
709573|NCT00222248|Older women|older women
709574|NCT00222235|schizophrenia|schizophrenia
709575|NCT00222235|schizoaffective disorder|schizoaffective disorder
709576|NCT00222235|negative symptoms|negative symptoms
709577|NCT00222235|cognitive impairments|cognitive impairments
709578|NCT00222222|severe sepsis|severe sepsis
709579|NCT00222222|prognostic markers|prognostic markers
709580|NCT00222222|polymorphisms|polymorphisms
709581|NCT00222222|SIRS|sirs
709582|NCT00222209|Experimental study|experimental study
709583|NCT00222209|chronic pain|chronic pain
709584|NCT00222209|operant learning|operant learning
709585|NCT00222209|comorbidity|comorbidity
709586|NCT00222209|stress|stress
709587|NCT00222209|Fibromyalgia w visceral hypersensitivity|fibromyalgia w visceral hypersensitivity
709588|NCT00222209|Fibromyalgia w/o visceral hypersensitivity|fibromyalgia w/o visceral hypersensitivity
709589|NCT00222196|atherosclerosis|atherosclerosis
709590|NCT00222196|quality of life|quality of life
709591|NCT00222196|pain-score|pain-score
709592|NCT00222196|biomarkers|biomarkers
709593|NCT00222183|Lupus erythematodes|lupus erythematodes
709594|NCT00222183|Elidel|elidel
709595|NCT00222183|Pimecrolimus|pimecrolimus
709596|NCT00222183|Chronic discoid lupus erythematosus (dLE)|chronic discoid lupus erythematosus (dle)
709690|NCT00221728|Kidney Failure, Chronic|kidney failure, chronic
709597|NCT00222183|subacute cutaneous lupus erythematosus (scLE)|subacute cutaneous lupus erythematosus (scle)
709598|NCT00222131|Epigastric Pain|epigastric pain
709599|NCT00222131|Non-Ulcer Dyspepsia (NUD)|non-ulcer dyspepsia (nud)
709600|NCT00222092|post-ERCP pancreatitis|post-ercp pancreatitis
709601|NCT00222092|prophylaxis|prophylaxis
709602|NCT00222092|prognosis|prognosis
709603|NCT00222092|natural course|natural course
709604|NCT00222092|molecular markers|molecular markers
709605|NCT00222066|Aspiration|aspiration
709606|NCT00222066|Fetal ovarian cyst|fetal ovarian cyst
709607|NCT00222066|Ovarian torsion|ovarian torsion
709608|NCT00222053|Myeloma|myeloma
709609|NCT00222053|Autologous transplantation|autologous transplantation
709610|NCT00222053|Maintenance therapy|maintenance therapy
709611|NCT00222053|Thalidomide|thalidomide
709612|NCT00222040|Stroke|stroke
709613|NCT00222040|thrombolysis|thrombolysis
709614|NCT00222040|ultrasound|ultrasound
709615|NCT00222040|microbubbles|microbubbles
709616|NCT00222040|alteplase|alteplase
709617|NCT00222027|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
709618|NCT00222027|adult patient|adult patient
709619|NCT00222027|chemotherapy|chemotherapy
709620|NCT00222027|stem cell transplantation|stem cell transplantation
709621|NCT00222027|Young adult patients|young adult patients
709622|NCT00222014|Refractory ascites|refractory ascites
709623|NCT00222014|Cirrhosis|cirrhosis
709624|NCT00222014|Paracentesesis|paracentesesis
709625|NCT00221988|Elderly|elderly
709626|NCT00221988|Epilepsy|epilepsy
709627|NCT00221988|Cognition|cognition
709628|NCT00221988|Health Outcome|health outcome
709629|NCT00221962|ADHD|adhd
709630|NCT00221923|Primary open angle glaucoma|primary open angle glaucoma
709631|NCT00221923|African American|african american
709632|NCT00221923|Glaucoma/pathology|glaucoma/pathology
709633|NCT00221923|Glaucoma/ physiopathology|glaucoma/ physiopathology
709634|NCT00221923|Nerve Fibers/pathology|nerve fibers/pathology
709635|NCT00221923|Risk factor glaucoma|risk factor glaucoma
709636|NCT00221897|Primary open angle glaucoma|primary open angle glaucoma
709637|NCT00221897|Glaucoma/pathology|glaucoma/pathology
709638|NCT00221897|Glaucoma/physiopathology|glaucoma/physiopathology
709639|NCT00221897|Nerve Fibers/pathology|nerve fibers/pathology
709640|NCT00221897|Risk factors glaucoma|risk factors glaucoma
709641|NCT00221845|Ramipril|ramipril
709642|NCT00221845|Hypertension|hypertension
709643|NCT00221845|Chronic renal failure|chronic renal failure
709644|NCT00221845|Disease progression|disease progression
709645|NCT00221845|Left ventricular hypertrophy|left ventricular hypertrophy
709646|NCT00221845|Intima media thickness|intima media thickness
709647|NCT00221845|Cardiovascular disease|cardiovascular disease
709648|NCT00221845|Biomarkers|biomarkers
709649|NCT00221845|Gene polymorphisms|gene polymorphisms
709650|NCT00221832|Long QT Syndrome|long qt syndrome
709651|NCT00221832|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
709652|NCT00221832|arrhythmogenic right ventricular dysplasia|arrhythmogenic right ventricular dysplasia
709653|NCT00221832|Short QT Syndrome|short qt syndrome
709654|NCT00221832|Brugada Syndrome|brugada syndrome
709655|NCT00221819|Humidification|humidification
709656|NCT00221819|Heat and moisture exchanger|heat and moisture exchanger
709657|NCT00221819|Heated humidifier, non invasive ventilation|heated humidifier, non invasive ventilation
709658|NCT00221806|Arteritis, femoro popliteal bypass, endothelialised prosthesis, saphenous vein graft, permeability, Doppler echography|arteritis, femoro popliteal bypass, endothelialised prosthesis, saphenous vein graft, permeability, doppler echography
709659|NCT00221793|Parkinson|parkinson
709660|NCT00221793|deep subthalamic stimulation|deep subthalamic stimulation
709661|NCT00221793|pharmacological treatment|pharmacological treatment
709662|NCT00221780|Heart failure|heart failure
709663|NCT00221780|Cardiomyopathy, dilated|cardiomyopathy, dilated
709664|NCT00221780|Coronary disease|coronary disease
709665|NCT00221780|Cardiac Pacing, Artificial|cardiac pacing, artificial
709666|NCT00221780|Hemodynamics|hemodynamics
709667|NCT00221780|Randomized Controlled Trials|randomized controlled trials
709668|NCT00221780|Single-Blind Study|single-blind study
709669|NCT00221767|Neurogenic bladder|neurogenic bladder
709670|NCT00221767|electric stimulation therapy|electric stimulation therapy
709671|NCT00221767|urinary tract infection|urinary tract infection
709672|NCT00221767|urinary incontinence|urinary incontinence
709673|NCT00221767|spinal cord injuries|spinal cord injuries
709674|NCT00221767|spinal nerve roots|spinal nerve roots
709675|NCT00221767|nonRandomized Controlled Trials|nonrandomized controlled trials
709676|NCT00221767|open Study|open study
709677|NCT00221754|HIV,|hiv,
709678|NCT00221754|protease inhibitors|protease inhibitors
709679|NCT00221754|pravastatin|pravastatin
709680|NCT00221754|Treatment Experienced|treatment experienced
709681|NCT00221741|Heart surgery|heart surgery
709682|NCT00221741|Blood Loss, Surgical|blood loss, surgical
709683|NCT00221741|Mortality|mortality
709684|NCT00221741|Blood Transfusion|blood transfusion
709685|NCT00221741|Cohort Studies|cohort studies
709686|NCT00221728|Kidney Neoplasms|kidney neoplasms
709687|NCT00221728|Surgery|surgery
709688|NCT00221728|Catheter Ablation|catheter ablation
709689|NCT00221728|Randomized controlled trials|randomized controlled trials
709692|NCT00221715|lower limb ischemia|lower limb ischemia
709693|NCT00221715|femoropopliteal artery bypass|femoropopliteal artery bypass
709694|NCT00221715|blood vessel prothesis implantation|blood vessel prothesis implantation
709695|NCT00221715|saphenous vein|saphenous vein
709696|NCT00221715|vascular permeability|vascular permeability
709697|NCT00221715|doppler ultrasonography|doppler ultrasonography
709698|NCT00221715|randomized clinical trials|randomized clinical trials
709699|NCT00221715|efficacy study|efficacy study
709700|NCT00221702|Melanoma|melanoma
709701|NCT00221702|Neoplasm metastasis|neoplasm metastasis
709702|NCT00221702|Interferon alfa-2b|interferon alfa-2b
709703|NCT00221702|Adjuvants|adjuvants
709704|NCT00221702|Randomized clinical trial|randomized clinical trial
709705|NCT00221702|Disease-free survival time|disease-free survival time
709706|NCT00221702|Safety|safety
709707|NCT00221702|Drug toxicity|drug toxicity
709708|NCT00221702|Quality of life|quality of life
709709|NCT00221689|Severe brain injury|severe brain injury
709710|NCT00221689|Coma|coma
709711|NCT00221689|Hypertonia|hypertonia
709712|NCT00221689|Dysautonomia|dysautonomia
709713|NCT00221689|Baclofen|baclofen
709714|NCT00221689|Randomized Controlled Trials|randomized controlled trials
709715|NCT00221676|influenza vaccine|influenza vaccine
709716|NCT00221676|general practitioner|general practitioner
709717|NCT00221663|Cardiac surgery|cardiac surgery
709718|NCT00221663|Aortic valve replacement|aortic valve replacement
709719|NCT00221663|Minimally invasive surgery|minimally invasive surgery
709720|NCT00221663|Perioperative course|perioperative course
709721|NCT00221650|Hepatitis C, Chronic|hepatitis c, chronic
709722|NCT00221650|HCV infection|hcv infection
709723|NCT00221650|HIV infection|hiv infection
709724|NCT00221650|Treatment Failure|treatment failure
709725|NCT00221650|PEG interferon|peg interferon
709726|NCT00221650|Interferons/therapeutic use|interferons/therapeutic use
709727|NCT00221650|Interferon Alfa-2a/adverse effects|interferon alfa-2a/adverse effects
709728|NCT00221650|Ribavirin/therapeutic use|ribavirin/therapeutic use
709729|NCT00221650|Ribavirin/adverse effects|ribavirin/adverse effects
709730|NCT00221650|Drug Therapy, Combination|drug therapy, combination
709731|NCT00221650|Treatment Experienced|treatment experienced
709732|NCT00221650|Treatment Naive|treatment naive
709733|NCT00221637|Neuralgia|neuralgia
709734|NCT00221637|Valproate|valproate
709735|NCT00221637|Anticonvulsant Drugs|anticonvulsant drugs
709736|NCT00221637|Pain Measurement|pain measurement
709737|NCT00221637|Randomized Controlled Trials|randomized controlled trials
709738|NCT00221624|Hepatitis C, chronic|hepatitis c, chronic
709739|NCT00221624|HCV infection|hcv infection
709740|NCT00221624|Treatment failure|treatment failure
709741|NCT00221624|PEG Interferon|peg interferon
709742|NCT00221624|(Interferons/therapeutic use|(interferons/therapeutic use
709743|NCT00221624|Interferon Alfa-2a/adverse effects)|interferon alfa-2a/adverse effects)
709744|NCT00221624|ribavirin|ribavirin
709745|NCT00221624|(Ribavirin/therapeutic use|(ribavirin/therapeutic use
709746|NCT00221624|Ribavirin/adverse effects)|ribavirin/adverse effects)
709747|NCT00221624|Amantadine|amantadine
709748|NCT00221624|Drug Therapy, Combination|drug therapy, combination
709749|NCT00221520|Sedation, mechanical ventilation|sedation, mechanical ventilation
709750|NCT00221507|Vaccination|vaccination
709751|NCT00221507|Prevention & Control|prevention & control
709752|NCT00221494|depression|depression
709753|NCT00221481|Bipolar|bipolar
709754|NCT00221481|Alcohol|alcohol
709755|NCT00221468|Adolescents|adolescents
709756|NCT00221455|Diabetes Mellitus|diabetes mellitus
709757|NCT00221455|Chronic disease management|chronic disease management
709758|NCT00221455|Patient portal|patient portal
709759|NCT00221455|Patient empowerment|patient empowerment
709760|NCT00221442|Adults|adults
709761|NCT00221442|Binge eating disorder|binge eating disorder
709762|NCT00221442|Blood draw|blood draw
709763|NCT00221442|E.Coli enterprotoxin|e.coli enterprotoxin
709764|NCT00221442|Eating disorders|eating disorders
709765|NCT00221442|Electrocardiogram|electrocardiogram
709766|NCT00221442|Females|females
709767|NCT00221442|Males|males
709768|NCT00221442|Physical exam|physical exam
709769|NCT00221442|Psychiatric evaluation|psychiatric evaluation
709770|NCT00221442|Questionnaire|questionnaire
709771|NCT00221429|child|child
709772|NCT00221429|adolescent|adolescent
709773|NCT00221416|child|child
709774|NCT00221416|adolescent|adolescent
709775|NCT00221403|child|child
709776|NCT00221403|adolescent|adolescent
709777|NCT00221403|bipolar disorder|bipolar disorder
709778|NCT00221390|stroke|stroke
709779|NCT00221390|Chronic stroke with hemiparesis|chronic stroke with hemiparesis
709780|NCT00221377|intubation|intubation
709781|NCT00221377|trachea|trachea
709782|NCT00221377|tube|tube
709783|NCT00221377|cuff|cuff
709784|NCT00221377|children|children
709785|NCT00221364|Trachoma|trachoma
709786|NCT00221364|Chlamydia|chlamydia
709787|NCT00221364|Azithromycin|azithromycin
709789|NCT00221351|acute bronchitis|acute bronchitis
709790|NCT00221351|upper respiratory tract infection|upper respiratory tract infection
709791|NCT00221351|pneumonia|pneumonia
709792|NCT00221351|lower respiratory tract infection|lower respiratory tract infection
709793|NCT00221338|gabapentin|gabapentin
709794|NCT00221338|pain|pain
709795|NCT00221338|surgery|surgery
709796|NCT00221338|delirium|delirium
709797|NCT00221338|cognitive decline|cognitive decline
709798|NCT00221325|Phase I Clinical Trial|phase i clinical trial
709799|NCT00221325|Pharmacokinetics|pharmacokinetics
709800|NCT00221325|Pharmacodynamics|pharmacodynamics
709801|NCT00221325|CNS Lymphoma|cns lymphoma
709802|NCT00221325|Ocular Lymphoma|ocular lymphoma
709803|NCT00221312|Perimenopausal bone loss|perimenopausal bone loss
709804|NCT00221299|Osteoporosis|osteoporosis
709805|NCT00221299|Steroids|steroids
709806|NCT00221299|Prednisone|prednisone
709807|NCT00221286|chronic hepatitis B|chronic hepatitis b
709808|NCT00221286|human immunodeficiency virus|human immunodeficiency virus
709809|NCT00221286|pegylated interferon|pegylated interferon
709810|NCT00221286|tenofovir DF|tenofovir df
709811|NCT00221286|emtricitabine|emtricitabine
709812|NCT00221260|Analgesia|analgesia
709813|NCT00221260|anesthesia|anesthesia
709814|NCT00221247|cerebral palsy; acupuncture|cerebral palsy; acupuncture
709815|NCT00221234|Diabetes|diabetes
709816|NCT00221234|Physical Activity|physical activity
709817|NCT00221221|breast cancer survivors|breast cancer survivors
709818|NCT00221221|physical activity|physical activity
709819|NCT00221221|health promotion|health promotion
709820|NCT00221208|Diabetes|diabetes
709821|NCT00221208|Resistance Training|resistance training
709822|NCT00221182|Angina|angina
709823|NCT00221182|Heart diseases|heart diseases
709824|NCT00221182|Pain|pain
709825|NCT00221182|Vascular diseases|vascular diseases
709826|NCT00221169|Non-small cell lung cancer|non-small cell lung cancer
709827|NCT00221169|Positron emission tomography|positron emission tomography
709828|NCT00221169|Gross tumor volume|gross tumor volume
709829|NCT00221169|Radiation therapy|radiation therapy
709830|NCT00221156|Abnormal Glucose Tolerance|abnormal glucose tolerance
709831|NCT00221156|coronary artery disease|coronary artery disease
709832|NCT00221156|diabetes mellitus|diabetes mellitus
709833|NCT00221156|clinical outcome|clinical outcome
709834|NCT00221143|Ulcer/ gangrene|ulcer/ gangrene
709835|NCT00221143|Leg diseases|leg diseases
709836|NCT00221143|Pain|pain
709837|NCT00221143|Vascular diseases|vascular diseases
709838|NCT00221143|Chronic limb ischemia|chronic limb ischemia
709839|NCT00221143|Peripheral artery disease|peripheral artery disease
709840|NCT00221130|Regenerative medicine|regenerative medicine
709841|NCT00221130|Periodontal tissue|periodontal tissue
709842|NCT00221117|Spinal Cord Injuries|spinal cord injuries
709843|NCT00221104|stroke|stroke
709844|NCT00221104|brain ischemia|brain ischemia
709845|NCT00221104|cerebrovascular accident|cerebrovascular accident
709846|NCT00221104|statin|statin
709847|NCT00221104|hydroxymethylglutaryl-CoA reductase inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
709848|NCT00221104|cholesterol|cholesterol
709849|NCT00221104|hypercholesterolemia|hypercholesterolemia
709850|NCT00221104|hyperlipidemia|hyperlipidemia
709851|NCT00221104|multicenter studies|multicenter studies
709852|NCT00221104|prospective studies|prospective studies
709853|NCT00221104|endpoint determination|endpoint determination
709854|NCT00221104|randomized controlled trials|randomized controlled trials
709855|NCT00221104|recurrence|recurrence
709856|NCT00221104|pravastatin|pravastatin
709857|NCT00221091|idiopathic normal pressure hydrocephalus|idiopathic normal pressure hydrocephalus
709858|NCT00221091|shunt|shunt
709859|NCT00221078|Cerebrovascular Accident|cerebrovascular accident
709860|NCT00221078|Stroke|stroke
709861|NCT00221065|Sleep Apnea Syndromes|sleep apnea syndromes
709862|NCT00221065|Cerebrovascular Accident|cerebrovascular accident
709863|NCT00221039|ECP|ecp
709864|NCT00221039|Photopheresis|photopheresis
709865|NCT00221039|CTCL|ctcl
709866|NCT00221039|Cutaneous T Cell Lymphoma|cutaneous t cell lymphoma
709867|NCT00221039|Mycosis Fungoides|mycosis fungoides
709868|NCT00221013|Acute Renal Failure|acute renal failure
709869|NCT00221013|Continuous Renal Replacement Therapy|continuous renal replacement therapy
709870|NCT00221013|Continuous Veno-Venous Haemofiltration|continuous veno-venous haemofiltration
709871|NCT00221013|Continuous Veno-Venous Haemodiafiltration|continuous veno-venous haemodiafiltration
709872|NCT00221013|Renal Replacement Therapy|renal replacement therapy
709873|NCT00221000|Rheumatoid Arthritis|rheumatoid arthritis
709874|NCT00220987|Hyperglycemia in the critically ill patient|hyperglycemia in the critically ill patient
709875|NCT00220987|Intensive Insulin Therapy|intensive insulin therapy
709876|NCT00220987|Conventional insulin therapy|conventional insulin therapy
709877|NCT00220987|Hypoglycaemia|hypoglycaemia
709878|NCT00220961|Impaired Glucose Tolerance|impaired glucose tolerance
709879|NCT00220961|Type 2 Diabetes|type 2 diabetes
709880|NCT00220961|Prevention|prevention
709881|NCT00220961|Pioglitazone|pioglitazone
709882|NCT00220948|discogenic pain|discogenic pain
709883|NCT00220948|myoelectric activity|myoelectric activity
709884|NCT00220935|Randomized controlled clinical trial|randomized controlled clinical trial
709885|NCT00220922|Copaxone|copaxone
709886|NCT00220909|Gastric erosions|gastric erosions
709887|NCT00220909|Proton pump inhibitors|proton pump inhibitors
709888|NCT00220896|Delirium|delirium
709889|NCT00220896|Prevention|prevention
709890|NCT00220896|Donepezil|donepezil
709891|NCT00220883|Functional Dyspepsia|functional dyspepsia
709892|NCT00220883|Electrogastrography|electrogastrography
709893|NCT00220870|schizophrenia|schizophrenia
709894|NCT00220870|shared decision making|shared decision making
709895|NCT00220870|compliance|compliance
709896|NCT00220870|maintenance therapy|maintenance therapy
709897|NCT00220857|Rabeprazole|rabeprazole
709898|NCT00220857|Nonsteroidal Antiinflammatory Drugs|nonsteroidal antiinflammatory drugs
709899|NCT00220857|Gastric erosions|gastric erosions
709900|NCT00220831|Diabetes|diabetes
709901|NCT00220831|MI|mi
709902|NCT00220831|CVD disease|cvd disease
709903|NCT00220818|Pediatric GERD|pediatric gerd
709904|NCT00220818|Pediatric Gastroesophageal Reflux Disease|pediatric gastroesophageal reflux disease
709905|NCT00220818|lansoprazole|lansoprazole
709906|NCT00220792|Primary breast cancer|primary breast cancer
709907|NCT00220792|support groups|support groups
709908|NCT00220792|mood disturbance|mood disturbance
709909|NCT00220766|Primary Immune Deficiency|primary immune deficiency
709910|NCT00220766|IGIV|igiv
709911|NCT00220766|Immunoglobulin G|immunoglobulin g
709912|NCT00220753|Dog allergy|dog allergy
709913|NCT00220753|Pet allergy|pet allergy
709914|NCT00220753|Air cleaners|air cleaners
709915|NCT00220753|HEPA filters|hepa filters
709916|NCT00220753|Air filtration|air filtration
709917|NCT00220753|Can f1|can f1
709918|NCT00220753|Asthma|asthma
709919|NCT00220753|Children|children
709920|NCT00220753|Adolescents|adolescents
709921|NCT00220753|Indoor environment|indoor environment
709922|NCT00220753|Indoor allergy|indoor allergy
709923|NCT00220753|Perennial allergy|perennial allergy
709924|NCT00220740|Immunoglobulin G|immunoglobulin g
709925|NCT00220727|Idiopathic (Immune) Thrombocytopenic Purpura|idiopathic (immune) thrombocytopenic purpura
709926|NCT00220727|Immunoglobulin G|immunoglobulin g
709927|NCT00220714|schizophrenia|schizophrenia
709928|NCT00220714|first-episode|first-episode
709929|NCT00220714|patient compliance|patient compliance
709930|NCT00220714|long-acting risperidone|long-acting risperidone
709931|NCT00220714|relapse|relapse
709932|NCT00220701|Dysthymic Disorder|dysthymic disorder
709933|NCT00220701|Depression|depression
709934|NCT00220701|Chronic Depression|chronic depression
709935|NCT00220701|Escitalopram|escitalopram
709936|NCT00220688|nausea|nausea
709937|NCT00220688|vomiting|vomiting
709938|NCT00220688|palliative|palliative
709939|NCT00220688|acupressure|acupressure
709940|NCT00220675|Malignant extradural spinal cord compression|malignant extradural spinal cord compression
709941|NCT00220675|Erythropoietin|erythropoietin
709942|NCT00220675|Neuroprotectant|neuroprotectant
709943|NCT00220675|Radiotherapy|radiotherapy
709944|NCT00220675|Palliation|palliation
709945|NCT00220662|anorexia nervosa|anorexia nervosa
709946|NCT00220662|bulimia nervosa|bulimia nervosa
709947|NCT00220662|readiness and motivation|readiness and motivation
709948|NCT00220649|solid tumors or adenocarcinoma of the exocrine pancreas|solid tumors or adenocarcinoma of the exocrine pancreas
709949|NCT00220636|Major Depression|major depression
709950|NCT00220636|Depression|depression
709951|NCT00220636|Unipolar Depression|unipolar depression
709952|NCT00220636|Treatment Resistant Depression|treatment resistant depression
709953|NCT00220636|Adjunctive treatment|adjunctive treatment
709954|NCT00220623|major depression|major depression
709955|NCT00220623|psychotherapy|psychotherapy
709956|NCT00220623|antidepressant medications|antidepressant medications
709957|NCT00220623|clincial trial|clincial trial
709958|NCT00220597|group therapy|group therapy
709959|NCT00220597|sexual revictimization|sexual revictimization
709960|NCT00220597|risky sex|risky sex
709961|NCT00220597|addiction|addiction
709962|NCT00220571|AMI|ami
709963|NCT00220571|stent|stent
709964|NCT00220571|PTCA|ptca
709965|NCT00220571|abciximab|abciximab
709966|NCT00220571|reteplase|reteplase
709967|NCT00220571|combo therapy|combo therapy
709968|NCT00220558|Percutaneous Transluminal Coronary Angioplasty|percutaneous transluminal coronary angioplasty
709969|NCT00220558|Bare metal stents|bare metal stents
709970|NCT00220558|drug eluting stents|drug eluting stents
709971|NCT00220545|Polycystic ovarY|polycystic ovary
709972|NCT00220545|Laparoscopic ovarian diathermy|laparoscopic ovarian diathermy
709973|NCT00220545|Induction of ovulation|induction of ovulation
709974|NCT00220545|Clomiphene citrate|clomiphene citrate
709975|NCT00220532|Randomised placebo controlled intervention trial|randomised placebo controlled intervention trial
709976|NCT00220532|Folic acid|folic acid
709977|NCT00220532|Riboflavin|riboflavin
709978|NCT00220532|cervical cancer|cervical cancer
709979|NCT00220506|provigil|provigil
709980|NCT00220506|fatigue|fatigue
709981|NCT00220506|Multiple Sclerosis|multiple sclerosis
709982|NCT00220506|cognition|cognition
709983|NCT00220493|MS|ms
709984|NCT00220493|RITALIN|ritalin
709985|NCT00220493|PASAT|pasat
709986|NCT00220493|COGNITION|cognition
709987|NCT00220493|ATTENTION|attention
710374|NCT00218166|baclofen|baclofen
709988|NCT00220493|Relapsing remitting|relapsing remitting
709989|NCT00220493|Secondary progressive|secondary progressive
709990|NCT00220493|Primary progressive|primary progressive
709991|NCT00220467|MCI|mci
709992|NCT00220467|aging|aging
709993|NCT00220467|cognition|cognition
709994|NCT00220467|exercise|exercise
709995|NCT00220467|aerobic|aerobic
709996|NCT00220467|insulin|insulin
709997|NCT00220454|cognition|cognition
709998|NCT00220454|estradiol|estradiol
709999|NCT00220454|cortisol|cortisol
710000|NCT00220454|postmenopause|postmenopause
710001|NCT00220441|IGT|igt
710002|NCT00220441|exercise|exercise
710003|NCT00220441|cognition|cognition
710004|NCT00220441|insulin|insulin
710005|NCT00220441|aging|aging
710006|NCT00220441|aerobic|aerobic
710007|NCT00220428|T cell|t cell
710008|NCT00220350|arousal|arousal
710009|NCT00220350|sex offender|sex offender
710010|NCT00220350|suppression of arousal|suppression of arousal
710011|NCT00220350|pedohilia|pedohilia
710012|NCT00220350|leuprolide acetate|leuprolide acetate
710013|NCT00220324|Contraception|contraception
710014|NCT00220285|Antigen|antigen
710015|NCT00220285|CD20|cd20
710016|NCT00220272|Parkinson Disease|parkinson disease
710017|NCT00220272|5-fluorodopa|5-fluorodopa
710018|NCT00220259|Cystic Fibrosis, inhaled corticosteroids|cystic fibrosis, inhaled corticosteroids
710019|NCT00220246|Hereditary colorectal cancer|hereditary colorectal cancer
710020|NCT00220246|Microsatellite instability|microsatellite instability
710021|NCT00220246|Chromosomal instability|chromosomal instability
710022|NCT00220207|Diabetes|diabetes
710023|NCT00220207|Health Education|health education
710024|NCT00220207|Information Technology|information technology
710025|NCT00220207|African Americans|african americans
710026|NCT00220207|Disease Management|disease management
710027|NCT00220207|Internet|internet
710028|NCT00220207|Patient Education|patient education
710029|NCT00220181|Nutritional status|nutritional status
710030|NCT00220181|Bowel symptoms|bowel symptoms
710031|NCT00220181|Radical radiotherapy to pelvis|radical radiotherapy to pelvis
710032|NCT00220181|Gynaecological, urological or rectal cancer|gynaecological, urological or rectal cancer
710033|NCT00220090|Irritable Bowel Syndrome|irritable bowel syndrome
710034|NCT00220090|Cholecystokinin|cholecystokinin
710035|NCT00220090|Dexloxiglumide|dexloxiglumide
710036|NCT00220090|Randomized/withdrawal|randomized/withdrawal
710037|NCT00219999|Hepatitis|hepatitis
710038|NCT00219999|Hepacivirus|hepacivirus
710039|NCT00219999|B Lymphocytes|b lymphocytes
710040|NCT00219999|Chemokines|chemokines
710041|NCT00219999|Antibodies|antibodies
710042|NCT00219986|Treatment Experienced|treatment experienced
710043|NCT00219986|HIV|hiv
710044|NCT00219973|venous thromboembolism|venous thromboembolism
710045|NCT00219973|deep vein thrombosis|deep vein thrombosis
710046|NCT00219973|pulmonary embolism|pulmonary embolism
710047|NCT00219973|bleeding|bleeding
710048|NCT00219973|low-molecular-weight heparin|low-molecular-weight heparin
710049|NCT00219973|cancer|cancer
710050|NCT00219973|surgery|surgery
710051|NCT00219960|Hypertension|hypertension
710052|NCT00219960|Blood Pressure|blood pressure
710053|NCT00219960|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
710054|NCT00219960|Complementary and Alternative Medicine|complementary and alternative medicine
710055|NCT00219960|Herbal|herbal
710056|NCT00219960|North American Ginseng|north american ginseng
710057|NCT00219960|Panax Quinquefolius|panax quinquefolius
710058|NCT00219947|HIV Infection|hiv infection
710059|NCT00219947|Acute HIV Infection|acute hiv infection
710060|NCT00219947|Primary HIV Infection|primary hiv infection
710061|NCT00219947|Acute Seroconversion Syndrome|acute seroconversion syndrome
710062|NCT00219934|New HIV Infection|new hiv infection
710063|NCT00219934|Acute HIV Infection|acute hiv infection
710064|NCT00219934|Primary HIV Infection|primary hiv infection
710065|NCT00219934|Acute Seroconversion Syndrome|acute seroconversion syndrome
710066|NCT00219921|total hip replacement|total hip replacement
710067|NCT00219921|pain treatment|pain treatment
710068|NCT00219908|Multiple sclerosis|multiple sclerosis
710069|NCT00219908|Mitoxantrone|mitoxantrone
710070|NCT00219908|Methylprednisolone|methylprednisolone
710071|NCT00219908|Interferon beta1b|interferon beta1b
710072|NCT00219908|Relapse|relapse
710073|NCT00219908|MRI|mri
710074|NCT00219908|EDSS|edss
710075|NCT00219895|Cystic Fibrosis|cystic fibrosis
710076|NCT00219895|Anti-inflammatory Agents|anti-inflammatory agents
710077|NCT00219895|Ibuprofen|ibuprofen
710078|NCT00219882|Cystic Fibrosis|cystic fibrosis
710079|NCT00219882|curcuminoids|curcuminoids
710080|NCT00219882|turmeric root extract|turmeric root extract
710081|NCT00219882|nasal potential difference (NPD)|nasal potential difference (npd)
710082|NCT00219882|sweat chloride|sweat chloride
710083|NCT00219869|Post|post
710084|NCT00219869|Traumatic|traumatic
710085|NCT00219869|Headache|headache
710086|NCT00219869|Cognitive|cognitive
710087|NCT00219856|Propofol|propofol
710088|NCT00219856|Hepatectomy|hepatectomy
710089|NCT00219856|Oxidative stress|oxidative stress
710090|NCT00219843|Stage III and IV melanoma|stage iii and iv melanoma
710091|NCT00219830|Cardiac Rehabilitation|cardiac rehabilitation
710092|NCT00219830|Walking|walking
710093|NCT00219830|Acute Myocardial Infarction|acute myocardial infarction
710094|NCT00219830|Secondary Prevention|secondary prevention
710095|NCT00219817|Anorexia|anorexia
710096|NCT00219817|Cachexia|cachexia
710097|NCT00219791|methotrexate|methotrexate
710098|NCT00219791|delayed elimination|delayed elimination
710099|NCT00219791|renal insufficiency|renal insufficiency
710100|NCT00219791|CPG2|cpg2
710101|NCT00219791|Voraxaze|voraxaze
710102|NCT00219765|CML|cml
710103|NCT00219765|Acute Phase|acute phase
710104|NCT00219765|Imatinib mesylate|imatinib mesylate
710105|NCT00219765|Cytarabine|cytarabine
710106|NCT00219765|Daunorubicine|daunorubicine
710107|NCT00219752|CML - ederly patients - Imatinib mesylate|cml - ederly patients - imatinib mesylate
710108|NCT00219739|CML|cml
710109|NCT00219739|Imatinib|imatinib
710110|NCT00219739|Interferon|interferon
710111|NCT00219739|Cytarabine|cytarabine
710112|NCT00219726|CML|cml
710113|NCT00219726|Imatinib mesylate|imatinib mesylate
710114|NCT00219726|Stem cell transplantation|stem cell transplantation
710115|NCT00219713|Nitrous oxide and oxygen|nitrous oxide and oxygen
710116|NCT00219713|Pain|pain
710117|NCT00219713|Bone marrow biopsy|bone marrow biopsy
710118|NCT00219713|Bone marrow aspiration|bone marrow aspiration
710119|NCT00219700|NSAID-PC|nsaid-pc
710120|NCT00219700|IBU-PC|ibu-pc
710121|NCT00219687|Heart arrest|heart arrest
710122|NCT00219687|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
710123|NCT00219687|Dispatcher|dispatcher
710124|NCT00219674|education|education
710125|NCT00219674|training, defibrillators|training, defibrillators
710126|NCT00219674|home defibrillators|home defibrillators
710127|NCT00219674|automated external defibrillators|automated external defibrillators
710128|NCT00219674|psychological adjustment|psychological adjustment
710129|NCT00219661|randomised control trial|randomised control trial
710130|NCT00219661|intensive care unit|intensive care unit
710131|NCT00219661|mechanical ventilation|mechanical ventilation
710132|NCT00219661|ventilator-associated pneumonia|ventilator-associated pneumonia
710133|NCT00219661|drainage of subglottic secretions|drainage of subglottic secretions
710134|NCT00219557|Randomized Phase 2 Study of AG-013736 in Combination with Gemcitabine versus Gemcitabine Alone in Advanced Pancreatic Cancer|randomized phase 2 study of ag-013736 in combination with gemcitabine versus gemcitabine alone in advanced pancreatic cancer
710135|NCT00219531|functional MRI|functional mri
710136|NCT00219531|pain perception|pain perception
710137|NCT00219531|anxiety|anxiety
710138|NCT00219531|brain-gut axis|brain-gut axis
710139|NCT00219518|Defecography|defecography
710140|NCT00219518|Pelvic floor dyssynergia|pelvic floor dyssynergia
710141|NCT00219518|Anismus|anismus
710142|NCT00219505|Diarrhea-predominant irritable bowel syndrome|diarrhea-predominant irritable bowel syndrome
710143|NCT00219505|Acupuncture|acupuncture
710144|NCT00219505|abdominal pain|abdominal pain
710145|NCT00219492|NCCP, mast cell, esophagus|nccp, mast cell, esophagus
710146|NCT00219479|seizure prophylaxis|seizure prophylaxis
710147|NCT00219479|enteral nutrition|enteral nutrition
710148|NCT00219453|Pilot Projects|pilot projects
710149|NCT00219453|Injections, Jet|injections, jet
710150|NCT00219453|Injections, Jet/instrumentation|injections, jet/instrumentation
710151|NCT00219453|Equipment Contamination/prevention and control|equipment contamination/prevention and control
710152|NCT00219453|Blood-Borne Pathogens|blood-borne pathogens
710153|NCT00219453|Disease Transmission, Horizontal|disease transmission, horizontal
710154|NCT00219427|Low vision|low vision
710155|NCT00219401|Pneumococcal vaccine|pneumococcal vaccine
710156|NCT00219401|Antibody responses|antibody responses
710157|NCT00219401|Cellular immunology|cellular immunology
710158|NCT00219401|Th1/Th2 immune responses|th1/th2 immune responses
710159|NCT00219401|Paediatric|paediatric
710160|NCT00219401|Neonatal|neonatal
710161|NCT00219401|Infectious diseases|infectious diseases
710162|NCT00219401|Papua New Guinea|papua new guinea
710163|NCT00219388|Safety|safety
710164|NCT00219388|Efficacy|efficacy
710165|NCT00219388|Levosimendan|levosimendan
710166|NCT00219388|Dobutamine|dobutamine
710167|NCT00219388|Intravenous|intravenous
710168|NCT00219388|Invasive hemodynamics|invasive hemodynamics
710169|NCT00219388|Decompensated Heart Failure|decompensated heart failure
710170|NCT00219375|sivelestat sodium hydrate|sivelestat sodium hydrate
710171|NCT00219375|acute lung injury|acute lung injury
710172|NCT00219375|systemic inflammatory response syndrome|systemic inflammatory response syndrome
710173|NCT00219375|Elaspol|elaspol
710174|NCT00219375|Acute Lung Injury (ALI) Associated With Systemic Inflammatory Response Syndrome (SIRS)|acute lung injury (ali) associated with systemic inflammatory response syndrome (sirs)
710175|NCT00219362|HIV-1 infection|hiv-1 infection
710176|NCT00219362|therapeutic vaccine|therapeutic vaccine
710177|NCT00219362|Treatment Experienced|treatment experienced
710178|NCT00219349|Anxiety Disorders|anxiety disorders
710179|NCT00219349|Anxiety Neuroses|anxiety neuroses
710180|NCT00219349|Behavior Therapy, Cognitive|behavior therapy, cognitive
710181|NCT00219349|Escitalopram|escitalopram
710182|NCT00219336|Prevent Alcohol Exposed Pregnancies|prevent alcohol exposed pregnancies
710183|NCT00219336|Reduced Alcohol Used|reduced alcohol used
710184|NCT00219336|Self-Guided Motivational Intervention|self-guided motivational intervention
710185|NCT00219336|Effective Contraception|effective contraception
710186|NCT00219336|Contraception|contraception
710187|NCT00219336|College Students|college students
710188|NCT00219323|Asthma, IgE, Omalizumab|asthma, ige, omalizumab
710189|NCT00219310|Recurrent Genital Herpes (RGH), famciclovir, episodic treatment, suppressive treatment, Polymerase Chain Reaction (PCR).|recurrent genital herpes (rgh), famciclovir, episodic treatment, suppressive treatment, polymerase chain reaction (pcr).
710190|NCT00219297|EPO|epo
710191|NCT00219297|EPO906|epo906
710192|NCT00219297|Brain cancer|brain cancer
710193|NCT00219297|Brain metastasis|brain metastasis
710194|NCT00219297|Lung cancer|lung cancer
710195|NCT00219297|Lung metastasis|lung metastasis
710196|NCT00219297|Brain metastasis from non-small cell lung cancer|brain metastasis from non-small cell lung cancer
710197|NCT00219284|Parkinson's disease, tremor|parkinson's disease, tremor
710198|NCT00219271|Prostate cancer|prostate cancer
710199|NCT00219271|molecular staging|molecular staging
710200|NCT00219271|antitumor potential|antitumor potential
710201|NCT00219245|Traumatic brain injury, head trauma, rivastigmine, cognitive deficits|traumatic brain injury, head trauma, rivastigmine, cognitive deficits
710202|NCT00219232|Alzheimer's disease|alzheimer's disease
710203|NCT00219232|Dementia|dementia
710204|NCT00219219|zoledronic acid|zoledronic acid
710205|NCT00219219|prostate cancer|prostate cancer
710206|NCT00219219|SRE|sre
710207|NCT00219193|Hypertension, aliskiren, blood pressure, valsartan, HCTZ|hypertension, aliskiren, blood pressure, valsartan, hctz
710208|NCT00219180|Hypertension, Aliskiren|hypertension, aliskiren
710209|NCT00219167|hypertension|hypertension
710210|NCT00219167|aliskiren|aliskiren
710211|NCT00219167|age|age
710212|NCT00219128|Hypertension, aliskiren, blood pressure, placebo|hypertension, aliskiren, blood pressure, placebo
710213|NCT00219115|Hypertension, aliskiren, blood pressure, irbesartan, amlodipine, hydrochlorothiazide|hypertension, aliskiren, blood pressure, irbesartan, amlodipine, hydrochlorothiazide
710214|NCT00219102|Hypertension,|hypertension,
710215|NCT00219102|diabetes,|diabetes,
710216|NCT00219102|aliskiren,|aliskiren,
710217|NCT00219102|blood pressure,|blood pressure,
710218|NCT00219102|valsartan,|valsartan,
710219|NCT00219102|hydrochlorothiazide|hydrochlorothiazide
710220|NCT00219089|Hypertension, aliskiren, blood pressure, diabetes mellitus, ramipril|hypertension, aliskiren, blood pressure, diabetes mellitus, ramipril
710221|NCT00219076|Hypertension, aliskiren, blood pressure, amlodipine|hypertension, aliskiren, blood pressure, amlodipine
710222|NCT00219063|Hypertension, aliskiren, blood pressure, Ramipril, hydrochlorothiazide|hypertension, aliskiren, blood pressure, ramipril, hydrochlorothiazide
710223|NCT00219037|Hypertension, blood pressure, aliskiren|hypertension, blood pressure, aliskiren
710224|NCT00219024|Hypertension, aliskiren, blood pressure, hydrochlorothiazide (HCTZ).|hypertension, aliskiren, blood pressure, hydrochlorothiazide (hctz).
710225|NCT00219011|Aliskiren, heart failure,hypertension|aliskiren, heart failure,hypertension
710226|NCT00218998|Exercise|exercise
710227|NCT00218998|Exercise therapy|exercise therapy
710228|NCT00218985|Aerobic capacity|aerobic capacity
710229|NCT00218985|Exercise training|exercise training
710230|NCT00218985|CABG|cabg
710231|NCT00218985|Endothelial function|endothelial function
710232|NCT00218972|Hypertension|hypertension
710233|NCT00218972|endurance training|endurance training
710234|NCT00218972|endothelial function|endothelial function
710235|NCT00218972|left ventricular function|left ventricular function
710236|NCT00218972|Echocardiography|echocardiography
710237|NCT00218972|Quality of life|quality of life
710238|NCT00218972|Essential hypertension grade 1 - 2|essential hypertension grade 1 - 2
710239|NCT00218959|PTSD|ptsd
710240|NCT00218959|trauma treatment|trauma treatment
710241|NCT00218959|refugees|refugees
710242|NCT00218959|randomized controlled|randomized controlled
710243|NCT00218946|pain|pain
710244|NCT00218946|infant, premature|infant, premature
710245|NCT00218946|intubation, gastrointestinal|intubation, gastrointestinal
710246|NCT00218946|Neonatal nursing|neonatal nursing
710247|NCT00218933|Interval training|interval training
710248|NCT00218933|Endothelial dysfunction|endothelial dysfunction
710249|NCT00218933|Aerobic capacity|aerobic capacity
710250|NCT00218933|Exercise|exercise
710251|NCT00218920|aerobic capacity|aerobic capacity
710252|NCT00218920|endothelial function|endothelial function
710253|NCT00218920|exercise|exercise
710254|NCT00218907|HIV prevention|hiv prevention
710255|NCT00218907|HIV counseling|hiv counseling
710256|NCT00218907|HIV testing|hiv testing
710257|NCT00218907|Emergency Medicine|emergency medicine
710258|NCT00218907|HIV Seronegativity|hiv seronegativity
710259|NCT00218894|Effect|effect
710260|NCT00218894|Balance|balance
710261|NCT00218894|Gait|gait
710262|NCT00218894|Falls|falls
710263|NCT00218881|HIV prevention|hiv prevention
710264|NCT00218881|HIV screening|hiv screening
710265|NCT00218881|Emergency Medicine|emergency medicine
710266|NCT00218881|HIV counseling and Testing|hiv counseling and testing
710267|NCT00218881|HIV Seronegativity|hiv seronegativity
710268|NCT00218868|Cytodiagnosis|cytodiagnosis
710269|NCT00218868|Skin Scrape|skin scrape
710270|NCT00218868|Touch Imprint|touch imprint
710271|NCT00218868|Papanicolaou|papanicolaou
710650|NCT00216541|cancer|cancer
710272|NCT00218868|May-Grunvald-Giemsa|may-grunvald-giemsa
710273|NCT00218855|Multiple Myeloma|multiple myeloma
710274|NCT00218855|Phase 3, randomised, double blind study|phase 3, randomised, double blind study
710275|NCT00218855|thalidomide|thalidomide
710276|NCT00218842|exercise|exercise
710277|NCT00218842|functioning|functioning
710278|NCT00218842|frail elderly|frail elderly
710279|NCT00218829|Photodynamic treatment|photodynamic treatment
710280|NCT00218829|Basal cell carcinoma|basal cell carcinoma
710281|NCT00218829|DMSO|dmso
710282|NCT00218790|Sleep|sleep
710283|NCT00218790|Renal failure|renal failure
710284|NCT00218790|Dialysis|dialysis
710285|NCT00218777|Chronic tic disorder|chronic tic disorder
710286|NCT00218777|Motor tics|motor tics
710287|NCT00218777|Vocal tics|vocal tics
710288|NCT00218751|Child abuse|child abuse
710289|NCT00218751|Neglect|neglect
710290|NCT00218751|Home Visitation|home visitation
710291|NCT00218751|Program Evaluation|program evaluation
710292|NCT00218725|Cognitive Therapy|cognitive therapy
710293|NCT00218725|Suicide|suicide
710294|NCT00218725|Addictions|addictions
710295|NCT00218725|Substance Abuse|substance abuse
710296|NCT00218712|HIV|hiv
710297|NCT00218712|AIDS|aids
710298|NCT00218712|MSM|msm
710299|NCT00218712|Cognitive-Behavioral|cognitive-behavioral
710300|NCT00218712|HIV Seronegativity|hiv seronegativity
710301|NCT00218699|HIV|hiv
710302|NCT00218699|MSM Men Who Have Sex with Men|msm men who have sex with men
710303|NCT00218699|Men Who Have Sex With Men|men who have sex with men
710304|NCT00218699|Cognitive-Behavioral|cognitive-behavioral
710305|NCT00218699|HIV Counseling and Testing|hiv counseling and testing
710306|NCT00218699|HIV Seronegativity|hiv seronegativity
710307|NCT00218686|HIV|hiv
710308|NCT00218686|injection drug use|injection drug use
710309|NCT00218686|social networks|social networks
710310|NCT00218673|HIV|hiv
710311|NCT00218673|injection drug use|injection drug use
710312|NCT00218673|social networks|social networks
710313|NCT00218621|Buprenorphine|buprenorphine
710314|NCT00218621|Methadone|methadone
710315|NCT00218608|Cocaine Abuse|cocaine abuse
710316|NCT00218582|12 step groups|12 step groups
710317|NCT00218582|self help|self help
710318|NCT00218582|psychiatric day treatment|psychiatric day treatment
710319|NCT00218582|co-occurring disorders|co-occurring disorders
710320|NCT00218582|dual diagnosis|dual diagnosis
710321|NCT00218569|Alcohol Dependence|alcohol dependence
710322|NCT00218569|Cocaine Dependence|cocaine dependence
710323|NCT00218556|Hepatitis C, Depressive Symptoms|hepatitis c, depressive symptoms
710324|NCT00218543|ADHD|adhd
710325|NCT00218543|Cocaine Abuse|cocaine abuse
710326|NCT00218517|cannabis use disorder|cannabis use disorder
710327|NCT00218465|Drugs, Investigational|drugs, investigational
710328|NCT00218465|Therapies for Relapse to Nicotine|therapies for relapse to nicotine
710329|NCT00218465|Relapse Prevention|relapse prevention
710330|NCT00218465|Nicotine Cessation Therapies|nicotine cessation therapies
710331|NCT00218465|Smoking Cessation|smoking cessation
710332|NCT00218465|Nicotine Dependence|nicotine dependence
710333|NCT00218452|Tobacco use cessation|tobacco use cessation
710334|NCT00218439|Smoking|smoking
710335|NCT00218413|Vaccine|vaccine
710336|NCT00218413|Immunogenicity|immunogenicity
710337|NCT00218413|Randomized Controlled Trial|randomized controlled trial
710338|NCT00218413|Addiction|addiction
710339|NCT00218374|Opiate Addiction|opiate addiction
710340|NCT00218374|Opiate Dependence|opiate dependence
710341|NCT00218361|Behavioral economics|behavioral economics
710342|NCT00218361|Drug self administration|drug self administration
710343|NCT00218361|Opioid|opioid
710344|NCT00218348|Cocaine Abuse|cocaine abuse
710345|NCT00218348|Dextro-Amphetamine Sulfate|dextro-amphetamine sulfate
710346|NCT00218335|HIV prevention Intervention, injection drug user,peer-oriented, randomized controlled trial, social network|hiv prevention intervention, injection drug user,peer-oriented, randomized controlled trial, social network
710347|NCT00218309|opiate dependence|opiate dependence
710348|NCT00218296|Nicotine Dependence|nicotine dependence
710349|NCT00218296|Tobacco Dependence|tobacco dependence
710350|NCT00218283|Nicotine Dependence|nicotine dependence
710351|NCT00218283|Tobacco Dependence|tobacco dependence
710352|NCT00218270|Smokeless tobacco, harm reduction|smokeless tobacco, harm reduction
710353|NCT00218257|Cocaine|cocaine
710354|NCT00218244|Brand Switching, smokeless tobacco use|brand switching, smokeless tobacco use
710355|NCT00218231|schizophrenia|schizophrenia
710356|NCT00218231|tobacco dependence|tobacco dependence
710357|NCT00218231|nicotine|nicotine
710358|NCT00218218|Nicotine Dependence|nicotine dependence
710359|NCT00218218|Tobacco Dependence|tobacco dependence
710360|NCT00218205|Epirubicin|epirubicin
710361|NCT00218205|Estramustine Phosphate|estramustine phosphate
710362|NCT00218205|Celecoxib|celecoxib
710363|NCT00218205|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
710364|NCT00218192|hepatitis c|hepatitis c
710365|NCT00218192|injection drug use|injection drug use
710366|NCT00218179|Lung Cancer|lung cancer
710367|NCT00218179|Cotinine|cotinine
710368|NCT00218179|NNAL|nnal
710369|NCT00218179|Carcinogens|carcinogens
710370|NCT00218179|Case-control|case-control
710371|NCT00218179|SNPs|snps
710375|NCT00218153|nicotine dependence|nicotine dependence
710376|NCT00218140|tobacco|tobacco
710377|NCT00218127|Heroin dependence|heroin dependence
710378|NCT00218114|ADHD, disruptive behavior disorder, marijuana abuse|adhd, disruptive behavior disorder, marijuana abuse
710379|NCT00218101|opioid dependence|opioid dependence
710380|NCT00218075|Cocaine addiction|cocaine addiction
710381|NCT00218075|cocaine treatment|cocaine treatment
710382|NCT00218036|Cocaine Abuse|cocaine abuse
710383|NCT00218036|Opiate Abuse|opiate abuse
710384|NCT00218023|cocaine|cocaine
710385|NCT00218023|cocaine addiction|cocaine addiction
710386|NCT00218023|cocaine abuse|cocaine abuse
710387|NCT00218023|relapse prevention|relapse prevention
710388|NCT00218010|methadone|methadone
710389|NCT00218010|lactation|lactation
710390|NCT00218010|breastfeeding|breastfeeding
710391|NCT00218010|maternal opioid dependency|maternal opioid dependency
710392|NCT00217997|cocaine abuse|cocaine abuse
710393|NCT00217997|Cocaine-Related Disorders|cocaine-related disorders
710394|NCT00217984|Tobacco use disorder|tobacco use disorder
710395|NCT00217984|Alcohol dependence|alcohol dependence
710396|NCT00217971|cannabis dependence|cannabis dependence
710397|NCT00217971|dronabinol|dronabinol
710398|NCT00217971|treatment|treatment
710399|NCT00217932|Behavioral Disorders|behavioral disorders
710400|NCT00217854|asthma, corticosteroids|asthma, corticosteroids
710401|NCT00217841|MRSA|mrsa
710402|NCT00217763|Dementia|dementia
710403|NCT00217763|Alzheimer's disease|alzheimer's disease
710404|NCT00217724|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
710405|NCT00217724|pain|pain
710406|NCT00217711|stage III colon cancer|stage iii colon cancer
710407|NCT00217711|stage IV colon cancer|stage iv colon cancer
710408|NCT00217711|stage III rectal cancer|stage iii rectal cancer
710409|NCT00217711|stage IV rectal cancer|stage iv rectal cancer
710410|NCT00217698|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
710411|NCT00217698|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
710412|NCT00217698|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
710413|NCT00217698|adenocarcinoma of the lung|adenocarcinoma of the lung
710414|NCT00217698|large cell lung cancer|large cell lung cancer
710415|NCT00217698|squamous cell lung cancer|squamous cell lung cancer
710416|NCT00217672|stage IV breast cancer|stage iv breast cancer
710417|NCT00217672|recurrent breast cancer|recurrent breast cancer
710418|NCT00217659|male breast cancer|male breast cancer
710419|NCT00217659|recurrent breast cancer|recurrent breast cancer
710420|NCT00217659|stage IV breast cancer|stage iv breast cancer
710421|NCT00217620|adult angiosarcoma|adult angiosarcoma
710422|NCT00217620|adult leiomyosarcoma|adult leiomyosarcoma
710423|NCT00217620|adult liposarcoma|adult liposarcoma
710424|NCT00217620|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
710425|NCT00217620|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
710426|NCT00217620|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
710427|NCT00217620|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
710428|NCT00217607|adult angiosarcoma|adult angiosarcoma
710429|NCT00217607|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
710430|NCT00217607|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
710431|NCT00217607|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
710432|NCT00217594|Immunosuppression|immunosuppression
710433|NCT00217594|T Cells|t cells
710434|NCT00217594|Hematopoiesis|hematopoiesis
710435|NCT00217594|Anti-CD52|anti-cd52
710436|NCT00217594|Monoclonal Antibody Therapy|monoclonal antibody therapy
710437|NCT00217581|recurrent gastric cancer|recurrent gastric cancer
710438|NCT00217581|stage III gastric cancer|stage iii gastric cancer
710439|NCT00217581|stage IV gastric cancer|stage iv gastric cancer
710440|NCT00217581|recurrent esophageal cancer|recurrent esophageal cancer
710441|NCT00217581|stage III esophageal cancer|stage iii esophageal cancer
710442|NCT00217581|stage IV esophageal cancer|stage iv esophageal cancer
710443|NCT00217581|adenocarcinoma of the stomach|adenocarcinoma of the stomach
710444|NCT00217568|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
710445|NCT00217568|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
710446|NCT00217568|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
710447|NCT00217568|peritoneal cavity cancer|peritoneal cavity cancer
710448|NCT00217555|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
710449|NCT00217555|fallopian tube cancer|fallopian tube cancer
710450|NCT00217555|peritoneal cavity cancer|peritoneal cavity cancer
710451|NCT00217529|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
710452|NCT00217529|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
710453|NCT00217529|peritoneal cavity cancer|peritoneal cavity cancer
710454|NCT00217529|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
710455|NCT00217529|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
710456|NCT00217529|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
710457|NCT00217529|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
710458|NCT00217529|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
710459|NCT00217529|Brenner tumor|brenner tumor
710460|NCT00217529|fallopian tube cancer|fallopian tube cancer
710461|NCT00217529|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
710462|NCT00217516|adenocarcinoma of the prostate|adenocarcinoma of the prostate
710463|NCT00217516|stage I prostate cancer|stage i prostate cancer
710464|NCT00217516|stage II prostate cancer|stage ii prostate cancer
710465|NCT00217503|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
710466|NCT00217490|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
710467|NCT00217477|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
710468|NCT00217464|adenocarcinoma of the prostate|adenocarcinoma of the prostate
710469|NCT00217464|recurrent prostate cancer|recurrent prostate cancer
710470|NCT00217451|Malaria|malaria
710471|NCT00217451|Fosmidomycin|fosmidomycin
710472|NCT00217451|Clindamycin|clindamycin
710473|NCT00217451|Gabon|gabon
710474|NCT00217425|anaplastic large cell lymphoma|anaplastic large cell lymphoma
710475|NCT00217425|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
710476|NCT00217425|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
710477|NCT00217425|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
710478|NCT00217425|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
710479|NCT00217425|peripheral T-cell lymphoma|peripheral t-cell lymphoma
710480|NCT00217386|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
710481|NCT00217386|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
710482|NCT00217386|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
710483|NCT00217386|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
710484|NCT00217386|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
710485|NCT00217347|Gastroesophageal reflux|gastroesophageal reflux
710486|NCT00217347|Dyspepsia|dyspepsia
710487|NCT00217347|Esophageal Capsule Endoscopy|esophageal capsule endoscopy
710488|NCT00217334|Hypertension|hypertension
710489|NCT00217334|Cardiovascular diseases|cardiovascular diseases
710490|NCT00217334|Randomized controlled trial|randomized controlled trial
710491|NCT00217334|Cluster randomization|cluster randomization
710492|NCT00217334|Primary care|primary care
710493|NCT00217321|Parkinson's disease|parkinson's disease
710494|NCT00217321|Parkinson disease|parkinson disease
710495|NCT00217321|Registry|registry
710496|NCT00217321|quality of life|quality of life
710497|NCT00217321|database|database
710498|NCT00217295|Relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
710499|NCT00217295|Brain atrophy|brain atrophy
710500|NCT00217295|Disease progression|disease progression
710501|NCT00217269|Restenosis|restenosis
710502|NCT00217256|Restenosis|restenosis
710503|NCT00217243|Pain|pain
710504|NCT00217243|Magnetoencephalography|magnetoencephalography
710505|NCT00217243|Median|median
710506|NCT00217243|Ulnar|ulnar
710507|NCT00217243|Causalgia|causalgia
710508|NCT00217243|Complex regional pain syndrome|complex regional pain syndrome
710509|NCT00217243|Evoked fields|evoked fields
710510|NCT00217243|Nerve injury|nerve injury
710511|NCT00217243|Neuropathic pain|neuropathic pain
710512|NCT00217217|non-pharmaceutical|non-pharmaceutical
710513|NCT00217217|alternative|alternative
710514|NCT00217217|imaging|imaging
710515|NCT00217217|magnetic resonance imaging|magnetic resonance imaging
710516|NCT00217217|low field magnetic stimulation|low field magnetic stimulation
710517|NCT00217217|bipolar disorder|bipolar disorder
710518|NCT00217217|depression|depression
710519|NCT00217217|bipolar depression|bipolar depression
710520|NCT00217204|Cystic fibrosis|cystic fibrosis
710521|NCT00217204|Pancreatic insufficiency|pancreatic insufficiency
710522|NCT00217204|Steatorrhea|steatorrhea
710523|NCT00217204|Fat malabsorption|fat malabsorption
710524|NCT00217204|Pancrelipase|pancrelipase
710525|NCT00217191|Premature Infants|premature infants
710526|NCT00217191|Patent ductus arteriosus|patent ductus arteriosus
710527|NCT00217191|Renal function|renal function
710528|NCT00217191|Ibuprofen|ibuprofen
710529|NCT00217178|Atherosclerosis|atherosclerosis
710530|NCT00217178|CV Risk Factors|cv risk factors
710531|NCT00217178|Homocysteine|homocysteine
710532|NCT00217178|CV disease|cv disease
710533|NCT00217178|Cardiovascular disease|cardiovascular disease
710534|NCT00217165|bipolar|bipolar
710535|NCT00217165|mania|mania
710536|NCT00217165|depression|depression
710537|NCT00217165|taurine|taurine
710538|NCT00217165|alternative|alternative
710539|NCT00217152|Kidney Transplant|kidney transplant
710540|NCT00217139|Hepatitis C|hepatitis c
710541|NCT00217139|Celgosivir|celgosivir
710542|NCT00217139|HCV|hcv
710543|NCT00217139|Genotype 1|genotype 1
710544|NCT00217139|Non-responders|non-responders
710545|NCT00217139|Early Viral Response|early viral response
710546|NCT00217139|EVR|evr
710547|NCT00217035|parenteral nutrition|parenteral nutrition
710548|NCT00217035|burn injury|burn injury
710549|NCT00217035|stable isotopes|stable isotopes
710550|NCT00217035|Proline Metabolic Kinetics|proline metabolic kinetics
710551|NCT00217035|Ornithine Metabolic Kinetics|ornithine metabolic kinetics
710552|NCT00217035|Glutamate Metabolic Kinetics|glutamate metabolic kinetics
710651|NCT00216541|transfusion|transfusion
710553|NCT00217035|Glutamine Metabolic Kinetics|glutamine metabolic kinetics
710554|NCT00217022|Lymphocytic Colitis|lymphocytic colitis
710555|NCT00217022|diarrhea|diarrhea
710556|NCT00217022|budesonide|budesonide
710557|NCT00216996|parenteral nutrition|parenteral nutrition
710558|NCT00216996|burn injury|burn injury
710559|NCT00216996|stable isotopes|stable isotopes
710560|NCT00216996|Glutamate Metabolic Kinetics|glutamate metabolic kinetics
710561|NCT00216996|Glutamine Metabolic Kinetics|glutamine metabolic kinetics
710562|NCT00216983|parenteral nutrition|parenteral nutrition
710563|NCT00216983|burn injury|burn injury
710564|NCT00216983|stable isotopes|stable isotopes
710565|NCT00216983|Proline Metabolic Kinetics|proline metabolic kinetics
710566|NCT00216983|Ornithine Metabolic Kinetics|ornithine metabolic kinetics
710567|NCT00216983|Glutamate Metabolic Kinetics|glutamate metabolic kinetics
710568|NCT00216983|Glutamine Metabolic Kinetics|glutamine metabolic kinetics
710569|NCT00216970|parenteral nutrition|parenteral nutrition
710570|NCT00216970|burn injury|burn injury
710571|NCT00216970|stable isotopes|stable isotopes
710572|NCT00216970|Arginine Metabolic Kinetics|arginine metabolic kinetics
710573|NCT00216970|Nitric Oxide Formation|nitric oxide formation
710574|NCT00216970|Glutamine Metabolic Kinetics|glutamine metabolic kinetics
710575|NCT00216944|Intubation|intubation
710576|NCT00216944|premedication|premedication
710577|NCT00216905|Patients with alcoholism according to ICD-10 after detoxification|patients with alcoholism according to icd-10 after detoxification
710578|NCT00216866|Embolism|embolism
710579|NCT00216866|Thrombosis|thrombosis
710580|NCT00216814|antiangiogenic effects of bcg treatment and prognosis|antiangiogenic effects of bcg treatment and prognosis
710581|NCT00216801|Upper Tract Transitional Cell (TCC)|upper tract transitional cell (tcc)
710582|NCT00216788|Sucrose|sucrose
710583|NCT00216788|Barrett's esophagus|barrett's esophagus
710584|NCT00216788|Esophagitis|esophagitis
710585|NCT00216788|GERD|gerd
710586|NCT00216788|Reflux|reflux
710587|NCT00216788|Esophagus|esophagus
710588|NCT00216788|Esomeprazole|esomeprazole
710589|NCT00216762|Urticaria|urticaria
710590|NCT00216762|Hives|hives
710591|NCT00216749|Cerebral Infarction Prevention|cerebral infarction prevention
710592|NCT00216749|Cilostazol|cilostazol
710593|NCT00216736|Migraine|migraine
710594|NCT00216736|Headache|headache
710595|NCT00216736|Rebound headache|rebound headache
710596|NCT00216723|Aripiprazole|aripiprazole
710597|NCT00216723|Schizophrenia|schizophrenia
710598|NCT00216723|Bipolar Disorder|bipolar disorder
710599|NCT00216710|Child abuse|child abuse
710600|NCT00216710|Neglect|neglect
710601|NCT00216710|Home visitation|home visitation
710602|NCT00216710|Program evaluation|program evaluation
710603|NCT00216697|Multiple myeloma|multiple myeloma
710604|NCT00216697|Proteasome inhibitor|proteasome inhibitor
710605|NCT00216697|Ubiquitin|ubiquitin
710606|NCT00216697|Boronic acids|boronic acids
710607|NCT00216697|Bortezomib|bortezomib
710608|NCT00216684|Fentanyl, Chronic intractable pain, Japanese patients|fentanyl, chronic intractable pain, japanese patients
710609|NCT00216671|Schizophrenia|schizophrenia
710610|NCT00216671|intramuscular injection|intramuscular injection
710611|NCT00216671|antipsychotic agents|antipsychotic agents
710612|NCT00216671|long-acting risperidone|long-acting risperidone
710613|NCT00216658|Fentanyl|fentanyl
710614|NCT00216658|Cancer pain|cancer pain
710615|NCT00216658|Japanese patients|japanese patients
710616|NCT00216645|Müllerian Carcinoma|müllerian carcinoma
710617|NCT00216645|Doxil|doxil
710618|NCT00216645|Japanese Patients|japanese patients
710619|NCT00216632|Schizophrenia, Schizoaffective disorder|schizophrenia, schizoaffective disorder
710620|NCT00216632|antipsychotic agents|antipsychotic agents
710621|NCT00216632|long-acting risperidone|long-acting risperidone
710622|NCT00216632|intramuscular injection|intramuscular injection
710623|NCT00216619|chronic migraine|chronic migraine
710624|NCT00216619|Topiramate|topiramate
710625|NCT00216619|migraine|migraine
710626|NCT00216619|headache|headache
710627|NCT00216619|chronic headache|chronic headache
710628|NCT00216606|Chronic migraine|chronic migraine
710629|NCT00216606|Migraine|migraine
710630|NCT00216606|Headache|headache
710631|NCT00216606|Migraine headache|migraine headache
710632|NCT00216606|Topiramate|topiramate
710633|NCT00216593|dementia|dementia
710634|NCT00216593|cognition function|cognition function
710635|NCT00216593|Alzheimer disease|alzheimer disease
710636|NCT00216593|behavioral symptoms|behavioral symptoms
710637|NCT00216593|galantamine hydrobromide|galantamine hydrobromide
710638|NCT00216580|Schizophrenia|schizophrenia
710639|NCT00216580|Intramuscular injection|intramuscular injection
710640|NCT00216580|Antipsychotic agents|antipsychotic agents
710641|NCT00216580|Long-acting risperidone|long-acting risperidone
710642|NCT00216580|Schizophreniform disorders|schizophreniform disorders
710643|NCT00216580|Schizoaffective disorder|schizoaffective disorder
710644|NCT00216567|Benign rolandic epilepsy|benign rolandic epilepsy
710645|NCT00216567|Topiramate|topiramate
710646|NCT00216554|Bipolar|bipolar
710647|NCT00216554|risperidone|risperidone
710648|NCT00216554|Adjunctive therapy|adjunctive therapy
710649|NCT00216541|Anemia|anemia
710652|NCT00216541|chemotherapy|chemotherapy
710653|NCT00216541|hemoglobin|hemoglobin
710654|NCT00216541|standard care|standard care
710655|NCT00216541|epoetin alfa|epoetin alfa
710656|NCT00216541|epoetin|epoetin
710657|NCT00216541|erythropoietin|erythropoietin
710658|NCT00216528|Schizophrenia|schizophrenia
710659|NCT00216528|risperidone|risperidone
710660|NCT00216528|Intramuscular injection, long-acting risperidone|intramuscular injection, long-acting risperidone
710661|NCT00216515|Alzheimer's disease|alzheimer's disease
710662|NCT00216515|galantamine|galantamine
710663|NCT00216515|attention|attention
710664|NCT00216515|executive function|executive function
710665|NCT00216502|Alzheimer's disease|alzheimer's disease
710666|NCT00216502|Dementia|dementia
710667|NCT00216502|galantamine|galantamine
710668|NCT00216502|placebo|placebo
710669|NCT00216502|Caregiver|caregiver
710670|NCT00216502|Brain disease|brain disease
710671|NCT00216502|Memory loss|memory loss
710672|NCT00216489|gastroesophageal reflux|gastroesophageal reflux
710673|NCT00216489|heartburn|heartburn
710674|NCT00216489|rabeprazole|rabeprazole
710675|NCT00216489|GERD|gerd
710676|NCT00216489|anti-ulcer agents|anti-ulcer agents
710677|NCT00216489|proton pump inhibitor|proton pump inhibitor
710678|NCT00216476|Schizophrenia, relapse prevention|schizophrenia, relapse prevention
710679|NCT00216476|Antipsychotic agents|antipsychotic agents
710680|NCT00216476|Long-acting risperidone|long-acting risperidone
710681|NCT00216476|Quetiapine|quetiapine
710682|NCT00216476|Aripiprazole|aripiprazole
710683|NCT00216463|LDL-cholesterol|ldl-cholesterol
710684|NCT00216463|apoB-100|apob-100
710685|NCT00216463|apoB-48|apob-48
710686|NCT00216450|rabeprazole|rabeprazole
710687|NCT00216450|proton pump inhibitor|proton pump inhibitor
710688|NCT00216450|Helicobacter infections|helicobacter infections
710689|NCT00216450|Helicobacter pylori|helicobacter pylori
710690|NCT00216450|H pylori|h pylori
710691|NCT00216450|bacterial infections|bacterial infections
710692|NCT00216437|Liver cancer|liver cancer
710693|NCT00216424|Colon cancer|colon cancer
710694|NCT00216424|Rectal cancer|rectal cancer
710695|NCT00216398|acromegaly|acromegaly
710696|NCT00216398|growth hormone|growth hormone
710697|NCT00216385|Tuberculosis|tuberculosis
710698|NCT00216385|Treatment|treatment
710699|NCT00216385|Quinolone|quinolone
710700|NCT00216385|Short course chemotherapy|short course chemotherapy
710701|NCT00216372|carcinomatosis|carcinomatosis
710702|NCT00216359|Treatment Experienced|treatment experienced
710703|NCT00216333|tuberculosis|tuberculosis
710704|NCT00216333|fixed dose combination|fixed dose combination
710705|NCT00216333|DOT|dot
710706|NCT00216333|shot-course chemotherapy|shot-course chemotherapy
710707|NCT00216320|electrical stimulation|electrical stimulation
710708|NCT00216294|Obsessive Compulsive Disorder|obsessive compulsive disorder
710709|NCT00216294|RG 1068 (Synthetic Human Secretin)|rg 1068 (synthetic human secretin)
710710|NCT00216281|Schizophrenia|schizophrenia
710711|NCT00216281|Clozapine|clozapine
710712|NCT00216281|Atomoxetine|atomoxetine
710713|NCT00216255|Persistent Developmental Stuttering|persistent developmental stuttering
710714|NCT00216242|influenza|influenza
710715|NCT00216242|vaccine|vaccine
710716|NCT00216242|efficacy|efficacy
710717|NCT00216242|safety|safety
710718|NCT00216242|immunogenicity|immunogenicity
710719|NCT00216229|combined hepatitis A and B vaccine|combined hepatitis a and b vaccine
710720|NCT00216229|hepatitis B virus|hepatitis b virus
710721|NCT00216229|immunity|immunity
710722|NCT00216203|Non-Small Cell Lung Cancer|non-small cell lung cancer
710723|NCT00216190|Sedation, ICU, Anesthesia, Dexmedetomidine, Midazolam|sedation, icu, anesthesia, dexmedetomidine, midazolam
710724|NCT00216164|Lymphoma|lymphoma
710725|NCT00216151|Multiple Myeloma|multiple myeloma
710726|NCT00216151|Bisphosphonates|bisphosphonates
710727|NCT00216138|Head and Neck Cancer|head and neck cancer
710728|NCT00216125|Non-Small Cell Lung Cancer|non-small cell lung cancer
710729|NCT00216112|Ovarian Cancer|ovarian cancer
710730|NCT00216099|Prostate Cancer|prostate cancer
710731|NCT00216086|Rectal Cancer|rectal cancer
710732|NCT00216073|Breast Cancer|breast cancer
710733|NCT00216047|Breast Cancer|breast cancer
710734|NCT00216034|Gastric Cancer|gastric cancer
710735|NCT00216034|TS-1|ts-1
710736|NCT00216034|PSK|psk
710737|NCT00216034|Disease-free survival|disease-free survival
710738|NCT00216034|Overall survival|overall survival
710739|NCT00216021|Breast Cancer|breast cancer
710740|NCT00215995|esophageal cancer|esophageal cancer
710741|NCT00215995|esophagogastric cancer|esophagogastric cancer
710742|NCT00215995|gastric cancer|gastric cancer
710743|NCT00215982|advanced|advanced
710744|NCT00215982|colon|colon
710745|NCT00215982|rectal|rectal
710746|NCT00215969|Pre-eclampsia|pre-eclampsia
710747|NCT00215969|Pregnancy|pregnancy
710748|NCT00215969|Hypercoagulation|hypercoagulation
710749|NCT00215969|Screening|screening
710750|NCT00215969|Cardiovascular complications|cardiovascular complications
710751|NCT00215956|Topotecan|topotecan
710752|NCT00215956|Rectal Neoplasms|rectal neoplasms
710753|NCT00215956|Radiosensitizing|radiosensitizing
710754|NCT00215943|hematologic malignancy|hematologic malignancy
710755|NCT00215930|malignant pleural effusion|malignant pleural effusion
710756|NCT00215917|Schizophrenia|schizophrenia
710757|NCT00215917|NMDA|nmda
710758|NCT00215917|D-serine|d-serine
710759|NCT00215891|Treatment Experienced|treatment experienced
710760|NCT00215852|Alferon LDO|alferon ldo
710761|NCT00215852|Low Dose Oral Interferon|low dose oral interferon
710762|NCT00215852|Alfa-n3|alfa-n3
710763|NCT00215852|Human Leukocyte Derived|human leukocyte derived
710764|NCT00215852|HIV|hiv
710765|NCT00215852|Asymptomatic HIV|asymptomatic hiv
710766|NCT00215852|Treatment Experienced|treatment experienced
710767|NCT00215839|Treatment Experienced|treatment experienced
710768|NCT00215826|SARS|sars
710769|NCT00215826|Alferon LDO|alferon ldo
710770|NCT00215826|Low Dose Oral Interferon ALFA-n3|low dose oral interferon alfa-n3
710771|NCT00215826|Human Leukocyte Derived|human leukocyte derived
710772|NCT00215826|Exposure to SARS|exposure to sars
710773|NCT00215826|Possible SARS|possible sars
710774|NCT00215813|Chronic Fatigue Syndrome|chronic fatigue syndrome
710775|NCT00215813|CFS|cfs
710776|NCT00215813|ME|me
710777|NCT00215813|Ampligen|ampligen
710778|NCT00215813|poly I:poly C12U|poly i:poly c12u
710779|NCT00215813|Rintatolimod|rintatolimod
710780|NCT00215800|Chronic Fatigue Syndrome|chronic fatigue syndrome
710781|NCT00215800|Myalgic Encephalomyelitis|myalgic encephalomyelitis
710782|NCT00215800|CFS|cfs
710783|NCT00215800|Ampligen|ampligen
710784|NCT00215800|Poly I:ploy C12U|poly i:ploy c12u
710785|NCT00215787|Nasal polyps|nasal polyps
710786|NCT00215787|Gastroesophageal Reflux|gastroesophageal reflux
710787|NCT00215774|Atrial fibrillation|atrial fibrillation
710788|NCT00215761|Atrial fibrillation|atrial fibrillation
710789|NCT00215761|Preventive stimulation|preventive stimulation
710790|NCT00215761|Pacemaker|pacemaker
710791|NCT00215748|Elderly|elderly
710792|NCT00215748|Weekly|weekly
710793|NCT00215735|diabetes|diabetes
710794|NCT00215735|Ulcer|ulcer
710795|NCT00215735|APC|apc
710796|NCT00215709|elderly|elderly
710797|NCT00215683|Prostate Cancer|prostate cancer
710798|NCT00215683|Androgen ablation therapy|androgen ablation therapy
710799|NCT00215670|AMD|amd
710800|NCT00215670|Macugen|macugen
710801|NCT00215670|Pharmacokinetics|pharmacokinetics
710802|NCT00215670|Age-Related Macular Degeneration|age-related macular degeneration
710803|NCT00215670|PK|pk
710804|NCT00215644|Esophagus|esophagus
710805|NCT00215644|Gastric|gastric
710806|NCT00215644|Adenocarcinoma|adenocarcinoma
710807|NCT00215644|EGFR|egfr
710808|NCT00215644|matuzumab|matuzumab
710809|NCT00215644|EMD 72000|emd 72000
710810|NCT00215644|randomized|randomized
710811|NCT00215644|Epirubicin|epirubicin
710812|NCT00215644|cisplatin|cisplatin
710813|NCT00215644|capecitabine|capecitabine
710814|NCT00215644|Metastatic Esophago-Gastric cancer|metastatic esophago-gastric cancer
710815|NCT00215631|prostate cancer|prostate cancer
710816|NCT00215631|radiotherapy|radiotherapy
710817|NCT00215631|erectile dysfunction|erectile dysfunction
710818|NCT00215631|tadalafil|tadalafil
710819|NCT00215605|Advanced Malignancies|advanced malignancies
710820|NCT00215605|Solid Tumor|solid tumor
710821|NCT00215605|Medullary Thyroid Cancer|medullary thyroid cancer
710822|NCT00215566|IBS|ibs
710823|NCT00215566|IBS-c|ibs-c
710824|NCT00215540|Double-blind|double-blind
710825|NCT00215540|Low Birth Weight|low birth weight
710826|NCT00215540|Surfactant|surfactant
710827|NCT00215540|Placebo-Controlled|placebo-controlled
710828|NCT00215540|Premature Birth|premature birth
710829|NCT00215527|mucopolysaccharidosis|mucopolysaccharidosis
710830|NCT00215527|Hurler-Scheie|hurler-scheie
710831|NCT00215527|Scheie|scheie
710832|NCT00215527|laronidase|laronidase
710833|NCT00215527|spinal cord compression|spinal cord compression
710834|NCT00215527|central nervous system|central nervous system
710835|NCT00215527|enzyme replacement therapy|enzyme replacement therapy
710836|NCT00215527|intrathecal|intrathecal
710837|NCT00215527|LA Biomed|la biomed
710838|NCT00215514|adjuvant chemoradiation|adjuvant chemoradiation
710839|NCT00215514|GE junction|ge junction
710840|NCT00215514|epirubicin|epirubicin
710841|NCT00215501|advanced solid tumor malignancy|advanced solid tumor malignancy
710842|NCT00215501|capecitabine|capecitabine
710843|NCT00215501|continuous infusion|continuous infusion
710844|NCT00215501|5-FU|5-fu
710845|NCT00215501|irinotecan|irinotecan
710846|NCT00215501|5-fluorouracil|5-fluorouracil
710847|NCT00215501|cisplatin|cisplatin
710848|NCT00215462|gastric adenocarcinoma|gastric adenocarcinoma
710849|NCT00215462|esophageal adenocarcinoma|esophageal adenocarcinoma
710850|NCT00215462|vinorelbine|vinorelbine
710851|NCT00215449|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
710852|NCT00215449|COPD|copd
710853|NCT00215449|formoterol|formoterol
710854|NCT00215449|formoterol fumarate|formoterol fumarate
710855|NCT00215436|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
710856|NCT00215436|COPD|copd
710857|NCT00215436|formoterol|formoterol
710858|NCT00215423|COPD|copd
710859|NCT00215423|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
710860|NCT00215423|Formoterol Fumarate|formoterol fumarate
710861|NCT00215423|Formoterol|formoterol
710862|NCT00215410|Asthma|asthma
710863|NCT00215410|Formoterol|formoterol
710864|NCT00215410|Fumarate|fumarate
710865|NCT00215397|Asthma|asthma
710866|NCT00215397|Formoterol|formoterol
710867|NCT00215397|Fumarate|fumarate
710868|NCT00215384|COPD|copd
710869|NCT00215384|formoterol|formoterol
710870|NCT00215371|Asthma|asthma
710871|NCT00215371|Pediatric|pediatric
710872|NCT00215371|Formoterol Fumarate|formoterol fumarate
710873|NCT00215371|Foradil|foradil
710874|NCT00215358|Asthma|asthma
710875|NCT00215358|Formoterol|formoterol
710876|NCT00215358|Fumarate|fumarate
710877|NCT00215358|Foradil|foradil
710878|NCT00215345|Celecoxib|celecoxib
710879|NCT00215345|Taxotere|taxotere
710880|NCT00215345|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
710881|NCT00215332|arthroplasty|arthroplasty
710882|NCT00215332|lumbar|lumbar
710883|NCT00215332|disc|disc
710884|NCT00215319|Degenerative disc disease at up to 2 levels (L2-S1)|degenerative disc disease at up to 2 levels (l2-s1)
710885|NCT00215306|arthroplasty|arthroplasty
710886|NCT00215306|lumbar|lumbar
710887|NCT00215306|spine|spine
710888|NCT00215293|fusion|fusion
710889|NCT00215293|cervical|cervical
710890|NCT00215293|spine|spine
710891|NCT00215280|Mansonella perstans|mansonella perstans
710892|NCT00215280|microfilaraemia|microfilaraemia
710893|NCT00215280|ivermectin|ivermectin
710894|NCT00215280|albendazole|albendazole
710895|NCT00215280|Uganda|uganda
710896|NCT00215267|Schistosoma mansoni|schistosoma mansoni
710897|NCT00215267|hepatosplenomegaly|hepatosplenomegaly
710898|NCT00215267|malaria|malaria
710899|NCT00215267|Uganda|uganda
710900|NCT00215254|quetiapine|quetiapine
710901|NCT00215254|social anxiety disorder|social anxiety disorder
710902|NCT00215254|antipsychotic|antipsychotic
710903|NCT00215254|pilot study|pilot study
710904|NCT00215241|PTSD|ptsd
710905|NCT00215241|sertraline|sertraline
710906|NCT00215241|risperidone|risperidone
710907|NCT00215241|antidepressant|antidepressant
710908|NCT00215241|antipsychotic|antipsychotic
710909|NCT00215241|anxiety|anxiety
710910|NCT00215241|trauma|trauma
710911|NCT00215215|Vagus Nerve Stimulation Therapy|vagus nerve stimulation therapy
710912|NCT00215215|Epilepsies, Partial|epilepsies, partial
710913|NCT00215215|Seizures|seizures
710914|NCT00215215|Antiepileptic Drugs|antiepileptic drugs
710915|NCT00215215|Refractory Partial Seizures|refractory partial seizures
710916|NCT00215202|Adrenocortical Cancer|adrenocortical cancer
710917|NCT00215202|Iressa|iressa
710918|NCT00215202|Adrenal Cancer|adrenal cancer
710919|NCT00215189|health|health
710920|NCT00215189|mental illness|mental illness
710921|NCT00215189|fitness|fitness
710922|NCT00215176|atypical depression|atypical depression
710923|NCT00215176|psychostimulants|psychostimulants
710924|NCT00215176|modafinil|modafinil
710925|NCT00215163|PTSD|ptsd
710926|NCT00215163|Anxiety|anxiety
710927|NCT00215163|CBT|cbt
710928|NCT00215163|Exposure|exposure
710929|NCT00215163|Paroxetine|paroxetine
710930|NCT00215163|Paroxetine-CR|paroxetine-cr
710931|NCT00215150|anxiety disorder|anxiety disorder
710932|NCT00215150|SAD|sad
710933|NCT00215150|ziprasidone|ziprasidone
710934|NCT00215150|sertraline|sertraline
710935|NCT00215150|antidepressant|antidepressant
710936|NCT00215150|antipsychotic|antipsychotic
710937|NCT00215137|OCD|ocd
710938|NCT00215137|SSRI|ssri
710939|NCT00215137|escitalopram|escitalopram
710940|NCT00215137|relapse|relapse
710941|NCT00215111|childhood obesity|childhood obesity
710942|NCT00215111|weight management|weight management
710943|NCT00215111|dietary interventions|dietary interventions
710944|NCT00215111|cardiovascular disease risk factors|cardiovascular disease risk factors
710945|NCT00215098|pediatric health|pediatric health
710946|NCT00215098|cardiac|cardiac
710947|NCT00215098|congenital heart surgery|congenital heart surgery
710948|NCT00215098|post-operative chylous effusions|post-operative chylous effusions
710949|NCT00215098|heart defects|heart defects
710950|NCT00215098|children|children
710951|NCT00215085|pediatric health|pediatric health
710952|NCT00215085|cardiac|cardiac
710953|NCT00215085|cardiac tumor|cardiac tumor
710954|NCT00215085|children|children
710955|NCT00215072|Death after heart surgery|death after heart surgery
710956|NCT00215072|surgical mortality|surgical mortality
710957|NCT00215072|post-operative mortality|post-operative mortality
710958|NCT00215072|pediatric health|pediatric health
710959|NCT00215072|cardiac|cardiac
710960|NCT00215059|angiogenic related growth factor|angiogenic related growth factor
710961|NCT00215046|vinblastine|vinblastine
710962|NCT00215046|methotrexate|methotrexate
710963|NCT00215033|Epstein-Barr virus|epstein-barr virus
710964|NCT00215033|pediatric health|pediatric health
710965|NCT00215033|cardiac|cardiac
710966|NCT00215033|heart transplant|heart transplant
710967|NCT00215033|lymphoproliferative disease|lymphoproliferative disease
710968|NCT00215033|post-transplant|post-transplant
710969|NCT00215033|pediatric transplant|pediatric transplant
710970|NCT00215020|Isoprostanes|isoprostanes
710971|NCT00214981|ADHD|adhd
710972|NCT00214981|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
710973|NCT00214929|Pulmonary Embolism|pulmonary embolism
710974|NCT00214929|Therapy|therapy
710975|NCT00214929|Home Nursing|home nursing
710976|NCT00214929|Economics|economics
710977|NCT00214916|Tight glycemic control with|tight glycemic control with
710978|NCT00214916|intensive insulin treatment|intensive insulin treatment
710979|NCT00214916|versus conventional glycemic control|versus conventional glycemic control
710980|NCT00214916|in infant or child in ICU|in infant or child in icu
710981|NCT00214903|Postmenopause|postmenopause
710982|NCT00214903|HRT|hrt
710983|NCT00214890|HIV|hiv
710984|NCT00214890|nucleoside pharmacology|nucleoside pharmacology
710985|NCT00214890|drug-drug interaction|drug-drug interaction
710986|NCT00214890|Treatment Naive|treatment naive
710987|NCT00214890|Drug resistance|drug resistance
710988|NCT00214890|Drug pharmacokinetics|drug pharmacokinetics
710989|NCT00214877|methylene blue for cognitive dysfunction in bipolar disorder|methylene blue for cognitive dysfunction in bipolar disorder
710990|NCT00214864|Metastatic Breast Cancer|metastatic breast cancer
710991|NCT00214864|Taxotere (docetaxel)|taxotere (docetaxel)
710992|NCT00214864|Xeloda (capecitabine)|xeloda (capecitabine)
710993|NCT00214851|Familial Cold Urticaria|familial cold urticaria
710994|NCT00214851|Kineret (anakinra)|kineret (anakinra)
710995|NCT00214851|Interleukin 1 beta|interleukin 1 beta
710996|NCT00214851|C-Reactive Protein|c-reactive protein
710997|NCT00214851|Serum Amyloid A protein|serum amyloid a protein
710998|NCT00214838|cancer, atiprimod|cancer, atiprimod
710999|NCT00214812|HIV Seronegativity|hiv seronegativity
711000|NCT00214812|HIV|hiv
711001|NCT00214786|Diabetes Mellitus|diabetes mellitus
711002|NCT00214786|Hypoglycemia|hypoglycemia
711003|NCT00214786|Hyperglycemia|hyperglycemia
711004|NCT00214760|Hip prosthesis|hip prosthesis
711005|NCT00214760|Centralizer|centralizer
711006|NCT00214760|Uncemented|uncemented
711007|NCT00214747|HIV Seronegativity|hiv seronegativity
711008|NCT00214747|HIV|hiv
711009|NCT00214708|Tuberculosis|tuberculosis
711010|NCT00214708|Screening|screening
711011|NCT00214708|Heaf|heaf
711012|NCT00214708|BCG|bcg
711013|NCT00214682|Depression|depression
711014|NCT00214682|Cognition|cognition
711015|NCT00214682|Depressive disorder|depressive disorder
711016|NCT00214682|Mental health literacy|mental health literacy
711017|NCT00214682|Older adults|older adults
711018|NCT00214682|Randomzed controlled trial|randomzed controlled trial
711019|NCT00214669|ethnicity|ethnicity
711020|NCT00214669|primary care|primary care
711021|NCT00214669|education|education
711022|NCT00214656|Cardiac surgical procedures|cardiac surgical procedures
711023|NCT00214656|Surgical blood loss|surgical blood loss
711024|NCT00214656|Surgical haemostasis|surgical haemostasis
711025|NCT00214656|Factor VIIa|factor viia
711026|NCT00214656|Anaesthesia|anaesthesia
711027|NCT00214643|Malaria|malaria
711028|NCT00214643|Fosmidomycin|fosmidomycin
711029|NCT00214643|Clindamycin|clindamycin
711030|NCT00214643|Chemotherapy|chemotherapy
711031|NCT00214643|Gabon|gabon
711032|NCT00214617|hypercholesterolemia|hypercholesterolemia
711033|NCT00214617|HMG CoA Reductase Inhibtors|hmg coa reductase inhibtors
711034|NCT00214617|tracer kinetics|tracer kinetics
711035|NCT00214617|Apolipoproteins|apolipoproteins
711036|NCT00214591|Type 2 diabetes|type 2 diabetes
711037|NCT00214578|Schizophrenia|schizophrenia
711038|NCT00214565|Type 2 diabetes|type 2 diabetes
711039|NCT00214552|GERD|gerd
711040|NCT00214552|Gastroesophageal reflux disease|gastroesophageal reflux disease
711041|NCT00214552|Asthma symptoms|asthma symptoms
711042|NCT00214539|Asthma|asthma
711043|NCT00214539|Bronchial Thermoplasty|bronchial thermoplasty
711044|NCT00214526|Asthma|asthma
711045|NCT00214526|Bronchial Thermoplasty|bronchial thermoplasty
711046|NCT00214526|Airway Hyperresponsiveness|airway hyperresponsiveness
711047|NCT00214487|Myopia Progression|myopia progression
711048|NCT00214487|Myopia Control|myopia control
711049|NCT00214487|Bifocal Contact Lenses|bifocal contact lenses
711050|NCT00214487|Esophoria|esophoria
711051|NCT00214487|Fixation Disparity|fixation disparity
711052|NCT00214474|Disease Management|disease management
711053|NCT00214474|Health Literacy|health literacy
711054|NCT00214474|Telephone Care|telephone care
711055|NCT00214474|Group Medical Visits|group medical visits
711056|NCT00214474|Type 2 Diabetes|type 2 diabetes
711057|NCT00214474|Access to Care|access to care
711058|NCT00214474|Technology|technology
711059|NCT00214474|Language Barriers|language barriers
711060|NCT00214461|Clostridium difficile|clostridium difficile
711061|NCT00214448|Multiple genetic conditions will be studied|multiple genetic conditions will be studied
711062|NCT00214435|HIV infection|hiv infection
711063|NCT00214435|AIDS|aids
711064|NCT00214435|Adherence|adherence
711065|NCT00214435|MEMS caps|mems caps
711066|NCT00214435|Treatment Experienced|treatment experienced
711067|NCT00214422|Prostate|prostate
711068|NCT00214422|Radiation|radiation
711069|NCT00214422|Cancer|cancer
711070|NCT00214422|Prostate Cancer|prostate cancer
711071|NCT00214383|pediatric asthma|pediatric asthma
711072|NCT00214370|pediatric|pediatric
711073|NCT00214370|acute leukemia/lymphoma|acute leukemia/lymphoma
711074|NCT00214344|dying|dying
711075|NCT00214227|patient who will undergo definitive radiotherapy|patient who will undergo definitive radiotherapy
711076|NCT00214175|low grade gliomas and benign CNS lesions|low grade gliomas and benign cns lesions
711077|NCT00214045|Bladder cancer surveillance|bladder cancer surveillance
711078|NCT00214045|Voiding dysfunction|voiding dysfunction
711079|NCT00214045|Cystoscopy|cystoscopy
711080|NCT00214032|lymphedema of the arm in breast cancer survivors|lymphedema of the arm in breast cancer survivors
711081|NCT00213980|bone mineral density|bone mineral density
711082|NCT00213980|postmenopausal women|postmenopausal women
711083|NCT00213967|Influenza vaccine|influenza vaccine
711084|NCT00213954|Nerve block anaesthesia|nerve block anaesthesia
711085|NCT00213954|ultrasound-guidance|ultrasound-guidance
711086|NCT00213941|transient tachypnoea of the newborn|transient tachypnoea of the newborn
711087|NCT00213941|surfactant deficiency|surfactant deficiency
711088|NCT00213941|persistant pulmonary hypertension of the neonate|persistant pulmonary hypertension of the neonate
711089|NCT00213941|lung maturity tests|lung maturity tests
711090|NCT00213915|L-arginine|l-arginine
711091|NCT00213915|exercise capacity|exercise capacity
711092|NCT00213915|renal function|renal function
711093|NCT00213915|nitric oxide|nitric oxide
711094|NCT00213915|exercise capacity using a maximal exercise test|exercise capacity using a maximal exercise test
711095|NCT00213915|urinary elimination of a saline load using blood and urinary samples|urinary elimination of a saline load using blood and urinary samples
711096|NCT00213902|Heart failure|heart failure
711097|NCT00213902|Diastolic|diastolic
711098|NCT00213902|functionClonidine|functionclonidine
711099|NCT00213902|Left ventricular diastolic dysfunction with preserved ejection fraction|left ventricular diastolic dysfunction with preserved ejection fraction
711100|NCT00213889|Facial clefting|facial clefting
711101|NCT00213889|twist|twist
711102|NCT00213889|craniofacial development genes|craniofacial development genes
711103|NCT00213889|Human cleft lip and palate|human cleft lip and palate
711104|NCT00213889|cleft lip and palate|cleft lip and palate
711105|NCT00213876|Brain tumours|brain tumours
711106|NCT00213876|oligodendrogliomas|oligodendrogliomas
711107|NCT00213876|allelotyping|allelotyping
711108|NCT00213876|SAGE|sage
711109|NCT00213876|Presence of molecular abnormalities statistically linked to survival or response to chemotherapy|presence of molecular abnormalities statistically linked to survival or response to chemotherapy
711110|NCT00213863|porous titanium implants|porous titanium implants
711111|NCT00213863|thyroplasty|thyroplasty
711112|NCT00213863|vocal cord paralysis|vocal cord paralysis
711113|NCT00213863|male or female more than 18 years old|male or female more than 18 years old
711114|NCT00213850|Interrupter technique|interrupter technique
711115|NCT00213850|Respiratory resistance|respiratory resistance
711116|NCT00213850|Normal adults|normal adults
711117|NCT00213837|porous titanium implants|porous titanium implants
711118|NCT00213837|thyroplasty|thyroplasty
711119|NCT00213837|vocal cord paralysis|vocal cord paralysis
711120|NCT00213837|male or female more than 18 years old|male or female more than 18 years old
711121|NCT00213824|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
711122|NCT00213824|Nogo gene|nogo gene
711123|NCT00213824|reticulon genes|reticulon genes
711124|NCT00213811|Bardet-Biedl syndrome, retinitis pigmentosa, obesity, genes|bardet-biedl syndrome, retinitis pigmentosa, obesity, genes
711125|NCT00213798|Lung cancer|lung cancer
711126|NCT00213798|plasma DNA|plasma dna
711127|NCT00213798|allelotyping|allelotyping
711128|NCT00213798|follow-up|follow-up
711129|NCT00213798|Prospective Study|prospective study
711130|NCT00213798|Non-Small Cell Lung Cancer|non-small cell lung cancer
711131|NCT00213798|Small Cell Lung Cancer|small cell lung cancer
711132|NCT00213785|AreET1|areet1
711133|NCT00213785|ANP|anp
711134|NCT00213785|BNP pronostic markers of stroke|bnp pronostic markers of stroke
711135|NCT00213772|Porphyria cutanea tarda|porphyria cutanea tarda
711136|NCT00213772|hepatitis C|hepatitis c
711137|NCT00213772|hemochromatosis|hemochromatosis
711138|NCT00213759|neutropenia|neutropenia
711139|NCT00213759|prematurity|prematurity
711140|NCT00213759|nosocomial infection|nosocomial infection
711141|NCT00213759|G-CSF|g-csf
711142|NCT00213746|Coronary Arteriosclerosis|coronary arteriosclerosis
711143|NCT00213746|Heart Failure, Congestive|heart failure, congestive
711144|NCT00213746|Myocardial Infarction|myocardial infarction
711145|NCT00213746|Myocardial Revascularization|myocardial revascularization
711146|NCT00213746|Tomography, Emission-Computed, Single-Photon|tomography, emission-computed, single-photon
711147|NCT00213746|Dobutamine|dobutamine
711148|NCT00213746|Myocardial Stunning|myocardial stunning
711149|NCT00213746|Myocardial Hibernation|myocardial hibernation
711150|NCT00213733|Lung cancer patients|lung cancer patients
711151|NCT00213733|non-small cell lung cancer|non-small cell lung cancer
711152|NCT00213733|molecular marker|molecular marker
711153|NCT00213733|lymph node completed resected|lymph node completed resected
711154|NCT00213733|Lung cancer samples and paired lymph node resected|lung cancer samples and paired lymph node resected
711155|NCT00213720|Hyperthyroidism|hyperthyroidism
711156|NCT00213720|atrial fibrillation|atrial fibrillation
711157|NCT00213720|quality of life|quality of life
711158|NCT00213720|radioiodine treatment|radioiodine treatment
711159|NCT00213707|Dendritic cells|dendritic cells
711160|NCT00213707|liver transplantation|liver transplantation
711161|NCT00213707|hepatitis C virus|hepatitis c virus
711162|NCT00213707|quasispecies|quasispecies
711163|NCT00213707|virological markers|virological markers
711164|NCT00213707|biochemical markers|biochemical markers
711165|NCT00213707|immunological markers|immunological markers
711166|NCT00213707|clinical markers|clinical markers
711167|NCT00213681|Pulmonary edema, respiratory failure, pressure support ventilation, continuous positive pressure|pulmonary edema, respiratory failure, pressure support ventilation, continuous positive pressure
711168|NCT00213668|glutamine|glutamine
711169|NCT00213668|premature neonate|premature neonate
711170|NCT00213668|gastric emptying|gastric emptying
711171|NCT00213642|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide
711172|NCT00213642|Radionuclide Imaging|radionuclide imaging
711173|NCT00213642|Cisplatin|cisplatin
711174|NCT00213642|Kidney failure|kidney failure
711175|NCT00213642|Drug Toxicity|drug toxicity
711176|NCT00213642|Cancer|cancer
711177|NCT00213629|myositis|myositis
711178|NCT00213629|cDNA arrays|cdna arrays
711179|NCT00213629|Genes, T-Cell Receptor beta|genes, t-cell receptor beta
711180|NCT00213616|bilateral vocal cord paralysis|bilateral vocal cord paralysis
711181|NCT00213616|reinnervation|reinnervation
711182|NCT00213616|phrenic nerve|phrenic nerve
711183|NCT00213603|precancerous lesions|precancerous lesions
711184|NCT00213603|Lung cancer|lung cancer
711185|NCT00213603|Follow-up|follow-up
711186|NCT00213603|Randomized study|randomized study
711187|NCT00213603|Autofluorescence endoscopy|autofluorescence endoscopy
711188|NCT00213603|precancerous conditions|precancerous conditions
711189|NCT00213577|overactive neurogenic bladder|overactive neurogenic bladder
711190|NCT00213499|Mechanical ventilation|mechanical ventilation
711191|NCT00213499|Weaning|weaning
711192|NCT00213499|Noninvasive ventilation|noninvasive ventilation
711193|NCT00213499|Acute on chronic respiratory failure|acute on chronic respiratory failure
711194|NCT00213473|acquired haemophilia|acquired haemophilia
711195|NCT00213434|prospective|prospective
711196|NCT00213434|randomized|randomized
711197|NCT00213434|polysomnography|polysomnography
711198|NCT00213434|orthodontic appliance, removable|orthodontic appliance, removable
711199|NCT00213408|Arrhythmia|arrhythmia
711200|NCT00213408|atrial flutter|atrial flutter
711201|NCT00213408|catheter ablation|catheter ablation
711202|NCT00213395|Noninvasive ventilation|noninvasive ventilation
711203|NCT00213395|Acute hypercapnic respiratory failure|acute hypercapnic respiratory failure
711204|NCT00213395|Cephalic mask|cephalic mask
711205|NCT00213395|Facial Mask|facial mask
711206|NCT00213382|swallowing|swallowing
711207|NCT00213382|ventilation|ventilation
711208|NCT00213382|pressure|pressure
711209|NCT00213382|EMG|emg
711210|NCT00213382|cortical magnetic stimulation|cortical magnetic stimulation
711211|NCT00213382|Brain Mapping|brain mapping
711212|NCT00213369|aspiration|aspiration
711213|NCT00213369|stroke|stroke
711214|NCT00213369|motor evoked potential|motor evoked potential
711215|NCT00213369|cortical evoked potential|cortical evoked potential
711216|NCT00213369|neuromodulation|neuromodulation
711217|NCT00213356|spinal cord injuries - anal sphincter - evoked potentials|spinal cord injuries - anal sphincter - evoked potentials
711218|NCT00213343|aspiration|aspiration
711219|NCT00213343|phrenic nerve|phrenic nerve
711220|NCT00213343|magnetic stimulation|magnetic stimulation
711221|NCT00213330|cerebral activity|cerebral activity
711222|NCT00213330|rectal distension|rectal distension
711223|NCT00213330|colitis ulcerative|colitis ulcerative
711224|NCT00213330|irritable bowel syndrome|irritable bowel syndrome
711225|NCT00213330|magnetic resonance imaging|magnetic resonance imaging
711226|NCT00213317|sacral magnetic stimulation|sacral magnetic stimulation
711227|NCT00213317|fecal incontinence|fecal incontinence
711228|NCT00213317|constipation|constipation
711229|NCT00213304|organ transplantation|organ transplantation
711230|NCT00213304|immunosuppression|immunosuppression
711231|NCT00213304|vaccine|vaccine
711232|NCT00213304|varicella|varicella
711233|NCT00213304|pediatrics|pediatrics
711234|NCT00213291|chronic kidney failure|chronic kidney failure
711235|NCT00213291|darbepoetin|darbepoetin
711236|NCT00213291|pediatrics|pediatrics
711237|NCT00213291|anemia|anemia
711238|NCT00213278|glioma|glioma
711239|NCT00213278|brain tumour|brain tumour
711240|NCT00213278|cancer|cancer
711241|NCT00213278|pediatrics|pediatrics
711242|NCT00213278|vinblastine sulfate|vinblastine sulfate
711243|NCT00213265|organ transplantation|organ transplantation
711244|NCT00213265|immunosuppression|immunosuppression
711245|NCT00213265|vaccine|vaccine
711246|NCT00213265|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
711247|NCT00213265|pediatrics|pediatrics
711248|NCT00213252|asthma, randomized trial, pediatrics|asthma, randomized trial, pediatrics
711249|NCT00213239|spinal puncture|spinal puncture
711250|NCT00213239|remifentanil|remifentanil
711251|NCT00213239|propofol|propofol
711252|NCT00213239|anesthesia|anesthesia
711253|NCT00213239|dose finding|dose finding
711254|NCT00213239|pediatrics|pediatrics
711255|NCT00213226|bronchiolitis|bronchiolitis
711256|NCT00213226|pediatrics|pediatrics
711257|NCT00213226|corticosteroids|corticosteroids
711258|NCT00213213|sucrose|sucrose
711259|NCT00213213|analgesia|analgesia
711260|NCT00213213|pain|pain
711261|NCT00213213|neonates|neonates
711262|NCT00213213|diabetes|diabetes
711263|NCT00213200|pain|pain
711264|NCT00213200|analgesia|analgesia
711265|NCT00213200|morphine|morphine
711266|NCT00213200|amethocaine|amethocaine
711267|NCT00213200|neonate|neonate
711268|NCT00213187|Juvenile Rheumatoid Arthritis,|juvenile rheumatoid arthritis,
711269|NCT00213187|Randomized Control Trial,|randomized control trial,
711270|NCT00213187|attention placebo,|attention placebo,
711271|NCT00213187|exercise testing,|exercise testing,
711272|NCT00213187|aerobics,|aerobics,
711273|NCT00213187|Qi Gong,|qi gong,
711274|NCT00213187|exercise video,|exercise video,
711275|NCT00213187|activities of daily living,|activities of daily living,
711276|NCT00213187|quality of life,|quality of life,
711277|NCT00213187|economy of walking,|economy of walking,
711278|NCT00213187|fitness|fitness
711279|NCT00213187|pediatrics|pediatrics
711280|NCT00213174|pediatrics|pediatrics
711281|NCT00213174|injury|injury
711282|NCT00213174|arm fractures|arm fractures
711283|NCT00213174|trauma|trauma
711284|NCT00213174|playground surfaces|playground surfaces
711285|NCT00213174|fractures|fractures
711286|NCT00213161|anemia|anemia
711287|NCT00213161|iron deficiency|iron deficiency
711288|NCT00213161|iron drops|iron drops
711289|NCT00213161|iron supplement|iron supplement
711290|NCT00213161|malnutrition|malnutrition
711291|NCT00213161|pediatrics|pediatrics
711292|NCT00213122|alpha-glucosidase inhibitor,Insulin|alpha-glucosidase inhibitor,insulin
711293|NCT00213109|alpha-glucosidase inhibitor,Insulin|alpha-glucosidase inhibitor,insulin
711294|NCT00213096|Contraceptive agents|contraceptive agents
711295|NCT00213096|female|female
711296|NCT00213083|Microbicide|microbicide
711297|NCT00213083|HIV|hiv
711298|NCT00213083|AIDS|aids
711299|NCT00213083|STIs|stis
711300|NCT00213083|STDs|stds
711301|NCT00213083|Efficacy|efficacy
711302|NCT00213083|HSV|hsv
711303|NCT00213083|Women|women
711304|NCT00213083|South Africa|south africa
711305|NCT00213083|seroconversion|seroconversion
711306|NCT00213083|condom|condom
711307|NCT00213083|safe-sex|safe-sex
711308|NCT00213083|vaginal intercourse|vaginal intercourse
711309|NCT00213083|prevention|prevention
711310|NCT00213083|HIV Seronegativity|hiv seronegativity
711311|NCT00213070|alpha-glucosidase inhibitor,Insulin|alpha-glucosidase inhibitor,insulin
711312|NCT00213057|Microbicides|microbicides
711313|NCT00213057|HIV prevention|hiv prevention
711314|NCT00213057|sexually transmitted infections|sexually transmitted infections
711315|NCT00213057|carrageenan|carrageenan
711316|NCT00213057|sero-concordant couples|sero-concordant couples
711317|NCT00213057|HIV Seronegativity|hiv seronegativity
711318|NCT00213057|HIV|hiv
711319|NCT00213044|Microbicides|microbicides
711320|NCT00213044|HIV prevention|hiv prevention
711321|NCT00213044|HIV-positive women|hiv-positive women
711322|NCT00213044|safety|safety
711323|NCT00213044|carrageenan|carrageenan
711324|NCT00213044|HIV|hiv
711325|NCT00213031|microbicides|microbicides
711326|NCT00213031|HIV prevention|hiv prevention
711327|NCT00213031|sexually transmitted infections|sexually transmitted infections
711328|NCT00213031|female-initiated protection|female-initiated protection
711329|NCT00213031|carrageenan|carrageenan
711330|NCT00213031|expanded safety trial|expanded safety trial
711331|NCT00213031|HIV Seronegativity|hiv seronegativity
711332|NCT00213031|HIV|hiv
711333|NCT00213018|microbicides|microbicides
711334|NCT00213018|HIV prevention|hiv prevention
711335|NCT00213018|sexually transmitted infections|sexually transmitted infections
711336|NCT00213018|female-initiated protection|female-initiated protection
711337|NCT00213018|carrageenan|carrageenan
711338|NCT00213018|expanded safety trial|expanded safety trial
711339|NCT00213018|HIV Seronegativity|hiv seronegativity
711340|NCT00213018|HIV|hiv
711341|NCT00213005|Microbicides|microbicides
711342|NCT00213005|HIV prevention|hiv prevention
711343|NCT00213005|HIV positive|hiv positive
711344|NCT00213005|carrageenan|carrageenan
711345|NCT00213005|safety trial|safety trial
711346|NCT00213005|Treatment Experienced|treatment experienced
711347|NCT00213005|HIV|hiv
711348|NCT00212992|defibrillation|defibrillation
711349|NCT00212992|ventricular fibrillation|ventricular fibrillation
711350|NCT00212992|heart arrest|heart arrest
711351|NCT00212979|glomerular filtration rate|glomerular filtration rate
711352|NCT00212979|cystatin C|cystatin c
711353|NCT00212979|creatinine|creatinine
711354|NCT00212966|psychosocial|psychosocial
711355|NCT00212953|Chest Pain,|chest pain,
711356|NCT00212953|Shortness of breath,|shortness of breath,
711357|NCT00212953|Injury,|injury,
711358|NCT00212953|Trauma|trauma
711359|NCT00212940|Treatment Naive|treatment naive
711360|NCT00212940|HIV|hiv
711361|NCT00212901|Diabetes|diabetes
711362|NCT00212901|Proteinuria|proteinuria
711363|NCT00212901|Angiotensin converting enzyme inhibitors|angiotensin converting enzyme inhibitors
711364|NCT00212901|Angiotensin receptor antagonists|angiotensin receptor antagonists
711365|NCT00212888|HIV|hiv
711366|NCT00212888|Vaccination|vaccination
711367|NCT00212875|Chronic Kidney disease|chronic kidney disease
711368|NCT00212875|anemia|anemia
711369|NCT00212862|Anemia|anemia
711370|NCT00212862|Cancer|cancer
711371|NCT00212862|Epoetin alfa|epoetin alfa
711372|NCT00212862|Darbepoetin alfa|darbepoetin alfa
711373|NCT00212862|Registry|registry
711374|NCT00212849|Articular Cartilage Lesions|articular cartilage lesions
711375|NCT00212849|Patellar lesions|patellar lesions
711376|NCT00212849|Trochlear lesions|trochlear lesions
711377|NCT00212849|Patellofemoral joint|patellofemoral joint
711378|NCT00212849|Carticel|carticel
711379|NCT00212849|Autologous Chondrocyte Implantation|autologous chondrocyte implantation
711380|NCT00212823|Migraine|migraine
711381|NCT00212810|Migraine|migraine
711382|NCT00212810|Headache|headache
711383|NCT00212810|Migraine Headache|migraine headache
711384|NCT00212758|Short stature|short stature
711385|NCT00212758|children|children
711386|NCT00212758|kidney failure, chronic|kidney failure, chronic
711387|NCT00212758|Growth|growth
711388|NCT00212745|Behavior Therapy|behavior therapy
711389|NCT00212745|Relaxation Techniques|relaxation techniques
711390|NCT00212732|ONO-8025, KRP-197, overactive bladder, antimuscarinic|ono-8025, krp-197, overactive bladder, antimuscarinic
711391|NCT00212719|ONO-5920, osteoporosis, bisphosphonate|ono-5920, osteoporosis, bisphosphonate
711392|NCT00212706|ONO-8025, KRP-197, overactive bladder, antimuscarinic|ono-8025, krp-197, overactive bladder, antimuscarinic
711393|NCT00212693|ONO-2506PO, Parkinson's disease|ono-2506po, parkinson's disease
711394|NCT00212680|ONO-1101,Landiolol Hydrochloride, Postoperative, Supraventricular Tachyarrhythmia|ono-1101,landiolol hydrochloride, postoperative, supraventricular tachyarrhythmia
711395|NCT00212667|ONO-5920, osteoporosis, bisphosphonate|ono-5920, osteoporosis, bisphosphonate
711396|NCT00212654|ONO-1101|ono-1101
711397|NCT00212654|Landiolol Hydrochloride|landiolol hydrochloride
711398|NCT00212654|Postoperative|postoperative
711399|NCT00212654|supraventricular tachyarrhythmia|supraventricular tachyarrhythmia
711400|NCT00212628|ONO-5920|ono-5920
711401|NCT00212628|osteoporosis|osteoporosis
711402|NCT00212628|bisphosphonate|bisphosphonate
711403|NCT00212615|Colorectal neoplasm|colorectal neoplasm
711404|NCT00212615|Capecitabine (Xeloda)|capecitabine (xeloda)
711405|NCT00212615|Oxaliplatin (Eloxatin)|oxaliplatin (eloxatin)
711406|NCT00212615|Advanced disease|advanced disease
711407|NCT00212615|Metastatic disease|metastatic disease
711408|NCT00212615|First-line treatment|first-line treatment
711409|NCT00212615|Phase II study|phase ii study
711410|NCT00212602|ONO-7436, Aprepitant, Vomiting, Nausea|ono-7436, aprepitant, vomiting, nausea
711411|NCT00212589|Patients preference|patients preference
711412|NCT00212589|Colorectal cancer|colorectal cancer
711413|NCT00212589|Capecitabine|capecitabine
711414|NCT00212589|Fluorouracil + folinic acid|fluorouracil + folinic acid
711415|NCT00212589|Cross-over study|cross-over study
711416|NCT00212576|Child development|child development
711417|NCT00212576|Language Development|language development
711418|NCT00212576|Parenting|parenting
711419|NCT00212537|Asthma and normal|asthma and normal
711420|NCT00212485|Hemophilia|hemophilia
711421|NCT00212485|Factor Deficiency|factor deficiency
711422|NCT00212485|synovitis|synovitis
711423|NCT00212485|sonogram|sonogram
711424|NCT00212459|Bleeding logs|bleeding logs
711425|NCT00212459|Factor Infusions|factor infusions
711426|NCT00212446|Tocolysis|tocolysis
711427|NCT00212446|Electrical Pacemaker|electrical pacemaker
711428|NCT00212433|colorectal neoplasia|colorectal neoplasia
711429|NCT00212433|CT colonography|ct colonography
711430|NCT00212433|faecal tagging|faecal tagging
711431|NCT00212420|fistula; enterocutaneous; nutrition;enteral; parenteral; TPN|fistula; enterocutaneous; nutrition;enteral; parenteral; tpn
711432|NCT00212407|Cord blood transplantation|cord blood transplantation
711433|NCT00212407|bone marrow transplantation|bone marrow transplantation
711434|NCT00212394|Tourniquet|tourniquet
711435|NCT00212394|paresis|paresis
711436|NCT00212381|cervical dysplasia, diindolylmethane, pap smear|cervical dysplasia, diindolylmethane, pap smear
711437|NCT00212329|Type 1 Diabetes|type 1 diabetes
711438|NCT00212329|Juvenile Onset Diabetes|juvenile onset diabetes
711439|NCT00212329|Insulin Dependent Diabetes|insulin dependent diabetes
711440|NCT00212329|T1D|t1d
711441|NCT00212316|Huntington's Disease|huntington's disease
711442|NCT00212316|phenylbutyrate|phenylbutyrate
711443|NCT00212316|HDAC inhibitors|hdac inhibitors
711444|NCT00212316|transcription|transcription
711445|NCT00212303|type 2 diabetes|type 2 diabetes
711446|NCT00212303|hypertension|hypertension
711447|NCT00212303|exercise training|exercise training
711448|NCT00212303|cardiac, peripheral|cardiac, peripheral
711449|NCT00212303|body composition|body composition
711450|NCT00212303|physical fitness|physical fitness
711451|NCT00212303|inflammation|inflammation
711452|NCT00212290|impaired glucose tolerance|impaired glucose tolerance
711453|NCT00212264|urinary incontinence|urinary incontinence
711454|NCT00212264|therapy|therapy
711455|NCT00212264|prostatectomy|prostatectomy
711456|NCT00212264|prostate cancer|prostate cancer
711457|NCT00212251|obesity|obesity
711458|NCT00212251|postpartum period|postpartum period
711459|NCT00212251|exercise|exercise
711460|NCT00212251|diet|diet
711461|NCT00212251|motivation|motivation
711462|NCT00212238|obesity|obesity
711463|NCT00212238|weight loss|weight loss
711464|NCT00212238|Internet|internet
711465|NCT00212238|cognitive behavior therapy|cognitive behavior therapy
711466|NCT00212238|computer assisted patient care|computer assisted patient care
711467|NCT00212238|human therapy evaluation|human therapy evaluation
711468|NCT00212238|physical activity|physical activity
711469|NCT00212238|clinical trial|clinical trial
711470|NCT00212238|nutrient intake activity|nutrient intake activity
711471|NCT00212238|outcomes research|outcomes research
711472|NCT00212238|personal log /diary|personal log /diary
711473|NCT00212238|reinforcer|reinforcer
711474|NCT00212238|self care|self care
711475|NCT00212238|social support network|social support network
711476|NCT00212238|weight control|weight control
711477|NCT00212238|behavioral /social science research tag|behavioral /social science research tag
711478|NCT00212238|clinical research|clinical research
711479|NCT00212238|human subject|human subject
711480|NCT00212238|questionnaire|questionnaire
711481|NCT00212225|gastric disease|gastric disease
711482|NCT00212225|H. pylori|h. pylori
711483|NCT00212225|children|children
711484|NCT00212225|Helicobacter pylori|helicobacter pylori
711485|NCT00212225|child|child
711486|NCT00212225|epidemiology|epidemiology
711487|NCT00212212|selenium supplements|selenium supplements
711488|NCT00212212|selenate|selenate
711489|NCT00212212|selenomethionine|selenomethionine
711490|NCT00212212|biomarkers|biomarkers
711491|NCT00212212|plasma selenium concentration|plasma selenium concentration
711492|NCT00212212|plasma glutathione peroxidase|plasma glutathione peroxidase
711493|NCT00212212|selenoprotein P|selenoprotein p
711494|NCT00212199|Obesity Treatment|obesity treatment
711495|NCT00212199|Effectiveness of weight management treatment|effectiveness of weight management treatment
711496|NCT00212199|Counseling for weight management|counseling for weight management
711497|NCT00212173|Adolescent|adolescent
711498|NCT00212173|Weight Management|weight management
711499|NCT00212173|Obesity Treatment|obesity treatment
711500|NCT00212173|Behavioral Treatment|behavioral treatment
711501|NCT00212147|cobalamin|cobalamin
711502|NCT00212147|anesthesia|anesthesia
711503|NCT00212147|cognition|cognition
711504|NCT00212134|cataract surgery|cataract surgery
711505|NCT00212134|intraocular lens|intraocular lens
711506|NCT00212134|contact lens|contact lens
711507|NCT00212134|infants|infants
711508|NCT00212134|aphakia|aphakia
711509|NCT00212121|breast cancer|breast cancer
711510|NCT00212121|radiotherapy|radiotherapy
711511|NCT00212121|microarrays|microarrays
711512|NCT00212108|celecoxib, NPC, gefitinib|celecoxib, npc, gefitinib
711513|NCT00212095|breast cancer|breast cancer
711514|NCT00212095|docetaxel|docetaxel
711515|NCT00212095|gene expression|gene expression
711516|NCT00212095|proteomics|proteomics
711517|NCT00212082|breast cancer|breast cancer
711518|NCT00212082|chemotherapy response|chemotherapy response
711519|NCT00212082|gene expression profiles|gene expression profiles
711520|NCT00212082|proteomics|proteomics
711521|NCT00212069|breast cancer|breast cancer
711522|NCT00212069|serum proteomics|serum proteomics
711523|NCT00212069|gemcitabine|gemcitabine
711524|NCT00212069|carboplatin|carboplatin
711525|NCT00212069|chemotherapy sensitivity|chemotherapy sensitivity
711526|NCT00212056|Acute myocardial infarction|acute myocardial infarction
711527|NCT00212056|Atrial natriuretic peptide|atrial natriuretic peptide
711528|NCT00212056|Data mining|data mining
711529|NCT00212056|Randomized clinical trial|randomized clinical trial
711530|NCT00212056|SNPs|snps
711531|NCT00212043|randomised phase II trial gemcitabine and carboplatin|randomised phase ii trial gemcitabine and carboplatin
711532|NCT00212030|Acute myocardial infarction|acute myocardial infarction
711533|NCT00212030|Data mining|data mining
711534|NCT00212030|Nicorandil|nicorandil
711535|NCT00212030|Randomized clinical trial|randomized clinical trial
711536|NCT00212030|SNPs|snps
711537|NCT00212017|IGT|igt
711538|NCT00212017|Myocardial Infarction|myocardial infarction
711539|NCT00212017|alpha-glucosidase inhibitor|alpha-glucosidase inhibitor
711540|NCT00212017|re-infarction prevention|re-infarction prevention
711541|NCT00212004|diabetes mellitus|diabetes mellitus
711542|NCT00212004|myocardial infarction|myocardial infarction
711543|NCT00212004|pioglitazone|pioglitazone
711544|NCT00211978|PhosLo (Calcium acetate)|phoslo (calcium acetate)
711545|NCT00211965|Knee replacement surgery|knee replacement surgery
711546|NCT00211965|hip replacement surgery|hip replacement surgery
711547|NCT00211965|nosocomial infections|nosocomial infections
711548|NCT00211965|Arthroplasty|arthroplasty
711549|NCT00211939|PhosLo (Calcium acetate)|phoslo (calcium acetate)
711550|NCT00211939|Renagel (sevelamer, polyallylamine HCL)|renagel (sevelamer, polyallylamine hcl)
711551|NCT00211939|kidney dialysis|kidney dialysis
711851|NCT00210808|bingeing|bingeing
711552|NCT00211939|hyperphosphatemia|hyperphosphatemia
711553|NCT00211939|Kidney failure|kidney failure
711554|NCT00211926|vaccine|vaccine
711555|NCT00211926|Staphylococcus aureus vaccine|staphylococcus aureus vaccine
711556|NCT00211887|Multiple Sclerosis|multiple sclerosis
711557|NCT00211887|Clinical trial|clinical trial
711558|NCT00211887|treatment trial|treatment trial
711559|NCT00211887|autoimmune disease|autoimmune disease
711560|NCT00211887|Relapsing Remitting|relapsing remitting
711561|NCT00211887|MS Treatment|ms treatment
711562|NCT00211887|interferon beta-1a|interferon beta-1a
711563|NCT00211887|glatiramer acetate|glatiramer acetate
711564|NCT00211874|Congestive heart failure|congestive heart failure
711565|NCT00211874|nurse management|nurse management
711566|NCT00211874|effectiveness trial|effectiveness trial
711567|NCT00211874|quality improvement|quality improvement
711568|NCT00211874|minority communities|minority communities
711569|NCT00211874|disease management|disease management
711570|NCT00211848|Chemical Compounds-drugs|chemical compounds-drugs
711571|NCT00211848|Human Subjects- adults|human subjects- adults
711572|NCT00211848|Gastrointestinal System-liver|gastrointestinal system-liver
711573|NCT00211848|Pathology|pathology
711574|NCT00211835|TBI|tbi
711575|NCT00211835|traumatic brain injury|traumatic brain injury
711576|NCT00211835|depression|depression
711577|NCT00211835|cognitive behavioral therapy|cognitive behavioral therapy
711578|NCT00211835|supportive psychotherapy|supportive psychotherapy
711579|NCT00211835|psychotherapy|psychotherapy
711580|NCT00211822|Pathological Gambling|pathological gambling
711581|NCT00211822|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
711582|NCT00211822|Go No-go|go no-go
711583|NCT00211822|Monetary incentives delay|monetary incentives delay
711584|NCT00211822|fMRI|fmri
711585|NCT00211809|Body Dysmorphic Disorder|body dysmorphic disorder
711586|NCT00211809|SRIs|sris
711587|NCT00211809|Cognitive Behavioral Therapy|cognitive behavioral therapy
711588|NCT00211796|autism|autism
711589|NCT00211796|divalproex sodium ER|divalproex sodium er
711590|NCT00211796|aggression|aggression
711591|NCT00211796|irritability|irritability
711592|NCT00211783|autism|autism
711593|NCT00211783|fMRI|fmri
711594|NCT00211783|response inhibition|response inhibition
711595|NCT00211783|face processing|face processing
711596|NCT00211783|linguistic processing|linguistic processing
711597|NCT00211770|Autism|autism
711598|NCT00211770|Functional Behavioral Assessment|functional behavioral assessment
711599|NCT00211770|Citalopram|citalopram
711600|NCT00211757|autism|autism
711601|NCT00211757|aggression|aggression
711602|NCT00211757|irritability|irritability
711603|NCT00211757|divalproex sodium|divalproex sodium
711604|NCT00211744|OCD|ocd
711605|NCT00211744|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
711606|NCT00211744|OCD treatment|ocd treatment
711607|NCT00211731|Acute stroke|acute stroke
711608|NCT00211731|recurrent stroke preventive measures|recurrent stroke preventive measures
711609|NCT00211731|racial disparities|racial disparities
711610|NCT00211718|shoulder pain|shoulder pain
711611|NCT00211718|arthritis|arthritis
711612|NCT00211718|intra-articular botulinum toxin a|intra-articular botulinum toxin a
711613|NCT00211718|joint pain|joint pain
711614|NCT00211705|Hyperlipidemia|hyperlipidemia
711615|NCT00211705|coronary heart disease|coronary heart disease
711616|NCT00211705|prevention|prevention
711617|NCT00211705|stroke|stroke
711618|NCT00211705|pravastatin|pravastatin
711619|NCT00211692|Hepatitis C|hepatitis c
711620|NCT00211692|interferon alfa|interferon alfa
711621|NCT00211692|ribavirin|ribavirin
711622|NCT00211692|interferon alfacon-1|interferon alfacon-1
711623|NCT00211692|antiviral therapy|antiviral therapy
711624|NCT00211679|Joint pain|joint pain
711625|NCT00211679|Knee Pain|knee pain
711626|NCT00211679|Arthritis|arthritis
711627|NCT00211679|Intra-articular Botulinum Toxin Type A|intra-articular botulinum toxin type a
711628|NCT00211666|Hypertension|hypertension
711629|NCT00211666|blood pressure|blood pressure
711630|NCT00211666|self management|self management
711631|NCT00211666|nurse management|nurse management
711632|NCT00211666|racial disparities|racial disparities
711633|NCT00211666|cardiovascular disease|cardiovascular disease
711634|NCT00211653|Kidney failure|kidney failure
711635|NCT00211653|Thoracic surgery|thoracic surgery
711636|NCT00211653|Acetylcysteine|acetylcysteine
711637|NCT00211614|Obstructive Sleep Apnea|obstructive sleep apnea
711638|NCT00211614|Gastroesophageal Reflux|gastroesophageal reflux
711639|NCT00211614|Proton Pump Inhibitor|proton pump inhibitor
711640|NCT00211614|Lansoprazole (Prevacid)|lansoprazole (prevacid)
711641|NCT00211614|Quality of Life|quality of life
711642|NCT00211588|cognition|cognition
711643|NCT00211562|weight gain|weight gain
711644|NCT00211562|weight gain supplementation|weight gain supplementation
711645|NCT00211562|antioxidants|antioxidants
711646|NCT00211562|olanzapine|olanzapine
711647|NCT00211549|Osteoarthritis|osteoarthritis
711648|NCT00211536|Diabetes|diabetes
711649|NCT00211536|Implantable Insulin Pump|implantable insulin pump
711650|NCT00211536|Intraperitoneal Insulin Delivery|intraperitoneal insulin delivery
711651|NCT00211523|acne|acne
711652|NCT00211523|acne vulgaris|acne vulgaris
711653|NCT00211523|MBI 226|mbi 226
711654|NCT00211523|Propionibacterium acnes|propionibacterium acnes
711655|NCT00211523|lesion counts|lesion counts
711656|NCT00211523|lesions|lesions
711657|NCT00211523|inflammatory|inflammatory
711658|NCT00211523|non-inflammatory|non-inflammatory
711659|NCT00211523|topical|topical
711660|NCT00211510|Diabetes|diabetes
711661|NCT00211510|Continuous Glucose Monitoring|continuous glucose monitoring
711662|NCT00211510|Glycemic Control|glycemic control
711663|NCT00211497|acne vulgaris|acne vulgaris
711664|NCT00211497|acne|acne
711665|NCT00211497|Propionibacterium acnes|propionibacterium acnes
711666|NCT00211497|topical|topical
711667|NCT00211497|inflammatory|inflammatory
711668|NCT00211497|non-inflammatory|non-inflammatory
711669|NCT00211497|lesion counts|lesion counts
711670|NCT00211497|lesions|lesions
711671|NCT00211458|Age-Related Macular Degeneration|age-related macular degeneration
711672|NCT00211419|Exudative Age-Related Macular Degeneration|exudative age-related macular degeneration
711673|NCT00211419|AMD|amd
711674|NCT00211380|cognition|cognition
711675|NCT00211380|schizophrenia|schizophrenia
711676|NCT00211380|schizoaffective disorder|schizoaffective disorder
711677|NCT00211367|Radiation Retinopathy|radiation retinopathy
711678|NCT00211341|Pregnancy|pregnancy
711679|NCT00211341|Mortality|mortality
711680|NCT00211341|Maternal|maternal
711681|NCT00211341|Vitamin A|vitamin a
711682|NCT00211302|Cognition|cognition
711683|NCT00211302|Schizophrenia|schizophrenia
711684|NCT00211302|Schizoaffective disorder|schizoaffective disorder
711685|NCT00211289|Educational Interventions|educational interventions
711686|NCT00211289|Heart Failure|heart failure
711687|NCT00211289|Compliance|compliance
711688|NCT00211263|Bipolar Disorder|bipolar disorder
711689|NCT00211250|Depakote Er and Valproic Acid|depakote er and valproic acid
711690|NCT00211237|Balloon Kyphoplasty|balloon kyphoplasty
711691|NCT00211237|Cancer|cancer
711692|NCT00211237|Vertebral Compression Fracture|vertebral compression fracture
711693|NCT00211237|Back Pain|back pain
711694|NCT00211237|Spine|spine
711695|NCT00211224|multiple system atrophy|multiple system atrophy
711696|NCT00211224|progressive supranuclear palsy|progressive supranuclear palsy
711697|NCT00211224|riluzole|riluzole
711698|NCT00211224|MSA|msa
711699|NCT00211224|PSP|psp
711700|NCT00211211|Osteopenia|osteopenia
711701|NCT00211211|Osteoporosis|osteoporosis
711702|NCT00211211|Multiple Myeloma|multiple myeloma
711703|NCT00211211|Osteolytic Metastatic Tumors|osteolytic metastatic tumors
711704|NCT00211211|Vertebral Compression Fracture|vertebral compression fracture
711705|NCT00211211|Back Pain|back pain
711706|NCT00211211|Spine|spine
711707|NCT00211198|Cutaneous|cutaneous
711708|NCT00211198|T-cell lymphoma|t-cell lymphoma
711709|NCT00211198|ONTAK|ontak
711710|NCT00211198|CD25|cd25
711711|NCT00211172|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
711712|NCT00211172|Heart Attack|heart attack
711713|NCT00211172|Adherence|adherence
711714|NCT00211172|Beta-blocker|beta-blocker
711715|NCT00211172|Behavior change|behavior change
711716|NCT00211159|Alzheimer's disease|alzheimer's disease
711717|NCT00211159|Omega-3 fatty acid|omega-3 fatty acid
711718|NCT00211159|Dietary supplementation|dietary supplementation
711719|NCT00211159|Cognition|cognition
711720|NCT00211159|Safety|safety
711721|NCT00211146|Anemia, erythropoetin, PROCRIT, deep vein thrombosis, thrombovascular event|anemia, erythropoetin, procrit, deep vein thrombosis, thrombovascular event
711722|NCT00211133|Anemia|anemia
711723|NCT00211133|Breast Cancer|breast cancer
711724|NCT00211133|Breast Tumor|breast tumor
711725|NCT00211133|Quality of Life|quality of life
711726|NCT00211133|Women|women
711727|NCT00211133|Female|female
711728|NCT00211133|Chemotherapy|chemotherapy
711729|NCT00211133|Hemoglobin|hemoglobin
711730|NCT00211133|Survival|survival
711731|NCT00211133|Epoetin|epoetin
711732|NCT00211133|Epoetin alfa|epoetin alfa
711733|NCT00211133|erythropoietin|erythropoietin
711734|NCT00211120|Anemia|anemia
711735|NCT00211120|Low Blood Count|low blood count
711736|NCT00211120|Chronic Kidney Failure|chronic kidney failure
711737|NCT00211120|Chronic Kidney Disease|chronic kidney disease
711738|NCT00211107|dapoxetine|dapoxetine
711739|NCT00211107|rapid ejaculation|rapid ejaculation
711740|NCT00211107|premature ejaculation|premature ejaculation
711741|NCT00211107|ejaculation|ejaculation
711742|NCT00211107|sexual dysfunction|sexual dysfunction
711743|NCT00211107|orgasmic disorder|orgasmic disorder
711744|NCT00211107|sexual intercourse|sexual intercourse
711745|NCT00211094|dapoxetine|dapoxetine
711746|NCT00211094|premature ejaculation|premature ejaculation
711747|NCT00211094|ejaculation|ejaculation
711748|NCT00211094|sexual dysfunction|sexual dysfunction
711749|NCT00211094|orgasmic disorder|orgasmic disorder
711750|NCT00211094|sexual intercourse|sexual intercourse
711751|NCT00211081|Congenital Heart Disease|congenital heart disease
711752|NCT00211081|Spironolactone|spironolactone
711753|NCT00211081|>17 years old|>17 years old
711754|NCT00211081|undergone Fontan procedure|undergone fontan procedure
711755|NCT00211081|endothelial function|endothelial function
711756|NCT00211068|Pure red-cell aplasia|pure red-cell aplasia
711757|NCT00211068|Chronic kidney failure|chronic kidney failure
711758|NCT00211068|Epoetin alfa (Eprex)|epoetin alfa (eprex)
711759|NCT00211068|Erythropoietin|erythropoietin
711760|NCT00211068|Kidney disease|kidney disease
711761|NCT00211068|Anemia|anemia
711762|NCT00211055|Critically Ill|critically ill
711763|NCT00211055|Intensive Care Unit|intensive care unit
711764|NCT00211055|Blood transfusion|blood transfusion
711765|NCT00211055|Blood loss|blood loss
711766|NCT00211055|Pediatric|pediatric
711767|NCT00211055|Children|children
711768|NCT00211055|Anemia, Pediatric Intensive Care Unit|anemia, pediatric intensive care unit
711769|NCT00211055|Hemoglobin|hemoglobin
711770|NCT00211055|Transfusion|transfusion
711771|NCT00211042|Pure red-cell aplasia|pure red-cell aplasia
711772|NCT00211042|Anemia|anemia
711773|NCT00211042|Red blood cells|red blood cells
711774|NCT00211042|Epoetin alfa (Eprex)|epoetin alfa (eprex)
711775|NCT00211042|Anti-erythropoietin antibodies|anti-erythropoietin antibodies
711776|NCT00211042|Recombinant human erythropoietin|recombinant human erythropoietin
711777|NCT00211029|Anemia, Hemoglobin, Red Blood Cells, Epoetin alfa|anemia, hemoglobin, red blood cells, epoetin alfa
711778|NCT00211029|Epoetin|epoetin
711779|NCT00211029|erythropoietin|erythropoietin
711780|NCT00211029|Red Cell Aplasia, Pure Red Cell Aplasia|red cell aplasia, pure red cell aplasia
711781|NCT00211029|Chronic Renal Failure|chronic renal failure
711782|NCT00211029|Kidney Failure|kidney failure
711783|NCT00211016|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
711784|NCT00211003|Hospital-Acquired Pneumonia|hospital-acquired pneumonia
711785|NCT00211003|Mechanical Ventilation|mechanical ventilation
711786|NCT00210990|Complicated Urinary Tract Infections|complicated urinary tract infections
711787|NCT00210990|Pyelonephritis|pyelonephritis
711788|NCT00210977|Anemia|anemia
711789|NCT00210977|Erythropoietin|erythropoietin
711790|NCT00210977|Epoetin alfa|epoetin alfa
711791|NCT00210977|Erythropoietin receptor agonist (ERA) therapy|erythropoietin receptor agonist (era) therapy
711792|NCT00210977|Anti-erythropoietin antibodies (anti-EPO Ab)|anti-erythropoietin antibodies (anti-epo ab)
711793|NCT00210977|Recombinant human erythropoietin|recombinant human erythropoietin
711794|NCT00210977|Pure red cell aplasia|pure red cell aplasia
711795|NCT00210977|Darbepoetin|darbepoetin
711796|NCT00210964|Ceftobiprole medocaril|ceftobiprole medocaril
711797|NCT00210964|Nosocominal Pneumonia|nosocominal pneumonia
711798|NCT00210964|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
711799|NCT00210964|Cephalosporins|cephalosporins
711800|NCT00210964|Methicillin-Resistant Staphylococcus Aureus|methicillin-resistant staphylococcus aureus
711801|NCT00210951|Epoetin alfa|epoetin alfa
711802|NCT00210951|Erythropoietin|erythropoietin
711803|NCT00210951|Red Cell Aplasia, Pure|red cell aplasia, pure
711804|NCT00210951|Chronic Renal Failure|chronic renal failure
711805|NCT00210938|Complicated Intra-Abdominal Infections|complicated intra-abdominal infections
711806|NCT00210938|Appendicitis|appendicitis
711807|NCT00210938|Cholecystitis|cholecystitis
711808|NCT00210938|Peritonitis|peritonitis
711809|NCT00210925|alcoholism|alcoholism
711810|NCT00210925|alcohol dependence|alcohol dependence
711811|NCT00210925|medication treatment.|medication treatment.
711812|NCT00210912|prevention|prevention
711813|NCT00210912|Migraine|migraine
711814|NCT00210912|chronic|chronic
711815|NCT00210912|headache|headache
711816|NCT00210899|Complicated Skin Infections|complicated skin infections
711817|NCT00210899|Infectious Skin Diseases|infectious skin diseases
711818|NCT00210899|Bacterial Skin Diseases|bacterial skin diseases
711819|NCT00210899|Staphylococcal Skin Infections|staphylococcal skin infections
711820|NCT00210899|Cephalosporin|cephalosporin
711821|NCT00210886|complicated urinary tract infection|complicated urinary tract infection
711822|NCT00210886|urinary tract infection|urinary tract infection
711823|NCT00210886|acute pyelonephritis|acute pyelonephritis
711824|NCT00210886|pyelonephritis|pyelonephritis
711825|NCT00210886|kidney infection|kidney infection
711826|NCT00210886|bladder infection|bladder infection
711827|NCT00210873|Migraine|migraine
711828|NCT00210873|headache|headache
711829|NCT00210873|chronic|chronic
711830|NCT00210873|prevention|prevention
711831|NCT00210860|chronic|chronic
711832|NCT00210860|headache|headache
711833|NCT00210860|prevention|prevention
711834|NCT00210860|Migraine|migraine
711835|NCT00210847|peripheral neuropathy|peripheral neuropathy
711836|NCT00210847|Diabetic neuropathy|diabetic neuropathy
711837|NCT00210847|pain|pain
711838|NCT00210847|diabetes|diabetes
711839|NCT00210847|extremities|extremities
711840|NCT00210847|neuropathy|neuropathy
711841|NCT00210847|diabetic|diabetic
711842|NCT00210834|PROCRIT, Erythropoietin, Epoetin alfa, Hemoglobin level|procrit, erythropoietin, epoetin alfa, hemoglobin level
711843|NCT00210821|migraine|migraine
711844|NCT00210821|headache|headache
711845|NCT00210821|analgesics|analgesics
711846|NCT00210821|prophylaxis|prophylaxis
711847|NCT00210821|prevention|prevention
711848|NCT00210808|Binge-Eating Disorder|binge-eating disorder
711849|NCT00210808|medication treatment|medication treatment
711850|NCT00210808|obesity|obesity
711852|NCT00210795|Anemia|anemia
711853|NCT00210795|Subcutaneous injection|subcutaneous injection
711854|NCT00210795|PROCRIT|procrit
711855|NCT00210795|Erythropoietin|erythropoietin
711856|NCT00210795|Epoetin Alfa|epoetin alfa
711857|NCT00210795|Hemoglobin Level|hemoglobin level
711858|NCT00210795|Elderly|elderly
711859|NCT00210782|epilepsy|epilepsy
711860|NCT00210782|seizures|seizures
711861|NCT00210782|epileptic seizures|epileptic seizures
711862|NCT00210782|complex partial seizures|complex partial seizures
711863|NCT00210782|generalized tonic-clonic seizures|generalized tonic-clonic seizures
711864|NCT00210769|schizophrenia|schizophrenia
711865|NCT00210769|extended release|extended release
711866|NCT00210769|oral administration|oral administration
711867|NCT00210769|antipsychotic agents|antipsychotic agents
711868|NCT00210769|dementia praecox|dementia praecox
711869|NCT00210769|mental disorders|mental disorders
711870|NCT00210769|paliperidone|paliperidone
711871|NCT00210769|PANSS|panss
711872|NCT00210756|Anemia|anemia
711873|NCT00210756|pharmacokinetics|pharmacokinetics
711874|NCT00210756|erythropoetin|erythropoetin
711875|NCT00210756|Epoetin alfa|epoetin alfa
711876|NCT00210756|erythropoetin recombinant|erythropoetin recombinant
711877|NCT00210756|Critical care|critical care
711878|NCT00210756|critical illness, intensive care,|critical illness, intensive care,
711879|NCT00210743|Anemia|anemia
711880|NCT00210743|chronic kidney disease|chronic kidney disease
711881|NCT00210743|erythropoetin, Epoetin alfa|erythropoetin, epoetin alfa
711882|NCT00210743|erythropoetin recombinant|erythropoetin recombinant
711883|NCT00210743|pre-dialysis|pre-dialysis
711884|NCT00210730|Anemia|anemia
711885|NCT00210730|Neoplasm|neoplasm
711886|NCT00210730|Hemoglobin Level|hemoglobin level
711887|NCT00210717|schizophrenia|schizophrenia
711888|NCT00210717|intramuscular injection|intramuscular injection
711889|NCT00210717|antipsychotic agents|antipsychotic agents
711890|NCT00210717|risperidone|risperidone
711891|NCT00210717|paliperidone palmitate|paliperidone palmitate
711892|NCT00210717|dementia praecox|dementia praecox
711893|NCT00210717|mental disorders|mental disorders
711894|NCT00210717|PANSS|panss
711895|NCT00210704|dapoxetine|dapoxetine
711896|NCT00210704|premature ejaculation|premature ejaculation
711897|NCT00210704|ejaculation|ejaculation
711898|NCT00210704|sexual dysfunction|sexual dysfunction
711899|NCT00210704|orgasmic disorder|orgasmic disorder
711900|NCT00210704|sexual intercourse|sexual intercourse
711901|NCT00210691|Schizophrenia|schizophrenia
711902|NCT00210691|intramuscular injection|intramuscular injection
711903|NCT00210691|psychotropic agents|psychotropic agents
711904|NCT00210691|long-acting risperidone|long-acting risperidone
711905|NCT00210678|Erectile Dysfunction|erectile dysfunction
711906|NCT00210678|Dapoxetine|dapoxetine
711907|NCT00210678|Premature ejaculation|premature ejaculation
711908|NCT00210678|Ejaculation|ejaculation
711909|NCT00210678|Sexual dysfunction|sexual dysfunction
711910|NCT00210678|Orgasmic disorder|orgasmic disorder
711911|NCT00210665|Sarcoma|sarcoma
711912|NCT00210665|Soft tissue sarcoma|soft tissue sarcoma
711913|NCT00210665|Standard care|standard care
711914|NCT00210665|Trabectedin|trabectedin
711915|NCT00210665|Antitumor agent|antitumor agent
711916|NCT00210665|Safety|safety
711917|NCT00210652|Epilepsy|epilepsy
711918|NCT00210652|Refractory partial epilepsy|refractory partial epilepsy
711919|NCT00210652|seizure disorder|seizure disorder
711920|NCT00210652|antiepileptic drugs|antiepileptic drugs
711921|NCT00210639|Musculoskeletal Diseases|musculoskeletal diseases
711922|NCT00210639|Musculoskeletal Disorders|musculoskeletal disorders
711923|NCT00210639|Childhood Disease|childhood disease
711924|NCT00210639|Bone Diseases|bone diseases
711925|NCT00210639|Joint Diseases|joint diseases
711926|NCT00210639|Levofloxacin|levofloxacin
711927|NCT00210639|Quinolones|quinolones
711928|NCT00210639|Bacterial infections|bacterial infections
711929|NCT00210626|Anemia, erythropoetin, Epoetin alfa, erythropoetin recombinant, Critical care, critical illness, intensive care|anemia, erythropoetin, epoetin alfa, erythropoetin recombinant, critical care, critical illness, intensive care
711930|NCT00210613|dapoxetine|dapoxetine
711931|NCT00210613|premature ejaculation|premature ejaculation
711932|NCT00210613|sexual dysfunction|sexual dysfunction
711933|NCT00210613|orgasmic disorder|orgasmic disorder
711934|NCT00210613|sexual intercourse|sexual intercourse
711935|NCT00210613|ejaculation|ejaculation
711936|NCT00210600|Anemia|anemia
711937|NCT00210600|Hemoglobin level|hemoglobin level
711938|NCT00210587|Anemia|anemia
711939|NCT00210587|Neoplasms|neoplasms
711940|NCT00210587|hemoglobin level|hemoglobin level
711941|NCT00210574|childhood absence epilepsy|childhood absence epilepsy
711942|NCT00210574|epilepsy|epilepsy
711943|NCT00210574|seizures|seizures
711944|NCT00210574|absence seizures|absence seizures
711945|NCT00210561|Pain|pain
711946|NCT00210561|Acute Low Back Pain|acute low back pain
711947|NCT00210561|Back|back
711948|NCT00210561|Lower back|lower back
711949|NCT00210548|schizophrenia|schizophrenia
711950|NCT00210548|intramuscular injection|intramuscular injection
711951|NCT00210548|antipsychotic agents|antipsychotic agents
711952|NCT00210548|dementia praecox|dementia praecox
711953|NCT00210548|paliperidone palmitate|paliperidone palmitate
711954|NCT00210548|mental disorders|mental disorders
711955|NCT00210548|PANSS.|panss.
711956|NCT00210535|Topiramate|topiramate
711957|NCT00210535|Migraine|migraine
711958|NCT00210535|Migraine headache|migraine headache
711959|NCT00210535|Migraine prevention|migraine prevention
711960|NCT00210535|Pediatric|pediatric
711961|NCT00210522|RWJ-333369|rwj-333369
711962|NCT00210522|Anticonvulsants|anticonvulsants
711963|NCT00210522|Epilepsy|epilepsy
711964|NCT00210522|Refractory partial epilepsy|refractory partial epilepsy
711965|NCT00210522|Seizure disorder|seizure disorder
711966|NCT00210522|Antiepileptic drugs|antiepileptic drugs
711967|NCT00210509|aura|aura
711968|NCT00210509|Migraine|migraine
711969|NCT00210509|pain|pain
711970|NCT00210509|headache|headache
711971|NCT00210496|Migraine headache|migraine headache
711972|NCT00210496|Topiramate, Almotriptan malate|topiramate, almotriptan malate
711973|NCT00210483|pain|pain
711974|NCT00210483|Migraine|migraine
711975|NCT00210483|aura|aura
711976|NCT00210483|headache|headache
711977|NCT00210470|Head and Neck Cancer|head and neck cancer
711978|NCT00210470|Immunotherapy|immunotherapy
711979|NCT00210470|IRX-2|irx-2
711980|NCT00210470|Mouth Cancer|mouth cancer
711981|NCT00210470|Throat Cancer|throat cancer
711982|NCT00210418|Malnutrition|malnutrition
711983|NCT00210418|Infant nutrition|infant nutrition
711984|NCT00210418|Food, fortified|food, fortified
711985|NCT00210418|Growth|growth
711986|NCT00210418|Randomized controlled trials|randomized controlled trials
711987|NCT00210418|Evaluation studies|evaluation studies
711988|NCT00210418|Haiti|haiti
711989|NCT00210405|Anemia|anemia
711990|NCT00210405|Infant nutrition|infant nutrition
711991|NCT00210405|Dietary supplements|dietary supplements
711992|NCT00210405|Randomized controlled trials|randomized controlled trials
711993|NCT00210405|Evaluation studies|evaluation studies
711994|NCT00210405|Haiti|haiti
711995|NCT00210301|MS|ms
711996|NCT00210301|cognition|cognition
711997|NCT00210301|attention|attention
711998|NCT00210301|fatigue|fatigue
711999|NCT00210288|Healthy Volunteer|healthy volunteer
712000|NCT00210288|Shigella|shigella
712001|NCT00210288|Oral Vaccine|oral vaccine
712002|NCT00210288|Double Blind|double blind
712003|NCT00210288|Placebo|placebo
712004|NCT00210288|Immunogenicity|immunogenicity
712005|NCT00210288|Safety|safety
712006|NCT00210249|Cancer|cancer
712007|NCT00210249|elderly|elderly
712008|NCT00210249|geriatric evaluation|geriatric evaluation
712009|NCT00210249|safety|safety
712010|NCT00210249|chemotherapy|chemotherapy
712011|NCT00210236|Breast neoplasms|breast neoplasms
712012|NCT00210236|Local recurrence|local recurrence
712013|NCT00210236|Survival|survival
712014|NCT00210236|Surgery|surgery
712015|NCT00210223|Radiofrequency|radiofrequency
712016|NCT00210223|Percutaneous technique|percutaneous technique
712017|NCT00210223|breast cancer|breast cancer
712018|NCT00210223|tolerance|tolerance
712019|NCT00210210|Post-operative-pain|post-operative-pain
712020|NCT00210210|Breast cancer|breast cancer
712021|NCT00210210|Morphine|morphine
712022|NCT00210210|Analgesia|analgesia
712023|NCT00210197|Hypercoagulability|hypercoagulability
712024|NCT00210197|Plasma coagulation parameters|plasma coagulation parameters
712025|NCT00210197|Breast cancer|breast cancer
712026|NCT00210184|Chemotherapy|chemotherapy
712027|NCT00210184|gastric cancer|gastric cancer
712028|NCT00210184|geriatric evaluation|geriatric evaluation
712029|NCT00210184|efficacy|efficacy
712030|NCT00210184|safety|safety
712031|NCT00210171|Carcinoma|carcinoma
712032|NCT00210171|Stage IIIA Non Small Cell Lung|stage iiia non small cell lung
712033|NCT00210171|Stage IIIB Non-Small-Cell Lung|stage iiib non-small-cell lung
712034|NCT00210171|Concomitant chemo-radiotherapy|concomitant chemo-radiotherapy
712035|NCT00210171|Consolidation chemotherapy|consolidation chemotherapy
712036|NCT00210158|Current opioid treatment|current opioid treatment
712037|NCT00210158|Nitrous oxide|nitrous oxide
712038|NCT00210158|Chronic pain|chronic pain
712039|NCT00210158|Opioid therapy|opioid therapy
712040|NCT00210158|Postoperative hyperalgesia|postoperative hyperalgesia
712041|NCT00210158|Acute opioid tolerance|acute opioid tolerance
712042|NCT00210145|Aesthetic care,|aesthetic care,
712043|NCT00210145|Mastectomy,|mastectomy,
712044|NCT00210145|Breast cancer,|breast cancer,
712045|NCT00210145|Quality of life,|quality of life,
712046|NCT00210145|Body image,|body image,
712047|NCT00210145|Psychological adjustment|psychological adjustment
712048|NCT00210132|Thoracic surgery|thoracic surgery
712049|NCT00210132|postoperative pain|postoperative pain
712050|NCT00210132|ropivacaine|ropivacaine
712051|NCT00210132|inter pleural analgesia|inter pleural analgesia
712052|NCT00210119|Chronic myeloid leukemia|chronic myeloid leukemia
712053|NCT00210119|imatinib mesylate|imatinib mesylate
712054|NCT00210119|zoledronate|zoledronate
712055|NCT00210119|molecular response|molecular response
712056|NCT00210106|Radiofrequency ablation|radiofrequency ablation
712057|NCT00210106|Colorectal cancer|colorectal cancer
712058|NCT00210106|Liver metastases|liver metastases
712059|NCT00210041|Genital Neoplasms, Male|genital neoplasms, male
712060|NCT00210028|Breast Neoplasms|breast neoplasms
712061|NCT00210028|Zarnestra|zarnestra
712062|NCT00210028|Tamoxifen|tamoxifen
712063|NCT00210028|estrogen receptor|estrogen receptor
712064|NCT00210028|progesterone receptor|progesterone receptor
712065|NCT00210002|Neoplasms|neoplasms
712066|NCT00210002|Solid|solid
712067|NCT00210002|Anemia|anemia
712068|NCT00210002|darbepoetin alfa|darbepoetin alfa
712069|NCT00210002|ferric saccharose|ferric saccharose
712070|NCT00210002|Venofer®|venofer®
712071|NCT00210002|Aranesp®|aranesp®
712072|NCT00209989|Glioblastoma Multiforme|glioblastoma multiforme
712073|NCT00209989|Zarnestra|zarnestra
712074|NCT00209989|Radiation therapy|radiation therapy
712075|NCT00209963|Primary insomnia|primary insomnia
712076|NCT00209950|Primary insomnia|primary insomnia
712077|NCT00209937|Primary insomnia|primary insomnia
712078|NCT00209924|Primary insomnia|primary insomnia
712079|NCT00209911|atrial volume|atrial volume
712080|NCT00209911|ventricular volume|ventricular volume
712081|NCT00209911|atrial function|atrial function
712082|NCT00209911|ventricular function|ventricular function
712083|NCT00209911|magnetic resonance imaging|magnetic resonance imaging
712084|NCT00209911|cardioversion|cardioversion
712085|NCT00209911|natriuretic peptides|natriuretic peptides
712086|NCT00209898|Chronic hepatits C|chronic hepatits c
712087|NCT00209898|peginterferon|peginterferon
712088|NCT00209898|ribavirin|ribavirin
712089|NCT00209898|inmate|inmate
712090|NCT00209898|fast initiation procedure|fast initiation procedure
712091|NCT00209846|Primary insomnia|primary insomnia
712092|NCT00209820|low back pain|low back pain
712093|NCT00209820|randomized clinical trial|randomized clinical trial
712094|NCT00209820|Nordic walking|nordic walking
712095|NCT00209820|supervision|supervision
712096|NCT00209820|Advice to stay active|advice to stay active
712097|NCT00209807|major depression|major depression
712098|NCT00209807|pain|pain
712099|NCT00209807|escitalopram|escitalopram
712100|NCT00209807|reboxetine|reboxetine
712101|NCT00209807|visceral sensitivity|visceral sensitivity
712102|NCT00209807|somatic sensitivity|somatic sensitivity
712103|NCT00209768|pediatric intensive care|pediatric intensive care
712104|NCT00209768|critically ill children|critically ill children
712105|NCT00209768|in-line filtration|in-line filtration
712106|NCT00209768|prospective randomized study|prospective randomized study
712107|NCT00209768|complications|complications
712108|NCT00209768|sepsis|sepsis
712109|NCT00209768|SIRS|sirs
712110|NCT00209768|thrombosis|thrombosis
712111|NCT00209768|organ failure|organ failure
712112|NCT00209755|chronic hepatitis C|chronic hepatitis c
712113|NCT00209742|Colorectal Cancer,UFT,LV,Krestin,adjuvant therapy,phase III|colorectal cancer,uft,lv,krestin,adjuvant therapy,phase iii
712114|NCT00209729|Docetaxel|docetaxel
712115|NCT00209729|S-1|s-1
712116|NCT00209729|Elderly Patients|elderly patients
712117|NCT00209729|Gastric cancer|gastric cancer
712118|NCT00209664|Irinotecan, S-1, Phase II, gastric cancer|irinotecan, s-1, phase ii, gastric cancer
712119|NCT00209651|Irinotecan, S-1, Phase II, colorectal cancer,|irinotecan, s-1, phase ii, colorectal cancer,
712120|NCT00209638|Irinotecan,|irinotecan,
712121|NCT00209638|S-1,|s-1,
712122|NCT00209638|Phase I/II,|phase i/ii,
712123|NCT00209638|gastric cancer|gastric cancer
712124|NCT00209625|Irinotecan, leucovorin, fluorouracil, PhaseI/II, colorectal cancer,|irinotecan, leucovorin, fluorouracil, phasei/ii, colorectal cancer,
712125|NCT00209599|Colonoscopy|colonoscopy
712126|NCT00209599|Seadation|seadation
712127|NCT00209586|Bronchoscopy|bronchoscopy
712128|NCT00209586|Sedation|sedation
712129|NCT00209573|Colonoscopy|colonoscopy
712130|NCT00209573|Sedation|sedation
712131|NCT00209560|AQUAVAN® Injection|aquavan® injection
712132|NCT00209560|Midazolam|midazolam
712133|NCT00209560|Minor surgical procedures|minor surgical procedures
712134|NCT00209560|Sedation|sedation
712135|NCT00209547|AQUAVAN® Injection|aquavan® injection
712136|NCT00209547|Midazolam|midazolam
712137|NCT00209547|Angioplasty|angioplasty
712138|NCT00209547|Coronary catheterization|coronary catheterization
712139|NCT00209521|Coronary Artery Bypass Surgery|coronary artery bypass surgery
712140|NCT00209521|AQUAVAN® Injection|aquavan® injection
712141|NCT00209521|DISOPRIVAN® Injectable Emulsion.|disoprivan® injectable emulsion.
712142|NCT00209521|ischemic coronary artery disease|ischemic coronary artery disease
712143|NCT00209508|Parkinson's Disease|parkinson's disease
712144|NCT00209508|SPECT Scanning|spect scanning
712145|NCT00209495|Abdominal hysterectomy|abdominal hysterectomy
712146|NCT00209495|Pregabalin|pregabalin
712147|NCT00209495|Dexamethasone|dexamethasone
712148|NCT00209495|Multimodal postoperative analgesia|multimodal postoperative analgesia
712149|NCT00209456|Lewy Body Dementia|lewy body dementia
712150|NCT00209456|non-DLB dementia|non-dlb dementia
712151|NCT00209456|Dopamine Transporter|dopamine transporter
712152|NCT00209456|Striatal Uptake|striatal uptake
712153|NCT00209443|Aorto-iliac Stenosis|aorto-iliac stenosis
712154|NCT00209443|Occlusion|occlusion
712155|NCT00209443|Diagnostic Imaging|diagnostic imaging
712156|NCT00209443|Omniscan|omniscan
712157|NCT00209443|Magnetic Resonance Angiography|magnetic resonance angiography
712158|NCT00209443|Contrast Media|contrast media
712159|NCT00209430|Iodixanol|iodixanol
712160|NCT00209430|Iopamidol|iopamidol
712161|NCT00209430|coronary angiography|coronary angiography
712162|NCT00209430|Contrast media-induced nephropathy|contrast media-induced nephropathy
712163|NCT00209417|Iodixanol|iodixanol
712164|NCT00209417|Iopamidol|iopamidol
712165|NCT00209417|computed tomography|computed tomography
712166|NCT00209417|Patients with pre-existing renal impairment and diabetes|patients with pre-existing renal impairment and diabetes
712167|NCT00209404|MDCT|mdct
712168|NCT00209404|Coronary Artery|coronary artery
712169|NCT00209404|Heart Rate|heart rate
712170|NCT00209404|Image Quality|image quality
712171|NCT00209404|Diagnostic Quality|diagnostic quality
712172|NCT00209391|Renal Artery Stenosis|renal artery stenosis
712173|NCT00209391|Occlusion|occlusion
712174|NCT00209391|Diagnostic Imaging|diagnostic imaging
712175|NCT00209391|Omniscan|omniscan
712176|NCT00209391|Magnetic Resonance Angiography|magnetic resonance angiography
712177|NCT00209391|Contrast Media|contrast media
712178|NCT00209378|Continuous venovenous hemofiltration (CVVH)|continuous venovenous hemofiltration (cvvh)
712179|NCT00209378|Continuous renal replacement therapy (CRRT)|continuous renal replacement therapy (crrt)
712180|NCT00209378|Acute Kidney Injury|acute kidney injury
712181|NCT00209378|Regional citrate anticoagulation|regional citrate anticoagulation
712182|NCT00209378|filter survival|filter survival
712183|NCT00209378|trisodium citrate|trisodium citrate
712184|NCT00209378|bleeding complication|bleeding complication
712185|NCT00209378|Hemofiltration|hemofiltration
712186|NCT00209352|Varicella Zoster Virus Infection|varicella zoster virus infection
712187|NCT00209352|VZV infection|vzv infection
712188|NCT00209352|Oral Acyclovir|oral acyclovir
712189|NCT00209352|Allogeneic Bone Marrow Transplantation|allogeneic bone marrow transplantation
712190|NCT00209352|Allogeneic Hematopoietic Cell Transplantation|allogeneic hematopoietic cell transplantation
712191|NCT00209339|Mitral Valve Insufficiency|mitral valve insufficiency
712192|NCT00209339|Mitral Valve Regurgitation|mitral valve regurgitation
712193|NCT00209339|Mitral Valve Incompetence|mitral valve incompetence
712194|NCT00209339|Mitral Regurgitation|mitral regurgitation
712195|NCT00209339|Mitral Insufficiency|mitral insufficiency
712196|NCT00209339|Mitral Valve|mitral valve
712197|NCT00209339|MR|mr
712198|NCT00209339|Mitral Valve Prolapse|mitral valve prolapse
712199|NCT00209339|E2E - Edge to Edge|e2e - edge to edge
712200|NCT00209339|Alfieri Technique|alfieri technique
712201|NCT00209339|MitraClip|mitraclip
712202|NCT00209339|Functional MR|functional mr
712203|NCT00209339|Degenerative MR|degenerative mr
712204|NCT00209339|Echocardiogram|echocardiogram
712205|NCT00209339|CAD - Coronary Artery Disease|cad - coronary artery disease
712206|NCT00209339|Heart Failure|heart failure
712207|NCT00209339|Heart Attack|heart attack
712208|NCT00209339|EVEREST|everest
712209|NCT00209339|EVEREST I|everest i
712210|NCT00209339|EVEREST II|everest ii
712211|NCT00209313|HIV-1|hiv-1
712212|NCT00209313|HSV-2|hsv-2
712213|NCT00209313|Coinfection|coinfection
712214|NCT00209313|Africa|africa
712215|NCT00209313|Cameroon|cameroon
712216|NCT00209300|Ulcerative Colitis for Maintenance of Remission|ulcerative colitis for maintenance of remission
712217|NCT00209287|Ulcerative Colitis for Maintenance of Remission|ulcerative colitis for maintenance of remission
712218|NCT00209274|Mitral Valve Insufficiency|mitral valve insufficiency
712219|NCT00209274|Mitral Valve Regurgitation|mitral valve regurgitation
712220|NCT00209274|Mitral Valve Incompetence|mitral valve incompetence
712221|NCT00209274|Mitral Regurgitation|mitral regurgitation
712222|NCT00209274|Mitral Insufficiency|mitral insufficiency
712223|NCT00209274|Mitral Valve|mitral valve
712224|NCT00209274|MR|mr
712225|NCT00209274|Mitral Valve Prolapse|mitral valve prolapse
712226|NCT00209274|Edge to Edge (E2E)|edge to edge (e2e)
712227|NCT00209274|Alfieri Technique|alfieri technique
712228|NCT00209274|MitraClip|mitraclip
712229|NCT00209274|Functional MR|functional mr
712230|NCT00209274|Degenerative MR|degenerative mr
712231|NCT00209274|Echocardiogram|echocardiogram
712232|NCT00209274|CAD - Coronary Artery Disease|cad - coronary artery disease
712233|NCT00209274|Heart Failure|heart failure
712234|NCT00209274|Heart Attack|heart attack
712235|NCT00209274|EVEREST|everest
712236|NCT00209274|EVEREST I|everest i
712237|NCT00209274|EVEREST II|everest ii
712238|NCT00209274|REALISM|realism
712239|NCT00209235|Pseudohypoparathyroidism Type 1A (PHP 1A)|pseudohypoparathyroidism type 1a (php 1a)
712240|NCT00209235|Albright Hereditary Osteodystrophy|albright hereditary osteodystrophy
712241|NCT00209235|Growth Hormone Deficiency|growth hormone deficiency
712242|NCT00209222|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
712243|NCT00209222|younger patients|younger patients
712244|NCT00209222|chemotherapy|chemotherapy
712245|NCT00209222|high dose therapy|high dose therapy
712246|NCT00209222|C04.557.386.480.300.725.500|c04.557.386.480.300.725.500
712247|NCT00209222|C15.604.515.569.480.300.725.500|c15.604.515.569.480.300.725.500
712248|NCT00209222|C20.683.515.761.480.300.725.500|c20.683.515.761.480.300.725.500
712249|NCT00209209|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
712250|NCT00209209|Elderly patients|elderly patients
712251|NCT00209209|Chemotherapy|chemotherapy
712252|NCT00209209|Maintenance therapy|maintenance therapy
712253|NCT00209209|C04.557.386.480.300.725.500|c04.557.386.480.300.725.500
712254|NCT00209209|C15.604.515.569.480.300.725.500|c15.604.515.569.480.300.725.500
712255|NCT00209209|C20.683.515.761.480.300.725.500|c20.683.515.761.480.300.725.500
712256|NCT00209196|pediatric|pediatric
712257|NCT00209196|transplantation|transplantation
712258|NCT00209196|psychosocial|psychosocial
712259|NCT00209196|kidney transplant recipient|kidney transplant recipient
712260|NCT00209196|liver transplant recipient|liver transplant recipient
712261|NCT00209196|heart transplant recipient|heart transplant recipient
712262|NCT00209196|lung transplant recipient|lung transplant recipient
712263|NCT00209196|heart-lung transplant recipient|heart-lung transplant recipient
712264|NCT00209144|Inflammation|inflammation
712265|NCT00209144|Thrombosis|thrombosis
712266|NCT00209144|Hyperglycemia|hyperglycemia
712267|NCT00209144|Myocardial Infarction|myocardial infarction
712268|NCT00209144|Angioplasty|angioplasty
712269|NCT00209131|urolithiasis|urolithiasis
712270|NCT00209118|Hepatitis C|hepatitis c
712271|NCT00209118|Interferon-alpha associated side effects|interferon-alpha associated side effects
712272|NCT00209118|Antidepressants|antidepressants
712273|NCT00209118|Prevention|prevention
712274|NCT00209105|Child Abuse|child abuse
712275|NCT00209105|Hypothalamic-Pituitary-Adrenal Axis|hypothalamic-pituitary-adrenal axis
712276|NCT00209105|Brain Imaging|brain imaging
712277|NCT00209105|Depression|depression
712278|NCT00209092|Breast Cancer|breast cancer
712279|NCT00209079|Gastric Adenocarcinoma|gastric adenocarcinoma
712280|NCT00209066|Major Depressive Disorder|major depressive disorder
712281|NCT00209066|Electroconvulsive Therapy|electroconvulsive therapy
712282|NCT00209066|Platelet Activation|platelet activation
712283|NCT00209040|PTSD|ptsd
712284|NCT00209040|Acoustic startle|acoustic startle
712285|NCT00209027|schizophrenia|schizophrenia
712286|NCT00209027|reward|reward
712287|NCT00209027|fMRI|fmri
712288|NCT00209014|B-Cell Lymphoma|b-cell lymphoma
712289|NCT00209014|Hodgkin's Disease|hodgkin's disease
712290|NCT00209001|Breast Cancer|breast cancer
712291|NCT00208988|Health literacy|health literacy
712292|NCT00208988|Physician-Patient Relationship|physician-patient relationship
712293|NCT00208988|Prostate Cancer|prostate cancer
712294|NCT00208975|Lymphoma|lymphoma
712295|NCT00208962|Hematologic Diseases|hematologic diseases
712296|NCT00208949|Hematologic Diseases|hematologic diseases
712297|NCT00208936|Esophageal Diseases|esophageal diseases
712298|NCT00208923|Hematologic Malignancies|hematologic malignancies
712299|NCT00208910|Anxiety|anxiety
712300|NCT00208910|Mental Health|mental health
712301|NCT00208897|Early Life Stress|early life stress
712302|NCT00208897|HPA-axis|hpa-axis
712303|NCT00208897|CRF|crf
712304|NCT00208884|pediatric|pediatric
712305|NCT00208884|orthotopic heart transplantation|orthotopic heart transplantation
712306|NCT00208884|graft failure|graft failure
712307|NCT00208871|Stereoscopic digital mammography|stereoscopic digital mammography
712308|NCT00208871|Breast cancer detection|breast cancer detection
712309|NCT00208871|Reduced rate of recall|reduced rate of recall
712310|NCT00208871|Focal abnormalities detection|focal abnormalities detection
712311|NCT00208832|Medication Compliance|medication compliance
712312|NCT00208832|Health Literacy|health literacy
712313|NCT00208819|Alzheimer's Disease|alzheimer's disease
712314|NCT00208819|Geriatric|geriatric
712315|NCT00208819|Dementia|dementia
712316|NCT00208819|Agitation|agitation
712317|NCT00208819|Behavioral Disturbances|behavioral disturbances
712318|NCT00208819|Psychosis|psychosis
712319|NCT00208806|Dilated Cardiomyopathy|dilated cardiomyopathy
712320|NCT00208806|Pediatric|pediatric
712321|NCT00208806|Bi-ventricular Pacemaker|bi-ventricular pacemaker
712322|NCT00208793|colonic polyps|colonic polyps
712323|NCT00208793|adenomatous polyps|adenomatous polyps
712324|NCT00208793|colon cancer prevention|colon cancer prevention
712325|NCT00208793|dietary supplements|dietary supplements
712326|NCT00208780|Oxidative Stress|oxidative stress
712327|NCT00208780|Endothelium|endothelium
712328|NCT00208767|Angiotensin receptor blockade|angiotensin receptor blockade
712329|NCT00208767|Oxidative stress|oxidative stress
712330|NCT00208767|Endothelial dysfunction|endothelial dysfunction
712331|NCT00208754|heart defects|heart defects
712332|NCT00208754|cardiology|cardiology
712333|NCT00208754|adults who have congenital heart defects|adults who have congenital heart defects
712334|NCT00208741|Social Anxiety Disorder|social anxiety disorder
712335|NCT00208741|Mental Health|mental health
712336|NCT00208728|pediatric|pediatric
712337|NCT00208728|congenital heart disease|congenital heart disease
712338|NCT00208728|cardiac surgery|cardiac surgery
712339|NCT00208715|Depression|depression
712340|NCT00208702|Major Depressive Disorder|major depressive disorder
712341|NCT00208702|Mental Health|mental health
712342|NCT00208702|Depression|depression
712343|NCT00208689|pediatric|pediatric
712344|NCT00208689|congenital heart disease|congenital heart disease
712345|NCT00208676|heart defects|heart defects
712346|NCT00208676|pediatrics|pediatrics
712347|NCT00208650|pediatrics|pediatrics
712348|NCT00208650|transplant|transplant
712349|NCT00208650|cardiac|cardiac
712350|NCT00208637|Maori|maori
712351|NCT00208637|insulin sensitivity|insulin sensitivity
712352|NCT00208637|cardiovascular risk|cardiovascular risk
712353|NCT00208637|diabetes prevention|diabetes prevention
712354|NCT00208637|diet modification|diet modification
712355|NCT00208624|arrhythmia|arrhythmia
712356|NCT00208624|pediatrics|pediatrics
712357|NCT00208624|cardiac|cardiac
712358|NCT00208598|Maori|maori
712359|NCT00208598|Body Composition|body composition
712360|NCT00208598|DEXA|dexa
712361|NCT00208598|Cardiovascular disease|cardiovascular disease
712362|NCT00208598|Diabetes|diabetes
712363|NCT00208572|Traumatic Brain Injury; Anxiety Disorders; SRI Treatment|traumatic brain injury; anxiety disorders; sri treatment
712364|NCT00208559|Autism|autism
712365|NCT00208559|Pervasive Developmental Disorder|pervasive developmental disorder
712366|NCT00208559|Ziprasidone|ziprasidone
712367|NCT00208559|Adolescents|adolescents
712368|NCT00208546|capecitabine|capecitabine
712369|NCT00208546|oxaliplatin|oxaliplatin
712370|NCT00208546|bevacizumab|bevacizumab
712371|NCT00208546|cetuximab|cetuximab
712372|NCT00208546|advanced colorectal cancer|advanced colorectal cancer
712373|NCT00208533|Autism|autism
712374|NCT00208533|Pervasive developmental disorder|pervasive developmental disorder
712375|NCT00208533|Aripiprazole|aripiprazole
712376|NCT00208533|Antipsychotic medication|antipsychotic medication
712377|NCT00208533|Adolescents|adolescents
712378|NCT00208520|Epilepsy|epilepsy
712379|NCT00208520|Valproate|valproate
712380|NCT00208520|Levetiracetam|levetiracetam
712381|NCT00208520|Lamotrigine|lamotrigine
712382|NCT00208520|Carbamazepine|carbamazepine
712383|NCT00208507|Joint Diseases|joint diseases
712384|NCT00208507|Non-Inflammatory Degenerative Joint Disease|non-inflammatory degenerative joint disease
712385|NCT00208494|Non-Inflammatory Degenerative Joint Disease|non-inflammatory degenerative joint disease
712386|NCT00208468|Hip|hip
712387|NCT00208468|Cementless|cementless
712388|NCT00208455|Arthroplasty|arthroplasty
712389|NCT00208455|Replacement|replacement
712390|NCT00208455|Hip|hip
712391|NCT00208455|Conservative|conservative
712392|NCT00208455|Anatomic|anatomic
712393|NCT00208455|Cementless|cementless
712394|NCT00208442|Hip|hip
712395|NCT00208442|Cemented|cemented
712396|NCT00208429|Hip|hip
712397|NCT00208429|Cementless|cementless
712399|NCT00208416|Surgical Technique|surgical technique
712400|NCT00208403|Hip|hip
712401|NCT00208403|Cement|cement
712402|NCT00208390|Hip|hip
712403|NCT00208390|Cementless|cementless
712404|NCT00208377|Hip|hip
712405|NCT00208377|Conservative|conservative
712406|NCT00208377|Metal-on-Metal|metal-on-metal
712407|NCT00208377|Resurfacing|resurfacing
712408|NCT00208364|Hip|hip
712409|NCT00208364|Cementless|cementless
712410|NCT00208364|Metal-on-Metal|metal-on-metal
712411|NCT00208351|Hip|hip
712412|NCT00208351|Cemented|cemented
712413|NCT00208338|Rotator cuff tear repair|rotator cuff tear repair
712414|NCT00208312|Lexiscan|lexiscan
712415|NCT00208312|Regadenoson|regadenoson
712416|NCT00208312|Adenoscan®|adenoscan®
712417|NCT00208312|Adenosine|adenosine
712418|NCT00208312|SPECT Myocardial Perfusion Imaging|spect myocardial perfusion imaging
712419|NCT00208312|Reversible Perfusion Defect|reversible perfusion defect
712420|NCT00208299|Lexiscan|lexiscan
712421|NCT00208299|Regadenoson|regadenoson
712422|NCT00208299|Adenoscan®|adenoscan®
712423|NCT00208299|Adenosine|adenosine
712424|NCT00208299|SPECT Myocardial Perfusion Imaging|spect myocardial perfusion imaging
712425|NCT00208299|Reversible Perfusion Defect|reversible perfusion defect
712426|NCT00208273|Postmenopausal breast cancer, radiohormonotherapy sequences|postmenopausal breast cancer, radiohormonotherapy sequences
712427|NCT00208273|ER+ and/or PgR+,|er+ and/or pgr+,
712428|NCT00208273|Postmenopausal Breast cancer,|postmenopausal breast cancer,
712429|NCT00208273|Adjuvant setting|adjuvant setting
712430|NCT00208234|asthma|asthma
712431|NCT00208221|Hypertension|hypertension
712432|NCT00208221|Diabetes|diabetes
712433|NCT00208221|Microalbuminuria|microalbuminuria
712434|NCT00208221|Blood pressure|blood pressure
712435|NCT00208208|Posttraumatic Stress Disorder|posttraumatic stress disorder
712436|NCT00208208|Post-traumatic Stress Disorder|post-traumatic stress disorder
712437|NCT00208208|PTSD|ptsd
712438|NCT00208208|Geodon|geodon
712439|NCT00208208|Ziprasidone|ziprasidone
712440|NCT00208195|Bipolar Disorder|bipolar disorder
712441|NCT00208195|Mania|mania
712442|NCT00208195|Substance Abuse|substance abuse
712443|NCT00208195|Substance Dependence|substance dependence
712444|NCT00208195|Comorbid|comorbid
712445|NCT00208169|Comorbid substance abuse/dependence|comorbid substance abuse/dependence
712446|NCT00208169|Comorbid diagnoses|comorbid diagnoses
712447|NCT00208169|Substance abuse and/or dependence|substance abuse and/or dependence
712448|NCT00208156|Depression|depression
712449|NCT00208156|Major Depression|major depression
712450|NCT00208156|Psychotic Major Depression|psychotic major depression
712451|NCT00208156|PMD|pmd
712452|NCT00208156|Psychosis|psychosis
712453|NCT00208143|Cocaine Abuse|cocaine abuse
712454|NCT00208143|Cocaine Dependence|cocaine dependence
712455|NCT00208143|Amphetamine Abuse|amphetamine abuse
712456|NCT00208143|Amphetamine Dependence|amphetamine dependence
712457|NCT00208143|Schizophrenia|schizophrenia
712458|NCT00208143|Comorbid|comorbid
712459|NCT00208143|Schizoaffective Disorder|schizoaffective disorder
712460|NCT00208130|PTSD|ptsd
712461|NCT00208130|trauma|trauma
712462|NCT00208117|depression|depression
712463|NCT00208117|inflammation|inflammation
712464|NCT00208117|heart disease|heart disease
712465|NCT00208117|randomized clinical trial|randomized clinical trial
712466|NCT00208117|sertraline|sertraline
712467|NCT00208117|simvastatin|simvastatin
712468|NCT00208117|placebo|placebo
712469|NCT00208104|Hypertension|hypertension
712470|NCT00208104|African Americans|african americans
712471|NCT00208104|Adherence|adherence
712472|NCT00208104|Motivational Interviewing|motivational interviewing
712473|NCT00208091|Myloboc|myloboc
712474|NCT00208091|Botulinum Toxin Type B|botulinum toxin type b
712475|NCT00208091|Focal Dystonia|focal dystonia
712476|NCT00208091|Musicians|musicians
712477|NCT00208091|Muscle Relaxants|muscle relaxants
712478|NCT00208091|Motor Impairments|motor impairments
712479|NCT00208091|Motor Performance|motor performance
712480|NCT00208091|Tremor|tremor
712481|NCT00208091|Abnormal Postures|abnormal postures
712482|NCT00208078|Hypercapnia|hypercapnia
712483|NCT00208078|Non-Invasive Ventilation|non-invasive ventilation
712484|NCT00208065|migraine|migraine
712485|NCT00208065|biological markers|biological markers
712486|NCT00208065|rhinosinusitis|rhinosinusitis
712487|NCT00208065|CGRP|cgrp
712488|NCT00208065|histamine|histamine
712489|NCT00208065|VIP|vip
712490|NCT00208039|Prematurity|prematurity
712491|NCT00208039|Lung Disease|lung disease
712492|NCT00208039|Hyaline Membrane|hyaline membrane
712493|NCT00208039|Surfactant|surfactant
712494|NCT00208013|resting energy expenditure|resting energy expenditure
712495|NCT00208013|cachexia|cachexia
712496|NCT00208013|advanced cancer|advanced cancer
712497|NCT00208013|advanced cancer patients|advanced cancer patients
712498|NCT00207987|controlled hypotension|controlled hypotension
712499|NCT00207974|Hyperuricemia, Anserine, Pharmacokinetic|hyperuricemia, anserine, pharmacokinetic
712500|NCT00207948|Human Immunodeficiency Virus|human immunodeficiency virus
712501|NCT00207948|Protease Inhibitors|protease inhibitors
712502|NCT00207948|Pharmacogenetics|pharmacogenetics
712503|NCT00207948|Genes, MDR1, Cytochrome P-450 enzymes|genes, mdr1, cytochrome p-450 enzymes
712504|NCT00207948|Pharmacokinetics|pharmacokinetics
712505|NCT00207948|Pediatrics|pediatrics
712506|NCT00207948|Treatment Experienced|treatment experienced
712507|NCT00207935|Seizures|seizures
712508|NCT00207935|Depakote|depakote
712509|NCT00207935|Developmental Delay|developmental delay
712510|NCT00207935|Mental Retardation|mental retardation
712511|NCT00207935|Swallow|swallow
712512|NCT00207922|cytokine|cytokine
712513|NCT00207922|T-cell|t-cell
712514|NCT00207922|chemokine|chemokine
712515|NCT00207922|graft-versus-host disease|graft-versus-host disease
712516|NCT00207909|Acute Renal Failure|acute renal failure
712517|NCT00207909|Contiuous Veno Venous Hemofiltration|contiuous veno venous hemofiltration
712518|NCT00207896|Pediatric Intensive Care|pediatric intensive care
712519|NCT00207896|Neuroendocrine Dysfunction|neuroendocrine dysfunction
712520|NCT00207883|Vascular Access|vascular access
712521|NCT00207883|Ultrasound|ultrasound
712522|NCT00207883|Pediatric|pediatric
712523|NCT00207883|Pediatric intensive care patient|pediatric intensive care patient
712524|NCT00207870|Type II Supracondylar Fracture|type ii supracondylar fracture
712525|NCT00207870|Orthopaedics|orthopaedics
712526|NCT00207857|Duchenne's Muscular Dystrophy|duchenne's muscular dystrophy
712527|NCT00207857|Scoliosis|scoliosis
712528|NCT00207844|Selenium|selenium
712529|NCT00207844|Oxidative stress|oxidative stress
712530|NCT00207844|Septic shock|septic shock
712531|NCT00207844|Sodium selenite|sodium selenite
712532|NCT00207831|rectal cancer|rectal cancer
712533|NCT00207831|neoadjuvant therapy|neoadjuvant therapy
712534|NCT00207831|UFT|uft
712535|NCT00207831|radiochemotherapy|radiochemotherapy
712536|NCT00207818|tissue engineered wound dressing; autologous skin substitute; biological dressing; wound care|tissue engineered wound dressing; autologous skin substitute; biological dressing; wound care
712537|NCT00207792|Granulocyte colony stimulating factor|granulocyte colony stimulating factor
712538|NCT00207779|central venous catheter|central venous catheter
712539|NCT00207779|catheter related bloodstream infection|catheter related bloodstream infection
712540|NCT00207779|heparin|heparin
712541|NCT00207766|Crohn's Disease|crohn's disease
712542|NCT00207766|infusions|infusions
712543|NCT00207753|ascaris|ascaris
712544|NCT00207753|trichuris|trichuris
712545|NCT00207753|strongyloides|strongyloides
712546|NCT00207753|hookworm|hookworm
712547|NCT00207753|head lice|head lice
712548|NCT00207740|Asthma|asthma
712549|NCT00207740|Severe Persistent Asthma|severe persistent asthma
712550|NCT00207740|Subcutaneous injections|subcutaneous injections
712551|NCT00207740|Immunology disorder|immunology disorder
712552|NCT00207740|Breathlesness|breathlesness
712553|NCT00207727|Multiple Sclerosis|multiple sclerosis
712554|NCT00207714|Rheumatoid Arthritis|rheumatoid arthritis
712555|NCT00207714|CNTO 148|cnto 148
712556|NCT00207714|Methotrexate|methotrexate
712557|NCT00207714|Joint pain|joint pain
712558|NCT00207714|Arthritis|arthritis
712559|NCT00207701|Ankylosing Spondylitis|ankylosing spondylitis
712560|NCT00207701|infusion|infusion
712561|NCT00207688|Ulcerative Colitis|ulcerative colitis
712562|NCT00207688|Infliximab|infliximab
712563|NCT00207688|Remicade|remicade
712564|NCT00207688|Safety|safety
712565|NCT00207675|Crohn's Disease|crohn's disease
712566|NCT00207675|pediatric Crohn's Disease|pediatric crohn's disease
712567|NCT00207662|Crohn's Disease|crohn's disease
712568|NCT00207649|shared decision-making|shared decision-making
712569|NCT00207649|prostate cancer screening|prostate cancer screening
712570|NCT00207649|evidence-based medicine|evidence-based medicine
712571|NCT00207649|computer-assisted learning tools|computer-assisted learning tools
712572|NCT00207649|standardized patients|standardized patients
712573|NCT00207649|randomized controlled trial|randomized controlled trial
712574|NCT00207649|educational intervention|educational intervention
712575|NCT00207649|patient education|patient education
712576|NCT00207649|physician education|physician education
712577|NCT00207636|Computer-Assisted Decision Making|computer-assisted decision making
712578|NCT00207636|Workplace|workplace
712579|NCT00207636|Screening|screening
712580|NCT00207623|arthritis|arthritis
712581|NCT00207623|self management|self management
712582|NCT00207623|patient education|patient education
712583|NCT00207610|Anemia|anemia
712584|NCT00207610|Postpartum|postpartum
712585|NCT00207610|iron|iron
712586|NCT00207610|supplements|supplements
712587|NCT00207571|computer|computer
712588|NCT00207571|video|video
712589|NCT00207571|partner notification|partner notification
712590|NCT00207519|overweight|overweight
712591|NCT00207519|obesity|obesity
712592|NCT00207519|adolescent|adolescent
712593|NCT00207506|Latino|latino
712594|NCT00207506|Lay Health|lay health
712595|NCT00207506|Access|access
712596|NCT00207506|Prevention|prevention
712597|NCT00207506|HIV Seronegativity|hiv seronegativity
712598|NCT00207506|HIV|hiv
712599|NCT00207493|sexually transmitted disease|sexually transmitted disease
712600|NCT00207493|structural intervention|structural intervention
712601|NCT00207493|behavioral intervention|behavioral intervention
712602|NCT00207467|patient-delivered partner treatment|patient-delivered partner treatment
712603|NCT00207467|partner referral|partner referral
712604|NCT00207467|sexually transmitted diseases|sexually transmitted diseases
712605|NCT00207454|Partner Referral|partner referral
712606|NCT00207454|Social Cognitive Intervention|social cognitive intervention
712607|NCT00207454|Partner Delivered Medication|partner delivered medication
712608|NCT00207441|arthritis|arthritis
712609|NCT00207441|chronic disease|chronic disease
712610|NCT00207441|self management|self management
712611|NCT00207441|self efficacy|self efficacy
712612|NCT00207428|Bronchial asthma|bronchial asthma
712613|NCT00207428|Carbamazepine|carbamazepine
712614|NCT00207428|Efficacy|efficacy
712615|NCT00207415|arthritis|arthritis
712616|NCT00207415|self management|self management
712617|NCT00207402|Hepatitis C|hepatitis c
712618|NCT00207402|Insulin resistance|insulin resistance
712619|NCT00207389|Incretins:GIP , GLP-1|incretins:gip , glp-1
712620|NCT00207389|Gastric bypass surgery|gastric bypass surgery
712621|NCT00207389|Laparoscopic gastric bypass surgery|laparoscopic gastric bypass surgery
712622|NCT00207389|Postprandial expression of GIP|postprandial expression of gip
712623|NCT00207363|Hepatitis C|hepatitis c
712624|NCT00207350|Brain Tumor|brain tumor
712625|NCT00207337|COPD (Chronic Obstructive Pulmonary Disease)|copd (chronic obstructive pulmonary disease)
712626|NCT00207337|Emphysema|emphysema
712627|NCT00207337|Minimally invasive|minimally invasive
712628|NCT00207311|Hepatitis C|hepatitis c
712629|NCT00207311|Fatty Liver|fatty liver
712630|NCT00207311|NASH|nash
712631|NCT00207311|Steatohepatitis|steatohepatitis
712632|NCT00207285|Police|police
712633|NCT00207285|Sleep|sleep
712634|NCT00207285|Fatigue|fatigue
712635|NCT00207285|Work Hours|work hours
712636|NCT00207285|Sleep disorder|sleep disorder
712637|NCT00207285|Performance|performance
712638|NCT00207272|Hypocaloric MCT oil liquid diet|hypocaloric mct oil liquid diet
712639|NCT00207272|Hypocaloric LCT oil liquid diet|hypocaloric lct oil liquid diet
712640|NCT00207272|Visceral and omental adipose tissue|visceral and omental adipose tissue
712641|NCT00207272|Subcutaneous abdominal adipose tissue|subcutaneous abdominal adipose tissue
712642|NCT00207272|Gastric bypass surgery|gastric bypass surgery
712643|NCT00207259|Prostate Cancer|prostate cancer
712644|NCT00207259|Reiki|reiki
712645|NCT00207259|Relaxation Response|relaxation response
712646|NCT00207259|Cognitive Restructuring|cognitive restructuring
712647|NCT00207259|Feasibility|feasibility
712648|NCT00207233|Weight loss|weight loss
712649|NCT00207233|MCT oil hypocaloric liquid diet|mct oil hypocaloric liquid diet
712650|NCT00207233|LCT oil hypocaloric liquid diet|lct oil hypocaloric liquid diet
712651|NCT00207233|Gastric Bypass|gastric bypass
712652|NCT00207220|heart failure|heart failure
712653|NCT00207220|preserved ejection fraction|preserved ejection fraction
712654|NCT00207220|vascular stiffness|vascular stiffness
712655|NCT00207207|Alternate Site|alternate site
712656|NCT00207207|Blood Glucose Testing|blood glucose testing
712657|NCT00207207|Blood Sugar Testing|blood sugar testing
712658|NCT00207207|Hemoglobin A1C|hemoglobin a1c
712659|NCT00207181|Cancer prevention|cancer prevention
712660|NCT00207181|Physical activity|physical activity
712661|NCT00207181|Self-report|self-report
712662|NCT00207181|Paper diary|paper diary
712663|NCT00207181|Electronic|electronic
712664|NCT00207181|Computerized|computerized
712665|NCT00207181|Measurement|measurement
712666|NCT00207181|PDA|pda
712667|NCT00207181|Accelerometer|accelerometer
712668|NCT00207142|Treatment Naive|treatment naive
712669|NCT00207142|HIV-1 infected treatment naive patients|hiv-1 infected treatment naive patients
712670|NCT00207116|Metastatic Non Small Cell Lung Cancer|metastatic non small cell lung cancer
712671|NCT00207103|Advanced metastatic or solid tumors|advanced metastatic or solid tumors
712672|NCT00207077|Advanced Solid Tumors|advanced solid tumors
712673|NCT00207064|first-episode|first-episode
712674|NCT00207064|altanserin|altanserin
712675|NCT00207064|5-HT2A receptors|5-ht2a receptors
712676|NCT00207064|MRI|mri
712677|NCT00207064|fMRI|fmri
712678|NCT00207064|PPI|ppi
712679|NCT00207064|P300|p300
712680|NCT00207064|P50 gating|p50 gating
712681|NCT00207064|endophenotypes|endophenotypes
712682|NCT00207064|vulnerability indicators|vulnerability indicators
712683|NCT00207064|quetiapine|quetiapine
712684|NCT00207051|Advanced Gastrointestinal Malignancies|advanced gastrointestinal malignancies
712685|NCT00207038|Asthma|asthma
712686|NCT00207038|Airway inflammation|airway inflammation
712687|NCT00207038|Sport|sport
712688|NCT00207025|Patients with advanced solid tumors|patients with advanced solid tumors
712689|NCT00206999|Psychophysiology|psychophysiology
712690|NCT00206999|PPI|ppi
712691|NCT00206999|P50 suppression|p50 suppression
712692|NCT00206999|Imipramine|imipramine
712693|NCT00206986|Schizophrenia|schizophrenia
712694|NCT00206986|Information processing|information processing
712695|NCT00206986|PPI|ppi
712696|NCT00206986|P50 gating|p50 gating
712697|NCT00206986|P300|p300
712698|NCT00206986|mismatch negativity|mismatch negativity
712699|NCT00206986|clonidine|clonidine
712700|NCT00206960|drug-naive|drug-naive
712701|NCT00206960|epidepride|epidepride
712702|NCT00206960|single tomography|single tomography
712703|NCT00206960|D2 receptor|d2 receptor
712704|NCT00206960|information processing|information processing
712705|NCT00206960|PPI|ppi
712706|NCT00206960|antipsychotic treatment|antipsychotic treatment
712707|NCT00206960|MRI|mri
712708|NCT00206960|fMRI|fmri
712709|NCT00206960|cognitive disturbances|cognitive disturbances
712710|NCT00206947|Cognitive deficits|cognitive deficits
712711|NCT00206947|Cholinergic Augmentation|cholinergic augmentation
712712|NCT00206947|Schizophrenia|schizophrenia
712713|NCT00206934|PPI|ppi
712714|NCT00206934|P50 suppression|p50 suppression
712715|NCT00206934|P300|p300
712716|NCT00206934|mismatch negativity|mismatch negativity
712717|NCT00206934|escitalopram|escitalopram
712718|NCT00206921|Telangiectasia|telangiectasia
712719|NCT00206921|Skin redness|skin redness
712720|NCT00206882|sunburn|sunburn
712721|NCT00206882|corticosteroids|corticosteroids
712722|NCT00206791|bone substitutes|bone substitutes
712723|NCT00206791|Bone Replacement Materials|bone replacement materials
712724|NCT00206791|bone void filler|bone void filler
712725|NCT00206791|Grafting, Bone|grafting, bone
712726|NCT00206791|Bone Cysts|bone cysts
712727|NCT00206778|Mixed mania|mixed mania
712728|NCT00206778|Bipolar Disorder|bipolar disorder
712729|NCT00206765|panic|panic
712730|NCT00206739|Malaria|malaria
712731|NCT00206739|Anemia|anemia
712732|NCT00206739|IPTi|ipti
712733|NCT00206739|Intermittent Preventive Treatment in Infants|intermittent preventive treatment in infants
712734|NCT00206739|Sulfadoxine-Pyrimethamine|sulfadoxine-pyrimethamine
712735|NCT00206739|Chemoprophylaxis|chemoprophylaxis
712736|NCT00206739|Ghana|ghana
712737|NCT00206713|Crohn Disease|crohn disease
712738|NCT00206674|Morbus Crohn|morbus crohn
712739|NCT00206674|Sargramostim|sargramostim
712740|NCT00206674|Phase III|phase iii
712741|NCT00206674|Placebo Controlled|placebo controlled
712742|NCT00206661|Crohn Disease|crohn disease
712743|NCT00206609|Cancer|cancer
712744|NCT00206609|palliative care|palliative care
712745|NCT00206609|dyspnoea|dyspnoea
712746|NCT00206609|oxygen|oxygen
712747|NCT00206570|Schizophrenia|schizophrenia
712748|NCT00206570|Gender differences|gender differences
712749|NCT00206570|Hormones|hormones
712750|NCT00206570|Estradiol|estradiol
712751|NCT00206570|PANSS|panss
712752|NCT00206557|Schizophrenia|schizophrenia
712753|NCT00206557|Mental Illness|mental illness
712754|NCT00206557|Hormone Therapy|hormone therapy
712755|NCT00206557|Post-menopausal|post-menopausal
712756|NCT00206557|SERM|serm
712757|NCT00206557|Raloxifene|raloxifene
712758|NCT00206544|Bipolar Affective Disorder|bipolar affective disorder
712759|NCT00206544|Mania|mania
712760|NCT00206544|Anti-Estrogen|anti-estrogen
712761|NCT00206544|Schizoaffective Disorder|schizoaffective disorder
712762|NCT00206544|Mood|mood
712763|NCT00206531|HIV-1|hiv-1
712764|NCT00206531|Naive T-cells|naive t-cells
712765|NCT00206531|CD31|cd31
712766|NCT00206531|Treatment Naive|treatment naive
712767|NCT00206518|Breast|breast
712768|NCT00206518|Cancer|cancer
712769|NCT00206518|Taxotere|taxotere
712770|NCT00206518|AC|ac
712771|NCT00206518|Validation|validation
712772|NCT00206518|Neoadjuvant|neoadjuvant
712773|NCT00206505|Breast|breast
712774|NCT00206505|Cancer|cancer
712775|NCT00206505|Neoadjuvant|neoadjuvant
712776|NCT00206505|Taxotere|taxotere
712777|NCT00206492|Breast|breast
712778|NCT00206492|Cancer|cancer
712779|NCT00206492|Neoadjuvant|neoadjuvant
712780|NCT00206492|HER2|her2
712781|NCT00206492|Overexpressing|overexpressing
712782|NCT00206466|neoadjuvant|neoadjuvant
712783|NCT00206466|chemosensitivity|chemosensitivity
712784|NCT00206466|chemotherapy|chemotherapy
712785|NCT00206466|breast cancer|breast cancer
712786|NCT00206466|tumor|tumor
712787|NCT00206466|taxotere|taxotere
712788|NCT00206466|AC|ac
712789|NCT00206453|Breast|breast
712790|NCT00206453|Cancer|cancer
712791|NCT00206453|Gene|gene
712792|NCT00206453|Expression|expression
712793|NCT00206453|Taxotere|taxotere
712794|NCT00206440|chemotherapy|chemotherapy
712795|NCT00206440|nausea|nausea
712796|NCT00206440|vomiting|vomiting
712797|NCT00206440|breast cancer|breast cancer
712798|NCT00206427|Advanced|advanced
712799|NCT00206427|Breast|breast
712800|NCT00206427|Cancer|cancer
712801|NCT00206427|Neoadjuvant|neoadjuvant
712802|NCT00206427|HER2|her2
712803|NCT00206414|HORMONE RECEPTOR POSITIVE BREAST CANCER|hormone receptor positive breast cancer
712804|NCT00206401|Adolescents|adolescents
712805|NCT00206401|Lantus|lantus
712806|NCT00206388|NEUROBLASTOMA|neuroblastoma
712807|NCT00206388|RECURRENT|recurrent
712808|NCT00206388|REFRACTORY|refractory
712809|NCT00206388|CORTICAL|cortical
712810|NCT00206388|BONE|bone
712811|NCT00206375|Hypothyroidism|hypothyroidism
712812|NCT00206375|Growth hormone|growth hormone
712813|NCT00206362|Depression|depression
712814|NCT00206362|Socioeconomic status|socioeconomic status
712815|NCT00206362|Type 1 diabetes mellitus|type 1 diabetes mellitus
712816|NCT00206362|Children|children
712817|NCT00206362|Adolescents|adolescents
712818|NCT00206349|Depression|depression
712819|NCT00206349|Socioeconomic status|socioeconomic status
712820|NCT00206349|Type 1 diabetes mellitus|type 1 diabetes mellitus
712821|NCT00206349|Children|children
712822|NCT00206349|Adolescents|adolescents
712823|NCT00206297|Type 1 diabetes|type 1 diabetes
712824|NCT00206297|hypoglycemia|hypoglycemia
712825|NCT00206297|hyperglycemia|hyperglycemia
712826|NCT00206284|GERD without erosive esophagitis|gerd without erosive esophagitis
712827|NCT00206271|whiplash injuries|whiplash injuries
712828|NCT00206271|neck pain|neck pain
712829|NCT00206271|exercise movement techniques|exercise movement techniques
712830|NCT00206271|immobilisation|immobilisation
712831|NCT00206258|type 1 diabetes|type 1 diabetes
712832|NCT00206258|hypoglycemia|hypoglycemia
712833|NCT00206258|hyperglycemia|hyperglycemia
712834|NCT00206245|GERD with erosive esophagitis|gerd with erosive esophagitis
712835|NCT00206232|Diastolic Heart Failure|diastolic heart failure
712836|NCT00206219|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
712837|NCT00206193|termination of pregnancy|termination of pregnancy
712838|NCT00206141|Bipolar disorder|bipolar disorder
712839|NCT00206141|bipolar depression|bipolar depression
712840|NCT00206141|depression|depression
712841|NCT00206128|Schizophrenia|schizophrenia
712842|NCT00206115|Schizophrenic disorder|schizophrenic disorder
712843|NCT00206102|Schizophrenia|schizophrenia
712844|NCT00206102|Schizoaffective Disorder|schizoaffective disorder
712845|NCT00206089|Prevention of venous thromboembolic events in patients undergoing elective hip replacement or hip fracture surgery|prevention of venous thromboembolic events in patients undergoing elective hip replacement or hip fracture surgery
712846|NCT00206076|Liver transplantation|liver transplantation
712847|NCT00206076|Calcineurin inhibitor withdraw|calcineurin inhibitor withdraw
712848|NCT00206076|mycophenolate mofetil|mycophenolate mofetil
712849|NCT00206076|Immunosuppression side effects|immunosuppression side effects
712850|NCT00206076|Graft rejection|graft rejection
712851|NCT00206037|Tibia osteotomy|tibia osteotomy
712852|NCT00206037|Bone healing|bone healing
712853|NCT00206037|Bone filler|bone filler
712854|NCT00206037|Equine Protein|equine protein
712855|NCT00206037|COLLOSS E|colloss e
712856|NCT00206037|TomoFix|tomofix
712857|NCT00206011|Condylar neck|condylar neck
712858|NCT00206011|fractures|fractures
712859|NCT00206011|endoscopic|endoscopic
712860|NCT00206011|Helkimo Dysfunction index|helkimo dysfunction index
712861|NCT00205998|Locking Compression Plate|locking compression plate
712862|NCT00205998|Conservative treatment|conservative treatment
712863|NCT00205998|Surgical treatment|surgical treatment
712864|NCT00205998|Radius fractures|radius fractures
712865|NCT00205998|AO 23|ao 23
712866|NCT00205985|Return to work|return to work
712867|NCT00205985|Scaphoid fracture|scaphoid fracture
712868|NCT00205985|Operative treatment|operative treatment
712869|NCT00205985|Activity level|activity level
712870|NCT00205972|Fractures|fractures
712871|NCT00205972|Humerus|humerus
712872|NCT00205972|Conservative treatment|conservative treatment
712873|NCT00205972|Operative treatment|operative treatment
712874|NCT00205959|Humerus|humerus
712875|NCT00205959|Fractures|fractures
712876|NCT00205959|Locking Plates|locking plates
712877|NCT00205959|Nail System|nail system
712878|NCT00205946|Reward Processing|reward processing
712879|NCT00205946|Wellbutrin|wellbutrin
712880|NCT00205946|Bupropion|bupropion
712881|NCT00205933|Depression|depression
712882|NCT00205933|Bipolar Disorder|bipolar disorder
712883|NCT00205933|Reward Processing|reward processing
712884|NCT00205920|emphysema|emphysema
712885|NCT00205920|pulmonary emphysema|pulmonary emphysema
712886|NCT00205920|COPD|copd
712887|NCT00205920|COLD|cold
712888|NCT00205920|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
712889|NCT00205907|BLVR|blvr
712890|NCT00205907|emphysema|emphysema
712891|NCT00205907|COPD|copd
712892|NCT00205907|COLD|cold
712893|NCT00205907|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
712894|NCT00205907|pulmonary emphysema|pulmonary emphysema
712895|NCT00205894|Headache|headache
712896|NCT00205894|Chronic headache|chronic headache
712897|NCT00205894|Migraine|migraine
712898|NCT00205894|Pain|pain
712899|NCT00205894|Cluster headache|cluster headache
712900|NCT00205881|HiResolution Bionic Ear|hiresolution bionic ear
712901|NCT00205881|severe to profound hearing loss|severe to profound hearing loss
712902|NCT00205881|bilateral implantation|bilateral implantation
712903|NCT00205868|Back Pain|back pain
712904|NCT00205868|Low Back Pain|low back pain
712905|NCT00205868|Chronic Pain|chronic pain
712906|NCT00205868|Spinal Cord Stimulation|spinal cord stimulation
712907|NCT00205855|Pain|pain
712908|NCT00205855|Chronic Pain|chronic pain
712909|NCT00205855|Neurostimulation|neurostimulation
712910|NCT00205829|Chronic headaches|chronic headaches
712911|NCT00205829|greater occipital nerve stimulation|greater occipital nerve stimulation
712912|NCT00205816|Bacterial Infections|bacterial infections
712913|NCT00205803|Infant Vaccine|infant vaccine
712914|NCT00205777|Osteoporosis|osteoporosis
712915|NCT00205777|Postmenopause|postmenopause
712916|NCT00205764|Multiple Myeloma|multiple myeloma
712917|NCT00205764|first line tretment|first line tretment
712918|NCT00205764|high dose chemotherapy|high dose chemotherapy
712919|NCT00205764|stem cell transplantation|stem cell transplantation
712920|NCT00205764|maintenance therapy|maintenance therapy
712921|NCT00205751|Multiple Myeloma|multiple myeloma
712922|NCT00205751|first line treatment|first line treatment
712923|NCT00205751|thalidomide|thalidomide
712924|NCT00205751|melphalan|melphalan
712925|NCT00205738|Schizophrenia|schizophrenia
712926|NCT00205738|BMI|bmi
712927|NCT00205738|T2DM|t2dm
712928|NCT00205725|Schizophrenia|schizophrenia
712929|NCT00205725|BMI|bmi
712930|NCT00205725|T2DM|t2dm
712931|NCT00205712|NMDA antagonist-induced psychosis|nmda antagonist-induced psychosis
712932|NCT00205712|Children|children
712933|NCT00205712|Memory Impairment|memory impairment
712934|NCT00205712|Decreased cognitive function|decreased cognitive function
712935|NCT00205712|Increased memory impairment|increased memory impairment
712936|NCT00205699|Antipsychotic treatment|antipsychotic treatment
712937|NCT00205699|Insulin action/secretion|insulin action/secretion
712938|NCT00205699|Abdominal fat mass, total body fat|abdominal fat mass, total body fat
712939|NCT00205699|Aggression|aggression
712940|NCT00205699|Resting metabolic rates|resting metabolic rates
712941|NCT00205686|Aging, dhea, bone density, muscle mass, insulin action|aging, dhea, bone density, muscle mass, insulin action
712942|NCT00205660|Schizophrenia|schizophrenia
712943|NCT00205660|Obesity|obesity
712944|NCT00205660|Hyperglycemia|hyperglycemia
712945|NCT00205660|Dyslipidemia|dyslipidemia
712946|NCT00205660|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
712947|NCT00205647|Chronic Bronchitis|chronic bronchitis
712948|NCT00205647|N-acetylcysteine (NAC)|n-acetylcysteine (nac)
712949|NCT00205647|Quality of Life|quality of life
712950|NCT00205647|Mucus|mucus
712951|NCT00205634|Cystic Fibrosis (CF)|cystic fibrosis (cf)
712952|NCT00205634|Macrolide antiobiotics|macrolide antiobiotics
712953|NCT00205634|airway inflammation|airway inflammation
712954|NCT00205621|Alzheimer's disease|alzheimer's disease
712955|NCT00205621|amyloid|amyloid
712956|NCT00205621|PET|pet
712957|NCT00205621|PIB|pib
712958|NCT00205621|FDDNP|fddnp
712959|NCT00205608|schizophrenia|schizophrenia
712960|NCT00205608|microglia|microglia
712961|NCT00205608|PET|pet
712962|NCT00205595|microglia|microglia
712963|NCT00205595|PET|pet
712964|NCT00205595|PK11195|pk11195
712965|NCT00205582|Traumatic Brain Injury|traumatic brain injury
712966|NCT00205582|PET|pet
712967|NCT00205582|microglia|microglia
712968|NCT00205569|brain injury, acute rehabilitation|brain injury, acute rehabilitation
712969|NCT00205556|online hemodiafiltration|online hemodiafiltration
712970|NCT00205556|low flux hemodialysis|low flux hemodialysis
712971|NCT00205556|cardiovascular disease|cardiovascular disease
712972|NCT00205556|endothelial dysfunction|endothelial dysfunction
712973|NCT00205556|uremic toxicity|uremic toxicity
712974|NCT00205556|quality of life|quality of life
712975|NCT00205556|nutritional status|nutritional status
712976|NCT00205543|obstructive sleep apnea|obstructive sleep apnea
712977|NCT00205543|airway obstruction|airway obstruction
712978|NCT00205543|sleep-disordered breathing|sleep-disordered breathing
712979|NCT00205530|brain injury, family treatment|brain injury, family treatment
712980|NCT00205504|Inflammatory markers, oral contraceptions, obesity, metabolic syndrome X|inflammatory markers, oral contraceptions, obesity, metabolic syndrome x
712981|NCT00205491|depression after brain injury|depression after brain injury
712982|NCT00205491|traumatic brain injury|traumatic brain injury
712983|NCT00205491|Venlafaxine|venlafaxine
712984|NCT00205426|Pulmonary hypertension in lung transplant recipients|pulmonary hypertension in lung transplant recipients
712985|NCT00205413|surveillance for lung cancer|surveillance for lung cancer
712986|NCT00205387|echocardiography|echocardiography
712987|NCT00205387|cardiac elastography|cardiac elastography
712988|NCT00205387|Normal volunteers|normal volunteers
712989|NCT00205309|intubated patients|intubated patients
712990|NCT00205283|HIV|hiv
712991|NCT00205270|Pre or post-lung transplant|pre or post-lung transplant
712992|NCT00205270|Healthy|healthy
712993|NCT00205231|HIV|hiv
712994|NCT00205192|Heart Failure|heart failure
712995|NCT00205192|Cardiac resynchronization|cardiac resynchronization
712996|NCT00205192|echocardiography|echocardiography
712997|NCT00205166|adenosine tracer scans|adenosine tracer scans
712998|NCT00205166|coronary artery disease|coronary artery disease
712999|NCT00205166|caffeine|caffeine
713000|NCT00205153|hypertension in African Americans|hypertension in african americans
713001|NCT00205127|Cardiac PET imaging|cardiac pet imaging
713002|NCT00205127|Radiopharmaceutical tracers|radiopharmaceutical tracers
713003|NCT00205101|Transforaminal lumbar interbody fusion|transforaminal lumbar interbody fusion
713004|NCT00205101|Posterior lumbar interbody fusion|posterior lumbar interbody fusion
713005|NCT00205101|Isthmic spondylolisthesis, degenerative spondylolisthesis|isthmic spondylolisthesis, degenerative spondylolisthesis
713006|NCT00205101|Pseudoarthritis|pseudoarthritis
713007|NCT00205101|Severe Foraminal Stenosis|severe foraminal stenosis
713008|NCT00205049|acute alcoholic hepatitis|acute alcoholic hepatitis
713009|NCT00204997|Cervical Cancer|cervical cancer
713010|NCT00204997|Squamous Cell|squamous cell
713011|NCT00204997|Laparoscopy|laparoscopy
713012|NCT00204997|Ovarian Function|ovarian function
713013|NCT00204984|arterial stiffness|arterial stiffness
713014|NCT00204984|echocardiography|echocardiography
713015|NCT00204984|nesiritide|nesiritide
713016|NCT00204958|bone marrow transplant (BMT)|bone marrow transplant (bmt)
713017|NCT00204958|hematopoietic stem cell transplant (HSCT)|hematopoietic stem cell transplant (hsct)
713018|NCT00204945|arterial stiffness|arterial stiffness
713019|NCT00204945|echocardiography|echocardiography
713020|NCT00204945|nesiritide|nesiritide
713021|NCT00204945|high heart pressures|high heart pressures
713022|NCT00204945|cardiac catheterization|cardiac catheterization
713023|NCT00204919|osteoporosis|osteoporosis
713024|NCT00204919|vitamin D deficiency|vitamin d deficiency
713025|NCT00204867|colorectal|colorectal
713026|NCT00204867|polyps|polyps
713027|NCT00204763|manometry catheters|manometry catheters
713028|NCT00204763|diffuse esophageal spasm or hypertensive LES|diffuse esophageal spasm or hypertensive les
713029|NCT00204763|incontinence|incontinence
713030|NCT00204750|lower esophageal ring|lower esophageal ring
713031|NCT00204750|dysphagia|dysphagia
713032|NCT00204750|electrosurgical incision|electrosurgical incision
713033|NCT00204750|bougie dilation|bougie dilation
713034|NCT00204750|GERD|gerd
713035|NCT00204711|patients having outpatient surgery with sedation|patients having outpatient surgery with sedation
713036|NCT00204711|patients having procedures with sedation|patients having procedures with sedation
713037|NCT00204672|Asthma|asthma
713038|NCT00204659|Rituximab|rituximab
713039|NCT00204659|CHOP|chop
713040|NCT00204659|DLBCL|dlbcl
713041|NCT00204659|gastric lymphoma|gastric lymphoma
713042|NCT00204594|mRNA|mrna
713043|NCT00204594|vaccination|vaccination
713044|NCT00204594|melanoma|melanoma
713045|NCT00204581|Melanoma|melanoma
713046|NCT00204581|Soft tissue metastases|soft tissue metastases
713047|NCT00204581|Interleukin-2|interleukin-2
713048|NCT00204555|nodular basal cell carcinoma|nodular basal cell carcinoma
713049|NCT00204555|Imiquimod|imiquimod
713050|NCT00204555|topical treatment|topical treatment
713051|NCT00204555|Adjuvants, Immunologic|adjuvants, immunologic
713052|NCT00204555|Antineoplastic Agents|antineoplastic agents
713053|NCT00204555|Interferon Inducers|interferon inducers
713054|NCT00204542|actinic keratosis|actinic keratosis
713055|NCT00204542|diclofenac sodium|diclofenac sodium
713056|NCT00204529|malignant melanoma|malignant melanoma
713057|NCT00204529|adjuvant therapy|adjuvant therapy
713058|NCT00204529|Adjuvants, Immunologic|adjuvants, immunologic
713059|NCT00204516|vaccination|vaccination
713060|NCT00204516|mRNA|mrna
713061|NCT00204503|Bipolar I or II|bipolar i or ii
713062|NCT00204503|Depression|depression
713063|NCT00204503|Alcohol Abuse or Dependence|alcohol abuse or dependence
713064|NCT00204503|Mental Health Issues|mental health issues
713065|NCT00204490|soy|soy
713066|NCT00204490|isoflavones|isoflavones
713067|NCT00204490|phytoestrogens|phytoestrogens
713068|NCT00204490|prevention|prevention
713069|NCT00204490|mammographic density|mammographic density
713070|NCT00204490|bone density|bone density
713071|NCT00204477|soy diet|soy diet
713072|NCT00204477|breast cancer|breast cancer
713073|NCT00204477|ovarian hormones|ovarian hormones
713074|NCT00204477|breast density|breast density
713075|NCT00204477|prevention|prevention
713076|NCT00204464|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
713077|NCT00204464|Exercise|exercise
713078|NCT00204451|emergency contraception|emergency contraception
713079|NCT00204451|follicle|follicle
713080|NCT00204451|ovulation|ovulation
713081|NCT00204451|blood pressure|blood pressure
713082|NCT00204451|Fertility Control|fertility control
713083|NCT00204451|Inhibition of fertilization|inhibition of fertilization
713084|NCT00204438|female contraception|female contraception
713085|NCT00204438|oral contraceptive|oral contraceptive
713086|NCT00204438|emergency contraceptive|emergency contraceptive
713087|NCT00204438|ovary|ovary
713088|NCT00204438|follicle|follicle
713089|NCT00204438|ovulation|ovulation
713090|NCT00204425|Osteoporosis|osteoporosis
713091|NCT00204425|Bone|bone
713092|NCT00204425|Exercise|exercise
713093|NCT00204425|Soy|soy
713094|NCT00204425|Isoflavone|isoflavone
713095|NCT00204425|Phytoestrogen|phytoestrogen
713096|NCT00204425|Menopause|menopause
713097|NCT00204425|Lipids|lipids
713098|NCT00204412|Cholesterol|cholesterol
713099|NCT00204412|High density lipoprotein|high density lipoprotein
713100|NCT00204412|Low density lipoprotein|low density lipoprotein
713101|NCT00204412|Triglyceride|triglyceride
713102|NCT00204412|Glucose|glucose
713103|NCT00204412|Exercise|exercise
713104|NCT00204412|Fitness|fitness
713105|NCT00204412|Flax|flax
713106|NCT00204412|Lignan|lignan
713107|NCT00204412|Phytoestrogen|phytoestrogen
713108|NCT00204412|bone|bone
713109|NCT00204386|Posttraumatic Stress Disorder|posttraumatic stress disorder
713110|NCT00204360|epilepsy|epilepsy
713111|NCT00204347|risperidone|risperidone
713112|NCT00204334|Kidney transplantation|kidney transplantation
713113|NCT00204334|anemia|anemia
713114|NCT00204334|vascular endothelium|vascular endothelium
713115|NCT00204334|monocytes|monocytes
713116|NCT00204334|apoptosis|apoptosis
713117|NCT00204321|rejection|rejection
713118|NCT00204321|vesselwall function|vesselwall function
713119|NCT00204321|endothelial cell function|endothelial cell function
713120|NCT00204321|monocytes|monocytes
713121|NCT00204308|HIV|hiv
713122|NCT00204308|Pregnancy|pregnancy
713123|NCT00204308|Mother-to-child transmission of HIV|mother-to-child transmission of hiv
713124|NCT00204308|Drug resistance|drug resistance
713125|NCT00204308|Nevirapine resistance|nevirapine resistance
713126|NCT00204308|NNRTI resistance|nnrti resistance
713127|NCT00204295|Brain neoplasms|brain neoplasms
713128|NCT00204295|Positron-Emission Tomography|positron-emission tomography
713129|NCT00204295|Amino Acids|amino acids
713130|NCT00204295|Magnetic Resonance Imaging|magnetic resonance imaging
713131|NCT00204282|Diabetes prevention|diabetes prevention
713132|NCT00204269|Hypogonadism|hypogonadism
713133|NCT00204269|Testosterone|testosterone
713134|NCT00204269|Substitution|substitution
713135|NCT00204256|chronic kidney disease|chronic kidney disease
713136|NCT00204256|anemia|anemia
713137|NCT00204256|intravenous iron|intravenous iron
713138|NCT00204256|recombinant human erythropoetin|recombinant human erythropoetin
713139|NCT00204243|naltrexone implant|naltrexone implant
713140|NCT00204243|methadone|methadone
713141|NCT00204243|inmates|inmates
713142|NCT00204243|randomized controlled trial|randomized controlled trial
713143|NCT00204230|Kidney Failure, Chronic|kidney failure, chronic
713144|NCT00204230|Kidney Transplantation|kidney transplantation
713145|NCT00204217|cardiac arrest|cardiac arrest
713146|NCT00204217|resuscitation|resuscitation
713147|NCT00204217|ventilation|ventilation
713148|NCT00204217|impedance|impedance
713149|NCT00204204|multiple trauma|multiple trauma
713150|NCT00204204|traffic accident|traffic accident
713151|NCT00204204|outcome|outcome
713152|NCT00204204|safety|safety
713153|NCT00204204|injury severity|injury severity
713154|NCT00204191|kidney transplantation|kidney transplantation
713155|NCT00204191|Immunosuppression|immunosuppression
713156|NCT00204191|Cyclosporine|cyclosporine
713157|NCT00204191|Tacrolimus|tacrolimus
713158|NCT00204178|Kidney transplantation|kidney transplantation
713159|NCT00204178|Reperfusion injury|reperfusion injury
713160|NCT00204152|Early onset depression|early onset depression
713161|NCT00204152|early adversity|early adversity
713162|NCT00204126|exercise testing|exercise testing
713163|NCT00204126|treadmill|treadmill
713164|NCT00204126|incomplete spinal cord injury|incomplete spinal cord injury
713165|NCT00204126|novel methods|novel methods
713166|NCT00204113|spinal cord injury|spinal cord injury
713167|NCT00204113|standing|standing
713168|NCT00204113|balance|balance
713169|NCT00204113|functional electrical stimulation|functional electrical stimulation
713170|NCT00204100|paraplegia|paraplegia
713171|NCT00204100|spinal cord injury|spinal cord injury
713172|NCT00204100|functional electrical stimulation|functional electrical stimulation
713173|NCT00204100|cycling|cycling
713174|NCT00204100|exercise|exercise
713175|NCT00204100|cardiopulmonary fitness|cardiopulmonary fitness
713176|NCT00204087|Schizophrenia|schizophrenia
713177|NCT00204087|Psychosis|psychosis
713178|NCT00204087|Prodrome|prodrome
713179|NCT00204087|Early Initial Prodromal State|early initial prodromal state
713180|NCT00204087|Early Intervention|early intervention
713181|NCT00204087|Cognitive Behavioral Therapy|cognitive behavioral therapy
713182|NCT00204074|Migraine|migraine
713183|NCT00204074|Menstrual cycle|menstrual cycle
713184|NCT00204074|17 beta-estradiol|17 beta-estradiol
713185|NCT00204074|Transdermal administration|transdermal administration
713186|NCT00204061|schizophrenia|schizophrenia
713187|NCT00204061|psychosis|psychosis
713188|NCT00204061|ultra high risk|ultra high risk
713189|NCT00204061|prodromal state|prodromal state
713190|NCT00204061|early intervention|early intervention
713191|NCT00204061|amisulpride|amisulpride
713192|NCT00204048|Hospitalists|hospitalists
713193|NCT00204035|Training early achievers for careers in health|training early achievers for careers in health
713194|NCT00204022|Lupus nephritis|lupus nephritis
713195|NCT00204022|Treatment|treatment
713196|NCT00204022|Maintenance therapy|maintenance therapy
713197|NCT00204022|Mycophenolate mofetil|mycophenolate mofetil
713198|NCT00204022|Azathioprine|azathioprine
713199|NCT00204009|children and adolescents|children and adolescents
713200|NCT00204009|epidemiology|epidemiology
713201|NCT00203996|polycystic ovary syndrome|polycystic ovary syndrome
713202|NCT00203996|metabolic syndrome|metabolic syndrome
713203|NCT00203996|obstructive sleep apnea|obstructive sleep apnea
713204|NCT00203996|impaired glucose tolerance|impaired glucose tolerance
713205|NCT00203996|insulin resistance|insulin resistance
713206|NCT00203970|Thrombosis|thrombosis
713207|NCT00203970|Low Molecular Weight Heparin|low molecular weight heparin
713208|NCT00203957|Parkinson's Disease|parkinson's disease
713209|NCT00203944|Adoption|adoption
713210|NCT00203944|Stress Response|stress response
713211|NCT00203944|Child Development|child development
713212|NCT00203931|Non-small cell lung cancer|non-small cell lung cancer
713213|NCT00203918|Prostate Cancer|prostate cancer
713214|NCT00203918|Cost-Effectiveness Analysis|cost-effectiveness analysis
713215|NCT00203918|Utility Assessment|utility assessment
713216|NCT00203905|Head and Neck Cancer|head and neck cancer
713217|NCT00203892|Adenocarcinoma|adenocarcinoma
713218|NCT00203892|Pancreas|pancreas
713219|NCT00203879|metastatic melanoma|metastatic melanoma
713220|NCT00203866|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
713221|NCT00203853|HIV|hiv
713222|NCT00203853|HAART|haart
713223|NCT00203853|medication adherance|medication adherance
713224|NCT00203853|pillbox|pillbox
713225|NCT00203853|wristwatch|wristwatch
713226|NCT00203840|Sleep Disorders|sleep disorders
713227|NCT00203827|Sleep Disorders|sleep disorders
713228|NCT00203814|Malaria|malaria
713229|NCT00203814|Efficacy|efficacy
713230|NCT00203814|Pharmacokinetic|pharmacokinetic
713231|NCT00203814|Gametocyte|gametocyte
713232|NCT00203814|Molecular markers|molecular markers
713233|NCT00203814|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
713234|NCT00203814|Artesunate|artesunate
713235|NCT00203814|Artemisinin|artemisinin
713236|NCT00203801|Malaria|malaria
713237|NCT00203801|Efficacy|efficacy
713238|NCT00203801|Pharmacokinetic|pharmacokinetic
713239|NCT00203801|Gametocyte|gametocyte
713240|NCT00203801|Molecular markers|molecular markers
713241|NCT00203801|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
713242|NCT00203801|Artesunate|artesunate
713243|NCT00203801|Artemisinin|artemisinin
713244|NCT00203788|work outcome|work outcome
713245|NCT00203788|supported employment|supported employment
713246|NCT00203788|social skills training|social skills training
713247|NCT00203788|risperidone|risperidone
713248|NCT00203788|cognition|cognition
713249|NCT00203788|first-episode schizophrenia|first-episode schizophrenia
713250|NCT00203762|Pragmatic cluster non-randomized controlled trial|pragmatic cluster non-randomized controlled trial
713251|NCT00203762|antiretroviral treatment|antiretroviral treatment
713252|NCT00203762|tuberculosis|tuberculosis
713253|NCT00203762|childhood immunization|childhood immunization
713254|NCT00203762|primary care|primary care
713255|NCT00203762|resource-restricted settings|resource-restricted settings
713256|NCT00203749|HIV|hiv
713257|NCT00203749|Testing|testing
713258|NCT00203749|Counseling|counseling
713259|NCT00203736|Malaria|malaria
713260|NCT00203736|Efficacy|efficacy
713261|NCT00203736|Pharmacokinetic|pharmacokinetic
713262|NCT00203736|Gametocyte|gametocyte
713881|NCT00200538|Mémantine|mémantine
713263|NCT00203736|Molecular Markers|molecular markers
713264|NCT00203736|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
713265|NCT00203736|Artesunate|artesunate
713266|NCT00203736|Artemisinin|artemisinin
713267|NCT00203723|mood disorder|mood disorder
713268|NCT00203723|affective disorder|affective disorder
713269|NCT00203723|depression|depression
713270|NCT00203723|treatment-resistant|treatment-resistant
713271|NCT00203710|Concentric Retriever Device|concentric retriever device
713272|NCT00203710|embolectomy|embolectomy
713273|NCT00203710|acute ischemic stroke|acute ischemic stroke
713274|NCT00203710|treatment|treatment
713275|NCT00203697|Eric Kleerup|eric kleerup
713276|NCT00203697|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
713277|NCT00203671|renal|renal
713278|NCT00203671|transplant|transplant
713279|NCT00203671|kidney|kidney
713280|NCT00203671|rejection|rejection
713281|NCT00203671|MMF|mmf
713282|NCT00203671|Mycophenolate Mofetil|mycophenolate mofetil
713283|NCT00203671|outcomes|outcomes
713284|NCT00203671|Kidney Transplantation|kidney transplantation
713285|NCT00203645|Problem gambling|problem gambling
713286|NCT00203645|Self-help manual|self-help manual
713287|NCT00203645|Motivation enhancement|motivation enhancement
713288|NCT00203645|Telephone support|telephone support
713289|NCT00203645|Treatment|treatment
713290|NCT00203645|Pathological gambling|pathological gambling
713291|NCT00203632|diabetes mellitus|diabetes mellitus
713292|NCT00203632|endothelium|endothelium
713293|NCT00203632|thiazolidinediones|thiazolidinediones
713294|NCT00203632|atherosclerosis|atherosclerosis
713295|NCT00203593|exercise|exercise
713296|NCT00203593|total peripheral resistance|total peripheral resistance
713297|NCT00203593|venoconstriction|venoconstriction
713298|NCT00203593|blood volume expansion|blood volume expansion
713299|NCT00203593|orthostatic tolerance|orthostatic tolerance
713300|NCT00203580|venous thromboembolism|venous thromboembolism
713301|NCT00203580|low-molecular-weight heparin|low-molecular-weight heparin
713302|NCT00203567|bipolar depression|bipolar depression
713303|NCT00203567|carbamazepine ER|carbamazepine er
713304|NCT00203567|Equetro|equetro
713305|NCT00203554|osteoporosis|osteoporosis
713306|NCT00203554|vertebra|vertebra
713307|NCT00203554|fracture|fracture
713308|NCT00203554|pain|pain
713309|NCT00203554|percutaneous|percutaneous
713310|NCT00203554|vertebroplasty|vertebroplasty
713311|NCT00203554|polymethylmetacrylate|polymethylmetacrylate
713312|NCT00203528|divalproex sodium|divalproex sodium
713313|NCT00203528|risperidone|risperidone
713314|NCT00203528|dual diagnosis|dual diagnosis
713315|NCT00203528|substance use|substance use
713316|NCT00203528|bipolar|bipolar
713317|NCT00203515|Urinary Catheterization|urinary catheterization
713318|NCT00203502|Operable and Locally advanced Breast Cancer|operable and locally advanced breast cancer
713319|NCT00203476|ezetimibe|ezetimibe
713320|NCT00203476|niacin|niacin
713321|NCT00203476|colestipol|colestipol
713322|NCT00203476|hyperlipidemia|hyperlipidemia
713323|NCT00203476|adjunct therapy|adjunct therapy
713324|NCT00203476|zetia|zetia
713325|NCT00203463|topiramate|topiramate
713326|NCT00203463|PTSD|ptsd
713327|NCT00203463|posttraumatic stress disorder|posttraumatic stress disorder
713328|NCT00203463|topamax|topamax
713329|NCT00203450|obesity|obesity
713330|NCT00203450|zonisamide|zonisamide
713331|NCT00203450|zonegran|zonegran
713332|NCT00203450|psychotropic weight gain|psychotropic weight gain
713333|NCT00203450|psychotropic|psychotropic
713334|NCT00203385|divalproex sodium, depakote, ptsd, long-term ptsd treatments|divalproex sodium, depakote, ptsd, long-term ptsd treatments
713335|NCT00203333|Epilepsy|epilepsy
713336|NCT00203281|renal transplantation|renal transplantation
713337|NCT00203268|migraine|migraine
713338|NCT00203268|cutaneous allodynia|cutaneous allodynia
713339|NCT00203255|Menstrually-Associated Migraine|menstrually-associated migraine
713340|NCT00203229|Double-Blind|double-blind
713341|NCT00203229|Placebo-Controlled|placebo-controlled
713342|NCT00203203|Autologous|autologous
713343|NCT00203203|Cardiac|cardiac
713344|NCT00203203|Stem Cell|stem cell
713345|NCT00203203|Transplant|transplant
713346|NCT00203047|Multiple Sclerosis|multiple sclerosis
713347|NCT00203047|brain atrophy|brain atrophy
713348|NCT00203047|Glatiramer Acetate|glatiramer acetate
713349|NCT00203047|Copaxone|copaxone
713350|NCT00203047|Steroids|steroids
713351|NCT00203047|Prednisone|prednisone
713352|NCT00202969|Stomach cancer|stomach cancer
713353|NCT00202943|TCRFVR, LAUP, Snorer|tcrfvr, laup, snorer
713354|NCT00202930|neuroblastoma|neuroblastoma
713355|NCT00202930|Opsoclonus-myoclonus|opsoclonus-myoclonus
713356|NCT00202930|rituximab|rituximab
713357|NCT00202917|haploidentical transplantation|haploidentical transplantation
713358|NCT00202917|immunomagnetic cell sorting|immunomagnetic cell sorting
713359|NCT00202917|allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
713360|NCT00202917|dose reduced conditioning|dose reduced conditioning
713361|NCT00202904|ezetimibe|ezetimibe
713362|NCT00202904|atorvastatin|atorvastatin
713363|NCT00202904|hypercholesterolemia|hypercholesterolemia
713364|NCT00202904|coronary heart disease|coronary heart disease
713365|NCT00202891|pyoderma|pyoderma
713366|NCT00202891|sisomicin|sisomicin
713367|NCT00202891|nadifloxacin|nadifloxacin
713368|NCT00202878|hypercholesterolemia|hypercholesterolemia
713369|NCT00202878|myocardial infarction|myocardial infarction
713370|NCT00202878|cholesterol|cholesterol
713371|NCT00202878|randomized controlled trials|randomized controlled trials
713372|NCT00202878|acute coronary syndrome|acute coronary syndrome
713373|NCT00202878|angina|angina
713374|NCT00202813|CVC|cvc
713375|NCT00202813|central venous catheter|central venous catheter
713376|NCT00202813|infection|infection
713377|NCT00202813|bloodstream infection|bloodstream infection
713378|NCT00202813|catheter infection|catheter infection
713379|NCT00202813|pediatric|pediatric
713380|NCT00202813|children|children
713381|NCT00202813|antibiotic impregnated catheters|antibiotic impregnated catheters
713382|NCT00202800|Pancreatic Cancer|pancreatic cancer
713383|NCT00202800|Gemcitabine/Etoposide|gemcitabine/etoposide
713384|NCT00202800|Ras-mutation|ras-mutation
713385|NCT00202787|colorectal cancer|colorectal cancer
713386|NCT00202787|cetuximab|cetuximab
713387|NCT00202787|FOLFOX4|folfox4
713388|NCT00202774|colorectal cancer, capecitabine, oxaliplatin, 5-fluorouracil|colorectal cancer, capecitabine, oxaliplatin, 5-fluorouracil
713389|NCT00202761|Cerebral palsy|cerebral palsy
713390|NCT00202761|Functional training|functional training
713391|NCT00202761|preschool children|preschool children
713392|NCT00202761|Gross Motor Functional Classification Level|gross motor functional classification level
713393|NCT00202761|Gross motor functional Measure test|gross motor functional measure test
713394|NCT00202761|Pediatric Evaluation of Disability Inventory|pediatric evaluation of disability inventory
713395|NCT00202761|Parental Stress Index|parental stress index
713396|NCT00202748|metabolic syndrome|metabolic syndrome
713397|NCT00202748|lifestyle|lifestyle
713398|NCT00202748|obesity|obesity
713399|NCT00202735|shoulder dislocation|shoulder dislocation
713400|NCT00202735|anterior|anterior
713401|NCT00202735|traumatic|traumatic
713402|NCT00202735|primary|primary
713403|NCT00202735|first time|first time
713404|NCT00202735|initial|initial
713405|NCT00202735|immobilization|immobilization
713406|NCT00202735|external|external
713407|NCT00202735|rotation|rotation
713408|NCT00202722|Remifentanil, parenteral opioids, obstetric analgesia, IVPCA|remifentanil, parenteral opioids, obstetric analgesia, ivpca
713409|NCT00202709|Anxiety disorder|anxiety disorder
713410|NCT00202709|Thought Field Therapy|thought field therapy
713411|NCT00202709|Psychotherapy|psychotherapy
713412|NCT00202709|Agoraphobia|agoraphobia
713413|NCT00202709|Social Phobia|social phobia
713414|NCT00202709|Post Traumatic Stress Disorder|post traumatic stress disorder
713415|NCT00202683|Altitude|altitude
713416|NCT00202683|Anoxemia|anoxemia
713417|NCT00202683|Mitochondria|mitochondria
713418|NCT00202683|Reflex|reflex
713419|NCT00202683|Genetic research|genetic research
713420|NCT00202670|coronary artery disease|coronary artery disease
713421|NCT00202670|stress myocardial scintigraphy|stress myocardial scintigraphy
713422|NCT00202670|stress echocardiography|stress echocardiography
713423|NCT00202657|parkinson's disease|parkinson's disease
713424|NCT00202657|pergolide|pergolide
713425|NCT00202657|heart valve disease|heart valve disease
713426|NCT00202631|tetraplegia|tetraplegia
713427|NCT00202631|quadriplegia|quadriplegia
713428|NCT00202631|spinal cord injury|spinal cord injury
713429|NCT00202631|functional electrical stimulation|functional electrical stimulation
713430|NCT00202631|abdominal stimulation|abdominal stimulation
713431|NCT00202618|Hypertension|hypertension
713432|NCT00202618|Type 2 diabetes mellitus|type 2 diabetes mellitus
713433|NCT00202618|Microalbuminuria|microalbuminuria
713434|NCT00202618|Amlodipine|amlodipine
713435|NCT00202618|Calcium channel blocker|calcium channel blocker
713436|NCT00202618|Valsartan|valsartan
713437|NCT00202618|Angiotensin type 2 receptor blocker|angiotensin type 2 receptor blocker
713438|NCT00202527|Sleep apnea|sleep apnea
713439|NCT00202527|Hypertension|hypertension
713440|NCT00202527|CPAP|cpap
713441|NCT00202514|alcoholism|alcoholism
713442|NCT00202514|alcohol related disorders|alcohol related disorders
713443|NCT00202514|mood disorders|mood disorders
713444|NCT00202514|anticonvulsants|anticonvulsants
713445|NCT00202514|divalproex sodium|divalproex sodium
713446|NCT00202488|anemia, iron-deficiency|anemia, iron-deficiency
713447|NCT00202488|Helicobacter pylori|helicobacter pylori
713448|NCT00202475|Dubble eerythrocytapheresis|dubble eerythrocytapheresis
713449|NCT00202462|testosterone|testosterone
713450|NCT00202462|depression|depression
713451|NCT00202462|subsyndromal depression|subsyndromal depression
713452|NCT00202462|quality of life|quality of life
713453|NCT00202449|Prazosin|prazosin
713454|NCT00202449|Paroxetine|paroxetine
713455|NCT00202449|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
713456|NCT00202449|Sleep Disorders|sleep disorders
713457|NCT00202423|Multiple sclerosis|multiple sclerosis
713458|NCT00202423|Cannabinoids|cannabinoids
713459|NCT00202423|Spasticity|spasticity
713460|NCT00202423|fMRI|fmri
713461|NCT00202423|TMS|tms
713462|NCT00202410|Multiple Sclerosis|multiple sclerosis
713463|NCT00202410|Tuberculosis vaccine|tuberculosis vaccine
713464|NCT00202410|Therapy|therapy
713465|NCT00202397|cerebellar ataxia|cerebellar ataxia
713466|NCT00202397|deep cerebellar nuclei (DCN)|deep cerebellar nuclei (dcn)
713467|NCT00202397|small-conductance calcium-activated potassium(SK)channels|small-conductance calcium-activated potassium(sk)channels
713468|NCT00202397|riluzole|riluzole
713469|NCT00202397|Sporadic ataxia|sporadic ataxia
713470|NCT00202397|Multiple system atrophy type C|multiple system atrophy type c
713471|NCT00202384|Multiple Sclerosis|multiple sclerosis
713472|NCT00202384|microarrays|microarrays
713473|NCT00202371|MDS, Fatigue, RBC transfusion|mds, fatigue, rbc transfusion
713474|NCT00202358|perioperative|perioperative
713475|NCT00202358|beta-blockers|beta-blockers
713476|NCT00202358|inflammation|inflammation
713477|NCT00202358|outcomes|outcomes
713478|NCT00202345|Creatinine Clearance|creatinine clearance
713479|NCT00202345|Hemoglobin|hemoglobin
713480|NCT00202345|Iron sucrose|iron sucrose
713481|NCT00202345|Oral iron therapy|oral iron therapy
713482|NCT00202345|Ferritin|ferritin
713483|NCT00202345|Transferrin saturation|transferrin saturation
713484|NCT00202345|Iron|iron
713485|NCT00202319|sedation|sedation
713486|NCT00202319|mechanical ventilation|mechanical ventilation
713487|NCT00202319|sedation protocols|sedation protocols
713488|NCT00202319|critical care|critical care
713489|NCT00202319|intensive care outcomes|intensive care outcomes
713490|NCT00202319|staffing|staffing
713491|NCT00202306|at risk mental state|at risk mental state
713492|NCT00202306|prodrome|prodrome
713493|NCT00202306|ultra high risk|ultra high risk
713494|NCT00202306|first episode psychosis|first episode psychosis
713495|NCT00202306|schizophrenia|schizophrenia
713496|NCT00202306|bipolar disorder|bipolar disorder
713497|NCT00202293|Bipolar|bipolar
713498|NCT00202293|Mania|mania
713499|NCT00202293|Drug treatment|drug treatment
713500|NCT00202293|First episode|first episode
713501|NCT00202293|Psychosis|psychosis
713502|NCT00202293|Therapy|therapy
713503|NCT00202293|Antipsychotic|antipsychotic
713504|NCT00202267|leg ulcer, compression, bandage, APBI, venous insufficiency|leg ulcer, compression, bandage, apbi, venous insufficiency
713505|NCT00202254|Mulitple Sclerosis|mulitple sclerosis
713506|NCT00202254|MS|ms
713507|NCT00202241|HIV|hiv
713508|NCT00202241|AIDS|aids
713509|NCT00202241|testosterone|testosterone
713510|NCT00202241|anabolic steroid|anabolic steroid
713511|NCT00202241|body composition|body composition
713512|NCT00202241|lipodystrophy|lipodystrophy
713513|NCT00202241|MRI|mri
713514|NCT00202241|BIA|bia
713515|NCT00202241|skinfold measurements|skinfold measurements
713516|NCT00202241|protease inhibitors|protease inhibitors
713517|NCT00202228|HIV|hiv
713518|NCT00202228|HIV/AIDS|hiv/aids
713519|NCT00202228|Lactic Acidosis|lactic acidosis
713520|NCT00202228|Supplementation|supplementation
713521|NCT00202228|Lactate Clearance|lactate clearance
713522|NCT00202228|Mitochondrial Toxicity|mitochondrial toxicity
713523|NCT00202228|HAART|haart
713524|NCT00202215|Day hospital treatment|day hospital treatment
713525|NCT00202202|personality disorder|personality disorder
713526|NCT00202202|user satisfaction|user satisfaction
713527|NCT00202189|COPD|copd
713528|NCT00202189|Pulmicort|pulmicort
713529|NCT00202189|Budesonide|budesonide
713530|NCT00202189|Chronic|chronic
713531|NCT00202189|Obstructive|obstructive
713532|NCT00202189|Pulmonary|pulmonary
713533|NCT00202189|Disease|disease
713534|NCT00202189|Exercise|exercise
713535|NCT00202189|Emphysema|emphysema
713536|NCT00202176|Chronic|chronic
713537|NCT00202176|Obstructive|obstructive
713538|NCT00202176|Pulmonary|pulmonary
713539|NCT00202176|Disease|disease
713540|NCT00202176|COPD|copd
713541|NCT00202176|Atrovent|atrovent
713542|NCT00202176|Ipratropium|ipratropium
713543|NCT00202176|Bromide|bromide
713544|NCT00202176|Exercise|exercise
713545|NCT00202176|Dyspnea|dyspnea
713546|NCT00202163|ED|ed
713547|NCT00202163|DHEA|dhea
713548|NCT00202163|testosterone|testosterone
713549|NCT00202150|Advanced chronic diseases|advanced chronic diseases
713550|NCT00202150|Heart failure|heart failure
713551|NCT00202150|Chronic obstructive lung disease|chronic obstructive lung disease
713552|NCT00202150|primary care|primary care
713553|NCT00202150|Chronic Care|chronic care
713554|NCT00202137|Home Blood Pressure, Hypertension, Blood Pressure Control|home blood pressure, hypertension, blood pressure control
713555|NCT00202111|Clinical Trial|clinical trial
713556|NCT00202111|Colonic Neoplasms|colonic neoplasms
713557|NCT00202111|Laparoscopic Surgery|laparoscopic surgery
713558|NCT00202111|Morbidity|morbidity
713559|NCT00202111|Port Site Metastasis|port site metastasis
713560|NCT00202111|Disease-Free Survival|disease-free survival
713561|NCT00202098|ARDS|ards
713562|NCT00202098|mechanical ventilation|mechanical ventilation
713563|NCT00202098|variable ventilation|variable ventilation
713564|NCT00202098|chaotic ventilation|chaotic ventilation
713565|NCT00202072|lung|lung
713566|NCT00202072|airway|airway
713567|NCT00202072|pulmonary exacerbation|pulmonary exacerbation
713568|NCT00202072|mucus|mucus
713569|NCT00202059|Breast cancer|breast cancer
713570|NCT00202059|Bone mineral density|bone mineral density
713571|NCT00202059|Chemotherapy|chemotherapy
713572|NCT00202046|Breast cancer|breast cancer
713573|NCT00202046|Lymphedema|lymphedema
713574|NCT00202046|Quality of life|quality of life
713575|NCT00202033|referred to|referred to
713576|NCT00202033|comprehensive|comprehensive
713577|NCT00202033|diabetes|diabetes
713578|NCT00202033|education|education
713579|NCT00202033|program|program
713580|NCT00202020|Cerebral infarction|cerebral infarction
713581|NCT00202020|Prevention|prevention
713582|NCT00202020|Cilostazol|cilostazol
713583|NCT00202020|Aspirin|aspirin
713584|NCT00202020|Stroke|stroke
713585|NCT00202020|Clinical trial|clinical trial
713586|NCT00202007|Aripiprazole|aripiprazole
713587|NCT00202007|Schizophrenia|schizophrenia
713588|NCT00202007|Clinical trial|clinical trial
713589|NCT00202007|Risperidone|risperidone
713590|NCT00201994|Sodium|sodium
713591|NCT00201994|SIADH|siadh
713592|NCT00201994|Vasopressin|vasopressin
713593|NCT00201994|CHF|chf
713594|NCT00201994|Cirrhosis|cirrhosis
713595|NCT00201994|salt|salt
713596|NCT00201994|water|water
713597|NCT00201994|electrolyte|electrolyte
713598|NCT00201981|dry eye|dry eye
713599|NCT00201981|keratoconjunctivitis sicca|keratoconjunctivitis sicca
713600|NCT00201955|dry eye|dry eye
713601|NCT00201955|keratoconjunctivitis sicca|keratoconjunctivitis sicca
713602|NCT00201942|Breast Cancer|breast cancer
713603|NCT00201942|Diagnosis|diagnosis
713604|NCT00201942|PET|pet
713605|NCT00201942|Positronic Emission Tomography|positronic emission tomography
713606|NCT00201942|fluorodeoxyglucose|fluorodeoxyglucose
713607|NCT00201929|breast cancer|breast cancer
713608|NCT00201929|decision aid|decision aid
713609|NCT00201929|Decision Board|decision board
713610|NCT00201929|information transfer|information transfer
713611|NCT00201916|prostate cancer|prostate cancer
713612|NCT00201916|prostate specific antigen|prostate specific antigen
713613|NCT00201916|PSA|psa
713614|NCT00201916|radiation fractionation|radiation fractionation
713615|NCT00201903|venous thromboembolism|venous thromboembolism
713616|NCT00201903|brain tumours|brain tumours
713617|NCT00201903|glioma|glioma
713618|NCT00201903|tissue factor|tissue factor
713619|NCT00201903|blood coagulation|blood coagulation
713620|NCT00201903|tumour progression|tumour progression
713621|NCT00201903|low molecular weight heparin|low molecular weight heparin
713622|NCT00201890|Breast Cancer|breast cancer
713623|NCT00201890|Lymphedema|lymphedema
713624|NCT00201890|Treatment|treatment
713625|NCT00201890|Massage|massage
713626|NCT00201890|Randomized|randomized
713627|NCT00201890|DLT therapy|dlt therapy
713628|NCT00201890|Quality of Life|quality of life
713629|NCT00201890|Decongestive Therapy|decongestive therapy
713630|NCT00201890|Breast Cancer related Lymphedema|breast cancer related lymphedema
713631|NCT00201877|Relapsed/Refractory|relapsed/refractory
713632|NCT00201877|NHL|nhl
713633|NCT00201877|Follicular|follicular
713634|NCT00201877|Mantle Cell|mantle cell
713635|NCT00201877|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
713636|NCT00201864|Postmenopausal|postmenopausal
713637|NCT00201864|Women|women
713638|NCT00201851|Asian|asian
713639|NCT00201851|Premenopausal|premenopausal
713640|NCT00201851|Women|women
713641|NCT00201851|Oophorectomy|oophorectomy
713642|NCT00201838|Advanced Stage|advanced stage
713643|NCT00201838|Chemotherapy Naive|chemotherapy naive
713644|NCT00201825|Previously Untreated|previously untreated
713645|NCT00201825|Advanced|advanced
713646|NCT00201812|Advanced Solid Tumors|advanced solid tumors
713647|NCT00201799|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
713648|NCT00201786|Corticosteroids|corticosteroids
713649|NCT00201773|Post-Menopause|post-menopause
713650|NCT00201773|Neoadjuvant Therapy|neoadjuvant therapy
713651|NCT00201760|metastatic|metastatic
713652|NCT00201747|Advanced|advanced
713653|NCT00201734|Adenocarcinoma|adenocarcinoma
713654|NCT00201721|Previously Untreated|previously untreated
713655|NCT00201708|Adjuvant Trial|adjuvant trial
713656|NCT00201708|Dose-Dense|dose-dense
713657|NCT00201708|Axillary Node-Positive|axillary node-positive
713658|NCT00201695|Untreated Patients|untreated patients
713659|NCT00201695|Symptomatic|symptomatic
713660|NCT00201682|Leukemia|leukemia
713661|NCT00201682|Lymphoma|lymphoma
713662|NCT00201669|Aggressive|aggressive
713663|NCT00201669|Clofarabine|clofarabine
713664|NCT00201656|PPROM|pprom
713665|NCT00201656|Cerclage|cerclage
713666|NCT00201656|Preterm Premature Rupture of the Membranes with Cerclage|preterm premature rupture of the membranes with cerclage
713667|NCT00201643|Preterm Labor|preterm labor
713668|NCT00201643|Preterm delivery|preterm delivery
713669|NCT00201630|Prostate|prostate
713670|NCT00201630|cancer|cancer
713671|NCT00201630|Brachytherapy|brachytherapy
713672|NCT00201630|Alpha Blocker|alpha blocker
713673|NCT00201617|Unilateral hearing loss|unilateral hearing loss
713674|NCT00201617|Unilateral deafness|unilateral deafness
713675|NCT00201617|Bone anchored hearing aid|bone anchored hearing aid
713676|NCT00201591|Coronary artery disease|coronary artery disease
713677|NCT00201591|Exercise training|exercise training
713678|NCT00201591|Intensity|intensity
713679|NCT00201591|Randomized|randomized
713680|NCT00201591|echocardiography|echocardiography
713681|NCT00201591|Aerobic Exercise|aerobic exercise
713682|NCT00201578|Herbal Drugs|herbal drugs
713683|NCT00201578|Alternative medicine|alternative medicine
713684|NCT00201565|pulse wave velocity|pulse wave velocity
713685|NCT00201565|cardiovascular disease|cardiovascular disease
713686|NCT00201539|analgesics, opioid/pharmacokinetics|analgesics, opioid/pharmacokinetics
713687|NCT00201539|humans|humans
713688|NCT00201539|morphine/therapeutic use*|morphine/therapeutic use*
713689|NCT00201539|neoplasms|neoplasms
713690|NCT00201539|pain/drugtherapy|pain/drugtherapy
713691|NCT00201526|Bipolar Disorder|bipolar disorder
713692|NCT00201513|Muscle, Skeletal|muscle, skeletal
713693|NCT00201513|Neuromuscular control|neuromuscular control
713694|NCT00201513|Stability|stability
713695|NCT00201513|Exercise|exercise
713696|NCT00201513|Anticipatory muscle control|anticipatory muscle control
713697|NCT00201474|brief depressive episodes|brief depressive episodes
713698|NCT00201474|affective disorders|affective disorders
713699|NCT00201474|EEG and QEEG|eeg and qeeg
713700|NCT00201474|epilepsy|epilepsy
713701|NCT00201474|organic brain disorders|organic brain disorders
713702|NCT00201474|acute psychiatry|acute psychiatry
713703|NCT00201461|Patent Foramen Ovale|patent foramen ovale
713704|NCT00201461|STARFlex|starflex
713705|NCT00201461|CLOSURE I|closure i
713706|NCT00201461|Septal Closure System|septal closure system
713707|NCT00201461|Stroke|stroke
713708|NCT00201461|Cerebrovascular Accident|cerebrovascular accident
713709|NCT00201461|Transient Ischemic Attack|transient ischemic attack
713710|NCT00201461|Heart Septal Defects, Atrial|heart septal defects, atrial
713711|NCT00201448|CMV, cytomegalovirus, vaccine, Towne strain|cmv, cytomegalovirus, vaccine, towne strain
713712|NCT00201435|Breast|breast
713713|NCT00201435|Cancer|cancer
713714|NCT00201435|Paclitaxel|paclitaxel
713715|NCT00201435|Docetaxel|docetaxel
713716|NCT00201435|Qulaity of life|qulaity of life
713717|NCT00201422|MALT lymphoma|malt lymphoma
713718|NCT00201422|diffuse large B-cell lymphoma,|diffuse large b-cell lymphoma,
713719|NCT00201422|stomach|stomach
713720|NCT00201422|Helicobacter pylori|helicobacter pylori
713721|NCT00201422|antibiotic therapy|antibiotic therapy
713722|NCT00201396|A Multicenter Phase III Trial|a multicenter phase iii trial
713723|NCT00201396|Induction Chemotherapy|induction chemotherapy
713724|NCT00201396|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
713725|NCT00201396|Stage IV Nasopharyngeal Carcinoma (NPC)|stage iv nasopharyngeal carcinoma (npc)
713726|NCT00201396|randomization|randomization
713727|NCT00201396|disease-free survival|disease-free survival
713728|NCT00201370|cervical neoplasia;|cervical neoplasia;
713729|NCT00201370|human papillomavirus,|human papillomavirus,
713730|NCT00201370|PCR,|pcr,
713731|NCT00201370|risk factors,|risk factors,
713732|NCT00201370|Taiwan|taiwan
713733|NCT00201357|hormone-refractory prostate cancer|hormone-refractory prostate cancer
713734|NCT00201357|thalidomide|thalidomide
713735|NCT00201357|quality of life|quality of life
713736|NCT00201344|Radiotherapy|radiotherapy
713737|NCT00201344|Adjuvant chemotherapy|adjuvant chemotherapy
713738|NCT00201344|Chemtherapy|chemtherapy
713739|NCT00201344|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
713740|NCT00201292|Metabolic syndrome|metabolic syndrome
713741|NCT00201292|Diabetes|diabetes
713742|NCT00201292|Insulin resistance|insulin resistance
713743|NCT00201292|pharmacogenetics|pharmacogenetics
713744|NCT00201201|Older Adults|older adults
713745|NCT00201201|Primary Care|primary care
713746|NCT00201201|Hypertension|hypertension
713747|NCT00201201|Adherence|adherence
713748|NCT00201136|Behavioral intervention|behavioral intervention
713749|NCT00201136|Lifestyle modification|lifestyle modification
713750|NCT00201136|Guidelines|guidelines
713751|NCT00201110|African Americans|african americans
713752|NCT00201058|urban|urban
713753|NCT00201058|adolescents|adolescents
713754|NCT00201058|African American|african american
713755|NCT00201058|web-based|web-based
713756|NCT00201058|computer tailoring|computer tailoring
713757|NCT00201058|school based|school based
713758|NCT00201045|Hypertension management|hypertension management
713759|NCT00201045|Pharmacist management|pharmacist management
713760|NCT00201045|Physician pharmacist collaboration|physician pharmacist collaboration
713761|NCT00201045|Blood pressure control|blood pressure control
713762|NCT00200954|prospective|prospective
713763|NCT00200954|intervention|intervention
713764|NCT00200954|randomised|randomised
713765|NCT00200954|probiotics|probiotics
713766|NCT00200954|atopy|atopy
713767|NCT00200941|Restless Legs Syndrome|restless legs syndrome
713768|NCT00200941|Topiramate|topiramate
713769|NCT00200941|Actigraphy|actigraphy
713770|NCT00200941|Polysomnography|polysomnography
713771|NCT00200928|prospective|prospective
713772|NCT00200928|randomised|randomised
713773|NCT00200928|intervention|intervention
713775|NCT00200928|atopy|atopy
713776|NCT00200902|Major depressive disorder|major depressive disorder
713777|NCT00200902|MDD|mdd
713778|NCT00200902|Antidepressant|antidepressant
713779|NCT00200889|Acupuncture|acupuncture
713780|NCT00200889|Magnetic Resonance Imaging, Functional|magnetic resonance imaging, functional
713781|NCT00200889|Brain Mapping|brain mapping
713782|NCT00200889|healthy volunteers|healthy volunteers
713783|NCT00200889|Neuromodulation|neuromodulation
713784|NCT00200876|Positron-Emission Tomography|positron-emission tomography
713785|NCT00200876|Endorphins|endorphins
713786|NCT00200876|Pain Relief|pain relief
713787|NCT00200876|Opioid Receptors|opioid receptors
713788|NCT00200876|Stress|stress
713789|NCT00200876|Analgesia|analgesia
713790|NCT00200863|light|light
713791|NCT00200863|wavelength|wavelength
713792|NCT00200863|action spectrum|action spectrum
713793|NCT00200863|circadian|circadian
713794|NCT00200863|melatonin|melatonin
713795|NCT00200863|alertness|alertness
713796|NCT00200863|performance|performance
713797|NCT00200863|arousal|arousal
713798|NCT00200850|Breathing|breathing
713799|NCT00200850|Allergy|allergy
713800|NCT00200850|Mites, House Dust|mites, house dust
713801|NCT00200837|oral mucosal pain|oral mucosal pain
713802|NCT00200837|oral inflammations|oral inflammations
713803|NCT00200837|anisillo|anisillo
713804|NCT00200837|cordonsillo|cordonsillo
713805|NCT00200837|Piperaceae|piperaceae
713806|NCT00200837|oral ulcers|oral ulcers
713807|NCT00200837|oral tumors|oral tumors
713808|NCT00200837|mucosal pain|mucosal pain
713809|NCT00200837|mucosal inflammations|mucosal inflammations
713810|NCT00200837|cordoncillo|cordoncillo
713811|NCT00200824|isoflavones|isoflavones
713812|NCT00200824|soy|soy
713813|NCT00200824|postmenopausal|postmenopausal
713814|NCT00200824|men|men
713815|NCT00200824|prostate|prostate
713816|NCT00200824|breast|breast
713817|NCT00200824|bone|bone
713818|NCT00200798|Milk Thistle|milk thistle
713819|NCT00200798|Silymarin|silymarin
713820|NCT00200798|pharmacokinetics|pharmacokinetics
713821|NCT00200798|drug interactions|drug interactions
713822|NCT00200798|Normal volunteers|normal volunteers
713823|NCT00200785|garlic|garlic
713824|NCT00200759|Vaccinium macrocarpon|vaccinium macrocarpon
713825|NCT00200759|Antioxidants|antioxidants
713826|NCT00200759|Drug Interactions|drug interactions
713827|NCT00200746|Hepatitis|hepatitis
713828|NCT00200746|Liver Diseases|liver diseases
713829|NCT00200746|Alcoholism|alcoholism
713830|NCT00200746|Arginine|arginine
713831|NCT00200733|acupuncture|acupuncture
713832|NCT00200733|patient narratives|patient narratives
713833|NCT00200733|qualitative methods|qualitative methods
713834|NCT00200720|Diet|diet
713835|NCT00200720|Carbohydrates|carbohydrates
713836|NCT00200720|Weight Loss|weight loss
713837|NCT00200707|Cell therapy|cell therapy
713838|NCT00200707|bone marrow mononuclear cells|bone marrow mononuclear cells
713839|NCT00200707|myocardial infarction|myocardial infarction
713840|NCT00200694|Proteinuria|proteinuria
713841|NCT00200694|ACEI|acei
713842|NCT00200694|ARB|arb
713843|NCT00200694|diuretics|diuretics
713844|NCT00200694|blood pressure|blood pressure
713845|NCT00200694|renal failure|renal failure
713846|NCT00200681|Secretory Multiple Myeloma|secretory multiple myeloma
713847|NCT00200681|First line treatment|first line treatment
713848|NCT00200681|Velcade®|velcade®
713849|NCT00200681|autograft|autograft
713850|NCT00200681|Newly diagnosed secretory Multiple Myeloma (MM)|newly diagnosed secretory multiple myeloma (mm)
713851|NCT00200642|Gastroesophageal reflux. PPI. Radiofrequency|gastroesophageal reflux. ppi. radiofrequency
713852|NCT00200629|Women|women
713853|NCT00200629|Diagnostic Testing|diagnostic testing
713854|NCT00200629|Radionuclide Imaging|radionuclide imaging
713855|NCT00200629|Stress Testing|stress testing
713856|NCT00200629|Adenosine|adenosine
713857|NCT00200616|Urinary tract infection|urinary tract infection
713858|NCT00200616|Vesico-renal reflux|vesico-renal reflux
713859|NCT00200616|Child|child
713860|NCT00200616|Antimicrobial prophylaxis|antimicrobial prophylaxis
713861|NCT00200616|Recurrence of urinary tract infection|recurrence of urinary tract infection
713862|NCT00200603|Calcium phosphate ceramic|calcium phosphate ceramic
713863|NCT00200603|tibial osteotomy|tibial osteotomy
713864|NCT00200603|osteoarthritis|osteoarthritis
713865|NCT00200590|prostaglandin|prostaglandin
713866|NCT00200590|analgesia|analgesia
713867|NCT00200590|congenital|congenital
713868|NCT00200590|heart|heart
713869|NCT00200590|defect|defect
713870|NCT00200590|induced|induced
713871|NCT00200577|Adjuvant therapy|adjuvant therapy
713872|NCT00200577|immunotherapy|immunotherapy
713873|NCT00200577|TIL|til
713874|NCT00200577|melanoma|melanoma
713875|NCT00200564|Pediatrics|pediatrics
713876|NCT00200564|ketamine|ketamine
713877|NCT00200564|postoperative analgesia|postoperative analgesia
713878|NCT00200564|nalbuphine|nalbuphine
713879|NCT00200564|Postoperative analgesia in children|postoperative analgesia in children
713880|NCT00200538|frontotemporal dementia|frontotemporal dementia
713882|NCT00200538|Patients with frontotemporal dementia|patients with frontotemporal dementia
713883|NCT00200499|Nebivolol|nebivolol
713884|NCT00200499|Hypertension|hypertension
713885|NCT00200499|Beta-Blocker|beta-blocker
713886|NCT00200486|genetic microarray|genetic microarray
713887|NCT00200486|head and neck cancer|head and neck cancer
713888|NCT00200473|Nebivolol|nebivolol
713889|NCT00200473|Hypertension|hypertension
713890|NCT00200473|Beta-Blockers|beta-blockers
713891|NCT00200460|Nebivolol|nebivolol
713892|NCT00200460|Hypertension|hypertension
713893|NCT00200460|Beta-Blocker|beta-blocker
713894|NCT00200447|Parkinson|parkinson
713895|NCT00200447|brain imaging|brain imaging
713896|NCT00200434|Nebivolol|nebivolol
713897|NCT00200434|Beta-Blocker|beta-blocker
713898|NCT00200434|Hypertension|hypertension
713899|NCT00200421|Nebivolol|nebivolol
713900|NCT00200421|Atenolol|atenolol
713901|NCT00200421|Exercise|exercise
713902|NCT00200421|Hypertension|hypertension
713903|NCT00200408|cancer of head and neck|cancer of head and neck
713904|NCT00200408|smoking|smoking
713905|NCT00200369|HIV|hiv
713906|NCT00200369|Adherence|adherence
713907|NCT00200369|Antiretroviral therapy|antiretroviral therapy
713908|NCT00200369|Protease inhibitor|protease inhibitor
713909|NCT00200369|Lopinavir|lopinavir
713910|NCT00200343|Chronic hepatitis C, Ursodeoxycholic acid|chronic hepatitis c, ursodeoxycholic acid
713911|NCT00200330|weight loss|weight loss
713912|NCT00200330|physical activity|physical activity
713913|NCT00200330|diet|diet
713914|NCT00200330|home environment|home environment
713915|NCT00200317|Exercise|exercise
713916|NCT00200317|Internet|internet
713917|NCT00200317|Print|print
713918|NCT00200317|Randomized Controlled Trial|randomized controlled trial
713919|NCT00200317|Exercise Intervention|exercise intervention
713920|NCT00200304|Obesity|obesity
713921|NCT00200304|Weight loss|weight loss
713922|NCT00200304|Internet|internet
713923|NCT00200278|Exercise|exercise
713924|NCT00200278|Intervention studies|intervention studies
713925|NCT00200278|Decision-making|decision-making
713926|NCT00200278|computer assisted Expert systems|computer assisted expert systems
713927|NCT00200278|telephone|telephone
713928|NCT00200252|oxytocin|oxytocin
713929|NCT00200252|third stage|third stage
713930|NCT00200252|dose|dose
713931|NCT00200252|route|route
713932|NCT00200252|blood loss|blood loss
713933|NCT00200226|pain/discomfort|pain/discomfort
713934|NCT00200226|cervical dilatation|cervical dilatation
713935|NCT00200226|side effects|side effects
713936|NCT00200200|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
713937|NCT00200200|DEXAMETHASONE|dexamethasone
713938|NCT00200200|FLOXURIDINE|floxuridine
713939|NCT00200200|FLUOROURACIL|fluorouracil
713940|NCT00200200|IRINOTECAN (CPT-11) CAMPTOSAR|irinotecan (cpt-11) camptosar
713941|NCT00200200|LEUCOVORIN|leucovorin
713942|NCT00200200|OXALIPLATIN|oxaliplatin
713943|NCT00200200|Colon|colon
713944|NCT00200200|Rectal|rectal
713945|NCT00200200|04-086|04-086
713946|NCT00200200|Adjuvant postoperative chemo for CLM|adjuvant postoperative chemo for clm
713947|NCT00200187|Prostatectomy|prostatectomy
713948|NCT00200187|Anesthesia|anesthesia
713949|NCT00200187|Blood Loss|blood loss
713950|NCT00200174|Breast cancer|breast cancer
713951|NCT00200174|estrogen|estrogen
713952|NCT00200174|postmenopausal|postmenopausal
713953|NCT00200148|Pancreaticoduodenectomy|pancreaticoduodenectomy
713954|NCT00200148|Hepatectomy|hepatectomy
713955|NCT00200148|Major Hepatic resection|major hepatic resection
713956|NCT00200148|Acute Normovolemic Hemodilution|acute normovolemic hemodilution
713957|NCT00200135|motorcycle accident|motorcycle accident
713958|NCT00200135|helmet|helmet
713959|NCT00200135|traumatic brain injury|traumatic brain injury
713960|NCT00200135|financial burden|financial burden
713961|NCT00200096|Cancer|cancer
713962|NCT00200096|Fatigue|fatigue
713963|NCT00200083|Obesity|obesity
713964|NCT00200083|Morbid Obesity|morbid obesity
713965|NCT00200083|SHAPE|shape
713966|NCT00200083|IGS|igs
713967|NCT00200083|Implantable Gastric Stimulator|implantable gastric stimulator
713968|NCT00200070|Angina Pectoris Pain|angina pectoris pain
713969|NCT00200057|Fecal Incontinence|fecal incontinence
713970|NCT00200057|InterStim|interstim
713971|NCT00200044|GERD|gerd
713972|NCT00200018|Obesity|obesity
713973|NCT00200018|Morbid obesity|morbid obesity
713974|NCT00200018|Diabetes|diabetes
713975|NCT00200005|Slow transit constipation|slow transit constipation
713976|NCT00200005|Fecal incontinence|fecal incontinence
713977|NCT00200005|Constipation|constipation
713978|NCT00200005|Idiopathic slow transit constipation|idiopathic slow transit constipation
713979|NCT00200005|Chronic constipation|chronic constipation
713980|NCT00199992|acute wounds|acute wounds
713981|NCT00199992|wounds|wounds
713982|NCT00199992|platelets|platelets
713983|NCT00199992|platelet gel|platelet gel
713984|NCT00199979|Antiretroviral Therapy|antiretroviral therapy
713985|NCT00199979|Nevirapine|nevirapine
713986|NCT00199979|HIV Viral Load|hiv viral load
713987|NCT00199979|Adherence|adherence
713988|NCT00199979|Quality of Life|quality of life
713989|NCT00199979|Resistance Mutations|resistance mutations
713990|NCT00199966|Bipolar Disorder; Pediatric Bipolar Disorder; Depakote ER|bipolar disorder; pediatric bipolar disorder; depakote er
713991|NCT00199953|Postnasal drainage|postnasal drainage
713992|NCT00199953|Extraesophageal reflux|extraesophageal reflux
713993|NCT00199940|Schizophrenia|schizophrenia
713994|NCT00199940|Pediatric psychotic disorders|pediatric psychotic disorders
713995|NCT00199940|Ziprasidone|ziprasidone
713996|NCT00199914|Diathermy|diathermy
713997|NCT00199914|Short-wave therapy|short-wave therapy
713998|NCT00199914|Osteoarthritis|osteoarthritis
713999|NCT00199914|Knee|knee
714000|NCT00199901|Phase II|phase ii
714001|NCT00199901|Randomized Controlled Trial|randomized controlled trial
714002|NCT00199901|Double-Blind|double-blind
714003|NCT00199901|Cancer Vaccine|cancer vaccine
714004|NCT00199901|NY-ESO-1 protein, human|ny-eso-1 protein, human
714005|NCT00199901|ISCOMATRIX, immunological adjuvant|iscomatrix, immunological adjuvant
714006|NCT00199888|Kidney Cancer|kidney cancer
714007|NCT00199888|Renal Cancer|renal cancer
714008|NCT00199888|Neoplasms, Kidney|neoplasms, kidney
714009|NCT00199888|cG250|cg250
714010|NCT00199888|antibody|antibody
714011|NCT00199888|Iodine 124|iodine 124
714012|NCT00199875|antibody|antibody
714013|NCT00199875|renal cell carcinoma|renal cell carcinoma
714014|NCT00199875|advanced renal cancer|advanced renal cancer
714015|NCT00199875|cG250|cg250
714016|NCT00199875|90Y|90y
714017|NCT00199862|huA33|hua33
714018|NCT00199862|antibody|antibody
714019|NCT00199862|colorectal cancer|colorectal cancer
714020|NCT00199862|Iodine 124|iodine 124
714021|NCT00199862|124I|124i
714022|NCT00199862|03-124|03-124
714023|NCT00199849|NY-ESO-1|ny-eso-1
714024|NCT00199849|DNA|dna
714025|NCT00199836|cancer vaccine|cancer vaccine
714026|NCT00199836|NY-ESO-1b peptide|ny-eso-1b peptide
714027|NCT00199836|CpG 7909|cpg 7909
714028|NCT00199836|Montanide ISA-51|montanide isa-51
714029|NCT00199836|LAGE-1|lage-1
714030|NCT00199836|immune response|immune response
714031|NCT00199836|safety|safety
714032|NCT00199823|Myocardial infarction|myocardial infarction
714033|NCT00199823|bone marrow cells|bone marrow cells
714034|NCT00199823|cell transplantation|cell transplantation
714035|NCT00199810|Cardiac output|cardiac output
714036|NCT00199810|Preeclamptic women|preeclamptic women
714037|NCT00199810|systemic vascular resistance|systemic vascular resistance
714038|NCT00199810|blood pressure|blood pressure
714039|NCT00199797|Colorectal Cancer|colorectal cancer
714040|NCT00199797|huA33|hua33
714041|NCT00199797|antibody|antibody
714042|NCT00199797|chemotherapy|chemotherapy
714043|NCT00199784|Hemodynamic|hemodynamic
714044|NCT00199784|Hypotension|hypotension
714045|NCT00199784|Spinal|spinal
714046|NCT00199784|Anesthesia|anesthesia
714047|NCT00199784|Healthy pregnant women for elective cesarean section|healthy pregnant women for elective cesarean section
714048|NCT00199771|Cardiac Surgery|cardiac surgery
714049|NCT00199771|Infant|infant
714050|NCT00199771|Infant, Newborn|infant, newborn
714051|NCT00199771|Hypertonic Solutions|hypertonic solutions
714052|NCT00199771|Saline Solution, Hypertonic|saline solution, hypertonic
714053|NCT00199771|Capillary leak|capillary leak
714054|NCT00199771|Inflammation Mediators|inflammation mediators
714055|NCT00199758|Non small cell lung carcinoma|non small cell lung carcinoma
714056|NCT00199758|Cisplatin|cisplatin
714057|NCT00199758|Gemcitabine|gemcitabine
714058|NCT00199758|Paclitaxel|paclitaxel
714059|NCT00199745|statin|statin
714060|NCT00199745|statins|statins
714061|NCT00199745|statin therapy|statin therapy
714062|NCT00199745|adverse events|adverse events
714063|NCT00199745|side effect|side effect
714064|NCT00199745|Myotoxicity|myotoxicity
714065|NCT00199745|atorvastatin|atorvastatin
714066|NCT00199745|Atorvastatin Therapy|atorvastatin therapy
714067|NCT00199732|Chronic hepatitis B|chronic hepatitis b
714068|NCT00199732|CCC DNA kinetics|ccc dna kinetics
714069|NCT00199732|Total HBV DNA kinetics|total hbv dna kinetics
714070|NCT00199732|Adefovir-Dipovixil|adefovir-dipovixil
714071|NCT00199732|Peg interferon alpha 2a|peg interferon alpha 2a
714072|NCT00199719|drug monitoring|drug monitoring
714073|NCT00199719|ribavirin-pharmacokinetic|ribavirin-pharmacokinetic
714074|NCT00199719|pharmacodynamics|pharmacodynamics
714075|NCT00199719|chronic hepatitis C|chronic hepatitis c
714076|NCT00199719|non 2 non 3 genotype|non 2 non 3 genotype
714077|NCT00199706|Intracranial Pressure|intracranial pressure
714078|NCT00199706|Intracranial Hypertension|intracranial hypertension
714079|NCT00199706|Hypertonic Solutions|hypertonic solutions
714080|NCT00199706|Saline Solutions, Hypertonic|saline solutions, hypertonic
714081|NCT00199693|Hemodynamic and respiratory changes and pregnancy|hemodynamic and respiratory changes and pregnancy
714082|NCT00199693|Healthy pregnant women|healthy pregnant women
714083|NCT00199680|PETscan, cervical cancer|petscan, cervical cancer
714084|NCT00199667|MMF, Monitoring, area under curve (AUC), kidney transplantation|mmf, monitoring, area under curve (auc), kidney transplantation
714085|NCT00199654|colorectal cancer stage II and III|colorectal cancer stage ii and iii
714288|NCT00198679|Skin Flora|skin flora
714086|NCT00199628|fetomaternal tissular alloimmunization|fetomaternal tissular alloimmunization
714087|NCT00199628|Mothers having a child suffering from:|mothers having a child suffering from:
714088|NCT00199628|neonatal membranous glomerulonephritis|neonatal membranous glomerulonephritis
714089|NCT00199628|unexplained neonatal tubular defect|unexplained neonatal tubular defect
714090|NCT00199628|unexplained thrombotic microangiopathy|unexplained thrombotic microangiopathy
714091|NCT00199628|neonatal hemochromatosis|neonatal hemochromatosis
714092|NCT00199615|lung cancer, 18 FDG, PET|lung cancer, 18 fdg, pet
714093|NCT00199589|Spastic equinovarus|spastic equinovarus
714094|NCT00199589|Botox|botox
714095|NCT00199589|Ankle foot orthosis|ankle foot orthosis
714096|NCT00199576|Corticosteroids|corticosteroids
714097|NCT00199576|Laryngotracheal injury|laryngotracheal injury
714098|NCT00199576|Intubation-extubation|intubation-extubation
714099|NCT00199563|Viagra|viagra
714100|NCT00199563|sildenafil|sildenafil
714101|NCT00199550|Transurethral Resection of Prostate|transurethral resection of prostate
714102|NCT00199550|TURP|turp
714103|NCT00199524|ureteroscopy|ureteroscopy
714104|NCT00199524|stone free|stone free
714105|NCT00199511|Brain Tumor|brain tumor
714106|NCT00199511|Intracranial Pressure|intracranial pressure
714107|NCT00199511|Osmolarity|osmolarity
714108|NCT00199511|Seric|seric
714109|NCT00199511|Hypertonic Solution|hypertonic solution
714110|NCT00199498|Permanent Pacemaker Implantation- Lead Position|permanent pacemaker implantation- lead position
714111|NCT00199485|prostate cancer|prostate cancer
714112|NCT00199485|Luteinizing Hormone Releasing Hormone|luteinizing hormone releasing hormone
714113|NCT00199485|LHRH|lhrh
714114|NCT00199459|calculi|calculi
714115|NCT00199459|proteomics|proteomics
714116|NCT00199446|Sleep -Sleep Disorder|sleep -sleep disorder
714117|NCT00199446|Sleep- Restless Legs Syndrome|sleep- restless legs syndrome
714118|NCT00199446|Clinical Trial|clinical trial
714119|NCT00199433|Parkinson's Disease|parkinson's disease
714120|NCT00199433|Movement Disorder|movement disorder
714121|NCT00199433|Neurology,|neurology,
714122|NCT00199433|Clinical Trial|clinical trial
714123|NCT00199420|levodopa|levodopa
714124|NCT00199420|end of dose wearing off|end of dose wearing off
714125|NCT00199420|OFF time|off time
714126|NCT00199407|Parkinson's disease|parkinson's disease
714127|NCT00199407|levodopa|levodopa
714128|NCT00199407|end of dose wearing off|end of dose wearing off
714129|NCT00199407|OFF time|off time
714130|NCT00199394|KW-6002 (istradefylline)|kw-6002 (istradefylline)
714131|NCT00199394|Entacapone|entacapone
714132|NCT00199394|Placebo|placebo
714133|NCT00199394|Parkinson's Disease|parkinson's disease
714134|NCT00199394|Motor Response Complications|motor response complications
714135|NCT00199394|Levodopa Therapy|levodopa therapy
714136|NCT00199381|Parkinson's Disease|parkinson's disease
714137|NCT00199381|levodopa|levodopa
714138|NCT00199381|end of dose wearing off|end of dose wearing off
714139|NCT00199381|OFF time|off time
714140|NCT00199368|Parkinson's disease|parkinson's disease
714141|NCT00199368|levodopa|levodopa
714142|NCT00199368|end of dose wearing off|end of dose wearing off
714143|NCT00199368|OFF time|off time
714144|NCT00199355|Parkinson's Disease|parkinson's disease
714145|NCT00199355|levodopa|levodopa
714146|NCT00199355|end of dose wearing off|end of dose wearing off
714147|NCT00199355|OFF time|off time
714148|NCT00199342|Melanoma|melanoma
714149|NCT00199342|Monoclonal Antibody|monoclonal antibody
714150|NCT00199342|Anti-GD-3|anti-gd-3
714151|NCT00199329|ondansetron|ondansetron
714152|NCT00199329|PCA|pca
714153|NCT00199316|patient who recieve kidney surgery and Patient controlled anesthesia with spinal morphine, intrathecal|patient who recieve kidney surgery and patient controlled anesthesia with spinal morphine, intrathecal
714154|NCT00199303|NMDAreceptor antagonist, dextromethorphan|nmdareceptor antagonist, dextromethorphan
714155|NCT00199303|pain, post-operative|pain, post-operative
714156|NCT00199303|opioid consumption, morphine|opioid consumption, morphine
714157|NCT00199290|Trafermin|trafermin
714158|NCT00199290|Periodontitis|periodontitis
714159|NCT00199264|antifungal oral therapy|antifungal oral therapy
714160|NCT00199264|efficacy acute candidiasis vulvaginitis|efficacy acute candidiasis vulvaginitis
714161|NCT00199251|URTICARIA, WHEALS, FLARE, ANTIHISTAMINE, ANTIHISTAMINE|urticaria, wheals, flare, antihistamine, antihistamine
714162|NCT00199238|ANTIHISTAMINE|antihistamine
714163|NCT00199238|RUPATADINE|rupatadine
714164|NCT00199238|WHEAL|wheal
714165|NCT00199238|FLARE|flare
714166|NCT00199238|DERMATOLOGY|dermatology
714167|NCT00199225|Thorough study QT/QTc|thorough study qt/qtc
714168|NCT00199225|Cardiac repolarization|cardiac repolarization
714169|NCT00199225|QT prolongation|qt prolongation
714170|NCT00199212|HER-2 positive|her-2 positive
714171|NCT00199212|metastatic breast cancer patients|metastatic breast cancer patients
714172|NCT00199173|colorectal cancer|colorectal cancer
714173|NCT00199173|liver metastasis|liver metastasis
714174|NCT00199173|intraarterial hepatic injection|intraarterial hepatic injection
714175|NCT00199173|yttrium loaded microspheres|yttrium loaded microspheres
714176|NCT00199173|colorectal neoplasm metastatic to the liver|colorectal neoplasm metastatic to the liver
714177|NCT00199160|local recurrence and or metastatic disease|local recurrence and or metastatic disease
714289|NCT00198679|Newborn|newborn
714178|NCT00199160|Previously treated with platinum|previously treated with platinum
714179|NCT00199160|carcinoma of the head and neck|carcinoma of the head and neck
714180|NCT00199134|neoadjuvant treatment|neoadjuvant treatment
714181|NCT00199108|CNS relapse|cns relapse
714182|NCT00199108|ALL|all
714183|NCT00199108|Treatment|treatment
714184|NCT00199095|ALL|all
714185|NCT00199095|Elderly|elderly
714186|NCT00199095|Chemotherapy|chemotherapy
714187|NCT00199082|High-grade NHL|high-grade nhl
714188|NCT00199082|De novo|de novo
714189|NCT00199082|Mature B-ALL|mature b-all
714190|NCT00199082|Burkitt'S NHL|burkitt's nhl
714191|NCT00199082|Chemotherapy|chemotherapy
714192|NCT00199082|Rituximab|rituximab
714193|NCT00199082|Primary mediastinal diffuse large cell lymphoma|primary mediastinal diffuse large cell lymphoma
714194|NCT00199082|B-precursor lymphoblastic lymphoma|b-precursor lymphoblastic lymphoma
714195|NCT00199069|ALL|all
714196|NCT00199069|Treatment|treatment
714197|NCT00199069|De Novo|de novo
714198|NCT00199069|Adult|adult
714199|NCT00199056|ALL|all
714200|NCT00199056|Treatment|treatment
714201|NCT00199056|De Novo|de novo
714202|NCT00199056|Adult|adult
714203|NCT00199030|Relapse|relapse
714204|NCT00199030|T-ALL|t-all
714205|NCT00199030|T-LBL|t-lbl
714206|NCT00199030|MabCampath|mabcampath
714207|NCT00199030|Minimal residual disease|minimal residual disease
714208|NCT00199030|Lymphoma, lymphoblastic, T-cell|lymphoma, lymphoblastic, t-cell
714209|NCT00199017|T-LBL|t-lbl
714210|NCT00199017|Treatment|treatment
714211|NCT00199017|De novo|de novo
714212|NCT00199017|Chemotherapy|chemotherapy
714213|NCT00199017|Adult|adult
714214|NCT00199017|Lymphoma, lymphoblastic, T-cell|lymphoma, lymphoblastic, t-cell
714215|NCT00199004|ALL|all
714216|NCT00199004|Treatment|treatment
714217|NCT00199004|De novo|de novo
714218|NCT00199004|Minimal residual disease|minimal residual disease
714219|NCT00199004|Rituximab|rituximab
714220|NCT00199004|Adult|adult
714221|NCT00198991|ALL|all
714222|NCT00198991|Treatment|treatment
714223|NCT00198991|de novo|de novo
714224|NCT00198991|Minimal residual disease|minimal residual disease
714225|NCT00198991|Adult|adult
714226|NCT00198978|ALL|all
714227|NCT00198978|Treatment|treatment
714228|NCT00198978|Elderly|elderly
714229|NCT00198978|De novo|de novo
714230|NCT00198939|drug prevention|drug prevention
714231|NCT00198939|adolescence|adolescence
714232|NCT00198939|middle school|middle school
714233|NCT00198939|randomized trial|randomized trial
714234|NCT00198939|family therapy|family therapy
714235|NCT00198939|cognitive-behavioral|cognitive-behavioral
714236|NCT00198939|efficacy|efficacy
714237|NCT00198939|selected youth|selected youth
714238|NCT00198939|indicated youth|indicated youth
714239|NCT00198887|newborn|newborn
714240|NCT00198887|operations research|operations research
714241|NCT00198887|newborn survival|newborn survival
714242|NCT00198887|Neonatal illness/mortality|neonatal illness/mortality
714243|NCT00198887|Delivery complications|delivery complications
714244|NCT00198874|drug abuse|drug abuse
714245|NCT00198874|drug dependence|drug dependence
714246|NCT00198874|treatment|treatment
714247|NCT00198874|randomized trial|randomized trial
714248|NCT00198874|stage II study|stage ii study
714249|NCT00198874|adolescents|adolescents
714250|NCT00198874|young adults|young adults
714251|NCT00198874|efficacy study|efficacy study
714252|NCT00198861|HIV Epidemiology|hiv epidemiology
714253|NCT00198861|Neurology|neurology
714254|NCT00198861|Neuropsychological|neuropsychological
714255|NCT00198861|HIV Risk Factors|hiv risk factors
714256|NCT00198861|Cognitive Risk Factors|cognitive risk factors
714257|NCT00198861|HIV|hiv
714258|NCT00198848|Iron deficiency anemia|iron deficiency anemia
714259|NCT00198848|Adolescent girls|adolescent girls
714260|NCT00198848|India|india
714261|NCT00198835|malnutrition|malnutrition
714262|NCT00198835|anemia|anemia
714263|NCT00198835|infants|infants
714264|NCT00198835|children|children
714265|NCT00198835|India|india
714266|NCT00198822|Maternal mortality|maternal mortality
714267|NCT00198822|Infant mortality|infant mortality
714268|NCT00198822|Vitamin A|vitamin a
714269|NCT00198822|Beta-carotene|beta-carotene
714270|NCT00198822|Micronutrients|micronutrients
714271|NCT00198822|Bangladesh|bangladesh
714272|NCT00198822|Neonatal mortality|neonatal mortality
714273|NCT00198731|maternal health|maternal health
714274|NCT00198731|Bangladesh|bangladesh
714275|NCT00198731|care seeking|care seeking
714276|NCT00198718|Vitamin A supplementation|vitamin a supplementation
714277|NCT00198718|HIV|hiv
714278|NCT00198718|Mother to child transmission of HIV|mother to child transmission of hiv
714279|NCT00198718|Breastfeeding|breastfeeding
714280|NCT00198692|amputation|amputation
714281|NCT00198692|depression|depression
714282|NCT00198692|pain|pain
714283|NCT00198692|anxiety|anxiety
714284|NCT00198692|self-management|self-management
714285|NCT00198692|secondary conditions|secondary conditions
714286|NCT00198679|skin cleansing|skin cleansing
714287|NCT00198679|Bangladesh|bangladesh
714290|NCT00198679|infectious disease|infectious disease
714291|NCT00198679|chlorhexidine|chlorhexidine
714292|NCT00198666|Pneumonia|pneumonia
714293|NCT00198666|zinc|zinc
714294|NCT00198653|Hypothermia|hypothermia
714295|NCT00198653|Newborn|newborn
714296|NCT00198653|India|india
714297|NCT00198653|Maternal/Child Health|maternal/child health
714298|NCT00198653|Infant|infant
714299|NCT00198653|Kangaroo Mother Care|kangaroo mother care
714300|NCT00198640|animal antibiotics|animal antibiotics
714301|NCT00198640|human antibiotics|human antibiotics
714302|NCT00198627|Neonatal bacterial infection|neonatal bacterial infection
714303|NCT00198614|Adrenergic beta-Antagonists|adrenergic beta-antagonists
714304|NCT00198614|Carvedilol|carvedilol
714305|NCT00198614|Metoprolol|metoprolol
714306|NCT00198614|Coronary Artery Bypass|coronary artery bypass
714307|NCT00198614|Atrial Fibrillation|atrial fibrillation
714308|NCT00198601|meningitis|meningitis
714309|NCT00198601|neonatal deaths|neonatal deaths
714310|NCT00198601|gentamicin|gentamicin
714312|NCT00198601|aminoglycoside|aminoglycoside
714313|NCT00198588|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
714314|NCT00198588|argatroban|argatroban
714315|NCT00198588|cardiac surgery|cardiac surgery
714316|NCT00198588|acute coronary syndrome|acute coronary syndrome
714317|NCT00198588|thrombosis|thrombosis
714318|NCT00198588|amputation|amputation
714319|NCT00198588|anticoagulation|anticoagulation
714320|NCT00198575|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
714321|NCT00198575|cardiovascular surgery|cardiovascular surgery
714322|NCT00198575|percutaneous coronary intervention|percutaneous coronary intervention
714323|NCT00198562|Antihypertensive therapy|antihypertensive therapy
714324|NCT00198562|Home blood pressure|home blood pressure
714325|NCT00198562|Systolic blood pressure|systolic blood pressure
714326|NCT00198562|Morning blood pressure|morning blood pressure
714327|NCT00198562|Calcium antagonist|calcium antagonist
714328|NCT00198562|Angiotensin receptor antagonist|angiotensin receptor antagonist
714329|NCT00198549|Adjuvants, Anesthesia|adjuvants, anesthesia
714330|NCT00198549|hyaluronate lyase|hyaluronate lyase
714331|NCT00198523|Cataract Extraction|cataract extraction
714332|NCT00198523|Anti-Bacterial Agents|anti-bacterial agents
714333|NCT00198523|Steroids|steroids
714334|NCT00198484|Adjuvants, Anesthesia|adjuvants, anesthesia
714335|NCT00198484|Spreading Factor|spreading factor
714336|NCT00198445|Cataract Extraction|cataract extraction
714337|NCT00198445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
714338|NCT00198393|stage IIIB/IV NSCLC|stage iiib/iv nsclc
714339|NCT00198393|patients with performance status 2 or 3.|patients with performance status 2 or 3.
714340|NCT00198380|Adenocarcinoma, Bronchiolo-Alveolar|adenocarcinoma, bronchiolo-alveolar
714341|NCT00198367|operable and resectable stage IIIA (T1-3, N2) NSCLC|operable and resectable stage iiia (t1-3, n2) nsclc
714342|NCT00198341|Post-surgical Non-small cell lung cancer|post-surgical non-small cell lung cancer
714343|NCT00198328|Squamous Cell Carcinoma|squamous cell carcinoma
714344|NCT00198328|carcinoma|carcinoma
714345|NCT00198328|head and neck cancer|head and neck cancer
714346|NCT00198328|larynx|larynx
714347|NCT00198328|electroporation|electroporation
714348|NCT00198328|medpulser|medpulser
714349|NCT00198328|bleomycin|bleomycin
714350|NCT00198328|cancer|cancer
714351|NCT00198328|Locally recurrent or second primary squamous cell carcinoma of the base of the tongue, posterior lateral pharyngeal wall, hypopharynx, or larynx|locally recurrent or second primary squamous cell carcinoma of the base of the tongue, posterior lateral pharyngeal wall, hypopharynx, or larynx
714352|NCT00198315|Squamous Cell Carcinoma|squamous cell carcinoma
714353|NCT00198315|Carcinoma|carcinoma
714354|NCT00198315|Head and Neck Cancer|head and neck cancer
714355|NCT00198315|Oral|oral
714356|NCT00198315|Soft Palate|soft palate
714357|NCT00198315|Cancer|cancer
714358|NCT00198315|Medpulser|medpulser
714359|NCT00198315|Electroporation|electroporation
714360|NCT00198315|Local recurrent or second primary squamous cell carcinoma of anterior oral cavity, soft palate, or tonsil|local recurrent or second primary squamous cell carcinoma of anterior oral cavity, soft palate, or tonsil
714361|NCT00198302|staphylococcus aureus|staphylococcus aureus
714362|NCT00198302|bacteremia|bacteremia
714363|NCT00198302|sepsis|sepsis
714364|NCT00198289|Cystic Fibrosis|cystic fibrosis
714365|NCT00198289|Staphylococcus aureus|staphylococcus aureus
714366|NCT00198289|lungs|lungs
714367|NCT00198276|cancer|cancer
714368|NCT00198276|cutaneous|cutaneous
714369|NCT00198276|subcutaneous|subcutaneous
714370|NCT00198276|MedPulser|medpulser
714371|NCT00198276|bleomycin|bleomycin
714372|NCT00198276|electroporation|electroporation
714373|NCT00198276|Cutaneous or subcutaneous cancer|cutaneous or subcutaneous cancer
714374|NCT00198263|head and neck cancer|head and neck cancer
714375|NCT00198263|cancer|cancer
714376|NCT00198263|bleomycin|bleomycin
714377|NCT00198263|medpulser|medpulser
714378|NCT00198263|electroporation|electroporation
714379|NCT00198263|primary oral cavity, primary pharyngeal, primary laryngeal, salivary gland, limited recurrent and second primary tumors|primary oral cavity, primary pharyngeal, primary laryngeal, salivary gland, limited recurrent and second primary tumors
714380|NCT00198250|Breast cancer survivorship|breast cancer survivorship
714381|NCT00198250|hot flashes|hot flashes
714382|NCT00198250|treatment|treatment
714383|NCT00198237|Breast Cancer|breast cancer
714384|NCT00198237|Stage II Breast Cancer|stage ii breast cancer
714385|NCT00198237|Stage III Breast Cancer|stage iii breast cancer
714386|NCT00198224|immunosuppression|immunosuppression
714387|NCT00198185|Full Thickness Tendon Defect of Rotator Cuff|full thickness tendon defect of rotator cuff
714388|NCT00198172|Germ Cell Tumor|germ cell tumor
714389|NCT00198172|Refractory Germ Cell Tumors|refractory germ cell tumors
714390|NCT00198172|Cisplatin plus Epirubicin Salvage Chemotherapy|cisplatin plus epirubicin salvage chemotherapy
714391|NCT00198159|Refractory Germ Cell Tumors|refractory germ cell tumors
714392|NCT00198159|Germ Cell Tumors|germ cell tumors
714393|NCT00198133|Thymoma|thymoma
714394|NCT00198133|Thymic Carcinoma|thymic carcinoma
714395|NCT00198120|Autistic Disorder|autistic disorder
714396|NCT00198120|cycloserine|cycloserine
714397|NCT00198120|pharmacology|pharmacology
714398|NCT00198120|glutamatergic agents|glutamatergic agents
714399|NCT00198120|communication|communication
714400|NCT00198120|social interaction|social interaction
714401|NCT00198120|Double-Blind Method|double-blind method
714402|NCT00198107|Children|children
714403|NCT00198107|Adolescents|adolescents
714404|NCT00198107|Aripiprazole|aripiprazole
714405|NCT00198107|Cycloserine|cycloserine
714406|NCT00198107|Aggression|aggression
714407|NCT00198107|Irritability|irritability
714408|NCT00198107|Self-Injurious Behavior|self-injurious behavior
714409|NCT00198107|Social Interaction|social interaction
714410|NCT00198107|Antipsychotics|antipsychotics
714411|NCT00198107|Pharmacology|pharmacology
714412|NCT00198107|Glutamatergic Agents|glutamatergic agents
714413|NCT00198081|celecoxib for pancreas lesions|celecoxib for pancreas lesions
714414|NCT00198068|Pregnancy outcomes|pregnancy outcomes
714415|NCT00198068|Systemic lupus erythematosus|systemic lupus erythematosus
714416|NCT00198068|Antiphospholipid syndrome|antiphospholipid syndrome
714417|NCT00198055|Aggression|aggression
714418|NCT00198055|Behavioral symptoms|behavioral symptoms
714419|NCT00198042|ACL|acl
714420|NCT00198042|Tunnel|tunnel
714421|NCT00198042|Widening|widening
714422|NCT00198029|Osteoarthritis|osteoarthritis
714423|NCT00198029|Hyaluronan|hyaluronan
714424|NCT00198029|Carpometacarpal|carpometacarpal
714425|NCT00198029|Outcomes|outcomes
714426|NCT00198016|coronary fistulas.|coronary fistulas.
714427|NCT00198016|coils embolization.|coils embolization.
714428|NCT00198003|hip arthritis|hip arthritis
714429|NCT00198003|total hip arthroplasty|total hip arthroplasty
714430|NCT00198003|expectations|expectations
714431|NCT00198003|education|education
714432|NCT00197990|total hip arthroplasty|total hip arthroplasty
714433|NCT00197990|expectations|expectations
714434|NCT00197990|satisfaction|satisfaction
714435|NCT00197990|quality of life|quality of life
714436|NCT00197977|knee arthritis|knee arthritis
714437|NCT00197977|total knee arthroplasty|total knee arthroplasty
714438|NCT00197977|expectations|expectations
714439|NCT00197977|education|education
714440|NCT00197964|Self-management|self-management
714441|NCT00197964|Self-efficacy|self-efficacy
714442|NCT00197964|Quality of life|quality of life
714443|NCT00197964|Resource utilization|resource utilization
714444|NCT00197951|Psychiatric symptoms associated to alcoholism recovery|psychiatric symptoms associated to alcoholism recovery
714445|NCT00197951|Alcoholism treatment|alcoholism treatment
714446|NCT00197951|Alcohol craving|alcohol craving
714447|NCT00197951|Relapse to heavy drinking|relapse to heavy drinking
714448|NCT00197951|Abuse of other substances during alcoholism recovery|abuse of other substances during alcoholism recovery
714449|NCT00197925|breast cancer|breast cancer
714450|NCT00197925|dendritic cells|dendritic cells
714451|NCT00197925|vaccine|vaccine
714452|NCT00197912|dendritic cell|dendritic cell
714453|NCT00197912|cancer vaccine|cancer vaccine
714454|NCT00197912|cyclophosphamide|cyclophosphamide
714455|NCT00197912|melanoma|melanoma
714456|NCT00197873|colorectal cancer|colorectal cancer
714457|NCT00197873|probiotics|probiotics
714458|NCT00197873|chemotherapy|chemotherapy
714459|NCT00197873|prevention|prevention
714460|NCT00197873|adverse effects|adverse effects
714461|NCT00197873|diarrhoea|diarrhoea
714462|NCT00197860|dendritic cell|dendritic cell
714463|NCT00197860|vaccine|vaccine
714464|NCT00197860|renal cell carcinoma|renal cell carcinoma
714465|NCT00197834|Depakote|depakote
714466|NCT00197834|Agitation|agitation
714467|NCT00197834|Dementia|dementia
714468|NCT00197834|Atypical antipsychotic|atypical antipsychotic
714469|NCT00197834|Behavioral Symptoms|behavioral symptoms
714470|NCT00197834|Psychiatric Symptoms|psychiatric symptoms
714471|NCT00197834|Psychological Symptoms|psychological symptoms
714472|NCT00197834|Geriatric|geriatric
714473|NCT00197834|Behavioral and Psychological Symptoms|behavioral and psychological symptoms
714474|NCT00197808|Streptococcus pneumoniae|streptococcus pneumoniae
714475|NCT00197808|Neisseria meningitidis|neisseria meningitidis
714476|NCT00197756|HIV|hiv
714477|NCT00197756|Breastfeeding|breastfeeding
714478|NCT00197756|Vitamins|vitamins
714479|NCT00197756|Tanzania|tanzania
714480|NCT00197756|Children|children
714481|NCT00197743|HIV|hiv
714482|NCT00197743|Multivitamins|multivitamins
714483|NCT00197743|Pregnancy outcomes|pregnancy outcomes
714484|NCT00197743|Tanzania|tanzania
714485|NCT00197743|Women|women
714486|NCT00197730|Birth Outcomes|birth outcomes
714487|NCT00197730|Nutrition|nutrition
714488|NCT00197730|HIV|hiv
714489|NCT00197730|AIDS|aids
714490|NCT00197730|Vitamins|vitamins
714491|NCT00197730|Multivitamins|multivitamins
714492|NCT00197730|Maternal and child health outcomes|maternal and child health outcomes
714493|NCT00197730|Tanzania|tanzania
714494|NCT00197730|Africa|africa
714495|NCT00197704|Tuberculosis|tuberculosis
714496|NCT00197704|HIV|hiv
714497|NCT00197704|Tanzania|tanzania
714498|NCT00197704|multivitamins|multivitamins
714499|NCT00197691|HIV infected mothers|hiv infected mothers
714500|NCT00197691|Infants at risk of HIV-infection|infants at risk of hiv-infection
714501|NCT00197691|Infant lower respiratory tract disease|infant lower respiratory tract disease
714502|NCT00197691|Infant bloodstream infection|infant bloodstream infection
714503|NCT00197678|HIV|hiv
714504|NCT00197678|AIDS|aids
714505|NCT00197678|Multivitamins|multivitamins
714506|NCT00197678|Pregnancy Outcomes|pregnancy outcomes
714507|NCT00197678|Women|women
714508|NCT00197678|Tanzania|tanzania
714509|NCT00197678|Africa|africa
714510|NCT00197652|Prevention of Mother-Infant HIV Transmission|prevention of mother-infant hiv transmission
714511|NCT00197639|indinavir, HIV, ritonavir, pharmacokinetics, Thailand|indinavir, hiv, ritonavir, pharmacokinetics, thailand
714512|NCT00197561|HIV|hiv
714513|NCT00197561|Selenium|selenium
714514|NCT00197561|Nutrition|nutrition
714515|NCT00197561|Women|women
714516|NCT00197561|Pregnancy|pregnancy
714517|NCT00197561|Tanzania|tanzania
714518|NCT00197561|Maternal and child health outcomes|maternal and child health outcomes
714519|NCT00197561|HIV/AIDS|hiv/aids
714520|NCT00197561|Pregnancy Outcome|pregnancy outcome
714521|NCT00197548|Women|women
714522|NCT00197548|Pregnancy Outcomes|pregnancy outcomes
714523|NCT00197548|Nutrition|nutrition
714524|NCT00197548|Vitamins|vitamins
714525|NCT00197548|Tanzania|tanzania
714526|NCT00197548|Maternal and Child Health Outcomes|maternal and child health outcomes
714527|NCT00197522|breast cancer|breast cancer
714528|NCT00197522|vaccination|vaccination
714529|NCT00197522|dendritic cells|dendritic cells
714530|NCT00197522|HER-2|her-2
714531|NCT00197522|CD34+ stem cells|cd34+ stem cells
714532|NCT00197509|Long-Term Care|long-term care
714533|NCT00197509|Clinical Protocols|clinical protocols
714534|NCT00197509|Sit-To-Stand|sit-to-stand
714535|NCT00197483|Pergolide|pergolide
714536|NCT00197483|Dopamine D1|dopamine d1
714537|NCT00197483|Schizophrenia|schizophrenia
714538|NCT00197483|Cognitive disturbance|cognitive disturbance
714539|NCT00197483|Negative symptoms|negative symptoms
714540|NCT00197444|esophageal cancer|esophageal cancer
714541|NCT00197444|Nedaplatin|nedaplatin
714542|NCT00197444|5-FU|5-fu
714543|NCT00197444|chemotherapy|chemotherapy
714544|NCT00197444|radiation|radiation
714545|NCT00197444|chemoradiotherapy|chemoradiotherapy
714546|NCT00197418|H. pylori infection|h. pylori infection
714547|NCT00197392|Ventriculostomy|ventriculostomy
714548|NCT00197392|EVD|evd
714549|NCT00197379|androgenetic alopecia|androgenetic alopecia
714550|NCT00197379|roxitromycin|roxitromycin
714551|NCT00197379|apoptosis|apoptosis
714552|NCT00197366|pregnancy|pregnancy
714553|NCT00197366|HIV-positive|hiv-positive
714554|NCT00197366|HIV resistance|hiv resistance
714555|NCT00197366|HIV|hiv
714556|NCT00197353|Anesthesia, Epidural|anesthesia, epidural
714557|NCT00197353|Pharmacology|pharmacology
714558|NCT00197353|Dose-Response Relationship, Drug|dose-response relationship, drug
714559|NCT00197353|Sympathectomy|sympathectomy
714560|NCT00197353|Photoplethysmography|photoplethysmography
714561|NCT00197340|Pre-Eclampsia|pre-eclampsia
714562|NCT00197340|Fetal Growth Retardation|fetal growth retardation
714563|NCT00197340|Anesthesia, Epidural|anesthesia, epidural
714564|NCT00197340|Placental Circulation|placental circulation
714565|NCT00197340|Dose-Response Relationship, Drug|dose-response relationship, drug
714566|NCT00197327|Labor Pain|labor pain
714567|NCT00197327|Analgesia, Obstetrical|analgesia, obstetrical
714568|NCT00197327|Pharmacology|pharmacology
714569|NCT00197327|Treatment Outcome|treatment outcome
714570|NCT00197314|Urinary stress incontinence|urinary stress incontinence
714571|NCT00197314|Randomized trial|randomized trial
714572|NCT00197314|circular muscle training|circular muscle training
714573|NCT00197314|pelvic floor training|pelvic floor training
714574|NCT00197314|bioequivalence|bioequivalence
714575|NCT00197301|Intranasal vaccination, Influenza|intranasal vaccination, influenza
714576|NCT00197288|Prophylaxis: Influenza virus infection|prophylaxis: influenza virus infection
714577|NCT00197275|Haemophilus influenzae type b|haemophilus influenzae type b
714578|NCT00197275|diphtheria|diphtheria
714579|NCT00197275|tetanus|tetanus
714580|NCT00197275|Prophylaxis diphtheria|prophylaxis diphtheria
714581|NCT00197275|pertussis|pertussis
714582|NCT00197275|hepatitis B|hepatitis b
714775|NCT00196274|AUTONOMIC NERVOUS SYSTEM|autonomic nervous system
714583|NCT00197275|meningococcal serogroups A & C diseases|meningococcal serogroups a & c diseases
714584|NCT00197262|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
714585|NCT00197262|GW685698X|gw685698x
714586|NCT00197262|allergic rhinitis|allergic rhinitis
714587|NCT00197262|Hayfever|hayfever
714588|NCT00197249|Hepatitis A & B|hepatitis a & b
714589|NCT00197249|Typhoid|typhoid
714590|NCT00197236|Hepatitis A|hepatitis a
714591|NCT00197197|HIV-1 GW873140 CCR5 antagonist treatment experienced|hiv-1 gw873140 ccr5 antagonist treatment experienced
714592|NCT00197184|Combined hepatitis A and B vaccine|combined hepatitis a and b vaccine
714593|NCT00197184|Twinrix™|twinrix™
714594|NCT00197145|HIV-1 GW873140 CCR5 antagonist experienced|hiv-1 gw873140 ccr5 antagonist experienced
714595|NCT00197132|Insulin resistance vasodilatory response|insulin resistance vasodilatory response
714596|NCT00197119|Hepatitis B|hepatitis b
714597|NCT00197119|TWINRIX™ Adult|twinrix™ adult
714598|NCT00197119|Hepatitis A|hepatitis a
714599|NCT00197119|TWINRIX™ Junior|twinrix™ junior
714600|NCT00197106|salmeterol/fluticasone combination|salmeterol/fluticasone combination
714601|NCT00197106|Asthma|asthma
714602|NCT00197106|bronchial hyperresponsiveness|bronchial hyperresponsiveness
714603|NCT00197106|Children|children
714604|NCT00197106|symptom control|symptom control
714605|NCT00197093|Schizophrenia|schizophrenia
714606|NCT00197093|safety|safety
714607|NCT00197093|tolerability|tolerability
714608|NCT00197093|pharmacokinetics|pharmacokinetics
714609|NCT00197080|Restless Legs Syndrome|restless legs syndrome
714610|NCT00197080|RLS|rls
714611|NCT00196989|Efficacy|efficacy
714612|NCT00196989|PPARpan|pparpan
714613|NCT00196989|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
714614|NCT00196989|Phase IIb|phase iib
714615|NCT00196989|Safety|safety
714616|NCT00196989|Pharmacokinetics|pharmacokinetics
714617|NCT00196989|GW677954|gw677954
714618|NCT00196989|Pharmacodynamics|pharmacodynamics
714619|NCT00196989|Tolerability|tolerability
714620|NCT00196989|Dose-Ranging|dose-ranging
714621|NCT00196976|Safety|safety
714622|NCT00196976|Meningococcal vaccine|meningococcal vaccine
714623|NCT00196976|Dose selection|dose selection
714624|NCT00196976|Toddlers|toddlers
714625|NCT00196976|Immunogenicity|immunogenicity
714626|NCT00196976|Conjugate vaccine|conjugate vaccine
714627|NCT00196976|Reactogenicity|reactogenicity
714628|NCT00196976|Children|children
714629|NCT00196937|HPV Vaccine Safety|hpv vaccine safety
714630|NCT00196898|Parkinson´s disease|parkinson´s disease
714631|NCT00196898|fibrotic valvular heart fibrosis|fibrotic valvular heart fibrosis
714632|NCT00196898|ergot dopamine agonists|ergot dopamine agonists
714633|NCT00196898|non-ergot dopamine agonists|non-ergot dopamine agonists
714634|NCT00196885|cancer cachexia|cancer cachexia
714635|NCT00196885|muscle wasting|muscle wasting
714636|NCT00196885|weight loss|weight loss
714637|NCT00196885|proteolysis|proteolysis
714638|NCT00196872|dose dense sequence|dose dense sequence
714639|NCT00196872|dose dense combination|dose dense combination
714640|NCT00196872|node positive disease|node positive disease
714641|NCT00196859|Early Breast Cancer in elderly Patients|early breast cancer in elderly patients
714642|NCT00196859|Ibandronate plus/minus Capecitabine in elderly patients|ibandronate plus/minus capecitabine in elderly patients
714643|NCT00196846|hormone insensitive breast cancer|hormone insensitive breast cancer
714644|NCT00196846|Prevention of Chemotherapy induced ovarian failure|prevention of chemotherapy induced ovarian failure
714645|NCT00196846|P.O.F.|p.o.f.
714646|NCT00196846|GnRH-Agonist Goserelin|gnrh-agonist goserelin
714647|NCT00196833|Breast Cancer in Pregnancy|breast cancer in pregnancy
714648|NCT00196833|Prospective and Retrospective Register|prospective and retrospective register
714649|NCT00196833|Study|study
714650|NCT00196820|Metastatic breast cancer|metastatic breast cancer
714651|NCT00196820|HER2 negative, medium-risk, metastatic breast cancer|her2 negative, medium-risk, metastatic breast cancer
714652|NCT00196807|prostate cancer screening|prostate cancer screening
714653|NCT00196807|medical decision making|medical decision making
714654|NCT00196807|informed decision making|informed decision making
714655|NCT00196807|patient education|patient education
714656|NCT00196807|male|male
714657|NCT00196794|Pseudomembranous Colitis|pseudomembranous colitis
714658|NCT00196794|Clostridium difficile-associated diarrhea|clostridium difficile-associated diarrhea
714659|NCT00196794|C. difficile|c. difficile
714660|NCT00196794|CDAD|cdad
714661|NCT00196781|prostate cancer treatment|prostate cancer treatment
714662|NCT00196781|medical decision making|medical decision making
714663|NCT00196781|informed decision making|informed decision making
714664|NCT00196781|shared decision making|shared decision making
714665|NCT00196781|decision aid|decision aid
714666|NCT00196781|patient education|patient education
714667|NCT00196768|relapsed|relapsed
714668|NCT00196768|acute promyelocytic leukemia|acute promyelocytic leukemia
714669|NCT00196768|arsenic|arsenic
714670|NCT00196742|alpha Galactosidase A|alpha galactosidase a
714671|NCT00196742|aGAL (alpha-galactosidase)|agal (alpha-galactosidase)
714672|NCT00196742|Fabry|fabry
714673|NCT00196742|GL3 (globotriaosylceramide)|gl3 (globotriaosylceramide)
714674|NCT00196742|Anderson-Fabry Disease|anderson-fabry disease
714675|NCT00196742|angiokeratomas|angiokeratomas
714676|NCT00196742|GLA deficiency (gene deficiency)|gla deficiency (gene deficiency)
714677|NCT00196742|errors in metabolism|errors in metabolism
714678|NCT00196716|alpha Galactosidase A|alpha galactosidase a
714679|NCT00196716|aGAL|agal
714680|NCT00196716|rh aGAL|rh agal
714681|NCT00196716|Fabry|fabry
714682|NCT00196716|GL3|gl3
714683|NCT00196716|Fabrazyme|fabrazyme
714684|NCT00196703|Aphasia|aphasia
714685|NCT00196703|Memantine|memantine
714686|NCT00196703|Constraint-induced language therapy|constraint-induced language therapy
714687|NCT00196703|Event-related potentials|event-related potentials
714688|NCT00196690|Aphasia|aphasia
714689|NCT00196690|Donepezil|donepezil
714690|NCT00196664|Chronic Hepatitis C|chronic hepatitis c
714691|NCT00196664|Paroxetine|paroxetine
714692|NCT00196664|Depression|depression
714693|NCT00196651|HIV infection|hiv infection
714694|NCT00196651|AIDS Vaccines|aids vaccines
714695|NCT00196651|ALVAC vaccine|alvac vaccine
714696|NCT00196651|Interleukin-2|interleukin-2
714697|NCT00196651|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
714698|NCT00196638|HIV infections|hiv infections
714699|NCT00196638|Primary acute infection|primary acute infection
714700|NCT00196638|Interferon-alpha|interferon-alpha
714701|NCT00196625|HIV infections|hiv infections
714702|NCT00196625|Salvage therapy|salvage therapy
714703|NCT00196625|Amprenavir|amprenavir
714704|NCT00196625|Lopinavir|lopinavir
714705|NCT00196625|Ritonavir|ritonavir
714706|NCT00196612|HIV Infections|hiv infections
714707|NCT00196612|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
714708|NCT00196612|Treatment simplification|treatment simplification
714709|NCT00196599|HIV infections|hiv infections
714710|NCT00196599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
714711|NCT00196586|Chronic Hepatitis C|chronic hepatitis c
714712|NCT00196586|HIV infection|hiv infection
714713|NCT00196586|Interleukin-2|interleukin-2
714714|NCT00196586|Pegylated interferon alpha 2 a|pegylated interferon alpha 2 a
714715|NCT00196586|ribavirin|ribavirin
714716|NCT00196573|Rotator Cuff|rotator cuff
714717|NCT00196573|Tendinosis|tendinosis
714718|NCT00196573|Impingement Syndrome|impingement syndrome
714719|NCT00196573|Partial Thickness Tears|partial thickness tears
714720|NCT00196573|Rotator Cuff Tendinosis|rotator cuff tendinosis
714721|NCT00196573|Partial Thickness Rotator Cuff Tears|partial thickness rotator cuff tears
714722|NCT00196560|Immobilization in External Rotation|immobilization in external rotation
714723|NCT00196560|Acute primary anterior shoulder dislocation|acute primary anterior shoulder dislocation
714724|NCT00196547|Asthma|asthma
714725|NCT00196547|Respiratory viral infections|respiratory viral infections
714726|NCT00196547|Exacerbations|exacerbations
714727|NCT00196547|Pediatric|pediatric
714728|NCT00196547|Leukotriene receptor antagonists|leukotriene receptor antagonists
714729|NCT00196547|School|school
714730|NCT00196508|Childbirth|childbirth
714731|NCT00196482|growth|growth
714732|NCT00196482|oral feeding|oral feeding
714733|NCT00196482|nutrition|nutrition
714734|NCT00196456|Photodynamic lasertherapy|photodynamic lasertherapy
714735|NCT00196456|Periodontol disease|periodontol disease
714736|NCT00196417|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
714737|NCT00196417|HIT|hit
714738|NCT00196417|unfractionated heparin|unfractionated heparin
714739|NCT00196417|UFH|ufh
714740|NCT00196417|low-molecular-weight heparin|low-molecular-weight heparin
714741|NCT00196417|LMWH|lmwh
714742|NCT00196417|thrombosis prophylaxis|thrombosis prophylaxis
714743|NCT00196417|HIT-antibody|hit-antibody
714744|NCT00196404|overactive bladder|overactive bladder
714745|NCT00196404|urge incontinence|urge incontinence
714746|NCT00196404|urinary incontinence|urinary incontinence
714747|NCT00196391|secondary amenorrhea|secondary amenorrhea
714748|NCT00196391|progesterone|progesterone
714749|NCT00196378|vaginal atrophy|vaginal atrophy
714750|NCT00196378|vaginal dryness|vaginal dryness
714751|NCT00196378|vaginal itching|vaginal itching
714752|NCT00196378|vaginal pain|vaginal pain
714753|NCT00196378|dyspareunia|dyspareunia
714754|NCT00196365|cyclic pelvic pain|cyclic pelvic pain
714755|NCT00196365|dysmenorrhea|dysmenorrhea
714756|NCT00196352|oral contraceptives|oral contraceptives
714757|NCT00196352|birth control|birth control
714758|NCT00196352|ethinyl estradiol|ethinyl estradiol
714759|NCT00196352|pregnancy prevention|pregnancy prevention
714760|NCT00196339|prostate cancer|prostate cancer
714761|NCT00196339|hot flashes|hot flashes
714762|NCT00196339|hot flushes|hot flushes
714763|NCT00196339|vasomotor symptoms|vasomotor symptoms
714764|NCT00196326|pregnancy prevention|pregnancy prevention
714765|NCT00196326|oral contraceptives|oral contraceptives
714766|NCT00196313|cyclic pelvic pain|cyclic pelvic pain
714767|NCT00196313|dysmenorrhea|dysmenorrhea
714768|NCT00196313|oral contraceptives|oral contraceptives
714769|NCT00196300|Assessment, Risk|assessment, risk
714770|NCT00196300|Autonomic nervous system|autonomic nervous system
714771|NCT00196300|Aged|aged
714772|NCT00196287|Assessment, risk|assessment, risk
714773|NCT00196287|autonomic nervous system|autonomic nervous system
714774|NCT00196287|Gender|gender
714776|NCT00196274|Assessment, Risk|assessment, risk
714777|NCT00196261|Assessment, Risk|assessment, risk
714778|NCT00196261|Autonomic nervous system|autonomic nervous system
714779|NCT00196235|Assessment, Risk|assessment, risk
714780|NCT00196235|Diabetes mellitus|diabetes mellitus
714781|NCT00196235|Autonomic nervous system|autonomic nervous system
714782|NCT00196209|atrial fibrillation|atrial fibrillation
714783|NCT00196209|catheter ablation|catheter ablation
714784|NCT00196196|Hydrocephalus|hydrocephalus
714785|NCT00196196|Codman Hakim Programmable Valve|codman hakim programmable valve
714786|NCT00196196|Programmable Valve|programmable valve
714787|NCT00196196|Shunt System|shunt system
714788|NCT00196131|morphine|morphine
714789|NCT00196131|head injury|head injury
714790|NCT00196131|SAH|sah
714791|NCT00196118|Pulmonary Embolism|pulmonary embolism
714792|NCT00196118|Venous Thromboembolism|venous thromboembolism
714793|NCT00196118|Inferior Vena Cava Filter|inferior vena cava filter
714794|NCT00196118|IVC|ivc
714795|NCT00196118|PE|pe
714796|NCT00196105|Stents|stents
714797|NCT00196105|Stent-graft|stent-graft
714798|NCT00196105|Minimally invasive|minimally invasive
714799|NCT00196105|Biliary Tract Cancer|biliary tract cancer
714800|NCT00196105|Pancreatic Cancer|pancreatic cancer
714801|NCT00196105|Jaundice|jaundice
714802|NCT00196105|Biliary Tract Neoplasms|biliary tract neoplasms
714803|NCT00196105|Pancreatic Neoplasms|pancreatic neoplasms
714804|NCT00196105|Jaundice, Obstructive|jaundice, obstructive
714805|NCT00196105|Zilver|zilver
714806|NCT00196079|coronary artery|coronary artery
714807|NCT00196079|stenosis|stenosis
714808|NCT00196079|drug eluting stent|drug eluting stent
714809|NCT00196079|stent|stent
714810|NCT00196053|Intrathecal pain management|intrathecal pain management
714811|NCT00196053|constant flow pump|constant flow pump
714812|NCT00196014|Registered Nurses|registered nurses
714813|NCT00196014|Workload|workload
714814|NCT00196014|Clinical staff nurses that are currently working|clinical staff nurses that are currently working
714815|NCT00196001|Adrenal sufficiency|adrenal sufficiency
714816|NCT00196001|Low-dose ACTH stimulation|low-dose acth stimulation
714817|NCT00196001|G proteins|g proteins
714818|NCT00195988|immunosuppression,|immunosuppression,
714819|NCT00195988|steroid avoidance,|steroid avoidance,
714820|NCT00195988|liver transplantation,|liver transplantation,
714821|NCT00195988|children|children
714822|NCT00195975|Abdominal Pain|abdominal pain
714823|NCT00195975|Functional Gastrointestinal Disorders|functional gastrointestinal disorders
714824|NCT00195975|Stress|stress
714825|NCT00195975|Anxiety|anxiety
714826|NCT00195975|Autonomic Nervous System|autonomic nervous system
714827|NCT00195962|Breastfeeding|breastfeeding
714828|NCT00195962|Post-partum mothers of healthy breast-fed newborns|post-partum mothers of healthy breast-fed newborns
714829|NCT00195949|Pyloric Stenosis|pyloric stenosis
714830|NCT00195949|Laparoscopy|laparoscopy
714831|NCT00195949|Idiopathic Hypertrophic Pyloric Stenosis|idiopathic hypertrophic pyloric stenosis
714832|NCT00195936|Cinacalcet|cinacalcet
714833|NCT00195936|PTH|pth
714834|NCT00195936|XLH|xlh
714835|NCT00195936|children and adolescents with hypophosphatemic rickets (XLH)|children and adolescents with hypophosphatemic rickets (xlh)
714836|NCT00195923|appendicitis|appendicitis
714837|NCT00195923|perforation|perforation
714838|NCT00195910|Acute|acute
714839|NCT00195910|Pain|pain
714840|NCT00195910|Emergency Department|emergency department
714841|NCT00195910|Morphine|morphine
714842|NCT00195910|Hydromorphone|hydromorphone
714843|NCT00195910|Dilaudid|dilaudid
714844|NCT00195897|Lymphoma|lymphoma
714845|NCT00195897|Anthracyclines|anthracyclines
714846|NCT00195897|Heart Failure|heart failure
714847|NCT00195897|Radionuclide|radionuclide
714848|NCT00195897|Magnetic Resonance Imaging|magnetic resonance imaging
714849|NCT00195897|Troponin|troponin
714850|NCT00195897|Natriuretic Peptide, Brain|natriuretic peptide, brain
714851|NCT00195884|Diabetes Mellitus|diabetes mellitus
714852|NCT00195884|Type 2 Diabetes|type 2 diabetes
714853|NCT00195884|Aerobic|aerobic
714854|NCT00195884|Resistance|resistance
714855|NCT00195884|weight training|weight training
714856|NCT00195884|Exercise|exercise
714857|NCT00195871|Non-Hodgkin|non-hodgkin
714858|NCT00195871|Lymphoma|lymphoma
714859|NCT00195871|Lymphoblastic|lymphoblastic
714860|NCT00195858|Youth|youth
714861|NCT00195858|Exercise|exercise
714862|NCT00195858|Physical Activity|physical activity
714863|NCT00195858|Aerobic|aerobic
714864|NCT00195858|Resistance|resistance
714865|NCT00195858|Overweight|overweight
714866|NCT00195858|obese|obese
714867|NCT00195858|Canada|canada
714868|NCT00195858|Sigal|sigal
714869|NCT00195819|ankylosing spondylitis|ankylosing spondylitis
714870|NCT00195819|adalimumab|adalimumab
714871|NCT00195806|Migraine|migraine
714872|NCT00195806|Depakote ER|depakote er
714873|NCT00195806|Divalproex sodium|divalproex sodium
714874|NCT00195793|Hyperlipidemia|hyperlipidemia
714875|NCT00195793|fenofibrate|fenofibrate
714876|NCT00195793|ezetimibe|ezetimibe
714877|NCT00195793|atorvastatin|atorvastatin
714878|NCT00195780|Bipolar I Disorder|bipolar i disorder
714879|NCT00195780|Depakote|depakote
714880|NCT00195767|Bipolar I Disorder|bipolar i disorder
714881|NCT00195767|Depakote ER|depakote er
714882|NCT00195767|divalproex sodium|divalproex sodium
714883|NCT00195754|Migraines|migraines
714884|NCT00195754|Depakote ER|depakote er
714885|NCT00195754|divalproex sodium|divalproex sodium
714886|NCT00195741|Migraine|migraine
714887|NCT00195741|Depakote ER|depakote er
714888|NCT00195728|Hydrocodone/Acetaminophen|hydrocodone/acetaminophen
714889|NCT00195728|Vicodin CR|vicodin cr
714890|NCT00195702|Rheumatoid Arthritis|rheumatoid arthritis
714891|NCT00195663|Early Rheumatoid Arthritis|early rheumatoid arthritis
714892|NCT00195650|Rheumatoid Arthritis|rheumatoid arthritis
714893|NCT00195637|GNE Gene|gne gene
714894|NCT00195637|Alpha-Dystroglycan|alpha-dystroglycan
714895|NCT00195637|Sialic Acid|sialic acid
714896|NCT00195637|Glycosylation|glycosylation
714897|NCT00195637|Dystroglycanopathy|dystroglycanopathy
714898|NCT00195637|Hereditary Inclusion Body Myopathy|hereditary inclusion body myopathy
714899|NCT00195637|Immune Globulin|immune globulin
714900|NCT00195637|HIBM|hibm
714901|NCT00195624|Immunosuppression|immunosuppression
714902|NCT00195624|Alemtuzumab/Campath|alemtuzumab/campath
714903|NCT00195624|Severe Aplastic Anemia|severe aplastic anemia
714904|NCT00195624|T-cells|t-cells
714905|NCT00195624|Hematopoiesis|hematopoiesis
714906|NCT00195624|Autoimmunity|autoimmunity
714907|NCT00195624|Thrombocytopenia|thrombocytopenia
714908|NCT00195624|Neutropenia|neutropenia
714909|NCT00195624|SAA|saa
714910|NCT00195611|Middle Ear Infection|middle ear infection
714911|NCT00195598|Panic Disorders|panic disorders
714912|NCT00195585|Colon Cancer|colon cancer
714913|NCT00195572|Gastric Cancer|gastric cancer
714914|NCT00195572|Advanced/Recurrent Gastric Cancer|advanced/recurrent gastric cancer
714915|NCT00195559|Premenstrual Syndrome (PMS)|premenstrual syndrome (pms)
714916|NCT00195559|Hormone Therapy|hormone therapy
714917|NCT00195546|Menopause|menopause
714918|NCT00195533|Leukemia|leukemia
714919|NCT00195533|Lymphoma|lymphoma
714920|NCT00195533|Myeloma|myeloma
714921|NCT00195520|Menopause|menopause
714922|NCT00195520|Sleep Disorder|sleep disorder
714923|NCT00195520|Hot Flashes|hot flashes
714924|NCT00195507|Psoriasis|psoriasis
714925|NCT00195494|Rheumatoid Arthritis|rheumatoid arthritis
714926|NCT00195481|Kidney|kidney
714927|NCT00195481|Transplant|transplant
714928|NCT00195468|Kidney Failure|kidney failure
714929|NCT00195468|Transplant|transplant
714930|NCT00195455|Postmenopause|postmenopause
714931|NCT00195442|Hemophilia A|hemophilia a
714932|NCT00195429|Kidney|kidney
714933|NCT00195429|Transplant|transplant
714934|NCT00195416|Ankylosing Spondylitis|ankylosing spondylitis
714935|NCT00195403|Rheumatoid Arthritis|rheumatoid arthritis
714936|NCT00195390|Vaccine|vaccine
714937|NCT00195390|heptavalent pneumococcal conjugate vaccine|heptavalent pneumococcal conjugate vaccine
714938|NCT00195364|Rheumatoid Arthritis|rheumatoid arthritis
714939|NCT00195351|Complicated intra-abdominal infection|complicated intra-abdominal infection
714940|NCT00195351|Appendicitis with abscess|appendicitis with abscess
714941|NCT00195351|Perforated diverticulitis|perforated diverticulitis
714942|NCT00195351|Purulent peritonitis|purulent peritonitis
714943|NCT00195351|Complicated cholecystitis|complicated cholecystitis
714944|NCT00195338|Rheumatoid Arthritis|rheumatoid arthritis
714945|NCT00195325|Advanced Malignant Solid Tumors|advanced malignant solid tumors
714946|NCT00195312|HIV|hiv
714947|NCT00195312|Vaccine|vaccine
714948|NCT00195312|Treatment Experienced|treatment experienced
714949|NCT00195299|Carcinoma|carcinoma
714950|NCT00195299|Head|head
714951|NCT00195299|Neck|neck
714952|NCT00195286|Urinary Infections|urinary infections
714953|NCT00195273|Kidney|kidney
714954|NCT00195273|Transplant|transplant
714955|NCT00195260|Solid tumors|solid tumors
714956|NCT00195247|Tumors|tumors
714957|NCT00195247|Advanced malignant solid tumors|advanced malignant solid tumors
714958|NCT00195234|HIV|hiv
714959|NCT00195234|Treatment Experienced|treatment experienced
714960|NCT00195221|Hemophilia B|hemophilia b
714961|NCT00195208|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
714962|NCT00195195|Transplantation|transplantation
714963|NCT00195182|Hypertension|hypertension
714964|NCT00195182|African-American|african-american
714965|NCT00195182|Perceived Racism|perceived racism
714966|NCT00195182|Psychological Stress|psychological stress
714967|NCT00195182|Medication Adherence|medication adherence
714968|NCT00195169|Myocardial Infarction|myocardial infarction
714969|NCT00195169|Social support|social support
714970|NCT00195156|Solid Tumor Malignancies|solid tumor malignancies
714971|NCT00195143|Parkinson's disease|parkinson's disease
714972|NCT00195143|GABA|gaba
714973|NCT00195143|Subthalamic nucleus|subthalamic nucleus
714974|NCT00195143|Adeno-associated virus|adeno-associated virus
714975|NCT00195143|AAV|aav
714976|NCT00195143|Gene therapy|gene therapy
714977|NCT00195130|prognosis|prognosis
714978|NCT00195130|risk of death|risk of death
714979|NCT00195130|morbidity|morbidity
714980|NCT00195130|mortality|mortality
715187|NCT00193973|Lymphoma|lymphoma
714981|NCT00195130|quality of life|quality of life
714982|NCT00195117|Asthma|asthma
714983|NCT00195117|Behavior change|behavior change
714984|NCT00195117|Physical activity|physical activity
714985|NCT00195117|Risk reduction|risk reduction
714986|NCT00195104|Myelodysplastic Syndrome|myelodysplastic syndrome
714987|NCT00195078|head and neck cancer|head and neck cancer
714988|NCT00195078|squamous cell carcinoma of the oral cavity|squamous cell carcinoma of the oral cavity
714989|NCT00195078|squamous cell carcinoma of the oropharynx|squamous cell carcinoma of the oropharynx
714990|NCT00195078|squamous cell carcinoma of the larynx|squamous cell carcinoma of the larynx
714991|NCT00195078|squamous cell carcinoma of the hypopharynx|squamous cell carcinoma of the hypopharynx
714992|NCT00195065|Asthma|asthma
714993|NCT00195065|Behavior change|behavior change
714994|NCT00195065|Physical activity|physical activity
714995|NCT00195065|Risk reduction|risk reduction
714996|NCT00195052|epilepsy|epilepsy
714997|NCT00195052|optical imaging|optical imaging
714998|NCT00195052|optical mapping|optical mapping
714999|NCT00195039|Prostate Cancer|prostate cancer
715000|NCT00195000|Acute Myeloid Leukemia|acute myeloid leukemia
715001|NCT00195000|Myelodysplastic Syndrome|myelodysplastic syndrome
715002|NCT00194987|Alloimmune thrombocytopenia|alloimmune thrombocytopenia
715003|NCT00194987|Fetal alloimmune thrombocytopenia|fetal alloimmune thrombocytopenia
715004|NCT00194974|pregnancy|pregnancy
715005|NCT00194974|chronic hypertension|chronic hypertension
715006|NCT00194974|Toxemia|toxemia
715007|NCT00194974|Blood Pressure|blood pressure
715008|NCT00194961|Chronic Kidney Disease|chronic kidney disease
715009|NCT00194961|Growth Failure|growth failure
715010|NCT00194961|Cytokines|cytokines
715011|NCT00194961|leptin|leptin
715012|NCT00194935|Ovarian Cancer|ovarian cancer
715013|NCT00194935|Cancer of the Ovary|cancer of the ovary
715014|NCT00194896|type 2 diabetes mellitus|type 2 diabetes mellitus
715015|NCT00194896|autoantibodies|autoantibodies
715016|NCT00194896|islet proteins|islet proteins
715017|NCT00194896|rosiglitazone|rosiglitazone
715018|NCT00194896|glyburide|glyburide
715019|NCT00194896|c-peptide|c-peptide
715020|NCT00194883|Recombinant Human Growth Hormone|recombinant human growth hormone
715021|NCT00194883|Leptin|leptin
715022|NCT00194883|Cytokines|cytokines
715023|NCT00194883|Chronic Renal Insufficiency|chronic renal insufficiency
715024|NCT00194883|Children|children
715025|NCT00194870|EEG|eeg
715026|NCT00194870|DBS|dbs
715027|NCT00194857|anemia|anemia
715028|NCT00194857|dose reduction|dose reduction
715029|NCT00194857|neutropenia|neutropenia
715030|NCT00194857|hepatitis C virus|hepatitis c virus
715031|NCT00194857|human immunodeficiency virus|human immunodeficiency virus
715032|NCT00194844|caring|caring
715033|NCT00194844|miscarriage|miscarriage
715034|NCT00194844|grief|grief
715035|NCT00194844|couples|couples
715036|NCT00194844|counseling|counseling
715037|NCT00194805|Internet|internet
715038|NCT00194805|Diabetes|diabetes
715039|NCT00194805|Education|education
715040|NCT00194805|Social Support|social support
715041|NCT00194766|Breast cancer|breast cancer
715042|NCT00194766|Soft tissue sarcoma|soft tissue sarcoma
715043|NCT00194753|Breast cancer|breast cancer
715044|NCT00194740|Breast cancer|breast cancer
715045|NCT00194727|Breast cancer|breast cancer
715046|NCT00194701|heart failure|heart failure
715047|NCT00194701|sleep|sleep
715048|NCT00194701|exercise|exercise
715049|NCT00194701|heart rate variability|heart rate variability
715050|NCT00194688|ammonia|ammonia
715051|NCT00194675|androgen deficiency|androgen deficiency
715052|NCT00194675|testosterone|testosterone
715053|NCT00194675|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
715054|NCT00194675|hypogonadism|hypogonadism
715055|NCT00194675|prostate|prostate
715056|NCT00194675|BPH|bph
715057|NCT00194649|Glycosphingolipids (GSL)|glycosphingolipids (gsl)
715058|NCT00194636|Prostatitis|prostatitis
715059|NCT00194636|Chronic Male Pelvic Pain Syndrome|chronic male pelvic pain syndrome
715060|NCT00194623|prostatitis|prostatitis
715061|NCT00194597|Prostatitis|prostatitis
715062|NCT00194584|children|children
715063|NCT00194584|chronic illness|chronic illness
715064|NCT00194584|parent education|parent education
715065|NCT00194584|parent support|parent support
715066|NCT00194571|breast cancer,|breast cancer,
715067|NCT00194571|child functioning,|child functioning,
715068|NCT00194571|parenting,|parenting,
715069|NCT00194571|self-efficacy,|self-efficacy,
715070|NCT00194571|psychoeducational intervention|psychoeducational intervention
715071|NCT00194571|counseling|counseling
715072|NCT00194558|Diabetes|diabetes
715073|NCT00194558|Health Education|health education
715074|NCT00194558|Information Technology|information technology
715075|NCT00194558|Disease Management|disease management
715076|NCT00194558|Internet|internet
715077|NCT00194558|Patient Education|patient education
715078|NCT00194545|HIV-1|hiv-1
715079|NCT00194545|pediatric adherence|pediatric adherence
715080|NCT00194545|medication diaries|medication diaries
715081|NCT00194545|HAART|haart
715082|NCT00194545|Treatment Naive|treatment naive
715083|NCT00194532|UTI|uti
715084|NCT00194519|HIV infection|hiv infection
715085|NCT00194519|HIV transmission|hiv transmission
715086|NCT00194519|genital herpes|genital herpes
715087|NCT00194519|sexual intercourse|sexual intercourse
715088|NCT00194519|sexual transmitted infection|sexual transmitted infection
715089|NCT00194519|acyclovir|acyclovir
715090|NCT00194519|HIV Seronegativity|hiv seronegativity
715091|NCT00194519|Treatment Naive|treatment naive
715092|NCT00194519|HIV-discordant couples|hiv-discordant couples
715093|NCT00194519|HIV serodiagnosis|hiv serodiagnosis
715094|NCT00194506|Diabetes|diabetes
715095|NCT00194506|Health Education|health education
715096|NCT00194506|Information Technology|information technology
715097|NCT00194506|Disease Management|disease management
715098|NCT00194506|Internet|internet
715099|NCT00194506|Patient Education|patient education
715100|NCT00194493|Cancer|cancer
715101|NCT00194493|Quality of Life|quality of life
715102|NCT00194493|Signs and Symptoms|signs and symptoms
715103|NCT00194493|Computers|computers
715104|NCT00194493|Patient-Reported Outcomes|patient-reported outcomes
715105|NCT00194480|Hepatitis C, peg-Interferon, drug abuse|hepatitis c, peg-interferon, drug abuse
715106|NCT00194454|Depressive symptoms|depressive symptoms
715107|NCT00194454|Behavior and behavior mechanisms|behavior and behavior mechanisms
715108|NCT00194454|Recovery|recovery
715109|NCT00194441|cerebral circulation|cerebral circulation
715110|NCT00194441|monitoring, physiologic|monitoring, physiologic
715111|NCT00194441|informatics|informatics
715112|NCT00194441|nursing care|nursing care
715113|NCT00194441|physiologic variability|physiologic variability
715114|NCT00194441|outcome|outcome
715115|NCT00194441|quality adjusted life years|quality adjusted life years
715116|NCT00194428|Obesity,|obesity,
715117|NCT00194428|Metabolic Syndrome,|metabolic syndrome,
715118|NCT00194428|BMI|bmi
715119|NCT00194402|cholesterol|cholesterol
715120|NCT00194402|dyslipidemia|dyslipidemia
715121|NCT00194402|hypercholesterolemia|hypercholesterolemia
715122|NCT00194402|C-reactive protein|c-reactive protein
715123|NCT00194363|breast cancer|breast cancer
715124|NCT00194363|breast cancer survivors|breast cancer survivors
715125|NCT00194363|lymphedema|lymphedema
715126|NCT00194363|strength training|strength training
715127|NCT00194363|breast cancer survivorship|breast cancer survivorship
715128|NCT00194350|Infertility|infertility
715129|NCT00194350|Factor V Leiden|factor v leiden
715130|NCT00194337|stage I breast cancer|stage i breast cancer
715131|NCT00194337|stage II breast cancer|stage ii breast cancer
715132|NCT00194337|stage IIIA breast cancer|stage iiia breast cancer
715133|NCT00194337|stage IIIB breast cancer|stage iiib breast cancer
715134|NCT00194337|stage IIIC breast cancer|stage iiic breast cancer
715135|NCT00194337|stage IV breast cancer|stage iv breast cancer
715136|NCT00194311|HPV|hpv
715137|NCT00194311|Pregnancy|pregnancy
715138|NCT00194298|diabetic foot disease|diabetic foot disease
715139|NCT00194298|osteomyelitis|osteomyelitis
715140|NCT00194298|charcot|charcot
715141|NCT00194298|neuropathy|neuropathy
715142|NCT00194298|hypoxia|hypoxia
715143|NCT00194298|[18 F] Fluorodeoxyglucose|[18 f] fluorodeoxyglucose
715144|NCT00194298|Positron Emission Tomography Imaging|positron emission tomography imaging
715145|NCT00194285|Prosthesis|prosthesis
715146|NCT00194285|[18 F] Fluorodeoxyglucose|[18 f] fluorodeoxyglucose
715147|NCT00194285|Positron Emission Tomography Imaging|positron emission tomography imaging
715148|NCT00194272|Ectopic pregnancy|ectopic pregnancy
715149|NCT00194272|Methotrexate|methotrexate
715150|NCT00194233|Endometriosis|endometriosis
715151|NCT00194220|Infertility|infertility
715152|NCT00194220|Oxidative stress|oxidative stress
715153|NCT00194207|Ectopic pregnancy|ectopic pregnancy
715154|NCT00194194|BMI|bmi
715155|NCT00194194|RMR|rmr
715156|NCT00194194|Personal Computer|personal computer
715157|NCT00194181|dialysis|dialysis
715158|NCT00194181|fibrin|fibrin
715159|NCT00194181|sheath|sheath
715160|NCT00194181|clot|clot
715161|NCT00194181|tpa|tpa
715162|NCT00194168|ectopic pregnancy|ectopic pregnancy
715163|NCT00194155|cytomegalovirus|cytomegalovirus
715164|NCT00194155|pregnancy|pregnancy
715165|NCT00194155|placenta|placenta
715166|NCT00194142|Pregnancy|pregnancy
715167|NCT00194142|Cytomegalovirus|cytomegalovirus
715168|NCT00194090|pain|pain
715169|NCT00194090|osteoarthritis|osteoarthritis
715170|NCT00194051|obesity|obesity
715171|NCT00194051|gait biomechanics|gait biomechanics
715172|NCT00194051|knee osteoarthritis|knee osteoarthritis
715173|NCT00194038|Bipolar Disorder|bipolar disorder
715174|NCT00194038|Geriatric Psychiatry|geriatric psychiatry
715175|NCT00194038|Aripiprazole|aripiprazole
715176|NCT00194025|Schizophrenia|schizophrenia
715177|NCT00194025|Anticonvulsants|anticonvulsants
715178|NCT00194025|Valproic Acid|valproic acid
715179|NCT00194025|Valproate|valproate
715180|NCT00194012|bipolar disorder|bipolar disorder
715181|NCT00193999|Nasogastric Tubes|nasogastric tubes
715182|NCT00193999|Nausea|nausea
715183|NCT00193999|Vomiting|vomiting
715184|NCT00193999|Cardiac surgery|cardiac surgery
715185|NCT00193986|Prepulse|prepulse
715186|NCT00193986|Defibrillator|defibrillator
715188|NCT00193973|PCNSL|pcnsl
715189|NCT00193973|Primary CNS lymphoma|primary cns lymphoma
715190|NCT00193960|Seton surgery, glaucoma, Ahmed valve, intraocular pressure|seton surgery, glaucoma, ahmed valve, intraocular pressure
715191|NCT00193934|Women's Health|women's health
715192|NCT00193934|Multidisciplinary, multicentre prospective study|multidisciplinary, multicentre prospective study
715193|NCT00193934|Cancer:mechanisms of growth, invasion, metastases|cancer:mechanisms of growth, invasion, metastases
715194|NCT00193934|Figo Stages cervical cancer|figo stages cervical cancer
715195|NCT00193934|Advances in diagnosis using radiological methods|advances in diagnosis using radiological methods
715196|NCT00193934|Quantitative Magnetic Resonance Imaging|quantitative magnetic resonance imaging
715197|NCT00193934|Patient Management Strategies|patient management strategies
715198|NCT00193934|Selecting patients for therapy|selecting patients for therapy
715199|NCT00193921|Chemoradiotherapy|chemoradiotherapy
715200|NCT00193921|High dose|high dose
715201|NCT00193921|palliative radiotherapy|palliative radiotherapy
715202|NCT00193921|Quality of life|quality of life
715203|NCT00193908|Skin care|skin care
715204|NCT00193908|Radiotherapy|radiotherapy
715205|NCT00193895|Skin cancer|skin cancer
715206|NCT00193895|radiotherapy|radiotherapy
715207|NCT00193895|chemotherapy|chemotherapy
715208|NCT00193895|surgery|surgery
715209|NCT00193882|Oesophageal|oesophageal
715210|NCT00193882|Dysphagia|dysphagia
715211|NCT00193882|Palliation|palliation
715212|NCT00193882|Quality of Life|quality of life
715213|NCT00193882|Radiotherapy|radiotherapy
715214|NCT00193882|Chemotherapy|chemotherapy
715215|NCT00193869|Radiotherapy|radiotherapy
715216|NCT00193869|Dose fractionation|dose fractionation
715217|NCT00193856|Prostate Cancer|prostate cancer
715218|NCT00193856|Androgen Deprivation|androgen deprivation
715219|NCT00193856|Hormone Therapy|hormone therapy
715220|NCT00193856|RadiotherapyBisphosphonate|radiotherapybisphosphonate
715221|NCT00193856|Prostate Specific Antigen (PSA)|prostate specific antigen (psa)
715222|NCT00193843|Oral cancer|oral cancer
715223|NCT00193843|Head and neck surgery|head and neck surgery
715224|NCT00193843|Accelerated radiotherapy|accelerated radiotherapy
715225|NCT00193843|Chemo-radiotherapy|chemo-radiotherapy
715226|NCT00193830|Cervical Cancer|cervical cancer
715227|NCT00193830|High Dose Rate (HDR) Brachytherapy|high dose rate (hdr) brachytherapy
715228|NCT00193830|Low Dose Rate (LDR) Brachytherapy|low dose rate (ldr) brachytherapy
715229|NCT00193830|Acute Toxicities|acute toxicities
715230|NCT00193830|Late Radiation Sequelae|late radiation sequelae
715231|NCT00193817|Cancer|cancer
715232|NCT00193817|Esophagus|esophagus
715233|NCT00193817|Lymphadenectomy|lymphadenectomy
715234|NCT00193804|Cervical Cancer|cervical cancer
715235|NCT00193804|FIGO STAGE IIB|figo stage iib
715236|NCT00193804|CHEMORADIATION|chemoradiation
715237|NCT00193804|Intensity Modulated Radiation Therapy(IMRT)|intensity modulated radiation therapy(imrt)
715238|NCT00193804|Conventional Radiation Therapy|conventional radiation therapy
715239|NCT00193804|Cancer of the Cervix|cancer of the cervix
715240|NCT00193804|Cervix Cancer|cervix cancer
715241|NCT00193791|Carcinoma Cervix|carcinoma cervix
715242|NCT00193791|FIGO Stage IIIB|figo stage iiib
715243|NCT00193791|Radiation therapy|radiation therapy
715244|NCT00193791|Chemoradiation|chemoradiation
715245|NCT00193791|Treatment related toxicities|treatment related toxicities
715246|NCT00193791|Cervical Cancer|cervical cancer
715247|NCT00193791|Cervix Cancer|cervix cancer
715248|NCT00193778|Metastatic breast cancer|metastatic breast cancer
715249|NCT00193778|Locoregional treatment|locoregional treatment
715250|NCT00193778|Survival|survival
715251|NCT00193765|neck dissection|neck dissection
715252|NCT00193765|survival|survival
715253|NCT00193765|early oral cancer|early oral cancer
715254|NCT00193765|Early oral cavity squamous cancer with node negative neck|early oral cavity squamous cancer with node negative neck
715255|NCT00193752|FDG-PET Imaging|fdg-pet imaging
715256|NCT00193752|Cervical Cancer|cervical cancer
715257|NCT00193752|Post-treatment evaluation|post-treatment evaluation
715258|NCT00193752|Para-aortic Nodal Staging|para-aortic nodal staging
715259|NCT00193752|Extended field Radiation|extended field radiation
715260|NCT00193752|Extended field IMRT|extended field imrt
715261|NCT00193739|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
715262|NCT00193739|Surgery|surgery
715263|NCT00193739|Cervix cancer|cervix cancer
715264|NCT00193739|Concurrent chemoradiation|concurrent chemoradiation
715265|NCT00193726|Estrogen|estrogen
715266|NCT00193726|Priming|priming
715267|NCT00193726|Adjuvant chemotherapy|adjuvant chemotherapy
715268|NCT00193726|Breast cancer|breast cancer
715269|NCT00193713|double-blind study in the treatment of schizophrenia|double-blind study in the treatment of schizophrenia
715270|NCT00193700|Hypogonadism|hypogonadism
715271|NCT00193687|open-label study in the treatment of schizophrenia|open-label study in the treatment of schizophrenia
715272|NCT00193674|Pregnancy|pregnancy
715273|NCT00193674|Immunology|immunology
715274|NCT00193674|Unexplained recurrent miscarriage|unexplained recurrent miscarriage
715275|NCT00193661|Hypogonadism|hypogonadism
715276|NCT00193648|FSGS|fsgs
715277|NCT00193648|Pharmacokinetics|pharmacokinetics
715278|NCT00193648|Rosiglitazone|rosiglitazone
715279|NCT00193648|PPAR-gamma agonist|ppar-gamma agonist
715280|NCT00193648|Adalimumab|adalimumab
715281|NCT00193648|TNF-alpha antagonist|tnf-alpha antagonist
715282|NCT00193648|Steroid and immunosuppressive drug resistance|steroid and immunosuppressive drug resistance
715283|NCT00193648|Resistant primary FSGS|resistant primary fsgs
715284|NCT00193635|Congenital uropathies|congenital uropathies
715285|NCT00193635|Mycophenolate mofetil|mycophenolate mofetil
715286|NCT00193635|GFR|gfr
715287|NCT00193635|Iothalamate clearance|iothalamate clearance
715288|NCT00193635|Urine cytometry|urine cytometry
715289|NCT00193635|Children|children
715290|NCT00193635|Congenital urological abnormalities which represent stuctural defects in the genitourinary system|congenital urological abnormalities which represent stuctural defects in the genitourinary system
715291|NCT00193609|Neoplasms, Unknown Primary|neoplasms, unknown primary
715292|NCT00193596|Neoplasms, Unknown Primary|neoplasms, unknown primary
715293|NCT00193492|Lymphoma|lymphoma
715294|NCT00193492|Bevacizumab|bevacizumab
715295|NCT00193492|Rituximab|rituximab
715296|NCT00193453|Lung Cancer|lung cancer
715297|NCT00193336|NSCLC Lung Cancer|nsclc lung cancer
715298|NCT00193336|Non Small Cell Lung Cancer|non small cell lung cancer
715299|NCT00193297|Ovary Cancer|ovary cancer
715300|NCT00193258|Recurrent clear cell renal cell carcinoma|recurrent clear cell renal cell carcinoma
715301|NCT00193258|Bevacizumab|bevacizumab
715302|NCT00193258|Erlotinib|erlotinib
715303|NCT00193258|Imatinib|imatinib
715304|NCT00193219|Colon Cancer|colon cancer
715305|NCT00193206|Locally Advanced Breast Cancer|locally advanced breast cancer
715306|NCT00193206|Inflammatory Breast Cancer|inflammatory breast cancer
715307|NCT00193206|Breast Cancer|breast cancer
715308|NCT00193206|Abraxane|abraxane
715309|NCT00193206|nab Paclitaxel|nab paclitaxel
715310|NCT00193206|Epirubicin|epirubicin
715311|NCT00193206|Gemcitabine|gemcitabine
715312|NCT00193206|Gemzar|gemzar
715313|NCT00193180|Breast Cancer|breast cancer
715314|NCT00193154|Kidney Cancer|kidney cancer
715315|NCT00193128|Esophagus Cancer|esophagus cancer
715316|NCT00193037|Breast Cancer|breast cancer
715317|NCT00192998|Affective disorder|affective disorder
715318|NCT00192998|Alzheimer dementia|alzheimer dementia
715319|NCT00192998|healthy controls|healthy controls
715320|NCT00192972|Catheter ablation|catheter ablation
715321|NCT00192972|Atrial fibrillation|atrial fibrillation
715322|NCT00192959|Anaesthesia|anaesthesia
715323|NCT00192959|Surgery|surgery
715324|NCT00192959|Postoperative|postoperative
715325|NCT00192959|Neuropsychological test|neuropsychological test
715326|NCT00192946|Cardiac resynchronization|cardiac resynchronization
715327|NCT00192946|Heart failure|heart failure
715328|NCT00192946|open heart surgery|open heart surgery
715329|NCT00192946|surgery|surgery
715330|NCT00192881|Percutaneous coronary intervention|percutaneous coronary intervention
715331|NCT00192881|Balloon angioplasty|balloon angioplasty
715332|NCT00192881|Restenosis|restenosis
715333|NCT00192881|Stents|stents
715334|NCT00192868|primary PCI|primary pci
715335|NCT00192868|distal protection|distal protection
715336|NCT00192868|drug eluting stent|drug eluting stent
715337|NCT00192868|restenosis|restenosis
715338|NCT00192855|schizophrenia|schizophrenia
715339|NCT00192855|negative symptoms|negative symptoms
715340|NCT00192855|entacapone|entacapone
715341|NCT00192842|carcinoma|carcinoma
715342|NCT00192842|pancreas|pancreas
715343|NCT00192842|gemcitabine|gemcitabine
715344|NCT00192842|curcumin|curcumin
715345|NCT00192829|Lung cancer|lung cancer
715346|NCT00192829|Thrombosis|thrombosis
715347|NCT00192829|Hypercoagulable|hypercoagulable
715348|NCT00192803|niddm|niddm
715349|NCT00192803|ace2|ace2
715350|NCT00192803|NIDDM patients|niddm patients
715351|NCT00192790|Therma,pain, Silent myocardial ischemia, catastrophizing|therma,pain, silent myocardial ischemia, catastrophizing
715352|NCT00192777|Solid Tumors|solid tumors
715353|NCT00192777|Bone Metastases|bone metastases
715354|NCT00192777|Radiotherapy|radiotherapy
715355|NCT00192777|Xeloda|xeloda
715356|NCT00192777|Concurrent|concurrent
715357|NCT00192777|Radiosensitization|radiosensitization
715358|NCT00192764|large cell lymphoma|large cell lymphoma
715359|NCT00192764|CHOP|chop
715360|NCT00192764|cyclophosphamide|cyclophosphamide
715361|NCT00192764|high-dose|high-dose
715362|NCT00192751|Schizophrenia|schizophrenia
715363|NCT00192751|Major depression|major depression
715364|NCT00192751|Bipolar disorder|bipolar disorder
715365|NCT00192751|Compliance|compliance
715366|NCT00192751|Relapse prevention|relapse prevention
715367|NCT00192738|telephone,|telephone,
715368|NCT00192738|internal medicine,|internal medicine,
715369|NCT00192738|readmission,|readmission,
715370|NCT00192738|patients' satisfaction|patients' satisfaction
715371|NCT00192725|bipolar disorder|bipolar disorder
715372|NCT00192725|acute mania|acute mania
715373|NCT00192725|tryptophan depletion|tryptophan depletion
715374|NCT00192725|placebo controlled add-on|placebo controlled add-on
715375|NCT00192725|Bipolar disorder- manic type|bipolar disorder- manic type
715376|NCT00192712|carcinoma|carcinoma
715377|NCT00192712|pancreas|pancreas
715378|NCT00192712|chemotherapy|chemotherapy
715379|NCT00192712|radiotherapy|radiotherapy
715380|NCT00192699|Osteoarthritis|osteoarthritis
715381|NCT00192673|Asparaginase|asparaginase
715382|NCT00192673|intramuscular administration|intramuscular administration
715383|NCT00192673|Silent antibodies|silent antibodies
715384|NCT00192673|Childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
715385|NCT00192673|Side effects|side effects
715386|NCT00192673|5-year EFS|5-year efs
715387|NCT00192660|HIV|hiv
715388|NCT00192660|Metabolic abnormality|metabolic abnormality
715389|NCT00192660|Lipodystrophy|lipodystrophy
715390|NCT00192660|Cardiovascular disease|cardiovascular disease
715391|NCT00192660|Treatment Naive|treatment naive
715392|NCT00192660|Treatment Experienced|treatment experienced
715393|NCT00192660|HIV Infections|hiv infections
715394|NCT00192634|HIV|hiv
715395|NCT00192634|Antiretroviral therapy|antiretroviral therapy
715396|NCT00192634|nucleoside analogue reverse transcriptase|nucleoside analogue reverse transcriptase
715397|NCT00192634|fixed dose combination|fixed dose combination
715398|NCT00192634|Treatment Experienced|treatment experienced
715399|NCT00192621|HIV negative healthy subjects|hiv negative healthy subjects
715400|NCT00192621|Lipid metabolism|lipid metabolism
715401|NCT00192621|Glucose metabolism|glucose metabolism
715402|NCT00192621|Metabolic abnormality|metabolic abnormality
715403|NCT00192621|Lipodystrophy|lipodystrophy
715404|NCT00192621|Cardiovascular disease|cardiovascular disease
715405|NCT00192621|Treatment Naive|treatment naive
715406|NCT00192621|HIV|hiv
715407|NCT00192608|Pharmacokinetics, atazanavir, saquinavir, ritonavir, HIV|pharmacokinetics, atazanavir, saquinavir, ritonavir, hiv
715408|NCT00192595|Hepatitis B|hepatitis b
715409|NCT00192595|HIV|hiv
715410|NCT00192595|Treatment Naive|treatment naive
715411|NCT00192582|Motivational interview|motivational interview
715412|NCT00192582|Care plan|care plan
715413|NCT00192582|Relapse prevention|relapse prevention
715414|NCT00192582|Psychoeducation|psychoeducation
715415|NCT00192582|Indigenous mental health|indigenous mental health
715416|NCT00192569|Acute Hepatitis C|acute hepatitis c
715417|NCT00192556|tuberculosis|tuberculosis
715418|NCT00192556|nutrition|nutrition
715419|NCT00192556|directly observed therapy|directly observed therapy
715420|NCT00192556|Timor Leste|timor leste
715421|NCT00192556|cost-effectiveness|cost-effectiveness
715422|NCT00192543|dialysis|dialysis
715423|NCT00192543|omega-3 fatty acids|omega-3 fatty acids
715424|NCT00192543|antioxidants|antioxidants
715425|NCT00192543|cardiovascular markers|cardiovascular markers
715426|NCT00192543|Mortality|mortality
715427|NCT00192543|End-stage renal disease|end-stage renal disease
715428|NCT00191971|Transitional cell carcinoma of urothelium|transitional cell carcinoma of urothelium
715429|NCT00191282|diabetes|diabetes
715430|NCT00191282|MI|mi
715431|NCT00191282|heart attack|heart attack
715432|NCT00191269|after|after
715433|NCT00191269|anthracycline|anthracycline
715434|NCT00191269|taxane|taxane
715435|NCT00191269|regimen|regimen
715436|NCT00191243|breast cancer|breast cancer
715437|NCT00191113|syndrome|syndrome
715438|NCT00191113|Turner|turner
715439|NCT00191113|Turner's|turner's
715440|NCT00191113|height|height
715441|NCT00191113|growth|growth
715442|NCT00191113|growth hormone|growth hormone
715443|NCT00191113|somatropin|somatropin
715444|NCT00191113|short stature|short stature
715445|NCT00191113|short|short
715446|NCT00191113|hearing|hearing
715447|NCT00191113|glucose metabolism|glucose metabolism
715448|NCT00190671|Advanced Breast Cancer|advanced breast cancer
715449|NCT00190580|CKD|ckd
715450|NCT00190580|chronic kidney disease|chronic kidney disease
715451|NCT00190580|hypertension|hypertension
715452|NCT00190580|angiotensin II receptor blocker|angiotensin ii receptor blocker
715453|NCT00190580|cardiovascular disease|cardiovascular disease
715454|NCT00190580|valsartan|valsartan
715455|NCT00190580|KVT|kvt
715456|NCT00190554|esophageal cancer|esophageal cancer
715457|NCT00190554|squamous cell carcinoma|squamous cell carcinoma
715458|NCT00190554|esophagectomy|esophagectomy
715459|NCT00190554|neoadjuvant chemotherapy|neoadjuvant chemotherapy
715460|NCT00190554|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
715461|NCT00190541|Rectal Cancer|rectal cancer
715462|NCT00190541|Lymph Node Dissection|lymph node dissection
715463|NCT00190541|Rectal Surgery|rectal surgery
715464|NCT00190541|Autonomic Nerves|autonomic nerves
715465|NCT00190541|Stage II, III lower rectal cancer|stage ii, iii lower rectal cancer
715466|NCT00190528|cervical cancer|cervical cancer
715467|NCT00190528|drug therapy|drug therapy
715468|NCT00190528|cisplatin|cisplatin
715469|NCT00190528|bleomycin|bleomycin
715470|NCT00190528|mitomycin|mitomycin
715471|NCT00190528|vincristine|vincristine
715472|NCT00190515|adjuvant chemotherapy|adjuvant chemotherapy
715473|NCT00190515|Stage III colorectal cancer|stage iii colorectal cancer
715474|NCT00190515|5-FU+l-LV|5-fu+l-lv
715475|NCT00190515|UFT+LV|uft+lv
715476|NCT00190515|randomized controlled trial|randomized controlled trial
715477|NCT00190502|Type 1 diabetes mellitus|type 1 diabetes mellitus
715478|NCT00190502|Immune intervention|immune intervention
715479|NCT00190502|Polyclonal antibodies|polyclonal antibodies
715874|NCT00188838|Depression|depression
715480|NCT00190502|Type 1 diabetes of recent onset|type 1 diabetes of recent onset
715481|NCT00190502|C-peptide level 0.3 pmol/l or higher|c-peptide level 0.3 pmol/l or higher
715482|NCT00190502|Positivity of at least one marker of autoimmunity (diabetes)|positivity of at least one marker of autoimmunity (diabetes)
715483|NCT00190489|metastatic breast cancer|metastatic breast cancer
715484|NCT00190489|drug therapy|drug therapy
715485|NCT00190489|doxorubicin|doxorubicin
715486|NCT00190489|docetaxel|docetaxel
715487|NCT00190476|Elderly|elderly
715488|NCT00190476|advanced|advanced
715489|NCT00190476|non-small-cell lung cancer|non-small-cell lung cancer
715490|NCT00190476|cisplatin|cisplatin
715491|NCT00190476|docetaxel|docetaxel
715492|NCT00190476|weekly|weekly
715493|NCT00190476|combination|combination
715494|NCT00190476|chemotherapy|chemotherapy
715495|NCT00190476|randomized trial|randomized trial
715496|NCT00190463|aspergillosis|aspergillosis
715497|NCT00190463|antifungal therapy|antifungal therapy
715498|NCT00190463|empirical antifungal treatment|empirical antifungal treatment
715499|NCT00190450|Huntington|huntington
715500|NCT00190450|graft|graft
715501|NCT00190450|cellular therapy|cellular therapy
715502|NCT00190450|striatum|striatum
715503|NCT00190437|Chronic Obstructive Lung Disease (COLD)|chronic obstructive lung disease (cold)
715504|NCT00190437|Randomized Clinical Trial|randomized clinical trial
715505|NCT00190437|Antibiotics|antibiotics
715506|NCT00190437|Acute Exacerbation|acute exacerbation
715507|NCT00190437|Mechanical|mechanical
715508|NCT00190437|Ventilation|ventilation
715509|NCT00190437|Intensive Care|intensive care
715510|NCT00190437|Length of Stay|length of stay
715511|NCT00190437|Mortality|mortality
715512|NCT00190424|Glioblastoma|glioblastoma
715513|NCT00190424|Immunotherapy|immunotherapy
715514|NCT00190411|Arteries|arteries
715515|NCT00190411|ultrasonography|ultrasonography
715516|NCT00190411|Ehlers Danlos syndrome|ehlers danlos syndrome
715517|NCT00190411|Cardiovascular disease|cardiovascular disease
715518|NCT00190411|beta adrenergic antagonists|beta adrenergic antagonists
715519|NCT00190398|Prospective|prospective
715520|NCT00190398|Randomised|randomised
715521|NCT00190398|Open|open
715522|NCT00190398|Blinded End-point|blinded end-point
715523|NCT00190398|PROBE Study|probe study
715524|NCT00190398|Ischemic stroke|ischemic stroke
715525|NCT00190385|Cirrhosis|cirrhosis
715526|NCT00190385|Hepatocellular carcinoma|hepatocellular carcinoma
715527|NCT00190385|Screening|screening
715528|NCT00190385|Randomized|randomized
715529|NCT00190385|HBV|hbv
715530|NCT00190385|HCV|hcv
715531|NCT00190385|alcohol|alcohol
715532|NCT00190385|hemochromatosis|hemochromatosis
715533|NCT00190372|Alzheimer's disease training programme|alzheimer's disease training programme
715534|NCT00190372|educational programme caregivers carers dementia treatment|educational programme caregivers carers dementia treatment
715535|NCT00190372|Dementia Cognitive disorder|dementia cognitive disorder
715536|NCT00190359|heart failure|heart failure
715537|NCT00190359|hormones|hormones
715538|NCT00190359|growth substances|growth substances
715539|NCT00190346|Acute respiratory distress|acute respiratory distress
715540|NCT00190346|with hypercapnia|with hypercapnia
715541|NCT00190346|with hypoxemia|with hypoxemia
715542|NCT00190346|requiring NIV|requiring niv
715543|NCT00190333|pulmonary hypertension|pulmonary hypertension
715544|NCT00190333|6 minutes walking test|6 minutes walking test
715545|NCT00190333|serotonin|serotonin
715546|NCT00190333|primary or associated pulmonary hypertension|primary or associated pulmonary hypertension
715547|NCT00190320|Fetal macrosomia|fetal macrosomia
715548|NCT00190320|Neonatal traumatism|neonatal traumatism
715549|NCT00190320|Maternal morbidity|maternal morbidity
715550|NCT00190307|Long term antiplatelet therapy|long term antiplatelet therapy
715551|NCT00190307|Scheduled surgery|scheduled surgery
715552|NCT00190294|Pregnancy Complications|pregnancy complications
715553|NCT00190281|FUNCTIONAL STUDY|functional study
715554|NCT00190281|CONTRAST-ENHANCED US|contrast-enhanced us
715555|NCT00190281|PERFUSION|perfusion
715556|NCT00190268|multiple sclerosis|multiple sclerosis
715557|NCT00190268|fatigue|fatigue
715558|NCT00190268|3,4-diaminopyridine|3,4-diaminopyridine
715559|NCT00190255|gastrointestinal haemorrhage|gastrointestinal haemorrhage
715560|NCT00190255|stomach ulcer|stomach ulcer
715561|NCT00190255|anti-inflammatory agents, non-steroidal|anti-inflammatory agents, non-steroidal
715562|NCT00190255|CYP2C9 protein, human|cyp2c9 protein, human
715563|NCT00190255|genotype|genotype
715564|NCT00190255|pharmacogenetics|pharmacogenetics
715565|NCT00190242|HIV|hiv
715566|NCT00190242|hepatitis A|hepatitis a
715567|NCT00190242|vaccine|vaccine
715568|NCT00190242|HBV and/or HCV co-infection|hbv and/or hcv co-infection
715569|NCT00190229|Vasculitis|vasculitis
715570|NCT00190229|Cyclophosphamide|cyclophosphamide
715571|NCT00190229|Renal failure|renal failure
715572|NCT00190216|Resistant depression|resistant depression
715573|NCT00190216|Transcranial Magnetic Stimulation,|transcranial magnetic stimulation,
715574|NCT00190216|Neuroimaging|neuroimaging
715575|NCT00190203|Malignant middle cerebral artery infarction|malignant middle cerebral artery infarction
715576|NCT00190203|Decompressive surgery|decompressive surgery
715577|NCT00190203|Hemicraniectomy|hemicraniectomy
715578|NCT00190203|Brain edema|brain edema
715579|NCT00190190|Macular hole|macular hole
715580|NCT00190190|internal limiting membrane|internal limiting membrane
715581|NCT00190190|retina|retina
715582|NCT00190190|surgery|surgery
715583|NCT00190164|Macular hole|macular hole
715584|NCT00190164|Vitrectomy|vitrectomy
715585|NCT00190164|positioning|positioning
715586|NCT00190164|retina|retina
715587|NCT00190164|surgery|surgery
715588|NCT00190151|ciprofloxacin|ciprofloxacin
715589|NCT00190151|commensal flora|commensal flora
715590|NCT00190151|resistance|resistance
715591|NCT00190151|Pharmacokinetic|pharmacokinetic
715592|NCT00190138|Bi-ventricular pacing|bi-ventricular pacing
715593|NCT00190138|ventricular resynchronization|ventricular resynchronization
715594|NCT00190138|baroreflex sensitivity|baroreflex sensitivity
715595|NCT00190138|heart rate variability|heart rate variability
715596|NCT00190125|Hemodialysis|hemodialysis
715597|NCT00190125|Malnutrition|malnutrition
715598|NCT00190125|Inflammation|inflammation
715599|NCT00190099|In-stent restenosis,|in-stent restenosis,
715600|NCT00190099|Drug eluting stent,|drug eluting stent,
715601|NCT00190099|dexamethasone,|dexamethasone,
715602|NCT00190099|Acute coronary syndrome|acute coronary syndrome
715603|NCT00190073|Epidermal nerves;protein gene product 9.5; ethanol|epidermal nerves;protein gene product 9.5; ethanol
715604|NCT00190060|Frailty|frailty
715605|NCT00190060|Muscle strength|muscle strength
715606|NCT00190060|Physical performance|physical performance
715607|NCT00190060|Bone mineral density|bone mineral density
715608|NCT00190060|Quality of life|quality of life
715609|NCT00190047|Cerebral Ischemia|cerebral ischemia
715610|NCT00190047|Ischemic Brain Injury|ischemic brain injury
715611|NCT00190047|Brain Infarction|brain infarction
715612|NCT00190047|Brain Ischemia|brain ischemia
715613|NCT00190034|Acetylcysteine|acetylcysteine
715614|NCT00190034|cardiac surgery|cardiac surgery
715615|NCT00190034|cardiopulmonary bypass|cardiopulmonary bypass
715616|NCT00190034|acute renal insufficiency|acute renal insufficiency
715617|NCT00190021|Alzheimer's type dementia|alzheimer's type dementia
715618|NCT00190021|donepezil|donepezil
715619|NCT00190021|double-blind|double-blind
715620|NCT00190008|tardive dyskinesia|tardive dyskinesia
715621|NCT00190008|piracetam|piracetam
715622|NCT00189995|schizophrenia|schizophrenia
715623|NCT00189995|aggression|aggression
715624|NCT00189995|clozapine|clozapine
715625|NCT00189995|efficacy|efficacy
715626|NCT00189995|double-blind|double-blind
715627|NCT00189982|Factor VIII Deficiency|factor viii deficiency
715628|NCT00189930|Treatment Experienced|treatment experienced
715629|NCT00189904|HIV|hiv
715630|NCT00189878|chronic idiopathic urticaria|chronic idiopathic urticaria
715631|NCT00189878|methotrexate|methotrexate
715632|NCT00189852|Telecare|telecare
715633|NCT00189852|chronic|chronic
715634|NCT00189852|older people|older people
715635|NCT00189852|heart failure|heart failure
715636|NCT00189839|Tacrolimus|tacrolimus
715637|NCT00189839|Kidney transplantation|kidney transplantation
715638|NCT00189839|Transplantation, kidney|transplantation, kidney
715639|NCT00189839|Renal Transplantation|renal transplantation
715640|NCT00189839|Transplantation, renal|transplantation, renal
715641|NCT00189826|Tacrolimus|tacrolimus
715642|NCT00189826|Liver transplantation|liver transplantation
715643|NCT00189813|Irritable Bowel Syndrome|irritable bowel syndrome
715644|NCT00189813|Diarrhea|diarrhea
715645|NCT00189813|Nasea®|nasea®
715646|NCT00189813|Irribow®|irribow®
715647|NCT00189813|ramosetron|ramosetron
715648|NCT00189800|Solifenacin|solifenacin
715649|NCT00189800|tolterodine|tolterodine
715650|NCT00189800|randomized controlled trial|randomized controlled trial
715651|NCT00189800|double-blind method|double-blind method
715652|NCT00189787|Tacrolimus|tacrolimus
715653|NCT00189787|Immunosuppressant|immunosuppressant
715654|NCT00189787|Anti-asthmatic drug|anti-asthmatic drug
715655|NCT00189787|Administration, inhalation|administration, inhalation
715656|NCT00189774|nateglinide|nateglinide
715657|NCT00189774|pioglitazone|pioglitazone
715658|NCT00189774|combination drug therapy|combination drug therapy
715659|NCT00189774|treatment|treatment
715660|NCT00189761|Tacrolimus|tacrolimus
715661|NCT00189761|Immunosuppression|immunosuppression
715662|NCT00189761|Bone Marrow Transplantation|bone marrow transplantation
715663|NCT00189761|Graft versus Host Disease|graft versus host disease
715664|NCT00189748|Tacrolimus|tacrolimus
715665|NCT00189748|Immunosuppression|immunosuppression
715666|NCT00189748|Bone Marrow Transplantation|bone marrow transplantation
715667|NCT00189748|Graft versus Host Disease|graft versus host disease
715668|NCT00189735|Treatment Efficacy|treatment efficacy
715669|NCT00189735|Treatment Effectiveness|treatment effectiveness
715670|NCT00189735|Anti-rejection therapy|anti-rejection therapy
715671|NCT00189735|Immunosuppression|immunosuppression
715672|NCT00189735|Antirejection|antirejection
715673|NCT00189735|Malononitrilamide|malononitrilamide
715674|NCT00189722|Tacrolimus|tacrolimus
715675|NCT00189722|Immunosuppressant|immunosuppressant
715676|NCT00189722|Anti-asthmatic drug|anti-asthmatic drug
715977|NCT00188188|Systemic|systemic
715677|NCT00189722|Administration, inhalation|administration, inhalation
715678|NCT00189709|micafungin|micafungin
715679|NCT00189709|fluconazole|fluconazole
715680|NCT00189709|invasive candidiasis|invasive candidiasis
715681|NCT00189709|candidemia|candidemia
715682|NCT00189696|Irritable Bowel Syndrome, Diarrhea|irritable bowel syndrome, diarrhea
715683|NCT00189618|Peripheral vascular disease|peripheral vascular disease
715684|NCT00189618|Peripheral arterial disease|peripheral arterial disease
715685|NCT00189618|Walking Capacity|walking capacity
715686|NCT00189618|Aspirin|aspirin
715687|NCT00189618|Clopidogrel|clopidogrel
715688|NCT00189605|Plasma disc decompression|plasma disc decompression
715689|NCT00189605|Intradiscal Pressure|intradiscal pressure
715690|NCT00189605|Steroid Injection|steroid injection
715691|NCT00189605|Epidural Steroid Injection|epidural steroid injection
715692|NCT00189605|Selective Nerve Root Injection|selective nerve root injection
715693|NCT00189605|Leg Pain|leg pain
715694|NCT00189605|Radicular Pain|radicular pain
715695|NCT00189605|Coblation|coblation
715696|NCT00189605|SNRI|snri
715697|NCT00189592|plantar fascia|plantar fascia
715698|NCT00189592|plantar fasciitis|plantar fasciitis
715699|NCT00189592|Coblation|coblation
715700|NCT00189592|fasciotomy|fasciotomy
715701|NCT00189592|conventional surgical fasciotomy|conventional surgical fasciotomy
715702|NCT00189592|heel spur|heel spur
715703|NCT00189592|heel pain|heel pain
715704|NCT00189592|aponeurosis|aponeurosis
715705|NCT00189592|plasma based radiofrequency|plasma based radiofrequency
715706|NCT00189592|angiogenesis|angiogenesis
715707|NCT00189579|HERCEPTIN|herceptin
715708|NCT00189579|Carboplatin|carboplatin
715709|NCT00189579|Paclitaxel|paclitaxel
715710|NCT00189579|Relapse|relapse
715711|NCT00189566|Relapse within 6 months|relapse within 6 months
715712|NCT00189566|Previously received taxane derivative|previously received taxane derivative
715713|NCT00189553|Extra-ovarian papillary serous tumors|extra-ovarian papillary serous tumors
715714|NCT00189553|Relapse over 6 months|relapse over 6 months
715715|NCT00189553|Previously received taxane derivative|previously received taxane derivative
715716|NCT00189540|Ischemic ulcers|ischemic ulcers
715717|NCT00189540|Critical Limb Ischemia|critical limb ischemia
715718|NCT00189514|obesity|obesity
715719|NCT00189514|weight loss|weight loss
715720|NCT00189514|Amylin|amylin
715721|NCT00189514|pramlintide|pramlintide
715722|NCT00189501|Chronic Kidney Disease, CKD,|chronic kidney disease, ckd,
715723|NCT00189501|Secondary Hyperparathyroidism, HPT|secondary hyperparathyroidism, hpt
715724|NCT00189488|Hematological Malignancies|hematological malignancies
715725|NCT00189488|Graft-versus-host-disease|graft-versus-host-disease
715726|NCT00189488|Oral Mucositis|oral mucositis
715727|NCT00189488|Allogeneic Transplantation|allogeneic transplantation
715728|NCT00189475|Cold|cold
715729|NCT00189475|Upper Respiratory Infection|upper respiratory infection
715730|NCT00189462|Ear Infections|ear infections
715731|NCT00189462|Otitis Media|otitis media
715732|NCT00189449|Allergic Rhinitis|allergic rhinitis
715733|NCT00189449|Allergy|allergy
715734|NCT00189449|Growth|growth
715735|NCT00189436|Asthma|asthma
715736|NCT00189423|Heart Arrest|heart arrest
715737|NCT00189423|Cardiac Arrest|cardiac arrest
715738|NCT00189423|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
715739|NCT00189423|Impedance Threshold Device|impedance threshold device
715740|NCT00189423|Active Compression Decompression|active compression decompression
715741|NCT00189423|ResQPOD|resqpod
715742|NCT00189423|ResQPump|resqpump
715743|NCT00189423|Survival|survival
715744|NCT00189423|Out-of-hospital|out-of-hospital
715745|NCT00189423|Prehospital|prehospital
715746|NCT00189423|ResQCPR System|resqcpr system
715747|NCT00189397|Parthenium dermatitis|parthenium dermatitis
715748|NCT00189384|Neonatal sepsis|neonatal sepsis
715749|NCT00189384|Neonatal pneumonia|neonatal pneumonia
715750|NCT00189384|Bacterial infections|bacterial infections
715751|NCT00189384|Young infants|young infants
715752|NCT00189384|Neonate|neonate
715753|NCT00189384|Community|community
715754|NCT00189384|Developing country|developing country
715755|NCT00189358|cancer|cancer
715756|NCT00189358|cancer alternative therapies|cancer alternative therapies
715757|NCT00189358|ovarian cancer|ovarian cancer
715758|NCT00189358|tyrosine kinase inhibitor|tyrosine kinase inhibitor
715759|NCT00189345|Cancer|cancer
715760|NCT00189345|Cancer alternative therapies|cancer alternative therapies
715761|NCT00189345|ovarian cancer|ovarian cancer
715762|NCT00189332|Oncology|oncology
715763|NCT00189332|Melanoma|melanoma
715764|NCT00189319|Tambocor|tambocor
715765|NCT00189319|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
715766|NCT00189319|Quality of Life|quality of life
715767|NCT00189306|Superficial Basal Cell Carcinoma|superficial basal cell carcinoma
715768|NCT00189306|Aldara|aldara
715769|NCT00189293|External Ano-Genital Warts|external ano-genital warts
715770|NCT00189293|Ablative Therapy|ablative therapy
715771|NCT00189293|Aldara|aldara
715772|NCT00189280|Aldara, sBCC|aldara, sbcc
715773|NCT00189267|Aldara|aldara
715774|NCT00189267|Actinic Keratosis|actinic keratosis
715775|NCT00189267|Graft Recipients|graft recipients
715776|NCT00189254|1 year follow up|1 year follow up
715777|NCT00189241|Aldara|aldara
715778|NCT00189241|Superficial Basal Cell Carcinoma|superficial basal cell carcinoma
715779|NCT00189241|Long-Term Study|long-term study
715780|NCT00189215|coronary artery disease|coronary artery disease
715781|NCT00189215|cardiopulmonary bypass|cardiopulmonary bypass
715782|NCT00189215|cognition disorders|cognition disorders
715783|NCT00189189|prevention|prevention
715784|NCT00189189|oppositional defiant disorder|oppositional defiant disorder
715785|NCT00189189|conduct disorder|conduct disorder
715786|NCT00189163|Hepatitis C|hepatitis c
715787|NCT00189163|Genotype 1|genotype 1
715788|NCT00189163|Insulin Resistance|insulin resistance
715789|NCT00189163|Pioglitazone|pioglitazone
715790|NCT00189150|Valganciclovir|valganciclovir
715791|NCT00189150|Mycophenolate Mofetil|mycophenolate mofetil
715792|NCT00189150|Pharmacokinetic|pharmacokinetic
715793|NCT00189150|Interaction|interaction
715794|NCT00189150|MPA|mpa
715795|NCT00189124|Systemic Lupus Erythematosus|systemic lupus erythematosus
715796|NCT00189124|Dehydroepiandrosterone (DHEA)|dehydroepiandrosterone (dhea)
715797|NCT00189124|DHEA|dhea
715798|NCT00189124|SLE|sle
715799|NCT00189124|Lupus|lupus
715800|NCT00189111|peripheral arterial disease|peripheral arterial disease
715801|NCT00189111|computed tomography|computed tomography
715802|NCT00189111|cardiac asymptomatic|cardiac asymptomatic
715803|NCT00189111|dobutamine magnetic resonance imaging|dobutamine magnetic resonance imaging
715804|NCT00189085|Metabolic syndrome|metabolic syndrome
715805|NCT00189072|gabapentin|gabapentin
715806|NCT00189072|neuropathic pain|neuropathic pain
715807|NCT00189072|driving|driving
715808|NCT00189072|attention|attention
715809|NCT00189059|neuropathic pain|neuropathic pain
715810|NCT00189059|erp|erp
715811|NCT00189059|driving|driving
715812|NCT00189059|attention|attention
715813|NCT00189059|amitriptyline|amitriptyline
715814|NCT00189046|driving, chronic pain, attention|driving, chronic pain, attention
715815|NCT00189033|Irritable Bowel Syndrome|irritable bowel syndrome
715816|NCT00189033|Diet Therapy|diet therapy
715817|NCT00189033|Dietary Fiber|dietary fiber
715818|NCT00189033|Randomized Controlled Trial|randomized controlled trial
715819|NCT00189033|Family Practice|family practice
715820|NCT00189020|pneumococcal conjugate vaccination|pneumococcal conjugate vaccination
715821|NCT00189020|nasopharyngeal carriage|nasopharyngeal carriage
715822|NCT00189020|herd immunity|herd immunity
715823|NCT00189020|antipneumococcal antibodies|antipneumococcal antibodies
715824|NCT00189020|respiratory tract infections|respiratory tract infections
715825|NCT00189020|National infant vaccination program|national infant vaccination program
715826|NCT00189007|allopurinol|allopurinol
715827|NCT00189007|neuroprotection|neuroprotection
715828|NCT00189007|reperfusion injury|reperfusion injury
715829|NCT00189007|fetal hypoxia|fetal hypoxia
715830|NCT00189007|post hypoxic-ischemic reperfusion damage|post hypoxic-ischemic reperfusion damage
715831|NCT00188994|Myocardial Protection|myocardial protection
715832|NCT00188994|Myocardial Metabolism|myocardial metabolism
715833|NCT00188994|Ventricular Function|ventricular function
715834|NCT00188994|Cardiovascular Disease|cardiovascular disease
715835|NCT00188994|Cardioplegic Additives|cardioplegic additives
715836|NCT00188981|psychosis|psychosis
715837|NCT00188981|high risk|high risk
715838|NCT00188981|prodrome|prodrome
715839|NCT00188981|Multiple Complex Developmental Disorder|multiple complex developmental disorder
715840|NCT00188968|Xanthines|xanthines
715841|NCT00188968|Reintubation|reintubation
715842|NCT00188968|Nasal Intermittent Ventilation|nasal intermittent ventilation
715843|NCT00188968|Nasal continous positive airway pressure|nasal continous positive airway pressure
715844|NCT00188955|pediatric|pediatric
715845|NCT00188955|chronic allograft nephropathy|chronic allograft nephropathy
715846|NCT00188955|chronic rejection|chronic rejection
715847|NCT00188955|interstitial fibrosis|interstitial fibrosis
715848|NCT00188942|Magnetic Resonance Imaging|magnetic resonance imaging
715849|NCT00188942|Diagnostic Imaging|diagnostic imaging
715850|NCT00188942|Mood Disorders|mood disorders
715851|NCT00188942|Major Depressive Disorder|major depressive disorder
715852|NCT00188942|Antipsychotic|antipsychotic
715853|NCT00188942|Olanzapine|olanzapine
715854|NCT00188942|Fluoxetine|fluoxetine
715855|NCT00188916|Bronchial blockers|bronchial blockers
715856|NCT00188916|Lung isolation|lung isolation
715857|NCT00188916|Thoracic Anesthesia|thoracic anesthesia
715858|NCT00188903|Cardiac Surgery|cardiac surgery
715859|NCT00188903|Diastolic Dysfunction|diastolic dysfunction
715860|NCT00188903|Atrial Fibrillation|atrial fibrillation
715861|NCT00188890|Lung Cancer|lung cancer
715862|NCT00188890|Mesothelioma|mesothelioma
715863|NCT00188890|Asbestos|asbestos
715864|NCT00188890|Screening|screening
715865|NCT00188890|Early Diagnosis|early diagnosis
715866|NCT00188851|HIV|hiv
715867|NCT00188851|salvage regimen|salvage regimen
715868|NCT00188851|virologic failure|virologic failure
715869|NCT00188851|treatment interruption|treatment interruption
715870|NCT00188851|ARV experienced|arv experienced
715871|NCT00188838|Bipolar Disorder|bipolar disorder
715872|NCT00188838|Psychosocial Factors|psychosocial factors
715873|NCT00188838|Mania|mania
715875|NCT00188838|Social Adjustment|social adjustment
715876|NCT00188838|Coping Skills|coping skills
715877|NCT00188825|Lung|lung
715878|NCT00188825|Transplant|transplant
715879|NCT00188825|Rejection|rejection
715880|NCT00188825|BOS|bos
715881|NCT00188812|dementia|dementia
715882|NCT00188812|stroke|stroke
715883|NCT00188773|n-acetylcysteine,|n-acetylcysteine,
715884|NCT00188773|free fatty acid,|free fatty acid,
715885|NCT00188773|glucose stimulated insulin secretion,|glucose stimulated insulin secretion,
715886|NCT00188773|insulin resistance syndrome|insulin resistance syndrome
715887|NCT00188773|antioxidant therapy|antioxidant therapy
715888|NCT00188773|Insulin Resistance|insulin resistance
715889|NCT00188760|Breast Transillumination Spectroscopy|breast transillumination spectroscopy
715890|NCT00188760|Optical Transillumination Spectroscopy|optical transillumination spectroscopy
715891|NCT00188760|Breast Cancer Risk|breast cancer risk
715892|NCT00188747|Coagulopathy|coagulopathy
715893|NCT00188747|Cardiac Surgery|cardiac surgery
715894|NCT00188747|Point of Care|point of care
715895|NCT00188747|Monitoring|monitoring
715896|NCT00188734|Lung Cancer|lung cancer
715897|NCT00188734|Eary Diagnosis|eary diagnosis
715898|NCT00188734|Screening|screening
715899|NCT00188721|Breast Cancer Risk|breast cancer risk
715900|NCT00188721|Optical Transillumination Spectroscopy|optical transillumination spectroscopy
715901|NCT00188721|Transillumination Breast Spectroscopy|transillumination breast spectroscopy
715902|NCT00188682|Optical Transillumination Spectroscopy|optical transillumination spectroscopy
715903|NCT00188682|Transillumination Breast Spectroscopy|transillumination breast spectroscopy
715904|NCT00188682|Breast Cancer Risk|breast cancer risk
715905|NCT00188643|Bipolar Disorder, Depression, Anticonvulsants, Antidepressants|bipolar disorder, depression, anticonvulsants, antidepressants
715906|NCT00188630|Cardiac Surgery|cardiac surgery
715907|NCT00188630|Acute Renal Failure|acute renal failure
715908|NCT00188630|N-acetylcysteine|n-acetylcysteine
715909|NCT00188630|Cardiopulmonary bypass|cardiopulmonary bypass
715910|NCT00188617|LUNG CANCER|lung cancer
715911|NCT00188617|IRESSA|iressa
715912|NCT00188617|GEFITINIB|gefitinib
715913|NCT00188617|STAGE 1A & 1B|stage 1a & 1b
715914|NCT00188617|NEOADJUVANT|neoadjuvant
715915|NCT00188617|PHASE 2|phase 2
715916|NCT00188591|Optical Transillumination Spectroscopy|optical transillumination spectroscopy
715917|NCT00188591|Breast Cancer Risk|breast cancer risk
715918|NCT00188500|epilepsy|epilepsy
715919|NCT00188500|atkins diet|atkins diet
715920|NCT00188396|Major Depressive Disorder|major depressive disorder
715921|NCT00188396|Women's Mental Health|women's mental health
715922|NCT00188396|Hormones|hormones
715923|NCT00188396|Citalopram|citalopram
715924|NCT00188396|Antidepressive agents|antidepressive agents
715925|NCT00188396|Mental Health|mental health
715926|NCT00188383|Hyperalgesia|hyperalgesia
715927|NCT00188383|Quantitative Sensory Testing|quantitative sensory testing
715928|NCT00188383|Pain|pain
715929|NCT00188383|Opioid use|opioid use
715930|NCT00188383|Elderly|elderly
715931|NCT00188344|laparoscopic myotomy|laparoscopic myotomy
715932|NCT00188344|pneumatic dilatation|pneumatic dilatation
715933|NCT00188344|motility disorder|motility disorder
715934|NCT00188344|dysphasia|dysphasia
715935|NCT00188344|health-related quality of life|health-related quality of life
715936|NCT00188331|cognitive function|cognitive function
715937|NCT00188331|fatigue|fatigue
715938|NCT00188331|colorectal cancer|colorectal cancer
715939|NCT00188331|chemotherapy|chemotherapy
715940|NCT00188331|cognitive impairment|cognitive impairment
715941|NCT00188305|Risk counselling|risk counselling
715942|NCT00188305|Health education|health education
715943|NCT00188305|Prevention|prevention
715944|NCT00188305|Behavioral|behavioral
715945|NCT00188305|Screening|screening
715946|NCT00188305|Intervention|intervention
715947|NCT00188305|Telephone vs in person|telephone vs in person
715948|NCT00188292|Human Papillomavirus|human papillomavirus
715949|NCT00188292|Anal|anal
715950|NCT00188292|Cancer screening|cancer screening
715951|NCT00188292|Immunodeficiency|immunodeficiency
715952|NCT00188292|HIV|hiv
715953|NCT00188279|ct|ct
715954|NCT00188279|scan|scan
715955|NCT00188279|lung|lung
715956|NCT00188279|follow-up|follow-up
715957|NCT00188253|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
715958|NCT00188253|PET scan|pet scan
715959|NCT00188253|MRI|mri
715960|NCT00188253|EBV virus|ebv virus
715961|NCT00188240|hepatitis C|hepatitis c
715962|NCT00188240|insulin resistance|insulin resistance
715963|NCT00188240|antiviral therapy|antiviral therapy
715964|NCT00188227|Bone marrow puncture|bone marrow puncture
715965|NCT00188227|Pain|pain
715966|NCT00188214|perfusion|perfusion
715967|NCT00188214|CT|ct
715968|NCT00188214|CAT|cat
715969|NCT00188214|non-small|non-small
715970|NCT00188214|lung|lung
715971|NCT00188201|Hepatitis C|hepatitis c
715972|NCT00188201|neucognitive functions|neucognitive functions
715973|NCT00188201|neuropsychological testing|neuropsychological testing
715974|NCT00188201|antiviral treatment|antiviral treatment
715975|NCT00188188|Endothelial|endothelial
715976|NCT00188188|Dysfunction|dysfunction
715978|NCT00188188|Lupus|lupus
715979|NCT00188149|Hodgkin's Lymphoma|hodgkin's lymphoma
715980|NCT00188149|Chemotherapy|chemotherapy
715981|NCT00188149|Radiation therapy|radiation therapy
715982|NCT00188149|PET|pet
715983|NCT00188136|AML, allogeneic transplantation, high-risk, karyotype|aml, allogeneic transplantation, high-risk, karyotype
715984|NCT00188123|Myocardial infarction|myocardial infarction
715985|NCT00188123|MRI late enhancement|mri late enhancement
715986|NCT00188123|Atrial fibrillation|atrial fibrillation
715987|NCT00188110|Water-Enema Computed Tomography|water-enema computed tomography
715988|NCT00188110|colon tumor|colon tumor
715989|NCT00188110|coloscopy|coloscopy
715990|NCT00188110|suspicion of colon tumor|suspicion of colon tumor
715991|NCT00188110|coloscopy or surgery|coloscopy or surgery
715992|NCT00188071|medical abortion|medical abortion
715993|NCT00188071|analgesia|analgesia
715994|NCT00188058|Acute respiratory distress syndrome|acute respiratory distress syndrome
715995|NCT00188058|Positive end-expiratory pressure|positive end-expiratory pressure
715996|NCT00188058|Acute lung injury|acute lung injury
715997|NCT00188058|Mechanical ventilation|mechanical ventilation
715998|NCT00188058|Randomized controlled trial|randomized controlled trial
715999|NCT00188045|Portal hypertension, alcoholic cirrhosis, Hepatic venous pressure gradient, hemodynamic, spironolactone, propranolol|portal hypertension, alcoholic cirrhosis, hepatic venous pressure gradient, hemodynamic, spironolactone, propranolol
716000|NCT00188032|pulmonary embolism|pulmonary embolism
716001|NCT00188032|clinical practice|clinical practice
716002|NCT00188032|quality of health care|quality of health care
716003|NCT00188032|diagnostic criteria|diagnostic criteria
716004|NCT00188032|Computer-Assisted Decision Support|computer-assisted decision support
716005|NCT00188032|reminders|reminders
716006|NCT00188006|cardiopulmonary bypass, inflammatory response|cardiopulmonary bypass, inflammatory response
716007|NCT00188006|neurologic injury|neurologic injury
716008|NCT00188006|neurocognitive deficit|neurocognitive deficit
716009|NCT00188006|biomaterials|biomaterials
716010|NCT00188006|coronary artery bypass surgery|coronary artery bypass surgery
716011|NCT00187993|growth hormone deficiency|growth hormone deficiency
716012|NCT00187993|growth hormone|growth hormone
716013|NCT00187993|energy expenditure|energy expenditure
716014|NCT00187993|body composition|body composition
716015|NCT00187954|women|women
716016|NCT00187954|chest pain|chest pain
716017|NCT00187954|microvascular dysfunction|microvascular dysfunction
716018|NCT00187954|retinal photography|retinal photography
716019|NCT00187954|Retinal vascular function|retinal vascular function
716020|NCT00187941|transplant|transplant
716021|NCT00187941|renal|renal
716022|NCT00187941|Cellcept|cellcept
716023|NCT00187941|therapeutic drug level|therapeutic drug level
716024|NCT00187941|MMF|mmf
716025|NCT00187941|MPA|mpa
716026|NCT00187941|immunosuppression|immunosuppression
716027|NCT00187928|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
716028|NCT00187928|Obsessions|obsessions
716029|NCT00187928|Compulsions|compulsions
716030|NCT00187928|Adjunctive treatment|adjunctive treatment
716031|NCT00187915|Renal transplant|renal transplant
716032|NCT00187915|Cellcept|cellcept
716033|NCT00187915|Therapeutic drug level|therapeutic drug level
716034|NCT00187915|Mycophenolate mofetil (MMF)|mycophenolate mofetil (mmf)
716035|NCT00187915|Mycophenolate Acid (MPA)|mycophenolate acid (mpa)
716036|NCT00187915|Oral Bioavailability|oral bioavailability
716037|NCT00187915|Immunosuppression|immunosuppression
716038|NCT00187902|Sexually Transmitted Diseases|sexually transmitted diseases
716039|NCT00187902|Chlamydia trachomatis|chlamydia trachomatis
716040|NCT00187902|Neisseria gonorrhoeae|neisseria gonorrhoeae
716041|NCT00187889|Microvascular Disease|microvascular disease
716042|NCT00187889|Women|women
716043|NCT00187889|Ischemic Heart Disease|ischemic heart disease
716044|NCT00187889|WISE|wise
716045|NCT00187850|Pulp capping|pulp capping
716046|NCT00187850|partial pulpotomy|partial pulpotomy
716047|NCT00187850|Exposure of the pulp|exposure of the pulp
716048|NCT00187837|Stepwise excavation|stepwise excavation
716049|NCT00187824|prospective|prospective
716050|NCT00187824|observational|observational
716051|NCT00187824|hormonal|hormonal
716052|NCT00187824|inflammatory|inflammatory
716053|NCT00187824|vioenergetic|vioenergetic
716054|NCT00187824|immune|immune
716055|NCT00187824|sepsis|sepsis
716056|NCT00187811|Angioplasty,|angioplasty,
716057|NCT00187811|Restenosis,|restenosis,
716058|NCT00187811|Photodynamic therapy|photodynamic therapy
716059|NCT00187798|Healthy Control Twins|healthy control twins
716060|NCT00187785|Hispanic|hispanic
716061|NCT00187785|communication|communication
716062|NCT00187772|domestic violence|domestic violence
716063|NCT00187772|preschoolers|preschoolers
716064|NCT00187772|trauma|trauma
716065|NCT00187772|intervention|intervention
716066|NCT00187759|Abscess|abscess
716067|NCT00187759|Antibitoics|antibitoics
716068|NCT00187759|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
716069|NCT00187746|Healthy Control|healthy control
716070|NCT00187733|L-carnitine|l-carnitine
716071|NCT00187720|Healthy Control|healthy control
716072|NCT00187681|Healthy controls|healthy controls
716073|NCT00187668|Healthy Cohort|healthy cohort
716074|NCT00187655|Healthy volunteers willing to be dosed with cefotaxime|healthy volunteers willing to be dosed with cefotaxime
716075|NCT00187616|adverse events|adverse events
716076|NCT00187616|clinical trial methodology|clinical trial methodology
716077|NCT00187603|tobacco|tobacco
716078|NCT00187603|cessation|cessation
716079|NCT00187603|smoking|smoking
716080|NCT00187603|smoking cessation|smoking cessation
716082|NCT00187590|case management|case management
716083|NCT00187577|Alopecia areata|alopecia areata
716084|NCT00187577|Eyelash growth|eyelash growth
716085|NCT00187577|Latanoprost|latanoprost
716086|NCT00187577|Bimatoprost|bimatoprost
716087|NCT00187564|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
716088|NCT00187564|lipoic acid|lipoic acid
716089|NCT00187564|oxidative stress|oxidative stress
716090|NCT00187551|enfuvirtide|enfuvirtide
716091|NCT00187551|T20|t20
716092|NCT00187551|Fuzeon|fuzeon
716093|NCT00187551|Treatment|treatment
716094|NCT00187551|Interruption|interruption
716095|NCT00187551|Resistance|resistance
716096|NCT00187551|HIV Drug Resistance|hiv drug resistance
716097|NCT00187551|Antiretroviral Agents|antiretroviral agents
716098|NCT00187551|Salvage Therapy|salvage therapy
716099|NCT00187551|Drug Resistance, Multiple|drug resistance, multiple
716100|NCT00187551|Human Immunodeficiency virus|human immunodeficiency virus
716101|NCT00187512|HIV|hiv
716102|NCT00187512|Antiretroviral Agents|antiretroviral agents
716103|NCT00187512|Drug Resistance, Multiple|drug resistance, multiple
716104|NCT00187512|Long Term Non Progression|long term non progression
716105|NCT00187512|Long Term Non Progressor|long term non progressor
716106|NCT00187512|Elite Suppression|elite suppression
716107|NCT00187512|Elite Suppressor|elite suppressor
716108|NCT00187512|Natural History|natural history
716109|NCT00187512|Observational|observational
716110|NCT00187499|Asthma|asthma
716111|NCT00187499|Corticosteroid|corticosteroid
716112|NCT00187499|Gene expression|gene expression
716113|NCT00187486|Glioblastoma Multiforme|glioblastoma multiforme
716114|NCT00187486|Gliosarcoma|gliosarcoma
716115|NCT00187486|GBM|gbm
716116|NCT00187486|GS|gs
716117|NCT00187486|Tarceva|tarceva
716118|NCT00187486|Temodar|temodar
716119|NCT00187486|Radiation|radiation
716120|NCT00187486|Newly Diagnosed|newly diagnosed
716121|NCT00187473|hepatitis C|hepatitis c
716122|NCT00187473|HCV|hcv
716123|NCT00187473|natural history|natural history
716124|NCT00187460|Acute myocardial infarction|acute myocardial infarction
716125|NCT00187460|Congestive heart failure|congestive heart failure
716126|NCT00187460|Quality of care|quality of care
716127|NCT00187460|Reperfusion|reperfusion
716128|NCT00187460|Report cards|report cards
716129|NCT00187460|Quality indicators|quality indicators
716130|NCT00187447|prematurity|prematurity
716131|NCT00187447|chronic lung disease|chronic lung disease
716132|NCT00187447|necrotizing enterocolitis|necrotizing enterocolitis
716133|NCT00187447|indomethacin|indomethacin
716134|NCT00187447|ductus arteriosus|ductus arteriosus
716135|NCT00187434|premature infant|premature infant
716136|NCT00187434|supporting extubation|supporting extubation
716137|NCT00187421|coronary disease|coronary disease
716138|NCT00187421|angiography|angiography
716139|NCT00187421|intraoperative care|intraoperative care
716140|NCT00187421|vascular patency|vascular patency
716141|NCT00187408|Thrombosis|thrombosis
716142|NCT00187408|Pulmonary Embolism|pulmonary embolism
716143|NCT00187408|Low Molecular Weight Heparin|low molecular weight heparin
716144|NCT00187408|Tibial Fractures|tibial fractures
716145|NCT00187395|hypertension|hypertension
716146|NCT00187395|blood pressure|blood pressure
716147|NCT00187395|pregnancy|pregnancy
716148|NCT00187382|antenatal corticosteroids|antenatal corticosteroids
716149|NCT00187382|preterm birth|preterm birth
716150|NCT00187382|multiple versus single doses|multiple versus single doses
716151|NCT00187382|follow-up|follow-up
716152|NCT00187369|twins|twins
716153|NCT00187369|twin births|twin births
716154|NCT00187369|multiples|multiples
716155|NCT00187356|Coronary Bypass Surgery|coronary bypass surgery
716156|NCT00187356|Coronary Artery Disease|coronary artery disease
716157|NCT00187356|Angiography|angiography
716158|NCT00187356|Arterial Grafts|arterial grafts
716159|NCT00187356|Radial Artery|radial artery
716160|NCT00187356|Saphenous Vein|saphenous vein
716161|NCT00187343|Radiotherapy|radiotherapy
716162|NCT00187343|IMRT|imrt
716163|NCT00187330|cardiopulmonary bypass|cardiopulmonary bypass
716164|NCT00187330|renal insufficiency|renal insufficiency
716165|NCT00187330|cardiac surgery|cardiac surgery
716166|NCT00187330|n-acetylcysteine|n-acetylcysteine
716167|NCT00187317|Exercise|exercise
716168|NCT00187317|Rehabilitation|rehabilitation
716169|NCT00187317|Postural Balance|postural balance
716170|NCT00187317|Accidental Falls|accidental falls
716171|NCT00187317|Geriatrics|geriatrics
716172|NCT00187291|T-Wave Alternans|t-wave alternans
716173|NCT00187291|ICD|icd
716174|NCT00187291|Primary Prevention|primary prevention
716175|NCT00187278|Standard pacing indication|standard pacing indication
716176|NCT00187252|Ventricular Dyssynchrony|ventricular dyssynchrony
716177|NCT00187239|ICDs|icds
716178|NCT00187239|Ventricular pacing|ventricular pacing
716179|NCT00187239|Patient has been implanted with a dual chamber SJM ICD with AICS for 1 month (± 2 weeks).|patient has been implanted with a dual chamber sjm icd with aics for 1 month (± 2 weeks).
716302|NCT00186329|Renal insufficiency|renal insufficiency
716180|NCT00187239|At the time of enrollment, patient is paced in the RV ≤25% of the time as determined by the device diagnostics.|at the time of enrollment, patient is paced in the rv ≤25% of the time as determined by the device diagnostics.
716181|NCT00187239|Patient is medically stable.|patient is medically stable.
716182|NCT00187226|Brain neoplasm|brain neoplasm
716183|NCT00187226|Brain cancer|brain cancer
716184|NCT00187226|Neoplasm intracranial|neoplasm intracranial
716185|NCT00187213|Ventricular Dyssynchrony|ventricular dyssynchrony
716186|NCT00187174|Brain tumors|brain tumors
716187|NCT00187174|Soft Tissue Sarcomas|soft tissue sarcomas
716188|NCT00187174|Refractory solid tumors|refractory solid tumors
716189|NCT00187174|Recurrent or Refractory Rhabdomyosarcomatous Soft Tissue and Non-Rhabdomyosarcoma Soft Tissue Sarcomas|recurrent or refractory rhabdomyosarcomatous soft tissue and non-rhabdomyosarcoma soft tissue sarcomas
716190|NCT00187161|Mature B-Cell Leukemia|mature b-cell leukemia
716191|NCT00187161|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
716192|NCT00187161|Burkitt's lymphoma|burkitt's lymphoma
716193|NCT00187161|Small noncleaved cell non Hodgkin lymphoma|small noncleaved cell non hodgkin lymphoma
716194|NCT00187161|Large cell lymphoma|large cell lymphoma
716195|NCT00187148|Vaccine|vaccine
716196|NCT00187148|Prevention|prevention
716197|NCT00187148|HIV|hiv
716198|NCT00187148|AIDS|aids
716199|NCT00187135|Pain Management|pain management
716200|NCT00187135|Bone Marrow Aspiration|bone marrow aspiration
716201|NCT00187122|Non-Hodgkin|non-hodgkin
716202|NCT00187122|Lymphoma|lymphoma
716203|NCT00187109|Thrombocytopenia|thrombocytopenia
716204|NCT00187109|Platelets|platelets
716205|NCT00187109|Thrombopoietin|thrombopoietin
716206|NCT00187096|Leukemia|leukemia
716207|NCT00187096|Myeloid|myeloid
716208|NCT00187096|Acute|acute
716209|NCT00187083|Leukemia|leukemia
716210|NCT00187083|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
716211|NCT00187083|Refractory Acute Lymphoblastic Leukemia|refractory acute lymphoblastic leukemia
716212|NCT00187083|Relapsed Acute Lymphoblastic Leukemia|relapsed acute lymphoblastic leukemia
716213|NCT00187057|Ataxia|ataxia
716214|NCT00187057|alphafetoprotein|alphafetoprotein
716215|NCT00187044|Vaccine|vaccine
716216|NCT00187044|Prevention|prevention
716217|NCT00187044|HIV|hiv
716218|NCT00187044|AIDS|aids
716219|NCT00187031|Wilms Tumor|wilms tumor
716220|NCT00187018|Collagen Disease|collagen disease
716221|NCT00187005|Leukemia|leukemia
716222|NCT00186992|Sarcoma|sarcoma
716223|NCT00186992|radiation therapy|radiation therapy
716224|NCT00186992|Other musculoskeletal tumors|other musculoskeletal tumors
716225|NCT00186979|Refractory Childhood Solid Tumors|refractory childhood solid tumors
716226|NCT00186953|Ultrasound|ultrasound
716227|NCT00186953|Abdominal tumors|abdominal tumors
716228|NCT00186953|Pelvic tumors|pelvic tumors
716229|NCT00186940|leukemia|leukemia
716230|NCT00186927|Vaccine|vaccine
716231|NCT00186927|Sendai virus vaccine|sendai virus vaccine
716232|NCT00186914|Bone marrow transplant|bone marrow transplant
716233|NCT00186914|bone marrow stromal cells|bone marrow stromal cells
716234|NCT00186914|allogeneic transplant|allogeneic transplant
716235|NCT00186914|Osteodysplasia|osteodysplasia
716236|NCT00186914|Osteogenesis imperfecta|osteogenesis imperfecta
716237|NCT00186914|Gene marking|gene marking
716238|NCT00186914|Stromal cell|stromal cell
716239|NCT00186901|Bone Density|bone density
716240|NCT00186888|Cancer of the Eye|cancer of the eye
716241|NCT00186888|Eye Enucleation|eye enucleation
716242|NCT00186875|Leukemia|leukemia
716243|NCT00186875|Lymphoblastic|lymphoblastic
716244|NCT00186875|Acute|acute
716245|NCT00186875|Lymphoma|lymphoma
716246|NCT00186875|Non-Hodgkin's|non-hodgkin's
716247|NCT00186862|Neuroblastoma|neuroblastoma
716248|NCT00186862|Immunotherapy|immunotherapy
716249|NCT00186862|Gene therapy|gene therapy
716250|NCT00186849|Neuroblastoma|neuroblastoma
716251|NCT00186836|Hepatitis A|hepatitis a
716252|NCT00186836|Hepatitis B|hepatitis b
716253|NCT00186836|Hemodialysis|hemodialysis
716254|NCT00186836|Vaccine|vaccine
716255|NCT00186823|Haploidentical stem cell transplant|haploidentical stem cell transplant
716256|NCT00186823|Allogeneic stem cell transplant|allogeneic stem cell transplant
716257|NCT00186823|Mismatched family member stem cell donor transplant|mismatched family member stem cell donor transplant
716258|NCT00186823|Bone marrow transplantHigh risk hematologic malignancies|bone marrow transplanthigh risk hematologic malignancies
716259|NCT00186810|Anemia|anemia
716260|NCT00186810|Sickle Cell|sickle cell
716261|NCT00186797|Aplastic Anemia|aplastic anemia
716262|NCT00186784|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
716263|NCT00186784|TMS|tms
716264|NCT00186771|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
716265|NCT00186771|Paired Pulse|paired pulse
716266|NCT00186758|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
716267|NCT00186758|TMS|tms
716268|NCT00186745|Venous thrombosis|venous thrombosis
716269|NCT00186745|Pulmonary embolism|pulmonary embolism
716270|NCT00186745|Kidney failure|kidney failure
716271|NCT00186745|Anticoagulants|anticoagulants
716272|NCT00186745|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight
716273|NCT00186732|wound closure|wound closure
716274|NCT00186732|Pfannenstiel incision|pfannenstiel incision
716275|NCT00186732|surgical staples|surgical staples
716276|NCT00186732|subcuticular suture|subcuticular suture
716277|NCT00186719|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
716278|NCT00186719|Smoking Related Disease|smoking related disease
716279|NCT00186719|Immune System Changes|immune system changes
716280|NCT00186706|Selenium|selenium
716281|NCT00186706|Chronic Obstructive Pulmonaary Disease|chronic obstructive pulmonaary disease
716282|NCT00186706|Cardiovascular Disease|cardiovascular disease
716283|NCT00186706|Anti-oxidant|anti-oxidant
716284|NCT00186706|Pulmonary|pulmonary
716285|NCT00186693|Airway remodeling|airway remodeling
716286|NCT00186693|Asthma|asthma
716287|NCT00186693|Hyper-responsiveness|hyper-responsiveness
716288|NCT00186641|chronic Graft vs Host Disease|chronic graft vs host disease
716289|NCT00186537|Insulin resistance|insulin resistance
716290|NCT00186537|Insulin resistance syndrome|insulin resistance syndrome
716291|NCT00186537|dyslipidemia|dyslipidemia
716292|NCT00186537|atherogenic dyslipidemia|atherogenic dyslipidemia
716293|NCT00186537|triglyceride/HDL-C ratio|triglyceride/hdl-c ratio
716294|NCT00186420|Prostate Cancer|prostate cancer
716295|NCT00186420|Taxotere|taxotere
716296|NCT00186368|Prostate cancer|prostate cancer
716297|NCT00186368|Gene expression|gene expression
716298|NCT00186368|tumor markers|tumor markers
716299|NCT00186368|microarray analysis|microarray analysis
716300|NCT00186329|Vasodilation|vasodilation
716301|NCT00186329|Congestive heart failure|congestive heart failure
716303|NCT00186329|Diuresis|diuresis
716304|NCT00186329|Serum creatinine|serum creatinine
716305|NCT00186199|voiding patterns|voiding patterns
716306|NCT00186199|flow rate|flow rate
716307|NCT00186199|ultrasound|ultrasound
716308|NCT00186173|Obesity|obesity
716309|NCT00186173|Physical activity|physical activity
716310|NCT00186134|Physical Activity|physical activity
716311|NCT00186134|Walking|walking
716312|NCT00186134|Primary Schools|primary schools
716313|NCT00186134|Transportation|transportation
716314|NCT00186108|Oral Triamcinalone|oral triamcinalone
716315|NCT00186108|Prostate Cancer|prostate cancer
716316|NCT00186095|Amyloidosis|amyloidosis
716317|NCT00186095|nonmyeloablative|nonmyeloablative
716318|NCT00186095|hematopoietic|hematopoietic
716319|NCT00186095|cell transplantation|cell transplantation
716320|NCT00186030|HIV|hiv
716321|NCT00186030|AIDS|aids
716322|NCT00186030|PTSD|ptsd
716323|NCT00186030|Prevention|prevention
716324|NCT00185978|obesity prevention|obesity prevention
716325|NCT00185978|preadolescents|preadolescents
716326|NCT00185978|schools|schools
716327|NCT00185965|non-Hodgkin|non-hodgkin
716328|NCT00185965|lymphoma|lymphoma
716329|NCT00185965|mycosis|mycosis
716330|NCT00185965|fungoides|fungoides
716331|NCT00185939|dog bites|dog bites
716332|NCT00185939|infection|infection
716333|NCT00185939|prophylactic antibiotics|prophylactic antibiotics
716334|NCT00185939|cost effectiveness|cost effectiveness
716335|NCT00185783|Sepsis|sepsis
716336|NCT00185783|Adrenal Insufficiency|adrenal insufficiency
716337|NCT00185783|Hydrocortisone|hydrocortisone
716338|NCT00185783|Gene Expression|gene expression
716339|NCT00185783|Microarray|microarray
716340|NCT00185783|RNA|rna
716341|NCT00185783|Critically Ill|critically ill
716342|NCT00185770|Obesity prevention|obesity prevention
716343|NCT00185770|Television|television
716344|NCT00185770|Screen time|screen time
716345|NCT00185770|Schools|schools
716346|NCT00185770|Preadolescents|preadolescents
716347|NCT00185705|Insulin resistance|insulin resistance
716348|NCT00185705|obesity|obesity
716349|NCT00185705|hypertension|hypertension
716350|NCT00185705|adolescents|adolescents
716351|NCT00185705|telmisartan|telmisartan
716352|NCT00185705|lifestyle intervention|lifestyle intervention
716353|NCT00185562|Osteoarthritis|osteoarthritis
716354|NCT00185549|Cystic Fibrosis;|cystic fibrosis;
716355|NCT00185549|patient education,|patient education,
716356|NCT00185549|Internet|internet
716357|NCT00185536|Taste|taste
716358|NCT00185536|preschool children|preschool children
716359|NCT00185536|fast food|fast food
716360|NCT00185484|Oral contraception|oral contraception
716361|NCT00185445|Non Hodgkin Lymphoma|non hodgkin lymphoma
716362|NCT00185393|Follicular Non Hodgkin lymphoma|follicular non hodgkin lymphoma
716363|NCT00185354|FC patch|fc patch
716364|NCT00185354|comparator study|comparator study
716365|NCT00185341|Endometriosis associated pelvic pain|endometriosis associated pelvic pain
716366|NCT00185328|Postmenopause|postmenopause
716367|NCT00185302|Non-resectable metastatic melanoma|non-resectable metastatic melanoma
716368|NCT00185276|Structural abnormalities of the infrarenal aorta and peripheral arteries|structural abnormalities of the infrarenal aorta and peripheral arteries
716369|NCT00185263|angina|angina
716370|NCT00185263|FGF-4|fgf-4
716371|NCT00185263|angiogenesis|angiogenesis
716372|NCT00185263|adenovector|adenovector
716373|NCT00185263|growth factor|growth factor
716374|NCT00185263|myocardial ischemia|myocardial ischemia
716375|NCT00185263|revascularization|revascularization
716376|NCT00185250|Cardiomyopathy|cardiomyopathy
716377|NCT00185250|idiopathic chronic heart failure|idiopathic chronic heart failure
716378|NCT00185250|Adenovirus|adenovirus
716379|NCT00185250|Enterovirus|enterovirus
716380|NCT00185250|Parvovirus|parvovirus
716381|NCT00185237|Menopause|menopause
716382|NCT00185198|Partial androgen deficiency of aging males (PADAM)|partial androgen deficiency of aging males (padam)
716383|NCT00185159|Microalbuminuria|microalbuminuria
716384|NCT00185133|Treatment of high blood pressure in mild to severe hypertensive patients|treatment of high blood pressure in mild to severe hypertensive patients
716385|NCT00185120|Hypertension|hypertension
716386|NCT00185120|angiotensin receptor blocker|angiotensin receptor blocker
716387|NCT00185120|calcium channel blocker|calcium channel blocker
716388|NCT00185120|angiotensin converting enzyme inhibitor hydroclorothiazide|angiotensin converting enzyme inhibitor hydroclorothiazide
716389|NCT00185107|Safety|safety
716390|NCT00185107|Efficacy|efficacy
716391|NCT00185107|WelChol®|welchol®
716392|NCT00185107|Zocor®|zocor®
716393|NCT00185107|Zetia®|zetia®
716394|NCT00185081|colon cancer|colon cancer
716395|NCT00185081|radioimmunoscintigraphy|radioimmunoscintigraphy
716396|NCT00185081|colon-specific antigen,|colon-specific antigen,
716397|NCT00185081|radioimmunotherapy,|radioimmunotherapy,
716398|NCT00185081|radioimmunodetection|radioimmunodetection
716399|NCT00185068|Systolic hypertension, Angiotensin receptor blocker|systolic hypertension, angiotensin receptor blocker
716400|NCT00185055|olmesartan|olmesartan
716401|NCT00185055|valsartan|valsartan
716402|NCT00185055|irbesartan|irbesartan
716403|NCT00185055|renin-angiotensin-aldosterone system|renin-angiotensin-aldosterone system
716404|NCT00185042|Atherosclerosis, intravascular ultrasound|atherosclerosis, intravascular ultrasound
716405|NCT00185029|prostate|prostate
716406|NCT00185029|ferumoxtran-10|ferumoxtran-10
716407|NCT00185029|lymph nodes|lymph nodes
716408|NCT00185029|USPIO|uspio
716409|NCT00185016|intimate partner abuse|intimate partner abuse
716410|NCT00185016|gender|gender
716411|NCT00185016|education|education
716412|NCT00185016|attitude|attitude
716413|NCT00185016|family doctor|family doctor
716414|NCT00185016|health care utilisation|health care utilisation
716415|NCT00185016|abused women|abused women
716416|NCT00185003|Endotoxemia|endotoxemia
716417|NCT00185003|vascular potassium channels|vascular potassium channels
716418|NCT00185003|cytokine|cytokine
716419|NCT00185003|norepinephrine|norepinephrine
716420|NCT00185003|regional blood flow,|regional blood flow,
716421|NCT00185003|inflammation,|inflammation,
716422|NCT00185003|ion channels,|ion channels,
716423|NCT00185003|nitric oxide synthase,|nitric oxide synthase,
716424|NCT00185003|pharmacology.|pharmacology.
716425|NCT00184990|Endotoxemia|endotoxemia
716426|NCT00184990|Aminoguanidine|aminoguanidine
716427|NCT00184977|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
716428|NCT00184977|Randomized Controlled Trial|randomized controlled trial
716429|NCT00184977|Family Practice|family practice
716430|NCT00184977|Respiratory Function Tests|respiratory function tests
716431|NCT00184977|Health Status|health status
716432|NCT00184951|HIV|hiv
716433|NCT00184938|opioids|opioids
716434|NCT00184938|ischemic preconditioning|ischemic preconditioning
716435|NCT00184938|morphine|morphine
716436|NCT00184899|free fatty acids|free fatty acids
716437|NCT00184899|vasodilation|vasodilation
716438|NCT00184899|sympathetic activity|sympathetic activity
716439|NCT00184873|randomized controlled trial|randomized controlled trial
716440|NCT00184873|health-counseling|health-counseling
716441|NCT00184873|multi-center study|multi-center study
716442|NCT00184847|acetylcholine|acetylcholine
716443|NCT00184847|adenosine|adenosine
716444|NCT00184847|caffeine|caffeine
716445|NCT00184847|ischemic preconditioning|ischemic preconditioning
716446|NCT00184834|colorectal|colorectal
716447|NCT00184834|liver|liver
716448|NCT00184834|metastases|metastases
716449|NCT00184834|health-related quality of life|health-related quality of life
716450|NCT00184834|surgery|surgery
716451|NCT00184821|Diabetes|diabetes
716452|NCT00184821|Ischemia|ischemia
716453|NCT00184821|Annexin A5 scintigraphy|annexin a5 scintigraphy
716454|NCT00184795|Hot flashes|hot flashes
716455|NCT00184782|colorectal cancer|colorectal cancer
716456|NCT00184782|liver metastases|liver metastases
716457|NCT00184782|metabolic activity|metabolic activity
716458|NCT00184587|prophylactic|prophylactic
716459|NCT00184587|episodic|episodic
716460|NCT00184587|cluster|cluster
716461|NCT00184587|candesartan|candesartan
716462|NCT00184587|angiotensin II receptor blocker|angiotensin ii receptor blocker
716463|NCT00184587|randomized placebo controlled parallel study|randomized placebo controlled parallel study
716464|NCT00184587|headache diary|headache diary
716465|NCT00184535|Low back pain|low back pain
716466|NCT00184535|Neuromuscular control|neuromuscular control
716467|NCT00184535|Anticipatory motor control|anticipatory motor control
716468|NCT00184535|Musculoskeletal Physiologic Processes|musculoskeletal physiologic processes
716469|NCT00184535|Muscle, Skeletal|muscle, skeletal
716470|NCT00184535|Ultrasonography|ultrasonography
716471|NCT00184535|Electromyography|electromyography
716472|NCT00184522|Gastroesophageal Reflux|gastroesophageal reflux
716473|NCT00184522|Esomeprazole|esomeprazole
716474|NCT00184522|Drug treatment|drug treatment
716475|NCT00184509|schizophrenia|schizophrenia
716476|NCT00184509|psychosocial treatment|psychosocial treatment
716477|NCT00184509|outcome|outcome
716478|NCT00184496|Analgesics, Opioid/pharmacokinetics|analgesics, opioid/pharmacokinetics
716479|NCT00184496|Humans|humans
716480|NCT00184496|Methadone/therapeutic use|methadone/therapeutic use
716481|NCT00184496|Neoplasms/complications|neoplasms/complications
716482|NCT00184496|pain/drug therapy|pain/drug therapy
716483|NCT00184483|Surgery|surgery
716484|NCT00184483|Lichtenstein|lichtenstein
716485|NCT00184483|Prolene Hernia System|prolene hernia system
716486|NCT00184483|Postoperative pain|postoperative pain
716487|NCT00184483|Recurrence|recurrence
716488|NCT00184470|Adult|adult
716489|NCT00184470|Child|child
716490|NCT00184470|Hospitalization/statistics & numerical data|hospitalization/statistics & numerical data
716491|NCT00184470|Retrospective studies|retrospective studies
716492|NCT00184457|Cardiac heart failure|cardiac heart failure
716493|NCT00184457|Leg press|leg press
716494|NCT00184457|Maximal strength training|maximal strength training
716495|NCT00184457|Serum testosterone|serum testosterone
716496|NCT00184457|Work economy|work economy
716497|NCT00184444|angina pectoris|angina pectoris
716498|NCT00184444|hyperoxia|hyperoxia
716499|NCT00184444|endurance training|endurance training
716500|NCT00184444|stroke volume|stroke volume
716501|NCT00184444|cardiac perfusion|cardiac perfusion
716502|NCT00184431|Cerebrovascular Accident|cerebrovascular accident
716503|NCT00184431|Physical Therapy Techniques|physical therapy techniques
716504|NCT00184431|Musculoskeletal Equilibrium|musculoskeletal equilibrium
716505|NCT00184431|Rehabilitation|rehabilitation
716506|NCT00184418|Immunity|immunity
716507|NCT00184418|Immune System|immune system
716508|NCT00184418|Cytokines|cytokines
716509|NCT00184418|Psychophysiology|psychophysiology
716510|NCT00184418|Psychoneuroimmunology|psychoneuroimmunology
716511|NCT00184405|Parents with psychiatric or addictive problems|parents with psychiatric or addictive problems
716512|NCT00184392|Sinus surgery|sinus surgery
716513|NCT00184392|endoscopic|endoscopic
716514|NCT00184392|postoperative care|postoperative care
716515|NCT00184392|debridement|debridement
716516|NCT00184392|randomized|randomized
716517|NCT00184392|acute recurrent rhinosinusitis|acute recurrent rhinosinusitis
716518|NCT00184392|chronic rhinosinusitis|chronic rhinosinusitis
716519|NCT00184392|nasal polyps|nasal polyps
716520|NCT00184392|Chronic rhinosinusitis with nasal polyps|chronic rhinosinusitis with nasal polyps
716521|NCT00184392|Chronic rhinosinusitis without nasal polyps|chronic rhinosinusitis without nasal polyps
716522|NCT00184379|Family|family
716523|NCT00184379|Coping Skills|coping skills
716524|NCT00184379|Psychoeducation|psychoeducation
716525|NCT00184379|Stress, Psychological|stress, psychological
716526|NCT00184379|Health Education|health education
716527|NCT00184366|drug therapy|drug therapy
716528|NCT00184366|efalizumab|efalizumab
716529|NCT00184353|brain metastasis|brain metastasis
716530|NCT00184353|signal to noise ratio|signal to noise ratio
716531|NCT00184353|spectral resolution|spectral resolution
716532|NCT00184340|eTherapy supplementary|etherapy supplementary
716533|NCT00184327|Severe and longstanding psychiatric symptoms in children|severe and longstanding psychiatric symptoms in children
716534|NCT00184301|Eating disorders|eating disorders
716535|NCT00184301|Anorexia nervosa|anorexia nervosa
716536|NCT00184301|Bulimia nervosa|bulimia nervosa
716537|NCT00184301|Personality disorders|personality disorders
716538|NCT00184301|In-patient treatment|in-patient treatment
716539|NCT00184301|out-patient treatment|out-patient treatment
716540|NCT00184301|group therapy|group therapy
716541|NCT00184288|Lipid|lipid
716542|NCT00184288|choline|choline
716543|NCT00184288|metastasis|metastasis
716544|NCT00184288|magnetic resonance spectroscopy|magnetic resonance spectroscopy
716545|NCT00184288|treatment response|treatment response
716546|NCT00184275|Brain metastasis|brain metastasis
716547|NCT00184275|HR MAS spectroscopy|hr mas spectroscopy
716548|NCT00184275|Tissue micro array|tissue micro array
716549|NCT00184275|DNA micro array|dna micro array
716550|NCT00184249|Catheter ablation|catheter ablation
716551|NCT00184249|Heart/surgery|heart/surgery
716552|NCT00184249|Cardial surgical procedures|cardial surgical procedures
716553|NCT00184236|Exercise Training|exercise training
716554|NCT00184236|Cardiovascular diseases|cardiovascular diseases
716555|NCT00184236|Risk factors|risk factors
716556|NCT00184223|Motivational Interviewing|motivational interviewing
716557|NCT00184223|Substance abuse|substance abuse
716558|NCT00184223|Acuteley admitted psychiatric patients|acuteley admitted psychiatric patients
716559|NCT00184223|Emergency Services, Psychiatric|emergency services, psychiatric
716560|NCT00184210|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
716561|NCT00184197|Injection|injection
716562|NCT00184197|Headache|headache
716563|NCT00184197|Cervical muscles|cervical muscles
716564|NCT00184184|Emergency Services, Psychiatric|emergency services, psychiatric
716565|NCT00184184|Tobacco use cessation|tobacco use cessation
716566|NCT00184184|Coffee use cessation|coffee use cessation
716567|NCT00184184|substance use detection|substance use detection
716568|NCT00184184|Substance Abuse Detection|substance abuse detection
716569|NCT00184171|Microscopic colitis|microscopic colitis
716570|NCT00184171|Drug treatment|drug treatment
716571|NCT00184171|Diarrhoea|diarrhoea
716572|NCT00184158|Cubital tunnel|cubital tunnel
716573|NCT00184158|treatment|treatment
716574|NCT00184158|nerve compression|nerve compression
716575|NCT00184145|Specific (Animal) Phobia|specific (animal) phobia
716576|NCT00184145|EMDR|emdr
716577|NCT00184145|Exposure therapy|exposure therapy
716578|NCT00184132|Intensive care units|intensive care units
716579|NCT00184132|Emergency services, psychiatric|emergency services, psychiatric
716580|NCT00184132|Interior Design and Furnishings|interior design and furnishings
716581|NCT00184132|Intensive Care|intensive care
716582|NCT00184119|Emergency services, psychiatric|emergency services, psychiatric
716583|NCT00184119|Intensive care units|intensive care units
716584|NCT00184119|Hospitals, psychiatric|hospitals, psychiatric
716585|NCT00184119|Aggression|aggression
716586|NCT00184119|Violence|violence
716587|NCT00184106|Phobic disorders|phobic disorders
716588|NCT00184106|Therapy, cognitive|therapy, cognitive
716589|NCT00184106|Paroxetine|paroxetine
716590|NCT00184093|Cervical Carcinoma|cervical carcinoma
716591|NCT00183976|Diffuse mixed NHL|diffuse mixed nhl
716592|NCT00183976|Diffuse or follicular large B-cell NHL|diffuse or follicular large b-cell nhl
716593|NCT00183976|Immunoblastic NHL|immunoblastic nhl
716594|NCT00183976|Burkitt or Burkitt-like lymphomas|burkitt or burkitt-like lymphomas
716595|NCT00183898|Gastroesophageal Junction Cancer|gastroesophageal junction cancer
716596|NCT00183872|Gastroesophageal cancer|gastroesophageal cancer
716597|NCT00183872|Gastric Adenocarcinoma|gastric adenocarcinoma
716598|NCT00183872|Gastroesophageal Junction Adenocarcinoma|gastroesophageal junction adenocarcinoma
716599|NCT00183859|solid tumor|solid tumor
716600|NCT00183859|phase I|phase i
716601|NCT00183859|phase one|phase one
716602|NCT00183846|pancreas|pancreas
716603|NCT00183846|stomach|stomach
716604|NCT00183846|common bile duct cancer|common bile duct cancer
716605|NCT00183846|ampulla of Vater cancer|ampulla of vater cancer
716606|NCT00183833|phase 1|phase 1
716607|NCT00183833|phase I|phase i
716608|NCT00183833|phase one|phase one
716609|NCT00183833|colon cancer|colon cancer
716610|NCT00183833|colorectal cancer|colorectal cancer
716611|NCT00183820|Testicular|testicular
716612|NCT00183820|Extra gonadal germ cell neoplasm|extra gonadal germ cell neoplasm
716613|NCT00183794|Primary Peritoneal|primary peritoneal
716614|NCT00183781|HIV|hiv
716615|NCT00183781|Telephone intervention|telephone intervention
716616|NCT00183768|Cognitive Behavioral Treatment For Depression|cognitive behavioral treatment for depression
716617|NCT00183768|Antidepressant Psychopharmacology|antidepressant psychopharmacology
716618|NCT00183768|HIV Risk Behavior|hiv risk behavior
716619|NCT00183768|Injection Drug Use|injection drug use
716620|NCT00183755|Reward Processing|reward processing
716621|NCT00183755|Anhedonia|anhedonia
716622|NCT00183755|Major Depressive Disorder|major depressive disorder
716623|NCT00183755|Depression|depression
716624|NCT00183742|Phase 1|phase 1
716625|NCT00183742|Phase I|phase i
716626|NCT00183742|Phase one|phase one
716627|NCT00183742|Solid tumor|solid tumor
716628|NCT00183729|Major depressive disorder|major depressive disorder
716629|NCT00183729|Rehabilitating|rehabilitating
716630|NCT00183729|Elderly|elderly
716631|NCT00183729|Apathy|apathy
716632|NCT00183716|PTSD|ptsd
716633|NCT00183716|Physical Abuse|physical abuse
716634|NCT00183716|Sexual Abuse|sexual abuse
716635|NCT00183716|Women|women
716636|NCT00183716|Trauma|trauma
716637|NCT00183716|Group Therapy|group therapy
716638|NCT00183716|Substance Abuse|substance abuse
716639|NCT00183703|Depression, Bipolar|depression, bipolar
716640|NCT00183703|Manic-Depressive Psychosis|manic-depressive psychosis
716641|NCT00183690|PTSD|ptsd
716642|NCT00183690|Anxiety Disorder|anxiety disorder
716643|NCT00183690|Trauma|trauma
716644|NCT00183690|Adolescents|adolescents
716645|NCT00183690|Cognitive Behavioral Therapy|cognitive behavioral therapy
716646|NCT00183677|Brain Bioenergetic Metabolism|brain bioenergetic metabolism
716647|NCT00183677|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
716648|NCT00183677|Major Depressive Disorder|major depressive disorder
716649|NCT00183677|Treatment Response|treatment response
716650|NCT00183651|Suicide|suicide
716651|NCT00183651|Women|women
716652|NCT00183651|Emotions|emotions
716653|NCT00183651|Psychotherapy, Group|psychotherapy, group
716654|NCT00183638|Internet|internet
716655|NCT00183638|Interactive Computer Program|interactive computer program
716656|NCT00183638|HIV Prevention|hiv prevention
716657|NCT00183625|Antipsychotic Agents|antipsychotic agents
716658|NCT00183625|Employment|employment
716659|NCT00183612|Child|child
716660|NCT00183612|Adolescent|adolescent
716661|NCT00183612|Mental Health|mental health
716662|NCT00183612|Olanzapine|olanzapine
716663|NCT00183612|Pharmacokinetics|pharmacokinetics
716664|NCT00183612|Pharmacology|pharmacology
716665|NCT00183599|Brief interventions|brief interventions
716666|NCT00183599|Motivational Enhancement Therapy|motivational enhancement therapy
716667|NCT00183599|Cognitive Behavioral Therapy|cognitive behavioral therapy
716668|NCT00183586|Treatment outcomes study|treatment outcomes study
716669|NCT00183586|Anorexia|anorexia
716670|NCT00183586|Anorexia nervosa|anorexia nervosa
716671|NCT00183573|STDs|stds
716672|NCT00183573|Sexual Behavior|sexual behavior
716673|NCT00183573|Health Behavior|health behavior
716674|NCT00183573|HIV Seronegativity|hiv seronegativity
716675|NCT00183560|Depression Recurrence|depression recurrence
716676|NCT00183560|Drug Therapy|drug therapy
716677|NCT00183560|Cognitive Therapy|cognitive therapy
716678|NCT00183560|Relapse|relapse
716679|NCT00183560|Antidepressants|antidepressants
716680|NCT00183547|Postpartum Depression|postpartum depression
716681|NCT00183547|Postpartum Period|postpartum period
716682|NCT00183547|Indians, North American|indians, north american
716683|NCT00183547|Adolescent|adolescent
716684|NCT00183547|Female|female
716685|NCT00183547|CBT|cbt
716686|NCT00183521|Hyperventilation|hyperventilation
716687|NCT00183521|Breathing Exercises|breathing exercises
716688|NCT00183521|Carbon Dioxide|carbon dioxide
716689|NCT00183521|Panic Attack|panic attack
716690|NCT00183508|PTSD|ptsd
716691|NCT00183508|Occupational Health|occupational health
716692|NCT00183508|Trauma|trauma
716693|NCT00183508|Job|job
716694|NCT00183508|CBT|cbt
716695|NCT00183495|Depression, Bipolar|depression, bipolar
716696|NCT00183495|Manic-Depressive Psychosis|manic-depressive psychosis
716697|NCT00183482|Parents|parents
716698|NCT00183482|Child|child
716699|NCT00183482|Stress|stress
716700|NCT00183482|CBT|cbt
716701|NCT00183469|Lamotrigine|lamotrigine
716702|NCT00183469|Divalproex|divalproex
716703|NCT00183469|Antidepressant|antidepressant
716704|NCT00183456|Sex Education|sex education
716705|NCT00183456|Peer Group|peer group
716706|NCT00183456|Social Identity Theory|social identity theory
716707|NCT00183456|HIV Seronegativity|hiv seronegativity
716708|NCT00183456|Intervention|intervention
716709|NCT00183456|women|women
716710|NCT00183456|Social Networks|social networks
716711|NCT00183456|Peer Education|peer education
716712|NCT00183443|Mania|mania
716713|NCT00183443|Manic-depressive|manic-depressive
716714|NCT00183443|Psychotic disorder|psychotic disorder
716715|NCT00183430|Prazosin|prazosin
716716|NCT00183430|Sleep Disorders|sleep disorders
716717|NCT00183417|Adolescent|adolescent
716718|NCT00183417|CBT|cbt
716719|NCT00183404|Drug Treatment|drug treatment
716720|NCT00183404|Child|child
716721|NCT00183404|Olanzapine|olanzapine
716722|NCT00183391|ADHD|adhd
716723|NCT00183391|Child|child
716724|NCT00183391|Adolescent|adolescent
716725|NCT00183391|School|school
716726|NCT00183378|Alzheimer's Disease|alzheimer's disease
716727|NCT00183378|Insomnia|insomnia
716728|NCT00183378|Sleep Problems|sleep problems
716729|NCT00183378|Elderly|elderly
716730|NCT00183378|Caregivers|caregivers
716731|NCT00183365|Family|family
716732|NCT00183365|Parenting|parenting
716733|NCT00183365|Depression|depression
716734|NCT00183365|Group Intervention|group intervention
716735|NCT00183352|Women|women
716736|NCT00183352|Mood|mood
716737|NCT00183352|Menarche|menarche
716738|NCT00183352|Menstruation|menstruation
716739|NCT00183339|Autism|autism
716740|NCT00183326|Posttraumatic Stress Disorder|posttraumatic stress disorder
716741|NCT00183326|Domestic Violence|domestic violence
716742|NCT00183326|Children|children
716743|NCT00183326|Cognitive Behavioral Therapy|cognitive behavioral therapy
716744|NCT00183326|CBT|cbt
716745|NCT00183313|Mental Health|mental health
716746|NCT00183313|Primary health care|primary health care
716747|NCT00183313|Case management|case management
716748|NCT00183300|Post-traumatic stress disorder|post-traumatic stress disorder
716749|NCT00183300|PTSD|ptsd
716750|NCT00183300|Prolonged Exposure|prolonged exposure
716751|NCT00183300|Cognitive-Behavior Therapy|cognitive-behavior therapy
716752|NCT00183274|Generalized Anxiety Disorder|generalized anxiety disorder
716753|NCT00183274|Chronic Mediation Treatment|chronic mediation treatment
716754|NCT00183274|Double-Blind|double-blind
716755|NCT00183274|Placebo Controlled|placebo controlled
716756|NCT00183274|Venlafaxine XR|venlafaxine xr
716757|NCT00183274|Relapse|relapse
716758|NCT00183261|Treatment Interruption|treatment interruption
716759|NCT00183261|HIV Therapeutic Vaccine|hiv therapeutic vaccine
716760|NCT00183261|Acute Infection|acute infection
716761|NCT00183261|Acute Retroviral Syndrome|acute retroviral syndrome
716762|NCT00183248|kidney|kidney
716763|NCT00183248|kidney transplant|kidney transplant
716764|NCT00183248|kidney transplantation|kidney transplantation
716765|NCT00183248|transplant|transplant
716766|NCT00183248|transplantation|transplantation
716767|NCT00183248|renal|renal
716768|NCT00183248|renal transplant|renal transplant
716769|NCT00183248|renal transplantation|renal transplantation
716770|NCT00183248|kidney disease|kidney disease
716771|NCT00183248|chronic|chronic
716772|NCT00183248|renal failure|renal failure
716773|NCT00183248|kidney failure|kidney failure
716774|NCT00183235|Alcohol dependence|alcohol dependence
716775|NCT00183235|Alcoholism|alcoholism
716776|NCT00183235|Craving|craving
716777|NCT00183222|Alcohol dependence|alcohol dependence
716778|NCT00183222|Alcoholism|alcoholism
716779|NCT00183222|Craving|craving
716780|NCT00183209|Substance use disorders|substance use disorders
716781|NCT00183209|Parent child relationship|parent child relationship
716782|NCT00183196|Alcohol dependence|alcohol dependence
716783|NCT00183196|Alcoholism|alcoholism
716784|NCT00183196|Heavy drinking|heavy drinking
716785|NCT00183183|Alcohol Abuse|alcohol abuse
716786|NCT00183183|Harm Reduction|harm reduction
716787|NCT00183183|Motivational Interviewing|motivational interviewing
716788|NCT00183183|Emergency Department|emergency department
716789|NCT00183183|Risky Drinking|risky drinking
716790|NCT00183183|Prevention|prevention
716791|NCT00183170|Alcohol abuse|alcohol abuse
716792|NCT00183170|Alcoholic beverages (beer)|alcoholic beverages (beer)
716793|NCT00183170|Residual effects|residual effects
716794|NCT00183170|Psychomotor performance|psychomotor performance
716795|NCT00183170|Psychomotor vigilance test|psychomotor vigilance test
716796|NCT00183170|Neurobehavioral Evaluation System|neurobehavioral evaluation system
716797|NCT00183170|Family history of alcohol use|family history of alcohol use
716798|NCT00183170|Alcoholic Consumption|alcoholic consumption
716799|NCT00183170|Unhealthy alcohol use|unhealthy alcohol use
716800|NCT00183170|Alcohol|alcohol
716801|NCT00183157|High risk drinking|high risk drinking
716802|NCT00183157|Alcohol dependence|alcohol dependence
716803|NCT00183157|Alcohol related injury|alcohol related injury
716804|NCT00183144|contingency management|contingency management
716805|NCT00183144|reinforcement|reinforcement
716806|NCT00183144|employment|employment
716807|NCT00183144|Therapeutic Workplace|therapeutic workplace
716809|NCT00183131|Alcohol abuse|alcohol abuse
716810|NCT00183131|Alcohol dependence|alcohol dependence
716811|NCT00183131|Alcohol consumption|alcohol consumption
716812|NCT00183131|Unhealthy alcohol use|unhealthy alcohol use
716813|NCT00183131|Screening|screening
716814|NCT00183131|Brief Intervention|brief intervention
716815|NCT00183131|Effectiveness|effectiveness
716816|NCT00183131|Electronic intervention|electronic intervention
716817|NCT00183131|Web-based intervention|web-based intervention
716818|NCT00183131|College students|college students
716819|NCT00183118|HIV|hiv
716820|NCT00183118|Russia|russia
716821|NCT00183118|Prevention|prevention
716822|NCT00183118|Behavioral intervention|behavioral intervention
716823|NCT00183118|Alcohol dependence|alcohol dependence
716824|NCT00183105|Alcohol|alcohol
716825|NCT00183105|Alcohol abuse|alcohol abuse
716826|NCT00183105|Alcohol dependence|alcohol dependence
716827|NCT00183105|Utilization|utilization
716828|NCT00183105|Alcohol consumption|alcohol consumption
716829|NCT00183105|Unhealthy alcohol use|unhealthy alcohol use
716830|NCT00183105|Hospitalization|hospitalization
716831|NCT00183105|Screening|screening
716832|NCT00183105|Brief Intervention|brief intervention
716833|NCT00183105|Motivational Interviewing|motivational interviewing
716834|NCT00183105|Randomized trial|randomized trial
716835|NCT00183105|Effectiveness|effectiveness
716836|NCT00183105|Unhealthy alcohol use (Risky alcohol consumption amounts, problem alcohol use, hazardous alcohol use, alcohol abuse and alcohol dependence)|unhealthy alcohol use (risky alcohol consumption amounts, problem alcohol use, hazardous alcohol use, alcohol abuse and alcohol dependence)
716837|NCT00183092|dementia|dementia
716838|NCT00183092|spongiform encephalopathy|spongiform encephalopathy
716839|NCT00183092|nervous system disorder|nervous system disorder
716840|NCT00183092|acridine|acridine
716841|NCT00183092|prion|prion
716842|NCT00183092|neuropharmacologic agent|neuropharmacologic agent
716843|NCT00183079|Depression|depression
716844|NCT00183079|Alcohol Use|alcohol use
716845|NCT00183079|Motivational Interviewing|motivational interviewing
716846|NCT00183053|Hospitalization|hospitalization
716847|NCT00183053|Fall Risk|fall risk
716848|NCT00183053|Frailty|frailty
716849|NCT00183040|andropause|andropause
716850|NCT00183040|hormone therapy|hormone therapy
716851|NCT00183040|HRT|hrt
716852|NCT00183027|Dietary restriction|dietary restriction
716853|NCT00183027|Caloric restriction|caloric restriction
716854|NCT00183014|behavior therapy|behavior therapy
716855|NCT00183014|exercise|exercise
716856|NCT00183014|gait|gait
716857|NCT00183014|physical activity|physical activity
716858|NCT00183001|nutritional supplement|nutritional supplement
716859|NCT00183001|dietary supplement|dietary supplement
716860|NCT00183001|vitamin therapy|vitamin therapy
716861|NCT00183001|Vitamin K deficiency|vitamin k deficiency
716862|NCT00183001|bone density|bone density
716863|NCT00182988|communication behavior|communication behavior
716864|NCT00182988|coping|coping
716865|NCT00182988|functional ability|functional ability
716866|NCT00182988|quality of life|quality of life
716867|NCT00182988|caregiving|caregiving
716868|NCT00182975|Metabolic syndrome|metabolic syndrome
717143|NCT00182000|OCD|ocd
716869|NCT00182962|Activities of Daily Living|activities of daily living
716870|NCT00182962|Low-income|low-income
716871|NCT00182962|geriatric medicine|geriatric medicine
716872|NCT00182962|computer assisted patient care|computer assisted patient care
716873|NCT00182949|Epidemiology|epidemiology
716874|NCT00182949|Genetics|genetics
716875|NCT00182949|Aging|aging
716876|NCT00182949|Sardinian Population|sardinian population
716877|NCT00182949|Cardiovascular Diseases|cardiovascular diseases
716878|NCT00182949|Personality Traits|personality traits
716879|NCT00182949|Frailty|frailty
716880|NCT00182936|Cognition disorder|cognition disorder
716881|NCT00182936|organic brain syndrome|organic brain syndrome
716882|NCT00182936|patient care management|patient care management
716883|NCT00182936|long term care|long term care
716884|NCT00182936|extended care facility|extended care facility
716885|NCT00182923|Blood pressure|blood pressure
716886|NCT00182923|genetics|genetics
716887|NCT00182897|caregiver|caregiver
716888|NCT00182897|home health care|home health care
716889|NCT00182897|coping|coping
716890|NCT00182884|Hospital acquired complications|hospital acquired complications
716891|NCT00182884|adverse effects|adverse effects
716892|NCT00182884|Cognitive Impairment|cognitive impairment
716893|NCT00182884|Aging|aging
716894|NCT00182871|geriatric medicine|geriatric medicine
716895|NCT00182871|hormone therapy|hormone therapy
716896|NCT00182871|HT|ht
716897|NCT00182871|andropause|andropause
716898|NCT00182858|Tissue|tissue
716899|NCT00182858|Procurement|procurement
716900|NCT00182858|Exploratory Methods|exploratory methods
716901|NCT00182858|Disease Correlation|disease correlation
716902|NCT00182858|Sampling|sampling
716903|NCT00182845|dementia|dementia
716904|NCT00182845|MCI|mci
716905|NCT00182845|Aricept|aricept
716906|NCT00182845|Adverse Effects|adverse effects
716907|NCT00182845|Hospital Acquired Complications|hospital acquired complications
716908|NCT00182845|Cognitive Impairment|cognitive impairment
716909|NCT00182845|Aging|aging
716910|NCT00182832|Physician Behavior|physician behavior
716911|NCT00182832|Hospital Acquired Complications|hospital acquired complications
716912|NCT00182832|MCI|mci
716913|NCT00182832|Mild Cognitive Impairment|mild cognitive impairment
716914|NCT00182819|adult oligodendroglioma|adult oligodendroglioma
716915|NCT00182819|adult diffuse astrocytoma|adult diffuse astrocytoma
716916|NCT00182819|adult mixed glioma|adult mixed glioma
716917|NCT00182806|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
716918|NCT00182806|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
716919|NCT00182806|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
716920|NCT00182806|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
716921|NCT00182793|stage IIIB breast cancer|stage iiib breast cancer
716922|NCT00182793|stage IIIC breast cancer|stage iiic breast cancer
716923|NCT00182793|stage IV breast cancer|stage iv breast cancer
716924|NCT00182793|inflammatory breast cancer|inflammatory breast cancer
716925|NCT00182793|male breast cancer|male breast cancer
716926|NCT00182793|recurrent breast cancer|recurrent breast cancer
716927|NCT00182793|invasive ductal breast carcinoma with predominant intraductal component|invasive ductal breast carcinoma with predominant intraductal component
716928|NCT00182793|invasive ductal breast carcinoma|invasive ductal breast carcinoma
716929|NCT00182793|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
716930|NCT00182793|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
716931|NCT00182793|Paget disease of the breast with invasive ductal carcinoma|paget disease of the breast with invasive ductal carcinoma
716932|NCT00182793|papillary ductal breast carcinoma|papillary ductal breast carcinoma
716933|NCT00182793|tubular ductal breast carcinoma|tubular ductal breast carcinoma
716934|NCT00182793|invasive lobular breast carcinoma with predominant in situ component|invasive lobular breast carcinoma with predominant in situ component
716935|NCT00182793|invasive lobular breast carcinoma|invasive lobular breast carcinoma
716936|NCT00182793|comedo ductal breast carcinoma|comedo ductal breast carcinoma
716937|NCT00182780|fatigue|fatigue
716938|NCT00182780|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
716939|NCT00182754|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
716940|NCT00182754|malignant ascites|malignant ascites
716941|NCT00182741|recurrent prostate cancer|recurrent prostate cancer
716942|NCT00182741|stage IV prostate cancer|stage iv prostate cancer
716943|NCT00182728|invasive ductal breast carcinoma|invasive ductal breast carcinoma
716944|NCT00182728|stage I breast cancer|stage i breast cancer
716945|NCT00182728|stage II breast cancer|stage ii breast cancer
716946|NCT00182715|adenocarcinoma of the colon|adenocarcinoma of the colon
716947|NCT00182715|stage IV colon cancer|stage iv colon cancer
716948|NCT00182715|adenocarcinoma of the rectum|adenocarcinoma of the rectum
716949|NCT00182715|stage IV rectal cancer|stage iv rectal cancer
716950|NCT00182650|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
716951|NCT00182650|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
716952|NCT00182650|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
716953|NCT00182637|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
717144|NCT00181987|ADHD|adhd
716954|NCT00182637|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
716955|NCT00182637|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
716956|NCT00182637|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
716957|NCT00182637|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
716958|NCT00182637|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
716959|NCT00182637|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
716960|NCT00182637|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
716961|NCT00182637|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
716962|NCT00182637|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
716963|NCT00182624|Prostate Cancer|prostate cancer
716964|NCT00182624|Magnetic Resonance Imaging|magnetic resonance imaging
716965|NCT00182624|Spectroscopy|spectroscopy
716966|NCT00182611|stage III gastric cancer|stage iii gastric cancer
716967|NCT00182611|adenocarcinoma of the stomach|adenocarcinoma of the stomach
716968|NCT00182598|buprenorphine|buprenorphine
716969|NCT00182598|computer|computer
716970|NCT00182598|treatment|treatment
716971|NCT00182598|opioid|opioid
716972|NCT00182598|heroin|heroin
716973|NCT00182585|HIV|hiv
716974|NCT00182585|hepatitis|hepatitis
716975|NCT00182585|STDs|stds
716976|NCT00182585|adolescents|adolescents
716977|NCT00182585|addiction|addiction
716978|NCT00182585|treatment|treatment
716979|NCT00182585|prevention|prevention
716980|NCT00182585|HIV and related risk behavior among youth in drug treatment|hiv and related risk behavior among youth in drug treatment
716981|NCT00182572|heroin|heroin
716982|NCT00182572|opiate|opiate
716983|NCT00182572|addiction|addiction
716984|NCT00182572|adolescent|adolescent
716985|NCT00182572|treatment|treatment
716986|NCT00182559|kidney|kidney
716987|NCT00182559|transplantation|transplantation
716988|NCT00182559|tacrolimus|tacrolimus
716989|NCT00182559|cyclosporine|cyclosporine
716990|NCT00182559|conversion|conversion
716991|NCT00182546|Pulmonary Embolism|pulmonary embolism
716992|NCT00182546|DVT|dvt
716993|NCT00182546|Venous Thrombosis|venous thrombosis
716994|NCT00182546|D dimer|d dimer
716995|NCT00182546|DD|dd
716996|NCT00182546|Thrombosis|thrombosis
716997|NCT00182546|Diagnosis|diagnosis
716998|NCT00182533|Generalized social phobia|generalized social phobia
716999|NCT00182533|Comorbid panic disorder with agoraphobia|comorbid panic disorder with agoraphobia
717000|NCT00182533|Comorbid obsessive compulsive disorder|comorbid obsessive compulsive disorder
717001|NCT00182533|Comorbid generalized anxiety disorder|comorbid generalized anxiety disorder
717002|NCT00182533|Comorbid major depressive disorder/Dysthymia|comorbid major depressive disorder/dysthymia
717003|NCT00182520|Treatment Refractory Obsessive Compulsive Disorder|treatment refractory obsessive compulsive disorder
717004|NCT00182494|Schizophrenia, Diabetes, Weight gain, Antipsychotic drugs|schizophrenia, diabetes, weight gain, antipsychotic drugs
717005|NCT00182481|asthma treatment|asthma treatment
717006|NCT00182481|induced sputum cell counts|induced sputum cell counts
717007|NCT00182481|asthma exacerbations|asthma exacerbations
717008|NCT00182481|eosinophilic bronchitis|eosinophilic bronchitis
717009|NCT00182481|non-eosinophilic bronchitis|non-eosinophilic bronchitis
717010|NCT00182468|Domestic violence|domestic violence
717011|NCT00182468|Spouse Abuse|spouse abuse
717012|NCT00182455|Treatment Refractory Generalized Social Phobia|treatment refractory generalized social phobia
717013|NCT00182442|Cognitive deficits|cognitive deficits
717014|NCT00182442|Psychosocial functioning|psychosocial functioning
717015|NCT00182442|Quality of Life|quality of life
717016|NCT00182429|Antibiotic associated diarrhea|antibiotic associated diarrhea
717017|NCT00182429|C. difficile|c. difficile
717018|NCT00182429|Metronidazole|metronidazole
717019|NCT00182429|Rifampin|rifampin
717020|NCT00182416|pacemakers|pacemakers
717021|NCT00182416|atrial fibrillation|atrial fibrillation
717022|NCT00182416|stroke|stroke
717023|NCT00182416|cardiovascular death|cardiovascular death
717024|NCT00182403|Unfractionated Heparin|unfractionated heparin
717025|NCT00182403|Low Molecular Weight Heparin|low molecular weight heparin
717026|NCT00182403|Venous Thromboembolism|venous thromboembolism
717027|NCT00182403|APTT|aptt
717028|NCT00182403|Treatment|treatment
717029|NCT00182390|ELBW premature infants|elbw premature infants
717030|NCT00182390|neonatal transfusion|neonatal transfusion
717031|NCT00182390|bronchopulmonary dysplasia|bronchopulmonary dysplasia
717032|NCT00182390|periventricular leukomalacia|periventricular leukomalacia
717033|NCT00182390|ventriculomegaly|ventriculomegaly
717034|NCT00182390|retinopathy of prematurity|retinopathy of prematurity
717035|NCT00182377|patients undergoing cardiac surgery requiring cardiopulmonary bypass|patients undergoing cardiac surgery requiring cardiopulmonary bypass
717036|NCT00182364|Critically Ill|critically ill
717037|NCT00182364|Deep Venous Thrombosis|deep venous thrombosis
717038|NCT00182364|Randomized Control Trial|randomized control trial
717039|NCT00182364|Pilot Study|pilot study
717040|NCT00182351|deep vein thrombosis|deep vein thrombosis
717041|NCT00182351|d-dimer|d-dimer
717042|NCT00182351|serial compression ultrasound|serial compression ultrasound
717043|NCT00182338|cardiovascular outcomes|cardiovascular outcomes
717044|NCT00182338|congestive heart failure|congestive heart failure
717045|NCT00182338|Peritoneal Membrane transport properties|peritoneal membrane transport properties
717046|NCT00182338|Arterial stiffening|arterial stiffening
717047|NCT00182338|Inflammatory markers|inflammatory markers
717048|NCT00182325|medical record|medical record
717049|NCT00182325|pregnancy|pregnancy
717050|NCT00182325|Internet|internet
717051|NCT00182312|preterm infants|preterm infants
717052|NCT00182312|very low birthweight|very low birthweight
717053|NCT00182312|apnea of prematurity|apnea of prematurity
717054|NCT00182312|methylxanthines|methylxanthines
717055|NCT00182312|developmental disabilities|developmental disabilities
717056|NCT00182286|Diabetes|diabetes
717057|NCT00182286|Continuity of Care|continuity of care
717058|NCT00182286|Patient Perspective|patient perspective
717059|NCT00182286|Health Service Organization|health service organization
717060|NCT00182273|Benign paroxysmal positional vertigo|benign paroxysmal positional vertigo
717061|NCT00182273|Canalith repositioning maneuver|canalith repositioning maneuver
717062|NCT00182273|Dizziness|dizziness
717063|NCT00182273|Primary Care|primary care
717064|NCT00182247|deep vein thrombosis|deep vein thrombosis
717065|NCT00182247|DVT|dvt
717066|NCT00182247|pulmonary embolism|pulmonary embolism
717067|NCT00182247|PE|pe
717068|NCT00182247|venous thromboembolism|venous thromboembolism
717069|NCT00182247|VTE|vte
717070|NCT00182247|d-dimer|d-dimer
717071|NCT00182247|IPG|ipg
717072|NCT00182234|unmet supportive care needs|unmet supportive care needs
717073|NCT00182221|Pulmonary Embolism|pulmonary embolism
717074|NCT00182221|Deep Vein Thrombosis|deep vein thrombosis
717075|NCT00182221|MDA D-Dimer Testing|mda d-dimer testing
717076|NCT00182221|Diagnostic Algorithm|diagnostic algorithm
717077|NCT00182208|PTS|pts
717078|NCT00182208|Post phlebitic Syndrome|post phlebitic syndrome
717079|NCT00182208|Activities of Daily Living|activities of daily living
717080|NCT00182208|Quality of Life|quality of life
717081|NCT00182182|Heart Failure|heart failure
717082|NCT00182182|Family physicians|family physicians
717083|NCT00182182|academic detailing|academic detailing
717084|NCT00182182|process of care|process of care
717085|NCT00182169|Severe heart failure|severe heart failure
717086|NCT00182169|Growth hormone|growth hormone
717087|NCT00182169|exercise capacity|exercise capacity
717088|NCT00182169|quality of life|quality of life
717089|NCT00182169|cardiac function|cardiac function
717090|NCT00182156|hemodialysis|hemodialysis
717091|NCT00182156|platelet function analyzer|platelet function analyzer
717092|NCT00182156|bioimpedance|bioimpedance
717093|NCT00182156|pulse wave velocity|pulse wave velocity
717094|NCT00182156|end stage renal disease|end stage renal disease
717095|NCT00182143|Critically Ill|critically ill
717096|NCT00182143|Deep Venous ThromboEmbolism|deep venous thromboembolism
717097|NCT00182143|Randomized Controlled Trial|randomized controlled trial
717098|NCT00182130|rectal cancer|rectal cancer
717099|NCT00182130|surgery|surgery
717100|NCT00182130|physician behaviour|physician behaviour
717101|NCT00182130|knowledge translation|knowledge translation
717102|NCT00182117|bleeding|bleeding
717103|NCT00182117|end stage renal disease|end stage renal disease
717104|NCT00182117|antiplatelet therapy|antiplatelet therapy
717105|NCT00182117|anticoagulant therapy|anticoagulant therapy
717106|NCT00182117|hemodialysis|hemodialysis
717107|NCT00182104|Fontan procedure|fontan procedure
717108|NCT00182104|Anticoagulation|anticoagulation
717109|NCT00182104|Thrombosis|thrombosis
717110|NCT00182104|Thromboembolism|thromboembolism
717111|NCT00182104|Prevention|prevention
717112|NCT00182091|Acromegaly|acromegaly
717113|NCT00182091|Growth Hormone Deficiency|growth hormone deficiency
717114|NCT00182091|Cardiovascular Risk|cardiovascular risk
717115|NCT00182091|Pituitary|pituitary
717116|NCT00182091|Hypothalamic|hypothalamic
717117|NCT00182078|sertraline|sertraline
717118|NCT00182078|children|children
717119|NCT00182078|adolescents|adolescents
717120|NCT00182078|posttraumatic stress disorder|posttraumatic stress disorder
717121|NCT00182078|depression|depression
717122|NCT00182078|prevention|prevention
717123|NCT00182078|burns|burns
717124|NCT00182078|injuries|injuries
717125|NCT00182065|Heart failure|heart failure
717126|NCT00182065|Functional decline|functional decline
717127|NCT00182065|Cognitive impairment|cognitive impairment
717128|NCT00182065|Neuropsychiatric health|neuropsychiatric health
717129|NCT00182065|Longitudinal|longitudinal
717130|NCT00182065|Long-term care|long-term care
717131|NCT00182065|Elderly|elderly
717132|NCT00182052|rosiglitazone|rosiglitazone
717133|NCT00182052|Avandia|avandia
717134|NCT00182052|androgen dependant prostate cancer|androgen dependant prostate cancer
717135|NCT00182039|randomized controlled trial|randomized controlled trial
717136|NCT00182039|blinded|blinded
717137|NCT00182039|noncardiac surgery|noncardiac surgery
717138|NCT00182039|cardiovascular events|cardiovascular events
717139|NCT00182026|diabetes|diabetes
717140|NCT00182026|community intervention|community intervention
717141|NCT00182026|self-management|self-management
717142|NCT00182026|prevention|prevention
717145|NCT00181987|bipolar disorder|bipolar disorder
717146|NCT00181987|children|children
717147|NCT00181987|Concerta|concerta
717148|NCT00181974|burns|burns
717149|NCT00181974|hemostasis|hemostasis
717150|NCT00181974|skin graft|skin graft
717151|NCT00181974|Surgical Hemostasis|surgical hemostasis
717152|NCT00181974|Grafting, Skin|grafting, skin
717153|NCT00181961|antidepressant-induced sexual dysfunction|antidepressant-induced sexual dysfunction
717154|NCT00181948|ADHD|adhd
717155|NCT00181948|children|children
717156|NCT00181948|stimulant non-responders|stimulant non-responders
717157|NCT00181948|Strattera|strattera
717158|NCT00181935|bipolar disorder|bipolar disorder
717159|NCT00181935|preschoolers|preschoolers
717160|NCT00181935|risperdal|risperdal
717161|NCT00181935|zyprexa|zyprexa
717162|NCT00181922|bipolar disorder|bipolar disorder
717163|NCT00181922|children|children
717164|NCT00181922|ziprasidone|ziprasidone
717165|NCT00181922|mania|mania
717166|NCT00181909|Pregnancy|pregnancy
717167|NCT00181909|Smoking cessation|smoking cessation
717168|NCT00181896|depression|depression
717169|NCT00181896|bipolar disorder|bipolar disorder
717170|NCT00181896|children|children
717171|NCT00181896|bupropion SR|bupropion sr
717172|NCT00181883|children|children
717173|NCT00181883|bipolar disorder|bipolar disorder
717174|NCT00181883|quetiapine|quetiapine
717175|NCT00181883|preschoolers|preschoolers
717176|NCT00181870|bipolar disorder|bipolar disorder
717177|NCT00181870|children|children
717178|NCT00181870|mania|mania
717179|NCT00181870|Equetro|equetro
717180|NCT00181857|ADHD NOS|adhd nos
717181|NCT00181857|familial risk|familial risk
717182|NCT00181857|children|children
717183|NCT00181844|bipolar disorder|bipolar disorder
717184|NCT00181844|lamotrigine|lamotrigine
717185|NCT00181844|children|children
717186|NCT00181844|mania|mania
717187|NCT00181831|SPECT|spect
717188|NCT00181831|bipolar disorder|bipolar disorder
717189|NCT00181831|ADHD|adhd
717190|NCT00181831|children|children
717191|NCT00181818|Smoking cessation|smoking cessation
717192|NCT00181818|Bupropion SR|bupropion sr
717193|NCT00181818|Hospital intervention|hospital intervention
717194|NCT00181818|Myocardial infarction|myocardial infarction
717195|NCT00181818|Unstable angina|unstable angina
717196|NCT00181805|GER|ger
717197|NCT00181792|ADHD|adhd
717198|NCT00181792|smoking|smoking
717199|NCT00181792|familial risk|familial risk
717200|NCT00181779|mania|mania
717201|NCT00181779|Abilify|abilify
717202|NCT00181779|children|children
717203|NCT00181779|bipolar disorder|bipolar disorder
717204|NCT00181766|ADHD NOS|adhd nos
717205|NCT00181766|Adults|adults
717206|NCT00181766|Strattera (atomoxetine)|strattera (atomoxetine)
717207|NCT00181766|Open-Label|open-label
717208|NCT00181753|glutamine metabolic kinetics|glutamine metabolic kinetics
717209|NCT00181753|glutamate metabolic kinetics|glutamate metabolic kinetics
717210|NCT00181753|enteral nutrition|enteral nutrition
717211|NCT00181753|parenteral nutrition|parenteral nutrition
717212|NCT00181753|burn injury|burn injury
717213|NCT00181753|stable isotopes|stable isotopes
717214|NCT00181740|ADHD NOS|adhd nos
717215|NCT00181740|Adults|adults
717216|NCT00181740|Concerta|concerta
717217|NCT00181740|Open-Label|open-label
717218|NCT00181727|bipolar disorder|bipolar disorder
717219|NCT00181727|mania|mania
717220|NCT00181727|depakote ER|depakote er
717221|NCT00181727|children|children
717222|NCT00181714|cigarette smoking|cigarette smoking
717223|NCT00181714|ADHD|adhd
717224|NCT00181714|adolescents|adolescents
717225|NCT00181714|Concerta|concerta
717226|NCT00181701|Ovarian cancer|ovarian cancer
717227|NCT00181701|Epithelial carcinoma of mullerian origin|epithelial carcinoma of mullerian origin
717228|NCT00181701|Intraperitoneal paclitaxel|intraperitoneal paclitaxel
717229|NCT00181701|Intraperitoneal carboplatin|intraperitoneal carboplatin
717230|NCT00181701|Primary peritoneal carcinoma|primary peritoneal carcinoma
717231|NCT00181701|Tubal carcinoma|tubal carcinoma
717232|NCT00181688|Iressa|iressa
717233|NCT00181688|ZD1839|zd1839
717234|NCT00181688|Anastrozole|anastrozole
717235|NCT00181688|Arimidex|arimidex
717236|NCT00181675|Adult|adult
717237|NCT00181675|ADHD|adhd
717238|NCT00181675|galantamine|galantamine
717239|NCT00181675|double-blind|double-blind
717240|NCT00181662|Curcumin|curcumin
717241|NCT00181662|Piperine|piperine
717242|NCT00181662|Silybin|silybin
717243|NCT00181662|Healthy volunteer|healthy volunteer
717244|NCT00181662|Female|female
717245|NCT00181649|Lactation|lactation
717246|NCT00181649|Breastfeeding|breastfeeding
717247|NCT00181649|Adoptive mothers|adoptive mothers
717248|NCT00181649|Prolactin|prolactin
717249|NCT00181649|Relative lactation insufficiency|relative lactation insufficiency
717250|NCT00181623|Lactation|lactation
717251|NCT00181623|Breastfeeding|breastfeeding
717252|NCT00181623|Prolactin|prolactin
717253|NCT00181623|Primary lactation insufficiency|primary lactation insufficiency
717254|NCT00181610|Lactation|lactation
717255|NCT00181610|Breastfeeding|breastfeeding
717256|NCT00181610|Premature infants|premature infants
717257|NCT00181610|Prolactin|prolactin
717258|NCT00181610|Primary lactation insufficiency|primary lactation insufficiency
717259|NCT00181597|Trilostane|trilostane
717260|NCT00181597|Androgen-independent prostate cancer|androgen-independent prostate cancer
717261|NCT00181584|Androgen deprivation therapy|androgen deprivation therapy
717262|NCT00181584|bone loss|bone loss
717263|NCT00181584|prostate cancer|prostate cancer
717264|NCT00181584|Zoledronic Acid|zoledronic acid
717265|NCT00181584|Zometa|zometa
717266|NCT00181571|ADHD|adhd
717267|NCT00181571|Adults|adults
717268|NCT00181571|Concerta|concerta
717269|NCT00181571|Double-Blind|double-blind
717270|NCT00181558|Prostate Cancer|prostate cancer
717271|NCT00181558|bone metastases|bone metastases
717272|NCT00181558|Atrasentan|atrasentan
717273|NCT00181558|Zometa|zometa
717274|NCT00181558|Androgen Independent Prostate Cancer|androgen independent prostate cancer
717275|NCT00181545|Non-small cell lung carcinoma|non-small cell lung carcinoma
717276|NCT00181545|radiotherapy|radiotherapy
717277|NCT00181545|mean lung dose|mean lung dose
717278|NCT00181532|NSCLC|nsclc
717279|NCT00181532|cox-2-inhibitor|cox-2-inhibitor
717280|NCT00181532|radiosensitizer|radiosensitizer
717281|NCT00181532|radiotherapy|radiotherapy
717282|NCT00181506|radiotherapy|radiotherapy
717283|NCT00181506|radiation dose|radiation dose
717284|NCT00181506|lung cancer|lung cancer
717285|NCT00181363|Breast cancer|breast cancer
717286|NCT00181363|Breast conserving surgery|breast conserving surgery
717287|NCT00181363|Radiotherapy|radiotherapy
717288|NCT00181363|Pendulous breasts|pendulous breasts
717289|NCT00181350|brain tumor|brain tumor
717290|NCT00181350|fractionated stereotactic radiotherapy|fractionated stereotactic radiotherapy
717291|NCT00181350|fixationsystems|fixationsystems
717292|NCT00181350|repositioning|repositioning
717293|NCT00181311|vaginal hysterectomy|vaginal hysterectomy
717294|NCT00181311|abdominal hysterectomy|abdominal hysterectomy
717295|NCT00181311|complications|complications
717296|NCT00181311|physical well being|physical well being
717297|NCT00181311|mental well being|mental well being
717298|NCT00181298|Memantine|memantine
717299|NCT00181298|SLE|sle
717300|NCT00181298|Anti NR2|anti nr2
717301|NCT00181298|ANAM|anam
717302|NCT00181298|Cognitive functioning|cognitive functioning
717303|NCT00181272|chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
717304|NCT00181272|undifferentiated asthma/COPD|undifferentiated asthma/copd
717305|NCT00181246|Neuropathic pain|neuropathic pain
717306|NCT00181246|Efficacy|efficacy
717307|NCT00181207|COPD|copd
717308|NCT00181194|Asthma|asthma
717309|NCT00181181|Hypertension|hypertension
717310|NCT00181168|thyroid cancer|thyroid cancer
717311|NCT00181168|PET scan|pet scan
717312|NCT00181168|recombinant thyrotropin|recombinant thyrotropin
717313|NCT00181168|thyroglobulin|thyroglobulin
717314|NCT00181168|Thyroid cancer, differentiated epithelial|thyroid cancer, differentiated epithelial
717315|NCT00181155|metabolism|metabolism
717316|NCT00181155|congestive heart failure|congestive heart failure
717317|NCT00181155|allopurinol|allopurinol
717318|NCT00181155|Adenosine triphosphate (ATP)|adenosine triphosphate (atp)
717319|NCT00181142|Induciton therapy, Daclizumab, Thymoglobulin, lung transplantation|induciton therapy, daclizumab, thymoglobulin, lung transplantation
717320|NCT00181129|Fatigue|fatigue
717321|NCT00181129|Cancer treatment|cancer treatment
717322|NCT00181116|Epilepsy|epilepsy
717323|NCT00181116|Benign rolandic|benign rolandic
717324|NCT00181116|Levetiracetam|levetiracetam
717325|NCT00181090|Epilepsy|epilepsy
717326|NCT00181090|Ketosis|ketosis
717327|NCT00181090|Atkins|atkins
717328|NCT00181090|seizures|seizures
717329|NCT00181077|preeclampsia, hypertonic saline, diuresis|preeclampsia, hypertonic saline, diuresis
717330|NCT00181064|headache|headache
717331|NCT00181064|Atkins|atkins
717332|NCT00181064|ketosis|ketosis
717333|NCT00181064|intractable|intractable
717334|NCT00181038|Oro-Pharyngeal Carcinoma Surgery|oro-pharyngeal carcinoma surgery
717335|NCT00181025|Limbs’ girdle|limbs’ girdle
717336|NCT00181012|Cancer Related Visceral Pain Resistant to Morphinics|cancer related visceral pain resistant to morphinics
717337|NCT00180947|Soft parts tissue|soft parts tissue
717338|NCT00180921|Adenoid cystic carcinoma of the head and neck|adenoid cystic carcinoma of the head and neck
717339|NCT00180908|Osteosarcoma|osteosarcoma
717340|NCT00180895|Burkitt lymphoma|burkitt lymphoma
717341|NCT00180895|B-cell non Hodgkin lymphoma|b-cell non hodgkin lymphoma
717342|NCT00180895|B-cell ALL|b-cell all
717343|NCT00180895|Refractory|refractory
717344|NCT00180895|Relapse|relapse
717345|NCT00180895|Rituximab|rituximab
717346|NCT00180895|Children|children
717347|NCT00180869|cancer|cancer
717348|NCT00180869|peroperative transfusion|peroperative transfusion
717349|NCT00180869|allogeneic red blood cell concentrate|allogeneic red blood cell concentrate
717350|NCT00180869|leuko-reduced red blood cell concentrate|leuko-reduced red blood cell concentrate
717351|NCT00180856|Lung metastasis|lung metastasis
717352|NCT00180856|Lung cancer|lung cancer
717353|NCT00180856|Radiofrequency ablation|radiofrequency ablation
717354|NCT00180791|Brain PNET|brain pnet
717355|NCT00180765|Leukocytes|leukocytes
717356|NCT00180765|Eosinophils|eosinophils
717357|NCT00180765|Neutrophils|neutrophils
717358|NCT00180765|Chronic Obstructive Airway Disease|chronic obstructive airway disease
717359|NCT00180765|Apoptosis|apoptosis
717360|NCT00180765|Signal Transduction|signal transduction
717361|NCT00180739|MR guided FUS|mr guided fus
717362|NCT00180739|Uterine Fibroids|uterine fibroids
717363|NCT00180739|Fertility|fertility
717364|NCT00180739|Pregnancy|pregnancy
717365|NCT00180726|asthma, inflammatory, corticosteroid|asthma, inflammatory, corticosteroid
717366|NCT00180713|Pulmonary hypertension|pulmonary hypertension
717367|NCT00180713|Simvastatin|simvastatin
717368|NCT00180713|Statins|statins
717369|NCT00180700|HIV|hiv
717370|NCT00180700|Stress|stress
717371|NCT00180700|Psychoneuroimmunology|psychoneuroimmunology
717372|NCT00180700|stress management|stress management
717373|NCT00180700|hypnosis|hypnosis
717374|NCT00180700|Johrei|johrei
717375|NCT00180700|psychological intervention|psychological intervention
717376|NCT00180687|Pain|pain
717377|NCT00180687|Nebulisation|nebulisation
717378|NCT00180687|Cholecystectomy|cholecystectomy
717379|NCT00180687|Laparoscopic|laparoscopic
717380|NCT00180687|Bupivacaine|bupivacaine
717381|NCT00180687|Local Anaesthetic|local anaesthetic
717382|NCT00180674|Hepatic fibrosis|hepatic fibrosis
717383|NCT00180674|anticoagulation|anticoagulation
717384|NCT00180674|Coumarin|coumarin
717385|NCT00180674|Warfarin|warfarin
717386|NCT00180674|Chronic hepatitis C virus infection|chronic hepatitis c virus infection
717387|NCT00180661|Severe asthma|severe asthma
717388|NCT00180661|corticosteroid responsiveness|corticosteroid responsiveness
717389|NCT00180648|Short Bowel Syndrome|short bowel syndrome
717390|NCT00180648|Intestinal Failure|intestinal failure
717391|NCT00180648|Glucagon Like Peptide 2|glucagon like peptide 2
717392|NCT00180648|Parenteral Nutrition|parenteral nutrition
717393|NCT00180518|Carotid artery disease|carotid artery disease
717394|NCT00180518|High risk|high risk
717395|NCT00180518|High surgical risk|high surgical risk
717396|NCT00180505|Peripheral Artery Disease|peripheral artery disease
717397|NCT00180505|Restenosis Rate|restenosis rate
717398|NCT00180505|Patency Rates|patency rates
717399|NCT00180505|Self-Expandable Nitinol Stents|self-expandable nitinol stents
717400|NCT00180505|Stent Fractures|stent fractures
717401|NCT00180492|Atherosclerotic disease|atherosclerotic disease
717402|NCT00180479|Everolimus|everolimus
717403|NCT00180466|drug eluting stents|drug eluting stents
717404|NCT00180466|stents|stents
717405|NCT00180466|angioplasty|angioplasty
717406|NCT00180466|coronary artery disease|coronary artery disease
717407|NCT00180466|total coronary occlusion|total coronary occlusion
717408|NCT00180466|coronary artery restenosis|coronary artery restenosis
717409|NCT00180466|stent thrombosis|stent thrombosis
717410|NCT00180466|vascular disease|vascular disease
717411|NCT00180466|myocardial ischemia|myocardial ischemia
717412|NCT00180466|coronary artery stenosis|coronary artery stenosis
717413|NCT00180453|Cardiovascular disease|cardiovascular disease
717414|NCT00180453|Ischemia|ischemia
717415|NCT00180414|heart failure|heart failure
717416|NCT00180388|cardiovascular system|cardiovascular system
717417|NCT00180388|veins|veins
717418|NCT00180388|saphenous vein|saphenous vein
717419|NCT00180336|Heart Failure|heart failure
717420|NCT00180336|Tachycardia|tachycardia
717421|NCT00180336|Atrial Fibrillation|atrial fibrillation
717422|NCT00180336|Atrial Flutter|atrial flutter
717423|NCT00180336|Ventricular Fibrillation|ventricular fibrillation
717424|NCT00180310|drug eluting stents|drug eluting stents
717425|NCT00180310|stents|stents
717426|NCT00180310|angioplasty|angioplasty
717427|NCT00180310|coronary artery disease|coronary artery disease
717428|NCT00180310|total coronary occlusion|total coronary occlusion
717429|NCT00180310|coronary artery restenosis|coronary artery restenosis
717430|NCT00180310|stent thrombosis|stent thrombosis
717431|NCT00180310|vascular disease|vascular disease
717432|NCT00180310|myocardial ischemia|myocardial ischemia
717433|NCT00180310|coronary artery stenosis|coronary artery stenosis
717434|NCT00180284|Pacemaker leads|pacemaker leads
717435|NCT00180284|Electrodes, implantable|electrodes, implantable
717436|NCT00180284|Cardiac pacing, aritificial|cardiac pacing, aritificial
717437|NCT00180271|Defibrillator|defibrillator
717438|NCT00180271|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
717439|NCT00180271|MADIT|madit
717440|NCT00180258|Cardiac Resynchronization Therapy (CRT)|cardiac resynchronization therapy (crt)
717441|NCT00180258|Heart Failure|heart failure
717442|NCT00180258|Defibrillator|defibrillator
717443|NCT00180258|Pacemaker|pacemaker
717444|NCT00180245|Radiation therapy|radiation therapy
717445|NCT00180245|F-18-FDG|f-18-fdg
717446|NCT00180219|G08.520.769.550.408|g08.520.769.550.408
717447|NCT00180219|G08.520.769.550.490|g08.520.769.550.490
717448|NCT00180219|G08.520.769.550.520|g08.520.769.550.520
717449|NCT00180206|Arthritis|arthritis
717450|NCT00180206|Hip|hip
717451|NCT00180206|Hip arthroplasty|hip arthroplasty
717659|NCT00179387|Neoplasms|neoplasms
717452|NCT00180206|Hip resurfacing arthroplasty|hip resurfacing arthroplasty
717453|NCT00180193|Radiotherapy|radiotherapy
717454|NCT00180193|F-18-OMFD|f-18-omfd
717455|NCT00180180|head-and-neck cancer|head-and-neck cancer
717456|NCT00180180|radiation therapy|radiation therapy
717457|NCT00180180|F-18-FMISO|f-18-fmiso
717458|NCT00180167|Chemotherapy|chemotherapy
717459|NCT00180167|elderly|elderly
717460|NCT00180154|radiation therapy|radiation therapy
717461|NCT00180154|F-18-FDG|f-18-fdg
717462|NCT00180154|NSCLC|nsclc
717463|NCT00180141|Atopic dermatitis on both lower arm.|atopic dermatitis on both lower arm.
717464|NCT00180128|acute promyelocytic leukemia|acute promyelocytic leukemia
717465|NCT00180128|risk adapted therapy|risk adapted therapy
717466|NCT00180115|acute myeloid leukemia|acute myeloid leukemia
717467|NCT00180115|cytarabine postremission dosage|cytarabine postremission dosage
717468|NCT00180115|risk adapted treatment strategy|risk adapted treatment strategy
717469|NCT00180115|allogeneic stem cell transplantation|allogeneic stem cell transplantation
717470|NCT00180115|autologous stem cell transplantation|autologous stem cell transplantation
717471|NCT00180102|acute myeloid leukemia|acute myeloid leukemia
717472|NCT00180102|risk adapted treatment|risk adapted treatment
717473|NCT00180102|early allogeneic stem cell transplantation|early allogeneic stem cell transplantation
717474|NCT00180102|autologous stem cell transplantation|autologous stem cell transplantation
717475|NCT00180089|graft-versus-host disease|graft-versus-host disease
717476|NCT00180089|budesonide|budesonide
717477|NCT00180089|stem cell transplantation|stem cell transplantation
717478|NCT00180076|collagenous colitis|collagenous colitis
717479|NCT00180076|microscopic colitis|microscopic colitis
717480|NCT00180076|budesonide|budesonide
717481|NCT00180050|lymphocytic colitis|lymphocytic colitis
717482|NCT00180050|microscopic colitis|microscopic colitis
717483|NCT00180050|budesonide|budesonide
717484|NCT00180037|Parkinson's disease|parkinson's disease
717485|NCT00180037|Coenzyme Q10|coenzyme q10
717486|NCT00180037|Treatment|treatment
717487|NCT00180037|Neuroprotection|neuroprotection
717488|NCT00180024|AT1-receptor|at1-receptor
717489|NCT00180024|AT2-receptor|at2-receptor
717490|NCT00180024|human pharmacology|human pharmacology
717491|NCT00180011|omalizumab|omalizumab
717492|NCT00180011|severe asthma|severe asthma
717493|NCT00180011|moderate asthma|moderate asthma
717494|NCT00180011|injectable asthma medication|injectable asthma medication
717495|NCT00180011|Xolair|xolair
717496|NCT00179998|Cystic fibrosis|cystic fibrosis
717497|NCT00179998|Infants|infants
717498|NCT00179998|Children|children
717499|NCT00179998|Pulmozyme|pulmozyme
717500|NCT00179998|Pulmonary function|pulmonary function
717501|NCT00179998|Computed tomography|computed tomography
717502|NCT00179985|Developmental Care|developmental care
717503|NCT00179985|Neonatal Intensive Care Unit (NICU)|neonatal intensive care unit (nicu)
717504|NCT00179972|Pulse oximetry|pulse oximetry
717505|NCT00179972|Pulse oximetry sensors|pulse oximetry sensors
717506|NCT00179972|Skin Integrity|skin integrity
717507|NCT00179972|Prematurity|prematurity
717508|NCT00179972|Neonatal Intensive Care Unit|neonatal intensive care unit
717509|NCT00179972|Infant, premature|infant, premature
717510|NCT00179933|developmental care|developmental care
717511|NCT00179933|Neonatal Intensive Care Unit|neonatal intensive care unit
717512|NCT00179894|ADHD|adhd
717513|NCT00179894|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
717514|NCT00179881|Brain stem glioma|brain stem glioma
717515|NCT00179868|cancer|cancer
717516|NCT00179868|leukemia|leukemia
717517|NCT00179868|stem cell transplant|stem cell transplant
717518|NCT00179868|complications|complications
717519|NCT00179855|graft versus host disease|graft versus host disease
717520|NCT00179855|ECP|ecp
717521|NCT00179855|extracorporeal photopheresis|extracorporeal photopheresis
717522|NCT00179855|allogeneic transplantation|allogeneic transplantation
717523|NCT00179829|leukemia|leukemia
717524|NCT00179829|acute lymphocytic leukemia|acute lymphocytic leukemia
717525|NCT00179829|chronic myelogenous leukemia|chronic myelogenous leukemia
717526|NCT00179829|acute myelogenous leukemia|acute myelogenous leukemia
717527|NCT00179816|wilm's tumor|wilm's tumor
717528|NCT00179816|stem cell transplantation|stem cell transplantation
717529|NCT00179816|solid tumor|solid tumor
717530|NCT00179803|brain tumor|brain tumor
717531|NCT00179803|medulloblastoma|medulloblastoma
717532|NCT00179803|germ cell tumor|germ cell tumor
717533|NCT00179803|CNS tumor|cns tumor
717534|NCT00179803|glioblastoma|glioblastoma
717535|NCT00179803|astrocytoma|astrocytoma
717536|NCT00179803|pineoblastoma|pineoblastoma
717537|NCT00179803|rhabdoid tumor|rhabdoid tumor
717538|NCT00179803|supratentorial PNET|supratentorial pnet
717539|NCT00179803|high grade astrocytoma|high grade astrocytoma
717540|NCT00179790|cancer|cancer
717541|NCT00179790|hemoglobinopathy|hemoglobinopathy
717542|NCT00179790|immune deficiency|immune deficiency
717543|NCT00179790|photopheresis|photopheresis
717544|NCT00179790|ECP|ecp
717545|NCT00179790|extracorporeal photopheresis|extracorporeal photopheresis
717546|NCT00179777|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
717547|NCT00179777|Genetic Predisposition to Disease|genetic predisposition to disease
717548|NCT00179777|Infant Nutrition|infant nutrition
717549|NCT00179777|Primary Prevention|primary prevention
717550|NCT00179764|Patients with recurrent solid tumors|patients with recurrent solid tumors
717551|NCT00179764|Patients with malignant melanoma|patients with malignant melanoma
717552|NCT00179764|Patients with hematological malignancies|patients with hematological malignancies
717553|NCT00179764|Acute lymphoblastic leukemia (ALL)|acute lymphoblastic leukemia (all)
717554|NCT00179764|Acute myelogenous leukemia (AML)|acute myelogenous leukemia (aml)
717555|NCT00179751|cc-5013|cc-5013
717556|NCT00179751|revlimid|revlimid
717557|NCT00179751|pancreatic cancer|pancreatic cancer
717558|NCT00179738|Androgen Independent Prostate Cancer|androgen independent prostate cancer
717559|NCT00179725|cc-5013|cc-5013
717560|NCT00179725|revlimid|revlimid
717561|NCT00179725|ovarian cancer|ovarian cancer
717562|NCT00179725|celgene|celgene
717563|NCT00179712|cc-5013|cc-5013
717564|NCT00179712|revlimid|revlimid
717565|NCT00179712|ovarian cancer|ovarian cancer
717566|NCT00179712|celgene|celgene
717567|NCT00179699|cc-5013|cc-5013
717568|NCT00179699|Non Small Cell Lung Cancer|non small cell lung cancer
717569|NCT00179699|revlimid|revlimid
717570|NCT00179699|celgene|celgene
717571|NCT00179699|cc5013|cc5013
717572|NCT00179686|celgene|celgene
717573|NCT00179686|cc-5013|cc-5013
717574|NCT00179686|NSCLC|nsclc
717575|NCT00179686|CC5013|cc5013
717576|NCT00179686|Revlimid|revlimid
717577|NCT00179686|Non-Small Cell Lung Cancer|non-small cell lung cancer
717578|NCT00179673|NHL|nhl
717579|NCT00179673|CC5013|cc5013
717580|NCT00179673|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
717581|NCT00179673|revlimid|revlimid
717582|NCT00179673|cc-5013|cc-5013
717583|NCT00179673|celgene|celgene
717584|NCT00179660|celgene|celgene
717585|NCT00179660|cc-5013|cc-5013
717586|NCT00179660|CC5013|cc5013
717587|NCT00179660|NHL|nhl
717588|NCT00179660|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
717589|NCT00179660|Revlimid|revlimid
717590|NCT00179647|Multiple Myeloma|multiple myeloma
717591|NCT00179647|MM|mm
717592|NCT00179647|Revlimid|revlimid
717593|NCT00179647|CC5013|cc5013
717594|NCT00179647|celgene|celgene
717595|NCT00179647|cc-5013|cc-5013
717596|NCT00179647|relapsed/refractory|relapsed/refractory
717597|NCT00179647|lenalidomide|lenalidomide
717598|NCT00179647|dexamethasone|dexamethasone
717599|NCT00179647|Decadron|decadron
717600|NCT00179634|Mastectomy|mastectomy
717601|NCT00179634|Randomized Controlled Trial|randomized controlled trial
717602|NCT00179634|Imagery|imagery
717603|NCT00179621|MDS|mds
717604|NCT00179621|transfusion dependent|transfusion dependent
717605|NCT00179621|anaemia|anaemia
717606|NCT00179621|cytogenetic abnormality 5q-|cytogenetic abnormality 5q-
717607|NCT00179621|erythroid response|erythroid response
717608|NCT00179621|leukaemia|leukaemia
717609|NCT00179621|CC-5013|cc-5013
717610|NCT00179621|Celgene|celgene
717611|NCT00179621|revlimid|revlimid
717612|NCT00179621|lenalidomide|lenalidomide
717613|NCT00179608|CC-5013|cc-5013
717614|NCT00179608|CC5013|cc5013
717615|NCT00179608|celgene|celgene
717616|NCT00179608|Melanoma|melanoma
717617|NCT00179608|Revlimid|revlimid
717618|NCT00179608|Metastatic Malignant Melanoma|metastatic malignant melanoma
717619|NCT00179608|Lenalidomide|lenalidomide
717620|NCT00179595|nitric oxide, volumetric oxygen consumption|nitric oxide, volumetric oxygen consumption
717621|NCT00179582|IBS|ibs
717622|NCT00179582|Functional bowel disorder|functional bowel disorder
717623|NCT00179582|Diarrhea|diarrhea
717624|NCT00179582|probiotic|probiotic
717625|NCT00179556|Hot flashes|hot flashes
717626|NCT00179556|Menopausal symptoms|menopausal symptoms
717627|NCT00179556|Soybean germ|soybean germ
717628|NCT00179556|Aglycones|aglycones
717629|NCT00179556|Menopause|menopause
717630|NCT00179517|Seizure|seizure
717631|NCT00179517|Epilepsy|epilepsy
717632|NCT00179517|Testosterone|testosterone
717633|NCT00179517|Hormone|hormone
717634|NCT00179517|Sexual Dysfunction|sexual dysfunction
717635|NCT00179517|Hypogonadism|hypogonadism
717636|NCT00179517|Men|men
717637|NCT00179491|coronary artery bypass grafting surgery|coronary artery bypass grafting surgery
717638|NCT00179478|Multiple sclerosis|multiple sclerosis
717639|NCT00179478|Interferon Beta|interferon beta
717640|NCT00179478|MRI|mri
717641|NCT00179478|Optic neuritis|optic neuritis
717642|NCT00179478|Transverse Myelitis|transverse myelitis
717643|NCT00179465|Treatment|treatment
717644|NCT00179465|fMRI|fmri
717645|NCT00179465|Cognition|cognition
717646|NCT00179465|Brain development|brain development
717647|NCT00179452|epilepsy, yoga|epilepsy, yoga
717648|NCT00179439|PSC|psc
717649|NCT00179439|IBD|ibd
717650|NCT00179439|CFTR|cftr
717651|NCT00179426|Seizure Disorder|seizure disorder
717652|NCT00179426|Hypogonadism|hypogonadism
717653|NCT00179426|Sexual Function|sexual function
717654|NCT00179426|Epilepsy|epilepsy
717655|NCT00179413|hepatitis C|hepatitis c
717656|NCT00179413|cirrhosis|cirrhosis
717657|NCT00179413|interferon|interferon
717658|NCT00179413|colchicine|colchicine
717660|NCT00179387|Needs Assessment|needs assessment
717661|NCT00179387|Adaptation Psychological|adaptation psychological
717662|NCT00179387|Minority Groups|minority groups
717663|NCT00179387|Psychotherapy, Group|psychotherapy, group
717664|NCT00179387|Program Evaluation|program evaluation
717665|NCT00179387|Spirituality|spirituality
717666|NCT00179387|Spiritual Therapies|spiritual therapies
717667|NCT00179374|Medication adherence|medication adherence
717668|NCT00179374|Self-care behaviors|self-care behaviors
717669|NCT00179374|Telephonic intervention|telephonic intervention
717670|NCT00179374|Diabetes|diabetes
717671|NCT00179374|Nutrition|nutrition
717672|NCT00179374|Exercise|exercise
717673|NCT00179335|Regular lopinavir/ritonavir or Efavirenz use|regular lopinavir/ritonavir or efavirenz use
717674|NCT00179335|Age >/= 55 y or </= 35 y|age >/= 55 y or </= 35 y
717675|NCT00179335|HIV+|hiv+
717676|NCT00179322|Sleep Architecture|sleep architecture
717677|NCT00179322|Sleep Measures|sleep measures
717678|NCT00179322|Speech Articulation|speech articulation
717679|NCT00179322|Cerebral Perfusion|cerebral perfusion
717680|NCT00179322|Neuroimaging|neuroimaging
717681|NCT00179322|Healthy Volunteer|healthy volunteer
717682|NCT00179322|HV|hv
717683|NCT00179309|CEA|cea
717684|NCT00179309|MUC-1|muc-1
717685|NCT00179309|Immunotherapy|immunotherapy
717686|NCT00179309|GM-CSF|gm-csf
717687|NCT00179309|Vaccine|vaccine
717688|NCT00179309|Breast Cancer|breast cancer
717689|NCT00179309|Metastatic Breast Cancer|metastatic breast cancer
717690|NCT00179257|Failure to Escitalopram|failure to escitalopram
717691|NCT00179244|Treatment Resistant Depression|treatment resistant depression
717692|NCT00179192|End Stage Renal Disease|end stage renal disease
717693|NCT00179192|ESRD|esrd
717694|NCT00179192|Chronic Maintenance Hemodialysis|chronic maintenance hemodialysis
717695|NCT00179127|Pediatrics|pediatrics
717696|NCT00179127|Diabetes|diabetes
717697|NCT00179127|Emergency Care|emergency care
717698|NCT00179127|Endocrinology|endocrinology
717699|NCT00179127|Critical Care|critical care
717700|NCT00179114|Spasticity|spasticity
717701|NCT00179114|Developmental Disabilities|developmental disabilities
717702|NCT00179114|Intrathecal baclofen (ITB)|intrathecal baclofen (itb)
717703|NCT00179114|Botulinum Toxin Type A (Botox)|botulinum toxin type a (botox)
717704|NCT00179101|Parkinson's Disease|parkinson's disease
717705|NCT00179101|Depression|depression
717706|NCT00179101|Quality of Life|quality of life
717707|NCT00179101|Deep Brain Stimulation|deep brain stimulation
717708|NCT00179088|Weight-Bearing|weight-bearing
717709|NCT00179088|Total Hip Replacement|total hip replacement
717710|NCT00179088|Non-cemented|non-cemented
717711|NCT00179088|Randomized|randomized
717712|NCT00179088|Fiber-Metal-Taper-Stem|fiber-metal-taper-stem
717713|NCT00179088|Hip|hip
717714|NCT00179088|Osteoarthritis|osteoarthritis
717715|NCT00179075|T-Lymphocyte Subsets|t-lymphocyte subsets
717716|NCT00179062|major depression with psychotic features|major depression with psychotic features
717717|NCT00179062|bipolar disorder with psychotic features|bipolar disorder with psychotic features
717718|NCT00179049|T-Lymphocyte Subsets|t-lymphocyte subsets
717719|NCT00179036|Blood supply|blood supply
717720|NCT00179036|Mesentery|mesentery
717721|NCT00179023|OBESITY|obesity
717722|NCT00179023|RESTING ENERGY EXPENDITURE|resting energy expenditure
717723|NCT00179023|SYMPATHETIC NERVOUS SYSTEM|sympathetic nervous system
717724|NCT00179023|HYPERTENSION|hypertension
717725|NCT00179023|AUTONOMIC FAILURE|autonomic failure
717726|NCT00179010|Adenosine|adenosine
717727|NCT00179010|AMP|amp
717728|NCT00179010|Microdialysis|microdialysis
717729|NCT00179010|Blood Flow|blood flow
717730|NCT00178997|Blood supply|blood supply
717731|NCT00178997|Mesentery|mesentery
717732|NCT00178984|Blood supply|blood supply
717733|NCT00178984|Mesentery|mesentery
717734|NCT00178919|Endothelial Nitric Oxide|endothelial nitric oxide
717735|NCT00178919|L-NMMA|l-nmma
717736|NCT00178919|Trimethaphan|trimethaphan
717737|NCT00178919|Autonomic Nervous System|autonomic nervous system
717738|NCT00178919|Nitric Oxide Inhibition|nitric oxide inhibition
717739|NCT00178906|depression|depression
717740|NCT00178906|suicide|suicide
717741|NCT00178906|voice|voice
717742|NCT00178880|depression|depression
717743|NCT00178880|MRI|mri
717744|NCT00178880|imaging|imaging
717745|NCT00178841|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
717746|NCT00178841|CTCL|ctcl
717747|NCT00178841|Mycosis Fungoides|mycosis fungoides
717748|NCT00178841|Sezary Syndrome|sezary syndrome
717749|NCT00178841|Bexarotene|bexarotene
717750|NCT00178841|Targretin|targretin
717751|NCT00178841|Rosiglitazone|rosiglitazone
717752|NCT00178841|Avandia|avandia
717753|NCT00178828|Depression|depression
717754|NCT00178828|antidepressant|antidepressant
717755|NCT00178828|SSRI|ssri
717756|NCT00178802|breast cancer|breast cancer
717757|NCT00178802|endometrial cancer|endometrial cancer
717758|NCT00178802|cervical cancer|cervical cancer
717759|NCT00178802|ovarian cancer|ovarian cancer
717760|NCT00178789|Deep Venous Thrombosis|deep venous thrombosis
717761|NCT00178789|Blood Clot|blood clot
717762|NCT00178789|Lower Extremity|lower extremity
717763|NCT00178789|Sonography|sonography
717764|NCT00178776|Group|group
717765|NCT00178776|Therapy|therapy
717766|NCT00178776|Cocaine|cocaine
717767|NCT00178776|Drugs|drugs
717768|NCT00178776|Trial|trial
717769|NCT00178776|Outcome|outcome
717770|NCT00178776|Study|study
717771|NCT00178776|Feasibility|feasibility
717772|NCT00178776|Transtheoretical|transtheoretical
717773|NCT00178776|Stages|stages
717774|NCT00178776|Motivation|motivation
717775|NCT00178776|Change|change
717776|NCT00178763|Cancer|cancer
717777|NCT00178763|Pancreatic Cancer|pancreatic cancer
717778|NCT00178763|Pancreas|pancreas
717779|NCT00178763|Neoplasms|neoplasms
717780|NCT00178750|Epidural placement|epidural placement
717781|NCT00178750|CompuFlo®|compuflo®
717782|NCT00178724|spinal cord injury|spinal cord injury
717783|NCT00178724|SCI|sci
717784|NCT00178724|traumatic spinal cord injury|traumatic spinal cord injury
717785|NCT00178724|acute spinal cord injury|acute spinal cord injury
717786|NCT00178724|paralysis|paralysis
717787|NCT00178711|Traumatic Brain Injury|traumatic brain injury
717788|NCT00178711|Hypothermia|hypothermia
717789|NCT00178698|thermochemotherapy|thermochemotherapy
717790|NCT00178698|fever range whole body|fever range whole body
717791|NCT00178698|cisplatin|cisplatin
717792|NCT00178698|gemcitabine|gemcitabine
717793|NCT00178698|daily low dose interferon alpha|daily low dose interferon alpha
717794|NCT00178685|Self-determination|self-determination
717795|NCT00178685|motivation|motivation
717796|NCT00178685|adherence|adherence
717797|NCT00178685|competence|competence
717798|NCT00178685|autonomy|autonomy
717799|NCT00178685|tobacco dependence|tobacco dependence
717800|NCT00178685|Tobacco use and dependence|tobacco use and dependence
717801|NCT00178685|Behavior change|behavior change
717802|NCT00178672|CVA|cva
717803|NCT00178672|TIA|tia
717804|NCT00178672|Carotid disease|carotid disease
717805|NCT00178672|Stroke|stroke
717806|NCT00178672|Neurology|neurology
717807|NCT00178672|Carotid Stenting|carotid stenting
717808|NCT00178659|Traumatic Brain Injury|traumatic brain injury
717809|NCT00178659|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
717810|NCT00178659|Proteomics|proteomics
717811|NCT00178646|Stroke|stroke
717812|NCT00178646|Brain Injuries|brain injuries
717813|NCT00178646|Spasticity|spasticity
717814|NCT00178646|Botulinum Toxins|botulinum toxins
717815|NCT00178633|Obesity|obesity
717816|NCT00178633|Insulin Resistance|insulin resistance
717817|NCT00178633|Free Fatty Acids|free fatty acids
717818|NCT00178633|Heart Failure|heart failure
717819|NCT00178620|Heart Disease|heart disease
717820|NCT00178620|Heart Attack|heart attack
717821|NCT00178620|Myocardial Infarction|myocardial infarction
717822|NCT00178620|Thrombolytic Therapy|thrombolytic therapy
717823|NCT00178620|Emergency Medicine|emergency medicine
717824|NCT00178607|Inhibitors|inhibitors
717825|NCT00178594|Hereditary Bleeding disorder|hereditary bleeding disorder
717826|NCT00178594|Thrombotic Disorder|thrombotic disorder
717827|NCT00178581|Trauma|trauma
717828|NCT00178581|Critical Illness|critical illness
717829|NCT00178581|Shock|shock
717830|NCT00178581|Enteral Nutrition|enteral nutrition
717831|NCT00178581|Glutamine|glutamine
717832|NCT00178568|Caregiving|caregiving
717833|NCT00178568|Spousal|spousal
717834|NCT00178568|Sleep disturbances|sleep disturbances
717835|NCT00178568|Progressive dementia|progressive dementia
717836|NCT00178568|Stress|stress
717837|NCT00178568|Health outcomes|health outcomes
717838|NCT00178568|Intervention|intervention
717839|NCT00178568|Affective self-management|affective self-management
717840|NCT00178568|Caregivers M01.526.485.200|caregivers m01.526.485.200
717841|NCT00178568|Spouses F01.829.263.500.660|spouses f01.829.263.500.660
717842|NCT00178568|Alzheimer's disease C10.574.945.249|alzheimer's disease c10.574.945.249
717843|NCT00178568|Parkinson's disease C10.574.812|parkinson's disease c10.574.812
717844|NCT00178568|Sleep disorder C10.886.425.800.800|sleep disorder c10.886.425.800.800
717845|NCT00178555|Endotracheal Intubation, Video Laryngoscopy|endotracheal intubation, video laryngoscopy
717846|NCT00178542|von Willebrand Disease|von willebrand disease
717847|NCT00178542|Healthy Women and Women with von Willebrand Disease|healthy women and women with von willebrand disease
717848|NCT00178529|Stroke|stroke
717849|NCT00178529|Caregivers|caregivers
717850|NCT00178516|male|male
717851|NCT00178516|infertility|infertility
717852|NCT00178490|Neurocognitive Function|neurocognitive function
717853|NCT00178464|sickle cell disease|sickle cell disease
717854|NCT00178464|hemoglobin SS disease|hemoglobin ss disease
717855|NCT00178464|hemoglobin S Beta-0 Thalassemia|hemoglobin s beta-0 thalassemia
717856|NCT00178464|silent infarction in sickle cell disease|silent infarction in sickle cell disease
717857|NCT00178464|overt stroke in sickle cell disease|overt stroke in sickle cell disease
717858|NCT00178464|aspirin|aspirin
717859|NCT00178464|transcranial Doppler ultrasound|transcranial doppler ultrasound
717860|NCT00178464|neurocognitive testing|neurocognitive testing
717861|NCT00178438|capsule endoscopy in small bowel|capsule endoscopy in small bowel
717862|NCT00178425|mycophenolate mofetil hydrochloride|mycophenolate mofetil hydrochloride
717863|NCT00178425|pharmacokinetics|pharmacokinetics
717864|NCT00178425|tacrolimus|tacrolimus
717865|NCT00178412|Hospitalized elders|hospitalized elders
717866|NCT00178412|Family caregivers|family caregivers
717867|NCT00178412|Acute care|acute care
717868|NCT00178386|cancer|cancer
717869|NCT00178386|education|education
717870|NCT00178386|learning|learning
717871|NCT00178386|brain tumor|brain tumor
717872|NCT00178386|school|school
717873|NCT00178373|cancer-related fatigue|cancer-related fatigue
717874|NCT00178373|chemotherapy|chemotherapy
717875|NCT00178373|modafinil|modafinil
717876|NCT00178360|Huntington's Disease, Music Therapy, quality of life|huntington's disease, music therapy, quality of life
717877|NCT00178321|Sleep|sleep
717878|NCT00178321|Criticall Ill|criticall ill
717879|NCT00178321|Children|children
717880|NCT00178321|Earplugs|earplugs
717881|NCT00178217|Botulinum Toxin|botulinum toxin
717882|NCT00178217|Music Therapy|music therapy
717883|NCT00178217|Cerebral Palsy|cerebral palsy
717884|NCT00178217|Procedural Support|procedural support
717885|NCT00178204|delta sleep|delta sleep
717886|NCT00178204|Cancer-related fatigue|cancer-related fatigue
717887|NCT00178204|Sleep Disturbance|sleep disturbance
717888|NCT00178204|chemotherapy|chemotherapy
717889|NCT00178178|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
717890|NCT00178178|Pain Care 3000|pain care 3000
717891|NCT00178178|Catheter Placement|catheter placement
717892|NCT00178178|Pain|pain
717893|NCT00178178|Breg, Inc|breg, inc
717894|NCT00178165|Family Caregivers|family caregivers
717895|NCT00178165|Dementia|dementia
717896|NCT00178165|Alzheimer Disease|alzheimer disease
717897|NCT00178165|Randomized Controlled Trial|randomized controlled trial
717898|NCT00178165|Intervention Studies|intervention studies
717899|NCT00178139|Music Therapy|music therapy
717900|NCT00178139|Mechanical ventilation|mechanical ventilation
717901|NCT00178139|Weaning from mechanical ventilation|weaning from mechanical ventilation
717902|NCT00178139|complementary and alternative therapy|complementary and alternative therapy
717903|NCT00178126|pressure ulcer|pressure ulcer
717904|NCT00178113|Prostatic Intraepithelial Neoplasia|prostatic intraepithelial neoplasia
717905|NCT00178113|Prostate-Specific Antigen|prostate-specific antigen
717906|NCT00178113|lycopene|lycopene
717907|NCT00178100|Depression|depression
717908|NCT00178100|Elderly|elderly
717909|NCT00178100|Late Life|late life
717910|NCT00178087|late-life depression|late-life depression
717911|NCT00178087|mild cognitive impairment|mild cognitive impairment
717912|NCT00178087|dementia|dementia
717913|NCT00178074|depression|depression
717914|NCT00178074|imaging|imaging
717915|NCT00178074|PET|pet
717916|NCT00178074|elderly|elderly
717917|NCT00178074|late life|late life
717918|NCT00178074|sleep deprivation|sleep deprivation
717919|NCT00178048|primary insomnia|primary insomnia
717920|NCT00178048|insomnia|insomnia
717921|NCT00178048|depression|depression
717922|NCT00178048|late life|late life
717923|NCT00178048|elderly|elderly
717924|NCT00178048|sleep disorders|sleep disorders
717925|NCT00178035|Depression|depression
717926|NCT00178035|Unipolar Depression|unipolar depression
717927|NCT00178035|Elderly depression|elderly depression
717928|NCT00178035|Late-Life|late-life
717929|NCT00178022|tbi|tbi
717930|NCT00178022|intervention|intervention
717931|NCT00178022|depression|depression
717932|NCT00178022|anxiety|anxiety
717933|NCT00178009|computer-assisted instruction|computer-assisted instruction
717934|NCT00178009|instruction (video)|instruction (video)
717935|NCT00177996|depression|depression
717936|NCT00177996|anxiety|anxiety
717937|NCT00177983|Schizophrenia|schizophrenia
717938|NCT00177983|Relapse|relapse
717939|NCT00177983|Psychological distress|psychological distress
717940|NCT00177957|Gram negative bacteremia|gram negative bacteremia
717941|NCT00177944|invasive fungal infection|invasive fungal infection
717942|NCT00177931|Liver transplant|liver transplant
717943|NCT00177931|cefepime|cefepime
717944|NCT00177931|antibiotics|antibiotics
717945|NCT00177918|Lung Transplant|lung transplant
717946|NCT00177892|Sleep fragmentation|sleep fragmentation
717947|NCT00177892|Intermittent hypoxia|intermittent hypoxia
717948|NCT00177892|Obstructive Sleep Apnea|obstructive sleep apnea
717949|NCT00177892|Metabolic Syndrome|metabolic syndrome
717950|NCT00177892|Insulin resistance|insulin resistance
717951|NCT00177879|website|website
717952|NCT00177879|comparison|comparison
717953|NCT00177853|Locally advanced pancreatic cancer|locally advanced pancreatic cancer
717954|NCT00177853|invasion of major arteries and veins around pancreas|invasion of major arteries and veins around pancreas
717955|NCT00177853|No prior radiation or chemo|no prior radiation or chemo
717956|NCT00177840|cancer-related fatigue|cancer-related fatigue
717957|NCT00177840|acupuncture|acupuncture
717958|NCT00177840|breast cancer|breast cancer
717959|NCT00177814|pipercillin|pipercillin
717960|NCT00177814|gram negative bacteria infections|gram negative bacteria infections
717961|NCT00177788|liver transplant|liver transplant
717962|NCT00177788|voriconazole prophylaxis|voriconazole prophylaxis
717963|NCT00177788|liver transplantation|liver transplantation
717964|NCT00177788|voriconazole|voriconazole
717965|NCT00177749|invasive fungal infections|invasive fungal infections
717966|NCT00177736|ventilator associated pneumonia|ventilator associated pneumonia
717967|NCT00177723|receiving antibiotic Linezolid clinically|receiving antibiotic linezolid clinically
717968|NCT00177671|Depression|depression
717969|NCT00177671|Dementia|dementia
717970|NCT00177671|Alzheimer's Disease|alzheimer's disease
717971|NCT00177671|Cognitive|cognitive
717972|NCT00177671|Donepezil|donepezil
717973|NCT00177671|Memory|memory
717974|NCT00177671|Function|function
717975|NCT00177671|Elderly|elderly
717976|NCT00177671|Late-Life|late-life
717977|NCT00177658|Salmonella|salmonella
717978|NCT00177645|cystic fibrosis|cystic fibrosis
717979|NCT00177645|mucus clearance|mucus clearance
717980|NCT00177619|Prostatic neoplasms|prostatic neoplasms
717981|NCT00177619|Bisphosphonates|bisphosphonates
717982|NCT00177619|Hypogonadism|hypogonadism
717983|NCT00177606|withdrawal|withdrawal
717984|NCT00177606|life-sustaining|life-sustaining
717985|NCT00177606|treatments|treatments
717986|NCT00177606|UNOS|unos
717987|NCT00177606|organ donation|organ donation
717988|NCT00177580|schizophrenia|schizophrenia
717989|NCT00177580|schizoaffective disorder|schizoaffective disorder
717990|NCT00177580|positive symptoms|positive symptoms
717991|NCT00177580|negative symptoms|negative symptoms
717992|NCT00177580|cognitive functioning|cognitive functioning
717993|NCT00177580|pravastatin|pravastatin
717994|NCT00177567|Bipolar Disorder|bipolar disorder
717995|NCT00177567|Manic Depression|manic depression
717996|NCT00177567|Elderly|elderly
717997|NCT00177567|Late-Life|late-life
717998|NCT00177554|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
717999|NCT00177541|urge incontinence|urge incontinence
718000|NCT00177541|biofeedback|biofeedback
718001|NCT00177541|pelvic floor muscle training|pelvic floor muscle training
718002|NCT00177541|behavior modification|behavior modification
718003|NCT00177528|Elderly|elderly
718004|NCT00177515|emergency contraception|emergency contraception
718005|NCT00177515|folic acid|folic acid
718006|NCT00177515|education|education
718007|NCT00177515|preventive health|preventive health
718008|NCT00177489|Family Caregivers|family caregivers
718009|NCT00177489|Dementia|dementia
718010|NCT00177489|Alzheimer Disease|alzheimer disease
718011|NCT00177489|Randomized Controlled Trial|randomized controlled trial
718012|NCT00177489|Intervention Studies|intervention studies
718013|NCT00177463|L-carnosine|l-carnosine
718014|NCT00177463|Bipolar I disorder|bipolar i disorder
718015|NCT00177463|Cognitive enhancement|cognitive enhancement
718016|NCT00177424|Rehabilitation|rehabilitation
718017|NCT00177411|Endocrine System Diseases|endocrine system diseases
718018|NCT00177411|MusculoSkeletal System Diseases|musculoskeletal system diseases
718019|NCT00177411|Hormone|hormone
718020|NCT00177411|Postmenopausal Women|postmenopausal women
718021|NCT00177398|Type 2 diabetes|type 2 diabetes
718022|NCT00177398|Hyperglycemia|hyperglycemia
718023|NCT00177398|Enteral nutrition|enteral nutrition
718024|NCT00177385|Sleep|sleep
718025|NCT00177385|Sleep Hygiene|sleep hygiene
718026|NCT00177385|Modest sleep deprivation|modest sleep deprivation
718027|NCT00177385|Healthy Aging and sleep|healthy aging and sleep
718028|NCT00177385|Health Promotion|health promotion
718029|NCT00177359|gait impairment|gait impairment
718030|NCT00177333|Abortion, Induced|abortion, induced
718031|NCT00177333|Doxycycline|doxycycline
718032|NCT00177333|Antibiotic Prophylaxis|antibiotic prophylaxis
718033|NCT00177333|Vomiting|vomiting
718034|NCT00177333|Abortion, Therapeutic|abortion, therapeutic
718035|NCT00177320|Rheumatic Disorders|rheumatic disorders
718036|NCT00177320|Computer Use|computer use
718037|NCT00177307|colon|colon
718038|NCT00177307|rectum|rectum
718039|NCT00177294|Elderly|elderly
718040|NCT00177294|Remission|remission
718041|NCT00177294|Escitalopram|escitalopram
718042|NCT00177294|Interpersonal Psychotherapy|interpersonal psychotherapy
718043|NCT00177294|Psychotherapy|psychotherapy
718044|NCT00177294|Caregiving|caregiving
718045|NCT00177294|Late-Life|late-life
718046|NCT00177268|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
718047|NCT00177268|Sezary Syndrome|sezary syndrome
718048|NCT00177268|Mycosis Fungoides|mycosis fungoides
718049|NCT00177268|Blood/tissue banking|blood/tissue banking
718050|NCT00177268|eczema|eczema
718051|NCT00177268|atopic dermatitis|atopic dermatitis
718052|NCT00177255|gastric|gastric
718053|NCT00177255|stomach|stomach
718054|NCT00177255|esophagus|esophagus
718055|NCT00177255|esophageal|esophageal
718056|NCT00177242|pancreas|pancreas
718057|NCT00177242|pancreatic|pancreatic
718058|NCT00177216|Primary Insomnia|primary insomnia
718059|NCT00177216|Insomnia|insomnia
718060|NCT00177216|Placebo-Controlled|placebo-controlled
718061|NCT00177216|Double-Blind|double-blind
718062|NCT00177216|Polysomnography|polysomnography
718063|NCT00177216|PET Studies|pet studies
718064|NCT00177216|Escitalopram|escitalopram
718065|NCT00177216|Zolpidem|zolpidem
718066|NCT00177203|Insomnia|insomnia
718067|NCT00177203|Sleep Disorders|sleep disorders
718068|NCT00177203|Sleeplessness|sleeplessness
718069|NCT00177203|Chronic Insomnia|chronic insomnia
718070|NCT00177203|Sleep Studies|sleep studies
718071|NCT00177203|Disorders of Initiating and Maintaining Sleep|disorders of initiating and maintaining sleep
718072|NCT00177203|Primary Care|primary care
718073|NCT00177190|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
718074|NCT00177190|Sezary Syndrome|sezary syndrome
718075|NCT00177190|Mycosis Fungoides|mycosis fungoides
718076|NCT00177190|Immune Responses|immune responses
718077|NCT00177177|L-carnosine|l-carnosine
718078|NCT00177177|Schizophrenia|schizophrenia
718079|NCT00177177|Schizoaffective disorder|schizoaffective disorder
718080|NCT00177177|Cognitive enhancement|cognitive enhancement
718081|NCT00177164|Bipolar I Disorder|bipolar i disorder
718082|NCT00177164|Risperidone Consta - Long Acting Injection|risperidone consta - long acting injection
718083|NCT00177164|Oral second generation antipsychotic agents|oral second generation antipsychotic agents
718084|NCT00177138|Campath Study|campath study
718085|NCT00177138|Pancreas After Kidney Transplantation|pancreas after kidney transplantation
718086|NCT00177138|Alemtuzumab|alemtuzumab
718087|NCT00177112|Cystoscopy|cystoscopy
718088|NCT00177047|stem cell transplantation|stem cell transplantation
718089|NCT00177047|chemotherapy|chemotherapy
718090|NCT00177047|multiple myeloma|multiple myeloma
718091|NCT00177047|autologous|autologous
718092|NCT00177034|Keratinocyte|keratinocyte
718093|NCT00177008|Schizophrenia|schizophrenia
718094|NCT00177008|Schizoaffective Disorder|schizoaffective disorder
718095|NCT00177008|Social Anxiety Disorder|social anxiety disorder
718096|NCT00176982|treatment of alopecia areata|treatment of alopecia areata
718097|NCT00176956|Post Pediatric Heart Transplant|post pediatric heart transplant
718098|NCT00176930|stem cell transplant|stem cell transplant
718099|NCT00176930|chronic leukemia|chronic leukemia
718100|NCT00176930|acute leukemia|acute leukemia
718101|NCT00176930|irradiation|irradiation
718102|NCT00176930|chemotherapy|chemotherapy
718103|NCT00176917|stem cell transplant|stem cell transplant
718104|NCT00176917|storage disease|storage disease
718105|NCT00176917|errors of metabolism|errors of metabolism
718106|NCT00176904|Inborn errors|inborn errors
718107|NCT00176904|Storage disease|storage disease
718108|NCT00176904|errors of metabolism|errors of metabolism
718109|NCT00176904|stem cell transplant|stem cell transplant
718110|NCT00176891|Laronidase ERT|laronidase ert
718111|NCT00176891|Stem cell transplant|stem cell transplant
718112|NCT00176891|storage disease|storage disease
718113|NCT00176891|inborn errors of metabolism|inborn errors of metabolism
718114|NCT00176891|hurler syndrome|hurler syndrome
718115|NCT00176891|glycosaminoglycans|glycosaminoglycans
718116|NCT00176891|enzyme replacement|enzyme replacement
718117|NCT00176878|Stem cell transplant|stem cell transplant
718118|NCT00176878|T-cell depletion|t-cell depletion
718119|NCT00176878|TLI|tli
718120|NCT00176878|bone marrow failure disorders|bone marrow failure disorders
718121|NCT00176865|Stem cell transplant|stem cell transplant
718122|NCT00176865|immunodeficiency|immunodeficiency
718123|NCT00176865|donor lymphocyte infusion|donor lymphocyte infusion
718124|NCT00176852|high risk hemoglobinopathy|high risk hemoglobinopathy
718125|NCT00176852|stem cell transplant|stem cell transplant
718126|NCT00176852|donor lymphocyte infusion|donor lymphocyte infusion
718127|NCT00176852|transfusion dependent|transfusion dependent
718128|NCT00176852|stem cell donor|stem cell donor
718129|NCT00176852|cord blood|cord blood
718130|NCT00176852|marrow|marrow
718131|NCT00176852|transfusion dependent non-malignant hematologic disorders|transfusion dependent non-malignant hematologic disorders
718132|NCT00176839|Stem Cell transplant|stem cell transplant
718133|NCT00176839|retransplant|retransplant
718134|NCT00176839|hematological malignancies|hematological malignancies
718135|NCT00176826|Stem Cell Transplant|stem cell transplant
718136|NCT00176826|T-cell depletion|t-cell depletion
718137|NCT00176826|immune deficiencies|immune deficiencies
718138|NCT00176826|Busulfan pharmacokinetics|busulfan pharmacokinetics
718139|NCT00176826|Non-Malignant Hematological Disorders|non-malignant hematological disorders
718140|NCT00176722|Spine Surgery|spine surgery
718141|NCT00176722|Intraocular Pressure|intraocular pressure
718142|NCT00176722|lumbar or thoracic Spine Surgery in the prone position|lumbar or thoracic spine surgery in the prone position
718143|NCT00176722|and its association with visual change|and its association with visual change
718144|NCT00176696|general anesthesia|general anesthesia
718145|NCT00176696|pain|pain
718146|NCT00176696|depth of anesthesia|depth of anesthesia
718147|NCT00176683|intubation|intubation
718148|NCT00176683|capnography|capnography
718149|NCT00176670|presurgical anxiety, children,|presurgical anxiety, children,
718150|NCT00176657|cardiac surgery|cardiac surgery
718151|NCT00176657|transfusion|transfusion
718152|NCT00176644|prostate cancer|prostate cancer
718153|NCT00176631|adenocarcinoma of the prostate|adenocarcinoma of the prostate
718154|NCT00176631|recurrent prostate cancer|recurrent prostate cancer
718155|NCT00176631|stage IV prostate cancer|stage iv prostate cancer
718156|NCT00176618|Aberrant Crypt Foci|aberrant crypt foci
718157|NCT00176605|prostate cancer|prostate cancer
718158|NCT00176605|recurrent prostate cancer|recurrent prostate cancer
718159|NCT00176605|stage IV prostate cancer|stage iv prostate cancer
718160|NCT00176592|Multiple Sclerosis|multiple sclerosis
718161|NCT00176592|Brain|brain
718162|NCT00176592|Betaseron|betaseron
718163|NCT00176592|Copaxone|copaxone
718164|NCT00176592|MRI|mri
718165|NCT00176579|osteoporosis|osteoporosis
718166|NCT00176579|stage I prostate cancer|stage i prostate cancer
718167|NCT00176566|oral leukoplakia|oral leukoplakia
718168|NCT00176553|methotrexate neurotoxicity|methotrexate neurotoxicity
718169|NCT00176540|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
718170|NCT00176540|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
718171|NCT00176540|fatigue|fatigue
718172|NCT00176527|recurrent prostate cancer|recurrent prostate cancer
718173|NCT00176527|stage IV prostate cancer|stage iv prostate cancer
718174|NCT00176514|mucositis|mucositis
718175|NCT00176501|recurrent renal cell cancer|recurrent renal cell cancer
718176|NCT00176501|clear cell renal cell carcinoma|clear cell renal cell carcinoma
718177|NCT00176501|stage IV renal cell cancer|stage iv renal cell cancer
718178|NCT00176488|recurrent breast cancer|recurrent breast cancer
718179|NCT00176488|stage II breast cancer|stage ii breast cancer
718180|NCT00176488|stage IIIA breast cancer|stage iiia breast cancer
718181|NCT00176488|stage IIIB breast cancer|stage iiib breast cancer
718182|NCT00176488|stage IV breast cancer|stage iv breast cancer
718183|NCT00176488|male breast cancer|male breast cancer
718184|NCT00176475|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
718185|NCT00176475|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
718186|NCT00176475|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
718187|NCT00176475|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
718188|NCT00176475|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
718189|NCT00176475|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
718190|NCT00176475|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
718191|NCT00176475|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
718192|NCT00176475|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
718193|NCT00176475|refractory hairy cell leukemia|refractory hairy cell leukemia
718194|NCT00176475|prolymphocytic leukemia|prolymphocytic leukemia
718195|NCT00176475|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
718196|NCT00176475|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
718197|NCT00176475|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
718198|NCT00176475|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
718199|NCT00176475|refractory multiple myeloma|refractory multiple myeloma
718200|NCT00176475|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
718201|NCT00176475|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
718202|NCT00176475|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
718203|NCT00176475|splenic marginal zone lymphoma|splenic marginal zone lymphoma
718204|NCT00176475|stage II multiple myeloma|stage ii multiple myeloma
718205|NCT00176475|stage III multiple myeloma|stage iii multiple myeloma
718206|NCT00176475|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
718207|NCT00176475|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
718208|NCT00176475|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
718209|NCT00176475|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
718210|NCT00176475|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
718211|NCT00176475|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
718212|NCT00176475|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
718213|NCT00176475|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
718214|NCT00176475|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
718215|NCT00176475|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
718216|NCT00176475|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
718217|NCT00176475|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
718218|NCT00176475|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
718219|NCT00176475|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
718220|NCT00176475|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
718221|NCT00176475|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
718222|NCT00176475|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
718223|NCT00176475|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
718224|NCT00176475|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
718225|NCT00176475|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
718226|NCT00176475|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
718227|NCT00176475|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
718228|NCT00176475|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
718229|NCT00176462|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
718230|NCT00176462|Leukemia|leukemia
718231|NCT00176449|Nicotine Dependence|nicotine dependence
718232|NCT00176449|Nicotine Use Disorder|nicotine use disorder
718233|NCT00176449|Tobacco Dependence|tobacco dependence
718234|NCT00176449|Tobacco-Use Disorder|tobacco-use disorder
718235|NCT00176449|Smoking Cessation|smoking cessation
718236|NCT00176436|Weight loss|weight loss
718237|NCT00176436|Support group|support group
718238|NCT00176436|Exercise|exercise
718239|NCT00176436|Atomoxetine|atomoxetine
718240|NCT00176423|schizophrenia|schizophrenia
718241|NCT00176423|acetylcholine|acetylcholine
718242|NCT00176423|cognitive impairments|cognitive impairments
718243|NCT00176423|attention|attention
718244|NCT00176423|processing speed|processing speed
718245|NCT00176423|sensory gating|sensory gating
718246|NCT00176423|eye-tracking|eye-tracking
718247|NCT00176410|aortic valve stenosis|aortic valve stenosis
718248|NCT00176410|statin therapy|statin therapy
718249|NCT00176397|left main coronary artery|left main coronary artery
718250|NCT00176397|coronary artery disease|coronary artery disease
718251|NCT00176384|chronic heart failure|chronic heart failure
718252|NCT00176384|exercise training|exercise training
718253|NCT00176371|Physical fitness|physical fitness
718254|NCT00176345|exercise training|exercise training
718255|NCT00176345|endothelial function|endothelial function
718256|NCT00176332|chronic heart failure|chronic heart failure
718257|NCT00176332|rosuvastatin|rosuvastatin
718258|NCT00176332|endothelial function|endothelial function
718259|NCT00176332|skeletal muscle|skeletal muscle
718260|NCT00176319|heart failure|heart failure
718261|NCT00176319|ageing|ageing
718262|NCT00176293|prostate|prostate
718263|NCT00176293|prostate cancer|prostate cancer
718264|NCT00176293|doxil|doxil
718265|NCT00176293|dexamethasone|dexamethasone
718266|NCT00176293|metastatic|metastatic
718267|NCT00176293|hormone refractory|hormone refractory
718268|NCT00176280|Renal|renal
718269|NCT00176280|Carcinoma|carcinoma
718270|NCT00176280|Renal Cell Carcinoma|renal cell carcinoma
718271|NCT00176280|RCC|rcc
718272|NCT00176280|Leukine|leukine
718273|NCT00176280|Dexamethasone|dexamethasone
718274|NCT00176280|Gemcitabine|gemcitabine
718275|NCT00176280|5 Fluorouracil|5 fluorouracil
718276|NCT00176280|5 FU|5 fu
718277|NCT00176280|Metastatic|metastatic
718278|NCT00176267|head and neck|head and neck
718279|NCT00176267|squamous cell carcinoma|squamous cell carcinoma
718280|NCT00176267|squamous cell|squamous cell
718281|NCT00176267|carcinoma|carcinoma
718282|NCT00176267|paclitaxel|paclitaxel
718283|NCT00176267|carboplatin|carboplatin
718284|NCT00176267|radiotherapy|radiotherapy
718285|NCT00176267|induction therapy|induction therapy
718286|NCT00176254|head and neck|head and neck
718287|NCT00176254|squamous cell carcinoma|squamous cell carcinoma
718288|NCT00176254|squamous cell|squamous cell
718289|NCT00176254|carcinoma|carcinoma
718290|NCT00176254|paclitaxel|paclitaxel
718291|NCT00176254|carboplatin|carboplatin
718292|NCT00176254|radiotherapy|radiotherapy
718293|NCT00176254|induction therapy|induction therapy
718294|NCT00176241|head and neck|head and neck
718295|NCT00176241|Gemcitabine|gemcitabine
718296|NCT00176241|Paclitaxel|paclitaxel
718297|NCT00176241|radiation|radiation
718298|NCT00176241|low-dose radiation|low-dose radiation
718299|NCT00176241|recurrent|recurrent
718300|NCT00176241|metastatic|metastatic
718301|NCT00176189|FPD, all-ceramic|fpd, all-ceramic
718302|NCT00176176|cerebral circulation|cerebral circulation
718303|NCT00176163|Fibromyalgia|fibromyalgia
718304|NCT00176163|Back pain|back pain
718305|NCT00176163|Behavior Therapy|behavior therapy
718306|NCT00176163|Operant learning|operant learning
718307|NCT00176163|Tetrahydrocannabinol|tetrahydrocannabinol
718308|NCT00176150|anorexia nervosa|anorexia nervosa
718309|NCT00176150|multidrug resistance|multidrug resistance
718310|NCT00176150|cholesterol metabolism|cholesterol metabolism
718311|NCT00176137|multimodality treatment|multimodality treatment
718312|NCT00176124|leukocyte depletion, autologous transfusion,|leukocyte depletion, autologous transfusion,
718313|NCT00176124|infection|infection
718314|NCT00176124|bacterial infection|bacterial infection
718315|NCT00176124|sepsis, antibiotics|sepsis, antibiotics
718316|NCT00176111|peripheral nerve stimulation|peripheral nerve stimulation
718317|NCT00176111|saline|saline
718318|NCT00176111|local anesthestics|local anesthestics
718319|NCT00176111|regional anesthestia|regional anesthestia
718320|NCT00176111|nerve damage|nerve damage
718321|NCT00176098|Cataract surgery|cataract surgery
718322|NCT00176098|Hypnosis|hypnosis
718323|NCT00176098|C11.510.245|c11.510.245
718324|NCT00176098|F04.754.424.771|f04.754.424.771
718325|NCT00176098|Suggestion|suggestion
718326|NCT00176059|immunoglobulins, intravenous|immunoglobulins, intravenous
718327|NCT00176059|kidney transplantation|kidney transplantation
718328|NCT00176059|acute rejection|acute rejection
718329|NCT00176059|chronic rejection|chronic rejection
718330|NCT00176059|regulatory autoantibodies|regulatory autoantibodies
718331|NCT00176059|Th1|th1
718332|NCT00176059|Th2|th2
718333|NCT00176059|B Cell|b cell
718334|NCT00176059|Monokines|monokines
718335|NCT00176059|Cytokine promoter gene polymorphisms|cytokine promoter gene polymorphisms
718336|NCT00176046|breast cancer|breast cancer
718337|NCT00176046|mistletoe|mistletoe
718338|NCT00176046|complementary therapy|complementary therapy
718339|NCT00176046|quality of life|quality of life
718340|NCT00176046|immune function|immune function
718341|NCT00176046|breast cancer (UICC stage I/II)|breast cancer (uicc stage i/ii)
718342|NCT00176033|ritonavir|ritonavir
718343|NCT00176033|lopinavir|lopinavir
718344|NCT00176033|HIV Infections|hiv infections
718345|NCT00176020|nicotinic acid|nicotinic acid
718346|NCT00176020|flush symptom|flush symptom
718347|NCT00176020|pharmacodynamic|pharmacodynamic
718348|NCT00176020|pharmacokinetic|pharmacokinetic
718349|NCT00175994|voriconazole|voriconazole
718350|NCT00175994|genotype|genotype
718351|NCT00175994|bioavailability|bioavailability
718352|NCT00175994|metabolic clearance|metabolic clearance
718353|NCT00175955|Neuroleptic-induced tardive dyskinesia|neuroleptic-induced tardive dyskinesia
718354|NCT00175955|Keppra, Levetiracetam|keppra, levetiracetam
718355|NCT00175942|acute myocardial infarction|acute myocardial infarction
718356|NCT00175942|ventricular fibrillation|ventricular fibrillation
718357|NCT00175942|coagulation|coagulation
718358|NCT00175942|inflammation|inflammation
718359|NCT00175929|Epilepsy|epilepsy
718360|NCT00175929|Focal Epilepsy|focal epilepsy
718361|NCT00175929|Partial Onset Seizures|partial onset seizures
718362|NCT00175929|Brivaracetam|brivaracetam
718363|NCT00175916|Brivaracetam|brivaracetam
718364|NCT00175916|Epilepsy|epilepsy
718365|NCT00175916|long term|long term
718366|NCT00175903|Newly Diagnosed Epilepsy|newly diagnosed epilepsy
718367|NCT00175903|Levetiracetam|levetiracetam
718368|NCT00175903|Keppra|keppra
718369|NCT00175903|Carbamazepine|carbamazepine
718370|NCT00175903|Valproate|valproate
718371|NCT00175890|Partial Onset Seizure|partial onset seizure
718372|NCT00175890|levetiracetam|levetiracetam
718373|NCT00175890|Video Electroencephalogram|video electroencephalogram
718374|NCT00175890|Keppra|keppra
718375|NCT00175877|Rheumatoid Arthritis|rheumatoid arthritis
718376|NCT00175877|CDP870|cdp870
718377|NCT00175877|Certolizumab Pegol|certolizumab pegol
718378|NCT00175877|Cimzia|cimzia
718379|NCT00175864|Partial Onset, Primary Generalized Seizures, Seletracetam|partial onset, primary generalized seizures, seletracetam
718380|NCT00175851|Partial onset, primary generalized seizures, seletracetam|partial onset, primary generalized seizures, seletracetam
718381|NCT00175838|Primary Thrombocythmeia|primary thrombocythmeia
718382|NCT00175838|Hydroxyurea|hydroxyurea
718383|NCT00175838|Randomised|randomised
718384|NCT00175838|Thrombosis|thrombosis
718385|NCT00175838|Haemorrhage|haemorrhage
718386|NCT00175825|Epilepsy: partial onset seizures|epilepsy: partial onset seizures
718387|NCT00175825|brivaracetam|brivaracetam
718388|NCT00175812|Acute myelogenous leukemia|acute myelogenous leukemia
718389|NCT00175812|Differentiation|differentiation
718390|NCT00175812|All trans retinoic acid|all trans retinoic acid
718391|NCT00175812|Valproic acid|valproic acid
718392|NCT00175812|Theophyllamin|theophyllamin
718393|NCT00175799|Observational study of physiological status at entry into PICU as a predictor of outcome, comparison of two commonly used scores (PRISM and PIM)|observational study of physiological status at entry into picu as a predictor of outcome, comparison of two commonly used scores (prism and pim)
718394|NCT00175799|Data from children admitted to a Paediatric Intensive Care unit|data from children admitted to a paediatric intensive care unit
718395|NCT00175786|Glaucoma|glaucoma
718396|NCT00175786|Normal Tensions Glaucoma|normal tensions glaucoma
718397|NCT00175786|Neuroradiology|neuroradiology
718398|NCT00175786|Tumor|tumor
718399|NCT00175786|MRI|mri
718400|NCT00175786|Magnetic Resonance Imaging|magnetic resonance imaging
718401|NCT00175786|Compressive Lesion|compressive lesion
718402|NCT00175773|Orthostatic stress|orthostatic stress
718403|NCT00175760|TTG|ttg
718404|NCT00175760|pediatric|pediatric
718405|NCT00175760|comparison study|comparison study
718406|NCT00175747|dysplasia|dysplasia
718407|NCT00175747|lung cancer|lung cancer
718408|NCT00175747|chemoprevention|chemoprevention
718409|NCT00175734|Vascular Reactivity|vascular reactivity
718410|NCT00175734|Anemia Correction Therapy|anemia correction therapy
718411|NCT00175734|Hemodialysis patients|hemodialysis patients
718412|NCT00175734|Diabetic and non-diabetic patients|diabetic and non-diabetic patients
718413|NCT00175734|Diabetes in Hemodialysis patients|diabetes in hemodialysis patients
718414|NCT00175721|Combined Clinic|combined clinic
718415|NCT00175721|Chronic Kidney Disease|chronic kidney disease
718416|NCT00175721|Diabetes|diabetes
718417|NCT00175708|Evaluation of an outcome tool|evaluation of an outcome tool
718418|NCT00175708|clubfoot|clubfoot
718419|NCT00175708|foot pressure profiles|foot pressure profiles
718420|NCT00175708|pedobarographs|pedobarographs
718421|NCT00175682|Autonomic Dysreflexia|autonomic dysreflexia
718422|NCT00175682|SCI|sci
718423|NCT00175682|Vibrostimulation|vibrostimulation
718424|NCT00175682|Ejaculation|ejaculation
718425|NCT00175669|Randomized control trial; placebo-control study|randomized control trial; placebo-control study
718426|NCT00175656|Femur fracture|femur fracture
718427|NCT00175656|titanium elastic nails|titanium elastic nails
718428|NCT00175643|actinic keratoses|actinic keratoses
718429|NCT00175643|imiquimod|imiquimod
718430|NCT00175643|pre-malignant|pre-malignant
718431|NCT00175643|squamous cell carcinoma|squamous cell carcinoma
718432|NCT00175643|immunosuppression|immunosuppression
718433|NCT00175630|ACL reconstruction|acl reconstruction
718434|NCT00175630|morphine sparing|morphine sparing
718435|NCT00175630|preemptive analgesia|preemptive analgesia
718436|NCT00175630|Post-operative pain and post- operative opioid use|post-operative pain and post- operative opioid use
718437|NCT00175604|Botox|botox
718438|NCT00175604|torticollis|torticollis
718439|NCT00175604|Congenital Muscular Torticollis (CMT)|congenital muscular torticollis (cmt)
718440|NCT00175591|Femur fracture|femur fracture
718441|NCT00175591|morphine sparing|morphine sparing
718442|NCT00175591|preemptive analgesia|preemptive analgesia
718443|NCT00175591|Post-operative pain and post- operative opioid use|post-operative pain and post- operative opioid use
718444|NCT00175578|Early stage (0/I) non-small cell lung cancer|early stage (0/i) non-small cell lung cancer
718445|NCT00175565|inflammation|inflammation
718446|NCT00175565|trial|trial
718447|NCT00175565|fluticasone|fluticasone
718448|NCT00175552|Depression|depression
718449|NCT00175552|Adolescents|adolescents
718450|NCT00175552|IPT|ipt
718451|NCT00175552|Knowledge translation|knowledge translation
718452|NCT00175552|Psychotherapy|psychotherapy
718453|NCT00175539|sexual dysfunction|sexual dysfunction
718454|NCT00175539|group treatment|group treatment
718455|NCT00175513|Psychosis|psychosis
718456|NCT00175513|early psychosis|early psychosis
718457|NCT00175513|first episode psychosis|first episode psychosis
718458|NCT00175513|schizophrenia|schizophrenia
718459|NCT00175513|schizoaffective|schizoaffective
718460|NCT00175513|schizophreniform|schizophreniform
718461|NCT00175513|bipolar disorder|bipolar disorder
718462|NCT00175513|valtrex|valtrex
718463|NCT00175513|valacyclovir.|valacyclovir.
718464|NCT00175500|Post-Arthroplasty Hip Dislocation|post-arthroplasty hip dislocation
718465|NCT00175487|Osteoarthritis/Avascular Necrosis|osteoarthritis/avascular necrosis
718466|NCT00175487|Hip|hip
718467|NCT00175435|Topical Immune Modulator|topical immune modulator
718468|NCT00175435|resiquimod gel|resiquimod gel
718469|NCT00175435|Hepatitis B booster response|hepatitis b booster response
718470|NCT00175435|Vaccine Evaluation|vaccine evaluation
718471|NCT00175435|Prevention of Hepatitis B disease|prevention of hepatitis b disease
718472|NCT00175422|Prevention|prevention
718473|NCT00175422|Randomized controlled trial|randomized controlled trial
718474|NCT00175422|Community education|community education
718475|NCT00175422|Shaken Baby Syndrome|shaken baby syndrome
718476|NCT00175422|Crying|crying
718477|NCT00175422|Colic|colic
718478|NCT00175409|Pain Response|pain response
718479|NCT00175396|ASCENDE-RT|ascende-rt
718480|NCT00175383|Prostate cancer, LHRH, hormone therapy, testosterone level|prostate cancer, lhrh, hormone therapy, testosterone level
718481|NCT00175370|Vancomycin|vancomycin
718482|NCT00175370|Coagulase Negative Staphylococcus|coagulase negative staphylococcus
718483|NCT00175370|Central Venous Catheter|central venous catheter
718484|NCT00175370|Bloodstream infection|bloodstream infection
718485|NCT00175370|CNS bloodstream infection|cns bloodstream infection
718486|NCT00175357|Opiate addiction|opiate addiction
718487|NCT00175357|medical heroin|medical heroin
718488|NCT00175357|methadoneRCT|methadonerct
718489|NCT00175344|Breast cancer|breast cancer
718490|NCT00175344|scar massage|scar massage
718491|NCT00175344|breast conserving surgery|breast conserving surgery
718492|NCT00175344|scar pain|scar pain
718493|NCT00175344|quality of life|quality of life
718494|NCT00175344|Breast cancer treated with breast conserving surgery with or without axillary dissection or sentinel node sampling.|breast cancer treated with breast conserving surgery with or without axillary dissection or sentinel node sampling.
718495|NCT00175318|Motivational interviewing|motivational interviewing
718496|NCT00175318|behavioural modification|behavioural modification
718497|NCT00175318|maternal counseling|maternal counseling
718498|NCT00175305|Prader-Willi Syndrome|prader-willi syndrome
718499|NCT00175305|Somatostatin|somatostatin
718500|NCT00175305|Ghrelin|ghrelin
718501|NCT00175305|Obesity|obesity
718502|NCT00175305|Hyperphagia|hyperphagia
718503|NCT00175305|Hyperphagia in Prader-Willi syndrome|hyperphagia in prader-willi syndrome
718504|NCT00175279|coronary disease|coronary disease
718505|NCT00175279|heart failure|heart failure
718506|NCT00175279|quality improvement|quality improvement
718507|NCT00175279|knowledge translation|knowledge translation
718508|NCT00175279|opinion leaders|opinion leaders
718509|NCT00175266|islet|islet
718510|NCT00175266|transplantation|transplantation
718511|NCT00175253|islet|islet
718512|NCT00175253|transplantation|transplantation
718513|NCT00175240|Coronary disease|coronary disease
718514|NCT00175240|quality improvement|quality improvement
718515|NCT00175240|knowledge translation|knowledge translation
718516|NCT00175227|contrast-induced nephropathy|contrast-induced nephropathy
718517|NCT00175227|prevention|prevention
718518|NCT00175227|renal failure|renal failure
718519|NCT00175227|cardiac angiogram|cardiac angiogram
718520|NCT00175214|osteoporosis|osteoporosis
718521|NCT00175214|wrist fractures|wrist fractures
718522|NCT00175214|quality improvement|quality improvement
718523|NCT00175214|knowledge translation|knowledge translation
718524|NCT00175188|RSA|rsa
718525|NCT00175188|DEXA|dexa
718526|NCT00175188|Osteoarthritis|osteoarthritis
718527|NCT00175188|Finger implant|finger implant
718528|NCT00175188|Micromotion|micromotion
718529|NCT00175188|Bone density|bone density
718530|NCT00175188|Cement|cement
718531|NCT00175175|osteoporosis treatment|osteoporosis treatment
718532|NCT00175175|osteoporosis testing|osteoporosis testing
718533|NCT00175175|hip fracture|hip fracture
718534|NCT00175175|quality improvement|quality improvement
718535|NCT00175162|RSA|rsa
718536|NCT00175162|DEXA|dexa
718537|NCT00175162|Genoarthrosis|genoarthrosis
718538|NCT00175162|Knee Arthroplasty|knee arthroplasty
718539|NCT00175162|Micromotion of polyethylene liner|micromotion of polyethylene liner
718540|NCT00175162|Cement|cement
718541|NCT00175149|CKD 3-4|ckd 3-4
718542|NCT00175136|RSA|rsa
718543|NCT00175136|DEXA|dexa
718544|NCT00175136|Gonarthrosis|gonarthrosis
718545|NCT00175136|Knee Arthroplasty|knee arthroplasty
718546|NCT00175136|Micromotion of polyethylen liner|micromotion of polyethylen liner
718547|NCT00175136|Stem arthroplasty design|stem arthroplasty design
718548|NCT00175123|Myelomeningocele|myelomeningocele
718549|NCT00175123|Neurogenic Bladder|neurogenic bladder
718550|NCT00175123|Intervention|intervention
718551|NCT00175123|Botulinum A toxin|botulinum a toxin
718552|NCT00175123|Oxybutynin|oxybutynin
718553|NCT00175110|pre-hypertension|pre-hypertension
718554|NCT00175110|mild hypertension|mild hypertension
718555|NCT00175097|soy protein|soy protein
718556|NCT00175097|lipids|lipids
718557|NCT00175097|lipoproteins|lipoproteins
718558|NCT00175097|apolipoproteins|apolipoproteins
718559|NCT00175097|cholesterol|cholesterol
718560|NCT00175097|endothelial function|endothelial function
718561|NCT00175058|Heart Attack|heart attack
718562|NCT00175045|Intravenous|intravenous
718563|NCT00175045|gastric acid secretion|gastric acid secretion
718564|NCT00175045|Lansoprazole|lansoprazole
718565|NCT00175045|Esophagitis|esophagitis
718566|NCT00175045|reflux|reflux
718567|NCT00175032|Low dose aspirin|low dose aspirin
718568|NCT00175032|Peptic Ulcer|peptic ulcer
718569|NCT00175032|gastric ulcer|gastric ulcer
718570|NCT00175032|duodenal ulcer|duodenal ulcer
718571|NCT00175032|NSAIDs|nsaids
718572|NCT00175019|uric acid|uric acid
718573|NCT00175019|xanthine oxidase|xanthine oxidase
718574|NCT00175019|hyperuricemia|hyperuricemia
718575|NCT00175019|tophi|tophi
718576|NCT00175019|Drug Therapy|drug therapy
718577|NCT00175006|Hyperuricemia|hyperuricemia
718578|NCT00175006|Tophi|tophi
718579|NCT00175006|Tophus|tophus
718580|NCT00175006|Drug Therapy|drug therapy
718581|NCT00174993|Glucose Metabolism Disorder|glucose metabolism disorder
718582|NCT00174993|Dysmetabolic Syndrome|dysmetabolic syndrome
718583|NCT00174993|Type II Diabetes; Diabetes Mellitus|type ii diabetes; diabetes mellitus
718584|NCT00174993|Lipoatrophic|lipoatrophic
718585|NCT00174993|Dyslipidemia|dyslipidemia
718586|NCT00174993|Drug Therapy|drug therapy
718587|NCT00174980|Oxycyte|oxycyte
718588|NCT00174980|perfluorocarbon oxygen carrier|perfluorocarbon oxygen carrier
718589|NCT00174980|brain oxygen tension|brain oxygen tension
718590|NCT00174967|Uric Acid|uric acid
718591|NCT00174967|xanthine oxidase|xanthine oxidase
718592|NCT00174967|tophi|tophi
718593|NCT00174967|Drug Therapy|drug therapy
718594|NCT00174954|Gout|gout
718595|NCT00174954|Tophus|tophus
718596|NCT00174954|MRI|mri
718597|NCT00174941|Uric acid|uric acid
718598|NCT00174941|xanthine oxidase|xanthine oxidase
718599|NCT00174941|tophi|tophi
718600|NCT00174941|Drug Therapy|drug therapy
718601|NCT00174928|Pediatric GERD|pediatric gerd
718602|NCT00174928|Pediatric Gastroesophageal Reflux Disease|pediatric gastroesophageal reflux disease
718603|NCT00174928|Neonates|neonates
718604|NCT00174928|lansoprazole|lansoprazole
718605|NCT00174915|Uric Acid, gout, xanthine oxidase, febuxostat, tophi|uric acid, gout, xanthine oxidase, febuxostat, tophi
718606|NCT00174902|Randomized controlled trial|randomized controlled trial
718607|NCT00174902|Blood platelets|blood platelets
718608|NCT00174902|Hemostasis|hemostasis
718609|NCT00174902|Stress, psychological|stress, psychological
718610|NCT00174902|Adrenergic beta-antagonists|adrenergic beta-antagonists
718611|NCT00174902|Aspirin|aspirin
718612|NCT00174902|Endothelium|endothelium
718613|NCT00174902|Arteriosclerosis|arteriosclerosis
718614|NCT00174889|Schizophrenia|schizophrenia
718615|NCT00174889|Pregnenolone|pregnenolone
718616|NCT00174889|Neurosteroids|neurosteroids
718617|NCT00174876|depression|depression
718618|NCT00174850|anxiety|anxiety
718619|NCT00174850|sexual dysfunction|sexual dysfunction
718620|NCT00174850|ssri|ssri
718621|NCT00174837|Tirapazamine|tirapazamine
718622|NCT00174837|Head and Neck Cancer|head and neck cancer
718623|NCT00174837|Cisplatin|cisplatin
718624|NCT00174837|Radiation|radiation
718625|NCT00174824|Diabetes|diabetes
718626|NCT00174824|Diabetic Retinopathy|diabetic retinopathy
718627|NCT00174811|acute otitis media|acute otitis media
718628|NCT00174811|controlled clinical trial|controlled clinical trial
718629|NCT00174811|telithromycin|telithromycin
718630|NCT00174811|cefuroxime axetil|cefuroxime axetil
718631|NCT00174811|middle ear infections|middle ear infections
720392|NCT00165997|pediatrics|pediatrics
718632|NCT00174811|tympanocentecis|tympanocentecis
718633|NCT00174798|Cystometry NK1 Antagonist SSR240600C|cystometry nk1 antagonist ssr240600c
718634|NCT00174785|Mortality, Hospitalization|mortality, hospitalization
718635|NCT00174746|Glucocorticosteroid; Dose response; Bronchospasm|glucocorticosteroid; dose response; bronchospasm
718636|NCT00174733|Glucocorticosteroid. Bronchospasm|glucocorticosteroid. bronchospasm
718637|NCT00174720|Glucocorticosteroid. Bronchospasm|glucocorticosteroid. bronchospasm
718638|NCT00174603|depression|depression
718639|NCT00174603|psychosis|psychosis
718640|NCT00174590|depression|depression
718641|NCT00174538|codeine|codeine
718642|NCT00174538|pain|pain
718643|NCT00174538|CYP2D6|cyp2d6
718644|NCT00174538|genotype|genotype
718645|NCT00174538|morphine|morphine
718646|NCT00174538|sickle cell|sickle cell
718647|NCT00174538|pharmacokinetic|pharmacokinetic
718648|NCT00174525|Alzheimer's Caregivers|alzheimer's caregivers
718649|NCT00174525|Alzheimer disease|alzheimer disease
718650|NCT00174499|Tooth stain|tooth stain
718651|NCT00174213|iliotibial tract|iliotibial tract
718652|NCT00174161|Premenstrual Syndrome,Health Related Quality of Life|premenstrual syndrome,health related quality of life
718653|NCT00174135|Sarcopenia|sarcopenia
718654|NCT00174135|exercise|exercise
718655|NCT00174122|Emergency department|emergency department
718656|NCT00174122|Blood culture|blood culture
718657|NCT00174122|Antimicrobial therapy|antimicrobial therapy
718658|NCT00174109|arecoline, oral cancer, MAP2, cell migration|arecoline, oral cancer, map2, cell migration
718659|NCT00174096|laryngeal cancer|laryngeal cancer
718660|NCT00174096|hypopharyngeal cancer|hypopharyngeal cancer
718661|NCT00174096|CXCR4|cxcr4
718662|NCT00174096|stromal-cell-derived factor-1(SDF-1)|stromal-cell-derived factor-1(sdf-1)
718663|NCT00174096|metastasis|metastasis
718664|NCT00174083|Tuberculosis, TB-ELISPOT, active tuberculosis latent infection interferon|tuberculosis, tb-elispot, active tuberculosis latent infection interferon
718665|NCT00174070|Respiratory failure|respiratory failure
718666|NCT00174070|Community|community
718667|NCT00174057|Graves' ophthalmopathy|graves' ophthalmopathy
718668|NCT00174057|real time PCR|real time pcr
718669|NCT00174057|cytokines|cytokines
718670|NCT00174057|Tsh receptor|tsh receptor
718671|NCT00174031|baseball|baseball
718672|NCT00174031|injury|injury
718673|NCT00174018|subacrominal space|subacrominal space
718674|NCT00174005|muscle|muscle
718675|NCT00174005|tendon|tendon
718676|NCT00173992|Stroke|stroke
718677|NCT00173992|Balance|balance
718678|NCT00173992|Proactive control|proactive control
718679|NCT00173992|Reactive control|reactive control
718680|NCT00173992|Recovery|recovery
718681|NCT00173992|Training|training
718682|NCT00173992|Fall|fall
718683|NCT00173979|muscle|muscle
718684|NCT00173979|tendon|tendon
718685|NCT00173953|H. pylori、immune response、lymphocytic subsets、cytokine|h. pylori、immune response、lymphocytic subsets、cytokine
718686|NCT00173940|chronic diseases, such as hypertension, diabetes, obesity, chronic renal failure, and so on|chronic diseases, such as hypertension, diabetes, obesity, chronic renal failure, and so on
718687|NCT00173927|extracranial atherosclerosis|extracranial atherosclerosis
718688|NCT00173927|imaging|imaging
718689|NCT00173927|biomarkers|biomarkers
718690|NCT00173914|1. Transplant vasculopathy|1. transplant vasculopathy
718691|NCT00173914|2. Endothelial dysfunction|2. endothelial dysfunction
718692|NCT00173914|3. Myocardial perfusion imaging|3. myocardial perfusion imaging
718693|NCT00173914|4. Intravascular vascular ultrasound|4. intravascular vascular ultrasound
718694|NCT00173901|ceftazidime|ceftazidime
718695|NCT00173901|safety|safety
718696|NCT00173901|infection|infection
718697|NCT00173888|Combination, Chemotherapy,non-small cell lung cancer|combination, chemotherapy,non-small cell lung cancer
718698|NCT00173875|EGFR Non-small cell lung cancer|egfr non-small cell lung cancer
718699|NCT00173862|Combination, Chemotherapy,transitional cell carcinoma|combination, chemotherapy,transitional cell carcinoma
718700|NCT00173849|oral cancer|oral cancer
718701|NCT00173849|CXCR4|cxcr4
718702|NCT00173849|stromal-cell-derived factor-1(SDF-1)|stromal-cell-derived factor-1(sdf-1)
718703|NCT00173849|metastasis|metastasis
718704|NCT00173836|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
718705|NCT00173836|Saliva|saliva
718706|NCT00173836|Swallowing|swallowing
718707|NCT00173836|Videofluoroscopy|videofluoroscopy
718708|NCT00173836|Radiation|radiation
718709|NCT00173810|stroke|stroke
718710|NCT00173810|movement|movement
718711|NCT00173810|psychomterics|psychomterics
718712|NCT00173797|depression|depression
718713|NCT00173797|psychometrics|psychometrics
718714|NCT00173784|psychometrics|psychometrics
718715|NCT00173784|activities of daily living|activities of daily living
718716|NCT00173771|stroke|stroke
718717|NCT00173771|activities of daily living|activities of daily living
718718|NCT00173771|psychometrics|psychometrics
718719|NCT00173758|IL-15|il-15
718720|NCT00173758|IL-15 receptor|il-15 receptor
718721|NCT00173758|decidual natural killer cells|decidual natural killer cells
718722|NCT00173758|endometrium|endometrium
718723|NCT00173745|cerebral palsy|cerebral palsy
718724|NCT00173745|drooling|drooling
718725|NCT00173745|botulinum toxin|botulinum toxin
718822|NCT00173186|ventricular septal defect|ventricular septal defect
718726|NCT00173732|Preimplantation genetic diagnosis (PGD)|preimplantation genetic diagnosis (pgd)
718727|NCT00173732|single cell|single cell
718728|NCT00173732|Multiple displacement amplification (MDA)|multiple displacement amplification (mda)
718729|NCT00173719|Hemiplegia|hemiplegia
718730|NCT00173719|Assisstive device|assisstive device
718731|NCT00173719|Walking|walking
718732|NCT00173719|Dynamic equilibrium|dynamic equilibrium
718733|NCT00173719|Reaction time|reaction time
718734|NCT00173719|Attention|attention
718735|NCT00173719|Dual task|dual task
718736|NCT00173706|L-Carnitine|l-carnitine
718737|NCT00173706|hemodialysis|hemodialysis
718738|NCT00173706|cardiac complications|cardiac complications
718739|NCT00173706|impaired exercise and functional capacities|impaired exercise and functional capacities
718740|NCT00173706|muscle symptoms|muscle symptoms
718741|NCT00173706|intradialytic hypotension|intradialytic hypotension
718742|NCT00173706|erythropoietin-resistant anemia|erythropoietin-resistant anemia
718743|NCT00173693|CEA, Osteoporosis, Fracture, Prevention, Exercise|cea, osteoporosis, fracture, prevention, exercise
718744|NCT00173615|ECMO|ecmo
718745|NCT00173615|CPR|cpr
718746|NCT00173602|Peritoneal Dialysis|peritoneal dialysis
718747|NCT00173563|Immunology|immunology
718748|NCT00173550|Menopause, premature|menopause, premature
718749|NCT00173550|Hysterectomy|hysterectomy
718750|NCT00173550|Ovariectomy|ovariectomy
718751|NCT00173550|Estrogen Replacement Therapy|estrogen replacement therapy
718752|NCT00173550|Knowledge|knowledge
718753|NCT00173550|Perception|perception
718754|NCT00173550|Attitude|attitude
718755|NCT00173537|idiopathic pulmonary artery hypertension|idiopathic pulmonary artery hypertension
718756|NCT00173524|EGFR Non-small cell lung cancer|egfr non-small cell lung cancer
718757|NCT00173498|atopic dermatitis, skin test|atopic dermatitis, skin test
718758|NCT00173485|peritonitis, peritoneal dialysis, dialysate|peritonitis, peritoneal dialysis, dialysate
718759|NCT00173472|colorectal cancer, MSI, TS, DPD, EGFR, chemotherapy.|colorectal cancer, msi, ts, dpd, egfr, chemotherapy.
718760|NCT00173446|Normal part of the adrenal gland|normal part of the adrenal gland
718761|NCT00173433|tuberculosis|tuberculosis
718762|NCT00173433|relapse|relapse
718763|NCT00173433|reinfection|reinfection
718764|NCT00173433|reactivation|reactivation
718765|NCT00173433|dormancy|dormancy
718766|NCT00173433|tuberculin skin test|tuberculin skin test
718767|NCT00173420|Normal Controls|normal controls
718768|NCT00173407|Ovarian endometrioid carcinoma|ovarian endometrioid carcinoma
718769|NCT00173407|invasion|invasion
718770|NCT00173407|IGFBP-3|igfbp-3
718771|NCT00173407|transfection|transfection
718772|NCT00173407|signal transduction|signal transduction
718773|NCT00173407|PTEN|pten
718774|NCT00173407|methylation|methylation
718775|NCT00173394|ovarian cancer|ovarian cancer
718776|NCT00173394|immunotherapy|immunotherapy
718777|NCT00173394|mesothelin|mesothelin
718778|NCT00173394|normal volunteer|normal volunteer
718779|NCT00173381|lymphangiogenesis|lymphangiogenesis
718780|NCT00173381|head and neck squamous cell carcinoma (HNSCC)|head and neck squamous cell carcinoma (hnscc)
718781|NCT00173381|vascular endothelial growth factor-C (VEGF-C)|vascular endothelial growth factor-c (vegf-c)
718782|NCT00173381|cyclooxygenase-2 (COX-2)|cyclooxygenase-2 (cox-2)
718783|NCT00173381|interleukin-6 (IL-6)|interleukin-6 (il-6)
718784|NCT00173368|Sphincterotomy|sphincterotomy
718785|NCT00173368|needle knife|needle knife
718786|NCT00173368|hemorrhage|hemorrhage
718787|NCT00173368|complication|complication
718788|NCT00173355|pediatric Dermatofibrosarcoma Protuberans|pediatric dermatofibrosarcoma protuberans
718789|NCT00173342|Right bundle branch block|right bundle branch block
718790|NCT00173342|Electrocardiography|electrocardiography
718791|NCT00173342|Ion channel|ion channel
718792|NCT00173329|HIV|hiv
718793|NCT00173316|vascular endothelial growth factor-C|vascular endothelial growth factor-c
718794|NCT00173316|VEGF-CR|vegf-cr
718795|NCT00173316|lymphangiogenesis|lymphangiogenesis
718796|NCT00173316|host inflammatory responses|host inflammatory responses
718797|NCT00173316|oral carcinogenesis|oral carcinogenesis
718798|NCT00173316|oral cancers|oral cancers
718799|NCT00173316|oral premalignant lesions|oral premalignant lesions
718800|NCT00173303|Breast neoplasms|breast neoplasms
718801|NCT00173303|Breast radiography|breast radiography
718802|NCT00173303|Cancer screening|cancer screening
718803|NCT00173290|Cervical cancer|cervical cancer
718804|NCT00173290|Breast cancer|breast cancer
718805|NCT00173290|T lymphocyte|t lymphocyte
718806|NCT00173290|NK receptor|nk receptor
718807|NCT00173277|colorectal cancer screening|colorectal cancer screening
718808|NCT00173277|colonoscopy|colonoscopy
718809|NCT00173238|atherosclerosis|atherosclerosis
718810|NCT00173238|optical coherence tomography|optical coherence tomography
718811|NCT00173238|polarization|polarization
718812|NCT00173238|phase retardation|phase retardation
718813|NCT00173238|birefringence|birefringence
718814|NCT00173225|nociceptin|nociceptin
718815|NCT00173225|sunstance P|sunstance p
718816|NCT00173225|asthma|asthma
718817|NCT00173225|COPD|copd
718818|NCT00173225|cough|cough
718819|NCT00173212|adenomyosis|adenomyosis
718820|NCT00173212|cell proliferation|cell proliferation
718821|NCT00173212|Immunocytochemistry|immunocytochemistry
718823|NCT00173186|aortic regurgitation|aortic regurgitation
718824|NCT00173173|Gifted dance students|gifted dance students
718825|NCT00173173|eating disorders|eating disorders
718826|NCT00173173|prevalence|prevalence
718827|NCT00173173|risk factors|risk factors
718828|NCT00173173|BITE|bite
718829|NCT00173160|Eating disorders|eating disorders
718830|NCT00173160|risk factors|risk factors
718831|NCT00173160|prospective study|prospective study
718832|NCT00173160|case-controled study|case-controled study
718833|NCT00173160|outcome|outcome
718834|NCT00173160|gifted dance students|gifted dance students
718835|NCT00173134|diabetes|diabetes
718836|NCT00173134|erectile dysfunction|erectile dysfunction
718837|NCT00173134|erectile dysfunction related quality of life|erectile dysfunction related quality of life
718838|NCT00173121|enterovirus, environment, aerosol, air|enterovirus, environment, aerosol, air
718839|NCT00173108|Prematurity|prematurity
718840|NCT00173108|Early intervention|early intervention
718841|NCT00173108|Neurodevelopment|neurodevelopment
718842|NCT00173108|Cost-effectiveness|cost-effectiveness
718843|NCT00173082|primary aldosteronism|primary aldosteronism
718844|NCT00173082|Insulin resistance|insulin resistance
718845|NCT00173082|Metabolic syndrome|metabolic syndrome
718846|NCT00173082|OGTT|ogtt
718847|NCT00173069|Schizophrenia|schizophrenia
718848|NCT00173069|PPI|ppi
718849|NCT00173069|P50I|p50i
718850|NCT00173069|MRS|mrs
718851|NCT00173069|Niacin|niacin
718852|NCT00173069|Candidate Genes|candidate genes
718853|NCT00173056|Peritoneal dialysis|peritoneal dialysis
718854|NCT00173017|N95 mask|n95 mask
718855|NCT00173017|medical staff|medical staff
718856|NCT00173017|hypoxemia|hypoxemia
718857|NCT00173017|hypercapnia|hypercapnia
718858|NCT00173017|neurological study|neurological study
718859|NCT00172965|Optic coherence tomography|optic coherence tomography
718860|NCT00172965|oral cancer|oral cancer
718861|NCT00172965|oral precancers|oral precancers
718862|NCT00172952|high myopia, genomic|high myopia, genomic
718863|NCT00172926|Physical Constitution|physical constitution
718864|NCT00172926|Disease Pattern|disease pattern
718865|NCT00172926|Laboratory Data|laboratory data
718866|NCT00172926|Integrative Chinese Medicine and Western Medicine|integrative chinese medicine and western medicine
718867|NCT00172913|Wavefront Aberration|wavefront aberration
718868|NCT00172913|LASIK|lasik
718869|NCT00172913|Contrast Sensitivity|contrast sensitivity
718870|NCT00172913|Visual Performance|visual performance
718871|NCT00172913|Ablation Profile|ablation profile
718872|NCT00172900|Diffusion tensor imaging|diffusion tensor imaging
718873|NCT00172900|MR spectroscopy|mr spectroscopy
718874|NCT00172900|dementia|dementia
718875|NCT00172900|white matter|white matter
718876|NCT00172887|Psychiatrists|psychiatrists
718877|NCT00172874|cross-cultural,|cross-cultural,
718878|NCT00172874|eating disorders,|eating disorders,
718879|NCT00172874|EDI,|edi,
718880|NCT00172874|psychometrics|psychometrics
718881|NCT00172861|gastric cancer, cyclooxygenase-2, microarray|gastric cancer, cyclooxygenase-2, microarray
718882|NCT00172835|pleural effusion|pleural effusion
718883|NCT00172835|procalcitonin|procalcitonin
718884|NCT00172822|appendicitis|appendicitis
718885|NCT00172809|Chronic Hepatitis C|chronic hepatitis c
718886|NCT00172809|End stage renal disease|end stage renal disease
718887|NCT00172809|Hemodialysis|hemodialysis
718888|NCT00172809|Interferon|interferon
718889|NCT00172809|Pegylated interferon|pegylated interferon
718890|NCT00172796|Metabolic syndrome|metabolic syndrome
718891|NCT00172783|TB|tb
718892|NCT00172783|PPD|ppd
718893|NCT00172783|ELISPOT|elispot
718894|NCT00172783|BCG|bcg
718895|NCT00172757|MSI, TS, Colorectal Cancer, DM.|msi, ts, colorectal cancer, dm.
718896|NCT00172744|stem cells|stem cells
718897|NCT00172744|periodontal cells|periodontal cells
718898|NCT00172744|mechanical stress|mechanical stress
718899|NCT00172744|differentiation|differentiation
718900|NCT00172744|periodontal ligament|periodontal ligament
718901|NCT00172692|Chewing efficiency,|chewing efficiency,
718902|NCT00172692|Gum chewing|gum chewing
718903|NCT00172692|Chewing velocity|chewing velocity
718904|NCT00172692|Occlusal surface area|occlusal surface area
718905|NCT00172692|EMG|emg
718906|NCT00172692|Jaw movement|jaw movement
718907|NCT00172679|Tai Chi|tai chi
718908|NCT00172679|NK Cells|nk cells
718909|NCT00172679|T lymphocytes|t lymphocytes
718910|NCT00172679|Exercise|exercise
718911|NCT00172666|SLE|sle
718912|NCT00172666|healthy subjects|healthy subjects
718913|NCT00172653|shoulder, reliability, validity|shoulder, reliability, validity
718914|NCT00172614|metabolic syndrome|metabolic syndrome
718915|NCT00172588|adenomyosis|adenomyosis
718916|NCT00172588|apoptosis|apoptosis
718917|NCT00172588|flowcytometry|flowcytometry
718918|NCT00172575|Lung neoplasms|lung neoplasms
718919|NCT00172575|Magnetic resonance imaging|magnetic resonance imaging
718920|NCT00172562|acute myeloid leukemia|acute myeloid leukemia
718921|NCT00172562|age and sex matched normal subjects|age and sex matched normal subjects
718922|NCT00172562|dynamic MRI|dynamic mri
718923|NCT00172562|bone marrow perfusion|bone marrow perfusion
719789|NCT00168597|BCG|bcg
718924|NCT00172562|tumor angiogenesis|tumor angiogenesis
718925|NCT00172497|aggressive acts|aggressive acts
718926|NCT00172484|cerebrovascular accident|cerebrovascular accident
718927|NCT00172484|stroke center|stroke center
718928|NCT00172484|stroke team|stroke team
718929|NCT00172484|intensive care of stroke|intensive care of stroke
718930|NCT00172484|rehabilitation of stroke|rehabilitation of stroke
718931|NCT00172419|statin, inflammation, FDG, positron emission tomography|statin, inflammation, fdg, positron emission tomography
718932|NCT00172393|EV71,|ev71,
718933|NCT00172393|CNS,|cns,
718934|NCT00172393|Outcome,|outcome,
718935|NCT00172393|Neurological,|neurological,
718936|NCT00172393|Psychiatric|psychiatric
718937|NCT00172367|Urothelial carcinoma|urothelial carcinoma
718938|NCT00172367|Lycopene|lycopene
718939|NCT00172367|uremia|uremia
718940|NCT00172367|prevention|prevention
718941|NCT00172367|biomarker|biomarker
718942|NCT00172367|progression|progression
718943|NCT00172367|anti-oxidant|anti-oxidant
718944|NCT00172328|Hepatitis B|hepatitis b
718945|NCT00172328|vaccine|vaccine
718946|NCT00172315|acquired immunodeficiency syndrome|acquired immunodeficiency syndrome
718947|NCT00172315|lipodystrophy|lipodystrophy
718948|NCT00172315|MR spectroscopy|mr spectroscopy
718949|NCT00172289|pulse wave velocity|pulse wave velocity
718950|NCT00172289|sympathetic nerve activity|sympathetic nerve activity
718951|NCT00172289|spinal cord injury|spinal cord injury
718952|NCT00172289|cerebrovascular accident|cerebrovascular accident
718953|NCT00172263|Immunology|immunology
718954|NCT00172237|eye-head coordination|eye-head coordination
718955|NCT00172237|proprioception|proprioception
718956|NCT00172237|cervical spine with degenerative disease|cervical spine with degenerative disease
718957|NCT00172237|degenerated cervical spine|degenerated cervical spine
718958|NCT00172224|osteoporosis|osteoporosis
718959|NCT00172224|compression fracture|compression fracture
718960|NCT00172224|bone marrow perfusion|bone marrow perfusion
718961|NCT00172224|MR spectroscopy|mr spectroscopy
718962|NCT00172224|hormone therapy|hormone therapy
718963|NCT00172211|Physioneal|physioneal
718964|NCT00172211|Peritoneal dialysis|peritoneal dialysis
718965|NCT00172211|Oxidative stress|oxidative stress
718966|NCT00172211|insulin resistance|insulin resistance
718967|NCT00172198|w-3 fish oil|w-3 fish oil
718968|NCT00172198|Nutrition|nutrition
718969|NCT00172198|immune|immune
718970|NCT00172198|intensive care|intensive care
718971|NCT00172198|patients|patients
718972|NCT00172185|Short Bowel Syndrome|short bowel syndrome
718973|NCT00172185|Parenteral Nutrition|parenteral nutrition
718974|NCT00172185|SBS|sbs
718975|NCT00172185|Teduglutide|teduglutide
718976|NCT00172172|Post-menopausal|post-menopausal
718977|NCT00172172|Osteoporosis|osteoporosis
718978|NCT00172172|Parathyroid Hormone|parathyroid hormone
718979|NCT00172172|PTH|pth
718980|NCT00172172|ALX1-11|alx1-11
718981|NCT00172159|Colorectal cancer|colorectal cancer
718982|NCT00172159|Chemotherapy|chemotherapy
718983|NCT00172159|Surgery|surgery
718984|NCT00172159|Liver metastasis|liver metastasis
718985|NCT00172146|Hemiplegia|hemiplegia
718986|NCT00172146|Regular cane|regular cane
718987|NCT00172146|Volitional stepping|volitional stepping
718988|NCT00172146|Dynamic equilibrium|dynamic equilibrium
718989|NCT00172146|Attention|attention
718990|NCT00172146|Dual task|dual task
718991|NCT00172133|Post-menopausal|post-menopausal
718992|NCT00172133|Osteoporosis|osteoporosis
718993|NCT00172133|Parathyroid Hormone|parathyroid hormone
718994|NCT00172133|PTH|pth
718995|NCT00172133|ALX1-11|alx1-11
718996|NCT00172120|Post-menopausal|post-menopausal
718997|NCT00172120|Osteoporosis|osteoporosis
718998|NCT00172120|Parathyroid Hormone|parathyroid hormone
718999|NCT00172120|PTH|pth
719000|NCT00172120|ALX1-11|alx1-11
719001|NCT00172107|Post-menopausal|post-menopausal
719002|NCT00172107|Osteoporosis|osteoporosis
719003|NCT00172107|Parathyroid Hormone|parathyroid hormone
719004|NCT00172107|PTH|pth
719005|NCT00172107|ALX1-11|alx1-11
719006|NCT00172094|Migraine|migraine
719007|NCT00172081|Post-menopausal|post-menopausal
719008|NCT00172081|Osteoporosis|osteoporosis
719009|NCT00172081|Parathyroid Hormone|parathyroid hormone
719010|NCT00172081|PTH|pth
719011|NCT00172081|ALX1-11|alx1-11
719012|NCT00172068|Primary breast cancer|primary breast cancer
719013|NCT00172068|Bone metastases|bone metastases
719014|NCT00172068|Minimal residual disease|minimal residual disease
719015|NCT00172068|Bisphosphonates|bisphosphonates
719016|NCT00172055|Zoledronic acid|zoledronic acid
719017|NCT00172055|Zometa|zometa
719018|NCT00172055|prostate cancer|prostate cancer
719019|NCT00172055|osteoporosis|osteoporosis
719020|NCT00172042|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
719021|NCT00172042|Bisphosphonates|bisphosphonates
719022|NCT00172042|Zoledronic acid|zoledronic acid
719023|NCT00172042|Bone metastases|bone metastases
719024|NCT00172042|Prevention of bone metastases|prevention of bone metastases
719025|NCT00172029|Zoledronic acid|zoledronic acid
719026|NCT00172029|Radiotherapy|radiotherapy
719027|NCT00172029|Bone pain|bone pain
719028|NCT00172029|Breast cancer|breast cancer
719029|NCT00172016|Zoledronic acid|zoledronic acid
719030|NCT00172016|SRE|sre
719031|NCT00172016|Prostate cancer|prostate cancer
719032|NCT00172003|Renal Cell Cancer|renal cell cancer
719033|NCT00172003|Bone metastasis|bone metastasis
719034|NCT00172003|Skeletal related event|skeletal related event
719035|NCT00172003|Renal Cell Cancer patients with bone metastasis|renal cell cancer patients with bone metastasis
719036|NCT00171990|genital herpes|genital herpes
719037|NCT00171990|herpes|herpes
719038|NCT00171990|famciclovir|famciclovir
719039|NCT00171977|GIST|gist
719040|NCT00171977|Imatinib|imatinib
719041|NCT00171977|Postoperative Adjuvant|postoperative adjuvant
719042|NCT00171964|Pain|pain
719043|NCT00171964|Bone metastasis|bone metastasis
719044|NCT00171964|Analgesic consumption|analgesic consumption
719045|NCT00171964|Cancer patients|cancer patients
719046|NCT00171964|Cancer patients with painful bone metastasis|cancer patients with painful bone metastasis
719047|NCT00171951|Cushing's disease|cushing's disease
719048|NCT00171951|ACTH|acth
719049|NCT00171951|Cortisol|cortisol
719050|NCT00171951|ACTH dependent Cushing's disease|acth dependent cushing's disease
719051|NCT00171938|Glioblastoma|glioblastoma
719052|NCT00171938|Brain tumors|brain tumors
719053|NCT00171938|Imatinib|imatinib
719054|NCT00171938|PDGFR|pdgfr
719055|NCT00171925|Multiple Myeloma|multiple myeloma
719056|NCT00171925|Stage I|stage i
719057|NCT00171925|Zoledronic acid|zoledronic acid
719058|NCT00171925|Progression|progression
719059|NCT00171912|Imatinib mesylate|imatinib mesylate
719060|NCT00171912|tyrosine kinases|tyrosine kinases
719061|NCT00171912|imatinib sensitivity|imatinib sensitivity
719062|NCT00171912|Diverse malignancies either associated with|diverse malignancies either associated with
719063|NCT00171912|or thought to be associated with|or thought to be associated with
719064|NCT00171912|activated tyrosine kinase enzymes|activated tyrosine kinase enzymes
719065|NCT00171912|including hypereosinophilic syndrome|including hypereosinophilic syndrome
719066|NCT00171912|systemic mastocytosis|systemic mastocytosis
719067|NCT00171912|chronic myelomonocytic leukaemia,|chronic myelomonocytic leukaemia,
719068|NCT00171912|dermatofibrosarcoma protuberans and other diseases.|dermatofibrosarcoma protuberans and other diseases.
719069|NCT00171912|Not included:|not included:
719070|NCT00171912|patients with chronic myeloid leukemia,|patients with chronic myeloid leukemia,
719071|NCT00171912|some other types of leukemias (abl-mutated)|some other types of leukemias (abl-mutated)
719072|NCT00171912|some types of gastrointestinal stromal tumours (c-KIT-positive),|some types of gastrointestinal stromal tumours (c-kit-positive),
719073|NCT00171912|some systemic mastocytosis (if c-KIT D816V mutation),|some systemic mastocytosis (if c-kit d816v mutation),
719074|NCT00171912|brain,|brain,
719075|NCT00171912|prostate,|prostate,
719076|NCT00171912|breast or lung cancers.|breast or lung cancers.
719077|NCT00171899|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
719078|NCT00171899|Complete cytogenetic response|complete cytogenetic response
719079|NCT00171899|Imatinib mesylate|imatinib mesylate
719080|NCT00171899|Major molecular response|major molecular response
719081|NCT00171899|Chronic phase Ph+ Chronic Myelogenous Leukemia|chronic phase ph+ chronic myelogenous leukemia
719082|NCT00171886|Acromegaly|acromegaly
719083|NCT00171886|Otreotide|otreotide
719084|NCT00171886|Tumor reduction|tumor reduction
719085|NCT00171873|Double blind|double blind
719086|NCT00171873|Phase III|phase iii
719087|NCT00171873|Disease|disease
719088|NCT00171873|Clinical trial|clinical trial
719089|NCT00171873|Octreotide|octreotide
719090|NCT00171873|Neuroendocrine tumor|neuroendocrine tumor
719091|NCT00171873|Cancer|cancer
719092|NCT00171873|Tumor|tumor
719093|NCT00171873|Midgut|midgut
719094|NCT00171860|Hypereosinophilic syndrome|hypereosinophilic syndrome
719095|NCT00171860|Imatinib|imatinib
719096|NCT00171847|Breast cancer|breast cancer
719097|NCT00171847|Metastatic|metastatic
719098|NCT00171847|Trastuzumab|trastuzumab
719099|NCT00171847|Letrozole|letrozole
719100|NCT00171834|EPO|epo
719101|NCT00171834|EPO906|epo906
719102|NCT00171834|Brain metastasis|brain metastasis
719103|NCT00171834|Lung cancer|lung cancer
719104|NCT00171834|Lung metastasis|lung metastasis
719105|NCT00171834|NSCLC|nsclc
719106|NCT00171821|Thalassemia|thalassemia
719107|NCT00171821|Myelodysplastic Syndrome|myelodysplastic syndrome
719108|NCT00171821|MDS|mds
719109|NCT00171821|Sickle cell|sickle cell
719110|NCT00171821|Diamond-Blackfan anemia|diamond-blackfan anemia
719111|NCT00171821|Transfusion|transfusion
719112|NCT00171821|Anemia|anemia
719113|NCT00171821|Fanconi|fanconi
719114|NCT00171821|Chelation|chelation
719115|NCT00171821|Deferasirox|deferasirox
719116|NCT00171808|Endometrial Cancer|endometrial cancer
719117|NCT00171808|Aromatase inhibitor|aromatase inhibitor
719118|NCT00171808|Advanced or recurrent|advanced or recurrent
719119|NCT00171808|hormone receptor positive|hormone receptor positive
719120|NCT00171795|Traumatic brain injury,|traumatic brain injury,
719121|NCT00171795|cognitive impairment,|cognitive impairment,
719122|NCT00171795|rivastigmine|rivastigmine
719123|NCT00171782|HYPERTENSION|hypertension
719124|NCT00171782|VALSARTAN|valsartan
719125|NCT00171782|VALSARTAN AND HYDROCHLOROTHIAZIDE|valsartan and hydrochlorothiazide
719126|NCT00171782|RISK FACTORS|risk factors
719127|NCT00171756|hypertension|hypertension
719128|NCT00171756|valsartan|valsartan
719129|NCT00171743|Adults|adults
719130|NCT00171743|Post transplant diabetes|post transplant diabetes
719131|NCT00171730|Acromegaly|acromegaly
719132|NCT00171730|Pasireotide|pasireotide
719133|NCT00171730|GH|gh
719134|NCT00171730|IGF-1|igf-1
719135|NCT00171717|Cyclosporine, liver transplantation, maintenance, diabetes|cyclosporine, liver transplantation, maintenance, diabetes
719136|NCT00171704|Breast Cancer|breast cancer
719137|NCT00171704|Letrozole|letrozole
719138|NCT00171704|Bone Mineral Density|bone mineral density
719139|NCT00171704|Bone Markers|bone markers
719140|NCT00171704|Serum lipid|serum lipid
719141|NCT00171704|Postmenopausal|postmenopausal
719142|NCT00171691|Knee osteoarthritis, Topical NSAID, Diclofenac sodium|knee osteoarthritis, topical nsaid, diclofenac sodium
719143|NCT00171678|Knee osteoarthritis, Topical NSAID, Diclofenac sodium|knee osteoarthritis, topical nsaid, diclofenac sodium
719144|NCT00171665|Hand osteoarthritis, Topical NSAID, Diclofenac sodium|hand osteoarthritis, topical nsaid, diclofenac sodium
719145|NCT00171652|Hand osteoarthritis, Topical NSAID, Diclofenac sodium|hand osteoarthritis, topical nsaid, diclofenac sodium
719146|NCT00171626|Knee osteoarthritis, Topical NSAID, Diclofenac sodium|knee osteoarthritis, topical nsaid, diclofenac sodium
719147|NCT00171613|Obesity|obesity
719148|NCT00171600|valsartan|valsartan
719149|NCT00171600|lisinopril|lisinopril
719150|NCT00171600|albuminuria|albuminuria
719151|NCT00171600|diabetic nephropathy|diabetic nephropathy
719152|NCT00171587|Metastatic solid tumors|metastatic solid tumors
719153|NCT00171587|PTK787/ZK 222584|ptk787/zk 222584
719154|NCT00171587|Vatalanib|vatalanib
719155|NCT00171587|Capecitabine|capecitabine
719156|NCT00171587|VEGF (vascular endothelial growth factor)|vegf (vascular endothelial growth factor)
719157|NCT00171587|Histologically confirmed metastatic solid tumors|histologically confirmed metastatic solid tumors
719158|NCT00171574|valsartan|valsartan
719159|NCT00171574|lisinopril|lisinopril
719160|NCT00171574|antiproteinuric|antiproteinuric
719161|NCT00171574|diabetic nephropathy|diabetic nephropathy
719162|NCT00171561|hypertension|hypertension
719163|NCT00171561|diabetes|diabetes
719164|NCT00171561|albuminuria|albuminuria
719165|NCT00171561|valsartan|valsartan
719166|NCT00171561|hydrochlorothiazide|hydrochlorothiazide
719167|NCT00171561|amlodipine|amlodipine
719168|NCT00171548|Metabolic syndrome, cardiovascular risk reduction|metabolic syndrome, cardiovascular risk reduction
719169|NCT00171535|hypertension|hypertension
719170|NCT00171535|high blood pressure|high blood pressure
719171|NCT00171535|valsartan|valsartan
719172|NCT00171535|amlodipine|amlodipine
719173|NCT00171522|Constipation|constipation
719174|NCT00171522|Tegaserod|tegaserod
719175|NCT00171522|Polyethylene Glycol 3350|polyethylene glycol 3350
719176|NCT00171522|PEG|peg
719177|NCT00171509|Liver transplant, adults, once a day administration, Immunosuppressants|liver transplant, adults, once a day administration, immunosuppressants
719178|NCT00171496|Kidney transplant, adults, NODM, immunosuppressants|kidney transplant, adults, nodm, immunosuppressants
719179|NCT00171483|GERD|gerd
719180|NCT00171483|PPI|ppi
719181|NCT00171483|heartburn|heartburn
719182|NCT00171483|regurgitation|regurgitation
719183|NCT00171470|dyspepsia|dyspepsia
719184|NCT00171470|hearburn|hearburn
719185|NCT00171470|female|female
719186|NCT00171470|PPI|ppi
719187|NCT00171457|functional heartburn|functional heartburn
719188|NCT00171457|dyspepsia|dyspepsia
719189|NCT00171457|male|male
719190|NCT00171457|female|female
719191|NCT00171457|visceral sensitivity|visceral sensitivity
719192|NCT00171444|hypertension,|hypertension,
719193|NCT00171444|valsartan+hydrochlorothiazide|valsartan+hydrochlorothiazide
719194|NCT00171431|IBS-C|ibs-c
719195|NCT00171431|female|female
719196|NCT00171418|GERD|gerd
719197|NCT00171418|PPI|ppi
719198|NCT00171405|hypertension|hypertension
719199|NCT00171405|aliskiren|aliskiren
719200|NCT00171405|hydrochlorothiazide|hydrochlorothiazide
719201|NCT00171392|Kidney transplantation; acute rejection; gastrointestinal adverse events; quality of life; mycophenolate sodium, tacrolimus.|kidney transplantation; acute rejection; gastrointestinal adverse events; quality of life; mycophenolate sodium, tacrolimus.
719202|NCT00171379|Kidney transplantation; acute rejection; gastrointestinal adverse events; quality of life; mycophenolate sodium.|kidney transplantation; acute rejection; gastrointestinal adverse events; quality of life; mycophenolate sodium.
719203|NCT00171366|amlodipine|amlodipine
719204|NCT00171366|benazepril|benazepril
719205|NCT00171366|hypertension|hypertension
719206|NCT00171366|diastolic|diastolic
719207|NCT00171353|arterial hypertension|arterial hypertension
719208|NCT00171353|albuminuria|albuminuria
719209|NCT00171353|valsartan|valsartan
719210|NCT00171340|Bone Loss|bone loss
719211|NCT00171340|Osteopenia|osteopenia
719212|NCT00171340|Breast cancer|breast cancer
719213|NCT00171340|letrozole|letrozole
719214|NCT00171340|zoledronic acid|zoledronic acid
719215|NCT00171340|postmenopausal|postmenopausal
719216|NCT00171327|arterial hypertension|arterial hypertension
719217|NCT00171327|dyslipidemia|dyslipidemia
719218|NCT00171327|valsartan|valsartan
719219|NCT00171327|fluvastatin|fluvastatin
719220|NCT00171314|breast cancer|breast cancer
719221|NCT00171314|letrozole|letrozole
719222|NCT00171314|zoledronic acid|zoledronic acid
719223|NCT00171314|adjuvant|adjuvant
719224|NCT00171314|postmenopausal|postmenopausal
719225|NCT00171301|Transfusional hemosiderosis|transfusional hemosiderosis
719226|NCT00171301|Beta-thalassemia major|beta-thalassemia major
719227|NCT00171301|Deferasirox|deferasirox
719228|NCT00171301|iron overload|iron overload
719229|NCT00171301|rare anemia|rare anemia
719230|NCT00171301|iron overload due to transfusion|iron overload due to transfusion
719231|NCT00171288|Dyslipidemia, ezetimibe, inflammatory markers, fluvastatin|dyslipidemia, ezetimibe, inflammatory markers, fluvastatin
719232|NCT00171275|Coronary disease|coronary disease
719233|NCT00171275|Myocardial infarction|myocardial infarction
719234|NCT00171275|Statins|statins
719235|NCT00171262|Dyslipidemia, chronic renal disease, fluvastatin|dyslipidemia, chronic renal disease, fluvastatin
719236|NCT00171249|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
719237|NCT00171249|CML|cml
719238|NCT00171249|Philadelphia Chromosome|philadelphia chromosome
719239|NCT00171249|Accelerated phase|accelerated phase
719240|NCT00171249|Acute Myelogenous Leukemia|acute myelogenous leukemia
719241|NCT00171249|AML|aml
719242|NCT00171249|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
719243|NCT00171249|ALL|all
719244|NCT00171249|Imatinib mesylate|imatinib mesylate
719245|NCT00171236|Heterozygous familial hypercholesterolemia|heterozygous familial hypercholesterolemia
719246|NCT00171236|mixed dyslipidemia|mixed dyslipidemia
719247|NCT00171223|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
719248|NCT00171223|CML|cml
719249|NCT00171223|Philadelphia Chromosome|philadelphia chromosome
719250|NCT00171223|Accelerated phase|accelerated phase
719251|NCT00171223|Acute Myelogenous Leukemia|acute myelogenous leukemia
719252|NCT00171223|AML|aml
719253|NCT00171223|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
719254|NCT00171223|ALL|all
719255|NCT00171223|Imatinib mesylate|imatinib mesylate
719256|NCT00171210|β-thalassemia|β-thalassemia
719257|NCT00171210|iron overload|iron overload
719258|NCT00171210|deferasirox|deferasirox
719259|NCT00171184|Overactive bladder, Darifenacin, M3 muscarinic receptor antagonist, elderly population|overactive bladder, darifenacin, m3 muscarinic receptor antagonist, elderly population
719260|NCT00171171|Thalassemia (beta-thal. major)|thalassemia (beta-thal. major)
719261|NCT00171171|Transfusional hemosiderosis|transfusional hemosiderosis
719262|NCT00171171|Deferasirox|deferasirox
719263|NCT00171171|Beta-thalassemia major patients|beta-thalassemia major patients
719264|NCT00171171|Unable to be chelated with deferoxamine or deferiprone|unable to be chelated with deferoxamine or deferiprone
719265|NCT00171158|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
719266|NCT00171158|CML|cml
719267|NCT00171158|Philadelphia Chromosome|philadelphia chromosome
719268|NCT00171158|Blast crisis|blast crisis
719269|NCT00171158|Imatinib mesylate|imatinib mesylate
719270|NCT00171145|Overactive Bladder, incontinence, antimuscarinic, warning time, darifenacin|overactive bladder, incontinence, antimuscarinic, warning time, darifenacin
719271|NCT00171132|Postmenopausal|postmenopausal
719272|NCT00171132|women|women
719273|NCT00171132|overweight|overweight
719274|NCT00171132|hypertension|hypertension
719275|NCT00171132|impaired|impaired
719276|NCT00171132|exercise|exercise
719277|NCT00171132|capacity|capacity
719278|NCT00171132|valsartan|valsartan
719279|NCT00171132|atenolol|atenolol
719280|NCT00171132|hydrochlorothiazide|hydrochlorothiazide
719281|NCT00171119|HYPERTENSION|hypertension
719282|NCT00171119|DIABETES MELLITUS TYPE II|diabetes mellitus type ii
719283|NCT00171119|VALSARTAN|valsartan
719284|NCT00171119|BENAZAPRIL|benazapril
719285|NCT00171106|diastolic dysfunction|diastolic dysfunction
719286|NCT00171106|heart failure|heart failure
719287|NCT00171106|exercise tolerance|exercise tolerance
719288|NCT00171106|valsartan|valsartan
719289|NCT00171093|HYPERTENSION|hypertension
719290|NCT00171093|HYPERCHOLESTEROLEMIA|hypercholesterolemia
719291|NCT00171093|BLOOD PRESSURE|blood pressure
719292|NCT00171093|CHOLESTEROL|cholesterol
719293|NCT00171093|VALSARTAN|valsartan
719294|NCT00171093|SIMVASTATIN|simvastatin
719295|NCT00171080|Hypertension|hypertension
719296|NCT00171080|Valsartan|valsartan
719297|NCT00171080|Dialysis|dialysis
719298|NCT00171080|Renal Disease|renal disease
719299|NCT00171067|Microalbuminuria, urinary albumin excretion, urinary albumin creatinine ratio, hypertension, valsartan, lisinopril, combination|microalbuminuria, urinary albumin excretion, urinary albumin creatinine ratio, hypertension, valsartan, lisinopril, combination
719300|NCT00171054|hypertension|hypertension
719301|NCT00171054|postmenopausal|postmenopausal
719302|NCT00171054|valsartan|valsartan
719303|NCT00171054|amlodipine|amlodipine
719304|NCT00171054|hydrochlorothiazide|hydrochlorothiazide
719305|NCT00171041|PEDIATRIC HYPERTENSION|pediatric hypertension
719306|NCT00171041|PEDIATRIC|pediatric
719307|NCT00171041|VALSARTAN|valsartan
719308|NCT00171028|PEDIATRIC HYPERTENSION|pediatric hypertension
719309|NCT00171028|PEDIATRIC|pediatric
719310|NCT00171028|VALSARTAN|valsartan
719311|NCT00171015|VALSARTAN|valsartan
719312|NCT00171015|HYDROCHLOROTHIAZIDE|hydrochlorothiazide
719313|NCT00171015|OLMESARTAN|olmesartan
719314|NCT00171015|HYPERTENSION|hypertension
719315|NCT00171002|Hypertension, high blood pressure, valsartan, amlodipine|hypertension, high blood pressure, valsartan, amlodipine
719316|NCT00170989|hypertension|hypertension
719317|NCT00170989|high blood pressure|high blood pressure
719318|NCT00170989|valsartan|valsartan
719319|NCT00170989|hydrochlorothiazide|hydrochlorothiazide
719320|NCT00170976|HYPERTENSION, VALSARTAN, AMLODIPINE< SAFETY|hypertension, valsartan, amlodipine< safety
719321|NCT00170963|Hypertension, high blood pressure, valsartan, amlodipine|hypertension, high blood pressure, valsartan, amlodipine
719322|NCT00170950|cardiovascular morbidity|cardiovascular morbidity
719323|NCT00170950|cardiovascular mortality|cardiovascular mortality
719324|NCT00170950|benazepril|benazepril
719325|NCT00170950|amlodipine|amlodipine
719326|NCT00170950|high risk population|high risk population
719327|NCT00170937|METABOLIC SYNDROME, VALSARTAN, HYDROCHLOROTHIAZIDE, HYPERTENSION,|metabolic syndrome, valsartan, hydrochlorothiazide, hypertension,
719328|NCT00170924|Hypertension, High Blood Pressure, Diastolic Dysfunction,|hypertension, high blood pressure, diastolic dysfunction,
719329|NCT00170924|Heart Disease|heart disease
719330|NCT00170911|Osteoporosis|osteoporosis
719331|NCT00170911|Postmenopausal women|postmenopausal women
719332|NCT00170911|Cathepsin K inhibitor|cathepsin k inhibitor
719333|NCT00170898|Musculoskeletal pain|musculoskeletal pain
719334|NCT00170898|cyclooxygenase-2 inhibitors|cyclooxygenase-2 inhibitors
719335|NCT00170898|lumiracoxib|lumiracoxib
719336|NCT00170898|naproxen|naproxen
719337|NCT00170885|acute rejection|acute rejection
719338|NCT00170885|renal function|renal function
719339|NCT00170885|everolimus|everolimus
719340|NCT00170885|cyclosporine microemulsion|cyclosporine microemulsion
719341|NCT00170872|Osteoarthritis|osteoarthritis
719342|NCT00170872|Rheumatoid Arthritis|rheumatoid arthritis
719343|NCT00170872|Cox-2|cox-2
719344|NCT00170872|lumiracoxib|lumiracoxib
719345|NCT00170859|everolimus|everolimus
719346|NCT00170859|cyclosporine microemulsion|cyclosporine microemulsion
719347|NCT00170859|renal function|renal function
719348|NCT00170846|Renal transplantation, everolimus, calcineurin inhibitors, GFR|renal transplantation, everolimus, calcineurin inhibitors, gfr
719349|NCT00170833|Renal/Kidney, transplantation, everolimus, calcineurin sparing|renal/kidney, transplantation, everolimus, calcineurin sparing
719350|NCT00170820|Renal transplantation, maintenance, switch, everolimus, CNI-free|renal transplantation, maintenance, switch, everolimus, cni-free
719351|NCT00170794|cardiac transplantation, everolimus, cyclosporine microemulsion, GFR|cardiac transplantation, everolimus, cyclosporine microemulsion, gfr
719352|NCT00170781|Pain, acute gout, arthritis, cyclooxygenase-2 inhibitors, lumiracoxib, indomethacin|pain, acute gout, arthritis, cyclooxygenase-2 inhibitors, lumiracoxib, indomethacin
719353|NCT00170768|Darifenacin, oxybutynin, cognition, memory|darifenacin, oxybutynin, cognition, memory
719354|NCT00170755|Overactive Bladder, incontinence, antimuscarinic, darifenacin, long-term treatment|overactive bladder, incontinence, antimuscarinic, darifenacin, long-term treatment
719355|NCT00170742|Open label,|open label,
719356|NCT00170742|phase III,|phase iii,
719357|NCT00170742|disease,|disease,
719358|NCT00170742|clinical trial,|clinical trial,
719359|NCT00170742|octreotide,|octreotide,
719360|NCT00170742|proliferative diabetic retinopathy, lasercoagulation|proliferative diabetic retinopathy, lasercoagulation
719361|NCT00170729|Prednisolone acetate,|prednisolone acetate,
719362|NCT00170729|efficacy,|efficacy,
719363|NCT00170729|cataract,|cataract,
719364|NCT00170729|eye drops,|eye drops,
719365|NCT00170729|tolerability,|tolerability,
719366|NCT00170729|inflammation|inflammation
719367|NCT00170716|Motor Cortex Electrical Stimulation|motor cortex electrical stimulation
719368|NCT00170716|Ischemic Stroke|ischemic stroke
719369|NCT00170716|Upper Extremity Hemiparesis|upper extremity hemiparesis
719370|NCT00170716|Rehabilitation|rehabilitation
719371|NCT00170716|Motor Recovery|motor recovery
719372|NCT00170716|Functional MRI|functional mri
719373|NCT00170703|Cortical Electrical Stimulation|cortical electrical stimulation
719374|NCT00170703|Ischemic Stroke|ischemic stroke
719375|NCT00170703|Broca's Aphasia|broca's aphasia
719376|NCT00170703|Speech Rehabilitation|speech rehabilitation
719377|NCT00170703|Functional MRI|functional mri
719378|NCT00170664|Ovarian neoplasms|ovarian neoplasms
719379|NCT00170664|paclitaxel, carboplatin|paclitaxel, carboplatin
719380|NCT00170664|clinical trials, phase II|clinical trials, phase ii
719381|NCT00170664|first-line chemotherapy|first-line chemotherapy
719382|NCT00170664|weekly therapy schedule|weekly therapy schedule
719383|NCT00170638|Tuberculosis, children, infants|tuberculosis, children, infants
719384|NCT00170625|platin-resistant|platin-resistant
719385|NCT00170612|Pneumococcal infections|pneumococcal infections
719386|NCT00170612|Fiji|fiji
719387|NCT00170612|infants|infants
719388|NCT00170612|vaccine|vaccine
719389|NCT00170586|Underglove, polyvinylidene fluoride, acrylic polymer|underglove, polyvinylidene fluoride, acrylic polymer
719390|NCT00170573|biweekly schedule of PLD - Ovarian cancer - pegylated liposomal doxorubicin -quality of life - Toxic skin reactions|biweekly schedule of pld - ovarian cancer - pegylated liposomal doxorubicin -quality of life - toxic skin reactions
719391|NCT00170560|hospital, acquired, infections, mortality|hospital, acquired, infections, mortality
719392|NCT00170547|inactivated, trivalent, influenza, vaccine, Fluzone|inactivated, trivalent, influenza, vaccine, fluzone
719393|NCT00170534|India, male, sexually transmitted infection, STI, STD|india, male, sexually transmitted infection, sti, std
719394|NCT00170521|group A streptococci, pharyngitis, epidemiology, Streptococcus pyogenes, children, Nicaragua|group a streptococci, pharyngitis, epidemiology, streptococcus pyogenes, children, nicaragua
719395|NCT00170508|Influenza, sub-study|influenza, sub-study
719396|NCT00170495|respiratory illness, influenza, bronchitis, pneumonia, cold|respiratory illness, influenza, bronchitis, pneumonia, cold
719397|NCT00170482|influenza vaccine, Fluzone, inactivated, trivalent|influenza vaccine, fluzone, inactivated, trivalent
719398|NCT00170469|Anthrax|anthrax
719399|NCT00170456|Anthrax vaccine|anthrax vaccine
719400|NCT00170443|Influenza, Baculovirus, Immunogenicity, Geriatrics|influenza, baculovirus, immunogenicity, geriatrics
719401|NCT00170430|HIV-1, sexually transmitted diseases, females, Kenya|hiv-1, sexually transmitted diseases, females, kenya
719402|NCT00170404|HIV Infections, Tuberculosis, Malnutrition, Tanzania|hiv infections, tuberculosis, malnutrition, tanzania
719403|NCT00170391|Insomnia|insomnia
719404|NCT00170391|Sleep|sleep
719406|NCT00170391|Behavioural treatment|behavioural treatment
719407|NCT00170378|Enoxaparin|enoxaparin
719408|NCT00170378|Safety|safety
719409|NCT00170365|Stress|stress
719410|NCT00170365|Yoga|yoga
719411|NCT00170352|hyperbaric oxygen|hyperbaric oxygen
719412|NCT00170352|cerebral metabolism|cerebral metabolism
719413|NCT00170352|hyperoxia|hyperoxia
719414|NCT00170352|traumatic brain injury|traumatic brain injury
719415|NCT00170339|Opiate Dependence|opiate dependence
719416|NCT00170339|Methadone Maintenance|methadone maintenance
719417|NCT00170339|Osteoporosis|osteoporosis
719418|NCT00170339|Hypogonadism|hypogonadism
719419|NCT00170326|Permanent Pacing artificial internal|permanent pacing artificial internal
719420|NCT00170313|Heart Failure|heart failure
719421|NCT00170313|Primary Prevention of Sudden Cardiac Death|primary prevention of sudden cardiac death
719422|NCT00170313|Secondary Prevention of Sudden Cardiac Death|secondary prevention of sudden cardiac death
719423|NCT00170313|Cardiac Desynchronization|cardiac desynchronization
719424|NCT00170313|CRT-D|crt-d
719425|NCT00170313|Cardiac Dyssynchrony|cardiac dyssynchrony
719426|NCT00170300|Cardiac resynchronisation therapy (CRT therapy),|cardiac resynchronisation therapy (crt therapy),
719427|NCT00170300|all-cause mortality,|all-cause mortality,
719428|NCT00170300|quality of life assesment,|quality of life assesment,
719429|NCT00170300|echocardiographic left ventricular function,|echocardiographic left ventricular function,
719430|NCT00170300|CRT and neurohormonal activation,|crt and neurohormonal activation,
719431|NCT00170300|CRT and health economics|crt and health economics
719432|NCT00170287|Unstable Ventricular Tachycardia|unstable ventricular tachycardia
719433|NCT00170274|Indication for cardiac pacing|indication for cardiac pacing
719434|NCT00170274|Atrial Arrhythmia|atrial arrhythmia
719435|NCT00170274|Indication for the implantation of a pacemaker according to the German guidelines|indication for the implantation of a pacemaker according to the german guidelines
719436|NCT00170274|Documented (ECG) atrial tachyarrhythmia within the last three months before enrollment|documented (ecg) atrial tachyarrhythmia within the last three months before enrollment
719437|NCT00170261|Syncope of uncertain etiology|syncope of uncertain etiology
719438|NCT00170261|Repeated presyncopes|repeated presyncopes
719439|NCT00170248|Asthma|asthma
719440|NCT00170248|Primary Care|primary care
719441|NCT00170248|Computer-Based Decision Support|computer-based decision support
719442|NCT00170248|Outcome Evaluation|outcome evaluation
719443|NCT00170235|Breast cancer|breast cancer
719444|NCT00170235|Prehabilitation|prehabilitation
719445|NCT00170235|Rehabilitation|rehabilitation
719446|NCT00170235|Exercise|exercise
719447|NCT00170222|Acute bronchitis|acute bronchitis
719448|NCT00170222|antibiotics|antibiotics
719449|NCT00170209|Tuberculosis|tuberculosis
719450|NCT00170209|Children|children
719451|NCT00170196|pneumonia|pneumonia
719452|NCT00170196|corticosteroids|corticosteroids
719453|NCT00170183|Heart failure|heart failure
719454|NCT00170183|Renal dysfunction|renal dysfunction
719455|NCT00170170|cytomegalovirus|cytomegalovirus
719456|NCT00170105|Age 18 years or older|age 18 years or older
719457|NCT00170105|No cognitive impairment or altered mental status|no cognitive impairment or altered mental status
719458|NCT00170105|Stable|stable
719459|NCT00170105|No aphasia|no aphasia
719460|NCT00170105|English-speaking|english-speaking
719461|NCT00170053|Kidney Transplantation|kidney transplantation
719462|NCT00170001|supraesophageal reflux|supraesophageal reflux
719463|NCT00170001|laryngopharyngeal symptoms|laryngopharyngeal symptoms
719464|NCT00170001|pharynx|pharynx
719465|NCT00170001|esophagus|esophagus
719466|NCT00169988|clinical high risk|clinical high risk
719467|NCT00169988|attenuated positive symptoms|attenuated positive symptoms
719468|NCT00169988|attenuated negative symptoms|attenuated negative symptoms
719469|NCT00169988|cognition|cognition
719470|NCT00169988|functional status|functional status
719471|NCT00169988|prodromal psychosis|prodromal psychosis
719472|NCT00169962|acute disease|acute disease
719473|NCT00169949|early intervention|early intervention
719474|NCT00169949|social functioning|social functioning
719475|NCT00169949|role functioning|role functioning
719476|NCT00169949|cognition|cognition
719477|NCT00169910|Renal Transplantation|renal transplantation
719478|NCT00169910|Calcineurin Inhibitor|calcineurin inhibitor
719479|NCT00169910|Mycophenolate Mofetil|mycophenolate mofetil
719892|NCT00168116|xerostomia|xerostomia
719480|NCT00169910|Cardiovascular Disease|cardiovascular disease
719481|NCT00169897|COPD|copd
719482|NCT00169897|Exercise|exercise
719483|NCT00169897|Self-management|self-management
719484|NCT00169897|Rehabilitation|rehabilitation
719485|NCT00169897|Quality of life|quality of life
719486|NCT00169897|Health economy|health economy
719487|NCT00169897|Cost effectiveness|cost effectiveness
719488|NCT00169897|Health care utilization|health care utilization
719489|NCT00169884|Deliberate Self-Harm,|deliberate self-harm,
719490|NCT00169884|cognitive-behavioural therapy,|cognitive-behavioural therapy,
719491|NCT00169884|integrative approach|integrative approach
719492|NCT00169858|Hepatitis B|hepatitis b
719493|NCT00169858|Vaccination|vaccination
719494|NCT00169858|Engerix-B|engerix-b
719495|NCT00169858|Immunogenicity|immunogenicity
719496|NCT00169858|Long-term immunity|long-term immunity
719497|NCT00169858|Booster dose|booster dose
719498|NCT00169858|Safety|safety
719499|NCT00169845|chemoprevention trial|chemoprevention trial
719500|NCT00169845|antioxidant|antioxidant
719501|NCT00169845|alpha-tocopherol|alpha-tocopherol
719502|NCT00169845|beta-carotene|beta-carotene
719503|NCT00169845|second primary cancer|second primary cancer
719504|NCT00169845|head and neck cancer|head and neck cancer
719505|NCT00169845|adverse effect of radiation therapy|adverse effect of radiation therapy
719506|NCT00169845|quality of life|quality of life
719507|NCT00169845|mortality|mortality
719508|NCT00169845|cancer free survival|cancer free survival
719509|NCT00169845|cancer recurrence|cancer recurrence
719510|NCT00169832|Atherosclerosis progression|atherosclerosis progression
719511|NCT00169832|Ischemic heart disease|ischemic heart disease
719512|NCT00169832|Saphenous vein graft|saphenous vein graft
719513|NCT00169832|Metabolic risk factors|metabolic risk factors
719514|NCT00169832|Rosiglitazone|rosiglitazone
719515|NCT00169819|Same day discharge|same day discharge
719516|NCT00169819|Trans-radial|trans-radial
719517|NCT00169819|Coronary artery stenting|coronary artery stenting
719518|NCT00169819|Abciximab bolus|abciximab bolus
719519|NCT00169806|Randall's Plaque|randall's plaque
719520|NCT00169806|Kidney stones|kidney stones
719521|NCT00169793|Obesity|obesity
719522|NCT00169793|Nephrolithiasis|nephrolithiasis
719523|NCT00169780|Renal Calculi|renal calculi
719524|NCT00169780|Radiology|radiology
719525|NCT00169780|High Reslolution CT|high reslolution ct
719526|NCT00169767|Enlarged Prostate|enlarged prostate
719527|NCT00169767|BPH|bph
719528|NCT00169754|Nephrolithiasis|nephrolithiasis
719529|NCT00169754|Renal Calculi|renal calculi
719530|NCT00169754|Perc|perc
719531|NCT00169754|Attached Stones|attached stones
719532|NCT00169741|Nephrolithiasis|nephrolithiasis
719533|NCT00169741|Renal Calculi|renal calculi
719534|NCT00169728|allogeneic haematopoietic stem cell transplantation|allogeneic haematopoietic stem cell transplantation
719535|NCT00169728|bone marrow transplantation|bone marrow transplantation
719536|NCT00169728|children|children
719537|NCT00169728|vaccination|vaccination
719538|NCT00169728|invasive pneumococcal disease|invasive pneumococcal disease
719539|NCT00169728|tetanus|tetanus
719540|NCT00169728|diphtheria|diphtheria
719541|NCT00169728|poliomyelitis|poliomyelitis
719542|NCT00169728|pertussis|pertussis
719543|NCT00169728|Hepatitis B|hepatitis b
719544|NCT00169728|Haemophilus influenzae type B infection|haemophilus influenzae type b infection
719545|NCT00169715|Kidney stones|kidney stones
719546|NCT00169715|renal Calculi|renal calculi
719547|NCT00169715|Tic|tic
719548|NCT00169715|Caliceal Diverticula|caliceal diverticula
719549|NCT00169702|Schizophrenia, weight management programme|schizophrenia, weight management programme
719550|NCT00169689|schizophrenia, rTMS|schizophrenia, rtms
719551|NCT00169676|Prostate Cancer|prostate cancer
719552|NCT00169663|Brushite Kidney Stones|brushite kidney stones
719553|NCT00169663|Nephrolithiasis|nephrolithiasis
719554|NCT00169650|UPJ Obstruction|upj obstruction
719555|NCT00169650|Renal Obstruction|renal obstruction
719556|NCT00169650|Delayed Renal Flow|delayed renal flow
719557|NCT00169637|Short bowel syndrome|short bowel syndrome
719558|NCT00169637|Growth hormone|growth hormone
719559|NCT00169637|Children|children
719560|NCT00169624|Diabetes,|diabetes,
719561|NCT00169624|coronary endothelial dysfunction,|coronary endothelial dysfunction,
719562|NCT00169624|metformin,|metformin,
719563|NCT00169624|glyclazide,|glyclazide,
719564|NCT00169624|MRI.|mri.
719565|NCT00169611|Neurofibromatosis type 1|neurofibromatosis type 1
719566|NCT00169611|Attention deficit with hyperactivity disorder school difficulties|attention deficit with hyperactivity disorder school difficulties
719567|NCT00169611|methylphenidate|methylphenidate
719568|NCT00169598|Lymphoma|lymphoma
719569|NCT00169598|positron emission tomography|positron emission tomography
719570|NCT00169598|stem cell transplantation|stem cell transplantation
719571|NCT00169598|therapeutic impact|therapeutic impact
719572|NCT00169585|diagnostic-therapeutic pathway|diagnostic-therapeutic pathway
719573|NCT00169585|PSA|psa
719574|NCT00169585|DRE|dre
719575|NCT00169585|Levofloxacin|levofloxacin
719576|NCT00169572|Nausea|nausea
719577|NCT00169572|Vomiting|vomiting
719578|NCT00169572|Emesis|emesis
719893|NCT00168116|prevention|prevention
719579|NCT00169572|Chemotherapy-induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
719580|NCT00169572|CINV|cinv
719581|NCT00169559|triglycerides|triglycerides
719582|NCT00169559|Hypertriglyceridemia|hypertriglyceridemia
719583|NCT00169559|cholesterol|cholesterol
719584|NCT00169559|LDL|ldl
719585|NCT00169559|HDL|hdl
719586|NCT00169546|Asthma|asthma
719587|NCT00169546|inhaled corticosteroids|inhaled corticosteroids
719588|NCT00169533|safety|safety
719589|NCT00169533|tolerating lapatinib|tolerating lapatinib
719590|NCT00169533|Lapatinib|lapatinib
719591|NCT00169520|Safety|safety
719592|NCT00169520|tolerability|tolerability
719593|NCT00169520|dose limiting toxicity|dose limiting toxicity
719594|NCT00169520|solid tumors|solid tumors
719595|NCT00169520|docetaxel|docetaxel
719596|NCT00169468|B Lymphoma|b lymphoma
719597|NCT00169468|Velcade|velcade
719598|NCT00169468|Chemotherapy|chemotherapy
719599|NCT00169416|chicken pox|chicken pox
719600|NCT00169416|varicella|varicella
719601|NCT00169416|VZV|vzv
719602|NCT00169416|pharmacokinetics|pharmacokinetics
719603|NCT00169403|Idiopathic dystonia|idiopathic dystonia
719604|NCT00169403|deep brain stimulation|deep brain stimulation
719605|NCT00169403|globus pallidus|globus pallidus
719606|NCT00169403|generalised Idiopathic dystonia|generalised idiopathic dystonia
719607|NCT00169390|smoking|smoking
719608|NCT00169390|pregnancy|pregnancy
719609|NCT00169390|newborns|newborns
719610|NCT00169390|monoamine oxidases|monoamine oxidases
719611|NCT00169377|Obsessive compulsive disorder|obsessive compulsive disorder
719612|NCT00169377|deep brain stimulation|deep brain stimulation
719613|NCT00169377|subthalamic nucleus|subthalamic nucleus
719614|NCT00169364|Parkinson's disease|parkinson's disease
719615|NCT00169364|parkin mutation|parkin mutation
719616|NCT00169364|Juvenile parkinson's disease|juvenile parkinson's disease
719617|NCT00169364|positron emission tomography|positron emission tomography
719618|NCT00169338|Dystonia|dystonia
719619|NCT00169338|deep brain stimulation|deep brain stimulation
719620|NCT00169338|globus pallidus|globus pallidus
719621|NCT00169338|Post-anoxic dystonia|post-anoxic dystonia
719622|NCT00169325|basal ganglia|basal ganglia
719623|NCT00169325|loss of psychic self-activation|loss of psychic self-activation
719624|NCT00169312|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
719625|NCT00169299|Menopause|menopause
719626|NCT00169299|Vasomotor|vasomotor
719627|NCT00169299|Black cohosh|black cohosh
719628|NCT00169299|Herbs|herbs
719629|NCT00169299|Hot flashes|hot flashes
719630|NCT00169299|HT|ht
719631|NCT00169299|CAM|cam
719632|NCT00169273|Obesity|obesity
719633|NCT00169273|Depression|depression
719634|NCT00169273|Behavioral|behavioral
719635|NCT00169273|Cognitive|cognitive
719636|NCT00169273|Treatment|treatment
719637|NCT00169260|smoking|smoking
719638|NCT00169260|tobacco|tobacco
719639|NCT00169260|behavior therapy|behavior therapy
719640|NCT00169247|larynx cancer|larynx cancer
719641|NCT00169247|hypopharynx cancer|hypopharynx cancer
719642|NCT00169247|larynx preservation|larynx preservation
719643|NCT00169247|concomitant radiochemotherapy|concomitant radiochemotherapy
719644|NCT00169247|cisplatin|cisplatin
719645|NCT00169247|cetuximab|cetuximab
719646|NCT00169247|randomized trial|randomized trial
719647|NCT00169234|Pneumococcal disease|pneumococcal disease
719648|NCT00169234|Vaccination|vaccination
719649|NCT00169234|Immunization|immunization
719650|NCT00169234|PPV23|ppv23
719651|NCT00169234|PCV7|pcv7
719652|NCT00169208|relapsed/refractory.|relapsed/refractory.
719653|NCT00169208|lymphoma, follicular|lymphoma, follicular
719654|NCT00169208|rituximab|rituximab
719655|NCT00169208|chemotherapy|chemotherapy
719656|NCT00169195|B-cell lymphoma|b-cell lymphoma
719657|NCT00169195|Salvage Therapy|salvage therapy
719658|NCT00169195|rituximab|rituximab
719659|NCT00169195|oxaliplatine|oxaliplatine
719660|NCT00169195|gemcitabine|gemcitabine
719661|NCT00169182|Larynx cancer|larynx cancer
719662|NCT00169182|Hypopharynx cancer|hypopharynx cancer
719663|NCT00169182|Chemotherapy|chemotherapy
719664|NCT00169182|Randomized trial|randomized trial
719665|NCT00169182|Larynx preservation|larynx preservation
719666|NCT00169169|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
719667|NCT00169169|Rituximab|rituximab
719668|NCT00169169|Autotransplant|autotransplant
719669|NCT00169156|T-cell angioimmunoblastic lymphoma|t-cell angioimmunoblastic lymphoma
719670|NCT00169156|Rituximab|rituximab
719671|NCT00169143|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
719672|NCT00169143|Pegfilgrastim|pegfilgrastim
719673|NCT00169143|Autotransplant|autotransplant
719674|NCT00169130|lymphoma|lymphoma
719675|NCT00169130|autologous stem cell transplant|autologous stem cell transplant
719676|NCT00169130|chemotherapy|chemotherapy
719677|NCT00169130|BCL2|bcl2
719678|NCT00169117|Mosquito nets|mosquito nets
719679|NCT00169117|Malaria prevention|malaria prevention
719680|NCT00169117|Songs|songs
719681|NCT00169117|Posters|posters
719682|NCT00169117|Net repair|net repair
719683|NCT00169117|Bednets|bednets
719684|NCT00169104|Breast cancer|breast cancer
719685|NCT00169104|Her-2/neu|her-2/neu
719686|NCT00169104|Granulocyte Colony Stimulating Factor|granulocyte colony stimulating factor
719687|NCT00169104|Trastuzumab|trastuzumab
719688|NCT00169104|Vinorelbine|vinorelbine
719689|NCT00169104|Antibody-dependent cellular cytotoxicity|antibody-dependent cellular cytotoxicity
719690|NCT00169104|Effector cells|effector cells
719691|NCT00169091|Clozapine|clozapine
719692|NCT00169091|Haloperidol|haloperidol
719693|NCT00169091|Schizophrenia|schizophrenia
719694|NCT00169078|Transmission intensity|transmission intensity
719695|NCT00169078|Insecticide-treated materials|insecticide-treated materials
719696|NCT00169078|antimalarial drug resistance|antimalarial drug resistance
719697|NCT00169065|Clozapine|clozapine
719698|NCT00169065|olanzapine|olanzapine
719699|NCT00169052|geriatric,|geriatric,
719700|NCT00169052|older|older
719701|NCT00169052|serious mental illness|serious mental illness
719702|NCT00169052|SMI|smi
719703|NCT00169039|Clozapine|clozapine
719704|NCT00169039|Chlorpromazine|chlorpromazine
719705|NCT00169039|Schizophrenia|schizophrenia
719706|NCT00169039|Biochemistry|biochemistry
719707|NCT00169026|Clozapine|clozapine
719708|NCT00169026|Atypical Antipsychotic|atypical antipsychotic
719709|NCT00169026|Conventional antipsychotic|conventional antipsychotic
719710|NCT00169026|Schizophrenia|schizophrenia
719711|NCT00169026|Dual Diagnosis|dual diagnosis
719712|NCT00169026|Substance Abuse|substance abuse
719713|NCT00169026|Alcohol Abuse|alcohol abuse
719714|NCT00169000|breast cancer|breast cancer
719715|NCT00169000|capecitabine|capecitabine
719716|NCT00169000|docetaxel|docetaxel
719717|NCT00169000|pharmacokinetic/pharmacodynamic|pharmacokinetic/pharmacodynamic
719718|NCT00169000|bcl-2|bcl-2
719719|NCT00169000|bax|bax
719720|NCT00168987|oral nutritional supplement|oral nutritional supplement
719721|NCT00168987|eicosapentanoic acid|eicosapentanoic acid
719722|NCT00168987|gastroenterological tumors|gastroenterological tumors
719723|NCT00168987|muscle function|muscle function
719724|NCT00168987|quality of life|quality of life
719725|NCT00168987|body composition|body composition
719726|NCT00168961|liver cirrhosis Child B or C|liver cirrhosis child b or c
719727|NCT00168948|Intermittent preventive treatment|intermittent preventive treatment
719728|NCT00168948|IPTi|ipti
719729|NCT00168948|Malaria control|malaria control
719730|NCT00168948|Ghana|ghana
719731|NCT00168922|recurrent SCLC|recurrent sclc
719732|NCT00168909|osteoporosis|osteoporosis
719733|NCT00168909|frailty|frailty
719734|NCT00168909|falls|falls
719735|NCT00168896|SCLC|sclc
719736|NCT00168883|NSCLC|nsclc
719737|NCT00168883|curative non-treatable NSCLC UICC stage IIIB and IV|curative non-treatable nsclc uicc stage iiib and iv
719738|NCT00168870|metastatic ocular melanoma|metastatic ocular melanoma
719739|NCT00168766|Combination therapy for multiple sclerosis|combination therapy for multiple sclerosis
719740|NCT00168753|Extended dosing|extended dosing
719741|NCT00168753|alefacept|alefacept
719742|NCT00168740|rituximab|rituximab
719743|NCT00168740|Rituxan|rituxan
719744|NCT00168740|B-cell lymphoma|b-cell lymphoma
719745|NCT00168740|low-grade|low-grade
719746|NCT00168740|follicular|follicular
719747|NCT00168740|anti-CD20 monoclonal antibody|anti-cd20 monoclonal antibody
719748|NCT00168727|Radioimmunotherapy|radioimmunotherapy
719749|NCT00168727|Antigens, CD20|antigens, cd20
719750|NCT00168714|AVONEX|avonex
719751|NCT00168714|Pregnancy|pregnancy
719752|NCT00168701|Multiple Sclerosis|multiple sclerosis
719753|NCT00168701|MRI|mri
719754|NCT00168688|micronutrient supplementation|micronutrient supplementation
719755|NCT00168688|pregnancy|pregnancy
719756|NCT00168688|birth weight|birth weight
719757|NCT00168688|perinatal mortality|perinatal mortality
719758|NCT00168662|Non-specific effects of vaccines|non-specific effects of vaccines
719759|NCT00168662|Infant mortality|infant mortality
719760|NCT00168662|Child mortality|child mortality
719761|NCT00168662|Mortality|mortality
719762|NCT00168662|Morbidity|morbidity
719763|NCT00168662|Measles vaccine|measles vaccine
719764|NCT00168662|Measles|measles
719765|NCT00168662|Immunisation|immunisation
719766|NCT00168662|Low income country|low income country
719767|NCT00168662|Guinea-Bissau|guinea-bissau
719768|NCT00168662|Bandim Health Project|bandim health project
719769|NCT00168662|Immunology|immunology
719770|NCT00168649|Vitamin A|vitamin a
719771|NCT00168649|Endotoxin|endotoxin
719772|NCT00168649|TNF-alfa|tnf-alfa
719773|NCT00168636|Vitamin A|vitamin a
719774|NCT00168636|Mortality|mortality
719775|NCT00168636|Morbidity|morbidity
719776|NCT00168636|OPV|opv
719777|NCT00168636|Sex|sex
719778|NCT00168623|Vitamin A|vitamin a
719779|NCT00168623|Vaccines|vaccines
719780|NCT00168623|Mortality|mortality
719781|NCT00168623|Morbidity|morbidity
719782|NCT00168610|Vitamin A|vitamin a
719783|NCT00168610|BCG|bcg
719784|NCT00168610|Infant mortality|infant mortality
719785|NCT00168610|Morbidity|morbidity
719786|NCT00168610|Low-income country|low-income country
719787|NCT00168610|Mortality|mortality
719788|NCT00168597|Vitamin A|vitamin a
719790|NCT00168597|Infant mortality|infant mortality
719791|NCT00168597|Morbidity|morbidity
719792|NCT00168597|Low-income country|low-income country
719793|NCT00168584|Vitamin A|vitamin a
719794|NCT00168584|Mortality|mortality
719795|NCT00168584|Morbidity|morbidity
719796|NCT00168584|Doses|doses
719797|NCT00168584|OPV|opv
719798|NCT00168571|Measles vaccine|measles vaccine
719799|NCT00168571|Measles|measles
719800|NCT00168571|Measles antibodies|measles antibodies
719801|NCT00168571|Immunisation|immunisation
719802|NCT00168571|Low income country|low income country
719803|NCT00168571|Guinea-Bissau|guinea-bissau
719804|NCT00168571|Bandim Health Project|bandim health project
719805|NCT00168571|Measles antibody level|measles antibody level
719806|NCT00168558|Non-specific effects of vaccines|non-specific effects of vaccines
719807|NCT00168558|Infant mortality|infant mortality
719808|NCT00168558|Child mortality|child mortality
719809|NCT00168558|Mortality|mortality
719810|NCT00168558|Morbidity|morbidity
719811|NCT00168558|Diphtheria-tetanus-pertussis vaccine|diphtheria-tetanus-pertussis vaccine
719812|NCT00168558|Measles vaccine|measles vaccine
719813|NCT00168558|Measles|measles
719814|NCT00168558|Immunisation|immunisation
719815|NCT00168558|Low income country|low income country
719816|NCT00168558|Guinea-Bissau|guinea-bissau
719817|NCT00168558|Bandim Health Project|bandim health project
719818|NCT00168558|Immunology|immunology
719819|NCT00168545|Non-specific effects of vaccines|non-specific effects of vaccines
719820|NCT00168545|Immunology|immunology
719821|NCT00168545|Cytokines|cytokines
719822|NCT00168545|Infant mortality|infant mortality
719823|NCT00168545|Child mortality|child mortality
719824|NCT00168545|Mortality|mortality
719825|NCT00168545|Morbidity|morbidity
719826|NCT00168545|Diphtheria-tetanus-pertussis vaccine|diphtheria-tetanus-pertussis vaccine
719827|NCT00168545|Measles vaccine|measles vaccine
719828|NCT00168545|Measles|measles
719829|NCT00168545|Immunisation|immunisation
719830|NCT00168545|Low income country|low income country
719831|NCT00168545|Guinea-Bissau|guinea-bissau
719832|NCT00168545|Bandim Health Project|bandim health project
719833|NCT00168545|Immunology of measles and DTP vaccination|immunology of measles and dtp vaccination
719834|NCT00168532|Prophylactic antibiotics|prophylactic antibiotics
719835|NCT00168532|Measles|measles
719836|NCT00168532|Pneumonia|pneumonia
719837|NCT00168532|Post-measles pneumonia|post-measles pneumonia
719838|NCT00168532|Low income country|low income country
719839|NCT00168532|Guinea-Bissau|guinea-bissau
719840|NCT00168532|Bandim Health Project|bandim health project
719841|NCT00168519|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
719842|NCT00168519|Blood Glucose|blood glucose
719843|NCT00168519|Exercise|exercise
719844|NCT00168519|Muscle Contraction|muscle contraction
719845|NCT00168519|Nitric Oxide|nitric oxide
719846|NCT00168519|Nitrates|nitrates
719847|NCT00168506|panic disorder|panic disorder
719848|NCT00168506|cardiac risk|cardiac risk
719849|NCT00168493|Major Depression|major depression
719850|NCT00168493|Cardiac disease|cardiac disease
719851|NCT00168402|Axillary Hyperhidrosis|axillary hyperhidrosis
719852|NCT00168376|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
719853|NCT00168376|Depression|depression
719854|NCT00168311|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
719855|NCT00168311|Schizophrenia|schizophrenia
719856|NCT00168311|Negative Symptoms|negative symptoms
719857|NCT00168285|Exercise|exercise
719858|NCT00168285|Pulmonary rehabilitation|pulmonary rehabilitation
719859|NCT00168285|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
719860|NCT00168285|Connective tissue disorders|connective tissue disorders
719861|NCT00168272|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
719862|NCT00168272|Depression|depression
719863|NCT00168259|Treatment Naive|treatment naive
719864|NCT00168259|HIV|hiv
719865|NCT00168246|HIV|hiv
719866|NCT00168233|Treatment Naive|treatment naive
719867|NCT00168233|HIV|hiv
719868|NCT00168220|Treatment Experienced|treatment experienced
719869|NCT00168220|HIV|hiv
719870|NCT00168207|Treatment Experienced|treatment experienced
719871|NCT00168207|HIV|hiv
719872|NCT00168194|HIV|hiv
719873|NCT00168181|salagen|salagen
719874|NCT00168181|gland transfer|gland transfer
719875|NCT00168181|randomized|randomized
719876|NCT00168181|xerostomia|xerostomia
719877|NCT00168168|G-CSF|g-csf
719878|NCT00168168|Filgrastim|filgrastim
719879|NCT00168168|Engraftment time|engraftment time
719880|NCT00168168|Autologus transplant|autologus transplant
719881|NCT00168155|resectable liver metastases|resectable liver metastases
719882|NCT00168155|colorectal adenocarcinoma|colorectal adenocarcinoma
719883|NCT00168155|survival|survival
719884|NCT00168155|neoadjuvant chemotherapy|neoadjuvant chemotherapy
719885|NCT00168142|Helical tomotherapy|helical tomotherapy
719886|NCT00168142|Megavoltage imaging|megavoltage imaging
719887|NCT00168129|tomotherapy|tomotherapy
719888|NCT00168129|bone metastases|bone metastases
719889|NCT00168129|radiotherapy|radiotherapy
719890|NCT00168129|intensity modulated|intensity modulated
719891|NCT00168116|nasopharynx|nasopharynx
719894|NCT00168103|C1 Inhibitor|c1 inhibitor
719895|NCT00168103|Hereditary angioedema|hereditary angioedema
719896|NCT00168103|Acute HAE attack|acute hae attack
719897|NCT00168090|von Willebrand Factor|von willebrand factor
719898|NCT00168090|Blood Coagulation Disorders|blood coagulation disorders
719899|NCT00168090|Factor VIII|factor viii
719900|NCT00168077|Prothrombin Complex Concentrate|prothrombin complex concentrate
719901|NCT00168077|Anticoagulant reversal|anticoagulant reversal
719902|NCT00168064|Mycosis Fungoides|mycosis fungoides
719903|NCT00168064|Nitrogen Mustard|nitrogen mustard
719904|NCT00168064|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
719905|NCT00168064|CTCL - Mycosis Fungoides|ctcl - mycosis fungoides
719906|NCT00168051|Hemophilia A|hemophilia a
719907|NCT00168038|Chronic Immune Thrombocytopenic Purpura|chronic immune thrombocytopenic purpura
719908|NCT00168038|Chronic Idiopathic Thrombocytopenic Purpura|chronic idiopathic thrombocytopenic purpura
719909|NCT00168038|Werlhofs Disease|werlhofs disease
719910|NCT00168038|Autoimmune Thrombocytopenia|autoimmune thrombocytopenia
719911|NCT00168038|Immunglobulin Intravenous|immunglobulin intravenous
719912|NCT00168038|Chronic ITP|chronic itp
719913|NCT00168038|Platelet count|platelet count
719914|NCT00168038|Thrombocytopenia|thrombocytopenia
719915|NCT00168025|Immunoglobulin Intravenous|immunoglobulin intravenous
719916|NCT00168025|Agammaglobulinemia|agammaglobulinemia
719917|NCT00168025|Hypogammaglobulinemia|hypogammaglobulinemia
719918|NCT00168025|Common variable immunodeficiency|common variable immunodeficiency
719919|NCT00168025|Immunoglobulin G|immunoglobulin g
719920|NCT00168025|Children|children
719921|NCT00168012|Immunoglobulin intravenous|immunoglobulin intravenous
719922|NCT00168012|Agammaglobulinemia|agammaglobulinemia
719923|NCT00168012|Hypogammaglobulinemia|hypogammaglobulinemia
719924|NCT00168012|Common variable immunodeficiency|common variable immunodeficiency
719925|NCT00168012|Immunoglobulin G|immunoglobulin g
719926|NCT00168012|Children|children
719927|NCT00167999|Bacterial Infections|bacterial infections
719928|NCT00167986|Bacterial Infections|bacterial infections
719929|NCT00167973|Hemophilia B|hemophilia b
719930|NCT00167960|Bacterial Infections|bacterial infections
719932|NCT00167947|Transplant|transplant
719933|NCT00167934|Diabetes|diabetes
719934|NCT00167934|Metabolic|metabolic
719935|NCT00167895|osteoarthritis|osteoarthritis
719936|NCT00167895|knee|knee
719937|NCT00167895|platelet concentrate|platelet concentrate
719938|NCT00167882|Crohn's disease|crohn's disease
719939|NCT00167882|Ulcerative colitis|ulcerative colitis
719940|NCT00167882|Inflammatory bowel disease|inflammatory bowel disease
719941|NCT00167882|azathioprine|azathioprine
719942|NCT00167882|6-mercaptopurine|6-mercaptopurine
719943|NCT00167882|5-aminosalicylate|5-aminosalicylate
719944|NCT00167882|metabolism|metabolism
719945|NCT00167869|hypertension|hypertension
719946|NCT00167869|blood pressure|blood pressure
719947|NCT00167869|dairy peptides|dairy peptides
719948|NCT00167869|bioactive peptides|bioactive peptides
719949|NCT00167869|randomized controlled trial|randomized controlled trial
719950|NCT00167856|Burning pain|burning pain
719951|NCT00167856|Clinical trial|clinical trial
719952|NCT00167856|Effexor|effexor
719953|NCT00167856|Pain|pain
719954|NCT00167856|Spinal cord injury|spinal cord injury
719955|NCT00167856|Venalafaxine|venalafaxine
719956|NCT00167856|Neuropathic Pain|neuropathic pain
719957|NCT00167843|Malaria|malaria
719958|NCT00167843|Anemia|anemia
719959|NCT00167843|Children|children
719960|NCT00167843|Gabon|gabon
719961|NCT00167843|Intermittent preventive treatment|intermittent preventive treatment
719962|NCT00167830|Pediatric Overweight,|pediatric overweight,
719963|NCT00167830|African American;|african american;
719964|NCT00167830|Adolescent;|adolescent;
719965|NCT00167830|Intervention,|intervention,
719966|NCT00167830|Teasing;|teasing;
719967|NCT00167830|Self-esteem|self-esteem
719968|NCT00167830|Quality of Life|quality of life
719969|NCT00167830|Metabolic syndrome|metabolic syndrome
719970|NCT00167830|Insulin resistance|insulin resistance
719971|NCT00167830|Diabetes|diabetes
719972|NCT00167830|Nutrition|nutrition
719973|NCT00167830|Motivation|motivation
719974|NCT00167830|Culture|culture
719975|NCT00167830|BMI|bmi
719976|NCT00167830|Cardiorespiratory fitness|cardiorespiratory fitness
719977|NCT00167830|Resistance Training|resistance training
719978|NCT00167830|Compliance|compliance
719979|NCT00167817|Schizophrenia|schizophrenia
719980|NCT00167817|Smoking|smoking
719981|NCT00167817|Metabolic|metabolic
719982|NCT00167817|Health|health
719983|NCT00167817|Glucose|glucose
719984|NCT00167817|Lipids|lipids
719985|NCT00167804|Exposure Therapy|exposure therapy
719986|NCT00167804|Post Traumatic Stress Disorder|post traumatic stress disorder
719987|NCT00167804|Treatment Outcome|treatment outcome
719988|NCT00167804|Veterans|veterans
719989|NCT00167804|Virtual Reality|virtual reality
719990|NCT00167791|transplant|transplant
719991|NCT00167791|desensitization|desensitization
719992|NCT00167791|kidney transplant|kidney transplant
719993|NCT00167778|Amputation|amputation
719994|NCT00167778|Amputee|amputee
720194|NCT00166998|diagnosis|diagnosis
719995|NCT00167778|Artificial limbs|artificial limbs
719996|NCT00167778|Gait|gait
719997|NCT00167778|Locomotion|locomotion
719998|NCT00167778|Walking|walking
719999|NCT00167765|stroke, ischemic|stroke, ischemic
720000|NCT00167765|acute ischemic stroke|acute ischemic stroke
720001|NCT00167739|Malaria|malaria
720002|NCT00167739|Quinine|quinine
720003|NCT00167739|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
720004|NCT00167739|Gabon|gabon
720005|NCT00167713|Malaria|malaria
720006|NCT00167713|Fever|fever
720007|NCT00167713|Ibuprofen|ibuprofen
720008|NCT00167713|Gabon|gabon
720009|NCT00167700|atopic disease|atopic disease
720010|NCT00167700|probiotics|probiotics
720011|NCT00167700|gut microbiota|gut microbiota
720012|NCT00167700|allergy|allergy
720013|NCT00167700|nutrition|nutrition
720014|NCT00167700|growth|growth
720015|NCT00167700|allergic rhinitis|allergic rhinitis
720016|NCT00167700|atopic sensitization|atopic sensitization
720017|NCT00167700|risk-markers of life-style related diseases|risk-markers of life-style related diseases
720018|NCT00167687|Alcoholism|alcoholism
720019|NCT00167687|Randomized Controlled Trial|randomized controlled trial
720020|NCT00167674|breastmilk|breastmilk
720021|NCT00167674|HIV-1|hiv-1
720022|NCT00167674|antiretroviral|antiretroviral
720023|NCT00167674|mother-to-child|mother-to-child
720024|NCT00167674|transmission|transmission
720025|NCT00167661|living or deceased donor renal transplant recipient|living or deceased donor renal transplant recipient
720026|NCT00167635|Irritable Bowel Syndrome|irritable bowel syndrome
720027|NCT00167635|Cognitive-behavioral intervention|cognitive-behavioral intervention
720028|NCT00167635|Psychological distress|psychological distress
720029|NCT00167635|Quality of life|quality of life
720030|NCT00167622|Guillain Barré|guillain barré
720031|NCT00167622|Mechanical ventilation, invasive|mechanical ventilation, invasive
720032|NCT00167622|Mechanical ventilation, non invasive|mechanical ventilation, non invasive
720033|NCT00167622|Pneumonia|pneumonia
720034|NCT00167609|myotonic dystrophy|myotonic dystrophy
720035|NCT00167609|hypersomnia|hypersomnia
720036|NCT00167609|dehydroepiandrosterone|dehydroepiandrosterone
720037|NCT00167596|near infrared spectroscopy|near infrared spectroscopy
720038|NCT00167596|tissue oxygenation|tissue oxygenation
720039|NCT00167596|organ dysfunction|organ dysfunction
720040|NCT00167596|mortality|mortality
720041|NCT00167583|Ocular Behcet`s disease|ocular behcet`s disease
720042|NCT00167583|Panuveitis|panuveitis
720043|NCT00167583|Posterior Uveitis|posterior uveitis
720044|NCT00167583|Retinal vasculitis|retinal vasculitis
720045|NCT00167583|Treatment|treatment
720046|NCT00167583|Interferon-alpha|interferon-alpha
720047|NCT00167583|Cyclosporin A|cyclosporin a
720048|NCT00167570|Artificial Limbs|artificial limbs
720049|NCT00167570|Amputees|amputees
720050|NCT00167570|Computer-Aided Design|computer-aided design
720051|NCT00167557|Liver Transplantation|liver transplantation
720052|NCT00167544|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
720053|NCT00167544|Encephalomalacia|encephalomalacia
720054|NCT00167544|Brain injury|brain injury
720055|NCT00167544|Neurosensory impairment|neurosensory impairment
720056|NCT00167544|Corticosteroids|corticosteroids
720057|NCT00167544|Anti-Inflammatory Agents|anti-inflammatory agents
720058|NCT00167544|Extremely Low Birth Weight (ELBW) infants|extremely low birth weight (elbw) infants
720059|NCT00167544|Premature Birth|premature birth
720060|NCT00167544|Magnetic Resonance Imaging|magnetic resonance imaging
720061|NCT00167531|Stroke|stroke
720062|NCT00167531|health outcomes|health outcomes
720063|NCT00167531|physiotherapy|physiotherapy
720064|NCT00167531|rehabilitation|rehabilitation
720065|NCT00167531|treadmill|treadmill
720066|NCT00167518|Diabetic macular oedema|diabetic macular oedema
720067|NCT00167518|Triamcinolone acetate|triamcinolone acetate
720068|NCT00167518|Intravitreal injection|intravitreal injection
720069|NCT00167518|Clinical trial|clinical trial
720070|NCT00167518|Laser treatment|laser treatment
720071|NCT00167505|adolescents|adolescents
720072|NCT00167505|sexual health|sexual health
720073|NCT00167505|HIV|hiv
720074|NCT00167505|STD|std
720075|NCT00167505|pregnancy prevention|pregnancy prevention
720076|NCT00167505|abstinence education|abstinence education
720077|NCT00167505|HIV Seronegativity|hiv seronegativity
720078|NCT00167505|human immunodeficiency virus|human immunodeficiency virus
720079|NCT00167479|Bipolar Anxiety|bipolar anxiety
720080|NCT00167479|Bipolar Disorder|bipolar disorder
720081|NCT00167479|Anxiety|anxiety
720082|NCT00167479|Panic Disorder|panic disorder
720083|NCT00167479|Generalized Anxiety Disorder|generalized anxiety disorder
720084|NCT00167479|GAD|gad
720085|NCT00167479|Risperidone|risperidone
720086|NCT00167479|Double-Blind|double-blind
720087|NCT00167479|Placebo Controlled|placebo controlled
720088|NCT00167466|periodontal disease|periodontal disease
720089|NCT00167466|toothbrush|toothbrush
720090|NCT00167466|titanium dioxide semiconductor|titanium dioxide semiconductor
720091|NCT00167466|mild-to-moderate periodontal disease|mild-to-moderate periodontal disease
720092|NCT00167466|adult patients 18 to 70 years of age|adult patients 18 to 70 years of age
720093|NCT00167453|Nervous system disease|nervous system disease
720094|NCT00167453|movement disorder|movement disorder
720095|NCT00167453|exercise|exercise
720096|NCT00167453|balance|balance
720097|NCT00167453|education|education
720098|NCT00167440|cardiac index|cardiac index
720099|NCT00167440|cardiac output|cardiac output
720100|NCT00167440|indwelling central venous catheter|indwelling central venous catheter
720101|NCT00167440|indwelling arterial catheter|indwelling arterial catheter
720102|NCT00167414|conformal radiotherapy|conformal radiotherapy
720103|NCT00167388|anemia|anemia
720104|NCT00167388|prematurity|prematurity
720105|NCT00167388|blood flow velocity|blood flow velocity
720106|NCT00167388|superior mesenteric artery|superior mesenteric artery
720107|NCT00167388|intestinal blood flow in premature infants|intestinal blood flow in premature infants
720108|NCT00167375|Insomnia|insomnia
720109|NCT00167375|polysomnography|polysomnography
720110|NCT00167375|sleep onset|sleep onset
720111|NCT00167375|time series analysis|time series analysis
720112|NCT00167362|Schizophrenia|schizophrenia
720113|NCT00167362|Cognition|cognition
720114|NCT00167362|Enhancement|enhancement
720115|NCT00167362|Randomized|randomized
720116|NCT00167349|cardiac surgery|cardiac surgery
720117|NCT00167349|cardiopulmonary bypass|cardiopulmonary bypass
720118|NCT00167349|cytokines|cytokines
720119|NCT00167336|Computer|computer
720120|NCT00167336|Kinematics|kinematics
720121|NCT00167336|Instrument development|instrument development
720122|NCT00167336|Reliability|reliability
720123|NCT00167336|Cumulative Trauma Disorder|cumulative trauma disorder
720124|NCT00167323|Bipolar|bipolar
720125|NCT00167323|Alcoholism|alcoholism
720126|NCT00167310|Omega-3 fatty acids|omega-3 fatty acids
720127|NCT00167310|Statins|statins
720128|NCT00167310|Antipsychotic drug|antipsychotic drug
720129|NCT00167310|Antidepressant drug|antidepressant drug
720130|NCT00167310|Antimanic drug|antimanic drug
720131|NCT00167310|Placebos|placebos
720132|NCT00167310|Double-blind method|double-blind method
720133|NCT00167310|Bipolar (depressed phase)|bipolar (depressed phase)
720134|NCT00167297|atomoxetine|atomoxetine
720135|NCT00167297|cannabis dependence|cannabis dependence
720136|NCT00167297|treatment|treatment
720137|NCT00167284|chronic care model, diabetes, community, diabetes education|chronic care model, diabetes, community, diabetes education
720138|NCT00167271|Cognitive therapy|cognitive therapy
720139|NCT00167245|Topiramate|topiramate
720140|NCT00167245|alcoholism|alcoholism
720141|NCT00167245|cocaine dependence|cocaine dependence
720142|NCT00167232|naltrexone|naltrexone
720143|NCT00167232|cocaine dependence|cocaine dependence
720144|NCT00167232|alcohol dependence|alcohol dependence
720145|NCT00167232|psychosocial treatment|psychosocial treatment
720146|NCT00167219|Stem cell transplant|stem cell transplant
720147|NCT00167219|long term survival|long term survival
720148|NCT00167219|retinoic acid|retinoic acid
720149|NCT00167206|Stem Cell Transplant|stem cell transplant
720150|NCT00167206|Thymic Shielding|thymic shielding
720151|NCT00167206|Total Body Irradiation|total body irradiation
720152|NCT00167206|Chemotherapy|chemotherapy
720153|NCT00167180|donor lymphocyte infusions|donor lymphocyte infusions
720154|NCT00167180|BMT|bmt
720155|NCT00167180|bone marrow transplant|bone marrow transplant
720156|NCT00167167|Donor Lymphocyte Infusion|donor lymphocyte infusion
720157|NCT00167167|relapse|relapse
720158|NCT00167167|post-transplant|post-transplant
720159|NCT00167154|suicidality|suicidality
720160|NCT00167154|antipsychotic|antipsychotic
720161|NCT00167154|antidepressant|antidepressant
720162|NCT00167154|treatment|treatment
720163|NCT00167141|male fertility|male fertility
720164|NCT00167141|semen parameters|semen parameters
720165|NCT00167128|Auditory Processing Disorder|auditory processing disorder
720166|NCT00167128|speech-in-noise intelligibility|speech-in-noise intelligibility
720167|NCT00167115|Alcohol|alcohol
720168|NCT00167115|Type 2 diabetes mellitus|type 2 diabetes mellitus
720169|NCT00167115|Plama glucose|plama glucose
720170|NCT00167115|HDL cholesterol|hdl cholesterol
720171|NCT00167102|Alopecia Areata|alopecia areata
720172|NCT00167089|Stroke|stroke
720173|NCT00167089|Hemiplegia|hemiplegia
720174|NCT00167089|Gait|gait
720175|NCT00167089|Ambulation training|ambulation training
720176|NCT00167089|Neurologic physical therapy|neurologic physical therapy
720177|NCT00167076|Stroke|stroke
720178|NCT00167076|Foot pressure|foot pressure
720179|NCT00167076|Walking speed|walking speed
720180|NCT00167076|Gait|gait
720181|NCT00167063|Stroke|stroke
720182|NCT00167063|Fall|fall
720183|NCT00167063|Fall prediction|fall prediction
720184|NCT00167063|Clinical manifestations|clinical manifestations
720185|NCT00167063|Frequent faller|frequent faller
720186|NCT00167037|Hemiplegia|hemiplegia
720187|NCT00167037|Waist pulling perturbation|waist pulling perturbation
720188|NCT00167037|Reactive balance strategy|reactive balance strategy
720189|NCT00167037|Trajectory of center of pressure|trajectory of center of pressure
720190|NCT00167037|Parameters of center of pressure|parameters of center of pressure
720191|NCT00167024|prostate cancer, DNA repair gene, genetic polymorphism|prostate cancer, dna repair gene, genetic polymorphism
720192|NCT00167011|coronary artery|coronary artery
720193|NCT00166998|Breast neoplasms|breast neoplasms
720195|NCT00166985|endometrial cancer, MRI, Doppler sonography, angiogenesis|endometrial cancer, mri, doppler sonography, angiogenesis
720196|NCT00166972|metastasis, survival, malignancy, female, trophinin|metastasis, survival, malignancy, female, trophinin
720197|NCT00166959|Stroke patients|stroke patients
720198|NCT00166959|Falls|falls
720199|NCT00166959|Reliability|reliability
720200|NCT00166959|Validity|validity
720201|NCT00166933|minimal erythema dose|minimal erythema dose
720203|NCT00166933|normal|normal
720204|NCT00166907|Stroke|stroke
720205|NCT00166907|Balance|balance
720206|NCT00166907|Proactive control|proactive control
720207|NCT00166907|Reactive control|reactive control
720208|NCT00166907|Recovery|recovery
720209|NCT00166907|Training|training
720210|NCT00166907|Fall|fall
720211|NCT00166894|pleural effusion|pleural effusion
720212|NCT00166894|TREM-1|trem-1
720213|NCT00166881|Combination, Chemotherapy, Inoperable Gastric Cancer|combination, chemotherapy, inoperable gastric cancer
720214|NCT00166868|Biliary atresia, cholangitis, probiotics, prophylaxis|biliary atresia, cholangitis, probiotics, prophylaxis
720215|NCT00166855|angiogenesis|angiogenesis
720216|NCT00166855|bone marrow perfusion|bone marrow perfusion
720217|NCT00166855|dynamic MRI|dynamic mri
720218|NCT00166855|multiple myeloma|multiple myeloma
720219|NCT00166855|prognosis|prognosis
720220|NCT00166842|Pharmacokinetics|pharmacokinetics
720221|NCT00166842|Sirolimus|sirolimus
720222|NCT00166842|Cyclosporine|cyclosporine
720223|NCT00166842|Tacrolimus|tacrolimus
720224|NCT00166842|Immunosuppressive Agents|immunosuppressive agents
720225|NCT00166842|Immunosuppression|immunosuppression
720226|NCT00166842|Transplantation|transplantation
720227|NCT00166842|Kidney Transplantation|kidney transplantation
720228|NCT00166829|Tacrolimus|tacrolimus
720229|NCT00166829|Sirolimus|sirolimus
720230|NCT00166829|Mycophenolic acid|mycophenolic acid
720231|NCT00166829|Immunosuppressive Agents|immunosuppressive agents
720232|NCT00166829|Immunosuppression|immunosuppression
720233|NCT00166829|Kidney Transplantation|kidney transplantation
720234|NCT00166829|Transplantation|transplantation
720235|NCT00166816|Sirolimus|sirolimus
720236|NCT00166816|Tacrolimus|tacrolimus
720237|NCT00166816|Cyclosporine|cyclosporine
720238|NCT00166816|Pharmacokinetics|pharmacokinetics
720239|NCT00166816|Immunosuppressive Agents|immunosuppressive agents
720240|NCT00166816|Immunosuppression|immunosuppression
720241|NCT00166816|Kidney Transplantation|kidney transplantation
720242|NCT00166816|Transplantation|transplantation
720243|NCT00166803|Diabetes Mellitus, PPARγ agonist, FDG PET|diabetes mellitus, pparγ agonist, fdg pet
720244|NCT00166790|Human Chorionic Gonadotropin|human chorionic gonadotropin
720245|NCT00166790|Dual Polarization Interferometry,|dual polarization interferometry,
720246|NCT00166790|Gestational Trophoblastic Neoplasms|gestational trophoblastic neoplasms
720247|NCT00166764|Psychiatric Disorders|psychiatric disorders
720248|NCT00166764|Evaluation of Mental Health Index|evaluation of mental health index
720249|NCT00166751|Videofluoroscopic examination,|videofluoroscopic examination,
720250|NCT00166751|ultrasound|ultrasound
720251|NCT00166751|laryngeal elevation|laryngeal elevation
720252|NCT00166751|dysphagia|dysphagia
720253|NCT00166738|Schizophrenia|schizophrenia
720254|NCT00166738|multiple genes|multiple genes
720255|NCT00166738|array-comparative genomic hybridization (CGH)|array-comparative genomic hybridization (cgh)
720256|NCT00166738|genomic DNA|genomic dna
720257|NCT00166738|Chinese Han People|chinese han people
720258|NCT00166725|HRPC|hrpc
720259|NCT00166725|octreotide LAR|octreotide lar
720260|NCT00166725|CgA|cga
720261|NCT00166712|Kidney Transplant|kidney transplant
720262|NCT00166712|Living Donor Kidney Transplant Recipients|living donor kidney transplant recipients
720263|NCT00166699|ultrasonography|ultrasonography
720264|NCT00166699|obesity|obesity
720265|NCT00166699|Cesarean Section|cesarean section
720266|NCT00166699|Anesthesia|anesthesia
720267|NCT00166699|Epidural|epidural
720268|NCT00166686|Cancer|cancer
720269|NCT00166686|Clonidine|clonidine
720270|NCT00166686|Neurocognitive sequelae|neurocognitive sequelae
720271|NCT00166673|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
720272|NCT00166673|Type 1 Diabetes|type 1 diabetes
720273|NCT00166673|Continuous Glucose Monitoring Devices|continuous glucose monitoring devices
720274|NCT00166673|Electronic Data Collection|electronic data collection
720275|NCT00166660|Preterm infants|preterm infants
720276|NCT00166660|Developmental Care|developmental care
720277|NCT00166660|NIDCAP|nidcap
720278|NCT00166660|Fetal Growth Restriction|fetal growth restriction
720279|NCT00166660|Neurobehavior|neurobehavior
720280|NCT00166660|APIB|apib
720281|NCT00166660|MRI|mri
720282|NCT00166660|EEG|eeg
720283|NCT00166660|Parent Stress|parent stress
720284|NCT00166647|Cancer|cancer
720285|NCT00166647|Chemotherapy|chemotherapy
720286|NCT00166647|Hematological disorder|hematological disorder
720287|NCT00166634|Hypertension|hypertension
720288|NCT00166634|ABPM|abpm
720289|NCT00166634|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
720290|NCT00166621|Autism|autism
720291|NCT00166621|Neuroplasticity|neuroplasticity
720292|NCT00166608|acetaminophen toxicity|acetaminophen toxicity
720293|NCT00166608|liver damage|liver damage
720294|NCT00166608|tylenol overdose|tylenol overdose
720295|NCT00166595|Risperidone|risperidone
720296|NCT00166595|Autism|autism
720297|NCT00166595|Pervasive Developmental Disorder (PDD)|pervasive developmental disorder (pdd)
720298|NCT00166582|pediatric asthma, medication adherence, adolescents|pediatric asthma, medication adherence, adolescents
720299|NCT00166569|Polycystic Ovary Syndrome|polycystic ovary syndrome
720300|NCT00166543|locally advanced breast carcinoma|locally advanced breast carcinoma
720301|NCT00166543|locally recurrent inoperable breast carcinoma|locally recurrent inoperable breast carcinoma
720302|NCT00166543|progressive metastatic breast carcinoma|progressive metastatic breast carcinoma
720303|NCT00166517|Gastrointestinal Rotavirus|gastrointestinal rotavirus
720304|NCT00166439|C04.557.386|c04.557.386
720305|NCT00166387|Hemophilia|hemophilia
720306|NCT00166387|Inhibitors|inhibitors
720307|NCT00166361|Extrinsic ureteral obstruction|extrinsic ureteral obstruction
720308|NCT00166361|Memokath 051 Ureteral Stent|memokath 051 ureteral stent
720309|NCT00166361|JJ Stent|jj stent
720310|NCT00166361|Stent|stent
720311|NCT00166348|Cognitive Rehabilitation|cognitive rehabilitation
720312|NCT00166322|IBZM-SPECT|ibzm-spect
720313|NCT00166322|Amphetamine Challenge|amphetamine challenge
720314|NCT00166322|Schizophrenia|schizophrenia
720315|NCT00166322|dopaminergic neurotransmission|dopaminergic neurotransmission
720316|NCT00166322|Persons at risk for the development of schizophrenia|persons at risk for the development of schizophrenia
720317|NCT00166322|healthy subjects|healthy subjects
720318|NCT00166309|Hemophilia A|hemophilia a
720319|NCT00166309|Inhibitors|inhibitors
720320|NCT00166296|Major depressive disorder, chemically induced.|major depressive disorder, chemically induced.
720321|NCT00166296|Peginterferon alfa-2a.|peginterferon alfa-2a.
720322|NCT00166296|Escitalopram.|escitalopram.
720323|NCT00166296|Chronic hepatitis C, psychology.|chronic hepatitis c, psychology.
720324|NCT00166296|Prophylactic treatment.|prophylactic treatment.
720325|NCT00166283|memory|memory
720326|NCT00166283|learning|learning
720327|NCT00166283|Multiple Sclerosis|multiple sclerosis
720328|NCT00166283|Cognition|cognition
720329|NCT00166283|treatment|treatment
720330|NCT00166283|therapy|therapy
720331|NCT00166270|Fibroids|fibroids
720332|NCT00166270|ExAblate|exablate
720333|NCT00166270|MrgFus|mrgfus
720334|NCT00166270|Uterine Fibroids|uterine fibroids
720335|NCT00166257|Paradoxical embolism, Patent foramen ovale,|paradoxical embolism, patent foramen ovale,
720336|NCT00166244|Mycophenolate mofetil|mycophenolate mofetil
720337|NCT00166244|Therapeutic Drug Monitoring|therapeutic drug monitoring
720338|NCT00166244|Adult kidney transplantation|adult kidney transplantation
720339|NCT00166244|Paediatric kidney transplantation|paediatric kidney transplantation
720340|NCT00166231|Innocent heart murmurs|innocent heart murmurs
720341|NCT00166231|Chest pain|chest pain
720342|NCT00166231|pediatric Cardiology|pediatric cardiology
720343|NCT00166231|Somatization|somatization
720344|NCT00166231|life stress|life stress
720345|NCT00166218|pediatrics|pediatrics
720346|NCT00166218|cardiac defects|cardiac defects
720347|NCT00166205|Obesity, Morbid|obesity, morbid
720348|NCT00166205|Obesity|obesity
720349|NCT00166205|Body Weight|body weight
720350|NCT00166192|Melasma|melasma
720351|NCT00166192|Jessner's solution|jessner's solution
720352|NCT00166192|Trichloroacetic acid (TCA)|trichloroacetic acid (tca)
720353|NCT00166179|CAD|cad
720354|NCT00166166|hyperlipidaemia|hyperlipidaemia
720355|NCT00166166|EDHF|edhf
720356|NCT00166166|FMD|fmd
720357|NCT00166153|cardiac transplantation|cardiac transplantation
720358|NCT00166153|pediatrics|pediatrics
720359|NCT00166153|cardiology|cardiology
720360|NCT00166153|drug metabolism|drug metabolism
720361|NCT00166140|pediatrics|pediatrics
720362|NCT00166140|cardiac|cardiac
720363|NCT00166140|surgery|surgery
720364|NCT00166127|heart failure|heart failure
720365|NCT00166127|cardiac surgery|cardiac surgery
720366|NCT00166127|pharmacokinetics|pharmacokinetics
720367|NCT00166127|pharmacodynamics|pharmacodynamics
720368|NCT00166114|platelet function|platelet function
720369|NCT00166114|childhood abuse|childhood abuse
720370|NCT00166114|depression|depression
720371|NCT00166114|antidepressants|antidepressants
720372|NCT00166114|immune function|immune function
720373|NCT00166114|stress response|stress response
720374|NCT00166101|pediatric|pediatric
720375|NCT00166101|cardiac surgery|cardiac surgery
720376|NCT00166088|Oxidative Stress|oxidative stress
720377|NCT00166088|Diet, Mediterranean|diet, mediterranean
720378|NCT00166075|Suicidality|suicidality
720379|NCT00166075|PTSD|ptsd
720380|NCT00166075|depression|depression
720381|NCT00166062|intimate partner violence|intimate partner violence
720382|NCT00166062|perpetration|perpetration
720383|NCT00166049|Heart failure|heart failure
720384|NCT00166049|Family partnership|family partnership
720385|NCT00166049|Patient family education|patient family education
720386|NCT00166023|pediatric|pediatric
720387|NCT00166023|cardiology|cardiology
720388|NCT00166010|drug|drug
720389|NCT00166010|pediatrics|pediatrics
720390|NCT00166010|cardiac|cardiac
720391|NCT00166010|Children with Cardiac Ventricular Failure|children with cardiac ventricular failure
720393|NCT00165997|cardiology|cardiology
720394|NCT00165997|Radiofrequency ablation|radiofrequency ablation
720395|NCT00165997|structurally normal heart|structurally normal heart
720396|NCT00165984|cardiac|cardiac
720397|NCT00165984|hypoplastic|hypoplastic
720398|NCT00165984|pediatric|pediatric
720399|NCT00165984|hypoplastic heart ventricle|hypoplastic heart ventricle
720400|NCT00165971|Cognitive decline|cognitive decline
720401|NCT00165971|Inflammation|inflammation
720402|NCT00165971|Monitoring|monitoring
720403|NCT00165971|Recovery|recovery
720404|NCT00165971|Bispectral index|bispectral index
720405|NCT00165958|Epidermal cyst|epidermal cyst
720406|NCT00165958|Epidermoid cyst|epidermoid cyst
720407|NCT00165958|Sebaceous cyst|sebaceous cyst
720408|NCT00165958|Pilar cyst|pilar cyst
720409|NCT00165945|pediatric, cardiology, diagnostic imaging using MRI|pediatric, cardiology, diagnostic imaging using mri
720410|NCT00165932|tachycardia|tachycardia
720411|NCT00165932|pediatrics|pediatrics
720412|NCT00165919|Hepatitis C|hepatitis c
720413|NCT00165919|HIV|hiv
720414|NCT00165919|Immunopathogenesis|immunopathogenesis
720415|NCT00165919|HIV-1|hiv-1
720416|NCT00165906|neonates|neonates
720417|NCT00165906|cardiac|cardiac
720418|NCT00165906|non-cardiac|non-cardiac
720419|NCT00165906|surgery|surgery
720420|NCT00165906|anticoagulation|anticoagulation
720421|NCT00165893|low back pain|low back pain
720422|NCT00165893|DDD|ddd
720423|NCT00165841|non-erosive symptomatic GERD|non-erosive symptomatic gerd
720424|NCT00165841|GERD|gerd
720425|NCT00165828|Epilepsy|epilepsy
720426|NCT00165802|Cancer|cancer
720427|NCT00165802|malignant tumors|malignant tumors
720428|NCT00165763|Vascular Dementia|vascular dementia
720429|NCT00165737|Dementia cerebrovascular disease|dementia cerebrovascular disease
720430|NCT00165698|Postmenopausal|postmenopausal
720431|NCT00165698|osteoporosis|osteoporosis
720432|NCT00165672|24-hour esophageal pH monitoring|24-hour esophageal ph monitoring
720433|NCT00165672|non-erosive gastroesophageal reflux disease|non-erosive gastroesophageal reflux disease
720434|NCT00165672|NERD|nerd
720435|NCT00165672|proton pump inhibitor|proton pump inhibitor
720436|NCT00165672|rabeprazole|rabeprazole
720437|NCT00165646|non-erosive gastroesophageal reflux disease|non-erosive gastroesophageal reflux disease
720438|NCT00165646|NERD|nerd
720439|NCT00165646|proton pump inhibitor|proton pump inhibitor
720440|NCT00165646|rabeprazole|rabeprazole
720441|NCT00165633|Hepatocellular|hepatocellular
720442|NCT00165633|Carcinoma|carcinoma
720443|NCT00165633|Hepatitis C Virus|hepatitis c virus
720444|NCT00165633|Hepatitis B Virus|hepatitis b virus
720445|NCT00165633|recurrence|recurrence
720446|NCT00165633|Vitamin K2|vitamin k2
720447|NCT00165633|E0167|e0167
720448|NCT00165594|gastric cancer|gastric cancer
720449|NCT00165594|Phase I|phase i
720450|NCT00165594|Phase IIa|phase iia
720451|NCT00165594|E7070|e7070
720452|NCT00165594|Indisulam|indisulam
720453|NCT00165594|Pharmacogenomic|pharmacogenomic
720454|NCT00165594|2C19|2c19
720455|NCT00165581|Intracavitary brachytherapy|intracavitary brachytherapy
720456|NCT00165581|radiation therapy|radiation therapy
720457|NCT00165581|Stage I breast cancer|stage i breast cancer
720458|NCT00165581|Stage II breast cancer|stage ii breast cancer
720459|NCT00165568|Positron emission tomography|positron emission tomography
720460|NCT00165568|PET|pet
720461|NCT00165568|bevacizumab|bevacizumab
720462|NCT00165568|5fluorouracil|5fluorouracil
720463|NCT00165568|Metastatic colorectal cancer|metastatic colorectal cancer
720464|NCT00165555|cisplatin|cisplatin
720465|NCT00165555|pleurectomy|pleurectomy
720466|NCT00165555|decortication|decortication
720467|NCT00165555|heated cisplatin|heated cisplatin
720468|NCT00165542|A-protein level|a-protein level
720469|NCT00165542|brain tumor|brain tumor
720470|NCT00165516|Extrapleural pneumonectomy|extrapleural pneumonectomy
720471|NCT00165516|cisplatin|cisplatin
720472|NCT00165516|heated cisplatin|heated cisplatin
720473|NCT00165503|pleurectomy|pleurectomy
720474|NCT00165503|decortication|decortication
720475|NCT00165503|cisplatin|cisplatin
720476|NCT00165503|ALIMTA|alimta
720477|NCT00165490|adenocarcinoma of esophagus|adenocarcinoma of esophagus
720478|NCT00165490|squamous cell carcinoma of esophagus|squamous cell carcinoma of esophagus
720479|NCT00165490|combination chemotherapy|combination chemotherapy
720480|NCT00165490|cisplatin|cisplatin
720481|NCT00165490|irinotecan|irinotecan
720482|NCT00165490|radiation therapy|radiation therapy
720483|NCT00165490|resectable esophageal cancer|resectable esophageal cancer
720484|NCT00165477|Glioblastoma|glioblastoma
720485|NCT00165477|Gliosarcoma|gliosarcoma
720486|NCT00165477|Malignant Gliomas|malignant gliomas
720487|NCT00165477|Radiation Therapy|radiation therapy
720488|NCT00165477|IMiD|imid
720489|NCT00165477|Lenalidomide|lenalidomide
720490|NCT00165464|Esophageal Cancer|esophageal cancer
720491|NCT00165464|Gastric Cancer|gastric cancer
720492|NCT00165464|GE Junction|ge junction
720493|NCT00165464|Cisplatin|cisplatin
720494|NCT00165464|Taxotere|taxotere
720495|NCT00165464|CPT-11|cpt-11
720496|NCT00165464|Irinotecan|irinotecan
720497|NCT00165451|Relapsed tumors|relapsed tumors
720498|NCT00165451|Progressive Poor Prognosis Tumors|progressive poor prognosis tumors
720499|NCT00165451|Thalidomide|thalidomide
720500|NCT00165451|Celecoxib|celecoxib
720501|NCT00165451|Etoposide|etoposide
720502|NCT00165451|Cyclophosphamide|cyclophosphamide
720503|NCT00165438|Pulmonary function|pulmonary function
720504|NCT00165438|Bleomycin-based chemotherapy|bleomycin-based chemotherapy
720505|NCT00165438|mediastinal irradiation|mediastinal irradiation
720506|NCT00165425|Cardiac screening|cardiac screening
720507|NCT00165425|Cardiac stress test|cardiac stress test
720508|NCT00165425|Echocardiogram|echocardiogram
720509|NCT00165412|Breast screening|breast screening
720510|NCT00165412|Breast MRI|breast mri
720511|NCT00165412|Mammogram|mammogram
720512|NCT00165412|Mammography|mammography
720513|NCT00165399|Prostate cancer|prostate cancer
720514|NCT00165399|PSA level|psa level
720515|NCT00165399|docetaxel|docetaxel
720516|NCT00165399|estramustine|estramustine
720517|NCT00165399|hormone therapy|hormone therapy
720518|NCT00165399|androgen withdrawal|androgen withdrawal
720519|NCT00165386|MRI-guided bone marrow biopsy|mri-guided bone marrow biopsy
720520|NCT00165373|pediatric solid tumors|pediatric solid tumors
720521|NCT00165373|rhEndostatin|rhendostatin
720522|NCT00165360|low-grade glioma|low-grade glioma
720523|NCT00165360|astrocytoma|astrocytoma
720524|NCT00165360|oligodendroglioma|oligodendroglioma
720525|NCT00165360|oligoastrocytoma|oligoastrocytoma
720526|NCT00165360|temozolomide|temozolomide
720527|NCT00165360|mixed oligoastrocytoma|mixed oligoastrocytoma
720528|NCT00165347|Multiple myeloma|multiple myeloma
720529|NCT00165347|PTK|ptk
720530|NCT00165347|Relapsed multiple myeloma|relapsed multiple myeloma
720531|NCT00165347|Refractory Multiple myeloma|refractory multiple myeloma
720532|NCT00165347|Myeloma|myeloma
720533|NCT00165334|Non-small cell lung cancer|non-small cell lung cancer
720534|NCT00165334|Cetuximab|cetuximab
720535|NCT00165334|Vinorelbine|vinorelbine
720536|NCT00165334|Navelbine|navelbine
720537|NCT00165334|Previously untreated lung cancer|previously untreated lung cancer
720538|NCT00165308|Hodgkin's disease|hodgkin's disease
720539|NCT00165308|breast cancer prevention|breast cancer prevention
720540|NCT00165308|tamoxifen|tamoxifen
720541|NCT00165295|sildenafil citrate|sildenafil citrate
720542|NCT00165295|Viagra|viagra
720543|NCT00165295|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
720544|NCT00165282|Meditation|meditation
720545|NCT00165282|Mindfulness meditation|mindfulness meditation
720546|NCT00165282|Bone Marrow Transplant|bone marrow transplant
720547|NCT00165282|Stem Cell Transplant|stem cell transplant
720548|NCT00165269|Hodgkin's Disease Stage IA-IIA|hodgkin's disease stage ia-iia
720549|NCT00165269|mantle irradiation|mantle irradiation
720550|NCT00165256|Ductal carcinoma in situ|ductal carcinoma in situ
720551|NCT00165256|DCIS|dcis
720552|NCT00165256|wide excision|wide excision
720553|NCT00165243|Axillary Dissection|axillary dissection
720554|NCT00165243|Tangential Radiation|tangential radiation
720555|NCT00165243|Breast Cancer|breast cancer
720556|NCT00165230|thalidomide|thalidomide
720557|NCT00165230|temodar|temodar
720558|NCT00165230|metastatic neuroendocrine tumor|metastatic neuroendocrine tumor
720559|NCT00165230|unresectable neuroendocrine tumor|unresectable neuroendocrine tumor
720560|NCT00165217|capecitabine|capecitabine
720561|NCT00165217|thalidomide|thalidomide
720562|NCT00165217|colorectal cancer|colorectal cancer
720563|NCT00165204|Tibolone|tibolone
720564|NCT00165204|High risk women|high risk women
720565|NCT00165204|Oophorectomy|oophorectomy
720566|NCT00165204|Breast Density|breast density
720567|NCT00165204|Bone Density|bone density
720568|NCT00165191|doxorubicin|doxorubicin
720569|NCT00165191|cisplatin|cisplatin
720570|NCT00165191|5-fluorouracil|5-fluorouracil
720571|NCT00165191|stomach cancer|stomach cancer
720572|NCT00165191|esophagus cancer|esophagus cancer
720573|NCT00165178|Acute lymphoblastic leukemia in children|acute lymphoblastic leukemia in children
720574|NCT00165178|High Risk ALL|high risk all
720575|NCT00165178|Standard Risk ALL|standard risk all
720576|NCT00165178|E. coli asparaginase|e. coli asparaginase
720577|NCT00165152|Genetic testing|genetic testing
720578|NCT00165152|BRCA1 gene|brca1 gene
720579|NCT00165152|BRCA2 gene|brca2 gene
720580|NCT00165152|Counseling interventions|counseling interventions
720581|NCT00165152|Genetic counseling|genetic counseling
720582|NCT00165139|Stem cell transplant|stem cell transplant
720583|NCT00165139|High-risk pediatric tumors|high-risk pediatric tumors
720584|NCT00165126|dosimetric analysis|dosimetric analysis
720585|NCT00165126|vaginal cuff brachytherapy|vaginal cuff brachytherapy
720586|NCT00165100|DAT|dat
720587|NCT00165100|imaging modality|imaging modality
720588|NCT00165087|childhood ALL|childhood all
720589|NCT00165087|standard risk|standard risk
720590|NCT00165087|high risk|high risk
720591|NCT00165087|infant/high risk|infant/high risk
720592|NCT00165074|Prematurity|prematurity
720593|NCT00165074|Lung Disease|lung disease
720594|NCT00165074|Hyaline Membrane|hyaline membrane
720595|NCT00165074|Surfactant|surfactant
720697|NCT00164411|Diptheria-Tetanus vaccine|diptheria-tetanus vaccine
720596|NCT00165035|Percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
720597|NCT00165035|Drug eluting stent (DES)|drug eluting stent (des)
720598|NCT00165009|Bleeding Peptic Ulcer|bleeding peptic ulcer
720599|NCT00165009|Endoscopic treatment|endoscopic treatment
720600|NCT00164996|upper endoscopy|upper endoscopy
720601|NCT00164996|local pharyngeal anaesthesia|local pharyngeal anaesthesia
720602|NCT00164996|ultrathin endoscope|ultrathin endoscope
720603|NCT00164944|Colonoscopy|colonoscopy
720604|NCT00164944|First degree relatives|first degree relatives
720605|NCT00164931|Peptic ulcer hemorrhage|peptic ulcer hemorrhage
720606|NCT00164931|Omeprazole|omeprazole
720607|NCT00164931|Scheduled second endoscopy|scheduled second endoscopy
720608|NCT00164905|Peptic ulcer hemorrhage|peptic ulcer hemorrhage
720609|NCT00164905|Doppler ultrasound|doppler ultrasound
720610|NCT00164879|Obstructing|obstructing
720611|NCT00164879|Left-sided|left-sided
720612|NCT00164879|Colorectal neoplasms|colorectal neoplasms
720613|NCT00164879|Obstructing left-sided colorectal cancers|obstructing left-sided colorectal cancers
720614|NCT00164866|Peptic ulcer|peptic ulcer
720615|NCT00164866|IVPPI prior endoscopy|ivppi prior endoscopy
720616|NCT00164840|GERD|gerd
720617|NCT00164788|24 hours pH monitoring|24 hours ph monitoring
720618|NCT00164775|Functional dyspepsia, refractory, antidepressant|functional dyspepsia, refractory, antidepressant
720619|NCT00164762|HIV|hiv
720620|NCT00164762|drug resistance|drug resistance
720621|NCT00164762|nevirapine|nevirapine
720622|NCT00164762|anti-retroviral drugs|anti-retroviral drugs
720623|NCT00164762|mother-to-child transmission|mother-to-child transmission
720624|NCT00164762|Treatment Naive|treatment naive
720625|NCT00164762|pregnancy|pregnancy
720626|NCT00164749|dementia|dementia
720627|NCT00164749|cognition|cognition
720628|NCT00164749|memory|memory
720629|NCT00164749|neurodegenerative disease|neurodegenerative disease
720630|NCT00164749|brain|brain
720631|NCT00164736|HIV|hiv
720632|NCT00164736|Clinical trial|clinical trial
720633|NCT00164736|breastfeeding|breastfeeding
720634|NCT00164736|mother-to-child-transmission|mother-to-child-transmission
720635|NCT00164736|nutrition|nutrition
720636|NCT00164736|HIV Seronegativity|hiv seronegativity
720637|NCT00164723|Capsule Endoscopy|capsule endoscopy
720638|NCT00164710|antimalarials|antimalarials
720639|NCT00164697|Child Development|child development
720640|NCT00164697|Parenting|parenting
720641|NCT00164697|Child Rearing|child rearing
720642|NCT00164697|Parent-Child Relations|parent-child relations
720643|NCT00164684|batterers|batterers
720644|NCT00164684|prevention|prevention
720645|NCT00164684|African American|african american
720646|NCT00164684|Latino|latino
720647|NCT00164671|Male condoms|male condoms
720648|NCT00164671|Female condoms|female condoms
720649|NCT00164671|Self-efficacy|self-efficacy
720650|NCT00164658|family history|family history
720651|NCT00164658|familial risk|familial risk
720652|NCT00164658|behavior change|behavior change
720653|NCT00164645|Emotional outcomes|emotional outcomes
720654|NCT00164645|health outcomes|health outcomes
720655|NCT00164645|traumatic brain injury|traumatic brain injury
720656|NCT00164645|caregiving|caregiving
720657|NCT00164619|controlled clinical trial|controlled clinical trial
720658|NCT00164619|behavioral intervention|behavioral intervention
720659|NCT00164619|prevention intervention|prevention intervention
720660|NCT00164606|child maltreatment|child maltreatment
720661|NCT00164606|child abuse|child abuse
720662|NCT00164606|prevention|prevention
720663|NCT00164593|Youth Violence|youth violence
720664|NCT00164593|Prevention|prevention
720665|NCT00164580|Homosexuality, Male|homosexuality, male
720666|NCT00164580|Adolescents|adolescents
720667|NCT00164580|Minority Groups|minority groups
720668|NCT00164580|Community Participation|community participation
720669|NCT00164580|Community Surveys|community surveys
720670|NCT00164580|HIV Seronegativity|hiv seronegativity
720671|NCT00164580|HIV|hiv
720672|NCT00164567|partner abuse|partner abuse
720673|NCT00164567|screening|screening
720674|NCT00164567|intimate partner violence|intimate partner violence
720675|NCT00164554|treatment|treatment
720676|NCT00164554|control|control
720677|NCT00164541|dating violence|dating violence
720678|NCT00164541|violence against women|violence against women
720679|NCT00164515|obesity, mobility limitations, women, physical activity|obesity, mobility limitations, women, physical activity
720680|NCT00164463|tuberculosis|tuberculosis
720681|NCT00164463|TB|tb
720682|NCT00164450|tuberculosis|tuberculosis
720683|NCT00164450|TB|tb
720684|NCT00164450|pharmacokinetics|pharmacokinetics
720685|NCT00164450|children|children
720686|NCT00164437|screening|screening
720687|NCT00164437|community healt education|community healt education
720688|NCT00164437|decision making|decision making
720689|NCT00164437|computer-assisted decision making|computer-assisted decision making
720690|NCT00164424|HSV2|hsv2
720691|NCT00164424|genital ulcer|genital ulcer
720692|NCT00164424|HIV|hiv
720693|NCT00164424|South Africa|south africa
720694|NCT00164424|Treatment|treatment
720695|NCT00164424|Acyclovir|acyclovir
720696|NCT00164424|Prevention|prevention
720698|NCT00164411|Pneumococcal vaccine|pneumococcal vaccine
720699|NCT00164411|Adverse events following vaccination|adverse events following vaccination
720700|NCT00164411|Immunization|immunization
720701|NCT00164411|Immunogenicity|immunogenicity
720702|NCT00164398|HIV|hiv
720703|NCT00164385|HIV/AIDS|hiv/aids
720704|NCT00164372|IV Drug users|iv drug users
720705|NCT00164372|HIV|hiv
720706|NCT00164372|hepatitis C virus|hepatitis c virus
720707|NCT00164372|HIV Seronegativity|hiv seronegativity
720708|NCT00164359|malaria, falciparum|malaria, falciparum
720709|NCT00164359|antimalarials|antimalarials
720710|NCT00164346|fetal alcohol syndrome (FAS)|fetal alcohol syndrome (fas)
720711|NCT00164346|alcohol-related neurodevelopmental disorder (ARND)|alcohol-related neurodevelopmental disorder (arnd)
720712|NCT00164281|TB|tb
720713|NCT00164281|Tuberculosis|tuberculosis
720714|NCT00164281|INH|inh
720715|NCT00164281|Isoniazid|isoniazid
720716|NCT00164281|Preventive therapy|preventive therapy
720717|NCT00164281|HIV|hiv
720718|NCT00164281|AIDS|aids
720719|NCT00164281|Botswana|botswana
720720|NCT00164281|LTBI|ltbi
720721|NCT00164281|Latent TB Infection|latent tb infection
720722|NCT00164268|Intimate partner violence|intimate partner violence
720723|NCT00164268|Sexual violence|sexual violence
720724|NCT00164268|Cultural intervention|cultural intervention
720725|NCT00164268|Native Hawaiian|native hawaiian
720726|NCT00164255|malaria|malaria
720727|NCT00164255|birthweight|birthweight
720728|NCT00164255|placental malaria|placental malaria
720729|NCT00164255|intermittent protective treatment|intermittent protective treatment
720730|NCT00164255|sulfadoxine/ pyrimethamine|sulfadoxine/ pyrimethamine
720731|NCT00164255|artesuate|artesuate
720732|NCT00164255|combination therapy|combination therapy
720733|NCT00164255|Pregnancy|pregnancy
720734|NCT00164242|Tardive dyskinesia|tardive dyskinesia
720735|NCT00164242|Galantamine|galantamine
720736|NCT00164242|Cholinesterase inhibitors|cholinesterase inhibitors
720737|NCT00164229|treatment|treatment
720738|NCT00164229|control|control
720739|NCT00164216|malaria|malaria
720740|NCT00164216|combination therapy|combination therapy
720741|NCT00164216|mefloquine|mefloquine
720742|NCT00164216|artesunate|artesunate
720743|NCT00164216|Peru|peru
720744|NCT00164216|malaria, uncomplicated|malaria, uncomplicated
720745|NCT00164190|Myocardial Infarction|myocardial infarction
720746|NCT00164190|Thrombolysis|thrombolysis
720747|NCT00164190|Angioplasty|angioplasty
720748|NCT00164190|ST Elevation Myocardial Infarction|st elevation myocardial infarction
720749|NCT00164177|virtual colonoscopy|virtual colonoscopy
720750|NCT00164177|colonoscopy preparation|colonoscopy preparation
720751|NCT00164177|bowel prep|bowel prep
720752|NCT00164164|colonoscopy preparation|colonoscopy preparation
720753|NCT00164164|prep|prep
720754|NCT00164151|colonoscopy preparation|colonoscopy preparation
720755|NCT00164151|prep|prep
720756|NCT00164138|Incontinence|incontinence
720757|NCT00164138|physiotherapy|physiotherapy
720758|NCT00164138|treatment|treatment
720759|NCT00164138|pelvic floor muscle function|pelvic floor muscle function
720760|NCT00164138|coughing|coughing
720761|NCT00164138|forced expirations|forced expirations
720762|NCT00164138|lung disease|lung disease
720763|NCT00164112|Cooperstown Cocktail|cooperstown cocktail
720764|NCT00164112|Drug Metabolizing Enzymes|drug metabolizing enzymes
720765|NCT00164112|Drug Interactions|drug interactions
720766|NCT00164112|Phenotyping|phenotyping
720767|NCT00164099|Coronary Artery Bypass|coronary artery bypass
720768|NCT00164099|Postoperative Complications|postoperative complications
720769|NCT00164099|Probiotics|probiotics
720770|NCT00164099|Surgical Wound infection|surgical wound infection
720771|NCT00164099|cystitis|cystitis
720772|NCT00164099|bacteremia|bacteremia
720773|NCT00164099|pneumonia|pneumonia
720774|NCT00164099|Enterocolitis, Pseudomembranous|enterocolitis, pseudomembranous
720775|NCT00164073|HCV and microarray|hcv and microarray
720776|NCT00164073|HCV|hcv
720777|NCT00164060|HCV|hcv
720778|NCT00164060|HIV co-infection|hiv co-infection
720779|NCT00164047|Nitrous Oxide|nitrous oxide
720780|NCT00164047|Anaesthesia|anaesthesia
720781|NCT00164047|Anesthesia|anesthesia
720782|NCT00164047|Recovery|recovery
720783|NCT00164047|Quality|quality
720784|NCT00164034|Trauma|trauma
720785|NCT00164034|Wounds|wounds
720786|NCT00164034|Injuries|injuries
720787|NCT00164021|gastroesophageal reflux, gastric reflux, acid reflux, lung transplantation, physiotherapy, anti-reflux medication|gastroesophageal reflux, gastric reflux, acid reflux, lung transplantation, physiotherapy, anti-reflux medication
720788|NCT00163995|Chronic Liver Disease|chronic liver disease
720789|NCT00163982|HVPG > 12 mmHg|hvpg > 12 mmhg
720790|NCT00163969|Pain|pain
720791|NCT00163969|Wind-up|wind-up
720792|NCT00163969|opioid|opioid
720793|NCT00163969|ketamine|ketamine
720794|NCT00163969|pre-emptive|pre-emptive
720795|NCT00163956|IVC filters|ivc filters
720796|NCT00163956|failed retrieval|failed retrieval
720797|NCT00163943|Metabolic syndrome|metabolic syndrome
720798|NCT00163943|Sympathetic nervous system activity|sympathetic nervous system activity
720799|NCT00163943|Insulin sensitivity|insulin sensitivity
720800|NCT00163943|weight loss|weight loss
720801|NCT00163943|aerobic exercise|aerobic exercise
720802|NCT00163930|Uterine Fibroids|uterine fibroids
720803|NCT00163930|embolisation|embolisation
720804|NCT00163930|pain management|pain management
720805|NCT00163917|Hypnosis|hypnosis
720806|NCT00163917|Analgesia|analgesia
720807|NCT00163904|Heart Failure|heart failure
720808|NCT00163904|Inflammatory mediators|inflammatory mediators
720809|NCT00163904|insulin sensitivity|insulin sensitivity
720810|NCT00163904|overweight|overweight
720811|NCT00163904|high monounsaturated diet|high monounsaturated diet
720812|NCT00163891|Respiratory Therapy|respiratory therapy
720813|NCT00163891|Postoperative Care|postoperative care
720814|NCT00163891|Treatment Outcome|treatment outcome
720815|NCT00163878|Sensory Stimulation Programs|sensory stimulation programs
720816|NCT00163865|Boredom|boredom
720817|NCT00163865|Adolescent|adolescent
720818|NCT00163865|Mental illness|mental illness
720819|NCT00163865|Depression|depression
720820|NCT00163865|Anxiety|anxiety
720821|NCT00163852|Cystic fibrosis|cystic fibrosis
720822|NCT00163852|Metabolic alkalosis|metabolic alkalosis
720823|NCT00163852|Hypercapnia|hypercapnia
720824|NCT00163852|Salt replacement|salt replacement
720825|NCT00163839|Dietary Intervention|dietary intervention
720826|NCT00163839|Pseudoallergen free diet|pseudoallergen free diet
720827|NCT00163826|cervical spine injury|cervical spine injury
720828|NCT00163826|multiple trauma|multiple trauma
720829|NCT00163813|Mechanically-ventilated|mechanically-ventilated
720830|NCT00163813|medical-surgical critically ill patients|medical-surgical critically ill patients
720831|NCT00163813|reduced gastric motility|reduced gastric motility
720832|NCT00163800|Outcome predictors|outcome predictors
720833|NCT00163800|Acute brain injury|acute brain injury
720834|NCT00163787|mobility|mobility
720835|NCT00163787|falls|falls
720836|NCT00163787|activity level|activity level
720837|NCT00163761|Lymphoma|lymphoma
720838|NCT00163748|Lymphoma|lymphoma
720839|NCT00163735|Food allergy|food allergy
720840|NCT00163735|wine|wine
720841|NCT00163735|milk allergy|milk allergy
720842|NCT00163735|egg allergy|egg allergy
720843|NCT00163735|nut allergy|nut allergy
720844|NCT00163735|fish allergy|fish allergy
720845|NCT00163709|Atrial natriuretic factor.|atrial natriuretic factor.
720846|NCT00163709|Biochemistry.|biochemistry.
720847|NCT00163709|Cardiac failure.|cardiac failure.
720848|NCT00163709|Randomised trials.|randomised trials.
720849|NCT00163709|Hormones.|hormones.
720850|NCT00163709|Systolic heart failure.|systolic heart failure.
720851|NCT00163709|Diastolic heart failure.|diastolic heart failure.
720852|NCT00163709|Ischaemic cardiomyopathy.|ischaemic cardiomyopathy.
720853|NCT00163709|Ventricular hypertrophy.|ventricular hypertrophy.
720854|NCT00163709|AMI|ami
720855|NCT00163696|MBNW|mbnw
720856|NCT00163696|Ventilation|ventilation
720857|NCT00163696|small airways|small airways
720858|NCT00163696|Lung Transplant recipients (Bronchiolitis Obliterans syndrome)|lung transplant recipients (bronchiolitis obliterans syndrome)
720859|NCT00163683|Dietary Intervention|dietary intervention
720860|NCT00163657|Hepatitis C Virus|hepatitis c virus
720861|NCT00163657|Immunosuppressive Agents|immunosuppressive agents
720862|NCT00163644|Hematological malignancies.|hematological malignancies.
720863|NCT00163644|Bone- marrow/ haemopoetic transplant|bone- marrow/ haemopoetic transplant
720864|NCT00163644|Exercise|exercise
720865|NCT00163618|tick-borne encephalitis|tick-borne encephalitis
720866|NCT00163605|Sinus augmentation|sinus augmentation
720867|NCT00163605|Alloplastic bone substitute|alloplastic bone substitute
720868|NCT00163605|Hydroxyl apatite|hydroxyl apatite
720869|NCT00163592|Vascular reconstruction|vascular reconstruction
720870|NCT00163592|Polytetraflouroethylene (PTFE) prosthesis|polytetraflouroethylene (ptfe) prosthesis
720871|NCT00163579|premature birth|premature birth
720872|NCT00163579|cerclage|cerclage
720873|NCT00163579|tocolysis|tocolysis
720874|NCT00163579|drug therapy|drug therapy
720875|NCT00163566|libido|libido
720876|NCT00163566|depression strength|depression strength
720877|NCT00163566|testosterone|testosterone
720878|NCT00163566|dihydrotestosterone|dihydrotestosterone
720879|NCT00163553|spinal surgery|spinal surgery
720880|NCT00163553|pethidine|pethidine
720881|NCT00163553|analgesia|analgesia
720882|NCT00163540|tick-borne encephalitis|tick-borne encephalitis
720883|NCT00163527|Asthma|asthma
720884|NCT00163527|Roflumilast|roflumilast
720885|NCT00163527|Corticosteroids|corticosteroids
720886|NCT00163514|Allergy|allergy
720887|NCT00163514|Perennial Allergic Rhinitis|perennial allergic rhinitis
720888|NCT00163514|Allergic Rhinitis|allergic rhinitis
720889|NCT00163514|Hay Fever|hay fever
720890|NCT00163501|Allergy|allergy
720891|NCT00163501|Perennial Allergic Rhinitis|perennial allergic rhinitis
720892|NCT00163501|Allergic Rhinitis|allergic rhinitis
720893|NCT00163501|Hay Fever|hay fever
720894|NCT00163488|Allergy|allergy
720895|NCT00163488|Perennial Allergic Rhinitis|perennial allergic rhinitis
720896|NCT00163488|Allergic Rhinitis|allergic rhinitis
720897|NCT00163488|Hay Fever|hay fever
720898|NCT00163475|Asthma|asthma
720899|NCT00163475|Roflumilast|roflumilast
720900|NCT00163462|Asthma|asthma
720901|NCT00163462|Ciclesonide|ciclesonide
720902|NCT00163462|Child|child
720903|NCT00163462|Fluticasone propionate|fluticasone propionate
720904|NCT00163462|Pediatric|pediatric
720905|NCT00163449|Asthma|asthma
720906|NCT00163449|Ciclesonide|ciclesonide
720907|NCT00163449|Child|child
720908|NCT00163449|Pediatric|pediatric
720909|NCT00163436|Asthma|asthma
720910|NCT00163436|Ciclesonide|ciclesonide
720911|NCT00163423|Asthma|asthma
720912|NCT00163423|Ciclesonide|ciclesonide
720913|NCT00163423|Fluticasone propionate|fluticasone propionate
720914|NCT00163410|Asthma|asthma
720915|NCT00163410|Ciclesonide|ciclesonide
720916|NCT00163410|Child|child
720917|NCT00163410|Fluticasone propionate|fluticasone propionate
720918|NCT00163410|Pediatric|pediatric
720919|NCT00163397|Asthma|asthma
720920|NCT00163397|Ciclesonide|ciclesonide
720921|NCT00163397|Budesonide|budesonide
720922|NCT00163384|Asthma|asthma
720923|NCT00163384|Ciclesonide|ciclesonide
720924|NCT00163384|Budesonide|budesonide
720925|NCT00163371|Asthma|asthma
720926|NCT00163371|Ciclesonide|ciclesonide
720927|NCT00163371|Child|child
720928|NCT00163371|Fluticasone propionate|fluticasone propionate
720929|NCT00163371|HPA-axis|hpa-axis
720930|NCT00163371|Pediatric|pediatric
720931|NCT00163371|Linear growth rate|linear growth rate
720932|NCT00163358|Asthma|asthma
720933|NCT00163358|Ciclesonide|ciclesonide
720934|NCT00163358|Fluticasone propionate|fluticasone propionate
720935|NCT00163358|Salmeterol|salmeterol
720936|NCT00163345|Asthma|asthma
720937|NCT00163345|Ciclesonide|ciclesonide
720938|NCT00163345|Small Airways|small airways
720939|NCT00163332|Asthma|asthma
720940|NCT00163332|Ciclesonide|ciclesonide
720941|NCT00163332|Fluticasone propionate|fluticasone propionate
720942|NCT00163319|Asthma|asthma
720943|NCT00163319|Ciclesonide|ciclesonide
720944|NCT00163319|Fluticasone propionate|fluticasone propionate
720945|NCT00163306|Gastroesophageal Reflux|gastroesophageal reflux
720946|NCT00163306|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
720947|NCT00163306|Pantoprazole|pantoprazole
720948|NCT00163293|Asthma|asthma
720949|NCT00163293|Ciclesonide|ciclesonide
720950|NCT00163293|Exacerbation|exacerbation
720951|NCT00163280|Mucositis|mucositis
720952|NCT00163280|Peripheral blood stem cell transplant|peripheral blood stem cell transplant
720953|NCT00163267|peripheral arterial intervention|peripheral arterial intervention
720954|NCT00163267|atherosclerosis|atherosclerosis
720955|NCT00163267|platelets|platelets
720956|NCT00163267|Age above 18|age above 18
720957|NCT00163254|Chronic limb ischemia|chronic limb ischemia
720958|NCT00163254|Intervention|intervention
720959|NCT00163254|Restenosis|restenosis
720960|NCT00163254|Patients above 18 years|patients above 18 years
720961|NCT00163228|C05.550.114.606.500|c05.550.114.606.500
720962|NCT00163228|C05.550.114.606.508|c05.550.114.606.508
720963|NCT00163176|cell proliferation|cell proliferation
720964|NCT00163176|PET|pet
720965|NCT00163176|radiotherapy|radiotherapy
720966|NCT00163124|chiropractic|chiropractic
720967|NCT00163124|spinal manipulation|spinal manipulation
720968|NCT00163124|low back pain|low back pain
720969|NCT00163072|transdermal|transdermal
720970|NCT00163072|Megace|megace
720971|NCT00163072|pharmacokinetics|pharmacokinetics
720972|NCT00163033|phase I study|phase i study
720973|NCT00163020|Preterm Birth|preterm birth
720974|NCT00163020|Preterm Delivery|preterm delivery
720975|NCT00163020|Multiple gestation|multiple gestation
720976|NCT00163020|17-alpha-hydroxyprogesterone caproate|17-alpha-hydroxyprogesterone caproate
720977|NCT00163020|Progesterone|progesterone
720978|NCT00162994|recurrent otitis media|recurrent otitis media
720979|NCT00162994|adenoidectomy|adenoidectomy
720980|NCT00162994|tympanostomy|tympanostomy
720981|NCT00162994|young children|young children
720982|NCT00162994|prevention|prevention
720983|NCT00162994|quality of life|quality of life
720984|NCT00162968|polyneuropathies|polyneuropathies
720985|NCT00162968|pain|pain
720986|NCT00162968|drug effects|drug effects
720987|NCT00162968|escitalopram|escitalopram
720988|NCT00162968|serotonin uptake inhibitors|serotonin uptake inhibitors
720989|NCT00162955|untreated adult Non-Hodgkin's Lymphoma|untreated adult non-hodgkin's lymphoma
720990|NCT00162955|CHOP protocol|chop protocol
720991|NCT00162955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
720992|NCT00162955|Cardiomyopathy|cardiomyopathy
720993|NCT00162942|Crohn's Disease|crohn's disease
720994|NCT00162929|metastatic breast cancer|metastatic breast cancer
720995|NCT00162929|locally recurrent breast cancer|locally recurrent breast cancer
720996|NCT00162916|Traumatic Brain Injury|traumatic brain injury
720997|NCT00162916|Depression|depression
720998|NCT00162916|Antidepressant medication|antidepressant medication
720999|NCT00162916|Double-Blind Study|double-blind study
721000|NCT00162916|Brain Injuries|brain injuries
721001|NCT00162916|Antidepressive Agents|antidepressive agents
721002|NCT00162916|Citalopram|citalopram
721003|NCT00162916|Double-Blind Method|double-blind method
721098|NCT00162539|foetal thyroid mensuration|foetal thyroid mensuration
721004|NCT00162903|Preterm infant, Patent ductus arteriosus, Nitric oxide,Endothelin-1|preterm infant, patent ductus arteriosus, nitric oxide,endothelin-1
721005|NCT00162890|degenerated cervical spine|degenerated cervical spine
721006|NCT00162890|assessment|assessment
721007|NCT00162890|physical therapy|physical therapy
721008|NCT00162877|rabeprazole, omeprazole, CYP2C19, H. pylori, PK/PD|rabeprazole, omeprazole, cyp2c19, h. pylori, pk/pd
721009|NCT00162864|asthma|asthma
721010|NCT00162864|COPD|copd
721011|NCT00162864|montelukast sodium|montelukast sodium
721012|NCT00162864|leukotriene modifier|leukotriene modifier
721013|NCT00162864|older adults|older adults
721014|NCT00162825|Psoriasis, T cell, inflammation, CD7, cytokine|psoriasis, t cell, inflammation, cd7, cytokine
721015|NCT00162812|neoadjuvant chemotherapy|neoadjuvant chemotherapy
721016|NCT00162812|early breast cancer|early breast cancer
721017|NCT00162812|inflammatory breast cancer|inflammatory breast cancer
721018|NCT00162799|insulin resistance and inflamation|insulin resistance and inflamation
721019|NCT00162799|insulin sensitibity|insulin sensitibity
721020|NCT00162799|obesity-induced insuline resistence|obesity-induced insuline resistence
721021|NCT00162799|obesity-diabetes link|obesity-diabetes link
721022|NCT00162799|salicylate|salicylate
721023|NCT00162799|insulin resistance in obesity health adults|insulin resistance in obesity health adults
721024|NCT00162786|Driving performance|driving performance
721025|NCT00162786|Antihistamine|antihistamine
721026|NCT00162773|asthma|asthma
721027|NCT00162747|Pre-term infants|pre-term infants
721028|NCT00162747|skin infections|skin infections
721029|NCT00162747|infant skin|infant skin
721030|NCT00162747|Aquaphor|aquaphor
721031|NCT00162747|sunflower seed oil|sunflower seed oil
721032|NCT00162747|nutrition|nutrition
721033|NCT00162747|skin care|skin care
721034|NCT00162734|Chronic Hepatitis C|chronic hepatitis c
721035|NCT00162734|Liver|liver
721036|NCT00162734|Pegylated|pegylated
721037|NCT00162734|Interferon|interferon
721038|NCT00162734|Alpha|alpha
721039|NCT00162734|Ribavirin|ribavirin
721040|NCT00162734|Combination|combination
721041|NCT00162734|Nonresponder|nonresponder
721042|NCT00162734|HCV|hcv
721043|NCT00162734|Infergen|infergen
721044|NCT00162734|SVR|svr
721045|NCT00162721|Uterine sarcoma non metastatic|uterine sarcoma non metastatic
721046|NCT00162708|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
721047|NCT00162708|Radiotherapy|radiotherapy
721048|NCT00162708|Chemotherapy|chemotherapy
721049|NCT00162682|HIV|hiv
721050|NCT00162682|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
721051|NCT00162682|Monitoring|monitoring
721052|NCT00162682|Viral load|viral load
721053|NCT00162682|CD4|cd4
721054|NCT00162682|Thailand|thailand
721055|NCT00162682|Future Drug Options|future drug options
721056|NCT00162682|Resistance|resistance
721057|NCT00162682|Developing Country|developing country
721058|NCT00162682|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
721059|NCT00162669|Hepatocellular carcinoma, advanced, bevacizumab, phase II, VGEF, neovascularization|hepatocellular carcinoma, advanced, bevacizumab, phase ii, vgef, neovascularization
721060|NCT00162656|B-Cell Lymphoma|b-cell lymphoma
721061|NCT00162643|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
721062|NCT00162643|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
721063|NCT00162643|Protease Inhibitors|protease inhibitors
721064|NCT00162643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
721065|NCT00162630|Hip fracture, pain, regional anaesthesia, analgesia|hip fracture, pain, regional anaesthesia, analgesia
721066|NCT00162617|Hip fracture|hip fracture
721067|NCT00162617|Rehabilitation|rehabilitation
721068|NCT00162617|Transfusion|transfusion
721069|NCT00162617|Outcome|outcome
721070|NCT00162604|Prophylactic antibiotic|prophylactic antibiotic
721071|NCT00162604|Postoperative infections|postoperative infections
721072|NCT00162604|Uterine prolapse grade I - II|uterine prolapse grade i - ii
721073|NCT00162604|cystocele|cystocele
721074|NCT00162604|rectocele|rectocele
721075|NCT00162604|enterocele|enterocele
721076|NCT00162604|defects of the perineal body|defects of the perineal body
721077|NCT00162591|Bispectral index|bispectral index
721078|NCT00162591|sedation|sedation
721079|NCT00162591|remifentanyl|remifentanyl
721080|NCT00162591|Bronchoalveolar lavage|bronchoalveolar lavage
721081|NCT00162591|Intensive care|intensive care
721082|NCT00162591|Nociceptive stimuli|nociceptive stimuli
721083|NCT00162591|Sedated patient|sedated patient
721084|NCT00162591|BIS variation|bis variation
721085|NCT00162578|pneumococcal meningitis|pneumococcal meningitis
721086|NCT00162578|intensive care unit|intensive care unit
721087|NCT00162578|vancomycin|vancomycin
721088|NCT00162578|dexamethasone|dexamethasone
721089|NCT00162578|drug diffusion in cerebrospinal fluid|drug diffusion in cerebrospinal fluid
721090|NCT00162565|Heart Failure, Congestive|heart failure, congestive
721091|NCT00162565|beta-Adrenergic Blockers|beta-adrenergic blockers
721092|NCT00162552|multicenter-randomized-trial|multicenter-randomized-trial
721093|NCT00162552|pentoxifyllinE|pentoxifylline
721094|NCT00162552|placebo|placebo
721095|NCT00162552|cirrhosis|cirrhosis
721096|NCT00162552|liver failure|liver failure
721097|NCT00162552|cytokine|cytokine
721099|NCT00162500|Metastatic solid tumors|metastatic solid tumors
721100|NCT00162474|Healthy Volunteers|healthy volunteers
721101|NCT00162461|Healthy Volunteers|healthy volunteers
721102|NCT00162448|Patients requiring dual-chamber pacemakers or defibrillators|patients requiring dual-chamber pacemakers or defibrillators
721103|NCT00162396|Albuterol|albuterol
721104|NCT00162396|β2 Adrenergic receptor|β2 adrenergic receptor
721105|NCT00162396|Polymorphism|polymorphism
721106|NCT00162240|Metabolics Diabetes New Onset|metabolics diabetes new onset
721107|NCT00162214|Advanced Solid Tumors|advanced solid tumors
721108|NCT00162123|ipilimumab|ipilimumab
721109|NCT00162123|previously treated|previously treated
721110|NCT00162019|Factor VIII Deficiency|factor viii deficiency
721111|NCT00162006|Chronic idiopathic thrombocytopenic purpura|chronic idiopathic thrombocytopenic purpura
721112|NCT00161993|Gammaglobulin|gammaglobulin
721113|NCT00161980|Axillary wound|axillary wound
721114|NCT00161980|Seroma|seroma
721115|NCT00161980|Fistulae|fistulae
721116|NCT00161967|tick-borne encephalitis|tick-borne encephalitis
721117|NCT00161954|Tick-Borne Encephalitis|tick-borne encephalitis
721118|NCT00161941|Meningococcal Vaccine|meningococcal vaccine
721119|NCT00161941|Meningococcal Meningitis, Serogroup C|meningococcal meningitis, serogroup c
721120|NCT00161941|Neisseria Meningitidis|neisseria meningitidis
721121|NCT00161928|Meningococcal Vaccine|meningococcal vaccine
721122|NCT00161928|Meningococcal Meningitis, Serogroup C|meningococcal meningitis, serogroup c
721123|NCT00161928|Neisseria Meningitidis|neisseria meningitidis
721124|NCT00161915|Liver cirrhosis|liver cirrhosis
721125|NCT00161902|Arthroplasty|arthroplasty
721126|NCT00161902|Hip Prosthesis|hip prosthesis
721127|NCT00161902|Cement Free Hip Prosthesis|cement free hip prosthesis
721128|NCT00161902|Femur Head Necrosis|femur head necrosis
721129|NCT00161902|Coxarthrosis|coxarthrosis
721130|NCT00161876|tick-borne encephalitis|tick-borne encephalitis
721131|NCT00161837|Influenza|influenza
721132|NCT00161837|Vaccine|vaccine
721133|NCT00161746|Tick-Borne Encephalitis|tick-borne encephalitis
721134|NCT00161733|Cardiopulmonary bypass|cardiopulmonary bypass
721135|NCT00161733|Median sternotomy|median sternotomy
721136|NCT00161733|Fibrin sealant|fibrin sealant
721137|NCT00161733|Clot|clot
721138|NCT00161733|Cardiac surgery|cardiac surgery
721139|NCT00161720|Severe Congenital Protein C Deficiency|severe congenital protein c deficiency
721140|NCT00161694|pain control|pain control
721141|NCT00161681|Levonorgestrel|levonorgestrel
721142|NCT00161681|ethinyl estradiol|ethinyl estradiol
721143|NCT00161681|premenstrual syndrome|premenstrual syndrome
721144|NCT00161681|menstrual cycle related symptoms|menstrual cycle related symptoms
721145|NCT00161668|Leukemia|leukemia
721146|NCT00161655|Psoriasis|psoriasis
721147|NCT00161655|Arthritis|arthritis
721148|NCT00161642|Malignant Tumors|malignant tumors
721149|NCT00161629|Distal Radius Fractures|distal radius fractures
721150|NCT00161616|Open Diaphyseal Tibia Fractures|open diaphyseal tibia fractures
721151|NCT00161603|Angioplasty|angioplasty
721152|NCT00161603|Behavior change|behavior change
721153|NCT00161603|Physical activity|physical activity
721154|NCT00161603|Risk reduction|risk reduction
721155|NCT00161590|NK cell lymphoma|nk cell lymphoma
721156|NCT00161590|Null cell lymphoma|null cell lymphoma
721157|NCT00161577|Ketorolac|ketorolac
721158|NCT00161564|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
721160|NCT00161564|Non-Malignant Hematology|non-malignant hematology
721161|NCT00161551|Cardiac Pacing, artificial|cardiac pacing, artificial
721162|NCT00161551|Atrial Fibrillation|atrial fibrillation
721163|NCT00161551|Heart Failure|heart failure
721164|NCT00161551|Pacemaker leads|pacemaker leads
721165|NCT00161551|Pacing Mode|pacing mode
721166|NCT00161538|Cardiac Pacing, artificial|cardiac pacing, artificial
721167|NCT00161538|Atrial fibrillation|atrial fibrillation
721168|NCT00161538|Pacemaker leads|pacemaker leads
721169|NCT00161538|Lead positions|lead positions
721170|NCT00161525|Subretinal Hemorrhage, Perfluorocarbon gas|subretinal hemorrhage, perfluorocarbon gas
721171|NCT00161486|Male contraception|male contraception
721172|NCT00161486|Prostate|prostate
721173|NCT00161486|Acyline|acyline
721174|NCT00161486|Androgen replacement|androgen replacement
721175|NCT00161473|double-blind|double-blind
721176|NCT00161473|treatment|treatment
721177|NCT00161473|prazosin|prazosin
721178|NCT00161460|Colorectal cancer|colorectal cancer
721179|NCT00161460|Mass screening|mass screening
721180|NCT00161447|Male contraception|male contraception
721181|NCT00161447|testosterone|testosterone
721182|NCT00161447|acyline|acyline
721183|NCT00161434|HIV-1|hiv-1
721184|NCT00161421|Male Contraception|male contraception
721185|NCT00161421|Testosterone|testosterone
721186|NCT00161421|Hypogonadism|hypogonadism
721187|NCT00161408|schizophrenia, first episode, cognitive behavioural therapy, psychoeducation|schizophrenia, first episode, cognitive behavioural therapy, psychoeducation
721188|NCT00161395|fertility|fertility
721189|NCT00161395|pregnancy|pregnancy
721190|NCT00161382|HIV Seronegativity|hiv seronegativity
721191|NCT00161382|HIV|hiv
721192|NCT00161369|homocysteine|homocysteine
721193|NCT00161369|asymmetric dimethylarginine|asymmetric dimethylarginine
721194|NCT00161369|atherosclerosis|atherosclerosis
721195|NCT00161369|cardiovascular event|cardiovascular event
721196|NCT00161369|hemodialysis|hemodialysis
721197|NCT00161343|HIV|hiv
721198|NCT00161343|Prevention Intervention|prevention intervention
721199|NCT00161343|Female|female
721200|NCT00161343|Adolescents|adolescents
721201|NCT00161343|STD|std
721202|NCT00161343|HIV Seronegativity|hiv seronegativity
721203|NCT00161330|urinary tract infection,|urinary tract infection,
721204|NCT00161330|antibiotic treatment|antibiotic treatment
721205|NCT00161330|childhood|childhood
721206|NCT00161330|amoxicilline/clavulanic acid|amoxicilline/clavulanic acid
721207|NCT00161330|ceftriaxone|ceftriaxone
721208|NCT00161330|renal ultrasonography|renal ultrasonography
721209|NCT00161330|renal scintigraphy|renal scintigraphy
721210|NCT00161291|Carcinoma of the breast|carcinoma of the breast
721211|NCT00161291|Breast cancer|breast cancer
721212|NCT00161252|Prostate Cancer|prostate cancer
721213|NCT00161239|T-Cell Lymphomas|t-cell lymphomas
721214|NCT00161226|endometrial cancer|endometrial cancer
721215|NCT00161213|recurrent pancreatic cancer|recurrent pancreatic cancer
721216|NCT00161213|stage IV pancreatic cancer|stage iv pancreatic cancer
721217|NCT00161213|stage III pancreatic cancer|stage iii pancreatic cancer
721218|NCT00161213|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
721219|NCT00161213|stage II pancreatic cancer|stage ii pancreatic cancer
721220|NCT00161200|Esophageal Metaplasia|esophageal metaplasia
721221|NCT00161187|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
721222|NCT00161187|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
721223|NCT00161187|prolymphocytic leukemia|prolymphocytic leukemia
721224|NCT00161187|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
721225|NCT00161187|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
721226|NCT00161187|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
721227|NCT00161187|splenic marginal zone lymphoma|splenic marginal zone lymphoma
721228|NCT00161187|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
721229|NCT00161187|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
721230|NCT00161187|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
721231|NCT00161187|stage I multiple myeloma|stage i multiple myeloma
721232|NCT00161187|stage II multiple myeloma|stage ii multiple myeloma
721233|NCT00161187|stage III multiple myeloma|stage iii multiple myeloma
721234|NCT00161187|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
721235|NCT00161187|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
721236|NCT00161187|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
721237|NCT00161187|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
721238|NCT00161187|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
721239|NCT00161187|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
721240|NCT00161187|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
721241|NCT00161187|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
721242|NCT00161187|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
721243|NCT00161187|anaplastic large cell lymphoma|anaplastic large cell lymphoma
721244|NCT00161187|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
721245|NCT00161187|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
721246|NCT00161187|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
721247|NCT00161187|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
721248|NCT00161187|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
721249|NCT00161187|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
721250|NCT00161187|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
721251|NCT00161187|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
721252|NCT00161187|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
721253|NCT00161187|recurrent renal cell cancer|recurrent renal cell cancer
721254|NCT00161187|stage IV renal cell cancer|stage iv renal cell cancer
721255|NCT00161187|recurrent bladder cancer|recurrent bladder cancer
721256|NCT00161187|stage IV bladder cancer|stage iv bladder cancer
721257|NCT00161187|recurrent prostate cancer|recurrent prostate cancer
721258|NCT00161187|stage IV prostate cancer|stage iv prostate cancer
721259|NCT00161187|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
721260|NCT00161187|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
721261|NCT00161187|recurrent gastric cancer|recurrent gastric cancer
721262|NCT00161187|stage IV gastric cancer|stage iv gastric cancer
721263|NCT00161187|recurrent pancreatic cancer|recurrent pancreatic cancer
721264|NCT00161187|stage IV pancreatic cancer|stage iv pancreatic cancer
721265|NCT00161187|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
721266|NCT00161187|recurrent adult primary liver cancer|recurrent adult primary liver cancer
721267|NCT00161187|recurrent childhood liver cancer|recurrent childhood liver cancer
721268|NCT00161187|recurrent colon cancer|recurrent colon cancer
721269|NCT00161187|stage IV colon cancer|stage iv colon cancer
721270|NCT00161187|recurrent rectal cancer|recurrent rectal cancer
721271|NCT00161187|stage IV rectal cancer|stage iv rectal cancer
721272|NCT00161187|recurrent breast cancer|recurrent breast cancer
721273|NCT00161187|stage IV breast cancer|stage iv breast cancer
721274|NCT00161187|extensive stage small cell lung cancer|extensive stage small cell lung cancer
721275|NCT00161187|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
721276|NCT00161187|recurrent small cell lung cancer|recurrent small cell lung cancer
721277|NCT00161187|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
721278|NCT00161187|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
721279|NCT00161187|recurrent cervical cancer|recurrent cervical cancer
721280|NCT00161187|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
721281|NCT00161187|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
721282|NCT00161187|chondrosarcoma|chondrosarcoma
721283|NCT00161187|recurrent osteosarcoma|recurrent osteosarcoma
721284|NCT00161187|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
721285|NCT00161187|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
721286|NCT00161187|ovarian sarcoma|ovarian sarcoma
721287|NCT00161187|recurrent uterine sarcoma|recurrent uterine sarcoma
721288|NCT00161187|stage IV uterine sarcoma|stage iv uterine sarcoma
721289|NCT00161187|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
721290|NCT00161187|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
721291|NCT00161187|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
721292|NCT00161187|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
721293|NCT00161187|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
721294|NCT00161187|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
721295|NCT00161187|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
721296|NCT00161187|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
721297|NCT00161187|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
721298|NCT00161187|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
721299|NCT00161187|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
721300|NCT00161187|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
721301|NCT00161187|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
721302|NCT00161187|advanced adult primary liver cancer|advanced adult primary liver cancer
721303|NCT00161187|ovarian stromal cancer|ovarian stromal cancer
721304|NCT00161187|stage IA cervical cancer|stage ia cervical cancer
721305|NCT00161187|stage IB cervical cancer|stage ib cervical cancer
721306|NCT00161187|stage IIA cervical cancer|stage iia cervical cancer
721307|NCT00161187|stage IIB cervical cancer|stage iib cervical cancer
721308|NCT00161187|stage III cervical cancer|stage iii cervical cancer
721309|NCT00161187|stage IVA cervical cancer|stage iva cervical cancer
721310|NCT00161187|stage IVB cervical cancer|stage ivb cervical cancer
721311|NCT00161187|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
721312|NCT00161187|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
721313|NCT00161187|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
721314|NCT00161187|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
721315|NCT00161187|recurrent endometrial carcinoma|recurrent endometrial carcinoma
721316|NCT00161187|stage I endometrial carcinoma|stage i endometrial carcinoma
721317|NCT00161187|stage II endometrial carcinoma|stage ii endometrial carcinoma
721318|NCT00161187|stage III endometrial carcinoma|stage iii endometrial carcinoma
721319|NCT00161187|stage IV endometrial carcinoma|stage iv endometrial carcinoma
721320|NCT00161187|childhood hepatocellular carcinoma|childhood hepatocellular carcinoma
721321|NCT00161187|stage III childhood liver cancer|stage iii childhood liver cancer
721322|NCT00161187|stage IV childhood liver cancer|stage iv childhood liver cancer
721323|NCT00161187|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
721324|NCT00161187|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
721325|NCT00161187|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
721326|NCT00161187|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
721327|NCT00161187|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
721328|NCT00161187|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
721329|NCT00161187|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
721330|NCT00161187|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
721331|NCT00161187|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
721332|NCT00161187|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
721333|NCT00161187|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
721334|NCT00161187|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
721335|NCT00161187|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
721336|NCT00161187|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
721337|NCT00161187|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
721767|NCT00159432|colorectal|colorectal
721338|NCT00161187|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
721339|NCT00161187|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
721340|NCT00161187|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
721341|NCT00161187|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
721342|NCT00161187|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
721343|NCT00161187|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
721344|NCT00161187|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
721345|NCT00161187|stage I marginal zone lymphoma|stage i marginal zone lymphoma
721346|NCT00161187|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
721347|NCT00161187|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
721348|NCT00161187|localized osteosarcoma|localized osteosarcoma
721349|NCT00161187|metastatic osteosarcoma|metastatic osteosarcoma
721350|NCT00161187|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
721351|NCT00161187|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
721352|NCT00161187|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
721353|NCT00161187|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
721354|NCT00161187|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
721355|NCT00161187|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
721356|NCT00161187|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
721357|NCT00161187|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
721358|NCT00161187|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
721359|NCT00161187|limited stage small cell lung cancer|limited stage small cell lung cancer
721360|NCT00161187|refractory multiple myeloma|refractory multiple myeloma
721361|NCT00161187|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
721362|NCT00161187|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
721363|NCT00161187|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
721364|NCT00161187|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
721365|NCT00161187|stage I bladder cancer|stage i bladder cancer
721366|NCT00161187|stage II bladder cancer|stage ii bladder cancer
721367|NCT00161187|stage III bladder cancer|stage iii bladder cancer
721368|NCT00161187|male breast cancer|male breast cancer
721369|NCT00161187|stage I breast cancer|stage i breast cancer
721370|NCT00161187|stage II breast cancer|stage ii breast cancer
721371|NCT00161187|stage IIIA breast cancer|stage iiia breast cancer
721372|NCT00161187|stage IIIB breast cancer|stage iiib breast cancer
721373|NCT00161187|stage IIIC breast cancer|stage iiic breast cancer
721374|NCT00161187|stage I colon cancer|stage i colon cancer
721375|NCT00161187|stage II colon cancer|stage ii colon cancer
721376|NCT00161187|stage III colon cancer|stage iii colon cancer
721377|NCT00161187|stage I gastric cancer|stage i gastric cancer
721378|NCT00161187|stage II gastric cancer|stage ii gastric cancer
721379|NCT00161187|stage III gastric cancer|stage iii gastric cancer
721380|NCT00161187|stage I non-small cell lung cancer|stage i non-small cell lung cancer
721381|NCT00161187|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
721382|NCT00161187|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
721383|NCT00161187|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
721384|NCT00161187|stage I pancreatic cancer|stage i pancreatic cancer
721385|NCT00161187|stage II pancreatic cancer|stage ii pancreatic cancer
721386|NCT00161187|stage III pancreatic cancer|stage iii pancreatic cancer
721387|NCT00161187|stage I prostate cancer|stage i prostate cancer
721388|NCT00161187|stage II prostate cancer|stage ii prostate cancer
721389|NCT00161187|stage III prostate cancer|stage iii prostate cancer
721390|NCT00161187|stage I rectal cancer|stage i rectal cancer
721391|NCT00161187|stage II rectal cancer|stage ii rectal cancer
721392|NCT00161187|stage III rectal cancer|stage iii rectal cancer
721393|NCT00161187|stage I renal cell cancer|stage i renal cell cancer
721394|NCT00161187|stage II renal cell cancer|stage ii renal cell cancer
721395|NCT00161187|stage III renal cell cancer|stage iii renal cell cancer
721396|NCT00161187|stage I uterine sarcoma|stage i uterine sarcoma
721397|NCT00161187|stage II uterine sarcoma|stage ii uterine sarcoma
721398|NCT00161187|stage III uterine sarcoma|stage iii uterine sarcoma
721399|NCT00161187|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
721400|NCT00161187|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
721401|NCT00161187|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
721402|NCT00161187|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
721403|NCT00161187|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
721404|NCT00161187|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
721405|NCT00161187|stage I mantle cell lymphoma|stage i mantle cell lymphoma
721406|NCT00161187|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
721407|NCT00161187|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
721408|NCT00161187|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
721409|NCT00161187|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
721410|NCT00161187|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
721411|NCT00161187|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
721412|NCT00161187|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
721413|NCT00161187|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
721414|NCT00161187|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
721415|NCT00161187|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
721416|NCT00161187|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
721417|NCT00161187|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
721418|NCT00161187|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
721419|NCT00161187|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
721420|NCT00161187|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
721421|NCT00161187|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
721422|NCT00161187|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
721423|NCT00161187|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
721424|NCT00161187|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
721425|NCT00161187|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
721426|NCT00161187|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
721427|NCT00161187|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
721428|NCT00161187|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
721429|NCT00161187|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
721430|NCT00161187|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
721431|NCT00161187|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
721432|NCT00161187|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
721433|NCT00161187|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
721434|NCT00161187|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
721435|NCT00161187|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
721436|NCT00161187|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
721437|NCT00161187|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
721438|NCT00161187|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
721439|NCT00161187|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
721440|NCT00161187|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
721441|NCT00161187|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
721442|NCT00161187|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
721443|NCT00161187|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
721444|NCT00161187|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
721445|NCT00161187|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
721446|NCT00161187|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
721447|NCT00161187|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
721448|NCT00161187|Burkitt lymphoma|burkitt lymphoma
721449|NCT00161187|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
721450|NCT00161187|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
721451|NCT00161187|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
721452|NCT00161187|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
721453|NCT00161187|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
721454|NCT00161187|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
721455|NCT00161187|childhood renal cell carcinoma|childhood renal cell carcinoma
721456|NCT00161187|stage IA melanoma|stage ia melanoma
721457|NCT00161187|stage IB melanoma|stage ib melanoma
721458|NCT00161187|stage IIA melanoma|stage iia melanoma
721459|NCT00161187|stage IIB melanoma|stage iib melanoma
721460|NCT00161187|stage IIC melanoma|stage iic melanoma
721461|NCT00161187|stage IIIA melanoma|stage iiia melanoma
721462|NCT00161187|stage IIIB melanoma|stage iiib melanoma
721463|NCT00161187|stage IIIC melanoma|stage iiic melanoma
721464|NCT00161187|stage IV melanoma|stage iv melanoma
721465|NCT00161187|recurrent melanoma|recurrent melanoma
721466|NCT00161174|testicular cancer|testicular cancer
721467|NCT00161174|cardiovascular morbidity|cardiovascular morbidity
721468|NCT00161174|cardiovascular risk factors|cardiovascular risk factors
721469|NCT00161174|pharmacogenomic determinants|pharmacogenomic determinants
721470|NCT00161161|ADHD; MRI; genetics|adhd; mri; genetics
721471|NCT00161148|PSC|psc
721472|NCT00161148|Liver biochemistry|liver biochemistry
721473|NCT00161148|Probiotics|probiotics
721474|NCT00161148|Pruritus|pruritus
721475|NCT00161135|MRI|mri
721476|NCT00161135|PDD-NOS, MCDD|pdd-nos, mcdd
721477|NCT00161109|22q11.2 deletion syndrome|22q11.2 deletion syndrome
721478|NCT00161109|Psychopathology|psychopathology
721479|NCT00161109|Psychiatry|psychiatry
721480|NCT00161109|Neuropsychology|neuropsychology
721481|NCT00161109|Psychiophysiology|psychiophysiology
721482|NCT00161109|Autism|autism
721483|NCT00161109|Psychosis|psychosis
721484|NCT00161109|Deletion size|deletion size
721485|NCT00161109|Candidate genes|candidate genes
721486|NCT00161109|Psychiatric symptoms|psychiatric symptoms
721487|NCT00161109|Neuropsychological impairments|neuropsychological impairments
721488|NCT00161109|Psychophysiological performance|psychophysiological performance
721489|NCT00161096|on-demand therapy|on-demand therapy
721490|NCT00161096|pantoprazole|pantoprazole
721491|NCT00161096|gastro-oesophageal reflux disease|gastro-oesophageal reflux disease
721492|NCT00161096|proton pump inhibitor|proton pump inhibitor
721493|NCT00161096|acid suppression|acid suppression
721494|NCT00161096|intermittent|intermittent
721495|NCT00161083|ursodeoxycholic acid|ursodeoxycholic acid
721496|NCT00161083|gallstone|gallstone
721497|NCT00161083|complications|complications
721498|NCT00161083|pancreatitis|pancreatitis
721499|NCT00161083|gallbladder motility|gallbladder motility
721500|NCT00161083|colic|colic
721501|NCT00161070|secondary prevention|secondary prevention
721502|NCT00161070|TIA / minor stroke|tia / minor stroke
721503|NCT00161070|atherosclerotic origin|atherosclerotic origin
721504|NCT00161070|TIA (Transient Ischemic Attack)|tia (transient ischemic attack)
721505|NCT00161070|prevention & control|prevention & control
721506|NCT00161057|Schizophrenia|schizophrenia
721507|NCT00161057|Medication-naive|medication-naive
721508|NCT00161057|Functional MRI|functional mri
721509|NCT00161057|Working memory|working memory
721510|NCT00161057|Language lateralization|language lateralization
721511|NCT00161057|schizoaffective disorder|schizoaffective disorder
721512|NCT00161057|psychotic disorder Not Otherwise Specified|psychotic disorder not otherwise specified
721513|NCT00161005|Acute myocardial infarction|acute myocardial infarction
721514|NCT00161005|Fibrinolysis|fibrinolysis
721515|NCT00161005|Health effects /Quality of life|health effects /quality of life
721516|NCT00160992|Adoptive cell transfer|adoptive cell transfer
721517|NCT00160992|peptide vaccination|peptide vaccination
721518|NCT00160992|melanoma|melanoma
721519|NCT00160992|immunosuppression and homeostatic proliferation|immunosuppression and homeostatic proliferation
721520|NCT00160966|kidney transplantation|kidney transplantation
721521|NCT00160966|polyoma virus associated transplant nephropathy|polyoma virus associated transplant nephropathy
721522|NCT00160966|tacrolimus|tacrolimus
721523|NCT00160966|mycophenolate mofetil|mycophenolate mofetil
721524|NCT00160966|everolimus|everolimus
721525|NCT00160966|cyclosporin A|cyclosporin a
721526|NCT00160966|BK virus PCR|bk virus pcr
721527|NCT00160966|viruria screening|viruria screening
721528|NCT00160966|BK polyomavirus|bk polyomavirus
721529|NCT00160966|immunosuppression|immunosuppression
721530|NCT00160940|gene expression|gene expression
721531|NCT00160940|viral hepatitis|viral hepatitis
721532|NCT00160940|autoimmune disease|autoimmune disease
721533|NCT00160927|microcirculation|microcirculation
721534|NCT00160927|Laser doppler flowmetry|laser doppler flowmetry
721535|NCT00160927|neuropathy|neuropathy
721536|NCT00160927|endothelial function|endothelial function
721537|NCT00160914|Childhood obesity|childhood obesity
721538|NCT00160901|Breast cancer|breast cancer
721539|NCT00160901|Chemotherapy|chemotherapy
721540|NCT00160901|Phytotherapy|phytotherapy
721541|NCT00160901|Nutritional counseling|nutritional counseling
721542|NCT00160875|esophageal|esophageal
721543|NCT00160875|esophagus|esophagus
721544|NCT00160875|irinotecan|irinotecan
721545|NCT00160875|CPT11|cpt11
721546|NCT00160875|cisplatin|cisplatin
721547|NCT00160849|Treatment Experienced|treatment experienced
721548|NCT00160836|Tissue diagnosis|tissue diagnosis
721549|NCT00160823|Colon cleansing|colon cleansing
721550|NCT00160823|Quality|quality
721551|NCT00160823|Cost-effectiveness|cost-effectiveness
721552|NCT00160810|distal|distal
721553|NCT00160810|radius|radius
721554|NCT00160810|fractures|fractures
721555|NCT00160745|endothelium, NO, renal, statins|endothelium, no, renal, statins
721556|NCT00160732|Islet Cell Transplant|islet cell transplant
721557|NCT00160732|Human islet cell infusion|human islet cell infusion
721558|NCT00160732|Juvenile-onset diabetes|juvenile-onset diabetes
721559|NCT00160693|Rheumatoid Arthritis|rheumatoid arthritis
721560|NCT00160693|America College of Rheumatology|america college of rheumatology
721561|NCT00160693|Disease modifying anti-rheumatic drug|disease modifying anti-rheumatic drug
721562|NCT00160693|Certolizumab Pegol (CDP870)|certolizumab pegol (cdp870)
721563|NCT00160680|Persistent Allergic Rhinitis, HDM, Parietaria, sneezing, rhinorrhea, ocular pruritus, Rhinasthma, inflammatory cells, ICAM-1, ATAREAL, Xyzal, Levocetirizine|persistent allergic rhinitis, hdm, parietaria, sneezing, rhinorrhea, ocular pruritus, rhinasthma, inflammatory cells, icam-1, atareal, xyzal, levocetirizine
721564|NCT00160667|Post-herpetic Neuralgia (PHN)|post-herpetic neuralgia (phn)
721565|NCT00160667|Brivaracetam|brivaracetam
721566|NCT00160654|Epilepsy|epilepsy
721567|NCT00160654|Partial Onset Seizures|partial onset seizures
721568|NCT00160654|Keppra|keppra
721569|NCT00160654|Levetiracetam|levetiracetam
721570|NCT00160641|Rheumatoid Arthritis|rheumatoid arthritis
721571|NCT00160641|CDP870|cdp870
721572|NCT00160641|Certolizumab Pegol|certolizumab pegol
721573|NCT00160641|Cimzia|cimzia
721574|NCT00160628|Epilepsy|epilepsy
721575|NCT00160628|Partial Onset Seizures|partial onset seizures
721576|NCT00160628|Keppra|keppra
721577|NCT00160628|Levetiracetam|levetiracetam
721578|NCT00160615|Epilepsy, Partial,|epilepsy, partial,
721579|NCT00160615|Keppra, levetiracetam|keppra, levetiracetam
721580|NCT00160602|Rheumatoid Arthritis|rheumatoid arthritis
721581|NCT00160602|Certolizumab Pegol, Cimzia|certolizumab pegol, cimzia
721582|NCT00160589|Allergic Rhinits, Symptoms (sneezing, rhinorrhea, nasal/ocular pruritus, nasal congestion), LEADER, Xyzal, Levocetirizine|allergic rhinits, symptoms (sneezing, rhinorrhea, nasal/ocular pruritus, nasal congestion), leader, xyzal, levocetirizine
721583|NCT00160576|Idiopathic Parkinson's Disease, levodopa induced dyskinesia,|idiopathic parkinson's disease, levodopa induced dyskinesia,
721584|NCT00160576|Levetiracetam, Keppra|levetiracetam, keppra
721585|NCT00160563|Pediatry|pediatry
721586|NCT00160563|EPAAC|epaac
721587|NCT00160563|atopic Children|atopic children
721588|NCT00160563|prevention of asthma|prevention of asthma
721589|NCT00160563|Levocetirizine|levocetirizine
721591|NCT00160550|Idiopathic Generalized Epilepsy, tonic-clonic seizures|idiopathic generalized epilepsy, tonic-clonic seizures
721592|NCT00160550|Levetiracetam, Keppra|levetiracetam, keppra
721593|NCT00160537|Seasonal Allergic Rhinitis (SAR), Grass pollen, SAR Symptoms (sneezing, rhinorrhea, nasal / ocular pruritus, nasal congestion)|seasonal allergic rhinitis (sar), grass pollen, sar symptoms (sneezing, rhinorrhea, nasal / ocular pruritus, nasal congestion)
721594|NCT00160537|POPULAR, Xyzal, Levocetirizine|popular, xyzal, levocetirizine
721595|NCT00160524|Certolizumab Pegol|certolizumab pegol
721596|NCT00160524|Cimzia|cimzia
721597|NCT00160524|CDP870|cdp870
721598|NCT00160524|CZP|czp
721599|NCT00160511|Postherpetic Neuralgia (PHN)|postherpetic neuralgia (phn)
721600|NCT00160511|Levetiracetam|levetiracetam
721601|NCT00160511|Keppra|keppra
721602|NCT00160511|Nerve Pain|nerve pain
721603|NCT00160498|Lercanidipine, calcium antagonist, hypertension, obesity|lercanidipine, calcium antagonist, hypertension, obesity
721604|NCT00160485|Gestational Diabetes|gestational diabetes
721605|NCT00160485|Pregnancy|pregnancy
721606|NCT00160485|Glyburide|glyburide
721607|NCT00160485|Insulin|insulin
721608|NCT00160472|vasopressin|vasopressin
721609|NCT00160472|ovarian|ovarian
721610|NCT00160472|neoplasm|neoplasm
721611|NCT00160459|Fibroid Uterus|fibroid uterus
721612|NCT00160459|Leiomyoma|leiomyoma
721613|NCT00160459|Uterine Fibroids|uterine fibroids
721614|NCT00160459|asoprisnil|asoprisnil
721615|NCT00160446|Pelvic pain|pelvic pain
721616|NCT00160446|Dysmenorrhea|dysmenorrhea
721617|NCT00160446|Dyspareunia|dyspareunia
721618|NCT00160446|Infertility|infertility
721619|NCT00160446|Asoprisnil|asoprisnil
721620|NCT00160433|Pelvic pain|pelvic pain
721621|NCT00160433|Dysmenorrhea|dysmenorrhea
721622|NCT00160433|Dyspareunia|dyspareunia
721623|NCT00160433|Infertility|infertility
721624|NCT00160433|asoprisnil|asoprisnil
721625|NCT00160420|Pelvic pain|pelvic pain
721626|NCT00160420|Dysmenorrhea|dysmenorrhea
721627|NCT00160420|Dyspareunia|dyspareunia
721628|NCT00160420|Infertility|infertility
721629|NCT00160420|asoprisnil|asoprisnil
721630|NCT00160407|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
721631|NCT00160407|enzyme inhibitors|enzyme inhibitors
721632|NCT00160407|lipase|lipase
721633|NCT00160407|obesity|obesity
721634|NCT00160407|insulin resistance|insulin resistance
721635|NCT00160394|Mild to Moderate|mild to moderate
721636|NCT00160381|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
721637|NCT00160381|Excessive Uterine Bleeding|excessive uterine bleeding
721638|NCT00160381|Uterine Hemorrhage|uterine hemorrhage
721639|NCT00160381|asoprisnil|asoprisnil
721640|NCT00160368|Hypertension, potassium salts|hypertension, potassium salts
721641|NCT00160355|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
721642|NCT00160355|Immunodeficiency|immunodeficiency
721643|NCT00160355|Haploidentical transplantation|haploidentical transplantation
721644|NCT00160342|Hormone replacement therapy, hot flushes, postmenopause|hormone replacement therapy, hot flushes, postmenopause
721645|NCT00160303|Prolotherapy|prolotherapy
721646|NCT00160303|Lateral Epicondylitis|lateral epicondylitis
721647|NCT00160303|Tennis Elbow|tennis elbow
721648|NCT00160303|Corticosteroid Therapy|corticosteroid therapy
721649|NCT00160290|lactulose|lactulose
721650|NCT00160290|randomised clinical trial|randomised clinical trial
721651|NCT00160290|hemorrhoids|hemorrhoids
721652|NCT00160290|anal fissures|anal fissures
721653|NCT00160277|Efficacy and safety of moxonidine in Indian hypertensives|efficacy and safety of moxonidine in indian hypertensives
721654|NCT00160264|lactulose; randomised clinical trial; osteopenia; postmenopause|lactulose; randomised clinical trial; osteopenia; postmenopause
721655|NCT00160251|PEG-Intron|peg-intron
721656|NCT00160251|Ribavirin|ribavirin
721657|NCT00160251|Protease Inhibitor|protease inhibitor
721658|NCT00160238|Meniere's disease|meniere's disease
721659|NCT00160238|Vestibular neurotomy|vestibular neurotomy
721660|NCT00160225|blood pressure, diabetic nephropathy, proteinuria|blood pressure, diabetic nephropathy, proteinuria
721661|NCT00160212|blood pressure|blood pressure
721662|NCT00160199|To collect additional data on 300 and 400 mg doses of PROMETRIUM in women with secondary amenorrhea|to collect additional data on 300 and 400 mg doses of prometrium in women with secondary amenorrhea
721663|NCT00160173|Post menopausal vasomotor symptoms|post menopausal vasomotor symptoms
721664|NCT00160160|comparator trial|comparator trial
721665|NCT00160160|hypertension|hypertension
721666|NCT00160160|diabetes|diabetes
721667|NCT00160160|blood pressure|blood pressure
721768|NCT00159432|cancer|cancer
721668|NCT00160134|congestive heart failure, adenosine receptor blocker, cardiac hemodynamic|congestive heart failure, adenosine receptor blocker, cardiac hemodynamic
721669|NCT00160095|larynx carcinoma|larynx carcinoma
721670|NCT00160095|Tumor hypoxia|tumor hypoxia
721671|NCT00160095|microregional imaging|microregional imaging
721672|NCT00160095|hypoxia modifying treatment|hypoxia modifying treatment
721673|NCT00160082|Post Polio Syndrome|post polio syndrome
721674|NCT00160082|PPS|pps
721675|NCT00160082|Poliomyelitis|poliomyelitis
721676|NCT00160082|Paralylic Polio|paralylic polio
721677|NCT00160082|Late effects of polio|late effects of polio
721678|NCT00160082|Late onset polio sequele|late onset polio sequele
721679|NCT00160082|Xepol|xepol
721680|NCT00160082|IvIg|ivig
721681|NCT00160082|Intravenous Immunoglobuline|intravenous immunoglobuline
721682|NCT00160069|Stage IIIB or stage IV non-small-cell lung cancer.|stage iiib or stage iv non-small-cell lung cancer.
721683|NCT00160056|Hypoglycemia unawareness|hypoglycemia unawareness
721684|NCT00160056|Diabetes|diabetes
721685|NCT00160056|adrenal receptor|adrenal receptor
721686|NCT00160056|adrenerg respons|adrenerg respons
721687|NCT00160056|adrenergic beta-agonists|adrenergic beta-agonists
721688|NCT00160056|salbutamol|salbutamol
721689|NCT00160017|Quality assurance health care|quality assurance health care
721690|NCT00160017|Diabetes|diabetes
721691|NCT00160017|Breakthrough collaborative (IHI)|breakthrough collaborative (ihi)
721692|NCT00160017|Evaluation|evaluation
721693|NCT00160004|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
721694|NCT00160004|Exercise|exercise
721695|NCT00160004|Fatigue|fatigue
721696|NCT00160004|Quality-of-life|quality-of-life
721697|NCT00159991|Coronary artery bypass grafting|coronary artery bypass grafting
721698|NCT00159991|Total arterial revascularization|total arterial revascularization
721699|NCT00159991|Internal mammary artery grafting|internal mammary artery grafting
721700|NCT00159991|Radial artery grafting|radial artery grafting
721701|NCT00159978|head and neck cancer|head and neck cancer
721702|NCT00159978|hypoxia|hypoxia
721703|NCT00159978|tumor cell proliferation|tumor cell proliferation
721704|NCT00159978|PET|pet
721705|NCT00159965|nonepileptic seizure|nonepileptic seizure
721706|NCT00159965|pseudoseizure|pseudoseizure
721707|NCT00159965|conversion disorder|conversion disorder
721708|NCT00159965|psychogenic|psychogenic
721709|NCT00159965|Depression|depression
721710|NCT00159965|Anxiety|anxiety
721711|NCT00159965|Abuse|abuse
721712|NCT00159965|post-traumatic stress disorder|post-traumatic stress disorder
721713|NCT00159965|sertraline|sertraline
721714|NCT00159965|serotonin|serotonin
721715|NCT00159965|randomized controlled trial|randomized controlled trial
721716|NCT00159952|Sepsis|sepsis
721717|NCT00159952|Septic shock|septic shock
721718|NCT00159952|Hyperglycemia|hyperglycemia
721719|NCT00159952|Fibrinolysis|fibrinolysis
721720|NCT00159952|PAI 1|pai 1
721721|NCT00159939|ARDS|ards
721722|NCT00159939|prone position|prone position
721723|NCT00159926|systemic inflammatory response syndrome|systemic inflammatory response syndrome
721724|NCT00159926|coronary artery bypass grafting|coronary artery bypass grafting
721725|NCT00159926|cell saver|cell saver
721726|NCT00159926|interleukins|interleukins
721727|NCT00159926|tumor necrosis factor alfa|tumor necrosis factor alfa
721728|NCT00159900|Impotence|impotence
721729|NCT00159874|children|children
721730|NCT00159627|heart failure, congestive|heart failure, congestive
721731|NCT00159627|diuretic|diuretic
721732|NCT00159614|renal insufficiency|renal insufficiency
721733|NCT00159614|diuretic|diuretic
721734|NCT00159614|heart failure, congestive|heart failure, congestive
721735|NCT00159601|Quality of Life|quality of life
721736|NCT00159601|Mental health|mental health
721737|NCT00159601|Children|children
721738|NCT00159601|Adolescents|adolescents
721739|NCT00159601|Normal population|normal population
721740|NCT00159588|Medication-overuse headache|medication-overuse headache
721741|NCT00159588|preventative medication|preventative medication
721742|NCT00159588|controls|controls
721743|NCT00159588|follow-up|follow-up
721744|NCT00159588|randomized|randomized
721745|NCT00159588|abrupt withdrawal|abrupt withdrawal
721746|NCT00159575|Polycystic ovarian syndrome|polycystic ovarian syndrome
721747|NCT00159575|Clinical pregnancy rate|clinical pregnancy rate
721748|NCT00159575|Oligo- or anovulation|oligo- or anovulation
721749|NCT00159562|Bipolar Disorder|bipolar disorder
721750|NCT00159562|Psycho-education|psycho-education
721751|NCT00159549|Patient education|patient education
721752|NCT00159536|PCOS|pcos
721753|NCT00159536|metformin|metformin
721754|NCT00159536|pregnancy|pregnancy
721755|NCT00159536|preeclampsia|preeclampsia
721756|NCT00159536|diabetes|diabetes
721757|NCT00159536|preterm delivery|preterm delivery
721758|NCT00159523|Prevention|prevention
721759|NCT00159523|Probiotics|probiotics
721760|NCT00159523|Allergy|allergy
721761|NCT00159523|Hypersensitivity|hypersensitivity
721762|NCT00159510|sepsis, methylene blue, nitric oxide, acute lung injury|sepsis, methylene blue, nitric oxide, acute lung injury
721763|NCT00159497|THA|tha
721764|NCT00159484|phase 1|phase 1
721765|NCT00159484|phase one|phase one
721766|NCT00159484|phase I|phase i
721769|NCT00159419|Osteogenesis Imperfecta|osteogenesis imperfecta
721770|NCT00159419|Fractures|fractures
721771|NCT00159419|Pediatric|pediatric
721772|NCT00159419|Osteoporosis|osteoporosis
721773|NCT00159419|Juvenile Pagets|juvenile pagets
721774|NCT00159406|BPH treatment|bph treatment
721775|NCT00159406|Laser Prostatectomy|laser prostatectomy
721776|NCT00159406|Treatment of enlarged Prostates|treatment of enlarged prostates
721777|NCT00159406|BPH|bph
721778|NCT00159393|Kidney stones|kidney stones
721779|NCT00159393|nephrolithotripsy percutaneous|nephrolithotripsy percutaneous
721780|NCT00159380|Healthy Volunteers|healthy volunteers
721781|NCT00159367|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
721782|NCT00159354|FDG−PET|fdg−pet
721783|NCT00159354|pulmonary inflammation,|pulmonary inflammation,
721784|NCT00159354|smoking,|smoking,
721785|NCT00159354|COPD|copd
721786|NCT00159354|steroid intervention|steroid intervention
721787|NCT00159341|cigarette smoke|cigarette smoke
721788|NCT00159341|nasal|nasal
721789|NCT00159341|whole blood|whole blood
721790|NCT00159341|cytokines|cytokines
721791|NCT00159341|chemokines|chemokines
721792|NCT00159341|nasal fluid|nasal fluid
721793|NCT00159341|filter paper|filter paper
721794|NCT00159328|Magnetic Resonance Guided Focused Ultrasound|magnetic resonance guided focused ultrasound
721795|NCT00159328|Gonadotrophin Releasing Hormone Agonist|gonadotrophin releasing hormone agonist
721796|NCT00159328|Uterine Fibroids|uterine fibroids
721797|NCT00159315|Healthy Volunteers (smokers)|healthy volunteers (smokers)
721798|NCT00159315|Healthy Volunteers (Non-smokers)|healthy volunteers (non-smokers)
721799|NCT00159315|Asthma Patients|asthma patients
721800|NCT00159315|COPD Patients|copd patients
721801|NCT00159289|Mild to moderate Chronic Obstructive Pulmonary Disease (COPD)|mild to moderate chronic obstructive pulmonary disease (copd)
721802|NCT00159289|Volunteers (healthy non-smokers)|volunteers (healthy non-smokers)
721803|NCT00159289|Volunteers (current or ex-smokers)|volunteers (current or ex-smokers)
721804|NCT00159250|Duchenne muscular dystrophy;|duchenne muscular dystrophy;
721805|NCT00159250|antisense oligonucleotides;|antisense oligonucleotides;
721806|NCT00159250|gene restoration;|gene restoration;
721807|NCT00159250|deletion|deletion
721808|NCT00159224|HIV|hiv
721809|NCT00159224|Simplification|simplification
721810|NCT00159224|Monotherapy|monotherapy
721811|NCT00159224|Treatment Naive|treatment naive
721812|NCT00159224|HIV-1 infection|hiv-1 infection
721813|NCT00159211|type 2 diabetes|type 2 diabetes
721814|NCT00159198|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
721815|NCT00159198|Frontotemporal dementia|frontotemporal dementia
721816|NCT00159198|Mutations spectrum|mutations spectrum
721817|NCT00159198|Linkage studies|linkage studies
721818|NCT00159198|Genetic epidemiology|genetic epidemiology
721819|NCT00159185|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
721820|NCT00159185|Epidemiology|epidemiology
721821|NCT00159172|Advanced parkinson disease|advanced parkinson disease
721822|NCT00159172|Stimulation|stimulation
721823|NCT00159172|Motor Cortex|motor cortex
721824|NCT00159172|Parkinson disease C10.574.812|parkinson disease c10.574.812
721825|NCT00159172|Electric Stimulation Therapy E02.831.580.438|electric stimulation therapy e02.831.580.438
721826|NCT00159172|Neuronavigation E05.873.249|neuronavigation e05.873.249
721827|NCT00159159|Cardiac Transplant|cardiac transplant
721828|NCT00159159|ciclosporine|ciclosporine
721829|NCT00159159|immunosuppressive|immunosuppressive
721830|NCT00159146|Major Depression|major depression
721831|NCT00159146|Pindolol|pindolol
721832|NCT00159146|Venlafaxine|venlafaxine
721833|NCT00159146|Augmentation|augmentation
721834|NCT00159146|Major depression (DSM-IVR)|major depression (dsm-ivr)
721835|NCT00159133|Schizophrenia|schizophrenia
721836|NCT00159133|first episode|first episode
721837|NCT00159133|prodrome based early intervention|prodrome based early intervention
721838|NCT00159133|antipsychotics - benzodiazepine|antipsychotics - benzodiazepine
721839|NCT00159133|maintenance treatment|maintenance treatment
721840|NCT00159133|drug discontinuation|drug discontinuation
721841|NCT00159120|Schizophrenia|schizophrenia
721842|NCT00159120|first episode|first episode
721843|NCT00159120|neuroleptic maintenance treatment|neuroleptic maintenance treatment
721844|NCT00159120|drug discontinuation|drug discontinuation
721845|NCT00159120|prodrome based early intervention|prodrome based early intervention
721846|NCT00159107|alcoholism|alcoholism
721847|NCT00159107|abstinence enhancement|abstinence enhancement
721848|NCT00159107|psychotherapy|psychotherapy
721849|NCT00159107|cognitive behavior therapy vs. supportive counseling|cognitive behavior therapy vs. supportive counseling
721850|NCT00159107|Acamprosate vs. Placebo|acamprosate vs. placebo
721851|NCT00159107|multi-center study|multi-center study
721852|NCT00159081|Schizophrenia|schizophrenia
721853|NCT00159081|first episode|first episode
721854|NCT00159081|long-term treatment|long-term treatment
721855|NCT00159081|typical vs. atypical neuroleptics|typical vs. atypical neuroleptics
721856|NCT00159003|drug metabolism and disposition enzymes|drug metabolism and disposition enzymes
721857|NCT00158990|major depression|major depression
721858|NCT00158990|bipolar disorder|bipolar disorder
721859|NCT00158990|unipolar depression|unipolar depression
721860|NCT00158990|sertraline|sertraline
721861|NCT00158990|triiodothyronine|triiodothyronine
721862|NCT00158977|heart failure|heart failure
721863|NCT00158977|atrial fibrillation|atrial fibrillation
721864|NCT00158977|cardiac resynchronization therapy defibrillator|cardiac resynchronization therapy defibrillator
721865|NCT00158964|left ventricular lead|left ventricular lead
721867|NCT00158964|heart failure|heart failure
721868|NCT00158951|Left Ventricular Lead|left ventricular lead
721869|NCT00158951|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
721870|NCT00158951|Congestive Heart Failure|congestive heart failure
721871|NCT00158938|Artificial Cardiac Pacemaker|artificial cardiac pacemaker
721872|NCT00158938|Implanted Electrodes|implanted electrodes
721873|NCT00158925|Artificial Cardiac Pacing|artificial cardiac pacing
721874|NCT00158925|Implanted Electrodes|implanted electrodes
721875|NCT00158899|HDLc|hdlc
721876|NCT00158899|high-density lipoprotein|high-density lipoprotein
721877|NCT00158899|Dyslipidemia|dyslipidemia
721878|NCT00158886|oral topotecan rectal cancer pelvic radiation|oral topotecan rectal cancer pelvic radiation
721879|NCT00158873|ICU mechanical ventilation analgesia sedation|icu mechanical ventilation analgesia sedation
721880|NCT00158860|VALTREX®|valtrex®
721881|NCT00158860|valaciclovir|valaciclovir
721882|NCT00158860|genital herpes|genital herpes
721883|NCT00158860|HSV-2|hsv-2
721884|NCT00158860|suppression|suppression
721885|NCT00158847|COPD inflammation sputum lung function biopsy|copd inflammation sputum lung function biopsy
721886|NCT00158834|Children|children
721887|NCT00158834|Asthma|asthma
721888|NCT00158834|bronchial hyperresponsiveness|bronchial hyperresponsiveness
721889|NCT00158834|symptoms|symptoms
721890|NCT00158821|HIV|hiv
721891|NCT00158821|Antiretroviral|antiretroviral
721892|NCT00158821|Treatment Experienced|treatment experienced
721893|NCT00158821|HIV-1|hiv-1
721894|NCT00158782|Cancer GW786034 Lapatinib Pazopanib|cancer gw786034 lapatinib pazopanib
721895|NCT00158769|Hepatic Impairment|hepatic impairment
721896|NCT00158769|GR270773|gr270773
721897|NCT00158769|Emulsion|emulsion
721898|NCT00158756|Diphtheria|diphtheria
721899|NCT00158756|Pertussis|pertussis
721900|NCT00158756|Prophylaxis|prophylaxis
721901|NCT00158756|Hepatitis B diseases|hepatitis b diseases
721902|NCT00158756|Tetanus|tetanus
721903|NCT00158743|Pre-eclampsia|pre-eclampsia
721904|NCT00158743|Hypertension|hypertension
721905|NCT00158743|Endogenous digitalis-like factor|endogenous digitalis-like factor
721906|NCT00158743|Anti-digoxin antibody|anti-digoxin antibody
721907|NCT00158743|Digibind|digibind
721908|NCT00158717|Chronic Hepatitis B|chronic hepatitis b
721909|NCT00158704|Chronic Hepatitis B|chronic hepatitis b
721910|NCT00158691|Head and Neck cancer|head and neck cancer
721911|NCT00158691|Radiotherapy|radiotherapy
721912|NCT00158691|Xerostomia|xerostomia
721913|NCT00158691|Randomized trial|randomized trial
721914|NCT00158678|oral cancer|oral cancer
721915|NCT00158678|oropharynx cancer|oropharynx cancer
721916|NCT00158678|hypopharynx cancer|hypopharynx cancer
721917|NCT00158678|IMRT|imrt
721918|NCT00158665|Influenza|influenza
721919|NCT00158665|Vaccination|vaccination
721920|NCT00158665|Immunization|immunization
721921|NCT00158665|Flu|flu
721922|NCT00158665|Immunogenicity|immunogenicity
721923|NCT00158652|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
721924|NCT00158652|Radiotherapy|radiotherapy
721925|NCT00158652|Chemotherapy|chemotherapy
721926|NCT00158639|Blood Pressure Monitoring, home|blood pressure monitoring, home
721927|NCT00158639|Pharmaceutical services|pharmaceutical services
721928|NCT00158639|Self care|self care
721929|NCT00158626|physical therapy|physical therapy
721930|NCT00158626|physiotherapy|physiotherapy
721931|NCT00158626|pelvic organ prolapse|pelvic organ prolapse
721932|NCT00158600|Glycogen Storage Disease Type II|glycogen storage disease type ii
721933|NCT00158600|GSD-II|gsd-ii
721934|NCT00158600|Pompe Disease|pompe disease
721935|NCT00158587|Vivax|vivax
721936|NCT00158587|Treatment|treatment
721937|NCT00158587|Primaquine|primaquine
721938|NCT00158587|Asia|asia
721939|NCT00158574|intermittent preventive treatment|intermittent preventive treatment
721940|NCT00158574|malaria|malaria
721941|NCT00158574|efficacy|efficacy
721942|NCT00158574|safety|safety
721943|NCT00158574|drug options|drug options
721944|NCT00158561|vivax|vivax
721945|NCT00158561|treatment|treatment
721946|NCT00158561|Asia|asia
721947|NCT00158548|Falciparum|falciparum
721948|NCT00158548|Vivax|vivax
721949|NCT00158548|Treatment|treatment
721950|NCT00158548|Asia|asia
721951|NCT00158535|Liver Transplantation|liver transplantation
721952|NCT00158535|Hepatitis C|hepatitis c
721953|NCT00158535|HIV Infections|hiv infections
721954|NCT00158522|Acute hepatitis C|acute hepatitis c
721955|NCT00158522|Genotype 4|genotype 4
721956|NCT00158522|Pegylated Interferon|pegylated interferon
721957|NCT00158522|Egypt|egypt
721958|NCT00158509|Valacyclovir|valacyclovir
721959|NCT00158509|HIV-1|hiv-1
721960|NCT00158509|HSV-2|hsv-2
721961|NCT00158509|genital shedding|genital shedding
721962|NCT00158509|herpes genitalis|herpes genitalis
721963|NCT00158509|HIV infection|hiv infection
721964|NCT00158496|Chronic Hepatitis C|chronic hepatitis c
721965|NCT00158496|Genotype 4|genotype 4
721966|NCT00158496|Pegylated Interferon|pegylated interferon
721967|NCT00158496|Ribavirin|ribavirin
721968|NCT00158496|Egypt|egypt
721969|NCT00158483|Genital herpes|genital herpes
721970|NCT00158483|Cofactors of sexual transmission|cofactors of sexual transmission
721971|NCT00158483|Syndromic treatment|syndromic treatment
721972|NCT00158483|Genital viral load|genital viral load
721973|NCT00158483|Ulcer|ulcer
721974|NCT00158470|HIV infection|hiv infection
721975|NCT00158470|injecting drug users|injecting drug users
721976|NCT00158470|HAART|haart
721977|NCT00158470|once daily regimen|once daily regimen
721978|NCT00158470|Treatment Naive|treatment naive
721979|NCT00158457|Simplification regimen|simplification regimen
721980|NCT00158457|HIV infection|hiv infection
721981|NCT00158457|Once a day|once a day
721982|NCT00158457|Naive patients|naive patients
721983|NCT00158457|Sub-saharian Africa|sub-saharian africa
721984|NCT00158457|Treatment Naive|treatment naive
721985|NCT00158431|osteoarthritis|osteoarthritis
721986|NCT00158431|randomized trial|randomized trial
721987|NCT00158431|knee|knee
721988|NCT00158431|quality of life|quality of life
721989|NCT00158418|osteoarthritis|osteoarthritis
721990|NCT00158418|shoulder|shoulder
721991|NCT00158418|randomized trial|randomized trial
721992|NCT00158418|cement|cement
721993|NCT00158405|HIV|hiv
721994|NCT00158405|Structured treatment interruption|structured treatment interruption
721995|NCT00158405|HAART|haart
721996|NCT00158405|Sub-saharian africa|sub-saharian africa
721997|NCT00158405|Treatment Interruption|treatment interruption
721998|NCT00158405|Treatment Naive|treatment naive
721999|NCT00158366|Weight Loss|weight loss
722000|NCT00158353|Mentors|mentors
722001|NCT00158353|Self-esteem|self-esteem
722002|NCT00158353|Adolescent|adolescent
722003|NCT00158353|Mental health|mental health
722004|NCT00158353|Social support|social support
722005|NCT00158353|Substance use|substance use
722006|NCT00158353|Violence|violence
722007|NCT00158353|Exercise|exercise
722008|NCT00158353|Nutrition|nutrition
722009|NCT00158353|Sexual behavior|sexual behavior
722010|NCT00158353|Female|female
722011|NCT00158340|Binge Eating|binge eating
722012|NCT00158340|Overeating|overeating
722013|NCT00158340|Compulsive Eating|compulsive eating
722014|NCT00158340|Hyperphagia|hyperphagia
722015|NCT00158327|Primary Health Care|primary health care
722016|NCT00158314|Pathological gambling|pathological gambling
722017|NCT00158314|Gambler's anonymous|gambler's anonymous
722018|NCT00158314|Cognitive behavioral therapy|cognitive behavioral therapy
722019|NCT00158314|CBT|cbt
722020|NCT00158301|Child|child
722021|NCT00158301|Adolescent|adolescent
722022|NCT00158301|CBT|cbt
722023|NCT00158301|Drug Therapy|drug therapy
722024|NCT00158288|Substance Use Disorders|substance use disorders
722025|NCT00158275|Cognitive behavioral therapy|cognitive behavioral therapy
722026|NCT00158275|Problem solving therapy|problem solving therapy
722027|NCT00158275|CBT|cbt
722028|NCT00158262|Post-Traumatic Stress Disorder|post-traumatic stress disorder
722029|NCT00158262|Prevention|prevention
722030|NCT00158262|Propranolol|propranolol
722031|NCT00158262|Psychophysiology|psychophysiology
722032|NCT00158249|citicoline, drug abuse, marijuana|citicoline, drug abuse, marijuana
722033|NCT00158236|Opiate Addiction|opiate addiction
722034|NCT00158236|Opiate Dependence|opiate dependence
722035|NCT00158223|Schizophrenia|schizophrenia
722036|NCT00158223|Clozapine|clozapine
722037|NCT00158223|Treatment|treatment
722038|NCT00158223|Combination|combination
722039|NCT00158223|Unresponsive|unresponsive
722040|NCT00158223|Schizoaffective Disorders|schizoaffective disorders
722041|NCT00158197|Adherence|adherence
722042|NCT00158197|Amphetamine-Related Disorders|amphetamine-related disorders
722043|NCT00158197|Behavior Therapy|behavior therapy
722044|NCT00158197|Contingency management|contingency management
722045|NCT00158197|Drug Counseling|drug counseling
722046|NCT00158197|health behaviors|health behaviors
722047|NCT00158197|methamphetamine|methamphetamine
722048|NCT00158197|sexual risk behaviors|sexual risk behaviors
722049|NCT00158197|substance dependence|substance dependence
722050|NCT00158184|Opiate|opiate
722051|NCT00158184|Opioid|opioid
722052|NCT00158184|Abuse Liability|abuse liability
722053|NCT00158184|Abuse Potential|abuse potential
722054|NCT00158171|smoking addiction|smoking addiction
722055|NCT00158158|smoking addiction|smoking addiction
722056|NCT00158132|cocaine|cocaine
722057|NCT00158119|strength training|strength training
722058|NCT00158119|power training|power training
722059|NCT00158119|exercise training|exercise training
722060|NCT00158119|functional performance tasks|functional performance tasks
722061|NCT00158106|functional communicative ability|functional communicative ability
722062|NCT00158106|cost effectiveness|cost effectiveness
722063|NCT00158106|service user preferences|service user preferences
722064|NCT00158067|Epilepsy|epilepsy
722065|NCT00158067|Neurostimulation|neurostimulation
722066|NCT00158054|depression|depression
722067|NCT00158054|acute coronary syndrome|acute coronary syndrome
722068|NCT00158054|clinical trials|clinical trials
722069|NCT00158041|Amifostine|amifostine
722070|NCT00158041|Mucositis|mucositis
722071|NCT00158041|Nausea|nausea
722072|NCT00158041|Hypotension|hypotension
722073|NCT00158041|Rash|rash
722074|NCT00158028|Schizotypal Personality Disorder|schizotypal personality disorder
722075|NCT00158028|Risperidone|risperidone
722076|NCT00158028|Treatment|treatment
722077|NCT00158028|Cognitive|cognitive
722078|NCT00158015|Echocardiography|echocardiography
722079|NCT00158015|tissue Doppler Imaging|tissue doppler imaging
722080|NCT00158015|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
722081|NCT00158002|Basilar/Hemiplegic Migraine|basilar/hemiplegic migraine
722082|NCT00158002|Prophylaxis|prophylaxis
722083|NCT00157989|Infant, Premature|infant, premature
722084|NCT00157976|Macular Degeneration|macular degeneration
722085|NCT00157976|AMD|amd
722086|NCT00157976|Visual Acuity|visual acuity
722087|NCT00157950|Human Papilloma Virus|human papilloma virus
722088|NCT00157885|Falciparum|falciparum
722089|NCT00157885|Vivax|vivax
722090|NCT00157885|Papua|papua
722091|NCT00157885|Amodiaquine|amodiaquine
722092|NCT00157885|Artekin|artekin
722093|NCT00157885|Artemisinin Combination Therapy|artemisinin combination therapy
722094|NCT00157885|Dihydroartemisinin|dihydroartemisinin
722095|NCT00157885|Piperaquine|piperaquine
722096|NCT00157885|Lumefantrine|lumefantrine
722097|NCT00157885|Artemether|artemether
722098|NCT00157859|Falciparum|falciparum
722099|NCT00157859|Vivax|vivax
722100|NCT00157859|Papua|papua
722101|NCT00157859|Chloroquine|chloroquine
722102|NCT00157859|Sulphadoxine-pyrimethamine|sulphadoxine-pyrimethamine
722103|NCT00157846|Heart Failure|heart failure
722104|NCT00157846|LVEF < 35%|lvef < 35%
722105|NCT00157846|Bradycardia|bradycardia
722106|NCT00157833|Coartemether|coartemether
722107|NCT00157833|Artekin|artekin
722108|NCT00157833|Papua|papua
722109|NCT00157833|Uncomplicated malaria|uncomplicated malaria
722110|NCT00157820|Defibrillators, Implantable|defibrillators, implantable
722111|NCT00157820|Atrial Fibrillation|atrial fibrillation
722112|NCT00157820|Ventricular Tachyarrhythmias|ventricular tachyarrhythmias
722113|NCT00157820|Clinical Trial|clinical trial
722114|NCT00157807|Persistent Atrial Fibrillation|persistent atrial fibrillation
722115|NCT00157807|Permanent Atrial Fibrillation|permanent atrial fibrillation
722116|NCT00157807|Mitral Valve Defect|mitral valve defect
722117|NCT00157807|Tricuspid Valve Defect|tricuspid valve defect
722118|NCT00157807|Aortic Valve Defect|aortic valve defect
722119|NCT00157794|Sinus Node Disease|sinus node disease
722120|NCT00157794|Pacemaker|pacemaker
722121|NCT00157794|Dual Chamber Pacemaker|dual chamber pacemaker
722122|NCT00157781|Atrial Fibrillation|atrial fibrillation
722123|NCT00157781|Atrial Tachyarrhythmia|atrial tachyarrhythmia
722124|NCT00157781|Pacing|pacing
722125|NCT00157781|Electrophysiology|electrophysiology
722126|NCT00157768|Acute myocardial infarction|acute myocardial infarction
722127|NCT00157768|Non-sustained ventricular tachycardia|non-sustained ventricular tachycardia
722128|NCT00157768|Left ventricular dysfunction|left ventricular dysfunction
722129|NCT00157768|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
722130|NCT00157768|ICD|icd
722131|NCT00157768|Risk-stratification|risk-stratification
722132|NCT00157755|Nausea and Vomiting|nausea and vomiting
722133|NCT00157742|Angina Pectoris|angina pectoris
722134|NCT00157742|Spinal Cord Stimulation (SCS)|spinal cord stimulation (scs)
722135|NCT00157742|Percutaneous Myocardial Revascularisation (PMR)|percutaneous myocardial revascularisation (pmr)
722136|NCT00157742|Refractory Angina Pectoris|refractory angina pectoris
722137|NCT00157729|Hypertension|hypertension
722138|NCT00157729|antihypertensive agents|antihypertensive agents
722139|NCT00157729|diabetes mellitus type 2|diabetes mellitus type 2
722140|NCT00157729|metabolic syndrome|metabolic syndrome
722141|NCT00157716|Coronary|coronary
722142|NCT00157716|surgery|surgery
722143|NCT00157716|ischemia|ischemia
722144|NCT00157716|reperfusion injury|reperfusion injury
722145|NCT00157716|cardiac|cardiac
722146|NCT00157716|heart|heart
722147|NCT00157716|neurological|neurological
722148|NCT00157716|cardiopulmonary bypass|cardiopulmonary bypass
722149|NCT00157716|cardioprotection|cardioprotection
722150|NCT00157703|Malignant glioma|malignant glioma
722151|NCT00157703|Glioblastoma multiforme|glioblastoma multiforme
722152|NCT00157703|GBM|gbm
722153|NCT00157703|Gliosarcoma|gliosarcoma
722154|NCT00157703|Anaplastic astrocytoma|anaplastic astrocytoma
722155|NCT00157703|Brain cancer|brain cancer
722156|NCT00157703|Brain tumor|brain tumor
722157|NCT00157703|Glioma|glioma
722158|NCT00157703|recurrent/progressive malignant glioma|recurrent/progressive malignant glioma
722159|NCT00157690|Alendronate|alendronate
722160|NCT00157690|Bisphosphonates|bisphosphonates
722161|NCT00157690|Cystic Fibrosis|cystic fibrosis
722162|NCT00157690|Osteoporosis|osteoporosis
722163|NCT00157677|deep vein thrombosis|deep vein thrombosis
722164|NCT00157677|pulmonary embolism|pulmonary embolism
722165|NCT00157677|D-dimer testing|d-dimer testing
722166|NCT00157651|end stage renal disease|end stage renal disease
722167|NCT00157651|thrombosis|thrombosis
722168|NCT00157651|bleeding|bleeding
722169|NCT00157638|pharmacist|pharmacist
722170|NCT00157638|physician|physician
722171|NCT00157638|primary care|primary care
722172|NCT00157638|collaboration|collaboration
722173|NCT00157638|therapeutics|therapeutics
722174|NCT00157625|urinary infections, catheters, bacteriuria, trial|urinary infections, catheters, bacteriuria, trial
722175|NCT00157612|pneumonia|pneumonia
722176|NCT00157612|lower respiratory tract infection|lower respiratory tract infection
722177|NCT00157612|clinical pathway|clinical pathway
722178|NCT00157612|nursing home|nursing home
722179|NCT00157612|long-term care|long-term care
722180|NCT00157612|randomized control trial|randomized control trial
722181|NCT00157599|deep vein thrombosis|deep vein thrombosis
722182|NCT00157599|DVT|dvt
722183|NCT00157573|Asymptomatic|asymptomatic
722184|NCT00157573|Clinical trial|clinical trial
722185|NCT00157573|Phase II|phase ii
722186|NCT00157573|GM-CSF|gm-csf
722187|NCT00157573|Immunotherapy|immunotherapy
722188|NCT00157547|Depression|depression
722189|NCT00157547|Quantitative EEG (QEEG)|quantitative eeg (qeeg)
722190|NCT00157547|Antidepressants|antidepressants
722191|NCT00157534|Hepatitis C|hepatitis c
722192|NCT00157534|Celgosivir|celgosivir
722193|NCT00157534|HCV|hcv
722194|NCT00157534|Genotype 1|genotype 1
722195|NCT00157378|first episode,|first episode,
722196|NCT00157378|schizophrenia,|schizophrenia,
722197|NCT00157378|atypical neuroleptics,|atypical neuroleptics,
722198|NCT00157378|negative symptoms|negative symptoms
722199|NCT00157326|High Blood Pressure|high blood pressure
722200|NCT00157313|Schizophrenia|schizophrenia
722201|NCT00157313|First episode psychosis|first episode psychosis
722202|NCT00157313|Psychosocial intervention|psychosocial intervention
722203|NCT00157300|erythropoietin|erythropoietin
722204|NCT00157300|kidney transplantation|kidney transplantation
722205|NCT00157300|delayed graft function|delayed graft function
722206|NCT00157274|Alemtuzumab|alemtuzumab
722207|NCT00157274|Mycosis fungoides|mycosis fungoides
722208|NCT00157274|Sezary|sezary
722209|NCT00157222|Charcot|charcot
722210|NCT00157222|Diabetic|diabetic
722211|NCT00157222|osteoporosis|osteoporosis
722212|NCT00157196|Carcinoma, Non-Small-Cell Lung, L-BLP25, Tecemotide|carcinoma, non-small-cell lung, l-blp25, tecemotide
722213|NCT00157183|cystic fibrosis|cystic fibrosis
722214|NCT00157183|hypoxia|hypoxia
722215|NCT00157183|oxygen|oxygen
722216|NCT00157183|noninvasive ventilation|noninvasive ventilation
722217|NCT00157183|quality of life|quality of life
722218|NCT00157170|exercise|exercise
722219|NCT00157170|self efficacy|self efficacy
722220|NCT00157170|quality of life|quality of life
722221|NCT00157170|HIV|hiv
722222|NCT00157157|Factor VIII Deficiency|factor viii deficiency
722223|NCT00157144|Lung Transplantation|lung transplantation
722224|NCT00157144|Heart Transplantation|heart transplantation
722225|NCT00157131|autologous sheet skin grafts|autologous sheet skin grafts
722226|NCT00157131|FS 4IU VH S/D|fs 4iu vh s/d
722227|NCT00157131|skin grafts|skin grafts
722228|NCT00157131|burn|burn
722229|NCT00157118|Severe congenital protein C deficiency|severe congenital protein c deficiency
722230|NCT00157079|PID|pid
722231|NCT00157079|Immunodeficiency|immunodeficiency
722232|NCT00157079|Immune Thrombocytopenic Purpura (ITP)|immune thrombocytopenic purpura (itp)
722233|NCT00157079|Kawasaki syndrome|kawasaki syndrome
722234|NCT00157066|Latent tuberculosis infection|latent tuberculosis infection
722235|NCT00157066|Active tuberculosis infection|active tuberculosis infection
722236|NCT00157053|Factor VIII Deficiency|factor viii deficiency
722237|NCT00157040|Factor VIII Deficiency|factor viii deficiency
722238|NCT00157027|Treatment Experienced|treatment experienced
722239|NCT00157027|HIV-1 Positive by ELISA Assay|hiv-1 positive by elisa assay
722240|NCT00157027|Confirmed by Western Blot|confirmed by western blot
722241|NCT00157027|Refractory or intolerant to HAART|refractory or intolerant to haart
722242|NCT00157014|Antirejection|antirejection
722243|NCT00157014|Treatment Outcome|treatment outcome
722244|NCT00157014|Immunosuppression|immunosuppression
722245|NCT00157014|Treatment Effectiveness|treatment effectiveness
722246|NCT00157014|Anti-rejection therapy|anti-rejection therapy
722247|NCT00156988|burns|burns
722248|NCT00156988|partial thickness|partial thickness
722249|NCT00156988|cerium flamazine|cerium flamazine
722250|NCT00156988|randomised clinical trial|randomised clinical trial
722251|NCT00156975|Oxaliplatin|oxaliplatin
722252|NCT00156975|Capecitabine|capecitabine
722253|NCT00156975|Chemotherapy|chemotherapy
722254|NCT00156975|Resection|resection
722255|NCT00156975|Liver metastases|liver metastases
722256|NCT00156975|Liver resection|liver resection
722257|NCT00156975|Adjuvant|adjuvant
722258|NCT00156962|Epogen|epogen
722259|NCT00156962|Procrit|procrit
722260|NCT00156962|Chronic Kidney Disease|chronic kidney disease
722261|NCT00156962|Anemia Treatment|anemia treatment
722262|NCT00156949|Epogen|epogen
722263|NCT00156949|Procrit|procrit
722264|NCT00156949|Chronic Kidney Disease|chronic kidney disease
722265|NCT00156949|Anemia Treatment for Dialysis Patients|anemia treatment for dialysis patients
722266|NCT00156923|Alcohol dependence|alcohol dependence
722267|NCT00156897|Non-insulin-dependent diabetes mellitus|non-insulin-dependent diabetes mellitus
722268|NCT00156897|NIDDM|niddm
722269|NCT00156897|Type II diabetes|type ii diabetes
722270|NCT00156897|Obesity|obesity
722271|NCT00156897|Lipase inhibitor|lipase inhibitor
722272|NCT00156884|prostate cancer|prostate cancer
722273|NCT00156884|cisplatin|cisplatin
722274|NCT00156884|strontium-89|strontium-89
722275|NCT00156884|phase II|phase ii
722276|NCT00156871|transplant|transplant
722277|NCT00156871|fatigue|fatigue
722278|NCT00156871|exercise|exercise
722279|NCT00156871|Malignant disease|malignant disease
722280|NCT00156858|pharmacokinetics|pharmacokinetics
722281|NCT00156858|transplantation|transplantation
722282|NCT00156858|busulfan|busulfan
722283|NCT00156845|coronary artery disease|coronary artery disease
722284|NCT00156845|ischemia|ischemia
722285|NCT00156845|echocardiography|echocardiography
722286|NCT00156845|cardiac imaging|cardiac imaging
722287|NCT00156845|heart disease|heart disease
722288|NCT00156845|myocardial contrast enhancement|myocardial contrast enhancement
722289|NCT00156845|myocardial perfusion|myocardial perfusion
722290|NCT00156845|wall motion|wall motion
722291|NCT00156845|ultrasound contrast agent|ultrasound contrast agent
722292|NCT00156819|Asthma|asthma
722293|NCT00156819|Asthma Control|asthma control
722294|NCT00156806|aloe|aloe
722295|NCT00156806|radiation dermatitis|radiation dermatitis
722296|NCT00156806|radiation therapy|radiation therapy
722297|NCT00156793|coronary artery disease|coronary artery disease
722298|NCT00156793|ischemia|ischemia
722299|NCT00156793|echocardiography|echocardiography
722300|NCT00156793|cardiac imaging|cardiac imaging
722301|NCT00156793|heart disease|heart disease
722302|NCT00156793|myocardial contrast enhancement|myocardial contrast enhancement
722303|NCT00156793|myocardial perfusion|myocardial perfusion
722304|NCT00156793|wall motion|wall motion
722305|NCT00156793|ultrasound contrast agent|ultrasound contrast agent
722306|NCT00156780|ultrasound contrast agent|ultrasound contrast agent
722307|NCT00156780|pharmacokinetics|pharmacokinetics
722308|NCT00156780|congestive heart failure|congestive heart failure
722309|NCT00156780|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
722310|NCT00156780|safety|safety
722311|NCT00156767|Critical Care|critical care
722312|NCT00156767|Adrenal Insufficiency|adrenal insufficiency
722313|NCT00156767|Septic Shock|septic shock
722314|NCT00156767|Cortrosyn|cortrosyn
722315|NCT00156767|Steroids|steroids
722316|NCT00156767|Cortisol|cortisol
722317|NCT00156767|Critical Care Unit|critical care unit
722318|NCT00156767|Adrenal Gland Function|adrenal gland function
722319|NCT00156741|Refined ventricular pacing|refined ventricular pacing
722320|NCT00156728|Pacemaker artificial, congestive heart failure and atrial fibrillation|pacemaker artificial, congestive heart failure and atrial fibrillation
722321|NCT00156715|Quetiapine|quetiapine
722322|NCT00156715|Seroquel|seroquel
722323|NCT00156715|Schizophrenia|schizophrenia
722324|NCT00156715|Dual Diagnosis|dual diagnosis
722325|NCT00156715|Substance Abuse|substance abuse
722326|NCT00156715|Alcohol Abuse|alcohol abuse
722327|NCT00156702|Smoking|smoking
722328|NCT00156702|Adolescents|adolescents
722329|NCT00156702|Motivational Interviewing|motivational interviewing
722330|NCT00156689|polyneuropathy|polyneuropathy
722331|NCT00156676|Disability|disability
722332|NCT00156676|Gait|gait
722333|NCT00156676|Multiple Sclerosis|multiple sclerosis
722334|NCT00156676|Rehabilitation|rehabilitation
722335|NCT00156676|Robot|robot
722336|NCT00156663|Women|women
722337|NCT00156663|Veterans|veterans
722338|NCT00156663|Delivery of Healthcare|delivery of healthcare
722339|NCT00156663|Intervention Studies|intervention studies
722340|NCT00156663|United States Department of Veterans Affairs|united states department of veterans affairs
722341|NCT00156663|Women's Health|women's health
722342|NCT00156650|Male contraception|male contraception
722343|NCT00156650|Testosterone|testosterone
722344|NCT00156637|schizophrenia|schizophrenia
722345|NCT00156637|quality of health care|quality of health care
722346|NCT00156637|quality indicators|quality indicators
722347|NCT00156637|intervention studies|intervention studies
722348|NCT00156624|Intervention|intervention
722349|NCT00156624|Peripheral Vascular Disease|peripheral vascular disease
722350|NCT00156624|Drug|drug
722351|NCT00156624|Restenosis|restenosis
722352|NCT00156624|18 years and above|18 years and above
722353|NCT00156611|peripheral vascular disease|peripheral vascular disease
722354|NCT00156611|intervention|intervention
722355|NCT00156611|restenosis|restenosis
722356|NCT00156611|Age above 18 years|age above 18 years
722357|NCT00156598|metal ion concentration|metal ion concentration
722358|NCT00156585|cerebral metastases|cerebral metastases
722359|NCT00156585|dynamic contrast enhanced magnetic resonance imaging|dynamic contrast enhanced magnetic resonance imaging
722360|NCT00156585|DCE-MRI|dce-mri
722361|NCT00156585|gamma knife|gamma knife
722362|NCT00156559|immunization|immunization
722363|NCT00156559|vaccine|vaccine
722364|NCT00156559|low birth weight infant|low birth weight infant
722365|NCT00156559|premature infant|premature infant
722744|NCT00154648|MRA|mra
722366|NCT00156546|Urinary tract infections|urinary tract infections
722367|NCT00156546|Children|children
722368|NCT00156546|Antibiotic prophylaxis|antibiotic prophylaxis
722369|NCT00156546|Renal scintigraphy|renal scintigraphy
722370|NCT00156546|Vesico ureteral reflux|vesico ureteral reflux
722371|NCT00156533|Insomnia|insomnia
722372|NCT00156533|Sleep|sleep
722373|NCT00156533|zolpidem|zolpidem
722374|NCT00156533|Ambien|ambien
722375|NCT00156533|Hypnotics|hypnotics
722376|NCT00156455|Children|children
722377|NCT00156455|Hypoplastic left heart syndrome|hypoplastic left heart syndrome
722378|NCT00156455|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
722379|NCT00156455|Single Ventricle Physiology|single ventricle physiology
722380|NCT00156442|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
722381|NCT00156442|Cleft lip/palate|cleft lip/palate
722382|NCT00156442|Children|children
722383|NCT00156429|genetic testing|genetic testing
722384|NCT00156416|menopause|menopause
722385|NCT00156416|hot flash|hot flash
722386|NCT00156416|night sweat|night sweat
722387|NCT00156416|meditation|meditation
722388|NCT00156416|breast cancer|breast cancer
722389|NCT00156403|pancreatitis, hereditary|pancreatitis, hereditary
722390|NCT00156403|trypsinogen, cationic|trypsinogen, cationic
722391|NCT00156403|pilot study|pilot study
722392|NCT00156377|Mupirocin|mupirocin
722393|NCT00156377|Staphylococcus aureus|staphylococcus aureus
722394|NCT00156377|Nasal Cavity|nasal cavity
722395|NCT00156377|Preventive measures|preventive measures
722396|NCT00156364|Diabetic Nephropathy|diabetic nephropathy
722397|NCT00156364|Kidney Transplant|kidney transplant
722398|NCT00156364|Pancreas Transplant|pancreas transplant
722399|NCT00156364|Renal Interstitium|renal interstitium
722400|NCT00156364|Diabetes Mellitus|diabetes mellitus
722401|NCT00156364|Cyclosporine|cyclosporine
722402|NCT00156364|Tacrolimus|tacrolimus
722403|NCT00156351|African Americans|african americans
722404|NCT00156351|Women|women
722405|NCT00156351|Internet|internet
722406|NCT00156351|Telephone Counseling|telephone counseling
722407|NCT00156338|Fluid therapy|fluid therapy
722408|NCT00156325|Bipolar Disorder|bipolar disorder
722409|NCT00156325|Depression|depression
722410|NCT00156325|Hypomania|hypomania
722411|NCT00156325|Mood Stabilizer|mood stabilizer
722412|NCT00156299|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
722413|NCT00156299|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
722414|NCT00156299|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
722415|NCT00156299|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
722416|NCT00156299|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
722417|NCT00156299|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
722418|NCT00156299|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
722419|NCT00156299|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
722420|NCT00156299|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
722421|NCT00156299|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
722422|NCT00156299|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
722423|NCT00156299|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
722424|NCT00156299|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
722425|NCT00156299|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
722426|NCT00156247|psoriasis|psoriasis
722427|NCT00156247|etanercept|etanercept
722428|NCT00156247|acitretin|acitretin
722429|NCT00156221|Autism|autism
722430|NCT00156221|MRI|mri
722431|NCT00156221|Developmental Disorders|developmental disorders
722432|NCT00156208|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
722433|NCT00156208|Excessive Uterine Bleeding|excessive uterine bleeding
722434|NCT00156208|Uterine Hemorrhage|uterine hemorrhage
722435|NCT00156208|asoprisnil|asoprisnil
722436|NCT00156195|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
722437|NCT00156195|Excessive Uterine Bleeding|excessive uterine bleeding
722438|NCT00156195|Uterine Hemorrhage|uterine hemorrhage
722439|NCT00156195|asoprisnil|asoprisnil
722440|NCT00156182|Fibroid Uterus|fibroid uterus
722441|NCT00156182|Leiomyoma|leiomyoma
722442|NCT00156182|Uterine Fibroids|uterine fibroids
722443|NCT00156182|asoprisnil|asoprisnil
722444|NCT00156156|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
722445|NCT00156156|Excessive Uterine Bleeding|excessive uterine bleeding
722446|NCT00156156|Uterine Hemorrhage|uterine hemorrhage
722447|NCT00156130|Breast Cancer|breast cancer
722448|NCT00156130|Lumpectomy|lumpectomy
722449|NCT00156130|Radiotherapy|radiotherapy
722450|NCT00156130|Hypofractionated Radiotherapy|hypofractionated radiotherapy
722451|NCT00156130|Long Term Outcomes|long term outcomes
722452|NCT00156052|Breast Cancer|breast cancer
722453|NCT00156052|Hypofractionated Radiotherapy|hypofractionated radiotherapy
722454|NCT00156052|Lumpectomy|lumpectomy
722455|NCT00156039|Breast Cancer|breast cancer
722456|NCT00156039|Follow-up Strategy|follow-up strategy
722457|NCT00156039|Follow-up Care|follow-up care
722458|NCT00156039|Family Physician|family physician
722459|NCT00156039|Oncologist|oncologist
722460|NCT00156026|CIN 1|cin 1
722461|NCT00156026|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
722462|NCT00156026|cervix|cervix
722463|NCT00156026|cancer|cancer
722464|NCT00156026|loop electrosurgical excision procedure|loop electrosurgical excision procedure
722465|NCT00156026|LEEP|leep
722466|NCT00156026|expectant management|expectant management
722467|NCT00156026|human papilloma virus|human papilloma virus
722468|NCT00156026|HPV|hpv
722469|NCT00156026|colposcopy|colposcopy
722470|NCT00156013|B-Cell NHL|b-cell nhl
722471|NCT00156000|Preterm Delivery|preterm delivery
722472|NCT00156000|Multifetal pregnancy|multifetal pregnancy
722473|NCT00156000|Preterm Birth|preterm birth
722474|NCT00156000|17-alpha Hydroxyprogesterone Caproate|17-alpha hydroxyprogesterone caproate
722475|NCT00156000|Markers of Preterm Birth|markers of preterm birth
722476|NCT00155987|Severe diffuse TBI refractory intracranial hypertension.|severe diffuse tbi refractory intracranial hypertension.
722477|NCT00155974|Influenza|influenza
722478|NCT00155974|Vaccination|vaccination
722479|NCT00155974|Hard-to-Reach Populations|hard-to-reach populations
722480|NCT00155974|Urban|urban
722481|NCT00155974|Disadvantaged|disadvantaged
722482|NCT00155961|Androgens|androgens
722483|NCT00155961|Metabolic syndrome|metabolic syndrome
722484|NCT00155961|Bone mineral density|bone mineral density
722485|NCT00155961|Body composition|body composition
722486|NCT00155961|Questionnaire|questionnaire
722487|NCT00155948|Ultrasonography|ultrasonography
722488|NCT00155948|Cervical Multifidus|cervical multifidus
722489|NCT00155935|ovarian cancer|ovarian cancer
722490|NCT00155935|immunotherapy|immunotherapy
722491|NCT00155935|folate receptor|folate receptor
722492|NCT00155935|Chemotherapy|chemotherapy
722493|NCT00155922|Diabetes mellitus|diabetes mellitus
722494|NCT00155922|Monocyte|monocyte
722495|NCT00155922|Gene expression|gene expression
722496|NCT00155922|Monocyte gene expression|monocyte gene expression
722497|NCT00155909|Radiation Pneumonitis|radiation pneumonitis
722498|NCT00155909|Radiotherapy Planning, Computer-Assisted|radiotherapy planning, computer-assisted
722499|NCT00155896|BRCA1 gene, BRCA2 gene, DHPLC, genetic diagnosis|brca1 gene, brca2 gene, dhplc, genetic diagnosis
722500|NCT00155870|laparoscopic assisted vaginal hysterectomy leiomyoma|laparoscopic assisted vaginal hysterectomy leiomyoma
722501|NCT00155870|adenomyosis|adenomyosis
722502|NCT00155870|quality of life|quality of life
722503|NCT00155857|glaucoma, genetic|glaucoma, genetic
722504|NCT00155831|Premature infants|premature infants
722505|NCT00155831|Kicking|kicking
722506|NCT00155831|Stepping|stepping
722507|NCT00155831|Walking|walking
722508|NCT00155831|Motor development|motor development
722509|NCT00155831|Kinematics|kinematics
722510|NCT00155818|DISC1|disc1
722511|NCT00155818|Schizophrenia|schizophrenia
722512|NCT00155818|Chromosome 1q|chromosome 1q
722513|NCT00155818|Polymorphism detection|polymorphism detection
722514|NCT00155818|Association study|association study
722515|NCT00155818|Balanced translocation|balanced translocation
722516|NCT00155818|DHPLC|dhplc
722517|NCT00155805|Gastroesophageal reflux disease|gastroesophageal reflux disease
722518|NCT00155805|reflux esophagitis|reflux esophagitis
722519|NCT00155805|nonerosive reflux disease|nonerosive reflux disease
722520|NCT00155805|Barrett’s esophagus|barrett’s esophagus
722521|NCT00155805|hiatus hernia|hiatus hernia
722522|NCT00155805|lower esophageal sphincter pressure|lower esophageal sphincter pressure
722523|NCT00155805|24 hours esophageal pH monitor|24 hours esophageal ph monitor
722524|NCT00155805|Helicobacter pylori|helicobacter pylori
722525|NCT00155792|ervical cancer, human papillomavirus, immunotherapy|ervical cancer, human papillomavirus, immunotherapy
722526|NCT00155779|adult respiratory distress syndrome|adult respiratory distress syndrome
722527|NCT00155779|angiotensin-converting enzyme|angiotensin-converting enzyme
722528|NCT00155779|polymorphism|polymorphism
722529|NCT00155766|cervical cancer, immunotherapy, DC|cervical cancer, immunotherapy, dc
722530|NCT00155753|pathological myopia, genomic|pathological myopia, genomic
722531|NCT00155740|ovarian cancer|ovarian cancer
722532|NCT00155740|tumor marker|tumor marker
722533|NCT00155740|mesothelin|mesothelin
722534|NCT00155727|colorectal cancer, laparoscopic colectomy|colorectal cancer, laparoscopic colectomy
722535|NCT00155714|pulmonary arterial hypertension|pulmonary arterial hypertension
722536|NCT00155714|type-5 phosphodiesterase Inhibitors|type-5 phosphodiesterase inhibitors
722537|NCT00155714|Sildenafil|sildenafil
722538|NCT00155701|DISC1|disc1
722539|NCT00155701|Schizophrenia|schizophrenia
722540|NCT00155701|Chromosome 1q|chromosome 1q
722541|NCT00155701|Polymorphism detection|polymorphism detection
722542|NCT00155701|Association study|association study
722543|NCT00155701|Balanced translocation|balanced translocation
722544|NCT00155701|DHPLC|dhplc
722545|NCT00155688|Schizophrenia|schizophrenia
722546|NCT00155688|linkage|linkage
722547|NCT00155688|Taiwan|taiwan
722548|NCT00155688|Han Chinese population|han chinese population
722549|NCT00155662|work hardening|work hardening
722550|NCT00155662|chronic low back pain over 3 months|chronic low back pain over 3 months
722551|NCT00155649|schizophrenia|schizophrenia
722552|NCT00155649|vulnerability gene|vulnerability gene
722553|NCT00155649|positional cloning|positional cloning
722554|NCT00155649|subtype definition|subtype definition
722555|NCT00155649|endophenotype|endophenotype
722556|NCT00155649|genetic marker|genetic marker
722557|NCT00155649|genetic linkage|genetic linkage
722558|NCT00155649|candidate genes|candidate genes
722559|NCT00155636|Schizophrenia|schizophrenia
722560|NCT00155623|H. pylori, 13C-urea breath test, serology, epidemiology|h. pylori, 13c-urea breath test, serology, epidemiology
722561|NCT00155610|diabetic cystopathy|diabetic cystopathy
722562|NCT00155610|bladder|bladder
722563|NCT00155610|voiding dysfunction|voiding dysfunction
722564|NCT00155610|current perception test|current perception test
722565|NCT00155597|physical therapy|physical therapy
722566|NCT00155597|post surgery|post surgery
722567|NCT00155584|warts|warts
722568|NCT00155584|photodynamic therapy|photodynamic therapy
722569|NCT00155584|5-ALA|5-ala
722570|NCT00155571|betel nut|betel nut
722571|NCT00155571|periodontitis|periodontitis
722572|NCT00155571|periodontal microbiology|periodontal microbiology
722573|NCT00155558|Colorectal Cancer, Maximum tolerated dose|colorectal cancer, maximum tolerated dose
722574|NCT00155545|functional scoliosis|functional scoliosis
722575|NCT00155545|idiopathic scoliosis|idiopathic scoliosis
722576|NCT00155545|leg length discrepancy|leg length discrepancy
722577|NCT00155545|motion analysis|motion analysis
722578|NCT00155545|biomechanics|biomechanics
722579|NCT00155532|Peripheral neuropathy;systemic lupus erythematosus|peripheral neuropathy;systemic lupus erythematosus
722580|NCT00155519|Schizophrenia|schizophrenia
722581|NCT00155519|Latent Schizophrenia|latent schizophrenia
722582|NCT00155519|Schizotypal Disorder|schizotypal disorder
722583|NCT00155519|Psychopathology|psychopathology
722584|NCT00155519|Neuropsychological Function|neuropsychological function
722585|NCT00155519|Family History|family history
722586|NCT00155519|Nosology|nosology
722587|NCT00155519|basic symptoms|basic symptoms
722588|NCT00155506|Schizophrenia|schizophrenia
722589|NCT00155506|Niacin|niacin
722590|NCT00155506|Genotyping|genotyping
722591|NCT00155506|candidate gene|candidate gene
722592|NCT00155506|one proband, normal parents and one normal sibling|one proband, normal parents and one normal sibling
722593|NCT00155480|thoracic aorta|thoracic aorta
722594|NCT00155480|finite element mesh|finite element mesh
722595|NCT00155467|CT|ct
722596|NCT00155467|children|children
722597|NCT00155467|congenital|congenital
722598|NCT00155454|Diabetic retinopathy|diabetic retinopathy
722599|NCT00155454|Vitrectomy|vitrectomy
722600|NCT00155454|Postoperative vitreous hemorrahge|postoperative vitreous hemorrahge
722601|NCT00155454|Intravitreal gas injection|intravitreal gas injection
722602|NCT00155441|sleep disorder|sleep disorder
722603|NCT00155441|peritoneal dialysis|peritoneal dialysis
722604|NCT00155441|cognitive-behavioral therapy|cognitive-behavioral therapy
722605|NCT00155441|sleep disorder:C23.888.592.796|sleep disorder:c23.888.592.796
722606|NCT00155441|peritoneal dialysis: F03.870.664|peritoneal dialysis: f03.870.664
722607|NCT00155428|biomodel|biomodel
722608|NCT00155428|rapid prototyping|rapid prototyping
722609|NCT00155428|computed tomograpgy|computed tomograpgy
722610|NCT00155415|Colonoscopy|colonoscopy
722611|NCT00155415|Polyethylene glycol(PEG)|polyethylene glycol(peg)
722612|NCT00155415|Colon neoplasm|colon neoplasm
722613|NCT00155415|Colon cleansing|colon cleansing
722614|NCT00155415|Timing|timing
722615|NCT00155402|fibrin glue|fibrin glue
722616|NCT00155402|corneal perforation|corneal perforation
722617|NCT00155402|pterygium|pterygium
722618|NCT00155402|conjunctiva|conjunctiva
722619|NCT00155402|corneal ulcer|corneal ulcer
722620|NCT00155389|Helicobacter pylori|helicobacter pylori
722621|NCT00155389|Gastric cancer|gastric cancer
722622|NCT00155389|single nucleotide polymorphism|single nucleotide polymorphism
722623|NCT00155350|atherosclerosis|atherosclerosis
722624|NCT00155350|calcification|calcification
722625|NCT00155350|coronary|coronary
722626|NCT00155350|inflammation|inflammation
722627|NCT00155350|insulin|insulin
722628|NCT00155350|plaque|plaque
722629|NCT00155350|Coronary calcification|coronary calcification
722630|NCT00155350|Plaque vulnerability|plaque vulnerability
722631|NCT00155337|leukoplakia|leukoplakia
722632|NCT00155337|erythroleukoplakia|erythroleukoplakia
722633|NCT00155337|photodynamic therapy|photodynamic therapy
722634|NCT00155324|plantar fasciitis|plantar fasciitis
722635|NCT00155324|ultrasonographic examination|ultrasonographic examination
722636|NCT00155311|orthodontic tooth movement|orthodontic tooth movement
722637|NCT00155311|OPG|opg
722638|NCT00155311|RANKL|rankl
722639|NCT00155285|heart diseases|heart diseases
722640|NCT00155285|congenital|congenital
722641|NCT00155272|Hepatocellular Carcinoma|hepatocellular carcinoma
722642|NCT00155272|Radiotherapy|radiotherapy
722643|NCT00155272|Thalidomide|thalidomide
722644|NCT00155272|Dynamic contrast enhanced MRI|dynamic contrast enhanced mri
722645|NCT00155259|Breast Cancer , Neoadjuvant Chemotherapy|breast cancer , neoadjuvant chemotherapy
722646|NCT00155246|CKD, pentoxifylline|ckd, pentoxifylline
722647|NCT00155233|analgeisa|analgeisa
722648|NCT00155233|postoperatve|postoperatve
722649|NCT00155233|side effects|side effects
722650|NCT00155207|Schizophrenia|schizophrenia
722651|NCT00155207|endophenotype|endophenotype
722652|NCT00155207|risk genetic mutation|risk genetic mutation
722653|NCT00155207|vulnerability genes|vulnerability genes
722654|NCT00155207|affected sib-pairs|affected sib-pairs
722655|NCT00155207|case-control design|case-control design
722656|NCT00155207|animal model|animal model
722657|NCT00155207|functional validity|functional validity
722658|NCT00155207|genetic epidemiological analysis|genetic epidemiological analysis
722659|NCT00155181|Epstein-Barr virus|epstein-barr virus
722660|NCT00155181|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
722661|NCT00155181|Carcinogenesis|carcinogenesis
722662|NCT00155168|Spinal muscular atrophy (SMA)|spinal muscular atrophy (sma)
722663|NCT00155168|SMN1/SMN2 gene|smn1/smn2 gene
722664|NCT00155168|denaturing high-performance liquid chromatography (DHPLC)|denaturing high-performance liquid chromatography (dhplc)
722665|NCT00155168|multiplex PCR|multiplex pcr
722666|NCT00155168|gene dose|gene dose
722667|NCT00155168|carrier test|carrier test
722668|NCT00155129|migraine|migraine
722669|NCT00155129|CGRP|cgrp
722670|NCT00155129|nociceptin|nociceptin
722671|NCT00155103|Hepatitis B|hepatitis b
722672|NCT00155103|Carcinoma, Hepatocellular|carcinoma, hepatocellular
722673|NCT00155103|Polymorphism, Genetic|polymorphism, genetic
722674|NCT00155090|Magnetic resonance imaging,|magnetic resonance imaging,
722675|NCT00155090|breast disease|breast disease
722676|NCT00155077|cervical cancer, chemoradiotherapy, angiogenesis|cervical cancer, chemoradiotherapy, angiogenesis
722677|NCT00155064|Primary aldosteronism|primary aldosteronism
722678|NCT00155064|kallikrein|kallikrein
722679|NCT00155064|aldosterone|aldosterone
722680|NCT00155064|captopril|captopril
722681|NCT00155038|Breast neoplasms|breast neoplasms
722682|NCT00155038|breast radiography|breast radiography
722683|NCT00155038|young women.|young women.
722684|NCT00155025|Prostatic neoplasms|prostatic neoplasms
722685|NCT00155025|Family history|family history
722686|NCT00154999|hyperbilirubinemia|hyperbilirubinemia
722687|NCT00154999|free radicals|free radicals
722688|NCT00154999|Health neonate|health neonate
722689|NCT00154986|invasion|invasion
722690|NCT00154986|migration|migration
722691|NCT00154986|metastasis|metastasis
722692|NCT00154986|IGFBP-3|igfbp-3
722693|NCT00154986|transfection|transfection
722694|NCT00154986|signal transduction.|signal transduction.
722695|NCT00154973|oral precancers|oral precancers
722696|NCT00154973|oral cancer|oral cancer
722697|NCT00154973|hypoxia-inducible factor|hypoxia-inducible factor
722698|NCT00154960|Spinal muscular atrophy (SMA)|spinal muscular atrophy (sma)
722699|NCT00154960|SMN1/SMN2 gene|smn1/smn2 gene
722700|NCT00154960|denaturing high-performance liquid chromatography (DHPLC)|denaturing high-performance liquid chromatography (dhplc)
722701|NCT00154960|multiplex PCR|multiplex pcr
722702|NCT00154960|gene dose|gene dose
722703|NCT00154960|carrier test|carrier test
722704|NCT00154960|screen|screen
722705|NCT00154960|stool|stool
722706|NCT00154960|microsatellite|microsatellite
722707|NCT00154895|minocycline|minocycline
722708|NCT00154895|pleurodesis|pleurodesis
722709|NCT00154895|thoracoscopy|thoracoscopy
722710|NCT00154895|primary spontaneous pneumothorax|primary spontaneous pneumothorax
722711|NCT00154895|clinical trial|clinical trial
722712|NCT00154882|Breast Cancer|breast cancer
722713|NCT00154882|First-line|first-line
722714|NCT00154869|Patients with dual chronic hepatitis B and C|patients with dual chronic hepatitis b and c
722715|NCT00154856|osteogenesis|osteogenesis
722716|NCT00154856|Ilizarov fixator|ilizarov fixator
722717|NCT00154856|motion analysis|motion analysis
722718|NCT00154856|FEM|fem
722719|NCT00154856|bone stress|bone stress
722720|NCT00154843|Lycopene|lycopene
722721|NCT00154843|BPH|bph
722722|NCT00154843|PSA|psa
722723|NCT00154843|IPSS|ipss
722724|NCT00154817|radiotherapy|radiotherapy
722725|NCT00154817|dynamic contrast enhanced MRI|dynamic contrast enhanced mri
722726|NCT00154817|hepatocellular carcinoma|hepatocellular carcinoma
722727|NCT00154804|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
722728|NCT00154804|Esophageal Cancer|esophageal cancer
722729|NCT00154791|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
722730|NCT00154791|Oxaliplatin|oxaliplatin
722731|NCT00154791|Gemcitabine|gemcitabine
722732|NCT00154791|5-FU|5-fu
722733|NCT00154778|Combination,Chemotherapy,Advanced Gastric Cancer|combination,chemotherapy,advanced gastric cancer
722734|NCT00154752|Rectal cancer, CCRT, Pelvic lymphadenoectomy.|rectal cancer, ccrt, pelvic lymphadenoectomy.
722735|NCT00154739|Combination, Chemotherapy,non-small cell lung cancer|combination, chemotherapy,non-small cell lung cancer
722736|NCT00154726|Paclitaxel-HDFL,Locally Advanced and Recurrent/Metastatic Gastric Cancer|paclitaxel-hdfl,locally advanced and recurrent/metastatic gastric cancer
722737|NCT00154713|colorectal cancer|colorectal cancer
722738|NCT00154713|dendritic cell|dendritic cell
722739|NCT00154713|CEA|cea
722740|NCT00154713|IL-2|il-2
722741|NCT00154700|Combination,Chemotherapy,Esophageal Cancer|combination,chemotherapy,esophageal cancer
722742|NCT00154687|Combination, Chemotherapy,transitional cell carcinoma|combination, chemotherapy,transitional cell carcinoma
722743|NCT00154661|glomerulonephritis|glomerulonephritis
722745|NCT00154648|DSA|dsa
722746|NCT00154648|gadovist|gadovist
722747|NCT00154648|angiography|angiography
722748|NCT00154635|Alzheimer's disease|alzheimer's disease
722749|NCT00154635|Fo-ti|fo-ti
722750|NCT00154635|Chinese herbs|chinese herbs
722751|NCT00154622|musculoskeletal disorder, work hardening, return to work|musculoskeletal disorder, work hardening, return to work
722752|NCT00154596|etiology|etiology
722753|NCT00154596|transmission|transmission
722754|NCT00154596|vasculitis|vasculitis
722755|NCT00154596|household|household
722756|NCT00154596|etiology of disease|etiology of disease
722757|NCT00154583|cervical cancer|cervical cancer
722758|NCT00154583|human papillomavirus|human papillomavirus
722759|NCT00154583|cancer vaccine|cancer vaccine
722760|NCT00154583|normal volunteer|normal volunteer
722761|NCT00154570|reflux esophagitis|reflux esophagitis
722762|NCT00154570|24 hour esophageal pH|24 hour esophageal ph
722763|NCT00154570|electrogastrography (EGG)|electrogastrography (egg)
722764|NCT00154570|Running Spectral Analysis (RSA)|running spectral analysis (rsa)
722765|NCT00154557|Judo, Performance, Injury|judo, performance, injury
722766|NCT00154518|orthodontic tooth movement|orthodontic tooth movement
722767|NCT00154518|matrix metalloproteinase|matrix metalloproteinase
722768|NCT00154518|Orthodontics|orthodontics
722769|NCT00154505|Scoliosis|scoliosis
722770|NCT00154505|Spinal Cord Injury|spinal cord injury
722771|NCT00154505|Lateral Trunk Support|lateral trunk support
722772|NCT00154505|Radiography|radiography
722773|NCT00154492|Active variceal bleeding in patients with advanced cirrhosis|active variceal bleeding in patients with advanced cirrhosis
722774|NCT00154479|Cervical cancer|cervical cancer
722775|NCT00154479|Human papillomavirus|human papillomavirus
722776|NCT00154479|Human leukocyte antigen|human leukocyte antigen
722777|NCT00154479|immunologic response|immunologic response
722778|NCT00154479|healthy volunteers|healthy volunteers
722779|NCT00154466|Myocardial infarction, stem cell, cardiac rehabilitation|myocardial infarction, stem cell, cardiac rehabilitation
722780|NCT00154453|Aging|aging
722781|NCT00154453|Orbicularis oculi|orbicularis oculi
722782|NCT00154453|Blepharoplasty|blepharoplasty
722783|NCT00154453|Myosin heavy chain (MHC)|myosin heavy chain (mhc)
722784|NCT00154440|primary gastric MALT lymphoma|primary gastric malt lymphoma
722785|NCT00154440|Helicobacter pylori|helicobacter pylori
722786|NCT00154440|eradication therapy|eradication therapy
722787|NCT00154440|radiation|radiation
722788|NCT00154440|marginal zone B-cell lymphoma|marginal zone b-cell lymphoma
722789|NCT00154440|Mucosa-associated Lymphoid Tissue|mucosa-associated lymphoid tissue
722790|NCT00154440|B-cell Non-Hodgkin's Lymphoma of the stomach|b-cell non-hodgkin's lymphoma of the stomach
722791|NCT00154440|primary gastric lymphoma|primary gastric lymphoma
722792|NCT00154388|adenocarcinoma|adenocarcinoma
722793|NCT00154388|leiomyosarcoma|leiomyosarcoma
722794|NCT00154388|angiosarcoma|angiosarcoma
722795|NCT00154388|synovial sarcoma|synovial sarcoma
722796|NCT00154388|myelodysplastic syndrome/HES|myelodysplastic syndrome/hes
722797|NCT00154388|CMML|cmml
722798|NCT00154388|multiple myeloma|multiple myeloma
722799|NCT00154388|embryonal rhabdomyosarcoma|embryonal rhabdomyosarcoma
722800|NCT00154388|endometrial sarcoma|endometrial sarcoma
722801|NCT00154388|adenoid cystic carcinoma|adenoid cystic carcinoma
722802|NCT00154388|fibromatosis|fibromatosis
722803|NCT00154388|ductal invasive breast carcinoma|ductal invasive breast carcinoma
722804|NCT00154388|chondrosarcoma|chondrosarcoma
722805|NCT00154388|pleural tumor|pleural tumor
722806|NCT00154388|brenner tumor|brenner tumor
722807|NCT00154388|ewing sarcoma|ewing sarcoma
722808|NCT00154388|round cell tumor|round cell tumor
722809|NCT00154388|seminoma|seminoma
722810|NCT00154388|thymic carcinoma|thymic carcinoma
722811|NCT00154388|malignant melanoma|malignant melanoma
722812|NCT00154388|fibrosarcoma breast|fibrosarcoma breast
722813|NCT00154388|dermatofibrosarcoma protuberans|dermatofibrosarcoma protuberans
722814|NCT00154388|DFSP|dfsp
722815|NCT00154388|ovarian stromal tumor|ovarian stromal tumor
722816|NCT00154388|osteosarcoma|osteosarcoma
722817|NCT00154388|chorioideal melanoma|chorioideal melanoma
722818|NCT00154388|hemangiopericytoma|hemangiopericytoma
722819|NCT00154388|myelofibrosis|myelofibrosis
722820|NCT00154388|liposarcoma|liposarcoma
722821|NCT00154388|SCLC|sclc
722822|NCT00154388|small cell lung carcinoma|small cell lung carcinoma
722823|NCT00154388|hypereosinophilic syndrome|hypereosinophilic syndrome
722824|NCT00154388|chronic myelo-monocytic leukemia|chronic myelo-monocytic leukemia
722825|NCT00154388|neurofibrosarcoma|neurofibrosarcoma
722826|NCT00154388|mesothelioma|mesothelioma
722827|NCT00154388|malignant mesenchymoma|malignant mesenchymoma
722828|NCT00154388|malignant schwannoma|malignant schwannoma
722829|NCT00154388|mast cell leukemia / mastocytosis|mast cell leukemia / mastocytosis
722830|NCT00154388|renal cell carcinoma|renal cell carcinoma
722831|NCT00154388|malignant histocytoma|malignant histocytoma
722832|NCT00154388|chordoma|chordoma
722833|NCT00154375|Open label|open label
722834|NCT00154375|Imatinib mesylate|imatinib mesylate
722835|NCT00154375|hydroxyurea|hydroxyurea
722836|NCT00154375|temozolomide|temozolomide
722837|NCT00154375|resistant|resistant
723501|NCT00150722|statins|statins
722838|NCT00154375|protein tyrosine kinases|protein tyrosine kinases
722839|NCT00154375|adenocarcinoma|adenocarcinoma
722840|NCT00154375|glioblastoma multiforme|glioblastoma multiforme
722841|NCT00154375|astrocytoma|astrocytoma
722842|NCT00154375|brain tumor|brain tumor
722843|NCT00154375|brain cancer|brain cancer
722844|NCT00154362|Oxcarbazepine, conduct disorder, adolescents|oxcarbazepine, conduct disorder, adolescents
722845|NCT00154349|Ph+ALL|ph+all
722846|NCT00154349|imatinib mesylate|imatinib mesylate
722847|NCT00154336|Rheumatoid arthritis, imatinib, methotrexate|rheumatoid arthritis, imatinib, methotrexate
722848|NCT00154323|Oxcarbazepine, bipolar disorder|oxcarbazepine, bipolar disorder
722849|NCT00154310|Renal transplantation, everolimus, immunosuppressants, CNI-free|renal transplantation, everolimus, immunosuppressants, cni-free
722850|NCT00154297|Renal transplantation|renal transplantation
722851|NCT00154297|everolimus|everolimus
722852|NCT00154297|immunosuppressants|immunosuppressants
722853|NCT00154297|wound-healing|wound-healing
722854|NCT00154284|Renal transplantation,|renal transplantation,
722855|NCT00154284|everolimus,|everolimus,
722856|NCT00154284|immunosuppressants,|immunosuppressants,
722857|NCT00154284|basiliximab,|basiliximab,
722858|NCT00154284|cyclosporine microemulsion discontinuation, cyclosporine microemulsion minimization|cyclosporine microemulsion discontinuation, cyclosporine microemulsion minimization
722859|NCT00154271|Hypertension (HTN)|hypertension (htn)
722860|NCT00154271|High Sensitivity C-Reactive Protein|high sensitivity c-reactive protein
722861|NCT00154258|Schizophrenia, treatment-resistant, clozapine|schizophrenia, treatment-resistant, clozapine
722862|NCT00154245|Enteric-coated mycophenolate sodium, transplantation, de novo, cyclosporine|enteric-coated mycophenolate sodium, transplantation, de novo, cyclosporine
722863|NCT00154232|Renal transplantation, DGF, basiliximab, EC-MPS, cyclosporine|renal transplantation, dgf, basiliximab, ec-mps, cyclosporine
722864|NCT00154219|Osteoarthritis, Hip, Lumiracoxib, Efficacy, Safety|osteoarthritis, hip, lumiracoxib, efficacy, safety
722865|NCT00154206|Enteric-coated mycophenolate sodium,|enteric-coated mycophenolate sodium,
722866|NCT00154206|de novo,|de novo,
722867|NCT00154206|renal transplantation,|renal transplantation,
722868|NCT00154206|pediatric|pediatric
722869|NCT00154206|De novo pediatric renal transplantation|de novo pediatric renal transplantation
722870|NCT00154193|Heart transplant, lung transplant, renal function, cyclosporine C2 Levels|heart transplant, lung transplant, renal function, cyclosporine c2 levels
722871|NCT00154180|Perimenopause|perimenopause
722872|NCT00154180|Coronary Disease|coronary disease
722873|NCT00154180|Estrogen Replacement Therapy|estrogen replacement therapy
722874|NCT00154180|Hormone Replacement Therapy|hormone replacement therapy
722875|NCT00154154|borderline personality disorder|borderline personality disorder
722876|NCT00154154|BPD|bpd
722877|NCT00154154|treatment|treatment
722878|NCT00154154|dialectical behavior therapy|dialectical behavior therapy
722879|NCT00154154|DBT|dbt
722880|NCT00154154|general Psychiatric management|general psychiatric management
722881|NCT00154154|GPM|gpm
722882|NCT00154154|suicide|suicide
722883|NCT00154154|parasuicide|parasuicide
722884|NCT00154154|randomized control trials|randomized control trials
722885|NCT00154128|temporomandibular disorder|temporomandibular disorder
722886|NCT00154128|craniomandibular disorder|craniomandibular disorder
722887|NCT00154128|occlusal appliance|occlusal appliance
722888|NCT00154128|clinical trial|clinical trial
722889|NCT00154115|heart failure|heart failure
722890|NCT00154115|levosimendan|levosimendan
722891|NCT00154115|cardiac surgery|cardiac surgery
722892|NCT00154102|Metastatic colorectal cancer|metastatic colorectal cancer
722893|NCT00154102|EGFR|egfr
722894|NCT00154102|Irinotecan|irinotecan
722895|NCT00154102|cetuximab|cetuximab
722896|NCT00154102|first-line treatment|first-line treatment
722897|NCT00154089|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
722898|NCT00154089|CIN|cin
722899|NCT00154089|HPV|hpv
722900|NCT00154050|restenosis|restenosis
722901|NCT00154050|intima hyperproliferation|intima hyperproliferation
722902|NCT00154050|stent angioplasty|stent angioplasty
722903|NCT00154050|pain-free walking distance|pain-free walking distance
722904|NCT00154037|vascular reactivity|vascular reactivity
722905|NCT00154037|venodilation|venodilation
722906|NCT00154037|pulse wave velocity|pulse wave velocity
722907|NCT00154024|venoconstriction|venoconstriction
722908|NCT00154024|venodilation|venodilation
722909|NCT00154024|pleiotropic effects|pleiotropic effects
722910|NCT00154011|vascular reactivity, venodilation|vascular reactivity, venodilation
722911|NCT00153998|Cetuximab|cetuximab
722912|NCT00153998|Oxaliplatin|oxaliplatin
722913|NCT00153998|Irinotecan|irinotecan
722914|NCT00153998|5-FU|5-fu
722915|NCT00153998|Chemotherapy|chemotherapy
722916|NCT00153998|Resection|resection
722917|NCT00153998|Liver resection|liver resection
722918|NCT00153998|Neoadjuvant|neoadjuvant
722919|NCT00153985|Hemoglobinopathies|hemoglobinopathies
722920|NCT00153985|Sickle cell anemia|sickle cell anemia
722921|NCT00153985|sickle cell-hemoglobin C disease|sickle cell-hemoglobin c disease
722922|NCT00153985|sickle cell-B-thalassemia|sickle cell-b-thalassemia
722923|NCT00153985|transfusion-dependant thalassemia|transfusion-dependant thalassemia
722924|NCT00153985|allogeneic transplant|allogeneic transplant
722925|NCT00153985|nonmyeloablative transplant|nonmyeloablative transplant
722926|NCT00153985|Stem cell transfusion|stem cell transfusion
722927|NCT00153985|graft vs. host disease|graft vs. host disease
722928|NCT00153972|Parkinson's disease|parkinson's disease
722929|NCT00153972|Fluoro-Dopa-PET|fluoro-dopa-pet
722930|NCT00153972|Dopamine agonists|dopamine agonists
722931|NCT00153972|Cabergoline|cabergoline
722932|NCT00153972|Surrogate marker|surrogate marker
722933|NCT00153972|Dopamine turnover|dopamine turnover
722934|NCT00153946|Free Radical Scavenger|free radical scavenger
722935|NCT00153946|Selective Thrombin Inhibitor|selective thrombin inhibitor
722936|NCT00153946|Acute ischemic stroke (nonlacunar and noncardioembolic)|acute ischemic stroke (nonlacunar and noncardioembolic)
722937|NCT00153933|Multiple Myeloma|multiple myeloma
722938|NCT00153933|bortezomib|bortezomib
722939|NCT00153933|Revlimid|revlimid
722940|NCT00153933|CC-5013|cc-5013
722941|NCT00153920|multiple myeloma|multiple myeloma
722942|NCT00153920|Velcade|velcade
722943|NCT00153920|bortezomib|bortezomib
722944|NCT00153907|Xeloda|xeloda
722945|NCT00153907|Navelbine|navelbine
722946|NCT00153907|capecitabine|capecitabine
722947|NCT00153907|metastatic breast cancer|metastatic breast cancer
722948|NCT00153894|Breast cancer survivor|breast cancer survivor
722949|NCT00153894|Insulin levels|insulin levels
722950|NCT00153894|exercise regimen|exercise regimen
722951|NCT00153894|endurance training|endurance training
722952|NCT00153894|strength training|strength training
722953|NCT00153881|Esophageal Cancer|esophageal cancer
722954|NCT00153881|Trimodality|trimodality
722955|NCT00153881|Capecitabine|capecitabine
722956|NCT00153881|Xeloda|xeloda
722957|NCT00153881|Gastro-esophageal Neoplasm|gastro-esophageal neoplasm
722958|NCT00153881|Carcinoma of the Esophagus|carcinoma of the esophagus
722959|NCT00153868|Anemia|anemia
722960|NCT00153868|Cancer|cancer
722961|NCT00153868|Quality of life|quality of life
722962|NCT00153868|Web-based|web-based
722963|NCT00153868|Aranesp|aranesp
722964|NCT00153868|Darbepoetin alfa|darbepoetin alfa
722965|NCT00153855|etiology|etiology
722966|NCT00153855|pathology|pathology
722967|NCT00153842|NSCLC|nsclc
722968|NCT00153842|Bexarotene|bexarotene
722969|NCT00153842|Targretin|targretin
722970|NCT00153829|Chronic Disease|chronic disease
722971|NCT00153829|Quality of Life|quality of life
722972|NCT00153816|Colorectal neoplasms|colorectal neoplasms
722973|NCT00153816|Adenomatous polyps|adenomatous polyps
722974|NCT00153803|Erlotinib|erlotinib
722975|NCT00153803|Tarceva|tarceva
722976|NCT00153803|Web based|web based
722977|NCT00153803|Stage III NSCLC|stage iii nsclc
722978|NCT00153790|green tea|green tea
722979|NCT00153790|weight|weight
722980|NCT00153790|women|women
722981|NCT00153777|HIV prevention|hiv prevention
722982|NCT00153777|Randomized controlled trial|randomized controlled trial
722983|NCT00153777|Women|women
722984|NCT00153777|Sexually transmitted infections|sexually transmitted infections
722985|NCT00153777|HIV Seronegativity|hiv seronegativity
722986|NCT00153764|supplement|supplement
722987|NCT00153764|omega-3 fatty acid|omega-3 fatty acid
722988|NCT00153764|Homocysteine|homocysteine
722989|NCT00153764|LDL cholesterol|ldl cholesterol
722990|NCT00153751|Traditional Chinese Medicine|traditional chinese medicine
722991|NCT00153738|LDL-C, phytosterol|ldl-c, phytosterol
722992|NCT00153712|Non-NSAID|non-nsaid
722993|NCT00153712|Non-Hp Bleeding Peptic Ulcer|non-hp bleeding peptic ulcer
722994|NCT00153699|Side effects|side effects
722995|NCT00153699|Topiramate|topiramate
722996|NCT00153686|Capsule Endoscopy|capsule endoscopy
722997|NCT00153686|Mesenteric angiogram|mesenteric angiogram
722998|NCT00153673|celecoxib|celecoxib
722999|NCT00153673|arthritis|arthritis
723000|NCT00153673|ulcer healing|ulcer healing
723001|NCT00153634|Cystic fibrosis|cystic fibrosis
723002|NCT00153634|Antibiotic susceptibility testing|antibiotic susceptibility testing
723003|NCT00153634|Pseudomonas aeruginosa|pseudomonas aeruginosa
723004|NCT00153634|Chronic bronchitis|chronic bronchitis
723005|NCT00153634|Biofilms|biofilms
723006|NCT00153621|Pediatrics|pediatrics
723007|NCT00153621|Chronic Kidney Failure|chronic kidney failure
723008|NCT00153621|HIV|hiv
723009|NCT00153621|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
723010|NCT00153621|AIDS-Associated Nephropathy|aids-associated nephropathy
723011|NCT00153595|Allergic rhinitis|allergic rhinitis
723012|NCT00153595|EWO1|ewo1
723013|NCT00153556|Haemophilus influenza type B|haemophilus influenza type b
723014|NCT00153556|Carrier state|carrier state
723015|NCT00153556|Bacterial Vaccines|bacterial vaccines
723016|NCT00153556|Anti-PRP antibody|anti-prp antibody
723017|NCT00153556|Antibody avidity|antibody avidity
723018|NCT00153556|Serum bacteriocidal antibody|serum bacteriocidal antibody
723019|NCT00153556|American Indians/Alaska Natives|american indians/alaska natives
723020|NCT00153556|Case control study|case control study
723021|NCT00153556|Adult vaccines|adult vaccines
723022|NCT00153530|primary central nervous system lymphoma|primary central nervous system lymphoma
723023|NCT00153517|Bacterial Vaginosis|bacterial vaginosis
723024|NCT00153517|Metronidazole|metronidazole
723025|NCT00153504|HIV|hiv
723026|NCT00153504|AIDS|aids
723027|NCT00153504|Homeless|homeless
723028|NCT00153504|Homelessness|homelessness
723029|NCT00153504|Housing|housing
723030|NCT00153504|HIV seropositive|hiv seropositive
723031|NCT00153504|HIV risk behavior|hiv risk behavior
723032|NCT00153491|malaria|malaria
723033|NCT00153491|artemether-lumefantrine|artemether-lumefantrine
723034|NCT00153491|co-artem|co-artem
723035|NCT00153491|Tanzania|tanzania
723036|NCT00153491|adherence|adherence
723037|NCT00153478|Alcohol-Exposed Pregnancy|alcohol-exposed pregnancy
723038|NCT00153478|Binge drinking|binge drinking
723039|NCT00153478|Frequent drinking|frequent drinking
723040|NCT00153478|Unintended pregnancy|unintended pregnancy
723041|NCT00153478|Fetal Alcohol Syndrome|fetal alcohol syndrome
723042|NCT00153465|Parent training|parent training
723043|NCT00153465|Child maltreatment|child maltreatment
723044|NCT00153465|Motivation|motivation
723045|NCT00153465|Program attrition|program attrition
723046|NCT00153439|parenting|parenting
723047|NCT00153439|motivation|motivation
723048|NCT00153439|child maltreatment|child maltreatment
723049|NCT00153439|program attrition|program attrition
723050|NCT00153400|CVD risk|cvd risk
723051|NCT00153361|HIV Seronegativity|hiv seronegativity
723052|NCT00153361|HIV|hiv
723053|NCT00153335|Health Risk Assessment|health risk assessment
723054|NCT00153335|Behavior Change|behavior change
723055|NCT00153335|Patient-Provider Interaction|patient-provider interaction
723056|NCT00153335|Employee Health|employee health
723057|NCT00153335|Absenteeism|absenteeism
723058|NCT00153335|Tobacco Use|tobacco use
723059|NCT00153335|Substance Use|substance use
723060|NCT00153335|Diet|diet
723061|NCT00153335|Exercise|exercise
723062|NCT00153335|Medication Adherence|medication adherence
723063|NCT00153322|Childhood Obesity|childhood obesity
723064|NCT00153322|Community-based Participatory Research|community-based participatory research
723065|NCT00153322|School intervention|school intervention
723066|NCT00153322|Parental Involvement|parental involvement
723067|NCT00153309|arthritis|arthritis
723068|NCT00153309|exercise|exercise
723069|NCT00153309|physical activity|physical activity
723070|NCT00153309|physical function|physical function
723071|NCT00153309|pain|pain
723072|NCT00153296|Bronchial asthma|bronchial asthma
723073|NCT00153296|Carbamazepine|carbamazepine
723074|NCT00153296|Antiepileptic drugs|antiepileptic drugs
723075|NCT00153296|Efficacy|efficacy
723076|NCT00153283|Bronchial asthma|bronchial asthma
723077|NCT00153283|Gabapentin|gabapentin
723078|NCT00153283|Antiepileptic drug|antiepileptic drug
723079|NCT00153283|Efficacy|efficacy
723080|NCT00153270|Bronchial asthma|bronchial asthma
723081|NCT00153270|Sodium valproate|sodium valproate
723082|NCT00153270|Antiepileptic drug|antiepileptic drug
723083|NCT00153270|Efficacy|efficacy
723084|NCT00153244|Bronchial asthma|bronchial asthma
723085|NCT00153244|Lamotrigine|lamotrigine
723086|NCT00153244|Antiepileptic drug|antiepileptic drug
723087|NCT00153244|Efficacy|efficacy
723088|NCT00153218|Metastatic Breast Cancer|metastatic breast cancer
723089|NCT00153218|Her2neu|her2neu
723090|NCT00153218|trastuzumab|trastuzumab
723091|NCT00153205|medication errors|medication errors
723092|NCT00153205|medical records systems, computerized|medical records systems, computerized
723093|NCT00153205|patient safety|patient safety
723094|NCT00153192|Marinol|marinol
723095|NCT00153192|Dronabinol|dronabinol
723096|NCT00153192|Cannabinoid|cannabinoid
723097|NCT00153192|Chronic Pain|chronic pain
723098|NCT00153179|insulin resistance|insulin resistance
723099|NCT00153179|insulin signaling|insulin signaling
723100|NCT00153179|endothelium-dependent vasodilation|endothelium-dependent vasodilation
723101|NCT00153166|peripheral arterial disease|peripheral arterial disease
723102|NCT00153166|intermittent claudication|intermittent claudication
723103|NCT00152945|intestinal lipoprotein|intestinal lipoprotein
723104|NCT00152945|very low density lipoprotein|very low density lipoprotein
723105|NCT00152945|free fatty acids|free fatty acids
723106|NCT00152945|Apo B48 and Apo B100|apo b48 and apo b100
723107|NCT00152945|triglycerides|triglycerides
723108|NCT00152945|Intestinal lipoprotein production|intestinal lipoprotein production
723109|NCT00152932|Glaucoma|glaucoma
723110|NCT00152932|Intraocular pressure|intraocular pressure
723111|NCT00152932|Ocular blood flow|ocular blood flow
723112|NCT00152932|Laser-Doppler Flowmetry|laser-doppler flowmetry
723113|NCT00152893|HIV|hiv
723114|NCT00152893|blood sugar > 6.1 mmol/l|blood sugar > 6.1 mmol/l
723115|NCT00152893|triglycerides > 2 mmol/l|triglycerides > 2 mmol/l
723116|NCT00152893|total cholesterol > 5.5 mmol/l or HDL < 0.9 mmol/l|total cholesterol > 5.5 mmol/l or hdl < 0.9 mmol/l
723117|NCT00152880|Hepatitis B, apoptosis|hepatitis b, apoptosis
723118|NCT00152867|quality of life|quality of life
723119|NCT00152867|dexamethasone|dexamethasone
723120|NCT00152867|emesis|emesis
723121|NCT00152854|cancer pain|cancer pain
723122|NCT00152854|acetaminophen|acetaminophen
723123|NCT00152854|opioids|opioids
723124|NCT00152815|HIV|hiv
723125|NCT00152815|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
723126|NCT00152802|liver transplant|liver transplant
723127|NCT00152802|antibody response|antibody response
723128|NCT00152802|opsonophagocytic assay|opsonophagocytic assay
723129|NCT00152802|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
723130|NCT00152802|pneumococcal polysaccharide vaccine|pneumococcal polysaccharide vaccine
723131|NCT00152776|menopausal symptoms|menopausal symptoms
723132|NCT00152776|complementary medicine|complementary medicine
723133|NCT00152763|health anxiety|health anxiety
723134|NCT00152750|Tourette's Syndrome|tourette's syndrome
723135|NCT00152750|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
723136|NCT00152750|Children|children
723137|NCT00152750|Sleep disorders|sleep disorders
723138|NCT00152750|Aggression|aggression
723139|NCT00152737|Intermittent Claudication|intermittent claudication
723140|NCT00152737|Peripheral Vascular Diseases|peripheral vascular diseases
723141|NCT00152737|Blood Gas Monitoring, Transcutaneous|blood gas monitoring, transcutaneous
723142|NCT00152737|Surgery|surgery
723143|NCT00152724|Physiology|physiology
723144|NCT00152724|Microcirculation|microcirculation
723145|NCT00152724|Laser-Doppler Flowmetry|laser-doppler flowmetry
723146|NCT00152659|Epilepsy|epilepsy
723147|NCT00152659|Tumor|tumor
723148|NCT00152659|Surgery|surgery
723149|NCT00152659|Brain|brain
723150|NCT00152633|endothelium, hypertension, retina, AT1|endothelium, hypertension, retina, at1
723151|NCT00152620|Inflammatory Bowel Disease (IBD)|inflammatory bowel disease (ibd)
723152|NCT00152607|Liver Transplantation|liver transplantation
723153|NCT00152607|Living Donors|living donors
723154|NCT00152607|End Stage Liver Disease|end stage liver disease
723155|NCT00152581|HCV, genotype 1, treatment, HCV kinetics, T-cells|hcv, genotype 1, treatment, hcv kinetics, t-cells
723156|NCT00152568|Car Seat Check|car seat check
723157|NCT00152555|SLE,|sle,
723158|NCT00152555|exercize,|exercize,
723159|NCT00152555|physical therapy,|physical therapy,
723160|NCT00152555|Systemic lupus erythematosus|systemic lupus erythematosus
723161|NCT00152555|relaxation therapy|relaxation therapy
723162|NCT00152542|Inhaled nitric oxide,|inhaled nitric oxide,
723163|NCT00152542|Lung recruitment,|lung recruitment,
723164|NCT00152542|Ventilatory approach,|ventilatory approach,
723165|NCT00152542|Neurodevelopmental outcomes,|neurodevelopmental outcomes,
723166|NCT00152542|School age children|school age children
723167|NCT00152529|Depression, educational site for depression|depression, educational site for depression
723168|NCT00152516|Partial Onset Seizures|partial onset seizures
723169|NCT00152516|levetiracetam|levetiracetam
723170|NCT00152516|Epilepsy|epilepsy
723171|NCT00152516|Keppra|keppra
723172|NCT00152503|Epilepsy, Partial Onset Seizures, Seletracetam|epilepsy, partial onset seizures, seletracetam
723173|NCT00152490|Crohn's disease, CDP870, CDAI, clinical response, remission,|crohn's disease, cdp870, cdai, clinical response, remission,
723174|NCT00152490|Certolizumab Pegol, Cimzia|certolizumab pegol, cimzia
723175|NCT00152477|Non-small-cell-lung cancer|non-small-cell-lung cancer
723176|NCT00152477|carboplatin|carboplatin
723177|NCT00152477|paclitaxel|paclitaxel
723178|NCT00152477|VEGF|vegf
723179|NCT00152477|monoclonal antibody|monoclonal antibody
723180|NCT00152464|EPAAC , atopic Children, asthma, XYZAL, levocetirizine|epaac , atopic children, asthma, xyzal, levocetirizine
723181|NCT00152451|Epilepsy: partial onset seizures, seletracetam|epilepsy: partial onset seizures, seletracetam
723182|NCT00152438|Vasomotor symptoms|vasomotor symptoms
723183|NCT00152438|Menopause|menopause
723184|NCT00152425|Crohn's disease, CDP870, CDAI, clinical response, remission, Certolizumab Pegol, Cimzia|crohn's disease, cdp870, cdai, clinical response, remission, certolizumab pegol, cimzia
723185|NCT00152412|Allergic Rhinitis, safety, levocetirizine, children|allergic rhinitis, safety, levocetirizine, children
723186|NCT00152412|Xyzal|xyzal
723187|NCT00152399|Peptic ulcer bleeding, upper intestinal bleeding, endoscopy, somatostatin|peptic ulcer bleeding, upper intestinal bleeding, endoscopy, somatostatin
723188|NCT00152386|Rheumatoid Arthritis, CDP870|rheumatoid arthritis, cdp870
723189|NCT00152386|Certolizumab pegol, Cimzia|certolizumab pegol, cimzia
723190|NCT00152373|Epilepsy, Partial Onset Seizures; Keppra; Levetiracetam|epilepsy, partial onset seizures; keppra; levetiracetam
723191|NCT00152360|Obesity|obesity
723192|NCT00152360|weight loss|weight loss
723193|NCT00152360|cardiovascular risk factors|cardiovascular risk factors
723194|NCT00152360|Obesity and obesity related pathology|obesity and obesity related pathology
723195|NCT00152334|Efficacy study|efficacy study
723196|NCT00152334|assessment of patient outcomes following treatment|assessment of patient outcomes following treatment
723197|NCT00152321|osteoporosis|osteoporosis
723198|NCT00152321|wrist fractures|wrist fractures
723199|NCT00152321|quality improvement|quality improvement
723200|NCT00152321|knowledge translation|knowledge translation
723201|NCT00152295|Postmenopausal|postmenopausal
723202|NCT00152295|Amenorrhea|amenorrhea
723203|NCT00152295|Hormone replacement therapy|hormone replacement therapy
723204|NCT00152295|HRT|hrt
723205|NCT00152295|asoprisnil|asoprisnil
723206|NCT00152295|Estrogen Replacement Therapy, postmenopause|estrogen replacement therapy, postmenopause
723207|NCT00152282|Postmenopausal|postmenopausal
723208|NCT00152282|Amenorrhea|amenorrhea
723209|NCT00152282|Hormone replacement therapy|hormone replacement therapy
723210|NCT00152282|HRT|hrt
723211|NCT00152282|asoprisnil|asoprisnil
723212|NCT00152269|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
723213|NCT00152269|Excessive Uterine Bleeding|excessive uterine bleeding
723599|NCT00149968|EC-MPS|ec-mps
723214|NCT00152269|Uterine Hemorrhage|uterine hemorrhage
723215|NCT00152269|asoprisnil|asoprisnil
723216|NCT00152256|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
723217|NCT00152256|Excessive Uterine Bleeding|excessive uterine bleeding
723218|NCT00152256|Uterine Hemorrhage|uterine hemorrhage
723219|NCT00152243|Stomach Cancer|stomach cancer
723220|NCT00152230|Colorectal Cancer|colorectal cancer
723221|NCT00152217|Stomach cancer|stomach cancer
723222|NCT00152204|Use-Effectiveness|use-effectiveness
723223|NCT00152204|Cost Effectiveness|cost effectiveness
723224|NCT00152204|Patient Acceptance of Health Care|patient acceptance of health care
723225|NCT00152204|Drug Resistance|drug resistance
723226|NCT00152204|Delivery of Health Care|delivery of health care
723227|NCT00152191|Breast Cancer|breast cancer
723228|NCT00152178|Breast Cancer|breast cancer
723229|NCT00152165|spinal motion|spinal motion
723230|NCT00152165|tantalum beads|tantalum beads
723231|NCT00152165|DYNESYS Stabilization system|dynesys stabilization system
723232|NCT00152165|spinal fusion|spinal fusion
723233|NCT00152165|Radiostereometric Analysis following spinal fusion|radiostereometric analysis following spinal fusion
723234|NCT00152165|Radiostereometric Analysis following surgery with DYNESYS Stabilization System|radiostereometric analysis following surgery with dynesys stabilization system
723235|NCT00152152|spinal motion|spinal motion
723236|NCT00152152|tantalum beads|tantalum beads
723237|NCT00152139|High risk hematologic malignancies|high risk hematologic malignancies
723238|NCT00152139|Allogeneic stem cell transplant|allogeneic stem cell transplant
723239|NCT00152139|Matched unrelated donor transplantation|matched unrelated donor transplantation
723240|NCT00152139|Unmanipulated stem cell graft|unmanipulated stem cell graft
723241|NCT00152139|Bone marrow transplantation|bone marrow transplantation
723242|NCT00152126|Autologous stem cell transplantation|autologous stem cell transplantation
723243|NCT00152126|CD133 cell selection|cd133 cell selection
723244|NCT00152126|CliniMACS device|clinimacs device
723245|NCT00152126|Tumor marker|tumor marker
723246|NCT00152126|Tumor purging|tumor purging
723247|NCT00152113|Sickle Cell Anemia|sickle cell anemia
723248|NCT00152113|Stem Cell Transplantation|stem cell transplantation
723249|NCT00152113|Haploidentical stem cell transplant|haploidentical stem cell transplant
723250|NCT00152113|T cell depletion|t cell depletion
723251|NCT00152113|CliniMACS device|clinimacs device
723252|NCT00152100|Severe combined immunodeficiency|severe combined immunodeficiency
723253|NCT00152100|Transplantation|transplantation
723254|NCT00152100|Haploidentical|haploidentical
723255|NCT00152087|Liver cancer|liver cancer
723256|NCT00152087|Brachytherapy|brachytherapy
723257|NCT00152074|Blood pressure|blood pressure
723258|NCT00152074|Sodium|sodium
723259|NCT00152074|Dietary|dietary
723260|NCT00152074|Hypertension or prehypertension|hypertension or prehypertension
723261|NCT00152061|HIV|hiv
723262|NCT00152061|Antiretroviral Drug Resistance|antiretroviral drug resistance
723263|NCT00152061|Treatment Experienced|treatment experienced
723264|NCT00151905|bronchiolitis|bronchiolitis
723265|NCT00151905|hypertonic saline|hypertonic saline
723266|NCT00151879|partial seizures with or without secondary generalization|partial seizures with or without secondary generalization
723267|NCT00151866|Thrombopenia|thrombopenia
723268|NCT00151866|Platelet transfusion|platelet transfusion
723269|NCT00151866|Increment|increment
723270|NCT00151866|Transfusion reactions|transfusion reactions
723271|NCT00151866|Bleeding complication|bleeding complication
723272|NCT00151853|CPB|cpb
723273|NCT00151853|oral anticoagulant therapy|oral anticoagulant therapy
723274|NCT00151853|plasma|plasma
723275|NCT00151853|PCC|pcc
723276|NCT00151840|Purpura, Thrombocytopenic, Idiopathic|purpura, thrombocytopenic, idiopathic
723277|NCT00151840|ITP|itp
723278|NCT00151840|Immunoglobulin, Intravenous|immunoglobulin, intravenous
723279|NCT00151814|Olmesartan PK in children|olmesartan pk in children
723280|NCT00151801|multiple sclerosis|multiple sclerosis
723281|NCT00151801|estroprogestins|estroprogestins
723282|NCT00151801|interferon-beta|interferon-beta
723283|NCT00151801|sex hormones|sex hormones
723284|NCT00151801|MRI|mri
723285|NCT00151775|Treatment of hypertension or high blood pressure in children ages 1-16 years.|treatment of hypertension or high blood pressure in children ages 1-16 years.
723286|NCT00151762|Open label, Diabetes Mellitus|open label, diabetes mellitus
723287|NCT00151762|Long term safety study, extension study|long term safety study, extension study
723288|NCT00151749|Diabetes mellitus|diabetes mellitus
723289|NCT00151736|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
723290|NCT00151736|CLL|cll
723291|NCT00151736|Leukemia|leukemia
723292|NCT00151723|endogenous subclinical hyperthyroidism|endogenous subclinical hyperthyroidism
723293|NCT00151697|diabetes|diabetes
723294|NCT00151697|failing oral treatment|failing oral treatment
723295|NCT00151697|weight gain|weight gain
723296|NCT00151684|Obesity|obesity
723297|NCT00151684|Hyperinsulinism|hyperinsulinism
723298|NCT00151684|Diazoxide|diazoxide
723299|NCT00151671|Surgery|surgery
723300|NCT00151671|Liver Cancer|liver cancer
723301|NCT00151671|Cirrhosis|cirrhosis
723302|NCT00151671|Nutrition|nutrition
723303|NCT00151658|Coronary complex lesions|coronary complex lesions
723304|NCT00151658|Restenosis|restenosis
723305|NCT00151658|Drug eluting stents|drug eluting stents
723306|NCT00151645|Immunotherapy|immunotherapy
723307|NCT00151645|Renal cell carcinoma|renal cell carcinoma
723308|NCT00151645|Metastasis|metastasis
723309|NCT00151645|Lymphokine activated killers|lymphokine activated killers
723310|NCT00151645|Cell therapy|cell therapy
723311|NCT00151632|Immunosuppression|immunosuppression
723312|NCT00151632|Liver transplantation|liver transplantation
723313|NCT00151632|Acute graft rejection|acute graft rejection
723314|NCT00151632|Treatment combination|treatment combination
723315|NCT00151619|Calcium channel blockers|calcium channel blockers
723316|NCT00151619|Heart failure|heart failure
723317|NCT00151619|Hemodynamics|hemodynamics
723318|NCT00151606|Infection prevention|infection prevention
723319|NCT00151606|Isolation|isolation
723320|NCT00151606|Resistant bacteria|resistant bacteria
723321|NCT00151606|MRSA colonization|mrsa colonization
723322|NCT00151593|Cold storage|cold storage
723323|NCT00151593|Liver transplantation|liver transplantation
723324|NCT00151593|Preservation solution|preservation solution
723325|NCT00151580|Hepatitis C|hepatitis c
723326|NCT00151580|Viral recurrence|viral recurrence
723327|NCT00151580|Ribavirin / Interferon|ribavirin / interferon
723328|NCT00151567|Ureterolithiasis|ureterolithiasis
723329|NCT00151567|Alpha1-blocker|alpha1-blocker
723330|NCT00151567|Lower ureteral stone|lower ureteral stone
723331|NCT00151554|Anxiety|anxiety
723332|NCT00151554|Intensive Care Unit (ICU)|intensive care unit (icu)
723333|NCT00151554|Preoperative Information|preoperative information
723334|NCT00151554|Randomized Controlled Trial (RCT)|randomized controlled trial (rct)
723335|NCT00151554|Chronic heart disease|chronic heart disease
723336|NCT00151541|Acne Vulgaris|acne vulgaris
723337|NCT00151541|Acne|acne
723338|NCT00151541|Dermatology|dermatology
723339|NCT00151541|Dapsone|dapsone
723340|NCT00151541|Dapsone Topical Gel|dapsone topical gel
723341|NCT00151515|Alopecia, Balding|alopecia, balding
723342|NCT00151476|Familial adenomatous polyposis|familial adenomatous polyposis
723343|NCT00151476|celecoxib|celecoxib
723344|NCT00151476|IRA|ira
723345|NCT00151476|IPAA|ipaa
723346|NCT00151411|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
723347|NCT00151411|Anovulation|anovulation
723348|NCT00151411|Elevated Testosterone|elevated testosterone
723349|NCT00151346|Epidural|epidural
723350|NCT00151346|Labour pain|labour pain
723351|NCT00151346|Pregnant women|pregnant women
723352|NCT00151346|Epidural anesthesia|epidural anesthesia
723353|NCT00151346|Labour, Obstetric|labour, obstetric
723354|NCT00151346|labor pain|labor pain
723355|NCT00151346|labor, obstetric|labor, obstetric
723356|NCT00151346|labor analgesia|labor analgesia
723357|NCT00151320|diffuse large B cell|diffuse large b cell
723358|NCT00151320|mantle cell lymphoma|mantle cell lymphoma
723359|NCT00151307|Heart surgery|heart surgery
723360|NCT00151307|Cerebral oxygen saturation|cerebral oxygen saturation
723361|NCT00151307|Neuropsychological function|neuropsychological function
723362|NCT00151294|Depression (mild to moderate)|depression (mild to moderate)
723363|NCT00151294|Affective symptoms|affective symptoms
723364|NCT00151294|Emotional lability|emotional lability
723365|NCT00151294|Multiple Sclerosis|multiple sclerosis
723366|NCT00151281|relapsed mantle cell lymphoma|relapsed mantle cell lymphoma
723367|NCT00151268|Batten Disease|batten disease
723368|NCT00151268|Late Infantile Neuronal Lipofuscinosis|late infantile neuronal lipofuscinosis
723369|NCT00151268|LINCL|lincl
723370|NCT00151255|age > 60 years|age > 60 years
723371|NCT00151229|isolated systolic hypertension|isolated systolic hypertension
723372|NCT00151229|valsartan|valsartan
723373|NCT00151229|target blood pressure|target blood pressure
723374|NCT00151216|Batten Disease|batten disease
723375|NCT00151216|Late Infantile Neuronal Ceroid Lipofuscinosis|late infantile neuronal ceroid lipofuscinosis
723376|NCT00151216|LINCL|lincl
723377|NCT00151203|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
723378|NCT00151177|ischemic stroke|ischemic stroke
723379|NCT00151177|CPAP ventilation|cpap ventilation
723380|NCT00151164|transplantation tolerance|transplantation tolerance
723381|NCT00151164|thymus|thymus
723382|NCT00151164|bone marrow|bone marrow
723383|NCT00151164|pediatric heart transplantation|pediatric heart transplantation
723384|NCT00151151|pregnancy prevention|pregnancy prevention
723385|NCT00151151|STD prevention|std prevention
723386|NCT00151151|adolescents|adolescents
723387|NCT00151151|motivational interviewing|motivational interviewing
723388|NCT00151151|abstinence|abstinence
723389|NCT00151151|contraception|contraception
723390|NCT00151151|transtheoretical model|transtheoretical model
723391|NCT00151151|sexual behavior|sexual behavior
723392|NCT00151138|cerebral blood flow, positron emission tomography, magnetic resonance imaging, neuropsychology|cerebral blood flow, positron emission tomography, magnetic resonance imaging, neuropsychology
723393|NCT00151125|Von Willebrand Disease|von willebrand disease
723394|NCT00151125|Bleeding|bleeding
723395|NCT00151125|Coagulation|coagulation
723396|NCT00151125|Hemostatic agent|hemostatic agent
723397|NCT00151112|nerve block|nerve block
723398|NCT00151112|regional anesthesia|regional anesthesia
723399|NCT00151112|injuries|injuries
723400|NCT00151112|diverse malformations|diverse malformations
723401|NCT00151099|preoperative nutrition|preoperative nutrition
723402|NCT00151099|postoperative nausea and vomiting|postoperative nausea and vomiting
723403|NCT00151099|Dysgnathia|dysgnathia
723404|NCT00151099|anesthesia|anesthesia
723405|NCT00151073|Zometa|zometa
723406|NCT00151073|Prostate Cancer|prostate cancer
723407|NCT00151073|Metastatic Prostate Cancer|metastatic prostate cancer
723408|NCT00151034|Urothelial Cancer|urothelial cancer
723409|NCT00151034|Herceptin|herceptin
723410|NCT00151034|Advanced Urothelial Cancer|advanced urothelial cancer
723411|NCT00151021|Diabetes|diabetes
723412|NCT00151021|Pedometer|pedometer
723413|NCT00151021|Behavioral|behavioral
723414|NCT00151008|psoriasis|psoriasis
723415|NCT00151008|bexarotene|bexarotene
723416|NCT00151008|narrow band|narrow band
723417|NCT00151008|UVB|uvb
723418|NCT00150982|psoriasis|psoriasis
723419|NCT00150982|alefacept|alefacept
723420|NCT00150969|vitamin K|vitamin k
723421|NCT00150969|bone mineral density|bone mineral density
723422|NCT00150969|post-menopausal women|post-menopausal women
723423|NCT00150969|randomized double blind placebo controlled trial|randomized double blind placebo controlled trial
723424|NCT00150969|osteoporosis|osteoporosis
723425|NCT00150969|women's health|women's health
723426|NCT00150943|Renal artery stenosis|renal artery stenosis
723427|NCT00150943|Stent|stent
723428|NCT00150943|Renal failure|renal failure
723429|NCT00150943|Atorvastatin|atorvastatin
723430|NCT00150943|Hypertension|hypertension
723431|NCT00150943|Atherosclerosis|atherosclerosis
723432|NCT00150930|psoriasis|psoriasis
723433|NCT00150930|ultraviolet|ultraviolet
723434|NCT00150930|UVB|uvb
723435|NCT00150930|phototherapy|phototherapy
723436|NCT00150930|home care|home care
723437|NCT00150930|narrowband|narrowband
723438|NCT00150917|Breast cancer|breast cancer
723439|NCT00150917|Genetics|genetics
723440|NCT00150917|Psychotherapy|psychotherapy
723441|NCT00150917|Group counselling|group counselling
723442|NCT00150917|Randomized control trial|randomized control trial
723443|NCT00150917|Risk counselling|risk counselling
723444|NCT00150917|Women's mental health|women's mental health
723445|NCT00150917|Familial breast cancer|familial breast cancer
723446|NCT00150904|HIV|hiv
723447|NCT00150904|hepatitis C|hepatitis c
723448|NCT00150904|virologic|virologic
723449|NCT00150904|immunologic|immunologic
723450|NCT00150904|HIV / Hepatitis C coinfection|hiv / hepatitis c coinfection
723451|NCT00150891|Th1|th1
723452|NCT00150891|Th2|th2
723453|NCT00150891|B cell|b cell
723454|NCT00150891|monokines|monokines
723455|NCT00150891|kidney transplantation|kidney transplantation
723456|NCT00150891|acute rejection|acute rejection
723457|NCT00150891|chronic rejection|chronic rejection
723458|NCT00150878|Reduced-intensity conditioning|reduced-intensity conditioning
723459|NCT00150878|Fludarabine|fludarabine
723460|NCT00150878|Acute myeloid Leukemia|acute myeloid leukemia
723461|NCT00150878|Treatment-related mortality|treatment-related mortality
723462|NCT00150865|ropivacaine|ropivacaine
723463|NCT00150865|posterior lumbar plexus block|posterior lumbar plexus block
723464|NCT00150865|hip arthroplasy|hip arthroplasy
723465|NCT00150865|analgesia|analgesia
723466|NCT00150865|postoperative|postoperative
723467|NCT00150852|Gastrostomy|gastrostomy
723468|NCT00150852|Wound infection|wound infection
723469|NCT00150852|Antibiotic prophylaxis|antibiotic prophylaxis
723470|NCT00150839|Depressive Disorder, Major|depressive disorder, major
723471|NCT00150839|Venlafaxine|venlafaxine
723472|NCT00150839|Mirtazapine|mirtazapine
723473|NCT00150839|Double-blind RCT|double-blind rct
723474|NCT00150839|Magnetic resonance imaging|magnetic resonance imaging
723475|NCT00150839|Hippocampal volume|hippocampal volume
723476|NCT00150826|microvascular disease|microvascular disease
723477|NCT00150826|women|women
723478|NCT00150826|renin angiotensin system|renin angiotensin system
723479|NCT00150826|WISE|wise
723480|NCT00150826|ischemic heart disease|ischemic heart disease
723481|NCT00150813|Monotherapy, epilepsy|monotherapy, epilepsy
723482|NCT00150813|Keppra, levetiracetam|keppra, levetiracetam
723483|NCT00150800|Brivaracetam|brivaracetam
723484|NCT00150800|Epilepsy|epilepsy
723485|NCT00150800|Partial Onset Seizures|partial onset seizures
723486|NCT00150800|open label|open label
723487|NCT00150787|Monotherapy, epilepsy|monotherapy, epilepsy
723488|NCT00150787|Levetiracetam|levetiracetam
723489|NCT00150787|Keppra|keppra
723490|NCT00150774|Idiopathic Generalized Epilepsy, Myoclonic seizures|idiopathic generalized epilepsy, myoclonic seizures
723491|NCT00150774|Keppra - Levetiracetam|keppra - levetiracetam
723492|NCT00150761|Nasal histamine provocation, facial thermography, levocetirizine, cetirizine,|nasal histamine provocation, facial thermography, levocetirizine, cetirizine,
723493|NCT00150761|Xyzal, Zyrtec|xyzal, zyrtec
723494|NCT00150748|Generalized Epilepsy, Primary Generalized Seizures|generalized epilepsy, primary generalized seizures
723495|NCT00150748|Keppra, Levetiracetam|keppra, levetiracetam
723496|NCT00150735|Monotherapy, epilepsy, Levetiracetam, Keppra.|monotherapy, epilepsy, levetiracetam, keppra.
723497|NCT00150722|atherosclerosis|atherosclerosis
723498|NCT00150722|endothelial function|endothelial function
723499|NCT00150722|HDL|hdl
723500|NCT00150722|Niacin|niacin
723502|NCT00150722|Stable Atherosclerotic Vascular Disease|stable atherosclerotic vascular disease
723503|NCT00150709|Epilepsy, Pediatric , partial onset epilepsy,|epilepsy, pediatric , partial onset epilepsy,
723504|NCT00150709|Levetiracetam (Keppra®)|levetiracetam (keppra®)
723505|NCT00150696|Osteoporosis|osteoporosis
723506|NCT00150696|Spinal Cord Injury|spinal cord injury
723507|NCT00150683|Spinal Cord Injury.|spinal cord injury.
723508|NCT00150683|Osteoporosis.|osteoporosis.
723509|NCT00150683|Standing.|standing.
723510|NCT00150683|Vibration.|vibration.
723511|NCT00150670|Stomach cancer|stomach cancer
723512|NCT00150644|Fibroid Uterus|fibroid uterus
723513|NCT00150644|Leiomyoma|leiomyoma
723514|NCT00150644|Uterine Fibroids|uterine fibroids
723515|NCT00150644|Hysterectomy|hysterectomy
723516|NCT00150644|Asoprisnil|asoprisnil
723517|NCT00150631|Hypertension|hypertension
723518|NCT00150631|Prevention|prevention
723519|NCT00150631|Offspring|offspring
723520|NCT00150631|Prevent or delay development of hypertension|prevent or delay development of hypertension
723521|NCT00150527|antidepressive agents|antidepressive agents
723522|NCT00150514|nasal biopsy grasspollen sublingual immunotherapy|nasal biopsy grasspollen sublingual immunotherapy
723523|NCT00150488|PBS|pbs
723524|NCT00150488|Painful Bladder Syndrome|painful bladder syndrome
723525|NCT00150488|Interstitial Cystitis|interstitial cystitis
723526|NCT00150488|chrondroitin sulfate|chrondroitin sulfate
723527|NCT00150475|Severe Acute Respiratory Syndrome|severe acute respiratory syndrome
723528|NCT00150462|Hematological|hematological
723529|NCT00150462|Proteasome|proteasome
723530|NCT00150462|Myeloma|myeloma
723531|NCT00150462|Lymphoma|lymphoma
723532|NCT00150371|(D006937)|(d006937)
723533|NCT00150345|Neutropenia|neutropenia
723534|NCT00150345|Fever of unknown origin|fever of unknown origin
723535|NCT00150345|Empirical treatment|empirical treatment
723536|NCT00150345|Voriconazole|voriconazole
723537|NCT00150189|Pain|pain
723538|NCT00150189|Procedural Pain|procedural pain
723539|NCT00150189|Sucrose|sucrose
723540|NCT00150189|Infant|infant
723541|NCT00150189|Newborn|newborn
723542|NCT00150163|Androgens|androgens
723543|NCT00150163|Bone|bone
723544|NCT00150163|Muscle|muscle
723545|NCT00150163|Estrogens|estrogens
723546|NCT00150163|Fat|fat
723547|NCT00150163|Lipid and glucose metabolism|lipid and glucose metabolism
723548|NCT00150150|Interventional ultrasound|interventional ultrasound
723549|NCT00150150|interstitial laser theraphy|interstitial laser theraphy
723550|NCT00150150|tumor ablation|tumor ablation
723551|NCT00150150|nodule reduction|nodule reduction
723552|NCT00150150|adverse effects|adverse effects
723553|NCT00150150|patient satesfaction|patient satesfaction
723554|NCT00150137|Radioiodine therapy|radioiodine therapy
723555|NCT00150137|Graves’ disease|graves’ disease
723556|NCT00150137|toxic nodular goiter|toxic nodular goiter
723557|NCT00150137|antithyroid drugs|antithyroid drugs
723558|NCT00150137|radioprotection|radioprotection
723559|NCT00150124|Radioiodine therapy|radioiodine therapy
723560|NCT00150124|Graves' disease|graves' disease
723561|NCT00150124|toxic nodular goiter|toxic nodular goiter
723562|NCT00150124|antithyroid drugs|antithyroid drugs
723563|NCT00150124|levothyroxine|levothyroxine
723564|NCT00150124|radioprotection|radioprotection
723565|NCT00150111|Graves disease|graves disease
723566|NCT00150111|thyroid|thyroid
723567|NCT00150111|ophthalmopathy|ophthalmopathy
723568|NCT00150111|autoimmunity|autoimmunity
723569|NCT00150111|B lymphocyte depletion|b lymphocyte depletion
723570|NCT00150111|rituximab|rituximab
723571|NCT00150111|immunization|immunization
723573|NCT00150098|vaccines|vaccines
723574|NCT00150098|women|women
723575|NCT00150098|substance use|substance use
723576|NCT00150085|diabetes, glucose, tacrolimus, cyclosporine micro-emulsion, liver, kidney, renal|diabetes, glucose, tacrolimus, cyclosporine micro-emulsion, liver, kidney, renal
723577|NCT00150072|chordoma|chordoma
723578|NCT00150072|imatinib|imatinib
723579|NCT00150072|PDGFR|pdgfr
723580|NCT00150059|atopic dermatitis, eczema, mild to moderate, children, IGA|atopic dermatitis, eczema, mild to moderate, children, iga
723581|NCT00150046|Heart transplantation|heart transplantation
723582|NCT00150046|Everolimus|everolimus
723583|NCT00150046|Heart transplant recipient|heart transplant recipient
723584|NCT00150033|thyroid disease|thyroid disease
723585|NCT00150033|Quality of Life|quality of life
723586|NCT00150033|Patient reported outcome|patient reported outcome
723587|NCT00150033|questionnaire|questionnaire
723588|NCT00150033|Quality of Life measurement|quality of life measurement
723589|NCT00150020|Renal/Kidney|renal/kidney
723590|NCT00150020|Transplantation|transplantation
723591|NCT00150020|MPA|mpa
723592|NCT00150020|EC-MPS|ec-mps
723593|NCT00150020|Renal Transplantation Patients with GI Intolerance with MMF|renal transplantation patients with gi intolerance with mmf
723594|NCT00150007|Kidney, maintenance transplant, GI complaints, patient reported outcome|kidney, maintenance transplant, gi complaints, patient reported outcome
723595|NCT00149994|Liver transplant, adults, C2 monitoring|liver transplant, adults, c2 monitoring
723596|NCT00149981|Kidney, heart, lung, liver, pancreas|kidney, heart, lung, liver, pancreas
723597|NCT00149968|Renal transplantation|renal transplantation
723598|NCT00149968|MMF|mmf
723600|NCT00149968|GI problems|gi problems
723601|NCT00149942|Enteric coated mycophenolate sodium|enteric coated mycophenolate sodium
723602|NCT00149942|transplantation|transplantation
723603|NCT00149942|gastrointestinal adverse events|gastrointestinal adverse events
723604|NCT00149942|Kidney and liver transplantation patients experiencing GI AEs with current MMF treatment|kidney and liver transplantation patients experiencing gi aes with current mmf treatment
723605|NCT00149929|Renal Transplant, adults, immunosuppressant|renal transplant, adults, immunosuppressant
723606|NCT00149916|Renal Transplant, adults, immunosuppressants|renal transplant, adults, immunosuppressants
723607|NCT00149890|pediatric|pediatric
723608|NCT00149890|liver transplantation|liver transplantation
723609|NCT00149890|Simulect|simulect
723610|NCT00149890|Basiliximab|basiliximab
723611|NCT00149890|ciclosporin microemulsion|ciclosporin microemulsion
723612|NCT00149890|steroid reduction|steroid reduction
723613|NCT00149890|pediatric liver transplantation|pediatric liver transplantation
723614|NCT00149877|Chronic constipation, tegaserod|chronic constipation, tegaserod
723615|NCT00149864|Renal Transplant, adults, immunosuppressant|renal transplant, adults, immunosuppressant
723616|NCT00149851|GERD, heartburn, regurgitation, reflux disease|gerd, heartburn, regurgitation, reflux disease
723617|NCT00149838|Electric Stimulation|electric stimulation
723618|NCT00149838|Magnetic Stimulation|magnetic stimulation
723619|NCT00149838|Prefrontal Cortex|prefrontal cortex
723620|NCT00149838|Brain|brain
723621|NCT00149825|Major Depressive Disorder|major depressive disorder
723622|NCT00149825|Insomnia|insomnia
723623|NCT00149825|Sleep|sleep
723624|NCT00149825|Mental Health|mental health
723625|NCT00149812|Depression|depression
723626|NCT00149812|Child disruptive behavior|child disruptive behavior
723627|NCT00149812|Family functioning|family functioning
723628|NCT00149799|Body Dysmorphic Disorder|body dysmorphic disorder
723629|NCT00149799|Escitalopram|escitalopram
723630|NCT00149799|Lexapro|lexapro
723631|NCT00149799|BDD|bdd
723632|NCT00149799|Body Image|body image
723633|NCT00149786|Anorexia Nervosa|anorexia nervosa
723634|NCT00149786|Adolescents|adolescents
723635|NCT00149786|Family therapy|family therapy
723636|NCT00149786|Individual therapy|individual therapy
723637|NCT00149773|Cognitive therapy|cognitive therapy
723638|NCT00149773|Suicide|suicide
723639|NCT00149773|Older men|older men
723640|NCT00149773|Death ideation|death ideation
723641|NCT00149773|Primary care|primary care
723642|NCT00149760|Cognitive Behavior Therapy|cognitive behavior therapy
723643|NCT00149760|Treatment Outcome|treatment outcome
723644|NCT00149760|Health Care Utilization|health care utilization
723645|NCT00149760|Somatization Disorder|somatization disorder
723646|NCT00149760|Somatoform Disorder|somatoform disorder
723647|NCT00149747|Sleep|sleep
723648|NCT00149747|Exercise|exercise
723649|NCT00149747|Older Adults|older adults
723650|NCT00149734|Schizophrenia|schizophrenia
723651|NCT00149734|Ondansetron|ondansetron
723652|NCT00149734|P50 sensory gating|p50 sensory gating
723653|NCT00149734|Evoked potentials|evoked potentials
723654|NCT00149734|5-HT3 receptors|5-ht3 receptors
723655|NCT00149734|Atypical antipsychotics|atypical antipsychotics
723656|NCT00149721|hydrocephalus|hydrocephalus
723657|NCT00149721|pituitary function|pituitary function
723658|NCT00149721|shunting|shunting
723659|NCT00149708|Growth hormone|growth hormone
723660|NCT00149708|Deficiency|deficiency
723661|NCT00149708|Cardiovascular risk|cardiovascular risk
723662|NCT00149708|Body composition|body composition
723663|NCT00149695|Obesity, beverages, weight loss, body mass index, diet|obesity, beverages, weight loss, body mass index, diet
723664|NCT00149682|Obesity|obesity
723665|NCT00149669|Behavior Therapy|behavior therapy
723666|NCT00149669|Cocaine|cocaine
723667|NCT00149669|Cocaine (IV)|cocaine (iv)
723668|NCT00149669|Cocaine Abuse|cocaine abuse
723669|NCT00149669|Cocaine Dependence|cocaine dependence
723670|NCT00149669|Contingency management|contingency management
723671|NCT00149669|HIV risk behaviors|hiv risk behaviors
723672|NCT00149669|Heroin|heroin
723673|NCT00149669|Naltrexone|naltrexone
723674|NCT00149669|Opioid Dependence|opioid dependence
723675|NCT00149669|sexual risk behaviors|sexual risk behaviors
723676|NCT00149656|Treatment Naive|treatment naive
723677|NCT00149656|Multivitamins|multivitamins
723678|NCT00149656|Selenium|selenium
723679|NCT00149656|Supplementation|supplementation
723680|NCT00149656|HIV Disease Progression|hiv disease progression
723681|NCT00149643|Cannabis|cannabis
723682|NCT00149643|MDD|mdd
723683|NCT00149630|Opioid Dependence|opioid dependence
723684|NCT00149630|Substance Related Disorders|substance related disorders
723685|NCT00149617|Marijuana|marijuana
723686|NCT00149617|Mood Disorder|mood disorder
723687|NCT00149604|metabolic syndrome|metabolic syndrome
723688|NCT00149604|hormone therapy|hormone therapy
723689|NCT00149604|abdominal adiposity|abdominal adiposity
723690|NCT00149604|lipolysis|lipolysis
723691|NCT00149591|Myocardial infarction|myocardial infarction
723692|NCT00149591|Viability|viability
723693|NCT00149591|Coronary angioplasty|coronary angioplasty
723694|NCT00149591|Prevention|prevention
723695|NCT00149591|Prognosis|prognosis
723696|NCT00149578|pancreatic cancer|pancreatic cancer
723697|NCT00149578|gemcitabine|gemcitabine
723698|NCT00149578|oxaliplatin|oxaliplatin
723699|NCT00149578|5-Fluorouracil|5-fluorouracil
723700|NCT00149578|radiation|radiation
723701|NCT00149552|Treatment Naive|treatment naive
723702|NCT00149552|Treatment Experienced|treatment experienced
723703|NCT00149461|Asthma Action Plans|asthma action plans
723704|NCT00149461|African Americans|african americans
723705|NCT00149461|Latinos|latinos
723706|NCT00149461|Health Literacy|health literacy
723707|NCT00149461|Asthma Education|asthma education
723708|NCT00149422|NT-proBNP|nt-probnp
723709|NCT00149396|Colorectal cancer metastases to liver|colorectal cancer metastases to liver
723710|NCT00149396|Colorectal Cancer|colorectal cancer
723711|NCT00149396|Colorectal Carcinoma|colorectal carcinoma
723712|NCT00149396|Colorectal Tumors|colorectal tumors
723713|NCT00149396|Colorectal Neoplasms|colorectal neoplasms
723714|NCT00149396|Rectum Cancer|rectum cancer
723715|NCT00149396|Rectum tumors|rectum tumors
723716|NCT00149396|Rectum carcinoma|rectum carcinoma
723717|NCT00149396|Colon cancer|colon cancer
723718|NCT00149396|Colon tumors|colon tumors
723719|NCT00149396|Colon carcinoma|colon carcinoma
723720|NCT00149396|Rectum Neoplasms|rectum neoplasms
723721|NCT00149396|Colon Neoplasms|colon neoplasms
723722|NCT00149396|Liver Neoplasms|liver neoplasms
723723|NCT00149396|Hepatic Neoplasms|hepatic neoplasms
723724|NCT00149396|Liver Tumors|liver tumors
723725|NCT00149396|Liver cancer|liver cancer
723726|NCT00149396|Hepatic Cancer|hepatic cancer
723727|NCT00149396|Hepatic tumors|hepatic tumors
723728|NCT00149396|metastatic to the liver|metastatic to the liver
723729|NCT00149383|randomized controlled trial|randomized controlled trial
723730|NCT00149383|malaria|malaria
723731|NCT00149383|Plasmodium falciparum|plasmodium falciparum
723732|NCT00149383|thiazolidinediones|thiazolidinediones
723733|NCT00149383|rosiglitazone|rosiglitazone
723734|NCT00149383|atovaquone-proguanil|atovaquone-proguanil
723735|NCT00149370|breast hypertrophy|breast hypertrophy
723736|NCT00149370|breast reduction surgery|breast reduction surgery
723737|NCT00149370|health-related quality of life|health-related quality of life
723738|NCT00149370|Health Utilities Index|health utilities index
723739|NCT00149370|HUI|hui
723740|NCT00149370|prospective|prospective
723741|NCT00149370|SF-36|sf-36
723742|NCT00149370|quality-adjusted life years|quality-adjusted life years
723743|NCT00149370|QALY|qaly
723744|NCT00149357|venous thromboembolism|venous thromboembolism
723745|NCT00149357|VTE|vte
723746|NCT00149357|thrombophilia|thrombophilia
723747|NCT00149357|fetal loss|fetal loss
723748|NCT00149344|cost-utility analysis;|cost-utility analysis;
723749|NCT00149344|breast reduction;|breast reduction;
723750|NCT00149344|vertical scar mammoplasty;|vertical scar mammoplasty;
723751|NCT00149344|pedicle reduction mammoplasty|pedicle reduction mammoplasty
723752|NCT00149331|Diabetes, Insulin, Education|diabetes, insulin, education
723753|NCT00149305|Gouty diathesis|gouty diathesis
723754|NCT00149305|Acid uric nephrolithiasis|acid uric nephrolithiasis
723755|NCT00149279|stomach neoplasms|stomach neoplasms
723756|NCT00149279|lymph node excision|lymph node excision
723757|NCT00149279|abdominal aorta|abdominal aorta
723758|NCT00149266|stomach neoplasms|stomach neoplasms
723759|NCT00149266|lymph node resection|lymph node resection
723760|NCT00149266|cardia|cardia
723761|NCT00149266|thoracotomy|thoracotomy
723762|NCT00149253|Abdominal hysterectomy,|abdominal hysterectomy,
723763|NCT00149253|Etoricoxib,|etoricoxib,
723764|NCT00149253|morphine consumption,|morphine consumption,
723765|NCT00149253|pre-emptive analgesia|pre-emptive analgesia
723766|NCT00149240|DYSPORT|dysport
723767|NCT00149240|botulinum toxin A|botulinum toxin a
723768|NCT00149240|myofascial pain syndrome|myofascial pain syndrome
723769|NCT00149227|High risk hypertension|high risk hypertension
723770|NCT00149227|Ischemic heart disease|ischemic heart disease
723771|NCT00149227|Angiotensin receptor blockers|angiotensin receptor blockers
723772|NCT00149227|Cardiovascular mortality- morbidity|cardiovascular mortality- morbidity
723773|NCT00149227|KYOTO HEART Study|kyoto heart study
723774|NCT00149201|gastric cancer|gastric cancer
723775|NCT00149201|peritoneal metastasis|peritoneal metastasis
723776|NCT00149201|randomized trial|randomized trial
723777|NCT00149201|5-FU|5-fu
723778|NCT00149201|MTX|mtx
723779|NCT00149188|Growth Hormone|growth hormone
723780|NCT00149175|Alzheimer's disease|alzheimer's disease
723781|NCT00149175|Dementia|dementia
723782|NCT00149175|Phenotype-genotype correlations|phenotype-genotype correlations
723783|NCT00149175|Candidate genes|candidate genes
723784|NCT00149175|Related disorders|related disorders
723785|NCT00149162|Controlled|controlled
723786|NCT00149162|Multicenter|multicenter
723787|NCT00149162|International|international
723788|NCT00149162|Randomized study|randomized study
723789|NCT00149162|Direct individual benefit|direct individual benefit
723790|NCT00149162|complete remission after chemotherapy|complete remission after chemotherapy
723791|NCT00149162|non allogeneic transplanted|non allogeneic transplanted
723792|NCT00149149|Reduction in NSAID related gut damage|reduction in nsaid related gut damage
723793|NCT00149136|Acute Lymphocytic Leukemia,|acute lymphocytic leukemia,
723794|NCT00149136|Ph+,|ph+,
723795|NCT00149136|elderly patients,|elderly patients,
723796|NCT00149136|Imatinib|imatinib
723797|NCT00149123|Burn|burn
723798|NCT00149123|adrenal insufficiency|adrenal insufficiency
723799|NCT00149123|hydrocortisone|hydrocortisone
723800|NCT00149123|short corticotropin test|short corticotropin test
723801|NCT00149110|Sleep deprivation|sleep deprivation
723802|NCT00149110|Exercise|exercise
723803|NCT00149110|Light therapy|light therapy
723804|NCT00149110|Major depression|major depression
723805|NCT00149110|Bipolar depression|bipolar depression
723806|NCT00149110|Sleep-wake cycle|sleep-wake cycle
723807|NCT00149084|The tailored H. pylori eradication therapy|the tailored h. pylori eradication therapy
723808|NCT00149084|CYP2C19 genotype|cyp2c19 genotype
723809|NCT00149084|23S rRNA|23s rrna
723810|NCT00149084|clarithromycin|clarithromycin
723811|NCT00149084|Lansoprazole|lansoprazole
723812|NCT00149084|Amoxicillin|amoxicillin
723813|NCT00149084|H. pylori infection|h. pylori infection
723814|NCT00149071|Transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
723815|NCT00149071|Major depression|major depression
723816|NCT00149071|treatment resistant major depression|treatment resistant major depression
723817|NCT00149058|acute myocardial infarction|acute myocardial infarction
723818|NCT00149058|primary angioplasty|primary angioplasty
723819|NCT00149045|familial peripheral Neuropathy Anticipation|familial peripheral neuropathy anticipation
723820|NCT00149032|Metastatic solid tumor|metastatic solid tumor
723821|NCT00149006|Metastatic solid tumor|metastatic solid tumor
723822|NCT00149006|Mismatch allogeneic cell mediated immunotherapy|mismatch allogeneic cell mediated immunotherapy
723823|NCT00148993|Tumor cell vaccine|tumor cell vaccine
723824|NCT00148980|Myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
723825|NCT00148980|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
723826|NCT00148980|Demineralized bone matrix (DBM)|demineralized bone matrix (dbm)
723827|NCT00148980|Bone marrow microenvironment|bone marrow microenvironment
723828|NCT00148967|right ventricular pacing|right ventricular pacing
723829|NCT00148967|implantable cardioverter defibrillator|implantable cardioverter defibrillator
723830|NCT00148915|Osteoporosis|osteoporosis
723831|NCT00148915|bisphosphonates|bisphosphonates
723832|NCT00148915|bone|bone
723833|NCT00148902|tumor|tumor
723834|NCT00148889|cervical dystonia|cervical dystonia
723835|NCT00148889|torticollis|torticollis
723836|NCT00148889|deep brain stimulation|deep brain stimulation
723837|NCT00148889|pallidal stimulation|pallidal stimulation
723838|NCT00148889|globus pallidus internus|globus pallidus internus
723839|NCT00148876|Progression after treatment with Trastuzumab|progression after treatment with trastuzumab
723840|NCT00148876|Metastatic Breast Cancer|metastatic breast cancer
723841|NCT00148876|Palliative Study|palliative study
723842|NCT00148863|Hepatitis C, Chronic|hepatitis c, chronic
723843|NCT00148863|Interferon Alfa-2a|interferon alfa-2a
723844|NCT00148863|Ribavirin|ribavirin
723845|NCT00148863|Interferon-gamma, Recombinant|interferon-gamma, recombinant
723846|NCT00148850|HIV-Associated Lipodystrophy Syndrome|hiv-associated lipodystrophy syndrome
723847|NCT00148850|pioglitazone|pioglitazone
723848|NCT00148850|HIV infections|hiv infections
723849|NCT00148850|Treatment Experienced|treatment experienced
723850|NCT00148837|Hepatitis C, Chronic|hepatitis c, chronic
723851|NCT00148837|Fibrosis|fibrosis
723852|NCT00148837|Interferon Alfa-2b|interferon alfa-2b
723853|NCT00148837|Ribavirin|ribavirin
723854|NCT00148837|Prazosin|prazosin
723855|NCT00148824|HIV infections|hiv infections
723856|NCT00148824|Pneumococcal vaccines|pneumococcal vaccines
723857|NCT00148824|Treatment Experienced|treatment experienced
723858|NCT00148824|Treatment Naive|treatment naive
723859|NCT00148798|Cetuximab|cetuximab
723860|NCT00148798|Non small cell lung cancer|non small cell lung cancer
723861|NCT00148798|Lung cancer|lung cancer
723862|NCT00148798|Cisplatin/vinorelbine|cisplatin/vinorelbine
723863|NCT00148798|Monoclonal antibody|monoclonal antibody
723864|NCT00148798|Erbitux|erbitux
723865|NCT00148785|Antiretroviral drugs|antiretroviral drugs
723866|NCT00148785|Pharmacokinetic|pharmacokinetic
723867|NCT00148785|Indinavir|indinavir
723868|NCT00148785|Ritonavir|ritonavir
723869|NCT00148785|Fosamprenavir|fosamprenavir
723870|NCT00148772|Prostate Cancer|prostate cancer
723871|NCT00148772|Rising PSA|rising psa
723872|NCT00148772|Erlotinib|erlotinib
723873|NCT00148772|Tarceva|tarceva
723874|NCT00148772|Androgen Deprivation Therapy|androgen deprivation therapy
723875|NCT00148772|Hormone Therapy|hormone therapy
723876|NCT00148772|Rising Prostate Specific Antigen (PSA)|rising prostate specific antigen (psa)
723877|NCT00148772|Non-Metastatic Prostate Cancer|non-metastatic prostate cancer
723878|NCT00148759|Sex differences|sex differences
723879|NCT00148759|Pharmacokinetic|pharmacokinetic
723880|NCT00148759|Lopinavir/ritonavir|lopinavir/ritonavir
723881|NCT00148759|Treatment Experienced|treatment experienced
723882|NCT00148759|HIV-infection|hiv-infection
723883|NCT00148746|atopic dermatitis, atopy|atopic dermatitis, atopy
723884|NCT00148733|Child|child
723885|NCT00148733|pneumonia|pneumonia
723886|NCT00148733|Zinc|zinc
723887|NCT00148733|clinical trial|clinical trial
723888|NCT00148733|Nepal|nepal
723889|NCT00148733|nutrition|nutrition
723890|NCT00148733|therapeutic|therapeutic
723891|NCT00148720|Invasive Breast Cancer|invasive breast cancer
723892|NCT00148720|Operable Breast Cancer|operable breast cancer
723893|NCT00148720|Capecitabine|capecitabine
723894|NCT00148707|Metastatic Breast Cancer|metastatic breast cancer
723895|NCT00148707|HER2-negative Breast Cancer|her2-negative breast cancer
723896|NCT00148707|CT-2103|ct-2103
723897|NCT00148707|Xyotax|xyotax
723898|NCT00148694|Cisplatin|cisplatin
723899|NCT00148694|Early Stage Breast Cancer|early stage breast cancer
723900|NCT00148694|ER Negative Breast Cancer|er negative breast cancer
723901|NCT00148694|PR Negative Breast Cancer|pr negative breast cancer
723902|NCT00148694|HER-2 Negative Breast Cancer|her-2 negative breast cancer
723903|NCT00148681|HER-2 Positive breast cancer|her-2 positive breast cancer
723904|NCT00148681|herceptin|herceptin
723905|NCT00148681|navelbine|navelbine
723906|NCT00148668|HER-2 Positive Breast Cancer|her-2 positive breast cancer
723907|NCT00148668|herceptin|herceptin
723908|NCT00148668|navelbine|navelbine
723909|NCT00148668|taxotere|taxotere
723910|NCT00148668|carboplatin|carboplatin
723911|NCT00148668|Early stage Breast Cancer|early stage breast cancer
723912|NCT00148655|educational intervention|educational intervention
723913|NCT00148655|decision board|decision board
723914|NCT00148655|DCIS|dcis
723915|NCT00148642|ventilator-associated pneumonia|ventilator-associated pneumonia
723916|NCT00148642|nosocomial pneumonia|nosocomial pneumonia
723917|NCT00148629|Anemia|anemia
723918|NCT00148629|Birth weight|birth weight
723919|NCT00148629|Neonatal Mortality|neonatal mortality
723920|NCT00148629|Tanzania|tanzania
723921|NCT00148629|Pregnancy|pregnancy
723922|NCT00148616|Memantine|memantine
723923|NCT00148616|Negative Syndrome|negative syndrome
723924|NCT00148616|Schizophrenia|schizophrenia
723925|NCT00148616|Cognitive impairment|cognitive impairment
723926|NCT00148603|dyspepsia|dyspepsia
723927|NCT00148603|eosinophilic gastroenteritis|eosinophilic gastroenteritis
723928|NCT00148603|montelukast|montelukast
723929|NCT00148590|Memantine|memantine
723930|NCT00148590|Negative syndrome|negative syndrome
723931|NCT00148590|Schizophrenia|schizophrenia
723932|NCT00148590|Cognitive impairment|cognitive impairment
723933|NCT00148590|Glutamate|glutamate
723934|NCT00148577|Pain Relief, TENS, Acupuncture Points|pain relief, tens, acupuncture points
723935|NCT00148564|weight gain|weight gain
723936|NCT00148564|schizophrenia|schizophrenia
723937|NCT00148564|atypical antipsychotics|atypical antipsychotics
723938|NCT00148551|AMD|amd
723939|NCT00148551|Triamcinolone|triamcinolone
723940|NCT00148551|Macular Degeneration|macular degeneration
723941|NCT00148538|Type 1 Diabetes|type 1 diabetes
723942|NCT00148538|Resistance Exercise|resistance exercise
723943|NCT00148538|Aerobic Exercise|aerobic exercise
723944|NCT00148538|Exercise & Disease|exercise & disease
723945|NCT00148538|Exercise|exercise
723946|NCT00148538|Diabetes|diabetes
723947|NCT00148525|automated telephony, cancer prevention, healthy diet|automated telephony, cancer prevention, healthy diet
723948|NCT00148473|Cervical ripening.|cervical ripening.
723949|NCT00148473|Induction of labor.|induction of labor.
723950|NCT00148473|Misoprostol.|misoprostol.
723951|NCT00148447|negative symptoms|negative symptoms
723952|NCT00148447|depression|depression
723953|NCT00148447|ssri|ssri
723954|NCT00148447|schizophrenia|schizophrenia
723955|NCT00148434|hypertension|hypertension
723956|NCT00148434|guidelines|guidelines
723957|NCT00148434|patient empowerment|patient empowerment
723958|NCT00148434|anxiety|anxiety
723959|NCT00148421|Non-myeloid malignancy|non-myeloid malignancy
723960|NCT00148421|Chemotherapy-induced anemia|chemotherapy-induced anemia
723961|NCT00148408|Asthma|asthma
723962|NCT00148408|Placebo|placebo
723963|NCT00148408|Education|education
723964|NCT00148382|Obesity|obesity
723965|NCT00148382|Pharmacokinetics|pharmacokinetics
723966|NCT00148382|Pharmacodynamics|pharmacodynamics
723967|NCT00148356|drug eluting stents|drug eluting stents
723968|NCT00148356|stents|stents
723969|NCT00148356|angioplasty|angioplasty
723970|NCT00148356|coronary artery disease|coronary artery disease
723971|NCT00148356|total coronary occlusion|total coronary occlusion
723972|NCT00148356|coronary artery restenosis|coronary artery restenosis
723973|NCT00148356|stent thrombosis|stent thrombosis
723974|NCT00148356|vascular disease|vascular disease
723975|NCT00148356|myocardial ischemia|myocardial ischemia
723976|NCT00148356|coronary artery stenosis|coronary artery stenosis
723977|NCT00148343|hemiplegia|hemiplegia
723978|NCT00148343|hemiparesis|hemiparesis
723979|NCT00148343|stroke|stroke
723980|NCT00148343|foot-drop|foot-drop
723981|NCT00148343|electrical stimulation|electrical stimulation
723982|NCT00148343|ankle-foot-orthosis|ankle-foot-orthosis
723983|NCT00148330|Diabetic macular oedema|diabetic macular oedema
723984|NCT00148330|Triamcinolone acetate|triamcinolone acetate
723985|NCT00148330|Intravitreal injection|intravitreal injection
723986|NCT00148330|Clinical trial|clinical trial
723987|NCT00148330|Laser treatment|laser treatment
723988|NCT00148304|Decision-making|decision-making
723989|NCT00148304|Insulin|insulin
723990|NCT00148304|Preference|preference
723991|NCT00148304|Treatment Variation|treatment variation
723992|NCT00148304|Provider|provider
723993|NCT00148304|Patient|patient
723994|NCT00148278|Catecholamines|catecholamines
723995|NCT00148278|Septic shock|septic shock
723996|NCT00148265|Diabetic macular oedema|diabetic macular oedema
723997|NCT00148265|Triamcinolone acetate|triamcinolone acetate
723998|NCT00148265|Intravitreal injection|intravitreal injection
723999|NCT00148265|Clinical trial|clinical trial
724000|NCT00148265|Laser treatment|laser treatment
724001|NCT00148252|Calcineurin|calcineurin
724002|NCT00148252|reduction|reduction
724003|NCT00148252|immunosuppression|immunosuppression
724004|NCT00148252|cyclosporine A|cyclosporine a
724005|NCT00148252|mycophenolate mofetil|mycophenolate mofetil
724006|NCT00148239|SCI|sci
724007|NCT00148239|Caregiving|caregiving
724008|NCT00148239|Aging|aging
724009|NCT00148239|Disability|disability
724010|NCT00148239|Paralysis|paralysis
724011|NCT00148226|Decision Aid|decision aid
724012|NCT00148226|Faecal Occult Blood Test|faecal occult blood test
724013|NCT00148226|Colorectal Cancer Screening|colorectal cancer screening
724014|NCT00148226|Informed Decision-making|informed decision-making
724015|NCT00148213|differentiated thyroid carcinoma|differentiated thyroid carcinoma
724016|NCT00148213|thyroglobulin|thyroglobulin
724017|NCT00148213|immunoassay|immunoassay
724018|NCT00148213|thyroidectomy|thyroidectomy
724019|NCT00148213|radioiodine therapy|radioiodine therapy
724020|NCT00148200|female sexual dysfunction|female sexual dysfunction
724021|NCT00148200|desire|desire
724022|NCT00148200|arousal|arousal
724023|NCT00148200|lubrification|lubrification
724024|NCT00148200|orgasm|orgasm
724025|NCT00148200|satisfaction|satisfaction
724026|NCT00148200|pain|pain
724027|NCT00148187|Medication adherence|medication adherence
724028|NCT00148187|Patient compliance|patient compliance
724029|NCT00148187|Kidney transplant|kidney transplant
724030|NCT00148187|Organ rejection|organ rejection
724031|NCT00148187|Allograft loss|allograft loss
724032|NCT00148187|Drug monitoring|drug monitoring
724033|NCT00148174|Medication adherence|medication adherence
724034|NCT00148174|Patient compliance|patient compliance
724035|NCT00148174|Kidney transplant|kidney transplant
724036|NCT00148174|Organ rejection|organ rejection
724037|NCT00148174|Allograft loss|allograft loss
724038|NCT00148174|Drug monitoring|drug monitoring
724039|NCT00148161|Magnetoencephalography|magnetoencephalography
724040|NCT00148161|Auditory cortex|auditory cortex
724041|NCT00148161|Stuttering|stuttering
724042|NCT00148161|Non stuttering|non stuttering
724043|NCT00148148|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
724044|NCT00148148|Caspofungin|caspofungin
724045|NCT00148148|Liposomal Amphotericin B|liposomal amphotericin b
724046|NCT00148135|Carcinoma of Unknown Primary Site (CUP)|carcinoma of unknown primary site (cup)
724047|NCT00148122|Squamous cell cancer of the oral cavity and pharynx|squamous cell cancer of the oral cavity and pharynx
724048|NCT00148109|Unresectable/metastatic high grade soft tissue bony sarcoma|unresectable/metastatic high grade soft tissue bony sarcoma
724049|NCT00148096|asthma|asthma
724050|NCT00148096|house dust mite|house dust mite
724051|NCT00148096|allergy|allergy
724052|NCT00148096|housing|housing
724053|NCT00148096|avoidance|avoidance
724054|NCT00148096|humidity|humidity
724055|NCT00148083|Schizophrenia|schizophrenia
724056|NCT00148083|Cognition|cognition
724057|NCT00148083|Clinical Trial|clinical trial
724058|NCT00148057|Diet|diet
724059|NCT00148057|Dietary fat|dietary fat
724060|NCT00148057|Breast cancer|breast cancer
724061|NCT00148057|Prevention|prevention
724062|NCT00148031|behavior modification|behavior modification
724063|NCT00148031|health care service utilization|health care service utilization
724064|NCT00148031|hepatitis C,|hepatitis c,
724065|NCT00148031|injection drug use|injection drug use
724066|NCT00148031|therapy compliance|therapy compliance
724067|NCT00148031|alcoholism|alcoholism
724068|NCT00148031|alcohol abuse|alcohol abuse
724069|NCT00148031|prevention|prevention
724070|NCT00148031|drug abuse|drug abuse
724071|NCT00148031|liver disorder|liver disorder
724072|NCT00148031|HCV|hcv
724073|NCT00148031|methadone|methadone
724074|NCT00148018|Hodgkin disease|hodgkin disease
724075|NCT00148018|Bortezomib|bortezomib
724076|NCT00148018|Relapse|relapse
724077|NCT00148018|Lymphoma|lymphoma
724078|NCT00147966|active disease despite concomitant methotrexate|active disease despite concomitant methotrexate
724079|NCT00147953|NHL|nhl
724080|NCT00147953|Lymphoma|lymphoma
724081|NCT00147953|Radiotherapy|radiotherapy
724082|NCT00147953|Rituximab|rituximab
724083|NCT00147953|Palliative treatment|palliative treatment
724084|NCT00147940|Allergy|allergy
724085|NCT00147927|email|email
724086|NCT00147927|internet|internet
724087|NCT00147927|health promotion|health promotion
724088|NCT00147927|behavior change|behavior change
724089|NCT00147927|health status|health status
724090|NCT00147927|work productivity|work productivity
724091|NCT00147927|healthcare cost|healthcare cost
724092|NCT00147927|employee|employee
724296|NCT00147056|ExAblate|exablate
724093|NCT00147914|Acute bacterial sinusitis|acute bacterial sinusitis
724094|NCT00147901|CLL|cll
724095|NCT00147901|Immunochemotherapy|immunochemotherapy
724096|NCT00147888|Mucosal congestion|mucosal congestion
724097|NCT00147888|Acoustic rhinometry|acoustic rhinometry
724098|NCT00147888|Physiology|physiology
724099|NCT00147875|Lymphoma|lymphoma
724100|NCT00147875|Gemcitabine|gemcitabine
724101|NCT00147875|Advanced stages Hodgkin's lymphoma|advanced stages hodgkin's lymphoma
724102|NCT00147875|Elderly|elderly
724103|NCT00147862|Tranexamic Acid|tranexamic acid
724104|NCT00147862|Antifibrinolytic Agents|antifibrinolytic agents
724105|NCT00147862|Head and Neck Neoplasms|head and neck neoplasms
724106|NCT00147862|Thromboelastography|thromboelastography
724107|NCT00147849|knowledge translation|knowledge translation
724108|NCT00147849|health care utilization|health care utilization
724109|NCT00147849|economic analysis|economic analysis
724110|NCT00147836|type 2 diabetes mellitus|type 2 diabetes mellitus
724111|NCT00147836|therapy|therapy
724112|NCT00147836|sulfonylureas|sulfonylureas
724113|NCT00147836|metformin|metformin
724114|NCT00147836|insulin|insulin
724115|NCT00147823|Bone formation|bone formation
724116|NCT00147823|Bone lesions|bone lesions
724117|NCT00147823|Benign bone lesion|benign bone lesion
724118|NCT00147810|telephone outreach|telephone outreach
724119|NCT00147810|asthma care|asthma care
724120|NCT00147797|Atherosclerosis|atherosclerosis
724121|NCT00147797|intima media thickness|intima media thickness
724122|NCT00147797|aortic stiffness|aortic stiffness
724123|NCT00147797|HIV infection|hiv infection
724124|NCT00147797|Dyslipidemia|dyslipidemia
724125|NCT00147797|Treatment Experienced|treatment experienced
724126|NCT00147784|Chronical Hepatitis C treatment|chronical hepatitis c treatment
724127|NCT00147784|Methadone Maintenance Treatment|methadone maintenance treatment
724128|NCT00147784|Pegylated Interferon and Ribavirin|pegylated interferon and ribavirin
724129|NCT00147784|14 weeks treatment|14 weeks treatment
724130|NCT00147784|Genotype 2 and 3|genotype 2 and 3
724131|NCT00147771|localized scleroderma|localized scleroderma
724132|NCT00147771|morphea|morphea
724133|NCT00147771|imiquimod|imiquimod
724134|NCT00147771|pediatrics|pediatrics
724135|NCT00147758|Diabetes Mellitus|diabetes mellitus
724136|NCT00147745|Mechanism of action insulin sensitivity|mechanism of action insulin sensitivity
724137|NCT00147732|larynx carcinoma|larynx carcinoma
724138|NCT00147732|radiotherapy|radiotherapy
724139|NCT00147732|carbogen|carbogen
724140|NCT00147732|nicotinamide|nicotinamide
724141|NCT00147719|Diabetes Mellitus|diabetes mellitus
724142|NCT00147706|Electronic Health Record|electronic health record
724143|NCT00147706|Patient Portal|patient portal
724144|NCT00147706|Chronic Diseases|chronic diseases
724145|NCT00147693|Dementia|dementia
724146|NCT00147693|Alzheimer Disease|alzheimer disease
724147|NCT00147693|Lewy-Body|lewy-body
724148|NCT00147693|Cost*|cost*
724149|NCT00147693|Community (dwelling)|community (dwelling)
724150|NCT00147693|Caregiver(s)|caregiver(s)
724151|NCT00147693|Institutionalization|institutionalization
724152|NCT00147693|Quality of life|quality of life
724153|NCT00147693|Randomized Control Trail|randomized control trail
724154|NCT00147693|Vascular dementia|vascular dementia
724155|NCT00147680|Uterine Papillary Serous Carcinoma (UPSC)|uterine papillary serous carcinoma (upsc)
724156|NCT00147667|COPD|copd
724157|NCT00147667|EXACERBATIONS|exacerbations
724158|NCT00147667|AIRWAY INFLAMMATION|airway inflammation
724159|NCT00147537|non-small cell lung cancer|non-small cell lung cancer
724160|NCT00147537|chemotherapy|chemotherapy
724161|NCT00147537|figitumumab|figitumumab
724162|NCT00147537|insulin-like growth 1 factor receptor|insulin-like growth 1 factor receptor
724163|NCT00147537|IGF-IR|igf-ir
724164|NCT00147537|monoclonal antibody|monoclonal antibody
724165|NCT00147498|oral JAK inhibitor|oral jak inhibitor
724166|NCT00147498|clinical trial|clinical trial
724167|NCT00147498|joint diseases|joint diseases
724168|NCT00147498|anti-Inflammatory agents|anti-inflammatory agents
724169|NCT00147498|rheumatic diseases|rheumatic diseases
724170|NCT00147498|DMARD|dmard
724171|NCT00147498|Antirheumatic Agents|antirheumatic agents
724172|NCT00147498|Autoimmune Diseases|autoimmune diseases
724173|NCT00147498|Immune System Diseases|immune system diseases
724174|NCT00147472|Head and neck|head and neck
724175|NCT00147472|Cancer|cancer
724176|NCT00147472|Diagnosis|diagnosis
724177|NCT00147472|Fluorodeoxyglucose|fluorodeoxyglucose
724178|NCT00147472|Positron-Emission Tomography|positron-emission tomography
724179|NCT00147472|PET|pet
724180|NCT00147472|Oncology|oncology
724181|NCT00147459|hepatitis B virus|hepatitis b virus
724182|NCT00147459|vaccine|vaccine
724183|NCT00147459|booster|booster
724184|NCT00147459|liver transplantation|liver transplantation
724185|NCT00147446|Stress|stress
724186|NCT00147446|Stress Management|stress management
724187|NCT00147446|Behavioral Medicine|behavioral medicine
724188|NCT00147446|Multiple Sclerosis|multiple sclerosis
724189|NCT00147446|Psychoneuroimmunology|psychoneuroimmunology
724190|NCT00147433|free thyroxine|free thyroxine
724191|NCT00147433|pregnancy|pregnancy
724192|NCT00147433|fetal brain development|fetal brain development
724193|NCT00147433|thyroid stimulating hormone|thyroid stimulating hormone
724194|NCT00147433|IQ|iq
724195|NCT00147420|Tibet|tibet
724196|NCT00147420|Third Stage Labor|third stage labor
724197|NCT00147420|Post Partum Hemorrhage|post partum hemorrhage
724198|NCT00147420|Misoprostol|misoprostol
724199|NCT00147420|Zhi Byed 11|zhi byed 11
724200|NCT00147420|Global Network|global network
724201|NCT00147394|Risperidone|risperidone
724202|NCT00147394|Autism|autism
724203|NCT00147394|PDD|pdd
724204|NCT00147394|Pervasive Developmental Disorder|pervasive developmental disorder
724205|NCT00147381|Campath-1H|campath-1h
724206|NCT00147381|Alemtuzumab|alemtuzumab
724207|NCT00147381|Tacrolimus|tacrolimus
724208|NCT00147381|renal transplantation|renal transplantation
724209|NCT00147381|immunosuppression|immunosuppression
724210|NCT00147381|prevention of acute rejection|prevention of acute rejection
724211|NCT00147368|falciparum|falciparum
724212|NCT00147368|malaria|malaria
724213|NCT00147368|arginine|arginine
724214|NCT00147355|rIL-2-toxicity|ril-2-toxicity
724215|NCT00147355|interleukin-2 therapy|interleukin-2 therapy
724216|NCT00147355|HIV|hiv
724217|NCT00147355|Toxicity substudy of ESPRIT|toxicity substudy of esprit
724218|NCT00147342|exercise|exercise
724219|NCT00147342|hypoglycemia|hypoglycemia
724220|NCT00147342|Diabetes Mellitus, Type I|diabetes mellitus, type i
724221|NCT00147342|glucose monitoring|glucose monitoring
724222|NCT00147316|acute stroke|acute stroke
724223|NCT00147316|thrombolytic therapy|thrombolytic therapy
724224|NCT00147316|tissue plasminogen activator|tissue plasminogen activator
724225|NCT00147290|ATP|atp
724226|NCT00147290|Tachycardia|tachycardia
724227|NCT00147290|CRT-D|crt-d
724228|NCT00147277|ATP|atp
724229|NCT00147277|Thachy|thachy
724230|NCT00147277|FVT|fvt
724231|NCT00147264|insulin resistance, myocellular lipids, adipose tissue|insulin resistance, myocellular lipids, adipose tissue
724232|NCT00147251|lowering LDL and BP below current targets|lowering ldl and bp below current targets
724233|NCT00147251|LDL cholesterol treatment|ldl cholesterol treatment
724234|NCT00147251|blood pressure treatment|blood pressure treatment
724235|NCT00147251|carotid intimal medial thickness|carotid intimal medial thickness
724236|NCT00147251|prevent progression of CVD|prevent progression of cvd
724237|NCT00147238|Bladder Cancer|bladder cancer
724238|NCT00147238|Genitourinary Cancer|genitourinary cancer
724239|NCT00147238|Prostate Cancer|prostate cancer
724240|NCT00147238|MR Lymphangiography|mr lymphangiography
724241|NCT00147238|Ferumoxtran-10|ferumoxtran-10
724242|NCT00147238|SPIO|spio
724243|NCT00147238|Ultra-small superparamagnetic agent iron oxide|ultra-small superparamagnetic agent iron oxide
724244|NCT00147225|Advanced Cancer|advanced cancer
724245|NCT00147225|Advanced Malignancy|advanced malignancy
724246|NCT00147225|Solid Tumors|solid tumors
724247|NCT00147225|Thrombocytopenia|thrombocytopenia
724248|NCT00147225|AMG 531|amg 531
724249|NCT00147225|Romiplostim|romiplostim
724250|NCT00147225|Carboplatin|carboplatin
724251|NCT00147225|Paraplatin|paraplatin
724252|NCT00147225|Platelets|platelets
724253|NCT00147225|Adriamycin|adriamycin
724254|NCT00147225|Doxorubicin|doxorubicin
724255|NCT00147225|Rubex|rubex
724256|NCT00147225|Ifosfamide|ifosfamide
724257|NCT00147225|Ifex|ifex
724258|NCT00147212|Advanced Prostate Cancer|advanced prostate cancer
724259|NCT00147212|Prostate Cancer|prostate cancer
724260|NCT00147212|Trabectedin|trabectedin
724261|NCT00147212|ET 743|et 743
724262|NCT00147212|Yondelis|yondelis
724263|NCT00147199|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
724264|NCT00147147|gastric neoplasm|gastric neoplasm
724265|NCT00147147|gastrectomy|gastrectomy
724266|NCT00147147|adjuvant chemotherapy|adjuvant chemotherapy
724267|NCT00147147|randomized trial|randomized trial
724268|NCT00147147|T3 and T4 carcinoma of the stomach/Gastric Neoplasm|t3 and t4 carcinoma of the stomach/gastric neoplasm
724269|NCT00147134|colorectal cancer|colorectal cancer
724270|NCT00147134|laparoscopic surgery|laparoscopic surgery
724271|NCT00147134|randomized controlled trial|randomized controlled trial
724272|NCT00147134|oncological outcome|oncological outcome
724273|NCT00147121|Rituximab|rituximab
724274|NCT00147121|CHOP|chop
724275|NCT00147121|Bi-weekly|bi-weekly
724276|NCT00147121|low-grade B-cell lymphoma|low-grade b-cell lymphoma
724277|NCT00147121|advanced stage|advanced stage
724278|NCT00147121|follicular lymphoma|follicular lymphoma
724279|NCT00147121|G-CSF|g-csf
724280|NCT00147121|Untreated stage III/IV low-grade B-cell lymphoma|untreated stage iii/iv low-grade b-cell lymphoma
724281|NCT00147108|Breast Cancer|breast cancer
724282|NCT00147095|macrophages|macrophages
724283|NCT00147095|neutrophils|neutrophils
724284|NCT00147095|lymphocytes|lymphocytes
724285|NCT00147082|chemokine|chemokine
724286|NCT00147082|chemokine receptor|chemokine receptor
724287|NCT00147082|neutrophil|neutrophil
724288|NCT00147082|lymphocyte|lymphocyte
724289|NCT00147082|monocyte|monocyte
724290|NCT00147069|sputum|sputum
724291|NCT00147069|macrophage|macrophage
724292|NCT00147069|neutrophil|neutrophil
724293|NCT00147056|Brain tumor|brain tumor
724294|NCT00147056|Brain Lesions|brain lesions
724295|NCT00147056|Brain Cancer|brain cancer
724297|NCT00147043|Adult stem cells|adult stem cells
724298|NCT00147043|Liver disease|liver disease
724299|NCT00147043|CD34 positive cells|cd34 positive cells
724300|NCT00147030|Hypoxia|hypoxia
724301|NCT00147030|Ischaemia|ischaemia
724302|NCT00147030|Encephalopathy|encephalopathy
724303|NCT00147030|Neonatal|neonatal
724304|NCT00147030|Hypothermia|hypothermia
724305|NCT00147030|Perinatal|perinatal
724306|NCT00147030|Cooling|cooling
724307|NCT00147030|Whole/Total Body|whole/total body
724308|NCT00147017|macrophage|macrophage
724309|NCT00147017|inflammation|inflammation
724310|NCT00147017|COPD|copd
724311|NCT00147004|Septic shock|septic shock
724312|NCT00147004|Steroids|steroids
724313|NCT00147004|Hydrocortisone|hydrocortisone
724314|NCT00147004|Mortality|mortality
724315|NCT00147004|Reversal of shock|reversal of shock
724316|NCT00147004|Adrenal insufficiency|adrenal insufficiency
724317|NCT00146952|Hemineglects|hemineglects
724318|NCT00146926|Propofol|propofol
724319|NCT00146926|pain|pain
724320|NCT00146926|general anesthesia|general anesthesia
724321|NCT00146926|prevention|prevention
724322|NCT00146913|Chronic myeloid leukaemia|chronic myeloid leukaemia
724323|NCT00146913|resistant|resistant
724324|NCT00146913|refractory|refractory
724325|NCT00146913|Imatinib mesylate|imatinib mesylate
724326|NCT00146900|Traumatic Events|traumatic events
724327|NCT00146900|Post-traumatic Stress Disorder|post-traumatic stress disorder
724328|NCT00146900|Treatment (psychological)|treatment (psychological)
724329|NCT00146900|Treatment (pharmacological)|treatment (pharmacological)
724330|NCT00146900|Prevention|prevention
724331|NCT00146900|SSRIs|ssris
724332|NCT00146887|Coronary CT|coronary ct
724333|NCT00146887|sensitivity|sensitivity
724334|NCT00146887|specificity|specificity
724335|NCT00146809|Multi-System-Atrophy|multi-system-atrophy
724336|NCT00146809|Minocycline|minocycline
724337|NCT00146796|Malaria|malaria
724338|NCT00146796|Diagnosis|diagnosis
724339|NCT00146796|RDT|rdt
724340|NCT00146796|Africa|africa
724341|NCT00146796|Tanzania|tanzania
724342|NCT00146783|intermittent preventive treatment|intermittent preventive treatment
724343|NCT00146783|malaria|malaria
724344|NCT00146783|pregnancy|pregnancy
724345|NCT00146783|efficacy|efficacy
724346|NCT00146783|safety|safety
724347|NCT00146731|malaria|malaria
724348|NCT00146731|pregnancy|pregnancy
724349|NCT00146731|treatment|treatment
724350|NCT00146731|Africa|africa
724351|NCT00146731|Tanzania|tanzania
724352|NCT00146718|malaria|malaria
724353|NCT00146718|drug resistance|drug resistance
724354|NCT00146718|antimalarials|antimalarials
724355|NCT00146705|chronic HBV|chronic hbv
724356|NCT00146705|Peginterferon|peginterferon
724357|NCT00146705|long term follow-up|long term follow-up
724358|NCT00146692|Malaria|malaria
724359|NCT00146692|Cost|cost
724360|NCT00146692|Treatment|treatment
724361|NCT00146692|Diagnosis|diagnosis
724362|NCT00146692|Africa|africa
724363|NCT00146692|Ghana|ghana
724364|NCT00146679|Heart failure|heart failure
724365|NCT00146679|Ventricular arrhythmias|ventricular arrhythmias
724366|NCT00146679|ICD|icd
724367|NCT00146679|Psychoeducational intervention|psychoeducational intervention
724368|NCT00146666|Peak walking time|peak walking time
724369|NCT00146666|Absolute claudication distance|absolute claudication distance
724370|NCT00146666|Claudication onset time|claudication onset time
724371|NCT00146666|Initial claudication distance|initial claudication distance
724372|NCT00146666|Intermittent compression|intermittent compression
724373|NCT00146653|pediatrics|pediatrics
724374|NCT00146653|cardiopulmonary bypass|cardiopulmonary bypass
724375|NCT00146653|surgery|surgery
724376|NCT00146640|active disease|active disease
724377|NCT00146640|morning stiffness of joints|morning stiffness of joints
724378|NCT00146640|nighttime application of prednisone|nighttime application of prednisone
724379|NCT00146640|modified releae prednisone|modified releae prednisone
724380|NCT00146627|Human African Trypanosomiasis|human african trypanosomiasis
724381|NCT00146627|Combination|combination
724382|NCT00146627|Trypanosoma brucei gambiense Human African Trypanosomiasis|trypanosoma brucei gambiense human african trypanosomiasis
724383|NCT00146614|Graft versus Host Disease|graft versus host disease
724384|NCT00146614|GVHD|gvhd
724385|NCT00146614|Stem Cell Transplantation|stem cell transplantation
724386|NCT00146614|Tacrolimus|tacrolimus
724387|NCT00146614|Sirolimus|sirolimus
724388|NCT00146614|Methotrexate|methotrexate
724389|NCT00146614|allogeneic stem cell transplantation|allogeneic stem cell transplantation
724390|NCT00146601|Fulvestrant|fulvestrant
724391|NCT00146601|Advanced breast cancer|advanced breast cancer
724392|NCT00146601|Invasive breast cancer|invasive breast cancer
724393|NCT00146601|Stage IV Breast Cancer|stage iv breast cancer
724394|NCT00146601|Hormone Receptor-Positive Breast Cancer|hormone receptor-positive breast cancer
724395|NCT00146588|Breast cancer|breast cancer
724396|NCT00146588|cytoxan|cytoxan
724397|NCT00146588|epirubicin|epirubicin
724398|NCT00146588|capecitabine|capecitabine
724399|NCT00146562|adjuvant chemotherapy|adjuvant chemotherapy
724400|NCT00146562|G-CSF|g-csf
724401|NCT00146562|pegfilgrastim|pegfilgrastim
724402|NCT00146562|darbepoetin alfa|darbepoetin alfa
724403|NCT00146549|HER2-positive Breast cancer|her2-positive breast cancer
724404|NCT00146549|HER2 overexpressing|her2 overexpressing
724405|NCT00146549|trastuzumab|trastuzumab
724406|NCT00146549|Herceptin|herceptin
724407|NCT00146549|vinorelbine|vinorelbine
724408|NCT00146549|Navelbine|navelbine
724409|NCT00146549|Taxotere|taxotere
724410|NCT00146549|taxol|taxol
724411|NCT00146536|ALH|alh
724412|NCT00146536|LCIS|lcis
724413|NCT00146536|DCIS|dcis
724414|NCT00146536|adjacent ipsilateral infiltrating carcinoma|adjacent ipsilateral infiltrating carcinoma
724415|NCT00146536|core needle biopsy|core needle biopsy
724416|NCT00146536|Lobular neoplasia of the breast|lobular neoplasia of the breast
724417|NCT00146523|Psychotic Major Depression|psychotic major depression
724418|NCT00146523|PMD|pmd
724419|NCT00146523|Depression|depression
724420|NCT00146523|Major Depression|major depression
724421|NCT00146523|Psychosis|psychosis
724422|NCT00146510|weight control|weight control
724423|NCT00146510|compliance|compliance
724424|NCT00146510|physical activity|physical activity
724425|NCT00146510|nutrition|nutrition
724426|NCT00146510|Health Behavior|health behavior
724427|NCT00146510|Patient Compliance|patient compliance
724428|NCT00146497|Respiratory distress syndrome (RDS)|respiratory distress syndrome (rds)
724429|NCT00146497|Premature infants|premature infants
724430|NCT00146497|Chronic lung disease (CLD)|chronic lung disease (cld)
724431|NCT00146497|Bronchoalveolar lavage fluid (BALF)|bronchoalveolar lavage fluid (balf)
724432|NCT00146497|Cytokines|cytokines
724433|NCT00146484|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
724434|NCT00146484|Child|child
724435|NCT00146484|Adolescent|adolescent
724436|NCT00146484|Disease Management|disease management
724437|NCT00146484|Newly Diagnosed|newly diagnosed
724438|NCT00146484|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
724439|NCT00146471|alcohol withdrawal|alcohol withdrawal
724440|NCT00146471|detoxification|detoxification
724441|NCT00146471|Inpatients|inpatients
724442|NCT00146471|alcohol dependence according to DSM-IV/ICD-10|alcohol dependence according to dsm-iv/icd-10
724443|NCT00146471|withdrawal symptoms|withdrawal symptoms
724444|NCT00146458|Cervical cancer|cervical cancer
724445|NCT00146458|FDG-PET|fdg-pet
724446|NCT00146458|Lymph node metastasis|lymph node metastasis
724447|NCT00146458|Radiotherapy|radiotherapy
724448|NCT00146458|Chemotherapy|chemotherapy
724449|NCT00146445|IV drug users|iv drug users
724450|NCT00146419|Treatment Experienced|treatment experienced
724451|NCT00146419|Treatment Naive|treatment naive
724452|NCT00146406|Adolescent Health|adolescent health
724453|NCT00146406|Sexually Transmitted Disease|sexually transmitted disease
724454|NCT00146406|Sexual Behavior|sexual behavior
724455|NCT00146393|exercise|exercise
724456|NCT00146393|physical activity|physical activity
724457|NCT00146393|physical conditioning|physical conditioning
724458|NCT00146393|pain|pain
724459|NCT00146393|physical function|physical function
724460|NCT00146380|Prevention Mother-to-Child HIV transmission|prevention mother-to-child hiv transmission
724461|NCT00146380|HIV Seronegativity|hiv seronegativity
724462|NCT00146367|arthritis|arthritis
724463|NCT00146367|osteoarthritis|osteoarthritis
724464|NCT00146367|rheumatoid arthritis|rheumatoid arthritis
724465|NCT00146367|rheumatic disease|rheumatic disease
724466|NCT00146367|exercise|exercise
724467|NCT00146367|physical activity|physical activity
724468|NCT00146367|physical function|physical function
724469|NCT00146367|disability|disability
724470|NCT00146354|Electronic Medical Record|electronic medical record
724471|NCT00146354|Electronic Results Tracking|electronic results tracking
724472|NCT00146354|Patient Safety|patient safety
724473|NCT00146354|Post-Discharge Test Results|post-discharge test results
724474|NCT00146315|Primary Health Care|primary health care
724475|NCT00146315|Family Practice|family practice
724476|NCT00146315|Family Physician|family physician
724477|NCT00146315|Exercise|exercise
724478|NCT00146315|Coronary Heart Disease|coronary heart disease
724479|NCT00146315|Randomized Controlled Trials|randomized controlled trials
724480|NCT00146315|Multicenter Studies|multicenter studies
724481|NCT00146302|Non-specific effects of vaccines|non-specific effects of vaccines
724482|NCT00146302|Infant mortality|infant mortality
724483|NCT00146302|Morbidity|morbidity
724484|NCT00146302|Low income country|low income country
724485|NCT00146302|BCG|bcg
724486|NCT00146302|Vaccine policy|vaccine policy
724487|NCT00146302|immunisation|immunisation
724488|NCT00146302|Low birth weight|low birth weight
724489|NCT00146302|Tuberculin|tuberculin
724490|NCT00146302|Mortality|mortality
724491|NCT00146276|bladder cancer|bladder cancer
724492|NCT00146276|cystectomy|cystectomy
724493|NCT00146276|gemcitabine|gemcitabine
724494|NCT00146276|adjuvant chemotherapy|adjuvant chemotherapy
724495|NCT00146276|locally advanced bladder cancer|locally advanced bladder cancer
724496|NCT00146263|mild cognitive impairment|mild cognitive impairment
724497|NCT00146263|dementia|dementia
724498|NCT00146263|Alzheimer's Disease|alzheimer's disease
724499|NCT00146263|cognitive training|cognitive training
724500|NCT00146237|phenytoin|phenytoin
724501|NCT00146237|SSRI failure|ssri failure
724502|NCT00146237|depression|depression
724503|NCT00146224|anemia|anemia
724504|NCT00146224|chronic kidney disease, CKD|chronic kidney disease, ckd
724505|NCT00146224|hemodialysis|hemodialysis
724506|NCT00146224|epoetin|epoetin
724507|NCT00146224|Epogen®|epogen®
724508|NCT00146211|Trial|trial
724509|NCT00146211|ethyl-EPA|ethyl-epa
724510|NCT00146211|Miraxion™|miraxion™
724511|NCT00146211|treating|treating
724512|NCT00146211|mild|mild
724513|NCT00146211|moderate|moderate
724514|NCT00146211|Huntington's|huntington's
724515|NCT00146198|Postoperative pain|postoperative pain
724516|NCT00146198|Inguinal Hernia Repair|inguinal hernia repair
724517|NCT00146198|Capsaicin|capsaicin
724518|NCT00146185|Needlestick pain|needlestick pain
724519|NCT00146185|Venipuncture pain|venipuncture pain
724520|NCT00146185|Procedural pain|procedural pain
724521|NCT00146172|Tumors|tumors
724522|NCT00146172|Neratinib|neratinib
724523|NCT00146172|HKI-272|hki-272
724524|NCT00146172|Nerlynx|nerlynx
724525|NCT00146159|Multiple Sclerosis|multiple sclerosis
724526|NCT00146146|transsexualism|transsexualism
724527|NCT00146146|testosterone|testosterone
724528|NCT00146146|dihydrotestosterone|dihydrotestosterone
724529|NCT00146146|estradiol|estradiol
724530|NCT00146133|Obesity, Aging, Frailty, exercise, weight loss|obesity, aging, frailty, exercise, weight loss
724531|NCT00146107|obesity|obesity
724532|NCT00146107|aging|aging
724533|NCT00146107|exercise|exercise
724534|NCT00146107|diet|diet
724535|NCT00146107|weight loss|weight loss
724536|NCT00146107|physical function|physical function
724537|NCT00146107|Obesity in the Elderly|obesity in the elderly
724538|NCT00146094|Osteopenia|osteopenia
724539|NCT00146094|osteoporosis|osteoporosis
724540|NCT00146094|bone mineral density|bone mineral density
724541|NCT00146094|HIV infection|hiv infection
724542|NCT00146094|bone metabolism|bone metabolism
724543|NCT00146094|Treatment Naive|treatment naive
724544|NCT00146081|African Americans|african americans
724545|NCT00146081|weight control|weight control
724546|NCT00146081|social support|social support
724547|NCT00146068|Clinically Isolated Syndrome|clinically isolated syndrome
724548|NCT00146029|Patients who participated in UMCC 9900/9901 (Phase II Studies of Tailored-Dose Docetaxel in Metastatic Breast Cancer)|patients who participated in umcc 9900/9901 (phase ii studies of tailored-dose docetaxel in metastatic breast cancer)
724549|NCT00146016|Chronic Hepatitis C|chronic hepatitis c
724550|NCT00146016|Amantadine|amantadine
724551|NCT00146016|Triple therapy|triple therapy
724552|NCT00146003|eczema|eczema
724553|NCT00146003|atopic dermatitis|atopic dermatitis
724554|NCT00146003|efalizumab|efalizumab
724555|NCT00145990|methacholine PC20|methacholine pc20
724556|NCT00145990|dosimeter|dosimeter
724557|NCT00145990|asthma|asthma
724558|NCT00145977|osteoporosis|osteoporosis
724559|NCT00145977|bone density|bone density
724560|NCT00145977|women|women
724561|NCT00145977|endocrine|endocrine
724562|NCT00145977|musculoskeletal|musculoskeletal
724563|NCT00145977|metabolic|metabolic
724564|NCT00145964|Biliary Cirrhosis, Primary|biliary cirrhosis, primary
724565|NCT00145964|genes|genes
724566|NCT00145964|autoimmune disease|autoimmune disease
724567|NCT00145938|Portopulmonary hypertension|portopulmonary hypertension
724568|NCT00145938|PTPH|ptph
724569|NCT00145938|pulmonary hypertension|pulmonary hypertension
724570|NCT00145938|high blood pressure in the pulmonary arteries|high blood pressure in the pulmonary arteries
724571|NCT00145925|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
724572|NCT00145925|Blood Pressure|blood pressure
724573|NCT00145925|Stroke|stroke
724574|NCT00145925|MI|mi
724575|NCT00145912|Depression in adolescents and young adults, depression web-base activity|depression in adolescents and young adults, depression web-base activity
724576|NCT00145886|low bone turnover; sclerosing bone disorders,|low bone turnover; sclerosing bone disorders,
724577|NCT00145886|osteopetrosis|osteopetrosis
724578|NCT00145873|heart failure|heart failure
724579|NCT00145873|nesiritide|nesiritide
724580|NCT00145873|heart disease|heart disease
724581|NCT00145873|cardiovascular disease|cardiovascular disease
724582|NCT00145860|Colorectal Cancer|colorectal cancer
724583|NCT00145847|alcohol|alcohol
724584|NCT00145847|schizophrenia|schizophrenia
724585|NCT00145847|naltrexone|naltrexone
724586|NCT00145834|psychosocial factors|psychosocial factors
724587|NCT00145834|breastfeeding|breastfeeding
724588|NCT00145834|postnatal intervention|postnatal intervention
724589|NCT00145834|health visitor|health visitor
724590|NCT00145808|Ulcerative colitis|ulcerative colitis
724591|NCT00145795|HIV|hiv
724592|NCT00145795|HAART (Highly Active Anti-Retroviral Therapy) partial immune response|haart (highly active anti-retroviral therapy) partial immune response
724593|NCT00145795|no immune response|no immune response
724594|NCT00145795|Treatment Experienced|treatment experienced
724595|NCT00145782|multiphasic screening|multiphasic screening
724596|NCT00145782|primary health care|primary health care
724597|NCT00145782|randomized controlled trial|randomized controlled trial
724598|NCT00145782|Risk factors|risk factors
724599|NCT00145769|rectal cancer|rectal cancer
724600|NCT00145769|radiotherapy|radiotherapy
724601|NCT00145769|chemotherapy|chemotherapy
724602|NCT00145769|chemoradiation|chemoradiation
724603|NCT00145769|adjuvant therapy|adjuvant therapy
724604|NCT00145756|Sodium Chloride|sodium chloride
724605|NCT00145756|Blood Pressure|blood pressure
724606|NCT00145756|Cardiovascular Diseases|cardiovascular diseases
724607|NCT00145756|Clinical Trial|clinical trial
724608|NCT00145743|Quality of Life|quality of life
724609|NCT00145743|Breast Cancer|breast cancer
724610|NCT00145743|Referee's Report|referee's report
724611|NCT00145743|Diagnostics|diagnostics
724612|NCT00145743|Therapy|therapy
724613|NCT00145730|osteoarthritis hip|osteoarthritis hip
724614|NCT00145730|arthroplasty|arthroplasty
724615|NCT00145730|ectopic bone formation|ectopic bone formation
724616|NCT00145730|non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
724617|NCT00145730|disability|disability
724618|NCT00145717|Phytosterols|phytosterols
724619|NCT00145717|Cholesterol|cholesterol
724620|NCT00145717|China|china
724621|NCT00145717|Randomized controlled trial|randomized controlled trial
724622|NCT00145704|osteopenia|osteopenia
724623|NCT00145704|growth hormone deficiency|growth hormone deficiency
724624|NCT00145704|pediatric malignancy|pediatric malignancy
724625|NCT00145678|borderline|borderline
724626|NCT00145678|alcohol|alcohol
724627|NCT00145678|substance|substance
724628|NCT00145678|psychodynamic|psychodynamic
724629|NCT00145678|psychotherapy|psychotherapy
724630|NCT00145678|psychoanalytic|psychoanalytic
724631|NCT00145665|FLT-PET|flt-pet
724632|NCT00145665|colorectal liver metastases|colorectal liver metastases
724633|NCT00145665|proliferation|proliferation
724634|NCT00145665|proliferation markers|proliferation markers
724635|NCT00145665|recurrence|recurrence
724636|NCT00145652|erythropoetin|erythropoetin
724637|NCT00145652|adjuvant iron therapy|adjuvant iron therapy
724638|NCT00145652|anemia|anemia
724639|NCT00145652|cancer|cancer
724640|NCT00145639|Osteosarcoma|osteosarcoma
724641|NCT00145639|Treatment, Carboplatin|treatment, carboplatin
724642|NCT00145626|Stem cell transplantation|stem cell transplantation
724643|NCT00145626|Stem cell transplant|stem cell transplant
724644|NCT00145626|Haploidentical transplant|haploidentical transplant
724645|NCT00145613|Haploidentical stem cell transplant|haploidentical stem cell transplant
724646|NCT00145613|High risk hematologic malignancies|high risk hematologic malignancies
724647|NCT00145613|Allogeneic stem cell transplant|allogeneic stem cell transplant
724648|NCT00145613|Mismatched family member stem cell donor|mismatched family member stem cell donor
724649|NCT00145600|Lymphoma|lymphoma
724650|NCT00145600|Hodgkin Disease|hodgkin disease
724651|NCT00145587|Osteopetrosis|osteopetrosis
724652|NCT00145587|Autosomal recessive bone disease|autosomal recessive bone disease
724653|NCT00145587|Haploidentical stem cell transplantation|haploidentical stem cell transplantation
724654|NCT00145587|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
724655|NCT00145587|T-cell depletion methodology|t-cell depletion methodology
724656|NCT00145587|Miltenyi Biotec CliniMACS stem cell selection device|miltenyi biotec clinimacs stem cell selection device
724657|NCT00145574|Pediatric|pediatric
724658|NCT00145574|hypercholesterolemia|hypercholesterolemia
724659|NCT00145574|colesevelam|colesevelam
724660|NCT00145561|HIV|hiv
724661|NCT00145548|COPD|copd
724662|NCT00145535|Glaucoma|glaucoma
724663|NCT00145535|Glaucoma, open angle|glaucoma, open angle
724664|NCT00145535|Intraocular Pressure|intraocular pressure
724665|NCT00145535|Trabeculoplasty|trabeculoplasty
724666|NCT00145535|laser|laser
724667|NCT00145535|laser, surgery|laser, surgery
724668|NCT00145522|Menopause, IGF-1, HRT|menopause, igf-1, hrt
724669|NCT00145418|Non small Cell Lung Cancer Stage IIIb and IV|non small cell lung cancer stage iiib and iv
724670|NCT00145405|Acromegaly|acromegaly
724671|NCT00145405|somatostatin analogues|somatostatin analogues
724672|NCT00145405|lanreotide|lanreotide
724673|NCT00145405|octreotide|octreotide
724674|NCT00145405|GH|gh
724675|NCT00145405|IGF-I|igf-i
724676|NCT00145405|injection site|injection site
724677|NCT00145392|Polycystic ovary syndrome|polycystic ovary syndrome
724678|NCT00145392|growth hormone|growth hormone
724679|NCT00145392|insulin resistance|insulin resistance
724680|NCT00145392|overweight|overweight
724681|NCT00145392|glucose metabolism|glucose metabolism
724682|NCT00145379|type 1 diabetes mellitus|type 1 diabetes mellitus
724683|NCT00145379|insulin resistance|insulin resistance
724684|NCT00145379|metformin|metformin
724685|NCT00145379|randomized, controlled study|randomized, controlled study
724686|NCT00145366|Benign nontoxic and toxic goiter|benign nontoxic and toxic goiter
724687|NCT00145366|rhTSH|rhtsh
724688|NCT00145366|131I|131i
724689|NCT00145366|goiter reduction|goiter reduction
724690|NCT00145366|131I kinetic|131i kinetic
724691|NCT00145366|thyroid size|thyroid size
724692|NCT00145366|patient satisfaction|patient satisfaction
724693|NCT00145366|adverse effects|adverse effects
724694|NCT00145366|BRT|brt
724695|NCT00145366|Graves' disease|graves' disease
724696|NCT00145353|type 1 diabetes mellitus|type 1 diabetes mellitus
724697|NCT00145353|hypoglycaemia|hypoglycaemia
724698|NCT00145353|insulin profiles|insulin profiles
724699|NCT00145353|growth hormone|growth hormone
724700|NCT00145353|cortisol|cortisol
724701|NCT00145353|glucagon|glucagon
724702|NCT00145340|polycystic ovary syndrome (PCOS)|polycystic ovary syndrome (pcos)
724703|NCT00145340|PPARgamma|ppargamma
724704|NCT00145340|growth hormone|growth hormone
724705|NCT00145340|insulin resistance|insulin resistance
724706|NCT00145340|pioglitazone|pioglitazone
724707|NCT00145340|glucose metabolism|glucose metabolism
724708|NCT00145340|microarray|microarray
724709|NCT00145327|Osteoporosis, Zoledronic Acid|osteoporosis, zoledronic acid
724710|NCT00145314|Metastatic colorectal cancer|metastatic colorectal cancer
724711|NCT00145314|FLOX|flox
724712|NCT00145314|Cetuximab|cetuximab
724713|NCT00145301|Osteoarthritis, lumiracoxib, retention on treatment, efficacy, safety|osteoarthritis, lumiracoxib, retention on treatment, efficacy, safety
724714|NCT00145288|hirsutism|hirsutism
724715|NCT00145288|type 2 diabetes|type 2 diabetes
724716|NCT00145288|polycystic ovary syndrome|polycystic ovary syndrome
724717|NCT00145288|metabolism|metabolism
724718|NCT00145275|zoledronic acid|zoledronic acid
724719|NCT00145275|bisphosphonate|bisphosphonate
724720|NCT00145275|Low bone mass|low bone mass
724721|NCT00145262|critical limb ischemia|critical limb ischemia
724722|NCT00145262|bone marrow mononuclear cells|bone marrow mononuclear cells
724723|NCT00145262|angiogenesis|angiogenesis
724724|NCT00145262|vasculogenesis|vasculogenesis
724725|NCT00145262|Arteriosclerosis Obliterans (ASO)|arteriosclerosis obliterans (aso)
724726|NCT00145262|Ischemic ulcers|ischemic ulcers
724727|NCT00145249|Bacterial infections, HIV infection, cryptococcal meningitis|bacterial infections, hiv infection, cryptococcal meningitis
724728|NCT00145236|Nebivolol|nebivolol
724729|NCT00145236|Beta-Blocker|beta-blocker
724730|NCT00145223|Wuchereria bancrofti, filariasis, Egypt|wuchereria bancrofti, filariasis, egypt
724731|NCT00145210|Nebivolol|nebivolol
724732|NCT00145197|breast cancer|breast cancer
724733|NCT00145197|adjuvant treatment|adjuvant treatment
724734|NCT00145197|racial disparities|racial disparities
724735|NCT00145197|Early-Stage Breast Cancer|early-stage breast cancer
724736|NCT00145184|multivitamin, supplements, tuberculosis, Tanzania|multivitamin, supplements, tuberculosis, tanzania
724737|NCT00145158|Melanoma|melanoma
724738|NCT00145158|Vaccine|vaccine
724739|NCT00145158|Peptide|peptide
724740|NCT00145158|Montanide|montanide
724741|NCT00145145|Melanoma|melanoma
724742|NCT00145145|Vaccine|vaccine
724743|NCT00145145|Peptide|peptide
724744|NCT00145145|MAGE|mage
724745|NCT00145145|CpG|cpg
724746|NCT00145132|depression|depression
724747|NCT00145132|β-CIT-SPECT|β-cit-spect
724748|NCT00145132|SERT|sert
724749|NCT00145132|DAT|dat
724750|NCT00145132|neurophysiology|neurophysiology
724751|NCT00145132|LDAEP|ldaep
724752|NCT00145132|escitalopram|escitalopram
724753|NCT00145132|SSRI|ssri
724754|NCT00145119|Acute myocardial infarction|acute myocardial infarction
724755|NCT00145119|Cardiac arrhythmias|cardiac arrhythmias
724756|NCT00145119|Left ventricular dysfunction|left ventricular dysfunction
724757|NCT00145119|Implantable loop recorder|implantable loop recorder
724758|NCT00145119|Risk stratifiers|risk stratifiers
724759|NCT00145106|acne, tazarotene, minocycline, maintenance, retinoid, efficacy, combination|acne, tazarotene, minocycline, maintenance, retinoid, efficacy, combination
724760|NCT00145093|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
724761|NCT00145093|Chromium|chromium
724762|NCT00145093|Saccharomyces cerevisiae|saccharomyces cerevisiae
724763|NCT00145028|Neoplasms|neoplasms
724764|NCT00145028|Carboplatin|carboplatin
724765|NCT00145028|optimal exposure|optimal exposure
724766|NCT00145028|AUC|auc
724767|NCT00145015|Intervention|intervention
724768|NCT00145015|Adults|adults
724769|NCT00145015|Colorectal cancer|colorectal cancer
724770|NCT00145015|Nutrition|nutrition
724771|NCT00145015|Fish|fish
724772|NCT00145015|n-3 fatty acids|n-3 fatty acids
724773|NCT00145015|Apoptosis|apoptosis
724774|NCT00145015|Ulcerative colitis|ulcerative colitis
724775|NCT00145015|Polyps|polyps
724776|NCT00145015|Gastro-intestinal tract|gastro-intestinal tract
724777|NCT00145002|ATLL|atll
724778|NCT00145002|chemotherapy|chemotherapy
724779|NCT00145002|phase III study|phase iii study
724780|NCT00145002|VCAP-AMP-VECP|vcap-amp-vecp
724781|NCT00145002|biweekly-CHOP|biweekly-chop
724782|NCT00144989|Small-cell lung cancer|small-cell lung cancer
724783|NCT00144989|Limited-Stage Small-Cell Lung Cancer|limited-stage small-cell lung cancer
724784|NCT00144989|Combined modality therapy|combined modality therapy
724785|NCT00144989|chemotherapy|chemotherapy
724786|NCT00144989|radiotherapy|radiotherapy
724787|NCT00144989|Irinotecan|irinotecan
724788|NCT00144989|Cisplatin|cisplatin
724789|NCT00144976|Head and Neck Neoplasms|head and neck neoplasms
724790|NCT00144976|Tarceva|tarceva
724791|NCT00144976|ENT|ent
724792|NCT00144911|exacerbations|exacerbations
724793|NCT00144911|breathing|breathing
724794|NCT00144911|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
724795|NCT00144898|Breast cancer|breast cancer
724796|NCT00144898|sentinel node resection|sentinel node resection
724797|NCT00144898|survival|survival
724798|NCT00144898|Breast cancer unifocal N0|breast cancer unifocal n0
724799|NCT00144885|Endocarditis|endocarditis
724800|NCT00144885|RMI|rmi
724801|NCT00144885|Impact measure|impact measure
724802|NCT00144872|Absence Seizures|absence seizures
724803|NCT00144872|EEG|eeg
724804|NCT00144872|LTG|ltg
724805|NCT00144872|Typical Absence Epilepsy|typical absence epilepsy
724806|NCT00144872|Epilepsy|epilepsy
724807|NCT00144872|LAMICTAL|lamictal
724808|NCT00144859|P38 map kinase|p38 map kinase
724809|NCT00144859|CRP|crp
724810|NCT00144859|COPD|copd
724811|NCT00144859|safety|safety
724812|NCT00144846|wheezing|wheezing
724813|NCT00144846|bronchospasm|bronchospasm
724814|NCT00144846|albuterol sulfate HFA|albuterol sulfate hfa
724815|NCT00144833|Protease inhibitors-experienced HIV-1 infected patients|protease inhibitors-experienced hiv-1 infected patients
724816|NCT00144833|Highly-resistant HIV-1|highly-resistant hiv-1
724817|NCT00144833|Dual boosted Pis|dual boosted pis
724818|NCT00144833|fosamprenavir|fosamprenavir
724819|NCT00144833|lopinavir|lopinavir
724820|NCT00144820|Hyaluronan|hyaluronan
724821|NCT00144820|Gonarthrosis|gonarthrosis
724822|NCT00144820|Osteoarthritis,knee|osteoarthritis,knee
724823|NCT00144820|Double-blinded|double-blinded
724824|NCT00144820|Placebo controlled|placebo controlled
724825|NCT00144820|Randomised|randomised
724826|NCT00144807|lymphoma, diffuse large B-cell|lymphoma, diffuse large b-cell
724827|NCT00144807|rituximab|rituximab
724828|NCT00144807|chemotherapy|chemotherapy
724829|NCT00144807|autologous stem cell transplant|autologous stem cell transplant
724830|NCT00144794|Hurler's Syndrome|hurler's syndrome
724831|NCT00144794|Hurler-Scheie Syndrome|hurler-scheie syndrome
724832|NCT00144794|Scheie Syndrome|scheie syndrome
724833|NCT00144755|lymphoma, diffuse large B-cell|lymphoma, diffuse large b-cell
724834|NCT00144755|rituximab|rituximab
724835|NCT00144755|chemotherapy|chemotherapy
724836|NCT00144755|erythropoetin|erythropoetin
724837|NCT00144755|darbepoetin alfa|darbepoetin alfa
724838|NCT00144716|Vector Control|vector control
724839|NCT00144716|repellent|repellent
724840|NCT00144716|ITN's|itn's
724841|NCT00144716|malaria|malaria
724842|NCT00144716|Amazon|amazon
724843|NCT00144703|Graft versus host disease|graft versus host disease
724844|NCT00144703|GVHD|gvhd
724845|NCT00144703|Stem cell transplantation|stem cell transplantation
724846|NCT00144703|sirolimus|sirolimus
724847|NCT00144703|tacrolimus|tacrolimus
724848|NCT00144690|Epilepsy refractory partial seizures|epilepsy refractory partial seizures
724849|NCT00144677|Graft versus Host Disease|graft versus host disease
724850|NCT00144677|GVHD|gvhd
724851|NCT00144677|sirolimus|sirolimus
724852|NCT00144677|tacrolimus|tacrolimus
724853|NCT00144677|Stem cell transplant|stem cell transplant
724854|NCT00144443|Aerobiology|aerobiology
724855|NCT00144443|Asthma|asthma
724856|NCT00144443|Indoor Fungi|indoor fungi
724857|NCT00144443|Allergen|allergen
724858|NCT00144443|Home Remediation|home remediation
724859|NCT00144430|chronic graft versus host disease|chronic graft versus host disease
724860|NCT00144430|graft|graft
724861|NCT00144430|host|host
724862|NCT00144430|transplant|transplant
724863|NCT00144430|stem cell|stem cell
724864|NCT00144430|pediatric|pediatric
724865|NCT00144430|GVH0313|gvh0313
724866|NCT00144430|leukemia|leukemia
724867|NCT00144417|tuberculosis|tuberculosis
724868|NCT00144417|TB|tb
724869|NCT00144417|treatment|treatment
724870|NCT00144417|efficacy|efficacy
724871|NCT00144417|safety|safety
724872|NCT00144378|gastric cancer|gastric cancer
724873|NCT00144378|metastatic|metastatic
724874|NCT00144378|irinotecan|irinotecan
724875|NCT00144365|HIV|hiv
724876|NCT00144365|Africa|africa
724877|NCT00144365|Adherence|adherence
724878|NCT00144365|HIV viral load|hiv viral load
724879|NCT00144365|Sexual behavior|sexual behavior
724880|NCT00144365|Voluntary counseling and testing|voluntary counseling and testing
724881|NCT00144352|Malaria|malaria
724882|NCT00144352|HIV|hiv
724883|NCT00144352|AIDS|aids
724884|NCT00144352|drug efficacy|drug efficacy
724885|NCT00144352|Kenya|kenya
724886|NCT00144352|Africa|africa
724887|NCT00144352|Sulfadoxine pyirmethamine|sulfadoxine pyirmethamine
724888|NCT00144352|fansidar|fansidar
724889|NCT00144313|vaccine|vaccine
724890|NCT00144313|hepatitis B|hepatitis b
724891|NCT00144313|immune memory|immune memory
724892|NCT00144144|Hypertension|hypertension
724893|NCT00144144|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
724894|NCT00144144|Calcium Channel Blocker|calcium channel blocker
724895|NCT00144144|Angiotensin II type 1 Receptor Blocker|angiotensin ii type 1 receptor blocker
724896|NCT00144131|Chemotherapy, Anemia|chemotherapy, anemia
724897|NCT00144131|Aranesp®, rHuEPO|aranesp®, rhuepo
724898|NCT00144131|Chemotherapy Induced Anemia|chemotherapy induced anemia
724899|NCT00144131|non-myeloid malignancy|non-myeloid malignancy
724900|NCT00144131|Non-Myeloid Malignancies|non-myeloid malignancies
724901|NCT00144131|Chemotherapy|chemotherapy
724996|NCT00143637|perception|perception
724902|NCT00144092|autologous and allogeneic stem cell transplantation|autologous and allogeneic stem cell transplantation
724903|NCT00144092|low grade lymphoma|low grade lymphoma
724904|NCT00144092|mantle cell|mantle cell
724905|NCT00144079|Differentiated thyroid carcinoma|differentiated thyroid carcinoma
724906|NCT00144079|radiotherapy|radiotherapy
724907|NCT00144079|radioiodine therapy|radioiodine therapy
724908|NCT00144079|thyroidectomy|thyroidectomy
724909|NCT00144040|Antibiotics|antibiotics
724910|NCT00144040|Respiratory Infections|respiratory infections
724911|NCT00144040|Quality Assurance, Healthcare|quality assurance, healthcare
724912|NCT00144040|Professional Education|professional education
724913|NCT00144040|Emergency Services, Medical|emergency services, medical
724914|NCT00144040|Education, Patient|education, patient
724915|NCT00144027|patient non-adherence|patient non-adherence
724916|NCT00144027|intervention studies|intervention studies
724917|NCT00144014|Acute|acute
724918|NCT00144014|Ischaemic|ischaemic
724919|NCT00144014|Stroke|stroke
724920|NCT00144001|Epilepsy|epilepsy
724921|NCT00144001|Pharmacoepidemiology|pharmacoepidemiology
724922|NCT00144001|Quality of Care|quality of care
724923|NCT00144001|Outcomes|outcomes
724924|NCT00143988|Blood Pressure|blood pressure
724925|NCT00143988|Heart Rate|heart rate
724926|NCT00143988|Sexual Activity|sexual activity
724927|NCT00143975|Acute myeloid leukemia|acute myeloid leukemia
724928|NCT00143975|gemtuzumab ozogamicin|gemtuzumab ozogamicin
724929|NCT00143975|refractory disease|refractory disease
724930|NCT00143962|Weight Loss|weight loss
724931|NCT00143949|diabetes|diabetes
724932|NCT00143949|nephropathy|nephropathy
724933|NCT00143949|kidney|kidney
724934|NCT00143949|retinopathy|retinopathy
724935|NCT00143936|Weight Loss|weight loss
724936|NCT00143923|Cardiovascular Diseases|cardiovascular diseases
724937|NCT00143923|Ethnic Groups|ethnic groups
724938|NCT00143923|Risk Factors|risk factors
724939|NCT00143923|Sleep disordered breathing|sleep disordered breathing
724940|NCT00143923|Environmental exposures|environmental exposures
724941|NCT00143923|Cognitive Function|cognitive function
724942|NCT00143910|Medication adherence|medication adherence
724943|NCT00143910|Patient compliance|patient compliance
724944|NCT00143910|Kidney transplant|kidney transplant
724945|NCT00143910|Organ rejection|organ rejection
724946|NCT00143910|Allograft loss|allograft loss
724947|NCT00143910|Drug monitoring|drug monitoring
724948|NCT00143858|Peripheral Pulse Volume|peripheral pulse volume
724949|NCT00143832|fMRI|fmri
724950|NCT00143819|psoriasis|psoriasis
724951|NCT00143819|dry skin|dry skin
724952|NCT00143819|eczema|eczema
724953|NCT00143819|atopic dermatitis|atopic dermatitis
724954|NCT00143806|psoriasis|psoriasis
724955|NCT00143806|cyclosporine|cyclosporine
724956|NCT00143806|transition|transition
724957|NCT00143806|alefacept|alefacept
724958|NCT00143793|natruretic peptides|natruretic peptides
724959|NCT00143793|NT-proBNP|nt-probnp
724960|NCT00143793|new biomarkers|new biomarkers
724961|NCT00143793|congestive heart failure|congestive heart failure
724962|NCT00143793|atrial fibrillation|atrial fibrillation
724963|NCT00143793|acute myocardial infarction|acute myocardial infarction
724964|NCT00143793|lung embolism|lung embolism
724965|NCT00143780|Bone Marrow Transplant|bone marrow transplant
724966|NCT00143780|Pneumonia|pneumonia
724967|NCT00143780|Vaccine|vaccine
724968|NCT00143780|Conjugate Vaccine|conjugate vaccine
724969|NCT00143780|Polysaccharide Vaccine|polysaccharide vaccine
724970|NCT00143767|Magnetic Resonance Imaging|magnetic resonance imaging
724971|NCT00143741|Kidney Disease, Lipitor, Atorvastatin, Allosensitization|kidney disease, lipitor, atorvastatin, allosensitization
724972|NCT00143728|HIV|hiv
724973|NCT00143728|Treatment Experienced|treatment experienced
724974|NCT00143715|Vitamin K1 (phytonadione)|vitamin k1 (phytonadione)
724975|NCT00143715|Randomized controlled trial|randomized controlled trial
724976|NCT00143715|Warfarin|warfarin
724977|NCT00143715|Coagulopathy|coagulopathy
724978|NCT00143715|Bleeding|bleeding
724979|NCT00143715|Thrombosis|thrombosis
724980|NCT00143715|Warfarin associated coagulopathy defined as an INR of 4.5 and 10.0 (for entry into randomized tria) or greater than 10.0 (for entry into parallel cohort study|warfarin associated coagulopathy defined as an inr of 4.5 and 10.0 (for entry into randomized tria) or greater than 10.0 (for entry into parallel cohort study
724981|NCT00143715|Warfarin associated coagulopathy|warfarin associated coagulopathy
724982|NCT00143702|Elevated Lactic Acid|elevated lactic acid
724983|NCT00143676|Hyperlipidemia|hyperlipidemia
724984|NCT00143676|Dyslipidemia|dyslipidemia
724985|NCT00143676|Drug Therapy|drug therapy
724986|NCT00143663|Hypercholesterolemia|hypercholesterolemia
724987|NCT00143663|Hyperlipidemia|hyperlipidemia
724988|NCT00143663|Drug Therapy|drug therapy
724989|NCT00143650|Upper airway, irritation inflammation, discomfort, house dust, damp buildings, climate chamber, humans|upper airway, irritation inflammation, discomfort, house dust, damp buildings, climate chamber, humans
724990|NCT00143637|Office dust|office dust
724991|NCT00143637|Glucan|glucan
724992|NCT00143637|dose-response|dose-response
724993|NCT00143637|lung function|lung function
724994|NCT00143637|peak expiratory flow|peak expiratory flow
724995|NCT00143637|inflammation|inflammation
724997|NCT00143624|Treatment Experienced|treatment experienced
724998|NCT00143624|HIV Metabolic Syndrome|hiv metabolic syndrome
724999|NCT00143624|Atherosclerosis in HIV|atherosclerosis in hiv
725000|NCT00143611|Shock, Septic|shock, septic
725001|NCT00143611|Sepsis Syndrome|sepsis syndrome
725002|NCT00143611|Respiratory Insufficiency|respiratory insufficiency
725003|NCT00143611|SIRS (Systemic Inflammatory Response Syndrome)|sirs (systemic inflammatory response syndrome)
725004|NCT00143611|Respiratory Failure|respiratory failure
725005|NCT00143611|Drug Therapy|drug therapy
725006|NCT00143598|Postphlebitic Syndrome|postphlebitic syndrome
725007|NCT00143598|Post-Thrombotic Syndrome|post-thrombotic syndrome
725008|NCT00143598|Elastic Stockings|elastic stockings
725009|NCT00143598|Stockings, Compression|stockings, compression
725010|NCT00143598|Randomized Controlled Trials|randomized controlled trials
725011|NCT00143598|Quality of Life|quality of life
725012|NCT00143585|angiogenesis|angiogenesis
725013|NCT00143585|VEGF|vegf
725014|NCT00143572|Hematologic Diseases|hematologic diseases
725015|NCT00143572|Anemia, Sickle Cell|anemia, sickle cell
725016|NCT00143559|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
725017|NCT00143559|Haploidentical stem cell transplant|haploidentical stem cell transplant
725018|NCT00143559|Mismatched family member stem cell donor transplant|mismatched family member stem cell donor transplant
725019|NCT00143559|Bone marrow transplant|bone marrow transplant
725020|NCT00143559|High risk hematological malignancies|high risk hematological malignancies
725021|NCT00143559|T-cell depletion methodology|t-cell depletion methodology
725022|NCT00143559|Miltenyi Biotec CliniMACS stem cell selection device|miltenyi biotec clinimacs stem cell selection device
725023|NCT00143546|Hepatic Veno-occlusive Disease|hepatic veno-occlusive disease
725024|NCT00143533|Solid Tumors|solid tumors
725025|NCT00143520|Placebo and active control dose response study of rivoglitazone in type 2 diabetics|placebo and active control dose response study of rivoglitazone in type 2 diabetics
725026|NCT00143468|gas exchange|gas exchange
725027|NCT00143468|respiratory mechanics|respiratory mechanics
725028|NCT00143429|Primary Open Angle Glaucoma|primary open angle glaucoma
725029|NCT00143312|Invasive Fungal Infection, Allogenic Stem Cell Transplant, prophylaxis, leukemia, voriconazole|invasive fungal infection, allogenic stem cell transplant, prophylaxis, leukemia, voriconazole
725030|NCT00143130|phase 4, open label, seizures, epilepsy, add-on therapy, pregabalin, lyrica|phase 4, open label, seizures, epilepsy, add-on therapy, pregabalin, lyrica
725031|NCT00143091|Major Depressive Disorder, Recurrent|major depressive disorder, recurrent
725032|NCT00143078|Obesity|obesity
725033|NCT00143078|Reproduction|reproduction
725034|NCT00143078|Weight Loss|weight loss
725035|NCT00143078|Reproductive System|reproductive system
725036|NCT00143065|Antigens, CD5|antigens, cd5
725037|NCT00143065|Antigens, CD19|antigens, cd19
725038|NCT00143065|Antigens, CD20|antigens, cd20
725039|NCT00143052|Hirsutism|hirsutism
725040|NCT00143052|Bone status|bone status
725041|NCT00143052|Androgens|androgens
725042|NCT00143052|insulin|insulin
725043|NCT00143039|NIH|nih
725044|NCT00143039|Severe Symmetrical IUGR|severe symmetrical iugr
725045|NCT00143039|Tandem Mass Spectrometry|tandem mass spectrometry
725046|NCT00143039|Nonimmune Hydrops|nonimmune hydrops
725047|NCT00143039|Severe Symmetrical Intrauterine Growth Restriction|severe symmetrical intrauterine growth restriction
725048|NCT00143026|Parkinson's disease, levodopa, motor fluctuations|parkinson's disease, levodopa, motor fluctuations
725049|NCT00143013|type 2 diabetes|type 2 diabetes
725050|NCT00143013|microarray|microarray
725051|NCT00143013|skeletal muscle|skeletal muscle
725052|NCT00143013|bioinformatics|bioinformatics
725053|NCT00143000|Hepatitis C Virus|hepatitis c virus
725054|NCT00143000|Genotype 2|genotype 2
725055|NCT00143000|Genotype 3|genotype 3
725056|NCT00142987|Tegaserod, IBS-C, women, mixed bowel habit|tegaserod, ibs-c, women, mixed bowel habit
725057|NCT00142974|Diabetes, tegaserod, gastropathy|diabetes, tegaserod, gastropathy
725058|NCT00142961|cannabis abuse|cannabis abuse
725059|NCT00142961|atomoxetine|atomoxetine
725060|NCT00142961|ADHD|adhd
725061|NCT00142948|Heroin Abuse|heroin abuse
725062|NCT00142948|Heroin Addiction|heroin addiction
725063|NCT00142935|HIV Prevention|hiv prevention
725064|NCT00142935|Opioid-Related Disorders|opioid-related disorders
725065|NCT00142935|Medication Assisted Treatment|medication assisted treatment
725066|NCT00142935|Methadone|methadone
725067|NCT00142922|Adherence|adherence
725068|NCT00142922|self-care|self-care
725069|NCT00142922|Behavioral intervention|behavioral intervention
725070|NCT00142922|Diabetes|diabetes
725071|NCT00142909|Opioid dependence|opioid dependence
725072|NCT00142896|Opiate Addiction|opiate addiction
725073|NCT00142896|Opiate Dependence|opiate dependence
725074|NCT00142883|addiction, crack, cocaine|addiction, crack, cocaine
725075|NCT00142870|marijuana|marijuana
725076|NCT00142870|treatment|treatment
725077|NCT00142844|cocaine|cocaine
725078|NCT00142831|nicotine dependence|nicotine dependence
725079|NCT00142818|Alcohol Abuse|alcohol abuse
725080|NCT00142818|Cocaine Abuse|cocaine abuse
725081|NCT00142805|ketones|ketones
725082|NCT00142805|Apolipoprotein E|apolipoprotein e
725083|NCT00142805|ApoE genotype|apoe genotype
725084|NCT00142805|cognitive function|cognitive function
725085|NCT00142805|glucose metabolism|glucose metabolism
725086|NCT00142792|stroke|stroke
725087|NCT00142792|recovery of function|recovery of function
725088|NCT00142792|functional electrical stimulation (FES)|functional electrical stimulation (fes)
725089|NCT00142779|Cocaine Addiction|cocaine addiction
725090|NCT00142779|Cocaine Dependence|cocaine dependence
725091|NCT00142779|Opiate Addiction|opiate addiction
725092|NCT00142779|Opiate Dependence|opiate dependence
725093|NCT00142766|Sedation|sedation
725094|NCT00142766|Mechanical ventilation|mechanical ventilation
725095|NCT00142766|Critical illness|critical illness
725096|NCT00142766|Analgesic|analgesic
725097|NCT00142766|Opioid Withdrawal|opioid withdrawal
725098|NCT00142766|Benzodiazepine Withdrawal|benzodiazepine withdrawal
725099|NCT00142766|Nurse|nurse
725100|NCT00142753|Hepatitis B vaccines|hepatitis b vaccines
725101|NCT00142753|HIV-infected adolescents|hiv-infected adolescents
725102|NCT00142753|Hepatitis B infection|hepatitis b infection
725103|NCT00142740|Hepatitis B vaccines|hepatitis b vaccines
725104|NCT00142740|HIV-infected adolescents|hiv-infected adolescents
725105|NCT00142740|Hepatitis B infection (negative)|hepatitis b infection (negative)
725106|NCT00142740|HIV vaccine trial|hiv vaccine trial
725107|NCT00142714|sexual response|sexual response
725108|NCT00142714|sexual dysfunction in females|sexual dysfunction in females
725109|NCT00142714|spinal cord injury|spinal cord injury
725110|NCT00142636|Chronic Kideny Disease|chronic kideny disease
725111|NCT00142636|Hypertension|hypertension
725112|NCT00142610|alpha tocopherol|alpha tocopherol
725113|NCT00142610|vitamin E|vitamin e
725114|NCT00142610|ascorbate|ascorbate
725115|NCT00142610|vitamin C|vitamin c
725116|NCT00142610|antioxidant|antioxidant
725117|NCT00142610|allergic|allergic
725118|NCT00142610|asthma|asthma
725119|NCT00142597|acupuncture|acupuncture
725120|NCT00142597|analgesia|analgesia
725121|NCT00142597|pain|pain
725122|NCT00142597|fibromyalgia|fibromyalgia
725123|NCT00142597|fMRI|fmri
725124|NCT00142597|PET|pet
725125|NCT00142584|safety and tolerability study|safety and tolerability study
725126|NCT00142584|hypertension|hypertension
725127|NCT00142584|beta-blockers|beta-blockers
725128|NCT00142571|Sarcoma, Soft Tissue|sarcoma, soft tissue
725129|NCT00142571|Gemcitabine|gemcitabine
725130|NCT00142571|Docetaxel|docetaxel
725131|NCT00142558|Arcoxia|arcoxia
725132|NCT00142532|Acupuncture|acupuncture
725133|NCT00142532|Pain|pain
725134|NCT00142532|Lung Cancer|lung cancer
725135|NCT00142532|Thoracotomy|thoracotomy
725136|NCT00142532|Surgery|surgery
725137|NCT00142519|Pain|pain
725138|NCT00142519|Analgesics|analgesics
725139|NCT00142519|Retroperitoneal lymph node dissection|retroperitoneal lymph node dissection
725140|NCT00142506|Prostate Cancer|prostate cancer
725141|NCT00142506|Cancer of the Prostate|cancer of the prostate
725142|NCT00142506|Prostate Neoplasms|prostate neoplasms
725143|NCT00142506|Prostatic Cancer|prostatic cancer
725144|NCT00142506|Viagra|viagra
725145|NCT00142506|05-007|05-007
725146|NCT00142493|Episodic Memory|episodic memory
725147|NCT00142493|Amnesia|amnesia
725148|NCT00142493|Amnesia, Temporary|amnesia, temporary
725149|NCT00142480|locally advanced biliary adenocarcinoma|locally advanced biliary adenocarcinoma
725150|NCT00142480|unresectable biliary adenocarcinoma|unresectable biliary adenocarcinoma
725151|NCT00142480|gallbladder adenocarcinoma|gallbladder adenocarcinoma
725152|NCT00142480|capecitabine|capecitabine
725153|NCT00142480|oxaliplatin|oxaliplatin
725154|NCT00142480|bevacizumab|bevacizumab
725155|NCT00142480|Biliary tract adenocarcinoma|biliary tract adenocarcinoma
725156|NCT00142467|Unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
725157|NCT00142467|Metastatic hepatocellular carcinoma|metastatic hepatocellular carcinoma
725158|NCT00142467|gemcitabine|gemcitabine
725159|NCT00142467|oxaliplatin|oxaliplatin
725160|NCT00142467|bevacizumab|bevacizumab
725161|NCT00142467|Avastin|avastin
725162|NCT00142454|Malignant melanoma|malignant melanoma
725163|NCT00142454|Stages IIB-III|stages iib-iii
725164|NCT00142441|Pulsed dye laser|pulsed dye laser
725165|NCT00142441|Keloids|keloids
725166|NCT00142441|Hypertrophic scars|hypertrophic scars
725167|NCT00142441|Pulse width|pulse width
725168|NCT00142441|Pulse duration|pulse duration
725169|NCT00142428|Hepatocellular carcinoma|hepatocellular carcinoma
725170|NCT00142428|cetuximab|cetuximab
725171|NCT00142428|Unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
725172|NCT00142428|Metastatic hepatocellular carcinoma|metastatic hepatocellular carcinoma
725173|NCT00142415|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
725174|NCT00142415|Clear Cell Renal Cell Carcinoma (CCRCC)|clear cell renal cell carcinoma (ccrcc)
725175|NCT00142415|Lutetium-177|lutetium-177
725176|NCT00142415|177-Lu|177-lu
725177|NCT00142415|cG250|cg250
725178|NCT00142415|DOTA-cG250|dota-cg250
725179|NCT00142415|Monoclonal Antibody|monoclonal antibody
725180|NCT00142402|Multiple Sclerosis|multiple sclerosis
725181|NCT00142402|Memory|memory
725182|NCT00142402|New Learning|new learning
725183|NCT00142402|Fatigue|fatigue
725184|NCT00142389|gestational immunization,|gestational immunization,
725185|NCT00142389|infant antibody,|infant antibody,
725286|NCT00142012|Obesity|obesity
725186|NCT00142389|cord antibody|cord antibody
725187|NCT00142363|Parkinson's disease|parkinson's disease
725188|NCT00142363|Parkin|parkin
725189|NCT00142363|Epilepsy|epilepsy
725190|NCT00142363|Phenotype-genotype correlations|phenotype-genotype correlations
725191|NCT00142363|Ionic channels|ionic channels
725192|NCT00142350|gastric cancer|gastric cancer
725193|NCT00142350|5-fluorouracil|5-fluorouracil
725194|NCT00142350|irinotecan|irinotecan
725195|NCT00142350|cisplatin|cisplatin
725196|NCT00142350|S-1|s-1
725197|NCT00142350|advanced or recurrent gastric cancer|advanced or recurrent gastric cancer
725198|NCT00142337|zidovudine|zidovudine
725199|NCT00142337|didanosine|didanosine
725200|NCT00142337|Prevention of mother to child transmission of HIV|prevention of mother to child transmission of hiv
725201|NCT00142337|nevirapine|nevirapine
725202|NCT00142337|Thailand|thailand
725203|NCT00142337|Resistance|resistance
725204|NCT00142337|HIV|hiv
725205|NCT00142337|Postpartum period|postpartum period
725206|NCT00142324|Dementia|dementia
725207|NCT00142311|Parkinson's disease|parkinson's disease
725208|NCT00142311|Parkin mutations|parkin mutations
725209|NCT00142311|Metabolic explorations|metabolic explorations
725210|NCT00142311|Clinics|clinics
725211|NCT00142311|Genetics|genetics
725212|NCT00142285|pneumonia|pneumonia
725213|NCT00142285|zinc|zinc
725214|NCT00142285|treatment|treatment
725215|NCT00142285|efficacy|efficacy
725216|NCT00142285|children|children
725217|NCT00142272|Ciprofloxacin|ciprofloxacin
725218|NCT00142272|children|children
725219|NCT00142272|V.cholerae O1 and O139|v.cholerae o1 and o139
725220|NCT00142272|drug resistance|drug resistance
725221|NCT00142272|Bangladesh|bangladesh
725222|NCT00142259|deep brain stimulation|deep brain stimulation
725223|NCT00142259|internal globus pallidus|internal globus pallidus
725224|NCT00142259|dystonia|dystonia
725225|NCT00142246|malaria|malaria
725226|NCT00142246|anaemia|anaemia
725227|NCT00142246|school performance|school performance
725228|NCT00142246|education|education
725229|NCT00142246|intermittent preventive treatment|intermittent preventive treatment
725230|NCT00142246|schools|schools
725231|NCT00142233|EUROPAC 2, ANTOX (vers)1.2, MGCT (Magnesiocard) Hereditary Pancreatitis, Idiopathic chronic pancreatitis.|europac 2, antox (vers)1.2, mgct (magnesiocard) hereditary pancreatitis, idiopathic chronic pancreatitis.
725232|NCT00142233|Hereditary Pancreatitis|hereditary pancreatitis
725233|NCT00142233|idiopathic chronic pancreatitis|idiopathic chronic pancreatitis
725234|NCT00142207|malaria|malaria
725235|NCT00142207|pregnancy|pregnancy
725236|NCT00142207|intermittent preventive treatment|intermittent preventive treatment
725237|NCT00142207|insecticide-treated nets|insecticide-treated nets
725238|NCT00142194|Atrial Fibrillation|atrial fibrillation
725239|NCT00142194|Oxidative stress|oxidative stress
725240|NCT00142194|Cardiology|cardiology
725241|NCT00142181|Lymphoplasmacytic lymphoma|lymphoplasmacytic lymphoma
725242|NCT00142181|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
725243|NCT00142181|Antibody|antibody
725244|NCT00142181|Campath-1H|campath-1h
725245|NCT00142168|CC-5103 (lenalidomide)|cc-5103 (lenalidomide)
725246|NCT00142168|rituximab|rituximab
725247|NCT00142168|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
725248|NCT00142155|monoclonal antibody|monoclonal antibody
725249|NCT00142155|Fc gamma RIII receptor expression|fc gamma riii receptor expression
725250|NCT00142155|rituximab|rituximab
725251|NCT00142129|bortezomib|bortezomib
725252|NCT00142129|Velcade|velcade
725253|NCT00142129|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
725254|NCT00142116|thalidomide|thalidomide
725255|NCT00142116|rituximab|rituximab
725256|NCT00142116|Waldenstrom's|waldenstrom's
725257|NCT00142103|Hepatitis c virus|hepatitis c virus
725258|NCT00142103|HCV|hcv
725259|NCT00142103|Liver|liver
725260|NCT00142090|Brain Concussion|brain concussion
725261|NCT00142090|Post-Concussion Syndrome|post-concussion syndrome
725262|NCT00142090|Closed Head Injury|closed head injury
725263|NCT00142090|Traumatic Brain Injury|traumatic brain injury
725264|NCT00142090|Hypertonic Saline Solution|hypertonic saline solution
725265|NCT00142077|Influenza|influenza
725266|NCT00142077|Electronic health record|electronic health record
725267|NCT00142077|Behavior modification|behavior modification
725268|NCT00142064|Topical analgesia|topical analgesia
725269|NCT00142064|Urinary catheterization|urinary catheterization
725270|NCT00142064|FlACC Pain Scale|flacc pain scale
725271|NCT00142064|Lidocaine jelly|lidocaine jelly
725272|NCT00142051|sickle cell disease|sickle cell disease
725273|NCT00142051|pain crisis|pain crisis
725274|NCT00142051|vaso-occlusive crisis|vaso-occlusive crisis
725275|NCT00142051|nitric oxide|nitric oxide
725276|NCT00142038|gastric cancer|gastric cancer
725277|NCT00142038|metastatic|metastatic
725278|NCT00142038|locally advanced|locally advanced
725279|NCT00142038|docetaxel|docetaxel
725280|NCT00142038|capecitabine|capecitabine
725281|NCT00142025|Bronchial asthma|bronchial asthma
725282|NCT00142025|Oxcarbazepine|oxcarbazepine
725283|NCT00142025|Antiepileptic drug|antiepileptic drug
725284|NCT00142025|Efficacy|efficacy
725285|NCT00142012|School-based|school-based
725287|NCT00142012|Prevention|prevention
725288|NCT00141999|vaccine|vaccine
725289|NCT00141999|hepatitis|hepatitis
725290|NCT00141986|vitamin D|vitamin d
725291|NCT00141986|type 1 diabetes|type 1 diabetes
725292|NCT00141986|prevention trial|prevention trial
725293|NCT00141973|Procalcitonin|procalcitonin
725294|NCT00141973|Sepsis|sepsis
725295|NCT00141973|Corticosteroids|corticosteroids
725296|NCT00141960|Treatment efficacy|treatment efficacy
725297|NCT00141960|Treatment effectiveness|treatment effectiveness
725298|NCT00141960|Gastrointestinal Diseases|gastrointestinal diseases
725299|NCT00141960|Reflux, Gastroesophageal|reflux, gastroesophageal
725300|NCT00141960|GERD|gerd
725301|NCT00141947|bexarotene|bexarotene
725302|NCT00141947|schizophrenia|schizophrenia
725303|NCT00141947|psychopathology|psychopathology
725304|NCT00141947|cognitive impairment|cognitive impairment
725305|NCT00141947|quality of life|quality of life
725306|NCT00141947|open lable trial|open lable trial
725307|NCT00141934|Rheumatoid Arthritis|rheumatoid arthritis
725308|NCT00141934|RA|ra
725309|NCT00141934|ACR20 endpoint|acr20 endpoint
725310|NCT00141934|Tender/swollen joints|tender/swollen joints
725311|NCT00141934|Improvement in pain|improvement in pain
725312|NCT00141934|Health assessment questionnaire|health assessment questionnaire
725313|NCT00141934|Profile of mood states|profile of mood states
725314|NCT00141921|Immunex|immunex
725315|NCT00141921|Amgen|amgen
725316|NCT00141921|Pediatric,|pediatric,
725317|NCT00141921|plaque psoriasis|plaque psoriasis
725318|NCT00141921|clinical trial|clinical trial
725319|NCT00141908|Hydroxyprogesterone Caproate, twins, preterm delivery|hydroxyprogesterone caproate, twins, preterm delivery
725320|NCT00141895|Intrauterine fetal death, 2nd trimester, induction|intrauterine fetal death, 2nd trimester, induction
725321|NCT00141869|Sensory Processing|sensory processing
725322|NCT00141869|Magnetoencephalogram|magnetoencephalogram
725323|NCT00141869|Tourete Syndrome|tourete syndrome
725324|NCT00141869|Trigeminal Nerve|trigeminal nerve
725325|NCT00141869|Tics|tics
725326|NCT00141869|TS|ts
725327|NCT00141869|Healthy Volunteer|healthy volunteer
725328|NCT00141869|HV|hv
725329|NCT00141856|Dis Management|dis management
725330|NCT00141856|Heart Decompensation|heart decompensation
725331|NCT00141856|Hearts|hearts
725332|NCT00141856|Veteran (M01.930)|veteran (m01.930)
725333|NCT00141843|Hemophilia A|hemophilia a
725334|NCT00141830|Rheumatoid Arthritis|rheumatoid arthritis
725335|NCT00141817|Gastrointestinal Reflux Disease|gastrointestinal reflux disease
725336|NCT00141804|renal transplantation|renal transplantation
725337|NCT00141804|immunosuppression|immunosuppression
725338|NCT00141804|prevention of acute rejection|prevention of acute rejection
725339|NCT00141791|Asthma|asthma
725340|NCT00141791|Anti-Asthmatic Agents|anti-asthmatic agents
725341|NCT00141791|Receptors|receptors
725342|NCT00141791|Tumor Necrosis Factor|tumor necrosis factor
725343|NCT00141778|atrial fibrillation|atrial fibrillation
725344|NCT00141778|cardiac surgery|cardiac surgery
725345|NCT00141752|Cerebrovascular Accident|cerebrovascular accident
725346|NCT00141752|Deglutition Disorders|deglutition disorders
725347|NCT00141752|stroke|stroke
725348|NCT00141752|dysphagia|dysphagia
725349|NCT00141752|screening|screening
725350|NCT00141739|Stem Cell Transplantation|stem cell transplantation
725351|NCT00141739|Graft-Versus-Host Disease|graft-versus-host disease
725352|NCT00141739|prophylaxis|prophylaxis
725353|NCT00141726|Enbrel|enbrel
725354|NCT00141726|Stem Cell Transplantation|stem cell transplantation
725355|NCT00141726|Lung Injury|lung injury
725356|NCT00141687|External cephalic version|external cephalic version
725357|NCT00141687|Cesarean section|cesarean section
725358|NCT00141687|pregnancy|pregnancy
725359|NCT00141687|labour|labour
725360|NCT00141687|Breech pregnancy|breech pregnancy
725361|NCT00141674|Blood transfusion|blood transfusion
725362|NCT00141674|Age of blood|age of blood
725363|NCT00141674|Traumatic Brain Injury|traumatic brain injury
725364|NCT00141674|Cerebral Oxygen Extraction Ratio|cerebral oxygen extraction ratio
725365|NCT00141674|Age of transfused blood in traumatic brain injury|age of transfused blood in traumatic brain injury
725366|NCT00141661|Interventional, Alzheimer, Safety and Tolerability|interventional, alzheimer, safety and tolerability
725367|NCT00141648|Osteolymphoma|osteolymphoma
725368|NCT00141648|Chemotherapy|chemotherapy
725369|NCT00141648|Radiotherapy|radiotherapy
725370|NCT00141648|Lymphoma|lymphoma
725371|NCT00141635|Quality of Life|quality of life
725372|NCT00141635|Breast Cancer|breast cancer
725373|NCT00141635|Referee's Report|referee's report
725374|NCT00141635|Diagnostics|diagnostics
725375|NCT00141635|Therapy|therapy
725376|NCT00141622|Endothelial dysfunction|endothelial dysfunction
725377|NCT00141622|ADMA|adma
725378|NCT00141622|DDAH|ddah
725379|NCT00141622|Sodium|sodium
725380|NCT00141609|End-stage renal failure|end-stage renal failure
725381|NCT00141609|Haemodialysis|haemodialysis
725382|NCT00141609|Sodium|sodium
725383|NCT00141609|Blood Pressure|blood pressure
725384|NCT00141596|Resistant Hypertension|resistant hypertension
725385|NCT00141596|Extracellular Fluid Volume|extracellular fluid volume
725580|NCT00140400|Vaccine|vaccine
725386|NCT00141583|Renin-angiotensin system|renin-angiotensin system
725387|NCT00141583|ACE Inhibitor|ace inhibitor
725388|NCT00141583|Angiotensin Receptor Blocker|angiotensin receptor blocker
725389|NCT00141570|Menopause; Postmenopause; Estrogen; Hormone Therapy|menopause; postmenopause; estrogen; hormone therapy
725390|NCT00141557|Menopause; Postmenopause; Estrogen; Hormone Therapy|menopause; postmenopause; estrogen; hormone therapy
725391|NCT00141544|Menopause; Postmenopause; Estrogen; Hormone Therapy|menopause; postmenopause; estrogen; hormone therapy
725392|NCT00141531|Bladder cancer|bladder cancer
725393|NCT00141531|Superficial|superficial
725394|NCT00141531|Carcinoma in situ|carcinoma in situ
725395|NCT00141531|Intravesical instillation|intravesical instillation
725396|NCT00141531|Chemotherapy|chemotherapy
725397|NCT00141531|Adjuvant|adjuvant
725398|NCT00141518|Health economics,Quality of life|health economics,quality of life
725399|NCT00141505|drug interaction|drug interaction
725400|NCT00141505|pharmacokinetics|pharmacokinetics
725401|NCT00141505|valproate|valproate
725402|NCT00141505|bipolar|bipolar
725403|NCT00141492|Type 2 diabetes|type 2 diabetes
725404|NCT00141492|hypogonadism|hypogonadism
725405|NCT00141492|testosterone|testosterone
725406|NCT00141492|glycosylated hemoglobin A1C|glycosylated hemoglobin a1c
725407|NCT00141479|Treatment interruption on reinitiation|treatment interruption on reinitiation
725408|NCT00141479|Schizophrenia|schizophrenia
725409|NCT00141479|Schizoaffective disorder|schizoaffective disorder
725410|NCT00141466|Hereditary colorectal cancer|hereditary colorectal cancer
725411|NCT00141466|Microsatellite instability|microsatellite instability
725412|NCT00141466|Physician roles|physician roles
725413|NCT00141466|Health care implementation|health care implementation
725414|NCT00141466|Intervention|intervention
725415|NCT00141453|angiotensin II type I receptor blockers|angiotensin ii type i receptor blockers
725416|NCT00141453|diabetic nephropathy|diabetic nephropathy
725417|NCT00141453|end-stage renal disease|end-stage renal disease
725418|NCT00141453|renal failure|renal failure
725419|NCT00141453|type 2 diabetes|type 2 diabetes
725420|NCT00141453|olmesartan medoxomil|olmesartan medoxomil
725421|NCT00141440|gas exchange|gas exchange
725422|NCT00141440|pressure support ventilation|pressure support ventilation
725423|NCT00141440|respiratory mechanics|respiratory mechanics
725424|NCT00141440|COPD patients|copd patients
725425|NCT00141297|Advanced cancer|advanced cancer
725426|NCT00141271|Bipolar I Disorder|bipolar i disorder
725427|NCT00141115|Substance-induced anxiety disorder|substance-induced anxiety disorder
725428|NCT00141102|GI events in high risk GI arthritis patients|gi events in high risk gi arthritis patients
725429|NCT00141089|Male patients, chronic constipation, tegaserod|male patients, chronic constipation, tegaserod
725430|NCT00141076|obesity|obesity
725431|NCT00141076|glycemic index|glycemic index
725432|NCT00141076|insulin resistance|insulin resistance
725433|NCT00141076|cardiovascular disease|cardiovascular disease
725434|NCT00141076|diabetes|diabetes
725435|NCT00141063|ADHD, children|adhd, children
725436|NCT00141050|ADHD, children|adhd, children
725437|NCT00141037|Organ Rejection|organ rejection
725438|NCT00141037|Corticosteroids|corticosteroids
725439|NCT00141037|Child|child
725440|NCT00141037|Adolescent|adolescent
725441|NCT00141037|Immunosuppression|immunosuppression
725442|NCT00141037|Steroids|steroids
725443|NCT00141024|HIV Seronegativity|hiv seronegativity
725444|NCT00141024|HIV Preventive Vaccine|hiv preventive vaccine
725445|NCT00141011|Stroke|stroke
725446|NCT00141011|Fibrinogen|fibrinogen
725447|NCT00141011|Reperfusion|reperfusion
725448|NCT00141011|Thrombolysis|thrombolysis
725449|NCT00140998|Turner syndrome|turner syndrome
725450|NCT00140998|Hypogonadism|hypogonadism
725451|NCT00140998|GH|gh
725452|NCT00140998|Estrogen|estrogen
725453|NCT00140998|Estrogen Patches|estrogen patches
725454|NCT00140998|IGF-I|igf-i
725455|NCT00140998|Body Composition|body composition
725456|NCT00140998|Protein Metabolism|protein metabolism
725457|NCT00140998|Lipolysis|lipolysis
725458|NCT00140972|Arcoxia|arcoxia
725459|NCT00140894|Osteoarthritis|osteoarthritis
725460|NCT00140894|Cancer Pain|cancer pain
725461|NCT00140868|Colonic Pseudo-Obstruction|colonic pseudo-obstruction
725462|NCT00140868|Large bowel obstruction|large bowel obstruction
725463|NCT00140868|Stents|stents
725464|NCT00140868|Laparotomy|laparotomy
725465|NCT00140868|Palliative Surgery|palliative surgery
725466|NCT00140868|Surgery, Palliative|surgery, palliative
725467|NCT00140868|Palliative Therapy|palliative therapy
725468|NCT00140855|synovial sarcoma|synovial sarcoma
725469|NCT00140855|immunotherapy|immunotherapy
725470|NCT00140855|cancer-testis antigen|cancer-testis antigen
725471|NCT00140855|cancer-germ cell antigen|cancer-germ cell antigen
725472|NCT00140855|soft tissue sarcoma|soft tissue sarcoma
725473|NCT00140855|SYT-SSX chromosomal translocation|syt-ssx chromosomal translocation
725474|NCT00140842|Obesity, adolescent, ghrelin, growth hormone, cortisol|obesity, adolescent, ghrelin, growth hormone, cortisol
725475|NCT00140829|Cerebellar ataxias|cerebellar ataxias
725476|NCT00140829|Spastic paraplegias|spastic paraplegias
725477|NCT00140829|Mutations spectrum|mutations spectrum
725478|NCT00140829|Linkage studies|linkage studies
725479|NCT00140829|Genetic counselling|genetic counselling
725480|NCT00140790|Cardiorenal syndrome|cardiorenal syndrome
725481|NCT00140790|Renal dysfunction|renal dysfunction
725482|NCT00140790|Cardiovascular events|cardiovascular events
725483|NCT00140790|Valsartan|valsartan
725484|NCT00140764|Genitourinary symptoms|genitourinary symptoms
725485|NCT00140751|HIV-1|hiv-1
725486|NCT00140751|Treatment simplification|treatment simplification
725487|NCT00140751|Lopinavir/ritonavir|lopinavir/ritonavir
725488|NCT00140751|Treatment Experienced|treatment experienced
725489|NCT00140751|HIV Seropositivity|hiv seropositivity
725490|NCT00140725|HBeAg-positive|hbeag-positive
725491|NCT00140725|chronic|chronic
725492|NCT00140725|Hepatitis B|hepatitis b
725493|NCT00140725|lamivudine|lamivudine
725494|NCT00140725|seroconversion|seroconversion
725495|NCT00140725|Chronic Hepatitis B|chronic hepatitis b
725496|NCT00140712|RLS|rls
725497|NCT00140712|PLMS|plms
725498|NCT00140712|Adolescent|adolescent
725499|NCT00140712|Periodic Limb Movements of Sleep|periodic limb movements of sleep
725500|NCT00140712|Ropinirole|ropinirole
725501|NCT00140699|Children, Hearing loss, Balance control, Sensory inputs|children, hearing loss, balance control, sensory inputs
725502|NCT00140660|lymphoma, diffuse large B-cell|lymphoma, diffuse large b-cell
725503|NCT00140660|rituximab|rituximab
725504|NCT00140660|chemotherapy|chemotherapy
725505|NCT00140647|atherosclerosis|atherosclerosis
725506|NCT00140647|carotid artery|carotid artery
725507|NCT00140647|ramipril|ramipril
725508|NCT00140647|rosiglitazone|rosiglitazone
725509|NCT00140647|impaired glucose tolerance|impaired glucose tolerance
725510|NCT00140647|impaired fasting glucose|impaired fasting glucose
725511|NCT00140647|diabetes prevention|diabetes prevention
725512|NCT00140621|cardiac fabry disease|cardiac fabry disease
725513|NCT00140608|sinus|sinus
725514|NCT00140595|Lymphoma, diffuse large B-cell|lymphoma, diffuse large b-cell
725515|NCT00140595|rituximab|rituximab
725516|NCT00140595|chemotherapy|chemotherapy
725517|NCT00140582|lymphoma|lymphoma
725518|NCT00140582|follicular|follicular
725519|NCT00140582|maintenance|maintenance
725520|NCT00140569|follicular lymphoma|follicular lymphoma
725521|NCT00140569|CHVP + interferon|chvp + interferon
725522|NCT00140569|fludarabine|fludarabine
725523|NCT00140569|autotransplant|autotransplant
725524|NCT00140556|head and neck cancer|head and neck cancer
725525|NCT00140556|targeted therapy|targeted therapy
725526|NCT00140556|bevacizumab|bevacizumab
725527|NCT00140556|erlotinib|erlotinib
725528|NCT00140556|Tarceva|tarceva
725529|NCT00140556|radiotherapy|radiotherapy
725530|NCT00140556|concurrent chemotherapy|concurrent chemotherapy
725531|NCT00140556|pharynx cancer|pharynx cancer
725532|NCT00140556|tonsil cancer|tonsil cancer
725533|NCT00140556|hyperfractionation|hyperfractionation
725534|NCT00140556|angiogenesis|angiogenesis
725535|NCT00140556|epidermal growth factor|epidermal growth factor
725536|NCT00140556|vascular endothelial growth factor|vascular endothelial growth factor
725537|NCT00140556|magnetic resonance spectroscopy|magnetic resonance spectroscopy
725538|NCT00140556|cancer of the head and neck|cancer of the head and neck
725539|NCT00140556|upper aerodigestive tract neoplasms|upper aerodigestive tract neoplasms
725540|NCT00140556|pharynx neoplasms|pharynx neoplasms
725541|NCT00140543|simultaneous pancreas/kidney transplantation|simultaneous pancreas/kidney transplantation
725542|NCT00140543|Immunosuppression|immunosuppression
725543|NCT00140517|Plasmodium falciparum|plasmodium falciparum
725544|NCT00140517|malaria|malaria
725545|NCT00140517|pregnancy|pregnancy
725546|NCT00140517|resistance|resistance
725547|NCT00140504|Adverse drug event|adverse drug event
725548|NCT00140504|Patient safety|patient safety
725549|NCT00140504|Internet portal|internet portal
725550|NCT00140504|PatientSite|patientsite
725551|NCT00140504|Preventive health|preventive health
725552|NCT00140504|Primary care|primary care
725553|NCT00140491|Non-Arteritic Anterior Ischemic Optic Neuropathy|non-arteritic anterior ischemic optic neuropathy
725554|NCT00140491|Visual Field Defect|visual field defect
725555|NCT00140491|Neuroplasticity|neuroplasticity
725556|NCT00140491|Rehabilitation|rehabilitation
725557|NCT00140478|Androgen Independent Prostate Cancer|androgen independent prostate cancer
725558|NCT00140478|Prostate Cancer|prostate cancer
725559|NCT00140478|Mifepristone|mifepristone
725560|NCT00140478|RU-486|ru-486
725561|NCT00140452|ALS|als
725562|NCT00140439|asthma|asthma
725563|NCT00140439|emergency department|emergency department
725564|NCT00140439|compliance|compliance
725565|NCT00140439|randomized clinical trial|randomized clinical trial
725566|NCT00140426|Anorexia Nervosa|anorexia nervosa
725567|NCT00140426|Risperidone|risperidone
725568|NCT00140426|Atypical Neuroleptics|atypical neuroleptics
725569|NCT00140426|Dopamine|dopamine
725570|NCT00140426|Leptin|leptin
725571|NCT00140426|Body Image|body image
725572|NCT00140426|Adolescents|adolescents
725573|NCT00140413|Optic Nerve Hypoplasia|optic nerve hypoplasia
725574|NCT00140400|Prostate|prostate
725575|NCT00140400|Cancer|cancer
725576|NCT00140400|Advanced prostate cancer|advanced prostate cancer
725577|NCT00140400|Metastatic|metastatic
725578|NCT00140400|Hormone-refractory|hormone-refractory
725579|NCT00140400|GVAX|gvax
725581|NCT00140400|Allogeneic cells|allogeneic cells
725582|NCT00140387|Prostate|prostate
725583|NCT00140387|Cancer|cancer
725584|NCT00140387|GVAX|gvax
725585|NCT00140387|Metastatic|metastatic
725586|NCT00140387|Vaccine|vaccine
725587|NCT00140387|Allogeneic cells|allogeneic cells
725588|NCT00140374|Prostate|prostate
725589|NCT00140374|Cancer|cancer
725590|NCT00140374|Vaccine|vaccine
725591|NCT00140374|GVAX|gvax
725592|NCT00140374|Allogeneic cells|allogeneic cells
725593|NCT00140361|malaria|malaria
725594|NCT00140361|sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
725595|NCT00140361|sulfadoxine-pyrimethamine plus artsunate|sulfadoxine-pyrimethamine plus artsunate
725596|NCT00140361|lumefantrine plus artemether|lumefantrine plus artemether
725597|NCT00140361|combination therapy|combination therapy
725598|NCT00140348|Prostate|prostate
725599|NCT00140348|Cancer|cancer
725600|NCT00140348|Advanced Prostate Cancer|advanced prostate cancer
725601|NCT00140348|Metastatic|metastatic
725602|NCT00140348|Hormone-refractory|hormone-refractory
725603|NCT00140348|GVAX|gvax
725604|NCT00140348|Vaccine|vaccine
725605|NCT00140348|Allogeneic cells|allogeneic cells
725606|NCT00140335|handwashing|handwashing
725607|NCT00140335|communicable diseases|communicable diseases
725608|NCT00140335|health education|health education
725609|NCT00140322|falls|falls
725610|NCT00140322|injury|injury
725611|NCT00140322|elderly|elderly
725612|NCT00140309|TB|tb
725613|NCT00140309|Pulmonary Tuberculosis|pulmonary tuberculosis
725614|NCT00140309|Tuberculosis|tuberculosis
725615|NCT00140309|Pulmonary TB|pulmonary tb
725616|NCT00140283|Effectiveness|effectiveness
725617|NCT00140283|Educational intervention|educational intervention
725618|NCT00140283|Primary health care|primary health care
725619|NCT00140257|Myocardial Infarction|myocardial infarction
725620|NCT00140244|leptin|leptin
725621|NCT00140244|lipodystrophy|lipodystrophy
725622|NCT00140244|insulin resistance|insulin resistance
725623|NCT00140244|hyperlipidemia|hyperlipidemia
725624|NCT00140244|metabolic syndrome|metabolic syndrome
725625|NCT00140231|leptin|leptin
725626|NCT00140231|fasting|fasting
725627|NCT00140231|reproductive|reproductive
725628|NCT00140231|neuroendocrine|neuroendocrine
725629|NCT00140231|immune function|immune function
725630|NCT00140231|energy deficiency associated with short-term fasting|energy deficiency associated with short-term fasting
725631|NCT00140218|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
725632|NCT00140218|pramipexole|pramipexole
725633|NCT00140218|oxidative stress|oxidative stress
725634|NCT00140218|neuroprotection|neuroprotection
725635|NCT00140205|leptin|leptin
725636|NCT00140205|fasting|fasting
725637|NCT00140205|pharmacokinetics|pharmacokinetics
725638|NCT00140192|creatine metabolism|creatine metabolism
725639|NCT00140192|schizophrenia|schizophrenia
725640|NCT00140192|energy metabolism|energy metabolism
725641|NCT00140179|valnoctamide|valnoctamide
725642|NCT00140179|teratogenicity|teratogenicity
725643|NCT00140179|double-blind|double-blind
725644|NCT00140179|mania|mania
725645|NCT00140166|schizophrenia|schizophrenia
725646|NCT00140166|niacinamide|niacinamide
725647|NCT00140153|androgel|androgel
725648|NCT00140153|female sexuale dysfunction|female sexuale dysfunction
725649|NCT00140153|controlled double-blind|controlled double-blind
725650|NCT00140153|testosterone|testosterone
725651|NCT00140140|Breast cancer|breast cancer
725652|NCT00140114|Vaginal, sublingual, misoprostol, cervical ripening|vaginal, sublingual, misoprostol, cervical ripening
725653|NCT00140101|drug eluting stents|drug eluting stents
725654|NCT00140101|stents|stents
725655|NCT00140101|angioplasty|angioplasty
725656|NCT00140101|coronary artery disease|coronary artery disease
725657|NCT00140101|total coronary occlusion|total coronary occlusion
725658|NCT00140101|coronary artery restenosis|coronary artery restenosis
725659|NCT00140101|stent thrombosis|stent thrombosis
725660|NCT00140101|vascular disease|vascular disease
725661|NCT00140101|myocardial ischemia|myocardial ischemia
725662|NCT00140101|coronary artery stenosis|coronary artery stenosis
725663|NCT00140088|Needlestick pain|needlestick pain
725664|NCT00140088|Venipuncture pain|venipuncture pain
725665|NCT00140010|aneurysm|aneurysm
725666|NCT00140010|autoregulation|autoregulation
725667|NCT00140010|erythropoietion|erythropoietion
725668|NCT00140010|stroke|stroke
725669|NCT00140010|subarachnoid hemorrhage|subarachnoid hemorrhage
725670|NCT00140010|vasospasm|vasospasm
725671|NCT00139997|Major Depression|major depression
725672|NCT00139997|Seasonal Affective Disorder (SAD)|seasonal affective disorder (sad)
725673|NCT00139984|Hypertension|hypertension
725674|NCT00139984|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
725675|NCT00139984|Blood pressure|blood pressure
725676|NCT00139984|Risk assessment|risk assessment
725677|NCT00139958|Acute coronary syndrome|acute coronary syndrome
725678|NCT00139958|HIV infection|hiv infection
725679|NCT00139958|Prognosis|prognosis
725680|NCT00139958|Coronary heart disease|coronary heart disease
725681|NCT00139958|Revascularization|revascularization
725682|NCT00139919|Decreasing Titration Study|decreasing titration study
725683|NCT00139919|Schizophrenia|schizophrenia
725684|NCT00139919|Bipolar|bipolar
725685|NCT00139919|Pharmacokinetic|pharmacokinetic
725686|NCT00139906|Titration Study|titration study
725687|NCT00139906|Schizophrenia|schizophrenia
725688|NCT00139906|BID dosing|bid dosing
725689|NCT00139906|Pharmacokinetic|pharmacokinetic
725690|NCT00139841|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
725691|NCT00139841|Rituximab Refractory|rituximab refractory
725692|NCT00139841|Rituximab Failure|rituximab failure
725693|NCT00139841|Indolent Non-Hodgkins Lymphoma|indolent non-hodgkins lymphoma
725694|NCT00139828|haemophilia B|haemophilia b
725695|NCT00139828|factor IX|factor ix
725696|NCT00139828|Product Surveillance, Postmarketing|product surveillance, postmarketing
725697|NCT00139828|plasma products|plasma products
725698|NCT00139815|unstable angina|unstable angina
725699|NCT00139815|acute coronary syndrome|acute coronary syndrome
725700|NCT00139815|fondaparinux sodium|fondaparinux sodium
725701|NCT00139815|non ST segment elevation myocardial infarction|non st segment elevation myocardial infarction
725702|NCT00139815|myocardial infarction|myocardial infarction
725703|NCT00139776|Chronic treatment osteoarthritis, Celecoxib, Continuous Use, Intermittent Use|chronic treatment osteoarthritis, celecoxib, continuous use, intermittent use
725704|NCT00139737|Open-label extension Ziprasidone study in Schizophrenia|open-label extension ziprasidone study in schizophrenia
725705|NCT00139633|esophageal cancer, chemotherapy, radiation|esophageal cancer, chemotherapy, radiation
725706|NCT00139620|advanced cancer, solid tumor|advanced cancer, solid tumor
725707|NCT00139594|Bipolar disorder, manic episode/treatment/licarbazepine|bipolar disorder, manic episode/treatment/licarbazepine
725708|NCT00139581|Atopic dermatitis, children, infants, pimecrolimus, bid, od|atopic dermatitis, children, infants, pimecrolimus, bid, od
725709|NCT00139568|Chronic constipation|chronic constipation
725710|NCT00139568|5-HT,5-HT4,|5-ht,5-ht4,
725711|NCT00139568|functional GI|functional gi
725712|NCT00139568|China|china
725713|NCT00139568|tegaserod|tegaserod
725714|NCT00139555|Hypertension|hypertension
725715|NCT00139555|Left ventricular hypertrophy|left ventricular hypertrophy
725716|NCT00139542|human|human
725717|NCT00139542|ventricular fibrillation|ventricular fibrillation
725718|NCT00139542|out-of-hospital|out-of-hospital
725719|NCT00139542|cardiac arrest|cardiac arrest
725720|NCT00139542|automated external defibrillators (AED)|automated external defibrillators (aed)
725721|NCT00139542|defibrillators|defibrillators
725722|NCT00139542|electrick countershock|electrick countershock
725723|NCT00139542|cardiopulmonary resuscitation|cardiopulmonary resuscitation
725724|NCT00139490|Blood Pressure, High|blood pressure, high
725725|NCT00139451|GH|gh
725726|NCT00139451|Delayed Growth|delayed growth
725727|NCT00139451|Energy Expenditure|energy expenditure
725728|NCT00139451|Puberty|puberty
725729|NCT00139451|Nutrition|nutrition
725730|NCT00139451|Short Stature|short stature
725731|NCT00139399|Coronary artery bypass|coronary artery bypass
725732|NCT00139399|Coronary arteries|coronary arteries
725733|NCT00139399|Atherosclerosis|atherosclerosis
725734|NCT00139399|Angiography|angiography
725735|NCT00139399|Blood flow|blood flow
725736|NCT00139386|Drug-eluting stent|drug-eluting stent
725737|NCT00139386|Candesartan|candesartan
725738|NCT00139386|Randomized control study|randomized control study
725739|NCT00139386|Coronary Angioplasty|coronary angioplasty
725740|NCT00139373|Progressive supranuclear palsy|progressive supranuclear palsy
725741|NCT00139373|Frontal lobe|frontal lobe
725742|NCT00139373|Oculomotor testing|oculomotor testing
725743|NCT00139373|Neuropsychological scores|neuropsychological scores
725744|NCT00139373|Motor disability (UPDRS)|motor disability (updrs)
725745|NCT00139373|Distractibility|distractibility
725746|NCT00139321|Gait disorders|gait disorders
725747|NCT00139321|Postural instability|postural instability
725748|NCT00139321|parkinsonian syndrome|parkinsonian syndrome
725749|NCT00139321|Gait initiation|gait initiation
725750|NCT00139321|Parkinson's disease|parkinson's disease
725751|NCT00139321|Adults|adults
725752|NCT00139308|Tourette's syndrome|tourette's syndrome
725753|NCT00139308|High frequency stimulation|high frequency stimulation
725754|NCT00139308|Globus pallidus|globus pallidus
725755|NCT00139308|Thalamus|thalamus
725756|NCT00139295|musculoskeletal|musculoskeletal
725757|NCT00139295|osteoarthritis of the knee|osteoarthritis of the knee
725758|NCT00139282|wet AMD|wet amd
725759|NCT00139282|macular degeneration|macular degeneration
725760|NCT00139269|Advanced Squamous Cell Carcinoma|advanced squamous cell carcinoma
725761|NCT00139269|Squamous cell Carcinoma of Head and Neck|squamous cell carcinoma of head and neck
725762|NCT00139269|SSCHN|sschn
725763|NCT00139269|Docetaxel|docetaxel
725764|NCT00139256|Glucocorticoid|glucocorticoid
725765|NCT00139256|Antepartum Betamethasone Treatment|antepartum betamethasone treatment
725766|NCT00139256|Elective Cesarean Section|elective cesarean section
725767|NCT00139256|Respiratory Distress in Infants|respiratory distress in infants
725768|NCT00139243|squamous cell carcinoma|squamous cell carcinoma
725769|NCT00139243|Taxotere|taxotere
725770|NCT00139243|carcinoma of head/neck|carcinoma of head/neck
725771|NCT00139243|Cisplatin|cisplatin
725772|NCT00139243|5-Fluorouracil|5-fluorouracil
725773|NCT00139243|Leucovorin|leucovorin
725869|NCT00138801|Neuroborreliosis|neuroborreliosis
725774|NCT00139230|Squamous Cell Carcinoma of Head and Neck|squamous cell carcinoma of head and neck
725775|NCT00139230|Compressed TPFL|compressed tpfl
725776|NCT00139230|Taxotere|taxotere
725777|NCT00139230|Growth Factor Support|growth factor support
725778|NCT00139217|Persistent pulmonary hypertension|persistent pulmonary hypertension
725779|NCT00139217|Non-invasive inhaled nitric oxide|non-invasive inhaled nitric oxide
725780|NCT00139217|iNO|ino
725781|NCT00139204|Prostate cancer|prostate cancer
725782|NCT00139204|Hormone-refractory prostate cancer|hormone-refractory prostate cancer
725783|NCT00139204|PET scan|pet scan
725784|NCT00139204|C11-methionine|c11-methionine
725785|NCT00139204|positron emission tomography|positron emission tomography
725786|NCT00139191|Prostate Cancer|prostate cancer
725787|NCT00139191|positron emission tomography|positron emission tomography
725788|NCT00139191|carbon 11 acetate|carbon 11 acetate
725789|NCT00139191|PET|pet
725790|NCT00139191|fatty acid synthase|fatty acid synthase
725791|NCT00139191|FAS|fas
725792|NCT00139165|Collagenous colitis|collagenous colitis
725793|NCT00139165|Budesonide treatment|budesonide treatment
725794|NCT00139165|Diarrhea|diarrhea
725795|NCT00139152|moderate to severe allergic asthma|moderate to severe allergic asthma
725796|NCT00139139|hepatitis A|hepatitis a
725797|NCT00139139|hepatitis A vaccine|hepatitis a vaccine
725798|NCT00139139|immune globulin|immune globulin
725799|NCT00139113|hepatitis A|hepatitis a
725800|NCT00139113|hepatitis A vaccine|hepatitis a vaccine
725801|NCT00139074|Bipolar I Disorder (DSM-IV 296.01, DSM-IV 296.4, DSM-IV 296.61)|bipolar i disorder (dsm-iv 296.01, dsm-iv 296.4, dsm-iv 296.61)
725802|NCT00139048|informed choice|informed choice
725803|NCT00139048|shared decision making|shared decision making
725804|NCT00139048|decision aid|decision aid
725805|NCT00139048|mammography screening|mammography screening
725806|NCT00139048|decision support|decision support
725807|NCT00139035|glucose intolerance|glucose intolerance
725808|NCT00139035|insulin|insulin
725809|NCT00139035|microvascular function|microvascular function
725810|NCT00139035|genotyping|genotyping
725811|NCT00139035|CYP3A5|cyp3a5
725812|NCT00139035|pharmacokinetics|pharmacokinetics
725813|NCT00139035|renal transplantation|renal transplantation
725814|NCT00139022|sleep apnea, home monitoring, CPAP|sleep apnea, home monitoring, cpap
725815|NCT00139009|intracellular concentration|intracellular concentration
725816|NCT00139009|cyclosporine A|cyclosporine a
725817|NCT00139009|renal biopsies|renal biopsies
725818|NCT00139009|heart biopsies|heart biopsies
725819|NCT00139009|Renal transplant recipients|renal transplant recipients
725820|NCT00138996|cardiac arrest|cardiac arrest
725821|NCT00138996|resuscitation|resuscitation
725822|NCT00138996|quality|quality
725823|NCT00138996|feedback|feedback
725824|NCT00138996|training|training
725825|NCT00138983|glucocorticoid-induced osteoporosis|glucocorticoid-induced osteoporosis
725826|NCT00138983|rheumatic diseases|rheumatic diseases
725827|NCT00138983|prevention|prevention
725828|NCT00138983|randomized double-blind, double placebo controlled trial|randomized double-blind, double placebo controlled trial
725829|NCT00138983|alendronate versus alfacalcidol|alendronate versus alfacalcidol
725830|NCT00138970|Cadaveric donor|cadaveric donor
725831|NCT00138970|Calcineurine free|calcineurine free
725832|NCT00138957|Laparoscopic parastomal hernia repair|laparoscopic parastomal hernia repair
725833|NCT00138957|Intraperitoneally|intraperitoneally
725834|NCT00138957|Mesh|mesh
725835|NCT00138957|Quality of life|quality of life
725836|NCT00138957|Postoperative pain|postoperative pain
725837|NCT00138957|Recurrence|recurrence
725838|NCT00138944|Essential hypertension|essential hypertension
725839|NCT00138931|Cardiomyopathy|cardiomyopathy
725840|NCT00138931|Arrhythmia|arrhythmia
725841|NCT00138931|Muscular Dystrophy|muscular dystrophy
725842|NCT00138918|Prostate Cancer|prostate cancer
725843|NCT00138918|Clusterin|clusterin
725844|NCT00138918|Neoadjuvant|neoadjuvant
725845|NCT00138918|Phase II|phase ii
725846|NCT00138905|Base station, EMF, human exposure study,Well-being,cognitive|base station, emf, human exposure study,well-being,cognitive
725847|NCT00138892|Quality of life|quality of life
725848|NCT00138892|waiting time|waiting time
725849|NCT00138892|total joint replacement|total joint replacement
725850|NCT00138879|Citrulline|citrulline
725851|NCT00138879|Parenteral Nutrition|parenteral nutrition
725852|NCT00138879|functioning intestinal mass|functioning intestinal mass
725853|NCT00138879|small bowel permeability and absorption|small bowel permeability and absorption
725854|NCT00138879|Granulomatous Enteritis|granulomatous enteritis
725855|NCT00138866|Spinal cord injury|spinal cord injury
725856|NCT00138853|RSA|rsa
725857|NCT00138853|Genoarthrosis|genoarthrosis
725858|NCT00138853|Knee arthroplasty|knee arthroplasty
725859|NCT00138853|Micromotion of polyethylene liner|micromotion of polyethylene liner
725860|NCT00138840|Crohn's disease|crohn's disease
725861|NCT00138840|Gastroenterology|gastroenterology
725862|NCT00138827|Radiotherapy|radiotherapy
725863|NCT00138827|Mucositis|mucositis
725864|NCT00138827|Xerostomia|xerostomia
725865|NCT00138814|Neoplasm recurrence, local|neoplasm recurrence, local
725866|NCT00138814|Radiotherapy dosage|radiotherapy dosage
725867|NCT00138814|Cosmesis|cosmesis
725868|NCT00138814|Mastectomy, segmental|mastectomy, segmental
725870|NCT00138788|Radiotherapy|radiotherapy
725871|NCT00138788|Qualify of life|qualify of life
725872|NCT00138788|Neoplasm metastasis of the brain|neoplasm metastasis of the brain
725873|NCT00138775|D-serine|d-serine
725874|NCT00138775|Negative symptoms|negative symptoms
725875|NCT00138775|Cognition|cognition
725876|NCT00138775|Schizophrenia|schizophrenia
725877|NCT00138775|Amino acid|amino acid
725878|NCT00138736|MBL-deficient|mbl-deficient
725879|NCT00138736|chemotherapy|chemotherapy
725880|NCT00138736|neutropenia|neutropenia
725881|NCT00138736|chemotherapy-induced neutropenia|chemotherapy-induced neutropenia
725882|NCT00138710|obesity|obesity
725883|NCT00138710|Hypogonadotrophic hypogonadism|hypogonadotrophic hypogonadism
725884|NCT00138710|aromatase inhibition|aromatase inhibition
725885|NCT00138697|Agammaglobulinemia|agammaglobulinemia
725886|NCT00138697|Hypogammaglobulinemia|hypogammaglobulinemia
725887|NCT00138697|Immunoglobulins, Intravenous|immunoglobulins, intravenous
725888|NCT00138684|insulin resistance|insulin resistance
725889|NCT00138684|iron overload|iron overload
725890|NCT00138684|phlebotomy|phlebotomy
725891|NCT00138684|hepatic iron overload|hepatic iron overload
725892|NCT00138658|NSCLC|nsclc
725893|NCT00138658|custirsen sodium|custirsen sodium
725894|NCT00138658|OGX-011|ogx-011
725895|NCT00138658|Stage IIIB or IV advanced non-small cell lung cancer|stage iiib or iv advanced non-small cell lung cancer
725896|NCT00138632|Wet Age-related macular degeneration|wet age-related macular degeneration
725897|NCT00138632|PTK787|ptk787
725898|NCT00138619|Type 2 diabetes|type 2 diabetes
725899|NCT00138619|vildagliptin|vildagliptin
725900|NCT00138606|Type 2 diabetes|type 2 diabetes
725901|NCT00138606|vildagliptin|vildagliptin
725902|NCT00138593|Type 2 diabetes|type 2 diabetes
725903|NCT00138593|vildagliptin|vildagliptin
725904|NCT00138580|Type 2 diabetes|type 2 diabetes
725905|NCT00138580|vildagliptin|vildagliptin
725906|NCT00138567|Type 2 diabetes|type 2 diabetes
725907|NCT00138567|vildagliptin|vildagliptin
725908|NCT00138554|Type 2 diabetes|type 2 diabetes
725909|NCT00138554|vildagliptin|vildagliptin
725910|NCT00138541|type 2 diabetes|type 2 diabetes
725911|NCT00138541|vildagliptin|vildagliptin
725912|NCT00138528|Metabolic Syndrome, fluvastatin|metabolic syndrome, fluvastatin
725913|NCT00138515|Type 2 diabetes|type 2 diabetes
725914|NCT00138515|vildagliptin|vildagliptin
725915|NCT00138502|Candidiasis, Funguria|candidiasis, funguria
725916|NCT00138489|Malaria, Papua New Guinea, infants, children|malaria, papua new guinea, infants, children
725917|NCT00138476|Norovirus, calicivirus, gastroenteritis, Norwalk virus, challenge|norovirus, calicivirus, gastroenteritis, norwalk virus, challenge
725918|NCT00138463|West Nile Virus, Neuroinvasive Disease|west nile virus, neuroinvasive disease
725919|NCT00138450|Schistosomiasis, S. haematobium, morbidity, Kenya|schistosomiasis, s. haematobium, morbidity, kenya
725920|NCT00138437|leprosy|leprosy
725921|NCT00138437|Colombia|colombia
725922|NCT00138424|Vistide®, Cidofovir, renal transplant, BK Virus Nephropathy|vistide®, cidofovir, renal transplant, bk virus nephropathy
725923|NCT00138411|anthrax, Bacillus anthracis, monoclonal antibody, ETI-204|anthrax, bacillus anthracis, monoclonal antibody, eti-204
725924|NCT00138398|Influenza, T cell, vaccine, Congestive heart failure|influenza, t cell, vaccine, congestive heart failure
725925|NCT00138385|inactivated, attenuated, influenza vaccine, FluMist, Fluzone|inactivated, attenuated, influenza vaccine, flumist, fluzone
725926|NCT00138372|malaria|malaria
725927|NCT00138372|immunity|immunity
725928|NCT00138372|MSP-1|msp-1
725929|NCT00138372|Kenya|kenya
725930|NCT00138372|infants|infants
725931|NCT00138359|T solium, cysticercus, pig triquina, solitaria, intestinal parasites, Niclosamide, tapeworms, Taeniasis|t solium, cysticercus, pig triquina, solitaria, intestinal parasites, niclosamide, tapeworms, taeniasis
725932|NCT00138346|hydatid disease, Echinococcus granulosus, tapeworm|hydatid disease, echinococcus granulosus, tapeworm
725933|NCT00138333|Thimerosal, mercury levels, low birth weight, Argentina|thimerosal, mercury levels, low birth weight, argentina
725934|NCT00138320|Herpes Simplex, vaccine, antibodies, mother|herpes simplex, vaccine, antibodies, mother
725935|NCT00138307|malaria, children, naturally acquired immunity, Ghana|malaria, children, naturally acquired immunity, ghana
725936|NCT00138294|influenza vaccine|influenza vaccine
725937|NCT00138294|live attenuated influenza vaccine (LAIV or FluMist)|live attenuated influenza vaccine (laiv or flumist)
725938|NCT00138294|inactivated influenza vaccine (IIV)|inactivated influenza vaccine (iiv)
725939|NCT00138294|School-based influenza vaccination program|school-based influenza vaccination program
725940|NCT00138294|children|children
725941|NCT00138294|herd protection|herd protection
725942|NCT00138281|influenza, vaccine, respiratory virus, Fluzone, FluMist|influenza, vaccine, respiratory virus, fluzone, flumist
725943|NCT00138268|umbilical cord blood, vaccine, pregnant women|umbilical cord blood, vaccine, pregnant women
725944|NCT00138242|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
725945|NCT00138242|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
725946|NCT00138242|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
725947|NCT00138242|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
725948|NCT00138242|fallopian tube cancer|fallopian tube cancer
725949|NCT00138242|primary peritoneal cavity cancer|primary peritoneal cavity cancer
725950|NCT00138229|recurrent melanoma|recurrent melanoma
725951|NCT00138229|stage IV melanoma|stage iv melanoma
727578|NCT00131781|impulsivity|impulsivity
725952|NCT00138216|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
725953|NCT00138216|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
725954|NCT00138216|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
725955|NCT00138216|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
725956|NCT00138216|recurrent childhood brain tumor|recurrent childhood brain tumor
725957|NCT00138216|recurrent childhood ependymoma|recurrent childhood ependymoma
725958|NCT00138216|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
725959|NCT00138216|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
725960|NCT00138216|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
725961|NCT00138216|childhood oligodendroglioma|childhood oligodendroglioma
725962|NCT00138216|childhood craniopharyngioma|childhood craniopharyngioma
725963|NCT00138216|childhood choroid plexus tumor|childhood choroid plexus tumor
725964|NCT00138216|childhood infratentorial ependymoma|childhood infratentorial ependymoma
725965|NCT00138216|childhood supratentorial ependymoma|childhood supratentorial ependymoma
725966|NCT00138216|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
725967|NCT00138216|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
725968|NCT00138216|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
725969|NCT00138216|childhood grade I meningioma|childhood grade i meningioma
725970|NCT00138216|childhood grade II meningioma|childhood grade ii meningioma
725971|NCT00138216|childhood grade III meningioma|childhood grade iii meningioma
725972|NCT00138216|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
725973|NCT00138216|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
725974|NCT00138164|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
725975|NCT00138164|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
725976|NCT00138164|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
725977|NCT00138164|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
725978|NCT00138164|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
725979|NCT00138151|recurrent cervical cancer|recurrent cervical cancer
725980|NCT00138151|stage IVB cervical cancer|stage ivb cervical cancer
725981|NCT00138125|stage IV breast cancer|stage iv breast cancer
725982|NCT00138125|recurrent breast cancer|recurrent breast cancer
725983|NCT00138112|Streptococcal Sepsis|streptococcal sepsis
725984|NCT00138112|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
725985|NCT00138112|Hematologic Malignancies|hematologic malignancies
725986|NCT00138112|Streptococci|streptococci
725987|NCT00138112|Transplant|transplant
725988|NCT00138099|Critically ill patients (ICU)|critically ill patients (icu)
725989|NCT00138099|Deep Venous Thromboembolism prevention|deep venous thromboembolism prevention
725990|NCT00138099|Renal Failure|renal failure
725991|NCT00138099|Critically ill|critically ill
725992|NCT00138086|lymphoma|lymphoma
725993|NCT00138086|chemotherapy|chemotherapy
725994|NCT00138086|Zevalin ( Yttrium-90 Ibritumomab Tiuxetan)|zevalin ( yttrium-90 ibritumomab tiuxetan)
725995|NCT00138073|pulmonary artery catheter|pulmonary artery catheter
725996|NCT00138073|waveform interpretation|waveform interpretation
725997|NCT00138073|computer-based learning|computer-based learning
725998|NCT00138073|medical education|medical education
725999|NCT00138060|genotypic profile|genotypic profile
726000|NCT00138060|metastatic colorectal cancer|metastatic colorectal cancer
726001|NCT00138047|zinc|zinc
726002|NCT00138047|HIV|hiv
726003|NCT00138047|children|children
726004|NCT00138034|Open infarct-related artery within 72 hours of thrombolysis|open infarct-related artery within 72 hours of thrombolysis
726005|NCT00138021|Serious mental illness|serious mental illness
726006|NCT00138021|Supported Employment|supported employment
726007|NCT00138021|Cognitive remediation|cognitive remediation
726008|NCT00138021|Cognitive impairments|cognitive impairments
726009|NCT00138008|prostate cancer|prostate cancer
726010|NCT00138008|radical prostatectomy|radical prostatectomy
726011|NCT00138008|PSA failure|psa failure
726012|NCT00138008|RCT|rct
726013|NCT00138008|radiation|radiation
726014|NCT00138008|endocrinotherapy|endocrinotherapy
726015|NCT00137995|Lymphoma|lymphoma
726016|NCT00137995|Chemotherapy|chemotherapy
726017|NCT00137995|rituximab|rituximab
726018|NCT00137982|Ectopic pregnancy|ectopic pregnancy
726019|NCT00137982|Surgical treatment|surgical treatment
726020|NCT00137982|Medical treatment|medical treatment
726021|NCT00137982|Fertility|fertility
726022|NCT00137969|Rituxan|rituxan
726023|NCT00137969|SLE|sle
726024|NCT00137969|Lupus|lupus
726025|NCT00137956|Endobronchial Valve|endobronchial valve
726026|NCT00137956|Endobronchial Valve ProcedureEBV|endobronchial valve procedureebv
726027|NCT00137956|EBV Procedure|ebv procedure
726028|NCT00137956|Endobronchial Lung Volume Reduction|endobronchial lung volume reduction
726029|NCT00137956|Lung Volume Reduction|lung volume reduction
726030|NCT00137943|Parent-child communication|parent-child communication
726031|NCT00137943|Primary prevention|primary prevention
726032|NCT00137943|sexual risk prevention|sexual risk prevention
726033|NCT00137943|HIV|hiv
726034|NCT00137930|Prophylaxis of rotavirus gastroenteritis|prophylaxis of rotavirus gastroenteritis
726035|NCT00137917|Prophylaxis meningococcal serogroup B disease|prophylaxis meningococcal serogroup b disease
726036|NCT00137904|multiple sclerosis|multiple sclerosis
726037|NCT00137904|fatigue|fatigue
726038|NCT00137904|sleep disorders|sleep disorders
726039|NCT00137891|Multinodular goiter|multinodular goiter
726040|NCT00137852|Esophageal Cancer|esophageal cancer
726041|NCT00137852|Resectable Esophageal Cancer|resectable esophageal cancer
726042|NCT00137852|Radiation Therapy|radiation therapy
726043|NCT00137852|Celecoxib|celecoxib
726044|NCT00137852|Irinotecan|irinotecan
726045|NCT00137852|Cisplatin|cisplatin
726046|NCT00137839|Tarceva|tarceva
726047|NCT00137839|Erlotinib|erlotinib
726048|NCT00137839|OSI-774|osi-774
726049|NCT00137839|Adenocarcinoma|adenocarcinoma
726050|NCT00137839|Advanced Lung Cancer|advanced lung cancer
726051|NCT00137826|Mesothelioma|mesothelioma
726052|NCT00137826|Avastin|avastin
726053|NCT00137826|Bevacizumab|bevacizumab
726054|NCT00137826|Tarceva|tarceva
726055|NCT00137826|OSI-774|osi-774
726056|NCT00137826|Erlotinib|erlotinib
726057|NCT00137813|Bevacizumab|bevacizumab
726058|NCT00137813|Docetaxel|docetaxel
726059|NCT00137813|AvaTax|avatax
726060|NCT00137813|Metastatic Esophagogastric Cancer|metastatic esophagogastric cancer
726061|NCT00137800|Non-Small Cell Lung Cancer|non-small cell lung cancer
726062|NCT00137800|Elderly Cancer Patients|elderly cancer patients
726063|NCT00137800|Tarceva|tarceva
726064|NCT00137800|Erlotinib|erlotinib
726065|NCT00137800|OSI-774|osi-774
726066|NCT00137800|Stage IIIB or IV Non-Small Cell Lung Cancer|stage iiib or iv non-small cell lung cancer
726067|NCT00137787|febrile neutropenia|febrile neutropenia
726068|NCT00137787|hematologic disease|hematologic disease
726069|NCT00137774|Metastatic Neuroendocrine Tumor|metastatic neuroendocrine tumor
726070|NCT00137774|Advanced Neuroendocrine tumor|advanced neuroendocrine tumor
726071|NCT00137774|Bevacizumab|bevacizumab
726072|NCT00137774|Temozolomide|temozolomide
726073|NCT00137761|Pancreatic Carcinoma|pancreatic carcinoma
726074|NCT00137761|Iressa|iressa
726075|NCT00137761|Docetaxel|docetaxel
726076|NCT00137748|Lung transplantation|lung transplantation
726077|NCT00137735|carpal tunnel syndrome|carpal tunnel syndrome
726078|NCT00137735|gabapentin|gabapentin
726079|NCT00137722|Asthma|asthma
726080|NCT00137722|Disease Management|disease management
726081|NCT00137722|Outcomes|outcomes
726082|NCT00137722|Utilization|utilization
726083|NCT00137709|epilepsy|epilepsy
726084|NCT00137709|hormone|hormone
726085|NCT00137696|polio|polio
726086|NCT00137696|vaccine|vaccine
726087|NCT00137696|immunogenicity|immunogenicity
726088|NCT00137683|screening|screening
726089|NCT00137683|prevention|prevention
726090|NCT00137683|community health education|community health education
726091|NCT00137670|Intervention studies|intervention studies
726092|NCT00137670|HIV|hiv
726093|NCT00137657|HIV|hiv
726094|NCT00137657|malaria|malaria
726095|NCT00137657|E. Coli|e. coli
726096|NCT00137657|S. pneumoniae|s. pneumoniae
726097|NCT00137657|drug resistance|drug resistance
726098|NCT00137657|antifolate|antifolate
726099|NCT00137657|opportunistic infections|opportunistic infections
726100|NCT00137657|Africa|africa
726101|NCT00137657|Kenya|kenya
726102|NCT00137657|East Africa|east africa
726103|NCT00137644|Adolescent|adolescent
726104|NCT00137644|*HIV Infections/ pc [Prevention & Control]|*hiv infections/ pc [prevention & control]
726105|NCT00137644|Male|male
726106|NCT00137644|Humans|humans
726107|NCT00137644|Risk-Taking|risk-taking
726108|NCT00137644|Safe Sex|safe sex
726109|NCT00137644|Sexual Behavior|sexual behavior
726110|NCT00137644|HIV|hiv
726111|NCT00137644|HIV Seronegativity|hiv seronegativity
726112|NCT00137631|Adult|adult
726113|NCT00137631|HIV Infections / pc [Prevention & Control]|hiv infections / pc [prevention & control]
726114|NCT00137631|Homosexuality, Male|homosexuality, male
726115|NCT00137631|Humans|humans
726116|NCT00137631|Male|male
726117|NCT00137631|Risk-Taking|risk-taking
726118|NCT00137631|Safe Sex|safe sex
726119|NCT00137631|Sexual Behavior|sexual behavior
726120|NCT00137631|HIV|hiv
726121|NCT00137618|Prostatic neoplasm|prostatic neoplasm
726122|NCT00137618|Prostate cancer|prostate cancer
726123|NCT00137618|Informed decision making|informed decision making
726124|NCT00137618|Prostate cancer screening|prostate cancer screening
726125|NCT00137618|Prostate specific antigen|prostate specific antigen
726126|NCT00137605|HIV|hiv
726127|NCT00137605|HIV Infections|hiv infections
726128|NCT00137592|screening|screening
726129|NCT00137592|community health education|community health education
726130|NCT00137579|Influenza Vaccines|influenza vaccines
726131|NCT00137579|Acenocoumarol|acenocoumarol
726132|NCT00137579|Drug Administration Routes|drug administration routes
726133|NCT00137579|Anticoagulants|anticoagulants
726134|NCT00137566|malaria|malaria
726135|NCT00137566|treatment|treatment
726136|NCT00137566|paracetamol|paracetamol
726137|NCT00137566|chloroquine|chloroquine
726138|NCT00137566|Guinea-Bissau|guinea-bissau
726139|NCT00137566|children|children
726140|NCT00137566|P.falciparum|p.falciparum
726141|NCT00137553|Children|children
726142|NCT00137553|malaria|malaria
726143|NCT00137553|sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
726144|NCT00137553|Guinea-Bissau|guinea-bissau
726145|NCT00137553|treatment|treatment
726146|NCT00137540|First line ablation therapy|first line ablation therapy
726147|NCT00137527|Cardiac Surgery|cardiac surgery
726148|NCT00137527|Cardiopulmonary Bypass|cardiopulmonary bypass
726149|NCT00137527|Cerebral Oxygenation|cerebral oxygenation
726150|NCT00137527|Neurologic Dysfunction|neurologic dysfunction
726151|NCT00137527|Neurocognitive Dysfunction|neurocognitive dysfunction
726152|NCT00137527|Neurological manifestations|neurological manifestations
726153|NCT00137527|Memory loss|memory loss
726154|NCT00137527|Delirium|delirium
726155|NCT00137527|Coronary Artery Bypass|coronary artery bypass
726156|NCT00137514|malaria|malaria
726157|NCT00137514|Plasmodium falciparum|plasmodium falciparum
726158|NCT00137514|chloroquine|chloroquine
726159|NCT00137514|amodiaquine|amodiaquine
726160|NCT00137514|treatment|treatment
726161|NCT00137514|Guinea-Bissau|guinea-bissau
726162|NCT00137514|children|children
726163|NCT00137488|non-enhancing lesion|non-enhancing lesion
726164|NCT00137488|low grade glioma|low grade glioma
726165|NCT00137488|high risk group selection|high risk group selection
726166|NCT00137475|IMRT|imrt
726167|NCT00137475|head and neck cancer|head and neck cancer
726168|NCT00137475|parotid sparing|parotid sparing
726169|NCT00137436|First-line treatment of metastatic hormone-refractory prostate cancer SUTENT in combination with docetaxel and prednisone|first-line treatment of metastatic hormone-refractory prostate cancer sutent in combination with docetaxel and prednisone
726170|NCT00137384|Magnetoencephalogram|magnetoencephalogram
726171|NCT00137384|Functional Connectivity|functional connectivity
726172|NCT00137384|Electroencephalogram (EEG)|electroencephalogram (eeg)
726173|NCT00137384|Focal Hand Dystonia|focal hand dystonia
726174|NCT00137384|Spectral Analysis|spectral analysis
726175|NCT00137384|Healthy Volunteer|healthy volunteer
726177|NCT00137371|Postmenopause|postmenopause
726178|NCT00137371|Vaginitis|vaginitis
726179|NCT00137358|Cervical|cervical
726180|NCT00137358|Uterine|uterine
726181|NCT00137358|Para-aortic|para-aortic
726182|NCT00137358|Nodes|nodes
726183|NCT00137358|IMRT|imrt
726184|NCT00137358|Cancer|cancer
726185|NCT00137345|Randomized controlled trial|randomized controlled trial
726186|NCT00137345|Clinical Trial Phase III|clinical trial phase iii
726187|NCT00137345|Drug therapy|drug therapy
726188|NCT00137345|Immunosuppression|immunosuppression
726189|NCT00137345|Treatment outcome|treatment outcome
726190|NCT00137345|Kidney transplantation|kidney transplantation
726191|NCT00137345|Kidney function tests|kidney function tests
726192|NCT00137332|Arrhythmia|arrhythmia
726193|NCT00137332|antiarrhythmic|antiarrhythmic
726194|NCT00137332|programmed electrical stimulation|programmed electrical stimulation
726195|NCT00137319|inspiratory impedance threshold device|inspiratory impedance threshold device
726196|NCT00137319|blood pressure regulation|blood pressure regulation
726197|NCT00137319|head-up tilt test|head-up tilt test
726198|NCT00137319|tilt table testing|tilt table testing
726199|NCT00137319|burn injury|burn injury
726200|NCT00137319|Burns|burns
726201|NCT00137306|Guideline Adherence|guideline adherence
726202|NCT00137306|Quality Assurance, Health Care|quality assurance, health care
726203|NCT00137293|Arrhythmia, syncope, antiarrhythmic|arrhythmia, syncope, antiarrhythmic
726204|NCT00137280|Randomized Controlled Trial|randomized controlled trial
726205|NCT00137280|Quality of Health Care|quality of health care
726206|NCT00137280|Health Services Research|health services research
726207|NCT00137280|Guidelines|guidelines
726208|NCT00137280|Medical Informatics Computing|medical informatics computing
726209|NCT00137280|Services, Mental Health|services, mental health
726210|NCT00137280|Medicine, Evidenced-Based|medicine, evidenced-based
726211|NCT00137280|Quality Assurance, Healthcare|quality assurance, healthcare
726212|NCT00137280|Quality Indicators, Health Care|quality indicators, health care
726213|NCT00137280|Veterans|veterans
726214|NCT00137280|Unemployment|unemployment
726215|NCT00137280|Obesity|obesity
726216|NCT00137280|Quality Improvement|quality improvement
726217|NCT00137267|Schizophrenia / disorders w psychotic features|schizophrenia / disorders w psychotic features
726218|NCT00137267|Substance-related disorders|substance-related disorders
726219|NCT00137267|Community Mental Health Services|community mental health services
726220|NCT00137267|Case Management|case management
726221|NCT00137267|Health Education|health education
726222|NCT00137254|Severe burns|severe burns
726223|NCT00137254|Hyperinsulinemia|hyperinsulinemia
726224|NCT00137254|Insulin|insulin
726225|NCT00137254|Muscle protein kinetics|muscle protein kinetics
726226|NCT00137254|Immune function|immune function
726227|NCT00137254|Exercise|exercise
726228|NCT00137241|health literacy|health literacy
726229|NCT00137241|screening|screening
726230|NCT00137241|cancer|cancer
726231|NCT00137241|health disparities|health disparities
726232|NCT00137228|Hand Edema|hand edema
726233|NCT00137228|Figure of eight method|figure of eight method
726234|NCT00137228|Measuring edema in burn patients|measuring edema in burn patients
726235|NCT00137215|burns|burns
726236|NCT00137215|donor site care|donor site care
726237|NCT00137215|Silverlon dressing|silverlon dressing
726238|NCT00137202|pruritus|pruritus
726239|NCT00137202|burn wound|burn wound
726240|NCT00137189|Motivation|motivation
726241|NCT00137189|Music Therapy|music therapy
726242|NCT00137189|Psychotherapy|psychotherapy
726243|NCT00137176|Clinically Isolated Syndrome|clinically isolated syndrome
726244|NCT00137163|burns|burns
726245|NCT00137163|donor site care|donor site care
726246|NCT00137163|Dermafill dressing|dermafill dressing
726247|NCT00137124|Essential hypertension|essential hypertension
726248|NCT00137111|Leukemia|leukemia
726249|NCT00137085|procedural sedation|procedural sedation
726250|NCT00136955|Weekly Irinotecan(60mg/sqm, D1, 8, 15) in combination with Cisplatin (60mg/sqm, D1), Squamous Cell Carcinoma Of The Uterine Cervix|weekly irinotecan(60mg/sqm, d1, 8, 15) in combination with cisplatin (60mg/sqm, d1), squamous cell carcinoma of the uterine cervix
726251|NCT00136929|AMI|ami
726252|NCT00136929|MI|mi
726253|NCT00136929|Acute myocardial infarction (AMI), (MI)|acute myocardial infarction (ami), (mi)
726254|NCT00136903|Graft vs Host Disease|graft vs host disease
726255|NCT00136903|GVHD|gvhd
726256|NCT00136903|Graft Versus Host Disease|graft versus host disease
726257|NCT00136903|Bone marrow transplant|bone marrow transplant
726258|NCT00136903|Stem cells|stem cells
726259|NCT00136903|Mesenchymal stem cells|mesenchymal stem cells
726260|NCT00136903|Adult stem cells|adult stem cells
726261|NCT00136903|Leukemia|leukemia
726262|NCT00136903|Lymphoma|lymphoma
726263|NCT00136890|Positron-Emission Tomography|positron-emission tomography
726264|NCT00136890|PET Scan|pet scan
726265|NCT00136890|Lung Cancer|lung cancer
726266|NCT00136890|Thoracic Surgery|thoracic surgery
726267|NCT00136890|Diagnostic|diagnostic
726268|NCT00136890|Randomized Controlled Trial|randomized controlled trial
726269|NCT00136890|Oncology|oncology
726270|NCT00136877|recurrent tonsillitis|recurrent tonsillitis
726271|NCT00136877|streptococcus|streptococcus
726272|NCT00136877|tonsillectomy|tonsillectomy
726273|NCT00136877|prevention|prevention
726274|NCT00136864|Positron-Emission Tomography|positron-emission tomography
726275|NCT00136864|PET Scan|pet scan
726276|NCT00136864|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
726277|NCT00136864|Diagnosis|diagnosis
726278|NCT00136864|Radiation Oncology|radiation oncology
726279|NCT00136864|Lung Cancer|lung cancer
726280|NCT00136864|Randomized Controlled Trial|randomized controlled trial
726281|NCT00136864|Oncology|oncology
726282|NCT00136864|Radiation Planning|radiation planning
726283|NCT00136851|Hypertension|hypertension
726284|NCT00136838|tobacco use|tobacco use
726286|NCT00136825|treatment|treatment
726287|NCT00136812|tobacco|tobacco
726288|NCT00136799|Mixed Dyslipidemia|mixed dyslipidemia
726289|NCT00136799|high cholesterol|high cholesterol
726290|NCT00136799|adults|adults
726291|NCT00136799|fluvastatin|fluvastatin
726292|NCT00136786|tobacco use|tobacco use
726293|NCT00136773|Albuminuria|albuminuria
726294|NCT00136773|Type 2 diabetes mellitus|type 2 diabetes mellitus
726295|NCT00136773|Hypertension|hypertension
726296|NCT00136760|tobacco|tobacco
726297|NCT00136747|tobacco use|tobacco use
726298|NCT00136734|ADHD|adhd
726299|NCT00136734|Cocaine dependence|cocaine dependence
726300|NCT00136734|treatment|treatment
726301|NCT00136734|methylphenidate|methylphenidate
726302|NCT00136721|Parkinson's disease|parkinson's disease
726303|NCT00136721|phenotype-genotype correlations|phenotype-genotype correlations
726304|NCT00136721|mutations spectrum|mutations spectrum
726305|NCT00136721|candidate genes|candidate genes
726306|NCT00136708|Global Network|global network
726307|NCT00136708|Neonatal mortality|neonatal mortality
726308|NCT00136708|Asphyxia|asphyxia
726309|NCT00136708|Maternal and child health|maternal and child health
726310|NCT00136708|International|international
726311|NCT00136708|Zambia|zambia
726312|NCT00136708|Pakistan|pakistan
726313|NCT00136708|India|india
726314|NCT00136708|Democratic Republic of Congo|democratic republic of congo
726315|NCT00136708|Uruguay|uruguay
726316|NCT00136708|Guatemala|guatemala
726317|NCT00136708|Argentina|argentina
726318|NCT00136708|Neonatal resuscitation|neonatal resuscitation
726319|NCT00136695|Aging|aging
726320|NCT00136682|Major abdominal or pelvic surgery|major abdominal or pelvic surgery
726321|NCT00136682|Patient-Controlled Epidural Analgesia (PCEA)|patient-controlled epidural analgesia (pcea)
726322|NCT00136682|Length of hospital stay after surgery|length of hospital stay after surgery
726323|NCT00136669|Acupuncture|acupuncture
726324|NCT00136669|Pain|pain
726325|NCT00136669|Pancreatic Neoplasms|pancreatic neoplasms
726326|NCT00136656|infant|infant
726327|NCT00136656|children|children
726328|NCT00136656|pyelonephritis|pyelonephritis
726329|NCT00136656|Renal scars|renal scars
726330|NCT00136656|DMSA scan|dmsa scan
726331|NCT00136643|microbicide|microbicide
726332|NCT00136643|Women|women
726333|NCT00136643|Prevention|prevention
726334|NCT00136643|HIV|hiv
726335|NCT00136643|STIs|stis
726336|NCT00136643|HIV Seronegativity|hiv seronegativity
726437|NCT00136305|pediatric asthma|pediatric asthma
728566|NCT00128232|untreated|untreated
726337|NCT00136643|prevention of sexually transmitted infections including HIV.|prevention of sexually transmitted infections including hiv.
726338|NCT00136630|dominant spinocerebellar degenerations|dominant spinocerebellar degenerations
726339|NCT00136630|new rate scales|new rate scales
726340|NCT00136630|natural history|natural history
726341|NCT00136630|molecular biology|molecular biology
726342|NCT00136630|candidate genes|candidate genes
726343|NCT00136617|Short Alcohol Withdrawal Scale|short alcohol withdrawal scale
726344|NCT00136617|Documentation|documentation
726345|NCT00136604|Prophylaxis diphtheria|prophylaxis diphtheria
726346|NCT00136604|Hib & meningococcal serogroup A & C disease|hib & meningococcal serogroup a & c disease
726347|NCT00136591|follicular lymphoma|follicular lymphoma
726348|NCT00136591|bortezomib|bortezomib
726349|NCT00136591|relapse|relapse
726350|NCT00136578|solid tumors|solid tumors
726351|NCT00136578|dose limiting toxicity|dose limiting toxicity
726352|NCT00136578|carboplatin|carboplatin
726353|NCT00136578|tolerability|tolerability
726354|NCT00136578|Safety|safety
726355|NCT00136565|peripheral T-cell lymphomas|peripheral t-cell lymphomas
726356|NCT00136565|bortezomib|bortezomib
726357|NCT00136565|ACVBP regimen|acvbp regimen
726358|NCT00136552|lymphoma|lymphoma
726359|NCT00136552|follicular|follicular
726360|NCT00136552|B-cell|b-cell
726361|NCT00136552|rituximab|rituximab
726362|NCT00136552|interferon|interferon
726363|NCT00136539|Breast Cancer|breast cancer
726364|NCT00136539|Early Stage Breast Cancer|early stage breast cancer
726365|NCT00136539|HER2-positive|her2-positive
726366|NCT00136539|HER2-positive breast cancer|her2-positive breast cancer
726367|NCT00136539|Herceptin|herceptin
726368|NCT00136539|Taxol|taxol
726369|NCT00136539|Stage II Breast Cancer|stage ii breast cancer
726370|NCT00136539|Stage III Breast Cancer|stage iii breast cancer
726371|NCT00136526|Prostate Cancer|prostate cancer
726372|NCT00136526|Hormone refractory prostate cancer|hormone refractory prostate cancer
726373|NCT00136526|Metastatic prostate cancer|metastatic prostate cancer
726374|NCT00136513|Safety|safety
726375|NCT00136513|tolerability|tolerability
726376|NCT00136513|dose limiting toxicity|dose limiting toxicity
726377|NCT00136513|solid tumors|solid tumors
726378|NCT00136500|genetics|genetics
726379|NCT00136500|biomarkers|biomarkers
726380|NCT00136500|pre-symptomatic|pre-symptomatic
726381|NCT00136500|natural history|natural history
726382|NCT00136487|Prostate Cancer|prostate cancer
726383|NCT00136487|Cancer of Prostate|cancer of prostate
726384|NCT00136487|Cancer of the Prostate|cancer of the prostate
726385|NCT00136487|Prostate-Specific Antigen|prostate-specific antigen
726386|NCT00136474|Lymphoma|lymphoma
726387|NCT00136474|Radiation therapy|radiation therapy
726388|NCT00136474|Amifostine|amifostine
726389|NCT00136461|AML|aml
726390|NCT00136461|acute myelogenous leukemia|acute myelogenous leukemia
726391|NCT00136461|MDS|mds
726392|NCT00136461|myelodysplastic syndrome|myelodysplastic syndrome
726393|NCT00136461|bryostatin 1|bryostatin 1
726394|NCT00136461|all-trans retinoic acid|all-trans retinoic acid
726395|NCT00136461|ATRA|atra
726396|NCT00136448|AML|aml
726397|NCT00136448|acute myelogenous leukemia|acute myelogenous leukemia
726398|NCT00136448|cytarabine|cytarabine
726399|NCT00136448|interleukin-2|interleukin-2
726400|NCT00136435|ALL|all
726401|NCT00136435|acute lymphoblastic leukemia|acute lymphoblastic leukemia
726402|NCT00136435|chemotherapy|chemotherapy
726403|NCT00136435|asparaginase|asparaginase
726404|NCT00136422|AML|aml
726405|NCT00136422|acute myelogenous leukemia|acute myelogenous leukemia
726407|NCT00136422|myelodysplasia|myelodysplasia
726408|NCT00136422|vaccine|vaccine
726409|NCT00136409|myelofibrosis|myelofibrosis
726410|NCT00136409|agnogenic myeloid metaplasia with myelofibrosis|agnogenic myeloid metaplasia with myelofibrosis
726411|NCT00136409|CMML|cmml
726412|NCT00136409|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
726413|NCT00136409|imatinib mesylate|imatinib mesylate
726414|NCT00136409|Gleevec|gleevec
726415|NCT00136396|Steroid-refractory Chronic Graft vs. Host Disease|steroid-refractory chronic graft vs. host disease
726416|NCT00136396|Chronic Graft vs. Host Disease|chronic graft vs. host disease
726417|NCT00136396|GVHD|gvhd
726418|NCT00136396|steroid-refractory|steroid-refractory
726419|NCT00136396|rituximab|rituximab
726420|NCT00136370|Chlorhexidine|chlorhexidine
726421|NCT00136370|Prevention|prevention
726422|NCT00136370|Neonatal sepsis|neonatal sepsis
726423|NCT00136370|Peripartum infections|peripartum infections
726424|NCT00136357|posttraumatic stress|posttraumatic stress
726425|NCT00136357|mind-body techniques|mind-body techniques
726426|NCT00136357|war|war
726427|NCT00136357|adolescents|adolescents
726428|NCT00136344|cataract surgery|cataract surgery
726429|NCT00136344|phacoemulsification|phacoemulsification
726430|NCT00136344|post-operative endophthalmitis|post-operative endophthalmitis
726431|NCT00136331|Pandemic|pandemic
726432|NCT00136331|Influenza|influenza
726433|NCT00136331|Prevention|prevention
726434|NCT00136331|Vaccine|vaccine
726435|NCT00136331|Prevention of Pandemic Influenza|prevention of pandemic influenza
726436|NCT00136318|Pegasys-Induced depression|pegasys-induced depression
726826|NCT00134472|Anesthesia|anesthesia
726438|NCT00136305|asthma action plans|asthma action plans
726439|NCT00136305|patient education|patient education
726440|NCT00136305|medication adherence|medication adherence
726441|NCT00136292|Gram-Positive Infection|gram-positive infection
726442|NCT00136279|adolescent behavior|adolescent behavior
726443|NCT00136279|sexual behavior|sexual behavior
726444|NCT00136279|smoking|smoking
726445|NCT00136279|parents|parents
726446|NCT00136279|communication|communication
726447|NCT00136279|health education|health education
726448|NCT00136279|schools|schools
726449|NCT00136279|Sexual initiation|sexual initiation
726450|NCT00136266|Adherence|adherence
726451|NCT00136266|Supplements|supplements
726452|NCT00136266|Iron|iron
726453|NCT00136266|Iron deficiency|iron deficiency
726454|NCT00136266|Anemia|anemia
726455|NCT00136266|Vitamins|vitamins
726456|NCT00136266|Minerals|minerals
726457|NCT00136227|screening,|screening,
726458|NCT00136227|community health education,|community health education,
726459|NCT00136227|decision making,|decision making,
726460|NCT00136227|computer-assisted decision making|computer-assisted decision making
726461|NCT00136201|Peritonitis|peritonitis
726462|NCT00136201|Community-Acquired Infections|community-acquired infections
726463|NCT00136201|Cross Infection|cross infection
726464|NCT00136188|Prediabetes|prediabetes
726465|NCT00136188|Metabolic Syndrome|metabolic syndrome
726466|NCT00136188|Healthy Controls|healthy controls
726467|NCT00136188|Endothelial function|endothelial function
726468|NCT00136175|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
726469|NCT00136110|ALS|als
726470|NCT00136110|Sodium Valproate|sodium valproate
726471|NCT00136110|randomised trial|randomised trial
726472|NCT00136110|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
726473|NCT00136097|colonisation of the catheter|colonisation of the catheter
726474|NCT00136084|Leukemia,Erythroblastic, Acute|leukemia,erythroblastic, acute
726475|NCT00136084|Erythroblastic Leukemia, Acute|erythroblastic leukemia, acute
726476|NCT00136084|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
726477|NCT00136084|Myeloid Leukemia, Acute|myeloid leukemia, acute
726478|NCT00136071|Stress Urinary Incontinence,|stress urinary incontinence,
726479|NCT00136071|TOT,|tot,
726480|NCT00136071|TVT-O|tvt-o
726481|NCT00136058|osteoporosis|osteoporosis
726482|NCT00136058|hip fracture|hip fracture
726483|NCT00136045|Idiopathic RLS|idiopathic rls
726484|NCT00136032|Growth Hormone|growth hormone
726485|NCT00136032|Cardiovascular risk|cardiovascular risk
726486|NCT00136032|Pituitary|pituitary
726487|NCT00136032|Hypothalamic|hypothalamic
726488|NCT00136032|GH Deficiency|gh deficiency
726489|NCT00136032|Pituitary Tumor|pituitary tumor
726490|NCT00136032|Pituitary Disease|pituitary disease
726491|NCT00136019|Epilepsy with partial seizures|epilepsy with partial seizures
726492|NCT00136006|Epidemiology|epidemiology
726493|NCT00136006|Lung health|lung health
726494|NCT00136006|lung function|lung function
726495|NCT00136006|COPD|copd
726496|NCT00135993|Idiopathic Restless Leg syndrome|idiopathic restless leg syndrome
726497|NCT00135967|membranous nephropathy|membranous nephropathy
726498|NCT00135967|mycophenolate mofetil|mycophenolate mofetil
726499|NCT00135967|cyclophosphamide|cyclophosphamide
726500|NCT00135967|prednisone|prednisone
726501|NCT00135954|membranous nephropathy|membranous nephropathy
726502|NCT00135954|cyclophosphamide|cyclophosphamide
726503|NCT00135954|prednisone|prednisone
726504|NCT00135941|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
726505|NCT00135928|ST-elevation myocardial infarction|st-elevation myocardial infarction
726506|NCT00135928|granulocyte-colony stimulating factor angiogenesis|granulocyte-colony stimulating factor angiogenesis
726507|NCT00135928|stem cells|stem cells
726508|NCT00135902|Preterm birth|preterm birth
726509|NCT00135902|Progesterone|progesterone
726510|NCT00135902|Omega-3 fatty acid|omega-3 fatty acid
726511|NCT00135902|Pregnancy|pregnancy
726512|NCT00135889|Total Knee Arthroplasty secondary to osteoarthritis|total knee arthroplasty secondary to osteoarthritis
726513|NCT00135876|deep vein thrombosis|deep vein thrombosis
726514|NCT00135876|pulmonary embolism|pulmonary embolism
726515|NCT00135876|glioma|glioma
726516|NCT00135876|fragmin|fragmin
726517|NCT00135876|anticoagulant|anticoagulant
726518|NCT00135876|prophylaxis|prophylaxis
726519|NCT00135876|dalteparin|dalteparin
726520|NCT00135850|Gene therapy|gene therapy
726521|NCT00135850|VEGF|vegf
726522|NCT00135850|Stem cells|stem cells
726523|NCT00135850|myocardial ischemia|myocardial ischemia
726524|NCT00135850|angiogenesis|angiogenesis
726525|NCT00135837|Age related Macula Degeneration,|age related macula degeneration,
726526|NCT00135837|AMD,|amd,
726527|NCT00135837|choroidal neovascularisation (CNV),|choroidal neovascularisation (cnv),
726528|NCT00135837|occult CNV lesion,|occult cnv lesion,
726529|NCT00135837|verteporfin for injection,|verteporfin for injection,
726530|NCT00135837|photodynamic therapy (PDT)|photodynamic therapy (pdt)
726531|NCT00135824|Artificial eye drops|artificial eye drops
726532|NCT00135824|tolerability|tolerability
726533|NCT00135824|healthy volunteers|healthy volunteers
726534|NCT00135824|povidone|povidone
726535|NCT00135824|healthy subjects|healthy subjects
726536|NCT00135811|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
726537|NCT00135798|Hepatitis C|hepatitis c
726538|NCT00135798|Ribavirin|ribavirin
726539|NCT00135798|PegInterferon alfa2b|peginterferon alfa2b
726540|NCT00135772|nicotine dependence|nicotine dependence
726541|NCT00135759|opiate dependence|opiate dependence
726542|NCT00135746|tobacco|tobacco
726543|NCT00135733|Lichen Planus|lichen planus
726544|NCT00135733|Mucosal lichen planus|mucosal lichen planus
726545|NCT00135733|Alefacept|alefacept
726546|NCT00135733|T-cell mediated|t-cell mediated
726547|NCT00135733|subcutaneous medication|subcutaneous medication
726548|NCT00135733|Autoimmune disease|autoimmune disease
726549|NCT00135720|Pemphigus Vulgaris|pemphigus vulgaris
726550|NCT00135720|Chronic Pemphigus|chronic pemphigus
726551|NCT00135720|Etanercept|etanercept
726552|NCT00135720|Enbrel|enbrel
726553|NCT00135720|anti-TNF-alpha|anti-tnf-alpha
726554|NCT00135720|TNF-alpha antagonist|tnf-alpha antagonist
726555|NCT00135720|biologic|biologic
726556|NCT00135720|immunomodulator|immunomodulator
726557|NCT00135720|subcutaneous medication|subcutaneous medication
726558|NCT00135707|Antioxidants|antioxidants
726559|NCT00135707|Preeclampsia|preeclampsia
726560|NCT00135707|Pregnancy|pregnancy
726561|NCT00135707|Hypertension|hypertension
726562|NCT00135694|hepatitis|hepatitis
726563|NCT00135694|hepatitis C|hepatitis c
726564|NCT00135694|HCV|hcv
726565|NCT00135694|liver|liver
726566|NCT00135694|liver disease|liver disease
726567|NCT00135694|liver transplant|liver transplant
726568|NCT00135694|liver transplantation|liver transplantation
726569|NCT00135694|transplant|transplant
726570|NCT00135694|hepatic|hepatic
726571|NCT00135694|hepatic transplantation|hepatic transplantation
726572|NCT00135694|immunosuppression|immunosuppression
726573|NCT00135694|rejection|rejection
726574|NCT00135668|children|children
726575|NCT00135668|sodium nitroprusside|sodium nitroprusside
726576|NCT00135668|controlled hypotension|controlled hypotension
726577|NCT00135668|dose-response|dose-response
726578|NCT00135668|pharmacokinetics|pharmacokinetics
726579|NCT00135668|pharmacodynamics|pharmacodynamics
726580|NCT00135668|safety|safety
726581|NCT00135668|efficacy|efficacy
726582|NCT00135655|macular edema|macular edema
726583|NCT00135655|post cataract extraction|post cataract extraction
726584|NCT00135655|cystoid macular edema|cystoid macular edema
726585|NCT00135655|post cataract extraction macular edema|post cataract extraction macular edema
726586|NCT00135642|Hayfever|hayfever
726587|NCT00135642|Subcutaneous Immunotherapy|subcutaneous immunotherapy
726588|NCT00135642|Grass pollen immunotherapy|grass pollen immunotherapy
726589|NCT00135642|Seasonal Allergic Rhinoconjunctivitis|seasonal allergic rhinoconjunctivitis
726590|NCT00135629|Hayfever|hayfever
726591|NCT00135629|Sublingual Immunotherapy|sublingual immunotherapy
726592|NCT00135629|Grass pollen immunotherapy|grass pollen immunotherapy
726593|NCT00135629|Late cutaneous response|late cutaneous response
726594|NCT00135629|Intradermal allergen challenge|intradermal allergen challenge
726595|NCT00135629|Seasonal Allergic Rhinoconjunctivitis|seasonal allergic rhinoconjunctivitis
726596|NCT00135616|urinary incontinence|urinary incontinence
726597|NCT00135616|stress incontinence|stress incontinence
726598|NCT00135616|urethra|urethra
726599|NCT00135616|gynaecologic surgical procedures|gynaecologic surgical procedures
726600|NCT00135616|suburethral sling|suburethral sling
726601|NCT00135603|appendicitis.|appendicitis.
726602|NCT00135603|adult.|adult.
726603|NCT00135603|treatment.|treatment.
726604|NCT00135603|antibiotic therapy.|antibiotic therapy.
726605|NCT00135603|CT scanning.|ct scanning.
726606|NCT00135603|randomized trial|randomized trial
726607|NCT00135603|safety|safety
726608|NCT00135590|Protein pulse-feeding|protein pulse-feeding
726609|NCT00135590|Nutritional supplementation|nutritional supplementation
726610|NCT00135590|Protein-energy malnutrition|protein-energy malnutrition
726611|NCT00135590|Elderly subjects|elderly subjects
726612|NCT00135590|Body composition|body composition
726613|NCT00135577|opioids|opioids
726614|NCT00135577|constipation|constipation
726615|NCT00135577|opioid-induced bowel dysfunction|opioid-induced bowel dysfunction
726616|NCT00135564|Haemophilus Influenzae type b/Meningococcal (vaccine)|haemophilus influenzae type b/meningococcal (vaccine)
726617|NCT00135564|Prophylaxis meningococcal serogroup C disease, Hib diseases|prophylaxis meningococcal serogroup c disease, hib diseases
726618|NCT00135551|Hypertension|hypertension
726619|NCT00135551|Multicenter clinical trial|multicenter clinical trial
726620|NCT00135551|PROBE|probe
726621|NCT00135551|Combination therapy|combination therapy
726622|NCT00135551|Benidipine|benidipine
726623|NCT00135551|Essential Hypertension|essential hypertension
726624|NCT00135538|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
726625|NCT00135538|Intermittent Positive-Pressure Ventilation|intermittent positive-pressure ventilation
726626|NCT00135538|Rehabilitation|rehabilitation
726627|NCT00135525|Generalized Anxiety Disorder|generalized anxiety disorder
726628|NCT00135512|MDD|mdd
726629|NCT00135499|Lymphoma|lymphoma
726630|NCT00135499|chemotherapy|chemotherapy
726631|NCT00135499|rituximab|rituximab
727296|NCT00132847|Child|child
726632|NCT00135486|Haemophilus Influenzae type b/Meningococcal vaccine|haemophilus influenzae type b/meningococcal vaccine
726633|NCT00135486|Prophylaxis meningococcal serogroup C disease, Hib diseases|prophylaxis meningococcal serogroup c disease, hib diseases
726634|NCT00135473|Severe sepsis|severe sepsis
726635|NCT00135473|septic shock|septic shock
726636|NCT00135473|volume substitution|volume substitution
726637|NCT00135473|intensive insulin therapy|intensive insulin therapy
726638|NCT00135473|colloids|colloids
726639|NCT00135473|crystalloids|crystalloids
726640|NCT00135473|outcome|outcome
726641|NCT00135473|safety|safety
726642|NCT00135460|HIV|hiv
726643|NCT00135460|Lipoatrophy|lipoatrophy
726644|NCT00135460|Lipodystrophy|lipodystrophy
726645|NCT00135460|Treatment Naive|treatment naive
726646|NCT00135460|HIV Infections|hiv infections
726647|NCT00135460|Hypercholesterolemia|hypercholesterolemia
726648|NCT00135447|HIV/AIDS|hiv/aids
726649|NCT00135447|Treatment Experienced|treatment experienced
726650|NCT00135408|Unresectable Stage III or IV Malignant Melanoma|unresectable stage iii or iv malignant melanoma
726651|NCT00135395|HIV/AIDS|hiv/aids
726652|NCT00135395|Treatment Experienced|treatment experienced
726653|NCT00135382|HIV/AIDS|hiv/aids
726654|NCT00135369|HIV-AIDS|hiv-aids
726655|NCT00135356|HIV infections|hiv infections
726656|NCT00135343|HIV/AIDS|hiv/aids
726657|NCT00135330|diabetes|diabetes
726658|NCT00135330|exenatide|exenatide
726659|NCT00135330|rosiglitazone|rosiglitazone
726660|NCT00135330|Amylin|amylin
726661|NCT00135330|Lilly|lilly
726662|NCT00135317|oncology|oncology
726663|NCT00135317|darbepoetin alfa|darbepoetin alfa
726664|NCT00135317|Aranesp®|aranesp®
726665|NCT00135317|Amgen|amgen
726666|NCT00135317|Non-myeloid malignancy|non-myeloid malignancy
726667|NCT00135304|Vitamin D|vitamin d
726668|NCT00135304|Sensipar®|sensipar®
726669|NCT00135304|Cinacalcet HCl|cinacalcet hcl
726670|NCT00135304|Chronic Kidney Disease|chronic kidney disease
726671|NCT00135291|transfusion-induced immunomodulation|transfusion-induced immunomodulation
726672|NCT00135291|leukoreduction|leukoreduction
726673|NCT00135291|surgical site infections|surgical site infections
726674|NCT00135291|nosocomial infections|nosocomial infections
726675|NCT00135291|transfusion|transfusion
726676|NCT00135291|Infection|infection
726677|NCT00135291|Sepsis|sepsis
726678|NCT00135291|Hemorrhage|hemorrhage
726679|NCT00135278|Neuroprotection|neuroprotection
726680|NCT00135278|inflammation|inflammation
726681|NCT00135278|cytokines|cytokines
726683|NCT00135265|smoking cessation|smoking cessation
726684|NCT00135265|adolescents|adolescents
726685|NCT00135252|developing chronic lung disease|developing chronic lung disease
726686|NCT00135239|back|back
726687|NCT00135239|Lower Mechanical Back Pain|lower mechanical back pain
726688|NCT00135239|Rehabilitation|rehabilitation
726689|NCT00135226|Diabetes Mellitus|diabetes mellitus
726690|NCT00135226|Cardiovascular Disease|cardiovascular disease
726691|NCT00135226|Aspirin|aspirin
726692|NCT00135226|Omega-3 fatty acids|omega-3 fatty acids
726693|NCT00135226|Primary prevention|primary prevention
726694|NCT00135226|Randomized Controlled Trial|randomized controlled trial
726695|NCT00135226|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
726696|NCT00135226|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
726697|NCT00135213|passive smoking|passive smoking
726698|NCT00135213|pediatric practice|pediatric practice
726699|NCT00135213|smoking cessation|smoking cessation
726700|NCT00135174|Pacemaker|pacemaker
726701|NCT00135174|routine|routine
726702|NCT00135174|follow-up|follow-up
726703|NCT00135174|complications|complications
726704|NCT00135174|Quality of Life|quality of life
726705|NCT00135161|neoplasms (squamous cell carcinoma of the head and neck region)|neoplasms (squamous cell carcinoma of the head and neck region)
726706|NCT00135135|Cancer|cancer
726707|NCT00135135|Childhood Tumor|childhood tumor
726708|NCT00135135|Neoplasms|neoplasms
726709|NCT00135122|migraine|migraine
726710|NCT00135122|analgesics|analgesics
726711|NCT00135122|tension type headache|tension type headache
726712|NCT00135070|Diabetes Mellitus|diabetes mellitus
726713|NCT00135044|taurine|taurine
726714|NCT00135044|intestinal failure|intestinal failure
726715|NCT00135044|HPN|hpn
726716|NCT00135044|hepatobiliary complications|hepatobiliary complications
726717|NCT00135044|chronic intestinal failure (CIF)|chronic intestinal failure (cif)
726718|NCT00135005|GIST|gist
726719|NCT00135005|AMN107|amn107
726720|NCT00135005|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
726721|NCT00134992|Prednisolone acetate|prednisolone acetate
726722|NCT00134992|eye drops|eye drops
726723|NCT00134992|tolerability|tolerability
726724|NCT00134992|Healthy volunteers|healthy volunteers
726725|NCT00134979|COPD, formoterol,|copd, formoterol,
726726|NCT00134966|Parkinson's disease, levodopa, dyskinesia|parkinson's disease, levodopa, dyskinesia
726727|NCT00134953|Mild cognitive impairment|mild cognitive impairment
726728|NCT00134953|Alzheimer's disease|alzheimer's disease
726729|NCT00134953|Dementia|dementia
726730|NCT00134953|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
726731|NCT00134940|Transplantation, heart|transplantation, heart
726732|NCT00134940|Organ transplant|organ transplant
726733|NCT00134914|opiate dependence|opiate dependence
726734|NCT00134901|Cocaine dependence|cocaine dependence
726735|NCT00134901|treatment|treatment
726736|NCT00134901|memantine|memantine
726737|NCT00134888|Opioid Dependence|opioid dependence
726738|NCT00134875|opioid dependence|opioid dependence
726739|NCT00134849|hypertension|hypertension
726740|NCT00134823|Parent Experience of Care|parent experience of care
726741|NCT00134823|Quality Improvement|quality improvement
726742|NCT00134823|Medication Errors|medication errors
726743|NCT00134823|Abnormal Lab Values|abnormal lab values
726744|NCT00134823|Guideline Adherence|guideline adherence
726745|NCT00134810|Myofascial pain syndrome|myofascial pain syndrome
726746|NCT00134797|GFR|gfr
726747|NCT00134797|serum creatinine|serum creatinine
726748|NCT00134784|parkinson|parkinson
726749|NCT00134784|brain imaging|brain imaging
726750|NCT00134771|Infants whose birthweight is less than the 20th centile for gestational age (UK standards)|infants whose birthweight is less than the 20th centile for gestational age (uk standards)
726751|NCT00134771|Infants who are formula fed from birth|infants who are formula fed from birth
726752|NCT00134771|Singletons|singletons
726753|NCT00134771|Infants free from major congenital disease|infants free from major congenital disease
726754|NCT00134758|Treatment of adenomas of the duodenum in FAP patients.|treatment of adenomas of the duodenum in fap patients.
726755|NCT00134758|Adenoma|adenoma
726756|NCT00134745|Turner Syndrome|turner syndrome
726757|NCT00134745|Hormonal replacement therapy|hormonal replacement therapy
726758|NCT00134745|Bone mineralization|bone mineralization
726759|NCT00134745|Uterine size|uterine size
726760|NCT00134745|aortic root dilatation|aortic root dilatation
726761|NCT00134732|Prophylaxis of Rotavirus Gastroenteritis|prophylaxis of rotavirus gastroenteritis
726762|NCT00134719|Invasive Hib & N. meningitidis diseases|invasive hib & n. meningitidis diseases
726763|NCT00134706|Prostate Cancer|prostate cancer
726764|NCT00134706|Cancer of the prostate|cancer of the prostate
726765|NCT00134706|Cancer of prostate|cancer of prostate
726766|NCT00134706|Docetaxel|docetaxel
726767|NCT00134706|Carboplatin|carboplatin
726768|NCT00134693|SB-681323 rheumatoid arthritis CRP biomarkers|sb-681323 rheumatoid arthritis crp biomarkers
726769|NCT00134680|estrogen receptor positive|estrogen receptor positive
726770|NCT00134680|progesterone receptor positive|progesterone receptor positive
726771|NCT00134680|ErbB2 positive|erbb2 positive
726772|NCT00134680|metastatic breast cancer|metastatic breast cancer
726773|NCT00134667|AMD|amd
726774|NCT00134667|Age-Related Macular Degeneration|age-related macular degeneration
726775|NCT00134667|Macular Degeneration|macular degeneration
726777|NCT00134667|Photodynamic Therapy|photodynamic therapy
726778|NCT00134667|PDT|pdt
726779|NCT00134667|Visudyne|visudyne
726780|NCT00134667|pegaptanib sodium|pegaptanib sodium
726781|NCT00134667|verteporfin|verteporfin
726782|NCT00134667|Predominantly Classic|predominantly classic
726783|NCT00134667|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
726784|NCT00134654|Androgen-independent prostate cancer|androgen-independent prostate cancer
726785|NCT00134654|Premarin|premarin
726786|NCT00134654|conjugated estrogen|conjugated estrogen
726787|NCT00134641|soft tissue sarcoma|soft tissue sarcoma
726788|NCT00134641|metastatic soft tissue sarcoma|metastatic soft tissue sarcoma
726789|NCT00134641|gemcitabine|gemcitabine
726790|NCT00134641|vinorelbine|vinorelbine
726791|NCT00134628|Hyperbaric Oxygenation|hyperbaric oxygenation
726792|NCT00134628|Radiation injuries|radiation injuries
726793|NCT00134628|Prophylaxis|prophylaxis
726794|NCT00134628|Proctitis|proctitis
726795|NCT00134628|Cystitis|cystitis
726796|NCT00134628|Enteritis|enteritis
726797|NCT00134628|Osteoradionecrosis|osteoradionecrosis
726798|NCT00134615|decision-making|decision-making
726799|NCT00134615|patient activation|patient activation
726800|NCT00134615|empowerment|empowerment
726801|NCT00134615|mental health|mental health
726802|NCT00134615|Depression|depression
726803|NCT00134615|Anxiety|anxiety
726804|NCT00134615|Other Psychiatric Disorder|other psychiatric disorder
726805|NCT00134602|HIV infection, antiretroviral therapy, adherence, pediatric|hiv infection, antiretroviral therapy, adherence, pediatric
726806|NCT00134589|Academic Detailing|academic detailing
726807|NCT00134589|Decision Aid|decision aid
726808|NCT00134589|Colorectal Cancer Screening|colorectal cancer screening
726809|NCT00134589|RECTAL NEOPLASMS|rectal neoplasms
726810|NCT00134589|COLONIC POLYPS|colonic polyps
726811|NCT00134563|Multiple Sclerosis|multiple sclerosis
726812|NCT00134563|Relapsing Remitting|relapsing remitting
726813|NCT00134563|Secondary Progressive|secondary progressive
726814|NCT00134563|Progressive Relapsing|progressive relapsing
726815|NCT00134550|Diabetes Mellitus|diabetes mellitus
726816|NCT00134550|Foot ulcers|foot ulcers
726817|NCT00134550|Complication|complication
726818|NCT00134550|Foot Ulcer, Diabetic|foot ulcer, diabetic
726819|NCT00134537|Degenerative Disc Disease of the lumbar spine|degenerative disc disease of the lumbar spine
726820|NCT00134524|Magnetics|magnetics
726821|NCT00134524|Electromagnetics|electromagnetics
726822|NCT00134524|Diabetic neuropathy|diabetic neuropathy
726823|NCT00134524|Pain|pain
726824|NCT00134472|Hypothermia, induced|hypothermia, induced
726825|NCT00134472|Traumatic Brain injuries|traumatic brain injuries
726827|NCT00134472|Neuro-intensive care|neuro-intensive care
726828|NCT00134472|neurochemistry|neurochemistry
726829|NCT00134459|Depression|depression
726830|NCT00134459|Bipolar Disorder|bipolar disorder
726831|NCT00134446|post traumatic stress disorder|post traumatic stress disorder
726832|NCT00134446|PTSD|ptsd
726833|NCT00134446|trauma|trauma
726834|NCT00134446|transcranial magnetic stimulation|transcranial magnetic stimulation
726835|NCT00134446|randomized clinical trial|randomized clinical trial
726836|NCT00134433|Coronary Artery Disease, Diffuse|coronary artery disease, diffuse
726837|NCT00134433|Coronary Artery Disease, Deemed Inoperable|coronary artery disease, deemed inoperable
726838|NCT00134420|Growth Hormone|growth hormone
726839|NCT00134420|Chromosomes, Human, Pair 18|chromosomes, human, pair 18
726840|NCT00134420|Child|child
726841|NCT00134407|Nutrition|nutrition
726842|NCT00134407|Postoperative|postoperative
726843|NCT00134407|oral|oral
726844|NCT00134407|jejunal|jejunal
726845|NCT00134407|feeding|feeding
726846|NCT00134407|Surgery|surgery
726847|NCT00134407|major|major
726848|NCT00134407|abdominal|abdominal
726849|NCT00134407|adult|adult
726850|NCT00134394|psoriasis|psoriasis
726851|NCT00134394|tacrolimus|tacrolimus
726852|NCT00134394|etanercept|etanercept
726853|NCT00134381|Normal volunteer study|normal volunteer study
726854|NCT00134368|vitiligo|vitiligo
726855|NCT00134368|etanercept|etanercept
726856|NCT00134355|antiangiogenesis therapy|antiangiogenesis therapy
726857|NCT00134355|vatalanib|vatalanib
726858|NCT00134342|tuberculosis|tuberculosis
726859|NCT00134342|tuberculin test|tuberculin test
726860|NCT00134342|immunologic tests|immunologic tests
726861|NCT00134342|Latent tuberculosis|latent tuberculosis
726862|NCT00134342|end stage renal disease|end stage renal disease
726863|NCT00134342|solid organ transplantation|solid organ transplantation
726864|NCT00134342|bone marrow transplantation|bone marrow transplantation
726865|NCT00134342|rheumatologic disease|rheumatologic disease
726866|NCT00134316|sexual dysfunction|sexual dysfunction
726867|NCT00134251|Parkinson's disease|parkinson's disease
726868|NCT00134251|adjunctive to L-dopa therapy|adjunctive to l-dopa therapy
726869|NCT00134251|Advanced stage Parkinson's disease|advanced stage parkinson's disease
726870|NCT00134225|Musculoskeletal abnormality|musculoskeletal abnormality
726871|NCT00134225|Musculoskeletal physiology|musculoskeletal physiology
726872|NCT00134225|Musculoskeletal disease|musculoskeletal disease
726873|NCT00134225|Musculoskeletal dysfunction|musculoskeletal dysfunction
726874|NCT00134212|Splanchnic perfusion, hepatic damage, oxidative stress.|splanchnic perfusion, hepatic damage, oxidative stress.
726875|NCT00134186|Kidney cancer|kidney cancer
726876|NCT00134186|Renal cell carcinoma|renal cell carcinoma
726877|NCT00134186|Motexafin gadolinium|motexafin gadolinium
726878|NCT00134160|Aged|aged
726879|NCT00134160|Hypertension|hypertension
726880|NCT00134160|Cardiovascular Diseases|cardiovascular diseases
726881|NCT00134160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
726882|NCT00134160|Calcium Channel Blockers|calcium channel blockers
726883|NCT00134160|Combination Drug Therapy|combination drug therapy
726884|NCT00134160|Diabetes Mellitus Type 2|diabetes mellitus type 2
726885|NCT00134134|hidradenitis suppurativa|hidradenitis suppurativa
726886|NCT00134134|efalizumab|efalizumab
726887|NCT00134134|biologic|biologic
726888|NCT00134134|Raptiva|raptiva
726889|NCT00134095|adenocarcinoma of the stomach|adenocarcinoma of the stomach
726890|NCT00134095|stage II gastric cancer|stage ii gastric cancer
726891|NCT00134095|stage III gastric cancer|stage iii gastric cancer
726892|NCT00134095|stage IV gastric cancer|stage iv gastric cancer
726893|NCT00134082|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
726894|NCT00134056|adenocarcinoma of the prostate|adenocarcinoma of the prostate
726895|NCT00134056|stage IV prostate cancer|stage iv prostate cancer
726896|NCT00134056|recurrent prostate cancer|recurrent prostate cancer
726897|NCT00134056|bone metastases|bone metastases
726898|NCT00134017|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
726899|NCT00134017|refractory anemia with excess blasts|refractory anemia with excess blasts
726900|NCT00134017|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
726901|NCT00134017|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
726902|NCT00134017|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
726903|NCT00134017|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
726904|NCT00134017|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
726905|NCT00134017|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
726906|NCT00134017|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
726907|NCT00134017|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
726908|NCT00134017|secondary acute myeloid leukemia|secondary acute myeloid leukemia
726909|NCT00134017|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
726910|NCT00134017|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
726911|NCT00134017|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
727297|NCT00132847|Adolescent|adolescent
726912|NCT00134017|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
726913|NCT00134017|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
726914|NCT00134017|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
726915|NCT00134017|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
726916|NCT00134017|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
726917|NCT00134017|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
726918|NCT00134017|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
726919|NCT00134017|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
726920|NCT00134017|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
726921|NCT00134017|chronic eosinophilic leukemia|chronic eosinophilic leukemia
726922|NCT00134017|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
726923|NCT00134017|chronic neutrophilic leukemia|chronic neutrophilic leukemia
726924|NCT00134017|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
726925|NCT00134017|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
726926|NCT00134017|stage II multiple myeloma|stage ii multiple myeloma
726927|NCT00134017|stage III multiple myeloma|stage iii multiple myeloma
726928|NCT00134017|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
726929|NCT00134017|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
726930|NCT00134017|splenic marginal zone lymphoma|splenic marginal zone lymphoma
726931|NCT00134017|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
726932|NCT00134017|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
726933|NCT00134017|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
726934|NCT00134017|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
726935|NCT00134017|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
726936|NCT00134017|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
726937|NCT00134017|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
726938|NCT00134017|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
726939|NCT00134017|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
726940|NCT00134017|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
726941|NCT00134017|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
726942|NCT00134017|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
726943|NCT00134017|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
726944|NCT00134017|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
726945|NCT00134017|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
726946|NCT00134017|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
726947|NCT00134017|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
726948|NCT00134017|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
726949|NCT00134017|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
726950|NCT00134017|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
726951|NCT00134017|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
726952|NCT00134017|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
726953|NCT00134017|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
726954|NCT00134017|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
726955|NCT00134017|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
726956|NCT00134017|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
726957|NCT00134017|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
726958|NCT00134017|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
726959|NCT00134017|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
726960|NCT00134017|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
726961|NCT00134017|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
726962|NCT00134017|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
726963|NCT00134017|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
726964|NCT00134017|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
726965|NCT00134017|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
726966|NCT00134017|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
726967|NCT00134017|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
726968|NCT00134017|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
726969|NCT00134017|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
726970|NCT00134017|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
726971|NCT00134017|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
726972|NCT00134017|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
726973|NCT00134017|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
726974|NCT00134017|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
726975|NCT00134017|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
726976|NCT00134017|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
726977|NCT00134017|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
726978|NCT00134017|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
726979|NCT00134017|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
726980|NCT00134017|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
726981|NCT00134017|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
726982|NCT00134017|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
726983|NCT00134017|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
726984|NCT00134017|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
726985|NCT00134017|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
726986|NCT00134017|refractory multiple myeloma|refractory multiple myeloma
726987|NCT00134017|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
726988|NCT00134017|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
726989|NCT00134017|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
726990|NCT00134004|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
726991|NCT00134004|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
726992|NCT00134004|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
726993|NCT00134004|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
726994|NCT00134004|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
726995|NCT00134004|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
726996|NCT00134004|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
726997|NCT00134004|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
726998|NCT00134004|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
726999|NCT00134004|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
727000|NCT00134004|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
727001|NCT00134004|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
727002|NCT00134004|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
727003|NCT00134004|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
727004|NCT00134004|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
727005|NCT00134004|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
727006|NCT00134004|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
727007|NCT00134004|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
727008|NCT00134004|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
727009|NCT00134004|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
727010|NCT00134004|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
727011|NCT00134004|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
727012|NCT00134004|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
727013|NCT00134004|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
727014|NCT00134004|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
727015|NCT00134004|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
727016|NCT00134004|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
727017|NCT00134004|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
727018|NCT00134004|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
727019|NCT00134004|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
727020|NCT00134004|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
727021|NCT00134004|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
727022|NCT00134004|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
727023|NCT00134004|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
727024|NCT00134004|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
727025|NCT00134004|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
727026|NCT00134004|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
727027|NCT00134004|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
727028|NCT00134004|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
727029|NCT00134004|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
727030|NCT00134004|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
727031|NCT00134004|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
727032|NCT00134004|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
727033|NCT00134004|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
727034|NCT00134004|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
727035|NCT00134004|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
727036|NCT00134004|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
727037|NCT00134004|refractory multiple myeloma|refractory multiple myeloma
727038|NCT00134004|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
727039|NCT00134004|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
727040|NCT00134004|splenic marginal zone lymphoma|splenic marginal zone lymphoma
727041|NCT00134004|stage I multiple myeloma|stage i multiple myeloma
727042|NCT00134004|stage II multiple myeloma|stage ii multiple myeloma
727043|NCT00134004|stage III multiple myeloma|stage iii multiple myeloma
727044|NCT00134004|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
727045|NCT00134004|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
727046|NCT00134004|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
727047|NCT00134004|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
727048|NCT00134004|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
727049|NCT00134004|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
727050|NCT00134004|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
727051|NCT00134004|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
727052|NCT00134004|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
727053|NCT00134004|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
727054|NCT00134004|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
727055|NCT00134004|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
727056|NCT00134004|polycythemia vera|polycythemia vera
727057|NCT00134004|essential thrombocythemia|essential thrombocythemia
727058|NCT00134004|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
727059|NCT00134004|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
727060|NCT00134004|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
727061|NCT00134004|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
727062|NCT00134004|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
727063|NCT00134004|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
727064|NCT00134004|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
727065|NCT00134004|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
727066|NCT00134004|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
727067|NCT00134004|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
727068|NCT00134004|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
727069|NCT00134004|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
727070|NCT00134004|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
727071|NCT00134004|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
727072|NCT00134004|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
727073|NCT00133991|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
727074|NCT00133991|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
727075|NCT00133991|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
727076|NCT00133991|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
727077|NCT00133991|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
727078|NCT00133991|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
727079|NCT00133991|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
727080|NCT00133978|randomized trial|randomized trial
727081|NCT00133978|antioxidants|antioxidants
727082|NCT00133978|glutamine|glutamine
727083|NCT00133978|organ failure|organ failure
727084|NCT00133965|Advanced Cancer|advanced cancer
727085|NCT00133965|Dignity Care|dignity care
727086|NCT00133965|Supportive Care|supportive care
727087|NCT00133965|Quality of Life|quality of life
727088|NCT00133965|Psychotherapy|psychotherapy
727089|NCT00133965|Palliative Care|palliative care
727090|NCT00133939|Proportional assisted ventilation|proportional assisted ventilation
727091|NCT00133939|Pressure support ventilation|pressure support ventilation
727092|NCT00133939|Synchronism during mechanical ventilation|synchronism during mechanical ventilation
727093|NCT00133939|Patients undergoing partial mechanical ventilation|patients undergoing partial mechanical ventilation
727094|NCT00133926|Periodontal disease|periodontal disease
727095|NCT00133926|Pregnancy|pregnancy
727096|NCT00133926|Pre-term birth|pre-term birth
727097|NCT00133926|Fetal growth|fetal growth
727098|NCT00133926|Pre-eclampsia|pre-eclampsia
727099|NCT00133926|Infant, Low Birth Weight|infant, low birth weight
727100|NCT00133913|metastatic colorectal cancer|metastatic colorectal cancer
727101|NCT00133900|hormone refractory prostate cancer|hormone refractory prostate cancer
727102|NCT00133887|Squamous cell carcinoma|squamous cell carcinoma
727103|NCT00133887|kidney transplant recipients|kidney transplant recipients
727104|NCT00133887|rapamycin|rapamycin
727105|NCT00133887|Skin cancers in kidney transplant recipients|skin cancers in kidney transplant recipients
727106|NCT00133874|topical antibacterial|topical antibacterial
727107|NCT00133874|topical antibiotic|topical antibiotic
727108|NCT00133874|impetigo|impetigo
727109|NCT00133861|cerebral palsy children|cerebral palsy children
727110|NCT00133861|Botulinum toxin|botulinum toxin
727111|NCT00133848|impetigo|impetigo
727112|NCT00133848|topical antibacterial|topical antibacterial
727113|NCT00133848|topical antibiotic|topical antibiotic
727114|NCT00133835|Randomized controlled trial|randomized controlled trial
727115|NCT00133835|Lithotripsy|lithotripsy
727116|NCT00133835|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
727117|NCT00133835|Abdominal pain|abdominal pain
727118|NCT00133822|Post-Traumatic Stress Disorder|post-traumatic stress disorder
727119|NCT00133822|Sertraline|sertraline
727120|NCT00133822|Risperidone|risperidone
727121|NCT00133809|Type 1 Diabetes|type 1 diabetes
727122|NCT00133809|Islet Transplantation|islet transplantation
727123|NCT00133809|Immunology|immunology
727124|NCT00133796|Breast Cancer|breast cancer
727125|NCT00133796|Advanced Breast Cancer|advanced breast cancer
727126|NCT00133783|Intermedin|intermedin
727127|NCT00133783|estradiol|estradiol
727128|NCT00133783|female hypertension|female hypertension
727129|NCT00133783|Premenopausal and postmenopausal women|premenopausal and postmenopausal women
727130|NCT00133783|Surgically-induced menopause women|surgically-induced menopause women
727131|NCT00133783|IVF treatment patients|ivf treatment patients
727132|NCT00133770|IV pantoprazole|iv pantoprazole
727133|NCT00133770|Esophagitis|esophagitis
727134|NCT00133757|Tobacco|tobacco
727135|NCT00133757|Nicotine|nicotine
727136|NCT00133757|Bupropion|bupropion
727137|NCT00133757|Cue-reactivity|cue-reactivity
727138|NCT00133757|Craving|craving
727139|NCT00133744|pregnancy|pregnancy
727140|NCT00133744|vitamins|vitamins
727141|NCT00133744|minerals|minerals
727142|NCT00133744|supplements|supplements
727143|NCT00133744|mortality|mortality
727144|NCT00133744|prenatal|prenatal
727145|NCT00133744|perinatal|perinatal
727146|NCT00133744|anemia|anemia
727147|NCT00133744|birthweight|birthweight
727148|NCT00133744|preterm|preterm
727149|NCT00133744|iron|iron
727150|NCT00133744|micronutrients|micronutrients
727151|NCT00133744|Stillbirths|stillbirths
727152|NCT00133744|Early neonatal deaths|early neonatal deaths
727153|NCT00133718|Type 2 diabetes mellitus|type 2 diabetes mellitus
727154|NCT00133718|Cardiovascular|cardiovascular
727155|NCT00133718|Coronary artery disease|coronary artery disease
727156|NCT00133718|Glycemic control|glycemic control
727157|NCT00133718|Treatment|treatment
727158|NCT00133718|Diabetes Mellitus|diabetes mellitus
727159|NCT00133705|A benign tumor derived from smooth uterine muscle tissue.|a benign tumor derived from smooth uterine muscle tissue.
727160|NCT00133692|Hypertension|hypertension
727161|NCT00133692|Coronary Artery Disease|coronary artery disease
727162|NCT00133692|INVEST|invest
727163|NCT00133692|Diabetes|diabetes
727164|NCT00133692|Verapamil SR|verapamil sr
727165|NCT00133692|Trandolapril|trandolapril
727166|NCT00133692|Atenolol|atenolol
727167|NCT00133692|HCTZ|hctz
727168|NCT00133679|Chronic lung disease|chronic lung disease
727169|NCT00133679|Nitric oxide|nitric oxide
727170|NCT00133679|cyclic guanosine monophosphate|cyclic guanosine monophosphate
727171|NCT00133679|phosphodiesterase inhibitor|phosphodiesterase inhibitor
727172|NCT00133653|Hypertension; Job Strain; Marital Strain; Blood Pressure|hypertension; job strain; marital strain; blood pressure
727173|NCT00133640|Vitamin D|vitamin d
727174|NCT00133640|Elderly|elderly
727175|NCT00133640|Hip fracture|hip fracture
727176|NCT00133640|Falls|falls
727177|NCT00133640|Physical Therapy|physical therapy
727178|NCT00133640|Disability|disability
727179|NCT00133627|Allergic|allergic
727180|NCT00133627|Conjunctivitis|conjunctivitis
727181|NCT00133627|Ketotifen|ketotifen
727182|NCT00133627|Histamine|histamine
727183|NCT00133588|influenza, vaccine, proteomic profiling, elderly|influenza, vaccine, proteomic profiling, elderly
727184|NCT00133575|MVA, smallpox, Acambis|mva, smallpox, acambis
727185|NCT00133562|Malnutrition, pediatric, Brazil, alanyl-glutamine|malnutrition, pediatric, brazil, alanyl-glutamine
727186|NCT00133549|pneumococcal vaccine, 23-valent polysaccharide vaccine, elderly|pneumococcal vaccine, 23-valent polysaccharide vaccine, elderly
727187|NCT00133536|H5N1, Influenza, children|h5n1, influenza, children
727188|NCT00133523|FLU-VACS, influenza, vaccine|flu-vacs, influenza, vaccine
727189|NCT00133510|children, immunocompromised, influenza, liver transplant|children, immunocompromised, influenza, liver transplant
727190|NCT00133497|cytomegalovirus, vaccine, women, children, parent protocol|cytomegalovirus, vaccine, women, children, parent protocol
727191|NCT00133484|Anthrax, rPA|anthrax, rpa
727192|NCT00133471|Influenza, vaccine, A/H9N2, MF59, adjuvant|influenza, vaccine, a/h9n2, mf59, adjuvant
727193|NCT00133458|Albenza, Subarachnoid cysticercosis|albenza, subarachnoid cysticercosis
727194|NCT00133445|Pentavalent vaccine, Pediarix, DTaP-Hep B-IPV vaccine|pentavalent vaccine, pediarix, dtap-hep b-ipv vaccine
727316|NCT00132704|Central nervous system gliomas|central nervous system gliomas
727195|NCT00133432|Pneumonia, acute respiratory infections, zinc, Tanzania, children, infants, hospitalization|pneumonia, acute respiratory infections, zinc, tanzania, children, infants, hospitalization
727196|NCT00133419|micronutrient, supplementation, Africa, children, HIV|micronutrient, supplementation, africa, children, hiv
727197|NCT00133406|Brazil, Child Nutrition Disorders, Deficiency Diseases|brazil, child nutrition disorders, deficiency diseases
727198|NCT00133367|Hematologic malignancy|hematologic malignancy
727199|NCT00133367|Cord blood transfusion|cord blood transfusion
727200|NCT00133367|Graft versus host disease|graft versus host disease
727201|NCT00133367|tacrolimus|tacrolimus
727202|NCT00133367|sirolimus|sirolimus
727203|NCT00133354|Puberty|puberty
727204|NCT00133354|Growth hormone deficiency|growth hormone deficiency
727205|NCT00133354|aromatase inhibitors|aromatase inhibitors
727206|NCT00133354|estrogen|estrogen
727207|NCT00133354|bone mineral density|bone mineral density
727208|NCT00133354|short stature|short stature
727209|NCT00133341|Allergic contact dermatitis,patch testing, dilution series|allergic contact dermatitis,patch testing, dilution series
727210|NCT00133328|stroke|stroke
727211|NCT00133328|myocardial infarction|myocardial infarction
727212|NCT00133328|angina|angina
727213|NCT00133328|renal damage|renal damage
727214|NCT00133302|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
727215|NCT00133302|intermediate-grade lymphoma|intermediate-grade lymphoma
727216|NCT00133302|high-grade lymphoma|high-grade lymphoma
727217|NCT00133302|CHOP protocol|chop protocol
727218|NCT00133302|granulocyte-colony stimulating factor|granulocyte-colony stimulating factor
727219|NCT00133276|Hepatitis C|hepatitis c
727220|NCT00133276|Peg-interferon|peg-interferon
727221|NCT00133276|Psychiatric side-effects|psychiatric side-effects
727222|NCT00133263|Randomized controlled trial|randomized controlled trial
727223|NCT00133263|Primary Care|primary care
727224|NCT00133224|Advanced Prostate Cancer|advanced prostate cancer
727225|NCT00133224|HRPC|hrpc
727226|NCT00133224|Prostate|prostate
727227|NCT00133224|Cancer|cancer
727228|NCT00133224|Metastatic|metastatic
727229|NCT00133224|Hormone-refractory|hormone-refractory
727230|NCT00133224|GVAX|gvax
727231|NCT00133224|Chemotherapy|chemotherapy
727232|NCT00133224|Taxotere|taxotere
727233|NCT00133224|Docetaxel|docetaxel
727234|NCT00133224|Prednisone|prednisone
727235|NCT00133224|Vaccine|vaccine
727236|NCT00133224|Allogeneic cells|allogeneic cells
727237|NCT00133211|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
727238|NCT00133211|Heart arrhythmia|heart arrhythmia
727239|NCT00133211|Ablation|ablation
727240|NCT00133211|Drug treatment|drug treatment
727241|NCT00133172|Treatment Efficacy|treatment efficacy
727242|NCT00133172|Treatment Effectiveness|treatment effectiveness
727243|NCT00133172|Anti-rejection therapy|anti-rejection therapy
727244|NCT00133172|Immunosuppression|immunosuppression
727245|NCT00133172|Antirejection|antirejection
727246|NCT00133172|Renal Transplantation|renal transplantation
727247|NCT00133172|Transplantation, Renal|transplantation, renal
727248|NCT00133172|Transplantation, Kidney|transplantation, kidney
727249|NCT00133172|Grafting, Kidney|grafting, kidney
727250|NCT00133159|Allergy|allergy
727251|NCT00133159|Specific Immunotherapy|specific immunotherapy
727252|NCT00133146|Allergy|allergy
727253|NCT00133146|Specific Immunotherapy|specific immunotherapy
727254|NCT00133133|Postoperative pain|postoperative pain
727255|NCT00133133|Open cholecystectomy|open cholecystectomy
727256|NCT00133133|Capsaicin|capsaicin
727257|NCT00133094|Hypercholesterolemia|hypercholesterolemia
727258|NCT00133094|Decision Support Systems, Clinical|decision support systems, clinical
727259|NCT00133081|epilepsy|epilepsy
727260|NCT00133081|antiepileptic drugs|antiepileptic drugs
727261|NCT00133081|side effects|side effects
727262|NCT00133081|quality of life|quality of life
727263|NCT00133068|High Blood Pressure|high blood pressure
727264|NCT00133068|Health Behaviors|health behaviors
727265|NCT00133068|Patient Compliance|patient compliance
727266|NCT00133055|parenting|parenting
727267|NCT00133055|sleep problems|sleep problems
727268|NCT00133055|behavior problems|behavior problems
727269|NCT00133055|brief intervention|brief intervention
727270|NCT00133055|self-help|self-help
727271|NCT00133055|preschool-age children|preschool-age children
727272|NCT00133055|psychosocial|psychosocial
727273|NCT00133042|anti-IgE, omalizumab|anti-ige, omalizumab
727274|NCT00133016|Induction of labor|induction of labor
727275|NCT00132990|Cervical dystonia|cervical dystonia
727276|NCT00132990|Deep brain stimulation|deep brain stimulation
727277|NCT00132977|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
727278|NCT00132977|Heart Failure|heart failure
727279|NCT00132977|Mechanical Dyssynchrony|mechanical dyssynchrony
727280|NCT00132964|pediatric|pediatric
727281|NCT00132964|ankle fractures|ankle fractures
727282|NCT00132964|randomized controlled trial|randomized controlled trial
727283|NCT00132964|management|management
727284|NCT00132925|allergic rhinitis|allergic rhinitis
727285|NCT00132912|Platelets|platelets
727286|NCT00132912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
727287|NCT00132912|Protease-Activated Receptor 1|protease-activated receptor 1
727288|NCT00132912|Hemorrhage|hemorrhage
727289|NCT00132899|Crohn's Disease|crohn's disease
727290|NCT00132899|multi-centre randomized placebo-controlled|multi-centre randomized placebo-controlled
727291|NCT00132899|infliximab|infliximab
727292|NCT00132899|methotrexate|methotrexate
727293|NCT00132899|inflammatory bowel disease|inflammatory bowel disease
727294|NCT00132873|Narcolepsy|narcolepsy
727295|NCT00132873|Cataplexy|cataplexy
727298|NCT00132847|Urban Health|urban health
727299|NCT00132821|Nicotine dependence|nicotine dependence
727300|NCT00132821|Sleep disorders|sleep disorders
727301|NCT00132821|smoking cessation|smoking cessation
727302|NCT00132821|Relapse|relapse
727303|NCT00132808|Postmenopausal osteoporosis|postmenopausal osteoporosis
727304|NCT00132808|osteopenia|osteopenia
727305|NCT00132808|zoledronic acid|zoledronic acid
727306|NCT00132808|Osteopenia (osteoporosis prevention)|osteopenia (osteoporosis prevention)
727307|NCT00132795|Cognitive Therapy|cognitive therapy
727308|NCT00132795|Recurrence|recurrence
727309|NCT00132795|Prevention|prevention
727310|NCT00132795|Educational Technology|educational technology
727311|NCT00132756|Hormone Refractory|hormone refractory
727312|NCT00132756|Taxane Refractory|taxane refractory
727313|NCT00132704|Lung cancer metastases to the CNS (adenocarcinomas)|lung cancer metastases to the cns (adenocarcinomas)
727314|NCT00132704|Melanoma metastases to the CNS|melanoma metastases to the cns
727315|NCT00132704|Breast cancer metastases to the CNS (ductal carcinomas)|breast cancer metastases to the cns (ductal carcinomas)
727317|NCT00132704|Colorectal cancers (adenocarcinomas)|colorectal cancers (adenocarcinomas)
727318|NCT00132704|Ovarian cancers (papillary serous carcinomas)|ovarian cancers (papillary serous carcinomas)
727319|NCT00132704|Endometrial cancers (endometrioid carcinomas)|endometrial cancers (endometrioid carcinomas)
727320|NCT00132704|Cervical cancers (squamous cell carcinomas)|cervical cancers (squamous cell carcinomas)
727321|NCT00132704|Sarcomas (liposarcomas and leiomyosarcomas)|sarcomas (liposarcomas and leiomyosarcomas)
727322|NCT00132704|Thoracic mesotheliomas|thoracic mesotheliomas
727323|NCT00132704|Colorectal cancers metastatic to the liver|colorectal cancers metastatic to the liver
727324|NCT00132704|Primary adenocarcinomas of the lung|primary adenocarcinomas of the lung
727325|NCT00132704|Primary squamous cell carcinomas of the lung|primary squamous cell carcinomas of the lung
727326|NCT00132704|Pancreatic Cancers-adenocarcinoma|pancreatic cancers-adenocarcinoma
727327|NCT00132691|uveitis|uveitis
727328|NCT00132691|non-infectious intermediate uveitis|non-infectious intermediate uveitis
727329|NCT00132691|non-infectious posterior uveitis|non-infectious posterior uveitis
727330|NCT00132691|non-infectious panuveitis|non-infectious panuveitis
727331|NCT00132678|Mood episodes|mood episodes
727332|NCT00132678|Bipolar 1 disorder|bipolar 1 disorder
727333|NCT00132678|Intramuscular Injectable|intramuscular injectable
727334|NCT00132678|risperidone|risperidone
727335|NCT00132678|safety and efficacy|safety and efficacy
727336|NCT00132665|non-small cell lung cancer|non-small cell lung cancer
727337|NCT00132665|elderly patients|elderly patients
727338|NCT00132665|carboplatin|carboplatin
727339|NCT00132665|chemoradiotherapy|chemoradiotherapy
727340|NCT00132639|pulmonary neoplasm|pulmonary neoplasm
727341|NCT00132639|preoperative chemotherapy|preoperative chemotherapy
727342|NCT00132639|cisplatin, docetaxel|cisplatin, docetaxel
727343|NCT00132639|randomized trial|randomized trial
727344|NCT00132639|clinical stage IB or II nonsmall cell lung cancer|clinical stage ib or ii nonsmall cell lung cancer
727345|NCT00132626|parkinson|parkinson
727346|NCT00132626|diagnosis|diagnosis
727347|NCT00132613|pulmonary neoplasm|pulmonary neoplasm
727348|NCT00132613|malignant pericardial effusion|malignant pericardial effusion
727349|NCT00132613|pericardial drainage|pericardial drainage
727350|NCT00132613|randomized trial|randomized trial
727351|NCT00132613|bleomycin|bleomycin
727352|NCT00132613|intrapericardial instillation|intrapericardial instillation
727353|NCT00132600|Allergic contact dermatitis|allergic contact dermatitis
727354|NCT00132600|Patch testing|patch testing
727355|NCT00132600|bacitracin|bacitracin
727356|NCT00132587|Knee arthroplasty|knee arthroplasty
727357|NCT00132587|Femoral loosening|femoral loosening
727358|NCT00132587|Total Knee Arthroplasty|total knee arthroplasty
727359|NCT00132574|acne, dairy|acne, dairy
727360|NCT00132548|Malaria|malaria
727361|NCT00132548|Children|children
727362|NCT00132548|Intermittent preventive treatment|intermittent preventive treatment
727363|NCT00132548|Senegal|senegal
727364|NCT00132535|Malaria in pregnancy|malaria in pregnancy
727365|NCT00132535|IPT|ipt
727366|NCT00132535|Sulphadoxine-pyrimethamine|sulphadoxine-pyrimethamine
727367|NCT00132535|Chloroquine|chloroquine
727368|NCT00132535|HIV|hiv
727369|NCT00132535|Viral load|viral load
727370|NCT00132535|birth weight|birth weight
727371|NCT00132535|anaemia|anaemia
727372|NCT00132522|EpCAM|epcam
727373|NCT00132522|monoclonal-antibody|monoclonal-antibody
727374|NCT00132522|targeted therapy|targeted therapy
727375|NCT00132522|colorectal|colorectal
727376|NCT00132522|prostate|prostate
727377|NCT00132522|non-small cell lung cancer|non-small cell lung cancer
727378|NCT00132522|ovarian|ovarian
727379|NCT00132522|solid tumor|solid tumor
727380|NCT00132509|rt-PA|rt-pa
727381|NCT00132509|thrombolysis|thrombolysis
727382|NCT00132509|Acute ischemic stroke|acute ischemic stroke
727383|NCT00132496|GERD|gerd
727384|NCT00132483|Physical activity|physical activity
727385|NCT00132483|cerebral infarct|cerebral infarct
727386|NCT00132457|Chlamydia|chlamydia
727387|NCT00132457|screening|screening
727388|NCT00132457|Sexually transmitted disease|sexually transmitted disease
727389|NCT00132444|HIV|hiv
727390|NCT00132444|topical microbicides|topical microbicides
727391|NCT00132431|calcimimetic|calcimimetic
727392|NCT00132431|cinacalcet|cinacalcet
727393|NCT00132431|hemodialysis|hemodialysis
727394|NCT00132431|secondary hyperparathyroidism|secondary hyperparathyroidism
727395|NCT00132431|chronic kidney disease|chronic kidney disease
727396|NCT00132418|rheumatoid arthritis and at least 1 qualifying comorbid condition (diabetes, chronic pulmonary disease, recent infection)|rheumatoid arthritis and at least 1 qualifying comorbid condition (diabetes, chronic pulmonary disease, recent infection)
727397|NCT00132418|RA|ra
727398|NCT00132418|rheumatoid arthritis|rheumatoid arthritis
727399|NCT00132405|Needlestick pain|needlestick pain
727400|NCT00132405|Venipuncture pain|venipuncture pain
727401|NCT00132405|Procedural pain|procedural pain
727402|NCT00132392|Arthroplasty|arthroplasty
727403|NCT00132392|Total knee arthroplasty|total knee arthroplasty
727404|NCT00132392|Capsaicin|capsaicin
727405|NCT00132392|Pain|pain
727406|NCT00132392|Analgesia|analgesia
727407|NCT00132366|Neurotransmission|neurotransmission
727408|NCT00132366|Cortical Excitability|cortical excitability
727409|NCT00132366|GABA|gaba
727410|NCT00132366|Seizures|seizures
727411|NCT00132366|Succinic Semialdehyde Dehydrogenase Deficiency|succinic semialdehyde dehydrogenase deficiency
727412|NCT00132366|SSADH|ssadh
727413|NCT00132366|Healthy Volunteer|healthy volunteer
727414|NCT00132366|HV|hv
727415|NCT00132353|Magnetic Stimulation|magnetic stimulation
727416|NCT00132353|Single Fiber EMG|single fiber emg
727417|NCT00132353|Ultrasonography|ultrasonography
727418|NCT00132353|Quantitative Sensory Testing|quantitative sensory testing
727419|NCT00132353|Near-nerve recording|near-nerve recording
727420|NCT00132353|Neurological Disorders|neurological disorders
727421|NCT00132353|Neuromuscular Transmission Disorders|neuromuscular transmission disorders
727422|NCT00132353|Central Demyelinating Disorders|central demyelinating disorders
727423|NCT00132353|Myelopathy|myelopathy
727424|NCT00132353|Motor Neuron Disease|motor neuron disease
727425|NCT00132353|Movement Disorders|movement disorders
727426|NCT00132353|Healthy Volunteer|healthy volunteer
727427|NCT00132340|Spasmodic Torticollis|spasmodic torticollis
727428|NCT00132340|Treatment|treatment
727429|NCT00132340|Physiology|physiology
727430|NCT00132340|Surgery|surgery
727431|NCT00132340|Cervical Dystonia|cervical dystonia
727432|NCT00132327|Lyme Disease|lyme disease
727433|NCT00132327|Borrelia Burgdorferi|borrelia burgdorferi
727434|NCT00132327|Inflammation|inflammation
727435|NCT00132327|Skin|skin
727436|NCT00132327|Host Response|host response
727437|NCT00132327|Erythema Migrans Rash|erythema migrans rash
727438|NCT00132327|Healthy Volunteer|healthy volunteer
727440|NCT00132301|multi-site clinical trial|multi-site clinical trial
727441|NCT00132301|prostate|prostate
727442|NCT00132301|radical prostatectomy|radical prostatectomy
727443|NCT00132301|randomized|randomized
727444|NCT00132288|Aging|aging
727445|NCT00132288|Frailty|frailty
727446|NCT00132288|Sedentary|sedentary
727447|NCT00132288|Falls|falls
727448|NCT00132288|Physical Activity|physical activity
727449|NCT00132275|bacterial|bacterial
727450|NCT00132275|sinusitis|sinusitis
727451|NCT00132275|treatment|treatment
727452|NCT00132275|diagnosis|diagnosis
727453|NCT00132275|guideline|guideline
727454|NCT00132275|acute bacterial sinusitis|acute bacterial sinusitis
727455|NCT00132262|Screening and Brief Intervention|screening and brief intervention
727456|NCT00132262|Ethnic Differences|ethnic differences
727457|NCT00132262|Trauma Center|trauma center
727458|NCT00132249|Traumatic Brain Injury|traumatic brain injury
727459|NCT00132249|Penetrating head wound|penetrating head wound
727460|NCT00132249|Closed head trauma|closed head trauma
727461|NCT00132249|Vietnam Veteran|vietnam veteran
727462|NCT00132236|smoking cessation|smoking cessation
727463|NCT00132236|nicotine sublingual tablets|nicotine sublingual tablets
727464|NCT00132236|behaviour support|behaviour support
727465|NCT00132236|smoking reduction|smoking reduction
727466|NCT00132236|quality of life|quality of life
727467|NCT00132236|COPD|copd
727468|NCT00132236|weight|weight
727469|NCT00132223|magnetic imaging|magnetic imaging
727470|NCT00132223|angiography|angiography
727471|NCT00132223|contrast agent|contrast agent
727472|NCT00132223|signal/noise ratio|signal/noise ratio
727473|NCT00132223|contrast/noise ratio|contrast/noise ratio
727474|NCT00132223|vessel|vessel
727475|NCT00132210|acute hepatitis C|acute hepatitis c
727476|NCT00132210|HIV|hiv
727477|NCT00132210|pegylated interferon|pegylated interferon
727478|NCT00132197|Functional somatic symptoms|functional somatic symptoms
727479|NCT00132197|Cognitive behavioral therapy|cognitive behavioral therapy
727480|NCT00132197|somatization disorder|somatization disorder
727481|NCT00132197|SF-36|sf-36
727482|NCT00132197|cost-effectiveness|cost-effectiveness
727483|NCT00132197|Medically unexplained symptoms|medically unexplained symptoms
727484|NCT00132184|Vitamin D|vitamin d
727485|NCT00132184|Crohns Disease|crohns disease
727486|NCT00132171|Helicobacter pylori|helicobacter pylori
727487|NCT00132171|Eradication|eradication
727488|NCT00132171|Sequential therapy|sequential therapy
727489|NCT00132171|Standard therapy|standard therapy
727490|NCT00132145|Vascular diseases|vascular diseases
727491|NCT00132145|Computerized decision support systems|computerized decision support systems
727492|NCT00132145|Shared care|shared care
727493|NCT00132145|Patient motivation|patient motivation
727494|NCT00132145|Quality of care|quality of care
727495|NCT00132132|BMI|bmi
727496|NCT00132132|obesity|obesity
727497|NCT00132132|behavioral intervention|behavioral intervention
727498|NCT00132132|longterm randomized controlled trial|longterm randomized controlled trial
727499|NCT00132132|exercise|exercise
727500|NCT00132132|empowerment|empowerment
727501|NCT00132132|nutrition|nutrition
727502|NCT00132093|Left ventricular remodelling|left ventricular remodelling
727503|NCT00132093|Acute myocardial infarction|acute myocardial infarction
727504|NCT00132093|Left ventricular dysfunction|left ventricular dysfunction
727505|NCT00132093|Eplerenone|eplerenone
727506|NCT00132093|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
727507|NCT00132054|extensive stage small cell lung cancer|extensive stage small cell lung cancer
727508|NCT00132054|recurrent small cell lung cancer|recurrent small cell lung cancer
727509|NCT00132041|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
727510|NCT00132041|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
727511|NCT00132015|Waldenström macroglobulinemia|waldenström macroglobulinemia
727512|NCT00132015|multicentric Castleman disease|multicentric castleman disease
727513|NCT00132015|unicentric Castleman disease|unicentric castleman disease
727514|NCT00132015|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
727515|NCT00132015|polycythemia vera|polycythemia vera
727516|NCT00132015|essential thrombocythemia|essential thrombocythemia
727517|NCT00132015|hairy cell leukemia|hairy cell leukemia
727518|NCT00132015|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
727519|NCT00132015|adult Burkitt lymphoma|adult burkitt lymphoma
727520|NCT00132015|adult diffuse large cell lymphoma|adult diffuse large cell lymphoma
727521|NCT00132015|adult diffuse mixed cell lymphoma|adult diffuse mixed cell lymphoma
727522|NCT00132015|adult diffuse small cleaved cell lymphoma|adult diffuse small cleaved cell lymphoma
727523|NCT00132015|adult immunoblastic large cell lymphoma|adult immunoblastic large cell lymphoma
727524|NCT00132015|adult lymphoblastic lymphoma|adult lymphoblastic lymphoma
727525|NCT00132015|grade 1 follicular lymphoma|grade 1 follicular lymphoma
727526|NCT00132015|grade 2 follicular lymphoma|grade 2 follicular lymphoma
727527|NCT00132015|grade 3 follicular lymphoma|grade 3 follicular lymphoma
727528|NCT00132015|mantle cell lymphoma|mantle cell lymphoma
727529|NCT00132015|marginal zone lymphoma|marginal zone lymphoma
727530|NCT00132015|small lymphocytic lymphoma|small lymphocytic lymphoma
727531|NCT00132015|precancerous condition|precancerous condition
727532|NCT00131963|stage One A (IA) breast cancer|stage one a (ia) breast cancer
727533|NCT00131963|stage Two (II) breast cancer|stage two (ii) breast cancer
727534|NCT00131963|stage Three A (IIIA) breast cancer|stage three a (iiia) breast cancer
727535|NCT00131963|stage Three B(IIIB) breast cancer|stage three b(iiib) breast cancer
727536|NCT00131963|stage Three C(IIIC) breast cancer|stage three c(iiic) breast cancer
727537|NCT00131963|stage One B (IB) breast cancer|stage one b (ib) breast cancer
727538|NCT00131950|breast cancer|breast cancer
727539|NCT00131924|recurrent breast cancer|recurrent breast cancer
727540|NCT00131924|stage IV breast cancer|stage iv breast cancer
727541|NCT00131898|IMRT+Surgery versus Surgery For Sarcoma|imrt+surgery versus surgery for sarcoma
727542|NCT00131885|Menstruation|menstruation
727543|NCT00131885|Complementary Therapies|complementary therapies
727544|NCT00131885|Pharmacokinetics|pharmacokinetics
727545|NCT00131885|Hypericum|hypericum
727546|NCT00131885|St. John's wort|st. john's wort
727547|NCT00131885|Levonorgestrel|levonorgestrel
727548|NCT00131885|Women|women
727549|NCT00131872|vascular access graft|vascular access graft
727550|NCT00131872|hemodialysis|hemodialysis
727551|NCT00131872|dialysis|dialysis
727552|NCT00131872|end stage renal disease|end stage renal disease
727553|NCT00131859|Perinatal brain injury|perinatal brain injury
727554|NCT00131859|Diffusion-tensor imaging|diffusion-tensor imaging
727555|NCT00131846|Thiazide diuretics|thiazide diuretics
727556|NCT00131846|Essential hypertension|essential hypertension
727557|NCT00131846|Type 2 diabetes|type 2 diabetes
727558|NCT00131846|Randomized clinical trial|randomized clinical trial
727559|NCT00131846|Cost-effectiveness|cost-effectiveness
727560|NCT00131833|salmonella|salmonella
727561|NCT00131833|typhoid vaccine|typhoid vaccine
727562|NCT00131833|enteric fever|enteric fever
727563|NCT00131820|Salmonella|salmonella
727564|NCT00131820|typhoid vaccine|typhoid vaccine
727565|NCT00131820|enteric fever|enteric fever
727566|NCT00131820|socioeconomic costs|socioeconomic costs
727567|NCT00131807|Blood Pressure|blood pressure
727568|NCT00131807|HIV|hiv
727569|NCT00131807|Antiretroviral therapy|antiretroviral therapy
727570|NCT00131794|Malaria|malaria
727571|NCT00131794|BCG vaccine|bcg vaccine
727572|NCT00131794|Guinea Bissau|guinea bissau
727573|NCT00131781|Borderline personality disorder|borderline personality disorder
727574|NCT00131781|Controlled trials|controlled trials
727575|NCT00131781|Cognitive Therapy|cognitive therapy
727576|NCT00131781|Supportive Therapy|supportive therapy
727577|NCT00131781|suicide|suicide
727579|NCT00131768|osteoarthritis of the ankle|osteoarthritis of the ankle
727580|NCT00131768|musculoskeletal|musculoskeletal
727581|NCT00131755|type 1 diabetes|type 1 diabetes
727582|NCT00131755|beta cell rest|beta cell rest
727583|NCT00131755|diazoxide|diazoxide
727584|NCT00131755|insulin secretion|insulin secretion
727585|NCT00131729|Amblyopia|amblyopia
727586|NCT00131729|Occlusion therapy|occlusion therapy
727587|NCT00131729|Compliance|compliance
727588|NCT00131729|Risk factors|risk factors
727589|NCT00131716|prevention|prevention
727590|NCT00131716|recurrence|recurrence
727591|NCT00131716|severe|severe
727592|NCT00131716|anaemia|anaemia
727593|NCT00131703|Screening|screening
727594|NCT00131703|Treatment|treatment
727595|NCT00131703|Amodiaquine|amodiaquine
727596|NCT00131703|Sulphadoxine-pyrimethamine|sulphadoxine-pyrimethamine
727597|NCT00131703|Malaria in pregnancy|malaria in pregnancy
727598|NCT00131690|Caffeine|caffeine
727599|NCT00131690|Coffee|coffee
727600|NCT00131690|Randomized|randomized
727601|NCT00131690|Birth weight|birth weight
727602|NCT00131651|renal|renal
727603|NCT00131651|cancer|cancer
727604|NCT00131651|advanced|advanced
727605|NCT00131651|unresectable|unresectable
727606|NCT00131651|metastatic|metastatic
727607|NCT00131651|recurrent|recurrent
727608|NCT00131651|anti-angiogenic|anti-angiogenic
727609|NCT00131651|targeted|targeted
727610|NCT00131651|ATN-161|atn-161
727611|NCT00131651|Recurrent renal cell cancer|recurrent renal cell cancer
727612|NCT00131651|Renal clear cell carcinoma|renal clear cell carcinoma
727613|NCT00131651|Advanced Renal Cell Cancer|advanced renal cell cancer
727614|NCT00131638|Oncology|oncology
727615|NCT00131638|KGF|kgf
727616|NCT00131638|Palifermin|palifermin
727617|NCT00131638|Oral mucositis|oral mucositis
727618|NCT00131638|Clinical Trial|clinical trial
727619|NCT00131638|Amgen|amgen
727620|NCT00131638|head and neck|head and neck
727621|NCT00131625|Exclusive breast-feeding|exclusive breast-feeding
727622|NCT00131625|Mortality|mortality
727623|NCT00131625|Morbidity|morbidity
727624|NCT00131625|Nutrition|nutrition
727625|NCT00131625|Low income country|low income country
727626|NCT00131612|adjuvant therapy|adjuvant therapy
727627|NCT00131612|epirubicin|epirubicin
727628|NCT00131612|uridine glucuronosyl/transferase 2B7|uridine glucuronosyl/transferase 2b7
727629|NCT00131612|pharmacogenetics|pharmacogenetics
727630|NCT00131599|5-fluorouracil|5-fluorouracil
727631|NCT00131599|thymidylate synthase|thymidylate synthase
727632|NCT00131599|pharmacogenetics|pharmacogenetics
727633|NCT00131586|platinum analogues|platinum analogues
727634|NCT00131586|cisplatin, carboplatin, oxaliplatin|cisplatin, carboplatin, oxaliplatin
727635|NCT00131586|proteomics|proteomics
727636|NCT00131586|hemoglobin|hemoglobin
727637|NCT00131573|Urgency-Frequency|urgency-frequency
727638|NCT00131573|Syndrome|syndrome
727639|NCT00131573|Urinary|urinary
727640|NCT00131573|Refractory|refractory
727641|NCT00131573|Stimulation|stimulation
727642|NCT00131573|Nerve|nerve
727643|NCT00131573|Neuromodulation|neuromodulation
727644|NCT00131573|Microstimulator|microstimulator
727645|NCT00131573|bion|bion
727646|NCT00131573|Pudendal|pudendal
727647|NCT00131573|Overactive bladder|overactive bladder
727648|NCT00131560|HIV, gene therapy, leukapheresis, autologous CD4 T cell, lentivector|hiv, gene therapy, leukapheresis, autologous cd4 t cell, lentivector
727649|NCT00131547|Obesity|obesity
727650|NCT00131547|Obstructive Sleep Apnea|obstructive sleep apnea
727651|NCT00131534|Complex trauma|complex trauma
727652|NCT00131534|Trauma recovery|trauma recovery
727653|NCT00131534|Resiliency|resiliency
727654|NCT00131534|Posttraumatic stress|posttraumatic stress
727655|NCT00131534|Individual psychotherapy|individual psychotherapy
727656|NCT00131534|Group psychotherapy|group psychotherapy
727657|NCT00131521|mucus obstruction, ventilator management|mucus obstruction, ventilator management
727658|NCT00131508|Hemoglobin S Disease|hemoglobin s disease
727659|NCT00131508|Sickle Cell Anemia|sickle cell anemia
727660|NCT00131495|Low Libido|low libido
727661|NCT00131495|Low Desire|low desire
727662|NCT00131495|Distress|distress
727663|NCT00131482|Chrysalin|chrysalin
727664|NCT00131482|TP508|tp508
727665|NCT00131482|Fracture|fracture
727666|NCT00131482|Wrist|wrist
727667|NCT00131482|Healing|healing
727668|NCT00131469|Osteogenesis Imperfecta|osteogenesis imperfecta
727669|NCT00131469|Brittle Bone Disease|brittle bone disease
727670|NCT00131469|Fragility Fractures|fragility fractures
727671|NCT00131456|cannabis dependence|cannabis dependence
727672|NCT00131456|depression|depression
727673|NCT00131456|treatment|treatment
727674|NCT00131456|venlafaxine|venlafaxine
727675|NCT00131443|Basilar/Hemiplegic Migraine|basilar/hemiplegic migraine
727676|NCT00131443|Prophylaxis|prophylaxis
727677|NCT00131417|severe|severe
727678|NCT00131417|malnutrition|malnutrition
727679|NCT00131417|ready-to-use-therapeutic-food|ready-to-use-therapeutic-food
727680|NCT00131417|children|children
727681|NCT00131417|Uganda|uganda
727682|NCT00131378|Visceral obesity|visceral obesity
727683|NCT00131378|Growth hormone|growth hormone
727684|NCT00131378|Cardiovascular risk|cardiovascular risk
727685|NCT00131378|Insulin resistance|insulin resistance
727686|NCT00131365|fibroids|fibroids
727687|NCT00131365|Uterine Fibroids|uterine fibroids
727688|NCT00131365|ExAblate|exablate
727689|NCT00131365|MrgFUS|mrgfus
727690|NCT00131352|Osteoarthritis of the knee|osteoarthritis of the knee
727691|NCT00131352|Musculoskeletal|musculoskeletal
727692|NCT00131339|panic disorder|panic disorder
727693|NCT00131339|cognitive behavioral therapy|cognitive behavioral therapy
727694|NCT00131339|D-cycloserine|d-cycloserine
727695|NCT00131339|medication|medication
727696|NCT00131339|treatment trial|treatment trial
727697|NCT00131339|placebo-controlled|placebo-controlled
727698|NCT00131339|double-blind|double-blind
727699|NCT00131339|randomized|randomized
727700|NCT00131326|osteoarthritis of the hip|osteoarthritis of the hip
727701|NCT00131326|Musculoskeletal Diseases|musculoskeletal diseases
727702|NCT00131313|Leukemia|leukemia
727703|NCT00131313|Cancer|cancer
727704|NCT00131313|Nipent|nipent
727705|NCT00131313|Rituxan|rituxan
727706|NCT00131313|Cytoxan|cytoxan
727707|NCT00131300|Osteoarthritis of the shoulder|osteoarthritis of the shoulder
727708|NCT00131300|Musculoskeletal|musculoskeletal
727709|NCT00131287|Agaricus Blazei Murill|agaricus blazei murill
727710|NCT00131287|type II DM|type ii dm
727711|NCT00131287|insulin index|insulin index
727712|NCT00131274|Pulmonary Fibrosis|pulmonary fibrosis
727713|NCT00131274|Respiratory Diseases|respiratory diseases
727714|NCT00131274|Interstitial Lung Disease|interstitial lung disease
727715|NCT00131274|Usual Interstitial Pneumonia|usual interstitial pneumonia
727716|NCT00131261|Multiple Myeloma|multiple myeloma
727717|NCT00131261|Neoplasms|neoplasms
727718|NCT00131235|Malaria|malaria
727719|NCT00131235|STI|sti
727720|NCT00131235|Pregnancy|pregnancy
727721|NCT00131235|Prevention|prevention
727722|NCT00131235|Preterm birth|preterm birth
727723|NCT00131235|Low birth weight|low birth weight
727724|NCT00131235|Sub-Saharan Africa|sub-saharan africa
727725|NCT00131222|Infant|infant
727726|NCT00131222|Malnutrition|malnutrition
727727|NCT00131222|Sub-Saharan Africa|sub-saharan africa
727728|NCT00131222|Treatment|treatment
727729|NCT00131222|Growth|growth
727730|NCT00131222|Haemoglobin|haemoglobin
727731|NCT00131222|Fortified spread|fortified spread
727732|NCT00131222|Food supplement|food supplement
727733|NCT00131209|Infant|infant
727734|NCT00131209|Sub-Saharan Africa|sub-saharan africa
727735|NCT00131209|Complementary feeding|complementary feeding
727736|NCT00131209|Malnutrition|malnutrition
727737|NCT00131209|Growth|growth
727738|NCT00131209|Fortified spread|fortified spread
727739|NCT00131209|Haemoglobin|haemoglobin
727740|NCT00131196|pneumonia|pneumonia
727741|NCT00131196|peritonitis|peritonitis
727742|NCT00131196|sepsis|sepsis
727743|NCT00131196|outcome|outcome
727744|NCT00131196|genomics|genomics
727745|NCT00131183|Angina Pectoris|angina pectoris
727746|NCT00131183|Arteriosclerosis|arteriosclerosis
727747|NCT00131183|Testosterone|testosterone
727748|NCT00131157|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
727749|NCT00131157|Family Practice|family practice
727750|NCT00131157|Spirometry|spirometry
727751|NCT00131157|Decision Support Systems|decision support systems
727752|NCT00131157|Feedback|feedback
727753|NCT00131144|Diabetic retinopathy,Octreotide Acetate in Microspheres|diabetic retinopathy,octreotide acetate in microspheres
727754|NCT00131131|physical activity|physical activity
727755|NCT00131131|cholelithiasis|cholelithiasis
727756|NCT00131131|pregnancy complication|pregnancy complication
727757|NCT00131118|Osteogenesis Imperfecta, Brittle bone disease, bisphosphonate, children|osteogenesis imperfecta, brittle bone disease, bisphosphonate, children
727758|NCT00131105|Healthy|healthy
727759|NCT00131105|Caregivers|caregivers
727760|NCT00131105|Aging|aging
727761|NCT00131092|exercise|exercise
727762|NCT00131092|aging|aging
727763|NCT00131092|physical activity|physical activity
727764|NCT00131079|Primary Health Care|primary health care
727765|NCT00131079|Physicians, Family|physicians, family
727766|NCT00131079|Family Practice|family practice
727767|NCT00131079|Health Promotion|health promotion
727768|NCT00131079|Randomized Controlled Trials|randomized controlled trials
727769|NCT00131079|Multicenter Studies|multicenter studies
727770|NCT00131079|Physical Fitness|physical fitness
727771|NCT00131079|Quality of Life|quality of life
727772|NCT00131066|Previously enrolled on a MEDI-507 for psoriasis|previously enrolled on a medi-507 for psoriasis
727773|NCT00131053|acute lymphoblastic leukemia|acute lymphoblastic leukemia
727774|NCT00131053|newly diagnosed|newly diagnosed
727775|NCT00131053|BCR-ABL-negative|bcr-abl-negative
727776|NCT00131040|Cardiopulmonary|cardiopulmonary
727777|NCT00131040|Surgery|surgery
727778|NCT00131040|leukocyte|leukocyte
727779|NCT00131040|inflammation|inflammation
727780|NCT00131040|Coronary Artery Bypass Grafting|coronary artery bypass grafting
727781|NCT00131027|acute lymphoblastic leukemia|acute lymphoblastic leukemia
727782|NCT00131027|newly diagnosed|newly diagnosed
727783|NCT00131027|BCR-ABL-negative|bcr-abl-negative
727784|NCT00131014|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
727785|NCT00131014|Hodgkin's disease|hodgkin's disease
727786|NCT00131014|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
727787|NCT00131014|Lymphoproliferative disorder|lymphoproliferative disorder
727788|NCT00131014|Genetics|genetics
727789|NCT00131001|Carotid artery stenosis|carotid artery stenosis
727790|NCT00131001|cost effectiveness|cost effectiveness
727791|NCT00131001|magnetic resonance angiography|magnetic resonance angiography
727792|NCT00131001|computed tomography angiography|computed tomography angiography
727793|NCT00131001|digital subtraction angiography|digital subtraction angiography
727794|NCT00130988|Somatoform Disorders|somatoform disorders
727795|NCT00130988|Medically unexplained symptoms|medically unexplained symptoms
727796|NCT00130988|Physician-Patient Relations|physician-patient relations
727797|NCT00130988|Primary Health Care|primary health care
727798|NCT00130988|Family Physician|family physician
727799|NCT00130988|psychosocial therapy|psychosocial therapy
727800|NCT00130988|re-attribution of symptoms|re-attribution of symptoms
727801|NCT00130988|cluster randomised controlled trial|cluster randomised controlled trial
727802|NCT00130975|Atrial fibrillation.|atrial fibrillation.
727803|NCT00130975|Cardioversion.|cardioversion.
727804|NCT00130975|Recurrence.|recurrence.
727805|NCT00130975|Candesartan.|candesartan.
727806|NCT00130962|Intermetatarsal neuroma|intermetatarsal neuroma
727807|NCT00130962|Morton's neuroma|morton's neuroma
727808|NCT00130962|ALGRX 4975|algrx 4975
727809|NCT00130962|capsaicin|capsaicin
727810|NCT00130949|Acute lateral epicondylitis|acute lateral epicondylitis
727811|NCT00130949|Tennis elbow|tennis elbow
727812|NCT00130949|Capsaicin|capsaicin
727813|NCT00130936|phase I|phase i
727814|NCT00130936|epirubicin|epirubicin
727815|NCT00130936|solid tumors|solid tumors
727816|NCT00130923|Risperidone|risperidone
727817|NCT00130923|Schizophrenia|schizophrenia
727818|NCT00130923|Substance Use Disorder|substance use disorder
727819|NCT00130923|Alcohol Use Disorder|alcohol use disorder
727820|NCT00130923|Treatment|treatment
727821|NCT00130923|Schizoaffective Disorder|schizoaffective disorder
727822|NCT00130910|HIV|hiv
727823|NCT00130910|Helminthiasis|helminthiasis
727824|NCT00130910|Co-infection|co-infection
727825|NCT00130910|Intestinal immune activation|intestinal immune activation
727826|NCT00130910|Treatment Naive|treatment naive
727827|NCT00130884|levosimendan|levosimendan
727828|NCT00130884|chronic heart failure|chronic heart failure
727829|NCT00130884|oral administration|oral administration
727830|NCT00130871|levosimendan|levosimendan
727831|NCT00130871|weaning|weaning
727832|NCT00130871|cardio-pulmonary bypass|cardio-pulmonary bypass
727833|NCT00130858|Sarcoma, Soft Tissue|sarcoma, soft tissue
727834|NCT00130845|Diabetic retinopathy, Octreotide Acetate in Microspheres|diabetic retinopathy, octreotide acetate in microspheres
727835|NCT00130819|Drug Dependence|drug dependence
727836|NCT00130819|Opiate Dependence|opiate dependence
727837|NCT00130819|Human Immunodeficiency Viruses|human immunodeficiency viruses
727838|NCT00130819|Buprenorphine|buprenorphine
727839|NCT00130780|Multi-modality treatment for lung cancer|multi-modality treatment for lung cancer
727840|NCT00130780|Carcinoma, Squamous Cell|carcinoma, squamous cell
727841|NCT00130780|Bevacizumab|bevacizumab
727842|NCT00130780|BEACON|beacon
727843|NCT00130780|05-052|05-052
727844|NCT00130767|Prostate|prostate
727845|NCT00130767|apoptosis|apoptosis
727846|NCT00130767|finasteride kinetics|finasteride kinetics
727847|NCT00130728|NSCLC|nsclc
727848|NCT00130728|Avastin|avastin
727849|NCT00130728|Tarceva|tarceva
727850|NCT00130728|Lung Cancer|lung cancer
727851|NCT00130715|Patients undergoing a variety of abdominal surgical procedures|patients undergoing a variety of abdominal surgical procedures
727852|NCT00130702|AML|aml
727853|NCT00130702|acute myelogenous leukemia|acute myelogenous leukemia
727854|NCT00130702|gefitinib|gefitinib
727855|NCT00130702|Iressa|iressa
727856|NCT00130689|Esophageal Cancer|esophageal cancer
727857|NCT00130689|Gastric Cancer|gastric cancer
727858|NCT00130689|Metastatic Esophageal Cancer|metastatic esophageal cancer
727859|NCT00130689|Metastatic Gastric Cancer|metastatic gastric cancer
727860|NCT00130689|Cetuximab|cetuximab
727861|NCT00130689|Metastatic Esophageal and Gastric Cancer|metastatic esophageal and gastric cancer
727862|NCT00130676|PMD|pmd
727863|NCT00130676|Psychotic Major Depression|psychotic major depression
727864|NCT00130676|Depression|depression
727865|NCT00130676|Major Depression|major depression
727866|NCT00130676|Psychosis|psychosis
727867|NCT00130650|IV|iv
727868|NCT00130650|cannulation|cannulation
727869|NCT00130650|Injections, Intravenous|injections, intravenous
727870|NCT00130637|Anterior Uveitis|anterior uveitis
727871|NCT00130637|Arthritis, Juvenile Idiopathic|arthritis, juvenile idiopathic
727872|NCT00130637|Daclizumab|daclizumab
727873|NCT00130637|Iritis|iritis
727874|NCT00130637|Immunosuppression|immunosuppression
727875|NCT00130637|Chronic Inflammatory Eye-Disease|chronic inflammatory eye-disease
727876|NCT00130637|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
727877|NCT00130624|Falls|falls
727878|NCT00130624|Elderly|elderly
727879|NCT00130624|multidisciplinary assessment|multidisciplinary assessment
727880|NCT00130611|heart failure|heart failure
727881|NCT00130611|cost effectiveness|cost effectiveness
727882|NCT00130611|BNP|bnp
727883|NCT00130611|private practice|private practice
727884|NCT00130611|Acute dyspnoea|acute dyspnoea
727885|NCT00130598|contrast nephropathy|contrast nephropathy
727886|NCT00130598|contrast media|contrast media
727887|NCT00130598|renal dysfunction|renal dysfunction
727888|NCT00130585|Folate|folate
727889|NCT00130585|Bioavailability|bioavailability
727890|NCT00130585|Stable isotopes|stable isotopes
727891|NCT00130559|Respiratory failure|respiratory failure
727892|NCT00130559|BNP|bnp
727893|NCT00130546|coronary artery disease|coronary artery disease
727894|NCT00130546|coronary intervention|coronary intervention
727895|NCT00130546|drug eluting stent implantation|drug eluting stent implantation
727896|NCT00130546|Cypher - Stent|cypher - stent
727897|NCT00130546|Sirolimus|sirolimus
727898|NCT00130546|Taxus - Stent|taxus - stent
727899|NCT00130546|Paclitaxel|paclitaxel
727900|NCT00130533|TNBC Triple-Negative Early Breast Cancer|tnbc triple-negative early breast cancer
727901|NCT00130533|Maintenance Adjuvant Chemotherapy|maintenance adjuvant chemotherapy
727902|NCT00130533|Capecitabine|capecitabine
727903|NCT00130533|Basal-like genotype|basal-like genotype
727904|NCT00130520|advanced ovarian cancer|advanced ovarian cancer
727905|NCT00130520|refractory ovarian cancer|refractory ovarian cancer
727906|NCT00130520|primary peritoneal cancer|primary peritoneal cancer
727907|NCT00130507|HER2 positive breast cancer.|her2 positive breast cancer.
727908|NCT00130507|Progression to trastuzumab and taxanes.|progression to trastuzumab and taxanes.
727909|NCT00130494|Non-symptomatic bone metastases.|non-symptomatic bone metastases.
727910|NCT00130481|Diabetes|diabetes
727911|NCT00130481|Children|children
727912|NCT00130481|Adolescents|adolescents
727913|NCT00130481|Arterial Compliance|arterial compliance
727914|NCT00130481|Physiology Cardiovascular Endothelium|physiology cardiovascular endothelium
727915|NCT00130442|phase II|phase ii
727916|NCT00130442|metastatic melanoma|metastatic melanoma
727917|NCT00130442|dacarbazine|dacarbazine
727918|NCT00130442|combination|combination
727919|NCT00130442|PI-88|pi-88
727920|NCT00130429|dementia|dementia
727921|NCT00130429|memory|memory
727922|NCT00130429|Hopkins verbal learning test|hopkins verbal learning test
727923|NCT00130429|paired associated learning|paired associated learning
727924|NCT00130416|behavior|behavior
727925|NCT00130416|randomized trial|randomized trial
727926|NCT00130416|communication|communication
727927|NCT00130416|patient|patient
727928|NCT00130416|internet|internet
727929|NCT00130416|coaching|coaching
727930|NCT00130416|self-efficacy|self-efficacy
727931|NCT00130416|nurse|nurse
727932|NCT00130416|primary care|primary care
727933|NCT00130416|physician|physician
727934|NCT00130416|screening|screening
727935|NCT00130416|survey|survey
727936|NCT00130416|pain|pain
727937|NCT00130416|mobility|mobility
727938|NCT00130416|disability|disability
727939|NCT00130416|depression|depression
727940|NCT00130390|Crohn's Disease|crohn's disease
727941|NCT00130377|Stem Cell|stem cell
727942|NCT00130377|Heart|heart
727943|NCT00130377|Lung|lung
727944|NCT00130377|Vascular|vascular
727945|NCT00130377|cell therapy registry|cell therapy registry
727946|NCT00130364|Atopic dermatitis|atopic dermatitis
727947|NCT00130364|T-cell|t-cell
727948|NCT00130364|pimecrolimus|pimecrolimus
727949|NCT00130364|children|children
727950|NCT00130364|facial|facial
727951|NCT00130364|Facial atopic dermatitis|facial atopic dermatitis
727952|NCT00130351|asthma, formoterol multi-dose dry powder inhaler (MDDPI)|asthma, formoterol multi-dose dry powder inhaler (mddpi)
727953|NCT00130338|Dementia|dementia
727954|NCT00130338|Vascular|vascular
727955|NCT00130338|Rivastigmine|rivastigmine
727956|NCT00130338|Stroke|stroke
727957|NCT00130338|Memory loss|memory loss
727958|NCT00130325|ELISPOT,|elispot,
727959|NCT00130325|tuberculosis,|tuberculosis,
727960|NCT00130325|Mycobacterium tuberculosis|mycobacterium tuberculosis
727961|NCT00130325|Isoniazid|isoniazid
727962|NCT00130325|Clinical trial|clinical trial
727963|NCT00130312|Diabetes|diabetes
727964|NCT00130312|Diabetic Nephropathy|diabetic nephropathy
727965|NCT00130312|Proteinuria|proteinuria
727966|NCT00130286|Lipodystrophy|lipodystrophy
727967|NCT00130286|HIV|hiv
727968|NCT00130286|Growth hormone|growth hormone
727969|NCT00130286|Rosiglitazone|rosiglitazone
727970|NCT00130286|Visceral fat|visceral fat
727971|NCT00130286|Metabolic syndrome|metabolic syndrome
727972|NCT00130286|Treatment Experienced|treatment experienced
727973|NCT00130286|Visceral fat accumulation|visceral fat accumulation
727974|NCT00130286|fat accumulation|fat accumulation
727975|NCT00130286|HIV-Associated Metabolic Syndrome|hiv-associated metabolic syndrome
727976|NCT00130273|HIV|hiv
727977|NCT00130273|AIDS|aids
727978|NCT00130273|Problem Solving|problem solving
727979|NCT00130273|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
727980|NCT00130273|Patient Compliance|patient compliance
727981|NCT00130260|Staphylococcus aureus|staphylococcus aureus
727982|NCT00130260|Vaccine|vaccine
728659|NCT00127790|Sleep|sleep
727983|NCT00130260|Randomized Controlled Trial|randomized controlled trial
727984|NCT00130247|Tuberculosis, Uganda, Brazil, Philippines|tuberculosis, uganda, brazil, philippines
727985|NCT00130234|urticaria|urticaria
727986|NCT00130234|hives|hives
727987|NCT00130234|Xolair|xolair
727988|NCT00130221|Chlorhexidine|chlorhexidine
727989|NCT00130221|Blood stream infections|blood stream infections
727990|NCT00130221|central venous catheter associated|central venous catheter associated
727991|NCT00130221|Nosocomial infection|nosocomial infection
727992|NCT00130221|Bacteremia|bacteremia
727993|NCT00130221|sepsis|sepsis
727994|NCT00130221|Pneumonia|pneumonia
727995|NCT00130221|Urinary tract infection|urinary tract infection
727996|NCT00130221|Clostridium Difficile|clostridium difficile
727997|NCT00130221|intensive care unit|intensive care unit
727998|NCT00130221|catheter|catheter
727999|NCT00130221|nosocomial pneumonia|nosocomial pneumonia
728000|NCT00130221|Infection control|infection control
728001|NCT00130208|Diabetes|diabetes
728002|NCT00130208|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
728003|NCT00130208|Albuminuria|albuminuria
728004|NCT00130208|Diabetic Nephropathy|diabetic nephropathy
728005|NCT00130195|acute lymphoblastic leukemia|acute lymphoblastic leukemia
728006|NCT00130195|BCR-ABL|bcr-abl
728007|NCT00130195|Philadelphia-chromosome|philadelphia-chromosome
728008|NCT00130195|newly diagnosed|newly diagnosed
728009|NCT00130182|lung disease|lung disease
728010|NCT00130169|Cancer|cancer
728011|NCT00130169|malignant tumors|malignant tumors
728012|NCT00130156|Blood pressure|blood pressure
728013|NCT00130156|SBP|sbp
728014|NCT00130156|DBP|dbp
728015|NCT00130117|leptin|leptin
728016|NCT00130117|hypothalamic amenorrhea|hypothalamic amenorrhea
728017|NCT00130117|exercise-induced amenorrhea|exercise-induced amenorrhea
728018|NCT00130117|neuroendocrine function|neuroendocrine function
728019|NCT00130117|bone metabolism|bone metabolism
728020|NCT00130104|digital block|digital block
728021|NCT00130104|regional anesthesia|regional anesthesia
728022|NCT00130104|finger repair|finger repair
728023|NCT00130104|Fingers|fingers
728024|NCT00130104|Anesthesia, Conduction|anesthesia, conduction
728025|NCT00130091|unilateral|unilateral
728026|NCT00130091|hernia|hernia
728027|NCT00130091|hydrocele|hydrocele
728028|NCT00130091|pediatric|pediatric
728029|NCT00130091|clonidine|clonidine
728030|NCT00130091|nerve block|nerve block
728031|NCT00130078|HIV Seronegativity|hiv seronegativity
728032|NCT00130078|HIV transmission|hiv transmission
728033|NCT00130065|Malaria|malaria
728034|NCT00130065|Pregnancy|pregnancy
728035|NCT00130065|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
728036|NCT00130065|Folic acid|folic acid
728037|NCT00130065|Folate|folate
728038|NCT00130039|Infarction, Cerebral|infarction, cerebral
728039|NCT00130039|cilostazol|cilostazol
728040|NCT00130039|stenosis|stenosis
728041|NCT00130039|atherosclerosis|atherosclerosis
728042|NCT00130039|clopidogrel|clopidogrel
728043|NCT00130013|Children|children
728044|NCT00130013|Non-severe pneumonia|non-severe pneumonia
728045|NCT00130013|Oral amoxicillin|oral amoxicillin
728046|NCT00130000|h5g.1|h5g.1
728047|NCT00130000|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
728048|NCT00130000|SHEPHERD|shepherd
728049|NCT00130000|PNH|pnh
728050|NCT00129987|Asthma|asthma
728051|NCT00129974|Lung cancer|lung cancer
728052|NCT00129974|Phase II|phase ii
728053|NCT00129974|Drug Therapy|drug therapy
728054|NCT00129961|Kidney|kidney
728055|NCT00129961|Transplant|transplant
728056|NCT00129961|Skin Cancer|skin cancer
728057|NCT00129948|Acute myeloid leukemia|acute myeloid leukemia
728058|NCT00129948|AML|aml
728059|NCT00129948|refractory|refractory
728060|NCT00129948|relapsed|relapsed
728061|NCT00129935|HER2 negative breast cancer|her2 negative breast cancer
728062|NCT00129935|Node positive breast cancer|node positive breast cancer
728063|NCT00129935|Adjuvant treatment|adjuvant treatment
728064|NCT00129935|Oral chemotherapy|oral chemotherapy
728065|NCT00129922|Axillary node positive breast cancer.|axillary node positive breast cancer.
728066|NCT00129922|Sequential drug administration.|sequential drug administration.
728067|NCT00129922|Weekly paclitaxel.|weekly paclitaxel.
728068|NCT00129909|hypertension|hypertension
728069|NCT00129909|family physicians|family physicians
728070|NCT00129909|fixed dose combination therapy|fixed dose combination therapy
728071|NCT00129909|cluster randomized controlled trial|cluster randomized controlled trial
728072|NCT00129896|Her2neu positive breast cancer.|her2neu positive breast cancer.
728073|NCT00129896|Neoadjuvant treatment.|neoadjuvant treatment.
728074|NCT00129883|quality of care|quality of care
728075|NCT00129883|antibiotic use|antibiotic use
728076|NCT00129883|intervention|intervention
728077|NCT00129883|lower respiratory tract infections|lower respiratory tract infections
728078|NCT00129883|Community acquired Pneumonia|community acquired pneumonia
728079|NCT00129883|Acute Exacerbation of Chronic Bronchitis or COPD|acute exacerbation of chronic bronchitis or copd
728080|NCT00129844|Motexafin Gadolinium|motexafin gadolinium
728081|NCT00129844|non-small cell, lung cancer|non-small cell, lung cancer
728082|NCT00129844|Lung cancer|lung cancer
728660|NCT00127790|Pain|pain
728083|NCT00129844|cancer of the lung|cancer of the lung
728084|NCT00129844|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
728085|NCT00129831|COPD, indacaterol, PK|copd, indacaterol, pk
728086|NCT00129818|Genital herpes|genital herpes
728087|NCT00129818|viral shedding|viral shedding
728088|NCT00129818|famciclovir|famciclovir
728089|NCT00129818|Symptomatic genital herpes|symptomatic genital herpes
728090|NCT00129818|Asymptomatic genital herpes|asymptomatic genital herpes
728091|NCT00129792|Blood Glucose|blood glucose
728092|NCT00129792|Cholesterol|cholesterol
728093|NCT00129792|Weight Loss|weight loss
728094|NCT00129792|Insulin|insulin
728095|NCT00129792|Complementary Therapies|complementary therapies
728096|NCT00129779|COPD|copd
728097|NCT00129766|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
728098|NCT00129766|motavizumab|motavizumab
728099|NCT00129766|palivizumab|palivizumab
728100|NCT00129766|Synagis|synagis
728101|NCT00129753|Campath-1H Monoclonal Antibody|campath-1h monoclonal antibody
728102|NCT00129753|Alemtuzumab|alemtuzumab
728103|NCT00129753|Campath|campath
728104|NCT00129753|Campath-1H|campath-1h
728105|NCT00129753|Relapsed and Resistant Classical Hodgkin's Disease|relapsed and resistant classical hodgkin's disease
728106|NCT00129753|Lymphoma|lymphoma
728107|NCT00129740|Chronic phase CML|chronic phase cml
728108|NCT00129740|Newly diagnosed chronic phase CML|newly diagnosed chronic phase cml
728109|NCT00129740|AMN107|amn107
728110|NCT00129727|Carboplatin|carboplatin
728111|NCT00129727|Paclitaxel|paclitaxel
728112|NCT00129727|Bevacizumab|bevacizumab
728113|NCT00129727|Ovarian|ovarian
728114|NCT00129727|Cancer|cancer
728115|NCT00129714|cervical radiculopathy conservative treatment|cervical radiculopathy conservative treatment
728116|NCT00129688|febrile neutropenia|febrile neutropenia
728117|NCT00129688|once-daily|once-daily
728118|NCT00129688|amikacin|amikacin
728119|NCT00129688|cloxacillin|cloxacillin
728120|NCT00129688|children|children
728121|NCT00129675|parkinson|parkinson
728122|NCT00129675|diagnosis|diagnosis
728123|NCT00129610|Agoraphobia|agoraphobia
728124|NCT00129610|panic disorder|panic disorder
728125|NCT00129610|Virtual Reality Therapy|virtual reality therapy
728126|NCT00129610|Cognitive Behavior Therapy|cognitive behavior therapy
728127|NCT00129610|cognition|cognition
728128|NCT00129610|spatial cognition|spatial cognition
728129|NCT00129610|PANIC DISORDER WITH AGORAPHOBIA|panic disorder with agoraphobia
728130|NCT00129597|Ketalar|ketalar
728131|NCT00129597|NMDA|nmda
728132|NCT00129597|mastectomy|mastectomy
728133|NCT00129597|postoperative chronic pain|postoperative chronic pain
728134|NCT00129597|Chronic pain after mastectomy for breast cancer|chronic pain after mastectomy for breast cancer
728135|NCT00129584|Endobronchial Valve (EBV) Procedure|endobronchial valve (ebv) procedure
728136|NCT00129584|Bronchoscopic Lung Volume Reduction|bronchoscopic lung volume reduction
728137|NCT00129545|Atrial Fibrillation|atrial fibrillation
728138|NCT00129545|AF|af
728139|NCT00129545|A Fib|a fib
728140|NCT00129545|Stroke|stroke
728141|NCT00129545|Coumadin|coumadin
728142|NCT00129545|Warfarin|warfarin
728143|NCT00129545|Blood thinning medication|blood thinning medication
728144|NCT00129545|transient ischemic attack (TIA)|transient ischemic attack (tia)
728145|NCT00129545|WATCHMAN|watchman
728146|NCT00129545|Left atrial appendage|left atrial appendage
728147|NCT00129545|LAA isolation|laa isolation
728148|NCT00129545|LAA occlusion|laa occlusion
728149|NCT00129532|HIV transmission|hiv transmission
728150|NCT00129519|BCC curettage|bcc curettage
728151|NCT00129506|medical abortion|medical abortion
728152|NCT00129506|methotrexate|methotrexate
728153|NCT00129506|misoprostol|misoprostol
728154|NCT00129493|Practice guidelines|practice guidelines
728155|NCT00129493|Hypertension|hypertension
728156|NCT00129493|Primary health care|primary health care
728157|NCT00129493|Patient-centered care|patient-centered care
728158|NCT00129493|Healthcare quality|healthcare quality
728159|NCT00129493|Office visits|office visits
728160|NCT00129493|Self-efficacy|self-efficacy
728161|NCT00129493|Self care|self care
728162|NCT00129493|Guideline adherence|guideline adherence
728163|NCT00129493|Patient noncompliance|patient noncompliance
728164|NCT00129480|veterans|veterans
728165|NCT00129480|pain and chronic disease|pain and chronic disease
728166|NCT00129480|disease management|disease management
728167|NCT00129480|depression|depression
728168|NCT00129480|primary health care|primary health care
728169|NCT00129480|practice guidelines|practice guidelines
728170|NCT00129480|guideline adherence|guideline adherence
728171|NCT00129480|narcotics|narcotics
728172|NCT00129480|patient compliance|patient compliance
728173|NCT00129480|randomized controlled trial|randomized controlled trial
728174|NCT00129467|Depression|depression
728175|NCT00129467|Hospice Care|hospice care
728176|NCT00129467|Antidepressive Agents|antidepressive agents
728177|NCT00129467|Methylphenidate|methylphenidate
728178|NCT00129467|Central Nervous System Stimulant|central nervous system stimulant
728179|NCT00129467|Pain|pain
728180|NCT00129467|Caregiver Burden|caregiver burden
728181|NCT00129467|Cancer|cancer
728182|NCT00129454|Telemedicine|telemedicine
729128|NCT00126035|Device|device
728183|NCT00129454|Cognitive Behavior Therapy|cognitive behavior therapy
728184|NCT00129454|Utilization|utilization
728185|NCT00129454|Randomized Control Trial|randomized control trial
728186|NCT00129454|Gulf War Illness|gulf war illness
728187|NCT00129454|Symptom-Based Illness|symptom-based illness
728188|NCT00129454|Multisymptom Illness|multisymptom illness
728189|NCT00129454|High utilization|high utilization
728190|NCT00129441|schizophrenia|schizophrenia
728191|NCT00129428|UVB|uvb
728192|NCT00129428|keloid|keloid
728193|NCT00129428|scleroderma|scleroderma
728194|NCT00129428|acne keloidalis nuchae|acne keloidalis nuchae
728195|NCT00129428|scars|scars
728196|NCT00129428|granuloma annulare|granuloma annulare
728197|NCT00129415|UVA1|uva1
728198|NCT00129415|UVB|uvb
728199|NCT00129415|atopic dermatitis|atopic dermatitis
728200|NCT00129415|psoriasis|psoriasis
728201|NCT00129415|alopecia|alopecia
728202|NCT00129415|mycosis fungoides (CTCL)|mycosis fungoides (ctcl)
728203|NCT00129415|urticaria|urticaria
728204|NCT00129415|inflammatory dermatoses|inflammatory dermatoses
728205|NCT00129415|stretch marks|stretch marks
728206|NCT00129402|cholesterol|cholesterol
728207|NCT00129402|drugs|drugs
728208|NCT00129402|hypercholesterolemia|hypercholesterolemia
728209|NCT00129402|adolescent|adolescent
728210|NCT00129402|randomized controlled trials|randomized controlled trials
728211|NCT00129389|Node negative, high risk breast cancer.|node negative, high risk breast cancer.
728212|NCT00129389|Prognostic gene profile.|prognostic gene profile.
728213|NCT00129389|Saint Gallen high risk criteria.|saint gallen high risk criteria.
728214|NCT00129389|Weekly paclitaxel.|weekly paclitaxel.
728215|NCT00129376|Stage II and IIIA breast Cancer.|stage ii and iiia breast cancer.
728216|NCT00129376|Neoadjuvant chemotherapy.|neoadjuvant chemotherapy.
728217|NCT00129376|Weekly docetaxel.|weekly docetaxel.
728218|NCT00129363|Adolescent|adolescent
728219|NCT00129363|Adrenergic alpha-Antagonists/therapeutic use|adrenergic alpha-antagonists/therapeutic use
728220|NCT00129363|Adrenergic alpha-Antagonists/pharmacokinetics|adrenergic alpha-antagonists/pharmacokinetics
728221|NCT00129363|Adrenergic alpha-Antagonists/administration & dosage|adrenergic alpha-antagonists/administration & dosage
728222|NCT00129363|Adrenergic beta-Antagonists/therapeutic use|adrenergic beta-antagonists/therapeutic use
728223|NCT00129363|Adrenergic beta-Antagonists/pharmacokinetics|adrenergic beta-antagonists/pharmacokinetics
728224|NCT00129363|Adrenergic beta-Antagonists/administration & dosage|adrenergic beta-antagonists/administration & dosage
728225|NCT00129363|Age Factors|age factors
728226|NCT00129363|Carbazoles/therapeutic use|carbazoles/therapeutic use
728227|NCT00129363|Carbazoles/administration & dosage|carbazoles/administration & dosage
728228|NCT00129363|Child|child
728229|NCT00129363|Child, Preschool|child, preschool
728230|NCT00129363|Drug Administration Schedule|drug administration schedule
728231|NCT00129363|Female|female
728232|NCT00129363|Heart Failure, Congestive/etiology|heart failure, congestive/etiology
728233|NCT00129363|Heart Failure, Congestive/drug therapy|heart failure, congestive/drug therapy
728234|NCT00129363|Heart Failure, Congestive/blood|heart failure, congestive/blood
728235|NCT00129363|Human|human
728236|NCT00129363|Infant|infant
728237|NCT00129363|Infant, Newborn|infant, newborn
728238|NCT00129363|Male|male
728239|NCT00129363|Natriuretic Peptide, Brain/blood|natriuretic peptide, brain/blood
728240|NCT00129363|Placebos|placebos
728241|NCT00129363|Propanolamines/therapeutic use|propanolamines/therapeutic use
728242|NCT00129363|Propanolamines/administration & dosage|propanolamines/administration & dosage
728243|NCT00129363|Prospective Studies|prospective studies
728244|NCT00129363|Support, Non-U.S. Gov't|support, non-u.s. gov't
728245|NCT00129363|Treatment Outcome|treatment outcome
728246|NCT00129363|Ventricular Dysfunction/drug therapy|ventricular dysfunction/drug therapy
728247|NCT00129363|Ventricular Dysfunction/complications|ventricular dysfunction/complications
728248|NCT00129363|Ventricular Dysfunction/blood|ventricular dysfunction/blood
728249|NCT00129363|Ventricular Function/drug effects|ventricular function/drug effects
728250|NCT00129363|Ventricular Remodeling/drug effects|ventricular remodeling/drug effects
728251|NCT00129350|End Stage Fibrotic Lung Disease|end stage fibrotic lung disease
728252|NCT00129337|monoclonal antibody|monoclonal antibody
728253|NCT00129337|phase 1|phase 1
728254|NCT00129337|solid tumor|solid tumor
728255|NCT00129337|anti-angiogenesis|anti-angiogenesis
728256|NCT00129337|refractory advanced solid tumor malignancy|refractory advanced solid tumor malignancy
728257|NCT00129324|HOME|home
728258|NCT00129324|Environmental Exposure|environmental exposure
728259|NCT00129324|Neurobehavior|neurobehavior
728260|NCT00129324|Child Development|child development
728261|NCT00129324|Lead Exposure|lead exposure
728262|NCT00129324|Child Injury|child injury
728263|NCT00129324|Adolescence|adolescence
728264|NCT00129324|Adiposity|adiposity
728265|NCT00129324|Neuroimaging|neuroimaging
728266|NCT00129311|Tobacco|tobacco
728267|NCT00129298|cocaine abuse|cocaine abuse
728268|NCT00129298|opiate dependent|opiate dependent
728269|NCT00129298|tiagabine|tiagabine
728270|NCT00129298|methadone|methadone
728271|NCT00129285|cocaine|cocaine
728272|NCT00129272|adolescents, cigarettes, smoking, tobacco|adolescents, cigarettes, smoking, tobacco
728273|NCT00129259|T1D|t1d
729129|NCT00126035|Migraid|migraid
728274|NCT00129259|type 1 diabetes|type 1 diabetes
728275|NCT00129259|type 1 diabetes mellitus|type 1 diabetes mellitus
728276|NCT00129259|juvenile diabetes|juvenile diabetes
728277|NCT00129259|autoimmune diabetes|autoimmune diabetes
728278|NCT00129259|autoimmune|autoimmune
728279|NCT00129259|anti-CD3 mAb|anti-cd3 mab
728280|NCT00129259|mAb hOKT3g1(Ala-Ala)|mab hokt3g1(ala-ala)
728281|NCT00129259|teplizumab|teplizumab
728282|NCT00129246|Tobacco|tobacco
728283|NCT00129246|Smoking|smoking
728284|NCT00129246|Weight|weight
728285|NCT00129246|Weight perception|weight perception
728286|NCT00129246|Naltrexone|naltrexone
728287|NCT00129246|Bupropion|bupropion
728288|NCT00129233|cardiovascular disease|cardiovascular disease
728289|NCT00129233|rennin-angiotensin system|rennin-angiotensin system
728290|NCT00129233|calcium channel blocker|calcium channel blocker
728291|NCT00129233|impaired glucose tolerance|impaired glucose tolerance
728292|NCT00129220|Manic or mixed episode associated with bipolar I disorder|manic or mixed episode associated with bipolar i disorder
728293|NCT00129207|pharmacokinetic|pharmacokinetic
728294|NCT00129207|pharmacodynamics|pharmacodynamics
728295|NCT00129207|VELCADE|velcade
728296|NCT00129207|Ketoconazole|ketoconazole
728297|NCT00129207|CYP 3A4|cyp 3a4
728298|NCT00129207|Solid Tumor|solid tumor
728299|NCT00129207|Advanced Solid Tumors|advanced solid tumors
728300|NCT00129194|HIV|hiv
728301|NCT00129194|Treatment Experienced|treatment experienced
728302|NCT00129181|parkinson|parkinson
728303|NCT00129181|brain imaging|brain imaging
728304|NCT00129181|diagnosis|diagnosis
728305|NCT00129168|Leukemia, Myeloid|leukemia, myeloid
728306|NCT00129168|Relapse|relapse
728307|NCT00129168|Chemotherapy|chemotherapy
728308|NCT00129168|Zosuquidar|zosuquidar
728309|NCT00129168|Daunorubicin|daunorubicin
728310|NCT00129168|Cytarabine|cytarabine
728311|NCT00129168|Acute|acute
728312|NCT00129168|AML|aml
728313|NCT00129168|Adult AML|adult aml
728314|NCT00129155|Allogenic stem cell transplantation|allogenic stem cell transplantation
728315|NCT00129155|Treosulfan|treosulfan
728316|NCT00129155|Haematological malignancies|haematological malignancies
728317|NCT00129155|allogeneic stem cell transplantation in patients with hematological malignancies|allogeneic stem cell transplantation in patients with hematological malignancies
728318|NCT00129142|Prostate cancer|prostate cancer
728319|NCT00129142|Bone Loss|bone loss
728320|NCT00129142|Osteoporosis|osteoporosis
728321|NCT00129142|Fractures|fractures
728322|NCT00129142|Androgen Deprivation Therapy|androgen deprivation therapy
728323|NCT00129129|Immunogenicity|immunogenicity
728324|NCT00129129|Primary & booster vaccination|primary & booster vaccination
728325|NCT00129129|Infants|infants
728326|NCT00129129|Meningococcal vaccine|meningococcal vaccine
728327|NCT00129129|Safety|safety
728328|NCT00129129|Children|children
728329|NCT00129129|Hib disease|hib disease
728330|NCT00129129|Meningococcal disease|meningococcal disease
728331|NCT00129116|Invasive bacterial disease caused by Hib|invasive bacterial disease caused by hib
728332|NCT00129116|Neisseria meningitidis serogroups C & Y|neisseria meningitidis serogroups c & y
728333|NCT00129077|Pediatric critical care|pediatric critical care
728334|NCT00129077|neuromuscular blocking agents|neuromuscular blocking agents
728335|NCT00129077|corneal abrasions|corneal abrasions
728336|NCT00129064|Referrals|referrals
728337|NCT00129064|Quality of care|quality of care
728338|NCT00129064|Ambulatory care|ambulatory care
728339|NCT00129064|Electronic medical record|electronic medical record
728340|NCT00129064|Referral communication|referral communication
728341|NCT00129051|tomotherapy|tomotherapy
728342|NCT00129051|metastatic carcinoma|metastatic carcinoma
728343|NCT00129025|conformal hypofractionated radiotherapy|conformal hypofractionated radiotherapy
728344|NCT00129025|localized prostate cancer|localized prostate cancer
728345|NCT00129012|radiation therapy|radiation therapy
728346|NCT00129012|carcinoma|carcinoma
728347|NCT00129012|non-small cell lung|non-small cell lung
728348|NCT00128999|radiation therapy|radiation therapy
728349|NCT00128986|radiotherapy|radiotherapy
728350|NCT00128986|brain|brain
728351|NCT00128973|CGD|cgd
728352|NCT00128973|LAD|lad
728353|NCT00128973|XSCID|xscid
728354|NCT00128973|cGVHD|cgvhd
728355|NCT00128973|Infection|infection
728356|NCT00128973|Abnormal Immune Function|abnormal immune function
728357|NCT00128973|Recurrent Infection|recurrent infection
728358|NCT00128973|Chronic Granulomatous Disease|chronic granulomatous disease
728359|NCT00128973|X-Linked Severe Combined Immune Deficiency (XSCID)|x-linked severe combined immune deficiency (xscid)
728360|NCT00128973|Leukocyte Adhesion Deficiency 1|leukocyte adhesion deficiency 1
728361|NCT00128973|Healthy Volunteer|healthy volunteer
728362|NCT00128973|HV|hv
728363|NCT00128960|Allogeneic Hematopoietic Stem Cell Transplant|allogeneic hematopoietic stem cell transplant
728364|NCT00128960|Health Related Quality of Life|health related quality of life
728365|NCT00128960|Symptom Experience|symptom experience
728366|NCT00128960|Fatigue|fatigue
728367|NCT00128960|Functional Status|functional status
728368|NCT00128960|Survey|survey
728369|NCT00128960|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
728370|NCT00128947|Immunosuppresant|immunosuppresant
729130|NCT00126035|Treatment|treatment
728371|NCT00128947|Pharmacogenetics|pharmacogenetics
728372|NCT00128947|Glucuronidation|glucuronidation
728373|NCT00128947|Metabolism|metabolism
728374|NCT00128947|UGT|ugt
728375|NCT00128934|Premenstrual Syndrome (PMS)|premenstrual syndrome (pms)
728376|NCT00128934|Hormone Therapy|hormone therapy
728377|NCT00128921|Multiple Myeloma|multiple myeloma
728378|NCT00128908|HIV-1|hiv-1
728379|NCT00128908|HAART|haart
728380|NCT00128908|sequential HAART|sequential haart
728381|NCT00128908|resistance|resistance
728382|NCT00128908|salvage therapy|salvage therapy
728383|NCT00128908|Treatment Experienced|treatment experienced
728384|NCT00128895|Wegener's granulomatosis, ANCA, vasculitis, proteinase 3|wegener's granulomatosis, anca, vasculitis, proteinase 3
728385|NCT00128895|ANCA-associated vasculitis|anca-associated vasculitis
728386|NCT00128895|ANCA|anca
728387|NCT00128882|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
728388|NCT00128882|Treatment|treatment
728389|NCT00128882|Anti-D|anti-d
728390|NCT00128882|Subcutaneous|subcutaneous
728391|NCT00128882|Clinical evaluation|clinical evaluation
728392|NCT00128882|Platelet count|platelet count
728393|NCT00128882|IVIG|ivig
728394|NCT00128869|Manipulation|manipulation
728395|NCT00128869|Mobilization|mobilization
728396|NCT00128869|Neck Pain|neck pain
728397|NCT00128869|Physical Therapy|physical therapy
728398|NCT00128856|Neoadjuvant chemotherapy.|neoadjuvant chemotherapy.
728399|NCT00128856|Stage III disease.|stage iii disease.
728400|NCT00128843|Metastatic breast cancer|metastatic breast cancer
728401|NCT00128843|First line of hormone treatment|first line of hormone treatment
728402|NCT00128843|Postmenopausal women|postmenopausal women
728403|NCT00128843|Positive hormone receptor tumours|positive hormone receptor tumours
728404|NCT00128830|Human Immunodeficiency Virus Type 1|human immunodeficiency virus type 1
728405|NCT00128830|HIV-1 infection|hiv-1 infection
728406|NCT00128830|TMC125|tmc125
728407|NCT00128830|Etravirine|etravirine
728408|NCT00128830|Enfuvirtide|enfuvirtide
728409|NCT00128830|Antiretroviral therapy|antiretroviral therapy
728410|NCT00128817|neoplasm|neoplasm
728411|NCT00128817|larynx|larynx
728412|NCT00128817|surgery|surgery
728413|NCT00128817|radiotherapy|radiotherapy
728414|NCT00128817|chemotherapy|chemotherapy
728415|NCT00128804|vitamin A|vitamin a
728416|NCT00128804|beta Carotene|beta carotene
728417|NCT00128804|diet|diet
728418|NCT00128804|nutrition|nutrition
728419|NCT00128804|nutritional requirements|nutritional requirements
728420|NCT00128791|myocardial infarction|myocardial infarction
728421|NCT00128791|angioplasty|angioplasty
728422|NCT00128791|nitric oxide|nitric oxide
728423|NCT00128791|prevention|prevention
728424|NCT00128791|acute myocardial infarction|acute myocardial infarction
728425|NCT00128778|Breast cancer|breast cancer
728426|NCT00128778|Metastases|metastases
728427|NCT00128778|Maintenance treatment|maintenance treatment
728428|NCT00128765|chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
728429|NCT00128765|self-management|self-management
728430|NCT00128765|practice nurse|practice nurse
728431|NCT00128765|cost-effectiveness|cost-effectiveness
728432|NCT00128765|randomized controlled trial|randomized controlled trial
728433|NCT00128752|vitamin A|vitamin a
728434|NCT00128752|beta Carotene|beta carotene
728435|NCT00128752|diet|diet
728436|NCT00128752|nutrition|nutrition
728437|NCT00128752|nutritional requirements|nutritional requirements
728438|NCT00128726|continuous combined oral contraceptive|continuous combined oral contraceptive
728439|NCT00128726|endometrial and ovarian suppression|endometrial and ovarian suppression
728440|NCT00128713|Blood Transfusion|blood transfusion
728441|NCT00128713|Blood Platelets|blood platelets
728442|NCT00128700|adult glioblastoma|adult glioblastoma
728443|NCT00128700|adult giant cell glioblastoma|adult giant cell glioblastoma
728444|NCT00128700|adult gliosarcoma|adult gliosarcoma
728445|NCT00128661|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
728446|NCT00128661|cervical cancer|cervical cancer
728447|NCT00128661|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
728448|NCT00128635|adult glioblastoma|adult glioblastoma
728449|NCT00128635|adult gliosarcoma|adult gliosarcoma
728450|NCT00128635|adult giant cell glioblastoma|adult giant cell glioblastoma
728451|NCT00128635|recurrent adult brain tumor|recurrent adult brain tumor
728452|NCT00128622|male breast cancer|male breast cancer
728453|NCT00128622|recurrent breast cancer|recurrent breast cancer
728454|NCT00128622|stage IV breast cancer|stage iv breast cancer
728455|NCT00128622|recurrent colon cancer|recurrent colon cancer
728456|NCT00128622|stage IV colon cancer|stage iv colon cancer
728457|NCT00128622|recurrent rectal cancer|recurrent rectal cancer
728458|NCT00128622|stage IV rectal cancer|stage iv rectal cancer
728459|NCT00128622|recurrent pancreatic cancer|recurrent pancreatic cancer
728460|NCT00128622|extensive stage small cell lung cancer|extensive stage small cell lung cancer
728461|NCT00128622|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
728462|NCT00128622|recurrent small cell lung cancer|recurrent small cell lung cancer
728463|NCT00128622|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
728567|NCT00128232|newly diagnosed|newly diagnosed
728464|NCT00128622|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
728465|NCT00128622|stage IV pancreatic cancer|stage iv pancreatic cancer
728466|NCT00128596|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
728467|NCT00128596|advanced adult primary liver cancer|advanced adult primary liver cancer
728468|NCT00128596|recurrent adult primary liver cancer|recurrent adult primary liver cancer
728469|NCT00128583|stage III melanoma|stage iii melanoma
728470|NCT00128570|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
728471|NCT00128557|Vitamin A|vitamin a
728472|NCT00128557|Newborn health|newborn health
728473|NCT00128557|Infant Mortality|infant mortality
728474|NCT00128557|Supplementation|supplementation
728475|NCT00128557|Micronutrients|micronutrients
728476|NCT00128557|Bangladesh|bangladesh
728477|NCT00128531|Phase III|phase iii
728478|NCT00128531|open label|open label
728479|NCT00128531|multiple dose|multiple dose
728480|NCT00128531|safety study|safety study
728481|NCT00128531|pharmacokinetic study|pharmacokinetic study
728482|NCT00128531|efficacy study|efficacy study
728483|NCT00128518|Hypertension - Drugs - Blood pressure response - Responders - pharmacogenetics|hypertension - drugs - blood pressure response - responders - pharmacogenetics
728484|NCT00128505|PMD|pmd
728485|NCT00128505|Depression|depression
728486|NCT00128505|Psychosis|psychosis
728487|NCT00128505|Psychotic Major Depression|psychotic major depression
728488|NCT00128505|Major Depression|major depression
728489|NCT00128492|cystic fibrosis|cystic fibrosis
728490|NCT00128492|Pseudomonas aeruginosa|pseudomonas aeruginosa
728491|NCT00128479|PMD|pmd
728492|NCT00128479|Psychotic Depression|psychotic depression
728493|NCT00128479|Psychosis|psychosis
728494|NCT00128479|Major Depression|major depression
728495|NCT00128479|Depression|depression
728496|NCT00128479|Psychotic Major Depression|psychotic major depression
728497|NCT00128466|bubonic plague|bubonic plague
728498|NCT00128466|pneumonic plague|pneumonic plague
728499|NCT00128466|septicemic plague|septicemic plague
728500|NCT00128466|Yersinia pestis|yersinia pestis
728501|NCT00128466|Pasteurella pestis|pasteurella pestis
728502|NCT00128453|Pericarditis|pericarditis
728503|NCT00128453|Recurrence|recurrence
728504|NCT00128453|Therapeutics|therapeutics
728505|NCT00128453|Prevention|prevention
728506|NCT00128453|Colchicine|colchicine
728507|NCT00128427|Postpericardiotomy Syndrome|postpericardiotomy syndrome
728508|NCT00128427|Pericarditis|pericarditis
728509|NCT00128427|Prevention|prevention
728510|NCT00128427|Colchicine|colchicine
728511|NCT00128427|Recurrence|recurrence
728512|NCT00128414|Pericarditis|pericarditis
728513|NCT00128414|Recurrence|recurrence
728514|NCT00128414|Therapeutics|therapeutics
728515|NCT00128414|Prevention|prevention
728516|NCT00128414|Colchicine|colchicine
728517|NCT00128401|Cognitive|cognitive
728518|NCT00128401|Behavioral|behavioral
728519|NCT00128401|Adolescent|adolescent
728520|NCT00128401|Therapy|therapy
728521|NCT00128401|Extinction|extinction
728522|NCT00128401|Social Phobia|social phobia
728523|NCT00128388|panic disorder,|panic disorder,
728524|NCT00128388|psychodynamic psychotherapy,|psychodynamic psychotherapy,
728525|NCT00128388|efficacy trial|efficacy trial
728526|NCT00128375|Smoking Cessation|smoking cessation
728527|NCT00128375|Work-site|work-site
728528|NCT00128375|Incentives|incentives
728529|NCT00128375|Cost Effectiveness|cost effectiveness
728530|NCT00128375|Health Behavior|health behavior
728531|NCT00128375|Smoking|smoking
728532|NCT00128362|Sentinel node|sentinel node
728533|NCT00128362|Axillary sampling|axillary sampling
728534|NCT00128362|Operable breast cancer|operable breast cancer
728535|NCT00128336|Weight|weight
728536|NCT00128336|Diet|diet
728537|NCT00128336|exercise|exercise
728538|NCT00128336|maintenance|maintenance
728539|NCT00128323|Children|children
728540|NCT00128323|oropharyngeal candidiasis|oropharyngeal candidiasis
728541|NCT00128323|GV solution|gv solution
728542|NCT00128323|nystatin drops|nystatin drops
728543|NCT00128310|Drug-resistant metastatic breast cancer|drug-resistant metastatic breast cancer
728544|NCT00128297|Breast cancer patients with symptomatic bone metastases|breast cancer patients with symptomatic bone metastases
728545|NCT00128284|gastroparesis|gastroparesis
728546|NCT00128284|Digestive|digestive
728547|NCT00128284|Gastrointestinal|gastrointestinal
728548|NCT00128284|Stomach|stomach
728549|NCT00128284|Motility|motility
728550|NCT00128284|Non-Invasive|non-invasive
728551|NCT00128284|Capsule|capsule
728552|NCT00128284|GI|gi
728553|NCT00128284|Device|device
728554|NCT00128284|Digestive System Diseases|digestive system diseases
728555|NCT00128271|HCV|hcv
728556|NCT00128271|monoclonal antibody|monoclonal antibody
728557|NCT00128271|phase 1|phase 1
728558|NCT00128258|Stem Cell|stem cell
728559|NCT00128258|Heart Failure|heart failure
728560|NCT00128258|Bone Marrow|bone marrow
728561|NCT00128245|KCS|kcs
728562|NCT00128245|dry eye|dry eye
728563|NCT00128245|pimecrolimus|pimecrolimus
728564|NCT00128245|Keratoconjunctivitis sicca (dry eye syndrome)|keratoconjunctivitis sicca (dry eye syndrome)
728565|NCT00128232|Acromegaly|acromegaly
728568|NCT00128232|octreotide LAR|octreotide lar
728569|NCT00128219|Group B Streptococcus, women, vaccine|group b streptococcus, women, vaccine
728570|NCT00128206|LTBI, tuberculosis, rifampin, isoniazid, prisoners|ltbi, tuberculosis, rifampin, isoniazid, prisoners
728571|NCT00128193|leprosy, Mycobacterium leprae, Hansen's Disease, skin test, Nepal|leprosy, mycobacterium leprae, hansen's disease, skin test, nepal
728572|NCT00128180|hantaviruses, methylprednisolone, cardiopulmonary syndrome|hantaviruses, methylprednisolone, cardiopulmonary syndrome
728573|NCT00128154|Chromium|chromium
728574|NCT00128154|Chromium picolinate|chromium picolinate
728575|NCT00128154|Blood Glucose|blood glucose
728576|NCT00128154|Cholesterol|cholesterol
728577|NCT00128154|Complementary Therapies|complementary therapies
728578|NCT00128128|Vaccinium macrocarpon|vaccinium macrocarpon
728579|NCT00128128|Cranberry|cranberry
728580|NCT00128128|Complementary Therapies|complementary therapies
728581|NCT00128102|Advanced malignant pleural mesothelioma|advanced malignant pleural mesothelioma
728582|NCT00128089|Obesity|obesity
728583|NCT00128089|Dietary treatment|dietary treatment
728584|NCT00128089|Fasting as medical therapy|fasting as medical therapy
728585|NCT00128076|shoulder surgery|shoulder surgery
728586|NCT00128076|rotator cuff|rotator cuff
728587|NCT00128076|arthroscopic repair|arthroscopic repair
728588|NCT00128076|mini-open repair|mini-open repair
728589|NCT00128063|HIV-1|hiv-1
728590|NCT00128063|succinylated human serum albumin|succinylated human serum albumin
728591|NCT00128063|Treatment Naive|treatment naive
728592|NCT00128050|Spontaneous intracerebral hemorrhage|spontaneous intracerebral hemorrhage
728593|NCT00128050|ICH|ich
728594|NCT00128050|intracerebral rebleeding|intracerebral rebleeding
728595|NCT00128050|cerebral hematoma evacuation|cerebral hematoma evacuation
728596|NCT00128050|cerebral hematoma volume|cerebral hematoma volume
728597|NCT00128037|pulmonary neoplasm|pulmonary neoplasm
728598|NCT00128037|preoperative chemoradiotherapy|preoperative chemoradiotherapy
728599|NCT00128037|surgical resection|surgical resection
728600|NCT00128037|superior sulcus tumor|superior sulcus tumor
728601|NCT00128037|chest wall invasion|chest wall invasion
728602|NCT00128037|mytomicin C|mytomicin c
728603|NCT00128037|vindesine|vindesine
728604|NCT00128037|cisplatin|cisplatin
728605|NCT00128024|randomized prospective study|randomized prospective study
728606|NCT00128024|lipid-lowering therapy with any available statins|lipid-lowering therapy with any available statins
728607|NCT00128024|multicenter study|multicenter study
728608|NCT00128024|Japanese|japanese
728609|NCT00128024|acute myocardial infarction|acute myocardial infarction
728610|NCT00128024|primary percutaneous coronary intervention|primary percutaneous coronary intervention
728611|NCT00128011|watery diarrhea|watery diarrhea
728612|NCT00128011|cholera vaccine|cholera vaccine
728613|NCT00127998|malaria|malaria
728614|NCT00127998|Plasmodium falciparum|plasmodium falciparum
728615|NCT00127998|drug resistance|drug resistance
728616|NCT00127998|antimalarials|antimalarials
728617|NCT00127998|genotype|genotype
728618|NCT00127998|treatment outcome|treatment outcome
728619|NCT00127985|multiple organ dysfunction syndrome|multiple organ dysfunction syndrome
728620|NCT00127985|corticosteroids|corticosteroids
728621|NCT00127985|mortality|mortality
728622|NCT00127972|nevirapine|nevirapine
728623|NCT00127972|efavirenz|efavirenz
728624|NCT00127972|hiv-1|hiv-1
728625|NCT00127972|Treatment Experienced|treatment experienced
728626|NCT00127959|HIV-1|hiv-1
728627|NCT00127959|HBV|hbv
728628|NCT00127959|treatment|treatment
728629|NCT00127959|tenofovir|tenofovir
728630|NCT00127959|emtricitabine|emtricitabine
728631|NCT00127959|Treatment Naive|treatment naive
728632|NCT00127959|HIV-1 infection|hiv-1 infection
728633|NCT00127959|Hepatitis B virus infection|hepatitis b virus infection
728634|NCT00127907|Out-of-hospital cardiac arrest - Vasopressin - Epinephrine|out-of-hospital cardiac arrest - vasopressin - epinephrine
728635|NCT00127881|Refractory or intolerant to Mycosis Fungoides and sezary syndrome|refractory or intolerant to mycosis fungoides and sezary syndrome
728636|NCT00127881|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
728637|NCT00127881|To evaluate the efficacy and safety of zanolimumab in Mycosis Fungoides and sezary syndrome|to evaluate the efficacy and safety of zanolimumab in mycosis fungoides and sezary syndrome
728638|NCT00127868|Tinea Capitis|tinea capitis
728639|NCT00127868|Children|children
728640|NCT00127868|Pediatric|pediatric
728641|NCT00127868|Treatment|treatment
728642|NCT00127868|Therapy|therapy
728643|NCT00127868|Adjunctive|adjunctive
728644|NCT00127868|Selenium Sulfide|selenium sulfide
728645|NCT00127868|Ciclopirox|ciclopirox
728646|NCT00127868|Shampoo|shampoo
728647|NCT00127855|Invasive bacterial disease caused by Hib|invasive bacterial disease caused by hib
728648|NCT00127855|Neisseria meningitidis serogroups C & Y|neisseria meningitidis serogroups c & y
728649|NCT00127842|Psoriatic Arthritis|psoriatic arthritis
728650|NCT00127842|PsA|psa
728651|NCT00127842|Commercial product|commercial product
728652|NCT00127842|American College of Rheumatology|american college of rheumatology
728653|NCT00127842|ACR/PASI|acr/pasi
728654|NCT00127829|Solid Tumors|solid tumors
728655|NCT00127816|brachytherapy|brachytherapy
728656|NCT00127816|implant radiotherapy|implant radiotherapy
728657|NCT00127803|Clostridium difficile|clostridium difficile
728658|NCT00127790|Insomnia|insomnia
728661|NCT00127790|Pain, Chronic|pain, chronic
728662|NCT00127790|Behavior Therapy|behavior therapy
728663|NCT00127790|CBT|cbt
728664|NCT00127790|CBT-I|cbt-i
728665|NCT00127790|cognitive-behavioral|cognitive-behavioral
728666|NCT00127777|HCV genotype 1|hcv genotype 1
728667|NCT00127777|peginterferon alfa-2a|peginterferon alfa-2a
728668|NCT00127777|ribavirin|ribavirin
728669|NCT00127777|amantadine|amantadine
728670|NCT00127777|treatment-naive|treatment-naive
728671|NCT00127764|pemphigus|pemphigus
728672|NCT00127764|dexamethasone|dexamethasone
728673|NCT00127764|glucocorticoids|glucocorticoids
728674|NCT00127764|pulse|pulse
728675|NCT00127764|therapy|therapy
728676|NCT00127764|randomised|randomised
728677|NCT00127764|placebo-controlled|placebo-controlled
728678|NCT00127751|Risk factor reduction|risk factor reduction
728679|NCT00127751|cardiovascular disease prevention|cardiovascular disease prevention
728680|NCT00127738|Hypertension|hypertension
728681|NCT00127738|Renal artery stenosis|renal artery stenosis
728682|NCT00127738|Kidney disease|kidney disease
728683|NCT00127738|Renal vascular disease|renal vascular disease
728684|NCT00127738|Atherosclerosis|atherosclerosis
728685|NCT00127725|tibia|tibia
728686|NCT00127725|fracture|fracture
728687|NCT00127725|PEMF|pemf
728688|NCT00127725|electromagnetic|electromagnetic
728689|NCT00127725|non-union|non-union
728690|NCT00127725|revision|revision
728691|NCT00127725|Diaphyseal fractures of the tibia|diaphyseal fractures of the tibia
728692|NCT00127712|amiodarone|amiodarone
728693|NCT00127712|atrial fibrillation|atrial fibrillation
728694|NCT00127712|surgical procedures, thoracic|surgical procedures, thoracic
728695|NCT00127699|Umbilical cord|umbilical cord
728696|NCT00127699|Triple dye|triple dye
728697|NCT00127699|Infant care|infant care
728698|NCT00127686|cough|cough
728699|NCT00127686|nocturnal cough|nocturnal cough
728700|NCT00127686|upper respiratory tract infection|upper respiratory tract infection
728701|NCT00127686|sleep quality|sleep quality
728702|NCT00127686|childhood cough|childhood cough
728703|NCT00127686|Dextromethorphan|dextromethorphan
728704|NCT00127686|Honey|honey
728705|NCT00127673|Antidepressants|antidepressants
728706|NCT00127673|Cognitive behavior therapy|cognitive behavior therapy
728707|NCT00127660|Behavior|behavior
728708|NCT00127621|ICU patients needing prolonged ventilatory support|icu patients needing prolonged ventilatory support
728709|NCT00127595|carcinoma of the urothelial tract|carcinoma of the urothelial tract
728710|NCT00127582|Myotonic dystrophy type 1|myotonic dystrophy type 1
728711|NCT00127582|Sudden cardiac death|sudden cardiac death
728712|NCT00127582|Ventricular tachyarrhythmias|ventricular tachyarrhythmias
728713|NCT00127582|Bradyarrhythmias|bradyarrhythmias
728714|NCT00127569|HIV infections|hiv infections
728715|NCT00127569|Giant Lymph Node Hyperplasia|giant lymph node hyperplasia
728716|NCT00127569|Herpesvirus 8, Human|herpesvirus 8, human
728717|NCT00127569|Rituximab (Mabthera)|rituximab (mabthera)
728718|NCT00127569|Antibodies, Monoclonal|antibodies, monoclonal
728719|NCT00127556|Transfusion|transfusion
728720|NCT00127556|Safety|safety
728721|NCT00127543|Medication Education|medication education
728722|NCT00127543|Pediatric|pediatric
728723|NCT00127530|Walking Ability|walking ability
728724|NCT00127517|Oncology|oncology
728725|NCT00127517|Palliative Care|palliative care
728726|NCT00127517|Advanced Cancer|advanced cancer
728727|NCT00127517|Palliative Cancer Care|palliative cancer care
728728|NCT00127504|Onchocerciasis|onchocerciasis
728729|NCT00127504|Wolbachia|wolbachia
728730|NCT00127504|Therapy|therapy
728731|NCT00127491|Acute Lung Injury|acute lung injury
728732|NCT00127491|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
728733|NCT00127491|Mechanical Ventilation|mechanical ventilation
728734|NCT00127491|Esophageal Pressures|esophageal pressures
728735|NCT00127491|Randomized Controlled Trial|randomized controlled trial
728736|NCT00127478|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
728737|NCT00127478|Adenocarcinoma of the Prostate|adenocarcinoma of the prostate
728738|NCT00127465|Medical Informatics|medical informatics
728739|NCT00127465|Patient education|patient education
728740|NCT00127465|Social support|social support
728741|NCT00127465|Cancer|cancer
728742|NCT00127465|Anxiety|anxiety
728743|NCT00127452|alpha-linolenic acid|alpha-linolenic acid
728744|NCT00127452|cardiovascular diseases|cardiovascular diseases
728745|NCT00127452|coronary heart disease|coronary heart disease
728746|NCT00127452|coronary patients|coronary patients
728747|NCT00127452|DHA|dha
728748|NCT00127452|dietary intervention|dietary intervention
728749|NCT00127452|dietary supplementation|dietary supplementation
728750|NCT00127452|docosahexaenoic acid|docosahexaenoic acid
728751|NCT00127452|eicosapentaenoic acid|eicosapentaenoic acid
728752|NCT00127452|EPA|epa
728753|NCT00127452|fish oil|fish oil
728754|NCT00127452|fish fatty acids|fish fatty acids
728755|NCT00127452|human subjects|human subjects
728756|NCT00127452|ischaemic heart disease|ischaemic heart disease
728757|NCT00127452|margarine|margarine
728758|NCT00127452|marine fatty acids|marine fatty acids
728759|NCT00127452|mortality|mortality
728760|NCT00127452|myocardial infarction|myocardial infarction
728761|NCT00127452|n-3 fatty acids|n-3 fatty acids
728762|NCT00127452|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
728763|NCT00127452|n-3 PUFA|n-3 pufa
728764|NCT00127452|omega-3 fatty acids|omega-3 fatty acids
728765|NCT00127452|omega-3 polyunsaturated fatty acids|omega-3 polyunsaturated fatty acids
728766|NCT00127452|prevention|prevention
728767|NCT00127452|randomized controlled trial|randomized controlled trial
728768|NCT00127452|secondary prevention|secondary prevention
728769|NCT00127439|Ambulatory Disability|ambulatory disability
728770|NCT00127439|Disability Ambulation|disability ambulation
728771|NCT00127439|Locomotion Disorders|locomotion disorders
728772|NCT00127439|Motor Activity|motor activity
728773|NCT00127439|Rehabilitation|rehabilitation
728774|NCT00127439|Spinal Cord Injury|spinal cord injury
728775|NCT00127413|Chronic pain|chronic pain
728776|NCT00127413|Co-morbid|co-morbid
728777|NCT00127413|Intervention|intervention
728778|NCT00127413|Posttraumatic Stress Disorder|posttraumatic stress disorder
728779|NCT00127413|Treatment|treatment
728780|NCT00127400|anger|anger
728781|NCT00127400|intermittent|intermittent
728782|NCT00127400|explosive|explosive
728783|NCT00127387|Bone metastasis|bone metastasis
728784|NCT00127387|Radiation therapy|radiation therapy
728785|NCT00127387|Lung cancer|lung cancer
728786|NCT00127387|Prostate cancer|prostate cancer
728787|NCT00127387|Advanced lung cancer receiving radiation therapy|advanced lung cancer receiving radiation therapy
728788|NCT00127387|Advanced prostate cancer receiving radiation therapy|advanced prostate cancer receiving radiation therapy
728789|NCT00127387|Any cancer with bone mets receiving radiation therapy|any cancer with bone mets receiving radiation therapy
728790|NCT00127374|Overweight; self-esteem; depression|overweight; self-esteem; depression
728791|NCT00127361|doula|doula
728792|NCT00127361|caregivers|caregivers
728793|NCT00127361|labor support|labor support
728794|NCT00127361|being with woman|being with woman
728795|NCT00127361|continuous labor support|continuous labor support
728796|NCT00127361|maternal outcomes|maternal outcomes
728797|NCT00127361|Parturition|parturition
728798|NCT00127335|rhabdomyolysis,|rhabdomyolysis,
728799|NCT00127335|myositis,|myositis,
728800|NCT00127335|myopathy,|myopathy,
728801|NCT00127335|statin side effects,|statin side effects,
728802|NCT00127335|fatty acid oxidation|fatty acid oxidation
728803|NCT00127335|Statin induced Muscle toxicity|statin induced muscle toxicity
728804|NCT00127322|Heart Failure, Congestive|heart failure, congestive
728805|NCT00127322|survival|survival
728806|NCT00127322|patient admission|patient admission
728807|NCT00127309|hangover|hangover
728808|NCT00127309|hangover symptoms|hangover symptoms
728810|NCT00127270|Overactive Bladder|overactive bladder
728811|NCT00127270|Bladder hyperactivity|bladder hyperactivity
728812|NCT00127270|Urge Incontinence|urge incontinence
728813|NCT00127270|Incontinence|incontinence
728814|NCT00127270|Bladder|bladder
728815|NCT00127257|Constipation|constipation
728816|NCT00127257|Biofeedback|biofeedback
728817|NCT00127257|Dyssynergia|dyssynergia
728818|NCT00127257|Pelvic floor dyssynergia|pelvic floor dyssynergia
728819|NCT00127257|Outlet dysfunction|outlet dysfunction
728820|NCT00127231|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
728821|NCT00127231|Alcohol Consumption|alcohol consumption
728822|NCT00127231|Behavioral Research|behavioral research
728823|NCT00127231|HIV|hiv
728824|NCT00127231|Alcohol Abuse|alcohol abuse
728825|NCT00127218|atherosclerotic plaque|atherosclerotic plaque
728826|NCT00127218|MRI|mri
728827|NCT00127218|inflammatory markers|inflammatory markers
728828|NCT00127218|statins|statins
728829|NCT00127205|stage I breast cancer|stage i breast cancer
728830|NCT00127205|stage II breast cancer|stage ii breast cancer
728831|NCT00127205|stage IIIA breast cancer|stage iiia breast cancer
728832|NCT00127205|stage IIIB breast cancer|stage iiib breast cancer
728833|NCT00127205|stage IIIC breast cancer|stage iiic breast cancer
728834|NCT00127127|Solid tumors|solid tumors
728835|NCT00127114|Behavioral disturbance|behavioral disturbance
728836|NCT00127114|Frontotemporal dementia|frontotemporal dementia
728837|NCT00127114|Dementia|dementia
728838|NCT00127114|Amantadine|amantadine
728839|NCT00127114|Behavioral disturbance due to frontotemporal dementia|behavioral disturbance due to frontotemporal dementia
728840|NCT00127088|Patients with localized Gleason 7 pT2a-pT2b adenocarcinoma of the prostate|patients with localized gleason 7 pt2a-pt2b adenocarcinoma of the prostate
728841|NCT00127075|Multiple sclerosis. Relapses. Post partum. Pregnancy. Delivery. Hormones. Progesterone. Estradiol. Clinical trial. Prevention.|multiple sclerosis. relapses. post partum. pregnancy. delivery. hormones. progesterone. estradiol. clinical trial. prevention.
728842|NCT00127062|Exposure to Oxford Street|exposure to oxford street
728843|NCT00127062|Exposure to Hyde Park|exposure to hyde park
728844|NCT00127049|Patients with relapsed non-seminomatous germ-cell tumors (NSGCT)|patients with relapsed non-seminomatous germ-cell tumors (nsgct)
728845|NCT00127036|colon|colon
728846|NCT00127036|adenocarcinoma|adenocarcinoma
728847|NCT00127036|adenocarcinoma-colon|adenocarcinoma-colon
728848|NCT00127036|adenocarcinoma-rectum|adenocarcinoma-rectum
728849|NCT00127023|Prophylaxis measles, mumps, rubella and chickenpox|prophylaxis measles, mumps, rubella and chickenpox
728948|NCT00126646|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
728850|NCT00127010|Prophylaxis measles, mumps, rubella and chickenpox|prophylaxis measles, mumps, rubella and chickenpox
728851|NCT00126997|Prophylaxis measles, mumps, rubella and chickenpox|prophylaxis measles, mumps, rubella and chickenpox
728852|NCT00126984|Safety|safety
728853|NCT00126984|Reactogenicity|reactogenicity
728854|NCT00126984|Immunogenicity|immunogenicity
728855|NCT00126984|Meningococcal vaccine|meningococcal vaccine
728856|NCT00126984|Dose selection|dose selection
728857|NCT00126984|Conjugate vaccine|conjugate vaccine
728858|NCT00126971|malaria|malaria
728859|NCT00126971|pregnancy|pregnancy
728860|NCT00126971|Plasmodium falciparum|plasmodium falciparum
728861|NCT00126971|antimalarials|antimalarials
728862|NCT00126971|pharmacokinetics|pharmacokinetics
728863|NCT00126971|treatment outcome|treatment outcome
728864|NCT00126971|safety|safety
728865|NCT00126958|superficial urothelial cell carcinoma|superficial urothelial cell carcinoma
728866|NCT00126958|urinary analysis|urinary analysis
728867|NCT00126958|Loss of heterozygosity|loss of heterozygosity
728868|NCT00126958|FGFR3 mutation|fgfr3 mutation
728869|NCT00126958|follow-up|follow-up
728870|NCT00126945|Meningococcal serogroups A, C, W-135, Y disease|meningococcal serogroups a, c, w-135, y disease
728871|NCT00126906|Malaria|malaria
728872|NCT00126906|Pregnancy|pregnancy
728873|NCT00126906|HIV|hiv
728874|NCT00126893|Leukemia|leukemia
728875|NCT00126893|AML|aml
728876|NCT00126893|CC401|cc401
728877|NCT00126893|CC-401|cc-401
728878|NCT00126893|Celgene|celgene
728879|NCT00126893|High Risk Myeloid Leukemia|high risk myeloid leukemia
728880|NCT00126893|Myeloid Leukemia|myeloid leukemia
728881|NCT00126880|Human Immunodeficiency Virus|human immunodeficiency virus
728882|NCT00126880|anti-retroviral therapy|anti-retroviral therapy
728883|NCT00126880|nucleoside analogue|nucleoside analogue
728884|NCT00126880|reverse transcriptase|reverse transcriptase
728885|NCT00126880|lamivudine|lamivudine
728886|NCT00126880|resistance mutation|resistance mutation
728887|NCT00126880|Treatment Experienced|treatment experienced
728888|NCT00126867|thymidylate synthase polymers|thymidylate synthase polymers
728889|NCT00126867|rapecitabine|rapecitabine
728890|NCT00126867|adjuvant|adjuvant
728891|NCT00126867|colon cancer|colon cancer
728892|NCT00126867|toxicity|toxicity
728893|NCT00126867|Stage II colon cancer|stage ii colon cancer
728894|NCT00126867|Stage III colon cancer|stage iii colon cancer
728895|NCT00126867|adenocarcinoma of the colon|adenocarcinoma of the colon
728896|NCT00126854|brachytherapy|brachytherapy
728897|NCT00126854|magnetic resonance spectroscopy|magnetic resonance spectroscopy
728898|NCT00126841|radiotherapy planning CT/MR fusion|radiotherapy planning ct/mr fusion
728899|NCT00126828|radiotherapy, conformal|radiotherapy, conformal
728900|NCT00126828|lung neoplasm|lung neoplasm
728901|NCT00126828|radiotherapy dosage|radiotherapy dosage
728902|NCT00126815|prostate cancer|prostate cancer
728903|NCT00126815|prostate specific antigen|prostate specific antigen
728904|NCT00126815|radiotherapy|radiotherapy
728905|NCT00126815|mathematical modeling|mathematical modeling
728906|NCT00126802|tomotherapy|tomotherapy
728907|NCT00126802|MRSZ|mrsz
728908|NCT00126802|high risk prostate cancer|high risk prostate cancer
728909|NCT00126789|Pain Cancer|pain cancer
728910|NCT00126789|Chronic Pain|chronic pain
728911|NCT00126776|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
728912|NCT00126776|case management|case management
728913|NCT00126776|self management|self management
728914|NCT00126763|Chronic Pain|chronic pain
728915|NCT00126763|Pain|pain
728916|NCT00126750|Myocardial Infarction|myocardial infarction
728917|NCT00126750|Comorbidities|comorbidities
728918|NCT00126750|Guidelines|guidelines
728919|NCT00126750|Computer Assisted Instruction|computer assisted instruction
728920|NCT00126750|Physician Practice Instruction|physician practice instruction
728921|NCT00126750|Online Systems|online systems
728922|NCT00126737|Elderly|elderly
728923|NCT00126737|Exercise|exercise
728924|NCT00126737|lean body mass|lean body mass
728925|NCT00126737|muscle strength|muscle strength
728926|NCT00126737|Nutrition program|nutrition program
728927|NCT00126737|Pain control|pain control
728928|NCT00126737|stair climb|stair climb
728929|NCT00126737|walking distance|walking distance
728930|NCT00126737|weight loss|weight loss
728931|NCT00126724|tgAAC94|tgaac94
728932|NCT00126724|Rheumatoid arthritis|rheumatoid arthritis
728933|NCT00126724|Inflammatory arthritis|inflammatory arthritis
728934|NCT00126724|Arthritis|arthritis
728935|NCT00126724|Gene therapy|gene therapy
728936|NCT00126724|AAV|aav
728937|NCT00126698|Bacteriuria|bacteriuria
728938|NCT00126698|Urinary Catheter|urinary catheter
728939|NCT00126698|Urinary tract infection|urinary tract infection
728940|NCT00126698|Prophylaxis|prophylaxis
728941|NCT00126698|Urinary catheter removal|urinary catheter removal
728942|NCT00126685|stage IV melanoma|stage iv melanoma
728943|NCT00126685|recurrent melanoma|recurrent melanoma
728944|NCT00126672|angiomyolipoma|angiomyolipoma
728945|NCT00126646|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
728946|NCT00126646|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
728947|NCT00126646|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
728949|NCT00126646|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
728950|NCT00126646|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
728951|NCT00126646|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
728952|NCT00126646|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
728953|NCT00126646|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
728954|NCT00126646|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
728955|NCT00126646|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
728956|NCT00126646|splenic marginal zone lymphoma|splenic marginal zone lymphoma
728957|NCT00126646|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
728958|NCT00126646|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
728959|NCT00126646|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
728960|NCT00126646|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
728961|NCT00126646|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
728962|NCT00126646|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
728963|NCT00126646|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
728964|NCT00126646|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
728965|NCT00126646|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
728966|NCT00126646|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
728967|NCT00126646|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
728968|NCT00126646|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
728969|NCT00126646|prolymphocytic leukemia|prolymphocytic leukemia
728970|NCT00126633|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
728971|NCT00126633|stage IV pancreatic cancer|stage iv pancreatic cancer
728972|NCT00126620|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
728973|NCT00126581|A Phase II Randomized Study of OSI-774|a phase ii randomized study of osi-774
728974|NCT00126555|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
728975|NCT00126555|recurrent skin cancer|recurrent skin cancer
728976|NCT00126555|non-melanomatous skin cancer|non-melanomatous skin cancer
728977|NCT00126555|Radiation|radiation
728978|NCT00126555|ZD1839|zd1839
728979|NCT00126555|Iressa|iressa
728980|NCT00126555|Gefitinib|gefitinib
728981|NCT00126516|silent brain infarction|silent brain infarction
728982|NCT00126516|cognitive decline|cognitive decline
728983|NCT00126516|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
728984|NCT00126516|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors
728985|NCT00126516|hypertension|hypertension
728986|NCT00126477|quality of life|quality of life
728987|NCT00126477|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
728988|NCT00126477|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
728989|NCT00126477|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
728990|NCT00126477|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
728991|NCT00126477|childhood Hodgkin lymphoma|childhood hodgkin lymphoma
728992|NCT00126477|childhood lymphoblastic lymphoma|childhood lymphoblastic lymphoma
728993|NCT00126477|childhood large cell lymphoma|childhood large cell lymphoma
728994|NCT00126477|childhood small noncleaved cell lymphoma|childhood small noncleaved cell lymphoma
728995|NCT00126477|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
728996|NCT00126477|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
728997|NCT00126477|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
728998|NCT00126464|ductal breast carcinoma in situ|ductal breast carcinoma in situ
728999|NCT00126464|breast cancer in situ|breast cancer in situ
729000|NCT00126438|Heart Failure|heart failure
729001|NCT00126438|nuclear cardiology|nuclear cardiology
729002|NCT00126438|sympathetic innervation|sympathetic innervation
729003|NCT00126438|123I-mIBG|123i-mibg
729004|NCT00126425|Heart Failure|heart failure
729005|NCT00126425|nuclear cardiology|nuclear cardiology
729006|NCT00126425|sympathetic innervation|sympathetic innervation
729007|NCT00126425|123I-mIBG|123i-mibg
729008|NCT00126412|Phaeochromocytoma|phaeochromocytoma
729009|NCT00126412|Neuroblastoma|neuroblastoma
729010|NCT00126412|diagnosis|diagnosis
729011|NCT00126412|123I-mIBG|123i-mibg
729012|NCT00126399|rosacea|rosacea
729013|NCT00126399|acne rosacea|acne rosacea
729014|NCT00126386|tumor induced hypercalcemia|tumor induced hypercalcemia
729015|NCT00126386|malignant bone pain|malignant bone pain
729016|NCT00126386|bisphosphonates|bisphosphonates
729017|NCT00126386|cancer|cancer
729018|NCT00126386|palliative|palliative
729019|NCT00126386|Zometa|zometa
729020|NCT00126386|palliative patient|palliative patient
729021|NCT00126386|treatment in community|treatment in community
729022|NCT00126373|Crohn disease|crohn disease
729023|NCT00126373|TNF-alpha|tnf-alpha
729024|NCT00126360|Breast Cancer|breast cancer
729025|NCT00126360|Timing of Radiotherapy|timing of radiotherapy
729026|NCT00126360|Local Control|local control
729027|NCT00126347|betaine|betaine
729028|NCT00126347|serine|serine
729029|NCT00126347|folic acid|folic acid
729030|NCT00126347|methionine load|methionine load
729031|NCT00126347|homocysteine|homocysteine
729032|NCT00126347|cardiovascular health|cardiovascular health
729033|NCT00126347|vascular function|vascular function
729034|NCT00126347|human|human
729035|NCT00126334|Myocardial Infarction|myocardial infarction
729036|NCT00126334|Anemia|anemia
729037|NCT00126334|Erythrocyte Transfusion|erythrocyte transfusion
729038|NCT00126321|AML, relapsed|aml, relapsed
729039|NCT00126321|cladribine|cladribine
729040|NCT00126321|chemotherapy|chemotherapy
729041|NCT00126308|HIV|hiv
729042|NCT00126308|Lipodystrophy|lipodystrophy
729043|NCT00126308|Intervention|intervention
729044|NCT00126308|Poly-L-lactic acid|poly-l-lactic acid
729045|NCT00126308|HIV facial lipoatrophy|hiv facial lipoatrophy
729046|NCT00126308|Treatment Experienced|treatment experienced
729047|NCT00126282|obsessive-compulsive disorder|obsessive-compulsive disorder
729048|NCT00126282|behavior therapy|behavior therapy
729049|NCT00126282|D-Cycloserine|d-cycloserine
729050|NCT00126282|medication|medication
729051|NCT00126282|treatment trial|treatment trial
729052|NCT00126282|placebo-controlled|placebo-controlled
729053|NCT00126282|double-blind|double-blind
729054|NCT00126282|randomized|randomized
729055|NCT00126269|Patients with Carcinoma of Unknown Primary and a Predicted Favorable Prognosis|patients with carcinoma of unknown primary and a predicted favorable prognosis
729056|NCT00126256|Colorectal cancer|colorectal cancer
729057|NCT00126256|metastatic|metastatic
729058|NCT00126256|chemotherapy|chemotherapy
729059|NCT00126256|randomized trial|randomized trial
729060|NCT00126243|AIDS related Lymphoma|aids related lymphoma
729061|NCT00126243|chemotherapy|chemotherapy
729062|NCT00126243|rituximab|rituximab
729063|NCT00126230|hormone-refractory advanced prostate cancer who achieve a response or a stabilization to docetaxel-estramustine|hormone-refractory advanced prostate cancer who achieve a response or a stabilization to docetaxel-estramustine
729064|NCT00126217|Non-specific effects of vaccines|non-specific effects of vaccines
729065|NCT00126217|Infant mortality|infant mortality
729066|NCT00126217|Morbidity|morbidity
729067|NCT00126217|Low income country|low income country
729068|NCT00126217|Malaria|malaria
729069|NCT00126217|BCG|bcg
729070|NCT00126217|immunisation|immunisation
729071|NCT00126217|BCG revaccination|bcg revaccination
729072|NCT00126217|Tuberculin|tuberculin
729073|NCT00126217|Mortality|mortality
729074|NCT00126204|endoleak|endoleak
729075|NCT00126204|doxycycline|doxycycline
729076|NCT00126204|matrix metalloproteinase|matrix metalloproteinase
729077|NCT00126204|inflammation|inflammation
729078|NCT00126204|endograft|endograft
729079|NCT00126204|circulating markers|circulating markers
729080|NCT00126191|Burkitt Lymphoma|burkitt lymphoma
729081|NCT00126191|atypical Burkitt lymphoma|atypical burkitt lymphoma
729082|NCT00126191|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
729083|NCT00126191|rituximab|rituximab
729084|NCT00126178|Kidney Cancer|kidney cancer
729085|NCT00126178|Renal|renal
729086|NCT00126178|Immunotherapy|immunotherapy
729087|NCT00126178|Vaccine|vaccine
729088|NCT00126165|prostate cancer|prostate cancer
729089|NCT00126165|radiotherapy|radiotherapy
729090|NCT00126165|hypofraction|hypofraction
729091|NCT00126165|radiosensitivity|radiosensitivity
729092|NCT00126165|image-guidance|image-guidance
729093|NCT00126152|Falls|falls
729094|NCT00126152|Exercise|exercise
729095|NCT00126152|Fall Risk Factors|fall risk factors
729096|NCT00126152|Older Adults|older adults
729097|NCT00126139|stroke, ischemic|stroke, ischemic
729098|NCT00126139|stenosis, internal carotid artery|stenosis, internal carotid artery
729099|NCT00126139|Acute ischemic stroke|acute ischemic stroke
729100|NCT00126139|Stenosis of extracranial internal carotid artery|stenosis of extracranial internal carotid artery
729101|NCT00126126|Artificial Limbs|artificial limbs
729102|NCT00126126|Evidence based medicine|evidence based medicine
729103|NCT00126126|Exercise|exercise
729104|NCT00126126|Outcomes research|outcomes research
729105|NCT00126126|Physical therapy|physical therapy
729106|NCT00126113|Audiologic rehabilitation|audiologic rehabilitation
729107|NCT00126113|Counseling|counseling
729108|NCT00126100|Stem Cells|stem cells
729109|NCT00126087|dopamine|dopamine
729110|NCT00126087|NMDA receptor|nmda receptor
729111|NCT00126087|brain imaging|brain imaging
729112|NCT00126087|neuroplasticity|neuroplasticity
729113|NCT00126087|learning|learning
729114|NCT00126087|transcranial direct current stimulation|transcranial direct current stimulation
729115|NCT00126087|rehabilitation|rehabilitation
729116|NCT00126087|aging|aging
729117|NCT00126074|Atrial fibrillation, atrial flutter, anti-arrhythmic agents, conversion to normal sinus rhythm|atrial fibrillation, atrial flutter, anti-arrhythmic agents, conversion to normal sinus rhythm
729118|NCT00126061|Atrial fibrillation|atrial fibrillation
729119|NCT00126061|atrial flutter|atrial flutter
729120|NCT00126061|anti-arrhythmic agents|anti-arrhythmic agents
729121|NCT00126061|conversion to normal sinus rhythm|conversion to normal sinus rhythm
729122|NCT00126048|Atopy|atopy
729123|NCT00126048|Statin|statin
729124|NCT00126048|Asthma|asthma
729125|NCT00126048|methacholine|methacholine
729126|NCT00126048|FEV1|fev1
729127|NCT00126035|Acute Migraine|acute migraine
729131|NCT00126035|Aura|aura
729132|NCT00126022|Atrial fibrillation|atrial fibrillation
729133|NCT00126022|atrial flutter|atrial flutter
729134|NCT00126022|anti-arrhythmic agents|anti-arrhythmic agents
729135|NCT00126022|conversion to normal sinus rhythm|conversion to normal sinus rhythm
729136|NCT00125996|ANAEMIA|anaemia
729137|NCT00125996|Iron Deficiency|iron deficiency
729138|NCT00125983|Birth Control Pills|birth control pills
729139|NCT00125983|Oral Contraceptives|oral contraceptives
729140|NCT00125983|Contraceptive Patch|contraceptive patch
729141|NCT00125983|Pharmacokinetics|pharmacokinetics
729142|NCT00125983|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
729143|NCT00125983|Protease Inhibitor|protease inhibitor
729144|NCT00125983|Treatment Experienced|treatment experienced
729145|NCT00125983|Treatment Naive|treatment naive
729146|NCT00125983|Contraception|contraception
729147|NCT00125970|HIV Seronegativity|hiv seronegativity
729148|NCT00125970|HIV Preventive Vaccine|hiv preventive vaccine
729149|NCT00125957|depression|depression
729150|NCT00125957|serotonin|serotonin
729151|NCT00125957|norepinephrine|norepinephrine
729152|NCT00125957|SSRI|ssri
729153|NCT00125957|Wellbutrin|wellbutrin
729154|NCT00125957|bupropion|bupropion
729155|NCT00125957|executive function|executive function
729156|NCT00125957|residual symptoms|residual symptoms
729157|NCT00125931|bipolar disorder|bipolar disorder
729158|NCT00125931|mania|mania
729159|NCT00125931|manic state|manic state
729160|NCT00125931|opiate|opiate
729161|NCT00125931|kappa|kappa
729162|NCT00125918|Hypertension, Pulmonary; Pulmonary Heart Disease|hypertension, pulmonary; pulmonary heart disease
729163|NCT00125905|Primary Care|primary care
729164|NCT00125905|Smoking Cessation|smoking cessation
729165|NCT00125905|Stages of Change Model|stages of change model
729166|NCT00125905|Health Education|health education
729167|NCT00125905|Clinical Practice guideline|clinical practice guideline
729168|NCT00125879|Glycogen Storage Disease Type II|glycogen storage disease type ii
729169|NCT00125879|GSD-II|gsd-ii
729170|NCT00125879|Pompe Disease|pompe disease
729171|NCT00125879|Pompe Disease (Late-onset)|pompe disease (late-onset)
729172|NCT00125879|Acid Maltase Deficiency Disease|acid maltase deficiency disease
729173|NCT00125879|Glycogenosis 2|glycogenosis 2
729174|NCT00125879|Glycogen Storage Disease Type II (GSD-II)|glycogen storage disease type ii (gsd-ii)
729175|NCT00125866|randomised double blind trial|randomised double blind trial
729176|NCT00125866|blood pressure|blood pressure
729177|NCT00125866|cocoa flavonoids|cocoa flavonoids
729178|NCT00125853|blood pressure|blood pressure
729179|NCT00125853|insulin sensitivity|insulin sensitivity
729180|NCT00125853|beta blockers|beta blockers
729181|NCT00125853|randomised double blind crossover trial|randomised double blind crossover trial
729182|NCT00125840|CLO151|clo151
729183|NCT00125840|Clolar|clolar
729184|NCT00125840|Pediatric ALL and AML|pediatric all and aml
729185|NCT00125840|Adult ALL and AML and MDS|adult all and aml and mds
729186|NCT00125827|CLO152|clo152
729187|NCT00125827|Clolar|clolar
729188|NCT00125814|Interferon Alfa-2b|interferon alfa-2b
729189|NCT00125814|HIV infections|hiv infections
729190|NCT00125788|sickle cell disease|sickle cell disease
729191|NCT00125788|sickle cell anemia|sickle cell anemia
729192|NCT00125788|L-glutamine|l-glutamine
729193|NCT00125788|Sickle Cell Anemia (homozygous)|sickle cell anemia (homozygous)
729194|NCT00125788|Sickle ß0-Thalassemia|sickle ß0-thalassemia
729195|NCT00125749|Dendritic|dendritic
729196|NCT00125749|Vaccine|vaccine
729197|NCT00125749|Melanoma|melanoma
729198|NCT00125749|Stage IV metastatic melanoma|stage iv metastatic melanoma
729199|NCT00125723|Phase 4 Clinical Trial|phase 4 clinical trial
729200|NCT00125723|Chemotherapy|chemotherapy
729201|NCT00125723|Neulasta®|neulasta®
729202|NCT00125723|Oncology|oncology
729203|NCT00125723|Malignancy|malignancy
729204|NCT00125710|cryogenic analysis|cryogenic analysis
729205|NCT00125710|oncogenes|oncogenes
729206|NCT00125697|malignant glioma|malignant glioma
729207|NCT00125697|spectroscopy|spectroscopy
729208|NCT00125697|magnetic resonance|magnetic resonance
729209|NCT00125684|transdermal morphine|transdermal morphine
729210|NCT00125684|cancer|cancer
729211|NCT00125684|pain|pain
729212|NCT00125684|bioavailability|bioavailability
729213|NCT00125684|pharmacokinetics|pharmacokinetics
729214|NCT00125684|cancer related pain|cancer related pain
729215|NCT00125684|stable baseline pain|stable baseline pain
729216|NCT00125684|currently taking opioids|currently taking opioids
729217|NCT00125671|Warfarin and Antiplatelet Vascular Evaluation|warfarin and antiplatelet vascular evaluation
729218|NCT00125671|Peripheral vascular disease|peripheral vascular disease
729219|NCT00125671|Atherosclerosis|atherosclerosis
729220|NCT00125671|cardiovascular events|cardiovascular events
729221|NCT00125671|Ischemia|ischemia
729222|NCT00125671|oral anticoagulants|oral anticoagulants
729223|NCT00125671|low ankle-brachial index|low ankle-brachial index
729224|NCT00125671|moderate intensity warfarin|moderate intensity warfarin
729225|NCT00125671|International normalized ratio [INR]|international normalized ratio [inr]
729226|NCT00125658|biomechanics|biomechanics
729227|NCT00125658|Cerebrovascular Accident|cerebrovascular accident
729228|NCT00125658|electromyography|electromyography
729229|NCT00125658|muscular weakness|muscular weakness
729230|NCT00125658|recovery of function|recovery of function
729231|NCT00125658|reflex variability stroke|reflex variability stroke
729232|NCT00125658|upper-extremity kinematics|upper-extremity kinematics
729234|NCT00125645|Left ventricular function|left ventricular function
729235|NCT00125645|Myocardial performance index|myocardial performance index
729236|NCT00125645|Acute myocardial infarction (AMI)|acute myocardial infarction (ami)
729237|NCT00125632|Reading|reading
729238|NCT00125632|Rehabilitation|rehabilitation
729239|NCT00125632|Treatment Outcomes|treatment outcomes
729240|NCT00125632|Low vision|low vision
729241|NCT00125619|biomechanics|biomechanics
729242|NCT00125619|stroke|stroke
729243|NCT00125619|electromyography|electromyography
729244|NCT00125619|Gait disability stroke|gait disability stroke
729245|NCT00125619|locomotor therapy|locomotor therapy
729246|NCT00125619|muscular weakness|muscular weakness
729247|NCT00125619|reflex variability stroke|reflex variability stroke
729248|NCT00125606|AML|aml
729249|NCT00125606|allogeneic HSCT|allogeneic hsct
729250|NCT00125606|reduced intensity conditioning|reduced intensity conditioning
729251|NCT00125606|randomized trail|randomized trail
729252|NCT00125593|Kidney Disease, Chronic|kidney disease, chronic
729253|NCT00125593|LDL cholesterol|ldl cholesterol
729254|NCT00125593|simvastatin|simvastatin
729255|NCT00125593|ezetimibe|ezetimibe
729256|NCT00125593|cardiovascular disease|cardiovascular disease
729257|NCT00125593|atherosclerosis|atherosclerosis
729258|NCT00125580|Obesity|obesity
729259|NCT00125580|Childhood Obesity|childhood obesity
729260|NCT00125580|Infant Sleep|infant sleep
729261|NCT00125580|Infant growth|infant growth
729262|NCT00125580|Infant feeding|infant feeding
729263|NCT00125554|Clinical trial|clinical trial
729264|NCT00125554|double-blind|double-blind
729265|NCT00125554|randomized placebo-controlled trial|randomized placebo-controlled trial
729266|NCT00125554|metyrapone|metyrapone
729267|NCT00125554|Major Depression|major depression
729268|NCT00125541|MeSH: angioneurotic edema, complement 1 inactivators|mesh: angioneurotic edema, complement 1 inactivators
729269|NCT00125541|Hereditary Angioedema Type I or II, Acquired Angioedema|hereditary angioedema type i or ii, acquired angioedema
729270|NCT00125528|chronic pain|chronic pain
729271|NCT00125528|low back pain|low back pain
729272|NCT00125528|D-cycloserine|d-cycloserine
729273|NCT00125515|Heroin|heroin
729274|NCT00125515|Opiates|opiates
729275|NCT00125515|naltrexone|naltrexone
729276|NCT00125515|memantine|memantine
729277|NCT00125502|CMV, Cytomegalovirus, vaccine, women, postpartum|cmv, cytomegalovirus, vaccine, women, postpartum
729278|NCT00125489|chloroquine, malaria, sulfadoxine/pyrimethamine, Malawi|chloroquine, malaria, sulfadoxine/pyrimethamine, malawi
729279|NCT00125476|Postmenopause|postmenopause
729280|NCT00125463|Hypertension|hypertension
729281|NCT00125463|clinical trial|clinical trial
729282|NCT00125463|Candesartan Antihypertensive Survival Evaluation in Japan trial|candesartan antihypertensive survival evaluation in japan trial
729283|NCT00125463|candesartan cilexetil|candesartan cilexetil
729284|NCT00125463|amlodipine besilate|amlodipine besilate
729285|NCT00125450|Acute Bronchiolitis|acute bronchiolitis
729286|NCT00125450|Chest Physiotherapy|chest physiotherapy
729287|NCT00125450|Forced Expiratory Techniques|forced expiratory techniques
729288|NCT00125450|Double Blind Trial|double blind trial
729289|NCT00125450|Children|children
729290|NCT00125450|Pediatric|pediatric
729291|NCT00125450|RESPIRATORY SYNCYTIAL VIRUS|respiratory syncytial virus
729292|NCT00125437|aldosterone antagonists|aldosterone antagonists
729293|NCT00125437|spironolactone|spironolactone
729294|NCT00125437|left ventricular remodeling|left ventricular remodeling
729295|NCT00125424|Colonoscopy|colonoscopy
729296|NCT00125424|Sedation|sedation
729297|NCT00125424|AQUAVAN|aquavan
729298|NCT00125424|(fospropofol disodium)|(fospropofol disodium)
729299|NCT00125424|Endoscopic sedation|endoscopic sedation
729300|NCT00125424|Endoscopic outcomes|endoscopic outcomes
729301|NCT00125424|Endoscopy|endoscopy
729302|NCT00125411|satraplatin|satraplatin
729303|NCT00125411|docetaxel|docetaxel
729304|NCT00125411|cancer|cancer
729305|NCT00125411|Phase I|phase i
729306|NCT00125411|advanced solid tumors|advanced solid tumors
729307|NCT00125398|AQUAVAN|aquavan
729308|NCT00125398|GPI 15715|gpi 15715
729310|NCT00125398|Sedation|sedation
729311|NCT00125385|IPF|ipf
729312|NCT00125385|Idiopathic|idiopathic
729313|NCT00125385|Pulmonary|pulmonary
729314|NCT00125385|Fibrosis|fibrosis
729315|NCT00125372|tarceva|tarceva
729316|NCT00125372|targretin|targretin
729317|NCT00125372|non-small cell lung cancer|non-small cell lung cancer
729318|NCT00125372|carcinoma, non-small cell lung cancer|carcinoma, non-small cell lung cancer
729319|NCT00125372|nsclc|nsclc
729320|NCT00125359|tarceva|tarceva
729321|NCT00125359|targretin|targretin
729322|NCT00125359|non-small cell lung cancer|non-small cell lung cancer
729323|NCT00125359|Carcinoma, non-small cell lung cancer|carcinoma, non-small cell lung cancer
729324|NCT00125359|NSCLC|nsclc
729325|NCT00125346|Tobramycin Inhalation Powder|tobramycin inhalation powder
729326|NCT00125333|atopic dermatitis, eczema|atopic dermatitis, eczema
729327|NCT00125320|Treatment|treatment
729328|NCT00125307|SLE|sle
729329|NCT00125307|glomerulonephritis|glomerulonephritis
729330|NCT00125307|immunosuppressive therapy|immunosuppressive therapy
729331|NCT00125307|type V (membranous) lupus nephritis|type v (membranous) lupus nephritis
729332|NCT00125294|cancer pain|cancer pain
729333|NCT00125294|breakthrough pain|breakthrough pain
729334|NCT00125294|methadone|methadone
729335|NCT00125294|dose titration|dose titration
729336|NCT00125294|sublingual route of administration|sublingual route of administration
729337|NCT00125294|Cancer related pain|cancer related pain
729338|NCT00125294|currently taking narcotics|currently taking narcotics
729339|NCT00125281|Fatigue|fatigue
729340|NCT00125281|Cirrhosis|cirrhosis
729341|NCT00125281|S-Adenosyl Methionine|s-adenosyl methionine
729342|NCT00125281|Primary Biliary Cirrhosis|primary biliary cirrhosis
729343|NCT00125281|Pruritus|pruritus
729344|NCT00125281|Symptomatic Releif|symptomatic releif
729345|NCT00125281|Serum Liver-Related Enzymes|serum liver-related enzymes
729346|NCT00125281|PBC|pbc
729347|NCT00125281|Liver Disease|liver disease
729348|NCT00125268|painful|painful
729349|NCT00125268|peripheral|peripheral
729350|NCT00125268|neuropathy|neuropathy
729351|NCT00125268|light|light
729352|NCT00125268|therapy|therapy
729353|NCT00125242|Aphasia|aphasia
729354|NCT00125242|Language therapy|language therapy
729355|NCT00125242|Rehabilitation of speech and language disorders|rehabilitation of speech and language disorders
729356|NCT00125242|Speech-language pathology|speech-language pathology
729357|NCT00125229|Hypertonic Saline|hypertonic saline
729358|NCT00125229|Mannitol|mannitol
729359|NCT00125229|Intracranial hypertension|intracranial hypertension
729360|NCT00125229|Cerebral blood flow|cerebral blood flow
729361|NCT00125229|Traumatic brain injury|traumatic brain injury
729362|NCT00125216|Aphasia|aphasia
729363|NCT00125216|Language Therapy|language therapy
729364|NCT00125216|Rehabilitation of speech and language disorders|rehabilitation of speech and language disorders
729365|NCT00125216|Speech-language pathology|speech-language pathology
729366|NCT00125203|ALS|als
729367|NCT00125203|Lou Gehrig's Disease|lou gehrig's disease
729368|NCT00125203|Motor Neuron Disease|motor neuron disease
729369|NCT00125203|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
729370|NCT00125203|Sialorrhea|sialorrhea
729371|NCT00125203|Hypersalivation|hypersalivation
729372|NCT00125203|Excessive Drooling|excessive drooling
729373|NCT00125203|Myobloc|myobloc
729374|NCT00125203|botulinum toxin type B|botulinum toxin type b
729375|NCT00125203|Clostridium botulinum B toxin|clostridium botulinum b toxin
729376|NCT00125203|botulinum B toxin|botulinum b toxin
729377|NCT00125203|botulinum neurotoxin B|botulinum neurotoxin b
729378|NCT00125203|NeuroBloc|neurobloc
729379|NCT00125190|Primary IGF-1 Deficiency|primary igf-1 deficiency
729380|NCT00125190|IGF-1|igf-1
729381|NCT00125177|pelvic muscle therapy|pelvic muscle therapy
729382|NCT00125177|urinary incontinence therapy|urinary incontinence therapy
729383|NCT00125177|stress incontinence intervention|stress incontinence intervention
729384|NCT00125177|incontinence intervention|incontinence intervention
729385|NCT00125177|Incontinence|incontinence
729386|NCT00125177|SUI|sui
729387|NCT00125177|Stress Incontinence|stress incontinence
729388|NCT00125164|Primary IGF-1 Deficiency|primary igf-1 deficiency
729389|NCT00125151|MeSH: angioneurotic edema, complement 1 inactivators|mesh: angioneurotic edema, complement 1 inactivators
729390|NCT00125151|Hereditary angioedema type I or II, Acquired angioedema|hereditary angioedema type i or ii, acquired angioedema
729391|NCT00125125|Dyslipidemia, adults, fluvastatin|dyslipidemia, adults, fluvastatin
729392|NCT00125112|binge eating|binge eating
729393|NCT00125112|weight loss|weight loss
729394|NCT00125112|obesity|obesity
729395|NCT00125099|Acute Infection|acute infection
729396|NCT00125099|Treatment Experienced|treatment experienced
729397|NCT00125099|Treatment Interruption|treatment interruption
729398|NCT00125099|HIV Therapeutic Vaccine|hiv therapeutic vaccine
729399|NCT00125086|wounds|wounds
729400|NCT00125086|healing|healing
729401|NCT00125086|Acute wounds healing by secondary intention|acute wounds healing by secondary intention
729402|NCT00125073|Standard Care|standard care
729403|NCT00125073|Nutritional Counseling|nutritional counseling
729404|NCT00125060|Aorta|aorta
729405|NCT00125060|Atherosclerosis|atherosclerosis
729406|NCT00125060|MRI|mri
729407|NCT00125060|statin|statin
729408|NCT00125060|inflammatory markers|inflammatory markers
729409|NCT00125047|Salmonellosis|salmonellosis
729410|NCT00125047|typhoid vaccine|typhoid vaccine
729411|NCT00125047|enteric fever|enteric fever
729412|NCT00125034|FOLFOX-4|folfox-4
729413|NCT00125034|Cetuximab|cetuximab
729414|NCT00125034|First-line mCRC|first-line mcrc
729415|NCT00125034|EGFR positive|egfr positive
729416|NCT00125034|metastatic CRC|metastatic crc
729417|NCT00125021|Second Line Therapy|second line therapy
729418|NCT00125021|Gemcitabine Refractory|gemcitabine refractory
729419|NCT00125021|Pancreatic Cancer|pancreatic cancer
729420|NCT00125021|Capecitabine|capecitabine
729421|NCT00125021|Tarceva|tarceva
729422|NCT00125021|OSI-774|osi-774
729423|NCT00125021|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
729424|NCT00125008|Salmonella|salmonella
729425|NCT00125008|Typhoid vaccine|typhoid vaccine
729426|NCT00125008|enteric fever|enteric fever
729427|NCT00124969|End-stage renal disease, hemodialysis|end-stage renal disease, hemodialysis
729428|NCT00124943|Prevention of Instent Restenosis|prevention of instent restenosis
729429|NCT00124930|olanzapine|olanzapine
729430|NCT00124930|haldol|haldol
729431|NCT00124930|cancer|cancer
729432|NCT00124930|nausea|nausea
729433|NCT00124930|second line treatment|second line treatment
729434|NCT00124930|refractory nausea|refractory nausea
729435|NCT00124917|Prostate Cancer|prostate cancer
729436|NCT00124917|MRI|mri
729437|NCT00124917|Fiducial Marker|fiducial marker
729438|NCT00124917|IMRT|imrt
729439|NCT00124904|Biofeedback|biofeedback
729440|NCT00124904|Incontinence|incontinence
729441|NCT00124891|Arrhythmias|arrhythmias
729442|NCT00124878|HIV|hiv
729443|NCT00124878|STDs|stds
729444|NCT00124878|Male circumcision|male circumcision
729445|NCT00124878|HIV+ males|hiv+ males
729446|NCT00124878|HIV-negative males|hiv-negative males
729447|NCT00124878|Female partners|female partners
729448|NCT00124878|STDs such as the following:|stds such as the following:
729449|NCT00124878|HPV|hpv
729450|NCT00124878|HSV-2|hsv-2
729451|NCT00124878|HIV Seronegativity|hiv seronegativity
729452|NCT00124865|Campylobacter|campylobacter
729453|NCT00124865|Bacterial enteritis|bacterial enteritis
729454|NCT00124852|cognition|cognition
729455|NCT00124852|depression|depression
729456|NCT00124852|elderly|elderly
729457|NCT00124839|Dissociation|dissociation
729458|NCT00124839|Flashbacks|flashbacks
729459|NCT00124839|Self-injurious behavior|self-injurious behavior
729460|NCT00124826|stroke|stroke
729461|NCT00124826|cerebrovascular disease|cerebrovascular disease
729462|NCT00124826|hyperglycemia|hyperglycemia
729463|NCT00124826|magnetic resonance imaging|magnetic resonance imaging
729464|NCT00124826|acute ischemic stroke|acute ischemic stroke
729465|NCT00124800|tinnitus|tinnitus
729466|NCT00124774|hernia|hernia
729467|NCT00124774|nucleoplasty|nucleoplasty
729468|NCT00124774|radicular pain|radicular pain
729469|NCT00124774|Contained lumbar herniated disc|contained lumbar herniated disc
729470|NCT00124761|Radiosurgery|radiosurgery
729471|NCT00124761|Brain metastases|brain metastases
729472|NCT00124761|Whole Brain Radiotherapy|whole brain radiotherapy
729473|NCT00124761|Neurosurgery|neurosurgery
729474|NCT00124761|Solitary Brain Metastases|solitary brain metastases
729475|NCT00124761|Adult Tumours Metastatic to Brain|adult tumours metastatic to brain
729476|NCT00124748|CML|cml
729477|NCT00124748|Philadelphia positive|philadelphia positive
729478|NCT00124748|Bcr-abl|bcr-abl
729479|NCT00124748|imatinib mesylate|imatinib mesylate
729480|NCT00124748|Chronic myeloid leukemia (CML) in chronic phase|chronic myeloid leukemia (cml) in chronic phase
729481|NCT00124709|Atopic, dermatitis, asthma, children, modification|atopic, dermatitis, asthma, children, modification
729482|NCT00124709|Atopic dermatitis/atopy|atopic dermatitis/atopy
729483|NCT00124696|cocaine dependence|cocaine dependence
729484|NCT00124683|nicotine dependence|nicotine dependence
729485|NCT00124657|adult anaplastic astrocytoma|adult anaplastic astrocytoma
729486|NCT00124657|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
729487|NCT00124657|adult glioblastoma|adult glioblastoma
729488|NCT00124657|adult giant cell glioblastoma|adult giant cell glioblastoma
729489|NCT00124657|adult gliosarcoma|adult gliosarcoma
729490|NCT00124657|adult mixed glioma|adult mixed glioma
729491|NCT00124657|childhood mixed glioma|childhood mixed glioma
729492|NCT00124657|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
729493|NCT00124657|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
729494|NCT00124657|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
729495|NCT00124657|childhood oligodendroglioma|childhood oligodendroglioma
729496|NCT00124657|childhood spinal cord neoplasm|childhood spinal cord neoplasm
729497|NCT00124644|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
729498|NCT00124644|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
729499|NCT00124644|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
729500|NCT00124644|secondary acute myeloid leukemia|secondary acute myeloid leukemia
729501|NCT00124618|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
729502|NCT00124618|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
729503|NCT00124579|stage I multiple myeloma|stage i multiple myeloma
729504|NCT00124579|stage II multiple myeloma|stage ii multiple myeloma
729505|NCT00124579|stage III multiple myeloma|stage iii multiple myeloma
729506|NCT00124579|refractory multiple myeloma|refractory multiple myeloma
729507|NCT00124566|Irofulven|irofulven
729508|NCT00124566|Docetaxel|docetaxel
729509|NCT00124566|Taxotere|taxotere
729510|NCT00124553|Type 2 diabetes|type 2 diabetes
729511|NCT00124553|cardiovascular risk|cardiovascular risk
729512|NCT00124553|glycaemic control|glycaemic control
729513|NCT00124553|dietary modification|dietary modification
729514|NCT00124540|Misoprostol|misoprostol
729515|NCT00124540|Active management|active management
729516|NCT00124540|Postpartum hemorrhage|postpartum hemorrhage
729517|NCT00124540|Maternal morbidity|maternal morbidity
729518|NCT00124540|Anemia|anemia
729519|NCT00124540|Developing countries|developing countries
729520|NCT00124527|Irofulven, Thyroid Cancer|irofulven, thyroid cancer
729521|NCT00124514|SLE|sle
729522|NCT00124514|Lupus|lupus
729523|NCT00124514|Ovarian damage|ovarian damage
729524|NCT00124514|Menopause|menopause
729525|NCT00124501|Biofeedback|biofeedback
729526|NCT00124488|radiotherapy planning|radiotherapy planning
729527|NCT00124488|computer assisted radiotherapy|computer assisted radiotherapy
729528|NCT00124488|conformal|conformal
729529|NCT00124475|Chronic Hand Dermatitis|chronic hand dermatitis
729530|NCT00124436|Patients who have been enrolled in study protocol BAP089, and whose severe chronic hand dermatitis responded with mild or moderate disease, or who relapsed|patients who have been enrolled in study protocol bap089, and whose severe chronic hand dermatitis responded with mild or moderate disease, or who relapsed
729531|NCT00124423|brachytherapy megavoltage CT imaging|brachytherapy megavoltage ct imaging
729532|NCT00124410|prostate cancer|prostate cancer
729533|NCT00124410|androgen suppression therapy (hormone therapy)|androgen suppression therapy (hormone therapy)
729534|NCT00124410|osteoporosis|osteoporosis
729535|NCT00124384|primary insomnia, stimulants, cognitive behavioral therapy|primary insomnia, stimulants, cognitive behavioral therapy
729536|NCT00124371|coronary artery bypass surgery|coronary artery bypass surgery
729537|NCT00124371|risk factors|risk factors
729538|NCT00124371|nurse-led secondary prevention|nurse-led secondary prevention
729539|NCT00124371|prehabilitation|prehabilitation
729540|NCT00124371|waiting period|waiting period
729541|NCT00124358|Drug Abuse|drug abuse
729542|NCT00124358|Drug Addiction|drug addiction
729543|NCT00124358|Drug Dependence|drug dependence
729544|NCT00124358|Drug Use Disorders|drug use disorders
729545|NCT00124358|Drug Use Disorder|drug use disorder
729546|NCT00124358|Substance Abuse|substance abuse
729547|NCT00124358|Substance Use Disorder|substance use disorder
729548|NCT00124358|Buprenorphine|buprenorphine
729549|NCT00124358|Opiate Addiction|opiate addiction
729550|NCT00124358|Substance-related disorders|substance-related disorders
729551|NCT00124358|HIV|hiv
729552|NCT00124345|temperature|temperature
729553|NCT00124345|humidity|humidity
729554|NCT00124345|non invasive mechanical ventilation|non invasive mechanical ventilation
729555|NCT00124319|Biomechanics|biomechanics
729556|NCT00124319|Neuromuscular|neuromuscular
729557|NCT00124319|Lower limb|lower limb
729558|NCT00124319|Injury|injury
729559|NCT00124319|ACL|acl
729560|NCT00124319|Anterior Cruciate Ligament injury|anterior cruciate ligament injury
729561|NCT00124306|painful bladder syndrome|painful bladder syndrome
729562|NCT00124306|interstitial cystitis|interstitial cystitis
729563|NCT00124306|newly diagnosed|newly diagnosed
729564|NCT00124280|Lung cancer|lung cancer
729565|NCT00124280|non-small cell|non-small cell
729566|NCT00124280|everolimus|everolimus
729567|NCT00124280|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
729568|NCT00124267|Cerebral|cerebral
729569|NCT00124267|malaria|malaria
729570|NCT00124267|intra-rectal|intra-rectal
729571|NCT00124267|quinine|quinine
729572|NCT00124267|children|children
729573|NCT00124267|Uganda|uganda
729574|NCT00124267|efficacy|efficacy
729575|NCT00124267|safety|safety
729576|NCT00124254|Metacarpophalangeal Joint|metacarpophalangeal joint
729577|NCT00124254|Arthroplasty|arthroplasty
729578|NCT00124254|Outcomes|outcomes
729579|NCT00124254|Michigan Hand Outcomes Questionnaire|michigan hand outcomes questionnaire
729580|NCT00124254|Joint Replacement|joint replacement
729581|NCT00124228|Cirrhosis|cirrhosis
729582|NCT00124228|Infection|infection
729583|NCT00124228|Sepsis|sepsis
729584|NCT00124228|Renal failure|renal failure
729585|NCT00124215|Hepatitis|hepatitis
729586|NCT00124215|HCV|hcv
729587|NCT00124215|vaccine|vaccine
729588|NCT00124215|Hepatitis C Infection|hepatitis c infection
729589|NCT00124202|a fatty meal|a fatty meal
729590|NCT00124202|ERCP|ercp
729591|NCT00124189|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
729592|NCT00124189|T-cell prolymphocytic leukemia|t-cell prolymphocytic leukemia
729593|NCT00124189|Chronic lymphoproliferative diseases|chronic lymphoproliferative diseases
729594|NCT00124189|Telomerase|telomerase
729595|NCT00124189|Telomerase Inhibition|telomerase inhibition
729596|NCT00124176|Asthma|asthma
729597|NCT00124176|Levalbuterol|levalbuterol
729598|NCT00124176|Albuterol|albuterol
729599|NCT00124176|Children|children
729600|NCT00124163|CT Virtual Colonoscopy|ct virtual colonoscopy
729601|NCT00124163|Optical Colonoscopy|optical colonoscopy
729602|NCT00124163|Stool Tagging|stool tagging
729603|NCT00124163|Patient Preparation|patient preparation
729604|NCT00124150|subarachnoid hemorrhage|subarachnoid hemorrhage
729605|NCT00124150|magnesium sulfate|magnesium sulfate
729606|NCT00124137|Ultrafiltration|ultrafiltration
729607|NCT00124137|acute decompensated heart failure|acute decompensated heart failure
729608|NCT00124137|fluid overload|fluid overload
729609|NCT00124137|pulmonary congestion|pulmonary congestion
729610|NCT00124111|clinical trial|clinical trial
729611|NCT00124111|pegfilgrastim|pegfilgrastim
729612|NCT00124111|haematopoietic growth factor|haematopoietic growth factor
729613|NCT00124111|neutropenia|neutropenia
729614|NCT00124111|CMF|cmf
729615|NCT00124111|Cancer|cancer
729616|NCT00124098|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
729617|NCT00124098|anemia, clinical trial|anemia, clinical trial
729618|NCT00124098|darbepoetin alfa|darbepoetin alfa
729619|NCT00124098|Aranesp®|aranesp®
729620|NCT00124098|Amgen|amgen
729621|NCT00124072|Myocardial infarction|myocardial infarction
729622|NCT00124072|Coronary heart disease|coronary heart disease
729623|NCT00124072|Cholesterol|cholesterol
729624|NCT00124072|Stroke|stroke
729625|NCT00124059|alcohol dependence|alcohol dependence
729626|NCT00124046|Urinary Incontinence in Children|urinary incontinence in children
729627|NCT00124046|Surgical Section of the Filum Terminale|surgical section of the filum terminale
729628|NCT00124046|Occult Tethered Cord Syndrome|occult tethered cord syndrome
729629|NCT00124046|Urodynamic Scale|urodynamic scale
729630|NCT00124046|Enuresis-Specific Quality of Life Scale|enuresis-specific quality of life scale
729631|NCT00124033|Cholecystectomy|cholecystectomy
729632|NCT00124033|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
729633|NCT00124007|HIV Seronegativity|hiv seronegativity
729634|NCT00124007|HIV Preventive Vaccine|hiv preventive vaccine
729635|NCT00123994|TaiChi|taichi
729636|NCT00123994|Hydrotherapy|hydrotherapy
729637|NCT00123994|Exercise|exercise
729638|NCT00123994|Joint pain|joint pain
729639|NCT00123994|Disability|disability
729640|NCT00123981|Off-pump Coronary Artery By-pass Grafting|off-pump coronary artery by-pass grafting
729641|NCT00123981|Randomization|randomization
729642|NCT00123981|stroke|stroke
729643|NCT00123981|myocardial infarction|myocardial infarction
729644|NCT00123981|mortality|mortality
729645|NCT00123981|graft patency|graft patency
729646|NCT00123981|quality of life|quality of life
729647|NCT00123968|HIV Seronegativity|hiv seronegativity
729648|NCT00123968|HIV Preventive Vaccine|hiv preventive vaccine
729649|NCT00123942|CD2+ Lymphoproliferative disorder|cd2+ lymphoproliferative disorder
729650|NCT00123929|breast cancer|breast cancer
729651|NCT00123929|neoadjuvant chemotherapy|neoadjuvant chemotherapy
729652|NCT00123929|genetic signature|genetic signature
729653|NCT00123929|doxorubicin|doxorubicin
729654|NCT00123929|docetaxel|docetaxel
729655|NCT00123916|Chagas Disease|chagas disease
729656|NCT00123916|Trypanosomiasis|trypanosomiasis
729657|NCT00123916|Benznidazole|benznidazole
729658|NCT00123916|Chronic Heart disease|chronic heart disease
729659|NCT00123916|Trypanosoma Cruzi|trypanosoma cruzi
729660|NCT00123903|hypertension|hypertension
729661|NCT00123903|urine albumin:creatinine ratio|urine albumin:creatinine ratio
729662|NCT00123903|microalbuminuria|microalbuminuria
729663|NCT00123890|HIV-1 GW873140 CCR5 antagonist experienced|hiv-1 gw873140 ccr5 antagonist experienced
729664|NCT00123877|Breast|breast
729665|NCT00123877|Cancer|cancer
729666|NCT00123877|Metastasis|metastasis
729667|NCT00123864|intensity modulated radiation therapy|intensity modulated radiation therapy
729668|NCT00123864|parotid|parotid
729669|NCT00123864|nasopharyngeal carcinoma|nasopharyngeal carcinoma
729670|NCT00123851|Colorectal|colorectal
729671|NCT00123851|Metastatic Colorectal Cancer|metastatic colorectal cancer
729672|NCT00123851|Oxaliplatin|oxaliplatin
729673|NCT00123851|Tarceva|tarceva
729674|NCT00123851|Capecitabine|capecitabine
729675|NCT00123851|Xeloda|xeloda
729676|NCT00123838|Prostate|prostate
729677|NCT00123838|Cancer|cancer
729678|NCT00123838|Radiotherapy|radiotherapy
729679|NCT00123838|Neoplasm|neoplasm
729680|NCT00123838|Localization|localization
729681|NCT00123838|Tracking|tracking
729682|NCT00123838|Cancer of Prostate|cancer of prostate
729683|NCT00123838|Neoplasms, Prostate|neoplasms, prostate
729684|NCT00123825|Gallbladder|gallbladder
729685|NCT00123825|Biliary Tract|biliary tract
729686|NCT00123825|Cholangiocarcinoma|cholangiocarcinoma
729687|NCT00123812|quality assurance|quality assurance
729688|NCT00123812|frequency of port films|frequency of port films
729689|NCT00123799|positron emission tomography|positron emission tomography
729690|NCT00123799|fluorodeoxyglucose F18|fluorodeoxyglucose f18
729691|NCT00123799|sentinel lymph node biopsy|sentinel lymph node biopsy
729692|NCT00123786|positron emission tomography|positron emission tomography
729693|NCT00123786|fluorodeoxyglucose F18|fluorodeoxyglucose f18
729694|NCT00123786|tomography scanners, x-ray computed|tomography scanners, x-ray computed
729695|NCT00123773|positron emission tomography|positron emission tomography
729696|NCT00123773|fluorodeoxyglucose F18|fluorodeoxyglucose f18
729697|NCT00123773|Tomography scanners, x-ray computed|tomography scanners, x-ray computed
729698|NCT00123760|Positron-Emission Tomography|positron-emission tomography
729699|NCT00123760|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
729700|NCT00123760|Tomography scanners, X-Ray computed|tomography scanners, x-ray computed
729701|NCT00123747|Positron Emission Tomography|positron emission tomography
729702|NCT00123747|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
729703|NCT00123747|Tomography scanners, X-Ray Computed|tomography scanners, x-ray computed
729704|NCT00123708|Spasticity|spasticity
729705|NCT00123708|Dystonia|dystonia
729706|NCT00123708|Movement Disorders|movement disorders
729707|NCT00123708|Walking|walking
729708|NCT00123708|Muscle Weakness|muscle weakness
729709|NCT00123708|Resistance|resistance
729710|NCT00123708|Gait|gait
729711|NCT00123708|Cerebral Palsy|cerebral palsy
729712|NCT00123708|CP|cp
729713|NCT00123695|Subarachnoid hemorrhage|subarachnoid hemorrhage
729714|NCT00123695|Takotsubo cardiomyopathy|takotsubo cardiomyopathy
729715|NCT00123695|Cardiac abnormalities|cardiac abnormalities
729716|NCT00123695|outcome|outcome
729717|NCT00123682|Smoking Cessation|smoking cessation
729718|NCT00123682|Care Management|care management
729719|NCT00123682|Substance Use Disorder QUERI|substance use disorder queri
729720|NCT00123682|Primary Care|primary care
729721|NCT00123682|Regional Expansion|regional expansion
729722|NCT00123682|Telephone|telephone
729723|NCT00123669|Cancer of the Breast|cancer of the breast
729724|NCT00123669|Neoplasm|neoplasm
729725|NCT00123656|Eosinophilic esophagitis|eosinophilic esophagitis
729726|NCT00123656|esomeprazole|esomeprazole
729727|NCT00123656|fluticasone|fluticasone
729728|NCT00123643|thiazolidinedione|thiazolidinedione
729729|NCT00123643|sulfonylurea|sulfonylurea
729730|NCT00123643|endothelial function|endothelial function
729731|NCT00123630|eosinophilic esophagitis|eosinophilic esophagitis
729732|NCT00123630|omalizumab|omalizumab
729733|NCT00123617|Chest pain|chest pain
729734|NCT00123617|Women|women
729735|NCT00123617|Syndrome X|syndrome x
729736|NCT00123617|Cardiac rehabilitation|cardiac rehabilitation
729737|NCT00123617|Psychological morbidity|psychological morbidity
729738|NCT00123617|Cardiovascular risk factors|cardiovascular risk factors
729739|NCT00123604|beta-blockers|beta-blockers
729740|NCT00123604|endothelial function|endothelial function
729741|NCT00123565|Coronary Disease|coronary disease
729742|NCT00123552|Uganda, malaria, combination antimalarial therapy|uganda, malaria, combination antimalarial therapy
729743|NCT00123487|Accelerated Phase Chronic Myeloid Leukemia|accelerated phase chronic myeloid leukemia
729744|NCT00123487|Lymphoid Blast Phase Chronic Myeloid Leukemia|lymphoid blast phase chronic myeloid leukemia
729745|NCT00123487|Myeloid Blast Phase Chronic Myeloid Leukemia|myeloid blast phase chronic myeloid leukemia
729746|NCT00123487|Philadelphia Positive Acute Lymphoblastic Leukemia|philadelphia positive acute lymphoblastic leukemia
729747|NCT00123474|Chronic Phase Chronic Myelogenous Leukemia|chronic phase chronic myelogenous leukemia
729748|NCT00123448|Mirror Neurons|mirror neurons
729749|NCT00123448|fMRI|fmri
729750|NCT00123448|Premotor Cortex|premotor cortex
729751|NCT00123448|gesture|gesture
729752|NCT00123448|Healthy Volunteer|healthy volunteer
729753|NCT00123448|HV|hv
729754|NCT00123435|Behavioral Research|behavioral research
729755|NCT00123435|Nutritional management|nutritional management
729756|NCT00123435|Physical activity|physical activity
729757|NCT00123435|Prevention|prevention
729758|NCT00123435|Randomized control trial|randomized control trial
729759|NCT00123435|walking program|walking program
729760|NCT00123435|Weight loss|weight loss
729761|NCT00123435|World wide web|world wide web
729762|NCT00123422|Breathing exercise|breathing exercise
729763|NCT00123422|Exercise Therapy|exercise therapy
729764|NCT00123422|Helium|helium
729765|NCT00123422|Oxygen inhalation therapy|oxygen inhalation therapy
729766|NCT00123422|Pulmonary emphysema|pulmonary emphysema
729767|NCT00123422|Pulmonary ventilation|pulmonary ventilation
729768|NCT00123422|Rehabilitation|rehabilitation
729769|NCT00123409|Primary Care|primary care
729770|NCT00123409|Telephone|telephone
729771|NCT00123409|Quality of Life|quality of life
729772|NCT00123396|Bioterrorism|bioterrorism
729773|NCT00123396|Education, Medical, Continuing|education, medical, continuing
729774|NCT00123396|Internet|internet
729775|NCT00123383|Modafinil|modafinil
729776|NCT00123383|Cocaine Dependence|cocaine dependence
729777|NCT00123383|Randomised placebo-controlled trial|randomised placebo-controlled trial
729778|NCT00123370|Modafinil|modafinil
729779|NCT00123370|Amphetamine Dependence|amphetamine dependence
729780|NCT00123370|Randomised placebo-controlled trial|randomised placebo-controlled trial
729781|NCT00123344|symptomatic bradycardia|symptomatic bradycardia
729782|NCT00123344|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
729783|NCT00123344|antitachycardia pacing therapies|antitachycardia pacing therapies
729784|NCT00123344|prevention algorithms|prevention algorithms
729785|NCT00123331|Heart transplantation|heart transplantation
729786|NCT00123331|Renal failure|renal failure
729787|NCT00123331|Cyclosporine|cyclosporine
729788|NCT00123331|Rapamycin|rapamycin
729789|NCT00123318|Gastric cancer|gastric cancer
729790|NCT00123318|Radiotherapy|radiotherapy
729791|NCT00123318|Chemotherapy|chemotherapy
729792|NCT00123318|Chemoradiation|chemoradiation
729793|NCT00123305|Stroke|stroke
729794|NCT00123305|Acute Ischemic Stroke|acute ischemic stroke
729795|NCT00123292|arterial occlusion|arterial occlusion
729796|NCT00123292|thromboembolism|thromboembolism
729797|NCT00123292|Acute Peripheral Arterial Occlusion|acute peripheral arterial occlusion
729798|NCT00123279|diabetic macular edema|diabetic macular edema
729799|NCT00123279|macular hole|macular hole
729800|NCT00123279|vitreomacular traction syndrome|vitreomacular traction syndrome
729801|NCT00123266|stroke|stroke
729802|NCT00123266|vertebrobasilar|vertebrobasilar
729803|NCT00123266|basilar|basilar
729804|NCT00123266|Acute vertebrobasilar artery occlusion|acute vertebrobasilar artery occlusion
729805|NCT00123253|HIV|hiv
729806|NCT00123253|Lipodystrophy|lipodystrophy
729807|NCT00123253|Abdominal fat accumulation|abdominal fat accumulation
729808|NCT00123253|Growth hormone releasing factor/Growth hormone releasing hormone|growth hormone releasing factor/growth hormone releasing hormone
729809|NCT00123253|Treatment Experienced|treatment experienced
729810|NCT00123240|overweight|overweight
729811|NCT00123240|obese|obese
729812|NCT00123240|diet|diet
729813|NCT00123227|Randomised controlled trial|randomised controlled trial
729814|NCT00123227|Rosiglitazone|rosiglitazone
729815|NCT00123227|Cardiovascular magnetic resonance|cardiovascular magnetic resonance
729816|NCT00123227|Diabetes Mellitus|diabetes mellitus
729817|NCT00123227|Vascular Diseases|vascular diseases
729818|NCT00123227|Hypertension|hypertension
729819|NCT00123214|Diet|diet
729820|NCT00123214|Chronic sleep deprivation|chronic sleep deprivation
729821|NCT00123214|Weight|weight
729822|NCT00123214|Cognitive impairment|cognitive impairment
729823|NCT00123214|Lipids|lipids
729824|NCT00123214|Inflammation|inflammation
729825|NCT00123214|Resting metabolic rate|resting metabolic rate
729826|NCT00123214|Weight Gain|weight gain
729827|NCT00123214|Percent Body Fat|percent body fat
729828|NCT00123214|Hyperlipidemia|hyperlipidemia
729829|NCT00123201|efficacy & safety, migraine headache, placebo-controlled|efficacy & safety, migraine headache, placebo-controlled
729830|NCT00123201|migraine headache with or without aura|migraine headache with or without aura
729831|NCT00123175|Endometrial Hyperplasia without atypia|endometrial hyperplasia without atypia
729832|NCT00123162|Sildenafil|sildenafil
729833|NCT00123149|Anemia|anemia
729834|NCT00123149|Rheumatoid arthritis|rheumatoid arthritis
729835|NCT00123149|Hemoglobin level|hemoglobin level
729836|NCT00123136|pulsed magnetic field therapy|pulsed magnetic field therapy
729837|NCT00123136|diabetic peripheral neuropathy|diabetic peripheral neuropathy
729838|NCT00123136|neuromodulation|neuromodulation
729839|NCT00123136|diabetic peripheral neuropathic pain|diabetic peripheral neuropathic pain
729840|NCT00123136|sleep benefit|sleep benefit
729841|NCT00123136|diabetic peripheral neuropathic functioning|diabetic peripheral neuropathic functioning
729842|NCT00123123|Ventilator-associated pneumonia|ventilator-associated pneumonia
729843|NCT00123097|Facial Neoplasms|facial neoplasms
729844|NCT00123097|Head and Neck Neoplasms|head and neck neoplasms
729845|NCT00123097|Head Injuries, Penetrating|head injuries, penetrating
729846|NCT00123097|Birth Injuries|birth injuries
729847|NCT00123084|Parkinson's disease|parkinson's disease
729848|NCT00123084|Swallowing difficulties|swallowing difficulties
729849|NCT00123084|speech|speech
729850|NCT00123084|voice|voice
729851|NCT00123058|Hypertension|hypertension
729852|NCT00123058|Cariovascular Diseases|cariovascular diseases
729853|NCT00123058|Health Illiteracy|health illiteracy
729854|NCT00122980|Blood Diseases|blood diseases
729855|NCT00122954|Fatty Acids, Omega-3|fatty acids, omega-3
729856|NCT00122954|Fish Oils|fish oils
729857|NCT00122954|Complementary Therapies|complementary therapies
729858|NCT00122941|multiple|multiple
729859|NCT00122941|micronutrients|micronutrients
729860|NCT00122941|supplementation|supplementation
729861|NCT00122941|HIV|hiv
729862|NCT00122941|children|children
729863|NCT00122941|randomised|randomised
729864|NCT00122941|trial|trial
729865|NCT00122941|mortality|mortality
729866|NCT00122941|morbidity|morbidity
729867|NCT00122941|growth|growth
729868|NCT00122941|Uganda|uganda
729869|NCT00122928|Worksite|worksite
729870|NCT00122928|Workplace|workplace
729871|NCT00122928|Return on Investment|return on investment
729872|NCT00122928|Financial Impact|financial impact
729873|NCT00122915|Motor Cortex Stimulation|motor cortex stimulation
729874|NCT00122915|Pain treatment|pain treatment
729875|NCT00122915|Central post-stroke pain (CPSP)|central post-stroke pain (cpsp)
729876|NCT00122915|Trigeminal neuropathic pain (TGN)|trigeminal neuropathic pain (tgn)
729877|NCT00122915|Facial pain|facial pain
729878|NCT00122915|Neurostimuation|neurostimuation
729879|NCT00122915|Cortical lead|cortical lead
729880|NCT00122915|Neuropathic pain|neuropathic pain
729881|NCT00122902|HIV|hiv
729882|NCT00122902|AIDS|aids
729883|NCT00122902|Spirituality|spirituality
729884|NCT00122889|Drug Interactions|drug interactions
729885|NCT00122889|Pharmacokinetics|pharmacokinetics
729886|NCT00122889|Garlic|garlic
729887|NCT00122889|Complementary Therapies|complementary therapies
729888|NCT00122889|Complementary and Alternative Medicine|complementary and alternative medicine
729889|NCT00122876|Hepatocellular Carcinoma|hepatocellular carcinoma
729890|NCT00122876|HCC|hcc
729891|NCT00122876|Photodynamic therapy|photodynamic therapy
729892|NCT00122876|Talaporfin Sodium (LS11)|talaporfin sodium (ls11)
729893|NCT00122876|Light emitting diodes (LEDs)|light emitting diodes (leds)
729894|NCT00122876|Litx|litx
729895|NCT00122876|Light Infusion Technology|light infusion technology
729896|NCT00122811|Aged|aged
729897|NCT00122811|Hypertension|hypertension
729898|NCT00122811|Stroke|stroke
729899|NCT00122798|Stroke, stroke treatment, atrial fibrillation, medication, rehabilitation|stroke, stroke treatment, atrial fibrillation, medication, rehabilitation
729900|NCT00122785|bronchiolitis|bronchiolitis
729901|NCT00122785|wheezing|wheezing
729902|NCT00122785|dexamethasone|dexamethasone
729903|NCT00122785|young children|young children
729904|NCT00122759|Mechanical ventilation|mechanical ventilation
729905|NCT00122759|Agitation|agitation
729906|NCT00122746|Cervical Cancer|cervical cancer
729907|NCT00122746|AIDS|aids
729908|NCT00122746|External Beam Radiotherapy|external beam radiotherapy
729909|NCT00122746|Brachytherapy|brachytherapy
729910|NCT00122746|Cisplatin|cisplatin
729911|NCT00122733|Mechanical ventilation|mechanical ventilation
729912|NCT00122733|Agitation|agitation
729913|NCT00122733|Difficult weaning|difficult weaning
729914|NCT00122720|colorectal cancer|colorectal cancer
729915|NCT00122720|erythropoietin|erythropoietin
729916|NCT00122720|rehabilitation|rehabilitation
729917|NCT00122720|physical capacity|physical capacity
729918|NCT00122707|catheter-related infection|catheter-related infection
729919|NCT00122707|mechanical complications of catheters|mechanical complications of catheters
729920|NCT00122694|carbon monoxide|carbon monoxide
729921|NCT00122694|COPD|copd
729922|NCT00122694|inflammation|inflammation
729923|NCT00122694|sputum induction|sputum induction
729924|NCT00122694|stable COPD|stable copd
729925|NCT00122668|HIV Protease Inhibitors|hiv protease inhibitors
729926|NCT00122668|HIV-Associated Lipodystrophy Syndrome|hiv-associated lipodystrophy syndrome
729927|NCT00122668|HIV infections|hiv infections
729928|NCT00122655|HIV infections|hiv infections
729929|NCT00122655|HIV Lipodystrophy Syndrome|hiv lipodystrophy syndrome
729930|NCT00122642|catheterization|catheterization
729931|NCT00122642|Catheters, Indwelling|catheters, indwelling
729932|NCT00122629|Hepatitis C, Chronic|hepatitis c, chronic
729933|NCT00122629|peginterferon alfa-2b|peginterferon alfa-2b
729934|NCT00122629|ribavirin|ribavirin
729935|NCT00122629|Amantadine|amantadine
729936|NCT00122616|HIV infections|hiv infections
729937|NCT00122616|peginterferon alfa-2a|peginterferon alfa-2a
729938|NCT00122616|Treatment Failure|treatment failure
729939|NCT00122616|Hepatitis C, Chronic|hepatitis c, chronic
729940|NCT00122616|Treatment Experienced|treatment experienced
729941|NCT00122603|HIV Protease Inhibitors|hiv protease inhibitors
729942|NCT00122603|HIV infections|hiv infections
729943|NCT00122603|Atazanavir|atazanavir
729944|NCT00122603|Saquinavir|saquinavir
729945|NCT00122603|Fosamprenavir|fosamprenavir
729946|NCT00122603|ritonavir|ritonavir
729947|NCT00122603|Treatment Naive|treatment naive
729948|NCT00122590|protease inhibitors|protease inhibitors
729949|NCT00122590|nelfinavir|nelfinavir
729950|NCT00122590|lopinavir|lopinavir
729951|NCT00122590|indinavir|indinavir
729952|NCT00122590|Pharmacokinetics|pharmacokinetics
729953|NCT00122577|HIV infections|hiv infections
729954|NCT00122577|Treatment Failure|treatment failure
729955|NCT00122577|tenofovir|tenofovir
729956|NCT00122577|atazanavir|atazanavir
729957|NCT00122564|HIV Vaccines|hiv vaccines
729958|NCT00122564|HIV Seronegativity|hiv seronegativity
729959|NCT00122551|HIV infections|hiv infections
729960|NCT00122538|HAART|haart
729961|NCT00122538|once-daily|once-daily
729962|NCT00122538|child|child
729963|NCT00122538|africa|africa
729964|NCT00122538|HIV|hiv
729965|NCT00122538|AIDS|aids
729966|NCT00122538|Treatment Naive|treatment naive
729967|NCT00122525|HIV|hiv
729968|NCT00122525|Male circumcision|male circumcision
729969|NCT00122525|Prevention|prevention
729970|NCT00122525|HSV-2|hsv-2
729971|NCT00122525|Africa|africa
729972|NCT00122525|Sexual behavior|sexual behavior
729973|NCT00122512|AE adverse event|ae adverse event
729974|NCT00122512|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
729975|NCT00122512|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
729976|NCT00122512|ART antiretroviral therapy|art antiretroviral therapy
729977|NCT00122512|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
729978|NCT00122512|DCF data collection forms|dcf data collection forms
729979|NCT00122512|DMC Data Monitoring Committee|dmc data monitoring committee
729980|NCT00122512|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
729981|NCT00122512|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
729982|NCT00122512|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
729983|NCT00122512|ICH International Conference of Harmonisation|ich international conference of harmonisation
729984|NCT00122512|IND Investigational New Drug Application|ind investigational new drug application
729985|NCT00122512|IRB Institutional Review Board|irb institutional review board
729986|NCT00122512|IU international units|iu international units
729987|NCT00122512|mg milligram(s)|mg milligram(s)
729988|NCT00122512|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
729989|NCT00122512|PCR polymerase chain reaction|pcr polymerase chain reaction
729990|NCT00122512|SAE serious adverse event|sae serious adverse event
729991|NCT00122512|TDF tenofovir disoproxil fumarate, GS-4331-05, PMPA prodrug|tdf tenofovir disoproxil fumarate, gs-4331-05, pmpa prodrug
729992|NCT00122512|µg microgram|µg microgram
729993|NCT00122512|ULN upper limit of the normal range|uln upper limit of the normal range
729994|NCT00122512|WB Western Blot|wb western blot
729995|NCT00122512|Human Immunodeficiency Virus|human immunodeficiency virus
729996|NCT00122512|HIV Seronegativity|hiv seronegativity
729997|NCT00122499|Prostate cancer|prostate cancer
729998|NCT00122499|Radiotherapy|radiotherapy
729999|NCT00122499|Erectile dysfunction|erectile dysfunction
730000|NCT00122499|Tadalafil|tadalafil
730001|NCT00122486|AE adverse event|ae adverse event
730002|NCT00122486|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
730003|NCT00122486|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
730004|NCT00122486|ART antiretroviral therapy|art antiretroviral therapy
730005|NCT00122486|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
730006|NCT00122486|DCF data collection forms|dcf data collection forms
730007|NCT00122486|DMC Data Monitoring Committee|dmc data monitoring committee
730008|NCT00122486|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
730009|NCT00122486|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
730010|NCT00122486|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
730011|NCT00122486|ICH International Conference of Harmonisation|ich international conference of harmonisation
730012|NCT00122486|IND Investigational New Drug Application|ind investigational new drug application
730013|NCT00122486|IRB Institutional Review Board|irb institutional review board
730014|NCT00122486|IU international units|iu international units
730015|NCT00122486|mg milligram(s)|mg milligram(s)
730016|NCT00122486|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
730017|NCT00122486|PCR polymerase chain reaction|pcr polymerase chain reaction
730018|NCT00122486|SAE serious adverse event|sae serious adverse event
730019|NCT00122486|µg microgram|µg microgram
730020|NCT00122486|ULN upper limit of the normal range|uln upper limit of the normal range
730021|NCT00122486|WB Western Blot|wb western blot
730022|NCT00122486|Human Immunodeficiency Virus|human immunodeficiency virus
730023|NCT00122473|Dermatofibrosarcoma|dermatofibrosarcoma
730024|NCT00122473|Imatinib|imatinib
730025|NCT00122473|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
730026|NCT00122460|Head and Neck Cancer|head and neck cancer
730027|NCT00122447|Prediabetic state|prediabetic state
730028|NCT00122447|Cardiovascular disease|cardiovascular disease
730029|NCT00122447|Diabetes|diabetes
730030|NCT00122447|Glucose intolerance|glucose intolerance
730031|NCT00122421|diabetes|diabetes
730032|NCT00122421|quality of care|quality of care
730033|NCT00122421|pharmacist recommendations|pharmacist recommendations
730034|NCT00122408|ventilator-associated pneumonia|ventilator-associated pneumonia
730035|NCT00122408|probiotic|probiotic
730036|NCT00122408|mechanical ventilation|mechanical ventilation
730037|NCT00122408|intensive care|intensive care
730038|NCT00122395|Domestic violence|domestic violence
730039|NCT00122395|Screening|screening
730040|NCT00122395|Emergency department|emergency department
730041|NCT00122382|abatacept, methotrexate, erosive RA|abatacept, methotrexate, erosive ra
730042|NCT00122369|Breast|breast
730043|NCT00122369|Biopsy|biopsy
730044|NCT00122369|Hypnosis|hypnosis
730045|NCT00122369|Relaxation|relaxation
730046|NCT00122369|Anxiety|anxiety
730047|NCT00122369|Pain|pain
730048|NCT00122369|Medical and Surgical Procedures|medical and surgical procedures
730049|NCT00122343|Endometrial|endometrial
730050|NCT00122343|Cancer|cancer
730051|NCT00122317|transfusion dependent|transfusion dependent
730052|NCT00122317|paroxysmal nocturnal hemoglobinuria|paroxysmal nocturnal hemoglobinuria
730053|NCT00122317|hemolytic|hemolytic
730054|NCT00122291|preoperative|preoperative
730055|NCT00122291|chemotherapy|chemotherapy
730056|NCT00122291|radiation therapy|radiation therapy
730057|NCT00122291|rectal cancer|rectal cancer
730058|NCT00122291|transmural rectal wall invasion|transmural rectal wall invasion
730059|NCT00122291|nodal metastasis|nodal metastasis
730060|NCT00122278|migraine, emergency department, dexamethasone|migraine, emergency department, dexamethasone
730061|NCT00122278|Migraine with or without aura or probable migraine without aura as defined by ICHD, 2nd edition|migraine with or without aura or probable migraine without aura as defined by ichd, 2nd edition
730062|NCT00122265|prostate cancer|prostate cancer
730063|NCT00122265|radiotherapy|radiotherapy
730064|NCT00122265|radiation toxicity|radiation toxicity
730065|NCT00122265|single nucleotide polymorphism|single nucleotide polymorphism
730066|NCT00122252|prostate cancer|prostate cancer
730067|NCT00122252|radiotherapy|radiotherapy
730068|NCT00122252|biological imaging|biological imaging
730069|NCT00122239|radiotherapy|radiotherapy
730070|NCT00122239|radiation toxicity|radiation toxicity
730071|NCT00122239|single nucleotide polymorphism|single nucleotide polymorphism
730072|NCT00122239|breast carcinoma|breast carcinoma
730073|NCT00122239|prostate carcinoma|prostate carcinoma
730074|NCT00122239|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
730075|NCT00122239|lung carcinoma (non-small cell)|lung carcinoma (non-small cell)
730076|NCT00122226|HIV|hiv
730077|NCT00122226|HIV-associated lipodystrophy syndrome|hiv-associated lipodystrophy syndrome
730078|NCT00122213|Prevention|prevention
730079|NCT00122213|Retirement|retirement
730080|NCT00122213|Physical activity|physical activity
730081|NCT00122213|Diet|diet
730082|NCT00122213|Weight gain|weight gain
730083|NCT00122213|Body composition|body composition
730084|NCT00122187|cancer|cancer
730085|NCT00122187|colonoscopy|colonoscopy
730086|NCT00122187|mass screening|mass screening
730087|NCT00122187|colorectal cancer|colorectal cancer
730088|NCT00122187|colorectal carcinoma|colorectal carcinoma
730089|NCT00122187|reminder systems|reminder systems
730090|NCT00122187|rectal cancers|rectal cancers
730091|NCT00122187|colorectal tumor|colorectal tumor
730092|NCT00122187|guidelines|guidelines
730093|NCT00122187|CRC secondary prevention|crc secondary prevention
730094|NCT00122187|colorectal neoplasms|colorectal neoplasms
730095|NCT00122187|colonic neoplasms|colonic neoplasms
730096|NCT00122187|colonic diseases|colonic diseases
730097|NCT00122187|hemoccult testing|hemoccult testing
730098|NCT00122174|Caregivers|caregivers
730099|NCT00122174|Stress|stress
730100|NCT00122174|Coping|coping
730101|NCT00122174|Immune|immune
730102|NCT00122174|Relaxation|relaxation
730103|NCT00122174|Biofeedback|biofeedback
730104|NCT00122174|Bioinstrumentation|bioinstrumentation
730105|NCT00122174|Homecare|homecare
730106|NCT00122161|Drug therapy|drug therapy
730107|NCT00122161|Practice guidelines|practice guidelines
730108|NCT00122161|Reminder systems|reminder systems
730109|NCT00122161|Ambulatory care|ambulatory care
730110|NCT00122161|Hypertension|hypertension
730111|NCT00122161|Clinical protocols|clinical protocols
730112|NCT00122161|Quality Assurance, Health Care|quality assurance, health care
730113|NCT00122148|Quality of health care|quality of health care
730114|NCT00122148|Feedback|feedback
730115|NCT00122135|end-of-life care|end-of-life care
730116|NCT00122135|clinical decision-making|clinical decision-making
730117|NCT00122135|values inventory|values inventory
730118|NCT00122135|racial disparities|racial disparities
730119|NCT00122109|Posttraumatic Stress Disorder|posttraumatic stress disorder
730120|NCT00122109|Anger Management|anger management
730121|NCT00122109|Telemedicine modality|telemedicine modality
730122|NCT00122096|neurosurgery|neurosurgery
730123|NCT00122096|COX-2|cox-2
730124|NCT00122096|inflammation|inflammation
730125|NCT00122096|pain|pain
730126|NCT00122083|Depression|depression
730127|NCT00122083|Students|students
730128|NCT00122083|Health education|health education
730129|NCT00122070|Borderline Personality Disorder|borderline personality disorder
730130|NCT00122070|Personality Disorder|personality disorder
730131|NCT00122070|Quetiapine|quetiapine
730132|NCT00122070|Atypical Antipsychotics|atypical antipsychotics
730133|NCT00122070|Seroquel|seroquel
730134|NCT00122070|Antipsychotics|antipsychotics
730135|NCT00122057|ventilator-associated tracheobronchitis|ventilator-associated tracheobronchitis
730136|NCT00122057|nosocomial tracheobronchitis|nosocomial tracheobronchitis
730137|NCT00122044|childhood|childhood
730138|NCT00122044|cerebral palsy|cerebral palsy
730139|NCT00122044|dystonia|dystonia
730140|NCT00122044|secondary|secondary
730141|NCT00122044|trihexyphenidyl|trihexyphenidyl
730142|NCT00122044|pediatric dystonia|pediatric dystonia
730143|NCT00122031|Major Depression|major depression
730144|NCT00122031|Treatment Refractory Major Depression|treatment refractory major depression
730145|NCT00122018|Kidney failure|kidney failure
730146|NCT00122018|Cardiac Surgery|cardiac surgery
730147|NCT00122018|Fenoldopam|fenoldopam
730148|NCT00122018|N-acetylcysteine|n-acetylcysteine
730149|NCT00122005|Metastatic|metastatic
730150|NCT00122005|Prostate|prostate
730151|NCT00122005|Advanced|advanced
730152|NCT00122005|Cancer|cancer
730153|NCT00122005|GVAX|gvax
730154|NCT00122005|Vaccine|vaccine
730155|NCT00121992|High risk node negative breast cancer|high risk node negative breast cancer
730156|NCT00121992|Disease-Free survival|disease-free survival
730157|NCT00121992|Quality of life|quality of life
730158|NCT00121979|HIV|hiv
730159|NCT00121979|treatment-experienced|treatment-experienced
730160|NCT00121979|lamivudine|lamivudine
730161|NCT00121979|3TC|3tc
730162|NCT00121966|Type 2 diabetes|type 2 diabetes
730163|NCT00121966|Insulin Aspart|insulin aspart
730164|NCT00121966|Insulin NPH|insulin nph
730165|NCT00121966|Metformin|metformin
730166|NCT00121966|Rosiglitazone|rosiglitazone
730167|NCT00121953|Endometriosis|endometriosis
730168|NCT00121953|Peritoneal fluid|peritoneal fluid
730169|NCT00121953|Cytokines|cytokines
730170|NCT00121953|Peroxisome Proliferator-Activated Receptors|peroxisome proliferator-activated receptors
730171|NCT00121940|Chronic Disease|chronic disease
730172|NCT00121940|Nurses|nurses
730173|NCT00121940|Caregivers|caregivers
730174|NCT00121940|Support Groups|support groups
730175|NCT00121927|intractable|intractable
730176|NCT00121927|ketogenic|ketogenic
730177|NCT00121927|ketosis|ketosis
730178|NCT00121927|Atkins|atkins
730179|NCT00121914|Carcinoma, Hepatocellular,|carcinoma, hepatocellular,
730180|NCT00121914|percutaneous ethanol instillation|percutaneous ethanol instillation
730181|NCT00121914|long-acting somatostatin|long-acting somatostatin
730182|NCT00121901|Pancreatitis|pancreatitis
730183|NCT00121901|Cholangiopancreatograpy, Endoscopic Retrograde/adverse|cholangiopancreatograpy, endoscopic retrograde/adverse
730184|NCT00121901|Nitroglycerin|nitroglycerin
730185|NCT00121901|Randomized Controlled Trial,|randomized controlled trial,
730186|NCT00121888|post traumatic stress disorder|post traumatic stress disorder
730467|NCT00120835|Genotype-1|genotype-1
730187|NCT00121888|Prolonged Exposure Therapy|prolonged exposure therapy
730188|NCT00121888|pharmacotherapy|pharmacotherapy
730189|NCT00121888|double-blind|double-blind
730190|NCT00121888|Anxiety Disorder|anxiety disorder
730191|NCT00121875|short stature|short stature
730192|NCT00121875|insulin resistance|insulin resistance
730193|NCT00121875|body composition|body composition
730194|NCT00121875|Turner syndrome|turner syndrome
730195|NCT00121875|intramyocellular lipid|intramyocellular lipid
730196|NCT00121875|glucose tolerance|glucose tolerance
730197|NCT00121862|Leishmaniasis|leishmaniasis
730198|NCT00121862|Subunit Vaccine|subunit vaccine
730199|NCT00121862|Prevention|prevention
730200|NCT00121862|T cell|t cell
730201|NCT00121849|Leishmaniasis,|leishmaniasis,
730202|NCT00121849|Subunit Vaccine,|subunit vaccine,
730203|NCT00121849|Prevention,|prevention,
730204|NCT00121849|T cell|t cell
730205|NCT00121823|Malaria|malaria
730206|NCT00121823|PCR|pcr
730207|NCT00121823|Vaccines|vaccines
730208|NCT00121823|Acceptability|acceptability
730209|NCT00121797|Postpartum Period|postpartum period
730210|NCT00121771|Malaria|malaria
730211|NCT00121771|Vaccines|vaccines
730212|NCT00121771|Safety|safety
730213|NCT00121771|Immunogenicity|immunogenicity
730214|NCT00121758|HIV Vaccines|hiv vaccines
730215|NCT00121758|HIV Seronegativity|hiv seronegativity
730216|NCT00121745|gene transfer|gene transfer
730217|NCT00121745|cell cycle control|cell cycle control
730218|NCT00121745|cancer gene therapy|cancer gene therapy
730219|NCT00121745|pathotropic targeting|pathotropic targeting
730220|NCT00121745|tumor targeted retroviral vector|tumor targeted retroviral vector
730221|NCT00121719|Resistant and refractory solid tumors|resistant and refractory solid tumors
730222|NCT00121719|lymphomas|lymphomas
730223|NCT00121719|hodgkins disease|hodgkins disease
730224|NCT00121719|non-hodgkins lymphoma|non-hodgkins lymphoma
730225|NCT00121719|neoplasms|neoplasms
730226|NCT00121693|Fall prevention|fall prevention
730227|NCT00121693|posturography|posturography
730228|NCT00121693|music therapy|music therapy
730229|NCT00121680|cancer|cancer
730230|NCT00121654|Angina pectoris|angina pectoris
730231|NCT00121654|Spinal cord stimulation|spinal cord stimulation
730232|NCT00121654|Refractory angina pectoris|refractory angina pectoris
730233|NCT00121628|Thyroid cancer|thyroid cancer
730234|NCT00121628|Advanced thyroid cancer|advanced thyroid cancer
730235|NCT00121628|Metastatic thyroid cancer|metastatic thyroid cancer
730236|NCT00121628|Medullary thyroid cancer|medullary thyroid cancer
730237|NCT00121628|Follicular thyroid cancer|follicular thyroid cancer
730238|NCT00121628|Papillary thyroid cancer|papillary thyroid cancer
730239|NCT00121628|Hurthle cell thyroid cancer|hurthle cell thyroid cancer
730240|NCT00121628|Thyroid cancer treatments|thyroid cancer treatments
730241|NCT00121628|Differentiated thyroid cancer and medullary thyroid cancer|differentiated thyroid cancer and medullary thyroid cancer
730242|NCT00121615|Clinical Trials|clinical trials
730243|NCT00121602|Hemodialysis|hemodialysis
730244|NCT00121602|Darbepoetin Alfa|darbepoetin alfa
730245|NCT00121602|Clinical Trials|clinical trials
730246|NCT00121602|Nephrology|nephrology
730247|NCT00121602|Amgen|amgen
730248|NCT00121602|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
730249|NCT00121589|AMD|amd
730250|NCT00121589|Macular Pigment|macular pigment
730251|NCT00121589|Serum Lutein Levels|serum lutein levels
730252|NCT00121589|Vitamin Supplementation|vitamin supplementation
730253|NCT00121589|Carotenoids|carotenoids
730254|NCT00121589|Lutein|lutein
730255|NCT00121589|Zeaxanthin|zeaxanthin
730256|NCT00121589|DHA|dha
730257|NCT00121589|Age Related Macular Degeneration|age related macular degeneration
730258|NCT00121563|Cytokines|cytokines
730259|NCT00121563|Inflammation|inflammation
730260|NCT00121563|Pain|pain
730261|NCT00121563|Injury|injury
730262|NCT00121563|Peripheral|peripheral
730263|NCT00121563|Wisdom Teeth|wisdom teeth
730264|NCT00121563|Third Molar Extraction|third molar extraction
730265|NCT00121550|Coronary heart disease|coronary heart disease
730266|NCT00121550|Clarithromycin|clarithromycin
730267|NCT00121550|Macrolides|macrolides
730268|NCT00121550|Cardiovascular mortality|cardiovascular mortality
730269|NCT00121550|Chlamydia pneumoniae|chlamydia pneumoniae
730270|NCT00121537|wounds-open|wounds-open
730271|NCT00121524|cardiac arrest|cardiac arrest
730272|NCT00121524|resuscitation|resuscitation
730273|NCT00121524|epinephrine|epinephrine
730274|NCT00121524|intravenous|intravenous
730275|NCT00121524|survival|survival
730276|NCT00121511|photoaging|photoaging
730277|NCT00121511|Actinic Keratoses|actinic keratoses
730278|NCT00121511|Efudex|efudex
730279|NCT00121511|5 fluorouracil|5 fluorouracil
730280|NCT00121498|Pain|pain
730281|NCT00121498|Hysterectomy|hysterectomy
730282|NCT00121498|Preemptive|preemptive
730283|NCT00121498|Lidocaine|lidocaine
730284|NCT00121485|Heart-assist devices|heart-assist devices
730285|NCT00121472|Heart-assist devices|heart-assist devices
730286|NCT00121459|Diaphragm|diaphragm
730287|NCT00121459|HIV prevention|hiv prevention
730288|NCT00121459|Southern/South Africa, Zimbabwe|southern/south africa, zimbabwe
730289|NCT00121459|female-controlled methods|female-controlled methods
730290|NCT00121459|Replens|replens
730291|NCT00121459|STI prevention|sti prevention
730292|NCT00121459|HIV Seronegativity|hiv seronegativity
730293|NCT00121446|Heart Attack|heart attack
730294|NCT00121446|ST Elevation Myocardial Infarction|st elevation myocardial infarction
730295|NCT00121446|fibrinolytic therapy|fibrinolytic therapy
730296|NCT00121446|percutaneous coronary intervention|percutaneous coronary intervention
730297|NCT00121446|Acute Myocardial Infarction|acute myocardial infarction
730298|NCT00121420|Brain Neoplasms/secondary|brain neoplasms/secondary
730299|NCT00121420|Brain neoplasms/radiotherapy|brain neoplasms/radiotherapy
730300|NCT00121420|Brain metastasis|brain metastasis
730301|NCT00121420|Neoplasm metastasis|neoplasm metastasis
730302|NCT00121420|Cranial irradiation|cranial irradiation
730303|NCT00121420|Radiosurgery|radiosurgery
730304|NCT00121420|Lung Neoplasms|lung neoplasms
730305|NCT00121420|Breast Neoplasms|breast neoplasms
730306|NCT00121420|Kidney Neoplasms|kidney neoplasms
730307|NCT00121420|Melanoma|melanoma
730308|NCT00121420|Radiotherapy|radiotherapy
730309|NCT00121420|Carcinoma, non-small cell lung|carcinoma, non-small cell lung
730310|NCT00121407|Age Related Macular Degeneration (AMD)|age related macular degeneration (amd)
730311|NCT00121407|Photodynamic Therapy (PDT)|photodynamic therapy (pdt)
730312|NCT00121407|Visudyne|visudyne
730313|NCT00121394|Chlorhexidine|chlorhexidine
730314|NCT00121394|Vaginal wash|vaginal wash
730315|NCT00121394|Neonatal mortality|neonatal mortality
730316|NCT00121394|Sepsis|sepsis
730317|NCT00121394|Global Network|global network
730318|NCT00121394|Maternal and child health|maternal and child health
730319|NCT00121394|Women's Health|women's health
730320|NCT00121394|International|international
730321|NCT00121394|Pakistan|pakistan
730322|NCT00121381|Atopic dermatitis|atopic dermatitis
730323|NCT00121381|T-cell|t-cell
730324|NCT00121381|pimecrolimus|pimecrolimus
730325|NCT00121381|children|children
730326|NCT00121381|topical corticosteroids|topical corticosteroids
730327|NCT00121368|Global Network|global network
730328|NCT00121368|Maternal and child health|maternal and child health
730329|NCT00121368|International|international
730330|NCT00121368|Women's health|women's health
730331|NCT00121368|Tobacco|tobacco
730332|NCT00121368|Smoking|smoking
730333|NCT00121368|Africa|africa
730334|NCT00121368|Latin America|latin america
730335|NCT00121368|South America|south america
730336|NCT00121368|Guatemala|guatemala
730337|NCT00121368|Zambia|zambia
730338|NCT00121368|India|india
730339|NCT00121368|Argentina|argentina
730340|NCT00121368|Democratic Republic of the Congo|democratic republic of the congo
730341|NCT00121329|Pain with procedures|pain with procedures
730342|NCT00121316|Atopic dermatitis|atopic dermatitis
730343|NCT00121316|pimecrolimus|pimecrolimus
730344|NCT00121303|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
730345|NCT00121303|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
730346|NCT00121303|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
730347|NCT00121303|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
730348|NCT00121303|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
730349|NCT00121303|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
730350|NCT00121303|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
730351|NCT00121303|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
730352|NCT00121303|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
730353|NCT00121303|refractory anemia with excess blasts|refractory anemia with excess blasts
730354|NCT00121303|secondary acute myeloid leukemia|secondary acute myeloid leukemia
730355|NCT00121303|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
730356|NCT00121303|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
730357|NCT00121303|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
730358|NCT00121303|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
730359|NCT00121303|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
730360|NCT00121303|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
730361|NCT00121303|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
730362|NCT00121303|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
730363|NCT00121277|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
730364|NCT00121212|stage I prostate cancer|stage i prostate cancer
730365|NCT00121212|stage IIB prostate cancer|stage iib prostate cancer
730366|NCT00121212|stage IIA prostate cancer|stage iia prostate cancer
730367|NCT00121212|stage III prostate cancer|stage iii prostate cancer
730368|NCT00121186|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
730369|NCT00121186|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
730370|NCT00121186|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
730371|NCT00121186|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
732496|NCT00113867|hormones|hormones
730372|NCT00121186|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
730373|NCT00121186|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
730374|NCT00121186|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
730375|NCT00121173|cervical cancer|cervical cancer
730376|NCT00121173|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
730377|NCT00121173|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
730378|NCT00121160|immune response to vaccines|immune response to vaccines
730379|NCT00121160|stress management|stress management
730380|NCT00121160|breast cancer|breast cancer
730381|NCT00121147|glaucoma|glaucoma
730382|NCT00121147|pseudoexfoliation|pseudoexfoliation
730383|NCT00121134|Bevacizumab|bevacizumab
730384|NCT00121134|Metronomic Chemotherapy|metronomic chemotherapy
730385|NCT00121134|Breast Cancer Stages II-III|breast cancer stages ii-iii
730386|NCT00121134|Invasive breast cancer stages II-III|invasive breast cancer stages ii-iii
730387|NCT00121121|HIV Vaccines|hiv vaccines
730388|NCT00121121|HIV Seronegativity|hiv seronegativity
730389|NCT00121095|prostate cancer|prostate cancer
730390|NCT00121069|specific phobia|specific phobia
730391|NCT00121069|anxiety|anxiety
730392|NCT00121069|SSRI|ssri
730393|NCT00121069|clinical trial|clinical trial
730394|NCT00121069|escitalopram|escitalopram
730395|NCT00121043|Rheumatoid Arthritis, Inflammation|rheumatoid arthritis, inflammation
730396|NCT00121043|Interleukin-1 (IL-1), r-metHuIL-1ra|interleukin-1 (il-1), r-methuil-1ra
730397|NCT00121043|Autoimmune, Kineret®|autoimmune, kineret®
730398|NCT00121043|Anakinra, Immunex|anakinra, immunex
730399|NCT00121043|Amgen, Clinical Trials|amgen, clinical trials
730400|NCT00121030|uterine cancer|uterine cancer
730401|NCT00121030|ovarian cancer|ovarian cancer
730402|NCT00121030|darbepoetin alfa|darbepoetin alfa
730403|NCT00121030|Amgen|amgen
730404|NCT00121030|Gynecological Malignancies|gynecological malignancies
730405|NCT00121017|HCV Infection|hcv infection
730406|NCT00121017|Treatment Naive|treatment naive
730407|NCT00121004|Advance Directive|advance directive
730408|NCT00121004|Living Will|living will
730409|NCT00121004|Terminal Illness|terminal illness
730410|NCT00120991|Coronary artery bypass grafting|coronary artery bypass grafting
730411|NCT00120991|OPCAB|opcab
730412|NCT00120978|Clinical Trial; C-reactive protein; fluticasone; salmeterol|clinical trial; c-reactive protein; fluticasone; salmeterol
730413|NCT00120965|Cardiac arrest|cardiac arrest
730414|NCT00120965|OOH-cardiac arrest|ooh-cardiac arrest
730415|NCT00120965|CPR|cpr
730416|NCT00120965|Chest compressions|chest compressions
730417|NCT00120965|Chest compression device|chest compression device
730418|NCT00120952|RSA|rsa
730419|NCT00120952|Osteoarthritis|osteoarthritis
730420|NCT00120952|Hip arthroplasty|hip arthroplasty
730421|NCT00120952|DEXA|dexa
730422|NCT00120952|Titanium|titanium
730423|NCT00120952|Cobalt chromium|cobalt chromium
730424|NCT00120952|Bone cement|bone cement
730425|NCT00120939|Lung Cancer|lung cancer
730426|NCT00120939|Breast Cancer|breast cancer
730427|NCT00120939|Prostate Cancer|prostate cancer
730428|NCT00120939|Ovarian Cancer|ovarian cancer
730429|NCT00120939|Head and Neck Cancer|head and neck cancer
730430|NCT00120939|Gastrointestinal Cancer|gastrointestinal cancer
730431|NCT00120939|Metastatic Cancer|metastatic cancer
730432|NCT00120939|Advanced Cancer|advanced cancer
730433|NCT00120939|Genitourinary Cancer|genitourinary cancer
730434|NCT00120939|Glioblastoma Multiforme|glioblastoma multiforme
730435|NCT00120939|Recurrent Cancer|recurrent cancer
730436|NCT00120939|Colon Cancer|colon cancer
730437|NCT00120939|Gastric Cancer|gastric cancer
730438|NCT00120939|Stomach Cancer|stomach cancer
730439|NCT00120939|Pancreatic Cancer|pancreatic cancer
730440|NCT00120939|Esophageal Cancer|esophageal cancer
730441|NCT00120939|Throat Cancer|throat cancer
730442|NCT00120939|Bladder Cancer|bladder cancer
730443|NCT00120939|Kidney Cancer|kidney cancer
730444|NCT00120939|Renal Cancer|renal cancer
730445|NCT00120939|Cervical Cancer|cervical cancer
730446|NCT00120939|Endometrial Cancer|endometrial cancer
730447|NCT00120939|Colorectal Cancer|colorectal cancer
730448|NCT00120926|Premature neonate|premature neonate
730449|NCT00120926|Parenteral nutrition|parenteral nutrition
730450|NCT00120926|Growth|growth
730451|NCT00120926|Amino Acids|amino acids
730452|NCT00120926|Nutrition|nutrition
730453|NCT00120913|Breakthrough bleeding while taking continuously dosed oral contraceptives|breakthrough bleeding while taking continuously dosed oral contraceptives
730454|NCT00120900|COX-2 inhibitor|cox-2 inhibitor
730455|NCT00120900|Knee osteoarthritis|knee osteoarthritis
730456|NCT00120887|Atherosclerosis, SLE, statins|atherosclerosis, sle, statins
730457|NCT00120874|Alzheimer's disease|alzheimer's disease
730458|NCT00120874|caregiver training|caregiver training
730459|NCT00120874|caregiver counseling|caregiver counseling
730460|NCT00120874|individualized management|individualized management
730461|NCT00120874|memantine|memantine
730462|NCT00120874|dementia|dementia
730463|NCT00120861|Genotype-1|genotype-1
730464|NCT00120861|Previously failed treatment|previously failed treatment
730465|NCT00120848|HPV vaccine efficacy|hpv vaccine efficacy
730466|NCT00120848|Prophylaxis HPV 16/18 infections|prophylaxis hpv 16/18 infections
730468|NCT00120835|Treatment-Naive|treatment-naive
730469|NCT00120822|Malaria|malaria
730470|NCT00120822|Pregnancy|pregnancy
730471|NCT00120822|Folic acid|folic acid
730472|NCT00120822|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
730473|NCT00120809|Malaria|malaria
730474|NCT00120809|Pregnancy|pregnancy
730475|NCT00120809|Multigravidae|multigravidae
730476|NCT00120809|Intermittent preventative treatment|intermittent preventative treatment
730477|NCT00120809|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
730478|NCT00120796|Hepatitis B|hepatitis b
730479|NCT00120796|Hepatitis B Vaccines|hepatitis b vaccines
730480|NCT00120796|Lamivudine|lamivudine
730481|NCT00120783|Treatment Failure|treatment failure
730482|NCT00120783|HIV infections|hiv infections
730483|NCT00120770|AE adverse event|ae adverse event
730484|NCT00120770|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
730485|NCT00120770|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
730486|NCT00120770|ART antiretroviral therapy|art antiretroviral therapy
730487|NCT00120770|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
730488|NCT00120770|DCF data collection forms|dcf data collection forms
730489|NCT00120770|DMC Data Monitoring Committee|dmc data monitoring committee
730490|NCT00120770|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
730491|NCT00120770|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
730492|NCT00120770|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
730493|NCT00120770|ICH International Conference of Harmonisation|ich international conference of harmonisation
730494|NCT00120770|IND Investigational New Drug Application|ind investigational new drug application
730495|NCT00120770|IRB Institutional Review Board|irb institutional review board
730496|NCT00120770|IU international units|iu international units
730497|NCT00120770|mg milligram(s)|mg milligram(s)
730498|NCT00120770|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
730499|NCT00120770|PCR polymerase chain reaction|pcr polymerase chain reaction
730500|NCT00120770|SAE serious adverse event|sae serious adverse event
730501|NCT00120770|µg microgram|µg microgram
730502|NCT00120770|ULN upper limit of the normal range|uln upper limit of the normal range
730503|NCT00120770|WB Western Blot|wb western blot
730504|NCT00120770|Human Immunodeficiency Virus|human immunodeficiency virus
730505|NCT00120770|Neisseria gonorrhoeae|neisseria gonorrhoeae
730506|NCT00120770|Chlamydia trachomatis|chlamydia trachomatis
730507|NCT00120770|HIV Seronegativity|hiv seronegativity
730508|NCT00120757|Osteoporosis|osteoporosis
730509|NCT00120731|Recurrent nephrolithiasis|recurrent nephrolithiasis
730510|NCT00120731|Potassium Citrate|potassium citrate
730511|NCT00120731|Hypercalciuria|hypercalciuria
730512|NCT00120731|Distal Renal Tubular Acidosis|distal renal tubular acidosis
730513|NCT00120731|Nephrolithiasis in children|nephrolithiasis in children
730514|NCT00120705|anemia|anemia
730515|NCT00120705|darbepoetin alfa|darbepoetin alfa
730516|NCT00120705|Amgen|amgen
730517|NCT00120705|Non-myeloid Malignancies|non-myeloid malignancies
730518|NCT00120692|breast cancer|breast cancer
730519|NCT00120692|darbepoetin alfa|darbepoetin alfa
730520|NCT00120692|Amgen|amgen
730521|NCT00120679|non-small cell lung cancer|non-small cell lung cancer
730522|NCT00120679|darbepoetin alfa|darbepoetin alfa
730523|NCT00120679|Amgen|amgen
730524|NCT00120666|Exercise|exercise
730525|NCT00120666|Stimulation|stimulation
730526|NCT00120666|Nerve|nerve
730527|NCT00120666|Electrical|electrical
730528|NCT00120666|Muscle|muscle
730529|NCT00120666|Healthy Volunteer|healthy volunteer
730530|NCT00120666|HV|hv
730531|NCT00120653|Reglan|reglan
730532|NCT00120653|Prolactin|prolactin
730533|NCT00120653|MDS|mds
730534|NCT00120653|Metoclopramide|metoclopramide
730535|NCT00120653|Myelodysplastic Syndrome|myelodysplastic syndrome
730536|NCT00120640|Premature birth|premature birth
730537|NCT00120640|Premature labor|premature labor
730538|NCT00120640|Progesterone|progesterone
730539|NCT00120627|Randomized Controlled Trial|randomized controlled trial
730540|NCT00120627|Intervention Study|intervention study
730541|NCT00120627|Mindfulness|mindfulness
730542|NCT00120627|Complementary Therapy|complementary therapy
730543|NCT00120627|Mind-Body Relations (Metaphysics)|mind-body relations (metaphysics)
730544|NCT00120627|Spiritual Therapy|spiritual therapy
730545|NCT00120627|Meditation|meditation
730546|NCT00120627|Qualitative Analysis|qualitative analysis
730547|NCT00120614|Premature Infant|premature infant
730548|NCT00120614|Premature Birth|premature birth
730549|NCT00120614|Parenting Interventions|parenting interventions
730550|NCT00120614|NICU Interventional studies|nicu interventional studies
730551|NCT00120614|Parental coping|parental coping
730552|NCT00120614|Low birthweight infant|low birthweight infant
730553|NCT00120614|Coping Behavior|coping behavior
730554|NCT00120614|Infant, Premature|infant, premature
730555|NCT00120601|treatment|treatment
730556|NCT00120601|alcohol|alcohol
730557|NCT00120601|dependence|dependence
730558|NCT00120601|medication|medication
730559|NCT00120588|brain protection|brain protection
730560|NCT00120588|white matter injury|white matter injury
730561|NCT00120588|neurodevelopmental sequelae|neurodevelopmental sequelae
730562|NCT00120588|magnesium sulfate|magnesium sulfate
730563|NCT00120588|intraventricular hemorrhage|intraventricular hemorrhage
730564|NCT00120575|Hemofiltration|hemofiltration
730565|NCT00120575|Pediatrics|pediatrics
730566|NCT00120562|weight loss surgery|weight loss surgery
730567|NCT00120562|gastric bypass surgery|gastric bypass surgery
730568|NCT00120549|Assisted Hatching|assisted hatching
730569|NCT00120549|Cleavage Stage, Ovum|cleavage stage, ovum
730570|NCT00120549|Embryo Transfer|embryo transfer
730571|NCT00120549|Pregnancy|pregnancy
730572|NCT00120549|Embryo Implantation|embryo implantation
730573|NCT00120536|Type 2 diabetes|type 2 diabetes
730574|NCT00120536|vildagliptin|vildagliptin
730575|NCT00120523|Atopic dermatitis, children, infants, pimecrolimus|atopic dermatitis, children, infants, pimecrolimus
730576|NCT00120510|Treatment Naive|treatment naive
730577|NCT00120510|TB|tb
730578|NCT00120497|short stature|short stature
730579|NCT00120497|intrauterine growth restriction|intrauterine growth restriction
730580|NCT00120497|insulin resistance|insulin resistance
730581|NCT00120497|intramyocellular lipid|intramyocellular lipid
730582|NCT00120497|small for gestational age|small for gestational age
730583|NCT00120497|glucose tolerance|glucose tolerance
730584|NCT00120484|Circadian Rhythm|circadian rhythm
730585|NCT00120484|Biological Clock|biological clock
730586|NCT00120484|Complementary and Alternative Medicine|complementary and alternative medicine
730587|NCT00120471|Perinatal Transmission|perinatal transmission
730588|NCT00120471|MTCT|mtct
730589|NCT00120471|HIV Seronegativity|hiv seronegativity
730590|NCT00120458|Black Cohosh|black cohosh
730591|NCT00120458|Cimicifuga|cimicifuga
730592|NCT00120458|Anxiety|anxiety
730593|NCT00120458|Women|women
730594|NCT00120458|Complementary and Alternative Medicine|complementary and alternative medicine
730595|NCT00120445|retinal detachment|retinal detachment
730596|NCT00120445|pneumatic retinopexy|pneumatic retinopexy
730597|NCT00120432|single dose|single dose
730598|NCT00120432|mydriatic drug|mydriatic drug
730599|NCT00120432|pupillary dilation|pupillary dilation
730600|NCT00120419|HIV-1 infection|hiv-1 infection
730601|NCT00120419|immunomodulatory therapy|immunomodulatory therapy
730602|NCT00120419|Treatment Naive|treatment naive
730603|NCT00120406|Peripheral Arterial Disease (PAD)|peripheral arterial disease (pad)
730604|NCT00120406|Peripheral Vascular Disease|peripheral vascular disease
730605|NCT00120406|Drug-Eluting Stent|drug-eluting stent
730606|NCT00120406|Drug-Coated Stent|drug-coated stent
730607|NCT00120393|Treatment Experienced|treatment experienced
730608|NCT00120380|Idiopathic pulmonary arterial hypertension|idiopathic pulmonary arterial hypertension
730609|NCT00120367|Leukoencephalopathy, Progressive Multifocal|leukoencephalopathy, progressive multifocal
730610|NCT00120367|HIV infections|hiv infections
730611|NCT00120367|HIV Fusion Inhibitors|hiv fusion inhibitors
730612|NCT00120354|Hepatitis B Virus|hepatitis b virus
730613|NCT00120354|Antiviral Resistance|antiviral resistance
730614|NCT00120354|Drug Withdrawal|drug withdrawal
730615|NCT00120354|Immune Response|immune response
730616|NCT00120354|Hepatitis B Surface Antigen|hepatitis b surface antigen
730617|NCT00120354|Liver Biopsy|liver biopsy
730618|NCT00120354|Hepatitis B|hepatitis b
730619|NCT00120328|serum creatinine|serum creatinine
730620|NCT00120328|end stage renal disease|end stage renal disease
730621|NCT00120328|cardiovascular mortality|cardiovascular mortality
730622|NCT00120328|cardiovascular morbidity|cardiovascular morbidity
730623|NCT00120328|non-cardiovascular mortality|non-cardiovascular mortality
730624|NCT00120328|non-cardiovascular morbidity|non-cardiovascular morbidity
730625|NCT00120315|dyspepsia|dyspepsia
730626|NCT00120315|discontinuation|discontinuation
730627|NCT00120315|Primary health care|primary health care
730628|NCT00120315|Helicobacter pylori|helicobacter pylori
730629|NCT00120315|Proton Pump Inhibitor|proton pump inhibitor
730630|NCT00120315|Histamine-2-receptor-antagonist|histamine-2-receptor-antagonist
730631|NCT00120302|Randomised|randomised
730632|NCT00120302|Placebo-controlled|placebo-controlled
730633|NCT00120302|Elidel|elidel
730634|NCT00120302|Quality of Life|quality of life
730635|NCT00120302|Atopic Eczema|atopic eczema
730636|NCT00120276|Functional Mitral Regurgitation (FMR)|functional mitral regurgitation (fmr)
730637|NCT00120276|Ischemic Mitral Regurgitation|ischemic mitral regurgitation
730638|NCT00120276|Less invasive repair|less invasive repair
730639|NCT00120276|Surgical MV repair|surgical mv repair
730640|NCT00120276|Mitral Valve Repair|mitral valve repair
730641|NCT00120276|Heart Failure|heart failure
730642|NCT00120276|Left Ventricular Dysfunction|left ventricular dysfunction
730643|NCT00120263|Plasma Exchange|plasma exchange
730644|NCT00120263|Myeloma|myeloma
730645|NCT00120263|Acute renal failure|acute renal failure
730646|NCT00120263|Light Chains|light chains
730647|NCT00120263|Bence Jones Proteins|bence jones proteins
730648|NCT00120263|Kidney Function|kidney function
730649|NCT00120250|PTSD|ptsd
730650|NCT00120250|Sleep disturbance|sleep disturbance
730651|NCT00120250|Eszopiclone|eszopiclone
730652|NCT00120250|Double-blind|double-blind
730653|NCT00120250|Crossover|crossover
730654|NCT00120237|Postpartum hemorrhage|postpartum hemorrhage
730655|NCT00120237|Misoprostol|misoprostol
730656|NCT00120237|Maternal morbidity|maternal morbidity
730657|NCT00120237|Developing countries|developing countries
730658|NCT00120237|Traditional birth attendants|traditional birth attendants
730659|NCT00120224|Mifepristone|mifepristone
730660|NCT00120224|Medical abortion|medical abortion
730661|NCT00120224|Ultrasound|ultrasound
730662|NCT00120198|NHL|nhl
730663|NCT00120198|elderly|elderly
730664|NCT00120185|HIV Infections|hiv infections
730665|NCT00120185|Interleukin-2|interleukin-2
730666|NCT00120172|colorectal|colorectal
730667|NCT00120172|metastatic|metastatic
730668|NCT00120172|elderly|elderly
730669|NCT00120172|metastatic colorectal cancer|metastatic colorectal cancer
730670|NCT00120159|Necrotizing Enterocolitis|necrotizing enterocolitis
730671|NCT00120133|Osteoporosis|osteoporosis
730672|NCT00120133|Bisphosphonates|bisphosphonates
730673|NCT00120133|Atorvastatin|atorvastatin
730674|NCT00120120|Radiculopathy|radiculopathy
730675|NCT00120120|Back Pain|back pain
730676|NCT00120120|Lumbar Pain|lumbar pain
730677|NCT00120120|CC-5013|cc-5013
730678|NCT00120120|Revlimid|revlimid
730679|NCT00120120|Lenalidomide|lenalidomide
730680|NCT00120094|Syncope|syncope
730681|NCT00120094|Electrocardiographic monitoring|electrocardiographic monitoring
730682|NCT00120081|Vaccine|vaccine
730683|NCT00120081|Hookworm|hookworm
730684|NCT00120081|Phase 1|phase 1
730685|NCT00120081|Human Hookworm Infection|human hookworm infection
730686|NCT00120081|Na-ASP-2|na-asp-2
730687|NCT00120042|Abortion|abortion
730688|NCT00120042|Retained placenta|retained placenta
730689|NCT00120042|Hemorrhage|hemorrhage
730690|NCT00120042|Postpartum ultrasound|postpartum ultrasound
730691|NCT00120029|weight loss|weight loss
730692|NCT00120029|survivorship|survivorship
730693|NCT00120029|breast ductal lavage|breast ductal lavage
730694|NCT00120029|exercise|exercise
730695|NCT00120029|diet|diet
730696|NCT00120016|cancer prevention|cancer prevention
730697|NCT00120016|diet|diet
730698|NCT00120016|nutrition|nutrition
730699|NCT00120016|polyunsaturated fat|polyunsaturated fat
730700|NCT00120016|olive oil|olive oil
730701|NCT00120003|Acute stroke|acute stroke
730702|NCT00120003|Elevated blood pressure|elevated blood pressure
730703|NCT00120003|Blood pressure lowering treatment|blood pressure lowering treatment
730704|NCT00119990|vasopressin|vasopressin
730705|NCT00119990|icodextrin|icodextrin
730706|NCT00119990|cardiac output|cardiac output
730707|NCT00119977|cartilage thickness|cartilage thickness
730708|NCT00119977|RSA|rsa
730709|NCT00119977|DEXA|dexa
730710|NCT00119977|ultra sound|ultra sound
730711|NCT00119977|MRI|mri
730712|NCT00119977|osteoarthritis|osteoarthritis
730713|NCT00119977|periacetabular osteotomy|periacetabular osteotomy
730714|NCT00119951|Behavioral|behavioral
730715|NCT00119938|Disease management|disease management
730716|NCT00119938|Patient access to records|patient access to records
730717|NCT00119938|Medical records systems, computerized|medical records systems, computerized
730718|NCT00119938|Questionnaires|questionnaires
730719|NCT00119938|Physician-patient relations|physician-patient relations
730720|NCT00119938|Medical records|medical records
730721|NCT00119925|infertility|infertility
730722|NCT00119925|guideline|guideline
730723|NCT00119925|health care implementation|health care implementation
730724|NCT00119925|intervention|intervention
730725|NCT00119925|gynecology|gynecology
730726|NCT00119912|screening|screening
730727|NCT00119912|flexible sigmoidoscopy|flexible sigmoidoscopy
730728|NCT00119912|fecal occult blood|fecal occult blood
730729|NCT00119912|cancer|cancer
730730|NCT00119912|colon|colon
730731|NCT00119912|rectum|rectum
730732|NCT00119899|Colorectal Cancer;|colorectal cancer;
730733|NCT00119899|Liver;|liver;
730734|NCT00119899|Metastases;|metastases;
730735|NCT00119899|Resection;|resection;
730736|NCT00119899|Fluorodeoxyglucose;|fluorodeoxyglucose;
730737|NCT00119899|Tomography;|tomography;
730738|NCT00119899|Positron-Emission|positron-emission
730739|NCT00119873|HIV Preventive Vaccine|hiv preventive vaccine
730740|NCT00119873|AIDS Vaccines|aids vaccines
730741|NCT00119873|Adenoviridae|adenoviridae
730742|NCT00119834|Heart Failure|heart failure
730743|NCT00119834|Intermacs|intermacs
730744|NCT00119834|Pedimacs|pedimacs
730745|NCT00119834|Mechanical Circulatory Support|mechanical circulatory support
730746|NCT00119834|Ventricular Assist Device|ventricular assist device
730747|NCT00119769|HIV|hiv
730748|NCT00119769|immune stimulation|immune stimulation
730749|NCT00119769|lipodystrophy|lipodystrophy
730750|NCT00119769|growth hormone|growth hormone
730751|NCT00119769|recombinant growth hormone|recombinant growth hormone
730752|NCT00119769|Treatment Experienced|treatment experienced
730753|NCT00119756|Schizophrenia|schizophrenia
730754|NCT00119756|Intramuscular injection|intramuscular injection
730755|NCT00119756|Deltoid muscle|deltoid muscle
730756|NCT00119756|Gluteus muscle|gluteus muscle
730757|NCT00119756|Paliperidone palmitate|paliperidone palmitate
730758|NCT00119743|Prophylaxis pneumococcal vaccine|prophylaxis pneumococcal vaccine
730759|NCT00119730|Fludarabine|fludarabine
730760|NCT00119730|Mitoxantrone|mitoxantrone
730761|NCT00119730|Rituximab|rituximab
730762|NCT00119730|Zevalin|zevalin
732497|NCT00113867|stress|stress
730763|NCT00119730|Mantle Cell Lymphoma|mantle cell lymphoma
730764|NCT00119730|Relapsed Mantle Cell Lymphoma|relapsed mantle cell lymphoma
730765|NCT00119717|acute|acute
730766|NCT00119717|ischemic|ischemic
730767|NCT00119717|stroke|stroke
730768|NCT00119717|randomized|randomized
730769|NCT00119717|device|device
730770|NCT00119717|treatment|treatment
730771|NCT00119678|SLE|sle
730772|NCT00119665|Postmenopausal symptoms|postmenopausal symptoms
730773|NCT00119665|Hot Flashes|hot flashes
730774|NCT00119665|Postmenopausal Hot Flashes|postmenopausal hot flashes
730775|NCT00119652|Bipolar disorder|bipolar disorder
730776|NCT00119652|bipolar depression|bipolar depression
730777|NCT00119652|depression|depression
730778|NCT00119626|Stroke, Acute|stroke, acute
730779|NCT00119626|Cerebrovascular Stroke|cerebrovascular stroke
730780|NCT00119613|Oncology|oncology
730781|NCT00119613|Clinical Trial|clinical trial
730782|NCT00119613|Hemoglobin|hemoglobin
730783|NCT00119613|Darbepoetin alfa|darbepoetin alfa
730784|NCT00119613|Survival|survival
730785|NCT00119613|Carboplatin|carboplatin
730786|NCT00119613|Cisplatin|cisplatin
730787|NCT00119613|Etoposide|etoposide
730788|NCT00119613|Extensive Stage Small Cell Lung Cancer|extensive stage small cell lung cancer
730789|NCT00119600|Non-myeloid malignancy|non-myeloid malignancy
730790|NCT00119600|Clinical Trial|clinical trial
730791|NCT00119587|Hemodialysis|hemodialysis
730792|NCT00119587|darbepoetin alfa|darbepoetin alfa
730793|NCT00119587|Clinical Trial|clinical trial
730794|NCT00119587|Amgen|amgen
730795|NCT00119574|Randomized Controlled Trial|randomized controlled trial
730796|NCT00119574|Quality of Health Care|quality of health care
730797|NCT00119574|Health Services Research|health services research
730798|NCT00119574|Guidelines|guidelines
730799|NCT00119574|Medical Informatics Computing|medical informatics computing
730800|NCT00119574|Services, Mental Health|services, mental health
730801|NCT00119574|Medicine, Evidence-Based|medicine, evidence-based
730802|NCT00119574|Quality Assurance, Healthcare|quality assurance, healthcare
730803|NCT00119574|Quality Indicators, Health Care|quality indicators, health care
730804|NCT00119574|Veterans|veterans
730805|NCT00119561|Caregiver|caregiver
730806|NCT00119561|Dementia|dementia
730807|NCT00119561|Alzheimer Disease|alzheimer disease
730808|NCT00119561|Telephone|telephone
730809|NCT00119561|Randomized Controlled Trials|randomized controlled trials
730810|NCT00119548|HIV Rapid Testing|hiv rapid testing
730811|NCT00119548|Cost-effectiveness|cost-effectiveness
730812|NCT00119548|HIV Seronegativity|hiv seronegativity
730813|NCT00119535|Diabetes mellitus|diabetes mellitus
730814|NCT00119535|Diabetic retinopathy|diabetic retinopathy
730815|NCT00119535|Organizational change|organizational change
730816|NCT00119535|Quality improvement|quality improvement
730817|NCT00119535|Quasi-experimental|quasi-experimental
730818|NCT00119522|wheelchairs|wheelchairs
730819|NCT00119522|falls|falls
730820|NCT00119522|spinal cord injury|spinal cord injury
730821|NCT00119522|accidental falls|accidental falls
730822|NCT00119522|safety|safety
730823|NCT00119509|Cervix Neoplasms|cervix neoplasms
730824|NCT00119509|Vaginal smears|vaginal smears
730825|NCT00119509|Papillomavirus - Human|papillomavirus - human
730826|NCT00119496|Corticosteroid|corticosteroid
730827|NCT00119496|Rosiglitazone|rosiglitazone
730828|NCT00119496|Theophylline|theophylline
730829|NCT00119496|Beclomethasone|beclomethasone
730830|NCT00119496|Inflammation|inflammation
730831|NCT00119496|Asthma|asthma
730832|NCT00119496|Smoking|smoking
730833|NCT00119496|Pulmonary|pulmonary
730834|NCT00119483|Men|men
730835|NCT00119483|testosterone|testosterone
730836|NCT00119483|hypogonadal|hypogonadal
730837|NCT00119483|aging|aging
730838|NCT00119483|body composition|body composition
730839|NCT00119483|quality og life|quality og life
730840|NCT00119483|Muscle strength|muscle strength
730841|NCT00119483|Aging male|aging male
730842|NCT00119457|antithrombotic agents|antithrombotic agents
730843|NCT00119457|anticoagulants|anticoagulants
730844|NCT00119457|prophylaxis|prophylaxis
730845|NCT00119457|embolism|embolism
730846|NCT00119457|deep vein thrombosis|deep vein thrombosis
730847|NCT00119457|hip fracture|hip fracture
730848|NCT00119444|PET|pet
730849|NCT00119444|Periacetabular osteotomy|periacetabular osteotomy
730850|NCT00119431|Hereditary angioedema type I (MeSH: angioneurotic edema, complement 1 inactivators)|hereditary angioedema type i (mesh: angioneurotic edema, complement 1 inactivators)
730851|NCT00119418|hot flash|hot flash
730852|NCT00119418|menopause|menopause
730853|NCT00119418|herbal medicine|herbal medicine
730854|NCT00119418|kampo|kampo
730855|NCT00119418|alternative medicine|alternative medicine
730856|NCT00119405|Lipoatrophy|lipoatrophy
730857|NCT00119405|Mitochondria|mitochondria
730858|NCT00119405|Treatment Naive|treatment naive
730859|NCT00119379|lipoatrophy|lipoatrophy
730860|NCT00119379|mitochondria|mitochondria
730861|NCT00119379|HIV|hiv
730862|NCT00119379|treatment experienced|treatment experienced
730863|NCT00119340|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
730967|NCT00118859|Mind-Body Therapy|mind-body therapy
730864|NCT00119340|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
730865|NCT00119340|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
730866|NCT00119340|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
730867|NCT00119314|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
730868|NCT00119314|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
730869|NCT00119301|recurrent osteosarcoma|recurrent osteosarcoma
730870|NCT00119210|Tobacco use cessation|tobacco use cessation
730871|NCT00119210|Bupropion|bupropion
730872|NCT00119210|Zyban|zyban
730873|NCT00119210|Puerperium|puerperium
730874|NCT00119197|watery diarrhea|watery diarrhea
730875|NCT00119197|cholera vaccine|cholera vaccine
730876|NCT00119184|anesthesia|anesthesia
730877|NCT00119184|breech|breech
730878|NCT00119184|external cephalic version|external cephalic version
730879|NCT00119184|spinal|spinal
730880|NCT00119184|success|success
730881|NCT00119184|anesthesia,spinal|anesthesia,spinal
730882|NCT00119171|Safety|safety
730883|NCT00119171|tolerability|tolerability
730884|NCT00119171|dose limiting toxicity|dose limiting toxicity
730885|NCT00119171|solid tumors|solid tumors
730886|NCT00119171|capecitabine|capecitabine
730887|NCT00119158|THerapy for acute moderate to severe flares|therapy for acute moderate to severe flares
730888|NCT00119145|antimalarial drugs|antimalarial drugs
730889|NCT00119145|efficacy|efficacy
730890|NCT00119145|safety|safety
730891|NCT00119145|trial|trial
730892|NCT00119132|intermittent preventive treatment|intermittent preventive treatment
730893|NCT00119132|effectiveness|effectiveness
730894|NCT00119132|malaria|malaria
730895|NCT00119119|Hepatitis C|hepatitis c
730896|NCT00119119|Liver Cirrhosis|liver cirrhosis
730897|NCT00119119|Tocopherols|tocopherols
730898|NCT00119106|HIV|hiv
730899|NCT00119106|Prevention|prevention
730900|NCT00119106|Tenofovir|tenofovir
730901|NCT00119106|HIV Seronegativity|hiv seronegativity
730902|NCT00119093|Antiretroviral therapy|antiretroviral therapy
730903|NCT00119093|HIV|hiv
730904|NCT00119093|Adherence|adherence
730905|NCT00119093|Viral Load|viral load
730906|NCT00119093|Opportunistic illness|opportunistic illness
730907|NCT00119080|Meningococcal carriage|meningococcal carriage
730908|NCT00119080|Conjugate vaccine|conjugate vaccine
730909|NCT00119067|Anthrax|anthrax
730910|NCT00119067|Vaccine|vaccine
730911|NCT00119067|Immunogenicity|immunogenicity
730912|NCT00119067|Reactogenicity|reactogenicity
730913|NCT00119054|Hypertension|hypertension
730914|NCT00119054|Diabetes Mellitus|diabetes mellitus
730915|NCT00119054|Telemedicine|telemedicine
730916|NCT00119054|Nursing Care|nursing care
730917|NCT00119041|Diabetes Mellitus|diabetes mellitus
730918|NCT00119041|Telemedicine|telemedicine
730919|NCT00119041|Referral|referral
730920|NCT00119041|Consultation|consultation
730921|NCT00119028|Quality Improvement|quality improvement
730922|NCT00119028|Cluster Randomized Trial|cluster randomized trial
730923|NCT00119028|Care Model|care model
730924|NCT00119015|perennial allergic rhinitis|perennial allergic rhinitis
730925|NCT00119002|randomized clinical trial|randomized clinical trial
730926|NCT00119002|placebo-controlled|placebo-controlled
730927|NCT00119002|double-blind|double-blind
730928|NCT00119002|double-masked|double-masked
730929|NCT00119002|infant|infant
730930|NCT00119002|dexamethasone|dexamethasone
730931|NCT00119002|wheezing|wheezing
730932|NCT00118989|Curcumin|curcumin
730933|NCT00118989|chemoprevention|chemoprevention
730934|NCT00118989|adenomatous polyps|adenomatous polyps
730935|NCT00118989|colorectal cancer|colorectal cancer
730936|NCT00118976|diabetic nephropathy|diabetic nephropathy
730937|NCT00118976|type 1 diabetes|type 1 diabetes
730938|NCT00118976|albuminuria|albuminuria
730939|NCT00118976|hypertension|hypertension
730940|NCT00118924|Dengue Vaccine|dengue vaccine
730941|NCT00118924|Tick-Borne Illnesses|tick-borne illnesses
730942|NCT00118924|Flavivirus|flavivirus
730943|NCT00118911|Adult|adult
730944|NCT00118911|ADHD|adhd
730945|NCT00118911|ADD|add
730946|NCT00118911|CBT|cbt
730947|NCT00118911|Relaxation Techniques|relaxation techniques
730948|NCT00118911|Education|education
730949|NCT00118898|Treatment Naive|treatment naive
730950|NCT00118885|Shingles|shingles
730951|NCT00118885|depression|depression
730952|NCT00118885|varicella zoster virus|varicella zoster virus
730953|NCT00118885|alternative medicine|alternative medicine
730954|NCT00118885|psychoneuroimmunology|psychoneuroimmunology
730955|NCT00118872|Growth and Development|growth and development
730956|NCT00118872|Pakistan|pakistan
730957|NCT00118872|Weaning|weaning
730958|NCT00118872|Probiotics|probiotics
730959|NCT00118872|Infant|infant
730960|NCT00118872|Lactobacillus GG|lactobacillus gg
730961|NCT00118859|Back Pain|back pain
730962|NCT00118859|Integrative Care|integrative care
730963|NCT00118859|Acupuncture|acupuncture
730964|NCT00118859|Chiropractic|chiropractic
730965|NCT00118859|Exercise|exercise
730966|NCT00118859|Massage Therapy|massage therapy
730968|NCT00118859|Nutritional Counseling|nutritional counseling
730969|NCT00118859|Complementary Therapies|complementary therapies
730970|NCT00118859|Complementary and Alternative Medicine|complementary and alternative medicine
730971|NCT00118846|Women|women
730972|NCT00118846|Complementary and Alternative Medicine|complementary and alternative medicine
730973|NCT00118846|CAM|cam
730974|NCT00118833|Social Anxiety Disorder|social anxiety disorder
730975|NCT00118833|Social Phobia|social phobia
730976|NCT00118833|Generalized Anxiety Disorder|generalized anxiety disorder
730977|NCT00118833|Hypericum|hypericum
730978|NCT00118833|St. John's wort|st. john's wort
730979|NCT00118833|Medicine, Herbal|medicine, herbal
730980|NCT00118833|Complementary Therapies|complementary therapies
730981|NCT00118820|Dry socket|dry socket
730982|NCT00118820|Third molar|third molar
730983|NCT00118820|Infection|infection
730984|NCT00118820|postop-infection|postop-infection
730985|NCT00118820|Antibiotic efficacy|antibiotic efficacy
730986|NCT00118820|Infection characterized by pus,erythema,edema and pain|infection characterized by pus,erythema,edema and pain
730987|NCT00118807|malaria treatment|malaria treatment
730988|NCT00118807|artemisinin based combination therapy|artemisinin based combination therapy
730989|NCT00118807|Plasmodium falciparum|plasmodium falciparum
730990|NCT00118807|pragmatic trial|pragmatic trial
730991|NCT00118807|effectiveness|effectiveness
730992|NCT00118794|uncomplicated malaria|uncomplicated malaria
730993|NCT00118794|G6PD deficiency|g6pd deficiency
730994|NCT00118794|haemolytic anaemia|haemolytic anaemia
730995|NCT00118794|Lapdap|lapdap
730996|NCT00118794|Artemsinin based combination treatment|artemsinin based combination treatment
730997|NCT00118794|compliance|compliance
730998|NCT00118794|pragmatic trials|pragmatic trials
730999|NCT00118781|ventilator-associated pneumonia|ventilator-associated pneumonia
731000|NCT00118781|VAP|vap
731001|NCT00118781|pneumonia|pneumonia
731002|NCT00118781|ICU infection|icu infection
731003|NCT00118768|Genotype-1, Chronic Hepatitis C|genotype-1, chronic hepatitis c
731004|NCT00118729|Ragweed|ragweed
731005|NCT00118729|GW685698X|gw685698x
731238|NCT00117936|growth factor|growth factor
731006|NCT00118729|seasonal allergic rhinitis|seasonal allergic rhinitis
731007|NCT00118729|onset|onset
731008|NCT00118716|asthma|asthma
731009|NCT00118716|bronchospasm|bronchospasm
731010|NCT00118703|nonallergic rhinitis|nonallergic rhinitis
731011|NCT00118703|GW685698X|gw685698x
731012|NCT00118703|VMR|vmr
731013|NCT00118703|vasomotor rhinitis|vasomotor rhinitis
731014|NCT00118690|bronchospasm|bronchospasm
731015|NCT00118690|asthma|asthma
731016|NCT00118677|HIV Infections|hiv infections
731017|NCT00118664|Septic Shock|septic shock
731018|NCT00118664|Thrombocytopenia|thrombocytopenia
731019|NCT00118664|Multiple Organ Failure|multiple organ failure
731020|NCT00118664|Pediatric|pediatric
731021|NCT00118651|pneumonia|pneumonia
731022|NCT00118651|chest x-ray|chest x-ray
731023|NCT00118651|diagnosis|diagnosis
731024|NCT00118638|Non-myeloid malignancy|non-myeloid malignancy
731025|NCT00118638|Darbepoetin alfa|darbepoetin alfa
731026|NCT00118638|Clinical Trial|clinical trial
731027|NCT00118625|Allergy|allergy
731028|NCT00118625|Specific Immunotherapy|specific immunotherapy
731029|NCT00118625|Adjuvant|adjuvant
731030|NCT00118625|Allergy Vaccination|allergy vaccination
731031|NCT00118625|Allergenicity|allergenicity
731032|NCT00118612|Allergy|allergy
731033|NCT00118612|Specific Immunotherapy|specific immunotherapy
731034|NCT00118612|Allergy Vaccination|allergy vaccination
731035|NCT00118612|Allergenicity|allergenicity
731036|NCT00118586|Neuroanatomy|neuroanatomy
731037|NCT00118586|Brain Damage|brain damage
731038|NCT00118586|Dystonia|dystonia
731039|NCT00118586|Pathology|pathology
731040|NCT00118586|Brain Imaging|brain imaging
731041|NCT00118586|Spasmodic Dysphonia|spasmodic dysphonia
731042|NCT00118586|SD|sd
731043|NCT00118586|Focal Dystonia|focal dystonia
731044|NCT00118586|Healthy Volunteer|healthy volunteer
731045|NCT00118586|HV|hv
731046|NCT00118573|abdominal aortic aneurysm|abdominal aortic aneurysm
731047|NCT00118573|randomized controlled trial|randomized controlled trial
731048|NCT00118573|endovascular aneurysm repair|endovascular aneurysm repair
731049|NCT00118560|Collateral Circulation|collateral circulation
731050|NCT00118560|Exercise Therapy|exercise therapy
731051|NCT00118560|Microcirculation|microcirculation
731052|NCT00118560|Oxygen|oxygen
731053|NCT00118560|Positron-emission tomography|positron-emission tomography
731054|NCT00118560|Walking|walking
731055|NCT00118547|Adherence|adherence
731056|NCT00118547|Medication|medication
731057|NCT00118547|Multiple Sclerosis|multiple sclerosis
731058|NCT00118534|addictive disorders|addictive disorders
731059|NCT00118534|clinical trial|clinical trial
731060|NCT00118534|cost effectiveness|cost effectiveness
731061|NCT00118534|mental health|mental health
731062|NCT00118534|military or environmental exposure|military or environmental exposure
731063|NCT00118534|multi-site trial|multi-site trial
731064|NCT00118534|nicotine|nicotine
731065|NCT00118534|nicotine replacement|nicotine replacement
731066|NCT00118534|post traumatic stress|post traumatic stress
731828|NCT00116012|factor VIIa|factor viia
731067|NCT00118534|post traumatic stress disorder|post traumatic stress disorder
731068|NCT00118534|psychiatric|psychiatric
731069|NCT00118534|psychological|psychological
731070|NCT00118534|PTSD|ptsd
731071|NCT00118534|smoking cessation|smoking cessation
731072|NCT00118534|smoking cessation medications|smoking cessation medications
731073|NCT00118534|substance abuse|substance abuse
731074|NCT00118521|Anterior Knee Pain|anterior knee pain
731075|NCT00118495|female sexual dysfunction|female sexual dysfunction
731076|NCT00118495|FSD|fsd
731077|NCT00118495|arousal|arousal
731078|NCT00118495|orgasm|orgasm
731079|NCT00118495|desire|desire
731080|NCT00118495|Zestra|zestra
731081|NCT00118495|Mixed FSD|mixed fsd
731082|NCT00118495|Hypoactive sexual desire disorder|hypoactive sexual desire disorder
731083|NCT00118495|Sexual arousal disorder|sexual arousal disorder
731084|NCT00118495|Orgasmic disorder|orgasmic disorder
731085|NCT00118482|vasovagal syncope|vasovagal syncope
731086|NCT00118482|randomized clinical trial|randomized clinical trial
731087|NCT00118482|quality of life|quality of life
731088|NCT00118469|Adolescent|adolescent
731089|NCT00118469|CBT|cbt
731090|NCT00118469|Parents|parents
731091|NCT00118456|Advanced cancers|advanced cancers
731092|NCT00118456|EGFR|egfr
731093|NCT00118456|Her2|her2
731094|NCT00118456|VEGFR|vegfr
731095|NCT00118443|Suicide Prevention|suicide prevention
731096|NCT00118443|Depression|depression
731097|NCT00118443|Adolescent|adolescent
731098|NCT00118443|Students|students
731099|NCT00118443|School Teachers|school teachers
731100|NCT00118430|Back Pain|back pain
731101|NCT00118430|Knee Pain|knee pain
731102|NCT00118430|Hip Pain|hip pain
731103|NCT00118430|Stepped Care|stepped care
731104|NCT00118430|Antidepressant|antidepressant
731105|NCT00118430|Relaxation Techniques|relaxation techniques
731106|NCT00118430|Exercise|exercise
731107|NCT00118417|Selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
731108|NCT00118417|Anxiety|anxiety
731109|NCT00118417|Pharmacotherapy|pharmacotherapy
731110|NCT00118417|Cognitive behavioral therapy|cognitive behavioral therapy
731111|NCT00118417|CBT|cbt
731112|NCT00118404|Cognitive therapy|cognitive therapy
731113|NCT00118404|Antidepressants|antidepressants
731114|NCT00118404|Psychotherapy|psychotherapy
731115|NCT00118391|Pathological Gambling|pathological gambling
731116|NCT00118391|CBT|cbt
731117|NCT00118391|CM|cm
731118|NCT00118378|HIV|hiv
731119|NCT00118378|AIDS|aids
731120|NCT00118378|Modafinil|modafinil
731121|NCT00118378|Depression|depression
731122|NCT00118339|oral complications|oral complications
731123|NCT00118339|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
731124|NCT00118339|stage I multiple myeloma|stage i multiple myeloma
731125|NCT00118339|stage II multiple myeloma|stage ii multiple myeloma
731126|NCT00118339|stage III multiple myeloma|stage iii multiple myeloma
731127|NCT00118326|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
731128|NCT00118326|disseminated neuroblastoma|disseminated neuroblastoma
731129|NCT00118326|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
731130|NCT00118326|recurrent neuroblastoma|recurrent neuroblastoma
731131|NCT00118326|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
731132|NCT00118326|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
731239|NCT00117923|Warts|warts
731133|NCT00118326|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
731134|NCT00118326|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
731135|NCT00118326|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
731136|NCT00118326|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
731137|NCT00118326|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
731138|NCT00118326|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
731139|NCT00118326|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
731140|NCT00118326|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
731141|NCT00118326|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
731142|NCT00118326|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
731143|NCT00118326|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
731144|NCT00118326|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
731145|NCT00118326|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
731146|NCT00118326|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
731147|NCT00118313|stage II melanoma|stage ii melanoma
731148|NCT00118313|stage III melanoma|stage iii melanoma
731149|NCT00118313|stage IV melanoma|stage iv melanoma
731150|NCT00118300|stage III cervical cancer|stage iii cervical cancer
731151|NCT00118300|stage IVA cervical cancer|stage iva cervical cancer
731152|NCT00118300|recurrent cervical cancer|recurrent cervical cancer
731153|NCT00118300|stage III endometrial carcinoma|stage iii endometrial carcinoma
731154|NCT00118300|recurrent endometrial carcinoma|recurrent endometrial carcinoma
731155|NCT00118300|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
731156|NCT00118300|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
731157|NCT00118300|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
731158|NCT00118300|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
731159|NCT00118300|stage III vaginal cancer|stage iii vaginal cancer
731160|NCT00118300|stage IVA vaginal cancer|stage iva vaginal cancer
731161|NCT00118300|recurrent vaginal cancer|recurrent vaginal cancer
731162|NCT00118300|ovarian sarcoma|ovarian sarcoma
731163|NCT00118300|ovarian stromal cancer|ovarian stromal cancer
731164|NCT00118300|stage IV endometrial carcinoma|stage iv endometrial carcinoma
731165|NCT00118300|stage IB cervical cancer|stage ib cervical cancer
731166|NCT00118300|stage IIA cervical cancer|stage iia cervical cancer
731167|NCT00118300|stage IIB cervical cancer|stage iib cervical cancer
731168|NCT00118300|stage II vaginal cancer|stage ii vaginal cancer
731169|NCT00118300|stage I vaginal cancer|stage i vaginal cancer
731170|NCT00118274|stage II melanoma|stage ii melanoma
731171|NCT00118274|stage III melanoma|stage iii melanoma
731172|NCT00118274|stage IV melanoma|stage iv melanoma
731173|NCT00118261|stage IV rectal cancer|stage iv rectal cancer
731174|NCT00118261|stage IV colon cancer|stage iv colon cancer
731175|NCT00118261|recurrent rectal cancer|recurrent rectal cancer
731176|NCT00118261|recurrent colon cancer|recurrent colon cancer
731177|NCT00118222|adult mixed glioma|adult mixed glioma
731178|NCT00118222|adult anaplastic astrocytoma|adult anaplastic astrocytoma
731179|NCT00118222|recurrent adult brain tumor|recurrent adult brain tumor
731180|NCT00118222|adult giant cell glioblastoma|adult giant cell glioblastoma
731181|NCT00118222|adult gliosarcoma|adult gliosarcoma
731182|NCT00118196|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
731183|NCT00118196|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
731184|NCT00118196|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
731185|NCT00118196|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
731186|NCT00118131|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
731187|NCT00118131|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
731188|NCT00118131|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
731189|NCT00118105|recurrent colon cancer|recurrent colon cancer
731190|NCT00118105|stage IV colon cancer|stage iv colon cancer
731191|NCT00118105|recurrent rectal cancer|recurrent rectal cancer
731192|NCT00118105|stage IV rectal cancer|stage iv rectal cancer
731193|NCT00118105|liver metastases|liver metastases
731194|NCT00118066|prostate cancer|prostate cancer
731195|NCT00118066|high grade prostatic intraepithelial neoplasia|high grade prostatic intraepithelial neoplasia
731196|NCT00118053|inflammatory breast cancer|inflammatory breast cancer
731197|NCT00118053|stage II breast cancer|stage ii breast cancer
731198|NCT00118053|stage IIIA breast cancer|stage iiia breast cancer
731199|NCT00118053|stage IIIB breast cancer|stage iiib breast cancer
731200|NCT00118053|stage IIIC breast cancer|stage iiic breast cancer
731201|NCT00118027|Malaria in pregnancy|malaria in pregnancy
731202|NCT00118027|Anaemia|anaemia
731203|NCT00118027|Low birth weight|low birth weight
731204|NCT00118014|Trichotillomania|trichotillomania
731205|NCT00118014|Habit Reversal Training|habit reversal training
731206|NCT00118014|Sertraline|sertraline
731207|NCT00118014|Zoloft|zoloft
731208|NCT00118001|Psychotherapy|psychotherapy
731209|NCT00118001|Generalized Anxiety Disorder|generalized anxiety disorder
731210|NCT00118001|randomized-controlled trial|randomized-controlled trial
731211|NCT00118001|worry exposure|worry exposure
731212|NCT00118001|applied relaxation|applied relaxation
731213|NCT00117975|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
731214|NCT00117975|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
731215|NCT00117975|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
731216|NCT00117975|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
731217|NCT00117975|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
731218|NCT00117975|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
731219|NCT00117975|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
731220|NCT00117975|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
731221|NCT00117975|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
731222|NCT00117975|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
731223|NCT00117975|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
731224|NCT00117975|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
731225|NCT00117962|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
731226|NCT00117962|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
731227|NCT00117962|squamous cell lung cancer|squamous cell lung cancer
731228|NCT00117962|large cell lung cancer|large cell lung cancer
731229|NCT00117962|adenocarcinoma of the lung|adenocarcinoma of the lung
731230|NCT00117962|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
731231|NCT00117949|Prostate Cancer|prostate cancer
731232|NCT00117949|Androgen ablation therapy|androgen ablation therapy
731233|NCT00117936|Angiogenesis|angiogenesis
731234|NCT00117936|No-option heart patients|no-option heart patients
731235|NCT00117936|Blocked coronary artery|blocked coronary artery
731236|NCT00117936|Revascularization|revascularization
731237|NCT00117936|FGF-1|fgf-1
731240|NCT00117923|Adults|adults
731241|NCT00117923|Common Warts|common warts
731242|NCT00117923|Resiquimod|resiquimod
731243|NCT00117910|Aged, Granulocyte Colony-Stimulating Factor|aged, granulocyte colony-stimulating factor
731244|NCT00117910|Combined Modality Therapy, Neutropenia|combined modality therapy, neutropenia
731245|NCT00117910|pegfilgrastim, Neulasta®|pegfilgrastim, neulasta®
731246|NCT00117910|FEC-100, Antineoplastic Agents|fec-100, antineoplastic agents
731247|NCT00117910|Breast Cancer, Female|breast cancer, female
731248|NCT00117897|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
731249|NCT00117897|R-CHOP-14|r-chop-14
731250|NCT00117897|pegfilgrastim|pegfilgrastim
731251|NCT00117897|neutropenia, clinical trial|neutropenia, clinical trial
731252|NCT00117897|haematopoietic growth factor|haematopoietic growth factor
731253|NCT00117884|Papillomavirus infections;|papillomavirus infections;
731254|NCT00117884|Cervix Dysplasia|cervix dysplasia
731255|NCT00117871|Warts|warts
731256|NCT00117871|Adults|adults
731257|NCT00117871|Common Warts|common warts
731258|NCT00117871|Resiquimod|resiquimod
731259|NCT00117858|Frontal Lobe|frontal lobe
731260|NCT00117858|Language|language
731261|NCT00117858|Behavior|behavior
731262|NCT00117858|Degenerative Diseases|degenerative diseases
731263|NCT00117858|Pick's Disease|pick's disease
731264|NCT00117858|Frontotemporal Dementia|frontotemporal dementia
731266|NCT00117845|Denileukin Diftitox (Ontak)|denileukin diftitox (ontak)
731267|NCT00117845|Recombinant Immunotoxin|recombinant immunotoxin
731268|NCT00117845|Human T-Cell Lymphotropic Virus (HTLV1)|human t-cell lymphotropic virus (htlv1)
731269|NCT00117845|CD25 Positive|cd25 positive
731270|NCT00117845|IL-2R|il-2r
731271|NCT00117845|ATL|atl
731272|NCT00117845|Ontak|ontak
731273|NCT00117845|Adult T-Cell Leukemia|adult t-cell leukemia
731274|NCT00117845|Lymphoproliferative Disorders|lymphoproliferative disorders
731275|NCT00117832|allergic rhinitis|allergic rhinitis
731276|NCT00117819|parkinson|parkinson
731277|NCT00117819|family history|family history
731278|NCT00117819|diagnosis|diagnosis
731279|NCT00117806|Adult|adult
731280|NCT00117806|Depression|depression
731281|NCT00117806|Employment, supported|employment, supported
731282|NCT00117806|Health Service/ut|health service/ut
731283|NCT00117806|Humans|humans
731284|NCT00117806|Outcomes|outcomes
731285|NCT00117806|Quality of life|quality of life
731286|NCT00117806|Veterans/rh (rehabilitation)|veterans/rh (rehabilitation)
731287|NCT00117806|Workplace|workplace
731288|NCT00117806|Spinal Cord Injuries|spinal cord injuries
731289|NCT00117793|Amputee|amputee
731290|NCT00117793|Artificial limbs|artificial limbs
731291|NCT00117793|Gait|gait
731292|NCT00117793|Walking|walking
731293|NCT00117767|Terbinafine, Tinea capitis, pediatric, antifungal|terbinafine, tinea capitis, pediatric, antifungal
731294|NCT00117754|Terbinafine, Tinea capitis, pediatric, antifungal|terbinafine, tinea capitis, pediatric, antifungal
731295|NCT00117741|Opiate Dependence|opiate dependence
731296|NCT00117741|DBT|dbt
731297|NCT00117741|Dialectical Behavior Therapy|dialectical behavior therapy
731298|NCT00117741|Drug Counseling|drug counseling
731299|NCT00117741|Therapy, Cognitive Behavior|therapy, cognitive behavior
731300|NCT00117728|Non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
731301|NCT00117728|Drug Resistance|drug resistance
731302|NCT00117728|HIV Seronegativity|hiv seronegativity
731303|NCT00117728|Treatment Naive|treatment naive
731304|NCT00117715|Developmental regulation of CYPs 1A2, 2D6, 3A4|developmental regulation of cyps 1a2, 2d6, 3a4
731305|NCT00117715|Ontogeny|ontogeny
731306|NCT00117715|pharmacokinetics|pharmacokinetics
731307|NCT00117715|drug biotransformation|drug biotransformation
731308|NCT00117715|enzymatic biotransformation of drugs|enzymatic biotransformation of drugs
731309|NCT00117702|GvHD|gvhd
731310|NCT00117702|Tacrolimus|tacrolimus
731311|NCT00117702|Everolimus|everolimus
731312|NCT00117702|Stem cell transplantation|stem cell transplantation
731313|NCT00117689|Anti-T cell antibodies|anti-t cell antibodies
731314|NCT00117689|Primary Liver Transplantation and Renal Dysfunction|primary liver transplantation and renal dysfunction
731315|NCT00117689|Liver Transplant Rejection|liver transplant rejection
731316|NCT00117689|Induction Therapy with reduction of Calcineurin inhibitors|induction therapy with reduction of calcineurin inhibitors
731317|NCT00117689|Primary Liver Transplantation|primary liver transplantation
731318|NCT00117689|Primary Transplant Rejection|primary transplant rejection
731319|NCT00117689|Transplantation, Liver|transplantation, liver
731320|NCT00117689|Rejection, Transplant|rejection, transplant
731321|NCT00117676|tenofovir|tenofovir
731322|NCT00117676|adefovir|adefovir
731323|NCT00117676|hepatitis B virus|hepatitis b virus
731324|NCT00117676|HBeAg Negative|hbeag negative
731325|NCT00117663|Randomized controlled trial|randomized controlled trial
731326|NCT00117663|Mammography|mammography
731327|NCT00117663|health care setting|health care setting
731328|NCT00117663|hormone replacement therapy|hormone replacement therapy
731329|NCT00117663|breast density|breast density
732493|NCT00113893|SCIO-469|scio-469
731330|NCT00117663|mammography performance|mammography performance
731331|NCT00117663|Breast Carcinoma|breast carcinoma
731332|NCT00117650|leg pain|leg pain
731333|NCT00117650|gene transfer|gene transfer
731334|NCT00117650|angiogenesis|angiogenesis
731335|NCT00117650|Phase 2|phase 2
731336|NCT00117650|Genzyme|genzyme
731337|NCT00117650|peripheral arterial disease|peripheral arterial disease
731338|NCT00117637|Renal Cell Cancer|renal cell cancer
731339|NCT00117637|RCC|rcc
731340|NCT00117637|Cancer|cancer
731341|NCT00117624|Non-myeloid malignancy|non-myeloid malignancy
731342|NCT00117624|Darbepoetin alfa|darbepoetin alfa
731343|NCT00117624|Clinical Trial|clinical trial
731344|NCT00117611|chronic sinusitis|chronic sinusitis
731345|NCT00117598|Lymphoma|lymphoma
731346|NCT00117585|Aging|aging
731347|NCT00117585|Blood pressure|blood pressure
731348|NCT00117585|Hypotension|hypotension
731349|NCT00117585|Orthostatic|orthostatic
731350|NCT00117585|Rehabilitation|rehabilitation
731351|NCT00117572|Cancer of the Pharynx (Nasopharynx, Oropharynx, Hypopharynx)|cancer of the pharynx (nasopharynx, oropharynx, hypopharynx)
731352|NCT00117572|Cancer of the Nasal Cavity and Paranasal Sinuses|cancer of the nasal cavity and paranasal sinuses
731353|NCT00117559|Psychotherapy,group|psychotherapy,group
731354|NCT00117559|Rehabilitation|rehabilitation
731355|NCT00117559|Telecommunications|telecommunications
731356|NCT00117546|CAPACITY trial|capacity trial
731357|NCT00117546|preeclampsia|preeclampsia
731358|NCT00117546|plasma volume|plasma volume
731359|NCT00117546|sympathetic activity|sympathetic activity
731360|NCT00117546|hypertension|hypertension
731361|NCT00117546|cardiovascular system|cardiovascular system
731362|NCT00117533|chronic hepatitis B;|chronic hepatitis b;
731363|NCT00117533|chronic hepatitis delta;|chronic hepatitis delta;
731364|NCT00117533|treatment;|treatment;
731365|NCT00117533|pegylated interferon alfa-2b;|pegylated interferon alfa-2b;
731366|NCT00117533|ribavirin|ribavirin
731367|NCT00117520|caffeine, endurance, postural stability, elderly|caffeine, endurance, postural stability, elderly
731368|NCT00117507|MDS|mds
731369|NCT00117507|Myelodysplastic Syndrome|myelodysplastic syndrome
731370|NCT00117507|ICL-670|icl-670
731371|NCT00117507|ICL-670 and Myelodysplastic Syndrome|icl-670 and myelodysplastic syndrome
731372|NCT00117494|Hyperlipidemia|hyperlipidemia
731373|NCT00117494|HIV infections|hiv infections
731374|NCT00117494|STATINS, HMG-COA|statins, hmg-coa
731375|NCT00117494|Protease Inhibitor|protease inhibitor
731376|NCT00117494|Treatment Experienced|treatment experienced
731377|NCT00117481|endometriosis|endometriosis
731378|NCT00117481|pelvic pain|pelvic pain
731379|NCT00117481|hormonal treatment|hormonal treatment
731380|NCT00117468|luteal phase replacement|luteal phase replacement
731381|NCT00117468|oocyte donation|oocyte donation
731382|NCT00117468|infertility|infertility
731383|NCT00117468|progesterone|progesterone
731384|NCT00117455|ICE|ice
731385|NCT00117455|BEAM|beam
731386|NCT00117455|PBPC transplant|pbpc transplant
731387|NCT00117442|solid tumour|solid tumour
731388|NCT00117442|unknown primary tumour|unknown primary tumour
731389|NCT00117442|carboplatin|carboplatin
731390|NCT00117442|paclitaxel|paclitaxel
731391|NCT00117429|HIV-1|hiv-1
731392|NCT00117429|therapeutic vaccination|therapeutic vaccination
731393|NCT00117429|cellular immunity|cellular immunity
731394|NCT00117429|humoral immunity|humoral immunity
731395|NCT00117429|HAART|haart
731396|NCT00117429|chronic HIV-1 infection|chronic hiv-1 infection
731397|NCT00117429|Treatment Experienced|treatment experienced
731398|NCT00117429|HIV Therapeutic Vaccine|hiv therapeutic vaccine
731399|NCT00117403|dementia|dementia
731400|NCT00117403|anti-oxidant|anti-oxidant
731401|NCT00117403|biomarkers|biomarkers
731402|NCT00117403|alpha-tocopherol|alpha-tocopherol
731403|NCT00117403|CoQ|coq
731404|NCT00117377|Atopic dermatitis, pimecrolimus, cellular, molecular|atopic dermatitis, pimecrolimus, cellular, molecular
731405|NCT00117364|chronic ulcer|chronic ulcer
731406|NCT00117364|poor healing|poor healing
731407|NCT00117364|The patients with a poorly healed wound, in which skin graft is clinically indicated, are included in this study|the patients with a poorly healed wound, in which skin graft is clinically indicated, are included in this study
731408|NCT00117351|Adenocarcinoma|adenocarcinoma
731409|NCT00117351|Bronchiolo-Alveolar|bronchiolo-alveolar
731410|NCT00117351|Carcinoma, Bronchioloalveolar|carcinoma, bronchioloalveolar
731411|NCT00117351|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
731412|NCT00117351|Carcinoma, Bronchiolo-Alveolar|carcinoma, bronchiolo-alveolar
731413|NCT00117325|Vasomotor Rhinitis|vasomotor rhinitis
731414|NCT00117325|VMR|vmr
731415|NCT00117325|nonallergic rhinitis|nonallergic rhinitis
731416|NCT00117325|GW685698X|gw685698x
731417|NCT00117312|Prostate Cancer|prostate cancer
731418|NCT00117312|Androgen ablation therapy|androgen ablation therapy
731419|NCT00117299|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
731420|NCT00117299|GIST|gist
731421|NCT00117299|Sarcoma|sarcoma
731422|NCT00117299|PTK787|ptk787
731423|NCT00117299|ZK 222584|zk 222584
731424|NCT00117299|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
731425|NCT00117299|Tyrosine kinase|tyrosine kinase
731426|NCT00117299|VEGF|vegf
731427|NCT00117299|Vascular endothelial growth factor|vascular endothelial growth factor
731428|NCT00117299|VEGFR|vegfr
731429|NCT00117299|Vascular endothelial growth factor receptor|vascular endothelial growth factor receptor
731430|NCT00117299|KDR|kdr
731431|NCT00117299|KIT|kit
731432|NCT00117299|c-KIT|c-kit
731433|NCT00117299|Platelet derived growth factor receptor|platelet derived growth factor receptor
731434|NCT00117299|PDGFR|pdgfr
731435|NCT00117286|Prostate Cancer|prostate cancer
731436|NCT00117286|Androgen ablation therapy|androgen ablation therapy
731437|NCT00117260|osteopenia|osteopenia
731438|NCT00117260|bone mineral density|bone mineral density
731439|NCT00117260|amenorrhea|amenorrhea
731440|NCT00117260|adolescents|adolescents
731441|NCT00117247|Heart Failure|heart failure
731442|NCT00117234|chronic heart failure|chronic heart failure
731443|NCT00117234|congestive heart failure|congestive heart failure
731444|NCT00117234|low hemoglobin|low hemoglobin
731445|NCT00117234|anemia|anemia
731446|NCT00117234|CHF|chf
731447|NCT00117234|Symptomatic Congestive Heart Failure (CHF)|symptomatic congestive heart failure (chf)
731448|NCT00117221|Magnetic Resonance Imaging|magnetic resonance imaging
731449|NCT00117221|Functional Imaging|functional imaging
731450|NCT00117221|Cerebral Blood Flow|cerebral blood flow
731451|NCT00117221|BOLD Effect|bold effect
731452|NCT00117221|Sleep|sleep
731453|NCT00117208|cystic fibrosis|cystic fibrosis
731454|NCT00117195|parkinson|parkinson
731455|NCT00117195|diagnosis|diagnosis
731456|NCT00117195|screening|screening
731457|NCT00117169|Pulmonary embolism|pulmonary embolism
731458|NCT00117169|multi-detector helical computed tomography clinical probability|multi-detector helical computed tomography clinical probability
731459|NCT00117169|clinical score|clinical score
731460|NCT00117156|Fludarabine|fludarabine
731461|NCT00117156|Rituximab|rituximab
731462|NCT00117156|Marginal Zone Lymphoma|marginal zone lymphoma
731463|NCT00117156|MALT lymphoma|malt lymphoma
731464|NCT00117143|Immune Thrombocytopenic Purpura|immune thrombocytopenic purpura
731465|NCT00117143|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
731466|NCT00117143|ITP|itp
731467|NCT00117143|Thrombocytopenia|thrombocytopenia
731468|NCT00117130|Kidney disease, Renal, CKD (Chronic Kidney Disease)|kidney disease, renal, ckd (chronic kidney disease)
731469|NCT00117130|CRI (Chronic Renal Insufficiency), Pre-dialysis, Amgen|cri (chronic renal insufficiency), pre-dialysis, amgen
731470|NCT00117130|Aranesp®, Darbepoetin alfa, QW dosing|aranesp®, darbepoetin alfa, qw dosing
731471|NCT00117130|Q2W dosing, Q4W dosing|q2w dosing, q4w dosing
731472|NCT00117130|Patient preference, Subject preference|patient preference, subject preference
731473|NCT00117117|Chemotherapy induced anemia|chemotherapy induced anemia
731474|NCT00117117|Amgen|amgen
731475|NCT00117117|Aranesp®|aranesp®
731476|NCT00117117|darbepoetin alfa|darbepoetin alfa
731477|NCT00117104|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
731478|NCT00117104|Kidney Disease, Dialysis|kidney disease, dialysis
731479|NCT00117104|Aranesp®, rHuEPO|aranesp®, rhuepo
731480|NCT00117104|Anemia, Hemoglobin|anemia, hemoglobin
731481|NCT00117104|Dosing, Amgen|dosing, amgen
731482|NCT00117091|Rheumatoid Arthritis|rheumatoid arthritis
731483|NCT00117091|RA|ra
731484|NCT00117091|Anakinra (Kineret®)|anakinra (kineret®)
731485|NCT00117078|Kidney disease, Renal, CKD (Chronic Kidney Disease)|kidney disease, renal, ckd (chronic kidney disease)
731486|NCT00117078|CRI (Chronic Renal Insufficiency), Pre-dialysis, Amgen|cri (chronic renal insufficiency), pre-dialysis, amgen
731487|NCT00117078|Aranesp®, Darbepoetin alfa, QW dosing|aranesp®, darbepoetin alfa, qw dosing
731488|NCT00117078|Q2W dosing, Q4W dosing|q2w dosing, q4w dosing
731489|NCT00117078|Patient preference, Subject preference|patient preference, subject preference
731490|NCT00117065|Kidney transplant, Renal transplant|kidney transplant, renal transplant
731491|NCT00117065|Aranesp®, Darbepoetin alfa|aranesp®, darbepoetin alfa
731492|NCT00117065|Amgen, Q2W dosing, Q4W dosing|amgen, q2w dosing, q4w dosing
731493|NCT00117052|Clinical trial|clinical trial
731494|NCT00117052|Amgen|amgen
731495|NCT00117052|Secondary HyperParaThyroidism (SHPT)|secondary hyperparathyroidism (shpt)
731496|NCT00117052|Dialysis|dialysis
731497|NCT00117052|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
731498|NCT00117052|KDOQI|kdoqi
731499|NCT00117052|Cinacalcet|cinacalcet
731500|NCT00117039|anemia|anemia
731501|NCT00117039|fatigue|fatigue
731502|NCT00117039|Aranesp®|aranesp®
731503|NCT00117039|clinical trial|clinical trial
731504|NCT00117026|Diabetes Complications|diabetes complications
731505|NCT00117026|benfotiamine|benfotiamine
731506|NCT00117026|type 1 diabetes|type 1 diabetes
731507|NCT00117026|elevated urinary albumin excretion|elevated urinary albumin excretion
731508|NCT00117026|nerve function|nerve function
731509|NCT00117026|advanced glycation end products|advanced glycation end products
731510|NCT00117013|Phase I|phase i
731511|NCT00117013|Antiangiogenesis|antiangiogenesis
731512|NCT00117013|Targeted Therapy|targeted therapy
731513|NCT00117013|Chronic Schedule|chronic schedule
731514|NCT00117013|VEGF|vegf
731515|NCT00117013|Cancer|cancer
731516|NCT00117013|Metastatic Solid Tumor|metastatic solid tumor
731517|NCT00117000|testosterone|testosterone
731518|NCT00117000|food, formulated|food, formulated
731519|NCT00117000|malnutrition|malnutrition
731520|NCT00117000|undernutrition|undernutrition
731521|NCT00117000|aging|aging
731522|NCT00117000|aged|aged
731523|NCT00117000|aged, 80 and over|aged, 80 and over
731524|NCT00117000|frail elderly|frail elderly
731525|NCT00116987|physiologic pacing|physiologic pacing
731526|NCT00116987|ventricular pacing|ventricular pacing
731527|NCT00116987|hospitalizations|hospitalizations
731528|NCT00116974|Dental scaling|dental scaling
731529|NCT00116948|Osteoarthrosis|osteoarthrosis
731530|NCT00116948|RSA|rsa
731531|NCT00116948|DEXA|dexa
731532|NCT00116948|Hip arthroplasty|hip arthroplasty
731533|NCT00116948|Metal ion|metal ion
731534|NCT00116948|Inflammatory response|inflammatory response
731535|NCT00116948|Gait analysis|gait analysis
731536|NCT00116935|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
731537|NCT00116935|GIST|gist
731538|NCT00116935|Sarcoma|sarcoma
731539|NCT00116935|Imatinib|imatinib
731540|NCT00116935|Adjuvant therapy|adjuvant therapy
731541|NCT00116935|KIT|kit
731542|NCT00116935|PDGFRA|pdgfra
731543|NCT00116935|Receptor tyrosine kinase|receptor tyrosine kinase
731544|NCT00116935|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
731545|NCT00116922|Diabetes|diabetes
731546|NCT00116922|Prevention.|prevention.
731547|NCT00116922|Rosiglitazone|rosiglitazone
731548|NCT00116922|Metformin|metformin
731549|NCT00116922|Lifestyle|lifestyle
731550|NCT00116922|Impaired glucose Tolerance|impaired glucose tolerance
731551|NCT00116883|GW685698X|gw685698x
731552|NCT00116883|perennial allergic rhinitis|perennial allergic rhinitis
731553|NCT00116883|pediatric|pediatric
731554|NCT00116883|intranasal corticosteroid|intranasal corticosteroid
731555|NCT00116883|HPA axis function|hpa axis function
731556|NCT00116870|CAD|cad
731557|NCT00116870|familial hypercholesterolemia|familial hypercholesterolemia
731558|NCT00116844|viral shedding|viral shedding
731559|NCT00116844|Recurrent|recurrent
731560|NCT00116844|herpes|herpes
731561|NCT00116844|genital herpes|genital herpes
731562|NCT00116831|atheroma|atheroma
731563|NCT00116831|IVUS|ivus
731564|NCT00116831|Intravascular ultrasound|intravascular ultrasound
731565|NCT00116831|atherosclerosis|atherosclerosis
731566|NCT00116818|perennial allergic rhinitis|perennial allergic rhinitis
731567|NCT00116818|intranasal corticosteroid|intranasal corticosteroid
731568|NCT00116818|HPA axis function|hpa axis function
731569|NCT00116818|GW685698X|gw685698x
731570|NCT00116805|tenofovir|tenofovir
731571|NCT00116805|adefovir|adefovir
731572|NCT00116805|hepatitis B|hepatitis b
731573|NCT00116805|HBeAg Positive|hbeag positive
731574|NCT00116792|CAD|cad
731575|NCT00116792|Diabetes Mellitus|diabetes mellitus
731576|NCT00116792|Restenosis|restenosis
731577|NCT00116792|ppar gamma|ppar gamma
731578|NCT00116792|glitazone|glitazone
731579|NCT00116779|Prostate Cancer|prostate cancer
731580|NCT00116779|Androgen ablation therapy|androgen ablation therapy
731581|NCT00116766|mosquitoes|mosquitoes
731582|NCT00116766|malaria|malaria
731583|NCT00116766|vector control|vector control
731584|NCT00116766|plant-based|plant-based
731585|NCT00116753|Prostate Cancer|prostate cancer
731586|NCT00116753|Androgen ablation therapy|androgen ablation therapy
731587|NCT00116740|Serotonin|serotonin
731588|NCT00116740|5-HT2c|5-ht2c
731589|NCT00116740|Satiety|satiety
731590|NCT00116740|Obesity|obesity
731591|NCT00116740|Appetite suppressant|appetite suppressant
731592|NCT00116740|Weight Loss|weight loss
731593|NCT00116740|Overweight|overweight
731594|NCT00116727|Rheumatoid Arthritis|rheumatoid arthritis
731595|NCT00116727|DMARD|dmard
731596|NCT00116714|rheumatoid arthritis|rheumatoid arthritis
731597|NCT00116714|RA|ra
731598|NCT00116714|DMARD|dmard
731599|NCT00116701|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
731600|NCT00116701|Haemoglobin (Hb)|haemoglobin (hb)
731601|NCT00116701|Erthropoetin (EPO)|erthropoetin (epo)
731602|NCT00116701|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
731603|NCT00116701|Recombinant Human Erthropoetic (rHuEPO)|recombinant human erthropoetic (rhuepo)
731604|NCT00116701|Anaemia|anaemia
731605|NCT00116701|Darbepoetin Alfa, Aranesp®|darbepoetin alfa, aranesp®
731606|NCT00116701|Haemodialysis|haemodialysis
731607|NCT00116701|Clinical Trial|clinical trial
731608|NCT00116688|Immune (Idiopathic) Thrombocytopenic Purpura (ITP)|immune (idiopathic) thrombocytopenic purpura (itp)
731609|NCT00116688|Thrombocytopenic|thrombocytopenic
731610|NCT00116675|Common Wart(s)|common wart(s)
731611|NCT00116675|Pediatric|pediatric
731612|NCT00116675|Wart(s)|wart(s)
731613|NCT00116675|Children|children
731614|NCT00116675|3M Pharmaceuticals|3m pharmaceuticals
731615|NCT00116675|Resiquimod|resiquimod
731616|NCT00116662|Wart(s)|wart(s)
731617|NCT00116662|Common Wart(s)|common wart(s)
731618|NCT00116662|Children|children
731619|NCT00116662|Pediatric|pediatric
731620|NCT00116662|3M Pharmaceuticals|3m pharmaceuticals
731621|NCT00116662|Resiquimod|resiquimod
731622|NCT00116649|actinic keratosis lesions large head torso extremities|actinic keratosis lesions large head torso extremities
731623|NCT00116649|actinic keratosis|actinic keratosis
731624|NCT00116636|HIV|hiv
731625|NCT00116636|Treatment Naive|treatment naive
731626|NCT00116610|small cell lung cancer|small cell lung cancer
731627|NCT00116610|resistant|resistant
731628|NCT00116610|refractory|refractory
731629|NCT00116610|platinum|platinum
731630|NCT00116610|chemotherapy|chemotherapy
731631|NCT00116610|second-line|second-line
731632|NCT00116610|relapse|relapse
731633|NCT00116610|sensitive|sensitive
731634|NCT00116597|Active Specific Immunotherapy|active specific immunotherapy
731635|NCT00116597|Intranodal|intranodal
731636|NCT00116597|Cancer|cancer
731637|NCT00116597|Melanoma stages IIb to IV|melanoma stages iib to iv
731638|NCT00116597|Gene Therapy|gene therapy
731639|NCT00116597|Recombinant Vaccinia virus|recombinant vaccinia virus
731640|NCT00116597|HLA-A2|hla-a2
731641|NCT00116597|Mart-1/Melan-A, Gp-100, tyrosinase|mart-1/melan-a, gp-100, tyrosinase
731642|NCT00116597|Clinical Trial|clinical trial
731643|NCT00116597|Phase I/II|phase i/ii
731644|NCT00116584|heliox|heliox
731645|NCT00116584|bronchiolitis|bronchiolitis
731646|NCT00116584|racemic epinephrine|racemic epinephrine
731647|NCT00116571|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
731648|NCT00116571|Photodynamic Therapy (PDT)|photodynamic therapy (pdt)
731649|NCT00116571|Lower Urinary Tract Symptoms (LUTS)|lower urinary tract symptoms (luts)
731650|NCT00116558|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
731651|NCT00116558|ALS|als
731652|NCT00116558|Lou Gehrig's disease|lou gehrig's disease
731653|NCT00116558|nutrition|nutrition
731654|NCT00116558|NIPPV|nippv
731655|NCT00116558|non-invasive positive pressure ventilation|non-invasive positive pressure ventilation
731656|NCT00116558|percutaneous endoscopic gastrostomy|percutaneous endoscopic gastrostomy
731657|NCT00116558|PEG|peg
731658|NCT00116545|IDDM|iddm
731659|NCT00116545|Insulin|insulin
731660|NCT00116545|cardiovascular disease|cardiovascular disease
731661|NCT00116532|Obsessive Compulsive Disorder|obsessive compulsive disorder
731662|NCT00116532|Escitalopram|escitalopram
731663|NCT00116532|SSRI|ssri
731664|NCT00116532|Open Label|open label
731665|NCT00116506|Metastatic Colorectal Cancer|metastatic colorectal cancer
731666|NCT00116506|Bevacizumab|bevacizumab
731667|NCT00116506|Erlotinib|erlotinib
731668|NCT00116506|FOLFOX|folfox
731669|NCT00116493|severe anemia|severe anemia
731670|NCT00116493|anthelminthic|anthelminthic
731671|NCT00116493|multivitamins|multivitamins
731672|NCT00116493|pregnancy|pregnancy
731673|NCT00116493|children|children
731674|NCT00116493|Pakistan|pakistan
731675|NCT00116480|Postpartum Haemorrhage|postpartum haemorrhage
731676|NCT00116480|Misoprostol|misoprostol
731677|NCT00116467|AML|aml
731678|NCT00116467|Acute Myelogenous Leukemia|acute myelogenous leukemia
731679|NCT00116467|GVAX|gvax
731680|NCT00116467|Vaccine|vaccine
731681|NCT00116467|Stem Cell Transplant|stem cell transplant
731682|NCT00116467|Autologous|autologous
731683|NCT00116454|Carcinoma, Hepatocellular|carcinoma, hepatocellular
731684|NCT00116454|Viral Hepatitis, Alcoholic Hepatitis|viral hepatitis, alcoholic hepatitis
731685|NCT00116441|Multiple Myeloma|multiple myeloma
731686|NCT00116441|Cancer|cancer
731687|NCT00116441|PSCT|psct
731688|NCT00116441|Peripheral Stem Cell Transplant|peripheral stem cell transplant
731689|NCT00116441|Chemotherapy|chemotherapy
731690|NCT00116441|GVAX|gvax
731691|NCT00116428|Atrial Fibrillation|atrial fibrillation
731692|NCT00116428|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
731693|NCT00116415|HIV/AIDS|hiv/aids
731694|NCT00116402|COPD|copd
731695|NCT00116402|Chronic Obstructive|chronic obstructive
731696|NCT00116402|Pulmonary Disease|pulmonary disease
731697|NCT00116402|Inhaled Corticosteroids|inhaled corticosteroids
731698|NCT00116402|Airway Inflammation|airway inflammation
731699|NCT00116402|Bronchoscopy|bronchoscopy
731700|NCT00116389|pancreatic cancer|pancreatic cancer
731701|NCT00116389|cancer of the pancreas|cancer of the pancreas
731702|NCT00116389|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
731703|NCT00116389|pancreatic neoplasms|pancreatic neoplasms
731704|NCT00116389|Metastatic pancreatic cancer (Stage IV)|metastatic pancreatic cancer (stage iv)
731705|NCT00116389|Stage IV Adenocarcinoma of the Pancreas|stage iv adenocarcinoma of the pancreas
731706|NCT00116376|GBM|gbm
731707|NCT00116376|recurrent/relapse|recurrent/relapse
731708|NCT00116376|EGFR|egfr
731709|NCT00116376|VEGFR|vegfr
731710|NCT00116363|gene therapy|gene therapy
731711|NCT00116363|melanoma|melanoma
731712|NCT00116363|adenovirus|adenovirus
731713|NCT00116363|in-transit melanoma|in-transit melanoma
731714|NCT00116363|metastatic melanoma|metastatic melanoma
731715|NCT00116350|Postpartum hemorrhage|postpartum hemorrhage
731716|NCT00116350|Misoprostol|misoprostol
731717|NCT00116350|Developing countries|developing countries
731718|NCT00116350|Maternal morbidity|maternal morbidity
731719|NCT00116350|Randomized controlled trial|randomized controlled trial
731720|NCT00116337|spinal cord injury|spinal cord injury
731721|NCT00116337|paralysis|paralysis
731722|NCT00116337|cough|cough
731723|NCT00116337|cervical spinal cord injury|cervical spinal cord injury
731724|NCT00116337|thoracic spinal cord injury|thoracic spinal cord injury
731725|NCT00116324|Asthma|asthma
731726|NCT00116324|Leukotriene receptor antagonist|leukotriene receptor antagonist
731727|NCT00116324|Hypertonic saline challenge|hypertonic saline challenge
731728|NCT00116311|Adenosine receptors|adenosine receptors
731729|NCT00116311|asthma|asthma
731730|NCT00116311|sputum|sputum
731731|NCT00116311|peripheral blood|peripheral blood
731732|NCT00116311|healthy|healthy
731733|NCT00116298|Antivirals|antivirals
731734|NCT00116298|HIV|hiv
731735|NCT00116285|allergy|allergy
731736|NCT00116285|skin prick test|skin prick test
731737|NCT00116285|allergoid|allergoid
731738|NCT00116285|allergenicity|allergenicity
731739|NCT00116285|specific immunotherapy|specific immunotherapy
731740|NCT00116272|pregnancy|pregnancy
731741|NCT00116272|Autoimmune Disease|autoimmune disease
731742|NCT00116259|clinical trial|clinical trial
731743|NCT00116259|aripiprazole|aripiprazole
731744|NCT00116259|Bipolar Disorder|bipolar disorder
731745|NCT00116259|Attention-Deficit Hyperactivity Disorder|attention-deficit hyperactivity disorder
731746|NCT00116259|ADHD|adhd
731747|NCT00116246|Labour|labour
731748|NCT00116246|vaginal delivery|vaginal delivery
731749|NCT00116246|primigravida|primigravida
731750|NCT00116246|McRobert's Manoeuvre|mcrobert's manoeuvre
731751|NCT00116246|operative delivery|operative delivery
731752|NCT00116233|post operative adhesions|post operative adhesions
731753|NCT00116220|Prostate Cancer|prostate cancer
731754|NCT00116220|Total Androgen Suppression|total androgen suppression
731755|NCT00116220|endorectal coil MRI|endorectal coil mri
731756|NCT00116220|External Beam Radiation Therapy|external beam radiation therapy
731757|NCT00116220|Prostate Cancer- High Risk, clinically Organ-Confined|prostate cancer- high risk, clinically organ-confined
731758|NCT00116207|Type 1 Diabetes|type 1 diabetes
731759|NCT00116207|Oxidative Stress|oxidative stress
731760|NCT00116207|Diabetic Complications|diabetic complications
731761|NCT00116207|Neuropathy|neuropathy
731762|NCT00116194|exercise|exercise
731763|NCT00116194|activities of daily living|activities of daily living
731764|NCT00116194|ADL|adl
731765|NCT00116194|loss of mobility|loss of mobility
731766|NCT00116194|risk of disability|risk of disability
731767|NCT00116194|physical activity|physical activity
731768|NCT00116194|mobility disability|mobility disability
731769|NCT00116155|Hormone Refractory Metastatic Prostate Cancer|hormone refractory metastatic prostate cancer
731770|NCT00116142|Prostate Cancer|prostate cancer
731771|NCT00116142|Hormone Refractory|hormone refractory
731772|NCT00116142|Metastatic|metastatic
731773|NCT00116142|Localized|localized
731774|NCT00116142|Locally Advanced|locally advanced
731775|NCT00116142|Prostate Cancer - High Risk Localized or Locally Advanced|prostate cancer - high risk localized or locally advanced
731776|NCT00116129|Fibromyalgia|fibromyalgia
731777|NCT00116129|Treatment|treatment
731778|NCT00116129|Growth hormone|growth hormone
731779|NCT00116129|IGF-1|igf-1
731780|NCT00116129|MK-0677|mk-0677
731781|NCT00116129|Oral growth hormone secretagogue|oral growth hormone secretagogue
731782|NCT00116116|HIV/AIDS|hiv/aids
731783|NCT00116103|Treatment Effectiveness|treatment effectiveness
731784|NCT00116103|Treatment Efficacy|treatment efficacy
731785|NCT00116103|Investigational, Therapies|investigational, therapies
731786|NCT00116103|Asthma|asthma
731787|NCT00116103|Antiasthmatics|antiasthmatics
731788|NCT00116103|Antiasthmatic agents|antiasthmatic agents
731789|NCT00116090|Uveitis|uveitis
731790|NCT00116090|Immunosuppression|immunosuppression
731791|NCT00116090|Cancer|cancer
731792|NCT00116090|Infections|infections
731793|NCT00116090|Mortality|mortality
731794|NCT00116090|Ocular Inflammatory Disease|ocular inflammatory disease
731795|NCT00116090|Scleritis|scleritis
731796|NCT00116090|Mucous Membranes Pemphigoid|mucous membranes pemphigoid
731797|NCT00116077|PET|pet
731798|NCT00116077|[C-11] NNC-112|[c-11] nnc-112
731799|NCT00116077|[F-18] Fallypride|[f-18] fallypride
731800|NCT00116077|Dopamine Receptors|dopamine receptors
731801|NCT00116077|Mood Disorders|mood disorders
731802|NCT00116077|DA Receptors|da receptors
731803|NCT00116077|Major Depressive Disorder|major depressive disorder
731804|NCT00116077|Bipolar Disorder|bipolar disorder
731805|NCT00116077|MDD|mdd
731806|NCT00116077|Bipolar Depression|bipolar depression
731807|NCT00116077|Healthy Volunteer|healthy volunteer
731808|NCT00116077|HV|hv
731809|NCT00116064|intranasal|intranasal
731810|NCT00116064|lorazepam|lorazepam
731811|NCT00116064|paediatric|paediatric
731812|NCT00116064|convulsions|convulsions
731813|NCT00116051|RSA|rsa
731814|NCT00116051|DEXA|dexa
731815|NCT00116051|Osteoarthritis|osteoarthritis
731816|NCT00116051|Hip arthroplasty|hip arthroplasty
731817|NCT00116038|RSA|rsa
731818|NCT00116038|Osteoarthritis|osteoarthritis
731819|NCT00116038|Hip arthroplasty|hip arthroplasty
731820|NCT00116038|DEXA|dexa
731821|NCT00116012|acute coronary syndrome|acute coronary syndrome
731822|NCT00116012|rNAPc2|rnapc2
731823|NCT00116012|unstable angina|unstable angina
731824|NCT00116012|Non-STE myocardial infarction|non-ste myocardial infarction
731825|NCT00116012|ST elevation|st elevation
731826|NCT00116012|cardiac enzymes|cardiac enzymes
731827|NCT00116012|acute coronary syndromes|acute coronary syndromes
731829|NCT00116012|tissue factor|tissue factor
731830|NCT00116012|nematode anticoagulant protein c2|nematode anticoagulant protein c2
731831|NCT00116012|anticoagulants|anticoagulants
731832|NCT00116012|thrombin inhibitors|thrombin inhibitors
731833|NCT00116012|thrombosis|thrombosis
731834|NCT00115999|PAO|pao
731835|NCT00115999|acute peripheral arterial occlusion|acute peripheral arterial occlusion
731836|NCT00115999|thrombolysis|thrombolysis
731837|NCT00115999|blood clot|blood clot
731838|NCT00115999|leg attack|leg attack
731839|NCT00115999|alfimeprase|alfimeprase
731840|NCT00115999|thrombus|thrombus
731841|NCT00115999|embolism|embolism
731842|NCT00115999|thromboembolism|thromboembolism
731843|NCT00115999|claudication|claudication
731844|NCT00115999|thrombolytic|thrombolytic
731845|NCT00115999|thrombosis|thrombosis
731846|NCT00115999|plasminogen activator|plasminogen activator
731847|NCT00115999|arterial flow|arterial flow
731848|NCT00115986|A/H5N1, Influenza, Vaccine, parent protocol|a/h5n1, influenza, vaccine, parent protocol
731849|NCT00115973|Pump|pump
731850|NCT00115973|Diabetes|diabetes
731851|NCT00115960|IL-12|il-12
731852|NCT00115960|IL-15|il-15
731853|NCT00115960|HIV Seronegativity|hiv seronegativity
731854|NCT00115960|HIV Preventive Vaccine|hiv preventive vaccine
731855|NCT00115921|Home-based care|home-based care
731856|NCT00115921|Malaria|malaria
731857|NCT00115921|Africa|africa
731858|NCT00115908|Hepatitis C|hepatitis c
731859|NCT00115895|radioiodine|radioiodine
731860|NCT00115895|serum thyroglobulin|serum thyroglobulin
731861|NCT00115895|whole body radioiodine scanning|whole body radioiodine scanning
731862|NCT00115882|Adolescent|adolescent
731863|NCT00115882|smoking|smoking
731864|NCT00115882|smoking cessation|smoking cessation
731865|NCT00115882|counseling|counseling
731866|NCT00115869|smoking prevention|smoking prevention
731867|NCT00115869|tobacco use prevention|tobacco use prevention
731868|NCT00115869|adolescent tobacco use|adolescent tobacco use
731869|NCT00115869|prevention intervention|prevention intervention
731870|NCT00115856|Arterial Disease|arterial disease
731871|NCT00115843|Atrial fibrillation|atrial fibrillation
731872|NCT00115843|Arrhythmia|arrhythmia
731873|NCT00115843|Tachycardia|tachycardia
731874|NCT00115804|Fibromyalgia|fibromyalgia
731875|NCT00115804|Juvenile|juvenile
731876|NCT00115791|Atrial Flutters|atrial flutters
731877|NCT00115791|Atrial Fibrillations|atrial fibrillations
731879|NCT00115778|Hypogammaglobulinemia|hypogammaglobulinemia
731880|NCT00115778|Lung Transplantation|lung transplantation
731881|NCT00115765|Panitumumab Advanced Colorectal Cancer Evaluation Study (PACCE Study)|panitumumab advanced colorectal cancer evaluation study (pacce study)
731882|NCT00115765|Colorectal, Colon, Rectal Cancer, Metastatic Colorectal|colorectal, colon, rectal cancer, metastatic colorectal
731883|NCT00115765|Cancer|cancer
731884|NCT00115765|EGFr, Clinical Trial|egfr, clinical trial
731885|NCT00115765|Panitumumab, ABX-EGF|panitumumab, abx-egf
731886|NCT00115765|Immunex, Abgenix, Amgen|immunex, abgenix, amgen
731887|NCT00115765|Metastatic Colorectal Cancer|metastatic colorectal cancer
731888|NCT00115765|Oncology|oncology
731889|NCT00115752|Single Nucleotide Polymorphism|single nucleotide polymorphism
731890|NCT00115752|Analgesic Efficacy|analgesic efficacy
731891|NCT00115752|Oral Surgery Model|oral surgery model
731892|NCT00115752|Cyclooxygenase Inhibitor|cyclooxygenase inhibitor
731893|NCT00115752|Gene Expression Profile|gene expression profile
731894|NCT00115752|Wisdom Teeth|wisdom teeth
731895|NCT00115752|Third Molar Extraction|third molar extraction
731896|NCT00115739|Anaplastic Thyroid Cancer|anaplastic thyroid cancer
731897|NCT00115726|anesthesia|anesthesia
731898|NCT00115726|hypotension|hypotension
731899|NCT00115726|furosemide|furosemide
731900|NCT00115726|blood pressure|blood pressure
731901|NCT00115726|peripheral edema|peripheral edema
731902|NCT00115726|diuretic|diuretic
731903|NCT00115726|surgery|surgery
731904|NCT00115726|congestive heart failure|congestive heart failure
731905|NCT00115713|Aerobic Exercise|aerobic exercise
731906|NCT00115713|Weight Lifting|weight lifting
731907|NCT00115713|Breast Cancer|breast cancer
731908|NCT00115713|Quality of Life|quality of life
731909|NCT00115700|Radiotherapy|radiotherapy
731910|NCT00115700|Chemotherapy|chemotherapy
731911|NCT00115700|Rituximab|rituximab
731912|NCT00115700|Randomised Trial|randomised trial
731913|NCT00115700|Stage I-II low grade follicular lymphoma|stage i-ii low grade follicular lymphoma
731914|NCT00115687|nicotine addiction|nicotine addiction
731915|NCT00115661|Peroxisome Proliferator-Activated Receptors|peroxisome proliferator-activated receptors
731916|NCT00115661|treatment of endometriosis|treatment of endometriosis
731917|NCT00115648|HIV|hiv
731918|NCT00115648|MTCT|mtct
731919|NCT00115648|Infants|infants
731920|NCT00115648|africa|africa
731921|NCT00115648|HIV Seronegativity|hiv seronegativity
731922|NCT00115635|Hormonal refractory, chemotherapy, docetaxel, gemcitabine|hormonal refractory, chemotherapy, docetaxel, gemcitabine
731923|NCT00115622|GW685698X|gw685698x
731924|NCT00115622|once daily|once daily
731925|NCT00115622|mountain cedar|mountain cedar
731926|NCT00115622|allergic rhinitis|allergic rhinitis
731927|NCT00115622|fluticasone furoate|fluticasone furoate
732494|NCT00113867|IVF|ivf
731928|NCT00115609|HIV infections|hiv infections
731929|NCT00115609|tuberculosis|tuberculosis
731930|NCT00115609|tuberculosis agents|tuberculosis agents
731931|NCT00115609|Anti HIV agents|anti hiv agents
731932|NCT00115609|Treatment Naive|treatment naive
731933|NCT00115596|Procedure|procedure
731934|NCT00115596|Training|training
731935|NCT00115596|Simulation|simulation
731936|NCT00115596|Pediatrics|pediatrics
731937|NCT00115596|Curriculum|curriculum
731938|NCT00115596|Evaluation|evaluation
731939|NCT00115570|Diabetes,Insulin-Dependent, pediatric,rapid acting injection|diabetes,insulin-dependent, pediatric,rapid acting injection
731940|NCT00115557|translational research|translational research
731941|NCT00115557|prevention|prevention
731942|NCT00115557|primary care|primary care
731943|NCT00115557|practice-based research network|practice-based research network
731944|NCT00115544|neonatal|neonatal
731945|NCT00115544|jaundice|jaundice
731946|NCT00115544|hyperbilirubinemia|hyperbilirubinemia
731947|NCT00115531|Elderly, influenza, vaccine, parent protocol|elderly, influenza, vaccine, parent protocol
731948|NCT00115505|stage IA breast cancer|stage ia breast cancer
731949|NCT00115505|stage II breast cancer|stage ii breast cancer
731950|NCT00115505|stage IB breast cancer|stage ib breast cancer
731951|NCT00115505|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
731952|NCT00115505|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
731953|NCT00115505|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
731954|NCT00115505|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
731955|NCT00115492|Breathing|breathing
731956|NCT00115492|Exacerbation|exacerbation
731957|NCT00115492|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
731958|NCT00115479|critical illness|critical illness
731959|NCT00115479|intensive care|intensive care
731960|NCT00115479|outcome|outcome
731961|NCT00115479|insulin|insulin
731962|NCT00115479|blood glucose|blood glucose
731963|NCT00115466|ASCs (adult stem cells derived from adipose tissue)|ascs (adult stem cells derived from adipose tissue)
731964|NCT00115466|Fistula|fistula
731965|NCT00115466|Cell Therapy|cell therapy
731966|NCT00115466|Complex perianal fistula|complex perianal fistula
731967|NCT00115453|glioblastoma|glioblastoma
731968|NCT00115453|boron neutron capture therapy|boron neutron capture therapy
731969|NCT00115453|boronophenylalanine|boronophenylalanine
731970|NCT00115453|brain tumor|brain tumor
731971|NCT00115440|glioblastoma|glioblastoma
731972|NCT00115440|anaplastic astrocytoma|anaplastic astrocytoma
731973|NCT00115440|boron neutron capture therapy|boron neutron capture therapy
731974|NCT00115440|radiation therapy|radiation therapy
731975|NCT00115440|boronophenylalanine|boronophenylalanine
731976|NCT00115427|Bilateral, Idiopathic Parkinson's Disease|bilateral, idiopathic parkinson's disease
731977|NCT00115414|Neulasta®|neulasta®
731978|NCT00115414|Chemotherapy|chemotherapy
731979|NCT00115414|TAC|tac
731980|NCT00115414|Amgen|amgen
731981|NCT00019500|breast cancer|breast cancer
731982|NCT00115401|Walking|walking
731983|NCT00115401|Compensation|compensation
731984|NCT00115401|Leg Weakness|leg weakness
731985|NCT00115401|Orthotics|orthotics
731986|NCT00115401|Joint Impairment|joint impairment
731987|NCT00115401|Healthy Volunteer|healthy volunteer
731988|NCT00115401|HV|hv
731989|NCT00115401|Joint Inmpairment|joint inmpairment
731990|NCT00115388|Pelvic inflammatory disease|pelvic inflammatory disease
731991|NCT00115388|Chlamydia trachomatis|chlamydia trachomatis
731992|NCT00115388|Screening|screening
731993|NCT00115375|THROMBOSIS|thrombosis
731994|NCT00115375|PLATELET AGGREGATION|platelet aggregation
731995|NCT00115375|Pediatrics|pediatrics
731996|NCT00115362|functional dyspepsia;|functional dyspepsia;
731997|NCT00115362|Serotonin Uptake Inhibitors;|serotonin uptake inhibitors;
731998|NCT00115362|Antidepressive Agents.|antidepressive agents.
731999|NCT00115336|Blood Diseases|blood diseases
732000|NCT00115336|Sickle Cell Anemia|sickle cell anemia
732001|NCT00115310|dermal assessment|dermal assessment
732002|NCT00115310|pain measurement|pain measurement
732003|NCT00115310|diary|diary
732004|NCT00115310|PHN|phn
732005|NCT00115310|shingles|shingles
732006|NCT00115310|neuropathy|neuropathy
732007|NCT00115310|analgesics|analgesics
732008|NCT00115310|capsaicin|capsaicin
732009|NCT00115310|postherpetic neuralgia|postherpetic neuralgia
732010|NCT00115284|Asthma|asthma
732011|NCT00115284|Education, Medical, Continuing|education, medical, continuing
732012|NCT00115284|American Board of Internal Medicine|american board of internal medicine
732013|NCT00115284|Recertification|recertification
732014|NCT00115284|Continuous Professional Development|continuous professional development
732015|NCT00115284|Practice improvement|practice improvement
732016|NCT00115271|Micronutrients|micronutrients
732017|NCT00115271|Supplementation|supplementation
732018|NCT00115271|Pregnancy|pregnancy
732019|NCT00115271|Birth weight|birth weight
732020|NCT00115271|Infant mortality|infant mortality
732021|NCT00115258|Nutrition, Parenteral|nutrition, parenteral
732022|NCT00115258|Body Composition|body composition
732023|NCT00115258|Energy Expenditure|energy expenditure
732024|NCT00115232|cardiovascular disease|cardiovascular disease
732025|NCT00115232|metabolic syndrome|metabolic syndrome
732026|NCT00115232|hypercholesterolemia|hypercholesterolemia
732027|NCT00115232|child|child
732028|NCT00115232|family history|family history
732029|NCT00115232|inflammation|inflammation
732030|NCT00115219|Rheumatoid Arthritis, RA|rheumatoid arthritis, ra
732031|NCT00115219|Enbrel® (etanercept)|enbrel® (etanercept)
732032|NCT00115219|Clinical Trials, Amgen|clinical trials, amgen
732033|NCT00115219|Immunex, Methotrexate (MTX)|immunex, methotrexate (mtx)
732034|NCT00115219|Rheumatoid Arthritis (RA)|rheumatoid arthritis (ra)
732035|NCT00115206|Non Small Cell Lung Cancer|non small cell lung cancer
732036|NCT00115206|NSCLC|nsclc
732037|NCT00115206|Fever|fever
732038|NCT00115206|Neutropenia|neutropenia
732039|NCT00115206|Neulasta®|neulasta®
732040|NCT00115206|Quality of Life|quality of life
732041|NCT00115206|Chemotherapy|chemotherapy
732042|NCT00115206|Amgen|amgen
732043|NCT00115193|Oncology|oncology
732044|NCT00115193|NHL|nhl
732045|NCT00115193|Mantle cell|mantle cell
732046|NCT00115193|Diffuse large B-cell|diffuse large b-cell
732047|NCT00115193|Chemotherapy|chemotherapy
732048|NCT00115193|RCHOP|rchop
732049|NCT00115193|Neulasta®|neulasta®
732050|NCT00115193|Neutropenia|neutropenia
732051|NCT00115193|Pegfilgrastim|pegfilgrastim
732052|NCT00115193|Amgen|amgen
732053|NCT00115180|analgesia|analgesia
732054|NCT00115180|adult|adult
732055|NCT00115180|opioid|opioid
732056|NCT00115180|Long Bone Fractures|long bone fractures
732057|NCT00115167|Oncology|oncology
732058|NCT00115167|Cancer-related anemia|cancer-related anemia
732059|NCT00115154|Actinic Keratosis|actinic keratosis
732060|NCT00115154|AK|ak
732061|NCT00115154|3M Pharmaceuticals|3m pharmaceuticals
732062|NCT00115154|Aldara|aldara
732063|NCT00115154|Imiquimod|imiquimod
732064|NCT00115154|Actinic Keratosis (AK)|actinic keratosis (ak)
732065|NCT00115141|Wart(s)|wart(s)
732066|NCT00115141|Adults|adults
732067|NCT00115141|Common Wart(s)|common wart(s)
732068|NCT00115128|normal PBPC donors|normal pbpc donors
732069|NCT00115115|Donor dopamine|donor dopamine
732070|NCT00115115|Immediate graft function|immediate graft function
732071|NCT00115115|Kidney transplantation|kidney transplantation
732072|NCT00115102|Atypical odontalgia|atypical odontalgia
732073|NCT00115102|capsaicin|capsaicin
732074|NCT00115102|pain|pain
732075|NCT00115102|neuropathic pain|neuropathic pain
732076|NCT00115089|Allergic Rhinitis|allergic rhinitis
732077|NCT00115089|Nasal Spray|nasal spray
732078|NCT00115089|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
732079|NCT00115076|skin|skin
732080|NCT00115076|psoriasis|psoriasis
732081|NCT00115063|obesity|obesity
732082|NCT00115063|Low Calorie Diet|low calorie diet
732083|NCT00115063|Obesity Pharmacotherapy|obesity pharmacotherapy
732084|NCT00115063|Pragmatic Clinical Trial|pragmatic clinical trial
732085|NCT00115050|HIV infections|hiv infections
732086|NCT00115050|Antiretroviral|antiretroviral
732087|NCT00115050|TMC114|tmc114
732088|NCT00115050|Ritonavir|ritonavir
732089|NCT00115050|Safety, TMC114-C209|safety, tmc114-c209
732090|NCT00115037|Alcoholism|alcoholism
732091|NCT00115037|alcohol abuse|alcohol abuse
732092|NCT00115037|therapy|therapy
732093|NCT00115037|drug resistance|drug resistance
732094|NCT00115037|naltrexone|naltrexone
732095|NCT00115037|patient care management|patient care management
732096|NCT00115037|human subject|human subject
732097|NCT00115024|cardiovascular disease|cardiovascular disease
732098|NCT00115024|CVD|cvd
732099|NCT00115024|estrogen|estrogen
732100|NCT00115024|cholesterol|cholesterol
732101|NCT00115024|LDL|ldl
732102|NCT00115024|lipids|lipids
732103|NCT00115024|postmenopausal|postmenopausal
732104|NCT00115011|Skin Picking|skin picking
732105|NCT00115011|Escitalopram|escitalopram
732106|NCT00115011|Lexapro|lexapro
732107|NCT00115011|Body Focused Repetitive Behaviors|body focused repetitive behaviors
732108|NCT00115011|Obsessive Compulsive Spectrum Disorders|obsessive compulsive spectrum disorders
732109|NCT00114985|Total Androgen Suppression|total androgen suppression
732110|NCT00114985|Simulation|simulation
732111|NCT00114985|3-D Conformal External Beam Radiation Therapy|3-d conformal external beam radiation therapy
732112|NCT00114985|Intra-rectal immobilization device|intra-rectal immobilization device
732113|NCT00114985|Quality of Life Assessment Questionnaire|quality of life assessment questionnaire
732114|NCT00114985|Rectal Bleeding|rectal bleeding
732115|NCT00114985|Late effects|late effects
732116|NCT00114972|Three-vessel coronary artery disease|three-vessel coronary artery disease
732117|NCT00114972|Left main coronary artery disease|left main coronary artery disease
732118|NCT00114959|ChemGenex Pharmaceuticals, Ltd|chemgenex pharmaceuticals, ltd
732119|NCT00114959|ChemGenex Pharmaceuticals|chemgenex pharmaceuticals
732120|NCT00114959|ChemGenex|chemgenex
732121|NCT00114959|Chronic Myeloid Leukemia|chronic myeloid leukemia
732122|NCT00114959|Myeloid Leukemia, Chronic|myeloid leukemia, chronic
732123|NCT00114959|Leukemia|leukemia
732124|NCT00114959|Myeloid Leukemia|myeloid leukemia
732125|NCT00114959|Chronic Phase|chronic phase
732126|NCT00114959|Accelerated Phase|accelerated phase
732127|NCT00114959|Blast Phase|blast phase
732128|NCT00114959|Myeloid, Leukemia, Chronic, Accelerated Phase|myeloid, leukemia, chronic, accelerated phase
732129|NCT00114959|Myeloid, Leukemia, Chronic|myeloid, leukemia, chronic
732130|NCT00114959|Leukemia, Myeloid, Chronic|leukemia, myeloid, chronic
732131|NCT00114959|Leukemia, Myeloid, Chronic-Phase|leukemia, myeloid, chronic-phase
732132|NCT00114959|Leukemia, Myeloid, Chronic Phase|leukemia, myeloid, chronic phase
732133|NCT00114959|Leukemia, Myeloid, Accelerated-Phase|leukemia, myeloid, accelerated-phase
732134|NCT00114959|Myeloid, Leukemia, Chronic, Chronic Phase|myeloid, leukemia, chronic, chronic phase
732135|NCT00114959|Leukemia, Myeloid, Accelerated Phase|leukemia, myeloid, accelerated phase
732136|NCT00114959|Homoharringtonine|homoharringtonine
732137|NCT00114959|Omacetaxine|omacetaxine
732138|NCT00114946|Metastatic Colorectal Cancer OASIS|metastatic colorectal cancer oasis
732139|NCT00114933|HIV|hiv
732140|NCT00114933|AIDS|aids
732141|NCT00114933|Treatment Experienced|treatment experienced
732142|NCT00114920|Wart(s)|wart(s)
732143|NCT00114920|Adults|adults
732144|NCT00114920|Common Wart(s)|common wart(s)
732145|NCT00114907|Tea|tea
732146|NCT00114907|Oxidative stress markers|oxidative stress markers
732147|NCT00114907|cardiovascular disease|cardiovascular disease
732148|NCT00114907|polyphenolics|polyphenolics
732149|NCT00114907|double blind|double blind
732150|NCT00114907|Ischaemic cardiac disease|ischaemic cardiac disease
732151|NCT00114894|Jellyfish|jellyfish
732152|NCT00114894|Stings|stings
732153|NCT00114894|Marine|marine
732154|NCT00114894|Envenomation|envenomation
732155|NCT00114894|Jellyfish stings|jellyfish stings
732156|NCT00114881|Children|children
732157|NCT00114881|Urban Health|urban health
732158|NCT00114881|Pregnancy|pregnancy
732159|NCT00114881|Asthma|asthma
732160|NCT00114868|vitamin A|vitamin a
732161|NCT00114868|mortality|mortality
732162|NCT00114868|newborn|newborn
732163|NCT00114868|liveborn infants|liveborn infants
732164|NCT00114855|Hypocol|hypocol
732165|NCT00114855|Red yeast rice|red yeast rice
732166|NCT00114855|Patients with mild Type IIa, Type IIb or IV hyperlipidaemia (LDL-cholesterol >3.0 mmol/L< 6.0 mmol/L.|patients with mild type iia, type iib or iv hyperlipidaemia (ldl-cholesterol >3.0 mmol/l< 6.0 mmol/l.
732167|NCT00114855|Mildly elevated blood glucose|mildly elevated blood glucose
732168|NCT00114842|colorectal polyps|colorectal polyps
732169|NCT00114842|colorectal cancer|colorectal cancer
732170|NCT00114842|Virtual colonoscopy|virtual colonoscopy
732171|NCT00114842|Fecal tagging|fecal tagging
732172|NCT00114842|MR colonography|mr colonography
732173|NCT00114829|Colorectal cancer|colorectal cancer
732174|NCT00114829|Colorectal tumor|colorectal tumor
732175|NCT00114829|Dynamic contrast uptake|dynamic contrast uptake
732176|NCT00114829|MR colonography|mr colonography
732177|NCT00114816|breast cancer|breast cancer
732178|NCT00114816|chemotherapy|chemotherapy
732179|NCT00114816|adjuvant|adjuvant
732180|NCT00114816|capecitabine|capecitabine
732181|NCT00114816|docetaxel|docetaxel
732182|NCT00114803|bone mineral density|bone mineral density
732183|NCT00114803|osteoporosis|osteoporosis
732184|NCT00114803|osteopenia|osteopenia
732185|NCT00114803|children|children
732186|NCT00114803|adolescents|adolescents
732187|NCT00114803|DXA|dxa
732188|NCT00114790|head and neck cancer|head and neck cancer
732189|NCT00114790|boron neutron capture therapy|boron neutron capture therapy
732190|NCT00114790|radiation therapy|radiation therapy
732191|NCT00114790|boronophenylalanine|boronophenylalanine
732192|NCT00114764|Acute myeloid leukaemia|acute myeloid leukaemia
732193|NCT00114764|Pegfilgrastim|pegfilgrastim
732194|NCT00114764|Neulasta®|neulasta®
732195|NCT00114764|Neutropenia|neutropenia
732196|NCT00114764|Induction chemotherapy|induction chemotherapy
732197|NCT00114764|Consolidation|consolidation
732198|NCT00114738|Proteasome Inhibition|proteasome inhibition
732199|NCT00114738|NF-Kappa-B|nf-kappa-b
732200|NCT00114738|Gene Expression Signature|gene expression signature
732201|NCT00114738|Cyclin D1|cyclin d1
732202|NCT00114738|Translational Studies|translational studies
732203|NCT00114738|Lymphoma|lymphoma
732204|NCT00114738|Mantle Cell Lymphoma|mantle cell lymphoma
732205|NCT00114738|MCL|mcl
732206|NCT00114725|In Vitro Fertilization|in vitro fertilization
732207|NCT00114725|Intracytoplasmic Sperm Injection|intracytoplasmic sperm injection
732208|NCT00114725|Oocytes|oocytes
732209|NCT00114725|Zona Pellucida|zona pellucida
732210|NCT00114725|Oolemma|oolemma
732211|NCT00114725|Fertilization|fertilization
732212|NCT00114725|Preimplantation Embryo Development|preimplantation embryo development
732213|NCT00114712|Birth Defects|birth defects
732214|NCT00114712|Pregnancy|pregnancy
732215|NCT00114712|Ribavirin|ribavirin
732216|NCT00114712|Hepatitis C|hepatitis c
732217|NCT00114699|HIV|hiv
732218|NCT00114699|Treatment Naive|treatment naive
732219|NCT00114686|Bipolar I Disorder|bipolar i disorder
732220|NCT00114686|Alcohol Dependency|alcohol dependency
732221|NCT00114673|Uneven skin color|uneven skin color
732222|NCT00114673|Wrinkles|wrinkles
732223|NCT00114673|Wrinkles and uneven skin color in the area around the eyes|wrinkles and uneven skin color in the area around the eyes
732224|NCT00114660|striae gravidarum|striae gravidarum
732225|NCT00114660|stretch marks|stretch marks
732226|NCT00114660|cocoa butter|cocoa butter
732227|NCT00114660|prevention|prevention
732228|NCT00114647|Plasmapheresis|plasmapheresis
732229|NCT00114647|Leukapheresis|leukapheresis
732230|NCT00114647|Lymphocytes|lymphocytes
732231|NCT00114647|Apheresis|apheresis
732232|NCT00114634|SLOS|slos
732233|NCT00114634|RSH syndrome|rsh syndrome
732234|NCT00114634|ABC Checklist|abc checklist
732235|NCT00114634|Cholesterol supplementation|cholesterol supplementation
732236|NCT00114634|Egg yolk|egg yolk
732237|NCT00114634|Smith-Lemli-Opitz Syndrome|smith-lemli-opitz syndrome
732238|NCT00114621|PA|pa
732239|NCT00114621|Phase I|phase i
732240|NCT00114621|Phase 2|phase 2
732241|NCT00114621|Safety|safety
732242|NCT00114621|Immunogenicity|immunogenicity
732243|NCT00114608|Electrical foot stimulation|electrical foot stimulation
732244|NCT00114608|Intermittent pneumatic compression|intermittent pneumatic compression
732245|NCT00114608|Venous thromboembolism|venous thromboembolism
732246|NCT00114608|Immobilization|immobilization
732247|NCT00114608|Total hip replacement|total hip replacement
732248|NCT00114608|Prolonged travel|prolonged travel
732249|NCT00114608|Venous thromboembolic disease (VTE)|venous thromboembolic disease (vte)
732250|NCT00114608|Deep vein thrombosis (DVT)|deep vein thrombosis (dvt)
732251|NCT00114608|Pulmonary embolism (PE)|pulmonary embolism (pe)
732252|NCT00114595|eicosapentaenoic acid|eicosapentaenoic acid
732253|NCT00114595|tardive dyskinesia|tardive dyskinesia
732254|NCT00114595|omega-3|omega-3
732255|NCT00114595|schizophrenia|schizophrenia
732256|NCT00114582|family style dinner|family style dinner
732257|NCT00114582|quality of life|quality of life
732258|NCT00114582|nutritional status|nutritional status
732259|NCT00114582|nursing home residents|nursing home residents
732260|NCT00114569|children|children
732261|NCT00114569|status epilepticus|status epilepticus
732262|NCT00114569|lorazepam|lorazepam
732263|NCT00114569|safety|safety
732264|NCT00114569|pharmacokinetics|pharmacokinetics
732265|NCT00114569|status epilepticus in children|status epilepticus in children
732266|NCT00114556|osteoporosis|osteoporosis
732267|NCT00114556|liver transplantation|liver transplantation
732268|NCT00114543|NICHD Neonatal Research Network|nichd neonatal research network
732269|NCT00114543|Bilirubin|bilirubin
732270|NCT00114543|Phototherapy|phototherapy
732271|NCT00114543|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
732272|NCT00114543|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
732273|NCT00114543|Prematurity|prematurity
732274|NCT00114543|Neurodevelopmental outcome|neurodevelopmental outcome
732275|NCT00114530|systemic sclerosis|systemic sclerosis
732276|NCT00114530|hematopoietic stem cell transplant|hematopoietic stem cell transplant
732277|NCT00114530|clinical trial|clinical trial
732278|NCT00114530|global rank composite score|global rank composite score
732279|NCT00114517|atherosclerosis|atherosclerosis
732281|NCT00114517|cardiac computed tomography|cardiac computed tomography
732282|NCT00114517|cardiovascular disease|cardiovascular disease
732283|NCT00114517|carotid artery intima-media thickness|carotid artery intima-media thickness
732284|NCT00114517|cognitive function|cognitive function
732285|NCT00114517|computed tomography|computed tomography
732286|NCT00114517|coronary artery calcium|coronary artery calcium
732287|NCT00114517|coronary artery disease|coronary artery disease
732288|NCT00114517|coronary artery lesions|coronary artery lesions
732289|NCT00114517|CVD|cvd
732290|NCT00114517|estrogen|estrogen
732291|NCT00114517|estrogen therapy|estrogen therapy
732292|NCT00114517|hormone therapy|hormone therapy
732293|NCT00114517|postmenopausal|postmenopausal
732294|NCT00114517|subclinical vascular disease|subclinical vascular disease
732295|NCT00114517|timing hypothesis|timing hypothesis
732296|NCT00114517|ultrasonography|ultrasonography
732297|NCT00114504|atherosclerosis|atherosclerosis
732298|NCT00114504|inflammation|inflammation
732299|NCT00114504|statins|statins
732300|NCT00114504|PET|pet
732301|NCT00114504|carotid ultrasonography|carotid ultrasonography
732302|NCT00114491|Aortic Stenosis|aortic stenosis
732303|NCT00114491|Statins|statins
732304|NCT00114491|Hypercholesterolemia|hypercholesterolemia
732305|NCT00114478|Bronchiolitis|bronchiolitis
732306|NCT00114478|disposition|disposition
732307|NCT00114478|pediatric|pediatric
732308|NCT00114478|epinephrine|epinephrine
732309|NCT00114478|albuterol|albuterol
732310|NCT00114465|Randomized|randomized
732311|NCT00114465|Double-Blind|double-blind
732312|NCT00114465|Probiotic|probiotic
732313|NCT00114465|Remission|remission
732314|NCT00114465|Crohn's Disease|crohn's disease
732315|NCT00114452|Acute Myocardial Infarction|acute myocardial infarction
732316|NCT00114452|Heart Attack|heart attack
732317|NCT00114452|Cardiovascular Disease|cardiovascular disease
732318|NCT00114452|Stem cells|stem cells
732319|NCT00114452|Congestive Heart Failure|congestive heart failure
732320|NCT00114452|Heart Attack Repair|heart attack repair
732321|NCT00114439|cannabis withdrawal|cannabis withdrawal
732322|NCT00114439|lithium|lithium
732323|NCT00114439|Cannabis withdrawal syndrome|cannabis withdrawal syndrome
732498|NCT00113867|memory|memory
732324|NCT00114426|randomized controlled trial; COPD|randomized controlled trial; copd
732325|NCT00114413|Exhaled Nitric Oxide|exhaled nitric oxide
732326|NCT00114413|Lung|lung
732327|NCT00114413|Urban Health|urban health
732328|NCT00114413|Child|child
732329|NCT00114413|Adolescent|adolescent
732330|NCT00114400|cardiovascular disease|cardiovascular disease
732331|NCT00114400|CVD|cvd
732332|NCT00114387|vitamin E|vitamin e
732333|NCT00114374|Acute Stress Disorder|acute stress disorder
732334|NCT00114374|Posttraumatic Stress Disorder|posttraumatic stress disorder
732335|NCT00114374|Escitalopram|escitalopram
732336|NCT00114374|Double-Blind|double-blind
732337|NCT00114361|HBeAg-negative|hbeag-negative
732338|NCT00114361|chronic|chronic
732339|NCT00114361|hepatitis B|hepatitis b
732340|NCT00114361|viral|viral
732341|NCT00114348|non-B ALL|non-b all
732342|NCT00114348|relapse|relapse
732343|NCT00114348|treatment|treatment
732344|NCT00114348|Relapsed non-B ALL or non-B non-Hodgkin lymphoma|relapsed non-b all or non-b non-hodgkin lymphoma
732345|NCT00114335|low molecular weight heparin|low molecular weight heparin
732346|NCT00114335|unfractionated heparin|unfractionated heparin
732347|NCT00114309|High grade recurrent glioma|high grade recurrent glioma
732348|NCT00114309|Phase II|phase ii
732349|NCT00114309|Multi-Center|multi-center
732350|NCT00114309|Open label|open label
732351|NCT00114309|Multiple dose|multiple dose
732352|NCT00114309|Brain Cancer|brain cancer
732353|NCT00114309|Brain Tumor|brain tumor
732354|NCT00114309|GBM|gbm
732355|NCT00114309|glioma|glioma
732356|NCT00114296|breast cancer|breast cancer
732357|NCT00114270|breast cancer|breast cancer
732358|NCT00114270|osteoporosis|osteoporosis
732359|NCT00114257|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
732360|NCT00114257|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
732361|NCT00114257|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
732362|NCT00114257|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
732363|NCT00114257|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
732364|NCT00114257|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
732365|NCT00114257|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
732366|NCT00114257|secondary acute myeloid leukemia|secondary acute myeloid leukemia
732367|NCT00114257|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
732368|NCT00114257|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
732369|NCT00114257|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
732370|NCT00114257|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
732371|NCT00114257|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
732372|NCT00114257|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
732373|NCT00114257|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
732374|NCT00114257|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
732375|NCT00114257|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
732376|NCT00114257|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
732377|NCT00114257|chronic eosinophilic leukemia|chronic eosinophilic leukemia
732378|NCT00114257|primary myelofibrosis|primary myelofibrosis
732379|NCT00114257|chronic neutrophilic leukemia|chronic neutrophilic leukemia
732380|NCT00114257|essential thrombocythemia|essential thrombocythemia
732381|NCT00114257|polycythemia vera|polycythemia vera
732382|NCT00114257|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
732383|NCT00114257|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
732384|NCT00114257|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
732385|NCT00114257|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
732386|NCT00114257|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
732387|NCT00114257|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
732388|NCT00114257|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
732389|NCT00114257|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
732390|NCT00114257|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
732391|NCT00114257|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
732392|NCT00114257|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
732393|NCT00114257|adult acute basophilic leukemia|adult acute basophilic leukemia
732394|NCT00114257|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
732395|NCT00114231|adenocarcinoma of the rectum|adenocarcinoma of the rectum
732396|NCT00114231|stage I rectal cancer|stage i rectal cancer
732397|NCT00114205|malignant pleural effusion|malignant pleural effusion
732398|NCT00114192|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
732399|NCT00114192|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
732400|NCT00114192|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
732495|NCT00113867|in vitro fertilization|in vitro fertilization
732401|NCT00114192|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
732402|NCT00114166|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
732403|NCT00114166|fallopian tube cancer|fallopian tube cancer
732404|NCT00114166|primary peritoneal cavity cancer|primary peritoneal cavity cancer
732405|NCT00114153|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
732406|NCT00114153|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
732407|NCT00114153|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
732408|NCT00114153|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
732409|NCT00114153|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
732410|NCT00114153|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
732411|NCT00114140|adult diffuse astrocytoma|adult diffuse astrocytoma
732412|NCT00114140|adult oligodendroglioma|adult oligodendroglioma
732413|NCT00114140|adult mixed glioma|adult mixed glioma
732414|NCT00114127|social anxiety disorder|social anxiety disorder
732415|NCT00114127|social phobia|social phobia
732416|NCT00114127|duloxetine|duloxetine
732417|NCT00114127|serotonin norepinephrine reuptake inhibitor|serotonin norepinephrine reuptake inhibitor
732418|NCT00114127|SNRI|snri
732419|NCT00114127|double blind|double blind
732420|NCT00114114|Testosterone|testosterone
732421|NCT00114114|Bone turnover|bone turnover
732422|NCT00114114|Aging|aging
732423|NCT00114114|Body composition|body composition
732424|NCT00114114|Hypogonadism|hypogonadism
732425|NCT00114114|Sexual function|sexual function
732426|NCT00114088|Hysterectomy,|hysterectomy,
732427|NCT00114088|Endometrial ablation,|endometrial ablation,
732428|NCT00114088|Ovulatory dysfunctional uterine bleeding,|ovulatory dysfunctional uterine bleeding,
732429|NCT00114088|Anovulatory dysfucntional uterine bleeding,|anovulatory dysfucntional uterine bleeding,
732430|NCT00114088|DUB|dub
732431|NCT00114088|Dysfunctional uterine bleeding|dysfunctional uterine bleeding
732432|NCT00114075|gait|gait
732433|NCT00114075|walking|walking
732434|NCT00114075|orthopedic surgery|orthopedic surgery
732435|NCT00114075|orthopaedic surgery|orthopaedic surgery
732436|NCT00114062|uveitis|uveitis
732437|NCT00114062|macular edema|macular edema
732438|NCT00114062|uveitis associated macular edema|uveitis associated macular edema
732439|NCT00114049|Dental Pain|dental pain
732440|NCT00114049|Dental Surgery|dental surgery
732441|NCT00114049|Cox-2 inhibitor|cox-2 inhibitor
732442|NCT00114036|Antibiotic prophylaxis|antibiotic prophylaxis
732443|NCT00114036|Surgical wound infections|surgical wound infections
732444|NCT00114023|AK|ak
732445|NCT00114023|Imiquimod 5% cream|imiquimod 5% cream
732446|NCT00114023|3M Pharmaceuticals|3m pharmaceuticals
732447|NCT00114023|Aldara|aldara
732448|NCT00114023|Actinic Keratosis|actinic keratosis
732449|NCT00114010|B Cells|b cells
732450|NCT00114010|T Cells|t cells
732451|NCT00114010|Erythrocyte Stage|erythrocyte stage
732452|NCT00114010|Antibody|antibody
732453|NCT00114010|Immunogenicity|immunogenicity
732454|NCT00114010|Healthy Volunteer|healthy volunteer
732455|NCT00113997|Anticoagulant|anticoagulant
732456|NCT00113997|Antidote|antidote
732457|NCT00113997|Pharmacokinetics|pharmacokinetics
732458|NCT00113997|Pharmacodynamics|pharmacodynamics
732459|NCT00113997|Healthy Volunteer|healthy volunteer
732460|NCT00113997|HV|hv
732461|NCT00113984|Monoclonal Antibody|monoclonal antibody
732462|NCT00113984|Vaccine|vaccine
732463|NCT00113984|Cytokines|cytokines
732464|NCT00113984|Immunotherapy|immunotherapy
732465|NCT00113984|Elispot Assay|elispot assay
732466|NCT00113984|Prostate Cancer|prostate cancer
732467|NCT00113984|Metastatic Prostate Cancer|metastatic prostate cancer
732468|NCT00113971|study of epratuzumab in systemic lupus erythematosus|study of epratuzumab in systemic lupus erythematosus
732469|NCT00113971|systemic lupus erythematosus|systemic lupus erythematosus
732470|NCT00113971|SLE|sle
732471|NCT00113958|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
732472|NCT00113958|secondary hyperparathyroidism (SHPT)|secondary hyperparathyroidism (shpt)
732473|NCT00113958|hemodialysis|hemodialysis
732474|NCT00113958|biPTH|bipth
732475|NCT00113958|AMG 073, Amgen|amg 073, amgen
732476|NCT00113945|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
732477|NCT00113945|secondary hyperparathyroidism|secondary hyperparathyroidism
732478|NCT00113945|hemodialysis, biPTH|hemodialysis, bipth
732479|NCT00113945|AMG 073, Amgen|amg 073, amgen
732480|NCT00113932|Myeloma|myeloma
732481|NCT00113919|Myeloma, MM|myeloma, mm
732482|NCT00113906|melatonin,|melatonin,
732483|NCT00113906|fatigue,|fatigue,
732484|NCT00113906|sleep quality,|sleep quality,
732485|NCT00113906|circadian,|circadian,
732486|NCT00113906|postoperative|postoperative
732487|NCT00113906|Postoperative fatigue|postoperative fatigue
732488|NCT00113906|postoperative sleep disturbance|postoperative sleep disturbance
732489|NCT00113906|general wellbeing|general wellbeing
732490|NCT00113893|Myelodysplastic syndromes|myelodysplastic syndromes
732491|NCT00113893|p38 MAP kinase|p38 map kinase
732492|NCT00113893|Bone marrow diseases|bone marrow diseases
732499|NCT00113867|Cognitive Function|cognitive function
732500|NCT00113867|adoption|adoption
732501|NCT00113854|cerebral|cerebral
732502|NCT00113854|malaria|malaria
732503|NCT00113854|children|children
732504|NCT00113854|mannitol|mannitol
732505|NCT00113854|adjunct|adjunct
732506|NCT00113854|therapy|therapy
732507|NCT00113854|Uganda|uganda
732508|NCT00113841|Multiple Myeloma|multiple myeloma
732509|NCT00113841|Diferuloylmethane Derivative|diferuloylmethane derivative
732510|NCT00113841|Curcumin|curcumin
732511|NCT00113841|Bioperine|bioperine
732512|NCT00113828|Non-Myeloablative|non-myeloablative
732513|NCT00113828|Stem Cell Transplantation|stem cell transplantation
732514|NCT00113828|T-cell Depletion|t-cell depletion
732515|NCT00113828|HLA-Matched|hla-matched
732516|NCT00113815|Partial seizure disorder|partial seizure disorder
732517|NCT00113815|Topiramate|topiramate
732518|NCT00113815|Epilepsy|epilepsy
732519|NCT00113815|Infants|infants
732520|NCT00113802|Epratuzumab (hLL2- anti-CD22 humanized antibody)|epratuzumab (hll2- anti-cd22 humanized antibody)
732521|NCT00113802|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
732522|NCT00113802|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
732523|NCT00113802|Hematologic Disease|hematologic disease
732524|NCT00113802|Hematologic Diseases|hematologic diseases
732525|NCT00113802|Paraproteinemias|paraproteinemias
732526|NCT00113802|Vascular Hemostatic Disorders|vascular hemostatic disorders
732527|NCT00113802|Lymphoproliferative Disorders|lymphoproliferative disorders
732528|NCT00113789|ovarian cancer|ovarian cancer
732529|NCT00113789|topotecan|topotecan
732530|NCT00113789|neutropenia|neutropenia
732531|NCT00113789|Neulasta®|neulasta®
732532|NCT00113776|Metastatic Colorectal Cancer, Colon|metastatic colorectal cancer, colon
732533|NCT00113776|Colorectal, Rectal Cancer, EGFr|colorectal, rectal cancer, egfr
732534|NCT00113776|Metastatic, Cancer, ABX-EGF|metastatic, cancer, abx-egf
732535|NCT00113776|Panitumumab, Clinical Trial|panitumumab, clinical trial
732536|NCT00113776|Immunex, Abgenix, Amgen|immunex, abgenix, amgen
732537|NCT00113763|Metastatic Colorectal Cancer, Colon|metastatic colorectal cancer, colon
732538|NCT00113763|Colorectal, Rectal Cancer, Cancer|colorectal, rectal cancer, cancer
732539|NCT00113763|Metastatic, EGFr, Clinical Trial|metastatic, egfr, clinical trial
732540|NCT00113763|Panitumumab, ABX-EGF|panitumumab, abx-egf
732541|NCT00113763|Immunex, Abgenix, Amgen|immunex, abgenix, amgen
732542|NCT00113750|Allergy|allergy
732543|NCT00113750|Allergoid|allergoid
732544|NCT00113750|Specific Immunotherapy|specific immunotherapy
732545|NCT00113724|taxane|taxane
732546|NCT00113724|multi-drug resistance|multi-drug resistance
732547|NCT00113724|mutant tubulin binding|mutant tubulin binding
732548|NCT00113724|Advanced malignancies|advanced malignancies
732549|NCT00113724|Hodgkin's or Non-Hodgkin's Lymphoma|hodgkin's or non-hodgkin's lymphoma
732550|NCT00113659|Asthma|asthma
732551|NCT00113659|Probiotics|probiotics
732552|NCT00113659|Prevention|prevention
732553|NCT00113659|Eczema|eczema
732554|NCT00113646|Non-Myeloablative|non-myeloablative
732555|NCT00113646|T-cell Depleted|t-cell depleted
732556|NCT00113646|Mismatched|mismatched
732557|NCT00113646|Stem Cell Transplantation|stem cell transplantation
732558|NCT00113633|Asthma|asthma
732559|NCT00113633|Emergency|emergency
732560|NCT00113633|Primary Care|primary care
732561|NCT00113633|Children|children
732562|NCT00113620|distal symmetrical|distal symmetrical
732563|NCT00113620|pain|pain
732564|NCT00113620|lower extremities|lower extremities
732565|NCT00113620|dextromethorphan|dextromethorphan
732566|NCT00113607|Ovarian cancer|ovarian cancer
732567|NCT00113607|Trabectedin|trabectedin
732568|NCT00113607|Yondelis|yondelis
732569|NCT00113607|Advanced Relapsed Ovarian Cancer|advanced relapsed ovarian cancer
732570|NCT00113607|DOXIL|doxil
732571|NCT00113607|CAELYX|caelyx
732572|NCT00113581|EMD 72000|emd 72000
732573|NCT00113581|matuzumab|matuzumab
732574|NCT00113581|Esophageal adenocarcinoma|esophageal adenocarcinoma
732575|NCT00113581|Gastric adenocarcinoma|gastric adenocarcinoma
732576|NCT00113568|Menorrhagia|menorrhagia
732577|NCT00113568|Heavy Menstrual Bleeding|heavy menstrual bleeding
732578|NCT00113555|urinary incontinence|urinary incontinence
732579|NCT00113542|Psoriasis|psoriasis
732580|NCT00113542|Tetrathiomolybdate|tetrathiomolybdate
732581|NCT00113516|Lung Neoplasms|lung neoplasms
732582|NCT00113503|Inflammatory Bowel Disease, Crohn's disease, Crohn's Colitis|inflammatory bowel disease, crohn's disease, crohn's colitis
732583|NCT00113490|motavizumab, palivizumab, synagis|motavizumab, palivizumab, synagis
732584|NCT00113490|Rezield, MEDI-524|rezield, medi-524
732585|NCT00113477|Q10|q10
732586|NCT00113477|CoQ10|coq10
732587|NCT00113477|Coenzyme Q10|coenzyme q10
732588|NCT00113477|selen|selen
732589|NCT00113477|selenoprotein|selenoprotein
732590|NCT00113477|selenoproteins|selenoproteins
732591|NCT00113477|adverse events|adverse events
732592|NCT00113477|adverse effects|adverse effects
732593|NCT00113477|AE|ae
732594|NCT00113477|myalgia|myalgia
732595|NCT00113477|muscle|muscle
732596|NCT00113477|statin therapy|statin therapy
732597|NCT00113477|Indication for statin therapy|indication for statin therapy
732598|NCT00113464|SCID (Severe Combined Immunodeficiency)|scid (severe combined immunodeficiency)
732599|NCT00113464|TREC (T cell Receptor Excision Circle)|trec (t cell receptor excision circle)
732600|NCT00113464|Bone Marrow Transplant|bone marrow transplant
732601|NCT00113464|Dried Blood Spots|dried blood spots
732602|NCT00113464|Early Detection|early detection
732603|NCT00113464|T Cell Immunodeficiency Diseases|t cell immunodeficiency diseases
732604|NCT00113464|Immunodeficiency Diseases|immunodeficiency diseases
732605|NCT00113464|Primary Immunodeficiency|primary immunodeficiency
732606|NCT00113464|T Cell Immunodeficiency Disease|t cell immunodeficiency disease
732607|NCT00113464|Severe Combined Immunodeficiency|severe combined immunodeficiency
732608|NCT00113464|SCID|scid
732609|NCT00113451|radial artery|radial artery
732610|NCT00113451|angina pectoris|angina pectoris
732611|NCT00113451|infarction|infarction
732612|NCT00113451|bypass|bypass
732613|NCT00113451|angiography|angiography
732614|NCT00113438|cancer|cancer
732615|NCT00113438|tumor|tumor
732616|NCT00113438|imageable|imageable
732617|NCT00113438|CA4P|ca4p
732618|NCT00113438|Combretastatin|combretastatin
732619|NCT00113438|Combretastatin A4 Phosphate|combretastatin a4 phosphate
732620|NCT00113438|Combretastatin A-4 Phosphate|combretastatin a-4 phosphate
732621|NCT00113438|Carboplatin|carboplatin
732622|NCT00113438|Paclitaxel|paclitaxel
732623|NCT00113438|carbo|carbo
732624|NCT00113438|taxol|taxol
732625|NCT00113425|non-ablative laser|non-ablative laser
732626|NCT00113425|acne|acne
732627|NCT00113425|photosensitizer|photosensitizer
732628|NCT00113425|photodynamic therapy|photodynamic therapy
732629|NCT00113412|HIV|hiv
732630|NCT00113412|Treatment Experienced|treatment experienced
732631|NCT00113399|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
732632|NCT00113399|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
732633|NCT00113399|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
732634|NCT00113399|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
732635|NCT00113399|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
732636|NCT00113399|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
732637|NCT00113386|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
732638|NCT00113386|adenocarcinoma of the lung|adenocarcinoma of the lung
732639|NCT00113386|large cell lung cancer|large cell lung cancer
732640|NCT00113386|squamous cell lung cancer|squamous cell lung cancer
732641|NCT00113386|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
732642|NCT00113360|Neuroendocrine Carcinoma|neuroendocrine carcinoma
732643|NCT00113360|Low Grade Neuroendocrine Carcinoma|low grade neuroendocrine carcinoma
732644|NCT00113360|Neuroendocrine Carcinoid|neuroendocrine carcinoid
732645|NCT00113360|Islet Cell Carcinoma|islet cell carcinoma
732646|NCT00113360|RAD001|rad001
732647|NCT00113360|Everolimus|everolimus
732648|NCT00113360|Octreotide Depot|octreotide depot
732649|NCT00113360|Sandostatin LAR|sandostatin lar
732650|NCT00113360|Octreotide long-acting release (LAR)|octreotide long-acting release (lar)
732651|NCT00113360|Octreotide LAR|octreotide lar
732652|NCT00113347|Head and Neck Cancer|head and neck cancer
732653|NCT00113347|Squamous Cell Carcinoma|squamous cell carcinoma
732654|NCT00113347|Erlotinib|erlotinib
732655|NCT00113347|Docetaxel|docetaxel
732656|NCT00113347|Radiation|radiation
732657|NCT00113347|Radiotherapy|radiotherapy
732658|NCT00113347|Concomitant Boost Radiation|concomitant boost radiation
732659|NCT00113334|Head and Neck Cancer|head and neck cancer
732660|NCT00113334|Thrombospondin Analogue|thrombospondin analogue
732661|NCT00113334|ABT-510|abt-510
732662|NCT00113334|Antiangiogenic agent|antiangiogenic agent
732663|NCT00113334|Lung|lung
732664|NCT00113334|Skin|skin
732665|NCT00113334|Thyroid|thyroid
732666|NCT00113321|Myelodysplastic Syndrome|myelodysplastic syndrome
732667|NCT00113321|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
732668|NCT00113321|Azacytidine Failure|azacytidine failure
732669|NCT00113321|Decitabine|decitabine
732670|NCT00113308|Rheumatoid Arthritis|rheumatoid arthritis
732671|NCT00113308|COX-2 Inhibitor|cox-2 inhibitor
732672|NCT00113295|generalized anxiety disorder|generalized anxiety disorder
732673|NCT00113295|pharmacotherapy|pharmacotherapy
732674|NCT00113295|treatment refractory|treatment refractory
732675|NCT00113295|double-blind|double-blind
732676|NCT00113282|Treatment failure|treatment failure
732677|NCT00113282|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
732678|NCT00113282|Interleukin-2|interleukin-2
732679|NCT00113282|Treatment Experienced|treatment experienced
732680|NCT00113269|Treatment Effectiveness|treatment effectiveness
732681|NCT00113269|Treatment Efficacy|treatment efficacy
732682|NCT00113269|Anti-rejection therapy|anti-rejection therapy
732683|NCT00113269|Immunosuppression|immunosuppression
732684|NCT00113269|Therapy, antirejection|therapy, antirejection
732685|NCT00113269|Renal Transplantation|renal transplantation
732686|NCT00113269|Transplantation, Kidney|transplantation, kidney
732687|NCT00113269|Transplantation, Renal|transplantation, renal
733114|NCT00111618|efficacy|efficacy
732688|NCT00113269|Grafting, Kidney|grafting, kidney
732689|NCT00113256|rubitecan|rubitecan
732690|NCT00113256|Orathecin|orathecin
732691|NCT00113256|9-nitrocamptothecin|9-nitrocamptothecin
732692|NCT00113256|gemcitabine|gemcitabine
732693|NCT00113256|Gemzar|gemzar
732694|NCT00113256|pancreatic cancer|pancreatic cancer
732695|NCT00113256|adenocarcinoma|adenocarcinoma
732696|NCT00113256|RFS 2000|rfs 2000
732697|NCT00113230|Rectal Cancer|rectal cancer
732698|NCT00113230|Bevacizumab|bevacizumab
732699|NCT00113230|RHUMAB VEGF|rhumab vegf
732700|NCT00113230|Avastin|avastin
732701|NCT00113230|Capecitabine|capecitabine
732702|NCT00113230|Neoadjuvant Concurrent Capecitabine|neoadjuvant concurrent capecitabine
732703|NCT00113230|Xeloda|xeloda
732704|NCT00113230|Radiation|radiation
732705|NCT00113230|Radiotherapy|radiotherapy
732706|NCT00113230|Radiation Therapy|radiation therapy
732707|NCT00113230|XRT|xrt
732708|NCT00113217|Renal Cell Carcinoma|renal cell carcinoma
732709|NCT00113217|Kidney Cancer|kidney cancer
732710|NCT00113217|Bevacizumab|bevacizumab
732711|NCT00113217|Avastin|avastin
732712|NCT00113217|RCC|rcc
732713|NCT00113204|Multiple myeloma|multiple myeloma
732714|NCT00113204|Relapsed|relapsed
732715|NCT00113204|Relapsed refractory|relapsed refractory
732716|NCT00113204|Hematologic cancer|hematologic cancer
732717|NCT00113204|hematologic disease|hematologic disease
732718|NCT00113204|plasma cells|plasma cells
732719|NCT00113191|late onset sepsis|late onset sepsis
732720|NCT00113191|premature infants|premature infants
732721|NCT00113191|staphylococcus|staphylococcus
732722|NCT00113191|candida|candida
732723|NCT00113191|prevention|prevention
732724|NCT00113178|atrial flutter|atrial flutter
732725|NCT00113178|cryoablation|cryoablation
732726|NCT00113165|partial seizures|partial seizures
732727|NCT00113165|Epilepsy|epilepsy
732728|NCT00113165|antiepileptic drugs|antiepileptic drugs
732729|NCT00113165|anticonvulsants|anticonvulsants
732730|NCT00113165|LAMICTAL|lamictal
732731|NCT00113165|seizures|seizures
732732|NCT00113165|lamotrigine|lamotrigine
732733|NCT00113152|Cardiac Arrhythmias|cardiac arrhythmias
732734|NCT00113152|Diastolic Dysfunction|diastolic dysfunction
732735|NCT00113152|Pulmonary Hypertension|pulmonary hypertension
732736|NCT00113152|Sickle Cell Anemia|sickle cell anemia
732737|NCT00113152|Sudden Death|sudden death
732738|NCT00113152|Thalassemia|thalassemia
732739|NCT00113126|Scheduled treatment interruptions|scheduled treatment interruptions
732740|NCT00113126|STI|sti
732741|NCT00113113|rubitecan|rubitecan
732742|NCT00113113|Orathecin|orathecin
732743|NCT00113113|9-nitrocamptothecin|9-nitrocamptothecin
732744|NCT00113113|solid tumors|solid tumors
732745|NCT00113113|organ dysfunction|organ dysfunction
732746|NCT00113113|renal dysfunction|renal dysfunction
732747|NCT00113113|hepatic dysfunction|hepatic dysfunction
732748|NCT00113113|RFS 2000|rfs 2000
732749|NCT00113100|skin|skin
732750|NCT00113100|estrogen|estrogen
732751|NCT00113100|sun damage|sun damage
732752|NCT00113100|Photodamaged Skin|photodamaged skin
732753|NCT00113061|Coronary Heart Disease Risk Reduction|coronary heart disease risk reduction
732754|NCT00113048|CD52 Expressing Hematologic Malignancies|cd52 expressing hematologic malignancies
732755|NCT00113035|Glycogen Storage Disease Type II|glycogen storage disease type ii
732756|NCT00113035|GSD-II|gsd-ii
732757|NCT00113035|Pompe Disease|pompe disease
732758|NCT00113035|Pompe Disease (Late-Onset)|pompe disease (late-onset)
732759|NCT00113035|Glycogen Storage Disease Type II (GSD-II)|glycogen storage disease type ii (gsd-ii)
732760|NCT00113035|Acid Maltase Deficiency|acid maltase deficiency
732761|NCT00113035|Glycogenosis 2|glycogenosis 2
732762|NCT00113022|Depression|depression
732763|NCT00113022|Glutamate|glutamate
732764|NCT00113022|Ampakine|ampakine
732765|NCT00113022|Treatment|treatment
732766|NCT00113022|Memory|memory
732767|NCT00113022|Major Depressive Disorder|major depressive disorder
732768|NCT00113022|AMPA Receptor Activation|ampa receptor activation
732769|NCT00113022|BDNF|bdnf
732770|NCT00113009|Peripheral arterial disease|peripheral arterial disease
732771|NCT00112996|neurotoxicity|neurotoxicity
732772|NCT00112996|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
732773|NCT00112996|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
732774|NCT00112983|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
732775|NCT00112983|adult acute myeloid leukemia|adult acute myeloid leukemia
732776|NCT00112957|fallopian tube cancer|fallopian tube cancer
732777|NCT00112957|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
732778|NCT00112957|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
732779|NCT00112957|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
732780|NCT00112957|peritoneal cavity cancer|peritoneal cavity cancer
732781|NCT00112931|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
732782|NCT00112931|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
732783|NCT00112931|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
732784|NCT00112931|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
732785|NCT00112931|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
732786|NCT00112931|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
732787|NCT00112931|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
732788|NCT00112931|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
732789|NCT00112931|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
732790|NCT00112931|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
732791|NCT00112931|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
732792|NCT00112931|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
732793|NCT00112918|stage II colon cancer|stage ii colon cancer
732794|NCT00112918|stage III colon cancer|stage iii colon cancer
732795|NCT00112892|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
732796|NCT00112775|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
732797|NCT00112775|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
732798|NCT00112775|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
732799|NCT00112749|stage I breast cancer|stage i breast cancer
732800|NCT00112749|stage II breast cancer|stage ii breast cancer
732801|NCT00112749|breast cancer in situ|breast cancer in situ
732802|NCT00112749|fatigue|fatigue
732803|NCT00112710|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
732804|NCT00112710|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
732805|NCT00112697|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
732806|NCT00112697|stage IV pancreatic cancer|stage iv pancreatic cancer
732807|NCT00112658|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
732808|NCT00112658|stage IV pancreatic cancer|stage iv pancreatic cancer
732809|NCT00112645|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
732810|NCT00112645|recurrent neuroblastoma|recurrent neuroblastoma
732811|NCT00112645|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
732812|NCT00112645|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
732813|NCT00112632|gastrointestinal stromal tumor|gastrointestinal stromal tumor
732814|NCT00112619|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
732815|NCT00112619|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
732816|NCT00112619|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
732817|NCT00112619|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
732818|NCT00112619|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
732819|NCT00112619|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
732820|NCT00112619|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
732821|NCT00112619|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
732822|NCT00112619|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
732823|NCT00112619|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
732824|NCT00112619|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
732825|NCT00112619|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
732826|NCT00112619|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
732827|NCT00112619|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
732828|NCT00112619|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
732829|NCT00112619|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
732830|NCT00112619|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
732831|NCT00112619|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
732832|NCT00112619|childhood grade I meningioma|childhood grade i meningioma
732833|NCT00112619|childhood grade II meningioma|childhood grade ii meningioma
732834|NCT00112619|childhood grade III meningioma|childhood grade iii meningioma
732835|NCT00112619|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
732836|NCT00112619|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
732837|NCT00112619|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
732838|NCT00112619|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
732839|NCT00112619|childhood choroid plexus tumor|childhood choroid plexus tumor
732840|NCT00112619|childhood craniopharyngioma|childhood craniopharyngioma
732841|NCT00112619|childhood infratentorial ependymoma|childhood infratentorial ependymoma
732842|NCT00112619|childhood supratentorial ependymoma|childhood supratentorial ependymoma
732843|NCT00112619|recurrent childhood ependymoma|recurrent childhood ependymoma
732844|NCT00112619|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
732845|NCT00112619|childhood oligodendroglioma|childhood oligodendroglioma
732846|NCT00112619|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
732847|NCT00112619|leptomeningeal metastases|leptomeningeal metastases
732848|NCT00112619|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
732849|NCT00112619|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
733116|NCT00111605|AIDS Vaccines|aids vaccines
732850|NCT00112619|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
732851|NCT00112619|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
732852|NCT00112619|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
732853|NCT00112619|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
732854|NCT00112619|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
732855|NCT00112619|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
732856|NCT00112619|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
732857|NCT00112619|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
732858|NCT00112619|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
732859|NCT00112619|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
732860|NCT00112619|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
732861|NCT00112619|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
732862|NCT00112619|meningeal leukemia|meningeal leukemia
732863|NCT00112619|secondary central nervous system Hodgkin lymphoma|secondary central nervous system hodgkin lymphoma
732864|NCT00112619|secondary central nervous system non-Hodgkin lymphoma|secondary central nervous system non-hodgkin lymphoma
732865|NCT00112593|HIV|hiv
732866|NCT00112593|Lymphoma|lymphoma
732867|NCT00112593|Leukemia|leukemia
732868|NCT00112580|recurrent pancreatic cancer|recurrent pancreatic cancer
732869|NCT00112580|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
732870|NCT00112580|stage IV pancreatic cancer|stage iv pancreatic cancer
732871|NCT00112567|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
732872|NCT00112567|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
732873|NCT00112567|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
732874|NCT00112567|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
732875|NCT00112567|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
732876|NCT00112567|secondary acute myeloid leukemia|secondary acute myeloid leukemia
732877|NCT00112567|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
732878|NCT00112567|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
732879|NCT00112567|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
732880|NCT00112567|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
732881|NCT00112567|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
732882|NCT00112567|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
732883|NCT00112567|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
732884|NCT00112554|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
732885|NCT00112554|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
732886|NCT00112554|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
732887|NCT00112554|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
732888|NCT00112554|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
732889|NCT00112554|adult acute basophilic leukemia|adult acute basophilic leukemia
732890|NCT00112554|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
732891|NCT00112554|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
732892|NCT00112554|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
732893|NCT00112554|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
732894|NCT00112554|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
732895|NCT00112554|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
732896|NCT00112554|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
732897|NCT00112554|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
732898|NCT00112554|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
732899|NCT00112554|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
732900|NCT00112528|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
732901|NCT00112528|recurrent pancreatic cancer|recurrent pancreatic cancer
732902|NCT00112528|stage IV pancreatic cancer|stage iv pancreatic cancer
732903|NCT00112515|depression|depression
732904|NCT00112515|cognitive/functional effects|cognitive/functional effects
732905|NCT00112515|fatigue|fatigue
732906|NCT00112515|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
732907|NCT00112502|adult giant cell glioblastoma|adult giant cell glioblastoma
732908|NCT00112502|adult gliosarcoma|adult gliosarcoma
732909|NCT00112502|adult glioblastoma|adult glioblastoma
732910|NCT00112489|recurrent uterine sarcoma|recurrent uterine sarcoma
732911|NCT00112489|stage III uterine sarcoma|stage iii uterine sarcoma
732912|NCT00112489|stage IV uterine sarcoma|stage iv uterine sarcoma
732913|NCT00112489|uterine carcinosarcoma|uterine carcinosarcoma
732914|NCT00112424|Superior cavo-pulmonary anastomosis|superior cavo-pulmonary anastomosis
732915|NCT00112424|Glenn operation|glenn operation
732916|NCT00112424|Congenital heart defects|congenital heart defects
733117|NCT00111605|HIV Vaccines|hiv vaccines
732917|NCT00112424|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
732918|NCT00112398|Head injuries|head injuries
732919|NCT00112398|Prehospital|prehospital
732920|NCT00112398|Advanced Interventions|advanced interventions
732921|NCT00112385|dermatomyositis|dermatomyositis
732922|NCT00112385|etanercept|etanercept
732923|NCT00112385|tumor necrosis factor alpha|tumor necrosis factor alpha
732924|NCT00112372|unresectable|unresectable
732925|NCT00112372|metastatic|metastatic
732926|NCT00112372|cancer|cancer
732927|NCT00112372|recurrent|recurrent
732928|NCT00112372|malignancies|malignancies
732929|NCT00112372|progressive|progressive
732930|NCT00112359|Cystic Fibrosis|cystic fibrosis
732931|NCT00112359|Pseudomonas aeruginosa|pseudomonas aeruginosa
732932|NCT00112359|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
732933|NCT00112346|Non-Small Lung Cancer|non-small lung cancer
732934|NCT00112333|Dyspepsia, fMRI|dyspepsia, fmri
732935|NCT00112320|Pulmonary Valve Regurgitation|pulmonary valve regurgitation
732936|NCT00112320|Right Ventricular Dysfunction|right ventricular dysfunction
732937|NCT00112320|Heart Diseases|heart diseases
732938|NCT00112307|MRI|mri
732939|NCT00112307|Brachytherapy|brachytherapy
732940|NCT00112307|Carcinoma|carcinoma
732941|NCT00112307|Cervix|cervix
732942|NCT00112307|Uterus|uterus
732943|NCT00112307|Vagina|vagina
732944|NCT00112307|Vulva|vulva
732945|NCT00112307|Carcinoma of the cervix|carcinoma of the cervix
732946|NCT00112307|Carcinoma of the uterus|carcinoma of the uterus
732947|NCT00112307|Carcinoma of the vagina|carcinoma of the vagina
732948|NCT00112307|Carcinoma of the vulva|carcinoma of the vulva
732949|NCT00112294|Non-Small Cell Lung Cancer|non-small cell lung cancer
732950|NCT00112281|"shock, cardiogenic, myocardial infarction"|"shock, cardiogenic, myocardial infarction"
732951|NCT00112268|randomized controlled trial|randomized controlled trial
732952|NCT00112268|primary health care|primary health care
732953|NCT00112268|smoking cessation|smoking cessation
732954|NCT00112255|Chlamydia trachomatis|chlamydia trachomatis
732955|NCT00112255|Chlamydia infections|chlamydia infections
732956|NCT00112255|Randomized controlled trials|randomized controlled trials
732957|NCT00112255|Contact tracing|contact tracing
732958|NCT00112255|Family practice|family practice
732959|NCT00112242|Immunotherapy|immunotherapy
732960|NCT00112242|Vaccination|vaccination
732961|NCT00112242|Melanoma|melanoma
732962|NCT00112242|Melan-A/Mart-1 peptide|melan-a/mart-1 peptide
732963|NCT00112242|MAGE-A10 peptide|mage-a10 peptide
732964|NCT00112242|NY-ESO-1 peptide|ny-eso-1 peptide
732965|NCT00112242|Montanide|montanide
732966|NCT00112229|Immunotherapy|immunotherapy
732967|NCT00112229|Vaccination|vaccination
732968|NCT00112229|Melanoma|melanoma
732969|NCT00112229|Melan-A/Mart-1 peptide|melan-a/mart-1 peptide
732970|NCT00112229|Tyrosinase peptide|tyrosinase peptide
732971|NCT00112229|CpG|cpg
732972|NCT00112229|Montanide|montanide
732973|NCT00112216|Immunotherapy|immunotherapy
732974|NCT00112216|Vaccination|vaccination
732975|NCT00112216|Melanoma|melanoma
732976|NCT00112216|Melan-A/Mart-1 peptide|melan-a/mart-1 peptide
732977|NCT00112216|Flu peptide|flu peptide
732978|NCT00112216|Mage-A10 peptide|mage-a10 peptide
732979|NCT00112216|SB AS-2 adjuvant|sb as-2 adjuvant
732980|NCT00112216|Montanide adjuvant|montanide adjuvant
732981|NCT00112203|Abdominal Symptom Relief|abdominal symptom relief
732982|NCT00112203|Fullness|fullness
732983|NCT00112203|Bloating|bloating
732984|NCT00112203|Indigestion|indigestion
732985|NCT00112203|Functional dyspepsia|functional dyspepsia
732986|NCT00112190|Functional dyspepsia|functional dyspepsia
732987|NCT00112190|Abdominal Symptom relief|abdominal symptom relief
732988|NCT00112190|Fullness|fullness
732989|NCT00112190|Bloating|bloating
732990|NCT00112190|Indigestion|indigestion
732991|NCT00112177|Functional dyspepsia|functional dyspepsia
732992|NCT00112177|Abdominal Symptom relief|abdominal symptom relief
732993|NCT00112177|Fullness|fullness
732994|NCT00112177|Bloating|bloating
732995|NCT00112177|Indigestion|indigestion
732996|NCT00112164|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
732997|NCT00112151|andropause|andropause
732998|NCT00112151|hypogonadism|hypogonadism
732999|NCT00112151|AndroGel|androgel
733000|NCT00112151|exercise|exercise
733001|NCT00112151|PRT|prt
733002|NCT00112151|Testosterone|testosterone
733003|NCT00112151|T supplementation|t supplementation
733004|NCT00112138|gabapentin|gabapentin
733005|NCT00112138|hot flashes or flushes|hot flashes or flushes
733006|NCT00112138|menopause|menopause
733007|NCT00112125|cardiac contractility modulation|cardiac contractility modulation
733008|NCT00112125|heart failure|heart failure
733009|NCT00112125|cardiopulmonary exercise test|cardiopulmonary exercise test
733010|NCT00112125|chronic heart disease|chronic heart disease
733011|NCT00112112|cancer, pediatric, influenza, vaccine|cancer, pediatric, influenza, vaccine
733012|NCT00112099|gastric neoplasm|gastric neoplasm
733013|NCT00112099|gastrectomy|gastrectomy
733014|NCT00112099|splenectomy|splenectomy
733015|NCT00112099|randomized trial|randomized trial
733115|NCT00111618|hormone refractory prostate cancer|hormone refractory prostate cancer
733016|NCT00112099|T2, T3 and T4 carcinoma in the proximal third of the stomach|t2, t3 and t4 carcinoma in the proximal third of the stomach
733017|NCT00112086|ovarian neoplasms|ovarian neoplasms
733018|NCT00112086|laparoscopy|laparoscopy
733019|NCT00112086|neoadjuvant therapy|neoadjuvant therapy
733020|NCT00112086|interval cytoreductive surgery|interval cytoreductive surgery
733021|NCT00112073|Alzheimer's disease|alzheimer's disease
733022|NCT00112073|immunotherapy|immunotherapy
733023|NCT00112073|beta amyloid|beta amyloid
733024|NCT00112060|Talotrexin|talotrexin
733025|NCT00112060|PT-523|pt-523
733026|NCT00112060|Non-Small Cell Lung Carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
733027|NCT00112047|Human Immunodeficiency Virus|human immunodeficiency virus
733028|NCT00112034|Multiple Sclerosis|multiple sclerosis
733029|NCT00112034|Relapsing-Remitting|relapsing-remitting
733030|NCT00112034|AVONEX|avonex
733031|NCT00112034|Combination|combination
733032|NCT00112034|Methotrexate|methotrexate
733033|NCT00112034|IV Methylprednisolone|iv methylprednisolone
733034|NCT00112034|IVMP|ivmp
733035|NCT00112034|ACT|act
733036|NCT00112034|MTX|mtx
733037|NCT00112021|obesity|obesity
733038|NCT00112021|weight loss|weight loss
733039|NCT00112021|Amylin|amylin
733040|NCT00112021|pramlintide|pramlintide
733041|NCT00112021|Symlin|symlin
733042|NCT00112008|Anemia|anemia
733043|NCT00111995|Chronic Renal Failure (CRF)|chronic renal failure (crf)
733044|NCT00111995|Anemia|anemia
733045|NCT00111982|bilateral, idiopathic Parkinson's Disease|bilateral, idiopathic parkinson's disease
733046|NCT00111969|Heart failure|heart failure
733047|NCT00111969|Immune modulation therapy|immune modulation therapy
733048|NCT00111969|Inflammation|inflammation
733049|NCT00111969|Chronic systolic heart failure|chronic systolic heart failure
733050|NCT00111956|TNF|tnf
733051|NCT00111956|metabolic syndrome|metabolic syndrome
733052|NCT00111956|inflammation|inflammation
733053|NCT00111956|CRP|crp
733054|NCT00111956|adiponectin|adiponectin
733055|NCT00111943|Anti-Infective Agents, Local|anti-infective agents, local
733056|NCT00111943|HIV Seronegativity|hiv seronegativity
733057|NCT00111943|Tenofovir|tenofovir
733058|NCT00111943|Vaginal gel|vaginal gel
733059|NCT00111943|Microbicide|microbicide
733060|NCT00111943|Vaginal Microbicide|vaginal microbicide
733061|NCT00111943|PMPA|pmpa
733062|NCT00111930|dehydroepiandrosterone|dehydroepiandrosterone
733063|NCT00111930|DHEAS|dheas
733064|NCT00111930|bone mineral density|bone mineral density
733065|NCT00111930|body composition|body composition
733066|NCT00111930|lean mass|lean mass
733067|NCT00111930|fat mass|fat mass
733068|NCT00111930|bone mass|bone mass
733069|NCT00111930|decreased DHEAS levels|decreased dheas levels
733070|NCT00111917|Chronic Beryllium Disease|chronic beryllium disease
733071|NCT00111917|Berylliosis|berylliosis
733072|NCT00111917|Beryllium Disease|beryllium disease
733073|NCT00111917|CBD|cbd
733074|NCT00111917|Infliximab|infliximab
733075|NCT00111904|stage III pancreatic cancer|stage iii pancreatic cancer
733076|NCT00111904|recurrent pancreatic cancer|recurrent pancreatic cancer
733077|NCT00111904|stage IV pancreatic cancer|stage iv pancreatic cancer
733078|NCT00111878|Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3)|respiratory syncytial virus (rsv) and parainfluenza virus type 3 (piv3)
733079|NCT00111865|physical exercise|physical exercise
733080|NCT00111865|quality of life|quality of life
733081|NCT00111865|lymphoma|lymphoma
733082|NCT00111852|Desmoteplase|desmoteplase
733083|NCT00111852|Acute Ischemic Stroke|acute ischemic stroke
733084|NCT00111852|Stroke, Acute|stroke, acute
733085|NCT00111839|Lung cancer|lung cancer
733086|NCT00111826|Intermittent Claudication|intermittent claudication
733087|NCT00111826|Peripheral Arterial Disease|peripheral arterial disease
733088|NCT00111826|Immune modulation therapy|immune modulation therapy
733089|NCT00111826|Inflammation|inflammation
733090|NCT00111800|NIDDM|niddm
733091|NCT00111787|breast cancer|breast cancer
733092|NCT00111774|Colon Cancer, Rectal Cancer|colon cancer, rectal cancer
733093|NCT00111774|Colorectal Carcinoma, EGFr|colorectal carcinoma, egfr
733094|NCT00111774|Metastatic Cancer, ABX-EGF|metastatic cancer, abx-egf
733095|NCT00111774|Panitumumab, Abgenix|panitumumab, abgenix
733096|NCT00111774|Clinical Trial, Immunex, Amgen|clinical trial, immunex, amgen
733097|NCT00111774|Metastatic Colorectal|metastatic colorectal
733098|NCT00111761|Immunex|immunex
733099|NCT00111761|Panitumumab|panitumumab
733100|NCT00111761|ABX-EGF|abx-egf
733101|NCT00111761|Abgenix|abgenix
733102|NCT00111748|Myeloma|myeloma
733103|NCT00111683|Myelodysplastic Syndrome[Refractory Anemia with|myelodysplastic syndrome[refractory anemia with
733104|NCT00111683|Excess Blasts-1 or 2 (WHO Classification)]|excess blasts-1 or 2 (who classification)]
733105|NCT00111683|Chronic Myelogenous Leukemia in blast crisis|chronic myelogenous leukemia in blast crisis
733106|NCT00111657|Gout|gout
733107|NCT00111657|Tophi|tophi
733108|NCT00111657|Tophaceous gout|tophaceous gout
733109|NCT00111657|Allergy to allopurinol|allergy to allopurinol
733110|NCT00111657|Post-transplant gout|post-transplant gout
733111|NCT00111618|vascular disrupting agent|vascular disrupting agent
733112|NCT00111618|safety|safety
733113|NCT00111618|tolerability|tolerability
733118|NCT00111605|HIV Preventive Vaccine|hiv preventive vaccine
733119|NCT00111605|HIV Seronegativity|hiv seronegativity
733120|NCT00111592|BPH|bph
733121|NCT00111592|benign prostatic hyperplasia|benign prostatic hyperplasia
733122|NCT00111566|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
733123|NCT00111566|Glycoprotein IIb/IIIa blockade|glycoprotein iib/iiia blockade
733124|NCT00111566|Ischemic complications following PCI|ischemic complications following pci
733125|NCT00111553|Leishmaniasis|leishmaniasis
733126|NCT00111553|Subunit vaccine|subunit vaccine
733127|NCT00111553|Therapeutic|therapeutic
733128|NCT00111553|T cell|t cell
733129|NCT00111553|Antimony|antimony
733130|NCT00111540|exenatide|exenatide
733131|NCT00111540|diabetes|diabetes
733132|NCT00111540|Amylin|amylin
733133|NCT00111540|exendin-4|exendin-4
733134|NCT00111527|Heart failure|heart failure
733135|NCT00111527|Atrial fibrillation|atrial fibrillation
733136|NCT00111527|Cardiac resynchronization|cardiac resynchronization
733137|NCT00111527|Cardiac pacing|cardiac pacing
733138|NCT00111527|Catheter ablation|catheter ablation
733139|NCT00111527|Quality of life|quality of life
733140|NCT00111527|Echocardiography|echocardiography
733141|NCT00111514|Leishmaniasis|leishmaniasis
733142|NCT00111514|Subunit vaccine|subunit vaccine
733143|NCT00111514|therapeutic|therapeutic
733144|NCT00111514|T-cell|t-cell
733145|NCT00111514|pentavalent antimony|pentavalent antimony
733146|NCT00111501|smoking|smoking
733147|NCT00111501|tobacco|tobacco
733148|NCT00111488|atrial fibrillation|atrial fibrillation
733149|NCT00111475|Immune Thrombocytopenic Purpura|immune thrombocytopenic purpura
733150|NCT00111475|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
733151|NCT00111475|Thrombocytopenic|thrombocytopenic
733152|NCT00111475|Thrombocytopenia|thrombocytopenia
733153|NCT00111475|ITP|itp
733154|NCT00111462|non-myeloid malignancy|non-myeloid malignancy
733155|NCT00111462|chemotherapy-induced anemia|chemotherapy-induced anemia
733156|NCT00111449|Psoriasis, adults|psoriasis, adults
733157|NCT00111449|skin, Phase 3|skin, phase 3
733158|NCT00111449|clinical trial, Amgen|clinical trial, amgen
733159|NCT00111449|etanercept, Enbrel®|etanercept, enbrel®
733160|NCT00111449|moderate, severe|moderate, severe
733161|NCT00111436|Psoriasis, adults, skin|psoriasis, adults, skin
733162|NCT00111436|Phase 3, clinical trial|phase 3, clinical trial
733163|NCT00111436|Amgen, etanercept|amgen, etanercept
733164|NCT00111436|Enbrel®, moderate|enbrel®, moderate
733165|NCT00111436|severe, extension|severe, extension
733166|NCT00111423|Rheumatoid Arthritis, Inflammation|rheumatoid arthritis, inflammation
733167|NCT00111423|Pegsunercept, PEG sTNF-RI|pegsunercept, peg stnf-ri
733168|NCT00111423|Autoimmune, Amgen|autoimmune, amgen
733169|NCT00111423|Clinical Trials|clinical trials
733170|NCT00111410|Rheumatoid Arthritis, Inflammation|rheumatoid arthritis, inflammation
733171|NCT00111410|Interleukin-1 (IL-1), r-metHuIL-1ra|interleukin-1 (il-1), r-methuil-1ra
733172|NCT00111410|Autoimmune, Kineret®|autoimmune, kineret®
733173|NCT00111410|Anakinra, Immunex|anakinra, immunex
733174|NCT00111410|Amgen, Clinical Trials|amgen, clinical trials
733175|NCT00111397|Mycobacterial|mycobacterial
733176|NCT00111397|Interferon|interferon
733177|NCT00111397|GM-CSF|gm-csf
733178|NCT00111397|Microarray|microarray
733179|NCT00111397|Proteomics|proteomics
733180|NCT00111397|Mycobacterium Avium Complex Infection|mycobacterium avium complex infection
733181|NCT00111397|MAC|mac
733182|NCT00111384|Phenotype|phenotype
733183|NCT00111384|NF1-associated tumors|nf1-associated tumors
733184|NCT00111384|NF1|nf1
733185|NCT00111384|EQTL|eqtl
733186|NCT00111384|Modifier Genes|modifier genes
733187|NCT00111384|Neurofibroma|neurofibroma
733188|NCT00111384|Neurofibromatosis Type 1|neurofibromatosis type 1
733189|NCT00111371|artificial grammar learning|artificial grammar learning
733190|NCT00111371|dyslexia|dyslexia
733191|NCT00111371|healthy subjects|healthy subjects
733192|NCT00111371|levodopa|levodopa
733193|NCT00111371|drug|drug
733194|NCT00111371|treatment|treatment
733195|NCT00111371|intervention|intervention
733196|NCT00111358|HIV, AIDS, metabolic syndrome|hiv, aids, metabolic syndrome
733197|NCT00111345|Acute|acute
733198|NCT00111345|myeloid|myeloid
733199|NCT00111345|leukemia|leukemia
733200|NCT00111345|Acute myeloid leukemia|acute myeloid leukemia
733201|NCT00111319|Front Line|front line
733202|NCT00111319|Multiple Myeloma|multiple myeloma
733203|NCT00111319|Untreated|untreated
733204|NCT00111306|Lupus|lupus
733205|NCT00111306|Antibody|antibody
733206|NCT00111306|B-cell immunotherapy|b-cell immunotherapy
733207|NCT00111293|Attention|attention
733208|NCT00111293|Executive Function|executive function
733209|NCT00111293|Vision|vision
733210|NCT00111293|fMRI|fmri
733211|NCT00111293|Top-Down|top-down
733212|NCT00111293|Visual Processing|visual processing
733213|NCT00111293|Lesion|lesion
733214|NCT00111293|Prefrontal|prefrontal
733215|NCT00111293|Parietal|parietal
733216|NCT00111293|Focal Brain Lesion|focal brain lesion
733217|NCT00111293|Healthy Volunteer|healthy volunteer
733218|NCT00111280|HIV infection|hiv infection
733219|NCT00111280|TMC125|tmc125
733220|NCT00111280|Nucleoside reverse transcriptase inhibitors (NRTIs)|nucleoside reverse transcriptase inhibitors (nrtis)
733221|NCT00111280|roll-over trial|roll-over trial
733222|NCT00111280|antiretrovirals (ARVs)|antiretrovirals (arvs)
733223|NCT00111267|vitamin B12|vitamin b12
733224|NCT00111267|cognitive function|cognitive function
733225|NCT00111267|oral supplementation|oral supplementation
733226|NCT00111267|elderly|elderly
733227|NCT00111254|microdermabrasion|microdermabrasion
733228|NCT00111254|skin|skin
733229|NCT00111254|wrinkles|wrinkles
733230|NCT00111254|collagen|collagen
733231|NCT00111254|photoaging|photoaging
733232|NCT00111254|wrinkled skin|wrinkled skin
733233|NCT00111241|bone fracture|bone fracture
733234|NCT00111241|cartilage|cartilage
733235|NCT00111241|osteoporosis|osteoporosis
733236|NCT00111241|breast cancer|breast cancer
733237|NCT00111241|aromatase inhibitors|aromatase inhibitors
733238|NCT00111241|knee articular cartilage volume|knee articular cartilage volume
733239|NCT00111228|Diabetes|diabetes
733240|NCT00111215|Menorrhagia|menorrhagia
733241|NCT00111215|Von Willebrand's Disease|von willebrand's disease
733242|NCT00111215|Platelet Disorder|platelet disorder
733243|NCT00111202|Genetic counseling|genetic counseling
733244|NCT00111202|Genetic counselling|genetic counselling
733245|NCT00111202|Genetics|genetics
733246|NCT00111202|Schizophrenia|schizophrenia
733247|NCT00111189|Schizophrenia|schizophrenia
733248|NCT00111189|Paliperidone palmitate|paliperidone palmitate
733249|NCT00111189|R092670|r092670
733250|NCT00111189|antipsychotic|antipsychotic
733251|NCT00111189|recurrence prevention|recurrence prevention
733252|NCT00111176|Thoracic Aortic Aneurysm|thoracic aortic aneurysm
733253|NCT00111176|Descending|descending
733254|NCT00111176|minimally invasive|minimally invasive
733255|NCT00111176|endovascular|endovascular
733256|NCT00111176|rupture|rupture
733257|NCT00111176|back pain|back pain
733258|NCT00111176|stent graft|stent graft
733259|NCT00111176|endovascular aneurysm repair|endovascular aneurysm repair
733260|NCT00111176|aortic aneurysm|aortic aneurysm
733261|NCT00111176|thoracic|thoracic
733262|NCT00111163|malaria|malaria
733263|NCT00111163|anemia|anemia
733264|NCT00111163|Plasmodium falciparum|plasmodium falciparum
733265|NCT00111163|infants|infants
733266|NCT00111163|prevention|prevention
733267|NCT00111163|safety|safety
733268|NCT00111163|efficacy|efficacy
733269|NCT00111163|antimalarials|antimalarials
733270|NCT00111150|HIV incidence|hiv incidence
733271|NCT00111150|HIV prevention|hiv prevention
733272|NCT00111137|darbepoetin alfa|darbepoetin alfa
733273|NCT00111137|anemia|anemia
733274|NCT00111137|Amgen|amgen
733275|NCT00111137|Chemotherapy|chemotherapy
733276|NCT00111124|psoriasis|psoriasis
733277|NCT00111124|arthritis|arthritis
733278|NCT00111124|Enbrel®|enbrel®
733279|NCT00111124|etanercept|etanercept
733280|NCT00111111|Psoriasis|psoriasis
733281|NCT00111098|Anemia|anemia
733282|NCT00111098|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
733283|NCT00111085|delayed ischemic neurological deficits (DIND)|delayed ischemic neurological deficits (dind)
733284|NCT00111085|vasospasm|vasospasm
733285|NCT00111085|clazosentan|clazosentan
733286|NCT00111085|cerebral vasospasm|cerebral vasospasm
733287|NCT00111085|computer tomography scan (CT scan)|computer tomography scan (ct scan)
733288|NCT00111085|digital subtraction angiography (DSA)|digital subtraction angiography (dsa)
733289|NCT00111085|endothelin A receptor|endothelin a receptor
733290|NCT00111085|aneurysmal subarachnoid hemorrhage (aSAH)|aneurysmal subarachnoid hemorrhage (asah)
733291|NCT00111059|obesity|obesity
733292|NCT00111059|cardiovascular disease|cardiovascular disease
733293|NCT00111059|depression|depression
733294|NCT00111059|stress|stress
733295|NCT00111046|Pain Relief|pain relief
733296|NCT00111046|Choroidal melanoma|choroidal melanoma
733297|NCT00111046|plaque radiotherapy|plaque radiotherapy
733298|NCT00110981|psoriasis|psoriasis
733299|NCT00110981|dermatology|dermatology
733300|NCT00110981|plaque psoriasis|plaque psoriasis
733301|NCT00110981|skin|skin
733302|NCT00110981|etanercept|etanercept
733303|NCT00110981|ENBREL|enbrel
733304|NCT00110981|NB-UVB, narrow-band UVB, phototherapy|nb-uvb, narrow-band uvb, phototherapy
733305|NCT00110981|combination therapy, 50 mg prefilled syringes|combination therapy, 50 mg prefilled syringes
733306|NCT00110968|Abdominal Symptom relief|abdominal symptom relief
733307|NCT00110968|Fullness|fullness
733308|NCT00110968|Bloating|bloating
733309|NCT00110968|Indigestion|indigestion
733310|NCT00110968|Functional dyspepsia|functional dyspepsia
733311|NCT00110955|Non-myeloid malignancy|non-myeloid malignancy
733312|NCT00110955|Chemotherapy-induced anemia|chemotherapy-induced anemia
733313|NCT00110942|Intra-articular|intra-articular
733314|NCT00110942|Osteoarthritis|osteoarthritis
733315|NCT00110942|OA|oa
733316|NCT00110942|anakinra|anakinra
733317|NCT00110942|Amgen|amgen
733318|NCT00110929|Sensipar®|sensipar®
733319|NCT00110929|Secondary HPT|secondary hpt
733320|NCT00110929|Mimpara®|mimpara®
733321|NCT00110929|Cinacalcet|cinacalcet
733322|NCT00110929|calcimimetic|calcimimetic
733323|NCT00110929|End-Stage Renal Disease (ESRD)|end-stage renal disease (esrd)
733324|NCT00110916|Intra-articular|intra-articular
733325|NCT00110916|Osteoarthritis|osteoarthritis
733326|NCT00110916|OA|oa
733327|NCT00110916|anakinra|anakinra
733328|NCT00110916|Amgen|amgen
733329|NCT00110903|Rheumatoid arthritis|rheumatoid arthritis
733330|NCT00110903|RA|ra
733331|NCT00110903|etanercept|etanercept
733332|NCT00110903|Immunex|immunex
733333|NCT00110903|Amgen|amgen
733334|NCT00110890|Secondary HyperParaThyroidism (SHPT)|secondary hyperparathyroidism (shpt)
733335|NCT00110890|Dialysis, End Stage Renal Disease (ESRD)|dialysis, end stage renal disease (esrd)
733336|NCT00110890|KDOQI, Cinacalcet|kdoqi, cinacalcet
733337|NCT00110890|Clinical Trial, Amgen|clinical trial, amgen
733338|NCT00111072|Mucosal Disease|mucosal disease
733339|NCT00111072|Topical Steroids|topical steroids
733340|NCT00111072|Salivary Diagnostics|salivary diagnostics
733341|NCT00111072|Oral Pain|oral pain
733342|NCT00111072|Quality of Life Indicators|quality of life indicators
733343|NCT00111072|Oral Lichen Planus|oral lichen planus
733344|NCT00110877|Human Immunodeficiency Virus|human immunodeficiency virus
733345|NCT00110877|Treatment Experienced|treatment experienced
733346|NCT00110877|TMC114-C214|tmc114-c214
733347|NCT00110864|diabetes, type 2|diabetes, type 2
733348|NCT00110851|diabetes, type 2|diabetes, type 2
733349|NCT00110838|fish oil|fish oil
733350|NCT00110838|n-3 fatty acids|n-3 fatty acids
733351|NCT00110838|n-3 PUFA|n-3 pufa
733352|NCT00110838|omega-3 fatty acids|omega-3 fatty acids
733353|NCT00110838|arrhythmia|arrhythmia
733354|NCT00110838|ICD|icd
733355|NCT00110838|human|human
733356|NCT00110838|Patients with an implantable cardioverter defibrillator|patients with an implantable cardioverter defibrillator
733357|NCT00110812|Treatment Naive|treatment naive
733358|NCT00110812|IL-2|il-2
733359|NCT00110812|rIL-2|ril-2
733360|NCT00110799|thrombopoietin|thrombopoietin
733361|NCT00110799|platelets|platelets
733362|NCT00110799|Hepatitis C-related thrombocytopenia|hepatitis c-related thrombocytopenia
733363|NCT00110799|Hepatitis C|hepatitis c
733364|NCT00110786|Allergy|allergy
733365|NCT00110786|Specific Immunotherapy|specific immunotherapy
733366|NCT00110786|Ragweed|ragweed
733367|NCT00110786|Environmental Exposure Chamber|environmental exposure chamber
733368|NCT00110721|colorectal cancer|colorectal cancer
733369|NCT00110721|DAVANAT|davanat
733370|NCT00110721|5-fluorouracil|5-fluorouracil
733371|NCT00110708|autism|autism
733372|NCT00110708|gastrointestinal dysfunction|gastrointestinal dysfunction
733373|NCT00110708|autistic disorder|autistic disorder
733374|NCT00110708|diarrhea|diarrhea
733375|NCT00110708|constipation|constipation
733376|NCT00110708|abdominal pain|abdominal pain
733377|NCT00110708|gastrointestinal problems associated with autism|gastrointestinal problems associated with autism
733378|NCT00110708|immune globulin|immune globulin
733379|NCT00110708|immunoglobulin|immunoglobulin
733380|NCT00110708|Immunoglobulins, Intravenous|immunoglobulins, intravenous
733381|NCT00110708|Intestinal Mucosa/immunology/pathology|intestinal mucosa/immunology/pathology
733382|NCT00110708|Administration, Oral|administration, oral
733383|NCT00110708|Autistic Disorder/*drug therapy|autistic disorder/*drug therapy
733384|NCT00110708|Child Behavior/*drug effects|child behavior/*drug effects
733385|NCT00110708|Constipation/drug therapy|constipation/drug therapy
733386|NCT00110708|Diarrhea/drug therapy|diarrhea/drug therapy
733387|NCT00110708|Gastrointestinal Agents/*therapeutic use|gastrointestinal agents/*therapeutic use
733388|NCT00110695|NSABP|nsabp
733389|NCT00110695|Abraxis|abraxis
733390|NCT00110695|Abraxane|abraxane
733391|NCT00110695|Locally advanced breast cancer|locally advanced breast cancer
733392|NCT00110695|Fluorouracil|fluorouracil
733393|NCT00110695|Epirubicin|epirubicin
733394|NCT00110695|Cyclophosphamide|cyclophosphamide
733395|NCT00110695|FEC|fec
733396|NCT00110682|Actinic Keratosis|actinic keratosis
733397|NCT00110682|Cryotherapy|cryotherapy
733398|NCT00110682|Imiquimod|imiquimod
733399|NCT00110669|Muscular dystrophy, Duchenne and Beckers|muscular dystrophy, duchenne and beckers
733400|NCT00110669|Beckers Muscular dystrophy|beckers muscular dystrophy
733401|NCT00110656|Kidney transplant|kidney transplant
733402|NCT00110643|Acne|acne
733403|NCT00110643|laser|laser
733404|NCT00110630|nicotine dependence|nicotine dependence
733405|NCT00110617|Sickle Cell Disease|sickle cell disease
733406|NCT00110617|Iron Overload from Repeated Blood Transfusions|iron overload from repeated blood transfusions
733407|NCT00110617|Iron Overload|iron overload
733408|NCT00110617|Blood Transfusions|blood transfusions
733409|NCT00110604|Folic acid|folic acid
733410|NCT00110604|Atherosclerosis|atherosclerosis
733411|NCT00110604|Cognitive function|cognitive function
733412|NCT00110604|Hearing|hearing
733413|NCT00110604|Inflammation|inflammation
733414|NCT00110604|Hemostasis|hemostasis
733415|NCT00110604|Arterial stiffness|arterial stiffness
733416|NCT00110578|Treatment Naive|treatment naive
733417|NCT00110578|Treatment Experienced|treatment experienced
733418|NCT00110565|Magnetics|magnetics
733419|NCT00110565|Pulsed Magnetic Pad|pulsed magnetic pad
733420|NCT00110565|Magnetic Field|magnetic field
733920|NCT00109707|CEL|cel
733421|NCT00110565|Electromagnetic Field|electromagnetic field
733422|NCT00110565|Women|women
733423|NCT00110565|Pulsed Magnetic Field|pulsed magnetic field
733424|NCT00110539|Medicine, Herbal|medicine, herbal
733425|NCT00110539|Dietary Supplements|dietary supplements
733426|NCT00110539|Complementary and Alternative Medicine|complementary and alternative medicine
733427|NCT00110539|Physicians|physicians
733428|NCT00110526|Prostate Cancer|prostate cancer
733429|NCT00110526|Radiation Therapy|radiation therapy
733430|NCT00110526|Local recurrence|local recurrence
733431|NCT00110526|Gene Therapy|gene therapy
733432|NCT00110513|Antithrombin Deficiency, Congenital or Hereditary|antithrombin deficiency, congenital or hereditary
733433|NCT00110513|Antithrombin III Deficiency|antithrombin iii deficiency
733434|NCT00110513|ATIII|atiii
733435|NCT00110513|Hereditary Antithrombin Deficiency (HD)|hereditary antithrombin deficiency (hd)
733436|NCT00110500|Diabetes|diabetes
733437|NCT00110500|Neuropathy|neuropathy
733438|NCT00110487|Endometriosis|endometriosis
733439|NCT00110474|Glucosamine sulfate|glucosamine sulfate
733440|NCT00110474|Osteoarthritis|osteoarthritis
733441|NCT00110474|Acetaminophen|acetaminophen
733442|NCT00110474|Paracetamol|paracetamol
733443|NCT00110474|Clinical trial|clinical trial
733444|NCT00110461|Aripiprazole|aripiprazole
733445|NCT00110461|Bipolar I Disorder, Manic or Mixed Episode with or without Psychotic Features|bipolar i disorder, manic or mixed episode with or without psychotic features
733446|NCT00110448|type 2 diabetes|type 2 diabetes
733447|NCT00110448|coronary heart diseases|coronary heart diseases
733448|NCT00110448|primary prevention|primary prevention
733449|NCT00110448|atherosclerosis|atherosclerosis
733450|NCT00110448|aspirin|aspirin
733451|NCT00110422|Metabolic Syndrome|metabolic syndrome
733452|NCT00110396|Multiple Sclerosis|multiple sclerosis
733453|NCT00110396|Relapsing forms of multiple sclerosis|relapsing forms of multiple sclerosis
733454|NCT00110344|Cancer|cancer
733455|NCT00110331|Encephalopathy|encephalopathy
733456|NCT00110331|Neuroimaging|neuroimaging
733457|NCT00110331|Cognition|cognition
733458|NCT00110331|Neuroinflammation|neuroinflammation
733459|NCT00110331|Opportunistic Infections|opportunistic infections
733460|NCT00110331|HIV|hiv
733461|NCT00110331|Central Nervous System Disease|central nervous system disease
733462|NCT00110331|Bipolar Disorder|bipolar disorder
733463|NCT00110331|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
733464|NCT00110331|ADHD|adhd
733465|NCT00110331|Major Depression|major depression
733466|NCT00110331|Psychosis|psychosis
733467|NCT00110318|Tennis Elbow|tennis elbow
733468|NCT00110318|Physical Therapy Techniques|physical therapy techniques
733469|NCT00110318|Evidence-Based Medicine|evidence-based medicine
733470|NCT00110318|Primary Health Care|primary health care
733471|NCT00110305|Human Immunodeficiency Virus Type 1|human immunodeficiency virus type 1
733472|NCT00110305|Human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
733473|NCT00110305|Antiretroviral|antiretroviral
733474|NCT00110305|Antiviral|antiviral
733475|NCT00110305|ARV|arv
733476|NCT00110305|TMC278|tmc278
733477|NCT00110305|Efavirenz|efavirenz
733478|NCT00110305|Combivir|combivir
733479|NCT00110305|Truvada|truvada
733480|NCT00110305|Zidovudine|zidovudine
733481|NCT00110305|Lamivudine|lamivudine
733482|NCT00110305|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
733483|NCT00110305|Emtricitabine|emtricitabine
733484|NCT00110292|Public health|public health
733485|NCT00110292|Primary care|primary care
733486|NCT00110292|Parenting education|parenting education
733487|NCT00110292|Child rearing|child rearing
733488|NCT00110292|Parenting newsletters|parenting newsletters
733489|NCT00110292|Child development|child development
733490|NCT00110292|Language delay|language delay
733491|NCT00110279|Bird Flu|bird flu
733492|NCT00110266|ICL670|icl670
733493|NCT00110266|Deferasirox|deferasirox
733494|NCT00110266|Iron chelation|iron chelation
733495|NCT00110266|Chelator|chelator
733496|NCT00110266|Desferal|desferal
733497|NCT00110240|Type 2 diabetes|type 2 diabetes
733498|NCT00110240|vildagliptin|vildagliptin
733499|NCT00110227|Complementary Therapies|complementary therapies
733500|NCT00110227|Tai Chi|tai chi
733501|NCT00110201|Acute renal failure|acute renal failure
733502|NCT00110201|Nesiritide|nesiritide
733503|NCT00110201|Cardiovascular surgery|cardiovascular surgery
733504|NCT00110188|prostate|prostate
733505|NCT00110188|cancer|cancer
733506|NCT00110175|Cortical Reorganization|cortical reorganization
733507|NCT00110175|Motor Function|motor function
733508|NCT00110175|Somatosensory Stimulation|somatosensory stimulation
733509|NCT00110175|Rehabilitation|rehabilitation
733510|NCT00110175|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
733511|NCT00110175|Direct Current Stimulation|direct current stimulation
733512|NCT00110175|Stroke|stroke
733513|NCT00110175|Healthy Volunteer|healthy volunteer
733514|NCT00110162|adenocarcinoma of the prostate|adenocarcinoma of the prostate
733515|NCT00110162|stage I prostate cancer|stage i prostate cancer
733516|NCT00110162|stage IIB prostate cancer|stage iib prostate cancer
733517|NCT00110162|stage IIA prostate cancer|stage iia prostate cancer
733921|NCT00109707|CML|cml
733518|NCT00110162|stage III prostate cancer|stage iii prostate cancer
733519|NCT00110162|stage IV prostate cancer|stage iv prostate cancer
733520|NCT00110162|recurrent prostate cancer|recurrent prostate cancer
733521|NCT00110149|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
733522|NCT00110149|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
733523|NCT00110149|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
733524|NCT00110149|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
733525|NCT00110149|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
733526|NCT00110149|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
733527|NCT00110149|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
733528|NCT00110149|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
733529|NCT00110149|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
733530|NCT00110149|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
733531|NCT00110149|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
733532|NCT00110149|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
733533|NCT00110149|splenic marginal zone lymphoma|splenic marginal zone lymphoma
733534|NCT00110149|stage I marginal zone lymphoma|stage i marginal zone lymphoma
733535|NCT00110149|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
733536|NCT00110149|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
733537|NCT00110149|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
733538|NCT00110149|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
733539|NCT00110149|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
733540|NCT00110149|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
733541|NCT00110149|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
733542|NCT00110149|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
733543|NCT00110149|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
733544|NCT00110136|recurrent breast cancer|recurrent breast cancer
733545|NCT00110136|stage I breast cancer|stage i breast cancer
733546|NCT00110136|stage II breast cancer|stage ii breast cancer
733547|NCT00110136|stage IIIA breast cancer|stage iiia breast cancer
733548|NCT00110136|stage IIIB breast cancer|stage iiib breast cancer
733549|NCT00110136|breast cancer in situ|breast cancer in situ
733550|NCT00110136|ductal breast carcinoma in situ|ductal breast carcinoma in situ
733551|NCT00110136|hot flashes|hot flashes
733552|NCT00110123|liver metastases|liver metastases
733553|NCT00110123|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
733554|NCT00110123|iris melanoma|iris melanoma
733555|NCT00110123|extraocular extension melanoma|extraocular extension melanoma
733556|NCT00110123|recurrent intraocular melanoma|recurrent intraocular melanoma
733557|NCT00110123|metastatic intraocular melanoma|metastatic intraocular melanoma
733558|NCT00110110|intraocular retinoblastoma|intraocular retinoblastoma
733559|NCT00110084|recurrent breast cancer|recurrent breast cancer
733560|NCT00110084|stage IV breast cancer|stage iv breast cancer
733561|NCT00110058|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
733562|NCT00110058|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
733563|NCT00110058|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
733564|NCT00110058|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
733565|NCT00110058|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
733566|NCT00110045|infection|infection
733567|NCT00110045|ataxia-telangiectasia|ataxia-telangiectasia
733568|NCT00110045|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
733569|NCT00110045|acute undifferentiated leukemia|acute undifferentiated leukemia
733570|NCT00110045|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
733571|NCT00110045|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
733572|NCT00110045|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
733573|NCT00110045|chronic eosinophilic leukemia|chronic eosinophilic leukemia
733574|NCT00110045|primary myelofibrosis|primary myelofibrosis
733575|NCT00110045|chronic neutrophilic leukemia|chronic neutrophilic leukemia
733576|NCT00110045|essential thrombocythemia|essential thrombocythemia
733577|NCT00110045|polycythemia vera|polycythemia vera
733578|NCT00110045|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
733579|NCT00110045|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
733580|NCT00110045|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
733581|NCT00110045|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
733582|NCT00110045|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
733583|NCT00110045|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
733584|NCT00110045|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
733585|NCT00110045|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
733922|NCT00109707|SM|sm
733586|NCT00110045|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
733587|NCT00110045|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
733588|NCT00110045|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
733589|NCT00110045|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
733590|NCT00110045|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
733591|NCT00110045|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
733592|NCT00110045|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
733593|NCT00110045|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
733594|NCT00110045|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
733595|NCT00110045|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
733596|NCT00110045|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
733597|NCT00110045|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
733598|NCT00110045|refractory hairy cell leukemia|refractory hairy cell leukemia
733599|NCT00110045|prolymphocytic leukemia|prolymphocytic leukemia
733600|NCT00110045|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
733601|NCT00110045|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
733602|NCT00110045|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
733603|NCT00110045|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
733604|NCT00110045|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
733605|NCT00110045|anaplastic large cell lymphoma|anaplastic large cell lymphoma
733606|NCT00110045|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
733607|NCT00110045|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
733608|NCT00110045|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
733609|NCT00110045|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
733610|NCT00110045|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
733611|NCT00110045|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
733612|NCT00110045|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
733613|NCT00110045|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
733614|NCT00110045|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
733615|NCT00110045|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
733616|NCT00110045|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
733617|NCT00110045|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
733618|NCT00110045|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
733619|NCT00110045|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
733620|NCT00110045|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
733621|NCT00110045|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
733622|NCT00110045|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
733623|NCT00110045|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
733624|NCT00110045|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
733625|NCT00110045|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
733626|NCT00110045|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
733627|NCT00110045|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
733628|NCT00110045|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
733629|NCT00110045|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
733630|NCT00110045|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
733631|NCT00110045|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
733632|NCT00110045|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
733633|NCT00110045|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
733634|NCT00110045|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
733635|NCT00110045|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
733636|NCT00110045|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
733637|NCT00110045|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
733638|NCT00110045|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
733639|NCT00110045|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
733640|NCT00110045|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
733641|NCT00110045|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
733642|NCT00110045|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
733643|NCT00110045|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
733644|NCT00110045|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
733645|NCT00110045|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
733646|NCT00110045|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
733647|NCT00110045|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
733648|NCT00110045|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
733649|NCT00110045|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
733650|NCT00110045|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
733651|NCT00110045|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
733652|NCT00110045|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
733653|NCT00110045|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
733654|NCT00110045|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
733655|NCT00110045|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
733656|NCT00110045|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
733657|NCT00110045|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
733658|NCT00110045|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
733659|NCT00110045|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
733660|NCT00110045|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
733661|NCT00110045|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
733662|NCT00110045|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
733663|NCT00110045|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
733664|NCT00110045|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
733665|NCT00110045|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
733666|NCT00110045|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
733667|NCT00110045|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
733668|NCT00110045|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
733669|NCT00110045|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
733670|NCT00110045|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
733671|NCT00110045|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
733672|NCT00110045|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
733673|NCT00110045|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
733674|NCT00110045|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
733675|NCT00110045|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
733676|NCT00110045|stage I mantle cell lymphoma|stage i mantle cell lymphoma
733677|NCT00110045|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
733678|NCT00110045|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
733679|NCT00110045|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
733680|NCT00110045|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
733681|NCT00110045|stage I marginal zone lymphoma|stage i marginal zone lymphoma
733682|NCT00110045|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
733683|NCT00110045|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
733684|NCT00110045|splenic marginal zone lymphoma|splenic marginal zone lymphoma
733685|NCT00110045|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
733686|NCT00110045|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
733687|NCT00110045|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
733688|NCT00110045|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
733689|NCT00110045|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
733690|NCT00110045|intraocular lymphoma|intraocular lymphoma
733691|NCT00110045|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
733692|NCT00110045|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
733693|NCT00110045|extramedullary plasmacytoma|extramedullary plasmacytoma
733694|NCT00110045|isolated plasmacytoma of bone|isolated plasmacytoma of bone
733695|NCT00110045|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
733696|NCT00110045|stage I multiple myeloma|stage i multiple myeloma
733697|NCT00110045|stage II multiple myeloma|stage ii multiple myeloma
733698|NCT00110045|stage III multiple myeloma|stage iii multiple myeloma
733699|NCT00110045|primary systemic amyloidosis|primary systemic amyloidosis
733700|NCT00110045|refractory multiple myeloma|refractory multiple myeloma
733701|NCT00110045|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
733702|NCT00110045|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
733703|NCT00110045|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
733704|NCT00110045|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
733705|NCT00110045|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
733706|NCT00110045|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
733707|NCT00110045|disseminated neuroblastoma|disseminated neuroblastoma
733708|NCT00110045|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
733709|NCT00110045|recurrent neuroblastoma|recurrent neuroblastoma
733710|NCT00110045|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
733711|NCT00110045|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
733712|NCT00110045|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
734121|NCT00109070|Metastatic|metastatic
733713|NCT00110045|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
733714|NCT00110045|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
733715|NCT00110045|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
733716|NCT00110045|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
733717|NCT00110045|secondary acute myeloid leukemia|secondary acute myeloid leukemia
733718|NCT00110045|stage IIIA breast cancer|stage iiia breast cancer
733719|NCT00110045|stage IIIB breast cancer|stage iiib breast cancer
733720|NCT00110045|stage IIIC breast cancer|stage iiic breast cancer
733721|NCT00110045|stage IV breast cancer|stage iv breast cancer
733722|NCT00110045|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
733723|NCT00110045|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
733724|NCT00110045|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
733725|NCT00110045|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
733726|NCT00110045|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
733727|NCT00110045|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
733728|NCT00110045|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
733729|NCT00110045|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
733730|NCT00110006|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
733731|NCT00110006|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
733732|NCT00110006|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
733733|NCT00110006|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
733734|NCT00110006|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
733735|NCT00110006|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
733736|NCT00110006|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
733737|NCT00110006|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
733738|NCT00110006|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
733739|NCT00110006|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
733740|NCT00110006|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
733741|NCT00110006|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
733742|NCT00110006|stage I mantle cell lymphoma|stage i mantle cell lymphoma
733743|NCT00110006|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
733744|NCT00110006|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
733745|NCT00110006|anaplastic large cell lymphoma|anaplastic large cell lymphoma
733746|NCT00109993|graft versus host disease|graft versus host disease
733747|NCT00109993|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
733748|NCT00109993|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
733749|NCT00109993|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
733750|NCT00109993|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
733751|NCT00109993|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
733752|NCT00109993|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
733753|NCT00109993|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
733754|NCT00109993|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
733755|NCT00109993|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
733756|NCT00109993|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
733757|NCT00109993|chronic eosinophilic leukemia|chronic eosinophilic leukemia
733758|NCT00109993|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
733759|NCT00109993|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
733760|NCT00109993|chronic neutrophilic leukemia|chronic neutrophilic leukemia
733761|NCT00109993|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
733762|NCT00109993|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
733763|NCT00109993|disseminated neuroblastoma|disseminated neuroblastoma
733764|NCT00109993|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
733765|NCT00109993|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
733766|NCT00109993|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
733767|NCT00109993|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
733768|NCT00109993|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
733769|NCT00109993|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
733770|NCT00109993|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
733771|NCT00109993|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
733772|NCT00109993|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
733838|NCT00109993|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
733773|NCT00109993|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
733774|NCT00109993|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
733775|NCT00109993|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
733776|NCT00109993|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
733777|NCT00109993|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
733778|NCT00109993|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
733779|NCT00109993|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
733780|NCT00109993|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
733781|NCT00109993|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
733782|NCT00109993|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
733783|NCT00109993|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
733784|NCT00109993|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
733785|NCT00109993|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
733786|NCT00109993|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
733787|NCT00109993|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
733788|NCT00109993|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
733789|NCT00109993|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
733790|NCT00109993|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
733791|NCT00109993|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
733792|NCT00109993|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
733793|NCT00109993|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
733794|NCT00109993|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
733795|NCT00109993|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
733796|NCT00109993|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
733797|NCT00109993|recurrent neuroblastoma|recurrent neuroblastoma
733798|NCT00109993|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
733799|NCT00109993|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
733800|NCT00109993|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
733801|NCT00109993|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
733802|NCT00109993|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
733803|NCT00109993|refractory multiple myeloma|refractory multiple myeloma
733804|NCT00109993|refractory hairy cell leukemia|refractory hairy cell leukemia
733805|NCT00109993|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
733806|NCT00109993|secondary acute myeloid leukemia|secondary acute myeloid leukemia
733807|NCT00109993|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
733808|NCT00109993|splenic marginal zone lymphoma|splenic marginal zone lymphoma
733809|NCT00109993|stage I multiple myeloma|stage i multiple myeloma
733810|NCT00109993|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
733811|NCT00109993|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
733812|NCT00109993|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
733813|NCT00109993|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
733814|NCT00109993|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
733815|NCT00109993|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
733816|NCT00109993|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
733817|NCT00109993|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
733818|NCT00109993|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
733819|NCT00109993|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
733820|NCT00109993|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
733821|NCT00109993|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
733822|NCT00109993|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
733823|NCT00109993|stage III multiple myeloma|stage iii multiple myeloma
733824|NCT00109993|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
733825|NCT00109993|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
733826|NCT00109993|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
733827|NCT00109993|stage IIIA breast cancer|stage iiia breast cancer
733828|NCT00109993|stage IIIB breast cancer|stage iiib breast cancer
733829|NCT00109993|stage IIIC breast cancer|stage iiic breast cancer
733830|NCT00109993|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
733831|NCT00109993|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
733832|NCT00109993|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
733833|NCT00109993|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
733834|NCT00109993|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
733835|NCT00109993|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
733836|NCT00109993|stage IV breast cancer|stage iv breast cancer
733837|NCT00109993|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
733839|NCT00109993|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
733840|NCT00109993|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
733841|NCT00109993|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
733842|NCT00109993|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
733843|NCT00109993|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
733844|NCT00109993|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
733845|NCT00109980|Complementary Therapies|complementary therapies
733846|NCT00109980|Plants, Medicinal|plants, medicinal
733847|NCT00109980|Dominican Republic|dominican republic
733848|NCT00109980|Hispanic Americans|hispanic americans
733849|NCT00109954|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
733850|NCT00109954|advanced adult primary liver cancer|advanced adult primary liver cancer
733851|NCT00109954|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
733852|NCT00109954|recurrent adult primary liver cancer|recurrent adult primary liver cancer
733853|NCT00109941|recurrent pancreatic cancer|recurrent pancreatic cancer
733854|NCT00109941|stage III pancreatic cancer|stage iii pancreatic cancer
733855|NCT00109941|stage IV pancreatic cancer|stage iv pancreatic cancer
733856|NCT00109928|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
733857|NCT00109928|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
733858|NCT00109928|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
733859|NCT00109928|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
733860|NCT00109928|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
733861|NCT00109928|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
733862|NCT00109928|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
733863|NCT00109928|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
733864|NCT00109928|anaplastic large cell lymphoma|anaplastic large cell lymphoma
733865|NCT00109889|extramedullary plasmacytoma|extramedullary plasmacytoma
733866|NCT00109889|isolated plasmacytoma of bone|isolated plasmacytoma of bone
733867|NCT00109876|stage I non-small cell lung cancer|stage i non-small cell lung cancer
733868|NCT00109863|recurrent melanoma|recurrent melanoma
733869|NCT00109863|stage IV melanoma|stage iv melanoma
733870|NCT00109850|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
733871|NCT00109850|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
733872|NCT00109850|stage III esophageal cancer|stage iii esophageal cancer
733873|NCT00109837|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
733874|NCT00109837|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
733875|NCT00109837|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
733876|NCT00109798|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
733877|NCT00109798|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
733878|NCT00109785|stage IIIA breast cancer|stage iiia breast cancer
733879|NCT00109785|stage IIIB breast cancer|stage iiib breast cancer
733880|NCT00109785|stage IIIC breast cancer|stage iiic breast cancer
733881|NCT00109785|male breast cancer|male breast cancer
733883|NCT00109772|RSDS|rsds
733884|NCT00109772|Pain|pain
733885|NCT00109772|CC-5013|cc-5013
733886|NCT00109772|Revlimid|revlimid
733887|NCT00109772|Complex Regional Pain Syndrome|complex regional pain syndrome
733888|NCT00109772|Reflex Sympathy Dystrophy Syndrome|reflex sympathy dystrophy syndrome
733889|NCT00109772|Lenalidomide|lenalidomide
733890|NCT00109772|CRPS Type I|crps type i
733891|NCT00109772|Celgene|celgene
733892|NCT00109759|allergy|allergy
733893|NCT00109759|allergoid|allergoid
733894|NCT00109759|specific immunotherapy|specific immunotherapy
733895|NCT00109759|ragweed|ragweed
733896|NCT00109746|HIV|hiv
733897|NCT00109746|Treatment Experienced|treatment experienced
733898|NCT00109746|Anti-Retroviral Agents|anti-retroviral agents
733899|NCT00109746|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
733900|NCT00109746|Picolinic acid|picolinic acid
733901|NCT00109746|Dietary Supplements|dietary supplements
733902|NCT00109733|Childhood-onset growth hormone deficiency (COGHD)|childhood-onset growth hormone deficiency (coghd)
733903|NCT00109733|Saizen®|saizen®
733904|NCT00109720|Diabetes|diabetes
733905|NCT00109720|Self Management|self management
733906|NCT00109720|Type 2 diabetes|type 2 diabetes
733907|NCT00109707|CML in blast crisis|cml in blast crisis
733908|NCT00109707|CML in chronic phase|cml in chronic phase
733909|NCT00109707|CML in accelerated phase|cml in accelerated phase
733910|NCT00109707|Gleevec resistance|gleevec resistance
733911|NCT00109707|Gleevec intolerant|gleevec intolerant
733912|NCT00109707|Gleevec and CML|gleevec and cml
733913|NCT00109707|imatinib resistance|imatinib resistance
733914|NCT00109707|imatinib intolerant|imatinib intolerant
733915|NCT00109707|Hypereosinophilic Syndrome|hypereosinophilic syndrome
733916|NCT00109707|Systemic Mastocytosis|systemic mastocytosis
733917|NCT00109707|Chronic eosinophilic syndrome|chronic eosinophilic syndrome
733918|NCT00109707|Philadelphia chromosome positive acute lymphoblastic leukemia|philadelphia chromosome positive acute lymphoblastic leukemia
733919|NCT00109707|HES|hes
733923|NCT00109707|Ph+ ALL refractory to standard therapy|ph+ all refractory to standard therapy
733924|NCT00109707|Ph+ALL relapsed|ph+all relapsed
733925|NCT00109707|AMN107A|amn107a
733926|NCT00109681|ACTIVE|active
733927|NCT00109681|iloprost|iloprost
733928|NCT00109681|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
733929|NCT00109681|pulmonary arterial hypertension|pulmonary arterial hypertension
733930|NCT00109655|Superficial Transitional Cell Carcinoma|superficial transitional cell carcinoma
733931|NCT00109655|Bacillus Calmette-Guerin (BCG)|bacillus calmette-guerin (bcg)
733932|NCT00109655|Superficial Bladder Cancer|superficial bladder cancer
733933|NCT00109655|Gene Therapy|gene therapy
733934|NCT00109655|Vaccine|vaccine
733935|NCT00109655|Adenovirus|adenovirus
733936|NCT00109655|Carcinoma in situ|carcinoma in situ
733937|NCT00109642|Amygdala|amygdala
733938|NCT00109642|Orbitofrontal Cortex|orbitofrontal cortex
733939|NCT00109642|Yohimbine|yohimbine
733940|NCT00109642|Emotion|emotion
733941|NCT00109642|Guanfacine|guanfacine
733942|NCT00109642|Norepinephrine|norepinephrine
733943|NCT00109642|Healthy Volunteer|healthy volunteer
733944|NCT00109629|HIV-Negative|hiv-negative
733945|NCT00109629|Healthy|healthy
733946|NCT00109629|Immunity|immunity
733947|NCT00109629|Preventive|preventive
733948|NCT00109629|Virus|virus
733949|NCT00109629|Healthy Volunteer|healthy volunteer
733950|NCT00109616|neonatal mortality|neonatal mortality
733951|NCT00109616|chlorhexidine|chlorhexidine
733952|NCT00109616|newborn cleansing|newborn cleansing
733953|NCT00109616|umbilical cord care|umbilical cord care
733954|NCT00109616|community-based trial|community-based trial
733955|NCT00109616|prevention trial|prevention trial
733956|NCT00109616|omphalitis|omphalitis
733957|NCT00109603|Treatment Experienced|treatment experienced
733958|NCT00109603|TDF|tdf
733959|NCT00109590|HIV Seronegativity|hiv seronegativity
733960|NCT00109590|Treatment Naive|treatment naive
733961|NCT00109590|Pregnancy|pregnancy
733962|NCT00109590|Perinatal Transmission|perinatal transmission
733963|NCT00109590|Vertical Transmission|vertical transmission
733964|NCT00109590|Mother-To-Child Transmission|mother-to-child transmission
733965|NCT00109590|MTCT|mtct
733966|NCT00109577|bipolar disorder|bipolar disorder
733967|NCT00109577|mood disorders|mood disorders
733968|NCT00109577|manic depression|manic depression
733969|NCT00109577|nutrition|nutrition
733970|NCT00109564|AAMI|aami
733971|NCT00109564|Memory Impairment|memory impairment
733972|NCT00109564|Decline in Cognitive Function|decline in cognitive function
733973|NCT00109564|Age Associated Memory Impairment|age associated memory impairment
733974|NCT00109551|zinc|zinc
733975|NCT00109551|child mortality|child mortality
733976|NCT00109551|child morbidity|child morbidity
733977|NCT00109551|community trial|community trial
733978|NCT00109551|prevention trial|prevention trial
733979|NCT00109551|dietary supplement|dietary supplement
733980|NCT00109538|Lonafarnib|lonafarnib
733981|NCT00109525|NICHD Neonatal Research Network|nichd neonatal research network
733982|NCT00109525|Fungal Infection|fungal infection
733983|NCT00109525|Mycosis|mycosis
733984|NCT00109525|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
733985|NCT00109525|Prematurity|prematurity
733986|NCT00109525|Clinical Judgement|clinical judgement
733987|NCT00109525|Polymerase chain reaction (PCR) testing|polymerase chain reaction (pcr) testing
733988|NCT00109525|Beta-glucan assay|beta-glucan assay
733989|NCT00109525|Mass Spectrometry|mass spectrometry
733990|NCT00109525|Lumbar puncture|lumbar puncture
733991|NCT00109512|endometriosis|endometriosis
733992|NCT00109512|pelvic pain|pelvic pain
733993|NCT00109512|painful periods|painful periods
733994|NCT00109512|dysmenorrhea|dysmenorrhea
733995|NCT00109512|painful menstruation|painful menstruation
733996|NCT00109512|GnRH|gnrh
733997|NCT00109512|agonist|agonist
733998|NCT00109512|antagonist|antagonist
733999|NCT00109512|menstrual pain|menstrual pain
734000|NCT00109499|Wet Age-Related Macular Degeneration|wet age-related macular degeneration
734001|NCT00109499|Age-Related Maculopathies|age-related maculopathies
734002|NCT00109486|GW685698X|gw685698x
734003|NCT00109486|seasonal allergic rhinitis|seasonal allergic rhinitis
734004|NCT00109486|perennial allergic rhinitis|perennial allergic rhinitis
734005|NCT00109486|knemometry|knemometry
734006|NCT00109486|children|children
734007|NCT00109473|Pediatric Crohn's disease|pediatric crohn's disease
734008|NCT00109473|Pediatric|pediatric
734009|NCT00109473|Crohn's Disease|crohn's disease
734010|NCT00024635|Screening|screening
734011|NCT00024635|Psychiatric History|psychiatric history
734012|NCT00024635|Medical History|medical history
734013|NCT00024635|Diagnostic Evaluation|diagnostic evaluation
734014|NCT00024635|Natural History|natural history
734015|NCT00024635|Anxiety|anxiety
734016|NCT00024635|HV|hv
734017|NCT00024635|Healthy Volunteer|healthy volunteer
734018|NCT00024635|Normal Control|normal control
734019|NCT00024635|Mood Disorder|mood disorder
734020|NCT00024635|PTSD|ptsd
734021|NCT00024635|Post-Traumatic Stress Disorder|post-traumatic stress disorder
734022|NCT00109460|Tobacco|tobacco
734023|NCT00109434|exercise|exercise
734024|NCT00109434|hypoglycemia|hypoglycemia
734025|NCT00109434|Diabetes Mellitus, Type I|diabetes mellitus, type i
734026|NCT00109434|glucose monitoring|glucose monitoring
734027|NCT00109421|adolescent|adolescent
734028|NCT00109421|female|female
734029|NCT00109421|community-based|community-based
734030|NCT00109421|social network|social network
734031|NCT00109421|HIV/STI intervention|hiv/sti intervention
734032|NCT00109421|High HIV-risk African American adolescent females|high hiv-risk african american adolescent females
734033|NCT00109395|Lorazepam|lorazepam
734034|NCT00109395|Midazolam|midazolam
734035|NCT00109395|Best Pharmaceuticals for Children Act|best pharmaceuticals for children act
734036|NCT00109395|Critically ill|critically ill
734037|NCT00109395|pediatrics|pediatrics
734038|NCT00109395|mechanical ventilation|mechanical ventilation
734039|NCT00109395|sedation|sedation
734040|NCT00109382|Transient Ischemic Attack|transient ischemic attack
734041|NCT00109382|Stroke|stroke
734042|NCT00109382|Stroke Prevention|stroke prevention
734043|NCT00109382|Recurrence|recurrence
734044|NCT00109382|Neuroprotection|neuroprotection
734045|NCT00109382|Antiplatelet Therapy|antiplatelet therapy
734046|NCT00109382|Statins|statins
734047|NCT00109369|Chronic Disease|chronic disease
734048|NCT00109369|Multi-Hospital Information Systems|multi-hospital information systems
734049|NCT00109369|Clinical Decision Support Systems|clinical decision support systems
734050|NCT00109369|Reminder Systems|reminder systems
734051|NCT00109369|Registries|registries
734052|NCT00109369|Quality of Healthcare|quality of healthcare
734053|NCT00109369|Guideline Adherence|guideline adherence
734054|NCT00109369|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
734055|NCT00109369|Technology Assessment, Biomedical|technology assessment, biomedical
734056|NCT00109369|Primary Health Care|primary health care
734057|NCT00109369|Hypercholesterolemia|hypercholesterolemia
734058|NCT00109369|Hypertension|hypertension
734059|NCT00109369|Hyperglycemia|hyperglycemia
734060|NCT00109356|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
734061|NCT00109356|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
734062|NCT00109356|Small Lymphocytic Leukemia|small lymphocytic leukemia
734063|NCT00109330|Prevention of Diphtheria, Tetanus, Pertussis|prevention of diphtheria, tetanus, pertussis
734064|NCT00109317|Moderate Plaque Psoriasis|moderate plaque psoriasis
734065|NCT00109317|Severe Plaque Psoriasis|severe plaque psoriasis
734066|NCT00109317|Topical|topical
734067|NCT00109304|Venezuelan Equine Encephalitis|venezuelan equine encephalitis
734068|NCT00109304|VEE|vee
734069|NCT00109304|Vaccine|vaccine
734070|NCT00109304|Provide protective immunity against VEE subtypes IA/B|provide protective immunity against vee subtypes ia/b
734071|NCT00109291|anemia|anemia
734072|NCT00109291|chronic kidney disease|chronic kidney disease
734073|NCT00109291|CKD|ckd
734074|NCT00109291|chronic renal failure|chronic renal failure
734075|NCT00109291|CRF|crf
734076|NCT00109291|dialysis|dialysis
734077|NCT00109291|erythropoietin|erythropoietin
734078|NCT00109291|EPO|epo
734079|NCT00109291|erythropoiesis stimulating agent|erythropoiesis stimulating agent
734080|NCT00109291|ESA|esa
734081|NCT00109291|Hematide™|hematide™
734082|NCT00109291|hemoglobin|hemoglobin
734083|NCT00109291|Hb|hb
734084|NCT00109291|Hgb|hgb
734085|NCT00109291|Omontys|omontys
734086|NCT00109291|peginesatide|peginesatide
734087|NCT00109291|red blood cell|red blood cell
734088|NCT00109291|red blood cell production|red blood cell production
734089|NCT00109278|Prevention of Measles|prevention of measles
734090|NCT00109265|Advanced Breast Cancer|advanced breast cancer
734091|NCT00109265|Metastatic Breast Cancer|metastatic breast cancer
734092|NCT00109265|Cancer|cancer
734093|NCT00109252|Plaque Psoriasis|plaque psoriasis
734094|NCT00109252|Topical|topical
734095|NCT00109239|Metastatic Breast Cancer|metastatic breast cancer
734096|NCT00109239|Metastatic|metastatic
734097|NCT00109239|Cancer|cancer
734098|NCT00109226|Metastatic Colorectal Cancer|metastatic colorectal cancer
734099|NCT00109226|Cancer|cancer
734100|NCT00109213|Spinal Stenosis|spinal stenosis
734101|NCT00109213|Lumbar Spine|lumbar spine
734102|NCT00109213|Decompression|decompression
734103|NCT00109213|Fusion|fusion
734104|NCT00109213|Spondylolisthesis|spondylolisthesis
734105|NCT00109213|Prospective, randomized clinical trial|prospective, randomized clinical trial
734106|NCT00109200|Allergic Asthma|allergic asthma
734107|NCT00109200|Severe Allergic Asthma|severe allergic asthma
734108|NCT00109187|Moderate Persistent Asthma|moderate persistent asthma
734109|NCT00109187|Severe Persistent Asthma|severe persistent asthma
734110|NCT00109174|Glutamate|glutamate
734111|NCT00109174|Excitatory Amino Acid|excitatory amino acid
734112|NCT00109174|Neurochemistry|neurochemistry
734113|NCT00109174|GABA|gaba
734114|NCT00109174|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
734115|NCT00109161|Multiple Sclerosis, MS, CNS, Daclizumab|multiple sclerosis, ms, cns, daclizumab
734116|NCT00109148|Obesity and obesity-related medical conditions|obesity and obesity-related medical conditions
734117|NCT00109083|Migraine|migraine
734118|NCT00109083|Headaches|headaches
734119|NCT00109083|Migraine headaches|migraine headaches
734120|NCT00109083|Head pain|head pain
734122|NCT00109057|Cancer|cancer
734123|NCT00109057|Advanced malignancies|advanced malignancies
734124|NCT00109044|Depression|depression
734125|NCT00109044|Major Depressive Disorder|major depressive disorder
734126|NCT00109044|Escitalopram|escitalopram
734127|NCT00109031|Cancer|cancer
734128|NCT00109031|Oncology|oncology
734129|NCT00109018|Risk Assessment|risk assessment
734130|NCT00109018|Coronary Heart Disease|coronary heart disease
734131|NCT00109018|Vascular Function|vascular function
734132|NCT00109018|Nitric Oxide Metabolites|nitric oxide metabolites
734133|NCT00109018|Blood Tests|blood tests
734134|NCT00109018|Nitrite|nitrite
734135|NCT00109018|Flow-Mediated Dilation|flow-mediated dilation
734136|NCT00109018|Biomarker|biomarker
734137|NCT00109018|Endothelial Dysfunction|endothelial dysfunction
734138|NCT00109018|Coronary Artery Disease|coronary artery disease
734139|NCT00109018|CAD|cad
734140|NCT00109018|Coronary Artery Disease At Risk|coronary artery disease at risk
734141|NCT00109018|Healthy Volunteer|healthy volunteer
734142|NCT00109005|Response Rate|response rate
734143|NCT00109005|Toxicity|toxicity
734144|NCT00109005|Progression-Free Survival|progression-free survival
734145|NCT00109005|Overall Survival|overall survival
734146|NCT00109005|Pharmacokinetic|pharmacokinetic
734147|NCT00109005|Ocular Melanoma|ocular melanoma
734148|NCT00108992|topical NSAID|topical nsaid
734149|NCT00108992|topical diclofenac|topical diclofenac
734150|NCT00108979|Depression|depression
734151|NCT00108979|Major Depressive Disorder|major depressive disorder
734152|NCT00108979|Escitalopram|escitalopram
734153|NCT00108953|Cancer|cancer
734154|NCT00108953|Liver Cancer|liver cancer
734155|NCT00108953|Hepatocellular carcinoma|hepatocellular carcinoma
734156|NCT00108953|HCC|hcc
734157|NCT00108940|stroke|stroke
734158|NCT00108940|ischemic stroke|ischemic stroke
734159|NCT00108940|siblings|siblings
734160|NCT00108927|Clinical trial|clinical trial
734161|NCT00108927|Diabetes|diabetes
734162|NCT00108927|Quality Improvement|quality improvement
734163|NCT00108914|Perennial allergic rhinitis|perennial allergic rhinitis
734164|NCT00108914|pediatric|pediatric
734165|NCT00108901|prevention|prevention
734166|NCT00108901|children|children
734167|NCT00108901|diabetes|diabetes
734168|NCT00108901|overweight|overweight
734169|NCT00108901|obesity|obesity
734170|NCT00108901|metabolic syndrome|metabolic syndrome
734171|NCT00108901|exercise|exercise
734172|NCT00108901|insulin resistance|insulin resistance
734173|NCT00108901|female|female
734174|NCT00108901|male|male
734175|NCT00108901|black, African-American|black, african-american
734176|NCT00108901|white, Caucasian|white, caucasian
734177|NCT00108901|cognition|cognition
734178|NCT00108901|executive function|executive function
734179|NCT00108875|Peptide vaccine therapy|peptide vaccine therapy
734180|NCT00108875|Survivin|survivin
734181|NCT00108862|Treatment Naive|treatment naive
734182|NCT00108862|TB|tb
734183|NCT00108862|HIV|hiv
734184|NCT00108862|Antiretroviral Agents|antiretroviral agents
734185|NCT00108862|Strategy Study|strategy study
734186|NCT00108836|GAD|gad
734187|NCT00108836|Anxiety|anxiety
734188|NCT00108836|XBD173|xbd173
734189|NCT00108836|Generalized Anxiety Disorder|generalized anxiety disorder
734190|NCT00108810|Pain|pain
734191|NCT00108810|Osteoarthritis|osteoarthritis
734192|NCT00108810|OA|oa
734193|NCT00108810|Mild to Moderate Osteoarthritis (OA) Pain of the Knee|mild to moderate osteoarthritis (oa) pain of the knee
734194|NCT00108784|reduced-energy-density diet|reduced-energy-density diet
734195|NCT00108784|fat-restricted diet|fat-restricted diet
734196|NCT00108784|fruit|fruit
734197|NCT00108784|vegetables|vegetables
734198|NCT00108784|ad libitum intake|ad libitum intake
734199|NCT00108784|weight loss|weight loss
734200|NCT00108784|obesity|obesity
734201|NCT00108771|Pain|pain
734202|NCT00108771|Chronic Pain|chronic pain
734203|NCT00108771|Osteoarthritis Pain|osteoarthritis pain
734204|NCT00108771|Osteoarthritis|osteoarthritis
734205|NCT00108706|Acute Stroke|acute stroke
734206|NCT00108706|Cerebrovascular Accident|cerebrovascular accident
734207|NCT00108706|Ischaemic Stroke|ischaemic stroke
734208|NCT00108706|Candesartan|candesartan
734209|NCT00108706|Angiotensin Receptor Blocker|angiotensin receptor blocker
734210|NCT00108680|Hemiparesis|hemiparesis
734211|NCT00108680|Rehabilitation|rehabilitation
734212|NCT00108680|Reaching|reaching
734213|NCT00108680|Interlimb Coupling|interlimb coupling
734214|NCT00108680|Cortical Excitability|cortical excitability
734215|NCT00108680|Stroke|stroke
734216|NCT00108667|Parkinson's Disease|parkinson's disease
734217|NCT00108667|AMPA Antagonist|ampa antagonist
734218|NCT00108667|Dyskinesias|dyskinesias
734219|NCT00108667|Glutamate Antagonist|glutamate antagonist
734220|NCT00108667|Parkinson Disease|parkinson disease
734221|NCT00108667|PD|pd
734222|NCT00108654|HIV-Negative|hiv-negative
734223|NCT00108654|Healthy|healthy
734224|NCT00108654|Immunity|immunity
734225|NCT00108654|Preventive|preventive
734226|NCT00108654|Virus|virus
734227|NCT00108654|Healthy Volunteer|healthy volunteer
734228|NCT00108628|Imagery|imagery
734229|NCT00108628|Nightmares|nightmares
734230|NCT00108628|Post-Traumatic Stress Disorder|post-traumatic stress disorder
734231|NCT00108628|Psychotherapy|psychotherapy
734232|NCT00108602|sleep apnea|sleep apnea
734233|NCT00108602|stroke|stroke
734234|NCT00108602|ventilatory control|ventilatory control
734235|NCT00108589|s-adenosylmethionine|s-adenosylmethionine
734236|NCT00108589|fatty liver|fatty liver
734237|NCT00108589|obesity|obesity
734238|NCT00108589|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
734239|NCT00108576|anticonvulsant|anticonvulsant
734240|NCT00108576|anxiety|anxiety
734241|NCT00108576|divalproex|divalproex
734242|NCT00108576|PTSD|ptsd
734243|NCT00108563|Hepatitis C|hepatitis c
734244|NCT00108563|Depression|depression
734245|NCT00108563|Interferon-alpha|interferon-alpha
734246|NCT00108563|Citalopram|citalopram
734247|NCT00108563|ribavirin|ribavirin
734248|NCT00108563|antidepressive agents|antidepressive agents
734249|NCT00108550|analgesia|analgesia
734250|NCT00108550|antidepressant agents|antidepressant agents
734251|NCT00108550|back pain|back pain
734252|NCT00108550|pain|pain
734253|NCT00108537|smoking|smoking
734254|NCT00108537|nicotine|nicotine
734255|NCT00108537|drug therapy|drug therapy
734256|NCT00108537|smoking cessation|smoking cessation
734257|NCT00108524|anti-obesity agents|anti-obesity agents
734258|NCT00108524|diet therapy|diet therapy
734259|NCT00108524|diet, reducing|diet, reducing
734260|NCT00108524|obesity|obesity
734261|NCT00108524|overweight|overweight
734262|NCT00108524|risk factors|risk factors
734263|NCT00108524|weight loss|weight loss
734264|NCT00108511|hypertriglyceridemia|hypertriglyceridemia
734265|NCT00108511|lipoproteins|lipoproteins
734266|NCT00108511|triglycerides|triglycerides
734267|NCT00108511|serum GPI-PLD (glycosylphosphatidylinositol-specific phospholipase D)|serum gpi-pld (glycosylphosphatidylinositol-specific phospholipase d)
734268|NCT00108498|sleep apnea|sleep apnea
734269|NCT00108498|mirtazapine|mirtazapine
734270|NCT00108498|sleep|sleep
734271|NCT00108485|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
734272|NCT00108485|Kidney Failure, Chronic|kidney failure, chronic
734273|NCT00108485|Hyperlipidemia|hyperlipidemia
734274|NCT00108485|Randomized Controlled Trials|randomized controlled trials
734275|NCT00108459|Obesity|obesity
734276|NCT00108459|Type 2 Diabetes|type 2 diabetes
734277|NCT00108459|Hyperlipidemia|hyperlipidemia
734278|NCT00108459|Insulin resistance|insulin resistance
734279|NCT00108446|Irritable Bowel Syndrome|irritable bowel syndrome
734280|NCT00108446|visceral hypersensitivity|visceral hypersensitivity
734281|NCT00108446|cutaneous hypersensitivity|cutaneous hypersensitivity
734282|NCT00108446|lidocaine|lidocaine
734283|NCT00108420|Prazosin|prazosin
734284|NCT00108420|Stress Disorders, Post-traumatic|stress disorders, post-traumatic
734285|NCT00108407|Alcohol Abuse/Dependence|alcohol abuse/dependence
734286|NCT00108407|Alcohol Use Disorders|alcohol use disorders
734287|NCT00108407|Cannabis Abuse/Dependence|cannabis abuse/dependence
734288|NCT00108407|Depression|depression
734289|NCT00108407|Dual diagnosis|dual diagnosis
734290|NCT00108407|Dysthymia|dysthymia
734291|NCT00108407|Stimulant Abuse/Dependence|stimulant abuse/dependence
734292|NCT00108407|Substance Use Disorders|substance use disorders
734293|NCT00108394|Uremia|uremia
734294|NCT00108394|Dialysis|dialysis
734295|NCT00108394|Clinical Trials|clinical trials
734296|NCT00108394|Bone Diseases, Metabolic|bone diseases, metabolic
734297|NCT00108394|adynamic bone disease|adynamic bone disease
734298|NCT00108394|low bone turnover|low bone turnover
734299|NCT00108381|chronic back pain|chronic back pain
734300|NCT00108381|cognitive-behavioral|cognitive-behavioral
734301|NCT00108381|pain|pain
734302|NCT00108381|stages of change|stages of change
734303|NCT00108368|schizophrenia|schizophrenia
734304|NCT00108368|cognition|cognition
734305|NCT00108368|antipsychotic medication|antipsychotic medication
734306|NCT00108368|information processing|information processing
734307|NCT00108368|social cognition|social cognition
734308|NCT00108368|Psychotic|psychotic
734309|NCT00108355|albumin|albumin
734310|NCT00108355|ascites|ascites
734311|NCT00108355|paracentesis|paracentesis
734312|NCT00108342|nicotine|nicotine
734313|NCT00108342|drug therapy|drug therapy
734314|NCT00108342|Smoking Cessation|smoking cessation
734315|NCT00108329|aging|aging
734316|NCT00108329|exercise|exercise
734317|NCT00108329|metabolic syndrome|metabolic syndrome
734318|NCT00108329|insulin resistance|insulin resistance
734319|NCT00108316|Depressive Disorder|depressive disorder
734320|NCT00108316|DNA|dna
734321|NCT00108316|Serotonin|serotonin
734322|NCT00108303|schizophrenia|schizophrenia
734323|NCT00108290|Prostate cancer|prostate cancer
734324|NCT00108290|chemotherapy|chemotherapy
734325|NCT00108290|hormone therapy|hormone therapy
734326|NCT00108290|surgery|surgery
734327|NCT00108290|PSA|psa
734328|NCT00108290|Gleason score|gleason score
734329|NCT00108277|Anxiety|anxiety
734330|NCT00108277|Breathing Training|breathing training
734331|NCT00108277|Respiratory Dysregulation|respiratory dysregulation
734332|NCT00108264|Prostatic Neoplasms|prostatic neoplasms
734333|NCT00108264|Neoplasm Metastasis|neoplasm metastasis
734334|NCT00108264|Immunotherapy|immunotherapy
734335|NCT00108264|Active|active
734336|NCT00108264|Dendritic Cells|dendritic cells
734337|NCT00108251|controlled clinical trial|controlled clinical trial
734338|NCT00108251|Diastole|diastole
734339|NCT00108251|Echocardiography|echocardiography
734340|NCT00108251|exercise tolerance|exercise tolerance
734341|NCT00108251|Heart Failure, Congestive|heart failure, congestive
734342|NCT00108251|Receptors, Aldosterone|receptors, aldosterone
734343|NCT00108238|endothelial function|endothelial function
734344|NCT00108238|hormone replacement therapy|hormone replacement therapy
734345|NCT00108238|coronary flow reserve|coronary flow reserve
734346|NCT00108238|posmenopausal women|posmenopausal women
734347|NCT00108238|women's cardiovascular heatlh|women's cardiovascular heatlh
734348|NCT00108225|Cholesterol|cholesterol
734349|NCT00108225|Creatinine Clearance|creatinine clearance
734350|NCT00108225|Diabetes|diabetes
734351|NCT00108225|Glycohemoglobin|glycohemoglobin
734352|NCT00108225|High Protein Diet|high protein diet
734353|NCT00108212|Diet|diet
734354|NCT00108212|triglyceride|triglyceride
734355|NCT00108212|inflammation|inflammation
734356|NCT00108212|Genetic polymorphism|genetic polymorphism
734357|NCT00108199|Schizophrenia|schizophrenia
734358|NCT00108199|vocational rehabilitation|vocational rehabilitation
734359|NCT00108199|neuropsychology|neuropsychology
734360|NCT00108186|cyclooxygenase 2|cyclooxygenase 2
734361|NCT00108186|lung cancer|lung cancer
734362|NCT00108186|lymphocytes|lymphocytes
734363|NCT00108186|non small cell|non small cell
734364|NCT00108186|therapeutics|therapeutics
734365|NCT00108173|Position Emission Tomography (PET)|position emission tomography (pet)
734366|NCT00108173|Nicotine dependence|nicotine dependence
734367|NCT00108173|functional magnetic resonance imaging|functional magnetic resonance imaging
734368|NCT00108173|cigarette cues|cigarette cues
734369|NCT00108160|mupirocin|mupirocin
734370|NCT00108160|prevention and control|prevention and control
734371|NCT00108160|s. aureus|s. aureus
734372|NCT00108147|Aged|aged
734373|NCT00108147|Congestive Heart Failure|congestive heart failure
734374|NCT00108147|Exercise|exercise
734375|NCT00108134|Superficial basal cell carcinoma|superficial basal cell carcinoma
734376|NCT00108134|basal cell carcinoma|basal cell carcinoma
734377|NCT00108134|sBCC|sbcc
734378|NCT00108134|BCC|bcc
734379|NCT00108134|PEP005|pep005
734380|NCT00108134|Topical|topical
734381|NCT00108134|Dermatology|dermatology
734382|NCT00108121|Nodular basal cell carcinoma|nodular basal cell carcinoma
734383|NCT00108121|basal cell carcinoma|basal cell carcinoma
734384|NCT00108121|nBCC|nbcc
734385|NCT00108121|BCC|bcc
734386|NCT00108121|PEP005|pep005
734387|NCT00108121|Topical|topical
734388|NCT00108121|Dermatology|dermatology
734389|NCT00108108|Lymphocytic Leukemia|lymphocytic leukemia
734390|NCT00108095|emesis|emesis
734391|NCT00108095|nausea|nausea
734392|NCT00108095|post operative nausea and vomiting|post operative nausea and vomiting
734393|NCT00108095|vomiting|vomiting
734394|NCT00108095|PONV|ponv
734395|NCT00108082|left ventricular hypertrophy (LVH)|left ventricular hypertrophy (lvh)
734396|NCT00108082|echocardiogram|echocardiogram
734397|NCT00108082|left ventricular mass regression|left ventricular mass regression
734398|NCT00108082|cardiac MRI|cardiac mri
734399|NCT00108082|left ventricular mass index (LVMI)hypertension|left ventricular mass index (lvmi)hypertension
734400|NCT00108069|Brain|brain
734401|NCT00108069|Tumor|tumor
734402|NCT00108069|Malignant|malignant
734403|NCT00108069|Therapy|therapy
734404|NCT00108069|Progression|progression
734405|NCT00108069|Chemotherapy|chemotherapy
734406|NCT00108069|Antiangiogenesis|antiangiogenesis
734407|NCT00108069|Radiation|radiation
734408|NCT00108069|Malignant Brain Tumor|malignant brain tumor
734409|NCT00108069|Malignant Glioma|malignant glioma
734410|NCT00108069|Glioma|glioma
734411|NCT00108056|Brain|brain
734412|NCT00108056|Tumor|tumor
734413|NCT00108056|Malignant|malignant
734414|NCT00108056|Therapy|therapy
734415|NCT00108056|Progression|progression
734416|NCT00108056|Malignant Brain Tumor|malignant brain tumor
734417|NCT00108056|Malignant Glioma|malignant glioma
734418|NCT00108056|Glioma|glioma
734419|NCT00108043|Functional Electrical Stimulation|functional electrical stimulation
734420|NCT00108043|Gait|gait
734421|NCT00108043|Blood pressure|blood pressure
734422|NCT00108043|Orthostatic Hypotension|orthostatic hypotension
734423|NCT00108043|Cardiovascular responses|cardiovascular responses
734424|NCT00108043|Near-infra red spectroscopy|near-infra red spectroscopy
734425|NCT00108030|PBWST training|pbwst training
734426|NCT00108030|Strength training|strength training
734427|NCT00108030|6-min walking endurance|6-min walking endurance
734428|NCT00108030|Cardiovascular fitness|cardiovascular fitness
734429|NCT00108030|Psychosocial attributes|psychosocial attributes
734430|NCT00108017|Ocular hypertension (excessive pressure in the eye)|ocular hypertension (excessive pressure in the eye)
734431|NCT00108004|Diabetes|diabetes
734432|NCT00108004|Amylin|amylin
734433|NCT00108004|Symlin|symlin
734534|NCT00107614|Waldenstrom|waldenstrom
734434|NCT00108004|pramlintide acetate|pramlintide acetate
734435|NCT00107991|clinical trial; efficacy; etanercept; hidradenitis suppurativa; quality of life; safety; tnf|clinical trial; efficacy; etanercept; hidradenitis suppurativa; quality of life; safety; tnf
734436|NCT00107978|cSSSI (complicated Skin and Skin Structure Infections)|csssi (complicated skin and skin structure infections)
734437|NCT00107978|Staph (Staphylococcus)|staph (staphylococcus)
734438|NCT00107978|MRSA (Methicillin-resistant Staphylococcus Aureus)|mrsa (methicillin-resistant staphylococcus aureus)
734439|NCT00107965|Actinic Keratosis|actinic keratosis
734440|NCT00107965|Solar Keratosis|solar keratosis
734442|NCT00107965|Sun spots|sun spots
734443|NCT00107965|PEP005|pep005
734444|NCT00107965|Topical|topical
734445|NCT00107965|Dermatology|dermatology
734446|NCT00107952|Nosocomial pneumonia|nosocomial pneumonia
734447|NCT00107952|MRSA|mrsa
734448|NCT00107939|bipolar disorder|bipolar disorder
734449|NCT00107939|manic episode|manic episode
734450|NCT00107939|treatment|treatment
734451|NCT00107939|licarbazepine|licarbazepine
734452|NCT00107926|bipolar disorder|bipolar disorder
734453|NCT00107926|manic episode|manic episode
734454|NCT00107926|treatment|treatment
734455|NCT00107926|licarbazepine|licarbazepine
734456|NCT00107913|Immune Thrombocytopenic Purpura|immune thrombocytopenic purpura
734457|NCT00107900|Deep Vein Thrombosis,|deep vein thrombosis,
734458|NCT00107900|Anticoagulant,|anticoagulant,
734459|NCT00107900|Venous thromboembolic|venous thromboembolic
734460|NCT00107887|TST|tst
734461|NCT00107887|isoniazid|isoniazid
734462|NCT00107887|HAART|haart
734463|NCT00107887|Brazil|brazil
734464|NCT00107887|HIV|hiv
734465|NCT00107874|Maternal|maternal
734466|NCT00107874|morbidity|morbidity
734467|NCT00107874|mortality|mortality
734468|NCT00107874|pregnancy|pregnancy
734469|NCT00107874|postpartum hemorrhage|postpartum hemorrhage
734470|NCT00107874|Cesarean Section|cesarean section
734471|NCT00107848|Pediatric Narcolepsy|pediatric narcolepsy
734472|NCT00107848|Pediatric OSA|pediatric osa
734473|NCT00107848|CPAP|cpap
734474|NCT00107848|Pediatric Narcolepsy or OSAHS|pediatric narcolepsy or osahs
734475|NCT00107835|Pain|pain
734476|NCT00107822|Pain|pain
734477|NCT00107809|Pediatric Obstructive sleep Apnea|pediatric obstructive sleep apnea
734478|NCT00107809|Excessive sleepiness|excessive sleepiness
734479|NCT00107809|CPAP|cpap
734480|NCT00107809|Pediatric OSAHS|pediatric osahs
734481|NCT00107796|Pediatric Narcolepsy|pediatric narcolepsy
734482|NCT00107796|Excessive sleepiness|excessive sleepiness
734483|NCT00107783|Arthritis|arthritis
734484|NCT00107783|Homogentisic Acid|homogentisic acid
734485|NCT00107783|Corneal Damage|corneal damage
734486|NCT00107783|Tyrosine|tyrosine
734487|NCT00107783|Alkaptonuria|alkaptonuria
734488|NCT00107783|Photophobia|photophobia
734489|NCT00107783|Nitisinone|nitisinone
734490|NCT00107770|ALS|als
734491|NCT00107770|histone deacetylase inhibition|histone deacetylase inhibition
734492|NCT00107770|open label|open label
734493|NCT00107770|safety study|safety study
734494|NCT00107770|sodium phenylbutyrate|sodium phenylbutyrate
734495|NCT00107757|pediatric|pediatric
734496|NCT00107757|Seasonal allergic rhinitis|seasonal allergic rhinitis
734497|NCT00107744|Blood Pressure; Lipids; Dietary Protein|blood pressure; lipids; dietary protein
734498|NCT00107731|Bipolar I Disorder|bipolar i disorder
734499|NCT00107731|Manic Depressive Disorder|manic depressive disorder
734500|NCT00107731|Manic Depression|manic depression
734501|NCT00107718|IL-18|il-18
734502|NCT00107718|treatment naive|treatment naive
734503|NCT00107718|Phase 2|phase 2
734504|NCT00107718|melanoma|melanoma
734505|NCT00107705|allergy|allergy
734506|NCT00107705|skin prick test|skin prick test
734507|NCT00107705|allergoid|allergoid
734508|NCT00107705|allergenicity|allergenicity
734509|NCT00107705|specific immunotherapy|specific immunotherapy
734510|NCT00107692|Child Obesity|child obesity
734511|NCT00107692|Physical activity|physical activity
734512|NCT00107692|community intervention study|community intervention study
734513|NCT00107692|competence|competence
734514|NCT00107692|diet and nutrition|diet and nutrition
734515|NCT00107692|Nutrition|nutrition
734516|NCT00107679|Treatment Experienced|treatment experienced
734517|NCT00107679|HIV|hiv
734518|NCT00107679|HPV|hpv
734519|NCT00107679|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
734520|NCT00107679|Papillomavirus, Human|papillomavirus, human
734521|NCT00107666|Coronary artery bypass grafting|coronary artery bypass grafting
734522|NCT00107666|Heart valve prosthesis implantation|heart valve prosthesis implantation
734523|NCT00107666|Cardiopulmonary bypass|cardiopulmonary bypass
734524|NCT00107666|Oxidative stress|oxidative stress
734525|NCT00107666|Inflammation|inflammation
734526|NCT00107666|Endotoxemia|endotoxemia
734527|NCT00107640|At-risk drinking|at-risk drinking
734528|NCT00107640|Alcohol education|alcohol education
734529|NCT00107640|Effectiveness|effectiveness
734530|NCT00107640|Cost-effectiveness|cost-effectiveness
734531|NCT00107627|Gynaecological Cancer|gynaecological cancer
734532|NCT00107627|Surgical Staples|surgical staples
734533|NCT00107627|Subcuticular Sutures|subcuticular sutures
734535|NCT00107601|Glucose|glucose
734536|NCT00107601|Glucose Control|glucose control
734537|NCT00107601|Insulin|insulin
734538|NCT00107601|Insulin therapy|insulin therapy
734539|NCT00107601|Critically ill|critically ill
734540|NCT00107601|Intensive Care|intensive care
734541|NCT00107588|marijuana dependence|marijuana dependence
734542|NCT00107588|self-efficacy|self-efficacy
734543|NCT00107588|coping skills|coping skills
734544|NCT00107588|attendance|attendance
734545|NCT00107588|marijuana abstinence|marijuana abstinence
734546|NCT00107575|tobacco|tobacco
734547|NCT00107575|alcohol|alcohol
734548|NCT00107562|risk behavior|risk behavior
734549|NCT00107562|social networks|social networks
734550|NCT00107562|behavior|behavior
734551|NCT00107549|Treatment Experienced|treatment experienced
734552|NCT00107549|HIV Therapeutic Vaccine|hiv therapeutic vaccine
734553|NCT00107523|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
734554|NCT00107523|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
734555|NCT00107523|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
734556|NCT00107523|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
734557|NCT00107523|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
734558|NCT00107523|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
734559|NCT00107523|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
734560|NCT00107510|stage II breast cancer|stage ii breast cancer
734561|NCT00107510|stage IIIA breast cancer|stage iiia breast cancer
734562|NCT00107510|stage IIIB breast cancer|stage iiib breast cancer
734563|NCT00107510|stage IIIC breast cancer|stage iiic breast cancer
734564|NCT00107510|male breast cancer|male breast cancer
734565|NCT00107497|stage I breast cancer|stage i breast cancer
734566|NCT00107497|stage II breast cancer|stage ii breast cancer
734567|NCT00107484|stage IV breast cancer|stage iv breast cancer
734568|NCT00107484|stage I breast cancer|stage i breast cancer
734569|NCT00107484|stage II breast cancer|stage ii breast cancer
734570|NCT00107484|stage IIIA breast cancer|stage iiia breast cancer
734571|NCT00107484|stage IIIB breast cancer|stage iiib breast cancer
734572|NCT00107484|stage IIIC breast cancer|stage iiic breast cancer
734573|NCT00107484|male breast cancer|male breast cancer
734574|NCT00107471|untreated childhood brain stem glioma|untreated childhood brain stem glioma
734575|NCT00107458|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
734576|NCT00107458|recurrent childhood brain tumor|recurrent childhood brain tumor
734577|NCT00107458|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
734578|NCT00107458|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
734579|NCT00107458|recurrent childhood ependymoma|recurrent childhood ependymoma
734580|NCT00107458|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
734581|NCT00107458|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
734582|NCT00107458|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
734583|NCT00107458|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
734584|NCT00107458|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
734585|NCT00107458|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
734586|NCT00107458|childhood infratentorial ependymoma|childhood infratentorial ependymoma
734587|NCT00107458|childhood supratentorial ependymoma|childhood supratentorial ependymoma
734588|NCT00107458|childhood spinal cord neoplasm|childhood spinal cord neoplasm
734589|NCT00107458|childhood grade I meningioma|childhood grade i meningioma
734590|NCT00107458|childhood grade II meningioma|childhood grade ii meningioma
734591|NCT00107458|childhood grade III meningioma|childhood grade iii meningioma
734592|NCT00107458|childhood craniopharyngioma|childhood craniopharyngioma
734593|NCT00107458|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
734594|NCT00107419|chondrosarcoma|chondrosarcoma
734595|NCT00107393|recurrent breast cancer|recurrent breast cancer
734596|NCT00107393|stage IV breast cancer|stage iv breast cancer
734597|NCT00107380|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
734598|NCT00107380|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
734599|NCT00107380|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
734600|NCT00107380|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
734601|NCT00107367|tumors metastatic to brain|tumors metastatic to brain
734602|NCT00107354|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
734603|NCT00107354|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
734604|NCT00107354|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
734605|NCT00107354|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
734606|NCT00107354|secondary acute myeloid leukemia|secondary acute myeloid leukemia
734607|NCT00107354|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
734608|NCT00107354|refractory anemia with excess blasts|refractory anemia with excess blasts
734893|NCT00106236|Inactivity|inactivity
734609|NCT00107354|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
734610|NCT00107354|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
734611|NCT00107354|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
734612|NCT00107354|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
734613|NCT00107354|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
734614|NCT00107354|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
734615|NCT00107354|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
734616|NCT00107354|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
734617|NCT00107354|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
734618|NCT00107354|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
734619|NCT00107354|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
734620|NCT00107354|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
734621|NCT00107354|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
734622|NCT00107341|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
734623|NCT00107341|stage IV esophageal cancer|stage iv esophageal cancer
734624|NCT00107341|recurrent esophageal cancer|recurrent esophageal cancer
734625|NCT00107315|recurrent colon cancer|recurrent colon cancer
734626|NCT00107315|stage IV colon cancer|stage iv colon cancer
734627|NCT00107315|recurrent rectal cancer|recurrent rectal cancer
734628|NCT00107315|stage IV rectal cancer|stage iv rectal cancer
734629|NCT00107289|metastatic pheochromocytoma|metastatic pheochromocytoma
734630|NCT00107289|recurrent pheochromocytoma|recurrent pheochromocytoma
734631|NCT00107289|regional pheochromocytoma|regional pheochromocytoma
734632|NCT00107289|recurrent neuroblastoma|recurrent neuroblastoma
734633|NCT00107289|04-148|04-148
734634|NCT00107276|stage IV breast cancer|stage iv breast cancer
734635|NCT00107276|recurrent breast cancer|recurrent breast cancer
734636|NCT00107263|osteoporosis|osteoporosis
734637|NCT00107263|stage I breast cancer|stage i breast cancer
734638|NCT00107263|stage II breast cancer|stage ii breast cancer
734639|NCT00107263|stage IIIA breast cancer|stage iiia breast cancer
734640|NCT00107250|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
734641|NCT00107250|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
734642|NCT00107250|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
734643|NCT00107250|stage IV colon cancer|stage iv colon cancer
734644|NCT00107250|stage IV rectal cancer|stage iv rectal cancer
734645|NCT00107250|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
734646|NCT00107237|adult glioblastoma|adult glioblastoma
734647|NCT00107237|recurrent adult brain tumor|recurrent adult brain tumor
734648|NCT00107237|adult giant cell glioblastoma|adult giant cell glioblastoma
734649|NCT00107237|adult gliosarcoma|adult gliosarcoma
734650|NCT00107211|ductal breast carcinoma in situ|ductal breast carcinoma in situ
734651|NCT00107211|breast cancer in situ|breast cancer in situ
734652|NCT00107185|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
734653|NCT00107185|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
734654|NCT00107185|childhood oligodendroglioma|childhood oligodendroglioma
734655|NCT00107172|stage I non-small cell lung cancer|stage i non-small cell lung cancer
734656|NCT00107159|recurrent melanoma|recurrent melanoma
734657|NCT00107159|stage III melanoma|stage iii melanoma
734658|NCT00107159|stage IV melanoma|stage iv melanoma
734659|NCT00107120|Major Depressive Disorder|major depressive disorder
734660|NCT00107120|Depression|depression
734661|NCT00107120|Adolescents|adolescents
734662|NCT00107120|Escitalopram|escitalopram
734663|NCT00107120|Pediatrics|pediatrics
734664|NCT00107107|Diabetes|diabetes
734665|NCT00107107|Amylin|amylin
734666|NCT00107107|pramlintide|pramlintide
734667|NCT00107107|Symlin|symlin
734668|NCT00107094|Breast Cancer|breast cancer
734669|NCT00107094|Adriamycin|adriamycin
734670|NCT00107094|Cyclophosphamide|cyclophosphamide
734671|NCT00107094|Abraxane|abraxane
734672|NCT00107081|children|children
734673|NCT00107081|oral antibiotics|oral antibiotics
734674|NCT00107081|outpatient treatment|outpatient treatment
734675|NCT00107081|fever and neutropenia|fever and neutropenia
734676|NCT00107068|Stroke|stroke
734677|NCT00107068|Exercise|exercise
734678|NCT00107068|Aerobic|aerobic
734679|NCT00107068|PRT|prt
734680|NCT00107068|Walking ability|walking ability
734681|NCT00107055|Herniated nucleus pulposus|herniated nucleus pulposus
734682|NCT00107055|Lumbosacral radiculopathy|lumbosacral radiculopathy
734683|NCT00107055|Anti-TNF alpha|anti-tnf alpha
734684|NCT00107055|Tumor necrosis factor alpha|tumor necrosis factor alpha
734685|NCT00107042|Hepatitis B|hepatitis b
734686|NCT00107042|HIV vaccine trial|hiv vaccine trial
734687|NCT00107029|HIV infection|hiv infection
734688|NCT00107029|CD8+ T-cells|cd8+ t-cells
734689|NCT00107029|HIV-1 genotype|hiv-1 genotype
734690|NCT00107016|Breast Cancer|breast cancer
734691|NCT00107016|Cancer of the Breast|cancer of the breast
734692|NCT00107016|Neo-adjuvant|neo-adjuvant
734693|NCT00107016|Primary breast cancer|primary breast cancer
734694|NCT00107016|postmenopausal|postmenopausal
734695|NCT00107016|pre-operative|pre-operative
734696|NCT00107003|Brain|brain
734697|NCT00107003|Tumor|tumor
734698|NCT00107003|Surgery|surgery
734699|NCT00107003|Therapy|therapy
734700|NCT00107003|Trial|trial
734701|NCT00107003|Brain Tumor|brain tumor
734702|NCT00107003|Glioblastoma Multiforme|glioblastoma multiforme
734703|NCT00107003|GBM|gbm
734704|NCT00107003|Gliosarcoma|gliosarcoma
734705|NCT00107003|GS|gs
734706|NCT00106977|Craniosynostosis|craniosynostosis
734707|NCT00106977|Hearing Loss|hearing loss
734708|NCT00106977|Genectic Disorders|genectic disorders
734709|NCT00106977|Muenke Syndrome|muenke syndrome
734710|NCT00106964|Hepatitis B vaccines|hepatitis b vaccines
734711|NCT00106964|HIV-infected adolescents|hiv-infected adolescents
734712|NCT00106964|Hepatitis B infection (negative)|hepatitis b infection (negative)
734713|NCT00106951|Surveillance|surveillance
734714|NCT00106951|coronary heart disease|coronary heart disease
734715|NCT00106951|neighborhood SES|neighborhood ses
734716|NCT00106938|Carotid stenting|carotid stenting
734717|NCT00106938|Carotid endarterectomy|carotid endarterectomy
734718|NCT00106938|Carotid artery disease with severe narrowing of the artery|carotid artery disease with severe narrowing of the artery
734719|NCT00106938|Stroke prevention|stroke prevention
734720|NCT00106925|Peripheral Blood Stem Cells|peripheral blood stem cells
734721|NCT00106925|Graft-Versus Leukemia/Myeloma|graft-versus leukemia/myeloma
734722|NCT00106925|Graft-Versus-Host Disease|graft-versus-host disease
734723|NCT00106925|Whole Body Irradiation|whole body irradiation
734724|NCT00106925|Leukemic Relapse|leukemic relapse
734725|NCT00106925|Allogeneic Stem Cell Transplantation Recipient|allogeneic stem cell transplantation recipient
734726|NCT00106912|Genetic|genetic
734727|NCT00106912|Stroke|stroke
734728|NCT00106912|Heart|heart
734729|NCT00106912|Lysosomal|lysosomal
734730|NCT00106912|Glycolipid|glycolipid
734731|NCT00106912|Fabry Disease|fabry disease
734732|NCT00106899|neuroimaging|neuroimaging
734733|NCT00106899|brain metabolism|brain metabolism
734734|NCT00106899|biomarkers|biomarkers
734735|NCT00106899|cognition disorder|cognition disorder
734736|NCT00106899|Mild Cognitive Impairment|mild cognitive impairment
734737|NCT00106886|homocysteine|homocysteine
734738|NCT00106886|folic acid|folic acid
734739|NCT00106886|micronutrients|micronutrients
734740|NCT00106886|multivitamins|multivitamins
734741|NCT00106886|vitamin supplements|vitamin supplements
734742|NCT00106860|Anxiety|anxiety
734743|NCT00106860|Generalized Anxiety Disorder|generalized anxiety disorder
734744|NCT00106847|plaque-type psoriasis|plaque-type psoriasis
734745|NCT00106847|psoriasis|psoriasis
734746|NCT00106847|drug safety|drug safety
734747|NCT00106847|drug efficacy|drug efficacy
734748|NCT00106847|maintenance therapy|maintenance therapy
734749|NCT00106847|induction therapy|induction therapy
734750|NCT00106847|remicade|remicade
734751|NCT00106834|Psoriasis|psoriasis
734752|NCT00106834|Infliximab|infliximab
734753|NCT00106834|Remicade|remicade
734754|NCT00106808|Type 2 Diabetes|type 2 diabetes
734755|NCT00106795|Antiretrovirals|antiretrovirals
734756|NCT00106795|Adipocytes|adipocytes
734757|NCT00106795|Skeletal Muscle|skeletal muscle
734758|NCT00106795|Fatigue|fatigue
734759|NCT00106795|HIV|hiv
734760|NCT00106795|AIDS|aids
734761|NCT00106795|Lymphocytes|lymphocytes
734762|NCT00106795|Lipodystrophy|lipodystrophy
734763|NCT00106795|HIV Positive|hiv positive
734764|NCT00106795|Healthy Volunteer|healthy volunteer
734765|NCT00106795|HV|hv
734766|NCT00106782|Electrical|electrical
734767|NCT00106782|Stimulation|stimulation
734768|NCT00106782|Dystonia|dystonia
734769|NCT00106782|Brain|brain
734770|NCT00106782|Focal Hand Dystonia|focal hand dystonia
734771|NCT00106782|FHD|fhd
734772|NCT00106769|Flavivirus|flavivirus
734773|NCT00106769|Mosquito|mosquito
734774|NCT00106769|Immunity|immunity
734775|NCT00106769|Preventive|preventive
734776|NCT00106769|Virus|virus
734777|NCT00106769|West Nile Fever|west nile fever
734778|NCT00106769|Healthy Volunteer|healthy volunteer
734779|NCT00106769|HV|hv
734780|NCT00106756|Exudation|exudation
734781|NCT00106756|Avascular Retina|avascular retina
734782|NCT00106756|Retina Fold|retina fold
734783|NCT00106743|Usher Syndrome|usher syndrome
734784|NCT00106743|Retinitis Pigmentosa|retinitis pigmentosa
734785|NCT00106743|Congenital Deafness|congenital deafness
734786|NCT00106717|Cancer pain|cancer pain
734787|NCT00106717|Quality of life|quality of life
734788|NCT00106717|Narrative medicine|narrative medicine
734789|NCT00106717|Pain relief|pain relief
734790|NCT00106691|neoplasia|neoplasia
734791|NCT00106691|chemoprevention|chemoprevention
734792|NCT00106691|cancer|cancer
734793|NCT00106691|premalignant|premalignant
734794|NCT00106691|precancerous|precancerous
734795|NCT00106691|Chemoprophylaxis|chemoprophylaxis
734796|NCT00106691|Intraepithelial Prostatic Neoplasia|intraepithelial prostatic neoplasia
734797|NCT00106691|Neoplasia, Prostatic Intraepithelial|neoplasia, prostatic intraepithelial
734798|NCT00106678|HIV|hiv
735626|NCT00103545|ACA 125|aca 125
734799|NCT00106678|Antiretroviral therapy (ART)|antiretroviral therapy (art)
734800|NCT00106678|HAART|haart
734801|NCT00106678|Adherence|adherence
734802|NCT00106678|Barriers|barriers
734803|NCT00106665|ICU acquired weakness|icu acquired weakness
734804|NCT00106665|Critical care polyneuropathy|critical care polyneuropathy
734805|NCT00106665|Critical care myopathy|critical care myopathy
734806|NCT00106652|autism|autism
734807|NCT00106652|neurodevelopment|neurodevelopment
734808|NCT00106652|neurotoxicology|neurotoxicology
734809|NCT00106652|perinatology|perinatology
734810|NCT00106652|teratology|teratology
734811|NCT00106639|tofacitinib|tofacitinib
734812|NCT00106639|CP-690550|cp-690550
734813|NCT00106639|kidney transplant|kidney transplant
734814|NCT00106626|Advanced solid tumors including MPM and NSCLC|advanced solid tumors including mpm and nsclc
734815|NCT00106613|Renal Cell Carcinoma|renal cell carcinoma
734816|NCT00106613|Metastatic Cancer|metastatic cancer
734817|NCT00106613|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
734818|NCT00106600|Relapsed|relapsed
734819|NCT00106600|Refractory|refractory
734820|NCT00106587|in stent restenosis|in stent restenosis
734821|NCT00106587|paclitaxel coated balloon catheter|paclitaxel coated balloon catheter
734822|NCT00106587|paccocath|paccocath
734823|NCT00106587|drug eluting balloon|drug eluting balloon
734824|NCT00106561|spironolactone|spironolactone
734825|NCT00106561|proteinuria|proteinuria
734826|NCT00106561|angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
734827|NCT00106561|angiotensin receptor blocker|angiotensin receptor blocker
734828|NCT00106561|renin angiotensin aldosterone system|renin angiotensin aldosterone system
734829|NCT00106561|aldosterone|aldosterone
734830|NCT00106509|Clostridium Enterocolitis|clostridium enterocolitis
734831|NCT00106509|Pseudomembranous Colitis|pseudomembranous colitis
734832|NCT00106509|Clostridium difficile-associated diarrhea|clostridium difficile-associated diarrhea
734833|NCT00106509|C. difficile|c. difficile
734834|NCT00106509|CDAD|cdad
734835|NCT00106496|Treatment Effectiveness|treatment effectiveness
734836|NCT00106496|Treatment Efficacy|treatment efficacy
734837|NCT00106496|Immunomodulator, Topical|immunomodulator, topical
734838|NCT00106496|Tacrolimus, Topical|tacrolimus, topical
734839|NCT00106496|Dermatitis, Atopic|dermatitis, atopic
734840|NCT00106496|Eczema, Atopic|eczema, atopic
734841|NCT00106496|Atopic Dermatitis|atopic dermatitis
734842|NCT00106483|Cardiovascular Diseases|cardiovascular diseases
734843|NCT00106483|Coronary Disease|coronary disease
734844|NCT00106483|Heart Diseases|heart diseases
734845|NCT00106470|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
734846|NCT00106431|romidepsin|romidepsin
734847|NCT00106418|Prostate Cancer|prostate cancer
734848|NCT00106418|Androgen independent metastatic prostate cancer patients with rising PSA|androgen independent metastatic prostate cancer patients with rising psa
734849|NCT00106418|romidepsin|romidepsin
734850|NCT00106405|Bipolar I Disorder|bipolar i disorder
734851|NCT00106405|Mania|mania
734852|NCT00106405|Memantine HCl|memantine hcl
734853|NCT00106392|Treatment effectiveness|treatment effectiveness
734854|NCT00106392|Treatment efficacy|treatment efficacy
734855|NCT00106392|Investigational, Therapies|investigational, therapies
734856|NCT00106392|Immunosuppressant|immunosuppressant
734857|NCT00106392|Erectile dysfunction|erectile dysfunction
734858|NCT00106392|Prostatectomy|prostatectomy
734859|NCT00106379|HIV-1|hiv-1
734860|NCT00106379|Treatment Naive|treatment naive
734861|NCT00106379|Treatment Experienced|treatment experienced
734862|NCT00106366|Diabetes, Type 2|diabetes, type 2
734863|NCT00106353|Pediatric Tumors|pediatric tumors
734864|NCT00106340|type 2 diabetes|type 2 diabetes
734865|NCT00106340|vildagliptin|vildagliptin
734866|NCT00106314|Dehydroepiandrosterone|dehydroepiandrosterone
734867|NCT00106314|DHEA|dhea
734868|NCT00106314|Crohn's disease|crohn's disease
734869|NCT00106314|C-reactive protein|c-reactive protein
734870|NCT00106314|CRP|crp
734871|NCT00106314|Crohn's Disease Activity Index|crohn's disease activity index
734872|NCT00106314|CDAI|cdai
734873|NCT00106314|Inflammatory Bowel Disease Questionnaire|inflammatory bowel disease questionnaire
734874|NCT00106314|IBDQ|ibdq
734875|NCT00106301|FK228|fk228
734876|NCT00106301|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
734877|NCT00106288|Candidaemia|candidaemia
734878|NCT00106288|Micafungin|micafungin
734879|NCT00106275|Fibromyalgia|fibromyalgia
734880|NCT00106275|Meditation|meditation
734881|NCT00106275|Stress, Psychological|stress, psychological
734882|NCT00106275|Monitoring, Ambulatory|monitoring, ambulatory
734883|NCT00106275|Electrocardiographie, Ambulatory|electrocardiographie, ambulatory
734884|NCT00106275|Psychophysiology|psychophysiology
734885|NCT00106262|advanced cervical cancer|advanced cervical cancer
734886|NCT00106262|metastatic cervical cancer|metastatic cervical cancer
734887|NCT00106249|TMS, Supplementary Motor Area, Obsessive-Compulsive Disorder|tms, supplementary motor area, obsessive-compulsive disorder
734888|NCT00106236|Exercise|exercise
734889|NCT00106236|Fitness Club|fitness club
734890|NCT00106236|Randomized Controlled Trial|randomized controlled trial
734891|NCT00106236|Cardiovascular Risk Factor|cardiovascular risk factor
734892|NCT00106236|Overweight|overweight
734894|NCT00106223|Cognitive Behavioral Therapy|cognitive behavioral therapy
734895|NCT00106223|CBT|cbt
734896|NCT00106223|BDD|bdd
734897|NCT00106223|Body dysmorphic disorder|body dysmorphic disorder
734898|NCT00106210|Child|child
734899|NCT00106197|Sleep, REM|sleep, rem
734900|NCT00106197|Antidepressant|antidepressant
734901|NCT00106197|Adolescent|adolescent
734902|NCT00106197|Cortisol|cortisol
734903|NCT00106184|rituximab|rituximab
734904|NCT00106184|myositis|myositis
734905|NCT00106184|dermatomyositis|dermatomyositis
734906|NCT00106184|polymyositis|polymyositis
734907|NCT00106184|refractory|refractory
734908|NCT00106184|Juvenile Dermatomyositis|juvenile dermatomyositis
734909|NCT00106171|HIV|hiv
734910|NCT00106171|Acute/Early Seroconverters|acute/early seroconverters
734911|NCT00106171|Acute Infection|acute infection
734912|NCT00106171|Treatment Naive|treatment naive
734913|NCT00106171|Primary HIV Infection|primary hiv infection
734914|NCT00106158|cancer/testis antigen|cancer/testis antigen
734915|NCT00106158|cancer vaccine|cancer vaccine
734916|NCT00106158|recombinant protein|recombinant protein
734917|NCT00106145|Advanced Breast Cancer|advanced breast cancer
734918|NCT00106145|Solid Tumors|solid tumors
734919|NCT00106145|Advanced Solid Tumors|advanced solid tumors
734920|NCT00106132|Macular Edema|macular edema
734921|NCT00106132|Steroid|steroid
734922|NCT00106132|Fluorescein Angiogram|fluorescein angiogram
734923|NCT00106132|Ocular Coherence Tomography|ocular coherence tomography
734924|NCT00106132|Laser|laser
734925|NCT00106132|Retinal Vein Occlusion|retinal vein occlusion
734926|NCT00106119|Levothyroxine|levothyroxine
734927|NCT00106119|Liothyronine|liothyronine
734928|NCT00106119|Lipid Metabolism|lipid metabolism
734929|NCT00106119|Gluconeogensis|gluconeogensis
734930|NCT00106119|Thyrotropin Releasing Hormone|thyrotropin releasing hormone
734931|NCT00106119|Deiodinase|deiodinase
734932|NCT00106119|Replacement Thyroid Hormone Therapy|replacement thyroid hormone therapy
734933|NCT00106119|Thyroidectomy|thyroidectomy
734934|NCT00106119|Near Total Thyroidectomy|near total thyroidectomy
734935|NCT00106106|Alcoholism|alcoholism
734936|NCT00106106|Acamprosate|acamprosate
734937|NCT00106106|Withdrawal|withdrawal
734938|NCT00106106|Glutamate|glutamate
734939|NCT00106106|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
734940|NCT00106106|Alcohol Dependence|alcohol dependence
734941|NCT00106106|Healthy Volunteer|healthy volunteer
734942|NCT00106106|HV|hv
734943|NCT00106093|Alcohol|alcohol
734944|NCT00106093|Alcohol Treatment|alcohol treatment
734945|NCT00106093|DNA|dna
734946|NCT00106093|Treatment|treatment
734947|NCT00106093|Alcohol Dependence|alcohol dependence
734948|NCT00106093|Alcoholism|alcoholism
734949|NCT00106093|Alcohol Drinking Related Problems|alcohol drinking related problems
734950|NCT00106080|Communication|communication
734951|NCT00106080|Palliative Care|palliative care
734952|NCT00106067|aging|aging
734953|NCT00106067|behavioral research|behavioral research
734954|NCT00106067|quality of life|quality of life
734955|NCT00106067|end of life|end of life
734956|NCT00106067|family relations|family relations
734957|NCT00106067|supportive care|supportive care
734958|NCT00106067|advanced care|advanced care
734959|NCT00106067|bereavement|bereavement
734960|NCT00106041|end of life care|end of life care
734961|NCT00106041|evaluation studies|evaluation studies
734962|NCT00106041|quality of death and dying|quality of death and dying
734963|NCT00106041|palliative care|palliative care
734964|NCT00106041|coordination of care|coordination of care
734965|NCT00106041|satisfaction with care|satisfaction with care
734966|NCT00106041|healthcare cost|healthcare cost
734967|NCT00106041|utilization of healthcare resources|utilization of healthcare resources
734968|NCT00106041|caregivers|caregivers
734969|NCT00106041|veterans|veterans
734970|NCT00106028|Primary disease: Osteogenesis Imperfecta|primary disease: osteogenesis imperfecta
734971|NCT00106015|inherited pure red cell aplasia|inherited pure red cell aplasia
734972|NCT00105963|abuse|abuse
734973|NCT00105950|ErbB2 overexpressing|erbb2 overexpressing
734974|NCT00105950|ErbB1 expressing|erbb1 expressing
734975|NCT00105950|relapsed breast cancer|relapsed breast cancer
734976|NCT00105950|refractory inflammatory breast cancer|refractory inflammatory breast cancer
734977|NCT00105937|Cancer|cancer
734978|NCT00105937|Pain|pain
734979|NCT00105911|Cognitive Behavioral Therapy|cognitive behavioral therapy
734980|NCT00105898|Diabetes mellitus|diabetes mellitus
734981|NCT00105898|Hypertension|hypertension
734982|NCT00105898|Telemedicine|telemedicine
734983|NCT00105898|Case management|case management
734984|NCT00105885|Telephone|telephone
734985|NCT00105885|Telemedicine|telemedicine
734986|NCT00105885|Psychopharmacology|psychopharmacology
734987|NCT00105872|insomnia|insomnia
734988|NCT00105872|cognitive behavior therapy|cognitive behavior therapy
734989|NCT00105820|Evaluation|evaluation
734990|NCT00105820|Quality improvement|quality improvement
734991|NCT00105820|Cluster randomized trial|cluster randomized trial
734992|NCT00105820|Care model|care model
734993|NCT00105820|Collaborative care|collaborative care
734994|NCT00105820|Informatics|informatics
734995|NCT00105794|advance directives|advance directives
734996|NCT00105794|advance directive adherence|advance directive adherence
734997|NCT00105794|patient-centered care|patient-centered care
734998|NCT00105794|patient satisfaction|patient satisfaction
734999|NCT00105794|coercion|coercion
735000|NCT00105794|informed consent|informed consent
735001|NCT00105794|commitment of mentally ill|commitment of mentally ill
735002|NCT00105794|physician-patient relations|physician-patient relations
735003|NCT00105781|Nurses|nurses
735004|NCT00105781|Telephone|telephone
735005|NCT00105781|Counseling|counseling
735006|NCT00105781|Exercise|exercise
735007|NCT00105755|Activity Cycles|activity cycles
735008|NCT00105755|Amputation|amputation
735009|NCT00105755|Prevention|prevention
735010|NCT00105755|Temperature|temperature
735011|NCT00105729|Self-help groups|self-help groups
735012|NCT00105729|Referral and consultation|referral and consultation
735013|NCT00105716|hypertension|hypertension
735014|NCT00105716|adherence|adherence
735015|NCT00105716|cardiovascular diseases|cardiovascular diseases
735016|NCT00105703|Nurse practitioners|nurse practitioners
735017|NCT00105703|Case management|case management
735018|NCT00105677|Racial/ethnic health disparities|racial/ethnic health disparities
735019|NCT00105677|Attitudes|attitudes
735020|NCT00105677|Osteoarthritis Management|osteoarthritis management
735021|NCT00105677|Patient Perceptions|patient perceptions
735022|NCT00105664|Outcomes Assessment|outcomes assessment
735023|NCT00105664|Primary Health Care|primary health care
735024|NCT00105664|Group Process|group process
735025|NCT00105638|Intervention studies|intervention studies
735026|NCT00105638|Health Care Costs|health care costs
735027|NCT00105638|Telephone|telephone
735028|NCT00105638|Caregivers|caregivers
735029|NCT00105625|Geriatrics|geriatrics
735030|NCT00105625|Nutrition|nutrition
735031|NCT00105625|Immune function|immune function
735032|NCT00105625|Infection|infection
735033|NCT00105625|Rehabilitation|rehabilitation
735034|NCT00105625|Inpatient|inpatient
735035|NCT00105612|Informed Consent|informed consent
735036|NCT00105612|Memory Aid|memory aid
735037|NCT00105586|Anxiety|anxiety
735038|NCT00105586|Elderly|elderly
735039|NCT00105586|Aged|aged
735040|NCT00105586|Serotonin Reuptake Inhibitors|serotonin reuptake inhibitors
735041|NCT00105586|SSRI|ssri
735042|NCT00105586|SERT|sert
735043|NCT00105573|Mother-Child Relations|mother-child relations
735044|NCT00105573|Infant|infant
735045|NCT00105573|Child Development|child development
735046|NCT00105573|Poverty|poverty
735047|NCT00105560|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
735048|NCT00105560|untreated childhood medulloblastoma|untreated childhood medulloblastoma
735049|NCT00105560|untreated childhood pineoblastoma|untreated childhood pineoblastoma
735050|NCT00105547|Alzheimer's|alzheimer's
735051|NCT00105547|Dementia|dementia
735052|NCT00105547|Dementia of Alzheimer Type|dementia of alzheimer type
735053|NCT00105534|Bacterial Conjunctivitis|bacterial conjunctivitis
735054|NCT00105534|Pink Eye|pink eye
735055|NCT00105534|Conjunctivitis|conjunctivitis
735056|NCT00105534|Eye Infection|eye infection
735057|NCT00105534|Eye Discharge|eye discharge
735058|NCT00105521|Parkinson's Disease|parkinson's disease
735059|NCT00105521|Dyskinesia|dyskinesia
735060|NCT00105521|Dyskinesia associated with dopaminergic treatment|dyskinesia associated with dopaminergic treatment
735061|NCT00105508|Parkinson's Disease|parkinson's disease
735062|NCT00105508|Dyskinesia|dyskinesia
735063|NCT00105508|Dyskinesia associated with dopaminergic treatment|dyskinesia associated with dopaminergic treatment
735064|NCT00105495|Iron Overload|iron overload
735065|NCT00105495|Thalassemia|thalassemia
735066|NCT00105495|Haemosiderosis|haemosiderosis
735067|NCT00105495|Cardiac|cardiac
735068|NCT00105495|Deferiprone|deferiprone
735069|NCT00105495|Chelation|chelation
735070|NCT00105482|Tobacco|tobacco
735071|NCT00105482|Smoking|smoking
735072|NCT00105482|Weight|weight
735073|NCT00105482|Weight perception|weight perception
735074|NCT00105482|Naltrexone|naltrexone
735075|NCT00105469|Bacterial Conjunctivitis|bacterial conjunctivitis
735076|NCT00105469|Pink Eye|pink eye
735077|NCT00105469|Conjunctivitis|conjunctivitis
735078|NCT00105469|Eye Infection|eye infection
735079|NCT00105456|HER2-Positive Metastatic Breast Cancer|her2-positive metastatic breast cancer
735080|NCT00105456|HER2|her2
735081|NCT00105443|Liver Cancer|liver cancer
735082|NCT00105443|Cancer|cancer
735083|NCT00105430|Surgery|surgery
735084|NCT00105430|Treatment|treatment
735085|NCT00105430|Physiology|physiology
735086|NCT00105430|Pediatric|pediatric
735087|NCT00105430|Neurosurgery|neurosurgery
735088|NCT00105430|Generalized Primary Dystonia|generalized primary dystonia
735089|NCT00105417|Immune Reconstitution|immune reconstitution
735090|NCT00105417|Thymus|thymus
735091|NCT00105417|Cytokines|cytokines
735092|NCT00105417|HIV|hiv
735093|NCT00105404|Steroid|steroid
735094|NCT00105404|Diabetic Macular Edema|diabetic macular edema
735095|NCT00105404|DME|dme
735096|NCT00105378|health care services research|health care services research
735902|NCT00102570|Outpatient|outpatient
735097|NCT00105378|frail elderly|frail elderly
735098|NCT00105378|intermediate care|intermediate care
735099|NCT00105378|patient centered care|patient centered care
735100|NCT00105378|comprehensive health care|comprehensive health care
735101|NCT00105378|geriatric nursing|geriatric nursing
735102|NCT00105378|Behavioral symptoms|behavioral symptoms
735103|NCT00105365|lateral wedge inserts|lateral wedge inserts
735104|NCT00105365|shoe inserts|shoe inserts
735105|NCT00105352|Type 1 Diabetes Study Group|type 1 diabetes study group
735106|NCT00105352|TrialNet|trialnet
735107|NCT00105352|type 1 diabetes|type 1 diabetes
735108|NCT00105352|juvenile onset diabetes|juvenile onset diabetes
735109|NCT00105339|consent form, vaccine trial|consent form, vaccine trial
735110|NCT00105339|Simplified consent form|simplified consent form
735111|NCT00105326|Schizophrenia|schizophrenia
735112|NCT00105326|Schizophrenia-related insomnia|schizophrenia-related insomnia
735113|NCT00105326|insomnia|insomnia
735114|NCT00105326|paliperidone|paliperidone
735115|NCT00105326|placebo|placebo
735116|NCT00105326|polysomnography|polysomnography
735117|NCT00105287|cancer|cancer
735118|NCT00105287|pain|pain
735119|NCT00105287|Breakthrough Pain in cancer patients|breakthrough pain in cancer patients
735120|NCT00105274|Velocardiofacial Syndrome|velocardiofacial syndrome
735121|NCT00105274|Susceptibility Genes|susceptibility genes
735122|NCT00105274|Neuroimaging|neuroimaging
735123|NCT00105274|22q11.2|22q11.2
735124|NCT00105274|Psychosis|psychosis
735125|NCT00105274|Mircodeletion|mircodeletion
735126|NCT00105274|DiGeorge Syndrome|digeorge syndrome
735127|NCT00105274|22q11.2 Syndrome|22q11.2 syndrome
735128|NCT00105248|acute repiratory infections|acute repiratory infections
735129|NCT00105248|antibiotic therapy|antibiotic therapy
735130|NCT00105248|patient-centred communication|patient-centred communication
735131|NCT00105248|randomized controlled trial|randomized controlled trial
735132|NCT00105235|transplantation|transplantation
735133|NCT00105235|liver transplant|liver transplant
735134|NCT00105235|rejection|rejection
735135|NCT00105235|tolerance|tolerance
735136|NCT00105235|antibody induction|antibody induction
735137|NCT00105222|Cycle Ergometer|cycle ergometer
735138|NCT00105222|Exercise Physiology|exercise physiology
735139|NCT00105222|Nitric Oxide|nitric oxide
735140|NCT00105222|Sodium Nitrite|sodium nitrite
735141|NCT00105222|Healthy Volunteers|healthy volunteers
735142|NCT00105222|Normal Volunteer|normal volunteer
735143|NCT00105222|Healthy Volunteer|healthy volunteer
735144|NCT00105222|HV|hv
735145|NCT00105209|Platelets|platelets
735146|NCT00105196|Single or recurrent|single or recurrent
735147|NCT00105196|non-psychotic episode of Major Depressive Disorder|non-psychotic episode of major depressive disorder
735148|NCT00105183|pulmonary transplantation|pulmonary transplantation
735149|NCT00105183|Pulmonary Allograft Rejection|pulmonary allograft rejection
735150|NCT00105170|Monoclonal antibody|monoclonal antibody
735151|NCT00105170|Advanced solid tumors|advanced solid tumors
735152|NCT00105170|Tumors|tumors
735153|NCT00105170|hCBE-11|hcbe-11
735154|NCT00105144|Treatment Effectiveness|treatment effectiveness
735155|NCT00105144|Treatment Efficacy|treatment efficacy
735156|NCT00105144|Investigational, Therapies|investigational, therapies
735157|NCT00105144|Antifungal, Systemic|antifungal, systemic
735158|NCT00105144|Antibiotics, Antifungal|antibiotics, antifungal
735159|NCT00105144|Micafungin|micafungin
735160|NCT00105131|Parkinson's Disease|parkinson's disease
735161|NCT00105131|Movement Disorders|movement disorders
735162|NCT00105131|Tremor|tremor
735163|NCT00105131|Alpha-Synuclein|alpha-synuclein
735164|NCT00105131|Lewy Bodies|lewy bodies
735165|NCT00105131|Parkinson Disease|parkinson disease
735166|NCT00105131|PD|pd
735167|NCT00105131|Movement Disorder|movement disorder
735168|NCT00105131|Healthy Volunteer|healthy volunteer
735169|NCT00105131|HV|hv
735170|NCT00105118|Cognition|cognition
735171|NCT00105118|Alpha|alpha
735172|NCT00105118|Schizophrenia|schizophrenia
735173|NCT00105118|Functional Connectivity|functional connectivity
735174|NCT00105118|Oscillatory Potential|oscillatory potential
735175|NCT00105105|Alzheimers|alzheimers
735176|NCT00105105|cognition|cognition
735177|NCT00105105|acetyl cholinesterase inhibitor|acetyl cholinesterase inhibitor
735178|NCT00105105|GR-II antagonist|gr-ii antagonist
735179|NCT00105066|Metabolic Syndrome|metabolic syndrome
735180|NCT00105066|triglycerides|triglycerides
735181|NCT00105066|HDL|hdl
735182|NCT00105066|LDL|ldl
735183|NCT00105066|High Blood Pressure|high blood pressure
735184|NCT00105066|High Cholesterol|high cholesterol
735185|NCT00105066|High Blood Sugar|high blood sugar
735186|NCT00105040|Partial onset seizures|partial onset seizures
735187|NCT00105040|epilepsy|epilepsy
735188|NCT00105040|levetiracetam|levetiracetam
735189|NCT00105040|Keppra|keppra
735190|NCT00105040|cognition|cognition
735191|NCT00105040|behavior|behavior
735192|NCT00105040|pediatry|pediatry
735193|NCT00105027|macular edema|macular edema
735194|NCT00105027|central retinal vein occlusion (CRVO)|central retinal vein occlusion (crvo)
735195|NCT00105027|branch retinal vein occlusion (BRVO)|branch retinal vein occlusion (brvo)
735196|NCT00104988|stage IV melanoma|stage iv melanoma
735197|NCT00104975|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
735198|NCT00104975|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
735199|NCT00104975|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
735200|NCT00104975|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
735201|NCT00104975|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
735202|NCT00104975|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
735203|NCT00104975|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
735204|NCT00104975|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
735205|NCT00104975|refractory anemia with excess blasts|refractory anemia with excess blasts
735206|NCT00104975|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
735207|NCT00104975|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
735208|NCT00104975|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
735209|NCT00104975|chronic eosinophilic leukemia|chronic eosinophilic leukemia
735210|NCT00104975|primary myelofibrosis|primary myelofibrosis
735211|NCT00104975|chronic neutrophilic leukemia|chronic neutrophilic leukemia
735212|NCT00104975|essential thrombocythemia|essential thrombocythemia
735213|NCT00104975|polycythemia vera|polycythemia vera
735214|NCT00104975|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
735215|NCT00104975|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
735216|NCT00104975|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
735217|NCT00104975|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
735218|NCT00104975|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
735219|NCT00104975|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
735220|NCT00104975|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
735221|NCT00104975|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
735222|NCT00104975|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
735223|NCT00104975|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
735224|NCT00104975|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
735225|NCT00104975|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
735226|NCT00104975|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
735227|NCT00104975|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
735228|NCT00104975|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
735229|NCT00104975|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
735230|NCT00104975|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
735231|NCT00104949|adult synovial sarcoma|adult synovial sarcoma
735232|NCT00104949|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
735233|NCT00104949|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
735234|NCT00104949|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
735235|NCT00104936|adult grade I meningioma|adult grade i meningioma
735236|NCT00104923|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
735237|NCT00104923|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
735238|NCT00104923|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
735239|NCT00104923|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
735240|NCT00104923|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
735241|NCT00104923|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
735242|NCT00104923|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
735243|NCT00104923|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
735244|NCT00104923|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
735245|NCT00104923|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
735246|NCT00104923|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
735247|NCT00104923|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
735248|NCT00104923|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
735249|NCT00104923|secondary acute myeloid leukemia|secondary acute myeloid leukemia
735250|NCT00104923|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
735251|NCT00104923|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
735252|NCT00104923|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
735253|NCT00104923|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
735254|NCT00104923|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
735255|NCT00104923|refractory multiple myeloma|refractory multiple myeloma
735256|NCT00104923|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
735257|NCT00104923|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
735258|NCT00104923|chronic eosinophilic leukemia|chronic eosinophilic leukemia
735259|NCT00104923|primary myelofibrosis|primary myelofibrosis
735260|NCT00104923|chronic neutrophilic leukemia|chronic neutrophilic leukemia
735903|NCT00102570|Allergy|allergy
735261|NCT00104923|essential thrombocythemia|essential thrombocythemia
735262|NCT00104923|polycythemia vera|polycythemia vera
735263|NCT00104923|stage II multiple myeloma|stage ii multiple myeloma
735264|NCT00104923|stage III multiple myeloma|stage iii multiple myeloma
735265|NCT00104923|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
735266|NCT00104923|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
735267|NCT00104923|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
735268|NCT00104923|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
735269|NCT00104923|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
735270|NCT00104923|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
735271|NCT00104923|splenic marginal zone lymphoma|splenic marginal zone lymphoma
735272|NCT00104923|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
735273|NCT00104897|recurrent melanoma|recurrent melanoma
735274|NCT00104897|stage IV melanoma|stage iv melanoma
735275|NCT00104884|stage III melanoma|stage iii melanoma
735276|NCT00104884|stage IV melanoma|stage iv melanoma
735277|NCT00104884|Depsipeptide|depsipeptide
735278|NCT00104871|National Thyroid Cancer Treatment Cooperative Study Group|national thyroid cancer treatment cooperative study group
735279|NCT00104871|NTCTCSG|ntctcsg
735280|NCT00104871|bortezomib|bortezomib
735281|NCT00104871|velcade|velcade
735282|NCT00104871|metastatic differentiated thyroid carcinoma|metastatic differentiated thyroid carcinoma
735283|NCT00104871|Differentiated thyroid carcinoma|differentiated thyroid carcinoma
735284|NCT00104871|follicular epithelial thyroid cells|follicular epithelial thyroid cells
735285|NCT00104871|papillary|papillary
735286|NCT00104871|oxyphilic cell|oxyphilic cell
735287|NCT00104871|Hurthle cell|hurthle cell
735288|NCT00104871|insular cell|insular cell
735289|NCT00104871|columnar cell|columnar cell
735290|NCT00104871|tall cell|tall cell
735291|NCT00104845|stage II melanoma|stage ii melanoma
735292|NCT00104845|stage III melanoma|stage iii melanoma
735293|NCT00104845|stage IV melanoma|stage iv melanoma
735294|NCT00104845|recurrent melanoma|recurrent melanoma
735295|NCT00104819|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
735296|NCT00104819|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
735297|NCT00104819|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
735298|NCT00104806|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
735299|NCT00104806|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
735300|NCT00104806|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
735301|NCT00104806|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
735302|NCT00104806|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
735303|NCT00104806|refractory anemia with excess blasts|refractory anemia with excess blasts
735304|NCT00104806|refractory anemia|refractory anemia
735305|NCT00104806|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
735306|NCT00104806|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
735307|NCT00104806|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
735308|NCT00104806|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
735309|NCT00104793|extensive stage small cell lung cancer|extensive stage small cell lung cancer
735310|NCT00104780|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
735311|NCT00104780|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
735312|NCT00104780|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
735313|NCT00104767|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
735314|NCT00104767|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
735315|NCT00104767|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
735316|NCT00104754|extensive stage small cell lung cancer|extensive stage small cell lung cancer
735317|NCT00104754|limited stage small cell lung cancer|limited stage small cell lung cancer
735318|NCT00104754|recurrent small cell lung cancer|recurrent small cell lung cancer
735319|NCT00104741|stage IIB prostate cancer|stage iib prostate cancer
735320|NCT00104741|stage IIA prostate cancer|stage iia prostate cancer
735321|NCT00104741|stage III prostate cancer|stage iii prostate cancer
735322|NCT00104728|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
735323|NCT00104728|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
735324|NCT00104728|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
735325|NCT00104728|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
735326|NCT00104715|adenocarcinoma of the prostate|adenocarcinoma of the prostate
735327|NCT00104715|recurrent prostate cancer|recurrent prostate cancer
735328|NCT00104715|stage IV prostate cancer|stage iv prostate cancer
735329|NCT00104702|stage I breast cancer|stage i breast cancer
735330|NCT00104702|stage II breast cancer|stage ii breast cancer
735331|NCT00104689|stage IV colon cancer|stage iv colon cancer
735332|NCT00104689|stage IV rectal cancer|stage iv rectal cancer
735333|NCT00104689|adenocarcinoma of the colon|adenocarcinoma of the colon
735334|NCT00104689|adenocarcinoma of the rectum|adenocarcinoma of the rectum
735335|NCT00104676|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
735336|NCT00104676|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
735337|NCT00104676|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
735338|NCT00104676|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
735339|NCT00104676|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
735340|NCT00104676|testicular choriocarcinoma|testicular choriocarcinoma
735341|NCT00104676|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
735342|NCT00104676|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
735343|NCT00104676|testicular embryonal carcinoma|testicular embryonal carcinoma
735344|NCT00104676|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
735345|NCT00104676|testicular yolk sac tumor|testicular yolk sac tumor
735346|NCT00104676|stage II extragonadal non-seminomatous germ cell tumor|stage ii extragonadal non-seminomatous germ cell tumor
735347|NCT00104676|stage III extragonadal non-seminomatous germ cell tumor|stage iii extragonadal non-seminomatous germ cell tumor
735348|NCT00104676|testicular immature teratoma|testicular immature teratoma
735349|NCT00104676|testicular mature teratoma|testicular mature teratoma
735350|NCT00104676|adult teratoma|adult teratoma
735351|NCT00104663|Creutzfeldt-Jakob disease|creutzfeldt-jakob disease
735352|NCT00104663|inherited|inherited
735353|NCT00104663|sporadic|sporadic
735354|NCT00104663|acquired|acquired
735355|NCT00104663|new variant CJD|new variant cjd
735356|NCT00104650|Bone Metastases|bone metastases
735357|NCT00104650|AMG 162|amg 162
735358|NCT00104650|Bisphosphonates|bisphosphonates
735359|NCT00104650|Solid Tumor Carcinomas|solid tumor carcinomas
735360|NCT00104650|Advanced|advanced
735361|NCT00104637|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
735362|NCT00104637|Emphysema|emphysema
735363|NCT00104637|Phosphodiesterase inhibitors|phosphodiesterase inhibitors
735364|NCT00104637|Sildenafil|sildenafil
735365|NCT00104637|Exercise testing|exercise testing
735366|NCT00104637|Quality of life|quality of life
735367|NCT00104624|stage IV breast cancer|stage iv breast cancer
735368|NCT00104624|recurrent breast cancer|recurrent breast cancer
735369|NCT00104611|Major Depressive Disorder|major depressive disorder
735370|NCT00104611|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
735371|NCT00104611|rTMS|rtms
735372|NCT00104611|Non-invasive Neuromodulation|non-invasive neuromodulation
735373|NCT00104611|Antidepressant|antidepressant
735374|NCT00104585|Parkinson's disease|parkinson's disease
735375|NCT00104585|PD|pd
735376|NCT00104585|gene|gene
735377|NCT00104585|environment|environment
735378|NCT00104585|early-onset Parkinson's disease|early-onset parkinson's disease
735379|NCT00104572|Estrogen|estrogen
735380|NCT00104572|Glucose Tolerance|glucose tolerance
735381|NCT00104572|Bone Density|bone density
735382|NCT00104572|Quality-of-Life|quality-of-life
735383|NCT00104572|Sarcopenia|sarcopenia
735384|NCT00104559|HIV|hiv
735385|NCT00104559|Informed Consent|informed consent
735386|NCT00104546|Dysmenorrhea|dysmenorrhea
735387|NCT00104546|Acupuncture|acupuncture
735388|NCT00104546|Vitamin K|vitamin k
735389|NCT00104546|Medicine, Chinese Traditional|medicine, chinese traditional
735390|NCT00104546|Women|women
735391|NCT00104546|Menstruation|menstruation
735392|NCT00104546|Pain, Menstrual|pain, menstrual
735393|NCT00104546|China|china
735394|NCT00104533|Static magnetic therapy|static magnetic therapy
735395|NCT00104533|Pain|pain
735396|NCT00104533|Analgesia|analgesia
735397|NCT00104533|Opioids|opioids
735398|NCT00104520|Cystic Fibrosis|cystic fibrosis
735399|NCT00104520|Pseudomonas aeruginosa|pseudomonas aeruginosa
735400|NCT00104520|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
735401|NCT00104507|Serotonin|serotonin
735402|NCT00104507|5-HT2c|5-ht2c
735403|NCT00104507|Satiety|satiety
735404|NCT00104507|Obesity|obesity
735405|NCT00104507|Appetite suppressant|appetite suppressant
735406|NCT00104507|Weight Loss|weight loss
735407|NCT00104507|Overweight|overweight
735408|NCT00104494|Cystic Fibrosis|cystic fibrosis
735409|NCT00104494|Zinc supplementation|zinc supplementation
735410|NCT00104494|Nutrition|nutrition
735411|NCT00104494|Zinc absorption|zinc absorption
735412|NCT00104494|Zinc excretion|zinc excretion
735413|NCT00104494|Zinc status|zinc status
735414|NCT00104481|cognitive behavior therapy|cognitive behavior therapy
735415|NCT00104481|coping|coping
735416|NCT00104481|smoking cessation|smoking cessation
735417|NCT00104481|acceptance|acceptance
735418|NCT00104481|expectancies|expectancies
735419|NCT00104481|quit smoking|quit smoking
735420|NCT00104481|quitting smoking|quitting smoking
735421|NCT00104468|Single-arm, open-label, multi-center, dose escalation, continuous infusion, multi-dose, acute myeloid leukemia|single-arm, open-label, multi-center, dose escalation, continuous infusion, multi-dose, acute myeloid leukemia
735422|NCT00104468|Acute myelogenous leukemia (AML) that has been refractory to prior therapy and/or is unlikely to benefit from known therapies|acute myelogenous leukemia (aml) that has been refractory to prior therapy and/or is unlikely to benefit from known therapies
735423|NCT00104455|rFVIIa|rfviia
735424|NCT00104455|Punch Biopsy|punch biopsy
735425|NCT00104455|Dose Response|dose response
736542|NCT00100308|Heparin|heparin
735426|NCT00104455|Healthy People Programs|healthy people programs
735427|NCT00104442|Alzheimer's disease|alzheimer's disease
735428|NCT00104442|memory loss|memory loss
735429|NCT00104442|dementia|dementia
735430|NCT00104442|senility|senility
735431|NCT00104442|forgetful|forgetful
735432|NCT00104442|geriatric|geriatric
735433|NCT00104442|behavior|behavior
735434|NCT00104442|mood swings|mood swings
735435|NCT00104429|HIV infections|hiv infections
735436|NCT00104429|therapy naive|therapy naive
735437|NCT00104416|antiepileptic drugs|antiepileptic drugs
735438|NCT00104416|seizures|seizures
735439|NCT00104416|primary generalized tonic-clonic seizures|primary generalized tonic-clonic seizures
735440|NCT00104416|Epilepsy|epilepsy
735441|NCT00104416|lamotrigine|lamotrigine
735442|NCT00104416|anticonvulsants|anticonvulsants
735443|NCT00104416|LAMICTAL|lamictal
735444|NCT00104403|Vomiting|vomiting
735445|NCT00104403|CINV|cinv
735446|NCT00104403|Emesis|emesis
735447|NCT00104403|Nausea|nausea
735448|NCT00104403|Chemotherapy-Induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
735449|NCT00104390|allergy|allergy
735450|NCT00104390|skin prick test|skin prick test
735451|NCT00104390|allergoid|allergoid
735452|NCT00104390|allergenicity|allergenicity
735453|NCT00104390|specific immunotherapy|specific immunotherapy
735454|NCT00104377|Allergy|allergy
735455|NCT00104377|Allergoid|allergoid
735456|NCT00104377|Specific Immunotherapy|specific immunotherapy
735457|NCT00104338|Investigational Therapies|investigational therapies
735458|NCT00104338|Treatment Effectiveness|treatment effectiveness
735459|NCT00104338|Treatment Efficacy|treatment efficacy
735460|NCT00104338|Immunosuppressant|immunosuppressant
735461|NCT00104338|BK Nephropathy|bk nephropathy
735462|NCT00104338|Polyomavirus, BK|polyomavirus, bk
735463|NCT00104338|Human Polyomavirus BK|human polyomavirus bk
735464|NCT00104338|Polyomavirus hominis 1|polyomavirus hominis 1
735465|NCT00104325|Cytapheresis|cytapheresis
735466|NCT00104325|Blood Collection|blood collection
735467|NCT00104325|Volunteer Donor|volunteer donor
735468|NCT00104325|White Blood Cells|white blood cells
735469|NCT00104312|Knee Osteoarthritis|knee osteoarthritis
735470|NCT00104312|Muscle|muscle
735471|NCT00104312|Cytokine|cytokine
735472|NCT00104312|Mobility|mobility
735473|NCT00104312|Function|function
735474|NCT00104299|ANCA|anca
735475|NCT00104299|Vasculitis|vasculitis
735476|NCT00104299|Wegener's Granulomatosis|wegener's granulomatosis
735477|NCT00104299|microscopic polyangiitis|microscopic polyangiitis
735478|NCT00104299|ANCA-positive|anca-positive
735479|NCT00104299|ANCA-associated|anca-associated
735480|NCT00104299|ANCA-associated vasculitis|anca-associated vasculitis
735481|NCT00104299|MPA|mpa
735482|NCT00104273|Dementia, Alzheimer's Disease|dementia, alzheimer's disease
735483|NCT00104247|Phenylalanine Hydroxylase|phenylalanine hydroxylase
735484|NCT00104195|Anxiety|anxiety
735485|NCT00104195|Adolescence|adolescence
735486|NCT00104195|Generalized Anxiety Disorder|generalized anxiety disorder
735487|NCT00104169|Anemia|anemia
735488|NCT00104169|Frailty|frailty
735489|NCT00104169|Epoetin|epoetin
735490|NCT00104169|Erythropoietin|erythropoietin
735491|NCT00104169|EPO|epo
735492|NCT00104156|Knee pain|knee pain
735493|NCT00104156|Arthritis|arthritis
735494|NCT00104156|Qigong|qigong
735495|NCT00104156|Qi|qi
735496|NCT00104156|Meditation|meditation
735497|NCT00104156|Breathing Exercises|breathing exercises
735498|NCT00104130|prostate|prostate
735499|NCT00104104|Z-MAX, multiple myeloma, zoledronic acid, bone metastases|z-max, multiple myeloma, zoledronic acid, bone metastases
735500|NCT00104091|Gross Total Resection|gross total resection
735501|NCT00104091|Convection Enhanced Delivery|convection enhanced delivery
735502|NCT00104091|Recurrent Glioblastoma Multiforme|recurrent glioblastoma multiforme
735503|NCT00104065|oral mucositis|oral mucositis
735504|NCT00104065|oncology - supportive care|oncology - supportive care
735505|NCT00104065|mouth diseases|mouth diseases
735506|NCT00104039|Amygdala|amygdala
735507|NCT00104039|Orbital Frontal Cortex|orbital frontal cortex
735508|NCT00104039|Serotonin|serotonin
735509|NCT00104039|Orbitofrontal Cortex|orbitofrontal cortex
735510|NCT00104039|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
735511|NCT00104039|ADHD|adhd
735512|NCT00104039|Anti-Social Behavior|anti-social behavior
735513|NCT00104039|Healthy Volunteer|healthy volunteer
735514|NCT00104039|HV|hv
735515|NCT00104026|Periodontal Disease|periodontal disease
735516|NCT00104026|Dilantin|dilantin
735517|NCT00104026|Cyclosporin|cyclosporin
735518|NCT00104026|Calcium-Channel Blockers|calcium-channel blockers
735519|NCT00104026|Genetics|genetics
735520|NCT00104026|Hereditary Gingival Fibromatosis|hereditary gingival fibromatosis
735521|NCT00104026|HGF|hgf
735522|NCT00104026|Gingival Overgrowth|gingival overgrowth
735523|NCT00104026|Gum Overgrowth|gum overgrowth
735524|NCT00104000|Neuromuscular|neuromuscular
735525|NCT00104000|Elevation|elevation
735526|NCT00104000|Current|current
735527|NCT00104000|Videofluoroscopy|videofluoroscopy
735528|NCT00104000|Nasoendoscopy|nasoendoscopy
735529|NCT00104000|Healthy Volunteer|healthy volunteer
735530|NCT00104000|HV|hv
735531|NCT00103987|Panic Disorder|panic disorder
735532|NCT00103987|Norepinephrine|norepinephrine
735533|NCT00103987|Yohimbine|yohimbine
735534|NCT00103987|Genes|genes
735535|NCT00103987|Pathophysiology|pathophysiology
735536|NCT00103987|Noradrenergic Mechanisms|noradrenergic mechanisms
735537|NCT00103987|PET Imaging|pet imaging
735538|NCT00103987|PD|pd
735539|NCT00103987|Healthy Volunteer|healthy volunteer
735540|NCT00103987|HV|hv
735541|NCT00103974|multiple sclerosis|multiple sclerosis
735542|NCT00103974|relapsing-remitting|relapsing-remitting
735543|NCT00103974|secondary progressive|secondary progressive
735544|NCT00103961|Acute Infection|acute infection
735545|NCT00103961|HIV|hiv
735546|NCT00103961|AIDS|aids
735547|NCT00103961|Acute HIV|acute hiv
735548|NCT00103961|Early HIV|early hiv
735549|NCT00103935|diabetes|diabetes
735550|NCT00103935|exenatide|exenatide
735551|NCT00103935|long acting release|long acting release
735552|NCT00103935|Amylin|amylin
735553|NCT00103935|Lilly|lilly
735554|NCT00103922|smokers cough|smokers cough
735555|NCT00103896|High-risk youth|high-risk youth
735556|NCT00103896|HIV infected youth|hiv infected youth
735557|NCT00103896|Community mobilization|community mobilization
735558|NCT00103896|HIV serosurveys|hiv serosurveys
735559|NCT00103883|HIV|hiv
735560|NCT00103883|Detuned Assay|detuned assay
735561|NCT00103883|Enzyme Immunoassay (EIA)|enzyme immunoassay (eia)
735562|NCT00103883|HIV Incidence|hiv incidence
735563|NCT00103883|Laboratory assay|laboratory assay
735564|NCT00103883|Sensitive/Less sensitive Assay|sensitive/less sensitive assay
735565|NCT00103883|Acute Infection|acute infection
735566|NCT00103870|Music Therapy|music therapy
735567|NCT00103870|Electric Stimulation|electric stimulation
735568|NCT00103870|Electric Shock|electric shock
735569|NCT00103870|Analgesics|analgesics
735570|NCT00103870|Distraction|distraction
735571|NCT00103844|Chronic Phase Philadelphia chromosome Positive (Ph+) chronic myeloid leukemia|chronic phase philadelphia chromosome positive (ph+) chronic myeloid leukemia
735572|NCT00103831|NSCLC - non-small cell lung cancer|nsclc - non-small cell lung cancer
735573|NCT00103805|language acquisition|language acquisition
735574|NCT00103805|plasticity|plasticity
735575|NCT00103805|stroke recovery|stroke recovery
735576|NCT00103805|associative learning|associative learning
735577|NCT00103792|Induction therapy|induction therapy
735578|NCT00103792|ANCA-associated vasculitis|anca-associated vasculitis
735579|NCT00103792|Wegener's granulomatosis|wegener's granulomatosis
735580|NCT00103792|microscopic polyangiitis|microscopic polyangiitis
735581|NCT00103792|mycophenolate mofetil|mycophenolate mofetil
735582|NCT00103792|cyclophosphamide|cyclophosphamide
735583|NCT00103779|Antigens, CD40|antigens, cd40
735584|NCT00103779|Antibody, Monoclonal|antibody, monoclonal
735585|NCT00103779|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
735586|NCT00103779|Lymphoma, B-Cell|lymphoma, b-cell
735587|NCT00103779|Hematologic Diseases|hematologic diseases
735588|NCT00103779|Immunoproliferative Disorders|immunoproliferative disorders
735589|NCT00103779|Lymphatic Diseases|lymphatic diseases
735590|NCT00103779|Lymphoproliferative Disorders|lymphoproliferative disorders
735591|NCT00103779|Lymphoma|lymphoma
735592|NCT00103766|Alteplase|alteplase
735593|NCT00103766|Empyema|empyema
735594|NCT00103766|Complicated Parapneumonic Effusion|complicated parapneumonic effusion
735595|NCT00103753|Randomized Controlled Trial|randomized controlled trial
735596|NCT00103753|Deferiprone|deferiprone
735597|NCT00103753|Deferoxamine|deferoxamine
735598|NCT00103753|Iron chelation|iron chelation
735599|NCT00103753|Beta Thalassemia Major|beta thalassemia major
735600|NCT00103740|Zoledronic acid, risedronate, Paget's disease of bone|zoledronic acid, risedronate, paget's disease of bone
735601|NCT00103727|paranoid|paranoid
735602|NCT00103727|catatonic|catatonic
735603|NCT00103727|undifferentiated types|undifferentiated types
735604|NCT00103727|disorganized|disorganized
735605|NCT00103714|lung disease|lung disease
735606|NCT00103701|Chronic myelogenous leukemia (CML) chronic, accelerated, blast phase|chronic myelogenous leukemia (cml) chronic, accelerated, blast phase
735607|NCT00103701|Philadelphia chromosome positive acute (Ph+ALL)|philadelphia chromosome positive acute (ph+all)
735608|NCT00103675|Acupuncture|acupuncture
735609|NCT00103636|Phlebitis/etiology|phlebitis/etiology
735610|NCT00103636|Infusions|infusions
735611|NCT00103636|Intravenous/adverse effects|intravenous/adverse effects
735612|NCT00103636|Randomised controlled trial|randomised controlled trial
735613|NCT00103636|Phlebitis/prevention|phlebitis/prevention
735614|NCT00103636|Adult|adult
735615|NCT00103636|Time factors|time factors
735616|NCT00103623|Advanced|advanced
735617|NCT00103623|Symptomatic|symptomatic
735618|NCT00103623|Prostate|prostate
735619|NCT00103623|Cancer|cancer
735620|NCT00103623|Advanced Symptomatic Prostate Cancer|advanced symptomatic prostate cancer
735621|NCT00103610|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
735622|NCT00103610|Stem cell mobilization|stem cell mobilization
735623|NCT00103597|Orthostatic hypotension|orthostatic hypotension
735624|NCT00103597|Parkinson's Disease|parkinson's disease
735625|NCT00103545|Ovarian Cancer|ovarian cancer
735627|NCT00103545|6 or 9 vaccinations|6 or 9 vaccinations
735628|NCT00103545|immune response|immune response
735629|NCT00103545|Fallopian tube cancer|fallopian tube cancer
735630|NCT00103545|Peritoneal cancer|peritoneal cancer
735631|NCT00103532|motivational enhancement|motivational enhancement
735632|NCT00103532|health behaviors|health behaviors
735633|NCT00103532|risk behaviors|risk behaviors
735634|NCT00103519|Heart Failure, DITPA|heart failure, ditpa
735635|NCT00103506|Multiple Myeloma|multiple myeloma
735636|NCT00103506|Doxil|doxil
735637|NCT00103506|Caelyx|caelyx
735638|NCT00103506|Doxorubicin|doxorubicin
735639|NCT00103506|Velcade|velcade
735640|NCT00103506|Bortezomib|bortezomib
735641|NCT00103454|allergic rhinitis|allergic rhinitis
735642|NCT00103454|GW685698X|gw685698x
735643|NCT00103454|Perennial Allergic Rhinitis|perennial allergic rhinitis
735644|NCT00103428|chemotherapy|chemotherapy
735645|NCT00103428|prostate cancer|prostate cancer
735646|NCT00103428|cancer|cancer
735647|NCT00103428|metastatic|metastatic
735648|NCT00103428|hormone refractory|hormone refractory
735649|NCT00103428|chemotherapy naive|chemotherapy naive
735650|NCT00103428|dose escalation|dose escalation
735651|NCT00103415|Depression|depression
735652|NCT00103415|Exercise|exercise
735653|NCT00103415|Job|job
735654|NCT00103402|Prostatitis|prostatitis
735655|NCT00103402|Non-bacterial Prostatitis|non-bacterial prostatitis
735656|NCT00103402|Prostatodynia|prostatodynia
735657|NCT00103402|Alfuzosin|alfuzosin
735658|NCT00103402|Alpha-adrenergic blocker|alpha-adrenergic blocker
735659|NCT00103389|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
735660|NCT00103389|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
735661|NCT00103389|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
735662|NCT00103376|adenocarcinoma of the prostate|adenocarcinoma of the prostate
735663|NCT00103376|recurrent prostate cancer|recurrent prostate cancer
735664|NCT00103363|non-small cell lung cancer|non-small cell lung cancer
735665|NCT00103363|small cell lung cancer|small cell lung cancer
735666|NCT00103350|myocardial infarction|myocardial infarction
735667|NCT00103350|infarct size|infarct size
735668|NCT00103350|angioplasty|angioplasty
735669|NCT00103350|percutaneous coronary intervention|percutaneous coronary intervention
735670|NCT00103350|Acute Myocardial Infarction|acute myocardial infarction
735671|NCT00103298|recurrent colon cancer|recurrent colon cancer
735672|NCT00103298|stage IV colon cancer|stage iv colon cancer
735673|NCT00103298|recurrent rectal cancer|recurrent rectal cancer
735674|NCT00103298|stage IV rectal cancer|stage iv rectal cancer
735675|NCT00103298|liver metastases|liver metastases
735676|NCT00103246|skin cancer|skin cancer
735677|NCT00103246|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
735678|NCT00103246|basal cell carcinoma of the skin|basal cell carcinoma of the skin
735679|NCT00103246|recurrent skin cancer|recurrent skin cancer
735680|NCT00103246|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
735681|NCT00103246|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
735682|NCT00103246|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
735683|NCT00103246|actinic keratosis|actinic keratosis
735684|NCT00103246|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
735685|NCT00103246|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
735686|NCT00103246|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
735687|NCT00103233|stage IV breast cancer|stage iv breast cancer
735688|NCT00103233|recurrent breast cancer|recurrent breast cancer
735689|NCT00103207|bronchioalveolar carcinoma (BAC)|bronchioalveolar carcinoma (bac)
735690|NCT00103207|adenocarcinoma with BAC features|adenocarcinoma with bac features
735691|NCT00103207|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
735692|NCT00103207|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
735693|NCT00103207|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
735694|NCT00103207|cetuximab|cetuximab
735695|NCT00103181|stage II breast cancer|stage ii breast cancer
735696|NCT00103181|ductal breast carcinoma in situ|ductal breast carcinoma in situ
735697|NCT00103181|breast cancer in situ|breast cancer in situ
735698|NCT00103181|stage IA breast cancer|stage ia breast cancer
735699|NCT00103181|stage IB breast cancer|stage ib breast cancer
735700|NCT00103168|gastrointestinal stromal tumor|gastrointestinal stromal tumor
735701|NCT00103155|stage I papillary thyroid cancer|stage i papillary thyroid cancer
735702|NCT00103142|liver metastases|liver metastases
735703|NCT00103142|adenocarcinoma of the colon|adenocarcinoma of the colon
735704|NCT00103142|recurrent colon cancer|recurrent colon cancer
735705|NCT00103142|stage IV colon cancer|stage iv colon cancer
735706|NCT00103142|adenocarcinoma of the rectum|adenocarcinoma of the rectum
735707|NCT00103142|recurrent rectal cancer|recurrent rectal cancer
735708|NCT00103142|stage IV rectal cancer|stage iv rectal cancer
735709|NCT00103142|lung metastases|lung metastases
735710|NCT00103116|stage I non-small cell lung cancer|stage i non-small cell lung cancer
735711|NCT00103116|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
735712|NCT00103116|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
735793|NCT00102908|Osteoporosis|osteoporosis
735713|NCT00103116|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
735714|NCT00103116|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
735715|NCT00103103|recurrent gastric cancer|recurrent gastric cancer
735716|NCT00103103|stage IV gastric cancer|stage iv gastric cancer
735717|NCT00103103|adenocarcinoma of the stomach|adenocarcinoma of the stomach
735718|NCT00103090|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
735719|NCT00103090|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
735720|NCT00103090|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
735721|NCT00103090|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
735722|NCT00103090|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
735723|NCT00103090|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
735724|NCT00103090|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
735725|NCT00103090|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
735726|NCT00103090|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
735727|NCT00103090|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
735728|NCT00103090|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
735729|NCT00103090|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
735730|NCT00103090|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
735731|NCT00103090|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
735732|NCT00103090|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
735733|NCT00103090|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
735734|NCT00103090|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
735735|NCT00103090|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
735736|NCT00103090|recurrent salivary gland cancer|recurrent salivary gland cancer
735737|NCT00103090|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
735738|NCT00103090|stage III salivary gland cancer|stage iii salivary gland cancer
735739|NCT00103090|stage IV salivary gland cancer|stage iv salivary gland cancer
735740|NCT00103090|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
735741|NCT00103090|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
735742|NCT00103051|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
735743|NCT00103025|Vasodilation|vasodilation
735744|NCT00103025|Hypotension|hypotension
735745|NCT00103025|Hypertension|hypertension
735746|NCT00103025|EDRF|edrf
735747|NCT00103025|Methemoglobinemia|methemoglobinemia
735748|NCT00103025|Healthy Volunteer|healthy volunteer
735750|NCT00103012|Antiretrovirals|antiretrovirals
735751|NCT00103012|Protease Inhibitors|protease inhibitors
735752|NCT00103012|Herbal Supplements|herbal supplements
735753|NCT00103012|Drug Interactions|drug interactions
735754|NCT00103012|Metabolism|metabolism
735755|NCT00103012|Healthy Volunteer|healthy volunteer
735756|NCT00103012|HV|hv
735757|NCT00102999|Learning|learning
735758|NCT00102999|PAS|pas
735759|NCT00102999|Upper Limb|upper limb
735760|NCT00102999|TMS|tms
735761|NCT00102999|Somatosensory|somatosensory
735762|NCT00102999|Dystonia|dystonia
735763|NCT00102999|Upper Limb Dystonia|upper limb dystonia
735764|NCT00102999|Healthy Volunteer|healthy volunteer
735765|NCT00102999|HV|hv
735766|NCT00102986|Kaletra|kaletra
735767|NCT00102986|Treatment Experienced|treatment experienced
735768|NCT00102973|Ovary|ovary
735769|NCT00102960|Infant|infant
735770|NCT00102960|Perinatal|perinatal
735771|NCT00102960|HIV|hiv
735772|NCT00102960|Disease Transmission, Vertical|disease transmission, vertical
735773|NCT00102960|Anti-Retroviral Agents|anti-retroviral agents
735774|NCT00102960|Treatment Interruption|treatment interruption
735775|NCT00102960|Treatment Naive|treatment naive
735776|NCT00102960|Acute Infection|acute infection
735777|NCT00102960|Mother-to-Child Transmission|mother-to-child transmission
735778|NCT00102947|renal impairment|renal impairment
735779|NCT00102947|daptomycin|daptomycin
735780|NCT00102947|Cubist|cubist
735781|NCT00102947|complicated skin and skin structure infections|complicated skin and skin structure infections
735782|NCT00102934|HIV|hiv
735783|NCT00102934|Drug Resistance|drug resistance
735784|NCT00102934|Viral Fitness|viral fitness
735785|NCT00102934|HIV Specific Immunity|hiv specific immunity
735786|NCT00102934|T Cell Activation|t cell activation
735787|NCT00102934|Drug Resistant Viremia|drug resistant viremia
735788|NCT00102934|Treatment Experienced|treatment experienced
735789|NCT00102921|Crohn Disease|crohn disease
735790|NCT00102921|oral medication|oral medication
735791|NCT00102908|Bone Metabolism|bone metabolism
735792|NCT00102908|Osteopenia|osteopenia
735901|NCT00102570|Rhinitis|rhinitis
735794|NCT00102908|Treatment Experienced|treatment experienced
735795|NCT00102882|genotype|genotype
735796|NCT00102882|Salmeterol|salmeterol
735797|NCT00102882|ADVAIR|advair
735798|NCT00102869|language acquisition|language acquisition
735799|NCT00102869|plasticity|plasticity
735800|NCT00102869|stroke recovery|stroke recovery
735801|NCT00102869|aphasia treatment|aphasia treatment
735802|NCT00102869|naming|naming
735803|NCT00102869|levodopa|levodopa
735804|NCT00102869|stroke|stroke
735805|NCT00102856|language acquisition|language acquisition
735806|NCT00102856|plasticity|plasticity
735807|NCT00102856|stroke recovery|stroke recovery
735808|NCT00102856|associative learning|associative learning
735809|NCT00102843|folic acid|folic acid
735810|NCT00102843|betaine|betaine
735811|NCT00102843|homocysteine|homocysteine
735812|NCT00102843|cardiovascular disease prevention|cardiovascular disease prevention
735813|NCT00102843|human|human
735814|NCT00102843|Cardiovascular health|cardiovascular health
735815|NCT00102830|Solid Tumor|solid tumor
735816|NCT00102830|Metastatic Cancer|metastatic cancer
735817|NCT00102830|Advanced Solid Tumors|advanced solid tumors
735818|NCT00102817|Growth Hormone Disorder|growth hormone disorder
735819|NCT00102791|Sickle Cell Anemia|sickle cell anemia
735820|NCT00102778|HIV infected|hiv infected
735821|NCT00102778|therapy-naive subjects|therapy-naive subjects
735822|NCT00102765|asthma exacerbation|asthma exacerbation
735823|NCT00102765|asthma|asthma
735824|NCT00102752|Pancreas|pancreas
735825|NCT00102752|Cancer|cancer
735826|NCT00102752|Metastatic|metastatic
735827|NCT00102752|Glufosfamide|glufosfamide
735828|NCT00102752|Advanced|advanced
735829|NCT00102752|Solid|solid
735830|NCT00102752|Tumor|tumor
735831|NCT00102752|Advanced Solid Tumors|advanced solid tumors
735832|NCT00102752|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
735833|NCT00102739|thrombopoietin|thrombopoietin
735834|NCT00102739|immune thrombocytopenic purpura|immune thrombocytopenic purpura
735835|NCT00102739|platelets|platelets
735836|NCT00102739|chronic thrombocytopenia|chronic thrombocytopenia
735837|NCT00102726|chemotherapy|chemotherapy
735838|NCT00102726|thrombopoietin|thrombopoietin
735839|NCT00102726|platelets|platelets
735840|NCT00102726|chemotherapy induced|chemotherapy induced
735841|NCT00102713|Partial Seizures|partial seizures
735842|NCT00102700|cancer|cancer
735843|NCT00102700|solid tumor|solid tumor
735844|NCT00102700|advanced solid tumor|advanced solid tumor
735845|NCT00102700|pancreas|pancreas
735846|NCT00102700|pancreatic cancer|pancreatic cancer
735847|NCT00102700|cancer of the pancreas|cancer of the pancreas
735848|NCT00102674|cangrelor|cangrelor
735849|NCT00102674|clopidogrel|clopidogrel
735850|NCT00102648|Glioblastoma Multiforme|glioblastoma multiforme
735851|NCT00102648|Gliosarcoma|gliosarcoma
735852|NCT00102648|Brain Tumors|brain tumors
735853|NCT00102648|Sarasar|sarasar
735854|NCT00102648|Temodar|temodar
735855|NCT00102648|Temozolomide|temozolomide
735856|NCT00102648|Lonafarnib|lonafarnib
735857|NCT00102648|SCH 66336|sch 66336
735858|NCT00102635|apoptotic activity|apoptotic activity
735859|NCT00102635|4-HPR|4-hpr
735860|NCT00102635|FTI|fti
735861|NCT00102635|Fenretinide|fenretinide
735862|NCT00102635|SCH66336|sch66336
735863|NCT00102635|Farnesyl Transferase Inhibitor|farnesyl transferase inhibitor
735864|NCT00102635|HNC|hnc
735865|NCT00102622|Ovary|ovary
735866|NCT00102622|ovarian cancer|ovarian cancer
735867|NCT00102622|biologic therapy|biologic therapy
735868|NCT00102622|platinum-resistant|platinum-resistant
735869|NCT00102622|platinum-refractory ovarian cancer|platinum-refractory ovarian cancer
735870|NCT00102622|platinum-resistant ovarian cancer|platinum-resistant ovarian cancer
735871|NCT00102622|paclitaxel|paclitaxel
735872|NCT00102622|tgDCC-E1A|tgdcc-e1a
735873|NCT00102622|E1A|e1a
735874|NCT00102622|Taxol|taxol
735875|NCT00102609|Doxorubicin|doxorubicin
735876|NCT00102609|Adriamycin|adriamycin
735877|NCT00102609|Trabectedin|trabectedin
735878|NCT00102609|Yondelis|yondelis
735879|NCT00102609|Ecteinascidin 743|ecteinascidin 743
735880|NCT00102609|Filgrastim, Antineoplastic|filgrastim, antineoplastic
735881|NCT00102609|Antineoplastic Agents|antineoplastic agents
735882|NCT00102609|Pharmacologic Actions|pharmacologic actions
735883|NCT00102609|Alkylating Agents|alkylating agents
735884|NCT00102596|Ethanol|ethanol
735885|NCT00102596|Alcohol Responsive|alcohol responsive
735886|NCT00102596|Movement Disorder|movement disorder
735887|NCT00102596|Gas Chromatography|gas chromatography
735888|NCT00102596|Bioavailability|bioavailability
735889|NCT00102596|Pharmacokinetics|pharmacokinetics
735890|NCT00102596|Essential Tremor|essential tremor
735891|NCT00102583|Dry Eye|dry eye
735892|NCT00102583|Lacrimal Gland|lacrimal gland
735893|NCT00102583|Tear Deficiency|tear deficiency
735894|NCT00102583|Keratitis Sicca|keratitis sicca
735895|NCT00102583|GVHD|gvhd
735896|NCT00102583|Ocular GVHD|ocular gvhd
735897|NCT00102583|Ocular Graft Vs Host Disease|ocular graft vs host disease
735898|NCT00102570|Pediatric|pediatric
735899|NCT00102570|Atopic|atopic
735900|NCT00102570|Asthma|asthma
735904|NCT00102570|Pediatric Allergy|pediatric allergy
735905|NCT00102570|Food Allergy|food allergy
735906|NCT00102570|Stinging Insect Allergy|stinging insect allergy
735907|NCT00102570|Atopic Dermatitis|atopic dermatitis
735908|NCT00102570|Insect Sting|insect sting
735909|NCT00102557|Vesiculobullous|vesiculobullous
735910|NCT00102557|Mucosal Lesions|mucosal lesions
735911|NCT00102557|Oral Health|oral health
735912|NCT00102557|Dermatology|dermatology
735913|NCT00102557|Plaquenil|plaquenil
735914|NCT00102557|Oral Lichen Planus|oral lichen planus
735915|NCT00102557|Mouth Lesions|mouth lesions
735916|NCT00102557|Oral Lesions|oral lesions
735917|NCT00102544|CT-Guided|ct-guided
735918|NCT00102544|Electromagnetic Tracking|electromagnetic tracking
735919|NCT00102544|Ultrasound-Guided Biopsy|ultrasound-guided biopsy
735920|NCT00102544|Ablation|ablation
735921|NCT00102544|Surgical Navigation|surgical navigation
735922|NCT00102531|Osteosarcoma|osteosarcoma
735923|NCT00102531|relapsed|relapsed
735924|NCT00102531|progressive|progressive
735925|NCT00102531|metastatic|metastatic
735926|NCT00102531|lung|lung
735927|NCT00102518|Open Label|open label
735928|NCT00102518|Aripiprazole|aripiprazole
735929|NCT00102518|Bipolar I Disorder, Manic or Mixed Episode|bipolar i disorder, manic or mixed episode
735930|NCT00102505|Non-Small Cell Lung Cancer|non-small cell lung cancer
735931|NCT00102505|Lung Cancer|lung cancer
735932|NCT00102505|Metastatic lung cancer|metastatic lung cancer
735933|NCT00102505|Inoperable lung cancer|inoperable lung cancer
735934|NCT00102505|Advanced lung cancer|advanced lung cancer
735935|NCT00102505|Large-cell lung cancer|large-cell lung cancer
735936|NCT00102505|Adenocarcinoma, lung|adenocarcinoma, lung
735937|NCT00102505|Squamous cell carcinoma, lung|squamous cell carcinoma, lung
735938|NCT00102505|Squamous cell lung cancer|squamous cell lung cancer
735939|NCT00102505|Large cell carcinoma, lung|large cell carcinoma, lung
735940|NCT00102505|Bronchogenic|bronchogenic
735941|NCT00102492|Major Depressive Disorder|major depressive disorder
735942|NCT00102492|Major Depression|major depression
735943|NCT00102492|Mood Disorders|mood disorders
735944|NCT00102492|Major Depressive Episode|major depressive episode
735945|NCT00102479|Pharmacokinetics,|pharmacokinetics,
735946|NCT00102479|Aripiprazole|aripiprazole
735947|NCT00102479|acute mania in pediatric populations|acute mania in pediatric populations
735948|NCT00102466|type 2 diabetes|type 2 diabetes
735949|NCT00102466|vildagliptin|vildagliptin
735950|NCT00102453|Duchenne|duchenne
735951|NCT00102453|Genetics|genetics
735952|NCT00102440|uric Acid|uric acid
735953|NCT00102440|xanthine oxidase|xanthine oxidase
735954|NCT00102440|tophi|tophi
735955|NCT00102440|Drug Therapy|drug therapy
735956|NCT00102427|Anxiety|anxiety
735957|NCT00102427|Panic|panic
735958|NCT00102427|Generalized Anxiety Disorder|generalized anxiety disorder
735959|NCT00102414|Ovarian cancer|ovarian cancer
735960|NCT00102414|Recurrence or progression|recurrence or progression
735961|NCT00102414|Gemcitabine plus Carboplatin vs Carboplatin|gemcitabine plus carboplatin vs carboplatin
735962|NCT00102401|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
735963|NCT00102401|Pulmonary Disease, chronic obstructive|pulmonary disease, chronic obstructive
735964|NCT00102401|Lung disease, obstructive|lung disease, obstructive
735965|NCT00102401|Self-care|self-care
735966|NCT00102401|Self-management|self-management
735967|NCT00102401|Patient education|patient education
735968|NCT00102388|type 2 diabetes|type 2 diabetes
735969|NCT00102388|vildagliptin|vildagliptin
735970|NCT00102375|Ovarian Cancer|ovarian cancer
735971|NCT00102375|first-line|first-line
735972|NCT00102375|Topotecan|topotecan
735973|NCT00102362|behavioral intervention|behavioral intervention
735974|NCT00102349|behavioral intervention|behavioral intervention
735975|NCT00102336|immune (idiopathic) thrombocytopenic purpura|immune (idiopathic) thrombocytopenic purpura
735976|NCT00102336|pre-splenectomy|pre-splenectomy
735977|NCT00102336|ITP|itp
735978|NCT00102336|Thrombopenia|thrombopenia
735979|NCT00102323|immune (idiopathic) thrombocytopenic purpura|immune (idiopathic) thrombocytopenic purpura
735980|NCT00102323|post-splenectomy|post-splenectomy
735981|NCT00102323|ITP|itp
735982|NCT00102323|Thrombopenia|thrombopenia
735983|NCT00102310|Nausea|nausea
735984|NCT00102310|Indigestion|indigestion
735985|NCT00102310|Bloating|bloating
735986|NCT00102310|Functional Dyspepsia|functional dyspepsia
735987|NCT00102310|Fullness after Meals|fullness after meals
735988|NCT00102297|Incipient Nephropathy|incipient nephropathy
735989|NCT00102297|Type 1 or Type 2 Diabetes|type 1 or type 2 diabetes
735990|NCT00102284|language acquisition|language acquisition
735991|NCT00102284|plasticity|plasticity
735992|NCT00102284|stroke recovery|stroke recovery
735993|NCT00102284|associative learning|associative learning
735994|NCT00102271|Sodium Nitrite|sodium nitrite
735995|NCT00102271|Oxypurinol|oxypurinol
735996|NCT00102271|Ascorbic Acid|ascorbic acid
735997|NCT00102271|Hypoxic Gas|hypoxic gas
735998|NCT00102271|Forearm Blood Flow|forearm blood flow
735999|NCT00102271|Healthy Volunteer|healthy volunteer
736000|NCT00102271|HV|hv
736001|NCT00102258|Short Stature|short stature
736002|NCT00102258|Constitutional Delay of Growth and Development|constitutional delay of growth and development
736003|NCT00102258|Body Composition|body composition
736004|NCT00102258|Energy Expenditure|energy expenditure
736005|NCT00102258|Dietary Supplements|dietary supplements
736006|NCT00102258|Constitutional Delay of Growth|constitutional delay of growth
736007|NCT00102258|CDGM|cdgm
736008|NCT00102245|Hemoglobin|hemoglobin
736009|NCT00102245|Hemoglobinapathies|hemoglobinapathies
736010|NCT00102245|Human Genome|human genome
736011|NCT00102245|Recombinant DNA Technology|recombinant dna technology
736012|NCT00102245|Sequencing|sequencing
736013|NCT00102245|Erythrocyte|erythrocyte
736014|NCT00102232|phosphatidylcholine|phosphatidylcholine
736015|NCT00102232|choline|choline
736016|NCT00102232|homocysteine|homocysteine
736017|NCT00102232|cardiovascular disease prevention|cardiovascular disease prevention
736018|NCT00102232|human|human
736019|NCT00102232|cardiovascular health|cardiovascular health
736020|NCT00102206|Treatment Experienced|treatment experienced
736021|NCT00102206|Child|child
736022|NCT00102193|Ulcerative Colitis, Apheresis|ulcerative colitis, apheresis
736023|NCT00102141|Postmenopausal|postmenopausal
736024|NCT00102141|vasomotor symptoms|vasomotor symptoms
736025|NCT00102141|essential hypertension|essential hypertension
736026|NCT00102115|Macular disease|macular disease
736027|NCT00102115|Wet AMD|wet amd
736028|NCT00102115|AMD|amd
736029|NCT00102115|Age-Related Macular Disease|age-related macular disease
736030|NCT00102115|PDT|pdt
736031|NCT00102115|Photodynamic Therapy|photodynamic therapy
736032|NCT00102102|Substance P|substance p
736033|NCT00102102|Neurokinin|neurokinin
736034|NCT00102102|Tachykinin|tachykinin
736035|NCT00102102|Anxiety|anxiety
736036|NCT00102102|Neuroreceptor Imaging|neuroreceptor imaging
736037|NCT00102102|Post-Traumatic Stress Disorder|post-traumatic stress disorder
736038|NCT00102102|PTSD|ptsd
736039|NCT00102102|Healthy Volunteer|healthy volunteer
736040|NCT00102102|HV|hv
736041|NCT00102089|HIV-Negative|hiv-negative
736042|NCT00102089|Healthy|healthy
736043|NCT00102089|Immunity|immunity
736044|NCT00102089|Preventive|preventive
736045|NCT00102089|Virus|virus
736046|NCT00102089|Healthy Volunteer|healthy volunteer
736047|NCT00102089|HV|hv
736048|NCT00102076|Minimal|minimal
736049|NCT00102076|Risk|risk
736050|NCT00102076|Regulations|regulations
736051|NCT00102076|Parents|parents
736052|NCT00102076|IRB|irb
736053|NCT00102076|Surgery|surgery
736054|NCT00102076|Assent Requirement|assent requirement
736055|NCT00102063|Schizophrenia|schizophrenia
736056|NCT00102063|Aripiprazole|aripiprazole
736057|NCT00102050|NM-702 tablets|nm-702 tablets
736058|NCT00102050|intermittent claudication|intermittent claudication
736059|NCT00102050|peripheral|peripheral
736060|NCT00102050|arterial|arterial
736061|NCT00102050|vascular|vascular
736062|NCT00102050|peripheral arterial disease|peripheral arterial disease
736063|NCT00102024|Metastatic Colorectal Adenocarcinoma|metastatic colorectal adenocarcinoma
736064|NCT00102024|Anti TAG-72|anti tag-72
736065|NCT00102024|Monoclonal Antibody|monoclonal antibody
736066|NCT00102011|colon cancer|colon cancer
736067|NCT00102011|rectal cancer|rectal cancer
736068|NCT00101998|OBD (Induced Bowel Dysfunction)|obd (induced bowel dysfunction)
736069|NCT00101998|cancer pain|cancer pain
736070|NCT00101998|pain medication|pain medication
736071|NCT00101998|constipation|constipation
736072|NCT00101998|bowel|bowel
736073|NCT00101998|bowel dysfunction|bowel dysfunction
736074|NCT00101985|Quality of Life|quality of life
736075|NCT00101985|Irritable bowel syndrome|irritable bowel syndrome
736076|NCT00101985|IBS|ibs
736077|NCT00101985|SB223412|sb223412
736078|NCT00101985|Qol|qol
736079|NCT00101972|adenocarcinoma of the bladder|adenocarcinoma of the bladder
736080|NCT00101972|adenocarcinoma of the colon|adenocarcinoma of the colon
736081|NCT00101972|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
736082|NCT00101972|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
736083|NCT00101972|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
736084|NCT00101972|adenocarcinoma of the lung|adenocarcinoma of the lung
736085|NCT00101972|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
736086|NCT00101972|adenocarcinoma of the prostate|adenocarcinoma of the prostate
736087|NCT00101972|adenocarcinoma of the rectum|adenocarcinoma of the rectum
736088|NCT00101972|adenocarcinoma of the stomach|adenocarcinoma of the stomach
736089|NCT00101972|adenocarcinoma with squamous metaplasia of the gallbladder|adenocarcinoma with squamous metaplasia of the gallbladder
736090|NCT00101972|cervical adenocarcinoma|cervical adenocarcinoma
736091|NCT00101972|endometrial adenocarcinoma|endometrial adenocarcinoma
736092|NCT00101972|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
736093|NCT00101972|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
736094|NCT00101972|salivary gland adenocarcinoma|salivary gland adenocarcinoma
736095|NCT00101972|small intestine adenocarcinoma|small intestine adenocarcinoma
736096|NCT00101972|vaginal adenocarcinoma|vaginal adenocarcinoma
736097|NCT00101972|vaginal clear cell adenocarcinoma|vaginal clear cell adenocarcinoma
736098|NCT00101972|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
736099|NCT00101972|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
736100|NCT00101972|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
736101|NCT00101972|stage IV bladder cancer|stage iv bladder cancer
736102|NCT00101972|stage IV breast cancer|stage iv breast cancer
736103|NCT00101972|stage IV colon cancer|stage iv colon cancer
736104|NCT00101972|stage IV endometrial carcinoma|stage iv endometrial carcinoma
736105|NCT00101972|stage IV esophageal cancer|stage iv esophageal cancer
736106|NCT00101972|stage IV gastric cancer|stage iv gastric cancer
736107|NCT00101972|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
736108|NCT00101972|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
736109|NCT00101972|stage IV prostate cancer|stage iv prostate cancer
736110|NCT00101972|stage IV rectal cancer|stage iv rectal cancer
736111|NCT00101972|stage IV renal cell cancer|stage iv renal cell cancer
736112|NCT00101972|stage IV salivary gland cancer|stage iv salivary gland cancer
736113|NCT00101972|stage IVA cervical cancer|stage iva cervical cancer
736114|NCT00101972|stage IVA vaginal cancer|stage iva vaginal cancer
736115|NCT00101972|stage IVB cervical cancer|stage ivb cervical cancer
736116|NCT00101972|stage IVB vaginal cancer|stage ivb vaginal cancer
736117|NCT00101972|recurrent bladder cancer|recurrent bladder cancer
736118|NCT00101972|recurrent breast cancer|recurrent breast cancer
736119|NCT00101972|recurrent cervical cancer|recurrent cervical cancer
736120|NCT00101972|recurrent colon cancer|recurrent colon cancer
736121|NCT00101972|recurrent endometrial carcinoma|recurrent endometrial carcinoma
736122|NCT00101972|recurrent esophageal cancer|recurrent esophageal cancer
736123|NCT00101972|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
736124|NCT00101972|recurrent gallbladder cancer|recurrent gallbladder cancer
736125|NCT00101972|recurrent gastric cancer|recurrent gastric cancer
736126|NCT00101972|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
736127|NCT00101972|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
736128|NCT00101972|recurrent pancreatic cancer|recurrent pancreatic cancer
736129|NCT00101972|recurrent prostate cancer|recurrent prostate cancer
736130|NCT00101972|recurrent rectal cancer|recurrent rectal cancer
736131|NCT00101972|recurrent renal cell cancer|recurrent renal cell cancer
736132|NCT00101972|recurrent salivary gland cancer|recurrent salivary gland cancer
736133|NCT00101972|recurrent small intestine cancer|recurrent small intestine cancer
736134|NCT00101972|recurrent vaginal cancer|recurrent vaginal cancer
736135|NCT00101972|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
736136|NCT00101972|unresectable gallbladder cancer|unresectable gallbladder cancer
736137|NCT00101972|stage IV pancreatic cancer|stage iv pancreatic cancer
736138|NCT00101946|CD|cd
736139|NCT00101946|Crohn's Disease|crohn's disease
736140|NCT00101933|Deep brain stimulation, DBS, SANTE|deep brain stimulation, dbs, sante
736141|NCT00101907|Advanced Cancer|advanced cancer
736142|NCT00101907|AMG 706|amg 706
736143|NCT00101907|Panitumumab|panitumumab
736144|NCT00101907|Gemcitabine-Cisplatin|gemcitabine-cisplatin
736145|NCT00101894|AMG 706|amg 706
736146|NCT00101894|Panitumumab|panitumumab
736147|NCT00101881|Cardiac arrest|cardiac arrest
736148|NCT00101881|Defibrillation|defibrillation
736149|NCT00101881|Biphasic defibrillation|biphasic defibrillation
736150|NCT00101881|Monophasic defibrillation|monophasic defibrillation
736151|NCT00101881|Ventricular fibrillation|ventricular fibrillation
736152|NCT00101868|Aged|aged
736153|NCT00101868|Hospitalists|hospitalists
736154|NCT00101868|Outcome and process assessment (health care)|outcome and process assessment (health care)
736155|NCT00101868|Human|human
736156|NCT00101868|Hospitals, teaching|hospitals, teaching
736157|NCT00101868|Physicians, family|physicians, family
736158|NCT00101868|Medical records|medical records
736159|NCT00101868|Quality assurance, health care|quality assurance, health care
736160|NCT00101868|Medical errors|medical errors
736161|NCT00101855|prevention|prevention
736162|NCT00101855|internet|internet
736163|NCT00101855|quality of care|quality of care
736164|NCT00101829|Autoimmune Diseases|autoimmune diseases
736165|NCT00101816|Myeloid blast phase Chronic Myeloid Leukemia (CML)|myeloid blast phase chronic myeloid leukemia (cml)
736166|NCT00101803|type 2 diabetes|type 2 diabetes
736167|NCT00101803|vildagliptin|vildagliptin
736168|NCT00101790|low back pain|low back pain
736169|NCT00101790|pamidronate|pamidronate
736170|NCT00101777|Anxiety|anxiety
736171|NCT00101777|Ventilation|ventilation
736172|NCT00101777|Panic Disorder|panic disorder
736173|NCT00101777|Children|children
736174|NCT00101777|Healthy Volunteer|healthy volunteer
736175|NCT00101777|HV|hv
736176|NCT00101777|Normal Control|normal control
736177|NCT00101764|AMD|amd
736178|NCT00101764|CRVO|crvo
736179|NCT00101764|BRVO|brvo
736180|NCT00101764|Uveitis|uveitis
736181|NCT00101764|Choroidal Neovascularization|choroidal neovascularization
736182|NCT00101764|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
736183|NCT00101764|Macular Edema|macular edema
736184|NCT00101764|Central Retinal Vein Occlusion|central retinal vein occlusion
736185|NCT00101764|Branch Retinal Vein Occlusion|branch retinal vein occlusion
736186|NCT00101764|Inflammation|inflammation
736187|NCT00101764|Age Related Macular Degeneration|age related macular degeneration
736188|NCT00101764|Retinal Disorder|retinal disorder
736189|NCT00101738|MPA|mpa
736190|NCT00101738|Kidney Transplantation|kidney transplantation
736191|NCT00101738|Acute rejection|acute rejection
736192|NCT00101738|Kidney function|kidney function
736193|NCT00101725|Diarrhea|diarrhea
736194|NCT00101725|IBS|ibs
736195|NCT00101725|Irritable Bowel Syndrome|irritable bowel syndrome
736196|NCT00101725|Abdominal pain|abdominal pain
736197|NCT00101712|type 2 diabetes|type 2 diabetes
736198|NCT00101712|vildagliptin|vildagliptin
736199|NCT00101699|Women|women
736200|NCT00101699|Soy Foods|soy foods
736201|NCT00101699|Middle Aged|middle aged
736202|NCT00101673|type 2 diabetes|type 2 diabetes
736203|NCT00101673|vildagliptin|vildagliptin
736204|NCT00101660|Chronic phase Philadelphia chromosome chronic myeloid leukemia (Ph+CML)|chronic phase philadelphia chromosome chronic myeloid leukemia (ph+cml)
736205|NCT00101647|Chronic myelogenous leukemia (CML): Accelerated phase|chronic myelogenous leukemia (cml): accelerated phase
736206|NCT00101634|Schizophrenia|schizophrenia
736207|NCT00101634|Paliperidone palmitate|paliperidone palmitate
736208|NCT00101634|R092670|r092670
736209|NCT00101634|antipsychotic|antipsychotic
736210|NCT00101621|cancer|cancer
736211|NCT00101621|pain|pain
736212|NCT00101621|Cancers, Pain|cancers, pain
736213|NCT00101608|urothelium|urothelium
736214|NCT00101595|Lymphoid blast phase chronic myeloid leukemia|lymphoid blast phase chronic myeloid leukemia
736215|NCT00101595|Philadelphia chromosome positive acute lymphoblastic leukemia|philadelphia chromosome positive acute lymphoblastic leukemia
736216|NCT00101582|SCCHN|scchn
736217|NCT00101582|Palifermin|palifermin
736218|NCT00101582|Mucositis|mucositis
736219|NCT00101582|Oral Cavity|oral cavity
736220|NCT00101582|Oropharynx|oropharynx
736221|NCT00101582|Nasopharynx|nasopharynx
736222|NCT00101582|Hypopharynx|hypopharynx
736223|NCT00101582|Larynx|larynx
736224|NCT00101582|Mouth Pain|mouth pain
736225|NCT00101582|Mouth Sores|mouth sores
736226|NCT00101582|Radiation Therapy|radiation therapy
736227|NCT00101582|Radiotherapy|radiotherapy
736228|NCT00101582|Radiochemotherapy|radiochemotherapy
736229|NCT00101582|Concurrent Chemotherapy|concurrent chemotherapy
736230|NCT00101582|Xerostomia|xerostomia
736231|NCT00101582|Stomatitis|stomatitis
736232|NCT00101582|Mucosa|mucosa
736233|NCT00101582|KGF|kgf
736234|NCT00101582|rHuKGF|rhukgf
736235|NCT00101582|Keratinocyte Growth Factor|keratinocyte growth factor
736236|NCT00101582|HNC|hnc
736237|NCT00101582|Head and Neck Cancer|head and neck cancer
736238|NCT00101582|Oral Mucositis|oral mucositis
736239|NCT00101543|Gait Training|gait training
736240|NCT00101543|Motor learning|motor learning
736241|NCT00101543|Electrical stimulation|electrical stimulation
736242|NCT00101543|Body Weight supported Treadmill Training|body weight supported treadmill training
736243|NCT00101543|Cerebrovascular Accident|cerebrovascular accident
736244|NCT00101465|Heart Failure|heart failure
736245|NCT00101452|Depression|depression
736246|NCT00101452|Antidepressive Agents|antidepressive agents
736247|NCT00101452|Complementary Therapies|complementary therapies
736248|NCT00101439|Primary Hypercholesterolemia|primary hypercholesterolemia
736249|NCT00101426|Diabetic sensorimotor polyneuropathy|diabetic sensorimotor polyneuropathy
736250|NCT00101426|Diabetic Neuropathy|diabetic neuropathy
736251|NCT00101413|NSCLC|nsclc
736252|NCT00101400|Cancer|cancer
736253|NCT00101387|Aged|aged
736254|NCT00101387|Acupuncture|acupuncture
736255|NCT00101374|Immunomodulatory Drug|immunomodulatory drug
736256|NCT00101374|Antiviral|antiviral
736257|NCT00101374|Ki67+|ki67+
736258|NCT00101374|Immune Activation|immune activation
736259|NCT00101374|T Cell Proliferation|t cell proliferation
736260|NCT00101374|HIV|hiv
736261|NCT00101374|Activated CD4+T-cell|activated cd4+t-cell
736262|NCT00101374|Proliferation|proliferation
736263|NCT00101361|dermatologic|dermatologic
736264|NCT00101361|skin|skin
736265|NCT00101361|clinical trial|clinical trial
736266|NCT00101361|androgen/anabolic|androgen/anabolic
736267|NCT00101335|hypopharyngeal cancer|hypopharyngeal cancer
736268|NCT00101335|lip and oral cavity cancer|lip and oral cavity cancer
736269|NCT00101335|nasopharyngeal cancer|nasopharyngeal cancer
736270|NCT00101335|oropharyngeal cancer|oropharyngeal cancer
736271|NCT00101335|tongue cancer|tongue cancer
736272|NCT00101335|oral leukoplakia|oral leukoplakia
736273|NCT00101309|recurrent neuroblastoma|recurrent neuroblastoma
736274|NCT00101309|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
736275|NCT00101283|advanced malignant mesothelioma|advanced malignant mesothelioma
736276|NCT00101283|recurrent malignant mesothelioma|recurrent malignant mesothelioma
736277|NCT00101257|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
736278|NCT00101257|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
736279|NCT00101257|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
736280|NCT00101257|peritoneal cavity cancer|peritoneal cavity cancer
736281|NCT00101192|recurrent cervical cancer|recurrent cervical cancer
736282|NCT00101192|cervical adenocarcinoma|cervical adenocarcinoma
736283|NCT00101192|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
736284|NCT00101192|cervical small cell carcinoma|cervical small cell carcinoma
736285|NCT00101192|cervical squamous cell carcinoma|cervical squamous cell carcinoma
736286|NCT00101192|stage III cervical cancer|stage iii cervical cancer
736287|NCT00101192|stage IVA cervical cancer|stage iva cervical cancer
736288|NCT00101192|stage IVB cervical cancer|stage ivb cervical cancer
736289|NCT00101166|recurrent melanoma|recurrent melanoma
736290|NCT00101166|stage III melanoma|stage iii melanoma
736291|NCT00101166|stage IV melanoma|stage iv melanoma
736292|NCT00101153|adult acute basophilic leukemia|adult acute basophilic leukemia
736293|NCT00101153|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
736294|NCT00101153|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
736295|NCT00101153|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
736296|NCT00101153|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
736297|NCT00101153|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
736298|NCT00101153|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
736299|NCT00101153|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
736300|NCT00101153|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
736301|NCT00101153|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
736302|NCT00101153|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
736303|NCT00101153|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
736304|NCT00101153|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
736305|NCT00101153|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
736306|NCT00101153|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
736307|NCT00101153|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
736308|NCT00101140|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
736309|NCT00101140|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
736310|NCT00101140|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
736311|NCT00101140|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
736312|NCT00101140|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
736313|NCT00101140|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
736314|NCT00101140|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
736315|NCT00101140|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
736316|NCT00101140|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
736317|NCT00101140|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
736318|NCT00101140|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
736319|NCT00101140|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
736320|NCT00101127|recurrent uterine sarcoma|recurrent uterine sarcoma
736321|NCT00101127|stage III uterine sarcoma|stage iii uterine sarcoma
736322|NCT00101127|stage IV uterine sarcoma|stage iv uterine sarcoma
736323|NCT00101127|uterine leiomyosarcoma|uterine leiomyosarcoma
736324|NCT00101101|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
736325|NCT00101101|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
736326|NCT00101101|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
736327|NCT00101101|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
736328|NCT00101101|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
736329|NCT00101075|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
736330|NCT00101075|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
736331|NCT00101075|salivary gland acinic cell tumor|salivary gland acinic cell tumor
736332|NCT00101075|salivary gland adenocarcinoma|salivary gland adenocarcinoma
736333|NCT00101075|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
736334|NCT00101075|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
736335|NCT00101075|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
736336|NCT00101075|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
736337|NCT00101075|recurrent salivary gland cancer|recurrent salivary gland cancer
736338|NCT00101075|stage III salivary gland cancer|stage iii salivary gland cancer
736339|NCT00101075|stage IV salivary gland cancer|stage iv salivary gland cancer
736340|NCT00101062|stage IIIA breast cancer|stage iiia breast cancer
736341|NCT00101062|stage IIIB breast cancer|stage iiib breast cancer
736342|NCT00101062|stage IIIC breast cancer|stage iiic breast cancer
736343|NCT00101062|stage IV breast cancer|stage iv breast cancer
736344|NCT00101062|recurrent breast cancer|recurrent breast cancer
736345|NCT00101010|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
736346|NCT00101010|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
736347|NCT00101010|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
736348|NCT00101010|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
736543|NCT00100308|Therapy|therapy
736349|NCT00100997|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
736350|NCT00100997|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
736351|NCT00100997|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
736352|NCT00100971|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
736353|NCT00100971|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
736354|NCT00100971|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
736355|NCT00100971|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
736356|NCT00100971|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
736357|NCT00100971|secondary acute myeloid leukemia|secondary acute myeloid leukemia
736358|NCT00100958|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
736359|NCT00100945|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
736360|NCT00100945|stage II esophageal cancer|stage ii esophageal cancer
736361|NCT00100919|Kinesithesia|kinesithesia
736362|NCT00100919|Sensorimotor Function|sensorimotor function
736363|NCT00100919|Somatosensory|somatosensory
736364|NCT00100919|Muscle Spindles|muscle spindles
736365|NCT00100919|Sensory Feedback|sensory feedback
736366|NCT00100919|Healthy Volunteer|healthy volunteer
736367|NCT00100919|HV|hv
736368|NCT00100906|stage IV renal cell cancer|stage iv renal cell cancer
736369|NCT00100906|recurrent renal cell cancer|recurrent renal cell cancer
736370|NCT00100906|clear cell renal cell carcinoma|clear cell renal cell carcinoma
736371|NCT00100893|breast cancer|breast cancer
736372|NCT00100867|Perinatal Transmission|perinatal transmission
736373|NCT00100867|Mother-to-Child Transmission|mother-to-child transmission
736374|NCT00100854|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
736375|NCT00100854|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
736376|NCT00100854|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
736377|NCT00100828|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
736378|NCT00100828|recurrent thyroid cancer|recurrent thyroid cancer
736379|NCT00100815|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
736380|NCT00100815|recurrent pancreatic cancer|recurrent pancreatic cancer
736381|NCT00100815|stage IV pancreatic cancer|stage iv pancreatic cancer
736382|NCT00100802|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
736383|NCT00100802|childhood spinal cord neoplasm|childhood spinal cord neoplasm
736384|NCT00100789|Recurrent|recurrent
736385|NCT00100789|stage IV|stage iv
736386|NCT00100789|squamous cell carcinoma|squamous cell carcinoma
736387|NCT00100789|hypopharynx|hypopharynx
736388|NCT00100789|larynx|larynx
736389|NCT00100789|lip|lip
736390|NCT00100789|oral cavity|oral cavity
736391|NCT00100789|nasopharynx|nasopharynx
736392|NCT00100789|oropharynx|oropharynx
736393|NCT00100789|paranasal|paranasal
736394|NCT00100789|nasal cavity|nasal cavity
736395|NCT00100789|metastatic|metastatic
736396|NCT00100789|neck cancer|neck cancer
736397|NCT00100737|non-hodgkins lymphoma|non-hodgkins lymphoma
736398|NCT00100737|interleukin-2|interleukin-2
736399|NCT00100737|rituximab|rituximab
736400|NCT00100737|CD20+ follicular B-cell non-hodgkins lymphoma (grade I, II,III)|cd20+ follicular b-cell non-hodgkins lymphoma (grade i, ii,iii)
736401|NCT00100724|Anthrax|anthrax
736402|NCT00100724|rPA102|rpa102
736403|NCT00100724|vaccine|vaccine
736404|NCT00100711|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
736405|NCT00100711|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
736406|NCT00100711|Leukemia|leukemia
736407|NCT00100711|Lymphoma|lymphoma
736408|NCT00100711|Motexafin Gadolinium|motexafin gadolinium
736409|NCT00100711|Relapsed Chronic Lymphocytic Leukemia|relapsed chronic lymphocytic leukemia
736410|NCT00100711|Relapsed Chronic Lymphocycic Lymphoma|relapsed chronic lymphocycic lymphoma
736411|NCT00100711|Refractory Chronic Lymphocytic Leukemia|refractory chronic lymphocytic leukemia
736412|NCT00100711|Refractory Small Lymphocytic Lymphoma|refractory small lymphocytic lymphoma
736413|NCT00100698|HIV|hiv
736414|NCT00100698|lipodystrophy|lipodystrophy
736415|NCT00100698|growth hormone|growth hormone
736416|NCT00100698|visceral fat|visceral fat
736417|NCT00100698|IGF-I|igf-i
736418|NCT00100698|Treatment Experienced|treatment experienced
736419|NCT00100685|Kidney|kidney
736420|NCT00100685|renal|renal
736421|NCT00100685|cancer|cancer
736422|NCT00100685|carcinoma|carcinoma
736423|NCT00100685|cell|cell
736424|NCT00100685|metastatic|metastatic
736425|NCT00100685|metastatic renal cell carcinoma|metastatic renal cell carcinoma
736426|NCT00100685|RCC|rcc
736427|NCT00100672|LErafAON-ETU|lerafaon-etu
736428|NCT00100672|Signal transduction|signal transduction
736429|NCT00100672|Neoplasm|neoplasm
736430|NCT00100672|Cancer|cancer
736431|NCT00100672|NeoPharm|neopharm
736432|NCT00100672|Liposomes|liposomes
736433|NCT00100672|Antisense|antisense
736434|NCT00100672|Anti-cancer|anti-cancer
736435|NCT00100672|Advanced neoplasm|advanced neoplasm
736436|NCT00100672|Advanced cancer|advanced cancer
736437|NCT00100672|Chemotherapy|chemotherapy
736438|NCT00100672|Refractory cancer|refractory cancer
736439|NCT00100672|Metastatic cancer|metastatic cancer
736440|NCT00100659|pediatric|pediatric
736441|NCT00100659|hepatitis|hepatitis
736442|NCT00100659|children|children
736443|NCT00100659|HCV|hcv
736444|NCT00100659|PEG|peg
736445|NCT00100659|PEG-2a|peg-2a
736446|NCT00100659|peginterferon alfa-2a|peginterferon alfa-2a
736447|NCT00100659|Pegylated Interferon|pegylated interferon
736448|NCT00100659|RV|rv
736449|NCT00100659|ribavirin|ribavirin
736450|NCT00100659|Pegasys|pegasys
736451|NCT00100659|CHC|chc
736452|NCT00100659|chronic hepatitis C|chronic hepatitis c
736453|NCT00100659|chronic hepatitis C virus|chronic hepatitis c virus
736454|NCT00100659|hepatitis c|hepatitis c
736455|NCT00100659|pediatric hepatitis|pediatric hepatitis
736456|NCT00100659|pediatric HCV|pediatric hcv
736457|NCT00100646|Treatment Interruption|treatment interruption
736458|NCT00100646|Treatment Naive|treatment naive
736459|NCT00100633|Hepatitis B Vaccine|hepatitis b vaccine
736460|NCT00100633|Treatment Experienced|treatment experienced
736461|NCT00100633|Treatment Naive|treatment naive
736462|NCT00100620|Corticosteroid induced osteoporosis|corticosteroid induced osteoporosis
736463|NCT00100620|prevention|prevention
736464|NCT00100620|treatment|treatment
736465|NCT00100620|zoledronic acid|zoledronic acid
736466|NCT00100607|osteoporosis/osteopenia, BMD, postmenopausal|osteoporosis/osteopenia, bmd, postmenopausal
736467|NCT00100594|Treatment Naive|treatment naive
736468|NCT00100581|Treatment Naive|treatment naive
736469|NCT00100568|Treatment Naive|treatment naive
736470|NCT00100555|Osteoporosis, osteopenia, post-menopausal, zoledronic acid|osteoporosis, osteopenia, post-menopausal, zoledronic acid
736471|NCT00100542|Treatment Experienced|treatment experienced
736472|NCT00100542|Treatment Naive|treatment naive
736473|NCT00100542|Psychopathology|psychopathology
736474|NCT00100542|Anti-Retroviral Agents|anti-retroviral agents
736475|NCT00100542|Child|child
736476|NCT00100542|Adolescent|adolescent
736477|NCT00100529|Facial Imaging|facial imaging
736478|NCT00100529|Genetics|genetics
736479|NCT00100529|Growth|growth
736480|NCT00100529|Development|development
736481|NCT00100529|Diagnostics|diagnostics
736482|NCT00100529|Craniofacial Dysmorphologies|craniofacial dysmorphologies
736483|NCT00100529|Facial Features|facial features
736484|NCT00100516|Renal|renal
736485|NCT00100516|Allografts|allografts
736486|NCT00100516|Nephrectomy|nephrectomy
736487|NCT00100516|Pneumoperitoneum|pneumoperitoneum
736488|NCT00100516|LaparoscopIC|laparoscopic
736489|NCT00100516|Kidney Donation|kidney donation
736490|NCT00100503|Rehabilitation|rehabilitation
736491|NCT00100503|Forced Use|forced use
736492|NCT00100503|Hemiplegia|hemiplegia
736493|NCT00100503|Magnetic Resonance Imaging|magnetic resonance imaging
736495|NCT00100503|Cerebral Palsy|cerebral palsy
736496|NCT00100503|Spastic Hemiplegia|spastic hemiplegia
736497|NCT00100503|Healthy Volunteer|healthy volunteer
736498|NCT00100503|HV|hv
736499|NCT00100477|Multiple Myeloma|multiple myeloma
736500|NCT00100477|Lymphoma|lymphoma
736501|NCT00100477|Leukemia|leukemia
736502|NCT00100477|Etoposide|etoposide
736503|NCT00100477|Drug Therapy|drug therapy
736504|NCT00100477|Clinical Trials|clinical trials
736505|NCT00100464|Serotonin|serotonin
736506|NCT00100464|Sleep Apnea Syndrome|sleep apnea syndrome
736507|NCT00100464|Pharyngeal Muscles|pharyngeal muscles
736508|NCT00100451|Adipose tissue|adipose tissue
736509|NCT00100451|Aging|aging
736510|NCT00100451|Exercise|exercise
736511|NCT00100451|Lipolysis|lipolysis
736512|NCT00100451|Estrogens|estrogens
736513|NCT00100425|Irritable Bowel Syndrome|irritable bowel syndrome
736514|NCT00100425|Visceral Hypersensitivity|visceral hypersensitivity
736515|NCT00100425|Visceral Pain|visceral pain
736516|NCT00100399|influenza, flu, Fluarix, vaccine, GSK, immunogenicity|influenza, flu, fluarix, vaccine, gsk, immunogenicity
736517|NCT00100386|Hand hygiene, antibiotic resistance, contact precautions|hand hygiene, antibiotic resistance, contact precautions
736518|NCT00100373|Respiratory Syncytial Virus Infections|respiratory syncytial virus infections
736519|NCT00100360|Gonadal Steroids|gonadal steroids
736520|NCT00100360|GnRH Agonist|gnrh agonist
736521|NCT00100360|Depression|depression
736522|NCT00100360|Menstrual Cycle|menstrual cycle
736523|NCT00100360|Menstrually Related Mood Disorder|menstrually related mood disorder
736524|NCT00100360|MRMD|mrmd
736525|NCT00100360|Healthy Volunteer|healthy volunteer
736526|NCT00100360|HV|hv
736527|NCT00100347|non-Hodgkin lymphoma|non-hodgkin lymphoma
736528|NCT00100347|non-Hodgkin’s lymphoma|non-hodgkin’s lymphoma
736529|NCT00100347|NHL|nhl
736530|NCT00100347|MetAP2|metap2
736531|NCT00100347|Solid Tumors|solid tumors
736532|NCT00100334|Alzheimer's Disease|alzheimer's disease
736533|NCT00100321|Tumor Antigen Identification|tumor antigen identification
736534|NCT00100321|Standard Treatment|standard treatment
736535|NCT00100321|Tissue Acquisition|tissue acquisition
736536|NCT00100321|Surgery|surgery
736537|NCT00100321|Adjuvant Chemotherapy|adjuvant chemotherapy
736538|NCT00100321|Pancreatic Cancer|pancreatic cancer
736539|NCT00100321|Pancreatic Tumor|pancreatic tumor
736540|NCT00100308|sepsis|sepsis
736541|NCT00100308|Randomized clinical trial|randomized clinical trial
736544|NCT00100295|Adolescent|adolescent
736545|NCT00100295|Child|child
736546|NCT00100295|Phytotherapy|phytotherapy
736547|NCT00100282|Mild-moderate Alzheimer's disease|mild-moderate alzheimer's disease
736548|NCT00100269|Male infertility|male infertility
736549|NCT00100269|sperm|sperm
736550|NCT00100269|pregnancy|pregnancy
736551|NCT00100269|IVF (in vitro fertilisation)|ivf (in vitro fertilisation)
736552|NCT00100269|oxidative stress|oxidative stress
736553|NCT00100269|free radicals|free radicals
736554|NCT00100269|DNA damage|dna damage
736555|NCT00100256|Advanced or recurrent stage IIIb or IV non small cell lung cancer|advanced or recurrent stage iiib or iv non small cell lung cancer
736556|NCT00100256|Disseminated or recurrent small cell lung cancer|disseminated or recurrent small cell lung cancer
736557|NCT00100243|androgen-independent|androgen-independent
736558|NCT00100243|prostate cancer|prostate cancer
736559|NCT00100230|retina|retina
736560|NCT00100230|electroretinography|electroretinography
736561|NCT00100230|clinical trial|clinical trial
736562|NCT00100230|docosahexaenoic acid|docosahexaenoic acid
736563|NCT00100230|omega-3 fatty acid|omega-3 fatty acid
736564|NCT00100230|x-linked inheritance|x-linked inheritance
736565|NCT00100217|Training|training
736566|NCT00100217|Critical Care|critical care
736567|NCT00100217|Heart Failure|heart failure
736568|NCT00100217|Pulmonary Hypertension|pulmonary hypertension
736569|NCT00100217|Infectious Diseases|infectious diseases
736570|NCT00100204|Head and Neck Radiation|head and neck radiation
736571|NCT00100204|Diabetes|diabetes
736572|NCT00100204|Sarcoidosis|sarcoidosis
736573|NCT00100204|Sjogren's Syndrome|sjogren's syndrome
736574|NCT00100204|Caries|caries
736575|NCT00100204|Healthy Volunteer|healthy volunteer
736576|NCT00100204|HV|hv
736577|NCT00100204|Saliva Sample|saliva sample
736578|NCT00100191|hysterectomy|hysterectomy
736579|NCT00100191|fibroids|fibroids
736580|NCT00100191|uterine artery embolization|uterine artery embolization
736581|NCT00100191|therapeutic embolization|therapeutic embolization
736582|NCT00100191|uterus|uterus
736583|NCT00100191|menorrhagia|menorrhagia
736584|NCT00100178|immunosuppressive therapy|immunosuppressive therapy
736585|NCT00100178|Type 1 Diabetes TrialNet|type 1 diabetes trialnet
736586|NCT00100178|TrialNet|trialnet
736587|NCT00100178|POPPII|poppii
736588|NCT00100178|POPPII-1|poppii-1
736589|NCT00100165|Schizophrenia|schizophrenia
736590|NCT00100152|Relapsed or refractory T-cell ALL acute lymphoblastic/leukemia|relapsed or refractory t-cell all acute lymphoblastic/leukemia
736591|NCT00100152|Relapsed/refractory T-cell acute Lymphoblastic/leukemia|relapsed/refractory t-cell acute lymphoblastic/leukemia
736592|NCT00100152|Acute/chronic myelogenous leukemia|acute/chronic myelogenous leukemia
736593|NCT00100152|Poor-risk myelodysplasia|poor-risk myelodysplasia
736594|NCT00100139|Neoplasm|neoplasm
736595|NCT00100139|Cancer|cancer
736596|NCT00100139|NeoPharm|neopharm
736597|NCT00100139|Liposomes|liposomes
736598|NCT00100139|Taxol|taxol
736599|NCT00100139|Paclitaxel|paclitaxel
736600|NCT00100139|Anti-cancer|anti-cancer
736601|NCT00100139|Advanced neoplasm|advanced neoplasm
736602|NCT00100139|Advanced cancer|advanced cancer
736603|NCT00100139|Chemotherapy|chemotherapy
736604|NCT00100139|Refractory cancer|refractory cancer
736605|NCT00100139|Metastatic cancer|metastatic cancer
736606|NCT00100126|Pharyngitis|pharyngitis
736607|NCT00100126|Strep throat|strep throat
736608|NCT00100113|cocaine dependence|cocaine dependence
736609|NCT00100100|cocaine dependence|cocaine dependence
736610|NCT00100087|macular degeneration|macular degeneration
736611|NCT00100087|brachytherapy|brachytherapy
736612|NCT00100087|choroidal neovascularization|choroidal neovascularization
736613|NCT00100087|retinal degeneration|retinal degeneration
736614|NCT00100087|retinal diseases|retinal diseases
736615|NCT00100061|Cranberry|cranberry
736616|NCT00100061|Vaccinium macrocarpon|vaccinium macrocarpon
736617|NCT00100035|Caregivers|caregivers
736618|NCT00100035|Complementary Therapies|complementary therapies
736619|NCT00100009|Steroid|steroid
736620|NCT00100009|Inflammation|inflammation
736621|NCT00100009|Choroidal Neovascularization|choroidal neovascularization
736622|NCT00100009|Intravitreal Injection|intravitreal injection
736623|NCT00100009|Verteporfin|verteporfin
736624|NCT00100009|Age-Related Macular Degeneration|age-related macular degeneration
736625|NCT00100009|Photodynamic Therapy|photodynamic therapy
736626|NCT00100009|Age Related Macular Degeneration|age related macular degeneration
736627|NCT00100009|AMD|amd
736628|NCT00099996|Sitosterolemia|sitosterolemia
736629|NCT00099996|Sitosterol|sitosterol
736630|NCT00099996|Ezetimibe|ezetimibe
736631|NCT00099996|Absorption|absorption
736632|NCT00099996|Intestine|intestine
736633|NCT00099996|Cholesterol|cholesterol
736634|NCT00099996|Atherosclerosis|atherosclerosis
736635|NCT00099996|Homozygous Sitosterolemia|homozygous sitosterolemia
736636|NCT00099983|PTSD|ptsd
736637|NCT00099970|Solid tumors|solid tumors
736638|NCT00099970|Metastatic melanoma|metastatic melanoma
736639|NCT00099957|type 2 diabetes|type 2 diabetes
736640|NCT00099957|vildagliptin|vildagliptin
736641|NCT00099944|type 2 diabetes|type 2 diabetes
736642|NCT00099944|vildagliptin|vildagliptin
736643|NCT00099931|type 2 diabetes|type 2 diabetes
736644|NCT00099931|vildagliptin|vildagliptin
736645|NCT00099918|type 2 diabetes|type 2 diabetes
736646|NCT00099918|vildagliptin|vildagliptin
736647|NCT00099905|type 2 diabetes|type 2 diabetes
736648|NCT00099905|vildagliptin|vildagliptin
736649|NCT00099892|type 2 diabetes|type 2 diabetes
736650|NCT00099892|vildagliptin|vildagliptin
736651|NCT00099866|type 2 diabetes|type 2 diabetes
736652|NCT00099866|vildagliptin|vildagliptin
736653|NCT00099853|type 2 diabetes|type 2 diabetes
736654|NCT00099853|vildagliptin|vildagliptin
736655|NCT00099840|common cold|common cold
736656|NCT00099840|pharyngitis|pharyngitis
736657|NCT00099840|tonsillitis|tonsillitis
736658|NCT00099840|rhinosinusitis|rhinosinusitis
736659|NCT00099840|tracheo-bronchitis|tracheo-bronchitis
736660|NCT00099840|otitis media|otitis media
736661|NCT00099840|acute exacerbations of asthma|acute exacerbations of asthma
736662|NCT00099840|acute exacerbations of chronic pulmonary disease|acute exacerbations of chronic pulmonary disease
736663|NCT00099840|community acquired pneumonia|community acquired pneumonia
736664|NCT00099827|Depression|depression
736665|NCT00099814|tooth movement|tooth movement
736666|NCT00099814|orthodontics|orthodontics
736667|NCT00099814|force|force
736668|NCT00099814|humans|humans
736669|NCT00099814|clinical trial|clinical trial
736670|NCT00099801|Kidney, Transplantation, Rejection, Immunosuppression|kidney, transplantation, rejection, immunosuppression
736671|NCT00099788|Acute Coronary Syndrome|acute coronary syndrome
736672|NCT00099788|Myocardial Infarction|myocardial infarction
736673|NCT00099788|Heart Attack|heart attack
736674|NCT00099788|Angina|angina
736675|NCT00099788|Chest pain|chest pain
736676|NCT00099788|Ischemia|ischemia
736677|NCT00099788|Non-ST Elevation Acute Coronary Syndrome|non-st elevation acute coronary syndrome
736678|NCT00099775|Mycoses|mycoses
736679|NCT00099775|Candida|candida
736680|NCT00099775|Echinocandin|echinocandin
736681|NCT00099775|Immunocompromised Host|immunocompromised host
736682|NCT00099775|Invasive Fungal Infection|invasive fungal infection
736683|NCT00099775|Fungal Infection|fungal infection
736684|NCT00099762|Tumor Induced Osteomalacia|tumor induced osteomalacia
736685|NCT00099762|FGF-23|fgf-23
736686|NCT00099762|Phosphatonin|phosphatonin
736687|NCT00099762|Hypophosphatemia|hypophosphatemia
736688|NCT00099762|Oncogenic Osteomalacia|oncogenic osteomalacia
736689|NCT00099762|Phosphaturic Mesenchymal Tumor|phosphaturic mesenchymal tumor
736690|NCT00099762|TIO|tio
736691|NCT00099762|Osteogenic Osteomalacia|osteogenic osteomalacia
736692|NCT00099762|OOM|oom
736693|NCT00099749|Kidney, immunosuppression, transplant, rejection|kidney, immunosuppression, transplant, rejection
736694|NCT00099736|Kidney, transplantation, rejection, immunosuppression|kidney, transplantation, rejection, immunosuppression
736695|NCT00099723|Hepatic steatosis|hepatic steatosis
736696|NCT00099723|adult-onset diabetes|adult-onset diabetes
736697|NCT00099723|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
736698|NCT00099710|Curcumin|curcumin
736699|NCT00099710|Turmeric|turmeric
736700|NCT00099710|Curry|curry
736701|NCT00099710|NSAID|nsaid
736702|NCT00099710|anti-inflammatory|anti-inflammatory
736703|NCT00099710|Cholesterol|cholesterol
736704|NCT00099710|anti-oxidant|anti-oxidant
736705|NCT00099697|abdominal fat|abdominal fat
736706|NCT00099697|dehydroepiandrosterone|dehydroepiandrosterone
736707|NCT00099697|Insulin sensitivity|insulin sensitivity
736708|NCT00099684|Treatment Experienced|treatment experienced
736709|NCT00099671|Treatment Experienced|treatment experienced
736710|NCT00099658|MTCT|mtct
736711|NCT00099645|Mifepristone|mifepristone
736712|NCT00099645|Mifeprex|mifeprex
736713|NCT00099645|RU486|ru486
736714|NCT00099645|VGX-410|vgx-410
736715|NCT00099645|Abortion Pill|abortion pill
736716|NCT00099645|Investigational Drug|investigational drug
736717|NCT00099632|Treatment Naive|treatment naive
736718|NCT00099619|exenatide|exenatide
736719|NCT00099619|exendin-4|exendin-4
736720|NCT00099619|diabetes|diabetes
736721|NCT00099619|Amylin|amylin
736722|NCT00099619|Lilly|lilly
736723|NCT00099593|Cutaneous T-cell lymphoma (CTCL)|cutaneous t-cell lymphoma (ctcl)
736724|NCT00099593|Sezary Syndrome|sezary syndrome
736725|NCT00099593|Mycosis Fungoides|mycosis fungoides
736726|NCT00099593|Vaccine|vaccine
736727|NCT00099580|Congestive Heart Failure|congestive heart failure
736728|NCT00099580|AC2592|ac2592
736729|NCT00099580|GLP-1|glp-1
736730|NCT00099580|Amylin|amylin
736731|NCT00099580|metabolic abnormality|metabolic abnormality
736732|NCT00099567|Metabolic Syndrome|metabolic syndrome
736733|NCT00099567|Alzheimer's Disease|alzheimer's disease
736734|NCT00099567|Cognitive Impairment|cognitive impairment
736735|NCT00099567|Inflammation|inflammation
736736|NCT00099541|Lung Cancer|lung cancer
736737|NCT00099541|Bone Metastases|bone metastases
736738|NCT00099541|Bone Markers|bone markers
736739|NCT00099541|NTX|ntx
736740|NCT00099541|zoledronic acid|zoledronic acid
736741|NCT00099541|Registry|registry
736742|NCT00099541|Unresectable Stage IV Non Small-cell Lung Cancer (NSCLC)|unresectable stage iv non small-cell lung cancer (nsclc)
737473|NCT00096928|Raptiva|raptiva
736743|NCT00099541|Unresectable Stage IIIB NSCLC with Pleural Effusion|unresectable stage iiib nsclc with pleural effusion
736744|NCT00099528|Post-herpetic neuralgia|post-herpetic neuralgia
736745|NCT00099528|Shingles|shingles
736746|NCT00099528|Herpes Zoster|herpes zoster
736747|NCT00099528|Neuropathic pain|neuropathic pain
736748|NCT00099528|Neuralgia|neuralgia
736749|NCT00099528|Anti-TNF agents|anti-tnf agents
736750|NCT00099528|Inflammatory cytokines|inflammatory cytokines
736751|NCT00099528|Hyperalgesia|hyperalgesia
736752|NCT00099528|Allodynia|allodynia
736753|NCT00099528|Irritable nociceptor|irritable nociceptor
736754|NCT00099502|Relapsing multiple sclerosis|relapsing multiple sclerosis
736755|NCT00099502|interferon beta 1b|interferon beta 1b
736756|NCT00099502|Betaferon|betaferon
736757|NCT00099502|Betaseron|betaseron
736758|NCT00099489|Chronic Inflammatory Demyelinating Polyradiculoneuropathy|chronic inflammatory demyelinating polyradiculoneuropathy
736759|NCT00099489|CIDP|cidp
736760|NCT00099489|IVIg|ivig
736761|NCT00099489|AVONEX|avonex
736762|NCT00099476|Epicatechin|epicatechin
736763|NCT00099476|Polyphenols|polyphenols
736764|NCT00099476|Chocolate|chocolate
736765|NCT00099476|Insulin Resistance|insulin resistance
736766|NCT00099476|Endothelial Dysfunction|endothelial dysfunction
736767|NCT00099476|Hypertension|hypertension
736768|NCT00099463|Coronavirus|coronavirus
736769|NCT00099463|Healthy|healthy
736770|NCT00099463|Immunity|immunity
736771|NCT00099463|Preventive|preventive
736772|NCT00099463|Virus|virus
736773|NCT00099463|Healthy Volunteer|healthy volunteer
736774|NCT00099463|HV|hv
736775|NCT00099450|bleeding|bleeding
736776|NCT00099450|blood transfusion|blood transfusion
736777|NCT00099450|surgeries|surgeries
736778|NCT00099437|Advanced Breast Cancer|advanced breast cancer
736779|NCT00099437|Metastatic Breast Cancer|metastatic breast cancer
736780|NCT00099424|exercise training|exercise training
736781|NCT00099424|resistance training|resistance training
736782|NCT00099424|endurance training|endurance training
736783|NCT00099424|Boeck's Sarcoid|boeck's sarcoid
736784|NCT00099424|Besnier-Boeck Disease|besnier-boeck disease
736785|NCT00099385|social development|social development
736786|NCT00099385|risk behaviors|risk behaviors
736787|NCT00099385|social emotional education|social emotional education
736788|NCT00099385|classroom instruction|classroom instruction
736789|NCT00099372|sacrocolpopexy|sacrocolpopexy
736790|NCT00099372|abdominal sacrocolpopexy|abdominal sacrocolpopexy
736791|NCT00099372|surgical procedure, prolapse|surgical procedure, prolapse
736792|NCT00099372|pelvic organ prolapse|pelvic organ prolapse
736793|NCT00099372|urinary incontinence|urinary incontinence
736794|NCT00099372|stress urinary incontinence|stress urinary incontinence
736795|NCT00099359|HIV|hiv
736796|NCT00099359|Perinatal|perinatal
736797|NCT00099359|Prevention|prevention
736798|NCT00099359|Transmission|transmission
736799|NCT00099359|Nevirapine|nevirapine
736800|NCT00099359|Epivir|epivir
736801|NCT00099359|Zidovudine|zidovudine
736802|NCT00099359|Nelfinavir|nelfinavir
736803|NCT00099359|ZDV|zdv
736804|NCT00099359|NVP|nvp
736805|NCT00099359|3TC|3tc
736806|NCT00099359|NFV|nfv
736807|NCT00099359|Viracept|viracept
736808|NCT00099359|Viramune|viramune
736809|NCT00099359|HIV Seronegativity|hiv seronegativity
736810|NCT00099359|Treatment Naive|treatment naive
736811|NCT00099333|exenatide|exenatide
736812|NCT00099333|exendin-4|exendin-4
736813|NCT00099333|Amylin|amylin
736814|NCT00099333|Eli Lilly|eli lilly
736815|NCT00099333|diabetes|diabetes
736816|NCT00099320|exenatide|exenatide
736817|NCT00099320|exendin-4|exendin-4
736818|NCT00099320|diabetes|diabetes
736819|NCT00099320|Amylin|amylin
736820|NCT00099320|Lilly|lilly
736821|NCT00099307|White Matter|white matter
736822|NCT00099307|Grey Matter|grey matter
736823|NCT00099307|Brain|brain
736824|NCT00099307|Disability|disability
736825|NCT00099307|Lesions|lesions
736826|NCT00099307|Multiple Sclerosis|multiple sclerosis
736827|NCT00099307|MS|ms
736828|NCT00099307|Healthy Volunteer|healthy volunteer
736829|NCT00099307|HV|hv
736830|NCT00099294|Pancreas|pancreas
736831|NCT00099294|Cancer|cancer
736832|NCT00099294|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
736833|NCT00099294|Metastatic|metastatic
736834|NCT00099294|Glufosfamide|glufosfamide
736835|NCT00099281|Metastatic breast cancer|metastatic breast cancer
736836|NCT00099268|Parkinson's disease, levodopa therapy, dyskinesia|parkinson's disease, levodopa therapy, dyskinesia
736837|NCT00099255|Keyword?|keyword?
736838|NCT00099255|Primary Cutaneous Anaplastic Large Cell Lymphoma|primary cutaneous anaplastic large cell lymphoma
737037|NCT00098384|prophylaxis|prophylaxis
736839|NCT00099255|Large Cell Transformation of Mycosis Fungoides|large cell transformation of mycosis fungoides
736840|NCT00099255|Lymphomatoid Papulosis|lymphomatoid papulosis
736841|NCT00099242|Alzheimer's Disease|alzheimer's disease
736842|NCT00099242|Dementia|dementia
736843|NCT00099229|bipolar disorder|bipolar disorder
736844|NCT00099229|manic episode|manic episode
736845|NCT00099229|treatment|treatment
736846|NCT00099229|licarbazepine|licarbazepine
736847|NCT00099216|Dementia,vascular,rivastigmine,stroke,memory loss|dementia,vascular,rivastigmine,stroke,memory loss
736848|NCT00099190|cancer|cancer
736849|NCT00099190|solid tumor|solid tumor
736850|NCT00099190|advanced solid tumor|advanced solid tumor
736851|NCT00099164|preterm birth|preterm birth
736852|NCT00099164|pregnancy|pregnancy
736853|NCT00099164|multifetal|multifetal
736854|NCT00099164|Progesterone|progesterone
736855|NCT00099151|Longevity|longevity
736856|NCT00099151|Dietary restriction|dietary restriction
736857|NCT00099151|Physical activity|physical activity
736858|NCT00099151|Weight Loss|weight loss
736859|NCT00099151|Diabetes|diabetes
736860|NCT00099138|Diet|diet
736861|NCT00099138|Caloric Restriction|caloric restriction
736862|NCT00099138|Exercise|exercise
736863|NCT00099138|Energy Metabolism|energy metabolism
736864|NCT00099138|Primary Aging|primary aging
736865|NCT00099138|Secondary Aging|secondary aging
736866|NCT00099125|adult giant cell glioblastoma|adult giant cell glioblastoma
736867|NCT00099125|adult gliosarcoma|adult gliosarcoma
736868|NCT00099125|adult glioblastoma|adult glioblastoma
736869|NCT00099112|basal cell carcinoma of the skin|basal cell carcinoma of the skin
736870|NCT00099112|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
736871|NCT00099112|actinic keratosis|actinic keratosis
736872|NCT00099099|Longevity|longevity
736873|NCT00099099|Calorie restriction|calorie restriction
736874|NCT00099099|Physical activity|physical activity
736875|NCT00099099|Weight loss|weight loss
736876|NCT00099086|adenocarcinoma of the prostate|adenocarcinoma of the prostate
736877|NCT00099086|stage IIB prostate cancer|stage iib prostate cancer
736878|NCT00099086|stage IIA prostate cancer|stage iia prostate cancer
736879|NCT00099086|stage III prostate cancer|stage iii prostate cancer
736880|NCT00099086|stage IV prostate cancer|stage iv prostate cancer
736881|NCT00099060|adult giant cell glioblastoma|adult giant cell glioblastoma
736882|NCT00099060|adult gliosarcoma|adult gliosarcoma
736883|NCT00099060|recurrent adult brain tumor|recurrent adult brain tumor
736884|NCT00099008|breast cancer|breast cancer
736885|NCT00099008|endometrial cancer|endometrial cancer
736886|NCT00098995|stage IB cervical cancer|stage ib cervical cancer
736887|NCT00098995|stage IIA cervical cancer|stage iia cervical cancer
736888|NCT00098995|stage IIB cervical cancer|stage iib cervical cancer
736889|NCT00098995|stage III cervical cancer|stage iii cervical cancer
736890|NCT00098995|stage IVA cervical cancer|stage iva cervical cancer
736891|NCT00098995|cervical adenocarcinoma|cervical adenocarcinoma
736892|NCT00098995|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
736893|NCT00098995|cervical squamous cell carcinoma|cervical squamous cell carcinoma
736894|NCT00098982|stage III colon cancer|stage iii colon cancer
736895|NCT00098982|stage IV colon cancer|stage iv colon cancer
736896|NCT00098982|stage III rectal cancer|stage iii rectal cancer
736897|NCT00098982|stage IV rectal cancer|stage iv rectal cancer
736898|NCT00098982|recurrent colon cancer|recurrent colon cancer
736899|NCT00098982|recurrent rectal cancer|recurrent rectal cancer
736900|NCT00098969|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
736901|NCT00098943|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
736902|NCT00098943|stage IV renal cell cancer|stage iv renal cell cancer
736903|NCT00098943|recurrent renal cell cancer|recurrent renal cell cancer
736904|NCT00098943|stage IV colon cancer|stage iv colon cancer
736905|NCT00098943|recurrent colon cancer|recurrent colon cancer
736906|NCT00098943|anaplastic thyroid cancer|anaplastic thyroid cancer
736907|NCT00098943|insular thyroid cancer|insular thyroid cancer
736908|NCT00098943|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
736909|NCT00098943|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
736910|NCT00098943|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
736911|NCT00098943|recurrent thyroid cancer|recurrent thyroid cancer
736912|NCT00098943|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
736913|NCT00098943|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
736914|NCT00098943|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
736915|NCT00098943|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
736916|NCT00098943|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
736917|NCT00098943|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
736918|NCT00098943|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
736919|NCT00098943|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
736920|NCT00098943|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
736921|NCT00098943|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
736922|NCT00098943|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
736923|NCT00098943|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
736924|NCT00098943|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
737474|NCT00096928|efalizumab|efalizumab
736925|NCT00098943|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
736926|NCT00098943|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
736927|NCT00098943|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
736928|NCT00098943|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
736929|NCT00098943|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
736930|NCT00098943|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
736931|NCT00098943|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
736932|NCT00098943|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
736933|NCT00098943|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
736934|NCT00098943|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
736935|NCT00098943|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
736936|NCT00098943|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
736937|NCT00098943|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
736938|NCT00098943|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
736939|NCT00098943|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
736940|NCT00098943|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
737038|NCT00098384|enterotoxigenic E. coli|enterotoxigenic e. coli
736941|NCT00098943|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
736942|NCT00098943|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
736943|NCT00098943|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
736944|NCT00098943|metastatic parathyroid cancer|metastatic parathyroid cancer
736945|NCT00098943|recurrent parathyroid cancer|recurrent parathyroid cancer
736946|NCT00098943|recurrent salivary gland cancer|recurrent salivary gland cancer
736947|NCT00098943|stage IV salivary gland cancer|stage iv salivary gland cancer
736948|NCT00098917|stage I non-small cell lung cancer|stage i non-small cell lung cancer
736949|NCT00098917|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
736950|NCT00098917|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
736951|NCT00098878|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
736952|NCT00098878|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
736953|NCT00098878|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
736954|NCT00098878|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
736955|NCT00098878|fallopian tube cancer|fallopian tube cancer
736956|NCT00098878|primary peritoneal cavity cancer|primary peritoneal cavity cancer
736957|NCT00098852|recurrent thyroid cancer|recurrent thyroid cancer
736958|NCT00098852|stage II follicular thyroid cancer|stage ii follicular thyroid cancer
736959|NCT00098852|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
736960|NCT00098852|stage II papillary thyroid cancer|stage ii papillary thyroid cancer
736961|NCT00098852|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
736962|NCT00098800|ovarian epithelial cancer|ovarian epithelial cancer
736963|NCT00098800|BRCA1 mutation carrier|brca1 mutation carrier
736964|NCT00098800|BRCA2 mutation carrier|brca2 mutation carrier
736965|NCT00098787|recurrent colon cancer|recurrent colon cancer
736966|NCT00098787|stage IV colon cancer|stage iv colon cancer
736967|NCT00098787|recurrent rectal cancer|recurrent rectal cancer
736968|NCT00098787|stage IV rectal cancer|stage iv rectal cancer
736969|NCT00098787|adenocarcinoma of the colon|adenocarcinoma of the colon
736970|NCT00098787|adenocarcinoma of the rectum|adenocarcinoma of the rectum
736971|NCT00098774|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
736972|NCT00098761|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
736973|NCT00098761|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
736974|NCT00098761|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
736975|NCT00098761|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
736976|NCT00098761|recurrent childhood ependymoma|recurrent childhood ependymoma
736977|NCT00098761|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
736978|NCT00098761|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
736979|NCT00098761|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
736980|NCT00098761|childhood choroid plexus tumor|childhood choroid plexus tumor
736981|NCT00098761|childhood craniopharyngioma|childhood craniopharyngioma
736982|NCT00098761|childhood infratentorial ependymoma|childhood infratentorial ependymoma
736983|NCT00098761|childhood grade I meningioma|childhood grade i meningioma
736984|NCT00098761|childhood grade II meningioma|childhood grade ii meningioma
736985|NCT00098761|childhood grade III meningioma|childhood grade iii meningioma
736986|NCT00098761|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
736987|NCT00098761|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
736988|NCT00098735|Kidney,Transplantation, rejection, immunosuppression|kidney,transplantation, rejection, immunosuppression
736989|NCT00098709|pregnancy|pregnancy
736990|NCT00098709|labor, obstetric|labor, obstetric
736991|NCT00098709|fetal monitoring|fetal monitoring
736992|NCT00098709|oximetry|oximetry
736993|NCT00098709|fetal heart rate|fetal heart rate
736994|NCT00098709|cardiotocography|cardiotocography
736995|NCT00098683|refractory anemia with excess blasts|refractory anemia with excess blasts
736996|NCT00098683|refractory anemia|refractory anemia
736997|NCT00098683|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
736998|NCT00098683|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
736999|NCT00098683|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
737000|NCT00098683|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
737001|NCT00098566|quality of life|quality of life
737002|NCT00098566|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
737003|NCT00098566|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
737004|NCT00098566|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
737005|NCT00098566|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
737006|NCT00098566|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
737007|NCT00098566|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
737008|NCT00098566|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
737009|NCT00098566|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
737010|NCT00098566|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
737011|NCT00098566|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
737012|NCT00098566|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
737013|NCT00098566|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
737014|NCT00098566|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
737015|NCT00098566|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
737016|NCT00098566|splenic marginal zone lymphoma|splenic marginal zone lymphoma
737017|NCT00098566|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
737018|NCT00098566|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
737019|NCT00098553|stage IV melanoma|stage iv melanoma
737020|NCT00098553|recurrent melanoma|recurrent melanoma
737021|NCT00098514|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
737022|NCT00098462|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
737023|NCT00098462|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
737024|NCT00098462|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
737025|NCT00098436|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
737026|NCT00098436|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
737027|NCT00098436|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
737028|NCT00098436|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
737029|NCT00098436|secondary acute myeloid leukemia|secondary acute myeloid leukemia
737030|NCT00098436|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
737031|NCT00098436|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
737032|NCT00098436|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
737033|NCT00098436|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
737034|NCT00098436|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
737035|NCT00098384|Travelers’ diarrhea|travelers’ diarrhea
737036|NCT00098384|rifaximin|rifaximin
737039|NCT00098358|Leukotrienes|leukotrienes
737040|NCT00098358|inflammation|inflammation
737041|NCT00098345|Caprelsa (vandetanib)|caprelsa (vandetanib)
737042|NCT00098345|ZD6474|zd6474
737043|NCT00098332|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
737044|NCT00098332|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
737045|NCT00098332|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
737046|NCT00098332|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
737047|NCT00098332|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
737048|NCT00098332|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
737049|NCT00098332|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
737050|NCT00098332|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
737051|NCT00098319|Cleft palate|cleft palate
737052|NCT00098319|Cleft lip|cleft lip
737053|NCT00098319|Folic acid|folic acid
737054|NCT00098319|Global Network|global network
737055|NCT00098319|Maternal and child health|maternal and child health
737056|NCT00098319|International|international
737057|NCT00098319|Women's health|women's health
737058|NCT00098319|Brazil|brazil
737059|NCT00098319|Brasil|brasil
737060|NCT00098319|Latin America|latin america
737061|NCT00098319|ECLAMC|eclamc
737062|NCT00098319|Congenital defects|congenital defects
737063|NCT00098319|Pregnancy|pregnancy
737064|NCT00098293|Aids|aids
737066|NCT00098280|H5g1|h5g1
737067|NCT00098280|PNH|pnh
737068|NCT00098280|TRIUMPH|triumph
737069|NCT00098280|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
737070|NCT00098267|Bacteria|bacteria
737071|NCT00098267|Biofilm Formation|biofilm formation
737072|NCT00098267|Secretory Antibodies|secretory antibodies
737073|NCT00098267|Teeth|teeth
737074|NCT00098267|Health and Disease|health and disease
737075|NCT00098254|Non-Small Cell|non-small cell
737076|NCT00098254|Molecular|molecular
737077|NCT00098254|Targeted|targeted
737078|NCT00098254|Therapies|therapies
737079|NCT00098254|Cancer|cancer
737080|NCT00098254|Non-Small Cell Lung Cancer|non-small cell lung cancer
737081|NCT00098254|NSCLC|nsclc
737082|NCT00098241|pediatric|pediatric
737083|NCT00098241|renal|renal
737084|NCT00098241|transplant recipients|transplant recipients
737085|NCT00098241|de novo|de novo
737086|NCT00098241|De novo renal pediatric transplant|de novo renal pediatric transplant
737087|NCT00098228|COPD, adults, QAB149|copd, adults, qab149
737088|NCT00098215|Residency training|residency training
737089|NCT00098202|Global Network|global network
737090|NCT00098202|Micronutrients|micronutrients
737091|NCT00098202|Zinc|zinc
737092|NCT00098202|Maternal and child health|maternal and child health
737093|NCT00098202|Women's health|women's health
737094|NCT00098202|International|international
737095|NCT00098202|Guatemala|guatemala
737096|NCT00098202|Nutrition|nutrition
737097|NCT00098202|Corn|corn
737098|NCT00098202|Maize|maize
737099|NCT00098189|Safety, psoriasis, adverse event, SAE, extension|safety, psoriasis, adverse event, sae, extension
737100|NCT00098163|HIV Seronegativity|hiv seronegativity
737101|NCT00098163|HIV Preventive Vaccine|hiv preventive vaccine
737102|NCT00098150|Safety, atopic dermatitis, adverse event, SAE, extension|safety, atopic dermatitis, adverse event, sae, extension
737103|NCT00098137|atrial fibrillation|atrial fibrillation
737104|NCT00098137|angiotensin II|angiotensin ii
737105|NCT00098137|angiotensin receptor antagonist|angiotensin receptor antagonist
737106|NCT00098137|drug|drug
737107|NCT00098137|controlled clinical trial|controlled clinical trial
737108|NCT00098124|NSRI|nsri
737109|NCT00098124|milnacipran|milnacipran
737110|NCT00098124|fibromyalgia|fibromyalgia
737111|NCT00098111|Crohn's disease|crohn's disease
737112|NCT00098111|inflammatory bowel disease|inflammatory bowel disease
737113|NCT00098111|IMURAN|imuran
737114|NCT00098111|azathioprine|azathioprine
737115|NCT00098098|Botulinum|botulinum
737116|NCT00098098|Recombinant Botulinum Vaccine|recombinant botulinum vaccine
737117|NCT00098098|botulinum neurotoxins|botulinum neurotoxins
737118|NCT00098085|Lung cancer|lung cancer
737119|NCT00098085|Non-small cell lung cancer|non-small cell lung cancer
737120|NCT00098085|Pulmonary|pulmonary
737121|NCT00098085|Immunotherapy|immunotherapy
737122|NCT00098085|Vaccine|vaccine
737123|NCT00098072|Cytometry|cytometry
737124|NCT00098072|Genes|genes
737125|NCT00098072|Hypertension|hypertension
737126|NCT00098072|Lung|lung
737127|NCT00098072|Proteomics|proteomics
737128|NCT00098072|Primary Pulmonary Hypertenion|primary pulmonary hypertenion
737129|NCT00098072|PPH|pph
737130|NCT00098072|Healthy Volunteers|healthy volunteers
737131|NCT00098072|HV|hv
737132|NCT00098059|herpes simplex|herpes simplex
737133|NCT00098059|cold sores|cold sores
737134|NCT00098059|fever blisters|fever blisters
737135|NCT00098059|children|children
737136|NCT00098059|Famvir|famvir
737137|NCT00098059|famciclovir|famciclovir
737138|NCT00098046|chickenpox|chickenpox
737139|NCT00098046|herpes zoster|herpes zoster
737140|NCT00098046|children|children
737141|NCT00098046|Famvir|famvir
737142|NCT00098046|varicella zoster virus|varicella zoster virus
737143|NCT00098033|clinical|clinical
737144|NCT00098033|pharmacodynamics|pharmacodynamics
737145|NCT00098033|investigational drug clofarabine|investigational drug clofarabine
737146|NCT00098033|AML, ALL, CML-accelerated phase, CML-blastic phase|aml, all, cml-accelerated phase, cml-blastic phase
737147|NCT00098033|Chronic Myelogenous Leukemia - accelerated phase|chronic myelogenous leukemia - accelerated phase
737148|NCT00098033|Chronic Myelogenous Leukemia - blastic phase|chronic myelogenous leukemia - blastic phase
737149|NCT00098020|Glomerulosclerosis|glomerulosclerosis
737150|NCT00098020|Proteinuria|proteinuria
737151|NCT00098020|Fibrosis|fibrosis
737152|NCT00098020|Chronic Kidney Disease|chronic kidney disease
737153|NCT00098020|Nephrotic Syndrome|nephrotic syndrome
737154|NCT00098007|Heart transplantation|heart transplantation
737155|NCT00098007|Everolimus|everolimus
737156|NCT00098007|De novo heart transplant patients|de novo heart transplant patients
737157|NCT00097994|Menopause|menopause
737158|NCT00097994|Quality of Life|quality of life
737159|NCT00097994|Health Services|health services
737160|NCT00097994|Complementary Therapies|complementary therapies
737161|NCT00097981|Multiple myeloma|multiple myeloma
737162|NCT00097981|Newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
737163|NCT00097981|Thalidomide|thalidomide
737164|NCT00097981|Dexamethasone|dexamethasone
737165|NCT00097981|DOXIL|doxil
737166|NCT00097981|Pegylated liposomal hydrochloride doxorubicin injection|pegylated liposomal hydrochloride doxorubicin injection
737167|NCT00097968|transplant, heart, adult, everolimus|transplant, heart, adult, everolimus
737168|NCT00097968|allograft rejection|allograft rejection
737169|NCT00097955|diabetes|diabetes
737170|NCT00097955|nephropathy|nephropathy
737171|NCT00097955|hypertension|hypertension
737172|NCT00097955|aliskiren|aliskiren
737173|NCT00097955|losartan|losartan
737174|NCT00097942|memantine|memantine
737175|NCT00097942|adjunctive therapy|adjunctive therapy
737176|NCT00097942|schizophrenia|schizophrenia
737177|NCT00097929|Relapsed Diffuse Large B-cell Lymphoma|relapsed diffuse large b-cell lymphoma
737178|NCT00097916|memantine HCl|memantine hcl
737179|NCT00097916|Dementia|dementia
737180|NCT00097916|Agitation|agitation
737181|NCT00097916|Alzheimer Disease|alzheimer disease
737182|NCT00097903|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
737183|NCT00097903|Solid Tumors|solid tumors
737184|NCT00097903|Oral|oral
737185|NCT00097890|Lysosomes|lysosomes
737186|NCT00097890|Storage|storage
737187|NCT00097890|Glycolipid|glycolipid
737188|NCT00097890|Fabry Disease|fabry disease
737189|NCT00097890|Stroke|stroke
737190|NCT00097877|Type 2 Diabetes|type 2 diabetes
737191|NCT00097851|second-line|second-line
737192|NCT00097851|combination|combination
737193|NCT00097851|chemotherapy|chemotherapy
737194|NCT00097851|anti-angiogenic|anti-angiogenic
737195|NCT00097838|HIV Seronegativity|hiv seronegativity
737196|NCT00097838|HIV Preventive Vaccine|hiv preventive vaccine
737197|NCT00097825|Male Osteoporosis|male osteoporosis
737198|NCT00097812|osteoporosis, osteopenia, post-menopausal, zoledronic acid|osteoporosis, osteopenia, post-menopausal, zoledronic acid
737199|NCT00097786|Prevention|prevention
737200|NCT00097786|Diabetes type 2|diabetes type 2
737201|NCT00097786|valsartan|valsartan
737202|NCT00097786|nateglinide|nateglinide
737203|NCT00097773|Lung Diseases|lung diseases
737204|NCT00097773|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
737205|NCT00097760|Multiple Sclerosis|multiple sclerosis
737206|NCT00097760|MS|ms
737207|NCT00097747|anemia|anemia
737208|NCT00097747|chronic kidney disease|chronic kidney disease
737209|NCT00097747|CKD|ckd
737210|NCT00097747|chronic renal failure|chronic renal failure
737211|NCT00097747|CRF|crf
737212|NCT00097747|erythropoietin|erythropoietin
737213|NCT00097747|EPO|epo
737214|NCT00097747|erythropoiesis stimulating agent|erythropoiesis stimulating agent
737215|NCT00097747|ESA|esa
737216|NCT00097747|Hematide™|hematide™
737217|NCT00097747|hemoglobin|hemoglobin
737218|NCT00097747|Hb|hb
737219|NCT00097747|Hgb|hgb
737220|NCT00097747|Omontys|omontys
737221|NCT00097747|peginesatide|peginesatide
737222|NCT00097747|red blood cell|red blood cell
737223|NCT00097747|red blood cell production|red blood cell production
737224|NCT00097734|diverticulitis|diverticulitis
737225|NCT00097734|Invanz|invanz
737226|NCT00097734|Ertapenem|ertapenem
737227|NCT00097734|acute attacks|acute attacks
737228|NCT00097734|sigmoid diverticulitis|sigmoid diverticulitis
737229|NCT00097734|Acute attacks of sigmoid diverticulitis|acute attacks of sigmoid diverticulitis
737230|NCT00097721|breast neoplasm|breast neoplasm
737231|NCT00097721|breast cancer|breast cancer
737232|NCT00097721|breast tumor|breast tumor
737233|NCT00097708|Double Blind, Placebo controlled, Safety and Efficacy|double blind, placebo controlled, safety and efficacy
737234|NCT00097708|Generalized Anxiety Disorder|generalized anxiety disorder
737235|NCT00097695|Hereditary Angioedema|hereditary angioedema
737236|NCT00097695|C1 inhibitor deficiency|c1 inhibitor deficiency
737237|NCT00097695|HAE|hae
737238|NCT00097695|Icatibant|icatibant
737239|NCT00097695|Bradykinin antagonist|bradykinin antagonist
737240|NCT00097695|acute attack|acute attack
737241|NCT00097695|subcutaneous|subcutaneous
737242|NCT00097682|Financial Ties|financial ties
737243|NCT00097682|Institution|institution
737244|NCT00097682|Research Doctor|research doctor
737245|NCT00097682|Oncology|oncology
737246|NCT00097682|Attitudes|attitudes
737247|NCT00097682|Cancer|cancer
737248|NCT00097682|Survey|survey
737249|NCT00097669|VITATOPS|vitatops
737250|NCT00097669|stroke|stroke
737251|NCT00097669|prevention|prevention
737252|NCT00097669|multivitamins|multivitamins
737253|NCT00097669|homocysteine|homocysteine
737254|NCT00097643|exercise|exercise
737255|NCT00097643|health promotion|health promotion
737256|NCT00097643|independent living|independent living
737257|NCT00097643|affective aspects|affective aspects
737258|NCT00097630|mechanical ventilation|mechanical ventilation
737259|NCT00097630|delirium|delirium
737260|NCT00097630|sedation scoring|sedation scoring
737261|NCT00097630|cognitive impairment|cognitive impairment
737262|NCT00097630|ventilation weaning|ventilation weaning
737263|NCT00097604|Sleep|sleep
737264|NCT00097604|Aged|aged
737265|NCT00097604|Valerian|valerian
737266|NCT00097604|Complementary Therapies|complementary therapies
737267|NCT00097604|Medicine, Herbal|medicine, herbal
737268|NCT00097565|Follicular Non-Hodgkin's Lymphoma|follicular non-hodgkin's lymphoma
737269|NCT00097539|Pediatric growth disorders|pediatric growth disorders
737270|NCT00097526|Growth Hormone Deficiency|growth hormone deficiency
737271|NCT00097513|Pubertal Growth Hormone Deficiency|pubertal growth hormone deficiency
737272|NCT00097500|diabetes|diabetes
737273|NCT00097500|exenatide|exenatide
737274|NCT00097500|exendin-4|exendin-4
737275|NCT00097500|Amylin|amylin
737276|NCT00097500|Lilly|lilly
737277|NCT00097487|Metastatic Breast Cancer|metastatic breast cancer
737278|NCT00097474|Cortisol|cortisol
737279|NCT00097474|Travel|travel
737280|NCT00097474|Saliva|saliva
737281|NCT00097474|Body Clock|body clock
737282|NCT00097474|Sleep|sleep
737283|NCT00097474|Healthy Volunteer|healthy volunteer
737284|NCT00097474|HV|hv
737285|NCT00097474|Jet Lag|jet lag
737286|NCT00097461|Employee Health|employee health
737287|NCT00097461|Insurance Benefit|insurance benefit
737288|NCT00097461|Fringe Benefit|fringe benefit
737289|NCT00097461|Health Status|health status
737290|NCT00097461|Socioeconomic Factors|socioeconomic factors
737291|NCT00097448|sudden hearing loss|sudden hearing loss
737292|NCT00097448|unilateral sudden sensorineural hearing loss|unilateral sudden sensorineural hearing loss
737293|NCT00097448|sudden sensorineural hearing loss|sudden sensorineural hearing loss
737294|NCT00097448|sudden unilateral hearing loss|sudden unilateral hearing loss
737295|NCT00097422|CDAD, diarrhea|cdad, diarrhea
737296|NCT00097422|Clostridium difficile-Associated Diarrhea|clostridium difficile-associated diarrhea
737297|NCT00097409|ovarian cancer|ovarian cancer
737298|NCT00097409|platinum/taxane-refractory chemotherapy|platinum/taxane-refractory chemotherapy
737299|NCT00097409|Persistent|persistent
737300|NCT00097409|Recurrent|recurrent
737301|NCT00097396|plague|plague
737302|NCT00097396|recombinant plague vaccine|recombinant plague vaccine
737303|NCT00097396|vaccine|vaccine
737304|NCT00097396|plague vaccine|plague vaccine
737305|NCT00097396|Protection against pneumonic plague|protection against pneumonic plague
737306|NCT00097370|Mepolizumab|mepolizumab
737307|NCT00097370|Open-label|open-label
737308|NCT00097370|Anti-IL-5|anti-il-5
737309|NCT00097370|Hypereosinophilic Syndrome|hypereosinophilic syndrome
737310|NCT00097370|Hypereosinophilia|hypereosinophilia
737311|NCT00097357|Prevention of deep vein thrombosis and pulmonary embolism|prevention of deep vein thrombosis and pulmonary embolism
737312|NCT00097357|Preventive therapy|preventive therapy
737313|NCT00097344|Aromatase inhibitor|aromatase inhibitor
737314|NCT00097344|Atamestane|atamestane
737315|NCT00097344|Breast neoplasms|breast neoplasms
737316|NCT00097344|Combined hormonal therapy|combined hormonal therapy
737317|NCT00097344|Complete estrogen blockade|complete estrogen blockade
737318|NCT00097344|Ductal breast carcinoma|ductal breast carcinoma
737319|NCT00097344|Estrogen blocker|estrogen blocker
737320|NCT00097344|Fareston®|fareston®
737321|NCT00097344|Femara®|femara®
737322|NCT00097344|First line therapy|first line therapy
737323|NCT00097344|Letrozole|letrozole
737324|NCT00097344|Lobular breast carcinoma|lobular breast carcinoma
737325|NCT00097344|Locally advanced breast cancer|locally advanced breast cancer
737326|NCT00097344|Locally recurrent breast cancer|locally recurrent breast cancer
737327|NCT00097344|Maximal estrogen inhibition|maximal estrogen inhibition
737328|NCT00097344|Metastatic breast cancer|metastatic breast cancer
737329|NCT00097344|Neoplasms, Hormone-dependent|neoplasms, hormone-dependent
737330|NCT00097344|Receptor-positive|receptor-positive
737331|NCT00097344|Stage IIIA breast cancer|stage iiia breast cancer
737332|NCT00097344|Stage IIIB breast cancer|stage iiib breast cancer
737333|NCT00097344|Stage IV breast cancer|stage iv breast cancer
737334|NCT00097344|Toremifene|toremifene
737335|NCT00097331|multiple sclerosis|multiple sclerosis
737336|NCT00097331|relapsing|relapsing
737337|NCT00097331|remitting|remitting
737338|NCT00097331|Relapsing-Remitting MS (RRMS)|relapsing-remitting ms (rrms)
737339|NCT00097318|Ischemic|ischemic
737340|NCT00097318|Brain|brain
737341|NCT00097318|Inflammation|inflammation
737342|NCT00097318|Clinical Trial|clinical trial
737343|NCT00097318|Stroke|stroke
737344|NCT00097305|Mental Health|mental health
737345|NCT00097305|Psychotherapy|psychotherapy
737346|NCT00097292|"at risk for developing type 1 diabetes"|"at risk for developing type 1 diabetes"
737347|NCT00097292|T1DM|t1dm
737348|NCT00097292|T1D|t1d
737349|NCT00097292|juvenile diabetes|juvenile diabetes
737350|NCT00097292|Type 1 Diabetes TrialNet|type 1 diabetes trialnet
737351|NCT00097292|TrialNet|trialnet
737352|NCT00097266|Bipolar Mania|bipolar mania
737353|NCT00097253|Aromatherapy|aromatherapy
737354|NCT00097253|Smell|smell
737355|NCT00097240|FOLLOW|follow
737356|NCT00097240|Psoriasis|psoriasis
737357|NCT00097240|Pregnancy|pregnancy
737358|NCT00097227|NSCLC|nsclc
737359|NCT00097227|non-small|non-small
737360|NCT00097227|lung|lung
737361|NCT00097227|IIIb|iiib
737362|NCT00097227|IV|iv
737363|NCT00097227|Carboplatin|carboplatin
737364|NCT00097227|Paclitaxel|paclitaxel
737365|NCT00097227|Cetuximab|cetuximab
737366|NCT00097227|Stage IIIB Non-Small Cell Lung Cancer|stage iiib non-small cell lung cancer
737367|NCT00097227|Stage IV Non-Small Cell Lung Cancer|stage iv non-small cell lung cancer
737368|NCT00097214|NSCLC|nsclc
737369|NCT00097214|Non-small|non-small
737370|NCT00097214|Lung|lung
737371|NCT00097214|IIIB|iiib
737372|NCT00097214|IV|iv
737373|NCT00097214|Carboplatin|carboplatin
737374|NCT00097214|Cetuximab|cetuximab
737375|NCT00097214|Stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
737376|NCT00097214|Stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
737377|NCT00097188|Relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
737378|NCT00097175|Major Depressive Disorder|major depressive disorder
737379|NCT00097175|Serotonin|serotonin
737380|NCT00097175|Functional MRI|functional mri
737381|NCT00097175|Genotype|genotype
737382|NCT00097175|Negative Affect|negative affect
737383|NCT00097175|MDD|mdd
737384|NCT00097175|Healthy Volunteer|healthy volunteer
737385|NCT00097175|HV|hv
737386|NCT00097162|Anisometropia|anisometropia
737387|NCT00097162|Strabismus|strabismus
737388|NCT00097162|Cortical Suppression|cortical suppression
737389|NCT00097162|Impaired Vision|impaired vision
737390|NCT00097162|Cortical Plasticity|cortical plasticity
737391|NCT00097162|Amblyopia|amblyopia
737392|NCT00097162|Adult Amblyopia|adult amblyopia
737393|NCT00097149|Congenital birth defects|congenital birth defects
737394|NCT00097149|Cleft lip|cleft lip
737395|NCT00097149|Cleft palate|cleft palate
737396|NCT00097149|Global Network|global network
737397|NCT00097149|Neurodevelopmental outcome|neurodevelopmental outcome
737398|NCT00097149|Maternal and child health|maternal and child health
737399|NCT00097149|International|international
737400|NCT00097149|Women's health|women's health
737401|NCT00097149|Brazil|brazil
737402|NCT00097149|Brasil|brasil
737403|NCT00097149|Latin America|latin america
737404|NCT00097149|ECLAMC|eclamc
737405|NCT00097149|Argentina|argentina
737406|NCT00097149|Bolivia|bolivia
737407|NCT00097149|Chile|chile
737408|NCT00097149|Colombia|colombia
737409|NCT00097149|Ecuador|ecuador
737410|NCT00097149|Venezuela|venezuela
737411|NCT00097123|Acute postpartum hemorrhage|acute postpartum hemorrhage
737412|NCT00097123|PPH|pph
737413|NCT00097123|Misoprostol|misoprostol
737414|NCT00097123|Global Network|global network
737415|NCT00097123|Uterotonics|uterotonics
737416|NCT00097123|India|india
737417|NCT00097123|Maternal and child health|maternal and child health
737418|NCT00097123|International|international
737419|NCT00097123|Women's health|women's health
737420|NCT00097110|Vitamin C|vitamin c
737421|NCT00097110|Vitamin E|vitamin e
737422|NCT00097110|Preeclampsia|preeclampsia
737423|NCT00097110|Antioxidants|antioxidants
737424|NCT00097110|Global Network|global network
737425|NCT00097110|Preterm birth|preterm birth
737426|NCT00097110|Low birth weight infants|low birth weight infants
737427|NCT00097110|Brazil|brazil
737428|NCT00097110|Brasil|brasil
737429|NCT00097110|Maternal and child health|maternal and child health
737430|NCT00097110|International|international
737431|NCT00097110|Women's health|women's health
737432|NCT00097097|Asphyxia|asphyxia
737433|NCT00097097|Neonatal mortality|neonatal mortality
737434|NCT00097097|Neonatal morbidity|neonatal morbidity
737435|NCT00097097|Hypoxic ischemic encephalopathy|hypoxic ischemic encephalopathy
737436|NCT00097097|Neurodevelopmental impairment|neurodevelopmental impairment
737437|NCT00097097|Neonatal resuscitation|neonatal resuscitation
737438|NCT00097097|Global Network|global network
737439|NCT00097097|Zambia|zambia
737440|NCT00097097|Africa|africa
737441|NCT00097097|Cerebral palsy|cerebral palsy
737442|NCT00097097|Child health|child health
737443|NCT00097097|International|international
737444|NCT00097071|Diabetes, Type 1|diabetes, type 1
737445|NCT00097058|Aging|aging
737446|NCT00097058|Menopause|menopause
737447|NCT00097058|Estrogen Replacement Therapy|estrogen replacement therapy
737448|NCT00097058|Cognitive Decline|cognitive decline
737449|NCT00097045|Hepatitis C|hepatitis c
737450|NCT00097045|HCV|hcv
737451|NCT00097045|Omega Interferon|omega interferon
737452|NCT00097045|Interferon|interferon
737453|NCT00097045|HCV genotype 1|hcv genotype 1
737454|NCT00097032|Bipolar I Disorder|bipolar i disorder
737455|NCT00097032|risperidone|risperidone
737456|NCT00097032|quetiapine|quetiapine
737457|NCT00097032|sedation|sedation
737458|NCT00097032|cognition|cognition
737459|NCT00097019|Recurrent ovarian cancer|recurrent ovarian cancer
737460|NCT00097019|Refractory ovarian cancer|refractory ovarian cancer
737461|NCT00096993|Omnitarg|omnitarg
737462|NCT00096993|Cancer|cancer
737463|NCT00096993|Platinum-Resistant|platinum-resistant
737464|NCT00096967|Metastatic breast cancer|metastatic breast cancer
737465|NCT00096967|Metastatic colorectal cancer|metastatic colorectal cancer
737466|NCT00096954|Omalizumab (Xolair)|omalizumab (xolair)
737467|NCT00096954|Atopic Asthma|atopic asthma
737468|NCT00096941|Advanced solid cancers|advanced solid cancers
737469|NCT00096941|HER2|her2
737470|NCT00096941|EGFR|egfr
737471|NCT00096928|Plaque Psoriasis|plaque psoriasis
737472|NCT00096928|RESPONSE|response
737475|NCT00096915|chronic kidney disease, CKD|chronic kidney disease, ckd
737476|NCT00096915|renal failure|renal failure
737477|NCT00096915|anemia|anemia
737478|NCT00096915|hemodialysis|hemodialysis
737479|NCT00096915|peritoneal dialysis|peritoneal dialysis
737480|NCT00096915|Aranesp®, Darbepoetin Alfa|aranesp®, darbepoetin alfa
737481|NCT00096902|Orthostatic Intolerance|orthostatic intolerance
737482|NCT00096902|Hypnosis|hypnosis
737483|NCT00096902|Cold Pressor|cold pressor
737484|NCT00096902|Isometric Exercise|isometric exercise
737485|NCT00096902|Behavior|behavior
737486|NCT00096902|Neurocardiogenic Syncope|neurocardiogenic syncope
737487|NCT00096876|Parkinsonian syndrome|parkinsonian syndrome
737488|NCT00096863|Delirium|delirium
737489|NCT00096863|Cognition Disorders|cognition disorders
737490|NCT00096863|Antipsychotics|antipsychotics
737491|NCT00096863|Mechanical Ventilation|mechanical ventilation
737492|NCT00096863|Critical Illness|critical illness
737493|NCT00096850|HIV Seronegativity|hiv seronegativity
737494|NCT00096850|Antitubercular agents|antitubercular agents
737495|NCT00096837|Myeloma|myeloma
737496|NCT00096837|Multiple Myeloma|multiple myeloma
737497|NCT00096837|Relapsed Multiple Myeloma|relapsed multiple myeloma
737498|NCT00096837|Refractory Multiple Myeloma|refractory multiple myeloma
737499|NCT00096824|Acute Infection|acute infection
737500|NCT00096824|Treatment Naive|treatment naive
737501|NCT00096798|Fatty Acids, Omega-3|fatty acids, omega-3
737502|NCT00096798|Antidepressive Agents|antidepressive agents
737503|NCT00096798|Eicosapentanoic Acid|eicosapentanoic acid
737504|NCT00096785|chronic hepatitis B infection|chronic hepatitis b infection
737505|NCT00096772|Genetic Testing|genetic testing
737506|NCT00096772|Genomics|genomics
737507|NCT00096772|Human Genetic Factors|human genetic factors
737508|NCT00096759|Arthritis|arthritis
737509|NCT00096759|Tai Chi|tai chi
737510|NCT00096759|Meditation|meditation
737511|NCT00096759|Relaxation Techniques|relaxation techniques
737512|NCT00096746|Treatment Experienced|treatment experienced
737513|NCT00096733|Living donors|living donors
737514|NCT00096733|Organ procurement|organ procurement
737515|NCT00096733|Liver transplantation|liver transplantation
737516|NCT00096733|Hepatitis C|hepatitis c
737517|NCT00096733|Hepatocellular carcinoma|hepatocellular carcinoma
737518|NCT00096733|Hepatectomy|hepatectomy
737519|NCT00096733|Liver regeneration|liver regeneration
737520|NCT00096733|Graft rejection|graft rejection
737521|NCT00096733|Quality of life|quality of life
737522|NCT00096733|Informed consent|informed consent
737523|NCT00096720|parkinson|parkinson
737524|NCT00096720|brain imaging|brain imaging
737525|NCT00096720|diagnosis|diagnosis
737526|NCT00096707|advanced solid tumors|advanced solid tumors
737527|NCT00096707|cancer|cancer
737528|NCT00096707|docetaxel|docetaxel
737529|NCT00096707|2-deoxy-D-glucose (2DG)|2-deoxy-d-glucose (2dg)
737530|NCT00096707|phase 1|phase 1
737531|NCT00096694|Intrauterine Device|intrauterine device
737532|NCT00096694|IUD|iud
737533|NCT00096694|Contraceptive|contraceptive
737534|NCT00096694|Levonorgestrel|levonorgestrel
737535|NCT00096668|Breast cancer|breast cancer
737536|NCT00096668|TOCOSOL Paclitaxel|tocosol paclitaxel
737537|NCT00096655|Ulcerative colitis|ulcerative colitis
737538|NCT00096655|Infliximab|infliximab
737539|NCT00096655|Remicade|remicade
737540|NCT00096642|cognitive behavioral therapy|cognitive behavioral therapy
737541|NCT00096642|depression|depression
737542|NCT00096642|group therapy|group therapy
737543|NCT00096642|parenting|parenting
737544|NCT00096642|children and adolescents|children and adolescents
737545|NCT00096629|recurrent renal cell cancer|recurrent renal cell cancer
737546|NCT00096629|stage I renal cell cancer|stage i renal cell cancer
737547|NCT00096629|stage II renal cell cancer|stage ii renal cell cancer
737548|NCT00096629|stage III renal cell cancer|stage iii renal cell cancer
737549|NCT00096629|stage IV renal cell cancer|stage iv renal cell cancer
737550|NCT00096603|Moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
737551|NCT00096590|thromboembolism|thromboembolism
737552|NCT00096590|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
737553|NCT00096564|Mirror Neuron|mirror neuron
737554|NCT00096564|Urge|urge
737555|NCT00096564|Statistical Parametric Mapping|statistical parametric mapping
737556|NCT00096564|Healthy Volunteer|healthy volunteer
737557|NCT00096564|HV|hv
737558|NCT00096551|Biochemical Failure|biochemical failure
737559|NCT00096551|Immunotherapy|immunotherapy
737560|NCT00096551|TRICOM|tricom
737561|NCT00096551|Pox-virus|pox-virus
737562|NCT00096551|Fowlpox|fowlpox
737563|NCT00096551|Prostate Cancer|prostate cancer
737564|NCT00096538|classic Kaposi sarcoma|classic kaposi sarcoma
737565|NCT00096538|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
737566|NCT00096525|recurrent renal cell cancer|recurrent renal cell cancer
737567|NCT00096525|stage III renal cell cancer|stage iii renal cell cancer
737568|NCT00096525|stage IV renal cell cancer|stage iv renal cell cancer
737569|NCT00096486|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
737570|NCT00096486|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
737571|NCT00096486|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
737572|NCT00096473|Alzheimer's Disease|alzheimer's disease
737573|NCT00096473|dementia|dementia
737574|NCT00096473|acetylcholinesterase|acetylcholinesterase
737575|NCT00096473|donepezil|donepezil
737576|NCT00096473|Aricept|aricept
737577|NCT00096473|memory loss|memory loss
737578|NCT00096473|Severe dementia of the Alzheimer's type|severe dementia of the alzheimer's type
737579|NCT00096421|Critical illness|critical illness
737580|NCT00096421|Critical care|critical care
737581|NCT00096421|Hyperglycemia|hyperglycemia
737582|NCT00096421|Intensive care|intensive care
737583|NCT00096421|Intensive Care Units|intensive care units
737584|NCT00096421|Insulin resistance|insulin resistance
737585|NCT00096421|Intensive insulin therapy|intensive insulin therapy
737586|NCT00096421|Conventional insulin therapy|conventional insulin therapy
737587|NCT00096408|Endometrial|endometrial
737588|NCT00096408|Endometrium|endometrium
737589|NCT00096408|Uterus|uterus
737590|NCT00096408|Cancer|cancer
737591|NCT00096408|Carcinoma|carcinoma
737592|NCT00096408|Adenocarcinoma|adenocarcinoma
737593|NCT00096408|Stage 1|stage 1
737594|NCT00096408|Hysterectomy|hysterectomy
737595|NCT00096408|Laparoscopy|laparoscopy
737596|NCT00096408|Abdominal|abdominal
737597|NCT00096408|Total|total
737598|NCT00096408|Surgery|surgery
737599|NCT00096408|Quality of Life|quality of life
737600|NCT00096408|Disease-free survival|disease-free survival
737601|NCT00096382|stage IV melanoma|stage iv melanoma
737602|NCT00096382|recurrent melanoma|recurrent melanoma
737603|NCT00096369|breast cancer|breast cancer
737604|NCT00096369|lobular breast carcinoma in situ|lobular breast carcinoma in situ
737605|NCT00096369|breast cancer in situ|breast cancer in situ
737606|NCT00096356|fatigue|fatigue
737607|NCT00096356|stage I breast cancer|stage i breast cancer
737608|NCT00096356|stage II breast cancer|stage ii breast cancer
737609|NCT00096356|stage IIIA breast cancer|stage iiia breast cancer
737610|NCT00096356|stage IIIB breast cancer|stage iiib breast cancer
737611|NCT00096356|stage IIIC breast cancer|stage iiic breast cancer
737612|NCT00096356|stage IV breast cancer|stage iv breast cancer
737613|NCT00096343|invasive ductal breast carcinoma|invasive ductal breast carcinoma
737614|NCT00096343|invasive lobular breast carcinoma|invasive lobular breast carcinoma
737615|NCT00096343|stage II breast cancer|stage ii breast cancer
737616|NCT00096343|stage IIIA breast cancer|stage iiia breast cancer
737617|NCT00096343|stage IIIB breast cancer|stage iiib breast cancer
737618|NCT00096343|inflammatory breast cancer|inflammatory breast cancer
737619|NCT00096330|colon cancer|colon cancer
737620|NCT00096330|rectal cancer|rectal cancer
737621|NCT00096317|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
737622|NCT00096304|adenocarcinoma of the prostate|adenocarcinoma of the prostate
737623|NCT00096304|recurrent prostate cancer|recurrent prostate cancer
737624|NCT00096304|stage IV prostate cancer|stage iv prostate cancer
737625|NCT00096291|stage II breast cancer|stage ii breast cancer
737626|NCT00096291|stage IIIA breast cancer|stage iiia breast cancer
737627|NCT00096291|stage IIIB breast cancer|stage iiib breast cancer
737628|NCT00096291|stage IIIC breast cancer|stage iiic breast cancer
737629|NCT00096239|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
737630|NCT00096239|primary peritoneal cavity cancer|primary peritoneal cavity cancer
737631|NCT00096239|fallopian tube cancer|fallopian tube cancer
737632|NCT00096226|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
737633|NCT00096226|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
737634|NCT00096213|chondrosarcoma|chondrosarcoma
737635|NCT00096187|low risk metastatic gestational trophoblastic tumor|low risk metastatic gestational trophoblastic tumor
737636|NCT00096187|recurrent gestational trophoblastic tumor|recurrent gestational trophoblastic tumor
737637|NCT00096187|nonmetastatic gestational trophoblastic tumor|nonmetastatic gestational trophoblastic tumor
737638|NCT00096174|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
737639|NCT00096174|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
737640|NCT00096174|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
737641|NCT00096174|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
737642|NCT00096135|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
737643|NCT00096135|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
737644|NCT00096135|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
737645|NCT00096135|TdT positive childhood acute lymphoblastic leukemia|tdt positive childhood acute lymphoblastic leukemia
737646|NCT00096096|graft versus host disease|graft versus host disease
737647|NCT00096096|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
737648|NCT00096096|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
737649|NCT00096096|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
737650|NCT00096096|refractory multiple myeloma|refractory multiple myeloma
737651|NCT00096096|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
737652|NCT00096096|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
737653|NCT00096096|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
737654|NCT00096096|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
737655|NCT00096096|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
737656|NCT00096096|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
737657|NCT00096096|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
737658|NCT00096096|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
737659|NCT00096096|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
737660|NCT00096096|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
737661|NCT00096096|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
737662|NCT00096096|secondary acute myeloid leukemia|secondary acute myeloid leukemia
737663|NCT00096096|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
737664|NCT00096096|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
737665|NCT00096096|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
737666|NCT00096096|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
737667|NCT00096096|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
737668|NCT00096096|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
737669|NCT00096096|refractory anemia with excess blasts|refractory anemia with excess blasts
737670|NCT00096096|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
737671|NCT00096096|refractory hairy cell leukemia|refractory hairy cell leukemia
737672|NCT00096096|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
737673|NCT00096096|chronic eosinophilic leukemia|chronic eosinophilic leukemia
737674|NCT00096096|chronic neutrophilic leukemia|chronic neutrophilic leukemia
737675|NCT00096096|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
737676|NCT00096096|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
737677|NCT00096096|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
737678|NCT00096096|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
737679|NCT00096096|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
737680|NCT00096096|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
737681|NCT00096096|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
737682|NCT00096096|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
737683|NCT00096096|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
737684|NCT00096096|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
737685|NCT00096096|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
737686|NCT00096096|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
737687|NCT00096096|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
737688|NCT00096096|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
737689|NCT00096096|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
737690|NCT00096096|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
737691|NCT00096096|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
737692|NCT00096096|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
737693|NCT00096096|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
737694|NCT00096096|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
737695|NCT00096096|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
737696|NCT00096096|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
737697|NCT00096096|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
737698|NCT00096096|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
737699|NCT00096096|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
737700|NCT00096096|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
737701|NCT00096096|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
737702|NCT00096096|stage I multiple myeloma|stage i multiple myeloma
737703|NCT00096096|stage II multiple myeloma|stage ii multiple myeloma
737704|NCT00096096|stage III multiple myeloma|stage iii multiple myeloma
737705|NCT00096096|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
737706|NCT00096096|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
737707|NCT00096096|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
737708|NCT00096096|splenic marginal zone lymphoma|splenic marginal zone lymphoma
737709|NCT00096096|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
737710|NCT00096096|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
737711|NCT00096096|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
737712|NCT00096096|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
737713|NCT00096096|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
737714|NCT00096096|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
737715|NCT00096096|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
737948|NCT00095290|Albuminuria|albuminuria
737716|NCT00096096|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
737717|NCT00096096|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
737718|NCT00096096|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
737719|NCT00096096|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
737720|NCT00096096|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
737721|NCT00096096|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
737722|NCT00096096|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
737723|NCT00096096|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
737724|NCT00096096|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
737725|NCT00096096|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
737726|NCT00096096|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
737727|NCT00096096|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
737728|NCT00096096|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
737729|NCT00096096|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
737730|NCT00096096|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
737731|NCT00096096|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
737732|NCT00096096|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
737733|NCT00096096|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
737734|NCT00096096|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
737735|NCT00096096|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
737736|NCT00096096|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
737737|NCT00096096|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
737738|NCT00096096|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
737739|NCT00096096|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
737740|NCT00096096|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
737741|NCT00096083|advanced adult primary liver cancer|advanced adult primary liver cancer
737742|NCT00096083|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
737743|NCT00096083|recurrent adult primary liver cancer|recurrent adult primary liver cancer
737744|NCT00096083|liver metastases|liver metastases
737745|NCT00096083|adenocarcinoma of the colon|adenocarcinoma of the colon
737746|NCT00096083|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
737747|NCT00096083|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
737748|NCT00096083|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
737749|NCT00096083|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
737750|NCT00096083|adenocarcinoma of the rectum|adenocarcinoma of the rectum
737751|NCT00096083|adenocarcinoma of the stomach|adenocarcinoma of the stomach
737752|NCT00096083|carcinoma of the appendix|carcinoma of the appendix
737753|NCT00096083|recurrent gallbladder cancer|recurrent gallbladder cancer
737754|NCT00096083|unresectable gallbladder cancer|unresectable gallbladder cancer
737755|NCT00096083|recurrent colon cancer|recurrent colon cancer
737756|NCT00096083|stage IV colon cancer|stage iv colon cancer
737757|NCT00096083|recurrent esophageal cancer|recurrent esophageal cancer
737758|NCT00096083|stage IV esophageal cancer|stage iv esophageal cancer
737759|NCT00096083|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
737760|NCT00096083|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
737761|NCT00096083|recurrent gastric cancer|recurrent gastric cancer
737762|NCT00096083|stage IV gastric cancer|stage iv gastric cancer
737763|NCT00096083|recurrent rectal cancer|recurrent rectal cancer
737764|NCT00096083|stage IV rectal cancer|stage iv rectal cancer
737765|NCT00096083|small intestine adenocarcinoma|small intestine adenocarcinoma
737766|NCT00096083|recurrent small intestine cancer|recurrent small intestine cancer
737767|NCT00096083|recurrent islet cell carcinoma|recurrent islet cell carcinoma
737768|NCT00096083|recurrent pheochromocytoma|recurrent pheochromocytoma
737769|NCT00096083|metastatic pheochromocytoma|metastatic pheochromocytoma
737770|NCT00096083|pulmonary carcinoid tumor|pulmonary carcinoid tumor
737771|NCT00096083|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
737772|NCT00096083|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
737773|NCT00096083|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
737774|NCT00096083|recurrent pancreatic cancer|recurrent pancreatic cancer
737775|NCT00096083|insulinoma|insulinoma
737776|NCT00096083|WDHA syndrome|wdha syndrome
737777|NCT00096083|glucagonoma|glucagonoma
737778|NCT00096083|pancreatic polypeptide tumor|pancreatic polypeptide tumor
737779|NCT00096083|somatostatinoma|somatostatinoma
737780|NCT00096083|stage IV pancreatic cancer|stage iv pancreatic cancer
737781|NCT00096083|intraocular melanoma|intraocular melanoma
737782|NCT00096083|conjunctival melanoma|conjunctival melanoma
737783|NCT00096083|iris melanoma|iris melanoma
737784|NCT00096083|recurrent melanoma|recurrent melanoma
737785|NCT00096083|stage IV melanoma|stage iv melanoma
737786|NCT00096057|recurrent breast cancer|recurrent breast cancer
737787|NCT00096057|stage IIIA breast cancer|stage iiia breast cancer
737788|NCT00096057|stage IIIB breast cancer|stage iiib breast cancer
738141|NCT00094510|HV|hv
737789|NCT00096057|stage IIIC breast cancer|stage iiic breast cancer
737790|NCT00096057|stage IV breast cancer|stage iv breast cancer
737791|NCT00096044|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
737792|NCT00096031|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
737793|NCT00096031|recurrent esophageal cancer|recurrent esophageal cancer
737794|NCT00096031|stage IV esophageal cancer|stage iv esophageal cancer
737795|NCT00096018|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
737796|NCT00096018|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
737797|NCT00096018|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
737798|NCT00096018|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
737799|NCT00096018|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
737800|NCT00095992|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
737801|NCT00095992|advanced adult primary liver cancer|advanced adult primary liver cancer
737802|NCT00095992|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
737803|NCT00095992|recurrent adult primary liver cancer|recurrent adult primary liver cancer
737804|NCT00095953|recurrent melanoma|recurrent melanoma
737805|NCT00095953|stage IV melanoma|stage iv melanoma
737806|NCT00095927|radiation toxicity|radiation toxicity
737807|NCT00095927|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
737808|NCT00095927|mucositis|mucositis
737809|NCT00095927|xerostomia|xerostomia
737810|NCT00095927|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
737811|NCT00095927|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
737812|NCT00095927|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
737813|NCT00095927|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
737814|NCT00095927|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
737815|NCT00095927|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
737816|NCT00095927|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
737817|NCT00095927|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
737818|NCT00095927|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
737819|NCT00095927|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
737820|NCT00095927|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
737821|NCT00095927|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
737822|NCT00095927|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
737823|NCT00095927|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
737824|NCT00095927|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
737825|NCT00095927|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
737826|NCT00095927|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
737827|NCT00095914|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
737828|NCT00095901|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
737829|NCT00095901|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
737830|NCT00095901|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
737831|NCT00095901|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
737832|NCT00095875|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
737833|NCT00095875|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
737834|NCT00095875|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
737835|NCT00095875|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
737836|NCT00095875|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
737837|NCT00095875|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
737838|NCT00095875|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
737839|NCT00095875|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
737840|NCT00095862|recurrent breast cancer|recurrent breast cancer
737841|NCT00095862|stage IV breast cancer|stage iv breast cancer
737842|NCT00095862|male breast cancer|male breast cancer
737843|NCT00095862|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
737844|NCT00095836|recurrent thyroid cancer|recurrent thyroid cancer
737845|NCT00095836|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
737846|NCT00095836|stage III papillary thyroid cancer|stage iii papillary thyroid cancer
737847|NCT00095836|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
737848|NCT00095836|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
737849|NCT00095836|anaplastic thyroid cancer|anaplastic thyroid cancer
737947|NCT00095303|Substance Abuse|substance abuse
737850|NCT00095836|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
737851|NCT00095810|Psychosis, Parkinson's Disease|psychosis, parkinson's disease
737852|NCT00095771|untreated childhood brain stem glioma|untreated childhood brain stem glioma
737853|NCT00095771|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
737854|NCT00095732|Pancreatic Insufficiency|pancreatic insufficiency
737855|NCT00095732|Cystic Fibrosis|cystic fibrosis
737856|NCT00095732|Enzymes|enzymes
737857|NCT00095719|Acute agitation in patients diagnosed with Dementia|acute agitation in patients diagnosed with dementia
737858|NCT00095706|Metastatic breast cancer|metastatic breast cancer
737859|NCT00095706|HER2|her2
737860|NCT00095706|Trastuzumab|trastuzumab
737861|NCT00095706|Herceptin|herceptin
737862|NCT00095706|VEGF|vegf
737863|NCT00095706|Bevacizumab|bevacizumab
737864|NCT00095706|Avastin|avastin
737865|NCT00095680|Multiple Myeloma|multiple myeloma
737866|NCT00095680|SCIO-469|scio-469
737867|NCT00095680|Bortezomib|bortezomib
737868|NCT00095680|p38 MAP kinase|p38 map kinase
737869|NCT00095654|diabetes prevention|diabetes prevention
737870|NCT00095654|ramipril|ramipril
737871|NCT00095654|rosiglitazone|rosiglitazone
737872|NCT00095654|impaired glucose tolerance|impaired glucose tolerance
737873|NCT00095654|isolated impaired fasting glucose|isolated impaired fasting glucose
737874|NCT00095654|Isolated Impaired Glucose Tolerance|isolated impaired glucose tolerance
737875|NCT00095589|bladder cancer|bladder cancer
737876|NCT00095589|stage 0 bladder cancer|stage 0 bladder cancer
737877|NCT00095589|stage I bladder cancer|stage i bladder cancer
737878|NCT00095589|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
737879|NCT00095550|Moderate Hypertension|moderate hypertension
737880|NCT00095537|Solid tumors|solid tumors
737881|NCT00095537|cancer|cancer
737882|NCT00095537|HER-2-expressing tumors|her-2-expressing tumors
737883|NCT00095524|Patient weight change|patient weight change
737884|NCT00095524|changes in metabolic status|changes in metabolic status
737885|NCT00095511|Bipolar Mania|bipolar mania
737886|NCT00095498|arthritis|arthritis
737887|NCT00095498|joint pain|joint pain
737888|NCT00095498|Methotrexate|methotrexate
737889|NCT00095485|Activity Level|activity level
737890|NCT00095485|Musculoskeletal|musculoskeletal
737891|NCT00095485|Healthy Volunteer|healthy volunteer
737892|NCT00095485|Physical Activity|physical activity
737893|NCT00095472|Blood Flow|blood flow
737894|NCT00095472|Nitric Oxide|nitric oxide
737895|NCT00095472|Vascular Function|vascular function
737896|NCT00095472|Vasodilation|vasodilation
737897|NCT00095472|Vaso-Occlusive Pain Crisis|vaso-occlusive pain crisis
737898|NCT00095472|Sickle Cell Disease|sickle cell disease
737899|NCT00095459|Raf-Kinase Inhibitor|raf-kinase inhibitor
737900|NCT00095459|Combinatorial Therapy|combinatorial therapy
737901|NCT00095459|Pathway Profiling|pathway profiling
737902|NCT00095459|VEGFR|vegfr
737903|NCT00095459|Bevacizumab|bevacizumab
737904|NCT00095459|Sorafenib|sorafenib
737905|NCT00095459|Advanced Solid Tumors|advanced solid tumors
737906|NCT00095459|Angiogenesis|angiogenesis
737907|NCT00095459|Targeted Therapy|targeted therapy
737908|NCT00095459|VEGF|vegf
737909|NCT00095459|Cancer|cancer
737910|NCT00095459|Solid Tumor|solid tumor
737911|NCT00095459|Metastatic Uresectable Solid Tumors|metastatic uresectable solid tumors
737912|NCT00095446|Diabetes Mellitus|diabetes mellitus
737913|NCT00095446|Diabetes|diabetes
737914|NCT00095433|AMD|amd
737915|NCT00095433|Neovascular age-related macular degeneration|neovascular age-related macular degeneration
737916|NCT00095420|Interpersonal Relationships|interpersonal relationships
737917|NCT00095420|Child|child
737918|NCT00095407|Social Cognition|social cognition
737919|NCT00095407|Semantic Memory|semantic memory
737920|NCT00095407|Prefrontal Cortex|prefrontal cortex
737921|NCT00095407|Temporal Cortex|temporal cortex
737922|NCT00095407|Conceptual Self|conceptual self
737923|NCT00095394|Severe Hypertension|severe hypertension
737924|NCT00095381|Leukemia, Lymphocytic, T-Cell|leukemia, lymphocytic, t-cell
737925|NCT00095381|Entry Term Lymphocytic Leukemia, T-Cell|entry term lymphocytic leukemia, t-cell
737926|NCT00095381|T-Cell Leukemia|t-cell leukemia
737927|NCT00095381|T-Lymphocytic Leukemia|t-lymphocytic leukemia
737928|NCT00095381|Leukemia, Lymphocytic, T Cell|leukemia, lymphocytic, t cell
737929|NCT00095381|T Lymphocytic Leukemia|t lymphocytic leukemia
737930|NCT00095381|BCX-1777|bcx-1777
737931|NCT00095381|forodesine hydrochloride|forodesine hydrochloride
737932|NCT00095381|BioCryst|biocryst
737933|NCT00095368|Pharyngitis|pharyngitis
737934|NCT00095368|Tonsillitis|tonsillitis
737935|NCT00095355|BDNF|bdnf
737936|NCT00095355|Lithium|lithium
737937|NCT00095355|Divalproex|divalproex
737938|NCT00095355|Huntington Disease|huntington disease
737939|NCT00095355|HD|hd
737940|NCT00095329|relapsing-remitting MS|relapsing-remitting ms
737941|NCT00095329|nonresponsive to standard of care MS|nonresponsive to standard of care ms
737942|NCT00095329|sirolimus|sirolimus
737943|NCT00095316|candidiasis, caspofungin, fungal infection, prophylaxis|candidiasis, caspofungin, fungal infection, prophylaxis
737944|NCT00095303|BSFT|bsft
737945|NCT00095303|Family Therapy|family therapy
737946|NCT00095303|Adolescents|adolescents
737949|NCT00095290|Hypertension|hypertension
737950|NCT00095290|Elevated Cardiovascular Risk|elevated cardiovascular risk
737951|NCT00095290|Albuminuria in Hypertensive Subjects at Elevated Cardiovascular Risk|albuminuria in hypertensive subjects at elevated cardiovascular risk
737952|NCT00095277|non-myeloid malignancies|non-myeloid malignancies
737953|NCT00095277|myeloma|myeloma
737954|NCT00095277|Anemia of Cancer|anemia of cancer
737955|NCT00095264|Myelodysplastic Syndrome|myelodysplastic syndrome
737956|NCT00095251|Delirium|delirium
737957|NCT00095251|Hypnotics and Sedatives|hypnotics and sedatives
737958|NCT00095251|Adrenergic alpha-Agonists|adrenergic alpha-agonists
737959|NCT00095251|efficacy of sedation|efficacy of sedation
737960|NCT00095251|cognitive impairment|cognitive impairment
737961|NCT00095225|Recurrent or refractory non-small cell lung cancer|recurrent or refractory non-small cell lung cancer
737962|NCT00095212|HIV|hiv
737963|NCT00095212|women|women
737964|NCT00095212|androgen|androgen
737965|NCT00095212|Treatment Experienced|treatment experienced
737966|NCT00095199|Recurrent or Progressive Non-Small Cell Lung Cancer|recurrent or progressive non-small cell lung cancer
737967|NCT00095199|Second-line therapy|second-line therapy
737968|NCT00095199|Docetaxel|docetaxel
737969|NCT00095199|Pemetrexed|pemetrexed
737970|NCT00095199|Cetuximab|cetuximab
737971|NCT00095199|Failed platinum-based therapy|failed platinum-based therapy
737972|NCT00095199|NSCLC|nsclc
737973|NCT00095186|Cancer|cancer
737974|NCT00095186|Metastatic|metastatic
737975|NCT00095186|Kidney|kidney
737976|NCT00095186|Refractive|refractive
737977|NCT00095186|Lactoferrin|lactoferrin
737978|NCT00095186|Oral|oral
737979|NCT00095173|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
737980|NCT00095160|Solid Organ Tumors|solid organ tumors
737981|NCT00095121|Hepatitis B|hepatitis b
737982|NCT00095121|Children|children
737983|NCT00095121|Pediatric|pediatric
737984|NCT00095121|Adefovir Dipivoxil|adefovir dipivoxil
737985|NCT00095108|Metastatic Melanoma|metastatic melanoma
737986|NCT00095108|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
737987|NCT00095095|Spine|spine
737988|NCT00095095|Lumbar spine|lumbar spine
737989|NCT00095095|Spinal fusion|spinal fusion
737990|NCT00095095|Low back pain|low back pain
737991|NCT00095095|Fusion cage|fusion cage
737992|NCT00095095|Posterior lumbar interbody fusion|posterior lumbar interbody fusion
737993|NCT00095095|Bioresorbable|bioresorbable
737994|NCT00095095|Peek|peek
737995|NCT00095082|Diabetes Mellitus, Type I|diabetes mellitus, type i
737996|NCT00095056|Type 2 Diabetes Mellitus and Chronic Renal Insufficiency|type 2 diabetes mellitus and chronic renal insufficiency
737997|NCT00095030|Diabetes|diabetes
737998|NCT00095017|Arcoxia|arcoxia
737999|NCT00094991|Type 2 diabetes|type 2 diabetes
738000|NCT00094978|Apoptosis|apoptosis
738001|NCT00094978|Toxicity|toxicity
738002|NCT00094978|Pharmacokinetic|pharmacokinetic
738003|NCT00094978|Gene Induction|gene induction
738004|NCT00094978|Maximally Tolerated Dose|maximally tolerated dose
738005|NCT00094978|Small Cell Lung Cancer|small cell lung cancer
738006|NCT00094978|SCLC|sclc
738007|NCT00094978|Non-Small Cell Lung Cancer|non-small cell lung cancer
738008|NCT00094978|NSCLC|nsclc
738009|NCT00094978|Esophageal Cancer|esophageal cancer
738010|NCT00094978|Pleural Mesothelioma|pleural mesothelioma
738011|NCT00094965|Advanced Gastrointestinal tumors and normal to severely abnormal renal function|advanced gastrointestinal tumors and normal to severely abnormal renal function
738012|NCT00094952|Mild Cognitive Impairment|mild cognitive impairment
738013|NCT00094952|Alzheimer's disease|alzheimer's disease
738014|NCT00094952|magnetic resonance imaging|magnetic resonance imaging
738015|NCT00094952|cerebrospinal fluid (CSF) biomarkers|cerebrospinal fluid (csf) biomarkers
738016|NCT00094939|mild cognitive impairment|mild cognitive impairment
738017|NCT00094939|Alzheimer disease|alzheimer disease
738018|NCT00094939|magnetic resonance imaging|magnetic resonance imaging
738019|NCT00094939|CSF tau protein|csf tau protein
738020|NCT00094939|Hippocampus|hippocampus
738021|NCT00094926|Risperidal CONSTA|risperidal consta
738022|NCT00094926|Bipolar disorder|bipolar disorder
738023|NCT00094926|mood episodes|mood episodes
738024|NCT00094926|Safety and efficacy, adjuvant therapy|safety and efficacy, adjuvant therapy
738025|NCT00094913|Aging|aging
738026|NCT00094913|Mild Cognitive Impairment|mild cognitive impairment
738027|NCT00094913|Alzheimer disease, preclinical|alzheimer disease, preclinical
738028|NCT00094913|Hippocampal formation|hippocampal formation
738029|NCT00094913|Glucose metabolism|glucose metabolism
738030|NCT00094900|Muckle Wells Syndrome|muckle wells syndrome
738031|NCT00094900|NOMID|nomid
738032|NCT00094900|Adult Stills Disease|adult stills disease
738033|NCT00094900|Familial Mediterranean|familial mediterranean
738034|NCT00094900|Treatment Trial/Fever|treatment trial/fever
738035|NCT00094900|Autoinflammatory Disease|autoinflammatory disease
738036|NCT00094887|Blood Flow|blood flow
738037|NCT00094887|Nitric Oxide|nitric oxide
738038|NCT00094887|Pain Crisis|pain crisis
738039|NCT00094887|Sickle Cell Anemia|sickle cell anemia
738040|NCT00094887|Vaso-Occlusive Crisis|vaso-occlusive crisis
738041|NCT00094887|Sickle Cell Disease|sickle cell disease
738042|NCT00094887|SCD|scd
738142|NCT00094484|Sensipar®|sensipar®
738043|NCT00094874|pelvic pain, bladder pain, urgency, frequency, nocturia|pelvic pain, bladder pain, urgency, frequency, nocturia
738044|NCT00094861|dysphagia|dysphagia
738045|NCT00094861|palifermin, KGF|palifermin, kgf
738046|NCT00094861|chemoradiotherapy|chemoradiotherapy
738047|NCT00094861|NSCLC, non-small cell lung cancer|nsclc, non-small cell lung cancer
738048|NCT00094861|lung cancer|lung cancer
738049|NCT00094861|supportive care|supportive care
738050|NCT00094861|clinical trial|clinical trial
738051|NCT00094861|consolidation chemotherapy|consolidation chemotherapy
738052|NCT00094861|radiotherapy|radiotherapy
738053|NCT00094835|Lung cancer, Non-small cell lung cancer, NSCLC|lung cancer, non-small cell lung cancer, nsclc
738054|NCT00094835|Clinical Trial, Panitumumab, AMG 706|clinical trial, panitumumab, amg 706
738055|NCT00094835|Anti-angiogenesis|anti-angiogenesis
738056|NCT00094835|Immunex, Abgenix, Amgen|immunex, abgenix, amgen
738057|NCT00094835|Stage IIIB, Stage IV, Unresectable|stage iiib, stage iv, unresectable
738058|NCT00094822|Metastatic Cancer|metastatic cancer
738059|NCT00094822|Neulasta®|neulasta®
738060|NCT00094822|pegfilgrastim|pegfilgrastim
738061|NCT00094809|Neulasta®|neulasta®
738062|NCT00094809|pegfilgrastim|pegfilgrastim
738063|NCT00094809|Advanced|advanced
738064|NCT00094809|Chemotherapy|chemotherapy
738065|NCT00094796|Insulin Resistance|insulin resistance
738066|NCT00094796|Brachial Artery Reactivity|brachial artery reactivity
738067|NCT00094796|Endothelial Progenitor Cells|endothelial progenitor cells
738068|NCT00094796|Metabolic Stress Test|metabolic stress test
738069|NCT00094796|Mitochondrial Function|mitochondrial function
738070|NCT00094796|Type 2 Diabetes|type 2 diabetes
738071|NCT00094796|T2DM|t2dm
738072|NCT00094796|Pre-Diabetes|pre-diabetes
738073|NCT00094783|Magnetic Resonance Imaging|magnetic resonance imaging
738074|NCT00094783|Interventional MRI|interventional mri
738075|NCT00094783|Arterial Stenosis|arterial stenosis
738076|NCT00094783|Revascularization|revascularization
738077|NCT00094783|Lllac Artery Stenosis|lllac artery stenosis
738078|NCT00094783|Peripheral Arterial Disease|peripheral arterial disease
738079|NCT00094783|Cardiovascular Disease|cardiovascular disease
738080|NCT00094731|Aging|aging
738081|NCT00094731|Memory|memory
738082|NCT00094731|Mental Recall|mental recall
738083|NCT00094731|Mental Processes|mental processes
738084|NCT00094718|Chimeric Virus Vaccine|chimeric virus vaccine
738085|NCT00094718|West Nile Virus|west nile virus
738086|NCT00094718|Dengue Virus|dengue virus
738087|NCT00094705|Dengue Vaccine|dengue vaccine
738088|NCT00094705|Dengue Virus|dengue virus
738089|NCT00094705|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
738090|NCT00094705|Dengue Shock Syndrome|dengue shock syndrome
738091|NCT00094692|Amblyopia|amblyopia
738092|NCT00094692|Patching|patching
738093|NCT00094692|Spectacles|spectacles
738094|NCT00094653|melanoma|melanoma
738095|NCT00094653|metastatic melanoma|metastatic melanoma
738096|NCT00094653|skin cancer|skin cancer
738097|NCT00094601|Positron Emission Tomograhy|positron emission tomograhy
738098|NCT00094601|[18F] FDOPA|[18f] fdopa
738099|NCT00094601|[11C] NNC-112|[11c] nnc-112
738100|NCT00094601|Dopamine|dopamine
738101|NCT00094601|Molecular Imaging|molecular imaging
738102|NCT00094601|Dopamine D1 Receptor|dopamine d1 receptor
738103|NCT00094601|PET|pet
738104|NCT00094601|Parkinson's Disease|parkinson's disease
738105|NCT00094601|Cognition|cognition
738106|NCT00094601|Parkinson Disease|parkinson disease
738107|NCT00094601|PD|pd
738108|NCT00094601|Healthy Volunteer|healthy volunteer
738109|NCT00094601|HV|hv
738110|NCT00094575|Abdominal|abdominal
738111|NCT00094575|Aortic Aneurysm|aortic aneurysm
738112|NCT00094575|cost of AAA repair|cost of aaa repair
738113|NCT00094575|Endovascular Repair|endovascular repair
738114|NCT00094575|Grafts|grafts
738115|NCT00094575|Long-term survival|long-term survival
738116|NCT00094575|secondary outcomes|secondary outcomes
738117|NCT00094562|Cancer|cancer
738118|NCT00094562|Cancer Cachexia|cancer cachexia
738119|NCT00094562|Weight Loss|weight loss
738120|NCT00094562|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
738121|NCT00094562|Chronic Heart Failure|chronic heart failure
738122|NCT00094562|Rheumatoid Arthritis|rheumatoid arthritis
738123|NCT00094536|Menorrhagia|menorrhagia
738124|NCT00094536|Excessive Uterine Bleeding|excessive uterine bleeding
738125|NCT00094536|Cryoablation|cryoablation
738126|NCT00094536|Menstrual disorder|menstrual disorder
738127|NCT00094536|Endometrial ablation|endometrial ablation
738128|NCT00094536|Abnormal uterine bleeding|abnormal uterine bleeding
738129|NCT00094536|Dysfunctional uterine bleeding|dysfunctional uterine bleeding
738130|NCT00094523|fosamprenavir LEXIVA non-inferiority safety tolerability|fosamprenavir lexiva non-inferiority safety tolerability
738131|NCT00094510|Prefrontal GABA|prefrontal gaba
738132|NCT00094510|Stress|stress
738133|NCT00094510|Emotion Recognition|emotion recognition
738134|NCT00094510|Differential Reward|differential reward
738135|NCT00094510|Gabapentin|gabapentin
738136|NCT00094510|GABA|gaba
738137|NCT00094510|Prefrontal Cortex|prefrontal cortex
738138|NCT00094510|Emotional Processing|emotional processing
738139|NCT00094510|Healthy Humans|healthy humans
738140|NCT00094510|Healthy Volunteer|healthy volunteer
738143|NCT00094484|Mimpara®|mimpara®
738144|NCT00094484|Cinacalcet|cinacalcet
738145|NCT00094484|Calcimimetic|calcimimetic
738146|NCT00094484|Chronic Kidney Disease|chronic kidney disease
738147|NCT00094458|Crohn's Disease|crohn's disease
738148|NCT00094458|infliximab|infliximab
738149|NCT00094458|azathioprine|azathioprine
738150|NCT00094458|Remicade|remicade
738151|NCT00094458|SONIC|sonic
738152|NCT00094445|Pancreatic Cancer|pancreatic cancer
738153|NCT00094445|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
738154|NCT00094445|Alternative therapy|alternative therapy
738155|NCT00094445|Pancreas|pancreas
738156|NCT00094445|Pancreatic Neoplasm|pancreatic neoplasm
738157|NCT00094445|Cancer of the pancreas|cancer of the pancreas
738158|NCT00094432|depressed|depressed
738159|NCT00094419|Complementary Therapies|complementary therapies
738160|NCT00094406|Lung Permeability|lung permeability
738161|NCT00094406|Endotoxin Tolerance|endotoxin tolerance
738162|NCT00094406|Bronchoscopy|bronchoscopy
738163|NCT00094406|Carbon Monoxide Inhalation|carbon monoxide inhalation
738164|NCT00094393|Ageing|ageing
738165|NCT00094393|Atherosclerosis|atherosclerosis
738166|NCT00094393|Lamin A|lamin a
738167|NCT00094393|Lipodystrophy|lipodystrophy
738168|NCT00094393|Growth Impairment|growth impairment
738169|NCT00094393|Premature Aging|premature aging
738170|NCT00094393|Hutchinson-Gilford Progeria Syndrome|hutchinson-gilford progeria syndrome
738171|NCT00094393|HGPS|hgps
738172|NCT00094380|SLE|sle
738173|NCT00094380|Lupus|lupus
738174|NCT00094380|Systemic Lupus Erythematosus|systemic lupus erythematosus
738175|NCT00094380|Lupus Nephritis|lupus nephritis
738176|NCT00094367|1592U89|1592u89
738177|NCT00094367|GR109714|gr109714
738178|NCT00094367|abacavir|abacavir
738179|NCT00094367|lamivudine|lamivudine
738180|NCT00094367|fixed-dose combination|fixed-dose combination
738181|NCT00094367|once-daily|once-daily
738182|NCT00094367|twice-daily|twice-daily
738183|NCT00094367|HIV infection|hiv infection
738184|NCT00094367|naive|naive
738185|NCT00094354|HIV infected former Plasma Donors|hiv infected former plasma donors
738186|NCT00094354|Needs assessment|needs assessment
738187|NCT00094354|HIV-related stigma and discrimination|hiv-related stigma and discrimination
738188|NCT00094354|In-depth interview|in-depth interview
738189|NCT00094354|Focus Groups|focus groups
738190|NCT00094341|Arthritis|arthritis
738191|NCT00094341|Rheumatology|rheumatology
738192|NCT00094328|Testotoxicosis|testotoxicosis
738193|NCT00094328|Familial Male-limited Precocious Puberty (FMPP)|familial male-limited precocious puberty (fmpp)
738194|NCT00094302|Heart Failure|heart failure
738195|NCT00094302|Diastolic Heart Failure|diastolic heart failure
738196|NCT00094302|Preserved Ejection Fraction|preserved ejection fraction
738197|NCT00094172|Early Multiple Sclerosis|early multiple sclerosis
738198|NCT00094172|MS|ms
738199|NCT00094172|Clinically Isolated Syndrome|clinically isolated syndrome
738200|NCT00094146|Primary Insulin Hypersecretion|primary insulin hypersecretion
738201|NCT00094146|PIH|pih
738202|NCT00094146|Obesity|obesity
738203|NCT00094133|cancer survivor|cancer survivor
738204|NCT00094133|stage IA breast cancer|stage ia breast cancer
738205|NCT00094133|stage IB breast cancer|stage ib breast cancer
738206|NCT00094133|stage II breast cancer|stage ii breast cancer
738207|NCT00094133|stage IIIA breast cancer|stage iiia breast cancer
738208|NCT00094133|stage IIIB breast cancer|stage iiib breast cancer
738209|NCT00094133|stage IIIC breast cancer|stage iiic breast cancer
738210|NCT00094133|stage IV breast cancer|stage iv breast cancer
738211|NCT00094133|breast cancer in situ|breast cancer in situ
738212|NCT00094133|inflammatory breast cancer|inflammatory breast cancer
738213|NCT00094133|hot flashes|hot flashes
738214|NCT00094120|Age-Related Macular Degeneration - Wet Type|age-related macular degeneration - wet type
738215|NCT00094107|melanoma|melanoma
738216|NCT00094107|antiangiogenesis|antiangiogenesis
738217|NCT00094081|squamous cell carcinoma|squamous cell carcinoma
738218|NCT00094081|oropharynx|oropharynx
738219|NCT00094081|oral cavity|oral cavity
738220|NCT00094081|larynx|larynx
738221|NCT00094081|hypopharynx|hypopharynx
738222|NCT00091468|Age-Related Memory Loss|age-related memory loss
738223|NCT00091468|Nicotine|nicotine
738224|NCT00091468|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
738225|NCT00094068|Gray Matter|gray matter
738226|NCT00094068|White Matter|white matter
738227|NCT00094068|Cerebral Blood Flow|cerebral blood flow
738228|NCT00094068|Cerebral Blood Volume|cerebral blood volume
738229|NCT00094068|Lesion|lesion
738230|NCT00094068|MRI|mri
738231|NCT00094068|Multiple Sclerosis|multiple sclerosis
738232|NCT00094068|Perfusion|perfusion
738233|NCT00094068|Imaging|imaging
738234|NCT00094068|Sildenafil|sildenafil
738235|NCT00094068|MS|ms
738236|NCT00094068|Healthy Volunteer|healthy volunteer
738237|NCT00094068|HV|hv
738238|NCT00094042|Socioeconomic Factors|socioeconomic factors
738239|NCT00094042|Dietary Supplementation|dietary supplementation
738240|NCT00094003|Liver metastases|liver metastases
738241|NCT00094003|Colorectal cancer|colorectal cancer
738242|NCT00094003|Gastric cancer|gastric cancer
738243|NCT00094003|Esophagus cancer|esophagus cancer
738244|NCT00094003|Breast cancer|breast cancer
738245|NCT00094003|Lung cancer|lung cancer
738246|NCT00094003|Skin cancer|skin cancer
738247|NCT00094003|Renal Cancer|renal cancer
738248|NCT00094003|Liver metastasis|liver metastasis
738249|NCT00093990|Myeloid leukemia acute disease|myeloid leukemia acute disease
738250|NCT00093990|Tipifarnib|tipifarnib
738251|NCT00093990|Bone marrow aspirate|bone marrow aspirate
738252|NCT00093977|Chronic Kidney Disease|chronic kidney disease
738253|NCT00093977|Dialysis|dialysis
738254|NCT00093977|Anemia|anemia
738255|NCT00093977|Nephrology|nephrology
738256|NCT00093964|brain cancer|brain cancer
738257|NCT00093964|brain tumor|brain tumor
738258|NCT00093951|Alzheimer disease|alzheimer disease
738259|NCT00093951|memory|memory
738260|NCT00093951|cognition|cognition
738261|NCT00093951|GABA(B)receptor antagonist|gaba(b)receptor antagonist
738262|NCT00093938|Vaccinium macrocarpon|vaccinium macrocarpon
738263|NCT00093938|Asymptomatic Bacteriuria|asymptomatic bacteriuria
738264|NCT00093925|Postoperative hypertension|postoperative hypertension
738265|NCT00093912|Perioperative Hypertension|perioperative hypertension
738266|NCT00093899|Mixed Hyperlipidemia|mixed hyperlipidemia
738267|NCT00093886|Preoperative hypertension|preoperative hypertension
738268|NCT00093873|Cancer|cancer
738269|NCT00093873|antiangiogenesis|antiangiogenesis
738270|NCT00093873|Solid Tumors|solid tumors
738271|NCT00093847|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors
738272|NCT00093847|S-adenosyl Methionine|s-adenosyl methionine
738273|NCT00093847|SSRI|ssri
738274|NCT00093847|SAMe|same
738275|NCT00093834|stage IV breast cancer|stage iv breast cancer
738276|NCT00093834|recurrent breast cancer|recurrent breast cancer
738277|NCT00093808|recurrent breast cancer|recurrent breast cancer
738278|NCT00093808|stage IV breast cancer|stage iv breast cancer
738279|NCT00093808|male breast cancer|male breast cancer
738280|NCT00093795|stage II breast cancer|stage ii breast cancer
738281|NCT00093795|stage IIIA breast cancer|stage iiia breast cancer
738282|NCT00093795|stage IIIC breast cancer|stage iiic breast cancer
738283|NCT00093769|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
738284|NCT00093769|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
738285|NCT00093769|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
738286|NCT00093769|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
738287|NCT00093769|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
738288|NCT00093769|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
738289|NCT00093769|splenic marginal zone lymphoma|splenic marginal zone lymphoma
738290|NCT00093730|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
738291|NCT00093704|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
738292|NCT00093704|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
738293|NCT00093704|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
738294|NCT00093704|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
738295|NCT00093704|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
738296|NCT00093704|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
738297|NCT00093678|pain|pain
738298|NCT00093678|cachexia|cachexia
738299|NCT00093678|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
738300|NCT00093678|recurrent uterine sarcoma|recurrent uterine sarcoma
738301|NCT00093678|stage III uterine sarcoma|stage iii uterine sarcoma
738302|NCT00093678|stage IV uterine sarcoma|stage iv uterine sarcoma
738303|NCT00093678|ovarian sarcoma|ovarian sarcoma
738304|NCT00093678|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
738305|NCT00093678|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
738306|NCT00093678|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
738307|NCT00093678|recurrent melanoma|recurrent melanoma
738308|NCT00093678|stage III melanoma|stage iii melanoma
738309|NCT00093678|stage IV melanoma|stage iv melanoma
738310|NCT00093678|chondrosarcoma|chondrosarcoma
738311|NCT00093678|metastatic osteosarcoma|metastatic osteosarcoma
738312|NCT00093678|recurrent osteosarcoma|recurrent osteosarcoma
738313|NCT00093678|classic Kaposi sarcoma|classic kaposi sarcoma
738314|NCT00093678|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
738315|NCT00093678|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
738316|NCT00093678|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
738317|NCT00093678|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
738318|NCT00093678|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
738319|NCT00093678|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
738320|NCT00093678|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
738321|NCT00093678|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
738322|NCT00093678|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
738323|NCT00093678|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
738324|NCT00093678|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
738641|NCT00091936|DOT|dot
738325|NCT00093678|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
738326|NCT00093678|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
738327|NCT00093678|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
738328|NCT00093678|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
738329|NCT00093678|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
738330|NCT00093678|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
738331|NCT00093678|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
738332|NCT00093678|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
738333|NCT00093678|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
738334|NCT00093678|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
738335|NCT00093678|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
738336|NCT00093678|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
738337|NCT00093678|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
738338|NCT00093678|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
738339|NCT00093678|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
738340|NCT00093678|intraocular lymphoma|intraocular lymphoma
738341|NCT00093678|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
738342|NCT00093678|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
738343|NCT00093678|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
738344|NCT00093678|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
738345|NCT00093678|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
738346|NCT00093678|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
738347|NCT00093678|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
738348|NCT00093678|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
738349|NCT00093678|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
738350|NCT00093678|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
738351|NCT00093678|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
738352|NCT00093678|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
738353|NCT00093678|primary central nervous system lymphoma|primary central nervous system lymphoma
738354|NCT00093678|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
738355|NCT00093678|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
738356|NCT00093678|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
738357|NCT00093678|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
738358|NCT00093678|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
738359|NCT00093678|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
738360|NCT00093678|anaplastic large cell lymphoma|anaplastic large cell lymphoma
738361|NCT00093678|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
738362|NCT00093678|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
738363|NCT00093678|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
738364|NCT00093678|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
738365|NCT00093678|splenic marginal zone lymphoma|splenic marginal zone lymphoma
738366|NCT00093678|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
738367|NCT00093678|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
738368|NCT00093678|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
738369|NCT00093678|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
738370|NCT00093678|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
738371|NCT00093678|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
738372|NCT00093678|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
738373|NCT00093678|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
738374|NCT00093678|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
738375|NCT00093678|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
738376|NCT00093678|immunosuppressive treatment related Kaposi sarcoma|immunosuppressive treatment related kaposi sarcoma
738377|NCT00093665|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
738378|NCT00093665|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
738379|NCT00093665|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
738380|NCT00093665|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
738381|NCT00093665|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
738382|NCT00093665|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
738383|NCT00093652|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
738384|NCT00093652|recurrent esophageal cancer|recurrent esophageal cancer
738385|NCT00093652|stage II esophageal cancer|stage ii esophageal cancer
738386|NCT00093652|stage III esophageal cancer|stage iii esophageal cancer
738387|NCT00093652|stage IV esophageal cancer|stage iv esophageal cancer
738388|NCT00093652|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
738642|NCT00091936|TB|tb
738389|NCT00093639|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
738390|NCT00093639|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
738391|NCT00093600|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
738392|NCT00093600|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
738393|NCT00093600|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
738394|NCT00093600|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
738395|NCT00093600|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
738396|NCT00093600|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
738397|NCT00093587|graft versus host disease|graft versus host disease
738398|NCT00093587|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
738399|NCT00093587|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
738400|NCT00093587|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
738401|NCT00093587|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
738402|NCT00093587|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
738403|NCT00093587|secondary acute myeloid leukemia|secondary acute myeloid leukemia
738404|NCT00093587|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
738405|NCT00093587|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
738406|NCT00093561|prostate cancer|prostate cancer
738407|NCT00093548|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
738408|NCT00093548|advanced adult primary liver cancer|advanced adult primary liver cancer
738409|NCT00093548|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
738410|NCT00093548|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
738411|NCT00093522|recurrent renal cell cancer|recurrent renal cell cancer
738412|NCT00093522|stage IV renal cell cancer|stage iv renal cell cancer
738413|NCT00093509|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
738414|NCT00093509|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
738415|NCT00093509|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
738416|NCT00093509|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
738417|NCT00093483|adult acute basophilic leukemia|adult acute basophilic leukemia
738418|NCT00093483|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
738419|NCT00093483|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
738420|NCT00093483|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
738421|NCT00093483|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
738422|NCT00093483|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
738423|NCT00093483|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
738424|NCT00093483|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
738425|NCT00093483|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
738426|NCT00093483|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
738427|NCT00093483|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
738428|NCT00093483|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
738429|NCT00093483|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
738430|NCT00093483|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
738431|NCT00093483|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
738432|NCT00093483|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
738433|NCT00093483|secondary acute myeloid leukemia|secondary acute myeloid leukemia
738434|NCT00093457|recurrent prostate cancer|recurrent prostate cancer
738435|NCT00093457|stage IV prostate cancer|stage iv prostate cancer
738436|NCT00093457|adenocarcinoma of the prostate|adenocarcinoma of the prostate
738437|NCT00093444|advanced adult primary liver cancer|advanced adult primary liver cancer
738438|NCT00093444|liver metastases|liver metastases
738439|NCT00093444|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
738440|NCT00093444|recurrent adult primary liver cancer|recurrent adult primary liver cancer
738441|NCT00093405|recurrent renal cell cancer|recurrent renal cell cancer
738442|NCT00093405|stage IV renal cell cancer|stage iv renal cell cancer
738443|NCT00093405|clear cell renal cell carcinoma|clear cell renal cell carcinoma
738444|NCT00093379|stage II anal cancer|stage ii anal cancer
738445|NCT00093379|stage IIIA anal cancer|stage iiia anal cancer
738446|NCT00093379|stage IIIB anal cancer|stage iiib anal cancer
738447|NCT00093379|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
738448|NCT00093379|Capecitabine|capecitabine
738449|NCT00093379|Xeloda|xeloda
738450|NCT00093379|Oxaliplatin|oxaliplatin
738451|NCT00093379|Eloxatin|eloxatin
738452|NCT00093379|Radiotherapy|radiotherapy
738454|NCT00093366|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
738455|NCT00093366|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
738456|NCT00093366|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
738457|NCT00093366|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
738458|NCT00093366|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
738459|NCT00093366|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
738460|NCT00093353|diarrhea|diarrhea
738461|NCT00093353|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
738462|NCT00093353|disseminated neuroblastoma|disseminated neuroblastoma
738463|NCT00093353|recurrent neuroblastoma|recurrent neuroblastoma
738464|NCT00093314|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
738465|NCT00093314|B-cell Lymphoma|b-cell lymphoma
738466|NCT00093860|Adrenaline|adrenaline
738467|NCT00093860|Norepinephrine|norepinephrine
738468|NCT00093860|Sympathetic Nervous System|sympathetic nervous system
738469|NCT00093860|Fainting|fainting
738470|NCT00093860|Hypotension|hypotension
738471|NCT00093860|Beta-Adrenoceptors|beta-adrenoceptors
738472|NCT00093860|Neurocardiogenic Syncope|neurocardiogenic syncope
738473|NCT00093860|Chronic Orthostatic Intolerance|chronic orthostatic intolerance
738474|NCT00093860|Sympathoadrenal Imbalance|sympathoadrenal imbalance
738475|NCT00093860|SAI|sai
738476|NCT00093860|Children|children
738477|NCT00093301|Shock|shock
738478|NCT00093301|Levosimendan|levosimendan
738479|NCT00093301|Inotropes|inotropes
738480|NCT00093301|Dobutamine|dobutamine
738481|NCT00093301|Heart failure|heart failure
738482|NCT00093301|Sepsis|sepsis
738483|NCT00093288|MDD|mdd
738484|NCT00093288|bupropion|bupropion
738485|NCT00093288|Depression|depression
738486|NCT00093262|Postoperative Hypertension|postoperative hypertension
738487|NCT00093249|Pre-operative hypertension|pre-operative hypertension
738488|NCT00093223|In-Stent Restenosis|in-stent restenosis
738489|NCT00093184|ST-Segment Elevation|st-segment elevation
738490|NCT00093184|Acute Myocardial Infarction|acute myocardial infarction
738491|NCT00093184|PCI|pci
738492|NCT00093184|Percutaneous Coronary Intervention|percutaneous coronary intervention
738493|NCT00093158|Acute Coronary Syndromes|acute coronary syndromes
738494|NCT00093145|Advanced Breast Cancer|advanced breast cancer
738495|NCT00002543|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
738496|NCT00002543|recurrent childhood brain tumor|recurrent childhood brain tumor
738497|NCT00002543|recurrent neuroblastoma|recurrent neuroblastoma
738498|NCT00002543|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
738499|NCT00002543|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
738500|NCT00002543|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
738501|NCT00002543|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
738502|NCT00002524|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
738503|NCT00002524|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
738504|NCT00002524|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
738505|NCT00002524|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
738506|NCT00002524|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
738507|NCT00002524|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
738508|NCT00002524|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
738509|NCT00093132|Non-Small Cell Lung Cancer (stage II or III)|non-small cell lung cancer (stage ii or iii)
738510|NCT00093132|NSCLC|nsclc
738511|NCT00093132|Squamous Cell Lung Cancer|squamous cell lung cancer
738512|NCT00093132|adenocarcinoma of the lung|adenocarcinoma of the lung
738513|NCT00093132|adenosquamous cell lung cancer|adenosquamous cell lung cancer
738514|NCT00093132|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
738515|NCT00093132|carcinoma, non-small cell lung|carcinoma, non-small cell lung
738516|NCT00093119|Metastatic Melanoma|metastatic melanoma
738517|NCT00093093|Viramidine|viramidine
738518|NCT00093093|Ribavirin|ribavirin
738519|NCT00093093|Valeant|valeant
738520|NCT00093093|Hepatitis C|hepatitis c
738521|NCT00093093|Pegylated interferon alfa-2a|pegylated interferon alfa-2a
738522|NCT00093080|Metastatic and/or unresectable soft tissue or|metastatic and/or unresectable soft tissue or
738523|NCT00093067|Gram-positive bacterial infections|gram-positive bacterial infections
738524|NCT00093067|Staph Aureus|staph aureus
738525|NCT00093067|endocarditis|endocarditis
738526|NCT00093067|bacteremia|bacteremia
738527|NCT00093067|Cubist|cubist
738528|NCT00093054|Vaccinium macrocarpon|vaccinium macrocarpon
738529|NCT00093041|Head and neck cancer|head and neck cancer
738530|NCT00093041|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
738531|NCT00093028|Myeloma|myeloma
738532|NCT00093028|Revlimid|revlimid
738533|NCT00093028|bortezomib|bortezomib
738534|NCT00093028|CC-5013|cc-5013
738535|NCT00093028|Dexamethasone|dexamethasone
738536|NCT00091520|Congestive heart failure|congestive heart failure
738537|NCT00091520|Nesiritide|nesiritide
738538|NCT00093002|Early Breast Cancer|early breast cancer
738539|NCT00093002|neoadjuvant therapy|neoadjuvant therapy
738540|NCT00093002|hormonal treatment|hormonal treatment
738541|NCT00093002|newly diagnosed breast cancer|newly diagnosed breast cancer
738542|NCT00093002|Estrogen Receptor Positive Breast Cancer|estrogen receptor positive breast cancer
738543|NCT00093002|treatment naïve|treatment naïve
738544|NCT00093002|neoadjuvant treatment|neoadjuvant treatment
738545|NCT00093002|neoadjuvant setting|neoadjuvant setting
738546|NCT00093002|invasive breast cancer|invasive breast cancer
738547|NCT00092976|Hemophilia A|hemophilia a
738548|NCT00092898|Sitosterolemia|sitosterolemia
738549|NCT00092846|High Blood Cholesterol Levels|high blood cholesterol levels
738550|NCT00092820|Homozygous Sitosterolemia|homozygous sitosterolemia
738551|NCT00092807|Homozygous Sitosterolemia|homozygous sitosterolemia
738552|NCT00092781|Arcoxia|arcoxia
738553|NCT00092768|Arcoxia|arcoxia
738554|NCT00092755|Arcoxia|arcoxia
738555|NCT00092742|Arcoxia|arcoxia
738556|NCT00092703|Arcoxia|arcoxia
738557|NCT00092664|Primary hypercholesterolemia|primary hypercholesterolemia
738558|NCT00092651|Primary hypercholesterolemia|primary hypercholesterolemia
738559|NCT00092573|Mixed hyperlipidemia (high cholesterol and high triglycerides)|mixed hyperlipidemia (high cholesterol and high triglycerides)
738560|NCT00092560|mixed hyperlipidemia|mixed hyperlipidemia
738561|NCT00092560|high cholesterol|high cholesterol
738562|NCT00092560|high triglycerides|high triglycerides
738563|NCT00092508|Ulcerative Colitis Remission|ulcerative colitis remission
738564|NCT00092508|ulcerative|ulcerative
738565|NCT00092508|colitis|colitis
738566|NCT00092508|remission|remission
738567|NCT00092508|relapse|relapse
738568|NCT00092508|Asacol®|asacol®
738569|NCT00092508|maintain|maintain
738570|NCT00092508|maintenance|maintenance
738571|NCT00092508|flare|flare
738572|NCT00092508|rectal|rectal
738573|NCT00092508|bleeding|bleeding
738574|NCT00092508|bowel|bowel
738575|NCT00092300|dental surgery|dental surgery
738576|NCT00092300|molar removal|molar removal
738577|NCT00092950|Exercise|exercise
738578|NCT00092950|Pedometer|pedometer
738579|NCT00092950|Physician Prescription|physician prescription
738580|NCT00092950|Biomarkers|biomarkers
738581|NCT00092950|Compliance|compliance
738582|NCT00092950|Breast Cancer Survivor|breast cancer survivor
738583|NCT00092950|Breast Cancer Risk|breast cancer risk
738584|NCT00092937|Chronic Granulomatous Disease|chronic granulomatous disease
738585|NCT00092937|Nonmyeloablative|nonmyeloablative
738586|NCT00092937|CD34 Positive Cells|cd34 positive cells
738587|NCT00092937|Donor Engraftment|donor engraftment
738588|NCT00092937|Myeloid Chimerism|myeloid chimerism
738589|NCT00092638|Elevated Cholesterol|elevated cholesterol
738590|NCT00092625|Elevated Cholesterol|elevated cholesterol
738591|NCT00092612|Elevated Cholesterol|elevated cholesterol
738592|NCT00092599|Elevated Cholesterol|elevated cholesterol
738593|NCT00092378|Bunionectomy|bunionectomy
738594|NCT00092339|dental surgery|dental surgery
738595|NCT00092339|molar removal|molar removal
738596|NCT00092326|dental surgery|dental surgery
738597|NCT00092326|molar removal|molar removal
738598|NCT00092313|dental surgery|dental surgery
738599|NCT00092313|molar removal|molar removal
738600|NCT00092287|Carcinoid Syndrome|carcinoid syndrome
738601|NCT00092287|Neuroendocrine Tumuors|neuroendocrine tumuors
738602|NCT00092274|Follicular Lymphoma|follicular lymphoma
738603|NCT00092274|Non Hodgkin´s Lymphoma|non hodgkin´s lymphoma
738604|NCT00092001|Non-small cell lung cancer, carcinoma, sunitinib, Phase 2|non-small cell lung cancer, carcinoma, sunitinib, phase 2
738605|NCT00092196|Chemotherapy-Induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
738606|NCT00092183|Chemotherapy-Induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
738607|NCT00092170|Intra-abdominal infections|intra-abdominal infections
738608|NCT00092170|Acute pelvic infections|acute pelvic infections
738609|NCT00092157|High cholesterol|high cholesterol
738610|NCT00092105|Rhinitis, Allergic|rhinitis, allergic
738611|NCT00092053|Postmenopausal|postmenopausal
738612|NCT00092053|Osteoporosis|osteoporosis
738613|NCT00092235|cGVHD-associated graft-versus-tumor effects (GVT)|cgvhd-associated graft-versus-tumor effects (gvt)
738614|NCT00092235|Allo-HSCT controls|allo-hsct controls
738615|NCT00092235|Leukapheresis|leukapheresis
738616|NCT00092235|Chronic Graft-Versus-Host Disease|chronic graft-versus-host disease
738617|NCT00092235|cGVHD|cgvhd
738618|NCT00092222|HHV-8|hhv-8
738619|NCT00092222|HIV|hiv
738620|NCT00092222|Malignancy|malignancy
738621|NCT00092222|Lymphoproliferation|lymphoproliferation
738622|NCT00092222|Lymph Node Hyperplasia|lymph node hyperplasia
738623|NCT00092222|Multicentric Castleman DIsease|multicentric castleman disease
738624|NCT00092222|MCD|mcd
738625|NCT00092222|KSHV-MCD|kshv-mcd
738626|NCT00092222|KSHV Associated MCD|kshv associated mcd
738627|NCT00092222|HIV Infections|hiv infections
738628|NCT00092222|Herpes Viruses|herpes viruses
738629|NCT00091988|Urinary Incontinence|urinary incontinence
738630|NCT00091988|Weight Loss|weight loss
738631|NCT00091988|Obesity|obesity
738632|NCT00091988|Motivation|motivation
738633|NCT00091975|Chronic Kidney Disease|chronic kidney disease
738634|NCT00091949|stroke|stroke
738635|NCT00091949|heart attack|heart attack
738636|NCT00091949|diabetes|diabetes
738637|NCT00091949|pioglitazone|pioglitazone
738638|NCT00091949|insulin resistance|insulin resistance
738639|NCT00091936|Treatment Naive|treatment naive
738640|NCT00091936|Directly Observed Therapy|directly observed therapy
738643|NCT00091910|Anemia|anemia
738644|NCT00091910|Epoetin alfa|epoetin alfa
738645|NCT00091910|Erythropoietin|erythropoietin
738646|NCT00091910|Blood transfusion|blood transfusion
738647|NCT00091910|Intensive care units|intensive care units
738648|NCT00091858|Cancer-related anemia|cancer-related anemia
738649|NCT00091845|West Nile Fever Myelitis|west nile fever myelitis
738650|NCT00091845|West Nile Fever Encephalitis|west nile fever encephalitis
738651|NCT00091845|West Nile Fever Meningitis|west nile fever meningitis
738652|NCT00091845|West Nile Fever Meningoencephalitis|west nile fever meningoencephalitis
738653|NCT00091832|Breast Cancer|breast cancer
738654|NCT00091832|Cancer|cancer
738655|NCT00091819|staph|staph
738656|NCT00091819|MRSA|mrsa
738657|NCT00091819|cSSSI|csssi
738658|NCT00091806|Targeted Therapy|targeted therapy
738659|NCT00091806|Solid tumors|solid tumors
738660|NCT00091806|ABX-EGF, panitumumab|abx-egf, panitumumab
738661|NCT00091806|EGFr|egfr
738662|NCT00091806|Immunex, Abgenix, Amgen|immunex, abgenix, amgen
738663|NCT00091806|Monoclonal Antibody|monoclonal antibody
738664|NCT00091793|Osteoporosis|osteoporosis
738665|NCT00091793|Postmenopausal|postmenopausal
738666|NCT00091897|RITUXAN|rituxan
738667|NCT00091897|GABA|gaba
738668|NCT00091897|B Cells|b cells
738669|NCT00091897|Humanized Monoclonal Antibodies|humanized monoclonal antibodies
738670|NCT00091897|GAD|gad
738671|NCT00091897|Stiff Person Syndrome|stiff person syndrome
738672|NCT00091897|SPS|sps
738673|NCT00091884|HIV|hiv
738674|NCT00091884|Immune Recovery|immune recovery
738675|NCT00091884|Reactivation|reactivation
738676|NCT00091884|Anti-Viral Medication|anti-viral medication
738677|NCT00091884|HAART|haart
738678|NCT00091884|CMV Retinitis|cmv retinitis
738679|NCT00091884|Retinal Disease|retinal disease
738680|NCT00091871|Genetic|genetic
738681|NCT00091871|Eosinophils|eosinophils
738682|NCT00091871|Familial Hypereosinophilia|familial hypereosinophilia
738683|NCT00091871|Hypereosinophilia|hypereosinophilia
738684|NCT00091871|FE|fe
738685|NCT00091741|HIV|hiv
738686|NCT00091741|Treatment Experienced|treatment experienced
738687|NCT00091741|Complementary Therapies|complementary therapies
738688|NCT00091728|epidemiology|epidemiology
738689|NCT00091728|relative risk|relative risk
738690|NCT00091728|cervical ectopy|cervical ectopy
738691|NCT00091728|hormonal contraceptives|hormonal contraceptives
738692|NCT00091728|sexually transmitted infections|sexually transmitted infections
738693|NCT00091715|Pulmonary arterial hypertension|pulmonary arterial hypertension
738694|NCT00091715|PAH|pah
738695|NCT00091715|PPH|pph
738696|NCT00091715|bosentan|bosentan
738697|NCT00091715|early|early
738698|NCT00091702|FluMist|flumist
738699|NCT00091702|Influenza Vaccine|influenza vaccine
738700|NCT00091702|Adolescent|adolescent
738701|NCT00091702|Treatment Experienced|treatment experienced
738702|NCT00091689|Advanced Metastatic Melanoma|advanced metastatic melanoma
738703|NCT00091676|follicular|follicular
738704|NCT00091676|lymphoma|lymphoma
738705|NCT00091676|Non-Hodgkins|non-hodgkins
738706|NCT00091676|idiotype|idiotype
738707|NCT00091676|vaccine|vaccine
738708|NCT00091676|indolent follicular Non-Hodgkins Lymphoma|indolent follicular non-hodgkins lymphoma
738709|NCT00091676|tumor-derived|tumor-derived
738710|NCT00091676|B-cell|b-cell
738711|NCT00091676|cancer|cancer
738712|NCT00091663|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
738713|NCT00004905|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
738714|NCT00004905|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
738715|NCT00004905|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
738716|NCT00004905|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
738717|NCT00004905|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
738718|NCT00004905|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
738719|NCT00004209|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
738720|NCT00004209|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
738721|NCT00004195|stage I colon cancer|stage i colon cancer
738722|NCT00004195|stage II colon cancer|stage ii colon cancer
738723|NCT00004195|stage III colon cancer|stage iii colon cancer
738724|NCT00004195|stage IV colon cancer|stage iv colon cancer
738725|NCT00004195|stage I rectal cancer|stage i rectal cancer
738726|NCT00004195|stage II rectal cancer|stage ii rectal cancer
738727|NCT00004195|stage III rectal cancer|stage iii rectal cancer
738728|NCT00004195|stage IV rectal cancer|stage iv rectal cancer
738729|NCT00004195|recurrent colon cancer|recurrent colon cancer
738730|NCT00004195|recurrent rectal cancer|recurrent rectal cancer
738731|NCT00004194|graft versus host disease|graft versus host disease
738732|NCT00004184|stage III melanoma|stage iii melanoma
738733|NCT00004184|stage IV melanoma|stage iv melanoma
738734|NCT00004184|recurrent melanoma|recurrent melanoma
738735|NCT00004172|stage IV breast cancer|stage iv breast cancer
738736|NCT00004172|stage IIIA breast cancer|stage iiia breast cancer
738737|NCT00004172|recurrent breast cancer|recurrent breast cancer
738738|NCT00004172|stage IIIB breast cancer|stage iiib breast cancer
738739|NCT00091624|CC-5013|cc-5013
738740|NCT00091624|CC5013|cc5013
738741|NCT00091624|Revlimid|revlimid
738742|NCT00091624|Lenalidomide|lenalidomide
738743|NCT00091624|Multiple myeloma|multiple myeloma
738744|NCT00091598|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
738745|NCT00091572|Metastatic Melanoma|metastatic melanoma
738746|NCT00091559|CTCL|ctcl
738747|NCT00004089|anaplastic thyroid cancer|anaplastic thyroid cancer
738748|NCT00004083|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
738749|NCT00004083|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
738750|NCT00004014|recurrent prostate cancer|recurrent prostate cancer
738751|NCT00003956|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
738752|NCT00003956|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
738753|NCT00003956|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
738754|NCT00003956|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
738755|NCT00003956|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
738756|NCT00003956|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
738757|NCT00003956|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
738758|NCT00003956|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
738759|NCT00003956|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
738760|NCT00003956|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
738761|NCT00003956|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
738762|NCT00003956|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
738763|NCT00003956|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
738764|NCT00003956|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
738765|NCT00003956|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
738766|NCT00003956|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
738767|NCT00003956|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
738768|NCT00003956|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
738769|NCT00003956|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
738770|NCT00003956|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
738771|NCT00003956|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
738772|NCT00003956|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
738773|NCT00003956|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
738774|NCT00003956|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
738775|NCT00003956|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
738776|NCT00003956|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
738777|NCT00003956|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
738778|NCT00003956|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
738779|NCT00003956|anaplastic large cell lymphoma|anaplastic large cell lymphoma
738780|NCT00003956|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
738781|NCT00003956|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
738782|NCT00003956|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
738783|NCT00003956|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
738784|NCT00003956|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
738785|NCT00003956|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
738786|NCT00003956|splenic marginal zone lymphoma|splenic marginal zone lymphoma
738787|NCT00003858|adenocarcinoma of the prostate|adenocarcinoma of the prostate
738788|NCT00003858|stage I prostate cancer|stage i prostate cancer
738789|NCT00003858|stage IIB prostate cancer|stage iib prostate cancer
738790|NCT00003858|stage IIA prostate cancer|stage iia prostate cancer
738791|NCT00003858|stage III prostate cancer|stage iii prostate cancer
738792|NCT00003858|stage IV prostate cancer|stage iv prostate cancer
738793|NCT00003842|recurrent adult brain tumor|recurrent adult brain tumor
738794|NCT00003842|adult glioblastoma|adult glioblastoma
738795|NCT00003842|adult anaplastic astrocytoma|adult anaplastic astrocytoma
738796|NCT00003842|adult giant cell glioblastoma|adult giant cell glioblastoma
738797|NCT00003842|adult gliosarcoma|adult gliosarcoma
738798|NCT00003780|stage II pancreatic cancer|stage ii pancreatic cancer
738799|NCT00003780|stage III pancreatic cancer|stage iii pancreatic cancer
738800|NCT00003780|stage IV pancreatic cancer|stage iv pancreatic cancer
738801|NCT00003775|recurrent adult brain tumor|recurrent adult brain tumor
738802|NCT00003775|adult anaplastic astrocytoma|adult anaplastic astrocytoma
738803|NCT00003775|adult mixed glioma|adult mixed glioma
738804|NCT00003714|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
738805|NCT00003714|advanced adult primary liver cancer|advanced adult primary liver cancer
738806|NCT00003714|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
738807|NCT00003714|liver metastases|liver metastases
738808|NCT00003711|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
738809|NCT00091611|Clinical Response|clinical response
738810|NCT00091611|Intravenous|intravenous
738811|NCT00091611|Intra-Arterial|intra-arterial
738812|NCT00091611|Lymphodepletion|lymphodepletion
738813|NCT00091611|Traffic of Cells|traffic of cells
738814|NCT00091611|T-Cell Transfer|t-cell transfer
738815|NCT00091611|Renal Cell Carcinoma|renal cell carcinoma
738816|NCT00091611|Metastatic Renal Cell Cancer|metastatic renal cell cancer
738817|NCT00091507|Acute Coronary Syndrome|acute coronary syndrome
738818|NCT00091481|Stage V Chronic Kidney Disease|stage v chronic kidney disease
738819|NCT00091442|Breast Cancer|breast cancer
738820|NCT00091442|Advanced breast cancer|advanced breast cancer
738821|NCT00091442|Breast Tumors|breast tumors
738822|NCT00091442|Cancer of Breast|cancer of breast
738823|NCT00091442|Human Mammary Carcinoma|human mammary carcinoma
738824|NCT00091442|Mammary Neoplasms, Human|mammary neoplasms, human
738825|NCT00091442|DOXIL|doxil
738826|NCT00091442|Docetaxel|docetaxel
738827|NCT00004057|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
738828|NCT00004057|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
738829|NCT00004057|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
738830|NCT00004057|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
738831|NCT00004057|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
738832|NCT00004057|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
738833|NCT00004057|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
738834|NCT00004057|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
738835|NCT00004057|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
738836|NCT00004057|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
738837|NCT00004057|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
738838|NCT00004057|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
738839|NCT00004057|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
738840|NCT00004057|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
738841|NCT00004057|anaplastic large cell lymphoma|anaplastic large cell lymphoma
738842|NCT00004057|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
738843|NCT00004057|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
738844|NCT00004057|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
738845|NCT00004057|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
738846|NCT00004057|splenic marginal zone lymphoma|splenic marginal zone lymphoma
738847|NCT00004036|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
738848|NCT00004036|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
738849|NCT00004036|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
738850|NCT00004036|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
738851|NCT00004036|isolated plasmacytoma of bone|isolated plasmacytoma of bone
738852|NCT00004036|extramedullary plasmacytoma|extramedullary plasmacytoma
738853|NCT00004036|refractory multiple myeloma|refractory multiple myeloma
738854|NCT00004036|Waldenström macroglobulinemia|waldenström macroglobulinemia
738855|NCT00004036|stage III multiple myeloma|stage iii multiple myeloma
738856|NCT00004036|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
738857|NCT00004036|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
738858|NCT00004036|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
738859|NCT00004036|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
738860|NCT00004036|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
738861|NCT00004036|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
738862|NCT00004036|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
738863|NCT00004036|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
738864|NCT00004036|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
738865|NCT00004036|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
738866|NCT00004036|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
738867|NCT00004036|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
738868|NCT00004036|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
738869|NCT00004036|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
738870|NCT00004036|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
738871|NCT00004036|polycythemia vera|polycythemia vera
738872|NCT00004036|primary myelofibrosis|primary myelofibrosis
738873|NCT00004036|essential thrombocythemia|essential thrombocythemia
738874|NCT00004036|untreated hairy cell leukemia|untreated hairy cell leukemia
738875|NCT00004036|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
738876|NCT00004036|refractory hairy cell leukemia|refractory hairy cell leukemia
738877|NCT00004036|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
738878|NCT00004036|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
738879|NCT00004036|acute undifferentiated leukemia|acute undifferentiated leukemia
738880|NCT00004036|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
738881|NCT00004036|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
738882|NCT00004036|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
738883|NCT00004036|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
738884|NCT00004036|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
738885|NCT00004036|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
738886|NCT00004036|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
738887|NCT00004036|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
738888|NCT00004036|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
738889|NCT00004036|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
738890|NCT00004036|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
738891|NCT00004036|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
738892|NCT00004036|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
738893|NCT00004036|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
738894|NCT00004036|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
738895|NCT00004036|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
738896|NCT00004036|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
738897|NCT00004036|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
738898|NCT00004036|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
738899|NCT00004036|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
738900|NCT00004036|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
738901|NCT00004036|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
738902|NCT00004036|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
738903|NCT00004036|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
738904|NCT00004036|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
738905|NCT00004036|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
738906|NCT00004036|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
738907|NCT00004036|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
738908|NCT00004036|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
738909|NCT00004036|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
738910|NCT00004036|secondary acute myeloid leukemia|secondary acute myeloid leukemia
738911|NCT00004036|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
738912|NCT00004036|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
738913|NCT00004036|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
738914|NCT00004036|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
738915|NCT00004036|prolymphocytic leukemia|prolymphocytic leukemia
738916|NCT00004036|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
738917|NCT00004036|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
738918|NCT00004036|primary systemic amyloidosis|primary systemic amyloidosis
738919|NCT00004036|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
738920|NCT00004036|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
738921|NCT00004036|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
738922|NCT00004036|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
738923|NCT00004036|anaplastic large cell lymphoma|anaplastic large cell lymphoma
738924|NCT00004036|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
738925|NCT00004036|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
738926|NCT00004036|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
738927|NCT00004036|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
738928|NCT00004036|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
738929|NCT00004036|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
738930|NCT00004036|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
738931|NCT00004036|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
738932|NCT00004036|splenic marginal zone lymphoma|splenic marginal zone lymphoma
738933|NCT00004022|stage III melanoma|stage iii melanoma
738934|NCT00004022|stage IV melanoma|stage iv melanoma
738935|NCT00004022|recurrent melanoma|recurrent melanoma
738936|NCT00003673|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
738937|NCT00003671|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
738938|NCT00003671|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
738939|NCT00003666|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
738940|NCT00003666|squamous cell lung cancer|squamous cell lung cancer
738941|NCT00003666|large cell lung cancer|large cell lung cancer
738942|NCT00003666|adenocarcinoma of the lung|adenocarcinoma of the lung
738943|NCT00003666|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
738944|NCT00003634|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
738945|NCT00003634|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
738946|NCT00003634|fallopian tube cancer|fallopian tube cancer
738947|NCT00003634|primary peritoneal cavity cancer|primary peritoneal cavity cancer
738948|NCT00003625|untreated childhood brain stem glioma|untreated childhood brain stem glioma
738949|NCT00003599|non-small cell lung cancer|non-small cell lung cancer
738950|NCT00003599|small cell lung cancer|small cell lung cancer
738951|NCT00003591|stage I pancreatic cancer|stage i pancreatic cancer
738952|NCT00003591|stage II pancreatic cancer|stage ii pancreatic cancer
738953|NCT00003591|stage III pancreatic cancer|stage iii pancreatic cancer
738954|NCT00003591|recurrent pancreatic cancer|recurrent pancreatic cancer
738955|NCT00003591|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
738956|NCT00003587|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
738957|NCT00003587|squamous cell lung cancer|squamous cell lung cancer
738958|NCT00003587|large cell lung cancer|large cell lung cancer
738959|NCT00003587|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
738960|NCT00003587|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
738961|NCT00003587|adenocarcinoma of the lung|adenocarcinoma of the lung
738962|NCT00003564|recurrent adult brain tumor|recurrent adult brain tumor
738963|NCT00003564|adult glioblastoma|adult glioblastoma
738964|NCT00003564|adult anaplastic astrocytoma|adult anaplastic astrocytoma
738965|NCT00003564|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
738966|NCT00003564|adult mixed glioma|adult mixed glioma
738967|NCT00003564|adult giant cell glioblastoma|adult giant cell glioblastoma
738968|NCT00003564|adult gliosarcoma|adult gliosarcoma
738969|NCT00003551|stage III renal cell cancer|stage iii renal cell cancer
738970|NCT00003551|stage IV renal cell cancer|stage iv renal cell cancer
738971|NCT00003551|recurrent renal cell cancer|recurrent renal cell cancer
738972|NCT00003546|stage I pancreatic cancer|stage i pancreatic cancer
738973|NCT00003546|stage II pancreatic cancer|stage ii pancreatic cancer
738974|NCT00003546|stage III pancreatic cancer|stage iii pancreatic cancer
738975|NCT00003546|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
738976|NCT00003451|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
738977|NCT00003451|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
738978|NCT00003451|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
738979|NCT00003451|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
738980|NCT00003451|isolated plasmacytoma of bone|isolated plasmacytoma of bone
738981|NCT00003451|extramedullary plasmacytoma|extramedullary plasmacytoma
738982|NCT00003451|refractory multiple myeloma|refractory multiple myeloma
738983|NCT00003451|Waldenström macroglobulinemia|waldenström macroglobulinemia
738984|NCT00003451|stage III multiple myeloma|stage iii multiple myeloma
738985|NCT00003451|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
738986|NCT00003451|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
738987|NCT00003451|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
738988|NCT00003451|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
738989|NCT00003451|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
738990|NCT00003451|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
738991|NCT00003451|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
738992|NCT00003451|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
738993|NCT00003451|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
738994|NCT00003451|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
738995|NCT00003451|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
738996|NCT00003451|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
738997|NCT00003451|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
738998|NCT00003451|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
738999|NCT00003451|polycythemia vera|polycythemia vera
739000|NCT00003451|primary myelofibrosis|primary myelofibrosis
739001|NCT00003451|essential thrombocythemia|essential thrombocythemia
739002|NCT00003451|untreated hairy cell leukemia|untreated hairy cell leukemia
739003|NCT00003451|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
739004|NCT00003451|refractory hairy cell leukemia|refractory hairy cell leukemia
739005|NCT00003451|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
739006|NCT00003451|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
739007|NCT00003451|acute undifferentiated leukemia|acute undifferentiated leukemia
739008|NCT00003451|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
739009|NCT00003451|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
739010|NCT00003451|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
739011|NCT00003451|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
739012|NCT00003451|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
739013|NCT00003451|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
739014|NCT00003451|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
739015|NCT00003451|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
739016|NCT00003451|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
739017|NCT00003451|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
739018|NCT00003451|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
739019|NCT00003451|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
739091|NCT00003331|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
739020|NCT00003451|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
739021|NCT00003451|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
739022|NCT00003451|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
739023|NCT00003451|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
739024|NCT00003451|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
739025|NCT00003451|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
739026|NCT00003451|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
739027|NCT00003451|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
739028|NCT00003451|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
739029|NCT00003451|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
739030|NCT00003451|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
739031|NCT00003451|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
739032|NCT00003451|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
739033|NCT00003451|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
739034|NCT00003451|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
739035|NCT00003451|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
739036|NCT00003451|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
739037|NCT00003451|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
739038|NCT00003451|secondary acute myeloid leukemia|secondary acute myeloid leukemia
739039|NCT00003451|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
739040|NCT00003451|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
739041|NCT00003451|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
739042|NCT00003451|prolymphocytic leukemia|prolymphocytic leukemia
739043|NCT00003451|primary systemic amyloidosis|primary systemic amyloidosis
739044|NCT00003451|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
739045|NCT00003451|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
739046|NCT00003451|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
739047|NCT00003451|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
739048|NCT00003451|anaplastic large cell lymphoma|anaplastic large cell lymphoma
739049|NCT00003451|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
739050|NCT00003451|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
739051|NCT00003451|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
739052|NCT00003451|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
739053|NCT00003451|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
739054|NCT00003451|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
739055|NCT00003451|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
739056|NCT00003451|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
739057|NCT00003451|splenic marginal zone lymphoma|splenic marginal zone lymphoma
739058|NCT00003451|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
739059|NCT00003441|stage IV colon cancer|stage iv colon cancer
739060|NCT00003441|stage IV rectal cancer|stage iv rectal cancer
739061|NCT00003441|recurrent colon cancer|recurrent colon cancer
739062|NCT00003441|recurrent rectal cancer|recurrent rectal cancer
739063|NCT00003441|adenocarcinoma of the colon|adenocarcinoma of the colon
739064|NCT00003441|adenocarcinoma of the rectum|adenocarcinoma of the rectum
739065|NCT00003441|6-hydroxymethylacylfulvene|6-hydroxymethylacylfulvene
739066|NCT00003441|MGI-114|mgi-114
739067|NCT00003441|Irofulven|irofulven
739068|NCT00003430|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
739069|NCT00003430|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
739070|NCT00003430|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
739071|NCT00003430|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
739072|NCT00003430|recurrent laryngeal cancer|recurrent laryngeal cancer
739073|NCT00003430|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
739074|NCT00003430|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
739075|NCT00003428|stage IV breast cancer|stage iv breast cancer
739076|NCT00003428|recurrent breast cancer|recurrent breast cancer
739077|NCT00003353|primary systemic amyloidosis|primary systemic amyloidosis
739078|NCT00003344|stage II colon cancer|stage ii colon cancer
739079|NCT00003344|stage III colon cancer|stage iii colon cancer
739080|NCT00003344|stage II rectal cancer|stage ii rectal cancer
739081|NCT00003344|stage III rectal cancer|stage iii rectal cancer
739082|NCT00003344|recurrent colon cancer|recurrent colon cancer
739083|NCT00003344|recurrent rectal cancer|recurrent rectal cancer
739084|NCT00003339|recurrent intraocular melanoma|recurrent intraocular melanoma
739085|NCT00003339|stage III melanoma|stage iii melanoma
739086|NCT00003339|stage IV melanoma|stage iv melanoma
739087|NCT00003339|recurrent melanoma|recurrent melanoma
739088|NCT00003331|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
739089|NCT00003331|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
739090|NCT00003331|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
739585|NCT00002873|stage II breast cancer|stage ii breast cancer
739092|NCT00003331|isolated plasmacytoma of bone|isolated plasmacytoma of bone
739093|NCT00003331|extramedullary plasmacytoma|extramedullary plasmacytoma
739094|NCT00003331|refractory multiple myeloma|refractory multiple myeloma
739095|NCT00003331|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
739096|NCT00003331|stage III multiple myeloma|stage iii multiple myeloma
739097|NCT00003331|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
739098|NCT00003331|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
739099|NCT00003331|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
739100|NCT00003331|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
739101|NCT00003331|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
739102|NCT00003331|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
739103|NCT00003331|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
739104|NCT00003331|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
739105|NCT00003331|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
739106|NCT00003331|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
739107|NCT00003331|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
739108|NCT00003331|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
739109|NCT00003331|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
739110|NCT00003331|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
739111|NCT00003331|polycythemia vera|polycythemia vera
739112|NCT00003331|primary myelofibrosis|primary myelofibrosis
739113|NCT00003331|essential thrombocythemia|essential thrombocythemia
739114|NCT00003331|untreated hairy cell leukemia|untreated hairy cell leukemia
739115|NCT00003331|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
739116|NCT00003331|refractory hairy cell leukemia|refractory hairy cell leukemia
739117|NCT00003331|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
739118|NCT00003331|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
739119|NCT00003331|acute undifferentiated leukemia|acute undifferentiated leukemia
739120|NCT00003331|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
739121|NCT00003331|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
739122|NCT00003331|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
739123|NCT00003331|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
739124|NCT00003331|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
739125|NCT00003331|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
739126|NCT00003331|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
739127|NCT00003331|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
739128|NCT00003331|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
739129|NCT00003331|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
739130|NCT00003331|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
739131|NCT00003331|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
739132|NCT00003331|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
739133|NCT00003331|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
739134|NCT00003331|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
739135|NCT00003331|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
739136|NCT00003331|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
739137|NCT00003331|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
739138|NCT00003331|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
739139|NCT00003331|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
739140|NCT00003331|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
739141|NCT00003331|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
739142|NCT00003331|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
739143|NCT00003331|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
739144|NCT00003331|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
739145|NCT00003331|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
739146|NCT00003331|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
739147|NCT00003331|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
739148|NCT00003331|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
739149|NCT00003331|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
739150|NCT00003331|secondary acute myeloid leukemia|secondary acute myeloid leukemia
739151|NCT00003331|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
739152|NCT00003331|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
739153|NCT00003331|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
739154|NCT00003331|prolymphocytic leukemia|prolymphocytic leukemia
739155|NCT00003331|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
739156|NCT00003331|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
741894|NCT00088309|Pediatric|pediatric
739157|NCT00003331|primary systemic amyloidosis|primary systemic amyloidosis
739158|NCT00003331|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
739159|NCT00003331|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
739160|NCT00003331|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
739161|NCT00003331|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
739162|NCT00003331|anaplastic large cell lymphoma|anaplastic large cell lymphoma
739163|NCT00003331|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
739164|NCT00003331|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
739165|NCT00003331|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
739166|NCT00003331|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
739167|NCT00003331|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
739168|NCT00003331|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
739169|NCT00003331|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
739170|NCT00003331|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
739171|NCT00003331|splenic marginal zone lymphoma|splenic marginal zone lymphoma
739172|NCT00003288|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
739173|NCT00003263|localized malignant mesothelioma|localized malignant mesothelioma
739174|NCT00091533|fMRI|fmri
739175|NCT00091533|Mirror Neuron System|mirror neuron system
739176|NCT00091533|Bimodal Neurons|bimodal neurons
739177|NCT00091533|Somatosensory Cortex|somatosensory cortex
739178|NCT00091533|Rehabilitation|rehabilitation
739179|NCT00091533|Healthy Volunteer|healthy volunteer
739180|NCT00091533|HV|hv
739181|NCT00091429|Angina|angina
739182|NCT00091429|Chest Pain|chest pain
739183|NCT00091429|Coronary Artery Disease|coronary artery disease
739184|NCT00091429|Heart Disease|heart disease
739185|NCT00003257|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
739186|NCT00003257|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
739187|NCT00003257|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
739188|NCT00003257|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
739189|NCT00003257|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
739190|NCT00003257|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
739191|NCT00003257|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
739192|NCT00003252|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
739193|NCT00003252|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
739194|NCT00003248|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
739195|NCT00003248|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
739196|NCT00003248|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
739197|NCT00003248|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
739198|NCT00003248|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
739199|NCT00003241|recurrent childhood brain tumor|recurrent childhood brain tumor
739200|NCT00003241|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
739201|NCT00003241|untreated childhood brain stem glioma|untreated childhood brain stem glioma
739202|NCT00003241|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
739203|NCT00003241|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
739204|NCT00003241|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
739205|NCT00003241|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
739206|NCT00003241|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
739207|NCT00003241|recurrent childhood ependymoma|recurrent childhood ependymoma
739208|NCT00003223|lip and oral cavity cancer|lip and oral cavity cancer
739209|NCT00091416|HIV Seronegativity|hiv seronegativity
739210|NCT00091416|HIV Preventive Vaccine|hiv preventive vaccine
739211|NCT00091390|adenocarcinoma of the prostate|adenocarcinoma of the prostate
739212|NCT00091390|stage IIB prostate cancer|stage iib prostate cancer
739213|NCT00091390|stage IIA prostate cancer|stage iia prostate cancer
739214|NCT00091390|stage III prostate cancer|stage iii prostate cancer
739215|NCT00091377|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
739216|NCT00091377|fallopian tube cancer|fallopian tube cancer
739217|NCT00091377|primary peritoneal cavity cancer|primary peritoneal cavity cancer
739218|NCT00091351|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
739219|NCT00091351|adult angiosarcoma|adult angiosarcoma
739220|NCT00091351|adult epithelioid sarcoma|adult epithelioid sarcoma
739221|NCT00091351|adult fibrosarcoma|adult fibrosarcoma
739222|NCT00091351|adult leiomyosarcoma|adult leiomyosarcoma
739223|NCT00091351|adult liposarcoma|adult liposarcoma
739224|NCT00091351|adult neurofibrosarcoma|adult neurofibrosarcoma
739225|NCT00091351|adult synovial sarcoma|adult synovial sarcoma
739226|NCT00091351|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
739227|NCT00091351|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
739228|NCT00091351|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
739229|NCT00091351|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
739230|NCT00091338|recurrent melanoma|recurrent melanoma
739231|NCT00091338|stage IV melanoma|stage iv melanoma
739232|NCT00091325|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
739233|NCT00091312|stage II colon cancer|stage ii colon cancer
739234|NCT00091312|adenocarcinoma of the colon|adenocarcinoma of the colon
739235|NCT00091299|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
739236|NCT00091286|recurrent colon cancer|recurrent colon cancer
739237|NCT00091286|stage IIB colon cancer|stage iib colon cancer
739238|NCT00091286|stage IIIA colon cancer|stage iiia colon cancer
739239|NCT00091286|stage IIIB colon cancer|stage iiib colon cancer
739240|NCT00091286|stage IIIC colon cancer|stage iiic colon cancer
739241|NCT00091286|stage IVA colon cancer|stage iva colon cancer
739242|NCT00091286|stage IVB colon cancer|stage ivb colon cancer
739243|NCT00091286|recurrent rectal cancer|recurrent rectal cancer
739244|NCT00091286|stage IIB rectal cancer|stage iib rectal cancer
739245|NCT00091286|stage IIIA rectal cancer|stage iiia rectal cancer
739246|NCT00091286|stage IIIB rectal cancer|stage iiib rectal cancer
739247|NCT00091286|stage IIIC rectal cancer|stage iiic rectal cancer
739248|NCT00091286|stage IVA rectal cancer|stage iva rectal cancer
739249|NCT00091286|stage IVB rectal cancer|stage ivb rectal cancer
739250|NCT00091273|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
739251|NCT00091273|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
739252|NCT00091273|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
739253|NCT00091273|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
739254|NCT00091273|primary peritoneal cavity cancer|primary peritoneal cavity cancer
739255|NCT00091260|primary systemic amyloidosis|primary systemic amyloidosis
739256|NCT00091247|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
739257|NCT00091234|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
739258|NCT00091234|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
739259|NCT00091234|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
739260|NCT00091234|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
739261|NCT00091234|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
739262|NCT00091234|secondary acute myeloid leukemia|secondary acute myeloid leukemia
739263|NCT00091234|adult acute basophilic leukemia|adult acute basophilic leukemia
739264|NCT00091234|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
739265|NCT00091234|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
739266|NCT00091234|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
739267|NCT00091234|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
739268|NCT00091234|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
739269|NCT00091234|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
739270|NCT00091234|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
739271|NCT00091234|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
739272|NCT00091234|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
739273|NCT00091234|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
739274|NCT00091169|fatigue|fatigue
739275|NCT00091169|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
739276|NCT00091169|levocarnitine|levocarnitine
739277|NCT00091169|depression|depression
739278|NCT00091169|pain|pain
739279|NCT00091169|carnitine deficiency|carnitine deficiency
739280|NCT00091156|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
739281|NCT00091156|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
739282|NCT00091143|recurrent melanoma|recurrent melanoma
739283|NCT00091143|stage III melanoma|stage iii melanoma
739284|NCT00091143|stage IV melanoma|stage iv melanoma
739285|NCT00091104|stage IV melanoma|stage iv melanoma
739286|NCT00091104|recurrent melanoma|recurrent melanoma
739287|NCT00091091|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
739288|NCT00091091|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
739289|NCT00091091|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
739290|NCT00091091|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
739291|NCT00091091|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
739292|NCT00091052|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
739293|NCT00091039|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
739294|NCT00091039|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
739295|NCT00090987|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
739296|NCT00090987|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
739297|NCT00090974|stage I breast cancer|stage i breast cancer
739298|NCT00090974|stage II breast cancer|stage ii breast cancer
739299|NCT00090974|stage IIIA breast cancer|stage iiia breast cancer
739300|NCT00090961|pulmonary complications|pulmonary complications
739301|NCT00090961|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
741895|NCT00088309|HIV|hiv
739302|NCT00090961|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
739303|NCT00090961|squamous cell lung cancer|squamous cell lung cancer
739304|NCT00090961|large cell lung cancer|large cell lung cancer
739305|NCT00090961|adenocarcinoma of the lung|adenocarcinoma of the lung
739306|NCT00090961|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
739307|NCT00090961|limited stage small cell lung cancer|limited stage small cell lung cancer
739308|NCT00090909|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
739309|NCT00090896|recurrent melanoma|recurrent melanoma
739310|NCT00090896|stage III melanoma|stage iii melanoma
739311|NCT00090896|stage IV melanoma|stage iv melanoma
739312|NCT00090870|stage IV renal cell cancer|stage iv renal cell cancer
739313|NCT00090857|breast cancer|breast cancer
739314|NCT00090857|stage I breast cancer|stage i breast cancer
739315|NCT00090857|stage II breast cancer|stage ii breast cancer
739316|NCT00090857|stage IIIA breast cancer|stage iiia breast cancer
739317|NCT00090857|stage IIIB breast cancer|stage iiib breast cancer
739318|NCT00090857|stage IIIC breast cancer|stage iiic breast cancer
739319|NCT00090857|stage IV breast cancer|stage iv breast cancer
739320|NCT00090857|breast cancer in situ|breast cancer in situ
739321|NCT00090857|ductal breast carcinoma in situ|ductal breast carcinoma in situ
739322|NCT00090844|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
739323|NCT00090844|hormone changes|hormone changes
739324|NCT00090844|stage I breast cancer|stage i breast cancer
739325|NCT00090844|stage II breast cancer|stage ii breast cancer
739326|NCT00090831|Emotional Learning|emotional learning
739327|NCT00090831|Neurotransmitter|neurotransmitter
739328|NCT00090831|Neural Systems|neural systems
739329|NCT00090831|Response Control|response control
739330|NCT00090831|Orbitofrontal Cortex|orbitofrontal cortex
739331|NCT00090831|Amygdala|amygdala
739332|NCT00090831|Serotonin|serotonin
739333|NCT00090831|Healthy Volunteer|healthy volunteer
739334|NCT00090831|HV|hv
739335|NCT00090818|Dental Abnormalities|dental abnormalities
739336|NCT00090818|Lichen Planus|lichen planus
739337|NCT00090818|Oral Mucosal Disease|oral mucosal disease
739338|NCT00090818|Genetic Disease|genetic disease
739339|NCT00090818|Amelogensis Imperfecta|amelogensis imperfecta
739340|NCT00090818|Maxillofacial Abnormalities|maxillofacial abnormalities
739341|NCT00090818|Craniofacial Abnormalities|craniofacial abnormalities
739342|NCT00090818|Craniofacial Genetic Abnormalities|craniofacial genetic abnormalities
739343|NCT00090779|Acute Infection|acute infection
739344|NCT00090779|Treatment Naive|treatment naive
739345|NCT00090727|diffuse|diffuse
739346|NCT00090727|follicular|follicular
739347|NCT00090727|chronic lymphocytic leukemia|chronic lymphocytic leukemia
739348|NCT00090727|colorectal cancer|colorectal cancer
739349|NCT00090727|pancreatic cancer|pancreatic cancer
739350|NCT00090727|acute myelogenous leukemia|acute myelogenous leukemia
739351|NCT00090727|head and neck cancer|head and neck cancer
739352|NCT00090727|breast cancer|breast cancer
739353|NCT00090727|prostate cancer|prostate cancer
739354|NCT00090727|ovarian cancer|ovarian cancer
739355|NCT00090727|bladder cancer|bladder cancer
739356|NCT00090727|hypoxia|hypoxia
739357|NCT00090727|refractory|refractory
739358|NCT00090727|metastatic|metastatic
739359|NCT00090714|DNA|dna
739360|NCT00090714|Circular|circular
739361|NCT00090714|Gene Therapy|gene therapy
739362|NCT00003217|childhood Burkitt lymphoma|childhood burkitt lymphoma
739363|NCT00003217|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
739364|NCT00003217|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
739365|NCT00003217|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
739366|NCT00003217|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
739367|NCT00003172|stage III gastric cancer|stage iii gastric cancer
739368|NCT00003172|stage IV gastric cancer|stage iv gastric cancer
739369|NCT00003172|recurrent gastric cancer|recurrent gastric cancer
739370|NCT00003139|oral complications|oral complications
739371|NCT00003139|lip and oral cavity squamous cell carcinoma|lip and oral cavity squamous cell carcinoma
739372|NCT00003139|oropharyngeal squamous cell carcinoma|oropharyngeal squamous cell carcinoma
739373|NCT00003134|recurrent adult brain tumor|recurrent adult brain tumor
739374|NCT00003134|adult brain stem glioma|adult brain stem glioma
739375|NCT00003134|adult oligodendroglioma|adult oligodendroglioma
739376|NCT00003134|adult mixed glioma|adult mixed glioma
739377|NCT00003134|adult diffuse astrocytoma|adult diffuse astrocytoma
739378|NCT00003100|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
739379|NCT00003088|stage II breast cancer|stage ii breast cancer
739380|NCT00003088|stage IIIA breast cancer|stage iiia breast cancer
739381|NCT00003072|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
739382|NCT00003072|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
739383|NCT00003072|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
739384|NCT00003072|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
739385|NCT00003072|neurotoxicity|neurotoxicity
739386|NCT00003048|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
739387|NCT00003048|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
739388|NCT00003048|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
739389|NCT00003048|Amifostine|amifostine
739390|NCT00003048|Ethyol|ethyol
739391|NCT00003048|Ethiofos|ethiofos
739392|NCT00003048|Gammaphos|gammaphos
739393|NCT00003039|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
739394|NCT00003039|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
739395|NCT00003039|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
739396|NCT00003039|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
739397|NCT00003039|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
739398|NCT00003039|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
739399|NCT00003039|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
739400|NCT00003039|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
739401|NCT00090688|diarrhea|diarrhea
739402|NCT00003005|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
739403|NCT00003005|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
739404|NCT00003005|TdT positive adult acute lymphoblastic leukemia|tdt positive adult acute lymphoblastic leukemia
739405|NCT00002993|stage III uterine sarcoma|stage iii uterine sarcoma
739406|NCT00002993|stage IV uterine sarcoma|stage iv uterine sarcoma
739407|NCT00002993|recurrent uterine sarcoma|recurrent uterine sarcoma
739408|NCT00002980|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
739409|NCT00002980|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
739410|NCT00002980|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
739411|NCT00002980|isolated plasmacytoma of bone|isolated plasmacytoma of bone
739412|NCT00002980|extramedullary plasmacytoma|extramedullary plasmacytoma
739413|NCT00002980|refractory multiple myeloma|refractory multiple myeloma
739414|NCT00002980|Waldenström macroglobulinemia|waldenström macroglobulinemia
739415|NCT00002980|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
739416|NCT00002980|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
739417|NCT00002980|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
739418|NCT00002980|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
739419|NCT00002980|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
739420|NCT00002980|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
739421|NCT00002980|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
739422|NCT00002980|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
739423|NCT00002980|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
739424|NCT00002980|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
739425|NCT00002980|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
739426|NCT00002980|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
739427|NCT00002980|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
739428|NCT00002980|polycythemia vera|polycythemia vera
739429|NCT00002980|primary myelofibrosis|primary myelofibrosis
739430|NCT00002980|essential thrombocythemia|essential thrombocythemia
739431|NCT00002980|untreated hairy cell leukemia|untreated hairy cell leukemia
739432|NCT00002980|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
739433|NCT00002980|refractory hairy cell leukemia|refractory hairy cell leukemia
739434|NCT00002980|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
739435|NCT00002980|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
739436|NCT00002980|acute undifferentiated leukemia|acute undifferentiated leukemia
739437|NCT00002980|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
739438|NCT00002980|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
739439|NCT00002980|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
739440|NCT00002980|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
739441|NCT00002980|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
739442|NCT00002980|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
739443|NCT00002980|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
739444|NCT00002980|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
739445|NCT00002980|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
739446|NCT00002980|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
739447|NCT00002980|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
739448|NCT00002980|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
739449|NCT00002980|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
739450|NCT00002980|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
739451|NCT00002980|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
739452|NCT00002980|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
739453|NCT00002980|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
739454|NCT00002980|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
739455|NCT00002980|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
739456|NCT00002980|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
739457|NCT00002980|secondary acute myeloid leukemia|secondary acute myeloid leukemia
739458|NCT00002980|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
739459|NCT00002980|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
739460|NCT00002980|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
739461|NCT00002980|prolymphocytic leukemia|prolymphocytic leukemia
739462|NCT00002980|primary systemic amyloidosis|primary systemic amyloidosis
739463|NCT00002980|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
739464|NCT00002980|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
739465|NCT00002980|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
739466|NCT00002980|anaplastic large cell lymphoma|anaplastic large cell lymphoma
739467|NCT00002980|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
739468|NCT00002980|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
739469|NCT00002980|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
739470|NCT00002980|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
739471|NCT00002980|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
739472|NCT00002980|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
739473|NCT00002980|splenic marginal zone lymphoma|splenic marginal zone lymphoma
739474|NCT00002967|stage I breast cancer|stage i breast cancer
739475|NCT00002967|stage II breast cancer|stage ii breast cancer
739476|NCT00002967|invasive ductal breast carcinoma|invasive ductal breast carcinoma
739477|NCT00002946|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
739478|NCT00002946|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
739479|NCT00002946|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
739480|NCT00002946|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
739481|NCT00002946|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
739482|NCT00002946|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
739483|NCT00002946|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
739484|NCT00002946|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
739485|NCT00002946|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
739486|NCT00002946|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
739487|NCT00002946|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
739488|NCT00002946|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
739489|NCT00002946|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
739490|NCT00002946|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
739491|NCT00002946|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
739492|NCT00002946|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
739493|NCT00002946|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
739494|NCT00002946|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
739495|NCT00002946|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
739496|NCT00002946|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
739497|NCT00002946|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
739498|NCT00002946|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
739499|NCT00002946|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
739500|NCT00002946|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
739501|NCT00002946|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
739502|NCT00002946|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
739503|NCT00002946|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
739504|NCT00002946|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
739505|NCT00002946|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
739506|NCT00002946|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
739507|NCT00002946|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
739508|NCT00002946|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
739509|NCT00002946|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
739510|NCT00002946|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
739511|NCT00002946|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
739512|NCT00002946|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
739513|NCT00002946|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
739514|NCT00002946|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
739515|NCT00002946|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
739516|NCT00002946|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
739517|NCT00002946|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
739518|NCT00002946|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
739519|NCT00002946|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
739520|NCT00002946|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
739662|NCT00002616|stage IV breast cancer|stage iv breast cancer
739521|NCT00002946|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
739522|NCT00002946|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
739523|NCT00002946|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
739524|NCT00002946|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
739525|NCT00002946|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
739526|NCT00002946|stage I mantle cell lymphoma|stage i mantle cell lymphoma
739527|NCT00002946|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
739528|NCT00002946|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
739529|NCT00002946|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
739530|NCT00002946|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
739531|NCT00002946|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
739532|NCT00002946|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
739533|NCT00002946|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
739534|NCT00002946|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
739535|NCT00002946|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
739536|NCT00002946|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
739537|NCT00002946|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
739538|NCT00002946|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
739539|NCT00002946|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
739540|NCT00002946|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
739541|NCT00002946|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
739542|NCT00002946|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
739543|NCT00002946|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
739544|NCT00002946|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
739545|NCT00002946|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
739546|NCT00002946|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
739547|NCT00002946|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
739548|NCT00002946|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
739549|NCT00002946|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
739550|NCT00002946|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
739551|NCT00002946|anaplastic large cell lymphoma|anaplastic large cell lymphoma
739552|NCT00002946|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
739553|NCT00002946|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
739554|NCT00002946|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
739555|NCT00002946|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
739556|NCT00002946|stage I marginal zone lymphoma|stage i marginal zone lymphoma
739557|NCT00002946|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
739558|NCT00002946|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
739559|NCT00002946|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
739560|NCT00002946|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
739561|NCT00002946|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
739562|NCT00002946|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
739563|NCT00002946|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
739564|NCT00002946|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
739565|NCT00002946|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
739566|NCT00002946|splenic marginal zone lymphoma|splenic marginal zone lymphoma
739567|NCT00002942|stage II breast cancer|stage ii breast cancer
739568|NCT00002942|stage IV breast cancer|stage iv breast cancer
739569|NCT00002942|stage IIIA breast cancer|stage iiia breast cancer
739570|NCT00002942|stage IIIB breast cancer|stage iiib breast cancer
739571|NCT00002937|recurrent breast cancer|recurrent breast cancer
739572|NCT00002932|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
739573|NCT00002932|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
739574|NCT00002932|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
739575|NCT00002932|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
739576|NCT00002904|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
739577|NCT00002897|stage II esophageal cancer|stage ii esophageal cancer
739578|NCT00002897|stage III esophageal cancer|stage iii esophageal cancer
739579|NCT00002897|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
739580|NCT00090662|Normal Volunteer|normal volunteer
739581|NCT00090662|Eosinophilopoiesis|eosinophilopoiesis
739582|NCT00090662|Healthy Volunteer|healthy volunteer
739584|NCT00002873|stage I breast cancer|stage i breast cancer
739586|NCT00002873|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
739587|NCT00002873|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
739588|NCT00002873|invasive ductal breast carcinoma|invasive ductal breast carcinoma
739589|NCT00002873|papillary ductal breast carcinoma|papillary ductal breast carcinoma
739590|NCT00002873|tubular ductal breast carcinoma|tubular ductal breast carcinoma
739591|NCT00002872|malignant pleural effusion|malignant pleural effusion
739592|NCT00002811|actinic keratosis|actinic keratosis
739593|NCT00002805|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
739594|NCT00002805|secondary acute myeloid leukemia|secondary acute myeloid leukemia
739595|NCT00002805|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
739596|NCT00002793|stage IV colon cancer|stage iv colon cancer
739597|NCT00002793|stage IV rectal cancer|stage iv rectal cancer
739598|NCT00002793|recurrent colon cancer|recurrent colon cancer
739599|NCT00002793|recurrent rectal cancer|recurrent rectal cancer
739600|NCT00002793|liver metastases|liver metastases
739601|NCT00002791|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
739602|NCT00002791|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
739603|NCT00002791|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
739604|NCT00002790|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
739605|NCT00002790|chronic lymphocytic leukemia|chronic lymphocytic leukemia
739606|NCT00002790|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
739607|NCT00002790|adult acute myeloid leukemia|adult acute myeloid leukemia
739608|NCT00002790|chronic myelogenous leukemia|chronic myelogenous leukemia
739609|NCT00002790|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
739610|NCT00002790|myelodysplastic syndromes|myelodysplastic syndromes
739611|NCT00002790|graft versus host disease|graft versus host disease
739612|NCT00002790|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
739613|NCT00002781|stage III melanoma|stage iii melanoma
739614|NCT00002781|recurrent melanoma|recurrent melanoma
739615|NCT00002775|adenocarcinoma of the prostate|adenocarcinoma of the prostate
739616|NCT00002775|stage IV prostate cancer|stage iv prostate cancer
739617|NCT00002775|recurrent prostate cancer|recurrent prostate cancer
739618|NCT00002767|stage IV melanoma|stage iv melanoma
739619|NCT00002767|recurrent melanoma|recurrent melanoma
739620|NCT00090623|Subfoveal neovascular|subfoveal neovascular
739621|NCT00090623|Age-related macular degeneration|age-related macular degeneration
739622|NCT00090623|AMD|amd
739623|NCT00090623|Wet AMD|wet amd
739624|NCT00002744|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
739625|NCT00002744|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
739626|NCT00002744|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
739627|NCT00002735|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
739628|NCT00002735|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
739629|NCT00002735|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
739630|NCT00002735|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
739631|NCT00002730|recurrent neuroblastoma|recurrent neuroblastoma
739632|NCT00002703|adenocarcinoma of the prostate|adenocarcinoma of the prostate
739633|NCT00002703|stage I prostate cancer|stage i prostate cancer
739634|NCT00002703|stage IIB prostate cancer|stage iib prostate cancer
739635|NCT00002703|stage IIA prostate cancer|stage iia prostate cancer
739636|NCT00090610|Relapsed ovarian cancer|relapsed ovarian cancer
739637|NCT00090584|Urge urinary incontinence (UUI)|urge urinary incontinence (uui)
739638|NCT00090584|Drug/Behavior treatment|drug/behavior treatment
739639|NCT00090493|Myeloma|myeloma
739640|NCT00090493|Mage-A3|mage-a3
739641|NCT00090493|Transplant|transplant
739642|NCT00090493|Peptide|peptide
739643|NCT00090493|DTPACE|dtpace
739644|NCT00090493|vaccines|vaccines
739645|NCT00090493|Immunotherapy|immunotherapy
739646|NCT00090493|NY-ESO-1|ny-eso-1
739647|NCT00090480|Cancer|cancer
739648|NCT00002659|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
739649|NCT00002659|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
739650|NCT00002659|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
739651|NCT00002659|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
739652|NCT00002659|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
739653|NCT00002659|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
739654|NCT00002631|stage I esophageal cancer|stage i esophageal cancer
739655|NCT00002631|stage II esophageal cancer|stage ii esophageal cancer
739656|NCT00002631|stage III esophageal cancer|stage iii esophageal cancer
739657|NCT00002631|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
739658|NCT00002631|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
739659|NCT00002628|stage IV breast cancer|stage iv breast cancer
739660|NCT00002628|recurrent breast cancer|recurrent breast cancer
739661|NCT00002622|malignant pleural effusion|malignant pleural effusion
739663|NCT00002616|recurrent breast cancer|recurrent breast cancer
739664|NCT00002616|stage IIIB breast cancer|stage iiib breast cancer
739665|NCT00002616|inflammatory breast cancer|inflammatory breast cancer
739666|NCT00002593|stage II colon cancer|stage ii colon cancer
739667|NCT00002593|stage III colon cancer|stage iii colon cancer
739668|NCT00002570|stage III colon cancer|stage iii colon cancer
739669|NCT00002570|stage IV colon cancer|stage iv colon cancer
739670|NCT00002570|stage III rectal cancer|stage iii rectal cancer
739671|NCT00002570|stage IV rectal cancer|stage iv rectal cancer
739672|NCT00002570|recurrent colon cancer|recurrent colon cancer
739673|NCT00002570|recurrent rectal cancer|recurrent rectal cancer
739674|NCT00002554|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
739675|NCT00002554|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
739676|NCT00002527|colon cancer|colon cancer
739677|NCT00002527|rectal cancer|rectal cancer
739678|NCT00002509|stage II breast cancer|stage ii breast cancer
739679|NCT00002509|stage IV breast cancer|stage iv breast cancer
739680|NCT00002509|stage IIIA breast cancer|stage iiia breast cancer
739681|NCT00002509|recurrent breast cancer|recurrent breast cancer
739682|NCT00002509|stage IIIB breast cancer|stage iiib breast cancer
739683|NCT00090571|JRA ASPs|jra asps
739684|NCT00090571|Genomics|genomics
739685|NCT00090376|Erectile Dysfunction|erectile dysfunction
739686|NCT00090376|Impotence|impotence
739687|NCT00090376|Prostate Cancer|prostate cancer
739688|NCT00090376|Prostatectomy|prostatectomy
739689|NCT00090363|rising PSA|rising psa
739690|NCT00090363|bone metastases|bone metastases
739691|NCT00090363|Clinical study|clinical study
739692|NCT00090363|pain-free or mildly symptomatic|pain-free or mildly symptomatic
739693|NCT00090324|Schizophrenia|schizophrenia
739694|NCT00090311|Bipolar I Mania|bipolar i mania
739695|NCT00004915|recurrent endometrial carcinoma|recurrent endometrial carcinoma
739696|NCT00004201|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
739697|NCT00004201|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
739698|NCT00004201|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
739699|NCT00004090|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
739700|NCT00004029|adenocarcinoma of the prostate|adenocarcinoma of the prostate
739701|NCT00004029|stage IV prostate cancer|stage iv prostate cancer
739702|NCT00004029|recurrent prostate cancer|recurrent prostate cancer
739703|NCT00002489|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
739704|NCT00002489|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
739705|NCT00002489|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
739706|NCT00002489|ovarian teratoma|ovarian teratoma
739707|NCT00002489|extragonadal germ cell tumor|extragonadal germ cell tumor
739708|NCT00002488|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
739709|NCT00002488|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
739710|NCT00002488|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
739711|NCT00002488|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
739712|NCT00002488|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
739713|NCT00002488|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
739714|NCT00002488|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
739715|NCT00002487|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
739716|NCT00002471|childhood Burkitt lymphoma|childhood burkitt lymphoma
739717|NCT00002471|L3 childhood acute lymphoblastic leukemia|l3 childhood acute lymphoblastic leukemia
739718|NCT00002471|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
739719|NCT00002471|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
739720|NCT00002471|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
739721|NCT00002471|recurrent adult non-Hodgkin lymphoma|recurrent adult non-hodgkin lymphoma
739722|NCT00002471|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
739723|NCT00002471|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
739724|NCT00002471|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
739725|NCT00002471|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
739726|NCT00002471|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
739727|NCT00002471|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
739728|NCT00002471|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
739729|NCT00002471|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
739730|NCT00002471|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
739731|NCT00002471|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
739732|NCT00002471|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
739733|NCT00002471|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
739734|NCT00002471|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
739735|NCT00002471|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
739736|NCT00002471|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
739932|NCT00090077|GW695634X|gw695634x
739737|NCT00002471|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
739738|NCT00002458|disseminated neuroblastoma|disseminated neuroblastoma
739739|NCT00002458|recurrent neuroblastoma|recurrent neuroblastoma
739740|NCT00090558|Atherosclerosis|atherosclerosis
739741|NCT00090558|Bone Marrow|bone marrow
739742|NCT00090558|Exercise|exercise
739743|NCT00090558|Endothelium|endothelium
739744|NCT00090558|Nitroglycerin|nitroglycerin
739745|NCT00090558|Coronary Artery Disease|coronary artery disease
739746|NCT00090558|CAD|cad
739747|NCT00090545|Hormone-Refractory|hormone-refractory
739748|NCT00090545|Proteomics|proteomics
739749|NCT00090545|Angiogenesis|angiogenesis
739750|NCT00090545|VEGFR|vegfr
739751|NCT00090545|Prostate Cancer|prostate cancer
739752|NCT00090545|Metastatic Prostate Cancer|metastatic prostate cancer
739753|NCT00090506|Yoga|yoga
739754|NCT00090506|Meditation|meditation
739755|NCT00090428|Autism|autism
739756|NCT00090428|Applied Behavioral Analysis|applied behavioral analysis
739757|NCT00090428|Gluten|gluten
739758|NCT00090428|Casein|casein
739759|NCT00090415|Autism|autism
739760|NCT00090415|Developmental Delay Disorders|developmental delay disorders
739761|NCT00090285|anogenital warts|anogenital warts
739762|NCT00090181|Arcoxia|arcoxia
739763|NCT00004026|adenocarcinoma of the prostate|adenocarcinoma of the prostate
739764|NCT00004026|stage IV prostate cancer|stage iv prostate cancer
739765|NCT00004026|recurrent prostate cancer|recurrent prostate cancer
739766|NCT00004009|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
739767|NCT00004009|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
739768|NCT00004009|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
739769|NCT00004009|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
739770|NCT00004009|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
739771|NCT00004009|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
739772|NCT00004009|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
739773|NCT00004009|secondary acute myeloid leukemia|secondary acute myeloid leukemia
739774|NCT00003989|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
739775|NCT00003989|stage III melanoma|stage iii melanoma
739776|NCT00003989|stage IV melanoma|stage iv melanoma
739777|NCT00003989|recurrent melanoma|recurrent melanoma
739778|NCT00003989|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
739779|NCT00003989|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
739780|NCT00003989|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
739781|NCT00003962|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
739782|NCT00003962|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
739783|NCT00003962|refractory multiple myeloma|refractory multiple myeloma
739784|NCT00003962|stage I multiple myeloma|stage i multiple myeloma
739785|NCT00003962|stage II multiple myeloma|stage ii multiple myeloma
739786|NCT00003962|stage III multiple myeloma|stage iii multiple myeloma
739787|NCT00003962|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
739788|NCT00003962|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
739789|NCT00003962|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
739790|NCT00003962|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
739791|NCT00003962|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
739792|NCT00003962|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
739793|NCT00003962|acute undifferentiated leukemia|acute undifferentiated leukemia
739794|NCT00003962|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
739795|NCT00003962|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
739796|NCT00003962|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
739797|NCT00003962|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
739798|NCT00003962|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
739799|NCT00003962|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
739800|NCT00003962|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
739801|NCT00003962|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
739802|NCT00003962|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
739803|NCT00003962|secondary acute myeloid leukemia|secondary acute myeloid leukemia
739804|NCT00003962|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
739805|NCT00003962|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
739806|NCT00003962|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
739807|NCT00003962|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
739808|NCT00003962|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
739809|NCT00003962|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
739810|NCT00003962|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
739811|NCT00003962|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
739812|NCT00003962|splenic marginal zone lymphoma|splenic marginal zone lymphoma
739813|NCT00003778|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
739814|NCT00003778|stage IV uterine sarcoma|stage iv uterine sarcoma
739815|NCT00003778|recurrent uterine sarcoma|recurrent uterine sarcoma
739816|NCT00003778|ovarian sarcoma|ovarian sarcoma
739817|NCT00003778|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
739818|NCT00090402|Fish Oils|fish oils
739819|NCT00090402|Thioctic Acid|thioctic acid
739820|NCT00090402|Antioxidants|antioxidants
739821|NCT00090402|Dietary Supplements|dietary supplements
739822|NCT00090389|Acupuncture|acupuncture
739823|NCT00090389|Medicine, Chinese Traditional|medicine, chinese traditional
739824|NCT00090337|pain|pain
739825|NCT00090337|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
739826|NCT00090337|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
739827|NCT00090337|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
739828|NCT00090337|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
739829|NCT00090337|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
739830|NCT00090337|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
739831|NCT00090337|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
739832|NCT00090337|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
739833|NCT00090337|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
739834|NCT00090337|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
739835|NCT00090337|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
739836|NCT00090337|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
739837|NCT00090337|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
739838|NCT00090337|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
739839|NCT00090337|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
739840|NCT00090337|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
739841|NCT00090337|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
739842|NCT00090337|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
739843|NCT00090337|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
739844|NCT00090337|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
739845|NCT00090337|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
739846|NCT00090337|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
739847|NCT00090337|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
739848|NCT00090337|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
739849|NCT00090337|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
739850|NCT00090337|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
739851|NCT00090337|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
739852|NCT00090337|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
739853|NCT00090337|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
739854|NCT00090337|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
739855|NCT00090337|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
739856|NCT00090337|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
739857|NCT00090337|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
739858|NCT00090337|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
739859|NCT00090337|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
739860|NCT00090337|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
739861|NCT00090337|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
739862|NCT00090337|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
739863|NCT00090337|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
739864|NCT00090337|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
739865|NCT00090337|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
739866|NCT00090337|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
739867|NCT00090337|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
739868|NCT00090337|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
739869|NCT00090337|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
741897|NCT00088309|Treatment Experienced|treatment experienced
739870|NCT00090337|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
739871|NCT00090337|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
739933|NCT00090077|GW678248X|gw678248x
739872|NCT00090337|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
739873|NCT00090337|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
739874|NCT00090337|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
739875|NCT00090337|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
739876|NCT00090337|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
739877|NCT00090337|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
739878|NCT00090337|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
739879|NCT00090337|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
739880|NCT00090337|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
739881|NCT00090337|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
739882|NCT00090337|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
739883|NCT00090337|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
739884|NCT00090337|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
739885|NCT00090337|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
739886|NCT00090337|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
739887|NCT00090337|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
739888|NCT00090337|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
739889|NCT00090337|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
739890|NCT00090337|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
739891|NCT00090337|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
739892|NCT00090337|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
739893|NCT00090337|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
739894|NCT00090337|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
739895|NCT00090337|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
739896|NCT00090337|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
739897|NCT00090337|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
739898|NCT00090337|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
739899|NCT00090337|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
739900|NCT00090337|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
739901|NCT00090337|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
739902|NCT00090337|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
739903|NCT00090337|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
739904|NCT00090337|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
739905|NCT00090337|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
739906|NCT00090337|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
739907|NCT00090337|recurrent salivary gland cancer|recurrent salivary gland cancer
739908|NCT00090337|stage I salivary gland cancer|stage i salivary gland cancer
739909|NCT00090337|stage II salivary gland cancer|stage ii salivary gland cancer
739910|NCT00090337|stage III salivary gland cancer|stage iii salivary gland cancer
739911|NCT00090337|stage IV salivary gland cancer|stage iv salivary gland cancer
739912|NCT00090194|Kidney Transplantation|kidney transplantation
739913|NCT00090194|Transplantation, Homologous|transplantation, homologous
739914|NCT00090194|HLA Antigens|hla antigens
739915|NCT00090194|Autoantibodies|autoantibodies
739916|NCT00090194|Immunoglobulins, Intravenous|immunoglobulins, intravenous
739917|NCT00090194|Living Donors|living donors
739918|NCT00090194|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
739919|NCT00090129|Psoriatic Arthritis|psoriatic arthritis
739920|NCT00090129|Moderate plaque psoriasis|moderate plaque psoriasis
739921|NCT00090129|severe plaque psoriasis|severe plaque psoriasis
739922|NCT00090129|Onercept|onercept
739923|NCT00090129|Placebo|placebo
739924|NCT00090116|Neramexane|neramexane
739925|NCT00090116|NMDA receptor antagonist|nmda receptor antagonist
739926|NCT00090116|Memory Loss|memory loss
739927|NCT00090116|Alzheimer Disease|alzheimer disease
739928|NCT00090103|Combination Therapy|combination therapy
739929|NCT00090103|dutasteride|dutasteride
739931|NCT00090077|GW695634G|gw695634g
739934|NCT00090077|pharmacokinetics|pharmacokinetics
739935|NCT00090077|NNRTI|nnrti
739936|NCT00090077|HIV|hiv
739937|NCT00003654|stage I breast cancer|stage i breast cancer
739938|NCT00003654|stage II breast cancer|stage ii breast cancer
739939|NCT00003601|melanoma|melanoma
739940|NCT00003588|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
739941|NCT00003588|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
739942|NCT00003519|stage II breast cancer|stage ii breast cancer
739943|NCT00003519|stage IIIA breast cancer|stage iiia breast cancer
739944|NCT00003519|stage IIIB breast cancer|stage iiib breast cancer
739945|NCT00003406|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
739946|NCT00003406|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
739947|NCT00003406|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
739948|NCT00003406|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
739949|NCT00003406|isolated plasmacytoma of bone|isolated plasmacytoma of bone
739950|NCT00003406|extramedullary plasmacytoma|extramedullary plasmacytoma
739951|NCT00003406|refractory multiple myeloma|refractory multiple myeloma
739952|NCT00003406|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
739953|NCT00003406|stage III multiple myeloma|stage iii multiple myeloma
739954|NCT00003406|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
739955|NCT00003406|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
739956|NCT00003406|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
739957|NCT00003406|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
739958|NCT00003406|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
739959|NCT00003406|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
739960|NCT00003406|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
739961|NCT00003406|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
739962|NCT00003406|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
739963|NCT00003406|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
739964|NCT00003406|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
739965|NCT00003406|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
739966|NCT00003406|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
739967|NCT00003406|polycythemia vera|polycythemia vera
739968|NCT00003406|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
739969|NCT00003406|essential thrombocythemia|essential thrombocythemia
739970|NCT00003406|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
739971|NCT00003406|refractory hairy cell leukemia|refractory hairy cell leukemia
739972|NCT00003406|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
739973|NCT00003406|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
739974|NCT00003406|acute undifferentiated leukemia|acute undifferentiated leukemia
739975|NCT00003406|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
739976|NCT00003406|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
739977|NCT00003406|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
739978|NCT00003406|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
739979|NCT00003406|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
739980|NCT00003406|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
739981|NCT00003406|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
739982|NCT00003406|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
739983|NCT00003406|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
739984|NCT00003406|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
739985|NCT00003406|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
739986|NCT00003406|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
739987|NCT00003406|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
739988|NCT00003406|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
739989|NCT00003406|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
739990|NCT00003406|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
739991|NCT00003406|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
739992|NCT00003406|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
739993|NCT00003406|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
739994|NCT00003406|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
739995|NCT00003406|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
739996|NCT00003406|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
739997|NCT00003406|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
739998|NCT00003406|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
739999|NCT00003406|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
740000|NCT00003406|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
740001|NCT00003406|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
741896|NCT00088309|Pediatrics|pediatrics
740002|NCT00003406|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
740003|NCT00003406|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
740004|NCT00003406|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
740005|NCT00003406|secondary acute myeloid leukemia|secondary acute myeloid leukemia
740006|NCT00003406|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
740007|NCT00003406|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
740008|NCT00003406|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
740009|NCT00003406|prolymphocytic leukemia|prolymphocytic leukemia
740010|NCT00003406|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
740011|NCT00003406|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
740012|NCT00003406|primary systemic amyloidosis|primary systemic amyloidosis
740013|NCT00003406|non-Hodgkin lymphoma during pregnancy|non-hodgkin lymphoma during pregnancy
740014|NCT00003406|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
740015|NCT00003406|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
740016|NCT00003406|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
740017|NCT00003406|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
740018|NCT00003406|anaplastic large cell lymphoma|anaplastic large cell lymphoma
740019|NCT00003406|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
740020|NCT00003406|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
740021|NCT00003406|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
740022|NCT00003406|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
740023|NCT00003406|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
740024|NCT00003406|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
740025|NCT00003406|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
740026|NCT00003406|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
740027|NCT00003406|splenic marginal zone lymphoma|splenic marginal zone lymphoma
740028|NCT00003406|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
740029|NCT00003390|stage IV renal cell cancer|stage iv renal cell cancer
740030|NCT00003390|recurrent renal cell cancer|recurrent renal cell cancer
740031|NCT00003378|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
740032|NCT00003378|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
740033|NCT00003378|primary peritoneal cavity cancer|primary peritoneal cavity cancer
740034|NCT00003362|stage III melanoma|stage iii melanoma
740035|NCT00003362|stage IV melanoma|stage iv melanoma
740036|NCT00003362|recurrent melanoma|recurrent melanoma
740037|NCT00003315|infection|infection
740038|NCT00003304|adult oligodendroglioma|adult oligodendroglioma
740039|NCT00090064|MDMA|mdma
740040|NCT00090064|Methylenedioxymethamphetamine|methylenedioxymethamphetamine
740041|NCT00090064|PTSD|ptsd
740042|NCT00090064|psychotherapy|psychotherapy
740043|NCT00003279|limited stage small cell lung cancer|limited stage small cell lung cancer
740044|NCT00003260|stage IV colon cancer|stage iv colon cancer
740045|NCT00003260|stage IV rectal cancer|stage iv rectal cancer
740046|NCT00003260|recurrent colon cancer|recurrent colon cancer
740047|NCT00003260|recurrent rectal cancer|recurrent rectal cancer
740048|NCT00003260|adenocarcinoma of the colon|adenocarcinoma of the colon
740049|NCT00003260|adenocarcinoma of the rectum|adenocarcinoma of the rectum
740050|NCT00003237|stage II gastric cancer|stage ii gastric cancer
740051|NCT00003237|stage III gastric cancer|stage iii gastric cancer
740052|NCT00003237|stage II esophageal cancer|stage ii esophageal cancer
740053|NCT00003237|stage III esophageal cancer|stage iii esophageal cancer
740054|NCT00003237|adenocarcinoma of the stomach|adenocarcinoma of the stomach
740055|NCT00003237|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
740056|NCT00003229|stage IV melanoma|stage iv melanoma
740057|NCT00003229|recurrent melanoma|recurrent melanoma
740058|NCT00003224|stage II melanoma|stage ii melanoma
740059|NCT00003224|stage III melanoma|stage iii melanoma
740060|NCT00003224|stage IV melanoma|stage iv melanoma
740061|NCT00003224|recurrent melanoma|recurrent melanoma
740062|NCT00003151|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
740063|NCT00003151|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
740064|NCT00003151|stage I marginal zone lymphoma|stage i marginal zone lymphoma
740065|NCT00003151|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
740066|NCT00003151|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
740067|NCT00003147|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
740068|NCT00003147|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
740069|NCT00003136|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
740070|NCT00003136|primary peritoneal cavity cancer|primary peritoneal cavity cancer
740071|NCT00003131|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
740072|NCT00002969|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
740073|NCT00002969|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
740074|NCT00002969|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
740075|NCT00002960|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
740076|NCT00002960|malignant ascites|malignant ascites
740077|NCT00002960|fallopian tube cancer|fallopian tube cancer
740078|NCT00002960|primary peritoneal cavity cancer|primary peritoneal cavity cancer
740079|NCT00002888|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
740080|NCT00002888|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
740081|NCT00002888|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
740082|NCT00002888|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
740083|NCT00002888|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
740084|NCT00002888|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
740085|NCT00002888|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
740086|NCT00002888|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
740087|NCT00002888|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
740088|NCT00002888|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
740089|NCT00002888|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
740090|NCT00002888|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
740091|NCT00002888|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
740092|NCT00002888|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
740093|NCT00002888|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
740094|NCT00002881|adenocarcinoma of the prostate|adenocarcinoma of the prostate
740095|NCT00002881|stage IV prostate cancer|stage iv prostate cancer
740096|NCT00002881|recurrent prostate cancer|recurrent prostate cancer
740097|NCT00002879|mantle cell lymphoma|mantle cell lymphoma
740098|NCT00002879|stage I mantle cell lymphoma|stage i mantle cell lymphoma
740099|NCT00002879|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
740100|NCT00002879|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
740101|NCT00002879|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
740102|NCT00002879|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
740103|NCT00002879|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
740104|NCT00002845|stage IV melanoma|stage iv melanoma
740105|NCT00002845|recurrent melanoma|recurrent melanoma
740106|NCT00002783|stage II gastric cancer|stage ii gastric cancer
740107|NCT00002783|stage III gastric cancer|stage iii gastric cancer
740108|NCT00002783|stage IV gastric cancer|stage iv gastric cancer
740109|NCT00002783|adenocarcinoma of the stomach|adenocarcinoma of the stomach
740110|NCT00002755|stage II breast cancer|stage ii breast cancer
740111|NCT00002755|stage IIIA breast cancer|stage iiia breast cancer
740112|NCT00002742|adult Hodgkin lymphoma|adult hodgkin lymphoma
740113|NCT00002742|adult non-Hodgkin lymphoma|adult non-hodgkin lymphoma
740114|NCT00002742|leukemia|leukemia
740115|NCT00002742|childhood non-Hodgkin lymphoma|childhood non-hodgkin lymphoma
740116|NCT00002742|chronic myeloproliferative disorders|chronic myeloproliferative disorders
740117|NCT00002742|myelodysplastic syndromes|myelodysplastic syndromes
740118|NCT00002742|childhood Hodgkin lymphoma|childhood hodgkin lymphoma
740119|NCT00002742|recurrent adult non-Hodgkin lymphoma|recurrent adult non-hodgkin lymphoma
740120|NCT00002742|infection|infection
740121|NCT00002742|multiple myeloma and other plasma cell neoplasms|multiple myeloma and other plasma cell neoplasms
740122|NCT00002742|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
740123|NCT00002711|stage I esophageal cancer|stage i esophageal cancer
740124|NCT00002711|stage II esophageal cancer|stage ii esophageal cancer
740125|NCT00002711|stage III esophageal cancer|stage iii esophageal cancer
740126|NCT00002711|recurrent esophageal cancer|recurrent esophageal cancer
740127|NCT00002711|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
740128|NCT00002711|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
740129|NCT00090025|Advanced Biliary Cancer|advanced biliary cancer
740130|NCT00090025|Cholangiocarcinoma|cholangiocarcinoma
740131|NCT00090025|Gall bladder tumor|gall bladder tumor
740132|NCT00090025|Gall bladder cancer|gall bladder cancer
740133|NCT00090025|Bile duct tumor|bile duct tumor
740134|NCT00090025|Tumor of biliary tree|tumor of biliary tree
740135|NCT00089999|lapatinib|lapatinib
740136|NCT00089999|advanced|advanced
740137|NCT00089999|metastatic breast cancer|metastatic breast cancer
740138|NCT00089999|GW572016|gw572016
740140|NCT00089986|severe sepsis|severe sepsis
740141|NCT00089986|septic shock|septic shock
740142|NCT00089986|Gram-negative infection|gram-negative infection
740143|NCT00089986|phospholipid emulsion|phospholipid emulsion
740144|NCT00005024|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
740145|NCT00004906|stage IV breast cancer|stage iv breast cancer
740146|NCT00004906|recurrent breast cancer|recurrent breast cancer
740147|NCT00002674|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
740148|NCT00002674|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
744694|NCT00084279|Pegasys|pegasys
740149|NCT00002674|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
740150|NCT00002674|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
740151|NCT00002634|localized resectable neuroblastoma|localized resectable neuroblastoma
740152|NCT00002634|regional neuroblastoma|regional neuroblastoma
740153|NCT00002634|disseminated neuroblastoma|disseminated neuroblastoma
740154|NCT00002634|recurrent neuroblastoma|recurrent neuroblastoma
740155|NCT00002634|localized unresectable neuroblastoma|localized unresectable neuroblastoma
740156|NCT00002579|stage I breast cancer|stage i breast cancer
740157|NCT00002579|stage II breast cancer|stage ii breast cancer
740158|NCT00002579|stage IIIA breast cancer|stage iiia breast cancer
740159|NCT00002510|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
740160|NCT00002510|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
740161|NCT00002510|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
740162|NCT00002510|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
740163|NCT00002510|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
740164|NCT00002499|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
740165|NCT00002498|stage IV breast cancer|stage iv breast cancer
740166|NCT00002498|recurrent breast cancer|recurrent breast cancer
740167|NCT00002493|stage III endometrial carcinoma|stage iii endometrial carcinoma
740168|NCT00002493|stage IV endometrial carcinoma|stage iv endometrial carcinoma
740169|NCT00002493|endometrial adenocarcinoma|endometrial adenocarcinoma
740170|NCT00002493|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
740171|NCT00002493|endometrial adenoacanthoma|endometrial adenoacanthoma
740172|NCT00002493|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
740173|NCT00002493|endometrial clear cell carcinoma|endometrial clear cell carcinoma
740174|NCT00002493|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
740175|NCT00002479|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
740176|NCT00002479|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
740177|NCT00002479|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
740178|NCT00002479|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
740179|NCT00089973|breast cancer|breast cancer
740180|NCT00089960|GIST|gist
740181|NCT00089947|Anti-T cell antibodies|anti-t cell antibodies
740182|NCT00089947|Living Donor Renal Transplantation|living donor renal transplantation
740183|NCT00089947|Acute Renal Allograft Rejection|acute renal allograft rejection
740184|NCT00089947|Induction Therapy with Reduction of Calcineurin inhibitors|induction therapy with reduction of calcineurin inhibitors
740185|NCT00089921|Rheumatoid Arthritis|rheumatoid arthritis
740186|NCT00089921|DMARDs|dmards
740187|NCT00089921|Methotrexate|methotrexate
740188|NCT00089921|p38 kinase|p38 kinase
740189|NCT00004900|stage IV breast cancer|stage iv breast cancer
740190|NCT00004900|recurrent breast cancer|recurrent breast cancer
740191|NCT00004900|stage IIIB breast cancer|stage iiib breast cancer
740192|NCT00004182|stage IV breast cancer|stage iv breast cancer
740193|NCT00004182|recurrent breast cancer|recurrent breast cancer
740194|NCT00004136|stage III childhood liver cancer|stage iii childhood liver cancer
740195|NCT00004136|stage IV childhood liver cancer|stage iv childhood liver cancer
740196|NCT00004136|recurrent childhood liver cancer|recurrent childhood liver cancer
740197|NCT00004136|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
740198|NCT00004136|advanced adult primary liver cancer|advanced adult primary liver cancer
740199|NCT00004136|recurrent adult primary liver cancer|recurrent adult primary liver cancer
740200|NCT00004136|liver metastases|liver metastases
740201|NCT00004042|stage III colon cancer|stage iii colon cancer
740202|NCT00004042|stage IV colon cancer|stage iv colon cancer
740203|NCT00004042|stage III rectal cancer|stage iii rectal cancer
740204|NCT00004042|stage IV rectal cancer|stage iv rectal cancer
740205|NCT00004042|recurrent colon cancer|recurrent colon cancer
740206|NCT00004042|recurrent rectal cancer|recurrent rectal cancer
740207|NCT00003974|stage I non-small cell lung cancer|stage i non-small cell lung cancer
740208|NCT00003974|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
740209|NCT00003974|localized malignant mesothelioma|localized malignant mesothelioma
740210|NCT00003974|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
740211|NCT00089908|Dengue Vaccine|dengue vaccine
740212|NCT00089908|Dengue Virus|dengue virus
740213|NCT00089908|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
740214|NCT00089908|Dengue Shock Syndrome|dengue shock syndrome
740215|NCT00089895|myocardial infarction|myocardial infarction
740216|NCT00089895|acute coronary syndrome|acute coronary syndrome
740217|NCT00089895|non-ST-segment elevation|non-st-segment elevation
740218|NCT00089895|eptifibatide|eptifibatide
740219|NCT00089895|Integrilin|integrilin
740220|NCT00089895|glycoprotein IIb/IIIa inhibitor (GP IIb/IIIa)|glycoprotein iib/iiia inhibitor (gp iib/iiia)
740221|NCT00089895|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
740222|NCT00089895|coronary artery bypass graph surgery (CABG)|coronary artery bypass graph surgery (cabg)
740223|NCT00089895|catheterization|catheterization
740224|NCT00089895|angina|angina
740225|NCT00089895|ischemia|ischemia
740226|NCT00089895|cardiac ischemia|cardiac ischemia
740227|NCT00089895|cardiovascular disease|cardiovascular disease
740228|NCT00089882|Alzheimer disease|alzheimer disease
740229|NCT00089882|Apolipoproteins E (APOE)|apolipoproteins e (apoe)
740230|NCT00089882|Genetic susceptibility testing|genetic susceptibility testing
740231|NCT00089856|Prostate|prostate
740232|NCT00089856|Cancer|cancer
740233|NCT00089856|Metastatic|metastatic
740234|NCT00089856|Hormone-refractory|hormone-refractory
740235|NCT00089856|GVAX|gvax
740236|NCT00089856|Chemotherapy|chemotherapy
740237|NCT00089856|Taxotere|taxotere
740238|NCT00089856|Docetaxel|docetaxel
740239|NCT00089856|Prednisone|prednisone
740240|NCT00089856|Vaccine|vaccine
740241|NCT00089856|Allogeneic cells|allogeneic cells
740242|NCT00089856|Advanced Prostate Cancer|advanced prostate cancer
740243|NCT00003951|recurrent pancreatic cancer|recurrent pancreatic cancer
740244|NCT00003951|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
740245|NCT00003951|stage IV pancreatic cancer|stage iv pancreatic cancer
740246|NCT00003897|stage IV melanoma|stage iv melanoma
740247|NCT00003897|recurrent melanoma|recurrent melanoma
740248|NCT00003885|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
740249|NCT00003885|stage I multiple myeloma|stage i multiple myeloma
740250|NCT00003885|stage II multiple myeloma|stage ii multiple myeloma
740251|NCT00003885|stage III multiple myeloma|stage iii multiple myeloma
740252|NCT00003885|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
740253|NCT00003885|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
740254|NCT00003885|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
740255|NCT00003885|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
740256|NCT00003885|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
740257|NCT00003885|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
740258|NCT00003885|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
740259|NCT00003885|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
740260|NCT00003885|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
740261|NCT00003885|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
740262|NCT00003885|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
740263|NCT00003885|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
740264|NCT00003885|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
740265|NCT00003885|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
740266|NCT00003885|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
740267|NCT00003885|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
740268|NCT00003885|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
740269|NCT00003885|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
740270|NCT00003885|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
740271|NCT00003885|splenic marginal zone lymphoma|splenic marginal zone lymphoma
740272|NCT00003776|metastatic osteosarcoma|metastatic osteosarcoma
740273|NCT00003751|adult glioblastoma|adult glioblastoma
740274|NCT00003751|adult giant cell glioblastoma|adult giant cell glioblastoma
740275|NCT00003751|adult gliosarcoma|adult gliosarcoma
740276|NCT00089843|Eating Disorders|eating disorders
740277|NCT00089843|Osteopenia|osteopenia
740278|NCT00089830|Subfoveal Choroidal Neovascularization|subfoveal choroidal neovascularization
740279|NCT00089830|Squalamine Lactate|squalamine lactate
740280|NCT00089804|Lupus|lupus
740281|NCT00089804|Nephritis|nephritis
740282|NCT00089804|Kidney|kidney
740283|NCT00089804|SLE|sle
740284|NCT00089804|Systemic Lupus Erythematosus|systemic lupus erythematosus
740285|NCT00089804|Nephritis, Lupus|nephritis, lupus
740286|NCT00003709|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
740287|NCT00003686|oral complications|oral complications
740288|NCT00003686|quality of life|quality of life
740289|NCT00003684|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
740290|NCT00003684|pulmonary complications|pulmonary complications
740291|NCT00003684|quality of life|quality of life
740292|NCT00003626|stage IV prostate cancer|stage iv prostate cancer
740293|NCT00003626|recurrent prostate cancer|recurrent prostate cancer
740294|NCT00003556|stage IV melanoma|stage iv melanoma
740295|NCT00003556|recurrent melanoma|recurrent melanoma
740296|NCT00089791|Postmenopausal Osteoporosis|postmenopausal osteoporosis
740297|NCT00003555|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
740298|NCT00003543|stage IV colon cancer|stage iv colon cancer
740299|NCT00003543|stage IV rectal cancer|stage iv rectal cancer
740300|NCT00003543|recurrent colon cancer|recurrent colon cancer
740301|NCT00003543|recurrent rectal cancer|recurrent rectal cancer
740302|NCT00003400|adenocarcinoma of the prostate|adenocarcinoma of the prostate
740303|NCT00003400|stage IV prostate cancer|stage iv prostate cancer
740304|NCT00003400|recurrent prostate cancer|recurrent prostate cancer
740305|NCT00003395|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
744695|NCT00084279|PegIntron|pegintron
740306|NCT00003395|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
740307|NCT00003395|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
740308|NCT00003395|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
740309|NCT00003395|refractory multiple myeloma|refractory multiple myeloma
740310|NCT00003395|Waldenström macroglobulinemia|waldenström macroglobulinemia
740311|NCT00003395|stage III multiple myeloma|stage iii multiple myeloma
740312|NCT00003395|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
740313|NCT00003395|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
740314|NCT00003395|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
740315|NCT00003395|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
740316|NCT00003395|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
740317|NCT00003395|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
740318|NCT00003395|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
740319|NCT00003395|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
740320|NCT00003395|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
740321|NCT00003395|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
740322|NCT00003395|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
740323|NCT00003395|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
740324|NCT00003395|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
740325|NCT00003395|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
740326|NCT00003395|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
740327|NCT00003395|adult acute basophilic leukemia|adult acute basophilic leukemia
740328|NCT00003395|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
740329|NCT00003395|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
740330|NCT00003395|refractory hairy cell leukemia|refractory hairy cell leukemia
740331|NCT00003395|acute undifferentiated leukemia|acute undifferentiated leukemia
740332|NCT00003395|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
740333|NCT00003395|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
740334|NCT00003395|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
740335|NCT00003395|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
740336|NCT00003395|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
740337|NCT00003395|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
740338|NCT00003395|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
740339|NCT00003395|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
740340|NCT00003395|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
740341|NCT00003395|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
740342|NCT00003395|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
740343|NCT00003395|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
740344|NCT00003395|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
740345|NCT00003395|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
740346|NCT00003395|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
740347|NCT00003395|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
740348|NCT00003395|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
740349|NCT00003395|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
740350|NCT00003395|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
740351|NCT00003395|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
740352|NCT00003395|secondary acute myeloid leukemia|secondary acute myeloid leukemia
740353|NCT00003395|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
740354|NCT00003395|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
740355|NCT00003395|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
740356|NCT00003395|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
740357|NCT00003395|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
740358|NCT00003395|intraocular lymphoma|intraocular lymphoma
740359|NCT00003395|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
740360|NCT00003395|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
740361|NCT00003395|anaplastic large cell lymphoma|anaplastic large cell lymphoma
740362|NCT00003395|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
740363|NCT00003395|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
740364|NCT00003395|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
740365|NCT00003395|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
740366|NCT00003395|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
740367|NCT00003395|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
740368|NCT00003395|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
740471|NCT00003284|recurrent small cell lung cancer|recurrent small cell lung cancer
740577|NCT00002955|stage IV pancreatic cancer|stage iv pancreatic cancer
740369|NCT00003395|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
740370|NCT00003395|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
740371|NCT00003395|splenic marginal zone lymphoma|splenic marginal zone lymphoma
740372|NCT00003380|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
740373|NCT00003380|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
740374|NCT00003380|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
740375|NCT00003380|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
740376|NCT00003380|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
740377|NCT00003380|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
740378|NCT00003380|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
740379|NCT00003380|fallopian tube cancer|fallopian tube cancer
740380|NCT00003380|primary peritoneal cavity cancer|primary peritoneal cavity cancer
740381|NCT00003380|Brenner tumor|brenner tumor
740382|NCT00003360|stage IV colon cancer|stage iv colon cancer
740383|NCT00003360|stage IV rectal cancer|stage iv rectal cancer
740384|NCT00003360|recurrent colon cancer|recurrent colon cancer
740385|NCT00003360|recurrent rectal cancer|recurrent rectal cancer
740386|NCT00003357|stage I breast cancer|stage i breast cancer
740387|NCT00003357|stage II breast cancer|stage ii breast cancer
740388|NCT00003357|stage III breast cancer|stage iii breast cancer
740389|NCT00003348|recurrent adult brain tumor|recurrent adult brain tumor
740390|NCT00003348|adult glioblastoma|adult glioblastoma
740391|NCT00003348|adult anaplastic astrocytoma|adult anaplastic astrocytoma
740392|NCT00003348|adult giant cell glioblastoma|adult giant cell glioblastoma
740393|NCT00003348|adult gliosarcoma|adult gliosarcoma
740394|NCT00003340|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
740395|NCT00003312|stage I prostate cancer|stage i prostate cancer
740396|NCT00003312|stage IIB prostate cancer|stage iib prostate cancer
740397|NCT00003312|stage IIA prostate cancer|stage iia prostate cancer
740398|NCT00089778|Clinical Response|clinical response
740399|NCT00089778|Toxicity|toxicity
740400|NCT00089778|Immunologic Response|immunologic response
740401|NCT00089778|Adjuvant|adjuvant
740402|NCT00089778|IL-2|il-2
740403|NCT00089778|Renal Cancer|renal cancer
740404|NCT00089765|Retinal Angioma|retinal angioma
740405|NCT00089765|Tumor|tumor
740406|NCT00089765|Anti-VEGF|anti-vegf
740407|NCT00089765|Monoclonal Antibody|monoclonal antibody
740408|NCT00089765|Macular Edema|macular edema
740409|NCT00089765|Von Hippel-Lindau Disease|von hippel-lindau disease
740410|NCT00089765|VEGF|vegf
740411|NCT00089765|Ranibizumab|ranibizumab
740412|NCT00089765|VHL|vhl
740413|NCT00003294|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
740414|NCT00003294|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
740415|NCT00003294|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
740416|NCT00003294|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
740417|NCT00003294|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
740418|NCT00003294|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
740419|NCT00003294|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
740420|NCT00003294|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
740421|NCT00003294|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
740422|NCT00003294|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
740423|NCT00003294|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
740424|NCT00003294|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
740425|NCT00003294|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
740426|NCT00003294|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
740427|NCT00003294|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
740428|NCT00003294|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
740429|NCT00003294|untreated hairy cell leukemia|untreated hairy cell leukemia
740430|NCT00003294|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
740431|NCT00003294|refractory hairy cell leukemia|refractory hairy cell leukemia
740432|NCT00003294|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
740433|NCT00003294|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
740434|NCT00003294|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
740435|NCT00003294|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
740436|NCT00003294|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
740437|NCT00003294|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
740438|NCT00003294|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
740439|NCT00003294|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
740440|NCT00003294|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
740441|NCT00003294|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
740442|NCT00003294|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
740443|NCT00003294|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
745085|NCT00083876|Doxorubicin|doxorubicin
740444|NCT00003294|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
740445|NCT00003294|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
740446|NCT00003294|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
740447|NCT00003294|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
740448|NCT00003294|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
740449|NCT00003294|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
740450|NCT00003294|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
740451|NCT00003294|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
740452|NCT00003294|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
740453|NCT00003294|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
740454|NCT00003294|prolymphocytic leukemia|prolymphocytic leukemia
740455|NCT00003294|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
740456|NCT00003294|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
740457|NCT00003294|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
740458|NCT00003294|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
740459|NCT00003294|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
740460|NCT00003294|anaplastic large cell lymphoma|anaplastic large cell lymphoma
740461|NCT00003294|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
740462|NCT00003294|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
740463|NCT00003294|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
740464|NCT00003294|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
740465|NCT00003294|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
740466|NCT00003294|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
740467|NCT00003294|splenic marginal zone lymphoma|splenic marginal zone lymphoma
740468|NCT00003284|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
740469|NCT00003284|limited stage small cell lung cancer|limited stage small cell lung cancer
740470|NCT00003284|extensive stage small cell lung cancer|extensive stage small cell lung cancer
740472|NCT00003284|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
740473|NCT00003284|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
740474|NCT00003284|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
740475|NCT00003251|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
740476|NCT00003251|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
740477|NCT00003251|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
740478|NCT00003251|stage III salivary gland cancer|stage iii salivary gland cancer
740479|NCT00003251|stage IV salivary gland cancer|stage iv salivary gland cancer
740480|NCT00003251|recurrent salivary gland cancer|recurrent salivary gland cancer
740481|NCT00003251|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
740482|NCT00003251|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
740483|NCT00003251|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
740484|NCT00003251|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
740485|NCT00003251|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
740486|NCT00003251|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
740487|NCT00003251|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
740488|NCT00003251|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
740489|NCT00003251|stage III laryngeal cancer|stage iii laryngeal cancer
740490|NCT00003251|stage IV laryngeal cancer|stage iv laryngeal cancer
740491|NCT00003251|recurrent laryngeal cancer|recurrent laryngeal cancer
740492|NCT00003251|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
740493|NCT00003251|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
740494|NCT00003251|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
740495|NCT00003251|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
740496|NCT00003251|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
740497|NCT00003251|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
740498|NCT00003251|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
740499|NCT00003251|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
740500|NCT00003251|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
740501|NCT00003251|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
740502|NCT00003251|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
740503|NCT00003251|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
740504|NCT00003251|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
740505|NCT00003251|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
740506|NCT00003251|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
740507|NCT00003251|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
740508|NCT00003251|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
740509|NCT00003251|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
740510|NCT00003251|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
740511|NCT00003251|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
740512|NCT00003251|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
740513|NCT00003251|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
740514|NCT00003251|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
740515|NCT00003251|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
740516|NCT00003251|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
740517|NCT00003251|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
740518|NCT00003251|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
740519|NCT00003251|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
740520|NCT00003251|radiation toxicity|radiation toxicity
740521|NCT00003220|stage IV colon cancer|stage iv colon cancer
740522|NCT00003220|stage IV rectal cancer|stage iv rectal cancer
740523|NCT00003220|recurrent colon cancer|recurrent colon cancer
740524|NCT00003220|recurrent rectal cancer|recurrent rectal cancer
740525|NCT00003220|adenocarcinoma of the colon|adenocarcinoma of the colon
740526|NCT00003220|adenocarcinoma of the rectum|adenocarcinoma of the rectum
740527|NCT00003200|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
740528|NCT00003200|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
740529|NCT00003200|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
740530|NCT00003200|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
740531|NCT00003200|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
740532|NCT00003200|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
740533|NCT00003200|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
740534|NCT00003200|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
740535|NCT00003200|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
740536|NCT00003200|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
740537|NCT00003200|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
740538|NCT00003200|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
740539|NCT00003200|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
740540|NCT00003200|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
740541|NCT00003200|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
740542|NCT00003200|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
740543|NCT00089739|Uveitis|uveitis
740544|NCT00089739|Suppressor of Cytokine Secretion|suppressor of cytokine secretion
740545|NCT00089739|GITR|gitr
740546|NCT00089739|Immunosuppression|immunosuppression
740547|NCT00089739|GITR Ligand|gitr ligand
740548|NCT00089739|Intraocular Inflammation|intraocular inflammation
740549|NCT00089726|cancer vaccine|cancer vaccine
740550|NCT00089726|NSCLC|nsclc
740551|NCT00089726|immunotherapy|immunotherapy
740552|NCT00089713|antihypertensive agents/therapeutic use|antihypertensive agents/therapeutic use
740553|NCT00089713|hypertension/drug therapy|hypertension/drug therapy
740554|NCT00089713|blood pressure|blood pressure
740555|NCT00089700|HIV|hiv
740556|NCT00089700|AIDS|aids
740557|NCT00089700|Treatment Experienced|treatment experienced
740558|NCT00089700|Optimized Background Therapy|optimized background therapy
740559|NCT00089700|HIV-1|hiv-1
740560|NCT00003197|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
740561|NCT00003123|refractory anemia|refractory anemia
740562|NCT00003123|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
740563|NCT00003123|refractory anemia with excess blasts|refractory anemia with excess blasts
740564|NCT00003123|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
740565|NCT00003115|prostate cancer|prostate cancer
740566|NCT00003115|pain|pain
740567|NCT00003102|stage IV renal cell cancer|stage iv renal cell cancer
740568|NCT00003102|recurrent renal cell cancer|recurrent renal cell cancer
740569|NCT00003058|adult liposarcoma|adult liposarcoma
740570|NCT00003058|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
740571|NCT00003044|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
740572|NCT00003025|stage I pancreatic cancer|stage i pancreatic cancer
740573|NCT00003025|stage II pancreatic cancer|stage ii pancreatic cancer
740574|NCT00003025|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
740575|NCT00003003|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
740576|NCT00003003|secondary acute myeloid leukemia|secondary acute myeloid leukemia
740578|NCT00002933|stage IV colon cancer|stage iv colon cancer
740579|NCT00002933|stage IV rectal cancer|stage iv rectal cancer
740580|NCT00002933|recurrent colon cancer|recurrent colon cancer
740581|NCT00002933|recurrent rectal cancer|recurrent rectal cancer
740582|NCT00002933|adenocarcinoma of the colon|adenocarcinoma of the colon
740583|NCT00002933|adenocarcinoma of the rectum|adenocarcinoma of the rectum
740584|NCT00089674|Prostate Cancer|prostate cancer
740585|NCT00089674|Bone Loss with Prostate Cancer|bone loss with prostate cancer
740586|NCT00089674|Treatment of bone loss in patients undergoing androgen deprivation therapy (ADT) for non-metastatic prostate cancer (PC).|treatment of bone loss in patients undergoing androgen deprivation therapy (adt) for non-metastatic prostate cancer (pc).
740587|NCT00089661|Breast Cancer|breast cancer
740588|NCT00089661|Bone loss associated with Aromatase Inhibitor therapy (AIT) for non-metastatic BC|bone loss associated with aromatase inhibitor therapy (ait) for non-metastatic bc
740589|NCT00089661|osteopenia|osteopenia
740590|NCT00089661|Low bone density|low bone density
740591|NCT00089635|Colon, Rectal Cancer|colon, rectal cancer
740592|NCT00089635|ABX-EGF, Panitumumab, EGFr|abx-egf, panitumumab, egfr
740593|NCT00089635|Immunex, Abgenix, Amgen|immunex, abgenix, amgen
740594|NCT00089635|Metastatic Colorectal Cancer|metastatic colorectal cancer
740595|NCT00089635|Vectibix|vectibix
740596|NCT00002914|recurrent bladder cancer|recurrent bladder cancer
740597|NCT00002914|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
740598|NCT00002914|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
740599|NCT00002914|adenocarcinoma of the bladder|adenocarcinoma of the bladder
740600|NCT00002914|recurrent urethral cancer|recurrent urethral cancer
740601|NCT00002914|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
740602|NCT00002909|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
740603|NCT00002909|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
740604|NCT00002909|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
740605|NCT00002909|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
740606|NCT00002909|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
740607|NCT00002909|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
740608|NCT00002909|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
740609|NCT00002909|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
740610|NCT00002909|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
740611|NCT00002909|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
740612|NCT00002909|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
740613|NCT00002909|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
740614|NCT00002909|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
740615|NCT00002909|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
740616|NCT00002909|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
740617|NCT00002909|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
740618|NCT00002909|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
740619|NCT00002909|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
740620|NCT00002909|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
740621|NCT00002909|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
740622|NCT00002909|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
740623|NCT00002909|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
740624|NCT00002909|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
740625|NCT00002909|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
740626|NCT00002909|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
740627|NCT00002909|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
740628|NCT00002909|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
740629|NCT00002909|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
740630|NCT00002909|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
740631|NCT00002909|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
740632|NCT00002909|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
740633|NCT00002909|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
740634|NCT00002909|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
740635|NCT00002909|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
740636|NCT00002909|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
740637|NCT00002909|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
740638|NCT00002909|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
740639|NCT00002909|anaplastic large cell lymphoma|anaplastic large cell lymphoma
740640|NCT00002909|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
740641|NCT00002909|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
740642|NCT00002909|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
740643|NCT00002909|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
740644|NCT00002909|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
745069|NCT00083915|Doxorubicin|doxorubicin
740645|NCT00002909|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
740646|NCT00002909|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
740647|NCT00002909|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
740648|NCT00002909|splenic marginal zone lymphoma|splenic marginal zone lymphoma
740649|NCT00002890|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
740650|NCT00002890|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
740651|NCT00002890|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
740652|NCT00002890|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
740653|NCT00002890|refractory anemia with excess blasts|refractory anemia with excess blasts
740654|NCT00002890|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
740655|NCT00002890|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
740656|NCT00002890|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
740657|NCT00002890|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
740658|NCT00002890|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
740659|NCT00002865|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
740660|NCT00002749|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
740661|NCT00002749|recurrent adult brain tumor|recurrent adult brain tumor
740662|NCT00002749|adult brain stem glioma|adult brain stem glioma
740663|NCT00002749|childhood oligodendroglioma|childhood oligodendroglioma
740664|NCT00002749|untreated childhood brain stem glioma|untreated childhood brain stem glioma
740665|NCT00002749|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
740666|NCT00002749|untreated childhood visual pathway glioma|untreated childhood visual pathway glioma
740667|NCT00002749|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
740668|NCT00002749|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
740669|NCT00002749|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
740670|NCT00002749|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
740671|NCT00002749|adult anaplastic astrocytoma|adult anaplastic astrocytoma
740672|NCT00002749|adult oligodendroglioma|adult oligodendroglioma
740673|NCT00002655|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
740674|NCT00002655|recurrent adult primary liver cancer|recurrent adult primary liver cancer
740675|NCT00002655|liver metastases|liver metastases
740676|NCT00002635|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
740677|NCT00002635|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
740678|NCT00002635|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
740679|NCT00002635|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
740680|NCT00002619|adult brain stem glioma|adult brain stem glioma
740681|NCT00002619|adult glioblastoma|adult glioblastoma
740682|NCT00002619|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
740683|NCT00002619|untreated childhood brain stem glioma|untreated childhood brain stem glioma
740684|NCT00002619|adult giant cell glioblastoma|adult giant cell glioblastoma
740685|NCT00002619|adult gliosarcoma|adult gliosarcoma
740686|NCT00002609|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
740687|NCT00002609|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
740688|NCT00002609|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
740689|NCT00002609|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
740690|NCT00002585|stage IV breast cancer|stage iv breast cancer
740691|NCT00002585|recurrent breast cancer|recurrent breast cancer
740692|NCT00089596|umbilical cord blood|umbilical cord blood
740693|NCT00089596|transplant|transplant
740694|NCT00089596|ALL|all
740695|NCT00089596|AML|aml
740696|NCT00089596|MDS|mds
740697|NCT00089596|NHL|nhl
740698|NCT00089596|CML|cml
740699|NCT00089583|antiretroviral therapy|antiretroviral therapy
740700|NCT00089583|pediatrics|pediatrics
740701|NCT00089583|AGENERASE|agenerase
740702|NCT00089583|amprenavir|amprenavir
740703|NCT00089583|fosamprenavir|fosamprenavir
740704|NCT00089583|HIV Infection|hiv infection
740705|NCT00089583|ritonavir|ritonavir
740706|NCT00089583|protease inhibitor|protease inhibitor
740707|NCT00089583|LEXIVA|lexiva
740708|NCT00005626|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
740709|NCT00005626|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
740710|NCT00005626|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
740711|NCT00005626|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
740712|NCT00005626|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
740713|NCT00005626|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
740714|NCT00005626|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
740715|NCT00005626|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
740716|NCT00005626|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
740717|NCT00005626|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
740718|NCT00005626|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
740719|NCT00005626|prolymphocytic leukemia|prolymphocytic leukemia
740720|NCT00005626|stage I mantle cell lymphoma|stage i mantle cell lymphoma
740721|NCT00005626|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
740722|NCT00005626|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
740723|NCT00005626|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
740724|NCT00005626|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
740725|NCT00005626|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
740726|NCT00005626|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
740727|NCT00005626|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
740728|NCT00005626|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
740729|NCT00005626|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
740730|NCT00005626|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
740731|NCT00005626|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
740732|NCT00005626|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
740733|NCT00005626|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
740734|NCT00005626|stage I marginal zone lymphoma|stage i marginal zone lymphoma
740735|NCT00005626|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
740736|NCT00005626|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
740737|NCT00005626|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
740738|NCT00005626|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
740739|NCT00005626|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
740740|NCT00005626|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
740741|NCT00005626|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
740742|NCT00005626|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
740743|NCT00005626|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
740744|NCT00005626|splenic marginal zone lymphoma|splenic marginal zone lymphoma
740745|NCT00005607|stage IV gastric cancer|stage iv gastric cancer
740746|NCT00005607|recurrent gastric cancer|recurrent gastric cancer
740747|NCT00005607|stage IV esophageal cancer|stage iv esophageal cancer
740748|NCT00005607|recurrent esophageal cancer|recurrent esophageal cancer
740749|NCT00005607|adenocarcinoma of the stomach|adenocarcinoma of the stomach
740750|NCT00005607|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
740751|NCT00002574|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
740752|NCT00002574|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
740753|NCT00002562|recurrent cervical cancer|recurrent cervical cancer
740754|NCT00002562|recurrent vaginal cancer|recurrent vaginal cancer
740755|NCT00002562|vaginal clear cell adenocarcinoma|vaginal clear cell adenocarcinoma
740756|NCT00002562|cervical adenocarcinoma|cervical adenocarcinoma
740757|NCT00002507|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
740758|NCT00002507|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
740759|NCT00002507|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
740760|NCT00002507|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
740761|NCT00002507|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
740762|NCT00002507|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
740763|NCT00002507|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
740764|NCT00002507|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
740765|NCT00002507|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
740766|NCT00002507|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
740767|NCT00002507|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
740768|NCT00002507|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
740769|NCT00002507|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
740770|NCT00002507|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
740771|NCT00002507|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
740772|NCT00002507|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
740773|NCT00002507|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
740774|NCT00002507|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
740775|NCT00002507|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
740776|NCT00002507|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
740777|NCT00002507|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
740778|NCT00002507|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
740779|NCT00002507|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
740780|NCT00002507|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
740781|NCT00002507|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
740782|NCT00002507|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
740783|NCT00002507|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
740784|NCT00002507|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
740785|NCT00002507|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
740786|NCT00002507|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
740787|NCT00002507|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
740788|NCT00002507|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
740789|NCT00002507|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
740790|NCT00002507|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
740791|NCT00002507|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
740792|NCT00002507|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
740793|NCT00002507|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
740794|NCT00002507|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
740795|NCT00002507|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
740796|NCT00002507|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
740797|NCT00002507|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
740798|NCT00002507|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
740799|NCT00089622|Parkinson's Disease|parkinson's disease
740800|NCT00089622|Motor Fluctuations|motor fluctuations
740801|NCT00089622|Intravenous Levodopa|intravenous levodopa
740802|NCT00089622|Antiparkinsonian Response|antiparkinsonian response
740803|NCT00089622|Lisuride Patch|lisuride patch
740804|NCT00089622|Parkinson Disease|parkinson disease
740805|NCT00089622|PD|pd
740806|NCT00089609|Hormones|hormones
740807|NCT00089609|Angiogenesis|angiogenesis
740808|NCT00089609|Markers|markers
740809|NCT00089609|Tumor|tumor
740810|NCT00089609|Prostate Cancer|prostate cancer
740811|NCT00089570|hepatorenal syndrome|hepatorenal syndrome
740812|NCT00089570|terlipressin|terlipressin
740813|NCT00089557|Dermal assessment|dermal assessment
740814|NCT00089557|Pain assessment|pain assessment
740815|NCT00089557|Diary|diary
740816|NCT00089557|Analgesics|analgesics
740817|NCT00089557|Capsaicin|capsaicin
740818|NCT00089557|Herpes zoster|herpes zoster
740819|NCT00089557|Neuralgia|neuralgia
740820|NCT00089557|Pain|pain
740821|NCT00089557|HIV Infections|hiv infections
740822|NCT00089557|Peripheral Nervous System Diseases|peripheral nervous system diseases
740823|NCT00089557|Diabetic Neuropathies|diabetic neuropathies
740824|NCT00089557|Diabetes Mellitus|diabetes mellitus
740825|NCT00089557|Polyneuropathies|polyneuropathies
740826|NCT00089557|Complementary Therapies|complementary therapies
740827|NCT00005591|stage III pancreatic cancer|stage iii pancreatic cancer
740828|NCT00005591|recurrent pancreatic cancer|recurrent pancreatic cancer
740829|NCT00005591|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
740830|NCT00005591|stage IV pancreatic cancer|stage iv pancreatic cancer
740831|NCT00005076|stage III colon cancer|stage iii colon cancer
740832|NCT00005076|stage IV colon cancer|stage iv colon cancer
740833|NCT00005076|stage III rectal cancer|stage iii rectal cancer
740834|NCT00005076|stage IV rectal cancer|stage iv rectal cancer
740835|NCT00005076|recurrent colon cancer|recurrent colon cancer
740836|NCT00005076|recurrent rectal cancer|recurrent rectal cancer
740837|NCT00005070|recurrent cervical cancer|recurrent cervical cancer
740838|NCT00005070|stage IVB cervical cancer|stage ivb cervical cancer
740839|NCT00005070|cervical squamous cell carcinoma|cervical squamous cell carcinoma
740840|NCT00005070|cervical adenocarcinoma|cervical adenocarcinoma
740841|NCT00005070|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
740842|NCT00005057|stage IV melanoma|stage iv melanoma
740843|NCT00005057|recurrent melanoma|recurrent melanoma
740844|NCT00005057|lentigo maligna malignant melanoma|lentigo maligna malignant melanoma
740845|NCT00005057|superficial spreading malignant melanoma|superficial spreading malignant melanoma
740846|NCT00005057|acral lentiginous malignant melanoma|acral lentiginous malignant melanoma
740847|NCT00005057|nodular malignant melanoma|nodular malignant melanoma
740848|NCT00005056|stage I renal cell cancer|stage i renal cell cancer
740849|NCT00005056|stage II renal cell cancer|stage ii renal cell cancer
740850|NCT00005056|stage III renal cell cancer|stage iii renal cell cancer
740851|NCT00005056|stage IV renal cell cancer|stage iv renal cell cancer
740852|NCT00005056|recurrent renal cell cancer|recurrent renal cell cancer
740853|NCT00004937|recurrent adult brain tumor|recurrent adult brain tumor
740854|NCT00004937|adult glioblastoma|adult glioblastoma
740855|NCT00004937|adult giant cell glioblastoma|adult giant cell glioblastoma
740856|NCT00004937|adult gliosarcoma|adult gliosarcoma
740857|NCT00004219|nausea and vomiting|nausea and vomiting
740858|NCT00004219|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
740859|NCT00004219|testicular seminoma|testicular seminoma
745070|NCT00083915|Etoposide|etoposide
740860|NCT00004215|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
740861|NCT00004215|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
740862|NCT00004215|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
740863|NCT00004215|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
740864|NCT00004215|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
740865|NCT00004215|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
740866|NCT00004215|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
740867|NCT00004215|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
740868|NCT00004215|anemia|anemia
740869|NCT00004215|neutropenia|neutropenia
740870|NCT00004215|thrombocytopenia|thrombocytopenia
740871|NCT00004215|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
740872|NCT00004207|stage IV breast cancer|stage iv breast cancer
740873|NCT00004207|recurrent breast cancer|recurrent breast cancer
740874|NCT00089531|Healthy|healthy
740875|NCT00089531|Virus|virus
740876|NCT00089531|T-Cells|t-cells
740877|NCT00089531|HIV-Negative|hiv-negative
740878|NCT00089531|Immunity|immunity
740879|NCT00089531|Healthy Volunteer|healthy volunteer
740880|NCT00089531|HV|hv
740881|NCT00089531|HIV Preventive Vaccine|hiv preventive vaccine
740882|NCT00089531|HIV Seronegativity|hiv seronegativity
740883|NCT00089518|Treatment Experienced|treatment experienced
740884|NCT00089505|Treatment Experienced|treatment experienced
740885|NCT00089505|Treatment Naive|treatment naive
740886|NCT00089505|MTCT|mtct
740887|NCT00089505|HIV Seronegativity|hiv seronegativity
740888|NCT00089466|Entry Inhibitors|entry inhibitors
740889|NCT00089466|CXCR4 Entry Inhibitors|cxcr4 entry inhibitors
740890|NCT00089466|Treatment Experienced|treatment experienced
740891|NCT00089466|Treatment Naive|treatment naive
740892|NCT00089453|Myeloma|myeloma
740893|NCT00089453|Transplant|transplant
740894|NCT00089453|Relapsed|relapsed
740895|NCT00089453|Donor|donor
740896|NCT00089453|Stem Cell|stem cell
740897|NCT00089453|Thalidomide|thalidomide
740898|NCT00089453|Dexamethasone|dexamethasone
740899|NCT00089453|Cisplatin|cisplatin
740900|NCT00089453|Adriamycin|adriamycin
740901|NCT00089453|Cyclophosphamide|cyclophosphamide
740902|NCT00089453|Etoposide|etoposide
740903|NCT00089453|Melphalan|melphalan
740904|NCT00089427|brain tumor|brain tumor
740905|NCT00089427|malignant glioma|malignant glioma
740906|NCT00089427|brain neoplasm|brain neoplasm
740907|NCT00089427|central nervous system|central nervous system
740908|NCT00089427|surgery|surgery
740909|NCT00089427|resection|resection
740910|NCT00089427|temozolomide|temozolomide
740911|NCT00089427|infusion|infusion
740912|NCT00089427|glioblastoma multiforme|glioblastoma multiforme
740913|NCT00089427|anaplastic astrocytoma|anaplastic astrocytoma
740914|NCT00089427|oligoastrocytoma|oligoastrocytoma
740915|NCT00089427|Temodar|temodar
740916|NCT00089427|radiation|radiation
740917|NCT00089427|convection-enhanced delivery|convection-enhanced delivery
740918|NCT00089427|GBM|gbm
740919|NCT00089414|Depression|depression
740920|NCT00089414|Menstrual Cycle|menstrual cycle
740921|NCT00089414|Gonadal Steroids|gonadal steroids
740922|NCT00089414|Ethinyl Estradiol|ethinyl estradiol
740923|NCT00089414|Drospirenone|drospirenone
740924|NCT00089414|Menstrually Related Mood Disorder|menstrually related mood disorder
740925|NCT00089414|MRMD|mrmd
740926|NCT00089401|recurrent colon cancer|recurrent colon cancer
740927|NCT00089401|stage IV colon cancer|stage iv colon cancer
740928|NCT00089401|recurrent rectal cancer|recurrent rectal cancer
740929|NCT00089401|stage IV rectal cancer|stage iv rectal cancer
740930|NCT00089401|liver metastases|liver metastases
740931|NCT00089323|stage IA breast cancer|stage ia breast cancer
740932|NCT00089323|stage II breast cancer|stage ii breast cancer
740933|NCT00089323|stage IIIA breast cancer|stage iiia breast cancer
740934|NCT00089323|male breast cancer|male breast cancer
740935|NCT00089323|stage IB breast cancer|stage ib breast cancer
740936|NCT00089310|stage I non-small cell lung cancer|stage i non-small cell lung cancer
740937|NCT00089297|Stage III head and neck cancer|stage iii head and neck cancer
740938|NCT00089297|Stage IV head and neck cancer|stage iv head and neck cancer
740939|NCT00089297|Cetuximab|cetuximab
740940|NCT00089297|Paclitaxel|paclitaxel
740941|NCT00089297|Carboplatin|carboplatin
740942|NCT00089258|localized unresectable neuroblastoma|localized unresectable neuroblastoma
740943|NCT00089258|disseminated neuroblastoma|disseminated neuroblastoma
740944|NCT00089258|regional neuroblastoma|regional neuroblastoma
740945|NCT00089258|stage 4S neuroblastoma|stage 4s neuroblastoma
740946|NCT00089258|recurrent neuroblastoma|recurrent neuroblastoma
740947|NCT00089245|leptomeningeal metastases|leptomeningeal metastases
740948|NCT00089245|recurrent neuroblastoma|recurrent neuroblastoma
740949|NCT00089245|disseminated neuroblastoma|disseminated neuroblastoma
740950|NCT00089245|recurrent adult brain tumor|recurrent adult brain tumor
740951|NCT00089245|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
740952|NCT00089245|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
740953|NCT00089245|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
740954|NCT00089245|recurrent osteosarcoma|recurrent osteosarcoma
740955|NCT00089245|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
740956|NCT00089245|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
740957|NCT00089245|adult medulloblastoma|adult medulloblastoma
740958|NCT00089245|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
740959|NCT00089245|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
740960|NCT00089245|metastatic osteosarcoma|metastatic osteosarcoma
740961|NCT00089245|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
740962|NCT00089245|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
740963|NCT00089245|adult rhabdomyosarcoma|adult rhabdomyosarcoma
740964|NCT00089245|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
740965|NCT00089245|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
740966|NCT00089219|stage III melanoma|stage iii melanoma
740967|NCT00089219|stage IV melanoma|stage iv melanoma
740968|NCT00089219|recurrent melanoma|recurrent melanoma
740969|NCT00089219|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
740970|NCT00089219|extraocular extension melanoma|extraocular extension melanoma
740971|NCT00089219|iris melanoma|iris melanoma
740972|NCT00089219|recurrent intraocular melanoma|recurrent intraocular melanoma
740973|NCT00089206|stage III melanoma|stage iii melanoma
740974|NCT00089206|stage IV melanoma|stage iv melanoma
740975|NCT00089206|recurrent melanoma|recurrent melanoma
740976|NCT00089206|recurrent intraocular melanoma|recurrent intraocular melanoma
740977|NCT00089206|iris melanoma|iris melanoma
740978|NCT00089206|extraocular extension melanoma|extraocular extension melanoma
740979|NCT00089206|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
740980|NCT00089193|stage II melanoma|stage ii melanoma
740981|NCT00089193|stage III melanoma|stage iii melanoma
740982|NCT00089193|stage IV melanoma|stage iv melanoma
740983|NCT00089193|recurrent melanoma|recurrent melanoma
740984|NCT00089167|primary systemic amyloidosis|primary systemic amyloidosis
740985|NCT00089141|graft versus host disease|graft versus host disease
740986|NCT00089141|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
740987|NCT00089141|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
740988|NCT00089141|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
740989|NCT00089141|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
740990|NCT00089141|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
740991|NCT00089141|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
740992|NCT00089141|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
740993|NCT00089141|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
740994|NCT00089141|chronic eosinophilic leukemia|chronic eosinophilic leukemia
740995|NCT00089141|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
740996|NCT00089141|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
740997|NCT00089141|chronic neutrophilic leukemia|chronic neutrophilic leukemia
740998|NCT00089141|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
740999|NCT00089141|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
741000|NCT00089141|disseminated neuroblastoma|disseminated neuroblastoma
741001|NCT00089141|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
741002|NCT00089141|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
741003|NCT00089141|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
741004|NCT00089141|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
741005|NCT00089141|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
741006|NCT00089141|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
741007|NCT00089141|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
741008|NCT00089141|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
741009|NCT00089141|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
741010|NCT00089141|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
741011|NCT00089141|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
741012|NCT00089141|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
741013|NCT00089141|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
741014|NCT00089141|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
741015|NCT00089141|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
741016|NCT00089141|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
741017|NCT00089141|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
741018|NCT00089141|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
741019|NCT00089141|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
741020|NCT00089141|secondary acute myeloid leukemia|secondary acute myeloid leukemia
741021|NCT00089141|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
741022|NCT00089141|splenic marginal zone lymphoma|splenic marginal zone lymphoma
741023|NCT00089141|stage I multiple myeloma|stage i multiple myeloma
741024|NCT00089141|stage II multiple myeloma|stage ii multiple myeloma
741025|NCT00089141|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
741026|NCT00089141|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
741027|NCT00089141|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
741028|NCT00089141|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
741029|NCT00089141|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
741030|NCT00089141|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
741031|NCT00089141|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
741032|NCT00089141|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
741033|NCT00089141|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
741034|NCT00089141|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
741035|NCT00089141|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
741036|NCT00089141|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
741037|NCT00089141|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
741038|NCT00089141|stage III multiple myeloma|stage iii multiple myeloma
741039|NCT00089141|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
741040|NCT00089141|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
741041|NCT00089141|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
741042|NCT00089141|stage IIIA breast cancer|stage iiia breast cancer
741043|NCT00089141|stage IIIB breast cancer|stage iiib breast cancer
741044|NCT00089141|stage IIIC breast cancer|stage iiic breast cancer
741045|NCT00089141|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
741046|NCT00089141|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
741047|NCT00089141|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
741048|NCT00089141|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
741049|NCT00089141|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
741050|NCT00089141|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
741051|NCT00089141|stage IV breast cancer|stage iv breast cancer
741052|NCT00089141|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
741053|NCT00089141|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
741054|NCT00089141|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
741055|NCT00089141|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
741056|NCT00089141|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
741057|NCT00089141|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
741058|NCT00089141|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
741059|NCT00089141|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
741060|NCT00089141|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
741061|NCT00089128|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
741062|NCT00089128|recurrent bladder cancer|recurrent bladder cancer
741063|NCT00089128|stage III bladder cancer|stage iii bladder cancer
741064|NCT00089128|stage IV bladder cancer|stage iv bladder cancer
741065|NCT00089115|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
741066|NCT00089115|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
741067|NCT00089115|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
741068|NCT00089115|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
741069|NCT00089115|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
741070|NCT00089115|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
741071|NCT00089115|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
741072|NCT00089115|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
741073|NCT00089115|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
741074|NCT00089115|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
741075|NCT00089115|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
741076|NCT00089115|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
741077|NCT00089115|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
741078|NCT00089115|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
741079|NCT00089115|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
741080|NCT00089115|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
741081|NCT00089115|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
741082|NCT00089115|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
741083|NCT00089102|recurrent renal cell cancer|recurrent renal cell cancer
741084|NCT00089102|stage III renal cell cancer|stage iii renal cell cancer
741085|NCT00089102|stage IV renal cell cancer|stage iv renal cell cancer
745072|NCT00083915|Thalidomide|thalidomide
741086|NCT00089050|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
741087|NCT00089050|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
741088|NCT00089050|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
741089|NCT00089050|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
741090|NCT00089050|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
741091|NCT00089050|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
741092|NCT00089050|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
741093|NCT00089050|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
741094|NCT00089050|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
741095|NCT00089050|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
741096|NCT00089050|adult acute basophilic leukemia|adult acute basophilic leukemia
741097|NCT00089050|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
741098|NCT00089050|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
741099|NCT00089050|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
741100|NCT00089050|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
741101|NCT00089050|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
741102|NCT00089037|graft versus host disease|graft versus host disease
741103|NCT00089037|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
741104|NCT00089037|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
741105|NCT00089037|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
741106|NCT00089037|chronic eosinophilic leukemia|chronic eosinophilic leukemia
741107|NCT00089037|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
741108|NCT00089037|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
741109|NCT00089037|chronic neutrophilic leukemia|chronic neutrophilic leukemia
741110|NCT00089037|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
741111|NCT00089037|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
741112|NCT00089037|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
741113|NCT00089037|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
741114|NCT00089037|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
741115|NCT00089037|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
741116|NCT00089037|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
741117|NCT00089037|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
741118|NCT00089037|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
741119|NCT00089037|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
741120|NCT00089037|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
741121|NCT00089037|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
741122|NCT00089037|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
741123|NCT00089037|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
741124|NCT00089037|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
741125|NCT00089037|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
741126|NCT00089037|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
741127|NCT00089037|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
741128|NCT00089037|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
741129|NCT00089037|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
741130|NCT00089037|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
741131|NCT00089037|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
741132|NCT00089037|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
741133|NCT00089037|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
741134|NCT00089037|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
741135|NCT00089037|refractory hairy cell leukemia|refractory hairy cell leukemia
741136|NCT00089037|refractory multiple myeloma|refractory multiple myeloma
741137|NCT00089037|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
741138|NCT00089037|secondary acute myeloid leukemia|secondary acute myeloid leukemia
741139|NCT00089037|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
741140|NCT00089037|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
741141|NCT00089037|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
741142|NCT00089037|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
741143|NCT00089037|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
741144|NCT00089037|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
741145|NCT00089037|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
741146|NCT00089037|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
741888|NCT00088335|Parkinson Disease|parkinson disease
741147|NCT00089037|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
741148|NCT00089037|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
741149|NCT00089037|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
741150|NCT00089037|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
741151|NCT00089037|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
741152|NCT00089037|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
741153|NCT00089037|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
741154|NCT00089037|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
741155|NCT00089037|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
741156|NCT00089037|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
741157|NCT00089037|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
741158|NCT00089037|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
741159|NCT00089037|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
741160|NCT00089037|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
741161|NCT00089037|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
741162|NCT00089037|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
741163|NCT00089037|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
741164|NCT00089037|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
741165|NCT00089037|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
741166|NCT00089037|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
741167|NCT00089037|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
741168|NCT00089037|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
741169|NCT00089037|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
741170|NCT00089037|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
741171|NCT00089037|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
741172|NCT00089037|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
741173|NCT00089037|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
741174|NCT00089037|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
741175|NCT00089037|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
741176|NCT00089037|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
741177|NCT00089037|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
741178|NCT00089037|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
741179|NCT00089037|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
741180|NCT00089037|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
741181|NCT00089037|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
741182|NCT00089037|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
741183|NCT00089037|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
741184|NCT00089037|splenic marginal zone lymphoma|splenic marginal zone lymphoma
741185|NCT00089037|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
741186|NCT00089037|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
741187|NCT00089037|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
741188|NCT00089037|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
741189|NCT00089037|stage I multiple myeloma|stage i multiple myeloma
741190|NCT00089037|stage II multiple myeloma|stage ii multiple myeloma
741191|NCT00089037|stage III multiple myeloma|stage iii multiple myeloma
741192|NCT00089037|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
741193|NCT00089037|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
741194|NCT00089037|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
741195|NCT00089024|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
741196|NCT00089024|stage II pancreatic cancer|stage ii pancreatic cancer
741197|NCT00089024|stage III pancreatic cancer|stage iii pancreatic cancer
741198|NCT00088998|male breast cancer|male breast cancer
741199|NCT00088998|recurrent breast cancer|recurrent breast cancer
741200|NCT00088998|stage IV breast cancer|stage iv breast cancer
741201|NCT00088985|recurrent breast cancer|recurrent breast cancer
741202|NCT00088985|stage IIIB breast cancer|stage iiib breast cancer
741203|NCT00088985|stage IIIC breast cancer|stage iiic breast cancer
741204|NCT00088985|stage IV breast cancer|stage iv breast cancer
741205|NCT00088972|breast cancer|breast cancer
741206|NCT00088972|breast cancer in situ|breast cancer in situ
741207|NCT00088972|lobular breast carcinoma in situ|lobular breast carcinoma in situ
741208|NCT00088972|ductal breast carcinoma|ductal breast carcinoma
741209|NCT00088946|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
741210|NCT00088946|stage 0 bladder cancer|stage 0 bladder cancer
741211|NCT00088946|stage I bladder cancer|stage i bladder cancer
741212|NCT00088907|docetaxel|docetaxel
741213|NCT00088907|gefitinib|gefitinib
741214|NCT00088907|head and neck cancer|head and neck cancer
741215|NCT00088868|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
741216|NCT00088868|anaplastic large cell lymphoma|anaplastic large cell lymphoma
741217|NCT00088868|intraocular lymphoma|intraocular lymphoma
741218|NCT00088868|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
741219|NCT00088868|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
741220|NCT00088868|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
741221|NCT00088868|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
741222|NCT00088868|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
741223|NCT00088868|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
741224|NCT00088868|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
741225|NCT00088868|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
741226|NCT00088868|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
741227|NCT00088868|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
741228|NCT00088868|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
741229|NCT00088868|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
741230|NCT00088868|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
741231|NCT00088868|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
741232|NCT00088868|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
741233|NCT00088868|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
741234|NCT00088868|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
741235|NCT00088868|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
741236|NCT00088868|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
741237|NCT00088868|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
741238|NCT00088868|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
741239|NCT00088868|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
741240|NCT00088868|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
741241|NCT00088868|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
741242|NCT00088868|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
741243|NCT00088868|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
741244|NCT00088868|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
741245|NCT00088868|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
741246|NCT00088868|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
741247|NCT00088868|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
741248|NCT00088868|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
741249|NCT00088868|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
741250|NCT00088868|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
741251|NCT00088868|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
741252|NCT00088868|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
741253|NCT00088868|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
741254|NCT00088868|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
741255|NCT00088868|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
741256|NCT00088868|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
741257|NCT00088868|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
741258|NCT00088868|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
741259|NCT00088868|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
741260|NCT00088868|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
741261|NCT00088868|small intestine lymphoma|small intestine lymphoma
741262|NCT00088868|Waldenström macroglobulinemia|waldenström macroglobulinemia
741263|NCT00088868|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
741264|NCT00088868|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
741265|NCT00088868|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
741266|NCT00088868|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
741267|NCT00088868|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
741268|NCT00088868|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
741269|NCT00088868|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
741270|NCT00088868|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
741271|NCT00088868|splenic marginal zone lymphoma|splenic marginal zone lymphoma
741272|NCT00088829|stage II breast cancer|stage ii breast cancer
741273|NCT00088829|stage IIIA breast cancer|stage iiia breast cancer
741274|NCT00088829|stage IIIB breast cancer|stage iiib breast cancer
741275|NCT00088829|stage IIIC breast cancer|stage iiic breast cancer
741276|NCT00088829|stage IV breast cancer|stage iv breast cancer
741277|NCT00088829|stage IA breast cancer|stage ia breast cancer
741278|NCT00088829|stage IB breast cancer|stage ib breast cancer
741279|NCT00088829|HER2-negative breast cancer|her2-negative breast cancer
741280|NCT00088829|HER2-positive breast cancer|her2-positive breast cancer
741281|NCT00088816|stage IV gastric cancer|stage iv gastric cancer
741282|NCT00088816|adenocarcinoma of the stomach|adenocarcinoma of the stomach
741283|NCT00088803|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
741284|NCT00088803|stage I Wilms tumor|stage i wilms tumor
741285|NCT00088803|stage II Wilms tumor|stage ii wilms tumor
741286|NCT00088803|stage III Wilms tumor|stage iii wilms tumor
741287|NCT00088803|stage IV Wilms tumor|stage iv wilms tumor
741288|NCT00088803|stage V Wilms tumor|stage v wilms tumor
741289|NCT00088790|advanced, solid, malignancies|advanced, solid, malignancies
741290|NCT00088764|Stress|stress
741291|NCT00088764|Coping|coping
741292|NCT00088764|Expressive Writing|expressive writing
741293|NCT00088764|Self-Efficacy|self-efficacy
741294|NCT00088764|Disclosure|disclosure
741295|NCT00004193|stage IV colon cancer|stage iv colon cancer
741296|NCT00004193|stage IV rectal cancer|stage iv rectal cancer
741297|NCT00004193|recurrent colon cancer|recurrent colon cancer
741298|NCT00004193|recurrent rectal cancer|recurrent rectal cancer
741299|NCT00004193|adenocarcinoma of the colon|adenocarcinoma of the colon
741300|NCT00004193|adenocarcinoma of the rectum|adenocarcinoma of the rectum
741301|NCT00004187|stage III colon cancer|stage iii colon cancer
741302|NCT00004187|stage IV colon cancer|stage iv colon cancer
741303|NCT00004187|stage III rectal cancer|stage iii rectal cancer
741304|NCT00004187|stage IV rectal cancer|stage iv rectal cancer
741305|NCT00004187|recurrent colon cancer|recurrent colon cancer
741306|NCT00004187|recurrent rectal cancer|recurrent rectal cancer
741307|NCT00004186|limited stage small cell lung cancer|limited stage small cell lung cancer
741308|NCT00004186|extensive stage small cell lung cancer|extensive stage small cell lung cancer
741309|NCT00004186|recurrent small cell lung cancer|recurrent small cell lung cancer
741310|NCT00004162|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
741311|NCT00004162|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
741312|NCT00004162|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
741313|NCT00004162|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
741314|NCT00004162|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
741315|NCT00004162|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
741316|NCT00004096|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
741317|NCT00004096|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
741318|NCT00004080|recurrent adult brain tumor|recurrent adult brain tumor
741319|NCT00004080|adult glioblastoma|adult glioblastoma
741320|NCT00004080|adult anaplastic astrocytoma|adult anaplastic astrocytoma
741321|NCT00004080|adult mixed glioma|adult mixed glioma
741322|NCT00004080|adult giant cell glioblastoma|adult giant cell glioblastoma
741323|NCT00004080|adult gliosarcoma|adult gliosarcoma
741324|NCT00004064|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
741325|NCT00004064|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
741326|NCT00004064|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
741327|NCT00004064|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
741328|NCT00004064|fallopian tube cancer|fallopian tube cancer
741329|NCT00004064|primary peritoneal cavity cancer|primary peritoneal cavity cancer
741330|NCT00004040|stage I multiple myeloma|stage i multiple myeloma
741331|NCT00004040|stage II multiple myeloma|stage ii multiple myeloma
741332|NCT00004040|stage III multiple myeloma|stage iii multiple myeloma
741333|NCT00004040|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
741334|NCT00004040|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
741335|NCT00004040|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
741336|NCT00004040|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
741337|NCT00004040|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
741338|NCT00004039|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
741339|NCT00004039|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
741340|NCT00004039|stage II adult diffuse small cleaved cell lymphoma|stage ii adult diffuse small cleaved cell lymphoma
741341|NCT00004039|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
741342|NCT00004039|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
741343|NCT00004039|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
741344|NCT00004039|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
741345|NCT00004039|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
741346|NCT00004039|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
741347|NCT00004039|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
741348|NCT00004039|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
741349|NCT00004039|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
741350|NCT00004039|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
741351|NCT00004039|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
741352|NCT00004039|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
741353|NCT00004039|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
741354|NCT00004039|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
741355|NCT00004039|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
741356|NCT00004039|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
741357|NCT00004039|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
741358|NCT00004039|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
741359|NCT00004039|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
741360|NCT00004039|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
741361|NCT00004039|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
741362|NCT00004039|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
741363|NCT00003957|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
741364|NCT00003957|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
741671|NCT00003002|stage III breast cancer|stage iii breast cancer
741365|NCT00003957|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
741366|NCT00003957|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
741367|NCT00003892|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
741368|NCT00003892|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
741369|NCT00003828|stage IV melanoma|stage iv melanoma
741370|NCT00003828|recurrent melanoma|recurrent melanoma
741371|NCT00003821|recurrent endometrial carcinoma|recurrent endometrial carcinoma
741372|NCT00003810|stage III pancreatic cancer|stage iii pancreatic cancer
741373|NCT00003810|stage IV pancreatic cancer|stage iv pancreatic cancer
741374|NCT00003810|recurrent pancreatic cancer|recurrent pancreatic cancer
741375|NCT00003810|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
741376|NCT00003798|stage II pancreatic cancer|stage ii pancreatic cancer
741377|NCT00003798|stage III pancreatic cancer|stage iii pancreatic cancer
741378|NCT00003798|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
741379|NCT00003786|stage IV colon cancer|stage iv colon cancer
741380|NCT00003786|stage IV rectal cancer|stage iv rectal cancer
741381|NCT00003786|recurrent colon cancer|recurrent colon cancer
741382|NCT00003786|recurrent rectal cancer|recurrent rectal cancer
741383|NCT00003786|adenocarcinoma of the colon|adenocarcinoma of the colon
741384|NCT00003786|adenocarcinoma of the rectum|adenocarcinoma of the rectum
741385|NCT00003784|Waldenström macroglobulinemia|waldenström macroglobulinemia
741386|NCT00003784|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
741387|NCT00003784|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
741388|NCT00003784|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
741389|NCT00003784|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
741390|NCT00003784|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
741391|NCT00003784|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
741392|NCT00003784|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
741393|NCT00003784|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
741394|NCT00003784|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
741395|NCT00003784|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
741396|NCT00003784|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
741397|NCT00003784|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
741398|NCT00003760|stage III pancreatic cancer|stage iii pancreatic cancer
741399|NCT00003760|stage IV pancreatic cancer|stage iv pancreatic cancer
741400|NCT00003760|recurrent pancreatic cancer|recurrent pancreatic cancer
741401|NCT00003760|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
741402|NCT00003708|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
741403|NCT00003681|refractory anemia|refractory anemia
741404|NCT00003681|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
741405|NCT00003681|refractory anemia with excess blasts|refractory anemia with excess blasts
741406|NCT00003681|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
741407|NCT00003681|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
741408|NCT00003681|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
741409|NCT00003681|anemia|anemia
741410|NCT00003663|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
741411|NCT00003663|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
741412|NCT00003663|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
741413|NCT00003663|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
741414|NCT00003663|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
741415|NCT00003663|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
741416|NCT00003663|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
741417|NCT00003663|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
741418|NCT00003663|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
741419|NCT00003663|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
741420|NCT00003663|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
741421|NCT00003663|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
741422|NCT00003663|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
741423|NCT00003663|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
741889|NCT00088335|PD|pd
741424|NCT00003663|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
741425|NCT00003663|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
741426|NCT00003663|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
741427|NCT00003663|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
741428|NCT00003663|splenic marginal zone lymphoma|splenic marginal zone lymphoma
741429|NCT00003662|noninvasive thymoma and thymic carcinoma|noninvasive thymoma and thymic carcinoma
741430|NCT00003662|recurrent thymoma and thymic carcinoma|recurrent thymoma and thymic carcinoma
741431|NCT00003662|refractory anemia|refractory anemia
741432|NCT00003662|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
741433|NCT00003662|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
741434|NCT00003662|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
741435|NCT00003662|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
741436|NCT00003662|graft versus host disease|graft versus host disease
741437|NCT00003662|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
741438|NCT00003661|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
741439|NCT00003661|stage 4S neuroblastoma|stage 4s neuroblastoma
741440|NCT00003661|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
741441|NCT00003661|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
741442|NCT00003661|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
741443|NCT00003661|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
741444|NCT00003661|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
741445|NCT00003661|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
741446|NCT00003661|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
741447|NCT00003661|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
741448|NCT00003661|refractory anemia with excess blasts|refractory anemia with excess blasts
741449|NCT00003661|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
741450|NCT00003661|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
741451|NCT00003661|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
741452|NCT00003661|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
741453|NCT00003661|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
741454|NCT00003661|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
741455|NCT00003661|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
741456|NCT00003661|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
741457|NCT00003661|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
741458|NCT00003661|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
741459|NCT00003661|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
741460|NCT00003661|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
741461|NCT00003661|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
741462|NCT00003661|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
741463|NCT00003661|graft versus host disease|graft versus host disease
741464|NCT00003661|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
741465|NCT00003661|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
741466|NCT00003661|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
741467|NCT00003661|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
741468|NCT00003661|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
741469|NCT00003661|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
741470|NCT00003661|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
741471|NCT00003661|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
741472|NCT00003661|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
741473|NCT00003661|splenic marginal zone lymphoma|splenic marginal zone lymphoma
741474|NCT00003661|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
741475|NCT00003605|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
741476|NCT00003605|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
741477|NCT00003605|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
741478|NCT00003605|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
741479|NCT00003605|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
741480|NCT00003605|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
741481|NCT00003605|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
741482|NCT00003605|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
741483|NCT00003605|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
741484|NCT00003605|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
741485|NCT00003605|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
741486|NCT00003605|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
745073|NCT00083915|Melphalan|melphalan
741487|NCT00003605|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
741488|NCT00003605|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
741489|NCT00003605|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
741490|NCT00003605|splenic marginal zone lymphoma|splenic marginal zone lymphoma
741491|NCT00003542|stage III renal cell cancer|stage iii renal cell cancer
741492|NCT00003542|stage IV renal cell cancer|stage iv renal cell cancer
741493|NCT00003539|stage IV breast cancer|stage iv breast cancer
741494|NCT00003539|recurrent breast cancer|recurrent breast cancer
741495|NCT00003431|stage IV colon cancer|stage iv colon cancer
741496|NCT00003431|lung metastases|lung metastases
741497|NCT00003431|liver metastases|liver metastases
741498|NCT00003424|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
741499|NCT00003424|advanced adult primary liver cancer|advanced adult primary liver cancer
741500|NCT00003424|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
741501|NCT00088673|Alzheimer Disease|alzheimer disease
741502|NCT00003416|Waldenström macroglobulinemia|waldenström macroglobulinemia
741503|NCT00003415|refractory anemia with excess blasts|refractory anemia with excess blasts
741504|NCT00003415|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
741505|NCT00003415|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
741506|NCT00003415|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
741507|NCT00003415|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
741508|NCT00003413|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
741509|NCT00003413|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
741510|NCT00003413|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
741511|NCT00088751|Frontotemporal Dementia|frontotemporal dementia
741512|NCT00088751|Alzheimer's Disease|alzheimer's disease
741513|NCT00088751|Atypical Antipsychotic|atypical antipsychotic
741514|NCT00088751|Stimulant|stimulant
741515|NCT00088751|Apathy|apathy
741516|NCT00088751|Disinhibition|disinhibition
741517|NCT00088751|Antipsychotic|antipsychotic
741518|NCT00088751|Biomarkers|biomarkers
741519|NCT00088751|Dementia|dementia
741520|NCT00088751|FTD|ftd
741521|NCT00088738|Tachykinin|tachykinin
741522|NCT00088738|Anxiety|anxiety
741523|NCT00088738|Neuroreceptor|neuroreceptor
741524|NCT00088738|Internalization|internalization
741525|NCT00088738|Carbon Dioxide|carbon dioxide
741526|NCT00088738|Healthy Volunteer|healthy volunteer
741527|NCT00088738|HV|hv
741528|NCT00088738|Panic Disorder|panic disorder
741529|NCT00088712|Behavior and Neurocognition|behavior and neurocognition
741530|NCT00088712|Functional Brian Activity|functional brian activity
741531|NCT00088712|Visual Perception|visual perception
741532|NCT00088712|Selective Attention|selective attention
741533|NCT00088712|Information Processing|information processing
741534|NCT00088712|Age Differences|age differences
741535|NCT00088712|Childhood Growth and Development|childhood growth and development
741536|NCT00088712|Cognitive Development|cognitive development
741537|NCT00088712|Brain Connectivity|brain connectivity
741538|NCT00088712|Healthy Volunteer|healthy volunteer
741539|NCT00088712|HV|hv
741540|NCT00088699|Depression|depression
741541|NCT00088699|NMDA Antagonist|nmda antagonist
741542|NCT00088699|Treatment Resistant|treatment resistant
741543|NCT00088699|Glutamatergic System|glutamatergic system
741544|NCT00088699|Bipolar Disorder|bipolar disorder
741545|NCT00088699|Major Depression|major depression
741546|NCT00088686|Preemptive Analgesia|preemptive analgesia
741547|NCT00088686|Vanilloid|vanilloid
741548|NCT00088686|Capsaicin|capsaicin
741549|NCT00088686|Acute Pain|acute pain
741550|NCT00088686|Orofacial|orofacial
741551|NCT00088686|Vanilloid Receptor (VR)|vanilloid receptor (vr)
741552|NCT00088686|Visual Analog Scale (VAS)|visual analog scale (vas)
741553|NCT00088686|Wisdom Teeth|wisdom teeth
741554|NCT00088686|Third Molar Extraction|third molar extraction
741555|NCT00088660|Metastatic|metastatic
741556|NCT00088647|advanced malignant solid tumors|advanced malignant solid tumors
741557|NCT00088647|breast cancer|breast cancer
741558|NCT00088634|Schizophrenia|schizophrenia
741559|NCT00088634|Latuda|latuda
741560|NCT00088634|Lurasidone|lurasidone
741561|NCT00088621|Schizophrenia|schizophrenia
741562|NCT00088621|Latuda|latuda
741563|NCT00088621|Lurasidone|lurasidone
741564|NCT00088595|SOM230|som230
741565|NCT00088595|Sandostatin|sandostatin
741566|NCT00088595|Carcinoid syndrome|carcinoid syndrome
741567|NCT00088582|Acromegaly|acromegaly
741568|NCT00088582|SOM230|som230
741569|NCT00088582|Sandostatin|sandostatin
741570|NCT00003358|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
741571|NCT00003358|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
741572|NCT00003358|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
741672|NCT00003002|stage IV breast cancer|stage iv breast cancer
741573|NCT00003358|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
741574|NCT00003358|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
741575|NCT00003358|fallopian tube cancer|fallopian tube cancer
741890|NCT00088309|Drug Resistance|drug resistance
741576|NCT00003358|primary peritoneal cavity cancer|primary peritoneal cavity cancer
741577|NCT00003305|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
741578|NCT00003305|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
741579|NCT00003305|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
741580|NCT00003305|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
741581|NCT00003259|stage IV prostate cancer|stage iv prostate cancer
741582|NCT00003256|adenocarcinoma of the prostate|adenocarcinoma of the prostate
741583|NCT00003256|stage IV prostate cancer|stage iv prostate cancer
741584|NCT00003214|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
741585|NCT00003214|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
741586|NCT00003213|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
741587|NCT00003213|nausea and vomiting|nausea and vomiting
741588|NCT00003182|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
741589|NCT00003182|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
741590|NCT00003182|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
741591|NCT00003182|stage III salivary gland cancer|stage iii salivary gland cancer
741592|NCT00003182|stage IV salivary gland cancer|stage iv salivary gland cancer
741593|NCT00003182|recurrent salivary gland cancer|recurrent salivary gland cancer
741594|NCT00003182|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
741595|NCT00003182|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
741596|NCT00003182|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
741597|NCT00003182|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
741598|NCT00003182|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
741599|NCT00003182|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
741600|NCT00003182|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
741601|NCT00003182|stage III laryngeal cancer|stage iii laryngeal cancer
741602|NCT00003182|stage IV laryngeal cancer|stage iv laryngeal cancer
741603|NCT00003182|recurrent laryngeal cancer|recurrent laryngeal cancer
741604|NCT00003182|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
741605|NCT00003182|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
741606|NCT00003182|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
741607|NCT00003182|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
741608|NCT00003182|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
741609|NCT00003182|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
741610|NCT00003182|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
741611|NCT00003182|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
741612|NCT00003182|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
741613|NCT00003182|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
741614|NCT00003182|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
741615|NCT00003182|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
741616|NCT00003182|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
741617|NCT00003182|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
741618|NCT00003182|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
741619|NCT00003182|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
741620|NCT00003182|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
741621|NCT00003182|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
741622|NCT00003182|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
741623|NCT00003182|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
741624|NCT00003182|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
741625|NCT00003182|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
741626|NCT00003182|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
741627|NCT00003182|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
741628|NCT00003158|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
741629|NCT00003158|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
741630|NCT00003152|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
741631|NCT00003152|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
741632|NCT00003152|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
741633|NCT00003152|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
741634|NCT00003152|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
741635|NCT00003152|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
741636|NCT00003097|basal cell carcinoma of the skin|basal cell carcinoma of the skin
741637|NCT00003097|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
741891|NCT00088309|HAART|haart
741638|NCT00003090|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
741639|NCT00003087|stage II esophageal cancer|stage ii esophageal cancer
741640|NCT00003087|stage III esophageal cancer|stage iii esophageal cancer
741641|NCT00003087|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
741642|NCT00003087|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
741643|NCT00003068|stage IV breast cancer|stage iv breast cancer
741644|NCT00003068|stage IIIA breast cancer|stage iiia breast cancer
741645|NCT00003068|recurrent breast cancer|recurrent breast cancer
741646|NCT00003068|stage IIIB breast cancer|stage iiib breast cancer
741647|NCT00003068|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
741648|NCT00088569|Frontal Lobe|frontal lobe
741649|NCT00088569|Working Memory|working memory
741650|NCT00088569|Treatment|treatment
741651|NCT00088569|Transcranial|transcranial
741652|NCT00088569|Electrical|electrical
741653|NCT00088569|Healthy Volunteer|healthy volunteer
741654|NCT00088569|HV|hv
741655|NCT00088556|Non-small cell lung cancer|non-small cell lung cancer
741656|NCT00088543|Acute myelogenous leukemia (AML)|acute myelogenous leukemia (aml)
741657|NCT00088543|Acute lymphocytic leukemia (ALL)|acute lymphocytic leukemia (all)
741658|NCT00088543|Anti-T cell antibodies|anti-t cell antibodies
741659|NCT00088543|Allogenic stem cell transplant|allogenic stem cell transplant
741660|NCT00088543|Graft vs. Host Disease (GvHD)|graft vs. host disease (gvhd)
741661|NCT00003055|stage III gastric cancer|stage iii gastric cancer
741662|NCT00003055|stage IV gastric cancer|stage iv gastric cancer
741663|NCT00003055|recurrent gastric cancer|recurrent gastric cancer
741664|NCT00003055|stage III esophageal cancer|stage iii esophageal cancer
741665|NCT00003055|stage IV esophageal cancer|stage iv esophageal cancer
741666|NCT00003055|recurrent esophageal cancer|recurrent esophageal cancer
741667|NCT00003055|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
741668|NCT00003050|stage II breast cancer|stage ii breast cancer
741669|NCT00003050|stage IIIA breast cancer|stage iiia breast cancer
741670|NCT00003050|stage IIIB breast cancer|stage iiib breast cancer
741673|NCT00003002|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
741674|NCT00003002|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
741675|NCT00003002|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
741676|NCT00003002|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
741677|NCT00003002|adenocarcinoma of the lung|adenocarcinoma of the lung
741678|NCT00003000|pain|pain
741679|NCT00002984|stage II esophageal cancer|stage ii esophageal cancer
741680|NCT00002984|stage III esophageal cancer|stage iii esophageal cancer
741681|NCT00002984|stage IV esophageal cancer|stage iv esophageal cancer
741682|NCT00002984|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
741683|NCT00002984|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
741684|NCT00002921|stage III adrenocortical carcinoma|stage iii adrenocortical carcinoma
741685|NCT00002921|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
741686|NCT00002833|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
741687|NCT00002833|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
741688|NCT00002833|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
741689|NCT00002833|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
741690|NCT00002833|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
741691|NCT00002833|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
741692|NCT00002833|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
741693|NCT00002833|refractory anemia with excess blasts|refractory anemia with excess blasts
741694|NCT00002833|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
741695|NCT00002833|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
741696|NCT00002833|graft versus host disease|graft versus host disease
741697|NCT00088530|Pixantrone|pixantrone
741698|NCT00088530|Non-Hodgkins lymphoma|non-hodgkins lymphoma
741699|NCT00002832|Decitabine|decitabine
741700|NCT00002832|Dacogen|dacogen
741701|NCT00002832|Filgrastim|filgrastim
741702|NCT00002832|G-CSF|g-csf
741703|NCT00002832|Neupogen|neupogen
741704|NCT00002832|Cyclosporine|cyclosporine
741705|NCT00002832|Sandimmune|sandimmune
741706|NCT00002832|CYA|cya
741707|NCT00002832|Cyclosporin A|cyclosporin a
741708|NCT00002832|Peripheral blood stem cells|peripheral blood stem cells
741709|NCT00002832|PBSC|pbsc
741710|NCT00002832|Allogeneic bone marrow transplantation|allogeneic bone marrow transplantation
741711|NCT00002832|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
741712|NCT00002832|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
741713|NCT00002832|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
741714|NCT00002832|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
741715|NCT00002832|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
741716|NCT00002832|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
741717|NCT00002832|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
741892|NCT00088309|Pamidronate|pamidronate
741718|NCT00002832|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
741719|NCT00002831|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
741720|NCT00002831|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
741721|NCT00002831|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
741722|NCT00002824|recurrent adult brain tumor|recurrent adult brain tumor
741723|NCT00002824|adult glioblastoma|adult glioblastoma
741724|NCT00002824|adult anaplastic astrocytoma|adult anaplastic astrocytoma
741725|NCT00002824|adult giant cell glioblastoma|adult giant cell glioblastoma
741726|NCT00002824|adult gliosarcoma|adult gliosarcoma
741727|NCT00002784|stage II breast cancer|stage ii breast cancer
741728|NCT00002784|stage IIIA breast cancer|stage iiia breast cancer
741729|NCT00002779|Waldenström macroglobulinemia|waldenström macroglobulinemia
741730|NCT00002779|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
741731|NCT00002779|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
741732|NCT00002779|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
741733|NCT00002779|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
741734|NCT00002779|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
741735|NCT00002779|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
741736|NCT00002779|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
741737|NCT00002754|recurrent adult brain tumor|recurrent adult brain tumor
741738|NCT00002754|adult glioblastoma|adult glioblastoma
741739|NCT00002754|stage IV melanoma|stage iv melanoma
741740|NCT00002754|tumors metastatic to brain|tumors metastatic to brain
741741|NCT00002754|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
741742|NCT00002754|adult anaplastic astrocytoma|adult anaplastic astrocytoma
741743|NCT00002754|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
741744|NCT00002754|adult mixed glioma|adult mixed glioma
741745|NCT00002754|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
741746|NCT00002754|adult giant cell glioblastoma|adult giant cell glioblastoma
741747|NCT00002754|adult gliosarcoma|adult gliosarcoma
741748|NCT00002753|childhood supratentorial ependymoma|childhood supratentorial ependymoma
741749|NCT00002753|recurrent childhood brain tumor|recurrent childhood brain tumor
741750|NCT00002753|recurrent adult brain tumor|recurrent adult brain tumor
741751|NCT00002753|adult glioblastoma|adult glioblastoma
741752|NCT00002753|adult anaplastic astrocytoma|adult anaplastic astrocytoma
741753|NCT00002753|adult myxopapillary ependymoma|adult myxopapillary ependymoma
741754|NCT00002753|adult anaplastic ependymoma|adult anaplastic ependymoma
741755|NCT00002753|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
741756|NCT00002753|adult mixed glioma|adult mixed glioma
741757|NCT00002753|adult ependymoblastoma|adult ependymoblastoma
741758|NCT00002753|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
741759|NCT00002753|recurrent childhood ependymoma|recurrent childhood ependymoma
741760|NCT00002753|adult giant cell glioblastoma|adult giant cell glioblastoma
741761|NCT00002753|adult gliosarcoma|adult gliosarcoma
741762|NCT00002688|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
741763|NCT00002675|intraocular retinoblastoma|intraocular retinoblastoma
741764|NCT00002665|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
741765|NCT00002665|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
741766|NCT00002665|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
741767|NCT00002665|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
741768|NCT00002665|neutropenia|neutropenia
741769|NCT00002665|thrombocytopenia|thrombocytopenia
741770|NCT00002630|refractory multiple myeloma|refractory multiple myeloma
741771|NCT00002630|stage II multiple myeloma|stage ii multiple myeloma
741772|NCT00002630|stage III multiple myeloma|stage iii multiple myeloma
741773|NCT00002627|stage II breast cancer|stage ii breast cancer
741774|NCT00002627|stage IIIA breast cancer|stage iiia breast cancer
741775|NCT00002627|stage IIIB breast cancer|stage iiib breast cancer
741776|NCT00002627|inflammatory breast cancer|inflammatory breast cancer
741777|NCT00002618|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
741778|NCT00002618|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
741779|NCT00002618|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
741780|NCT00002618|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
741781|NCT00002618|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
741782|NCT00002618|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
741783|NCT00002618|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
741784|NCT00002618|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
741785|NCT00002604|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
741786|NCT00002588|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
741787|NCT00002588|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
741788|NCT00002588|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
741789|NCT00002588|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
741893|NCT00088309|Osteopenia|osteopenia
741790|NCT00002588|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
741791|NCT00002588|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
741792|NCT00002588|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
741793|NCT00002588|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
741794|NCT00002588|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
741795|NCT00002588|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
741796|NCT00002588|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
741797|NCT00002588|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
741798|NCT00002588|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
741799|NCT00002588|secondary acute myeloid leukemia|secondary acute myeloid leukemia
741800|NCT00002588|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
741801|NCT00002588|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
741802|NCT00002572|recurrent adult brain tumor|recurrent adult brain tumor
741803|NCT00002572|adult glioblastoma|adult glioblastoma
741804|NCT00002572|adult anaplastic astrocytoma|adult anaplastic astrocytoma
741805|NCT00002572|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
741806|NCT00002572|adult mixed glioma|adult mixed glioma
741807|NCT00002572|adult giant cell glioblastoma|adult giant cell glioblastoma
741808|NCT00002572|adult gliosarcoma|adult gliosarcoma
741809|NCT00002542|stage I breast cancer|stage i breast cancer
741810|NCT00002542|stage II breast cancer|stage ii breast cancer
741811|NCT00002542|stage IIIA breast cancer|stage iiia breast cancer
741812|NCT00002535|stage III melanoma|stage iii melanoma
741813|NCT00002535|stage IV melanoma|stage iv melanoma
741814|NCT00002535|recurrent melanoma|recurrent melanoma
741815|NCT00002529|stage II breast cancer|stage ii breast cancer
741816|NCT00002529|stage IIIA breast cancer|stage iiia breast cancer
741817|NCT00088517|Biodistribution|biodistribution
741818|NCT00088517|MIRD|mird
741819|NCT00088517|Radiation Absorbed Dose|radiation absorbed dose
741820|NCT00088517|Healthy|healthy
741821|NCT00088517|Prefrontal Cortex|prefrontal cortex
741822|NCT00088517|Radiation Exposure|radiation exposure
741823|NCT00088517|PET|pet
741824|NCT00088517|Dopamine D1 Receptor|dopamine d1 receptor
741825|NCT00088517|(11C)NNC-112|(11c)nnc-112
741826|NCT00088517|Healthy Volunteer|healthy volunteer
741827|NCT00088517|HV|hv
741828|NCT00088504|Hepatitis|hepatitis
741829|NCT00088452|childhood absence epilepsy|childhood absence epilepsy
741830|NCT00088452|CAE|cae
741831|NCT00088452|petit mal epilepsy|petit mal epilepsy
741832|NCT00088452|epilepsy|epilepsy
741833|NCT00088452|seizures|seizures
741834|NCT00088452|ethosuximide|ethosuximide
741835|NCT00088452|lamotrigine|lamotrigine
741836|NCT00088452|valproic acid|valproic acid
741837|NCT00088426|Holoprosencephaly|holoprosencephaly
741838|NCT00088426|HPE|hpe
741839|NCT00088413|CEA|cea
741840|NCT00088413|Vaccine|vaccine
741841|NCT00088413|Immunotherapy|immunotherapy
741842|NCT00088413|MUC-1|muc-1
741843|NCT00088413|Cancer|cancer
741844|NCT00088413|Adenocarcinoma|adenocarcinoma
741845|NCT00088413|Metastatic Adenocarcinoma|metastatic adenocarcinoma
741846|NCT00088400|Transferrin|transferrin
741847|NCT00088400|Brain Tumor|brain tumor
741848|NCT00088400|Convection|convection
741849|NCT00088400|Immunotherapy|immunotherapy
741850|NCT00088400|Targeted Protein Toxin|targeted protein toxin
741851|NCT00088400|Glioblastoma Multiforme|glioblastoma multiforme
741852|NCT00088400|GBM|gbm
741853|NCT00088387|Tau|tau
741854|NCT00088387|T181|t181
741855|NCT00088387|T231|t231
741856|NCT00088387|Amyloid Beta|amyloid beta
741857|NCT00088387|Beta-Catenin|beta-catenin
741858|NCT00088387|Alzheimer Disease|alzheimer disease
741859|NCT00088387|AD|ad
741860|NCT00088374|Kidney Cancer|kidney cancer
741861|NCT00088374|VHL|vhl
741862|NCT00088374|17 AAG|17 aag
741863|NCT00088374|Chemotherapy|chemotherapy
741864|NCT00088374|Von Hippel Lindau Disease|von hippel lindau disease
741865|NCT00088374|Renal Tumor|renal tumor
741866|NCT00088361|Reconstruction|reconstruction
741867|NCT00088361|PET Artifacts|pet artifacts
741868|NCT00088361|PET/CT Motion Artifacts|pet/ct motion artifacts
741869|NCT00088361|Liver|liver
741870|NCT00088361|Heart|heart
741871|NCT00088361|Respiratory Motion|respiratory motion
741872|NCT00088348|Cornea|cornea
741873|NCT00088348|Conjunctiva|conjunctiva
741874|NCT00088348|Keratitis|keratitis
741875|NCT00088348|Ocular Surface|ocular surface
741876|NCT00088348|Inflammation|inflammation
741877|NCT00088348|Evaluation|evaluation
741878|NCT00088348|Screening|screening
741879|NCT00088348|Ocular Surface Disease|ocular surface disease
741880|NCT00088348|Eye|eye
741881|NCT00088348|Ocular Disease|ocular disease
741882|NCT00088348|Anterior Segment Disease|anterior segment disease
741883|NCT00088335|Parkinsonism|parkinsonism
741884|NCT00088335|Biomarker|biomarker
741885|NCT00088335|Proteomics|proteomics
741886|NCT00088335|Parkinson's Disease|parkinson's disease
741887|NCT00088335|Neurodegenerative Disorders|neurodegenerative disorders
741898|NCT00088296|Osteoarthritis|osteoarthritis
741899|NCT00088296|MS Contin|ms contin
741901|NCT00088296|Cortisol|cortisol
741902|NCT00088296|Testosterone|testosterone
741903|NCT00088296|Degenerative Joint Disease|degenerative joint disease
741904|NCT00088296|OA|oa
741905|NCT00088296|Arthritis|arthritis
741906|NCT00088296|Joint Pain|joint pain
741907|NCT00088296|Arthritic Pain|arthritic pain
741908|NCT00088296|Opioid|opioid
741909|NCT00088283|CRVO|crvo
741910|NCT00088283|Central Retinal Vein Occlusion|central retinal vein occlusion
741911|NCT00088283|RVO|rvo
741912|NCT00088283|Retinal Vein Occlusion|retinal vein occlusion
741913|NCT00005884|basal cell carcinoma of the skin|basal cell carcinoma of the skin
741914|NCT00005884|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
741915|NCT00005852|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
741916|NCT00005852|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
741917|NCT00005852|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
741918|NCT00005852|refractory multiple myeloma|refractory multiple myeloma
741919|NCT00005852|stage I multiple myeloma|stage i multiple myeloma
741920|NCT00005852|stage II multiple myeloma|stage ii multiple myeloma
741921|NCT00005852|stage III multiple myeloma|stage iii multiple myeloma
741922|NCT00005852|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
741923|NCT00005852|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
741924|NCT00005852|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
741925|NCT00005852|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
741926|NCT00005852|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
741927|NCT00005852|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
741928|NCT00005852|primary myelofibrosis|primary myelofibrosis
741929|NCT00005852|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
741930|NCT00005852|refractory hairy cell leukemia|refractory hairy cell leukemia
741931|NCT00005852|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
741932|NCT00005852|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
741933|NCT00005852|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
741934|NCT00005852|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
741935|NCT00005852|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
741936|NCT00005852|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
741937|NCT00005852|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
741938|NCT00005852|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
741939|NCT00005852|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
741940|NCT00005852|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
741941|NCT00005852|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
741942|NCT00005852|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
741943|NCT00005852|graft versus host disease|graft versus host disease
741944|NCT00005852|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
741945|NCT00005852|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
741946|NCT00005852|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
741947|NCT00005852|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
741948|NCT00005852|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
741949|NCT00005852|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
741950|NCT00005852|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
741951|NCT00005852|splenic marginal zone lymphoma|splenic marginal zone lymphoma
741952|NCT00005852|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
741953|NCT00005805|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
741954|NCT00005805|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
741955|NCT00005805|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
741956|NCT00005805|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
741957|NCT00005805|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
741958|NCT00005805|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
741959|NCT00005805|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
741960|NCT00005805|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
741961|NCT00005805|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
741962|NCT00005805|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
741963|NCT00005805|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
741964|NCT00005805|childhood Burkitt lymphoma|childhood burkitt lymphoma
741965|NCT00005805|isolated plasmacytoma of bone|isolated plasmacytoma of bone
741966|NCT00005805|extramedullary plasmacytoma|extramedullary plasmacytoma
741967|NCT00005805|refractory multiple myeloma|refractory multiple myeloma
741968|NCT00005805|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
741969|NCT00005805|Waldenström macroglobulinemia|waldenström macroglobulinemia
741970|NCT00005805|stage I multiple myeloma|stage i multiple myeloma
741971|NCT00005805|stage II multiple myeloma|stage ii multiple myeloma
741972|NCT00005805|stage III multiple myeloma|stage iii multiple myeloma
741973|NCT00005805|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
741974|NCT00005805|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
741975|NCT00005805|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
741976|NCT00005805|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
741977|NCT00005805|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
741978|NCT00005805|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
741979|NCT00005805|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
741980|NCT00005805|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
741981|NCT00005805|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
741982|NCT00005805|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
741983|NCT00005805|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
741984|NCT00005805|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
741985|NCT00005805|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
741986|NCT00005805|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
741987|NCT00005805|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
741988|NCT00005805|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
741989|NCT00005805|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
741990|NCT00005805|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
741991|NCT00005805|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
741992|NCT00005805|polycythemia vera|polycythemia vera
741993|NCT00005805|primary myelofibrosis|primary myelofibrosis
741994|NCT00005805|essential thrombocythemia|essential thrombocythemia
741995|NCT00005805|untreated hairy cell leukemia|untreated hairy cell leukemia
741996|NCT00005805|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
741997|NCT00005805|refractory hairy cell leukemia|refractory hairy cell leukemia
741998|NCT00005805|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
741999|NCT00005805|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
742000|NCT00005805|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
742001|NCT00005805|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
742002|NCT00005805|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
742003|NCT00005805|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
742004|NCT00005805|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
742005|NCT00005805|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
742006|NCT00005805|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
742007|NCT00005805|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
742008|NCT00005805|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
742009|NCT00005805|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
742010|NCT00005805|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
742011|NCT00005805|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
742012|NCT00005805|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
742013|NCT00005805|stage I adult non-Hodgkin lymphoma|stage i adult non-hodgkin lymphoma
742014|NCT00005805|stage II adult non-Hodgkin lymphoma|stage ii adult non-hodgkin lymphoma
742015|NCT00005805|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
742016|NCT00005805|stage II grade 1 follicular lymphoma|stage ii grade 1 follicular lymphoma
742017|NCT00005805|stage II grade 2 follicular lymphoma|stage ii grade 2 follicular lymphoma
742018|NCT00005805|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
742019|NCT00005805|stage II adult diffuse small cleaved cell lymphoma|stage ii adult diffuse small cleaved cell lymphoma
742020|NCT00005805|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
742021|NCT00005805|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
742022|NCT00005805|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
742023|NCT00005805|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
742024|NCT00005805|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
742025|NCT00005805|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
742026|NCT00005805|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
742027|NCT00005805|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
742028|NCT00005805|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
742029|NCT00005805|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
742030|NCT00005805|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
742031|NCT00005805|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
742032|NCT00005805|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
742033|NCT00005805|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
742034|NCT00005805|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
742648|NCT00003082|polycythemia vera|polycythemia vera
742035|NCT00005805|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
742036|NCT00005805|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
742037|NCT00005805|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
742038|NCT00005805|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
742039|NCT00005805|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
742040|NCT00005805|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
742041|NCT00005805|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
742042|NCT00005805|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
742043|NCT00005805|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
742044|NCT00005805|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
742045|NCT00005805|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
742046|NCT00005805|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
742047|NCT00005805|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
742048|NCT00005805|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
742049|NCT00005805|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
742050|NCT00005805|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
742051|NCT00005805|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
742052|NCT00005805|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
742053|NCT00005805|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
742054|NCT00005805|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
742055|NCT00005805|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
742056|NCT00005805|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
742057|NCT00005805|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
742058|NCT00005805|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
742059|NCT00005805|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
742060|NCT00005805|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
742061|NCT00005805|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
742062|NCT00005805|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
742063|NCT00005805|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
742065|NCT00005805|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
742066|NCT00005805|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
742067|NCT00005805|primary systemic amyloidosis|primary systemic amyloidosis
742068|NCT00005805|intraocular lymphoma|intraocular lymphoma
742069|NCT00005805|stage I mantle cell lymphoma|stage i mantle cell lymphoma
742070|NCT00005805|contiguous stage II adult non-Hodgkin lymphoma|contiguous stage ii adult non-hodgkin lymphoma
742071|NCT00005805|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
742072|NCT00005805|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
742073|NCT00005805|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
742074|NCT00005805|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
742075|NCT00005805|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
742076|NCT00005805|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
742077|NCT00005805|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
742078|NCT00005805|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
742079|NCT00005805|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
742080|NCT00005805|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
742081|NCT00005805|noncontiguous stage II adult non-Hodgkin lymphoma|noncontiguous stage ii adult non-hodgkin lymphoma
742082|NCT00005805|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
742083|NCT00005805|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
742084|NCT00005805|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
742085|NCT00005805|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
742086|NCT00005805|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
742087|NCT00005805|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
742088|NCT00005805|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
742089|NCT00005805|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
742090|NCT00005805|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
742091|NCT00005805|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
742092|NCT00005805|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
742093|NCT00005805|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
742094|NCT00005805|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
742095|NCT00005805|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
742096|NCT00005805|anaplastic large cell lymphoma|anaplastic large cell lymphoma
742097|NCT00005805|stage II mantle cell lymphoma|stage ii mantle cell lymphoma
742098|NCT00005805|multiple myeloma|multiple myeloma
742099|NCT00005805|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
742100|NCT00005805|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
742101|NCT00005805|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
742102|NCT00005805|stage I marginal zone lymphoma|stage i marginal zone lymphoma
742103|NCT00005805|stage II marginal zone lymphoma|stage ii marginal zone lymphoma
742104|NCT00005805|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
742105|NCT00005805|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
742106|NCT00005805|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
742107|NCT00005805|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
742108|NCT00005805|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
742109|NCT00005805|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
742110|NCT00005805|splenic marginal zone lymphoma|splenic marginal zone lymphoma
742111|NCT00005633|stage III melanoma|stage iii melanoma
742112|NCT00005633|stage IV melanoma|stage iv melanoma
742113|NCT00005633|recurrent melanoma|recurrent melanoma
742114|NCT00005624|refractory multiple myeloma|refractory multiple myeloma
742115|NCT00005624|stage II multiple myeloma|stage ii multiple myeloma
742116|NCT00005624|stage III multiple myeloma|stage iii multiple myeloma
742117|NCT00005624|plasma cell neoplasm|plasma cell neoplasm
742118|NCT00005614|stage IV breast cancer|stage iv breast cancer
742119|NCT00005614|recurrent breast cancer|recurrent breast cancer
742120|NCT00005611|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
742121|NCT00004902|refractory multiple myeloma|refractory multiple myeloma
742122|NCT00004902|stage I multiple myeloma|stage i multiple myeloma
742123|NCT00004902|stage II multiple myeloma|stage ii multiple myeloma
742124|NCT00004902|stage III multiple myeloma|stage iii multiple myeloma
742125|NCT00004901|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
742126|NCT00004901|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
742127|NCT00004901|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
742128|NCT00004901|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
742129|NCT00004901|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
742130|NCT00004901|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
742131|NCT00004901|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
742132|NCT00004901|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
742133|NCT00004901|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
742134|NCT00004901|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
742135|NCT00004901|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
742136|NCT00004901|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
742137|NCT00004901|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
742138|NCT00004901|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
742139|NCT00004901|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
742140|NCT00004901|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
742141|NCT00004901|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
742142|NCT00004901|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
742143|NCT00004901|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
742144|NCT00004901|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
742145|NCT00004901|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
742146|NCT00004901|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
742147|NCT00004901|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
742148|NCT00004901|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
742149|NCT00004897|stage I esophageal cancer|stage i esophageal cancer
742150|NCT00004897|stage II esophageal cancer|stage ii esophageal cancer
742151|NCT00004897|stage III esophageal cancer|stage iii esophageal cancer
742152|NCT00004897|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
742153|NCT00004897|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
742154|NCT00004875|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
742155|NCT00004875|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
742156|NCT00004875|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
742157|NCT00004875|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
742158|NCT00004875|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
742159|NCT00004875|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
742160|NCT00004875|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
742161|NCT00004875|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
742971|NCT00087828|Vaccinium macrocarpon|vaccinium macrocarpon
742162|NCT00004875|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
742163|NCT00004875|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
742164|NCT00004875|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
742165|NCT00004875|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
742166|NCT00004875|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
742167|NCT00004875|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
742168|NCT00004875|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
742169|NCT00004875|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
742170|NCT00004875|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
742171|NCT00004875|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
742172|NCT00004875|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
742173|NCT00004875|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
742174|NCT00004875|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
742175|NCT00004875|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
742176|NCT00004875|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
742177|NCT00004875|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
742178|NCT00004875|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
742179|NCT00004875|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
742180|NCT00004875|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
742470|NCT00003781|pain|pain
742181|NCT00004875|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
742182|NCT00004875|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
742183|NCT00004875|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
742184|NCT00004875|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
742185|NCT00004875|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
742186|NCT00004875|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
742187|NCT00004875|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
742188|NCT00004875|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
742189|NCT00004875|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
742190|NCT00004875|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
742191|NCT00004875|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
742192|NCT00004875|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
742193|NCT00004875|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
742194|NCT00004875|stage I mantle cell lymphoma|stage i mantle cell lymphoma
742195|NCT00004875|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
742196|NCT00004875|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
742197|NCT00004875|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
742198|NCT00004875|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
742199|NCT00004875|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
742200|NCT00004875|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
742201|NCT00004875|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
742202|NCT00004875|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
742203|NCT00004875|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
742204|NCT00004875|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
742205|NCT00004875|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
742206|NCT00004875|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
742207|NCT00004875|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
742208|NCT00004875|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
742209|NCT00004875|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
742210|NCT00004875|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
742211|NCT00004875|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
742212|NCT00004875|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
742213|NCT00004875|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
742214|NCT00004875|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
742215|NCT00004875|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
742216|NCT00004875|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
742217|NCT00004875|anaplastic large cell lymphoma|anaplastic large cell lymphoma
742218|NCT00004875|thromboembolism|thromboembolism
742219|NCT00004875|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
742220|NCT00004875|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
742221|NCT00004875|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
745074|NCT00083902|Myeloma|myeloma
742222|NCT00004875|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
742223|NCT00004875|stage I marginal zone lymphoma|stage i marginal zone lymphoma
742224|NCT00004875|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
742225|NCT00004875|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
742226|NCT00004875|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
742227|NCT00004875|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
742228|NCT00004875|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
742229|NCT00004875|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
742230|NCT00004875|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
742231|NCT00004875|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
742232|NCT00004875|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
742233|NCT00004875|splenic marginal zone lymphoma|splenic marginal zone lymphoma
742234|NCT00004265|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
742235|NCT00004264|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
742236|NCT00004264|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
742237|NCT00004264|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
742238|NCT00004263|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
742239|NCT00004263|refractory anemia with excess blasts|refractory anemia with excess blasts
742240|NCT00004263|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
742241|NCT00004263|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
742242|NCT00004263|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
742243|NCT00004263|Ara-C|ara-c
742244|NCT00004263|Cytosar|cytosar
742245|NCT00004263|DepoCyt|depocyt
742246|NCT00004263|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
742247|NCT00004263|cytarabine|cytarabine
742248|NCT00004263|7-hydroxystaurosporine|7-hydroxystaurosporine
742249|NCT00004263|UCN-01|ucn-01
742250|NCT00004258|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
742251|NCT00004258|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
742252|NCT00004258|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
742253|NCT00004258|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
742254|NCT00004258|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
742255|NCT00004258|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
742256|NCT00004258|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
742257|NCT00004258|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
742258|NCT00004258|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
742259|NCT00004258|isolated plasmacytoma of bone|isolated plasmacytoma of bone
742260|NCT00004258|extramedullary plasmacytoma|extramedullary plasmacytoma
742261|NCT00004258|refractory multiple myeloma|refractory multiple myeloma
742262|NCT00004258|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
742263|NCT00004258|stage III multiple myeloma|stage iii multiple myeloma
742264|NCT00004258|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
742265|NCT00004258|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
742266|NCT00004258|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
742267|NCT00004258|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
742268|NCT00004258|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
742269|NCT00004258|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
742270|NCT00004258|small intestine lymphoma|small intestine lymphoma
742271|NCT00004258|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
742272|NCT00004258|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
742273|NCT00004258|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
742274|NCT00004258|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
742275|NCT00004258|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
742276|NCT00004258|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
742277|NCT00004258|polycythemia vera|polycythemia vera
742278|NCT00004258|essential thrombocythemia|essential thrombocythemia
742279|NCT00004258|untreated hairy cell leukemia|untreated hairy cell leukemia
742280|NCT00004258|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
742281|NCT00004258|refractory hairy cell leukemia|refractory hairy cell leukemia
742282|NCT00004258|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
742283|NCT00004258|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
742284|NCT00004258|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
742285|NCT00004258|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
742286|NCT00004258|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
742287|NCT00004258|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
742288|NCT00004258|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
742289|NCT00004258|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
742290|NCT00004258|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
742291|NCT00004258|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
742292|NCT00004258|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
742293|NCT00004258|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
742294|NCT00004258|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
742295|NCT00004258|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
742296|NCT00004258|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
742297|NCT00004258|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
742298|NCT00004258|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
742299|NCT00004258|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
742300|NCT00004258|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
742301|NCT00004258|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
742302|NCT00004258|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
742303|NCT00004258|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
742304|NCT00004258|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
742305|NCT00004258|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
742306|NCT00004258|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
742307|NCT00004258|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
742308|NCT00004258|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
742309|NCT00004258|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
742310|NCT00004258|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
742311|NCT00004258|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
742312|NCT00004258|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
742313|NCT00004258|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
742314|NCT00004258|secondary acute myeloid leukemia|secondary acute myeloid leukemia
742315|NCT00004258|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
742316|NCT00004258|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
742317|NCT00004258|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
742318|NCT00004258|prolymphocytic leukemia|prolymphocytic leukemia
742319|NCT00004258|primary systemic amyloidosis|primary systemic amyloidosis
742320|NCT00004258|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
742321|NCT00004258|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
742322|NCT00004258|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
742323|NCT00004258|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
742324|NCT00004258|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
742325|NCT00004258|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
742326|NCT00004258|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
742327|NCT00004258|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
742328|NCT00004258|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
742329|NCT00004258|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
742330|NCT00004258|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
742331|NCT00004258|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
742332|NCT00004258|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
742333|NCT00004258|splenic marginal zone lymphoma|splenic marginal zone lymphoma
742334|NCT00004169|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
742335|NCT00004169|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
742336|NCT00004159|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
742337|NCT00004159|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
742338|NCT00003942|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
742339|NCT00003942|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
742340|NCT00003942|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
742341|NCT00003942|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
742342|NCT00003942|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
742343|NCT00003942|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
742344|NCT00003942|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
742345|NCT00003936|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
742346|NCT00003929|primary central nervous system lymphoma|primary central nervous system lymphoma
742347|NCT00003929|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
742348|NCT00002506|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
742349|NCT00002506|recurrent esophageal cancer|recurrent esophageal cancer
742350|NCT00002506|recurrent cervical cancer|recurrent cervical cancer
742351|NCT00002506|squamous cell lung cancer|squamous cell lung cancer
742352|NCT00002506|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
742353|NCT00002506|recurrent penile cancer|recurrent penile cancer
742354|NCT00002506|recurrent skin cancer|recurrent skin cancer
742355|NCT00002506|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
742356|NCT00002506|cervical squamous cell carcinoma|cervical squamous cell carcinoma
742357|NCT00002506|penile squamous cell carcinoma|penile squamous cell carcinoma
742358|NCT00002506|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
742359|NCT00002506|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
742360|NCT00002506|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
742361|NCT00002506|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
742362|NCT00002506|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
742363|NCT00002506|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
742364|NCT00002504|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
742365|NCT00002504|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
742366|NCT00002504|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
742367|NCT00002504|isolated plasmacytoma of bone|isolated plasmacytoma of bone
742368|NCT00002504|extramedullary plasmacytoma|extramedullary plasmacytoma
742369|NCT00002504|refractory multiple myeloma|refractory multiple myeloma
742370|NCT00002504|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
742371|NCT00002504|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
742372|NCT00002504|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
742373|NCT00002504|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
742374|NCT00002504|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
742375|NCT00002504|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
742376|NCT00002504|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
742377|NCT00002504|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
742378|NCT00002504|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
742379|NCT00002504|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
742380|NCT00002504|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
742381|NCT00002504|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
742382|NCT00002504|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
742383|NCT00002504|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
742384|NCT00002504|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
742385|NCT00002504|polycythemia vera|polycythemia vera
742386|NCT00002504|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
742387|NCT00002504|essential thrombocythemia|essential thrombocythemia
742388|NCT00002504|untreated hairy cell leukemia|untreated hairy cell leukemia
742389|NCT00002504|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
742390|NCT00002504|refractory hairy cell leukemia|refractory hairy cell leukemia
742391|NCT00002504|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
742392|NCT00002504|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
742393|NCT00002504|acute undifferentiated leukemia|acute undifferentiated leukemia
742394|NCT00002504|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
742395|NCT00002504|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
742396|NCT00002504|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
742397|NCT00002504|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
742398|NCT00002504|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
742399|NCT00002504|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
742400|NCT00002504|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
742401|NCT00002504|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
742402|NCT00002504|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
742403|NCT00002504|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
742404|NCT00002504|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
742405|NCT00002504|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
742406|NCT00002504|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
742407|NCT00002504|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
742408|NCT00002504|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
742409|NCT00002504|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
742410|NCT00002504|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
742411|NCT00002504|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
742412|NCT00002504|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
742413|NCT00002504|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
742414|NCT00002504|secondary acute myeloid leukemia|secondary acute myeloid leukemia
742415|NCT00002504|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
742416|NCT00002504|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
742417|NCT00002504|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
742418|NCT00002504|prolymphocytic leukemia|prolymphocytic leukemia
742419|NCT00002504|primary systemic amyloidosis|primary systemic amyloidosis
742420|NCT00002504|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
742421|NCT00002504|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
742422|NCT00002504|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
742423|NCT00002504|anaplastic large cell lymphoma|anaplastic large cell lymphoma
742424|NCT00002504|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
742425|NCT00002504|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
742426|NCT00002504|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
742427|NCT00002504|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
742428|NCT00002504|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
742429|NCT00002504|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
742430|NCT00002504|splenic marginal zone lymphoma|splenic marginal zone lymphoma
742431|NCT00002462|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
742432|NCT00002462|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
742433|NCT00088231|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
742434|NCT00088231|Agnogenic Myeloid Metaplasia (AMM)|agnogenic myeloid metaplasia (amm)
742435|NCT00088231|Chronic Myelogenous Leukemia-Blastic Phase (CML-BP)|chronic myelogenous leukemia-blastic phase (cml-bp)
742436|NCT00088218|Acute Myeloid Leukemia|acute myeloid leukemia
742437|NCT00088218|AML|aml
742438|NCT00088218|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
742439|NCT00088218|MDS|mds
742440|NCT00088218|Clofarabine|clofarabine
742441|NCT00088218|Cytarabine|cytarabine
742442|NCT00088218|ara-C|ara-c
742443|NCT00088179|CABG|cabg
742444|NCT00088179|CPB|cpb
742445|NCT00087997|sarcoma|sarcoma
742446|NCT00088192|AMD|amd
742447|NCT00088192|Age-Related Macular Degeneration|age-related macular degeneration
742448|NCT00088192|Exudative Subfoveal Age Related Macular Degeneration with Subfoveal Choroidal Neovascularization|exudative subfoveal age related macular degeneration with subfoveal choroidal neovascularization
742449|NCT00088166|peritumoral brain edema|peritumoral brain edema
742450|NCT00088166|edema|edema
742451|NCT00088166|malignant brain tumor|malignant brain tumor
742452|NCT00088166|astrocytoma|astrocytoma
742453|NCT00088166|brain tumor|brain tumor
742454|NCT00088166|dexamethasone|dexamethasone
742455|NCT00088166|Decadron|decadron
742456|NCT00003884|hypercalcemia of malignancy|hypercalcemia of malignancy
742457|NCT00003884|pain|pain
742458|NCT00003884|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
742459|NCT00003884|recurrent small cell lung cancer|recurrent small cell lung cancer
742460|NCT00003884|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
742461|NCT00003884|bone metastases|bone metastases
742462|NCT00003812|limited stage small cell lung cancer|limited stage small cell lung cancer
742463|NCT00003808|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
742464|NCT00003808|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
742465|NCT00003808|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
742466|NCT00003808|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
742467|NCT00003781|adenocarcinoma of the prostate|adenocarcinoma of the prostate
742468|NCT00003781|stage IV prostate cancer|stage iv prostate cancer
742469|NCT00003781|recurrent prostate cancer|recurrent prostate cancer
742471|NCT00003763|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
742472|NCT00003763|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
742473|NCT00003763|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
742474|NCT00003763|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
742475|NCT00003763|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
742476|NCT00003763|ovarian stromal cancer|ovarian stromal cancer
742477|NCT00003763|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
742478|NCT00003763|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
742479|NCT00003763|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
742480|NCT00003763|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
742481|NCT00003763|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
742482|NCT00003763|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
742483|NCT00003763|ovarian sarcoma|ovarian sarcoma
742484|NCT00003748|stage I gastric cancer|stage i gastric cancer
742485|NCT00003748|stage II gastric cancer|stage ii gastric cancer
742486|NCT00003748|stage III gastric cancer|stage iii gastric cancer
742487|NCT00003748|stage IV gastric cancer|stage iv gastric cancer
742488|NCT00003748|recurrent gastric cancer|recurrent gastric cancer
742489|NCT00003748|stage I esophageal cancer|stage i esophageal cancer
742490|NCT00003748|stage II esophageal cancer|stage ii esophageal cancer
742491|NCT00003748|stage III esophageal cancer|stage iii esophageal cancer
742492|NCT00003748|stage IV esophageal cancer|stage iv esophageal cancer
742493|NCT00003748|recurrent esophageal cancer|recurrent esophageal cancer
742494|NCT00003748|adenocarcinoma of the stomach|adenocarcinoma of the stomach
742495|NCT00003748|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
742496|NCT00003725|stage 0 bladder cancer|stage 0 bladder cancer
742497|NCT00003725|stage I bladder cancer|stage i bladder cancer
742498|NCT00003725|recurrent bladder cancer|recurrent bladder cancer
743165|NCT00003664|recurrent renal cell cancer|recurrent renal cell cancer
742499|NCT00003725|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
742500|NCT00003677|recurrent pancreatic cancer|recurrent pancreatic cancer
742501|NCT00003677|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
742502|NCT00003677|stage IV pancreatic cancer|stage iv pancreatic cancer
742503|NCT00003675|refractory anemia|refractory anemia
742504|NCT00003675|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
742505|NCT00003675|refractory anemia with excess blasts|refractory anemia with excess blasts
742506|NCT00003675|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
742507|NCT00003675|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
742508|NCT00003675|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
742509|NCT00003675|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
742510|NCT00003675|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
742511|NCT00003675|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
742512|NCT00003585|stage IV renal cell cancer|stage iv renal cell cancer
742513|NCT00003585|recurrent renal cell cancer|recurrent renal cell cancer
742514|NCT00003557|advanced adult primary liver cancer|advanced adult primary liver cancer
742515|NCT00003557|recurrent adult primary liver cancer|recurrent adult primary liver cancer
742516|NCT00003557|unresectable gallbladder cancer|unresectable gallbladder cancer
742517|NCT00003557|recurrent gallbladder cancer|recurrent gallbladder cancer
742518|NCT00003557|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
742519|NCT00003557|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
742520|NCT00003557|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
742521|NCT00003557|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
742522|NCT00003392|stage IV breast cancer|stage iv breast cancer
742523|NCT00003392|recurrent breast cancer|recurrent breast cancer
742524|NCT00003391|adenocarcinoma of the prostate|adenocarcinoma of the prostate
742525|NCT00003391|stage IV prostate cancer|stage iv prostate cancer
742526|NCT00003391|recurrent prostate cancer|recurrent prostate cancer
742527|NCT00003267|stage I cervical cancer|stage i cervical cancer
742528|NCT00003267|stage II cervical cancer|stage ii cervical cancer
742529|NCT00003267|stage I vaginal cancer|stage i vaginal cancer
742530|NCT00003267|stage II vaginal cancer|stage ii vaginal cancer
742531|NCT00003267|stage I endometrial carcinoma|stage i endometrial carcinoma
742532|NCT00003267|stage II endometrial carcinoma|stage ii endometrial carcinoma
742533|NCT00003267|infection|infection
742534|NCT00003267|perioperative/postoperative complications|perioperative/postoperative complications
742535|NCT00088153|Anorexia Nervosa|anorexia nervosa
742536|NCT00088153|Amenorrhea|amenorrhea
742537|NCT00088153|Bone Mass|bone mass
742538|NCT00088153|Growth hormone|growth hormone
742539|NCT00088101|Hematological Malignancies|hematological malignancies
742540|NCT00088101|Leukemia|leukemia
742541|NCT00088101|Lymphoma|lymphoma
742542|NCT00088101|Metastatic|metastatic
742543|NCT00088101|Unresectable solid tumors|unresectable solid tumors
742544|NCT00088075|Schizophrenia|schizophrenia
742545|NCT00088075|Risperidone|risperidone
742546|NCT00088075|Adolescents|adolescents
742547|NCT00088062|Crohn's Disease|crohn's disease
742548|NCT00003238|recurrent prostate cancer|recurrent prostate cancer
742549|NCT00003225|stage IV colon cancer|stage iv colon cancer
742550|NCT00003225|stage IV rectal cancer|stage iv rectal cancer
742551|NCT00003225|recurrent colon cancer|recurrent colon cancer
742552|NCT00003225|recurrent rectal cancer|recurrent rectal cancer
742553|NCT00088023|Solid tumors|solid tumors
742554|NCT00087984|Kidney cancer|kidney cancer
742555|NCT00087984|Renal cancer|renal cancer
742556|NCT00087958|Metastatic breast cancer|metastatic breast cancer
742557|NCT00087945|Treatment Experienced|treatment experienced
742558|NCT00087880|smoking cessation|smoking cessation
742559|NCT00087867|Multiple Myeloma|multiple myeloma
742560|NCT00087867|SCIO-469|scio-469
742561|NCT00087867|p38 MAP kinase|p38 map kinase
742562|NCT00087867|myeloma|myeloma
742563|NCT00087867|bone marrow|bone marrow
742564|NCT00005996|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
742565|NCT00005806|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
742566|NCT00005806|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
742567|NCT00005806|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
742568|NCT00005806|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
742569|NCT00005632|recurrent prostate cancer|recurrent prostate cancer
742570|NCT00005619|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
742571|NCT00005619|refractory hairy cell leukemia|refractory hairy cell leukemia
742572|NCT00005042|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
742573|NCT00005042|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
742574|NCT00005029|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
742575|NCT00005029|primary peritoneal cavity cancer|primary peritoneal cavity cancer
742576|NCT00004199|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
742577|NCT00004199|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
742578|NCT00004164|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
745075|NCT00083902|Thalidomide|thalidomide
742579|NCT00004164|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
742580|NCT00004164|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
742581|NCT00004160|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
742582|NCT00004160|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
742583|NCT00004158|refractory multiple myeloma|refractory multiple myeloma
742584|NCT00004158|stage I multiple myeloma|stage i multiple myeloma
742585|NCT00004158|stage II multiple myeloma|stage ii multiple myeloma
742586|NCT00004158|stage III multiple myeloma|stage iii multiple myeloma
742587|NCT00004104|stage III melanoma|stage iii melanoma
742588|NCT00004060|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
742589|NCT00004060|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
742590|NCT00004060|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
742591|NCT00004060|fallopian tube cancer|fallopian tube cancer
742592|NCT00004060|primary peritoneal cavity cancer|primary peritoneal cavity cancer
742593|NCT00004047|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
742594|NCT00004047|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
742595|NCT00004047|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
742596|NCT00004047|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
742597|NCT00004047|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
742598|NCT00004047|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
742599|NCT00004047|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
742600|NCT00004047|refractory anemia with excess blasts|refractory anemia with excess blasts
742601|NCT00004047|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
742602|NCT00004047|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
742603|NCT00004047|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
742604|NCT00004041|recurrent adult brain tumor|recurrent adult brain tumor
742605|NCT00004041|adult glioblastoma|adult glioblastoma
742606|NCT00004041|adult anaplastic astrocytoma|adult anaplastic astrocytoma
742607|NCT00004041|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
742608|NCT00004041|adult mixed glioma|adult mixed glioma
742609|NCT00004041|adult giant cell glioblastoma|adult giant cell glioblastoma
742610|NCT00004041|adult gliosarcoma|adult gliosarcoma
742611|NCT00003881|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
742612|NCT00003881|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
742613|NCT00003881|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
742614|NCT00003219|stage IV breast cancer|stage iv breast cancer
742615|NCT00003219|recurrent breast cancer|recurrent breast cancer
742616|NCT00003171|refractory anemia|refractory anemia
742617|NCT00003171|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
742618|NCT00003171|refractory anemia with excess blasts|refractory anemia with excess blasts
742619|NCT00003171|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
742620|NCT00003171|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
742621|NCT00003171|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
742622|NCT00003171|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
742623|NCT00003171|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
742624|NCT00003082|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
742625|NCT00003082|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
742626|NCT00003082|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
742627|NCT00003082|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
742628|NCT00003082|isolated plasmacytoma of bone|isolated plasmacytoma of bone
742629|NCT00003082|extramedullary plasmacytoma|extramedullary plasmacytoma
742630|NCT00003082|refractory multiple myeloma|refractory multiple myeloma
742631|NCT00003082|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
742632|NCT00003082|stage III multiple myeloma|stage iii multiple myeloma
742633|NCT00003082|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
742634|NCT00003082|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
742635|NCT00003082|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
742636|NCT00003082|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
742637|NCT00003082|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
742638|NCT00003082|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
742639|NCT00003082|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
742640|NCT00003082|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
742641|NCT00003082|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
742642|NCT00003082|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
742643|NCT00003082|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
742644|NCT00003082|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
742645|NCT00003082|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
742646|NCT00003082|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
742647|NCT00003082|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
742649|NCT00003082|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
742650|NCT00003082|essential thrombocythemia|essential thrombocythemia
742651|NCT00003082|untreated hairy cell leukemia|untreated hairy cell leukemia
742652|NCT00003082|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
742653|NCT00003082|refractory hairy cell leukemia|refractory hairy cell leukemia
742654|NCT00003082|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
742655|NCT00003082|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
742656|NCT00003082|acute undifferentiated leukemia|acute undifferentiated leukemia
742657|NCT00003082|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
742658|NCT00003082|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
742659|NCT00003082|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
742660|NCT00003082|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
742661|NCT00003082|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
742662|NCT00003082|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
742663|NCT00003082|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
742664|NCT00003082|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
742665|NCT00003082|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
742666|NCT00003082|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
742667|NCT00003082|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
742668|NCT00003082|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
742669|NCT00003082|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
742670|NCT00003082|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
742671|NCT00003082|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
742672|NCT00003082|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
742673|NCT00003082|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
742674|NCT00003082|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
742675|NCT00003082|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
742676|NCT00003082|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
742677|NCT00003082|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
742678|NCT00003082|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
742679|NCT00003082|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
742680|NCT00003082|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
742681|NCT00003082|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
742682|NCT00003082|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
742683|NCT00003082|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
742684|NCT00003082|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
742685|NCT00003082|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
742686|NCT00003082|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
742687|NCT00003082|secondary acute myeloid leukemia|secondary acute myeloid leukemia
742688|NCT00003082|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
742689|NCT00003082|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
742690|NCT00003082|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
742691|NCT00003082|prolymphocytic leukemia|prolymphocytic leukemia
742692|NCT00003082|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
742693|NCT00003082|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
742694|NCT00003082|primary systemic amyloidosis|primary systemic amyloidosis
742695|NCT00003082|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
742696|NCT00003082|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
742697|NCT00003082|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
742698|NCT00003082|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
742699|NCT00003082|anaplastic large cell lymphoma|anaplastic large cell lymphoma
742700|NCT00003082|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
742701|NCT00003082|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
742702|NCT00003082|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
742703|NCT00003082|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
742704|NCT00003082|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
742705|NCT00003082|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
742706|NCT00003082|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
742707|NCT00003082|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
742708|NCT00003082|splenic marginal zone lymphoma|splenic marginal zone lymphoma
742709|NCT00003057|colon cancer|colon cancer
742710|NCT00003057|rectal cancer|rectal cancer
742711|NCT00003057|diarrhea|diarrhea
742712|NCT00002998|stage IV breast cancer|stage iv breast cancer
742713|NCT00002998|recurrent breast cancer|recurrent breast cancer
742714|NCT00002994|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
742715|NCT00002956|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
742716|NCT00002956|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
742717|NCT00002956|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
742718|NCT00002956|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
742719|NCT00002956|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
742720|NCT00002956|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
742721|NCT00002956|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
742722|NCT00002956|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
742723|NCT00002956|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
742724|NCT00002956|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
742725|NCT00002956|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
742726|NCT00002956|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
742727|NCT00002956|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
742728|NCT00002956|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
742729|NCT00002956|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
742730|NCT00002956|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
742731|NCT00002956|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
742732|NCT00002956|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
742733|NCT00002956|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
742734|NCT00002956|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
742735|NCT00002956|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
742736|NCT00002956|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
742737|NCT00002956|splenic marginal zone lymphoma|splenic marginal zone lymphoma
742738|NCT00002925|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
742739|NCT00002925|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
742740|NCT00002925|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
742741|NCT00002925|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
742742|NCT00002925|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
742743|NCT00002925|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
742744|NCT00002925|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
742745|NCT00002925|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
742746|NCT00002925|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
742747|NCT00002908|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
742748|NCT00002908|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
742749|NCT00002908|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
742750|NCT00002908|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
742751|NCT00002908|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
742752|NCT00002908|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
742753|NCT00002908|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
742754|NCT00002908|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
742755|NCT00002908|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
742756|NCT00002908|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
742757|NCT00002908|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
742758|NCT00002908|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
742759|NCT00002908|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
742760|NCT00002908|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
742761|NCT00002908|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
742762|NCT00002908|splenic marginal zone lymphoma|splenic marginal zone lymphoma
742763|NCT00002907|refractory multiple myeloma|refractory multiple myeloma
742764|NCT00002862|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
742765|NCT00002862|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
742766|NCT00002862|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
742767|NCT00002862|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
742768|NCT00002862|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
742769|NCT00002862|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
742770|NCT00002862|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
742771|NCT00002862|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
742772|NCT00002862|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
742773|NCT00002862|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
742774|NCT00002862|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
742775|NCT00002862|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
742776|NCT00002862|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
742777|NCT00002862|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
757396|NCT00072644|HIV|hiv
742778|NCT00002862|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
742779|NCT00002862|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
742780|NCT00002862|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
742781|NCT00002862|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
742782|NCT00002862|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
742783|NCT00002862|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
742784|NCT00002862|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
742785|NCT00002862|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
742786|NCT00002862|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
742787|NCT00002862|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
742788|NCT00002862|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
742789|NCT00002862|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
742790|NCT00002862|anaplastic large cell lymphoma|anaplastic large cell lymphoma
742791|NCT00002862|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
742792|NCT00002862|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
742793|NCT00002862|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
742794|NCT00002862|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
742795|NCT00002862|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
742796|NCT00002862|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
742797|NCT00002862|splenic marginal zone lymphoma|splenic marginal zone lymphoma
742798|NCT00002763|stage III melanoma|stage iii melanoma
742799|NCT00002763|recurrent melanoma|recurrent melanoma
742800|NCT00002760|adenocarcinoma of the prostate|adenocarcinoma of the prostate
742801|NCT00002760|recurrent prostate cancer|recurrent prostate cancer
742802|NCT00002667|stage I non-small cell lung cancer|stage i non-small cell lung cancer
742803|NCT00002620|adult anaplastic astrocytoma|adult anaplastic astrocytoma
742804|NCT00002563|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
742805|NCT00002563|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
742806|NCT00002563|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
742807|NCT00002557|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
742808|NCT00002557|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
742809|NCT00002557|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
742810|NCT00002549|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
742811|NCT00002549|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
742812|NCT00002549|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
742813|NCT00002549|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
742814|NCT00002549|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
742815|NCT00002549|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
742816|NCT00002549|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
742817|NCT00002549|secondary acute myeloid leukemia|secondary acute myeloid leukemia
742818|NCT00002549|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
742819|NCT00002545|adult glioblastoma|adult glioblastoma
742820|NCT00002545|adult giant cell glioblastoma|adult giant cell glioblastoma
742821|NCT00002545|adult gliosarcoma|adult gliosarcoma
742822|NCT00002502|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
742823|NCT00002502|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
742824|NCT00002502|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
742825|NCT00002502|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
742826|NCT00002502|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
742827|NCT00002502|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
742828|NCT00002502|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
742829|NCT00002502|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
742830|NCT00002502|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
742831|NCT00002502|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
742832|NCT00002502|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
742833|NCT00002502|childhood Burkitt lymphoma|childhood burkitt lymphoma
742834|NCT00002502|refractory multiple myeloma|refractory multiple myeloma
742835|NCT00002502|Waldenström macroglobulinemia|waldenström macroglobulinemia
742836|NCT00002502|stage I multiple myeloma|stage i multiple myeloma
742837|NCT00002502|stage II multiple myeloma|stage ii multiple myeloma
742838|NCT00002502|stage III multiple myeloma|stage iii multiple myeloma
742839|NCT00002502|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
742840|NCT00002502|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
742841|NCT00002502|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
742842|NCT00002502|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
742843|NCT00002502|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
742844|NCT00002502|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
742845|NCT00002502|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
742846|NCT00002502|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
742847|NCT00002502|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
742848|NCT00002502|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
742849|NCT00002502|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
742850|NCT00002502|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
742851|NCT00002502|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
742852|NCT00002502|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
742853|NCT00002502|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
742854|NCT00002502|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
742855|NCT00002502|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
742856|NCT00002502|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
742857|NCT00002502|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
742858|NCT00002502|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
742859|NCT00002502|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
742860|NCT00002502|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
742861|NCT00002502|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
742862|NCT00002502|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
742863|NCT00002502|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
744050|NCT00085904|Advanced cancer|advanced cancer
742864|NCT00002502|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
742865|NCT00002502|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
742866|NCT00002502|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
742867|NCT00002502|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
742868|NCT00002502|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
742869|NCT00002502|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
742870|NCT00002502|refractory anemia|refractory anemia
742871|NCT00002502|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
742872|NCT00002502|refractory anemia with excess blasts|refractory anemia with excess blasts
742873|NCT00002502|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
742874|NCT00002502|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
742875|NCT00002502|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
742876|NCT00002502|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
742877|NCT00002502|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
742878|NCT00002502|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
742879|NCT00002502|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
742880|NCT00002502|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
742881|NCT00002502|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
742882|NCT00002502|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
742883|NCT00002502|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
742884|NCT00002502|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
742885|NCT00002502|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
742886|NCT00002502|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
742887|NCT00002502|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
742888|NCT00002502|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
742889|NCT00002502|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
742890|NCT00002502|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
742891|NCT00002502|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
742892|NCT00002502|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
742893|NCT00002502|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
742894|NCT00002502|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
742895|NCT00002502|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
742896|NCT00002502|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
742897|NCT00002502|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
742898|NCT00002502|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
742899|NCT00002502|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
742900|NCT00002502|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
742901|NCT00002502|secondary acute myeloid leukemia|secondary acute myeloid leukemia
742902|NCT00002502|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
742903|NCT00002502|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
742904|NCT00002502|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
742905|NCT00002502|intraocular lymphoma|intraocular lymphoma
742906|NCT00002502|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
742907|NCT00002502|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
742908|NCT00002502|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
742909|NCT00002502|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
742910|NCT00002502|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
742911|NCT00002502|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
742912|NCT00002502|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
742913|NCT00002502|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
742914|NCT00002502|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
742915|NCT00002502|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
742916|NCT00002502|stage I mantle cell lymphoma|stage i mantle cell lymphoma
742917|NCT00002502|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
742918|NCT00002502|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
742919|NCT00002502|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
742920|NCT00002502|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
742921|NCT00002502|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
742922|NCT00002502|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
742923|NCT00002502|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
742924|NCT00002502|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
742925|NCT00002502|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
742926|NCT00002502|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
742927|NCT00002502|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
742928|NCT00002502|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
742929|NCT00002502|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
742930|NCT00002502|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
742931|NCT00002502|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
742932|NCT00002502|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
742933|NCT00002502|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
742934|NCT00002502|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
742935|NCT00002502|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
742936|NCT00002502|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
742937|NCT00002502|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
742938|NCT00002502|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
742939|NCT00002502|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
742940|NCT00002502|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
742941|NCT00002502|anaplastic large cell lymphoma|anaplastic large cell lymphoma
742942|NCT00002502|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
742943|NCT00002502|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
742944|NCT00002502|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
742945|NCT00002502|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
742946|NCT00002502|stage I marginal zone lymphoma|stage i marginal zone lymphoma
742947|NCT00002502|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
742948|NCT00002502|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
742949|NCT00002502|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
742950|NCT00002502|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
742951|NCT00002502|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
742952|NCT00002502|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
742953|NCT00002502|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
744051|NCT00085904|IL-18|il-18
742954|NCT00002502|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
742955|NCT00002502|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
742956|NCT00002502|splenic marginal zone lymphoma|splenic marginal zone lymphoma
742957|NCT00002502|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
742958|NCT00002495|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
742959|NCT00002495|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
742960|NCT00002465|stage IV breast cancer|stage iv breast cancer
742961|NCT00002465|recurrent breast cancer|recurrent breast cancer
742962|NCT00002465|advanced malignant mesothelioma|advanced malignant mesothelioma
742963|NCT00002465|recurrent malignant mesothelioma|recurrent malignant mesothelioma
742964|NCT00002465|stage IV endometrial carcinoma|stage iv endometrial carcinoma
742965|NCT00002465|recurrent endometrial carcinoma|recurrent endometrial carcinoma
742966|NCT00087932|Complementary Therapies|complementary therapies
742967|NCT00087841|Hypnosis|hypnosis
742968|NCT00087841|Analgesia|analgesia
742969|NCT00087841|Embolization, Therapeutic|embolization, therapeutic
742970|NCT00087841|Chemoembolization, Therapeutic|chemoembolization, therapeutic
742972|NCT00087815|cognitive/functional effects|cognitive/functional effects
742973|NCT00087815|radiation toxicity|radiation toxicity
742974|NCT00087815|adult brain tumor|adult brain tumor
742975|NCT00087815|childhood brain tumor|childhood brain tumor
742976|NCT00087789|Alzheimer's Disease|alzheimer's disease
742977|NCT00087789|Gene Transfer|gene transfer
742978|NCT00087763|AMD|amd
742979|NCT00087763|Age Related Macular Degeneration|age related macular degeneration
742980|NCT00087763|Exudative Subfoveal Age Related Macular Degeneration with Subfoveal Choroidal Neovascularization|exudative subfoveal age related macular degeneration with subfoveal choroidal neovascularization
742981|NCT00082511|Lupus|lupus
742982|NCT00082511|Systemic Lupus Erythematosus|systemic lupus erythematosus
742983|NCT00082511|SLE|sle
742984|NCT00082511|Bone Loss|bone loss
742985|NCT00082511|DHEA|dhea
742986|NCT00003877|stage IV breast cancer|stage iv breast cancer
742987|NCT00003877|recurrent breast cancer|recurrent breast cancer
742988|NCT00003874|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
742989|NCT00003874|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
742990|NCT00003874|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
742991|NCT00003874|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
742992|NCT00003874|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
742993|NCT00003874|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
742994|NCT00003874|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
742995|NCT00003874|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
742996|NCT00003874|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
742997|NCT00003874|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
742998|NCT00003874|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
742999|NCT00003874|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
743000|NCT00003874|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
743001|NCT00003874|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
743002|NCT00003874|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
743003|NCT00003874|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
743004|NCT00003874|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
743005|NCT00003874|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
743006|NCT00003874|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
743007|NCT00003874|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
743008|NCT00003874|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
743009|NCT00003874|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
743010|NCT00003874|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
743011|NCT00003874|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
743012|NCT00003874|splenic marginal zone lymphoma|splenic marginal zone lymphoma
743013|NCT00003853|primary systemic amyloidosis|primary systemic amyloidosis
743014|NCT00003805|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
743015|NCT00003805|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
743016|NCT00003805|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
743017|NCT00003805|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
743018|NCT00003805|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
743019|NCT00003805|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
743020|NCT00003805|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
743021|NCT00003805|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
743022|NCT00003805|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
743023|NCT00003805|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
743024|NCT00003805|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
743025|NCT00003805|Burkitt lymphoma|burkitt lymphoma
743026|NCT00003805|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
743027|NCT00003805|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
743028|NCT00003805|stage I multiple myeloma|stage i multiple myeloma
743029|NCT00003805|stage II multiple myeloma|stage ii multiple myeloma
743030|NCT00003805|stage III multiple myeloma|stage iii multiple myeloma
743031|NCT00003805|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
743032|NCT00003805|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
743033|NCT00003805|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
743034|NCT00003805|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
743035|NCT00003805|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
743036|NCT00003805|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
743037|NCT00003805|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
743038|NCT00003805|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
743039|NCT00003805|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
743040|NCT00003805|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
743041|NCT00003805|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
743042|NCT00003805|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
743043|NCT00003805|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
743044|NCT00003805|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
743045|NCT00003805|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
743046|NCT00003805|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
743047|NCT00003805|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
743048|NCT00003805|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
743049|NCT00003805|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
743050|NCT00003805|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
743051|NCT00003805|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
744052|NCT00085904|repeat dosing|repeat dosing
743052|NCT00003805|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
743053|NCT00003805|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
743054|NCT00003805|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
743055|NCT00003805|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
743056|NCT00003805|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
743057|NCT00003805|fever, sweats, and hot flashes|fever, sweats, and hot flashes
743058|NCT00003805|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
743059|NCT00003805|refractory hairy cell leukemia|refractory hairy cell leukemia
743060|NCT00003805|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
743061|NCT00003805|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
743062|NCT00003805|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
743063|NCT00003805|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
743064|NCT00003805|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
743065|NCT00003805|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
743066|NCT00003805|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
743067|NCT00003805|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
743068|NCT00003805|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
743069|NCT00003805|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
743070|NCT00003805|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
743071|NCT00003805|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
743072|NCT00003805|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
743073|NCT00003805|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
743074|NCT00003805|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
743075|NCT00003805|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
743076|NCT00003805|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
743077|NCT00003805|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
743078|NCT00003805|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
743079|NCT00003805|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
743080|NCT00003805|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
743081|NCT00003805|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
743082|NCT00003805|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
743083|NCT00003805|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
743084|NCT00003805|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
743085|NCT00003805|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
743086|NCT00003805|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
743087|NCT00003805|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
743088|NCT00003805|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
743089|NCT00003805|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
743090|NCT00003805|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
743091|NCT00003805|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
743092|NCT00003805|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
743093|NCT00003805|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
743094|NCT00003805|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
743095|NCT00003805|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
743096|NCT00003805|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
743097|NCT00003805|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
743098|NCT00003805|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
743099|NCT00003805|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
743100|NCT00003805|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
743101|NCT00003805|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
743102|NCT00003805|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
743103|NCT00003805|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
743104|NCT00003805|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
743105|NCT00003805|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
743106|NCT00003805|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
743107|NCT00003805|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
743108|NCT00003805|infection|infection
743109|NCT00003805|bone marrow suppression|bone marrow suppression
743110|NCT00003805|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
743111|NCT00003805|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
743112|NCT00003805|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
743113|NCT00003805|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
743114|NCT00003805|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
743115|NCT00003805|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
743116|NCT00003805|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
743117|NCT00003805|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
743118|NCT00003805|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
743119|NCT00003805|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
743120|NCT00003805|stage I mantle cell lymphoma|stage i mantle cell lymphoma
743121|NCT00003805|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
743122|NCT00003805|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
743123|NCT00003805|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
743124|NCT00003805|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
743125|NCT00003805|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
743126|NCT00003805|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
743127|NCT00003805|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
743128|NCT00003805|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
743129|NCT00003805|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
743130|NCT00003805|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
743131|NCT00003805|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
743132|NCT00003805|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
743133|NCT00003805|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
743134|NCT00003805|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
743135|NCT00003805|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
743136|NCT00003805|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
743137|NCT00003805|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
743138|NCT00003805|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
743139|NCT00003805|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
743140|NCT00003805|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
743141|NCT00003805|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
743142|NCT00003805|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
743143|NCT00003805|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
743144|NCT00003805|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
743145|NCT00003805|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
743146|NCT00003805|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
743147|NCT00003805|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
743148|NCT00003805|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
743149|NCT00003805|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
743150|NCT00003805|stage I marginal zone lymphoma|stage i marginal zone lymphoma
743151|NCT00003805|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
743152|NCT00003805|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
743153|NCT00003805|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
743154|NCT00003805|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
743155|NCT00003805|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
743156|NCT00003805|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
743157|NCT00003805|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
743158|NCT00003805|splenic marginal zone lymphoma|splenic marginal zone lymphoma
743159|NCT00003805|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
743160|NCT00003804|stage I Wilms tumor|stage i wilms tumor
743161|NCT00003792|stage IV melanoma|stage iv melanoma
743162|NCT00003792|recurrent melanoma|recurrent melanoma
743163|NCT00003743|disseminated neuroblastoma|disseminated neuroblastoma
743164|NCT00003664|stage IV renal cell cancer|stage iv renal cell cancer
757702|NCT00071682|clotting|clotting
743166|NCT00003639|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
743167|NCT00003639|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
743168|NCT00003639|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
743169|NCT00003639|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
743170|NCT00003639|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
743171|NCT00003639|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
743172|NCT00003639|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
743173|NCT00003639|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
743174|NCT00003639|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
743175|NCT00003639|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
743176|NCT00003639|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
743177|NCT00003639|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
743178|NCT00003639|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
743179|NCT00003639|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
743180|NCT00003639|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
743181|NCT00003639|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
743182|NCT00003639|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
743183|NCT00003639|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
743184|NCT00003639|splenic marginal zone lymphoma|splenic marginal zone lymphoma
743185|NCT00003604|stage III renal cell cancer|stage iii renal cell cancer
743186|NCT00003604|stage IV renal cell cancer|stage iv renal cell cancer
743187|NCT00003359|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
743188|NCT00003343|stage IV prostate cancer|stage iv prostate cancer
743189|NCT00003328|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
743190|NCT00003328|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
743191|NCT00003328|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
743192|NCT00003328|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
743193|NCT00003328|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
743194|NCT00003328|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
743195|NCT00003328|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
743196|NCT00003328|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
743197|NCT00087685|Recurrent Endometrial Cancer|recurrent endometrial cancer
743198|NCT00087685|Endometrial|endometrial
743199|NCT00087685|Endometrioid|endometrioid
743200|NCT00087685|RAD001|rad001
743201|NCT00087685|Uterine Cancer|uterine cancer
743202|NCT00087672|Myelofibrosis|myelofibrosis
743203|NCT00087672|Philadelphia negative myeloproliferative disorder|philadelphia negative myeloproliferative disorder
743204|NCT00087672|CC-5013|cc-5013
743205|NCT00087672|Lenalidomide|lenalidomide
743206|NCT00087672|Revlimid|revlimid
743207|NCT00087672|Antiangiogenesis|antiangiogenesis
743208|NCT00087659|ADT, BMD, US63, H014|adt, bmd, us63, h014
743209|NCT00087555|Fibromyalgia|fibromyalgia
743210|NCT00087555|Pain|pain
743211|NCT00087542|Hallucinosis/Psychosis|hallucinosis/psychosis
743212|NCT00087529|PPMS|ppms
743213|NCT00087529|Primary progressive MS|primary progressive ms
743214|NCT00087529|Primary progressive multiple sclerosis|primary progressive multiple sclerosis
743215|NCT00087529|Rituxan|rituxan
743216|NCT00087529|MS|ms
743217|NCT00087477|Malignant Melanoma, Pivanex, Histone deacetylases inhibitor|malignant melanoma, pivanex, histone deacetylases inhibitor
743218|NCT00087464|Acute Infection|acute infection
743219|NCT00087464|Treatment Naive|treatment naive
743220|NCT00087464|Treatment Interruption|treatment interruption
743221|NCT00087451|Progressive or recurrent malignant glioma|progressive or recurrent malignant glioma
743222|NCT00086645|Autism|autism
743223|NCT00086645|Asperger Syndrome|asperger syndrome
743224|NCT00086645|Pervasive Developmental Disorder|pervasive developmental disorder
743225|NCT00086645|PDD|pdd
743226|NCT00086645|Rituals|rituals
743227|NCT00086645|Compulsions|compulsions
743228|NCT00086645|Stereotypy|stereotypy
743229|NCT00086645|Routines|routines
743230|NCT00086645|Repetitive behavior|repetitive behavior
743231|NCT00086645|SSRI|ssri
743232|NCT00086645|Serotonin|serotonin
743233|NCT00003589|recurrent small cell lung cancer|recurrent small cell lung cancer
743234|NCT00003589|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
743235|NCT00003589|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
743236|NCT00087438|stage I non-small cell lung cancer|stage i non-small cell lung cancer
743237|NCT00087438|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
743238|NCT00087438|squamous cell lung cancer|squamous cell lung cancer
743239|NCT00087438|large cell lung cancer|large cell lung cancer
743240|NCT00087438|adenocarcinoma of the lung|adenocarcinoma of the lung
743241|NCT00087438|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
743242|NCT00087425|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
743243|NCT00087425|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
744053|NCT00085904|Phase 1|phase 1
743244|NCT00087425|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
743245|NCT00087425|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
743246|NCT00087425|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
743247|NCT00087425|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
743248|NCT00087425|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
743249|NCT00087425|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
743250|NCT00087425|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
743251|NCT00087425|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
743252|NCT00087425|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
743253|NCT00087425|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
743254|NCT00087425|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
743255|NCT00087425|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
743256|NCT00087425|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
743257|NCT00087425|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
743258|NCT00087425|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
743259|NCT00087425|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
743260|NCT00087425|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
743261|NCT00087425|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
743262|NCT00087425|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
743263|NCT00087425|Waldenström macroglobulinemia|waldenström macroglobulinemia
743264|NCT00087425|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
743265|NCT00087425|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
743266|NCT00087425|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
743267|NCT00087425|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
743268|NCT00087425|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
743269|NCT00087399|breast cancer|breast cancer
743270|NCT00087399|hot flashes|hot flashes
743271|NCT00087360|colon cancer|colon cancer
743272|NCT00087360|rectal cancer|rectal cancer
743273|NCT00087347|recurrent prostate cancer|recurrent prostate cancer
743274|NCT00087347|stage I prostate cancer|stage i prostate cancer
743275|NCT00087347|stage IIB prostate cancer|stage iib prostate cancer
743276|NCT00087347|stage IIA prostate cancer|stage iia prostate cancer
743277|NCT00087347|stage III prostate cancer|stage iii prostate cancer
743278|NCT00087347|stage IV prostate cancer|stage iv prostate cancer
743279|NCT00087347|stage I breast cancer|stage i breast cancer
743280|NCT00087347|stage II breast cancer|stage ii breast cancer
743281|NCT00087347|stage IIIA breast cancer|stage iiia breast cancer
743282|NCT00087347|stage IIIB breast cancer|stage iiib breast cancer
743283|NCT00087347|stage IIIC breast cancer|stage iiic breast cancer
743284|NCT00087347|stage IV breast cancer|stage iv breast cancer
743285|NCT00087347|recurrent breast cancer|recurrent breast cancer
743286|NCT00087334|recurrent colon cancer|recurrent colon cancer
743287|NCT00087334|stage IV colon cancer|stage iv colon cancer
743288|NCT00087334|recurrent rectal cancer|recurrent rectal cancer
743289|NCT00087334|stage IV rectal cancer|stage iv rectal cancer
743290|NCT00087295|recurrent bladder cancer|recurrent bladder cancer
743291|NCT00087295|stage IV bladder cancer|stage iv bladder cancer
743292|NCT00087295|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
743293|NCT00087295|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
743294|NCT00087295|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
743295|NCT00087295|anterior urethral cancer|anterior urethral cancer
743296|NCT00087295|posterior urethral cancer|posterior urethral cancer
743297|NCT00087295|recurrent urethral cancer|recurrent urethral cancer
743298|NCT00087295|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
743299|NCT00087282|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
743300|NCT00087282|advanced adult primary liver cancer|advanced adult primary liver cancer
743301|NCT00087282|recurrent adult primary liver cancer|recurrent adult primary liver cancer
743302|NCT00087256|stage I colon cancer|stage i colon cancer
743303|NCT00087256|adenocarcinoma of the colon|adenocarcinoma of the colon
743304|NCT00087178|stage I breast cancer|stage i breast cancer
743305|NCT00087178|stage II breast cancer|stage ii breast cancer
743306|NCT00087165|adenocarcinoma of the prostate|adenocarcinoma of the prostate
743307|NCT00087165|recurrent prostate cancer|recurrent prostate cancer
743308|NCT00087152|stage IV breast cancer|stage iv breast cancer
743309|NCT00087152|recurrent breast cancer|recurrent breast cancer
743310|NCT00087126|recurrent cervical cancer|recurrent cervical cancer
743311|NCT00087126|cervical squamous cell carcinoma|cervical squamous cell carcinoma
757794|NCT00071435|HV|hv
743312|NCT00087113|cervical squamous cell carcinoma|cervical squamous cell carcinoma
743313|NCT00087113|recurrent cervical cancer|recurrent cervical cancer
743314|NCT00087113|stage III cervical cancer|stage iii cervical cancer
743315|NCT00087113|stage IVA cervical cancer|stage iva cervical cancer
743316|NCT00087113|stage IVB cervical cancer|stage ivb cervical cancer
743317|NCT00087100|recurrent endometrial carcinoma|recurrent endometrial carcinoma
743318|NCT00087100|endometrial adenocarcinoma|endometrial adenocarcinoma
743319|NCT00087100|stage III endometrial carcinoma|stage iii endometrial carcinoma
743320|NCT00087100|stage IV endometrial carcinoma|stage iv endometrial carcinoma
743321|NCT00087087|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
743322|NCT00087087|primary peritoneal cavity cancer|primary peritoneal cavity cancer
743323|NCT00087061|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
743324|NCT00087061|recurrent adult brain tumor|recurrent adult brain tumor
743325|NCT00087061|adult glioblastoma|adult glioblastoma
743326|NCT00087061|adult anaplastic astrocytoma|adult anaplastic astrocytoma
743327|NCT00087061|adult giant cell glioblastoma|adult giant cell glioblastoma
743328|NCT00087061|adult gliosarcoma|adult gliosarcoma
743329|NCT00087048|extensive stage small cell lung cancer|extensive stage small cell lung cancer
743330|NCT00087048|recurrent small cell lung cancer|recurrent small cell lung cancer
743331|NCT00087035|adenocarcinoma of the prostate|adenocarcinoma of the prostate
743332|NCT00087035|recurrent prostate cancer|recurrent prostate cancer
743333|NCT00087022|clear cell renal cell carcinoma|clear cell renal cell carcinoma
743334|NCT00087022|stage I renal cell cancer|stage i renal cell cancer
743335|NCT00087022|stage II renal cell cancer|stage ii renal cell cancer
743336|NCT00087022|stage III renal cell cancer|stage iii renal cell cancer
743337|NCT00087022|stage IV renal cell cancer|stage iv renal cell cancer
743338|NCT00087009|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
743339|NCT00087009|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
743340|NCT00087009|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
743341|NCT00087009|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
743342|NCT00087009|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
743343|NCT00087009|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
743344|NCT00087009|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
743345|NCT00087009|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
743346|NCT00086996|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
743347|NCT00086996|stage II esophageal cancer|stage ii esophageal cancer
743348|NCT00086996|stage III esophageal cancer|stage iii esophageal cancer
743349|NCT00086957|stage IV breast cancer|stage iv breast cancer
743350|NCT00086957|male breast cancer|male breast cancer
743351|NCT00086957|recurrent breast cancer|recurrent breast cancer
743352|NCT00086931|adenocarcinoma of the rectum|adenocarcinoma of the rectum
743353|NCT00086931|stage III rectal cancer|stage iii rectal cancer
743354|NCT00086931|stage II rectal cancer|stage ii rectal cancer
743355|NCT00086892|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
743356|NCT00086892|primary peritoneal cavity cancer|primary peritoneal cavity cancer
743357|NCT00086879|adult glioblastoma|adult glioblastoma
743358|NCT00086879|recurrent adult brain tumor|recurrent adult brain tumor
743359|NCT00086879|adult giant cell glioblastoma|adult giant cell glioblastoma
743360|NCT00086879|adult gliosarcoma|adult gliosarcoma
743361|NCT00086866|stage III melanoma|stage iii melanoma
743362|NCT00086866|stage IV melanoma|stage iv melanoma
743363|NCT00086866|recurrent melanoma|recurrent melanoma
743364|NCT00086801|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
743365|NCT00086801|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
743366|NCT00086775|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
743367|NCT00086775|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
743368|NCT00086762|nausea and vomiting|nausea and vomiting
743369|NCT00086762|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
743370|NCT00086762|mindfulness relaxation|mindfulness relaxation
743371|NCT00086749|breast cancer|breast cancer
743372|NCT00086749|stage I breast cancer|stage i breast cancer
743373|NCT00086749|stage II breast cancer|stage ii breast cancer
743374|NCT00086749|stage IIIA breast cancer|stage iiia breast cancer
743375|NCT00086749|stage IIIB breast cancer|stage iiib breast cancer
743376|NCT00086749|stage IIIC breast cancer|stage iiic breast cancer
743377|NCT00086736|stage I prostate cancer|stage i prostate cancer
743378|NCT00086736|stage IIB prostate cancer|stage iib prostate cancer
743379|NCT00086736|stage IIA prostate cancer|stage iia prostate cancer
743380|NCT00086736|stage III prostate cancer|stage iii prostate cancer
743381|NCT00086723|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
743382|NCT00086684|Interstitial Cystitis|interstitial cystitis
743383|NCT00086684|Urinary Bladder Pain|urinary bladder pain
743384|NCT00086658|Hypereosinophilic Syndrome Hypereosinophilia|hypereosinophilic syndrome hypereosinophilia
743385|NCT00086658|mepolizumab|mepolizumab
743386|NCT00086658|anti IL-5|anti il-5
743387|NCT00086632|oregovomab|oregovomab
743388|NCT00086632|ovarex|ovarex
743389|NCT00086632|ovarian cancer|ovarian cancer
743390|NCT00086632|ovary|ovary
743391|NCT00086632|ovarian carcinoma|ovarian carcinoma
743392|NCT00086632|front-line|front-line
743393|NCT00086606|Peanut|peanut
743394|NCT00086619|Osteoporosis|osteoporosis
743395|NCT00086619|Parathyroid hormone|parathyroid hormone
743396|NCT00086619|Teriparatide|teriparatide
743397|NCT00086619|Bone formation|bone formation
743398|NCT00086619|Bone resorption|bone resorption
743399|NCT00086593|adjunctive|adjunctive
743400|NCT00086593|atypical antipsychotics|atypical antipsychotics
743401|NCT00086593|add-on|add-on
743402|NCT00086593|Schizophrenia|schizophrenia
743403|NCT00086593|psychosis|psychosis
743404|NCT00003297|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
743405|NCT00003297|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
743406|NCT00003297|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
743407|NCT00003296|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
743408|NCT00003296|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
743409|NCT00003296|advanced adult primary liver cancer|advanced adult primary liver cancer
743410|NCT00003296|recurrent adult primary liver cancer|recurrent adult primary liver cancer
743411|NCT00003296|localized gallbladder cancer|localized gallbladder cancer
743412|NCT00003296|unresectable gallbladder cancer|unresectable gallbladder cancer
743413|NCT00003296|recurrent gallbladder cancer|recurrent gallbladder cancer
743414|NCT00003296|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
743415|NCT00003296|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
743416|NCT00003296|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
743417|NCT00003296|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
743418|NCT00003296|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
743419|NCT00003296|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
743420|NCT00003296|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
743421|NCT00003230|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
743422|NCT00003230|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
743423|NCT00003230|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
743424|NCT00003230|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
743425|NCT00003230|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
743426|NCT00003198|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
743427|NCT00003109|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
743428|NCT00086541|Chronic Hepatitis C|chronic hepatitis c
743429|NCT00086541|Liver|liver
743430|NCT00086541|Pegylated|pegylated
743431|NCT00086541|Interferon|interferon
743432|NCT00086541|Alpha|alpha
743433|NCT00086541|Ribavirin|ribavirin
743434|NCT00086541|Combination|combination
743435|NCT00086541|Nonresponder|nonresponder
743437|NCT00086541|Infergen|infergen
743438|NCT00086541|SVR|svr
743439|NCT00086528|Solid Tumors|solid tumors
743440|NCT00086411|light smokers, smoking cessation treatment programs|light smokers, smoking cessation treatment programs
743441|NCT00086385|Smoking cessation|smoking cessation
743442|NCT00086385|Tobacco|tobacco
743443|NCT00003091|stage IV renal cell cancer|stage iv renal cell cancer
743444|NCT00003091|recurrent renal cell cancer|recurrent renal cell cancer
743445|NCT00003091|stage IV melanoma|stage iv melanoma
743446|NCT00003091|recurrent melanoma|recurrent melanoma
743447|NCT00002953|stage IV breast cancer|stage iv breast cancer
743448|NCT00002922|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
743449|NCT00002922|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
743450|NCT00002922|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
743451|NCT00002922|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
743452|NCT00002922|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
743453|NCT00002922|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
743454|NCT00002922|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
743455|NCT00002922|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
743456|NCT00002922|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
743457|NCT00002922|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
743458|NCT00002922|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
743459|NCT00002922|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
743460|NCT00002863|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
743461|NCT00002863|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
743462|NCT00002863|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
743463|NCT00002863|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
743464|NCT00002863|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
743465|NCT00002863|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
743466|NCT00002863|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
743467|NCT00002863|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
743468|NCT00002863|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
743470|NCT00086567|Testing|testing
743471|NCT00086567|Gynecologic|gynecologic
743472|NCT00086567|Urine|urine
743473|NCT00086567|CA125|ca125
743474|NCT00086567|Epithelial Ovarian Cancer|epithelial ovarian cancer
743475|NCT00086567|Peritoneal Cancer|peritoneal cancer
743476|NCT00086567|Fallopian Tube Cancer|fallopian tube cancer
743477|NCT00086554|Surgery|surgery
743478|NCT00086554|Intestinal Resection|intestinal resection
743479|NCT00086554|Blood Sample|blood sample
743480|NCT00086515|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
743481|NCT00086489|metastatic melanoma|metastatic melanoma
743482|NCT00086489|multiple dose|multiple dose
743483|NCT00086463|STEP|step
743484|NCT00086463|PAH|pah
743485|NCT00086463|iloprost|iloprost
743486|NCT00086463|inhalation|inhalation
743487|NCT00086463|prostacyclin|prostacyclin
743488|NCT00002999|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
743489|NCT00002999|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
743490|NCT00086476|Gray Platelet Syndrome|gray platelet syndrome
743491|NCT00086476|Hermansky-Pudlak Syndrome|hermansky-pudlak syndrome
743492|NCT00086476|Storage Pool Deficiency|storage pool deficiency
743493|NCT00086476|Organelle Formation|organelle formation
743494|NCT00086476|Megakaryocyte Development|megakaryocyte development
743495|NCT00086476|Megakaryocytes|megakaryocytes
743496|NCT00086476|Platelets|platelets
743497|NCT00086476|Dense Granules|dense granules
743498|NCT00086476|Alpha Granules|alpha granules
743499|NCT00086476|Lysosome-related Organelles|lysosome-related organelles
743500|NCT00086476|GPS|gps
743501|NCT00086476|HPS|hps
743502|NCT00086476|Griscelli Disease|griscelli disease
743503|NCT00086476|Chediak Higashi Syndrome|chediak higashi syndrome
743504|NCT00086476|Wiskott Aldrich Syndrome|wiskott aldrich syndrome
743505|NCT00086476|Platelet|platelet
743506|NCT00086476|Congenital Bleeding Disorders|congenital bleeding disorders
743507|NCT00086476|SAC|sac
743508|NCT00086476|Vesicle|vesicle
743509|NCT00086346|Liver|liver
743510|NCT00086346|Transplant|transplant
743511|NCT00086333|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
743512|NCT00086333|Taxotere|taxotere
743513|NCT00086333|docetaxel|docetaxel
743514|NCT00086333|taxanes|taxanes
743515|NCT00086372|Acute Infection|acute infection
743516|NCT00086372|Treatment Experienced|treatment experienced
743517|NCT00086372|Treatment Naive|treatment naive
743518|NCT00086359|Treatment Naive|treatment naive
743519|NCT00086359|Perinatal Transmission|perinatal transmission
743520|NCT00086359|Mother-to-Child Transmission|mother-to-child transmission
743521|NCT00086359|MTCT|mtct
743522|NCT00086359|Treatment Experienced|treatment experienced
743523|NCT00086320|Schizophrenia|schizophrenia
743524|NCT00086320|paliperidone|paliperidone
743525|NCT00086320|Risperidone|risperidone
743526|NCT00086281|Sleep-disordered breathing|sleep-disordered breathing
743527|NCT00086281|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
743528|NCT00086268|lung cancer|lung cancer
743529|NCT00086268|ZPACT|zpact
743530|NCT00086268|US75|us75
743531|NCT00086268|Bone Metastases|bone metastases
743532|NCT00002837|stage IV breast cancer|stage iv breast cancer
743533|NCT00002837|recurrent breast cancer|recurrent breast cancer
743534|NCT00002804|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
743535|NCT00002804|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
743536|NCT00002751|leptomeningeal metastases|leptomeningeal metastases
743537|NCT00002733|stage IV renal cell cancer|stage iv renal cell cancer
743538|NCT00002733|stage IV melanoma|stage iv melanoma
743539|NCT00002733|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
743540|NCT00002705|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
743541|NCT00002705|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
743542|NCT00002705|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
743543|NCT00002704|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
743544|NCT00002704|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
743545|NCT00002704|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
743546|NCT00002704|TdT positive childhood acute lymphoblastic leukemia|tdt positive childhood acute lymphoblastic leukemia
743547|NCT00002691|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
743548|NCT00002691|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
743549|NCT00002691|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
743550|NCT00002691|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
743551|NCT00002691|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
743552|NCT00002654|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
743553|NCT00002654|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
743554|NCT00002654|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
743555|NCT00002654|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
743556|NCT00002654|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
743557|NCT00002654|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
743558|NCT00002654|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
743559|NCT00002654|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
743560|NCT00086307|Pramipexole|pramipexole
743561|NCT00086307|Escitalopran|escitalopran
743562|NCT00086307|Antidepressant|antidepressant
743563|NCT00086307|Dopaminergic Receptor Agonist|dopaminergic receptor agonist
743564|NCT00086307|Depression|depression
743565|NCT00086307|Major Depression|major depression
743566|NCT00086294|Non-Dopaminergic|non-dopaminergic
743567|NCT00086294|Dyskinesias|dyskinesias
743568|NCT00086294|Fluctuations|fluctuations
743569|NCT00086294|Inverse Agonist|inverse agonist
743570|NCT00086294|ACP-103|acp-103
743571|NCT00086294|Parkinson Disease|parkinson disease
743572|NCT00086294|PD|pd
743573|NCT00086255|cocaine dependence|cocaine dependence
743574|NCT00086216|Multiple myeloma|multiple myeloma
743575|NCT00002642|squamous cell lung cancer|squamous cell lung cancer
743576|NCT00002642|large cell lung cancer|large cell lung cancer
743577|NCT00002642|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
743578|NCT00002642|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
743579|NCT00002642|adenocarcinoma of the lung|adenocarcinoma of the lung
743580|NCT00002642|adenosquamous cell lung cancer|adenosquamous cell lung cancer
743581|NCT00002565|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
743582|NCT00002565|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
743583|NCT00002565|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
743584|NCT00002565|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
743585|NCT00002565|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
743586|NCT00002565|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
743587|NCT00002565|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
743588|NCT00002565|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
743589|NCT00002565|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
743590|NCT00002565|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
743591|NCT00002565|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
743592|NCT00002565|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
743593|NCT00002565|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
743594|NCT00002565|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
743595|NCT00002565|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
743596|NCT00002565|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
743597|NCT00002565|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
743598|NCT00002565|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
743599|NCT00002565|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
743600|NCT00002565|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
743601|NCT00002565|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
743602|NCT00002565|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
743603|NCT00002565|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
743604|NCT00002565|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
743605|NCT00086242|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
743606|NCT00086242|stage IA cervical cancer|stage ia cervical cancer
743607|NCT00086242|stage IB cervical cancer|stage ib cervical cancer
743608|NCT00086242|stage IIA cervical cancer|stage iia cervical cancer
743609|NCT00086242|stage IIB cervical cancer|stage iib cervical cancer
743610|NCT00086242|stage III cervical cancer|stage iii cervical cancer
743611|NCT00086229|Complementary Therapies|complementary therapies
743612|NCT00086190|Parkinson disease|parkinson disease
743613|NCT00086190|depression|depression
743614|NCT00086190|Parkinson's disease|parkinson's disease
743615|NCT00086190|paroxetine|paroxetine
743616|NCT00086190|venlafaxine|venlafaxine
743617|NCT00086190|antidepressant|antidepressant
743618|NCT00086177|Pregnancy,|pregnancy,
743619|NCT00086177|prevention of preterm birth,|prevention of preterm birth,
743620|NCT00086177|prevention of preterm labor,|prevention of preterm labor,
743621|NCT00086164|edifoligide|edifoligide
743622|NCT00086164|E2F Decoy|e2f decoy
743623|NCT00086164|Chronic Renal failure|chronic renal failure
743624|NCT00086164|hemodialysis|hemodialysis
743625|NCT00086164|AV Graft|av graft
743626|NCT00086164|neointimal hyperplasia|neointimal hyperplasia
743627|NCT00086138|Alzheimer's disease|alzheimer's disease
743628|NCT00086138|Depression|depression
743629|NCT00086125|Relapsed or refractory hematologic malignancies|relapsed or refractory hematologic malignancies
743630|NCT00086112|Anxiety|anxiety
743631|NCT00086112|antipsychotic|antipsychotic
743632|NCT00006041|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
743633|NCT00006041|fallopian tube cancer|fallopian tube cancer
743634|NCT00006041|primary peritoneal cavity cancer|primary peritoneal cavity cancer
743635|NCT00005975|stage I breast cancer|stage i breast cancer
743636|NCT00005975|stage II breast cancer|stage ii breast cancer
743637|NCT00005975|hot flashes|hot flashes
743638|NCT00005854|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
743639|NCT00005854|refractory multiple myeloma|refractory multiple myeloma
743640|NCT00005854|stage I multiple myeloma|stage i multiple myeloma
743641|NCT00005854|stage II multiple myeloma|stage ii multiple myeloma
743642|NCT00005854|stage III multiple myeloma|stage iii multiple myeloma
743643|NCT00005854|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
743644|NCT00005854|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
743645|NCT00005854|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
743646|NCT00005854|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
743647|NCT00005854|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
743648|NCT00005854|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
743649|NCT00005854|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
743650|NCT00005854|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
743651|NCT00005854|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
743652|NCT00005854|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
743653|NCT00005854|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
743654|NCT00005854|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
743655|NCT00005854|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
743656|NCT00005854|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
743657|NCT00005854|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
743658|NCT00005854|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
743659|NCT00005854|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
743660|NCT00005854|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
743661|NCT00005854|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
743662|NCT00005854|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
743663|NCT00005854|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
743664|NCT00005854|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
743665|NCT00005854|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
743666|NCT00005854|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
743667|NCT00005854|secondary acute myeloid leukemia|secondary acute myeloid leukemia
743668|NCT00005854|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
743669|NCT00005854|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
743670|NCT00005854|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
743671|NCT00005854|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
743672|NCT00005854|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
743673|NCT00005854|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
743674|NCT00005854|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
743675|NCT00005854|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
743676|NCT00005854|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
743677|NCT00005854|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
743678|NCT00005854|splenic marginal zone lymphoma|splenic marginal zone lymphoma
743679|NCT00005854|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
743680|NCT00002505|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
743681|NCT00002482|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
743682|NCT00005613|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
743683|NCT00005613|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
743684|NCT00005613|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
743685|NCT00005613|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
743686|NCT00005613|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
743687|NCT00005613|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
743688|NCT00005613|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
743689|NCT00005613|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
743690|NCT00005613|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
743691|NCT00005613|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
743692|NCT00005613|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
743693|NCT00005613|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
743694|NCT00005613|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
743695|NCT00005613|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
743696|NCT00005613|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
743697|NCT00005613|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
743698|NCT00005613|splenic marginal zone lymphoma|splenic marginal zone lymphoma
743699|NCT00004202|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
743700|NCT00004202|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
743701|NCT00004202|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
743702|NCT00004197|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
743703|NCT00004197|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
743704|NCT00004197|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
743705|NCT00004197|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
743706|NCT00004197|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
743707|NCT00004197|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
743708|NCT00004197|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
743709|NCT00004197|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
743710|NCT00004197|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
743711|NCT00004197|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
743712|NCT00004197|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
743713|NCT00004197|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
743714|NCT00004197|stage I mantle cell lymphoma|stage i mantle cell lymphoma
743715|NCT00004197|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
743716|NCT00004197|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
743717|NCT00004197|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
743718|NCT00004197|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
743719|NCT00004197|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
743720|NCT00004197|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
743721|NCT00004197|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
743722|NCT00004197|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
743723|NCT00004197|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
743724|NCT00004197|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
743725|NCT00004197|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
743726|NCT00004197|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
743727|NCT00004192|neutropenia|neutropenia
743728|NCT00004192|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
743729|NCT00004192|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
743730|NCT00004192|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
743731|NCT00004192|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
743732|NCT00004192|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
743733|NCT00004192|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
743734|NCT00004192|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
743735|NCT00004192|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
743736|NCT00004192|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
743737|NCT00004192|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
743738|NCT00004192|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
743739|NCT00004192|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
743740|NCT00004192|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
743741|NCT00004192|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
743742|NCT00004192|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
743743|NCT00004192|splenic marginal zone lymphoma|splenic marginal zone lymphoma
743744|NCT00003995|stage IV colon cancer|stage iv colon cancer
743745|NCT00003995|stage IV rectal cancer|stage iv rectal cancer
743746|NCT00003995|recurrent colon cancer|recurrent colon cancer
743747|NCT00003995|recurrent rectal cancer|recurrent rectal cancer
743748|NCT00003946|stage IV endometrial carcinoma|stage iv endometrial carcinoma
743749|NCT00003946|recurrent endometrial carcinoma|recurrent endometrial carcinoma
743750|NCT00086086|Symptomatic Congestive Heart Failure|symptomatic congestive heart failure
743751|NCT00086086|CHF|chf
743752|NCT00086086|Anaemia|anaemia
743753|NCT00086086|Anemia|anemia
743754|NCT00086073|Parkinson disease|parkinson disease
743755|NCT00086073|Parkinson's disease|parkinson's disease
743756|NCT00086073|PD|pd
743757|NCT00086073|genetics|genetics
743758|NCT00086073|genes|genes
743759|NCT00086073|siblings|siblings
743760|NCT00086073|family|family
743761|NCT00003762|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
743762|NCT00003762|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
757888|NCT00071149|Diagnosis|diagnosis
743763|NCT00003762|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
743764|NCT00003723|advanced malignant mesothelioma|advanced malignant mesothelioma
743765|NCT00003723|epithelial mesothelioma|epithelial mesothelioma
743766|NCT00003723|sarcomatous mesothelioma|sarcomatous mesothelioma
743767|NCT00003691|stage III endometrial carcinoma|stage iii endometrial carcinoma
743768|NCT00003691|stage IV endometrial carcinoma|stage iv endometrial carcinoma
743769|NCT00003691|recurrent endometrial carcinoma|recurrent endometrial carcinoma
743770|NCT00003667|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
743771|NCT00003667|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
743772|NCT00003667|extraosseous Ewing sarcoma/peripheral primitive neuroectodermal tumor|extraosseous ewing sarcoma/peripheral primitive neuroectodermal tumor
743773|NCT00003667|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
743774|NCT00003667|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
743775|NCT00003630|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
743776|NCT00003630|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
743777|NCT00003549|stage II neuroendocrine carcinoma of the skin|stage ii neuroendocrine carcinoma of the skin
743778|NCT00003549|stage III neuroendocrine carcinoma of the skin|stage iii neuroendocrine carcinoma of the skin
743779|NCT00003549|recurrent neuroendocrine carcinoma of the skin|recurrent neuroendocrine carcinoma of the skin
743780|NCT00003369|stage IV cervical cancer|stage iv cervical cancer
743781|NCT00003369|recurrent cervical cancer|recurrent cervical cancer
743782|NCT00003369|cervical squamous cell carcinoma|cervical squamous cell carcinoma
743783|NCT00003369|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
743784|NCT00003317|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
743785|NCT00003127|stage IV endometrial carcinoma|stage iv endometrial carcinoma
743786|NCT00003127|recurrent endometrial carcinoma|recurrent endometrial carcinoma
743787|NCT00003127|endometrial adenocarcinoma|endometrial adenocarcinoma
743788|NCT00003127|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
743789|NCT00003127|endometrial clear cell carcinoma|endometrial clear cell carcinoma
743790|NCT00086060|Internal-External Control|internal-external control
743791|NCT00086060|Magnetic Resonance Imaging|magnetic resonance imaging
743792|NCT00086060|fMRI|fmri
743793|NCT00086060|Exercise|exercise
743794|NCT00086060|Relaxation|relaxation
743795|NCT00086047|Juvenile Fibromyalgia Syndrome|juvenile fibromyalgia syndrome
743796|NCT00086047|JPFS|jpfs
743797|NCT00086047|Fibromyalgia|fibromyalgia
743798|NCT00086047|Chronic Pain|chronic pain
743799|NCT00086047|Pediatric Pain|pediatric pain
743800|NCT00086047|Juvenile Fibromyalgia|juvenile fibromyalgia
743801|NCT00086034|Lymphoma|lymphoma
743802|NCT00086034|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
743803|NCT00086034|Indolent lymphoma|indolent lymphoma
743804|NCT00086034|Relapsed lymphoma|relapsed lymphoma
743805|NCT00086034|Refractory lymphoma|refractory lymphoma
743806|NCT00086034|Motexafin gadolinium|motexafin gadolinium
743807|NCT00003078|stage III cervical cancer|stage iii cervical cancer
743808|NCT00003078|stage IIB cervical cancer|stage iib cervical cancer
743809|NCT00003078|stage IVA cervical cancer|stage iva cervical cancer
743810|NCT00003078|cervical squamous cell carcinoma|cervical squamous cell carcinoma
743811|NCT00003078|cervical adenocarcinoma|cervical adenocarcinoma
743812|NCT00003078|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
743813|NCT00002844|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
743814|NCT00002844|Cyclophosphamide|cyclophosphamide
743815|NCT00002844|Cytoxan|cytoxan
743816|NCT00002844|Neosar|neosar
743817|NCT00002844|Bone Marrow Transplantation|bone marrow transplantation
743818|NCT00002844|total body irradiation|total body irradiation
743819|NCT00002844|chronic lymphocytic leukemia|chronic lymphocytic leukemia
743820|NCT00002844|allogeneic|allogeneic
743821|NCT00002844|autologous|autologous
743822|NCT00002816|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
743823|NCT00002747|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
743824|NCT00002747|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
743825|NCT00002747|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
743826|NCT00002725|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
743827|NCT00002725|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
743828|NCT00002725|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
743829|NCT00002725|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
743830|NCT00002725|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
743831|NCT00002725|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
743832|NCT00002725|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
743833|NCT00002725|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
743834|NCT00002725|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
743835|NCT00002725|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
743836|NCT00002725|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
743837|NCT00002725|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
743838|NCT00002725|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
743839|NCT00002725|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
743840|NCT00002725|splenic marginal zone lymphoma|splenic marginal zone lymphoma
743841|NCT00086021|Headache|headache
743842|NCT00086021|Acupuncture|acupuncture
743843|NCT00085969|diabetes|diabetes
743844|NCT00085969|exenatide|exenatide
743845|NCT00085969|Amylin|amylin
743846|NCT00085969|Lilly|lilly
743847|NCT00006241|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
743848|NCT00006241|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
743849|NCT00006241|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
743850|NCT00006241|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
743851|NCT00006241|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
743852|NCT00006241|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
743853|NCT00006241|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
743854|NCT00006241|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
743855|NCT00006241|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
743856|NCT00006241|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
743857|NCT00006241|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
743858|NCT00006241|splenic marginal zone lymphoma|splenic marginal zone lymphoma
743859|NCT00006235|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
743860|NCT00006235|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
743861|NCT00006235|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
744054|NCT00085904|pharmacokinetics|pharmacokinetics
743862|NCT00006235|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
743863|NCT00006235|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
743864|NCT00006235|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
743865|NCT00006235|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
743866|NCT00006235|fallopian tube cancer|fallopian tube cancer
743867|NCT00006235|primary peritoneal cavity cancer|primary peritoneal cavity cancer
743868|NCT00006235|Brenner tumor|brenner tumor
743869|NCT00006214|prostate cancer|prostate cancer
743870|NCT00006117|stage III pancreatic cancer|stage iii pancreatic cancer
743871|NCT00006117|stage IV pancreatic cancer|stage iv pancreatic cancer
743872|NCT00006117|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
743873|NCT00006116|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
743874|NCT00006116|squamous cell lung cancer|squamous cell lung cancer
743875|NCT00006116|large cell lung cancer|large cell lung cancer
743876|NCT00006116|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
743877|NCT00006116|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
743878|NCT00006116|adenocarcinoma of the lung|adenocarcinoma of the lung
743879|NCT00006088|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
743880|NCT00002717|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
743881|NCT00002717|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
743882|NCT00002717|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
743883|NCT00002717|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
743884|NCT00002717|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
743885|NCT00002717|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
743886|NCT00002717|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
743887|NCT00002717|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
743888|NCT00002717|primary peritoneal cavity cancer|primary peritoneal cavity cancer
743889|NCT00002717|Brenner tumor|brenner tumor
743890|NCT00002657|isolated plasmacytoma of bone|isolated plasmacytoma of bone
743891|NCT00002657|extramedullary plasmacytoma|extramedullary plasmacytoma
743892|NCT00002657|refractory multiple myeloma|refractory multiple myeloma
743893|NCT00002657|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
743894|NCT00002657|stage I multiple myeloma|stage i multiple myeloma
743895|NCT00002657|stage II multiple myeloma|stage ii multiple myeloma
743896|NCT00002657|stage III multiple myeloma|stage iii multiple myeloma
743897|NCT00002657|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
743898|NCT00002657|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
743899|NCT00002657|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
743900|NCT00002657|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
743901|NCT00002657|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
743902|NCT00002657|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
743903|NCT00002657|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
743904|NCT00002657|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
743905|NCT00002657|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
743906|NCT00002657|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
758558|NCT00069719|POAG|poag
743907|NCT00002657|stage II grade 1 follicular lymphoma|stage ii grade 1 follicular lymphoma
743908|NCT00002657|stage II grade 2 follicular lymphoma|stage ii grade 2 follicular lymphoma
743909|NCT00002657|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
743910|NCT00002657|stage II adult diffuse small cleaved cell lymphoma|stage ii adult diffuse small cleaved cell lymphoma
743911|NCT00002657|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
743912|NCT00002657|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
743913|NCT00002657|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
743914|NCT00002657|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
743915|NCT00002657|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
743916|NCT00002657|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
743917|NCT00002657|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
743918|NCT00002657|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
743919|NCT00002657|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
743920|NCT00002657|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
743921|NCT00002657|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
743922|NCT00002657|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
743923|NCT00002657|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
743924|NCT00002657|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
743925|NCT00002657|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
743926|NCT00002657|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
743927|NCT00002657|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
743928|NCT00002657|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
743929|NCT00002657|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
743930|NCT00002657|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
743931|NCT00002657|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
743932|NCT00002657|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
743933|NCT00002657|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
743934|NCT00002657|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
743935|NCT00002657|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
743936|NCT00002657|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
743937|NCT00002657|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
743938|NCT00002657|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
743939|NCT00002657|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
743940|NCT00002657|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
743941|NCT00002657|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
743942|NCT00002657|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
743943|NCT00002657|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
743944|NCT00002657|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
743945|NCT00002657|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
743946|NCT00002657|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
743947|NCT00002657|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
743948|NCT00002657|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
743949|NCT00002657|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
743950|NCT00002657|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
743951|NCT00002657|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
743952|NCT00002657|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
743953|NCT00002657|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
743954|NCT00002657|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
743955|NCT00002657|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
743956|NCT00002657|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
743957|NCT00002657|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
743958|NCT00002657|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
743959|NCT00002657|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
743960|NCT00002657|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
743961|NCT00002657|stage I marginal zone lymphoma|stage i marginal zone lymphoma
743962|NCT00002657|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
743963|NCT00002657|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
743964|NCT00002657|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
743965|NCT00002657|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
744033|NCT00005993|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
743966|NCT00002657|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
743967|NCT00002657|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
743968|NCT00002657|splenic marginal zone lymphoma|splenic marginal zone lymphoma
743969|NCT00085995|Syndesmophyte|syndesmophyte
743970|NCT00085995|Ankylosing Spondylitis|ankylosing spondylitis
743971|NCT00085995|AS|as
743972|NCT00085995|Spondyloarthropathy|spondyloarthropathy
743973|NCT00085995|Spondyloarthritis|spondyloarthritis
743974|NCT00085982|Rabson Mendenhall|rabson mendenhall
743975|NCT00085982|Type B Insulin Resistance|type b insulin resistance
743976|NCT00085982|Type A Insulin Resistance|type a insulin resistance
743977|NCT00085982|Diabetes|diabetes
743978|NCT00085943|ritonavir|ritonavir
743979|NCT00085943|abacavir|abacavir
743980|NCT00085943|HIV|hiv
743981|NCT00085943|lopinavir|lopinavir
743982|NCT00085943|lamivudine|lamivudine
743983|NCT00085943|fosamprenavir|fosamprenavir
743984|NCT00085943|Epzicom|epzicom
743985|NCT00085930|Neuroblastoma|neuroblastoma
743986|NCT00006035|stage III melanoma|stage iii melanoma
743987|NCT00006035|stage IV melanoma|stage iv melanoma
743988|NCT00006035|recurrent melanoma|recurrent melanoma
743989|NCT00006033|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
743990|NCT00006033|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
743991|NCT00006033|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
743992|NCT00006033|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
743993|NCT00006033|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
743994|NCT00006033|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
743995|NCT00006033|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
743996|NCT00006033|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
743997|NCT00006033|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
743998|NCT00006033|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
743999|NCT00006033|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
744000|NCT00006033|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
744001|NCT00006033|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
744002|NCT00006033|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
744003|NCT00006033|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
744004|NCT00006033|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
744005|NCT00006033|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
744006|NCT00006033|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
744007|NCT00006033|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
744008|NCT00005993|stage IV breast cancer|stage iv breast cancer
744009|NCT00005993|stage IIIA breast cancer|stage iiia breast cancer
744010|NCT00005993|recurrent breast cancer|recurrent breast cancer
744011|NCT00005993|stage IIIB breast cancer|stage iiib breast cancer
744012|NCT00005993|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
744013|NCT00005993|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
744014|NCT00005993|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
744015|NCT00005993|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
744016|NCT00005993|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
744017|NCT00005993|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
744018|NCT00005993|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
744019|NCT00005993|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
744020|NCT00005993|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
744021|NCT00005993|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
744022|NCT00005993|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
744023|NCT00005993|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
744024|NCT00005993|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
744025|NCT00005993|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
744026|NCT00005993|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
744027|NCT00005993|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
744028|NCT00005993|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
744029|NCT00005993|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
744030|NCT00005993|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
744031|NCT00005993|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
744032|NCT00005993|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
744034|NCT00005993|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
744035|NCT00005993|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
744036|NCT00005993|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
744037|NCT00005993|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
744038|NCT00005993|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
744039|NCT00005993|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
744040|NCT00005993|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
744041|NCT00005993|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
744042|NCT00005993|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
744043|NCT00005993|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
744044|NCT00005993|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
744045|NCT00005993|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
744046|NCT00005993|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
744047|NCT00005993|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
744048|NCT00005993|splenic marginal zone lymphoma|splenic marginal zone lymphoma
744049|NCT00005968|stage IV melanoma|stage iv melanoma
744055|NCT00085904|oncology|oncology
744056|NCT00085891|Schizophrenia|schizophrenia
744057|NCT00085891|Schizophrenic disorder|schizophrenic disorder
744058|NCT00085878|IL-18|il-18
744059|NCT00085878|subcutaneous|subcutaneous
744060|NCT00085878|pharmacokinetics|pharmacokinetics
744061|NCT00085878|Phase 1|phase 1
744062|NCT00005829|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
744063|NCT00005829|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
744064|NCT00005826|adult glioblastoma|adult glioblastoma
744065|NCT00005826|adult giant cell glioblastoma|adult giant cell glioblastoma
744066|NCT00005826|adult gliosarcoma|adult gliosarcoma
744067|NCT00005616|stage I colon cancer|stage i colon cancer
744068|NCT00005616|stage II colon cancer|stage ii colon cancer
744069|NCT00005616|stage III colon cancer|stage iii colon cancer
744070|NCT00005616|stage IV colon cancer|stage iv colon cancer
744071|NCT00005616|stage I rectal cancer|stage i rectal cancer
744072|NCT00005616|stage II rectal cancer|stage ii rectal cancer
744073|NCT00005616|stage III rectal cancer|stage iii rectal cancer
744074|NCT00005616|stage IV rectal cancer|stage iv rectal cancer
744075|NCT00005616|recurrent colon cancer|recurrent colon cancer
744076|NCT00005616|recurrent rectal cancer|recurrent rectal cancer
744077|NCT00005616|liver metastases|liver metastases
744078|NCT00005093|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
744079|NCT00005093|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
744080|NCT00005093|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
744081|NCT00005093|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
744082|NCT00005073|stage I prostate cancer|stage i prostate cancer
744083|NCT00005073|stage IIB prostate cancer|stage iib prostate cancer
744084|NCT00005073|stage IIA prostate cancer|stage iia prostate cancer
744085|NCT00005073|stage III prostate cancer|stage iii prostate cancer
744086|NCT00005073|recurrent prostate cancer|recurrent prostate cancer
744087|NCT00005048|adenocarcinoma of the prostate|adenocarcinoma of the prostate
744088|NCT00005048|recurrent prostate cancer|recurrent prostate cancer
744089|NCT00005041|extensive stage small cell lung cancer|extensive stage small cell lung cancer
744090|NCT00005041|recurrent small cell lung cancer|recurrent small cell lung cancer
744091|NCT00004929|recurrent prostate cancer|recurrent prostate cancer
744092|NCT00004861|stage II pancreatic cancer|stage ii pancreatic cancer
744093|NCT00004861|stage III pancreatic cancer|stage iii pancreatic cancer
744094|NCT00004861|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
744095|NCT00004861|stage IV pancreatic cancer|stage iv pancreatic cancer
744096|NCT00004260|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
744097|NCT00004260|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
744098|NCT00004260|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
744099|NCT00004260|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
744100|NCT00004260|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
744101|NCT00004260|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
744102|NCT00004260|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
744103|NCT00004260|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
744104|NCT00004260|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
744105|NCT00004260|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
744106|NCT00004260|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
744107|NCT00004260|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
744108|NCT00004260|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
744109|NCT00004260|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
744110|NCT00004260|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
744171|NCT00004217|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
744111|NCT00004260|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
744112|NCT00004260|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
744113|NCT00004260|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
744114|NCT00004260|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
744115|NCT00004260|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
744116|NCT00004260|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
744117|NCT00004260|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
744118|NCT00004260|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
744119|NCT00004260|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
744120|NCT00004260|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
744121|NCT00004260|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
744122|NCT00004260|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
744123|NCT00004260|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
744124|NCT00004260|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
744125|NCT00004260|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
744126|NCT00004260|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
744127|NCT00004260|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
744128|NCT00004260|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
744129|NCT00004260|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
744130|NCT00004260|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
744131|NCT00004260|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
744132|NCT00004260|stage I mantle cell lymphoma|stage i mantle cell lymphoma
744133|NCT00004260|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
744134|NCT00004260|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
744135|NCT00004260|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
744136|NCT00004260|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
744137|NCT00004260|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
744138|NCT00004260|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
744139|NCT00004260|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
744140|NCT00004260|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
744141|NCT00004260|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
744142|NCT00004260|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
744143|NCT00004260|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
744144|NCT00004260|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
744145|NCT00004260|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
744146|NCT00004260|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
744147|NCT00004260|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
744148|NCT00004260|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
744149|NCT00004260|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
744150|NCT00004260|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
744151|NCT00004260|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
744152|NCT00004260|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
744153|NCT00004260|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
744154|NCT00004260|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
744155|NCT00004260|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
744156|NCT00004260|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
744157|NCT00004260|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
744158|NCT00004260|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
744159|NCT00004260|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
744160|NCT00004260|stage I marginal zone lymphoma|stage i marginal zone lymphoma
744161|NCT00004260|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
744162|NCT00004260|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
744163|NCT00004260|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
744164|NCT00004260|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
744165|NCT00004260|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
744166|NCT00004260|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
744167|NCT00004260|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
744168|NCT00004260|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
744169|NCT00004260|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
744170|NCT00004260|splenic marginal zone lymphoma|splenic marginal zone lymphoma
758559|NCT00069706|open-angle|open-angle
744172|NCT00004217|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
744173|NCT00004217|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
744174|NCT00004217|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
744175|NCT00004217|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
744176|NCT00004217|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
744177|NCT00004217|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
744178|NCT00004217|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
744179|NCT00004217|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
744181|NCT00085917|Ribavirin|ribavirin
744182|NCT00085917|Early Virological Response|early virological response
744183|NCT00085917|Hepatitis C|hepatitis c
744184|NCT00085917|HIV|hiv
744185|NCT00085852|emphysema|emphysema
744186|NCT00085852|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
744187|NCT00085852|lung volume reduction|lung volume reduction
744188|NCT00085852|bronchoscopic|bronchoscopic
744189|NCT00085852|bronchoscopy|bronchoscopy
744190|NCT00085852|bronchoscope|bronchoscope
744191|NCT00085839|Tarceva|tarceva
744192|NCT00085839|NSCLC|nsclc
744193|NCT00085839|EGFR|egfr
744194|NCT00085839|ECOG Performance Status 2|ecog performance status 2
744195|NCT00085839|erlotinib|erlotinib
744196|NCT00085839|Non-Small Cell Lung Cancer|non-small cell lung cancer
744197|NCT00085839|OSI-774|osi-774
744198|NCT00085826|Lung Cancer|lung cancer
744199|NCT00085826|NSCLC|nsclc
744200|NCT00085826|Non-small Cell Lung Cancer|non-small cell lung cancer
744201|NCT00085813|Platinum-Refractory|platinum-refractory
744202|NCT00085813|Platinum-Relapsed|platinum-relapsed
744203|NCT00085813|Non-Small Cell Lung Cancer|non-small cell lung cancer
744204|NCT00085774|albuterol|albuterol
744205|NCT00085774|aerosol inhaler|aerosol inhaler
744206|NCT00085774|metered-dose inhaler|metered-dose inhaler
744207|NCT00085774|breath-actuated inhaler|breath-actuated inhaler
744208|NCT00085774|exercise-induced bronchospasm|exercise-induced bronchospasm
744209|NCT00085761|Dermal assessment|dermal assessment
744210|NCT00085761|Pain measurement|pain measurement
744211|NCT00085761|Diary|diary
744212|NCT00085761|Neuropathy|neuropathy
744213|NCT00085761|Analgesics/*therapeutic use|analgesics/*therapeutic use
744214|NCT00085761|Capsaicin/*administration & dosage/adverse effects|capsaicin/*administration & dosage/adverse effects
744215|NCT00085761|HIV Infections/*complications/*drug therapy|hiv infections/*complications/*drug therapy
744216|NCT00085761|Pain|pain
744217|NCT00085761|Complementary Therapies|complementary therapies
744218|NCT00004251|stage IV endometrial carcinoma|stage iv endometrial carcinoma
744219|NCT00004251|recurrent endometrial carcinoma|recurrent endometrial carcinoma
744220|NCT00004251|endometrial adenocarcinoma|endometrial adenocarcinoma
744221|NCT00004251|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
744222|NCT00004076|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
744223|NCT00004043|adenocarcinoma of the prostate|adenocarcinoma of the prostate
744224|NCT00004043|recurrent prostate cancer|recurrent prostate cancer
744225|NCT00003996|adult glioblastoma|adult glioblastoma
744226|NCT00003996|adult giant cell glioblastoma|adult giant cell glioblastoma
744227|NCT00003996|adult gliosarcoma|adult gliosarcoma
744228|NCT00003920|stage IV breast cancer|stage iv breast cancer
744229|NCT00003920|recurrent breast cancer|recurrent breast cancer
744230|NCT00003898|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
744231|NCT00003898|oral complications|oral complications
744232|NCT00003894|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
744233|NCT00003894|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
744234|NCT00003894|graft versus host disease|graft versus host disease
744235|NCT00003891|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
744236|NCT00085865|5 HT|5 ht
744237|NCT00085865|Neuroreceptors|neuroreceptors
744238|NCT00085865|Radiotracer|radiotracer
744239|NCT00085865|Neuroimaging|neuroimaging
744240|NCT00085865|Serotonin Transporter|serotonin transporter
744241|NCT00085865|Alcoholism|alcoholism
744242|NCT00085865|PET|pet
744243|NCT00085865|Healthy Volunteer|healthy volunteer
744244|NCT00085865|HV|hv
744245|NCT00085748|schizophrenia|schizophrenia
744246|NCT00085748|geriatric|geriatric
744247|NCT00085748|elderly|elderly
744248|NCT00085722|Injection Therapy|injection therapy
744249|NCT00085709|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
744250|NCT00085709|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
744251|NCT00085709|adult acute basophilic leukemia|adult acute basophilic leukemia
744252|NCT00085709|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
744253|NCT00085709|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
744254|NCT00085709|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
744255|NCT00085709|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
744323|NCT00003206|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
744256|NCT00085709|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
744257|NCT00085709|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
744258|NCT00085709|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
744259|NCT00085709|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
744260|NCT00085709|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
744261|NCT00085709|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
744262|NCT00085709|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
744263|NCT00085709|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
744264|NCT00003871|stage IV prostate cancer|stage iv prostate cancer
744265|NCT00003871|recurrent prostate cancer|recurrent prostate cancer
744266|NCT00003860|extensive stage small cell lung cancer|extensive stage small cell lung cancer
744267|NCT00003847|recurrent small cell lung cancer|recurrent small cell lung cancer
744268|NCT00003847|intermediate type small cell lung cancer|intermediate type small cell lung cancer
744269|NCT00003829|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
744270|NCT00003829|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
744271|NCT00003829|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
744272|NCT00003829|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
744273|NCT00003829|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
744274|NCT00003720|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
744275|NCT00003720|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
744276|NCT00003624|stage I cervical cancer|stage i cervical cancer
744277|NCT00003624|stage II cervical cancer|stage ii cervical cancer
744278|NCT00003624|stage III cervical cancer|stage iii cervical cancer
744279|NCT00003624|stage IV cervical cancer|stage iv cervical cancer
744280|NCT00003624|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
744281|NCT00003624|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
744282|NCT00003624|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
744283|NCT00003624|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
744284|NCT00003624|stage I endometrial carcinoma|stage i endometrial carcinoma
744285|NCT00003624|stage II endometrial carcinoma|stage ii endometrial carcinoma
744286|NCT00003624|stage III endometrial carcinoma|stage iii endometrial carcinoma
744287|NCT00003624|stage IV endometrial carcinoma|stage iv endometrial carcinoma
744288|NCT00003624|endometrial adenocarcinoma|endometrial adenocarcinoma
744289|NCT00003624|fallopian tube cancer|fallopian tube cancer
744290|NCT00003624|primary peritoneal cavity cancer|primary peritoneal cavity cancer
744291|NCT00003624|stage I uterine sarcoma|stage i uterine sarcoma
744292|NCT00003624|stage II uterine sarcoma|stage ii uterine sarcoma
744293|NCT00003624|stage III uterine sarcoma|stage iii uterine sarcoma
744294|NCT00003624|stage IV uterine sarcoma|stage iv uterine sarcoma
744295|NCT00003624|neurotoxicity|neurotoxicity
744296|NCT00003592|stage IV salivary gland cancer|stage iv salivary gland cancer
744297|NCT00003592|recurrent salivary gland cancer|recurrent salivary gland cancer
744298|NCT00003592|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
744299|NCT00003592|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
744300|NCT00003592|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
744301|NCT00003592|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
744302|NCT00003592|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
744303|NCT00003592|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
744304|NCT00003592|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
744305|NCT00003592|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
744306|NCT00003592|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
744307|NCT00003592|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
744308|NCT00003592|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
744309|NCT00003592|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
744310|NCT00003592|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
744311|NCT00003574|recurrent adult brain tumor|recurrent adult brain tumor
744312|NCT00003574|adult glioblastoma|adult glioblastoma
744313|NCT00003574|adult anaplastic astrocytoma|adult anaplastic astrocytoma
744314|NCT00003574|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
744315|NCT00003574|adult giant cell glioblastoma|adult giant cell glioblastoma
744316|NCT00003574|adult gliosarcoma|adult gliosarcoma
744317|NCT00003254|stage IV colon cancer|stage iv colon cancer
744318|NCT00003254|stage IV rectal cancer|stage iv rectal cancer
744319|NCT00003254|recurrent colon cancer|recurrent colon cancer
744320|NCT00003254|recurrent rectal cancer|recurrent rectal cancer
744321|NCT00003242|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
744322|NCT00003206|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
744324|NCT00003143|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
744325|NCT00003143|Waldenström macroglobulinemia|waldenström macroglobulinemia
744326|NCT00003143|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
744327|NCT00003143|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
744328|NCT00003143|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
744329|NCT00003143|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
744330|NCT00003143|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
744331|NCT00003143|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
744332|NCT00003143|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
744333|NCT00003143|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
744334|NCT00003143|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
744335|NCT00003143|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
744336|NCT00003143|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
744337|NCT00003143|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
744338|NCT00003143|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
744339|NCT00003143|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
744340|NCT00003143|splenic marginal zone lymphoma|splenic marginal zone lymphoma
744341|NCT00003099|breast cancer|breast cancer
744342|NCT00003099|Tamoxifen|tamoxifen
744343|NCT00003099|Fenretinide|fenretinide
744344|NCT00003099|Chemoprevention Therapy|chemoprevention therapy
744345|NCT00003099|N-(4-hydroxyphenyl) Retinamide|n-(4-hydroxyphenyl) retinamide
744346|NCT00003099|4-HPR|4-hpr
744347|NCT00003099|Breast Neoplasia|breast neoplasia
744348|NCT00003099|Diagnostic Core Biopsy|diagnostic core biopsy
744349|NCT00003099|Surgery|surgery
744350|NCT00003085|stage I pancreatic cancer|stage i pancreatic cancer
744351|NCT00003085|stage II pancreatic cancer|stage ii pancreatic cancer
744352|NCT00003028|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
744353|NCT00003009|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
744354|NCT00002973|stage III melanoma|stage iii melanoma
744355|NCT00002973|stage IV melanoma|stage iv melanoma
744356|NCT00002973|recurrent melanoma|recurrent melanoma
744357|NCT00002949|stage II cervical cancer|stage ii cervical cancer
744358|NCT00002949|stage III cervical cancer|stage iii cervical cancer
744359|NCT00002949|stage IV cervical cancer|stage iv cervical cancer
744360|NCT00002949|stage II vaginal cancer|stage ii vaginal cancer
744361|NCT00002949|stage III vaginal cancer|stage iii vaginal cancer
744362|NCT00002949|stage IVA vaginal cancer|stage iva vaginal cancer
744363|NCT00002949|stage IVB vaginal cancer|stage ivb vaginal cancer
744364|NCT00002949|stage II endometrial carcinoma|stage ii endometrial carcinoma
744365|NCT00002949|stage III endometrial carcinoma|stage iii endometrial carcinoma
744366|NCT00002949|stage IV endometrial carcinoma|stage iv endometrial carcinoma
744367|NCT00002949|stage II bladder cancer|stage ii bladder cancer
744368|NCT00002949|stage III bladder cancer|stage iii bladder cancer
744369|NCT00002949|stage IV bladder cancer|stage iv bladder cancer
744370|NCT00002915|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
744371|NCT00002864|stage I breast cancer|stage i breast cancer
744372|NCT00002864|stage II breast cancer|stage ii breast cancer
744373|NCT00002864|stage III breast cancer|stage iii breast cancer
744374|NCT00002838|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
744375|NCT00002838|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
744376|NCT00002838|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
744377|NCT00002785|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
744378|NCT00002740|disseminated neuroblastoma|disseminated neuroblastoma
744379|NCT00085696|Lymphoma|lymphoma
744380|NCT00085696|Non-Hodgkin's|non-hodgkin's
744381|NCT00085696|NHL|nhl
744382|NCT00085696|B-Cell|b-cell
744383|NCT00085696|Indolent|indolent
744384|NCT00085683|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
744385|NCT00085683|Lumbar Puncture|lumbar puncture
744386|NCT00085683|Healthy Control Subjects|healthy control subjects
744387|NCT00085683|Mesial Temporal Sclerosis|mesial temporal sclerosis
744388|NCT00085683|Neuroexcitotoxicity|neuroexcitotoxicity
744389|NCT00085683|Seizure Disorder|seizure disorder
744390|NCT00085683|Epilepsy|epilepsy
744391|NCT00085683|Healthy Volunteer|healthy volunteer
744392|NCT00085683|HV|hv
744393|NCT00085670|Tumor Necrosis Factor Alpha (TNF-Alpha)|tumor necrosis factor alpha (tnf-alpha)
744394|NCT00085670|Interferon-Gamma (IFN-Gamma)|interferon-gamma (ifn-gamma)
744395|NCT00085670|Transforming Growth Factor Beta 1 (TGF-B1)|transforming growth factor beta 1 (tgf-b1)
744396|NCT00085670|Interleukin-10 (IL-10)|interleukin-10 (il-10)
744397|NCT00085670|Interleukin-1 Receptor Antagonist (IL-1 Ra)|interleukin-1 receptor antagonist (il-1 ra)
744398|NCT00085670|Vitamin D Receptor (VitD R)|vitamin d receptor (vitd r)
744399|NCT00085670|Interleukin-6 (IL-6)|interleukin-6 (il-6)
744400|NCT00085670|Bone Marrow Failure|bone marrow failure
744401|NCT00085670|Aplastic Anemia|aplastic anemia
744402|NCT00085670|Myelodysplastic Syndrome|myelodysplastic syndrome
744403|NCT00085670|MDS|mds
744404|NCT00085670|Pure Red Cell Aplasia|pure red cell aplasia
744405|NCT00085670|PRCA|prca
744406|NCT00085657|Direct Current Stimulation|direct current stimulation
744407|NCT00085657|Cortical Reorganization|cortical reorganization
744408|NCT00085657|Rehabilitation|rehabilitation
744409|NCT00085657|Acute Stroke|acute stroke
744410|NCT00085657|Stroke|stroke
744411|NCT00085631|stage IA cervical cancer|stage ia cervical cancer
744412|NCT00085631|stage IB cervical cancer|stage ib cervical cancer
744413|NCT00085631|stage IIA cervical cancer|stage iia cervical cancer
744414|NCT00085631|stage IIB cervical cancer|stage iib cervical cancer
744415|NCT00085631|stage III cervical cancer|stage iii cervical cancer
744416|NCT00085631|stage IVA cervical cancer|stage iva cervical cancer
744417|NCT00085631|cervical adenocarcinoma|cervical adenocarcinoma
744418|NCT00085631|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
744419|NCT00085631|cervical squamous cell carcinoma|cervical squamous cell carcinoma
744420|NCT00085579|stage III melanoma|stage iii melanoma
744421|NCT00085579|stage IV melanoma|stage iv melanoma
744422|NCT00085566|adult glioblastoma|adult glioblastoma
744423|NCT00085566|recurrent prostate cancer|recurrent prostate cancer
744424|NCT00085566|recurrent adult brain tumor|recurrent adult brain tumor
744425|NCT00085566|stage IV prostate cancer|stage iv prostate cancer
744426|NCT00085566|adult giant cell glioblastoma|adult giant cell glioblastoma
744427|NCT00085566|adult gliosarcoma|adult gliosarcoma
744428|NCT00085527|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
744429|NCT00085527|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
744430|NCT00085527|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
744431|NCT00085501|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
744432|NCT00085501|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
744433|NCT00085501|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
744434|NCT00085501|adenocarcinoma of the lung|adenocarcinoma of the lung
744435|NCT00085501|squamous cell lung cancer|squamous cell lung cancer
744436|NCT00085501|large cell lung cancer|large cell lung cancer
744437|NCT00085488|recurrent melanoma|recurrent melanoma
744438|NCT00085488|stage III melanoma|stage iii melanoma
744439|NCT00085488|stage IV melanoma|stage iv melanoma
744440|NCT00085475|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
744441|NCT00085475|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
744442|NCT00085475|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
744443|NCT00085475|adult fibrosarcoma|adult fibrosarcoma
744444|NCT00085475|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
744445|NCT00085462|recurrent melanoma|recurrent melanoma
744446|NCT00085462|stage IV melanoma|stage iv melanoma
744447|NCT00085449|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
744448|NCT00085449|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
744449|NCT00085449|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
744450|NCT00085449|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
744451|NCT00085449|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
744452|NCT00085449|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
744453|NCT00085449|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
744454|NCT00085449|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
744455|NCT00085449|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
744456|NCT00085449|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
744457|NCT00085449|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
744458|NCT00085449|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
744459|NCT00085449|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
744460|NCT00085449|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
744461|NCT00085449|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
744462|NCT00085449|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
744463|NCT00085449|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
744464|NCT00085449|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
744566|NCT00084721|stage III rectal cancer|stage iii rectal cancer
744465|NCT00085449|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
744466|NCT00085449|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
744467|NCT00085449|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
744468|NCT00085449|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
744469|NCT00085449|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
744470|NCT00085449|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
744471|NCT00085449|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
744472|NCT00085449|refractory multiple myeloma|refractory multiple myeloma
744473|NCT00085449|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
744474|NCT00085449|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
744475|NCT00085449|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
744548|NCT00084825|stage IV prostate cancer|stage iv prostate cancer
744476|NCT00085449|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
744477|NCT00085449|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
744478|NCT00085449|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
744479|NCT00085449|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
744480|NCT00085436|recurrent renal cell cancer|recurrent renal cell cancer
744481|NCT00085436|stage IV renal cell cancer|stage iv renal cell cancer
744482|NCT00085423|recurrent melanoma|recurrent melanoma
744483|NCT00085423|stage IV melanoma|stage iv melanoma
744484|NCT00085397|recurrent melanoma|recurrent melanoma
744485|NCT00085397|stage III melanoma|stage iii melanoma
744486|NCT00085397|stage IV melanoma|stage iv melanoma
744487|NCT00085384|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
744488|NCT00085384|peritoneal cavity cancer|peritoneal cavity cancer
744489|NCT00085384|fallopian tube cancer|fallopian tube cancer
744490|NCT00085332|recurrent endometrial carcinoma|recurrent endometrial carcinoma
744491|NCT00085332|stage III endometrial carcinoma|stage iii endometrial carcinoma
744492|NCT00085332|stage IV endometrial carcinoma|stage iv endometrial carcinoma
744493|NCT00085306|recurrent melanoma|recurrent melanoma
744494|NCT00085306|stage IV melanoma|stage iv melanoma
744495|NCT00085306|iris melanoma|iris melanoma
744496|NCT00085306|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
744497|NCT00085306|extraocular extension melanoma|extraocular extension melanoma
744498|NCT00085306|recurrent intraocular melanoma|recurrent intraocular melanoma
744499|NCT00085228|adenocarcinoma of the prostate|adenocarcinoma of the prostate
744500|NCT00085228|recurrent prostate cancer|recurrent prostate cancer
744501|NCT00085228|stage IV prostate cancer|stage iv prostate cancer
744502|NCT00085202|untreated childhood medulloblastoma|untreated childhood medulloblastoma
744503|NCT00085202|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
744504|NCT00085202|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
744505|NCT00085202|untreated childhood pineoblastoma|untreated childhood pineoblastoma
744506|NCT00085176|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
744507|NCT00085176|neurotoxicity|neurotoxicity
744508|NCT00085176|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
744509|NCT00085176|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
744510|NCT00085163|adenocarcinoma of the colon|adenocarcinoma of the colon
744511|NCT00085163|stage III colon cancer|stage iii colon cancer
744512|NCT00085150|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
744513|NCT00085150|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
744514|NCT00085150|childhood Burkitt lymphoma|childhood burkitt lymphoma
744515|NCT00085150|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
744516|NCT00085150|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
744517|NCT00085150|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
744518|NCT00085150|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
744519|NCT00085150|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
744520|NCT00085150|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
744521|NCT00085150|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
744522|NCT00085150|acute undifferentiated leukemia|acute undifferentiated leukemia
744523|NCT00085098|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
744524|NCT00085059|stage IV melanoma|stage iv melanoma
744525|NCT00085059|recurrent melanoma|recurrent melanoma
744526|NCT00085020|stage IV breast cancer|stage iv breast cancer
744527|NCT00085020|male breast cancer|male breast cancer
744528|NCT00085020|recurrent breast cancer|recurrent breast cancer
744529|NCT00084942|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
744530|NCT00084942|recurrent gallbladder cancer|recurrent gallbladder cancer
744531|NCT00084942|unresectable gallbladder cancer|unresectable gallbladder cancer
744532|NCT00084942|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
744533|NCT00084942|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
744534|NCT00084942|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
744535|NCT00084929|colon cancer|colon cancer
744536|NCT00084929|rectal cancer|rectal cancer
744537|NCT00084903|cervical cancer|cervical cancer
744538|NCT00084903|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
744539|NCT00084890|stage IVB cervical cancer|stage ivb cervical cancer
744540|NCT00084890|recurrent cervical cancer|recurrent cervical cancer
744541|NCT00084890|cervical squamous cell carcinoma|cervical squamous cell carcinoma
744542|NCT00084864|adenocarcinoma of the prostate|adenocarcinoma of the prostate
744543|NCT00084864|stage II prostate cancer|stage ii prostate cancer
744544|NCT00084864|stage III prostate cancer|stage iii prostate cancer
744545|NCT00084838|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
744546|NCT00084825|adenocarcinoma of the prostate|adenocarcinoma of the prostate
744547|NCT00084825|recurrent prostate cancer|recurrent prostate cancer
744549|NCT00084825|bone metastases|bone metastases
744550|NCT00084812|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
744551|NCT00084799|recurrent small cell lung cancer|recurrent small cell lung cancer
744552|NCT00084786|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
744553|NCT00084773|recurrent rectal cancer|recurrent rectal cancer
744554|NCT00084773|stage II rectal cancer|stage ii rectal cancer
744555|NCT00084773|stage III rectal cancer|stage iii rectal cancer
744556|NCT00084773|adenocarcinoma of the rectum|adenocarcinoma of the rectum
744557|NCT00084747|stage II multiple myeloma|stage ii multiple myeloma
744558|NCT00084747|stage III multiple myeloma|stage iii multiple myeloma
744559|NCT00084734|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
744560|NCT00084721|diarrhea|diarrhea
744561|NCT00084721|recurrent colon cancer|recurrent colon cancer
744562|NCT00084721|stage IV colon cancer|stage iv colon cancer
744563|NCT00084721|recurrent rectal cancer|recurrent rectal cancer
744564|NCT00084721|stage IV rectal cancer|stage iv rectal cancer
744565|NCT00084721|stage III colon cancer|stage iii colon cancer
744567|NCT00084708|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
744568|NCT00084695|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
744569|NCT00084695|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
744570|NCT00084695|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
744571|NCT00084695|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
744572|NCT00084695|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
744573|NCT00084695|disseminated neuroblastoma|disseminated neuroblastoma
744574|NCT00084695|regional neuroblastoma|regional neuroblastoma
744575|NCT00084695|recurrent neuroblastoma|recurrent neuroblastoma
744576|NCT00084695|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
744577|NCT00084695|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
744578|NCT00084695|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
744579|NCT00084695|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
744580|NCT00084695|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
744581|NCT00084695|childhood Burkitt lymphoma|childhood burkitt lymphoma
744582|NCT00084695|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
744583|NCT00084695|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
744584|NCT00084695|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
744585|NCT00084695|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
744586|NCT00084695|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
744587|NCT00084695|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
744588|NCT00084695|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
744589|NCT00084695|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
744590|NCT00084695|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
744591|NCT00084695|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
744592|NCT00084695|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
744593|NCT00084695|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
744594|NCT00084695|Fanconi anemia|fanconi anemia
744595|NCT00084695|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
744596|NCT00084695|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
744597|NCT00084695|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
744598|NCT00084695|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
744599|NCT00084695|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
744600|NCT00084695|childhood Langerhans cell histiocytosis|childhood langerhans cell histiocytosis
744601|NCT00084695|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
744602|NCT00084695|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
744603|NCT00084669|hot flashes|hot flashes
744604|NCT00084669|sleep disorders|sleep disorders
744605|NCT00084669|ductal breast carcinoma in situ|ductal breast carcinoma in situ
744606|NCT00084669|breast cancer in situ|breast cancer in situ
744607|NCT00084669|lobular breast carcinoma in situ|lobular breast carcinoma in situ
744608|NCT00084669|lobular breast carcinoma|lobular breast carcinoma
744609|NCT00084669|recurrent breast cancer|recurrent breast cancer
744610|NCT00084669|stage I breast cancer|stage i breast cancer
744611|NCT00084669|stage II breast cancer|stage ii breast cancer
744612|NCT00084669|stage IIIA breast cancer|stage iiia breast cancer
744613|NCT00084669|stage IIIB breast cancer|stage iiib breast cancer
744614|NCT00084669|stage IIIC breast cancer|stage iiic breast cancer
744615|NCT00084669|stage IV breast cancer|stage iv breast cancer
744616|NCT00084656|stage III melanoma|stage iii melanoma
744617|NCT00084656|stage IV melanoma|stage iv melanoma
744618|NCT00084656|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
744619|NCT00084656|extraocular extension melanoma|extraocular extension melanoma
744620|NCT00084656|iris melanoma|iris melanoma
744621|NCT00084656|recurrent melanoma|recurrent melanoma
744622|NCT00084656|recurrent intraocular melanoma|recurrent intraocular melanoma
744623|NCT00084656|metastatic intraocular melanoma|metastatic intraocular melanoma
744624|NCT00084591|stage II rectal cancer|stage ii rectal cancer
744625|NCT00084591|stage III rectal cancer|stage iii rectal cancer
744626|NCT00084591|adenocarcinoma of the rectum|adenocarcinoma of the rectum
744627|NCT00084578|stage 0 bladder cancer|stage 0 bladder cancer
744628|NCT00084578|stage I bladder cancer|stage i bladder cancer
744629|NCT00084578|stage II bladder cancer|stage ii bladder cancer
744630|NCT00084578|stage III bladder cancer|stage iii bladder cancer
744631|NCT00084578|stage IV bladder cancer|stage iv bladder cancer
744632|NCT00084578|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
744633|NCT00084565|stage IV prostate cancer|stage iv prostate cancer
744634|NCT00084565|adenocarcinoma of the prostate|adenocarcinoma of the prostate
744635|NCT00084552|sexual dysfunction|sexual dysfunction
744636|NCT00084552|sexuality and reproductive issues|sexuality and reproductive issues
744637|NCT00084552|adenocarcinoma of the prostate|adenocarcinoma of the prostate
744638|NCT00084552|stage IIB prostate cancer|stage iib prostate cancer
744639|NCT00084552|stage IIA prostate cancer|stage iia prostate cancer
744640|NCT00084539|stage I breast cancer|stage i breast cancer
744641|NCT00084539|stage II breast cancer|stage ii breast cancer
744642|NCT00084539|breast cancer in situ|breast cancer in situ
744643|NCT00084526|recurrent prostate cancer|recurrent prostate cancer
744644|NCT00084526|stage I prostate cancer|stage i prostate cancer
744645|NCT00084526|stage II prostate cancer|stage ii prostate cancer
744646|NCT00084526|stage III prostate cancer|stage iii prostate cancer
744647|NCT00084526|stage IV prostate cancer|stage iv prostate cancer
744648|NCT00084513|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
744649|NCT00084448|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
744650|NCT00084448|primary peritoneal cavity cancer|primary peritoneal cavity cancer
744651|NCT00084435|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
744652|NCT00084435|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
744653|NCT00084435|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
744654|NCT00084435|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
744655|NCT00084435|stage III salivary gland cancer|stage iii salivary gland cancer
744656|NCT00084435|stage IV salivary gland cancer|stage iv salivary gland cancer
744657|NCT00084435|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
744658|NCT00084435|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
744659|NCT00084435|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
744660|NCT00084435|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
744661|NCT00084435|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
744662|NCT00084435|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
744663|NCT00084435|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
744664|NCT00084422|recurrent neuroblastoma|recurrent neuroblastoma
745084|NCT00083876|Cyclophosphamide|cyclophosphamide
744665|NCT00084409|non-small cell lung cancer|non-small cell lung cancer
744666|NCT00084409|squamous lung dysplasia|squamous lung dysplasia
744667|NCT00084396|stage II breast cancer|stage ii breast cancer
744668|NCT00084396|stage IIIA breast cancer|stage iiia breast cancer
744669|NCT00084396|stage IIIB breast cancer|stage iiib breast cancer
744670|NCT00084383|stage I pancreatic cancer|stage i pancreatic cancer
744671|NCT00084383|stage II pancreatic cancer|stage ii pancreatic cancer
744672|NCT00084383|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
744673|NCT00084370|ovarian epithelial cancer|ovarian epithelial cancer
744674|NCT00084370|BRCA1 mutation carrier|brca1 mutation carrier
744675|NCT00084370|BRCA2 mutation carrier|brca2 mutation carrier
744676|NCT00084344|breast cancer|breast cancer
744677|NCT00084318|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
744678|NCT00084318|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
744679|NCT00084318|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
744680|NCT00084318|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
744681|NCT00084318|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
744682|NCT00084318|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
744683|NCT00084318|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
744684|NCT00084318|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
744685|NCT00084279|Chronic Hepatitis C|chronic hepatitis c
744686|NCT00084279|Liver|liver
744687|NCT00084279|Pegylated|pegylated
744688|NCT00084279|Interferon|interferon
744689|NCT00084279|Alpha|alpha
744690|NCT00084279|Gamma|gamma
744691|NCT00084279|Ribavirin|ribavirin
744692|NCT00084279|Combination|combination
744693|NCT00084279|Nonresponder|nonresponder
744696|NCT00084266|Staphylococcal pneumonia|staphylococcal pneumonia
744697|NCT00084266|Methicillin-resistant staphylococcal pneumonia|methicillin-resistant staphylococcal pneumonia
744698|NCT00084266|healthcare-associated pneumonia|healthcare-associated pneumonia
744699|NCT00084253|HIV|hiv
744700|NCT00084253|Treatment Naive|treatment naive
744701|NCT00084305|Bronchoscopy|bronchoscopy
744702|NCT00084305|Pulmonary Fibrosis|pulmonary fibrosis
744703|NCT00084305|Lung Biopsy (Clinically-Indicated)|lung biopsy (clinically-indicated)
744704|NCT00084305|Hereditary Pulmonary Fibrosis|hereditary pulmonary fibrosis
744705|NCT00084305|Healthy Volunteer|healthy volunteer
744706|NCT00084305|HV|hv
744707|NCT00084292|Ischemia|ischemia
744708|NCT00084292|Pediatric|pediatric
744709|NCT00084292|Etiology|etiology
744710|NCT00084292|Treatment|treatment
744711|NCT00084292|Outcome|outcome
744712|NCT00084292|Childhood Stroke|childhood stroke
744713|NCT00084292|Pediatric Stroke|pediatric stroke
744714|NCT00084292|Ischemic Stroke|ischemic stroke
744715|NCT00084292|Spastic Hemiplegia|spastic hemiplegia
744716|NCT00084292|Hemiplegic cerebral palsy|hemiplegic cerebral palsy
744717|NCT00084214|metastatic|metastatic
744718|NCT00084214|increased antitumor effect|increased antitumor effect
744719|NCT00002682|Antibiotic Treatment|antibiotic treatment
744720|NCT00002682|Gastric Malt Lymphoma|gastric malt lymphoma
744721|NCT00002682|stage I marginal zone lymphoma|stage i marginal zone lymphoma
744722|NCT00002682|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
744723|NCT00002676|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
744724|NCT00002670|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
744725|NCT00002670|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
744726|NCT00002670|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
744727|NCT00002670|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
744728|NCT00002670|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
744729|NCT00002670|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
744730|NCT00002670|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
744731|NCT00002670|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
744732|NCT00002670|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
744733|NCT00002670|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
744734|NCT00002670|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
744735|NCT00002670|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
744736|NCT00002656|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
744737|NCT00002656|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
744738|NCT00002656|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
744739|NCT00002646|stage II breast cancer|stage ii breast cancer
744740|NCT00002646|stage IIIA breast cancer|stage iiia breast cancer
744741|NCT00002637|recurrent prostate cancer|recurrent prostate cancer
744742|NCT00002632|stage IV salivary gland cancer|stage iv salivary gland cancer
744743|NCT00002632|recurrent salivary gland cancer|recurrent salivary gland cancer
744744|NCT00002632|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
744745|NCT00002632|salivary gland adenocarcinoma|salivary gland adenocarcinoma
744746|NCT00002625|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
744747|NCT00002625|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
744748|NCT00002625|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
744749|NCT00002625|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
744750|NCT00002625|recurrent esophageal cancer|recurrent esophageal cancer
744751|NCT00002625|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
744752|NCT00002625|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
744753|NCT00002625|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
744754|NCT00002625|recurrent small cell lung cancer|recurrent small cell lung cancer
744755|NCT00002625|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
744756|NCT00002625|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
744757|NCT00002625|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
744758|NCT00002625|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
744759|NCT00002625|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
744760|NCT00002625|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
744761|NCT00002625|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
744762|NCT00002625|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
744763|NCT00002625|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
744764|NCT00002625|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
744765|NCT00002625|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
744766|NCT00002625|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
744767|NCT00002625|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
744768|NCT00002625|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
744769|NCT00002625|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
744770|NCT00002625|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
744771|NCT00002625|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
744772|NCT00002625|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
744773|NCT00002625|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
744774|NCT00002625|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
744775|NCT00002625|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
744776|NCT00002625|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
744777|NCT00002625|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
744778|NCT00002625|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
744779|NCT00002625|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
744780|NCT00002625|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
744781|NCT00002625|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
744782|NCT00002625|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
744783|NCT00002625|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
744784|NCT00002625|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
744785|NCT00002625|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
744786|NCT00002625|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
744787|NCT00002625|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
744788|NCT00002625|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
744789|NCT00002625|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
744790|NCT00002625|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
744791|NCT00002625|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
744792|NCT00002625|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
744793|NCT00002625|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
744794|NCT00002625|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
744795|NCT00002625|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
744796|NCT00002625|splenic marginal zone lymphoma|splenic marginal zone lymphoma
744797|NCT00002551|stage II rectal cancer|stage ii rectal cancer
744798|NCT00002551|stage III rectal cancer|stage iii rectal cancer
744799|NCT00002551|adenocarcinoma of the rectum|adenocarcinoma of the rectum
744800|NCT00002538|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
744801|NCT00002538|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
744802|NCT00002538|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
744803|NCT00002538|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
744804|NCT00002538|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
744805|NCT00002538|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
744806|NCT00002538|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
744807|NCT00002538|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
744808|NCT00002538|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
744809|NCT00002538|fallopian tube cancer|fallopian tube cancer
744810|NCT00002538|primary peritoneal cavity cancer|primary peritoneal cavity cancer
744811|NCT00084201|Vaccinium macrocarpon|vaccinium macrocarpon
744812|NCT00084188|behavioral intervention|behavioral intervention
744813|NCT00084175|behavioral intervention|behavioral intervention
744814|NCT00006451|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
744815|NCT00006451|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
744816|NCT00006451|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
744817|NCT00006451|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
744818|NCT00006451|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
744819|NCT00006451|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
744820|NCT00006451|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
744821|NCT00006451|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
744822|NCT00006451|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
744823|NCT00006451|acute undifferentiated leukemia|acute undifferentiated leukemia
744824|NCT00006451|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
744825|NCT00006451|graft versus host disease|graft versus host disease
744826|NCT00006387|stage IV colon cancer|stage iv colon cancer
744827|NCT00006387|recurrent pancreatic cancer|recurrent pancreatic cancer
744828|NCT00006387|stage IV rectal cancer|stage iv rectal cancer
744829|NCT00006387|recurrent colon cancer|recurrent colon cancer
744830|NCT00006387|recurrent rectal cancer|recurrent rectal cancer
744831|NCT00006387|adenocarcinoma of the colon|adenocarcinoma of the colon
744832|NCT00006387|adenocarcinoma of the rectum|adenocarcinoma of the rectum
744833|NCT00006387|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
744834|NCT00006387|stage IV pancreatic cancer|stage iv pancreatic cancer
758560|NCT00069706|glaucoma|glaucoma
744835|NCT00006382|non-small cell lung cancer|non-small cell lung cancer
744836|NCT00006382|small cell lung cancer|small cell lung cancer
744837|NCT00006380|stage III prostate cancer|stage iii prostate cancer
744838|NCT00006380|stage IV prostate cancer|stage iv prostate cancer
744839|NCT00006380|recurrent prostate cancer|recurrent prostate cancer
744840|NCT00006378|squamous cell lung cancer|squamous cell lung cancer
744841|NCT00006378|large cell lung cancer|large cell lung cancer
744842|NCT00006378|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
744843|NCT00006378|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
744844|NCT00006378|adenocarcinoma of the lung|adenocarcinoma of the lung
744845|NCT00006378|adenosquamous cell lung cancer|adenosquamous cell lung cancer
744846|NCT00006378|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
744847|NCT00006374|extensive stage small cell lung cancer|extensive stage small cell lung cancer
744848|NCT00006374|recurrent small cell lung cancer|recurrent small cell lung cancer
744849|NCT00005994|nausea and vomiting|nausea and vomiting
744850|NCT00005994|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
744851|NCT00005790|adult brain stem glioma|adult brain stem glioma
744852|NCT00005790|adult ependymoma|adult ependymoma
744853|NCT00005790|adult craniopharyngioma|adult craniopharyngioma
744854|NCT00005790|adult medulloblastoma|adult medulloblastoma
744855|NCT00005790|adult meningioma|adult meningioma
744856|NCT00005790|adult glioblastoma|adult glioblastoma
744857|NCT00005790|adult oligodendroglioma|adult oligodendroglioma
744858|NCT00005790|adult anaplastic astrocytoma|adult anaplastic astrocytoma
744859|NCT00005790|adult myxopapillary ependymoma|adult myxopapillary ependymoma
744860|NCT00005790|adult anaplastic ependymoma|adult anaplastic ependymoma
744861|NCT00005790|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
744862|NCT00005790|adult mixed glioma|adult mixed glioma
744863|NCT00005790|adult pineal parenchymal tumor|adult pineal parenchymal tumor
744864|NCT00005790|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
744865|NCT00005790|adult pilocytic astrocytoma|adult pilocytic astrocytoma
744866|NCT00005790|adult subependymoma|adult subependymoma
745086|NCT00083876|Etoposide|etoposide
744867|NCT00005790|adult diffuse astrocytoma|adult diffuse astrocytoma
744868|NCT00005790|adult ependymoblastoma|adult ependymoblastoma
744869|NCT00005790|adult pineocytoma|adult pineocytoma
744870|NCT00005790|adult pineoblastoma|adult pineoblastoma
744871|NCT00005790|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
744872|NCT00005790|adult choroid plexus tumor|adult choroid plexus tumor
744873|NCT00005790|adult grade III meningioma|adult grade iii meningioma
744874|NCT00005790|adult giant cell glioblastoma|adult giant cell glioblastoma
744875|NCT00005790|adult gliosarcoma|adult gliosarcoma
744876|NCT00005084|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
744877|NCT00005084|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
744878|NCT00005084|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
744879|NCT00005045|stage III renal cell cancer|stage iii renal cell cancer
744880|NCT00005045|stage IV renal cell cancer|stage iv renal cell cancer
744881|NCT00005045|recurrent renal cell cancer|recurrent renal cell cancer
744882|NCT00004236|stage III gastric cancer|stage iii gastric cancer
744883|NCT00004236|stage IV gastric cancer|stage iv gastric cancer
744884|NCT00004236|recurrent gastric cancer|recurrent gastric cancer
744885|NCT00004236|stage III esophageal cancer|stage iii esophageal cancer
744886|NCT00004236|stage IV esophageal cancer|stage iv esophageal cancer
744887|NCT00004236|recurrent esophageal cancer|recurrent esophageal cancer
744888|NCT00004236|adenocarcinoma of the stomach|adenocarcinoma of the stomach
744889|NCT00004236|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
744890|NCT00003992|stage II breast cancer|stage ii breast cancer
744891|NCT00003992|stage IIIA breast cancer|stage iiia breast cancer
744892|NCT00003859|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
744893|NCT00003859|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
744894|NCT00003733|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
744895|NCT00003733|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
744896|NCT00003733|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
744897|NCT00003584|stage IV renal cell cancer|stage iv renal cell cancer
744898|NCT00003584|recurrent renal cell cancer|recurrent renal cell cancer
744899|NCT00003435|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
744900|NCT00003435|secondary acute myeloid leukemia|secondary acute myeloid leukemia
744901|NCT00003435|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
744902|NCT00003435|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
744903|NCT00003410|adult glioblastoma|adult glioblastoma
744904|NCT00003410|adult giant cell glioblastoma|adult giant cell glioblastoma
744905|NCT00003410|adult gliosarcoma|adult gliosarcoma
744906|NCT00003372|recurrent adult brain tumor|recurrent adult brain tumor
744907|NCT00003372|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
744908|NCT00003372|adult mixed glioma|adult mixed glioma
744909|NCT00003236|recurrent breast cancer|recurrent breast cancer
744910|NCT00002905|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
744911|NCT00002496|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
744912|NCT00002496|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
744913|NCT00002478|recurrent cervical cancer|recurrent cervical cancer
744914|NCT00002478|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
744915|NCT00002476|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
744916|NCT00002476|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
744917|NCT00002476|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
744918|NCT00002476|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
744919|NCT00002476|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
744920|NCT00002476|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
744921|NCT00002476|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
744922|NCT00002476|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
744923|NCT00002476|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
744924|NCT00002476|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
744925|NCT00002476|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
744926|NCT00002476|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
744927|NCT00002476|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
744928|NCT00002476|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
744929|NCT00002476|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
744930|NCT00002476|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
744931|NCT00002476|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
744932|NCT00002476|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
744933|NCT00002476|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
744934|NCT00002476|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
744935|NCT00002476|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
744936|NCT00002476|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
744937|NCT00002476|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
744938|NCT00002476|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
744939|NCT00002460|stage I breast cancer|stage i breast cancer
744940|NCT00002460|stage II breast cancer|stage ii breast cancer
744941|NCT00002460|stage IIIA breast cancer|stage iiia breast cancer
744942|NCT00084162|PET|pet
744943|NCT00084162|Heart Rate Variability|heart rate variability
744944|NCT00084162|N-Back Task|n-back task
744945|NCT00084162|Isometric Handgrip|isometric handgrip
744946|NCT00084162|MRI|mri
744947|NCT00084162|Depression|depression
744948|NCT00084162|MDD|mdd
744949|NCT00084162|Heart|heart
744950|NCT00084149|Acute Infection|acute infection
744951|NCT00084149|Treatment Naive|treatment naive
744952|NCT00084136|Treatment Naive|treatment naive
744953|NCT00084136|Adherence|adherence
744954|NCT00084136|Drug Resistance|drug resistance
744955|NCT00084136|Treatment Failure|treatment failure
744956|NCT00084123|Relaxation Techniques|relaxation techniques
744957|NCT00084123|Radiation|radiation
744958|NCT00084123|Drug Therapy|drug therapy
744959|NCT00084123|Healing Touch|healing touch
744960|NCT00084110|Aged|aged
744961|NCT00084110|Mexican Americans|mexican americans
744962|NCT00084110|Complementary Therapies|complementary therapies
744963|NCT00083993|Breast Cancer|breast cancer
744964|NCT00005960|adenocarcinoma of the prostate|adenocarcinoma of the prostate
744965|NCT00005960|stage I prostate cancer|stage i prostate cancer
744966|NCT00005960|stage IIB prostate cancer|stage iib prostate cancer
744967|NCT00005960|stage IIA prostate cancer|stage iia prostate cancer
745087|NCT00083876|Filgrastim|filgrastim
744968|NCT00005960|stage III prostate cancer|stage iii prostate cancer
744969|NCT00005960|stage IV prostate cancer|stage iv prostate cancer
744970|NCT00005960|recurrent prostate cancer|recurrent prostate cancer
744971|NCT00005960|pain|pain
744972|NCT00005641|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
744973|NCT00005641|refractory multiple myeloma|refractory multiple myeloma
744974|NCT00005641|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
744975|NCT00005641|stage I multiple myeloma|stage i multiple myeloma
744976|NCT00005641|stage II multiple myeloma|stage ii multiple myeloma
744977|NCT00005641|stage III multiple myeloma|stage iii multiple myeloma
744978|NCT00005641|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
744979|NCT00005641|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
744980|NCT00005641|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
744981|NCT00005641|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
745071|NCT00083915|Sargramostim|sargramostim
744982|NCT00005641|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
744983|NCT00005641|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
744984|NCT00005641|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
744985|NCT00005641|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
744986|NCT00005641|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
744987|NCT00005641|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
744988|NCT00005641|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
744989|NCT00005641|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
744990|NCT00005641|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
744991|NCT00005641|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
744992|NCT00005641|polycythemia vera|polycythemia vera
744993|NCT00005641|primary myelofibrosis|primary myelofibrosis
744994|NCT00005641|essential thrombocythemia|essential thrombocythemia
744995|NCT00005641|refractory anemia|refractory anemia
744996|NCT00005641|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
744997|NCT00005641|refractory anemia with excess blasts|refractory anemia with excess blasts
744998|NCT00005641|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
744999|NCT00005641|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
745000|NCT00005641|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
745001|NCT00005641|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
745002|NCT00005641|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
745003|NCT00005641|graft versus host disease|graft versus host disease
745004|NCT00005641|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
745005|NCT00005641|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
745006|NCT00005091|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
745007|NCT00005091|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
745008|NCT00005091|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
745009|NCT00005054|stage IV breast cancer|stage iv breast cancer
745010|NCT00005054|stage IIIA breast cancer|stage iiia breast cancer
745011|NCT00005054|recurrent breast cancer|recurrent breast cancer
745012|NCT00005054|stage IIIB breast cancer|stage iiib breast cancer
745013|NCT00005050|stage III colon cancer|stage iii colon cancer
745014|NCT00005050|stage IV colon cancer|stage iv colon cancer
745015|NCT00005050|stage III rectal cancer|stage iii rectal cancer
745016|NCT00005050|stage IV rectal cancer|stage iv rectal cancer
745017|NCT00005050|recurrent colon cancer|recurrent colon cancer
745018|NCT00005050|recurrent rectal cancer|recurrent rectal cancer
745019|NCT00084097|Allergy|allergy
745020|NCT00084097|IgE|ige
745021|NCT00084097|Eosinophil|eosinophil
745022|NCT00084097|Monoclonal Antibody|monoclonal antibody
745023|NCT00084097|Eosinophilic Gastroenteritis|eosinophilic gastroenteritis
745024|NCT00084097|EG|eg
745025|NCT00084084|Lysosomes|lysosomes
745026|NCT00084084|Storage|storage
745027|NCT00084084|Glycolipid|glycolipid
745028|NCT00084084|Fabry disease|fabry disease
745029|NCT00084084|Stroke|stroke
745030|NCT00084084|Children|children
745031|NCT00084084|Pediatrics|pediatrics
745032|NCT00084058|Dose Intensification|dose intensification
745033|NCT00084058|Pharmacokinetic Sampling|pharmacokinetic sampling
745034|NCT00084058|Treatment Experienced|treatment experienced
745035|NCT00084058|Child|child
745036|NCT00084045|HIV Seronegativity|hiv seronegativity
745037|NCT00084045|Treatment Naive|treatment naive
745038|NCT00084045|Pediatric HIV|pediatric hiv
745039|NCT00084045|Perinatal Transmission|perinatal transmission
745040|NCT00084032|Acute Infection|acute infection
745041|NCT00084032|Treatment Interruption|treatment interruption
745042|NCT00084032|Treatment Naive|treatment naive
745043|NCT00084032|Primary HIV Infection|primary hiv infection
745044|NCT00084032|PHI|phi
745045|NCT00084019|Treatment Experienced|treatment experienced
745046|NCT00083980|Kava|kava
745047|NCT00083980|Complementary Therapies|complementary therapies
745048|NCT00083980|Medicine, Herbal|medicine, herbal
745049|NCT00083967|rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
745050|NCT00083967|detached retina|detached retina
745051|NCT00083967|retinal tear|retinal tear
745052|NCT00083967|retinal break|retinal break
745053|NCT00083954|Bipolar I Disorder|bipolar i disorder
745054|NCT00083941|Renal Cell Cancer|renal cell cancer
745055|NCT00083941|Requiring IL-2 treatment|requiring il-2 treatment
745056|NCT00083941|Stage IV Renal Cell Cancer|stage iv renal cell cancer
745057|NCT00083928|Asymptomatic|asymptomatic
745058|NCT00083928|subcutaneous|subcutaneous
745059|NCT00083928|CA125 Progression|ca125 progression
745060|NCT00083928|Angstrom|angstrom
745061|NCT00083928|Ångstrom|ångstrom
745062|NCT00083928|ovarian cancer|ovarian cancer
745063|NCT00083915|Multiple Myeloma|multiple myeloma
745064|NCT00083915|DTPACE|dtpace
745065|NCT00083915|Tandem Transplant|tandem transplant
745066|NCT00083915|Cisplatin|cisplatin
745067|NCT00083915|Cyclophosphamide|cyclophosphamide
745068|NCT00083915|Dexamethasone|dexamethasone
745076|NCT00083902|Dexamethasone|dexamethasone
745077|NCT00083876|Multiple Myeloma|multiple myeloma
745078|NCT00083876|D.T. PACE|d.t. pace
745079|NCT00083876|Melphalan|melphalan
745080|NCT00083876|Transplant|transplant
745081|NCT00083876|Thalidomide|thalidomide
745082|NCT00083876|Dexamethasone|dexamethasone
745083|NCT00083876|Cisplatin|cisplatin
745088|NCT00083876|Interferon-alpha 2b|interferon-alpha 2b
745089|NCT00083876|Sargramostim|sargramostim
745090|NCT00005032|recurrent small cell lung cancer|recurrent small cell lung cancer
745091|NCT00005030|stage IV colon cancer|stage iv colon cancer
745092|NCT00005030|stage IV rectal cancer|stage iv rectal cancer
745093|NCT00005030|recurrent colon cancer|recurrent colon cancer
745094|NCT00005030|recurrent rectal cancer|recurrent rectal cancer
745095|NCT00005030|liver metastases|liver metastases
745096|NCT00004979|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
745097|NCT00004927|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
745098|NCT00004877|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
745099|NCT00004161|lip and oral cavity cancer|lip and oral cavity cancer
745100|NCT00004071|stage IV prostate cancer|stage iv prostate cancer
745101|NCT00004071|recurrent prostate cancer|recurrent prostate cancer
745102|NCT00004070|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
745103|NCT00004070|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
745104|NCT00004070|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
745105|NCT00004070|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
745106|NCT00004070|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
745107|NCT00004070|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
745108|NCT00004070|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
745109|NCT00004070|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
745110|NCT00004070|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
745111|NCT00004070|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
745112|NCT00004070|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
745113|NCT00004070|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
745114|NCT00004070|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
745115|NCT00004070|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
745116|NCT00004070|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
745117|NCT00004070|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
745118|NCT00004070|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
745119|NCT00004070|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
745120|NCT00004070|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
745121|NCT00004070|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
745122|NCT00004062|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
745123|NCT00004062|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
745124|NCT00004062|recurrent thyroid cancer|recurrent thyroid cancer
745125|NCT00083772|Heart failure|heart failure
745126|NCT00083772|Diastolic heart failure|diastolic heart failure
745127|NCT00083772|Congestive heart failure|congestive heart failure
745128|NCT00083772|Nesiritide|nesiritide
745129|NCT00083772|Natrecor|natrecor
745130|NCT00083772|Left ventricular (LV) diastolic function|left ventricular (lv) diastolic function
745131|NCT00083772|Fatigue|fatigue
745132|NCT00083772|Shortness of breath|shortness of breath
745133|NCT00083772|Edema|edema
745134|NCT00083772|Heart disease|heart disease
745135|NCT00004055|extensive stage small cell lung cancer|extensive stage small cell lung cancer
745136|NCT00003998|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
745137|NCT00003998|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
745138|NCT00003998|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
745139|NCT00003998|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
745140|NCT00003998|primary peritoneal cavity cancer|primary peritoneal cavity cancer
745141|NCT00003997|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
745142|NCT00003997|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
745143|NCT00003997|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
745144|NCT00003997|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
745145|NCT00003997|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
745146|NCT00003991|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
745147|NCT00003939|adult angiosarcoma|adult angiosarcoma
745148|NCT00003939|adult fibrosarcoma|adult fibrosarcoma
758561|NCT00069706|ocular|ocular
745149|NCT00003939|adult leiomyosarcoma|adult leiomyosarcoma
745150|NCT00003939|adult liposarcoma|adult liposarcoma
745151|NCT00003939|adult neurofibrosarcoma|adult neurofibrosarcoma
745152|NCT00003939|adult synovial sarcoma|adult synovial sarcoma
745153|NCT00003939|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
745154|NCT00003939|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
745155|NCT00003939|small intestine leiomyosarcoma|small intestine leiomyosarcoma
745156|NCT00003939|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
745157|NCT00003939|adult epithelioid sarcoma|adult epithelioid sarcoma
745158|NCT00003939|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
745159|NCT00003939|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
745160|NCT00003939|adult malignant mesenchymoma|adult malignant mesenchymoma
745161|NCT00003939|adult rhabdomyosarcoma|adult rhabdomyosarcoma
745162|NCT00003939|stage IV uterine sarcoma|stage iv uterine sarcoma
745163|NCT00003939|recurrent uterine sarcoma|recurrent uterine sarcoma
745164|NCT00003939|uterine carcinosarcoma|uterine carcinosarcoma
745165|NCT00003939|uterine leiomyosarcoma|uterine leiomyosarcoma
745166|NCT00003939|endometrial stromal sarcoma|endometrial stromal sarcoma
745167|NCT00003939|ovarian sarcoma|ovarian sarcoma
745168|NCT00003939|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
745169|NCT00003939|gastrointestinal stromal tumor|gastrointestinal stromal tumor
745170|NCT00003856|recurrent salivary gland cancer|recurrent salivary gland cancer
745171|NCT00003856|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
745172|NCT00003856|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
745173|NCT00003856|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
745174|NCT00003856|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
745175|NCT00003856|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
745176|NCT00003856|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
745177|NCT00003856|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
745178|NCT00003850|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
745179|NCT00003850|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
745180|NCT00003850|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
745181|NCT00003850|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
745390|NCT00083538|Multiple Myeloma|multiple myeloma
745182|NCT00003850|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
745183|NCT00003850|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
745184|NCT00003850|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
745185|NCT00003850|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
745186|NCT00003850|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
745187|NCT00003850|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
745188|NCT00003850|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
745189|NCT00003850|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
745190|NCT00003850|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
745191|NCT00003850|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
745192|NCT00003787|stage I breast cancer|stage i breast cancer
745193|NCT00003787|stage II breast cancer|stage ii breast cancer
745194|NCT00003787|stage IIIA breast cancer|stage iiia breast cancer
745195|NCT00003787|recurrent breast cancer|recurrent breast cancer
745196|NCT00003773|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
745197|NCT00003758|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
745198|NCT00003758|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
745199|NCT00003758|adult acute monoblastic leukemia and acute monocytic leukemia (M5)|adult acute monoblastic leukemia and acute monocytic leukemia (m5)
745200|NCT00003758|childhood acute monoblastic leukemia and acute monocytic leukemia (M5)|childhood acute monoblastic leukemia and acute monocytic leukemia (m5)
745201|NCT00003758|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
745202|NCT00003758|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
745203|NCT00003758|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
745204|NCT00003758|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
745205|NCT00003758|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
745206|NCT00003758|adult acute basophilic leukemia|adult acute basophilic leukemia
745207|NCT00003758|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
745208|NCT00003758|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
745209|NCT00003758|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
745210|NCT00003758|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
745211|NCT00003758|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
745212|NCT00003758|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
745213|NCT00003758|childhood acute basophilic leukemia|childhood acute basophilic leukemia
745214|NCT00003758|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
745215|NCT00003758|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
745216|NCT00003758|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
745217|NCT00003755|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
745218|NCT00003740|stage IV prostate cancer|stage iv prostate cancer
745219|NCT00003740|recurrent prostate cancer|recurrent prostate cancer
745220|NCT00003443|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
745221|NCT00003443|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
745222|NCT00003443|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
745223|NCT00003443|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
745224|NCT00003443|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
745225|NCT00003443|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
745226|NCT00003443|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
745227|NCT00003443|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
745228|NCT00003443|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
745229|NCT00003443|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
745230|NCT00003443|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
745231|NCT00003443|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
745232|NCT00003401|refractory multiple myeloma|refractory multiple myeloma
745233|NCT00003401|stage I multiple myeloma|stage i multiple myeloma
745234|NCT00003401|stage II multiple myeloma|stage ii multiple myeloma
745235|NCT00003401|stage III multiple myeloma|stage iii multiple myeloma
745236|NCT00003399|refractory multiple myeloma|refractory multiple myeloma
745237|NCT00003399|stage I multiple myeloma|stage i multiple myeloma
745238|NCT00003399|stage II multiple myeloma|stage ii multiple myeloma
745239|NCT00003399|stage III multiple myeloma|stage iii multiple myeloma
745240|NCT00003396|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
745241|NCT00003396|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
745242|NCT00003396|refractory multiple myeloma|refractory multiple myeloma
745243|NCT00003396|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
745244|NCT00003396|stage I multiple myeloma|stage i multiple myeloma
745245|NCT00003396|stage II multiple myeloma|stage ii multiple myeloma
745246|NCT00003396|stage III multiple myeloma|stage iii multiple myeloma
745247|NCT00003396|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
745248|NCT00003396|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
745249|NCT00003396|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
745250|NCT00003396|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
745251|NCT00003396|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
745252|NCT00003396|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
745253|NCT00003396|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
745254|NCT00003396|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
745255|NCT00003396|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
745256|NCT00003396|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
745257|NCT00003396|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
745258|NCT00003396|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
745259|NCT00003396|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
745260|NCT00003396|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
745261|NCT00003396|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
745262|NCT00003396|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
745263|NCT00003396|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
745264|NCT00003396|adult acute basophilic leukemia|adult acute basophilic leukemia
745265|NCT00003396|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
745266|NCT00003396|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
745267|NCT00003396|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
745268|NCT00003396|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
745269|NCT00003396|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
745391|NCT00083538|DTPACE|dtpace
745270|NCT00003396|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
745271|NCT00003396|childhood acute basophilic leukemia|childhood acute basophilic leukemia
745272|NCT00003396|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
745273|NCT00003396|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
745274|NCT00003396|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
745275|NCT00003396|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
745276|NCT00003396|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
745277|NCT00003396|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
745278|NCT00003396|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
745279|NCT00003396|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
745280|NCT00003396|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
745281|NCT00003396|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
745282|NCT00003396|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
745283|NCT00003396|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
745284|NCT00003396|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
745285|NCT00003396|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
745286|NCT00003396|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
745287|NCT00003396|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
745288|NCT00003396|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
745289|NCT00003396|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
745290|NCT00003396|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
745291|NCT00003396|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
745292|NCT00003396|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
745293|NCT00003396|splenic marginal zone lymphoma|splenic marginal zone lymphoma
745294|NCT00003396|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
745295|NCT00003293|recurrent adult brain tumor|recurrent adult brain tumor
745296|NCT00003293|adult glioblastoma|adult glioblastoma
745297|NCT00003293|adult giant cell glioblastoma|adult giant cell glioblastoma
745298|NCT00003293|adult gliosarcoma|adult gliosarcoma
745299|NCT00003249|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
745300|NCT00003231|squamous cell lung cancer|squamous cell lung cancer
745301|NCT00003231|large cell lung cancer|large cell lung cancer
745302|NCT00003231|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
745303|NCT00003231|adenocarcinoma of the lung|adenocarcinoma of the lung
745304|NCT00083720|EGFR-undetectable|egfr-undetectable
745305|NCT00083720|Metastatic Colorectal Cancer|metastatic colorectal cancer
745306|NCT00083733|Gene Expression|gene expression
745307|NCT00083733|Microarray|microarray
745308|NCT00083733|Stem Cell|stem cell
745309|NCT00083733|Proteomics|proteomics
745310|NCT00083733|Metastases|metastases
745311|NCT00083733|Breast Tissue|breast tissue
745312|NCT00083733|Normal Breast Tissue|normal breast tissue
745313|NCT00083733|Breast Cancer|breast cancer
745314|NCT00083707|Macroglobulinemia|macroglobulinemia
745315|NCT00083707|Waldenstrom|waldenstrom
745316|NCT00083707|Thalidomide|thalidomide
745317|NCT00083694|Leukemia|leukemia
745318|NCT00083694|Thalidomide|thalidomide
745319|NCT00083694|relapsed|relapsed
745320|NCT00083681|Multiple Myeloma|multiple myeloma
745321|NCT00083681|Thalidomide|thalidomide
745322|NCT00083681|G-CSF|g-csf
745323|NCT00083681|Cisplatin|cisplatin
745324|NCT00083681|Etoposide|etoposide
745325|NCT00083681|Dexamethasone|dexamethasone
745326|NCT00083681|Cytoxan|cytoxan
745327|NCT00083681|DCEP|dcep
745328|NCT00083681|Relapse|relapse
745329|NCT00083668|Schizophrenia|schizophrenia
745330|NCT00083668|Paliperidone|paliperidone
745331|NCT00083668|Olanzapine|olanzapine
745332|NCT00083668|PANSS|panss
745333|NCT00083668|Extended release|extended release
745334|NCT00083668|Atypical neuroleptic|atypical neuroleptic
745335|NCT00083616|EGFr|egfr
745336|NCT00083616|Clinical Trial|clinical trial
745337|NCT00083616|Panitumumab|panitumumab
745338|NCT00083616|ABX-EGF|abx-egf
745339|NCT00083616|Immunex|immunex
745340|NCT00083616|Metastatic Cancer|metastatic cancer
745341|NCT00083616|Vectibix|vectibix
745342|NCT00083616|Abgenix|abgenix
745343|NCT00083616|Amgen|amgen
745344|NCT00083564|Multiple myeloma|multiple myeloma
745345|NCT00083564|Primary refractory multiple myeloma|primary refractory multiple myeloma
745346|NCT00083564|STR|str
745347|NCT00083564|Skeletal Targeted Radiotherapy|skeletal targeted radiotherapy
745348|NCT00083564|Holmium-166|holmium-166
745349|NCT00083564|166-Ho-DOTMP|166-ho-dotmp
745350|NCT00083642|Brain Plasticity|brain plasticity
745351|NCT00083642|Functional MRI|functional mri
745352|NCT00083642|Finger Movement|finger movement
745353|NCT00083642|Rehabilitation|rehabilitation
745354|NCT00083642|Improvement|improvement
745355|NCT00083642|Stroke|stroke
745356|NCT00083642|Motor Recovery|motor recovery
745357|NCT00083642|Observation|observation
745358|NCT00083642|fMRI|fmri
745359|NCT00083642|Healthy Volunteer|healthy volunteer
745360|NCT00083642|HV|hv
745361|NCT00083629|[18F]FECNT|[18f]fecnt
745362|NCT00083629|Biodistribution|biodistribution
745363|NCT00083629|Dosimetry|dosimetry
745364|NCT00083629|Dopamine Transporter|dopamine transporter
745365|NCT00083629|MIRD|mird
745366|NCT00083629|Kinetic Analysis|kinetic analysis
745367|NCT00083629|Compartment Analysis|compartment analysis
745368|NCT00083629|Healthy Volunteer|healthy volunteer
745369|NCT00083629|HV|hv
745370|NCT00083603|HIV Seronegativity|hiv seronegativity
745371|NCT00083603|HIV Preventive Vaccine|hiv preventive vaccine
745372|NCT00083603|Vaccinia vector|vaccinia vector
745373|NCT00083603|Pox vector|pox vector
745374|NCT00083590|Alzheimer disease|alzheimer disease
745375|NCT00083590|Cholinesterase inhibitor|cholinesterase inhibitor
745376|NCT00083577|Multiple Myeloma|multiple myeloma
745377|NCT00083577|Thalidomide|thalidomide
745378|NCT00083577|Anti-Angiogenesis|anti-angiogenesis
745379|NCT00083551|Multiple Myeloma|multiple myeloma
745380|NCT00083551|Cancer|cancer
745381|NCT00083551|Therapy|therapy
745382|NCT00083551|Thalidomide|thalidomide
745383|NCT00083551|DTPACE|dtpace
745384|NCT00083551|Transplant|transplant
745385|NCT00083551|VAD|vad
745386|NCT00083551|DCEP|dcep
745387|NCT00083551|CAD|cad
745388|NCT00083551|Consolidation|consolidation
745389|NCT00083551|Melphalan|melphalan
745392|NCT00083538|Dexamethasone|dexamethasone
745393|NCT00083538|Thalidomide|thalidomide
745394|NCT00083538|Cisplatin|cisplatin
745395|NCT00083538|Cytoxan|cytoxan
745396|NCT00083538|Doxorubicin|doxorubicin
745397|NCT00083538|Etoposide|etoposide
745398|NCT00083538|Dendritic Cell Vaccination|dendritic cell vaccination
745399|NCT00083538|Leukapheresis|leukapheresis
745400|NCT00003160|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
745401|NCT00003160|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
745402|NCT00003160|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
745403|NCT00003160|fallopian tube cancer|fallopian tube cancer
745404|NCT00003160|primary peritoneal cavity cancer|primary peritoneal cavity cancer
745405|NCT00003079|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
745406|NCT00003079|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
745407|NCT00003079|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
745408|NCT00003079|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
745409|NCT00003075|cervical cancer|cervical cancer
745410|NCT00003075|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
745411|NCT00003075|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
745412|NCT00003031|infection|infection
745413|NCT00003031|pulmonary complications|pulmonary complications
745414|NCT00003015|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
745415|NCT00003015|childhood oligodendroglioma|childhood oligodendroglioma
745416|NCT00003015|untreated childhood visual pathway glioma|untreated childhood visual pathway glioma
745417|NCT00003015|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
745418|NCT00083473|Leukemia Lymphocytic Chronic,|leukemia lymphocytic chronic,
745419|NCT00083473|Pivanex,|pivanex,
745420|NCT00083473|Histone deacetylase inhibitor|histone deacetylase inhibitor
745421|NCT00083460|Multiple Myeloma|multiple myeloma
745422|NCT00083460|Thalidomide|thalidomide
745423|NCT00083460|Velcade|velcade
745424|NCT00083460|PS-341|ps-341
745425|NCT00083460|Refractory|refractory
745426|NCT00083460|Bortezomid|bortezomid
745427|NCT00083447|brain tumor|brain tumor
745428|NCT00083447|GBM|gbm
745429|NCT00083447|glioblastoma|glioblastoma
745430|NCT00083447|glioblastoma multiforme|glioblastoma multiforme
745431|NCT00083447|brain cancer|brain cancer
745432|NCT00083447|treatment|treatment
745433|NCT00083434|Anemia|anemia
745434|NCT00083434|Cancer|cancer
745435|NCT00006877|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
745436|NCT00006877|squamous cell lung cancer|squamous cell lung cancer
745437|NCT00006877|large cell lung cancer|large cell lung cancer
745438|NCT00006877|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
745439|NCT00006877|adenocarcinoma of the lung|adenocarcinoma of the lung
745440|NCT00006358|recurrent adult brain tumor|recurrent adult brain tumor
745441|NCT00006358|adult glioblastoma|adult glioblastoma
745442|NCT00006358|adult giant cell glioblastoma|adult giant cell glioblastoma
745443|NCT00006358|adult gliosarcoma|adult gliosarcoma
745444|NCT00006343|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
745445|NCT00006343|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
745446|NCT00006222|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
745447|NCT00006222|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
745448|NCT00006212|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
745449|NCT00006212|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
745450|NCT00006212|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
745451|NCT00006083|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
745452|NCT00006083|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
745453|NCT00006083|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
745454|NCT00006083|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
745455|NCT00006083|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
745456|NCT00006083|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
745457|NCT00006083|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
745458|NCT00006083|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
745459|NCT00006083|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
745460|NCT00006083|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
745461|NCT00006083|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
745462|NCT00006083|stage IB cervical cancer|stage ib cervical cancer
745463|NCT00006083|Burkitt lymphoma|burkitt lymphoma
745464|NCT00006083|isolated plasmacytoma of bone|isolated plasmacytoma of bone
745465|NCT00006083|extramedullary plasmacytoma|extramedullary plasmacytoma
745466|NCT00006083|refractory multiple myeloma|refractory multiple myeloma
745467|NCT00006083|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
745468|NCT00006083|stage I multiple myeloma|stage i multiple myeloma
745469|NCT00006083|stage II multiple myeloma|stage ii multiple myeloma
745470|NCT00006083|stage III multiple myeloma|stage iii multiple myeloma
745471|NCT00006083|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
745472|NCT00006083|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
745473|NCT00006083|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
745474|NCT00006083|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
745475|NCT00006083|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
745476|NCT00006083|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
745477|NCT00006083|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
745478|NCT00006083|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
745479|NCT00006083|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
745480|NCT00006083|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
745481|NCT00006083|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
745482|NCT00006083|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
745483|NCT00006083|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
745484|NCT00006083|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
745485|NCT00006083|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
745486|NCT00006083|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
745487|NCT00006083|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
745488|NCT00006083|essential thrombocythemia|essential thrombocythemia
745489|NCT00006083|untreated hairy cell leukemia|untreated hairy cell leukemia
745490|NCT00006083|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
745491|NCT00006083|refractory hairy cell leukemia|refractory hairy cell leukemia
745492|NCT00006083|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
745493|NCT00006083|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
745494|NCT00006083|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
745495|NCT00006083|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
748241|NCT00082017|T-Cell Lymphoma|t-cell lymphoma
745496|NCT00006083|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
745497|NCT00006083|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
745498|NCT00006083|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
745499|NCT00006083|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
745500|NCT00006083|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
745501|NCT00006083|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
745502|NCT00006083|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
745503|NCT00006083|acute undifferentiated leukemia|acute undifferentiated leukemia
745504|NCT00006083|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
745505|NCT00006083|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
745506|NCT00006083|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
745507|NCT00006083|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
745508|NCT00006083|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
745509|NCT00006083|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
745510|NCT00006083|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
745511|NCT00006083|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
745512|NCT00006083|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
745513|NCT00006083|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
745514|NCT00006083|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
745515|NCT00006083|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
745516|NCT00006083|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
745517|NCT00006083|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
745518|NCT00006083|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
745519|NCT00006083|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
745520|NCT00006083|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
745521|NCT00006083|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
745522|NCT00006083|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
745523|NCT00006083|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
745524|NCT00006083|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
745525|NCT00006083|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
745526|NCT00006083|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
745527|NCT00006083|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
745528|NCT00006083|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
745529|NCT00006083|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
745530|NCT00006083|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
745531|NCT00006083|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
745532|NCT00006083|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
745533|NCT00006083|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
745534|NCT00006083|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
745535|NCT00006083|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
745536|NCT00006083|secondary acute myeloid leukemia|secondary acute myeloid leukemia
745537|NCT00006083|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
745538|NCT00006083|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
745539|NCT00006083|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
745540|NCT00006083|primary central nervous system lymphoma|primary central nervous system lymphoma
745541|NCT00006083|prolymphocytic leukemia|prolymphocytic leukemia
745542|NCT00006083|primary systemic amyloidosis|primary systemic amyloidosis
745543|NCT00006083|veno-occlusive disease|veno-occlusive disease
745544|NCT00006083|stage I mantle cell lymphoma|stage i mantle cell lymphoma
745545|NCT00006083|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
745546|NCT00006083|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
745547|NCT00006083|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
745548|NCT00006083|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
745549|NCT00006083|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
745550|NCT00006083|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
745551|NCT00006083|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
745552|NCT00006083|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
745553|NCT00006083|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
745554|NCT00006083|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
745555|NCT00006083|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
745556|NCT00006083|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
745557|NCT00006083|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
745558|NCT00006083|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
745559|NCT00006083|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
745560|NCT00006083|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
745561|NCT00006083|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
745562|NCT00006083|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
745563|NCT00006083|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
745564|NCT00006083|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
745565|NCT00006083|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
745566|NCT00006083|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
745567|NCT00006083|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
745568|NCT00006083|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
745569|NCT00006083|anaplastic large cell lymphoma|anaplastic large cell lymphoma
745570|NCT00006083|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
745571|NCT00006083|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
745572|NCT00006083|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
745573|NCT00006083|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
745574|NCT00006083|stage I marginal zone lymphoma|stage i marginal zone lymphoma
745575|NCT00006083|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
745576|NCT00006083|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
745577|NCT00006083|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
745578|NCT00006083|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
745579|NCT00006083|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
745580|NCT00006083|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
745581|NCT00006083|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
745582|NCT00006083|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
745583|NCT00006083|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
745584|NCT00006083|splenic marginal zone lymphoma|splenic marginal zone lymphoma
745585|NCT00006079|cervical cancer|cervical cancer
745586|NCT00006079|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
748242|NCT00081991|Cataract|cataract
745587|NCT00006079|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
745588|NCT00006079|Eflornithine|eflornithine
745589|NCT00006001|stage III colon cancer|stage iii colon cancer
745590|NCT00006001|stage IV colon cancer|stage iv colon cancer
745591|NCT00006001|stage III rectal cancer|stage iii rectal cancer
745592|NCT00006001|stage IV rectal cancer|stage iv rectal cancer
745593|NCT00006001|recurrent colon cancer|recurrent colon cancer
745594|NCT00006001|recurrent rectal cancer|recurrent rectal cancer
745595|NCT00006001|adenocarcinoma of the colon|adenocarcinoma of the colon
745596|NCT00006001|adenocarcinoma of the rectum|adenocarcinoma of the rectum
745597|NCT00005939|stage I prostate cancer|stage i prostate cancer
745598|NCT00005939|stage IIB prostate cancer|stage iib prostate cancer
745599|NCT00005939|stage IIA prostate cancer|stage iia prostate cancer
745600|NCT00005939|stage III prostate cancer|stage iii prostate cancer
745601|NCT00005939|recurrent prostate cancer|recurrent prostate cancer
745602|NCT00005841|iris melanoma|iris melanoma
745603|NCT00005841|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
745604|NCT00005841|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
745605|NCT00005841|extraocular extension melanoma|extraocular extension melanoma
745606|NCT00005841|recurrent intraocular melanoma|recurrent intraocular melanoma
745607|NCT00005841|stage III melanoma|stage iii melanoma
745608|NCT00005841|stage IV melanoma|stage iv melanoma
745609|NCT00005841|recurrent melanoma|recurrent melanoma
745610|NCT00005645|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
745611|NCT00005645|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
745612|NCT00005645|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
745613|NCT00005645|liver metastases|liver metastases
745614|NCT00005645|malignant pericardial effusion|malignant pericardial effusion
745615|NCT00005645|malignant pleural effusion|malignant pleural effusion
745616|NCT00005645|malignant ascites|malignant ascites
745617|NCT00005645|fallopian tube cancer|fallopian tube cancer
745618|NCT00005645|primary peritoneal cavity cancer|primary peritoneal cavity cancer
745619|NCT00005640|stage I colon cancer|stage i colon cancer
745620|NCT00005640|stage II colon cancer|stage ii colon cancer
745621|NCT00005640|stage III colon cancer|stage iii colon cancer
745622|NCT00005640|stage I rectal cancer|stage i rectal cancer
745623|NCT00005640|stage II rectal cancer|stage ii rectal cancer
745624|NCT00005640|stage III rectal cancer|stage iii rectal cancer
745625|NCT00005636|localized malignant mesothelioma|localized malignant mesothelioma
745626|NCT00005636|advanced malignant mesothelioma|advanced malignant mesothelioma
745627|NCT00005636|recurrent malignant mesothelioma|recurrent malignant mesothelioma
745628|NCT00005578|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
745629|NCT00005578|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
745630|NCT00005578|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
745631|NCT00005578|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
745632|NCT00005578|cardiac toxicity|cardiac toxicity
745633|NCT00005088|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
745634|NCT00005088|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
745635|NCT00005088|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
745636|NCT00005088|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
745637|NCT00005088|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
745638|NCT00005088|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
745639|NCT00005088|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
745640|NCT00005088|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
745641|NCT00005069|stage IV renal cell cancer|stage iv renal cell cancer
745642|NCT00005069|recurrent renal cell cancer|recurrent renal cell cancer
745643|NCT00005059|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
745644|NCT00005059|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
745645|NCT00002923|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
745646|NCT00002917|stage 0 bladder cancer|stage 0 bladder cancer
745647|NCT00002917|stage I bladder cancer|stage i bladder cancer
745648|NCT00002917|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
745649|NCT00002911|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
745650|NCT00002911|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
745651|NCT00002829|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
745652|NCT00002829|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
745653|NCT00002829|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
745654|NCT00002829|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
745655|NCT00002829|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
745656|NCT00002829|extranodal marginal zone B-cell lymphoma|extranodal marginal zone b-cell lymphoma
745657|NCT00002829|mucosa-associated lymphoid tissue|mucosa-associated lymphoid tissue
745658|NCT00002829|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
745659|NCT00002829|splenic marginal zone lymphoma|splenic marginal zone lymphoma
745660|NCT00002827|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
745661|NCT00002827|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
745662|NCT00002827|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
745663|NCT00002827|cardiac toxicity|cardiac toxicity
745664|NCT00002819|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
745665|NCT00002819|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
745666|NCT00002819|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
745667|NCT00002819|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
745668|NCT00002819|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
745669|NCT00002819|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
745670|NCT00002819|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
745671|NCT00002819|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
745672|NCT00002819|Brenner tumor|brenner tumor
745673|NCT00002806|adult diffuse astrocytoma|adult diffuse astrocytoma
745674|NCT00002721|recurrent prostate cancer|recurrent prostate cancer
745675|NCT00002639|recurrent adult brain tumor|recurrent adult brain tumor
745676|NCT00002639|adult glioblastoma|adult glioblastoma
745677|NCT00002639|adult anaplastic astrocytoma|adult anaplastic astrocytoma
745678|NCT00002639|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
745679|NCT00002639|adult mixed glioma|adult mixed glioma
745680|NCT00002639|adult giant cell glioblastoma|adult giant cell glioblastoma
745681|NCT00002639|adult gliosarcoma|adult gliosarcoma
745682|NCT00002602|adenocarcinoma of the prostate|adenocarcinoma of the prostate
745683|NCT00002602|stage IIB prostate cancer|stage iib prostate cancer
745684|NCT00002602|stage IIA prostate cancer|stage iia prostate cancer
745685|NCT00002602|stage III prostate cancer|stage iii prostate cancer
745686|NCT00002555|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
745687|NCT00002555|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
745688|NCT00002555|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
745689|NCT00002555|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
745690|NCT00002555|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
745691|NCT00002555|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
745692|NCT00002555|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
745693|NCT00002555|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
745694|NCT00002477|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
745695|NCT00002477|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
745696|NCT00083512|Blood|blood
745697|NCT00083512|Urine|urine
745698|NCT00083512|GBM|gbm
745699|NCT00083512|Radiation|radiation
745700|NCT00083512|Glioblastoma Multiforme|glioblastoma multiforme
745701|NCT00083499|Pental of Cantrell|pental of cantrell
745702|NCT00083499|TAS Syndrome|tas syndrome
745703|NCT00083499|Midline Defects|midline defects
745704|NCT00083499|Contractile Proteins|contractile proteins
745705|NCT00083499|Herniation|herniation
745706|NCT00083499|Nonmuscle Myosin IIC|nonmuscle myosin iic
745707|NCT00083499|Pentalogy of Cantrell|pentalogy of cantrell
745708|NCT00083499|Non-muscle Myosin Heavy Chain Genes|non-muscle myosin heavy chain genes
745709|NCT00083408|Multiple Myeloma|multiple myeloma
745710|NCT00083408|Pamidronate|pamidronate
745711|NCT00083408|Thalidomide|thalidomide
745712|NCT00083408|refractory myeloma|refractory myeloma
745713|NCT00083408|bisphosphonates|bisphosphonates
745714|NCT00083408|Aredia|aredia
745715|NCT00004881|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
745716|NCT00004200|adult glioblastoma|adult glioblastoma
745717|NCT00004200|adult giant cell glioblastoma|adult giant cell glioblastoma
745718|NCT00004200|adult gliosarcoma|adult gliosarcoma
745719|NCT00004190|stage III pancreatic cancer|stage iii pancreatic cancer
745720|NCT00004190|recurrent pancreatic cancer|recurrent pancreatic cancer
745721|NCT00004190|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
745722|NCT00004190|stage IV pancreatic cancer|stage iv pancreatic cancer
745723|NCT00004176|limited stage small cell lung cancer|limited stage small cell lung cancer
745724|NCT00004176|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
745725|NCT00004176|radiation toxicity|radiation toxicity
745726|NCT00004139|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
745727|NCT00004139|squamous cell lung cancer|squamous cell lung cancer
745728|NCT00004139|large cell lung cancer|large cell lung cancer
745729|NCT00004139|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
745730|NCT00004139|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
745731|NCT00004139|adenocarcinoma of the lung|adenocarcinoma of the lung
745732|NCT00004139|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
745733|NCT00004112|stage II adult diffuse small cleaved cell lymphoma|stage ii adult diffuse small cleaved cell lymphoma
745734|NCT00004112|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
745735|NCT00004112|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
745736|NCT00004112|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
745737|NCT00004112|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
745738|NCT00004112|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
745739|NCT00004112|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
745740|NCT00004112|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
745741|NCT00004112|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
745742|NCT00004112|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
745743|NCT00004112|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
745744|NCT00004112|anaplastic large cell lymphoma|anaplastic large cell lymphoma
745745|NCT00004112|stage II mantle cell lymphoma|stage ii mantle cell lymphoma
745746|NCT00004112|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
745747|NCT00004112|stage II marginal zone lymphoma|stage ii marginal zone lymphoma
745748|NCT00004112|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
745749|NCT00004112|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
745750|NCT00004112|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
745751|NCT00004112|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
745752|NCT00004112|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
745753|NCT00004112|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
745754|NCT00004112|splenic marginal zone lymphoma|splenic marginal zone lymphoma
745755|NCT00004105|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
745756|NCT00004105|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
745757|NCT00004105|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
745758|NCT00004105|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
745759|NCT00004105|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
745760|NCT00004105|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
745761|NCT00004105|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
745762|NCT00004105|childhood fibrosarcoma|childhood fibrosarcoma
745763|NCT00004105|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
745764|NCT00004105|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
745765|NCT00004105|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
745766|NCT00004105|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
745767|NCT00004105|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
745768|NCT00004105|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
745769|NCT00004105|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
745770|NCT00004105|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
745771|NCT00004105|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
745772|NCT00004105|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
745773|NCT00004105|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
745774|NCT00004105|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
745775|NCT00004105|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
745776|NCT00004105|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
745777|NCT00004105|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
745778|NCT00004105|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
745779|NCT00004105|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
745780|NCT00004105|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
745781|NCT00004105|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
745782|NCT00004105|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
745783|NCT00004105|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
745784|NCT00004105|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
745785|NCT00004105|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
745786|NCT00004105|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
745787|NCT00004105|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
748243|NCT00081991|Blindness|blindness
745788|NCT00004105|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
745789|NCT00004105|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
745790|NCT00004105|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
745791|NCT00004105|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
745792|NCT00004105|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
745793|NCT00004105|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
745794|NCT00004105|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
745795|NCT00004105|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
745796|NCT00004105|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
745797|NCT00004105|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
745798|NCT00004105|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
745799|NCT00004105|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
745800|NCT00004105|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
745801|NCT00004105|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
745802|NCT00004105|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
745803|NCT00004105|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
745804|NCT00004105|splenic marginal zone lymphoma|splenic marginal zone lymphoma
745805|NCT00004061|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
745806|NCT00004061|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
745807|NCT00004061|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
745808|NCT00004061|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
745809|NCT00004061|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
745810|NCT00004061|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
745811|NCT00004061|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
745812|NCT00004061|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
745813|NCT00004061|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
745814|NCT00004061|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
745815|NCT00004061|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
745816|NCT00004061|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
745817|NCT00004061|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
745818|NCT00004061|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
745819|NCT00004061|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
745820|NCT00004061|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
745821|NCT00004061|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
745822|NCT00004061|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
745823|NCT00004061|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
745824|NCT00004061|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
745825|NCT00004061|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
745826|NCT00004061|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
745827|NCT00004061|oral complications|oral complications
745828|NCT00004061|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
745829|NCT00004061|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
745830|NCT00004061|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
745831|NCT00004061|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
745832|NCT00004061|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
745833|NCT00004061|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
745834|NCT00004061|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
745835|NCT00004061|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
745836|NCT00004061|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
745837|NCT00004061|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
745838|NCT00004061|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
745839|NCT00004061|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
745840|NCT00004061|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
745841|NCT00004061|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
745842|NCT00004061|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
745843|NCT00004061|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
745844|NCT00004061|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
745845|NCT00004061|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
745846|NCT00004061|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
745847|NCT00004061|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
745848|NCT00004061|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
745849|NCT00004061|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
745850|NCT00004061|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
745851|NCT00004061|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
745852|NCT00004061|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
745853|NCT00004061|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
745854|NCT00004061|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
745855|NCT00004061|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
745856|NCT00004061|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
745857|NCT00004061|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
745858|NCT00004061|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
745859|NCT00004061|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
745860|NCT00004061|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
745861|NCT00004061|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
745862|NCT00004061|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
745863|NCT00004061|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
745864|NCT00004061|secondary acute myeloid leukemia|secondary acute myeloid leukemia
745865|NCT00004061|stage I mantle cell lymphoma|stage i mantle cell lymphoma
745866|NCT00004061|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
745867|NCT00004061|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
745868|NCT00004061|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
745869|NCT00004061|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
745870|NCT00004061|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
745871|NCT00004061|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
745872|NCT00004061|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
745873|NCT00004061|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
745874|NCT00004061|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
745875|NCT00004061|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
745876|NCT00004061|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
745877|NCT00004061|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
745878|NCT00004061|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
745879|NCT00004061|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
745880|NCT00004061|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
745881|NCT00004061|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
745882|NCT00004061|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
745883|NCT00004061|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
745884|NCT00004061|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
745885|NCT00004061|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
745886|NCT00004061|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
745887|NCT00004061|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
745888|NCT00004061|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
745889|NCT00004061|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
745890|NCT00004061|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
745891|NCT00004061|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
745892|NCT00004061|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
745893|NCT00004061|stage I marginal zone lymphoma|stage i marginal zone lymphoma
745894|NCT00004061|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
745895|NCT00004061|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
745896|NCT00004061|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
745897|NCT00004061|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
745898|NCT00004061|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
745899|NCT00004061|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
745900|NCT00004061|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
745901|NCT00004061|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
745902|NCT00004061|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
745903|NCT00004061|splenic marginal zone lymphoma|splenic marginal zone lymphoma
745904|NCT00004030|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
745905|NCT00004012|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
745906|NCT00004012|fallopian tube cancer|fallopian tube cancer
745907|NCT00004012|primary peritoneal cavity cancer|primary peritoneal cavity cancer
745908|NCT00003985|non-small cell lung cancer|non-small cell lung cancer
745909|NCT00003985|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
745910|NCT00003984|refractory anemia with excess blasts|refractory anemia with excess blasts
745911|NCT00003984|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
745912|NCT00003984|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
745913|NCT00003984|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
745914|NCT00003984|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
745915|NCT00003982|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
745916|NCT00003982|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
745917|NCT00003980|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
745918|NCT00003944|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
745919|NCT00003944|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
745920|NCT00003944|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
745921|NCT00003944|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
745922|NCT00003944|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
745923|NCT00003944|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
745924|NCT00003944|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
745925|NCT00003944|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
745926|NCT00003944|fallopian tube cancer|fallopian tube cancer
745927|NCT00003944|peritoneal cavity cancer|peritoneal cavity cancer
745928|NCT00003846|regional neuroblastoma|regional neuroblastoma
745929|NCT00003846|disseminated neuroblastoma|disseminated neuroblastoma
745930|NCT00003846|stage 4S neuroblastoma|stage 4s neuroblastoma
745931|NCT00003846|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
745932|NCT00003846|untreated childhood medulloblastoma|untreated childhood medulloblastoma
745933|NCT00003846|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
745934|NCT00003752|stage IV breast cancer|stage iv breast cancer
745935|NCT00003752|recurrent breast cancer|recurrent breast cancer
745936|NCT00003669|stage IV endometrial carcinoma|stage iv endometrial carcinoma
745937|NCT00003669|recurrent endometrial carcinoma|recurrent endometrial carcinoma
745938|NCT00003580|oral complications|oral complications
745939|NCT00003580|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
745940|NCT00003580|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
745941|NCT00003580|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
745942|NCT00003580|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
745943|NCT00003580|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
745944|NCT00003580|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
745945|NCT00003580|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
745946|NCT00003580|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
745947|NCT00003580|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
745948|NCT00003580|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
745949|NCT00003580|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
745950|NCT00003580|radiation toxicity|radiation toxicity
745951|NCT00083395|ARVC/ARVD|arvc/arvd
745952|NCT00083395|Genetics|genetics
745953|NCT00083395|Sudden Death|sudden death
745954|NCT00083395|Heart|heart
745955|NCT00083395|MRI|mri
745956|NCT00083395|Cardiomyopathy|cardiomyopathy
745957|NCT00083395|Arrhythmogenic Right Ventricular|arrhythmogenic right ventricular
745958|NCT00083395|ARVC|arvc
745959|NCT00083395|Healthy Volunteer|healthy volunteer
745960|NCT00083395|HV|hv
745961|NCT00083382|Myeloma|myeloma
745962|NCT00083382|Thalidomide|thalidomide
745963|NCT00083382|Pamidronate|pamidronate
745964|NCT00083382|Aredia|aredia
745965|NCT00083382|Bisphosphonate|bisphosphonate
745966|NCT00083382|Anti-Angiogenesis|anti-angiogenesis
745967|NCT00083382|Smoldering/Indolent Myeloma|smoldering/indolent myeloma
745968|NCT00083382|Zometa|zometa
745969|NCT00008229|stage I multiple myeloma|stage i multiple myeloma
745970|NCT00008229|stage II multiple myeloma|stage ii multiple myeloma
745971|NCT00008229|stage III multiple myeloma|stage iii multiple myeloma
745972|NCT00008073|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
745973|NCT00006344|limited stage small cell lung cancer|limited stage small cell lung cancer
745974|NCT00006344|extensive stage small cell lung cancer|extensive stage small cell lung cancer
745975|NCT00006269|stage IV colon cancer|stage iv colon cancer
745976|NCT00006269|stage IV rectal cancer|stage iv rectal cancer
745977|NCT00006269|recurrent colon cancer|recurrent colon cancer
745978|NCT00006269|recurrent rectal cancer|recurrent rectal cancer
745979|NCT00006269|diarrhea|diarrhea
745980|NCT00003614|adenocarcinoma of the prostate|adenocarcinoma of the prostate
745981|NCT00003614|stage IV prostate cancer|stage iv prostate cancer
745982|NCT00003614|recurrent prostate cancer|recurrent prostate cancer
745983|NCT00003523|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
745984|NCT00003523|primary peritoneal cavity cancer|primary peritoneal cavity cancer
745985|NCT00003518|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
745986|NCT00003518|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
745987|NCT00003518|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
745988|NCT00003518|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
745989|NCT00003444|stage III melanoma|stage iii melanoma
745990|NCT00003444|stage IV melanoma|stage iv melanoma
745991|NCT00003444|recurrent melanoma|recurrent melanoma
745992|NCT00003405|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
745993|NCT00003405|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
763608|NCT00060502|anorexia|anorexia
745994|NCT00003405|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
745995|NCT00003405|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
745996|NCT00003405|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
745997|NCT00003405|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
745998|NCT00003405|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
745999|NCT00003405|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
746000|NCT00003405|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
746001|NCT00003405|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
746002|NCT00003405|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
746003|NCT00003405|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
746004|NCT00003405|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
746005|NCT00003405|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
746006|NCT00003405|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
746007|NCT00003405|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
746008|NCT00003403|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
746009|NCT00003269|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
746010|NCT00003269|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
746011|NCT00003269|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
746012|NCT00003269|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
746013|NCT00003269|stage I breast cancer|stage i breast cancer
746014|NCT00003269|stage II breast cancer|stage ii breast cancer
746015|NCT00003269|stage IV breast cancer|stage iv breast cancer
746016|NCT00003269|stage IIIA breast cancer|stage iiia breast cancer
746017|NCT00003269|stage I non-small cell lung cancer|stage i non-small cell lung cancer
746018|NCT00003269|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
746019|NCT00003269|stage IIIB breast cancer|stage iiib breast cancer
746020|NCT00003269|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
746021|NCT00003269|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
746022|NCT00003269|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
746023|NCT00003269|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
746024|NCT00003269|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
746025|NCT00003269|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
746026|NCT00003269|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
746027|NCT00003269|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
746028|NCT00003269|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
746029|NCT00003269|limited stage small cell lung cancer|limited stage small cell lung cancer
746030|NCT00003269|extensive stage small cell lung cancer|extensive stage small cell lung cancer
746031|NCT00003269|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
746032|NCT00003269|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
746033|NCT00003269|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
746034|NCT00003269|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
746035|NCT00003269|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
746036|NCT00003269|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
746037|NCT00003269|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
746038|NCT00003269|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
746039|NCT00003269|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
746040|NCT00003269|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
746041|NCT00003269|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
746042|NCT00003269|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
746043|NCT00003269|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
746044|NCT00003269|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
746045|NCT00003269|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
746046|NCT00003269|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
746047|NCT00003269|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
746048|NCT00003269|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
746049|NCT00003269|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
746050|NCT00003269|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
746051|NCT00003269|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
746052|NCT00003269|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
746053|NCT00003269|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
746054|NCT00003269|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
746055|NCT00003269|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
746056|NCT00003269|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
746057|NCT00003269|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
763609|NCT00060502|anemia|anemia
746058|NCT00003269|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
746059|NCT00003269|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
746060|NCT00003269|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
746061|NCT00003269|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
746062|NCT00003269|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
746063|NCT00003269|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
746064|NCT00003269|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
746065|NCT00003269|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
746066|NCT00003269|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
746067|NCT00003269|stage I mantle cell lymphoma|stage i mantle cell lymphoma
746068|NCT00003269|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
746069|NCT00003269|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
746070|NCT00003269|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
746071|NCT00003269|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
746072|NCT00003269|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
748244|NCT00081991|Clinical|clinical
746073|NCT00003269|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
746074|NCT00003269|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
746075|NCT00003269|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
746076|NCT00003269|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
746077|NCT00003269|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
746078|NCT00003269|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
746079|NCT00003269|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
746080|NCT00003269|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
746081|NCT00003269|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
746082|NCT00003269|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
746083|NCT00003269|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
746084|NCT00003269|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
746085|NCT00003269|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
746086|NCT00003269|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
746087|NCT00003269|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
746088|NCT00003269|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
746089|NCT00003269|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
746090|NCT00003269|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
746091|NCT00003269|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
746092|NCT00003269|stage I marginal zone lymphoma|stage i marginal zone lymphoma
746093|NCT00003269|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
746094|NCT00003269|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
746095|NCT00003269|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
746096|NCT00003269|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
746097|NCT00003269|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
746098|NCT00003269|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
746099|NCT00003269|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
746100|NCT00003269|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
746101|NCT00003269|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
746102|NCT00003269|splenic marginal zone lymphoma|splenic marginal zone lymphoma
746103|NCT00003195|refractory multiple myeloma|refractory multiple myeloma
746104|NCT00003195|stage II multiple myeloma|stage ii multiple myeloma
746105|NCT00003195|stage III multiple myeloma|stage iii multiple myeloma
746106|NCT00003187|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
746107|NCT00003187|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
746108|NCT00003187|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
746109|NCT00003187|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
746110|NCT00003187|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
746111|NCT00003187|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
746112|NCT00003187|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
746113|NCT00003187|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
746114|NCT00003187|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
746115|NCT00003187|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
746116|NCT00003187|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
746447|NCT00002692|liver metastases|liver metastases
746117|NCT00003187|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
746118|NCT00003187|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
746119|NCT00003187|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
746120|NCT00003187|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
746121|NCT00003187|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
746122|NCT00003187|refractory anemia|refractory anemia
746123|NCT00003187|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
746124|NCT00003187|refractory anemia with excess blasts|refractory anemia with excess blasts
746125|NCT00003187|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
746126|NCT00003187|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
746127|NCT00003187|acute undifferentiated leukemia|acute undifferentiated leukemia
746128|NCT00003187|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
746129|NCT00003187|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
746130|NCT00003187|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
746131|NCT00003187|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
746132|NCT00003187|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
746133|NCT00003098|breast cancer|breast cancer
746134|NCT00003084|adenocarcinoma of the prostate|adenocarcinoma of the prostate
746135|NCT00003084|stage I prostate cancer|stage i prostate cancer
746136|NCT00003084|stage II prostate cancer|stage ii prostate cancer
746137|NCT00003084|stage III prostate cancer|stage iii prostate cancer
746138|NCT00003084|stage IV prostate cancer|stage iv prostate cancer
746139|NCT00003084|recurrent prostate cancer|recurrent prostate cancer
746140|NCT00003084|Chemotherapy|chemotherapy
746141|NCT00003084|Ketoconazole|ketoconazole
746142|NCT00003084|Estramustine|estramustine
746143|NCT00003084|Etoposide|etoposide
746144|NCT00003084|Paclitaxel|paclitaxel
746145|NCT00003084|Doxorubicin|doxorubicin
746146|NCT00003084|Vinblastine|vinblastine
746147|NCT00003056|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
746148|NCT00003056|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
746149|NCT00003056|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
746150|NCT00003056|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
746151|NCT00003056|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
746152|NCT00003056|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
746153|NCT00003056|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
746154|NCT00003056|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
746155|NCT00003056|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
746156|NCT00003056|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
746157|NCT00003056|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
746158|NCT00003056|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
746159|NCT00003056|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
746160|NCT00003056|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
746161|NCT00003056|graft versus host disease|graft versus host disease
746162|NCT00003056|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
746163|NCT00003056|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
746164|NCT00003056|splenic marginal zone lymphoma|splenic marginal zone lymphoma
746165|NCT00003056|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
746257|NCT00002567|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
746166|NCT00003056|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
746167|NCT00003056|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
746168|NCT00003056|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
746169|NCT00003056|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
746170|NCT00003004|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
746171|NCT00002924|adenocarcinoma of the prostate|adenocarcinoma of the prostate
746172|NCT00002924|recurrent prostate cancer|recurrent prostate cancer
746173|NCT00002902|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
746174|NCT00002875|untreated childhood medulloblastoma|untreated childhood medulloblastoma
746175|NCT00002780|stage IV breast cancer|stage iv breast cancer
746176|NCT00002780|recurrent breast cancer|recurrent breast cancer
746177|NCT00002780|stage IIIB breast cancer|stage iiib breast cancer
746178|NCT00002750|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
746179|NCT00002750|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
746180|NCT00002750|Waldenström macroglobulinemia|waldenström macroglobulinemia
746181|NCT00002750|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
746182|NCT00002750|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
746183|NCT00002750|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
746184|NCT00002750|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
746185|NCT00002750|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
746186|NCT00002750|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
746187|NCT00002750|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
746188|NCT00002750|recurrent adult non-Hodgkin lymphoma|recurrent adult non-hodgkin lymphoma
746189|NCT00002750|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
746190|NCT00002750|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
746191|NCT00002750|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
746192|NCT00002750|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
746193|NCT00002750|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
746194|NCT00002750|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
746195|NCT00002750|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
746196|NCT00002750|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
746197|NCT00002750|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
746198|NCT00002750|extragonadal germ cell tumor|extragonadal germ cell tumor
746199|NCT00002750|leptomeningeal metastases|leptomeningeal metastases
746200|NCT00002750|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
746201|NCT00002750|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
746202|NCT00002750|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
746203|NCT00002750|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
746204|NCT00002750|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
746205|NCT00002750|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
746206|NCT00002750|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
746207|NCT00002750|splenic marginal zone lymphoma|splenic marginal zone lymphoma
746208|NCT00002734|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
746209|NCT00002734|primary peritoneal cavity cancer|primary peritoneal cavity cancer
746210|NCT00002671|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
746211|NCT00002671|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
746212|NCT00002671|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
746213|NCT00002664|recurrent colon cancer|recurrent colon cancer
746214|NCT00002664|recurrent rectal cancer|recurrent rectal cancer
746215|NCT00002576|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
746216|NCT00002576|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
746217|NCT00002576|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
746218|NCT00002576|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
746219|NCT00002576|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
746220|NCT00002576|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
746221|NCT00002576|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
746222|NCT00002576|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
746223|NCT00002576|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
746224|NCT00002576|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
746225|NCT00002576|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
746226|NCT00002576|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
746227|NCT00002576|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
746228|NCT00002576|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
746229|NCT00002576|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
746230|NCT00002576|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
746231|NCT00002576|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
746232|NCT00002576|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
746233|NCT00002576|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
746234|NCT00002576|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
746235|NCT00002576|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
746236|NCT00002576|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
746237|NCT00002576|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
746238|NCT00002576|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
746239|NCT00002576|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
746240|NCT00002576|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
746241|NCT00002576|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
746242|NCT00002576|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
746243|NCT00002576|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
746244|NCT00002576|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
746245|NCT00002571|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
746246|NCT00002571|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
763610|NCT00060502|Remicade.|remicade.
746247|NCT00002571|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
746248|NCT00002571|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
746249|NCT00002571|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
746250|NCT00002571|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
746251|NCT00002567|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
746252|NCT00002567|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
746253|NCT00002567|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
746254|NCT00002567|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
746255|NCT00002567|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
746256|NCT00002567|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
746258|NCT00002567|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
746259|NCT00002567|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
746260|NCT00002567|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
746261|NCT00002567|bone marrow ablation|bone marrow ablation
746262|NCT00002567|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
746263|NCT00002552|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
746264|NCT00002552|refractory multiple myeloma|refractory multiple myeloma
746265|NCT00002552|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
746266|NCT00002552|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
746267|NCT00002552|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
746268|NCT00002552|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
746269|NCT00002552|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
746270|NCT00002552|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
746271|NCT00002552|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
746272|NCT00002552|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
746273|NCT00002552|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
746274|NCT00002552|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
746275|NCT00002552|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
746276|NCT00002552|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
746277|NCT00002552|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
746278|NCT00002552|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
746279|NCT00002552|splenic marginal zone lymphoma|splenic marginal zone lymphoma
746280|NCT00002552|adult unfavorable prognosis Hodgkin lymphoma|adult unfavorable prognosis hodgkin lymphoma
746281|NCT00002552|childhood unfavorable prognosis Hodgkin lymphoma|childhood unfavorable prognosis hodgkin lymphoma
746282|NCT00002547|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
746283|NCT00002547|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
746284|NCT00002547|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
746285|NCT00002547|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
746286|NCT00002547|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
746287|NCT00002547|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
746288|NCT00002547|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
746289|NCT00002547|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
746290|NCT00002547|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
746291|NCT00002547|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
746292|NCT00002547|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
746293|NCT00002547|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
746294|NCT00002547|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
746295|NCT00002547|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
746296|NCT00002547|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
746297|NCT00002547|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
746298|NCT00002547|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
746299|NCT00002547|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
746300|NCT00002547|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
746301|NCT00002547|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
746302|NCT00002547|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
746303|NCT00002547|refractory anemia with excess blasts|refractory anemia with excess blasts
746304|NCT00002547|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
746305|NCT00002547|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
746306|NCT00002547|secondary acute myeloid leukemia|secondary acute myeloid leukemia
746307|NCT00002547|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
746377|NCT00003322|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
746308|NCT00002547|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
746309|NCT00002547|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
746310|NCT00083356|Pain|pain
746311|NCT00083356|Kinins|kinins
746312|NCT00083356|Inflammation|inflammation
746313|NCT00083356|Gene Expression|gene expression
746314|NCT00083356|Oral Surgey|oral surgey
746315|NCT00083356|Bradykinin B1 Receptors|bradykinin b1 receptors
746316|NCT00083356|Acute Peripheral Inflammation|acute peripheral inflammation
746317|NCT00083356|Inflammatory Gene Expression|inflammatory gene expression
746318|NCT00083356|Wisdom Teeth|wisdom teeth
746319|NCT00083356|Third Molar Extraction|third molar extraction
746320|NCT00005648|Stage II pancreatic cancer|stage ii pancreatic cancer
746321|NCT00005648|Stage III pancreatic cancer|stage iii pancreatic cancer
746322|NCT00005648|Recurrent pancreatic cancer|recurrent pancreatic cancer
746323|NCT00005648|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
746324|NCT00005648|Stage IV pancreatic cancer|stage iv pancreatic cancer
746325|NCT00004198|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
746326|NCT00004198|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
746327|NCT00004198|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
746328|NCT00004198|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
746329|NCT00004126|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
746330|NCT00004126|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
746331|NCT00004126|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
746332|NCT00004122|stage I bladder cancer|stage i bladder cancer
746333|NCT00004122|recurrent bladder cancer|recurrent bladder cancer
746334|NCT00004122|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
746335|NCT00004113|recurrent adult brain tumor|recurrent adult brain tumor
746336|NCT00004113|adult glioblastoma|adult glioblastoma
746337|NCT00004113|adult anaplastic astrocytoma|adult anaplastic astrocytoma
746338|NCT00004113|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
746339|NCT00004113|adult mixed glioma|adult mixed glioma
746340|NCT00004113|adult giant cell glioblastoma|adult giant cell glioblastoma
746341|NCT00004113|adult gliosarcoma|adult gliosarcoma
746342|NCT00003976|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
746343|NCT00003908|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
746344|NCT00003908|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
746345|NCT00003908|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
746346|NCT00003908|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
746347|NCT00003908|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
746348|NCT00003908|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
746349|NCT00003908|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
746350|NCT00003908|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
746351|NCT00003908|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
747326|NCT00002893|stage IV colon cancer|stage iv colon cancer
746352|NCT00003908|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
746353|NCT00003908|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
746354|NCT00003908|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
746355|NCT00003908|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
746356|NCT00003908|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
746357|NCT00003822|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
746358|NCT00003747|stage IV melanoma|stage iv melanoma
746359|NCT00003747|recurrent melanoma|recurrent melanoma
746360|NCT00003724|lung metastases|lung metastases
746361|NCT00003670|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
746362|NCT00003670|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
746363|NCT00003670|primary peritoneal cavity cancer|primary peritoneal cavity cancer
746364|NCT00003606|extensive stage small cell lung cancer|extensive stage small cell lung cancer
746365|NCT00003562|squamous cell lung cancer|squamous cell lung cancer
746366|NCT00003562|large cell lung cancer|large cell lung cancer
746367|NCT00003562|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
746368|NCT00003562|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
746369|NCT00003562|adenocarcinoma of the lung|adenocarcinoma of the lung
746370|NCT00003490|refractory multiple myeloma|refractory multiple myeloma
746371|NCT00003490|stage I multiple myeloma|stage i multiple myeloma
746372|NCT00003490|stage II multiple myeloma|stage ii multiple myeloma
746373|NCT00003490|stage III multiple myeloma|stage iii multiple myeloma
746374|NCT00003447|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
746375|NCT00003447|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
746376|NCT00003365|colon cancer|colon cancer
765260|NCT00057005|LEUKEMIA|leukemia
746378|NCT00003322|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
746379|NCT00003322|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
746380|NCT00003322|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
746381|NCT00003322|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
746382|NCT00003322|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
746383|NCT00003322|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
746384|NCT00003322|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
746385|NCT00003322|primary peritoneal cavity cancer|primary peritoneal cavity cancer
746386|NCT00003322|Brenner tumor|brenner tumor
746387|NCT00003289|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
746388|NCT00003289|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
746389|NCT00003289|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
746390|NCT00003289|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
746391|NCT00003289|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
746392|NCT00003289|refractory hairy cell leukemia|refractory hairy cell leukemia
746393|NCT00003289|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
746394|NCT00003289|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
746395|NCT00003289|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
746396|NCT00003289|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
746397|NCT00003289|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
746398|NCT00003289|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
746399|NCT00003289|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
746400|NCT00003289|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
746401|NCT00003289|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
746402|NCT00003289|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
746403|NCT00003289|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
746404|NCT00003289|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
746405|NCT00003289|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
746406|NCT00003289|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
746407|NCT00003289|prolymphocytic leukemia|prolymphocytic leukemia
746408|NCT00003289|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
746409|NCT00003289|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
746410|NCT00003289|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
746411|NCT00003289|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
746412|NCT00003289|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
746413|NCT00003289|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
746414|NCT00003289|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
746415|NCT00003289|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
746416|NCT00003289|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
746417|NCT00003289|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
746418|NCT00003289|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
746419|NCT00003289|splenic marginal zone lymphoma|splenic marginal zone lymphoma
746420|NCT00003250|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
746421|NCT00003101|adult oligodendroglioma|adult oligodendroglioma
746422|NCT00003101|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
746423|NCT00002880|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
746424|NCT00002880|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
746425|NCT00002880|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
746426|NCT00002880|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
746427|NCT00002880|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
746428|NCT00002880|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
746429|NCT00002880|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
746430|NCT00002880|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
746431|NCT00002880|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
746432|NCT00002876|recurrent adult brain tumor|recurrent adult brain tumor
746433|NCT00002876|adult myxopapillary ependymoma|adult myxopapillary ependymoma
746434|NCT00002876|adult anaplastic ependymoma|adult anaplastic ependymoma
746435|NCT00002813|recurrent cervical cancer|recurrent cervical cancer
746436|NCT00002813|stage IVB cervical cancer|stage ivb cervical cancer
746437|NCT00002813|cervical squamous cell carcinoma|cervical squamous cell carcinoma
746438|NCT00002707|stage I breast cancer|stage i breast cancer
746439|NCT00002707|stage II breast cancer|stage ii breast cancer
746440|NCT00002707|stage IIIA breast cancer|stage iiia breast cancer
746441|NCT00002692|stage IV colon cancer|stage iv colon cancer
746442|NCT00002692|stage IV rectal cancer|stage iv rectal cancer
746443|NCT00002692|recurrent colon cancer|recurrent colon cancer
746444|NCT00002692|recurrent rectal cancer|recurrent rectal cancer
746445|NCT00002692|adenocarcinoma of the colon|adenocarcinoma of the colon
746446|NCT00002692|adenocarcinoma of the rectum|adenocarcinoma of the rectum
746448|NCT00002673|stage IV breast cancer|stage iv breast cancer
746449|NCT00002673|stage IIIA breast cancer|stage iiia breast cancer
746450|NCT00002673|stage IIIB breast cancer|stage iiib breast cancer
746451|NCT00002673|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
746452|NCT00002673|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
746453|NCT00002673|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
746454|NCT00002673|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
746455|NCT00002673|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
746456|NCT00002673|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
746457|NCT00002673|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
746458|NCT00002673|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
746459|NCT00002673|disseminated neuroblastoma|disseminated neuroblastoma
746460|NCT00002673|recurrent neuroblastoma|recurrent neuroblastoma
746461|NCT00002673|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
746462|NCT00002673|stage I multiple myeloma|stage i multiple myeloma
746463|NCT00002673|stage II multiple myeloma|stage ii multiple myeloma
746464|NCT00002673|stage III multiple myeloma|stage iii multiple myeloma
746465|NCT00002673|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
746466|NCT00002673|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
746467|NCT00002673|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
746468|NCT00002673|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
746469|NCT00002673|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
746470|NCT00002673|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
746471|NCT00002673|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
746472|NCT00002673|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
746473|NCT00002673|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
746474|NCT00002673|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
746475|NCT00002673|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
746476|NCT00002673|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
746477|NCT00002673|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
746478|NCT00002673|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
746479|NCT00002673|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
746480|NCT00002673|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
746481|NCT00002673|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
746482|NCT00002673|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
746483|NCT00002673|testicular embryonal carcinoma|testicular embryonal carcinoma
746484|NCT00002673|testicular choriocarcinoma|testicular choriocarcinoma
746485|NCT00002673|testicular teratoma|testicular teratoma
746486|NCT00002673|testicular yolk sac tumor|testicular yolk sac tumor
746487|NCT00002673|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
746488|NCT00002673|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
746489|NCT00002673|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
746490|NCT00002673|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
746491|NCT00002673|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
746492|NCT00002673|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
746493|NCT00002673|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
746494|NCT00002673|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
746495|NCT00002673|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
746496|NCT00002673|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
746497|NCT00002673|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
746498|NCT00002673|refractory hairy cell leukemia|refractory hairy cell leukemia
746499|NCT00002673|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
746500|NCT00002673|ovarian germ cell tumor|ovarian germ cell tumor
746501|NCT00002673|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
746502|NCT00002673|ovarian yolk sac tumor|ovarian yolk sac tumor
746503|NCT00002673|ovarian embryonal carcinoma|ovarian embryonal carcinoma
746504|NCT00002673|ovarian polyembryoma|ovarian polyembryoma
746505|NCT00002673|ovarian choriocarcinoma|ovarian choriocarcinoma
746506|NCT00002673|ovarian teratoma|ovarian teratoma
746507|NCT00002673|ovarian immature teratoma|ovarian immature teratoma
746508|NCT00002673|ovarian mature teratoma|ovarian mature teratoma
746509|NCT00002673|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
746510|NCT00002673|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
746511|NCT00002673|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
746512|NCT00002673|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
746513|NCT00002673|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
746514|NCT00002673|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
746515|NCT00002673|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
746516|NCT00002673|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
746517|NCT00002673|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
746518|NCT00002673|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
746519|NCT00002673|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
746520|NCT00002673|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
746521|NCT00002673|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
746522|NCT00002673|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
746523|NCT00002673|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
746524|NCT00002673|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
746525|NCT00002673|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
746526|NCT00002673|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
746527|NCT00002673|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
746528|NCT00002673|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
746529|NCT00002673|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
746530|NCT00002673|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
746531|NCT00002673|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
746532|NCT00002673|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
746533|NCT00002673|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
746534|NCT00002673|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
746535|NCT00002673|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
746536|NCT00002673|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
746537|NCT00002673|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
746538|NCT00002673|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
746539|NCT00002673|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
746540|NCT00002673|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
746541|NCT00002673|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
746542|NCT00002673|infection|infection
746543|NCT00002673|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
746544|NCT00002673|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
746545|NCT00002673|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
746546|NCT00002673|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
746547|NCT00002673|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
746548|NCT00002673|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
746549|NCT00002673|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
746550|NCT00002673|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
746551|NCT00002673|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
746552|NCT00002673|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
746553|NCT00002673|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
746554|NCT00002673|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
746555|NCT00002673|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
746556|NCT00002673|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
746557|NCT00002673|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
746558|NCT00002673|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
746559|NCT00002673|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
746560|NCT00002673|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
746561|NCT00002673|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
746562|NCT00002673|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
746563|NCT00002673|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
746564|NCT00002673|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
746565|NCT00002673|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
746566|NCT00002673|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
746567|NCT00002673|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
746568|NCT00002673|splenic marginal zone lymphoma|splenic marginal zone lymphoma
746569|NCT00002673|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
746570|NCT00002599|stage I multiple myeloma|stage i multiple myeloma
746571|NCT00002599|stage II multiple myeloma|stage ii multiple myeloma
746572|NCT00002599|stage III multiple myeloma|stage iii multiple myeloma
746573|NCT00083330|Healthy|healthy
746574|NCT00083330|T Cells|t cells
746575|NCT00083330|Immunity|immunity
746576|NCT00083330|Healthy Volunteer|healthy volunteer
746577|NCT00083330|HV|hv
746578|NCT00083278|Breast Cancer|breast cancer
746579|NCT00083278|Stage IV adenocarcinoma of the breast|stage iv adenocarcinoma of the breast
746580|NCT00012350|refractory multiple myeloma|refractory multiple myeloma
746581|NCT00012350|stage II multiple myeloma|stage ii multiple myeloma
746582|NCT00012350|stage III multiple myeloma|stage iii multiple myeloma
746583|NCT00012350|plasma cell neoplasm|plasma cell neoplasm
746584|NCT00010088|stage II pancreatic cancer|stage ii pancreatic cancer
746585|NCT00010088|stage III pancreatic cancer|stage iii pancreatic cancer
746586|NCT00010088|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
746587|NCT00010088|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
746588|NCT00010088|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
746589|NCT00010088|stage IV pancreatic cancer|stage iv pancreatic cancer
746590|NCT00006220|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
746591|NCT00006220|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
746592|NCT00006220|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
746593|NCT00006220|refractory multiple myeloma|refractory multiple myeloma
746594|NCT00006220|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
746595|NCT00006220|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
746596|NCT00006220|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
746597|NCT00006220|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
746598|NCT00006220|refractory anemia with excess blasts|refractory anemia with excess blasts
746599|NCT00006220|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
746600|NCT00006220|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
746601|NCT00006220|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
746602|NCT00006220|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
746603|NCT00006220|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
746604|NCT00006220|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
746605|NCT00006220|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
746606|NCT00006220|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
746607|NCT00006220|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
746608|NCT00006220|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
746609|NCT00006220|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
746610|NCT00006220|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
746611|NCT00006220|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
746612|NCT00006220|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
746613|NCT00006220|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
746614|NCT00006220|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
746615|NCT00006220|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
746616|NCT00006220|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
746617|NCT00006220|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
746618|NCT00006220|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
746619|NCT00006220|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
746620|NCT00006220|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
746621|NCT00006220|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
746622|NCT00006220|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
746623|NCT00006220|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
746624|NCT00006220|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
746625|NCT00006220|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
746626|NCT00005814|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
746627|NCT00005814|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
746628|NCT00005814|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
746629|NCT00005814|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
746630|NCT00005814|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
746631|NCT00005814|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
746632|NCT00005814|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
746633|NCT00005814|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
746634|NCT00005814|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
746635|NCT00005814|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
746636|NCT00005814|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
746637|NCT00005814|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
746638|NCT00005814|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
746639|NCT00005814|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
746640|NCT00005814|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
746641|NCT00005581|stage II breast cancer|stage ii breast cancer
746642|NCT00005581|stage IIIA breast cancer|stage iiia breast cancer
746643|NCT00005581|stage IIIB breast cancer|stage iiib breast cancer
746644|NCT00004880|stage IV renal cell cancer|stage iv renal cell cancer
746645|NCT00004880|recurrent renal cell cancer|recurrent renal cell cancer
746646|NCT00004211|stage IV prostate cancer|stage iv prostate cancer
746647|NCT00004211|recurrent prostate cancer|recurrent prostate cancer
746648|NCT00004156|stage I breast cancer|stage i breast cancer
746649|NCT00004156|stage II breast cancer|stage ii breast cancer
746650|NCT00004156|stage IV breast cancer|stage iv breast cancer
746651|NCT00004156|stage IIIA breast cancer|stage iiia breast cancer
746652|NCT00004156|recurrent breast cancer|recurrent breast cancer
746653|NCT00004156|stage IIIB breast cancer|stage iiib breast cancer
746654|NCT00004132|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
746655|NCT00004132|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
746656|NCT00004132|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
746657|NCT00004132|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
746658|NCT00004132|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
746659|NCT00004132|childhood Burkitt lymphoma|childhood burkitt lymphoma
746660|NCT00004132|refractory multiple myeloma|refractory multiple myeloma
746661|NCT00004132|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
746662|NCT00004132|stage I multiple myeloma|stage i multiple myeloma
746663|NCT00004132|stage II multiple myeloma|stage ii multiple myeloma
746664|NCT00004132|stage III multiple myeloma|stage iii multiple myeloma
746665|NCT00004132|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
746666|NCT00004132|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
746667|NCT00004132|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
746668|NCT00004132|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
746669|NCT00004132|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
746670|NCT00004132|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
746671|NCT00004132|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
746672|NCT00004132|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
746673|NCT00004132|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
746674|NCT00004132|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
746675|NCT00004132|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
746676|NCT00004132|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
746677|NCT00004132|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
746678|NCT00004132|oral complications|oral complications
746679|NCT00004132|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
746680|NCT00004132|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
746681|NCT00004132|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
746682|NCT00004132|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
746683|NCT00004132|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
746684|NCT00004132|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
746685|NCT00004132|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
746686|NCT00004132|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
746687|NCT00004132|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
746688|NCT00004132|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
746689|NCT00004132|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
746690|NCT00004132|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
746691|NCT00004132|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
746692|NCT00004132|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
746693|NCT00004132|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
746694|NCT00004132|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
746695|NCT00004132|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
746696|NCT00004132|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
746697|NCT00004132|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
746698|NCT00004132|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
746699|NCT00004132|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
746700|NCT00004132|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
746701|NCT00004132|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
746702|NCT00004132|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
746703|NCT00004132|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
746704|NCT00004132|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
746705|NCT00004132|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
746706|NCT00004132|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
746707|NCT00004132|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
746708|NCT00004132|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
746709|NCT00004132|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
746710|NCT00004132|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
746711|NCT00004132|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
746712|NCT00004132|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
746713|NCT00004132|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
746714|NCT00004132|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
746715|NCT00004132|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
746716|NCT00004132|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
746717|NCT00004132|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
746718|NCT00004132|radiation toxicity|radiation toxicity
746719|NCT00004132|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
746720|NCT00004132|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
746721|NCT00004132|stage I mantle cell lymphoma|stage i mantle cell lymphoma
746722|NCT00004132|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
746723|NCT00004132|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
746724|NCT00004132|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
746725|NCT00004132|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
746726|NCT00004132|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
746727|NCT00004132|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
746728|NCT00004132|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
746729|NCT00004132|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
746730|NCT00004132|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
747327|NCT00002893|stage III rectal cancer|stage iii rectal cancer
746731|NCT00004132|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
746732|NCT00004132|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
746733|NCT00004132|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
746734|NCT00004132|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
746735|NCT00004132|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
746736|NCT00004132|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
746737|NCT00004132|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
746738|NCT00004132|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
746739|NCT00004132|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
746740|NCT00004132|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
746741|NCT00004132|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
746742|NCT00004132|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
746743|NCT00004132|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
746744|NCT00004132|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
746745|NCT00004132|anaplastic large cell lymphoma|anaplastic large cell lymphoma
746746|NCT00004132|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
746747|NCT00004132|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
746748|NCT00004132|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
746749|NCT00004132|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
746750|NCT00004132|stage I marginal zone lymphoma|stage i marginal zone lymphoma
746751|NCT00004132|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
746752|NCT00004132|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
746753|NCT00004132|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
746754|NCT00004132|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
746755|NCT00004132|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
746756|NCT00004132|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
746757|NCT00004132|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
746758|NCT00004132|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
746759|NCT00004132|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
746760|NCT00004132|splenic marginal zone lymphoma|splenic marginal zone lymphoma
746761|NCT00004073|adult glioblastoma|adult glioblastoma
746762|NCT00004073|adult giant cell glioblastoma|adult giant cell glioblastoma
746763|NCT00004073|adult gliosarcoma|adult gliosarcoma
746764|NCT00004056|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
746765|NCT00004056|childhood acute monoblastic leukemia and acute monocytic leukemia (M5)|childhood acute monoblastic leukemia and acute monocytic leukemia (m5)
746766|NCT00004056|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
746767|NCT00004056|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
746768|NCT00004056|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
746769|NCT00004056|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
746770|NCT00004056|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
746771|NCT00004056|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
746772|NCT00004051|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
746773|NCT00004038|stage I breast cancer|stage i breast cancer
746774|NCT00004038|stage II breast cancer|stage ii breast cancer
746775|NCT00004038|stage IV breast cancer|stage iv breast cancer
746776|NCT00004038|stage IIIA breast cancer|stage iiia breast cancer
746777|NCT00004038|recurrent breast cancer|recurrent breast cancer
746778|NCT00004038|stage IIIB breast cancer|stage iiib breast cancer
746779|NCT00003924|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
746780|NCT00003924|Waldenström macroglobulinemia|waldenström macroglobulinemia
746781|NCT00003924|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
746782|NCT00003924|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
746783|NCT00003924|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
746784|NCT00003924|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
746785|NCT00003924|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
746786|NCT00003924|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
746787|NCT00003924|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
746788|NCT00003924|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
746789|NCT00003924|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
746790|NCT00003924|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
746791|NCT00003924|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
746792|NCT00003924|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
746793|NCT00003924|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
746794|NCT00003924|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
746795|NCT00003924|splenic marginal zone lymphoma|splenic marginal zone lymphoma
746796|NCT00003876|recurrent adult brain tumor|recurrent adult brain tumor
746797|NCT00003876|adult brain stem glioma|adult brain stem glioma
746798|NCT00003876|adult glioblastoma|adult glioblastoma
746799|NCT00003876|adult anaplastic astrocytoma|adult anaplastic astrocytoma
746800|NCT00003876|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
746801|NCT00003876|adult mixed glioma|adult mixed glioma
746802|NCT00003876|adult giant cell glioblastoma|adult giant cell glioblastoma
746803|NCT00003876|adult gliosarcoma|adult gliosarcoma
746804|NCT00003801|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
746805|NCT00003801|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
746806|NCT00003731|adult oligodendroglioma|adult oligodendroglioma
746807|NCT00003731|adult mixed glioma|adult mixed glioma
746808|NCT00003700|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
746809|NCT00003700|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
746810|NCT00003700|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
746811|NCT00003698|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
746812|NCT00003697|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
746813|NCT00003685|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
746814|NCT00003685|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
746815|NCT00003685|squamous cell lung cancer|squamous cell lung cancer
746816|NCT00003685|large cell lung cancer|large cell lung cancer
746817|NCT00003685|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
746818|NCT00003685|adenocarcinoma of the lung|adenocarcinoma of the lung
746819|NCT00003685|adenosquamous cell lung cancer|adenosquamous cell lung cancer
746820|NCT00003685|fatigue|fatigue
746821|NCT00003685|nausea and vomiting|nausea and vomiting
746822|NCT00003685|pain|pain
746823|NCT00003685|pulmonary complications|pulmonary complications
746824|NCT00003685|quality of life|quality of life
746825|NCT00003640|stage II bladder cancer|stage ii bladder cancer
747328|NCT00002893|stage IV rectal cancer|stage iv rectal cancer
746826|NCT00003640|stage III bladder cancer|stage iii bladder cancer
746827|NCT00003640|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
746828|NCT00003575|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
746829|NCT00003575|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
746830|NCT00003575|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
746831|NCT00003575|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
746832|NCT00003439|stage IV colon cancer|stage iv colon cancer
746833|NCT00003439|stage IV gastric cancer|stage iv gastric cancer
746834|NCT00003439|recurrent gastric cancer|recurrent gastric cancer
746835|NCT00003439|recurrent pancreatic cancer|recurrent pancreatic cancer
746836|NCT00003439|stage IV rectal cancer|stage iv rectal cancer
746837|NCT00003439|recurrent colon cancer|recurrent colon cancer
746838|NCT00003439|recurrent rectal cancer|recurrent rectal cancer
746839|NCT00003439|stage IV anal cancer|stage iv anal cancer
746840|NCT00003439|recurrent anal cancer|recurrent anal cancer
746841|NCT00003439|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
746842|NCT00003439|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
746843|NCT00003439|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
746844|NCT00003439|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
746845|NCT00003439|advanced adult primary liver cancer|advanced adult primary liver cancer
746846|NCT00003439|recurrent adult primary liver cancer|recurrent adult primary liver cancer
746847|NCT00003439|stage IV endometrial carcinoma|stage iv endometrial carcinoma
746848|NCT00003439|recurrent endometrial carcinoma|recurrent endometrial carcinoma
746849|NCT00003439|small intestine adenocarcinoma|small intestine adenocarcinoma
746850|NCT00003439|unresectable gallbladder cancer|unresectable gallbladder cancer
746851|NCT00003439|recurrent gallbladder cancer|recurrent gallbladder cancer
746852|NCT00003439|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
746853|NCT00003439|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
746854|NCT00003439|recurrent small intestine cancer|recurrent small intestine cancer
746855|NCT00003439|stage IV prostate cancer|stage iv prostate cancer
746856|NCT00003439|recurrent prostate cancer|recurrent prostate cancer
746857|NCT00003439|fallopian tube cancer|fallopian tube cancer
746858|NCT00003439|primary peritoneal cavity cancer|primary peritoneal cavity cancer
746859|NCT00003439|stage IV pancreatic cancer|stage iv pancreatic cancer
746860|NCT00003423|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
746861|NCT00003423|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
746862|NCT00003423|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
746863|NCT00003423|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
746864|NCT00003423|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
746865|NCT00003423|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
746866|NCT00003423|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
746867|NCT00003423|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
746868|NCT00003330|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
746869|NCT00003326|stage IV esophageal cancer|stage iv esophageal cancer
746870|NCT00003326|recurrent esophageal cancer|recurrent esophageal cancer
746871|NCT00003326|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
746872|NCT00003326|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
746873|NCT00003255|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
746874|NCT00003255|secondary acute myeloid leukemia|secondary acute myeloid leukemia
746875|NCT00002578|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
746876|NCT00002578|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
746877|NCT00002578|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
746878|NCT00002578|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
746879|NCT00002578|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
746880|NCT00002578|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
746881|NCT00002578|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
746882|NCT00002503|recurrent prostate cancer|recurrent prostate cancer
746883|NCT00002503|bone metastases|bone metastases
746884|NCT00083317|PFC|pfc
746885|NCT00083317|Competition|competition
746886|NCT00083317|Bargaining Games|bargaining games
746887|NCT00083317|Hyper-Brain Scanning|hyper-brain scanning
746888|NCT00083317|fMRI|fmri
746889|NCT00083317|Healthy Volunteer|healthy volunteer
746890|NCT00083317|HV|hv
746891|NCT00083304|Breast|breast
746892|NCT00083304|Brain|brain
746893|NCT00083304|RSR13|rsr13
746894|NCT00083304|efaproxiral|efaproxiral
746895|NCT00083304|Whole Brain Radiation Therapy|whole brain radiation therapy
746896|NCT00083304|Brain metastases|brain metastases
746897|NCT00083304|Metastatic breast cancer|metastatic breast cancer
746898|NCT00083213|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
746899|NCT00083213|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
746900|NCT00083213|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
746901|NCT00083213|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
746902|NCT00083213|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
746903|NCT00083213|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
746904|NCT00083213|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
746905|NCT00083213|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
746906|NCT00083213|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
746907|NCT00083213|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
746908|NCT00083213|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
746909|NCT00083213|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
746910|NCT00083213|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
746911|NCT00083213|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
746912|NCT00083213|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
746913|NCT00083213|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
746914|NCT00083213|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
746915|NCT00083213|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
746916|NCT00083213|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
746917|NCT00083213|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
746918|NCT00083213|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
746919|NCT00083213|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
746920|NCT00083213|recurrent adult primary liver cancer|recurrent adult primary liver cancer
746921|NCT00083213|advanced adult primary liver cancer|advanced adult primary liver cancer
746922|NCT00083213|recurrent cervical cancer|recurrent cervical cancer
746923|NCT00083213|stage IVA cervical cancer|stage iva cervical cancer
746924|NCT00083213|stage IVB cervical cancer|stage ivb cervical cancer
746925|NCT00083213|fallopian tube cancer|fallopian tube cancer
746926|NCT00083213|ovarian sarcoma|ovarian sarcoma
747329|NCT00002893|recurrent colon cancer|recurrent colon cancer
746927|NCT00083213|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
746928|NCT00083213|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
746929|NCT00083213|recurrent endometrial carcinoma|recurrent endometrial carcinoma
746930|NCT00083213|stage IV endometrial carcinoma|stage iv endometrial carcinoma
746931|NCT00083213|recurrent uterine sarcoma|recurrent uterine sarcoma
746932|NCT00083213|stage IV uterine sarcoma|stage iv uterine sarcoma
746933|NCT00083213|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
746934|NCT00083213|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
746935|NCT00083213|ovarian stromal cancer|ovarian stromal cancer
746936|NCT00083213|recurrent vaginal cancer|recurrent vaginal cancer
746937|NCT00083213|stage IVA vaginal cancer|stage iva vaginal cancer
746938|NCT00083213|stage IVB vaginal cancer|stage ivb vaginal cancer
746939|NCT00083213|recurrent prostate cancer|recurrent prostate cancer
746940|NCT00083213|stage IV prostate cancer|stage iv prostate cancer
746941|NCT00083213|recurrent penile cancer|recurrent penile cancer
746942|NCT00083213|stage IV penile cancer|stage iv penile cancer
746943|NCT00083213|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
746944|NCT00083213|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
746945|NCT00083213|recurrent bladder cancer|recurrent bladder cancer
746946|NCT00083213|stage IV bladder cancer|stage iv bladder cancer
746947|NCT00083213|recurrent vulvar cancer|recurrent vulvar cancer
746948|NCT00083213|stage IVB vulvar cancer|stage ivb vulvar cancer
746949|NCT00083213|distal urethral cancer|distal urethral cancer
746950|NCT00083213|proximal urethral cancer|proximal urethral cancer
746951|NCT00083213|recurrent urethral cancer|recurrent urethral cancer
746952|NCT00083213|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
746953|NCT00083213|primary peritoneal cavity cancer|primary peritoneal cavity cancer
746954|NCT00083213|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
746955|NCT00083213|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
746956|NCT00083213|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
746957|NCT00083213|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
746958|NCT00083213|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
746959|NCT00083213|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
746960|NCT00083213|splenic marginal zone lymphoma|splenic marginal zone lymphoma
746961|NCT00083213|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
746962|NCT00082940|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
746963|NCT00082940|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
746964|NCT00082927|stage IV prostate cancer|stage iv prostate cancer
746965|NCT00082927|bone metastases|bone metastases
746966|NCT00082927|pain|pain
746967|NCT00082927|recurrent prostate cancer|recurrent prostate cancer
746968|NCT00082914|recurrent renal cell cancer|recurrent renal cell cancer
746969|NCT00082914|stage IV renal cell cancer|stage iv renal cell cancer
746970|NCT00082914|recurrent melanoma|recurrent melanoma
746971|NCT00082914|stage IV melanoma|stage iv melanoma
746972|NCT00082862|stage II pancreatic cancer|stage ii pancreatic cancer
746973|NCT00082862|stage III pancreatic cancer|stage iii pancreatic cancer
746974|NCT00082862|recurrent pancreatic cancer|recurrent pancreatic cancer
746975|NCT00082862|stage IV pancreatic cancer|stage iv pancreatic cancer
746976|NCT00082836|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
746977|NCT00082823|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
746978|NCT00082823|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
746979|NCT00082823|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
746980|NCT00082823|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
746981|NCT00082823|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
746982|NCT00082823|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
746983|NCT00082823|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
746984|NCT00082823|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
746985|NCT00082823|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
746986|NCT00082823|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
746987|NCT00082823|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
746988|NCT00082823|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
746989|NCT00082823|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
746990|NCT00082823|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
746991|NCT00082823|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
746992|NCT00082823|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
746993|NCT00082823|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
746994|NCT00082823|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
746995|NCT00082823|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
746996|NCT00082823|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
746997|NCT00082823|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
746998|NCT00082823|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
746999|NCT00082823|advanced adult primary liver cancer|advanced adult primary liver cancer
747000|NCT00082823|recurrent adult primary liver cancer|recurrent adult primary liver cancer
747001|NCT00082823|recurrent cervical cancer|recurrent cervical cancer
747002|NCT00082823|stage IVA cervical cancer|stage iva cervical cancer
747003|NCT00082823|stage IVB cervical cancer|stage ivb cervical cancer
747004|NCT00082823|fallopian tube cancer|fallopian tube cancer
747005|NCT00082823|ovarian sarcoma|ovarian sarcoma
747006|NCT00082823|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
747007|NCT00082823|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
747008|NCT00082823|recurrent endometrial carcinoma|recurrent endometrial carcinoma
747009|NCT00082823|stage IV endometrial carcinoma|stage iv endometrial carcinoma
747010|NCT00082823|recurrent uterine sarcoma|recurrent uterine sarcoma
747011|NCT00082823|stage IV uterine sarcoma|stage iv uterine sarcoma
747012|NCT00082823|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
747013|NCT00082823|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
747014|NCT00082823|ovarian stromal cancer|ovarian stromal cancer
747015|NCT00082823|recurrent vaginal cancer|recurrent vaginal cancer
747016|NCT00082823|stage IVA vaginal cancer|stage iva vaginal cancer
747017|NCT00082823|stage IVB vaginal cancer|stage ivb vaginal cancer
747018|NCT00082823|recurrent prostate cancer|recurrent prostate cancer
747019|NCT00082823|stage IV prostate cancer|stage iv prostate cancer
747020|NCT00082823|recurrent penile cancer|recurrent penile cancer
747021|NCT00082823|stage IV penile cancer|stage iv penile cancer
747022|NCT00082823|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
747023|NCT00082823|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
747024|NCT00082823|recurrent bladder cancer|recurrent bladder cancer
747025|NCT00082823|stage IV bladder cancer|stage iv bladder cancer
747026|NCT00082823|recurrent vulvar cancer|recurrent vulvar cancer
747027|NCT00082823|stage IVB vulvar cancer|stage ivb vulvar cancer
747028|NCT00082823|distal urethral cancer|distal urethral cancer
747029|NCT00082823|proximal urethral cancer|proximal urethral cancer
747030|NCT00082823|recurrent urethral cancer|recurrent urethral cancer
747031|NCT00082823|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
747032|NCT00082823|primary peritoneal cavity cancer|primary peritoneal cavity cancer
747033|NCT00082823|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
747034|NCT00082823|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
747035|NCT00082823|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
747036|NCT00082823|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
747037|NCT00082823|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
747038|NCT00082823|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
747039|NCT00082823|splenic marginal zone lymphoma|splenic marginal zone lymphoma
747040|NCT00082823|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
747041|NCT00082797|adult glioblastoma|adult glioblastoma
747042|NCT00082797|adult giant cell glioblastoma|adult giant cell glioblastoma
747043|NCT00082797|adult gliosarcoma|adult gliosarcoma
747044|NCT00082758|recurrent neuroblastoma|recurrent neuroblastoma
747045|NCT00082732|stage I prostate cancer|stage i prostate cancer
747046|NCT00082732|stage II prostate cancer|stage ii prostate cancer
747047|NCT00082732|adenocarcinoma of the prostate|adenocarcinoma of the prostate
747048|NCT00082719|stage II bladder cancer|stage ii bladder cancer
747049|NCT00082719|stage III bladder cancer|stage iii bladder cancer
747050|NCT00082719|stage IV bladder cancer|stage iv bladder cancer
747051|NCT00082719|localized transitional cell cancer of the renal pelvis and ureter|localized transitional cell cancer of the renal pelvis and ureter
747052|NCT00082719|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
747053|NCT00082719|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
747054|NCT00082719|anterior urethral cancer|anterior urethral cancer
747055|NCT00082719|posterior urethral cancer|posterior urethral cancer
747188|NCT00003118|stage III esophageal cancer|stage iii esophageal cancer
747056|NCT00082719|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
747057|NCT00082706|adenocarcinoma of the bladder|adenocarcinoma of the bladder
747058|NCT00082706|recurrent bladder cancer|recurrent bladder cancer
747059|NCT00082706|stage IV bladder cancer|stage iv bladder cancer
747060|NCT00082706|recurrent urethral cancer|recurrent urethral cancer
747061|NCT00082706|anterior urethral cancer|anterior urethral cancer
747062|NCT00082706|posterior urethral cancer|posterior urethral cancer
747063|NCT00082706|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
747064|NCT00082706|stage III bladder cancer|stage iii bladder cancer
747065|NCT00082667|breast cancer in situ|breast cancer in situ
747066|NCT00082667|ductal breast carcinoma in situ|ductal breast carcinoma in situ
747067|NCT00082654|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
747068|NCT00082654|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
747069|NCT00082654|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
747070|NCT00082654|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
747071|NCT00082654|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
747072|NCT00082654|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
747073|NCT00082654|chronic eosinophilic leukemia|chronic eosinophilic leukemia
747074|NCT00082654|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
747075|NCT00082654|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
747076|NCT00082654|chronic neutrophilic leukemia|chronic neutrophilic leukemia
747077|NCT00082654|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
747078|NCT00082654|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
747079|NCT00082654|disseminated neuroblastoma|disseminated neuroblastoma
747080|NCT00082654|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
747081|NCT00082654|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
747082|NCT00082654|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
747083|NCT00082654|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
747084|NCT00082654|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
747085|NCT00082654|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
747086|NCT00082654|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
747087|NCT00082654|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
747088|NCT00082654|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
747089|NCT00082654|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
747090|NCT00082654|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
747091|NCT00082654|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
747092|NCT00082654|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
747093|NCT00082654|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
747094|NCT00082654|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
747095|NCT00082654|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
747096|NCT00082654|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
747097|NCT00082654|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
747098|NCT00082654|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
747099|NCT00082654|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
747100|NCT00082654|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
747101|NCT00082654|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
747102|NCT00082654|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
747103|NCT00082654|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
747104|NCT00082654|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
747105|NCT00082654|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
747106|NCT00082654|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
747107|NCT00082654|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
747108|NCT00082654|recurrent neuroblastoma|recurrent neuroblastoma
747109|NCT00082654|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
747110|NCT00082654|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
747111|NCT00082654|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
747112|NCT00082654|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
747113|NCT00082654|refractory hairy cell leukemia|refractory hairy cell leukemia
747114|NCT00082654|refractory multiple myeloma|refractory multiple myeloma
747115|NCT00082654|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
747116|NCT00082654|secondary acute myeloid leukemia|secondary acute myeloid leukemia
747117|NCT00082654|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
747118|NCT00082654|stage I multiple myeloma|stage i multiple myeloma
747119|NCT00082654|stage II multiple myeloma|stage ii multiple myeloma
747120|NCT00082654|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
747121|NCT00082654|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
747122|NCT00082654|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
747123|NCT00082654|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
747124|NCT00082654|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
747125|NCT00082654|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
747126|NCT00082654|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
747127|NCT00082654|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
747128|NCT00082654|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
747129|NCT00082654|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
747130|NCT00082654|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
747131|NCT00082654|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
747132|NCT00082654|stage III multiple myeloma|stage iii multiple myeloma
747133|NCT00082654|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
747134|NCT00082654|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
747135|NCT00082654|stage IIIA breast cancer|stage iiia breast cancer
747136|NCT00082654|stage IIIB breast cancer|stage iiib breast cancer
747137|NCT00082654|stage IIIC breast cancer|stage iiic breast cancer
747138|NCT00082654|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
747139|NCT00082654|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
747140|NCT00082654|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
747141|NCT00082654|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
747142|NCT00082654|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
747143|NCT00082654|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
747144|NCT00082654|stage IV breast cancer|stage iv breast cancer
747145|NCT00082654|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
747146|NCT00082654|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
747147|NCT00082654|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
747148|NCT00082654|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
747149|NCT00082654|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
747150|NCT00082654|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
747151|NCT00082654|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
747152|NCT00082654|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
747153|NCT00082654|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
747154|NCT00082654|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
747155|NCT00082654|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
747156|NCT00082654|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
747157|NCT00082654|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
747158|NCT00082654|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
747159|NCT00082654|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
747160|NCT00082654|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
747161|NCT00082654|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
747162|NCT00082654|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
747163|NCT00082654|splenic marginal zone lymphoma|splenic marginal zone lymphoma
747164|NCT00082654|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
747165|NCT00082654|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
747166|NCT00082654|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
747167|NCT00082654|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
747168|NCT00082654|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
747169|NCT00082641|stage IIIA breast cancer|stage iiia breast cancer
747170|NCT00082641|stage IIIB breast cancer|stage iiib breast cancer
747171|NCT00003186|stage I colon cancer|stage i colon cancer
747172|NCT00003186|stage II colon cancer|stage ii colon cancer
747173|NCT00003186|stage III colon cancer|stage iii colon cancer
747174|NCT00003186|stage IV colon cancer|stage iv colon cancer
747175|NCT00003186|stage I rectal cancer|stage i rectal cancer
747176|NCT00003186|stage II rectal cancer|stage ii rectal cancer
747177|NCT00003186|stage III rectal cancer|stage iii rectal cancer
747178|NCT00003186|stage IV rectal cancer|stage iv rectal cancer
747179|NCT00003186|adenocarcinoma of the colon|adenocarcinoma of the colon
747180|NCT00003186|liver metastases|liver metastases
747181|NCT00003183|adenocarcinoma of the prostate|adenocarcinoma of the prostate
747182|NCT00003183|stage IV prostate cancer|stage iv prostate cancer
747183|NCT00003183|recurrent prostate cancer|recurrent prostate cancer
747184|NCT00003154|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
747185|NCT00003154|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
747186|NCT00003118|stage I esophageal cancer|stage i esophageal cancer
747187|NCT00003118|stage II esophageal cancer|stage ii esophageal cancer
779183|NCT00001772|Screening|screening
747189|NCT00003118|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
747190|NCT00003118|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
747191|NCT00003117|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
747192|NCT00003117|squamous cell lung cancer|squamous cell lung cancer
747193|NCT00003117|large cell lung cancer|large cell lung cancer
747194|NCT00003117|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
747195|NCT00003117|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
747196|NCT00003117|adenocarcinoma of the lung|adenocarcinoma of the lung
747197|NCT00003117|adenosquamous cell lung cancer|adenosquamous cell lung cancer
747198|NCT00003095|stage II breast cancer|stage ii breast cancer
747199|NCT00003095|stage III breast cancer|stage iii breast cancer
747200|NCT00003020|leptomeningeal metastases|leptomeningeal metastases
747201|NCT00002988|recurrent adult brain tumor|recurrent adult brain tumor
747202|NCT00002985|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
747203|NCT00002961|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
747204|NCT00002961|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
747205|NCT00083291|Dry Eyes|dry eyes
747206|NCT00083291|Conjunctiva|conjunctiva
747207|NCT00083291|Infection|infection
747208|NCT00083291|Antibodies|antibodies
747209|NCT00083291|Inflammation|inflammation
747210|NCT00083291|Ocular Surface Disease|ocular surface disease
747211|NCT00083291|Helicobacter Pylori|helicobacter pylori
747212|NCT00083265|Adenosine Receptor|adenosine receptor
747213|NCT00083265|Panic Disorder|panic disorder
747214|NCT00083265|Polymorphism|polymorphism
747215|NCT00083265|Challenge Study|challenge study
747216|NCT00083265|Caffeine|caffeine
747217|NCT00083265|Healthy Volunteer|healthy volunteer
747218|NCT00083265|HV|hv
747219|NCT00083226|doxorubicin|doxorubicin
747220|NCT00083226|doxorubicin hydrochloride|doxorubicin hydrochloride
747221|NCT00083226|bortezomib|bortezomib
747222|NCT00083226|hepatocellular carcinoma|hepatocellular carcinoma
747223|NCT00083187|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
747224|NCT00083187|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
747330|NCT00002893|recurrent rectal cancer|recurrent rectal cancer
747225|NCT00083187|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
747226|NCT00083187|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
747227|NCT00083187|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
747228|NCT00083187|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
747229|NCT00083187|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
747230|NCT00083187|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
747231|NCT00083187|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
747232|NCT00083187|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
747233|NCT00083187|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
747234|NCT00083187|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
747235|NCT00083174|breast cancer|breast cancer
747236|NCT00083161|extensive stage small cell lung cancer|extensive stage small cell lung cancer
747237|NCT00083161|recurrent small cell lung cancer|recurrent small cell lung cancer
747238|NCT00083148|recurrent breast cancer|recurrent breast cancer
747239|NCT00083148|stage IV breast cancer|stage iv breast cancer
747240|NCT00083135|recurrent neuroblastoma|recurrent neuroblastoma
747241|NCT00083096|recurrent adult brain tumor|recurrent adult brain tumor
747242|NCT00083096|adult mixed glioma|adult mixed glioma
747243|NCT00083096|adult anaplastic astrocytoma|adult anaplastic astrocytoma
747244|NCT00083096|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
747245|NCT00083096|adult glioblastoma|adult glioblastoma
747246|NCT00083096|adult pilocytic astrocytoma|adult pilocytic astrocytoma
747247|NCT00083096|adult anaplastic ependymoma|adult anaplastic ependymoma
747248|NCT00083096|adult subependymoma|adult subependymoma
747249|NCT00083096|adult myxopapillary ependymoma|adult myxopapillary ependymoma
747250|NCT00083096|adult oligodendroglioma|adult oligodendroglioma
747251|NCT00083096|adult giant cell glioblastoma|adult giant cell glioblastoma
747252|NCT00083096|adult gliosarcoma|adult gliosarcoma
747253|NCT00083096|adult diffuse astrocytoma|adult diffuse astrocytoma
747254|NCT00083096|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
747255|NCT00083096|adult pineal gland astrocytoma|adult pineal gland astrocytoma
747256|NCT00083083|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
747257|NCT00083083|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
747258|NCT00083083|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
747259|NCT00083070|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
747260|NCT00083070|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
747261|NCT00083070|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
747262|NCT00083070|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
747263|NCT00083070|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
747348|NCT00082498|Treatment Experienced|treatment experienced
747264|NCT00083057|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
747265|NCT00083057|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
747266|NCT00083057|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
747267|NCT00083057|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
747268|NCT00083057|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
747269|NCT00083057|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
747270|NCT00083057|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
747271|NCT00083057|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
747272|NCT00083057|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
747273|NCT00083057|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
747274|NCT00083057|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
747275|NCT00083057|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
747276|NCT00083057|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
747277|NCT00083057|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
747278|NCT00083057|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
747279|NCT00083057|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
747280|NCT00083044|breast cancer|breast cancer
747281|NCT00083044|breast cancer in situ|breast cancer in situ
747282|NCT00083044|stage I breast cancer|stage i breast cancer
747283|NCT00083044|lobular breast carcinoma in situ|lobular breast carcinoma in situ
747284|NCT00083044|ductal breast carcinoma in situ|ductal breast carcinoma in situ
747285|NCT00083031|recurrent breast cancer|recurrent breast cancer
747286|NCT00083031|stage IV breast cancer|stage iv breast cancer
747287|NCT00083018|stage II breast cancer|stage ii breast cancer
747288|NCT00083018|stage IIIA breast cancer|stage iiia breast cancer
747289|NCT00083018|stage IIIB breast cancer|stage iiib breast cancer
747290|NCT00083018|stage IIIC breast cancer|stage iiic breast cancer
747291|NCT00083018|stage IA breast cancer|stage ia breast cancer
747292|NCT00083018|stage IB breast cancer|stage ib breast cancer
747293|NCT00083005|adenocarcinoma of the prostate|adenocarcinoma of the prostate
747294|NCT00083005|recurrent prostate cancer|recurrent prostate cancer
747295|NCT00083005|stage IV prostate cancer|stage iv prostate cancer
747296|NCT00082979|breast cancer|breast cancer
747297|NCT00082628|growth hormone|growth hormone
747298|NCT00082628|Serostim®|serostim®
747299|NCT00082628|Human Adipose Redistribution Syndrome|human adipose redistribution syndrome
747300|NCT00082628|Human Immunodeficiency Virus lipodystrophy|human immunodeficiency virus lipodystrophy
747301|NCT00082628|Treatment Experienced|treatment experienced
747302|NCT00082602|galantamine|galantamine
747303|NCT00082602|Alzheimer's disease|alzheimer's disease
747304|NCT00082615|Movement Disorders|movement disorders
747305|NCT00082615|Recovery Cycle|recovery cycle
747306|NCT00082615|Blink Reflex|blink reflex
747307|NCT00082615|Cervical Dystonia|cervical dystonia
747308|NCT00082615|Blepharospasm|blepharospasm
747309|NCT00082615|Dystonia|dystonia
747310|NCT00082615|Craniofacial Dystonia|craniofacial dystonia
747311|NCT00082615|Healthy Volunteer|healthy volunteer
747313|NCT00002936|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
747314|NCT00002936|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
747315|NCT00002936|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
747316|NCT00002903|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
747317|NCT00002903|testicular seminoma|testicular seminoma
747318|NCT00002903|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
747319|NCT00002903|extragonadal germ cell tumor|extragonadal germ cell tumor
747320|NCT00002896|stage II rectal cancer|stage ii rectal cancer
747321|NCT00002896|stage III rectal cancer|stage iii rectal cancer
747322|NCT00002896|recurrent rectal cancer|recurrent rectal cancer
747323|NCT00002896|adenocarcinoma of the rectum|adenocarcinoma of the rectum
747324|NCT00002896|mucinous adenocarcinoma of the rectum|mucinous adenocarcinoma of the rectum
747325|NCT00002893|stage III colon cancer|stage iii colon cancer
747331|NCT00002893|adenocarcinoma of the colon|adenocarcinoma of the colon
747332|NCT00002893|adenocarcinoma of the rectum|adenocarcinoma of the rectum
747333|NCT00002892|stage II melanoma|stage ii melanoma
747334|NCT00002892|stage III melanoma|stage iii melanoma
747335|NCT00002892|recurrent melanoma|recurrent melanoma
747336|NCT00082550|Genetics|genetics
747337|NCT00082550|Serotonin Transporter|serotonin transporter
747338|NCT00082550|Brain Imaging|brain imaging
747339|NCT00082550|Neurotransmitter|neurotransmitter
747341|NCT00082550|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
747342|NCT00082550|PET|pet
747343|NCT00082550|Obsessive Compulsive Disorder|obsessive compulsive disorder
747344|NCT00082550|Healthy Volunteer|healthy volunteer
747345|NCT00082550|HV|hv
747346|NCT00082498|SCH-D|sch-d
747347|NCT00082498|Schering D|schering d
779499|NCT00001571|Pesticides|pesticides
747349|NCT00082498|Entry Inhibitors|entry inhibitors
747350|NCT00082498|Fusion Inhibitors|fusion inhibitors
747351|NCT00082498|Vicriviroc|vicriviroc
747352|NCT00082485|Cocaine Dependence|cocaine dependence
747353|NCT00082472|NSCLC|nsclc
747354|NCT00082472|Metastatic|metastatic
747355|NCT00082472|Unresectable|unresectable
747356|NCT00082472|No Prior Chemotherapy|no prior chemotherapy
747357|NCT00082459|Kidney Cancer|kidney cancer
747358|NCT00082459|Renal|renal
747359|NCT00082459|Tumor|tumor
747360|NCT00082459|Immunotherapy|immunotherapy
747361|NCT00082420|Vitamin A malnutrition|vitamin a malnutrition
747362|NCT00082420|low vitamin A status|low vitamin a status
747363|NCT00002870|stage IV breast cancer|stage iv breast cancer
747364|NCT00002870|recurrent breast cancer|recurrent breast cancer
747365|NCT00002826|stage IV breast cancer|stage iv breast cancer
747366|NCT00002826|recurrent breast cancer|recurrent breast cancer
747367|NCT00002803|localized resectable neuroblastoma|localized resectable neuroblastoma
747368|NCT00002803|regional neuroblastoma|regional neuroblastoma
747369|NCT00002803|stage 4S neuroblastoma|stage 4s neuroblastoma
747370|NCT00002803|localized unresectable neuroblastoma|localized unresectable neuroblastoma
747371|NCT00002802|localized resectable neuroblastoma|localized resectable neuroblastoma
747372|NCT00002802|regional neuroblastoma|regional neuroblastoma
747373|NCT00002802|disseminated neuroblastoma|disseminated neuroblastoma
747374|NCT00002802|stage 4S neuroblastoma|stage 4s neuroblastoma
747375|NCT00002802|localized unresectable neuroblastoma|localized unresectable neuroblastoma
747376|NCT00082446|Smallpox, vaccine|smallpox, vaccine
747377|NCT00082381|Diabetes|diabetes
747378|NCT00082381|Insulin glargine|insulin glargine
747379|NCT00082381|comparator|comparator
747380|NCT00082381|Amylin|amylin
747381|NCT00082381|Lilly|lilly
747382|NCT00002788|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
747383|NCT00002788|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
747384|NCT00002788|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
747385|NCT00002788|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
747386|NCT00002737|stage IV renal cell cancer|stage iv renal cell cancer
747387|NCT00002737|recurrent renal cell cancer|recurrent renal cell cancer
747388|NCT00002677|stage IV prostate cancer|stage iv prostate cancer
747389|NCT00002677|recurrent prostate cancer|recurrent prostate cancer
747390|NCT00002677|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
747391|NCT00002644|breast cancer|breast cancer
747392|NCT00002587|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
747393|NCT00082407|diabetes|diabetes
747394|NCT00082407|exendin|exendin
747395|NCT00082407|Amylin|amylin
747396|NCT00082407|Lilly|lilly
747397|NCT00082407|insulin aspart|insulin aspart
747398|NCT00082394|safety|safety
747399|NCT00082394|drug efficacy|drug efficacy
747400|NCT00082394|TRIZIVIR|trizivir
747401|NCT00082394|tolerability|tolerability
747402|NCT00082394|COMBIVIR|combivir
747403|NCT00082394|HIV|hiv
747404|NCT00082394|atazanavir|atazanavir
747405|NCT00082316|Dermal assessment|dermal assessment
747406|NCT00082316|Pain assessment|pain assessment
747407|NCT00082316|Diary|diary
747408|NCT00082316|Analgesics|analgesics
747409|NCT00082316|Capsaicin|capsaicin
747410|NCT00082316|Herpes zoster|herpes zoster
747411|NCT00082316|Neuralgia|neuralgia
747412|NCT00082316|HIV Infections|hiv infections
747413|NCT00082316|Peripheral Nervous System Diseases|peripheral nervous system diseases
747414|NCT00082316|Diabetic Neuropathies|diabetic neuropathies
747415|NCT00082316|Diabetes Mellitus|diabetes mellitus
747416|NCT00082316|Polyneuropathies|polyneuropathies
747417|NCT00082316|Complementary Therapies|complementary therapies
747418|NCT00082368|Tariquidar|tariquidar
747419|NCT00082368|PET|pet
747420|NCT00082368|Sestamibi|sestamibi
747421|NCT00082368|Cancer|cancer
747422|NCT00082355|r-tPA|r-tpa
747423|NCT00082355|Thrombolysis|thrombolysis
747424|NCT00082355|Clot|clot
747425|NCT00082355|Anticoagulation|anticoagulation
747426|NCT00082355|Fibrinolysis|fibrinolysis
747427|NCT00082355|Deep Vein Thrombosis|deep vein thrombosis
747428|NCT00082355|DVT|dvt
747429|NCT00082342|Human Brain|human brain
747430|NCT00082342|Electrical Stimulation|electrical stimulation
747431|NCT00082342|Parkinson Disease|parkinson disease
747432|NCT00082342|PD|pd
747433|NCT00082329|Hematopoietic Stem Cells|hematopoietic stem cells
747434|NCT00082329|PBSC's|pbsc's
747435|NCT00082329|Mobilization|mobilization
747436|NCT00082329|Alloreactivity|alloreactivity
747437|NCT00082329|T Cell Polarization|t cell polarization
747438|NCT00082329|Dendritic Cells|dendritic cells
747439|NCT00082329|CXCR4|cxcr4
747440|NCT00082329|Plerixafor|plerixafor
747441|NCT00082329|Healthy Volunteer (HV)|healthy volunteer (hv)
747442|NCT00082303|Music Therapy|music therapy
747443|NCT00082303|Anxiety|anxiety
747444|NCT00082303|Depression|depression
747445|NCT00082290|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
747446|NCT00082290|pain|pain
748066|NCT00003038|recurrent breast cancer|recurrent breast cancer
747447|NCT00082277|hormone-receptor positive, breast cancer|hormone-receptor positive, breast cancer
747448|NCT00082277|Osteopenia|osteopenia
747449|NCT00082277|Osteoporosis|osteoporosis
747450|NCT00082277|risk of fracture|risk of fracture
747451|NCT00082277|bone loss|bone loss
747452|NCT00082251|Dyslipidemia|dyslipidemia
747453|NCT00082251|High Blood Cholesterol|high blood cholesterol
747454|NCT00082251|Coronary Heart Disease|coronary heart disease
747455|NCT00082251|Hypertension|hypertension
747456|NCT00082251|National Cholesterol Education Program|national cholesterol education program
747457|NCT00082251|Adult Treatment Panel III|adult treatment panel iii
747458|NCT00082251|Niacin|niacin
747459|NCT00082251|Simvastatin|simvastatin
747460|NCT00082251|Diabetes|diabetes
747461|NCT00082251|Peripheral Vascular Disease|peripheral vascular disease
747462|NCT00082251|Cerebrovascular disease|cerebrovascular disease
747463|NCT00082251|Stroke|stroke
747464|NCT00082251|High-Density Lipoprotein Cholesterol|high-density lipoprotein cholesterol
747465|NCT00082251|Hydroxymethyl Glutaryl Coenzyme A|hydroxymethyl glutaryl coenzyme a
747466|NCT00082251|High-Sensitivity C-Reactive Protein|high-sensitivity c-reactive protein
747467|NCT00082251|Low-Density Lipoprotein Cholesterol|low-density lipoprotein cholesterol
747468|NCT00082251|Lipoprotein (a)|lipoprotein (a)
747469|NCT00082251|Lipoprotein A-I|lipoprotein a-i
747470|NCT00082251|Total Cholesterol|total cholesterol
747471|NCT00082251|Triglycerides|triglycerides
747472|NCT00082225|Hodgkins|hodgkins
747473|NCT00082225|Non-Hodgkins|non-hodgkins
747474|NCT00082225|Lymphoma|lymphoma
747475|NCT00082212|ovarian|ovarian
747476|NCT00082212|primary peritoneal cancer|primary peritoneal cancer
747477|NCT00082212|Persistent or Recurrent Ovarian Cancer|persistent or recurrent ovarian cancer
747478|NCT00082212|Primary Peritoneal Carcinoma|primary peritoneal carcinoma
747479|NCT00014651|perioperative/postoperative complications|perioperative/postoperative complications
747480|NCT00014651|stage I pancreatic cancer|stage i pancreatic cancer
747481|NCT00010322|stage IV breast cancer|stage iv breast cancer
747482|NCT00010322|recurrent breast cancer|recurrent breast cancer
747483|NCT00008255|non-small cell lung cancer|non-small cell lung cancer
747484|NCT00008255|small cell lung cancer|small cell lung cancer
747485|NCT00002568|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
747486|NCT00002568|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
747487|NCT00002568|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
747488|NCT00002568|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
747489|NCT00002568|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
747490|NCT00002568|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
747491|NCT00002568|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
747492|NCT00002568|Brenner tumor|brenner tumor
747493|NCT00002516|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
747494|NCT00002516|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
747495|NCT00082160|Meditation|meditation
747496|NCT00082160|Relaxation|relaxation
747497|NCT00082134|Prostate cancer|prostate cancer
747498|NCT00082134|Hormone-refractory prostate cancer|hormone-refractory prostate cancer
747499|NCT00082134|HRPC|hrpc
747500|NCT00082134|Prostate|prostate
747501|NCT00082134|Docetaxel|docetaxel
747502|NCT00082134|PSA progression|psa progression
747503|NCT00082134|PSA progressed|psa progressed
747504|NCT00082121|cardiac bypass|cardiac bypass
747505|NCT00082121|CABG|cabg
747506|NCT00082121|complement activation|complement activation
747507|NCT00011934|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
747508|NCT00011934|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
747509|NCT00011934|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
747510|NCT00011934|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
747511|NCT00008242|stage II multiple myeloma|stage ii multiple myeloma
747512|NCT00008242|stage III multiple myeloma|stage iii multiple myeloma
747513|NCT00008125|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
747514|NCT00008099|stage I pancreatic cancer|stage i pancreatic cancer
747515|NCT00008099|stage II pancreatic cancer|stage ii pancreatic cancer
747516|NCT00008099|stage III pancreatic cancer|stage iii pancreatic cancer
747517|NCT00008099|stage IV pancreatic cancer|stage iv pancreatic cancer
747518|NCT00006682|stage IV breast cancer|stage iv breast cancer
747519|NCT00006682|recurrent breast cancer|recurrent breast cancer
747520|NCT00006669|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
747521|NCT00006669|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
747522|NCT00006669|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
747523|NCT00006669|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
747524|NCT00006342|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
747525|NCT00006342|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
747526|NCT00006342|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
747527|NCT00006342|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
747528|NCT00006342|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
747529|NCT00006342|childhood infratentorial ependymoma|childhood infratentorial ependymoma
747530|NCT00006342|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
747531|NCT00006342|childhood supratentorial ependymoma|childhood supratentorial ependymoma
747532|NCT00006342|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
747533|NCT00006342|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
747534|NCT00006342|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
747535|NCT00006342|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
747536|NCT00006342|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
747537|NCT00006342|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
747538|NCT00006342|untreated childhood brain stem glioma|untreated childhood brain stem glioma
747539|NCT00006342|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
747540|NCT00006342|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
747541|NCT00006342|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
747542|NCT00006342|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
747543|NCT00006342|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
747544|NCT00006342|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
747545|NCT00006342|untreated childhood medulloblastoma|untreated childhood medulloblastoma
747546|NCT00006342|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
747547|NCT00006342|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
747548|NCT00006342|recurrent childhood ependymoma|recurrent childhood ependymoma
747549|NCT00006112|stage IV colon cancer|stage iv colon cancer
747550|NCT00006112|stage IV rectal cancer|stage iv rectal cancer
747551|NCT00006112|adenocarcinoma of the colon|adenocarcinoma of the colon
747552|NCT00006112|adenocarcinoma of the rectum|adenocarcinoma of the rectum
747553|NCT00006112|carcinoma of the appendix|carcinoma of the appendix
747554|NCT00006112|primary peritoneal cavity cancer|primary peritoneal cavity cancer
747555|NCT00006097|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
747556|NCT00006097|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
747557|NCT00006053|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
747558|NCT00006053|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
747559|NCT00006053|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
747560|NCT00006053|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
747561|NCT00006039|small intestine lymphoma|small intestine lymphoma
747562|NCT00006039|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
747563|NCT00006039|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
747564|NCT00006039|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
747565|NCT00006039|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
747566|NCT00006039|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
747567|NCT00006039|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
747568|NCT00006039|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
747569|NCT00006039|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
747570|NCT00006039|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
747571|NCT00006039|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
747572|NCT00006039|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
747573|NCT00006039|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
747574|NCT00006039|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
747575|NCT00006039|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
747576|NCT00006039|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
747577|NCT00006039|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
747578|NCT00006039|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
747579|NCT00006039|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
747580|NCT00006039|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
747581|NCT00006039|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
747582|NCT00006039|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
747583|NCT00006039|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
747584|NCT00006039|splenic marginal zone lymphoma|splenic marginal zone lymphoma
747585|NCT00005988|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
747586|NCT00005988|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
747587|NCT00005988|refractory multiple myeloma|refractory multiple myeloma
747588|NCT00005988|stage I multiple myeloma|stage i multiple myeloma
747589|NCT00005988|stage II multiple myeloma|stage ii multiple myeloma
747590|NCT00005988|stage III multiple myeloma|stage iii multiple myeloma
747591|NCT00005988|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
747592|NCT00005988|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
747593|NCT00005988|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
747594|NCT00005988|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
747595|NCT00005988|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
747596|NCT00005988|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
747597|NCT00005988|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
747598|NCT00005988|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
747599|NCT00005988|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
747600|NCT00005988|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
747601|NCT00005988|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
747602|NCT00005988|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
747603|NCT00005988|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
747604|NCT00005988|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
747605|NCT00005988|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
747606|NCT00005988|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
747607|NCT00005988|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
747608|NCT00005988|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
747609|NCT00005988|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
747610|NCT00005988|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
747611|NCT00005988|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
747612|NCT00005988|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
747613|NCT00005988|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
747614|NCT00005988|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
747615|NCT00005988|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
747616|NCT00005988|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
747617|NCT00005988|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
747618|NCT00005988|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
747619|NCT00005988|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
747620|NCT00005988|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
747621|NCT00005988|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
747622|NCT00005988|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
747623|NCT00005988|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
747624|NCT00005988|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
747625|NCT00005988|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
747626|NCT00005988|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
747627|NCT00005988|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
747628|NCT00005988|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
747629|NCT00005988|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
747630|NCT00005988|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
747631|NCT00005988|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
747632|NCT00005988|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
747633|NCT00005988|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
747634|NCT00005988|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
747635|NCT00005988|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
747636|NCT00005988|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
747637|NCT00005988|graft versus host disease|graft versus host disease
747638|NCT00005988|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
747639|NCT00005988|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
747640|NCT00005988|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
747641|NCT00005988|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
747642|NCT00005988|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
747643|NCT00005988|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
747644|NCT00005988|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
747645|NCT00005988|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
747646|NCT00005988|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
747647|NCT00005988|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
747648|NCT00005988|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
747649|NCT00005988|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
747650|NCT00005988|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
747651|NCT00005988|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
747652|NCT00005988|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
747653|NCT00005988|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
747654|NCT00005988|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
747655|NCT00005988|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
747656|NCT00005988|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
747657|NCT00005988|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
747658|NCT00005988|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
747659|NCT00005988|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
747660|NCT00005988|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
747661|NCT00005988|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
747662|NCT00005988|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
747663|NCT00005988|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
747664|NCT00005974|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
747665|NCT00005974|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
747666|NCT00005871|recurrent pancreatic cancer|recurrent pancreatic cancer
747667|NCT00005871|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
747668|NCT00005612|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
747669|NCT00005612|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
747670|NCT00005612|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
747671|NCT00005594|stage III pancreatic cancer|stage iii pancreatic cancer
747672|NCT00005594|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
747673|NCT00005594|stage IV pancreatic cancer|stage iv pancreatic cancer
747674|NCT00005081|recurrent adult brain tumor|recurrent adult brain tumor
747675|NCT00005081|adult glioblastoma|adult glioblastoma
747676|NCT00005081|adult anaplastic astrocytoma|adult anaplastic astrocytoma
747677|NCT00005081|adult mixed glioma|adult mixed glioma
747678|NCT00005081|adult giant cell glioblastoma|adult giant cell glioblastoma
747679|NCT00005081|adult gliosarcoma|adult gliosarcoma
747680|NCT00005055|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
747681|NCT00005055|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
747682|NCT00005055|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
747683|NCT00005055|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
747684|NCT00005053|stage III pancreatic cancer|stage iii pancreatic cancer
747685|NCT00005053|recurrent pancreatic cancer|recurrent pancreatic cancer
747686|NCT00005053|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
747687|NCT00005053|stage IV pancreatic cancer|stage iv pancreatic cancer
747688|NCT00005021|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
747689|NCT00005021|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
747690|NCT00005021|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
747691|NCT00005021|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
747692|NCT00005021|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
747693|NCT00005021|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
747694|NCT00005021|small intestine lymphoma|small intestine lymphoma
747695|NCT00005021|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
747696|NCT00005021|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
747697|NCT00005021|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
747698|NCT00005021|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
747699|NCT00005021|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
747700|NCT00005021|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
747701|NCT00005021|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
747702|NCT00005021|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
747703|NCT00005021|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
747704|NCT00005021|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
747705|NCT00005021|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
747706|NCT00005021|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
747707|NCT00005021|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
747708|NCT00005021|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
747709|NCT00005021|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
747710|NCT00005021|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
747711|NCT00005021|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
747712|NCT00005021|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
747713|NCT00005021|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
747714|NCT00005021|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
747715|NCT00005021|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
747716|NCT00005021|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
747717|NCT00005021|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
747718|NCT00005021|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
779500|NCT00001571|Serum|serum
747719|NCT00005021|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
747720|NCT00005021|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
747721|NCT00005021|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
747722|NCT00005021|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
747723|NCT00005021|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
747724|NCT00005021|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
747725|NCT00005021|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
747726|NCT00005021|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
747727|NCT00005021|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
747728|NCT00005021|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
747729|NCT00005021|intraocular lymphoma|intraocular lymphoma
747730|NCT00005021|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
747731|NCT00005021|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
747732|NCT00005021|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
747733|NCT00005021|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
747734|NCT00005021|anaplastic large cell lymphoma|anaplastic large cell lymphoma
747735|NCT00005021|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
747736|NCT00005021|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
747737|NCT00005021|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
747738|NCT00005021|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
747739|NCT00005021|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
747740|NCT00005021|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
747741|NCT00005021|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
747742|NCT00005021|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
747743|NCT00005021|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
747842|NCT00004230|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
747744|NCT00005021|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
747745|NCT00005021|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
747746|NCT00005021|splenic marginal zone lymphoma|splenic marginal zone lymphoma
747747|NCT00004893|stage IV breast cancer|stage iv breast cancer
747748|NCT00004893|recurrent breast cancer|recurrent breast cancer
747749|NCT00004892|recurrent adult brain tumor|recurrent adult brain tumor
747750|NCT00004892|adult brain stem glioma|adult brain stem glioma
747751|NCT00004892|adult ependymoma|adult ependymoma
747752|NCT00004892|adult glioblastoma|adult glioblastoma
747753|NCT00004892|adult oligodendroglioma|adult oligodendroglioma
747754|NCT00004892|adult anaplastic astrocytoma|adult anaplastic astrocytoma
747755|NCT00004892|adult mixed glioma|adult mixed glioma
747756|NCT00004892|adult giant cell glioblastoma|adult giant cell glioblastoma
747757|NCT00004892|adult gliosarcoma|adult gliosarcoma
747758|NCT00004884|stage III pancreatic cancer|stage iii pancreatic cancer
747759|NCT00004884|recurrent pancreatic cancer|recurrent pancreatic cancer
747760|NCT00004884|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
747761|NCT00004884|stage IV pancreatic cancer|stage iv pancreatic cancer
747762|NCT00004246|Radiation Therapy|radiation therapy
747764|NCT00004246|Radiotherapy|radiotherapy
747765|NCT00004246|Fludarabine|fludarabine
747766|NCT00004246|Fludara|fludara
747767|NCT00004246|Fludarabine Phosphate|fludarabine phosphate
747768|NCT00004246|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
747769|NCT00004246|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
747770|NCT00004246|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
747771|NCT00004246|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
747772|NCT00004246|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
747773|NCT00004246|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
747774|NCT00004246|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
747775|NCT00004246|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
747776|NCT00004246|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
747777|NCT00004246|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
747778|NCT00004230|pulmonary complications|pulmonary complications
747779|NCT00004230|stage IV breast cancer|stage iv breast cancer
747780|NCT00004230|stage IIIA breast cancer|stage iiia breast cancer
747781|NCT00004230|stage IIIB breast cancer|stage iiib breast cancer
747782|NCT00004230|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
747783|NCT00004230|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
747784|NCT00004230|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
747785|NCT00004230|refractory multiple myeloma|refractory multiple myeloma
747786|NCT00004230|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
747787|NCT00004230|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
779605|NCT00001502|Children|children
747788|NCT00004230|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
747789|NCT00004230|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
747790|NCT00004230|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
747791|NCT00004230|disseminated neuroblastoma|disseminated neuroblastoma
747792|NCT00004230|recurrent neuroblastoma|recurrent neuroblastoma
747793|NCT00004230|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
747794|NCT00004230|stage I multiple myeloma|stage i multiple myeloma
747795|NCT00004230|stage II multiple myeloma|stage ii multiple myeloma
747796|NCT00004230|stage III multiple myeloma|stage iii multiple myeloma
747797|NCT00004230|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
747798|NCT00004230|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
747799|NCT00004230|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
747800|NCT00004230|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
747801|NCT00004230|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
747802|NCT00004230|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
747803|NCT00004230|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
747804|NCT00004230|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
747805|NCT00004230|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
747806|NCT00004230|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
747807|NCT00004230|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
747808|NCT00004230|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
747809|NCT00004230|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
747810|NCT00004230|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
747811|NCT00004230|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
747812|NCT00004230|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
747813|NCT00004230|testicular embryonal carcinoma|testicular embryonal carcinoma
747814|NCT00004230|testicular choriocarcinoma|testicular choriocarcinoma
747815|NCT00004230|testicular teratoma|testicular teratoma
747816|NCT00004230|testicular yolk sac tumor|testicular yolk sac tumor
747817|NCT00004230|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
747818|NCT00004230|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
747819|NCT00004230|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
747820|NCT00004230|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
747821|NCT00004230|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
747822|NCT00004230|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
747823|NCT00004230|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
747824|NCT00004230|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
747825|NCT00004230|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
747826|NCT00004230|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
747827|NCT00004230|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
747828|NCT00004230|refractory hairy cell leukemia|refractory hairy cell leukemia
747829|NCT00004230|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
747830|NCT00004230|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
747831|NCT00004230|ovarian yolk sac tumor|ovarian yolk sac tumor
747832|NCT00004230|ovarian embryonal carcinoma|ovarian embryonal carcinoma
747833|NCT00004230|ovarian polyembryoma|ovarian polyembryoma
747834|NCT00004230|ovarian choriocarcinoma|ovarian choriocarcinoma
747835|NCT00004230|ovarian immature teratoma|ovarian immature teratoma
747836|NCT00004230|ovarian mature teratoma|ovarian mature teratoma
747837|NCT00004230|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
747838|NCT00004230|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
747839|NCT00004230|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
747840|NCT00004230|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
747841|NCT00004230|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
747843|NCT00004230|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
747844|NCT00004230|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
747845|NCT00004230|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
747846|NCT00004230|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
747847|NCT00004230|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
747848|NCT00004230|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
747849|NCT00004230|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
747850|NCT00004230|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
747851|NCT00004230|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
747852|NCT00004230|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
747853|NCT00004230|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
747915|NCT00004101|splenic marginal zone lymphoma|splenic marginal zone lymphoma
747854|NCT00004230|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
747855|NCT00004230|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
747856|NCT00004230|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
747857|NCT00004230|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
747858|NCT00004230|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
747859|NCT00004230|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
747860|NCT00004230|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
747861|NCT00004230|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
747862|NCT00004230|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
747863|NCT00004230|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
747864|NCT00004230|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
747865|NCT00004230|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
747866|NCT00004230|secondary acute myeloid leukemia|secondary acute myeloid leukemia
747867|NCT00004230|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
747868|NCT00004230|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
747869|NCT00004230|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
747870|NCT00004230|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
747871|NCT00004230|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
747872|NCT00004230|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
747873|NCT00004230|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
747874|NCT00004230|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
747875|NCT00004230|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
747876|NCT00004230|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
747877|NCT00004230|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
747878|NCT00004230|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
747879|NCT00004230|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
747880|NCT00004230|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
747881|NCT00004230|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
747882|NCT00004230|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
747883|NCT00004230|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
747884|NCT00004230|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
747885|NCT00004230|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
747886|NCT00004230|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
747887|NCT00004230|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
747888|NCT00004230|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
747889|NCT00004230|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
747890|NCT00004230|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
747891|NCT00004230|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
747892|NCT00004230|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
747893|NCT00004230|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
747894|NCT00004230|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
747895|NCT00004230|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
747896|NCT00004230|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
747897|NCT00004230|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
747898|NCT00004230|splenic marginal zone lymphoma|splenic marginal zone lymphoma
747899|NCT00004230|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
747900|NCT00004213|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
747901|NCT00004101|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
747902|NCT00004101|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
747903|NCT00004101|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
747904|NCT00004101|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
747905|NCT00004101|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
747906|NCT00004101|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
747907|NCT00004101|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
747908|NCT00004101|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
747909|NCT00004101|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
747910|NCT00004101|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
747911|NCT00004101|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
747912|NCT00004101|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
747913|NCT00004101|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
747914|NCT00004101|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
747916|NCT00004049|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
747917|NCT00003972|stage II breast cancer|stage ii breast cancer
747918|NCT00003972|stage IIIA breast cancer|stage iiia breast cancer
747919|NCT00003968|stage IV renal cell cancer|stage iv renal cell cancer
747920|NCT00003968|recurrent renal cell cancer|recurrent renal cell cancer
747921|NCT00003943|extensive stage small cell lung cancer|extensive stage small cell lung cancer
747922|NCT00003943|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
747923|NCT00003900|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
747924|NCT00003900|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
747925|NCT00003849|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
747926|NCT00003849|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
747927|NCT00003849|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
747928|NCT00003825|radiation enteritis|radiation enteritis
747929|NCT00003825|diarrhea|diarrhea
747930|NCT00003768|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
747931|NCT00003726|extensive stage small cell lung cancer|extensive stage small cell lung cancer
747932|NCT00003726|recurrent small cell lung cancer|recurrent small cell lung cancer
747933|NCT00003713|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
747934|NCT00003680|stage III breast cancer|stage iii breast cancer
747935|NCT00003680|inflammatory breast cancer|inflammatory breast cancer
747936|NCT00003646|adult solid tumor|adult solid tumor
747937|NCT00003646|body system/site cancer|body system/site cancer
747939|NCT00003646|melanoma|melanoma
747940|NCT00003646|recurrent melanoma|recurrent melanoma
747941|NCT00003646|skin tumor|skin tumor
747942|NCT00003646|solid tumor|solid tumor
747943|NCT00003646|stage III melanoma|stage iii melanoma
747944|NCT00003646|stage IV melanoma|stage iv melanoma
747945|NCT00003646|stage, melanoma|stage, melanoma
747946|NCT00003638|stage IV breast cancer|stage iv breast cancer
747947|NCT00003638|recurrent breast cancer|recurrent breast cancer
747948|NCT00003622|adenocarcinoma of the prostate|adenocarcinoma of the prostate
747949|NCT00003622|stage IV prostate cancer|stage iv prostate cancer
747950|NCT00003622|recurrent prostate cancer|recurrent prostate cancer
747951|NCT00082147|MRI|mri
747952|NCT00082147|Biopsy|biopsy
747953|NCT00082147|Fiducial Marker|fiducial marker
747954|NCT00082147|Prostate Cancer|prostate cancer
747955|NCT00082108|Registry|registry
747956|NCT00082108|FSHD|fshd
747957|NCT00082108|DM|dm
747958|NCT00082108|Muscular Dystrophy|muscular dystrophy
747959|NCT00082108|Facioscapulohumeral Myotonic Dystrophy|facioscapulohumeral myotonic dystrophy
747960|NCT00082108|Myotonic Dystrophy|myotonic dystrophy
747961|NCT00082108|DM1|dm1
747962|NCT00082108|DM2|dm2
747963|NCT00082108|FSH|fsh
747964|NCT00082108|MMD|mmd
747965|NCT00082095|Metastatic breast cancer|metastatic breast cancer
747966|NCT00082095|Breast Cancer|breast cancer
747967|NCT00082095|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
747968|NCT00082095|Capecitabine|capecitabine
747969|NCT00082095|DOXIL|doxil
747970|NCT00082095|Xeloda|xeloda
747971|NCT00082069|Shigella|shigella
747972|NCT00082069|diarrhea|diarrhea
747973|NCT00081978|HIV infection|hiv infection
747974|NCT00081978|TMC125|tmc125
747975|NCT00081978|Non-nucleoside reverse transcriptase inhibitor, TMC125-C223|non-nucleoside reverse transcriptase inhibitor, tmc125-c223
747976|NCT00003583|limited stage small cell lung cancer|limited stage small cell lung cancer
747977|NCT00003583|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
747978|NCT00003583|radiation toxicity|radiation toxicity
747979|NCT00003563|tumors metastatic to brain|tumors metastatic to brain
747980|NCT00003554|stage I multiple myeloma|stage i multiple myeloma
747981|NCT00003554|stage II multiple myeloma|stage ii multiple myeloma
747982|NCT00003554|stage III multiple myeloma|stage iii multiple myeloma
747983|NCT00003397|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
747984|NCT00003397|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
747985|NCT00003397|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
747986|NCT00003397|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
747987|NCT00003397|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
747988|NCT00003397|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
747989|NCT00003397|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
747990|NCT00003397|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
747991|NCT00003397|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
747992|NCT00003397|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
747993|NCT00003397|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
747994|NCT00003397|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
747995|NCT00003397|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
747996|NCT00003397|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
747997|NCT00003397|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
747998|NCT00003397|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
747999|NCT00003397|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
748000|NCT00003397|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
748001|NCT00003397|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
748002|NCT00003397|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
748003|NCT00003397|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
748004|NCT00003397|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
748005|NCT00003397|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
748006|NCT00003397|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
748007|NCT00003397|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
748008|NCT00003397|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
748009|NCT00003397|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
748010|NCT00003397|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
748011|NCT00003397|stage I mantle cell lymphoma|stage i mantle cell lymphoma
748012|NCT00003397|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
748013|NCT00003397|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
748014|NCT00003397|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
748015|NCT00003397|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
748016|NCT00003397|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
748017|NCT00003397|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
748018|NCT00003397|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
748019|NCT00003397|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
748020|NCT00003397|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
748021|NCT00003397|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
748022|NCT00003397|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
748023|NCT00003397|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
748024|NCT00003397|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
748025|NCT00003397|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
748026|NCT00003397|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
748027|NCT00003397|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
748028|NCT00003397|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
748029|NCT00003397|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
748030|NCT00003397|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
748031|NCT00003394|adenocarcinoma of the prostate|adenocarcinoma of the prostate
748032|NCT00003394|stage I prostate cancer|stage i prostate cancer
748033|NCT00003394|stage IIB prostate cancer|stage iib prostate cancer
748034|NCT00003394|stage IIA prostate cancer|stage iia prostate cancer
748035|NCT00003394|stage III prostate cancer|stage iii prostate cancer
748036|NCT00003394|stage IV prostate cancer|stage iv prostate cancer
748037|NCT00003394|recurrent prostate cancer|recurrent prostate cancer
748038|NCT00003276|unresectable gallbladder cancer|unresectable gallbladder cancer
748039|NCT00003276|recurrent gallbladder cancer|recurrent gallbladder cancer
748040|NCT00003239|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
748041|NCT00003239|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
748042|NCT00003239|Homoharringtonine|homoharringtonine
748043|NCT00003239|HHT|hht
748044|NCT00003239|cephalotaxus alkaloid|cephalotaxus alkaloid
748045|NCT00003239|cytarabine|cytarabine
748046|NCT00003239|Interferon Alpha 2-A|interferon alpha 2-a
748047|NCT00003239|Roferon-A|roferon-a
748048|NCT00003239|Ara-C|ara-c
748049|NCT00003239|DepotCyt|depotcyt
748050|NCT00003239|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
748051|NCT00003181|stage IV renal cell cancer|stage iv renal cell cancer
748052|NCT00003181|recurrent renal cell cancer|recurrent renal cell cancer
748053|NCT00003175|recurrent bladder cancer|recurrent bladder cancer
748054|NCT00003175|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
748055|NCT00003175|recurrent urethral cancer|recurrent urethral cancer
748056|NCT00003175|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
748057|NCT00003165|stage IV breast cancer|stage iv breast cancer
748058|NCT00003165|recurrent breast cancer|recurrent breast cancer
748059|NCT00003133|stage III bladder cancer|stage iii bladder cancer
748060|NCT00003133|stage IV bladder cancer|stage iv bladder cancer
748061|NCT00003133|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
748062|NCT00003133|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
748063|NCT00003133|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
748064|NCT00003038|stage IV colon cancer|stage iv colon cancer
748065|NCT00003038|stage IV breast cancer|stage iv breast cancer
748067|NCT00003038|recurrent colon cancer|recurrent colon cancer
748068|NCT00003038|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
748069|NCT00003038|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
748070|NCT00003038|stage IV prostate cancer|stage iv prostate cancer
748071|NCT00003038|recurrent prostate cancer|recurrent prostate cancer
748072|NCT00003038|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
748073|NCT00003019|desmoid tumor|desmoid tumor
748074|NCT00081926|CML|cml
748075|NCT00081926|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
748076|NCT00081926|RIGHT Trial|right trial
748077|NCT00081926|US177|us177
748078|NCT00081926|CSTI571|csti571
748079|NCT00014365|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
748080|NCT00006483|stage IV renal cell cancer|stage iv renal cell cancer
748081|NCT00006483|recurrent renal cell cancer|recurrent renal cell cancer
748082|NCT00006483|lung metastases|lung metastases
748083|NCT00006261|stage IV breast cancer|stage iv breast cancer
748084|NCT00006261|recurrent breast cancer|recurrent breast cancer
748085|NCT00006106|adult solid tumor|adult solid tumor
748086|NCT00006106|body system/site cancer|body system/site cancer
748087|NCT00006106|cancer|cancer
748088|NCT00006106|cellular diagnosis, hypopharyngeal cancer|cellular diagnosis, hypopharyngeal cancer
748089|NCT00006106|cellular diagnosis, laryngeal cancer|cellular diagnosis, laryngeal cancer
748090|NCT00006106|cellular diagnosis, lip and oral cavity cancer|cellular diagnosis, lip and oral cavity cancer
748091|NCT00006106|cellular diagnosis, nasopharyngeal cancer|cellular diagnosis, nasopharyngeal cancer
748092|NCT00006106|cellular diagnosis, oropharyngeal cancer|cellular diagnosis, oropharyngeal cancer
748093|NCT00006106|cellular diagnosis, paranasal sinus and nasal cavity cancer|cellular diagnosis, paranasal sinus and nasal cavity cancer
748094|NCT00006106|head and neck cancer|head and neck cancer
748095|NCT00006106|hypopharyngeal cancer|hypopharyngeal cancer
748096|NCT00006106|hypopharyngeal squamous cell carcinoma|hypopharyngeal squamous cell carcinoma
748097|NCT00006106|laryngeal cancer|laryngeal cancer
748098|NCT00006106|laryngeal squamous cell carcinoma|laryngeal squamous cell carcinoma
748099|NCT00006106|lip and oral cavity cancer|lip and oral cavity cancer
748100|NCT00006106|lip and oral cavity squamous cell carcinoma|lip and oral cavity squamous cell carcinoma
748101|NCT00006106|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
748102|NCT00006106|nasopharyngeal cancer|nasopharyngeal cancer
748103|NCT00006106|nasopharyngeal squamous cell carcinoma|nasopharyngeal squamous cell carcinoma
748104|NCT00006106|oropharyngeal cancer|oropharyngeal cancer
748105|NCT00006106|oropharyngeal squamous cell carcinoma|oropharyngeal squamous cell carcinoma
748106|NCT00006106|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
748107|NCT00006106|paranasal sinus and nasal cavity squamous cell carcinoma|paranasal sinus and nasal cavity squamous cell carcinoma
748108|NCT00006106|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
748109|NCT00006106|recurrent laryngeal cancer|recurrent laryngeal cancer
748110|NCT00006106|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
748111|NCT00006106|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
748112|NCT00006106|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
748113|NCT00006106|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
748114|NCT00006106|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
748115|NCT00006106|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
748116|NCT00006106|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
748117|NCT00006106|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
748118|NCT00006106|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
748119|NCT00006106|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
748120|NCT00006106|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
748121|NCT00006106|solid tumor|solid tumor
748122|NCT00006106|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
748123|NCT00006106|stage III laryngeal cancer|stage iii laryngeal cancer
748124|NCT00006106|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
748125|NCT00006106|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
748126|NCT00006106|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
748127|NCT00006106|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
748128|NCT00006106|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
748129|NCT00006106|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
748130|NCT00006106|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
748131|NCT00006106|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
748132|NCT00006106|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
748133|NCT00006106|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
748134|NCT00006106|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
748135|NCT00006106|stage IV laryngeal cancer|stage iv laryngeal cancer
748136|NCT00006106|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
748137|NCT00006106|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
748138|NCT00006106|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
748139|NCT00006106|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
748140|NCT00006106|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
748141|NCT00006106|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
748142|NCT00006106|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
748143|NCT00006106|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
748144|NCT00006106|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
748145|NCT00006106|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
748146|NCT00006106|stage, hypopharyngeal cancer|stage, hypopharyngeal cancer
748147|NCT00006106|stage, laryngeal cancer|stage, laryngeal cancer
748148|NCT00006106|stage, lip and oral cavity cancer|stage, lip and oral cavity cancer
748149|NCT00006106|stage, metastatic squamous neck cancer with occult primary|stage, metastatic squamous neck cancer with occult primary
748150|NCT00006106|stage, nasopharyngeal cancer|stage, nasopharyngeal cancer
748151|NCT00006106|stage, oropharyngeal cancer|stage, oropharyngeal cancer
748152|NCT00006106|stage, paranasal sinus and nasal cavity cancer|stage, paranasal sinus and nasal cavity cancer
748153|NCT00003001|stage IV colon cancer|stage iv colon cancer
748154|NCT00003001|stage IV rectal cancer|stage iv rectal cancer
748155|NCT00003001|recurrent colon cancer|recurrent colon cancer
748156|NCT00003001|recurrent rectal cancer|recurrent rectal cancer
748157|NCT00002977|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
748158|NCT00002977|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
748159|NCT00002977|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
748160|NCT00002977|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
748161|NCT00002977|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
748162|NCT00002977|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
748163|NCT00002977|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
748164|NCT00002977|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
748165|NCT00002977|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
748166|NCT00002977|Brenner tumor|brenner tumor
748167|NCT00002939|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
748168|NCT00002912|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
748169|NCT00002912|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
748170|NCT00002912|secondary acute myeloid leukemia|secondary acute myeloid leukemia
748171|NCT00002884|stage I esophageal cancer|stage i esophageal cancer
748172|NCT00002884|stage II esophageal cancer|stage ii esophageal cancer
748173|NCT00002884|stage III esophageal cancer|stage iii esophageal cancer
748174|NCT00002884|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
748175|NCT00002884|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
748176|NCT00002773|stage II pancreatic cancer|stage ii pancreatic cancer
748177|NCT00002773|stage III pancreatic cancer|stage iii pancreatic cancer
748178|NCT00002773|recurrent pancreatic cancer|recurrent pancreatic cancer
748179|NCT00002773|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
748180|NCT00002773|stage IV pancreatic cancer|stage iv pancreatic cancer
748181|NCT00002719|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
748182|NCT00002719|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
748183|NCT00002719|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
748184|NCT00002719|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
748185|NCT00002719|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
748186|NCT00002719|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
748187|NCT00002719|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
748188|NCT00002719|secondary acute myeloid leukemia|secondary acute myeloid leukemia
748189|NCT00002719|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
748190|NCT00002719|neutropenia|neutropenia
748191|NCT00002719|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
748192|NCT00002680|stage IV breast cancer|stage iv breast cancer
748193|NCT00002680|recurrent breast cancer|recurrent breast cancer
748194|NCT00002590|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
748195|NCT00002590|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
748196|NCT00002564|recurrent breast cancer|recurrent breast cancer
748197|NCT00002481|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
748198|NCT00002481|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
748199|NCT00002481|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
748200|NCT00002481|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
748201|NCT00002481|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
748202|NCT00002481|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
779606|NCT00001502|Glioma|glioma
748203|NCT00002481|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
748204|NCT00002481|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
748205|NCT00002481|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
748206|NCT00002481|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
748207|NCT00002481|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
748208|NCT00002481|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
748209|NCT00002481|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
748210|NCT00002481|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
748211|NCT00002481|splenic marginal zone lymphoma|splenic marginal zone lymphoma
748212|NCT00082043|Neurosteroids|neurosteroids
748213|NCT00082043|5 Alpha-Reductase Inhibitor|5 alpha-reductase inhibitor
748214|NCT00082043|Depression|depression
748215|NCT00082043|Menstrual Cycle|menstrual cycle
748216|NCT00082043|Gonadal Steroids|gonadal steroids
748217|NCT00082043|Menstrual Cycle Related Mood Disorder|menstrual cycle related mood disorder
748218|NCT00082043|MRMD|mrmd
748219|NCT00082043|Healthy Volunteer|healthy volunteer
748220|NCT00082030|Depression|depression
748221|NCT00082030|PET|pet
748222|NCT00082030|fMRI|fmri
748223|NCT00082030|Dopamine|dopamine
748224|NCT00082030|Norepinephrine Depletion|norepinephrine depletion
748225|NCT00082030|Emotional Stimuli|emotional stimuli
748226|NCT00082030|Anhedonia|anhedonia
748227|NCT00082030|Norepinephrine|norepinephrine
748228|NCT00082030|Dopamine Depletion|dopamine depletion
748229|NCT00082030|Major Depressive Disorder|major depressive disorder
748230|NCT00082030|MDD|mdd
748231|NCT00082030|Healthy Volunteer|healthy volunteer
748232|NCT00082030|HV|hv
748233|NCT00082017|Protein Kinase Inhibition|protein kinase inhibition
748234|NCT00082017|Soluble Tac|soluble tac
748235|NCT00082017|Gene Expression Profiling|gene expression profiling
748236|NCT00082017|ALK Expression|alk expression
748237|NCT00082017|Apoptosis|apoptosis
748238|NCT00082017|Lymphoma|lymphoma
748239|NCT00082017|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
748240|NCT00082017|ALCL|alcl
748245|NCT00081991|Human Aging|human aging
748246|NCT00081991|Dynamic Light Scattering (DLS)|dynamic light scattering (dls)
748247|NCT00081991|Aging-Related Lens Changes|aging-related lens changes
748248|NCT00081991|Early Cataract|early cataract
748249|NCT00081991|Lens|lens
748250|NCT00081991|AREDS Grading|areds grading
748251|NCT00081991|In Vivo|in vivo
748252|NCT00081991|Healthy Volunteer|healthy volunteer
748253|NCT00081965|breast cancer in situ|breast cancer in situ
748254|NCT00081965|stage I breast cancer|stage i breast cancer
748255|NCT00081965|stage II breast cancer|stage ii breast cancer
748256|NCT00081965|stage IIIA breast cancer|stage iiia breast cancer
748257|NCT00081965|stage IIIB breast cancer|stage iiib breast cancer
748258|NCT00081965|stage IV breast cancer|stage iv breast cancer
748259|NCT00081965|recurrent breast cancer|recurrent breast cancer
748260|NCT00081965|stage IIIC breast cancer|stage iiic breast cancer
748261|NCT00081965|hot flashes|hot flashes
748262|NCT00081952|Postmenopause|postmenopause
748263|NCT00081913|Apheresis|apheresis
748264|NCT00081913|Cell Transfer|cell transfer
748265|NCT00081913|Chest Pain|chest pain
748266|NCT00081913|Adult Stem Cell Therapy|adult stem cell therapy
748267|NCT00081900|Carcinoma, Hepatocellular|carcinoma, hepatocellular
748268|NCT00005969|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
748269|NCT00005969|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
748270|NCT00005883|non-small cell lung cancer|non-small cell lung cancer
748271|NCT00005883|small cell lung cancer|small cell lung cancer
748272|NCT00005796|recurrent adult brain tumor|recurrent adult brain tumor
748273|NCT00005796|adult brain stem glioma|adult brain stem glioma
748274|NCT00005796|adult ependymoma|adult ependymoma
748275|NCT00005796|adult medulloblastoma|adult medulloblastoma
748276|NCT00005796|adult glioblastoma|adult glioblastoma
748277|NCT00005796|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
748278|NCT00005796|childhood oligodendroglioma|childhood oligodendroglioma
748279|NCT00005796|adult anaplastic astrocytoma|adult anaplastic astrocytoma
748280|NCT00005796|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
748281|NCT00005796|adult mixed glioma|adult mixed glioma
748282|NCT00005796|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
748283|NCT00005796|bone marrow suppression|bone marrow suppression
748284|NCT00005796|untreated childhood brain stem glioma|untreated childhood brain stem glioma
748285|NCT00005796|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
748286|NCT00005796|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
748287|NCT00005796|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
748288|NCT00005796|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
748289|NCT00005796|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
748290|NCT00005796|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
748291|NCT00005796|recurrent childhood ependymoma|recurrent childhood ependymoma
748292|NCT00005796|adult giant cell glioblastoma|adult giant cell glioblastoma
748293|NCT00005796|adult gliosarcoma|adult gliosarcoma
748294|NCT00005649|stage IV breast cancer|stage iv breast cancer
748295|NCT00005649|recurrent breast cancer|recurrent breast cancer
748296|NCT00004933|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
748297|NCT00004933|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
748298|NCT00004933|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
748299|NCT00004923|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
748300|NCT00004903|refractory multiple myeloma|refractory multiple myeloma
748301|NCT00004903|stage I multiple myeloma|stage i multiple myeloma
748302|NCT00004903|stage II multiple myeloma|stage ii multiple myeloma
748303|NCT00004903|stage III multiple myeloma|stage iii multiple myeloma
748304|NCT00004878|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
748305|NCT00004878|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
748306|NCT00004878|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
748307|NCT00004878|graft versus host disease|graft versus host disease
748308|NCT00004872|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
748309|NCT00004858|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
748310|NCT00004858|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
748311|NCT00004858|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
748312|NCT00004858|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
748313|NCT00004858|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
748314|NCT00004858|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
748315|NCT00004858|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
748316|NCT00004858|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
748317|NCT00004858|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
748318|NCT00004858|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
748319|NCT00004858|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
748320|NCT00004858|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
748321|NCT00004858|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
748322|NCT00004858|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
748323|NCT00004858|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
748324|NCT00004604|stage IV colon cancer|stage iv colon cancer
748325|NCT00004604|stage IV breast cancer|stage iv breast cancer
748326|NCT00004604|recurrent breast cancer|recurrent breast cancer
748327|NCT00004604|stage IV gastric cancer|stage iv gastric cancer
748328|NCT00004604|recurrent gastric cancer|recurrent gastric cancer
748329|NCT00004604|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
748330|NCT00004604|recurrent pancreatic cancer|recurrent pancreatic cancer
748331|NCT00004604|stage IV rectal cancer|stage iv rectal cancer
748332|NCT00004604|recurrent colon cancer|recurrent colon cancer
748333|NCT00004604|recurrent rectal cancer|recurrent rectal cancer
748334|NCT00004604|inflammatory breast cancer|inflammatory breast cancer
748335|NCT00004604|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
748336|NCT00004604|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
748337|NCT00004604|extensive stage small cell lung cancer|extensive stage small cell lung cancer
748338|NCT00004604|recurrent small cell lung cancer|recurrent small cell lung cancer
748339|NCT00004604|unresectable gallbladder cancer|unresectable gallbladder cancer
748340|NCT00004604|recurrent gallbladder cancer|recurrent gallbladder cancer
748341|NCT00004604|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
748342|NCT00004604|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
748343|NCT00004604|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
748344|NCT00004604|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
748345|NCT00004604|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
748346|NCT00004604|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
748347|NCT00004604|stage IV salivary gland cancer|stage iv salivary gland cancer
748348|NCT00004604|recurrent salivary gland cancer|recurrent salivary gland cancer
748349|NCT00004604|Paget disease of the breast with invasive ductal carcinoma|paget disease of the breast with invasive ductal carcinoma
748350|NCT00004604|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
748351|NCT00004604|testicular yolk sac tumor|testicular yolk sac tumor
748352|NCT00004604|lung metastases|lung metastases
748353|NCT00004604|liver metastases|liver metastases
748354|NCT00004604|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
748355|NCT00004604|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
748356|NCT00004604|male breast cancer|male breast cancer
748357|NCT00004604|stage IV pancreatic cancer|stage iv pancreatic cancer
748358|NCT00004249|limited stage small cell lung cancer|limited stage small cell lung cancer
748359|NCT00004174|stage IV breast cancer|stage iv breast cancer
748360|NCT00004174|stage IIIA breast cancer|stage iiia breast cancer
748361|NCT00004174|recurrent breast cancer|recurrent breast cancer
779915|NCT00001324|Ataxia|ataxia
748362|NCT00004174|stage IIIB breast cancer|stage iiib breast cancer
748363|NCT00003960|refractory multiple myeloma|refractory multiple myeloma
748364|NCT00003960|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
748365|NCT00003960|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
748366|NCT00003960|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
748367|NCT00003960|refractory anemia with excess blasts|refractory anemia with excess blasts
748368|NCT00003960|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
748369|NCT00003960|acute undifferentiated leukemia|acute undifferentiated leukemia
748370|NCT00003960|secondary acute myeloid leukemia|secondary acute myeloid leukemia
748371|NCT00003960|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
748372|NCT00003960|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
748373|NCT00003960|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
748374|NCT00003953|stage II breast cancer|stage ii breast cancer
748375|NCT00003953|stage IIIA breast cancer|stage iiia breast cancer
748376|NCT00003953|stage IIIB breast cancer|stage iiib breast cancer
748377|NCT00081887|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
748378|NCT00081887|CLL|cll
748379|NCT00081887|Leukemia|leukemia
748380|NCT00081887|Clofarabine|clofarabine
748381|NCT00081887|Clofarex|clofarex
748382|NCT00081887|Clolar|clolar
748383|NCT00081874|Leukemia|leukemia
748384|NCT00081874|Mantle cell lymphoma|mantle cell lymphoma
748385|NCT00081874|Myelofibrosis|myelofibrosis
748386|NCT00081874|Relapsed or Refractory Acute Myeloid Leukemia|relapsed or refractory acute myeloid leukemia
748387|NCT00081874|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
748388|NCT00081874|Chronic Myeloid Leukemia in Blastic-Phase|chronic myeloid leukemia in blastic-phase
748389|NCT00081874|Agnogenic Myeloid Metaplasia|agnogenic myeloid metaplasia
748390|NCT00081874|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
748391|NCT00081874|T-Cell Leukemia|t-cell leukemia
748392|NCT00081874|RAD001|rad001
748393|NCT00081874|Everolimus|everolimus
748394|NCT00081874|Afinitor|afinitor
748395|NCT00081861|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
748396|NCT00081861|B-Cell Lymphoma|b-cell lymphoma
748397|NCT00081861|Lymphoma|lymphoma
748398|NCT00081861|Avastin|avastin
748399|NCT00081861|Bevacizumab|bevacizumab
748400|NCT00081861|Rituximab|rituximab
748401|NCT00081861|Rituxan|rituxan
748402|NCT00003950|stage IV colon cancer|stage iv colon cancer
748403|NCT00003950|stage IV rectal cancer|stage iv rectal cancer
748404|NCT00003950|recurrent colon cancer|recurrent colon cancer
748405|NCT00003950|recurrent rectal cancer|recurrent rectal cancer
748406|NCT00003950|adenocarcinoma of the colon|adenocarcinoma of the colon
748407|NCT00003950|adenocarcinoma of the rectum|adenocarcinoma of the rectum
748408|NCT00003914|stage IV renal cell cancer|stage iv renal cell cancer
748409|NCT00003914|recurrent renal cell cancer|recurrent renal cell cancer
748410|NCT00003887|stage IV breast cancer|stage iv breast cancer
748411|NCT00003887|stage IIIA breast cancer|stage iiia breast cancer
748412|NCT00003887|stage IIIB breast cancer|stage iiib breast cancer
748413|NCT00003887|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
748414|NCT00003887|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
748415|NCT00003887|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
748416|NCT00003887|refractory multiple myeloma|refractory multiple myeloma
748417|NCT00003887|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
748418|NCT00003887|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
748419|NCT00003887|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
748420|NCT00003887|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
748421|NCT00003887|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
748422|NCT00003887|disseminated neuroblastoma|disseminated neuroblastoma
748423|NCT00003887|recurrent neuroblastoma|recurrent neuroblastoma
748424|NCT00003887|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
748425|NCT00003887|stage I multiple myeloma|stage i multiple myeloma
748426|NCT00003887|stage II multiple myeloma|stage ii multiple myeloma
748427|NCT00003887|stage III multiple myeloma|stage iii multiple myeloma
748428|NCT00003887|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
748429|NCT00003887|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
748430|NCT00003887|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
748431|NCT00003887|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
748432|NCT00003887|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
748433|NCT00003887|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
748434|NCT00003887|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
748435|NCT00003887|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
748436|NCT00003887|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
748437|NCT00003887|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
748438|NCT00003887|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
748439|NCT00003887|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
748440|NCT00003887|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
748441|NCT00003887|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
748442|NCT00003887|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
748443|NCT00003887|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
748444|NCT00003887|testicular embryonal carcinoma|testicular embryonal carcinoma
748445|NCT00003887|testicular choriocarcinoma|testicular choriocarcinoma
748446|NCT00003887|testicular teratoma|testicular teratoma
748447|NCT00003887|testicular yolk sac tumor|testicular yolk sac tumor
748448|NCT00003887|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
748449|NCT00003887|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
748450|NCT00003887|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
748451|NCT00003887|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
748452|NCT00003887|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
748453|NCT00003887|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
748454|NCT00003887|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
748455|NCT00003887|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
748456|NCT00003887|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
748457|NCT00003887|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
748458|NCT00003887|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
748459|NCT00003887|refractory hairy cell leukemia|refractory hairy cell leukemia
748460|NCT00003887|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
748461|NCT00003887|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
748462|NCT00003887|ovarian yolk sac tumor|ovarian yolk sac tumor
748463|NCT00003887|ovarian embryonal carcinoma|ovarian embryonal carcinoma
748464|NCT00003887|ovarian polyembryoma|ovarian polyembryoma
748465|NCT00003887|ovarian choriocarcinoma|ovarian choriocarcinoma
748466|NCT00003887|ovarian immature teratoma|ovarian immature teratoma
748467|NCT00003887|ovarian mature teratoma|ovarian mature teratoma
748468|NCT00003887|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
748469|NCT00003887|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
748470|NCT00003887|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
748471|NCT00003887|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
748472|NCT00003887|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
748473|NCT00003887|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
748474|NCT00003887|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
748475|NCT00003887|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
748476|NCT00003887|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
748477|NCT00003887|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
748478|NCT00003887|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
748479|NCT00003887|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
748480|NCT00003887|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
748481|NCT00003887|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
748482|NCT00003887|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
748483|NCT00003887|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
748484|NCT00003887|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
748485|NCT00003887|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
748486|NCT00003887|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
748487|NCT00003887|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
748488|NCT00003887|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
748489|NCT00003887|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
748490|NCT00003887|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
748491|NCT00003887|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
748492|NCT00003887|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
748493|NCT00003887|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
748494|NCT00003887|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
748495|NCT00003887|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
748496|NCT00003887|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
748497|NCT00003887|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
748498|NCT00003887|secondary acute myeloid leukemia|secondary acute myeloid leukemia
748499|NCT00003887|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
748500|NCT00003887|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
748501|NCT00003887|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
748502|NCT00003887|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
748503|NCT00003887|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
779916|NCT00001324|Brain|brain
748504|NCT00003887|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
748505|NCT00003887|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
748506|NCT00003887|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
748507|NCT00003887|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
748508|NCT00003887|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
748509|NCT00003887|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
748510|NCT00003887|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
748511|NCT00003887|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
748512|NCT00003887|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
748513|NCT00003887|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
748514|NCT00003887|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
748515|NCT00003887|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
748516|NCT00003887|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
748517|NCT00003887|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
748518|NCT00003887|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
748519|NCT00003887|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
748520|NCT00003887|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
748521|NCT00003887|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
748522|NCT00003887|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
748523|NCT00003887|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
748524|NCT00003887|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
748525|NCT00003887|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
748526|NCT00003887|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
748527|NCT00003887|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
748528|NCT00003887|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
748529|NCT00003887|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
748530|NCT00003887|splenic marginal zone lymphoma|splenic marginal zone lymphoma
748531|NCT00003887|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
748532|NCT00003819|stage I prostate cancer|stage i prostate cancer
748533|NCT00003819|stage IIB prostate cancer|stage iib prostate cancer
748534|NCT00003819|stage IIA prostate cancer|stage iia prostate cancer
748535|NCT00003819|stage III prostate cancer|stage iii prostate cancer
748536|NCT00003819|recurrent prostate cancer|recurrent prostate cancer
748537|NCT00003783|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
748538|NCT00003783|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
748539|NCT00003783|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
748540|NCT00003783|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
748541|NCT00003765|childhood craniopharyngioma|childhood craniopharyngioma
748542|NCT00003765|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
748543|NCT00003765|childhood oligodendroglioma|childhood oligodendroglioma
748544|NCT00003765|childhood choroid plexus tumor|childhood choroid plexus tumor
748829|NCT00006357|uterine leiomyosarcoma|uterine leiomyosarcoma
748545|NCT00003765|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
748546|NCT00003765|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
748547|NCT00003765|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
748548|NCT00003765|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
748549|NCT00003765|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
748550|NCT00003765|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
748551|NCT00003765|recurrent childhood ependymoma|recurrent childhood ependymoma
748552|NCT00003619|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
748553|NCT00003619|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
748554|NCT00003619|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
748555|NCT00003619|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
748556|NCT00003619|polycythemia vera|polycythemia vera
748557|NCT00003619|primary myelofibrosis|primary myelofibrosis
748558|NCT00003619|refractory anemia|refractory anemia
748559|NCT00003619|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
748560|NCT00003619|refractory anemia with excess blasts|refractory anemia with excess blasts
748561|NCT00003619|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
748562|NCT00003619|secondary acute myeloid leukemia|secondary acute myeloid leukemia
748563|NCT00003619|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
748564|NCT00003619|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
748565|NCT00003619|thrombocytopenia|thrombocytopenia
748566|NCT00003544|stage IV colon cancer|stage iv colon cancer
748567|NCT00003544|stage IV rectal cancer|stage iv rectal cancer
780230|NCT00050245|Retuximab|retuximab
748568|NCT00003544|recurrent colon cancer|recurrent colon cancer
748569|NCT00003544|recurrent rectal cancer|recurrent rectal cancer
748570|NCT00003434|stage I pancreatic cancer|stage i pancreatic cancer
748571|NCT00003434|stage II pancreatic cancer|stage ii pancreatic cancer
748572|NCT00003434|stage III pancreatic cancer|stage iii pancreatic cancer
748573|NCT00003434|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
748574|NCT00003427|stage IV colon cancer|stage iv colon cancer
748575|NCT00003427|stage IV gastric cancer|stage iv gastric cancer
748576|NCT00003427|recurrent gastric cancer|recurrent gastric cancer
748577|NCT00003427|recurrent pancreatic cancer|recurrent pancreatic cancer
748578|NCT00003427|stage IV rectal cancer|stage iv rectal cancer
748579|NCT00003427|recurrent colon cancer|recurrent colon cancer
748580|NCT00003427|recurrent rectal cancer|recurrent rectal cancer
748581|NCT00003427|stage IV anal cancer|stage iv anal cancer
748582|NCT00003427|recurrent anal cancer|recurrent anal cancer
748583|NCT00003427|stage IV esophageal cancer|stage iv esophageal cancer
748584|NCT00003427|recurrent esophageal cancer|recurrent esophageal cancer
748585|NCT00003427|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
748586|NCT00003427|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
748587|NCT00003427|advanced adult primary liver cancer|advanced adult primary liver cancer
748588|NCT00003427|recurrent adult primary liver cancer|recurrent adult primary liver cancer
748589|NCT00003427|unresectable gallbladder cancer|unresectable gallbladder cancer
748590|NCT00003427|recurrent gallbladder cancer|recurrent gallbladder cancer
748591|NCT00003427|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
748592|NCT00003427|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
748593|NCT00003427|recurrent small intestine cancer|recurrent small intestine cancer
748594|NCT00003427|stage IV pancreatic cancer|stage iv pancreatic cancer
748595|NCT00003407|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
748596|NCT00003407|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
748597|NCT00003407|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
748598|NCT00003407|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
748599|NCT00003407|secondary acute myeloid leukemia|secondary acute myeloid leukemia
748600|NCT00003407|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
748601|NCT00003407|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
748602|NCT00003407|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
748603|NCT00003407|neutropenia|neutropenia
748604|NCT00003398|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
748605|NCT00003398|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
748606|NCT00003398|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
748607|NCT00003398|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
748608|NCT00003398|Burkitt lymphoma|burkitt lymphoma
748609|NCT00003398|refractory multiple myeloma|refractory multiple myeloma
748610|NCT00003398|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
748611|NCT00003398|stage I multiple myeloma|stage i multiple myeloma
748612|NCT00003398|stage II multiple myeloma|stage ii multiple myeloma
748613|NCT00003398|stage III multiple myeloma|stage iii multiple myeloma
748614|NCT00003398|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
748615|NCT00003398|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
748616|NCT00003398|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
748617|NCT00003398|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
748618|NCT00003398|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
748619|NCT00003398|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
748620|NCT00003398|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
748621|NCT00003398|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
748622|NCT00003398|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
748623|NCT00003398|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
748624|NCT00003398|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
748625|NCT00003398|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
748626|NCT00003398|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
748627|NCT00003398|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
748628|NCT00003398|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
748629|NCT00003398|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
748630|NCT00003398|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
748631|NCT00003398|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
748632|NCT00003398|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
748633|NCT00003398|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
748634|NCT00003398|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
748635|NCT00003398|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
748636|NCT00003398|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
748637|NCT00003398|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
748638|NCT00003398|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
748639|NCT00003398|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
748640|NCT00003398|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
748641|NCT00003398|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
748642|NCT00003398|adult acute basophilic leukemia|adult acute basophilic leukemia
748643|NCT00003398|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
748644|NCT00003398|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
748645|NCT00003398|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
748646|NCT00003398|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
748647|NCT00003398|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
748648|NCT00003398|childhood acute basophilic leukemia|childhood acute basophilic leukemia
748649|NCT00003398|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
748650|NCT00003398|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
748651|NCT00003398|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
748652|NCT00003398|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
748653|NCT00003398|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
748654|NCT00003398|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
748655|NCT00003398|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
748656|NCT00003398|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
748657|NCT00003398|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
748658|NCT00003398|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
748659|NCT00003398|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
748660|NCT00003398|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
748661|NCT00003398|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
748662|NCT00003398|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
748663|NCT00003398|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
748664|NCT00003398|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
748665|NCT00003398|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
748666|NCT00003398|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
748667|NCT00003398|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
748668|NCT00003398|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
748669|NCT00003398|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
748670|NCT00003398|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
748671|NCT00003398|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
748672|NCT00003398|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
748673|NCT00003398|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
748674|NCT00003398|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
748675|NCT00003398|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
748676|NCT00003398|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
748677|NCT00003398|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
748678|NCT00003398|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
748679|NCT00003398|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
748680|NCT00003398|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
748681|NCT00003398|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
748682|NCT00003398|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
748683|NCT00003398|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
748684|NCT00003398|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
748685|NCT00003398|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
748686|NCT00003398|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
748687|NCT00003398|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
748688|NCT00003398|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
748690|NCT00003398|graft versus host disease|graft versus host disease
748691|NCT00003398|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
748692|NCT00003398|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
748693|NCT00003398|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
748694|NCT00003398|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
748695|NCT00003398|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
748696|NCT00003398|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
748697|NCT00003398|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
748698|NCT00003398|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
748699|NCT00003398|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
748700|NCT00003398|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
748701|NCT00003398|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
748702|NCT00003398|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
748703|NCT00003398|stage I mantle cell lymphoma|stage i mantle cell lymphoma
748704|NCT00003398|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
748705|NCT00003398|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
748706|NCT00003398|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
748707|NCT00003398|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
748708|NCT00003398|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
748709|NCT00003398|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
748710|NCT00003398|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
748711|NCT00003398|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
748712|NCT00003398|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
748713|NCT00003398|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
748714|NCT00003398|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
748715|NCT00003398|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
748716|NCT00003398|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
748717|NCT00003398|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
748718|NCT00003398|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
748719|NCT00003398|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
748720|NCT00003398|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
748721|NCT00003398|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
748722|NCT00003398|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
748723|NCT00003398|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
748724|NCT00003398|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
748725|NCT00003398|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
748726|NCT00003398|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
748727|NCT00003398|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
748728|NCT00003398|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
748729|NCT00003398|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
748730|NCT00003398|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
748731|NCT00003398|stage I marginal zone lymphoma|stage i marginal zone lymphoma
748732|NCT00003398|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
748733|NCT00003398|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
748734|NCT00003398|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
748735|NCT00003398|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
748736|NCT00003398|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
748737|NCT00003398|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
748738|NCT00003398|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
748739|NCT00003398|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
748740|NCT00003398|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
748741|NCT00003398|splenic marginal zone lymphoma|splenic marginal zone lymphoma
748742|NCT00003398|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
748743|NCT00003270|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
748744|NCT00003270|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
748745|NCT00003270|Burkitt lymphoma|burkitt lymphoma
748746|NCT00003270|refractory multiple myeloma|refractory multiple myeloma
748747|NCT00003270|stage I multiple myeloma|stage i multiple myeloma
748748|NCT00003270|stage II multiple myeloma|stage ii multiple myeloma
748749|NCT00003270|stage III multiple myeloma|stage iii multiple myeloma
748750|NCT00003270|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
748751|NCT00003270|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
748752|NCT00003270|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
748753|NCT00003270|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
748754|NCT00003270|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
748755|NCT00003270|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
748756|NCT00003270|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
748757|NCT00003270|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
748758|NCT00003270|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
748759|NCT00003270|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
748760|NCT00003270|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
748761|NCT00003270|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
780337|NCT00049998|Hycamtin|hycamtin
748762|NCT00003270|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
748763|NCT00003270|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
748764|NCT00003270|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
748765|NCT00003270|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
748766|NCT00003270|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
748767|NCT00003270|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
748768|NCT00003270|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
748769|NCT00003270|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
748770|NCT00003270|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
748771|NCT00003270|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
748772|NCT00003270|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
748773|NCT00003270|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
748774|NCT00003270|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
748775|NCT00003270|secondary acute myeloid leukemia|secondary acute myeloid leukemia
748776|NCT00003270|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
748777|NCT00003270|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
748778|NCT00003270|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
748779|NCT00003270|graft versus host disease|graft versus host disease
748780|NCT00003270|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
748781|NCT00003270|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
748782|NCT00003270|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
748783|NCT00003270|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
748784|NCT00003270|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
748785|NCT00003270|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
748786|NCT00003270|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
748787|NCT00003270|splenic marginal zone lymphoma|splenic marginal zone lymphoma
748788|NCT00003270|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
748789|NCT00003144|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
748790|NCT00003144|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
748791|NCT00003094|cervical cancer|cervical cancer
748792|NCT00003081|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
748793|NCT00003081|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
748794|NCT00003081|adult rhabdomyosarcoma|adult rhabdomyosarcoma
748795|NCT00003081|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
748796|NCT00002964|stage 0 oropharyngeal cancer|stage 0 oropharyngeal cancer
748797|NCT00002964|stage 0 laryngeal cancer|stage 0 laryngeal cancer
748798|NCT00002964|stage 0 hypopharyngeal cancer|stage 0 hypopharyngeal cancer
748799|NCT00002964|stage 0 lip and oral cavity cancer|stage 0 lip and oral cavity cancer
748800|NCT00002964|stage I lip and oral cavity cancer|stage i lip and oral cavity cancer
748801|NCT00002964|stage I hypopharyngeal cancer|stage i hypopharyngeal cancer
748802|NCT00002964|stage I laryngeal cancer|stage i laryngeal cancer
748803|NCT00002964|stage I oropharyngeal cancer|stage i oropharyngeal cancer
748804|NCT00002866|stage IV breast cancer|stage iv breast cancer
748805|NCT00002866|recurrent breast cancer|recurrent breast cancer
748806|NCT00002866|neutropenia|neutropenia
748807|NCT00006475|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
748808|NCT00006475|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
748809|NCT00006475|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
748810|NCT00006475|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
748811|NCT00006463|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
748812|NCT00006357|adult angiosarcoma|adult angiosarcoma
748813|NCT00006357|adult fibrosarcoma|adult fibrosarcoma
748814|NCT00006357|adult leiomyosarcoma|adult leiomyosarcoma
748815|NCT00006357|adult liposarcoma|adult liposarcoma
748816|NCT00006357|adult neurofibrosarcoma|adult neurofibrosarcoma
748817|NCT00006357|adult synovial sarcoma|adult synovial sarcoma
748818|NCT00006357|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
748819|NCT00006357|small intestine leiomyosarcoma|small intestine leiomyosarcoma
748820|NCT00006357|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
748821|NCT00006357|adult epithelioid sarcoma|adult epithelioid sarcoma
748822|NCT00006357|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
748823|NCT00006357|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
748824|NCT00006357|adult malignant mesenchymoma|adult malignant mesenchymoma
748825|NCT00006357|adult rhabdomyosarcoma|adult rhabdomyosarcoma
748826|NCT00006357|ovarian stromal cancer|ovarian stromal cancer
748827|NCT00006357|recurrent uterine sarcoma|recurrent uterine sarcoma
748828|NCT00006357|uterine carcinosarcoma|uterine carcinosarcoma
748830|NCT00006357|endometrial stromal sarcoma|endometrial stromal sarcoma
748831|NCT00006357|ovarian sarcoma|ovarian sarcoma
748832|NCT00006357|gastrointestinal stromal tumor|gastrointestinal stromal tumor
748833|NCT00006216|stage IA malignant mesothelioma|stage ia malignant mesothelioma
748834|NCT00006216|stage IB malignant mesothelioma|stage ib malignant mesothelioma
748835|NCT00006216|stage II malignant mesothelioma|stage ii malignant mesothelioma
748836|NCT00006216|stage III malignant mesothelioma|stage iii malignant mesothelioma
748837|NCT00006049|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
748838|NCT00006049|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
748839|NCT00006049|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
748840|NCT00006048|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
748841|NCT00006048|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
748842|NCT00006048|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
748843|NCT00005870|recurrent pancreatic cancer|recurrent pancreatic cancer
748844|NCT00005870|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
748845|NCT00005849|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
748846|NCT00005849|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
748847|NCT00005849|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
748848|NCT00005842|stage III colon cancer|stage iii colon cancer
748849|NCT00005842|stage IV colon cancer|stage iv colon cancer
748850|NCT00005842|stage IV breast cancer|stage iv breast cancer
748851|NCT00005842|stage IIIA breast cancer|stage iiia breast cancer
748852|NCT00005842|recurrent breast cancer|recurrent breast cancer
748853|NCT00005842|stage III gastric cancer|stage iii gastric cancer
748854|NCT00005842|stage IV gastric cancer|stage iv gastric cancer
748855|NCT00005842|recurrent gastric cancer|recurrent gastric cancer
748856|NCT00005842|occult non-small cell lung cancer|occult non-small cell lung cancer
748857|NCT00005842|stage IIIB breast cancer|stage iiib breast cancer
748858|NCT00005842|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
748859|NCT00005842|stage III pancreatic cancer|stage iii pancreatic cancer
748860|NCT00005842|recurrent pancreatic cancer|recurrent pancreatic cancer
748861|NCT00005842|stage III rectal cancer|stage iii rectal cancer
748862|NCT00005842|stage IV rectal cancer|stage iv rectal cancer
748863|NCT00005842|recurrent colon cancer|recurrent colon cancer
748864|NCT00005842|recurrent rectal cancer|recurrent rectal cancer
748865|NCT00005842|stage IV anal cancer|stage iv anal cancer
748866|NCT00005842|recurrent anal cancer|recurrent anal cancer
748867|NCT00005842|stage III esophageal cancer|stage iii esophageal cancer
748868|NCT00005842|stage IV esophageal cancer|stage iv esophageal cancer
748869|NCT00005842|stage IIIA anal cancer|stage iiia anal cancer
748870|NCT00005842|stage IIIB anal cancer|stage iiib anal cancer
748871|NCT00005842|recurrent esophageal cancer|recurrent esophageal cancer
748872|NCT00005842|stage III cervical cancer|stage iii cervical cancer
748873|NCT00005842|recurrent cervical cancer|recurrent cervical cancer
748874|NCT00005842|stage IVB cervical cancer|stage ivb cervical cancer
748875|NCT00005842|stage IVA cervical cancer|stage iva cervical cancer
748876|NCT00005842|inflammatory breast cancer|inflammatory breast cancer
748877|NCT00005842|stage III renal cell cancer|stage iii renal cell cancer
748878|NCT00005842|stage IV renal cell cancer|stage iv renal cell cancer
748879|NCT00005842|recurrent renal cell cancer|recurrent renal cell cancer
748880|NCT00005842|metastatic parathyroid cancer|metastatic parathyroid cancer
748881|NCT00005842|recurrent parathyroid cancer|recurrent parathyroid cancer
748882|NCT00005842|stage III vulvar cancer|stage iii vulvar cancer
748883|NCT00005842|stage IVB vulvar cancer|stage ivb vulvar cancer
748884|NCT00005842|recurrent vulvar cancer|recurrent vulvar cancer
748885|NCT00005842|stage III vaginal cancer|stage iii vaginal cancer
748886|NCT00005842|stage IVA vaginal cancer|stage iva vaginal cancer
748887|NCT00005842|stage IVB vaginal cancer|stage ivb vaginal cancer
748888|NCT00005842|recurrent vaginal cancer|recurrent vaginal cancer
748889|NCT00005842|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
748890|NCT00005842|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
748891|NCT00005842|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
748892|NCT00005842|advanced adult primary liver cancer|advanced adult primary liver cancer
748893|NCT00005842|recurrent adult primary liver cancer|recurrent adult primary liver cancer
748894|NCT00005842|gastrinoma|gastrinoma
748895|NCT00005842|stage III endometrial carcinoma|stage iii endometrial carcinoma
748896|NCT00005842|stage IV endometrial carcinoma|stage iv endometrial carcinoma
748897|NCT00005842|recurrent endometrial carcinoma|recurrent endometrial carcinoma
748898|NCT00005842|small intestine adenocarcinoma|small intestine adenocarcinoma
748899|NCT00005842|unresectable gallbladder cancer|unresectable gallbladder cancer
748900|NCT00005842|recurrent gallbladder cancer|recurrent gallbladder cancer
748901|NCT00005842|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
748902|NCT00005842|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
748903|NCT00005842|recurrent small intestine cancer|recurrent small intestine cancer
748904|NCT00005842|stage III adrenocortical carcinoma|stage iii adrenocortical carcinoma
748905|NCT00005842|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
748906|NCT00005842|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
748907|NCT00005842|stage III bladder cancer|stage iii bladder cancer
748908|NCT00005842|recurrent bladder cancer|recurrent bladder cancer
748909|NCT00005842|stage IV bladder cancer|stage iv bladder cancer
748910|NCT00005842|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
748911|NCT00005842|stage III prostate cancer|stage iii prostate cancer
748912|NCT00005842|stage IV prostate cancer|stage iv prostate cancer
748913|NCT00005842|recurrent prostate cancer|recurrent prostate cancer
748914|NCT00005842|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
748915|NCT00005842|insulinoma|insulinoma
748916|NCT00005842|recurrent islet cell carcinoma|recurrent islet cell carcinoma
748917|NCT00005842|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
748918|NCT00005842|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
748919|NCT00005842|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
748920|NCT00005842|anaplastic thyroid cancer|anaplastic thyroid cancer
748921|NCT00005842|recurrent thyroid cancer|recurrent thyroid cancer
748922|NCT00005842|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
748923|NCT00005842|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
748924|NCT00005842|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
748925|NCT00005842|stage III salivary gland cancer|stage iii salivary gland cancer
748926|NCT00005842|stage IV salivary gland cancer|stage iv salivary gland cancer
748927|NCT00005842|recurrent salivary gland cancer|recurrent salivary gland cancer
748928|NCT00005842|WDHA syndrome|wdha syndrome
748929|NCT00005842|somatostatinoma|somatostatinoma
748930|NCT00005842|pancreatic polypeptide tumor|pancreatic polypeptide tumor
748931|NCT00005842|glucagonoma|glucagonoma
748932|NCT00005842|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
748933|NCT00005842|stage III papillary thyroid cancer|stage iii papillary thyroid cancer
748934|NCT00005842|recurrent urethral cancer|recurrent urethral cancer
748935|NCT00005842|distal urethral cancer|distal urethral cancer
748936|NCT00005842|proximal urethral cancer|proximal urethral cancer
748937|NCT00005842|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
748938|NCT00005842|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
748939|NCT00005842|pulmonary carcinoid tumor|pulmonary carcinoid tumor
748940|NCT00005842|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
748941|NCT00005842|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
748942|NCT00005842|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
748943|NCT00005842|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
748944|NCT00005842|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
748945|NCT00005842|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
748946|NCT00005842|tumors metastatic to brain|tumors metastatic to brain
748947|NCT00005842|lung metastases|lung metastases
748948|NCT00005842|liver metastases|liver metastases
748949|NCT00005842|bone metastases|bone metastases
748950|NCT00005842|skin metastases|skin metastases
748951|NCT00005842|leptomeningeal metastases|leptomeningeal metastases
748952|NCT00005842|malignant pericardial effusion|malignant pericardial effusion
748953|NCT00005842|malignant pleural effusion|malignant pleural effusion
748954|NCT00005842|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
748955|NCT00005842|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
748956|NCT00005842|carcinoma of the appendix|carcinoma of the appendix
748957|NCT00005842|primary peritoneal cavity cancer|primary peritoneal cavity cancer
748958|NCT00005842|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
748959|NCT00005842|male breast cancer|male breast cancer
748960|NCT00005842|stage IV pancreatic cancer|stage iv pancreatic cancer
748961|NCT00005832|stage II pancreatic cancer|stage ii pancreatic cancer
748962|NCT00005832|stage III pancreatic cancer|stage iii pancreatic cancer
748963|NCT00005832|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
748964|NCT00005832|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
748965|NCT00005832|stage IV pancreatic cancer|stage iv pancreatic cancer
748966|NCT00002794|intraocular retinoblastoma|intraocular retinoblastoma
748967|NCT00002553|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
748968|NCT00002553|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
748969|NCT00002553|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
748970|NCT00002553|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
748971|NCT00002553|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
748972|NCT00002553|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
748973|NCT00002553|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
748974|NCT00002553|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
748975|NCT00002553|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
748976|NCT00002553|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
748977|NCT00002553|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
748978|NCT00002553|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
748979|NCT00002553|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
780338|NCT00049998|oral|oral
748980|NCT00002553|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
748981|NCT00002553|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
748982|NCT00002553|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
748983|NCT00002553|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
748984|NCT00002553|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
748985|NCT00002553|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
748986|NCT00002553|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
748987|NCT00002553|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
748988|NCT00002553|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
748989|NCT00002553|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
748990|NCT00002553|recurrent adult non-Hodgkin lymphoma|recurrent adult non-hodgkin lymphoma
748991|NCT00002553|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
748992|NCT00002553|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
748993|NCT00002553|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
748994|NCT00002553|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
748995|NCT00002553|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
748996|NCT00002553|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
748997|NCT00002553|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
748998|NCT00002553|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
748999|NCT00002553|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
749000|NCT00002553|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
749001|NCT00002553|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
749002|NCT00002553|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
749003|NCT00002553|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
749004|NCT00002553|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
749005|NCT00002553|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
749006|NCT00002553|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
749007|NCT00002553|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
749008|NCT00002553|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
749009|NCT00002553|splenic marginal zone lymphoma|splenic marginal zone lymphoma
749010|NCT00002485|localized osteosarcoma|localized osteosarcoma
749011|NCT00002485|metastatic osteosarcoma|metastatic osteosarcoma
749012|NCT00002485|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
749013|NCT00002485|childhood infratentorial ependymoma|childhood infratentorial ependymoma
749014|NCT00002485|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
749015|NCT00002485|childhood supratentorial ependymoma|childhood supratentorial ependymoma
749016|NCT00002485|childhood craniopharyngioma|childhood craniopharyngioma
749017|NCT00002485|localized resectable neuroblastoma|localized resectable neuroblastoma
749018|NCT00002485|regional neuroblastoma|regional neuroblastoma
749019|NCT00002485|disseminated neuroblastoma|disseminated neuroblastoma
749020|NCT00002485|stage 4S neuroblastoma|stage 4s neuroblastoma
749021|NCT00002485|recurrent neuroblastoma|recurrent neuroblastoma
749022|NCT00002485|stage I childhood liver cancer|stage i childhood liver cancer
749023|NCT00002485|stage II childhood liver cancer|stage ii childhood liver cancer
749024|NCT00002485|stage III childhood liver cancer|stage iii childhood liver cancer
749025|NCT00002485|stage IV childhood liver cancer|stage iv childhood liver cancer
749026|NCT00002485|recurrent childhood liver cancer|recurrent childhood liver cancer
749027|NCT00002485|childhood hepatoblastoma|childhood hepatoblastoma
749028|NCT00002485|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
749029|NCT00002485|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
749030|NCT00002485|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
749031|NCT00002485|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
749032|NCT00002485|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
749033|NCT00002485|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
749034|NCT00002485|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
749035|NCT00002485|recurrent osteosarcoma|recurrent osteosarcoma
749036|NCT00002485|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
749037|NCT00002485|childhood germ cell tumor|childhood germ cell tumor
749038|NCT00002485|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
749039|NCT00002485|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
749040|NCT00002485|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
749041|NCT00002485|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
749042|NCT00002485|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
749043|NCT00002485|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
749044|NCT00002485|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
749045|NCT00002485|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
749046|NCT00002485|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
749047|NCT00002485|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
749048|NCT00002485|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
749049|NCT00002485|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
749050|NCT00002485|extragonadal germ cell tumor|extragonadal germ cell tumor
749051|NCT00002485|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
749052|NCT00002485|childhood oligodendroglioma|childhood oligodendroglioma
749053|NCT00002485|childhood choroid plexus tumor|childhood choroid plexus tumor
749054|NCT00002485|childhood meningioma|childhood meningioma
749055|NCT00002485|localized unresectable neuroblastoma|localized unresectable neuroblastoma
749056|NCT00002485|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
749057|NCT00002485|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
749058|NCT00002485|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
749059|NCT00002485|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
749060|NCT00002485|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
749061|NCT00002485|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
749062|NCT00002485|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
749063|NCT00002485|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
749064|NCT00002485|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
749065|NCT00002485|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
749066|NCT00002485|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
749067|NCT00002485|untreated childhood brain stem glioma|untreated childhood brain stem glioma
749068|NCT00002485|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
749069|NCT00002485|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
749070|NCT00002485|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
749071|NCT00002485|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
749072|NCT00002485|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
749073|NCT00002485|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
749074|NCT00002485|untreated childhood medulloblastoma|untreated childhood medulloblastoma
749075|NCT00002485|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
749076|NCT00002485|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
749077|NCT00002485|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
749078|NCT00002485|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
749079|NCT00002485|recurrent childhood ependymoma|recurrent childhood ependymoma
749080|NCT00002485|childhood teratoma|childhood teratoma
749081|NCT00002485|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
749082|NCT00002485|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
749083|NCT00002485|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
749084|NCT00002485|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
749085|NCT00002485|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
749086|NCT00002466|localized osteosarcoma|localized osteosarcoma
749087|NCT00002466|metastatic osteosarcoma|metastatic osteosarcoma
749088|NCT00002466|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
749089|NCT00002466|stage III Wilms tumor|stage iii wilms tumor
749090|NCT00002466|stage IV Wilms tumor|stage iv wilms tumor
749091|NCT00002466|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
749092|NCT00002466|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
749093|NCT00002466|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
749094|NCT00002466|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
749095|NCT00002466|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
749096|NCT00002466|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
749097|NCT00002466|Askin tumor|askin tumor
749098|NCT00002466|peripheral primitive neuroectodermal tumor|peripheral primitive neuroectodermal tumor
749099|NCT00002456|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
749100|NCT00002456|childhood non-Hodgkin lymphoma|childhood non-hodgkin lymphoma
749101|NCT00002456|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
749102|NCT00002456|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
749103|NCT00002456|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
749104|NCT00002456|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
749105|NCT00002456|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
749106|NCT00002456|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
780339|NCT00049998|docetaxel|docetaxel
749107|NCT00002456|recurrent adult non-Hodgkin lymphoma|recurrent adult non-hodgkin lymphoma
749108|NCT00002456|graft versus host disease|graft versus host disease
749109|NCT00081822|Foran|foran
749110|NCT00081822|clofarabine|clofarabine
749111|NCT00081822|cytosine arabinoside|cytosine arabinoside
749112|NCT00081822|acute myeloid leukemia|acute myeloid leukemia
749113|NCT00081809|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
749114|NCT00081809|Brill-Symmers Disease|brill-symmers disease
749115|NCT00081809|Follicular Lymphoma|follicular lymphoma
749116|NCT00081809|Lymphoma, Giant Follicular|lymphoma, giant follicular
749117|NCT00081809|Lymphoma, Nodular|lymphoma, nodular
749118|NCT00081809|Follicular Lymphoma, Giant|follicular lymphoma, giant
749119|NCT00081809|Giant Follicular Lymphoma|giant follicular lymphoma
749120|NCT00081809|Lymphocytic Lymphoma, Diffuse, Well-Differentiated|lymphocytic lymphoma, diffuse, well-differentiated
749121|NCT00081809|Lymphocytic Lymphoma, Well-Differentiated|lymphocytic lymphoma, well-differentiated
749122|NCT00081809|Lymphoma, Lymphocytic, Diffuse, Well-Differentiated|lymphoma, lymphocytic, diffuse, well-differentiated
749123|NCT00081809|Lymphoma, Lymphocytic, Well-Differentiated|lymphoma, lymphocytic, well-differentiated
749124|NCT00081809|Lymphoma, Lymphoplasmacytoid, CLL|lymphoma, lymphoplasmacytoid, cll
749125|NCT00081809|Lymphoma, Small Lymphocytic, Plasmacytoid|lymphoma, small lymphocytic, plasmacytoid
749126|NCT00081809|Lymphoplasmacytoid Lymphoma, CLL|lymphoplasmacytoid lymphoma, cll
749127|NCT00081809|Diffuse Well-Differentiated Lymphocytic Lymphoma|diffuse well-differentiated lymphocytic lymphoma
749128|NCT00081809|Lymphocytic Lymphoma, Diffuse, Well Differentiated|lymphocytic lymphoma, diffuse, well differentiated
749129|NCT00081809|Lymphocytic Lymphoma, Well Differentiated|lymphocytic lymphoma, well differentiated
749130|NCT00081809|Lymphoma, Lymphocytic, Diffuse, Well Differentiated|lymphoma, lymphocytic, diffuse, well differentiated
749131|NCT00081809|Lymphoma, Lymphocytic, Well Differentiated|lymphoma, lymphocytic, well differentiated
749132|NCT00081809|Lymphoma, Mucosa-Associated Lymphoid Tissue|lymphoma, mucosa-associated lymphoid tissue
749133|NCT00081809|MALT Lymphoma|malt lymphoma
749134|NCT00081809|Lymphoma of Mucosa-Associated Lymphoid Tissue|lymphoma of mucosa-associated lymphoid tissue
749135|NCT00081809|Mucosa-Associated Lymphoid Tissue Lymphoma|mucosa-associated lymphoid tissue lymphoma
749136|NCT00081809|Monocytoid B-cell lymphoma|monocytoid b-cell lymphoma
749137|NCT00081809|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
749138|NCT00081809|Marginal zone lymphoma|marginal zone lymphoma
749139|NCT00005092|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
749140|NCT00005092|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
749141|NCT00005092|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
749142|NCT00005092|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
749143|NCT00005092|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
749144|NCT00005092|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
749145|NCT00005092|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
749146|NCT00005092|refractory multiple myeloma|refractory multiple myeloma
749147|NCT00005092|stage III multiple myeloma|stage iii multiple myeloma
749148|NCT00005092|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
749149|NCT00005092|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
749150|NCT00005092|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
749151|NCT00005092|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
749152|NCT00005092|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
749153|NCT00005092|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
749154|NCT00005092|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
749155|NCT00005092|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
749156|NCT00005092|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
749157|NCT00005092|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
749158|NCT00005092|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
749159|NCT00005092|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
749160|NCT00005092|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
749161|NCT00005092|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
749162|NCT00005092|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
749163|NCT00005092|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
749164|NCT00005092|adult acute monoblastic leukemia and acute monocytic leukemia (M5)|adult acute monoblastic leukemia and acute monocytic leukemia (m5)
749165|NCT00005092|childhood acute monoblastic leukemia and acute monocytic leukemia (M5)|childhood acute monoblastic leukemia and acute monocytic leukemia (m5)
749166|NCT00005092|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
749167|NCT00005092|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
749168|NCT00005092|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
749169|NCT00005092|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
749170|NCT00005092|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
749171|NCT00005092|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
749172|NCT00005092|L3 childhood acute lymphoblastic leukemia|l3 childhood acute lymphoblastic leukemia
749173|NCT00005092|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
749174|NCT00005092|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
749175|NCT00005092|non-T, non-B childhood acute lymphoblastic leukemia|non-t, non-b childhood acute lymphoblastic leukemia
749176|NCT00005092|non-T, non-B, cALLa positive childhood acute lymphoblastic leukemia|non-t, non-b, calla positive childhood acute lymphoblastic leukemia
749177|NCT00005092|non-T, non-B, cALLa negative childhood acute lymphoblastic leukemia|non-t, non-b, calla negative childhood acute lymphoblastic leukemia
749178|NCT00005092|non-T, non-B, cALLa positive, pre-B childhood acute lymphoblastic leukemia|non-t, non-b, calla positive, pre-b childhood acute lymphoblastic leukemia
749179|NCT00005092|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
749180|NCT00005092|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
749181|NCT00005092|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
749182|NCT00005092|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
749183|NCT00005092|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
749184|NCT00005092|non-T, non-B adult acute lymphoblastic leukemia|non-t, non-b adult acute lymphoblastic leukemia
749185|NCT00005092|non-T, non-B, cALLa positive adult acute lymphoblastic leukemia|non-t, non-b, calla positive adult acute lymphoblastic leukemia
749186|NCT00005092|non-T, non-B, cALLa positive, pre-B adult acute lymphoblastic leukemia|non-t, non-b, calla positive, pre-b adult acute lymphoblastic leukemia
749187|NCT00005092|non-T, non-B, cALLa negative adult acute lymphoblastic leukemia|non-t, non-b, calla negative adult acute lymphoblastic leukemia
749188|NCT00005092|TdT positive adult acute lymphoblastic leukemia|tdt positive adult acute lymphoblastic leukemia
749189|NCT00005092|TdT negative adult acute lymphoblastic leukemia|tdt negative adult acute lymphoblastic leukemia
749190|NCT00005092|TdT negative childhood acute lymphoblastic leukemia|tdt negative childhood acute lymphoblastic leukemia
749191|NCT00005092|TdT positive childhood acute lymphoblastic leukemia|tdt positive childhood acute lymphoblastic leukemia
749192|NCT00005092|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
749193|NCT00005092|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
749194|NCT00005092|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
749195|NCT00005092|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
749196|NCT00005092|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
749197|NCT00005092|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
749198|NCT00005092|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
749199|NCT00005092|adult acute basophilic leukemia|adult acute basophilic leukemia
749200|NCT00005092|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
749201|NCT00005092|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
749202|NCT00005092|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
749203|NCT00005092|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
749204|NCT00005092|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
749205|NCT00005092|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
749206|NCT00005092|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
749207|NCT00005092|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
749208|NCT00005092|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
749209|NCT00005092|childhood acute basophilic leukemia|childhood acute basophilic leukemia
749210|NCT00005092|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
749211|NCT00005092|untreated hairy cell leukemia|untreated hairy cell leukemia
749212|NCT00005092|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
749213|NCT00005092|acute undifferentiated leukemia|acute undifferentiated leukemia
749214|NCT00005092|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
749215|NCT00005092|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
749216|NCT00005092|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
749217|NCT00005092|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
749218|NCT00005092|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
749219|NCT00005092|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
749220|NCT00005092|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
749221|NCT00005092|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
749222|NCT00005092|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
749223|NCT00005092|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
749224|NCT00005092|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
749225|NCT00005092|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
749226|NCT00005092|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
749227|NCT00005092|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
749228|NCT00005092|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
749229|NCT00005092|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
749230|NCT00005092|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
749231|NCT00005092|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
749232|NCT00005092|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
749233|NCT00005092|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
749234|NCT00005092|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
749235|NCT00005092|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
749236|NCT00005092|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
749237|NCT00005092|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
749238|NCT00005092|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
749239|NCT00005092|secondary acute myeloid leukemia|secondary acute myeloid leukemia
749240|NCT00005092|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
749241|NCT00005092|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
749242|NCT00005092|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
749243|NCT00005092|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
749244|NCT00005092|prolymphocytic leukemia|prolymphocytic leukemia
749245|NCT00005092|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
749246|NCT00005092|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
749247|NCT00005092|intraocular lymphoma|intraocular lymphoma
749248|NCT00005092|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
749249|NCT00005092|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
749250|NCT00005092|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
749251|NCT00005092|childhood large cell lymphoma|childhood large cell lymphoma
749252|NCT00005092|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
749253|NCT00005092|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
749254|NCT00005092|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
749255|NCT00005092|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
749256|NCT00005092|anaplastic large cell lymphoma|anaplastic large cell lymphoma
749257|NCT00005092|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
749258|NCT00005092|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
749259|NCT00005092|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
749260|NCT00005092|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
749261|NCT00005082|adult medulloblastoma|adult medulloblastoma
749262|NCT00005082|adult glioblastoma|adult glioblastoma
749263|NCT00005082|adult anaplastic astrocytoma|adult anaplastic astrocytoma
749264|NCT00005082|adult myxopapillary ependymoma|adult myxopapillary ependymoma
749265|NCT00005082|adult anaplastic ependymoma|adult anaplastic ependymoma
749266|NCT00005082|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
749267|NCT00005082|adult mixed glioma|adult mixed glioma
749268|NCT00005082|adult pilocytic astrocytoma|adult pilocytic astrocytoma
749269|NCT00005082|adult subependymoma|adult subependymoma
749270|NCT00005082|adult ependymoblastoma|adult ependymoblastoma
749271|NCT00005082|adult oligodendroglioma|adult oligodendroglioma
749272|NCT00005082|adult giant cell glioblastoma|adult giant cell glioblastoma
749273|NCT00005082|adult gliosarcoma|adult gliosarcoma
749274|NCT00005023|stage IV breast cancer|stage iv breast cancer
749275|NCT00005023|stage IIIA breast cancer|stage iiia breast cancer
749276|NCT00005023|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
749277|NCT00005023|stage IIIB breast cancer|stage iiib breast cancer
749278|NCT00005023|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
749279|NCT00005023|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
749280|NCT00005023|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
749281|NCT00005023|adenocarcinoma of the lung|adenocarcinoma of the lung
749282|NCT00004870|stage IV colon cancer|stage iv colon cancer
749283|NCT00004870|stage IV rectal cancer|stage iv rectal cancer
749284|NCT00004870|recurrent colon cancer|recurrent colon cancer
749285|NCT00004870|recurrent rectal cancer|recurrent rectal cancer
749286|NCT00004870|adenocarcinoma of the colon|adenocarcinoma of the colon
749287|NCT00004870|adenocarcinoma of the rectum|adenocarcinoma of the rectum
749288|NCT00004254|localized malignant mesothelioma|localized malignant mesothelioma
749289|NCT00004254|advanced malignant mesothelioma|advanced malignant mesothelioma
749290|NCT00004254|recurrent malignant mesothelioma|recurrent malignant mesothelioma
749291|NCT00004013|stage IV breast cancer|stage iv breast cancer
749292|NCT00004013|recurrent breast cancer|recurrent breast cancer
749293|NCT00003899|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
749294|NCT00003880|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
749295|NCT00003880|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
749296|NCT00003880|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
749297|NCT00003880|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
749298|NCT00003880|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
749299|NCT00003880|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
749300|NCT00003880|primary peritoneal cavity cancer|primary peritoneal cavity cancer
749301|NCT00003790|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
749302|NCT00003790|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
749303|NCT00003790|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
749304|NCT00003790|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
749305|NCT00003790|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
749306|NCT00003735|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
749307|NCT00003735|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
749308|NCT00003735|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
749309|NCT00003715|stage III melanoma|stage iii melanoma
749310|NCT00003701|stage III bladder cancer|stage iii bladder cancer
749416|NCT00002764|adult neurofibrosarcoma|adult neurofibrosarcoma
749311|NCT00003701|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
749312|NCT00003701|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
749313|NCT00003621|adult anaplastic astrocytoma|adult anaplastic astrocytoma
749314|NCT00003445|stage III cervical cancer|stage iii cervical cancer
749315|NCT00003445|stage IIB cervical cancer|stage iib cervical cancer
749316|NCT00003445|stage IVA cervical cancer|stage iva cervical cancer
749317|NCT00003445|cervical squamous cell carcinoma|cervical squamous cell carcinoma
749318|NCT00003386|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
749319|NCT00003386|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
749320|NCT00003148|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
749321|NCT00003146|stage I multiple myeloma|stage i multiple myeloma
749322|NCT00003146|stage II multiple myeloma|stage ii multiple myeloma
749323|NCT00003146|stage III multiple myeloma|stage iii multiple myeloma
749324|NCT00003076|esophageal cancer|esophageal cancer
749325|NCT00003041|recurrent breast cancer|recurrent breast cancer
749326|NCT00081848|Colon Cancer|colon cancer
749327|NCT00081848|Gastrointestinal Cancer|gastrointestinal cancer
749328|NCT00081848|Cytokines|cytokines
749329|NCT00081848|Immunotherapy|immunotherapy
749330|NCT00081848|Cancer|cancer
749331|NCT00081848|Solid Tumor|solid tumor
749332|NCT00081848|Liver Metastasis|liver metastasis
749333|NCT00081835|Smallpox|smallpox
749334|NCT00081835|Cowpox|cowpox
749335|NCT00081835|Corneal Ulcer|corneal ulcer
749336|NCT00081835|Keratitis|keratitis
749337|NCT00081835|Immune Response, Vaccine|immune response, vaccine
749338|NCT00081835|Cornea|cornea
749339|NCT00081835|Vaccinia|vaccinia
749340|NCT00081835|Vaccinia Immune Globulin (VIG)|vaccinia immune globulin (vig)
749341|NCT00081835|Conjunctivitis|conjunctivitis
749342|NCT00081835|Vaccinia Vaccination|vaccinia vaccination
749343|NCT00081835|Smallpox Vaccination|smallpox vaccination
749344|NCT00081796|Metastatic Breast Cancer|metastatic breast cancer
749345|NCT00081783|T Cells|t cells
749346|NCT00081783|Immunotherapy|immunotherapy
749347|NCT00081783|NHL|nhl
749348|NCT00081783|Xcellerated T Cells|xcellerated t cells
749349|NCT00081757|Advanced|advanced
749350|NCT00081757|Refractory|refractory
749351|NCT00081757|Plasmacytoma|plasmacytoma
749352|NCT00081757|Myeloma Proteins|myeloma proteins
749353|NCT00021346|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
749354|NCT00019357|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
749355|NCT00003018|stage II pancreatic cancer|stage ii pancreatic cancer
749356|NCT00003018|stage III pancreatic cancer|stage iii pancreatic cancer
749357|NCT00003018|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
749358|NCT00003017|stage IV cervical cancer|stage iv cervical cancer
749359|NCT00003017|recurrent cervical cancer|recurrent cervical cancer
749360|NCT00003017|cervical squamous cell carcinoma|cervical squamous cell carcinoma
749361|NCT00003017|cervical adenocarcinoma|cervical adenocarcinoma
749362|NCT00003017|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
749363|NCT00002952|stage IV melanoma|stage iv melanoma
749364|NCT00002952|recurrent melanoma|recurrent melanoma
749365|NCT00002889|adenocarcinoma of the prostate|adenocarcinoma of the prostate
749366|NCT00002889|stage I prostate cancer|stage i prostate cancer
749367|NCT00002889|stage II prostate cancer|stage ii prostate cancer
749368|NCT00002889|stage III prostate cancer|stage iii prostate cancer
749369|NCT00002889|stage IV prostate cancer|stage iv prostate cancer
749370|NCT00002818|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
749371|NCT00002818|refractory multiple myeloma|refractory multiple myeloma
749372|NCT00002818|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
749373|NCT00002818|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
749374|NCT00002818|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
749375|NCT00002818|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
749376|NCT00002818|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
749377|NCT00002818|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
749378|NCT00002818|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
749379|NCT00002818|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
749380|NCT00002818|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
749381|NCT00002818|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
749382|NCT00002818|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
749383|NCT00002818|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
749384|NCT00002818|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
749385|NCT00002818|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
749386|NCT00002818|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
749387|NCT00002818|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
749388|NCT00002818|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
749389|NCT00002818|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
749390|NCT00002818|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
749391|NCT00002818|splenic marginal zone lymphoma|splenic marginal zone lymphoma
749392|NCT00002800|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
749393|NCT00002800|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
749394|NCT00002800|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
749395|NCT00002800|refractory anemia with excess blasts|refractory anemia with excess blasts
749396|NCT00002800|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
749397|NCT00002800|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
749398|NCT00002800|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
749399|NCT00002800|neutropenia|neutropenia
749400|NCT00002772|stage II breast cancer|stage ii breast cancer
749401|NCT00002772|stage IIIA breast cancer|stage iiia breast cancer
749402|NCT00002768|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
749403|NCT00002768|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
749404|NCT00002768|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
749405|NCT00002768|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
749406|NCT00002768|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
749407|NCT00002768|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
749408|NCT00002768|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
749409|NCT00002768|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
749410|NCT00002768|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
749411|NCT00002768|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
749412|NCT00002764|adult angiosarcoma|adult angiosarcoma
749413|NCT00002764|adult fibrosarcoma|adult fibrosarcoma
749414|NCT00002764|adult leiomyosarcoma|adult leiomyosarcoma
749415|NCT00002764|adult liposarcoma|adult liposarcoma
749417|NCT00002764|adult synovial sarcoma|adult synovial sarcoma
749418|NCT00002764|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
749419|NCT00002764|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
749420|NCT00002764|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
749421|NCT00002764|adult malignant mesenchymoma|adult malignant mesenchymoma
749422|NCT00002764|localized benign pheochromocytoma|localized benign pheochromocytoma
749423|NCT00002764|regional pheochromocytoma|regional pheochromocytoma
749424|NCT00002764|lung metastases|lung metastases
749425|NCT00002764|stage IV uterine sarcoma|stage iv uterine sarcoma
749426|NCT00002764|recurrent uterine sarcoma|recurrent uterine sarcoma
749427|NCT00002764|uterine leiomyosarcoma|uterine leiomyosarcoma
749428|NCT00002764|endometrial stromal sarcoma|endometrial stromal sarcoma
749429|NCT00002764|ovarian sarcoma|ovarian sarcoma
749430|NCT00002764|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
749431|NCT00002764|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
749432|NCT00002745|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
749433|NCT00002745|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
749434|NCT00002745|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
749435|NCT00002745|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
749436|NCT00002722|stage III gastric cancer|stage iii gastric cancer
749437|NCT00002722|stage IV gastric cancer|stage iv gastric cancer
749438|NCT00002595|desmoid tumor|desmoid tumor
749439|NCT00002583|stage I non-small cell lung cancer|stage i non-small cell lung cancer
749440|NCT00002583|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
749441|NCT00002534|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
749442|NCT00002534|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
749443|NCT00002534|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
749444|NCT00002534|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
749445|NCT00002534|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
749446|NCT00002534|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
749447|NCT00002534|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
749448|NCT00002534|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
749449|NCT00002534|acute undifferentiated leukemia|acute undifferentiated leukemia
749450|NCT00002519|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
749451|NCT00002519|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
749452|NCT00002501|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
749453|NCT00002501|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
749454|NCT00002501|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
749455|NCT00002501|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
749456|NCT00002492|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
749457|NCT00002492|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
749458|NCT00002492|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
749459|NCT00002463|childhood infratentorial ependymoma|childhood infratentorial ependymoma
749460|NCT00002463|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
749461|NCT00002463|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
749462|NCT00002463|childhood supratentorial ependymoma|childhood supratentorial ependymoma
749463|NCT00002463|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
749464|NCT00002463|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
749465|NCT00002463|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
749466|NCT00002463|untreated childhood medulloblastoma|untreated childhood medulloblastoma
749467|NCT00002463|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
749468|NCT00002463|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
749469|NCT00081744|Bacterial Infections|bacterial infections
749470|NCT00019344|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
749471|NCT00019344|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
749472|NCT00019344|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
749473|NCT00019344|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
749474|NCT00019344|small intestine lymphoma|small intestine lymphoma
749475|NCT00019344|stage IV prostate cancer|stage iv prostate cancer
749476|NCT00019344|recurrent prostate cancer|recurrent prostate cancer
749477|NCT00019344|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
749478|NCT00019344|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
749479|NCT00019344|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
749480|NCT00019344|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
749481|NCT00019344|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
749482|NCT00019344|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
749483|NCT00019344|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
749484|NCT00019344|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
749485|NCT00019344|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
749486|NCT00019344|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
749487|NCT00019344|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
749488|NCT00019344|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
749489|NCT00019344|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
749490|NCT00019344|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
749491|NCT00019344|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
749492|NCT00019344|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
749493|NCT00019344|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
749494|NCT00019344|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
749495|NCT00019344|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
749496|NCT00019344|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
749497|NCT00019344|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
749498|NCT00019344|intraocular lymphoma|intraocular lymphoma
749499|NCT00019344|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
749500|NCT00019344|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
749501|NCT00019344|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
749502|NCT00019344|anaplastic large cell lymphoma|anaplastic large cell lymphoma
749503|NCT00019344|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
749504|NCT00019344|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
749505|NCT00019344|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
749506|NCT00019344|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
749507|NCT00019344|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
749508|NCT00019344|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
749509|NCT00019344|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
749510|NCT00019344|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
749511|NCT00019344|splenic marginal zone lymphoma|splenic marginal zone lymphoma
749512|NCT00019240|classic Kaposi sarcoma|classic kaposi sarcoma
749513|NCT00019240|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
749514|NCT00019240|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
749515|NCT00016900|stage III esophageal cancer|stage iii esophageal cancer
749516|NCT00016900|stage IV esophageal cancer|stage iv esophageal cancer
749517|NCT00016900|recurrent esophageal cancer|recurrent esophageal cancer
749518|NCT00016900|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
749519|NCT00016900|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
749520|NCT00010010|stage IV breast cancer|stage iv breast cancer
749521|NCT00010010|recurrent breast cancer|recurrent breast cancer
749522|NCT00009828|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
749523|NCT00081614|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
749524|NCT00081549|Pancreatic Cancer|pancreatic cancer
749525|NCT00081549|Neoplasms Pancreatic|neoplasms pancreatic
749526|NCT00081549|Pancreas Cancer|pancreas cancer
749527|NCT00081549|Pancreas Neoplasms|pancreas neoplasms
749528|NCT00081549|Pancreatic Tumor|pancreatic tumor
749529|NCT00081549|Pancreas Tumor|pancreas tumor
749530|NCT00081549|Unresectable|unresectable
749531|NCT00081549|Metastatic|metastatic
749532|NCT00081549|Refractory|refractory
749533|NCT00081536|Colorectal Neoplasms|colorectal neoplasms
749534|NCT00081536|Colorectal Cancer|colorectal cancer
749535|NCT00081536|Colorectal Carcinoma|colorectal carcinoma
749536|NCT00081536|Colorectal Tumor|colorectal tumor
749537|NCT00081536|Neoplasms, Colorectal|neoplasms, colorectal
749538|NCT00081536|Unresectable|unresectable
749539|NCT00081536|Metastatic|metastatic
749540|NCT00081536|Refractory|refractory
749541|NCT00012129|stage IV breast cancer|stage iv breast cancer
749542|NCT00012129|stage IIIA breast cancer|stage iiia breast cancer
749543|NCT00012129|recurrent breast cancer|recurrent breast cancer
749544|NCT00012129|stage IIIB breast cancer|stage iiib breast cancer
749545|NCT00012129|male breast cancer|male breast cancer
749546|NCT00009815|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
749547|NCT00005989|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
749548|NCT00005989|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
749549|NCT00005958|stage III bladder cancer|stage iii bladder cancer
749550|NCT00005958|recurrent bladder cancer|recurrent bladder cancer
749551|NCT00005958|stage IV bladder cancer|stage iv bladder cancer
749552|NCT00005958|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
749553|NCT00005958|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
749554|NCT00005958|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
749555|NCT00005958|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
749556|NCT00005938|localized gallbladder cancer|localized gallbladder cancer
749557|NCT00005938|unresectable gallbladder cancer|unresectable gallbladder cancer
749558|NCT00005938|recurrent gallbladder cancer|recurrent gallbladder cancer
749559|NCT00005938|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
749560|NCT00005938|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
749561|NCT00005938|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
749562|NCT00005938|liver and intrahepatic biliary tract cancer|liver and intrahepatic biliary tract cancer
749563|NCT00005938|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
749564|NCT00005938|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
749565|NCT00005938|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
749566|NCT00005828|stage IV prostate cancer|stage iv prostate cancer
749567|NCT00005828|recurrent prostate cancer|recurrent prostate cancer
749568|NCT00005827|adenocarcinoma of the prostate|adenocarcinoma of the prostate
749569|NCT00005827|stage II prostate cancer|stage ii prostate cancer
749570|NCT00005827|stage III prostate cancer|stage iii prostate cancer
749571|NCT00005827|stage IV prostate cancer|stage iv prostate cancer
749572|NCT00005827|recurrent prostate cancer|recurrent prostate cancer
749573|NCT00081640|HIV Seronegativity|hiv seronegativity
749574|NCT00081640|Vaginal Microbicide|vaginal microbicide
749575|NCT00081601|prostate cancer|prostate cancer
749576|NCT00081601|prostate specific antigen|prostate specific antigen
749577|NCT00081601|PSA|psa
749578|NCT00081588|TMC114-C215|tmc114-c215
749579|NCT00081588|Ritonavir|ritonavir
749580|NCT00081588|HIV infections|hiv infections
749581|NCT00081588|TMC114-C202|tmc114-c202
749582|NCT00081588|TMC114-C213|tmc114-c213
749583|NCT00081575|Bacterial Pneumonia|bacterial pneumonia
749584|NCT00081380|Bipolar I Disorder|bipolar i disorder
749585|NCT00081380|Manic Depressive Disorder|manic depressive disorder
749586|NCT00081380|Manic Depression, Mixed|manic depression, mixed
749587|NCT00005810|adenocarcinoma of the prostate|adenocarcinoma of the prostate
749588|NCT00005810|stage IV prostate cancer|stage iv prostate cancer
749589|NCT00005810|recurrent prostate cancer|recurrent prostate cancer
749590|NCT00005809|colon cancer|colon cancer
749591|NCT00005809|rectal cancer|rectal cancer
749592|NCT00005643|stage IV uterine sarcoma|stage iv uterine sarcoma
749593|NCT00005643|recurrent uterine sarcoma|recurrent uterine sarcoma
749594|NCT00005643|uterine carcinosarcoma|uterine carcinosarcoma
749595|NCT00005643|uterine leiomyosarcoma|uterine leiomyosarcoma
749596|NCT00005643|endometrial stromal sarcoma|endometrial stromal sarcoma
749597|NCT00005625|metastatic osteosarcoma|metastatic osteosarcoma
749598|NCT00005625|recurrent osteosarcoma|recurrent osteosarcoma
749599|NCT00005608|stage IV breast cancer|stage iv breast cancer
749600|NCT00005608|recurrent breast cancer|recurrent breast cancer
749601|NCT00005071|stage I non-small cell lung cancer|stage i non-small cell lung cancer
749602|NCT00005071|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
749603|NCT00005071|limited stage small cell lung cancer|limited stage small cell lung cancer
749604|NCT00004252|stage IV colon cancer|stage iv colon cancer
749605|NCT00004252|stage IV rectal cancer|stage iv rectal cancer
749606|NCT00004252|recurrent colon cancer|recurrent colon cancer
749607|NCT00004252|recurrent rectal cancer|recurrent rectal cancer
749608|NCT00004252|adenocarcinoma of the colon|adenocarcinoma of the colon
749609|NCT00004229|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
749610|NCT00004178|stage III colon cancer|stage iii colon cancer
749611|NCT00004178|stage IV colon cancer|stage iv colon cancer
749612|NCT00004178|stage III gastric cancer|stage iii gastric cancer
749613|NCT00004178|stage IV gastric cancer|stage iv gastric cancer
749614|NCT00004178|recurrent gastric cancer|recurrent gastric cancer
749615|NCT00004178|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
749616|NCT00004178|stage II pancreatic cancer|stage ii pancreatic cancer
749617|NCT00004178|stage III pancreatic cancer|stage iii pancreatic cancer
749618|NCT00004178|recurrent pancreatic cancer|recurrent pancreatic cancer
749619|NCT00004178|stage III rectal cancer|stage iii rectal cancer
749620|NCT00004178|stage IV rectal cancer|stage iv rectal cancer
749621|NCT00004178|recurrent colon cancer|recurrent colon cancer
749622|NCT00004178|recurrent rectal cancer|recurrent rectal cancer
749623|NCT00004178|stage II esophageal cancer|stage ii esophageal cancer
749624|NCT00004178|stage III esophageal cancer|stage iii esophageal cancer
749625|NCT00004178|stage IV esophageal cancer|stage iv esophageal cancer
749626|NCT00004178|recurrent esophageal cancer|recurrent esophageal cancer
749627|NCT00004178|stage III cervical cancer|stage iii cervical cancer
749628|NCT00004178|recurrent cervical cancer|recurrent cervical cancer
749629|NCT00004178|stage IVB cervical cancer|stage ivb cervical cancer
749630|NCT00004178|stage IVA cervical cancer|stage iva cervical cancer
749631|NCT00004178|adenocarcinoma of the prostate|adenocarcinoma of the prostate
749632|NCT00004178|stage III renal cell cancer|stage iii renal cell cancer
749633|NCT00004178|stage IV renal cell cancer|stage iv renal cell cancer
749634|NCT00004178|recurrent renal cell cancer|recurrent renal cell cancer
749635|NCT00004178|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
749636|NCT00004178|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
749637|NCT00004178|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
749638|NCT00004178|adenocarcinoma of the stomach|adenocarcinoma of the stomach
749639|NCT00004178|extensive stage small cell lung cancer|extensive stage small cell lung cancer
749640|NCT00004178|recurrent small cell lung cancer|recurrent small cell lung cancer
749641|NCT00004178|stage III vaginal cancer|stage iii vaginal cancer
749642|NCT00004178|stage IVA vaginal cancer|stage iva vaginal cancer
749643|NCT00004178|stage IVB vaginal cancer|stage ivb vaginal cancer
749644|NCT00004178|recurrent vaginal cancer|recurrent vaginal cancer
749645|NCT00004178|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
749646|NCT00004178|advanced adult primary liver cancer|advanced adult primary liver cancer
749647|NCT00004178|recurrent adult primary liver cancer|recurrent adult primary liver cancer
749648|NCT00004178|stage III endometrial carcinoma|stage iii endometrial carcinoma
749649|NCT00004178|stage IV endometrial carcinoma|stage iv endometrial carcinoma
749650|NCT00004178|recurrent endometrial carcinoma|recurrent endometrial carcinoma
749651|NCT00004178|small intestine adenocarcinoma|small intestine adenocarcinoma
749652|NCT00004178|unresectable gallbladder cancer|unresectable gallbladder cancer
749653|NCT00004178|recurrent gallbladder cancer|recurrent gallbladder cancer
749654|NCT00004178|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
749655|NCT00004178|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
749656|NCT00004178|recurrent small intestine cancer|recurrent small intestine cancer
749657|NCT00004178|stage III bladder cancer|stage iii bladder cancer
749658|NCT00004178|recurrent bladder cancer|recurrent bladder cancer
749659|NCT00004178|stage IV bladder cancer|stage iv bladder cancer
749660|NCT00004178|stage III prostate cancer|stage iii prostate cancer
749661|NCT00004178|stage IV prostate cancer|stage iv prostate cancer
749662|NCT00004178|recurrent prostate cancer|recurrent prostate cancer
749663|NCT00004178|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
749664|NCT00004178|stage III salivary gland cancer|stage iii salivary gland cancer
749665|NCT00004178|stage IV salivary gland cancer|stage iv salivary gland cancer
749666|NCT00004178|recurrent salivary gland cancer|recurrent salivary gland cancer
749667|NCT00004178|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
749668|NCT00004178|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
749669|NCT00004178|adenocarcinoma of the lung|adenocarcinoma of the lung
749670|NCT00004178|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
749671|NCT00004178|intestinal adenocarcinoma of the stomach|intestinal adenocarcinoma of the stomach
749672|NCT00004178|adenocarcinoma of the colon|adenocarcinoma of the colon
749673|NCT00004178|diffuse adenocarcinoma of the stomach|diffuse adenocarcinoma of the stomach
749674|NCT00004178|mixed adenocarcinoma of the stomach|mixed adenocarcinoma of the stomach
749675|NCT00004178|mucinous adenocarcinoma of the colon|mucinous adenocarcinoma of the colon
749676|NCT00004178|signet ring adenocarcinoma of the colon|signet ring adenocarcinoma of the colon
749677|NCT00004178|adenocarcinoma of the rectum|adenocarcinoma of the rectum
749678|NCT00004178|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
749679|NCT00004178|mucinous adenocarcinoma of the rectum|mucinous adenocarcinoma of the rectum
749680|NCT00004178|signet ring adenocarcinoma of the rectum|signet ring adenocarcinoma of the rectum
749681|NCT00004178|adenocarcinoma with squamous metaplasia of the gallbladder|adenocarcinoma with squamous metaplasia of the gallbladder
749682|NCT00004178|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
749683|NCT00004178|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
749684|NCT00004178|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
749685|NCT00004178|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
749686|NCT00004178|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
749687|NCT00004178|vaginal adenocarcinoma|vaginal adenocarcinoma
749688|NCT00004178|vaginal clear cell adenocarcinoma|vaginal clear cell adenocarcinoma
749689|NCT00004178|endometrial adenocarcinoma|endometrial adenocarcinoma
749690|NCT00004178|cervical adenocarcinoma|cervical adenocarcinoma
749691|NCT00004178|adenocarcinoma of the bladder|adenocarcinoma of the bladder
749692|NCT00004178|salivary gland adenocarcinoma|salivary gland adenocarcinoma
749693|NCT00004178|adenocarcinoma of unknown primary|adenocarcinoma of unknown primary
749694|NCT00004178|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
749695|NCT00004178|stage IV pancreatic cancer|stage iv pancreatic cancer
749696|NCT00081497|alpha-galactosidase A|alpha-galactosidase a
749697|NCT00081497|a-GAL|a-gal
749698|NCT00081497|r-haGAL|r-hagal
749699|NCT00081497|Fabry|fabry
749700|NCT00081497|GL-3|gl-3
749701|NCT00081497|Fabrazyme|fabrazyme
749702|NCT00004177|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
749703|NCT00004108|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
749704|NCT00004108|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
749705|NCT00004108|advanced adult primary liver cancer|advanced adult primary liver cancer
749706|NCT00004108|recurrent adult primary liver cancer|recurrent adult primary liver cancer
749707|NCT00004108|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
749708|NCT00004107|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
749709|NCT00004107|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
749710|NCT00004107|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
749711|NCT00004107|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
749712|NCT00004107|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
749713|NCT00004107|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
749714|NCT00004107|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
749715|NCT00004107|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
749716|NCT00004107|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
749717|NCT00004107|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
749718|NCT00004107|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
749719|NCT00004107|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
749720|NCT00004107|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
749721|NCT00004107|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
749722|NCT00004107|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
749723|NCT00004107|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
750300|NCT00005875|recurrent melanoma|recurrent melanoma
749724|NCT00004107|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
749725|NCT00004107|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
749726|NCT00004107|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
749727|NCT00004107|splenic marginal zone lymphoma|splenic marginal zone lymphoma
749728|NCT00004100|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
749729|NCT00004100|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
749730|NCT00004087|stage IV colon cancer|stage iv colon cancer
749731|NCT00004087|stage IV pancreatic cancer|stage iv pancreatic cancer
749732|NCT00004087|recurrent pancreatic cancer|recurrent pancreatic cancer
749733|NCT00004087|stage IV rectal cancer|stage iv rectal cancer
749734|NCT00004087|recurrent colon cancer|recurrent colon cancer
749735|NCT00004087|recurrent rectal cancer|recurrent rectal cancer
749736|NCT00081523|Hemoglobin|hemoglobin
749737|NCT00081523|Pain Crisis|pain crisis
749738|NCT00081523|Treatment Options|treatment options
749739|NCT00081523|Sickle Cell Disease|sickle cell disease
749740|NCT00081523|Sickle Cell Trait|sickle cell trait
749741|NCT00081523|Red Blood Cell Disorder|red blood cell disorder
749742|NCT00081523|Thalassemia|thalassemia
749743|NCT00081523|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
749744|NCT00081523|Hemolytic Disorders|hemolytic disorders
749745|NCT00004086|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
749746|NCT00004086|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
749747|NCT00004086|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
749748|NCT00004086|refractory hairy cell leukemia|refractory hairy cell leukemia
749749|NCT00004086|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
749750|NCT00004086|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
749751|NCT00004086|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
749752|NCT00004086|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
749753|NCT00004086|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
749754|NCT00004086|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
749755|NCT00004086|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
749756|NCT00004086|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
749757|NCT00004086|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
749758|NCT00004086|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
749759|NCT00004086|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
749760|NCT00004086|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
749761|NCT00004086|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
749762|NCT00004086|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
749763|NCT00004086|splenic marginal zone lymphoma|splenic marginal zone lymphoma
749764|NCT00004085|stage IV breast cancer|stage iv breast cancer
749765|NCT00004085|recurrent breast cancer|recurrent breast cancer
749766|NCT00004084|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
749767|NCT00004084|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
749768|NCT00004084|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
749769|NCT00004084|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
749770|NCT00004084|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
749771|NCT00004084|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
749772|NCT00004084|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
749773|NCT00004084|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
749774|NCT00004084|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
749775|NCT00004084|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
749776|NCT00004084|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
749777|NCT00004084|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
749778|NCT00004084|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
749779|NCT00004084|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
749780|NCT00004084|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
749781|NCT00004084|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
749782|NCT00004084|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
749783|NCT00004084|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
749784|NCT00004084|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
749785|NCT00004084|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
749786|NCT00004084|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
749787|NCT00004084|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
749788|NCT00004084|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
749789|NCT00004084|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
749790|NCT00004084|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
749791|NCT00004084|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
749792|NCT00004084|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
749793|NCT00004084|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
749794|NCT00004084|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
749795|NCT00004084|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
749796|NCT00004084|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
749797|NCT00004084|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
749798|NCT00004084|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
749799|NCT00004084|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
749800|NCT00004084|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
749801|NCT00004084|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
749802|NCT00004084|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
749803|NCT00004084|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
749804|NCT00004084|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
749805|NCT00004084|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
749806|NCT00004084|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
749807|NCT00004084|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
749808|NCT00004084|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
749809|NCT00004084|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
749810|NCT00004084|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
749811|NCT00004084|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
749812|NCT00004084|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
749813|NCT00004084|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
749814|NCT00004084|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
749815|NCT00004084|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
749816|NCT00004084|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
749817|NCT00004084|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
749818|NCT00004084|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
749819|NCT00004084|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
749820|NCT00004084|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
749821|NCT00004084|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
749822|NCT00004084|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
749823|NCT00004084|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
749824|NCT00004084|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
749825|NCT00004084|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
749826|NCT00004084|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
749827|NCT00004084|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
749828|NCT00004084|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
749829|NCT00004084|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
749830|NCT00004084|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
749831|NCT00004084|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
749832|NCT00004084|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
749833|NCT00004084|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
749834|NCT00004084|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
749835|NCT00004084|stage I marginal zone lymphoma|stage i marginal zone lymphoma
749836|NCT00004084|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
749837|NCT00004084|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
749838|NCT00004084|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
749839|NCT00004084|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
749840|NCT00004084|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
749841|NCT00004084|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
749842|NCT00004084|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
749843|NCT00004084|splenic marginal zone lymphoma|splenic marginal zone lymphoma
749844|NCT00004048|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
749845|NCT00004046|stage IV breast cancer|stage iv breast cancer
749846|NCT00004046|recurrent breast cancer|recurrent breast cancer
749847|NCT00004045|stage IV prostate cancer|stage iv prostate cancer
749848|NCT00004045|recurrent prostate cancer|recurrent prostate cancer
749849|NCT00004033|localized malignant mesothelioma|localized malignant mesothelioma
749850|NCT00004033|advanced malignant mesothelioma|advanced malignant mesothelioma
749851|NCT00004033|recurrent malignant mesothelioma|recurrent malignant mesothelioma
749852|NCT00004016|stage III melanoma|stage iii melanoma
749853|NCT00004016|stage IV melanoma|stage iv melanoma
749854|NCT00004016|recurrent melanoma|recurrent melanoma
749855|NCT00004016|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
749856|NCT00004010|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
749857|NCT00004010|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
749858|NCT00004010|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
749859|NCT00004010|childhood lymphocyte predominant Hodgkin lymphoma|childhood lymphocyte predominant hodgkin lymphoma
749860|NCT00004010|childhood lymphocyte depletion Hodgkin lymphoma|childhood lymphocyte depletion hodgkin lymphoma
749861|NCT00004010|childhood nodular sclerosis Hodgkin lymphoma|childhood nodular sclerosis hodgkin lymphoma
749862|NCT00004010|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
749863|NCT00081458|Short Bowel Syndrome|short bowel syndrome
749864|NCT00081458|Parenteral Nutrition|parenteral nutrition
749865|NCT00081458|SBS|sbs
749866|NCT00003917|limited stage small cell lung cancer|limited stage small cell lung cancer
749867|NCT00003917|extensive stage small cell lung cancer|extensive stage small cell lung cancer
749868|NCT00003917|recurrent small cell lung cancer|recurrent small cell lung cancer
749869|NCT00003870|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
749870|NCT00003870|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
749871|NCT00003870|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
749872|NCT00003870|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
749873|NCT00003834|stage IV colon cancer|stage iv colon cancer
749874|NCT00003834|stage IV rectal cancer|stage iv rectal cancer
749875|NCT00003834|recurrent colon cancer|recurrent colon cancer
749876|NCT00003834|recurrent rectal cancer|recurrent rectal cancer
780445|NCT00048737|NHL|nhl
749877|NCT00003834|adenocarcinoma of the colon|adenocarcinoma of the colon
749878|NCT00003834|adenocarcinoma of the rectum|adenocarcinoma of the rectum
749879|NCT00003834|liver metastases|liver metastases
749880|NCT00003824|stage 0 bladder cancer|stage 0 bladder cancer
749881|NCT00003824|recurrent bladder cancer|recurrent bladder cancer
749882|NCT00003824|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
749883|NCT00003809|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
749884|NCT00003809|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
749885|NCT00003809|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
749886|NCT00003809|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
749887|NCT00003809|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
749888|NCT00003809|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
749889|NCT00003809|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
749890|NCT00003809|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
749891|NCT00003809|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
749892|NCT00003809|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
749893|NCT00003809|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
749894|NCT00003809|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
749895|NCT00003809|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
749896|NCT00003809|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
749897|NCT00003809|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
749898|NCT00003809|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
749899|NCT00003809|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
749900|NCT00003719|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
749901|NCT00003719|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
749902|NCT00003718|adult angiosarcoma|adult angiosarcoma
749903|NCT00003718|adult fibrosarcoma|adult fibrosarcoma
749904|NCT00003718|adult leiomyosarcoma|adult leiomyosarcoma
749905|NCT00003718|adult liposarcoma|adult liposarcoma
749906|NCT00003718|adult neurofibrosarcoma|adult neurofibrosarcoma
749907|NCT00003718|adult synovial sarcoma|adult synovial sarcoma
749908|NCT00003718|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
749909|NCT00003718|adult extraskeletal chondrosarcoma|adult extraskeletal chondrosarcoma
749910|NCT00003718|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
749911|NCT00003718|adult epithelioid sarcoma|adult epithelioid sarcoma
749912|NCT00003718|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
749913|NCT00003718|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
749914|NCT00003718|adult malignant mesenchymoma|adult malignant mesenchymoma
749915|NCT00003718|adult rhabdomyosarcoma|adult rhabdomyosarcoma
749916|NCT00003718|stage IV uterine sarcoma|stage iv uterine sarcoma
749917|NCT00003718|recurrent uterine sarcoma|recurrent uterine sarcoma
749918|NCT00003718|uterine carcinosarcoma|uterine carcinosarcoma
749919|NCT00003718|uterine leiomyosarcoma|uterine leiomyosarcoma
749920|NCT00003718|endometrial stromal sarcoma|endometrial stromal sarcoma
749921|NCT00003718|ovarian sarcoma|ovarian sarcoma
749922|NCT00003718|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
749923|NCT00003717|adenocarcinoma of the prostate|adenocarcinoma of the prostate
749924|NCT00003717|stage IV prostate cancer|stage iv prostate cancer
749925|NCT00003717|recurrent prostate cancer|recurrent prostate cancer
749926|NCT00003674|stage IV colon cancer|stage iv colon cancer
749927|NCT00003674|stage IV breast cancer|stage iv breast cancer
749928|NCT00003674|recurrent breast cancer|recurrent breast cancer
749929|NCT00003674|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
749930|NCT00003674|stage IV rectal cancer|stage iv rectal cancer
749931|NCT00003674|recurrent colon cancer|recurrent colon cancer
749932|NCT00003674|recurrent rectal cancer|recurrent rectal cancer
749933|NCT00003674|extensive stage small cell lung cancer|extensive stage small cell lung cancer
749934|NCT00003674|recurrent small cell lung cancer|recurrent small cell lung cancer
749935|NCT00003674|stage IV prostate cancer|stage iv prostate cancer
749936|NCT00003674|recurrent prostate cancer|recurrent prostate cancer
749937|NCT00003674|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
749938|NCT00003674|veno-occlusive disease|veno-occlusive disease
749939|NCT00003493|refractory multiple myeloma|refractory multiple myeloma
749940|NCT00003493|stage I multiple myeloma|stage i multiple myeloma
749941|NCT00003493|stage II multiple myeloma|stage ii multiple myeloma
749942|NCT00003493|stage III multiple myeloma|stage iii multiple myeloma
749943|NCT00003307|adenocarcinoma of the prostate|adenocarcinoma of the prostate
749944|NCT00003307|stage I prostate cancer|stage i prostate cancer
749945|NCT00003307|stage II prostate cancer|stage ii prostate cancer
749946|NCT00003307|stage III prostate cancer|stage iii prostate cancer
749947|NCT00003307|radiation toxicity|radiation toxicity
749948|NCT00003283|invasive thymoma and thymic carcinoma|invasive thymoma and thymic carcinoma
749949|NCT00003283|recurrent thymoma and thymic carcinoma|recurrent thymoma and thymic carcinoma
749950|NCT00003235|squamous cell lung cancer|squamous cell lung cancer
749951|NCT00003235|large cell lung cancer|large cell lung cancer
749952|NCT00003235|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
749953|NCT00003235|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
749954|NCT00003235|adenocarcinoma of the lung|adenocarcinoma of the lung
749955|NCT00003209|stage IB cervical cancer|stage ib cervical cancer
749956|NCT00003209|stage IIA cervical cancer|stage iia cervical cancer
749957|NCT00003209|cervical squamous cell carcinoma|cervical squamous cell carcinoma
749958|NCT00003209|cervical adenocarcinoma|cervical adenocarcinoma
749959|NCT00003209|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
749960|NCT00003125|stage IV breast cancer|stage iv breast cancer
749961|NCT00003125|stage IIIA breast cancer|stage iiia breast cancer
749962|NCT00003125|stage III gastric cancer|stage iii gastric cancer
749963|NCT00003125|stage IV gastric cancer|stage iv gastric cancer
749964|NCT00003125|stage IIIB breast cancer|stage iiib breast cancer
749965|NCT00003125|stage II pancreatic cancer|stage ii pancreatic cancer
749966|NCT00003125|stage III pancreatic cancer|stage iii pancreatic cancer
749967|NCT00003125|stage II esophageal cancer|stage ii esophageal cancer
749968|NCT00003125|stage III esophageal cancer|stage iii esophageal cancer
749969|NCT00003125|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
749970|NCT00003125|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
749971|NCT00003125|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
749972|NCT00003125|stage IV pancreatic cancer|stage iv pancreatic cancer
749973|NCT00003080|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
749974|NCT00003080|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
749975|NCT00003080|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
749976|NCT00003061|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
749977|NCT00003032|stage IV breast cancer|stage iv breast cancer
749978|NCT00003032|recurrent breast cancer|recurrent breast cancer
749979|NCT00003010|recurrent breast cancer|recurrent breast cancer
749980|NCT00021398|stage II rectal cancer|stage ii rectal cancer
749981|NCT00021398|stage III rectal cancer|stage iii rectal cancer
749982|NCT00021398|adenocarcinoma of the rectum|adenocarcinoma of the rectum
749983|NCT00021281|stage IV colon cancer|stage iv colon cancer
749984|NCT00021281|stage IV rectal cancer|stage iv rectal cancer
749985|NCT00021281|recurrent colon cancer|recurrent colon cancer
749986|NCT00021281|recurrent rectal cancer|recurrent rectal cancer
749987|NCT00021281|adenocarcinoma of the colon|adenocarcinoma of the colon
749988|NCT00021281|adenocarcinoma of the rectum|adenocarcinoma of the rectum
749989|NCT00021151|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
749990|NCT00021151|prolymphocytic leukemia|prolymphocytic leukemia
749991|NCT00021008|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
749992|NCT00021008|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
749993|NCT00021008|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
749994|NCT00020774|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
749995|NCT00020774|recurrent adult primary liver cancer|recurrent adult primary liver cancer
749996|NCT00020774|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
749997|NCT00020774|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
749998|NCT00019552|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
749999|NCT00019552|fallopian tube cancer|fallopian tube cancer
750000|NCT00019552|primary peritoneal cavity cancer|primary peritoneal cavity cancer
750001|NCT00019474|stage III gastric cancer|stage iii gastric cancer
750002|NCT00019474|stage IV gastric cancer|stage iv gastric cancer
750003|NCT00019474|recurrent gastric cancer|recurrent gastric cancer
750004|NCT00019474|stage II pancreatic cancer|stage ii pancreatic cancer
750005|NCT00019474|stage III pancreatic cancer|stage iii pancreatic cancer
750006|NCT00019474|recurrent pancreatic cancer|recurrent pancreatic cancer
750007|NCT00019474|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
750008|NCT00019474|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
750009|NCT00019474|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
750010|NCT00019474|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
750011|NCT00019474|advanced adult primary liver cancer|advanced adult primary liver cancer
750012|NCT00019474|recurrent adult primary liver cancer|recurrent adult primary liver cancer
750013|NCT00019474|small intestine adenocarcinoma|small intestine adenocarcinoma
750014|NCT00019474|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
750015|NCT00019474|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
750016|NCT00019474|recurrent small intestine cancer|recurrent small intestine cancer
750017|NCT00019474|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
750018|NCT00019474|stage IV pancreatic cancer|stage iv pancreatic cancer
750019|NCT00019318|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
750148|NCT00012311|stage IV breast cancer|stage iv breast cancer
750020|NCT00019318|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
750021|NCT00019318|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
750022|NCT00019318|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
750023|NCT00019318|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
750024|NCT00019318|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
750025|NCT00019123|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
750026|NCT00014391|stage IV breast cancer|stage iv breast cancer
750027|NCT00014391|stage IIIA breast cancer|stage iiia breast cancer
750028|NCT00014391|stage IIIB breast cancer|stage iiib breast cancer
750029|NCT00014391|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
750030|NCT00014391|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
750031|NCT00014391|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
750032|NCT00014391|refractory multiple myeloma|refractory multiple myeloma
750033|NCT00014391|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
750034|NCT00014391|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
750035|NCT00014391|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
750036|NCT00014391|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
750037|NCT00014391|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
750038|NCT00014391|disseminated neuroblastoma|disseminated neuroblastoma
750039|NCT00014391|recurrent neuroblastoma|recurrent neuroblastoma
750040|NCT00014391|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
750041|NCT00014391|stage I multiple myeloma|stage i multiple myeloma
750042|NCT00014391|stage II multiple myeloma|stage ii multiple myeloma
750043|NCT00014391|stage III multiple myeloma|stage iii multiple myeloma
750044|NCT00014391|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
750045|NCT00014391|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
750046|NCT00014391|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
750047|NCT00014391|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
750048|NCT00014391|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
750049|NCT00014391|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
750050|NCT00014391|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
750051|NCT00014391|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
750052|NCT00014391|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
750053|NCT00014391|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
750054|NCT00014391|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
750055|NCT00014391|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
750056|NCT00014391|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
750057|NCT00014391|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
750058|NCT00014391|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
750059|NCT00014391|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
750060|NCT00014391|testicular embryonal carcinoma|testicular embryonal carcinoma
750061|NCT00014391|testicular choriocarcinoma|testicular choriocarcinoma
750062|NCT00014391|testicular teratoma|testicular teratoma
750063|NCT00014391|testicular yolk sac tumor|testicular yolk sac tumor
750064|NCT00014391|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
750065|NCT00014391|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
750066|NCT00014391|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
750067|NCT00014391|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
750068|NCT00014391|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
750069|NCT00014391|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
750070|NCT00014391|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
750071|NCT00014391|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
750072|NCT00014391|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
750073|NCT00014391|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
750074|NCT00014391|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
750075|NCT00014391|refractory hairy cell leukemia|refractory hairy cell leukemia
750076|NCT00014391|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
750077|NCT00014391|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
750078|NCT00014391|ovarian yolk sac tumor|ovarian yolk sac tumor
750079|NCT00014391|ovarian embryonal carcinoma|ovarian embryonal carcinoma
750080|NCT00014391|ovarian polyembryoma|ovarian polyembryoma
750081|NCT00014391|ovarian choriocarcinoma|ovarian choriocarcinoma
750082|NCT00014391|ovarian immature teratoma|ovarian immature teratoma
750083|NCT00014391|ovarian mature teratoma|ovarian mature teratoma
750084|NCT00014391|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
750085|NCT00014391|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
750086|NCT00014391|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
750087|NCT00014391|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
750088|NCT00014391|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
750089|NCT00014391|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
750090|NCT00014391|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
750091|NCT00014391|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
750092|NCT00014391|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
750093|NCT00014391|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
750094|NCT00014391|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
750095|NCT00014391|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
750096|NCT00014391|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
750097|NCT00014391|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
750098|NCT00014391|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
750099|NCT00014391|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
750100|NCT00014391|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
750101|NCT00014391|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
750102|NCT00014391|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
750103|NCT00014391|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
750104|NCT00014391|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
750105|NCT00014391|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
750106|NCT00014391|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
750107|NCT00014391|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
750108|NCT00014391|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
750109|NCT00014391|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
750110|NCT00014391|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
750111|NCT00014391|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
750301|NCT00005874|adult leiomyosarcoma|adult leiomyosarcoma
750112|NCT00014391|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
750113|NCT00014391|secondary acute myeloid leukemia|secondary acute myeloid leukemia
750114|NCT00014391|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
750115|NCT00014391|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
750116|NCT00014391|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
750117|NCT00014391|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
750118|NCT00014391|infection|infection
750119|NCT00014391|pulmonary complications|pulmonary complications
750120|NCT00014391|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
750121|NCT00014391|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
750122|NCT00014391|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
750123|NCT00014391|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
750124|NCT00014391|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
750125|NCT00014391|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
750126|NCT00014391|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
750127|NCT00014391|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
750128|NCT00014391|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
750129|NCT00014391|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
750130|NCT00014391|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
750131|NCT00014391|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
750132|NCT00014391|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
750133|NCT00014391|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
750134|NCT00014391|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
750135|NCT00014391|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
750136|NCT00014391|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
750137|NCT00014391|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
750138|NCT00014391|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
750139|NCT00014391|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
750140|NCT00014391|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
750141|NCT00014391|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
750142|NCT00014391|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
750143|NCT00014391|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
750144|NCT00014391|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
750145|NCT00014391|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
750146|NCT00014391|splenic marginal zone lymphoma|splenic marginal zone lymphoma
750147|NCT00014391|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
750149|NCT00012311|recurrent breast cancer|recurrent breast cancer
750150|NCT00010283|stage III breast cancer|stage iii breast cancer
750151|NCT00010283|stage IV breast cancer|stage iv breast cancer
750152|NCT00010283|stage IIIA breast cancer|stage iiia breast cancer
750153|NCT00010283|stage IIIB breast cancer|stage iiib breast cancer
750154|NCT00010283|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
750155|NCT00010283|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
750156|NCT00010283|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
750157|NCT00010283|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
750158|NCT00010283|Burkitt lymphoma|burkitt lymphoma
750159|NCT00010283|extramedullary plasmacytoma|extramedullary plasmacytoma
750160|NCT00010283|refractory multiple myeloma|refractory multiple myeloma
750161|NCT00010283|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
750162|NCT00010283|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
750163|NCT00010283|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
750164|NCT00010283|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
750165|NCT00010283|disseminated neuroblastoma|disseminated neuroblastoma
750166|NCT00010283|recurrent neuroblastoma|recurrent neuroblastoma
750167|NCT00010283|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
750168|NCT00010283|stage I multiple myeloma|stage i multiple myeloma
750169|NCT00010283|stage II multiple myeloma|stage ii multiple myeloma
750170|NCT00010283|stage III multiple myeloma|stage iii multiple myeloma
750171|NCT00010283|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
750172|NCT00010283|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
750173|NCT00010283|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
750174|NCT00010283|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
750175|NCT00010283|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
750176|NCT00010283|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
750177|NCT00010283|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
750178|NCT00010283|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
750179|NCT00010283|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
750180|NCT00010283|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
750181|NCT00010283|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
750182|NCT00010283|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
750183|NCT00010283|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
750184|NCT00010283|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
750185|NCT00010283|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
750186|NCT00010283|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
750187|NCT00010283|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
750188|NCT00010283|essential thrombocythemia|essential thrombocythemia
750189|NCT00010283|testicular embryonal carcinoma|testicular embryonal carcinoma
750190|NCT00010283|testicular choriocarcinoma|testicular choriocarcinoma
750191|NCT00010283|testicular teratoma|testicular teratoma
750192|NCT00010283|testicular yolk sac tumor|testicular yolk sac tumor
750193|NCT00010283|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
750194|NCT00010283|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
750195|NCT00010283|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
750196|NCT00010283|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
750197|NCT00010283|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
750198|NCT00010283|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
750199|NCT00010283|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
750200|NCT00010283|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
750201|NCT00010283|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
750202|NCT00010283|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
750203|NCT00010283|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
750204|NCT00010283|refractory hairy cell leukemia|refractory hairy cell leukemia
750205|NCT00010283|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
750206|NCT00010283|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
750207|NCT00010283|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
750208|NCT00010283|ovarian yolk sac tumor|ovarian yolk sac tumor
750209|NCT00010283|ovarian embryonal carcinoma|ovarian embryonal carcinoma
750210|NCT00010283|ovarian polyembryoma|ovarian polyembryoma
750211|NCT00010283|ovarian choriocarcinoma|ovarian choriocarcinoma
750212|NCT00010283|ovarian immature teratoma|ovarian immature teratoma
750213|NCT00010283|ovarian mature teratoma|ovarian mature teratoma
750214|NCT00010283|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
750215|NCT00010283|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
750216|NCT00010283|acute undifferentiated leukemia|acute undifferentiated leukemia
780446|NCT00048737|CLL|cll
750217|NCT00010283|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
750218|NCT00010283|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
750219|NCT00010283|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
750220|NCT00010283|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
750221|NCT00010283|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
750222|NCT00010283|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
750223|NCT00010283|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
750224|NCT00010283|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
750225|NCT00010283|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
750226|NCT00010283|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
750227|NCT00010283|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
750228|NCT00010283|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
750229|NCT00010283|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
750230|NCT00010283|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
750231|NCT00010283|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
750232|NCT00010283|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
750233|NCT00010283|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
750234|NCT00010283|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
750235|NCT00010283|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
750236|NCT00010283|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
750237|NCT00010283|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
750238|NCT00010283|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
750239|NCT00010283|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
750240|NCT00010283|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
750241|NCT00010283|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
750242|NCT00010283|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
750243|NCT00010283|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
750244|NCT00010283|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
750245|NCT00010283|secondary acute myeloid leukemia|secondary acute myeloid leukemia
750246|NCT00010283|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
750247|NCT00010283|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
750248|NCT00010283|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
750249|NCT00010283|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
750250|NCT00010283|graft versus host disease|graft versus host disease
750251|NCT00010283|prolymphocytic leukemia|prolymphocytic leukemia
750252|NCT00010283|primary systemic amyloidosis|primary systemic amyloidosis
750253|NCT00010283|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
750254|NCT00010283|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
750255|NCT00010283|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
750256|NCT00010283|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
750257|NCT00010283|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
750258|NCT00010283|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
750259|NCT00010283|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
750260|NCT00010283|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
750261|NCT00010283|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
750262|NCT00010283|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
750263|NCT00010283|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
750264|NCT00010283|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
750265|NCT00010283|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
750266|NCT00010283|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
750267|NCT00010283|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
750268|NCT00010283|anaplastic large cell lymphoma|anaplastic large cell lymphoma
750269|NCT00010283|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
750270|NCT00010283|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
750271|NCT00010283|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
750272|NCT00010283|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
750273|NCT00010283|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
750274|NCT00010283|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
750275|NCT00010283|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
750276|NCT00010283|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
750277|NCT00010283|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
750278|NCT00010283|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
780552|NCT00047957|Stimulation|stimulation
750279|NCT00010283|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
750280|NCT00010283|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
750281|NCT00010283|splenic marginal zone lymphoma|splenic marginal zone lymphoma
750282|NCT00010283|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
750283|NCT00007943|stage III colon cancer|stage iii colon cancer
750284|NCT00007943|stage IV colon cancer|stage iv colon cancer
750285|NCT00007943|stage III rectal cancer|stage iii rectal cancer
750286|NCT00007943|stage IV rectal cancer|stage iv rectal cancer
750287|NCT00007943|recurrent colon cancer|recurrent colon cancer
750288|NCT00007943|recurrent rectal cancer|recurrent rectal cancer
750289|NCT00006045|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
750290|NCT00006045|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
750291|NCT00006045|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
750292|NCT00006045|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
750293|NCT00006045|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
750294|NCT00006045|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
750295|NCT00006045|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
750296|NCT00006045|secondary acute myeloid leukemia|secondary acute myeloid leukemia
750297|NCT00006045|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
750298|NCT00006045|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
750299|NCT00005875|stage IV melanoma|stage iv melanoma
750302|NCT00005874|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
750303|NCT00005874|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
750304|NCT00005874|small intestine leiomyosarcoma|small intestine leiomyosarcoma
750305|NCT00005874|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
750306|NCT00005874|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
750307|NCT00005874|childhood leiomyosarcoma|childhood leiomyosarcoma
750308|NCT00005874|gastrointestinal stromal tumor|gastrointestinal stromal tumor
750309|NCT00005874|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
750310|NCT00005873|stage IV breast cancer|stage iv breast cancer
750311|NCT00005873|recurrent breast cancer|recurrent breast cancer
750312|NCT00002708|tumors metastatic to brain|tumors metastatic to brain
750313|NCT00081432|Seizures|seizures
750314|NCT00081432|Language|language
750315|NCT00081432|Memory|memory
750316|NCT00081432|Brain|brain
750317|NCT00081432|Imaging|imaging
750318|NCT00081432|Epilepsy|epilepsy
750319|NCT00081432|Temporal Lobe Epilepsy|temporal lobe epilepsy
750320|NCT00081419|Bereitschaftspotential|bereitschaftspotential
750321|NCT00081419|Timing of Volition|timing of volition
750322|NCT00081419|Urge|urge
750323|NCT00081419|Conscious Will|conscious will
750324|NCT00081419|Libet's Clock|libet's clock
750325|NCT00081419|Tourette Syndrome|tourette syndrome
750326|NCT00081419|Tic Disorder|tic disorder
750327|NCT00081419|Healthy Volunteer|healthy volunteer
750328|NCT00081419|HV|hv
750329|NCT00081367|Minority Groups|minority groups
750330|NCT00005872|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
750331|NCT00005833|stage IV colon cancer|stage iv colon cancer
750332|NCT00005833|stage IV rectal cancer|stage iv rectal cancer
750333|NCT00005833|recurrent colon cancer|recurrent colon cancer
750334|NCT00005833|recurrent rectal cancer|recurrent rectal cancer
750335|NCT00005833|adenocarcinoma of the colon|adenocarcinoma of the colon
750336|NCT00005833|adenocarcinoma of the rectum|adenocarcinoma of the rectum
750337|NCT00005820|adenocarcinoma of the prostate|adenocarcinoma of the prostate
750338|NCT00005820|stage IV prostate cancer|stage iv prostate cancer
750339|NCT00005820|recurrent prostate cancer|recurrent prostate cancer
750340|NCT00005801|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
750341|NCT00005801|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
750342|NCT00005801|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
750343|NCT00005801|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
750344|NCT00005801|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
750345|NCT00005801|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
750346|NCT00005801|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
750347|NCT00005801|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
750348|NCT00005077|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
750349|NCT00005066|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
750350|NCT00005066|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
750351|NCT00005061|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
750352|NCT00005058|stage I breast cancer|stage i breast cancer
750353|NCT00005058|stage II breast cancer|stage ii breast cancer
750354|NCT00005058|stage IIIA breast cancer|stage iiia breast cancer
750355|NCT00005058|stage IIIB breast cancer|stage iiib breast cancer
750356|NCT00005058|inflammatory breast cancer|inflammatory breast cancer
780553|NCT00047957|Motor|motor
750357|NCT00005040|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
750358|NCT00005040|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
750359|NCT00005040|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
750360|NCT00005040|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
750361|NCT00005040|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
750362|NCT00005040|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
750363|NCT00005040|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
750364|NCT00005040|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
750365|NCT00005040|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
750366|NCT00005040|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
750367|NCT00005040|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
750368|NCT00005040|anaplastic large cell lymphoma|anaplastic large cell lymphoma
750369|NCT00004885|stage IV colon cancer|stage iv colon cancer
750370|NCT00004885|stage IV rectal cancer|stage iv rectal cancer
750371|NCT00004885|recurrent colon cancer|recurrent colon cancer
750372|NCT00004885|recurrent rectal cancer|recurrent rectal cancer
750373|NCT00004885|adenocarcinoma of the colon|adenocarcinoma of the colon
750374|NCT00004885|adenocarcinoma of the rectum|adenocarcinoma of the rectum
750375|NCT00004860|stage III colon cancer|stage iii colon cancer
750376|NCT00004860|stage IV colon cancer|stage iv colon cancer
750377|NCT00004860|stage III rectal cancer|stage iii rectal cancer
750378|NCT00004860|stage IV rectal cancer|stage iv rectal cancer
750379|NCT00004860|recurrent colon cancer|recurrent colon cancer
750380|NCT00004860|recurrent rectal cancer|recurrent rectal cancer
750381|NCT00004860|adenocarcinoma of the colon|adenocarcinoma of the colon
750382|NCT00004860|adenocarcinoma of the rectum|adenocarcinoma of the rectum
750383|NCT00004238|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
750384|NCT00004238|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
750385|NCT00004238|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
750386|NCT00004166|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
750387|NCT00004166|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
750388|NCT00004166|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
750389|NCT00004166|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
750390|NCT00004166|quality of life|quality of life
750391|NCT00004137|extensive stage small cell lung cancer|extensive stage small cell lung cancer
750392|NCT00004102|stage IV colon cancer|stage iv colon cancer
750393|NCT00004102|stage IV rectal cancer|stage iv rectal cancer
750394|NCT00004102|recurrent colon cancer|recurrent colon cancer
750395|NCT00004102|recurrent rectal cancer|recurrent rectal cancer
750396|NCT00004102|adenocarcinoma of the colon|adenocarcinoma of the colon
750397|NCT00004102|adenocarcinoma of the rectum|adenocarcinoma of the rectum
750398|NCT00004082|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
750399|NCT00004082|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
750400|NCT00004082|stage III endometrial carcinoma|stage iii endometrial carcinoma
750401|NCT00004082|stage IV endometrial carcinoma|stage iv endometrial carcinoma
750402|NCT00004082|endometrial adenocarcinoma|endometrial adenocarcinoma
750403|NCT00004082|fallopian tube cancer|fallopian tube cancer
750404|NCT00004082|primary peritoneal cavity cancer|primary peritoneal cavity cancer
750405|NCT00004002|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
750406|NCT00004002|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
750407|NCT00004002|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
750510|NCT00081237|recurrent colon cancer|recurrent colon cancer
750408|NCT00004002|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
750409|NCT00004002|small intestine lymphoma|small intestine lymphoma
750410|NCT00004002|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
750411|NCT00004002|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
750412|NCT00004002|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
750413|NCT00004002|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
750414|NCT00004002|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
750415|NCT00004002|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
750416|NCT00004002|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
750417|NCT00004002|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
750418|NCT00004002|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
750419|NCT00004002|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
750420|NCT00004002|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
750421|NCT00004002|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
750422|NCT00004002|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
750423|NCT00004002|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
750424|NCT00004002|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
750425|NCT00004002|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
750501|NCT00081302|adenocarcinoma of the lung|adenocarcinoma of the lung
750426|NCT00004002|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
750427|NCT00004002|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
750428|NCT00004002|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
750429|NCT00004002|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
750430|NCT00004002|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
750431|NCT00004002|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
750432|NCT00004002|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
750433|NCT00004002|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
750434|NCT00004002|intraocular lymphoma|intraocular lymphoma
750435|NCT00004002|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
750436|NCT00004002|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
750437|NCT00004002|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
750438|NCT00004002|anaplastic large cell lymphoma|anaplastic large cell lymphoma
750439|NCT00004002|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
750440|NCT00004002|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
750441|NCT00004002|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
750442|NCT00004002|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
750443|NCT00004002|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
750444|NCT00004002|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
750445|NCT00004002|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
750446|NCT00004002|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
750447|NCT00004002|splenic marginal zone lymphoma|splenic marginal zone lymphoma
750448|NCT00003911|stage IV melanoma|stage iv melanoma
750449|NCT00003911|recurrent melanoma|recurrent melanoma
750450|NCT00003911|tumors metastatic to brain|tumors metastatic to brain
750451|NCT00003840|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
750452|NCT00003840|secondary acute myeloid leukemia|secondary acute myeloid leukemia
750453|NCT00081354|Esophageal Adenocarcinoma|esophageal adenocarcinoma
750454|NCT00081354|Dysplasia|dysplasia
750455|NCT00081354|Surveillance|surveillance
750456|NCT00081354|Proteomics|proteomics
750457|NCT00081354|SNP's|snp's
750458|NCT00081354|Barrett Esophagus|barrett esophagus
750459|NCT00081354|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
750460|NCT00081354|GERD|gerd
750461|NCT00081354|Dysphagia|dysphagia
750462|NCT00081354|Swallowing Difficulty|swallowing difficulty
750463|NCT00081315|- Non-Small cell lung cancer|- non-small cell lung cancer
750464|NCT00005943|stage IV melanoma|stage iv melanoma
750465|NCT00005943|recurrent melanoma|recurrent melanoma
750466|NCT00003754|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
750467|NCT00003710|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
750468|NCT00003692|occult non-small cell lung cancer|occult non-small cell lung cancer
750469|NCT00003692|stage I non-small cell lung cancer|stage i non-small cell lung cancer
750470|NCT00003692|stage 0 non-small cell lung cancer|stage 0 non-small cell lung cancer
750471|NCT00003642|stage II bladder cancer|stage ii bladder cancer
750472|NCT00003642|stage III bladder cancer|stage iii bladder cancer
750473|NCT00003642|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
750474|NCT00003446|stage IV colon cancer|stage iv colon cancer
750475|NCT00003446|stage IV rectal cancer|stage iv rectal cancer
750476|NCT00003446|recurrent colon cancer|recurrent colon cancer
750477|NCT00003446|recurrent rectal cancer|recurrent rectal cancer
750478|NCT00003376|stage III bladder cancer|stage iii bladder cancer
750479|NCT00003376|stage IV bladder cancer|stage iv bladder cancer
750480|NCT00003376|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
750481|NCT00003376|anterior urethral cancer|anterior urethral cancer
750482|NCT00003376|posterior urethral cancer|posterior urethral cancer
750483|NCT00003376|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
750484|NCT00003376|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
750485|NCT00003376|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
750486|NCT00003316|recurrent uterine sarcoma|recurrent uterine sarcoma
750487|NCT00003316|uterine leiomyosarcoma|uterine leiomyosarcoma
750488|NCT00003301|recurrent adult brain tumor|recurrent adult brain tumor
750489|NCT00003301|adult glioblastoma|adult glioblastoma
750490|NCT00003301|adult anaplastic astrocytoma|adult anaplastic astrocytoma
750491|NCT00003301|adult giant cell glioblastoma|adult giant cell glioblastoma
750492|NCT00003301|adult gliosarcoma|adult gliosarcoma
750493|NCT00003232|adenocarcinoma of the prostate|adenocarcinoma of the prostate
750494|NCT00003232|recurrent prostate cancer|recurrent prostate cancer
750495|NCT00003232|pain|pain
750496|NCT00003232|quality of life|quality of life
750497|NCT00081302|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
750498|NCT00081302|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
750499|NCT00081302|squamous cell lung cancer|squamous cell lung cancer
750500|NCT00081302|large cell lung cancer|large cell lung cancer
750502|NCT00081302|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
750503|NCT00081289|stage III rectal cancer|stage iii rectal cancer
750504|NCT00081289|adenocarcinoma of the rectum|adenocarcinoma of the rectum
750505|NCT00081289|stage II rectal cancer|stage ii rectal cancer
750506|NCT00081250|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
750507|NCT00081250|cachexia|cachexia
750508|NCT00081250|anorexia|anorexia
750509|NCT00081250|weight changes|weight changes
750511|NCT00081237|stage III colon cancer|stage iii colon cancer
750512|NCT00081237|stage IV colon cancer|stage iv colon cancer
750513|NCT00081237|recurrent rectal cancer|recurrent rectal cancer
750514|NCT00081237|stage III rectal cancer|stage iii rectal cancer
750515|NCT00081237|stage IV rectal cancer|stage iv rectal cancer
750516|NCT00081224|adenocarcinoma of the rectum|adenocarcinoma of the rectum
750517|NCT00081224|stage II rectal cancer|stage ii rectal cancer
750518|NCT00081224|stage III rectal cancer|stage iii rectal cancer
750519|NCT00081172|adenocarcinoma of the prostate|adenocarcinoma of the prostate
750520|NCT00081172|recurrent prostate cancer|recurrent prostate cancer
750521|NCT00081172|stage IV prostate cancer|stage iv prostate cancer
750522|NCT00081159|recurrent prostate cancer|recurrent prostate cancer
750523|NCT00081159|stage IV prostate cancer|stage iv prostate cancer
750524|NCT00081159|bone metastases|bone metastases
750525|NCT00081133|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
750526|NCT00081133|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
750527|NCT00081133|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
750528|NCT00081133|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
750529|NCT00081107|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
750530|NCT00081107|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
750531|NCT00081107|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
750532|NCT00081094|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
750533|NCT00081094|recurrent adult primary liver cancer|recurrent adult primary liver cancer
750534|NCT00081094|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
750535|NCT00081068|Waldenström macroglobulinemia|waldenström macroglobulinemia
750536|NCT00081055|graft versus host disease|graft versus host disease
750537|NCT00081055|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
750538|NCT00081055|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
750539|NCT00081055|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
750540|NCT00081055|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
750541|NCT00081055|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
750542|NCT00081055|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
750543|NCT00081055|refractory anemia|refractory anemia
750544|NCT00081055|refractory anemia with excess blasts|refractory anemia with excess blasts
750545|NCT00081055|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
750546|NCT00081055|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
750547|NCT00081055|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
750548|NCT00081055|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
750549|NCT00081055|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
750550|NCT00081055|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
750551|NCT00081055|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
750552|NCT00081055|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
750553|NCT00081055|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
750554|NCT00081042|recurrent melanoma|recurrent melanoma
750555|NCT00081042|stage III melanoma|stage iii melanoma
750556|NCT00081042|stage IV melanoma|stage iv melanoma
750557|NCT00081029|xerostomia|xerostomia
750558|NCT00081029|radiation toxicity|radiation toxicity
750559|NCT00081029|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
750560|NCT00081029|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
750561|NCT00081029|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
750562|NCT00081029|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
750563|NCT00081029|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
750564|NCT00081029|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
750565|NCT00081029|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
750566|NCT00081029|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
750567|NCT00081003|breast cancer|breast cancer
750568|NCT00080977|recurrent renal cell cancer|recurrent renal cell cancer
750569|NCT00080977|stage IV renal cell cancer|stage iv renal cell cancer
750570|NCT00080951|stage IV colon cancer|stage iv colon cancer
750571|NCT00080951|stage IV rectal cancer|stage iv rectal cancer
750572|NCT00080951|adenocarcinoma of the colon|adenocarcinoma of the colon
750573|NCT00080951|adenocarcinoma of the rectum|adenocarcinoma of the rectum
750574|NCT00080938|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
750575|NCT00080938|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
750576|NCT00080938|squamous cell lung cancer|squamous cell lung cancer
750577|NCT00080938|adenocarcinoma of the lung|adenocarcinoma of the lung
750578|NCT00080938|large cell lung cancer|large cell lung cancer
750579|NCT00080938|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
750580|NCT00080938|adenosquamous cell lung cancer|adenosquamous cell lung cancer
750581|NCT00080938|tumors metastatic to brain|tumors metastatic to brain
750582|NCT00080925|prolymphocytic leukemia|prolymphocytic leukemia
750583|NCT00080925|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
750584|NCT00080925|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
750585|NCT00080925|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
750586|NCT00080925|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
750587|NCT00080925|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
750588|NCT00080925|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
750589|NCT00080925|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
750590|NCT00080925|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
750591|NCT00080925|secondary acute myeloid leukemia|secondary acute myeloid leukemia
750592|NCT00080925|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
750593|NCT00080925|refractory anemia with excess blasts|refractory anemia with excess blasts
750594|NCT00080925|refractory multiple myeloma|refractory multiple myeloma
750595|NCT00080925|primary myelofibrosis|primary myelofibrosis
750596|NCT00080925|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
750597|NCT00080925|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
750598|NCT00080925|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
750599|NCT00080925|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
750600|NCT00080925|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
750601|NCT00080925|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
750602|NCT00080925|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
750603|NCT00080925|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
750604|NCT00080925|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
750605|NCT00080925|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
750606|NCT00080925|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
750607|NCT00080925|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
750608|NCT00080925|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
750609|NCT00080925|polycythemia vera|polycythemia vera
750610|NCT00080925|essential thrombocythemia|essential thrombocythemia
750611|NCT00080925|stage II multiple myeloma|stage ii multiple myeloma
750612|NCT00080925|stage III multiple myeloma|stage iii multiple myeloma
750613|NCT00080925|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
750614|NCT00080925|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
750615|NCT00080925|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
750616|NCT00080925|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
750617|NCT00080925|splenic marginal zone lymphoma|splenic marginal zone lymphoma
750618|NCT00080925|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
750619|NCT00080925|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
750620|NCT00080925|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
750621|NCT00080925|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
750622|NCT00080925|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
750623|NCT00080912|bone metastases|bone metastases
750624|NCT00080912|pain|pain
750625|NCT00080886|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
750626|NCT00080886|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
750627|NCT00080886|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
750628|NCT00080886|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
750629|NCT00080886|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
750630|NCT00080886|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
750631|NCT00080886|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
750632|NCT00080886|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
750633|NCT00080886|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
750634|NCT00080886|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
750635|NCT00080886|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
750636|NCT00080886|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
750637|NCT00080886|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
750638|NCT00080886|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
750639|NCT00080886|splenic marginal zone lymphoma|splenic marginal zone lymphoma
750640|NCT00080873|oral complications|oral complications
750641|NCT00080873|disseminated neuroblastoma|disseminated neuroblastoma
750642|NCT00080873|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
750643|NCT00080873|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
750644|NCT00080873|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
750645|NCT00080873|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
750646|NCT00080873|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
750647|NCT00080873|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
750648|NCT00080873|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
750649|NCT00080873|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
750650|NCT00080873|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
750651|NCT00080873|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
750652|NCT00080873|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
750653|NCT00080873|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
750654|NCT00080873|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
750655|NCT00080873|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
750656|NCT00080873|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
750657|NCT00080873|recurrent neuroblastoma|recurrent neuroblastoma
750658|NCT00080860|stage II breast cancer|stage ii breast cancer
750659|NCT00080860|stage IIIA breast cancer|stage iiia breast cancer
750660|NCT00080860|stage IIIB breast cancer|stage iiib breast cancer
750661|NCT00080860|stage IIIC breast cancer|stage iiic breast cancer
750662|NCT00080860|stage IV breast cancer|stage iv breast cancer
750663|NCT00080834|adenocarcinoma of the colon|adenocarcinoma of the colon
750664|NCT00080834|adenocarcinoma of the rectum|adenocarcinoma of the rectum
750665|NCT00080834|recurrent colon cancer|recurrent colon cancer
750666|NCT00080834|recurrent rectal cancer|recurrent rectal cancer
750667|NCT00080834|stage III colon cancer|stage iii colon cancer
750668|NCT00080834|stage IV colon cancer|stage iv colon cancer
750669|NCT00080834|stage III rectal cancer|stage iii rectal cancer
750670|NCT00080834|stage IV rectal cancer|stage iv rectal cancer
750671|NCT00080808|perioperative/postoperative complications|perioperative/postoperative complications
750672|NCT00080808|sexual dysfunction and infertility|sexual dysfunction and infertility
750673|NCT00080808|sexuality and reproductive issues|sexuality and reproductive issues
750674|NCT00080808|adenocarcinoma of the prostate|adenocarcinoma of the prostate
750675|NCT00080808|stage I prostate cancer|stage i prostate cancer
750676|NCT00080808|stage II prostate cancer|stage ii prostate cancer
750677|NCT00080808|prostaglandin E1|prostaglandin e1
750678|NCT00080808|papaverine|papaverine
750679|NCT00080808|phentolamine|phentolamine
750680|NCT00080808|Nerve-sparing radical prostatectomy|nerve-sparing radical prostatectomy
750681|NCT00080808|nerve grafting|nerve grafting
750682|NCT00080795|stage III bladder cancer|stage iii bladder cancer
750683|NCT00080795|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
750684|NCT00080795|anterior urethral cancer|anterior urethral cancer
750685|NCT00080795|posterior urethral cancer|posterior urethral cancer
750686|NCT00080795|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
750687|NCT00080782|recurrent prostate cancer|recurrent prostate cancer
750688|NCT00080782|stage IV prostate cancer|stage iv prostate cancer
750689|NCT00080782|bone metastases|bone metastases
750690|NCT00080782|Progressive Androgen-Independent Prostate Cancer|progressive androgen-independent prostate cancer
750691|NCT00080782|Metastron|metastron
750692|NCT00080782|Sr-89|sr-89
750693|NCT00080782|Strontium-89|strontium-89
750694|NCT00080782|strontium chloride Sr 89|strontium chloride sr 89
750695|NCT00080782|Celecoxib|celecoxib
750696|NCT00080782|Celebrex|celebrex
750697|NCT00080782|Doxorubicin|doxorubicin
750698|NCT00080782|Rubex|rubex
750699|NCT00080782|Adriamycin|adriamycin
750700|NCT00080756|breast cancer|breast cancer
750701|NCT00080756|BRCA1 mutation carrier|brca1 mutation carrier
750702|NCT00080756|BRCA2 mutation carrier|brca2 mutation carrier
750703|NCT00080743|recurrent breast cancer|recurrent breast cancer
750704|NCT00080743|stage IV breast cancer|stage iv breast cancer
750705|NCT00080678|adenocarcinoma of the prostate|adenocarcinoma of the prostate
750706|NCT00080678|recurrent prostate cancer|recurrent prostate cancer
750707|NCT00080678|stage IV prostate cancer|stage iv prostate cancer
750708|NCT00080678|bone metastases|bone metastases
750709|NCT00080665|male breast cancer|male breast cancer
750710|NCT00080665|stage IIIB breast cancer|stage iiib breast cancer
750711|NCT00080665|stage IIIC breast cancer|stage iiic breast cancer
750712|NCT00080665|stage IV breast cancer|stage iv breast cancer
750713|NCT00080665|recurrent breast cancer|recurrent breast cancer
750714|NCT00080639|ovarian epithelial cancer|ovarian epithelial cancer
750715|NCT00080626|stage I breast cancer|stage i breast cancer
750716|NCT00080626|stage II breast cancer|stage ii breast cancer
750717|NCT00080626|stage IIIA breast cancer|stage iiia breast cancer
780554|NCT00047957|Cortex|cortex
750718|NCT00080626|stage IIIB breast cancer|stage iiib breast cancer
750719|NCT00080626|stage IIIC breast cancer|stage iiic breast cancer
750720|NCT00080626|stage IV breast cancer|stage iv breast cancer
750721|NCT00080600|Post Polio Syndrome|post polio syndrome
750722|NCT00080600|Magnetic Stimulation|magnetic stimulation
750723|NCT00080600|Fatigue|fatigue
750724|NCT00080600|Exercise|exercise
750725|NCT00080600|Weakness|weakness
750726|NCT00080600|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
750727|NCT00080600|Post-Exercise Fatigue|post-exercise fatigue
750728|NCT00080600|Motor Neuron Disease|motor neuron disease
750729|NCT00080600|Cortical Reorganization|cortical reorganization
750730|NCT00080600|Intracortical Facilitation|intracortical facilitation
750731|NCT00080600|Polio|polio
750732|NCT00080600|Healthy Volunteer|healthy volunteer
750733|NCT00080600|HV|hv
750734|NCT00080587|Intravascular Ultrasound|intravascular ultrasound
750735|NCT00080587|Magnetic Resonance Imaging|magnetic resonance imaging
750736|NCT00080587|Hyperlipidemia|hyperlipidemia
750737|NCT00080587|Cholesterol|cholesterol
750738|NCT00080587|Coronary Artery Disease|coronary artery disease
750739|NCT00080574|Pharmacokinetics|pharmacokinetics
750740|NCT00080574|Drug Metabolism|drug metabolism
750741|NCT00080574|Levothyroxine|levothyroxine
750742|NCT00080574|Hypothyroidism|hypothyroidism
750743|NCT00080574|Hyperthyroidism|hyperthyroidism
750744|NCT00080574|Drug Interactions|drug interactions
750745|NCT00080574|Cytochrome P450|cytochrome p450
750746|NCT00080574|P-Glycoprotein|p-glycoprotein
750747|NCT00080574|Drug Transport Proteins|drug transport proteins
750748|NCT00080574|Thyroid Hormone|thyroid hormone
750749|NCT00080574|Thyroid Cancer|thyroid cancer
750750|NCT00080548|Bereitschafts Potential|bereitschafts potential
750751|NCT00080548|Timing of Volition|timing of volition
750752|NCT00080548|Somatic Passivity Phenomenon|somatic passivity phenomenon
750753|NCT00080548|Conscious Will|conscious will
750754|NCT00080548|Libet's Clock|libet's clock
750755|NCT00080548|Schizophrenia|schizophrenia
750756|NCT00080548|Healthy Volunteer|healthy volunteer
750757|NCT00080548|HV|hv
750758|NCT00080535|LMB-2|lmb-2
750759|NCT00080535|Cutaneous T Cell Lymphoma|cutaneous t cell lymphoma
750760|NCT00080535|CTCL|ctcl
750761|NCT00080535|Immunotoxin|immunotoxin
750762|NCT00080535|Oncology|oncology
750763|NCT00080522|Treatment Naive|treatment naive
750764|NCT00080522|Resource Poor Setting|resource poor setting
750765|NCT00080522|Drug Delivery|drug delivery
750766|NCT00080522|Household|household
750767|NCT00080522|South Africa|south africa
750768|NCT00080496|Pneumonia|pneumonia
750769|NCT00003176|recurrent adult brain tumor|recurrent adult brain tumor
750770|NCT00003176|adult glioblastoma|adult glioblastoma
750771|NCT00003176|adult anaplastic astrocytoma|adult anaplastic astrocytoma
750772|NCT00003176|adult mixed glioma|adult mixed glioma
750773|NCT00003176|adult giant cell glioblastoma|adult giant cell glioblastoma
750774|NCT00003176|adult gliosarcoma|adult gliosarcoma
750775|NCT00003156|recurrent uterine sarcoma|recurrent uterine sarcoma
750776|NCT00003156|uterine carcinosarcoma|uterine carcinosarcoma
750777|NCT00003132|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
750778|NCT00003110|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
750779|NCT00003110|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
750780|NCT00003110|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
750781|NCT00003110|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
750782|NCT00003110|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
750783|NCT00003110|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
750784|NCT00003110|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
750785|NCT00003110|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
750786|NCT00003110|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
750787|NCT00003110|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
750788|NCT00003110|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
750789|NCT00003110|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
750790|NCT00003110|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
750791|NCT00003110|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
750792|NCT00003110|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
750793|NCT00003110|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
750794|NCT00003110|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
750795|NCT00003110|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
750796|NCT00002997|stage IV colon cancer|stage iv colon cancer
750797|NCT00002997|stage IV rectal cancer|stage iv rectal cancer
750798|NCT00002997|recurrent colon cancer|recurrent colon cancer
750799|NCT00002997|recurrent rectal cancer|recurrent rectal cancer
750800|NCT00002997|adenocarcinoma of the colon|adenocarcinoma of the colon
750801|NCT00002997|adenocarcinoma of the rectum|adenocarcinoma of the rectum
750802|NCT00002997|liver metastases|liver metastases
750803|NCT00024063|stage III colon cancer|stage iii colon cancer
750804|NCT00024063|stage IV colon cancer|stage iv colon cancer
750805|NCT00024063|stage IV breast cancer|stage iv breast cancer
750806|NCT00024063|stage IIIA breast cancer|stage iiia breast cancer
750807|NCT00024063|recurrent breast cancer|recurrent breast cancer
750808|NCT00024063|stage III gastric cancer|stage iii gastric cancer
750809|NCT00024063|stage IV gastric cancer|stage iv gastric cancer
750810|NCT00024063|recurrent gastric cancer|recurrent gastric cancer
750811|NCT00024063|stage IIIB breast cancer|stage iiib breast cancer
750812|NCT00024063|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
750813|NCT00024063|stage II pancreatic cancer|stage ii pancreatic cancer
750814|NCT00024063|stage III pancreatic cancer|stage iii pancreatic cancer
750815|NCT00024063|recurrent pancreatic cancer|recurrent pancreatic cancer
750816|NCT00024063|stage III rectal cancer|stage iii rectal cancer
750817|NCT00024063|stage IV rectal cancer|stage iv rectal cancer
750818|NCT00024063|recurrent colon cancer|recurrent colon cancer
750819|NCT00024063|recurrent rectal cancer|recurrent rectal cancer
750820|NCT00024063|refractory multiple myeloma|refractory multiple myeloma
750821|NCT00024063|stage III renal cell cancer|stage iii renal cell cancer
750822|NCT00024063|stage IV renal cell cancer|stage iv renal cell cancer
750823|NCT00024063|recurrent renal cell cancer|recurrent renal cell cancer
751900|NCT00080119|Treatment Naive|treatment naive
750824|NCT00024063|stage III multiple myeloma|stage iii multiple myeloma
750825|NCT00024063|stage III prostate cancer|stage iii prostate cancer
750826|NCT00024063|stage IV prostate cancer|stage iv prostate cancer
750827|NCT00024063|recurrent prostate cancer|recurrent prostate cancer
750828|NCT00024063|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
750829|NCT00024063|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
750830|NCT00024063|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
750831|NCT00024063|male breast cancer|male breast cancer
750832|NCT00024063|stage IV pancreatic cancer|stage iv pancreatic cancer
750833|NCT00003107|stage IV breast cancer|stage iv breast cancer
750834|NCT00003107|stage IIIA breast cancer|stage iiia breast cancer
750835|NCT00003107|stage IIIB breast cancer|stage iiib breast cancer
750836|NCT00003107|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
750837|NCT00003107|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
750838|NCT00003107|refractory multiple myeloma|refractory multiple myeloma
750839|NCT00003107|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
750840|NCT00003107|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
750841|NCT00003107|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
750842|NCT00003107|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
750843|NCT00003107|disseminated neuroblastoma|disseminated neuroblastoma
750844|NCT00003107|recurrent neuroblastoma|recurrent neuroblastoma
750845|NCT00003107|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
750846|NCT00003107|stage I multiple myeloma|stage i multiple myeloma
750847|NCT00003107|stage II multiple myeloma|stage ii multiple myeloma
750848|NCT00003107|stage III multiple myeloma|stage iii multiple myeloma
750849|NCT00003107|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
750850|NCT00003107|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
750851|NCT00003107|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
750852|NCT00003107|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
750853|NCT00003107|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
750854|NCT00003107|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
750855|NCT00003107|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
750856|NCT00003107|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
750857|NCT00003107|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
750858|NCT00003107|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
750859|NCT00003107|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
750860|NCT00003107|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
750861|NCT00003107|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
750862|NCT00003107|testicular embryonal carcinoma|testicular embryonal carcinoma
750863|NCT00003107|testicular choriocarcinoma|testicular choriocarcinoma
750864|NCT00003107|testicular teratoma|testicular teratoma
750865|NCT00003107|testicular yolk sac tumor|testicular yolk sac tumor
750866|NCT00003107|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
750867|NCT00003107|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
750868|NCT00003107|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
750869|NCT00003107|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
750870|NCT00003107|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
750871|NCT00003107|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
750872|NCT00003107|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
750873|NCT00003107|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
750874|NCT00003107|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
750875|NCT00003107|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
750876|NCT00003107|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
750877|NCT00003107|refractory hairy cell leukemia|refractory hairy cell leukemia
750878|NCT00003107|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
750879|NCT00003107|ovarian yolk sac tumor|ovarian yolk sac tumor
750880|NCT00003107|ovarian embryonal carcinoma|ovarian embryonal carcinoma
750881|NCT00003107|ovarian polyembryoma|ovarian polyembryoma
750882|NCT00003107|ovarian choriocarcinoma|ovarian choriocarcinoma
750883|NCT00003107|ovarian immature teratoma|ovarian immature teratoma
750884|NCT00003107|ovarian mature teratoma|ovarian mature teratoma
750885|NCT00003107|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
750886|NCT00003107|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
750887|NCT00003107|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
750888|NCT00003107|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
750889|NCT00003107|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
750890|NCT00003107|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
750891|NCT00003107|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
750892|NCT00003107|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
750893|NCT00003107|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
750894|NCT00003107|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
750895|NCT00003107|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
750896|NCT00003107|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
750897|NCT00003107|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
750898|NCT00003107|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
750899|NCT00003107|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
750900|NCT00003107|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
750901|NCT00003107|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
750902|NCT00003107|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
750903|NCT00003107|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
750904|NCT00003107|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
750905|NCT00003107|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
750906|NCT00003107|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
750907|NCT00003107|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
750908|NCT00003107|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
750909|NCT00003107|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
750910|NCT00003107|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
750911|NCT00003107|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
750912|NCT00003107|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
750913|NCT00003107|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
750914|NCT00003107|secondary acute myeloid leukemia|secondary acute myeloid leukemia
750915|NCT00003107|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
750916|NCT00003107|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
750917|NCT00003107|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
750918|NCT00003107|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
751901|NCT00080119|INH Prophylaxis|inh prophylaxis
750919|NCT00003107|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
750920|NCT00003107|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
750921|NCT00003107|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
750922|NCT00003107|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
750923|NCT00003107|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
750924|NCT00003107|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
750925|NCT00003107|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
750926|NCT00003107|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
750927|NCT00003107|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
750928|NCT00003107|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
750929|NCT00003107|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
750930|NCT00003107|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
750931|NCT00003107|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
750932|NCT00003107|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
750933|NCT00003107|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
750934|NCT00003107|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
750935|NCT00003107|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
750936|NCT00003107|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
751136|NCT00020540|stage IV renal cell cancer|stage iv renal cell cancer
750937|NCT00003107|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
750938|NCT00003107|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
750939|NCT00003107|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
750940|NCT00003107|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
750941|NCT00003107|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
750942|NCT00003107|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
750943|NCT00003107|splenic marginal zone lymphoma|splenic marginal zone lymphoma
750944|NCT00003103|stage III colon cancer|stage iii colon cancer
750945|NCT00003103|stage IV colon cancer|stage iv colon cancer
750946|NCT00003103|stage IV breast cancer|stage iv breast cancer
750947|NCT00003103|stage IIIA breast cancer|stage iiia breast cancer
750948|NCT00003103|recurrent breast cancer|recurrent breast cancer
750949|NCT00003103|stage IIIB breast cancer|stage iiib breast cancer
750950|NCT00003103|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
750951|NCT00003103|stage III rectal cancer|stage iii rectal cancer
750952|NCT00003103|stage IV rectal cancer|stage iv rectal cancer
750953|NCT00003103|recurrent colon cancer|recurrent colon cancer
750954|NCT00003103|recurrent rectal cancer|recurrent rectal cancer
750955|NCT00003103|stage II esophageal cancer|stage ii esophageal cancer
750956|NCT00003103|stage III esophageal cancer|stage iii esophageal cancer
750957|NCT00003103|stage IV esophageal cancer|stage iv esophageal cancer
750958|NCT00003103|recurrent esophageal cancer|recurrent esophageal cancer
750959|NCT00003103|stage III renal cell cancer|stage iii renal cell cancer
750960|NCT00003103|stage IV renal cell cancer|stage iv renal cell cancer
750961|NCT00003103|recurrent renal cell cancer|recurrent renal cell cancer
750962|NCT00003103|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
750963|NCT00003103|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
750964|NCT00003103|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
750965|NCT00003103|stage III Wilms tumor|stage iii wilms tumor
750966|NCT00003103|stage IV Wilms tumor|stage iv wilms tumor
750967|NCT00003103|stage V Wilms tumor|stage v wilms tumor
750968|NCT00003103|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
750969|NCT00003103|stage III bladder cancer|stage iii bladder cancer
750970|NCT00003103|recurrent bladder cancer|recurrent bladder cancer
750971|NCT00003103|stage IV bladder cancer|stage iv bladder cancer
750972|NCT00003103|stage III prostate cancer|stage iii prostate cancer
750973|NCT00003103|stage IV prostate cancer|stage iv prostate cancer
750974|NCT00003103|recurrent prostate cancer|recurrent prostate cancer
750975|NCT00003103|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
750976|NCT00003103|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
750977|NCT00003103|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
750978|NCT00003103|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
750979|NCT00003103|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
750980|NCT00003103|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
750981|NCT00003103|ovarian stromal cancer|ovarian stromal cancer
750982|NCT00003103|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
750983|NCT00003103|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
750984|NCT00003103|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
750985|NCT00003103|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
750986|NCT00003103|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
750987|NCT00003103|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
750988|NCT00003103|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
750989|NCT00003103|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
750990|NCT00003103|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
750991|NCT00003103|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
750992|NCT00003103|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
750993|NCT00003103|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
750994|NCT00003103|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
750995|NCT00003103|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
750996|NCT00003103|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
750997|NCT00003103|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
750998|NCT00003103|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
750999|NCT00003103|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
751000|NCT00003103|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
751001|NCT00003103|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
751002|NCT00003103|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
751003|NCT00003103|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
751004|NCT00003103|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
751005|NCT00003103|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
751006|NCT00003103|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
751007|NCT00003103|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
751008|NCT00003103|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
751009|NCT00003103|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
751010|NCT00003103|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
751011|NCT00003103|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
751012|NCT00003103|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
751013|NCT00003103|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
751014|NCT00003103|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
751015|NCT00003103|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
751016|NCT00003103|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
751017|NCT00003103|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
751018|NCT00003103|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
751019|NCT00003103|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
751020|NCT00003103|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
751021|NCT00003103|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
751022|NCT00003103|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
751023|NCT00003103|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
751024|NCT00003103|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
751025|NCT00003103|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
751026|NCT00003103|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
751027|NCT00003103|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
751028|NCT00003103|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
751029|NCT00003103|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
751030|NCT00003103|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
751031|NCT00003103|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
751032|NCT00003103|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
751033|NCT00003103|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
751034|NCT00003103|ovarian sarcoma|ovarian sarcoma
751035|NCT00003103|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
751036|NCT00003103|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
751037|NCT00003012|stage II breast cancer|stage ii breast cancer
751038|NCT00003012|stage IIIA breast cancer|stage iiia breast cancer
751039|NCT00002987|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
751040|NCT00002987|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
751041|NCT00002814|recurrent adult brain tumor|recurrent adult brain tumor
751042|NCT00002814|adult glioblastoma|adult glioblastoma
751043|NCT00002814|adult anaplastic astrocytoma|adult anaplastic astrocytoma
751044|NCT00002814|adult giant cell glioblastoma|adult giant cell glioblastoma
751045|NCT00002814|adult gliosarcoma|adult gliosarcoma
751046|NCT00002774|stage III|stage iii
751047|NCT00002774|stage IV|stage iv
751048|NCT00002774|recurrent|recurrent
751049|NCT00002714|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
751050|NCT00002714|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
751051|NCT00002600|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
751052|NCT00002600|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
751053|NCT00002600|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
751054|NCT00002600|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
751055|NCT00002600|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
751056|NCT00002600|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
751057|NCT00002600|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
751058|NCT00002600|fallopian tube cancer|fallopian tube cancer
751059|NCT00002600|primary peritoneal cavity cancer|primary peritoneal cavity cancer
751060|NCT00002525|stage II colon cancer|stage ii colon cancer
751061|NCT00002525|stage III colon cancer|stage iii colon cancer
751062|NCT00002494|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
751063|NCT00002494|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
751064|NCT00002494|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
780874|NCT00046085|Family|family
751065|NCT00002494|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
751066|NCT00002494|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
751067|NCT00002494|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
751068|NCT00002494|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
751069|NCT00002494|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
751070|NCT00080470|Incontinence|incontinence
751071|NCT00080470|Refractory|refractory
751072|NCT00080470|Urinary|urinary
751073|NCT00080470|Urge|urge
751074|NCT00080470|Stimulation|stimulation
751075|NCT00080470|Nerve|nerve
751076|NCT00080470|Microstimulator|microstimulator
751077|NCT00080470|Neuromodulation|neuromodulation
751078|NCT00080457|Primary or secondary pulmonary arterial hypertension|primary or secondary pulmonary arterial hypertension
751079|NCT00080457|Scleroderma|scleroderma
751080|NCT00080457|Connective tissue disease|connective tissue disease
751081|NCT00080457|Congenital heart defects|congenital heart defects
751082|NCT00080457|Lupus|lupus
751083|NCT00080457|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
751084|NCT00023816|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
751085|NCT00023816|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
751086|NCT00023816|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
751087|NCT00023816|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
751088|NCT00023816|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
751089|NCT00023816|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
751090|NCT00023816|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
751091|NCT00023816|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
751092|NCT00023816|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
751093|NCT00023816|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
751094|NCT00023816|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
751095|NCT00023816|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
751096|NCT00023816|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
751097|NCT00023816|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
751098|NCT00023816|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
751099|NCT00023816|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
751100|NCT00023816|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
751101|NCT00023816|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
751102|NCT00023816|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
751103|NCT00023816|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
751104|NCT00023816|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
751105|NCT00023816|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
751106|NCT00023816|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
751902|NCT00080119|HIV Seronegativity|hiv seronegativity
751107|NCT00023816|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
751108|NCT00023816|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
751109|NCT00023816|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
751110|NCT00023816|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
751111|NCT00023816|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
751112|NCT00023816|intraocular lymphoma|intraocular lymphoma
751113|NCT00023816|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
751114|NCT00023816|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
751115|NCT00023816|anaplastic large cell lymphoma|anaplastic large cell lymphoma
751116|NCT00023816|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
751117|NCT00023816|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
751118|NCT00023816|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
751119|NCT00023816|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
751120|NCT00023816|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
751121|NCT00023816|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
751122|NCT00023816|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
751123|NCT00023816|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
751124|NCT00023816|splenic marginal zone lymphoma|splenic marginal zone lymphoma
751125|NCT00022386|stage I breast cancer|stage i breast cancer
751126|NCT00022386|stage II breast cancer|stage ii breast cancer
751127|NCT00022386|stage IIIA breast cancer|stage iiia breast cancer
751128|NCT00022386|stage IIIB breast cancer|stage iiib breast cancer
751129|NCT00022386|anemia|anemia
751130|NCT00022386|fatigue|fatigue
751131|NCT00022256|adult glioblastoma|adult glioblastoma
751132|NCT00022256|adult giant cell glioblastoma|adult giant cell glioblastoma
751133|NCT00022256|adult gliosarcoma|adult gliosarcoma
751134|NCT00020605|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
751135|NCT00020605|constipation, impaction, and bowel obstruction|constipation, impaction, and bowel obstruction
751137|NCT00020540|recurrent renal cell cancer|recurrent renal cell cancer
751138|NCT00020540|stage IV melanoma|stage iv melanoma
751139|NCT00020540|recurrent melanoma|recurrent melanoma
751140|NCT00019071|adult glioblastoma|adult glioblastoma
751141|NCT00019071|adult anaplastic astrocytoma|adult anaplastic astrocytoma
751142|NCT00019071|adult giant cell glioblastoma|adult giant cell glioblastoma
751143|NCT00019071|adult gliosarcoma|adult gliosarcoma
751144|NCT00019058|adult glioblastoma|adult glioblastoma
751145|NCT00019058|adult giant cell glioblastoma|adult giant cell glioblastoma
751146|NCT00019058|adult gliosarcoma|adult gliosarcoma
751147|NCT00016042|stage IV colon cancer|stage iv colon cancer
751148|NCT00016042|stage IV rectal cancer|stage iv rectal cancer
751149|NCT00016042|recurrent colon cancer|recurrent colon cancer
751150|NCT00016042|recurrent rectal cancer|recurrent rectal cancer
751151|NCT00016042|stage IV renal cell cancer|stage iv renal cell cancer
751152|NCT00016042|recurrent renal cell cancer|recurrent renal cell cancer
751153|NCT00014573|childhood infratentorial ependymoma|childhood infratentorial ependymoma
751154|NCT00014573|childhood supratentorial ependymoma|childhood supratentorial ependymoma
751155|NCT00014573|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
751156|NCT00014573|recurrent adult brain tumor|recurrent adult brain tumor
751157|NCT00014573|adult brain stem glioma|adult brain stem glioma
751158|NCT00014573|adult medulloblastoma|adult medulloblastoma
751159|NCT00014573|adult glioblastoma|adult glioblastoma
751160|NCT00014573|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
751161|NCT00014573|adult anaplastic astrocytoma|adult anaplastic astrocytoma
751162|NCT00014573|childhood choroid plexus tumor|childhood choroid plexus tumor
751163|NCT00014573|childhood grade III meningioma|childhood grade iii meningioma
751164|NCT00014573|adult anaplastic ependymoma|adult anaplastic ependymoma
751165|NCT00014573|adult mixed glioma|adult mixed glioma
751166|NCT00014573|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
751167|NCT00014573|adult ependymoblastoma|adult ependymoblastoma
751168|NCT00014573|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
751169|NCT00014573|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
751170|NCT00014573|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
751171|NCT00014573|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
751172|NCT00014573|adult choroid plexus tumor|adult choroid plexus tumor
751173|NCT00014573|recurrent childhood ependymoma|recurrent childhood ependymoma
751174|NCT00014573|adult grade III meningioma|adult grade iii meningioma
751175|NCT00014573|adult giant cell glioblastoma|adult giant cell glioblastoma
751176|NCT00014573|adult gliosarcoma|adult gliosarcoma
751177|NCT00080418|neoplasm|neoplasm
751178|NCT00080418|cancer|cancer
751179|NCT00080418|NeoPharm|neopharm
751180|NCT00080418|liposomes|liposomes
751181|NCT00080418|Taxol|taxol
751182|NCT00080418|paclitaxel|paclitaxel
751183|NCT00080418|anti-cancer|anti-cancer
751184|NCT00080418|advanced neoplasm|advanced neoplasm
751185|NCT00080418|advanced cancer|advanced cancer
751186|NCT00080418|chemotherapy|chemotherapy
751187|NCT00080418|refractory cancer|refractory cancer
751188|NCT00080418|metastatic cancer|metastatic cancer
751189|NCT00080405|Relapsed|relapsed
751190|NCT00080405|Multiple Myeloma|multiple myeloma
751191|NCT00080405|Pharmacokinetic|pharmacokinetic
751192|NCT00080405|Pharmacodynamic|pharmacodynamic
751193|NCT00009841|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
751194|NCT00009841|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
751195|NCT00009841|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
751196|NCT00009841|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
751197|NCT00009841|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
751198|NCT00009841|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
751199|NCT00009841|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
751200|NCT00009841|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
751201|NCT00009841|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
751202|NCT00009841|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
751203|NCT00009841|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
751204|NCT00009841|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
751205|NCT00009841|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
751206|NCT00009841|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
751207|NCT00009841|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
751208|NCT00007813|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
751209|NCT00007813|childhood craniopharyngioma|childhood craniopharyngioma
751210|NCT00007813|recurrent childhood brain tumor|recurrent childhood brain tumor
751211|NCT00007813|disseminated neuroblastoma|disseminated neuroblastoma
751212|NCT00007813|stage 4S neuroblastoma|stage 4s neuroblastoma
751213|NCT00007813|recurrent neuroblastoma|recurrent neuroblastoma
751214|NCT00007813|stage IV childhood liver cancer|stage iv childhood liver cancer
751215|NCT00007813|recurrent childhood liver cancer|recurrent childhood liver cancer
751216|NCT00007813|childhood hepatoblastoma|childhood hepatoblastoma
751217|NCT00007813|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
751218|NCT00007813|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
751219|NCT00007813|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
751220|NCT00007813|childhood germ cell tumor|childhood germ cell tumor
751221|NCT00007813|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
751222|NCT00007813|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
751223|NCT00007813|extragonadal germ cell tumor|extragonadal germ cell tumor
751224|NCT00007813|childhood oligodendroglioma|childhood oligodendroglioma
751225|NCT00007813|childhood choroid plexus tumor|childhood choroid plexus tumor
751226|NCT00007813|childhood grade III meningioma|childhood grade iii meningioma
751227|NCT00007813|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
751228|NCT00007813|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
751229|NCT00007813|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
751230|NCT00007813|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
751231|NCT00007813|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
751232|NCT00007813|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
751233|NCT00007813|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
751234|NCT00007813|recurrent childhood ependymoma|recurrent childhood ependymoma
751235|NCT00007813|childhood teratoma|childhood teratoma
751236|NCT00007813|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
751237|NCT00007813|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
751238|NCT00007813|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
751239|NCT00007813|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
751240|NCT00007813|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
751241|NCT00006487|limited stage small cell lung cancer|limited stage small cell lung cancer
751242|NCT00006458|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
751243|NCT00006458|squamous cell lung cancer|squamous cell lung cancer
751244|NCT00006458|large cell lung cancer|large cell lung cancer
751245|NCT00006458|adenocarcinoma of the lung|adenocarcinoma of the lung
751246|NCT00006458|adenosquamous cell lung cancer|adenosquamous cell lung cancer
751247|NCT00006376|stage II bladder cancer|stage ii bladder cancer
751248|NCT00006376|stage III bladder cancer|stage iii bladder cancer
751249|NCT00006376|recurrent bladder cancer|recurrent bladder cancer
751250|NCT00006376|stage IV bladder cancer|stage iv bladder cancer
751251|NCT00006376|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
751252|NCT00006376|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
751253|NCT00006376|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
751254|NCT00006376|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
751255|NCT00006371|adenocarcinoma of the prostate|adenocarcinoma of the prostate
751256|NCT00006371|stage IV prostate cancer|stage iv prostate cancer
751257|NCT00006371|recurrent prostate cancer|recurrent prostate cancer
751258|NCT00006370|stage IV breast cancer|stage iv breast cancer
751259|NCT00006370|recurrent breast cancer|recurrent breast cancer
751260|NCT00006370|recurrent small cell lung cancer|recurrent small cell lung cancer
751261|NCT00006370|male breast cancer|male breast cancer
751262|NCT00006369|stage IV breast cancer|stage iv breast cancer
751263|NCT00006369|recurrent breast cancer|recurrent breast cancer
751264|NCT00006368|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
751265|NCT00006368|stage IV breast cancer|stage iv breast cancer
751266|NCT00006368|recurrent breast cancer|recurrent breast cancer
751267|NCT00006368|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
751268|NCT00006368|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
751269|NCT00006368|extensive stage small cell lung cancer|extensive stage small cell lung cancer
751270|NCT00006368|recurrent small cell lung cancer|recurrent small cell lung cancer
751271|NCT00006368|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
751272|NCT00006368|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
751273|NCT00006368|gastrinoma|gastrinoma
751274|NCT00006368|recurrent adult brain tumor|recurrent adult brain tumor
751275|NCT00006368|insulinoma|insulinoma
751276|NCT00006368|recurrent islet cell carcinoma|recurrent islet cell carcinoma
751277|NCT00006368|ACTH-producing pituitary tumor|acth-producing pituitary tumor
751278|NCT00006368|prolactin-producing pituitary tumor|prolactin-producing pituitary tumor
751279|NCT00006368|growth hormone-producing pituitary tumor|growth hormone-producing pituitary tumor
751280|NCT00006368|recurrent pituitary tumor|recurrent pituitary tumor
751281|NCT00006368|TSH producing pituitary tumor|tsh producing pituitary tumor
751282|NCT00006368|nonfunctioning pituitary tumor|nonfunctioning pituitary tumor
751283|NCT00006368|adult brain stem glioma|adult brain stem glioma
751284|NCT00006368|adult craniopharyngioma|adult craniopharyngioma
751285|NCT00006368|adult medulloblastoma|adult medulloblastoma
751286|NCT00006368|adult meningioma|adult meningioma
751287|NCT00006368|adult glioblastoma|adult glioblastoma
751288|NCT00006368|stage IV melanoma|stage iv melanoma
751289|NCT00006368|recurrent melanoma|recurrent melanoma
751290|NCT00006368|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
751291|NCT00006368|WDHA syndrome|wdha syndrome
751292|NCT00006368|somatostatinoma|somatostatinoma
751293|NCT00006368|pancreatic polypeptide tumor|pancreatic polypeptide tumor
751294|NCT00006368|glucagonoma|glucagonoma
751295|NCT00006368|pulmonary carcinoid tumor|pulmonary carcinoid tumor
751296|NCT00006368|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
751297|NCT00006368|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
751298|NCT00006368|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
751299|NCT00006368|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
751300|NCT00006368|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
751301|NCT00006368|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
751302|NCT00006368|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
751303|NCT00006368|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
751304|NCT00006368|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
751305|NCT00006368|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
751306|NCT00006368|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
751307|NCT00006368|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
751308|NCT00006368|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
751903|NCT00080106|HIV Therapeutic Vaccine|hiv therapeutic vaccine
751309|NCT00006368|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
751310|NCT00006368|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
751311|NCT00006368|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
751312|NCT00006368|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
751313|NCT00006368|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
751314|NCT00006368|adult anaplastic astrocytoma|adult anaplastic astrocytoma
751315|NCT00006368|adult myxopapillary ependymoma|adult myxopapillary ependymoma
751316|NCT00006368|adult anaplastic ependymoma|adult anaplastic ependymoma
751317|NCT00006368|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
751318|NCT00006368|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
751319|NCT00006368|adult pilocytic astrocytoma|adult pilocytic astrocytoma
751320|NCT00006368|adult subependymoma|adult subependymoma
751321|NCT00006368|adult ependymoblastoma|adult ependymoblastoma
751322|NCT00006368|adult pineocytoma|adult pineocytoma
751323|NCT00006368|adult pineoblastoma|adult pineoblastoma
751324|NCT00006368|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
751325|NCT00006368|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
751326|NCT00006368|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
751327|NCT00006368|adult choroid plexus tumor|adult choroid plexus tumor
751328|NCT00006368|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
751329|NCT00006368|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
751330|NCT00006368|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
751331|NCT00006368|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
751332|NCT00006368|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
751333|NCT00006368|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
751334|NCT00006368|splenic marginal zone lymphoma|splenic marginal zone lymphoma
751335|NCT00006368|adult grade III meningioma|adult grade iii meningioma
751336|NCT00006368|adult giant cell glioblastoma|adult giant cell glioblastoma
751337|NCT00006368|adult gliosarcoma|adult gliosarcoma
751338|NCT00006052|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
751339|NCT00006052|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
751340|NCT00006052|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
751341|NCT00006043|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
751342|NCT00006043|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
751343|NCT00006043|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
751344|NCT00006043|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
751345|NCT00006032|stage IV breast cancer|stage iv breast cancer
751346|NCT00006032|recurrent breast cancer|recurrent breast cancer
751347|NCT00006031|biopsy|biopsy
751348|NCT00006031|radioactive seed|radioactive seed
751349|NCT00006031|nonpalpable lesions|nonpalpable lesions
751350|NCT00005948|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
751351|NCT00005948|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
751768|NCT00012142|stage IV prostate cancer|stage iv prostate cancer
751352|NCT00005948|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
751353|NCT00005860|stage IV colon cancer|stage iv colon cancer
751354|NCT00005860|stage IV gastric cancer|stage iv gastric cancer
751355|NCT00005860|recurrent gastric cancer|recurrent gastric cancer
751356|NCT00005860|recurrent pancreatic cancer|recurrent pancreatic cancer
751357|NCT00005860|recurrent colon cancer|recurrent colon cancer
751358|NCT00005860|regional neuroblastoma|regional neuroblastoma
751359|NCT00005860|stage 4S neuroblastoma|stage 4s neuroblastoma
751360|NCT00005860|recurrent neuroblastoma|recurrent neuroblastoma
751361|NCT00005860|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
751362|NCT00005860|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
751363|NCT00005860|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
751364|NCT00005860|advanced adult primary liver cancer|advanced adult primary liver cancer
751365|NCT00005860|recurrent adult primary liver cancer|recurrent adult primary liver cancer
751366|NCT00005860|gastrinoma|gastrinoma
751367|NCT00005860|small intestine adenocarcinoma|small intestine adenocarcinoma
751368|NCT00005860|small intestine lymphoma|small intestine lymphoma
751369|NCT00005860|small intestine leiomyosarcoma|small intestine leiomyosarcoma
751370|NCT00005860|unresectable gallbladder cancer|unresectable gallbladder cancer
751371|NCT00005860|recurrent gallbladder cancer|recurrent gallbladder cancer
751372|NCT00005860|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
751373|NCT00005860|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
751374|NCT00005860|recurrent small intestine cancer|recurrent small intestine cancer
751375|NCT00005860|insulinoma|insulinoma
751376|NCT00005860|recurrent islet cell carcinoma|recurrent islet cell carcinoma
751377|NCT00005860|WDHA syndrome|wdha syndrome
751378|NCT00005860|somatostatinoma|somatostatinoma
751379|NCT00005860|pancreatic polypeptide tumor|pancreatic polypeptide tumor
751380|NCT00005860|glucagonoma|glucagonoma
751381|NCT00005860|regional pheochromocytoma|regional pheochromocytoma
751382|NCT00005860|metastatic pheochromocytoma|metastatic pheochromocytoma
751383|NCT00005860|recurrent pheochromocytoma|recurrent pheochromocytoma
751384|NCT00005860|extragonadal germ cell tumor|extragonadal germ cell tumor
751385|NCT00005860|liver metastases|liver metastases
751386|NCT00005860|malignant ascites|malignant ascites
751387|NCT00005860|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
751388|NCT00005860|carcinoma of the appendix|carcinoma of the appendix
751389|NCT00005860|pseudomyxoma peritonei|pseudomyxoma peritonei
751390|NCT00005860|fallopian tube cancer|fallopian tube cancer
751391|NCT00005860|primary peritoneal cavity cancer|primary peritoneal cavity cancer
751392|NCT00005860|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
751393|NCT00005860|gastrointestinal stromal tumor|gastrointestinal stromal tumor
751394|NCT00005860|stage IV pancreatic cancer|stage iv pancreatic cancer
751395|NCT00005798|stage II breast cancer|stage ii breast cancer
751396|NCT00005798|stage IV breast cancer|stage iv breast cancer
751397|NCT00005798|stage IIIA breast cancer|stage iiia breast cancer
751398|NCT00005798|recurrent breast cancer|recurrent breast cancer
751399|NCT00005798|stage IIIB breast cancer|stage iiib breast cancer
751400|NCT00005798|inflammatory breast cancer|inflammatory breast cancer
751401|NCT00005628|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
751402|NCT00005628|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
751403|NCT00005618|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
751404|NCT00005618|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
751405|NCT00005618|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
751406|NCT00005618|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
751407|NCT00005615|stage III melanoma|stage iii melanoma
751408|NCT00005615|recurrent melanoma|recurrent melanoma
751409|NCT00005577|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
751410|NCT00005097|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
751411|NCT00005068|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
751412|NCT00003864|stage III esophageal cancer|stage iii esophageal cancer
751413|NCT00003864|stage IV esophageal cancer|stage iv esophageal cancer
751414|NCT00003864|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
751415|NCT00080431|Reservoir|reservoir
751416|NCT00080431|Viral Load|viral load
751417|NCT00080431|Immunosuppression|immunosuppression
751418|NCT00080431|Activation|activation
751419|NCT00080431|Latency|latency
751420|NCT00080431|HIV|hiv
751421|NCT00080431|HAART|haart
751422|NCT00080431|Immunosuppressive Drug|immunosuppressive drug
751423|NCT00080431|Viral Reservoirs|viral reservoirs
751424|NCT00005031|recurrent endometrial carcinoma|recurrent endometrial carcinoma
751425|NCT00004248|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
751426|NCT00004248|recurrent adult primary liver cancer|recurrent adult primary liver cancer
751427|NCT00004248|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
751428|NCT00004097|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
751429|NCT00004097|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
752528|NCT00005635|recurrent breast cancer|recurrent breast cancer
751430|NCT00004097|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
751431|NCT00004097|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
751432|NCT00004097|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
751433|NCT00004097|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
751434|NCT00004097|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
751435|NCT00004097|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
751436|NCT00004097|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
751437|NCT00004097|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
751438|NCT00004097|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
751439|NCT00004097|stage III laryngeal cancer|stage iii laryngeal cancer
751440|NCT00004097|stage IV laryngeal cancer|stage iv laryngeal cancer
751441|NCT00004097|recurrent laryngeal cancer|recurrent laryngeal cancer
751442|NCT00004097|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
751443|NCT00004097|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
751444|NCT00004097|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
751445|NCT00004097|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
751446|NCT00004097|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
751447|NCT00004097|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
751448|NCT00003967|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
751449|NCT00003967|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
751450|NCT00003967|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
751451|NCT00003967|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
751452|NCT00003967|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
751453|NCT00003967|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
751454|NCT00003967|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
751455|NCT00003967|fallopian tube cancer|fallopian tube cancer
751456|NCT00003967|primary peritoneal cavity cancer|primary peritoneal cavity cancer
751457|NCT00003967|Brenner tumor|brenner tumor
751458|NCT00003883|stage IV breast cancer|stage iv breast cancer
751459|NCT00003883|stage IIIA breast cancer|stage iiia breast cancer
751460|NCT00003883|stage IIIB breast cancer|stage iiib breast cancer
751461|NCT00003883|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
751462|NCT00003883|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
751463|NCT00003883|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
751464|NCT00003883|refractory multiple myeloma|refractory multiple myeloma
751465|NCT00003883|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
751466|NCT00003883|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
751467|NCT00003883|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
751468|NCT00003883|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
751469|NCT00003883|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
751470|NCT00003883|disseminated neuroblastoma|disseminated neuroblastoma
751471|NCT00003883|recurrent neuroblastoma|recurrent neuroblastoma
751472|NCT00003883|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
751473|NCT00003883|stage I multiple myeloma|stage i multiple myeloma
751474|NCT00003883|stage II multiple myeloma|stage ii multiple myeloma
751475|NCT00003883|stage III multiple myeloma|stage iii multiple myeloma
751476|NCT00003883|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
751477|NCT00003883|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
751478|NCT00003883|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
751479|NCT00003883|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
751480|NCT00003883|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
751481|NCT00003883|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
751482|NCT00003883|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
751483|NCT00003883|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
751484|NCT00003883|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
751485|NCT00003883|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
751486|NCT00003883|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
751487|NCT00003883|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
751488|NCT00003883|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
751489|NCT00003883|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
751490|NCT00003883|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
751491|NCT00003883|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
751492|NCT00003883|testicular embryonal carcinoma|testicular embryonal carcinoma
751493|NCT00003883|testicular choriocarcinoma|testicular choriocarcinoma
751494|NCT00003883|testicular teratoma|testicular teratoma
751495|NCT00003883|testicular yolk sac tumor|testicular yolk sac tumor
751496|NCT00003883|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
751497|NCT00003883|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
751498|NCT00003883|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
751499|NCT00003883|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
751500|NCT00003883|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
751501|NCT00003883|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
751502|NCT00003883|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
751503|NCT00003883|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
751504|NCT00003883|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
751505|NCT00003883|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
751506|NCT00003883|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
751507|NCT00003883|refractory hairy cell leukemia|refractory hairy cell leukemia
751508|NCT00003883|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
751509|NCT00003883|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
751510|NCT00003883|ovarian yolk sac tumor|ovarian yolk sac tumor
751511|NCT00003883|ovarian embryonal carcinoma|ovarian embryonal carcinoma
751512|NCT00003883|ovarian polyembryoma|ovarian polyembryoma
751513|NCT00003883|ovarian choriocarcinoma|ovarian choriocarcinoma
751514|NCT00003883|ovarian immature teratoma|ovarian immature teratoma
751515|NCT00003883|ovarian mature teratoma|ovarian mature teratoma
751516|NCT00003883|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
751517|NCT00003883|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
751518|NCT00003883|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
751519|NCT00003883|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
751520|NCT00003883|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
751521|NCT00003883|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
751522|NCT00003883|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
751523|NCT00003883|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
751524|NCT00003883|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
751525|NCT00003883|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
751526|NCT00003883|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
751527|NCT00003883|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
751528|NCT00003883|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
751529|NCT00003883|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
751530|NCT00003883|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
751531|NCT00003883|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
751532|NCT00003883|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
751533|NCT00003883|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
751534|NCT00003883|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
751535|NCT00003883|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
751536|NCT00003883|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
751537|NCT00003883|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
751538|NCT00003883|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
751539|NCT00003883|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
751540|NCT00003883|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
751541|NCT00003883|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
751542|NCT00003883|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
751543|NCT00003883|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
751544|NCT00003883|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
751545|NCT00003883|secondary acute myeloid leukemia|secondary acute myeloid leukemia
751546|NCT00003883|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
751547|NCT00003883|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
751548|NCT00003883|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
751549|NCT00003883|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
751550|NCT00003883|infection|infection
751551|NCT00003883|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
751552|NCT00003883|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
751553|NCT00003883|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
751554|NCT00003883|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
751555|NCT00003883|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
751556|NCT00003883|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
751557|NCT00003883|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
751558|NCT00003883|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
751559|NCT00003883|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
752529|NCT00005085|stage IV colon cancer|stage iv colon cancer
751560|NCT00003883|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
751561|NCT00003883|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
751562|NCT00003883|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
751563|NCT00003883|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
751564|NCT00003883|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
751565|NCT00003883|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
751566|NCT00003883|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
751567|NCT00003883|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
751568|NCT00003883|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
751569|NCT00003883|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
751570|NCT00003883|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
751571|NCT00003883|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
751572|NCT00003883|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
751573|NCT00003883|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
751574|NCT00003883|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
751575|NCT00003883|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
751576|NCT00003883|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
751577|NCT00003883|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
751578|NCT00003883|splenic marginal zone lymphoma|splenic marginal zone lymphoma
751579|NCT00003883|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
751580|NCT00003769|stage II pancreatic cancer|stage ii pancreatic cancer
751581|NCT00003769|stage III pancreatic cancer|stage iii pancreatic cancer
751582|NCT00003769|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
751583|NCT00003657|metastatic osteosarcoma|metastatic osteosarcoma
751584|NCT00003657|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
751585|NCT00003657|chondrosarcoma|chondrosarcoma
751586|NCT00003657|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
751587|NCT00003657|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
751588|NCT00003657|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
751589|NCT00003657|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
751590|NCT00003657|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
751591|NCT00003657|extensive stage small cell lung cancer|extensive stage small cell lung cancer
751592|NCT00003657|recurrent small cell lung cancer|recurrent small cell lung cancer
751593|NCT00003657|recurrent osteosarcoma|recurrent osteosarcoma
751594|NCT00003657|stage III bladder cancer|stage iii bladder cancer
751595|NCT00003657|recurrent bladder cancer|recurrent bladder cancer
751596|NCT00003657|stage IV bladder cancer|stage iv bladder cancer
751597|NCT00003657|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
751598|NCT00003657|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
751599|NCT00003657|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
751600|NCT00003657|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
751601|NCT00003657|classic Kaposi sarcoma|classic kaposi sarcoma
751602|NCT00003657|immunosuppressive treatment related Kaposi sarcoma|immunosuppressive treatment related kaposi sarcoma
751603|NCT00003657|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
751604|NCT00003657|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
751605|NCT00003657|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
751606|NCT00003657|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
751607|NCT00003657|ovarian stromal cancer|ovarian stromal cancer
751608|NCT00003657|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
751609|NCT00003657|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
751610|NCT00003657|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
751611|NCT00003657|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
751612|NCT00003657|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
751613|NCT00003657|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
751614|NCT00003657|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
751615|NCT00003657|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
751616|NCT00003657|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
751617|NCT00003657|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
751618|NCT00003657|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
751619|NCT00003657|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
751620|NCT00003657|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
751621|NCT00003657|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
751622|NCT00003657|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
751623|NCT00003657|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
751624|NCT00003657|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
751625|NCT00003657|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
751626|NCT00003657|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
751627|NCT00003657|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
751628|NCT00003657|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
751629|NCT00003657|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
751630|NCT00003657|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
751631|NCT00003657|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
751632|NCT00003657|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
751633|NCT00003657|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
751634|NCT00003657|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
751635|NCT00003657|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
751636|NCT00003657|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
751637|NCT00003657|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
751638|NCT00003657|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
751639|NCT00003657|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
751640|NCT00003657|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
751641|NCT00003657|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
751642|NCT00003657|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
751643|NCT00003657|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
751644|NCT00003657|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
751645|NCT00003657|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
751646|NCT00003657|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
751647|NCT00003657|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
751648|NCT00003657|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
751649|NCT00003657|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
751650|NCT00003657|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
751651|NCT00003657|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
751652|NCT00003657|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
751653|NCT00003657|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
751654|NCT00003657|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
751655|NCT00003657|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
751656|NCT00003657|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
751657|NCT00003657|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
751658|NCT00003657|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
751659|NCT00003657|extragonadal germ cell tumor|extragonadal germ cell tumor
751660|NCT00003657|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
751661|NCT00003657|stage III uterine sarcoma|stage iii uterine sarcoma
751662|NCT00003657|stage IV uterine sarcoma|stage iv uterine sarcoma
751663|NCT00003657|recurrent uterine sarcoma|recurrent uterine sarcoma
751664|NCT00003657|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
751665|NCT00003657|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
751666|NCT00003657|ovarian sarcoma|ovarian sarcoma
751667|NCT00003657|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
751668|NCT00003657|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
751669|NCT00003657|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
751670|NCT00003657|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
751671|NCT00003657|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
751672|NCT00003635|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
751673|NCT00003635|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
751674|NCT00003635|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
751675|NCT00003412|stage IV breast cancer|stage iv breast cancer
751676|NCT00003412|recurrent breast cancer|recurrent breast cancer
751677|NCT00003402|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
751678|NCT00003402|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
751679|NCT00003402|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
751680|NCT00003402|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
751681|NCT00003402|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
751682|NCT00003402|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
751683|NCT00003402|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
751684|NCT00003402|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
751685|NCT00003402|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
751686|NCT00003402|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
751687|NCT00003402|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
751688|NCT00003402|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
751689|NCT00003402|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
751690|NCT00080392|Gene Transfer|gene transfer
751691|NCT00080392|Therapeutic Angiogenesis|therapeutic angiogenesis
751692|NCT00080392|Peripheral Arterial Disease|peripheral arterial disease
751693|NCT00080392|Perfusion|perfusion
751694|NCT00080392|Magnetic Resonance Imaging|magnetic resonance imaging
751695|NCT00080392|Peripheral Vascular Disease|peripheral vascular disease
751696|NCT00080392|Claudication|claudication
751697|NCT00080392|PAD|pad
751698|NCT00080392|Leg Claudication|leg claudication
751699|NCT00080392|Intermittent Claudication|intermittent claudication
751700|NCT00080314|Bipolar 1 Disorder, depressed|bipolar 1 disorder, depressed
751701|NCT00080301|Metastatic Breast Cancer|metastatic breast cancer
751702|NCT00003345|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
751703|NCT00003345|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
751704|NCT00003345|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
751705|NCT00003345|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
751706|NCT00003345|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
751707|NCT00003345|fallopian tube cancer|fallopian tube cancer
751708|NCT00003345|primary peritoneal cavity cancer|primary peritoneal cavity cancer
751709|NCT00003192|stage III gastric cancer|stage iii gastric cancer
751710|NCT00003192|stage IV gastric cancer|stage iv gastric cancer
751711|NCT00003192|recurrent gastric cancer|recurrent gastric cancer
751712|NCT00003192|stage III esophageal cancer|stage iii esophageal cancer
751713|NCT00003192|stage IV esophageal cancer|stage iv esophageal cancer
751714|NCT00003192|recurrent esophageal cancer|recurrent esophageal cancer
751715|NCT00003192|adenocarcinoma of the stomach|adenocarcinoma of the stomach
751716|NCT00003157|stage IV gastric cancer|stage iv gastric cancer
751717|NCT00003157|recurrent gastric cancer|recurrent gastric cancer
751718|NCT00003157|recurrent pancreatic cancer|recurrent pancreatic cancer
751719|NCT00003157|stage IV pancreatic cancer|stage iv pancreatic cancer
751720|NCT00003149|stage I multiple myeloma|stage i multiple myeloma
751721|NCT00003149|stage II multiple myeloma|stage ii multiple myeloma
751722|NCT00003149|stage III multiple myeloma|stage iii multiple myeloma
751723|NCT00002974|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
751724|NCT00002974|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
751725|NCT00080366|Essential Tremor|essential tremor
751726|NCT00080366|Cross over Design|cross over design
751727|NCT00080366|Accelerometry|accelerometry
751728|NCT00080366|Placebo|placebo
751729|NCT00080366|Alcohol Responsive|alcohol responsive
751730|NCT00080366|Double Blind|double blind
751731|NCT00080366|1-Octanol|1-octanol
751732|NCT00080353|Complete Tumor Regression|complete tumor regression
751733|NCT00080353|Cell Survival|cell survival
751734|NCT00080353|Chemotherapy Preparative Regimen|chemotherapy preparative regimen
751735|NCT00080353|IL-2|il-2
751736|NCT00080353|Toxicity|toxicity
751737|NCT00080353|Metastatic Melanoma|metastatic melanoma
751738|NCT00080288|Excessive Sleepiness|excessive sleepiness
751739|NCT00080288|Chronic Shift Work Sleep Disorder|chronic shift work sleep disorder
751740|NCT00080288|Chronic SWSD|chronic swsd
751741|NCT00080288|Circadian Rhythm Disorder|circadian rhythm disorder
751742|NCT00080288|Shift Worker|shift worker
751743|NCT00080288|Cephalon|cephalon
751744|NCT00080288|Cephalon, Inc|cephalon, inc
751745|NCT00080288|Nuvigil|nuvigil
751746|NCT00080275|Niacin|niacin
751747|NCT00080275|Statin|statin
751748|NCT00080275|Zocor|zocor
751749|NCT00080275|Simvastatin|simvastatin
751750|NCT00080275|Coronary Heart Disease|coronary heart disease
751751|NCT00080275|Dyslipidemia|dyslipidemia
751752|NCT00080275|Atherosclerosis|atherosclerosis
751753|NCT00080275|Hypercholesterolemia|hypercholesterolemia
751754|NCT00080275|Stroke|stroke
751755|NCT00080275|High-Density Lipoprotein Cholesterol|high-density lipoprotein cholesterol
751756|NCT00080275|Low-Density Lipoprotein Cholesterol|low-density lipoprotein cholesterol
751757|NCT00080275|Lipoprotein|lipoprotein
751758|NCT00080275|Lipid|lipid
751759|NCT00080275|Niacin ER/simvastatin|niacin er/simvastatin
751760|NCT00080275|Total Cholesterol|total cholesterol
751761|NCT00080275|Triglycerides|triglycerides
751762|NCT00080262|Metastatic Breast Cancer|metastatic breast cancer
751763|NCT00080236|Liver Transplantation|liver transplantation
751764|NCT00080223|pulmonary fibrosis|pulmonary fibrosis
751765|NCT00080223|respiratory diseases|respiratory diseases
751766|NCT00080158|Dysthymic Disorder|dysthymic disorder
751767|NCT00080158|Adolescent|adolescent
751769|NCT00002950|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
751770|NCT00002947|stage IV renal cell cancer|stage iv renal cell cancer
751771|NCT00002947|recurrent renal cell cancer|recurrent renal cell cancer
751772|NCT00002947|extensive stage small cell lung cancer|extensive stage small cell lung cancer
751773|NCT00002947|recurrent small cell lung cancer|recurrent small cell lung cancer
751774|NCT00002947|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
751775|NCT00002947|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
751776|NCT00002947|gastrinoma|gastrinoma
751777|NCT00002947|insulinoma|insulinoma
751778|NCT00002947|recurrent islet cell carcinoma|recurrent islet cell carcinoma
751779|NCT00002947|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
751780|NCT00002947|prolactin-producing pituitary tumor|prolactin-producing pituitary tumor
751781|NCT00002947|iris melanoma|iris melanoma
751782|NCT00002947|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
751783|NCT00002947|extraocular extension melanoma|extraocular extension melanoma
751784|NCT00002947|recurrent intraocular melanoma|recurrent intraocular melanoma
751785|NCT00002947|stage IV melanoma|stage iv melanoma
751786|NCT00002947|recurrent melanoma|recurrent melanoma
751787|NCT00002947|WDHA syndrome|wdha syndrome
751788|NCT00002947|somatostatinoma|somatostatinoma
751789|NCT00002947|pancreatic polypeptide tumor|pancreatic polypeptide tumor
751790|NCT00002947|glucagonoma|glucagonoma
751791|NCT00002947|childhood Langerhans cell histiocytosis|childhood langerhans cell histiocytosis
751792|NCT00002947|metastatic pheochromocytoma|metastatic pheochromocytoma
751793|NCT00002947|recurrent pheochromocytoma|recurrent pheochromocytoma
751794|NCT00002947|pulmonary carcinoid tumor|pulmonary carcinoid tumor
751795|NCT00002947|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
751796|NCT00002947|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
751797|NCT00002947|stage III neuroendocrine carcinoma of the skin|stage iii neuroendocrine carcinoma of the skin
751798|NCT00002947|recurrent neuroendocrine carcinoma of the skin|recurrent neuroendocrine carcinoma of the skin
751799|NCT00002887|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
751800|NCT00002759|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
751801|NCT00002759|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
751802|NCT00002759|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
751803|NCT00002759|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
751804|NCT00002759|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
751805|NCT00002759|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
751806|NCT00002759|small intestine lymphoma|small intestine lymphoma
751807|NCT00002759|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
751808|NCT00002759|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
751809|NCT00002759|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
751810|NCT00002759|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
751811|NCT00002759|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
751812|NCT00002759|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
751813|NCT00002759|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
751814|NCT00002759|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
751815|NCT00002759|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
751816|NCT00002759|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
751817|NCT00002759|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
751818|NCT00002759|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
751819|NCT00002759|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
751820|NCT00002759|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
751821|NCT00002759|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
751822|NCT00002759|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
751823|NCT00002759|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
751824|NCT00002759|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
751825|NCT00002759|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
751826|NCT00002759|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
751827|NCT00002759|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
751828|NCT00002759|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
751829|NCT00002759|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
751830|NCT00002759|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
751831|NCT00002759|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
751832|NCT00002759|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
751833|NCT00002759|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
751834|NCT00002759|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
751835|NCT00002759|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
751836|NCT00002759|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
751837|NCT00002759|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
751838|NCT00002759|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
751839|NCT00002759|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
751840|NCT00002759|neutropenia|neutropenia
751841|NCT00002759|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
751842|NCT00002759|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
751843|NCT00002759|intraocular lymphoma|intraocular lymphoma
751844|NCT00002759|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
751845|NCT00002759|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
751846|NCT00002759|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
751847|NCT00002759|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
751848|NCT00002759|anaplastic large cell lymphoma|anaplastic large cell lymphoma
751849|NCT00002759|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
751850|NCT00002759|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
751851|NCT00002759|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
751852|NCT00002759|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
751853|NCT00002759|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
751854|NCT00002759|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
751855|NCT00002759|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
751856|NCT00002759|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
751857|NCT00002759|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
751858|NCT00002759|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
751859|NCT00002759|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
751860|NCT00002759|splenic marginal zone lymphoma|splenic marginal zone lymphoma
751861|NCT00002592|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
751862|NCT00002592|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
751863|NCT00002592|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
751864|NCT00002536|stage IB cervical cancer|stage ib cervical cancer
751865|NCT00002461|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
751866|NCT00002461|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
751867|NCT00002461|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
751868|NCT00002461|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
751869|NCT00002461|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
751870|NCT00002461|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
751871|NCT00002461|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
751872|NCT00002461|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
751873|NCT00002461|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
751874|NCT00002461|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
751875|NCT00002461|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
751876|NCT00002461|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
751877|NCT00002461|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
751878|NCT00002461|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
751879|NCT00002461|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
751880|NCT00002461|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
751881|NCT00080210|elevated uric acid|elevated uric acid
751882|NCT00080210|Elevated serum uric acid level|elevated serum uric acid level
751883|NCT00080210|Symptomatic gout|symptomatic gout
751884|NCT00080197|Breast Cancer|breast cancer
751885|NCT00080197|Cancer of the Breast|cancer of the breast
751886|NCT00080184|Fibromyalgia|fibromyalgia
751887|NCT00080184|Electroencephalograph (EEG) biofeedback|electroencephalograph (eeg) biofeedback
751888|NCT00080184|Electromagnetic stimulation|electromagnetic stimulation
751889|NCT00080184|Neurofeedback|neurofeedback
751890|NCT00080184|Neurotherapy|neurotherapy
751891|NCT00080184|Complementary and Alternative Medicine|complementary and alternative medicine
751892|NCT00080171|Osteoarthritis|osteoarthritis
751893|NCT00080171|Knee Pain|knee pain
751894|NCT00080171|Knee Health|knee health
751895|NCT00080145|Autistic Disorder|autistic disorder
751896|NCT00080145|Asperger Syndrome|asperger syndrome
751897|NCT00080132|HTG|htg
751898|NCT00080132|Hypertriglyceridemia, Fredrickson Type I|hypertriglyceridemia, fredrickson type i
751899|NCT00080132|Hypertriglyceridemia, Fredrickson Type V|hypertriglyceridemia, fredrickson type v
751904|NCT00080106|Treatment Experienced|treatment experienced
751905|NCT00080106|Treatment Interruption|treatment interruption
751906|NCT00080106|Adenovirus Vector|adenovirus vector
751907|NCT00008320|stage IV breast cancer|stage iv breast cancer
751908|NCT00008320|recurrent breast cancer|recurrent breast cancer
751909|NCT00008151|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
751910|NCT00008151|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
751911|NCT00008151|refractory anemia with excess blasts|refractory anemia with excess blasts
751912|NCT00008151|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
751913|NCT00008151|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
751914|NCT00008151|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
751915|NCT00008151|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
751916|NCT00008151|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
751917|NCT00006348|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
751918|NCT00006348|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
751919|NCT00006348|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
751920|NCT00006348|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
751921|NCT00006348|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
751922|NCT00006348|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
751923|NCT00006348|isolated plasmacytoma of bone|isolated plasmacytoma of bone
751924|NCT00006348|extramedullary plasmacytoma|extramedullary plasmacytoma
751925|NCT00006348|refractory multiple myeloma|refractory multiple myeloma
751926|NCT00006348|Waldenström macroglobulinemia|waldenström macroglobulinemia
751927|NCT00006348|stage III multiple myeloma|stage iii multiple myeloma
751928|NCT00006348|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
751929|NCT00006348|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
751930|NCT00006348|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
751931|NCT00006348|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
751932|NCT00006348|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
751933|NCT00006348|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
751934|NCT00006348|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
751935|NCT00006348|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
751936|NCT00006348|small intestine lymphoma|small intestine lymphoma
751937|NCT00006348|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
751938|NCT00006348|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
751939|NCT00006348|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
751940|NCT00006348|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
751941|NCT00006348|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
751942|NCT00006348|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
751943|NCT00006348|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
751944|NCT00006348|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
751945|NCT00006348|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
751946|NCT00006348|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
751947|NCT00006348|polycythemia vera|polycythemia vera
751948|NCT00006348|primary myelofibrosis|primary myelofibrosis
751949|NCT00006348|essential thrombocythemia|essential thrombocythemia
751950|NCT00006348|untreated hairy cell leukemia|untreated hairy cell leukemia
751951|NCT00006348|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
751952|NCT00006348|refractory hairy cell leukemia|refractory hairy cell leukemia
751953|NCT00006348|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
751954|NCT00006348|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
751955|NCT00006348|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
751956|NCT00006348|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
751957|NCT00006348|acute undifferentiated leukemia|acute undifferentiated leukemia
751958|NCT00006348|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
751959|NCT00006348|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
751960|NCT00006348|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
751961|NCT00006348|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
751962|NCT00006348|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
751963|NCT00006348|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
751964|NCT00006348|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
751965|NCT00006348|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
751966|NCT00006348|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
751967|NCT00006348|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
751968|NCT00006348|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
751969|NCT00006348|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
751970|NCT00006348|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
751971|NCT00006348|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
751972|NCT00006348|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
751973|NCT00006348|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
751974|NCT00006348|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
751975|NCT00006348|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
751976|NCT00006348|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
751977|NCT00006348|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
751978|NCT00006348|secondary acute myeloid leukemia|secondary acute myeloid leukemia
751979|NCT00006348|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
751980|NCT00006348|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
751981|NCT00006348|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
751982|NCT00006348|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
751983|NCT00006348|nausea and vomiting|nausea and vomiting
751984|NCT00006348|prolymphocytic leukemia|prolymphocytic leukemia
751985|NCT00006348|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
751986|NCT00006348|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
751987|NCT00006348|primary systemic amyloidosis|primary systemic amyloidosis
751988|NCT00006348|intraocular lymphoma|intraocular lymphoma
751989|NCT00006348|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
751990|NCT00006348|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
751991|NCT00006348|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
751992|NCT00006348|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
751993|NCT00006348|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
751994|NCT00006348|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
751995|NCT00006348|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
751996|NCT00006348|anaplastic large cell lymphoma|anaplastic large cell lymphoma
751997|NCT00006348|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
751998|NCT00006348|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
751999|NCT00006348|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
752000|NCT00006348|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
752001|NCT00006348|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
752002|NCT00006348|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
752003|NCT00006348|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
752004|NCT00006348|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
752005|NCT00006348|splenic marginal zone lymphoma|splenic marginal zone lymphoma
752006|NCT00006348|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
752007|NCT00006345|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
752008|NCT00006345|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
752009|NCT00006345|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
752010|NCT00006262|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
752011|NCT00006262|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
752012|NCT00006262|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
752013|NCT00006090|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
752014|NCT00006090|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
752015|NCT00006084|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
752016|NCT00006084|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
752017|NCT00006084|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
752018|NCT00006084|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
752019|NCT00006084|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
752020|NCT00006084|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
752021|NCT00006084|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
752022|NCT00006084|secondary acute myeloid leukemia|secondary acute myeloid leukemia
752023|NCT00006084|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
752024|NCT00006084|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
752025|NCT00006051|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
752026|NCT00006051|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
752027|NCT00006051|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
752028|NCT00006051|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
752029|NCT00006051|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
752030|NCT00006051|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
752031|NCT00006051|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
752032|NCT00006051|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
752033|NCT00006051|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
752034|NCT00006051|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
752035|NCT00006051|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
752036|NCT00006051|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
752037|NCT00006051|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
752680|NCT00079638|Stroke|stroke
752038|NCT00006051|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
752039|NCT00006051|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
752040|NCT00006051|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
752041|NCT00006036|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
752042|NCT00006036|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
752043|NCT00006036|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
752044|NCT00006036|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
752045|NCT00006036|extensive stage small cell lung cancer|extensive stage small cell lung cancer
752046|NCT00006036|recurrent small cell lung cancer|recurrent small cell lung cancer
752047|NCT00006036|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
752048|NCT00006036|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
752049|NCT00006036|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
752050|NCT00006036|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
752051|NCT00006036|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
752052|NCT00006036|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
752053|NCT00006036|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
752054|NCT00006036|ovarian stromal cancer|ovarian stromal cancer
752055|NCT00006036|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
752056|NCT00006036|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
752057|NCT00006036|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
752058|NCT00006036|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
752059|NCT00006036|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
752060|NCT00006036|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
752061|NCT00006036|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
752062|NCT00006036|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
752063|NCT00006036|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
752064|NCT00006036|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
752065|NCT00006036|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
752066|NCT00006036|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
752067|NCT00006036|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
752068|NCT00006036|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
752069|NCT00006036|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
752070|NCT00006036|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
752071|NCT00006036|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
752072|NCT00006036|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
752073|NCT00006036|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
752074|NCT00006036|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
752075|NCT00006036|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
752076|NCT00006036|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
752077|NCT00006036|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
752078|NCT00006036|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
752079|NCT00006036|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
752080|NCT00006036|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
752081|NCT00006036|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
752082|NCT00006036|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
752083|NCT00006036|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
752084|NCT00006036|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
752085|NCT00006036|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
752086|NCT00006036|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
752087|NCT00006036|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
752088|NCT00006036|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
752089|NCT00006036|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
752090|NCT00006036|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
752091|NCT00006036|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
752092|NCT00006036|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
752093|NCT00006036|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
752094|NCT00006036|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
752175|NCT00003693|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
752095|NCT00006036|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
752096|NCT00006036|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
752097|NCT00006036|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
752098|NCT00006036|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
752099|NCT00006036|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
752100|NCT00006036|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
752101|NCT00006036|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
752102|NCT00006036|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
752103|NCT00006036|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
752104|NCT00006036|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
752105|NCT00006036|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
752106|NCT00006036|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
752107|NCT00006036|ovarian sarcoma|ovarian sarcoma
752108|NCT00006030|stage I breast cancer|stage i breast cancer
752110|NCT00080093|HIV Seronegativity|hiv seronegativity
752111|NCT00080093|HIV Prevention|hiv prevention
752112|NCT00080093|Behavioral Intervention|behavioral intervention
752113|NCT00006023|stage IV prostate cancer|stage iv prostate cancer
752114|NCT00006023|recurrent prostate cancer|recurrent prostate cancer
752115|NCT00005992|stage IV prostate cancer|stage iv prostate cancer
752116|NCT00005992|recurrent prostate cancer|recurrent prostate cancer
752117|NCT00005972|recurrent small cell lung cancer|recurrent small cell lung cancer
752118|NCT00005944|recurrent colon cancer|recurrent colon cancer
752119|NCT00005944|recurrent rectal cancer|recurrent rectal cancer
752120|NCT00005944|adenocarcinoma of the colon|adenocarcinoma of the colon
752121|NCT00005944|adenocarcinoma of the rectum|adenocarcinoma of the rectum
752122|NCT00005944|liver metastases|liver metastases
752123|NCT00005944|primary peritoneal cavity cancer|primary peritoneal cavity cancer
752124|NCT00005865|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
752125|NCT00005865|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
752126|NCT00080067|Movement|movement
752127|NCT00080067|Anticipation|anticipation
752128|NCT00080067|Stimulation|stimulation
752129|NCT00080067|Timing|timing
752130|NCT00080067|Execution|execution
752131|NCT00080067|Perception|perception
752132|NCT00080067|Rhythm|rhythm
752133|NCT00080067|Healthy Volunteer|healthy volunteer
752134|NCT00080067|HV|hv
752135|NCT00080054|Malignant Glioma|malignant glioma
752136|NCT00080054|Glioblastoma multiforme|glioblastoma multiforme
752137|NCT00080054|GBM|gbm
752138|NCT00080054|Anaplastic astrocytoma|anaplastic astrocytoma
752139|NCT00080054|AA|aa
752140|NCT00080054|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
752141|NCT00080054|Anaplastic mixed glioma|anaplastic mixed glioma
752142|NCT00080054|Brain tumor|brain tumor
752143|NCT00080054|Brain neoplasm|brain neoplasm
752144|NCT00080054|Glioma|glioma
752145|NCT00080041|Antineoplastic Combined Chemotherapy Protocols|antineoplastic combined chemotherapy protocols
752146|NCT00080028|Head and Neck Cancer|head and neck cancer
752147|NCT00080028|SCCHN|scchn
752148|NCT00080028|Oropharynx Cancer|oropharynx cancer
752149|NCT00080028|Hypopharynx Cancer|hypopharynx cancer
752150|NCT00080028|Larynx Cancer|larynx cancer
752151|NCT00080028|Soft palate Cancer|soft palate cancer
752152|NCT00080028|Tonsil Cancer|tonsil cancer
752153|NCT00080028|Base of tongue Cancer|base of tongue cancer
752154|NCT00080028|Supraglottic Cancer|supraglottic cancer
752155|NCT00080028|Glottic Cancer|glottic cancer
752156|NCT00080028|Pyriform Sinus Cancer|pyriform sinus cancer
752157|NCT00080028|Pharyngeal wall Cancer|pharyngeal wall cancer
752158|NCT00080028|Throat cancer|throat cancer
752159|NCT00080002|cancer|cancer
752160|NCT00080002|gastric|gastric
752161|NCT00080002|gastroesophageal junction|gastroesophageal junction
752162|NCT00080002|neoplasms|neoplasms
752163|NCT00080002|gastric cancer|gastric cancer
752164|NCT00080002|gastric neoplasms|gastric neoplasms
752165|NCT00079989|Bacterial Infections|bacterial infections
752166|NCT00005816|stage III renal cell cancer|stage iii renal cell cancer
752167|NCT00005816|stage IV renal cell cancer|stage iv renal cell cancer
752168|NCT00004123|adult leiomyosarcoma|adult leiomyosarcoma
752169|NCT00004123|adult liposarcoma|adult liposarcoma
752170|NCT00004123|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
752171|NCT00004123|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
752172|NCT00004123|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
752173|NCT00003817|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
752174|NCT00003817|nausea and vomiting|nausea and vomiting
752681|NCT00079638|VA-HIT|va-hit
752176|NCT00003693|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
752177|NCT00003693|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
752178|NCT00003693|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
752179|NCT00003693|refractory anemia with excess blasts|refractory anemia with excess blasts
752180|NCT00003693|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
752181|NCT00003693|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
752182|NCT00003693|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
752183|NCT00003693|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
752184|NCT00003647|adult solid tumor|adult solid tumor
752185|NCT00003647|body system/site cancer|body system/site cancer
752186|NCT00003647|cancer|cancer
752187|NCT00003647|melanoma|melanoma
752188|NCT00003647|recurrent melanoma|recurrent melanoma
752189|NCT00003647|skin tumor|skin tumor
752190|NCT00003647|solid tumor|solid tumor
752191|NCT00003647|stage III melanoma|stage iii melanoma
752192|NCT00003647|stage IV melanoma|stage iv melanoma
752193|NCT00003647|stage, melanoma|stage, melanoma
752194|NCT00079976|Staphylococcus aureus|staphylococcus aureus
752195|NCT00079976|Bacterial Infections|bacterial infections
752196|NCT00079950|soft|soft
752197|NCT00079950|sarcoma|sarcoma
752198|NCT00079950|metastatic|metastatic
752199|NCT00079937|allergic|allergic
752200|NCT00079937|asthma|asthma
752201|NCT00079937|atopic|atopic
752202|NCT00079937|omalizumab|omalizumab
752203|NCT00079937|immunoglobulin E|immunoglobulin e
752204|NCT00079937|IgE|ige
752205|NCT00079937|anti-IgE|anti-ige
752206|NCT00003561|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
752207|NCT00003561|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
752208|NCT00003561|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
752209|NCT00003356|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
752210|NCT00003356|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
752211|NCT00003356|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
752212|NCT00003356|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
752213|NCT00003356|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
752214|NCT00003356|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
752215|NCT00003356|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
752216|NCT00003356|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
752217|NCT00003356|stage I mantle cell lymphoma|stage i mantle cell lymphoma
752218|NCT00003356|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
752219|NCT00003356|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
752220|NCT00003356|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
752221|NCT00003356|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
752222|NCT00003356|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
752223|NCT00003356|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
752224|NCT00003356|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
752225|NCT00003356|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
752226|NCT00003356|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
752227|NCT00003356|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
752228|NCT00003356|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
752229|NCT00003356|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
752230|NCT00003356|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
752231|NCT00003356|stage I marginal zone lymphoma|stage i marginal zone lymphoma
752232|NCT00003356|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
752233|NCT00003356|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
752234|NCT00003356|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
752235|NCT00003356|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
752236|NCT00003356|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
752237|NCT00003356|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
752238|NCT00003356|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
752239|NCT00003356|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
752240|NCT00003356|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
752241|NCT00003356|splenic marginal zone lymphoma|splenic marginal zone lymphoma
752242|NCT00003327|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
752243|NCT00003327|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
752244|NCT00003327|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
752245|NCT00003327|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
752246|NCT00003327|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
752247|NCT00003327|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
752248|NCT00003327|stage IV laryngeal cancer|stage iv laryngeal cancer
752249|NCT00003327|recurrent laryngeal cancer|recurrent laryngeal cancer
752250|NCT00003327|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
752251|NCT00003327|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
752252|NCT00003327|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
752253|NCT00003327|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
752254|NCT00003321|stage I esophageal cancer|stage i esophageal cancer
752255|NCT00003321|stage II esophageal cancer|stage ii esophageal cancer
752256|NCT00003321|stage III esophageal cancer|stage iii esophageal cancer
752257|NCT00003321|stage IV esophageal cancer|stage iv esophageal cancer
752258|NCT00003321|recurrent esophageal cancer|recurrent esophageal cancer
752259|NCT00003274|stage II melanoma|stage ii melanoma
752260|NCT00079911|Herpes|herpes
752261|NCT00079911|Genital Herpes|genital herpes
752262|NCT00079911|HIV|hiv
752263|NCT00079911|HSV|hsv
752264|NCT00079885|Bacterial Pneumonia|bacterial pneumonia
752265|NCT00022360|recurrent adult brain tumor|recurrent adult brain tumor
752266|NCT00022360|adult glioblastoma|adult glioblastoma
752267|NCT00022360|adult anaplastic astrocytoma|adult anaplastic astrocytoma
752268|NCT00022360|adult giant cell glioblastoma|adult giant cell glioblastoma
752269|NCT00022360|adult gliosarcoma|adult gliosarcoma
752270|NCT00022165|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
752271|NCT00021138|non-small cell lung cancer|non-small cell lung cancer
752272|NCT00021138|small cell lung cancer|small cell lung cancer
752273|NCT00021138|esophageal cancer|esophageal cancer
752274|NCT00021138|hypopharyngeal cancer|hypopharyngeal cancer
752275|NCT00021138|laryngeal cancer|laryngeal cancer
752276|NCT00021138|nasopharyngeal cancer|nasopharyngeal cancer
752277|NCT00021138|oropharyngeal cancer|oropharyngeal cancer
752278|NCT00021138|lip and oral cavity cancer|lip and oral cavity cancer
752279|NCT00021138|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
752280|NCT00021138|tongue cancer|tongue cancer
752281|NCT00002789|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
752282|NCT00002789|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
752283|NCT00002789|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
752284|NCT00079859|Heterozygous Familial Hypercholesterolemia (HeFH)|heterozygous familial hypercholesterolemia (hefh)
752285|NCT00079846|Homozygous Familial Hypercholesterolemia (HoFH)|homozygous familial hypercholesterolemia (hofh)
752286|NCT00079833|gastric acid hypersecretory conditions|gastric acid hypersecretory conditions
752287|NCT00079833|Idiopathic Hypersecretion|idiopathic hypersecretion
752288|NCT00079833|Excessive Gastric Acid secretion|excessive gastric acid secretion
752289|NCT00079820|Smallpox|smallpox
752290|NCT00079820|Smallpox Vaccine|smallpox vaccine
752291|NCT00079820|Variola virus|variola virus
752292|NCT00079820|Smallpox Virus|smallpox virus
752293|NCT00079820|MODIFIED VACCINIA ANKARA|modified vaccinia ankara
752294|NCT00079820|MVA|mva
752295|NCT00079820|Dryvax|dryvax
752296|NCT00079820|Dryvax vaccine|dryvax vaccine
752297|NCT00079820|Protection against smallpox|protection against smallpox
752298|NCT00020930|stage IV colon cancer|stage iv colon cancer
752299|NCT00020930|stage IV rectal cancer|stage iv rectal cancer
752300|NCT00020930|recurrent colon cancer|recurrent colon cancer
752301|NCT00020930|recurrent rectal cancer|recurrent rectal cancer
752302|NCT00020865|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
752303|NCT00020865|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
752304|NCT00020865|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
752305|NCT00020865|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
752306|NCT00020865|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
752307|NCT00020865|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
752308|NCT00020865|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
752309|NCT00020865|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
752310|NCT00020865|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
752311|NCT00020865|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
752312|NCT00020865|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
752313|NCT00020865|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
752314|NCT00020865|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
752315|NCT00020865|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
752316|NCT00020865|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
752317|NCT00020865|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
752318|NCT00020865|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
752319|NCT00020865|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
752320|NCT00020865|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
752321|NCT00020865|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
752322|NCT00020865|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
752323|NCT00020865|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
752324|NCT00020865|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
752526|NCT00005834|stage III multiple myeloma|stage iii multiple myeloma
752325|NCT00020865|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
752326|NCT00020865|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
752327|NCT00020865|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
752328|NCT00020865|fever, sweats, and hot flashes|fever, sweats, and hot flashes
752329|NCT00020865|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
752330|NCT00020865|refractory hairy cell leukemia|refractory hairy cell leukemia
752331|NCT00020865|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
752332|NCT00020865|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
752333|NCT00020865|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
752334|NCT00020865|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
752335|NCT00020865|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
752336|NCT00020865|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
752337|NCT00020865|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
752338|NCT00020865|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
752339|NCT00020865|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
752340|NCT00020865|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
752341|NCT00020865|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
752342|NCT00020865|acute undifferentiated leukemia|acute undifferentiated leukemia
752343|NCT00020865|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
752344|NCT00020865|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
752345|NCT00020865|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
752346|NCT00020865|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
752347|NCT00020865|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
752348|NCT00020865|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
752349|NCT00020865|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
752350|NCT00020865|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
752351|NCT00020865|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
752352|NCT00020865|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
752353|NCT00020865|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
752354|NCT00020865|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
752355|NCT00020865|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
752356|NCT00020865|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
752357|NCT00020865|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
752358|NCT00020865|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
752359|NCT00020865|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
752360|NCT00020865|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
752361|NCT00020865|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
752362|NCT00020865|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
752363|NCT00020865|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
752364|NCT00020865|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
752365|NCT00020865|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
752366|NCT00020865|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
752367|NCT00020865|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
752368|NCT00020865|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
752369|NCT00020865|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
752370|NCT00020865|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
752371|NCT00020865|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
752372|NCT00020865|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
752373|NCT00020865|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
752374|NCT00020865|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
752375|NCT00020865|secondary acute myeloid leukemia|secondary acute myeloid leukemia
752376|NCT00020865|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
752377|NCT00020865|neutropenia|neutropenia
752378|NCT00020865|infection|infection
752379|NCT00020865|prolymphocytic leukemia|prolymphocytic leukemia
752380|NCT00020865|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
752381|NCT00020865|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
752382|NCT00020865|intraocular lymphoma|intraocular lymphoma
752383|NCT00020865|stage I mantle cell lymphoma|stage i mantle cell lymphoma
752384|NCT00020865|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
752385|NCT00020865|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
752386|NCT00020865|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
752387|NCT00020865|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
752388|NCT00020865|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
752527|NCT00005635|stage IV breast cancer|stage iv breast cancer
752389|NCT00020865|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
752390|NCT00020865|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
752391|NCT00020865|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
752392|NCT00020865|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
752393|NCT00020865|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
752394|NCT00020865|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
752395|NCT00020865|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
752396|NCT00020865|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
752397|NCT00020865|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
752398|NCT00020865|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
752399|NCT00020865|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
752400|NCT00020865|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
752401|NCT00020865|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
752402|NCT00020865|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
752403|NCT00020865|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
752404|NCT00020865|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
752405|NCT00020865|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
752406|NCT00020865|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
752407|NCT00020865|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
752408|NCT00020865|anaplastic large cell lymphoma|anaplastic large cell lymphoma
752409|NCT00020865|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
752410|NCT00020865|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
752411|NCT00020865|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
752412|NCT00020865|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
752413|NCT00020865|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
752414|NCT00020865|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
752415|NCT00020865|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
752416|NCT00020865|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
752417|NCT00020865|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
752418|NCT00020865|stage I marginal zone lymphoma|stage i marginal zone lymphoma
752419|NCT00020865|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
752420|NCT00020865|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
752421|NCT00020865|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
752422|NCT00020865|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
752423|NCT00020865|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
752424|NCT00020865|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
752425|NCT00020865|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
752426|NCT00020865|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
752427|NCT00020865|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
752428|NCT00020865|splenic marginal zone lymphoma|splenic marginal zone lymphoma
752429|NCT00014300|recurrent adult brain tumor|recurrent adult brain tumor
752430|NCT00014300|adult glioblastoma|adult glioblastoma
752431|NCT00014300|adult giant cell glioblastoma|adult giant cell glioblastoma
752432|NCT00014300|adult gliosarcoma|adult gliosarcoma
752433|NCT00012337|stage IV renal cell cancer|stage iv renal cell cancer
752434|NCT00012337|recurrent renal cell cancer|recurrent renal cell cancer
752435|NCT00006812|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
752436|NCT00006812|primary peritoneal cavity cancer|primary peritoneal cavity cancer
752437|NCT00006708|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
752438|NCT00006708|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
752439|NCT00006218|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
752440|NCT00006215|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
752441|NCT00006215|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
752442|NCT00006098|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
752443|NCT00006098|refractory multiple myeloma|refractory multiple myeloma
752444|NCT00006098|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
752445|NCT00006098|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
752446|NCT00006098|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
752447|NCT00006098|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
752448|NCT00006098|refractory anemia with excess blasts|refractory anemia with excess blasts
752449|NCT00006098|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
752450|NCT00006098|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
752451|NCT00006098|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
752452|NCT00006098|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
752453|NCT00006098|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
752454|NCT00006098|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
752455|NCT00006098|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
752456|NCT00006098|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
752457|NCT00006098|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
752458|NCT00006098|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
752459|NCT00006098|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
752460|NCT00006098|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
752461|NCT00006098|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
752462|NCT00006098|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
752463|NCT00006098|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
752464|NCT00006098|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
752465|NCT00006098|splenic marginal zone lymphoma|splenic marginal zone lymphoma
752466|NCT00079807|HIV|hiv
752467|NCT00079807|Peripheral neuropathy|peripheral neuropathy
752468|NCT00079807|Alpha-Lipoic Acid|alpha-lipoic acid
752469|NCT00079807|ALA|ala
752470|NCT00079807|Complementary Therapies|complementary therapies
752471|NCT00079794|lung cancer|lung cancer
752472|NCT00079794|herbal medicine|herbal medicine
752473|NCT00079794|non-small cell cancer|non-small cell cancer
752474|NCT00079794|Iscar|iscar
752475|NCT00079794|mistletoe|mistletoe
752476|NCT00079781|Responsive Stimulation|responsive stimulation
752477|NCT00079781|Brain Stimulator|brain stimulator
752478|NCT00079781|Epilepsy|epilepsy
752479|NCT00079781|Seizures|seizures
752480|NCT00079755|Anaplastic Large-Cell Lymphoma|anaplastic large-cell lymphoma
752481|NCT00079755|Lymphoma|lymphoma
752482|NCT00079755|antigens, CD30|antigens, cd30
752483|NCT00079755|Monoclonal Antibody|monoclonal antibody
752484|NCT00079742|Growth restriction in children with cystic fibrosis|growth restriction in children with cystic fibrosis
752485|NCT00079716|Antigens, CD40|antigens, cd40
752486|NCT00079716|Antibody, Monoclonal|antibody, monoclonal
752487|NCT00079716|Blood Coagulation Disorders|blood coagulation disorders
752488|NCT00079716|Hematologic Diseases|hematologic diseases
752489|NCT00079716|Hemorrhagic Disorders|hemorrhagic disorders
752490|NCT00079716|Hemostatic Disorders|hemostatic disorders
752491|NCT00079716|Immunoproliferative Disorders|immunoproliferative disorders
752492|NCT00079716|Lymphoproliferative Disorders|lymphoproliferative disorders
752493|NCT00079716|Paraproteinemias|paraproteinemias
752494|NCT00079716|Vascular Diseases|vascular diseases
752495|NCT00079716|Antibody-Dependent Cell Cytotoxicity|antibody-dependent cell cytotoxicity
752496|NCT00006091|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
752497|NCT00006091|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
752498|NCT00006091|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
752499|NCT00006085|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
752500|NCT00006026|recurrent bladder cancer|recurrent bladder cancer
752501|NCT00006026|stage IV bladder cancer|stage iv bladder cancer
752502|NCT00006026|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
752503|NCT00006026|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
752504|NCT00006026|adenocarcinoma of the bladder|adenocarcinoma of the bladder
752505|NCT00006026|recurrent urethral cancer|recurrent urethral cancer
752506|NCT00006026|anterior urethral cancer|anterior urethral cancer
752507|NCT00006026|posterior urethral cancer|posterior urethral cancer
752508|NCT00006026|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
752509|NCT00006026|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
752510|NCT00006026|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
752511|NCT00006026|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
752512|NCT00005866|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
752513|NCT00005866|refractory anemia with excess blasts|refractory anemia with excess blasts
752514|NCT00005866|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
752515|NCT00005866|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
752516|NCT00005866|secondary acute myeloid leukemia|secondary acute myeloid leukemia
752517|NCT00005866|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
752518|NCT00005866|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
752519|NCT00005866|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
752520|NCT00005848|adenocarcinoma of the prostate|adenocarcinoma of the prostate
752521|NCT00005848|stage IV prostate cancer|stage iv prostate cancer
752522|NCT00005848|recurrent prostate cancer|recurrent prostate cancer
752523|NCT00005834|refractory multiple myeloma|refractory multiple myeloma
752524|NCT00005834|stage I multiple myeloma|stage i multiple myeloma
752525|NCT00005834|stage II multiple myeloma|stage ii multiple myeloma
752530|NCT00005085|stage IV rectal cancer|stage iv rectal cancer
752531|NCT00005085|recurrent colon cancer|recurrent colon cancer
752532|NCT00005085|recurrent rectal cancer|recurrent rectal cancer
752533|NCT00005085|adenocarcinoma of the colon|adenocarcinoma of the colon
752534|NCT00005085|adenocarcinoma of the rectum|adenocarcinoma of the rectum
752535|NCT00005037|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
752536|NCT00005037|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
752537|NCT00005037|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
752538|NCT00004926|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
752539|NCT00004913|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
752540|NCT00004909|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
752541|NCT00004909|peritoneal cavity cancer|peritoneal cavity cancer
752542|NCT00004909|quality of life|quality of life
752543|NCT00004865|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
752544|NCT00004865|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
752545|NCT00004865|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
752546|NCT00004865|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
752547|NCT00004865|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
752548|NCT00004865|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
752549|NCT00004865|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
752550|NCT00004865|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
752551|NCT00004865|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
752552|NCT00004865|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
752553|NCT00004865|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
752554|NCT00004865|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
752555|NCT00004865|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
752556|NCT00004865|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
752557|NCT00004864|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
752558|NCT00004863|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
752559|NCT00004163|stage III salivary gland cancer|stage iii salivary gland cancer
752560|NCT00004163|stage IV salivary gland cancer|stage iv salivary gland cancer
752561|NCT00004163|recurrent salivary gland cancer|recurrent salivary gland cancer
752562|NCT00004163|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
752563|NCT00004163|salivary gland acinic cell tumor|salivary gland acinic cell tumor
752564|NCT00004163|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
752565|NCT00004163|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
752566|NCT00004163|salivary gland adenocarcinoma|salivary gland adenocarcinoma
752567|NCT00004163|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
752568|NCT00004163|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
752569|NCT00004163|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
752570|NCT00004151|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
752571|NCT00004151|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
752572|NCT00004151|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
752573|NCT00004151|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
752574|NCT00004142|stage IV colon cancer|stage iv colon cancer
752575|NCT00004142|stage IV rectal cancer|stage iv rectal cancer
752576|NCT00004142|recurrent colon cancer|recurrent colon cancer
752577|NCT00004142|recurrent rectal cancer|recurrent rectal cancer
752578|NCT00004142|liver metastases|liver metastases
752579|NCT00004109|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
752580|NCT00004109|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
752581|NCT00004109|Doxorubicin|doxorubicin
752582|NCT00004109|External-Beam RT|external-beam rt
752583|NCT00004109|XRT|xrt
752584|NCT00004109|cancer|cancer
754054|NCT00078377|Sleep Attacks|sleep attacks
752585|NCT00004109|PREOPERATIVE CONCURRENT CHEMORADIATION|preoperative concurrent chemoradiation
752586|NCT00004109|EXTREMITY SOFT TISSUE SARCOMAS|extremity soft tissue sarcomas
752587|NCT00004109|TRUNK SOFT TISSUE SARCOMAS|trunk soft tissue sarcomas
752588|NCT00004109|Concurrent Chemoradiation|concurrent chemoradiation
752589|NCT00004109|Surgical Resection|surgical resection
752590|NCT00004109|Localized Extremity Soft Tissue Sarcomas|localized extremity soft tissue sarcomas
752591|NCT00004109|Body Wall Soft Tissue Sarcomas|body wall soft tissue sarcomas
752592|NCT00003959|refractory anemia|refractory anemia
752593|NCT00003959|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
752594|NCT00003959|refractory anemia with excess blasts|refractory anemia with excess blasts
752595|NCT00003959|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
780977|NCT00044772|Panic|panic
752596|NCT00003959|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
752597|NCT00003959|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
752598|NCT00003959|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
752599|NCT00003779|stage 0 bladder cancer|stage 0 bladder cancer
752600|NCT00003779|stage I bladder cancer|stage i bladder cancer
752601|NCT00003772|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
752602|NCT00003772|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
752603|NCT00003772|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
752604|NCT00003772|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
752605|NCT00003772|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
752606|NCT00003742|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
752607|NCT00003706|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
752608|NCT00003705|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
752609|NCT00003704|stage III colon cancer|stage iii colon cancer
752610|NCT00003704|stage III rectal cancer|stage iii rectal cancer
752611|NCT00003704|recurrent colon cancer|recurrent colon cancer
752612|NCT00003704|recurrent rectal cancer|recurrent rectal cancer
752613|NCT00003704|recurrent anal cancer|recurrent anal cancer
752614|NCT00003704|stage IIIA anal cancer|stage iiia anal cancer
752615|NCT00003704|stage IIIB anal cancer|stage iiib anal cancer
752616|NCT00003704|stage III cervical cancer|stage iii cervical cancer
752617|NCT00003704|recurrent cervical cancer|recurrent cervical cancer
752618|NCT00003704|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
752619|NCT00003704|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
752620|NCT00003704|stage III vulvar cancer|stage iii vulvar cancer
752621|NCT00003704|recurrent vulvar cancer|recurrent vulvar cancer
752622|NCT00003704|stage III vaginal cancer|stage iii vaginal cancer
752623|NCT00003704|recurrent vaginal cancer|recurrent vaginal cancer
752624|NCT00003704|stage III penile cancer|stage iii penile cancer
752625|NCT00003704|recurrent penile cancer|recurrent penile cancer
752626|NCT00003704|stage III endometrial carcinoma|stage iii endometrial carcinoma
752627|NCT00003704|recurrent endometrial carcinoma|recurrent endometrial carcinoma
752628|NCT00003704|stage III bladder cancer|stage iii bladder cancer
752629|NCT00003704|recurrent bladder cancer|recurrent bladder cancer
752630|NCT00003704|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
752631|NCT00003704|stage III prostate cancer|stage iii prostate cancer
752632|NCT00003704|recurrent prostate cancer|recurrent prostate cancer
752633|NCT00003704|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
752634|NCT00003704|ovarian stromal cancer|ovarian stromal cancer
752635|NCT00003704|recurrent urethral cancer|recurrent urethral cancer
752636|NCT00003704|distal urethral cancer|distal urethral cancer
752637|NCT00003704|proximal urethral cancer|proximal urethral cancer
752638|NCT00003704|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
752639|NCT00003704|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
752640|NCT00003704|fallopian tube cancer|fallopian tube cancer
752641|NCT00003704|primary peritoneal cavity cancer|primary peritoneal cavity cancer
752642|NCT00003704|stage III uterine sarcoma|stage iii uterine sarcoma
752643|NCT00003704|recurrent uterine sarcoma|recurrent uterine sarcoma
752644|NCT00003704|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
752645|NCT00003704|ovarian sarcoma|ovarian sarcoma
752646|NCT00003703|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
752647|NCT00003695|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
752648|NCT00003695|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
752649|NCT00079768|Inflammation|inflammation
752650|NCT00079768|Myositis|myositis
752651|NCT00079768|Humanized Monoclonal Antibody|humanized monoclonal antibody
752652|NCT00079768|Cytotoxic T Cells|cytotoxic t cells
752653|NCT00079768|Endomysial T Cells|endomysial t cells
752654|NCT00079768|Alemtuzumab|alemtuzumab
752655|NCT00079768|Monoclonal Antibodies|monoclonal antibodies
752656|NCT00079768|IBM|ibm
752657|NCT00079768|Anti-CD 52|anti-cd 52
752658|NCT00079768|Inclusion Body Myositis|inclusion body myositis
752659|NCT00079729|Treatment Experienced|treatment experienced
752660|NCT00079677|Excessive Sleepiness|excessive sleepiness
752661|NCT00079677|Obstructive Sleep Apnea|obstructive sleep apnea
752662|NCT00079677|Obstructive Sleep Hypopnea|obstructive sleep hypopnea
752663|NCT00079677|nCPAP|ncpap
752664|NCT00079677|Cephalon|cephalon
752665|NCT00079677|Cephalon, Inc|cephalon, inc
752666|NCT00079677|Nuvigil|nuvigil
752667|NCT00079664|Tai Ji|tai ji
752668|NCT00079651|Aged|aged
752669|NCT00079651|Nursing Homes|nursing homes
752670|NCT00079651|Assisted Living Facilities|assisted living facilities
752671|NCT00079638|Niaspan|niaspan
752672|NCT00079638|Niacin|niacin
752673|NCT00079638|Statin|statin
752674|NCT00079638|Cholesterol|cholesterol
752675|NCT00079638|Triglycerides|triglycerides
752676|NCT00079638|Lipid-Modifying Therapies|lipid-modifying therapies
752677|NCT00079638|Dyslipidemia|dyslipidemia
752678|NCT00079638|Coronary Heart Disease|coronary heart disease
752679|NCT00079638|Atherosclerosis|atherosclerosis
752682|NCT00079638|Niacin Statin Combination Threrapy|niacin statin combination threrapy
752683|NCT00079638|High Density Lipoprotein|high density lipoprotein
752684|NCT00079638|Low Density Lipoprotein|low density lipoprotein
752685|NCT00079638|Hypertension|hypertension
752686|NCT00079638|Diabetes|diabetes
752687|NCT00079638|Adult Treatment Panel III|adult treatment panel iii
752688|NCT00078039|Schizophrenia, paliperidone|schizophrenia, paliperidone
752689|NCT00003617|stage I gastric cancer|stage i gastric cancer
752690|NCT00003465|recurrent adult brain tumor|recurrent adult brain tumor
752691|NCT00003465|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
752692|NCT00003421|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
752693|NCT00003421|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
752694|NCT00003421|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
752695|NCT00003421|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
754572|NCT00003046|recurrent anal cancer|recurrent anal cancer
752696|NCT00003368|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
752697|NCT00003368|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
752698|NCT00003368|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
752699|NCT00003368|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
752700|NCT00003368|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
752701|NCT00003368|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
752702|NCT00003368|small intestine lymphoma|small intestine lymphoma
752703|NCT00003368|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
752704|NCT00003368|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
752705|NCT00003368|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
752706|NCT00003368|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
752707|NCT00003368|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
752708|NCT00003368|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
752709|NCT00003368|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
752710|NCT00003368|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
752711|NCT00003368|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
752712|NCT00003368|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
752713|NCT00003368|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
752714|NCT00003368|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
752715|NCT00003368|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
752716|NCT00003368|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
752717|NCT00003368|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
752718|NCT00003368|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
752719|NCT00003368|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
752720|NCT00003368|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
752721|NCT00003368|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
752722|NCT00003368|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
752723|NCT00003368|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
752724|NCT00003368|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
752725|NCT00003368|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
752726|NCT00003368|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
752727|NCT00003368|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
752728|NCT00003368|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
752729|NCT00003368|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
752730|NCT00003368|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
752731|NCT00003368|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
752732|NCT00003368|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
752733|NCT00003368|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
752734|NCT00003368|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
752735|NCT00003368|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
752736|NCT00003368|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
752737|NCT00003368|intraocular lymphoma|intraocular lymphoma
752738|NCT00003368|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
752739|NCT00003368|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
752740|NCT00003368|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
752741|NCT00003368|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
752742|NCT00003368|anaplastic large cell lymphoma|anaplastic large cell lymphoma
752743|NCT00003368|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
752744|NCT00003368|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
752745|NCT00003368|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
752746|NCT00003368|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
752747|NCT00003368|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
753155|NCT00079287|large cell lung cancer|large cell lung cancer
752748|NCT00003368|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
752749|NCT00003368|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
752750|NCT00003368|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
752751|NCT00003368|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
752752|NCT00003368|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
752753|NCT00003368|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
752754|NCT00003368|splenic marginal zone lymphoma|splenic marginal zone lymphoma
752755|NCT00003361|refractory anemia|refractory anemia
752756|NCT00003361|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
752757|NCT00003361|refractory anemia with excess blasts|refractory anemia with excess blasts
752758|NCT00003361|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
752759|NCT00003361|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
752760|NCT00003361|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
752761|NCT00003361|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
752762|NCT00003361|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
752763|NCT00003361|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
752764|NCT00003338|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
752765|NCT00003338|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
752766|NCT00003338|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
752767|NCT00003338|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
752768|NCT00003338|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
752769|NCT00003338|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
752770|NCT00003338|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
752771|NCT00003338|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
752772|NCT00003338|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
752773|NCT00003338|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
752774|NCT00003338|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
752775|NCT00003338|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
752776|NCT00003338|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
752777|NCT00003338|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
752778|NCT00003338|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
752779|NCT00003338|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
752780|NCT00003338|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
752781|NCT00003338|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
752782|NCT00003338|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
752783|NCT00003338|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
752784|NCT00003338|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
752785|NCT00003338|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
752786|NCT00003338|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
752787|NCT00003338|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
752788|NCT00003338|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
752789|NCT00003338|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
752790|NCT00003338|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
752791|NCT00003338|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
752792|NCT00003338|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
752793|NCT00003338|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
752794|NCT00003338|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
752795|NCT00003338|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
752796|NCT00003338|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
752797|NCT00003338|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
752798|NCT00003338|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
752799|NCT00003338|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
752800|NCT00003338|stage I mantle cell lymphoma|stage i mantle cell lymphoma
752801|NCT00003338|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
752802|NCT00003338|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
752803|NCT00003338|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
752804|NCT00003338|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
752805|NCT00003338|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
752806|NCT00003338|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
752807|NCT00003338|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
752808|NCT00003338|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
752809|NCT00003338|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
753436|NCT00006890|stage III multiple myeloma|stage iii multiple myeloma
752810|NCT00003338|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
752811|NCT00003338|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
752812|NCT00003338|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
752813|NCT00003338|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
752814|NCT00003338|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
752815|NCT00003338|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
752816|NCT00003338|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
752817|NCT00003338|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
752818|NCT00003338|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
752819|NCT00003338|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
752820|NCT00003338|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
752821|NCT00003338|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
752822|NCT00003338|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
752823|NCT00003338|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
752824|NCT00003338|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
752825|NCT00003338|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
752826|NCT00003338|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
752827|NCT00003338|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
752828|NCT00003338|stage I marginal zone lymphoma|stage i marginal zone lymphoma
752829|NCT00003338|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
752830|NCT00003338|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
752831|NCT00003338|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
752832|NCT00003338|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
752833|NCT00003338|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
752834|NCT00003338|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
752835|NCT00003338|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
752836|NCT00003338|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
752837|NCT00003338|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
752838|NCT00003338|splenic marginal zone lymphoma|splenic marginal zone lymphoma
752839|NCT00003337|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
752840|NCT00003337|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
752841|NCT00003337|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
752842|NCT00003337|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
752843|NCT00003337|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
752844|NCT00003337|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
752845|NCT00003337|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
752846|NCT00003337|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
752847|NCT00003337|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
752848|NCT00003337|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
752849|NCT00003337|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
752850|NCT00003337|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
752851|NCT00003337|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
752852|NCT00003337|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
752853|NCT00003337|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
752854|NCT00003337|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
752855|NCT00003337|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
752856|NCT00003337|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
752857|NCT00003337|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
752858|NCT00003337|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
752859|NCT00003337|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
752860|NCT00003337|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
752861|NCT00003337|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
752862|NCT00003337|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
752863|NCT00003337|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
752864|NCT00003337|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
752865|NCT00003337|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
752866|NCT00003337|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
752867|NCT00003337|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
752868|NCT00003337|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
752869|NCT00003337|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
752870|NCT00003337|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
753437|NCT00006467|stage III pancreatic cancer|stage iii pancreatic cancer
752871|NCT00003337|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
752872|NCT00003337|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
752873|NCT00003337|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
752874|NCT00003337|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
752875|NCT00003337|stage I mantle cell lymphoma|stage i mantle cell lymphoma
752876|NCT00003337|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
752877|NCT00003337|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
752878|NCT00003337|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
752879|NCT00003337|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
752880|NCT00003337|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
752881|NCT00003337|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
752882|NCT00003337|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
752883|NCT00003337|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
752884|NCT00003337|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
752885|NCT00003337|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
752886|NCT00003337|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
752887|NCT00003337|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
752888|NCT00003337|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
752889|NCT00003337|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
752890|NCT00003337|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
752891|NCT00003337|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
752892|NCT00003337|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
752893|NCT00003337|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
752894|NCT00003337|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
752895|NCT00003337|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
752896|NCT00003337|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
752897|NCT00003337|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
752898|NCT00003337|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
752899|NCT00003337|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
752900|NCT00003337|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
752901|NCT00003337|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
752902|NCT00003337|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
752903|NCT00003337|stage I marginal zone lymphoma|stage i marginal zone lymphoma
752904|NCT00003337|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
752905|NCT00003337|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
752906|NCT00003337|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
752907|NCT00003337|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
752908|NCT00003337|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
752909|NCT00003337|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
752910|NCT00003337|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
752911|NCT00003337|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
752912|NCT00003337|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
752913|NCT00003337|splenic marginal zone lymphoma|splenic marginal zone lymphoma
752914|NCT00003212|adult angiosarcoma|adult angiosarcoma
752915|NCT00003212|adult fibrosarcoma|adult fibrosarcoma
752916|NCT00003212|adult leiomyosarcoma|adult leiomyosarcoma
752917|NCT00003212|adult liposarcoma|adult liposarcoma
752918|NCT00003212|adult neurofibrosarcoma|adult neurofibrosarcoma
752919|NCT00003212|adult synovial sarcoma|adult synovial sarcoma
752920|NCT00003212|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
752921|NCT00003212|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
752922|NCT00003212|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
752923|NCT00003212|adult rhabdomyosarcoma|adult rhabdomyosarcoma
752924|NCT00003212|stage IV uterine sarcoma|stage iv uterine sarcoma
752925|NCT00003212|recurrent uterine sarcoma|recurrent uterine sarcoma
752926|NCT00003212|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
752927|NCT00003021|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
752928|NCT00003014|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
752929|NCT00003014|testicular seminoma|testicular seminoma
752930|NCT00002930|stage I non-small cell lung cancer|stage i non-small cell lung cancer
752931|NCT00002930|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
752932|NCT00002930|stage I esophageal cancer|stage i esophageal cancer
752933|NCT00002930|stage II esophageal cancer|stage ii esophageal cancer
752934|NCT00002930|stage III esophageal cancer|stage iii esophageal cancer
780978|NCT00044772|Disorder|disorder
752935|NCT00002930|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
752936|NCT00002930|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
752937|NCT00002928|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
752938|NCT00002919|stage II bladder cancer|stage ii bladder cancer
752939|NCT00002919|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
752940|NCT00002901|stage IV breast cancer|stage iv breast cancer
752941|NCT00002901|stage IIIA breast cancer|stage iiia breast cancer
752942|NCT00002901|recurrent breast cancer|recurrent breast cancer
752943|NCT00002901|stage IIIB breast cancer|stage iiib breast cancer
752944|NCT00002901|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
752945|NCT00002901|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
752946|NCT00002901|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
752947|NCT00002901|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
752948|NCT00002901|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
752949|NCT00002901|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
752950|NCT00002901|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
752951|NCT00002901|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
752952|NCT00002901|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
752953|NCT00002901|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
752954|NCT00002901|ovarian stromal cancer|ovarian stromal cancer
752955|NCT00002901|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
752956|NCT00002901|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
752957|NCT00002901|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
752958|NCT00002901|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
752959|NCT00002901|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
752960|NCT00002901|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
752961|NCT00002901|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
752962|NCT00002901|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
752963|NCT00002901|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
752964|NCT00002901|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
752965|NCT00002901|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
752966|NCT00002901|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
752967|NCT00002901|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
752968|NCT00002901|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
752969|NCT00002901|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
752970|NCT00002901|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
754961|NCT00077922|Oncology|oncology
752971|NCT00002901|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
752972|NCT00002901|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
752973|NCT00002901|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
752974|NCT00002901|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
752975|NCT00002901|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
752976|NCT00002901|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
752977|NCT00002901|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
752978|NCT00002901|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
752979|NCT00002901|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
752980|NCT00002901|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
752981|NCT00002901|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
752982|NCT00002901|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
752983|NCT00002901|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
752984|NCT00002901|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
752985|NCT00002901|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
752986|NCT00002901|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
752987|NCT00002901|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
752988|NCT00002901|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
752989|NCT00002901|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
752990|NCT00002901|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
752991|NCT00002901|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
752992|NCT00002901|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
752993|NCT00002901|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
753438|NCT00006467|recurrent pancreatic cancer|recurrent pancreatic cancer
752994|NCT00002901|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
752995|NCT00002901|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
752996|NCT00002901|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
752997|NCT00002901|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
752998|NCT00002901|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
752999|NCT00002901|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
753000|NCT00002901|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
753001|NCT00002901|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
753002|NCT00002901|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
753003|NCT00002901|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
753004|NCT00002901|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
753005|NCT00002901|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
753006|NCT00002901|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
753007|NCT00002901|ovarian sarcoma|ovarian sarcoma
753008|NCT00002858|limited stage small cell lung cancer|limited stage small cell lung cancer
753009|NCT00079612|Renal Cell Cancer|renal cell cancer
753010|NCT00079612|RCC|rcc
753011|NCT00079612|Cancer|cancer
753012|NCT00079508|Heparin-induced Thrombocytopenia|heparin-induced thrombocytopenia
753013|NCT00079508|Heparin-induced Thrombocytopenia/Thrombosis Syndrome|heparin-induced thrombocytopenia/thrombosis syndrome
753014|NCT00079508|HIT/HITTS|hit/hitts
753015|NCT00079508|Heparin anti-body positive|heparin anti-body positive
753016|NCT00021359|stage I multiple myeloma|stage i multiple myeloma
753017|NCT00021359|stage II multiple myeloma|stage ii multiple myeloma
753018|NCT00021359|stage III multiple myeloma|stage iii multiple myeloma
753019|NCT00017030|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
753020|NCT00017030|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
753021|NCT00017030|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
753022|NCT00016978|stage IV colon cancer|stage iv colon cancer
753023|NCT00016978|stage IV rectal cancer|stage iv rectal cancer
753024|NCT00016978|recurrent colon cancer|recurrent colon cancer
753025|NCT00016978|recurrent rectal cancer|recurrent rectal cancer
753026|NCT00016978|adenocarcinoma of the colon|adenocarcinoma of the colon
753027|NCT00016978|adenocarcinoma of the rectum|adenocarcinoma of the rectum
753028|NCT00014547|extensive stage small cell lung cancer|extensive stage small cell lung cancer
753029|NCT00014547|recurrent small cell lung cancer|recurrent small cell lung cancer
753030|NCT00007969|stage III melanoma|stage iii melanoma
753031|NCT00007969|stage IV melanoma|stage iv melanoma
753032|NCT00007969|recurrent melanoma|recurrent melanoma
753033|NCT00002823|stage I non-small cell lung cancer|stage i non-small cell lung cancer
753034|NCT00002823|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
753035|NCT00002823|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
753036|NCT00002823|squamous cell lung cancer|squamous cell lung cancer
753037|NCT00002823|large cell lung cancer|large cell lung cancer
753038|NCT00002823|adenocarcinoma of the lung|adenocarcinoma of the lung
753039|NCT00002823|adenosquamous cell lung cancer|adenosquamous cell lung cancer
753040|NCT00002650|colon cancer|colon cancer
753041|NCT00002650|rectal cancer|rectal cancer
753042|NCT00002601|metastatic osteosarcoma|metastatic osteosarcoma
753043|NCT00002601|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
753044|NCT00002601|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
753045|NCT00002601|recurrent osteosarcoma|recurrent osteosarcoma
753046|NCT00002601|adult rhabdomyosarcoma|adult rhabdomyosarcoma
753047|NCT00002601|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
753048|NCT00002601|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
753049|NCT00002601|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
753050|NCT00002601|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
753051|NCT00002601|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
753052|NCT00002601|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
753053|NCT00002581|stage I breast cancer|stage i breast cancer
753054|NCT00002581|stage II breast cancer|stage ii breast cancer
753055|NCT00002581|stage IIIA breast cancer|stage iiia breast cancer
753056|NCT00002580|stage I breast cancer|stage i breast cancer
753057|NCT00002580|stage II breast cancer|stage ii breast cancer
753058|NCT00002580|stage IIIA breast cancer|stage iiia breast cancer
753059|NCT00002537|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
753060|NCT00002537|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
753061|NCT00002537|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
753062|NCT00002537|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
753063|NCT00002526|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
753064|NCT00002526|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
753065|NCT00002526|stage III uterine sarcoma|stage iii uterine sarcoma
753066|NCT00002526|stage IV uterine sarcoma|stage iv uterine sarcoma
753067|NCT00002526|recurrent uterine sarcoma|recurrent uterine sarcoma
753068|NCT00002526|ovarian sarcoma|ovarian sarcoma
753069|NCT00002526|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
753070|NCT00002508|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
753071|NCT00002508|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
753072|NCT00002508|extragonadal germ cell tumor|extragonadal germ cell tumor
753073|NCT00002480|adenocarcinoma of the prostate|adenocarcinoma of the prostate
753074|NCT00002480|stage IIB prostate cancer|stage iib prostate cancer
753075|NCT00002480|stage IIA prostate cancer|stage iia prostate cancer
753076|NCT00002480|stage III prostate cancer|stage iii prostate cancer
753077|NCT00002459|stage I uterine sarcoma|stage i uterine sarcoma
753078|NCT00002459|stage II uterine sarcoma|stage ii uterine sarcoma
753079|NCT00002459|uterine carcinosarcoma|uterine carcinosarcoma
753080|NCT00002459|uterine leiomyosarcoma|uterine leiomyosarcoma
753081|NCT00002459|endometrial stromal sarcoma|endometrial stromal sarcoma
753082|NCT00079625|Engraftment|engraftment
753083|NCT00079625|Graft-Versus-Host Disease|graft-versus-host disease
753084|NCT00079625|Metastatic Breast Cancer|metastatic breast cancer
753085|NCT00079625|MBC|mbc
753086|NCT00079599|Carnitine Deficiency|carnitine deficiency
753087|NCT00079599|Fatigue|fatigue
753088|NCT00079599|Complementary Therapies|complementary therapies
753089|NCT00079573|Weight Loss|weight loss
753090|NCT00079573|Obesity|obesity
753091|NCT00079573|Overweight|overweight
753092|NCT00079573|Premenopausal women|premenopausal women
753093|NCT00079573|Diet|diet
753094|NCT00079560|HIV|hiv
753095|NCT00079560|Marijuana|marijuana
753096|NCT00079560|Marinol|marinol
753097|NCT00079560|Oral THC|oral thc
753098|NCT00079560|Appetite|appetite
753099|NCT00079560|Complementary Therapies|complementary therapies
753100|NCT00079547|Weight Loss|weight loss
753101|NCT00079534|AIDS|aids
753102|NCT00079534|HIV|hiv
753103|NCT00079534|Prayer|prayer
753104|NCT00079534|Healing|healing
753105|NCT00079534|Complementary Therapies|complementary therapies
753106|NCT00079521|Bone Metabolism|bone metabolism
753107|NCT00079521|Therapeutic Touch|therapeutic touch
753108|NCT00079495|MS|ms
753109|NCT00079495|Autoimmune disease|autoimmune disease
753110|NCT00079495|relapsing|relapsing
753111|NCT00079495|progressive|progressive
753112|NCT00079495|Myelin|myelin
753113|NCT00079495|Myelin Basic Protein|myelin basic protein
753114|NCT00079495|MBP|mbp
753115|NCT00079495|acute fulminating|acute fulminating
753116|NCT00079495|chronic progressive|chronic progressive
753117|NCT00079495|Altered Peptide Ligand|altered peptide ligand
753118|NCT00079495|APL|apl
753119|NCT00079495|Neurocrine|neurocrine
753120|NCT00079495|NBI-5788|nbi-5788
753121|NCT00079495|Relapse|relapse
753122|NCT00079482|AML|aml
753123|NCT00079469|cancer survivor|cancer survivor
753124|NCT00079469|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
753125|NCT00079391|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
753126|NCT00079391|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
753127|NCT00079391|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
753128|NCT00079391|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
753129|NCT00079391|Myelodysplastic Syndromes (MDS)|myelodysplastic syndromes (mds)
753130|NCT00079391|Peripheral Blood Stem Cells|peripheral blood stem cells
753131|NCT00079391|Graft-Versus Leukemia/Myeloma|graft-versus leukemia/myeloma
753132|NCT00079391|Graft-Versus-Host Disease (GVHD)|graft-versus-host disease (gvhd)
753133|NCT00079391|Cyclosporine|cyclosporine
753134|NCT00079391|Fludarabine|fludarabine
753135|NCT00079391|Leukemia|leukemia
753136|NCT00079391|Myelodysplastic Syndrome|myelodysplastic syndrome
753137|NCT00079391|Myeloproliferative Syndrome|myeloproliferative syndrome
753138|NCT00079391|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
753139|NCT00079365|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
753140|NCT00079365|stage II pancreatic cancer|stage ii pancreatic cancer
753141|NCT00079365|stage III pancreatic cancer|stage iii pancreatic cancer
753142|NCT00079365|stage IV pancreatic cancer|stage iv pancreatic cancer
753143|NCT00079313|CMML|cmml
753144|NCT00079313|CML|cml
753145|NCT00079313|Gleevec|gleevec
753146|NCT00079313|Glivec|glivec
753147|NCT00079313|STI-571|sti-571
753148|NCT00079313|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
753149|NCT00079313|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
753150|NCT00079313|Atypical Chronic Myelogenous Leukemia|atypical chronic myelogenous leukemia
753151|NCT00079313|Chronic Myelomoncytic Leukemia|chronic myelomoncytic leukemia
753152|NCT00079313|Leukemia|leukemia
753153|NCT00079300|basal cell carcinoma of the skin|basal cell carcinoma of the skin
753154|NCT00079287|adenocarcinoma of the lung|adenocarcinoma of the lung
753156|NCT00079287|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
753157|NCT00079287|squamous cell lung cancer|squamous cell lung cancer
753158|NCT00079287|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
753159|NCT00079287|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
753160|NCT00079261|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
753161|NCT00079261|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
753162|NCT00079261|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
753163|NCT00079261|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
753164|NCT00079261|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
753165|NCT00079261|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
753166|NCT00079261|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
753167|NCT00079261|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
753168|NCT00079261|anaplastic large cell lymphoma|anaplastic large cell lymphoma
753169|NCT00079261|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
753170|NCT00079261|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
753171|NCT00079261|small intestine lymphoma|small intestine lymphoma
753172|NCT00079248|osteoporosis|osteoporosis
753173|NCT00079248|stage I breast cancer|stage i breast cancer
753174|NCT00079248|stage II breast cancer|stage ii breast cancer
753175|NCT00079248|menopausal symptoms|menopausal symptoms
753176|NCT00079248|hot flashes|hot flashes
753177|NCT00079222|infection|infection
753178|NCT00079222|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
753179|NCT00079222|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
753180|NCT00079222|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
753181|NCT00079222|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
753182|NCT00079222|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
753183|NCT00079222|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
753184|NCT00079222|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
753185|NCT00079222|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
753186|NCT00079222|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
753187|NCT00079222|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
753188|NCT00079222|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
753189|NCT00079222|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
753190|NCT00079222|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
753191|NCT00079222|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
753192|NCT00079222|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
753193|NCT00079222|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
753194|NCT00079222|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
753195|NCT00079222|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
753196|NCT00079222|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
753197|NCT00079222|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
753198|NCT00079222|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
753199|NCT00079222|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
753200|NCT00079222|secondary acute myeloid leukemia|secondary acute myeloid leukemia
753201|NCT00079222|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
753202|NCT00079222|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
753203|NCT00079222|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
753204|NCT00079222|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
753205|NCT00079222|chronic eosinophilic leukemia|chronic eosinophilic leukemia
753206|NCT00079222|primary myelofibrosis|primary myelofibrosis
753207|NCT00079222|chronic neutrophilic leukemia|chronic neutrophilic leukemia
753208|NCT00079222|stage I multiple myeloma|stage i multiple myeloma
753209|NCT00079222|stage II multiple myeloma|stage ii multiple myeloma
753210|NCT00079222|stage III multiple myeloma|stage iii multiple myeloma
753211|NCT00079222|refractory hairy cell leukemia|refractory hairy cell leukemia
753212|NCT00079222|refractory multiple myeloma|refractory multiple myeloma
753213|NCT00079222|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
753214|NCT00079222|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
753215|NCT00079222|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
753216|NCT00079222|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
753217|NCT00079222|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
753218|NCT00079222|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
753219|NCT00079222|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
753220|NCT00079222|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
753221|NCT00079222|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
753222|NCT00079222|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
753223|NCT00079222|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
753224|NCT00079222|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
753225|NCT00079222|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
753226|NCT00079222|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
753227|NCT00079222|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
753228|NCT00079222|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
753229|NCT00079222|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
753230|NCT00079222|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
753231|NCT00079222|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
753232|NCT00079222|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
753233|NCT00079222|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
753234|NCT00079222|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
753235|NCT00079222|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
753236|NCT00079222|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
753237|NCT00079222|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
753238|NCT00079222|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
753239|NCT00079222|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
753240|NCT00079222|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
753241|NCT00079222|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
753242|NCT00079222|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
753243|NCT00079222|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
753244|NCT00079222|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
753245|NCT00079222|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
753246|NCT00079222|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
753247|NCT00079222|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
753248|NCT00079222|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
753249|NCT00079222|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
753250|NCT00079222|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
753251|NCT00079222|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
753252|NCT00079222|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
753253|NCT00079222|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
753254|NCT00079222|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
753255|NCT00079222|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
753256|NCT00079222|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
753257|NCT00079222|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
753258|NCT00079222|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
753259|NCT00079222|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
753260|NCT00079222|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
753261|NCT00079222|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
753262|NCT00079222|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
753263|NCT00079222|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
753264|NCT00079222|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
753265|NCT00079222|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
753266|NCT00079222|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
753267|NCT00079222|disseminated neuroblastoma|disseminated neuroblastoma
753268|NCT00079222|recurrent neuroblastoma|recurrent neuroblastoma
753269|NCT00079222|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
753270|NCT00079222|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
753271|NCT00079222|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
753272|NCT00079222|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
753273|NCT00079222|stage IIIA breast cancer|stage iiia breast cancer
753274|NCT00079222|stage IIIB breast cancer|stage iiib breast cancer
753275|NCT00079222|stage IIIC breast cancer|stage iiic breast cancer
753276|NCT00079222|stage IV breast cancer|stage iv breast cancer
753277|NCT00079222|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
753278|NCT00079222|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
753279|NCT00079222|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
753280|NCT00079222|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
753281|NCT00079222|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
753282|NCT00079222|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
753283|NCT00079222|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
753284|NCT00079222|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
753285|NCT00079222|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
753286|NCT00079222|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
753287|NCT00079222|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
753288|NCT00079222|splenic marginal zone lymphoma|splenic marginal zone lymphoma
753289|NCT00079222|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
753290|NCT00079222|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
753291|NCT00079222|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
753292|NCT00079222|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
753293|NCT00079222|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
753294|NCT00079222|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
753295|NCT00079170|male breast cancer|male breast cancer
753296|NCT00079170|recurrent breast cancer|recurrent breast cancer
753297|NCT00079170|stage IIIA breast cancer|stage iiia breast cancer
753298|NCT00079170|stage IIIB breast cancer|stage iiib breast cancer
753299|NCT00079170|stage IIIC breast cancer|stage iiic breast cancer
753300|NCT00079170|stage IV breast cancer|stage iv breast cancer
753301|NCT00079157|recurrent breast cancer|recurrent breast cancer
753302|NCT00079157|stage IV breast cancer|stage iv breast cancer
753303|NCT00079144|recurrent melanoma|recurrent melanoma
753304|NCT00079144|stage IV melanoma|stage iv melanoma
753305|NCT00079118|stage IV breast cancer|stage iv breast cancer
753306|NCT00079118|recurrent breast cancer|recurrent breast cancer
753307|NCT00079118|male breast cancer|male breast cancer
753308|NCT00079105|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
753309|NCT00079105|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
753310|NCT00079105|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
753311|NCT00079105|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
753312|NCT00079092|recurrent adult brain tumor|recurrent adult brain tumor
753313|NCT00079092|adult anaplastic astrocytoma|adult anaplastic astrocytoma
753314|NCT00079092|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
753315|NCT00079092|adult glioblastoma|adult glioblastoma
753316|NCT00079092|adult mixed glioma|adult mixed glioma
753317|NCT00079092|adult giant cell glioblastoma|adult giant cell glioblastoma
753318|NCT00079092|adult gliosarcoma|adult gliosarcoma
753319|NCT00079079|stage II salivary gland cancer|stage ii salivary gland cancer
753320|NCT00079079|stage III salivary gland cancer|stage iii salivary gland cancer
753321|NCT00079079|stage IV salivary gland cancer|stage iv salivary gland cancer
753322|NCT00079079|recurrent salivary gland cancer|recurrent salivary gland cancer
753323|NCT00079079|salivary gland acinic cell tumor|salivary gland acinic cell tumor
753324|NCT00079079|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
753325|NCT00079079|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
753326|NCT00079079|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
753327|NCT00079079|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
753328|NCT00079079|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
753329|NCT00079079|salivary gland adenocarcinoma|salivary gland adenocarcinoma
753330|NCT00079079|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
753331|NCT00079079|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
753332|NCT00079066|quality of life|quality of life
753333|NCT00079066|stage IV colon cancer|stage iv colon cancer
753334|NCT00079066|recurrent colon cancer|recurrent colon cancer
753335|NCT00079066|recurrent rectal cancer|recurrent rectal cancer
753336|NCT00079066|stage IV rectal cancer|stage iv rectal cancer
753337|NCT00079053|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
753338|NCT00079053|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
753339|NCT00079053|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
753340|NCT00079053|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
753341|NCT00079053|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
753342|NCT00079053|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
753343|NCT00079053|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
753344|NCT00079053|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
753345|NCT00079053|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
753346|NCT00079053|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
753347|NCT00079053|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
753348|NCT00079053|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
753349|NCT00079053|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
753350|NCT00079053|stage III salivary gland cancer|stage iii salivary gland cancer
753351|NCT00079053|stage IV salivary gland cancer|stage iv salivary gland cancer
753352|NCT00079027|advanced adult primary liver cancer|advanced adult primary liver cancer
753353|NCT00079027|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
753354|NCT00079001|adenocarcinoma of the prostate|adenocarcinoma of the prostate
753355|NCT00079001|recurrent prostate cancer|recurrent prostate cancer
753356|NCT00079001|stage IV prostate cancer|stage iv prostate cancer
753357|NCT00079001|bone metastases|bone metastases
753358|NCT00078988|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
753359|NCT00078988|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
753360|NCT00078988|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
753361|NCT00078975|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
753362|NCT00078975|recurrent pancreatic cancer|recurrent pancreatic cancer
753363|NCT00078975|stage II pancreatic cancer|stage ii pancreatic cancer
753364|NCT00078975|stage III pancreatic cancer|stage iii pancreatic cancer
753365|NCT00078975|stage IV pancreatic cancer|stage iv pancreatic cancer
753366|NCT00078949|anaplastic large cell lymphoma|anaplastic large cell lymphoma
753367|NCT00078949|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
753368|NCT00078949|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
753369|NCT00078949|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
753370|NCT00078923|stage I prostate cancer|stage i prostate cancer
753371|NCT00078923|stage II prostate cancer|stage ii prostate cancer
753372|NCT00078923|adenocarcinoma of the prostate|adenocarcinoma of the prostate
753373|NCT00078910|adenocarcinoma of the prostate|adenocarcinoma of the prostate
753374|NCT00078910|stage IIB prostate cancer|stage iib prostate cancer
753375|NCT00078910|stage IIA prostate cancer|stage iia prostate cancer
753376|NCT00078910|stage III prostate cancer|stage iii prostate cancer
753377|NCT00078897|colon cancer|colon cancer
753378|NCT00078897|rectal cancer|rectal cancer
753379|NCT00078897|colorectal cancer|colorectal cancer
753380|NCT00078897|adenomatous polyp|adenomatous polyp
753381|NCT00078845|neurotoxicity|neurotoxicity
753382|NCT00078845|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
753383|NCT00078845|recurrent prostate cancer|recurrent prostate cancer
753384|NCT00078845|stage I prostate cancer|stage i prostate cancer
753385|NCT00078845|stage IIB prostate cancer|stage iib prostate cancer
753386|NCT00078845|stage IIA prostate cancer|stage iia prostate cancer
753387|NCT00078845|stage III prostate cancer|stage iii prostate cancer
753388|NCT00078845|stage IV prostate cancer|stage iv prostate cancer
753389|NCT00078845|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
753390|NCT00078845|stage I non-small cell lung cancer|stage i non-small cell lung cancer
753391|NCT00078845|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
753392|NCT00078845|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
753393|NCT00078845|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
753394|NCT00078845|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
753395|NCT00078845|limited stage small cell lung cancer|limited stage small cell lung cancer
753396|NCT00078845|extensive stage small cell lung cancer|extensive stage small cell lung cancer
753397|NCT00078845|recurrent small cell lung cancer|recurrent small cell lung cancer
753398|NCT00078845|recurrent breast cancer|recurrent breast cancer
753399|NCT00078845|stage I breast cancer|stage i breast cancer
753400|NCT00078845|stage II breast cancer|stage ii breast cancer
753401|NCT00078845|stage IIIA breast cancer|stage iiia breast cancer
753402|NCT00078845|stage IIIB breast cancer|stage iiib breast cancer
753403|NCT00078845|stage IIIC breast cancer|stage iiic breast cancer
753404|NCT00078845|stage IV breast cancer|stage iv breast cancer
753405|NCT00078845|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
753406|NCT00078845|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
753407|NCT00078845|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
753408|NCT00078845|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
753409|NCT00078845|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
753410|NCT00078832|breast cancer, chemoprevention|breast cancer, chemoprevention
753411|NCT00078819|Pediatric Psoriasis|pediatric psoriasis
753412|NCT00078806|Systemic Onset Juvenile Rheumatoid Arthiritis|systemic onset juvenile rheumatoid arthiritis
753414|NCT00078806|Fever|fever
753415|NCT00078806|Rash|rash
753416|NCT00078806|Joint Pain|joint pain
753417|NCT00078793|JRA|jra
753418|NCT00078793|Registry|registry
753419|NCT00078767|PTSD|ptsd
753420|NCT00078767|Depression|depression
753421|NCT00078767|Anxiety|anxiety
753422|NCT00078741|Psychotic Disorders|psychotic disorders
753423|NCT00078728|Anxiety|anxiety
753424|NCT00078611|Crohn's disease|crohn's disease
753425|NCT00078611|Inflammatory Bowel Disease|inflammatory bowel disease
753426|NCT00078611|IBD|ibd
753427|NCT00078611|Gastroenterology|gastroenterology
753428|NCT00078611|Regional Enteritis|regional enteritis
753429|NCT00078611|Colitis|colitis
753430|NCT00007007|tumors metastatic to brain|tumors metastatic to brain
753431|NCT00007007|radiation toxicity|radiation toxicity
753432|NCT00007007|cognitive/functional effects|cognitive/functional effects
753433|NCT00006890|refractory multiple myeloma|refractory multiple myeloma
753434|NCT00006890|stage I multiple myeloma|stage i multiple myeloma
753435|NCT00006890|stage II multiple myeloma|stage ii multiple myeloma
780979|NCT00044759|Hematologic|hematologic
753439|NCT00006467|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
753440|NCT00006467|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
753441|NCT00006467|stage IV pancreatic cancer|stage iv pancreatic cancer
753442|NCT00006452|adult glioblastoma|adult glioblastoma
753443|NCT00006452|adult giant cell glioblastoma|adult giant cell glioblastoma
753444|NCT00006452|adult gliosarcoma|adult gliosarcoma
753445|NCT00006350|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
753446|NCT00006350|refractory multiple myeloma|refractory multiple myeloma
753447|NCT00006350|stage I multiple myeloma|stage i multiple myeloma
753448|NCT00006350|stage II multiple myeloma|stage ii multiple myeloma
753449|NCT00006350|stage III multiple myeloma|stage iii multiple myeloma
753450|NCT00006350|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
753451|NCT00006350|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
753452|NCT00006350|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
753453|NCT00006350|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
753454|NCT00006350|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
753455|NCT00006350|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
753456|NCT00006350|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
753457|NCT00006350|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
753458|NCT00006350|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
753459|NCT00006350|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
753460|NCT00006350|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
753461|NCT00006350|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
753462|NCT00006350|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
753463|NCT00006350|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
753464|NCT00006350|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
753465|NCT00006350|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
753466|NCT00006350|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
753467|NCT00006350|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
753468|NCT00006350|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
753469|NCT00006350|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
753470|NCT00006350|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
753471|NCT00006350|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
753472|NCT00006350|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
753473|NCT00006350|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
753474|NCT00006350|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
753475|NCT00006350|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
753476|NCT00006350|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
753477|NCT00006350|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
753478|NCT00006350|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
753479|NCT00006350|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
753480|NCT00006350|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
753481|NCT00006350|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
753482|NCT00006350|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
753483|NCT00006350|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
753484|NCT00006350|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
753485|NCT00006350|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
753486|NCT00006350|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
753487|NCT00006350|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
753488|NCT00006350|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
753489|NCT00006350|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
753490|NCT00006350|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
753491|NCT00006350|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
753492|NCT00006350|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
753493|NCT00006350|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
753494|NCT00006350|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
753495|NCT00006350|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
753496|NCT00006350|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
753497|NCT00006350|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
753498|NCT00006350|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
753499|NCT00006350|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
753500|NCT00006350|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
753501|NCT00006350|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
753577|NCT00005946|refractory multiple myeloma|refractory multiple myeloma
753502|NCT00006350|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
753503|NCT00006350|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
753504|NCT00006350|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
753505|NCT00006350|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
753506|NCT00006350|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
753507|NCT00006350|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
753508|NCT00006350|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
753509|NCT00006350|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
753510|NCT00006350|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
753511|NCT00006350|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
753512|NCT00006350|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
753513|NCT00006350|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
753514|NCT00006350|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
753515|NCT00006350|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
753516|NCT00006350|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
753517|NCT00006350|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
753518|NCT00006350|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
753519|NCT00006350|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
753520|NCT00006350|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
753521|NCT00006350|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
753522|NCT00006350|splenic marginal zone lymphoma|splenic marginal zone lymphoma
753523|NCT00006259|tumors metastatic to brain|tumors metastatic to brain
753524|NCT00006253|symptom management|symptom management
753525|NCT00006253|cancer|cancer
753526|NCT00006253|chemotherapy treatment|chemotherapy treatment
753527|NCT00006253|Behavioral Research|behavioral research
753528|NCT00006253|Physiological Effects of Drugs|physiological effects of drugs
753529|NCT00006253|Clinical Trial, Phase II|clinical trial, phase ii
753530|NCT00006126|stage IV breast cancer|stage iv breast cancer
753531|NCT00006126|recurrent breast cancer|recurrent breast cancer
753532|NCT00006126|stage IV renal cell cancer|stage iv renal cell cancer
753533|NCT00006126|recurrent renal cell cancer|recurrent renal cell cancer
753534|NCT00006126|extensive stage small cell lung cancer|extensive stage small cell lung cancer
753535|NCT00006126|recurrent small cell lung cancer|recurrent small cell lung cancer
753536|NCT00006126|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
753537|NCT00006126|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
753538|NCT00006126|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
753539|NCT00006126|stage IV melanoma|stage iv melanoma
753540|NCT00006126|recurrent melanoma|recurrent melanoma
753541|NCT00006115|stage IV colon cancer|stage iv colon cancer
753542|NCT00006115|stage IV rectal cancer|stage iv rectal cancer
753543|NCT00006115|recurrent colon cancer|recurrent colon cancer
753544|NCT00006115|recurrent rectal cancer|recurrent rectal cancer
753545|NCT00006115|adenocarcinoma of the colon|adenocarcinoma of the colon
753546|NCT00006115|adenocarcinoma of the rectum|adenocarcinoma of the rectum
753547|NCT00006018|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
753548|NCT00078715|Yohimbine|yohimbine
753549|NCT00078715|Sleep Deprivation|sleep deprivation
753550|NCT00078715|Depression|depression
753551|NCT00078715|Mood Disorder|mood disorder
753552|NCT00078715|Fast|fast
753553|NCT00078715|Affective Disorder|affective disorder
753554|NCT00078715|Rapid Onset|rapid onset
753555|NCT00078715|Major Depression|major depression
753556|NCT00078715|MDD|mdd
753557|NCT00078689|Sirolimus|sirolimus
753558|NCT00078689|Daclizumab|daclizumab
753559|NCT00078689|Inflammation|inflammation
753560|NCT00078689|Induce Tolerance|induce tolerance
753561|NCT00078689|Uveitis|uveitis
753562|NCT00078689|Immune Tolerance|immune tolerance
753563|NCT00078689|T Cell|t cell
753564|NCT00006000|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
753565|NCT00005965|stage III cervical cancer|stage iii cervical cancer
753566|NCT00005965|recurrent cervical cancer|recurrent cervical cancer
753567|NCT00005965|stage IVB cervical cancer|stage ivb cervical cancer
753568|NCT00005965|stage IVA cervical cancer|stage iva cervical cancer
753569|NCT00005965|cervical squamous cell carcinoma|cervical squamous cell carcinoma
753570|NCT00005965|cervical adenocarcinoma|cervical adenocarcinoma
753571|NCT00005965|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
753572|NCT00005947|adenocarcinoma of the prostate|adenocarcinoma of the prostate
753573|NCT00005947|stage IV prostate cancer|stage iv prostate cancer
753574|NCT00005947|recurrent prostate cancer|recurrent prostate cancer
753575|NCT00005946|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
753576|NCT00005946|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
780980|NCT00044759|Neoplasms|neoplasms
753578|NCT00005946|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
753579|NCT00005946|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
753580|NCT00005946|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
753581|NCT00005946|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
753582|NCT00005946|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
753583|NCT00005946|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
753584|NCT00005946|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
753585|NCT00005946|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
753586|NCT00005946|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
753587|NCT00005946|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
753588|NCT00005946|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
753589|NCT00005946|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
753590|NCT00005946|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
753591|NCT00005946|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
753592|NCT00005946|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
753593|NCT00005946|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
753594|NCT00005946|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
753595|NCT00005946|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
753596|NCT00005946|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
753597|NCT00005946|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
753598|NCT00005946|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
753599|NCT00005946|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
753600|NCT00005946|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
753601|NCT00005946|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
753602|NCT00005946|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
753603|NCT00005946|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
753604|NCT00005946|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
753605|NCT00005946|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
753606|NCT00005946|splenic marginal zone lymphoma|splenic marginal zone lymphoma
753607|NCT00005946|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
753608|NCT00005843|recurrent pancreatic cancer|recurrent pancreatic cancer
753609|NCT00005843|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
753610|NCT00005843|stage IV pancreatic cancer|stage iv pancreatic cancer
753611|NCT00078663|Oral Care|oral care
753613|NCT00078663|Pneumonia|pneumonia
753614|NCT00078663|Pathogens|pathogens
753615|NCT00078663|Intubation|intubation
753616|NCT00078663|Intubated|intubated
753617|NCT00078663|Oral Hygiene|oral hygiene
753618|NCT00078663|Intensive Care|intensive care
753619|NCT00078624|Osteoarthritis|osteoarthritis
753620|NCT00078624|Knee Joint|knee joint
753621|NCT00078624|Joint Stability|joint stability
753622|NCT00078624|Motor Control|motor control
753623|NCT00078624|Exercise Therapy|exercise therapy
753624|NCT00005595|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
753625|NCT00005096|adenocarcinoma of the prostate|adenocarcinoma of the prostate
753626|NCT00005096|stage II prostate cancer|stage ii prostate cancer
753627|NCT00005096|stage III prostate cancer|stage iii prostate cancer
753628|NCT00005035|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
753629|NCT00005035|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
753630|NCT00005035|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
753631|NCT00005035|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
753632|NCT00005035|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
753633|NCT00005035|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
753634|NCT00005035|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
753635|NCT00005035|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
753636|NCT00005035|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
753637|NCT00005035|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
753638|NCT00005035|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
753639|NCT00005035|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
753640|NCT00005035|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
753641|NCT00005035|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
753642|NCT00005035|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
753643|NCT00005035|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
753713|NCT00004904|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
753644|NCT00005035|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
753645|NCT00005035|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
753646|NCT00005035|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
753647|NCT00004914|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
753648|NCT00004914|anemia|anemia
753649|NCT00004914|fatigue|fatigue
753650|NCT00078598|Relapsed|relapsed
753651|NCT00078598|Follicular|follicular
753652|NCT00078572|XELODA|xeloda
753653|NCT00078572|Metastatic|metastatic
753654|NCT00078572|Breast Cancer|breast cancer
753655|NCT00078572|Advanced|advanced
753656|NCT00078572|HERCEPTIN|herceptin
753657|NCT00078507|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
753658|NCT00078507|Behavior Control|behavior control
753659|NCT00078507|Sensation|sensation
753660|NCT00078507|Randomized Controlled Trials|randomized controlled trials
753661|NCT00078507|Adolescent|adolescent
753662|NCT00078507|Adult|adult
753663|NCT00004912|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
753664|NCT00004912|fatigue|fatigue
753665|NCT00004912|cachexia|cachexia
753666|NCT00004908|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
753667|NCT00004908|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
753668|NCT00004908|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
753669|NCT00004908|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
753670|NCT00004908|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
753671|NCT00004908|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
753672|NCT00004908|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
753673|NCT00004908|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
753674|NCT00004908|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
753675|NCT00004908|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
753676|NCT00004908|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
753677|NCT00004908|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
753678|NCT00004908|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
753679|NCT00004908|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
753680|NCT00004908|splenic marginal zone lymphoma|splenic marginal zone lymphoma
753681|NCT00004904|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
753682|NCT00004904|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
753683|NCT00004904|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
753684|NCT00004904|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
753685|NCT00004904|isolated plasmacytoma of bone|isolated plasmacytoma of bone
753686|NCT00004904|extramedullary plasmacytoma|extramedullary plasmacytoma
753687|NCT00004904|refractory multiple myeloma|refractory multiple myeloma
753688|NCT00004904|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
753689|NCT00004904|stage III multiple myeloma|stage iii multiple myeloma
753690|NCT00004904|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
753691|NCT00004904|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
753692|NCT00004904|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
753693|NCT00004904|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
753694|NCT00004904|small intestine lymphoma|small intestine lymphoma
753695|NCT00004904|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
753696|NCT00004904|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
753697|NCT00004904|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
753698|NCT00004904|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
753699|NCT00004904|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
753700|NCT00004904|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
753701|NCT00004904|polycythemia vera|polycythemia vera
753702|NCT00004904|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
753703|NCT00004904|essential thrombocythemia|essential thrombocythemia
753704|NCT00004904|refractory hairy cell leukemia|refractory hairy cell leukemia
753705|NCT00004904|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
753706|NCT00004904|acute undifferentiated leukemia|acute undifferentiated leukemia
753707|NCT00004904|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
753708|NCT00004904|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
753709|NCT00004904|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
753710|NCT00004904|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
753711|NCT00004904|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
753712|NCT00004904|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
754042|NCT00078390|Stage III|stage iii
753714|NCT00004904|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
753715|NCT00004904|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
753716|NCT00004904|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
753717|NCT00004904|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
753718|NCT00004904|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
753719|NCT00004904|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
753720|NCT00004904|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
753721|NCT00004904|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
753722|NCT00004904|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
753723|NCT00004904|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
753724|NCT00004904|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
753725|NCT00004904|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
753726|NCT00004904|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
753727|NCT00004904|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
753728|NCT00004904|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
753729|NCT00004904|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
753730|NCT00004904|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
753731|NCT00004904|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
753732|NCT00004904|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
753733|NCT00004904|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
753734|NCT00004904|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
753735|NCT00004904|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
753736|NCT00004904|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
753737|NCT00004904|secondary acute myeloid leukemia|secondary acute myeloid leukemia
753738|NCT00004904|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
753739|NCT00004904|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
753740|NCT00004904|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
753741|NCT00004904|graft versus host disease|graft versus host disease
753742|NCT00004904|primary systemic amyloidosis|primary systemic amyloidosis
753743|NCT00004904|intraocular lymphoma|intraocular lymphoma
753744|NCT00004904|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
753745|NCT00004904|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
753746|NCT00004904|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
753747|NCT00004904|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
753748|NCT00004904|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
753749|NCT00004904|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
753750|NCT00004904|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
753751|NCT00004904|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
753752|NCT00004904|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
753753|NCT00004904|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
753754|NCT00004904|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
753755|NCT00004904|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
753756|NCT00004904|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
753757|NCT00004904|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
753758|NCT00004904|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
753759|NCT00004904|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
753760|NCT00004904|splenic marginal zone lymphoma|splenic marginal zone lymphoma
753761|NCT00004904|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
753762|NCT00004898|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
753763|NCT00004898|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
753764|NCT00004898|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
753765|NCT00004898|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
753766|NCT00004898|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
753767|NCT00004898|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
753768|NCT00004898|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
753769|NCT00004898|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
753770|NCT00004898|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
753771|NCT00004898|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
753772|NCT00004898|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
753773|NCT00004898|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
753774|NCT00004898|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
753775|NCT00004898|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
753776|NCT00004898|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
753777|NCT00004898|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
753778|NCT00004898|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
753779|NCT00004898|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
753780|NCT00004898|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
753781|NCT00004898|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
753782|NCT00004898|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
753783|NCT00004898|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
753784|NCT00004898|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
753785|NCT00004898|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
753786|NCT00004898|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
753787|NCT00004898|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
753788|NCT00004898|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
753789|NCT00004898|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
753790|NCT00004898|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
753791|NCT00004898|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
753792|NCT00004898|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
753793|NCT00004898|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
753794|NCT00004898|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
753795|NCT00004898|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
753796|NCT00004235|stage IV gastric cancer|stage iv gastric cancer
753797|NCT00004235|recurrent gastric cancer|recurrent gastric cancer
753798|NCT00004235|stage II esophageal cancer|stage ii esophageal cancer
753799|NCT00004235|stage III esophageal cancer|stage iii esophageal cancer
753800|NCT00004235|stage IV esophageal cancer|stage iv esophageal cancer
753801|NCT00004235|recurrent esophageal cancer|recurrent esophageal cancer
753802|NCT00004235|adenocarcinoma of the stomach|adenocarcinoma of the stomach
753803|NCT00004235|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
753804|NCT00004175|stage IIIA breast cancer|stage iiia breast cancer
753805|NCT00004175|stage IIIB breast cancer|stage iiib breast cancer
753806|NCT00078559|Immunosuppression|immunosuppression
753807|NCT00078559|Renal Failure|renal failure
753809|NCT00078546|NASOPHARYNGEAL|nasopharyngeal
753810|NCT00078546|CARCINOMA|carcinoma
753811|NCT00078546|EBV POSITIVE NASOPHARYNGEAL CARCINOMA|ebv positive nasopharyngeal carcinoma
753812|NCT00078533|Allogeneic|allogeneic
753813|NCT00078533|Transplant|transplant
753814|NCT00078533|CMV|cmv
753815|NCT00078533|Stem Cell|stem cell
753816|NCT00078533|Donor|donor
753817|NCT00078533|Allogeneic stem cell recipients at risk for CMV reactivation|allogeneic stem cell recipients at risk for cmv reactivation
753818|NCT00078520|Leukemia|leukemia
753819|NCT00078494|Immunization|immunization
753820|NCT00078494|Vaccine|vaccine
753821|NCT00078494|Nasopharyngeal Cancer|nasopharyngeal cancer
753822|NCT00078494|Immunotherapy|immunotherapy
753823|NCT00078494|Cancer|cancer
753824|NCT00078494|NPC|npc
753825|NCT00078481|Neurodegeneration|neurodegeneration
753826|NCT00078481|Anti-Oxidant|anti-oxidant
753827|NCT00078481|Neuropathy|neuropathy
753828|NCT00078481|Hereditary|hereditary
753829|NCT00078481|Spinocerebellar|spinocerebellar
753830|NCT00078481|Friedreich Ataxia|friedreich ataxia
753831|NCT00078481|FRDA|frda
753832|NCT00078455|NSCLC|nsclc
753833|NCT00078455|Non-small Cell Lung Cancer|non-small cell lung cancer
753834|NCT00078455|Non-small Cell Lung Carcinoma|non-small cell lung carcinoma
753835|NCT00078455|Locally Advanced NSCLC|locally advanced nsclc
753836|NCT00078455|Metastatic NSCLC|metastatic nsclc
753837|NCT00078221|Dry AMD|dry amd
753838|NCT00078221|Age-related Macular Degeneration|age-related macular degeneration
753839|NCT00078221|Rheopheresis|rheopheresis
753840|NCT00004171|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
753841|NCT00004171|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
753842|NCT00004171|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
753843|NCT00004171|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
753844|NCT00004171|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
753845|NCT00004171|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
753846|NCT00004171|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
753847|NCT00004171|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
753848|NCT00004091|cervical cancer|cervical cancer
753849|NCT00003351|stage IV breast cancer|stage iv breast cancer
753850|NCT00003302|breast cancer|breast cancer
753851|NCT00003264|stage IV salivary gland cancer|stage iv salivary gland cancer
753852|NCT00003264|recurrent salivary gland cancer|recurrent salivary gland cancer
753853|NCT00003264|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
753854|NCT00003264|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
753855|NCT00003264|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
754043|NCT00078390|chemotherapy|chemotherapy
754044|NCT00078390|radiation|radiation
753856|NCT00003264|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
753857|NCT00003264|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
753858|NCT00003264|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
753859|NCT00003264|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
753860|NCT00003264|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
753861|NCT00003264|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
753862|NCT00003264|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
753863|NCT00003264|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
753864|NCT00003264|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
753865|NCT00003264|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
753866|NCT00003264|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
753867|NCT00003264|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
753868|NCT00003070|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
753869|NCT00003070|cardiac toxicity|cardiac toxicity
753870|NCT00003040|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
753871|NCT00003040|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
753872|NCT00003040|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
753873|NCT00002825|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
753874|NCT00002825|recurrent neuroblastoma|recurrent neuroblastoma
753875|NCT00002825|recurrent osteosarcoma|recurrent osteosarcoma
753876|NCT00002825|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
753877|NCT00002825|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
753878|NCT00002825|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
753879|NCT00002825|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
753880|NCT00002825|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
753881|NCT00002825|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
753882|NCT00002825|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
753883|NCT00002825|recurrent childhood ependymoma|recurrent childhood ependymoma
753884|NCT00002652|refractory multiple myeloma|refractory multiple myeloma
753885|NCT00026429|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
753886|NCT00026429|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
753887|NCT00026429|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
753888|NCT00026429|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
753889|NCT00026429|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
753890|NCT00026429|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
753891|NCT00026429|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
753892|NCT00026429|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
753893|NCT00026429|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
753894|NCT00026429|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
753895|NCT00026429|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
753896|NCT00026429|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
753897|NCT00026429|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
753898|NCT00026429|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
753899|NCT00026429|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
753900|NCT00026429|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
753901|NCT00026429|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
753902|NCT00026429|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
753903|NCT00026429|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
753904|NCT00026429|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
753905|NCT00026429|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
753906|NCT00026429|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
753907|NCT00026429|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
753908|NCT00026429|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
753909|NCT00026429|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
753910|NCT00026429|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
753911|NCT00026429|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
753912|NCT00026429|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
753913|NCT00026429|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
753914|NCT00026429|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
753915|NCT00026429|stage I mantle cell lymphoma|stage i mantle cell lymphoma
754045|NCT00078390|chemoradiation|chemoradiation
753916|NCT00026429|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
753917|NCT00026429|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
753918|NCT00026429|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
753919|NCT00026429|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
753920|NCT00026429|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
753921|NCT00026429|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
753922|NCT00026429|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
753923|NCT00026429|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
753924|NCT00026429|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
753925|NCT00026429|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
753926|NCT00026429|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
753927|NCT00026429|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
753928|NCT00026429|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
753929|NCT00026429|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
753930|NCT00026429|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
753931|NCT00026429|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
753932|NCT00026429|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
753933|NCT00026429|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
753934|NCT00026429|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
753935|NCT00026429|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
753936|NCT00026429|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
753937|NCT00026429|stage I marginal zone lymphoma|stage i marginal zone lymphoma
753938|NCT00026429|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
753939|NCT00026429|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
753940|NCT00026429|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
753941|NCT00026429|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
753942|NCT00026429|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
753943|NCT00026429|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
753944|NCT00026429|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
753945|NCT00026429|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
753946|NCT00025012|basal cell carcinoma of the skin|basal cell carcinoma of the skin
753947|NCT00025012|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
753948|NCT00025012|melanoma|melanoma
753949|NCT00024037|oral complications|oral complications
753950|NCT00022308|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
753951|NCT00022308|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
753952|NCT00022308|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
753953|NCT00022308|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
753954|NCT00022217|recurrent salivary gland cancer|recurrent salivary gland cancer
753955|NCT00022217|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
753956|NCT00022217|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
753957|NCT00022217|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
754962|NCT00077922|Lymphocytes|lymphocytes
753958|NCT00022217|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
753959|NCT00022217|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
753960|NCT00022217|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
753961|NCT00022217|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
753962|NCT00022217|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
753963|NCT00022217|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
753964|NCT00022217|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
753965|NCT00022217|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
753966|NCT00022217|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
753967|NCT00022178|adenocarcinoma of unknown primary|adenocarcinoma of unknown primary
753968|NCT00022178|squamous cell carcinoma of unknown primary|squamous cell carcinoma of unknown primary
753969|NCT00022178|undifferentiated carcinoma of unknown primary|undifferentiated carcinoma of unknown primary
753970|NCT00022178|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
753971|NCT00021996|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
753972|NCT00021996|pain|pain
753973|NCT00021372|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
753974|NCT00021372|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
753975|NCT00021372|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
754046|NCT00078390|matrix metalloproteinases|matrix metalloproteinases
753976|NCT00021372|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
753977|NCT00021372|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
753978|NCT00021372|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
753979|NCT00021372|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
753980|NCT00021372|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
753981|NCT00021372|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
753982|NCT00021372|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
753983|NCT00021372|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
753984|NCT00021372|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
753985|NCT00021372|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
753986|NCT00021372|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
753987|NCT00021372|splenic marginal zone lymphoma|splenic marginal zone lymphoma
753988|NCT00020618|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
753989|NCT00020618|pain|pain
753990|NCT00020098|breast cancer|breast cancer
753991|NCT00019409|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
753992|NCT00019409|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
753993|NCT00019409|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
753994|NCT00019409|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
753995|NCT00017303|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
753996|NCT00017303|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
753997|NCT00017303|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
753998|NCT00017303|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
753999|NCT00017303|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
754000|NCT00017303|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
754001|NCT00017303|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
754002|NCT00017303|primary peritoneal cavity cancer|primary peritoneal cavity cancer
754003|NCT00017303|Brenner tumor|brenner tumor
754004|NCT00016367|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
754005|NCT00016367|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
754006|NCT00015964|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
754007|NCT00015964|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
754008|NCT00015964|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
754009|NCT00015964|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
754010|NCT00015964|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
754011|NCT00015964|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
754012|NCT00015964|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
754013|NCT00015964|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
754014|NCT00015964|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
754015|NCT00015964|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
754016|NCT00015964|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
754017|NCT00015964|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
754018|NCT00015964|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
754019|NCT00015964|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
754020|NCT00002597|adenocarcinoma of the prostate|adenocarcinoma of the prostate
754021|NCT00002597|stage I prostate cancer|stage i prostate cancer
754022|NCT00002597|stage IIB prostate cancer|stage iib prostate cancer
754023|NCT00002597|stage IIA prostate cancer|stage iia prostate cancer
754024|NCT00002577|stage I non-small cell lung cancer|stage i non-small cell lung cancer
754025|NCT00002577|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
754026|NCT00002577|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
754027|NCT00002577|squamous cell lung cancer|squamous cell lung cancer
754028|NCT00002577|large cell lung cancer|large cell lung cancer
754029|NCT00002577|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
754030|NCT00002577|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
754031|NCT00002577|adenocarcinoma of the lung|adenocarcinoma of the lung
754032|NCT00002454|lung papilloma|lung papilloma
754033|NCT00078442|Treatment Experienced|treatment experienced
754034|NCT00078442|Treatment Interruption|treatment interruption
754035|NCT00078442|Treatment Naive|treatment naive
754036|NCT00078390|Lung cancer|lung cancer
754037|NCT00078390|Lung carcinoma|lung carcinoma
754038|NCT00078390|Non small cell lung cancer|non small cell lung cancer
754039|NCT00078390|Stage IIIA non small cell lung cancer|stage iiia non small cell lung cancer
754040|NCT00078390|Stage IIIB non small cell lung cancer|stage iiib non small cell lung cancer
754041|NCT00078390|NSCLC|nsclc
754047|NCT00078390|neovascularization|neovascularization
754048|NCT00078390|antiangiogenesis|antiangiogenesis
754049|NCT00078390|type IV collagenases|type iv collagenases
754050|NCT00078390|Unresectable locally advanced non-small cell lung cancer|unresectable locally advanced non-small cell lung cancer
754051|NCT00078377|Narcolepsy|narcolepsy
754052|NCT00078377|Excessive Sleepiness|excessive sleepiness
754053|NCT00078377|Cataplexy|cataplexy
754055|NCT00078377|Excessive Sleepiness associated with Narcolepsy|excessive sleepiness associated with narcolepsy
754056|NCT00078377|Cephalon|cephalon
754057|NCT00078377|Cephalon, Inc|cephalon, inc
754059|NCT00014690|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
754060|NCT00014690|fallopian tube cancer|fallopian tube cancer
754061|NCT00014690|primary peritoneal cavity cancer|primary peritoneal cavity cancer
754062|NCT00014339|stage II multiple myeloma|stage ii multiple myeloma
754063|NCT00014339|stage III multiple myeloma|stage iii multiple myeloma
754064|NCT00012259|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
754065|NCT00012259|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
754066|NCT00012259|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
754067|NCT00010179|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
754068|NCT00010179|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
754069|NCT00010179|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
754070|NCT00010179|fallopian tube cancer|fallopian tube cancer
754071|NCT00010179|peritoneal cavity cancer|peritoneal cavity cancer
754072|NCT00006472|stage I esophageal cancer|stage i esophageal cancer
754073|NCT00006472|stage II esophageal cancer|stage ii esophageal cancer
754074|NCT00006472|stage III esophageal cancer|stage iii esophageal cancer
754075|NCT00006472|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
754076|NCT00006472|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
754077|NCT00006365|adenocarcinoma of the prostate|adenocarcinoma of the prostate
754078|NCT00006365|stage I prostate cancer|stage i prostate cancer
754079|NCT00006365|stage IIB prostate cancer|stage iib prostate cancer
754080|NCT00006365|stage IIA prostate cancer|stage iia prostate cancer
754081|NCT00006108|stage IV breast cancer|stage iv breast cancer
754082|NCT00006108|recurrent breast cancer|recurrent breast cancer
754083|NCT00006037|stage IV colon cancer|stage iv colon cancer
754084|NCT00006037|stage IV rectal cancer|stage iv rectal cancer
754085|NCT00006037|recurrent colon cancer|recurrent colon cancer
754086|NCT00006037|recurrent rectal cancer|recurrent rectal cancer
754087|NCT00006037|adenocarcinoma of the colon|adenocarcinoma of the colon
754088|NCT00006037|adenocarcinoma of the rectum|adenocarcinoma of the rectum
754089|NCT00006014|advanced malignant mesothelioma|advanced malignant mesothelioma
754090|NCT00006014|recurrent malignant mesothelioma|recurrent malignant mesothelioma
754091|NCT00006014|epithelial mesothelioma|epithelial mesothelioma
754092|NCT00006014|sarcomatous mesothelioma|sarcomatous mesothelioma
754093|NCT00078403|Treatment Experienced|treatment experienced
754094|NCT00078325|Excessive Sleepiness|excessive sleepiness
754095|NCT00078325|Obstructive Sleep Apnea|obstructive sleep apnea
754096|NCT00078325|Obstructive Sleep Hypopnea|obstructive sleep hypopnea
754097|NCT00078325|nCPAP|ncpap
754098|NCT00078325|Cephalon|cephalon
754099|NCT00078325|Cephalon, Inc|cephalon, inc
754100|NCT00078325|NUVIGIL|nuvigil
754101|NCT00078312|Excessive Sleepiness|excessive sleepiness
754102|NCT00078312|Narcolepsy|narcolepsy
754103|NCT00078312|Cataplexy|cataplexy
754104|NCT00078312|Sleep Attacks|sleep attacks
754105|NCT00078312|Obstructive Sleep Apnea|obstructive sleep apnea
754106|NCT00078312|Obstructive Sleep Hypopnea|obstructive sleep hypopnea
754107|NCT00078312|nCPAP|ncpap
754108|NCT00078312|Chronic Shift Work Sleep Disorder|chronic shift work sleep disorder
754109|NCT00078312|Chronic SWSD|chronic swsd
754110|NCT00078312|Circadian Rhythm Disorder|circadian rhythm disorder
754111|NCT00078312|Shift Worker|shift worker
754112|NCT00078312|Cepahlon|cepahlon
754113|NCT00078312|Cephalon, Inc|cephalon, inc
754114|NCT00078312|Nuvigil|nuvigil
754115|NCT00005991|stage IV breast cancer|stage iv breast cancer
754116|NCT00005991|recurrent breast cancer|recurrent breast cancer
754117|NCT00005880|non-small cell lung cancer|non-small cell lung cancer
754118|NCT00005880|small cell lung cancer|small cell lung cancer
754119|NCT00005869|stage II pancreatic cancer|stage ii pancreatic cancer
754120|NCT00005869|stage III pancreatic cancer|stage iii pancreatic cancer
754121|NCT00005869|recurrent pancreatic cancer|recurrent pancreatic cancer
754122|NCT00005869|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
754123|NCT00005869|stage IV pancreatic cancer|stage iv pancreatic cancer
754124|NCT00005864|stage IV colon cancer|stage iv colon cancer
754125|NCT00005864|stage IV rectal cancer|stage iv rectal cancer
754126|NCT00005864|recurrent colon cancer|recurrent colon cancer
754127|NCT00005864|recurrent rectal cancer|recurrent rectal cancer
754128|NCT00005593|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
754129|NCT00005593|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
754130|NCT00005593|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
754131|NCT00005593|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
780981|NCT00044746|Diabetes|diabetes
754132|NCT00005593|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
754133|NCT00005593|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
754134|NCT00005593|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
754135|NCT00005593|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
754136|NCT00005593|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
754137|NCT00005593|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
754138|NCT00005593|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
754139|NCT00005593|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
754140|NCT00005593|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
754141|NCT00005593|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
754142|NCT00005593|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
754143|NCT00005593|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
754144|NCT00005593|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
754145|NCT00005593|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
754146|NCT00005593|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
754147|NCT00005593|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
754148|NCT00005593|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
754149|NCT00005593|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
754150|NCT00005593|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
754151|NCT00005593|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
754152|NCT00005593|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
754153|NCT00005593|refractory anemia with excess blasts|refractory anemia with excess blasts
754154|NCT00005593|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
754155|NCT00005593|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
754156|NCT00005593|secondary acute myeloid leukemia|secondary acute myeloid leukemia
754157|NCT00005593|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
754158|NCT00005593|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
754159|NCT00005593|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
754160|NCT00005593|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
754161|NCT00005593|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
754162|NCT00005593|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
754163|NCT00005075|stage I prostate cancer|stage i prostate cancer
754164|NCT00005075|stage II prostate cancer|stage ii prostate cancer
754165|NCT00005075|recurrent prostate cancer|recurrent prostate cancer
754166|NCT00005026|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
754167|NCT00005026|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
754168|NCT00005026|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
754169|NCT00005026|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
754170|NCT00005026|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
754171|NCT00005026|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
754172|NCT00005026|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
754173|NCT00005026|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
754174|NCT00005026|primary peritoneal cavity cancer|primary peritoneal cavity cancer
754175|NCT00005026|Brenner tumor|brenner tumor
754176|NCT00004223|stage III bladder cancer|stage iii bladder cancer
754177|NCT00004223|recurrent bladder cancer|recurrent bladder cancer
754178|NCT00004223|stage IV bladder cancer|stage iv bladder cancer
754179|NCT00004223|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
754180|NCT00004223|posterior urethral cancer|posterior urethral cancer
754181|NCT00004223|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
754182|NCT00004223|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
754183|NCT00004216|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
754184|NCT00004183|localized malignant mesothelioma|localized malignant mesothelioma
754185|NCT00004183|advanced malignant mesothelioma|advanced malignant mesothelioma
754186|NCT00004183|recurrent malignant mesothelioma|recurrent malignant mesothelioma
754187|NCT00004183|epithelial mesothelioma|epithelial mesothelioma
754188|NCT00004183|sarcomatous mesothelioma|sarcomatous mesothelioma
754189|NCT00078364|MRI|mri
754190|NCT00078364|NSAID Analgesia|nsaid analgesia
754191|NCT00078364|Pain Mechanisms|pain mechanisms
754192|NCT00078364|SNP's|snp's
754193|NCT00078364|Acute Pain|acute pain
754194|NCT00078364|Wisdom Teeth|wisdom teeth
754195|NCT00078364|Third Molar Extraction|third molar extraction
754196|NCT00078364|Third Molar Impaction|third molar impaction
754197|NCT00078351|Chronic Pain|chronic pain
754198|NCT00078351|Synvisc|synvisc
754199|NCT00078351|Temporomandibular Joint|temporomandibular joint
754200|NCT00078351|Osteoarthritis|osteoarthritis
754201|NCT00078351|TMD|tmd
754202|NCT00078351|Temporomandibular Joint Osteoarthritis|temporomandibular joint osteoarthritis
754203|NCT00078351|TMJ OA|tmj oa
754204|NCT00078351|Temporomandibular Joint Disease|temporomandibular joint disease
754205|NCT00078351|TMJ|tmj
754206|NCT00078286|Antidepressive Agents|antidepressive agents
754207|NCT00078273|Gambling|gambling
754208|NCT00078273|Pathological Gambling|pathological gambling
754209|NCT00078273|Problem Gambling|problem gambling
754210|NCT00078273|College Students|college students
754211|NCT00078273|Prevention|prevention
754212|NCT00078299|Cortical|cortical
754213|NCT00078299|Nuclear Sclerosis|nuclear sclerosis
754214|NCT00078299|Posterior Subcapsular|posterior subcapsular
754215|NCT00078299|Photographic Methods|photographic methods
754216|NCT00078299|Reproducibility (intra and interobserver)|reproducibility (intra and interobserver)
754217|NCT00078299|Cataract|cataract
754218|NCT00078299|Agreement|agreement
754219|NCT00078299|Grading System|grading system
754220|NCT00078247|Antiretroviral Therapy|antiretroviral therapy
754221|NCT00078247|Africa|africa
754222|NCT00078234|CLL|cll
754223|NCT00078234|Leukemia|leukemia
754224|NCT00078234|Chronic|chronic
754225|NCT00078234|Cancer|cancer
754226|NCT00078234|Adult|adult
754227|NCT00078234|Lymphocytic|lymphocytic
754228|NCT00078234|Genasense|genasense
754229|NCT00078234|G3139|g3139
754230|NCT00078234|Genta|genta
754231|NCT00078234|Bcl-2|bcl-2
754232|NCT00078234|Antisense|antisense
754233|NCT00078234|Oligonucleotide|oligonucleotide
754234|NCT00078234|oblimersen|oblimersen
754235|NCT00078169|behavioral intervention|behavioral intervention
754236|NCT00078156|behavioral intervention|behavioral intervention
754237|NCT00078143|behavioral intervention|behavioral intervention
754238|NCT00078208|Pediatric|pediatric
754239|NCT00078208|Non-Invasive|non-invasive
754240|NCT00078208|Anti-Inflammatory|anti-inflammatory
754241|NCT00078208|pH|ph
754242|NCT00078208|Mediators|mediators
754243|NCT00078208|Asthma|asthma
754244|NCT00078208|Childhood Asthma|childhood asthma
754245|NCT00078208|Healthy Volunteer|healthy volunteer
754246|NCT00078208|HV|hv
754247|NCT00078195|Ragweed|ragweed
754248|NCT00078195|Immunotherapy|immunotherapy
754249|NCT00078195|Rush Immunotherapy|rush immunotherapy
754250|NCT00078195|RIT|rit
754251|NCT00078195|Hayfever|hayfever
754252|NCT00078195|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
754253|NCT00078182|HIV Prevention|hiv prevention
754254|NCT00078130|opioid dependence|opioid dependence
754255|NCT00078130|behavioral intervention|behavioral intervention
754256|NCT00078117|opiate dependence|opiate dependence
754257|NCT00078065|multiple myeloma|multiple myeloma
754258|NCT00078065|fludarabine|fludarabine
754259|NCT00078065|Xcellerated T Cells|xcellerated t cells
754260|NCT00004148|stage III melanoma|stage iii melanoma
754261|NCT00004148|stage IV melanoma|stage iv melanoma
754262|NCT00004148|recurrent melanoma|recurrent melanoma
754263|NCT00003935|untreated childhood brain stem glioma|untreated childhood brain stem glioma
754264|NCT00003814|stage 0 bladder cancer|stage 0 bladder cancer
754265|NCT00003814|stage I bladder cancer|stage i bladder cancer
754266|NCT00003814|recurrent bladder cancer|recurrent bladder cancer
754267|NCT00003814|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
754268|NCT00003766|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
754269|NCT00003623|recurrent bladder cancer|recurrent bladder cancer
754270|NCT00003615|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
754271|NCT00003615|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
754272|NCT00003615|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
754273|NCT00003615|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
754274|NCT00003615|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
754275|NCT00003615|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
754963|NCT00077922|Hematological Disease|hematological disease
754276|NCT00003615|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
754277|NCT00003615|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
754278|NCT00003615|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
754279|NCT00003615|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
754280|NCT00003615|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
754281|NCT00003615|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
754282|NCT00003615|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
754283|NCT00003615|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
754284|NCT00003615|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
754285|NCT00003615|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
754286|NCT00003615|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
754287|NCT00003615|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
754288|NCT00003615|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
754289|NCT00003615|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
754570|NCT00003046|recurrent rectal cancer|recurrent rectal cancer
754290|NCT00003615|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
754291|NCT00003615|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
754292|NCT00003615|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
754293|NCT00003615|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
754294|NCT00003615|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
754295|NCT00003615|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
754296|NCT00003615|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
754297|NCT00003615|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
754298|NCT00003615|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
754299|NCT00003615|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
754300|NCT00003615|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
754301|NCT00003615|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
754302|NCT00003615|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
754303|NCT00003615|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
754304|NCT00003615|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
754305|NCT00003615|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
754306|NCT00003615|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
754307|NCT00003615|splenic marginal zone lymphoma|splenic marginal zone lymphoma
754308|NCT00003573|untreated childhood medulloblastoma|untreated childhood medulloblastoma
754309|NCT00003572|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
754310|NCT00003572|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
754311|NCT00003572|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
754312|NCT00003572|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
754313|NCT00003572|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
754314|NCT00003572|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
754315|NCT00003572|stage I multiple myeloma|stage i multiple myeloma
754316|NCT00003572|stage II multiple myeloma|stage ii multiple myeloma
754317|NCT00003572|stage III multiple myeloma|stage iii multiple myeloma
754318|NCT00003572|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
754319|NCT00003572|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
754320|NCT00003572|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
754321|NCT00003572|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
754322|NCT00003572|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
754323|NCT00003572|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
754324|NCT00003572|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
754325|NCT00003572|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
754326|NCT00003572|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
754327|NCT00003572|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
754328|NCT00003572|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
754329|NCT00003572|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
754330|NCT00003572|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
754331|NCT00003572|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
754332|NCT00003572|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
754333|NCT00003572|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
754334|NCT00003572|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
754335|NCT00003572|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
754336|NCT00003572|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
754337|NCT00003572|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
754338|NCT00003572|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
754339|NCT00003572|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
754340|NCT00003572|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
754341|NCT00003572|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
754342|NCT00003572|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
754343|NCT00003572|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
754344|NCT00003572|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
754345|NCT00003572|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
754346|NCT00003572|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
754347|NCT00003572|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
754348|NCT00003572|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
754349|NCT00003572|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
754350|NCT00003572|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
754351|NCT00003572|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
754352|NCT00003572|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
754353|NCT00003572|stage I mantle cell lymphoma|stage i mantle cell lymphoma
754354|NCT00003572|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
754355|NCT00003572|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
754356|NCT00003572|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
754357|NCT00003572|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
754358|NCT00003572|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
754359|NCT00003572|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
754360|NCT00003572|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
754361|NCT00003572|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
754362|NCT00003572|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
754363|NCT00003572|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
754364|NCT00003572|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
754365|NCT00003572|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
754366|NCT00003572|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
754367|NCT00003572|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
754368|NCT00003572|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
754369|NCT00003572|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
754370|NCT00003572|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
754371|NCT00003572|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
754372|NCT00003572|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
754373|NCT00003572|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
754374|NCT00003572|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
754375|NCT00003572|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
754376|NCT00003572|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
754377|NCT00003572|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
754378|NCT00003572|stage I marginal zone lymphoma|stage i marginal zone lymphoma
754379|NCT00003572|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
754380|NCT00003572|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
754381|NCT00003572|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
754382|NCT00003572|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
754383|NCT00003572|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
754384|NCT00003572|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
754385|NCT00003572|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
754386|NCT00003572|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
754387|NCT00003572|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
754388|NCT00003572|splenic marginal zone lymphoma|splenic marginal zone lymphoma
754389|NCT00003548|stage IV colon cancer|stage iv colon cancer
754390|NCT00003548|stage IV breast cancer|stage iv breast cancer
754391|NCT00003548|recurrent breast cancer|recurrent breast cancer
754392|NCT00003548|stage IV gastric cancer|stage iv gastric cancer
754393|NCT00003548|recurrent gastric cancer|recurrent gastric cancer
754394|NCT00003548|recurrent pancreatic cancer|recurrent pancreatic cancer
754395|NCT00003548|stage IV rectal cancer|stage iv rectal cancer
754396|NCT00003548|recurrent colon cancer|recurrent colon cancer
754397|NCT00003548|recurrent rectal cancer|recurrent rectal cancer
754398|NCT00003548|stage IV anal cancer|stage iv anal cancer
754399|NCT00003548|recurrent anal cancer|recurrent anal cancer
754400|NCT00003548|stage IV esophageal cancer|stage iv esophageal cancer
754401|NCT00003548|recurrent esophageal cancer|recurrent esophageal cancer
754402|NCT00003548|stage IV cervical cancer|stage iv cervical cancer
754403|NCT00003548|recurrent cervical cancer|recurrent cervical cancer
754404|NCT00003548|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
754405|NCT00003548|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
754406|NCT00003548|stage IV vulvar cancer|stage iv vulvar cancer
754407|NCT00003548|recurrent vulvar cancer|recurrent vulvar cancer
754408|NCT00003548|stage IVA vaginal cancer|stage iva vaginal cancer
754409|NCT00003548|stage IVB vaginal cancer|stage ivb vaginal cancer
754410|NCT00003548|recurrent vaginal cancer|recurrent vaginal cancer
754411|NCT00003548|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
754412|NCT00003548|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
754413|NCT00003548|advanced adult primary liver cancer|advanced adult primary liver cancer
754414|NCT00003548|recurrent adult primary liver cancer|recurrent adult primary liver cancer
754415|NCT00003548|recurrent gestational trophoblastic tumor|recurrent gestational trophoblastic tumor
754416|NCT00003548|stage IV endometrial carcinoma|stage iv endometrial carcinoma
754417|NCT00003548|recurrent endometrial carcinoma|recurrent endometrial carcinoma
754418|NCT00003548|unresectable gallbladder cancer|unresectable gallbladder cancer
754419|NCT00003548|recurrent gallbladder cancer|recurrent gallbladder cancer
754420|NCT00003548|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
754421|NCT00003548|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
754422|NCT00003548|recurrent small intestine cancer|recurrent small intestine cancer
754423|NCT00003548|carcinoma of the appendix|carcinoma of the appendix
754424|NCT00003548|fallopian tube cancer|fallopian tube cancer
754425|NCT00003548|stage IV uterine sarcoma|stage iv uterine sarcoma
754426|NCT00003548|recurrent uterine sarcoma|recurrent uterine sarcoma
754427|NCT00003548|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
754428|NCT00003548|stage IV pancreatic cancer|stage iv pancreatic cancer
754429|NCT00003425|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
754430|NCT00003425|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
754431|NCT00003425|stage IV breast cancer|stage iv breast cancer
754432|NCT00003425|stage IIIA breast cancer|stage iiia breast cancer
754433|NCT00003425|recurrent breast cancer|recurrent breast cancer
754434|NCT00003425|stage IIIB breast cancer|stage iiib breast cancer
754435|NCT00003425|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
754436|NCT00003425|refractory multiple myeloma|refractory multiple myeloma
754437|NCT00003425|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
754438|NCT00003425|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
754439|NCT00003425|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
754440|NCT00003425|regional neuroblastoma|regional neuroblastoma
754441|NCT00003425|disseminated neuroblastoma|disseminated neuroblastoma
754442|NCT00003425|stage 4S neuroblastoma|stage 4s neuroblastoma
754443|NCT00003425|recurrent neuroblastoma|recurrent neuroblastoma
754444|NCT00003425|stage III multiple myeloma|stage iii multiple myeloma
754445|NCT00003425|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
754446|NCT00003425|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
754447|NCT00003425|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
754448|NCT00003425|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
754449|NCT00003425|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
754450|NCT00003425|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
754451|NCT00003425|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
754452|NCT00003425|ovarian stromal cancer|ovarian stromal cancer
754453|NCT00003425|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
754454|NCT00003425|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
754455|NCT00003425|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
754456|NCT00003425|acute undifferentiated leukemia|acute undifferentiated leukemia
754457|NCT00003425|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
754458|NCT00003425|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
754459|NCT00003425|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
754460|NCT00003425|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
754461|NCT00003425|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
754462|NCT00003425|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
754463|NCT00003425|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
754464|NCT00003425|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
754465|NCT00003425|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
754466|NCT00003425|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
754467|NCT00003425|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
754468|NCT00003425|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
754469|NCT00003425|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
754470|NCT00003425|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
754471|NCT00003425|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
754472|NCT00003425|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
754473|NCT00003425|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
754474|NCT00003425|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
754475|NCT00003425|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
754476|NCT00003425|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
754477|NCT00003425|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
754478|NCT00003425|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
754479|NCT00003425|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
754480|NCT00003425|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
754481|NCT00003425|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
754482|NCT00003425|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
754483|NCT00003425|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
754484|NCT00003425|secondary acute myeloid leukemia|secondary acute myeloid leukemia
754485|NCT00003425|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
754486|NCT00003425|ovarian sarcoma|ovarian sarcoma
754487|NCT00003425|localized unresectable neuroblastoma|localized unresectable neuroblastoma
754488|NCT00003425|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
754489|NCT00003425|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
754490|NCT00003425|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
754491|NCT00003425|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
754492|NCT00003425|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
754493|NCT00003425|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
754494|NCT00003425|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
754495|NCT00003425|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
754496|NCT00003425|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
754497|NCT00003425|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
754498|NCT00003425|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
754499|NCT00003425|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
754500|NCT00003425|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
754501|NCT00003425|splenic marginal zone lymphoma|splenic marginal zone lymphoma
754502|NCT00003411|stage II pancreatic cancer|stage ii pancreatic cancer
754503|NCT00003411|stage III pancreatic cancer|stage iii pancreatic cancer
754504|NCT00003411|unresectable gallbladder cancer|unresectable gallbladder cancer
754505|NCT00003411|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
754506|NCT00003411|stage IV pancreatic cancer|stage iv pancreatic cancer
754507|NCT00003299|extensive stage small cell lung cancer|extensive stage small cell lung cancer
754508|NCT00003240|stage I non-small cell lung cancer|stage i non-small cell lung cancer
754509|NCT00003240|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
754510|NCT00003240|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
754511|NCT00003240|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
754512|NCT00003240|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
754513|NCT00003120|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
754514|NCT00003120|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
754515|NCT00003120|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
754516|NCT00003120|fallopian tube cancer|fallopian tube cancer
754517|NCT00003120|peritoneal cavity cancer|peritoneal cavity cancer
754518|NCT00078104|Prostanoid|prostanoid
754519|NCT00078104|Cyclooxygenase (COX)|cyclooxygenase (cox)
754520|NCT00078104|Selective Cox Inhibitor|selective cox inhibitor
754521|NCT00078104|Acute Peripheral Inflammation|acute peripheral inflammation
754522|NCT00078104|Neuronal Expression of COX|neuronal expression of cox
754524|NCT00078104|Coxibs|coxibs
754525|NCT00078104|Wisdom Teeth|wisdom teeth
754526|NCT00078104|Third Molar Extraction|third molar extraction
754527|NCT00078104|Third Molar Impaction|third molar impaction
754528|NCT00078091|Obesity|obesity
754529|NCT00078091|Retinopathy|retinopathy
754530|NCT00078091|Dyslipidemia|dyslipidemia
754531|NCT00078091|Insulin Resistance|insulin resistance
754532|NCT00078091|Hypogonadism|hypogonadism
754533|NCT00078091|Polydactyly|polydactyly
754534|NCT00078091|Bardet-Biedl Syndrome|bardet-biedl syndrome
754535|NCT00078091|BBS|bbs
754536|NCT00078078|Vitamin B12|vitamin b12
754537|NCT00078078|Methylmalonic Acidemia|methylmalonic acidemia
754538|NCT00078078|Hyperhomocysteinemia|hyperhomocysteinemia
754539|NCT00078078|MMA|mma
754540|NCT00078078|Metabolic Disease|metabolic disease
754541|NCT00078026|Apomine|apomine
754542|NCT00078026|Osteoporosis|osteoporosis
754543|NCT00078026|Bone Mass|bone mass
754544|NCT00078026|Postmenopausal|postmenopausal
754545|NCT00030602|adenocarcinoma of the prostate|adenocarcinoma of the prostate
754546|NCT00030602|recurrent prostate cancer|recurrent prostate cancer
754547|NCT00003089|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
754548|NCT00003089|squamous cell lung cancer|squamous cell lung cancer
754549|NCT00003089|large cell lung cancer|large cell lung cancer
754550|NCT00003089|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
754551|NCT00003089|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
754552|NCT00003089|adenocarcinoma of the lung|adenocarcinoma of the lung
754553|NCT00003089|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
754554|NCT00003046|anal cancer|anal cancer
754555|NCT00003046|carcinoma of the appendix|carcinoma of the appendix
754556|NCT00003046|colorectal cancer|colorectal cancer
754557|NCT00003046|extrahepatic bile duct cancer|extrahepatic bile duct cancer
754558|NCT00003046|gallbladder cancer|gallbladder cancer
754559|NCT00003046|gastric cancer|gastric cancer
754560|NCT00003046|gastrointestinal carcinoid tumor|gastrointestinal carcinoid tumor
754561|NCT00003046|malignant mesothelioma|malignant mesothelioma
754562|NCT00003046|pancreatic cancer|pancreatic cancer
754563|NCT00003046|small intestine cancer|small intestine cancer
754564|NCT00003046|stage IV colon cancer|stage iv colon cancer
754565|NCT00003046|stage IV gastric cancer|stage iv gastric cancer
754566|NCT00003046|recurrent gastric cancer|recurrent gastric cancer
754567|NCT00003046|recurrent pancreatic cancer|recurrent pancreatic cancer
754568|NCT00003046|stage IV rectal cancer|stage iv rectal cancer
754569|NCT00003046|recurrent colon cancer|recurrent colon cancer
780982|NCT00044733|Leukemia|leukemia
754571|NCT00003046|stage IV anal cancer|stage iv anal cancer
754573|NCT00003046|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
754574|NCT00003046|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
754575|NCT00003046|advanced malignant mesothelioma|advanced malignant mesothelioma
754576|NCT00003046|recurrent malignant mesothelioma|recurrent malignant mesothelioma
754577|NCT00003046|small intestine adenocarcinoma|small intestine adenocarcinoma
754578|NCT00003046|unresectable gallbladder cancer|unresectable gallbladder cancer
754579|NCT00003046|recurrent gallbladder cancer|recurrent gallbladder cancer
754580|NCT00003046|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
754581|NCT00003046|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
754582|NCT00003046|recurrent small intestine cancer|recurrent small intestine cancer
754583|NCT00003046|stage IV pancreatic cancer|stage iv pancreatic cancer
754584|NCT00003035|stage IIIA breast cancer|stage iiia breast cancer
754585|NCT00003035|stage IIIB breast cancer|stage iiib breast cancer
754586|NCT00078013|AMI|ami
754587|NCT00078013|STEMI|stemi
754588|NCT00078013|Infarct|infarct
754589|NCT00078013|acute myocardial infarction with ST segment elevation|acute myocardial infarction with st segment elevation
754590|NCT00077961|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
754591|NCT00077961|NHL|nhl
754592|NCT00077961|CAMPATH|campath
754593|NCT00077961|alemtuzumab|alemtuzumab
754594|NCT00077948|positive inotrope|positive inotrope
754595|NCT00077948|enoximone|enoximone
754596|NCT00077948|beta-blocker|beta-blocker
754597|NCT00077948|intolerant|intolerant
754598|NCT00077870|Moderate to severe rheumatoid arthritis|moderate to severe rheumatoid arthritis
754599|NCT00077792|Receiving fibrinolytic therapy|receiving fibrinolytic therapy
754600|NCT00077727|Schizophrenia|schizophrenia
754601|NCT00077727|cognitive impairment|cognitive impairment
754602|NCT00077727|galantamine|galantamine
754603|NCT00077727|acetylcholinesterase inhibitors|acetylcholinesterase inhibitors
754604|NCT00077727|antipsychotic drugs|antipsychotic drugs
754605|NCT00077727|BACS|bacs
754606|NCT00077714|Schizophrenia|schizophrenia
754607|NCT00077714|Paliperidone|paliperidone
754608|NCT00076973|RSV Bronchiolitis|rsv bronchiolitis
754609|NCT00027924|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
754610|NCT00027924|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
754611|NCT00027924|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
754612|NCT00027924|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
754613|NCT00027924|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
754614|NCT00027924|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
754615|NCT00027924|refractory anemia|refractory anemia
754616|NCT00027924|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
754617|NCT00027924|refractory anemia with excess blasts|refractory anemia with excess blasts
754618|NCT00027924|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
754619|NCT00027924|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
754620|NCT00027924|secondary acute myeloid leukemia|secondary acute myeloid leukemia
754621|NCT00027924|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
754622|NCT00027924|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
754623|NCT00027924|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
754624|NCT00027924|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
754625|NCT00023647|stage IV melanoma|stage iv melanoma
754626|NCT00023647|recurrent melanoma|recurrent melanoma
754627|NCT00021294|basal cell carcinoma of the skin|basal cell carcinoma of the skin
754628|NCT00021294|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
754629|NCT00021294|actinic keratosis|actinic keratosis
754630|NCT00021034|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
754631|NCT00021034|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
754632|NCT00021034|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
754633|NCT00021034|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
754634|NCT00021034|fallopian tube cancer|fallopian tube cancer
754635|NCT00021034|primary peritoneal cavity cancer|primary peritoneal cavity cancer
754636|NCT00021021|stage IV renal cell cancer|stage iv renal cell cancer
754637|NCT00021021|clear cell renal cell carcinoma|clear cell renal cell carcinoma
754638|NCT00020917|stage IV colon cancer|stage iv colon cancer
754639|NCT00020917|stage IV rectal cancer|stage iv rectal cancer
754640|NCT00020553|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
754641|NCT00017459|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
754642|NCT00017459|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
754643|NCT00017459|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
754644|NCT00017199|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
754645|NCT00017199|gastrinoma|gastrinoma
754646|NCT00017199|insulinoma|insulinoma
754647|NCT00017199|somatostatinoma|somatostatinoma
754648|NCT00017199|glucagonoma|glucagonoma
754649|NCT00017056|stage IV gastric cancer|stage iv gastric cancer
754650|NCT00017056|recurrent gastric cancer|recurrent gastric cancer
754651|NCT00017056|stage IV esophageal cancer|stage iv esophageal cancer
754652|NCT00017056|recurrent esophageal cancer|recurrent esophageal cancer
754653|NCT00017056|adenocarcinoma of the stomach|adenocarcinoma of the stomach
754654|NCT00017056|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
754655|NCT00016172|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
754656|NCT00016172|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
754657|NCT00016172|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
754658|NCT00016172|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
754659|NCT00016172|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
754660|NCT00016172|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
754661|NCT00016172|small intestine lymphoma|small intestine lymphoma
754662|NCT00016172|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
754663|NCT00016172|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
754664|NCT00016172|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
754665|NCT00016172|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
754666|NCT00016172|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
754667|NCT00016172|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
754668|NCT00016172|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
754669|NCT00016172|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
754670|NCT00016172|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
754671|NCT00016172|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
754672|NCT00016172|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
754673|NCT00016172|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
754674|NCT00016172|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
754675|NCT00016172|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
754676|NCT00016172|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
754677|NCT00016172|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
754678|NCT00016172|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
754679|NCT00016172|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
754680|NCT00016172|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
754681|NCT00016172|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
754682|NCT00016172|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
754683|NCT00016172|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
754684|NCT00016172|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
754685|NCT00016172|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
754686|NCT00016172|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
754687|NCT00016172|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
754688|NCT00016172|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
754689|NCT00016172|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
754690|NCT00016172|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
754691|NCT00016172|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
754692|NCT00016172|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
754693|NCT00016172|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
754694|NCT00016172|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
754695|NCT00016172|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
754696|NCT00016172|intraocular lymphoma|intraocular lymphoma
754697|NCT00016172|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
754698|NCT00016172|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
754699|NCT00016172|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
754700|NCT00016172|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
754701|NCT00016172|anaplastic large cell lymphoma|anaplastic large cell lymphoma
754702|NCT00016172|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
754703|NCT00016172|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
754704|NCT00016172|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
754705|NCT00016172|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
754706|NCT00016172|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
754707|NCT00016172|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
754708|NCT00016172|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
754709|NCT00016172|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
754710|NCT00016172|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
754711|NCT00016172|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
754712|NCT00016172|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
754713|NCT00016172|splenic marginal zone lymphoma|splenic marginal zone lymphoma
754714|NCT00014625|stage IV melanoma|stage iv melanoma
754715|NCT00014625|recurrent melanoma|recurrent melanoma
754716|NCT00014430|stage IV breast cancer|stage iv breast cancer
754717|NCT00014430|stage IIIA breast cancer|stage iiia breast cancer
754718|NCT00014430|recurrent breast cancer|recurrent breast cancer
754719|NCT00014430|stage IIIB breast cancer|stage iiib breast cancer
754720|NCT00008281|stage IV colon cancer|stage iv colon cancer
754721|NCT00008281|stage IV rectal cancer|stage iv rectal cancer
754722|NCT00008281|recurrent colon cancer|recurrent colon cancer
754723|NCT00008281|recurrent rectal cancer|recurrent rectal cancer
754724|NCT00008281|adenocarcinoma of the colon|adenocarcinoma of the colon
754725|NCT00008281|adenocarcinoma of the rectum|adenocarcinoma of the rectum
754726|NCT00006122|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
754727|NCT00006122|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
754728|NCT00006122|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
754729|NCT00006122|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
754730|NCT00006122|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
754731|NCT00006122|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
754732|NCT00006122|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
754733|NCT00006122|secondary acute myeloid leukemia|secondary acute myeloid leukemia
754734|NCT00006122|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
754735|NCT00006122|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
754736|NCT00005795|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
754737|NCT00005795|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
754738|NCT00005795|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
754739|NCT00005795|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
754740|NCT00005795|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
754741|NCT00005795|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
754742|NCT00005795|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
754743|NCT00005795|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
754744|NCT00005795|secondary acute myeloid leukemia|secondary acute myeloid leukemia
754745|NCT00005795|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
754746|NCT00005795|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
754747|NCT00005791|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
754748|NCT00005631|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
754749|NCT00005631|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
754750|NCT00005631|anaplastic large cell lymphoma|anaplastic large cell lymphoma
754751|NCT00005609|Waldenström macroglobulinemia|waldenström macroglobulinemia
754752|NCT00005089|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
754753|NCT00005089|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
754754|NCT00005089|stage I mantle cell lymphoma|stage i mantle cell lymphoma
754755|NCT00005089|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
754756|NCT00005089|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
754757|NCT00005089|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
754758|NCT00005089|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
754759|NCT00005089|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
754760|NCT00005089|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
754761|NCT00004152|stage III melanoma|stage iii melanoma
754762|NCT00004152|stage IV melanoma|stage iv melanoma
754763|NCT00004152|recurrent melanoma|recurrent melanoma
754764|NCT00004145|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
754765|NCT00004145|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
754766|NCT00004145|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
754767|NCT00004145|refractory multiple myeloma|refractory multiple myeloma
754768|NCT00004145|stage I multiple myeloma|stage i multiple myeloma
754769|NCT00004145|stage II multiple myeloma|stage ii multiple myeloma
754770|NCT00004145|stage III multiple myeloma|stage iii multiple myeloma
754771|NCT00004145|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
754772|NCT00004145|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
754773|NCT00004145|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
754774|NCT00004145|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
754775|NCT00004145|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
754776|NCT00004145|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
754777|NCT00004145|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
754778|NCT00004145|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
754779|NCT00004145|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
754780|NCT00004145|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
754781|NCT00004145|refractory anemia|refractory anemia
754782|NCT00004145|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
755134|NCT00004157|disseminated neuroblastoma|disseminated neuroblastoma
754783|NCT00004145|refractory anemia with excess blasts|refractory anemia with excess blasts
754784|NCT00004145|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
754785|NCT00004145|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
754786|NCT00004145|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
754787|NCT00004145|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
754788|NCT00004145|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
754789|NCT00004145|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
754790|NCT00004145|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
754791|NCT00004145|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
754792|NCT00004145|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
754793|NCT00004145|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
754794|NCT00004145|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
754795|NCT00004145|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
754796|NCT00004145|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
754797|NCT00004145|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
754798|NCT00004145|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
754799|NCT00004145|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
754800|NCT00004145|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
754801|NCT00004145|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
754802|NCT00004145|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
754803|NCT00004145|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
754804|NCT00004145|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
754805|NCT00004145|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
754806|NCT00004145|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
754807|NCT00004145|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
754808|NCT00004145|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
754809|NCT00004145|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
754810|NCT00004145|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
754811|NCT00004145|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
754812|NCT00004145|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
754813|NCT00004145|secondary acute myeloid leukemia|secondary acute myeloid leukemia
754814|NCT00004145|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
754815|NCT00004145|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
754816|NCT00004145|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
754817|NCT00004145|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
754818|NCT00004145|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
754819|NCT00004145|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
754820|NCT00004145|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
754821|NCT00004145|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
754822|NCT00004145|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
754823|NCT00004145|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
754824|NCT00004145|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
754825|NCT00004145|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
754826|NCT00004145|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
754827|NCT00004145|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
754828|NCT00004145|splenic marginal zone lymphoma|splenic marginal zone lymphoma
754829|NCT00004114|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
754830|NCT00004114|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
754831|NCT00004114|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
754832|NCT00004114|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
754833|NCT00004114|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
754834|NCT00004114|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
754835|NCT00004114|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
754836|NCT00004114|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
754837|NCT00004114|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
754838|NCT00004114|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
754839|NCT00004114|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
754840|NCT00004114|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
754841|NCT00004114|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
754842|NCT00004114|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
754843|NCT00004114|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
754844|NCT00004114|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
754845|NCT00004114|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
754846|NCT00004114|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
754847|NCT00004114|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
754848|NCT00004114|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
754849|NCT00004114|anaplastic large cell lymphoma|anaplastic large cell lymphoma
754850|NCT00004114|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
754851|NCT00004114|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
754852|NCT00004114|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
754853|NCT00004114|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
754854|NCT00004114|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
754855|NCT00004114|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
754856|NCT00004114|splenic marginal zone lymphoma|splenic marginal zone lymphoma
754857|NCT00003916|adult glioblastoma|adult glioblastoma
754858|NCT00003916|adult anaplastic astrocytoma|adult anaplastic astrocytoma
754859|NCT00003916|adult giant cell glioblastoma|adult giant cell glioblastoma
754860|NCT00003916|adult gliosarcoma|adult gliosarcoma
754861|NCT00003867|stage III colon cancer|stage iii colon cancer
754862|NCT00003867|stage IV colon cancer|stage iv colon cancer
754863|NCT00003867|stage IV breast cancer|stage iv breast cancer
754864|NCT00003867|stage IIIA breast cancer|stage iiia breast cancer
754865|NCT00003867|recurrent breast cancer|recurrent breast cancer
754866|NCT00003867|stage III gastric cancer|stage iii gastric cancer
754867|NCT00003867|stage IV gastric cancer|stage iv gastric cancer
754868|NCT00003867|recurrent gastric cancer|recurrent gastric cancer
754869|NCT00003867|stage IIIB breast cancer|stage iiib breast cancer
754870|NCT00003867|stage II pancreatic cancer|stage ii pancreatic cancer
754871|NCT00003867|stage III pancreatic cancer|stage iii pancreatic cancer
754872|NCT00003867|recurrent pancreatic cancer|recurrent pancreatic cancer
754873|NCT00003867|stage III rectal cancer|stage iii rectal cancer
754874|NCT00003867|stage IV rectal cancer|stage iv rectal cancer
754875|NCT00003867|recurrent colon cancer|recurrent colon cancer
754876|NCT00003867|recurrent rectal cancer|recurrent rectal cancer
754877|NCT00003867|stage IV anal cancer|stage iv anal cancer
754878|NCT00003867|recurrent anal cancer|recurrent anal cancer
754879|NCT00003867|stage II esophageal cancer|stage ii esophageal cancer
754880|NCT00003867|stage III esophageal cancer|stage iii esophageal cancer
754881|NCT00003867|stage IV esophageal cancer|stage iv esophageal cancer
754882|NCT00003867|stage IIIA anal cancer|stage iiia anal cancer
754883|NCT00003867|stage IIIB anal cancer|stage iiib anal cancer
754884|NCT00003867|recurrent esophageal cancer|recurrent esophageal cancer
754885|NCT00003867|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
754886|NCT00003867|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
754887|NCT00003867|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
754888|NCT00003867|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
754889|NCT00003867|advanced adult primary liver cancer|advanced adult primary liver cancer
754890|NCT00003867|recurrent adult primary liver cancer|recurrent adult primary liver cancer
754891|NCT00003867|small intestine adenocarcinoma|small intestine adenocarcinoma
754892|NCT00003867|small intestine lymphoma|small intestine lymphoma
754893|NCT00003867|small intestine leiomyosarcoma|small intestine leiomyosarcoma
754894|NCT00003867|unresectable gallbladder cancer|unresectable gallbladder cancer
754895|NCT00003867|recurrent gallbladder cancer|recurrent gallbladder cancer
754896|NCT00003867|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
754897|NCT00003867|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
754898|NCT00003867|recurrent small intestine cancer|recurrent small intestine cancer
754899|NCT00003867|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
754900|NCT00003867|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
754901|NCT00003867|carcinoma of the appendix|carcinoma of the appendix
754902|NCT00003867|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
754903|NCT00003867|stage IV pancreatic cancer|stage iv pancreatic cancer
754904|NCT00003632|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
754905|NCT00003582|squamous cell carcinoma of unknown primary|squamous cell carcinoma of unknown primary
754906|NCT00003582|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
754907|NCT00003582|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
754908|NCT00003582|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
754909|NCT00003582|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
754910|NCT00003582|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
754911|NCT00003582|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
754912|NCT00003582|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
754913|NCT00003582|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
754914|NCT00003582|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
754915|NCT00003582|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
756011|NCT00075842|fatigue|fatigue
754916|NCT00003582|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
754917|NCT00003582|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
754918|NCT00003545|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
754919|NCT00003545|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
754920|NCT00003545|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
754921|NCT00003545|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
754922|NCT00003545|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
754923|NCT00003545|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
754924|NCT00003545|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
754925|NCT00003207|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
754926|NCT00003207|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
754927|NCT00003207|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
754928|NCT00003150|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
754929|NCT00003150|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
754930|NCT00003150|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
754931|NCT00003150|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
754932|NCT00003150|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
754933|NCT00003150|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
754934|NCT00003150|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
754935|NCT00003150|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
754936|NCT00003150|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
754937|NCT00003150|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
754938|NCT00003150|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
754939|NCT00003150|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
754940|NCT00003150|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
754941|NCT00003150|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
754942|NCT00003150|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
754943|NCT00003066|stage IV breast cancer|stage iv breast cancer
754944|NCT00003066|recurrent breast cancer|recurrent breast cancer
754945|NCT00003062|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
754946|NCT00003062|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
754947|NCT00003011|recurrent small cell lung cancer|recurrent small cell lung cancer
754948|NCT00002869|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
754949|NCT00002869|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
754950|NCT00002869|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
754951|NCT00002868|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
754952|NCT00002532|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
754953|NCT00002531|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
754954|NCT00002531|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
754955|NCT00002531|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
754956|NCT00002531|non-T, non-B adult acute lymphoblastic leukemia|non-t, non-b adult acute lymphoblastic leukemia
754957|NCT00077922|LMB-2|lmb-2
754958|NCT00077922|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
754959|NCT00077922|CLL|cll
754960|NCT00077922|Immunotoxin|immunotoxin
754964|NCT00077922|Monoclonal Antibody|monoclonal antibody
754965|NCT00077922|Neutralizing Antibodies|neutralizing antibodies
754966|NCT00077909|Proteomics|proteomics
754967|NCT00077909|Infection|infection
754968|NCT00077909|Pneumonia|pneumonia
754969|NCT00077909|Mass Spectrometry|mass spectrometry
754970|NCT00077909|BAL|bal
754971|NCT00077909|Lung|lung
754972|NCT00077909|Pulmonary Disease|pulmonary disease
754973|NCT00077909|Lung Infiltrates|lung infiltrates
754974|NCT00077896|Treatment|treatment
754975|NCT00077896|Transcranial Stimulation|transcranial stimulation
754976|NCT00077896|Frontal Lobe|frontal lobe
754977|NCT00077896|Pick's Disease|pick's disease
754978|NCT00077896|Cognitive Impairment|cognitive impairment
754979|NCT00077896|Dementia|dementia
754980|NCT00077896|Frontotemporal Dementia|frontotemporal dementia
754981|NCT00077896|FTD|ftd
754982|NCT00077675|Abscess|abscess
754983|NCT00077675|Burns|burns
754984|NCT00077675|Cellulitis|cellulitis
754985|NCT00077675|Ulcer|ulcer
754986|NCT00077675|Wound infections|wound infections
754987|NCT00077662|Pompe Disease|pompe disease
754988|NCT00077662|Glycogen Storage Disease Type II|glycogen storage disease type ii
754989|NCT00077662|GSD-II|gsd-ii
754990|NCT00077662|Acid Maltase Deficiency Disease|acid maltase deficiency disease
754991|NCT00077662|Glycogenosis 2|glycogenosis 2
754992|NCT00077558|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
754993|NCT00077558|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
754994|NCT00077558|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
754995|NCT00077558|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
754996|NCT00077558|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
754997|NCT00077558|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
754998|NCT00077558|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
754999|NCT00077558|prolymphocytic leukemia|prolymphocytic leukemia
755000|NCT00077558|refractory anemia with excess blasts|refractory anemia with excess blasts
755001|NCT00077558|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
755002|NCT00077558|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
755003|NCT00077558|secondary acute myeloid leukemia|secondary acute myeloid leukemia
755004|NCT00077558|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
755005|NCT00077558|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
755006|NCT00077558|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
755007|NCT00077558|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
755008|NCT00077558|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
755009|NCT00077558|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
755010|NCT00077558|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
755011|NCT00077558|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
755012|NCT00077558|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
755013|NCT00077558|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
755014|NCT00077558|adult acute basophilic leukemia|adult acute basophilic leukemia
755015|NCT00077558|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
755016|NCT00077558|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
755017|NCT00077558|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
755018|NCT00077558|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
755019|NCT00077558|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
755020|NCT00077558|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
755021|NCT00077558|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
755022|NCT00077532|stage IV melanoma|stage iv melanoma
755023|NCT00077532|recurrent melanoma|recurrent melanoma
755024|NCT00077519|stage II pancreatic cancer|stage ii pancreatic cancer
755025|NCT00077519|stage III pancreatic cancer|stage iii pancreatic cancer
755026|NCT00077519|recurrent pancreatic cancer|recurrent pancreatic cancer
755027|NCT00077493|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
755028|NCT00077493|Burkitt lymphoma|burkitt lymphoma
755029|NCT00077493|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
755030|NCT00077493|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
755031|NCT00077493|childhood non-Hodgkin lymphoma|childhood non-hodgkin lymphoma
755032|NCT00077415|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
755033|NCT00077415|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
755034|NCT00077415|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
755035|NCT00077415|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
755036|NCT00077415|adenocarcinoma of the lung|adenocarcinoma of the lung
755037|NCT00077415|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
755038|NCT00077415|large cell lung cancer|large cell lung cancer
755039|NCT00077415|squamous cell lung cancer|squamous cell lung cancer
755040|NCT00077402|recurrent prostate cancer|recurrent prostate cancer
755041|NCT00077402|stage III prostate cancer|stage iii prostate cancer
755042|NCT00077402|stage IV prostate cancer|stage iv prostate cancer
755043|NCT00077402|adenocarcinoma of the prostate|adenocarcinoma of the prostate
755044|NCT00077389|childhood hepatoblastoma|childhood hepatoblastoma
755045|NCT00077389|stage IV childhood liver cancer|stage iv childhood liver cancer
755046|NCT00077337|recurrent colon cancer|recurrent colon cancer
755047|NCT00077337|stage III colon cancer|stage iii colon cancer
755048|NCT00077337|stage IV colon cancer|stage iv colon cancer
755049|NCT00077337|recurrent rectal cancer|recurrent rectal cancer
755050|NCT00077337|stage III rectal cancer|stage iii rectal cancer
755051|NCT00077337|stage IV rectal cancer|stage iv rectal cancer
755052|NCT00077324|stage I non-small cell lung cancer|stage i non-small cell lung cancer
755053|NCT00077311|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
755054|NCT00077311|anemia|anemia
755055|NCT00077311|neutropenia|neutropenia
755056|NCT00077311|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
755057|NCT00077311|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
755058|NCT00077311|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
755059|NCT00077311|squamous cell lung cancer|squamous cell lung cancer
755060|NCT00077311|large cell lung cancer|large cell lung cancer
755061|NCT00077311|adenocarcinoma of the lung|adenocarcinoma of the lung
755062|NCT00077311|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
755063|NCT00077311|adenosquamous cell lung cancer|adenosquamous cell lung cancer
755064|NCT00007852|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
755065|NCT00007852|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
755066|NCT00007852|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
755067|NCT00007852|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
755068|NCT00007852|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
755816|NCT00076310|OSI-774|osi-774
755069|NCT00007852|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
755070|NCT00007852|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
755071|NCT00007852|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
755072|NCT00007852|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
755073|NCT00007852|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
755074|NCT00007852|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
755075|NCT00007852|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
755076|NCT00007852|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
755077|NCT00007852|splenic marginal zone lymphoma|splenic marginal zone lymphoma
755078|NCT00006786|stage IV colon cancer|stage iv colon cancer
755079|NCT00006786|stage IV rectal cancer|stage iv rectal cancer
755080|NCT00006786|recurrent colon cancer|recurrent colon cancer
755081|NCT00006786|recurrent rectal cancer|recurrent rectal cancer
755082|NCT00006786|adenocarcinoma of the colon|adenocarcinoma of the colon
755083|NCT00006786|adenocarcinoma of the rectum|adenocarcinoma of the rectum
755084|NCT00006459|stage IV breast cancer|stage iv breast cancer
755085|NCT00006459|stage IIIA breast cancer|stage iiia breast cancer
755086|NCT00006459|recurrent breast cancer|recurrent breast cancer
755087|NCT00006459|stage IIIB breast cancer|stage iiib breast cancer
755088|NCT00006388|adult glioblastoma|adult glioblastoma
755089|NCT00006388|adult giant cell glioblastoma|adult giant cell glioblastoma
755090|NCT00006388|adult gliosarcoma|adult gliosarcoma
755091|NCT00006375|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
755092|NCT00006123|stage IV breast cancer|stage iv breast cancer
755093|NCT00006047|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
755094|NCT00006038|stage II gastric cancer|stage ii gastric cancer
755095|NCT00006038|stage III gastric cancer|stage iii gastric cancer
755096|NCT00006038|stage IV gastric cancer|stage iv gastric cancer
755097|NCT00006038|stage II esophageal cancer|stage ii esophageal cancer
755098|NCT00006038|stage III esophageal cancer|stage iii esophageal cancer
755099|NCT00006038|adenocarcinoma of the stomach|adenocarcinoma of the stomach
755100|NCT00006038|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
755101|NCT00005995|stage IV renal cell cancer|stage iv renal cell cancer
755102|NCT00005995|recurrent renal cell cancer|recurrent renal cell cancer
755103|NCT00005986|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
755104|NCT00005986|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
755105|NCT00005986|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
755106|NCT00005877|stage III colon cancer|stage iii colon cancer
755107|NCT00005877|stage IV colon cancer|stage iv colon cancer
755108|NCT00005877|stage III rectal cancer|stage iii rectal cancer
755109|NCT00005877|stage IV rectal cancer|stage iv rectal cancer
755110|NCT00005877|recurrent colon cancer|recurrent colon cancer
755111|NCT00005877|recurrent rectal cancer|recurrent rectal cancer
755112|NCT00005862|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
755113|NCT00005862|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
755114|NCT00005862|gastrointestinal stromal tumor|gastrointestinal stromal tumor
755115|NCT00005862|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
755116|NCT00005610|stage IV melanoma|stage iv melanoma
755117|NCT00005610|recurrent melanoma|recurrent melanoma
755118|NCT00005610|lung metastases|lung metastases
755119|NCT00004889|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
755120|NCT00004203|recurrent bladder cancer|recurrent bladder cancer
755121|NCT00004203|stage IV bladder cancer|stage iv bladder cancer
755122|NCT00004203|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
755123|NCT00004203|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
755124|NCT00004203|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
755125|NCT00004157|stage IV breast cancer|stage iv breast cancer
755126|NCT00004157|stage IIIA breast cancer|stage iiia breast cancer
755127|NCT00004157|stage IIIB breast cancer|stage iiib breast cancer
755128|NCT00004157|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
755129|NCT00004157|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
755130|NCT00004157|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
755131|NCT00004157|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
755132|NCT00004157|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
755133|NCT00004157|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
755135|NCT00004157|recurrent neuroblastoma|recurrent neuroblastoma
755136|NCT00004157|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
755137|NCT00004157|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
755138|NCT00004157|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
755139|NCT00004157|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
755140|NCT00004157|testicular embryonal carcinoma|testicular embryonal carcinoma
755141|NCT00004157|testicular choriocarcinoma|testicular choriocarcinoma
755142|NCT00004157|testicular teratoma|testicular teratoma
755143|NCT00004157|testicular yolk sac tumor|testicular yolk sac tumor
755144|NCT00004157|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
755145|NCT00004157|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
755146|NCT00004157|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
755147|NCT00004157|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
755148|NCT00004157|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
755149|NCT00004157|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
755150|NCT00004157|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
755151|NCT00004157|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
755152|NCT00004157|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
755153|NCT00004157|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
755154|NCT00004157|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
755155|NCT00004157|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
755156|NCT00004157|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
755157|NCT00004157|ovarian yolk sac tumor|ovarian yolk sac tumor
755158|NCT00004157|ovarian embryonal carcinoma|ovarian embryonal carcinoma
755159|NCT00004157|ovarian polyembryoma|ovarian polyembryoma
755160|NCT00004157|ovarian choriocarcinoma|ovarian choriocarcinoma
755161|NCT00004157|ovarian immature teratoma|ovarian immature teratoma
755162|NCT00004157|ovarian mature teratoma|ovarian mature teratoma
755163|NCT00004157|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
755164|NCT00004157|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
755165|NCT00004157|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
755166|NCT00004157|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
755167|NCT00004157|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
755168|NCT00004157|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
755169|NCT00004157|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
755170|NCT00004157|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
755171|NCT00004157|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
755172|NCT00004157|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
755173|NCT00004157|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
755174|NCT00004157|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
755175|NCT00004157|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
755176|NCT00004157|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
755177|NCT00004157|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
755178|NCT00004157|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
755179|NCT00004157|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
755180|NCT00004157|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
755181|NCT00004157|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
755182|NCT00004157|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
755183|NCT00004157|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
755184|NCT00004157|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
755185|NCT00004157|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
755186|NCT00004157|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
755187|NCT00004157|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
755188|NCT00004157|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
755189|NCT00004157|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
755190|NCT00004157|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
755191|NCT00004157|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
755192|NCT00004157|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
755193|NCT00004157|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
755194|NCT00004157|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
755195|NCT00004157|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
755196|NCT00004157|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
755197|NCT00004157|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
781196|NCT00044083|Dopamine|dopamine
755198|NCT00004157|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
755199|NCT00004157|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
755200|NCT00004157|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
755201|NCT00004157|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
755202|NCT00004157|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
755203|NCT00004157|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
755204|NCT00004157|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
755205|NCT00004157|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
755206|NCT00004157|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
755207|NCT00004157|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
755208|NCT00004157|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
755209|NCT00004157|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
755210|NCT00004157|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
755211|NCT00004157|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
755212|NCT00004157|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
755213|NCT00004157|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
755214|NCT00004157|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
755215|NCT00004157|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
755216|NCT00004157|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
755217|NCT00004157|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
755218|NCT00004157|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
755219|NCT00004157|splenic marginal zone lymphoma|splenic marginal zone lymphoma
755220|NCT00004003|stage III pancreatic cancer|stage iii pancreatic cancer
755221|NCT00004003|recurrent pancreatic cancer|recurrent pancreatic cancer
755222|NCT00004003|stage IV pancreatic cancer|stage iv pancreatic cancer
755223|NCT00077584|Scleroderma|scleroderma
755224|NCT00077584|Finger Ulcers|finger ulcers
755225|NCT00077584|Digital Ulcers|digital ulcers
755226|NCT00077584|Systemic Sclerosis|systemic sclerosis
755227|NCT00077285|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
755228|NCT00077285|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
755229|NCT00077285|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
755230|NCT00077285|adult rhabdomyosarcoma|adult rhabdomyosarcoma
755231|NCT00077285|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
755232|NCT00077285|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
755233|NCT00077285|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
755234|NCT00077285|childhood malignant mesenchymoma|childhood malignant mesenchymoma
755235|NCT00077285|adult malignant mesenchymoma|adult malignant mesenchymoma
755236|NCT00077285|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
755237|NCT00077285|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
755238|NCT00077285|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
755239|NCT00077259|recurrent colon cancer|recurrent colon cancer
755240|NCT00077259|recurrent rectal cancer|recurrent rectal cancer
755241|NCT00077259|stage III colon cancer|stage iii colon cancer
755242|NCT00077259|stage III rectal cancer|stage iii rectal cancer
755243|NCT00077259|stage IV colon cancer|stage iv colon cancer
755244|NCT00077259|stage IV rectal cancer|stage iv rectal cancer
755245|NCT00077259|adenocarcinoma of the colon|adenocarcinoma of the colon
755246|NCT00077259|adenocarcinoma of the rectum|adenocarcinoma of the rectum
755247|NCT00077246|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
755248|NCT00077246|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
755249|NCT00077233|adenocarcinoma of the colon|adenocarcinoma of the colon
755250|NCT00077233|adenocarcinoma of the rectum|adenocarcinoma of the rectum
755251|NCT00077233|recurrent colon cancer|recurrent colon cancer
755252|NCT00077233|recurrent rectal cancer|recurrent rectal cancer
755253|NCT00077233|stage IV colon cancer|stage iv colon cancer
755254|NCT00077233|stage IV rectal cancer|stage iv rectal cancer
755255|NCT00077220|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
755256|NCT00077220|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
755257|NCT00077220|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
755258|NCT00077207|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
755259|NCT00077207|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
755260|NCT00077207|childhood spinal cord neoplasm|childhood spinal cord neoplasm
755261|NCT00077207|childhood oligodendroglioma|childhood oligodendroglioma
755262|NCT00077207|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
755263|NCT00077194|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
755264|NCT00077194|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
755265|NCT00077194|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
755266|NCT00077168|ductal breast carcinoma in situ|ductal breast carcinoma in situ
755267|NCT00077168|breast cancer in situ|breast cancer in situ
755268|NCT00077142|advanced adult primary liver cancer|advanced adult primary liver cancer
755269|NCT00077142|recurrent adult primary liver cancer|recurrent adult primary liver cancer
755270|NCT00077142|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
755271|NCT00077142|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
755272|NCT00077142|Oral TAC-101|oral tac-101
755273|NCT00077129|stage III renal cell cancer|stage iii renal cell cancer
755274|NCT00077129|stage IV renal cell cancer|stage iv renal cell cancer
755275|NCT00077129|recurrent renal cell cancer|recurrent renal cell cancer
755276|NCT00077116|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
755277|NCT00077116|refractory anemia with excess blasts|refractory anemia with excess blasts
755278|NCT00077116|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
755279|NCT00077116|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
755280|NCT00077116|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
755281|NCT00077116|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
755282|NCT00077116|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
755283|NCT00077116|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
755284|NCT00077116|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
755285|NCT00077116|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
755286|NCT00077116|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
755287|NCT00077116|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
755288|NCT00077103|anaplastic thyroid cancer|anaplastic thyroid cancer
755289|NCT00077090|lymphedema|lymphedema
755290|NCT00077090|radiation fibrosis|radiation fibrosis
755291|NCT00077090|perioperative/postoperative complications|perioperative/postoperative complications
755292|NCT00077090|stage I breast cancer|stage i breast cancer
755293|NCT00077090|stage II breast cancer|stage ii breast cancer
755294|NCT00077090|stage IIIA breast cancer|stage iiia breast cancer
755295|NCT00077077|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
755296|NCT00077064|radiation fibrosis|radiation fibrosis
755297|NCT00077064|pulmonary complications|pulmonary complications
755298|NCT00077064|limited stage small cell lung cancer|limited stage small cell lung cancer
755299|NCT00077064|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
755300|NCT00077064|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
755301|NCT00077064|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
755302|NCT00077064|stage I non-small cell lung cancer|stage i non-small cell lung cancer
755303|NCT00077051|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
755304|NCT00077051|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
755305|NCT00077051|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
755306|NCT00077051|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
755307|NCT00077025|metastatic breast cancer|metastatic breast cancer
755308|NCT00077012|BPH|bph
755309|NCT00077038|Visual Feedback|visual feedback
755310|NCT00077038|Cortical Connectivity|cortical connectivity
755311|NCT00077038|Magnetoencephalography|magnetoencephalography
755312|NCT00077038|Eye Tracking|eye tracking
755313|NCT00077038|Healthy Volunteer|healthy volunteer
755314|NCT00077038|HV|hv
755315|NCT00076986|brain tumor|brain tumor
755316|NCT00076986|recurrent malignant glioma|recurrent malignant glioma
755317|NCT00076986|brain neoplasm|brain neoplasm
755318|NCT00076986|central nervous system|central nervous system
755319|NCT00076986|surgery|surgery
755320|NCT00076986|resection|resection
755321|NCT00076986|GLIADEL|gliadel
755322|NCT00076986|infusion|infusion
755323|NCT00076986|glioblastoma multiforme|glioblastoma multiforme
755324|NCT00076986|convection-enhanced delivery|convection-enhanced delivery
755325|NCT00076986|first recurrence|first recurrence
755326|NCT00076986|recurrent GBM|recurrent gbm
755327|NCT00076986|GBM|gbm
755328|NCT00076986|supratentorial GBM|supratentorial gbm
755329|NCT00076960|hyperbilirubinemia|hyperbilirubinemia
755330|NCT00076960|jaundice|jaundice
755331|NCT00076960|tin-mesoporphyrin|tin-mesoporphyrin
755332|NCT00076960|stannsoporfin|stannsoporfin
755333|NCT00076960|exchange transfusion|exchange transfusion
755334|NCT00076960|neonatal hyperbilirubinemia|neonatal hyperbilirubinemia
755335|NCT00076947|HIV Preventive Vaccine|hiv preventive vaccine
755336|NCT00076947|HIV Seronegativity|hiv seronegativity
755337|NCT00076947|Protein|protein
755338|NCT00076934|Ataxia|ataxia
755339|NCT00076934|MRI|mri
755340|NCT00076934|MS|ms
755341|NCT00076934|CTLA4-IgG4m|ctla4-igg4m
755342|NCT00076934|Costimulatory Signals|costimulatory signals
755343|NCT00076934|Autoimmune Disorders|autoimmune disorders
755344|NCT00003937|localized osteosarcoma|localized osteosarcoma
755345|NCT00003937|cardiac toxicity|cardiac toxicity
755346|NCT00003923|stage I pancreatic cancer|stage i pancreatic cancer
755347|NCT00003923|stage II pancreatic cancer|stage ii pancreatic cancer
755348|NCT00003923|stage III pancreatic cancer|stage iii pancreatic cancer
781307|NCT00043680|Neovascular|neovascular
755349|NCT00003923|stage IV pancreatic cancer|stage iv pancreatic cancer
755350|NCT00003923|recurrent pancreatic cancer|recurrent pancreatic cancer
755351|NCT00003923|unresectable gallbladder cancer|unresectable gallbladder cancer
755352|NCT00003923|recurrent gallbladder cancer|recurrent gallbladder cancer
755353|NCT00003923|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
755354|NCT00003923|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
755355|NCT00003923|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
755356|NCT00003923|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
755357|NCT00003923|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
755358|NCT00003721|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
755359|NCT00003665|stage IV melanoma|stage iv melanoma
755360|NCT00003665|recurrent melanoma|recurrent melanoma
755361|NCT00003616|recurrent adult brain tumor|recurrent adult brain tumor
755362|NCT00003616|adult brain stem glioma|adult brain stem glioma
755363|NCT00003616|adult oligodendroglioma|adult oligodendroglioma
755364|NCT00003616|adult mixed glioma|adult mixed glioma
755365|NCT00003616|adult diffuse astrocytoma|adult diffuse astrocytoma
755366|NCT00003370|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
755367|NCT00003367|adenocarcinoma of the prostate|adenocarcinoma of the prostate
755368|NCT00003367|stage I prostate cancer|stage i prostate cancer
755369|NCT00003367|stage IIB prostate cancer|stage iib prostate cancer
755370|NCT00003367|stage IIA prostate cancer|stage iia prostate cancer
755371|NCT00003367|stage III prostate cancer|stage iii prostate cancer
755372|NCT00003367|stage IV prostate cancer|stage iv prostate cancer
755373|NCT00003367|recurrent prostate cancer|recurrent prostate cancer
755374|NCT00003334|stage IV endometrial carcinoma|stage iv endometrial carcinoma
755375|NCT00003334|recurrent endometrial carcinoma|recurrent endometrial carcinoma
755376|NCT00003334|fallopian tube cancer|fallopian tube cancer
755377|NCT00003334|stage IV uterine sarcoma|stage iv uterine sarcoma
755378|NCT00003334|recurrent uterine sarcoma|recurrent uterine sarcoma
755379|NCT00003334|uterine carcinosarcoma|uterine carcinosarcoma
755380|NCT00003334|uterine leiomyosarcoma|uterine leiomyosarcoma
755381|NCT00003334|endometrial stromal sarcoma|endometrial stromal sarcoma
755382|NCT00003334|ovarian sarcoma|ovarian sarcoma
755383|NCT00003334|ovarian carcinosarcoma|ovarian carcinosarcoma
755384|NCT00003222|stage III melanoma|stage iii melanoma
755385|NCT00003222|stage IV melanoma|stage iv melanoma
755386|NCT00003222|recurrent melanoma|recurrent melanoma
755387|NCT00003185|adult glioblastoma|adult glioblastoma
755388|NCT00003185|adult anaplastic astrocytoma|adult anaplastic astrocytoma
755389|NCT00003185|adult giant cell glioblastoma|adult giant cell glioblastoma
755390|NCT00003185|adult gliosarcoma|adult gliosarcoma
755391|NCT00003108|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
755392|NCT00003086|stage IV breast cancer|stage iv breast cancer
755393|NCT00076869|Definite or probable Invasive Aspergillosis either refractory or intolerant to prior antifungal treatment.|definite or probable invasive aspergillosis either refractory or intolerant to prior antifungal treatment.
755394|NCT00076817|HIV Preventive Vaccine|hiv preventive vaccine
755395|NCT00076817|ALVAC Vaccine|alvac vaccine
755396|NCT00076817|Immunization Site|immunization site
755397|NCT00076817|Deltoid|deltoid
755398|NCT00076817|Groin|groin
755399|NCT00076817|Targeted Inguinal Lymph Node|targeted inguinal lymph node
755400|NCT00076817|TILN|tiln
755401|NCT00076804|Directly Observed Therapy|directly observed therapy
755402|NCT00076804|DOT|dot
755403|NCT00076791|HIV Seronegativity|hiv seronegativity
755404|NCT00033592|non-small cell lung cancer|non-small cell lung cancer
755405|NCT00033592|small cell lung cancer|small cell lung cancer
755406|NCT00026377|adenocarcinoma of the prostate|adenocarcinoma of the prostate
755407|NCT00026377|stage IIB prostate cancer|stage iib prostate cancer
755408|NCT00026377|stage IIA prostate cancer|stage iia prostate cancer
755409|NCT00026377|stage III prostate cancer|stage iii prostate cancer
755410|NCT00026377|stage IV prostate cancer|stage iv prostate cancer
755411|NCT00024362|stage III pancreatic cancer|stage iii pancreatic cancer
755412|NCT00024362|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
755413|NCT00024362|stage IV pancreatic cancer|stage iv pancreatic cancer
755414|NCT00003320|tumors metastatic to brain|tumors metastatic to brain
755415|NCT00003073|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
755416|NCT00003073|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
755417|NCT00003073|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
755418|NCT00003073|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
755419|NCT00003073|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
755420|NCT00003073|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
755421|NCT00003073|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
755422|NCT00003073|leptomeningeal metastases|leptomeningeal metastases
755423|NCT00003073|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
755424|NCT00003073|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
755425|NCT00002801|stage II colon cancer|stage ii colon cancer
755426|NCT00002801|stage III colon cancer|stage iii colon cancer
755427|NCT00002801|stage I rectal cancer|stage i rectal cancer
755428|NCT00002801|stage II rectal cancer|stage ii rectal cancer
755429|NCT00002801|stage III rectal cancer|stage iii rectal cancer
755430|NCT00002679|stage II breast cancer|stage ii breast cancer
755431|NCT00002679|stage IIIA breast cancer|stage iiia breast cancer
755432|NCT00002679|male breast cancer|male breast cancer
755433|NCT00076843|Interleukin-15|interleukin-15
755434|NCT00076843|CD8+ T-cells|cd8+ t-cells
755435|NCT00076843|HAM/TSP|ham/tsp
755436|NCT00076843|HTLV-1|htlv-1
755437|NCT00076843|HTLV-1 Associated Myelopathy|htlv-1 associated myelopathy
755438|NCT00076843|Tropical Spastic Paraparesis|tropical spastic paraparesis
755439|NCT00076830|Errors of Bone Matrix and Metabolism|errors of bone matrix and metabolism
755440|NCT00076830|Connective Tissue Disorders|connective tissue disorders
755441|NCT00076726|Giant Cell Arteritis|giant cell arteritis
755442|NCT00076726|infliximab|infliximab
755443|NCT00076544|Intrathecal|intrathecal
755444|NCT00076518|Treatment Experienced|treatment experienced
755445|NCT00022373|stage I nasopharyngeal cancer|stage i nasopharyngeal cancer
755446|NCT00022373|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
755447|NCT00022373|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
755448|NCT00022373|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
755449|NCT00022373|stage I salivary gland cancer|stage i salivary gland cancer
755450|NCT00022373|stage II salivary gland cancer|stage ii salivary gland cancer
755451|NCT00022373|stage III salivary gland cancer|stage iii salivary gland cancer
755452|NCT00022373|stage IV salivary gland cancer|stage iv salivary gland cancer
755453|NCT00022373|recurrent salivary gland cancer|recurrent salivary gland cancer
755454|NCT00022373|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
755455|NCT00022373|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
755456|NCT00022373|stage I lip and oral cavity cancer|stage i lip and oral cavity cancer
755457|NCT00022373|stage II lip and oral cavity cancer|stage ii lip and oral cavity cancer
755458|NCT00022373|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
755459|NCT00022373|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
755460|NCT00022373|stage I hypopharyngeal cancer|stage i hypopharyngeal cancer
755461|NCT00022373|stage II hypopharyngeal cancer|stage ii hypopharyngeal cancer
755462|NCT00022373|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
755463|NCT00022373|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
755464|NCT00022373|stage I oropharyngeal cancer|stage i oropharyngeal cancer
755465|NCT00022373|stage II oropharyngeal cancer|stage ii oropharyngeal cancer
755466|NCT00022373|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
755467|NCT00022373|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
755468|NCT00022373|radiation toxicity|radiation toxicity
755469|NCT00022373|oral complications of radiation therapy|oral complications of radiation therapy
755470|NCT00022243|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
755471|NCT00022243|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
755472|NCT00022243|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
755473|NCT00022243|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
755474|NCT00022204|stage I breast cancer|stage i breast cancer
755475|NCT00022204|stage II breast cancer|stage ii breast cancer
755476|NCT00022204|stage IIIA breast cancer|stage iiia breast cancer
755477|NCT00022204|lymphedema|lymphedema
755478|NCT00022204|male breast cancer|male breast cancer
755479|NCT00021385|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
755480|NCT00021385|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
755481|NCT00021385|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
755482|NCT00021385|ovarian stromal cancer|ovarian stromal cancer
755483|NCT00021385|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
755484|NCT00021385|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
755485|NCT00021385|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
755486|NCT00021385|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
755487|NCT00021385|ovarian sarcoma|ovarian sarcoma
755488|NCT00020696|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
755489|NCT00020696|primary peritoneal cavity cancer|primary peritoneal cavity cancer
755490|NCT00017407|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
755491|NCT00017407|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
755492|NCT00017407|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
755493|NCT00014105|recurrent adult brain tumor|recurrent adult brain tumor
755494|NCT00014105|adult glioblastoma|adult glioblastoma
755495|NCT00014105|adult giant cell glioblastoma|adult giant cell glioblastoma
755496|NCT00014105|adult gliosarcoma|adult gliosarcoma
755497|NCT00014066|stage I non-small cell lung cancer|stage i non-small cell lung cancer
755498|NCT00014066|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
755499|NCT00014066|limited stage small cell lung cancer|limited stage small cell lung cancer
755500|NCT00014066|recurrent small cell lung cancer|recurrent small cell lung cancer
755501|NCT00014066|stage 0 non-small cell lung cancer|stage 0 non-small cell lung cancer
755502|NCT00010244|stage IIB prostate cancer|stage iib prostate cancer
755503|NCT00010244|stage IIA prostate cancer|stage iia prostate cancer
755504|NCT00010244|stage III prostate cancer|stage iii prostate cancer
755505|NCT00076752|Refractory SLE|refractory sle
755506|NCT00076752|Immunoablation|immunoablation
755507|NCT00076752|Immunological Recovery|immunological recovery
755508|NCT00076752|Efficacy|efficacy
755509|NCT00076752|Mechanism of Disease|mechanism of disease
755511|NCT00076752|Systemic Lupus Erythematosus|systemic lupus erythematosus
755512|NCT00076752|SLE|sle
755513|NCT00076739|Prefrontal Cortex|prefrontal cortex
755514|NCT00076739|Semantic Memory|semantic memory
755515|NCT00076739|Semantic Relations|semantic relations
755516|NCT00076739|Priming Paradigm|priming paradigm
755517|NCT00076739|fMRI|fmri
755518|NCT00076739|Healthy Volunteer|healthy volunteer
755519|NCT00076739|HV|hv
755520|NCT00076713|Antiphospholipid|antiphospholipid
755521|NCT00009997|stage II breast cancer|stage ii breast cancer
755522|NCT00009997|stage IIIA breast cancer|stage iiia breast cancer
755523|NCT00009997|stage IIIB breast cancer|stage iiib breast cancer
755524|NCT00008333|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
755525|NCT00008333|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
755526|NCT00008034|stage II breast cancer|stage ii breast cancer
755527|NCT00008034|stage IIIA breast cancer|stage iiia breast cancer
755528|NCT00008034|stage IIIB breast cancer|stage iiib breast cancer
755529|NCT00008034|inflammatory breast cancer|inflammatory breast cancer
755530|NCT00006460|adult glioblastoma|adult glioblastoma
755531|NCT00006460|adult giant cell glioblastoma|adult giant cell glioblastoma
755532|NCT00006460|adult gliosarcoma|adult gliosarcoma
755533|NCT00006454|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
755534|NCT00006454|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
755535|NCT00006454|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
755536|NCT00006454|fallopian tube cancer|fallopian tube cancer
755537|NCT00006111|stage II bladder cancer|stage ii bladder cancer
755538|NCT00006111|stage III bladder cancer|stage iii bladder cancer
755539|NCT00006111|stage IV bladder cancer|stage iv bladder cancer
755540|NCT00006111|anterior urethral cancer|anterior urethral cancer
755541|NCT00006111|posterior urethral cancer|posterior urethral cancer
755542|NCT00006111|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
755543|NCT00006111|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
755544|NCT00006111|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
755545|NCT00076700|Cross-Modal Plasticity|cross-modal plasticity
755546|NCT00076700|Functional MRI|functional mri
755547|NCT00076700|Behavior|behavior
755548|NCT00076700|Memory|memory
755549|NCT00076700|Blind|blind
755550|NCT00076700|Blindness|blindness
755551|NCT00076700|Healthy Volunteer|healthy volunteer
755552|NCT00076700|HV|hv
755553|NCT00006050|stage IV colon cancer|stage iv colon cancer
755554|NCT00006050|stage IV rectal cancer|stage iv rectal cancer
755555|NCT00006050|liver metastases|liver metastases
755556|NCT00005881|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
755557|NCT00005881|childhood Burkitt lymphoma|childhood burkitt lymphoma
755558|NCT00005881|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
755559|NCT00005881|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
755560|NCT00005881|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
755561|NCT00005881|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
755562|NCT00005881|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
755563|NCT00005881|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
755564|NCT00005881|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
755565|NCT00005881|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
755566|NCT00005881|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
755567|NCT00005881|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
755568|NCT00005881|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
755569|NCT00005881|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
755570|NCT00005881|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
755571|NCT00005881|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
755572|NCT00005881|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
755573|NCT00005881|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
755574|NCT00005881|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
755575|NCT00005881|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
755576|NCT00005881|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
755577|NCT00005881|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
755578|NCT00005881|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
755579|NCT00005881|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
755580|NCT00005881|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
755581|NCT00005881|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
755582|NCT00005881|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
755583|NCT00005792|refractory multiple myeloma|refractory multiple myeloma
755584|NCT00005792|stage I multiple myeloma|stage i multiple myeloma
755585|NCT00005792|stage II multiple myeloma|stage ii multiple myeloma
755586|NCT00005792|stage III multiple myeloma|stage iii multiple myeloma
755587|NCT00076635|Idiopathic|idiopathic
755588|NCT00076635|Pulmonary|pulmonary
755589|NCT00076635|Fibrosis|fibrosis
755590|NCT00076635|IPF|ipf
755591|NCT00076635|Lung|lung
755592|NCT00076635|Actimmune|actimmune
755593|NCT00076635|Interferon|interferon
755594|NCT00076635|Gamma|gamma
755595|NCT00076635|InterMune|intermune
755596|NCT00076674|Parkinson's Disease|parkinson's disease
755597|NCT00076674|Keppra|keppra
755598|NCT00076674|Motor Fluctuations|motor fluctuations
755599|NCT00076674|Intravenous Levodopa|intravenous levodopa
755600|NCT00076674|Antiparkinsonian Response|antiparkinsonian response
755601|NCT00076674|Parkinson Disease|parkinson disease
755602|NCT00076674|PD|pd
755603|NCT00076622|Antidepressant drugs|antidepressant drugs
755604|NCT00076622|Nursing Homes|nursing homes
755605|NCT00005022|limited stage small cell lung cancer|limited stage small cell lung cancer
755606|NCT00004862|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
755607|NCT00004862|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
755608|NCT00004239|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
755609|NCT00004239|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
755610|NCT00004239|refractory multiple myeloma|refractory multiple myeloma
755611|NCT00004239|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
755612|NCT00004239|stage III multiple myeloma|stage iii multiple myeloma
755613|NCT00004239|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
755614|NCT00004239|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
755615|NCT00004239|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
755616|NCT00004239|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
755617|NCT00004239|polycythemia vera|polycythemia vera
755618|NCT00004239|primary myelofibrosis|primary myelofibrosis
755619|NCT00004239|essential thrombocythemia|essential thrombocythemia
755620|NCT00004239|refractory hairy cell leukemia|refractory hairy cell leukemia
755621|NCT00004239|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
755622|NCT00004239|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
755623|NCT00004239|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
755624|NCT00004239|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
755625|NCT00004239|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
755626|NCT00004239|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
755627|NCT00004239|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
755628|NCT00004239|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
755629|NCT00004239|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
755630|NCT00004239|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
755631|NCT00004239|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
755632|NCT00004239|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
755633|NCT00004239|prolymphocytic leukemia|prolymphocytic leukemia
755634|NCT00004239|primary systemic amyloidosis|primary systemic amyloidosis
755635|NCT00004239|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
755636|NCT00004239|anaplastic large cell lymphoma|anaplastic large cell lymphoma
755637|NCT00004239|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
755638|NCT00004239|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
755639|NCT00004239|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
755640|NCT00004239|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
755641|NCT00004239|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
755642|NCT00004239|splenic marginal zone lymphoma|splenic marginal zone lymphoma
755643|NCT00003888|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
755644|NCT00003888|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
755645|NCT00003888|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
755646|NCT00003888|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
755647|NCT00003888|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
755648|NCT00003888|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
755649|NCT00003888|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
755650|NCT00003888|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
755651|NCT00076609|hepatocellular carcinoma|hepatocellular carcinoma
755652|NCT00076609|advanced|advanced
755653|NCT00076609|unresectable|unresectable
755654|NCT00076609|liver cancer|liver cancer
755655|NCT00076609|systemic chemotherapy|systemic chemotherapy
755656|NCT00076609|botanical|botanical
755657|NCT00076609|herbal|herbal
755658|NCT00076609|alternative and complementary medicine|alternative and complementary medicine
755659|NCT00076609|capecitabine|capecitabine
755660|NCT00076609|PHY906|phy906
755661|NCT00076609|oral|oral
755662|NCT00076609|HCC|hcc
755663|NCT00076609|traditional chinese medicine|traditional chinese medicine
755664|NCT00076609|tcm|tcm
755665|NCT00076609|QOL|qol
755666|NCT00076609|quality of life|quality of life
755667|NCT00076557|Hemophilia B|hemophilia b
755668|NCT00076557|Factor IX|factor ix
755669|NCT00076557|Gene Transfer|gene transfer
755670|NCT00076557|Adeno-Associated Virus (AAV)|adeno-associated virus (aav)
755671|NCT00076596|Corticospinal Tracts|corticospinal tracts
755672|NCT00076596|Spastic Hemiplegia|spastic hemiplegia
755673|NCT00076596|Spastic Diplegia|spastic diplegia
755674|NCT00076596|Cortical Re-Organization|cortical re-organization
755675|NCT00076596|Functional Outcome|functional outcome
755676|NCT00076596|Cerebral Palsy|cerebral palsy
755677|NCT00076583|Motor Learning|motor learning
755678|NCT00076583|Co-contraction|co-contraction
755679|NCT00076583|Reciprocal Inhibition|reciprocal inhibition
755680|NCT00076583|Spinal Plasticity|spinal plasticity
755681|NCT00076583|Rhythmic Movement|rhythmic movement
755682|NCT00076583|Healthy Volunteer|healthy volunteer
755683|NCT00076583|HV|hv
755684|NCT00076570|Tolerance|tolerance
755685|NCT00076570|Kidney|kidney
755686|NCT00076570|Transplant|transplant
755687|NCT00076570|Polyclonal|polyclonal
755688|NCT00076570|Antibody|antibody
755689|NCT00076570|Kidney Transplant|kidney transplant
755690|NCT00076531|Prostate|prostate
755691|NCT00076531|Cancer|cancer
755692|NCT00076531|PSA|psa
755693|NCT00076531|Leuprolide|leuprolide
755694|NCT00076492|Parkinson's disease|parkinson's disease
755695|NCT00076492|Parkinson disease|parkinson disease
755696|NCT00076492|CoQ10|coq10
755697|NCT00076492|GPI 1485|gpi 1485
755698|NCT00003882|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
755699|NCT00003852|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
755700|NCT00003852|childhood germ cell tumor|childhood germ cell tumor
755701|NCT00003852|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
755702|NCT00003852|extragonadal germ cell tumor|extragonadal germ cell tumor
755703|NCT00003683|stage IV renal cell cancer|stage iv renal cell cancer
755704|NCT00003682|stage IV prostate cancer|stage iv prostate cancer
755705|NCT00003682|recurrent prostate cancer|recurrent prostate cancer
755706|NCT00003578|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
755707|NCT00003578|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
755708|NCT00003578|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
755709|NCT00003578|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
755710|NCT00003578|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
755711|NCT00003578|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
755712|NCT00003578|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
755713|NCT00003578|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
755714|NCT00076505|Mitochondria|mitochondria
755715|NCT00076505|Proteasome|proteasome
755716|NCT00076505|Lipid|lipid
755717|NCT00076505|Polymorphism|polymorphism
755718|NCT00076505|Genetic|genetic
755719|NCT00076505|Parkinson's Disease|parkinson's disease
755720|NCT00076505|Parkinson Disease|parkinson disease
755721|NCT00076505|PD|pd
755722|NCT00076505|Heredity|heredity
755723|NCT00076505|Parkinson Disease At Risk|parkinson disease at risk
755724|NCT00076505|Healthy Volunteer|healthy volunteer
755725|NCT00076505|HV|hv
755726|NCT00076453|Knee Pain|knee pain
755727|NCT00076453|Degenerative Arthritis|degenerative arthritis
755728|NCT00076453|Cartilage Disease|cartilage disease
755729|NCT00076453|Non-drug Therapy|non-drug therapy
755730|NCT00076440|Alzheimer disease|alzheimer disease
755731|NCT00076401|CLL|cll
755732|NCT00076401|chronic lymphocytic leukemia|chronic lymphocytic leukemia
755733|NCT00076401|relapsed chronic lymphocytic leukemia|relapsed chronic lymphocytic leukemia
755734|NCT00076401|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
755735|NCT00076401|Leukemia|leukemia
755736|NCT00076401|Motexafin gadolinium|motexafin gadolinium
755737|NCT00076401|Chronic leukemia|chronic leukemia
755738|NCT00076401|Lymphocytic leukemia, chronic|lymphocytic leukemia, chronic
755739|NCT00076479|Aphasia|aphasia
755740|NCT00076479|Rehabilitation|rehabilitation
755741|NCT00076479|Neuroplasticity|neuroplasticity
755742|NCT00076479|Picture Naming|picture naming
755743|NCT00076479|Transcranial Magnetic|transcranial magnetic
755744|NCT00076479|Stroke|stroke
755745|NCT00076479|Healthy Volunteer|healthy volunteer
755746|NCT00076479|HV|hv
755747|NCT00076466|Brain Excitability|brain excitability
755748|NCT00076466|Reaction Time|reaction time
755749|NCT00076466|Plasticity|plasticity
755750|NCT00076466|Motor Evoked Potential|motor evoked potential
755751|NCT00076466|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
755752|NCT00076466|Healthy Volunteer|healthy volunteer
755753|NCT00076466|HV|hv
755754|NCT00076388|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
755755|NCT00076375|Atopic Dermatitis|atopic dermatitis
755756|NCT00076375|Eczema|eczema
755757|NCT00003541|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
755758|NCT00003541|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
755759|NCT00003418|stage I breast cancer|stage i breast cancer
755760|NCT00003418|stage II breast cancer|stage ii breast cancer
755761|NCT00003418|stage III breast cancer|stage iii breast cancer
755762|NCT00003364|limited stage small cell lung cancer|limited stage small cell lung cancer
755763|NCT00003298|stage II gastric cancer|stage ii gastric cancer
755764|NCT00003298|stage III gastric cancer|stage iii gastric cancer
755765|NCT00003298|stage IV gastric cancer|stage iv gastric cancer
755766|NCT00003298|adenocarcinoma of the stomach|adenocarcinoma of the stomach
755767|NCT00003287|stage IV colon cancer|stage iv colon cancer
755768|NCT00003287|stage IV rectal cancer|stage iv rectal cancer
755769|NCT00003287|recurrent colon cancer|recurrent colon cancer
755770|NCT00003287|recurrent rectal cancer|recurrent rectal cancer
755771|NCT00003287|adenocarcinoma of the colon|adenocarcinoma of the colon
755772|NCT00003287|adenocarcinoma of the rectum|adenocarcinoma of the rectum
755773|NCT00076427|Immunity|immunity
755774|NCT00076427|Liver|liver
755775|NCT00076427|Apheresis|apheresis
755776|NCT00076427|Cytokine|cytokine
755777|NCT00076427|Virology|virology
755778|NCT00076427|Hepatitis C|hepatitis c
755779|NCT00076427|HCV|hcv
755780|NCT00076427|Hepatitis C co-infection|hepatitis c co-infection
755781|NCT00076414|Endothelial Function|endothelial function
755782|NCT00076414|Lopinavir/Ritonavir|lopinavir/ritonavir
755783|NCT00076414|HIV|hiv
755784|NCT00076414|Blood Flow Studies|blood flow studies
755785|NCT00076414|Flow-Mediated Vasodilatation|flow-mediated vasodilatation
755786|NCT00076414|Healthy Volunteer|healthy volunteer
755787|NCT00076414|HV|hv
755788|NCT00076349|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
755789|NCT00076349|NHL|nhl
755790|NCT00076349|Rituxan|rituxan
755791|NCT00076349|Mantle Cell|mantle cell
755792|NCT00076349|mabs|mabs
755793|NCT00003137|stage IV gastric cancer|stage iv gastric cancer
755794|NCT00003137|stage IV esophageal cancer|stage iv esophageal cancer
755795|NCT00003137|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
755796|NCT00003137|intestinal adenocarcinoma of the stomach|intestinal adenocarcinoma of the stomach
755797|NCT00003137|diffuse adenocarcinoma of the stomach|diffuse adenocarcinoma of the stomach
755798|NCT00003137|mixed adenocarcinoma of the stomach|mixed adenocarcinoma of the stomach
755799|NCT00003007|refractory multiple myeloma|refractory multiple myeloma
755800|NCT00003007|stage III multiple myeloma|stage iii multiple myeloma
755801|NCT00002840|recurrent adult brain tumor|recurrent adult brain tumor
755802|NCT00002840|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
755803|NCT00002840|adult mixed glioma|adult mixed glioma
755804|NCT00002817|stage III melanoma|stage iii melanoma
755805|NCT00002817|stage IV melanoma|stage iv melanoma
755806|NCT00002817|recurrent melanoma|recurrent melanoma
755807|NCT00002748|recurrent neuroblastoma|recurrent neuroblastoma
755808|NCT00076323|G6PD|g6pd
755809|NCT00076323|Favism|favism
755810|NCT00076323|G6PD Deficiency|g6pd deficiency
755811|NCT00076323|hemolysis|hemolysis
755812|NCT00076323|drug reaction|drug reaction
755813|NCT00076323|drug-induced hemolysis|drug-induced hemolysis
755814|NCT00076310|Head and Neck Cancer|head and neck cancer
755815|NCT00076310|Squamous Cell Cancer|squamous cell cancer
755817|NCT00076310|Cisplatin|cisplatin
755818|NCT00076310|Platinol®-AQ|platinol®-aq
755819|NCT00076310|Platinol®|platinol®
755820|NCT00076310|CDDP|cddp
755821|NCT00076310|Docetaxel|docetaxel
755822|NCT00076310|Taxotere|taxotere
755823|NCT00076310|Tarceva|tarceva
755824|NCT00076310|HNSCC|hnscc
755825|NCT00076310|Erlotinib Hydrochloride|erlotinib hydrochloride
755826|NCT00076284|CCR5 Antagonist|ccr5 antagonist
755827|NCT00076284|Coreceptor Inhibitor|coreceptor inhibitor
755828|NCT00076284|Fusion Inhibitor|fusion inhibitor
755829|NCT00076284|Entry Inhibitor|entry inhibitor
755830|NCT00076284|Antiretroviral|antiretroviral
755831|NCT00076284|HIV|hiv
755832|NCT00076271|Strabismus|strabismus
755833|NCT00076271|Cataract, Pediatric|cataract, pediatric
755834|NCT00076271|Optic Nerve Anomaly|optic nerve anomaly
755835|NCT00076271|Coloboma|coloboma
755836|NCT00076271|Evaluation and Treatment|evaluation and treatment
755837|NCT00076271|Pediatric Ophthalmology|pediatric ophthalmology
755838|NCT00076271|Genetic Eye Disease|genetic eye disease
755839|NCT00076271|Nystagmus|nystagmus
755840|NCT00076271|Pediatric Eye Disease|pediatric eye disease
755841|NCT00076271|Developmental Eye Condition|developmental eye condition
755842|NCT00076271|Cataract|cataract
755843|NCT00076271|Juvenile Glaucoma|juvenile glaucoma
755844|NCT00076271|Eye Movement Disorder|eye movement disorder
755845|NCT00076258|Exercise therapy|exercise therapy
755846|NCT00076258|Complementary Therapies|complementary therapies
755847|NCT00076245|Phototherapy|phototherapy
755848|NCT00076219|Acute Renal Failure|acute renal failure
755849|NCT00076219|Renal Replacement Therapy|renal replacement therapy
755850|NCT00076219|multi-site randomization trial|multi-site randomization trial
755851|NCT00076219|Hemodialysis|hemodialysis
755852|NCT00076219|Hemofiltration|hemofiltration
755853|NCT00076219|Critical Illness|critical illness
755854|NCT00076219|Hemodiafiltration|hemodiafiltration
755855|NCT00076232|HIV Seronegativity|hiv seronegativity
755856|NCT00076154|ALS|als
755857|NCT00076141|relatively healthy male|relatively healthy male
755858|NCT00076115|Bipolar|bipolar
755859|NCT00076115|Mania|mania
755860|NCT00076115|Manic|manic
755861|NCT00076115|Depressive|depressive
755862|NCT00076115|Manic Depressive|manic depressive
755863|NCT00076115|Bipolar mania|bipolar mania
755864|NCT00076115|risperidone|risperidone
755865|NCT00076115|adolescents|adolescents
755866|NCT00076115|children|children
755867|NCT00076180|cytotoxic activity against T-LGL cells|cytotoxic activity against t-lgl cells
755868|NCT00076180|chronic lymphoproliferative disorder|chronic lymphoproliferative disorder
755869|NCT00076180|T-LGL Leukemia|t-lgl leukemia
755870|NCT00076180|Natural Killer Cells|natural killer cells
755871|NCT00076180|Leukemia|leukemia
755872|NCT00076180|Lymphocytic Leukemia|lymphocytic leukemia
755873|NCT00076180|T-LGL|t-lgl
755874|NCT00076089|Roflumilast|roflumilast
755875|NCT00076089|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
755876|NCT00076089|COPD|copd
755877|NCT00076076|Roflumilast|roflumilast
755878|NCT00076076|Asthma|asthma
755879|NCT00033735|recurrent pancreatic cancer|recurrent pancreatic cancer
755880|NCT00033735|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
755881|NCT00027508|advanced malignant mesothelioma|advanced malignant mesothelioma
755882|NCT00027508|recurrent malignant mesothelioma|recurrent malignant mesothelioma
755883|NCT00024401|stage IV colon cancer|stage iv colon cancer
755884|NCT00024401|stage IV rectal cancer|stage iv rectal cancer
755885|NCT00024401|recurrent colon cancer|recurrent colon cancer
755886|NCT00024401|recurrent rectal cancer|recurrent rectal cancer
755887|NCT00002566|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
755888|NCT00002566|extragonadal germ cell tumor|extragonadal germ cell tumor
755889|NCT00076102|Side Effect|side effect
755890|NCT00076102|Oral Administration|oral administration
755891|NCT00076102|Nerve Sheath Tumor|nerve sheath tumor
755892|NCT00076102|Antifibrotic Agent|antifibrotic agent
755893|NCT00076102|Volumetric Tumor Measurement|volumetric tumor measurement
755894|NCT00076102|Plexiform Neurofibroma|plexiform neurofibroma
755895|NCT00076102|Neurofibromatosis Type 1|neurofibromatosis type 1
755896|NCT00076102|Volumetric MRI Analysis|volumetric mri analysis
755897|NCT00076102|Time to Progression|time to progression
755898|NCT00076102|NF1|nf1
755899|NCT00076063|HIV Seronegativity|hiv seronegativity
755900|NCT00076063|ALVAC-HIV vCP1452|alvac-hiv vcp1452
755901|NCT00076063|ALVAC Vaccine|alvac vaccine
755902|NCT00076063|HIV-1|hiv-1
755903|NCT00076063|Normal Values|normal values
755904|NCT00076063|HIV Preventive Vaccine|hiv preventive vaccine
755905|NCT00076037|HIV Preventive Vaccine|hiv preventive vaccine
755906|NCT00076037|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
755907|NCT00076037|AIDS Vaccines|aids vaccines
755908|NCT00076037|HIV-1|hiv-1
755909|NCT00076037|HIV Seronegativity|hiv seronegativity
755910|NCT00076037|Injections, Intramuscular|injections, intramuscular
755911|NCT00076037|RC529|rc529
755912|NCT00076037|Epitopes|epitopes
755913|NCT00076037|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
755914|NCT00076024|metastatic breast cancer|metastatic breast cancer
755915|NCT00075998|Idiopathic|idiopathic
755916|NCT00075998|Pulmonary|pulmonary
755917|NCT00075998|Fibrosis|fibrosis
755918|NCT00075998|IPF|ipf
755919|NCT00075998|Lung|lung
755920|NCT00075998|Interferon|interferon
755921|NCT00075998|Gamma|gamma
755922|NCT00075998|Actimmune|actimmune
755923|NCT00075998|INSPIRE|inspire
755924|NCT00075998|InterMune|intermune
755925|NCT00075959|Stroke|stroke
755926|NCT00075959|cerebral vascular accident|cerebral vascular accident
755927|NCT00075959|CVA|cva
755928|NCT00075959|Hemorrhage|hemorrhage
755929|NCT00075959|Intracerebral Hemorrhage (ICH)|intracerebral hemorrhage (ich)
755930|NCT00075959|Brain Attack|brain attack
755931|NCT00075959|Cataplexy|cataplexy
755932|NCT00075946|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
755933|NCT00075946|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
755934|NCT00075946|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
755935|NCT00075946|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
755936|NCT00075946|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
755937|NCT00075946|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
755938|NCT00075946|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
755939|NCT00075946|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
756038|NCT00075699|epithelial mesothelioma|epithelial mesothelioma
755940|NCT00075946|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
781308|NCT00043680|Celecoxib|celecoxib
755941|NCT00075946|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
755942|NCT00075946|splenic marginal zone lymphoma|splenic marginal zone lymphoma
755943|NCT00024388|stage III renal cell cancer|stage iii renal cell cancer
755944|NCT00024388|stage IV renal cell cancer|stage iv renal cell cancer
755945|NCT00024388|recurrent renal cell cancer|recurrent renal cell cancer
755946|NCT00022347|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
755947|NCT00022347|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
755948|NCT00022347|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
755949|NCT00022347|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
755950|NCT00022347|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
755951|NCT00022347|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
755952|NCT00022347|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
755953|NCT00022347|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
755954|NCT00022347|fallopian tube cancer|fallopian tube cancer
755955|NCT00022347|primary peritoneal cavity cancer|primary peritoneal cavity cancer
755956|NCT00022321|refractory anemia|refractory anemia
755957|NCT00022321|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
755958|NCT00022321|refractory anemia with excess blasts|refractory anemia with excess blasts
755959|NCT00022321|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
755960|NCT00022321|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
755961|NCT00021333|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
755962|NCT00021333|recurrent small cell lung cancer|recurrent small cell lung cancer
755963|NCT00021333|recurrent thyroid cancer|recurrent thyroid cancer
755964|NCT00021333|recurrent salivary gland cancer|recurrent salivary gland cancer
755965|NCT00021333|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
755966|NCT00021333|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
755967|NCT00021333|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
755968|NCT00021333|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
755969|NCT00021333|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
755970|NCT00021333|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
755971|NCT00021333|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
755972|NCT00021333|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
755973|NCT00021333|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
755974|NCT00021333|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
755975|NCT00021333|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
755976|NCT00021333|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
755977|NCT00021333|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
755978|NCT00021333|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
755979|NCT00021333|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
755980|NCT00021333|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
755981|NCT00021307|recurrent adult brain tumor|recurrent adult brain tumor
755982|NCT00021307|adult glioblastoma|adult glioblastoma
755983|NCT00021307|adult giant cell glioblastoma|adult giant cell glioblastoma
755984|NCT00021307|adult gliosarcoma|adult gliosarcoma
755985|NCT00075907|Acute Infection|acute infection
755986|NCT00075907|Treatment Experienced|treatment experienced
755987|NCT00075907|Treatment Naive|treatment naive
755988|NCT00075894|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
755989|NCT00075894|adult anaplastic astrocytoma|adult anaplastic astrocytoma
755990|NCT00075894|adult glioblastoma|adult glioblastoma
755991|NCT00075894|recurrent adult brain tumor|recurrent adult brain tumor
755992|NCT00075894|adult giant cell glioblastoma|adult giant cell glioblastoma
755993|NCT00075894|adult gliosarcoma|adult gliosarcoma
755994|NCT00075868|radiation enteritis|radiation enteritis
755995|NCT00075868|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
755996|NCT00075868|stage I rectal cancer|stage i rectal cancer
755997|NCT00075868|stage II rectal cancer|stage ii rectal cancer
755998|NCT00075868|stage III rectal cancer|stage iii rectal cancer
755999|NCT00075868|stage IIIA anal cancer|stage iiia anal cancer
756000|NCT00075868|stage IIIB anal cancer|stage iiib anal cancer
756001|NCT00075868|recurrent anal cancer|recurrent anal cancer
756002|NCT00075868|stage I anal cancer|stage i anal cancer
756003|NCT00075868|stage II anal cancer|stage ii anal cancer
756004|NCT00075868|recurrent rectal cancer|recurrent rectal cancer
756005|NCT00075855|sexual dysfunction|sexual dysfunction
756006|NCT00075855|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
756007|NCT00075855|sexuality and reproductive issues|sexuality and reproductive issues
756008|NCT00075855|cancer survivor|cancer survivor
756009|NCT00075842|sleep disorders|sleep disorders
756010|NCT00075842|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
756012|NCT00075829|Stage II Multiple Myeloma|stage ii multiple myeloma
756013|NCT00075829|Stage III Multiple Myeloma|stage iii multiple myeloma
756014|NCT00075829|Refractory Plasma Cell Neoplasm|refractory plasma cell neoplasm
756015|NCT00075803|Myelodysplastic and Myeloproliferative Diseases|myelodysplastic and myeloproliferative diseases
756016|NCT00075777|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
756017|NCT00075777|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
756018|NCT00075764|stage IV breast cancer|stage iv breast cancer
756019|NCT00075764|recurrent breast cancer|recurrent breast cancer
756020|NCT00075738|stage IV esophageal cancer|stage iv esophageal cancer
756021|NCT00075738|recurrent esophageal cancer|recurrent esophageal cancer
756022|NCT00075725|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
756023|NCT00075725|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
756024|NCT00075725|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
756025|NCT00075725|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
756026|NCT00075712|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
756027|NCT00075712|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
756028|NCT00075712|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
756029|NCT00075712|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
756030|NCT00075712|stage IV fallopian tube cancer|stage iv fallopian tube cancer
756031|NCT00075712|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
756032|NCT00075712|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
756033|NCT00075712|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
756034|NCT00075712|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
756035|NCT00075712|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
756036|NCT00075712|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
756037|NCT00075712|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
756039|NCT00075699|localized malignant mesothelioma|localized malignant mesothelioma
756040|NCT00075699|advanced malignant mesothelioma|advanced malignant mesothelioma
756041|NCT00075686|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
756042|NCT00075686|stage III pancreatic cancer|stage iii pancreatic cancer
756043|NCT00075686|stage IV pancreatic cancer|stage iv pancreatic cancer
756044|NCT00075920|Heart|heart
756045|NCT00075920|Function|function
756046|NCT00075920|Ultrasound|ultrasound
756047|NCT00075920|MRI|mri
756048|NCT00075920|Left Ventricle|left ventricle
756049|NCT00075920|Healthy Volunteer|healthy volunteer
756050|NCT00075920|HV|hv
756051|NCT00075920|Heart Disease|heart disease
756052|NCT00075673|recurrent breast cancer|recurrent breast cancer
756053|NCT00075673|stage IV breast cancer|stage iv breast cancer
756054|NCT00075660|recurrent renal cell cancer|recurrent renal cell cancer
756055|NCT00075660|stage III renal cell cancer|stage iii renal cell cancer
756056|NCT00075660|stage IV renal cell cancer|stage iv renal cell cancer
756057|NCT00075621|primary systemic amyloidosis|primary systemic amyloidosis
756058|NCT00075608|primary systemic amyloidosis|primary systemic amyloidosis
756059|NCT00075595|stage IV colon cancer|stage iv colon cancer
756060|NCT00075595|stage IV rectal cancer|stage iv rectal cancer
756061|NCT00075595|recurrent colon cancer|recurrent colon cancer
756062|NCT00075595|recurrent rectal cancer|recurrent rectal cancer
756063|NCT00075595|adenocarcinoma of the colon|adenocarcinoma of the colon
756064|NCT00075595|adenocarcinoma of the rectum|adenocarcinoma of the rectum
756065|NCT00075569|cervical cancer|cervical cancer
756066|NCT00075569|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
756067|NCT00075556|stage III colon cancer|stage iii colon cancer
756068|NCT00075556|stage IV colon cancer|stage iv colon cancer
756069|NCT00075556|stage III rectal cancer|stage iii rectal cancer
756070|NCT00075556|stage IV rectal cancer|stage iv rectal cancer
756071|NCT00075556|adenocarcinoma of the rectum|adenocarcinoma of the rectum
756072|NCT00075556|adenocarcinoma of the colon|adenocarcinoma of the colon
756073|NCT00075543|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
756074|NCT00075543|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
756075|NCT00075543|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
756076|NCT00075517|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
756077|NCT00075517|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
756078|NCT00075517|adenocarcinoma of the lung|adenocarcinoma of the lung
756079|NCT00075517|large cell lung cancer|large cell lung cancer
756080|NCT00075517|squamous cell lung cancer|squamous cell lung cancer
756081|NCT00075465|adenocarcinoma of the stomach|adenocarcinoma of the stomach
756082|NCT00075465|stage III gastric cancer|stage iii gastric cancer
756083|NCT00075465|stage IV gastric cancer|stage iv gastric cancer
756084|NCT00075452|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
756085|NCT00075452|stage II pancreatic cancer|stage ii pancreatic cancer
756086|NCT00075452|stage III pancreatic cancer|stage iii pancreatic cancer
756087|NCT00075452|stage IV pancreatic cancer|stage iv pancreatic cancer
756088|NCT00075426|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
756089|NCT00075426|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
756090|NCT00075426|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
756091|NCT00075426|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
756092|NCT00075413|stage IIIB breast cancer|stage iiib breast cancer
756093|NCT00075413|stage IIIC breast cancer|stage iiic breast cancer
756094|NCT00075413|stage IV breast cancer|stage iv breast cancer
756095|NCT00075413|recurrent breast cancer|recurrent breast cancer
756096|NCT00075413|stage IIIA breast cancer|stage iiia breast cancer
756097|NCT00075374|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
756098|NCT00075374|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
756099|NCT00075374|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
756100|NCT00075348|renal cell carcinoma|renal cell carcinoma
756101|NCT00075348|von Hippel-Lindau syndrome|von hippel-lindau syndrome
756102|NCT00075335|Hematopoietic Stem Cells|hematopoietic stem cells
756103|NCT00075335|Mobilization|mobilization
756104|NCT00075335|Alloreactivity|alloreactivity
756105|NCT00075335|T Cell Polarization|t cell polarization
756106|NCT00075335|Dendritic Cells|dendritic cells
756107|NCT00075335|Plerixafor|plerixafor
756108|NCT00075335|Mozobil|mozobil
756109|NCT00075335|Healthy Volunteer (HV)|healthy volunteer (hv)
756110|NCT00075296|Major Depressive Disorder|major depressive disorder
756111|NCT00075296|Bipolar Disorder|bipolar disorder
756112|NCT00075296|Negative Feedback|negative feedback
756113|NCT00075296|Cognitive Performance|cognitive performance
756114|NCT00075296|Negative Affect|negative affect
756115|NCT00075296|Depression|depression
756116|NCT00075296|Major Depression|major depression
756117|NCT00075296|MDD|mdd
756118|NCT00075296|Healthy Volunteer|healthy volunteer
756119|NCT00075296|HV|hv
756120|NCT00075283|Physical Therapy|physical therapy
756121|NCT00075283|Locomotion therapy|locomotion therapy
756122|NCT00075283|Gait training|gait training
756123|NCT00075283|Stroke|stroke
756124|NCT00075283|Robotics|robotics
756125|NCT00075283|Rehabilitation|rehabilitation
756126|NCT00075283|Treadmill|treadmill
756127|NCT00075283|Hemiparetic stroke|hemiparetic stroke
756128|NCT00075283|Unilateral brain lesion|unilateral brain lesion
756129|NCT00075270|metastatic breast cancer|metastatic breast cancer
756130|NCT00075270|ErbB1|erbb1
756131|NCT00075270|kinase inhibitor|kinase inhibitor
756132|NCT00075270|ErbB2|erbb2
756133|NCT00075270|EGFR|egfr
756134|NCT00075270|lapatinib|lapatinib
756135|NCT00075270|Her2-neu|her2-neu
756136|NCT00075231|Treatment Naive|treatment naive
756137|NCT00075153|ADOLESCENCE|adolescence
756138|NCT00075153|HIV INFECTION|hiv infection
756139|NCT00075153|PEDIATRIC AIDS|pediatric aids
756140|NCT00075153|QUALITY OF LIFE|quality of life
756141|NCT00075153|HIV|hiv
756142|NCT00020787|stage IV gastric cancer|stage iv gastric cancer
756143|NCT00020787|recurrent gastric cancer|recurrent gastric cancer
756144|NCT00020787|stage IV esophageal cancer|stage iv esophageal cancer
756145|NCT00020787|recurrent esophageal cancer|recurrent esophageal cancer
756146|NCT00020787|adenocarcinoma of the stomach|adenocarcinoma of the stomach
756147|NCT00020787|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
756148|NCT00017576|adenocarcinoma of the prostate|adenocarcinoma of the prostate
756149|NCT00017576|stage IV prostate cancer|stage iv prostate cancer
756150|NCT00017576|recurrent prostate cancer|recurrent prostate cancer
756151|NCT00017537|stage IV breast cancer|stage iv breast cancer
756152|NCT00017537|recurrent breast cancer|recurrent breast cancer
756153|NCT00017537|stage IV gastric cancer|stage iv gastric cancer
756154|NCT00017537|recurrent gastric cancer|recurrent gastric cancer
756155|NCT00017537|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
756156|NCT00017537|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
756157|NCT00017537|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
756158|NCT00017537|adenocarcinoma of the stomach|adenocarcinoma of the stomach
756159|NCT00017537|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
756160|NCT00017537|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
756161|NCT00017433|refractory multiple myeloma|refractory multiple myeloma
756162|NCT00017433|stage II multiple myeloma|stage ii multiple myeloma
756163|NCT00017433|stage III multiple myeloma|stage iii multiple myeloma
756164|NCT00075244|Lysosomes|lysosomes
756165|NCT00075244|Storage|storage
756166|NCT00075244|Glycolipid|glycolipid
756167|NCT00075244|Fabry Disease|fabry disease
756168|NCT00075244|Stroke|stroke
756169|NCT00017082|stage IV colon cancer|stage iv colon cancer
756170|NCT00017082|stage IV rectal cancer|stage iv rectal cancer
756171|NCT00017082|recurrent colon cancer|recurrent colon cancer
756172|NCT00017082|recurrent rectal cancer|recurrent rectal cancer
756173|NCT00017082|adenocarcinoma of the colon|adenocarcinoma of the colon
756174|NCT00017082|adenocarcinoma of the rectum|adenocarcinoma of the rectum
756175|NCT00016237|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
756176|NCT00016237|squamous cell lung cancer|squamous cell lung cancer
756177|NCT00016237|stage IV renal cell cancer|stage iv renal cell cancer
756178|NCT00016237|recurrent renal cell cancer|recurrent renal cell cancer
756179|NCT00016237|extensive stage small cell lung cancer|extensive stage small cell lung cancer
756180|NCT00016237|recurrent small cell lung cancer|recurrent small cell lung cancer
781513|NCT00042328|Cancer|cancer
756181|NCT00016237|recurrent bladder cancer|recurrent bladder cancer
756182|NCT00016237|stage IV bladder cancer|stage iv bladder cancer
756183|NCT00016237|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
756184|NCT00016237|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
756185|NCT00016237|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
756186|NCT00016198|stage IV colon cancer|stage iv colon cancer
756187|NCT00016198|stage IV rectal cancer|stage iv rectal cancer
756188|NCT00016198|recurrent colon cancer|recurrent colon cancer
756189|NCT00016198|recurrent rectal cancer|recurrent rectal cancer
756190|NCT00016198|adenocarcinoma of the colon|adenocarcinoma of the colon
756191|NCT00016198|adenocarcinoma of the rectum|adenocarcinoma of the rectum
756192|NCT00014404|lip and oral cavity cancer|lip and oral cavity cancer
756193|NCT00014287|stage 0 bladder cancer|stage 0 bladder cancer
756194|NCT00014287|stage I bladder cancer|stage i bladder cancer
756195|NCT00014287|recurrent bladder cancer|recurrent bladder cancer
756196|NCT00075205|Alcohol Consumption|alcohol consumption
756197|NCT00075205|Alcohol Treatment|alcohol treatment
756198|NCT00075205|Medication Trial|medication trial
756199|NCT00075205|Craving|craving
756200|NCT00075205|Cannabinoids|cannabinoids
756201|NCT00075205|CB 1 Receptor Antagonist|cb 1 receptor antagonist
756202|NCT00075205|SR141716|sr141716
756203|NCT00075205|Alcoholism|alcoholism
756204|NCT00075179|Pulmonary hypertension|pulmonary hypertension
756205|NCT00075179|cancer|cancer
756206|NCT00075179|lung cancer|lung cancer
756207|NCT00075179|lung disease|lung disease
756208|NCT00075179|cardiothoracic surgery|cardiothoracic surgery
756209|NCT00075179|Nesiritide|nesiritide
756210|NCT00075179|Natrecor|natrecor
756211|NCT00075179|CV Surgery|cv surgery
756212|NCT00075179|Lung Tumor|lung tumor
756213|NCT00075166|Stereotactic|stereotactic
756214|NCT00075166|Carcinoma|carcinoma
756215|NCT00075166|Melanoma|melanoma
756216|NCT00075166|Surgical Resection|surgical resection
756217|NCT00075166|Metastases|metastases
756218|NCT00075166|Metastatic Brain Tumor|metastatic brain tumor
756219|NCT00075166|Surgery|surgery
756220|NCT00075166|Radiosurgery|radiosurgery
756221|NCT00075166|Treatment|treatment
756222|NCT00075140|Patient Care Management|patient care management
756223|NCT00075140|Family|family
756224|NCT00075140|Huntington's Disease|huntington's disease
756225|NCT00075114|Self Care|self care
756226|NCT00075114|Behavior Modification|behavior modification
756227|NCT00075101|Drug Adverse Effect|drug adverse effect
756228|NCT00075101|Pediatric Cancer|pediatric cancer
756229|NCT00075088|Telemedicine|telemedicine
756230|NCT00075088|Emergency Care|emergency care
756231|NCT00075088|Cardiac|cardiac
756232|NCT00075075|Infliximab|infliximab
756233|NCT00075075|Scleritis|scleritis
756234|NCT00075075|Intraocular Inflammatory Disease|intraocular inflammatory disease
756235|NCT00075075|Corticosteroids|corticosteroids
756236|NCT00075075|Immunosuppressives|immunosuppressives
756237|NCT00075049|malaria|malaria
756238|NCT00014183|stage IV renal cell cancer|stage iv renal cell cancer
756239|NCT00014183|recurrent renal cell cancer|recurrent renal cell cancer
756240|NCT00012116|tumors metastatic to brain|tumors metastatic to brain
756241|NCT00009893|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
756242|NCT00009893|advanced adult primary liver cancer|advanced adult primary liver cancer
756243|NCT00009893|recurrent adult primary liver cancer|recurrent adult primary liver cancer
756244|NCT00009893|unresectable gallbladder cancer|unresectable gallbladder cancer
756245|NCT00009893|recurrent gallbladder cancer|recurrent gallbladder cancer
756246|NCT00009893|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
756247|NCT00009893|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
756248|NCT00075036|Health Disparities|health disparities
756249|NCT00075036|Transplantation|transplantation
756250|NCT00075036|Trust|trust
756251|NCT00075036|Interview|interview
756252|NCT00075036|Ethnic Bias|ethnic bias
756253|NCT00075023|Stomatitis|stomatitis
756254|NCT00075023|Oropharyngeal pain|oropharyngeal pain
756255|NCT00075023|TNF-alpha|tnf-alpha
756256|NCT00075023|Allogeneic hematopoietic stem cell transplant|allogeneic hematopoietic stem cell transplant
756257|NCT00075023|Inflammation|inflammation
756258|NCT00075023|Thalidomide|thalidomide
756259|NCT00075023|Oral chronic graft-versus-host disease|oral chronic graft-versus-host disease
756260|NCT00075010|Relapsed/Refractory Leukemia|relapsed/refractory leukemia
756261|NCT00075010|Myelodysplastic Syndromes|myelodysplastic syndromes
756262|NCT00074997|Gene Therapy|gene therapy
756263|NCT00074997|Anti-HIV-1 Ribozyme|anti-hiv-1 ribozyme
756264|NCT00074997|OZ1|oz1
756265|NCT00074997|HIV-1 Infections|hiv-1 infections
756266|NCT00009698|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
756267|NCT00009698|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
756268|NCT00009698|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
756269|NCT00009698|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
756270|NCT00006481|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
756389|NCT00074711|Bone Mineral Density|bone mineral density
756271|NCT00006481|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
756272|NCT00006481|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
756273|NCT00006481|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
756274|NCT00006481|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
756275|NCT00006481|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
756276|NCT00006481|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
756277|NCT00006481|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
756278|NCT00006481|skin reactions secondary to radiation therapy|skin reactions secondary to radiation therapy
756279|NCT00006480|disseminated neuroblastoma|disseminated neuroblastoma
756280|NCT00006480|recurrent neuroblastoma|recurrent neuroblastoma
756281|NCT00074984|a-Galactosidase A|a-galactosidase a
756282|NCT00074984|aGAL|agal
756283|NCT00074984|r-haGAL|r-hagal
756284|NCT00074984|Fabry|fabry
756285|NCT00074984|GL-3|gl-3
756286|NCT00074984|Fabrazyme|fabrazyme
756287|NCT00074971|a-Galactosidase A|a-galactosidase a
756288|NCT00074971|aGAL|agal
756289|NCT00074971|r-haGAL|r-hagal
756290|NCT00074971|Fabry|fabry
756291|NCT00074971|GL-3|gl-3
756292|NCT00074971|Fabrazyme|fabrazyme
756293|NCT00074958|a-Galactosidase A|a-galactosidase a
756294|NCT00074958|aGal|agal
756295|NCT00074958|r-haGAL|r-hagal
756296|NCT00074958|Fabry|fabry
756297|NCT00074958|GL-3|gl-3
756298|NCT00074958|Fabrazyme|fabrazyme
756299|NCT00074932|Glycogen Storage Disease Type II|glycogen storage disease type ii
756300|NCT00074932|GSD-II|gsd-ii
756301|NCT00074932|Pompe Disease|pompe disease
756302|NCT00074932|Acid Maltase Deficiency Disease|acid maltase deficiency disease
756303|NCT00074919|Glycogen Storage Disease Type II|glycogen storage disease type ii
756304|NCT00074919|GSD-II|gsd-ii
756305|NCT00074919|Pompe Disease|pompe disease
756306|NCT00074919|Acid Maltase Deficiency Disease|acid maltase deficiency disease
756307|NCT00074906|Aspiration of gastric contents|aspiration of gastric contents
756308|NCT00074945|Obesity|obesity
756309|NCT00074945|Resting Energy Expenditure|resting energy expenditure
756310|NCT00074945|Metabolic Rate|metabolic rate
756311|NCT00074945|Visceral Fat|visceral fat
756312|NCT00074945|Body Fat Distribution|body fat distribution
756313|NCT00074893|Repetitive Strain Injuries|repetitive strain injuries
756314|NCT00074893|Vibration Damping|vibration damping
756315|NCT00074893|Protective Brace|protective brace
756316|NCT00074893|Piezoelectric|piezoelectric
756317|NCT00074893|SmartWear|smartwear
756318|NCT00074841|MALARIA|malaria
756319|NCT00074841|INDIA|india
756320|NCT00074841|CHLOROQUINE|chloroquine
756321|NCT00074841|PLASMODIUM FALCIPARUM|plasmodium falciparum
756322|NCT00074841|SULFADOXINE-PYRIMETHAMINE|sulfadoxine-pyrimethamine
756323|NCT00006384|stage IV renal cell cancer|stage iv renal cell cancer
756324|NCT00006384|recurrent renal cell cancer|recurrent renal cell cancer
756325|NCT00006353|adult glioblastoma|adult glioblastoma
756326|NCT00006353|adult giant cell glioblastoma|adult giant cell glioblastoma
756327|NCT00006353|adult gliosarcoma|adult gliosarcoma
756328|NCT00006247|childhood craniopharyngioma|childhood craniopharyngioma
756329|NCT00006247|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
756330|NCT00006247|childhood oligodendroglioma|childhood oligodendroglioma
756331|NCT00006247|childhood choroid plexus tumor|childhood choroid plexus tumor
756332|NCT00006247|childhood grade I meningioma|childhood grade i meningioma
756333|NCT00006247|childhood grade II meningioma|childhood grade ii meningioma
756334|NCT00006247|childhood grade III meningioma|childhood grade iii meningioma
756335|NCT00006247|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
756336|NCT00006247|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
756337|NCT00006247|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
756338|NCT00006247|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
756339|NCT00006247|recurrent childhood ependymoma|recurrent childhood ependymoma
756340|NCT00006104|stage IV breast cancer|stage iv breast cancer
756341|NCT00006104|recurrent breast cancer|recurrent breast cancer
756342|NCT00074880|Cardiac Hypertrophy|cardiac hypertrophy
756343|NCT00074880|Diastolic Dysfunction|diastolic dysfunction
756344|NCT00074880|Cardiac Glycosides|cardiac glycosides
756345|NCT00074880|Cardiac Fibrosis|cardiac fibrosis
756346|NCT00074880|Atrial Systole|atrial systole
756347|NCT00074828|elective|elective
756348|NCT00074828|primary unilateral|primary unilateral
756349|NCT00074763|Leukemia|leukemia
756350|NCT00074763|Lymphoma|lymphoma
756351|NCT00074763|ALL|all
756352|NCT00074763|CLL|cll
756353|NCT00074763|AML|aml
756354|NCT00074763|CML|cml
756355|NCT00074763|MDS|mds
756356|NCT00074763|Remission|remission
756357|NCT00074763|Hematologic Disorder|hematologic disorder
756358|NCT00074763|Transfusion|transfusion
756359|NCT00074763|Thrombosol|thrombosol
756360|NCT00074763|Autologous Platelet Transfusion|autologous platelet transfusion
756361|NCT00074763|Platelet Transfusion|platelet transfusion
756362|NCT00074763|Single donor platelet apheresis|single donor platelet apheresis
756363|NCT00074763|Cryopreservation|cryopreservation
756364|NCT00074763|Thrombocytopenia|thrombocytopenia
756365|NCT00074750|AML|aml
756366|NCT00074750|CMML|cmml
756367|NCT00074737|Refractory or Relapsed Acute Myelogenous Leukemia (AML)|refractory or relapsed acute myelogenous leukemia (aml)
756368|NCT00074737|Antisense|antisense
756369|NCT00006099|ovarian epithelial cancer|ovarian epithelial cancer
756370|NCT00006087|non-small cell lung cancer|non-small cell lung cancer
756371|NCT00006087|small cell lung cancer|small cell lung cancer
756372|NCT00006080|recurrent adult brain tumor|recurrent adult brain tumor
756373|NCT00006080|adult anaplastic astrocytoma|adult anaplastic astrocytoma
756374|NCT00006080|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
756375|NCT00006080|adult mixed glioma|adult mixed glioma
756376|NCT00005978|localized resectable neuroblastoma|localized resectable neuroblastoma
756377|NCT00005978|regional neuroblastoma|regional neuroblastoma
756378|NCT00005978|disseminated neuroblastoma|disseminated neuroblastoma
756379|NCT00005978|stage 4S neuroblastoma|stage 4s neuroblastoma
756380|NCT00005978|recurrent neuroblastoma|recurrent neuroblastoma
756381|NCT00005978|localized unresectable neuroblastoma|localized unresectable neuroblastoma
756382|NCT00005963|stage IV breast cancer|stage iv breast cancer
756383|NCT00005963|recurrent breast cancer|recurrent breast cancer
756384|NCT00074815|Child|child
756385|NCT00074815|Adolescent|adolescent
756386|NCT00074802|Social Phobia|social phobia
756387|NCT00074789|Early Head Start Program|early head start program
756388|NCT00074776|Bipolar Depression|bipolar depression
756390|NCT00074711|Calcium|calcium
756391|NCT00074698|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
756392|NCT00074698|IPF|ipf
756393|NCT00074698|Pulmonary fibrosis|pulmonary fibrosis
756394|NCT00074698|Respiratory disease|respiratory disease
756395|NCT00074685|Congenital|congenital
756396|NCT00074685|Epidermal nevus|epidermal nevus
756397|NCT00074685|Erythroderma|erythroderma
756398|NCT00074685|Darier|darier
756399|NCT00074685|Hailey-Hailey|hailey-hailey
756400|NCT00074685|Harlequin|harlequin
756401|NCT00074685|Ichthyosiform|ichthyosiform
756402|NCT00074685|Ichthyosiform erythroderma|ichthyosiform erythroderma
756403|NCT00074685|Keratoderma|keratoderma
756404|NCT00074685|Keratosis|keratosis
756405|NCT00074685|Pachyonychia|pachyonychia
756406|NCT00074685|Sjogren-Larsson|sjogren-larsson
756407|NCT00074646|CC-8490|cc-8490
756408|NCT00074646|CC8490|cc8490
756409|NCT00074646|Glio|glio
756410|NCT00074646|Glioblastoma|glioblastoma
756411|NCT00074646|Malignant Gliomas|malignant gliomas
756412|NCT00074633|Type 2 Diabetes|type 2 diabetes
756413|NCT00074633|Self-Esteem|self-esteem
756414|NCT00074620|Haemodialysis|haemodialysis
756415|NCT00074620|PEG-Hirudin|peg-hirudin
756416|NCT00074620|Vascular graft occlusion|vascular graft occlusion
756417|NCT00074620|Renal replacement therapy|renal replacement therapy
756418|NCT00074620|Hemodialysis|hemodialysis
756419|NCT00074672|Prepulse Inhibition|prepulse inhibition
756420|NCT00074672|PPI|ppi
756421|NCT00074672|Dopamine|dopamine
756422|NCT00074672|Sensorimotor Integration|sensorimotor integration
756423|NCT00074672|Dopaminergic|dopaminergic
756424|NCT00074607|Neoplastic meningitis|neoplastic meningitis
756425|NCT00074581|HIV Infections|hiv infections
756426|NCT00074581|HIV Seronegativity|hiv seronegativity
756427|NCT00074568|Genetic Study|genetic study
756428|NCT00074568|Transmission Dysequilibrium Testing|transmission dysequilibrium testing
756429|NCT00074568|Genome Wide Scan|genome wide scan
756430|NCT00074568|Family Study|family study
756431|NCT00074555|African American, Rheumatoid Arthritis|african american, rheumatoid arthritis
756432|NCT00005959|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
756433|NCT00005959|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
756434|NCT00005959|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
756435|NCT00005959|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
756436|NCT00005959|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
756437|NCT00005959|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
756438|NCT00005959|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
756439|NCT00005959|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
756440|NCT00005959|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
756441|NCT00005959|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
756442|NCT00005959|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
756443|NCT00005959|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
756444|NCT00005959|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
756445|NCT00005959|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
756446|NCT00005959|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
756447|NCT00005959|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
756448|NCT00005959|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
756449|NCT00005959|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
756450|NCT00005959|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
756451|NCT00005959|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
756452|NCT00005959|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
756453|NCT00005959|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
756454|NCT00005959|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
756455|NCT00005959|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
756456|NCT00005876|stage III gastric cancer|stage iii gastric cancer
756457|NCT00005876|stage IV gastric cancer|stage iv gastric cancer
756458|NCT00005876|recurrent gastric cancer|recurrent gastric cancer
756459|NCT00005876|stage III esophageal cancer|stage iii esophageal cancer
756460|NCT00005876|stage IV esophageal cancer|stage iv esophageal cancer
756461|NCT00005876|recurrent esophageal cancer|recurrent esophageal cancer
756462|NCT00005876|adenocarcinoma of the stomach|adenocarcinoma of the stomach
756463|NCT00005876|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
756464|NCT00005646|extensive stage small cell lung cancer|extensive stage small cell lung cancer
756465|NCT00005642|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
756466|NCT00005634|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
756467|NCT00005634|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
756468|NCT00005634|isolated plasmacytoma of bone|isolated plasmacytoma of bone
756469|NCT00005634|extramedullary plasmacytoma|extramedullary plasmacytoma
756470|NCT00005634|refractory multiple myeloma|refractory multiple myeloma
756471|NCT00005634|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
756472|NCT00005634|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
756473|NCT00005634|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
756474|NCT00005634|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
756475|NCT00005634|small intestine lymphoma|small intestine lymphoma
756476|NCT00005634|recurrent prostate cancer|recurrent prostate cancer
756477|NCT00005634|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
756478|NCT00005634|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
756479|NCT00005634|refractory hairy cell leukemia|refractory hairy cell leukemia
756480|NCT00005634|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
756481|NCT00005634|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
756482|NCT00005634|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
756483|NCT00005634|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
756484|NCT00005634|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
756485|NCT00005634|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
756486|NCT00005634|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
756487|NCT00005634|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
756488|NCT00005634|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
756489|NCT00005634|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
756490|NCT00005634|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
756491|NCT00005634|secondary acute myeloid leukemia|secondary acute myeloid leukemia
756492|NCT00005634|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
756493|NCT00005634|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
756494|NCT00005634|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
756495|NCT00005634|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
756496|NCT00005634|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
756497|NCT00005634|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
756498|NCT00005634|splenic marginal zone lymphoma|splenic marginal zone lymphoma
756499|NCT00074542|Crohn's|crohn's
756500|NCT00074542|colon|colon
756501|NCT00074542|small bowel|small bowel
756502|NCT00074542|inflammation|inflammation
756503|NCT00074542|steroid therapy|steroid therapy
756504|NCT00074542|free fatty acids|free fatty acids
756505|NCT00005598|refractory anemia|refractory anemia
756506|NCT00005598|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
756507|NCT00005598|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
756508|NCT00005598|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
756509|NCT00005592|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
756510|NCT00005592|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
756511|NCT00005592|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
756512|NCT00005592|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
756513|NCT00005592|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
756514|NCT00005592|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
781514|NCT00042289|Pregnancy|pregnancy
756515|NCT00005592|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
756516|NCT00005592|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
756517|NCT00005592|splenic marginal zone lymphoma|splenic marginal zone lymphoma
756518|NCT00005083|adult glioblastoma|adult glioblastoma
756519|NCT00005083|adult anaplastic astrocytoma|adult anaplastic astrocytoma
756520|NCT00005083|adult myxopapillary ependymoma|adult myxopapillary ependymoma
756521|NCT00005083|adult anaplastic ependymoma|adult anaplastic ependymoma
756522|NCT00005083|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
756523|NCT00005083|adult mixed glioma|adult mixed glioma
756524|NCT00005083|adult pilocytic astrocytoma|adult pilocytic astrocytoma
756525|NCT00005083|adult subependymoma|adult subependymoma
756526|NCT00005083|adult ependymoblastoma|adult ependymoblastoma
756527|NCT00005083|adult oligodendroglioma|adult oligodendroglioma
756528|NCT00005083|adult giant cell glioblastoma|adult giant cell glioblastoma
756529|NCT00005083|adult gliosarcoma|adult gliosarcoma
756530|NCT00004890|stage I renal cell cancer|stage i renal cell cancer
756531|NCT00004890|stage II renal cell cancer|stage ii renal cell cancer
756532|NCT00004890|stage III renal cell cancer|stage iii renal cell cancer
756533|NCT00004890|stage IV renal cell cancer|stage iv renal cell cancer
756534|NCT00004890|recurrent renal cell cancer|recurrent renal cell cancer
756535|NCT00004890|drug extravasation|drug extravasation
756536|NCT00004874|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
756537|NCT00004874|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
756538|NCT00004874|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
756539|NCT00074516|Immunosuppression|immunosuppression
756540|NCT00074516|Kidney|kidney
756541|NCT00074516|Cysteamine|cysteamine
756542|NCT00074516|Steroid-Free|steroid-free
756543|NCT00074516|Outcomes|outcomes
756544|NCT00074503|Positron Emission Tomography|positron emission tomography
756545|NCT00074503|Phospholipids|phospholipids
756546|NCT00074503|Alcoholism|alcoholism
756547|NCT00074503|[11C]Docosahexaenoate|[11c]docosahexaenoate
756548|NCT00074503|[150]Water|[150]water
756549|NCT00074503|Brain|brain
756550|NCT00074503|Fatty Acids|fatty acids
756551|NCT00074503|Blood Flow|blood flow
756552|NCT00074503|Healthy|healthy
756553|NCT00074490|Leukemia|leukemia
756554|NCT00074490|Lymphoma|lymphoma
756555|NCT00074490|Multiple Myeloma|multiple myeloma
756556|NCT00074490|Bone Marrow Transplantation|bone marrow transplantation
756557|NCT00074490|Immune Therapy|immune therapy
756558|NCT00074477|Schizophrenia|schizophrenia
756559|NCT00074477|Paliperidone palmitate|paliperidone palmitate
756560|NCT00074477|R092670|r092670
756561|NCT00074477|antipsychotic|antipsychotic
756562|NCT00074438|Rituxan|rituxan
756563|NCT00074438|RA|ra
756564|NCT00074425|HIV Seronegativity|hiv seronegativity
756565|NCT00074425|Anti-Infective Agents, Local|anti-infective agents, local
756566|NCT00074425|BufferGel|buffergel
756567|NCT00074425|PRO 2000|pro 2000
756568|NCT00074425|Vagina|vagina
756569|NCT00074425|Risk Factors|risk factors
756570|NCT00074412|HIV Seronegativity|hiv seronegativity
756571|NCT00074412|Treatment Experienced|treatment experienced
756572|NCT00074412|Treatment Naive|treatment naive
756573|NCT00074399|Maternal/Infant Transmisson|maternal/infant transmisson
756574|NCT00074399|Vertical Transmission|vertical transmission
756575|NCT00074399|Pregnancy|pregnancy
756576|NCT00074399|HIV Seronegativity|hiv seronegativity
756577|NCT00074386|HIV|hiv
756578|NCT00074386|Transplant|transplant
756579|NCT00074386|Liver|liver
756580|NCT00074386|Kidney|kidney
756581|NCT00074386|Organ|organ
756582|NCT00074386|Treatment Experienced|treatment experienced
756583|NCT00074386|Kidney Transplant|kidney transplant
756584|NCT00074386|Liver Transplant|liver transplant
756585|NCT00074373|Anti-SSA/Ro Antibodies|anti-ssa/ro antibodies
756586|NCT00074373|Anti-SSB/La Antibodies|anti-ssb/la antibodies
756587|NCT00021983|refractory hairy cell leukemia|refractory hairy cell leukemia
756588|NCT00074360|Ethanol|ethanol
756589|NCT00074360|fMRI|fmri
756590|NCT00074360|Blood Flow|blood flow
756591|NCT00074360|Conditioning|conditioning
756592|NCT00074360|Reinforcement|reinforcement
756593|NCT00074334|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
756594|NCT00074334|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
756595|NCT00074334|childhood oligodendroglioma|childhood oligodendroglioma
756596|NCT00074334|childhood supratentorial ependymoma|childhood supratentorial ependymoma
756597|NCT00074334|recurrent childhood ependymoma|recurrent childhood ependymoma
756598|NCT00074334|recurrent childhood brain tumor|recurrent childhood brain tumor
756599|NCT00074295|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
756600|NCT00074295|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
756601|NCT00074295|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
756602|NCT00074295|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
756603|NCT00074282|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
756604|NCT00074282|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
756605|NCT00074269|recurrent breast cancer|recurrent breast cancer
756606|NCT00074269|stage IV breast cancer|stage iv breast cancer
756607|NCT00074243|adult anaplastic astrocytoma|adult anaplastic astrocytoma
756608|NCT00074243|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
756609|NCT00074243|adult glioblastoma|adult glioblastoma
756610|NCT00074243|adult mixed glioma|adult mixed glioma
756611|NCT00074243|adult brain stem glioma|adult brain stem glioma
756612|NCT00074243|recurrent adult brain tumor|recurrent adult brain tumor
756613|NCT00074243|adult giant cell glioblastoma|adult giant cell glioblastoma
756614|NCT00074243|adult gliosarcoma|adult gliosarcoma
756615|NCT00074230|stage IV melanoma|stage iv melanoma
756616|NCT00074230|recurrent melanoma|recurrent melanoma
756617|NCT00074204|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
756618|NCT00074204|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
756619|NCT00074204|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
756620|NCT00074191|intraocular lymphoma|intraocular lymphoma
756621|NCT00074191|primary central nervous system lymphoma|primary central nervous system lymphoma
756622|NCT00074178|primary central nervous system lymphoma|primary central nervous system lymphoma
756623|NCT00074178|intraocular lymphoma|intraocular lymphoma
756624|NCT00074165|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
756625|NCT00074165|thrombocytopenia|thrombocytopenia
756626|NCT00074165|intraocular lymphoma|intraocular lymphoma
756627|NCT00074165|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
756628|NCT00074165|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
756629|NCT00074152|recurrent breast cancer|recurrent breast cancer
756630|NCT00074152|stage I breast cancer|stage i breast cancer
756631|NCT00074152|stage II breast cancer|stage ii breast cancer
756632|NCT00074152|stage IIIA breast cancer|stage iiia breast cancer
756633|NCT00074152|stage IIIB breast cancer|stage iiib breast cancer
756634|NCT00074152|stage IIIC breast cancer|stage iiic breast cancer
756635|NCT00074139|stage IIIA breast cancer|stage iiia breast cancer
756636|NCT00074139|recurrent breast cancer|recurrent breast cancer
756637|NCT00074139|stage IIIB breast cancer|stage iiib breast cancer
756638|NCT00074139|stage IIIC breast cancer|stage iiic breast cancer
756639|NCT00074139|stage IV breast cancer|stage iv breast cancer
756640|NCT00074100|stage IV breast cancer|stage iv breast cancer
756641|NCT00074100|recurrent breast cancer|recurrent breast cancer
756642|NCT00074087|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
756643|NCT00074087|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
756644|NCT00074087|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
756645|NCT00074087|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
756646|NCT00074087|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
756647|NCT00074087|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
756648|NCT00074074|refractory anemia with excess blasts|refractory anemia with excess blasts
756649|NCT00074074|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
756650|NCT00074074|refractory anemia|refractory anemia
756651|NCT00074074|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
756652|NCT00074074|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
756653|NCT00074074|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
756654|NCT00074048|refractory hairy cell leukemia|refractory hairy cell leukemia
756655|NCT00074009|recurrent gastric cancer|recurrent gastric cancer
756656|NCT00074009|stage III gastric cancer|stage iii gastric cancer
756657|NCT00074009|stage IV gastric cancer|stage iv gastric cancer
756658|NCT00074009|adenocarcinoma of the stomach|adenocarcinoma of the stomach
756659|NCT00073983|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
756660|NCT00073983|chondrosarcoma|chondrosarcoma
756661|NCT00073983|recurrent osteosarcoma|recurrent osteosarcoma
756662|NCT00073970|recurrent prostate cancer|recurrent prostate cancer
756663|NCT00073970|stage I prostate cancer|stage i prostate cancer
756664|NCT00073970|stage II prostate cancer|stage ii prostate cancer
756665|NCT00073970|adenocarcinoma of the prostate|adenocarcinoma of the prostate
756666|NCT00073957|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
756667|NCT00073957|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
756668|NCT00073957|anaplastic large cell lymphoma|anaplastic large cell lymphoma
756669|NCT00073944|acute undifferentiated leukemia|acute undifferentiated leukemia
756670|NCT00073944|anaplastic large cell lymphoma|anaplastic large cell lymphoma
756671|NCT00073944|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
756672|NCT00073944|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
756673|NCT00073944|chronic eosinophilic leukemia|chronic eosinophilic leukemia
756674|NCT00073944|primary myelofibrosis|primary myelofibrosis
756675|NCT00073944|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
756676|NCT00073944|chronic neutrophilic leukemia|chronic neutrophilic leukemia
756677|NCT00073944|essential thrombocythemia|essential thrombocythemia
756678|NCT00073944|intraocular lymphoma|intraocular lymphoma
756679|NCT00073944|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
781620|NCT00041990|Methylation|methylation
756680|NCT00073944|polycythemia vera|polycythemia vera
756681|NCT00073944|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
756682|NCT00073944|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
756683|NCT00073944|prolymphocytic leukemia|prolymphocytic leukemia
756684|NCT00073944|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
756685|NCT00073944|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
756686|NCT00073944|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
756687|NCT00073944|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
756688|NCT00073944|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
756689|NCT00073944|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
756690|NCT00073944|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
756691|NCT00073944|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
756692|NCT00073944|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
756693|NCT00073944|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
756694|NCT00073944|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
756695|NCT00073944|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
756696|NCT00073944|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
756697|NCT00073944|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
756698|NCT00073944|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
756699|NCT00073944|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
756700|NCT00073944|refractory hairy cell leukemia|refractory hairy cell leukemia
756701|NCT00073944|refractory multiple myeloma|refractory multiple myeloma
756702|NCT00073944|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
756703|NCT00073944|secondary acute myeloid leukemia|secondary acute myeloid leukemia
756704|NCT00073944|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
756705|NCT00073944|Waldenström macroglobulinemia|waldenström macroglobulinemia
756706|NCT00073944|adenocarcinoma of the colon|adenocarcinoma of the colon
756707|NCT00073944|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
756708|NCT00073944|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
756709|NCT00073944|adenocarcinoma of the rectum|adenocarcinoma of the rectum
757024|NCT00003253|recurrent breast cancer|recurrent breast cancer
756710|NCT00073944|recurrent adult brain tumor|recurrent adult brain tumor
756711|NCT00073944|recurrent adult primary liver cancer|recurrent adult primary liver cancer
756712|NCT00073944|recurrent colon cancer|recurrent colon cancer
756713|NCT00073944|recurrent esophageal cancer|recurrent esophageal cancer
756714|NCT00073944|recurrent gastric cancer|recurrent gastric cancer
756715|NCT00073944|recurrent melanoma|recurrent melanoma
756716|NCT00073944|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
756717|NCT00073944|recurrent pancreatic cancer|recurrent pancreatic cancer
756718|NCT00073944|recurrent rectal cancer|recurrent rectal cancer
756719|NCT00073944|adenocarcinoma of the stomach|adenocarcinoma of the stomach
756720|NCT00073944|adult anaplastic astrocytoma|adult anaplastic astrocytoma
756721|NCT00073944|adult glioblastoma|adult glioblastoma
756722|NCT00073944|adult pilocytic astrocytoma|adult pilocytic astrocytoma
756723|NCT00073944|adult subependymoma|adult subependymoma
756724|NCT00073944|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
756725|NCT00073944|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
756726|NCT00073944|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
756727|NCT00073944|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
756728|NCT00073944|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
756729|NCT00073944|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
756730|NCT00073944|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
756731|NCT00073944|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
756732|NCT00073944|splenic marginal zone lymphoma|splenic marginal zone lymphoma
756733|NCT00073944|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
756734|NCT00073944|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
756735|NCT00073944|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
756736|NCT00073944|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
756737|NCT00073944|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
756738|NCT00073944|adult diffuse astrocytoma|adult diffuse astrocytoma
756739|NCT00073944|adult giant cell glioblastoma|adult giant cell glioblastoma
756740|NCT00073944|adult gliosarcoma|adult gliosarcoma
756741|NCT00073944|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
756742|NCT00073931|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
756743|NCT00073931|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
756744|NCT00073931|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
756745|NCT00073931|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
756746|NCT00073931|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
756747|NCT00073931|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
756748|NCT00073931|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
756749|NCT00073931|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
756750|NCT00073931|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
756751|NCT00073931|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
756752|NCT00073905|unresectable gallbladder cancer|unresectable gallbladder cancer
756753|NCT00073905|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
756754|NCT00073905|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
756755|NCT00073905|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
756756|NCT00073905|pain|pain
756757|NCT00073905|recurrent gallbladder cancer|recurrent gallbladder cancer
756758|NCT00073905|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
756759|NCT00073905|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
756760|NCT00073905|advanced adult primary liver cancer|advanced adult primary liver cancer
756761|NCT00073905|recurrent adult primary liver cancer|recurrent adult primary liver cancer
756762|NCT00073892|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
756763|NCT00073892|stage IV melanoma|stage iv melanoma
756764|NCT00073892|recurrent melanoma|recurrent melanoma
756765|NCT00073879|stage IV renal cell cancer|stage iv renal cell cancer
756766|NCT00073879|recurrent renal cell cancer|recurrent renal cell cancer
756767|NCT00073866|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
756768|NCT00073866|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
756769|NCT00073866|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
756770|NCT00073853|paraplegia|paraplegia
756771|NCT00073853|quadraplegia|quadraplegia
756772|NCT00073853|tetraplegia|tetraplegia
756773|NCT00073853|paralysis|paralysis
756774|NCT00073853|nerve regeneration|nerve regeneration
756775|NCT00073853|Acute, Complete SCI|acute, complete sci
756776|NCT00073840|levalbuterol|levalbuterol
756777|NCT00073840|asthma|asthma
756778|NCT00073840|bronchoconstriction|bronchoconstriction
756779|NCT00073840|adolescent|adolescent
756780|NCT00073840|adult|adult
756781|NCT00073827|adolescent|adolescent
756782|NCT00073827|adult|adult
756783|NCT00073827|asthma|asthma
756784|NCT00073827|levalbuterol|levalbuterol
756785|NCT00073827|bronchoconstriction|bronchoconstriction
756786|NCT00004857|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
756787|NCT00004857|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
756788|NCT00004857|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
756789|NCT00004857|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
756790|NCT00004857|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
756791|NCT00004261|stage I breast cancer|stage i breast cancer
756792|NCT00004261|stage II breast cancer|stage ii breast cancer
756793|NCT00004261|stage IV breast cancer|stage iv breast cancer
756794|NCT00004261|stage IIIA breast cancer|stage iiia breast cancer
756795|NCT00004261|breast cancer in situ|breast cancer in situ
756796|NCT00004261|recurrent breast cancer|recurrent breast cancer
756797|NCT00004261|stage IIIB breast cancer|stage iiib breast cancer
756798|NCT00004261|stage 0 cervical cancer|stage 0 cervical cancer
756799|NCT00004261|stage III cervical cancer|stage iii cervical cancer
756800|NCT00004261|recurrent cervical cancer|recurrent cervical cancer
756801|NCT00004261|stage IB cervical cancer|stage ib cervical cancer
756802|NCT00004261|stage IIB cervical cancer|stage iib cervical cancer
756803|NCT00004261|stage IVB cervical cancer|stage ivb cervical cancer
756804|NCT00004261|stage IA cervical cancer|stage ia cervical cancer
756805|NCT00004261|stage IIA cervical cancer|stage iia cervical cancer
756806|NCT00004261|stage IVA cervical cancer|stage iva cervical cancer
756807|NCT00004261|inflammatory breast cancer|inflammatory breast cancer
756808|NCT00004261|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
756809|NCT00004261|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
756810|NCT00004261|stage I prostate cancer|stage i prostate cancer
756811|NCT00004261|stage IIB prostate cancer|stage iib prostate cancer
756812|NCT00004261|stage IIA prostate cancer|stage iia prostate cancer
756813|NCT00004261|stage III prostate cancer|stage iii prostate cancer
757025|NCT00003253|male breast cancer|male breast cancer
756814|NCT00004261|stage IV prostate cancer|stage iv prostate cancer
756815|NCT00004261|recurrent prostate cancer|recurrent prostate cancer
756816|NCT00004261|stage I nasopharyngeal cancer|stage i nasopharyngeal cancer
756817|NCT00004261|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
756818|NCT00004261|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
756819|NCT00004261|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
756820|NCT00004261|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
756821|NCT00004261|stage 0 paranasal sinus and nasal cavity cancer|stage 0 paranasal sinus and nasal cavity cancer
756822|NCT00004261|stage 0 nasopharyngeal cancer|stage 0 nasopharyngeal cancer
756823|NCT00004261|stage 0 oropharyngeal cancer|stage 0 oropharyngeal cancer
756824|NCT00004261|stage 0 laryngeal cancer|stage 0 laryngeal cancer
756825|NCT00004261|stage 0 hypopharyngeal cancer|stage 0 hypopharyngeal cancer
781621|NCT00041990|STI 571|sti 571
756826|NCT00004261|stage I salivary gland cancer|stage i salivary gland cancer
756827|NCT00004261|stage II salivary gland cancer|stage ii salivary gland cancer
756828|NCT00004261|stage III salivary gland cancer|stage iii salivary gland cancer
756829|NCT00004261|stage IV salivary gland cancer|stage iv salivary gland cancer
756830|NCT00004261|recurrent salivary gland cancer|recurrent salivary gland cancer
756831|NCT00004261|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
756832|NCT00004261|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
756833|NCT00004261|stage 0 lip and oral cavity cancer|stage 0 lip and oral cavity cancer
756834|NCT00004261|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
756835|NCT00004261|stage I lip and oral cavity cancer|stage i lip and oral cavity cancer
756836|NCT00004261|stage II lip and oral cavity cancer|stage ii lip and oral cavity cancer
756837|NCT00004261|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
756838|NCT00004261|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
756839|NCT00004261|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
756840|NCT00004261|stage I hypopharyngeal cancer|stage i hypopharyngeal cancer
756841|NCT00004261|stage II hypopharyngeal cancer|stage ii hypopharyngeal cancer
756842|NCT00004261|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
756843|NCT00004261|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
756844|NCT00004261|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
756845|NCT00004261|stage I laryngeal cancer|stage i laryngeal cancer
756846|NCT00004261|stage II laryngeal cancer|stage ii laryngeal cancer
756847|NCT00004261|stage III laryngeal cancer|stage iii laryngeal cancer
756848|NCT00004261|stage IV laryngeal cancer|stage iv laryngeal cancer
756849|NCT00004261|recurrent laryngeal cancer|recurrent laryngeal cancer
756850|NCT00004261|stage I paranasal sinus and nasal cavity cancer|stage i paranasal sinus and nasal cavity cancer
756851|NCT00004261|stage II paranasal sinus and nasal cavity cancer|stage ii paranasal sinus and nasal cavity cancer
756852|NCT00004261|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
756853|NCT00004261|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
756854|NCT00004261|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
756855|NCT00004261|stage I oropharyngeal cancer|stage i oropharyngeal cancer
756856|NCT00004261|stage II oropharyngeal cancer|stage ii oropharyngeal cancer
756857|NCT00004261|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
756858|NCT00004261|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
756859|NCT00004261|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
756860|NCT00004261|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
756861|NCT00004261|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
756862|NCT00004242|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
756863|NCT00003927|stage II breast cancer|stage ii breast cancer
756864|NCT00003927|stage IV breast cancer|stage iv breast cancer
756865|NCT00003927|stage IIIA breast cancer|stage iiia breast cancer
756866|NCT00003927|stage IIIB breast cancer|stage iiib breast cancer
756867|NCT00073814|levalbuterol|levalbuterol
756868|NCT00073814|pediatric|pediatric
756869|NCT00073814|asthma|asthma
756870|NCT00003811|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
756871|NCT00003811|childhood teratoma|childhood teratoma
756872|NCT00003811|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
756873|NCT00003811|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
756874|NCT00003811|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
756875|NCT00003811|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
756876|NCT00003777|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
756877|NCT00003777|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
756878|NCT00003777|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
756879|NCT00003777|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
756880|NCT00003777|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
756881|NCT00003777|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
756882|NCT00003777|stage III laryngeal cancer|stage iii laryngeal cancer
756883|NCT00003777|stage IV laryngeal cancer|stage iv laryngeal cancer
756884|NCT00003777|recurrent laryngeal cancer|recurrent laryngeal cancer
756885|NCT00003777|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
756886|NCT00003777|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
756887|NCT00003777|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
756888|NCT00003777|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
756889|NCT00003777|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
756890|NCT00003777|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
756891|NCT00003761|stage IV breast cancer|stage iv breast cancer
756892|NCT00003761|recurrent breast cancer|recurrent breast cancer
756893|NCT00003729|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
756894|NCT00003729|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
756895|NCT00003729|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
781926|NCT00040105|Tipifarnib|tipifarnib
756896|NCT00073801|Neuromusculoskeletal Pain|neuromusculoskeletal pain
756897|NCT00073801|Laparoscopy|laparoscopy
756898|NCT00073801|Cytokines|cytokines
756899|NCT00073801|HPA Axis|hpa axis
756900|NCT00073801|Neuroimmune|neuroimmune
756901|NCT00073801|Endometriosis|endometriosis
756902|NCT00073801|Surgical Excision|surgical excision
756903|NCT00073801|Inflammatory Cytokines|inflammatory cytokines
756904|NCT00003734|adenocarcinoma of the prostate|adenocarcinoma of the prostate
756905|NCT00003734|stage I prostate cancer|stage i prostate cancer
756906|NCT00003734|stage IIB prostate cancer|stage iib prostate cancer
756907|NCT00003734|stage IIA prostate cancer|stage iia prostate cancer
756908|NCT00003734|stage III prostate cancer|stage iii prostate cancer
756909|NCT00003734|stage IV prostate cancer|stage iv prostate cancer
756910|NCT00073749|B-Cell|b-cell
756911|NCT00073749|Non-Hodgkin's|non-hodgkin's
756912|NCT00073749|Lymphoma|lymphoma
756913|NCT00073736|Hepatocellular|hepatocellular
756914|NCT00073736|Carcinoma|carcinoma
756915|NCT00073736|Liver|liver
756916|NCT00073736|Cancer|cancer
756917|NCT00073723|Non-Small Cell Lung Cancer|non-small cell lung cancer
756918|NCT00073723|Taxol|taxol
756919|NCT00073723|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
756920|NCT00003716|childhood Burkitt lymphoma|childhood burkitt lymphoma
756921|NCT00003716|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
756922|NCT00003716|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
756923|NCT00003716|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
756924|NCT00003716|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
756925|NCT00003716|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
756926|NCT00003716|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
756927|NCT00003716|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
756928|NCT00003716|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
756929|NCT00003716|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
756930|NCT00003679|stage IIIA breast cancer|stage iiia breast cancer
756931|NCT00003679|stage IIIB breast cancer|stage iiib breast cancer
756932|NCT00003679|inflammatory breast cancer|inflammatory breast cancer
756933|NCT00003598|cervical cancer|cervical cancer
756934|NCT00003598|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
756935|NCT00003598|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
756936|NCT00003450|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
756937|NCT00003450|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
756938|NCT00003450|peritoneal cavity cancer|peritoneal cavity cancer
756939|NCT00073710|secondary hyperparathyroidism|secondary hyperparathyroidism
756940|NCT00073697|Psychotherapy|psychotherapy
756941|NCT00073697|Depressive disorder|depressive disorder
756942|NCT00073697|Antidepressive agents|antidepressive agents
756943|NCT00073697|Citalopram|citalopram
756944|NCT00073684|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
756945|NCT00073684|Depression|depression
756946|NCT00073684|Anxiety|anxiety
756947|NCT00073671|Adolescent|adolescent
756948|NCT00073658|Alzheimer disease|alzheimer disease
756949|NCT00073658|Aggression|aggression
756950|NCT00073658|Delusions|delusions
756951|NCT00073658|Paranoid behavior|paranoid behavior
756952|NCT00073619|Violence|violence
756953|NCT00073619|School based|school based
756954|NCT00073619|Urban Youth|urban youth
756955|NCT00073619|Prevention|prevention
756956|NCT00073619|Community|community
756957|NCT00073606|Spinal Reflexes|spinal reflexes
756958|NCT00073606|Locomotion|locomotion
756959|NCT00073606|Motor Practice|motor practice
756960|NCT00073606|Healthy Volunteer|healthy volunteer
756962|NCT00003426|stage II pancreatic cancer|stage ii pancreatic cancer
756963|NCT00003426|stage III pancreatic cancer|stage iii pancreatic cancer
756964|NCT00003426|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
756965|NCT00003414|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
756966|NCT00003414|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
756967|NCT00003414|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
756968|NCT00003414|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
756969|NCT00003414|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
756970|NCT00003414|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
756971|NCT00003414|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
756972|NCT00003414|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
756973|NCT00003414|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
756974|NCT00003414|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
756975|NCT00003414|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
756976|NCT00003414|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
756977|NCT00003414|graft versus host disease|graft versus host disease
756978|NCT00003414|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
757196|NCT00025532|adenocarcinoma of the colon|adenocarcinoma of the colon
756979|NCT00003414|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
756980|NCT00003414|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
756981|NCT00003414|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
756982|NCT00003414|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
756983|NCT00003414|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
756984|NCT00003414|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
756985|NCT00003414|splenic marginal zone lymphoma|splenic marginal zone lymphoma
756986|NCT00003409|adult glioblastoma|adult glioblastoma
756987|NCT00003409|adult giant cell glioblastoma|adult giant cell glioblastoma
756988|NCT00003409|adult gliosarcoma|adult gliosarcoma
756989|NCT00003388|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
756990|NCT00003388|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
756991|NCT00003388|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
756992|NCT00003388|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
756993|NCT00003388|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
756994|NCT00003388|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
756995|NCT00003388|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
756996|NCT00003388|anaplastic large cell lymphoma|anaplastic large cell lymphoma
756997|NCT00073593|Off-Pump Coronary Artery Bypass Graft Surgery|off-pump coronary artery bypass graft surgery
756998|NCT00073593|CABG|cabg
756999|NCT00073593|OPCAB|opcab
757000|NCT00073593|Heparin|heparin
757001|NCT00073593|Patients requiring off-pump CABG|patients requiring off-pump cabg
757002|NCT00073580|HIT|hit
757003|NCT00073580|HITTS|hitts
757004|NCT00073580|Heparin-antibodies|heparin-antibodies
757005|NCT00073580|Coronary artery bypass surgery|coronary artery bypass surgery
757006|NCT00073580|CABG|cabg
757007|NCT00073580|Heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
757008|NCT00073580|Heparin-induced thrombocytopenia and thrombosis syndrome|heparin-induced thrombocytopenia and thrombosis syndrome
757009|NCT00073541|EGFR; HER-1; monoclonal antibody; targeted therapy|egfr; her-1; monoclonal antibody; targeted therapy
757010|NCT00073528|metastatic|metastatic
757011|NCT00073528|advanced breast cancer|advanced breast cancer
757012|NCT00073528|breast cancer|breast cancer
757013|NCT00003387|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
757014|NCT00003387|squamous cell lung cancer|squamous cell lung cancer
757015|NCT00003387|large cell lung cancer|large cell lung cancer
757016|NCT00003387|adenocarcinoma of the lung|adenocarcinoma of the lung
757017|NCT00003313|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
757018|NCT00003313|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
757019|NCT00003313|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
757020|NCT00003313|oral complications|oral complications
757021|NCT00003313|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
757022|NCT00003313|radiation toxicity|radiation toxicity
757023|NCT00003253|stage IV breast cancer|stage iv breast cancer
757026|NCT00003202|squamous cell lung cancer|squamous cell lung cancer
757027|NCT00003202|large cell lung cancer|large cell lung cancer
757028|NCT00003202|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
757029|NCT00003202|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
757030|NCT00003202|adenocarcinoma of the lung|adenocarcinoma of the lung
757031|NCT00003202|adenosquamous cell lung cancer|adenosquamous cell lung cancer
757032|NCT00003191|recurrent neuroblastoma|recurrent neuroblastoma
757033|NCT00003191|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
757034|NCT00073515|central venous access device|central venous access device
757035|NCT00073515|thrombosis|thrombosis
757036|NCT00073515|central venous catheter|central venous catheter
757037|NCT00073515|thrombolysis|thrombolysis
757038|NCT00073515|fibrinolysis|fibrinolysis
757039|NCT00073489|chronic leukemia|chronic leukemia
757040|NCT00073489|leukemia|leukemia
757041|NCT00073489|CLL|cll
757042|NCT00073463|Gene Transfer|gene transfer
757043|NCT00073463|Pulmonary function|pulmonary function
757044|NCT00003130|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
757045|NCT00003060|recurrent melanoma|recurrent melanoma
757046|NCT00003037|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
757047|NCT00003037|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
757048|NCT00002989|stage I multiple myeloma|stage i multiple myeloma
757049|NCT00002989|stage II multiple myeloma|stage ii multiple myeloma
757050|NCT00002989|stage III multiple myeloma|stage iii multiple myeloma
757051|NCT00002989|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
757052|NCT00002989|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
757053|NCT00002989|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
757054|NCT00002989|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
757055|NCT00002989|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
757056|NCT00002989|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
757395|NCT00072657|Depression|depression
757057|NCT00002989|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
757058|NCT00002989|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
757059|NCT00002989|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
757060|NCT00002989|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
757061|NCT00002989|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
757062|NCT00002989|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
757063|NCT00002989|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
757064|NCT00002989|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
757065|NCT00002989|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
757066|NCT00002989|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
757067|NCT00002989|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
757068|NCT00002989|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
757069|NCT00002989|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
757070|NCT00002989|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
757071|NCT00002989|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
757072|NCT00002989|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
757073|NCT00002989|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
757074|NCT00002989|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
757075|NCT00002989|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
757076|NCT00002989|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
757077|NCT00002989|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
757078|NCT00002989|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
757079|NCT00002989|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
757080|NCT00002989|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
757081|NCT00002989|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
757082|NCT00002989|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
757083|NCT00002989|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
757084|NCT00002989|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
757085|NCT00002989|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
757086|NCT00002989|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
757087|NCT00002989|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
757088|NCT00002989|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
757089|NCT00002989|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
757090|NCT00002989|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
757091|NCT00002989|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
757092|NCT00002989|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
757093|NCT00002989|stage I mantle cell lymphoma|stage i mantle cell lymphoma
757094|NCT00002989|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
757095|NCT00002989|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
757096|NCT00002989|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
757097|NCT00002989|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
757098|NCT00002989|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
757099|NCT00002989|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
757100|NCT00002989|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
757101|NCT00002989|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
757102|NCT00002989|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
757103|NCT00002989|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
757104|NCT00002989|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
757105|NCT00002989|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
757106|NCT00002989|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
757107|NCT00002989|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
757108|NCT00002989|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
757109|NCT00002989|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
757110|NCT00002989|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
757111|NCT00002989|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
757112|NCT00002989|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
757113|NCT00002989|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
757114|NCT00002989|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
757115|NCT00002989|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
757116|NCT00002989|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
757117|NCT00002989|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
757118|NCT00002989|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
757119|NCT00002989|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
757120|NCT00002989|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
757121|NCT00002989|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
757122|NCT00002989|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
757123|NCT00002989|stage I marginal zone lymphoma|stage i marginal zone lymphoma
757124|NCT00002989|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
757125|NCT00002989|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
757126|NCT00002989|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
757127|NCT00002989|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
757128|NCT00002989|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
757129|NCT00002989|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
757130|NCT00002989|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
757131|NCT00002989|splenic marginal zone lymphoma|splenic marginal zone lymphoma
757132|NCT00002989|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
757133|NCT00073450|Squamous Cell Carcinoma of the Head & Neck|squamous cell carcinoma of the head & neck
757134|NCT00073437|Sarcoidosis|sarcoidosis
757135|NCT00073437|Infliximab|infliximab
757136|NCT00073437|Pulmonary involvement|pulmonary involvement
757137|NCT00073437|Remicade|remicade
757138|NCT00002940|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
757139|NCT00002836|recurrent breast cancer|recurrent breast cancer
757140|NCT00002828|stage III colon cancer|stage iii colon cancer
757141|NCT00002828|stage IV colon cancer|stage iv colon cancer
757142|NCT00002828|stage III rectal cancer|stage iii rectal cancer
757143|NCT00002828|stage IV rectal cancer|stage iv rectal cancer
757144|NCT00002828|recurrent colon cancer|recurrent colon cancer
757145|NCT00002828|recurrent rectal cancer|recurrent rectal cancer
757146|NCT00002812|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
757147|NCT00002812|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
757148|NCT00002812|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
757149|NCT00002761|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
757150|NCT00002761|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
757151|NCT00002761|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
757152|NCT00073424|Treatment Experienced|treatment experienced
757153|NCT00073385|Lung cancer, Docetaxel, Histone deacetylase inhibitor|lung cancer, docetaxel, histone deacetylase inhibitor
757154|NCT00073372|Acute ischemic stroke|acute ischemic stroke
757155|NCT00073372|abciximab|abciximab
757156|NCT00073372|ReoPro|reopro
757157|NCT00073372|drug safety|drug safety
757158|NCT00073372|drug efficacy|drug efficacy
757159|NCT00073372|intracranial hemorrhage|intracranial hemorrhage
757160|NCT00073372|stroke|stroke
757161|NCT00073359|Adolescent|adolescent
757162|NCT00073346|Compulsive Hoarding|compulsive hoarding
757163|NCT00073333|Phobic Disorders|phobic disorders
757164|NCT00073320|Schizophrenia|schizophrenia
757165|NCT00073320|Paliperidone palmitate|paliperidone palmitate
757166|NCT00073320|R092670|r092670
757167|NCT00073320|antipsychotic|antipsychotic
757168|NCT00073307|Renal Cell Cancer (RCC)|renal cell cancer (rcc)
757169|NCT00073307|Cancer|cancer
757170|NCT00036920|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
757171|NCT00036920|squamous cell lung cancer|squamous cell lung cancer
757172|NCT00036920|large cell lung cancer|large cell lung cancer
757173|NCT00036920|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
757174|NCT00036920|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
757175|NCT00036920|adenocarcinoma of the lung|adenocarcinoma of the lung
757176|NCT00036920|adenosquamous cell lung cancer|adenosquamous cell lung cancer
757177|NCT00036920|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
757178|NCT00027521|stage III pancreatic cancer|stage iii pancreatic cancer
757179|NCT00027521|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
757180|NCT00025532|stage III colon cancer|stage iii colon cancer
757181|NCT00025532|stage IV colon cancer|stage iv colon cancer
757182|NCT00025532|stage III gastric cancer|stage iii gastric cancer
757183|NCT00025532|stage IV gastric cancer|stage iv gastric cancer
757184|NCT00025532|recurrent gastric cancer|recurrent gastric cancer
757185|NCT00025532|stage III pancreatic cancer|stage iii pancreatic cancer
757186|NCT00025532|recurrent pancreatic cancer|recurrent pancreatic cancer
757187|NCT00025532|stage III rectal cancer|stage iii rectal cancer
757188|NCT00025532|stage IV rectal cancer|stage iv rectal cancer
757189|NCT00025532|recurrent colon cancer|recurrent colon cancer
757190|NCT00025532|recurrent rectal cancer|recurrent rectal cancer
757191|NCT00025532|stage III esophageal cancer|stage iii esophageal cancer
757192|NCT00025532|stage IV esophageal cancer|stage iv esophageal cancer
757193|NCT00025532|recurrent esophageal cancer|recurrent esophageal cancer
757194|NCT00025532|adenocarcinoma of the stomach|adenocarcinoma of the stomach
757195|NCT00025532|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
757197|NCT00025532|adenocarcinoma of the rectum|adenocarcinoma of the rectum
757198|NCT00025532|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
757199|NCT00025532|stage IV pancreatic cancer|stage iv pancreatic cancer
757200|NCT00002561|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
757201|NCT00002561|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
757202|NCT00002561|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
757203|NCT00002561|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
757204|NCT00002561|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
757205|NCT00002561|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
757206|NCT00073398|Anti-tumor Vaccination|anti-tumor vaccination
757207|NCT00073398|Alpha (1,3) Galactosyltransferase|alpha (1,3) galactosyltransferase
757208|NCT00073398|Allogeneic Tumor Cells|allogeneic tumor cells
757209|NCT00073398|Hyperacute Lung|hyperacute lung
757210|NCT00073398|NSCLC|nsclc
757211|NCT00073398|Lung Cancer|lung cancer
757212|NCT00073398|Non-Small Cell Lung Cancer|non-small cell lung cancer
757213|NCT00073294|diabetes|diabetes
757214|NCT00073281|diabetes|diabetes
757215|NCT00073281|autoimmunity|autoimmunity
757216|NCT00073268|diabetes|diabetes
757217|NCT00073268|adolescent|adolescent
757218|NCT00073242|leptin|leptin
757219|NCT00073242|obesity|obesity
757220|NCT00073229|AIDS|aids
757221|NCT00073229|Vertical Transmission|vertical transmission
757222|NCT00073229|Acute Infection|acute infection
757223|NCT00073216|HIV Seronegativity|hiv seronegativity
757224|NCT00073216|HIV Preventive Vaccine|hiv preventive vaccine
757225|NCT00073190|Patient Education|patient education
757226|NCT00073190|Physician Education|physician education
757227|NCT00073125|Advanced histologically documented renal cell carcinoma|advanced histologically documented renal cell carcinoma
757228|NCT00073047|Ulcerative Colitis|ulcerative colitis
757229|NCT00073047|Inflammatory Bowel Disease|inflammatory bowel disease
757230|NCT00073047|Gastrointestinal|gastrointestinal
757231|NCT00073047|Humanized Monoclonal antibody|humanized monoclonal antibody
757232|NCT00073034|Neuropathic Pain|neuropathic pain
757233|NCT00073034|Diabetic Neuropathy|diabetic neuropathy
757234|NCT00073099|Dry Eye|dry eye
757235|NCT00073099|Lissamine Green|lissamine green
757236|NCT00073099|Fluorescein|fluorescein
757237|NCT00073099|Conjunctiva|conjunctiva
757238|NCT00073099|Cornea|cornea
757239|NCT00073099|Digital Photography|digital photography
757240|NCT00073099|Corneal and Conjunctival Staining|corneal and conjunctival staining
757241|NCT00073086|Coronavirus|coronavirus
757242|NCT00073086|Pneumonia|pneumonia
757243|NCT00073086|Asia|asia
757244|NCT00073086|China|china
757245|NCT00073086|Severe Acut Respiratory Syndrome|severe acut respiratory syndrome
757246|NCT00073086|SARS|sars
757247|NCT00073086|Suspected SARS|suspected sars
757248|NCT00073073|Chemoprevention|chemoprevention
757249|NCT00073073|Mammographic Density|mammographic density
757250|NCT00073073|Bone Mineral Density|bone mineral density
757251|NCT00073073|Biomarkers|biomarkers
757252|NCT00073073|Safety|safety
757253|NCT00073073|Breast Cancer|breast cancer
757254|NCT00073073|Postmenopausal|postmenopausal
757255|NCT00073060|Plateletpheresis|plateletpheresis
757256|NCT00073060|Lymphocytapheresis|lymphocytapheresis
757257|NCT00073060|Apheresis|apheresis
757258|NCT00073060|Citrate|citrate
757259|NCT00073060|Bone Density|bone density
757260|NCT00073060|Healthy Volunteer|healthy volunteer
757261|NCT00073060|HV|hv
757262|NCT00073008|EGFR|egfr
757263|NCT00073008|ErbB1|erbb1
757264|NCT00073008|ErbB2|erbb2
757265|NCT00073008|metastatic|metastatic
757266|NCT00073008|lapatinib|lapatinib
757267|NCT00073008|Her-2/neu|her-2/neu
757268|NCT00073008|protein kinase inhibitor|protein kinase inhibitor
757269|NCT00073008|BAC|bac
757270|NCT00073008|GW572016|gw572016
757271|NCT00073008|Advanced|advanced
757272|NCT00073008|NSCLC|nsclc
757273|NCT00072982|Fish oil|fish oil
757274|NCT00072982|Borage oil|borage oil
757275|NCT00072943|Crohn's Disease|crohn's disease
757276|NCT00072943|Colitis|colitis
757277|NCT00072943|Monoclonal antibody therapy|monoclonal antibody therapy
757278|NCT00072943|anti-interferon gamma|anti-interferon gamma
757279|NCT00072917|obesity|obesity
757280|NCT00072917|thinness|thinness
757281|NCT00072917|weight gain|weight gain
757282|NCT00072917|physical activity|physical activity
757283|NCT00072917|diet|diet
757284|NCT00072917|fat oxidation|fat oxidation
757285|NCT00072917|hunger|hunger
757286|NCT00072917|feeding behavior|feeding behavior
757287|NCT00072917|overfeeding|overfeeding
757288|NCT00072904|Cystic Fibrosis Related Diabetes|cystic fibrosis related diabetes
757289|NCT00072904|Diabetes without Fasting Hyperglycemia|diabetes without fasting hyperglycemia
757290|NCT00072891|Diabetes|diabetes
757291|NCT00072969|Immunosuppression|immunosuppression
757292|NCT00072969|Myelodysplastic Syndrome|myelodysplastic syndrome
757293|NCT00072969|MDS|mds
757294|NCT00072956|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
757295|NCT00072956|Torticollis|torticollis
757296|NCT00072956|Cervical Dystonia|cervical dystonia
757297|NCT00072956|Surround Inhibition|surround inhibition
757298|NCT00072956|Sensory Tricks|sensory tricks
757299|NCT00072787|gastric cancer|gastric cancer
757300|NCT00072787|phase 2 clinical trial|phase 2 clinical trial
757301|NCT00072774|Depressive Disorder, Major|depressive disorder, major
757302|NCT00072774|Melancholia, Involutional|melancholia, involutional
757303|NCT00072774|Depression, Involutional|depression, involutional
757304|NCT00072761|silent cerebral infarct|silent cerebral infarct
757305|NCT00072761|silent stroke|silent stroke
757306|NCT00072761|sickle cell anemia|sickle cell anemia
757307|NCT00072761|stroke|stroke
757308|NCT00072761|transfusion therapy|transfusion therapy
757309|NCT00072748|Advanced Colorectal Cancer|advanced colorectal cancer
757310|NCT00072748|Colorectal Carcinoma|colorectal carcinoma
757311|NCT00072748|Colorectal Tumors|colorectal tumors
757312|NCT00072748|Neoplasms, Colorectal|neoplasms, colorectal
757313|NCT00072722|Prostate Cancer|prostate cancer
757314|NCT00072722|Metastatic Hormone Refractory Prostate Cancer|metastatic hormone refractory prostate cancer
757315|NCT00072722|CC4047|cc4047
757316|NCT00072722|CC-4047|cc-4047
757317|NCT00072722|Prostate Carcinoma|prostate carcinoma
757318|NCT00072722|Celgene|celgene
757319|NCT00017017|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
757320|NCT00017017|fallopian tube cancer|fallopian tube cancer
757321|NCT00017017|primary peritoneal cavity cancer|primary peritoneal cavity cancer
757322|NCT00014677|recurrent adult brain tumor|recurrent adult brain tumor
757323|NCT00014677|adult glioblastoma|adult glioblastoma
757324|NCT00014677|adult giant cell glioblastoma|adult giant cell glioblastoma
757325|NCT00014677|adult gliosarcoma|adult gliosarcoma
757326|NCT00014638|stage IV breast cancer|stage iv breast cancer
757327|NCT00014638|recurrent breast cancer|recurrent breast cancer
757328|NCT00014352|stage III prostate cancer|stage iii prostate cancer
757329|NCT00014352|stage IV prostate cancer|stage iv prostate cancer
757330|NCT00014352|recurrent prostate cancer|recurrent prostate cancer
757331|NCT00014352|thromboembolism|thromboembolism
757332|NCT00072826|3-hydroxy-3-methlglutaryl (HMG)|3-hydroxy-3-methlglutaryl (hmg)
757333|NCT00072826|Inhibitors|inhibitors
757334|NCT00072826|Endothelial Function|endothelial function
757335|NCT00072826|Leukocyte Gene Expression|leukocyte gene expression
757336|NCT00072826|Statins|statins
757337|NCT00072826|Atorvastatin|atorvastatin
757338|NCT00072826|Sickle Cell Disease|sickle cell disease
757339|NCT00072813|Genetics|genetics
757340|NCT00072813|Seizures|seizures
757341|NCT00072813|Brain Imaging|brain imaging
757342|NCT00072813|Diffusion|diffusion
757343|NCT00072813|Temporal Lobe|temporal lobe
757344|NCT00072800|Reliability|reliability
757345|NCT00072800|Muscle Tone Abnormality|muscle tone abnormality
757346|NCT00072800|Spasticity|spasticity
757347|NCT00072800|Dystonia|dystonia
757348|NCT00072800|Rigidity|rigidity
757349|NCT00072800|Cerebral Palsy|cerebral palsy
757350|NCT00072800|CP|cp
757351|NCT00072800|Children|children
757352|NCT00072709|ALS|als
757353|NCT00072709|Lou Gehrig's disease|lou gehrig's disease
757354|NCT00072683|Sodium|sodium
757355|NCT00072683|SIADH|siadh
757356|NCT00072683|Vasopressin|vasopressin
757357|NCT00072683|CHF|chf
757358|NCT00072683|Cirrhosis|cirrhosis
757359|NCT00072683|salt|salt
757360|NCT00072683|water|water
757361|NCT00072683|electrolyte|electrolyte
757362|NCT00072670|Prostate cancer|prostate cancer
757363|NCT00072670|Advanced prostate cancer|advanced prostate cancer
757364|NCT00072670|Metastatic prostate cancer|metastatic prostate cancer
757365|NCT00072670|Trabectedin|trabectedin
757366|NCT00072670|Yondelis|yondelis
757367|NCT00072670|ET-743|et-743
757368|NCT00012090|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
757369|NCT00012090|fallopian tube cancer|fallopian tube cancer
757370|NCT00012090|primary peritoneal cavity cancer|primary peritoneal cavity cancer
757371|NCT00010309|stage II melanoma|stage ii melanoma
757372|NCT00010309|stage III melanoma|stage iii melanoma
757373|NCT00010309|stage IV melanoma|stage iv melanoma
757374|NCT00008372|extensive stage small cell lung cancer|extensive stage small cell lung cancer
757375|NCT00008372|recurrent small cell lung cancer|recurrent small cell lung cancer
757376|NCT00006367|polycythemia vera|polycythemia vera
757377|NCT00006367|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
757378|NCT00006367|essential thrombocythemia|essential thrombocythemia
757379|NCT00006224|recurrent cervical cancer|recurrent cervical cancer
757380|NCT00006224|cervical adenocarcinoma|cervical adenocarcinoma
757381|NCT00006224|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
757382|NCT00072735|Use Dependent Plasticity|use dependent plasticity
757383|NCT00072735|Cortical Reorganization|cortical reorganization
757384|NCT00072735|Rehabilitation|rehabilitation
757385|NCT00072735|Somatosensory Nerve|somatosensory nerve
757386|NCT00072735|Amphetamine|amphetamine
757387|NCT00072735|Stroke|stroke
757388|NCT00072735|Healthy Volunteer|healthy volunteer
757389|NCT00072735|HV|hv
757390|NCT00072657|Arthritis|arthritis
757391|NCT00072657|Pain|pain
757392|NCT00072657|Meditation|meditation
757393|NCT00072657|Tai Chi|tai chi
757394|NCT00072657|Chronic Illness|chronic illness
757397|NCT00072644|Osteonecrosis|osteonecrosis
757398|NCT00072644|Drug Interaction|drug interaction
757399|NCT00072644|P-Glycoprotein|p-glycoprotein
757400|NCT00072644|Cytochrome P 450|cytochrome p 450
757401|NCT00072644|Healthy Volunteer|healthy volunteer
757402|NCT00072644|HV|hv
757403|NCT00072631|Tarceva|tarceva
757404|NCT00072631|erlotinib|erlotinib
757405|NCT00072631|NSCLC|nsclc
757406|NCT00072631|Non-Small Cell Lung Cancer|non-small cell lung cancer
757407|NCT00072631|EGFR|egfr
757408|NCT00072631|OSI-774|osi-774
757409|NCT00072501|breast cancer|breast cancer
757410|NCT00072488|disseminated neuroblastoma|disseminated neuroblastoma
757411|NCT00072488|localized resectable neuroblastoma|localized resectable neuroblastoma
757412|NCT00072488|localized unresectable neuroblastoma|localized unresectable neuroblastoma
757413|NCT00072488|regional neuroblastoma|regional neuroblastoma
757414|NCT00072488|stage 4S neuroblastoma|stage 4s neuroblastoma
757415|NCT00072488|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
757416|NCT00072488|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
757417|NCT00072488|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
757418|NCT00072488|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
757419|NCT00072488|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
757420|NCT00072488|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
757421|NCT00072488|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
757422|NCT00072488|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
757423|NCT00072488|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
757424|NCT00072488|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
757425|NCT00072488|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
757426|NCT00072488|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
757427|NCT00072488|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
757428|NCT00072488|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
757429|NCT00072488|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
757430|NCT00072488|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
757431|NCT00072488|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
757432|NCT00072488|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
757433|NCT00072488|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
757434|NCT00072488|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
757435|NCT00072475|refractory anemia with excess blasts|refractory anemia with excess blasts
757436|NCT00072475|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
757437|NCT00072475|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
757438|NCT00072475|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
757439|NCT00072475|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
757440|NCT00072475|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
757441|NCT00072475|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
757442|NCT00072475|refractory anemia|refractory anemia
757443|NCT00072475|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
757444|NCT00072462|ductal breast carcinoma in situ|ductal breast carcinoma in situ
757445|NCT00072462|breast cancer in situ|breast cancer in situ
757446|NCT00072449|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
757447|NCT00072410|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
757448|NCT00072410|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
757449|NCT00072358|disseminated neuroblastoma|disseminated neuroblastoma
757450|NCT00072358|localized unresectable neuroblastoma|localized unresectable neuroblastoma
757451|NCT00072358|recurrent neuroblastoma|recurrent neuroblastoma
757452|NCT00072358|regional neuroblastoma|regional neuroblastoma
757453|NCT00072358|stage 4S neuroblastoma|stage 4s neuroblastoma
757454|NCT00072345|stage III melanoma|stage iii melanoma
757455|NCT00072345|stage IV melanoma|stage iv melanoma
757456|NCT00072345|recurrent melanoma|recurrent melanoma
757457|NCT00072345|iris melanoma|iris melanoma
757458|NCT00072345|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
757459|NCT00072345|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
757460|NCT00072345|extraocular extension melanoma|extraocular extension melanoma
757461|NCT00072345|recurrent intraocular melanoma|recurrent intraocular melanoma
757462|NCT00072332|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
757463|NCT00072332|stage IV esophageal cancer|stage iv esophageal cancer
757464|NCT00072332|stage IV gastric cancer|stage iv gastric cancer
757465|NCT00072319|stage I breast cancer|stage i breast cancer
757466|NCT00072319|stage II breast cancer|stage ii breast cancer
757467|NCT00072319|stage IIIA breast cancer|stage iiia breast cancer
757468|NCT00072319|stage IIIB breast cancer|stage iiib breast cancer
757469|NCT00072319|stage IIIC breast cancer|stage iiic breast cancer
757470|NCT00072319|inflammatory breast cancer|inflammatory breast cancer
757471|NCT00072293|stage IA breast cancer|stage ia breast cancer
757472|NCT00072293|stage IB breast cancer|stage ib breast cancer
757473|NCT00072293|stage II breast cancer|stage ii breast cancer
757474|NCT00072293|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
757475|NCT00072293|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
757476|NCT00072293|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
757477|NCT00072293|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
757478|NCT00072280|childhood fibrosarcoma|childhood fibrosarcoma
757479|NCT00072280|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
757480|NCT00072267|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
757481|NCT00072267|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
757482|NCT00072267|primary peritoneal cavity cancer|primary peritoneal cavity cancer
757483|NCT00072267|fallopian tube cancer|fallopian tube cancer
757484|NCT00072267|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
757485|NCT00072215|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
757486|NCT00072215|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
757487|NCT00072215|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
757488|NCT00072215|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
757489|NCT00072215|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
757490|NCT00072215|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
757491|NCT00072215|testicular choriocarcinoma|testicular choriocarcinoma
757492|NCT00072215|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
757493|NCT00072215|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
757494|NCT00072215|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
757495|NCT00072215|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
757496|NCT00072215|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
757497|NCT00072215|testicular embryonal carcinoma|testicular embryonal carcinoma
757498|NCT00072215|testicular seminoma|testicular seminoma
757499|NCT00072215|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
757500|NCT00072215|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
757501|NCT00072215|testicular yolk sac tumor|testicular yolk sac tumor
757502|NCT00072215|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
757503|NCT00072215|recurrent extragonadal seminoma|recurrent extragonadal seminoma
757504|NCT00072215|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
757505|NCT00072215|stage IV extragonadal seminoma|stage iv extragonadal seminoma
757506|NCT00072215|testicular immature teratoma|testicular immature teratoma
757507|NCT00072215|testicular mature teratoma|testicular mature teratoma
757508|NCT00072215|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
757509|NCT00072124|stage IV melanoma|stage iv melanoma
757510|NCT00072124|recurrent melanoma|recurrent melanoma
757511|NCT00072111|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
757512|NCT00072098|stage IV colon cancer|stage iv colon cancer
757513|NCT00072098|stage IV rectal cancer|stage iv rectal cancer
757514|NCT00072098|liver metastases|liver metastases
757515|NCT00072098|recurrent rectal cancer|recurrent rectal cancer
757516|NCT00072098|recurrent colon cancer|recurrent colon cancer
757517|NCT00072085|stage IV melanoma|stage iv melanoma
757518|NCT00072085|recurrent melanoma|recurrent melanoma
757519|NCT00072072|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
757520|NCT00072072|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
757521|NCT00072072|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
757522|NCT00072059|anemia|anemia
757523|NCT00072059|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
757524|NCT00072059|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
757525|NCT00072059|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
757526|NCT00072046|stage IV renal cell cancer|stage iv renal cell cancer
757527|NCT00072046|clear cell renal cell carcinoma|clear cell renal cell carcinoma
757528|NCT00072046|recurrent renal cell cancer|recurrent renal cell cancer
757529|NCT00072033|stage II esophageal cancer|stage ii esophageal cancer
757530|NCT00072033|stage III esophageal cancer|stage iii esophageal cancer
757531|NCT00072033|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
757532|NCT00072033|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
757533|NCT00072020|bone metastases|bone metastases
757534|NCT00072020|stage II breast cancer|stage ii breast cancer
757535|NCT00072020|stage IIIA breast cancer|stage iiia breast cancer
757536|NCT00072020|stage IIIB breast cancer|stage iiib breast cancer
757537|NCT00072020|stage IIIC breast cancer|stage iiic breast cancer
757538|NCT00072007|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
757539|NCT00072007|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
757540|NCT00072007|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
757541|NCT00072007|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
757542|NCT00072007|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
757543|NCT00072007|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
757544|NCT00071981|stage IV melanoma|stage iv melanoma
757545|NCT00071981|recurrent melanoma|recurrent melanoma
757546|NCT00071968|adenocarcinoma of the prostate|adenocarcinoma of the prostate
757547|NCT00071968|stage IIB prostate cancer|stage iib prostate cancer
757548|NCT00071968|stage IIA prostate cancer|stage iia prostate cancer
757549|NCT00071968|stage I prostate cancer|stage i prostate cancer
757550|NCT00071955|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
757551|NCT00071955|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
757552|NCT00071955|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
757553|NCT00071955|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
757554|NCT00071955|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
757555|NCT00071955|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
757556|NCT00071955|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
757557|NCT00071955|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
757558|NCT00071955|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
757559|NCT00071929|recurrent endometrial carcinoma|recurrent endometrial carcinoma
757560|NCT00003141|childhood infratentorial ependymoma|childhood infratentorial ependymoma
757561|NCT00003141|childhood supratentorial ependymoma|childhood supratentorial ependymoma
757562|NCT00003141|disseminated neuroblastoma|disseminated neuroblastoma
757563|NCT00003141|stage 4S neuroblastoma|stage 4s neuroblastoma
757564|NCT00003141|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
757565|NCT00003141|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
757566|NCT00003141|childhood choroid plexus tumor|childhood choroid plexus tumor
757567|NCT00003141|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
757568|NCT00003141|untreated childhood brain stem glioma|untreated childhood brain stem glioma
757569|NCT00003141|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
757570|NCT00003141|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
757571|NCT00003141|untreated childhood medulloblastoma|untreated childhood medulloblastoma
757572|NCT00003141|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
757573|NCT00003141|localized resectable neuroblastoma|localized resectable neuroblastoma
757574|NCT00003141|localized unresectable neuroblastoma|localized unresectable neuroblastoma
757575|NCT00003141|regional neuroblastoma|regional neuroblastoma
757576|NCT00003141|childhood spinal cord neoplasm|childhood spinal cord neoplasm
757577|NCT00003141|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
757578|NCT00003141|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
757579|NCT00003141|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
757580|NCT00003141|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
757581|NCT00003141|childhood central nervous system germinoma|childhood central nervous system germinoma
757582|NCT00003141|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
757583|NCT00003141|childhood central nervous system teratoma|childhood central nervous system teratoma
757584|NCT00003141|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
757586|NCT00072605|T Cells|t cells
757587|NCT00072605|Immunity|immunity
757588|NCT00072605|Hemorrhagic Fever|hemorrhagic fever
757589|NCT00072605|Healthy Volunteer|healthy volunteer
757590|NCT00072605|HV|hv
757591|NCT00072592|ANCA|anca
757592|NCT00072592|B Lymphocyte|b lymphocyte
757593|NCT00072592|Vasculitis|vasculitis
757594|NCT00072592|Treatment|treatment
757595|NCT00072592|Remission|remission
757596|NCT00072592|Wegener Granulomatosis|wegener granulomatosis
757597|NCT00072592|WG|wg
757598|NCT00072579|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
757599|NCT00072579|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
757600|NCT00072553|stage IV rectal cancer|stage iv rectal cancer
757601|NCT00072553|stage IV colon cancer|stage iv colon cancer
757602|NCT00072553|adenocarcinoma of the colon|adenocarcinoma of the colon
757603|NCT00072553|adenocarcinoma of the rectum|adenocarcinoma of the rectum
757604|NCT00072553|recurrent rectal cancer|recurrent rectal cancer
757605|NCT00072553|recurrent colon cancer|recurrent colon cancer
757606|NCT00072527|limited stage small cell lung cancer|limited stage small cell lung cancer
757607|NCT00071916|Hepatitis C, African Americans, ribavirin|hepatitis c, african americans, ribavirin
757608|NCT00071851|HIV Seronegativity|hiv seronegativity
757609|NCT00071851|HIV Preventive Vaccine|hiv preventive vaccine
757610|NCT00071812|RA|ra
757611|NCT00006008|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
757612|NCT00006008|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
757613|NCT00006008|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
757614|NCT00006008|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
757615|NCT00005964|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
757616|NCT00005964|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
757617|NCT00005964|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
757618|NCT00005964|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
757619|NCT00005964|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
757620|NCT00005964|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
757621|NCT00005964|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
757622|NCT00005964|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
757623|NCT00005964|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
757624|NCT00005964|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
757625|NCT00005964|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
757626|NCT00005964|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
757627|NCT00005962|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
757628|NCT00005962|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
757629|NCT00005962|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
757630|NCT00005962|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
757631|NCT00005962|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
757632|NCT00005962|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
757633|NCT00005962|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
757634|NCT00005962|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
757635|NCT00005962|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
757636|NCT00005962|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
757637|NCT00071903|Thrombophilia|thrombophilia
757638|NCT00071903|Idiopathic Intracranial Hypertension|idiopathic intracranial hypertension
757639|NCT00071903|Kidney Involvement|kidney involvement
757640|NCT00071903|Lysosomal Storage Disorder|lysosomal storage disorder
757641|NCT00071903|Cystine|cystine
757642|NCT00071903|Pseudotumor Cerebri|pseudotumor cerebri
757643|NCT00071903|Susceptibility to Thrombosis|susceptibility to thrombosis
757644|NCT00071903|Nephropathic Cystinosis|nephropathic cystinosis
757645|NCT00071903|PTC|ptc
757646|NCT00071903|Intracranial Hypertension|intracranial hypertension
757647|NCT00071890|Interleukin 2|interleukin 2
757648|NCT00071890|Treatment Interruption|treatment interruption
757649|NCT00071890|HIV|hiv
757650|NCT00071877|Lysosomal Disease|lysosomal disease
757651|NCT00071877|Hypohidrosis|hypohidrosis
757652|NCT00071877|Pain|pain
757653|NCT00071877|Neuropathy|neuropathy
757654|NCT00071877|X-Linked|x-linked
757655|NCT00071877|Fabry Disease|fabry disease
757656|NCT00071877|Children|children
757657|NCT00005072|stage I prostate cancer|stage i prostate cancer
757658|NCT00005072|stage IIB prostate cancer|stage iib prostate cancer
757659|NCT00005072|stage IIA prostate cancer|stage iia prostate cancer
757660|NCT00005072|recurrent prostate cancer|recurrent prostate cancer
757661|NCT00005046|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
757662|NCT00005046|primary peritoneal cavity cancer|primary peritoneal cavity cancer
757663|NCT00004206|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
757664|NCT00004093|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
757665|NCT00004093|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
757666|NCT00071838|Neuroimmunology|neuroimmunology
757667|NCT00071838|Therapy|therapy
757668|NCT00071838|Demyelinating Disease|demyelinating disease
757669|NCT00071838|Immunological Mechanism|immunological mechanism
757670|NCT00071838|MRI|mri
757671|NCT00071838|Multiple Sclerosis|multiple sclerosis
757672|NCT00071838|MS|ms
757673|NCT00071773|diabetic macular edema|diabetic macular edema
757674|NCT00071773|laser photocoagulation|laser photocoagulation
757675|NCT00071773|etdrs|etdrs
757676|NCT00071773|macular grid photocoagulation|macular grid photocoagulation
757677|NCT00071773|DME|dme
757678|NCT00071786|Bipolar Mood Disorder|bipolar mood disorder
757679|NCT00071786|Migraine|migraine
757680|NCT00071786|Behavior Genetics|behavior genetics
757681|NCT00071786|Genetic Epidemiology|genetic epidemiology
757682|NCT00071786|Family Study|family study
757683|NCT00071760|pediatrics|pediatrics
757684|NCT00071760|ritonavir|ritonavir
757685|NCT00071760|amprenavir|amprenavir
757686|NCT00071760|AGENERASE|agenerase
757687|NCT00071760|HIV|hiv
757688|NCT00071760|Lexiva|lexiva
757689|NCT00071760|protease inhibitors|protease inhibitors
757690|NCT00071760|HIV Infection|hiv infection
757691|NCT00071760|fosamprenavir|fosamprenavir
757692|NCT00071747|schizophrenia|schizophrenia
757693|NCT00071747|lamotrigine|lamotrigine
757694|NCT00071721|Alzheimer disease|alzheimer disease
757695|NCT00071721|Agitation|agitation
757696|NCT00071721|Psychosis|psychosis
757697|NCT00071682|herbal medicine|herbal medicine
757698|NCT00071682|alternative medicines|alternative medicines
757699|NCT00071682|anticoagulation|anticoagulation
757700|NCT00071682|side effects|side effects
757701|NCT00071682|bleeding|bleeding
757703|NCT00071669|Mood Disorder|mood disorder
757704|NCT00071669|Acupuncture|acupuncture
757705|NCT00071643|Stroke|stroke
757706|NCT00071630|Adolescent|adolescent
757707|NCT00071617|Suicide|suicide
757708|NCT00071617|Adolescence|adolescence
757709|NCT00071578|Psychotherapy|psychotherapy
757710|NCT00071578|Treatment|treatment
757711|NCT00071734|fMRI|fmri
757712|NCT00071734|Auditory Feedback|auditory feedback
757713|NCT00071734|Motor Control|motor control
757714|NCT00071734|Adult|adult
757715|NCT00071734|BOLD|bold
757716|NCT00071734|Healthy Volunteer|healthy volunteer
757717|NCT00071734|HV|hv
757718|NCT00071565|familial intracranial aneurysm|familial intracranial aneurysm
757719|NCT00071565|intracranial aneurysm|intracranial aneurysm
757720|NCT00071565|brain aneurysm|brain aneurysm
757721|NCT00071565|aneurysm|aneurysm
757722|NCT00071565|subarachnoid hemorrhage|subarachnoid hemorrhage
757723|NCT00071565|stroke|stroke
757724|NCT00071552|Poorly Controlled Asthma|poorly controlled asthma
757725|NCT00071539|gross total resection|gross total resection
757726|NCT00004050|stage IIB prostate cancer|stage iib prostate cancer
757727|NCT00004050|stage IIA prostate cancer|stage iia prostate cancer
757728|NCT00004050|stage III prostate cancer|stage iii prostate cancer
757729|NCT00004025|stage III melanoma|stage iii melanoma
757730|NCT00004025|stage IV melanoma|stage iv melanoma
757731|NCT00004025|recurrent melanoma|recurrent melanoma
757732|NCT00003794|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
757733|NCT00003794|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
757734|NCT00003794|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
757735|NCT00003794|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
757736|NCT00003794|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
757737|NCT00003648|stage I colon cancer|stage i colon cancer
757738|NCT00003648|stage II colon cancer|stage ii colon cancer
757739|NCT00003648|stage III colon cancer|stage iii colon cancer
757740|NCT00003648|stage IV colon cancer|stage iv colon cancer
757741|NCT00003648|stage I rectal cancer|stage i rectal cancer
757742|NCT00003648|stage II rectal cancer|stage ii rectal cancer
757743|NCT00003648|stage III rectal cancer|stage iii rectal cancer
757744|NCT00003648|stage IV rectal cancer|stage iv rectal cancer
757745|NCT00003648|recurrent colon cancer|recurrent colon cancer
757746|NCT00003648|recurrent rectal cancer|recurrent rectal cancer
757747|NCT00071526|Vitamin C|vitamin c
757748|NCT00071526|Diabetes Mellitus|diabetes mellitus
757749|NCT00071526|Proteinuria|proteinuria
757750|NCT00071526|Renal Threshold|renal threshold
757751|NCT00071526|Healthy Volunteer|healthy volunteer
757752|NCT00071513|Adolescent|adolescent
757753|NCT00071513|Substance Abuse|substance abuse
757754|NCT00071513|At-risk|at-risk
757755|NCT00071500|Compliance|compliance
757756|NCT00071500|Adherence|adherence
757757|NCT00071500|Computerized|computerized
757758|NCT00071500|Electronic Pillbox|electronic pillbox
757759|NCT00071500|Treatment Experienced|treatment experienced
757760|NCT00071487|SLE|sle
757761|NCT00003595|childhood Burkitt lymphoma|childhood burkitt lymphoma
757762|NCT00003595|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
757763|NCT00003595|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
757764|NCT00003595|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
757765|NCT00003595|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
757766|NCT00003266|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
757767|NCT00003266|fatigue|fatigue
757768|NCT00003234|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
757769|NCT00003234|recurrent neuroblastoma|recurrent neuroblastoma
757770|NCT00003234|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
757771|NCT00003234|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
757772|NCT00003234|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
757773|NCT00003234|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
757774|NCT00003234|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
757775|NCT00003234|recurrent childhood ependymoma|recurrent childhood ependymoma
757776|NCT00003126|renal cell cancer|renal cell cancer
757777|NCT00003126|renal cell carcinoma|renal cell carcinoma
757778|NCT00003126|interleukin-2|interleukin-2
757779|NCT00071474|temporomandibular disroders|temporomandibular disroders
757780|NCT00071474|shamanism|shamanism
757781|NCT00071474|chronic pain|chronic pain
757782|NCT00071461|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
757783|NCT00071461|Interstitial lung disease|interstitial lung disease
757784|NCT00071461|Bosentan|bosentan
757785|NCT00071461|BUILD|build
757786|NCT00071435|EEG|eeg
757787|NCT00071435|Voluntary Movement|voluntary movement
757788|NCT00071435|Motor Cortex|motor cortex
757789|NCT00071435|Reaction Time|reaction time
757790|NCT00071435|Corticospinal|corticospinal
757791|NCT00071435|Primary Lateral Sclerosis|primary lateral sclerosis
757792|NCT00071435|PLS|pls
757793|NCT00071435|Healthy Volunteer|healthy volunteer
757795|NCT00071422|Type 2 diabetes|type 2 diabetes
757796|NCT00071409|Type 1 diabetes|type 1 diabetes
757797|NCT00071396|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
757798|NCT00071396|CD-52 and CD-20 Positive|cd-52 and cd-20 positive
757799|NCT00071396|Refractory|refractory
757800|NCT00071396|Relapsed|relapsed
757801|NCT00033527|non-small cell lung cancer|non-small cell lung cancer
757802|NCT00033527|small cell lung cancer|small cell lung cancer
757803|NCT00025350|stage IV colon cancer|stage iv colon cancer
757804|NCT00025350|stage IV rectal cancer|stage iv rectal cancer
757805|NCT00025350|recurrent colon cancer|recurrent colon cancer
757806|NCT00025350|recurrent rectal cancer|recurrent rectal cancer
757807|NCT00025350|adenocarcinoma of the colon|adenocarcinoma of the colon
757808|NCT00025350|adenocarcinoma of the rectum|adenocarcinoma of the rectum
757809|NCT00002935|stage 0 esophageal cancer|stage 0 esophageal cancer
757810|NCT00002723|adenocarcinoma of the prostate|adenocarcinoma of the prostate
757811|NCT00002723|stage III prostate cancer|stage iii prostate cancer
757812|NCT00002723|stage IV prostate cancer|stage iv prostate cancer
757813|NCT00002723|recurrent prostate cancer|recurrent prostate cancer
757814|NCT00071331|chronic heart failure|chronic heart failure
757815|NCT00071331|heart failure|heart failure
757816|NCT00071292|rheumatoid arthritis|rheumatoid arthritis
757817|NCT00071292|stress reduction|stress reduction
757818|NCT00071292|meditation|meditation
757819|NCT00071292|mindfulness|mindfulness
757821|NCT00071292|mindfulness-based stress reduction|mindfulness-based stress reduction
757822|NCT00071292|mind-body skills|mind-body skills
757823|NCT00030420|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
757824|NCT00030420|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
757825|NCT00030420|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
757826|NCT00030420|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
757827|NCT00026260|recurrent cervical cancer|recurrent cervical cancer
757828|NCT00026260|cervical squamous cell carcinoma|cervical squamous cell carcinoma
757829|NCT00024128|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
757830|NCT00024128|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
757831|NCT00023738|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
757832|NCT00023738|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
757833|NCT00023738|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
757834|NCT00071370|Magnetoencephalography|magnetoencephalography
757835|NCT00071370|Electroencephalogram (EEG)|electroencephalogram (eeg)
757836|NCT00071370|Interictal Epileptiform Discharges|interictal epileptiform discharges
757837|NCT00071370|Epilepsy|epilepsy
757838|NCT00071370|Sleep Deprivation|sleep deprivation
757839|NCT00071370|Seizure|seizure
757840|NCT00071305|Magnetoencephalography|magnetoencephalography
757841|NCT00071305|Electroencephalography|electroencephalography
757842|NCT00071305|Epilepsy|epilepsy
757843|NCT00071305|Dipole Modeling|dipole modeling
757844|NCT00071305|Surgery|surgery
757845|NCT00071266|Intermittent Claudication|intermittent claudication
757846|NCT00071266|Peripheral Arterial Disease|peripheral arterial disease
757847|NCT00071266|Atherosclerosis|atherosclerosis
757848|NCT00071266|Niacin|niacin
757849|NCT00071266|Lovastatin|lovastatin
757850|NCT00071266|PAD|pad
757851|NCT00071266|IC|ic
757852|NCT00071253|Bipolar Disorder - Mania|bipolar disorder - mania
757853|NCT00071240|Growth Hormone|growth hormone
757854|NCT00071240|HIV|hiv
757855|NCT00071240|AIDS|aids
757856|NCT00071240|Thymus|thymus
757857|NCT00071240|CD4 Cell|cd4 cell
757858|NCT00071240|Immune System|immune system
757859|NCT00071240|Treatment Experienced|treatment experienced
757860|NCT00071214|Staphylococcal infection|staphylococcal infection
757861|NCT00071214|Gram positive bacteria|gram positive bacteria
757862|NCT00071214|Staphylococcus|staphylococcus
757863|NCT00071214|Staphylococcus aureus|staphylococcus aureus
757864|NCT00071214|Staphylococcus aureus infection|staphylococcus aureus infection
757865|NCT00064428|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
757866|NCT00064428|fondaparinux|fondaparinux
757867|NCT00064428|Acute Myocardial Infarction|acute myocardial infarction
757868|NCT00064428|acute coronary syndrome|acute coronary syndrome
757869|NCT00071227|Age Related Macular Degeneration|age related macular degeneration
757870|NCT00071227|Macular Edema|macular edema
757871|NCT00071227|Inflammation|inflammation
757872|NCT00071227|Choroidal Neovascularization|choroidal neovascularization
757873|NCT00071227|CRVO|crvo
757874|NCT00071227|Diabetic Retinopathy|diabetic retinopathy
757875|NCT00071227|Age Related Macular Edema|age related macular edema
757876|NCT00071227|AMD|amd
757877|NCT00071188|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
757878|NCT00071175|Lupus|lupus
757879|NCT00071175|Genetics|genetics
757880|NCT00071162|Pain|pain
757881|NCT00071162|Fatigue|fatigue
757882|NCT00071162|Sleep|sleep
757883|NCT00071162|Depression|depression
757884|NCT00071162|Irritable Bowel Syndrome|irritable bowel syndrome
757885|NCT00071162|Chronic Fatigue Syndrome|chronic fatigue syndrome
757886|NCT00071149|Rheumatoid Arthritis|rheumatoid arthritis
757887|NCT00071149|TCM|tcm
757889|NCT00071149|Traditional Chinese Medicine|traditional chinese medicine
757890|NCT00071149|Complementary Therapies|complementary therapies
757891|NCT00071110|Acupuncture|acupuncture
757892|NCT00071110|Electroacupuncture|electroacupuncture
757893|NCT00071110|Alternative therapy|alternative therapy
757894|NCT00071097|HIV|hiv
757895|NCT00071097|TMC114|tmc114
757896|NCT00071097|Ritonavir|ritonavir
757897|NCT00071097|Tolerability|tolerability
757898|NCT00071097|Safety and efficacy|safety and efficacy
757899|NCT00071097|TMC114-C211|tmc114-c211
757900|NCT00071084|Skin cancer|skin cancer
757901|NCT00071084|Lymphoma|lymphoma
757902|NCT00071084|Mycosis fungoides|mycosis fungoides
757903|NCT00071084|Sezary syndrome|sezary syndrome
757904|NCT00071071|Skin cancer|skin cancer
757905|NCT00071071|Lymphoma|lymphoma
757906|NCT00071071|Mycosis fungoides|mycosis fungoides
757907|NCT00071071|Sezary syndrome|sezary syndrome
757908|NCT00023725|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
757909|NCT00023699|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
757910|NCT00023699|primary peritoneal cavity cancer|primary peritoneal cavity cancer
757911|NCT00022282|refractory multiple myeloma|refractory multiple myeloma
757912|NCT00016250|stage IV colon cancer|stage iv colon cancer
757913|NCT00016250|stage IV rectal cancer|stage iv rectal cancer
757914|NCT00016250|recurrent colon cancer|recurrent colon cancer
757915|NCT00016250|recurrent rectal cancer|recurrent rectal cancer
757916|NCT00016250|adenocarcinoma of the colon|adenocarcinoma of the colon
757917|NCT00016250|adenocarcinoma of the rectum|adenocarcinoma of the rectum
757918|NCT00015886|stage IV breast cancer|stage iv breast cancer
757919|NCT00015886|recurrent breast cancer|recurrent breast cancer
757920|NCT00015886|stage IIIB breast cancer|stage iiib breast cancer
757921|NCT00014144|recurrent bladder cancer|recurrent bladder cancer
757922|NCT00014144|stage IV bladder cancer|stage iv bladder cancer
757923|NCT00014144|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
757924|NCT00014144|recurrent urethral cancer|recurrent urethral cancer
757925|NCT00014144|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
757926|NCT00014144|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
757927|NCT00014144|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
757928|NCT00014144|anterior urethral cancer|anterior urethral cancer
757929|NCT00014144|posterior urethral cancer|posterior urethral cancer
757930|NCT00007917|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
757931|NCT00071383|Herceptin|herceptin
757932|NCT00071383|Trastuzumab|trastuzumab
757933|NCT00071383|Microdissection|microdissection
757934|NCT00071383|Proteomics|proteomics
757935|NCT00071383|Microarrays|microarrays
757936|NCT00071383|Metastatic Brain Tumor|metastatic brain tumor
757937|NCT00071383|Breast Cancer|breast cancer
757938|NCT00071383|Brain|brain
757939|NCT00071383|Carcinoma|carcinoma
757940|NCT00071383|Genomics|genomics
757941|NCT00071383|Metastatic Breast Cancer|metastatic breast cancer
757942|NCT00071383|Metastatic Breast Tumor|metastatic breast tumor
757943|NCT00071357|Microarray|microarray
757944|NCT00071357|Herceptin|herceptin
757945|NCT00071357|Trastuzumab|trastuzumab
757946|NCT00071357|Carcinoma|carcinoma
757947|NCT00071357|Proteomics|proteomics
757948|NCT00071357|Breast Cancer|breast cancer
757949|NCT00071357|Metastatic Breast Cancer|metastatic breast cancer
757950|NCT00071357|Metastatic Breast Tumor|metastatic breast tumor
757951|NCT00071344|Microarray|microarray
757952|NCT00071344|Genomics|genomics
757953|NCT00071344|Trastuzumab|trastuzumab
757954|NCT00071344|Carcinoma|carcinoma
757955|NCT00071344|Non-Small Cell Lung Cancer|non-small cell lung cancer
757956|NCT00071344|Metastatic Brain Tumor|metastatic brain tumor
757957|NCT00071344|Brain|brain
757958|NCT00071344|Microarrays|microarrays
757959|NCT00071344|Microdissection|microdissection
757960|NCT00071344|Lung Cancer|lung cancer
757961|NCT00071344|NSCLC|nsclc
757962|NCT00071123|fMRI|fmri
757963|NCT00071123|Habituation|habituation
757964|NCT00071123|Extinction|extinction
757965|NCT00071123|Amygdala|amygdala
757966|NCT00071123|Emotion|emotion
757967|NCT00071123|Major Depressive Disorder|major depressive disorder
757968|NCT00071123|Medial Prefrontal Cortex|medial prefrontal cortex
757969|NCT00071123|Backward Masking|backward masking
757970|NCT00071123|Depression|depression
757971|NCT00071123|MDD|mdd
757972|NCT00071123|Healthy Volunteer|healthy volunteer
757973|NCT00071123|HV|hv
757974|NCT00071032|Blood Disease|blood disease
757975|NCT00071032|blood transfusion|blood transfusion
757976|NCT00070993|ALS|als
757977|NCT00070993|Creatine|creatine
757978|NCT00070980|Complementary Therapies|complementary therapies
757979|NCT00070967|Acupuncture|acupuncture
757980|NCT00070967|Quality of Life|quality of life
757981|NCT00070967|Complementary Therapies|complementary therapies
757982|NCT00070967|TCM|tcm
757983|NCT00070967|Traditional Chinese Medicine|traditional chinese medicine
757984|NCT00070954|ECT|ect
757985|NCT00070954|Memory|memory
757986|NCT00070954|Ginkgo biloba|ginkgo biloba
757987|NCT00070941|Parkinsons Disease|parkinsons disease
757988|NCT00070941|Depression|depression
757989|NCT00070941|SAM-e|sam-e
757990|NCT00070928|Sleep|sleep
757991|NCT00070902|Spinal Manipulation|spinal manipulation
757992|NCT00070902|Chiropractic|chiropractic
757993|NCT00070902|Zygapophysial Joints|zygapophysial joints
757994|NCT00070889|Complementary Therapies|complementary therapies
757995|NCT00070850|Screening|screening
757996|NCT00070850|Prenatal|prenatal
757997|NCT00070850|Amniocentesis|amniocentesis
757998|NCT00070824|Acupuncture|acupuncture
757999|NCT00070824|SPECT|spect
758000|NCT00070824|f-MRI|f-mri
758001|NCT00070824|Functional brain imaging|functional brain imaging
758002|NCT00070824|RCT|rct
758003|NCT00070811|Facial form|facial form
758004|NCT00070811|Facial animation|facial animation
758005|NCT00070811|Lip muscle reconstruction|lip muscle reconstruction
758006|NCT00070811|Lip form|lip form
758007|NCT00070811|Lip function|lip function
758008|NCT00070720|Behavior change|behavior change
758009|NCT00070720|Change in practitioner behavior|change in practitioner behavior
758010|NCT00070720|Episiotomy|episiotomy
758011|NCT00070720|Active management of third stage of labor|active management of third stage of labor
758012|NCT00070720|Global Network|global network
758013|NCT00070720|Latin America|latin america
758014|NCT00070720|Uruguay|uruguay
758015|NCT00070720|Argentina|argentina
758016|NCT00070720|Maternal and child health|maternal and child health
758017|NCT00070720|International|international
758018|NCT00070720|Women's health|women's health
758019|NCT00071058|P-glycoprotein Inhibition|p-glycoprotein inhibition
758020|NCT00071058|Drug Resistance Reversal|drug resistance reversal
758021|NCT00071058|Pharmacodynamics|pharmacodynamics
758022|NCT00071058|Molecular Target|molecular target
758023|NCT00071058|Endocrine Cancer|endocrine cancer
758024|NCT00071058|Adrenocortical Cancer|adrenocortical cancer
758025|NCT00071058|ACC|acc
758026|NCT00071058|Adrenocortical Tumor|adrenocortical tumor
758027|NCT00071045|Tissue Procurement|tissue procurement
758028|NCT00071045|Sample Collection|sample collection
758029|NCT00071045|Laboratory Research|laboratory research
758030|NCT00071045|Tissue Sample|tissue sample
758031|NCT00071045|Solid Tumor|solid tumor
758032|NCT00071045|Blood Disorder|blood disorder
758033|NCT00071045|HLA Donor|hla donor
758034|NCT00070746|Perinatal mortality [PNM]|perinatal mortality [pnm]
758035|NCT00070746|Neonatal mortality|neonatal mortality
758036|NCT00070746|Low birth weight [LBW]|low birth weight [lbw]
758037|NCT00070746|Spontaneous preterm delivery [SPTD]|spontaneous preterm delivery [sptd]
758038|NCT00070746|Premature rupture of membranes [PROM]|premature rupture of membranes [prom]
758039|NCT00070746|Histological chorioamnionitis|histological chorioamnionitis
758040|NCT00070746|Global Network|global network
758041|NCT00070746|Pakistan|pakistan
758042|NCT00070746|Maternal and child health|maternal and child health
758043|NCT00070746|International|international
758044|NCT00070746|Women's health|women's health
758045|NCT00070733|Testosterone|testosterone
758046|NCT00070733|5-alpha Reductase|5-alpha reductase
758047|NCT00070733|Muscle Strength|muscle strength
758049|NCT00070733|Sexual Function|sexual function
758050|NCT00070733|Muscle Mass|muscle mass
758051|NCT00070733|Testosterone 5-alpha-Reductase|testosterone 5-alpha-reductase
758052|NCT00070707|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
758053|NCT00070707|Concomitant Asthma|concomitant asthma
758054|NCT00070876|Child|child
758055|NCT00070876|Adolescent|adolescent
758056|NCT00069433|Psychotic Disorders|psychotic disorders
758057|NCT00017368|regional neuroblastoma|regional neuroblastoma
758058|NCT00017368|disseminated neuroblastoma|disseminated neuroblastoma
758059|NCT00017368|localized unresectable neuroblastoma|localized unresectable neuroblastoma
758060|NCT00017368|stage 4S neuroblastoma|stage 4s neuroblastoma
758061|NCT00003907|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
758062|NCT00003907|advanced adult primary liver cancer|advanced adult primary liver cancer
758063|NCT00003907|recurrent adult primary liver cancer|recurrent adult primary liver cancer
758064|NCT00003907|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
758065|NCT00003907|liver metastases|liver metastases
758066|NCT00070785|Nasopharyngeal Cancer|nasopharyngeal cancer
758067|NCT00070785|EBV Virus|ebv virus
758068|NCT00070785|Epitope Mapping|epitope mapping
758069|NCT00070785|Epstein-Barr Virus|epstein-barr virus
758070|NCT00070785|Latent Protein-2|latent protein-2
758071|NCT00070785|Healthy Volunteer|healthy volunteer
758072|NCT00070785|HV|hv
758073|NCT00070759|Daclizumab|daclizumab
758074|NCT00070759|Uveitis|uveitis
758075|NCT00070759|Active|active
758076|NCT00070759|Acute|acute
758077|NCT00070642|Immunotherapy, skin cancer|immunotherapy, skin cancer
758078|NCT00070629|Immunotherapy|immunotherapy
758079|NCT00070629|lung cancer|lung cancer
758080|NCT00070616|mucositis|mucositis
758081|NCT00070616|chemotherapy|chemotherapy
758082|NCT00070616|radiation therapy|radiation therapy
758083|NCT00070590|Scleroderma|scleroderma
758084|NCT00070590|Fibrosing alveolitis|fibrosing alveolitis
758085|NCT00070590|Build|build
758086|NCT00070590|bosentan|bosentan
758087|NCT00007839|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
758088|NCT00007839|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
758089|NCT00007839|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
758090|NCT00007839|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
758091|NCT00007839|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
758092|NCT00007839|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
758093|NCT00007839|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
758094|NCT00007839|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
758095|NCT00007839|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
758096|NCT00007839|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
758097|NCT00007839|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
758098|NCT00007839|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
758099|NCT00007839|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
758100|NCT00007839|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
758101|NCT00007839|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
758102|NCT00007839|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
758103|NCT00007839|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
758104|NCT00007839|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
758105|NCT00007839|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
758106|NCT00007839|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
758107|NCT00007839|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
758108|NCT00007839|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
758109|NCT00007839|stage I marginal zone lymphoma|stage i marginal zone lymphoma
758110|NCT00007839|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
758111|NCT00007839|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
758112|NCT00007839|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
758113|NCT00007839|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
758114|NCT00007839|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
758115|NCT00007839|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
758116|NCT00007839|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
758117|NCT00007839|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
758118|NCT00007839|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
758119|NCT00007839|splenic marginal zone lymphoma|splenic marginal zone lymphoma
758120|NCT00006482|recurrent cervical cancer|recurrent cervical cancer
758121|NCT00006482|stage IVB cervical cancer|stage ivb cervical cancer
758122|NCT00006482|stage IVA cervical cancer|stage iva cervical cancer
758123|NCT00006482|cervical squamous cell carcinoma|cervical squamous cell carcinoma
758124|NCT00006466|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
758125|NCT00006466|isolated plasmacytoma of bone|isolated plasmacytoma of bone
758126|NCT00006466|extramedullary plasmacytoma|extramedullary plasmacytoma
758127|NCT00006466|refractory multiple myeloma|refractory multiple myeloma
758128|NCT00006466|stage I multiple myeloma|stage i multiple myeloma
758129|NCT00006466|stage II multiple myeloma|stage ii multiple myeloma
758130|NCT00006466|stage III multiple myeloma|stage iii multiple myeloma
758131|NCT00006257|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
758132|NCT00006121|stage III breast cancer|stage iii breast cancer
758133|NCT00006121|stage IV breast cancer|stage iv breast cancer
758134|NCT00006121|recurrent breast cancer|recurrent breast cancer
758135|NCT00006012|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
758136|NCT00006012|radiation toxicity|radiation toxicity
758137|NCT00006012|limited stage small cell lung cancer|limited stage small cell lung cancer
758138|NCT00006009|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
758139|NCT00006009|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
758140|NCT00006009|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
758141|NCT00006009|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
758142|NCT00006009|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
758143|NCT00006009|small intestine lymphoma|small intestine lymphoma
758144|NCT00006009|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
758145|NCT00006009|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
758146|NCT00006009|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
758147|NCT00006009|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
758148|NCT00006009|anaplastic large cell lymphoma|anaplastic large cell lymphoma
758149|NCT00006009|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
758150|NCT00006009|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
758151|NCT00006009|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
758152|NCT00006009|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
758153|NCT00006009|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
758154|NCT00005998|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
758155|NCT00005998|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
758156|NCT00005998|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
758157|NCT00005998|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
758158|NCT00005998|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
758159|NCT00005998|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
758160|NCT00005998|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
758161|NCT00005998|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
758162|NCT00005998|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
758163|NCT00005998|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
758164|NCT00005998|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
758165|NCT00005998|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
758166|NCT00005998|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
758167|NCT00005998|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
758168|NCT00005998|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
758169|NCT00005998|splenic marginal zone lymphoma|splenic marginal zone lymphoma
758170|NCT00005800|stage IIIA breast cancer|stage iiia breast cancer
758171|NCT00005800|stage IIIB breast cancer|stage iiib breast cancer
758172|NCT00005800|inflammatory breast cancer|inflammatory breast cancer
758173|NCT00005794|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
758174|NCT00070694|Affective Disorders|affective disorders
758175|NCT00070694|Refractory|refractory
758176|NCT00070694|Augmentation|augmentation
758177|NCT00070694|Polysomogram|polysomogram
758178|NCT00070694|Combination Therapy|combination therapy
758179|NCT00070694|Affective Disorder|affective disorder
758180|NCT00070694|Depression|depression
758181|NCT00070694|Major Depression|major depression
758182|NCT00070564|stage II breast cancer|stage ii breast cancer
758183|NCT00070564|stage IA breast cancer|stage ia breast cancer
758184|NCT00070564|stage IB breast cancer|stage ib breast cancer
758185|NCT00070564|stage IIIC breast cancer|stage iiic breast cancer
758186|NCT00070564|male breast cancer|male breast cancer
758187|NCT00070564|HER2-positive breast cancer|her2-positive breast cancer
758188|NCT00070564|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
758189|NCT00070564|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
758190|NCT00070564|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
758191|NCT00070564|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
758192|NCT00070538|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
758193|NCT00070538|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
758194|NCT00070538|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
758195|NCT00070538|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
758196|NCT00070538|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
758197|NCT00070538|refractory anemia with excess blasts|refractory anemia with excess blasts
758198|NCT00070538|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
758199|NCT00070538|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
758200|NCT00070538|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
758201|NCT00070538|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
758202|NCT00070538|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
758203|NCT00070538|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
758204|NCT00070538|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
758205|NCT00070538|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
758206|NCT00070538|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
758207|NCT00070538|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
758208|NCT00070538|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
758209|NCT00070486|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
758210|NCT00070486|adenocarcinoma of the lung|adenocarcinoma of the lung
758211|NCT00070486|squamous cell lung cancer|squamous cell lung cancer
758212|NCT00070486|large cell lung cancer|large cell lung cancer
758213|NCT00070486|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
758214|NCT00070473|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
758215|NCT00070447|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
758216|NCT00070447|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
758217|NCT00070447|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
758218|NCT00070447|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
758219|NCT00070434|stage II rectal cancer|stage ii rectal cancer
758220|NCT00070434|stage III rectal cancer|stage iii rectal cancer
758221|NCT00070434|adenocarcinoma of the rectum|adenocarcinoma of the rectum
758222|NCT00070421|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
758223|NCT00070421|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
758224|NCT00070421|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
758225|NCT00070421|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
758226|NCT00070421|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
758227|NCT00070421|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
758228|NCT00070421|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
758229|NCT00070421|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
758230|NCT00070421|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
758231|NCT00070421|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
758232|NCT00070421|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
758233|NCT00070421|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
758234|NCT00070421|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
758235|NCT00070421|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
758236|NCT00070421|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
758237|NCT00070421|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
758238|NCT00070421|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
758239|NCT00070421|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
758642|NCT00069628|Type 1 Diabetes|type 1 diabetes
758240|NCT00070421|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
758241|NCT00070421|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
758242|NCT00070421|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
758243|NCT00070421|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
758244|NCT00070421|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
758245|NCT00070421|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
758246|NCT00070421|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
758247|NCT00070421|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
758248|NCT00070382|anemia|anemia
758249|NCT00070382|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
758250|NCT00070382|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
758251|NCT00070382|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
758252|NCT00070382|extramedullary plasmacytoma|extramedullary plasmacytoma
758253|NCT00070382|isolated plasmacytoma of bone|isolated plasmacytoma of bone
758254|NCT00070382|refractory multiple myeloma|refractory multiple myeloma
758255|NCT00070382|primary systemic amyloidosis|primary systemic amyloidosis
758256|NCT00070382|stage I multiple myeloma|stage i multiple myeloma
758257|NCT00070382|stage II multiple myeloma|stage ii multiple myeloma
758258|NCT00070382|stage III multiple myeloma|stage iii multiple myeloma
758259|NCT00070382|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
758260|NCT00070382|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
758261|NCT00070382|anaplastic large cell lymphoma|anaplastic large cell lymphoma
758262|NCT00070382|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
758263|NCT00070382|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
758264|NCT00070382|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
758265|NCT00070382|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
758266|NCT00070382|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
758267|NCT00070382|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
758268|NCT00070382|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
758269|NCT00070382|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
758270|NCT00070382|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
758271|NCT00070382|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
758272|NCT00070382|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
758273|NCT00070382|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
758274|NCT00070382|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
758275|NCT00070382|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
758276|NCT00070382|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
758277|NCT00070382|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
758278|NCT00070382|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
758279|NCT00070382|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
758280|NCT00070382|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
758281|NCT00070382|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
758282|NCT00070382|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
758283|NCT00070382|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
758284|NCT00070382|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
758285|NCT00070382|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
758286|NCT00070382|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
758287|NCT00070382|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
758288|NCT00070382|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
758289|NCT00070382|prolymphocytic leukemia|prolymphocytic leukemia
758290|NCT00070382|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
758291|NCT00070382|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
758292|NCT00070382|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
758293|NCT00070382|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
758294|NCT00070382|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
758295|NCT00070382|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
758296|NCT00070382|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
758297|NCT00070382|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
758298|NCT00070382|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
758299|NCT00070382|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
758300|NCT00070382|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
758301|NCT00070382|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
758302|NCT00070382|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
758303|NCT00070382|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
758304|NCT00070382|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
758305|NCT00070382|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
758306|NCT00070382|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
758307|NCT00070382|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
758308|NCT00070382|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
758309|NCT00070382|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
758310|NCT00070382|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
758311|NCT00070382|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
758312|NCT00070382|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
758313|NCT00070382|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
758314|NCT00070382|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
758315|NCT00070382|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
758316|NCT00070382|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
758317|NCT00070382|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
758318|NCT00070382|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
758319|NCT00070382|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
758320|NCT00070382|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
758321|NCT00070382|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
758322|NCT00070382|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
758323|NCT00070382|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
758324|NCT00070382|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
758325|NCT00070382|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
758326|NCT00070382|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
758327|NCT00070382|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
758328|NCT00070382|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
758329|NCT00070382|stage I mantle cell lymphoma|stage i mantle cell lymphoma
758330|NCT00070382|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
758331|NCT00070382|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
758332|NCT00070382|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
758333|NCT00070382|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
758334|NCT00070382|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
758335|NCT00070382|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
758336|NCT00070382|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
758337|NCT00070382|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
758338|NCT00070343|stage IV melanoma|stage iv melanoma
758339|NCT00070343|stage III melanoma|stage iii melanoma
758340|NCT00070304|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
758341|NCT00070304|childhood lymphocyte predominant Hodgkin lymphoma|childhood lymphocyte predominant hodgkin lymphoma
758342|NCT00070304|childhood lymphocyte depletion Hodgkin lymphoma|childhood lymphocyte depletion hodgkin lymphoma
758343|NCT00070304|childhood nodular sclerosis Hodgkin lymphoma|childhood nodular sclerosis hodgkin lymphoma
758344|NCT00070304|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
758345|NCT00070291|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
758346|NCT00070278|stage II breast cancer|stage ii breast cancer
758347|NCT00070278|stage IIIA breast cancer|stage iiia breast cancer
758348|NCT00070278|stage IIIB breast cancer|stage iiib breast cancer
758349|NCT00070278|stage IIIC breast cancer|stage iiic breast cancer
758350|NCT00070213|adenocarcinoma of the colon|adenocarcinoma of the colon
758351|NCT00070213|adenocarcinoma of the rectum|adenocarcinoma of the rectum
758352|NCT00070213|stage IV rectal cancer|stage iv rectal cancer
758353|NCT00070213|stage IV colon cancer|stage iv colon cancer
758354|NCT00070213|recurrent rectal cancer|recurrent rectal cancer
758355|NCT00070213|recurrent colon cancer|recurrent colon cancer
758356|NCT00070200|recurrent neuroblastoma|recurrent neuroblastoma
758357|NCT00070200|stage 4S neuroblastoma|stage 4s neuroblastoma
758358|NCT00070200|localized unresectable neuroblastoma|localized unresectable neuroblastoma
758359|NCT00070200|localized resectable neuroblastoma|localized resectable neuroblastoma
758360|NCT00070200|regional neuroblastoma|regional neuroblastoma
758361|NCT00070200|disseminated neuroblastoma|disseminated neuroblastoma
758362|NCT00070187|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
758363|NCT00070187|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
758364|NCT00070174|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
758365|NCT00070174|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
758366|NCT00070174|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
758367|NCT00070174|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
758368|NCT00070174|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
758369|NCT00070174|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
758370|NCT00070174|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
758371|NCT00070174|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
758372|NCT00070174|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
758373|NCT00070161|radiation toxicity|radiation toxicity
758374|NCT00070161|adult mixed glioma|adult mixed glioma
758375|NCT00070161|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
758376|NCT00070161|adult brain stem glioma|adult brain stem glioma
758377|NCT00070161|adult craniopharyngioma|adult craniopharyngioma
758378|NCT00070161|adult medulloblastoma|adult medulloblastoma
758379|NCT00070161|adult meningioma|adult meningioma
758380|NCT00070161|adult choroid plexus tumor|adult choroid plexus tumor
758381|NCT00070161|adult tumors metastatic to brain|adult tumors metastatic to brain
758382|NCT00070161|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
758383|NCT00070161|adult anaplastic astrocytoma|adult anaplastic astrocytoma
758384|NCT00070161|adult pilocytic astrocytoma|adult pilocytic astrocytoma
758385|NCT00070161|adult subependymoma|adult subependymoma
758386|NCT00070161|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
758387|NCT00070161|adult ependymoblastoma|adult ependymoblastoma
758388|NCT00070161|adult anaplastic ependymoma|adult anaplastic ependymoma
758389|NCT00070161|adult pineoblastoma|adult pineoblastoma
758390|NCT00070161|adult pineocytoma|adult pineocytoma
758391|NCT00070161|adult myxopapillary ependymoma|adult myxopapillary ependymoma
758392|NCT00070161|adult glioblastoma|adult glioblastoma
758393|NCT00070161|adult grade III meningioma|adult grade iii meningioma
758394|NCT00070161|adult oligodendroglioma|adult oligodendroglioma
758395|NCT00070161|adult giant cell glioblastoma|adult giant cell glioblastoma
758396|NCT00070161|adult gliosarcoma|adult gliosarcoma
758397|NCT00070161|adult ependymoma|adult ependymoma
758398|NCT00070148|weight changes|weight changes
758399|NCT00070148|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
758400|NCT00070135|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
758401|NCT00070135|secondary acute myeloid leukemia|secondary acute myeloid leukemia
758402|NCT00070135|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
758403|NCT00070135|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
758404|NCT00070135|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
758405|NCT00070135|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
758406|NCT00070135|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
758407|NCT00070135|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
758408|NCT00070135|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
758409|NCT00070135|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
758410|NCT00070135|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
758411|NCT00070135|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
758412|NCT00070135|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
758413|NCT00070135|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
758414|NCT00070096|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
758415|NCT00070096|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
758562|NCT00069706|hypertension|hypertension
758416|NCT00070096|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
758417|NCT00070096|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
758418|NCT00070096|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
758419|NCT00070096|testicular seminoma|testicular seminoma
758420|NCT00070096|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
758421|NCT00070096|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
758422|NCT00070096|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
758423|NCT00070096|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
758424|NCT00070096|testicular choriocarcinoma|testicular choriocarcinoma
758425|NCT00070096|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
758426|NCT00070096|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
758427|NCT00070096|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
758643|NCT00069628|Diabetes in Children|diabetes in children
758428|NCT00070096|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
758429|NCT00070096|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
758430|NCT00070096|testicular embryonal carcinoma|testicular embryonal carcinoma
758431|NCT00070096|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
758432|NCT00070096|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
758433|NCT00070096|testicular yolk sac tumor|testicular yolk sac tumor
758434|NCT00070096|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
758435|NCT00070096|recurrent extragonadal seminoma|recurrent extragonadal seminoma
758436|NCT00070096|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
758437|NCT00070096|stage IV extragonadal seminoma|stage iv extragonadal seminoma
758438|NCT00070096|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
758439|NCT00070096|testicular immature teratoma|testicular immature teratoma
758440|NCT00070096|testicular mature teratoma|testicular mature teratoma
758441|NCT00070083|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
758442|NCT00070083|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
758443|NCT00070083|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
758444|NCT00070083|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
758445|NCT00070070|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
758446|NCT00070070|stage I bladder cancer|stage i bladder cancer
758447|NCT00070031|recurrent breast cancer|recurrent breast cancer
758448|NCT00070031|stage IIIA breast cancer|stage iiia breast cancer
758449|NCT00070031|stage IIIB breast cancer|stage iiib breast cancer
758450|NCT00070031|stage IIIC breast cancer|stage iiic breast cancer
758451|NCT00070031|stage IV breast cancer|stage iv breast cancer
758452|NCT00070018|stage I mantle cell lymphoma|stage i mantle cell lymphoma
758453|NCT00070018|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
758454|NCT00070018|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
758455|NCT00070018|anaplastic large cell lymphoma|anaplastic large cell lymphoma
758456|NCT00070018|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
758457|NCT00070018|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
758458|NCT00070018|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
758459|NCT00070018|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
758460|NCT00070018|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
758461|NCT00070018|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
758462|NCT00070005|perioperative/postoperative complications|perioperative/postoperative complications
758463|NCT00070005|stage I rectal cancer|stage i rectal cancer
758464|NCT00070005|stage II rectal cancer|stage ii rectal cancer
758465|NCT00070005|stage III rectal cancer|stage iii rectal cancer
758466|NCT00070005|adenocarcinoma of the rectum|adenocarcinoma of the rectum
758467|NCT00069992|polycythemia vera|polycythemia vera
758468|NCT00069992|essential thrombocythemia|essential thrombocythemia
758469|NCT00069992|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
758470|NCT00069992|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
758471|NCT00069992|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
758472|NCT00069992|primary myelofibrosis|primary myelofibrosis
758473|NCT00069992|chronic myelogenous leukemia|chronic myelogenous leukemia
758474|NCT00069992|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
758475|NCT00069992|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
758476|NCT00069992|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
758477|NCT00069992|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
758478|NCT00069992|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
758479|NCT00069992|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
758563|NCT00069706|POAG|poag
758480|NCT00069966|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
758481|NCT00069966|anaplastic large cell lymphoma|anaplastic large cell lymphoma
758482|NCT00069966|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
758483|NCT00069966|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
758484|NCT00069966|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
758485|NCT00069966|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
758486|NCT00069953|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
758487|NCT00069953|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
758488|NCT00069953|stage II esophageal cancer|stage ii esophageal cancer
758489|NCT00069953|stage III esophageal cancer|stage iii esophageal cancer
758490|NCT00069940|adult glioblastoma|adult glioblastoma
758491|NCT00069940|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
758492|NCT00069940|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
758493|NCT00069940|adult synovial sarcoma|adult synovial sarcoma
758494|NCT00069940|childhood synovial sarcoma|childhood synovial sarcoma
758495|NCT00069940|childhood leiomyosarcoma|childhood leiomyosarcoma
758496|NCT00069940|adult leiomyosarcoma|adult leiomyosarcoma
758497|NCT00069940|adult liposarcoma|adult liposarcoma
758498|NCT00069940|childhood liposarcoma|childhood liposarcoma
758499|NCT00069940|gastrointestinal stromal tumor|gastrointestinal stromal tumor
758500|NCT00069940|recurrent childhood brain tumor|recurrent childhood brain tumor
758501|NCT00069940|recurrent adult brain tumor|recurrent adult brain tumor
758502|NCT00069940|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
758503|NCT00069940|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
758504|NCT00069940|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
758505|NCT00069940|adult giant cell glioblastoma|adult giant cell glioblastoma
758506|NCT00069940|adult gliosarcoma|adult gliosarcoma
758507|NCT00069940|adult anaplastic astrocytoma|adult anaplastic astrocytoma
758508|NCT00069940|adult oligodendroglioma|adult oligodendroglioma
758509|NCT00069940|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
758510|NCT00069940|adult diffuse astrocytoma|adult diffuse astrocytoma
758511|NCT00069940|adult mixed glioma|adult mixed glioma
758512|NCT00069940|adult myxopapillary ependymoma|adult myxopapillary ependymoma
758513|NCT00069940|adult anaplastic ependymoma|adult anaplastic ependymoma
758514|NCT00069940|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
758515|NCT00069940|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
758516|NCT00069940|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
758517|NCT00069940|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
758518|NCT00069940|childhood infratentorial ependymoma|childhood infratentorial ependymoma
758519|NCT00069940|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
758520|NCT00069940|recurrent childhood ependymoma|recurrent childhood ependymoma
758521|NCT00069940|childhood oligodendroglioma|childhood oligodendroglioma
758522|NCT00069927|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
758523|NCT00069927|depression|depression
758524|NCT00069927|neurotoxicity|neurotoxicity
758525|NCT00006034|stage 0 bladder cancer|stage 0 bladder cancer
758942|NCT00069134|glutathione kinetics|glutathione kinetics
758526|NCT00006034|recurrent bladder cancer|recurrent bladder cancer
758527|NCT00003868|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
758528|NCT00003868|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
758529|NCT00003868|secondary acute myeloid leukemia|secondary acute myeloid leukemia
758530|NCT00003868|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
758531|NCT00003868|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
758532|NCT00003868|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
758533|NCT00003868|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
758534|NCT00003868|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
758535|NCT00070577|Alcohol Clamp|alcohol clamp
758536|NCT00070577|Pharmacokinetics|pharmacokinetics
758537|NCT00070577|Pharmacodynamics|pharmacodynamics
758538|NCT00070577|Alcohol|alcohol
758539|NCT00070577|Metabolism|metabolism
758540|NCT00070577|Response|response
758541|NCT00070577|Age|age
758542|NCT00070577|Sex|sex
758543|NCT00070577|Healthy Volunteer|healthy volunteer
758544|NCT00070577|HV|hv
758545|NCT00069901|ovarian cancer|ovarian cancer
758546|NCT00069901|paclitaxel|paclitaxel
758547|NCT00069901|carboplatin|carboplatin
758548|NCT00069784|Impaired Fasting Glucose (IFG)|impaired fasting glucose (ifg)
758549|NCT00069784|Impaired Glucose Tolerance (IGT)|impaired glucose tolerance (igt)
758550|NCT00069745|Prostatic Neoplasms|prostatic neoplasms
758551|NCT00069745|Cancer Treatment Protocols|cancer treatment protocols
758552|NCT00069745|Antineoplastic protocols|antineoplastic protocols
758553|NCT00069745|One Prior Cytotoxic Chemotherapy Regimen|one prior cytotoxic chemotherapy regimen
758554|NCT00069719|open-angle|open-angle
758555|NCT00069719|glaucoma|glaucoma
758556|NCT00069719|ocular|ocular
758557|NCT00069719|hypertension|hypertension
758564|NCT00069914|Immunization|immunization
758565|NCT00069914|Immune Activation|immune activation
758566|NCT00069914|Flu|flu
758567|NCT00069914|Antibodies|antibodies
758568|NCT00069914|Titers|titers
758569|NCT00069914|HIV|hiv
758570|NCT00069914|Healthy Volunteer|healthy volunteer
758571|NCT00069914|HV|hv
758572|NCT00069862|Beta Thalassemia|beta thalassemia
758573|NCT00069836|AVANDAMET insulin type 2 diabetes|avandamet insulin type 2 diabetes
758574|NCT00069732|Overweight|overweight
758575|NCT00069732|Weight loss maintenance|weight loss maintenance
758576|NCT00069732|CAM therapy|cam therapy
758577|NCT00069732|Qigong|qigong
758578|NCT00069732|Acupressure|acupressure
758579|NCT00069732|Traditional Chinese Medicine|traditional chinese medicine
758580|NCT00069758|NHL, indolent NHL, non-Hodgkin's lymphoma, lymphoma|nhl, indolent nhl, non-hodgkin's lymphoma, lymphoma
758581|NCT00069641|Mucopolysaccharidosis II|mucopolysaccharidosis ii
758582|NCT00069641|MPS II|mps ii
758583|NCT00069641|Hunter Syndrome|hunter syndrome
758584|NCT00069641|iduronate-2-sulfatase|iduronate-2-sulfatase
758585|NCT00069641|I2S|i2s
758586|NCT00069641|Iduronate-2-sulfatase deficiency|iduronate-2-sulfatase deficiency
758587|NCT00069524|Highly active antiretroviral therapy (HAART)|highly active antiretroviral therapy (haart)
758588|NCT00069524|Ritonavir|ritonavir
758589|NCT00069524|Oyster mushrooms|oyster mushrooms
758590|NCT00069524|Non-HDL cholesterol|non-hdl cholesterol
758591|NCT00069524|Complementary Therapies|complementary therapies
758592|NCT00069524|Treatment Experienced|treatment experienced
758593|NCT00005630|stage I non-small cell lung cancer|stage i non-small cell lung cancer
758594|NCT00005630|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
758595|NCT00005630|large cell lung cancer|large cell lung cancer
758596|NCT00005630|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
758597|NCT00005630|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
758598|NCT00005630|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
758599|NCT00005630|adenocarcinoma of the lung|adenocarcinoma of the lung
758600|NCT00005630|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
758601|NCT00005629|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
758602|NCT00005629|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
758603|NCT00005629|advanced adult primary liver cancer|advanced adult primary liver cancer
758604|NCT00005629|recurrent adult primary liver cancer|recurrent adult primary liver cancer
758605|NCT00005629|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
758606|NCT00004922|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
758607|NCT00004922|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
758608|NCT00004922|stage III neuroendocrine carcinoma of the skin|stage iii neuroendocrine carcinoma of the skin
758609|NCT00004922|recurrent neuroendocrine carcinoma of the skin|recurrent neuroendocrine carcinoma of the skin
758610|NCT00004922|neuroendocrine carcinoma|neuroendocrine carcinoma
758611|NCT00004886|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
758612|NCT00069693|Dysautonomia|dysautonomia
758613|NCT00069693|Sympathetic Nervous System|sympathetic nervous system
758614|NCT00069693|Autonomic Nervous System|autonomic nervous system
758615|NCT00069693|Syncope|syncope
758616|NCT00069693|Post Tachycardia Syndrome|post tachycardia syndrome
758617|NCT00069693|POTS|pots
758618|NCT00069693|Neurocardiogenic Syncope|neurocardiogenic syncope
758619|NCT00069693|Baroreflex|baroreflex
758620|NCT00069693|Norepinephrine|norepinephrine
758621|NCT00069693|Epinephrine|epinephrine
758622|NCT00069693|Neurocardiology|neurocardiology
758623|NCT00069693|Chronic Orthostatic Intolerance|chronic orthostatic intolerance
758624|NCT00069693|COI|coi
758625|NCT00069693|Healthy Volunteer|healthy volunteer
758626|NCT00069693|HV|hv
758627|NCT00069680|Gene Identification|gene identification
758628|NCT00069680|Linkage Analysis|linkage analysis
758629|NCT00069680|Homozygosity Mapping|homozygosity mapping
758630|NCT00069680|Gray Platelet Syndrome|gray platelet syndrome
758631|NCT00069680|GPS|gps
758632|NCT00069680|Platelet Function Defect|platelet function defect
758633|NCT00069680|Bleeding Disorder|bleeding disorder
758634|NCT00069654|Endothelium|endothelium
758635|NCT00069654|Atherosclerosis|atherosclerosis
758636|NCT00069654|Vasodilation|vasodilation
758637|NCT00069654|Ischemia|ischemia
758638|NCT00069654|Exercise|exercise
758639|NCT00069654|Coronary Artery Disease|coronary artery disease
758640|NCT00069654|CAD|cad
758641|NCT00069628|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
758644|NCT00069628|Continuous Glucose Monitoring Devices|continuous glucose monitoring devices
758645|NCT00069615|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
758646|NCT00069615|Type 1 Diabetes|type 1 diabetes
758647|NCT00069615|Continuous Glucose Monitoring Devices|continuous glucose monitoring devices
758648|NCT00069615|Electronic Data Collection|electronic data collection
758649|NCT00069602|Continuous Glucose Monitoring Devices|continuous glucose monitoring devices
758650|NCT00069602|Blood glucose profiles in normal children|blood glucose profiles in normal children
758651|NCT00069602|Blood glucose profiles in non-diabetic children|blood glucose profiles in non-diabetic children
758652|NCT00069589|Baldness|baldness
758653|NCT00069589|Autoimmunity|autoimmunity
758654|NCT00069589|Hair|hair
758655|NCT00069589|Alopecia Areata|alopecia areata
758656|NCT00069589|Alopecia Partialis|alopecia partialis
758657|NCT00069589|Alopecia Totalis|alopecia totalis
758658|NCT00069589|Alopecia Universalis|alopecia universalis
758659|NCT00069589|Autoimmune Hair Loss|autoimmune hair loss
758660|NCT00069576|Mild gestational diabetes mellitus|mild gestational diabetes mellitus
758661|NCT00069576|Maternal Fetal Medicine Units Network|maternal fetal medicine units network
758662|NCT00069563|Internalizing psychopathology|internalizing psychopathology
758663|NCT00069563|Externalizing psychopathology|externalizing psychopathology
758664|NCT00069550|Glutamate/NMDA receptors|glutamate/nmda receptors
758665|NCT00069550|Cholinergic upregulation|cholinergic upregulation
758666|NCT00069550|Dextromethorphan|dextromethorphan
758667|NCT00069550|Donepezil hydrochloride|donepezil hydrochloride
758668|NCT00069550|Aricept|aricept
758669|NCT00069537|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
758670|NCT00069537|Type 1 Diabetes|type 1 diabetes
758671|NCT00069537|Diabetes in Children|diabetes in children
758672|NCT00069537|Continuous Glucose Monitoring Devices|continuous glucose monitoring devices
758673|NCT00069511|Hepatitis C|hepatitis c
758674|NCT00069498|Mucosa|mucosa
758675|NCT00069498|Inflammation|inflammation
758676|NCT00069498|Tissue Viral Load|tissue viral load
758677|NCT00069498|Anti-inflammatory|anti-inflammatory
758678|NCT00069498|HIV-related diarrhea|hiv-related diarrhea
758679|NCT00069498|Mucosal Inflammation|mucosal inflammation
758680|NCT00069498|Treatment Experienced|treatment experienced
758681|NCT00069485|HIV Seronegativity|hiv seronegativity
758682|NCT00003930|stage II bladder cancer|stage ii bladder cancer
758683|NCT00003930|stage III bladder cancer|stage iii bladder cancer
758684|NCT00069472|Genetics|genetics
758685|NCT00069459|Winter depression, winter blues, depression, seasonal depression, seasonal affective disorder|winter depression, winter blues, depression, seasonal depression, seasonal affective disorder
758686|NCT00069446|Diabetes|diabetes
758687|NCT00069446|Diabetic|diabetic
758688|NCT00069446|Diabetic Foot Ulcer|diabetic foot ulcer
758689|NCT00069368|Healthy|healthy
758690|NCT00069407|Bipolar Disorder|bipolar disorder
758691|NCT00003827|refractory anemia with excess blasts|refractory anemia with excess blasts
758692|NCT00003827|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
758693|NCT00003827|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
758694|NCT00003827|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
758695|NCT00003827|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
758696|NCT00003594|stage III colon cancer|stage iii colon cancer
758697|NCT00003594|stage IV colon cancer|stage iv colon cancer
758698|NCT00003594|stage III rectal cancer|stage iii rectal cancer
758699|NCT00003594|stage IV rectal cancer|stage iv rectal cancer
758700|NCT00003594|recurrent colon cancer|recurrent colon cancer
758701|NCT00003594|recurrent rectal cancer|recurrent rectal cancer
758702|NCT00003594|adenocarcinoma of the colon|adenocarcinoma of the colon
758703|NCT00003594|adenocarcinoma of the rectum|adenocarcinoma of the rectum
758704|NCT00003540|stage IV breast cancer|stage iv breast cancer
758705|NCT00003540|recurrent breast cancer|recurrent breast cancer
758706|NCT00003463|recurrent adult brain tumor|recurrent adult brain tumor
758707|NCT00003463|adult brain stem glioma|adult brain stem glioma
758708|NCT00003463|adult glioblastoma|adult glioblastoma
758709|NCT00003463|adult anaplastic astrocytoma|adult anaplastic astrocytoma
758710|NCT00003463|adult mixed glioma|adult mixed glioma
758711|NCT00003463|adult giant cell glioblastoma|adult giant cell glioblastoma
758712|NCT00003463|adult gliosarcoma|adult gliosarcoma
758713|NCT00069355|PTSD|ptsd
758714|NCT00069355|Catecholamines|catecholamines
758715|NCT00069355|Conditioning|conditioning
758716|NCT00069355|Memory|memory
758717|NCT00069355|Psychophysiology|psychophysiology
758718|NCT00069355|Acute Stress Disorder|acute stress disorder
758719|NCT00069355|Post-Traumatic Stress Disorder|post-traumatic stress disorder
758720|NCT00069342|Chronic Pain|chronic pain
758721|NCT00069342|Pain|pain
758722|NCT00069342|Rheumatoid Arthritis|rheumatoid arthritis
758723|NCT00069342|Depression|depression
758724|NCT00069342|Function|function
758725|NCT00069342|Rheumatic Disease|rheumatic disease
758726|NCT00069277|Cancer, tumors|cancer, tumors
758727|NCT00069264|Metastatic Tumors|metastatic tumors
758728|NCT00069264|Advanced Solid Tumors|advanced solid tumors
758729|NCT00069264|Stage IV Tumors|stage iv tumors
758730|NCT00069264|Solid Tumors|solid tumors
758731|NCT00069264|Recurrent Solid Tumors|recurrent solid tumors
758732|NCT00069251|amphetamine dependence|amphetamine dependence
758733|NCT00003449|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
758734|NCT00003281|recurrent small cell lung cancer|recurrent small cell lung cancer
758735|NCT00003280|stage I mantle cell lymphoma|stage i mantle cell lymphoma
758736|NCT00003280|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
758737|NCT00003280|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
758738|NCT00003280|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
758739|NCT00003280|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
758740|NCT00003280|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
758741|NCT00003245|Waldenström macroglobulinemia|waldenström macroglobulinemia
758742|NCT00003245|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
758743|NCT00003245|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
758744|NCT00003245|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
758745|NCT00003245|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
758746|NCT00003245|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
758747|NCT00003245|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
758748|NCT00003245|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
758749|NCT00003245|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
758750|NCT00003245|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
758751|NCT00003245|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
758752|NCT00003245|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
758753|NCT00003245|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
758754|NCT00003245|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
758755|NCT00003245|splenic marginal zone lymphoma|splenic marginal zone lymphoma
758756|NCT00003113|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
758757|NCT00003113|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
758758|NCT00003113|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
758759|NCT00003113|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
758760|NCT00003113|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
758761|NCT00003113|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
758762|NCT00003113|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
758763|NCT00003113|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
758764|NCT00003113|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
758765|NCT00003113|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
758766|NCT00003113|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
758767|NCT00003113|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
758768|NCT00003113|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
758769|NCT00003113|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
758770|NCT00003113|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
758771|NCT00003113|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
758772|NCT00003113|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
758773|NCT00003113|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
758774|NCT00003113|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
758775|NCT00003113|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
758776|NCT00003113|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
758777|NCT00003113|stage I mantle cell lymphoma|stage i mantle cell lymphoma
758778|NCT00003113|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
758779|NCT00003113|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
758780|NCT00003113|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
758781|NCT00003113|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
758782|NCT00003113|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
758783|NCT00003113|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
758784|NCT00003113|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
758785|NCT00003113|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
758786|NCT00003113|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
758787|NCT00003113|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
758788|NCT00003113|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
758789|NCT00003113|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
758790|NCT00003113|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
758791|NCT00003113|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
758792|NCT00003113|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
758793|NCT00003113|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
758794|NCT00003113|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
758795|NCT00003113|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
758796|NCT00003113|stage II mantle cell lymphoma|stage ii mantle cell lymphoma
758797|NCT00069329|Central Nervous System|central nervous system
758798|NCT00069329|Abnormalities|abnormalities
758799|NCT00069329|Arthropathy|arthropathy
758800|NCT00069329|Urticaria|urticaria
758801|NCT00069329|Papilledema|papilledema
758802|NCT00069329|Auto-Inflammation|auto-inflammation
758803|NCT00069329|Inflammatory Disease|inflammatory disease
758804|NCT00069329|Neonatal Onset Multisystem Inflammatory Disease|neonatal onset multisystem inflammatory disease
758805|NCT00069329|NOMID|nomid
758806|NCT00069329|CINCA Syndrome|cinca syndrome
758807|NCT00069316|West Nile Virus|west nile virus
758808|NCT00069316|Encephalitis|encephalitis
758809|NCT00069316|Virus|virus
758810|NCT00069316|Mosquito|mosquito
758811|NCT00069316|Fever|fever
758812|NCT00069316|WNV|wnv
758813|NCT00069316|Myelitis|myelitis
758814|NCT00069303|West Nile Virus|west nile virus
758815|NCT00069303|Encephalitis|encephalitis
758816|NCT00069303|Virus|virus
758817|NCT00069303|Mosquito|mosquito
758818|NCT00069303|Fever|fever
758819|NCT00069303|WNV|wnv
758820|NCT00069303|Myelitis|myelitis
758821|NCT00069186|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
758822|NCT00069186|ALS|als
758823|NCT00069186|Creatine|creatine
758824|NCT00069186|Creatine Monohydrate|creatine monohydrate
758825|NCT00069186|Muscle Strength|muscle strength
758826|NCT00069238|Lymphoma|lymphoma
758827|NCT00069238|T-Cell Lymphoma|t-cell lymphoma
758828|NCT00069238|NK -Cell Lymphoma|nk -cell lymphoma
758829|NCT00069225|fMRI|fmri
758830|NCT00069225|Prolonged Exposure|prolonged exposure
758831|NCT00069225|Brain Activation|brain activation
758832|NCT00069225|Conditioning|conditioning
758833|NCT00069225|Paroxetine|paroxetine
758834|NCT00069225|PTSD|ptsd
758835|NCT00069225|Differential Fear Conditioning|differential fear conditioning
758836|NCT00069225|Masked Faces|masked faces
758837|NCT00069225|Amygdala|amygdala
758838|NCT00069225|Hippocampus|hippocampus
758839|NCT00069225|Post-Traumatic Stress Disorder|post-traumatic stress disorder
758840|NCT00069212|Post-Traumatic Stress Disorder|post-traumatic stress disorder
758841|NCT00069212|Neural Circuits|neural circuits
758842|NCT00069212|Fear|fear
758843|NCT00069212|Emotional Regulation|emotional regulation
758844|NCT00069212|Reward|reward
758845|NCT00069212|PTSD|ptsd
758846|NCT00069199|Reproducibility|reproducibility
758847|NCT00069199|Macular Edema|macular edema
758848|NCT00069199|OCT2|oct2
758849|NCT00069199|OCT3|oct3
758850|NCT00069199|Retina|retina
758851|NCT00002638|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
758852|NCT00002559|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
758853|NCT00002559|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
758854|NCT00002533|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
758855|NCT00002533|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
758856|NCT00002533|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
758857|NCT00002533|oral complications|oral complications
758858|NCT00002533|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
758859|NCT00002533|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
758860|NCT00002533|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
758861|NCT00002533|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
758862|NCT00002533|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
758863|NCT00002533|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
758864|NCT00002533|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
758865|NCT00002533|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
758866|NCT00002533|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
758867|NCT00002533|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
758868|NCT00002533|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
758869|NCT00002533|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
758870|NCT00002533|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
758871|NCT00002533|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
758872|NCT00002533|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
758873|NCT00002533|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
758874|NCT00002533|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
758875|NCT00002533|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
758876|NCT00002533|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
758877|NCT00002533|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
758878|NCT00002533|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
758879|NCT00002533|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
758880|NCT00002533|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
759030|NCT00068835|Brain imaging|brain imaging
781928|NCT00040105|Gleevec|gleevec
758881|NCT00002533|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
758882|NCT00002533|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
758883|NCT00002533|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
758884|NCT00002533|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
758885|NCT00002533|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
758886|NCT00002533|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
758887|NCT00002533|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
758888|NCT00002533|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
758889|NCT00002533|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
758890|NCT00002533|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
758891|NCT00002533|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
758892|NCT00002533|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
758893|NCT00002533|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
758894|NCT00002533|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
758895|NCT00002533|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
758896|NCT00002533|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
758897|NCT00002533|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
758898|NCT00002533|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
758899|NCT00002533|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
758900|NCT00002533|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
758901|NCT00002533|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
758902|NCT00002533|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
758903|NCT00002533|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
758904|NCT00002533|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
758905|NCT00002533|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
758906|NCT00002533|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
758907|NCT00002533|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
758908|NCT00002533|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
758909|NCT00002533|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
758910|NCT00002533|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
758911|NCT00002533|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
758912|NCT00002533|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
758913|NCT00002533|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
758914|NCT00002533|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
758915|NCT00002533|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
758916|NCT00002533|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
758917|NCT00002533|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
758918|NCT00002533|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
758919|NCT00002533|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
758920|NCT00002533|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
758921|NCT00002533|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
758922|NCT00002533|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
758923|NCT00002533|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
758924|NCT00002533|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
758925|NCT00002533|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
758926|NCT00002533|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
758927|NCT00002533|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
758928|NCT00002533|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
758929|NCT00002533|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
758930|NCT00002533|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
758931|NCT00002533|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
758932|NCT00002533|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
758933|NCT00002533|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
758934|NCT00002533|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
758935|NCT00002533|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
758936|NCT00002533|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
758937|NCT00002533|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
758938|NCT00002533|infection|infection
758939|NCT00069173|Females|females
758940|NCT00069173|Sedentary|sedentary
758941|NCT00069173|School-based|school-based
758943|NCT00069134|oxidant damage|oxidant damage
758944|NCT00069134|anti-oxidant capacity|anti-oxidant capacity
758945|NCT00069134|oxidative stress|oxidative stress
758946|NCT00069134|cysteine kinetics|cysteine kinetics
758947|NCT00069134|severe childhood malnutrition|severe childhood malnutrition
758948|NCT00026286|stage I breast cancer|stage i breast cancer
758949|NCT00026286|stage II breast cancer|stage ii breast cancer
758950|NCT00026286|breast cancer in situ|breast cancer in situ
758951|NCT00026286|ductal breast carcinoma|ductal breast carcinoma
758952|NCT00026286|hot flashes|hot flashes
758953|NCT00026286|menopausal symptoms|menopausal symptoms
758954|NCT00025116|adenocarcinoma of the prostate|adenocarcinoma of the prostate
758955|NCT00025116|recurrent prostate cancer|recurrent prostate cancer
758956|NCT00069160|Pharmacokinetics|pharmacokinetics
758957|NCT00069160|Pharmacodynamics|pharmacodynamics
758958|NCT00069160|Multidrug Resistance Reversal|multidrug resistance reversal
758959|NCT00069160|Molecular Target|molecular target
758960|NCT00069160|P-Glycoprotein Inhibition|p-glycoprotein inhibition
758961|NCT00069160|Lung Cancer|lung cancer
758962|NCT00069160|Ovarian Cancer|ovarian cancer
758963|NCT00069160|Cervical Cancer|cervical cancer
758964|NCT00069160|Renal Cancer|renal cancer
758965|NCT00069082|Headache|headache
758966|NCT00069082|Cluster|cluster
758967|NCT00069082|EC|ec
758968|NCT00069082|Episodic Cluster|episodic cluster
758969|NCT00069030|HIV Seronegativity|hiv seronegativity
758970|NCT00069030|HIV Preventive Vaccine|hiv preventive vaccine
758971|NCT00069030|HIV-1|hiv-1
758972|NCT00069030|AIDS Vaccines|aids vaccines
758973|NCT00069030|Vaccines, DNA|vaccines, dna
758974|NCT00069030|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
758975|NCT00069030|Cytokines|cytokines
758976|NCT00069030|Plasmids|plasmids
758977|NCT00069030|Adjuvants, Immunologic|adjuvants, immunologic
758978|NCT00069030|Drug Administration Schedule|drug administration schedule
758979|NCT00069030|Interleukin|interleukin
758980|NCT00069030|IL2|il2
758981|NCT00069030|Ig|ig
758982|NCT00069030|IL@/Ig|il@/ig
758983|NCT00069004|HIV-Associated Lipodystrophy Syndrome|hiv-associated lipodystrophy syndrome
758984|NCT00069004|HIV Lipodystrophy Syndrome|hiv lipodystrophy syndrome
758985|NCT00069004|Treatment Experienced|treatment experienced
758986|NCT00069004|Lipodystrophy|lipodystrophy
758987|NCT00069004|Dyslipidemia|dyslipidemia
758988|NCT00069004|Osteoporosis|osteoporosis
758989|NCT00069004|Osteopenia|osteopenia
758990|NCT00068991|Behavioral Intervention Study|behavioral intervention study
758991|NCT00068991|Randomized Prevention Trial|randomized prevention trial
758992|NCT00068991|China|china
758993|NCT00068991|Condom Use|condom use
758994|NCT00068991|STDs|stds
758995|NCT00068991|Sexual Partners|sexual partners
758996|NCT00068991|HIV Seronegativity|hiv seronegativity
758997|NCT00068978|HIV Seronegativity|hiv seronegativity
758998|NCT00068978|HIV Preventive Vaccine|hiv preventive vaccine
758999|NCT00068978|HIV Therapeutic Vaccine|hiv therapeutic vaccine
759000|NCT00069069|Stroke|stroke
759001|NCT00069069|TIA|tia
759002|NCT00069056|Grid Laser|grid laser
759003|NCT00069056|Focal Laser|focal laser
759004|NCT00069056|Glycemic Control|glycemic control
759005|NCT00069056|Diabetes|diabetes
759006|NCT00069056|Diabetic Macular Edema|diabetic macular edema
759007|NCT00069056|Macular Edema|macular edema
759008|NCT00068887|type 2 diabetes|type 2 diabetes
759009|NCT00068887|some studies - family history of type 2 diabetes|some studies - family history of type 2 diabetes
759010|NCT00068926|Biodefense|biodefense
759011|NCT00068926|Prevention|prevention
759012|NCT00068926|Emergent|emergent
759013|NCT00068926|Virus|virus
759014|NCT00068926|Immune Response|immune response
759015|NCT00068926|Healthy Volunteer|healthy volunteer
759016|NCT00068926|HV|hv
759017|NCT00068913|Lactic Acidosis|lactic acidosis
759018|NCT00068913|Mitochondrial Disorder|mitochondrial disorder
759019|NCT00068913|Stroke|stroke
759020|NCT00068913|Seizure|seizure
759021|NCT00068874|African American|african american
759022|NCT00068874|Adolescent|adolescent
759023|NCT00068874|Coping|coping
759024|NCT00068874|Adjustment|adjustment
759025|NCT00068874|Quality of Life|quality of life
759026|NCT00068848|Oral Contraceptives|oral contraceptives
759027|NCT00068848|Initiation|initiation
759028|NCT00068848|Continuation|continuation
759029|NCT00068835|Reading|reading
759031|NCT00068822|Vertebroplasty|vertebroplasty
759032|NCT00068822|Crushed Vertebrae|crushed vertebrae
759033|NCT00068822|Back Pain|back pain
759034|NCT00068822|Structurally Unstable Vertebrae|structurally unstable vertebrae
759035|NCT00068822|polymethylmethacrylate|polymethylmethacrylate
759036|NCT00068822|INVEST|invest
759037|NCT00068822|PMMA|pmma
759038|NCT00068822|RDQ|rdq
759039|NCT00068809|Treatment experienced|treatment experienced
759040|NCT00068809|Treatment interruption|treatment interruption
759041|NCT00068770|adult glioblastoma|adult glioblastoma
759042|NCT00068770|adult giant cell glioblastoma|adult giant cell glioblastoma
759043|NCT00068770|adult gliosarcoma|adult gliosarcoma
759044|NCT00068757|recurrent breast cancer|recurrent breast cancer
759045|NCT00068757|stage IIIB breast cancer|stage iiib breast cancer
759046|NCT00068757|stage IIIC breast cancer|stage iiic breast cancer
759047|NCT00068757|stage IV breast cancer|stage iv breast cancer
759048|NCT00068757|male breast cancer|male breast cancer
759049|NCT00068757|HER2-positive breast cancer|her2-positive breast cancer
759050|NCT00068744|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
759051|NCT00068744|stage II anal cancer|stage ii anal cancer
759052|NCT00068744|stage IIIA anal cancer|stage iiia anal cancer
759053|NCT00068744|stage IIIB anal cancer|stage iiib anal cancer
759054|NCT00068731|stage IV prostate cancer|stage iv prostate cancer
759055|NCT00068731|recurrent prostate cancer|recurrent prostate cancer
759056|NCT00068666|stage IV melanoma|stage iv melanoma
759057|NCT00068666|recurrent melanoma|recurrent melanoma
759058|NCT00068666|tumors metastatic to brain|tumors metastatic to brain
759059|NCT00068653|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
759060|NCT00068614|stage IV breast cancer|stage iv breast cancer
759061|NCT00068614|stage II breast cancer|stage ii breast cancer
759062|NCT00068614|stage IIIA breast cancer|stage iiia breast cancer
759063|NCT00068614|stage IIIB breast cancer|stage iiib breast cancer
759064|NCT00068614|stage IIIC breast cancer|stage iiic breast cancer
759065|NCT00068601|infertility|infertility
759066|NCT00068601|menopausal symptoms|menopausal symptoms
759067|NCT00068601|stage II breast cancer|stage ii breast cancer
759068|NCT00068601|stage IIIA breast cancer|stage iiia breast cancer
759069|NCT00068601|stage IA breast cancer|stage ia breast cancer
759070|NCT00068601|stage IB breast cancer|stage ib breast cancer
759071|NCT00068601|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
759072|NCT00068601|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
759073|NCT00068575|stage I pancreatic cancer|stage i pancreatic cancer
759074|NCT00068575|stage II pancreatic cancer|stage ii pancreatic cancer
759075|NCT00068575|stage III pancreatic cancer|stage iii pancreatic cancer
759076|NCT00068575|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
759077|NCT00068523|refractory multiple myeloma|refractory multiple myeloma
759078|NCT00068523|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
759079|NCT00068523|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
759080|NCT00068523|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
759081|NCT00068523|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
759082|NCT00068523|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
759083|NCT00068523|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
759084|NCT00068523|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
759085|NCT00068523|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
759086|NCT00068523|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
759087|NCT00068523|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
759088|NCT00068523|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
759089|NCT00068523|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
759090|NCT00068523|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
759091|NCT00068523|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
759092|NCT00068523|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
759093|NCT00068523|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
759094|NCT00068523|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
759095|NCT00068523|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
759096|NCT00068523|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
759097|NCT00068523|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
759098|NCT00068523|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
759099|NCT00068523|refractory anemia with excess blasts|refractory anemia with excess blasts
759100|NCT00068523|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
759101|NCT00068523|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
759102|NCT00068523|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
759103|NCT00068523|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
759104|NCT00068523|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
759105|NCT00068523|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
759261|NCT00016939|stage III renal cell cancer|stage iii renal cell cancer
759106|NCT00068523|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
759107|NCT00068523|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
759108|NCT00068523|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
759109|NCT00068523|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
759110|NCT00068523|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
759111|NCT00068523|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
759112|NCT00068523|secondary acute myeloid leukemia|secondary acute myeloid leukemia
759113|NCT00068523|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
759114|NCT00068523|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
759115|NCT00068523|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
759116|NCT00068523|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
759117|NCT00068523|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
759118|NCT00068523|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
759119|NCT00068523|splenic marginal zone lymphoma|splenic marginal zone lymphoma
759120|NCT00068523|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
759121|NCT00068523|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
759122|NCT00068523|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
759123|NCT00068523|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
759124|NCT00068523|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
759125|NCT00068510|adult glioblastoma|adult glioblastoma
759126|NCT00068510|adult anaplastic astrocytoma|adult anaplastic astrocytoma
759127|NCT00068510|adult brain tumor|adult brain tumor
759128|NCT00068510|adult giant cell glioblastoma|adult giant cell glioblastoma
759129|NCT00068510|adult gliosarcoma|adult gliosarcoma
759130|NCT00068510|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
759131|NCT00068471|infection|infection
759132|NCT00068471|neutropenia|neutropenia
759133|NCT00068471|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
759134|NCT00068458|weight changes|weight changes
759135|NCT00068458|depression|depression
759136|NCT00068458|stage I breast cancer|stage i breast cancer
759137|NCT00068458|stage II breast cancer|stage ii breast cancer
759138|NCT00068458|stage IIIA breast cancer|stage iiia breast cancer
759139|NCT00068445|neurotoxicity|neurotoxicity
759140|NCT00068445|pain|pain
759141|NCT00068445|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
759142|NCT00068432|recurrent pancreatic cancer|recurrent pancreatic cancer
759143|NCT00068432|stage IV pancreatic cancer|stage iv pancreatic cancer
759144|NCT00068393|Sarcomatoid|sarcomatoid
759145|NCT00068393|Gemcitabine|gemcitabine
759146|NCT00068393|Doxorubicin|doxorubicin
759147|NCT00068393|Renal cell cancer|renal cell cancer
759148|NCT00068393|Kidney cancer|kidney cancer
759149|NCT00068367|adult neurofibrosarcoma|adult neurofibrosarcoma
759150|NCT00068367|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
759151|NCT00068367|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
759152|NCT00068367|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
759153|NCT00068367|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
759154|NCT00068341|stage IIIA breast cancer|stage iiia breast cancer
759155|NCT00068341|stage IIIB breast cancer|stage iiib breast cancer
759156|NCT00068341|stage IIIC breast cancer|stage iiic breast cancer
759157|NCT00068341|stage II breast cancer|stage ii breast cancer
759158|NCT00068328|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
759159|NCT00068328|stage II breast cancer|stage ii breast cancer
759160|NCT00068328|stage IIIA breast cancer|stage iiia breast cancer
759161|NCT00068328|stage IIIB breast cancer|stage iiib breast cancer
759162|NCT00068328|stage IIIC breast cancer|stage iiic breast cancer
759163|NCT00068328|stage IA breast cancer|stage ia breast cancer
759164|NCT00068328|stage IB breast cancer|stage ib breast cancer
759165|NCT00068328|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
759166|NCT00068328|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
759167|NCT00068302|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
759168|NCT00068302|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
759169|NCT00068302|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
759170|NCT00068302|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
759171|NCT00068302|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
759172|NCT00068289|extensive stage small cell lung cancer|extensive stage small cell lung cancer
759173|NCT00068289|recurrent small cell lung cancer|recurrent small cell lung cancer
759174|NCT00068276|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
759175|NCT00068276|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
759176|NCT00068276|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
759177|NCT00068276|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
759178|NCT00068276|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
759179|NCT00068276|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
759180|NCT00068263|stage I breast cancer|stage i breast cancer
759181|NCT00068263|stage II breast cancer|stage ii breast cancer
759182|NCT00068250|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
759183|NCT00068250|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
759184|NCT00068237|xerostomia|xerostomia
759185|NCT00068237|radiation toxicity|radiation toxicity
759186|NCT00068237|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
759187|NCT00068237|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
759188|NCT00068237|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
759189|NCT00068237|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
759190|NCT00068237|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
759191|NCT00068237|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
759192|NCT00068237|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
759193|NCT00068237|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
759194|NCT00068237|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
759195|NCT00068237|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
759196|NCT00068211|Metastatic Melanoma|metastatic melanoma
759197|NCT00068211|Melanoma|melanoma
759198|NCT00068211|Inoperable Locally Advanced Melanoma|inoperable locally advanced melanoma
759199|NCT00068224|Caroli's Syndrome|caroli's syndrome
759200|NCT00068224|Congenital Hepatic Fibrosis|congenital hepatic fibrosis
759201|NCT00068224|Ductal Plate Malformation|ductal plate malformation
759202|NCT00068224|Ciliopathy|ciliopathy
759203|NCT00068224|Polycystic Kidney|polycystic kidney
759204|NCT00068224|Polycystic Liver|polycystic liver
759205|NCT00068224|Nephronophthisis|nephronophthisis
759206|NCT00068224|Molar Tooth Sign|molar tooth sign
759207|NCT00068224|Dandy-Walker Malformation|dandy-walker malformation
759208|NCT00068224|Retinopathy|retinopathy
759209|NCT00068224|Situs Inversus|situs inversus
759210|NCT00068224|Heterotaxia|heterotaxia
759211|NCT00068224|Cerebellar Vermis Hypoplasia|cerebellar vermis hypoplasia
759212|NCT00068224|Autosomal Recessive Polycystic Kidney Disease|autosomal recessive polycystic kidney disease
759213|NCT00068224|ARPKD|arpkd
759214|NCT00068224|Kidney|kidney
759215|NCT00068224|Liver|liver
759216|NCT00068185|Black cohosh|black cohosh
759217|NCT00068185|Pharmacokinetics|pharmacokinetics
759218|NCT00068185|Alternative therapies|alternative therapies
759219|NCT00068185|Natural product|natural product
759220|NCT00021268|stage IV colon cancer|stage iv colon cancer
759221|NCT00021268|stage IV rectal cancer|stage iv rectal cancer
759222|NCT00021268|recurrent colon cancer|recurrent colon cancer
759223|NCT00021268|recurrent rectal cancer|recurrent rectal cancer
759224|NCT00020904|stage IV breast cancer|stage iv breast cancer
759225|NCT00020904|recurrent breast cancer|recurrent breast cancer
759226|NCT00068159|Hereditary Disease|hereditary disease
759227|NCT00068159|Diastolic Dysfunction|diastolic dysfunction
759228|NCT00068159|Exercise Tolerance|exercise tolerance
759229|NCT00068159|Exercise Stress Echocardiography|exercise stress echocardiography
759230|NCT00068159|MRI|mri
759231|NCT00068159|Hereditary Hemochromatosis|hereditary hemochromatosis
759232|NCT00068159|HH|hh
759233|NCT00068159|Iron Overload|iron overload
759234|NCT00068146|Adenopathy|adenopathy
759235|NCT00068146|Genetic Disorder|genetic disorder
759236|NCT00068146|Apoptosis|apoptosis
759237|NCT00068146|Diagnostic Imaging|diagnostic imaging
759238|NCT00068146|Hodgkins|hodgkins
759239|NCT00068146|Autoimmune Lymphoproliferative|autoimmune lymphoproliferative
759240|NCT00068146|Syndrome|syndrome
759241|NCT00068146|ALPS|alps
759242|NCT00068146|ALPS-Associated Lymphoma|alps-associated lymphoma
759243|NCT00068120|Urinary tract infection|urinary tract infection
759244|NCT00068094|Probiotics|probiotics
759245|NCT00068094|Bacteria|bacteria
759246|NCT00068081|Dermal assessment|dermal assessment
759247|NCT00068081|Pain measurement|pain measurement
759248|NCT00068081|Diary|diary
759249|NCT00068081|Analgesics/*therapeutic use|analgesics/*therapeutic use
759250|NCT00068081|Capsaicin/*administration & dosage/adverse effects|capsaicin/*administration & dosage/adverse effects
759251|NCT00068081|Herpes zoster/*complication/drug therapy|herpes zoster/*complication/drug therapy
759252|NCT00068081|Neuralgia/*drug therapy/etiology|neuralgia/*drug therapy/etiology
759253|NCT00068081|Pain|pain
759254|NCT00068081|Peripheral nervous system diseases/*complications|peripheral nervous system diseases/*complications
759255|NCT00017043|stage IV gastric cancer|stage iv gastric cancer
759256|NCT00017043|recurrent gastric cancer|recurrent gastric cancer
759257|NCT00017043|stage IV esophageal cancer|stage iv esophageal cancer
759258|NCT00017043|recurrent esophageal cancer|recurrent esophageal cancer
759259|NCT00017043|adenocarcinoma of the stomach|adenocarcinoma of the stomach
759260|NCT00017043|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
759262|NCT00016939|stage IV renal cell cancer|stage iv renal cell cancer
759263|NCT00016939|recurrent renal cell cancer|recurrent renal cell cancer
759264|NCT00016874|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
759265|NCT00016341|stage III endometrial carcinoma|stage iii endometrial carcinoma
759266|NCT00016341|stage IV endometrial carcinoma|stage iv endometrial carcinoma
759267|NCT00016341|recurrent endometrial carcinoma|recurrent endometrial carcinoma
759268|NCT00068107|Lysosomal Storage|lysosomal storage
759269|NCT00068107|Renal Insufficiency|renal insufficiency
759270|NCT00068107|Stroke|stroke
759271|NCT00068107|Hypohidrosis|hypohidrosis
759272|NCT00068107|Peripheral Neuropathy|peripheral neuropathy
759273|NCT00068107|Fabry Disease|fabry disease
759274|NCT00068068|Photodynamic therapy|photodynamic therapy
759275|NCT00068068|Liver metastases|liver metastases
759276|NCT00068068|Colorectal cancer|colorectal cancer
759278|NCT00068068|Light Infusion Technology™|light infusion technology™
759279|NCT00068068|Talaporfin sodium|talaporfin sodium
759280|NCT00068068|LS11|ls11
759281|NCT00068068|Liver mets|liver mets
759282|NCT00068068|Metastatic colorectal cancer|metastatic colorectal cancer
759283|NCT00068068|Light emittting diodes (LED)|light emittting diodes (led)
759284|NCT00068068|Tumor ablation|tumor ablation
759285|NCT00068068|Combination therapy|combination therapy
759286|NCT00068055|West Nile Virus, encephalitis, myelitis, immunoglobulin G|west nile virus, encephalitis, myelitis, immunoglobulin g
759287|NCT00067899|cigarette smoking|cigarette smoking
759288|NCT00067899|tocopherol|tocopherol
759289|NCT00067899|bioavailability|bioavailability
759290|NCT00067899|metabolism|metabolism
759291|NCT00067899|oxidative stress|oxidative stress
759292|NCT00067990|chronic allograft nephropathy|chronic allograft nephropathy
759293|NCT00067990|post transplant proteinuria|post transplant proteinuria
759294|NCT00067951|Hyperglycemia|hyperglycemia
759295|NCT00067951|HbA1c|hba1c
759296|NCT00067951|Hemoglobin A1c|hemoglobin a1c
759297|NCT00067951|Type 2 diabetes mellitus|type 2 diabetes mellitus
759298|NCT00067938|bipolar disorder|bipolar disorder
759299|NCT00067938|lamotrigine|lamotrigine
759300|NCT00068003|Adoptive Cell Therapy|adoptive cell therapy
759301|NCT00068003|Screening|screening
759302|NCT00068003|Cell Harvest|cell harvest
759303|NCT00068003|Blood|blood
759304|NCT00068003|Tumor Tissue|tumor tissue
759305|NCT00067925|Weight-bearing physical activity|weight-bearing physical activity
759306|NCT00067925|Calcium intake|calcium intake
759307|NCT00067925|School-based health education|school-based health education
759308|NCT00067925|Adolescent girls|adolescent girls
759309|NCT00067925|Child nutrition|child nutrition
759310|NCT00067925|Diet|diet
759311|NCT00010036|adult glioblastoma|adult glioblastoma
759312|NCT00010036|adult giant cell glioblastoma|adult giant cell glioblastoma
759313|NCT00010036|adult gliosarcoma|adult gliosarcoma
759314|NCT00008359|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
759315|NCT00008359|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
759316|NCT00008359|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
759317|NCT00008359|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
759318|NCT00008359|stage IV breast cancer|stage iv breast cancer
759319|NCT00008359|stage IIIA breast cancer|stage iiia breast cancer
759320|NCT00008359|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
759321|NCT00008359|stage IIIB breast cancer|stage iiib breast cancer
759322|NCT00008359|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
759323|NCT00008359|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
759324|NCT00008359|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
759325|NCT00008359|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
759326|NCT00008359|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
759327|NCT00008359|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
759328|NCT00008359|isolated plasmacytoma of bone|isolated plasmacytoma of bone
759329|NCT00008359|extramedullary plasmacytoma|extramedullary plasmacytoma
759330|NCT00008359|refractory multiple myeloma|refractory multiple myeloma
759331|NCT00008359|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
759332|NCT00008359|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
759333|NCT00008359|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
759334|NCT00008359|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
759335|NCT00008359|disseminated neuroblastoma|disseminated neuroblastoma
759336|NCT00008359|recurrent neuroblastoma|recurrent neuroblastoma
759337|NCT00008359|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
759338|NCT00008359|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
759339|NCT00008359|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
759340|NCT00008359|stage I multiple myeloma|stage i multiple myeloma
759341|NCT00008359|stage II multiple myeloma|stage ii multiple myeloma
759342|NCT00008359|stage III multiple myeloma|stage iii multiple myeloma
759343|NCT00008359|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
759344|NCT00008359|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
781929|NCT00040105|Imatinib|imatinib
759345|NCT00008359|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
759346|NCT00008359|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
759347|NCT00008359|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
759348|NCT00008359|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
759349|NCT00008359|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
759350|NCT00008359|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
759351|NCT00008359|small intestine lymphoma|small intestine lymphoma
759352|NCT00008359|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
759353|NCT00008359|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
759354|NCT00008359|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
759355|NCT00008359|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
759356|NCT00008359|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
759357|NCT00008359|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
759358|NCT00008359|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
759359|NCT00008359|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
759360|NCT00008359|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
759361|NCT00008359|polycythemia vera|polycythemia vera
759362|NCT00008359|primary myelofibrosis|primary myelofibrosis
759363|NCT00008359|essential thrombocythemia|essential thrombocythemia
759364|NCT00008359|fever, sweats, and hot flashes|fever, sweats, and hot flashes
759365|NCT00008359|testicular embryonal carcinoma|testicular embryonal carcinoma
759366|NCT00008359|testicular choriocarcinoma|testicular choriocarcinoma
759367|NCT00008359|testicular teratoma|testicular teratoma
759368|NCT00008359|testicular yolk sac tumor|testicular yolk sac tumor
759369|NCT00008359|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
759370|NCT00008359|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
759371|NCT00008359|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
759372|NCT00008359|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
759373|NCT00008359|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
759374|NCT00008359|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
759375|NCT00008359|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
759376|NCT00008359|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
759377|NCT00008359|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
759378|NCT00008359|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
759379|NCT00008359|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
759380|NCT00008359|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
759381|NCT00008359|refractory hairy cell leukemia|refractory hairy cell leukemia
759382|NCT00008359|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
759383|NCT00008359|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
759384|NCT00008359|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
759385|NCT00008359|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
759386|NCT00008359|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
759387|NCT00008359|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
759388|NCT00008359|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
759389|NCT00008359|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
759390|NCT00008359|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
759391|NCT00008359|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
759392|NCT00008359|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
759393|NCT00008359|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
759394|NCT00008359|ovarian yolk sac tumor|ovarian yolk sac tumor
759395|NCT00008359|ovarian embryonal carcinoma|ovarian embryonal carcinoma
759396|NCT00008359|ovarian polyembryoma|ovarian polyembryoma
759397|NCT00008359|ovarian choriocarcinoma|ovarian choriocarcinoma
759398|NCT00008359|ovarian immature teratoma|ovarian immature teratoma
759399|NCT00008359|ovarian mature teratoma|ovarian mature teratoma
759400|NCT00008359|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
759401|NCT00008359|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
759402|NCT00008359|acute undifferentiated leukemia|acute undifferentiated leukemia
759403|NCT00008359|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
759404|NCT00008359|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
759405|NCT00008359|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
759406|NCT00008359|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
759407|NCT00008359|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
759408|NCT00008359|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
759409|NCT00008359|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
759410|NCT00008359|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
759411|NCT00008359|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
759412|NCT00008359|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
759413|NCT00008359|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
759414|NCT00008359|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
759415|NCT00008359|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
759416|NCT00008359|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
759417|NCT00008359|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
759418|NCT00008359|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
759419|NCT00008359|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
759420|NCT00008359|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
759421|NCT00008359|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
759422|NCT00008359|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
759423|NCT00008359|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
759424|NCT00008359|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
759425|NCT00008359|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
759426|NCT00008359|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
759427|NCT00008359|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
759428|NCT00008359|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
759429|NCT00008359|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
759430|NCT00008359|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
759431|NCT00008359|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
759432|NCT00008359|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
759433|NCT00008359|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
759434|NCT00008359|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
759435|NCT00008359|secondary acute myeloid leukemia|secondary acute myeloid leukemia
759436|NCT00008359|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
759437|NCT00008359|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
759438|NCT00008359|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
759439|NCT00008359|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
759440|NCT00008359|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
759441|NCT00008359|neutropenia|neutropenia
759442|NCT00008359|infection|infection
759443|NCT00008359|prolymphocytic leukemia|prolymphocytic leukemia
759444|NCT00008359|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
759445|NCT00008359|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
759446|NCT00008359|primary systemic amyloidosis|primary systemic amyloidosis
759447|NCT00008359|intraocular lymphoma|intraocular lymphoma
759448|NCT00008359|stage I mantle cell lymphoma|stage i mantle cell lymphoma
759449|NCT00008359|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
759450|NCT00008359|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
759451|NCT00008359|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
759452|NCT00008359|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
759453|NCT00008359|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
759454|NCT00008359|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
759455|NCT00008359|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
759456|NCT00008359|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
759457|NCT00008359|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
759458|NCT00008359|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
759459|NCT00008359|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
759460|NCT00008359|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
759461|NCT00008359|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
759462|NCT00008359|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
759463|NCT00008359|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
759464|NCT00008359|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
759465|NCT00008359|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
759466|NCT00008359|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
759467|NCT00008359|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
759468|NCT00008359|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
759469|NCT00008359|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
759470|NCT00008359|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
759471|NCT00008359|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
759795|NCT00067392|Bone atrophy|bone atrophy
781930|NCT00040105|STI571|sti571
759472|NCT00008359|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
759473|NCT00008359|anaplastic large cell lymphoma|anaplastic large cell lymphoma
759474|NCT00008359|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
759475|NCT00008359|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
759476|NCT00008359|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
759477|NCT00008359|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
759478|NCT00008359|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
759479|NCT00008359|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
759480|NCT00008359|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
759481|NCT00008359|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
759482|NCT00008359|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
759483|NCT00008359|stage I marginal zone lymphoma|stage i marginal zone lymphoma
759484|NCT00008359|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
759485|NCT00008359|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
759486|NCT00008359|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
759487|NCT00008359|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
759488|NCT00008359|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
759489|NCT00008359|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
759490|NCT00008359|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
759491|NCT00008359|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
759492|NCT00008359|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
759493|NCT00008359|splenic marginal zone lymphoma|splenic marginal zone lymphoma
759494|NCT00008359|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
759495|NCT00008086|recurrent adult brain tumor|recurrent adult brain tumor
759496|NCT00008086|adult brain stem glioma|adult brain stem glioma
759497|NCT00008086|adult craniopharyngioma|adult craniopharyngioma
759498|NCT00008086|adult medulloblastoma|adult medulloblastoma
759499|NCT00008086|adult meningioma|adult meningioma
759500|NCT00008086|adult glioblastoma|adult glioblastoma
759501|NCT00008086|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
759502|NCT00008086|adult anaplastic astrocytoma|adult anaplastic astrocytoma
759503|NCT00008086|adult myxopapillary ependymoma|adult myxopapillary ependymoma
759504|NCT00008086|adult anaplastic ependymoma|adult anaplastic ependymoma
759505|NCT00008086|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
759506|NCT00008086|adult mixed glioma|adult mixed glioma
759507|NCT00008086|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
759508|NCT00008086|adult pilocytic astrocytoma|adult pilocytic astrocytoma
759509|NCT00008086|adult subependymoma|adult subependymoma
759510|NCT00008086|adult ependymoblastoma|adult ependymoblastoma
759511|NCT00008086|adult pineocytoma|adult pineocytoma
759512|NCT00008086|adult pineoblastoma|adult pineoblastoma
759513|NCT00008086|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
759514|NCT00008086|adult choroid plexus tumor|adult choroid plexus tumor
759515|NCT00008086|adult grade III meningioma|adult grade iii meningioma
759516|NCT00008086|adult oligodendroglioma|adult oligodendroglioma
759517|NCT00008086|adult giant cell glioblastoma|adult giant cell glioblastoma
759518|NCT00008086|adult gliosarcoma|adult gliosarcoma
759519|NCT00006346|stage II breast cancer|stage ii breast cancer
759520|NCT00006346|stage IV breast cancer|stage iv breast cancer
759521|NCT00006346|stage IIIA breast cancer|stage iiia breast cancer
759522|NCT00006346|stage IIIB breast cancer|stage iiib breast cancer
759523|NCT00006346|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
759524|NCT00006265|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
759525|NCT00006254|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
759526|NCT00006223|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
759527|NCT00006223|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
759528|NCT00006223|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
759529|NCT00006223|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
759530|NCT00006223|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
759531|NCT00006223|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
759532|NCT00006223|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
759533|NCT00006223|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
759534|NCT00006223|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
759535|NCT00006223|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
759536|NCT00006103|stage III colon cancer|stage iii colon cancer
759537|NCT00006103|stage IV colon cancer|stage iv colon cancer
759538|NCT00006103|stage III rectal cancer|stage iii rectal cancer
759539|NCT00006103|stage IV rectal cancer|stage iv rectal cancer
759540|NCT00006103|recurrent colon cancer|recurrent colon cancer
759541|NCT00006103|recurrent rectal cancer|recurrent rectal cancer
759542|NCT00006103|adenocarcinoma of the colon|adenocarcinoma of the colon
759543|NCT00006103|adenocarcinoma of the rectum|adenocarcinoma of the rectum
759544|NCT00006096|stage I vulvar cancer|stage i vulvar cancer
759545|NCT00006096|stage II vulvar cancer|stage ii vulvar cancer
759546|NCT00006096|stage III vulvar cancer|stage iii vulvar cancer
759547|NCT00006096|stage IVB vulvar cancer|stage ivb vulvar cancer
759548|NCT00006096|squamous cell carcinoma of the vulva|squamous cell carcinoma of the vulva
759549|NCT00067847|obesity|obesity
759550|NCT00067847|food policy|food policy
759551|NCT00067847|physical fitness (Respiratory Burst)|physical fitness (respiratory burst)
759552|NCT00067847|academic achievement|academic achievement
759553|NCT00067834|Electromagnetic Fields|electromagnetic fields
759554|NCT00067834|Bone|bone
759555|NCT00067834|Forelimb|forelimb
759556|NCT00067834|Radius|radius
759557|NCT00006019|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
759558|NCT00006019|refractory multiple myeloma|refractory multiple myeloma
759559|NCT00006019|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
759560|NCT00006019|recurrent prostate cancer|recurrent prostate cancer
759561|NCT00006019|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
759562|NCT00006019|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
759563|NCT00006019|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
759564|NCT00006019|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
759565|NCT00006019|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
759566|NCT00006019|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
759567|NCT00006019|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
759568|NCT00006019|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
759569|NCT00006019|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
759570|NCT00006019|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
759571|NCT00006019|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
759572|NCT00006019|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
759573|NCT00006019|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
759574|NCT00006019|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
759575|NCT00006019|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
759576|NCT00006019|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
759577|NCT00006019|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
759578|NCT00006019|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
759579|NCT00006019|splenic marginal zone lymphoma|splenic marginal zone lymphoma
759580|NCT00006002|stage IV prostate cancer|stage iv prostate cancer
759581|NCT00006002|recurrent prostate cancer|recurrent prostate cancer
759582|NCT00005887|tumors metastatic to brain|tumors metastatic to brain
759583|NCT00005886|stage I breast cancer|stage i breast cancer
759584|NCT00005886|stage II breast cancer|stage ii breast cancer
759585|NCT00005886|ductal breast carcinoma in situ|ductal breast carcinoma in situ
759586|NCT00005886|breast cancer in situ|breast cancer in situ
759587|NCT00005857|stage IV prostate cancer|stage iv prostate cancer
759588|NCT00005857|recurrent prostate cancer|recurrent prostate cancer
759589|NCT00067821|Brain Tumor|brain tumor
759590|NCT00067821|Children|children
759591|NCT00067821|Metabolic|metabolic
759592|NCT00067821|Spectroscopy|spectroscopy
759593|NCT00067821|PET|pet
759594|NCT00067808|Myelodysplastic Syndrome|myelodysplastic syndrome
759595|NCT00067808|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
759596|NCT00067808|MDS|mds
759597|NCT00067808|Decitabine|decitabine
759598|NCT00067808|Dacogen|dacogen
759599|NCT00067808|Methylation|methylation
759600|NCT00067795|Treatment Experienced|treatment experienced
759601|NCT00067795|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
759602|NCT00067795|HIV Antigens|hiv antigens
759603|NCT00067795|Cohort Studies|cohort studies
759604|NCT00067795|Immunity, Cellular|immunity, cellular
759605|NCT00067795|T-Lymphocytes|t-lymphocytes
759606|NCT00067782|HIV|hiv
759607|NCT00067782|Treatment Experienced|treatment experienced
759608|NCT00067769|Encopresis|encopresis
759609|NCT00067769|Internet|internet
759610|NCT00067769|Web|web
759611|NCT00067769|Treatment|treatment
759612|NCT00067769|Intervention|intervention
759613|NCT00005804|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
759614|NCT00005804|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
759615|NCT00005804|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
759616|NCT00005804|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
759617|NCT00005804|Burkitt lymphoma|burkitt lymphoma
759618|NCT00005804|isolated plasmacytoma of bone|isolated plasmacytoma of bone
759619|NCT00005804|extramedullary plasmacytoma|extramedullary plasmacytoma
759620|NCT00005804|refractory multiple myeloma|refractory multiple myeloma
759621|NCT00005804|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
759622|NCT00005804|stage III multiple myeloma|stage iii multiple myeloma
759623|NCT00005804|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
759624|NCT00005804|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
759625|NCT00005804|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
759626|NCT00005804|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
759627|NCT00005804|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
759628|NCT00005804|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
759629|NCT00005804|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
759630|NCT00005804|small intestine lymphoma|small intestine lymphoma
759631|NCT00005804|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
759632|NCT00005804|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
759633|NCT00005804|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
759634|NCT00005804|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
759635|NCT00005804|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
759636|NCT00005804|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
759637|NCT00005804|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
759638|NCT00005804|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
759639|NCT00005804|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
759640|NCT00005804|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
759641|NCT00005804|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
759642|NCT00005804|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
759643|NCT00005804|polycythemia vera|polycythemia vera
759644|NCT00005804|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
759645|NCT00005804|essential thrombocythemia|essential thrombocythemia
759646|NCT00005804|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
759647|NCT00005804|refractory hairy cell leukemia|refractory hairy cell leukemia
759648|NCT00005804|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
759649|NCT00005804|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
759650|NCT00005804|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
759651|NCT00005804|acute undifferentiated leukemia|acute undifferentiated leukemia
759652|NCT00005804|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
759653|NCT00005804|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
759654|NCT00005804|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
759655|NCT00005804|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
759656|NCT00005804|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
759657|NCT00005804|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
759658|NCT00005804|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
759659|NCT00005804|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
759660|NCT00005804|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
759661|NCT00005804|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
759662|NCT00005804|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
759663|NCT00005804|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
759664|NCT00005804|secondary acute myeloid leukemia|secondary acute myeloid leukemia
759665|NCT00005804|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
759666|NCT00005804|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
759667|NCT00005804|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
759668|NCT00005804|prolymphocytic leukemia|prolymphocytic leukemia
759669|NCT00005804|primary systemic amyloidosis|primary systemic amyloidosis
759670|NCT00005804|intraocular lymphoma|intraocular lymphoma
759671|NCT00005804|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
759672|NCT00005804|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
759673|NCT00005804|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
759796|NCT00067392|Bone healing|bone healing
759674|NCT00005804|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
759675|NCT00005804|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
759676|NCT00005804|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
759677|NCT00005804|anaplastic large cell lymphoma|anaplastic large cell lymphoma
759678|NCT00005804|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
759679|NCT00005804|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
759680|NCT00005804|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
759681|NCT00005804|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
759682|NCT00005804|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
759683|NCT00005804|splenic marginal zone lymphoma|splenic marginal zone lymphoma
759684|NCT00005804|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
759685|NCT00005090|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
759686|NCT00005090|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
781931|NCT00040105|NSC-716051|nsc-716051
759687|NCT00067756|Pulmonary Disease|pulmonary disease
759688|NCT00067756|Liver Disease|liver disease
759689|NCT00067743|Pain|pain
759690|NCT00067743|Pain syndrome|pain syndrome
759691|NCT00067743|Reflex sympathetic dystrophy|reflex sympathetic dystrophy
759692|NCT00067743|CC-5013|cc-5013
759693|NCT00067743|CC5013|cc5013
759694|NCT00067743|Revlimid|revlimid
759695|NCT00067743|Celgene|celgene
759696|NCT00067743|CRPS|crps
759697|NCT00067717|breast reconstruction surgery|breast reconstruction surgery
759698|NCT00067717|prayer|prayer
759699|NCT00067717|distance healing|distance healing
759700|NCT00067717|wound healing|wound healing
759701|NCT00067704|Complementary Therapies|complementary therapies
759702|NCT00067691|Lung cancer|lung cancer
759703|NCT00067691|Breast cancer|breast cancer
759704|NCT00067691|Shortness of breath|shortness of breath
759705|NCT00067691|Dyspnea|dyspnea
759706|NCT00067691|Metastasis|metastasis
759707|NCT00067691|Breathlessness|breathlessness
759708|NCT00067691|Acupuncture|acupuncture
759709|NCT00067678|diabetic nephropathy|diabetic nephropathy
759710|NCT00067678|nephropathy|nephropathy
759711|NCT00067678|diabetes|diabetes
759712|NCT00067678|diabetes mellitus|diabetes mellitus
759713|NCT00067678|type I diabetes|type i diabetes
759714|NCT00067678|soy protein|soy protein
759715|NCT00067665|hemodialysis|hemodialysis
759716|NCT00067639|Multiple Myeloma|multiple myeloma
759717|NCT00067639|PBSC mobilization|pbsc mobilization
759718|NCT00067639|Pegfilgrastim|pegfilgrastim
759719|NCT00067639|Neulasta|neulasta
759720|NCT00067639|PEG-G-CSF|peg-g-csf
759721|NCT00067626|glucose tolerance test|glucose tolerance test
759722|NCT00067626|minerals|minerals
759723|NCT00067626|chromium|chromium
759724|NCT00067626|complementary and alternative medicine|complementary and alternative medicine
759725|NCT00067613|NICHD Neonatal Research Network|nichd neonatal research network
759726|NCT00067613|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
759727|NCT00067613|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
759728|NCT00067613|Prematurity|prematurity
759729|NCT00067613|Mechanical ventilation|mechanical ventilation
759730|NCT00067613|Benchmarking|benchmarking
759731|NCT00067613|Chronic Lung Disease (CLD)|chronic lung disease (cld)
759732|NCT00067587|Treatment experienced|treatment experienced
759733|NCT00067587|Treatment naive|treatment naive
759734|NCT00067574|Structured treatment interruption|structured treatment interruption
759735|NCT00067574|Treatment experienced|treatment experienced
759736|NCT00067561|Dose-ranging|dose-ranging
759737|NCT00067561|Diarrhea-Predominant Irritable Bowel Syndrome|diarrhea-predominant irritable bowel syndrome
759738|NCT00067561|d-IBS|d-ibs
759739|NCT00067561|IBS|ibs
759740|NCT00067561|Irritable Bowel Syndrome|irritable bowel syndrome
759741|NCT00067548|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
759742|NCT00067535|cocaine dependence|cocaine dependence
759743|NCT00067522|Family Planning|family planning
759744|NCT00067522|Sexually Transmitted Diseases|sexually transmitted diseases
759745|NCT00067522|HIV|hiv
759746|NCT00067522|Africa|africa
759747|NCT00067522|Zambia|zambia
759748|NCT00067522|AIDS|aids
759749|NCT00067522|Contraception|contraception
759750|NCT00067522|HIV Prevention|hiv prevention
759751|NCT00067509|Female|female
759752|NCT00004256|stage I laryngeal cancer|stage i laryngeal cancer
759753|NCT00004256|stage II laryngeal cancer|stage ii laryngeal cancer
759754|NCT00004256|recurrent laryngeal cancer|recurrent laryngeal cancer
759755|NCT00004256|oral complications|oral complications
759756|NCT00004256|radiation toxicity|radiation toxicity
759757|NCT00004233|stage III gastric cancer|stage iii gastric cancer
759758|NCT00004233|stage IV gastric cancer|stage iv gastric cancer
759759|NCT00004233|recurrent gastric cancer|recurrent gastric cancer
759760|NCT00004233|stage III esophageal cancer|stage iii esophageal cancer
759761|NCT00004233|stage IV esophageal cancer|stage iv esophageal cancer
759762|NCT00004233|recurrent esophageal cancer|recurrent esophageal cancer
759763|NCT00004233|adenocarcinoma of the stomach|adenocarcinoma of the stomach
759764|NCT00004233|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
759765|NCT00004125|stage II breast cancer|stage ii breast cancer
759766|NCT00004125|stage IIIA breast cancer|stage iiia breast cancer
759767|NCT00067496|Pain|pain
759768|NCT00067496|Weakness|weakness
759769|NCT00067496|Depression|depression
759770|NCT00067496|Poliomyelitis|poliomyelitis
759771|NCT00067496|Sleep Apnea|sleep apnea
759772|NCT00067496|Post-Polio Syndrome|post-polio syndrome
759773|NCT00067496|PPS|pps
759774|NCT00067483|Cataract|cataract
759775|NCT00067483|Pre-Senile|pre-senile
759776|NCT00067483|Dynamic Light Scattering (DLS)|dynamic light scattering (dls)
759777|NCT00067483|Light Scattering|light scattering
759778|NCT00067483|Lens|lens
759779|NCT00067483|Cataracts|cataracts
759780|NCT00067457|PRN|prn
759781|NCT00067457|Diarrhea-Predominant Irritable Bowel Syndrome|diarrhea-predominant irritable bowel syndrome
759782|NCT00067457|Irritable Bowel Syndrome (IBS)|irritable bowel syndrome (ibs)
759783|NCT00067444|Elderly|elderly
759784|NCT00067444|Major Depressive Disorder|major depressive disorder
759785|NCT00067444|MDD|mdd
759786|NCT00067431|Partial Seizures|partial seizures
759787|NCT00067405|Fibromyalgia|fibromyalgia
759788|NCT00067405|Intravenous micronutrient therapy|intravenous micronutrient therapy
759789|NCT00067405|IVMT|ivmt
759790|NCT00067405|alternative medicine|alternative medicine
759791|NCT00067405|complementary medicine|complementary medicine
759792|NCT00067405|vitamins|vitamins
759793|NCT00067405|vitamin supplements|vitamin supplements
759794|NCT00067392|Partial edentulism|partial edentulism
759797|NCT00004004|recurrent adult brain tumor|recurrent adult brain tumor
759798|NCT00004004|adult glioblastoma|adult glioblastoma
759799|NCT00004004|adult anaplastic astrocytoma|adult anaplastic astrocytoma
759800|NCT00004004|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
759801|NCT00004004|adult giant cell glioblastoma|adult giant cell glioblastoma
759802|NCT00004004|adult gliosarcoma|adult gliosarcoma
759803|NCT00003931|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
759804|NCT00003931|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
759805|NCT00003890|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
759806|NCT00003736|breast cancer|breast cancer
759807|NCT00003464|adult glioblastoma|adult glioblastoma
759808|NCT00003464|adult giant cell glioblastoma|adult giant cell glioblastoma
759809|NCT00003464|adult gliosarcoma|adult gliosarcoma
759810|NCT00067418|Glioma|glioma
759811|NCT00067418|Brain Tumor|brain tumor
759812|NCT00067418|Spectroscopy|spectroscopy
759813|NCT00067353|Early Childhood Caries|early childhood caries
759814|NCT00067327|Relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
759815|NCT00067327|Multiple sclerosis|multiple sclerosis
759816|NCT00067327|Peroxynitrite|peroxynitrite
759817|NCT00067327|Uric acid|uric acid
759818|NCT00067327|Inosine|inosine
759819|NCT00067301|depression|depression
759820|NCT00067301|citalopram|citalopram
759821|NCT00067301|Celexa|celexa
759822|NCT00067301|Polyunsaturated Fatty Acids|polyunsaturated fatty acids
759823|NCT00067301|omega-3|omega-3
759824|NCT00067301|EPA|epa
759825|NCT00067301|antidepressants|antidepressants
759826|NCT00067288|Stage 3 cancer;|stage 3 cancer;
759827|NCT00067288|Stage 4 cancer;|stage 4 cancer;
759828|NCT00067288|solid tumor cancer;|solid tumor cancer;
759829|NCT00067288|Non-Hodgkin's Lymphoma;|non-hodgkin's lymphoma;
759830|NCT00067288|solid tumors;|solid tumors;
759831|NCT00067288|end-stage cancer;|end-stage cancer;
759832|NCT00067288|group psychotherapy;|group psychotherapy;
759833|NCT00067288|psychotherapy;|psychotherapy;
759834|NCT00067288|emotional support;|emotional support;
759835|NCT00067288|support groups|support groups
759836|NCT00067262|Bipolar Disorder Type 1 (manic or mixed type)|bipolar disorder type 1 (manic or mixed type)
759837|NCT00067249|Race|race
759838|NCT00067249|Ethnicity|ethnicity
759839|NCT00067249|Complementary and Alternative Medicine|complementary and alternative medicine
759840|NCT00067249|Women's health|women's health
759841|NCT00067249|Social determinants of Health|social determinants of health
759842|NCT00067275|Stroke|stroke
759843|NCT00067275|Motor Training|motor training
759844|NCT00067275|Positron Emission Tomograhy|positron emission tomograhy
759845|NCT00067275|Plasticity|plasticity
759846|NCT00067275|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
759847|NCT00067275|Healthy Volunteer|healthy volunteer
759848|NCT00067275|HV|hv
759849|NCT00067223|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
759850|NCT00067223|Unilateral Finger Movement|unilateral finger movement
759851|NCT00067223|Interhemispheric Inhibition|interhemispheric inhibition
759852|NCT00067223|Motor Training|motor training
759853|NCT00067223|Plasticity|plasticity
759854|NCT00067223|Healthy Volunteer|healthy volunteer
759855|NCT00067223|HV|hv
759856|NCT00067210|Brain|brain
759857|NCT00067210|Epilepsy|epilepsy
759858|NCT00067210|Core|core
759859|NCT00067210|Temperature|temperature
759860|NCT00067197|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
759861|NCT00067197|Cortical Reorganization|cortical reorganization
759862|NCT00067197|Rehabilitation|rehabilitation
759863|NCT00067197|Motor Learning|motor learning
759864|NCT00067197|Activity of Daily Living (ADL)|activity of daily living (adl)
759865|NCT00067197|Stroke|stroke
759866|NCT00067197|Healthy Volunteer|healthy volunteer
759867|NCT00067197|HV|hv
759868|NCT00067184|methadone|methadone
759869|NCT00067184|fetus|fetus
759870|NCT00067171|behavioral intervention|behavioral intervention
759871|NCT00067158|nicotine dependence|nicotine dependence
759872|NCT00067119|Graft Failure|graft failure
759873|NCT00067119|Access Blood Flow Monitoring|access blood flow monitoring
759874|NCT00067119|Clinical Trial Vascular Access|clinical trial vascular access
759875|NCT00067119|Fistula Failure|fistula failure
759876|NCT00067119|Hemodialysis|hemodialysis
759877|NCT00067119|Vascular Access|vascular access
759878|NCT00067106|HIV|hiv
759879|NCT00067106|Women|women
759880|NCT00067106|Genital tract|genital tract
759881|NCT00067106|Treatment experienced|treatment experienced
759882|NCT00067106|Drug resistance|drug resistance
759883|NCT00067080|Sickle cell disease|sickle cell disease
759884|NCT00067080|iron overload|iron overload
759885|NCT00067080|deferoxamine|deferoxamine
759886|NCT00067080|hemosiderosis|hemosiderosis
759887|NCT00067041|Critical Limb Ischemia|critical limb ischemia
759888|NCT00067041|Autogenous Bypass Graft|autogenous bypass graft
759889|NCT00067041|CLI|cli
759890|NCT00067028|Chronic Myeloid Leukemia|chronic myeloid leukemia
759891|NCT00067028|CML Myeloid Blast Phase|cml myeloid blast phase
759892|NCT00067028|Acute Myeloid Leukemia|acute myeloid leukemia
759893|NCT00067028|Myelodysplastic Syndrome|myelodysplastic syndrome
759894|NCT00067028|Clofarabine|clofarabine
759895|NCT00067028|Clofarex|clofarex
759896|NCT00067028|Clolar|clolar
759897|NCT00067028|Ara-C|ara-c
759898|NCT00067028|Cytarabine|cytarabine
759899|NCT00067028|Cytosar|cytosar
759900|NCT00067028|DepoCyt|depocyt
759901|NCT00067028|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
759902|NCT00067028|Idarubicin|idarubicin
759903|NCT00067028|Idamycin|idamycin
759904|NCT00003433|stage IV colon cancer|stage iv colon cancer
759905|NCT00003433|liver metastases|liver metastases
759906|NCT00003323|adenocarcinoma of the prostate|adenocarcinoma of the prostate
759907|NCT00003323|recurrent prostate cancer|recurrent prostate cancer
759908|NCT00003323|sexual dysfunction and infertility|sexual dysfunction and infertility
759909|NCT00003114|AIDS-related lymphoma|aids-related lymphoma
759910|NCT00003114|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
759911|NCT00003006|stage I non-small cell lung cancer|stage i non-small cell lung cancer
759912|NCT00067067|Glioma|glioma
759913|NCT00067067|Brain Tumor|brain tumor
759914|NCT00067067|Endothelial Progenitor Cells|endothelial progenitor cells
759915|NCT00067054|Volunteer|volunteer
759916|NCT00067054|Plasmapheresis|plasmapheresis
759917|NCT00067054|Leukapheresis|leukapheresis
759918|NCT00067054|Immunology|immunology
759919|NCT00067054|Leukocyte|leukocyte
759920|NCT00067054|Healthy Volunteer|healthy volunteer
759921|NCT00067054|HV|hv
759922|NCT00067015|adenocarcinoma of the prostate|adenocarcinoma of the prostate
759923|NCT00067015|stage III prostate cancer|stage iii prostate cancer
759924|NCT00067002|ALL|all
759925|NCT00067002|Leukemia, Lymphocytic, Acute|leukemia, lymphocytic, acute
759926|NCT00067002|AML|aml
759927|NCT00067002|Leukemia, Myelocytic, Acute|leukemia, myelocytic, acute
759928|NCT00067002|CML|cml
759929|NCT00067002|Leukemia, Myeloid, Chronic|leukemia, myeloid, chronic
759930|NCT00067002|NHL|nhl
759931|NCT00067002|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
759932|NCT00067002|double cord blood transplant|double cord blood transplant
759933|NCT00067002|expanded cord blood transplant|expanded cord blood transplant
759934|NCT00067002|Rituxan|rituxan
759935|NCT00067002|Rituximab|rituximab
759936|NCT00067002|Melphalan|melphalan
759937|NCT00067002|Alkeran|alkeran
759938|NCT00067002|Thiotepa|thiotepa
759939|NCT00067002|Fludarabine|fludarabine
759940|NCT00067002|Fludarabine phosphate|fludarabine phosphate
759941|NCT00067002|Fludara|fludara
759942|NCT00067002|Cyclophosphamide|cyclophosphamide
759943|NCT00067002|Cytoxan|cytoxan
759944|NCT00067002|Neosar|neosar
759945|NCT00067002|Mesna|mesna
759946|NCT00067002|Mesnex|mesnex
759947|NCT00066989|Staphylococcal infection|staphylococcal infection
759948|NCT00066989|Gram positive bacteria|gram positive bacteria
759949|NCT00066989|Staphylococcus|staphylococcus
759950|NCT00066989|Staphylococcus aureus|staphylococcus aureus
759951|NCT00046878|adult glioblastoma|adult glioblastoma
759952|NCT00046878|adult giant cell glioblastoma|adult giant cell glioblastoma
759953|NCT00046878|adult gliosarcoma|adult gliosarcoma
759954|NCT00002621|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
759955|NCT00002621|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
759956|NCT00002621|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
759957|NCT00002621|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
759958|NCT00002621|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
759959|NCT00002621|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
759960|NCT00002621|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
759961|NCT00002621|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
759962|NCT00002621|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
759963|NCT00002621|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
759964|NCT00002621|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
759965|NCT00002621|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
759966|NCT00002621|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
759967|NCT00002621|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
759968|NCT00002621|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
759969|NCT00002621|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
759970|NCT00002621|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
759971|NCT00002621|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
760175|NCT00066807|stage I breast cancer|stage i breast cancer
759972|NCT00002621|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
759973|NCT00002621|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
759974|NCT00002621|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
759975|NCT00002621|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
759976|NCT00002621|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
759977|NCT00002621|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
759978|NCT00002548|stage I multiple myeloma|stage i multiple myeloma
759979|NCT00002548|stage II multiple myeloma|stage ii multiple myeloma
759980|NCT00002548|stage III multiple myeloma|stage iii multiple myeloma
759981|NCT00002520|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
759982|NCT00002520|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
759983|NCT00002520|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
759984|NCT00002520|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
759985|NCT00002520|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
759986|NCT00002520|stage I colon cancer|stage i colon cancer
759987|NCT00002520|stage II colon cancer|stage ii colon cancer
759988|NCT00002520|stage I breast cancer|stage i breast cancer
759989|NCT00002520|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
759990|NCT00002520|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
759991|NCT00002520|anaplastic large cell lymphoma|anaplastic large cell lymphoma
759992|NCT00002520|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
759993|NCT00002520|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
759994|NCT00002520|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
759995|NCT00002520|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
759996|NCT00002520|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
759997|NCT00002520|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
759998|NCT00002520|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
759999|NCT00002520|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
760000|NCT00002520|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
760001|NCT00002520|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
760002|NCT00002520|intraocular lymphoma|intraocular lymphoma
760003|NCT00002520|limited stage small cell lung cancer|limited stage small cell lung cancer
760004|NCT00002520|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
760005|NCT00002520|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
760006|NCT00002520|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
760007|NCT00002520|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
760008|NCT00002520|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
760009|NCT00002520|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
760010|NCT00002520|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
760011|NCT00002520|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
760012|NCT00002520|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
760013|NCT00002520|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
760014|NCT00002520|primary central nervous system lymphoma|primary central nervous system lymphoma
760015|NCT00002520|tobacco use disorder|tobacco use disorder
760016|NCT00002520|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
760017|NCT00002520|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
760018|NCT00002520|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
760019|NCT00002520|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
760408|NCT00066378|stage IV breast cancer|stage iv breast cancer
760020|NCT00002520|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
760021|NCT00002520|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
760022|NCT00002520|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
760023|NCT00002520|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
760024|NCT00002520|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
760025|NCT00002520|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
760026|NCT00002520|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
760027|NCT00002520|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
760028|NCT00002520|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
760029|NCT00002520|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
760030|NCT00002520|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
760031|NCT00002520|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
760032|NCT00002520|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
760033|NCT00002520|stage I mantle cell lymphoma|stage i mantle cell lymphoma
760034|NCT00002520|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
760035|NCT00002520|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
760036|NCT00002520|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
760037|NCT00002520|stage I non-small cell lung cancer|stage i non-small cell lung cancer
760038|NCT00002520|stage I prostate cancer|stage i prostate cancer
760039|NCT00002520|stage I rectal cancer|stage i rectal cancer
760040|NCT00002520|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
760041|NCT00002520|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
760042|NCT00002520|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
760043|NCT00002520|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
760044|NCT00002520|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
760045|NCT00002520|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
760046|NCT00002520|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
760047|NCT00002520|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
760048|NCT00002520|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
760049|NCT00002520|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
760050|NCT00002520|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
760051|NCT00002520|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
760052|NCT00002520|stage II bladder cancer|stage ii bladder cancer
760053|NCT00002520|stage II breast cancer|stage ii breast cancer
760054|NCT00002520|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
760055|NCT00002520|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
760056|NCT00002520|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
760057|NCT00002520|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
760058|NCT00002520|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
760059|NCT00002520|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
760060|NCT00002520|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
760061|NCT00002520|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
760062|NCT00002520|stage I bladder cancer|stage i bladder cancer
760063|NCT00002520|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
760064|NCT00002520|stage II prostate cancer|stage ii prostate cancer
760065|NCT00002520|stage II rectal cancer|stage ii rectal cancer
760066|NCT00002520|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
760067|NCT00002520|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
760068|NCT00002520|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
760069|NCT00002520|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
760070|NCT00002520|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
760071|NCT00002520|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
760072|NCT00002520|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
760073|NCT00002520|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
760074|NCT00002520|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
760075|NCT00002520|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
760076|NCT00002520|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
760077|NCT00002520|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
760078|NCT00002520|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
760079|NCT00002520|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
760080|NCT00002520|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
760081|NCT00002520|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
760082|NCT00002520|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
760083|NCT00002520|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
760084|NCT00002520|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
760085|NCT00002520|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
760086|NCT00002520|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
760087|NCT00002520|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
760088|NCT00002520|stage III prostate cancer|stage iii prostate cancer
760089|NCT00002520|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
760090|NCT00002520|stage IIIA breast cancer|stage iiia breast cancer
760091|NCT00002520|stage IIIB breast cancer|stage iiib breast cancer
760092|NCT00002520|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
760093|NCT00002520|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
760094|NCT00002520|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
760095|NCT00002520|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
760096|NCT00002520|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
760097|NCT00002520|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
760098|NCT00002520|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
760099|NCT00002520|stage IV breast cancer|stage iv breast cancer
760100|NCT00002520|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
760101|NCT00002520|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
760102|NCT00002520|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
760103|NCT00002520|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
760104|NCT00002520|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
760105|NCT00002520|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
760106|NCT00002520|stage IV prostate cancer|stage iv prostate cancer
760107|NCT00002520|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
760108|NCT00002520|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
760409|NCT00066365|metastatic osteosarcoma|metastatic osteosarcoma
760109|NCT00002520|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
760110|NCT00002520|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
760111|NCT00002520|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
760112|NCT00002520|stage I marginal zone lymphoma|stage i marginal zone lymphoma
760113|NCT00002520|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
760114|NCT00002520|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
760115|NCT00002520|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
760116|NCT00002520|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
760117|NCT00002520|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
760118|NCT00002520|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
760119|NCT00002520|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
760120|NCT00002520|splenic marginal zone lymphoma|splenic marginal zone lymphoma
760121|NCT00066976|Prenatal|prenatal
760122|NCT00066976|Respiration|respiration
760123|NCT00066976|Ultrasound|ultrasound
760124|NCT00066976|Prematurity|prematurity
760125|NCT00066976|Diagnoses|diagnoses
760126|NCT00066976|Fetal Breathing-Movement|fetal breathing-movement
760127|NCT00066976|Doppler Sonography|doppler sonography
760128|NCT00066976|Amniotic Fluid|amniotic fluid
760129|NCT00066976|Oligohydraminos|oligohydraminos
760130|NCT00066976|Polyhydraminos|polyhydraminos
760131|NCT00066976|Pregnancy|pregnancy
760132|NCT00066963|Early Childhood Caries|early childhood caries
760133|NCT00066950|Early childhood caries|early childhood caries
760134|NCT00066924|spirituality|spirituality
760135|NCT00066924|religiosity|religiosity
760136|NCT00066924|immune functioning|immune functioning
760137|NCT00066924|psychoneuroimmunology|psychoneuroimmunology
760138|NCT00066924|cytokines|cytokines
760139|NCT00066924|cancer|cancer
760140|NCT00066924|death|death
760141|NCT00066924|depression|depression
760142|NCT00066898|succinobucol|succinobucol
760143|NCT00066898|AGI-1067|agi-1067
760144|NCT00066898|coronary artery disease|coronary artery disease
760145|NCT00066885|DN101|dn101
760146|NCT00066885|Calcitriol|calcitriol
760147|NCT00066885|Lung Cancer|lung cancer
760148|NCT00066885|NSCLC|nsclc
760149|NCT00066885|Taxotere|taxotere
760150|NCT00011973|stage III renal cell cancer|stage iii renal cell cancer
760151|NCT00011973|stage IV renal cell cancer|stage iv renal cell cancer
760152|NCT00011973|recurrent renal cell cancer|recurrent renal cell cancer
760153|NCT00005027|stage III renal cell cancer|stage iii renal cell cancer
760154|NCT00005027|stage IV renal cell cancer|stage iv renal cell cancer
760155|NCT00005027|recurrent renal cell cancer|recurrent renal cell cancer
760156|NCT00066911|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
760157|NCT00066911|Vocalization|vocalization
760158|NCT00066911|Spasmodic Dysphonia|spasmodic dysphonia
760159|NCT00066911|Muscular Tension Dysphonia|muscular tension dysphonia
760160|NCT00066911|Topical Lidocaine|topical lidocaine
760161|NCT00066911|Voice Disorders|voice disorders
760162|NCT00066911|Vocal Tremor|vocal tremor
760163|NCT00066911|Healthy Volunteer|healthy volunteer
760164|NCT00066911|HV|hv
760165|NCT00066872|basal cell carcinoma of the skin|basal cell carcinoma of the skin
760166|NCT00066859|depression|depression
760167|NCT00066859|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
760168|NCT00066846|adenocarcinoma of the colon|adenocarcinoma of the colon
760169|NCT00066846|adenocarcinoma of the rectum|adenocarcinoma of the rectum
760170|NCT00066846|stage IV rectal cancer|stage iv rectal cancer
760171|NCT00066846|recurrent rectal cancer|recurrent rectal cancer
760172|NCT00066846|stage IV colon cancer|stage iv colon cancer
760173|NCT00066846|recurrent colon cancer|recurrent colon cancer
760174|NCT00066807|stage IIIA breast cancer|stage iiia breast cancer
760176|NCT00066807|stage II breast cancer|stage ii breast cancer
760177|NCT00066794|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
760178|NCT00066794|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
760179|NCT00066794|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
760180|NCT00066794|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
760181|NCT00066794|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
760182|NCT00066794|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
760183|NCT00066794|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
760184|NCT00066794|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
760185|NCT00066794|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
760186|NCT00066794|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
760187|NCT00066794|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
760188|NCT00066794|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
760189|NCT00066794|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
760190|NCT00066794|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
760191|NCT00066781|adenocarcinoma of unknown primary|adenocarcinoma of unknown primary
760192|NCT00066781|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
760193|NCT00066781|squamous cell carcinoma of unknown primary|squamous cell carcinoma of unknown primary
760194|NCT00066781|undifferentiated carcinoma of unknown primary|undifferentiated carcinoma of unknown primary
760195|NCT00066729|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
760196|NCT00066729|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
760197|NCT00066729|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
760198|NCT00066729|primary peritoneal cavity cancer|primary peritoneal cavity cancer
760199|NCT00066729|fallopian tube cancer|fallopian tube cancer
760200|NCT00066716|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
760201|NCT00066716|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
760202|NCT00066716|stage I esophageal cancer|stage i esophageal cancer
760203|NCT00066716|stage II esophageal cancer|stage ii esophageal cancer
760204|NCT00066716|stage III esophageal cancer|stage iii esophageal cancer
760205|NCT00066716|stage IV esophageal cancer (lymph node metastasis only)|stage iv esophageal cancer (lymph node metastasis only)
760206|NCT00066703|stage II breast cancer|stage ii breast cancer
760207|NCT00066703|stage IIIA breast cancer|stage iiia breast cancer
760208|NCT00066703|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
760209|NCT00066703|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
760210|NCT00066703|stage IA breast cancer|stage ia breast cancer
760211|NCT00066703|stage IB breast cancer|stage ib breast cancer
760212|NCT00066690|tamoxifen|tamoxifen
760213|NCT00066690|ovarian function suppression + tamoxifen|ovarian function suppression + tamoxifen
760214|NCT00066690|ovarian function suppression + exemestane|ovarian function suppression + exemestane
760215|NCT00066677|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
760216|NCT00066677|recurrent pancreatic cancer|recurrent pancreatic cancer
760217|NCT00066677|stage IV pancreatic cancer|stage iv pancreatic cancer
760218|NCT00066664|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
760219|NCT00066664|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
760220|NCT00066664|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
760221|NCT00066664|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
760222|NCT00066664|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
760223|NCT00066664|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
760224|NCT00066664|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
760225|NCT00066664|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
760226|NCT00066664|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
760227|NCT00066664|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
760228|NCT00066651|ovarian carcinosarcoma|ovarian carcinosarcoma
760229|NCT00066651|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
760230|NCT00066651|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
760231|NCT00066651|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
760232|NCT00066651|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
760233|NCT00066651|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
760234|NCT00066651|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
760235|NCT00066651|Brenner tumor|brenner tumor
760236|NCT00066651|primary peritoneal cavity cancer|primary peritoneal cavity cancer
760237|NCT00066651|fallopian tube cancer|fallopian tube cancer
760238|NCT00066651|epithelial mesothelioma|epithelial mesothelioma
760239|NCT00066651|recurrent malignant mesothelioma|recurrent malignant mesothelioma
760240|NCT00066651|recurrent pancreatic cancer|recurrent pancreatic cancer
760241|NCT00066651|cervical squamous cell carcinoma|cervical squamous cell carcinoma
760242|NCT00066651|recurrent cervical cancer|recurrent cervical cancer
781932|NCT00040092|Virulizin|virulizin
760243|NCT00066651|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
760244|NCT00066651|squamous cell lung cancer|squamous cell lung cancer
760245|NCT00066651|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
760246|NCT00066651|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
760247|NCT00066651|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
760248|NCT00066651|recurrent salivary gland cancer|recurrent salivary gland cancer
760249|NCT00066651|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
760250|NCT00066651|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
760251|NCT00066651|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
760252|NCT00066651|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
760253|NCT00066651|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
760254|NCT00066612|recurrent bladder cancer|recurrent bladder cancer
760255|NCT00066612|stage IV bladder cancer|stage iv bladder cancer
760256|NCT00066612|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
760257|NCT00066612|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
760258|NCT00066612|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
760259|NCT00066612|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
760260|NCT00066612|anterior urethral cancer|anterior urethral cancer
760261|NCT00066612|posterior urethral cancer|posterior urethral cancer
760262|NCT00066612|recurrent urethral cancer|recurrent urethral cancer
760263|NCT00066612|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
760264|NCT00066599|neutropenia|neutropenia
760265|NCT00066599|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
760266|NCT00066599|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
760267|NCT00066599|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
760268|NCT00066599|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
760269|NCT00066599|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
760270|NCT00066599|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
760271|NCT00066599|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
760272|NCT00066599|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
760273|NCT00066599|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
760274|NCT00066599|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
760275|NCT00066599|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
760276|NCT00066599|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
760277|NCT00066599|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
760278|NCT00066599|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
760279|NCT00066599|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
760280|NCT00066599|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
760281|NCT00066599|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
760282|NCT00066599|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
760283|NCT00066599|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
760284|NCT00066599|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
760285|NCT00066599|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
760286|NCT00066599|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
760287|NCT00066599|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
760288|NCT00066599|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
760289|NCT00066599|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
760290|NCT00066599|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
760291|NCT00066599|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
760292|NCT00066599|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
760293|NCT00066599|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
760294|NCT00066599|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
760295|NCT00066599|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
760296|NCT00066599|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
760297|NCT00066599|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
760298|NCT00066599|anaplastic large cell lymphoma|anaplastic large cell lymphoma
760299|NCT00066599|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
760300|NCT00066599|intraocular lymphoma|intraocular lymphoma
760301|NCT00066599|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
760302|NCT00066599|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
760303|NCT00066599|acute undifferentiated leukemia|acute undifferentiated leukemia
760304|NCT00066599|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
760305|NCT00066599|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
760306|NCT00066599|secondary acute myeloid leukemia|secondary acute myeloid leukemia
760307|NCT00066599|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
760308|NCT00066599|disseminated neuroblastoma|disseminated neuroblastoma
760309|NCT00066599|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
760310|NCT00066599|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
760311|NCT00066599|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
760312|NCT00066599|stage I multiple myeloma|stage i multiple myeloma
760313|NCT00066599|stage II multiple myeloma|stage ii multiple myeloma
760314|NCT00066599|stage III multiple myeloma|stage iii multiple myeloma
760315|NCT00066599|refractory multiple myeloma|refractory multiple myeloma
760316|NCT00066599|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
760317|NCT00066599|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
760318|NCT00066599|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
760319|NCT00066599|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
760320|NCT00066599|recurrent neuroblastoma|recurrent neuroblastoma
760321|NCT00066599|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
760322|NCT00066599|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
760323|NCT00066586|breast cancer|breast cancer
760324|NCT00066573|stage IIIA breast cancer|stage iiia breast cancer
760325|NCT00066573|stage I breast cancer|stage i breast cancer
760326|NCT00066573|stage II breast cancer|stage ii breast cancer
760327|NCT00066547|recurrent breast cancer|recurrent breast cancer
760328|NCT00066547|stage IIIA breast cancer|stage iiia breast cancer
760329|NCT00066547|stage IIIB breast cancer|stage iiib breast cancer
760330|NCT00066547|stage IIIC breast cancer|stage iiic breast cancer
760331|NCT00066547|stage IV breast cancer|stage iv breast cancer
760332|NCT00066508|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
760333|NCT00066482|childhood teratoma|childhood teratoma
760334|NCT00066482|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
760335|NCT00066469|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
760336|NCT00066443|stage IIIA breast cancer|stage iiia breast cancer
760337|NCT00066443|stage IIIB breast cancer|stage iiib breast cancer
760338|NCT00066443|stage IIIC breast cancer|stage iiic breast cancer
760339|NCT00066443|inflammatory breast cancer|inflammatory breast cancer
760340|NCT00066430|anal cancer|anal cancer
760341|NCT00066430|high-grade squamous intraepithelial lesion|high-grade squamous intraepithelial lesion
760342|NCT00066417|essential thrombocythemia|essential thrombocythemia
760343|NCT00066417|polycythemia vera|polycythemia vera
760344|NCT00066417|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
760345|NCT00066417|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
760346|NCT00066417|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
760347|NCT00066417|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
760348|NCT00066417|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
760349|NCT00066417|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
760350|NCT00066417|secondary acute myeloid leukemia|secondary acute myeloid leukemia
760351|NCT00066417|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
760352|NCT00066417|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
760353|NCT00066417|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
760354|NCT00066417|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
760355|NCT00066417|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
760356|NCT00066417|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
760357|NCT00066417|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
760358|NCT00066417|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
760359|NCT00066417|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
760360|NCT00066417|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
760361|NCT00066417|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
760362|NCT00066417|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
760363|NCT00066417|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
760364|NCT00066417|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
760365|NCT00066417|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
760366|NCT00066404|advanced malignant mesothelioma|advanced malignant mesothelioma
760367|NCT00066404|male breast cancer|male breast cancer
760368|NCT00066404|localized malignant mesothelioma|localized malignant mesothelioma
760369|NCT00066404|recurrent bladder cancer|recurrent bladder cancer
760370|NCT00066404|recurrent renal cell cancer|recurrent renal cell cancer
760371|NCT00066404|recurrent urethral cancer|recurrent urethral cancer
782040|NCT00038974|Viral load|viral load
760372|NCT00066404|recurrent breast cancer|recurrent breast cancer
760373|NCT00066404|recurrent penile cancer|recurrent penile cancer
760374|NCT00066404|recurrent prostate cancer|recurrent prostate cancer
760375|NCT00066404|recurrent anal cancer|recurrent anal cancer
760376|NCT00066404|recurrent colon cancer|recurrent colon cancer
760377|NCT00066404|recurrent esophageal cancer|recurrent esophageal cancer
760378|NCT00066404|recurrent gastric cancer|recurrent gastric cancer
760379|NCT00066404|recurrent pancreatic cancer|recurrent pancreatic cancer
760380|NCT00066404|recurrent rectal cancer|recurrent rectal cancer
760381|NCT00066404|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
760382|NCT00066404|recurrent small intestine cancer|recurrent small intestine cancer
760383|NCT00066404|recurrent gallbladder cancer|recurrent gallbladder cancer
760384|NCT00066404|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
760385|NCT00066404|recurrent adult primary liver cancer|recurrent adult primary liver cancer
760386|NCT00066404|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
760387|NCT00066404|recurrent small cell lung cancer|recurrent small cell lung cancer
760388|NCT00066404|recurrent thymoma and thymic carcinoma|recurrent thymoma and thymic carcinoma
760389|NCT00066404|recurrent melanoma|recurrent melanoma
760390|NCT00066404|recurrent malignant mesothelioma|recurrent malignant mesothelioma
760391|NCT00066404|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
760392|NCT00066404|recurrent cervical cancer|recurrent cervical cancer
760393|NCT00066404|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
760394|NCT00066404|fallopian tube cancer|fallopian tube cancer
760395|NCT00066404|recurrent vulvar cancer|recurrent vulvar cancer
760396|NCT00066404|recurrent vaginal cancer|recurrent vaginal cancer
760397|NCT00066404|recurrent gestational trophoblastic tumor|recurrent gestational trophoblastic tumor
760398|NCT00066404|recurrent endometrial carcinoma|recurrent endometrial carcinoma
760399|NCT00066404|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
760400|NCT00066404|malignant pleural effusion|malignant pleural effusion
760401|NCT00066391|penile squamous cell carcinoma|penile squamous cell carcinoma
760402|NCT00066391|stage III penile cancer|stage iii penile cancer
760403|NCT00066391|stage IV penile cancer|stage iv penile cancer
760404|NCT00066378|recurrent breast cancer|recurrent breast cancer
760405|NCT00066378|stage IIIA breast cancer|stage iiia breast cancer
760406|NCT00066378|stage IIIB breast cancer|stage iiib breast cancer
760407|NCT00066378|stage IIIC breast cancer|stage iiic breast cancer
760410|NCT00066365|recurrent osteosarcoma|recurrent osteosarcoma
760411|NCT00066365|lung metastases|lung metastases
760412|NCT00066352|recurrent bladder cancer|recurrent bladder cancer
760413|NCT00066352|stage IV bladder cancer|stage iv bladder cancer
760414|NCT00066352|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
760415|NCT00066352|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
760416|NCT00066352|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
760417|NCT00066352|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
760418|NCT00066339|stage IV breast cancer|stage iv breast cancer
760419|NCT00066339|recurrent breast cancer|recurrent breast cancer
760420|NCT00066326|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
760421|NCT00066326|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
760422|NCT00066326|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
760423|NCT00066326|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
760424|NCT00066326|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
760425|NCT00066313|extensive stage small cell lung cancer|extensive stage small cell lung cancer
760426|NCT00066313|limited stage small cell lung cancer|limited stage small cell lung cancer
760427|NCT00066274|stage IV colon cancer|stage iv colon cancer
760428|NCT00066274|stage IV rectal cancer|stage iv rectal cancer
760429|NCT00066248|cachexia|cachexia
760430|NCT00066248|unspecified childhood solid tumor|unspecified childhood solid tumor
760431|NCT00066248|childhood spinal cord neoplasm|childhood spinal cord neoplasm
760432|NCT00066248|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
760433|NCT00066248|untreated childhood medulloblastoma|untreated childhood medulloblastoma
760434|NCT00066248|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
760435|NCT00066248|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
760436|NCT00066248|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
760437|NCT00066248|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
760438|NCT00066248|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
760439|NCT00066248|childhood oligodendroglioma|childhood oligodendroglioma
760440|NCT00066248|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
760441|NCT00066248|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
760442|NCT00066248|hypothalamic glioma|hypothalamic glioma
760443|NCT00066248|untreated childhood brain stem glioma|untreated childhood brain stem glioma
760444|NCT00066248|untreated childhood visual pathway|untreated childhood visual pathway
760509|NCT00020462|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
760445|NCT00066248|childhood supratentorial primitive neuroectodermal tumor|childhood supratentorial primitive neuroectodermal tumor
760446|NCT00066248|childhood craniopharyngioma|childhood craniopharyngioma
760447|NCT00066248|childhood infratentorial ependymoma|childhood infratentorial ependymoma
760448|NCT00066248|childhood supratentorial ependymoma|childhood supratentorial ependymoma
760449|NCT00066248|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
760450|NCT00066248|recurrent childhood ependymoma|recurrent childhood ependymoma
760451|NCT00066248|childhood choroid plexus tumor|childhood choroid plexus tumor
760452|NCT00066248|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
760453|NCT00066248|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
760454|NCT00066248|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
760455|NCT00066248|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
760456|NCT00066248|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
760457|NCT00066248|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
760458|NCT00066248|untreated childhood acute myeloid leukemia|untreated childhood acute myeloid leukemia
760459|NCT00066248|other myeloid malignancies|other myeloid malignancies
760460|NCT00066248|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
760461|NCT00066248|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
760462|NCT00066248|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
760463|NCT00066248|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
760464|NCT00066248|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
760465|NCT00066248|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
760466|NCT00066248|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
760467|NCT00066248|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
760468|NCT00066248|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
760469|NCT00066248|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
760470|NCT00066248|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
760471|NCT00066248|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
760472|NCT00066248|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
760473|NCT00066248|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
760474|NCT00066248|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
760475|NCT00066248|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
760476|NCT00066248|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
760477|NCT00066248|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
760478|NCT00066248|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
760479|NCT00066248|refractory hairy cell leukemia|refractory hairy cell leukemia
760480|NCT00066248|untreated hairy cell leukemia|untreated hairy cell leukemia
760481|NCT00066248|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
760482|NCT00066248|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
760483|NCT00066248|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
760484|NCT00066248|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
760485|NCT00066248|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
760486|NCT00066248|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
760487|NCT00066248|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
760488|NCT00066248|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
760489|NCT00066248|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
760490|NCT00066248|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
760491|NCT00066248|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
760492|NCT00066248|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
760493|NCT00066248|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
760494|NCT00066248|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
760495|NCT00066248|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
760496|NCT00066248|recurrent childhood brain tumor|recurrent childhood brain tumor
760497|NCT00066248|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
760498|NCT00066248|myelodysplastic/myeloproliferative disease|myelodysplastic/myeloproliferative disease
760499|NCT00066248|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
760500|NCT00066248|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
760501|NCT00066248|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
760502|NCT00066248|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
760503|NCT00066248|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
760504|NCT00066222|limited stage small cell lung cancer|limited stage small cell lung cancer
760505|NCT00020462|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
760506|NCT00020462|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
760507|NCT00020462|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
760508|NCT00020462|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
760510|NCT00020462|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
760511|NCT00020462|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
760512|NCT00020462|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
760513|NCT00020462|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
760514|NCT00019721|stage IV melanoma|stage iv melanoma
760515|NCT00019721|recurrent melanoma|recurrent melanoma
760516|NCT00019383|recurrent melanoma|recurrent melanoma
760517|NCT00066209|Inflammation|inflammation
760518|NCT00066209|Coronavirus|coronavirus
760519|NCT00066209|Immunity|immunity
760520|NCT00066209|Interferon|interferon
760521|NCT00066209|Cytokine|cytokine
760522|NCT00066209|Severe Acute Respiratory Syndrome|severe acute respiratory syndrome
760523|NCT00066209|SARS|sars
760524|NCT00066209|Healthy Volunteer|healthy volunteer
760525|NCT00066209|HV|hv
760526|NCT00066170|Narcolepsy|narcolepsy
760527|NCT00066170|Daytime Sleepiness|daytime sleepiness
760528|NCT00066170|Daytime sleepiness in narcolepsy|daytime sleepiness in narcolepsy
760529|NCT00033722|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
760530|NCT00033722|squamous cell lung cancer|squamous cell lung cancer
760531|NCT00033722|large cell lung cancer|large cell lung cancer
760532|NCT00033722|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
760533|NCT00033722|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
760534|NCT00033722|adenocarcinoma of the lung|adenocarcinoma of the lung
760535|NCT00033722|adenosquamous cell lung cancer|adenosquamous cell lung cancer
760536|NCT00033306|stage IV colon cancer|stage iv colon cancer
760537|NCT00033306|stage IV rectal cancer|stage iv rectal cancer
760538|NCT00033306|recurrent colon cancer|recurrent colon cancer
760539|NCT00033306|recurrent rectal cancer|recurrent rectal cancer
760540|NCT00033306|adenocarcinoma of the colon|adenocarcinoma of the colon
760541|NCT00033306|adenocarcinoma of the rectum|adenocarcinoma of the rectum
760542|NCT00031811|stage I breast cancer|stage i breast cancer
760543|NCT00031811|stage II breast cancer|stage ii breast cancer
760544|NCT00031811|stage IIIA breast cancer|stage iiia breast cancer
760545|NCT00031811|stage IIIB breast cancer|stage iiib breast cancer
760546|NCT00031811|osteoporosis|osteoporosis
760547|NCT00031811|menopausal symptoms|menopausal symptoms
760548|NCT00031785|stage I non-small cell lung cancer|stage i non-small cell lung cancer
760549|NCT00031785|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
760550|NCT00031785|limited stage small cell lung cancer|limited stage small cell lung cancer
760551|NCT00031785|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
760552|NCT00031785|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
760553|NCT00031785|anorexia|anorexia
760554|NCT00031785|cachexia|cachexia
760555|NCT00066183|Fibroblast Growth Factor 23|fibroblast growth factor 23
760556|NCT00066183|FGF-23|fgf-23
760557|NCT00066183|Hypophosphatemia|hypophosphatemia
760558|NCT00066183|Phosphaturia|phosphaturia
760559|NCT00066183|Phosphorus|phosphorus
760560|NCT00066183|Phosphorus Metabolism|phosphorus metabolism
760561|NCT00066157|Alzheimer disease|alzheimer disease
760562|NCT00066157|Hormone replacement therapy|hormone replacement therapy
760563|NCT00066157|Postmenopausal women|postmenopausal women
760564|NCT00066144|menopause|menopause
760565|NCT00066144|hot flashes|hot flashes
760566|NCT00066144|red clover|red clover
760567|NCT00066144|black cohosh|black cohosh
760568|NCT00066144|sexual dysfunction|sexual dysfunction
760569|NCT00066118|neurologic|neurologic
760570|NCT00066118|nerve conduction|nerve conduction
760571|NCT00066118|neurobehavioral|neurobehavioral
760572|NCT00066118|renal disease|renal disease
760573|NCT00066092|PBPC transplant|pbpc transplant
760574|NCT00066092|Hodgkin's Disease|hodgkin's disease
760575|NCT00066092|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
760576|NCT00066092|NHL|nhl
760577|NCT00066092|mobilization|mobilization
760578|NCT00066079|Sickle Cell Pain|sickle cell pain
760579|NCT00066079|Sickle Cell Disease|sickle cell disease
760580|NCT00066079|Chronic Pain|chronic pain
760581|NCT00066079|Alternative Medicine/Therapy|alternative medicine/therapy
760582|NCT00066079|Complementary Medicine|complementary medicine
760583|NCT00066079|Massage Therapy|massage therapy
760584|NCT00066079|Relaxation Technique|relaxation technique
760585|NCT00066079|Home-based Therapy|home-based therapy
760586|NCT00066053|Heart attacks|heart attacks
760587|NCT00066053|Stroke|stroke
760588|NCT00066053|Angina|angina
760589|NCT00066040|mutans streptococci infections|mutans streptococci infections
760590|NCT00066027|periodontitis, metabolic bone diseases, doxycycline|periodontitis, metabolic bone diseases, doxycycline
760591|NCT00066014|Dental Implantation-Osseointegrated|dental implantation-osseointegrated
760592|NCT00066014|Dentures|dentures
760593|NCT00066014|Dental Prostheses|dental prostheses
760594|NCT00066014|Denture, Implant-Supported|denture, implant-supported
760595|NCT00065975|chronic low back pain|chronic low back pain
760596|NCT00065975|acupuncture|acupuncture
760597|NCT00065975|chiropractic|chiropractic
760598|NCT00065975|massage therapy|massage therapy
760599|NCT00065975|CAM therapies|cam therapies
760600|NCT00065962|Pervasive Developmental Disorders|pervasive developmental disorders
760601|NCT00065962|Secretin, synthetic porcine|secretin, synthetic porcine
760602|NCT00065962|Secretin, biological porcine|secretin, biological porcine
760603|NCT00065962|Autism Diagnostic Observation Schedule - Generic (ADOS-G)|autism diagnostic observation schedule - generic (ados-g)
760604|NCT00065962|Rimland Questionnaire|rimland questionnaire
760605|NCT00065962|Expressive Vocabulary Test|expressive vocabulary test
760606|NCT00065962|MacArthur Communication Inventory|macarthur communication inventory
760607|NCT00065962|Aberrant Behavior Checklist|aberrant behavior checklist
760608|NCT00065949|Low birthweight infants|low birthweight infants
760609|NCT00065949|Magnesium supplementation|magnesium supplementation
760610|NCT00065949|Intracranial hemorrhage|intracranial hemorrhage
760611|NCT00065949|Cystic periventricular leukomalacia|cystic periventricular leukomalacia
760612|NCT00065949|Mental retardation|mental retardation
760613|NCT00065936|Intractable self-injurious behavior|intractable self-injurious behavior
760614|NCT00065936|Naltrexone|naltrexone
760615|NCT00065936|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
760616|NCT00065936|Substance P|substance p
760617|NCT00065936|Met-enkephalin|met-enkephalin
760618|NCT00065936|Cortisol|cortisol
760619|NCT00065923|Prader-Willi Syndrome|prader-willi syndrome
760620|NCT00065923|Self-Injurious Behavior|self-injurious behavior
760621|NCT00065910|Joint attention|joint attention
760622|NCT00065910|Developmental delay|developmental delay
760623|NCT00065910|Caregiver interaction|caregiver interaction
760624|NCT00065897|Amniocentesis|amniocentesis
760625|NCT00065897|Transabdominal chorionic villus sampling|transabdominal chorionic villus sampling
760626|NCT00065897|Fluorescence in situ hybridization|fluorescence in situ hybridization
760627|NCT00065897|Alpha fetoprotein|alpha fetoprotein
760628|NCT00065897|Acetylcholinesterase|acetylcholinesterase
760629|NCT00065897|Prenatal testing|prenatal testing
760630|NCT00065897|Prenatal diagnosis|prenatal diagnosis
760631|NCT00065884|Adolescents|adolescents
760632|NCT00065871|Pharmacist prescribers|pharmacist prescribers
760633|NCT00065871|Increased access|increased access
760634|NCT00065871|Hormonal contraception|hormonal contraception
760635|NCT00065871|Birth control pills|birth control pills
760636|NCT00065871|Birth control patch|birth control patch
760637|NCT00065871|Vaginal contraceptive ring|vaginal contraceptive ring
760638|NCT00065858|Contraception|contraception
760639|NCT00065858|Nonoxynol 9|nonoxynol 9
760640|NCT00065858|Microbicide|microbicide
760641|NCT00065858|Spermicide|spermicide
760642|NCT00065845|Urinary incontinence|urinary incontinence
760643|NCT00065845|Pelvic organ prolapse|pelvic organ prolapse
760644|NCT00065845|Stress incontinence|stress incontinence
760645|NCT00065845|Sacrocolpopexy|sacrocolpopexy
760646|NCT00065845|Burch urethropexy|burch urethropexy
760647|NCT00065845|Surgical Trials|surgical trials
760648|NCT00031707|anorexia|anorexia
760649|NCT00031707|cachexia|cachexia
760650|NCT00026273|stage III colon cancer|stage iii colon cancer
760651|NCT00026273|stage III rectal cancer|stage iii rectal cancer
760652|NCT00026273|adenocarcinoma of the colon|adenocarcinoma of the colon
760653|NCT00026273|adenocarcinoma of the rectum|adenocarcinoma of the rectum
760654|NCT00025688|stage IV breast cancer|stage iv breast cancer
760655|NCT00025688|recurrent breast cancer|recurrent breast cancer
760656|NCT00024024|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
760657|NCT00024024|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
760658|NCT00022477|stage IV colon cancer|stage iv colon cancer
760659|NCT00022477|stage IV rectal cancer|stage iv rectal cancer
760660|NCT00022477|recurrent colon cancer|recurrent colon cancer
760661|NCT00022477|recurrent rectal cancer|recurrent rectal cancer
760662|NCT00022477|adenocarcinoma of the colon|adenocarcinoma of the colon
760663|NCT00022477|adenocarcinoma of the rectum|adenocarcinoma of the rectum
760664|NCT00065832|Reading disabilities|reading disabilities
760665|NCT00065832|Inner-city|inner-city
760666|NCT00065832|Urban|urban
760667|NCT00065819|HIV|hiv
760668|NCT00065819|African American|african american
760669|NCT00065819|Symptom Management|symptom management
760670|NCT00065806|Pediatric lupus|pediatric lupus
760671|NCT00065806|Atherosclerosis|atherosclerosis
760672|NCT00065806|SLE|sle
760673|NCT00065806|HMG CoA reductase inhibitor|hmg coa reductase inhibitor
760674|NCT00065767|Alzheimer disease|alzheimer disease
760675|NCT00065767|Postmenopausal women|postmenopausal women
760676|NCT00065767|Hormone therapy|hormone therapy
760677|NCT00065754|Placebo|placebo
760678|NCT00065754|Analgesia|analgesia
760679|NCT00065754|Pain|pain
760680|NCT00065754|Brain mechanism|brain mechanism
760681|NCT00065754|Expectation|expectation
760682|NCT00065741|Milk thistle|milk thistle
760683|NCT00065741|silymarin|silymarin
760684|NCT00065741|piperine|piperine
760685|NCT00065741|glucarate|glucarate
760686|NCT00065741|zidovudine|zidovudine
760687|NCT00065741|abacavir|abacavir
760688|NCT00065741|mycophenolate mofetil|mycophenolate mofetil
760689|NCT00065741|HIV|hiv
760690|NCT00065741|pharmacokinetics|pharmacokinetics
760691|NCT00065741|interaction|interaction
760692|NCT00065741|glucuronidation|glucuronidation
760693|NCT00065741|Healthy|healthy
760694|NCT00065741|Complementary Therapies|complementary therapies
760695|NCT00065728|AMD|amd
782041|NCT00038974|Genetics|genetics
760696|NCT00065728|age-related macular degeneration|age-related macular degeneration
760697|NCT00065728|Anecortave|anecortave
760698|NCT00065728|Acetate|acetate
760699|NCT00065728|Wet form of age-related macular degeneration|wet form of age-related macular degeneration
760700|NCT00065728|CNV|cnv
760701|NCT00065728|Anecortave Acetate|anecortave acetate
760702|NCT00065715|head cold|head cold
760703|NCT00065715|common cold|common cold
760704|NCT00065715|echinacea|echinacea
760705|NCT00065715|placebo|placebo
760706|NCT00065702|fibromyalgia|fibromyalgia
760707|NCT00065702|homeopathy|homeopathy
760708|NCT00065702|EEG|eeg
760709|NCT00065702|EKG|ekg
760710|NCT00065702|chronic pain|chronic pain
760711|NCT00065689|Alzheimer's disease|alzheimer's disease
760712|NCT00065689|light therapy|light therapy
760713|NCT00065689|long-term care|long-term care
760714|NCT00065689|depression|depression
760715|NCT00065689|sleep|sleep
760716|NCT00065689|agitation|agitation
760717|NCT00065676|Hyperglycemia|hyperglycemia
760718|NCT00065676|Hyperinsulinemia|hyperinsulinemia
760719|NCT00065676|OGTT|ogtt
760720|NCT00065676|GLUT2|glut2
760721|NCT00065676|Post-Prandial|post-prandial
760722|NCT00065676|Type 2 Diabetes|type 2 diabetes
760723|NCT00065676|Obesity|obesity
760724|NCT00065663|gene transfer|gene transfer
760725|NCT00065663|adenovirus|adenovirus
760726|NCT00065663|platelet-derived growth factor-B|platelet-derived growth factor-b
760727|NCT00065663|collagen|collagen
760728|NCT00065663|diabetic ulcer|diabetic ulcer
760729|NCT00065663|foot|foot
760730|NCT00065663|wounds|wounds
760731|NCT00065663|diabetic|diabetic
760732|NCT00065663|ulcers|ulcers
760733|NCT00065650|Diabetes Mellitus Type 2|diabetes mellitus type 2
760734|NCT00065650|Vedic medicine|vedic medicine
760735|NCT00065650|Ayurveda|ayurveda
760736|NCT00065650|Transcendental Meditation|transcendental meditation
760737|NCT00065624|Lipoic acid|lipoic acid
760738|NCT00065624|F2-isoprostanes|f2-isoprostanes
760739|NCT00065624|endothelial dysfunction|endothelial dysfunction
760740|NCT00065624|natural product|natural product
760741|NCT00065585|low back pain|low back pain
760742|NCT00065585|acupuncture|acupuncture
760743|NCT00065572|Kidney Cancer|kidney cancer
760744|NCT00065572|Metastatic|metastatic
760745|NCT00065572|Newly diagnosed renal cell carcinoma|newly diagnosed renal cell carcinoma
760746|NCT00014560|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
760950|NCT00065286|Barnes test|barnes test
760747|NCT00014560|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
760748|NCT00014560|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
760749|NCT00014560|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
760750|NCT00014560|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
760751|NCT00014560|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
760752|NCT00014560|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
760753|NCT00014560|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
760754|NCT00014560|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
760755|NCT00014560|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
760756|NCT00014560|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
760757|NCT00014560|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
760758|NCT00014261|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
760759|NCT00014248|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
760760|NCT00014248|cachexia|cachexia
760761|NCT00014209|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
760762|NCT00014209|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
760763|NCT00014209|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
760764|NCT00014209|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
760765|NCT00014209|anaplastic large cell lymphoma|anaplastic large cell lymphoma
760766|NCT00010127|adenocarcinoma of the prostate|adenocarcinoma of the prostate
760767|NCT00010127|stage IV prostate cancer|stage iv prostate cancer
760768|NCT00065611|Steroids|steroids
760769|NCT00065611|Osteoporosis|osteoporosis
760770|NCT00065611|Proteinuria|proteinuria
760771|NCT00065611|Minimal Change Disease|minimal change disease
760772|NCT00065611|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
760773|NCT00065611|FSGS|fsgs
760774|NCT00065611|MCD|mcd
760775|NCT00065611|Kidney Disease|kidney disease
760776|NCT00065507|hepatic decompensation|hepatic decompensation
760777|NCT00006799|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
760778|NCT00006799|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
760779|NCT00006799|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
760780|NCT00006799|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
760781|NCT00006799|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
761023|NCT00065078|Community nurse|community nurse
760782|NCT00006799|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
760783|NCT00006799|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
760784|NCT00006799|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
760785|NCT00006799|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
760786|NCT00006799|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
760787|NCT00006799|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
760788|NCT00006799|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
760789|NCT00006799|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
760790|NCT00006799|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
760791|NCT00006799|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
760792|NCT00006799|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
760793|NCT00006799|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
760794|NCT00006799|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
760795|NCT00006799|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
760796|NCT00006799|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
760797|NCT00006799|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
760798|NCT00006799|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
760799|NCT00006799|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
760800|NCT00006799|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
760801|NCT00006799|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
760802|NCT00006799|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
760803|NCT00006799|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
760804|NCT00006799|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
760805|NCT00006799|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
760806|NCT00006799|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
760807|NCT00006799|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
760808|NCT00006799|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
760809|NCT00006799|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
760810|NCT00006799|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
760811|NCT00006799|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
760812|NCT00006799|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
760813|NCT00006799|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
760814|NCT00006799|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
760815|NCT00006799|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
760816|NCT00006799|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
760817|NCT00006799|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
760818|NCT00006799|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
760819|NCT00006799|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
760820|NCT00006799|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
760821|NCT00006799|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
760822|NCT00006799|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
760823|NCT00006799|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
760824|NCT00006799|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
760825|NCT00006799|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
760826|NCT00006799|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
760827|NCT00006799|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
760828|NCT00006799|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
760829|NCT00006799|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
760830|NCT00006799|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
760831|NCT00006799|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
760832|NCT00006799|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
760833|NCT00006799|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
761078|NCT00064909|Perfusion|perfusion
760834|NCT00006799|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
760835|NCT00006799|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
760836|NCT00006799|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
760837|NCT00006799|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
760838|NCT00006799|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
760839|NCT00006799|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
760840|NCT00006799|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
760841|NCT00006799|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
760842|NCT00006799|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
760843|NCT00006799|anorexia|anorexia
760844|NCT00006799|cachexia|cachexia
760845|NCT00006799|quality of life|quality of life
760846|NCT00006453|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
760847|NCT00006352|limited stage small cell lung cancer|limited stage small cell lung cancer
760848|NCT00006240|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
760849|NCT00065468|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
760850|NCT00065468|Kidney Cancer|kidney cancer
760851|NCT00006229|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
760852|NCT00006229|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
760853|NCT00006081|stage III gastric cancer|stage iii gastric cancer
760854|NCT00006081|stage IV gastric cancer|stage iv gastric cancer
760855|NCT00006081|stage III esophageal cancer|stage iii esophageal cancer
760856|NCT00006081|stage IV esophageal cancer|stage iv esophageal cancer
760857|NCT00006081|adenocarcinoma of the stomach|adenocarcinoma of the stomach
760858|NCT00006081|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
760859|NCT00065455|Retinitis Pigmentosa|retinitis pigmentosa
760860|NCT00065455|Vitamin A|vitamin a
760861|NCT00065455|ERG|erg
760862|NCT00065455|RP|rp
760863|NCT00065442|prostate cancer|prostate cancer
760864|NCT00065442|prostate|prostate
760865|NCT00065442|AIPC|aipc
760866|NCT00065442|androgen-independent|androgen-independent
760867|NCT00065442|androgen independent|androgen independent
760868|NCT00065442|hormone insensitive|hormone insensitive
760869|NCT00065442|hormone-insensitive|hormone-insensitive
760870|NCT00065442|PSA|psa
760871|NCT00065442|prostatic adenocarcinoma|prostatic adenocarcinoma
760872|NCT00065442|hormone-refractory|hormone-refractory
760873|NCT00065442|hormone refractory|hormone refractory
760874|NCT00065442|HRPC|hrpc
760875|NCT00065442|LHRH|lhrh
760876|NCT00065442|immune therapy|immune therapy
760877|NCT00065442|immunotherapy|immunotherapy
760878|NCT00065442|vaccine|vaccine
760879|NCT00065442|dendritic cells|dendritic cells
760880|NCT00065442|antigen-presenting cells|antigen-presenting cells
760881|NCT00065442|antigen presenting cells|antigen presenting cells
760882|NCT00065442|cancer vaccine|cancer vaccine
760883|NCT00065442|therapeutic vaccine|therapeutic vaccine
760884|NCT00065442|therapeutic cancer vaccine|therapeutic cancer vaccine
760885|NCT00065442|recombinant|recombinant
760886|NCT00065442|biological|biological
760887|NCT00065442|biopharmaceutical|biopharmaceutical
760888|NCT00065442|biotechnology|biotechnology
760889|NCT00065442|biotech|biotech
760890|NCT00004887|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
760891|NCT00004887|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
760892|NCT00004887|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
760893|NCT00065416|neck pain|neck pain
760894|NCT00065416|cervicalgia|cervicalgia
760895|NCT00065416|massage|massage
760896|NCT00065403|Irritable Bowel Syndrome|irritable bowel syndrome
760897|NCT00065403|Acupuncture|acupuncture
760898|NCT00065364|Preterm infant|preterm infant
760899|NCT00065364|Premature infant|premature infant
760900|NCT00065364|Developmental care|developmental care
760901|NCT00065364|MRI|mri
760902|NCT00065364|qEEG|qeeg
760903|NCT00065364|Neurodevelopment|neurodevelopment
760904|NCT00065364|Behavior|behavior
760905|NCT00065364|Infants|infants
760906|NCT00065364|NICU|nicu
760907|NCT00065351|Multiple Myeloma|multiple myeloma
760908|NCT00065351|CC-5013|cc-5013
760909|NCT00065351|Revlimid|revlimid
760910|NCT00065351|MM|mm
760911|NCT00065351|CC5013|cc5013
760912|NCT00065351|relapsed and refractory multiple myeloma|relapsed and refractory multiple myeloma
760913|NCT00065338|Physical activity|physical activity
760914|NCT00065325|Locally advanced breast cancer|locally advanced breast cancer
760915|NCT00065325|metastatic breast cancer|metastatic breast cancer
760916|NCT00065325|Breast Cancer|breast cancer
760917|NCT00065325|Cancer of Breast|cancer of breast
760918|NCT00065325|Cancer of the Breast|cancer of the breast
760919|NCT00004253|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
760920|NCT00004253|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
782042|NCT00038974|Cytokines|cytokines
760921|NCT00004253|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
760922|NCT00065390|ALPS|alps
760923|NCT00065390|Pyrimethamine|pyrimethamine
760924|NCT00065390|Folinic Acid|folinic acid
760925|NCT00065390|Lymphadenopathy|lymphadenopathy
760926|NCT00065390|Splenomegaly|splenomegaly
760927|NCT00065390|Autoimmune Lymphoproliferative Syndrome|autoimmune lymphoproliferative syndrome
760928|NCT00065377|Diabetes|diabetes
760929|NCT00065377|Insulin Resistance|insulin resistance
760930|NCT00065377|Capillary Blood Flow|capillary blood flow
760931|NCT00065377|Osteoarthritis|osteoarthritis
760932|NCT00065377|Endothelial Dysfunction|endothelial dysfunction
760933|NCT00065377|Obesity|obesity
760934|NCT00065377|Healthy Volunteer|healthy volunteer
760935|NCT00065377|HV|hv
760936|NCT00065312|Type 2 diabetes|type 2 diabetes
760937|NCT00065299|Hyperphenylalaninemia|hyperphenylalaninemia
760938|NCT00065299|PKU|pku
760939|NCT00065299|Maternal PKU|maternal pku
760940|NCT00065299|Pregnancy outcome|pregnancy outcome
760941|NCT00065299|Phenylalanine restricted diet|phenylalanine restricted diet
760942|NCT00065299|Tyrosine supplementation|tyrosine supplementation
760943|NCT00065299|Maternal hyperphenylalanemia during pregnancy|maternal hyperphenylalanemia during pregnancy
760944|NCT00065286|Akathisia|akathisia
760945|NCT00065286|Mental retardation|mental retardation
760946|NCT00065286|Schizophrenia|schizophrenia
760947|NCT00065286|Neuroleptic medication|neuroleptic medication
760948|NCT00065286|Tardive dyskinesia|tardive dyskinesia
760949|NCT00065286|Brief Psychiatric Rating Scale|brief psychiatric rating scale
760951|NCT00065286|Stereotypy Checklist Test|stereotypy checklist test
760952|NCT00065286|DISCUS Tardive Dyskinesia test|discus tardive dyskinesia test
760953|NCT00065273|Severe aberrant behavior|severe aberrant behavior
760954|NCT00065273|Risperidone|risperidone
760955|NCT00065273|Clozapine|clozapine
760956|NCT00065273|Haloperidol|haloperidol
760957|NCT00065273|Laboratory operant tasks|laboratory operant tasks
760958|NCT00065273|Simple acquisition procedures|simple acquisition procedures
760959|NCT00065273|Matching to sample task|matching to sample task
760960|NCT00065273|Lag sequential analysis|lag sequential analysis
760961|NCT00065247|Bone|bone
760962|NCT00065247|Children|children
760963|NCT00065247|After-school program|after-school program
760964|NCT00065247|Osteoporosis|osteoporosis
760965|NCT00065247|Calcium|calcium
760966|NCT00065247|Physical activity|physical activity
760967|NCT00065234|Colostomy|colostomy
760968|NCT00065234|Ileostomy|ileostomy
760969|NCT00065221|Ginger|ginger
760970|NCT00065221|Plant preparation|plant preparation
760971|NCT00065221|Herbal medicine|herbal medicine
760972|NCT00065221|Chemotherapy|chemotherapy
760973|NCT00065221|Nausea|nausea
760974|NCT00065208|Prostate cancer|prostate cancer
760975|NCT00065208|Reiki|reiki
760976|NCT00065208|Energy Healing|energy healing
760977|NCT00065260|Alemtuzumab (Campath-1H)|alemtuzumab (campath-1h)
760978|NCT00065260|Rabbit ATG|rabbit atg
760979|NCT00065260|Severe Aplastic Anemia|severe aplastic anemia
760980|NCT00065260|Cyclosporine|cyclosporine
760981|NCT00065260|Thrombocytopenia|thrombocytopenia
760982|NCT00065260|Leukopenia|leukopenia
760983|NCT00065260|Neutropenia|neutropenia
760984|NCT00065260|Autoimmunity|autoimmunity
760985|NCT00065260|Relapse|relapse
760986|NCT00065260|Anemia|anemia
760987|NCT00065195|Massage|massage
760988|NCT00065195|Palliative Care|palliative care
760989|NCT00065195|Hospices|hospices
760990|NCT00065195|Cancer|cancer
760991|NCT00065182|Stage IIIB/IV|stage iiib/iv
760992|NCT00065182|topotecan|topotecan
760993|NCT00065182|docetaxel|docetaxel
760994|NCT00065182|TAXOTERE|taxotere
760995|NCT00065182|HYCAMTIN|hycamtin
760996|NCT00065182|non-small cell lung cancer|non-small cell lung cancer
760997|NCT00065182|Advanced|advanced
760998|NCT00065182|NSCLC|nsclc
760999|NCT00065156|MDS|mds
761000|NCT00065156|CC-5013|cc-5013
761001|NCT00065156|Revlimid|revlimid
761002|NCT00065156|Celgene|celgene
761003|NCT00065143|Newly diagnosed and previously untreated acute myeloid leukemia (AML)|newly diagnosed and previously untreated acute myeloid leukemia (aml)
761004|NCT00065143|High-risk myelodysplastic syndrome (MDS) (>/= 10% bone marrow blasts)|high-risk myelodysplastic syndrome (mds) (>/= 10% bone marrow blasts)
761005|NCT00065143|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
761006|NCT00065143|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
761007|NCT00065117|metastatic|metastatic
761008|NCT00065117|colorectal|colorectal
761009|NCT00065117|first-line|first-line
761010|NCT00065117|adjuvant|adjuvant
761011|NCT00065117|cancer|cancer
761012|NCT00065117|Colorectal Cancer|colorectal cancer
761013|NCT00065117|Colorectal Carcinoma|colorectal carcinoma
761014|NCT00065117|Colorectal Tumors|colorectal tumors
761015|NCT00065117|Neoplasms, Colorectal|neoplasms, colorectal
761016|NCT00065104|HIV|hiv
761017|NCT00065104|DHEA|dhea
761018|NCT00065104|immune system|immune system
761019|NCT00065104|hormones|hormones
761020|NCT00065104|body composition|body composition
761021|NCT00065104|quality of life|quality of life
761022|NCT00065078|Home-visits|home-visits
782043|NCT00038974|Immunology|immunology
761024|NCT00065078|Unintended pregnancy|unintended pregnancy
761025|NCT00065065|Rosiglitazone|rosiglitazone
761026|NCT00065065|Ulcerative|ulcerative
761027|NCT00065065|Colitis|colitis
761028|NCT00065052|physical activity|physical activity
761029|NCT00065052|television|television
761030|NCT00065052|child obesity|child obesity
761031|NCT00065052|Reduce TV|reduce tv
761032|NCT00065052|Usual control|usual control
761033|NCT00065013|obesity|obesity
761034|NCT00065013|gastric bypass|gastric bypass
761035|NCT00065013|obesity surgery|obesity surgery
761036|NCT00065013|bariatric surgery|bariatric surgery
761037|NCT00065013|exercise|exercise
761038|NCT00004204|recurrent adult brain tumor|recurrent adult brain tumor
761039|NCT00004204|adult anaplastic astrocytoma|adult anaplastic astrocytoma
761040|NCT00004204|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
761041|NCT00004006|intraocular retinoblastoma|intraocular retinoblastoma
761042|NCT00004006|extraocular retinoblastoma|extraocular retinoblastoma
761043|NCT00004006|recurrent retinoblastoma|recurrent retinoblastoma
761044|NCT00003795|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
761045|NCT00003795|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
761046|NCT00003795|stage I endometrial carcinoma|stage i endometrial carcinoma
761047|NCT00003795|stage II endometrial carcinoma|stage ii endometrial carcinoma
761048|NCT00003759|stage 0 bladder cancer|stage 0 bladder cancer
761049|NCT00003759|stage I bladder cancer|stage i bladder cancer
761050|NCT00003759|recurrent bladder cancer|recurrent bladder cancer
761051|NCT00064987|Male reproduction hormones|male reproduction hormones
761052|NCT00064987|Hypogonadotropic hypogonadism|hypogonadotropic hypogonadism
761053|NCT00064987|FSH|fsh
761054|NCT00064987|LH|lh
761055|NCT00064987|GnRH|gnrh
761056|NCT00064974|MDS|mds
761057|NCT00064974|CC-5013|cc-5013
761058|NCT00064974|Revlimid|revlimid
761059|NCT00064974|Celgene|celgene
761060|NCT00064961|Smoking Cessation|smoking cessation
761061|NCT00064935|Endometrium|endometrium
761062|NCT00064935|Luteal phase|luteal phase
761063|NCT00064935|Endometrial biopsy|endometrial biopsy
761064|NCT00064922|nicotine dependence|nicotine dependence
761065|NCT00064870|Alzheimer disease|alzheimer disease
761066|NCT00064870|Late Onset Alzheimer disease risk factor genes|late onset alzheimer disease risk factor genes
761067|NCT00064870|Genetics|genetics
761068|NCT00064870|Initiative|initiative
761069|NCT00064870|Dementia|dementia
761070|NCT00064857|lymphedema|lymphedema
761071|NCT00064857|breast|breast
761072|NCT00064857|cancer|cancer
761073|NCT00064857|plant preparation|plant preparation
761074|NCT00064857|herbal preparation|herbal preparation
761075|NCT00064857|pine bark extract|pine bark extract
761076|NCT00064909|Multiple Sclerosis|multiple sclerosis
761077|NCT00064909|MRI|mri
761079|NCT00064909|Imaging|imaging
761080|NCT00064909|Cerebral Blood Flow|cerebral blood flow
761081|NCT00064909|Cerebral Blood Volume|cerebral blood volume
761082|NCT00064909|CO2 Inhalation|co2 inhalation
761083|NCT00064909|Contrast Agent|contrast agent
761084|NCT00064909|Healthy Volunteer|healthy volunteer
761085|NCT00064909|HV|hv
761086|NCT00064896|Blood Flow|blood flow
761087|NCT00064896|Revascularization|revascularization
761088|NCT00064896|Image Fusion|image fusion
761089|NCT00064896|Fluoroscopy|fluoroscopy
761090|NCT00064896|MRI|mri
761091|NCT00064896|Chronic Total Occlusion of Arteries|chronic total occlusion of arteries
761092|NCT00064896|Claudication|claudication
761093|NCT00064896|Safety|safety
761094|NCT00064896|Atherosclerosis|atherosclerosis
761095|NCT00064896|Cardiovascular Disease|cardiovascular disease
761096|NCT00064883|Radiation Therapy|radiation therapy
761097|NCT00064883|Children|children
761098|NCT00064883|Cancer|cancer
761099|NCT00064883|Late Effects|late effects
761100|NCT00064883|Natural History|natural history
761101|NCT00064883|Radiation|radiation
761102|NCT00064844|Smoking|smoking
761103|NCT00064844|Alcoholism|alcoholism
761104|NCT00064831|estrogen stimulation|estrogen stimulation
761105|NCT00064831|relief of hot flashes|relief of hot flashes
761106|NCT00064831|nipple aspirate fluid|nipple aspirate fluid
761107|NCT00064831|body fluid levels of black cohosh|body fluid levels of black cohosh
761108|NCT00064818|connective tissue|connective tissue
761109|NCT00064818|ultrasound|ultrasound
761110|NCT00064818|acupuncture|acupuncture
761111|NCT00064805|Cognitive therapy|cognitive therapy
761112|NCT00064805|Aphasia therapy|aphasia therapy
761113|NCT00064805|Alexia|alexia
761114|NCT00064805|Acquired dyslexia|acquired dyslexia
761115|NCT00064805|Phonological deficits|phonological deficits
761116|NCT00064805|Orthographic deficits|orthographic deficits
761117|NCT00064805|Brain disorders|brain disorders
761118|NCT00064805|Brain injury|brain injury
761119|NCT00064805|Stroke|stroke
761120|NCT00064779|CNS neoplasms|cns neoplasms
761121|NCT00064779|Brain neoplasms|brain neoplasms
761122|NCT00064779|neurosurgery|neurosurgery
761123|NCT00064779|intralesional infusion|intralesional infusion
761124|NCT00064779|recombinant proteins|recombinant proteins
761125|NCT00064779|immunotoxins|immunotoxins
761126|NCT00064766|Norplant|norplant
761127|NCT00064766|Periodontal disease|periodontal disease
761128|NCT00064766|Endometrial bleeding|endometrial bleeding
761129|NCT00064766|Progestin-induced endometrial bleeding|progestin-induced endometrial bleeding
761130|NCT00064753|homocysteine|homocysteine
761131|NCT00064753|multi-vitamin|multi-vitamin
761132|NCT00064753|cardiovascular disease|cardiovascular disease
761133|NCT00064753|renal transplant recipients|renal transplant recipients
761134|NCT00003712|recurrent adult brain tumor|recurrent adult brain tumor
761135|NCT00003712|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
761136|NCT00003712|tumors metastatic to brain|tumors metastatic to brain
761137|NCT00003707|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
761138|NCT00003645|stage I prostate cancer|stage i prostate cancer
761139|NCT00003645|stage II prostate cancer|stage ii prostate cancer
761140|NCT00003571|stage III colon cancer|stage iii colon cancer
761141|NCT00003571|adenocarcinoma of the colon|adenocarcinoma of the colon
761142|NCT00003382|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
761143|NCT00003382|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
761144|NCT00003382|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
761145|NCT00003382|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
761146|NCT00003382|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
761147|NCT00003382|fallopian tube cancer|fallopian tube cancer
761148|NCT00003382|primary peritoneal cavity cancer|primary peritoneal cavity cancer
761149|NCT00064792|Cholesterol|cholesterol
761150|NCT00064792|SLOS|slos
761151|NCT00064792|HMG-COA Reductase Inhibitor|hmg-coa reductase inhibitor
761152|NCT00064792|Malformation Syndrome|malformation syndrome
761153|NCT00064792|Mental Retardation|mental retardation
761154|NCT00064792|Smith-Lemli-Opitz Syndrome|smith-lemli-opitz syndrome
761155|NCT00064740|Human Immunodeficiency Viruses|human immunodeficiency viruses
761156|NCT00064740|Relaxation|relaxation
761157|NCT00064740|Acupuncture|acupuncture
761158|NCT00064740|Complementary therapies|complementary therapies
761159|NCT00064701|De Novo Kidney Transplant|de novo kidney transplant
761160|NCT00064701|cyclosporine|cyclosporine
761161|NCT00064701|Prograf®|prograf®
761162|NCT00064701|mycophenolate mofetil|mycophenolate mofetil
761163|NCT00064701|tacrolimus|tacrolimus
761164|NCT00006073|Evaluation|evaluation
761165|NCT00006073|Endocrinology|endocrinology
761166|NCT00006073|Hormones|hormones
761167|NCT00006073|Metabolism|metabolism
761168|NCT00006073|Teaching|teaching
761169|NCT00006073|Endocrine Disorder|endocrine disorder
761170|NCT00064727|Ventricular Contractile Function|ventricular contractile function
761171|NCT00064727|Diastolic Dysfunction|diastolic dysfunction
761172|NCT00064727|PPAR gamma|ppar gamma
761173|NCT00064727|Gene Expression Patterns|gene expression patterns
761174|NCT00064727|Insulin Sensitization|insulin sensitization
761175|NCT00064727|Glucose Intolerance|glucose intolerance
761176|NCT00064727|Intolerance|intolerance
761177|NCT00064714|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
761178|NCT00064714|Beta-Cell|beta-cell
761179|NCT00064714|C-Peptide|c-peptide
761180|NCT00064714|Immunosuppression|immunosuppression
761181|NCT00064714|Insulin|insulin
761182|NCT00064714|Islet|islet
761183|NCT00064714|Function|function
761184|NCT00064714|AC2993 (Synthetic Exendin-4)|ac2993 (synthetic exendin-4)
761185|NCT00064714|Diabetes Mellitus|diabetes mellitus
761186|NCT00064714|Type I Diabetes Mellitus|type i diabetes mellitus
761187|NCT00064714|T1DM|t1dm
761188|NCT00064662|Stress urinary incontinence|stress urinary incontinence
761189|NCT00064662|Surgery|surgery
761190|NCT00064649|prostate|prostate
761191|NCT00064649|benign disease|benign disease
761192|NCT00064649|TUNA|tuna
761193|NCT00064649|TUMT|tumt
761194|NCT00064649|medical therapy|medical therapy
761195|NCT00064623|Dermal assessment|dermal assessment
761196|NCT00064623|Pain measurement|pain measurement
761197|NCT00064623|Diary|diary
761198|NCT00064623|Analgesics/*therapeutic use|analgesics/*therapeutic use
761199|NCT00064623|Capsaicin/*administration & dosage/adverse effects|capsaicin/*administration & dosage/adverse effects
761200|NCT00064623|HIV Infections/*complications/*drug therapy|hiv infections/*complications/*drug therapy
761391|NCT00064181|stage IV rectal cancer|stage iv rectal cancer
761201|NCT00064623|Peripheral Nervous System Diseases/*complications/diagnosis/*therapy|peripheral nervous system diseases/*complications/diagnosis/*therapy
761202|NCT00064623|Peripheral Nervous System Diseases/drug therapy/*etiology/physiopathology|peripheral nervous system diseases/drug therapy/*etiology/physiopathology
761203|NCT00064610|Advanced androgen-independent prostate cancer|advanced androgen-independent prostate cancer
761204|NCT00064597|Fetal cells|fetal cells
761205|NCT00064597|Prenatal diagnosis|prenatal diagnosis
761206|NCT00064597|Cytogenetic disorders|cytogenetic disorders
761207|NCT00064597|Chromosomal disorders|chromosomal disorders
761208|NCT00064597|Single gene mutation detection|single gene mutation detection
761209|NCT00064597|Abnormal serum marker profile|abnormal serum marker profile
761210|NCT00064597|Fluorescence activated cell sorting (FACS)|fluorescence activated cell sorting (facs)
761211|NCT00064597|Magnetic activated cell sorting (MACS)|magnetic activated cell sorting (macs)
761212|NCT00064597|Fluorescence in situ hybridization (FISH)|fluorescence in situ hybridization (fish)
761213|NCT00064597|Chromosomal disorders of the fetus|chromosomal disorders of the fetus
761214|NCT00064597|Single gene defects of the fetus|single gene defects of the fetus
761215|NCT00063726|Relapsed Multiple Myeloma|relapsed multiple myeloma
761216|NCT00063726|Refractory Multiple Myeloma|refractory multiple myeloma
761217|NCT00003184|stage IV breast cancer|stage iv breast cancer
761218|NCT00003184|recurrent breast cancer|recurrent breast cancer
761219|NCT00003045|adenocarcinoma of the prostate|adenocarcinoma of the prostate
761220|NCT00003045|stage II prostate cancer|stage ii prostate cancer
761221|NCT00003045|stage III prostate cancer|stage iii prostate cancer
761222|NCT00003008|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
761223|NCT00003008|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
761224|NCT00002965|recurrent adult brain tumor|recurrent adult brain tumor
761225|NCT00064571|unilateral vocal fold paralysis|unilateral vocal fold paralysis
761226|NCT00064467|lethargic|lethargic
761227|NCT00064467|decreased interest|decreased interest
761228|NCT00064467|decreased motivation|decreased motivation
761229|NCT00064467|depression|depression
761230|NCT00064454|Ulcerative Colitis|ulcerative colitis
761231|NCT00064441|Ulcerative Colitis|ulcerative colitis
761232|NCT00064376|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
761233|NCT00064376|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
761234|NCT00064376|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
761235|NCT00064376|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
761236|NCT00064376|refractory anemia with excess blasts|refractory anemia with excess blasts
761237|NCT00064376|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
761238|NCT00064376|refractory anemia|refractory anemia
761239|NCT00064376|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
761240|NCT00064363|recurrent adult brain tumor|recurrent adult brain tumor
761241|NCT00064363|adult anaplastic astrocytoma|adult anaplastic astrocytoma
761242|NCT00064363|adult glioblastoma|adult glioblastoma
761243|NCT00064363|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
761244|NCT00064363|adult mixed glioma|adult mixed glioma
761245|NCT00064363|adult giant cell glioblastoma|adult giant cell glioblastoma
761246|NCT00064363|adult gliosarcoma|adult gliosarcoma
761247|NCT00064363|adult brain stem glioma|adult brain stem glioma
761248|NCT00064350|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
761249|NCT00064350|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
761250|NCT00064350|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
761251|NCT00064350|sorafenib|sorafenib
761252|NCT00064337|primary systemic amyloidosis|primary systemic amyloidosis
761253|NCT00064337|stage II multiple myeloma|stage ii multiple myeloma
761254|NCT00064337|stage III multiple myeloma|stage iii multiple myeloma
761255|NCT00064311|infection|infection
761256|NCT00064311|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
761257|NCT00064311|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
761258|NCT00064311|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
761259|NCT00064311|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
761260|NCT00064311|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
761261|NCT00064311|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
761262|NCT00064311|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
761263|NCT00064311|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
761264|NCT00064311|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
761265|NCT00064311|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
761266|NCT00064311|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
761267|NCT00064311|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
761268|NCT00064311|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
761269|NCT00064311|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
761270|NCT00064311|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
761271|NCT00064311|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
761272|NCT00064311|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
761273|NCT00064311|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
761274|NCT00064311|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
761275|NCT00064311|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
761276|NCT00064311|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
761277|NCT00064311|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
761278|NCT00064311|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
761279|NCT00064311|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
761280|NCT00064311|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
761281|NCT00064311|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
761282|NCT00064311|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
761283|NCT00064311|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
761284|NCT00064311|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
761285|NCT00064311|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
761286|NCT00064311|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
761287|NCT00064311|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
761288|NCT00064311|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
761289|NCT00064311|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
761290|NCT00064311|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
761291|NCT00064311|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
761292|NCT00064311|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
761293|NCT00064311|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
761294|NCT00064311|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
761295|NCT00064311|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
761296|NCT00064311|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
761297|NCT00064311|refractory hairy cell leukemia|refractory hairy cell leukemia
761298|NCT00064311|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
761706|NCT00063388|Cancer|cancer
761299|NCT00064311|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
761300|NCT00064311|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
761301|NCT00064311|stage I multiple myeloma|stage i multiple myeloma
761302|NCT00064311|stage II multiple myeloma|stage ii multiple myeloma
761303|NCT00064311|stage III multiple myeloma|stage iii multiple myeloma
761304|NCT00064311|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
761305|NCT00064311|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
761306|NCT00064311|disseminated neuroblastoma|disseminated neuroblastoma
761307|NCT00064311|recurrent neuroblastoma|recurrent neuroblastoma
761308|NCT00064311|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
761309|NCT00064311|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
761310|NCT00064311|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
761311|NCT00064311|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
761312|NCT00064311|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
761313|NCT00064311|stage IIIA breast cancer|stage iiia breast cancer
761314|NCT00064311|stage IIIB breast cancer|stage iiib breast cancer
761315|NCT00064311|stage IV breast cancer|stage iv breast cancer
761316|NCT00064311|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
761317|NCT00064311|primary myelofibrosis|primary myelofibrosis
761318|NCT00064311|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
761319|NCT00064311|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
761320|NCT00064311|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
761321|NCT00064311|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
761322|NCT00064311|secondary acute myeloid leukemia|secondary acute myeloid leukemia
761323|NCT00064311|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
761324|NCT00064311|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
761325|NCT00064311|stage IIIC breast cancer|stage iiic breast cancer
761326|NCT00064311|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
761327|NCT00064311|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
761328|NCT00064311|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
761329|NCT00064311|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
761330|NCT00064311|splenic marginal zone lymphoma|splenic marginal zone lymphoma
761331|NCT00064311|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
761332|NCT00064311|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
761333|NCT00064311|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
761334|NCT00064311|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
761335|NCT00064311|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
761336|NCT00064298|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
761337|NCT00064298|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
761338|NCT00064298|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
761339|NCT00064298|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
761340|NCT00064298|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
761341|NCT00064298|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
761342|NCT00064298|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
761343|NCT00064298|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
761344|NCT00064298|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
761345|NCT00064298|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
761891|NCT00062972|Treatment Interventions|treatment interventions
761346|NCT00064298|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
761347|NCT00064298|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
761348|NCT00064298|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
761349|NCT00064298|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
761350|NCT00064298|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
761351|NCT00064298|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
761352|NCT00064285|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
761353|NCT00064285|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
761354|NCT00064285|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
761355|NCT00064285|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
761356|NCT00064285|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
761357|NCT00064285|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
761358|NCT00064285|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
761359|NCT00064285|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
761360|NCT00064285|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
761361|NCT00064285|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
761362|NCT00064285|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
761363|NCT00064285|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
761364|NCT00064285|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
761365|NCT00064285|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
761366|NCT00064285|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
761367|NCT00064272|nausea and vomiting|nausea and vomiting
761368|NCT00064272|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
761369|NCT00064233|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
761370|NCT00064233|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
761371|NCT00064233|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
761372|NCT00064220|adult leiomyosarcoma|adult leiomyosarcoma
761373|NCT00064220|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
761374|NCT00064220|adult liposarcoma|adult liposarcoma
761375|NCT00064220|adult rhabdomyosarcoma|adult rhabdomyosarcoma
761376|NCT00064220|adult synovial sarcoma|adult synovial sarcoma
761377|NCT00064220|adult fibrosarcoma|adult fibrosarcoma
761378|NCT00064220|adult angiosarcoma|adult angiosarcoma
761379|NCT00064220|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
761380|NCT00064220|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
761381|NCT00064220|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
761382|NCT00064207|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
761383|NCT00064207|stage I pancreatic cancer|stage i pancreatic cancer
761384|NCT00064207|stage II pancreatic cancer|stage ii pancreatic cancer
761385|NCT00064207|stage III pancreatic cancer|stage iii pancreatic cancer
761386|NCT00064194|prostate cancer|prostate cancer
761387|NCT00064194|high grade prostatic intraepithelial neoplasia|high grade prostatic intraepithelial neoplasia
761388|NCT00064181|adenocarcinoma of the colon|adenocarcinoma of the colon
761389|NCT00064181|adenocarcinoma of the rectum|adenocarcinoma of the rectum
761390|NCT00064181|stage IV colon cancer|stage iv colon cancer
761392|NCT00064116|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
761393|NCT00064116|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
761394|NCT00064116|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
761395|NCT00064116|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
761396|NCT00064116|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
761397|NCT00064090|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
761398|NCT00064090|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
761399|NCT00064090|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
761400|NCT00064090|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
761401|NCT00064090|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
761402|NCT00064090|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
761403|NCT00064090|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
761404|NCT00064090|refractory anemia with excess blasts|refractory anemia with excess blasts
761405|NCT00064090|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
761406|NCT00064090|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
761407|NCT00064090|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
761408|NCT00064090|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
761409|NCT00064090|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
762828|NCT00061334|Attitudes|attitudes
761410|NCT00064090|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
761411|NCT00064090|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
761412|NCT00064090|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
761413|NCT00064064|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
761414|NCT00064064|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
761415|NCT00064051|stage II pancreatic cancer|stage ii pancreatic cancer
761416|NCT00064051|stage III pancreatic cancer|stage iii pancreatic cancer
761417|NCT00064051|recurrent pancreatic cancer|recurrent pancreatic cancer
761418|NCT00064051|stage IV pancreatic cancer|stage iv pancreatic cancer
761419|NCT00064038|stage I multiple myeloma|stage i multiple myeloma
761420|NCT00064038|stage II multiple myeloma|stage ii multiple myeloma
761421|NCT00064038|stage III multiple myeloma|stage iii multiple myeloma
761422|NCT00064012|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
761423|NCT00064012|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
761424|NCT00064012|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
761425|NCT00063986|esophageal cancer|esophageal cancer
761426|NCT00063986|minimally invasive esophagectomy (MIE)|minimally invasive esophagectomy (mie)
761427|NCT00063960|stage IV colon cancer|stage iv colon cancer
761428|NCT00063960|adenocarcinoma of the colon|adenocarcinoma of the colon
761429|NCT00063960|adenocarcinoma of the rectum|adenocarcinoma of the rectum
761430|NCT00063960|stage IV rectal cancer|stage iv rectal cancer
761431|NCT00063960|liver metastases|liver metastases
761432|NCT00063882|stage IIB prostate cancer|stage iib prostate cancer
761433|NCT00063882|stage IIA prostate cancer|stage iia prostate cancer
761434|NCT00063882|adenocarcinoma of the prostate|adenocarcinoma of the prostate
761435|NCT00063869|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
761436|NCT00063869|Fibrosis, Pulmonary|fibrosis, pulmonary
761437|NCT00063869|Pulmonary Fibroses|pulmonary fibroses
761438|NCT00063869|Fibroses, Pulmonary|fibroses, pulmonary
761439|NCT00023907|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
761440|NCT00023907|primary peritoneal cavity cancer|primary peritoneal cavity cancer
761441|NCT00003211|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
761442|NCT00003211|untreated childhood medulloblastoma|untreated childhood medulloblastoma
761443|NCT00002878|refractory multiple myeloma|refractory multiple myeloma
761444|NCT00063856|Smallpox, wetvax|smallpox, wetvax
761445|NCT00063843|Bacillus anthracis (anthrax)|bacillus anthracis (anthrax)
761446|NCT00063830|Ulcerative Colitis|ulcerative colitis
761447|NCT00063817|End-stage renal disease|end-stage renal disease
761448|NCT00063817|Renal Transplant|renal transplant
761449|NCT00063817|Bone Marrow Transplant|bone marrow transplant
761450|NCT00063817|nonmyeloablative conditioning regimen|nonmyeloablative conditioning regimen
761451|NCT00063804|HIV Seronegativity|hiv seronegativity
761452|NCT00063804|CXCR4|cxcr4
761453|NCT00063804|AMD11070|amd11070
761454|NCT00063791|Relapsed or Refractory|relapsed or refractory
761455|NCT00063778|HIV Seronegativity|hiv seronegativity
761456|NCT00063778|HIV Preventive Vaccine|hiv preventive vaccine
761457|NCT00063778|AIDS Vaccines|aids vaccines
761458|NCT00063778|Gene Products, gag|gene products, gag
761459|NCT00063778|HIV-1|hiv-1
761460|NCT00063778|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
761461|NCT00063778|Injections, Subcutaneous|injections, subcutaneous
761462|NCT00045357|recurrent melanoma|recurrent melanoma
761463|NCT00045357|stage IV melanoma|stage iv melanoma
761464|NCT00042900|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
761465|NCT00042900|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
761466|NCT00042900|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
761467|NCT00042900|Waldenström macroglobulinemia|waldenström macroglobulinemia
761468|NCT00042900|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
761469|NCT00042900|acute undifferentiated leukemia|acute undifferentiated leukemia
761470|NCT00042900|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
761471|NCT00042900|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
761472|NCT00042900|primary myelofibrosis|primary myelofibrosis
761473|NCT00042900|anaplastic large cell lymphoma|anaplastic large cell lymphoma
761474|NCT00042900|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
761475|NCT00042900|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
761476|NCT00042900|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
761477|NCT00042900|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
761478|NCT00042900|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
761479|NCT00042900|essential thrombocythemia|essential thrombocythemia
761480|NCT00042900|extramedullary plasmacytoma|extramedullary plasmacytoma
761481|NCT00042900|intraocular lymphoma|intraocular lymphoma
761482|NCT00042900|isolated plasmacytoma of bone|isolated plasmacytoma of bone
761483|NCT00042900|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
761484|NCT00042900|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
761485|NCT00042900|polycythemia vera|polycythemia vera
762829|NCT00061334|fMRI|fmri
761486|NCT00042900|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
761487|NCT00042900|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
761488|NCT00042900|primary systemic amyloidosis|primary systemic amyloidosis
761489|NCT00042900|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
761490|NCT00042900|prolymphocytic leukemia|prolymphocytic leukemia
761491|NCT00042900|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
761707|NCT00063362|Depression|depression
761492|NCT00042900|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
761493|NCT00042900|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
761494|NCT00042900|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
761495|NCT00042900|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
761496|NCT00042900|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
761497|NCT00042900|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
761498|NCT00042900|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
761499|NCT00042900|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
761500|NCT00042900|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
761501|NCT00042900|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
761502|NCT00042900|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
761503|NCT00042900|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
761504|NCT00042900|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
761505|NCT00042900|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
761506|NCT00042900|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
761507|NCT00042900|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
761508|NCT00042900|refractory hairy cell leukemia|refractory hairy cell leukemia
761509|NCT00042900|refractory multiple myeloma|refractory multiple myeloma
761510|NCT00042900|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
761511|NCT00042900|secondary acute myeloid leukemia|secondary acute myeloid leukemia
761512|NCT00042900|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
761513|NCT00042900|small intestine lymphoma|small intestine lymphoma
761514|NCT00042900|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
761515|NCT00042900|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
761516|NCT00042900|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
761517|NCT00042900|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
761518|NCT00042900|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
761519|NCT00042900|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
761520|NCT00042900|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
761521|NCT00042900|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
761522|NCT00042900|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
761523|NCT00042900|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
761524|NCT00042900|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
761525|NCT00042900|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
761526|NCT00042900|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
761527|NCT00042900|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
761528|NCT00042900|stage III multiple myeloma|stage iii multiple myeloma
761529|NCT00042900|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
761530|NCT00042900|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
761531|NCT00042900|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
761532|NCT00042900|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
761533|NCT00042900|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
761534|NCT00042900|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
761535|NCT00042900|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
761536|NCT00042900|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
761537|NCT00042900|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
761538|NCT00042900|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
761539|NCT00042900|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
761540|NCT00042900|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
761541|NCT00042900|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
761542|NCT00042900|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
761543|NCT00042900|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
761544|NCT00042900|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
761545|NCT00042900|untreated hairy cell leukemia|untreated hairy cell leukemia
761546|NCT00042900|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
761547|NCT00042900|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
761548|NCT00042900|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
761549|NCT00042900|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
761550|NCT00042900|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
761551|NCT00042900|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
761552|NCT00042900|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
761553|NCT00042900|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
761554|NCT00042900|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
761555|NCT00042900|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
761556|NCT00042900|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
761557|NCT00042900|splenic marginal zone lymphoma|splenic marginal zone lymphoma
761558|NCT00040820|stage III colon cancer|stage iii colon cancer
761559|NCT00040820|stage IV colon cancer|stage iv colon cancer
761560|NCT00040820|stage III rectal cancer|stage iii rectal cancer
761561|NCT00040820|stage IV rectal cancer|stage iv rectal cancer
761562|NCT00040820|recurrent colon cancer|recurrent colon cancer
761563|NCT00040820|recurrent rectal cancer|recurrent rectal cancer
761564|NCT00040820|adenocarcinoma of the colon|adenocarcinoma of the colon
761565|NCT00040820|adenocarcinoma of the rectum|adenocarcinoma of the rectum
761566|NCT00039169|stage III renal cell cancer|stage iii renal cell cancer
761567|NCT00039169|stage IV renal cell cancer|stage iv renal cell cancer
761568|NCT00039169|recurrent renal cell cancer|recurrent renal cell cancer
761569|NCT00036660|recurrent adult brain tumor|recurrent adult brain tumor
761570|NCT00036660|adult glioblastoma|adult glioblastoma
761571|NCT00036660|adult anaplastic astrocytoma|adult anaplastic astrocytoma
761572|NCT00036660|adult giant cell glioblastoma|adult giant cell glioblastoma
761573|NCT00036660|adult gliosarcoma|adult gliosarcoma
761574|NCT00033384|stage III colon cancer|stage iii colon cancer
761575|NCT00033384|stage IV colon cancer|stage iv colon cancer
761576|NCT00033384|stage IV breast cancer|stage iv breast cancer
761577|NCT00033384|stage IIIA breast cancer|stage iiia breast cancer
761578|NCT00033384|recurrent breast cancer|recurrent breast cancer
761579|NCT00033384|stage IIIB breast cancer|stage iiib breast cancer
761580|NCT00033384|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
761581|NCT00033384|stage II pancreatic cancer|stage ii pancreatic cancer
761582|NCT00033384|stage III pancreatic cancer|stage iii pancreatic cancer
761583|NCT00033384|recurrent pancreatic cancer|recurrent pancreatic cancer
761584|NCT00033384|recurrent colon cancer|recurrent colon cancer
761585|NCT00033384|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
761586|NCT00033384|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
761587|NCT00033384|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
761588|NCT00033384|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
761589|NCT00033384|stage IV pancreatic cancer|stage iv pancreatic cancer
761590|NCT00002752|childhood supratentorial ependymoma|childhood supratentorial ependymoma
761591|NCT00002752|recurrent childhood brain tumor|recurrent childhood brain tumor
761592|NCT00002752|recurrent adult brain tumor|recurrent adult brain tumor
761593|NCT00002752|adult medulloblastoma|adult medulloblastoma
761594|NCT00002752|adult glioblastoma|adult glioblastoma
761595|NCT00002752|tumors metastatic to brain|tumors metastatic to brain
761596|NCT00002752|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
761597|NCT00002752|adult anaplastic astrocytoma|adult anaplastic astrocytoma
761598|NCT00002752|adult myxopapillary ependymoma|adult myxopapillary ependymoma
761599|NCT00002752|adult anaplastic ependymoma|adult anaplastic ependymoma
761600|NCT00002752|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
761601|NCT00002752|adult mixed glioma|adult mixed glioma
761602|NCT00002752|adult pilocytic astrocytoma|adult pilocytic astrocytoma
761603|NCT00002752|adult subependymoma|adult subependymoma
761604|NCT00002752|adult ependymoblastoma|adult ependymoblastoma
761605|NCT00002752|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
761606|NCT00002752|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
761607|NCT00002752|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
761608|NCT00002752|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
761609|NCT00002752|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
761610|NCT00002752|recurrent childhood ependymoma|recurrent childhood ependymoma
761611|NCT00002752|adult oligodendroglioma|adult oligodendroglioma
761612|NCT00002752|adult giant cell glioblastoma|adult giant cell glioblastoma
761613|NCT00002752|adult gliosarcoma|adult gliosarcoma
761614|NCT00002582|stage I breast cancer|stage i breast cancer
761615|NCT00002582|stage II breast cancer|stage ii breast cancer
761616|NCT00002582|stage IIIA breast cancer|stage iiia breast cancer
761617|NCT00063765|NT-501|nt-501
761618|NCT00063765|CNTF|cntf
761619|NCT00063765|Retinitis Pigmentosa|retinitis pigmentosa
761620|NCT00063765|RP|rp
761621|NCT00063700|obesity in school aged children|obesity in school aged children
761622|NCT00063674|exercise|exercise
761623|NCT00063674|eating|eating
761624|NCT00063674|dance|dance
761625|NCT00063674|health education|health education
761626|NCT00063674|obesity prevention|obesity prevention
761627|NCT00063674|diabetes prevention|diabetes prevention
761628|NCT00063674|children|children
761629|NCT00063648|PTLD|ptld
761630|NCT00063648|CTL Therapy|ctl therapy
761631|NCT00063648|Post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
761632|NCT00063635|Non alcoholic fatty liver disease|non alcoholic fatty liver disease
761633|NCT00063622|Non alcoholic steatohepatitis|non alcoholic steatohepatitis
761634|NCT00063622|Steatohepatitis|steatohepatitis
761635|NCT00063609|Prostate Cancer|prostate cancer
761636|NCT00063609|Bone Loss|bone loss
761637|NCT00063609|Osteoporosis|osteoporosis
761638|NCT00063609|Bone Mineral Density|bone mineral density
761639|NCT00063609|Androgen Deprivation Therapy|androgen deprivation therapy
761640|NCT00063661|fMRI|fmri
761641|NCT00063661|Brain Activity|brain activity
761642|NCT00063661|Overlearned|overlearned
761643|NCT00063661|Dual-Task|dual-task
761644|NCT00063661|Mechanism|mechanism
761645|NCT00063661|Parkinson Disease|parkinson disease
761646|NCT00063661|PD|pd
761647|NCT00063596|Vitamin A|vitamin a
761648|NCT00063596|Hepatitis B vaccine|hepatitis b vaccine
761649|NCT00063596|Immune responses|immune responses
761650|NCT00063596|T-cell subsets|t-cell subsets
761651|NCT00063596|Chronic lung disease|chronic lung disease
761652|NCT00063596|Cytokines, intracytoplasmic|cytokines, intracytoplasmic
761653|NCT00063596|Antibodies, hepatitis B and tetanus toxoid|antibodies, hepatitis b and tetanus toxoid
761654|NCT00063583|Kidney disease|kidney disease
761655|NCT00063570|Cancer of Breast|cancer of breast
761656|NCT00063570|Cancer of the Breast|cancer of the breast
761657|NCT00063323|Maintenance treatment|maintenance treatment
761658|NCT00063323|Smoking relapse|smoking relapse
761659|NCT00063323|Bupropion|bupropion
761660|NCT00063323|Nicotine replacement|nicotine replacement
761661|NCT00033319|colon cancer|colon cancer
761662|NCT00033319|rectal cancer|rectal cancer
761663|NCT00031954|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
761664|NCT00031954|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
761665|NCT00031954|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
761666|NCT00031954|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
761667|NCT00031954|fallopian tube cancer|fallopian tube cancer
761668|NCT00031954|primary peritoneal cavity cancer|primary peritoneal cavity cancer
761669|NCT00031889|adenocarcinoma of the prostate|adenocarcinoma of the prostate
761670|NCT00031889|stage IV prostate cancer|stage iv prostate cancer
761671|NCT00031889|recurrent prostate cancer|recurrent prostate cancer
761672|NCT00031668|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
761673|NCT00031668|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
761674|NCT00031668|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
761675|NCT00031668|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
761676|NCT00031668|anaplastic large cell lymphoma|anaplastic large cell lymphoma
761677|NCT00028938|squamous cell lung cancer|squamous cell lung cancer
761678|NCT00028938|large cell lung cancer|large cell lung cancer
761679|NCT00028938|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
761680|NCT00028938|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
761681|NCT00028938|adenocarcinoma of the lung|adenocarcinoma of the lung
761682|NCT00028938|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
761683|NCT00063479|Osteogenesis Imperfecta|osteogenesis imperfecta
761684|NCT00063479|OI|oi
761685|NCT00063479|bone markers|bone markers
761686|NCT00063479|fracture|fracture
761687|NCT00063479|bone loss|bone loss
761688|NCT00063479|pediatric|pediatric
761689|NCT00063479|bisphosphonate|bisphosphonate
761690|NCT00063479|brittle bone disease|brittle bone disease
761691|NCT00063479|pamidronate|pamidronate
761692|NCT00028925|extensive stage small cell lung cancer|extensive stage small cell lung cancer
761693|NCT00028613|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
761694|NCT00063427|Colorectal Cancer|colorectal cancer
761695|NCT00063427|Colorectal Carcinoma|colorectal carcinoma
761696|NCT00063427|Colorectal Tumors|colorectal tumors
761697|NCT00063427|Neoplasms, Colorectal|neoplasms, colorectal
761698|NCT00063427|Colorectal Neoplasms|colorectal neoplasms
761699|NCT00063401|ovarian|ovarian
761700|NCT00063401|primary peritoneal cancer|primary peritoneal cancer
761701|NCT00063401|fallopian tube cancer|fallopian tube cancer
761702|NCT00063388|Non|non
761703|NCT00063388|Small|small
761704|NCT00063388|Cell|cell
761705|NCT00063388|Lung|lung
761708|NCT00030446|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
761709|NCT00030446|fallopian tube cancer|fallopian tube cancer
761710|NCT00030446|peritoneal cavity cancer|peritoneal cavity cancer
761711|NCT00028483|stage IV breast cancer|stage iv breast cancer
761712|NCT00028483|recurrent breast cancer|recurrent breast cancer
761713|NCT00006968|stage III renal cell cancer|stage iii renal cell cancer
761714|NCT00006968|stage IV renal cell cancer|stage iv renal cell cancer
761715|NCT00006968|recurrent renal cell cancer|recurrent renal cell cancer
761716|NCT00003352|stage IV breast cancer|stage iv breast cancer
761717|NCT00003352|recurrent breast cancer|recurrent breast cancer
761718|NCT00003352|stage IIIB breast cancer|stage iiib breast cancer
761719|NCT00063310|Alzheimer disease|alzheimer disease
761720|NCT00063310|Aging Women|aging women
761721|NCT00063310|Hormone therapy|hormone therapy
762830|NCT00061334|Development|development
761722|NCT00063297|schizophrenia with negative symptoms|schizophrenia with negative symptoms
761723|NCT00040729|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
761724|NCT00063284|Electrical Stimulation|electrical stimulation
761725|NCT00063284|Human Brain|human brain
761726|NCT00063284|Parkinson Disease|parkinson disease
761727|NCT00063284|PD|pd
761728|NCT00063258|Non-Small Cell Lung Cancer|non-small cell lung cancer
761729|NCT00063258|Lung Cancer|lung cancer
761730|NCT00063258|OSI-774|osi-774
761731|NCT00063258|Tarceva|tarceva
761732|NCT00063258|Carboplatin|carboplatin
761733|NCT00063258|Paclitaxel|paclitaxel
761734|NCT00063258|NSCLC|nsclc
761735|NCT00063219|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
761736|NCT00063219|Lung Cancer|lung cancer
761737|NCT00063219|Cancer of Lung|cancer of lung
761738|NCT00063206|Depressive Disorder, Major|depressive disorder, major
761739|NCT00063206|Depression, Involutional|depression, involutional
761740|NCT00063193|Parkinson's disease|parkinson's disease
761741|NCT00063193|minocycline|minocycline
761742|NCT00063193|creatine|creatine
761743|NCT00063193|neuroprotection|neuroprotection
761744|NCT00063154|Lung cancer|lung cancer
761745|NCT00030797|stage III colon cancer|stage iii colon cancer
761746|NCT00030797|stage IV colon cancer|stage iv colon cancer
761747|NCT00030797|stage III rectal cancer|stage iii rectal cancer
761748|NCT00030797|stage IV rectal cancer|stage iv rectal cancer
761749|NCT00026520|stage IV melanoma|stage iv melanoma
761750|NCT00026520|recurrent melanoma|recurrent melanoma
761751|NCT00026364|stage IV colon cancer|stage iv colon cancer
761752|NCT00026364|stage IV rectal cancer|stage iv rectal cancer
761753|NCT00026364|recurrent colon cancer|recurrent colon cancer
761754|NCT00026364|recurrent rectal cancer|recurrent rectal cancer
761755|NCT00026364|adenocarcinoma of the colon|adenocarcinoma of the colon
761756|NCT00026364|adenocarcinoma of the rectum|adenocarcinoma of the rectum
761757|NCT00026351|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
761758|NCT00026351|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
761759|NCT00026351|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
761760|NCT00026351|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
761761|NCT00026351|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
761762|NCT00026351|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
761763|NCT00026351|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
761764|NCT00026351|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
761765|NCT00026351|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
761766|NCT00026351|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
761767|NCT00026351|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
761768|NCT00026351|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
761769|NCT00026351|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
761770|NCT00026351|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
761771|NCT00026351|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
761772|NCT00026351|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
761773|NCT00026351|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
761774|NCT00026351|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
761775|NCT00026351|prolymphocytic leukemia|prolymphocytic leukemia
761776|NCT00026351|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
761777|NCT00026351|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
761778|NCT00026351|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
761779|NCT00026351|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
761780|NCT00026351|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
761781|NCT00026351|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
761782|NCT00026351|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
761783|NCT00026351|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
761784|NCT00026351|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
761785|NCT00026351|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
761786|NCT00026351|stage I marginal zone lymphoma|stage i marginal zone lymphoma
761787|NCT00026351|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
761788|NCT00026351|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
761789|NCT00026351|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
761790|NCT00026351|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
761791|NCT00026351|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
761792|NCT00026351|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
761793|NCT00026351|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
761794|NCT00026351|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
761795|NCT00025571|squamous cell lung cancer|squamous cell lung cancer
761796|NCT00025571|large cell lung cancer|large cell lung cancer
761797|NCT00025571|adenocarcinoma of the lung|adenocarcinoma of the lung
761798|NCT00025571|stage I non-small cell lung cancer|stage i non-small cell lung cancer
761799|NCT00025571|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
761800|NCT00006013|refractory multiple myeloma|refractory multiple myeloma
761801|NCT00004037|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
761802|NCT00004037|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
761803|NCT00004037|primary peritoneal cavity cancer|primary peritoneal cavity cancer
761804|NCT00003054|recurrent uterine sarcoma|recurrent uterine sarcoma
761805|NCT00003054|uterine leiomyosarcoma|uterine leiomyosarcoma
761806|NCT00063245|Motor Cortex|motor cortex
761807|NCT00063245|Mood|mood
761808|NCT00063245|Reward|reward
761809|NCT00063245|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
761810|NCT00063245|Magnetic Coil|magnetic coil
761811|NCT00063245|Healthy Volunteer|healthy volunteer
761812|NCT00063245|HV|hv
761813|NCT00063232|Insulin|insulin
761814|NCT00063232|Obesity|obesity
761815|NCT00063232|Fatty Liver|fatty liver
761816|NCT00063232|Diabetes|diabetes
761817|NCT00063232|Cirrhosis|cirrhosis
761818|NCT00063232|Metformin|metformin
761819|NCT00063232|Insulin Resistance|insulin resistance
761820|NCT00063232|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
761821|NCT00063232|Hepatitis|hepatitis
761822|NCT00063232|NASH|nash
761823|NCT00063180|Diaschisis|diaschisis
761824|NCT00063180|Glucose|glucose
761825|NCT00063180|GABA|gaba
761826|NCT00063180|N-Acetylaspartate|n-acetylaspartate
761827|NCT00063180|Glutamate|glutamate
761828|NCT00063180|Stroke|stroke
761829|NCT00063180|Healthy Volunteer|healthy volunteer
761831|NCT00063115|Praxis Movements|praxis movements
761832|NCT00063115|Pantomime|pantomime
761833|NCT00063115|Statistical Parametric Mapping|statistical parametric mapping
761834|NCT00063115|Functional Connectivity|functional connectivity
761835|NCT00063115|Path Analysis|path analysis
761836|NCT00063115|Ideomotor Apraxia|ideomotor apraxia
761837|NCT00063115|Healthy Volunteer|healthy volunteer
761838|NCT00063115|HV|hv
761839|NCT00063089|Staphylococcal infection|staphylococcal infection
761840|NCT00063089|Gram positive bacteria|gram positive bacteria
761841|NCT00063089|Staphylococcus|staphylococcus
761842|NCT00063089|Staphylococcus aureus|staphylococcus aureus
761843|NCT00063076|Alopecia Areata|alopecia areata
761844|NCT00063076|Alopecia Totalis|alopecia totalis
761845|NCT00063076|Alopecia Universalis|alopecia universalis
761846|NCT00063076|Targretin Gel|targretin gel
761847|NCT00063063|NICHD Neonatal Research Network|nichd neonatal research network
761848|NCT00063063|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
761849|NCT00063063|Prematurity|prematurity
761850|NCT00063050|Bone density|bone density
761851|NCT00063050|Children|children
761852|NCT00063050|Adolescents|adolescents
761853|NCT00063050|Behavior|behavior
761854|NCT00063050|Health education|health education
761855|NCT00063050|Health promotion|health promotion
761856|NCT00063050|Physical fitness|physical fitness
761857|NCT00063050|Diet|diet
761858|NCT00063050|Parent training|parent training
761859|NCT00063050|Injury control|injury control
761860|NCT00063037|Bone mass|bone mass
761861|NCT00063037|Calcium intake|calcium intake
761862|NCT00063037|Prevention of osteoporosis|prevention of osteoporosis
761863|NCT00063037|Optimizing peak bone mass|optimizing peak bone mass
761864|NCT00063037|Bone mineral density|bone mineral density
761865|NCT00063024|Bone health|bone health
761866|NCT00063024|Weight-bearing physical activity|weight-bearing physical activity
761867|NCT00063024|Calcium|calcium
761868|NCT00063011|Weight-bearing exercise|weight-bearing exercise
761869|NCT00063011|Calcium-rich diet|calcium-rich diet
761870|NCT00063011|Adolescents|adolescents
761871|NCT00063011|Females|females
761872|NCT00063011|Bone mass|bone mass
761873|NCT00063011|Osteopenia|osteopenia
761874|NCT00025545|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
761875|NCT00025545|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
761876|NCT00025545|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
761877|NCT00025545|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
761878|NCT00025545|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
761879|NCT00025545|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
761880|NCT00025545|acute undifferentiated leukemia|acute undifferentiated leukemia
761881|NCT00025545|secondary acute myeloid leukemia|secondary acute myeloid leukemia
761882|NCT00024323|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
761883|NCT00024310|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
761884|NCT00024310|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
761885|NCT00024141|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
761886|NCT00062985|obesity treatment|obesity treatment
761887|NCT00062985|weight management|weight management
761888|NCT00062985|managed care|managed care
761889|NCT00062972|Multiple Sclerosis|multiple sclerosis
761890|NCT00062972|Cognitive Dysfunction|cognitive dysfunction
761892|NCT00062972|Verbal memory deficits|verbal memory deficits
761893|NCT00062959|Adolescence|adolescence
761894|NCT00062959|Parenting|parenting
761895|NCT00062959|School|school
761896|NCT00062959|Primary Prevention|primary prevention
761897|NCT00062959|School-based intervention|school-based intervention
761898|NCT00062894|Iodine I 131 Tositumomab|iodine i 131 tositumomab
761899|NCT00062894|BEXXAR|bexxar
761900|NCT00062894|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
761901|NCT00062946|Thalamus|thalamus
761902|NCT00062946|Cerebral Cortices|cerebral cortices
761903|NCT00062946|Quantification|quantification
761904|NCT00062946|Reproducibility|reproducibility
761905|NCT00062946|Dopamine Release|dopamine release
761906|NCT00062946|(18F) Fallypride|(18f) fallypride
761907|NCT00062946|D-Amphetamine|d-amphetamine
761908|NCT00062946|Alpha-Methyl-Para-Tyrosine (AMPT)|alpha-methyl-para-tyrosine (ampt)
761909|NCT00062946|PET|pet
761910|NCT00062946|Dopamine D2 Receptor|dopamine d2 receptor
761911|NCT00062946|Healthy Volunteer|healthy volunteer
761912|NCT00062946|HV|hv
761913|NCT00062933|Clinical Response|clinical response
761914|NCT00062933|Duration of Response|duration of response
761915|NCT00062933|Quality of Life|quality of life
761916|NCT00062933|Hyperthermia|hyperthermia
761917|NCT00062933|Survival|survival
761918|NCT00062933|Melanoma|melanoma
761919|NCT00062933|Ocular Melanoma|ocular melanoma
761920|NCT00062933|Eye Cancer|eye cancer
761921|NCT00062881|Cancer|cancer
761922|NCT00062881|Leukemia|leukemia
761923|NCT00062881|Lymphoma|lymphoma
761924|NCT00062881|Solid Tumor|solid tumor
761925|NCT00062868|Lymphoma|lymphoma
761926|NCT00062868|EBV-T/NK lymphoproliferative disease|ebv-t/nk lymphoproliferative disease
761927|NCT00062868|Severe Chronic EBV|severe chronic ebv
761928|NCT00062868|LMP1/2|lmp1/2
761929|NCT00062868|CTL|ctl
761930|NCT00062868|EBV|ebv
761931|NCT00062868|Relapse|relapse
761932|NCT00062855|GENE MODIFIED AUTOLOGOUS NEUROBLASTOMA CELLS|gene modified autologous neuroblastoma cells
761933|NCT00062855|Gene Therapy|gene therapy
761934|NCT00062829|Teen driving|teen driving
761935|NCT00062829|Adolescent risk behavior|adolescent risk behavior
761936|NCT00062829|Parenting|parenting
761937|NCT00062829|Checkpoints Program|checkpoints program
761938|NCT00062829|Health Education|health education
761939|NCT00062816|Hepatitis|hepatitis
761940|NCT00062816|Chronic|chronic
761941|NCT00002643|neutropenia|neutropenia
761942|NCT00002643|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
761943|NCT00062790|Testosterone|testosterone
761944|NCT00062790|DHT|dht
761945|NCT00062790|TURP|turp
761946|NCT00027612|adult glioblastoma|adult glioblastoma
761947|NCT00027612|adult giant cell glioblastoma|adult giant cell glioblastoma
761948|NCT00027612|adult gliosarcoma|adult gliosarcoma
761949|NCT00025376|stage IV renal cell cancer|stage iv renal cell cancer
761950|NCT00025376|recurrent renal cell cancer|recurrent renal cell cancer
761951|NCT00023868|stage IV colon cancer|stage iv colon cancer
761952|NCT00023868|stage IV rectal cancer|stage iv rectal cancer
761953|NCT00023868|recurrent colon cancer|recurrent colon cancer
761954|NCT00023868|recurrent rectal cancer|recurrent rectal cancer
761955|NCT00023868|adenocarcinoma of the colon|adenocarcinoma of the colon
761956|NCT00023868|adenocarcinoma of the rectum|adenocarcinoma of the rectum
761957|NCT00023868|liver metastases|liver metastases
761958|NCT00022594|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
761959|NCT00022594|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
761960|NCT00022594|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
761961|NCT00022594|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
761962|NCT00022594|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
761963|NCT00022594|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
761964|NCT00022594|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
761965|NCT00022594|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
761966|NCT00022594|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
761967|NCT00022594|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
761968|NCT00022594|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
761969|NCT00022594|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
761970|NCT00022594|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
761971|NCT00022594|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
761972|NCT00062777|Genetics|genetics
761973|NCT00062777|Populations|populations
761974|NCT00062777|CVD Risk|cvd risk
761975|NCT00062777|Gene Mapping|gene mapping
761976|NCT00062777|Epidemiology|epidemiology
761977|NCT00062777|Framingham Study|framingham study
761978|NCT00062777|Vascular Diseases|vascular diseases
762831|NCT00061334|Stereotypes|stereotypes
761979|NCT00062764|Insulin Resistance|insulin resistance
761980|NCT00062764|Obesity|obesity
761981|NCT00062764|Fatty Liver|fatty liver
761982|NCT00062764|Cirrhosis|cirrhosis
761983|NCT00062764|Diabetes|diabetes
761984|NCT00062764|Pioglitazone|pioglitazone
761985|NCT00062764|Thiazolidinediones|thiazolidinediones
761986|NCT00062764|Peroxisome Proliferator-Advanced Receptor Gamma|peroxisome proliferator-advanced receptor gamma
761987|NCT00062764|PPAR Gama|ppar gama
761988|NCT00062764|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
761989|NCT00062764|Hepatitis|hepatitis
761990|NCT00062764|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
761991|NCT00062764|NASH|nash
761992|NCT00062751|breast|breast
761993|NCT00062751|neoplasms|neoplasms
761994|NCT00062738|Parkinson's disease|parkinson's disease
761995|NCT00062738|Parkinson disease|parkinson disease
761996|NCT00062738|depression|depression
761997|NCT00062738|antidepressants|antidepressants
761998|NCT00062738|nortriptyline|nortriptyline
761999|NCT00062738|paroxetine|paroxetine
762000|NCT00062712|Immunosuppression|immunosuppression
762001|NCT00062712|Transplant|transplant
762002|NCT00062712|Kidney Transplant|kidney transplant
762003|NCT00062686|Lapatinib|lapatinib
762004|NCT00062686|Metastatic Breast Cancer|metastatic breast cancer
762005|NCT00062686|HERCEPTIN refractory|herceptin refractory
762006|NCT00062634|Female condom use|female condom use
762007|NCT00062634|Male condom use|male condom use
762008|NCT00062634|AIDS education|aids education
762009|NCT00062634|AIDS prevention|aids prevention
762010|NCT00062634|HIV Seronegativity|hiv seronegativity
762011|NCT00062621|Immune tolerance|immune tolerance
762012|NCT00062621|Graft vs host disease|graft vs host disease
762013|NCT00062621|Kidney Failure|kidney failure
762014|NCT00062621|Kidney diseases|kidney diseases
762015|NCT00062621|End Stage Renal Disease|end stage renal disease
762016|NCT00062621|Multiple Myeloma|multiple myeloma
762017|NCT00062621|Bone Marrow Transplant|bone marrow transplant
762018|NCT00062621|Kidney Transplant|kidney transplant
762019|NCT00062621|Renal Transplant|renal transplant
762020|NCT00062621|Tolerance|tolerance
762021|NCT00062621|Chimerism|chimerism
762022|NCT00062621|ESRD|esrd
762023|NCT00062608|Abdominal|abdominal
762024|NCT00062595|Menopause|menopause
762025|NCT00062595|Vitamin K|vitamin k
762026|NCT00062595|Bone turnover|bone turnover
762027|NCT00062595|Bone Density|bone density
762028|NCT00062569|Alzheimer disease|alzheimer disease
762029|NCT00062569|Resistiveness to baths|resistiveness to baths
762030|NCT00062569|Caregiver stress|caregiver stress
762031|NCT00062569|Bathing support intervention|bathing support intervention
762032|NCT00062569|Reminiscence|reminiscence
762033|NCT00062569|Agitated behavior|agitated behavior
762034|NCT00062569|Resistiveness to care|resistiveness to care
762035|NCT00062556|Intermittent Claudication|intermittent claudication
762036|NCT00062556|Peripheral Arterial Disease|peripheral arterial disease
762037|NCT00062556|Atherosclerosis|atherosclerosis
762038|NCT00062556|Niacin|niacin
762039|NCT00062556|Lovastatin|lovastatin
762040|NCT00062556|PAD|pad
762041|NCT00062556|IC|ic
762042|NCT00062543|Severe hepatic dysfunction post stem cell transplantation|severe hepatic dysfunction post stem cell transplantation
762043|NCT00062543|Stem Cell Transplantation|stem cell transplantation
762044|NCT00062543|Hepatic Artery Infusion|hepatic artery infusion
762045|NCT00062543|Liver Diseases|liver diseases
762046|NCT00062543|CD34+ Cells|cd34+ cells
762047|NCT00062543|SCT|sct
762048|NCT00062530|AIDS|aids
762049|NCT00062530|HIV seronegativity|hiv seronegativity
762050|NCT00062530|HIV preventive vaccine|hiv preventive vaccine
762051|NCT00022009|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
762052|NCT00022009|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
762053|NCT00022009|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
762054|NCT00018954|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
762055|NCT00018954|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
762056|NCT00018954|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
762057|NCT00018954|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
762058|NCT00018954|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
762059|NCT00018954|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
762060|NCT00018954|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
762061|NCT00018954|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
762062|NCT00018954|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
762063|NCT00018954|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
762064|NCT00018954|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
762065|NCT00018954|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
762066|NCT00018954|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
762067|NCT00018954|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
762068|NCT00018954|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
762069|NCT00018954|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
762070|NCT00018954|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
762071|NCT00018954|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
762072|NCT00018954|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
762073|NCT00018954|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
762074|NCT00018954|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
762075|NCT00018954|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
762076|NCT00018954|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
762077|NCT00018954|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
762078|NCT00018954|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
762079|NCT00018954|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
762080|NCT00018954|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
762081|NCT00018954|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
762082|NCT00018954|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
762083|NCT00018954|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
762084|NCT00018954|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
762085|NCT00018954|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
762086|NCT00018954|stage I mantle cell lymphoma|stage i mantle cell lymphoma
762087|NCT00018954|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
762088|NCT00018954|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
762089|NCT00018954|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
762090|NCT00018954|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
762091|NCT00018954|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
762092|NCT00018954|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
762093|NCT00018954|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
762094|NCT00018954|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
762095|NCT00018954|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
762096|NCT00018954|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
762097|NCT00018954|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
762098|NCT00018954|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
762099|NCT00018954|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
762100|NCT00018954|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
762101|NCT00018954|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
762102|NCT00018954|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
762103|NCT00018954|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
762104|NCT00018954|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
762105|NCT00018954|stage I marginal zone lymphoma|stage i marginal zone lymphoma
762106|NCT00018954|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
762107|NCT00018954|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
762108|NCT00018954|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
762109|NCT00018954|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
762110|NCT00018954|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
762111|NCT00018954|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
762112|NCT00018954|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
762113|NCT00018954|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
762114|NCT00018954|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
762115|NCT00018954|splenic marginal zone lymphoma|splenic marginal zone lymphoma
762116|NCT00017446|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
762117|NCT00017446|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
762118|NCT00017446|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
762119|NCT00017316|stage IV melanoma|stage iv melanoma
762120|NCT00017316|recurrent melanoma|recurrent melanoma
762121|NCT00062582|Roflumilast|roflumilast
762122|NCT00062582|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
762123|NCT00062582|COPD|copd
762124|NCT00014664|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
762125|NCT00014664|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
762126|NCT00014664|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
762127|NCT00014664|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
762128|NCT00014664|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
762129|NCT00014664|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
762130|NCT00014534|stage III bladder cancer|stage iii bladder cancer
762131|NCT00014534|stage IV bladder cancer|stage iv bladder cancer
762132|NCT00014534|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
762133|NCT00062517|Amygdala|amygdala
762134|NCT00062517|Generalized Anxiety Disorder|generalized anxiety disorder
762135|NCT00062517|Anxiety Disorder|anxiety disorder
762136|NCT00062517|GAD|gad
762137|NCT00062517|Social Anxiety Disorder|social anxiety disorder
762138|NCT00062517|SAD|sad
762139|NCT00012155|stage IV colon cancer|stage iv colon cancer
762140|NCT00012155|recurrent colon cancer|recurrent colon cancer
762141|NCT00012155|adenocarcinoma of the colon|adenocarcinoma of the colon
762142|NCT00012155|liver metastases|liver metastases
762143|NCT00062465|DMARD|dmard
762144|NCT00062465|Clinical Trial|clinical trial
762145|NCT00062465|Thunder God Vine|thunder god vine
762146|NCT00062465|Chinese Herb|chinese herb
762147|NCT00062465|Rheumatoid Arthritis|rheumatoid arthritis
762148|NCT00062465|RA|ra
762149|NCT00062452|Esophageal|esophageal
762150|NCT00062452|Airway|airway
762151|NCT00062439|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
762152|NCT00062439|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
762153|NCT00062439|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
762154|NCT00062426|adenocarcinoma of the colon|adenocarcinoma of the colon
762155|NCT00062426|adenocarcinoma of the rectum|adenocarcinoma of the rectum
762156|NCT00062426|recurrent colon cancer|recurrent colon cancer
762157|NCT00062426|stage IV colon cancer|stage iv colon cancer
762158|NCT00062426|recurrent rectal cancer|recurrent rectal cancer
762159|NCT00062426|stage IV rectal cancer|stage iv rectal cancer
762160|NCT00062400|sexual dysfunction and infertility|sexual dysfunction and infertility
762161|NCT00062400|sexuality and reproductive issues|sexuality and reproductive issues
762162|NCT00062400|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
762163|NCT00062400|stage II breast cancer|stage ii breast cancer
762164|NCT00062400|stage IA breast cancer|stage ia breast cancer
762165|NCT00062400|stage IB breast cancer|stage ib breast cancer
762166|NCT00062387|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
762167|NCT00062387|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
762168|NCT00062387|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
762169|NCT00062387|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
762170|NCT00062387|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
762171|NCT00062387|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
762172|NCT00062387|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
762173|NCT00062387|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
762174|NCT00062387|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
762175|NCT00062387|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
762176|NCT00062387|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
762177|NCT00062387|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
762178|NCT00062387|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
762179|NCT00062387|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
762180|NCT00062387|recurrent salivary gland cancer|recurrent salivary gland cancer
762181|NCT00062387|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
762182|NCT00062387|stage IV salivary gland cancer|stage iv salivary gland cancer
762183|NCT00062348|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
762184|NCT00062348|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
762185|NCT00062348|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
762186|NCT00062348|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
762187|NCT00062348|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
762188|NCT00062348|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
762189|NCT00062348|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
762190|NCT00062348|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
762191|NCT00062348|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
762192|NCT00062348|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
762193|NCT00062348|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
762194|NCT00062348|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
762195|NCT00062348|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
762196|NCT00062348|recurrent thyroid cancer|recurrent thyroid cancer
762197|NCT00062348|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
762198|NCT00062348|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
762199|NCT00062348|stage IVA colon cancer|stage iva colon cancer
762200|NCT00062348|stage IVB colon cancer|stage ivb colon cancer
762201|NCT00062348|recurrent colon cancer|recurrent colon cancer
762202|NCT00062348|adenocarcinoma of the colon|adenocarcinoma of the colon
762203|NCT00062348|recurrent rectal cancer|recurrent rectal cancer
762204|NCT00062348|stage IVA rectal cancer|stage iva rectal cancer
762205|NCT00062348|stage IVB rectal cancer|stage ivb rectal cancer
762206|NCT00062348|adenocarcinoma of the rectum|adenocarcinoma of the rectum
762207|NCT00062348|anaplastic thyroid cancer|anaplastic thyroid cancer
762208|NCT00062348|insular thyroid cancer|insular thyroid cancer
762209|NCT00062348|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
762210|NCT00062348|liver metastases|liver metastases
762211|NCT00062348|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
762212|NCT00062348|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
762213|NCT00062348|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
762214|NCT00062348|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
762215|NCT00062348|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
762216|NCT00062348|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
762217|NCT00062348|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
762218|NCT00062348|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
762219|NCT00062348|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
762220|NCT00062348|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
762221|NCT00062348|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
762222|NCT00062348|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
762223|NCT00062348|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
762224|NCT00062348|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
762225|NCT00062348|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
762226|NCT00062348|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
762227|NCT00062348|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
762228|NCT00062348|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
762229|NCT00062348|stage I papillary thyroid cancer|stage i papillary thyroid cancer
762230|NCT00062348|stage II papillary thyroid cancer|stage ii papillary thyroid cancer
762231|NCT00062348|stage III papillary thyroid cancer|stage iii papillary thyroid cancer
762232|NCT00062348|stage I follicular thyroid cancer|stage i follicular thyroid cancer
762233|NCT00062348|stage II follicular thyroid cancer|stage ii follicular thyroid cancer
762234|NCT00062348|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
762235|NCT00062348|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
762236|NCT00062348|recurrent salivary gland cancer|recurrent salivary gland cancer
762237|NCT00062348|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
762238|NCT00062348|stage I salivary gland cancer|stage i salivary gland cancer
762239|NCT00062348|stage II salivary gland cancer|stage ii salivary gland cancer
762240|NCT00062348|stage III salivary gland cancer|stage iii salivary gland cancer
762241|NCT00062348|stage IV salivary gland cancer|stage iv salivary gland cancer
762242|NCT00062348|tongue cancer|tongue cancer
762243|NCT00062335|stage I non-small cell lung cancer|stage i non-small cell lung cancer
762244|NCT00062335|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
762245|NCT00062335|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
762246|NCT00062322|limited stage small cell lung cancer|limited stage small cell lung cancer
762247|NCT00062309|stage II prostate cancer|stage ii prostate cancer
762248|NCT00062309|stage III prostate cancer|stage iii prostate cancer
762249|NCT00062309|adenocarcinoma of the prostate|adenocarcinoma of the prostate
762250|NCT00062296|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
762251|NCT00062296|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
762252|NCT00062296|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
762253|NCT00062296|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
762254|NCT00062296|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
762255|NCT00062296|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
762256|NCT00062296|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
762257|NCT00062296|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
762258|NCT00062296|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
762259|NCT00062296|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
762260|NCT00062296|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
762261|NCT00062296|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
762262|NCT00062296|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
762263|NCT00062296|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
762264|NCT00062296|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
762265|NCT00062296|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
762266|NCT00062296|splenic marginal zone lymphoma|splenic marginal zone lymphoma
762267|NCT00062283|advanced malignant mesothelioma|advanced malignant mesothelioma
762268|NCT00062283|recurrent malignant mesothelioma|recurrent malignant mesothelioma
762269|NCT00062283|metastatic osteosarcoma|metastatic osteosarcoma
762270|NCT00062283|recurrent osteosarcoma|recurrent osteosarcoma
762271|NCT00062283|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
762272|NCT00062283|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
762273|NCT00062283|chondrosarcoma|chondrosarcoma
762274|NCT00062283|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
762275|NCT00062283|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
762276|NCT00062283|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
762277|NCT00062283|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
762278|NCT00062283|recurrent pancreatic cancer|recurrent pancreatic cancer
762279|NCT00062283|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
762280|NCT00062283|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
762281|NCT00062283|stage IV pancreatic cancer|stage iv pancreatic cancer
762282|NCT00062270|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
762283|NCT00062270|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
762284|NCT00062257|recurrent gastric cancer|recurrent gastric cancer
762285|NCT00062257|stage IV gastric cancer|stage iv gastric cancer
762286|NCT00062257|adenocarcinoma of the stomach|adenocarcinoma of the stomach
762287|NCT00062231|infection|infection
762288|NCT00062231|neutropenia|neutropenia
762289|NCT00062231|fever, sweats, and hot flashes|fever, sweats, and hot flashes
762290|NCT00062231|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
762291|NCT00062231|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
762292|NCT00062231|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
762293|NCT00062231|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
762294|NCT00062231|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
762295|NCT00062231|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
762296|NCT00062231|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
762297|NCT00062231|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
762298|NCT00062231|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
762299|NCT00062231|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
762300|NCT00062231|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
762301|NCT00062231|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
762302|NCT00062231|isolated plasmacytoma of bone|isolated plasmacytoma of bone
762303|NCT00062231|extramedullary plasmacytoma|extramedullary plasmacytoma
762304|NCT00062231|refractory multiple myeloma|refractory multiple myeloma
762305|NCT00062231|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
762306|NCT00062231|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
762307|NCT00062231|stage I multiple myeloma|stage i multiple myeloma
762308|NCT00062231|stage II multiple myeloma|stage ii multiple myeloma
762309|NCT00062231|stage III multiple myeloma|stage iii multiple myeloma
762310|NCT00062231|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
762311|NCT00062231|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
762312|NCT00062231|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
762313|NCT00062231|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
762314|NCT00062231|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
762315|NCT00062231|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
762316|NCT00062231|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
762317|NCT00062231|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
762318|NCT00062231|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
762319|NCT00062231|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
762320|NCT00062231|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
762321|NCT00062231|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
762322|NCT00062231|polycythemia vera|polycythemia vera
762323|NCT00062231|primary myelofibrosis|primary myelofibrosis
762324|NCT00062231|essential thrombocythemia|essential thrombocythemia
762325|NCT00062231|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
762326|NCT00062231|refractory hairy cell leukemia|refractory hairy cell leukemia
762327|NCT00062231|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
762328|NCT00062231|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
762329|NCT00062231|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
762330|NCT00062231|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
762331|NCT00062231|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
762332|NCT00062231|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
762333|NCT00062231|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
762334|NCT00062231|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
762335|NCT00062231|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
762336|NCT00062231|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
762337|NCT00062231|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
762338|NCT00062231|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
762339|NCT00062231|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
762340|NCT00062231|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
762341|NCT00062231|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
762342|NCT00062231|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
762343|NCT00062231|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
762344|NCT00062231|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
762345|NCT00062231|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
762346|NCT00062231|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
762347|NCT00062231|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
762348|NCT00062231|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
762349|NCT00062231|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
762350|NCT00062231|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
762351|NCT00062231|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
762352|NCT00062231|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
762353|NCT00062231|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
762354|NCT00062231|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
762355|NCT00062231|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
762356|NCT00062231|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
762357|NCT00062231|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
762358|NCT00062231|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
762359|NCT00062231|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
762360|NCT00062231|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
762361|NCT00062231|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
762362|NCT00062231|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
762363|NCT00062231|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
762364|NCT00062231|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
762365|NCT00062231|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
762366|NCT00062231|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
762367|NCT00062231|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
762368|NCT00062231|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
762369|NCT00062231|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
762370|NCT00062231|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
762371|NCT00062231|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
762372|NCT00062231|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
762373|NCT00062231|acute undifferentiated leukemia|acute undifferentiated leukemia
762374|NCT00062231|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
762375|NCT00062231|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
762376|NCT00062231|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
762377|NCT00062231|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
762378|NCT00062231|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
762379|NCT00062231|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
762380|NCT00062231|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
762381|NCT00062231|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
762382|NCT00062231|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
762383|NCT00062231|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
762384|NCT00062231|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
762385|NCT00062231|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
762386|NCT00062231|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
762387|NCT00062231|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
762388|NCT00062231|prolymphocytic leukemia|prolymphocytic leukemia
762389|NCT00062231|primary systemic amyloidosis|primary systemic amyloidosis
762390|NCT00062231|intraocular lymphoma|intraocular lymphoma
762391|NCT00062231|stage I mantle cell lymphoma|stage i mantle cell lymphoma
762392|NCT00062231|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
762393|NCT00062231|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
762394|NCT00062231|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
762395|NCT00062231|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
762396|NCT00062231|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
762397|NCT00062231|anaplastic large cell lymphoma|anaplastic large cell lymphoma
762398|NCT00062231|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
762399|NCT00062231|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
762400|NCT00062231|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
762401|NCT00062231|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
762402|NCT00062231|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
762403|NCT00062231|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
762404|NCT00062231|chronic eosinophilic leukemia|chronic eosinophilic leukemia
762405|NCT00062231|chronic neutrophilic leukemia|chronic neutrophilic leukemia
762406|NCT00062231|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
762407|NCT00062231|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
762408|NCT00062231|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
762409|NCT00062231|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
762410|NCT00062231|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
762411|NCT00062231|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
762412|NCT00062231|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
762413|NCT00062231|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
762414|NCT00062231|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
762415|NCT00062231|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
762416|NCT00062231|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
762417|NCT00062231|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
762418|NCT00062231|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
762419|NCT00062231|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
762420|NCT00062231|splenic marginal zone lymphoma|splenic marginal zone lymphoma
762421|NCT00062231|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
762422|NCT00062231|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
762423|NCT00062231|stage I marginal zone lymphoma|stage i marginal zone lymphoma
762424|NCT00062231|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
762425|NCT00062231|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
762426|NCT00062231|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
762427|NCT00062231|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
762428|NCT00062231|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
762429|NCT00062231|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
762430|NCT00062231|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
762431|NCT00062231|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
762432|NCT00062231|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
762433|NCT00062231|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
762434|NCT00062205|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
762435|NCT00062179|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
762436|NCT00062166|Imaging Studies|imaging studies
762437|NCT00062166|Rate of Tumor Growth|rate of tumor growth
762438|NCT00062166|Familial Cancer Syndrome|familial cancer syndrome
762439|NCT00062166|Surgical Resection|surgical resection
762440|NCT00062140|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
762441|NCT00062140|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
762442|NCT00062140|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
762443|NCT00062140|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
762444|NCT00062140|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
762445|NCT00062140|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
762446|NCT00062140|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
762447|NCT00062140|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
762448|NCT00062140|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
762449|NCT00062140|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
762450|NCT00062140|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
762451|NCT00062140|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
762452|NCT00062140|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
762453|NCT00062140|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
762454|NCT00062140|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
762455|NCT00062140|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
762832|NCT00061334|Memory|memory
762456|NCT00062140|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
762457|NCT00062140|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
762458|NCT00062140|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
762459|NCT00062140|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
762460|NCT00062140|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
762461|NCT00062140|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
762462|NCT00062140|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
762463|NCT00062140|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
762464|NCT00062140|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
762465|NCT00062140|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
762466|NCT00062140|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
762467|NCT00062140|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
762468|NCT00062140|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
762469|NCT00062140|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
762470|NCT00062140|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
762471|NCT00062140|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
762472|NCT00062140|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
762473|NCT00062140|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
762474|NCT00062140|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
762475|NCT00062140|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
762476|NCT00062140|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
762477|NCT00062140|secondary acute myeloid leukemia|secondary acute myeloid leukemia
762478|NCT00062140|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
762479|NCT00062140|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
762480|NCT00062140|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
762481|NCT00062140|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
762482|NCT00062140|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
762483|NCT00062140|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
762484|NCT00062140|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
762485|NCT00062140|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
762486|NCT00062140|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
762487|NCT00062140|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
762488|NCT00062140|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
762489|NCT00062140|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
762490|NCT00062140|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
762491|NCT00062140|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
762492|NCT00062140|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
762493|NCT00062140|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
762494|NCT00062140|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
762495|NCT00062140|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
762496|NCT00062140|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
762497|NCT00062140|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
762498|NCT00062140|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
762499|NCT00062140|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
762500|NCT00062140|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
762501|NCT00062140|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
762502|NCT00062140|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
762503|NCT00062140|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
762504|NCT00062140|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
762505|NCT00062140|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
762506|NCT00062140|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
762507|NCT00062140|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
762508|NCT00062140|splenic marginal zone lymphoma|splenic marginal zone lymphoma
762509|NCT00062140|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
762510|NCT00062140|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
762511|NCT00062140|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
762512|NCT00062140|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
762513|NCT00062140|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
762514|NCT00062114|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
762515|NCT00062114|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
762516|NCT00062114|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
762517|NCT00062062|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
762518|NCT00062062|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
762519|NCT00062049|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
762520|NCT00062036|stage IV melanoma|stage iv melanoma
762521|NCT00062036|recurrent melanoma|recurrent melanoma
762522|NCT00062023|colorectal cancer|colorectal cancer
762523|NCT00062023|stage I colon cancer|stage i colon cancer
762524|NCT00062023|stage II colon cancer|stage ii colon cancer
762525|NCT00062023|stage III colon cancer|stage iii colon cancer
762526|NCT00062023|stage IV colon cancer|stage iv colon cancer
762527|NCT00062010|recurrent small cell lung cancer|recurrent small cell lung cancer
762528|NCT00061997|non-small cell lung cancer|non-small cell lung cancer
762529|NCT00061997|small cell lung cancer|small cell lung cancer
762530|NCT00061997|precancerous condition|precancerous condition
762531|NCT00061984|adult angiosarcoma|adult angiosarcoma
762532|NCT00061984|adult epithelioid sarcoma|adult epithelioid sarcoma
762533|NCT00061984|adult fibrosarcoma|adult fibrosarcoma
762534|NCT00061984|adult leiomyosarcoma|adult leiomyosarcoma
762535|NCT00061984|adult liposarcoma|adult liposarcoma
762536|NCT00061984|adult rhabdomyosarcoma|adult rhabdomyosarcoma
762537|NCT00061984|adult synovial sarcoma|adult synovial sarcoma
762538|NCT00061984|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
762539|NCT00061984|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
762540|NCT00061984|adult neurofibrosarcoma|adult neurofibrosarcoma
762541|NCT00061984|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
762542|NCT00061984|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
762543|NCT00061919|extensive stage small cell lung cancer|extensive stage small cell lung cancer
762544|NCT00061919|limited stage small cell lung cancer|limited stage small cell lung cancer
762545|NCT00061906|insular thyroid cancer|insular thyroid cancer
762546|NCT00061906|recurrent thyroid cancer|recurrent thyroid cancer
762547|NCT00061906|stage II follicular thyroid cancer|stage ii follicular thyroid cancer
762548|NCT00061906|stage II papillary thyroid cancer|stage ii papillary thyroid cancer
762549|NCT00061906|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
762550|NCT00061906|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
762551|NCT00061893|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
762552|NCT00061880|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
762553|NCT00061880|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
762554|NCT00061880|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
762555|NCT00061880|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
762556|NCT00061880|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
762557|NCT00061880|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
762558|NCT00061880|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
762559|NCT00061880|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
762560|NCT00061880|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
762561|NCT00061880|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
762562|NCT00061867|adenocarcinoma of the prostate|adenocarcinoma of the prostate
762563|NCT00061867|stage III prostate cancer|stage iii prostate cancer
762564|NCT00061867|stage IV prostate cancer|stage iv prostate cancer
762565|NCT00061854|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
762566|NCT00061854|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
762567|NCT00061854|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
762568|NCT00061854|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
762569|NCT00010231|adenocarcinoma of the prostate|adenocarcinoma of the prostate
762570|NCT00010231|stage III prostate cancer|stage iii prostate cancer
762571|NCT00010231|stage IV prostate cancer|stage iv prostate cancer
762572|NCT00010231|recurrent prostate cancer|recurrent prostate cancer
762573|NCT00010114|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
762574|NCT00010114|childhood choroid plexus tumor|childhood choroid plexus tumor
762575|NCT00010114|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
762576|NCT00010114|untreated childhood medulloblastoma|untreated childhood medulloblastoma
762577|NCT00010114|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
762578|NCT00009932|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
762579|NCT00009802|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
762580|NCT00009789|stage I non-small cell lung cancer|stage i non-small cell lung cancer
762581|NCT00009789|squamous cell lung cancer|squamous cell lung cancer
762582|NCT00009789|large cell lung cancer|large cell lung cancer
762583|NCT00009789|adenocarcinoma of the lung|adenocarcinoma of the lung
762584|NCT00009789|adenosquamous cell lung cancer|adenosquamous cell lung cancer
762585|NCT00009789|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
762586|NCT00008424|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
762587|NCT00008398|stage I nasopharyngeal cancer|stage i nasopharyngeal cancer
762588|NCT00008398|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
762589|NCT00008398|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
762590|NCT00008398|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
762591|NCT00008398|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
762592|NCT00008398|stage 0 paranasal sinus and nasal cavity cancer|stage 0 paranasal sinus and nasal cavity cancer
762593|NCT00008398|stage 0 nasopharyngeal cancer|stage 0 nasopharyngeal cancer
762594|NCT00008398|stage 0 oropharyngeal cancer|stage 0 oropharyngeal cancer
762595|NCT00008398|stage 0 laryngeal cancer|stage 0 laryngeal cancer
762596|NCT00008398|stage 0 hypopharyngeal cancer|stage 0 hypopharyngeal cancer
762597|NCT00008398|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
762598|NCT00008398|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
762599|NCT00008398|stage 0 lip and oral cavity cancer|stage 0 lip and oral cavity cancer
762600|NCT00008398|stage I lip and oral cavity cancer|stage i lip and oral cavity cancer
762601|NCT00008398|stage II lip and oral cavity cancer|stage ii lip and oral cavity cancer
762602|NCT00008398|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
762603|NCT00008398|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
762604|NCT00008398|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
762605|NCT00008398|stage I hypopharyngeal cancer|stage i hypopharyngeal cancer
762606|NCT00008398|stage II hypopharyngeal cancer|stage ii hypopharyngeal cancer
762607|NCT00008398|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
762608|NCT00008398|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
762609|NCT00008398|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
762610|NCT00008398|stage I paranasal sinus and nasal cavity cancer|stage i paranasal sinus and nasal cavity cancer
762611|NCT00008398|stage II paranasal sinus and nasal cavity cancer|stage ii paranasal sinus and nasal cavity cancer
762612|NCT00008398|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
762613|NCT00008398|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
762614|NCT00008398|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
762615|NCT00008398|stage I oropharyngeal cancer|stage i oropharyngeal cancer
762616|NCT00008398|stage II oropharyngeal cancer|stage ii oropharyngeal cancer
762617|NCT00008398|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
762618|NCT00008398|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
762619|NCT00008398|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
762620|NCT00008398|oral complications|oral complications
762621|NCT00008398|radiation toxicity|radiation toxicity
762622|NCT00008203|stage II breast cancer|stage ii breast cancer
762623|NCT00008203|stage IIIA breast cancer|stage iiia breast cancer
762624|NCT00008203|stage IIIB breast cancer|stage iiib breast cancer
762625|NCT00008112|stage III cervical cancer|stage iii cervical cancer
762626|NCT00008112|stage IIB cervical cancer|stage iib cervical cancer
762627|NCT00008112|stage IVA cervical cancer|stage iva cervical cancer
762628|NCT00008112|cervical squamous cell carcinoma|cervical squamous cell carcinoma
762629|NCT00008112|cervical adenocarcinoma|cervical adenocarcinoma
762630|NCT00008112|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
762631|NCT00061789|Schizophrenia|schizophrenia
762632|NCT00061789|SPECT|spect
762633|NCT00061789|Nicotinic Acetylcholine Receptors|nicotinic acetylcholine receptors
762634|NCT00061789|Cigarette Smoking|cigarette smoking
762635|NCT00061789|Cognitive Dysfunction|cognitive dysfunction
762636|NCT00061789|Reproducibility|reproducibility
762637|NCT00061789|Quantification|quantification
762638|NCT00061789|Healthy Volunteer|healthy volunteer
762640|NCT00061776|Dermal assessment|dermal assessment
762641|NCT00061776|Pain measurement|pain measurement
762642|NCT00061776|Diary|diary
762643|NCT00061776|Shingles|shingles
762644|NCT00061776|Neuropathy|neuropathy
762645|NCT00061776|Analgesics/*therapeutic use|analgesics/*therapeutic use
762646|NCT00061776|Capsaicin/*administration & dosage/adverse effects|capsaicin/*administration & dosage/adverse effects
762647|NCT00061776|Herpes Zoster/*complications/drug therapy|herpes zoster/*complications/drug therapy
762648|NCT00061776|Neuralgia/*drug therapy/etiology|neuralgia/*drug therapy/etiology
762649|NCT00061776|Pain|pain
762650|NCT00061776|Peripheral Nervous System Diseases/*complications|peripheral nervous system diseases/*complications
762651|NCT00061763|beta-thalassemia|beta-thalassemia
762652|NCT00061763|iron overload|iron overload
762653|NCT00061763|deferoxamine|deferoxamine
762654|NCT00061763|Myelodysplastic Syndromes|myelodysplastic syndromes
762655|NCT00061763|Fanconi Syndrome|fanconi syndrome
762656|NCT00061763|Anemia, Diamond-Blackfan|anemia, diamond-blackfan
762657|NCT00061763|Anemia, Aplastic|anemia, aplastic
762658|NCT00061750|Thalassemia, iron overload, deferoxamine, hemosiderosis|thalassemia, iron overload, deferoxamine, hemosiderosis
762659|NCT00061737|Pediatric IBD|pediatric ibd
762660|NCT00061737|Inflammatory|inflammatory
762661|NCT00061737|Bowel|bowel
762662|NCT00061724|Esophageal|esophageal
762663|NCT00061724|Reflux|reflux
762664|NCT00061672|Non-Hodgkin's Lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
762665|NCT00061672|Hodgkin's Lymphoma (HL)|hodgkin's lymphoma (hl)
762666|NCT00061659|high grade locally advanced/metastatic soft tissue sarcoma|high grade locally advanced/metastatic soft tissue sarcoma
762667|NCT00061646|Stage IIIb with pleural effusion or IV NSCLC|stage iiib with pleural effusion or iv nsclc
762668|NCT00051714|Social Behavior Disorders|social behavior disorders
762669|NCT00061620|Investigational|investigational
762670|NCT00061620|Chemotherapy|chemotherapy
762671|NCT00061620|Hematologic Malignancies|hematologic malignancies
762672|NCT00061620|Nucleoside analogue|nucleoside analogue
762673|NCT00059462|Treatment experienced|treatment experienced
762674|NCT00008021|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
762675|NCT00008021|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
762676|NCT00008021|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
762677|NCT00008021|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
762678|NCT00008021|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
762679|NCT00008021|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
762680|NCT00008021|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
762681|NCT00008021|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
762682|NCT00008021|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
762683|NCT00008021|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
762684|NCT00008021|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
762685|NCT00008021|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
762686|NCT00008021|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
762687|NCT00008021|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
762688|NCT00008021|splenic marginal zone lymphoma|splenic marginal zone lymphoma
762689|NCT00006864|stage IV renal cell cancer|stage iv renal cell cancer
762690|NCT00006864|recurrent renal cell cancer|recurrent renal cell cancer
762691|NCT00006864|clear cell renal cell carcinoma|clear cell renal cell carcinoma
762692|NCT00006484|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
762693|NCT00006484|squamous cell lung cancer|squamous cell lung cancer
762694|NCT00006484|large cell lung cancer|large cell lung cancer
762695|NCT00006484|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
762696|NCT00006484|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
762697|NCT00006484|adenocarcinoma of the lung|adenocarcinoma of the lung
762698|NCT00061607|Motor Neuron Disease|motor neuron disease
762699|NCT00061607|Neuromuscular Disease|neuromuscular disease
762700|NCT00061607|Histone Deacytelase Inhibitors|histone deacytelase inhibitors
762701|NCT00061607|Spinal Muscular Atrophy|spinal muscular atrophy
762702|NCT00061607|SMA|sma
762703|NCT00061594|Neovascular age-related macular degeneration|neovascular age-related macular degeneration
762704|NCT00061542|Glaucoma|glaucoma
762705|NCT00061542|Ocular Hypertension|ocular hypertension
762706|NCT00061529|Open-Angle Glaucoma|open-angle glaucoma
762707|NCT00061529|Ocular Hypertension|ocular hypertension
762708|NCT00061516|Glaucoma|glaucoma
762709|NCT00061516|Ocular Hypertension|ocular hypertension
762710|NCT00061503|Glaucoma|glaucoma
762711|NCT00061503|Ocular Hypertension|ocular hypertension
762712|NCT00006464|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
762713|NCT00006457|non-small cell lung cancer|non-small cell lung cancer
762714|NCT00006457|small cell lung cancer|small cell lung cancer
762715|NCT00006383|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
762716|NCT00006383|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
762717|NCT00006383|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
762718|NCT00006383|anaplastic large cell lymphoma|anaplastic large cell lymphoma
762719|NCT00006377|stage III endometrial carcinoma|stage iii endometrial carcinoma
762720|NCT00006377|stage IV endometrial carcinoma|stage iv endometrial carcinoma
762721|NCT00006377|recurrent endometrial carcinoma|recurrent endometrial carcinoma
762722|NCT00006361|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
762723|NCT00006361|recurrent skin cancer|recurrent skin cancer
762724|NCT00006361|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
762725|NCT00006361|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
762726|NCT00006361|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
762727|NCT00006361|squamous cell carcinoma of unknown primary|squamous cell carcinoma of unknown primary
762728|NCT00006361|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
762729|NCT00006361|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
762730|NCT00006361|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
762731|NCT00006361|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
762732|NCT00006361|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
762733|NCT00006361|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
762734|NCT00006361|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
762735|NCT00006361|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
762736|NCT00006361|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
762737|NCT00006361|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
762738|NCT00006361|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
762739|NCT00006361|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
762740|NCT00006361|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
762741|NCT00061581|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
762742|NCT00061581|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
762743|NCT00061581|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
762744|NCT00061581|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
762745|NCT00061581|Myelodysplastic Syndrome|myelodysplastic syndrome
762746|NCT00061581|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
762747|NCT00061581|Graft-Versus Leukemia/Myeloma|graft-versus leukemia/myeloma
762748|NCT00061581|Graft-Versus-Host Disease|graft-versus-host disease
762749|NCT00061581|Cyclosporine|cyclosporine
762750|NCT00061581|Fludarabine|fludarabine
762751|NCT00061581|Myelodysplasia Syndrome|myelodysplasia syndrome
762752|NCT00061568|Stem Cell Transplant|stem cell transplant
762753|NCT00061568|Low Dose Radiation|low dose radiation
762754|NCT00061568|Alemtuzumab (Campath)|alemtuzumab (campath)
762755|NCT00061568|Sirolimus (Rapamune)|sirolimus (rapamune)
762756|NCT00061568|Donor Apheresis|donor apheresis
762757|NCT00061568|Graft-Versus-Host Disease|graft-versus-host disease
762758|NCT00061568|Graft-Versus-Marrow|graft-versus-marrow
762759|NCT00061568|Host-Donor Chimerism|host-donor chimerism
762760|NCT00061568|Peripheral Blood Stem Cells|peripheral blood stem cells
762761|NCT00061568|Low Dose Irradiation|low dose irradiation
762762|NCT00061568|Sickle Cell Anemia|sickle cell anemia
762763|NCT00061568|SCA|sca
762764|NCT00061568|Thalassemia|thalassemia
762765|NCT00061568|Diamond-Blackfan Anemia|diamond-blackfan anemia
762766|NCT00061568|DBA|dba
762767|NCT00061490|Osteoarthritis|osteoarthritis
762768|NCT00061490|Arthritis|arthritis
762769|NCT00061490|Weight Loss|weight loss
762770|NCT00006349|depression|depression
762771|NCT00006349|delirium|delirium
762772|NCT00006349|cognitive/functional effects|cognitive/functional effects
762773|NCT00006349|radiation toxicity|radiation toxicity
762774|NCT00006349|limited stage small cell lung cancer|limited stage small cell lung cancer
762775|NCT00006349|extensive stage small cell lung cancer|extensive stage small cell lung cancer
762776|NCT00006349|recurrent small cell lung cancer|recurrent small cell lung cancer
762777|NCT00006341|stage I lip and oral cavity cancer|stage i lip and oral cavity cancer
762778|NCT00006341|stage II lip and oral cavity cancer|stage ii lip and oral cavity cancer
762779|NCT00006341|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
762780|NCT00061438|non-infected necrotizing pancreatitis|non-infected necrotizing pancreatitis
762781|NCT00061438|pancreatic infection|pancreatic infection
762782|NCT00061438|peripancreatic infection|peripancreatic infection
762783|NCT00061425|NHL|nhl
762784|NCT00061425|recurrent B-cell lymphoma|recurrent b-cell lymphoma
762785|NCT00061412|Low reading and writing achievement|low reading and writing achievement
762786|NCT00061412|At-risk students|at-risk students
762787|NCT00061412|Reading Disability|reading disability
762788|NCT00061412|Writing Disability|writing disability
762789|NCT00061399|TBI|tbi
762790|NCT00061399|Prospective memory|prospective memory
762791|NCT00061386|Postpartum|postpartum
762792|NCT00061386|Low income|low income
762793|NCT00061386|Diet|diet
762794|NCT00061386|Physical activity|physical activity
762795|NCT00061321|Nevirapine|nevirapine
762796|NCT00061321|Pregnancy|pregnancy
762797|NCT00061321|Maternal to Infant transmission|maternal to infant transmission
762798|NCT00061321|Infant|infant
762799|NCT00061321|Breastfeeding|breastfeeding
762800|NCT00061321|HIV Seronegativity|hiv seronegativity
762801|NCT00061308|Ovarian cancer|ovarian cancer
762802|NCT00061308|peritoneal cancer|peritoneal cancer
762803|NCT00061308|cancer|cancer
762804|NCT00061308|Fallopian cancer|fallopian cancer
762805|NCT00061295|Locomotion|locomotion
762806|NCT00061295|Spinal Cord Injury|spinal cord injury
762807|NCT00061295|Body Weight Supported Walking|body weight supported walking
762808|NCT00045149|recurrent melanoma|recurrent melanoma
762809|NCT00045149|stage IV melanoma|stage iv melanoma
762810|NCT00019734|stage IV melanoma|stage iv melanoma
762811|NCT00019734|recurrent melanoma|recurrent melanoma
762812|NCT00061373|Alteplase|alteplase
762813|NCT00061373|Recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
762814|NCT00061373|Reperfusion therapy|reperfusion therapy
762815|NCT00061373|Magnetic Resonance Imaging|magnetic resonance imaging
762816|NCT00061373|Clinical Trial|clinical trial
762817|NCT00061373|Tinzaparin|tinzaparin
762818|NCT00061373|Eptifibatide|eptifibatide
762819|NCT00061373|Ischemic Stroke|ischemic stroke
762820|NCT00061360|Bone Marrow Failure|bone marrow failure
762821|NCT00061360|Cyclosporine|cyclosporine
762822|NCT00061360|Anti Thymocyte Globulin|anti thymocyte globulin
762823|NCT00061360|Severe Aplastic Anemia|severe aplastic anemia
762824|NCT00061347|Fiducial Marker|fiducial marker
762825|NCT00061347|MRI|mri
762826|NCT00061347|Prostate Cancer|prostate cancer
762827|NCT00061347|Radiation|radiation
762833|NCT00061334|Healthy Volunteer|healthy volunteer
762834|NCT00061334|HV|hv
762835|NCT00061282|Pouchitis|pouchitis
762836|NCT00061282|Colitis|colitis
762837|NCT00061282|Ileitis|ileitis
762838|NCT00041353|ductal breast carcinoma in situ|ductal breast carcinoma in situ
762839|NCT00041353|lobular breast carcinoma in situ|lobular breast carcinoma in situ
762840|NCT00019175|stage IV melanoma|stage iv melanoma
762841|NCT00019175|recurrent melanoma|recurrent melanoma
762842|NCT00002786|stage IV melanoma|stage iv melanoma
762843|NCT00002786|recurrent melanoma|recurrent melanoma
762844|NCT00061269|Infected pancreatic necrosis|infected pancreatic necrosis
762845|NCT00061256|Bone Mineral Density|bone mineral density
762846|NCT00061256|Lumbar Vertebrae|lumbar vertebrae
762847|NCT00061256|Treatment Experienced|treatment experienced
762848|NCT00061243|HIV|hiv
762849|NCT00061243|Vaccine|vaccine
762850|NCT00061243|DNA prime|dna prime
762851|NCT00061243|Protein boost|protein boost
762852|NCT00061243|HIV Seronegativity|hiv seronegativity
762853|NCT00061243|HIV preventive vaccine|hiv preventive vaccine
762854|NCT00061230|Relaxation training|relaxation training
762855|NCT00061217|Transtibial amputees|transtibial amputees
762856|NCT00061217|Rectified sockets|rectified sockets
762857|NCT00061217|Unrectified sockets|unrectified sockets
762858|NCT00061217|Gait|gait
762859|NCT00061217|Energy expenditure|energy expenditure
762860|NCT00061217|Prosthetic evaluation questionnaire|prosthetic evaluation questionnaire
762861|NCT00061165|obesity|obesity
762862|NCT00061165|overweight|overweight
762863|NCT00061165|children|children
762864|NCT00061165|adolescents|adolescents
762865|NCT00061165|African American|african american
762866|NCT00061165|diet|diet
762867|NCT00061165|nutrition|nutrition
762868|NCT00061165|physical activity|physical activity
762869|NCT00061165|Chicago|chicago
762870|NCT00019084|stage IV colon cancer|stage iv colon cancer
762871|NCT00019084|stage IV breast cancer|stage iv breast cancer
762872|NCT00019084|recurrent breast cancer|recurrent breast cancer
762873|NCT00019084|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
762874|NCT00019084|stage II pancreatic cancer|stage ii pancreatic cancer
762875|NCT00019084|stage III pancreatic cancer|stage iii pancreatic cancer
762876|NCT00019084|recurrent pancreatic cancer|recurrent pancreatic cancer
762877|NCT00019084|recurrent colon cancer|recurrent colon cancer
762878|NCT00019084|recurrent cervical cancer|recurrent cervical cancer
762879|NCT00019084|stage IVB cervical cancer|stage ivb cervical cancer
762880|NCT00019084|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
762881|NCT00019084|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
762882|NCT00019084|extensive stage small cell lung cancer|extensive stage small cell lung cancer
762883|NCT00019084|recurrent small cell lung cancer|recurrent small cell lung cancer
762884|NCT00019084|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
762885|NCT00019084|stage IV pancreatic cancer|stage iv pancreatic cancer
762886|NCT00004868|recurrent adult brain tumor|recurrent adult brain tumor
762887|NCT00004868|adult meningioma|adult meningioma
762888|NCT00004868|adult glioblastoma|adult glioblastoma
762889|NCT00004868|adult anaplastic astrocytoma|adult anaplastic astrocytoma
762890|NCT00004868|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
762891|NCT00004868|adult mixed glioma|adult mixed glioma
762892|NCT00004868|adult grade III meningioma|adult grade iii meningioma
762893|NCT00004868|adult giant cell glioblastoma|adult giant cell glioblastoma
762894|NCT00004868|adult gliosarcoma|adult gliosarcoma
762895|NCT00003408|stage IV breast cancer|stage iv breast cancer
762896|NCT00003408|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
762897|NCT00003408|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
762898|NCT00003408|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
762899|NCT00003408|refractory multiple myeloma|refractory multiple myeloma
762900|NCT00003408|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
762901|NCT00003408|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
762902|NCT00003408|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
762903|NCT00003408|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
762904|NCT00003408|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
762905|NCT00003408|disseminated neuroblastoma|disseminated neuroblastoma
762906|NCT00003408|recurrent neuroblastoma|recurrent neuroblastoma
762907|NCT00003408|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
762908|NCT00003408|stage I multiple myeloma|stage i multiple myeloma
762909|NCT00003408|stage II multiple myeloma|stage ii multiple myeloma
762910|NCT00003408|stage III multiple myeloma|stage iii multiple myeloma
762911|NCT00003408|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
762912|NCT00003408|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
762913|NCT00003408|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
762914|NCT00003408|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
762915|NCT00003408|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
762916|NCT00003408|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
763334|NCT00060606|ONTD|ontd
762917|NCT00003408|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
762918|NCT00003408|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
762919|NCT00003408|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
762920|NCT00003408|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
762921|NCT00003408|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
762922|NCT00003408|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
762923|NCT00003408|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
762924|NCT00003408|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
762925|NCT00003408|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
762926|NCT00003408|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
762927|NCT00003408|testicular embryonal carcinoma|testicular embryonal carcinoma
762928|NCT00003408|testicular choriocarcinoma|testicular choriocarcinoma
762929|NCT00003408|testicular teratoma|testicular teratoma
762930|NCT00003408|testicular yolk sac tumor|testicular yolk sac tumor
762931|NCT00003408|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
762932|NCT00003408|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
762933|NCT00003408|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
762934|NCT00003408|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
762935|NCT00003408|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
762936|NCT00003408|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
762937|NCT00003408|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
762938|NCT00003408|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
762939|NCT00003408|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
762940|NCT00003408|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
762941|NCT00003408|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
762942|NCT00003408|refractory hairy cell leukemia|refractory hairy cell leukemia
762943|NCT00003408|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
762944|NCT00003408|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
762945|NCT00003408|ovarian yolk sac tumor|ovarian yolk sac tumor
762946|NCT00003408|ovarian embryonal carcinoma|ovarian embryonal carcinoma
762947|NCT00003408|ovarian polyembryoma|ovarian polyembryoma
762948|NCT00003408|ovarian choriocarcinoma|ovarian choriocarcinoma
762949|NCT00003408|ovarian immature teratoma|ovarian immature teratoma
762950|NCT00003408|ovarian mature teratoma|ovarian mature teratoma
762951|NCT00003408|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
762952|NCT00003408|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
762953|NCT00003408|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
762954|NCT00003408|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
762955|NCT00003408|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
762956|NCT00003408|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
762957|NCT00003408|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
762958|NCT00003408|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
762959|NCT00003408|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
762960|NCT00003408|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
762961|NCT00003408|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
762962|NCT00003408|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
762963|NCT00003408|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
762964|NCT00003408|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
762965|NCT00003408|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
762966|NCT00003408|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
762967|NCT00003408|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
762968|NCT00003408|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
762969|NCT00003408|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
762970|NCT00003408|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
762971|NCT00003408|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
762972|NCT00003408|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
762973|NCT00003408|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
762974|NCT00003408|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
762975|NCT00003408|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
762976|NCT00003408|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
762977|NCT00003408|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
762978|NCT00003408|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
762979|NCT00003408|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
762980|NCT00003408|secondary acute myeloid leukemia|secondary acute myeloid leukemia
763605|NCT00060502|cachexia|cachexia
762981|NCT00003408|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
762982|NCT00003408|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
762983|NCT00003408|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
762984|NCT00003408|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
762985|NCT00003408|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
762986|NCT00003408|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
762987|NCT00003408|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
762988|NCT00003408|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
762989|NCT00003408|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
762990|NCT00003408|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
762991|NCT00003408|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
762992|NCT00003408|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
762993|NCT00003408|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
762994|NCT00003408|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
762995|NCT00003408|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
762996|NCT00003408|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
762997|NCT00003408|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
762998|NCT00003408|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
762999|NCT00003408|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
763000|NCT00003408|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
763001|NCT00003408|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
763002|NCT00003408|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
763003|NCT00003408|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
763004|NCT00003408|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
763005|NCT00003408|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
763006|NCT00003408|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
763007|NCT00003408|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
763008|NCT00003408|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
763009|NCT00003408|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
763010|NCT00003408|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
763011|NCT00003408|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
763012|NCT00003408|splenic marginal zone lymphoma|splenic marginal zone lymphoma
763013|NCT00003408|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
763014|NCT00061204|fMRI|fmri
763015|NCT00061204|Susceptibility Artifacts|susceptibility artifacts
763016|NCT00061204|Prefrontal Cortex|prefrontal cortex
763017|NCT00061204|Temporal Lobes|temporal lobes
763018|NCT00061204|Methodology|methodology
763019|NCT00061204|Healthy Volunteer|healthy volunteer
763020|NCT00061204|HV|hv
763021|NCT00061152|Pain Measurement|pain measurement
763022|NCT00061152|Diary|diary
763023|NCT00061152|Painful HIV Neuropathy|painful hiv neuropathy
763024|NCT00061152|HIV Neuropathy|hiv neuropathy
763025|NCT00061152|Capsaicin|capsaicin
763026|NCT00061152|Analgesics/*therapeutic use|analgesics/*therapeutic use
763027|NCT00061152|Capsaicin/*administration & dosage/adverse effects|capsaicin/*administration & dosage/adverse effects
763028|NCT00061152|Peripheral Nervous System Diseases/*complications/diagnosis/*therapy|peripheral nervous system diseases/*complications/diagnosis/*therapy
763029|NCT00061152|Peripheral Nervous System Diseases/drug therapy/*etiology/physiopathology|peripheral nervous system diseases/drug therapy/*etiology/physiopathology
763030|NCT00061152|Pain|pain
763031|NCT00061139|Cerebral palsy|cerebral palsy
763032|NCT00061139|Hemiparesis|hemiparesis
763033|NCT00061139|Pediatric CI therapy|pediatric ci therapy
763034|NCT00061139|Upper extremity|upper extremity
763035|NCT00061139|Training|training
763036|NCT00061139|Limb restraint|limb restraint
763037|NCT00061126|Prostate Cancer|prostate cancer
763038|NCT00061126|PSA|psa
763039|NCT00061126|Hormone refractory|hormone refractory
763040|NCT00061126|Rising PSA|rising psa
763041|NCT00061113|alcohol dependence|alcohol dependence
763042|NCT00061113|marijuana dependence|marijuana dependence
763043|NCT00061100|HIV|hiv
763044|NCT00061100|methadone maintenance|methadone maintenance
763045|NCT00061087|ADHD|adhd
763046|NCT00061087|Cocaine|cocaine
763047|NCT00061087|Treatment|treatment
763048|NCT00061087|Methadone|methadone
763049|NCT00061074|Smoking|smoking
763050|NCT00061061|Tobacco Cessation|tobacco cessation
763051|NCT00061061|Postmenopausal Women|postmenopausal women
763052|NCT00061035|Prostate Cancer; Immunotherapy|prostate cancer; immunotherapy
763053|NCT00006095|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
763054|NCT00006086|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
763055|NCT00006082|extensive stage small cell lung cancer|extensive stage small cell lung cancer
763056|NCT00006082|recurrent small cell lung cancer|recurrent small cell lung cancer
763057|NCT00061048|Monoclonal Antibody|monoclonal antibody
763058|NCT00061048|HTLV-1|htlv-1
763059|NCT00061048|CD52|cd52
763060|NCT00061048|Flow Cytometry|flow cytometry
763061|NCT00061048|Antibody Saturation|antibody saturation
763062|NCT00061048|Adult T-Cell Leukemia (ATL)|adult t-cell leukemia (atl)
763064|NCT00061022|Stroke|stroke
763065|NCT00061022|cerebral vascular accident|cerebral vascular accident
763066|NCT00061022|CVA|cva
763067|NCT00061022|Ischemia|ischemia
763068|NCT00061022|Hemorrhage|hemorrhage
763069|NCT00061022|TIA|tia
763070|NCT00061022|Transient Ischemic Attack|transient ischemic attack
763071|NCT00061022|Brain Attack|brain attack
763072|NCT00061022|Cataplexy|cataplexy
763073|NCT00006046|stage IV colon cancer|stage iv colon cancer
763074|NCT00006046|stage IV rectal cancer|stage iv rectal cancer
763075|NCT00006046|recurrent colon cancer|recurrent colon cancer
763076|NCT00006046|recurrent rectal cancer|recurrent rectal cancer
763077|NCT00005999|recurrent cervical cancer|recurrent cervical cancer
763078|NCT00005999|stage IVB cervical cancer|stage ivb cervical cancer
763079|NCT00005999|cervical squamous cell carcinoma|cervical squamous cell carcinoma
763080|NCT00005999|cervical adenocarcinoma|cervical adenocarcinoma
763081|NCT00005977|childhood Burkitt lymphoma|childhood burkitt lymphoma
763082|NCT00005977|L3 childhood acute lymphoblastic leukemia|l3 childhood acute lymphoblastic leukemia
763083|NCT00005977|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
763084|NCT00005977|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
763085|NCT00005977|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
763086|NCT00005977|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
763087|NCT00005977|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
763088|NCT00005977|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
763089|NCT00005977|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
763090|NCT00005971|stage IV melanoma|stage iv melanoma
763091|NCT00005956|stage II breast cancer|stage ii breast cancer
763092|NCT00005956|stage IV breast cancer|stage iv breast cancer
763093|NCT00005956|stage IIIA breast cancer|stage iiia breast cancer
763094|NCT00005956|stage II gastric cancer|stage ii gastric cancer
763095|NCT00005956|stage III gastric cancer|stage iii gastric cancer
763096|NCT00005956|stage IV gastric cancer|stage iv gastric cancer
763097|NCT00005956|stage IIIB breast cancer|stage iiib breast cancer
763098|NCT00005956|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
763099|NCT00005956|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
763100|NCT00005868|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
763101|NCT00061009|Chronic Orthostatic Intolerance|chronic orthostatic intolerance
763102|NCT00061009|Dysautonomia|dysautonomia
763103|NCT00061009|Postural Tachycardia Syndrome|postural tachycardia syndrome
763104|NCT00061009|Neurocardiogenic|neurocardiogenic
763105|NCT00061009|Syncope|syncope
763106|NCT00061009|Neurocardiogenic Syncope|neurocardiogenic syncope
763107|NCT00061009|COI|coi
763108|NCT00061009|POTS|pots
763109|NCT00061009|Neurocardogenic Syncope|neurocardogenic syncope
763110|NCT00061009|NCS|ncs
763111|NCT00061009|Healthy Volunteer|healthy volunteer
763112|NCT00061009|HV|hv
763113|NCT00060996|Critical Limb Ischemia|critical limb ischemia
763114|NCT00060996|Peripheral Vascular Disease|peripheral vascular disease
763115|NCT00060996|UT-15|ut-15
763116|NCT00060996|Remodulin|remodulin
763117|NCT00060996|treprostinil|treprostinil
763118|NCT00005813|adult glioblastoma|adult glioblastoma
763119|NCT00005813|adult giant cell glioblastoma|adult giant cell glioblastoma
763120|NCT00005813|adult gliosarcoma|adult gliosarcoma
763121|NCT00060983|Locomotion|locomotion
763122|NCT00060983|Spinal Cord Injury, ASIA C|spinal cord injury, asia c
763123|NCT00060983|Body weight support (BWS)|body weight support (bws)
763124|NCT00060983|Functional electrical stimulation (FES)|functional electrical stimulation (fes)
763125|NCT00060983|Gait|gait
763126|NCT00060983|Treadmill training|treadmill training
763127|NCT00060983|Physical Therapy|physical therapy
763128|NCT00060970|Disuse atrophy|disuse atrophy
763129|NCT00060970|Ankle fracture|ankle fracture
763130|NCT00060970|Exercise, therapy|exercise, therapy
763131|NCT00060970|Cast immobilization|cast immobilization
763132|NCT00060970|Deconditioning|deconditioning
763133|NCT00060970|Sarcopenia|sarcopenia
763134|NCT00060957|Cerebral Palsy|cerebral palsy
763135|NCT00060957|Spasticity|spasticity
763136|NCT00060957|Botulinum toxin|botulinum toxin
763137|NCT00060957|BOTOX|botox
763138|NCT00060944|Trabectedin|trabectedin
763139|NCT00060944|Yondelis|yondelis
763140|NCT00060944|ET-743|et-743
763141|NCT00060944|Ecteinascidin|ecteinascidin
763142|NCT00060944|Anthracycline|anthracycline
763143|NCT00060944|Ifosfamide|ifosfamide
763144|NCT00060944|Dexamethasone|dexamethasone
763145|NCT00060944|Intravenous|intravenous
763146|NCT00060944|Cancer|cancer
763147|NCT00060944|Malignant|malignant
763148|NCT00060944|Metastatic|metastatic
763149|NCT00005861|stage III endometrial carcinoma|stage iii endometrial carcinoma
782363|NCT00038272|DAPD|dapd
763150|NCT00005861|stage IV endometrial carcinoma|stage iv endometrial carcinoma
763151|NCT00005861|recurrent endometrial carcinoma|recurrent endometrial carcinoma
763152|NCT00005588|stage I breast cancer|stage i breast cancer
763153|NCT00005588|stage II breast cancer|stage ii breast cancer
763154|NCT00005588|stage IIIA breast cancer|stage iiia breast cancer
763155|NCT00005587|stage I breast cancer|stage i breast cancer
763156|NCT00005587|stage II breast cancer|stage ii breast cancer
763157|NCT00005587|stage IIIA breast cancer|stage iiia breast cancer
763158|NCT00003203|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
763159|NCT00003203|untreated childhood medulloblastoma|untreated childhood medulloblastoma
763160|NCT00003203|localized unresectable neuroblastoma|localized unresectable neuroblastoma
763161|NCT00003203|regional neuroblastoma|regional neuroblastoma
763162|NCT00003203|stage 4S neuroblastoma|stage 4s neuroblastoma
763163|NCT00060931|hypertension|hypertension
763164|NCT00060931|beta-blockers|beta-blockers
763165|NCT00060931|Type 2 diabetes|type 2 diabetes
763166|NCT00060918|Type 2 diabetes|type 2 diabetes
763167|NCT00060918|hypertension|hypertension
763168|NCT00060918|beta-blockers|beta-blockers
763169|NCT00060905|Bipolar Disorder (manic or mixed type)|bipolar disorder (manic or mixed type)
763170|NCT00060892|Critical Limb Ischemia|critical limb ischemia
763171|NCT00005086|stage IV bladder cancer|stage iv bladder cancer
763172|NCT00005086|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
763173|NCT00005078|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
763174|NCT00060866|Beta-Adrenoceptors|beta-adrenoceptors
763175|NCT00060866|Beta-Adrenoceptor Blocker|beta-adrenoceptor blocker
763176|NCT00060866|Neurocardiogenic Syncope|neurocardiogenic syncope
763177|NCT00060866|Chronic Orthostatic Intolerance|chronic orthostatic intolerance
763178|NCT00060866|Neurocardiogenic|neurocardiogenic
763179|NCT00060866|Dysautonomia|dysautonomia
763180|NCT00060866|Autonomic Nervous System|autonomic nervous system
763181|NCT00060866|Nurocardiogenic Syncope|nurocardiogenic syncope
763182|NCT00060866|NCS|ncs
763183|NCT00060866|Sympathoadrenal Imbalance|sympathoadrenal imbalance
763184|NCT00060866|SAI|sai
763185|NCT00060866|Orthostatic Intolerance|orthostatic intolerance
763186|NCT00060840|Left Ventricular Assist Device Implantation|left ventricular assist device implantation
763187|NCT00060840|Progressive Left Ventricular Failure|progressive left ventricular failure
763188|NCT00060827|Mild traumatic brain injury|mild traumatic brain injury
763189|NCT00060853|Amygdala|amygdala
763190|NCT00060853|Orbitofrontal Cortex|orbitofrontal cortex
763191|NCT00060853|Emotion|emotion
763192|NCT00060853|Cognition|cognition
763193|NCT00060853|Theory of Mind|theory of mind
763194|NCT00060853|Healthy Volunteer|healthy volunteer
763195|NCT00060853|HV|hv
763196|NCT00060801|Cystic Fibrosis|cystic fibrosis
763197|NCT00060801|BIIL 284|biil 284
763198|NCT00060801|Boehringer Ingelheim|boehringer ingelheim
763199|NCT00060788|Antisocial behavior|antisocial behavior
763200|NCT00060788|Mauritius Child Health Project|mauritius child health project
763201|NCT00060788|Intergenerational transmission|intergenerational transmission
763202|NCT00004928|adenocarcinoma of the prostate|adenocarcinoma of the prostate
763203|NCT00004928|stage I prostate cancer|stage i prostate cancer
763204|NCT00004928|stage IIB prostate cancer|stage iib prostate cancer
763205|NCT00004928|stage IIA prostate cancer|stage iia prostate cancer
763206|NCT00004928|stage III prostate cancer|stage iii prostate cancer
763207|NCT00004928|stage IV prostate cancer|stage iv prostate cancer
763208|NCT00004928|recurrent prostate cancer|recurrent prostate cancer
763209|NCT00004925|stage IV breast cancer|stage iv breast cancer
763210|NCT00004925|recurrent breast cancer|recurrent breast cancer
763211|NCT00004925|stage IIIB breast cancer|stage iiib breast cancer
763212|NCT00004925|inflammatory breast cancer|inflammatory breast cancer
763213|NCT00004916|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
763214|NCT00004916|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
763215|NCT00004916|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
763216|NCT00004916|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
763217|NCT00004916|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
763218|NCT00004911|stage I colon cancer|stage i colon cancer
763219|NCT00004911|stage II colon cancer|stage ii colon cancer
763220|NCT00004911|stage III colon cancer|stage iii colon cancer
763221|NCT00004911|stage IV colon cancer|stage iv colon cancer
763222|NCT00004911|stage I gastric cancer|stage i gastric cancer
763223|NCT00004911|stage II gastric cancer|stage ii gastric cancer
763224|NCT00004911|stage III gastric cancer|stage iii gastric cancer
763225|NCT00004911|stage IV gastric cancer|stage iv gastric cancer
763226|NCT00004911|recurrent gastric cancer|recurrent gastric cancer
763227|NCT00004911|stage I rectal cancer|stage i rectal cancer
763228|NCT00004911|stage II rectal cancer|stage ii rectal cancer
763229|NCT00004911|stage III rectal cancer|stage iii rectal cancer
763230|NCT00004911|stage IV rectal cancer|stage iv rectal cancer
763231|NCT00004911|recurrent colon cancer|recurrent colon cancer
763232|NCT00004911|recurrent rectal cancer|recurrent rectal cancer
763233|NCT00004911|localized gastrointestinal carcinoid tumor|localized gastrointestinal carcinoid tumor
763234|NCT00004911|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
763235|NCT00004911|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
763236|NCT00004911|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
763237|NCT00004911|small intestine adenocarcinoma|small intestine adenocarcinoma
763238|NCT00004911|small intestine lymphoma|small intestine lymphoma
763239|NCT00004911|small intestine leiomyosarcoma|small intestine leiomyosarcoma
763240|NCT00004911|recurrent small intestine cancer|recurrent small intestine cancer
763241|NCT00004911|constipation, impaction, and bowel obstruction|constipation, impaction, and bowel obstruction
763242|NCT00004911|quality of life|quality of life
763243|NCT00004911|gastrointestinal stromal tumor|gastrointestinal stromal tumor
763244|NCT00060775|Magnetic Resonance Imaging|magnetic resonance imaging
763245|NCT00060775|fMRI|fmri
763246|NCT00060775|Emotion|emotion
763247|NCT00060775|Children|children
763248|NCT00060775|Adolescence|adolescence
763249|NCT00060775|Affective Neuroscience|affective neuroscience
763250|NCT00060775|Neuroimaging|neuroimaging
763251|NCT00060775|Behavioral Inhibition|behavioral inhibition
763252|NCT00060775|Depression|depression
763253|NCT00060775|Anxiety|anxiety
763254|NCT00060775|Normal Volunteers|normal volunteers
763255|NCT00060775|Healthy Volunteer|healthy volunteer
763256|NCT00060775|HV|hv
763257|NCT00060762|Weight Loss|weight loss
763258|NCT00060723|Polysomnography|polysomnography
763259|NCT00060723|Sleep-disordered breathing|sleep-disordered breathing
763260|NCT00060723|Sleep apnea, obstructive|sleep apnea, obstructive
763261|NCT00060723|Hyperactivity|hyperactivity
763262|NCT00060723|Sleep|sleep
763263|NCT00060723|Child|child
763264|NCT00060710|melanoma|melanoma
763265|NCT00060749|Stargardt|stargardt
763266|NCT00060749|Macular Dystrophy|macular dystrophy
763267|NCT00060749|ELOVL4|elovl4
763268|NCT00060749|DHA|dha
763269|NCT00060749|Stargardt's Disease|stargardt's disease
763270|NCT00060749|Autosomal Dominant Macular Dystrophy|autosomal dominant macular dystrophy
763271|NCT00060749|Autosomal Recessive Macular Dystrophy|autosomal recessive macular dystrophy
763272|NCT00060736|Hormone Replacement|hormone replacement
763273|NCT00060736|Gonadal Steroids|gonadal steroids
763274|NCT00060736|Estrogen|estrogen
763275|NCT00060736|Major Depression|major depression
763276|NCT00060736|Minor Depression|minor depression
763277|NCT00060736|Perimenopause|perimenopause
763278|NCT00060736|Estradiol|estradiol
763279|NCT00060736|Depression|depression
763280|NCT00060736|Perimenopausal Depression|perimenopausal depression
763281|NCT00060697|Sexual risk taking|sexual risk taking
763282|NCT00060697|Mother-child communication|mother-child communication
763283|NCT00060697|Problem behaviors|problem behaviors
763284|NCT00060684|Pixantrone|pixantrone
763285|NCT00060684|BBR 2778|bbr 2778
763286|NCT00060684|chemotherapy|chemotherapy
763287|NCT00060684|DNA Intercalator|dna intercalator
763288|NCT00060684|mitoxantrone|mitoxantrone
763289|NCT00060684|fludarabine|fludarabine
763290|NCT00060684|dexamethasone|dexamethasone
763291|NCT00060684|Rituximab|rituximab
763292|NCT00060684|Rituxan|rituxan
763293|NCT00060684|Mabthera|mabthera
763294|NCT00060684|monoclonal antibody|monoclonal antibody
763295|NCT00060684|antibody|antibody
763296|NCT00060684|NHL|nhl
763297|NCT00060684|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
763298|NCT00060684|indolent|indolent
763299|NCT00060684|low grade|low grade
763300|NCT00060684|Novuspharma|novuspharma
763301|NCT00060671|Pixantrone|pixantrone
763302|NCT00060671|BBR 2778|bbr 2778
763303|NCT00060671|chemotherapy|chemotherapy
763304|NCT00060671|DNA Intercalator|dna intercalator
763305|NCT00060671|Anthracycline|anthracycline
763306|NCT00060671|Rituximab|rituximab
763307|NCT00060671|Rituxan|rituxan
763308|NCT00060671|Mabthera|mabthera
763309|NCT00060671|monoclonal antibody|monoclonal antibody
763310|NCT00060671|antibody|antibody
763311|NCT00060671|NHL|nhl
763312|NCT00060671|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
763313|NCT00060671|indolent|indolent
763314|NCT00060671|low grade|low grade
763315|NCT00060671|Novuspharma|novuspharma
763316|NCT00060645|Advanced, refractory or recurrent solid tumors|advanced, refractory or recurrent solid tumors
763317|NCT00060632|Advanced, refractory or recurrent solid tumors|advanced, refractory or recurrent solid tumors
763318|NCT00060619|Migraine|migraine
763319|NCT00060619|Functional abdominal pain|functional abdominal pain
763320|NCT00060619|Biofeedback|biofeedback
763321|NCT00060619|Psychological assessment|psychological assessment
763322|NCT00060658|Prefrontal Cortex|prefrontal cortex
763323|NCT00060658|Calculation|calculation
763324|NCT00060658|Mathematician|mathematician
763325|NCT00060658|Cognition|cognition
763326|NCT00060658|Brain Mapping|brain mapping
763327|NCT00060658|Healthy Volunteer|healthy volunteer
763328|NCT00060658|HV|hv
763329|NCT00060606|Maternal fetal surgery|maternal fetal surgery
763330|NCT00060606|Fetal diagnosis|fetal diagnosis
763331|NCT00060606|Myelomeningocele|myelomeningocele
763332|NCT00060606|Meningomyelocele|meningomyelocele
763333|NCT00060606|Open neural tube defect|open neural tube defect
763335|NCT00060606|Spina bifida|spina bifida
763336|NCT00060567|E7070|e7070
763337|NCT00060567|Irinotecan|irinotecan
763338|NCT00060567|hydrochloride|hydrochloride
763339|NCT00060567|gastrointestinal|gastrointestinal
763340|NCT00060567|cancer|cancer
763341|NCT00004910|stage I colon cancer|stage i colon cancer
763342|NCT00004910|stage II colon cancer|stage ii colon cancer
763343|NCT00004910|stage III colon cancer|stage iii colon cancer
763344|NCT00004910|stage IV colon cancer|stage iv colon cancer
763345|NCT00004910|stage I gastric cancer|stage i gastric cancer
763346|NCT00004910|stage II gastric cancer|stage ii gastric cancer
763347|NCT00004910|stage III gastric cancer|stage iii gastric cancer
763348|NCT00004910|stage IV gastric cancer|stage iv gastric cancer
763349|NCT00004910|recurrent gastric cancer|recurrent gastric cancer
763350|NCT00004910|stage I pancreatic cancer|stage i pancreatic cancer
763351|NCT00004910|stage II pancreatic cancer|stage ii pancreatic cancer
763352|NCT00004910|stage III pancreatic cancer|stage iii pancreatic cancer
763353|NCT00004910|recurrent pancreatic cancer|recurrent pancreatic cancer
763354|NCT00004910|recurrent colon cancer|recurrent colon cancer
763355|NCT00004910|localized gastrointestinal carcinoid tumor|localized gastrointestinal carcinoid tumor
763356|NCT00004910|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
763357|NCT00004910|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
763358|NCT00004910|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
763359|NCT00004910|small intestine adenocarcinoma|small intestine adenocarcinoma
763360|NCT00004910|small intestine lymphoma|small intestine lymphoma
763361|NCT00004910|small intestine leiomyosarcoma|small intestine leiomyosarcoma
763362|NCT00004910|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
763363|NCT00004910|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
763364|NCT00004910|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
763365|NCT00004910|recurrent small intestine cancer|recurrent small intestine cancer
763366|NCT00004910|constipation, impaction, and bowel obstruction|constipation, impaction, and bowel obstruction
763367|NCT00004910|quality of life|quality of life
763368|NCT00004910|gastrointestinal stromal tumor|gastrointestinal stromal tumor
763369|NCT00004910|stage IV pancreatic cancer|stage iv pancreatic cancer
763370|NCT00004895|stage I colon cancer|stage i colon cancer
763371|NCT00004895|stage II colon cancer|stage ii colon cancer
763372|NCT00004895|stage III colon cancer|stage iii colon cancer
763373|NCT00004895|stage IV colon cancer|stage iv colon cancer
763374|NCT00004895|stage I gastric cancer|stage i gastric cancer
763375|NCT00004895|stage II gastric cancer|stage ii gastric cancer
763376|NCT00004895|stage III gastric cancer|stage iii gastric cancer
763377|NCT00004895|stage IV gastric cancer|stage iv gastric cancer
763378|NCT00004895|recurrent gastric cancer|recurrent gastric cancer
763379|NCT00004895|stage I pancreatic cancer|stage i pancreatic cancer
763380|NCT00004895|stage II pancreatic cancer|stage ii pancreatic cancer
763381|NCT00004895|stage III pancreatic cancer|stage iii pancreatic cancer
763382|NCT00004895|stage IV pancreatic cancer|stage iv pancreatic cancer
763383|NCT00004895|recurrent pancreatic cancer|recurrent pancreatic cancer
763384|NCT00004895|stage I rectal cancer|stage i rectal cancer
763385|NCT00004895|stage II rectal cancer|stage ii rectal cancer
763386|NCT00004895|stage III rectal cancer|stage iii rectal cancer
763387|NCT00004895|stage IV rectal cancer|stage iv rectal cancer
763388|NCT00004895|recurrent colon cancer|recurrent colon cancer
763389|NCT00004895|recurrent rectal cancer|recurrent rectal cancer
763390|NCT00004895|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
763391|NCT00004895|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
763392|NCT00004895|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
763393|NCT00004895|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
763394|NCT00004895|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
763395|NCT00004895|small intestine adenocarcinoma|small intestine adenocarcinoma
763396|NCT00004895|small intestine lymphoma|small intestine lymphoma
763397|NCT00004895|small intestine leiomyosarcoma|small intestine leiomyosarcoma
763398|NCT00004895|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
763399|NCT00004895|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
763400|NCT00004895|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
763401|NCT00004895|recurrent small intestine cancer|recurrent small intestine cancer
763402|NCT00004895|constipation, impaction, and bowel obstruction|constipation, impaction, and bowel obstruction
763403|NCT00004895|peritoneal cavity cancer|peritoneal cavity cancer
763404|NCT00004895|nausea and vomiting|nausea and vomiting
763405|NCT00004895|gastrointestinal stromal tumor|gastrointestinal stromal tumor
763406|NCT00004255|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
763407|NCT00004255|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
763408|NCT00004255|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
763409|NCT00004255|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
763410|NCT00004255|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
763411|NCT00004255|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
763606|NCT00060502|pancreatic cancer|pancreatic cancer
763412|NCT00004255|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
763413|NCT00004255|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
763414|NCT00004255|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
763415|NCT00004255|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
763416|NCT00004255|refractory anemia with excess blasts|refractory anemia with excess blasts
763417|NCT00004255|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
763418|NCT00004255|secondary acute myeloid leukemia|secondary acute myeloid leukemia
763419|NCT00004255|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
763420|NCT00004255|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
763421|NCT00004255|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
763422|NCT00004255|graft versus host disease|graft versus host disease
763423|NCT00004255|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
763424|NCT00004232|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
763425|NCT00004232|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
763426|NCT00004232|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
763427|NCT00004232|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
763428|NCT00004232|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
763429|NCT00004232|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
763430|NCT00004232|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
763431|NCT00004232|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
763432|NCT00004232|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
763433|NCT00004232|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
763434|NCT00004232|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
763435|NCT00004232|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
763436|NCT00004232|Burkitt lymphoma|burkitt lymphoma
763437|NCT00004232|isolated plasmacytoma of bone|isolated plasmacytoma of bone
763438|NCT00004232|extramedullary plasmacytoma|extramedullary plasmacytoma
763439|NCT00004232|refractory multiple myeloma|refractory multiple myeloma
763440|NCT00004232|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
763441|NCT00004232|stage I multiple myeloma|stage i multiple myeloma
763442|NCT00004232|stage II multiple myeloma|stage ii multiple myeloma
763443|NCT00004232|stage III multiple myeloma|stage iii multiple myeloma
763444|NCT00004232|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
763445|NCT00004232|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
763446|NCT00004232|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
763447|NCT00004232|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
763448|NCT00004232|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
763449|NCT00004232|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
763450|NCT00004232|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
763451|NCT00004232|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
763452|NCT00004232|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
763453|NCT00004232|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
763454|NCT00004232|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
763455|NCT00004232|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
763456|NCT00004232|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
763457|NCT00004232|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
763458|NCT00004232|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
763459|NCT00004232|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
763460|NCT00004232|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
763461|NCT00004232|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
763462|NCT00004232|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
763463|NCT00004232|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
763464|NCT00004232|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
763465|NCT00004232|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
763466|NCT00004232|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
763467|NCT00004232|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
763468|NCT00004232|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
763469|NCT00004232|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
763470|NCT00004232|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
763471|NCT00004232|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
763472|NCT00004232|essential thrombocythemia|essential thrombocythemia
763473|NCT00004232|untreated hairy cell leukemia|untreated hairy cell leukemia
763474|NCT00004232|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
763475|NCT00004232|refractory hairy cell leukemia|refractory hairy cell leukemia
763476|NCT00004232|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
763477|NCT00004232|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
763478|NCT00004232|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
763479|NCT00004232|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
763480|NCT00004232|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
763481|NCT00004232|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
763482|NCT00004232|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
763483|NCT00004232|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
763484|NCT00004232|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
763485|NCT00004232|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
763486|NCT00004232|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
763487|NCT00004232|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
763488|NCT00004232|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
763489|NCT00004232|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
763685|NCT00060333|recurrent melanoma|recurrent melanoma
763490|NCT00004232|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
763491|NCT00004232|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
763492|NCT00004232|acute undifferentiated leukemia|acute undifferentiated leukemia
763493|NCT00004232|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
763494|NCT00004232|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
763495|NCT00004232|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
763496|NCT00004232|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
763497|NCT00004232|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
763498|NCT00004232|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
763499|NCT00004232|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
763500|NCT00004232|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
763501|NCT00004232|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
763502|NCT00004232|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
763503|NCT00004232|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
763504|NCT00004232|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
763505|NCT00004232|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
763506|NCT00004232|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
763507|NCT00004232|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
763508|NCT00004232|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
763509|NCT00004232|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
763510|NCT00004232|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
763511|NCT00004232|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
763512|NCT00004232|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
763513|NCT00004232|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
763514|NCT00004232|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
763515|NCT00004232|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
763516|NCT00004232|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
763517|NCT00004232|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
763518|NCT00004232|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
763519|NCT00004232|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
763520|NCT00004232|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
763521|NCT00004232|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
763522|NCT00004232|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
763523|NCT00004232|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
763524|NCT00004232|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
763525|NCT00004232|secondary acute myeloid leukemia|secondary acute myeloid leukemia
763526|NCT00004232|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
763527|NCT00004232|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
763528|NCT00004232|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
763529|NCT00004232|graft versus host disease|graft versus host disease
763530|NCT00004232|prolymphocytic leukemia|prolymphocytic leukemia
763531|NCT00004232|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
763532|NCT00004232|primary systemic amyloidosis|primary systemic amyloidosis
763533|NCT00004232|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
763534|NCT00004232|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
763535|NCT00004232|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
763536|NCT00004232|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
763537|NCT00004232|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
763538|NCT00004232|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
763607|NCT00060502|infliximab|infliximab
763539|NCT00004232|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
763540|NCT00004232|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
763541|NCT00004232|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
763542|NCT00004232|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
763543|NCT00004232|stage I mantle cell lymphoma|stage i mantle cell lymphoma
763544|NCT00004232|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
763545|NCT00004232|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
763546|NCT00004232|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
763547|NCT00004232|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
763548|NCT00004232|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
763549|NCT00004232|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
763550|NCT00004232|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
763551|NCT00004232|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
763552|NCT00004232|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
763553|NCT00004232|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
763554|NCT00004232|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
763555|NCT00004232|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
763556|NCT00004232|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
763557|NCT00004232|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
763558|NCT00004232|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
763559|NCT00004232|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
763560|NCT00004232|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
763561|NCT00004232|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
763562|NCT00004232|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
763563|NCT00004232|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
763564|NCT00004232|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
763565|NCT00004232|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
763566|NCT00004232|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
763567|NCT00004232|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
763568|NCT00004232|anaplastic large cell lymphoma|anaplastic large cell lymphoma
763569|NCT00004232|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
763570|NCT00004232|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
763571|NCT00004232|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
763572|NCT00004232|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
763573|NCT00004232|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
763574|NCT00004232|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
763575|NCT00004232|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
763576|NCT00004232|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
763577|NCT00004232|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
763578|NCT00004232|stage I marginal zone lymphoma|stage i marginal zone lymphoma
763579|NCT00004232|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
763580|NCT00004232|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
763581|NCT00004232|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
763582|NCT00004232|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
763583|NCT00004232|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
763584|NCT00004232|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
763585|NCT00004232|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
763586|NCT00004232|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
763587|NCT00004232|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
763588|NCT00004232|splenic marginal zone lymphoma|splenic marginal zone lymphoma
763589|NCT00004232|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
763590|NCT00004180|adult liposarcoma|adult liposarcoma
763591|NCT00004180|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
763593|NCT00060593|Functional Connectivity|functional connectivity
763594|NCT00060593|Healthy Volunteer|healthy volunteer
763595|NCT00060593|HV|hv
763596|NCT00060580|Retinal Measurements|retinal measurements
763597|NCT00060580|Lutein in Vivo|lutein in vivo
763598|NCT00060580|Raman Spectroscopy|raman spectroscopy
763599|NCT00060580|Retinal Measurements of Lutein in Vivo in the Human Eye|retinal measurements of lutein in vivo in the human eye
763600|NCT00060580|Healthy Volunteer|healthy volunteer
763601|NCT00060580|HV|hv
763602|NCT00060554|Elective PCI|elective pci
763603|NCT00060554|Heart catherization|heart catherization
763604|NCT00060554|Acute coronary syndromes|acute coronary syndromes
763611|NCT00060489|Bipolar Depression|bipolar depression
763612|NCT00004094|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
763613|NCT00004094|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
763614|NCT00004094|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
763615|NCT00004094|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
763616|NCT00004094|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
763617|NCT00004094|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
763618|NCT00004094|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
763619|NCT00004094|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
763620|NCT00004094|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
763621|NCT00004068|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
763622|NCT00004068|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
763623|NCT00004068|childhood oligodendroglioma|childhood oligodendroglioma
763624|NCT00004068|untreated childhood brain stem glioma|untreated childhood brain stem glioma
763625|NCT00004068|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
763626|NCT00004059|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
763627|NCT00004052|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
763628|NCT00004052|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
763629|NCT00004008|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
763630|NCT00004008|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
763631|NCT00004008|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
763632|NCT00004008|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
763633|NCT00004008|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
763634|NCT00060541|Brain Tumor|brain tumor
763635|NCT00060541|Epilepsy|epilepsy
763636|NCT00060541|Pituitary Adenoma|pituitary adenoma
763637|NCT00060541|Parkinson's Disease|parkinson's disease
763638|NCT00060541|Vascular Malformation|vascular malformation
763639|NCT00060541|Neurosurgery|neurosurgery
763640|NCT00060541|Glioblastoma|glioblastoma
763641|NCT00060541|Astrocytoma|astrocytoma
763642|NCT00060541|Oligodendroglioma|oligodendroglioma
763643|NCT00060541|Spinal Arteriovenous Malformation|spinal arteriovenous malformation
763644|NCT00060541|Oncogenes|oncogenes
763645|NCT00060541|Proteomics|proteomics
763646|NCT00060528|Immunotherapy|immunotherapy
763647|NCT00060528|Cytokines|cytokines
763648|NCT00060528|Immune Assays|immune assays
763649|NCT00060528|Prostate Cancer|prostate cancer
763650|NCT00060463|Emergency contraceptive pills|emergency contraceptive pills
763651|NCT00060463|Pregnancy|pregnancy
763652|NCT00060463|Sexually transmitted infection|sexually transmitted infection
763653|NCT00060463|Chlamydia|chlamydia
763654|NCT00060463|Gonorrhea|gonorrhea
763655|NCT00060463|Trichomonas|trichomonas
763656|NCT00060463|Contraception|contraception
763657|NCT00060450|Ischemia-reperfusion lung injury|ischemia-reperfusion lung injury
763658|NCT00060450|IRLI|irli
763659|NCT00060437|stage IV prostate cancer|stage iv prostate cancer
763660|NCT00060437|recurrent prostate cancer|recurrent prostate cancer
763661|NCT00060437|adenocarcinoma of the prostate|adenocarcinoma of the prostate
763662|NCT00060398|recurrent prostate cancer|recurrent prostate cancer
763663|NCT00060398|anemia|anemia
763664|NCT00060398|fatigue|fatigue
763665|NCT00060385|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
763666|NCT00060385|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
763667|NCT00060385|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
763668|NCT00060385|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
763669|NCT00060385|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
763670|NCT00060385|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
763671|NCT00060385|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
763672|NCT00060385|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
763673|NCT00060385|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
763674|NCT00060385|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
763675|NCT00060385|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
763676|NCT00060385|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
763677|NCT00060385|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
763678|NCT00060385|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
763679|NCT00060385|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
763680|NCT00060385|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
763681|NCT00060385|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
763682|NCT00060346|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
763683|NCT00060346|Rituximab|rituximab
763684|NCT00060346|CHOP|chop
763686|NCT00060333|stage I melanoma|stage i melanoma
763687|NCT00060333|stage II melanoma|stage ii melanoma
763688|NCT00060333|stage III melanoma|stage iii melanoma
763689|NCT00060320|stage IV breast cancer|stage iv breast cancer
763690|NCT00060320|stage I breast cancer|stage i breast cancer
763691|NCT00060320|stage II breast cancer|stage ii breast cancer
763692|NCT00060320|stage IIIA breast cancer|stage iiia breast cancer
763693|NCT00060320|stage IIIB breast cancer|stage iiib breast cancer
763694|NCT00060320|stage IIIC breast cancer|stage iiic breast cancer
763695|NCT00060320|hot flashes|hot flashes
763696|NCT00060294|Waldenström macroglobulinemia|waldenström macroglobulinemia
763697|NCT00060268|recurrent esophageal cancer|recurrent esophageal cancer
763698|NCT00060268|stage I esophageal cancer|stage i esophageal cancer
763699|NCT00060268|stage II esophageal cancer|stage ii esophageal cancer
763700|NCT00060268|stage III esophageal cancer|stage iii esophageal cancer
763701|NCT00060268|stage IV esophageal cancer|stage iv esophageal cancer
763702|NCT00060255|stage IV breast cancer|stage iv breast cancer
763703|NCT00060255|male breast cancer|male breast cancer
763704|NCT00060255|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
763705|NCT00060255|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
763706|NCT00060255|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
763707|NCT00060255|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
763708|NCT00060255|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
763709|NCT00060255|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
763710|NCT00060255|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
763711|NCT00060255|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
763712|NCT00060255|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
763713|NCT00060255|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
763714|NCT00060255|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
763715|NCT00060255|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
763716|NCT00060255|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
763717|NCT00060255|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
763718|NCT00060255|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
763719|NCT00060255|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
763720|NCT00060255|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
763721|NCT00060255|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
763722|NCT00060255|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
763723|NCT00060255|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
763724|NCT00060255|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
763725|NCT00060255|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
763726|NCT00060255|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
763727|NCT00060255|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
763728|NCT00060255|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
763729|NCT00060255|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
763730|NCT00060255|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
763731|NCT00060255|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
763732|NCT00060255|stage IIIA breast cancer|stage iiia breast cancer
763733|NCT00060255|stage IIIB breast cancer|stage iiib breast cancer
763734|NCT00060255|stage IIIC breast cancer|stage iiic breast cancer
763735|NCT00060255|recurrent breast cancer|recurrent breast cancer
763736|NCT00060255|primary systemic amyloidosis|primary systemic amyloidosis
763737|NCT00060255|refractory multiple myeloma|refractory multiple myeloma
763738|NCT00060255|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
763739|NCT00060255|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
763740|NCT00060255|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
763741|NCT00060255|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
763742|NCT00060255|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
763743|NCT00060255|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
763744|NCT00060255|splenic marginal zone lymphoma|splenic marginal zone lymphoma
763745|NCT00060255|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
763746|NCT00060255|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
763747|NCT00060255|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
763748|NCT00060255|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
763749|NCT00060255|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
763750|NCT00060242|anaplastic thyroid cancer|anaplastic thyroid cancer
763751|NCT00060242|recurrent thyroid cancer|recurrent thyroid cancer
763752|NCT00060203|stage III multiple myeloma|stage iii multiple myeloma
763753|NCT00060203|refractory multiple myeloma|refractory multiple myeloma
763822|NCT00060021|stage III multiple myeloma|stage iii multiple myeloma
763754|NCT00060151|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
763755|NCT00060138|hypercalcemia of malignancy|hypercalcemia of malignancy
763756|NCT00060138|stage IV breast cancer|stage iv breast cancer
763757|NCT00060138|recurrent breast cancer|recurrent breast cancer
763758|NCT00060138|bone metastases|bone metastases
763759|NCT00060138|pain|pain
763760|NCT00060099|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
763761|NCT00060099|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
763762|NCT00060099|human papilloma virus infection|human papilloma virus infection
763763|NCT00060086|adenocarcinoma of the prostate|adenocarcinoma of the prostate
763764|NCT00060086|recurrent prostate cancer|recurrent prostate cancer
763765|NCT00060021|oral complications|oral complications
763766|NCT00060021|pain|pain
763767|NCT00060021|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
763768|NCT00060021|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
763769|NCT00060021|chronic eosinophilic leukemia|chronic eosinophilic leukemia
763770|NCT00060021|primary myelofibrosis|primary myelofibrosis
763771|NCT00060021|chronic neutrophilic leukemia|chronic neutrophilic leukemia
763772|NCT00060021|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
763773|NCT00060021|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
763774|NCT00060021|disseminated neuroblastoma|disseminated neuroblastoma
763775|NCT00060021|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
763776|NCT00060021|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
763777|NCT00060021|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
763778|NCT00060021|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
763779|NCT00060021|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
763780|NCT00060021|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
763781|NCT00060021|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
763782|NCT00060021|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
763783|NCT00060021|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
763784|NCT00060021|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
763785|NCT00060021|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
763786|NCT00060021|ovarian choriocarcinoma|ovarian choriocarcinoma
763787|NCT00060021|ovarian embryonal carcinoma|ovarian embryonal carcinoma
763788|NCT00060021|ovarian yolk sac tumor|ovarian yolk sac tumor
763789|NCT00060021|ovarian immature teratoma|ovarian immature teratoma
763790|NCT00060021|ovarian mature teratoma|ovarian mature teratoma
763791|NCT00060021|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
763792|NCT00060021|ovarian polyembryoma|ovarian polyembryoma
763793|NCT00060021|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
763794|NCT00060021|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
763795|NCT00060021|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
763796|NCT00060021|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
763797|NCT00060021|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
763798|NCT00060021|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
763799|NCT00060021|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
763800|NCT00060021|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
763801|NCT00060021|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
763802|NCT00060021|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
763803|NCT00060021|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
763804|NCT00060021|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
763805|NCT00060021|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
763806|NCT00060021|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
763807|NCT00060021|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
763808|NCT00060021|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
763809|NCT00060021|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
763810|NCT00060021|recurrent neuroblastoma|recurrent neuroblastoma
763811|NCT00060021|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
763812|NCT00060021|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
763813|NCT00060021|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
763814|NCT00060021|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
763815|NCT00060021|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
763816|NCT00060021|refractory hairy cell leukemia|refractory hairy cell leukemia
763817|NCT00060021|refractory multiple myeloma|refractory multiple myeloma
763818|NCT00060021|secondary acute myeloid leukemia|secondary acute myeloid leukemia
763819|NCT00060021|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
763820|NCT00060021|stage I multiple myeloma|stage i multiple myeloma
763821|NCT00060021|stage II multiple myeloma|stage ii multiple myeloma
763823|NCT00060021|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
763824|NCT00060021|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
763825|NCT00060021|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
763826|NCT00060021|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
763827|NCT00060021|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
763828|NCT00060021|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
763829|NCT00060021|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
763830|NCT00060021|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
763831|NCT00060021|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
763832|NCT00060021|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
763833|NCT00060021|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
763834|NCT00060021|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
763835|NCT00060021|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
763836|NCT00060021|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
763837|NCT00060021|stage IIIA breast cancer|stage iiia breast cancer
763838|NCT00060021|stage IIIB breast cancer|stage iiib breast cancer
763839|NCT00060021|stage IIIC breast cancer|stage iiic breast cancer
763840|NCT00060021|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
763841|NCT00060021|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
763842|NCT00060021|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
763843|NCT00060021|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
763844|NCT00060021|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
763845|NCT00060021|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
763846|NCT00060021|stage IV breast cancer|stage iv breast cancer
763847|NCT00060021|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
763848|NCT00060021|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
763849|NCT00060021|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
763850|NCT00060021|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
763851|NCT00060021|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
763852|NCT00060021|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
763853|NCT00060021|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
763854|NCT00060021|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
763855|NCT00060021|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
763856|NCT00060021|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
763857|NCT00060021|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
763858|NCT00060021|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
763859|NCT00060021|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
763860|NCT00060021|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
763861|NCT00060021|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
763862|NCT00060021|testicular embryonal carcinoma|testicular embryonal carcinoma
763863|NCT00060021|testicular teratoma|testicular teratoma
763864|NCT00060021|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
763865|NCT00060021|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
763866|NCT00060021|testicular yolk sac tumor|testicular yolk sac tumor
763867|NCT00060021|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
763868|NCT00060021|testicular choriocarcinoma|testicular choriocarcinoma
763869|NCT00060021|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
763870|NCT00060021|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
763871|NCT00060021|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
763872|NCT00060021|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
763873|NCT00060021|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
763874|NCT00060021|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
763875|NCT00060021|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
763876|NCT00060021|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
764176|NCT00059683|Cervical length|cervical length
763877|NCT00060021|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
763878|NCT00060021|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
763879|NCT00060021|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
763880|NCT00060021|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
763881|NCT00060021|splenic marginal zone lymphoma|splenic marginal zone lymphoma
763882|NCT00060008|neurofibromatosis type 1|neurofibromatosis type 1
763883|NCT00060008|plexiform neurofibroma|plexiform neurofibroma
763884|NCT00059995|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
763885|NCT00059995|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
763886|NCT00059995|anaplastic large cell lymphoma|anaplastic large cell lymphoma
763887|NCT00059995|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
763888|NCT00059995|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
763889|NCT00059995|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
763890|NCT00059982|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
763891|NCT00059982|stage II pancreatic cancer|stage ii pancreatic cancer
763892|NCT00059982|stage III pancreatic cancer|stage iii pancreatic cancer
763893|NCT00059982|stage IV pancreatic cancer|stage iv pancreatic cancer
763894|NCT00059943|stage IV breast cancer|stage iv breast cancer
763895|NCT00059943|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
763896|NCT00059943|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
763897|NCT00059943|recurrent breast cancer|recurrent breast cancer
763898|NCT00059943|stage IV prostate cancer|stage iv prostate cancer
763899|NCT00059943|recurrent prostate cancer|recurrent prostate cancer
763900|NCT00059930|liver metastases|liver metastases
763901|NCT00059930|stage IV colon cancer|stage iv colon cancer
763902|NCT00059930|stage IV rectal cancer|stage iv rectal cancer
763903|NCT00059930|adenocarcinoma of the colon|adenocarcinoma of the colon
763904|NCT00059930|adenocarcinoma of the rectum|adenocarcinoma of the rectum
763905|NCT00059930|recurrent colon cancer|recurrent colon cancer
763906|NCT00059930|recurrent rectal cancer|recurrent rectal cancer
763907|NCT00059917|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
763908|NCT00059904|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
763909|NCT00059904|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
763910|NCT00059904|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
763911|NCT00059891|perioperative/postoperative complications|perioperative/postoperative complications
763912|NCT00059891|stage II anal cancer|stage ii anal cancer
763913|NCT00059891|stage I anal cancer|stage i anal cancer
763914|NCT00059891|stage III anal cancer|stage iii anal cancer
763915|NCT00059891|stage I rectal cancer|stage i rectal cancer
763916|NCT00059891|stage II rectal cancer|stage ii rectal cancer
763917|NCT00059891|stage III rectal cancer|stage iii rectal cancer
763918|NCT00059878|infection|infection
763919|NCT00059878|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
763920|NCT00059865|advanced adult primary liver cancer|advanced adult primary liver cancer
763921|NCT00059865|unresectable gallbladder cancer|unresectable gallbladder cancer
763922|NCT00059865|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
763923|NCT00059865|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
763924|NCT00059852|male breast cancer|male breast cancer
763925|NCT00059852|recurrent breast cancer|recurrent breast cancer
763926|NCT00059852|stage IV breast cancer|stage iv breast cancer
763927|NCT00059839|anaplastic large cell lymphoma|anaplastic large cell lymphoma
763928|NCT00059826|stage I pancreatic cancer|stage i pancreatic cancer
763929|NCT00059826|stage II pancreatic cancer|stage ii pancreatic cancer
763930|NCT00059826|stage III pancreatic cancer|stage iii pancreatic cancer
763931|NCT00059826|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
763932|NCT00059800|recurrent melanoma|recurrent melanoma
763933|NCT00059800|stage 0 melanoma|stage 0 melanoma
763934|NCT00059800|stage I melanoma|stage i melanoma
763935|NCT00059800|stage II melanoma|stage ii melanoma
763936|NCT00059800|stage III melanoma|stage iii melanoma
763937|NCT00059800|stage IV melanoma|stage iv melanoma
763938|NCT00059761|limited stage small cell lung cancer|limited stage small cell lung cancer
763939|NCT00059735|kidney cancer|kidney cancer
763940|NCT00059735|kidney neoplasms|kidney neoplasms
763941|NCT00059735|renal cell cancer|renal cell cancer
763942|NCT00043108|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
763943|NCT00043108|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
763944|NCT00043108|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
763945|NCT00030524|stage III colon cancer|stage iii colon cancer
763946|NCT00030524|stage IV colon cancer|stage iv colon cancer
763947|NCT00030524|stage III rectal cancer|stage iii rectal cancer
763948|NCT00030524|stage IV rectal cancer|stage iv rectal cancer
763949|NCT00030524|recurrent colon cancer|recurrent colon cancer
763950|NCT00030524|recurrent rectal cancer|recurrent rectal cancer
763951|NCT00030524|adenocarcinoma of the colon|adenocarcinoma of the colon
763952|NCT00030524|adenocarcinoma of the rectum|adenocarcinoma of the rectum
763953|NCT00027599|adenocarcinoma of the prostate|adenocarcinoma of the prostate
763954|NCT00027599|stage I prostate cancer|stage i prostate cancer
763955|NCT00027599|stage IIB prostate cancer|stage iib prostate cancer
763956|NCT00027599|stage IIA prostate cancer|stage iia prostate cancer
763957|NCT00027599|stage III prostate cancer|stage iii prostate cancer
763958|NCT00027599|stage IV prostate cancer|stage iv prostate cancer
763959|NCT00027599|recurrent prostate cancer|recurrent prostate cancer
763960|NCT00017134|ovarian epithelial cancer|ovarian epithelial cancer
763961|NCT00016315|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
763962|NCT00016315|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
763963|NCT00006225|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
763964|NCT00006225|stage IV breast cancer|stage iv breast cancer
763965|NCT00006225|stage IIIA breast cancer|stage iiia breast cancer
763966|NCT00006225|recurrent breast cancer|recurrent breast cancer
763967|NCT00006225|stage IIIB breast cancer|stage iiib breast cancer
763968|NCT00006225|stage IIIC breast cancer|stage iiic breast cancer
763969|NCT00006225|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
763970|NCT00006225|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
763971|NCT00006225|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
763972|NCT00006225|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
763973|NCT00006225|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
763974|NCT00006225|isolated plasmacytoma of bone|isolated plasmacytoma of bone
763975|NCT00006225|extramedullary plasmacytoma|extramedullary plasmacytoma
763976|NCT00006225|refractory multiple myeloma|refractory multiple myeloma
763977|NCT00006225|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
763978|NCT00006225|stage I multiple myeloma|stage i multiple myeloma
763979|NCT00006225|stage II multiple myeloma|stage ii multiple myeloma
763980|NCT00006225|stage III multiple myeloma|stage iii multiple myeloma
763981|NCT00006225|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
763982|NCT00006225|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
763983|NCT00006225|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
763984|NCT00006225|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
763985|NCT00006225|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
763986|NCT00006225|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
763987|NCT00006225|acute undifferentiated leukemia|acute undifferentiated leukemia
763988|NCT00006225|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
763989|NCT00006225|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
763990|NCT00006225|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
763991|NCT00006225|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
763992|NCT00006225|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
763993|NCT00006225|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
763994|NCT00006225|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
763995|NCT00006225|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
763996|NCT00006225|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
763997|NCT00006225|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
763998|NCT00006225|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
763999|NCT00006225|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
764000|NCT00006225|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
764001|NCT00006225|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
764002|NCT00006225|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
764003|NCT00006225|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
764004|NCT00006225|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
764005|NCT00006225|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
764006|NCT00006225|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
764007|NCT00006225|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
764008|NCT00006225|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
764009|NCT00006225|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
764010|NCT00006225|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
764011|NCT00006225|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
764012|NCT00006225|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
764013|NCT00006225|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
764014|NCT00006225|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
764015|NCT00006225|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
764016|NCT00006225|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
764017|NCT00006225|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
764018|NCT00006225|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
764019|NCT00006225|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
764020|NCT00006225|primary central nervous system lymphoma|primary central nervous system lymphoma
764021|NCT00006225|male breast cancer|male breast cancer
764022|NCT00006225|intraocular lymphoma|intraocular lymphoma
764023|NCT00006225|stage I mantle cell lymphoma|stage i mantle cell lymphoma
764024|NCT00006225|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
764025|NCT00006225|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
764026|NCT00006225|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
764027|NCT00006225|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
764028|NCT00006225|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
764029|NCT00006225|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
764092|NCT00004095|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
764030|NCT00006225|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
764031|NCT00006225|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
764032|NCT00006225|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
764033|NCT00006225|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
764034|NCT00006225|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
764035|NCT00006225|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
764036|NCT00006225|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
764037|NCT00006225|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
764038|NCT00006225|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
764039|NCT00006225|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
764040|NCT00006225|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
764041|NCT00006225|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
764042|NCT00006225|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
764043|NCT00006225|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
764044|NCT00006225|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
764045|NCT00006225|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
764046|NCT00006225|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
764047|NCT00006225|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
764048|NCT00006225|anaplastic large cell lymphoma|anaplastic large cell lymphoma
764049|NCT00006225|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
764050|NCT00006225|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
764051|NCT00006225|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
764052|NCT00006225|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
764053|NCT00006225|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
764054|NCT00006225|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
764055|NCT00006225|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
764056|NCT00006225|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
764057|NCT00006225|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
764058|NCT00006225|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
764059|NCT00006225|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
764060|NCT00006225|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
764061|NCT00006225|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
764062|NCT00006225|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
764063|NCT00006225|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
764064|NCT00006225|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
764065|NCT00006225|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
764066|NCT00006225|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
764067|NCT00006225|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
764068|NCT00006225|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
764069|NCT00006225|splenic marginal zone lymphoma|splenic marginal zone lymphoma
764070|NCT00005793|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
764071|NCT00005793|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
764072|NCT00005793|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
764073|NCT00005793|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
764074|NCT00005793|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
764075|NCT00005793|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
764076|NCT00005793|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
764077|NCT00005793|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
764078|NCT00005793|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
764079|NCT00005793|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
764080|NCT00005793|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
764081|NCT00005793|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
764082|NCT00005793|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
764083|NCT00004127|stage IV gastric cancer|stage iv gastric cancer
764084|NCT00004127|recurrent gastric cancer|recurrent gastric cancer
764085|NCT00004127|stage IV esophageal cancer|stage iv esophageal cancer
764086|NCT00004127|recurrent esophageal cancer|recurrent esophageal cancer
764087|NCT00004127|adenocarcinoma of the stomach|adenocarcinoma of the stomach
764088|NCT00004127|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
764089|NCT00004095|stage IV colon cancer|stage iv colon cancer
764090|NCT00004095|stage IV breast cancer|stage iv breast cancer
764091|NCT00004095|recurrent breast cancer|recurrent breast cancer
764093|NCT00004095|recurrent pancreatic cancer|recurrent pancreatic cancer
764094|NCT00004095|stage IV rectal cancer|stage iv rectal cancer
764095|NCT00004095|recurrent colon cancer|recurrent colon cancer
764096|NCT00004095|recurrent rectal cancer|recurrent rectal cancer
764097|NCT00004095|stage IV renal cell cancer|stage iv renal cell cancer
764098|NCT00004095|recurrent renal cell cancer|recurrent renal cell cancer
764099|NCT00004095|extensive stage small cell lung cancer|extensive stage small cell lung cancer
764100|NCT00004095|recurrent small cell lung cancer|recurrent small cell lung cancer
764101|NCT00004095|recurrent bladder cancer|recurrent bladder cancer
764102|NCT00004095|stage IV bladder cancer|stage iv bladder cancer
764103|NCT00004095|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
764104|NCT00004095|stage IV pancreatic cancer|stage iv pancreatic cancer
764105|NCT00059748|Central Nervous System Abnormalities|central nervous system abnormalities
764106|NCT00059748|Arthropathy|arthropathy
764107|NCT00059748|Urticaria|urticaria
764108|NCT00059748|Papilledema|papilledema
764109|NCT00059748|Autoinflammation|autoinflammation
764110|NCT00059748|Neonatal Onset Multisystem Imflammatory|neonatal onset multisystem imflammatory
764111|NCT00059748|Disease|disease
764112|NCT00059748|NOMID|nomid
764113|NCT00019435|stage IV colon cancer|stage iv colon cancer
764114|NCT00019435|stage IV breast cancer|stage iv breast cancer
764115|NCT00019435|recurrent breast cancer|recurrent breast cancer
764116|NCT00019435|stage IV gastric cancer|stage iv gastric cancer
764117|NCT00019435|recurrent gastric cancer|recurrent gastric cancer
764118|NCT00019435|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
764119|NCT00019435|recurrent pancreatic cancer|recurrent pancreatic cancer
764120|NCT00019435|recurrent colon cancer|recurrent colon cancer
764121|NCT00019435|stage IV esophageal cancer|stage iv esophageal cancer
764122|NCT00019435|recurrent esophageal cancer|recurrent esophageal cancer
764123|NCT00019435|recurrent bladder cancer|recurrent bladder cancer
764124|NCT00019435|stage IV bladder cancer|stage iv bladder cancer
764125|NCT00019435|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
764126|NCT00019435|stage IV pancreatic cancer|stage iv pancreatic cancer
764127|NCT00002765|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
764128|NCT00002765|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
764129|NCT00002765|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
764130|NCT00002765|Waldenström macroglobulinemia|waldenström macroglobulinemia
764131|NCT00002765|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
764132|NCT00002765|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
764133|NCT00002765|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
764134|NCT00002765|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
764135|NCT00002765|refractory hairy cell leukemia|refractory hairy cell leukemia
764136|NCT00002765|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
764137|NCT00002765|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
764138|NCT00002765|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
764139|NCT00002765|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
764140|NCT00002765|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
764141|NCT00002765|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
764142|NCT00002765|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
764143|NCT00002765|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
764144|NCT00002765|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
764145|NCT00002765|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
764146|NCT00002765|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
764147|NCT00002765|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
764148|NCT00002765|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
764149|NCT00002765|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
764150|NCT00002765|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
764151|NCT00002765|prolymphocytic leukemia|prolymphocytic leukemia
764152|NCT00002765|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
764153|NCT00002765|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
764154|NCT00002765|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
764155|NCT00002765|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
764156|NCT00002765|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
764157|NCT00002765|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
764158|NCT00002765|splenic marginal zone lymphoma|splenic marginal zone lymphoma
764159|NCT00059722|NSCLC|nsclc
764160|NCT00059722|locally advanced or metastatic|locally advanced or metastatic
764161|NCT00059722|second-line|second-line
764162|NCT00059709|Conflict Resolution training|conflict resolution training
764163|NCT00059709|Children|children
764164|NCT00059696|Constraint-Induced Movement Therapy|constraint-induced movement therapy
764165|NCT00059696|CI therapy|ci therapy
764166|NCT00059696|Rehabilitation|rehabilitation
764167|NCT00059696|Cerebrovascular accident|cerebrovascular accident
764168|NCT00059696|Upper extremity|upper extremity
764169|NCT00059696|Concentrated, extended practice|concentrated, extended practice
764170|NCT00059696|Limb restraint|limb restraint
764171|NCT00059696|Motor Deficits|motor deficits
764172|NCT00059683|Preterm Birth|preterm birth
764173|NCT00059683|Premature Birth|premature birth
764174|NCT00059683|Cervical cerclage|cervical cerclage
764175|NCT00059683|Vaginal ultrasound|vaginal ultrasound
764177|NCT00018941|stage IV renal cell cancer|stage iv renal cell cancer
764178|NCT00018941|recurrent renal cell cancer|recurrent renal cell cancer
764179|NCT00005837|recurrent cervical cancer|recurrent cervical cancer
764180|NCT00005837|cervical squamous cell carcinoma|cervical squamous cell carcinoma
764181|NCT00005025|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
764182|NCT00005025|fallopian tube cancer|fallopian tube cancer
764183|NCT00005025|primary peritoneal cavity cancer|primary peritoneal cavity cancer
764184|NCT00002971|recurrent adult brain tumor|recurrent adult brain tumor
764185|NCT00002971|adult glioblastoma|adult glioblastoma
764186|NCT00002971|adult anaplastic astrocytoma|adult anaplastic astrocytoma
764187|NCT00002971|adult giant cell glioblastoma|adult giant cell glioblastoma
764188|NCT00002971|adult gliosarcoma|adult gliosarcoma
764189|NCT00059670|UES|ues
764190|NCT00059670|Dysphagia|dysphagia
764191|NCT00059657|Ecraprost in lipid emulsion|ecraprost in lipid emulsion
764192|NCT00059657|CLI|cli
764193|NCT00059657|peripheral, vascular|peripheral, vascular
764194|NCT00059657|amputation|amputation
764195|NCT00059657|Angioplasty|angioplasty
764196|NCT00059657|by-pass|by-pass
764197|NCT00059657|Critical Limb Ischemia due to peripheral arterial disease|critical limb ischemia due to peripheral arterial disease
764198|NCT00059644|Ecraprost in lipid emulsion|ecraprost in lipid emulsion
764199|NCT00059644|CLI|cli
764200|NCT00059644|peripheral|peripheral
764201|NCT00059644|vascular|vascular
764202|NCT00059644|amputation|amputation
764203|NCT00059644|Critical Limb Ischemia due to peripheral arterial disease|critical limb ischemia due to peripheral arterial disease
764204|NCT00003933|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
764205|NCT00003926|soft tissue sarcoma|soft tissue sarcoma
764206|NCT00003926|regional neuroblastoma|regional neuroblastoma
764207|NCT00003926|disseminated neuroblastoma|disseminated neuroblastoma
764208|NCT00003926|recurrent Wilms tumor|recurrent wilms tumor
764209|NCT00003926|recurrent retinoblastoma|recurrent retinoblastoma
764210|NCT00003926|recurrent adult brain tumor|recurrent adult brain tumor
764211|NCT00003926|adult rhabdomyosarcoma|adult rhabdomyosarcoma
764212|NCT00003926|ovarian germ cell tumor|ovarian germ cell tumor
764213|NCT00003926|chordoma|chordoma
764214|NCT00003926|ovarian sarcoma|ovarian sarcoma
764215|NCT00003926|unresectable neuroblastoma|unresectable neuroblastoma
764216|NCT00003926|desmoplastic small round cell tumor|desmoplastic small round cell tumor
764217|NCT00003926|rhabdomyosarcoma|rhabdomyosarcoma
764218|NCT00003926|Ewing sarcoma|ewing sarcoma
764219|NCT00003926|neuroectodermal tumor|neuroectodermal tumor
764220|NCT00003926|teratoma|teratoma
764221|NCT00003926|malignant testicular germ cell tumor|malignant testicular germ cell tumor
764222|NCT00003926|malignant ovarian germ cell tumor|malignant ovarian germ cell tumor
764223|NCT00003926|extragonadal germ cell tumor|extragonadal germ cell tumor
764224|NCT00003926|malignant germ cell tumor|malignant germ cell tumor
764225|NCT00003926|hepatoblastoma|hepatoblastoma
764226|NCT00003926|liver cancer|liver cancer
764227|NCT00003926|medulloblastoma|medulloblastoma
764228|NCT00003926|cerebellar astrocytoma|cerebellar astrocytoma
764229|NCT00003926|brain stem glioma|brain stem glioma
764230|NCT00003926|glioma|glioma
764231|NCT00003926|cerebral astrocytoma|cerebral astrocytoma
764232|NCT00003926|ependymoma|ependymoma
764233|NCT00003925|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
764234|NCT00003802|iris melanoma|iris melanoma
764235|NCT00003802|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
764236|NCT00003802|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
764237|NCT00003802|extraocular extension melanoma|extraocular extension melanoma
764238|NCT00003802|recurrent intraocular melanoma|recurrent intraocular melanoma
764239|NCT00003802|stage IV melanoma|stage iv melanoma
764240|NCT00003802|recurrent melanoma|recurrent melanoma
764241|NCT00003797|recurrent pancreatic cancer|recurrent pancreatic cancer
764242|NCT00003797|stage IV pancreatic cancer|stage iv pancreatic cancer
764243|NCT00059631|Prostate Cancer|prostate cancer
764244|NCT00059631|Advanced Androgen-Independent Prostate Cancer|advanced androgen-independent prostate cancer
764245|NCT00059631|AI-PCa|ai-pca
764246|NCT00059631|Advanced Prostate Cancer|advanced prostate cancer
764247|NCT00059631|Novantrone|novantrone
764248|NCT00059631|Mitoxantrone|mitoxantrone
764249|NCT00059631|PS-341|ps-341
764250|NCT00059631|Bortezomib|bortezomib
764251|NCT00059631|Velcade|velcade
764252|NCT00059631|LDP-341|ldp-341
764253|NCT00059631|MLN341|mln341
764254|NCT00059631|20S proteasome|20s proteasome
764255|NCT00059618|Platinum Resistant|platinum resistant
764256|NCT00059618|Taxane Resistant|taxane resistant
764257|NCT00059618|Ovarian Cancer|ovarian cancer
764258|NCT00059618|Primary Peritoneal Cancer|primary peritoneal cancer
764259|NCT00059618|Fallopian Tube Cancer|fallopian tube cancer
764260|NCT00059618|Bortezomib|bortezomib
764261|NCT00059618|PS-341|ps-341
764262|NCT00059618|Velcade|velcade
764263|NCT00059618|LDP-341|ldp-341
764264|NCT00059618|MLN341|mln341
764265|NCT00059618|Carboplatin|carboplatin
764266|NCT00059618|Paraplatin|paraplatin
764267|NCT00059605|Non-Small Cell Lung Cancer|non-small cell lung cancer
764268|NCT00059605|Small Cell Lung Cancer|small cell lung cancer
764269|NCT00059605|Lung Cancer|lung cancer
764270|NCT00059605|NSCLC|nsclc
764271|NCT00059605|SCLC|sclc
764272|NCT00059605|DOTAP:Chol-fus1|dotap:chol-fus1
764273|NCT00059605|gene|gene
764274|NCT00059605|gene transfer|gene transfer
764275|NCT00003757|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
764276|NCT00003757|refractory hairy cell leukemia|refractory hairy cell leukemia
764277|NCT00003649|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
764278|NCT00003649|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
764279|NCT00003649|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
764280|NCT00003649|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
764281|NCT00003627|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
764282|NCT00003627|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
764283|NCT00003627|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
764284|NCT00003627|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
764285|NCT00003484|localized resectable neuroblastoma|localized resectable neuroblastoma
764286|NCT00003484|recurrent adult brain tumor|recurrent adult brain tumor
764287|NCT00003484|adult craniopharyngioma|adult craniopharyngioma
764288|NCT00003484|adult medulloblastoma|adult medulloblastoma
764289|NCT00003484|adult meningioma|adult meningioma
764290|NCT00003484|adult glioblastoma|adult glioblastoma
764291|NCT00003484|adult oligodendroglioma|adult oligodendroglioma
764292|NCT00003484|adult anaplastic astrocytoma|adult anaplastic astrocytoma
764293|NCT00003484|adult mixed glioma|adult mixed glioma
764294|NCT00003484|adult pineal parenchymal tumor|adult pineal parenchymal tumor
764295|NCT00003484|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
764296|NCT00003484|adult grade III meningioma|adult grade iii meningioma
764297|NCT00003484|adult pilocytic astrocytoma|adult pilocytic astrocytoma
764298|NCT00003484|adult giant cell glioblastoma|adult giant cell glioblastoma
764299|NCT00003484|adult gliosarcoma|adult gliosarcoma
764300|NCT00003436|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
764301|NCT00003436|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
764302|NCT00003436|refractory anemia with excess blasts|refractory anemia with excess blasts
764303|NCT00003436|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
764304|NCT00003436|secondary acute myeloid leukemia|secondary acute myeloid leukemia
764305|NCT00003436|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
764306|NCT00003436|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
764307|NCT00003436|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
764308|NCT00059579|Reward|reward
764309|NCT00059579|Cortex|cortex
764310|NCT00059579|Dopamine|dopamine
764311|NCT00059579|Neuroimaging|neuroimaging
764312|NCT00059579|Strirtum|strirtum
764313|NCT00059579|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
764314|NCT00059579|Melancholic Features|melancholic features
764315|NCT00059579|Brain Imaging|brain imaging
764316|NCT00059579|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
764317|NCT00059579|Dopaminergic Mechanisms|dopaminergic mechanisms
764318|NCT00059579|Anhedonia|anhedonia
764319|NCT00059579|Depression|depression
764320|NCT00059579|Major Depressive Disorder|major depressive disorder
764321|NCT00059579|MDD|mdd
764322|NCT00059579|Healthy Volunteer|healthy volunteer
764323|NCT00059579|HV|hv
764324|NCT00059553|spinal cord injury|spinal cord injury
764325|NCT00059553|walking|walking
764326|NCT00059553|training|training
764327|NCT00059553|treadmill|treadmill
764328|NCT00059553|incomplete spinal cord injury|incomplete spinal cord injury
764329|NCT00059540|NICHD Neonatal Research Network|nichd neonatal research network
764330|NCT00059540|Maternal Lifestyle Study|maternal lifestyle study
764331|NCT00059540|Cocaine abuse|cocaine abuse
764332|NCT00059540|Cocaine dependence|cocaine dependence
764333|NCT00059540|Opiate abuse|opiate abuse
764334|NCT00059540|Opiate dependence|opiate dependence
764335|NCT00059540|Follow-up|follow-up
764336|NCT00059540|Neurodevelopmental outcome|neurodevelopmental outcome
764337|NCT00059540|Substance-related disorders|substance-related disorders
764338|NCT00059527|Physical Activity|physical activity
764339|NCT00059527|Nutrition|nutrition
764340|NCT00059527|Self Efficacy|self efficacy
764341|NCT00059527|Middle School|middle school
764342|NCT00059527|Intervention|intervention
764343|NCT00059514|Youth|youth
764344|NCT00059514|Adolescents|adolescents
764345|NCT00059514|Smoking cessation|smoking cessation
764346|NCT00059514|Smoking prevention|smoking prevention
764347|NCT00059514|Risk factors|risk factors
764348|NCT00059514|Arab Americans|arab americans
764349|NCT00059449|Enterocolitis|enterocolitis
764350|NCT00005836|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
764351|NCT00005836|primary peritoneal cavity cancer|primary peritoneal cavity cancer
764352|NCT00059501|Postural Stability|postural stability
764353|NCT00059501|EEG|eeg
764354|NCT00059501|Aging|aging
764355|NCT00059501|Falls|falls
764356|NCT00059501|Healthy Volunteer|healthy volunteer
764357|NCT00059501|HV|hv
764358|NCT00059475|Adjuvant Therapy|adjuvant therapy
764359|NCT00059475|MART-1 Peptides|mart-1 peptides
764360|NCT00059475|GP100 Peptide|gp100 peptide
764361|NCT00059475|Immunologic Response|immunologic response
764362|NCT00059475|Melanoma|melanoma
764363|NCT00059436|Muscle strengthening|muscle strengthening
764364|NCT00059436|Skeletal muscle Contractions|skeletal muscle contractions
764365|NCT00059436|Rehabilitative exercise|rehabilitative exercise
764366|NCT00059410|Alzheimer disease|alzheimer disease
764367|NCT00059410|Caregivers|caregivers
764368|NCT00059410|African Americans|african americans
764369|NCT00059410|Perceptions|perceptions
764370|NCT00059410|Cultural Competency|cultural competency
764371|NCT00059423|Leukapheresis|leukapheresis
764372|NCT00059423|G-CSF|g-csf
764373|NCT00059423|Dexamethasone|dexamethasone
764374|NCT00059423|mRNA|mrna
764375|NCT00059423|Benign Ethnic Neutropenia|benign ethnic neutropenia
764376|NCT00059423|BEN|ben
764377|NCT00059423|Healthy Volunteer|healthy volunteer
764378|NCT00059423|HV|hv
764379|NCT00059397|Hepatitis C|hepatitis c
764380|NCT00003432|stage IV breast cancer|stage iv breast cancer
764381|NCT00003346|stage III melanoma|stage iii melanoma
764382|NCT00003346|stage IV melanoma|stage iv melanoma
764383|NCT00003346|recurrent melanoma|recurrent melanoma
764384|NCT00003341|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
764385|NCT00003341|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
764386|NCT00003341|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
764387|NCT00003341|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
764388|NCT00003341|refractory multiple myeloma|refractory multiple myeloma
764389|NCT00003341|Waldenström macroglobulinemia|waldenström macroglobulinemia
764390|NCT00003341|stage II multiple myeloma|stage ii multiple myeloma
764391|NCT00003341|stage III multiple myeloma|stage iii multiple myeloma
764392|NCT00003341|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
764393|NCT00003341|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
764394|NCT00003341|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
764395|NCT00003341|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
764396|NCT00003341|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
764397|NCT00003341|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
764398|NCT00003341|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
764399|NCT00003341|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
764400|NCT00003341|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
764401|NCT00003341|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
764402|NCT00003341|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
764403|NCT00003341|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
764404|NCT00003341|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
764405|NCT00003341|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
764406|NCT00003341|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
764407|NCT00003341|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
764408|NCT00003341|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
764409|NCT00003341|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
764410|NCT00003341|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
764411|NCT00003341|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
764412|NCT00003341|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
764413|NCT00003341|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
764414|NCT00003341|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
764415|NCT00003341|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
764416|NCT00003341|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
764417|NCT00003341|anemia|anemia
764418|NCT00003341|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
764419|NCT00003341|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
764420|NCT00003341|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
764421|NCT00003341|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
764422|NCT00003341|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
764423|NCT00003341|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
764424|NCT00003341|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
764425|NCT00003341|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
764426|NCT00003341|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
764427|NCT00003341|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
764428|NCT00003341|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
764429|NCT00003341|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
764430|NCT00003341|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
764431|NCT00003341|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
764432|NCT00003341|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
764433|NCT00003341|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
764434|NCT00003341|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
764435|NCT00003341|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
764436|NCT00003341|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
764437|NCT00003341|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
764438|NCT00003341|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
764439|NCT00003341|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
764440|NCT00003341|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
764441|NCT00003341|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
764442|NCT00003341|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
764443|NCT00003341|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
764444|NCT00003341|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
764445|NCT00003341|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
764446|NCT00003341|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
764447|NCT00003341|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
764448|NCT00003341|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
764449|NCT00003341|splenic marginal zone lymphoma|splenic marginal zone lymphoma
764450|NCT00003324|tumors metastatic to brain|tumors metastatic to brain
764451|NCT00003311|stage I mantle cell lymphoma|stage i mantle cell lymphoma
764452|NCT00003311|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
764453|NCT00003311|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
764454|NCT00003311|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
764455|NCT00003311|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
764456|NCT00059384|Treatment experienced|treatment experienced
764457|NCT00059384|Therapeutic Drug Monitoring|therapeutic drug monitoring
764458|NCT00059371|Male circumcision|male circumcision
764459|NCT00059371|HIV acquisition|hiv acquisition
764460|NCT00059371|Sexually transmitted infection|sexually transmitted infection
764461|NCT00059371|HIV Seronegativity|hiv seronegativity
764462|NCT00059358|HIV|hiv
764463|NCT00059358|HCV|hcv
764464|NCT00059358|Ribavirin|ribavirin
764465|NCT00059358|Interferon|interferon
764466|NCT00059358|Co-infection|co-infection
764467|NCT00059358|Treatment experienced|treatment experienced
764468|NCT00059345|Acupuncture|acupuncture
764469|NCT00059345|Arthritis|arthritis
764470|NCT00059332|stroke|stroke
764471|NCT00059332|brain attack|brain attack
764472|NCT00059332|magnesium sulfate|magnesium sulfate
764473|NCT00059332|neuroprotection|neuroprotection
764474|NCT00059332|prehospital care|prehospital care
764475|NCT00059332|emergency medical services|emergency medical services
764476|NCT00059319|coronary artery bypass graft surgery|coronary artery bypass graft surgery
764477|NCT00059319|CABG surgery|cabg surgery
764478|NCT00059319|neurobehavioral impairment|neurobehavioral impairment
764479|NCT00059319|aorta clamping|aorta clamping
764480|NCT00059319|aorta manipulation|aorta manipulation
764481|NCT00059319|microemboli|microemboli
764482|NCT00059306|stroke|stroke
764483|NCT00059306|hypertension|hypertension
764484|NCT00059306|high blood pressure|high blood pressure
764485|NCT00059306|lacunar stroke|lacunar stroke
764486|NCT00059306|subcortical stroke|subcortical stroke
764487|NCT00059306|aspirin|aspirin
764488|NCT00059306|clopidogrel|clopidogrel
764489|NCT00058981|Diabetes|diabetes
764490|NCT00058981|LADA|lada
764491|NCT00058981|latent autoimmune diabetes in adults|latent autoimmune diabetes in adults
764492|NCT00059280|Pompe disease|pompe disease
764493|NCT00059280|Glycogen storage disease type II|glycogen storage disease type ii
764494|NCT00059280|GSD-II|gsd-ii
764495|NCT00059280|Acid maltase deficiency disease|acid maltase deficiency disease
764496|NCT00059280|Glycogenosis 2|glycogenosis 2
764497|NCT00059254|fatty acids|fatty acids
764498|NCT00059254|oleic acid|oleic acid
764499|NCT00059254|palmitic acid|palmitic acid
764500|NCT00059254|fat oxidation|fat oxidation
764501|NCT00059254|energy expenditure|energy expenditure
764502|NCT00059254|body composition|body composition
764503|NCT00059254|monounsaturated fat|monounsaturated fat
764504|NCT00059254|human|human
764505|NCT00059241|Early sexual initiation|early sexual initiation
765155|NCT00057499|Insulin|insulin
764506|NCT00059241|Prevention of early sexual activity|prevention of early sexual activity
764507|NCT00059241|Middle childhood|middle childhood
764508|NCT00003290|stage IIB prostate cancer|stage iib prostate cancer
764509|NCT00003290|stage IIA prostate cancer|stage iia prostate cancer
764510|NCT00003290|stage III prostate cancer|stage iii prostate cancer
764511|NCT00003262|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
764512|NCT00003262|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
764709|NCT00059033|Parkinson's Disease|parkinson's disease
764513|NCT00003262|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
764514|NCT00003262|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
764515|NCT00003262|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
764516|NCT00003262|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
764517|NCT00003205|stage IV breast cancer|stage iv breast cancer
764518|NCT00003205|recurrent breast cancer|recurrent breast cancer
764519|NCT00003193|oral complications|oral complications
764520|NCT00003193|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
764521|NCT00003193|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
764522|NCT00003193|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
764523|NCT00003193|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
764524|NCT00003193|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
764525|NCT00003193|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
764526|NCT00003193|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
764527|NCT00003193|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
764528|NCT00003193|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
764529|NCT00003193|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
764530|NCT00003193|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
764531|NCT00003193|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
764532|NCT00003173|intraocular retinoblastoma|intraocular retinoblastoma
764533|NCT00003173|recurrent retinoblastoma|recurrent retinoblastoma
764534|NCT00003173|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
764535|NCT00003173|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
764536|NCT00003173|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
764537|NCT00003173|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
764538|NCT00003173|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
764539|NCT00003173|childhood germ cell tumor|childhood germ cell tumor
764540|NCT00003173|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
764541|NCT00003173|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
764542|NCT00003173|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
764543|NCT00003173|extragonadal germ cell tumor|extragonadal germ cell tumor
764544|NCT00003173|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
764545|NCT00003173|childhood teratoma|childhood teratoma
764546|NCT00003173|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
764547|NCT00003173|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
764548|NCT00003173|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
764549|NCT00003173|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
764550|NCT00059228|Pregnancy|pregnancy
764551|NCT00059228|Gonadal Steroids|gonadal steroids
764552|NCT00059228|Antidepressants|antidepressants
764553|NCT00059228|Puerperium|puerperium
764554|NCT00059228|Depression|depression
764555|NCT00059228|Postpartum|postpartum
764556|NCT00059228|Estradiol|estradiol
764557|NCT00059228|Estrogen Response Element|estrogen response element
764558|NCT00059228|Postpartum Depression|postpartum depression
764559|NCT00059202|Urso|urso
764560|NCT00059202|PSC|psc
764561|NCT00059189|Occipital Cortex|occipital cortex
764562|NCT00059189|Prefrontal Cortex|prefrontal cortex
764563|NCT00059189|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
764564|NCT00059189|Inhibition|inhibition
764565|NCT00059189|Cortical Excitability|cortical excitability
764566|NCT00059189|Blindness|blindness
764567|NCT00059189|Healthy Volunteer|healthy volunteer
764568|NCT00059189|HV|hv
764569|NCT00005839|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
764570|NCT00004220|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
764571|NCT00059137|Gating|gating
764572|NCT00059137|Respiratory Misregistration|respiratory misregistration
764573|NCT00059137|Abdominal Belt|abdominal belt
764574|NCT00059137|Percutaneous|percutaneous
764575|NCT00059137|CT Guided Biopsy|ct guided biopsy
764576|NCT00059137|Respiratory Cycle|respiratory cycle
764577|NCT00059137|Needle Biopsy|needle biopsy
764578|NCT00004257|stage I esophageal cancer|stage i esophageal cancer
765156|NCT00057499|Vaccine|vaccine
764579|NCT00004257|stage II esophageal cancer|stage ii esophageal cancer
764580|NCT00004257|stage III esophageal cancer|stage iii esophageal cancer
764581|NCT00004257|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
764582|NCT00004257|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
764583|NCT00004243|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
764584|NCT00003597|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
764585|NCT00003597|recurrent renal cell cancer|recurrent renal cell cancer
764586|NCT00003597|recurrent neuroblastoma|recurrent neuroblastoma
764587|NCT00003597|recurrent childhood liver cancer|recurrent childhood liver cancer
764588|NCT00003597|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
764589|NCT00003597|recurrent retinoblastoma|recurrent retinoblastoma
764590|NCT00003597|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
764591|NCT00003597|recurrent osteosarcoma|recurrent osteosarcoma
764592|NCT00003597|recurrent gestational trophoblastic tumor|recurrent gestational trophoblastic tumor
764593|NCT00003597|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
764594|NCT00003597|recurrent intraocular melanoma|recurrent intraocular melanoma
764595|NCT00003597|recurrent melanoma|recurrent melanoma
764596|NCT00003597|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
764597|NCT00003597|childhood germ cell tumor|childhood germ cell tumor
764598|NCT00003597|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
764599|NCT00003597|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
764600|NCT00003597|extragonadal germ cell tumor|extragonadal germ cell tumor
764601|NCT00003597|recurrent uterine sarcoma|recurrent uterine sarcoma
764602|NCT00003597|neutropenia|neutropenia
764603|NCT00003597|thrombocytopenia|thrombocytopenia
764604|NCT00003597|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
764605|NCT00003597|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
764606|NCT00003597|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
764607|NCT00003597|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
764608|NCT00003597|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
764609|NCT00003597|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
764610|NCT00003597|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
764611|NCT00003163|refractory multiple myeloma|refractory multiple myeloma
764612|NCT00003163|Waldenström macroglobulinemia|waldenström macroglobulinemia
764613|NCT00003163|stage I multiple myeloma|stage i multiple myeloma
764614|NCT00003163|stage II multiple myeloma|stage ii multiple myeloma
764615|NCT00003163|stage III multiple myeloma|stage iii multiple myeloma
764616|NCT00003163|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
764617|NCT00003163|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
764618|NCT00003163|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
764619|NCT00003163|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
764620|NCT00003163|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
764621|NCT00003163|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
764622|NCT00003163|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
764623|NCT00003163|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
764624|NCT00003163|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
764625|NCT00003163|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
764626|NCT00003163|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
764627|NCT00003163|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
764628|NCT00003163|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
764629|NCT00003163|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
764630|NCT00003163|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
764631|NCT00003163|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
764632|NCT00003163|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
764633|NCT00003163|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
764634|NCT00003163|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
764635|NCT00003163|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
764636|NCT00003163|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
764637|NCT00003163|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
764638|NCT00003163|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
764639|NCT00003163|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
764640|NCT00003163|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
764641|NCT00003163|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
764642|NCT00003163|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
764643|NCT00003163|primary systemic amyloidosis|primary systemic amyloidosis
764644|NCT00003163|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
782364|NCT00038272|MMF|mmf
764645|NCT00003163|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
764646|NCT00003163|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
764647|NCT00003163|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
764648|NCT00003163|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
764649|NCT00003163|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
764650|NCT00003163|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
764651|NCT00003163|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
764652|NCT00003163|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
764653|NCT00003163|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
764654|NCT00003163|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
764655|NCT00003163|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
764656|NCT00003163|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
764657|NCT00003163|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
764658|NCT00003163|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
764659|NCT00003163|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
764660|NCT00003163|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
764661|NCT00003163|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
764662|NCT00003163|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
764663|NCT00003163|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
764664|NCT00003163|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
764665|NCT00003163|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
764666|NCT00003163|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
764667|NCT00003163|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
764668|NCT00003163|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
764669|NCT00003163|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
764670|NCT00003163|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
764671|NCT00003163|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
764672|NCT00003163|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
764673|NCT00003163|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
764674|NCT00003163|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
764675|NCT00003163|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
764676|NCT00003163|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
764677|NCT00003163|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
764678|NCT00003163|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
764679|NCT00003163|splenic marginal zone lymphoma|splenic marginal zone lymphoma
764680|NCT00003162|stage IV breast cancer|stage iv breast cancer
764681|NCT00003162|recurrent breast cancer|recurrent breast cancer
764682|NCT00003162|stage IV prostate cancer|stage iv prostate cancer
764683|NCT00003162|recurrent prostate cancer|recurrent prostate cancer
764684|NCT00003162|bone metastases|bone metastases
764685|NCT00003162|pain|pain
764686|NCT00003129|stage 0 bladder cancer|stage 0 bladder cancer
764687|NCT00003129|stage I bladder cancer|stage i bladder cancer
764688|NCT00003129|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
764689|NCT00003124|adenocarcinoma of the prostate|adenocarcinoma of the prostate
764690|NCT00003124|stage I prostate cancer|stage i prostate cancer
764691|NCT00003124|stage IIB prostate cancer|stage iib prostate cancer
764692|NCT00003124|stage IIA prostate cancer|stage iia prostate cancer
764693|NCT00003124|stage III prostate cancer|stage iii prostate cancer
764694|NCT00003064|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
764695|NCT00003064|fallopian tube cancer|fallopian tube cancer
764696|NCT00003064|primary peritoneal cavity cancer|primary peritoneal cavity cancer
764697|NCT00002972|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
764698|NCT00002972|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
764699|NCT00002972|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
764700|NCT00002972|adenocarcinoma of the lung|adenocarcinoma of the lung
764701|NCT00059046|Neuroreceptors|neuroreceptors
764702|NCT00059046|PET Measurements|pet measurements
764703|NCT00059046|Kinetic Analysis|kinetic analysis
764704|NCT00059046|Test/Retest|test/retest
764705|NCT00059046|Healthy Volunteer|healthy volunteer
764706|NCT00059046|HV|hv
764707|NCT00059033|6-[18F]Fluorodopamine|6-[18f]fluorodopamine
764708|NCT00059033|Autonomic Failure|autonomic failure
764710|NCT00059033|Multiple System Atrophy|multiple system atrophy
764711|NCT00059033|Pure Autonomic Failure|pure autonomic failure
764712|NCT00059033|Primary Chronic Autonomic Failure|primary chronic autonomic failure
764713|NCT00059033|CAF|caf
764714|NCT00059020|Glioma|glioma
764715|NCT00059020|Brain Tumor|brain tumor
764716|NCT00059020|Epidermal Growth Factor|epidermal growth factor
764717|NCT00059020|Polymorphisms|polymorphisms
764718|NCT00058994|AMD|amd
764719|NCT00058994|anecortave acetate|anecortave acetate
764720|NCT00058994|wet AMD|wet amd
764721|NCT00058994|age-related macular degeneration|age-related macular degeneration
764722|NCT00058994|Macular Degeneration|macular degeneration
764723|NCT00058994|Maculopathy, Age-Related|maculopathy, age-related
764724|NCT00058994|Age-Related Maculopathies|age-related maculopathies
764725|NCT00058994|Age-Related Maculopathy|age-related maculopathy
764726|NCT00058994|Maculopathies, Age-Related|maculopathies, age-related
764727|NCT00058968|neuropathy|neuropathy
764728|NCT00058968|pain|pain
764729|NCT00058968|diabetes|diabetes
764730|NCT00058968|chronic pain|chronic pain
764731|NCT00058968|persistent pain|persistent pain
764732|NCT00058968|leg pain|leg pain
764733|NCT00058968|peripheral neuropathy|peripheral neuropathy
764734|NCT00058968|foot pain|foot pain
764735|NCT00058968|painful neuropathy|painful neuropathy
764736|NCT00058968|diabetic neuropathy|diabetic neuropathy
764737|NCT00058955|ghb|ghb
764738|NCT00058955|Xyrem|xyrem
764739|NCT00058955|triazolam|triazolam
764740|NCT00058955|pentobarbital|pentobarbital
764741|NCT00058955|sedative|sedative
764742|NCT00058955|abuse|abuse
764743|NCT00058942|Drinking Water|drinking water
764744|NCT00058903|Cholestatic|cholestatic
764745|NCT00058903|Pruritus|pruritus
764746|NCT00058903|Sertraline|sertraline
764747|NCT00058903|primary biliary cirrhosis|primary biliary cirrhosis
764748|NCT00058903|hepatitis C|hepatitis c
764749|NCT00058890|itching|itching
764750|NCT00058890|pruritus|pruritus
764751|NCT00058890|cholestasis|cholestasis
764752|NCT00058890|liver disease|liver disease
764753|NCT00058890|hepatitis|hepatitis
764754|NCT00058890|cirrhosis|cirrhosis
764755|NCT00002945|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
764756|NCT00002945|adult acute monoblastic leukemia and acute monocytic leukemia (M5)|adult acute monoblastic leukemia and acute monocytic leukemia (m5)
764757|NCT00002945|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
764758|NCT00002945|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
764759|NCT00002945|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
764760|NCT00002945|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
764761|NCT00002945|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
764762|NCT00002945|secondary acute myeloid leukemia|secondary acute myeloid leukemia
764763|NCT00002945|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
764764|NCT00002934|breast cancer in situ|breast cancer in situ
764765|NCT00002934|ductal breast carcinoma|ductal breast carcinoma
764766|NCT00002835|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
764767|NCT00002835|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
764768|NCT00002835|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
764769|NCT00002835|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
764770|NCT00002835|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
764771|NCT00002835|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
764772|NCT00002835|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
764773|NCT00002835|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
764774|NCT00002835|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
764775|NCT00002835|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
764776|NCT00002835|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
764777|NCT00002835|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
764778|NCT00002835|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
764779|NCT00002835|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
764780|NCT00002835|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
764781|NCT00002835|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
764782|NCT00002835|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
764783|NCT00002835|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
764784|NCT00002835|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
764785|NCT00002835|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
764786|NCT00002835|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
764787|NCT00002835|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
764788|NCT00002835|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
764789|NCT00002835|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
764790|NCT00002835|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
765157|NCT00057499|Type 1 Diabetes|type 1 diabetes
764791|NCT00002822|limited stage small cell lung cancer|limited stage small cell lung cancer
764792|NCT00002822|extensive stage small cell lung cancer|extensive stage small cell lung cancer
764793|NCT00058851|Manual lymph drainage|manual lymph drainage
764794|NCT00058851|Combined physiotherapy|combined physiotherapy
764795|NCT00058825|Campath|campath
764796|NCT00058825|stem cell transplant|stem cell transplant
764797|NCT00058812|Cytotoxic T Lymphocytes|cytotoxic t lymphocytes
764798|NCT00058812|bone marrow transplant|bone marrow transplant
764799|NCT00058812|EBV+ lymphoproliferative disease|ebv+ lymphoproliferative disease
764800|NCT00058773|Hodgkin disease|hodgkin disease
764801|NCT00058773|non-Hodgkins Lymphoma|non-hodgkins lymphoma
764802|NCT00058773|bone marrow transplant|bone marrow transplant
764803|NCT00058760|Prevention of early sexual behavior|prevention of early sexual behavior
764804|NCT00058760|NIA intervention|nia intervention
764805|NCT00058747|Granulocytic Leukemia, Chronic|granulocytic leukemia, chronic
764806|NCT00058747|Leukemia, Granulocytic, Chronic|leukemia, granulocytic, chronic
764807|NCT00058747|Leukemia, Myelocytic, Chronic|leukemia, myelocytic, chronic
764808|NCT00058747|Leukemia, Myelogenous, Chronic|leukemia, myelogenous, chronic
764809|NCT00058747|Myelocytic Leukemia, Chronic|myelocytic leukemia, chronic
764810|NCT00058747|Myelogenous Leukemia, Chronic|myelogenous leukemia, chronic
764811|NCT00058747|Myeloid Leukemia, Chronic|myeloid leukemia, chronic
764812|NCT00058734|Dendritic Cell|dendritic cell
764813|NCT00058734|Immunotherapy|immunotherapy
764814|NCT00058734|Acute HIV|acute hiv
764815|NCT00058734|Human Immunodeficiency Virus|human immunodeficiency virus
764816|NCT00058734|AIDS|aids
764817|NCT00058734|HIV Therapeutic Vaccine|hiv therapeutic vaccine
764818|NCT00058734|Treatment Experienced|treatment experienced
764819|NCT00058734|Treatment Interruption|treatment interruption
764820|NCT00058721|Dementia|dementia
764821|NCT00058721|Feasibility|feasibility
764822|NCT00058721|Dopamine|dopamine
764823|NCT00058721|Lewy Body|lewy body
764824|NCT00058721|Parkinson Disease|parkinson disease
764825|NCT00058721|PD|pd
764826|NCT00058721|Healthy Volunteer|healthy volunteer
764827|NCT00058721|HV|hv
764828|NCT00058695|Macualar Degeneration|macualar degeneration
764829|NCT00058695|AMD|amd
764830|NCT00058695|Healthy Volunteer|healthy volunteer
764831|NCT00058695|HV|hv
764832|NCT00058682|Fungal Infection|fungal infection
764833|NCT00058682|Mycoses|mycoses
764834|NCT00058682|Candida Species|candida species
764835|NCT00058682|Candidiasis|candidiasis
764836|NCT00002777|stage IV breast cancer|stage iv breast cancer
764837|NCT00002777|recurrent breast cancer|recurrent breast cancer
764838|NCT00002701|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
764839|NCT00002701|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
764840|NCT00002695|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
764841|NCT00002695|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
764842|NCT00002695|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
764843|NCT00002695|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
764844|NCT00002695|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
764845|NCT00002695|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
764846|NCT00002695|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
764847|NCT00002695|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
764848|NCT00002695|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
764849|NCT00002695|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
764850|NCT00002695|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
764851|NCT00002695|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
764852|NCT00002695|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
764853|NCT00002695|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
764854|NCT00002695|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
764855|NCT00002695|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
764856|NCT00002695|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
764857|NCT00002695|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
764858|NCT00002695|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
764859|NCT00002695|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
764860|NCT00002695|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
764861|NCT00002695|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
764862|NCT00002695|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
764863|NCT00002695|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
764864|NCT00002695|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
764865|NCT00002693|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
764866|NCT00002693|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
764867|NCT00002693|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
764868|NCT00002693|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
764869|NCT00002693|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
764870|NCT00002693|neutropenia|neutropenia
764871|NCT00002669|stage IV melanoma|stage iv melanoma
764872|NCT00002669|recurrent melanoma|recurrent melanoma
764873|NCT00058656|Immunotherapy|immunotherapy
764874|NCT00058656|T Cell Therapy|t cell therapy
764875|NCT00058656|Adoptive immunotherapy|adoptive immunotherapy
764876|NCT00058656|Xcellerate|xcellerate
764877|NCT00058656|Xcellerated|xcellerated
764878|NCT00002658|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
764879|NCT00002658|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
764880|NCT00002658|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
764881|NCT00002658|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
764882|NCT00002658|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
764883|NCT00002658|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
764884|NCT00002658|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
764885|NCT00002658|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
764886|NCT00002658|secondary acute myeloid leukemia|secondary acute myeloid leukemia
764887|NCT00002658|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
764888|NCT00002658|neutropenia|neutropenia
764889|NCT00002658|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
764890|NCT00002653|stage I multiple myeloma|stage i multiple myeloma
764891|NCT00002653|stage II multiple myeloma|stage ii multiple myeloma
764892|NCT00002653|stage III multiple myeloma|stage iii multiple myeloma
764893|NCT00002575|stage I colon cancer|stage i colon cancer
764894|NCT00002575|stage II colon cancer|stage ii colon cancer
764895|NCT00002575|stage III colon cancer|stage iii colon cancer
764896|NCT00002575|adenocarcinoma of the colon|adenocarcinoma of the colon
764897|NCT00002550|squamous cell lung cancer|squamous cell lung cancer
764898|NCT00002550|large cell lung cancer|large cell lung cancer
764899|NCT00002550|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
764900|NCT00002550|adenocarcinoma of the lung|adenocarcinoma of the lung
764901|NCT00002550|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
764902|NCT00002539|localized osteosarcoma|localized osteosarcoma
764903|NCT00058617|EBV Positive Hodgkin's Lymphoma|ebv positive hodgkin's lymphoma
764904|NCT00058617|EBV Positive Non-Hodgkin's Lymphoma|ebv positive non-hodgkin's lymphoma
764905|NCT00058617|EBV Specific Cytotoxic T-Lymphocytes|ebv specific cytotoxic t-lymphocytes
764906|NCT00058552|Advanced, refractory, or recurrent ovarian cancer|advanced, refractory, or recurrent ovarian cancer
764907|NCT00058526|dHER2-AS15 ASCI|dher2-as15 asci
764908|NCT00058526|Immunotherapeutic|immunotherapeutic
764909|NCT00058526|Dose escalation|dose escalation
764910|NCT00058526|Breast cancer|breast cancer
764911|NCT00058487|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
764912|NCT00058487|advanced adult primary liver cancer|advanced adult primary liver cancer
764913|NCT00058487|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
764914|NCT00058487|recurrent adult primary liver cancer|recurrent adult primary liver cancer
764915|NCT00058474|stage II rectal cancer|stage ii rectal cancer
764916|NCT00058474|stage III rectal cancer|stage iii rectal cancer
764917|NCT00058474|adenocarcinoma of the rectum|adenocarcinoma of the rectum
764918|NCT00058448|stage II penile cancer|stage ii penile cancer
764919|NCT00058448|stage III penile cancer|stage iii penile cancer
764920|NCT00058448|stage IV penile cancer|stage iv penile cancer
764921|NCT00058435|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
764922|NCT00058435|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
764923|NCT00058435|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
764924|NCT00058435|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
764925|NCT00058435|fallopian tube cancer|fallopian tube cancer
764926|NCT00058435|primary peritoneal cavity cancer|primary peritoneal cavity cancer
764927|NCT00058422|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
764928|NCT00058422|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
764929|NCT00058422|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
764930|NCT00058396|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
764931|NCT00058396|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
764932|NCT00058396|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
764933|NCT00058396|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
764934|NCT00058396|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
764935|NCT00058396|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
782470|NCT00037830|PD|pd
764936|NCT00058396|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
764937|NCT00058396|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
764938|NCT00058396|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
764939|NCT00058396|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
764940|NCT00058396|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
764941|NCT00058370|adult medulloblastoma|adult medulloblastoma
764942|NCT00058370|untreated childhood medulloblastoma|untreated childhood medulloblastoma
764943|NCT00058357|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
764944|NCT00058357|pain|pain
764945|NCT00058318|stage IV renal cell cancer|stage iv renal cell cancer
764946|NCT00058318|stage III renal cell cancer|stage iii renal cell cancer
764947|NCT00058292|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
764948|NCT00058292|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
764949|NCT00058292|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
764950|NCT00058292|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
764951|NCT00058292|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
764952|NCT00058292|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
764953|NCT00058292|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
764954|NCT00058292|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
764955|NCT00058292|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
764956|NCT00058292|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
764957|NCT00058292|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
764958|NCT00058292|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
764959|NCT00058292|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
764960|NCT00058292|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
764961|NCT00058292|splenic marginal zone lymphoma|splenic marginal zone lymphoma
764962|NCT00058279|stage IV melanoma|stage iv melanoma
764963|NCT00058279|extraocular extension melanoma|extraocular extension melanoma
764964|NCT00058279|recurrent melanoma|recurrent melanoma
764965|NCT00058279|iris melanoma|iris melanoma
764966|NCT00058279|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
764967|NCT00058279|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
764968|NCT00058279|recurrent intraocular melanoma|recurrent intraocular melanoma
764969|NCT00058266|stage I prostate cancer|stage i prostate cancer
764970|NCT00058266|stage II prostate cancer|stage ii prostate cancer
764971|NCT00058201|acinar cell adenocarcinoma of the pancreas|acinar cell adenocarcinoma of the pancreas
764972|NCT00058201|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
764973|NCT00058201|stage I pancreatic cancer|stage i pancreatic cancer
764974|NCT00058201|stage II pancreatic cancer|stage ii pancreatic cancer
764975|NCT00058201|stage III pancreatic cancer|stage iii pancreatic cancer
764976|NCT00058201|stage IV pancreatic cancer|stage iv pancreatic cancer
764977|NCT00058188|osteoporosis|osteoporosis
764978|NCT00058188|stage III prostate cancer|stage iii prostate cancer
764979|NCT00058188|stage IV prostate cancer|stage iv prostate cancer
764980|NCT00058149|stage II pancreatic cancer|stage ii pancreatic cancer
764981|NCT00058149|stage III pancreatic cancer|stage iii pancreatic cancer
764982|NCT00058149|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
764983|NCT00058149|stage IV pancreatic cancer|stage iv pancreatic cancer
764984|NCT00058123|adult anaplastic astrocytoma|adult anaplastic astrocytoma
764985|NCT00058123|adult mixed glioma|adult mixed glioma
764986|NCT00058123|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
764987|NCT00058123|recurrent adult brain tumor|recurrent adult brain tumor
764988|NCT00058123|adult anaplastic ependymoma|adult anaplastic ependymoma
764989|NCT00058071|peripheral neuropathy|peripheral neuropathy
764990|NCT00058071|neurotoxicity|neurotoxicity
764991|NCT00058071|hydatidiform mole|hydatidiform mole
764992|NCT00058071|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
764993|NCT00058058|ductal breast carcinoma in situ|ductal breast carcinoma in situ
764994|NCT00058058|invasive ductal breast carcinoma|invasive ductal breast carcinoma
764995|NCT00058058|invasive lobular breast carcinoma|invasive lobular breast carcinoma
764996|NCT00058058|breast cancer in situ|breast cancer in situ
764997|NCT00058058|stage I breast cancer|stage i breast cancer
764998|NCT00058058|stage II breast cancer|stage ii breast cancer
764999|NCT00058058|stage IIIA breast cancer|stage iiia breast cancer
765000|NCT00058058|stage IIIB breast cancer|stage iiib breast cancer
765001|NCT00058058|stage IIIC breast cancer|stage iiic breast cancer
765002|NCT00058058|stage IV breast cancer|stage iv breast cancer
765003|NCT00058045|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
765004|NCT00058032|ovarian epithelial cancer|ovarian epithelial cancer
765005|NCT00058006|stage I non-small cell lung cancer|stage i non-small cell lung cancer
765006|NCT00058006|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
765007|NCT00058006|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
765158|NCT00057499|Diabetes Mellitus|diabetes mellitus
765008|NCT00058006|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
765009|NCT00058006|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
765010|NCT00058006|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
765011|NCT00058006|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
765012|NCT00058006|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
765013|NCT00058006|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
765014|NCT00058006|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
765015|NCT00058006|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
765111|NCT00057707|Catecholamines|catecholamines
765016|NCT00058006|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
765017|NCT00058006|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
765018|NCT00058006|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
765019|NCT00058006|stage I salivary gland cancer|stage i salivary gland cancer
765020|NCT00058006|stage II salivary gland cancer|stage ii salivary gland cancer
765021|NCT00057993|stage IV breast cancer|stage iv breast cancer
765022|NCT00057993|stage IIIA breast cancer|stage iiia breast cancer
765023|NCT00057993|stage IIIB breast cancer|stage iiib breast cancer
765024|NCT00057993|stage IIIC breast cancer|stage iiic breast cancer
765025|NCT00057980|advanced adult primary liver cancer|advanced adult primary liver cancer
765026|NCT00057980|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
765027|NCT00057980|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
765028|NCT00057967|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
765029|NCT00057967|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
765030|NCT00057967|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
765031|NCT00057967|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
765032|NCT00057967|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
765033|NCT00057967|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
765034|NCT00057967|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
765035|NCT00057967|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
765036|NCT00057967|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
765037|NCT00057967|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
765038|NCT00057954|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
765039|NCT00057954|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
765040|NCT00057954|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
765041|NCT00057954|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
765042|NCT00057954|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
765043|NCT00057954|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
765044|NCT00057954|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
765045|NCT00057954|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
765046|NCT00057954|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
765047|NCT00057954|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
765048|NCT00057954|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
765049|NCT00057954|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
765050|NCT00057954|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
765051|NCT00057954|anaplastic large cell lymphoma|anaplastic large cell lymphoma
765052|NCT00057954|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
765053|NCT00057954|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
765054|NCT00057954|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
765055|NCT00057954|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
765056|NCT00057954|splenic marginal zone lymphoma|splenic marginal zone lymphoma
765057|NCT00057928|recurrent cervical cancer|recurrent cervical cancer
765058|NCT00057928|stage IVB cervical cancer|stage ivb cervical cancer
765059|NCT00057915|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
765060|NCT00057889|clear cell renal cell carcinoma|clear cell renal cell carcinoma
765061|NCT00057889|stage IV renal cell cancer|stage iv renal cell cancer
765062|NCT00057889|recurrent renal cell cancer|recurrent renal cell cancer
765063|NCT00057876|stage III pancreatic cancer|stage iii pancreatic cancer
765064|NCT00057876|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
765065|NCT00057850|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
765066|NCT00057850|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
765067|NCT00057850|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
765068|NCT00057850|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
765159|NCT00057486|Chronic Diarrhea|chronic diarrhea
765069|NCT00057850|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
765070|NCT00057850|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
765071|NCT00057850|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
765072|NCT00057850|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
765073|NCT00057850|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
765074|NCT00057850|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
765075|NCT00057850|recurrent salivary gland cancer|recurrent salivary gland cancer
765076|NCT00057850|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
765077|NCT00057850|stage IV salivary gland cancer|stage iv salivary gland cancer
765078|NCT00057837|extensive stage small cell lung cancer|extensive stage small cell lung cancer
765079|NCT00057837|Topotecan|topotecan
765080|NCT00057837|Etoposide|etoposide
765081|NCT00057837|Cisplatin|cisplatin
765082|NCT00057837|Irinotecan|irinotecan
765083|NCT00057798|stage I non-small cell lung cancer|stage i non-small cell lung cancer
765084|NCT00057798|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
765085|NCT00057798|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
765086|NCT00057798|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
765087|NCT00057785|oral complications of radiation therapy|oral complications of radiation therapy
765088|NCT00057785|radiation toxicity|radiation toxicity
765089|NCT00057785|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
765090|NCT00057785|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
765091|NCT00057785|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
765092|NCT00057785|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
765093|NCT00057759|sexual dysfunction|sexual dysfunction
765094|NCT00057759|sexuality and reproductive issues|sexuality and reproductive issues
765095|NCT00057759|radiation toxicity|radiation toxicity
765096|NCT00057759|stage IIB prostate cancer|stage iib prostate cancer
765097|NCT00057759|stage IIA prostate cancer|stage iia prostate cancer
765098|NCT00057759|stage III prostate cancer|stage iii prostate cancer
765099|NCT00057759|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
765100|NCT00057746|limited stage small cell lung cancer|limited stage small cell lung cancer
765101|NCT00057733|anxiety disorder|anxiety disorder
765102|NCT00057733|depression|depression
765103|NCT00057733|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
765104|NCT00023673|squamous cell lung cancer|squamous cell lung cancer
765105|NCT00023673|large cell lung cancer|large cell lung cancer
765106|NCT00023673|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
765107|NCT00023673|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
765108|NCT00023673|adenocarcinoma of the lung|adenocarcinoma of the lung
765109|NCT00023673|adenosquamous cell lung cancer|adenosquamous cell lung cancer
765110|NCT00057720|ovary|ovary
765112|NCT00057707|Dopamine|dopamine
765113|NCT00057707|fMRI|fmri
765114|NCT00057707|Working Memory|working memory
765115|NCT00057707|Clinical Trial|clinical trial
765116|NCT00057707|Stabilization|stabilization
765117|NCT00057707|Inpatients|inpatients
765118|NCT00057707|Placebo|placebo
765119|NCT00057707|Modafinil|modafinil
765120|NCT00057707|Normal Volunteers|normal volunteers
765121|NCT00057707|Schizophrenia|schizophrenia
765122|NCT00057707|Schizoaffective Disorder|schizoaffective disorder
765123|NCT00057707|Healthy Volunteer|healthy volunteer
765124|NCT00057707|HV|hv
765125|NCT00057694|Qualitative|qualitative
765126|NCT00057694|Telephone Interviews|telephone interviews
765127|NCT00057694|Genetic Counseling|genetic counseling
765128|NCT00057694|Family History|family history
765129|NCT00057694|Health Information|health information
765130|NCT00057694|Adult Adoptees|adult adoptees
765131|NCT00057694|Adult Adoptee|adult adoptee
765132|NCT00057694|Interview|interview
765133|NCT00057681|Mania|mania
765134|NCT00057655|Social Welfare|social welfare
765135|NCT00057655|Mentally Ill Persons|mentally ill persons
765136|NCT00057655|Mental Health Services|mental health services
765137|NCT00057642|Hispanic Americans|hispanic americans
765138|NCT00057629|Rape|rape
765139|NCT00057629|Sex Offenses|sex offenses
765140|NCT00057616|Metastatic Melanoma|metastatic melanoma
765141|NCT00057616|Melanoma|melanoma
765142|NCT00057616|Revimid|revimid
765143|NCT00057616|CC5013|cc5013
765144|NCT00057564|Newly Diagnosed Multiple Myeloma|newly diagnosed multiple myeloma
765145|NCT00057564|Multiple Myeloma|multiple myeloma
765146|NCT00057538|HIV|hiv
765147|NCT00057538|Randomized Trial|randomized trial
765148|NCT00057538|Stress|stress
765149|NCT00057538|Spirituality|spirituality
765150|NCT00057538|Quality of Life|quality of life
765151|NCT00057538|Complementary Therapies|complementary therapies
765152|NCT00057525|Anthrax|anthrax
765153|NCT00057499|Juvenile diabetes|juvenile diabetes
765154|NCT00057499|Diabetes|diabetes
765160|NCT00057486|Interleukin 12|interleukin 12
765161|NCT00057473|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
765162|NCT00057447|lymphoma|lymphoma
765163|NCT00057434|Vitamin A|vitamin a
765164|NCT00057421|Tuberculosis|tuberculosis
765165|NCT00057421|HIV infection|hiv infection
765166|NCT00057421|Prednisolone|prednisolone
765167|NCT00057421|Safety|safety
765168|NCT00057421|Immune activation|immune activation
765169|NCT00057460|Antiepileptic Drug|antiepileptic drug
765170|NCT00057460|Neuroprotection|neuroprotection
765171|NCT00057460|Seizure Disorder|seizure disorder
765172|NCT00057460|TMS Stimulation|tms stimulation
765173|NCT00057460|EEG|eeg
765174|NCT00057460|AMPA Antagonist|ampa antagonist
765175|NCT00057460|Dosing|dosing
765176|NCT00057460|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
765177|NCT00057460|Healthy Volunteer|healthy volunteer
765178|NCT00057460|HV|hv
765179|NCT00057408|Autism|autism
765180|NCT00057408|Pervasive Developmental Disorder|pervasive developmental disorder
765181|NCT00057408|Treatment|treatment
765182|NCT00057408|Olanzapine|olanzapine
765183|NCT00057408|Antipsychotic|antipsychotic
765184|NCT00057395|Esophageal Neoplasms|esophageal neoplasms
765185|NCT00057395|Esophagus Neoplasm|esophagus neoplasm
765186|NCT00057395|Esophagus Cancer|esophagus cancer
765187|NCT00057395|Esophageal Cancer|esophageal cancer
765188|NCT00057395|Esophageal Tumors|esophageal tumors
765189|NCT00057395|Esophagus Tumors|esophagus tumors
765190|NCT00057395|Neoplasms, Esophageal|neoplasms, esophageal
765191|NCT00057395|Hepatocellular Carcinoma|hepatocellular carcinoma
765192|NCT00057395|Carcinoma, Hepatocellular|carcinoma, hepatocellular
765193|NCT00057395|Hepatoma|hepatoma
765194|NCT00057395|Colorectal Neoplasms|colorectal neoplasms
765195|NCT00057395|Colorectal Cancer|colorectal cancer
765196|NCT00057395|Colorectal Carcinoma|colorectal carcinoma
765197|NCT00057395|Colorectal Tumor|colorectal tumor
765198|NCT00057395|Neoplasms, Colorectal|neoplasms, colorectal
765199|NCT00057395|Ovarian Neoplasms|ovarian neoplasms
765200|NCT00057395|Ovary Neoplasms|ovary neoplasms
765201|NCT00057395|Ovary Cancer|ovary cancer
765202|NCT00057395|Ovary Carcinoma|ovary carcinoma
765203|NCT00057395|Ovarian Cancer|ovarian cancer
765204|NCT00057395|Ovarian Carcinoma|ovarian carcinoma
765205|NCT00057395|Neoplasms, Ovarian|neoplasms, ovarian
765206|NCT00057395|Pancreatic Neoplasms|pancreatic neoplasms
765207|NCT00057395|Pancreatic Cancer|pancreatic cancer
765208|NCT00057395|Pancreas Neoplasms|pancreas neoplasms
765209|NCT00057395|Pancreas Cancer|pancreas cancer
765210|NCT00057395|Neoplasms, Pancreatic|neoplasms, pancreatic
765211|NCT00057395|Neoplasms, Pancreas|neoplasms, pancreas
765212|NCT00057395|and other solid tumors|and other solid tumors
765213|NCT00057382|liver cancer|liver cancer
765214|NCT00057356|Chronic Heart Failure|chronic heart failure
765215|NCT00057356|YM078|ym078
765216|NCT00057291|Orphanage|orphanage
765217|NCT00057291|Caregiving|caregiving
765218|NCT00057291|Training|training
765219|NCT00057291|Child development|child development
765220|NCT00057031|myelodysplastic syndrome|myelodysplastic syndrome
765221|NCT00057031|MDS|mds
765222|NCT00057278|Gabapentin|gabapentin
765223|NCT00057200|Home Care|home care
765224|NCT00057252|Diagnostic Radiology|diagnostic radiology
765225|NCT00057252|Imaging|imaging
765226|NCT00057252|Algorithms|algorithms
765227|NCT00057252|Healthy Volunteer|healthy volunteer
765228|NCT00057252|HV|hv
765229|NCT00057239|GW353162|gw353162
765230|NCT00057239|Major Depressive Disorder|major depressive disorder
765231|NCT00057239|MDD|mdd
765232|NCT00057226|GW353162,|gw353162,
765233|NCT00057226|Major depressive disorder,|major depressive disorder,
765234|NCT00057226|flexible|flexible
765235|NCT00057213|Major Depressive Disorder (MDD),|major depressive disorder (mdd),
765236|NCT00057213|Flexible|flexible
765237|NCT00057213|GW353162,|gw353162,
765238|NCT00057174|Proton pump inhibitor|proton pump inhibitor
765239|NCT00057148|massage therapy|massage therapy
765240|NCT00057148|pain management|pain management
765241|NCT00057148|post-surgical|post-surgical
765242|NCT00057148|complementary therapy|complementary therapy
765243|NCT00057135|Schizophrenia|schizophrenia
765244|NCT00057135|Treatment Refusal|treatment refusal
765245|NCT00057135|Drug Packaging|drug packaging
765246|NCT00057135|Reminder Systems|reminder systems
765247|NCT00057135|Antipsychotic Agents|antipsychotic agents
765248|NCT00057122|Preventive therapy|preventive therapy
765249|NCT00057083|Telemedicine|telemedicine
765250|NCT00057083|Remote consultation|remote consultation
765251|NCT00057083|Patient Satisfaction|patient satisfaction
765252|NCT00057083|Physician patient relations|physician patient relations
765253|NCT00057083|Provider satisfaction|provider satisfaction
765254|NCT00057083|Doctor-patient relations|doctor-patient relations
765255|NCT00057018|stroke|stroke
765256|NCT00057018|cerebrovascular accident|cerebrovascular accident
765257|NCT00057018|upper extremity|upper extremity
765258|NCT00057018|physical therapy|physical therapy
765259|NCT00057018|constraint-induced therapy|constraint-induced therapy
765261|NCT00056979|Metabolic diseases|metabolic diseases
765262|NCT00056966|Acute myeloid leukemia|acute myeloid leukemia
765263|NCT00056966|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
765264|NCT00056966|Chronic myeloid leukemia|chronic myeloid leukemia
765265|NCT00056966|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
765266|NCT00056966|Hodgkin's disease|hodgkin's disease
765267|NCT00056966|Myelodysplastic syndrome|myelodysplastic syndrome
765268|NCT00056966|Myeloproliferative disorders|myeloproliferative disorders
765269|NCT00056966|Multiple myeloma|multiple myeloma
765270|NCT00056966|Severe aplastic anemia|severe aplastic anemia
765271|NCT00056953|health behavior|health behavior
765272|NCT00056953|adolescent behavior|adolescent behavior
765273|NCT00056953|peer mentoring|peer mentoring
765274|NCT00056940|Prevention|prevention
765275|NCT00056940|Parenting strategies|parenting strategies
765276|NCT00056940|Media use|media use
765277|NCT00056940|Discipline|discipline
765278|NCT00056940|Firearm storage|firearm storage
765279|NCT00056927|Smoking|smoking
765280|NCT00056927|Primary Prevention|primary prevention
765281|NCT00056927|Health Education|health education
765282|NCT00056927|Child|child
765283|NCT00056927|Parents|parents
765284|NCT00056927|Parenting Education|parenting education
765285|NCT00056927|Communication|communication
765286|NCT00056875|graft versus host disease|graft versus host disease
765287|NCT00056875|bone marrow transplant|bone marrow transplant
765288|NCT00056875|alternative donor|alternative donor
765289|NCT00056914|Magnetic Resonance Imaging|magnetic resonance imaging
765290|NCT00056914|Functional Imaging|functional imaging
765291|NCT00056914|Cerebral Blood Flow|cerebral blood flow
765292|NCT00056914|Parallel Imaging|parallel imaging
765293|NCT00056914|BOLD Effect|bold effect
765294|NCT00056914|Spectroscopic Imaging|spectroscopic imaging
765295|NCT00056914|Healthy Volunteer|healthy volunteer
765296|NCT00056914|HV|hv
765297|NCT00056901|Puerperium|puerperium
765298|NCT00056901|Pregnancy|pregnancy
765299|NCT00056901|Mood Disorders|mood disorders
765300|NCT00056901|Estradiol|estradiol
765301|NCT00056901|Progesterone|progesterone
765302|NCT00056901|Mood|mood
765303|NCT00056901|Behavior|behavior
765304|NCT00056901|Cognition|cognition
765305|NCT00056901|Perimenopause|perimenopause
765306|NCT00056901|Menopause|menopause
765307|NCT00056901|Post Partum Depression|post partum depression
765308|NCT00056901|PPD|ppd
765309|NCT00056901|Healthy Volunteer|healthy volunteer
765310|NCT00056901|HV|hv
765311|NCT00056888|Electroencephalogram|electroencephalogram
765312|NCT00056888|Functional (BOLD) MRI|functional (bold) mri
765313|NCT00056888|Startle Reflex|startle reflex
765314|NCT00056888|Electromyogram|electromyogram
765315|NCT00056888|Psychogenic|psychogenic
765316|NCT00056888|Paroxysmal|paroxysmal
765317|NCT00056888|Dyskinesia|dyskinesia
765318|NCT00056888|Kinesiogenic|kinesiogenic
765319|NCT00056888|EEG|eeg
765320|NCT00056888|Movement-Related Potential|movement-related potential
765321|NCT00056888|Movement Disorder|movement disorder
765322|NCT00056888|Paroxysmal Hyperkinetic Movement|paroxysmal hyperkinetic movement
765323|NCT00056888|Disorder|disorder
765324|NCT00056888|Paroxysmal Dyskinesia|paroxysmal dyskinesia
765325|NCT00056836|AMD|amd
765326|NCT00056836|Neovascular age-related macular degeneration|neovascular age-related macular degeneration
765327|NCT00056823|AMD|amd
765328|NCT00056862|Hepatitis C Virus|hepatitis c virus
765329|NCT00056862|Antiviral Agents|antiviral agents
765330|NCT00056862|Hemolysis|hemolysis
765331|NCT00056862|Neutropenia|neutropenia
765332|NCT00056862|Cirrhosis|cirrhosis
765333|NCT00056862|Hemolytic Anemia|hemolytic anemia
765334|NCT00056862|Viral Hepatitis|viral hepatitis
765335|NCT00056862|Ribavirin|ribavirin
765336|NCT00056862|Alfa Interferon|alfa interferon
765337|NCT00056862|Pegylated Interferon|pegylated interferon
765338|NCT00056862|Hepatitis C|hepatitis c
765339|NCT00056862|HCV|hcv
765340|NCT00056849|Arthritis|arthritis
765341|NCT00056849|Spondyloarthropathy|spondyloarthropathy
765342|NCT00056849|Spine|spine
765343|NCT00056849|Hereditary|hereditary
765344|NCT00056849|Disability|disability
765345|NCT00056849|Ankylosing Spondylitis|ankylosing spondylitis
765346|NCT00056849|AS|as
765347|NCT00056849|Spondyloarthritis|spondyloarthritis
765348|NCT00056810|Guillain Barre Syndrome|guillain barre syndrome
765349|NCT00056810|4-aminopyridine|4-aminopyridine
765350|NCT00056797|HIV Therapeutic vaccine|hiv therapeutic vaccine
765351|NCT00056797|IL-2|il-2
765352|NCT00056797|Structured Treatment Interruption|structured treatment interruption
765353|NCT00056797|Treatment Experienced|treatment experienced
765354|NCT00056784|TGF-Beta|tgf-beta
765355|NCT00056784|Kidney|kidney
765356|NCT00056784|Transplantation|transplantation
765357|NCT00056784|Rejection|rejection
765358|NCT00056784|Immunosuppression|immunosuppression
765359|NCT00056784|Kidney Transplant|kidney transplant
765360|NCT00056784|Chronic Allograft Nephropathy|chronic allograft nephropathy
765361|NCT00056784|CAN|can
765362|NCT00056771|Cataract|cataract
765363|NCT00056771|Congenital Cataracts|congenital cataracts
783097|NCT00034593|metastatic|metastatic
765364|NCT00056771|Hereditary Cataracts|hereditary cataracts
765365|NCT00056758|HIV-1|hiv-1
765366|NCT00056758|HAART|haart
765367|NCT00056758|Therapeutic immunization|therapeutic immunization
765368|NCT00056758|HIV Therapeutic Vaccine|hiv therapeutic vaccine
765369|NCT00056758|Treatment Experienced|treatment experienced
765370|NCT00056745|HIV seronegativity|hiv seronegativity
765371|NCT00056745|HIV preventive vaccine|hiv preventive vaccine
765372|NCT00056693|Neuroendocrine tumor, advanced disease, sunitinib, Phase 2|neuroendocrine tumor, advanced disease, sunitinib, phase 2
765373|NCT00056680|Prematurity|prematurity
765374|NCT00056680|low birthweight|low birthweight
765375|NCT00056680|parenting|parenting
765376|NCT00056680|intervention|intervention
765377|NCT00056667|Treatment|treatment
765378|NCT00056667|Pain|pain
765379|NCT00056667|Relaxation Response|relaxation response
765380|NCT00056667|Cognitive Behavioral Therapy|cognitive behavioral therapy
765381|NCT00056654|Leuprolide|leuprolide
765382|NCT00056654|Prostatic Neoplasms|prostatic neoplasms
765383|NCT00056654|Testosterone|testosterone
765384|NCT00056654|Prostate-specific Antigen|prostate-specific antigen
765385|NCT00056654|Pharmacokinetics|pharmacokinetics
765386|NCT00056654|luprolide acetate|luprolide acetate
765387|NCT00056719|Arthritis|arthritis
765388|NCT00056719|Spondylarthropathy|spondylarthropathy
765389|NCT00056719|Spine|spine
765390|NCT00056719|Hereditary|hereditary
765391|NCT00056719|Disability|disability
765392|NCT00056719|Ankylosing Spondylitis|ankylosing spondylitis
765393|NCT00056719|Spondyloarthropathy|spondyloarthropathy
765394|NCT00056719|Spondyloarthritis|spondyloarthritis
765395|NCT00056719|AS|as
765396|NCT00056706|Motor Deficit|motor deficit
765397|NCT00056706|Somatosensory Deficit|somatosensory deficit
765398|NCT00056706|Cortical Reorganization|cortical reorganization
765399|NCT00056706|Disinhibition|disinhibition
765400|NCT00056706|Rehabilitation|rehabilitation
765401|NCT00056706|Plasticity|plasticity
765402|NCT00056706|Stroke|stroke
765403|NCT00056628|Alzheimer disease|alzheimer disease
765404|NCT00056628|Dementia|dementia
765405|NCT00056628|Ventriculoperitoneal shunt|ventriculoperitoneal shunt
765406|NCT00056628|Tau|tau
765407|NCT00056628|ABeta|abeta
765408|NCT00056602|Utility|utility
765409|NCT00056602|Health Status|health status
765410|NCT00056602|Preferences|preferences
765411|NCT00056602|Response Criteria|response criteria
765412|NCT00056602|Treatment|treatment
765413|NCT00056602|Rheumatoid Arthritis|rheumatoid arthritis
765414|NCT00056602|RA|ra
765415|NCT00056576|Monotherapy|monotherapy
765416|NCT00056576|Complex Partial Seizures|complex partial seizures
765417|NCT00056576|Epilepsy|epilepsy
765418|NCT00056576|anti-epilepsy drug|anti-epilepsy drug
765419|NCT00056576|AED|aed
765420|NCT00056563|Parkinson's disease|parkinson's disease
765421|NCT00056563|levo-dopa|levo-dopa
765422|NCT00056563|tremor|tremor
765423|NCT00056563|dyskinesia|dyskinesia
765424|NCT00056563|subthalamic nucleus|subthalamic nucleus
765425|NCT00056563|globus pallidus|globus pallidus
765426|NCT00056550|Antithrombin Deficiency, Congenital|antithrombin deficiency, congenital
765427|NCT00056550|Antithrombin III Deficiency|antithrombin iii deficiency
765428|NCT00056524|ALS|als
765429|NCT00056524|MS|ms
765430|NCT00056524|CNS|cns
765431|NCT00056524|AD|ad
765432|NCT00056524|TBI|tbi
765433|NCT00056524|Dextromethorphan|dextromethorphan
765434|NCT00056524|IEED|ieed
765435|NCT00056524|Emotional|emotional
765436|NCT00056511|Garlic|garlic
765437|NCT00056511|Supplements|supplements
765438|NCT00056511|Adults|adults
765439|NCT00056511|Hypercholesterolemics|hypercholesterolemics
765440|NCT00056511|Randomized Clinical Trial|randomized clinical trial
765441|NCT00056485|Nursing homes|nursing homes
765442|NCT00056485|Aging|aging
765443|NCT00056472|Major depressive disorder with psychotic features|major depressive disorder with psychotic features
765444|NCT00056472|Delusional Depression|delusional depression
765445|NCT00056472|Randomized Trial|randomized trial
765446|NCT00056472|Combination Treatment|combination treatment
765447|NCT00056472|SSRI|ssri
765448|NCT00056472|Atypical Antipsychotic|atypical antipsychotic
765449|NCT00012454|Transforming Growth Factor-Beta|transforming growth factor-beta
765450|NCT00012454|Stroke|stroke
765451|NCT00012454|Prevention|prevention
765452|NCT00012454|Mucosal Tolerance|mucosal tolerance
765453|NCT00012454|E-selectin|e-selectin
765454|NCT00056459|Colorectal Cancer|colorectal cancer
765455|NCT00056459|PTK787|ptk787
765456|NCT00056459|Vatalanib|vatalanib
765457|NCT00056459|VEGF inhibitor|vegf inhibitor
765458|NCT00056459|Oxaliplatin|oxaliplatin
765459|NCT00056459|Angiogenesis|angiogenesis
765460|NCT00056459|Rectal Cancer|rectal cancer
765461|NCT00056459|Colon Cancer|colon cancer
765462|NCT00056459|Colorectal Carcinoma|colorectal carcinoma
765463|NCT00056459|Colorectal Tumor|colorectal tumor
765464|NCT00056446|Colorectal Cancer|colorectal cancer
765465|NCT00056446|Oxaliplatin|oxaliplatin
765466|NCT00056446|VEGF inhibitor|vegf inhibitor
765467|NCT00056446|Vatalanib|vatalanib
765468|NCT00056446|PTK787|ptk787
765469|NCT00056446|Colon Cancer|colon cancer
765470|NCT00056446|Colorectal Carcinoma|colorectal carcinoma
765471|NCT00056446|Rectal Cancer|rectal cancer
765472|NCT00056446|Colorectal Tumor|colorectal tumor
765473|NCT00056433|Fetal Hemoglobin Induction|fetal hemoglobin induction
765474|NCT00056433|L-Arginine|l-arginine
765475|NCT00056433|Nitric Oxide Therapy|nitric oxide therapy
765476|NCT00056433|Sickle Cell Disease|sickle cell disease
765477|NCT00056433|Sildenafil (Viagra)|sildenafil (viagra)
765478|NCT00056433|Sickle Cell Anemia|sickle cell anemia
765479|NCT00056420|Tourette's Syndrome|tourette's syndrome
765480|NCT00056420|Tic Disorder|tic disorder
765481|NCT00056420|(EEG) Electroencephalography|(eeg) electroencephalography
765482|NCT00056420|Event-Related Desynchronization/Synchronization|event-related desynchronization/synchronization
765483|NCT00056420|Coherence|coherence
765484|NCT00056420|Tourette's|tourette's
765485|NCT00056420|Tourette Syndrome|tourette syndrome
765486|NCT00056420|Healthy Volunteer|healthy volunteer
765487|NCT00056420|HV|hv
765488|NCT00056407|Prostate cancer prevention|prostate cancer prevention
765489|NCT00056407|prostate|prostate
765490|NCT00056407|BPH|bph
765491|NCT00056407|enlarged prostate|enlarged prostate
765492|NCT00056407|PSA|psa
765493|NCT00056407|prostate cancer|prostate cancer
765494|NCT00056394|Early Rheumatoid Arthritis|early rheumatoid arthritis
765495|NCT00056394|Coping Skills Training|coping skills training
765496|NCT00056394|Pain|pain
765497|NCT00056394|Physical Disability|physical disability
765498|NCT00056394|Psychological Disability|psychological disability
765499|NCT00056394|Daily Diary Measures|daily diary measures
765500|NCT00056381|neutropenia|neutropenia
765501|NCT00056381|fever|fever
765502|NCT00056381|febrile neutropenia|febrile neutropenia
765503|NCT00056368|Candida blood stream infections|candida blood stream infections
765504|NCT00056368|Candida infections|candida infections
765505|NCT00056368|Candidemia|candidemia
765506|NCT00056368|Invasive Candidiasis|invasive candidiasis
765507|NCT00056329|Aging Persons|aging persons
765508|NCT00056329|Down Syndrome|down syndrome
765509|NCT00056329|Vitamin E|vitamin e
765510|NCT00056329|Alzheimer disease|alzheimer disease
765511|NCT00056355|Pheresis|pheresis
765512|NCT00056355|Cytokine|cytokine
765513|NCT00056355|Lymphocyte|lymphocyte
765514|NCT00056355|Remission|remission
765515|NCT00056355|Ultraviolet A Light|ultraviolet a light
765516|NCT00056355|Crohn's Disease|crohn's disease
765517|NCT00056355|Crohn Disease|crohn disease
765518|NCT00056316|Caregiving|caregiving
765519|NCT00056316|Dementia|dementia
765520|NCT00056316|Alzheimer's|alzheimer's
765521|NCT00056316|Depression|depression
765522|NCT00056316|Technology|technology
765523|NCT00056316|Treatment|treatment
765524|NCT00056303|Attachment|attachment
765525|NCT00056303|Intervention|intervention
765526|NCT00056303|Prevention|prevention
765527|NCT00056290|Diabetes Mellitus|diabetes mellitus
765528|NCT00056290|Neuropathy|neuropathy
765529|NCT00056290|Peripheral Artery Disease|peripheral artery disease
765530|NCT00056264|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
765531|NCT00056264|COPD|copd
765532|NCT00056264|Infliximab|infliximab
765533|NCT00056264|Remicade|remicade
765534|NCT00056251|Interstitial Cystitis|interstitial cystitis
765535|NCT00056251|Bladder|bladder
765536|NCT00056238|Neurologic Diseases (General)|neurologic diseases (general)
765537|NCT00056238|Hemorrhagic Stroke|hemorrhagic stroke
765538|NCT00056238|Cerebral Amyloid Angiopathy|cerebral amyloid angiopathy
765539|NCT00056238|Cerebrovascular Accident|cerebrovascular accident
765540|NCT00056225|homocysteine|homocysteine
765541|NCT00056173|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
765542|NCT00056199|Vision Loss|vision loss
765543|NCT00056199|Optic Nerve Tumors|optic nerve tumors
765544|NCT00056199|Macular Edema|macular edema
765545|NCT00056199|Von Hippel-Lindau Disease|von hippel-lindau disease
765546|NCT00056199|VEGF|vegf
765547|NCT00056199|EYE001|eye001
765548|NCT00056199|VHL|vhl
765549|NCT00056186|Adaptation|adaptation
765550|NCT00056186|Neurodegenerative|neurodegenerative
765551|NCT00056186|Health Care Provider|health care provider
765552|NCT00056186|Psychosocial|psychosocial
765553|NCT00056186|Chronic Illness/Disability|chronic illness/disability
765554|NCT00056186|Friedreich's Ataxia|friedreich's ataxia
765555|NCT00056186|Friedreich Ataxia|friedreich ataxia
765556|NCT00056186|FA|fa
765557|NCT00056160|Multiple Myeloma|multiple myeloma
765558|NCT00056160|Refractory and Relapsed|refractory and relapsed
765559|NCT00056160|Revlimid|revlimid
765560|NCT00056160|CC5013|cc5013
765561|NCT00056147|cystic fibrosis|cystic fibrosis
765562|NCT00056134|recurrent melanoma|recurrent melanoma
765563|NCT00056134|stage IV melanoma|stage iv melanoma
765564|NCT00056134|stage IIIA melanoma|stage iiia melanoma
765565|NCT00056134|stage IIIB melanoma|stage iiib melanoma
765566|NCT00056134|stage IIIC melanoma|stage iiic melanoma
765567|NCT00056095|recurrent renal cell cancer|recurrent renal cell cancer
765568|NCT00056095|stage IV renal cell cancer|stage iv renal cell cancer
765569|NCT00056082|breast cancer|breast cancer
765570|NCT00056069|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
765571|NCT00056069|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
765572|NCT00056056|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
765573|NCT00056056|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
765574|NCT00056056|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
765575|NCT00056030|liver metastases|liver metastases
765576|NCT00056030|stage IV colon cancer|stage iv colon cancer
765577|NCT00056030|stage IV rectal cancer|stage iv rectal cancer
765578|NCT00056030|adenocarcinoma of the colon|adenocarcinoma of the colon
765579|NCT00056030|adenocarcinoma of the rectum|adenocarcinoma of the rectum
765580|NCT00056004|non-small cell lung cancer|non-small cell lung cancer
765581|NCT00056004|small cell lung cancer|small cell lung cancer
765582|NCT00056004|stage I non-small cell lung cancer|stage i non-small cell lung cancer
765583|NCT00056004|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
765584|NCT00056004|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
765585|NCT00056004|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
765586|NCT00056004|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
765587|NCT00056004|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
765588|NCT00056004|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
765589|NCT00056004|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
765590|NCT00056004|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
765591|NCT00056004|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
765592|NCT00056004|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
765593|NCT00055991|breast cancer|breast cancer
765594|NCT00055978|non-small cell lung cancer|non-small cell lung cancer
765595|NCT00055978|stage I non-small cell lung cancer|stage i non-small cell lung cancer
765596|NCT00055965|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
765597|NCT00055965|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
765598|NCT00055965|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
765599|NCT00055952|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
765600|NCT00055952|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
765601|NCT00055952|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
765602|NCT00055952|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
765603|NCT00055952|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
765604|NCT00055952|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
765605|NCT00055952|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
765606|NCT00055939|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
765607|NCT00055939|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
765608|NCT00055926|recurrent breast cancer|recurrent breast cancer
765609|NCT00055926|stage IV breast cancer|stage iv breast cancer
765610|NCT00055926|male breast cancer|male breast cancer
765611|NCT00055887|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
765612|NCT00055887|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
765613|NCT00055887|adenocarcinoma of the lung|adenocarcinoma of the lung
765614|NCT00055887|squamous cell lung cancer|squamous cell lung cancer
765615|NCT00055887|large cell lung cancer|large cell lung cancer
765616|NCT00055874|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
765617|NCT00055874|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
765618|NCT00055874|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
765619|NCT00055848|adenocarcinoma of the colon|adenocarcinoma of the colon
765620|NCT00055848|stage I colon cancer|stage i colon cancer
765621|NCT00055848|stage II colon cancer|stage ii colon cancer
765622|NCT00055848|stage III colon cancer|stage iii colon cancer
765623|NCT00055848|stage IV colon cancer|stage iv colon cancer
765624|NCT00055835|recurrent bladder cancer|recurrent bladder cancer
765625|NCT00055835|stage III bladder cancer|stage iii bladder cancer
765626|NCT00055835|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
765627|NCT00055835|stage II bladder cancer|stage ii bladder cancer
765628|NCT00055835|recurrent urethral cancer|recurrent urethral cancer
765629|NCT00055835|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
765630|NCT00055835|distal urethral cancer|distal urethral cancer
765631|NCT00055835|proximal urethral cancer|proximal urethral cancer
765632|NCT00055835|stage IV bladder cancer|stage iv bladder cancer
765633|NCT00055835|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
765634|NCT00055822|adenocarcinoma of the colon|adenocarcinoma of the colon
765635|NCT00055822|recurrent colon cancer|recurrent colon cancer
765636|NCT00055822|stage III colon cancer|stage iii colon cancer
765637|NCT00055822|stage IV colon cancer|stage iv colon cancer
765638|NCT00055822|adenocarcinoma of the rectum|adenocarcinoma of the rectum
765639|NCT00055822|recurrent rectal cancer|recurrent rectal cancer
765640|NCT00055822|stage III rectal cancer|stage iii rectal cancer
765641|NCT00055822|stage IV rectal cancer|stage iv rectal cancer
765642|NCT00055783|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
765643|NCT00055731|stage III prostate cancer|stage iii prostate cancer
765644|NCT00055731|stage IIB prostate cancer|stage iib prostate cancer
765645|NCT00055731|stage IIA prostate cancer|stage iia prostate cancer
765646|NCT00055718|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
765647|NCT00055718|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
765648|NCT00055705|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
765649|NCT00055705|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
765650|NCT00055705|fallopian tube cancer|fallopian tube cancer
765651|NCT00055705|primary peritoneal cavity cancer|primary peritoneal cavity cancer
765652|NCT00055705|recurrent colon cancer|recurrent colon cancer
765653|NCT00055705|stage IV colon cancer|stage iv colon cancer
765654|NCT00055705|ovarian sarcoma|ovarian sarcoma
765655|NCT00055705|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
765656|NCT00055705|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
765657|NCT00055705|recurrent endometrial carcinoma|recurrent endometrial carcinoma
765658|NCT00055705|stage IV endometrial carcinoma|stage iv endometrial carcinoma
765659|NCT00055705|recurrent uterine sarcoma|recurrent uterine sarcoma
765660|NCT00055705|stage IV uterine sarcoma|stage iv uterine sarcoma
765661|NCT00055705|ovarian stromal cancer|ovarian stromal cancer
765662|NCT00055705|recurrent rectal cancer|recurrent rectal cancer
765663|NCT00055705|stage IV rectal cancer|stage iv rectal cancer
765664|NCT00055705|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
765665|NCT00055705|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
765666|NCT00055705|gastrointestinal stromal tumor|gastrointestinal stromal tumor
765667|NCT00055705|advanced malignant mesothelioma|advanced malignant mesothelioma
765668|NCT00055705|recurrent malignant mesothelioma|recurrent malignant mesothelioma
765669|NCT00055705|recurrent gastric cancer|recurrent gastric cancer
765670|NCT00055705|stage IV gastric cancer|stage iv gastric cancer
765671|NCT00055705|carcinoma of the appendix|carcinoma of the appendix
765672|NCT00055705|small intestine adenocarcinoma|small intestine adenocarcinoma
765673|NCT00055705|small intestine leiomyosarcoma|small intestine leiomyosarcoma
765674|NCT00055705|small intestine lymphoma|small intestine lymphoma
765675|NCT00055705|recurrent small intestine cancer|recurrent small intestine cancer
765676|NCT00055705|recurrent gallbladder cancer|recurrent gallbladder cancer
765677|NCT00055705|unresectable gallbladder cancer|unresectable gallbladder cancer
765678|NCT00055705|advanced adult primary liver cancer|advanced adult primary liver cancer
765679|NCT00055705|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
765680|NCT00055705|recurrent adult primary liver cancer|recurrent adult primary liver cancer
765681|NCT00055679|stage I breast cancer|stage i breast cancer
765682|NCT00055666|graft versus host disease|graft versus host disease
765683|NCT00055653|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
765684|NCT00055653|refractory anemia with excess blasts|refractory anemia with excess blasts
765685|NCT00055653|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
765686|NCT00055653|refractory anemia|refractory anemia
765687|NCT00055653|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
765688|NCT00055653|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
765689|NCT00055653|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
765690|NCT00055653|secondary acute myeloid leukemia|secondary acute myeloid leukemia
765691|NCT00055653|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
765692|NCT00055653|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
765693|NCT00055653|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
765694|NCT00055653|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
765695|NCT00055653|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
765696|NCT00055653|acute undifferentiated leukemia|acute undifferentiated leukemia
765697|NCT00055653|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
765698|NCT00055653|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
765699|NCT00055653|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
765700|NCT00055653|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
765701|NCT00055653|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
765702|NCT00055653|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
765703|NCT00055653|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
765704|NCT00055653|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
765705|NCT00055653|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
765706|NCT00055653|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
765707|NCT00055653|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
765708|NCT00055640|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
765803|NCT00055289|Dorsal Premotor Cortex|dorsal premotor cortex
765709|NCT00055640|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
765710|NCT00055640|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
765711|NCT00055640|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
765712|NCT00055640|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
765713|NCT00055614|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
765714|NCT00055614|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
765715|NCT00055614|fallopian tube cancer|fallopian tube cancer
765716|NCT00055614|primary peritoneal cavity cancer|primary peritoneal cavity cancer
765717|NCT00055601|stage II bladder cancer|stage ii bladder cancer
765718|NCT00055601|stage III bladder cancer|stage iii bladder cancer
765719|NCT00022139|stage III gastric cancer|stage iii gastric cancer
765720|NCT00022139|stage II esophageal cancer|stage ii esophageal cancer
765721|NCT00022139|stage III esophageal cancer|stage iii esophageal cancer
765722|NCT00022139|adenocarcinoma of the stomach|adenocarcinoma of the stomach
765723|NCT00022139|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
765724|NCT00022139|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
765725|NCT00005028|adenocarcinoma of the prostate|adenocarcinoma of the prostate
765726|NCT00005028|stage IV prostate cancer|stage iv prostate cancer
765727|NCT00005028|recurrent prostate cancer|recurrent prostate cancer
765728|NCT00055588|Spinal Reflexes|spinal reflexes
765729|NCT00055588|Motor Practice|motor practice
765730|NCT00055588|Spinal Cord Injury|spinal cord injury
765731|NCT00055588|Locomotion|locomotion
765732|NCT00055588|Healthy Volunteer|healthy volunteer
765733|NCT00055588|HV|hv
765734|NCT00055575|Scopolamine|scopolamine
765735|NCT00055575|Depression|depression
765736|NCT00055575|fMRI|fmri
765737|NCT00055575|Cognition|cognition
765738|NCT00055575|Emotion|emotion
765739|NCT00055575|Brain|brain
765740|NCT00055575|Bipolar Disorder|bipolar disorder
765741|NCT00055575|Major Depressive Disorder|major depressive disorder
765742|NCT00055575|MDD|mdd
765743|NCT00055575|Healthy Volunteer|healthy volunteer
765744|NCT00055575|HV|hv
765745|NCT00055562|Metastatic Melanoma|metastatic melanoma
765746|NCT00055562|Metastatic Malignant Melanoma|metastatic malignant melanoma
765747|NCT00055562|Revimid|revimid
765748|NCT00055562|CC5013|cc5013
765749|NCT00055549|Dextromethorphan|dextromethorphan
765750|NCT00055549|Sensorimotor Modulation|sensorimotor modulation
765751|NCT00055549|Spasmodic Dysphonia|spasmodic dysphonia
765752|NCT00055549|Muscular Tension Dysphonia|muscular tension dysphonia
765753|NCT00055549|Voice Tremor|voice tremor
765754|NCT00055549|Lorazepam|lorazepam
765755|NCT00055549|Dysphonia|dysphonia
765756|NCT00055549|Macular Tension Dysphonia|macular tension dysphonia
765757|NCT00055510|BO-653|bo-653
765758|NCT00055510|Coronary restenosis|coronary restenosis
765759|NCT00055510|Stent restenosis|stent restenosis
765760|NCT00055510|LDL oxidative inhibitor|ldl oxidative inhibitor
765761|NCT00055510|Antioxidant|antioxidant
765762|NCT00055484|Migraine Headache|migraine headache
765763|NCT00055484|prophylaxis|prophylaxis
765764|NCT00055484|AED|aed
765765|NCT00055484|migraine prophylaxis|migraine prophylaxis
765766|NCT00055471|prostate cancer|prostate cancer
765767|NCT00055471|Metastatic prostate cancer|metastatic prostate cancer
765768|NCT00055471|bone metastases|bone metastases
765769|NCT00055445|Complementary Therapies|complementary therapies
765770|NCT00055445|IdB 1016|idb 1016
765771|NCT00055445|Silybin|silybin
765772|NCT00055445|Antioxidant|antioxidant
765773|NCT00055445|Hepatitis C Virus|hepatitis c virus
765774|NCT00055445|Phosphatidylcholine|phosphatidylcholine
765775|NCT00055432|recurrent ovarian cancer|recurrent ovarian cancer
765776|NCT00055432|platinum-resistant|platinum-resistant
765777|NCT00055432|platinum-sensitive|platinum-sensitive
765778|NCT00055432|folate receptor antagonist|folate receptor antagonist
765779|NCT00055419|Stage IV colorectal cancer|stage iv colorectal cancer
765780|NCT00055380|Molecular Targets|molecular targets
765781|NCT00055380|Keratinocytes|keratinocytes
765782|NCT00055380|Cell Cycle|cell cycle
765783|NCT00055380|Small Molecule|small molecule
765784|NCT00055380|Gene Expression|gene expression
765785|NCT00055380|Pharmacodynamics|pharmacodynamics
765786|NCT00055380|Surrogate Markers|surrogate markers
765787|NCT00055380|Targeted Therapy|targeted therapy
765788|NCT00055380|Buccal Mucosa|buccal mucosa
765789|NCT00055380|Pharmacogenomics|pharmacogenomics
765790|NCT00055380|Oral Mucosa|oral mucosa
765791|NCT00055354|Acupuncture|acupuncture
765792|NCT00055354|Medicine, Chinese Traditional|medicine, chinese traditional
765793|NCT00055302|vaginal bleeding|vaginal bleeding
765794|NCT00055302|advanced bone age|advanced bone age
765795|NCT00055302|fibrous dysplasia|fibrous dysplasia
765796|NCT00055302|MAS|mas
765797|NCT00055302|McCune-Albright Syndrome|mccune-albright syndrome
765798|NCT00055263|advanced solid tumor malignancies|advanced solid tumor malignancies
765799|NCT00055289|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
765800|NCT00055289|Counting|counting
765801|NCT00055289|Sensorimotor Integration|sensorimotor integration
765802|NCT00055289|Superior Temporal Cortex|superior temporal cortex
765804|NCT00055289|Healthy Volunteer|healthy volunteer
765805|NCT00055289|HV|hv
765806|NCT00055237|Angiogenesis|angiogenesis
765807|NCT00055237|Cancer|cancer
765808|NCT00055237|HHV-8|hhv-8
765809|NCT00055237|KSHV|kshv
765810|NCT00055237|Skin|skin
765811|NCT00055237|Kaposi Sarcoma|kaposi sarcoma
765812|NCT00055237|KS|ks
765813|NCT00055224|Anxiety Disorder|anxiety disorder
765814|NCT00055224|Fear|fear
765815|NCT00055224|Aversive Conditioning|aversive conditioning
765816|NCT00055224|Psychophysiology|psychophysiology
765817|NCT00055224|Predictability|predictability
765818|NCT00055224|Startle|startle
765819|NCT00055224|Context Conditioning|context conditioning
765820|NCT00055224|Fear Conditioning|fear conditioning
765821|NCT00055224|Agoraphobia|agoraphobia
765822|NCT00055224|Panic Disorder|panic disorder
765823|NCT00055224|Generalized Anxiety Disorder|generalized anxiety disorder
765824|NCT00055224|GAD|gad
765825|NCT00055224|Healthy Volunteer|healthy volunteer
765826|NCT00055224|HV|hv
765827|NCT00055198|Gram positive bacterial infections|gram positive bacterial infections
765828|NCT00055198|expanded access program|expanded access program
765829|NCT00055198|resistant infections|resistant infections
765830|NCT00055198|bacteremia|bacteremia
765831|NCT00055198|Bacterial and fungal infections|bacterial and fungal infections
765832|NCT00055198|bacterial infections|bacterial infections
765833|NCT00055185|Treatment Experienced|treatment experienced
765834|NCT00055133|rheumatoid arthritis|rheumatoid arthritis
765835|NCT00055133|Paxceed|paxceed
765836|NCT00055133|Micellar Paclitaxel|micellar paclitaxel
765837|NCT00055172|Cytokines|cytokines
765838|NCT00055172|Mutation|mutation
765839|NCT00055172|DNA|dna
765840|NCT00055172|Phenotype|phenotype
765841|NCT00055172|T Cell|t cell
765842|NCT00055172|Immunodeficiency|immunodeficiency
765843|NCT00055172|Inherited Immunodeficiency|inherited immunodeficiency
765844|NCT00055159|RT PA|rt pa
765845|NCT00055159|Blood Clots|blood clots
765846|NCT00055159|Catheter Directed Thrombolytic Therapy|catheter directed thrombolytic therapy
765847|NCT00055159|Alteplase|alteplase
765848|NCT00055159|Deep Vein Thrombosis|deep vein thrombosis
765849|NCT00055159|DVT|dvt
765850|NCT00055120|Anti-HIV Agents|anti-hiv agents
765851|NCT00055120|Disease Progression|disease progression
765852|NCT00055120|Drug Administration Schedule|drug administration schedule
765853|NCT00055120|Viral Load|viral load
765854|NCT00055120|HIV-1|hiv-1
765855|NCT00055120|Treatment Outcome|treatment outcome
765856|NCT00055120|Survival Analysis|survival analysis
765857|NCT00055120|Treatment Naive|treatment naive
765858|NCT00055107|Nitazoxanide|nitazoxanide
765859|NCT00055107|Antiprotozoal Agents|antiprotozoal agents
765860|NCT00055107|Cryptosporidiosis|cryptosporidiosis
765861|NCT00055107|Cryptosporidium parvum|cryptosporidium parvum
765862|NCT00055107|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
765863|NCT00055107|Pharmacokinetics|pharmacokinetics
765864|NCT00055107|Drug Adminstration Schedule|drug adminstration schedule
765865|NCT00055094|Immune system|immune system
765866|NCT00055094|Helper T-Cells|helper t-cells
765867|NCT00055094|Acute Infection|acute infection
765868|NCT00055094|Treatment naive|treatment naive
765869|NCT00055081|Homeless Persons|homeless persons
765870|NCT00055055|Autoimmunity Pathogenesis|autoimmunity pathogenesis
765871|NCT00055055|Microarray Analyses|microarray analyses
765872|NCT00055055|Microchimerism|microchimerism
765873|NCT00055055|Genetic and Environmental Risk Factors|genetic and environmental risk factors
765874|NCT00055055|Adult and Pediatric Disease|adult and pediatric disease
765875|NCT00055055|Rheumatoid Arthritis|rheumatoid arthritis
765876|NCT00055055|Systemic Lupus Erythematosus|systemic lupus erythematosus
765877|NCT00055055|Systemic Sclerosis|systemic sclerosis
765878|NCT00055055|Idiopathic Inflammatory Myopathies|idiopathic inflammatory myopathies
765879|NCT00055055|Inflammatory Myopathies|inflammatory myopathies
765880|NCT00055055|Dermatomyositis|dermatomyositis
765881|NCT00055055|Scleroderma|scleroderma
765882|NCT00055055|SLE|sle
765883|NCT00055055|Lupus|lupus
765884|NCT00055055|Rheumatic Disease|rheumatic disease
765885|NCT00055055|RA|ra
765886|NCT00055055|Healthy Volunteer|healthy volunteer
765887|NCT00055055|HV|hv
765888|NCT00055042|Types 1 and 2 Diabetes|types 1 and 2 diabetes
765889|NCT00055042|Diode Laser Photocoagulation|diode laser photocoagulation
765890|NCT00055042|Vitamin E|vitamin e
765891|NCT00055042|Elevated Low-Density Lipoprotein (LDL-C) Cholesterol|elevated low-density lipoprotein (ldl-c) cholesterol
765892|NCT00055042|Diabetes Type I|diabetes type i
765893|NCT00055042|Diabetes Type II|diabetes type ii
765894|NCT00055042|Diabetic Macular Edema|diabetic macular edema
765895|NCT00055029|Retinoschisis|retinoschisis
765896|NCT00055029|Genomic DNA|genomic dna
765897|NCT00055029|Pedigree Analysis|pedigree analysis
765898|NCT00055029|Genetic Analysis|genetic analysis
765899|NCT00055029|Macular Degeneration|macular degeneration
765900|NCT00055029|Juvenile Retinoschisis|juvenile retinoschisis
765901|NCT00055029|X-Linked Juvenile Retinoschisis|x-linked juvenile retinoschisis
765902|NCT00055029|XLRS|xlrs
765903|NCT00055016|Lysosomal Disease|lysosomal disease
765904|NCT00055016|Renal Function|renal function
765905|NCT00055016|Stroke|stroke
765906|NCT00055016|Cardiac Disease|cardiac disease
765907|NCT00055016|Natural History|natural history
765908|NCT00055016|Fabry Disease|fabry disease
765909|NCT00055003|Amygdala|amygdala
765910|NCT00055003|Medial Prefrontal Cortex|medial prefrontal cortex
765911|NCT00055003|Orbitofrontal Cortex|orbitofrontal cortex
765912|NCT00055003|Cortisol|cortisol
765913|NCT00055003|Memory|memory
765914|NCT00055003|Glucocorticoid|glucocorticoid
765915|NCT00055003|Hydrocortisone|hydrocortisone
765916|NCT00055003|Stress|stress
765917|NCT00055003|Perception|perception
765918|NCT00055003|Affect|affect
765919|NCT00055003|Healthy Volunteer|healthy volunteer
765920|NCT00055003|HV|hv
765921|NCT00054990|Antiepileptic Drugs|antiepileptic drugs
765922|NCT00054990|Cortical Excitability|cortical excitability
765923|NCT00054990|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
765924|NCT00054990|Epilepsy|epilepsy
765925|NCT00054990|TMS|tms
765926|NCT00054990|Healthy Volunteer|healthy volunteer
765927|NCT00054990|HV|hv
765928|NCT00054977|cancer|cancer
765929|NCT00054977|tumor|tumor
765930|NCT00054951|Hepatoma|hepatoma
765931|NCT00054951|Liver Cancer|liver cancer
765932|NCT00054938|SLE|sle
765933|NCT00054938|Accelerated Atherosclerosis|accelerated atherosclerosis
765934|NCT00054938|Cholesterol|cholesterol
765935|NCT00054912|vaccine|vaccine
765936|NCT00054912|colon|colon
765937|NCT00054912|cancer|cancer
765938|NCT00054912|colorectal|colorectal
765939|NCT00054912|neoplasm|neoplasm
765940|NCT00054912|Colonic Cancer|colonic cancer
765941|NCT00054912|Colon Cancer|colon cancer
765942|NCT00054912|Cancer of the Colon|cancer of the colon
765943|NCT00054899|vaccine|vaccine
765944|NCT00054899|lung|lung
765945|NCT00054899|cancer|cancer
765946|NCT00054899|Carcinoma, Large Cell|carcinoma, large cell
765947|NCT00054899|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
765948|NCT00054873|Adenocarcinoma of the esophagus or stomach|adenocarcinoma of the esophagus or stomach
765949|NCT00054860|HIV Preventive Vaccine|hiv preventive vaccine
765950|NCT00054860|HIV Seronegativity|hiv seronegativity
765951|NCT00054860|HIV-1|hiv-1
765952|NCT00054860|AIDS Vaccines|aids vaccines
765953|NCT00054860|Vaccines, DNA|vaccines, dna
765954|NCT00054860|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
765955|NCT00054860|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
765956|NCT00054860|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
765957|NCT00054860|Epitopes|epitopes
765958|NCT00054847|CABG|cabg
765959|NCT00054847|cardiovascular|cardiovascular
765960|NCT00054847|chronic diseases|chronic diseases
765961|NCT00054847|clinical trial|clinical trial
765962|NCT00054847|heart|heart
765963|NCT00054847|multi-site trial|multi-site trial
765964|NCT00054847|prospective|prospective
765965|NCT00054821|Osteoarthritis, Ankle|osteoarthritis, ankle
765966|NCT00054821|Ankle Distraction|ankle distraction
765967|NCT00054808|Gallium Nitrate|gallium nitrate
765968|NCT00054808|Ganite|ganite
765969|NCT00054808|NHL|nhl
765970|NCT00054808|Relapsed|relapsed
765971|NCT00054795|Brain Neoplasms/radiotherapy|brain neoplasms/radiotherapy
765972|NCT00054795|Neoplasms/complications/prevention & control,|neoplasms/complications/prevention & control,
765973|NCT00054795|Neuropsychological Tests,|neuropsychological tests,
765974|NCT00054795|Metalloporphyrins/therapeutic use,|metalloporphyrins/therapeutic use,
765975|NCT00054795|Combined Modality Therapy,|combined modality therapy,
765976|NCT00054795|Drug therapy,|drug therapy,
765977|NCT00054795|Quality of Life,|quality of life,
765978|NCT00054795|Cranial Irradiation,|cranial irradiation,
765979|NCT00054795|Radiotherapy/Targeted,|radiotherapy/targeted,
765980|NCT00054795|Prospective Studies,|prospective studies,
765981|NCT00054795|Neoplasm Recurrence/Local,|neoplasm recurrence/local,
765982|NCT00054795|Treatment Outcome|treatment outcome
765983|NCT00054795|Brain metastases|brain metastases
765984|NCT00054795|Brain Neoplasms/secondary|brain neoplasms/secondary
765985|NCT00054795|Non-small cell lung cancer|non-small cell lung cancer
765986|NCT00054769|Pediatrics|pediatrics
765987|NCT00054769|Polymerase Chain Reaction|polymerase chain reaction
765988|NCT00054730|Fragile X Syndrome|fragile x syndrome
765989|NCT00054730|Autism|autism
765990|NCT00054756|Hypothalamic Releasing Factor|hypothalamic releasing factor
765991|NCT00054756|Neuropeptide|neuropeptide
765992|NCT00054756|Diagnostic Testing|diagnostic testing
765993|NCT00054756|Pituitary Tumors|pituitary tumors
765994|NCT00054756|Central Hypothyroidism|central hypothyroidism
765995|NCT00054756|Pituitary Disorder|pituitary disorder
765996|NCT00054756|Thyroid Disorder|thyroid disorder
765997|NCT00054756|Healthy Volunteer|healthy volunteer
765998|NCT00054756|HV|hv
765999|NCT00054743|Race|race
766000|NCT00054743|Ethnicity|ethnicity
766001|NCT00054743|Pharmacogenetics|pharmacogenetics
766002|NCT00054743|Cytochrome P450|cytochrome p450
766003|NCT00054743|Population Pharmacokinetics|population pharmacokinetics
766004|NCT00054743|HIV|hiv
766005|NCT00054704|Riluzole|riluzole
766006|NCT00054704|Neuroprotective|neuroprotective
766007|NCT00054704|Open-Label Study|open-label study
766008|NCT00054704|Glutamate Dysfunction|glutamate dysfunction
766009|NCT00054704|Bipolar Mood Disorder|bipolar mood disorder
766010|NCT00054704|Bipolar Disorder|bipolar disorder
766011|NCT00054704|Mood Disorder|mood disorder
766012|NCT00054691|Skin Cancer|skin cancer
766013|NCT00054691|Squamous Cell Carcinoma of the Skin|squamous cell carcinoma of the skin
766014|NCT00054691|Gefitinib|gefitinib
766015|NCT00054691|ZD1839|zd1839
766016|NCT00054691|Iressa|iressa
766017|NCT00054691|Epidermal Growth Factor Receptor|epidermal growth factor receptor
766018|NCT00054691|EGFR|egfr
766019|NCT00054678|Myocardial infarction|myocardial infarction
766020|NCT00054678|Heart disease|heart disease
766021|NCT00054678|Endoventricular|endoventricular
766022|NCT00054678|Cardiovascular|cardiovascular
766023|NCT00054678|Interventional|interventional
766024|NCT00054678|ICD|icd
766025|NCT00054678|Heart failure|heart failure
766026|NCT00054678|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
766027|NCT00050531|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
766028|NCT00050531|CML|cml
766029|NCT00050531|Early Chronic Phase Chronic Myelogenous Leukemia|early chronic phase chronic myelogenous leukemia
766030|NCT00050531|Imatinib Mesylate|imatinib mesylate
766031|NCT00050531|Gleevec|gleevec
766032|NCT00050531|Peg-Alpha Interferon|peg-alpha interferon
766033|NCT00050531|Peg-Intron|peg-intron
766034|NCT00050531|Sargramostim|sargramostim
766035|NCT00050531|GM-CSF|gm-csf
766036|NCT00054665|BCL-2|bcl-2
766037|NCT00054665|NFK-B|nfk-b
766038|NCT00054665|Drug Resistance|drug resistance
766039|NCT00054665|Translational|translational
766040|NCT00054665|Lymphoma|lymphoma
766041|NCT00054665|Large B-Cell Lymphoma|large b-cell lymphoma
766042|NCT00054652|Geste Antagoniste|geste antagoniste
766043|NCT00054652|TMS|tms
766044|NCT00054652|Sensorimotor Integration|sensorimotor integration
766045|NCT00054652|Writer's Cramp|writer's cramp
766046|NCT00054652|Sensory Input|sensory input
766047|NCT00054652|Focal Dystonia|focal dystonia
766048|NCT00054626|stage II bladder cancer|stage ii bladder cancer
766049|NCT00054626|stage III bladder cancer|stage iii bladder cancer
766050|NCT00054626|stage IV bladder cancer|stage iv bladder cancer
766051|NCT00054626|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
766052|NCT00054613|Graft-versus-Host Disease|graft-versus-host disease
766053|NCT00054613|Extracorporeal Photopheresis|extracorporeal photopheresis
766054|NCT00054600|Extracorporeal Photopheresis|extracorporeal photopheresis
766055|NCT00054600|Graft-versus-Host Disease|graft-versus-host disease
766056|NCT00054587|stage II breast cancer|stage ii breast cancer
766057|NCT00054587|stage IIIA breast cancer|stage iiia breast cancer
766058|NCT00054574|recurrent prostate cancer|recurrent prostate cancer
766059|NCT00054574|stage I prostate cancer|stage i prostate cancer
766060|NCT00054574|stage II prostate cancer|stage ii prostate cancer
766061|NCT00054574|stage III prostate cancer|stage iii prostate cancer
766062|NCT00054561|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
766063|NCT00054561|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
766064|NCT00054561|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
766065|NCT00054561|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
766066|NCT00054561|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
766067|NCT00054561|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
766068|NCT00054561|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
766069|NCT00054561|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
766070|NCT00054535|stage IV melanoma|stage iv melanoma
766071|NCT00054535|recurrent melanoma|recurrent melanoma
766072|NCT00054522|adenocarcinoma of the prostate|adenocarcinoma of the prostate
766073|NCT00054522|recurrent prostate cancer|recurrent prostate cancer
766074|NCT00054496|adult glioblastoma|adult glioblastoma
766075|NCT00054496|recurrent adult brain tumor|recurrent adult brain tumor
766365|NCT00053794|adult synovial sarcoma|adult synovial sarcoma
766076|NCT00054496|adult giant cell glioblastoma|adult giant cell glioblastoma
766077|NCT00054496|adult gliosarcoma|adult gliosarcoma
766078|NCT00054470|stage IV breast cancer|stage iv breast cancer
766079|NCT00054470|recurrent breast cancer|recurrent breast cancer
766080|NCT00054470|male breast cancer|male breast cancer
766081|NCT00054457|adenocarcinoma of the stomach|adenocarcinoma of the stomach
766082|NCT00054457|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
766083|NCT00054457|stage IV gastric cancer|stage iv gastric cancer
766084|NCT00054457|recurrent gastric cancer|recurrent gastric cancer
766085|NCT00054457|stage IV esophageal cancer|stage iv esophageal cancer
766086|NCT00054457|recurrent esophageal cancer|recurrent esophageal cancer
766087|NCT00054418|osteoporosis|osteoporosis
766088|NCT00054418|stage I breast cancer|stage i breast cancer
766089|NCT00054418|stage II breast cancer|stage ii breast cancer
766090|NCT00054418|stage IIIA breast cancer|stage iiia breast cancer
766091|NCT00054418|stage IIIB breast cancer|stage iiib breast cancer
783195|NCT00034242|Cerebellum|cerebellum
766092|NCT00054392|adenosquamous cell lung cancer|adenosquamous cell lung cancer
766093|NCT00054392|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
766094|NCT00054392|large cell lung cancer|large cell lung cancer
766095|NCT00054392|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
766096|NCT00054392|squamous cell lung cancer|squamous cell lung cancer
766097|NCT00054392|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
766098|NCT00054392|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
766099|NCT00054392|adenocarcinoma of the lung|adenocarcinoma of the lung
766100|NCT00054340|graft versus host disease|graft versus host disease
766101|NCT00054340|polycythemia vera|polycythemia vera
766102|NCT00054340|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
766103|NCT00054340|essential thrombocythemia|essential thrombocythemia
766104|NCT00054340|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
766105|NCT00054340|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
766106|NCT00054340|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
766107|NCT00054340|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
766108|NCT00054340|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
766109|NCT00054340|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
766110|NCT00054340|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
766111|NCT00054340|chronic eosinophilic leukemia|chronic eosinophilic leukemia
766112|NCT00054340|chronic neutrophilic leukemia|chronic neutrophilic leukemia
766113|NCT00054340|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
766114|NCT00054340|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
766115|NCT00054340|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
766116|NCT00054340|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
766117|NCT00054340|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
766118|NCT00054340|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
766119|NCT00054340|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
766120|NCT00054327|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
766121|NCT00054327|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
766122|NCT00054327|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
766123|NCT00054327|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
766124|NCT00054327|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
766125|NCT00054327|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
766126|NCT00054327|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
766127|NCT00054327|refractory anemia with excess blasts|refractory anemia with excess blasts
766128|NCT00054327|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
766129|NCT00054327|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
766130|NCT00054327|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
766131|NCT00054327|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
766132|NCT00054327|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
766133|NCT00054327|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
766134|NCT00054327|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
766135|NCT00054327|secondary acute myeloid leukemia|secondary acute myeloid leukemia
766136|NCT00054327|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
766137|NCT00054327|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
766138|NCT00054327|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
766139|NCT00054327|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
766140|NCT00054327|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
766141|NCT00054327|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
766142|NCT00054327|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
766143|NCT00054327|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
766144|NCT00054327|refractory anemia|refractory anemia
766145|NCT00054327|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
766146|NCT00054327|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
766147|NCT00054327|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
766148|NCT00054327|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
766149|NCT00054327|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
766150|NCT00054327|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
766151|NCT00054327|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
766152|NCT00054327|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
766153|NCT00054327|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
766154|NCT00054327|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
766155|NCT00054327|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
766156|NCT00054327|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
766157|NCT00054327|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
766158|NCT00054327|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
766159|NCT00054327|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
766160|NCT00054327|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
766161|NCT00054314|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
766162|NCT00054301|stage I breast cancer|stage i breast cancer
766163|NCT00054301|stage II breast cancer|stage ii breast cancer
766164|NCT00054301|stage IIIA breast cancer|stage iiia breast cancer
766165|NCT00054301|ductal breast carcinoma in situ|ductal breast carcinoma in situ
766166|NCT00054301|breast cancer in situ|breast cancer in situ
766167|NCT00054288|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
766168|NCT00054275|recurrent breast cancer|recurrent breast cancer
766169|NCT00054275|stage IV breast cancer|stage iv breast cancer
766170|NCT00054275|male breast cancer|male breast cancer
766171|NCT00054262|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
766172|NCT00054262|advanced adult primary liver cancer|advanced adult primary liver cancer
766173|NCT00054262|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
766174|NCT00054249|recurrent gastric cancer|recurrent gastric cancer
766175|NCT00054236|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
766176|NCT00054236|refractory anemia with excess blasts|refractory anemia with excess blasts
766177|NCT00054236|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
766178|NCT00054236|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
766179|NCT00054236|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
766180|NCT00054236|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
766181|NCT00054236|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
766182|NCT00054236|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
766183|NCT00054236|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
766184|NCT00054236|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
766185|NCT00054236|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
766186|NCT00054236|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
766187|NCT00054236|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
766188|NCT00054236|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
766189|NCT00054236|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
766190|NCT00054236|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
766191|NCT00054236|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
766192|NCT00054236|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
766193|NCT00054236|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
766194|NCT00054236|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
766195|NCT00054236|stage I multiple myeloma|stage i multiple myeloma
766196|NCT00054236|stage II multiple myeloma|stage ii multiple myeloma
766197|NCT00054236|stage III multiple myeloma|stage iii multiple myeloma
766198|NCT00054236|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
766199|NCT00054236|polycythemia vera|polycythemia vera
766200|NCT00054236|primary myelofibrosis|primary myelofibrosis
766201|NCT00054236|essential thrombocythemia|essential thrombocythemia
766202|NCT00054236|refractory multiple myeloma|refractory multiple myeloma
766203|NCT00054236|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
766204|NCT00054236|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
766205|NCT00054236|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
766206|NCT00054236|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
766207|NCT00054236|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
766208|NCT00054236|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
766209|NCT00054236|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
766210|NCT00054236|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
766211|NCT00054236|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
766212|NCT00054236|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
766213|NCT00054236|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
766214|NCT00054236|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
766215|NCT00054236|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
766216|NCT00054236|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
766217|NCT00054236|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
766218|NCT00054236|Burkitt lymphoma|burkitt lymphoma
766219|NCT00054236|anaplastic large cell lymphoma|anaplastic large cell lymphoma
766220|NCT00054236|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
766288|NCT00053989|stage I multiple myeloma|stage i multiple myeloma
766221|NCT00054236|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
766222|NCT00054236|chronic eosinophilic leukemia|chronic eosinophilic leukemia
766223|NCT00054236|chronic neutrophilic leukemia|chronic neutrophilic leukemia
766224|NCT00054236|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
766225|NCT00054236|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
766226|NCT00054236|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
766227|NCT00054236|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
766228|NCT00054236|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
766229|NCT00054236|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
766230|NCT00054236|splenic marginal zone lymphoma|splenic marginal zone lymphoma
766231|NCT00054236|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
766232|NCT00054236|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
766233|NCT00054236|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
766234|NCT00054236|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
766235|NCT00054236|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
766236|NCT00054236|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
766237|NCT00054223|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
766238|NCT00054223|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
766239|NCT00054210|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
766240|NCT00054210|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
766241|NCT00054210|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
766242|NCT00054197|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
766243|NCT00054197|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
766244|NCT00054197|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
766245|NCT00054184|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
766246|NCT00054184|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
766247|NCT00054184|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
766248|NCT00054171|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
766249|NCT00054171|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
766250|NCT00054171|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
766251|NCT00054171|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
766252|NCT00054171|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
766253|NCT00054158|stage I multiple myeloma|stage i multiple myeloma
766254|NCT00054158|stage II multiple myeloma|stage ii multiple myeloma
766255|NCT00054158|stage III multiple myeloma|stage iii multiple myeloma
766256|NCT00054145|male breast cancer|male breast cancer
766257|NCT00054145|recurrent breast cancer|recurrent breast cancer
766258|NCT00054145|stage IV breast cancer|stage iv breast cancer
766259|NCT00054145|stage IIIA breast cancer|stage iiia breast cancer
766260|NCT00054145|stage IIIB breast cancer|stage iiib breast cancer
766261|NCT00054145|stage IIIC breast cancer|stage iiic breast cancer
766262|NCT00054106|adenocarcinoma of the prostate|adenocarcinoma of the prostate
766263|NCT00054106|stage III prostate cancer|stage iii prostate cancer
766264|NCT00054106|stage II prostate cancer|stage ii prostate cancer
766265|NCT00054067|cervical adenocarcinoma|cervical adenocarcinoma
766266|NCT00054067|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
766267|NCT00054067|cervical squamous cell carcinoma|cervical squamous cell carcinoma
766268|NCT00054067|stage IB cervical cancer|stage ib cervical cancer
766269|NCT00054054|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
766270|NCT00054054|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
766271|NCT00054054|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
766272|NCT00054054|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
766273|NCT00054054|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
766274|NCT00054054|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
766275|NCT00054015|recurrent prostate cancer|recurrent prostate cancer
766276|NCT00054015|stage IV prostate cancer|stage iv prostate cancer
766277|NCT00054002|localized malignant mesothelioma|localized malignant mesothelioma
766278|NCT00054002|recurrent malignant mesothelioma|recurrent malignant mesothelioma
766279|NCT00054002|epithelial mesothelioma|epithelial mesothelioma
766280|NCT00054002|sarcomatous mesothelioma|sarcomatous mesothelioma
766281|NCT00053989|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
766282|NCT00053989|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
766283|NCT00053989|primary myelofibrosis|primary myelofibrosis
766284|NCT00053989|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
766285|NCT00053989|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
766286|NCT00053989|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
766287|NCT00053989|refractory anemia with excess blasts|refractory anemia with excess blasts
766289|NCT00053989|stage II multiple myeloma|stage ii multiple myeloma
766290|NCT00053989|stage III multiple myeloma|stage iii multiple myeloma
766291|NCT00053989|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
766292|NCT00053989|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
766293|NCT00053989|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
766294|NCT00053989|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
766295|NCT00053989|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
766296|NCT00053989|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
766297|NCT00053989|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
766298|NCT00053989|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
766299|NCT00053989|secondary acute myeloid leukemia|secondary acute myeloid leukemia
766300|NCT00053989|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
766301|NCT00053989|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
766302|NCT00053989|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
766303|NCT00053989|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
766304|NCT00053989|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
766305|NCT00053989|refractory multiple myeloma|refractory multiple myeloma
766306|NCT00053989|refractory anemia|refractory anemia
766307|NCT00053989|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
766308|NCT00053989|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
766309|NCT00053989|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
766310|NCT00053989|grade 1 follicular lymphoma|grade 1 follicular lymphoma
766311|NCT00053989|grade 2 follicular lymphoma|grade 2 follicular lymphoma
766312|NCT00053989|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
766313|NCT00053989|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
766314|NCT00053989|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
766315|NCT00053989|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
766316|NCT00053989|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
766317|NCT00053989|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
766318|NCT00053989|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
766319|NCT00053989|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
766320|NCT00053989|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
766321|NCT00053989|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
766322|NCT00053989|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
766323|NCT00053989|splenic marginal zone lymphoma|splenic marginal zone lymphoma
766324|NCT00053989|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
766325|NCT00053989|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
766326|NCT00053989|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
766327|NCT00053989|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
766328|NCT00053989|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
766329|NCT00053989|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
766330|NCT00053976|graft versus host disease|graft versus host disease
766331|NCT00053937|plexiform neurofibroma|plexiform neurofibroma
766332|NCT00053937|neurofibromatosis type 1|neurofibromatosis type 1
766333|NCT00053924|recurrent pancreatic cancer|recurrent pancreatic cancer
766334|NCT00053924|stage II pancreatic cancer|stage ii pancreatic cancer
766335|NCT00053924|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
766336|NCT00053924|stage III pancreatic cancer|stage iii pancreatic cancer
766337|NCT00053924|stage IV pancreatic cancer|stage iv pancreatic cancer
766338|NCT00053911|recurrent breast cancer|recurrent breast cancer
766339|NCT00053911|stage I breast cancer|stage i breast cancer
766340|NCT00053911|stage II breast cancer|stage ii breast cancer
766341|NCT00053911|stage IIIA breast cancer|stage iiia breast cancer
766342|NCT00053898|breast cancer in situ|breast cancer in situ
766343|NCT00053898|ductal breast carcinoma in situ|ductal breast carcinoma in situ
766344|NCT00053885|advanced malignant mesothelioma|advanced malignant mesothelioma
766345|NCT00053885|epithelial mesothelioma|epithelial mesothelioma
766346|NCT00053885|recurrent malignant mesothelioma|recurrent malignant mesothelioma
766347|NCT00053885|sarcomatous mesothelioma|sarcomatous mesothelioma
766348|NCT00053872|untreated childhood medulloblastoma|untreated childhood medulloblastoma
766349|NCT00053846|dyspnea|dyspnea
766350|NCT00053846|pulmonary complications|pulmonary complications
766351|NCT00053846|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
766352|NCT00053833|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
766353|NCT00053833|fallopian tube cancer|fallopian tube cancer
766354|NCT00053833|primary peritoneal cavity cancer|primary peritoneal cavity cancer
766355|NCT00053833|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
766356|NCT00053833|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
766357|NCT00053820|stage IV renal cell cancer|stage iv renal cell cancer
766358|NCT00053807|stage III renal cell cancer|stage iii renal cell cancer
766359|NCT00053807|stage IV renal cell cancer|stage iv renal cell cancer
766360|NCT00053794|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
766361|NCT00053794|adult angiosarcoma|adult angiosarcoma
766362|NCT00053794|adult fibrosarcoma|adult fibrosarcoma
766363|NCT00053794|adult leiomyosarcoma|adult leiomyosarcoma
766364|NCT00053794|adult liposarcoma|adult liposarcoma
766366|NCT00053794|endometrial stromal sarcoma|endometrial stromal sarcoma
766367|NCT00053794|uterine leiomyosarcoma|uterine leiomyosarcoma
766368|NCT00053794|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
766369|NCT00053794|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
766370|NCT00053794|stage III uterine sarcoma|stage iii uterine sarcoma
766371|NCT00053794|stage IV uterine sarcoma|stage iv uterine sarcoma
766372|NCT00053794|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
766373|NCT00053794|recurrent uterine sarcoma|recurrent uterine sarcoma
766374|NCT00053794|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
766375|NCT00053794|adult neurofibrosarcoma|adult neurofibrosarcoma
766376|NCT00053794|adult rhabdomyosarcoma|adult rhabdomyosarcoma
766377|NCT00053794|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
766378|NCT00053781|recurrent melanoma|recurrent melanoma
766379|NCT00053781|stage IV melanoma|stage iv melanoma
766380|NCT00053768|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
766381|NCT00053768|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
766382|NCT00053768|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
766383|NCT00053768|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
766384|NCT00053768|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
766385|NCT00053768|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
766386|NCT00053768|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
766387|NCT00053768|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
766388|NCT00053768|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
766389|NCT00053768|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
766390|NCT00053768|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
766391|NCT00053768|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
766392|NCT00053768|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
766393|NCT00053768|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
766394|NCT00053768|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
766395|NCT00053768|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
766396|NCT00053768|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
766397|NCT00053768|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
766398|NCT00053768|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
766399|NCT00053768|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
766400|NCT00053768|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
766401|NCT00053768|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
766402|NCT00053768|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
766403|NCT00053768|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
766404|NCT00053768|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
766405|NCT00053768|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
766406|NCT00053768|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
766407|NCT00053768|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
766408|NCT00053768|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
766409|NCT00053768|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
766410|NCT00053768|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
766411|NCT00053768|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
766412|NCT00053768|stage I mantle cell lymphoma|stage i mantle cell lymphoma
766413|NCT00053768|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
766414|NCT00053768|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
766415|NCT00053716|Angioplasty & PGE1 Treatment of Peripheral Vascular Disease|angioplasty & pge1 treatment of peripheral vascular disease
766416|NCT00045123|adenocarcinoma of the prostate|adenocarcinoma of the prostate
766417|NCT00045123|recurrent prostate cancer|recurrent prostate cancer
766418|NCT00028678|adult glioblastoma|adult glioblastoma
766419|NCT00028678|adult giant cell glioblastoma|adult giant cell glioblastoma
766420|NCT00028678|adult gliosarcoma|adult gliosarcoma
766421|NCT00017342|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
766422|NCT00017342|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
766423|NCT00017342|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
766424|NCT00017342|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
766513|NCT00053248|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
766425|NCT00017342|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
766426|NCT00017342|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
766427|NCT00053742|Smallpox|smallpox
766428|NCT00053742|Vaccine|vaccine
766429|NCT00053742|Vaccination|vaccination
766430|NCT00053742|Variola|variola
766431|NCT00053742|Adults|adults
766432|NCT00053742|Healthy Volunteer|healthy volunteer
766433|NCT00053742|HV|hv
766434|NCT00053742|Smallpox Vaccine|smallpox vaccine
766435|NCT00053703|Psychotic Disorders|psychotic disorders
766436|NCT00053703|Schizophreniform Disorder|schizophreniform disorder
766437|NCT00053690|Comorbidity|comorbidity
766438|NCT00053690|Schizophrenia|schizophrenia
766439|NCT00053690|Bipolar Disorder|bipolar disorder
766440|NCT00053690|Depression|depression
766441|NCT00053677|Impulse Control Disorders|impulse control disorders
766442|NCT00053638|HIV-1 Efavirenz Tenofovir|hiv-1 efavirenz tenofovir
766443|NCT00053625|Parkinson's disease|parkinson's disease
766444|NCT00053625|PD|pd
766445|NCT00053625|deep brain stimulation|deep brain stimulation
766446|NCT00053625|DBS|dbs
766447|NCT00053612|HIV-1|hiv-1
766448|NCT00053612|Women|women
766449|NCT00053612|Vitamin A|vitamin a
766450|NCT00053612|Shedding|shedding
766451|NCT00053599|Cholesterol-lowering drug|cholesterol-lowering drug
766452|NCT00053599|Mild to Moderate Alzheimer disease|mild to moderate alzheimer disease
766453|NCT00053573|Glycogen Storage Disease Type II|glycogen storage disease type ii
766454|NCT00053573|GSD-II|gsd-ii
766455|NCT00053573|Pompe Disease|pompe disease
766456|NCT00053560|lupus|lupus
766457|NCT00053560|systemic lupus erythematosus|systemic lupus erythematosus
766458|NCT00053560|SLE|sle
766459|NCT00053560|bone loss|bone loss
766460|NCT00053560|DHEA|dhea
766461|NCT00053495|Smallpox|smallpox
766462|NCT00053482|Smallpox vaccines|smallpox vaccines
766463|NCT00053482|Dryvax®|dryvax®
766464|NCT00053482|Orthopoxvirus|orthopoxvirus
766465|NCT00053482|Vaccinia virus|vaccinia virus
766466|NCT00053482|ACAM2000|acam2000
766467|NCT00053469|Cognitive Development|cognitive development
766468|NCT00053469|Motor Planning|motor planning
766469|NCT00053469|Categorization|categorization
766470|NCT00053469|Perception|perception
766471|NCT00053469|Adaptation|adaptation
766472|NCT00053456|Endothelium|endothelium
766473|NCT00053456|Nitric Oxide|nitric oxide
766474|NCT00053456|Myocardial Ischemia|myocardial ischemia
766475|NCT00053456|Exercise|exercise
766476|NCT00053456|Endothelial Progenitor Cells|endothelial progenitor cells
766477|NCT00053443|Adherence|adherence
766478|NCT00053443|Treatment Experienced|treatment experienced
766479|NCT00053430|Immune Modulation|immune modulation
766480|NCT00053430|Thalidomide|thalidomide
766481|NCT00053430|Immune reconstitution|immune reconstitution
766482|NCT00053430|Treatment Experienced|treatment experienced
766483|NCT00053417|Walking Ability|walking ability
766484|NCT00053417|Muscle strength|muscle strength
766485|NCT00053417|Spasticity|spasticity
766486|NCT00053404|Treatment Experienced|treatment experienced
766487|NCT00053404|Drug Resistance|drug resistance
766488|NCT00053391|stage III melanoma|stage iii melanoma
766489|NCT00053391|stage IV melanoma|stage iv melanoma
766490|NCT00053391|recurrent melanoma|recurrent melanoma
766491|NCT00053378|hypocalcemia, ionized calcium, intensive care|hypocalcemia, ionized calcium, intensive care
766492|NCT00053300|extensive stage small cell lung cancer|extensive stage small cell lung cancer
766493|NCT00053287|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
766494|NCT00053287|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
766495|NCT00053287|refractory anemia with excess blasts|refractory anemia with excess blasts
766496|NCT00053287|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
766497|NCT00053287|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
766498|NCT00053287|secondary acute myeloid leukemia|secondary acute myeloid leukemia
766499|NCT00053287|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
766500|NCT00053287|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
766501|NCT00053287|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
766502|NCT00053287|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
766503|NCT00053287|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
766504|NCT00053287|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
766505|NCT00053287|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
766506|NCT00053287|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
766507|NCT00053287|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
766508|NCT00053287|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
766509|NCT00053287|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
766510|NCT00053287|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
766511|NCT00053261|sexuality and reproductive issues|sexuality and reproductive issues
766512|NCT00053261|stage IB cervical cancer|stage ib cervical cancer
766514|NCT00053248|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
766515|NCT00053222|recurrent pancreatic cancer|recurrent pancreatic cancer
766516|NCT00053222|stage II pancreatic cancer|stage ii pancreatic cancer
766517|NCT00053222|stage III pancreatic cancer|stage iii pancreatic cancer
766518|NCT00053222|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
766519|NCT00053222|stage IV pancreatic cancer|stage iv pancreatic cancer
766520|NCT00053209|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
766521|NCT00053209|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
766522|NCT00053209|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
766523|NCT00053209|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
766524|NCT00053209|recurrent bladder cancer|recurrent bladder cancer
766525|NCT00053209|stage III bladder cancer|stage iii bladder cancer
766526|NCT00053209|stage IV bladder cancer|stage iv bladder cancer
766527|NCT00053209|anterior urethral cancer|anterior urethral cancer
766528|NCT00053209|posterior urethral cancer|posterior urethral cancer
766529|NCT00053209|recurrent urethral cancer|recurrent urethral cancer
766530|NCT00053209|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
766531|NCT00053196|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
766532|NCT00053196|prolymphocytic leukemia|prolymphocytic leukemia
766533|NCT00053196|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
766534|NCT00053196|stage I multiple myeloma|stage i multiple myeloma
766535|NCT00053196|stage II multiple myeloma|stage ii multiple myeloma
766536|NCT00053196|stage III multiple myeloma|stage iii multiple myeloma
766537|NCT00053196|refractory multiple myeloma|refractory multiple myeloma
766538|NCT00053196|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
766539|NCT00053196|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
766540|NCT00053196|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
766541|NCT00053196|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
766542|NCT00053196|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
766543|NCT00053196|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
766544|NCT00053196|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
766545|NCT00053196|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
766546|NCT00053196|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
766547|NCT00053196|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
766548|NCT00053196|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
766549|NCT00053196|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
766550|NCT00053196|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
766551|NCT00053196|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
766552|NCT00053196|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
766553|NCT00053196|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
766554|NCT00053196|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
766555|NCT00053196|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
766556|NCT00053196|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
766557|NCT00053196|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
766558|NCT00053196|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
766559|NCT00053196|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
766560|NCT00053196|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
766561|NCT00053196|splenic marginal zone lymphoma|splenic marginal zone lymphoma
766562|NCT00053196|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
766563|NCT00053196|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
766564|NCT00053196|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
766565|NCT00053196|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
766566|NCT00053196|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
766567|NCT00053196|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
766568|NCT00053183|adult glioblastoma|adult glioblastoma
766569|NCT00053183|adult giant cell glioblastoma|adult giant cell glioblastoma
766570|NCT00053183|adult gliosarcoma|adult gliosarcoma
766571|NCT00053157|graft versus host disease|graft versus host disease
766572|NCT00053157|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
766573|NCT00053157|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
766574|NCT00053157|primary myelofibrosis|primary myelofibrosis
766575|NCT00053157|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
766576|NCT00053157|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
766577|NCT00053157|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
783703|NCT00031291|Anthrax|anthrax
766578|NCT00053157|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
766579|NCT00053157|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
766580|NCT00053157|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
766581|NCT00053157|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
766582|NCT00053157|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
766583|NCT00053157|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
766584|NCT00053157|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
766585|NCT00053157|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
766586|NCT00053157|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
766587|NCT00053157|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
766588|NCT00053157|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
766589|NCT00053157|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
766590|NCT00053157|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
766591|NCT00053157|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
766592|NCT00053157|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
766593|NCT00053157|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
766594|NCT00053157|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
766595|NCT00053157|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
766596|NCT00053157|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
766597|NCT00053157|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
766598|NCT00053157|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
766599|NCT00053157|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
766600|NCT00053157|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
766601|NCT00053157|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
766602|NCT00053157|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
766603|NCT00053157|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
766604|NCT00053157|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
766605|NCT00053157|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
766606|NCT00053157|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
766607|NCT00053157|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
766608|NCT00053157|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
766609|NCT00053157|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
766610|NCT00053157|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
766611|NCT00053157|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
766612|NCT00053157|secondary acute myeloid leukemia|secondary acute myeloid leukemia
766613|NCT00053157|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
766614|NCT00053157|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
766615|NCT00053157|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
766616|NCT00053157|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
766617|NCT00053157|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
766618|NCT00053157|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
766619|NCT00053157|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
766620|NCT00053157|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
766621|NCT00053157|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
766622|NCT00053157|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
766623|NCT00053157|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
766624|NCT00053157|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
766625|NCT00053157|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
766626|NCT00053157|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
766627|NCT00053157|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
766628|NCT00053157|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
766629|NCT00053157|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
766630|NCT00053157|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
766631|NCT00053157|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
766632|NCT00053157|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
766633|NCT00053157|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
766634|NCT00053157|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
766635|NCT00053157|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
766636|NCT00053157|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
766637|NCT00053157|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
766638|NCT00053157|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
783806|NCT00031005|Fludarabine|fludarabine
766639|NCT00053157|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
766640|NCT00053157|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
766641|NCT00053157|chronic eosinophilic leukemia|chronic eosinophilic leukemia
766642|NCT00053157|chronic neutrophilic leukemia|chronic neutrophilic leukemia
766643|NCT00053157|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
766644|NCT00053157|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
766645|NCT00053157|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
766646|NCT00053157|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
766647|NCT00053157|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
766648|NCT00053157|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
766649|NCT00053157|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
766650|NCT00053157|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
766651|NCT00053157|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
766652|NCT00053157|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
766653|NCT00053157|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
766654|NCT00053157|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
766655|NCT00053157|splenic marginal zone lymphoma|splenic marginal zone lymphoma
766656|NCT00053157|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
766657|NCT00053157|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
766847|NCT00052728|recurrent breast cancer|recurrent breast cancer
766658|NCT00053157|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
766659|NCT00053157|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
766660|NCT00053157|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
766661|NCT00053157|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
766662|NCT00053144|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
766663|NCT00053144|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
766664|NCT00053144|secondary acute myeloid leukemia|secondary acute myeloid leukemia
766665|NCT00053144|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
766666|NCT00053144|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
766667|NCT00053144|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
766668|NCT00053144|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
766669|NCT00053144|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
766670|NCT00053144|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
766671|NCT00053144|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
766672|NCT00053144|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
766673|NCT00053144|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
766674|NCT00053144|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
766675|NCT00053144|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
766676|NCT00053131|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
766677|NCT00053131|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
766678|NCT00053131|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
766679|NCT00053131|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
766680|NCT00053118|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
766681|NCT00053118|childhood choroid plexus tumor|childhood choroid plexus tumor
766682|NCT00053118|childhood craniopharyngioma|childhood craniopharyngioma
766683|NCT00053118|childhood grade I meningioma|childhood grade i meningioma
766684|NCT00053118|childhood grade II meningioma|childhood grade ii meningioma
766685|NCT00053118|childhood grade III meningioma|childhood grade iii meningioma
766686|NCT00053118|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
766687|NCT00053118|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
766688|NCT00053118|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
766689|NCT00053118|recurrent childhood ependymoma|recurrent childhood ependymoma
766690|NCT00053118|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
766691|NCT00053118|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
766692|NCT00053118|recurrent neuroblastoma|recurrent neuroblastoma
766693|NCT00053118|recurrent retinoblastoma|recurrent retinoblastoma
766694|NCT00053118|childhood visual pathway and hypothalamic glioma|childhood visual pathway and hypothalamic glioma
766695|NCT00053118|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
766696|NCT00053118|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
766697|NCT00053105|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
766698|NCT00053105|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
766763|NCT00053014|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
766699|NCT00053105|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
766700|NCT00053105|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
766701|NCT00053092|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
766702|NCT00053092|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
766703|NCT00053092|stage I mantle cell lymphoma|stage i mantle cell lymphoma
766704|NCT00053092|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
766705|NCT00053092|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
766706|NCT00053053|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
766707|NCT00053053|cachexia|cachexia
766708|NCT00053053|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
766709|NCT00053053|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
766710|NCT00053053|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
766711|NCT00053053|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
766712|NCT00053053|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
766713|NCT00053053|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
766714|NCT00053053|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
766715|NCT00053053|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
766716|NCT00053053|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
766717|NCT00053053|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
766718|NCT00053053|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
766719|NCT00053053|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
766720|NCT00053053|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
766721|NCT00053053|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
766722|NCT00053053|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
766723|NCT00053053|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
766724|NCT00053053|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
766725|NCT00053053|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
766726|NCT00053053|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
766727|NCT00053053|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
766728|NCT00053053|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
766729|NCT00053053|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
766730|NCT00053053|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
766731|NCT00053053|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
766732|NCT00053053|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
766733|NCT00053053|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
766734|NCT00053053|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
766735|NCT00053053|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
766736|NCT00053053|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
766737|NCT00053053|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
766738|NCT00053053|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
766739|NCT00053053|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
766740|NCT00053053|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
766741|NCT00053053|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
766742|NCT00053053|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
766743|NCT00053053|intraocular lymphoma|intraocular lymphoma
766744|NCT00053053|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
766745|NCT00053053|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
766746|NCT00053053|anaplastic large cell lymphoma|anaplastic large cell lymphoma
766747|NCT00053053|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
766748|NCT00053053|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
766749|NCT00053053|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
766848|NCT00052715|adult glioblastoma|adult glioblastoma
766750|NCT00053053|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
766751|NCT00053053|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
766752|NCT00053053|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
766753|NCT00053053|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
766754|NCT00053053|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
766755|NCT00053053|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
766756|NCT00053053|splenic marginal zone lymphoma|splenic marginal zone lymphoma
766757|NCT00053040|recurrent childhood brain tumor|recurrent childhood brain tumor
766758|NCT00053027|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
766759|NCT00053027|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
766760|NCT00053027|stage I mantle cell lymphoma|stage i mantle cell lymphoma
766761|NCT00053027|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
766762|NCT00053027|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
767178|NCT00049465|ovarian yolk sac tumor|ovarian yolk sac tumor
766764|NCT00053014|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
766765|NCT00053014|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
766766|NCT00053014|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
766767|NCT00053014|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
766768|NCT00053001|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
766769|NCT00053001|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
766770|NCT00053001|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
766771|NCT00053001|anemia|anemia
766772|NCT00053001|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
766773|NCT00053001|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
766774|NCT00053001|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
766775|NCT00041275|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
766776|NCT00041275|advanced adult primary liver cancer|advanced adult primary liver cancer
766777|NCT00041275|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
766778|NCT00003830|stage I breast cancer|stage i breast cancer
766779|NCT00003830|stage II breast cancer|stage ii breast cancer
766780|NCT00052962|Appendiceal Cancer|appendiceal cancer
766781|NCT00052962|Regional Therapy|regional therapy
766782|NCT00052962|Carcinomatosis|carcinomatosis
766783|NCT00052962|Hyperthermia|hyperthermia
766784|NCT00052936|anaplastic large cell lymphoma|anaplastic large cell lymphoma
766785|NCT00052936|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
766786|NCT00052936|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
766787|NCT00052936|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
766788|NCT00052936|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
766789|NCT00052936|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
766790|NCT00052936|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
766791|NCT00052936|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
766792|NCT00052936|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
766793|NCT00052936|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
766794|NCT00052936|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
766795|NCT00052936|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
766796|NCT00052936|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
766797|NCT00052936|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
766798|NCT00052936|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
766799|NCT00052936|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
766800|NCT00052936|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
766801|NCT00052936|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
766802|NCT00052936|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
766803|NCT00052936|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
766804|NCT00052936|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
766805|NCT00052936|stage I mantle cell lymphoma|stage i mantle cell lymphoma
766806|NCT00052936|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
766807|NCT00052936|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
766808|NCT00052936|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
766809|NCT00052936|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
766810|NCT00052936|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
766811|NCT00052936|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
766812|NCT00052936|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
766813|NCT00052936|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
766814|NCT00052936|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
766815|NCT00052936|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
766816|NCT00052936|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
766817|NCT00052936|splenic marginal zone lymphoma|splenic marginal zone lymphoma
766818|NCT00052936|stage I marginal zone lymphoma|stage i marginal zone lymphoma
766819|NCT00052936|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
766820|NCT00052936|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
766821|NCT00052923|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
766822|NCT00052910|stage I gastric cancer|stage i gastric cancer
766823|NCT00052910|stage II gastric cancer|stage ii gastric cancer
766824|NCT00052910|stage III gastric cancer|stage iii gastric cancer
766825|NCT00052910|adenocarcinoma of the stomach|adenocarcinoma of the stomach
766826|NCT00052910|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
766827|NCT00052910|stage I esophageal cancer|stage i esophageal cancer
766828|NCT00052910|stage II esophageal cancer|stage ii esophageal cancer
766829|NCT00052910|stage III esophageal cancer|stage iii esophageal cancer
766830|NCT00052897|anal cancer|anal cancer
784226|NCT00029068|HV|hv
766831|NCT00052884|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
766832|NCT00052884|primary systemic amyloidosis|primary systemic amyloidosis
766833|NCT00052845|adenocarcinoma of the prostate|adenocarcinoma of the prostate
766834|NCT00052845|recurrent prostate cancer|recurrent prostate cancer
766835|NCT00052845|stage IV prostate cancer|stage iv prostate cancer
766836|NCT00052832|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
766837|NCT00052832|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
766838|NCT00052832|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
766839|NCT00052832|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
766840|NCT00052832|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
766841|NCT00052832|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
766842|NCT00052754|adult synovial sarcoma|adult synovial sarcoma
766843|NCT00052754|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
766844|NCT00052754|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
766845|NCT00052754|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
766846|NCT00052728|stage IV breast cancer|stage iv breast cancer
766849|NCT00052715|adult giant cell glioblastoma|adult giant cell glioblastoma
766850|NCT00052715|adult gliosarcoma|adult gliosarcoma
766851|NCT00052676|stage I breast cancer|stage i breast cancer
766852|NCT00052676|stage II breast cancer|stage ii breast cancer
766853|NCT00052637|bladder cancer|bladder cancer
766854|NCT00052637|recurrent bladder cancer|recurrent bladder cancer
766855|NCT00052637|stage 0 bladder cancer|stage 0 bladder cancer
766856|NCT00052624|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
766857|NCT00052611|lip and oral cavity cancer|lip and oral cavity cancer
766858|NCT00052611|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
766859|NCT00052611|hypopharyngeal cancer|hypopharyngeal cancer
766860|NCT00052611|laryngeal cancer|laryngeal cancer
766861|NCT00052611|oropharyngeal cancer|oropharyngeal cancer
766862|NCT00052611|nasopharyngeal cancer|nasopharyngeal cancer
766863|NCT00052611|salivary gland cancer|salivary gland cancer
766864|NCT00052572|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
766865|NCT00052572|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
766866|NCT00052572|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
766867|NCT00052572|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
766868|NCT00052572|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
766869|NCT00052572|Waldenström macroglobulinemia|waldenström macroglobulinemia
766870|NCT00052572|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
766871|NCT00052572|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
766872|NCT00052572|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
766873|NCT00052572|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
766874|NCT00052572|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
766875|NCT00052572|splenic marginal zone lymphoma|splenic marginal zone lymphoma
766876|NCT00052507|stage IV colon cancer|stage iv colon cancer
766877|NCT00052507|stage IV rectal cancer|stage iv rectal cancer
766878|NCT00052507|adenocarcinoma of the colon|adenocarcinoma of the colon
766879|NCT00052507|adenocarcinoma of the rectum|adenocarcinoma of the rectum
766880|NCT00052507|recurrent colon cancer|recurrent colon cancer
766881|NCT00052507|recurrent rectal cancer|recurrent rectal cancer
766882|NCT00052494|extensive stage small cell lung cancer|extensive stage small cell lung cancer
766883|NCT00052494|recurrent small cell lung cancer|recurrent small cell lung cancer
766884|NCT00052481|stage IIB prostate cancer|stage iib prostate cancer
766885|NCT00052481|stage IIA prostate cancer|stage iia prostate cancer
766886|NCT00052481|adenocarcinoma of the prostate|adenocarcinoma of the prostate
766887|NCT00052468|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
766888|NCT00052468|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
766889|NCT00052468|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
766890|NCT00052468|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
766891|NCT00052468|fallopian tube cancer|fallopian tube cancer
766892|NCT00052455|adult glioblastoma|adult glioblastoma
766893|NCT00052455|adult anaplastic astrocytoma|adult anaplastic astrocytoma
766894|NCT00052455|recurrent adult brain tumor|recurrent adult brain tumor
766895|NCT00052455|adult giant cell glioblastoma|adult giant cell glioblastoma
766896|NCT00052455|adult gliosarcoma|adult gliosarcoma
766897|NCT00052442|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
766898|NCT00052442|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
766899|NCT00052442|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
766900|NCT00052442|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
766901|NCT00052442|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
766902|NCT00052442|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
766903|NCT00052442|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
766904|NCT00052442|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
766905|NCT00052429|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
784227|NCT00029042|MRI|mri
766906|NCT00052429|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
766907|NCT00052429|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
766908|NCT00052429|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
766909|NCT00052429|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
766910|NCT00052429|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
766911|NCT00052416|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
766912|NCT00052416|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
766913|NCT00052416|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
766914|NCT00052416|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
766915|NCT00052416|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
766916|NCT00052416|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
766917|NCT00052416|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
766918|NCT00052416|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
766919|NCT00052416|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
766920|NCT00052416|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
766921|NCT00052416|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
766922|NCT00052416|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
766923|NCT00052416|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
766924|NCT00052416|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
766925|NCT00052416|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
766926|NCT00052416|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
766927|NCT00052416|Waldenström macroglobulinemia|waldenström macroglobulinemia
766928|NCT00052416|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
766929|NCT00052416|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
766930|NCT00052416|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
766931|NCT00052416|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
766932|NCT00052416|stage I marginal zone lymphoma|stage i marginal zone lymphoma
766933|NCT00052416|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
766934|NCT00052416|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
766935|NCT00052416|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
766936|NCT00052416|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
766937|NCT00052416|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
766938|NCT00052416|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
766939|NCT00052416|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
766940|NCT00052416|splenic marginal zone lymphoma|splenic marginal zone lymphoma
766941|NCT00052390|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
766942|NCT00052390|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
766943|NCT00052390|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
766944|NCT00052351|stage II breast cancer|stage ii breast cancer
766945|NCT00052351|stage IIIA breast cancer|stage iiia breast cancer
766946|NCT00052351|stage IIIB breast cancer|stage iiib breast cancer
766947|NCT00052325|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
766948|NCT00052325|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
766949|NCT00052312|recurrent endometrial carcinoma|recurrent endometrial carcinoma
766950|NCT00052312|stage III endometrial carcinoma|stage iii endometrial carcinoma
766951|NCT00052312|stage IV endometrial carcinoma|stage iv endometrial carcinoma
766952|NCT00052312|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
766953|NCT00052299|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
766954|NCT00052299|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
766955|NCT00052299|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
766956|NCT00052299|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
766957|NCT00052299|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
766958|NCT00052299|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
766959|NCT00052299|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
766960|NCT00052299|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
766961|NCT00052299|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
766962|NCT00052299|secondary acute myeloid leukemia|secondary acute myeloid leukemia
766963|NCT00052299|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
766964|NCT00052299|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
766965|NCT00052299|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
766966|NCT00052299|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
766967|NCT00052286|adult brain tumor|adult brain tumor
766968|NCT00052286|fatigue|fatigue
766969|NCT00052286|cognitive/functional effects|cognitive/functional effects
784328|NCT00028236|NK Cell|nk cell
766970|NCT00052273|unspecified adult solid tumor|unspecified adult solid tumor
766971|NCT00052273|protocol specific|protocol specific
766972|NCT00052221|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
766973|NCT00052221|fatigue|fatigue
766974|NCT00052195|Mycobacterium vaccae|mycobacterium vaccae
766975|NCT00052195|BCG|bcg
766976|NCT00052195|Disseminated tuberculosis|disseminated tuberculosis
766977|NCT00052195|SRL-172|srl-172
766978|NCT00052195|DAR-901|dar-901
766979|NCT00052182|HIV Therapeutic Vaccine|hiv therapeutic vaccine
766980|NCT00052182|CTL Epitope|ctl epitope
766981|NCT00052182|Treatment Experienced|treatment experienced
766982|NCT00052169|metastatic breast cancer|metastatic breast cancer
766983|NCT00052169|docetaxel|docetaxel
766984|NCT00052169|Taxotere|taxotere
766985|NCT00052169|ZD 1839|zd 1839
766986|NCT00052169|gefitinib|gefitinib
766987|NCT00052169|NSABP|nsabp
766988|NCT00052169|advanced breast cancer|advanced breast cancer
766989|NCT00052169|AstraZeneca|astrazeneca
766990|NCT00049712|anaplastic large cell lymphoma|anaplastic large cell lymphoma
766991|NCT00049712|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
766992|NCT00049712|intraocular lymphoma|intraocular lymphoma
766993|NCT00049712|primary central nervous system lymphoma|primary central nervous system lymphoma
766994|NCT00049712|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
766995|NCT00049712|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
766996|NCT00049712|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
766997|NCT00049712|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
766998|NCT00049712|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
766999|NCT00049712|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
767000|NCT00049712|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
767001|NCT00049712|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
767002|NCT00049712|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
767003|NCT00049712|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
767004|NCT00049712|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
767005|NCT00049712|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
767006|NCT00049712|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
767007|NCT00049712|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
767008|NCT00049712|small intestine lymphoma|small intestine lymphoma
767009|NCT00049712|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
767010|NCT00049712|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
767011|NCT00049712|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
767012|NCT00049712|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
767013|NCT00049712|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
767014|NCT00049712|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
767015|NCT00049712|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
767016|NCT00049712|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
767017|NCT00049712|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
767018|NCT00049712|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
767019|NCT00049712|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
767020|NCT00049712|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
767021|NCT00049712|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
767022|NCT00049712|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
767023|NCT00049712|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
767024|NCT00049712|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
767025|NCT00049712|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
767026|NCT00049712|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
767027|NCT00049712|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
767028|NCT00049712|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
767029|NCT00049712|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
767030|NCT00049712|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
767031|NCT00049712|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
767032|NCT00049712|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
767033|NCT00049712|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
767034|NCT00049712|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
767035|NCT00049712|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
767036|NCT00049712|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
767037|NCT00049712|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
767038|NCT00049712|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
767039|NCT00049712|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
767040|NCT00049712|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
767041|NCT00049712|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
767042|NCT00049712|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
767043|NCT00049712|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
767044|NCT00049712|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
767045|NCT00049712|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
767046|NCT00049712|splenic marginal zone lymphoma|splenic marginal zone lymphoma
767047|NCT00049699|anaplastic large cell lymphoma|anaplastic large cell lymphoma
767048|NCT00049699|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
767049|NCT00049699|intraocular lymphoma|intraocular lymphoma
767050|NCT00049699|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
767051|NCT00049699|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
767052|NCT00049699|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
767053|NCT00049699|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
767054|NCT00049699|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
767055|NCT00049699|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
767056|NCT00049699|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
767057|NCT00049699|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
767058|NCT00049699|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
767059|NCT00049699|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
767060|NCT00049699|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
767061|NCT00049699|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
767062|NCT00049699|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
767063|NCT00049699|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
767064|NCT00049699|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
767065|NCT00049699|small intestine lymphoma|small intestine lymphoma
767066|NCT00049699|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
767067|NCT00049699|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
767068|NCT00049699|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
767069|NCT00049699|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
767070|NCT00049699|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
767071|NCT00049699|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
767072|NCT00049699|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
767073|NCT00049699|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
767074|NCT00049699|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
767075|NCT00049699|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
767076|NCT00049699|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
767077|NCT00049699|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
767078|NCT00049699|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
767079|NCT00049699|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
767080|NCT00049699|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
767081|NCT00049699|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
767082|NCT00049699|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
767083|NCT00049699|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
767084|NCT00049699|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
767085|NCT00049699|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
767086|NCT00049699|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
767087|NCT00049699|splenic marginal zone lymphoma|splenic marginal zone lymphoma
767088|NCT00049686|acute undifferentiated leukemia|acute undifferentiated leukemia
767089|NCT00049686|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
767090|NCT00049686|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
767091|NCT00049686|prolymphocytic leukemia|prolymphocytic leukemia
767092|NCT00049686|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
767093|NCT00049686|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
767094|NCT00049686|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
767095|NCT00049686|refractory anemia with excess blasts|refractory anemia with excess blasts
767096|NCT00049686|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
767097|NCT00049686|refractory hairy cell leukemia|refractory hairy cell leukemia
767098|NCT00049686|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
767099|NCT00049686|secondary acute myeloid leukemia|secondary acute myeloid leukemia
767100|NCT00049686|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
767101|NCT00049686|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
767102|NCT00049686|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
767103|NCT00049673|stage I multiple myeloma|stage i multiple myeloma
767104|NCT00049673|stage II multiple myeloma|stage ii multiple myeloma
767105|NCT00049673|stage III multiple myeloma|stage iii multiple myeloma
767106|NCT00049660|stage IV breast cancer|stage iv breast cancer
767107|NCT00049634|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
767108|NCT00049634|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
767109|NCT00049634|essential thrombocythemia|essential thrombocythemia
767110|NCT00049634|polycythemia vera|polycythemia vera
767111|NCT00049634|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
767112|NCT00049634|refractory anemia with excess blasts|refractory anemia with excess blasts
767113|NCT00049634|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
767114|NCT00049634|secondary acute myeloid leukemia|secondary acute myeloid leukemia
767115|NCT00049634|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
767116|NCT00049634|chronic eosinophilic leukemia|chronic eosinophilic leukemia
767117|NCT00049634|chronic neutrophilic leukemia|chronic neutrophilic leukemia
767118|NCT00049634|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
767119|NCT00049634|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
767120|NCT00049608|male breast cancer|male breast cancer
767121|NCT00049608|recurrent breast cancer|recurrent breast cancer
767122|NCT00049608|recurrent colon cancer|recurrent colon cancer
767123|NCT00049608|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
767124|NCT00049608|recurrent pancreatic cancer|recurrent pancreatic cancer
767125|NCT00049608|recurrent rectal cancer|recurrent rectal cancer
767126|NCT00049608|stage III colon cancer|stage iii colon cancer
767127|NCT00049608|stage III pancreatic cancer|stage iii pancreatic cancer
767128|NCT00049608|stage III rectal cancer|stage iii rectal cancer
767129|NCT00049608|stage IIIA breast cancer|stage iiia breast cancer
767130|NCT00049608|stage IIIB breast cancer|stage iiib breast cancer
767131|NCT00049608|stage IIIC breast cancer|stage iiic breast cancer
767132|NCT00049608|stage IV breast cancer|stage iv breast cancer
767133|NCT00049608|stage IV colon cancer|stage iv colon cancer
767134|NCT00049608|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
767135|NCT00049608|stage IV rectal cancer|stage iv rectal cancer
767136|NCT00049608|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
767137|NCT00049608|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
767138|NCT00049608|stage IV pancreatic cancer|stage iv pancreatic cancer
767139|NCT00049595|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
767140|NCT00049595|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
767141|NCT00049595|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
767142|NCT00049595|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
767143|NCT00049595|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
767144|NCT00049556|fallopian tube cancer|fallopian tube cancer
767145|NCT00049556|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
767146|NCT00049556|primary peritoneal cavity cancer|primary peritoneal cavity cancer
767147|NCT00049556|recurrent cervical cancer|recurrent cervical cancer
767148|NCT00049556|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
767149|NCT00049530|recurrent melanoma|recurrent melanoma
767150|NCT00049530|stage IV melanoma|stage iv melanoma
767151|NCT00049517|acute myeloid leukemia|acute myeloid leukemia
767152|NCT00049517|autologous transplantation|autologous transplantation
767153|NCT00049517|gemtuzumab ozogamicin|gemtuzumab ozogamicin
767154|NCT00049465|depression|depression
767155|NCT00049465|fatigue|fatigue
767156|NCT00049465|menopausal symptoms|menopausal symptoms
767157|NCT00049465|transitional care planning|transitional care planning
767158|NCT00049465|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
767159|NCT00049465|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
767160|NCT00049465|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
767161|NCT00049465|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
767162|NCT00049465|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
767163|NCT00049465|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
767164|NCT00049465|disseminated neuroblastoma|disseminated neuroblastoma
767165|NCT00049465|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
767166|NCT00049465|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
767167|NCT00049465|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
767168|NCT00049465|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
767169|NCT00049465|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
767170|NCT00049465|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
767171|NCT00049465|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
767172|NCT00049465|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
767173|NCT00049465|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
767174|NCT00049465|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
767175|NCT00049465|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
767176|NCT00049465|ovarian choriocarcinoma|ovarian choriocarcinoma
767177|NCT00049465|ovarian embryonal carcinoma|ovarian embryonal carcinoma
767179|NCT00049465|ovarian immature teratoma|ovarian immature teratoma
767180|NCT00049465|ovarian mature teratoma|ovarian mature teratoma
767181|NCT00049465|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
767182|NCT00049465|ovarian polyembryoma|ovarian polyembryoma
767183|NCT00049465|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
767184|NCT00049465|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
767185|NCT00049465|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
767186|NCT00049465|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
767187|NCT00049465|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
767188|NCT00049465|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
767189|NCT00049465|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
767190|NCT00049465|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
767191|NCT00049465|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
767192|NCT00049465|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
767193|NCT00049465|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
767194|NCT00049465|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
767195|NCT00049465|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
767196|NCT00049465|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
767197|NCT00049465|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
767198|NCT00049465|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
767199|NCT00049465|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
767200|NCT00049465|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
767201|NCT00049465|recurrent neuroblastoma|recurrent neuroblastoma
767202|NCT00049465|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
767203|NCT00049465|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
767204|NCT00049465|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
767205|NCT00049465|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
767206|NCT00049465|refractory hairy cell leukemia|refractory hairy cell leukemia
767207|NCT00049465|refractory multiple myeloma|refractory multiple myeloma
767208|NCT00049465|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
767209|NCT00049465|secondary acute myeloid leukemia|secondary acute myeloid leukemia
767210|NCT00049465|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
767211|NCT00049465|stage I multiple myeloma|stage i multiple myeloma
767212|NCT00049465|stage II multiple myeloma|stage ii multiple myeloma
767213|NCT00049465|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
767214|NCT00049465|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
767215|NCT00049465|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
767216|NCT00049465|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
767217|NCT00049465|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
767218|NCT00049465|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
767219|NCT00049465|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
767220|NCT00049465|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
767221|NCT00049465|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
767222|NCT00049465|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
767223|NCT00049465|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
767224|NCT00049465|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
767225|NCT00049465|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
767226|NCT00049465|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
767227|NCT00049465|stage IIIA breast cancer|stage iiia breast cancer
767228|NCT00049465|stage IIIB breast cancer|stage iiib breast cancer
767229|NCT00049465|stage IIIC breast cancer|stage iiic breast cancer
767230|NCT00049465|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
767231|NCT00049465|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
767232|NCT00049465|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
767233|NCT00049465|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
767234|NCT00049465|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
767235|NCT00049465|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
767236|NCT00049465|stage IV breast cancer|stage iv breast cancer
767237|NCT00049465|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
767238|NCT00049465|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
767239|NCT00049465|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
767240|NCT00049465|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
767241|NCT00049465|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
767242|NCT00049465|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
767243|NCT00049465|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
767244|NCT00049465|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
784639|NCT00026832|MRI|mri
767245|NCT00049465|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
767246|NCT00049465|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
767247|NCT00049465|testicular choriocarcinoma|testicular choriocarcinoma
767248|NCT00049465|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
767249|NCT00049465|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
767250|NCT00049465|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
767251|NCT00049465|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
767252|NCT00049465|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
767253|NCT00049465|testicular embryonal carcinoma|testicular embryonal carcinoma
767254|NCT00049465|testicular teratoma|testicular teratoma
767255|NCT00049465|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
767256|NCT00049465|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
767257|NCT00049465|testicular yolk sac tumor|testicular yolk sac tumor
767258|NCT00049465|stage III multiple myeloma|stage iii multiple myeloma
767259|NCT00049465|chronic eosinophilic leukemia|chronic eosinophilic leukemia
767260|NCT00049465|chronic neutrophilic leukemia|chronic neutrophilic leukemia
767261|NCT00049465|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
767262|NCT00049465|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
767263|NCT00049465|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
767264|NCT00049465|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
767265|NCT00049465|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
767266|NCT00049465|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
767267|NCT00049465|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
767268|NCT00049465|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
767269|NCT00049465|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
767270|NCT00049465|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
767271|NCT00049465|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
767272|NCT00049465|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
767273|NCT00049465|splenic marginal zone lymphoma|splenic marginal zone lymphoma
767274|NCT00049452|osteoporosis|osteoporosis
767275|NCT00049452|stage I breast cancer|stage i breast cancer
767276|NCT00049452|stage II breast cancer|stage ii breast cancer
767277|NCT00049439|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
767278|NCT00049439|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
767279|NCT00049439|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
767280|NCT00049439|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
767281|NCT00049439|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
767282|NCT00049439|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
767283|NCT00049413|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
767284|NCT00049413|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
767285|NCT00049413|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
767286|NCT00049413|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
767287|NCT00049413|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
767288|NCT00049413|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
767289|NCT00049413|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
767290|NCT00049413|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
767291|NCT00049413|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
767292|NCT00049413|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
767293|NCT00049413|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
767294|NCT00049413|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
767295|NCT00049400|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
767296|NCT00049400|anaplastic large cell lymphoma|anaplastic large cell lymphoma
767297|NCT00049400|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
767298|NCT00049400|intraocular lymphoma|intraocular lymphoma
767299|NCT00049400|primary central nervous system lymphoma|primary central nervous system lymphoma
767300|NCT00049400|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
767301|NCT00049400|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
767302|NCT00049400|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
767303|NCT00049400|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
767304|NCT00049400|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
767305|NCT00049400|recurrent grade 1, 2, or 3 follicular lymphoma|recurrent grade 1, 2, or 3 follicular lymphoma
767306|NCT00049400|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
767307|NCT00049400|small intestine lymphoma|small intestine lymphoma
767308|NCT00049400|stage IV adult diffuse large cell or mixed cell lymphoma|stage iv adult diffuse large cell or mixed cell lymphoma
767382|NCT00049296|primary central nervous system lymphoma|primary central nervous system lymphoma
767309|NCT00049400|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
767310|NCT00049400|stage IV adult Burkitt lymphoma or Hodgkin lymphoma|stage iv adult burkitt lymphoma or hodgkin lymphoma
767311|NCT00049400|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
767312|NCT00049400|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
767313|NCT00049400|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
767314|NCT00049400|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
767315|NCT00049400|stage IV grade 1, 2, or 3 follicular lymphoma|stage iv grade 1, 2, or 3 follicular lymphoma
767316|NCT00049400|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
767317|NCT00049400|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
767318|NCT00049400|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
767319|NCT00049400|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
767320|NCT00049400|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
767321|NCT00049400|extranodal marginal zone B-cell lymphoma of MALT|extranodal marginal zone b-cell lymphoma of malt
767322|NCT00049400|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
767323|NCT00049400|splenic marginal zone lymphoma|splenic marginal zone lymphoma
767324|NCT00049400|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
767325|NCT00049400|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
767326|NCT00049400|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
767327|NCT00049400|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
767328|NCT00049374|refractory multiple myeloma|refractory multiple myeloma
767329|NCT00049361|adult tumors metastatic to brain|adult tumors metastatic to brain
767330|NCT00049361|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
767331|NCT00049348|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
767332|NCT00049348|stage II pancreatic cancer|stage ii pancreatic cancer
767333|NCT00049348|stage III pancreatic cancer|stage iii pancreatic cancer
767334|NCT00049335|recurrent colon cancer|recurrent colon cancer
767335|NCT00049335|stage IV colon cancer|stage iv colon cancer
767336|NCT00049335|recurrent rectal cancer|recurrent rectal cancer
767337|NCT00049335|stage IV rectal cancer|stage iv rectal cancer
767338|NCT00049322|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
767339|NCT00049322|recurrent adult primary liver cancer|recurrent adult primary liver cancer
767340|NCT00049322|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
767341|NCT00049309|stage I prostate cancer|stage i prostate cancer
767342|NCT00049309|stage IIB prostate cancer|stage iib prostate cancer
767343|NCT00049309|stage IIA prostate cancer|stage iia prostate cancer
767344|NCT00049309|stage III prostate cancer|stage iii prostate cancer
767345|NCT00049296|adult anaplastic astrocytoma|adult anaplastic astrocytoma
767346|NCT00049296|male breast cancer|male breast cancer
767347|NCT00049296|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
767348|NCT00049296|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
767349|NCT00049296|adult brain stem glioma|adult brain stem glioma
767350|NCT00049296|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
767351|NCT00049296|adult choroid plexus tumor|adult choroid plexus tumor
767352|NCT00049296|adult craniopharyngioma|adult craniopharyngioma
767353|NCT00049296|adult ependymoblastoma|adult ependymoblastoma
767354|NCT00049296|adult glioblastoma|adult glioblastoma
767355|NCT00049296|adult pilocytic astrocytoma|adult pilocytic astrocytoma
767356|NCT00049296|adult anaplastic ependymoma|adult anaplastic ependymoma
767357|NCT00049296|adult medulloblastoma|adult medulloblastoma
767358|NCT00049296|adult meningioma|adult meningioma
767359|NCT00049296|adult pineoblastoma|adult pineoblastoma
767360|NCT00049296|adult pineocytoma|adult pineocytoma
767361|NCT00049296|adult subependymoma|adult subependymoma
767362|NCT00049296|adult myxopapillary ependymoma|adult myxopapillary ependymoma
767363|NCT00049296|advanced adult primary liver cancer|advanced adult primary liver cancer
767364|NCT00049296|anterior urethral cancer|anterior urethral cancer
767365|NCT00049296|carcinoma of the appendix|carcinoma of the appendix
767366|NCT00049296|chondrosarcoma|chondrosarcoma
767367|NCT00049296|classic Kaposi sarcoma|classic kaposi sarcoma
767368|NCT00049296|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
767369|NCT00049296|immunosuppressive treatment related Kaposi sarcoma|immunosuppressive treatment related kaposi sarcoma
767370|NCT00049296|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
767371|NCT00049296|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
767372|NCT00049296|disseminated neuroblastoma|disseminated neuroblastoma
767373|NCT00049296|extensive stage small cell lung cancer|extensive stage small cell lung cancer
767374|NCT00049296|gastrointestinal stromal tumor|gastrointestinal stromal tumor
767375|NCT00049296|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
767376|NCT00049296|metastatic osteosarcoma|metastatic osteosarcoma
767377|NCT00049296|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
767378|NCT00049296|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
767379|NCT00049296|adult mixed glioma|adult mixed glioma
767380|NCT00049296|ovarian sarcoma|ovarian sarcoma
767381|NCT00049296|posterior urethral cancer|posterior urethral cancer
767383|NCT00049296|pulmonary carcinoid tumor|pulmonary carcinoid tumor
767384|NCT00049296|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
767385|NCT00049296|recurrent adult brain tumor|recurrent adult brain tumor
767386|NCT00049296|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
767387|NCT00049296|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
767388|NCT00049296|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
767389|NCT00049296|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
767390|NCT00049296|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
767391|NCT00049296|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
767392|NCT00049296|recurrent adult primary liver cancer|recurrent adult primary liver cancer
767393|NCT00049296|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
767394|NCT00049296|recurrent anal cancer|recurrent anal cancer
767395|NCT00049296|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
767396|NCT00049296|recurrent bladder cancer|recurrent bladder cancer
767397|NCT00049296|recurrent breast cancer|recurrent breast cancer
767398|NCT00049296|recurrent colon cancer|recurrent colon cancer
767399|NCT00049296|recurrent esophageal cancer|recurrent esophageal cancer
767400|NCT00049296|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
767401|NCT00049296|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
767402|NCT00049296|recurrent gallbladder cancer|recurrent gallbladder cancer
767403|NCT00049296|recurrent gastric cancer|recurrent gastric cancer
767404|NCT00049296|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
767405|NCT00049296|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
767406|NCT00049296|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
767407|NCT00049296|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
767408|NCT00049296|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
767409|NCT00049296|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
767410|NCT00049296|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
767411|NCT00049296|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
767412|NCT00049296|recurrent melanoma|recurrent melanoma
767413|NCT00049296|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
767414|NCT00049296|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
767415|NCT00049296|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
767416|NCT00049296|recurrent neuroblastoma|recurrent neuroblastoma
767417|NCT00049296|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
767418|NCT00049296|recurrent osteosarcoma|recurrent osteosarcoma
767419|NCT00049296|recurrent pancreatic cancer|recurrent pancreatic cancer
767420|NCT00049296|recurrent rectal cancer|recurrent rectal cancer
767421|NCT00049296|recurrent renal cell cancer|recurrent renal cell cancer
767422|NCT00049296|recurrent small cell lung cancer|recurrent small cell lung cancer
767423|NCT00049296|recurrent small intestine cancer|recurrent small intestine cancer
767424|NCT00049296|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
767425|NCT00049296|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
767426|NCT00049296|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
767427|NCT00049296|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
767428|NCT00049296|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
767429|NCT00049296|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
767430|NCT00049296|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
767431|NCT00049296|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
767432|NCT00049296|recurrent urethral cancer|recurrent urethral cancer
767433|NCT00049296|recurrent uterine sarcoma|recurrent uterine sarcoma
767434|NCT00049296|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
767435|NCT00049296|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
767436|NCT00049296|refractory multiple myeloma|refractory multiple myeloma
767437|NCT00049296|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
767438|NCT00049296|small intestine adenocarcinoma|small intestine adenocarcinoma
767439|NCT00049296|small intestine leiomyosarcoma|small intestine leiomyosarcoma
767440|NCT00049296|small intestine lymphoma|small intestine lymphoma
767441|NCT00049296|stage II esophageal cancer|stage ii esophageal cancer
767442|NCT00049296|stage II pancreatic cancer|stage ii pancreatic cancer
767443|NCT00049296|stage III esophageal cancer|stage iii esophageal cancer
767444|NCT00049296|stage III multiple myeloma|stage iii multiple myeloma
767445|NCT00049296|stage III pancreatic cancer|stage iii pancreatic cancer
767446|NCT00049296|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
767447|NCT00049296|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
767448|NCT00049296|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
767449|NCT00049296|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
767450|NCT00049296|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
767451|NCT00049296|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
767452|NCT00049296|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
767453|NCT00049296|stage IV anal cancer|stage iv anal cancer
767454|NCT00049296|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
767455|NCT00049296|stage IV bladder cancer|stage iv bladder cancer
767456|NCT00049296|stage IV breast cancer|stage iv breast cancer
767457|NCT00049296|stage IV colon cancer|stage iv colon cancer
767458|NCT00049296|stage IV esophageal cancer|stage iv esophageal cancer
767459|NCT00049296|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
767460|NCT00049296|stage IV gastric cancer|stage iv gastric cancer
767461|NCT00049296|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
767462|NCT00049296|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
767463|NCT00049296|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
767464|NCT00049296|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
767465|NCT00049296|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
767466|NCT00049296|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
767467|NCT00049296|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
767468|NCT00049296|stage IV melanoma|stage iv melanoma
767469|NCT00049296|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
767470|NCT00049296|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
767471|NCT00049296|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
767472|NCT00049296|stage IV rectal cancer|stage iv rectal cancer
767473|NCT00049296|stage IV renal cell cancer|stage iv renal cell cancer
767474|NCT00049296|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
767475|NCT00049296|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
767476|NCT00049296|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
767477|NCT00049296|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
767478|NCT00049296|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
767479|NCT00049296|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
767480|NCT00049296|stage IV uterine sarcoma|stage iv uterine sarcoma
767481|NCT00049296|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
767482|NCT00049296|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
767483|NCT00049296|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
767484|NCT00049296|unresectable gallbladder cancer|unresectable gallbladder cancer
767485|NCT00049296|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
767486|NCT00049296|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
767487|NCT00049296|recurrent salivary gland cancer|recurrent salivary gland cancer
767488|NCT00049296|stage IV salivary gland cancer|stage iv salivary gland cancer
767489|NCT00049296|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
767490|NCT00049296|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
767491|NCT00049296|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
767492|NCT00049296|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
767493|NCT00049296|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
767494|NCT00049296|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
767495|NCT00049296|splenic marginal zone lymphoma|splenic marginal zone lymphoma
767496|NCT00049296|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
767497|NCT00049296|adult grade III meningioma|adult grade iii meningioma
767498|NCT00049296|adult oligodendroglioma|adult oligodendroglioma
767499|NCT00049296|adult giant cell glioblastoma|adult giant cell glioblastoma
767500|NCT00049296|adult gliosarcoma|adult gliosarcoma
767501|NCT00049296|stage IV pancreatic cancer|stage iv pancreatic cancer
767502|NCT00049257|adenocarcinoma of the prostate|adenocarcinoma of the prostate
767503|NCT00049257|recurrent prostate cancer|recurrent prostate cancer
767504|NCT00049257|stage IV prostate cancer|stage iv prostate cancer
767505|NCT00049244|recurrent breast cancer|recurrent breast cancer
767506|NCT00049244|stage IV breast cancer|stage iv breast cancer
767507|NCT00049231|cervical adenocarcinoma|cervical adenocarcinoma
767508|NCT00049231|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
767509|NCT00049231|cervical squamous cell carcinoma|cervical squamous cell carcinoma
767510|NCT00049231|stage IIB cervical cancer|stage iib cervical cancer
767511|NCT00049231|stage III cervical cancer|stage iii cervical cancer
767512|NCT00049231|stage IVA cervical cancer|stage iva cervical cancer
767513|NCT00049218|extensive stage small cell lung cancer|extensive stage small cell lung cancer
767514|NCT00049179|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
767515|NCT00049179|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
767516|NCT00049179|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
767517|NCT00049179|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
767518|NCT00049179|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
767519|NCT00049179|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
767520|NCT00049179|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
767521|NCT00049179|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
767522|NCT00049179|secondary acute myeloid leukemia|secondary acute myeloid leukemia
767523|NCT00049179|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
767524|NCT00049179|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
767525|NCT00049179|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
767526|NCT00049179|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
767527|NCT00049140|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
767528|NCT00049140|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
767529|NCT00049140|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
767530|NCT00049140|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
767531|NCT00049140|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
767532|NCT00049140|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
767533|NCT00049140|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
767534|NCT00049140|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
767535|NCT00049140|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
767536|NCT00049140|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
767537|NCT00049140|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
767538|NCT00049140|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
767539|NCT00049140|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
767540|NCT00049140|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
767541|NCT00049140|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
767542|NCT00049140|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
767543|NCT00049140|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
767544|NCT00049140|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
767545|NCT00049140|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
767546|NCT00049140|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
767547|NCT00049140|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
767548|NCT00049140|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
767549|NCT00049140|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
767550|NCT00049140|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
767551|NCT00049140|stage I salivary gland cancer|stage i salivary gland cancer
767552|NCT00049140|stage II salivary gland cancer|stage ii salivary gland cancer
767553|NCT00049140|stage III salivary gland cancer|stage iii salivary gland cancer
767554|NCT00049140|stage IV salivary gland cancer|stage iv salivary gland cancer
767555|NCT00049140|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
767556|NCT00049101|recurrent colon cancer|recurrent colon cancer
767557|NCT00049101|stage IV colon cancer|stage iv colon cancer
767558|NCT00049101|recurrent rectal cancer|recurrent rectal cancer
767559|NCT00049101|stage IV rectal cancer|stage iv rectal cancer
767560|NCT00049075|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
767561|NCT00049075|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
767562|NCT00049075|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
767563|NCT00049075|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
767564|NCT00049075|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
767565|NCT00049062|recurrent breast cancer|recurrent breast cancer
767566|NCT00049062|stage IIIB breast cancer|stage iiib breast cancer
767567|NCT00049062|stage IIIC breast cancer|stage iiic breast cancer
767568|NCT00049062|stage IV breast cancer|stage iv breast cancer
767569|NCT00049023|childhood grade III meningioma|childhood grade iii meningioma
767570|NCT00049023|disseminated neuroblastoma|disseminated neuroblastoma
767571|NCT00049023|localized unresectable neuroblastoma|localized unresectable neuroblastoma
767572|NCT00049023|metastatic pheochromocytoma|metastatic pheochromocytoma
767573|NCT00049023|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
767574|NCT00049023|recurrent childhood brain tumor|recurrent childhood brain tumor
767575|NCT00049023|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
767576|NCT00049023|recurrent neuroblastoma|recurrent neuroblastoma
767577|NCT00049023|recurrent pheochromocytoma|recurrent pheochromocytoma
767578|NCT00049023|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
767579|NCT00049023|regional neuroblastoma|regional neuroblastoma
767580|NCT00049023|regional pheochromocytoma|regional pheochromocytoma
767581|NCT00049023|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
767582|NCT00049023|recurrent childhood ependymoma|recurrent childhood ependymoma
767583|NCT00049023|childhood infratentorial ependymoma|childhood infratentorial ependymoma
767584|NCT00049023|childhood supratentorial ependymoma|childhood supratentorial ependymoma
767585|NCT00049023|recurrent islet cell carcinoma|recurrent islet cell carcinoma
767586|NCT00049023|gastrinoma|gastrinoma
767587|NCT00049023|insulinoma|insulinoma
767588|NCT00049023|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
767589|NCT00049023|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
767590|NCT00049023|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
767591|NCT00049010|stage I melanoma|stage i melanoma
767592|NCT00049010|stage II melanoma|stage ii melanoma
767593|NCT00048997|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
767594|NCT00048997|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
767595|NCT00048971|adenocarcinoma of the colon|adenocarcinoma of the colon
767596|NCT00048971|stage III colon cancer|stage iii colon cancer
767597|NCT00048971|diarrhea|diarrhea
767598|NCT00048971|neutropenia|neutropenia
767599|NCT00047385|small cell lung cancer|small cell lung cancer
767600|NCT00047385|non-small cell lung cancer|non-small cell lung cancer
767601|NCT00047320|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
767602|NCT00047320|childhood teratoma|childhood teratoma
767603|NCT00047320|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
767604|NCT00047320|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
767605|NCT00047320|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
767606|NCT00047320|childhood central nervous system germinoma|childhood central nervous system germinoma
767607|NCT00047320|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
767608|NCT00047320|childhood central nervous system teratoma|childhood central nervous system teratoma
767609|NCT00047320|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
767610|NCT00047320|recurrent childhood central nervous system embryonal tumor|recurrent childhood central nervous system embryonal tumor
767611|NCT00047294|adult mixed glioma|adult mixed glioma
767612|NCT00047294|adult glioblastoma|adult glioblastoma
767613|NCT00047294|adult giant cell glioblastoma|adult giant cell glioblastoma
767614|NCT00047294|adult gliosarcoma|adult gliosarcoma
767615|NCT00047281|adult anaplastic astrocytoma|adult anaplastic astrocytoma
767616|NCT00047281|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
767617|NCT00047281|adult glioblastoma|adult glioblastoma
767618|NCT00047281|adult mixed glioma|adult mixed glioma
767619|NCT00047281|recurrent adult brain tumor|recurrent adult brain tumor
767620|NCT00047281|adult giant cell glioblastoma|adult giant cell glioblastoma
767621|NCT00047281|adult gliosarcoma|adult gliosarcoma
767622|NCT00047268|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
767910|NCT00045474|adult glioblastoma|adult glioblastoma
767623|NCT00047268|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
767624|NCT00047268|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
767625|NCT00047268|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
767626|NCT00047268|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
767627|NCT00047255|stage IIIB breast cancer|stage iiib breast cancer
767628|NCT00047255|stage IIIC breast cancer|stage iiic breast cancer
767629|NCT00047255|stage IV breast cancer|stage iv breast cancer
767630|NCT00047255|recurrent breast cancer|recurrent breast cancer
767631|NCT00047242|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
767632|NCT00047229|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
767633|NCT00047229|advanced adult primary liver cancer|advanced adult primary liver cancer
767634|NCT00047229|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
767635|NCT00047229|recurrent adult primary liver cancer|recurrent adult primary liver cancer
767636|NCT00047216|recurrent bladder cancer|recurrent bladder cancer
767637|NCT00047216|stage 0 bladder cancer|stage 0 bladder cancer
767638|NCT00047216|stage I bladder cancer|stage i bladder cancer
767639|NCT00047216|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
767640|NCT00047177|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
767641|NCT00047177|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
767642|NCT00047177|recurrent childhood ependymoma|recurrent childhood ependymoma
767643|NCT00047177|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
767644|NCT00047164|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
767843|NCT00046865|stage IIIA breast cancer|stage iiia breast cancer
767645|NCT00047164|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
767646|NCT00047164|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
767647|NCT00047164|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
767648|NCT00047164|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
767649|NCT00047164|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
767650|NCT00047164|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
767651|NCT00047164|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
767652|NCT00047164|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
767653|NCT00047164|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
767654|NCT00047164|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
767655|NCT00047164|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
767656|NCT00047164|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
767657|NCT00047164|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
767658|NCT00047164|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
767659|NCT00047164|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
767660|NCT00047164|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
767661|NCT00047164|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
767662|NCT00047164|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
767663|NCT00047164|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
767664|NCT00047164|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
767665|NCT00047164|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
767666|NCT00047164|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
767667|NCT00047164|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
767668|NCT00047164|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
767669|NCT00047164|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
767670|NCT00047164|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
767671|NCT00047164|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
767672|NCT00047164|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
767673|NCT00047164|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
767674|NCT00047164|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
767675|NCT00047164|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
767676|NCT00047164|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
767677|NCT00047164|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
767678|NCT00047164|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
767679|NCT00047164|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
767680|NCT00047164|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
767681|NCT00047164|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
767682|NCT00047164|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
767683|NCT00047164|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
767684|NCT00047164|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
767685|NCT00047164|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
767686|NCT00047164|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
767687|NCT00047164|stage I mantle cell lymphoma|stage i mantle cell lymphoma
767688|NCT00047164|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
767689|NCT00047164|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
767690|NCT00047164|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
767691|NCT00047164|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
767692|NCT00047164|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
767693|NCT00047164|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
767694|NCT00047164|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
767695|NCT00047164|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
767696|NCT00047164|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
767697|NCT00047164|stage II adult diffuse small cleaved cell lymphoma|stage ii adult diffuse small cleaved cell lymphoma
767698|NCT00047164|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
767699|NCT00047164|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
767700|NCT00047164|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
767701|NCT00047164|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
767702|NCT00047164|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
767703|NCT00047164|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
767704|NCT00047164|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
767705|NCT00047164|splenic marginal zone lymphoma|splenic marginal zone lymphoma
767706|NCT00047164|stage I marginal zone lymphoma|stage i marginal zone lymphoma
767707|NCT00047164|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
767708|NCT00047164|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
767709|NCT00047164|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
767710|NCT00047164|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
767711|NCT00047164|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
767712|NCT00047164|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
767713|NCT00047164|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
767714|NCT00047164|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
767715|NCT00047164|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
767716|NCT00047164|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
767717|NCT00047164|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
767718|NCT00047164|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
767719|NCT00047164|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
767720|NCT00047164|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
767721|NCT00047164|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
767722|NCT00047164|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
767723|NCT00047164|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
767724|NCT00047164|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
767725|NCT00047138|blastema predominant Wilms tumor|blastema predominant wilms tumor
767726|NCT00047138|epithelial predominant Wilms tumor|epithelial predominant wilms tumor
767727|NCT00047138|mixed cell type Wilms tumor|mixed cell type wilms tumor
767728|NCT00047138|stage I Wilms tumor|stage i wilms tumor
767729|NCT00047138|stage II Wilms tumor|stage ii wilms tumor
767730|NCT00047138|stage III Wilms tumor|stage iii wilms tumor
767731|NCT00047138|stage IV Wilms tumor|stage iv wilms tumor
767732|NCT00047138|stage V Wilms tumor|stage v wilms tumor
767733|NCT00047138|stromal predominant Wilms tumor|stromal predominant wilms tumor
767734|NCT00047125|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
767735|NCT00047125|squamous cell carcinoma of unknown primary|squamous cell carcinoma of unknown primary
767736|NCT00047112|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
767737|NCT00047112|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
767738|NCT00047112|stage I esophageal cancer|stage i esophageal cancer
767739|NCT00047112|stage II esophageal cancer|stage ii esophageal cancer
767740|NCT00047099|stage II breast cancer|stage ii breast cancer
767741|NCT00047099|stage IIIA breast cancer|stage iiia breast cancer
767742|NCT00047099|stage IIIB breast cancer|stage iiib breast cancer
767743|NCT00047073|recurrent adult brain tumor|recurrent adult brain tumor
767744|NCT00047073|adult glioblastoma|adult glioblastoma
767745|NCT00047073|adult giant cell glioblastoma|adult giant cell glioblastoma
767746|NCT00047073|adult gliosarcoma|adult gliosarcoma
767747|NCT00047060|Cutaneous T Cell Lymphoma|cutaneous t cell lymphoma
767748|NCT00047060|Allogeneic PBSCT|allogeneic pbsct
767749|NCT00047060|Low Intensity Regimen|low intensity regimen
767750|NCT00047060|Mycosis Fungoides|mycosis fungoides
767751|NCT00047060|Sezary Syndrome|sezary syndrome
767753|NCT00047021|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
767754|NCT00047021|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
767755|NCT00047021|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
767756|NCT00047021|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
767757|NCT00047021|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
767758|NCT00047021|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
767759|NCT00047021|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
767760|NCT00047021|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
767761|NCT00047021|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
767762|NCT00047021|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
767763|NCT00047021|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
767764|NCT00047021|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
767765|NCT00047021|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
767766|NCT00047021|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
767767|NCT00047021|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
767768|NCT00047021|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
767769|NCT00047021|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
767770|NCT00047021|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
767771|NCT00047021|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
767772|NCT00047021|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
767773|NCT00047021|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
767774|NCT00047021|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
767775|NCT00047021|secondary acute myeloid leukemia|secondary acute myeloid leukemia
767776|NCT00047021|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
767777|NCT00047021|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
767778|NCT00047021|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
767779|NCT00047021|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
767780|NCT00047021|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
767781|NCT00047021|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
767782|NCT00047021|splenic marginal zone lymphoma|splenic marginal zone lymphoma
767783|NCT00047021|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
767784|NCT00047021|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
767785|NCT00047021|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
767786|NCT00047021|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
767787|NCT00047021|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
767788|NCT00047008|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
767789|NCT00047008|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
767790|NCT00047008|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
767791|NCT00047008|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
767792|NCT00047008|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
767793|NCT00047008|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
767794|NCT00047008|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
767795|NCT00047008|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
767796|NCT00046995|adenocarcinoma of the colon|adenocarcinoma of the colon
767797|NCT00046995|stage IIB colon cancer|stage iib colon cancer
767798|NCT00046995|stage IIIA colon cancer|stage iiia colon cancer
767799|NCT00046995|stage IIIB colon cancer|stage iiib colon cancer
767800|NCT00046995|stage IIIC colon cancer|stage iiic colon cancer
767801|NCT00046969|anemia|anemia
767802|NCT00046969|stage IIB cervical cancer|stage iib cervical cancer
767803|NCT00046969|stage III cervical cancer|stage iii cervical cancer
767804|NCT00046969|stage IVA cervical cancer|stage iva cervical cancer
767805|NCT00046969|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
767806|NCT00046969|cervical squamous cell carcinoma|cervical squamous cell carcinoma
767807|NCT00046969|cervical adenocarcinoma|cervical adenocarcinoma
767808|NCT00046943|adenocarcinoma of the prostate|adenocarcinoma of the prostate
767809|NCT00046943|recurrent prostate cancer|recurrent prostate cancer
767810|NCT00046943|stage IIB prostate cancer|stage iib prostate cancer
767811|NCT00046943|stage IIA prostate cancer|stage iia prostate cancer
767812|NCT00046943|stage III prostate cancer|stage iii prostate cancer
767813|NCT00046943|stage IV prostate cancer|stage iv prostate cancer
767814|NCT00046930|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
767815|NCT00046930|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
767816|NCT00046930|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
767817|NCT00046930|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
767818|NCT00046930|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
767819|NCT00046930|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
767820|NCT00046930|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
767821|NCT00046930|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
767822|NCT00046930|refractory anemia with excess blasts|refractory anemia with excess blasts
767823|NCT00046930|secondary acute myeloid leukemia|secondary acute myeloid leukemia
767824|NCT00046930|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
767825|NCT00046930|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
767826|NCT00046930|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
767827|NCT00046930|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
767828|NCT00046930|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
767829|NCT00046930|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
767830|NCT00046930|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
767831|NCT00046904|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
767832|NCT00046904|anorexia|anorexia
767833|NCT00046904|cachexia|cachexia
767834|NCT00046891|neurotoxicity|neurotoxicity
767835|NCT00046891|stage I breast cancer|stage i breast cancer
767836|NCT00046891|stage II breast cancer|stage ii breast cancer
767837|NCT00046891|stage IIIA breast cancer|stage iiia breast cancer
767838|NCT00046891|stage IIIB breast cancer|stage iiib breast cancer
767839|NCT00046891|stage IIIC breast cancer|stage iiic breast cancer
767840|NCT00046865|nausea and vomiting|nausea and vomiting
767841|NCT00046865|stage I breast cancer|stage i breast cancer
767842|NCT00046865|stage II breast cancer|stage ii breast cancer
767844|NCT00046865|stage IIIB breast cancer|stage iiib breast cancer
767845|NCT00046865|stage IIIC breast cancer|stage iiic breast cancer
767846|NCT00046865|stage IV breast cancer|stage iv breast cancer
767847|NCT00046852|infection|infection
767848|NCT00046852|refractory multiple myeloma|refractory multiple myeloma
767849|NCT00046852|stage I multiple myeloma|stage i multiple myeloma
767850|NCT00046852|stage II multiple myeloma|stage ii multiple myeloma
767851|NCT00046852|stage III multiple myeloma|stage iii multiple myeloma
767852|NCT00046839|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
767853|NCT00046839|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
767854|NCT00046839|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
767855|NCT00046826|adenocarcinoma of the prostate|adenocarcinoma of the prostate
767856|NCT00046826|stage IV prostate cancer|stage iv prostate cancer
767857|NCT00046826|recurrent prostate cancer|recurrent prostate cancer
767858|NCT00045747|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
767859|NCT00045747|recurrent pancreatic cancer|recurrent pancreatic cancer
767860|NCT00045747|stage IV pancreatic cancer|stage iv pancreatic cancer
767861|NCT00045721|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
767862|NCT00045695|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
767863|NCT00045669|recurrent salivary gland cancer|recurrent salivary gland cancer
767864|NCT00045669|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
767865|NCT00045669|stage III salivary gland cancer|stage iii salivary gland cancer
767866|NCT00045669|stage IV salivary gland cancer|stage iv salivary gland cancer
767867|NCT00045630|anterior urethral cancer|anterior urethral cancer
767868|NCT00045630|localized transitional cell cancer of the renal pelvis and ureter|localized transitional cell cancer of the renal pelvis and ureter
767869|NCT00045630|posterior urethral cancer|posterior urethral cancer
767870|NCT00045630|stage II bladder cancer|stage ii bladder cancer
767871|NCT00045630|stage III bladder cancer|stage iii bladder cancer
767872|NCT00045630|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
767873|NCT00045630|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
767874|NCT00045630|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
767875|NCT00045617|limited stage small cell lung cancer|limited stage small cell lung cancer
767876|NCT00045604|extensive stage small cell lung cancer|extensive stage small cell lung cancer
767877|NCT00045591|recurrent breast cancer|recurrent breast cancer
767878|NCT00045591|stage IV breast cancer|stage iv breast cancer
767879|NCT00045539|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
767880|NCT00045513|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
767881|NCT00045513|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
767882|NCT00045500|anaplastic large cell lymphoma|anaplastic large cell lymphoma
767883|NCT00045500|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
767884|NCT00045500|intraocular lymphoma|intraocular lymphoma
767885|NCT00045500|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
767886|NCT00045500|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
767887|NCT00045500|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
767888|NCT00045500|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
767889|NCT00045500|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
767890|NCT00045500|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
767891|NCT00045500|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
767892|NCT00045500|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
767893|NCT00045500|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
767894|NCT00045500|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
767895|NCT00045500|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
767896|NCT00045500|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
767897|NCT00045500|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
767898|NCT00045500|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
767899|NCT00045500|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
767900|NCT00045500|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
767901|NCT00045500|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
767902|NCT00045500|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
767903|NCT00045500|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
767904|NCT00045500|splenic marginal zone lymphoma|splenic marginal zone lymphoma
767905|NCT00045487|recurrent renal cell cancer|recurrent renal cell cancer
767906|NCT00045487|stage III renal cell cancer|stage iii renal cell cancer
767907|NCT00045487|stage IV renal cell cancer|stage iv renal cell cancer
767908|NCT00045474|adult anaplastic astrocytoma|adult anaplastic astrocytoma
767909|NCT00045474|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
767911|NCT00045474|recurrent adult brain tumor|recurrent adult brain tumor
767912|NCT00045474|adult giant cell glioblastoma|adult giant cell glioblastoma
767913|NCT00045474|adult gliosarcoma|adult gliosarcoma
768108|NCT00045097|stage IIIC breast cancer|stage iiic breast cancer
767914|NCT00045461|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
767915|NCT00045461|recurrent fallopian tube cancer|recurrent fallopian tube cancer
767916|NCT00045461|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
767917|NCT00045461|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
767918|NCT00045461|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
767919|NCT00045461|stage IV fallopian tube cancer|stage iv fallopian tube cancer
767920|NCT00045461|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
767921|NCT00045461|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
767922|NCT00045461|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
767923|NCT00045461|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
767924|NCT00045461|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
767925|NCT00045461|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
767926|NCT00045461|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
767927|NCT00045461|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
767928|NCT00045461|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
767929|NCT00045448|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
767930|NCT00045422|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
767931|NCT00045422|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
767932|NCT00045422|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
767933|NCT00045370|recurrent renal cell cancer|recurrent renal cell cancer
767934|NCT00045370|stage III renal cell cancer|stage iii renal cell cancer
767935|NCT00045370|stage IV renal cell cancer|stage iv renal cell cancer
767936|NCT00045331|recurrent prostate cancer|recurrent prostate cancer
767937|NCT00045331|stage I prostate cancer|stage i prostate cancer
767938|NCT00045331|stage IIB prostate cancer|stage iib prostate cancer
767939|NCT00045331|stage IIA prostate cancer|stage iia prostate cancer
767940|NCT00045331|stage III prostate cancer|stage iii prostate cancer
767941|NCT00045331|stage IV prostate cancer|stage iv prostate cancer
767942|NCT00045318|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
767943|NCT00045305|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
767944|NCT00045305|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
767945|NCT00045305|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
767946|NCT00045305|refractory anemia|refractory anemia
767947|NCT00045305|refractory anemia with excess blasts|refractory anemia with excess blasts
767948|NCT00045305|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
767949|NCT00045305|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
767950|NCT00045305|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
767951|NCT00045305|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
767952|NCT00045292|infection|infection
767953|NCT00045292|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
767954|NCT00045292|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
767955|NCT00045292|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
767956|NCT00045292|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
767957|NCT00045292|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
767958|NCT00045292|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
767959|NCT00045292|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
767960|NCT00045292|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
767961|NCT00045292|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
767962|NCT00045292|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
767963|NCT00045292|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
767964|NCT00045292|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
767965|NCT00045292|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
767966|NCT00045292|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
767967|NCT00045292|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
767968|NCT00045292|secondary acute myeloid leukemia|secondary acute myeloid leukemia
767969|NCT00045292|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
767970|NCT00045292|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
767971|NCT00045292|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
767972|NCT00045292|chronic eosinophilic leukemia|chronic eosinophilic leukemia
767973|NCT00045292|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
767974|NCT00045292|chronic neutrophilic leukemia|chronic neutrophilic leukemia
767975|NCT00045292|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
767976|NCT00045292|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
767977|NCT00045292|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
767978|NCT00045292|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
768109|NCT00045097|stage IV breast cancer|stage iv breast cancer
767979|NCT00045292|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
767980|NCT00045292|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
767981|NCT00045292|disseminated neuroblastoma|disseminated neuroblastoma
767982|NCT00045292|recurrent neuroblastoma|recurrent neuroblastoma
767983|NCT00045292|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
767984|NCT00045292|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
767985|NCT00045292|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
767986|NCT00045292|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
767987|NCT00045292|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
767988|NCT00045292|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
767989|NCT00045292|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
767990|NCT00045292|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
767991|NCT00045292|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
767992|NCT00045292|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
767993|NCT00045292|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
767994|NCT00045292|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
767995|NCT00045292|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
767996|NCT00045292|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
767997|NCT00045292|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
767998|NCT00045292|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
767999|NCT00045292|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
768000|NCT00045292|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
768001|NCT00045292|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
768002|NCT00045292|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
770070|NCT00025441|childhood angiosarcoma|childhood angiosarcoma
768003|NCT00045292|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
768004|NCT00045292|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
768005|NCT00045292|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
768006|NCT00045292|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
768007|NCT00045292|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
768008|NCT00045292|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
768009|NCT00045292|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
768010|NCT00045292|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
768011|NCT00045292|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
768012|NCT00045292|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
768013|NCT00045292|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
768014|NCT00045292|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
768015|NCT00045292|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
768016|NCT00045292|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
768017|NCT00045292|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
768018|NCT00045292|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
768019|NCT00045292|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
768020|NCT00045292|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
768021|NCT00045292|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
768022|NCT00045292|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
768023|NCT00045292|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
768024|NCT00045292|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
768025|NCT00045292|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
768026|NCT00045292|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
768027|NCT00045292|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
768028|NCT00045292|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
768029|NCT00045292|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
768030|NCT00045292|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
768031|NCT00045292|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
768032|NCT00045292|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
768033|NCT00045292|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
768034|NCT00045292|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
768035|NCT00045292|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
768036|NCT00045292|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
768037|NCT00045292|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
768038|NCT00045292|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
768039|NCT00045292|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
768040|NCT00045292|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
768041|NCT00045292|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
768042|NCT00045292|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
768043|NCT00045292|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
768044|NCT00045292|refractory hairy cell leukemia|refractory hairy cell leukemia
768045|NCT00045292|refractory multiple myeloma|refractory multiple myeloma
768046|NCT00045292|stage I multiple myeloma|stage i multiple myeloma
768047|NCT00045292|stage II multiple myeloma|stage ii multiple myeloma
768048|NCT00045292|stage III multiple myeloma|stage iii multiple myeloma
768049|NCT00045292|stage IIIA breast cancer|stage iiia breast cancer
768050|NCT00045292|stage IIIB breast cancer|stage iiib breast cancer
768051|NCT00045292|stage IIIC breast cancer|stage iiic breast cancer
768052|NCT00045292|stage IV breast cancer|stage iv breast cancer
768053|NCT00045292|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
768054|NCT00045292|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
768055|NCT00045292|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
768056|NCT00045292|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
768057|NCT00045292|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
768058|NCT00045292|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
768059|NCT00045292|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
768060|NCT00045292|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
768061|NCT00045292|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
768062|NCT00045292|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
768063|NCT00045292|splenic marginal zone lymphoma|splenic marginal zone lymphoma
768064|NCT00045292|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
768065|NCT00045279|stage IV renal cell cancer|stage iv renal cell cancer
768066|NCT00045266|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
768067|NCT00045266|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
768068|NCT00045266|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
768069|NCT00045266|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
768070|NCT00045266|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
768071|NCT00045266|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
768072|NCT00045266|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
768073|NCT00045266|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
768074|NCT00045266|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
768075|NCT00045266|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
768076|NCT00045266|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
768077|NCT00045266|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
768078|NCT00045266|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
768079|NCT00045266|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
768080|NCT00045266|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
768081|NCT00045266|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
768082|NCT00045266|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
768083|NCT00045266|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
768084|NCT00045266|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
768085|NCT00045266|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
768086|NCT00045266|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
768087|NCT00045266|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
768088|NCT00045266|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
768089|NCT00045266|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
768090|NCT00045266|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
768091|NCT00045266|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
768092|NCT00045266|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
768093|NCT00045266|splenic marginal zone lymphoma|splenic marginal zone lymphoma
768094|NCT00045227|adenocarcinoma of the prostate|adenocarcinoma of the prostate
768095|NCT00045227|recurrent prostate cancer|recurrent prostate cancer
768096|NCT00045227|stage IV prostate cancer|stage iv prostate cancer
768097|NCT00045175|primary peritoneal cavity cancer|primary peritoneal cavity cancer
768098|NCT00045175|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
768099|NCT00045175|fallopian tube cancer|fallopian tube cancer
768100|NCT00045162|extensive stage small cell lung cancer|extensive stage small cell lung cancer
768101|NCT00045136|refractory multiple myeloma|refractory multiple myeloma
768102|NCT00045136|stage I multiple myeloma|stage i multiple myeloma
768103|NCT00045136|stage II multiple myeloma|stage ii multiple myeloma
768104|NCT00045136|stage III multiple myeloma|stage iii multiple myeloma
768105|NCT00045097|male breast cancer|male breast cancer
768106|NCT00045097|recurrent breast cancer|recurrent breast cancer
768107|NCT00045097|stage IIIB breast cancer|stage iiib breast cancer
784748|NCT00026598|HV|hv
768110|NCT00045045|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
768111|NCT00045045|testicular choriocarcinoma|testicular choriocarcinoma
768112|NCT00045045|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
768113|NCT00045045|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
768114|NCT00045045|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
768115|NCT00045045|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
768116|NCT00045045|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
768117|NCT00045045|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
768118|NCT00045045|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
768119|NCT00045045|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
768120|NCT00045045|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
768121|NCT00045045|testicular embryonal carcinoma|testicular embryonal carcinoma
768122|NCT00045045|testicular teratoma|testicular teratoma
768123|NCT00045045|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
768124|NCT00045045|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
768125|NCT00045045|testicular yolk sac tumor|testicular yolk sac tumor
768126|NCT00045019|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
768127|NCT00045006|acute undifferentiated leukemia|acute undifferentiated leukemia
768128|NCT00045006|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
768129|NCT00045006|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
768130|NCT00045006|ovarian sarcoma|ovarian sarcoma
768131|NCT00045006|ovarian stromal cancer|ovarian stromal cancer
768132|NCT00045006|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
768133|NCT00045006|prolymphocytic leukemia|prolymphocytic leukemia
768134|NCT00045006|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
768135|NCT00045006|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
768136|NCT00045006|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
768137|NCT00045006|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
768138|NCT00045006|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
768139|NCT00045006|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
768140|NCT00045006|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
768141|NCT00045006|recurrent bladder cancer|recurrent bladder cancer
768142|NCT00045006|recurrent breast cancer|recurrent breast cancer
768143|NCT00045006|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
768144|NCT00045006|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
768145|NCT00045006|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
768146|NCT00045006|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
768147|NCT00045006|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
768148|NCT00045006|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
768149|NCT00045006|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
768150|NCT00045006|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
768151|NCT00045006|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
768152|NCT00045006|recurrent prostate cancer|recurrent prostate cancer
768153|NCT00045006|recurrent renal cell cancer|recurrent renal cell cancer
768154|NCT00045006|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
768155|NCT00045006|refractory hairy cell leukemia|refractory hairy cell leukemia
768156|NCT00045006|refractory multiple myeloma|refractory multiple myeloma
768157|NCT00045006|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
768158|NCT00045006|secondary acute myeloid leukemia|secondary acute myeloid leukemia
768159|NCT00045006|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
768160|NCT00045006|stage III multiple myeloma|stage iii multiple myeloma
768161|NCT00045006|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
768162|NCT00045006|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
768163|NCT00045006|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
768164|NCT00045006|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
768165|NCT00045006|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
768166|NCT00045006|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
768167|NCT00045006|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
768168|NCT00045006|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
768169|NCT00045006|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
768170|NCT00045006|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
768171|NCT00045006|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
768172|NCT00045006|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
768173|NCT00045006|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
768174|NCT00045006|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
785467|NCT00013520|Stavudine|stavudine
768175|NCT00045006|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
768176|NCT00045006|stage III bladder cancer|stage iii bladder cancer
768177|NCT00045006|stage IV bladder cancer|stage iv bladder cancer
768178|NCT00045006|stage IIIA breast cancer|stage iiia breast cancer
768179|NCT00045006|stage IIIB breast cancer|stage iiib breast cancer
768180|NCT00045006|stage IIIC breast cancer|stage iiic breast cancer
768181|NCT00045006|stage IV breast cancer|stage iv breast cancer
768182|NCT00045006|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
768183|NCT00045006|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
768184|NCT00045006|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
768185|NCT00045006|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
768186|NCT00045006|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
768187|NCT00045006|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
768188|NCT00045006|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
768189|NCT00045006|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
768190|NCT00045006|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
768191|NCT00045006|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
768192|NCT00045006|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
768193|NCT00045006|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
768194|NCT00045006|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
768195|NCT00045006|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
768196|NCT00045006|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
768197|NCT00045006|stage III prostate cancer|stage iii prostate cancer
768198|NCT00045006|stage IV prostate cancer|stage iv prostate cancer
768199|NCT00045006|stage III renal cell cancer|stage iii renal cell cancer
768200|NCT00045006|stage IV renal cell cancer|stage iv renal cell cancer
768201|NCT00045006|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
768202|NCT00045006|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
768203|NCT00045006|recurrent salivary gland cancer|recurrent salivary gland cancer
768204|NCT00045006|stage IV salivary gland cancer|stage iv salivary gland cancer
768205|NCT00045006|stage III salivary gland cancer|stage iii salivary gland cancer
768206|NCT00045006|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
768207|NCT00045006|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
768208|NCT00045006|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
768209|NCT00045006|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
768210|NCT00045006|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
768211|NCT00045006|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
768212|NCT00045006|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
768213|NCT00045006|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
768214|NCT00045006|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
768215|NCT00045006|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
768216|NCT00045006|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
768217|NCT00045006|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
768218|NCT00045006|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
768219|NCT00045006|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
768220|NCT00045006|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
768221|NCT00045006|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
768222|NCT00045006|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
768223|NCT00045006|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
768224|NCT00045006|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
768225|NCT00045006|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
768226|NCT00045006|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
768227|NCT00045006|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
768228|NCT00045006|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
768229|NCT00045006|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
768230|NCT00045006|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
768231|NCT00045006|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
768232|NCT00045006|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
768233|NCT00045006|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
768234|NCT00045006|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
768441|NCT00041171|recurrent breast cancer|recurrent breast cancer
768235|NCT00045006|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
768236|NCT00045006|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
768237|NCT00045006|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
768238|NCT00045006|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
768239|NCT00045006|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
768240|NCT00045006|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
768241|NCT00045006|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
768242|NCT00045006|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
768243|NCT00045006|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
768244|NCT00045006|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
768245|NCT00045006|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
768246|NCT00045006|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
768247|NCT00045006|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
768248|NCT00045006|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
768249|NCT00045006|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
768250|NCT00045006|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
768251|NCT00045006|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
768252|NCT00045006|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
768253|NCT00045006|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
768254|NCT00045006|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
768255|NCT00045006|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
768256|NCT00045006|male breast cancer|male breast cancer
768257|NCT00044993|male breast cancer|male breast cancer
768258|NCT00044993|stage IIIA breast cancer|stage iiia breast cancer
768259|NCT00044993|stage IIIB breast cancer|stage iiib breast cancer
768260|NCT00044993|stage IIIC breast cancer|stage iiic breast cancer
768261|NCT00044993|stage IV breast cancer|stage iv breast cancer
768262|NCT00044980|malnutrition|malnutrition
768263|NCT00044980|stage I prostate cancer|stage i prostate cancer
768264|NCT00044980|stage II B prostate cancer|stage ii b prostate cancer
768265|NCT00044980|stage II A prostate cancer|stage ii a prostate cancer
768266|NCT00044967|stage I colon cancer|stage i colon cancer
768267|NCT00044967|stage II colon cancer|stage ii colon cancer
768268|NCT00044967|stage III colon cancer|stage iii colon cancer
768269|NCT00044967|stage I rectal cancer|stage i rectal cancer
768270|NCT00044967|stage II rectal cancer|stage ii rectal cancer
768271|NCT00044967|stage III rectal cancer|stage iii rectal cancer
768272|NCT00044967|adenocarcinoma of the colon|adenocarcinoma of the colon
768273|NCT00044967|adenocarcinoma of the rectum|adenocarcinoma of the rectum
768274|NCT00044954|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
768275|NCT00044954|stage I multiple myeloma|stage i multiple myeloma
768276|NCT00044954|stage II multiple myeloma|stage ii multiple myeloma
768277|NCT00044954|stage III multiple myeloma|stage iii multiple myeloma
768278|NCT00044954|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
768279|NCT00044954|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
768280|NCT00044954|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
768281|NCT00044954|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
768282|NCT00044954|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
768283|NCT00044954|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
768284|NCT00044954|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
768285|NCT00044954|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
768286|NCT00044954|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
768287|NCT00044954|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
768288|NCT00044954|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
768289|NCT00044954|refractory multiple myeloma|refractory multiple myeloma
768290|NCT00044954|stage I mantle cell lymphoma|stage i mantle cell lymphoma
768291|NCT00044954|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
768292|NCT00044954|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
768293|NCT00044954|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
768294|NCT00044954|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
768295|NCT00044954|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
768296|NCT00044954|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
768297|NCT00044954|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
768442|NCT00041171|stage IIIB breast cancer|stage iiib breast cancer
768298|NCT00044954|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
768299|NCT00044954|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
768300|NCT00044954|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
768301|NCT00043147|graft versus host disease|graft versus host disease
768302|NCT00043134|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
768303|NCT00043134|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
768304|NCT00043134|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
768305|NCT00043134|refractory anemia|refractory anemia
768306|NCT00043134|refractory anemia with excess blasts|refractory anemia with excess blasts
768307|NCT00043134|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
768308|NCT00043134|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
768309|NCT00043134|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
768310|NCT00043134|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
768311|NCT00043134|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
768312|NCT00043134|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
768313|NCT00043095|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
768314|NCT00043082|peritoneal cavity cancer|peritoneal cavity cancer
768315|NCT00043082|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
768316|NCT00043082|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
768317|NCT00043082|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
768318|NCT00043069|osteoporosis|osteoporosis
768319|NCT00043069|stage I prostate cancer|stage i prostate cancer
768320|NCT00043069|stage IIB prostate cancer|stage iib prostate cancer
768321|NCT00043069|stage IIA prostate cancer|stage iia prostate cancer
768322|NCT00043069|stage III prostate cancer|stage iii prostate cancer
768323|NCT00043043|colorectal cancer|colorectal cancer
768324|NCT00043030|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
768325|NCT00043030|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
768326|NCT00043017|stage IIIA breast cancer|stage iiia breast cancer
768327|NCT00043017|stage IIIB breast cancer|stage iiib breast cancer
768328|NCT00043017|stage IIIC breast cancer|stage iiic breast cancer
768329|NCT00043004|liver metastases|liver metastases
768330|NCT00043004|stage IV colon cancer|stage iv colon cancer
768331|NCT00043004|stage IV rectal cancer|stage iv rectal cancer
768332|NCT00042965|recurrent renal cell cancer|recurrent renal cell cancer
768333|NCT00042965|stage IV renal cell cancer|stage iv renal cell cancer
768334|NCT00042939|pancreatic cancer|pancreatic cancer
768335|NCT00042939|metastatic pancreatic cancer|metastatic pancreatic cancer
768336|NCT00042939|EGF-r|egf-r
768337|NCT00042939|irinotecan|irinotecan
768338|NCT00042939|docetaxel|docetaxel
768339|NCT00042939|cetuximab|cetuximab
768340|NCT00042926|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
768341|NCT00042926|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
768342|NCT00042913|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
768343|NCT00042887|stage 0 bladder cancer|stage 0 bladder cancer
768344|NCT00042887|stage I bladder cancer|stage i bladder cancer
768345|NCT00042887|recurrent bladder cancer|recurrent bladder cancer
768346|NCT00042887|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
768347|NCT00042861|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
768348|NCT00042848|fatigue|fatigue
768349|NCT00042848|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
768350|NCT00042822|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
768351|NCT00042822|refractory anemia with excess blasts|refractory anemia with excess blasts
768352|NCT00042822|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
768353|NCT00042822|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
768354|NCT00042822|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
768355|NCT00042822|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
768356|NCT00042822|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
768357|NCT00042822|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
768358|NCT00042822|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
768359|NCT00042822|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
768360|NCT00042822|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
768361|NCT00042822|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
768362|NCT00042822|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
768363|NCT00042822|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
768364|NCT00042822|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
768365|NCT00042822|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
768629|NCT00039611|stage III colon cancer|stage iii colon cancer
768366|NCT00042822|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
768367|NCT00042822|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
768368|NCT00042822|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
768369|NCT00042822|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
768370|NCT00042783|stage IV melanoma|stage iv melanoma
768371|NCT00042783|recurrent melanoma|recurrent melanoma
768372|NCT00042770|malignant pleural effusion|malignant pleural effusion
768373|NCT00042770|pulmonary complications|pulmonary complications
768374|NCT00042731|stage I prostate cancer|stage i prostate cancer
768375|NCT00042731|stage IIB prostate cancer|stage iib prostate cancer
768376|NCT00042731|stage IIA prostate cancer|stage iia prostate cancer
768377|NCT00041379|Waldenström macroglobulinemia|waldenström macroglobulinemia
768378|NCT00041327|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
768379|NCT00041327|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
768380|NCT00041327|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
768381|NCT00041327|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
768382|NCT00041314|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
768383|NCT00041314|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
768384|NCT00041314|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
768385|NCT00041301|stage I prostate cancer|stage i prostate cancer
768386|NCT00041301|stage IIB prostate cancer|stage iib prostate cancer
768387|NCT00041301|stage IIA prostate cancer|stage iia prostate cancer
768388|NCT00041301|stage III prostate cancer|stage iii prostate cancer
768389|NCT00041301|stage IV prostate cancer|stage iv prostate cancer
768390|NCT00041288|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
768391|NCT00041288|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
768392|NCT00041288|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
768393|NCT00041288|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
768394|NCT00041288|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
768395|NCT00041288|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
768396|NCT00041262|stage IIB esophageal cancer|stage iib esophageal cancer
768397|NCT00041262|stage IIIA esophageal cancer|stage iiia esophageal cancer
768398|NCT00041262|stage IIIB esophageal cancer|stage iiib esophageal cancer
768399|NCT00041262|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
768400|NCT00041249|adult angiosarcoma|adult angiosarcoma
768401|NCT00041249|adult fibrosarcoma|adult fibrosarcoma
768402|NCT00041249|adult leiomyosarcoma|adult leiomyosarcoma
768403|NCT00041249|adult liposarcoma|adult liposarcoma
768404|NCT00041249|adult neurofibrosarcoma|adult neurofibrosarcoma
768405|NCT00041249|adult synovial sarcoma|adult synovial sarcoma
768406|NCT00041249|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
768407|NCT00041249|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
768408|NCT00041249|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
768409|NCT00041249|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
768410|NCT00041249|adult rhabdomyosarcoma|adult rhabdomyosarcoma
768411|NCT00041249|gastrointestinal stromal tumor|gastrointestinal stromal tumor
768412|NCT00041249|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
768413|NCT00041236|adult angiosarcoma|adult angiosarcoma
768414|NCT00041236|adult fibrosarcoma|adult fibrosarcoma
768415|NCT00041236|adult leiomyosarcoma|adult leiomyosarcoma
768416|NCT00041236|adult liposarcoma|adult liposarcoma
768417|NCT00041236|adult neurofibrosarcoma|adult neurofibrosarcoma
768418|NCT00041236|adult synovial sarcoma|adult synovial sarcoma
768419|NCT00041236|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
768420|NCT00041236|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
768421|NCT00041236|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
768422|NCT00041236|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
768423|NCT00041236|adult rhabdomyosarcoma|adult rhabdomyosarcoma
768424|NCT00041236|stage IV uterine sarcoma|stage iv uterine sarcoma
768425|NCT00041236|recurrent uterine sarcoma|recurrent uterine sarcoma
768426|NCT00041236|uterine leiomyosarcoma|uterine leiomyosarcoma
768427|NCT00041223|radiation fibrosis|radiation fibrosis
768428|NCT00041223|stage I breast cancer|stage i breast cancer
768429|NCT00041223|stage II breast cancer|stage ii breast cancer
768430|NCT00041223|stage IIIA breast cancer|stage iiia breast cancer
768431|NCT00041210|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
768432|NCT00041210|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
768433|NCT00041210|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
768434|NCT00041210|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
768435|NCT00041210|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
768436|NCT00041210|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
768437|NCT00041210|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
768438|NCT00041210|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
768439|NCT00041171|stage IV breast cancer|stage iv breast cancer
768440|NCT00041171|stage IIIA breast cancer|stage iiia breast cancer
768443|NCT00041171|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
768444|NCT00041171|extensive stage small cell lung cancer|extensive stage small cell lung cancer
768445|NCT00041171|recurrent small cell lung cancer|recurrent small cell lung cancer
768446|NCT00041171|stage III bladder cancer|stage iii bladder cancer
768447|NCT00041171|recurrent bladder cancer|recurrent bladder cancer
768448|NCT00041171|stage IV bladder cancer|stage iv bladder cancer
768449|NCT00041171|stage III prostate cancer|stage iii prostate cancer
768450|NCT00041171|stage IV prostate cancer|stage iv prostate cancer
768451|NCT00041171|recurrent prostate cancer|recurrent prostate cancer
768452|NCT00041171|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
768453|NCT00041171|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
768454|NCT00041171|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
768455|NCT00041171|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
768456|NCT00041171|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
768457|NCT00041171|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
768458|NCT00041171|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
768459|NCT00041171|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
768460|NCT00041171|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
768461|NCT00041171|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
768462|NCT00041171|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
768463|NCT00041171|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
768464|NCT00041171|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
768465|NCT00041171|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
768466|NCT00041171|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
768467|NCT00041171|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
768468|NCT00041171|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
768469|NCT00041171|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
768470|NCT00041171|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
768471|NCT00041171|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
768472|NCT00041171|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
768473|NCT00041171|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
768474|NCT00041171|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
768475|NCT00041171|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
768476|NCT00041171|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
768477|NCT00041171|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
768478|NCT00041171|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
768479|NCT00041171|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
768480|NCT00041171|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
768481|NCT00041171|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
768482|NCT00041171|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
768483|NCT00041171|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
768484|NCT00041171|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
768485|NCT00041171|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
768486|NCT00041171|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
768487|NCT00041171|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
768488|NCT00041171|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
768489|NCT00041171|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
768490|NCT00041171|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
768491|NCT00041171|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
768492|NCT00041171|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
768493|NCT00041171|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
768494|NCT00041171|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
768495|NCT00041171|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
768496|NCT00041171|stage III inverting papilloma of the paranasal sinus and nasal cavity|stage iii inverting papilloma of the paranasal sinus and nasal cavity
768497|NCT00041171|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
768498|NCT00041171|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
785468|NCT00013520|Lamivudine|lamivudine
768499|NCT00041171|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
768500|NCT00041171|stage IV inverting papilloma of the paranasal sinus and nasal cavity|stage iv inverting papilloma of the paranasal sinus and nasal cavity
768501|NCT00041171|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
768502|NCT00041171|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
768503|NCT00041171|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
768504|NCT00041171|recurrent inverting papilloma of the paranasal sinus and nasal cavity|recurrent inverting papilloma of the paranasal sinus and nasal cavity
768505|NCT00041171|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
768506|NCT00041171|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
768507|NCT00041171|recurrent salivary gland cancer|recurrent salivary gland cancer
768508|NCT00041171|stage III salivary gland cancer|stage iii salivary gland cancer
768509|NCT00041171|stage IV salivary gland cancer|stage iv salivary gland cancer
768510|NCT00041132|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
768511|NCT00041132|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
768512|NCT00041132|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
768513|NCT00041132|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
768514|NCT00041119|stage IB breast cancer|stage ib breast cancer
768515|NCT00041119|stage II breast cancer|stage ii breast cancer
768516|NCT00041067|stage IV breast cancer|stage iv breast cancer
768517|NCT00041067|recurrent breast cancer|recurrent breast cancer
768518|NCT00041054|extensive stage small cell lung cancer|extensive stage small cell lung cancer
768519|NCT00041028|stage I non-small cell lung cancer|stage i non-small cell lung cancer
768520|NCT00041028|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
768521|NCT00041028|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
768522|NCT00041028|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
768523|NCT00041015|extensive stage small cell lung cancer|extensive stage small cell lung cancer
768524|NCT00041015|recurrent small cell lung cancer|recurrent small cell lung cancer
768525|NCT00040950|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
768526|NCT00040950|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
768527|NCT00040950|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
768528|NCT00040950|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
768529|NCT00040950|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
768530|NCT00040950|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
768531|NCT00040950|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
768532|NCT00040950|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
768533|NCT00040950|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
768534|NCT00040950|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
768535|NCT00040950|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
768536|NCT00040950|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
768537|NCT00040950|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
768538|NCT00040950|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
768539|NCT00040950|splenic marginal zone lymphoma|splenic marginal zone lymphoma
768540|NCT00040937|stage I multiple myeloma|stage i multiple myeloma
768541|NCT00040937|stage II multiple myeloma|stage ii multiple myeloma
768542|NCT00040937|stage III multiple myeloma|stage iii multiple myeloma
768543|NCT00040911|nausea and vomiting|nausea and vomiting
768544|NCT00040911|localized osteosarcoma|localized osteosarcoma
768545|NCT00040911|metastatic osteosarcoma|metastatic osteosarcoma
768546|NCT00040911|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
768547|NCT00040911|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
768548|NCT00040911|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
768549|NCT00040911|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
768550|NCT00040911|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
768551|NCT00040911|childhood teratoma|childhood teratoma
768552|NCT00040911|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
768553|NCT00040911|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
768554|NCT00040911|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
768555|NCT00040911|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
768556|NCT00040911|localized resectable neuroblastoma|localized resectable neuroblastoma
768557|NCT00040911|localized unresectable neuroblastoma|localized unresectable neuroblastoma
768558|NCT00040911|disseminated neuroblastoma|disseminated neuroblastoma
768559|NCT00040911|regional neuroblastoma|regional neuroblastoma
768560|NCT00040911|stage 4S neuroblastoma|stage 4s neuroblastoma
768561|NCT00040911|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
768562|NCT00040911|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
768563|NCT00040911|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
768564|NCT00040911|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
768565|NCT00040911|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
768566|NCT00040911|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
768567|NCT00040911|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
768568|NCT00040911|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
768569|NCT00040911|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
768570|NCT00040911|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
768571|NCT00040911|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
768572|NCT00040911|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
768573|NCT00040911|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
768574|NCT00040911|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
768575|NCT00040911|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
768576|NCT00040911|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
768577|NCT00040898|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
768578|NCT00040898|advanced adult primary liver cancer|advanced adult primary liver cancer
768579|NCT00040898|recurrent adult primary liver cancer|recurrent adult primary liver cancer
768580|NCT00040898|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
768581|NCT00040885|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
768582|NCT00040885|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
768583|NCT00040885|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
768584|NCT00040885|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
768586|NCT00040885|anorexia|anorexia
768587|NCT00040885|cachexia|cachexia
768588|NCT00040872|regional neuroblastoma|regional neuroblastoma
768589|NCT00040872|disseminated neuroblastoma|disseminated neuroblastoma
768590|NCT00040872|recurrent neuroblastoma|recurrent neuroblastoma
768591|NCT00040872|localized unresectable neuroblastoma|localized unresectable neuroblastoma
768592|NCT00040859|stage IV gastric cancer|stage iv gastric cancer
768593|NCT00040859|recurrent gastric cancer|recurrent gastric cancer
768594|NCT00040859|stage III esophageal cancer|stage iii esophageal cancer
768595|NCT00040859|stage IV esophageal cancer|stage iv esophageal cancer
768596|NCT00040859|recurrent esophageal cancer|recurrent esophageal cancer
768597|NCT00040859|adenocarcinoma of the stomach|adenocarcinoma of the stomach
768598|NCT00040859|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
768599|NCT00040833|stage III pancreatic cancer|stage iii pancreatic cancer
768600|NCT00040833|recurrent pancreatic cancer|recurrent pancreatic cancer
768601|NCT00040833|pain|pain
768602|NCT00040833|stage IV pancreatic cancer|stage iv pancreatic cancer
768603|NCT00040807|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
768604|NCT00040807|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
768605|NCT00040807|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
768606|NCT00040807|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
768607|NCT00040807|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
768608|NCT00040807|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
768609|NCT00040807|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
768610|NCT00040807|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
768611|NCT00040807|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
768612|NCT00040807|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
768613|NCT00040807|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
768614|NCT00040807|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
768615|NCT00040807|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
768616|NCT00040807|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
768617|NCT00040807|recurrent salivary gland cancer|recurrent salivary gland cancer
768618|NCT00040807|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
768619|NCT00040807|stage IV salivary gland cancer|stage iv salivary gland cancer
768620|NCT00040742|nausea|nausea
768621|NCT00040742|vomiting|vomiting
768622|NCT00040690|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
768623|NCT00040690|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
768624|NCT00040690|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
768625|NCT00040690|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
768626|NCT00040690|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
768627|NCT00040690|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
768628|NCT00040690|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
768630|NCT00039611|stage IV colon cancer|stage iv colon cancer
768631|NCT00039611|stage III rectal cancer|stage iii rectal cancer
768632|NCT00039611|stage IV rectal cancer|stage iv rectal cancer
768633|NCT00039611|recurrent colon cancer|recurrent colon cancer
768634|NCT00039611|recurrent rectal cancer|recurrent rectal cancer
768635|NCT00039585|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
768636|NCT00039585|fallopian tube cancer|fallopian tube cancer
768637|NCT00039585|primary peritoneal cavity cancer|primary peritoneal cavity cancer
768638|NCT00039585|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
768639|NCT00039572|adult glioblastoma|adult glioblastoma
768640|NCT00039572|stage IV melanoma|stage iv melanoma
768641|NCT00039572|tumors metastatic to brain|tumors metastatic to brain
768642|NCT00039572|adult giant cell glioblastoma|adult giant cell glioblastoma
768643|NCT00039572|adult gliosarcoma|adult gliosarcoma
768644|NCT00039559|ovarian epithelial cancer|ovarian epithelial cancer
768645|NCT00039546|stage I breast cancer|stage i breast cancer
768646|NCT00039546|stage II breast cancer|stage ii breast cancer
768647|NCT00039520|stage IV breast cancer|stage iv breast cancer
768648|NCT00039520|recurrent breast cancer|recurrent breast cancer
768649|NCT00039507|stage I non-small cell lung cancer|stage i non-small cell lung cancer
768650|NCT00039507|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
768651|NCT00039468|adult glioblastoma|adult glioblastoma
768652|NCT00039468|recurrent adult brain tumor|recurrent adult brain tumor
768653|NCT00039468|adult giant cell glioblastoma|adult giant cell glioblastoma
768654|NCT00039468|adult gliosarcoma|adult gliosarcoma
768655|NCT00039429|stage IV renal cell cancer|stage iv renal cell cancer
768656|NCT00039429|recurrent renal cell cancer|recurrent renal cell cancer
768657|NCT00039364|recurrent adult brain tumor|recurrent adult brain tumor
768658|NCT00039364|adult glioblastoma|adult glioblastoma
768659|NCT00039364|adult anaplastic astrocytoma|adult anaplastic astrocytoma
768660|NCT00039364|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
768661|NCT00039364|adult mixed glioma|adult mixed glioma
768662|NCT00039364|adult pilocytic astrocytoma|adult pilocytic astrocytoma
768663|NCT00039364|adult subependymoma|adult subependymoma
768664|NCT00039364|adult giant cell glioblastoma|adult giant cell glioblastoma
768665|NCT00039364|adult gliosarcoma|adult gliosarcoma
768666|NCT00039364|adult diffuse astrocytoma|adult diffuse astrocytoma
768667|NCT00039351|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
768668|NCT00039351|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
768669|NCT00039351|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
768670|NCT00039351|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
768671|NCT00039351|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
768672|NCT00039351|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
768673|NCT00039338|stage IB cervical cancer|stage ib cervical cancer
768674|NCT00039338|stage IIB cervical cancer|stage iib cervical cancer
768675|NCT00039338|stage IIA cervical cancer|stage iia cervical cancer
768676|NCT00039338|cervical squamous cell carcinoma|cervical squamous cell carcinoma
768677|NCT00039338|cervical adenocarcinoma|cervical adenocarcinoma
768678|NCT00039338|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
768679|NCT00039325|stage IV melanoma|stage iv melanoma
768680|NCT00039325|recurrent melanoma|recurrent melanoma
768681|NCT00039312|cervical cancer|cervical cancer
768682|NCT00039299|adenocarcinoma of the prostate|adenocarcinoma of the prostate
768683|NCT00039299|recurrent prostate cancer|recurrent prostate cancer
768684|NCT00039286|stage II breast cancer|stage ii breast cancer
768685|NCT00039286|stage IIIA breast cancer|stage iiia breast cancer
768686|NCT00039286|recurrent breast cancer|recurrent breast cancer
768687|NCT00039273|stage IV colon cancer|stage iv colon cancer
768688|NCT00039273|stage IV rectal cancer|stage iv rectal cancer
768689|NCT00039273|recurrent colon cancer|recurrent colon cancer
768690|NCT00039273|recurrent rectal cancer|recurrent rectal cancer
768691|NCT00039234|stage IV melanoma|stage iv melanoma
768692|NCT00039234|recurrent melanoma|recurrent melanoma
768693|NCT00039234|liver metastases|liver metastases
768694|NCT00039208|stage III colon cancer|stage iii colon cancer
768695|NCT00039208|stage IV colon cancer|stage iv colon cancer
768696|NCT00039208|stage III rectal cancer|stage iii rectal cancer
768697|NCT00039208|stage IV rectal cancer|stage iv rectal cancer
768698|NCT00039208|recurrent colon cancer|recurrent colon cancer
768699|NCT00039208|recurrent rectal cancer|recurrent rectal cancer
768700|NCT00039195|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
768701|NCT00039195|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
768702|NCT00039195|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
768703|NCT00039195|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
768704|NCT00039195|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
768705|NCT00039156|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
768706|NCT00039156|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
768707|NCT00039156|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
768708|NCT00039156|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
768709|NCT00039156|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
768710|NCT00039156|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
768711|NCT00039156|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
768712|NCT00039130|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
768713|NCT00039130|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
768714|NCT00039130|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
768715|NCT00039130|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
768716|NCT00039130|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
768717|NCT00039130|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
768718|NCT00039130|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
768719|NCT00039078|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
768720|NCT00039078|recurrent adult primary liver cancer|recurrent adult primary liver cancer
768721|NCT00039078|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
768722|NCT00039052|stage IV breast cancer|stage iv breast cancer
768723|NCT00039052|recurrent breast cancer|recurrent breast cancer
768724|NCT00039052|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
768725|NCT00039052|stage IV renal cell cancer|stage iv renal cell cancer
768726|NCT00039052|recurrent renal cell cancer|recurrent renal cell cancer
768727|NCT00039052|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
768728|NCT00039052|male breast cancer|male breast cancer
768729|NCT00039039|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
768730|NCT00039039|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
768731|NCT00039039|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
768732|NCT00037037|stage III melanoma|stage iii melanoma
768733|NCT00037037|stage IV melanoma|stage iv melanoma
768734|NCT00037037|recurrent melanoma|recurrent melanoma
768735|NCT00037024|stage I breast cancer|stage i breast cancer
768736|NCT00037024|stage II breast cancer|stage ii breast cancer
768737|NCT00037024|stage I prostate cancer|stage i prostate cancer
768738|NCT00037024|stage II B prostate cancer|stage ii b prostate cancer
768739|NCT00037024|stage II A prostate cancer|stage ii a prostate cancer
768740|NCT00037024|male breast cancer|male breast cancer
768741|NCT00037024|fatigue|fatigue
768742|NCT00037024|malnutrition|malnutrition
768743|NCT00037024|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
768744|NCT00037024|depression|depression
768745|NCT00037011|disseminated neuroblastoma|disseminated neuroblastoma
768746|NCT00037011|recurrent neuroblastoma|recurrent neuroblastoma
768747|NCT00036998|stage I breast cancer|stage i breast cancer
768748|NCT00036998|stage II breast cancer|stage ii breast cancer
768749|NCT00036985|stage IIIA breast cancer|stage iiia breast cancer
768750|NCT00036972|recurrent adult brain tumor|recurrent adult brain tumor
768751|NCT00036972|adult glioblastoma|adult glioblastoma
768752|NCT00036972|adult anaplastic astrocytoma|adult anaplastic astrocytoma
768753|NCT00036972|adult mixed glioma|adult mixed glioma
768754|NCT00036972|adult giant cell glioblastoma|adult giant cell glioblastoma
768755|NCT00036972|adult gliosarcoma|adult gliosarcoma
768756|NCT00036959|metastatic osteosarcoma|metastatic osteosarcoma
768757|NCT00036959|childhood infratentorial ependymoma|childhood infratentorial ependymoma
768758|NCT00036959|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
768759|NCT00036959|childhood supratentorial ependymoma|childhood supratentorial ependymoma
768760|NCT00036959|childhood craniopharyngioma|childhood craniopharyngioma
768761|NCT00036959|disseminated neuroblastoma|disseminated neuroblastoma
768762|NCT00036959|recurrent neuroblastoma|recurrent neuroblastoma
768763|NCT00036959|recurrent childhood liver cancer|recurrent childhood liver cancer
768764|NCT00036959|stage IV childhood liver cancer|stage iv childhood liver cancer
768765|NCT00036959|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
768766|NCT00036959|stage IV Wilms tumor|stage iv wilms tumor
768767|NCT00036959|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
768768|NCT00036959|recurrent osteosarcoma|recurrent osteosarcoma
768769|NCT00036959|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
768770|NCT00036959|childhood germ cell tumor|childhood germ cell tumor
768771|NCT00036959|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
768772|NCT00036959|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
768773|NCT00036959|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
768774|NCT00036959|childhood oligodendroglioma|childhood oligodendroglioma
768775|NCT00036959|childhood choroid plexus tumor|childhood choroid plexus tumor
768776|NCT00036959|childhood grade I meningioma|childhood grade i meningioma
768777|NCT00036959|childhood grade II meningioma|childhood grade ii meningioma
768778|NCT00036959|childhood grade III meningioma|childhood grade iii meningioma
768779|NCT00036959|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
768780|NCT00036959|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
768781|NCT00036959|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
768982|NCT00036712|primary myelofibrosis|primary myelofibrosis
768782|NCT00036959|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
768783|NCT00036959|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
768784|NCT00036959|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
768785|NCT00036959|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
768786|NCT00036959|recurrent childhood ependymoma|recurrent childhood ependymoma
768787|NCT00036959|childhood teratoma|childhood teratoma
768788|NCT00036959|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
768789|NCT00036959|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
768790|NCT00036959|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
768791|NCT00036959|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
768792|NCT00036946|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
768793|NCT00036946|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
768794|NCT00036946|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
768795|NCT00036946|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
768796|NCT00036946|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
768797|NCT00036946|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
768798|NCT00036946|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
768799|NCT00036946|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
768800|NCT00036946|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
768801|NCT00036946|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
768802|NCT00036946|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
768803|NCT00036946|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
768804|NCT00036946|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
768805|NCT00036946|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
768806|NCT00036946|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
768807|NCT00036946|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
768808|NCT00036946|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
768809|NCT00036946|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
768810|NCT00036946|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
768811|NCT00036946|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
768812|NCT00036946|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
768813|NCT00036946|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
768814|NCT00036946|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
768815|NCT00036946|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
768816|NCT00036946|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
768817|NCT00036946|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
768818|NCT00036946|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
768819|NCT00036946|splenic marginal zone lymphoma|splenic marginal zone lymphoma
768820|NCT00036933|stage III prostate cancer|stage iii prostate cancer
768821|NCT00036933|recurrent prostate cancer|recurrent prostate cancer
768822|NCT00036894|recurrent adult brain tumor|recurrent adult brain tumor
768823|NCT00036894|adult glioblastoma|adult glioblastoma
768824|NCT00036894|adult anaplastic astrocytoma|adult anaplastic astrocytoma
768825|NCT00036894|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
768826|NCT00036894|adult mixed glioma|adult mixed glioma
768827|NCT00036894|adult ependymoblastoma|adult ependymoblastoma
768828|NCT00036894|adult anaplastic ependymoma|adult anaplastic ependymoma
768829|NCT00036894|adult myxopapillary ependymoma|adult myxopapillary ependymoma
768830|NCT00036894|adult meningioma|adult meningioma
768831|NCT00036894|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
768832|NCT00036894|adult brain stem glioma|adult brain stem glioma
768833|NCT00036894|adult grade III meningioma|adult grade iii meningioma
768834|NCT00036894|adult giant cell glioblastoma|adult giant cell glioblastoma
768835|NCT00036894|adult gliosarcoma|adult gliosarcoma
768836|NCT00036868|stage IV breast cancer|stage iv breast cancer
768837|NCT00036868|recurrent breast cancer|recurrent breast cancer
768838|NCT00036842|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
768839|NCT00036842|extragonadal germ cell tumor|extragonadal germ cell tumor
768840|NCT00036829|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
768841|NCT00036829|pain|pain
768842|NCT00036816|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
768843|NCT00036790|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
768844|NCT00036790|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
768845|NCT00036790|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
768846|NCT00036790|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
768847|NCT00036790|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
768848|NCT00036790|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
768849|NCT00036790|isolated plasmacytoma of bone|isolated plasmacytoma of bone
768850|NCT00036790|extramedullary plasmacytoma|extramedullary plasmacytoma
768851|NCT00036790|refractory multiple myeloma|refractory multiple myeloma
768852|NCT00036790|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
768853|NCT00036790|stage III multiple myeloma|stage iii multiple myeloma
768854|NCT00036790|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
768855|NCT00036790|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
768856|NCT00036790|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
768857|NCT00036790|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
768858|NCT00036790|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
768859|NCT00036790|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
768860|NCT00036790|small intestine lymphoma|small intestine lymphoma
768861|NCT00036790|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
768862|NCT00036790|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
768863|NCT00036790|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
768864|NCT00036790|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
768865|NCT00036790|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
768866|NCT00036790|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
768867|NCT00036790|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
768868|NCT00036790|refractory hairy cell leukemia|refractory hairy cell leukemia
768869|NCT00036790|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
768870|NCT00036790|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
768871|NCT00036790|acute undifferentiated leukemia|acute undifferentiated leukemia
768872|NCT00036790|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
768873|NCT00036790|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
768874|NCT00036790|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
768875|NCT00036790|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
768876|NCT00036790|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
768877|NCT00036790|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
768878|NCT00036790|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
768879|NCT00036790|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
768880|NCT00036790|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
768881|NCT00036790|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
768882|NCT00036790|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
768883|NCT00036790|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
768884|NCT00036790|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
768885|NCT00036790|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
768886|NCT00036790|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
768887|NCT00036790|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
768888|NCT00036790|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
768889|NCT00036790|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
768890|NCT00036790|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
768891|NCT00036790|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
768892|NCT00036790|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
768893|NCT00036790|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
768894|NCT00036790|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
768895|NCT00036790|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
768896|NCT00036790|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
768897|NCT00036790|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
768898|NCT00036790|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
768899|NCT00036790|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
768900|NCT00036790|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
768901|NCT00036790|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
768902|NCT00036790|secondary acute myeloid leukemia|secondary acute myeloid leukemia
768903|NCT00036790|prolymphocytic leukemia|prolymphocytic leukemia
768904|NCT00036790|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
768905|NCT00036790|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
768906|NCT00036790|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
768907|NCT00036790|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
768908|NCT00036790|anaplastic large cell lymphoma|anaplastic large cell lymphoma
768909|NCT00036790|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
768910|NCT00036790|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
768911|NCT00036790|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
768912|NCT00036790|chronic eosinophilic leukemia|chronic eosinophilic leukemia
768913|NCT00036790|chronic neutrophilic leukemia|chronic neutrophilic leukemia
768914|NCT00036790|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
768915|NCT00036790|recurrent small cell lung cancer|recurrent small cell lung cancer
768916|NCT00036790|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
768917|NCT00036790|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
768918|NCT00036790|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
768919|NCT00036790|extensive stage small cell lung cancer|extensive stage small cell lung cancer
768920|NCT00036790|limited stage small cell lung cancer|limited stage small cell lung cancer
768921|NCT00036790|recurrent breast cancer|recurrent breast cancer
768922|NCT00036790|stage IIIA breast cancer|stage iiia breast cancer
768923|NCT00036790|stage IIIB breast cancer|stage iiib breast cancer
768924|NCT00036790|stage IIIC breast cancer|stage iiic breast cancer
768925|NCT00036790|stage IV breast cancer|stage iv breast cancer
768926|NCT00036790|recurrent colon cancer|recurrent colon cancer
768927|NCT00036790|stage III colon cancer|stage iii colon cancer
768928|NCT00036790|stage IV colon cancer|stage iv colon cancer
768929|NCT00036790|recurrent prostate cancer|recurrent prostate cancer
768930|NCT00036790|stage III prostate cancer|stage iii prostate cancer
768931|NCT00036790|stage IV prostate cancer|stage iv prostate cancer
768932|NCT00036790|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
768933|NCT00036790|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
768934|NCT00036790|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
768935|NCT00036790|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
768936|NCT00036790|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
768937|NCT00036790|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
768938|NCT00036790|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
768939|NCT00036790|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
768940|NCT00036790|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
768941|NCT00036790|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
768942|NCT00036790|recurrent laryngeal cancer|recurrent laryngeal cancer
768943|NCT00036790|stage III laryngeal cancer|stage iii laryngeal cancer
768944|NCT00036790|stage IV laryngeal cancer|stage iv laryngeal cancer
768945|NCT00036790|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
768946|NCT00036790|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
768947|NCT00036790|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
768948|NCT00036790|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
768949|NCT00036790|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
768950|NCT00036790|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
768951|NCT00036790|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
768952|NCT00036790|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
768953|NCT00036790|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
768954|NCT00036790|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
768955|NCT00036790|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
768956|NCT00036790|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
768957|NCT00036790|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
768958|NCT00036790|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
768959|NCT00036790|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
768960|NCT00036790|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
768961|NCT00036790|splenic marginal zone lymphoma|splenic marginal zone lymphoma
768962|NCT00036790|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
768963|NCT00036790|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
768964|NCT00036790|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
768965|NCT00036790|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
768966|NCT00036790|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
768967|NCT00036712|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
768968|NCT00036712|refractory multiple myeloma|refractory multiple myeloma
768969|NCT00036712|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
768970|NCT00036712|disseminated neuroblastoma|disseminated neuroblastoma
768971|NCT00036712|recurrent neuroblastoma|recurrent neuroblastoma
768972|NCT00036712|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
768973|NCT00036712|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
768974|NCT00036712|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
768975|NCT00036712|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
768976|NCT00036712|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
768977|NCT00036712|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
768978|NCT00036712|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
768979|NCT00036712|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
768980|NCT00036712|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
768981|NCT00036712|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
785469|NCT00013520|RNA, Viral|rna, viral
768983|NCT00036712|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
768984|NCT00036712|refractory hairy cell leukemia|refractory hairy cell leukemia
768985|NCT00036712|oral complications|oral complications
768986|NCT00036712|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
768987|NCT00036712|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
768988|NCT00036712|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
768989|NCT00036712|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
768990|NCT00036712|pain|pain
768991|NCT00036712|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
768992|NCT00036712|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
768993|NCT00036712|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
768994|NCT00036712|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
768995|NCT00036712|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
768996|NCT00036712|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
768997|NCT00036712|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
768998|NCT00036712|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
768999|NCT00036686|stage I breast cancer|stage i breast cancer
769000|NCT00036686|stage II breast cancer|stage ii breast cancer
769001|NCT00036686|stage IIIA breast cancer|stage iiia breast cancer
769002|NCT00036686|stage IIIB breast cancer|stage iiib breast cancer
769003|NCT00036686|stage IIIC breast cancer|stage iiic breast cancer
769004|NCT00036686|recurrent breast cancer|recurrent breast cancer
769005|NCT00036686|stage IV breast cancer|stage iv breast cancer
769006|NCT00033748|stage IV colon cancer|stage iv colon cancer
769007|NCT00033748|stage IV rectal cancer|stage iv rectal cancer
769008|NCT00033748|recurrent colon cancer|recurrent colon cancer
769009|NCT00033748|recurrent rectal cancer|recurrent rectal cancer
769010|NCT00033748|liver metastases|liver metastases
769011|NCT00033709|adult leiomyosarcoma|adult leiomyosarcoma
769012|NCT00033709|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
769013|NCT00033709|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
769014|NCT00033709|stage III uterine sarcoma|stage iii uterine sarcoma
769015|NCT00033709|stage IV uterine sarcoma|stage iv uterine sarcoma
769016|NCT00033709|recurrent uterine sarcoma|recurrent uterine sarcoma
769017|NCT00033709|uterine leiomyosarcoma|uterine leiomyosarcoma
769018|NCT00033709|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
769019|NCT00033696|limited stage small cell lung cancer|limited stage small cell lung cancer
769020|NCT00033683|stage I breast cancer|stage i breast cancer
769021|NCT00033683|stage II breast cancer|stage ii breast cancer
769022|NCT00033657|stage I gastric cancer|stage i gastric cancer
769023|NCT00033657|stage II gastric cancer|stage ii gastric cancer
769024|NCT00033657|stage III gastric cancer|stage iii gastric cancer
769025|NCT00033657|stage IV gastric cancer|stage iv gastric cancer
769026|NCT00033657|stage I esophageal cancer|stage i esophageal cancer
769027|NCT00033657|stage II esophageal cancer|stage ii esophageal cancer
769028|NCT00033657|stage III esophageal cancer|stage iii esophageal cancer
769029|NCT00033657|stage IV esophageal cancer|stage iv esophageal cancer
769030|NCT00033657|adenocarcinoma of the stomach|adenocarcinoma of the stomach
769031|NCT00033657|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
769032|NCT00033644|stage IV uterine sarcoma|stage iv uterine sarcoma
769033|NCT00033644|recurrent uterine sarcoma|recurrent uterine sarcoma
769034|NCT00033644|uterine leiomyosarcoma|uterine leiomyosarcoma
769035|NCT00033631|adenocarcinoma of the prostate|adenocarcinoma of the prostate
769036|NCT00033631|stage IIB prostate cancer|stage iib prostate cancer
769037|NCT00033631|stage IIA prostate cancer|stage iia prostate cancer
769038|NCT00033566|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
769039|NCT00033553|squamous cell lung cancer|squamous cell lung cancer
769040|NCT00033553|large cell lung cancer|large cell lung cancer
769041|NCT00033553|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
769042|NCT00033553|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
769043|NCT00033553|adenocarcinoma of the lung|adenocarcinoma of the lung
769044|NCT00033553|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
769045|NCT00033540|unresectable gallbladder cancer|unresectable gallbladder cancer
769046|NCT00033540|recurrent gallbladder cancer|recurrent gallbladder cancer
769047|NCT00033540|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
769048|NCT00033540|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
769049|NCT00033540|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
769050|NCT00033540|adenocarcinoma with squamous metaplasia of the gallbladder|adenocarcinoma with squamous metaplasia of the gallbladder
769051|NCT00033540|squamous cell carcinoma of the gallbladder|squamous cell carcinoma of the gallbladder
769052|NCT00033540|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
769053|NCT00033540|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
769054|NCT00033540|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
769055|NCT00033514|stage IV breast cancer|stage iv breast cancer
769056|NCT00033514|recurrent breast cancer|recurrent breast cancer
769057|NCT00033488|ovarian epithelial cancer|ovarian epithelial cancer
769058|NCT00033475|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
769059|NCT00033436|stage I bladder cancer|stage i bladder cancer
769060|NCT00033436|stage II bladder cancer|stage ii bladder cancer
769061|NCT00033436|stage III bladder cancer|stage iii bladder cancer
769062|NCT00033436|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
769063|NCT00033423|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
769064|NCT00033423|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
769065|NCT00033423|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
769066|NCT00033423|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
769067|NCT00033423|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
769068|NCT00033423|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
769069|NCT00033423|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
769070|NCT00033423|splenic marginal zone lymphoma|splenic marginal zone lymphoma
769071|NCT00033410|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
769072|NCT00033410|squamous cell lung cancer|squamous cell lung cancer
769073|NCT00033410|large cell lung cancer|large cell lung cancer
769074|NCT00033410|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
769075|NCT00033410|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
769076|NCT00033410|adenocarcinoma of the lung|adenocarcinoma of the lung
769077|NCT00033397|stage II breast cancer|stage ii breast cancer
769078|NCT00033397|stage IV breast cancer|stage iv breast cancer
769079|NCT00033397|stage IIIA breast cancer|stage iiia breast cancer
769080|NCT00033397|stage IIIB breast cancer|stage iiib breast cancer
769081|NCT00033397|stage IIIC breast cancer|stage iiic breast cancer
769082|NCT00033397|inflammatory breast cancer|inflammatory breast cancer
769083|NCT00033345|breast cancer|breast cancer
769084|NCT00033332|stage I multiple myeloma|stage i multiple myeloma
769085|NCT00033332|stage II multiple myeloma|stage ii multiple myeloma
769086|NCT00033332|stage III multiple myeloma|stage iii multiple myeloma
769087|NCT00033280|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
769088|NCT00033280|adult mixed glioma|adult mixed glioma
769089|NCT00033241|stage II pancreatic cancer|stage ii pancreatic cancer
769090|NCT00033241|stage III pancreatic cancer|stage iii pancreatic cancer
769091|NCT00033241|recurrent pancreatic cancer|recurrent pancreatic cancer
769092|NCT00033241|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
769093|NCT00033241|stage IV pancreatic cancer|stage iv pancreatic cancer
769094|NCT00033228|stage IV melanoma|stage iv melanoma
769095|NCT00033228|recurrent melanoma|recurrent melanoma
769096|NCT00032175|stage III pancreatic cancer|stage iii pancreatic cancer
769097|NCT00032175|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
769098|NCT00032175|stage IV pancreatic cancer|stage iv pancreatic cancer
769099|NCT00032162|stage III cervical cancer|stage iii cervical cancer
769100|NCT00032162|recurrent cervical cancer|recurrent cervical cancer
769101|NCT00032162|stage IB cervical cancer|stage ib cervical cancer
769102|NCT00032162|stage IIB cervical cancer|stage iib cervical cancer
769103|NCT00032162|stage IVB cervical cancer|stage ivb cervical cancer
769104|NCT00032162|stage IA cervical cancer|stage ia cervical cancer
769105|NCT00032162|stage IIA cervical cancer|stage iia cervical cancer
769106|NCT00032162|stage IVA cervical cancer|stage iva cervical cancer
769107|NCT00032162|stage I endometrial carcinoma|stage i endometrial carcinoma
769108|NCT00032162|stage II endometrial carcinoma|stage ii endometrial carcinoma
769109|NCT00032162|stage III endometrial carcinoma|stage iii endometrial carcinoma
769110|NCT00032162|stage IV endometrial carcinoma|stage iv endometrial carcinoma
769111|NCT00032162|recurrent endometrial carcinoma|recurrent endometrial carcinoma
769112|NCT00032162|fallopian tube cancer|fallopian tube cancer
769113|NCT00032162|stage I uterine sarcoma|stage i uterine sarcoma
769114|NCT00032162|stage II uterine sarcoma|stage ii uterine sarcoma
769115|NCT00032162|stage III uterine sarcoma|stage iii uterine sarcoma
769116|NCT00032162|stage IV uterine sarcoma|stage iv uterine sarcoma
769117|NCT00032162|recurrent uterine sarcoma|recurrent uterine sarcoma
769118|NCT00032162|ovarian sarcoma|ovarian sarcoma
769119|NCT00032162|ovarian carcinosarcoma|ovarian carcinosarcoma
769120|NCT00032149|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
769121|NCT00032149|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
769122|NCT00032149|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
769123|NCT00032149|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
769124|NCT00032149|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
769125|NCT00032149|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
769126|NCT00032149|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
769127|NCT00032149|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
769128|NCT00032136|stage I breast cancer|stage i breast cancer
769129|NCT00032136|stage II breast cancer|stage ii breast cancer
769130|NCT00032123|stage IV gastric cancer|stage iv gastric cancer
769131|NCT00032123|stage IV esophageal cancer|stage iv esophageal cancer
785670|NCT00006617|Zidovudine|zidovudine
769132|NCT00032123|adenocarcinoma of the stomach|adenocarcinoma of the stomach
769133|NCT00032123|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
769134|NCT00032123|recurrent esophageal cancer|recurrent esophageal cancer
769135|NCT00032123|recurrent gastric cancer|recurrent gastric cancer
769136|NCT00032097|adult glioblastoma|adult glioblastoma
769137|NCT00032097|adult giant cell glioblastoma|adult giant cell glioblastoma
769138|NCT00032097|adult gliosarcoma|adult gliosarcoma
769139|NCT00032084|non-small cell lung cancer|non-small cell lung cancer
769140|NCT00032084|stage I non-small cell lung cancer|stage i non-small cell lung cancer
769141|NCT00032084|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
769142|NCT00032058|adenocarcinoma of the prostate|adenocarcinoma of the prostate
769143|NCT00032058|stage I prostate cancer|stage i prostate cancer
769144|NCT00032058|stage IIB prostate cancer|stage iib prostate cancer
769145|NCT00032058|stage IIA prostate cancer|stage iia prostate cancer
769146|NCT00032045|iris melanoma|iris melanoma
769147|NCT00032045|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
769148|NCT00032045|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
769149|NCT00032045|extraocular extension melanoma|extraocular extension melanoma
769150|NCT00032045|recurrent intraocular melanoma|recurrent intraocular melanoma
769151|NCT00032045|stage IV melanoma|stage iv melanoma
769152|NCT00032045|recurrent melanoma|recurrent melanoma
769153|NCT00032032|stage I non-small cell lung cancer|stage i non-small cell lung cancer
769154|NCT00032032|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
769155|NCT00032032|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
769156|NCT00032032|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
769157|NCT00032019|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
769158|NCT00032019|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
769159|NCT00032019|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
769160|NCT00032019|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
769161|NCT00032019|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
769162|NCT00032019|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
769163|NCT00032019|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
769164|NCT00032019|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
769165|NCT00032006|adenocarcinoma of the prostate|adenocarcinoma of the prostate
769166|NCT00032006|stage I prostate cancer|stage i prostate cancer
769167|NCT00032006|stage IIB prostate cancer|stage iib prostate cancer
769168|NCT00032006|stage IIA prostate cancer|stage iia prostate cancer
769169|NCT00032006|recurrent prostate cancer|recurrent prostate cancer
769170|NCT00031980|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
769171|NCT00031980|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
769172|NCT00031980|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
769173|NCT00031980|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
769174|NCT00031980|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
769175|NCT00031980|anemia|anemia
769176|NCT00031980|neutropenia|neutropenia
769177|NCT00031980|thrombocytopenia|thrombocytopenia
769178|NCT00031967|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
769179|NCT00031967|tumors metastatic to brain|tumors metastatic to brain
769180|NCT00031967|radiation toxicity|radiation toxicity
769181|NCT00031941|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
769182|NCT00031941|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
769183|NCT00031941|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
769184|NCT00031941|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
769185|NCT00031941|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
769186|NCT00031941|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
769187|NCT00031941|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
769188|NCT00031941|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
769189|NCT00031941|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
769190|NCT00031941|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
769191|NCT00031941|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
769192|NCT00031941|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
769193|NCT00031941|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
769194|NCT00031941|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
769195|NCT00031941|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
769196|NCT00031941|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
769197|NCT00031941|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
769198|NCT00031941|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
769199|NCT00031941|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
769200|NCT00031941|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
769201|NCT00031941|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
769202|NCT00031941|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
769203|NCT00031941|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
769204|NCT00031941|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
769205|NCT00031941|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
769206|NCT00031941|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
769207|NCT00031941|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
769208|NCT00031941|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
769209|NCT00031941|anaplastic large cell lymphoma|anaplastic large cell lymphoma
769210|NCT00031941|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
769211|NCT00031941|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
769212|NCT00031941|small intestine lymphoma|small intestine lymphoma
769213|NCT00031941|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
769214|NCT00031941|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
769215|NCT00031941|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
769216|NCT00031941|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
769217|NCT00031941|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
769218|NCT00031941|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
769219|NCT00031941|splenic marginal zone lymphoma|splenic marginal zone lymphoma
769220|NCT00031928|leptomeningeal metastases|leptomeningeal metastases
769221|NCT00031915|metastatic osteosarcoma|metastatic osteosarcoma
769222|NCT00031915|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
769223|NCT00031915|recurrent osteosarcoma|recurrent osteosarcoma
769224|NCT00031915|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
769225|NCT00031915|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
769226|NCT00031915|pleomorphic childhood rhabdomyosarcoma|pleomorphic childhood rhabdomyosarcoma
769227|NCT00031915|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
769228|NCT00031915|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
769229|NCT00031915|childhood fibrosarcoma|childhood fibrosarcoma
769230|NCT00031915|childhood synovial sarcoma|childhood synovial sarcoma
769231|NCT00031915|childhood liposarcoma|childhood liposarcoma
769232|NCT00031915|childhood alveolar soft-part sarcoma|childhood alveolar soft-part sarcoma
769233|NCT00031915|childhood neurofibrosarcoma|childhood neurofibrosarcoma
769234|NCT00031915|childhood angiosarcoma|childhood angiosarcoma
769235|NCT00031915|childhood malignant fibrous histiocytoma of bone|childhood malignant fibrous histiocytoma of bone
769236|NCT00031915|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
769237|NCT00031915|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
769238|NCT00031915|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
769239|NCT00031915|fibrosarcomatous osteosarcoma|fibrosarcomatous osteosarcoma
769240|NCT00031902|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
769241|NCT00031902|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
769242|NCT00031902|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
769243|NCT00031902|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
769244|NCT00031902|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
769245|NCT00031902|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
769246|NCT00031902|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
769247|NCT00031876|stage IV breast cancer|stage iv breast cancer
769248|NCT00031876|recurrent breast cancer|recurrent breast cancer
769249|NCT00031863|stage II colon cancer|stage ii colon cancer
769250|NCT00031863|stage III colon cancer|stage iii colon cancer
769251|NCT00031863|stage II rectal cancer|stage ii rectal cancer
769252|NCT00031863|stage III rectal cancer|stage iii rectal cancer
769253|NCT00031850|breast cancer|breast cancer
769254|NCT00031837|thromboembolism|thromboembolism
769255|NCT00031837|stage III pancreatic cancer|stage iii pancreatic cancer
769256|NCT00031837|recurrent pancreatic cancer|recurrent pancreatic cancer
769257|NCT00031837|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
769258|NCT00031837|stage IV pancreatic cancer|stage iv pancreatic cancer
769259|NCT00031824|graft versus host disease|graft versus host disease
769260|NCT00031798|fatigue|fatigue
769261|NCT00031798|depression|depression
769262|NCT00031798|quality of life|quality of life
769263|NCT00031798|cognitive/functional effects|cognitive/functional effects
769264|NCT00031798|recurrent adult brain tumor|recurrent adult brain tumor
769265|NCT00031798|adult brain stem glioma|adult brain stem glioma
769266|NCT00031798|adult glioblastoma|adult glioblastoma
769267|NCT00031798|adult tumors metastatic to brain|adult tumors metastatic to brain
769268|NCT00031798|adult anaplastic astrocytoma|adult anaplastic astrocytoma
769269|NCT00031798|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
769270|NCT00031798|adult mixed glioma|adult mixed glioma
769271|NCT00031798|adult meningioma|adult meningioma
769272|NCT00031798|adult anaplastic ependymoma|adult anaplastic ependymoma
769489|NCT00030264|neurofibromatosis type 1|neurofibromatosis type 1
769273|NCT00031798|adult myxopapillary ependymoma|adult myxopapillary ependymoma
769274|NCT00031798|adult ependymoblastoma|adult ependymoblastoma
769275|NCT00031798|adult pilocytic astrocytoma|adult pilocytic astrocytoma
769276|NCT00031798|adult subependymoma|adult subependymoma
769277|NCT00031798|adult grade III meningioma|adult grade iii meningioma
769278|NCT00031798|adult giant cell glioblastoma|adult giant cell glioblastoma
769279|NCT00031798|adult gliosarcoma|adult gliosarcoma
769280|NCT00031798|adult grade II meningioma|adult grade ii meningioma
769281|NCT00031772|recurrent breast cancer|recurrent breast cancer
769282|NCT00031772|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
769283|NCT00031759|cervical cancer|cervical cancer
769284|NCT00031759|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
769285|NCT00031759|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
769286|NCT00031759|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
769287|NCT00031746|prostate cancer|prostate cancer
769288|NCT00031733|iris melanoma|iris melanoma
769289|NCT00031733|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
769290|NCT00031733|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
769291|NCT00031733|extraocular extension melanoma|extraocular extension melanoma
769292|NCT00031733|recurrent intraocular melanoma|recurrent intraocular melanoma
769293|NCT00031733|stage II melanoma|stage ii melanoma
769294|NCT00031733|stage III melanoma|stage iii melanoma
769295|NCT00031733|stage IV melanoma|stage iv melanoma
769296|NCT00031733|recurrent melanoma|recurrent melanoma
769297|NCT00031720|lobular breast carcinoma in situ|lobular breast carcinoma in situ
769298|NCT00031720|stage I breast cancer|stage i breast cancer
769299|NCT00031720|stage II breast cancer|stage ii breast cancer
769300|NCT00031720|stage IIIA breast cancer|stage iiia breast cancer
769301|NCT00031720|recurrent breast cancer|recurrent breast cancer
769302|NCT00031720|ductal breast carcinoma in situ|ductal breast carcinoma in situ
769303|NCT00031720|hot flashes|hot flashes
769304|NCT00031642|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
769305|NCT00031642|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
769306|NCT00031642|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
769307|NCT00031642|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
769308|NCT00031642|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
769309|NCT00031642|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
769310|NCT00031642|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
769311|NCT00031642|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
769312|NCT00031642|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
769313|NCT00031642|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
769314|NCT00031642|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
769315|NCT00031642|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
769316|NCT00031642|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
769317|NCT00031642|splenic marginal zone lymphoma|splenic marginal zone lymphoma
769318|NCT00031616|stage IV colon cancer|stage iv colon cancer
769319|NCT00031616|stage IV rectal cancer|stage iv rectal cancer
769320|NCT00031616|recurrent colon cancer|recurrent colon cancer
769321|NCT00031616|recurrent rectal cancer|recurrent rectal cancer
769322|NCT00031616|adenocarcinoma of the colon|adenocarcinoma of the colon
769323|NCT00031616|adenocarcinoma of the rectum|adenocarcinoma of the rectum
769324|NCT00031590|untreated childhood medulloblastoma|untreated childhood medulloblastoma
769325|NCT00031590|PNET|pnet
769326|NCT00031590|craniospinal radiotherapy|craniospinal radiotherapy
769327|NCT00031577|untreated childhood brain stem glioma|untreated childhood brain stem glioma
769328|NCT00031564|stage IV|stage iv
769329|NCT00031564|renal cell carcinoma|renal cell carcinoma
769330|NCT00030914|hot flashes|hot flashes
769331|NCT00030901|prostate cancer|prostate cancer
769332|NCT00030901|high grade prostatic intraepithelial neoplasia|high grade prostatic intraepithelial neoplasia
769333|NCT00030888|stage III renal cell cancer|stage iii renal cell cancer
769334|NCT00030888|stage IV renal cell cancer|stage iv renal cell cancer
769335|NCT00030888|recurrent renal cell cancer|recurrent renal cell cancer
769336|NCT00030875|stage I mantle cell lymphoma|stage i mantle cell lymphoma
769337|NCT00030875|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
769338|NCT00030875|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
769339|NCT00030875|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
769340|NCT00030875|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
769341|NCT00030875|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
769342|NCT00030862|stage II esophageal cancer|stage ii esophageal cancer
769343|NCT00030862|stage III esophageal cancer|stage iii esophageal cancer
769344|NCT00030862|stage IV esophageal cancer|stage iv esophageal cancer
769345|NCT00030862|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
769346|NCT00030862|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
769347|NCT00030849|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
786065|NCT00005764|Didanosine|didanosine
769348|NCT00030849|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
769349|NCT00030849|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
769350|NCT00030849|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
769351|NCT00030849|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
769352|NCT00030823|stage I breast cancer|stage i breast cancer
769353|NCT00030823|stage II breast cancer|stage ii breast cancer
769354|NCT00030823|stage IV breast cancer|stage iv breast cancer
769355|NCT00030823|stage IIIA breast cancer|stage iiia breast cancer
769356|NCT00030823|recurrent breast cancer|recurrent breast cancer
769357|NCT00030823|stage IIIB breast cancer|stage iiib breast cancer
769358|NCT00030823|stage IIIC breast cancer|stage iiic breast cancer
769359|NCT00030823|male breast cancer|male breast cancer
769360|NCT00030810|squamous cell lung cancer|squamous cell lung cancer
769361|NCT00030810|large cell lung cancer|large cell lung cancer
769362|NCT00030810|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
769363|NCT00030810|adenosquamous cell lung cancer|adenosquamous cell lung cancer
769364|NCT00030784|adult angiosarcoma|adult angiosarcoma
769365|NCT00030784|adult fibrosarcoma|adult fibrosarcoma
769366|NCT00030784|adult leiomyosarcoma|adult leiomyosarcoma
769367|NCT00030784|adult liposarcoma|adult liposarcoma
769368|NCT00030784|adult neurofibrosarcoma|adult neurofibrosarcoma
769369|NCT00030784|adult synovial sarcoma|adult synovial sarcoma
769370|NCT00030784|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
769371|NCT00030784|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
769372|NCT00030784|adult epithelioid sarcoma|adult epithelioid sarcoma
770735|NCT00020579|intraocular lymphoma|intraocular lymphoma
769373|NCT00030784|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
769374|NCT00030784|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
769375|NCT00030784|adult malignant mesenchymoma|adult malignant mesenchymoma
769376|NCT00030784|adult rhabdomyosarcoma|adult rhabdomyosarcoma
769377|NCT00030784|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
769378|NCT00030771|squamous cell lung cancer|squamous cell lung cancer
769379|NCT00030771|large cell lung cancer|large cell lung cancer
769380|NCT00030771|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
769381|NCT00030771|adenosquamous cell lung cancer|adenosquamous cell lung cancer
769382|NCT00030758|neutropenia|neutropenia
769383|NCT00030758|stage I breast cancer|stage i breast cancer
769384|NCT00030758|stage II breast cancer|stage ii breast cancer
769385|NCT00030745|stage IA malignant mesothelioma|stage ia malignant mesothelioma
769386|NCT00030745|stage IB malignant mesothelioma|stage ib malignant mesothelioma
769387|NCT00030745|stage II malignant mesothelioma|stage ii malignant mesothelioma
769388|NCT00030745|stage III malignant mesothelioma|stage iii malignant mesothelioma
769389|NCT00030732|stage III pancreatic cancer|stage iii pancreatic cancer
769390|NCT00030732|recurrent pancreatic cancer|recurrent pancreatic cancer
769391|NCT00030732|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
769392|NCT00030732|stage IV pancreatic cancer|stage iv pancreatic cancer
769393|NCT00030719|regional neuroblastoma|regional neuroblastoma
769394|NCT00030719|disseminated neuroblastoma|disseminated neuroblastoma
769395|NCT00030719|stage 4S neuroblastoma|stage 4s neuroblastoma
769396|NCT00030719|localized unresectable neuroblastoma|localized unresectable neuroblastoma
769397|NCT00030706|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
769398|NCT00030706|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
769399|NCT00030706|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
769400|NCT00030706|peritoneal cavity cancer|peritoneal cavity cancer
769401|NCT00030680|desmoid tumor|desmoid tumor
769402|NCT00030654|adenocarcinoma of the prostate|adenocarcinoma of the prostate
769403|NCT00030654|stage IIB prostate cancer|stage iib prostate cancer
769404|NCT00030654|stage IIA prostate cancer|stage iia prostate cancer
769405|NCT00030654|stage III prostate cancer|stage iii prostate cancer
769406|NCT00030654|stage IV prostate cancer|stage iv prostate cancer
769407|NCT00030654|recurrent prostate cancer|recurrent prostate cancer
769408|NCT00030641|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
769409|NCT00030641|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
769410|NCT00030641|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
769411|NCT00030628|tumors metastatic to brain|tumors metastatic to brain
769412|NCT00030589|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
769413|NCT00030589|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
769414|NCT00030589|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
769415|NCT00030589|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
769416|NCT00030589|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
769417|NCT00030589|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
769418|NCT00030576|recurrent metastatic squamous neck cancer occult primary|recurrent metastatic squamous neck cancer occult primary
769419|NCT00030576|neck cancer with occult primary squamous carcinoma|neck cancer with occult primary squamous carcinoma
769420|NCT00030576|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
769900|NCT00027534|stage IV gastric cancer|stage iv gastric cancer
769421|NCT00030576|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
769422|NCT00030576|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
769423|NCT00030576|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
769424|NCT00030576|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
769425|NCT00030576|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
769426|NCT00030576|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
769427|NCT00030576|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
769428|NCT00030576|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
769429|NCT00030576|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
769430|NCT00030576|squamous cell carcinoma of paranasal sinus and nasal cavity|squamous cell carcinoma of paranasal sinus and nasal cavity
769431|NCT00030576|recurrent squamous cell carcinoma of sinus and nasal cavity|recurrent squamous cell carcinoma of sinus and nasal cavity
769432|NCT00030563|liver metastases|liver metastases
769433|NCT00030563|stage IV colon cancer|stage iv colon cancer
769434|NCT00030563|stage IV rectal cancer|stage iv rectal cancer
769435|NCT00030563|adenocarcinoma of the colon|adenocarcinoma of the colon
769436|NCT00030563|adenocarcinoma of the rectum|adenocarcinoma of the rectum
769437|NCT00030563|recurrent colon cancer|recurrent colon cancer
769438|NCT00030563|recurrent rectal cancer|recurrent rectal cancer
769439|NCT00030550|refractory anemia|refractory anemia
769440|NCT00030550|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
769441|NCT00030550|refractory anemia with excess blasts|refractory anemia with excess blasts
769442|NCT00030550|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
769443|NCT00030550|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
769444|NCT00030550|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
769445|NCT00030550|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
769446|NCT00030550|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
769447|NCT00030537|stage IV breast cancer|stage iv breast cancer
769448|NCT00030537|recurrent breast cancer|recurrent breast cancer
769449|NCT00030537|stage IIIB breast cancer|stage iiib breast cancer
769450|NCT00030537|male breast cancer|male breast cancer
769451|NCT00030511|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
769452|NCT00030511|recurrent adult primary liver cancer|recurrent adult primary liver cancer
769453|NCT00030511|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
769454|NCT00030511|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
769455|NCT00030485|stage IV endometrial carcinoma|stage iv endometrial carcinoma
769456|NCT00030485|recurrent endometrial carcinoma|recurrent endometrial carcinoma
769457|NCT00030485|endometrial adenocarcinoma|endometrial adenocarcinoma
769458|NCT00030485|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
769459|NCT00030472|recurrent cervical cancer|recurrent cervical cancer
769460|NCT00030472|stage IVB cervical cancer|stage ivb cervical cancer
769461|NCT00030472|cervical squamous cell carcinoma|cervical squamous cell carcinoma
769462|NCT00030459|localized malignant mesothelioma|localized malignant mesothelioma
769463|NCT00030459|advanced malignant mesothelioma|advanced malignant mesothelioma
769464|NCT00030459|recurrent malignant mesothelioma|recurrent malignant mesothelioma
769465|NCT00030433|extensive stage small cell lung cancer|extensive stage small cell lung cancer
769466|NCT00030407|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
769467|NCT00030407|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
769468|NCT00030355|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
769469|NCT00030355|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
769470|NCT00030355|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
771129|NCT00019773|recurrent rectal cancer|recurrent rectal cancer
769471|NCT00030355|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
769472|NCT00030355|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
769473|NCT00030342|stage IV colon cancer|stage iv colon cancer
769474|NCT00030342|stage IV rectal cancer|stage iv rectal cancer
769475|NCT00030342|recurrent colon cancer|recurrent colon cancer
769476|NCT00030342|recurrent rectal cancer|recurrent rectal cancer
769477|NCT00030342|stage IV renal cell cancer|stage iv renal cell cancer
769478|NCT00030342|recurrent renal cell cancer|recurrent renal cell cancer
769479|NCT00030303|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
769480|NCT00030303|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
769481|NCT00030290|stage I prostate cancer|stage i prostate cancer
769482|NCT00030290|stage IIB prostate cancer|stage iib prostate cancer
769483|NCT00030290|stage IIA prostate cancer|stage iia prostate cancer
769484|NCT00030277|stage I prostate cancer|stage i prostate cancer
769485|NCT00030277|stage IIB prostate cancer|stage iib prostate cancer
769486|NCT00030277|stage IIA prostate cancer|stage iia prostate cancer
769487|NCT00030277|recurrent prostate cancer|recurrent prostate cancer
769488|NCT00030264|plexiform neurofibroma|plexiform neurofibroma
786268|NCT00004855|Nevirapine|nevirapine
769490|NCT00030108|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
769491|NCT00030108|childhood craniopharyngioma|childhood craniopharyngioma
769492|NCT00030108|recurrent neuroblastoma|recurrent neuroblastoma
769493|NCT00030108|recurrent childhood liver cancer|recurrent childhood liver cancer
769494|NCT00030108|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
769495|NCT00030108|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
769496|NCT00030108|recurrent osteosarcoma|recurrent osteosarcoma
769497|NCT00030108|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
769498|NCT00030108|childhood germ cell tumor|childhood germ cell tumor
769499|NCT00030108|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
769500|NCT00030108|childhood oligodendroglioma|childhood oligodendroglioma
769501|NCT00030108|childhood choroid plexus tumor|childhood choroid plexus tumor
769502|NCT00030108|childhood grade I meningioma|childhood grade i meningioma
769503|NCT00030108|childhood grade II meningioma|childhood grade ii meningioma
769504|NCT00030108|childhood grade III meningioma|childhood grade iii meningioma
769505|NCT00030108|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
769506|NCT00030108|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
769507|NCT00030108|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
769508|NCT00030108|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
769509|NCT00030108|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
769510|NCT00030108|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
769511|NCT00030108|recurrent childhood ependymoma|recurrent childhood ependymoma
769512|NCT00030108|childhood teratoma|childhood teratoma
769513|NCT00030108|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
769514|NCT00030108|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
769515|NCT00030108|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
769516|NCT00030108|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
769517|NCT00030108|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
769518|NCT00030108|childhood acute basophilic leukemia|childhood acute basophilic leukemia
769519|NCT00030108|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
769520|NCT00030108|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
769521|NCT00030108|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
769522|NCT00030108|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
769523|NCT00030108|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
769524|NCT00030108|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
769525|NCT00030108|L3 childhood acute lymphoblastic leukemia|l3 childhood acute lymphoblastic leukemia
769526|NCT00030108|non-T, non-B, cALLa negative childhood acute lymphoblastic leukemia|non-t, non-b, calla negative childhood acute lymphoblastic leukemia
769527|NCT00030108|non-T, non-B, cALLa positive childhood acute lymphoblastic leukemia|non-t, non-b, calla positive childhood acute lymphoblastic leukemia
769528|NCT00030108|non-T, non-B, cALLa positive, pre-B childhood acute lymphoblastic leukemia|non-t, non-b, calla positive, pre-b childhood acute lymphoblastic leukemia
769529|NCT00030108|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
769530|NCT00030108|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
769531|NCT00030108|TdT negative childhood acute lymphoblastic leukemia|tdt negative childhood acute lymphoblastic leukemia
769532|NCT00030108|TdT positive childhood acute lymphoblastic leukemia|tdt positive childhood acute lymphoblastic leukemia
769533|NCT00030108|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
769534|NCT00030108|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
769535|NCT00030095|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
769536|NCT00030082|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
769537|NCT00030082|advanced adult primary liver cancer|advanced adult primary liver cancer
769538|NCT00030082|recurrent adult primary liver cancer|recurrent adult primary liver cancer
769539|NCT00030082|liver metastases|liver metastases
769540|NCT00029029|bone metastases|bone metastases
769542|NCT00028990|stage IV breast cancer|stage iv breast cancer
769543|NCT00028990|recurrent breast cancer|recurrent breast cancer
769544|NCT00028990|male breast cancer|male breast cancer
769545|NCT00028977|stage IV breast cancer|stage iv breast cancer
769546|NCT00028977|recurrent breast cancer|recurrent breast cancer
769547|NCT00028964|stage I breast cancer|stage i breast cancer
769548|NCT00028964|stage II breast cancer|stage ii breast cancer
769549|NCT00028964|stage IIIA breast cancer|stage iiia breast cancer
769550|NCT00028964|recurrent breast cancer|recurrent breast cancer
769551|NCT00028964|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
769552|NCT00028951|lymphedema|lymphedema
769553|NCT00028951|perioperative/postoperative complications|perioperative/postoperative complications
769554|NCT00028951|stage I vulvar cancer|stage i vulvar cancer
769555|NCT00028951|stage II vulvar cancer|stage ii vulvar cancer
769556|NCT00028951|stage III vulvar cancer|stage iii vulvar cancer
769557|NCT00028951|stage IVB vulvar cancer|stage ivb vulvar cancer
769558|NCT00028912|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
769559|NCT00028912|primary peritoneal cavity cancer|primary peritoneal cavity cancer
769560|NCT00028912|fallopian tube cancer|fallopian tube cancer
769561|NCT00028899|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
769562|NCT00028899|secondary acute myeloid leukemia|secondary acute myeloid leukemia
769563|NCT00028899|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
769564|NCT00028886|stage II multiple myeloma|stage ii multiple myeloma
769565|NCT00028886|stage III multiple myeloma|stage iii multiple myeloma
769566|NCT00028873|stage IV breast cancer|stage iv breast cancer
769567|NCT00028873|recurrent breast cancer|recurrent breast cancer
769568|NCT00028860|stage III bladder cancer|stage iii bladder cancer
769569|NCT00028860|stage IV bladder cancer|stage iv bladder cancer
769570|NCT00028860|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
769571|NCT00028860|localized transitional cell cancer of the renal pelvis and ureter|localized transitional cell cancer of the renal pelvis and ureter
769572|NCT00028860|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
769573|NCT00028847|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
769574|NCT00028847|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
769575|NCT00028795|childhood brain stem glioma|childhood brain stem glioma
769576|NCT00028795|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
769577|NCT00028795|childhood spinal cord neoplasm|childhood spinal cord neoplasm
769578|NCT00028795|untreated childhood brain stem glioma|untreated childhood brain stem glioma
769579|NCT00028769|adenocarcinoma of the prostate|adenocarcinoma of the prostate
769580|NCT00028769|stage IV prostate cancer|stage iv prostate cancer
769581|NCT00028769|recurrent prostate cancer|recurrent prostate cancer
769582|NCT00028743|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
769583|NCT00028743|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
769584|NCT00028743|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
769585|NCT00028743|fallopian tube cancer|fallopian tube cancer
769586|NCT00028743|peritoneal cavity cancer|peritoneal cavity cancer
769587|NCT00028730|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
769588|NCT00028730|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
769589|NCT00028730|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
769590|NCT00028730|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
769591|NCT00028730|secondary acute myeloid leukemia|secondary acute myeloid leukemia
769592|NCT00028730|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
769593|NCT00028730|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
769594|NCT00028730|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
769595|NCT00028730|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
769596|NCT00028730|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
769597|NCT00028730|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
769598|NCT00028717|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
769599|NCT00028717|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
769600|NCT00028717|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
769601|NCT00028717|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
769602|NCT00028717|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
769603|NCT00028717|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
769604|NCT00028717|stage I mantle cell lymphoma|stage i mantle cell lymphoma
769605|NCT00028717|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
769606|NCT00028717|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
769607|NCT00028717|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
769608|NCT00028717|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
769609|NCT00028717|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
769610|NCT00028717|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
769611|NCT00028717|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
769612|NCT00028717|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
769613|NCT00028704|stage II breast cancer|stage ii breast cancer
769614|NCT00028704|stage IIIA breast cancer|stage iiia breast cancer
769615|NCT00028704|stage IIIB breast cancer|stage iiib breast cancer
769616|NCT00028704|inflammatory breast cancer|inflammatory breast cancer
769617|NCT00028691|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
769618|NCT00028691|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
769619|NCT00028691|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
769620|NCT00028691|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
769621|NCT00028691|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
769622|NCT00028691|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
769623|NCT00028665|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
769901|NCT00027534|recurrent pancreatic cancer|recurrent pancreatic cancer
769624|NCT00028665|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
769625|NCT00028665|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
769626|NCT00028665|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
769627|NCT00028665|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
769628|NCT00028665|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
769629|NCT00028665|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
769630|NCT00028665|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
769631|NCT00028665|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
769632|NCT00028665|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
769633|NCT00028665|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
769634|NCT00028665|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
769635|NCT00028665|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
769636|NCT00028665|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
769637|NCT00028665|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
769638|NCT00028665|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
769639|NCT00028665|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
769640|NCT00028665|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
769641|NCT00028665|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
769642|NCT00028665|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
769643|NCT00028665|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
769644|NCT00028665|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
769645|NCT00028665|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
769646|NCT00028665|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
769647|NCT00028665|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
769648|NCT00028665|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
769649|NCT00028652|skin metastases|skin metastases
769650|NCT00028639|stage IV breast cancer|stage iv breast cancer
769651|NCT00028639|recurrent breast cancer|recurrent breast cancer
769652|NCT00028626|liver metastases|liver metastases
769653|NCT00028626|adenocarcinoma of the colon|adenocarcinoma of the colon
769654|NCT00028626|recurrent colon cancer|recurrent colon cancer
769655|NCT00028626|stage IV colon cancer|stage iv colon cancer
769656|NCT00028626|adenocarcinoma of the rectum|adenocarcinoma of the rectum
769657|NCT00028626|recurrent rectal cancer|recurrent rectal cancer
769658|NCT00028626|stage IV rectal cancer|stage iv rectal cancer
769659|NCT00028600|refractory multiple myeloma|refractory multiple myeloma
769660|NCT00028600|stage I multiple myeloma|stage i multiple myeloma
769661|NCT00028600|stage II multiple myeloma|stage ii multiple myeloma
769662|NCT00028600|stage III multiple myeloma|stage iii multiple myeloma
769663|NCT00028574|stage I prostate cancer|stage i prostate cancer
769664|NCT00028574|stage IIB prostate cancer|stage iib prostate cancer
769665|NCT00028574|stage IIA prostate cancer|stage iia prostate cancer
769666|NCT00028574|stage III prostate cancer|stage iii prostate cancer
769667|NCT00028574|stage IV prostate cancer|stage iv prostate cancer
769668|NCT00028574|recurrent prostate cancer|recurrent prostate cancer
769669|NCT00028574|hot flashes|hot flashes
769670|NCT00028548|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
769671|NCT00028509|neurotoxicity|neurotoxicity
769672|NCT00028509|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
769673|NCT00028015|stage IV colon cancer|stage iv colon cancer
769674|NCT00028015|stage IV rectal cancer|stage iv rectal cancer
769675|NCT00028015|recurrent colon cancer|recurrent colon cancer
769676|NCT00028015|recurrent rectal cancer|recurrent rectal cancer
769677|NCT00027989|stage IV breast cancer|stage iv breast cancer
769678|NCT00027976|actinic keratosis|actinic keratosis
769679|NCT00027963|neurotoxicity|neurotoxicity
769680|NCT00027963|pain|pain
769681|NCT00027937|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
769682|NCT00027937|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
769683|NCT00027937|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
769684|NCT00027937|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
769685|NCT00027937|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
769686|NCT00027937|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
769687|NCT00027937|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
769688|NCT00027937|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
769689|NCT00027937|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
769690|NCT00027937|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
769691|NCT00027937|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
769692|NCT00027937|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
769693|NCT00027937|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
769694|NCT00027937|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
769695|NCT00027937|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
769696|NCT00027937|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
769697|NCT00027937|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
769698|NCT00027937|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
769699|NCT00027937|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
769700|NCT00027937|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
769701|NCT00027937|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
769702|NCT00027937|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
769703|NCT00027937|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
769704|NCT00027937|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
769705|NCT00027937|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
769706|NCT00027937|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
769707|NCT00027937|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
769708|NCT00027937|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
769709|NCT00027937|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
769710|NCT00027937|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
769711|NCT00027937|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
769712|NCT00027937|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
769713|NCT00027937|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
769714|NCT00027937|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
769715|NCT00027937|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
769716|NCT00027937|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
769717|NCT00027937|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
769718|NCT00027937|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
769719|NCT00027937|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
769720|NCT00027937|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
769721|NCT00027937|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
769722|NCT00027937|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
769723|NCT00027937|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
769724|NCT00027937|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
769725|NCT00027937|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
769726|NCT00027937|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
769727|NCT00027937|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
769728|NCT00027937|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
769729|NCT00027937|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
769730|NCT00027937|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
769731|NCT00027937|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
769732|NCT00027937|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
769733|NCT00027937|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
769734|NCT00027937|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
769735|NCT00027937|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
769736|NCT00027937|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
769737|NCT00027937|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
769738|NCT00027937|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
769739|NCT00027937|stage I mantle cell lymphoma|stage i mantle cell lymphoma
769740|NCT00027937|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
769741|NCT00027937|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
769742|NCT00027937|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
769743|NCT00027937|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
769744|NCT00027937|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
769745|NCT00027937|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
769746|NCT00027937|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
769747|NCT00027937|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
769748|NCT00027937|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
769749|NCT00027937|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
769750|NCT00027937|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
769751|NCT00027937|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
769752|NCT00027937|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
769753|NCT00027937|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
769754|NCT00027937|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
769755|NCT00027937|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
769756|NCT00027937|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
769757|NCT00027937|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
771884|NCT00014599|recurrent vulvar cancer|recurrent vulvar cancer
769758|NCT00027937|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
769759|NCT00027937|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
769760|NCT00027937|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
769761|NCT00027937|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
769762|NCT00027937|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
769763|NCT00027937|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
769764|NCT00027937|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
769765|NCT00027937|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
769766|NCT00027937|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
769767|NCT00027937|stage I marginal zone lymphoma|stage i marginal zone lymphoma
769768|NCT00027937|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
769769|NCT00027937|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
769770|NCT00027937|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
769771|NCT00027937|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
769772|NCT00027937|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
769773|NCT00027937|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
769774|NCT00027937|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
769775|NCT00027937|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
769776|NCT00027937|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
769777|NCT00027937|splenic marginal zone lymphoma|splenic marginal zone lymphoma
769778|NCT00027911|adult synovial sarcoma|adult synovial sarcoma
769779|NCT00027911|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
769780|NCT00027911|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
769781|NCT00027911|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
769782|NCT00027911|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
769783|NCT00027885|stage IV breast cancer|stage iv breast cancer
769784|NCT00027885|stage IIIA breast cancer|stage iiia breast cancer
769785|NCT00027885|stage IIIB breast cancer|stage iiib breast cancer
769786|NCT00027885|stage IIIC breast cancer|stage iiic breast cancer
769787|NCT00027885|male breast cancer|male breast cancer
769788|NCT00027859|adenocarcinoma of the prostate|adenocarcinoma of the prostate
769789|NCT00027859|stage III prostate cancer|stage iii prostate cancer
769790|NCT00027846|childhood supratentorial ependymoma|childhood supratentorial ependymoma
769791|NCT00027846|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
769792|NCT00027846|childhood infratentorial ependymoma|childhood infratentorial ependymoma
769793|NCT00027833|stage IV colon cancer|stage iv colon cancer
769794|NCT00027833|stage IV rectal cancer|stage iv rectal cancer
769795|NCT00027833|adenocarcinoma of the colon|adenocarcinoma of the colon
769796|NCT00027833|adenocarcinoma of the rectum|adenocarcinoma of the rectum
769797|NCT00027807|stage IV breast cancer|stage iv breast cancer
769798|NCT00027807|recurrent breast cancer|recurrent breast cancer
769799|NCT00027807|ductal breast carcinoma|ductal breast carcinoma
769800|NCT00027794|adenocarcinoma of the prostate|adenocarcinoma of the prostate
769801|NCT00027794|stage III prostate cancer|stage iii prostate cancer
769802|NCT00027781|adenocarcinoma of the prostate|adenocarcinoma of the prostate
769803|NCT00027781|recurrent prostate cancer|recurrent prostate cancer
769804|NCT00027768|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
769805|NCT00027768|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
769806|NCT00027742|iris melanoma|iris melanoma
769807|NCT00027742|extraocular extension melanoma|extraocular extension melanoma
769808|NCT00027742|recurrent intraocular melanoma|recurrent intraocular melanoma
769809|NCT00027742|stage III melanoma|stage iii melanoma
769810|NCT00027742|stage IV melanoma|stage iv melanoma
769811|NCT00027742|recurrent melanoma|recurrent melanoma
769812|NCT00027729|recurrent colon cancer|recurrent colon cancer
769813|NCT00027729|recurrent rectal cancer|recurrent rectal cancer
769814|NCT00027716|metastatic osteosarcoma|metastatic osteosarcoma
769815|NCT00027716|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
769816|NCT00027716|recurrent osteosarcoma|recurrent osteosarcoma
769817|NCT00027716|adult rhabdomyosarcoma|adult rhabdomyosarcoma
769818|NCT00027716|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
769819|NCT00027716|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
769820|NCT00027716|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
769821|NCT00027677|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
769822|NCT00027664|stage IV renal cell cancer|stage iv renal cell cancer
769823|NCT00027638|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
769824|NCT00027638|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
769825|NCT00027638|gastrinoma|gastrinoma
769826|NCT00027638|insulinoma|insulinoma
769827|NCT00027638|recurrent islet cell carcinoma|recurrent islet cell carcinoma
769828|NCT00027638|WDHA syndrome|wdha syndrome
769829|NCT00027638|somatostatinoma|somatostatinoma
769830|NCT00027638|pancreatic polypeptide tumor|pancreatic polypeptide tumor
769831|NCT00027638|glucagonoma|glucagonoma
769832|NCT00027638|pulmonary carcinoid tumor|pulmonary carcinoid tumor
769833|NCT00027625|recurrent adult brain tumor|recurrent adult brain tumor
769834|NCT00027625|adult glioblastoma|adult glioblastoma
769835|NCT00027625|adult anaplastic astrocytoma|adult anaplastic astrocytoma
769836|NCT00027625|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
769837|NCT00027625|adult mixed glioma|adult mixed glioma
769838|NCT00027625|adult giant cell glioblastoma|adult giant cell glioblastoma
769839|NCT00027625|adult gliosarcoma|adult gliosarcoma
769840|NCT00027586|stage IV melanoma|stage iv melanoma
769841|NCT00027586|recurrent melanoma|recurrent melanoma
769842|NCT00027586|Imatinib Mesylate|imatinib mesylate
769843|NCT00027586|Gleevec|gleevec
769844|NCT00027586|protein tyrosine kinases|protein tyrosine kinases
769846|NCT00027586|Gleevec targets|gleevec targets
769847|NCT00027586|metastatic melanoma|metastatic melanoma
769848|NCT00027573|stage IV renal cell cancer|stage iv renal cell cancer
769849|NCT00027573|recurrent renal cell cancer|recurrent renal cell cancer
769850|NCT00027573|clear cell renal cell carcinoma|clear cell renal cell carcinoma
769851|NCT00027573|papillary renal cell carcinoma|papillary renal cell carcinoma
769852|NCT00027560|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
769853|NCT00027560|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
769854|NCT00027560|refractory multiple myeloma|refractory multiple myeloma
769855|NCT00027560|stage II multiple myeloma|stage ii multiple myeloma
769856|NCT00027560|stage III multiple myeloma|stage iii multiple myeloma
769857|NCT00027560|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
769858|NCT00027560|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
769859|NCT00027560|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
769860|NCT00027560|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
769861|NCT00027560|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
769862|NCT00027560|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
769863|NCT00027560|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
769864|NCT00027560|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
769865|NCT00027560|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
769866|NCT00027560|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
769867|NCT00027560|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
769868|NCT00027560|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
769869|NCT00027560|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
769870|NCT00027560|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
769871|NCT00027560|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
769872|NCT00027560|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
769873|NCT00027560|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
769874|NCT00027560|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
769875|NCT00027560|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
769876|NCT00027560|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
769877|NCT00027560|Waldenström macroglobulinemia|waldenström macroglobulinemia
769878|NCT00027560|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
769879|NCT00027560|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
769880|NCT00027560|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
769881|NCT00027560|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
769882|NCT00027560|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
769883|NCT00027560|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
769884|NCT00027560|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
769885|NCT00027560|splenic marginal zone lymphoma|splenic marginal zone lymphoma
769886|NCT00027560|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
769887|NCT00027560|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
769888|NCT00027547|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
769889|NCT00027547|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
769890|NCT00027534|recurrent colon cancer|recurrent colon cancer
769891|NCT00027534|stage III colon cancer|stage iii colon cancer
769892|NCT00027534|stage IV colon cancer|stage iv colon cancer
769893|NCT00027534|recurrent breast cancer|recurrent breast cancer
769894|NCT00027534|stage IIIA breast cancer|stage iiia breast cancer
769895|NCT00027534|stage IIIB breast cancer|stage iiib breast cancer
769896|NCT00027534|stage IIIC breast cancer|stage iiic breast cancer
769897|NCT00027534|stage IV breast cancer|stage iv breast cancer
769898|NCT00027534|recurrent gastric cancer|recurrent gastric cancer
769899|NCT00027534|stage III gastric cancer|stage iii gastric cancer
769902|NCT00027534|stage II pancreatic cancer|stage ii pancreatic cancer
769903|NCT00027534|stage III pancreatic cancer|stage iii pancreatic cancer
769904|NCT00027534|recurrent rectal cancer|recurrent rectal cancer
769905|NCT00027534|stage III rectal cancer|stage iii rectal cancer
769906|NCT00027534|stage IV rectal cancer|stage iv rectal cancer
769907|NCT00027534|advanced adult primary liver cancer|advanced adult primary liver cancer
769908|NCT00027534|recurrent adult primary liver cancer|recurrent adult primary liver cancer
769909|NCT00027534|recurrent gallbladder cancer|recurrent gallbladder cancer
769910|NCT00027534|unresectable gallbladder cancer|unresectable gallbladder cancer
769911|NCT00027534|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
769912|NCT00027534|recurrent salivary gland cancer|recurrent salivary gland cancer
769913|NCT00027534|stage III salivary gland cancer|stage iii salivary gland cancer
769914|NCT00027534|stage IV salivary gland cancer|stage iv salivary gland cancer
769915|NCT00027534|Paget disease of the breast with intraductal carcinoma|paget disease of the breast with intraductal carcinoma
769916|NCT00027534|Paget disease of the breast with invasive ductal carcinoma|paget disease of the breast with invasive ductal carcinoma
769917|NCT00027534|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
769918|NCT00027534|diffuse adenocarcinoma of the stomach|diffuse adenocarcinoma of the stomach
769919|NCT00027534|intestinal adenocarcinoma of the stomach|intestinal adenocarcinoma of the stomach
769920|NCT00027534|mixed adenocarcinoma of the stomach|mixed adenocarcinoma of the stomach
769921|NCT00027534|adenocarcinoma of the colon|adenocarcinoma of the colon
769922|NCT00027534|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
769923|NCT00027534|adenocarcinoma of the rectum|adenocarcinoma of the rectum
769924|NCT00027534|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
769925|NCT00027534|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
769926|NCT00027534|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
769927|NCT00027534|male breast cancer|male breast cancer
769928|NCT00027534|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
769929|NCT00027534|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
769930|NCT00027534|salivary gland adenocarcinoma|salivary gland adenocarcinoma
769931|NCT00027534|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
769932|NCT00027534|stage IV pancreatic cancer|stage iv pancreatic cancer
769933|NCT00027495|colon cancer|colon cancer
769934|NCT00026533|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
769935|NCT00026533|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
769936|NCT00026533|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
769937|NCT00026533|recurrent thyroid cancer|recurrent thyroid cancer
769938|NCT00026533|insular thyroid cancer|insular thyroid cancer
769939|NCT00026494|tumors metastatic to brain|tumors metastatic to brain
769940|NCT00026468|colon cancer|colon cancer
769941|NCT00026468|rectal cancer|rectal cancer
769942|NCT00026468|small intestine cancer|small intestine cancer
769943|NCT00026442|stage IV breast cancer|stage iv breast cancer
769944|NCT00026442|stage IIIA breast cancer|stage iiia breast cancer
769945|NCT00026442|stage IIIB breast cancer|stage iiib breast cancer
769946|NCT00026442|stage IIIC breast cancer|stage iiic breast cancer
769947|NCT00026416|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
769948|NCT00026416|localized osteosarcoma|localized osteosarcoma
769949|NCT00026416|metastatic osteosarcoma|metastatic osteosarcoma
769950|NCT00026416|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
769951|NCT00026416|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
769952|NCT00026403|stage III pancreatic cancer|stage iii pancreatic cancer
769953|NCT00026403|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
769954|NCT00026403|stage IV pancreatic cancer|stage iv pancreatic cancer
769955|NCT00026338|stage III pancreatic cancer|stage iii pancreatic cancer
769956|NCT00026338|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
769957|NCT00026338|stage IV pancreatic cancer|stage iv pancreatic cancer
769958|NCT00026299|stage IV colon cancer|stage iv colon cancer
769959|NCT00026299|stage IV rectal cancer|stage iv rectal cancer
769960|NCT00026299|recurrent colon cancer|recurrent colon cancer
769961|NCT00026299|recurrent rectal cancer|recurrent rectal cancer
769962|NCT00026299|adenocarcinoma of the colon|adenocarcinoma of the colon
769963|NCT00026299|adenocarcinoma of the rectum|adenocarcinoma of the rectum
769964|NCT00026247|bone metastases|bone metastases
769966|NCT00026247|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
769967|NCT00026195|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
769968|NCT00026156|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
769969|NCT00026156|squamous cell lung cancer|squamous cell lung cancer
769970|NCT00026156|large cell lung cancer|large cell lung cancer
769971|NCT00026156|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
769972|NCT00026156|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
769973|NCT00026156|adenocarcinoma of the lung|adenocarcinoma of the lung
769974|NCT00026130|stage II pancreatic cancer|stage ii pancreatic cancer
769975|NCT00026130|stage III pancreatic cancer|stage iii pancreatic cancer
769976|NCT00026130|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
769977|NCT00026117|stage IV colon cancer|stage iv colon cancer
769978|NCT00026117|stage IV breast cancer|stage iv breast cancer
769979|NCT00026117|recurrent breast cancer|recurrent breast cancer
769980|NCT00026117|stage IV rectal cancer|stage iv rectal cancer
769981|NCT00026117|recurrent colon cancer|recurrent colon cancer
769982|NCT00026117|recurrent rectal cancer|recurrent rectal cancer
769983|NCT00026117|male breast cancer|male breast cancer
769984|NCT00026078|stage IV breast cancer|stage iv breast cancer
769985|NCT00026078|recurrent breast cancer|recurrent breast cancer
769986|NCT00025675|recurrent adult brain tumor|recurrent adult brain tumor
769987|NCT00025675|adult meningioma|adult meningioma
769988|NCT00025675|adult glioblastoma|adult glioblastoma
769989|NCT00025675|adult anaplastic astrocytoma|adult anaplastic astrocytoma
769990|NCT00025675|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
769991|NCT00025675|adult pilocytic astrocytoma|adult pilocytic astrocytoma
769992|NCT00025675|adult subependymoma|adult subependymoma
769993|NCT00025675|adult mixed glioma|adult mixed glioma
769994|NCT00025675|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
769995|NCT00025675|adult grade III meningioma|adult grade iii meningioma
769996|NCT00025675|adult giant cell glioblastoma|adult giant cell glioblastoma
769997|NCT00025675|adult gliosarcoma|adult gliosarcoma
769998|NCT00025675|adult grade I meningioma|adult grade i meningioma
769999|NCT00025675|adult grade II meningioma|adult grade ii meningioma
770000|NCT00025662|Peripheral Blood Stem Cell|peripheral blood stem cell
770001|NCT00025662|Melphalan|melphalan
770002|NCT00025662|Fludarabine|fludarabine
770003|NCT00025662|Donor Apheresis|donor apheresis
770004|NCT00025662|Non-Myeloablative|non-myeloablative
770005|NCT00025662|MDS|mds
770006|NCT00025662|Chronic Myeloid Leukemia|chronic myeloid leukemia
770007|NCT00025662|CML|cml
770008|NCT00025662|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
770009|NCT00025662|CLL|cll
770010|NCT00025662|Lymphoma|lymphoma
770011|NCT00025662|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
770012|NCT00025662|Hodgkin's Disease|hodgkin's disease
770013|NCT00025662|Mantle Cell Lymphoma|mantle cell lymphoma
770014|NCT00025662|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
770015|NCT00025662|Chronic Myeloid Leukemia (CML)|chronic myeloid leukemia (cml)
770016|NCT00025662|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
770017|NCT00025662|Myelodysplasia (MDS)|myelodysplasia (mds)
770018|NCT00025662|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
770019|NCT00025662|Bone Marrow Transplant|bone marrow transplant
770020|NCT00025649|localized resectable neuroblastoma|localized resectable neuroblastoma
770021|NCT00025649|regional neuroblastoma|regional neuroblastoma
770022|NCT00025649|disseminated neuroblastoma|disseminated neuroblastoma
770023|NCT00025649|stage 4S neuroblastoma|stage 4s neuroblastoma
770024|NCT00025649|localized unresectable neuroblastoma|localized unresectable neuroblastoma
770025|NCT00025636|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
770026|NCT00025623|disseminated neuroblastoma|disseminated neuroblastoma
770027|NCT00025610|disseminated neuroblastoma|disseminated neuroblastoma
770028|NCT00025610|stage 4S neuroblastoma|stage 4s neuroblastoma
770029|NCT00025597|localized unresectable neuroblastoma|localized unresectable neuroblastoma
770030|NCT00025558|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
770031|NCT00025558|recurrent adult brain tumor|recurrent adult brain tumor
770032|NCT00025558|adult medulloblastoma|adult medulloblastoma
770033|NCT00025558|adult glioblastoma|adult glioblastoma
770034|NCT00025558|adult anaplastic astrocytoma|adult anaplastic astrocytoma
770035|NCT00025558|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
770036|NCT00025558|adult mixed glioma|adult mixed glioma
770037|NCT00025558|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
770038|NCT00025558|adult pineoblastoma|adult pineoblastoma
770039|NCT00025558|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
770040|NCT00025558|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
770041|NCT00025558|recurrent childhood ependymoma|recurrent childhood ependymoma
770042|NCT00025558|adult giant cell glioblastoma|adult giant cell glioblastoma
770043|NCT00025558|adult gliosarcoma|adult gliosarcoma
770044|NCT00025558|adult anaplastic ependymoma|adult anaplastic ependymoma
770045|NCT00025558|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
770046|NCT00025519|stage IV renal cell cancer|stage iv renal cell cancer
770047|NCT00025519|recurrent renal cell cancer|recurrent renal cell cancer
770048|NCT00025519|clear cell renal cell carcinoma|clear cell renal cell carcinoma
770049|NCT00025493|stage IV breast cancer|stage iv breast cancer
770050|NCT00025493|recurrent breast cancer|recurrent breast cancer
770051|NCT00025480|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
770052|NCT00025480|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
770053|NCT00025454|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
770054|NCT00025441|chondrosarcoma|chondrosarcoma
770055|NCT00025441|small intestine leiomyosarcoma|small intestine leiomyosarcoma
770056|NCT00025441|fibrosarcomatous osteosarcoma|fibrosarcomatous osteosarcoma
770057|NCT00025441|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
770058|NCT00025441|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
770059|NCT00025441|pleomorphic childhood rhabdomyosarcoma|pleomorphic childhood rhabdomyosarcoma
770060|NCT00025441|mixed childhood rhabdomyosarcoma|mixed childhood rhabdomyosarcoma
770061|NCT00025441|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
770062|NCT00025441|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
770063|NCT00025441|extraosseous Ewing sarcoma/peripheral primitive neuroectodermal tumor|extraosseous ewing sarcoma/peripheral primitive neuroectodermal tumor
770064|NCT00025441|childhood fibrosarcoma|childhood fibrosarcoma
770065|NCT00025441|childhood synovial sarcoma|childhood synovial sarcoma
770066|NCT00025441|childhood malignant hemangiopericytoma|childhood malignant hemangiopericytoma
770067|NCT00025441|childhood liposarcoma|childhood liposarcoma
770068|NCT00025441|childhood alveolar soft-part sarcoma|childhood alveolar soft-part sarcoma
770069|NCT00025441|childhood leiomyosarcoma|childhood leiomyosarcoma
770071|NCT00025441|childhood epithelioid sarcoma|childhood epithelioid sarcoma
770072|NCT00025441|childhood malignant mesenchymoma|childhood malignant mesenchymoma
770073|NCT00025441|stage IV uterine sarcoma|stage iv uterine sarcoma
770074|NCT00025441|uterine leiomyosarcoma|uterine leiomyosarcoma
770075|NCT00025441|ovarian sarcoma|ovarian sarcoma
770076|NCT00025441|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
770077|NCT00025441|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
770078|NCT00025428|localized unresectable neuroblastoma|localized unresectable neuroblastoma
770079|NCT00025402|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
770080|NCT00025402|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
770081|NCT00025402|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
770082|NCT00025402|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
770083|NCT00025402|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
770084|NCT00025389|stage I non-small cell lung cancer|stage i non-small cell lung cancer
770085|NCT00025389|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
770086|NCT00025389|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
770087|NCT00025324|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
770088|NCT00025324|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
770089|NCT00025311|leptomeningeal metastases|leptomeningeal metastases
770090|NCT00025298|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
770091|NCT00025298|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
770092|NCT00025298|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
770093|NCT00025298|oral complications|oral complications
770094|NCT00025298|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
770095|NCT00025298|radiation toxicity|radiation toxicity
770096|NCT00025285|squamous cell lung cancer|squamous cell lung cancer
770097|NCT00025285|large cell lung cancer|large cell lung cancer
770098|NCT00025285|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
770099|NCT00025285|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
770100|NCT00025285|adenocarcinoma of the lung|adenocarcinoma of the lung
770101|NCT00025285|adenosquamous cell lung cancer|adenosquamous cell lung cancer
770102|NCT00025285|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
770103|NCT00025272|extensive stage small cell lung cancer|extensive stage small cell lung cancer
770104|NCT00025194|adenocarcinoma of the prostate|adenocarcinoma of the prostate
770105|NCT00025194|stage IV prostate cancer|stage iv prostate cancer
770106|NCT00025194|recurrent prostate cancer|recurrent prostate cancer
770107|NCT00025181|iris melanoma|iris melanoma
770108|NCT00025181|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
770109|NCT00025181|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
770110|NCT00025181|extraocular extension melanoma|extraocular extension melanoma
770111|NCT00025181|recurrent intraocular melanoma|recurrent intraocular melanoma
770112|NCT00025181|stage III melanoma|stage iii melanoma
770113|NCT00025181|stage IV melanoma|stage iv melanoma
770114|NCT00025181|recurrent melanoma|recurrent melanoma
770115|NCT00025168|stage III pancreatic cancer|stage iii pancreatic cancer
770116|NCT00025142|stage IV colon cancer|stage iv colon cancer
770117|NCT00025142|stage IV rectal cancer|stage iv rectal cancer
770118|NCT00025142|recurrent colon cancer|recurrent colon cancer
770119|NCT00025142|recurrent rectal cancer|recurrent rectal cancer
770120|NCT00025142|adenocarcinoma of the colon|adenocarcinoma of the colon
770121|NCT00025142|adenocarcinoma of the rectum|adenocarcinoma of the rectum
770122|NCT00025129|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
770123|NCT00025129|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
770124|NCT00025129|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
770125|NCT00025129|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
770126|NCT00025129|small intestine lymphoma|small intestine lymphoma
770127|NCT00025129|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
770128|NCT00025129|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
770129|NCT00025129|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
770130|NCT00025129|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
770131|NCT00025129|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
770132|NCT00025129|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
770133|NCT00025129|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
770134|NCT00025129|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
770135|NCT00025129|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
770136|NCT00025129|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
770137|NCT00025129|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
770138|NCT00025129|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
770139|NCT00025129|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
770140|NCT00025129|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
770141|NCT00025129|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
770142|NCT00025129|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
770143|NCT00025129|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
770144|NCT00025129|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
770145|NCT00025129|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
770146|NCT00025129|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
770147|NCT00025129|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
770148|NCT00025129|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
770149|NCT00025129|intraocular lymphoma|intraocular lymphoma
770150|NCT00025129|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
770151|NCT00025129|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
770152|NCT00025129|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
770153|NCT00025129|anaplastic large cell lymphoma|anaplastic large cell lymphoma
770154|NCT00025129|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
770155|NCT00025129|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
770156|NCT00025129|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
770157|NCT00025129|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
770158|NCT00025129|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
770159|NCT00025129|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
770160|NCT00025129|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
770161|NCT00025129|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
770162|NCT00025129|splenic marginal zone lymphoma|splenic marginal zone lymphoma
770163|NCT00025103|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
770164|NCT00025103|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
770165|NCT00025090|stage I anal cancer|stage i anal cancer
770166|NCT00025090|stage II anal cancer|stage ii anal cancer
770167|NCT00025090|stage IIIA anal cancer|stage iiia anal cancer
770168|NCT00025090|stage IIIB anal cancer|stage iiib anal cancer
770169|NCT00025090|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
770170|NCT00025090|cloacogenic carcinoma of the anus|cloacogenic carcinoma of the anus
770171|NCT00025090|basaloid carcinoma of the anus|basaloid carcinoma of the anus
770172|NCT00025077|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
770173|NCT00025077|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
770174|NCT00025064|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
770175|NCT00025064|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
770176|NCT00025064|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
770177|NCT00025064|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
770178|NCT00025064|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
770179|NCT00025051|basal cell carcinoma of the skin|basal cell carcinoma of the skin
770180|NCT00025051|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
770181|NCT00025025|colon cancer|colon cancer
770182|NCT00025025|rectal cancer|rectal cancer
770183|NCT00024466|stage I multiple myeloma|stage i multiple myeloma
770184|NCT00024466|stage II multiple myeloma|stage ii multiple myeloma
770185|NCT00024466|stage III multiple myeloma|stage iii multiple myeloma
770186|NCT00024453|infection|infection
770187|NCT00024440|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
770188|NCT00024440|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
770189|NCT00024427|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
770190|NCT00024427|stage II pancreatic cancer|stage ii pancreatic cancer
770191|NCT00024427|stage III pancreatic cancer|stage iii pancreatic cancer
770192|NCT00024427|recurrent pancreatic cancer|recurrent pancreatic cancer
770193|NCT00024427|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
770194|NCT00024427|stage IV pancreatic cancer|stage iv pancreatic cancer
770195|NCT00024414|adenocarcinoma of the prostate|adenocarcinoma of the prostate
770196|NCT00024414|stage IV prostate cancer|stage iv prostate cancer
770197|NCT00024414|recurrent prostate cancer|recurrent prostate cancer
770198|NCT00024375|recurrent pancreatic cancer|recurrent pancreatic cancer
770199|NCT00024375|stage IV pancreatic cancer|stage iv pancreatic cancer
770200|NCT00024349|stage II bladder cancer|stage ii bladder cancer
770201|NCT00024349|stage III bladder cancer|stage iii bladder cancer
770202|NCT00024349|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
770203|NCT00024349|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
770204|NCT00024349|adenocarcinoma of the bladder|adenocarcinoma of the bladder
770205|NCT00024336|untreated childhood brain stem glioma|untreated childhood brain stem glioma
770206|NCT00024297|thromboembolism|thromboembolism
770207|NCT00024284|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
770208|NCT00024271|localized malignant mesothelioma|localized malignant mesothelioma
770209|NCT00024271|advanced malignant mesothelioma|advanced malignant mesothelioma
770210|NCT00024271|recurrent malignant mesothelioma|recurrent malignant mesothelioma
770211|NCT00024258|metastatic osteosarcoma|metastatic osteosarcoma
770212|NCT00024258|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
770213|NCT00024258|regional neuroblastoma|regional neuroblastoma
770214|NCT00024258|disseminated neuroblastoma|disseminated neuroblastoma
770215|NCT00024258|stage 4S neuroblastoma|stage 4s neuroblastoma
770216|NCT00024258|recurrent neuroblastoma|recurrent neuroblastoma
770217|NCT00024258|stage III childhood liver cancer|stage iii childhood liver cancer
770218|NCT00024258|stage IV childhood liver cancer|stage iv childhood liver cancer
770219|NCT00024258|recurrent childhood liver cancer|recurrent childhood liver cancer
770220|NCT00024258|childhood hepatoblastoma|childhood hepatoblastoma
770221|NCT00024258|stage III Wilms tumor|stage iii wilms tumor
770222|NCT00024258|stage IV Wilms tumor|stage iv wilms tumor
770223|NCT00024258|stage V Wilms tumor|stage v wilms tumor
770224|NCT00024258|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
770225|NCT00024258|intraocular retinoblastoma|intraocular retinoblastoma
770226|NCT00024258|extraocular retinoblastoma|extraocular retinoblastoma
770227|NCT00024258|recurrent retinoblastoma|recurrent retinoblastoma
770228|NCT00024258|recurrent osteosarcoma|recurrent osteosarcoma
770229|NCT00024258|childhood germ cell tumor|childhood germ cell tumor
770230|NCT00024258|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
770231|NCT00024258|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
770232|NCT00024258|localized unresectable neuroblastoma|localized unresectable neuroblastoma
770233|NCT00024258|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
770234|NCT00024258|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
770235|NCT00024258|untreated childhood medulloblastoma|untreated childhood medulloblastoma
770236|NCT00024258|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
770237|NCT00024258|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
770238|NCT00024258|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
770239|NCT00024258|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
770240|NCT00024258|childhood teratoma|childhood teratoma
770241|NCT00024258|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
770242|NCT00024258|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
770243|NCT00024258|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
770244|NCT00024258|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
770245|NCT00024245|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
770246|NCT00024232|stage IV prostate cancer|stage iv prostate cancer
770247|NCT00024232|recurrent prostate cancer|recurrent prostate cancer
770248|NCT00024193|stage 4S neuroblastoma|stage 4s neuroblastoma
770249|NCT00024180|Waldenström macroglobulinemia|waldenström macroglobulinemia
770250|NCT00024180|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
770251|NCT00024180|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
770252|NCT00024180|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
770253|NCT00024180|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
770254|NCT00024180|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
770255|NCT00024180|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
770256|NCT00024167|adenocarcinoma of the prostate|adenocarcinoma of the prostate
770257|NCT00024167|stage IV prostate cancer|stage iv prostate cancer
770258|NCT00024167|recurrent prostate cancer|recurrent prostate cancer
770259|NCT00024167|Strontium-89|strontium-89
770260|NCT00024167|Induction Chemotherapy|induction chemotherapy
770261|NCT00024167|Androgen-Independent Prostate Cancer|androgen-independent prostate cancer
770262|NCT00024115|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
770263|NCT00024115|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
770264|NCT00024115|stage III grade I follicular small cleaved cell lymphoma|stage iii grade i follicular small cleaved cell lymphoma
770265|NCT00024115|stage III grade II follicular mixed cell lymphoma|stage iii grade ii follicular mixed cell lymphoma
770266|NCT00024115|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
770267|NCT00024115|stage IV grade I follicular small cleaved cell lymphoma|stage iv grade i follicular small cleaved cell lymphoma
770268|NCT00024115|stage IV grade II follicular mixed cell lymphoma|stage iv grade ii follicular mixed cell lymphoma
772919|NCT00007826|stage III colon cancer|stage iii colon cancer
770457|NCT00022633|recurrent urethral cancer|recurrent urethral cancer
770269|NCT00024115|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
770270|NCT00024115|recurrent grade I follicular small cleaved cell lymphoma|recurrent grade i follicular small cleaved cell lymphoma
770271|NCT00024115|recurrent grade II follicular mixed cell lymphoma|recurrent grade ii follicular mixed cell lymphoma
770272|NCT00024115|recurrent grade III follicular large cell lymphoma|recurrent grade iii follicular large cell lymphoma
770273|NCT00024115|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
770274|NCT00024115|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
770275|NCT00024115|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
770276|NCT00024115|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
770277|NCT00024115|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
770278|NCT00024115|recurrent adult diffuse small noncleaved cell/Burkitt's lymphoma|recurrent adult diffuse small noncleaved cell/burkitt's lymphoma
770279|NCT00024115|prolymphocytic leukemia|prolymphocytic leukemia
770280|NCT00024115|contiguous stage II grade I follicular small cleaved cell lymphoma|contiguous stage ii grade i follicular small cleaved cell lymphoma
770281|NCT00024115|contiguous stage II grade II follicular mixed cell lymphoma|contiguous stage ii grade ii follicular mixed cell lymphoma
770282|NCT00024115|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
770283|NCT00024115|noncontiguous stage II grade I follicular small cleaved cell lymphoma|noncontiguous stage ii grade i follicular small cleaved cell lymphoma
770284|NCT00024115|noncontiguous stage II grade II follicular mixed cell lymphoma|noncontiguous stage ii grade ii follicular mixed cell lymphoma
770285|NCT00024115|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
770286|NCT00024115|stage III diffuse small lymphocytic/marginal zone lymphoma|stage iii diffuse small lymphocytic/marginal zone lymphoma
770287|NCT00024115|contiguous stage II diffuse small lymphocytic/marginal zone lymphoma|contiguous stage ii diffuse small lymphocytic/marginal zone lymphoma
770288|NCT00024115|noncontiguous stage II diffuse small lymphocytic/marginal zone lymphoma|noncontiguous stage ii diffuse small lymphocytic/marginal zone lymphoma
770289|NCT00024115|stage IV diffuse small lymphocytic/marginal zone lymphoma|stage iv diffuse small lymphocytic/marginal zone lymphoma
770290|NCT00024115|recurrent diffuse small lymphocytic/marginal zone lymphoma|recurrent diffuse small lymphocytic/marginal zone lymphoma
770291|NCT00024115|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
770292|NCT00024102|stage I breast cancer|stage i breast cancer
770293|NCT00024102|stage II breast cancer|stage ii breast cancer
770294|NCT00024102|stage IIIA breast cancer|stage iiia breast cancer
770295|NCT00024102|stage IIIB breast cancer|stage iiib breast cancer
770296|NCT00024102|stage IIIC breast cancer|stage iiic breast cancer
770297|NCT00024089|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
770298|NCT00024089|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
770299|NCT00024089|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
770300|NCT00024089|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
770301|NCT00024089|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
770302|NCT00024089|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
770303|NCT00024089|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
770304|NCT00024089|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
770305|NCT00024089|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
770306|NCT00024089|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
770307|NCT00024089|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
770308|NCT00024089|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
770309|NCT00024089|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
770310|NCT00024089|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
770311|NCT00024089|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
770312|NCT00024076|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
770313|NCT00024076|recurrent small cell lung cancer|recurrent small cell lung cancer
770314|NCT00024076|recurrent malignant mesothelioma|recurrent malignant mesothelioma
770315|NCT00024076|recurrent thymoma and thymic carcinoma|recurrent thymoma and thymic carcinoma
770316|NCT00024076|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
770317|NCT00024076|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
770318|NCT00024076|pulmonary carcinoid tumor|pulmonary carcinoid tumor
770319|NCT00024076|lung metastases|lung metastases
770320|NCT00024050|refractory anemia|refractory anemia
770321|NCT00024050|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
770322|NCT00024050|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
770323|NCT00024050|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
770324|NCT00024050|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
770325|NCT00024050|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
786269|NCT00004855|Stavudine|stavudine
770326|NCT00023985|stage I non-small cell lung cancer|stage i non-small cell lung cancer
770327|NCT00023985|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
770328|NCT00023985|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
770329|NCT00023972|stage III pancreatic cancer|stage iii pancreatic cancer
770330|NCT00023972|stage IV pancreatic cancer|stage iv pancreatic cancer
770331|NCT00023894|recurrent endometrial carcinoma|recurrent endometrial carcinoma
770332|NCT00023881|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
770333|NCT00023881|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
770334|NCT00023881|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
770335|NCT00023881|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
770336|NCT00023855|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
770337|NCT00023842|stage 0 bladder cancer|stage 0 bladder cancer
770338|NCT00023842|recurrent bladder cancer|recurrent bladder cancer
770339|NCT00023842|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
770340|NCT00023829|stage III prostate cancer|stage iii prostate cancer
770341|NCT00023829|stage IIB prostate cancer|stage iib prostate cancer
770342|NCT00023829|stage IIA prostate cancer|stage iia prostate cancer
770343|NCT00023790|stage IV breast cancer|stage iv breast cancer
770344|NCT00023790|recurrent breast cancer|recurrent breast cancer
770345|NCT00023790|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
770346|NCT00023790|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
770347|NCT00023790|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
770348|NCT00023790|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
770349|NCT00023790|basal cell carcinoma of the skin|basal cell carcinoma of the skin
770350|NCT00023790|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
770351|NCT00023790|recurrent skin cancer|recurrent skin cancer
770352|NCT00023790|classic Kaposi sarcoma|classic kaposi sarcoma
770353|NCT00023790|immunosuppressive treatment related Kaposi sarcoma|immunosuppressive treatment related kaposi sarcoma
770354|NCT00023790|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
770355|NCT00023790|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
770356|NCT00023790|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
770357|NCT00023790|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
772920|NCT00007826|stage IV colon cancer|stage iv colon cancer
770358|NCT00023790|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
770359|NCT00023790|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
770360|NCT00023790|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
770361|NCT00023790|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
770362|NCT00023790|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
770363|NCT00023790|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
770364|NCT00023790|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
770365|NCT00023790|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
770366|NCT00023790|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
770367|NCT00023790|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
770368|NCT00023790|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
770369|NCT00023790|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
770370|NCT00023790|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
770371|NCT00023790|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
770372|NCT00023790|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
770373|NCT00023790|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
770374|NCT00023790|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
770375|NCT00023790|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
770376|NCT00023790|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
770377|NCT00023790|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
770378|NCT00023790|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
770379|NCT00023790|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
770380|NCT00023790|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
770381|NCT00023790|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
770382|NCT00023790|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
770383|NCT00023790|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
770384|NCT00023790|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
770458|NCT00022633|anterior urethral cancer|anterior urethral cancer
770385|NCT00023790|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
770386|NCT00023790|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
770387|NCT00023790|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
770388|NCT00023790|skin metastases|skin metastases
770389|NCT00023790|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
770390|NCT00023790|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
770391|NCT00023790|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
770392|NCT00023790|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
770393|NCT00023790|male breast cancer|male breast cancer
770394|NCT00023777|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
770395|NCT00023777|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
770396|NCT00023777|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
770397|NCT00023777|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
770398|NCT00023777|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
770399|NCT00023777|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
770400|NCT00023777|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
770401|NCT00023777|adult acute basophilic leukemia|adult acute basophilic leukemia
770402|NCT00023777|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
770403|NCT00023777|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
770404|NCT00023777|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
770405|NCT00023751|stage I rectal cancer|stage i rectal cancer
770406|NCT00023751|adenocarcinoma of the rectum|adenocarcinoma of the rectum
770407|NCT00023686|adenocarcinoma of the prostate|adenocarcinoma of the prostate
770408|NCT00023686|stage IIB prostate cancer|stage iib prostate cancer
770409|NCT00023686|stage IIA prostate cancer|stage iia prostate cancer
770410|NCT00023660|stage III cervical cancer|stage iii cervical cancer
770411|NCT00023660|stage IB cervical cancer|stage ib cervical cancer
770412|NCT00023660|stage IIB cervical cancer|stage iib cervical cancer
770413|NCT00023660|stage IIA cervical cancer|stage iia cervical cancer
770414|NCT00023660|stage IVA cervical cancer|stage iva cervical cancer
770415|NCT00023660|cervical squamous cell carcinoma|cervical squamous cell carcinoma
770416|NCT00023660|cervical adenocarcinoma|cervical adenocarcinoma
770417|NCT00023660|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
770418|NCT00023634|stage II gastric cancer|stage ii gastric cancer
770419|NCT00023634|stage III gastric cancer|stage iii gastric cancer
770420|NCT00023634|stage IV gastric cancer|stage iv gastric cancer
770421|NCT00023634|recurrent gastric cancer|recurrent gastric cancer
770422|NCT00023634|adenocarcinoma of the prostate|adenocarcinoma of the prostate
770423|NCT00023634|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
770424|NCT00023634|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
770425|NCT00023634|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
770426|NCT00023634|recurrent adult brain tumor|recurrent adult brain tumor
770427|NCT00023634|stage IV prostate cancer|stage iv prostate cancer
770428|NCT00023634|recurrent prostate cancer|recurrent prostate cancer
770429|NCT00023634|adult anaplastic astrocytoma|adult anaplastic astrocytoma
770430|NCT00023621|basal cell carcinoma of the skin|basal cell carcinoma of the skin
770431|NCT00022724|recurrent adult brain tumor|recurrent adult brain tumor
770432|NCT00022724|adult glioblastoma|adult glioblastoma
770433|NCT00022724|adult anaplastic astrocytoma|adult anaplastic astrocytoma
770434|NCT00022724|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
770435|NCT00022724|adult mixed glioma|adult mixed glioma
770436|NCT00022724|adult giant cell glioblastoma|adult giant cell glioblastoma
770437|NCT00022724|adult gliosarcoma|adult gliosarcoma
770438|NCT00022711|recurrent small cell lung cancer|recurrent small cell lung cancer
770439|NCT00022711|intermediate type small cell lung cancer|intermediate type small cell lung cancer
770440|NCT00022698|stage III colon cancer|stage iii colon cancer
770441|NCT00022698|stage IV colon cancer|stage iv colon cancer
770442|NCT00022698|stage III rectal cancer|stage iii rectal cancer
770443|NCT00022698|stage IV rectal cancer|stage iv rectal cancer
770444|NCT00022698|recurrent colon cancer|recurrent colon cancer
770445|NCT00022698|recurrent rectal cancer|recurrent rectal cancer
770446|NCT00022698|adenocarcinoma of the colon|adenocarcinoma of the colon
770447|NCT00022698|adenocarcinoma of the rectum|adenocarcinoma of the rectum
770448|NCT00022685|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
770449|NCT00022685|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
770450|NCT00022646|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
770451|NCT00022646|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
770452|NCT00022633|recurrent bladder cancer|recurrent bladder cancer
770453|NCT00022633|stage IV bladder cancer|stage iv bladder cancer
770454|NCT00022633|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
770455|NCT00022633|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
770456|NCT00022633|adenocarcinoma of the bladder|adenocarcinoma of the bladder
770459|NCT00022633|posterior urethral cancer|posterior urethral cancer
770460|NCT00022633|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
770461|NCT00022633|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
770462|NCT00022633|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
770463|NCT00022633|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
770464|NCT00022620|recurrent endometrial carcinoma|recurrent endometrial carcinoma
770465|NCT00022620|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
770466|NCT00022607|refractory multiple myeloma|refractory multiple myeloma
770467|NCT00022607|stage I multiple myeloma|stage i multiple myeloma
770468|NCT00022607|stage II multiple myeloma|stage ii multiple myeloma
770469|NCT00022607|stage III multiple myeloma|stage iii multiple myeloma
770470|NCT00022568|stage IV melanoma|stage iv melanoma
770471|NCT00022568|recurrent melanoma|recurrent melanoma
770472|NCT00022516|stage IA breast cancer|stage ia breast cancer
770473|NCT00022516|stage II breast cancer|stage ii breast cancer
770474|NCT00022516|stage IIIA breast cancer|stage iiia breast cancer
770475|NCT00022516|stage IIIB breast cancer|stage iiib breast cancer
770476|NCT00022516|stage IB breast cancer|stage ib breast cancer
770477|NCT00022516|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
770478|NCT00022516|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
770479|NCT00022516|triple-negative breast cancer|triple-negative breast cancer
770480|NCT00022516|low-dose maintenance chemotherapy|low-dose maintenance chemotherapy
770481|NCT00022516|stroma|stroma
770482|NCT00022516|angiogenesis|angiogenesis
770483|NCT00022490|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
770484|NCT00022490|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
770485|NCT00022464|stage IV melanoma|stage iv melanoma
770486|NCT00022464|recurrent melanoma|recurrent melanoma
770487|NCT00022451|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
770488|NCT00022451|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
770489|NCT00022451|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
770490|NCT00022451|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
770491|NCT00022451|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
770492|NCT00022451|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
770493|NCT00022451|acute undifferentiated leukemia|acute undifferentiated leukemia
770494|NCT00022451|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
770495|NCT00022451|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
770496|NCT00022438|stage IV melanoma|stage iv melanoma
770497|NCT00022438|recurrent melanoma|recurrent melanoma
770498|NCT00022425|recurrent breast cancer|recurrent breast cancer
770499|NCT00022412|adenocarcinoma of the prostate|adenocarcinoma of the prostate
770500|NCT00022412|stage I prostate cancer|stage i prostate cancer
770501|NCT00022412|stage II prostate cancer|stage ii prostate cancer
770502|NCT00022399|stage I prostate cancer|stage i prostate cancer
770503|NCT00022399|stage IIB prostate cancer|stage iib prostate cancer
770504|NCT00022399|stage IIA prostate cancer|stage iia prostate cancer
770505|NCT00022399|adenocarcinoma of the prostate|adenocarcinoma of the prostate
770506|NCT00022334|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
770507|NCT00022334|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
770508|NCT00022334|advanced adult primary liver cancer|advanced adult primary liver cancer
770509|NCT00022334|recurrent adult primary liver cancer|recurrent adult primary liver cancer
770510|NCT00022334|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
770511|NCT00022295|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
770512|NCT00022230|stage II breast cancer|stage ii breast cancer
770513|NCT00022230|stage IIIA breast cancer|stage iiia breast cancer
770514|NCT00022230|stage IIIB breast cancer|stage iiib breast cancer
770515|NCT00022230|stage IIIC breast cancer|stage iiic breast cancer
770516|NCT00022191|stage IV bladder cancer|stage iv bladder cancer
770517|NCT00022191|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
770518|NCT00022191|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
770519|NCT00022191|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
770520|NCT00022191|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
770521|NCT00022152|stage IV breast cancer|stage iv breast cancer
770522|NCT00022152|recurrent breast cancer|recurrent breast cancer
770523|NCT00022126|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
770524|NCT00022126|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
770525|NCT00022126|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
770526|NCT00022126|acute undifferentiated leukemia|acute undifferentiated leukemia
770527|NCT00022087|osteoporosis|osteoporosis
770528|NCT00022087|stage I breast cancer|stage i breast cancer
786755|NCT00002387|Indinavir|indinavir
770529|NCT00022087|stage II breast cancer|stage ii breast cancer
770530|NCT00022087|stage IV breast cancer|stage iv breast cancer
770531|NCT00022087|stage IIIA breast cancer|stage iiia breast cancer
770532|NCT00022087|stage IIIB breast cancer|stage iiib breast cancer
770533|NCT00022087|stage IIIC breast cancer|stage iiic breast cancer
770534|NCT00022074|stage I breast cancer|stage i breast cancer
770535|NCT00022074|stage II breast cancer|stage ii breast cancer
770536|NCT00022074|stage IV breast cancer|stage iv breast cancer
770537|NCT00022074|stage IIIA breast cancer|stage iiia breast cancer
770538|NCT00022074|recurrent breast cancer|recurrent breast cancer
770539|NCT00022074|stage IIIB breast cancer|stage iiib breast cancer
770540|NCT00022074|stage IIIC breast cancer|stage iiic breast cancer
770541|NCT00022074|anxiety disorder|anxiety disorder
770542|NCT00022074|depression|depression
770543|NCT00022074|hot flashes|hot flashes
770544|NCT00022048|refractory anemia|refractory anemia
770545|NCT00022048|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
770546|NCT00022048|refractory anemia with excess blasts|refractory anemia with excess blasts
770547|NCT00022048|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
770548|NCT00022048|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
770549|NCT00022048|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
770550|NCT00022048|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
770551|NCT00022048|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
770552|NCT00022048|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
770553|NCT00022035|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
770554|NCT00022035|infection|infection
770555|NCT00022022|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
770556|NCT00022022|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
770557|NCT00022022|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
770558|NCT00021450|stage IIB prostate cancer|stage iib prostate cancer
770559|NCT00021450|stage IIA prostate cancer|stage iia prostate cancer
770560|NCT00021424|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
770561|NCT00021424|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
770562|NCT00021424|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
770563|NCT00021424|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
770564|NCT00021424|skin metastases|skin metastases
770565|NCT00021320|stage 0 esophageal cancer|stage 0 esophageal cancer
770566|NCT00021320|stage I esophageal cancer|stage i esophageal cancer
770567|NCT00021320|stage II esophageal cancer|stage ii esophageal cancer
770568|NCT00021320|stage III esophageal cancer|stage iii esophageal cancer
770569|NCT00021320|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
770570|NCT00021320|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
770571|NCT00021242|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
770572|NCT00021242|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
770573|NCT00021242|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
770574|NCT00021229|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
770575|NCT00021229|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
770576|NCT00021229|untreated childhood brain stem glioma|untreated childhood brain stem glioma
770577|NCT00021229|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
770578|NCT00021229|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
770579|NCT00021164|stage IV melanoma|stage iv melanoma
770580|NCT00021164|recurrent melanoma|recurrent melanoma
770581|NCT00021164|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
770582|NCT00021125|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
770583|NCT00021125|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
770584|NCT00021125|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
770585|NCT00021125|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
770586|NCT00021125|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
770587|NCT00021125|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
770588|NCT00021125|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
770589|NCT00021125|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
770590|NCT00021125|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
770591|NCT00021125|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
770592|NCT00021125|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
770593|NCT00021125|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
770594|NCT00021125|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
770794|NCT00020579|stage III esophageal cancer|stage iii esophageal cancer
770595|NCT00021125|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
770596|NCT00021125|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
770597|NCT00021125|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
770598|NCT00021125|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
770599|NCT00021125|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
770600|NCT00021125|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
770601|NCT00021125|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
770602|NCT00021125|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
770603|NCT00021125|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
770604|NCT00021125|stage I salivary gland cancer|stage i salivary gland cancer
770605|NCT00021125|stage II salivary gland cancer|stage ii salivary gland cancer
770606|NCT00021125|stage III salivary gland cancer|stage iii salivary gland cancer
770607|NCT00021125|stage IV salivary gland cancer|stage iv salivary gland cancer
770608|NCT00021112|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
770609|NCT00021047|stage IV gastric cancer|stage iv gastric cancer
770610|NCT00021047|recurrent gastric cancer|recurrent gastric cancer
770611|NCT00021047|stage II esophageal cancer|stage ii esophageal cancer
770612|NCT00021047|stage III esophageal cancer|stage iii esophageal cancer
770613|NCT00021047|stage IV esophageal cancer|stage iv esophageal cancer
770614|NCT00021047|recurrent esophageal cancer|recurrent esophageal cancer
770615|NCT00021047|advanced adult primary liver cancer|advanced adult primary liver cancer
770616|NCT00021047|recurrent adult primary liver cancer|recurrent adult primary liver cancer
770617|NCT00021047|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
770618|NCT00021047|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
770619|NCT00021047|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
770620|NCT00021047|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
770621|NCT00021047|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
770622|NCT00021047|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
770623|NCT00021047|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
770624|NCT00021047|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
770625|NCT00021047|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
770626|NCT00021047|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
770627|NCT00021047|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
770628|NCT00021047|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
770629|NCT00021047|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
770630|NCT00021047|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
770631|NCT00021047|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
770632|NCT00021047|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
770633|NCT00021047|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
770634|NCT00021047|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
770635|NCT00021047|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
770636|NCT00021047|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
770637|NCT00021047|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
770638|NCT00021047|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
770639|NCT00021047|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
770640|NCT00021047|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
772921|NCT00007826|stage II rectal cancer|stage ii rectal cancer
770641|NCT00021047|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
770642|NCT00021047|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
770643|NCT00021047|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
770644|NCT00021047|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
770645|NCT00021047|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
770646|NCT00021047|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
770647|NCT00021047|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
770648|NCT00021047|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
770649|NCT00021047|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
770650|NCT00021047|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
770651|NCT00021047|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
770652|NCT00021047|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
770653|NCT00021047|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
770654|NCT00021047|recurrent salivary gland cancer|recurrent salivary gland cancer
770655|NCT00021047|stage IV salivary gland cancer|stage iv salivary gland cancer
770656|NCT00020995|adenocarcinoma of the prostate|adenocarcinoma of the prostate
770657|NCT00020995|stage I prostate cancer|stage i prostate cancer
770658|NCT00020995|stage IIB prostate cancer|stage iib prostate cancer
770659|NCT00020995|stage IIA prostate cancer|stage iia prostate cancer
770660|NCT00020995|stage III prostate cancer|stage iii prostate cancer
770661|NCT00020995|stage IV prostate cancer|stage iv prostate cancer
770662|NCT00020969|refractory anemia|refractory anemia
770663|NCT00020969|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
770664|NCT00020969|refractory anemia with excess blasts|refractory anemia with excess blasts
770665|NCT00020969|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
770666|NCT00020969|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
770667|NCT00020969|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
770668|NCT00020969|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
770669|NCT00020969|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
770670|NCT00020969|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
770671|NCT00020969|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
770672|NCT00020943|stage I mantle cell lymphoma|stage i mantle cell lymphoma
770673|NCT00020943|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
770674|NCT00020943|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
770675|NCT00020943|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
770676|NCT00020943|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
770677|NCT00020891|stage I prostate cancer|stage i prostate cancer
770678|NCT00020891|stage IIB prostate cancer|stage iib prostate cancer
770679|NCT00020891|stage IIA prostate cancer|stage iia prostate cancer
770680|NCT00020891|stage III prostate cancer|stage iii prostate cancer
770681|NCT00020891|stage IV prostate cancer|stage iv prostate cancer
770682|NCT00020891|recurrent prostate cancer|recurrent prostate cancer
770683|NCT00020878|non-small cell lung cancer|non-small cell lung cancer
770684|NCT00020852|stage I breast cancer|stage i breast cancer
770685|NCT00020852|stage II breast cancer|stage ii breast cancer
770686|NCT00020839|stage IV melanoma|stage iv melanoma
770687|NCT00020839|recurrent melanoma|recurrent melanoma
770688|NCT00020839|tumors metastatic to brain|tumors metastatic to brain
770689|NCT00020826|adenocarcinoma of the stomach|adenocarcinoma of the stomach
770690|NCT00020800|Waldenström macroglobulinemia|waldenström macroglobulinemia
770691|NCT00020761|stage IV gastric cancer|stage iv gastric cancer
770692|NCT00020761|recurrent gastric cancer|recurrent gastric cancer
770693|NCT00020761|stage IV esophageal cancer|stage iv esophageal cancer
770694|NCT00020761|recurrent esophageal cancer|recurrent esophageal cancer
770695|NCT00020761|adenocarcinoma of the stomach|adenocarcinoma of the stomach
770696|NCT00020761|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
770697|NCT00020748|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
770698|NCT00020735|adenocarcinoma of the prostate|adenocarcinoma of the prostate
770699|NCT00020735|stage I prostate cancer|stage i prostate cancer
770700|NCT00020735|stage II prostate cancer|stage ii prostate cancer
770701|NCT00020722|stage IV breast cancer|stage iv breast cancer
770702|NCT00020722|recurrent breast cancer|recurrent breast cancer
770703|NCT00020670|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
770704|NCT00020670|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
770705|NCT00020670|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
770706|NCT00020670|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
770707|NCT00020657|nausea and vomiting|nausea and vomiting
770708|NCT00020657|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
770709|NCT00020644|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
770710|NCT00020631|radiation fibrosis|radiation fibrosis
770711|NCT00020579|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
770712|NCT00020579|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
770713|NCT00020579|small intestine lymphoma|small intestine lymphoma
770714|NCT00020579|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
770715|NCT00020579|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
770716|NCT00020579|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
770717|NCT00020579|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
770718|NCT00020579|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
770719|NCT00020579|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
770795|NCT00020579|stage IV esophageal cancer|stage iv esophageal cancer
770720|NCT00020579|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
770721|NCT00020579|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
770722|NCT00020579|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
770723|NCT00020579|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
770724|NCT00020579|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
770725|NCT00020579|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
770726|NCT00020579|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
770727|NCT00020579|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
770728|NCT00020579|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
770729|NCT00020579|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
770730|NCT00020579|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
770731|NCT00020579|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
770732|NCT00020579|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
770733|NCT00020579|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
770734|NCT00020579|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
770736|NCT00020579|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
770737|NCT00020579|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
770738|NCT00020579|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
770739|NCT00020579|anaplastic large cell lymphoma|anaplastic large cell lymphoma
770740|NCT00020579|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
770741|NCT00020579|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
770742|NCT00020579|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
770743|NCT00020579|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
770744|NCT00020579|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
770745|NCT00020579|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
770746|NCT00020579|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
770747|NCT00020579|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
770748|NCT00020579|splenic marginal zone lymphoma|splenic marginal zone lymphoma
770749|NCT00020579|male breast cancer|male breast cancer
770750|NCT00020579|stage IIIA breast cancer|stage iiia breast cancer
770751|NCT00020579|stage IIIB breast cancer|stage iiib breast cancer
770752|NCT00020579|stage IIIC breast cancer|stage iiic breast cancer
770753|NCT00020579|stage IV breast cancer|stage iv breast cancer
770754|NCT00020579|recurrent pancreatic cancer|recurrent pancreatic cancer
770755|NCT00020579|stage III pancreatic cancer|stage iii pancreatic cancer
770756|NCT00020579|recurrent colon cancer|recurrent colon cancer
770757|NCT00020579|stage III colon cancer|stage iii colon cancer
770758|NCT00020579|stage IV colon cancer|stage iv colon cancer
770759|NCT00020579|recurrent rectal cancer|recurrent rectal cancer
770760|NCT00020579|stage III rectal cancer|stage iii rectal cancer
770761|NCT00020579|stage IV rectal cancer|stage iv rectal cancer
770762|NCT00020579|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
770763|NCT00020579|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
770764|NCT00020579|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
770765|NCT00020579|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
770766|NCT00020579|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
770767|NCT00020579|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
770768|NCT00020579|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
770769|NCT00020579|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
770770|NCT00020579|recurrent cervical cancer|recurrent cervical cancer
770771|NCT00020579|stage III cervical cancer|stage iii cervical cancer
770772|NCT00020579|stage IVA cervical cancer|stage iva cervical cancer
770773|NCT00020579|stage IVB cervical cancer|stage ivb cervical cancer
770774|NCT00020579|recurrent endometrial carcinoma|recurrent endometrial carcinoma
770775|NCT00020579|stage III endometrial carcinoma|stage iii endometrial carcinoma
770776|NCT00020579|stage IV endometrial carcinoma|stage iv endometrial carcinoma
770777|NCT00020579|fallopian tube cancer|fallopian tube cancer
770778|NCT00020579|primary peritoneal cavity cancer|primary peritoneal cavity cancer
770779|NCT00020579|recurrent uterine sarcoma|recurrent uterine sarcoma
770780|NCT00020579|stage III uterine sarcoma|stage iii uterine sarcoma
770781|NCT00020579|stage IV uterine sarcoma|stage iv uterine sarcoma
770782|NCT00020579|recurrent vaginal cancer|recurrent vaginal cancer
770783|NCT00020579|stage III vaginal cancer|stage iii vaginal cancer
770784|NCT00020579|stage IVA vaginal cancer|stage iva vaginal cancer
770785|NCT00020579|stage IVB vaginal cancer|stage ivb vaginal cancer
770786|NCT00020579|recurrent vulvar cancer|recurrent vulvar cancer
770787|NCT00020579|stage III vulvar cancer|stage iii vulvar cancer
770788|NCT00020579|stage IV vulvar cancer|stage iv vulvar cancer
770789|NCT00020579|recurrent anal cancer|recurrent anal cancer
770790|NCT00020579|stage IIIA anal cancer|stage iiia anal cancer
770791|NCT00020579|stage IIIB anal cancer|stage iiib anal cancer
770792|NCT00020579|stage IV anal cancer|stage iv anal cancer
770793|NCT00020579|recurrent esophageal cancer|recurrent esophageal cancer
770796|NCT00020579|recurrent gastric cancer|recurrent gastric cancer
770797|NCT00020579|stage III gastric cancer|stage iii gastric cancer
770798|NCT00020579|stage IV gastric cancer|stage iv gastric cancer
770799|NCT00020579|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
770800|NCT00020579|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
770801|NCT00020579|advanced adult primary liver cancer|advanced adult primary liver cancer
770802|NCT00020579|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
770803|NCT00020579|recurrent adult primary liver cancer|recurrent adult primary liver cancer
770804|NCT00020579|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
770805|NCT00020579|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
770806|NCT00020579|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
770807|NCT00020579|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
770808|NCT00020579|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
770809|NCT00020579|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
770810|NCT00020579|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
770811|NCT00020579|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
770812|NCT00020579|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
770813|NCT00020579|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
770814|NCT00020579|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
770815|NCT00020579|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
770816|NCT00020579|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
770817|NCT00020579|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
770818|NCT00020579|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
770819|NCT00020579|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
770820|NCT00020579|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
770821|NCT00020579|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
770822|NCT00020579|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
770823|NCT00020579|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
770824|NCT00020579|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
770825|NCT00020579|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
770826|NCT00020579|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
770827|NCT00020579|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
770828|NCT00020579|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
770829|NCT00020579|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
770830|NCT00020579|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
770831|NCT00020579|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
772922|NCT00007826|stage III rectal cancer|stage iii rectal cancer
770832|NCT00020579|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
770833|NCT00020579|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
770834|NCT00020579|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
770835|NCT00020579|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
770836|NCT00020579|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
770837|NCT00020579|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
770838|NCT00020579|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
770839|NCT00020579|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
770840|NCT00020579|metastatic parathyroid cancer|metastatic parathyroid cancer
770841|NCT00020579|recurrent parathyroid cancer|recurrent parathyroid cancer
770842|NCT00020579|recurrent salivary gland cancer|recurrent salivary gland cancer
770843|NCT00020579|stage III salivary gland cancer|stage iii salivary gland cancer
770844|NCT00020579|stage IV salivary gland cancer|stage iv salivary gland cancer
770845|NCT00020579|recurrent bladder cancer|recurrent bladder cancer
770846|NCT00020579|recurrent gallbladder cancer|recurrent gallbladder cancer
770847|NCT00020579|stage III bladder cancer|stage iii bladder cancer
770848|NCT00020579|stage IV bladder cancer|stage iv bladder cancer
770849|NCT00020579|unresectable gallbladder cancer|unresectable gallbladder cancer
770850|NCT00020579|recurrent renal cell cancer|recurrent renal cell cancer
770851|NCT00020579|stage III renal cell cancer|stage iii renal cell cancer
770852|NCT00020579|stage IV renal cell cancer|stage iv renal cell cancer
770853|NCT00020579|stage III Wilms tumor|stage iii wilms tumor
770854|NCT00020579|stage IV Wilms tumor|stage iv wilms tumor
770855|NCT00020579|stage V Wilms tumor|stage v wilms tumor
770856|NCT00020579|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
770857|NCT00020579|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
770858|NCT00020579|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
770859|NCT00020579|anterior urethral cancer|anterior urethral cancer
770860|NCT00020579|posterior urethral cancer|posterior urethral cancer
770861|NCT00020579|recurrent urethral cancer|recurrent urethral cancer
770862|NCT00020579|recurrent penile cancer|recurrent penile cancer
770863|NCT00020579|stage III penile cancer|stage iii penile cancer
770864|NCT00020579|stage IV penile cancer|stage iv penile cancer
770865|NCT00020579|recurrent prostate cancer|recurrent prostate cancer
770866|NCT00020579|stage III prostate cancer|stage iii prostate cancer
770867|NCT00020579|stage IV prostate cancer|stage iv prostate cancer
770868|NCT00020579|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
770869|NCT00020579|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
770870|NCT00020579|metastatic osteosarcoma|metastatic osteosarcoma
770871|NCT00020579|recurrent osteosarcoma|recurrent osteosarcoma
770872|NCT00020579|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
770873|NCT00020579|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
770874|NCT00020579|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
770875|NCT00020579|classic Kaposi sarcoma|classic kaposi sarcoma
770876|NCT00020579|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
770877|NCT00020579|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
770878|NCT00020579|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
770879|NCT00020579|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
770880|NCT00020579|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
770881|NCT00020579|extraocular extension melanoma|extraocular extension melanoma
770882|NCT00020579|iris melanoma|iris melanoma
770883|NCT00020579|recurrent intraocular melanoma|recurrent intraocular melanoma
770884|NCT00020579|recurrent melanoma|recurrent melanoma
770885|NCT00020579|stage III melanoma|stage iii melanoma
770886|NCT00020579|stage IV melanoma|stage iv melanoma
770887|NCT00020579|extensive stage small cell lung cancer|extensive stage small cell lung cancer
770888|NCT00020579|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
770889|NCT00020579|recurrent small cell lung cancer|recurrent small cell lung cancer
770890|NCT00020579|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
770891|NCT00020579|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
770892|NCT00020579|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
770893|NCT00020579|recurrent thymoma and thymic carcinoma|recurrent thymoma and thymic carcinoma
770894|NCT00020579|advanced malignant mesothelioma|advanced malignant mesothelioma
770895|NCT00020579|recurrent malignant mesothelioma|recurrent malignant mesothelioma
770896|NCT00020579|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
770897|NCT00020579|stage III adrenocortical carcinoma|stage iii adrenocortical carcinoma
770898|NCT00020579|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
770899|NCT00020579|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
770900|NCT00020579|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
770901|NCT00020579|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
770902|NCT00020579|desmoid tumor|desmoid tumor
770903|NCT00020579|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
770904|NCT00020579|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
770905|NCT00020579|undifferentiated carcinoma of unknown primary|undifferentiated carcinoma of unknown primary
770906|NCT00020579|carcinoma of the appendix|carcinoma of the appendix
770907|NCT00020579|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
770908|NCT00020579|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
770909|NCT00020579|recurrent pituitary tumor|recurrent pituitary tumor
770910|NCT00020579|adult anaplastic astrocytoma|adult anaplastic astrocytoma
770911|NCT00020579|adult astrocytic tumors|adult astrocytic tumors
770912|NCT00020579|adult diffuse astrocytoma|adult diffuse astrocytoma
770913|NCT00020579|adult pilocytic astrocytoma|adult pilocytic astrocytoma
770914|NCT00020579|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
770915|NCT00020579|adult brain stem glioma|adult brain stem glioma
770916|NCT00020579|adult oligodendroglioma|adult oligodendroglioma
770917|NCT00020579|adult mixed glioma|adult mixed glioma
770918|NCT00020579|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
770919|NCT00020579|adult choroid plexus tumor|adult choroid plexus tumor
770920|NCT00020579|adult craniopharyngioma|adult craniopharyngioma
770921|NCT00020579|adult anaplastic ependymoma|adult anaplastic ependymoma
770922|NCT00020579|adult subependymoma|adult subependymoma
770923|NCT00020579|adult medulloblastoma|adult medulloblastoma
786858|NCT00002372|VX 478|vx 478
770924|NCT00020579|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
770925|NCT00020579|adult ependymoblastoma|adult ependymoblastoma
770926|NCT00020579|adult ependymoma|adult ependymoma
770927|NCT00020579|adult myxopapillary ependymoma|adult myxopapillary ependymoma
770928|NCT00020579|adult anaplastic meningioma|adult anaplastic meningioma
772923|NCT00007826|stage IV rectal cancer|stage iv rectal cancer
770929|NCT00020579|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
770930|NCT00020579|adult meningioma|adult meningioma
770931|NCT00020579|adult papillary meningioma|adult papillary meningioma
770932|NCT00020579|adult grade I meningioma|adult grade i meningioma
770933|NCT00020579|adult grade II meningioma|adult grade ii meningioma
770934|NCT00020579|adult grade III meningioma|adult grade iii meningioma
770935|NCT00020579|adult pineal parenchymal tumor|adult pineal parenchymal tumor
770936|NCT00020579|recurrent adult brain tumor|recurrent adult brain tumor
770937|NCT00020579|stage IV pancreatic cancer|stage iv pancreatic cancer
770938|NCT00020579|stage III thymoma|stage iii thymoma
770939|NCT00020579|stage IVA thymoma|stage iva thymoma
770940|NCT00020579|stage IVB thymoma|stage ivb thymoma
770941|NCT00020566|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
770942|NCT00020566|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
770943|NCT00020527|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
770944|NCT00020527|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
770945|NCT00020527|disseminated neuroblastoma|disseminated neuroblastoma
770946|NCT00020527|recurrent neuroblastoma|recurrent neuroblastoma
770947|NCT00020527|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
770948|NCT00020527|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
770949|NCT00020527|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
770950|NCT00020527|fever, sweats, and hot flashes|fever, sweats, and hot flashes
770951|NCT00020527|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
770952|NCT00020527|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
770953|NCT00020527|neutropenia|neutropenia
770954|NCT00020527|infection|infection
770955|NCT00020527|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
770956|NCT00020527|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
770957|NCT00020527|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
770958|NCT00020501|stage IV colon cancer|stage iv colon cancer
770959|NCT00020501|stage IV rectal cancer|stage iv rectal cancer
770960|NCT00020501|recurrent colon cancer|recurrent colon cancer
770961|NCT00020501|recurrent rectal cancer|recurrent rectal cancer
770962|NCT00020501|liver metastases|liver metastases
770963|NCT00020488|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
770964|NCT00020449|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
770965|NCT00020449|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
770966|NCT00020410|stage IV breast cancer|stage iv breast cancer
770967|NCT00020410|recurrent breast cancer|recurrent breast cancer
770968|NCT00020410|male breast cancer|male breast cancer
770969|NCT00020397|recurrent melanoma|recurrent melanoma
770970|NCT00020397|stage IV melanoma|stage iv melanoma
770971|NCT00020358|stage I melanoma|stage i melanoma
770972|NCT00020358|stage II melanoma|stage ii melanoma
770973|NCT00020358|stage III melanoma|stage iii melanoma
770974|NCT00020358|stage IV melanoma|stage iv melanoma
770975|NCT00020358|recurrent melanoma|recurrent melanoma
770976|NCT00020332|stage IV breast cancer|stage iv breast cancer
770977|NCT00020332|stage IIIA breast cancer|stage iiia breast cancer
770978|NCT00020332|recurrent breast cancer|recurrent breast cancer
770979|NCT00020332|stage IIIB breast cancer|stage iiib breast cancer
770980|NCT00020332|male breast cancer|male breast cancer
770981|NCT00020254|adenocarcinoma of the prostate|adenocarcinoma of the prostate
770982|NCT00020254|recurrent prostate cancer|recurrent prostate cancer
770983|NCT00020189|thromboembolism|thromboembolism
770984|NCT00020189|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
770985|NCT00020189|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
770986|NCT00020189|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
770987|NCT00020189|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
770988|NCT00020189|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
770989|NCT00020189|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
770990|NCT00020189|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
770991|NCT00020189|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
770992|NCT00020189|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
770993|NCT00020189|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
770994|NCT00020189|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
770995|NCT00020189|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
770996|NCT00020189|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
770997|NCT00020189|recurrent salivary gland cancer|recurrent salivary gland cancer
770998|NCT00020189|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
770999|NCT00020189|stage IV salivary gland cancer|stage iv salivary gland cancer
771000|NCT00020176|stage IV breast cancer|stage iv breast cancer
771001|NCT00020176|recurrent breast cancer|recurrent breast cancer
771002|NCT00020176|male breast cancer|male breast cancer
771003|NCT00020150|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
771004|NCT00020150|childhood craniopharyngioma|childhood craniopharyngioma
771005|NCT00020150|recurrent childhood brain tumor|recurrent childhood brain tumor
771006|NCT00020150|recurrent neuroblastoma|recurrent neuroblastoma
771007|NCT00020150|recurrent childhood liver cancer|recurrent childhood liver cancer
771008|NCT00020150|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
771009|NCT00020150|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
771010|NCT00020150|recurrent osteosarcoma|recurrent osteosarcoma
771011|NCT00020150|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
771012|NCT00020150|childhood germ cell tumor|childhood germ cell tumor
771013|NCT00020150|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
771014|NCT00020150|childhood oligodendroglioma|childhood oligodendroglioma
771015|NCT00020150|childhood choroid plexus tumor|childhood choroid plexus tumor
771016|NCT00020150|childhood grade I meningioma|childhood grade i meningioma
771017|NCT00020150|childhood grade II meningioma|childhood grade ii meningioma
771018|NCT00020150|childhood grade III meningioma|childhood grade iii meningioma
771019|NCT00020150|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
771020|NCT00020150|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
771021|NCT00020150|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
771022|NCT00020150|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
771023|NCT00020150|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
771024|NCT00020150|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
771025|NCT00020150|recurrent childhood ependymoma|recurrent childhood ependymoma
771026|NCT00020150|childhood teratoma|childhood teratoma
775386|NCT00004065|recurrent breast cancer|recurrent breast cancer
771027|NCT00020150|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
771028|NCT00020150|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
771029|NCT00020150|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
771030|NCT00020150|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
771031|NCT00020124|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
771032|NCT00020124|extensive stage small cell lung cancer|extensive stage small cell lung cancer
771033|NCT00020124|recurrent small cell lung cancer|recurrent small cell lung cancer
771034|NCT00020124|advanced malignant mesothelioma|advanced malignant mesothelioma
771035|NCT00020124|recurrent malignant mesothelioma|recurrent malignant mesothelioma
771036|NCT00020124|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
771037|NCT00020124|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
771038|NCT00020124|pulmonary carcinoid tumor|pulmonary carcinoid tumor
771039|NCT00020124|lung metastases|lung metastases
771040|NCT00020111|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
771041|NCT00020111|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
771042|NCT00020111|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
771043|NCT00020111|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
771044|NCT00020111|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
771045|NCT00020111|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
771046|NCT00020111|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
771047|NCT00020111|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
771048|NCT00020111|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
771049|NCT00020072|cutaneous T-cell non-Hodgkin lymphoma|cutaneous t-cell non-hodgkin lymphoma
771050|NCT00020072|mycosis fungoides/Sezary syndrome|mycosis fungoides/sezary syndrome
771051|NCT00020007|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
771052|NCT00020007|limited stage small cell lung cancer|limited stage small cell lung cancer
771053|NCT00020007|extensive stage small cell lung cancer|extensive stage small cell lung cancer
771054|NCT00020007|recurrent small cell lung cancer|recurrent small cell lung cancer
771055|NCT00020007|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
771056|NCT00020007|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
771057|NCT00020007|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
771058|NCT00020007|lung metastases|lung metastases
771059|NCT00020007|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
771060|NCT00020007|pulmonary carcinoid tumor|pulmonary carcinoid tumor
771061|NCT00019994|stage IV melanoma|stage iv melanoma
771062|NCT00019994|recurrent melanoma|recurrent melanoma
771063|NCT00019955|stage I renal cell cancer|stage i renal cell cancer
771064|NCT00019955|stage II renal cell cancer|stage ii renal cell cancer
771065|NCT00019929|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
771066|NCT00019929|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
771067|NCT00019916|stage IV breast cancer|stage iv breast cancer
771068|NCT00019916|recurrent breast cancer|recurrent breast cancer
771069|NCT00019916|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
771070|NCT00019916|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
771071|NCT00019864|cardiac toxicity|cardiac toxicity
771072|NCT00019864|localized osteosarcoma|localized osteosarcoma
771073|NCT00019864|metastatic osteosarcoma|metastatic osteosarcoma
771074|NCT00019864|recurrent osteosarcoma|recurrent osteosarcoma
771075|NCT00019838|Waldenström macroglobulinemia|waldenström macroglobulinemia
771076|NCT00019838|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
771077|NCT00019838|refractory hairy cell leukemia|refractory hairy cell leukemia
771078|NCT00019838|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
771079|NCT00019838|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
771080|NCT00019838|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
771081|NCT00019838|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
771082|NCT00019838|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
771083|NCT00019838|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
771084|NCT00019838|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
771085|NCT00019838|splenic marginal zone lymphoma|splenic marginal zone lymphoma
771086|NCT00019825|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
771087|NCT00019825|stage II esophageal cancer|stage ii esophageal cancer
771088|NCT00019825|stage III esophageal cancer|stage iii esophageal cancer
771089|NCT00019825|stage IV esophageal cancer|stage iv esophageal cancer
771090|NCT00019825|recurrent esophageal cancer|recurrent esophageal cancer
771091|NCT00019825|extensive stage small cell lung cancer|extensive stage small cell lung cancer
771092|NCT00019825|recurrent small cell lung cancer|recurrent small cell lung cancer
771093|NCT00019825|advanced malignant mesothelioma|advanced malignant mesothelioma
771094|NCT00019825|recurrent malignant mesothelioma|recurrent malignant mesothelioma
771095|NCT00019825|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
771096|NCT00019825|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
771097|NCT00019825|malignant pleural effusion|malignant pleural effusion
771098|NCT00019812|stage IV breast cancer|stage iv breast cancer
771099|NCT00019812|male breast cancer|male breast cancer
771100|NCT00019786|stage IV colon cancer|stage iv colon cancer
771101|NCT00019786|stage IV rectal cancer|stage iv rectal cancer
771102|NCT00019786|recurrent colon cancer|recurrent colon cancer
771103|NCT00019786|recurrent rectal cancer|recurrent rectal cancer
771104|NCT00019786|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
771105|NCT00019786|recurrent adult primary liver cancer|recurrent adult primary liver cancer
771106|NCT00019786|recurrent islet cell carcinoma|recurrent islet cell carcinoma
771107|NCT00019786|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
771108|NCT00019786|adenocarcinoma of the colon|adenocarcinoma of the colon
771109|NCT00019786|adenocarcinoma of the rectum|adenocarcinoma of the rectum
771110|NCT00019786|liver metastases|liver metastases
771111|NCT00019786|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
771112|NCT00019786|advanced adult primary liver cancer|advanced adult primary liver cancer
771113|NCT00019786|recurrent childhood liver cancer|recurrent childhood liver cancer
771114|NCT00019786|childhood hepatocellular carcinoma|childhood hepatocellular carcinoma
771115|NCT00019786|stage III childhood liver cancer|stage iii childhood liver cancer
771116|NCT00019786|stage IV childhood liver cancer|stage iv childhood liver cancer
771117|NCT00019786|neuroendocrine carcinoma|neuroendocrine carcinoma
771118|NCT00019773|stage I colon cancer|stage i colon cancer
771119|NCT00019773|stage II colon cancer|stage ii colon cancer
771120|NCT00019773|stage III colon cancer|stage iii colon cancer
771121|NCT00019773|stage IV colon cancer|stage iv colon cancer
771122|NCT00019773|stage 0 colon cancer|stage 0 colon cancer
771123|NCT00019773|stage 0 rectal cancer|stage 0 rectal cancer
771124|NCT00019773|stage I rectal cancer|stage i rectal cancer
771125|NCT00019773|stage II rectal cancer|stage ii rectal cancer
771126|NCT00019773|stage III rectal cancer|stage iii rectal cancer
771127|NCT00019773|stage IV rectal cancer|stage iv rectal cancer
771128|NCT00019773|recurrent colon cancer|recurrent colon cancer
771130|NCT00019773|small intestine adenocarcinoma|small intestine adenocarcinoma
771131|NCT00019773|small intestine lymphoma|small intestine lymphoma
771132|NCT00019773|small intestine leiomyosarcoma|small intestine leiomyosarcoma
771133|NCT00019773|recurrent small intestine cancer|recurrent small intestine cancer
771134|NCT00019773|carcinoma of the appendix|carcinoma of the appendix
771135|NCT00019747|stage IV colon cancer|stage iv colon cancer
771136|NCT00019747|stage IV rectal cancer|stage iv rectal cancer
771137|NCT00019747|recurrent colon cancer|recurrent colon cancer
771138|NCT00019747|recurrent rectal cancer|recurrent rectal cancer
771139|NCT00019669|stage IV melanoma|stage iv melanoma
771140|NCT00019669|recurrent melanoma|recurrent melanoma
771141|NCT00019656|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
771142|NCT00019656|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
771143|NCT00019656|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
771144|NCT00019656|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
771145|NCT00019656|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
771146|NCT00019656|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
771147|NCT00019656|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
771148|NCT00019656|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
771149|NCT00019656|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
771150|NCT00019656|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
771151|NCT00019656|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
771152|NCT00019656|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
771153|NCT00019656|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
771154|NCT00019656|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
771155|NCT00019656|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
771156|NCT00019656|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
771157|NCT00019656|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
771158|NCT00019656|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
771159|NCT00019656|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
771160|NCT00019656|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
771161|NCT00019656|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
771162|NCT00019656|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
771163|NCT00019656|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
771164|NCT00019656|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
771165|NCT00019656|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
771166|NCT00019656|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
771167|NCT00019656|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
771168|NCT00019656|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
771169|NCT00019656|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
771170|NCT00019656|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
771171|NCT00019656|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
771172|NCT00019656|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
771173|NCT00019656|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
771174|NCT00019656|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
771175|NCT00019656|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
771176|NCT00019656|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
771177|NCT00019656|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
771178|NCT00019656|splenic marginal zone lymphoma|splenic marginal zone lymphoma
771179|NCT00019604|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
771180|NCT00019604|recurrent adult primary liver cancer|recurrent adult primary liver cancer
771181|NCT00019604|liver metastases|liver metastases
771182|NCT00019604|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
771183|NCT00019591|stage III colon cancer|stage iii colon cancer
771184|NCT00019591|stage IV colon cancer|stage iv colon cancer
771185|NCT00019591|stage III rectal cancer|stage iii rectal cancer
771186|NCT00019591|stage IV rectal cancer|stage iv rectal cancer
771187|NCT00019591|recurrent colon cancer|recurrent colon cancer
771188|NCT00019591|recurrent rectal cancer|recurrent rectal cancer
771189|NCT00019565|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
771190|NCT00019513|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
771191|NCT00019513|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
771192|NCT00019513|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
771193|NCT00019513|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
771194|NCT00019513|small intestine lymphoma|small intestine lymphoma
771195|NCT00019513|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
771196|NCT00019513|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
771197|NCT00019513|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
771198|NCT00019513|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
771199|NCT00019513|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
771200|NCT00019513|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
771201|NCT00019513|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
771202|NCT00019513|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
771203|NCT00019513|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
771204|NCT00019513|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
771205|NCT00019513|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
771206|NCT00019513|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
771207|NCT00019513|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
771208|NCT00019513|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
771209|NCT00019513|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
771210|NCT00019513|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
771211|NCT00019513|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
771212|NCT00019513|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
771213|NCT00019513|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
771214|NCT00019513|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
771215|NCT00019513|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
771216|NCT00019513|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
771217|NCT00019513|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
771218|NCT00019513|anaplastic large cell lymphoma|anaplastic large cell lymphoma
771219|NCT00019513|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
771220|NCT00019513|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
771221|NCT00019513|recurrent adult primary liver cancer|recurrent adult primary liver cancer
771222|NCT00019513|advanced adult primary liver cancer|advanced adult primary liver cancer
771223|NCT00019513|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
771224|NCT00019513|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
771225|NCT00019513|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
771226|NCT00019513|extensive stage small cell lung cancer|extensive stage small cell lung cancer
771227|NCT00019513|recurrent small cell lung cancer|recurrent small cell lung cancer
771228|NCT00019513|recurrent pancreatic cancer|recurrent pancreatic cancer
771229|NCT00019513|stage IV esophageal cancer|stage iv esophageal cancer
771230|NCT00019513|recurrent esophageal cancer|recurrent esophageal cancer
771231|NCT00019513|recurrent colon cancer|recurrent colon cancer
771232|NCT00019513|stage IV colon cancer|stage iv colon cancer
771233|NCT00019513|recurrent gallbladder cancer|recurrent gallbladder cancer
771234|NCT00019513|unresectable gallbladder cancer|unresectable gallbladder cancer
771235|NCT00019513|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
771236|NCT00019513|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
771237|NCT00019513|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
771238|NCT00019513|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
771239|NCT00019513|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
771240|NCT00019513|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
771241|NCT00019513|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
771242|NCT00019513|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
771243|NCT00019513|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
771244|NCT00019513|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
771245|NCT00019513|splenic marginal zone lymphoma|splenic marginal zone lymphoma
771246|NCT00019513|stage IV pancreatic cancer|stage iv pancreatic cancer
771247|NCT00019487|stage IV melanoma|stage iv melanoma
771248|NCT00019487|recurrent melanoma|recurrent melanoma
771249|NCT00019461|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
771250|NCT00019461|fallopian tube cancer|fallopian tube cancer
771251|NCT00019461|primary peritoneal cavity cancer|primary peritoneal cavity cancer
771252|NCT00019422|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
771253|NCT00019422|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
771254|NCT00019422|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
771255|NCT00019422|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
771256|NCT00019422|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
771257|NCT00019422|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
771258|NCT00019422|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
771259|NCT00019422|recurrent childhood ependymoma|recurrent childhood ependymoma
771260|NCT00019331|stage IV colon cancer|stage iv colon cancer
771261|NCT00019331|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
771262|NCT00019331|stage II pancreatic cancer|stage ii pancreatic cancer
771263|NCT00019331|stage III pancreatic cancer|stage iii pancreatic cancer
771264|NCT00019331|recurrent pancreatic cancer|recurrent pancreatic cancer
771265|NCT00019331|recurrent colon cancer|recurrent colon cancer
771266|NCT00019331|extensive stage small cell lung cancer|extensive stage small cell lung cancer
771267|NCT00019331|recurrent small cell lung cancer|recurrent small cell lung cancer
771268|NCT00019331|advanced adult primary liver cancer|advanced adult primary liver cancer
771269|NCT00019331|recurrent adult primary liver cancer|recurrent adult primary liver cancer
771270|NCT00019331|stage IV endometrial carcinoma|stage iv endometrial carcinoma
771271|NCT00019331|recurrent endometrial carcinoma|recurrent endometrial carcinoma
771272|NCT00019331|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
771273|NCT00019331|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
771274|NCT00019331|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
771275|NCT00019331|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
771276|NCT00019331|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
771277|NCT00019331|anaplastic thyroid cancer|anaplastic thyroid cancer
771278|NCT00019331|recurrent thyroid cancer|recurrent thyroid cancer
771279|NCT00019331|stage IV melanoma|stage iv melanoma
771280|NCT00019331|recurrent melanoma|recurrent melanoma
771281|NCT00019331|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
771282|NCT00019331|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
771283|NCT00019331|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
771284|NCT00019331|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
771285|NCT00019331|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
771286|NCT00019331|pulmonary carcinoid tumor|pulmonary carcinoid tumor
771287|NCT00019331|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
771288|NCT00019331|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
771289|NCT00019331|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
771290|NCT00019331|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
771291|NCT00019331|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
771292|NCT00019331|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
771293|NCT00019331|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
771294|NCT00019331|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
771295|NCT00019331|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
771296|NCT00019331|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
771297|NCT00019331|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
771298|NCT00019331|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
771299|NCT00019331|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
771300|NCT00019331|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
771301|NCT00019331|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
771302|NCT00019331|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
771303|NCT00019331|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
771304|NCT00019331|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
771305|NCT00019331|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
771306|NCT00019331|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
771307|NCT00019331|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
771308|NCT00019331|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
771309|NCT00019331|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
771310|NCT00019331|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
771311|NCT00019331|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
771312|NCT00019331|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
771313|NCT00019331|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
771314|NCT00019331|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
771315|NCT00019331|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
771316|NCT00019331|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
771317|NCT00019331|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
771318|NCT00019331|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
771319|NCT00019331|insular thyroid cancer|insular thyroid cancer
771320|NCT00019331|recurrent salivary gland cancer|recurrent salivary gland cancer
771321|NCT00019331|stage IV salivary gland cancer|stage iv salivary gland cancer
771322|NCT00019331|stage IV pancreatic cancer|stage iv pancreatic cancer
771323|NCT00019227|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
771324|NCT00019227|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
771325|NCT00019227|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
771326|NCT00019227|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
771327|NCT00019227|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
771328|NCT00019227|radiation toxicity|radiation toxicity
771329|NCT00019214|recurrent melanoma|recurrent melanoma
771330|NCT00019201|stage I non-small cell lung cancer|stage i non-small cell lung cancer
771526|NCT00017602|stage I multiple myeloma|stage i multiple myeloma
771331|NCT00019201|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
771332|NCT00019201|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
771333|NCT00019201|limited stage small cell lung cancer|limited stage small cell lung cancer
771334|NCT00019201|stage I nasopharyngeal cancer|stage i nasopharyngeal cancer
771335|NCT00019201|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
771336|NCT00019201|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
771337|NCT00019201|stage I lip and oral cavity cancer|stage i lip and oral cavity cancer
771338|NCT00019201|stage II lip and oral cavity cancer|stage ii lip and oral cavity cancer
771339|NCT00019201|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
771340|NCT00019201|stage I hypopharyngeal cancer|stage i hypopharyngeal cancer
771341|NCT00019201|stage II hypopharyngeal cancer|stage ii hypopharyngeal cancer
771342|NCT00019201|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
771343|NCT00019201|stage I laryngeal cancer|stage i laryngeal cancer
771344|NCT00019201|stage II laryngeal cancer|stage ii laryngeal cancer
771345|NCT00019201|stage III laryngeal cancer|stage iii laryngeal cancer
771346|NCT00019201|stage I paranasal sinus and nasal cavity cancer|stage i paranasal sinus and nasal cavity cancer
771347|NCT00019201|stage II paranasal sinus and nasal cavity cancer|stage ii paranasal sinus and nasal cavity cancer
771348|NCT00019201|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
771349|NCT00019201|stage I oropharyngeal cancer|stage i oropharyngeal cancer
771350|NCT00019201|stage II oropharyngeal cancer|stage ii oropharyngeal cancer
771351|NCT00019201|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
771352|NCT00019136|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
771353|NCT00019110|stage IV anal cancer|stage iv anal cancer
771354|NCT00019110|recurrent anal cancer|recurrent anal cancer
771355|NCT00019110|stage II esophageal cancer|stage ii esophageal cancer
771356|NCT00019110|stage III esophageal cancer|stage iii esophageal cancer
771357|NCT00019110|stage IV esophageal cancer|stage iv esophageal cancer
771358|NCT00019110|stage IIIA anal cancer|stage iiia anal cancer
771359|NCT00019110|stage IIIB anal cancer|stage iiib anal cancer
771360|NCT00019110|recurrent esophageal cancer|recurrent esophageal cancer
771361|NCT00019110|stage III cervical cancer|stage iii cervical cancer
771362|NCT00019110|stage IV cervical cancer|stage iv cervical cancer
771363|NCT00019110|recurrent cervical cancer|recurrent cervical cancer
771364|NCT00019110|stage III vulvar cancer|stage iii vulvar cancer
771365|NCT00019110|stage IVB vulvar cancer|stage ivb vulvar cancer
771366|NCT00019110|recurrent vulvar cancer|recurrent vulvar cancer
771367|NCT00019110|stage III penile cancer|stage iii penile cancer
771368|NCT00019110|stage IV penile cancer|stage iv penile cancer
771369|NCT00019110|recurrent penile cancer|recurrent penile cancer
771370|NCT00019110|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
771371|NCT00019110|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
771372|NCT00019110|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
771373|NCT00019110|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
771374|NCT00019110|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
771375|NCT00019110|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
771376|NCT00019110|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
771377|NCT00019110|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
771378|NCT00019110|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
771379|NCT00019110|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
771380|NCT00019110|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
771381|NCT00019110|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
771382|NCT00019110|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
771383|NCT00019110|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
771384|NCT00019110|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
771385|NCT00019110|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
771386|NCT00019110|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
771387|NCT00019110|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
771388|NCT00019110|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
771389|NCT00019110|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
771390|NCT00019110|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
771391|NCT00019110|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
771392|NCT00019110|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
771393|NCT00019110|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
771394|NCT00019110|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
771395|NCT00019110|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
786859|NCT00002371|HIV-1|hiv-1
771396|NCT00019110|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
771397|NCT00019110|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
771398|NCT00019110|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
771399|NCT00019110|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
771400|NCT00019110|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
771401|NCT00019110|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
771402|NCT00019110|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
771403|NCT00019110|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
771404|NCT00019110|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
771405|NCT00019110|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
771406|NCT00019110|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
771407|NCT00019110|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
771408|NCT00019110|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
771504|NCT00019019|anaplastic large cell lymphoma|anaplastic large cell lymphoma
771409|NCT00019110|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
771410|NCT00019110|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
771411|NCT00019110|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
771412|NCT00019110|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
771413|NCT00019110|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
771414|NCT00019110|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
771415|NCT00019110|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
771416|NCT00019110|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
771417|NCT00019110|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
771418|NCT00019110|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
771419|NCT00019110|recurrent salivary gland cancer|recurrent salivary gland cancer
771420|NCT00019110|stage IV salivary gland cancer|stage iv salivary gland cancer
771421|NCT00019110|stage III salivary gland cancer|stage iii salivary gland cancer
771422|NCT00019032|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
771423|NCT00019032|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
771424|NCT00019019|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
771425|NCT00019019|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
771426|NCT00019019|stage IV breast cancer|stage iv breast cancer
771427|NCT00019019|stage IIIA breast cancer|stage iiia breast cancer
771428|NCT00019019|recurrent breast cancer|recurrent breast cancer
771429|NCT00019019|stage IIIB breast cancer|stage iiib breast cancer
771430|NCT00019019|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
771431|NCT00019019|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
771432|NCT00019019|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
771433|NCT00019019|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
771434|NCT00019019|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
771435|NCT00019019|stage III renal cell cancer|stage iii renal cell cancer
771436|NCT00019019|stage IV renal cell cancer|stage iv renal cell cancer
771437|NCT00019019|recurrent renal cell cancer|recurrent renal cell cancer
771438|NCT00019019|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
771439|NCT00019019|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
771440|NCT00019019|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
771441|NCT00019019|recurrent adult brain tumor|recurrent adult brain tumor
771442|NCT00019019|small intestine lymphoma|small intestine lymphoma
771443|NCT00019019|adult brain stem glioma|adult brain stem glioma
771444|NCT00019019|adult craniopharyngioma|adult craniopharyngioma
771445|NCT00019019|adult medulloblastoma|adult medulloblastoma
771446|NCT00019019|adult meningioma|adult meningioma
771447|NCT00019019|adult glioblastoma|adult glioblastoma
771448|NCT00019019|stage III melanoma|stage iii melanoma
771449|NCT00019019|stage IV melanoma|stage iv melanoma
771450|NCT00019019|recurrent melanoma|recurrent melanoma
771451|NCT00019019|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
771452|NCT00019019|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
771453|NCT00019019|stage IIIC breast cancer|stage iiic breast cancer
771454|NCT00019019|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
771455|NCT00019019|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
771456|NCT00019019|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
771457|NCT00019019|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
771458|NCT00019019|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
771459|NCT00019019|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
771460|NCT00019019|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
771461|NCT00019019|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
771462|NCT00019019|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
771463|NCT00019019|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
771464|NCT00019019|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
771465|NCT00019019|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
771466|NCT00019019|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
771467|NCT00019019|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
771468|NCT00019019|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
771469|NCT00019019|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
771470|NCT00019019|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
771471|NCT00019019|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
771472|NCT00019019|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
771473|NCT00019019|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
771474|NCT00019019|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
771475|NCT00019019|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
771476|NCT00019019|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
771477|NCT00019019|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
771478|NCT00019019|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
771479|NCT00019019|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
771480|NCT00019019|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
771481|NCT00019019|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
771482|NCT00019019|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
771483|NCT00019019|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
771484|NCT00019019|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
771485|NCT00019019|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
771486|NCT00019019|adult anaplastic astrocytoma|adult anaplastic astrocytoma
771487|NCT00019019|adult myxopapillary ependymoma|adult myxopapillary ependymoma
771488|NCT00019019|adult anaplastic ependymoma|adult anaplastic ependymoma
771489|NCT00019019|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
771490|NCT00019019|adult mixed glioma|adult mixed glioma
771491|NCT00019019|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
771492|NCT00019019|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
771493|NCT00019019|adult pilocytic astrocytoma|adult pilocytic astrocytoma
771494|NCT00019019|adult subependymoma|adult subependymoma
771495|NCT00019019|adult ependymoblastoma|adult ependymoblastoma
771496|NCT00019019|adult pineocytoma|adult pineocytoma
771497|NCT00019019|adult pineoblastoma|adult pineoblastoma
771498|NCT00019019|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
771499|NCT00019019|intraocular lymphoma|intraocular lymphoma
771500|NCT00019019|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
771501|NCT00019019|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
771502|NCT00019019|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
771503|NCT00019019|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
771505|NCT00019019|adult choroid plexus tumor|adult choroid plexus tumor
771506|NCT00019019|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
771507|NCT00019019|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
771508|NCT00019019|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
771509|NCT00019019|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
771510|NCT00019019|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
771511|NCT00019019|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
771512|NCT00019019|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
771513|NCT00019019|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
771514|NCT00019019|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
771515|NCT00019019|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
771516|NCT00019019|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
771517|NCT00019019|splenic marginal zone lymphoma|splenic marginal zone lymphoma
771518|NCT00019019|adult grade III meningioma|adult grade iii meningioma
771519|NCT00019019|adult oligodendroglioma|adult oligodendroglioma
771520|NCT00019019|adult giant cell glioblastoma|adult giant cell glioblastoma
771521|NCT00019019|adult gliosarcoma|adult gliosarcoma
771522|NCT00018967|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
771523|NCT00018967|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
771524|NCT00018967|neurotoxicity|neurotoxicity
771525|NCT00017602|refractory multiple myeloma|refractory multiple myeloma
771527|NCT00017602|stage II multiple myeloma|stage ii multiple myeloma
771528|NCT00017602|stage III multiple myeloma|stage iii multiple myeloma
771529|NCT00017589|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
771530|NCT00017563|adenocarcinoma of the prostate|adenocarcinoma of the prostate
771531|NCT00017563|stage II prostate cancer|stage ii prostate cancer
771532|NCT00017563|stage III prostate cancer|stage iii prostate cancer
771533|NCT00017550|refractory anemia|refractory anemia
771534|NCT00017550|refractory anemia with excess blasts|refractory anemia with excess blasts
771535|NCT00017550|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
771536|NCT00017550|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
771537|NCT00017524|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
771538|NCT00017511|stage I salivary gland cancer|stage i salivary gland cancer
771539|NCT00017511|stage II salivary gland cancer|stage ii salivary gland cancer
771540|NCT00017511|stage III salivary gland cancer|stage iii salivary gland cancer
771541|NCT00017511|stage IV salivary gland cancer|stage iv salivary gland cancer
771542|NCT00017511|recurrent salivary gland cancer|recurrent salivary gland cancer
771543|NCT00017511|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
771544|NCT00017511|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
771545|NCT00017511|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
771546|NCT00017511|oral complications|oral complications
771547|NCT00017511|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
771548|NCT00017511|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
771549|NCT00017511|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
771550|NCT00017511|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
771551|NCT00017511|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
771552|NCT00017511|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
771553|NCT00017511|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
771554|NCT00017511|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
771555|NCT00017511|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
771556|NCT00017511|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
771557|NCT00017511|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
771558|NCT00017511|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
771559|NCT00017511|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
771560|NCT00017511|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
771561|NCT00017511|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
771562|NCT00017511|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
771563|NCT00017511|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
771564|NCT00017511|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
771565|NCT00017511|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
771566|NCT00017511|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
771567|NCT00017511|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
771568|NCT00017511|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
771569|NCT00017511|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
771570|NCT00017511|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
771571|NCT00017511|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
771572|NCT00017511|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
771573|NCT00017511|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
771574|NCT00017511|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
771575|NCT00017511|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
771576|NCT00017511|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
771577|NCT00017511|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
771578|NCT00017511|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
771579|NCT00017511|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
771580|NCT00017511|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
771581|NCT00017511|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
771582|NCT00017511|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
771583|NCT00017511|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
771584|NCT00017511|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
771585|NCT00017511|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
771586|NCT00017511|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
771587|NCT00017511|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
771588|NCT00017511|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
771589|NCT00017511|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
771590|NCT00017511|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
771591|NCT00017511|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
771592|NCT00017511|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
771593|NCT00017511|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
771883|NCT00014599|stage IV vulvar cancer|stage iv vulvar cancer
771594|NCT00017511|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
771595|NCT00017511|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
771596|NCT00017511|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
771597|NCT00017511|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
771598|NCT00017511|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
771599|NCT00017511|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
771600|NCT00017511|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
771601|NCT00017511|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
771602|NCT00017511|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
771603|NCT00017511|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
771604|NCT00017511|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
771605|NCT00017511|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
771606|NCT00017511|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
771607|NCT00017511|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
771608|NCT00017511|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
771609|NCT00017511|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
771610|NCT00017511|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
771611|NCT00017511|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
771612|NCT00017511|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
771613|NCT00017511|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
771614|NCT00017511|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
771615|NCT00017511|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
771616|NCT00017511|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
771617|NCT00017511|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
771618|NCT00017511|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
771619|NCT00017511|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
771620|NCT00017511|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
771621|NCT00017511|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
771622|NCT00017511|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
771623|NCT00017511|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
771624|NCT00017511|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
771625|NCT00017511|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
771626|NCT00017511|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
771627|NCT00017511|radiation toxicity|radiation toxicity
771628|NCT00017498|stage IV salivary gland cancer|stage iv salivary gland cancer
771629|NCT00017498|recurrent salivary gland cancer|recurrent salivary gland cancer
771630|NCT00017498|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
771631|NCT00017498|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
771632|NCT00017498|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
771633|NCT00017485|basal cell carcinoma of the skin|basal cell carcinoma of the skin
771634|NCT00017485|recurrent skin cancer|recurrent skin cancer
771635|NCT00017355|stage IV melanoma|stage iv melanoma
771636|NCT00017355|recurrent melanoma|recurrent melanoma
771637|NCT00017329|stage IV renal cell cancer|stage iv renal cell cancer
771638|NCT00017290|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
771639|NCT00017290|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
771640|NCT00017290|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
771641|NCT00017290|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
771642|NCT00017290|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
771643|NCT00017290|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
771644|NCT00017277|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
771645|NCT00017277|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
771646|NCT00017277|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
771647|NCT00017277|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
771648|NCT00017277|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
771649|NCT00017277|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
771650|NCT00017277|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
771651|NCT00017277|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
771652|NCT00017277|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
771653|NCT00017277|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
771654|NCT00017277|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
771655|NCT00017277|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
771656|NCT00017277|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
771657|NCT00017277|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
771658|NCT00017277|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
771659|NCT00017277|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
771660|NCT00017264|recurrent adult brain tumor|recurrent adult brain tumor
771661|NCT00017264|adult glioblastoma|adult glioblastoma
771662|NCT00017264|adult anaplastic astrocytoma|adult anaplastic astrocytoma
771663|NCT00017264|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
771664|NCT00017264|adult giant cell glioblastoma|adult giant cell glioblastoma
771665|NCT00017264|adult gliosarcoma|adult gliosarcoma
771666|NCT00017225|localized resectable neuroblastoma|localized resectable neuroblastoma
771667|NCT00017225|regional neuroblastoma|regional neuroblastoma
771668|NCT00017225|disseminated neuroblastoma|disseminated neuroblastoma
771669|NCT00017225|stage 4S neuroblastoma|stage 4s neuroblastoma
771670|NCT00017225|recurrent neuroblastoma|recurrent neuroblastoma
771671|NCT00017225|localized unresectable neuroblastoma|localized unresectable neuroblastoma
771672|NCT00017212|stage III gastric cancer|stage iii gastric cancer
771673|NCT00017212|stage IV gastric cancer|stage iv gastric cancer
771674|NCT00017212|recurrent gastric cancer|recurrent gastric cancer
771675|NCT00017212|stage III esophageal cancer|stage iii esophageal cancer
771676|NCT00017212|stage IV esophageal cancer|stage iv esophageal cancer
771677|NCT00017212|recurrent esophageal cancer|recurrent esophageal cancer
771678|NCT00017212|adenocarcinoma of the stomach|adenocarcinoma of the stomach
771679|NCT00017212|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
771680|NCT00017186|localized malignant mesothelioma|localized malignant mesothelioma
771681|NCT00017186|advanced malignant mesothelioma|advanced malignant mesothelioma
771682|NCT00017186|recurrent malignant mesothelioma|recurrent malignant mesothelioma
771683|NCT00017173|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
771684|NCT00017173|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
771685|NCT00017173|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
771686|NCT00017173|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
771687|NCT00017173|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
771688|NCT00017173|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
771689|NCT00017173|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
771690|NCT00017173|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
771691|NCT00017147|adult glioblastoma|adult glioblastoma
771692|NCT00017147|adult giant cell glioblastoma|adult giant cell glioblastoma
771693|NCT00017147|adult gliosarcoma|adult gliosarcoma
771694|NCT00017121|stage IV melanoma|stage iv melanoma
771695|NCT00017121|recurrent melanoma|recurrent melanoma
771696|NCT00017121|lung metastases|lung metastases
771697|NCT00017108|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
771698|NCT00017108|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
771699|NCT00017108|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
771700|NCT00017095|stage II breast cancer|stage ii breast cancer
771701|NCT00017095|stage IIIA breast cancer|stage iiia breast cancer
771702|NCT00017095|stage IIIB breast cancer|stage iiib breast cancer
771703|NCT00017095|stage IIIC breast cancer|stage iiic breast cancer
771704|NCT00017095|inflammatory breast cancer|inflammatory breast cancer
771705|NCT00017069|refractory multiple myeloma|refractory multiple myeloma
771706|NCT00017069|stage II multiple myeloma|stage ii multiple myeloma
771707|NCT00017069|stage III multiple myeloma|stage iii multiple myeloma
771708|NCT00016991|recurrent adult brain tumor|recurrent adult brain tumor
771709|NCT00016991|adult glioblastoma|adult glioblastoma
771710|NCT00016991|adult giant cell glioblastoma|adult giant cell glioblastoma
771711|NCT00016991|adult gliosarcoma|adult gliosarcoma
771712|NCT00016965|stage II pancreatic cancer|stage ii pancreatic cancer
771713|NCT00016965|stage III pancreatic cancer|stage iii pancreatic cancer
771714|NCT00016965|recurrent pancreatic cancer|recurrent pancreatic cancer
771715|NCT00016965|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
771716|NCT00016965|stage IV pancreatic cancer|stage iv pancreatic cancer
771717|NCT00016952|stage IV colon cancer|stage iv colon cancer
771718|NCT00016952|stage IV rectal cancer|stage iv rectal cancer
771719|NCT00016952|recurrent colon cancer|recurrent colon cancer
771720|NCT00016952|recurrent rectal cancer|recurrent rectal cancer
771721|NCT00016952|adenocarcinoma of the colon|adenocarcinoma of the colon
771722|NCT00016952|adenocarcinoma of the rectum|adenocarcinoma of the rectum
771723|NCT00016926|stage III cervical cancer|stage iii cervical cancer
771724|NCT00016926|recurrent cervical cancer|recurrent cervical cancer
771725|NCT00016926|stage IVB cervical cancer|stage ivb cervical cancer
771726|NCT00016926|stage IVA cervical cancer|stage iva cervical cancer
771727|NCT00016926|cervical squamous cell carcinoma|cervical squamous cell carcinoma
771728|NCT00016913|adenocarcinoma of the prostate|adenocarcinoma of the prostate
771729|NCT00016913|stage III prostate cancer|stage iii prostate cancer
771730|NCT00016887|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
771731|NCT00016887|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
771732|NCT00016861|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
771733|NCT00016432|stage I breast cancer|stage i breast cancer
771734|NCT00016432|stage II breast cancer|stage ii breast cancer
771735|NCT00016432|stage IIIA breast cancer|stage iiia breast cancer
771736|NCT00016419|refractory anemia|refractory anemia
771737|NCT00016419|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
771738|NCT00016419|refractory anemia with excess blasts|refractory anemia with excess blasts
771739|NCT00016419|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
771740|NCT00016419|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
771741|NCT00016419|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
771742|NCT00016406|stage II breast cancer|stage ii breast cancer
771743|NCT00016406|stage IIIA breast cancer|stage iiia breast cancer
771744|NCT00016406|stage IIIB breast cancer|stage iiib breast cancer
771745|NCT00016406|stage IIIC breast cancer|stage iiic breast cancer
771746|NCT00016406|inflammatory breast cancer|inflammatory breast cancer
771747|NCT00016393|adenocarcinoma of the prostate|adenocarcinoma of the prostate
771748|NCT00016393|stage IV prostate cancer|stage iv prostate cancer
771749|NCT00016393|recurrent prostate cancer|recurrent prostate cancer
771750|NCT00016380|nausea and vomiting|nausea and vomiting
771751|NCT00016380|stage I colon cancer|stage i colon cancer
771752|NCT00016380|stage II colon cancer|stage ii colon cancer
771753|NCT00016380|stage III colon cancer|stage iii colon cancer
771754|NCT00016380|stage IV colon cancer|stage iv colon cancer
771755|NCT00016380|stage I gastric cancer|stage i gastric cancer
771756|NCT00016380|stage II gastric cancer|stage ii gastric cancer
771757|NCT00016380|stage III gastric cancer|stage iii gastric cancer
771758|NCT00016380|stage IV gastric cancer|stage iv gastric cancer
771759|NCT00016380|recurrent gastric cancer|recurrent gastric cancer
771760|NCT00016380|stage I pancreatic cancer|stage i pancreatic cancer
771761|NCT00016380|stage II pancreatic cancer|stage ii pancreatic cancer
771762|NCT00016380|stage III pancreatic cancer|stage iii pancreatic cancer
771763|NCT00016380|recurrent pancreatic cancer|recurrent pancreatic cancer
771764|NCT00016380|recurrent colon cancer|recurrent colon cancer
771765|NCT00016380|recurrent cervical cancer|recurrent cervical cancer
771766|NCT00016380|stage IB cervical cancer|stage ib cervical cancer
771767|NCT00016380|stage IIB cervical cancer|stage iib cervical cancer
771768|NCT00016380|stage IVB cervical cancer|stage ivb cervical cancer
771769|NCT00016380|stage IA cervical cancer|stage ia cervical cancer
771770|NCT00016380|stage IIA cervical cancer|stage iia cervical cancer
771771|NCT00016380|stage IVA cervical cancer|stage iva cervical cancer
771772|NCT00016380|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
771773|NCT00016380|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
771774|NCT00016380|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
771775|NCT00016380|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
771776|NCT00016380|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
771777|NCT00016380|localized gastrointestinal carcinoid tumor|localized gastrointestinal carcinoid tumor
771778|NCT00016380|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
771779|NCT00016380|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
771780|NCT00016380|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
771781|NCT00016380|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
771782|NCT00016380|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
771783|NCT00016380|advanced adult primary liver cancer|advanced adult primary liver cancer
771784|NCT00016380|recurrent adult primary liver cancer|recurrent adult primary liver cancer
771785|NCT00016380|small intestine adenocarcinoma|small intestine adenocarcinoma
771786|NCT00016380|small intestine lymphoma|small intestine lymphoma
771787|NCT00016380|small intestine leiomyosarcoma|small intestine leiomyosarcoma
771788|NCT00016380|localized gallbladder cancer|localized gallbladder cancer
771789|NCT00016380|unresectable gallbladder cancer|unresectable gallbladder cancer
771790|NCT00016380|recurrent gallbladder cancer|recurrent gallbladder cancer
771791|NCT00016380|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
771792|NCT00016380|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
771793|NCT00016380|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
771794|NCT00016380|recurrent small intestine cancer|recurrent small intestine cancer
771795|NCT00016380|testicular seminoma|testicular seminoma
771796|NCT00016380|carcinoma of the appendix|carcinoma of the appendix
771797|NCT00016380|quality of life|quality of life
771798|NCT00016380|stage IV pancreatic cancer|stage iv pancreatic cancer
771799|NCT00016354|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
771800|NCT00016263|stage III melanoma|stage iii melanoma
771801|NCT00016263|stage IV melanoma|stage iv melanoma
771802|NCT00016263|recurrent melanoma|recurrent melanoma
771803|NCT00016224|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
771804|NCT00016211|extensive stage small cell lung cancer|extensive stage small cell lung cancer
771805|NCT00016185|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
771806|NCT00016159|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
771807|NCT00016159|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
771808|NCT00016159|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
771809|NCT00016159|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
771810|NCT00016159|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
771811|NCT00016146|recurrent prostate cancer|recurrent prostate cancer
771812|NCT00016133|stage II colon cancer|stage ii colon cancer
771813|NCT00016133|stage III colon cancer|stage iii colon cancer
771814|NCT00016133|adenocarcinoma of the colon|adenocarcinoma of the colon
771815|NCT00016081|infection|infection
771816|NCT00016068|infection|infection
771817|NCT00016055|stage IV melanoma|stage iv melanoma
771818|NCT00016055|recurrent melanoma|recurrent melanoma
771819|NCT00016029|colon cancer|colon cancer
771820|NCT00016029|rectal cancer|rectal cancer
771821|NCT00015977|adenocarcinoma of the prostate|adenocarcinoma of the prostate
771822|NCT00015977|stage IV prostate cancer|stage iv prostate cancer
771823|NCT00015977|recurrent prostate cancer|recurrent prostate cancer
771824|NCT00015951|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
771825|NCT00015951|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
771826|NCT00015951|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
771827|NCT00015951|refractory anemia with excess blasts|refractory anemia with excess blasts
771828|NCT00015951|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
771829|NCT00015951|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
771830|NCT00015951|secondary acute myeloid leukemia|secondary acute myeloid leukemia
771831|NCT00015951|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
771832|NCT00015951|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
771833|NCT00015938|stage IV breast cancer|stage iv breast cancer
771834|NCT00015938|recurrent breast cancer|recurrent breast cancer
771835|NCT00015925|refractory multiple myeloma|refractory multiple myeloma
771836|NCT00015925|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
771837|NCT00015925|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
771838|NCT00015925|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
771839|NCT00015925|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
771840|NCT00015925|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
771841|NCT00015925|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
771842|NCT00015925|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
771843|NCT00015925|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
771844|NCT00015925|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
771845|NCT00015925|refractory anemia with excess blasts|refractory anemia with excess blasts
771846|NCT00015925|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
771847|NCT00015925|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
771848|NCT00015925|secondary acute myeloid leukemia|secondary acute myeloid leukemia
771849|NCT00015925|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
771850|NCT00015925|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
771851|NCT00015925|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
771852|NCT00015925|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
771853|NCT00015925|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
771854|NCT00015925|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
771855|NCT00015925|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
771856|NCT00015925|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
771857|NCT00015925|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
771858|NCT00015899|childhood craniopharyngioma|childhood craniopharyngioma
771859|NCT00015899|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
771860|NCT00015899|childhood oligodendroglioma|childhood oligodendroglioma
771861|NCT00015899|childhood choroid plexus tumor|childhood choroid plexus tumor
771862|NCT00015899|childhood grade I meningioma|childhood grade i meningioma
771863|NCT00015899|childhood grade II meningioma|childhood grade ii meningioma
771864|NCT00015899|childhood grade III meningioma|childhood grade iii meningioma
771865|NCT00015899|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
771866|NCT00015899|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
771867|NCT00015899|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
771868|NCT00015899|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
771869|NCT00015899|recurrent childhood ependymoma|recurrent childhood ependymoma
771870|NCT00015899|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
771871|NCT00015899|childhood spinal cord neoplasm|childhood spinal cord neoplasm
771872|NCT00015873|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
771873|NCT00015860|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
771874|NCT00015860|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
771875|NCT00015860|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
771876|NCT00015847|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
771877|NCT00015847|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
771878|NCT00015847|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
771879|NCT00014612|stage IA breast cancer|stage ia breast cancer
771880|NCT00014612|stage IB breast cancer|stage ib breast cancer
771881|NCT00014612|stage II breast cancer|stage ii breast cancer
771882|NCT00014599|stage III vulvar cancer|stage iii vulvar cancer
771885|NCT00014599|squamous cell carcinoma of the vulva|squamous cell carcinoma of the vulva
771886|NCT00014586|stage I prostate cancer|stage i prostate cancer
771887|NCT00014586|stage IIB prostate cancer|stage iib prostate cancer
771888|NCT00014586|stage IIA prostate cancer|stage iia prostate cancer
771889|NCT00014586|stage III prostate cancer|stage iii prostate cancer
771890|NCT00014521|recurrent adult brain tumor|recurrent adult brain tumor
771891|NCT00014521|adult glioblastoma|adult glioblastoma
771892|NCT00014521|adult anaplastic astrocytoma|adult anaplastic astrocytoma
771893|NCT00014521|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
771894|NCT00014521|adult giant cell glioblastoma|adult giant cell glioblastoma
771895|NCT00014521|adult gliosarcoma|adult gliosarcoma
771896|NCT00014508|refractory multiple myeloma|refractory multiple myeloma
771897|NCT00014508|stage I multiple myeloma|stage i multiple myeloma
771898|NCT00014508|stage II multiple myeloma|stage ii multiple myeloma
771899|NCT00014508|stage III multiple myeloma|stage iii multiple myeloma
771900|NCT00014495|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
771901|NCT00014495|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
771902|NCT00014495|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
771903|NCT00014495|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
771904|NCT00014495|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
771905|NCT00014495|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
771906|NCT00014495|refractory anemia with excess blasts|refractory anemia with excess blasts
771907|NCT00014495|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
771908|NCT00014495|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
771909|NCT00014495|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
771910|NCT00014495|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
771911|NCT00014495|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
771912|NCT00014495|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
771913|NCT00014495|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
771914|NCT00014495|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
771915|NCT00014495|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
771916|NCT00014495|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
771917|NCT00014495|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
771918|NCT00014495|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
771919|NCT00014495|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
771920|NCT00014482|anxiety disorder|anxiety disorder
771921|NCT00014482|depression|depression
771922|NCT00014482|pain|pain
771923|NCT00014482|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
771924|NCT00014482|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
771925|NCT00014482|refractory multiple myeloma|refractory multiple myeloma
771926|NCT00014482|stage I multiple myeloma|stage i multiple myeloma
771927|NCT00014482|stage II multiple myeloma|stage ii multiple myeloma
771928|NCT00014482|stage III multiple myeloma|stage iii multiple myeloma
771929|NCT00014482|primary myelofibrosis|primary myelofibrosis
771930|NCT00014482|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
771931|NCT00014482|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
771932|NCT00014482|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
771933|NCT00014482|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
771934|NCT00014482|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
771935|NCT00014482|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
771936|NCT00014482|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
771937|NCT00014482|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
771938|NCT00014482|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
771939|NCT00014482|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
771940|NCT00014482|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
771941|NCT00014482|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
771942|NCT00014482|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
771943|NCT00014482|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
771944|NCT00014482|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
771945|NCT00014482|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
771946|NCT00014482|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
771947|NCT00014482|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
771948|NCT00014482|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
771949|NCT00014482|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
771950|NCT00014482|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
771951|NCT00014482|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
771952|NCT00014482|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
771953|NCT00014482|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
771954|NCT00014482|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
771955|NCT00014482|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
771956|NCT00014482|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
771957|NCT00014482|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
771958|NCT00014482|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
771959|NCT00014482|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
771960|NCT00014482|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
771961|NCT00014482|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
771962|NCT00014482|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
771963|NCT00014482|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
771964|NCT00014482|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
771965|NCT00014482|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
771966|NCT00014482|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
771967|NCT00014482|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
771968|NCT00014482|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
771969|NCT00014482|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
771970|NCT00014482|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
771971|NCT00014482|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
771972|NCT00014482|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
771973|NCT00014482|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
771974|NCT00014482|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
771975|NCT00014482|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
771976|NCT00014482|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
771977|NCT00014482|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
771978|NCT00014482|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
771979|NCT00014482|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
771980|NCT00014482|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
771981|NCT00014482|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
771982|NCT00014482|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
771983|NCT00014482|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
771984|NCT00014482|splenic marginal zone lymphoma|splenic marginal zone lymphoma
772253|NCT00010270|stage IV rectal cancer|stage iv rectal cancer
771985|NCT00014469|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
771986|NCT00014469|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
771987|NCT00014469|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
771988|NCT00014469|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
771989|NCT00014469|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
771990|NCT00014469|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
771991|NCT00014469|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
771992|NCT00014469|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
771993|NCT00014469|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
771994|NCT00014469|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
771995|NCT00014469|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
771996|NCT00014469|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
771997|NCT00014469|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
771998|NCT00014469|refractory anemia with excess blasts|refractory anemia with excess blasts
771999|NCT00014469|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
772000|NCT00014469|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
772001|NCT00014469|acute undifferentiated leukemia|acute undifferentiated leukemia
772002|NCT00014469|secondary acute myeloid leukemia|secondary acute myeloid leukemia
772003|NCT00014469|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
772004|NCT00014469|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
772005|NCT00014469|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
772006|NCT00014469|graft versus host disease|graft versus host disease
772007|NCT00014469|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
772008|NCT00014469|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
772009|NCT00014469|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
772010|NCT00014469|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
772011|NCT00014469|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
772012|NCT00014469|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
772013|NCT00014469|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
772014|NCT00014469|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
772015|NCT00014469|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
772016|NCT00014469|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
772017|NCT00014456|stage IV breast cancer|stage iv breast cancer
772018|NCT00014456|recurrent breast cancer|recurrent breast cancer
772019|NCT00014456|stage IV gastric cancer|stage iv gastric cancer
772020|NCT00014456|recurrent gastric cancer|recurrent gastric cancer
772021|NCT00014456|metastatic osteosarcoma|metastatic osteosarcoma
772022|NCT00014456|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
772023|NCT00014456|stage II pancreatic cancer|stage ii pancreatic cancer
772024|NCT00014456|stage III pancreatic cancer|stage iii pancreatic cancer
772025|NCT00014456|recurrent pancreatic cancer|recurrent pancreatic cancer
772026|NCT00014456|stage II esophageal cancer|stage ii esophageal cancer
772027|NCT00014456|stage III esophageal cancer|stage iii esophageal cancer
772028|NCT00014456|stage IV esophageal cancer|stage iv esophageal cancer
772029|NCT00014456|recurrent esophageal cancer|recurrent esophageal cancer
772030|NCT00014456|chondrosarcoma|chondrosarcoma
772031|NCT00014456|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
772032|NCT00014456|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
772033|NCT00014456|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
772034|NCT00014456|extensive stage small cell lung cancer|extensive stage small cell lung cancer
772035|NCT00014456|recurrent small cell lung cancer|recurrent small cell lung cancer
772036|NCT00014456|recurrent osteosarcoma|recurrent osteosarcoma
772037|NCT00014456|recurrent bladder cancer|recurrent bladder cancer
772038|NCT00014456|stage IV bladder cancer|stage iv bladder cancer
772039|NCT00014456|stage IV prostate cancer|stage iv prostate cancer
772040|NCT00014456|recurrent prostate cancer|recurrent prostate cancer
772041|NCT00014456|stage IV melanoma|stage iv melanoma
772042|NCT00014456|recurrent melanoma|recurrent melanoma
772043|NCT00014456|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
772044|NCT00014456|stage IV salivary gland cancer|stage iv salivary gland cancer
772045|NCT00014456|recurrent salivary gland cancer|recurrent salivary gland cancer
772046|NCT00014456|classic Kaposi sarcoma|classic kaposi sarcoma
772047|NCT00014456|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
772048|NCT00014456|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
772049|NCT00014456|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
772050|NCT00014456|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
772051|NCT00014456|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
772052|NCT00014456|stage IV uterine sarcoma|stage iv uterine sarcoma
772053|NCT00014456|recurrent uterine sarcoma|recurrent uterine sarcoma
772054|NCT00014456|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
772055|NCT00014456|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
772056|NCT00014456|ovarian sarcoma|ovarian sarcoma
772057|NCT00014456|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
772058|NCT00014456|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
772059|NCT00014456|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
772060|NCT00014456|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
772061|NCT00014456|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
772062|NCT00014456|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
772063|NCT00014456|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
772064|NCT00014456|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
772065|NCT00014456|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
772066|NCT00014456|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
772067|NCT00014456|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
772068|NCT00014456|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
772069|NCT00014456|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
772070|NCT00014456|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
772071|NCT00014456|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
772072|NCT00014456|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
772073|NCT00014456|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
772074|NCT00014456|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
772075|NCT00014456|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
772076|NCT00014456|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
772077|NCT00014456|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
772078|NCT00014456|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
772079|NCT00014456|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
772080|NCT00014456|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
772081|NCT00014456|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
772082|NCT00014456|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
772083|NCT00014456|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
772084|NCT00014456|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
772085|NCT00014456|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
772086|NCT00014456|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
772087|NCT00014456|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
772088|NCT00014456|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
772089|NCT00014456|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
772090|NCT00014456|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
772091|NCT00014456|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
772092|NCT00014456|stage IV pancreatic cancer|stage iv pancreatic cancer
772093|NCT00014443|recurrent adult brain tumor|recurrent adult brain tumor
772094|NCT00014443|adult glioblastoma|adult glioblastoma
772095|NCT00014443|adult anaplastic astrocytoma|adult anaplastic astrocytoma
772096|NCT00014443|adult giant cell glioblastoma|adult giant cell glioblastoma
772097|NCT00014443|adult gliosarcoma|adult gliosarcoma
772098|NCT00014378|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
772099|NCT00014326|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
772100|NCT00014326|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
772101|NCT00014326|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
772102|NCT00014326|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
772103|NCT00014326|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
772104|NCT00014326|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
772105|NCT00014326|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
772106|NCT00014326|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
772107|NCT00014326|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
772108|NCT00014326|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
772109|NCT00014326|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
787229|NCT00002295|Zidovudine|zidovudine
772110|NCT00014326|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
772111|NCT00014326|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
772112|NCT00014326|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
772113|NCT00014326|stage I marginal zone lymphoma|stage i marginal zone lymphoma
772114|NCT00014326|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
772115|NCT00014313|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
772116|NCT00014274|stage III bladder cancer|stage iii bladder cancer
772117|NCT00014274|stage IV bladder cancer|stage iv bladder cancer
772118|NCT00014274|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
772119|NCT00014274|anterior urethral cancer|anterior urethral cancer
772120|NCT00014274|posterior urethral cancer|posterior urethral cancer
772121|NCT00014274|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
772122|NCT00014274|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
772123|NCT00014274|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
772124|NCT00014222|stage I breast cancer|stage i breast cancer
772125|NCT00014222|stage II breast cancer|stage ii breast cancer
772126|NCT00014222|stage IIIA breast cancer|stage iiia breast cancer
772127|NCT00014222|stage IIIB breast cancer|stage iiib breast cancer
772128|NCT00014196|squamous cell lung cancer|squamous cell lung cancer
772129|NCT00014196|large cell lung cancer|large cell lung cancer
772130|NCT00014196|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
772131|NCT00014196|adenocarcinoma of the lung|adenocarcinoma of the lung
772132|NCT00014131|stage III renal cell cancer|stage iii renal cell cancer
772133|NCT00014131|stage IV renal cell cancer|stage iv renal cell cancer
772134|NCT00014131|recurrent renal cell cancer|recurrent renal cell cancer
772135|NCT00014118|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
772136|NCT00014118|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
772137|NCT00014118|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
772138|NCT00014118|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
772139|NCT00014092|stage IV melanoma|stage iv melanoma
772140|NCT00014092|recurrent melanoma|recurrent melanoma
772141|NCT00014079|colon cancer|colon cancer
772142|NCT00014079|rectal cancer|rectal cancer
772143|NCT00012389|stage IV colon cancer|stage iv colon cancer
772144|NCT00012389|stage IV rectal cancer|stage iv rectal cancer
772145|NCT00012389|recurrent colon cancer|recurrent colon cancer
772146|NCT00012389|recurrent rectal cancer|recurrent rectal cancer
772147|NCT00012363|stage IV gastric cancer|stage iv gastric cancer
772148|NCT00012363|recurrent gastric cancer|recurrent gastric cancer
772149|NCT00012363|stage IV esophageal cancer|stage iv esophageal cancer
772150|NCT00012363|recurrent esophageal cancer|recurrent esophageal cancer
772151|NCT00012363|adenocarcinoma of the stomach|adenocarcinoma of the stomach
772152|NCT00012363|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
772153|NCT00012363|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
772154|NCT00012324|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
772155|NCT00012324|advanced adult primary liver cancer|advanced adult primary liver cancer
772156|NCT00012324|recurrent adult primary liver cancer|recurrent adult primary liver cancer
772157|NCT00012324|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
772158|NCT00012246|stage II colon cancer|stage ii colon cancer
772159|NCT00012246|stage III colon cancer|stage iii colon cancer
772160|NCT00012246|stage IV colon cancer|stage iv colon cancer
772161|NCT00012246|stage II gastric cancer|stage ii gastric cancer
772162|NCT00012246|stage III gastric cancer|stage iii gastric cancer
772163|NCT00012246|stage IV gastric cancer|stage iv gastric cancer
772164|NCT00012246|recurrent gastric cancer|recurrent gastric cancer
772165|NCT00012246|stage II pancreatic cancer|stage ii pancreatic cancer
772166|NCT00012246|stage III pancreatic cancer|stage iii pancreatic cancer
772167|NCT00012246|recurrent pancreatic cancer|recurrent pancreatic cancer
772168|NCT00012246|stage II rectal cancer|stage ii rectal cancer
772169|NCT00012246|stage III rectal cancer|stage iii rectal cancer
772170|NCT00012246|stage IV rectal cancer|stage iv rectal cancer
772171|NCT00012246|recurrent colon cancer|recurrent colon cancer
772172|NCT00012246|recurrent rectal cancer|recurrent rectal cancer
772173|NCT00012246|stage II esophageal cancer|stage ii esophageal cancer
772174|NCT00012246|stage III esophageal cancer|stage iii esophageal cancer
772175|NCT00012246|stage IV esophageal cancer|stage iv esophageal cancer
772176|NCT00012246|recurrent esophageal cancer|recurrent esophageal cancer
772177|NCT00012246|adenocarcinoma of the stomach|adenocarcinoma of the stomach
772178|NCT00012246|small intestine adenocarcinoma|small intestine adenocarcinoma
772179|NCT00012246|localized gallbladder cancer|localized gallbladder cancer
772180|NCT00012246|unresectable gallbladder cancer|unresectable gallbladder cancer
772181|NCT00012246|recurrent gallbladder cancer|recurrent gallbladder cancer
772182|NCT00012246|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
772183|NCT00012246|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
787319|NCT00002277|Mycoses|mycoses
772184|NCT00012246|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
772185|NCT00012246|recurrent small intestine cancer|recurrent small intestine cancer
772186|NCT00012246|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
772187|NCT00012246|adenocarcinoma of the colon|adenocarcinoma of the colon
772188|NCT00012246|adenocarcinoma of the rectum|adenocarcinoma of the rectum
772189|NCT00012246|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
772190|NCT00012246|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
772191|NCT00012246|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
772192|NCT00012246|stage IV pancreatic cancer|stage iv pancreatic cancer
772193|NCT00012220|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
772194|NCT00012220|stage IV pancreatic cancer|stage iv pancreatic cancer
772195|NCT00012207|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
772196|NCT00012207|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
772197|NCT00012207|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
772198|NCT00012207|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
772199|NCT00012207|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
772200|NCT00012207|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
772201|NCT00012207|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
772202|NCT00012168|stage 0 oropharyngeal cancer|stage 0 oropharyngeal cancer
772203|NCT00012168|stage 0 lip and oral cavity cancer|stage 0 lip and oral cavity cancer
772204|NCT00012168|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
772205|NCT00012168|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
772206|NCT00012168|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
772207|NCT00012168|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
772208|NCT00012168|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
772209|NCT00012168|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
772210|NCT00012168|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
772211|NCT00012168|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
772212|NCT00012103|non-small cell lung cancer|non-small cell lung cancer
772213|NCT00012103|small cell lung cancer|small cell lung cancer
772214|NCT00012064|stage IV melanoma|stage iv melanoma
772215|NCT00012064|recurrent melanoma|recurrent melanoma
772216|NCT00012051|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
772217|NCT00012051|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
772218|NCT00012038|recurrent adult brain tumor|recurrent adult brain tumor
772219|NCT00012038|adult glioblastoma|adult glioblastoma
772220|NCT00012038|adult anaplastic astrocytoma|adult anaplastic astrocytoma
772221|NCT00012038|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
772222|NCT00012038|adult giant cell glioblastoma|adult giant cell glioblastoma
772223|NCT00012038|adult gliosarcoma|adult gliosarcoma
772224|NCT00012025|stage IV breast cancer|stage iv breast cancer
772225|NCT00012025|recurrent breast cancer|recurrent breast cancer
772226|NCT00012025|stage IIIB breast cancer|stage iiib breast cancer
772227|NCT00012025|stage IIIC breast cancer|stage iiic breast cancer
772228|NCT00012012|radiation toxicity|radiation toxicity
772229|NCT00012012|stage III cervical cancer|stage iii cervical cancer
772230|NCT00012012|stage IVA cervical cancer|stage iva cervical cancer
772231|NCT00012012|cervical squamous cell carcinoma|cervical squamous cell carcinoma
772232|NCT00012012|cervical adenocarcinoma|cervical adenocarcinoma
772233|NCT00012012|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
772234|NCT00011999|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
772235|NCT00011999|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
772236|NCT00011999|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
772237|NCT00011999|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
772238|NCT00011999|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
772239|NCT00011999|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
772240|NCT00011999|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
772241|NCT00011999|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
772242|NCT00011960|stage I gastric cancer|stage i gastric cancer
772243|NCT00011960|stage II gastric cancer|stage ii gastric cancer
772244|NCT00011960|stage III gastric cancer|stage iii gastric cancer
772245|NCT00011960|stage I esophageal cancer|stage i esophageal cancer
772246|NCT00011960|stage II esophageal cancer|stage ii esophageal cancer
772247|NCT00011960|stage III esophageal cancer|stage iii esophageal cancer
772248|NCT00011960|adenocarcinoma of the stomach|adenocarcinoma of the stomach
772249|NCT00011960|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
772250|NCT00011921|limited stage small cell lung cancer|limited stage small cell lung cancer
772251|NCT00011921|extensive stage small cell lung cancer|extensive stage small cell lung cancer
772252|NCT00010270|stage IV colon cancer|stage iv colon cancer
772254|NCT00010270|recurrent colon cancer|recurrent colon cancer
772255|NCT00010270|recurrent rectal cancer|recurrent rectal cancer
772256|NCT00010270|adenocarcinoma of the colon|adenocarcinoma of the colon
772257|NCT00010270|stage III pancreatic cancer|stage iii pancreatic cancer
772258|NCT00010270|stage II pancreatic cancer|stage ii pancreatic cancer
772259|NCT00010270|recurrent pancreatic cancer|recurrent pancreatic cancer
772260|NCT00010270|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
772261|NCT00010270|stage IV gastric cancer|stage iv gastric cancer
772262|NCT00010270|adenocarcinoma of the stomach|adenocarcinoma of the stomach
772263|NCT00010270|recurrent gastric cancer|recurrent gastric cancer
772264|NCT00010270|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
772265|NCT00010270|stage IV esophageal cancer|stage iv esophageal cancer
772266|NCT00010270|stage III esophageal cancer|stage iii esophageal cancer
772267|NCT00010270|recurrent esophageal cancer|recurrent esophageal cancer
772268|NCT00010270|stage II esophageal cancer|stage ii esophageal cancer
772269|NCT00010270|adenocarcinoma of the rectum|adenocarcinoma of the rectum
772270|NCT00010270|stage III colon cancer|stage iii colon cancer
772271|NCT00010270|stage III rectal cancer|stage iii rectal cancer
772272|NCT00010270|stage III gastric cancer|stage iii gastric cancer
772273|NCT00010270|stage IV pancreatic cancer|stage iv pancreatic cancer
772274|NCT00010257|thymoma|thymoma
772275|NCT00010257|thymic carcinoma|thymic carcinoma
772276|NCT00010218|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
772277|NCT00010218|squamous cell lung cancer|squamous cell lung cancer
772278|NCT00010218|large cell lung cancer|large cell lung cancer
772279|NCT00010218|adenocarcinoma of the lung|adenocarcinoma of the lung
772280|NCT00010218|adenosquamous cell lung cancer|adenosquamous cell lung cancer
772281|NCT00010218|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
772282|NCT00010166|stage I pancreatic cancer|stage i pancreatic cancer
772283|NCT00010166|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
772284|NCT00010153|stage I breast cancer|stage i breast cancer
772285|NCT00010153|stage II breast cancer|stage ii breast cancer
772286|NCT00010140|stage II breast cancer|stage ii breast cancer
772287|NCT00010140|stage IIIA breast cancer|stage iiia breast cancer
772288|NCT00010140|stage IIIB breast cancer|stage iiib breast cancer
772289|NCT00010140|stage IIIC breast cancer|stage iiic breast cancer
772290|NCT00010101|childhood choroid plexus tumor|childhood choroid plexus tumor
772291|NCT00010101|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
772292|NCT00010101|untreated childhood medulloblastoma|untreated childhood medulloblastoma
772293|NCT00010101|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
772294|NCT00010075|stage IV breast cancer|stage iv breast cancer
772295|NCT00010075|recurrent breast cancer|recurrent breast cancer
772296|NCT00010062|stage I pancreatic cancer|stage i pancreatic cancer
772297|NCT00010062|stage II pancreatic cancer|stage ii pancreatic cancer
772298|NCT00010062|stage III pancreatic cancer|stage iii pancreatic cancer
772299|NCT00010062|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
772300|NCT00010062|stage IV pancreatic cancer|stage iv pancreatic cancer
772301|NCT00010049|recurrent adult brain tumor|recurrent adult brain tumor
772302|NCT00010049|adult meningioma|adult meningioma
772303|NCT00010049|adult glioblastoma|adult glioblastoma
772304|NCT00010049|adult anaplastic astrocytoma|adult anaplastic astrocytoma
772305|NCT00010049|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
772306|NCT00010049|adult mixed glioma|adult mixed glioma
772307|NCT00010049|adult pilocytic astrocytoma|adult pilocytic astrocytoma
772308|NCT00010049|adult subependymoma|adult subependymoma
772309|NCT00010049|adult grade III meningioma|adult grade iii meningioma
772310|NCT00010049|adult giant cell glioblastoma|adult giant cell glioblastoma
772311|NCT00010049|adult gliosarcoma|adult gliosarcoma
772312|NCT00010023|stage IV breast cancer|stage iv breast cancer
772313|NCT00010023|stage IIIA breast cancer|stage iiia breast cancer
772314|NCT00010023|recurrent breast cancer|recurrent breast cancer
772315|NCT00010023|stage III gastric cancer|stage iii gastric cancer
772316|NCT00010023|stage IV gastric cancer|stage iv gastric cancer
772317|NCT00010023|recurrent gastric cancer|recurrent gastric cancer
772318|NCT00010023|stage IIIB breast cancer|stage iiib breast cancer
772319|NCT00010023|stage IIIC breast cancer|stage iiic breast cancer
772320|NCT00010023|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
772321|NCT00010023|stage III pancreatic cancer|stage iii pancreatic cancer
772322|NCT00010023|recurrent pancreatic cancer|recurrent pancreatic cancer
772323|NCT00010023|stage III esophageal cancer|stage iii esophageal cancer
772324|NCT00010023|stage IV esophageal cancer|stage iv esophageal cancer
772325|NCT00010023|recurrent esophageal cancer|recurrent esophageal cancer
772326|NCT00010023|extensive stage small cell lung cancer|extensive stage small cell lung cancer
772327|NCT00010023|recurrent small cell lung cancer|recurrent small cell lung cancer
772328|NCT00010023|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
772329|NCT00010023|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
772330|NCT00010023|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
772331|NCT00010023|advanced adult primary liver cancer|advanced adult primary liver cancer
772332|NCT00010023|recurrent adult primary liver cancer|recurrent adult primary liver cancer
772333|NCT00010023|small intestine adenocarcinoma|small intestine adenocarcinoma
772334|NCT00010023|unresectable gallbladder cancer|unresectable gallbladder cancer
772335|NCT00010023|recurrent gallbladder cancer|recurrent gallbladder cancer
772336|NCT00010023|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
772337|NCT00010023|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
772338|NCT00010023|recurrent small intestine cancer|recurrent small intestine cancer
772339|NCT00010023|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
772340|NCT00010023|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
772341|NCT00010023|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
772342|NCT00010023|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
772343|NCT00010023|pulmonary carcinoid tumor|pulmonary carcinoid tumor
772344|NCT00010023|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
772345|NCT00010023|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
772346|NCT00010023|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
772347|NCT00010023|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
772348|NCT00010023|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
772349|NCT00010023|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
772350|NCT00010023|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
772351|NCT00010023|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
772352|NCT00010023|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
772353|NCT00010023|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
772354|NCT00010023|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
772355|NCT00010023|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
772356|NCT00010023|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
772357|NCT00010023|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
772358|NCT00010023|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
772359|NCT00010023|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
772360|NCT00010023|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
772361|NCT00010023|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
772362|NCT00010023|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
772363|NCT00010023|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
772364|NCT00010023|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
772365|NCT00010023|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
772366|NCT00010023|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
772367|NCT00010023|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
772368|NCT00010023|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
772369|NCT00010023|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
772370|NCT00010023|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
772371|NCT00010023|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
772372|NCT00010023|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
772373|NCT00010023|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
772374|NCT00010023|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
772375|NCT00010023|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
772376|NCT00010023|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
772377|NCT00010023|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
772378|NCT00010023|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
772379|NCT00010023|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
772380|NCT00010023|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
772381|NCT00010023|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
772382|NCT00010023|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
772383|NCT00010023|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
772384|NCT00010023|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
772385|NCT00010023|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
772386|NCT00010023|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
772456|NCT00008307|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
772387|NCT00010023|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
772388|NCT00010023|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
772389|NCT00010023|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
772390|NCT00010023|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
772391|NCT00010023|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
772392|NCT00010023|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
772393|NCT00010023|carcinoma of the appendix|carcinoma of the appendix
772394|NCT00010023|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
772395|NCT00010023|gastrointestinal stromal tumor|gastrointestinal stromal tumor
772396|NCT00010023|recurrent salivary gland cancer|recurrent salivary gland cancer
772397|NCT00010023|stage III salivary gland cancer|stage iii salivary gland cancer
772398|NCT00010023|stage IV salivary gland cancer|stage iv salivary gland cancer
772399|NCT00010023|stage IV pancreatic cancer|stage iv pancreatic cancer
772400|NCT00009971|limited stage small cell lung cancer|limited stage small cell lung cancer
772401|NCT00009971|extensive stage small cell lung cancer|extensive stage small cell lung cancer
772402|NCT00009971|recurrent small cell lung cancer|recurrent small cell lung cancer
772403|NCT00009945|stage I breast cancer|stage i breast cancer
772404|NCT00009945|stage II breast cancer|stage ii breast cancer
772405|NCT00009880|stage I gastric cancer|stage i gastric cancer
772406|NCT00009880|stage II gastric cancer|stage ii gastric cancer
772407|NCT00009880|stage III gastric cancer|stage iii gastric cancer
772408|NCT00009880|stage I esophageal cancer|stage i esophageal cancer
772409|NCT00009880|stage II esophageal cancer|stage ii esophageal cancer
772410|NCT00009880|stage III esophageal cancer|stage iii esophageal cancer
772411|NCT00009880|adenocarcinoma of the stomach|adenocarcinoma of the stomach
772412|NCT00009880|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
772413|NCT00009880|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
772414|NCT00009854|adult glioblastoma|adult glioblastoma
772415|NCT00009854|tumors metastatic to brain|tumors metastatic to brain
772416|NCT00009854|adult anaplastic astrocytoma|adult anaplastic astrocytoma
772417|NCT00009854|adult anaplastic ependymoma|adult anaplastic ependymoma
772418|NCT00009854|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
772419|NCT00009854|adult giant cell glioblastoma|adult giant cell glioblastoma
772420|NCT00009854|adult gliosarcoma|adult gliosarcoma
772421|NCT00009776|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
772422|NCT00009776|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
772423|NCT00009776|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
772424|NCT00009776|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
772425|NCT00009776|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
772426|NCT00009776|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
772427|NCT00009776|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
772428|NCT00009776|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
772429|NCT00009776|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
772430|NCT00009776|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
772431|NCT00009776|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
772432|NCT00009776|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
772433|NCT00009776|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
772434|NCT00009776|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
772435|NCT00009776|splenic marginal zone lymphoma|splenic marginal zone lymphoma
772436|NCT00009763|stage IV breast cancer|stage iv breast cancer
772437|NCT00009763|recurrent breast cancer|recurrent breast cancer
772438|NCT00009750|stage IV prostate cancer|stage iv prostate cancer
772439|NCT00009750|recurrent prostate cancer|recurrent prostate cancer
772440|NCT00009711|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
772441|NCT00009711|pulmonary complications|pulmonary complications
772442|NCT00008697|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
772443|NCT00008697|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
772444|NCT00008697|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
772445|NCT00008697|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
772446|NCT00008437|stage I breast cancer|stage i breast cancer
772447|NCT00008437|stage II breast cancer|stage ii breast cancer
772448|NCT00008437|stage IIIA breast cancer|stage iiia breast cancer
772449|NCT00008411|stage IV breast cancer|stage iv breast cancer
772450|NCT00008411|recurrent breast cancer|recurrent breast cancer
772451|NCT00008385|stage I non-small cell lung cancer|stage i non-small cell lung cancer
772452|NCT00008346|breast cancer|breast cancer
772453|NCT00008307|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
772454|NCT00008307|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
772455|NCT00008307|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
772457|NCT00008307|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
772458|NCT00008307|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
772459|NCT00008307|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
772460|NCT00008307|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
772461|NCT00008307|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
772462|NCT00008307|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
772463|NCT00008307|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
772464|NCT00008307|refractory multiple myeloma|refractory multiple myeloma
772465|NCT00008307|stage I multiple myeloma|stage i multiple myeloma
772466|NCT00008307|stage II multiple myeloma|stage ii multiple myeloma
772467|NCT00008307|stage III multiple myeloma|stage iii multiple myeloma
772468|NCT00008307|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
772469|NCT00008307|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
772470|NCT00008307|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
772471|NCT00008307|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
772472|NCT00008307|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
772473|NCT00008307|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
772474|NCT00008307|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
772475|NCT00008307|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
772476|NCT00008307|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
772477|NCT00008307|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
772478|NCT00008307|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
772479|NCT00008307|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
772480|NCT00008307|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
772481|NCT00008307|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
772482|NCT00008307|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
772483|NCT00008307|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
772484|NCT00008307|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
772485|NCT00008307|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
772486|NCT00008307|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
772487|NCT00008307|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
772488|NCT00008307|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
772489|NCT00008307|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
772490|NCT00008307|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
772491|NCT00008307|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
772492|NCT00008307|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
772493|NCT00008307|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
772494|NCT00008307|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
772495|NCT00008307|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
772496|NCT00008307|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
772497|NCT00008307|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
772498|NCT00008307|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
772499|NCT00008307|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
772500|NCT00008307|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
772501|NCT00008307|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
772502|NCT00008307|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
772503|NCT00008307|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
772504|NCT00008307|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
772505|NCT00008307|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
772506|NCT00008307|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
772507|NCT00008307|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
772508|NCT00008307|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
772509|NCT00008307|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
772510|NCT00008307|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
772511|NCT00008307|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
772512|NCT00008307|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
772513|NCT00008307|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
772514|NCT00008307|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
772515|NCT00008307|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
772516|NCT00008307|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
772517|NCT00008307|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
772518|NCT00008307|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
772519|NCT00008307|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
772520|NCT00008307|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
772521|NCT00008307|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
772522|NCT00008307|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
772523|NCT00008307|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
772524|NCT00008307|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
772525|NCT00008307|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
772526|NCT00008307|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
772527|NCT00008307|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
772528|NCT00008307|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
772529|NCT00008307|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
772530|NCT00008307|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
772531|NCT00008307|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
772532|NCT00008307|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
772533|NCT00008307|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
772534|NCT00008307|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
772535|NCT00008307|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
772536|NCT00008307|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
772537|NCT00008307|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
772538|NCT00008307|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
772539|NCT00008307|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
772540|NCT00008307|intraocular lymphoma|intraocular lymphoma
772541|NCT00008307|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
772542|NCT00008307|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
772543|NCT00008307|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
772544|NCT00008307|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
772545|NCT00008307|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
772546|NCT00008307|stage I mantle cell lymphoma|stage i mantle cell lymphoma
772547|NCT00008307|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
772548|NCT00008307|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
772549|NCT00008307|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
772641|NCT00008216|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
772550|NCT00008307|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
772551|NCT00008307|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
772552|NCT00008307|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
772553|NCT00008307|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
772554|NCT00008307|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
772555|NCT00008307|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
772556|NCT00008307|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
772557|NCT00008307|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
772558|NCT00008307|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
772559|NCT00008307|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
772560|NCT00008307|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
772561|NCT00008307|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
772562|NCT00008307|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
772563|NCT00008307|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
772564|NCT00008307|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
772565|NCT00008307|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
772566|NCT00008307|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
772567|NCT00008307|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
772568|NCT00008307|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
772569|NCT00008307|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
772570|NCT00008307|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
772571|NCT00008307|anaplastic large cell lymphoma|anaplastic large cell lymphoma
772572|NCT00008307|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
772573|NCT00008307|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
772574|NCT00008307|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
772575|NCT00008307|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
772576|NCT00008307|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
772577|NCT00008307|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
772578|NCT00008307|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
772579|NCT00008307|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
772580|NCT00008307|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
772581|NCT00008307|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
772582|NCT00008307|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
772583|NCT00008307|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
772584|NCT00008307|splenic marginal zone lymphoma|splenic marginal zone lymphoma
772585|NCT00008307|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
772586|NCT00008307|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
772587|NCT00008307|stage I marginal zone lymphoma|stage i marginal zone lymphoma
772588|NCT00008307|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
772589|NCT00008307|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
772590|NCT00008307|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
772591|NCT00008307|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
772592|NCT00008307|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
772593|NCT00008307|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
772594|NCT00008307|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
772595|NCT00008307|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
772596|NCT00008307|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
772597|NCT00008307|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
772598|NCT00008307|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
772599|NCT00008294|stage IV colon cancer|stage iv colon cancer
772600|NCT00008294|stage IV rectal cancer|stage iv rectal cancer
772601|NCT00008294|adenocarcinoma of the colon|adenocarcinoma of the colon
772602|NCT00008294|adenocarcinoma of the rectum|adenocarcinoma of the rectum
772603|NCT00008294|liver metastases|liver metastases
772604|NCT00008294|recurrent colon cancer|recurrent colon cancer
772605|NCT00008294|recurrent rectal cancer|recurrent rectal cancer
772606|NCT00008268|stage I multiple myeloma|stage i multiple myeloma
772607|NCT00008268|stage II multiple myeloma|stage ii multiple myeloma
772608|NCT00008268|stage III multiple myeloma|stage iii multiple myeloma
772609|NCT00008216|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
772610|NCT00008216|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
772611|NCT00008216|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
772612|NCT00008216|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
772613|NCT00008216|refractory multiple myeloma|refractory multiple myeloma
772614|NCT00008216|stage I multiple myeloma|stage i multiple myeloma
772615|NCT00008216|stage II multiple myeloma|stage ii multiple myeloma
772616|NCT00008216|stage III multiple myeloma|stage iii multiple myeloma
772617|NCT00008216|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
772618|NCT00008216|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
772619|NCT00008216|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
772620|NCT00008216|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
772621|NCT00008216|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
772622|NCT00008216|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
772623|NCT00008216|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
772624|NCT00008216|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
772625|NCT00008216|childhood Langerhans cell histiocytosis|childhood langerhans cell histiocytosis
772626|NCT00008216|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
772627|NCT00008216|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
772628|NCT00008216|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
772629|NCT00008216|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
772630|NCT00008216|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
772631|NCT00008216|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
772632|NCT00008216|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
772633|NCT00008216|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
772634|NCT00008216|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
772635|NCT00008216|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
772636|NCT00008216|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
772637|NCT00008216|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
772638|NCT00008216|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
772639|NCT00008216|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
772640|NCT00008216|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
772642|NCT00008216|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
772643|NCT00008216|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
772895|NCT00007930|stage I rectal cancer|stage i rectal cancer
772644|NCT00008216|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
772645|NCT00008216|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
772646|NCT00008216|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
772647|NCT00008216|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
772648|NCT00008216|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
772649|NCT00008216|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
772650|NCT00008216|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
772651|NCT00008216|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
772652|NCT00008216|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
772653|NCT00008216|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
772654|NCT00008216|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
772655|NCT00008216|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
772656|NCT00008216|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
772657|NCT00008216|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
772658|NCT00008216|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
772659|NCT00008216|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
772660|NCT00008216|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
772661|NCT00008216|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
772662|NCT00008216|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
772663|NCT00008216|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
772664|NCT00008216|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
772665|NCT00008216|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
772666|NCT00008216|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
772667|NCT00008216|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
772668|NCT00008216|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
772669|NCT00008216|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
772670|NCT00008216|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
772671|NCT00008216|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
772672|NCT00008216|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
772673|NCT00008216|secondary acute myeloid leukemia|secondary acute myeloid leukemia
772674|NCT00008216|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
772675|NCT00008216|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
772676|NCT00008216|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
772677|NCT00008216|intraocular lymphoma|intraocular lymphoma
772678|NCT00008216|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
772679|NCT00008216|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
772680|NCT00008216|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
772681|NCT00008216|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
772682|NCT00008216|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
772683|NCT00008216|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
772684|NCT00008216|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
772685|NCT00008216|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
772686|NCT00008216|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
772687|NCT00008216|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
772688|NCT00008216|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
772689|NCT00008216|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
772690|NCT00008216|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
772691|NCT00008216|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
772692|NCT00008216|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
772693|NCT00008216|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
772694|NCT00008216|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
772695|NCT00008216|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
772696|NCT00008216|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
772697|NCT00008216|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
772698|NCT00008216|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
772699|NCT00008216|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
772700|NCT00008216|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
772701|NCT00008216|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
772702|NCT00008216|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
772825|NCT00008164|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
772703|NCT00008216|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
772704|NCT00008216|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
772705|NCT00008216|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
772706|NCT00008216|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
772707|NCT00008216|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
772708|NCT00008216|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
772709|NCT00008216|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
772710|NCT00008216|anaplastic large cell lymphoma|anaplastic large cell lymphoma
772711|NCT00008216|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
772712|NCT00008216|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
772713|NCT00008216|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
772714|NCT00008216|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
772715|NCT00008216|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
772716|NCT00008216|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
772717|NCT00008216|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
772718|NCT00008216|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
772719|NCT00008216|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
772720|NCT00008216|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
772721|NCT00008216|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
772722|NCT00008216|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
772723|NCT00008216|splenic marginal zone lymphoma|splenic marginal zone lymphoma
772724|NCT00008216|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
772725|NCT00008216|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
772726|NCT00008216|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
772727|NCT00008216|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
772728|NCT00008216|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
772729|NCT00008216|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
772730|NCT00008216|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
772918|NCT00007826|stage II colon cancer|stage ii colon cancer
772731|NCT00008216|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
772732|NCT00008216|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
772733|NCT00008216|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
772734|NCT00008216|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
772735|NCT00008216|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
772736|NCT00008216|adult Langerhans cell histiocytosis|adult langerhans cell histiocytosis
772737|NCT00008190|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
772738|NCT00008190|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
772739|NCT00008190|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
772740|NCT00008190|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
772741|NCT00008190|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
772742|NCT00008190|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
772743|NCT00008190|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
772744|NCT00008190|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
772745|NCT00008190|secondary acute myeloid leukemia|secondary acute myeloid leukemia
772746|NCT00008164|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
772747|NCT00008164|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
772748|NCT00008164|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
772749|NCT00008164|refractory multiple myeloma|refractory multiple myeloma
772750|NCT00008164|stage I multiple myeloma|stage i multiple myeloma
772751|NCT00008164|stage II multiple myeloma|stage ii multiple myeloma
772752|NCT00008164|stage III multiple myeloma|stage iii multiple myeloma
772753|NCT00008164|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
772754|NCT00008164|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
772755|NCT00008164|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
772756|NCT00008164|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
772757|NCT00008164|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
772758|NCT00008164|childhood Langerhans cell histiocytosis|childhood langerhans cell histiocytosis
772759|NCT00008164|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
772760|NCT00008164|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
772761|NCT00008164|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
772762|NCT00008164|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
772763|NCT00008164|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
772764|NCT00008164|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
772765|NCT00008164|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
772766|NCT00008164|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
772767|NCT00008164|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
772768|NCT00008164|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
772769|NCT00008164|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
772770|NCT00008164|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
772771|NCT00008164|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
772772|NCT00008164|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
772773|NCT00008164|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
772774|NCT00008164|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
772775|NCT00008164|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
772776|NCT00008164|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
772777|NCT00008164|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
772778|NCT00008164|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
772779|NCT00008164|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
772780|NCT00008164|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
772781|NCT00008164|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
772782|NCT00008164|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
772783|NCT00008164|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
772784|NCT00008164|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
772785|NCT00008164|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
772786|NCT00008164|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
772787|NCT00008164|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
772788|NCT00008164|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
772789|NCT00008164|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
772790|NCT00008164|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
772791|NCT00008164|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
772792|NCT00008164|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
772793|NCT00008164|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
772794|NCT00008164|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
772795|NCT00008164|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
772796|NCT00008164|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
772797|NCT00008164|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
772798|NCT00008164|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
772799|NCT00008164|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
772800|NCT00008164|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
772801|NCT00008164|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
772802|NCT00008164|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
772803|NCT00008164|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
772804|NCT00008164|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
772805|NCT00008164|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
772806|NCT00008164|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
772807|NCT00008164|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
772808|NCT00008164|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
772809|NCT00008164|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
772810|NCT00008164|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
772811|NCT00008164|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
772812|NCT00008164|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
772813|NCT00008164|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
772814|NCT00008164|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
772815|NCT00008164|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
772816|NCT00008164|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
772817|NCT00008164|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
772818|NCT00008164|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
772819|NCT00008164|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
772820|NCT00008164|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
772821|NCT00008164|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
772822|NCT00008164|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
772823|NCT00008164|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
772824|NCT00008164|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
772826|NCT00008164|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
772827|NCT00008164|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
772828|NCT00008164|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
772829|NCT00008164|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
772830|NCT00008164|splenic marginal zone lymphoma|splenic marginal zone lymphoma
772831|NCT00008164|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
772832|NCT00008164|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
772833|NCT00008164|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
772834|NCT00008164|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
772835|NCT00008164|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
772836|NCT00008164|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
772837|NCT00008138|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
772838|NCT00008138|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
772839|NCT00008138|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
772840|NCT00008138|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
772841|NCT00008138|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
772842|NCT00008138|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
772843|NCT00008138|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
772844|NCT00008138|fallopian tube cancer|fallopian tube cancer
772845|NCT00008138|peritoneal cavity cancer|peritoneal cavity cancer
772846|NCT00008060|stage IV colon cancer|stage iv colon cancer
772847|NCT00008060|stage IV rectal cancer|stage iv rectal cancer
772848|NCT00008060|recurrent colon cancer|recurrent colon cancer
772849|NCT00008060|recurrent rectal cancer|recurrent rectal cancer
772850|NCT00008060|adenocarcinoma of the colon|adenocarcinoma of the colon
772851|NCT00008060|adenocarcinoma of the rectum|adenocarcinoma of the rectum
772852|NCT00008047|stage II esophageal cancer|stage ii esophageal cancer
772853|NCT00008047|stage III esophageal cancer|stage iii esophageal cancer
772854|NCT00008008|childhood infratentorial ependymoma|childhood infratentorial ependymoma
772855|NCT00008008|childhood supratentorial ependymoma|childhood supratentorial ependymoma
772856|NCT00008008|recurrent adult brain tumor|recurrent adult brain tumor
772857|NCT00008008|adult medulloblastoma|adult medulloblastoma
772858|NCT00008008|adult glioblastoma|adult glioblastoma
772859|NCT00008008|adult oligodendroglioma|adult oligodendroglioma
772860|NCT00008008|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
772861|NCT00008008|childhood oligodendroglioma|childhood oligodendroglioma
772862|NCT00008008|adult anaplastic astrocytoma|adult anaplastic astrocytoma
772863|NCT00008008|adult anaplastic ependymoma|adult anaplastic ependymoma
772864|NCT00008008|adult mixed glioma|adult mixed glioma
772865|NCT00008008|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
772866|NCT00008008|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
772867|NCT00008008|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
772868|NCT00008008|recurrent childhood ependymoma|recurrent childhood ependymoma
772869|NCT00008008|adult giant cell glioblastoma|adult giant cell glioblastoma
772870|NCT00008008|adult gliosarcoma|adult gliosarcoma
772871|NCT00008008|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
772872|NCT00007995|refractory multiple myeloma|refractory multiple myeloma
772873|NCT00007995|stage I multiple myeloma|stage i multiple myeloma
772874|NCT00007995|stage II multiple myeloma|stage ii multiple myeloma
772875|NCT00007995|stage III multiple myeloma|stage iii multiple myeloma
772876|NCT00007995|primary systemic amyloidosis|primary systemic amyloidosis
772877|NCT00007982|recurrent adult brain tumor|recurrent adult brain tumor
772878|NCT00007982|adult medulloblastoma|adult medulloblastoma
772879|NCT00007982|adult oligodendroglioma|adult oligodendroglioma
772880|NCT00007982|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
772881|NCT00007982|adult anaplastic astrocytoma|adult anaplastic astrocytoma
772882|NCT00007982|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
772883|NCT00007982|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
772884|NCT00007982|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
772885|NCT00007956|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
772886|NCT00007956|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
772887|NCT00007956|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
772888|NCT00007956|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
772889|NCT00007956|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
772890|NCT00007956|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
772891|NCT00007956|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
772892|NCT00007956|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
772893|NCT00007956|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
772894|NCT00007956|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
772896|NCT00007930|stage II rectal cancer|stage ii rectal cancer
772897|NCT00007930|stage III rectal cancer|stage iii rectal cancer
772898|NCT00007904|stage II breast cancer|stage ii breast cancer
772899|NCT00007904|stage IIIA breast cancer|stage iiia breast cancer
772900|NCT00007904|male breast cancer|male breast cancer
772901|NCT00007891|stage IV breast cancer|stage iv breast cancer
772902|NCT00007891|recurrent breast cancer|recurrent breast cancer
772903|NCT00007891|male breast cancer|male breast cancer
772904|NCT00007865|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
772905|NCT00007865|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
772906|NCT00007865|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
772907|NCT00007865|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
772908|NCT00007865|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
772909|NCT00007865|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
772910|NCT00007865|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
772911|NCT00007865|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
772912|NCT00007865|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
772913|NCT00007865|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
772914|NCT00007865|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
772915|NCT00007865|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
772916|NCT00007865|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
772917|NCT00007865|splenic marginal zone lymphoma|splenic marginal zone lymphoma
772924|NCT00007826|adenocarcinoma of the colon|adenocarcinoma of the colon
772925|NCT00007826|adenocarcinoma of the rectum|adenocarcinoma of the rectum
772926|NCT00006994|oral complications of radiation therapy|oral complications of radiation therapy
772927|NCT00006994|pain|pain
772928|NCT00006994|radiation toxicity|radiation toxicity
772929|NCT00006994|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
772930|NCT00006994|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
772931|NCT00006994|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
772932|NCT00006994|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
772933|NCT00006994|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
772934|NCT00006994|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
772935|NCT00006994|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
772936|NCT00006994|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
772937|NCT00006981|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
772938|NCT00006981|stage III cervical cancer|stage iii cervical cancer
772939|NCT00006981|recurrent cervical cancer|recurrent cervical cancer
772940|NCT00006981|stage IVB cervical cancer|stage ivb cervical cancer
772941|NCT00006981|stage IVA cervical cancer|stage iva cervical cancer
772942|NCT00006981|squamous cell lung cancer|squamous cell lung cancer
772943|NCT00006981|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
772944|NCT00006981|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
772945|NCT00006981|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
772946|NCT00006981|advanced malignant mesothelioma|advanced malignant mesothelioma
772947|NCT00006981|recurrent malignant mesothelioma|recurrent malignant mesothelioma
772948|NCT00006981|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
772949|NCT00006981|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
772950|NCT00006981|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
772951|NCT00006981|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
772952|NCT00006981|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
772953|NCT00006981|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
772954|NCT00006981|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
772955|NCT00006981|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
772956|NCT00006981|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
772957|NCT00006981|cervical squamous cell carcinoma|cervical squamous cell carcinoma
772958|NCT00006981|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
772959|NCT00006981|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
772960|NCT00006981|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
772961|NCT00006981|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
772962|NCT00006981|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
772963|NCT00006981|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
772964|NCT00006981|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
772965|NCT00006981|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
773097|NCT00006386|adult glioblastoma|adult glioblastoma
772966|NCT00006981|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
772967|NCT00006981|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
772968|NCT00006981|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
772969|NCT00006981|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
772970|NCT00006981|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
772971|NCT00006981|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
772972|NCT00006981|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
772973|NCT00006981|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
772974|NCT00006981|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
772975|NCT00006981|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
772976|NCT00006981|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
772977|NCT00006981|fallopian tube cancer|fallopian tube cancer
772978|NCT00006981|primary peritoneal cavity cancer|primary peritoneal cavity cancer
772979|NCT00006981|ovarian carcinosarcoma|ovarian carcinosarcoma
772980|NCT00006981|Brenner tumor|brenner tumor
772981|NCT00006981|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
772982|NCT00006981|recurrent salivary gland cancer|recurrent salivary gland cancer
772983|NCT00006981|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
772984|NCT00006981|stage III salivary gland cancer|stage iii salivary gland cancer
772985|NCT00006981|stage IV salivary gland cancer|stage iv salivary gland cancer
772986|NCT00006981|recurrent pancreatic cancer|recurrent pancreatic cancer
772987|NCT00006981|stage II pancreatic cancer|stage ii pancreatic cancer
772988|NCT00006981|stage III pancreatic cancer|stage iii pancreatic cancer
772989|NCT00006981|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
772990|NCT00006981|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
772991|NCT00006981|ovarian sarcoma|ovarian sarcoma
772992|NCT00006981|ovarian stromal cancer|ovarian stromal cancer
772993|NCT00006981|stage IV pancreatic cancer|stage iv pancreatic cancer
772994|NCT00006916|adult glioblastoma|adult glioblastoma
772995|NCT00006916|adult giant cell glioblastoma|adult giant cell glioblastoma
772996|NCT00006916|adult gliosarcoma|adult gliosarcoma
772997|NCT00006825|stage IV breast cancer|stage iv breast cancer
772998|NCT00006825|recurrent breast cancer|recurrent breast cancer
772999|NCT00006760|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
773000|NCT00006760|childhood lymphocyte predominant Hodgkin lymphoma|childhood lymphocyte predominant hodgkin lymphoma
773001|NCT00006760|childhood lymphocyte depletion Hodgkin lymphoma|childhood lymphocyte depletion hodgkin lymphoma
773002|NCT00006760|childhood nodular sclerosis Hodgkin lymphoma|childhood nodular sclerosis hodgkin lymphoma
773003|NCT00006760|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
773004|NCT00006747|graft versus host disease|graft versus host disease
773005|NCT00006747|stage I mantle cell lymphoma|stage i mantle cell lymphoma
773006|NCT00006747|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
773007|NCT00006747|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
773008|NCT00006747|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
773009|NCT00006747|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
773010|NCT00006747|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
773011|NCT00006734|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
773012|NCT00006721|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
773013|NCT00006721|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
773014|NCT00006721|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
773015|NCT00006721|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
773016|NCT00006721|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
773017|NCT00006721|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
773018|NCT00006721|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
773019|NCT00006721|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
773020|NCT00006721|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
773021|NCT00006721|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
773022|NCT00006721|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
773023|NCT00006721|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
773024|NCT00006695|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
773025|NCT00006695|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
773026|NCT00006695|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
773027|NCT00006656|recurrent adult brain tumor|recurrent adult brain tumor
773028|NCT00006656|adult glioblastoma|adult glioblastoma
773029|NCT00006656|adult giant cell glioblastoma|adult giant cell glioblastoma
773030|NCT00006656|adult gliosarcoma|adult gliosarcoma
773031|NCT00006485|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
773032|NCT00006479|stage IV colon cancer|stage iv colon cancer
773033|NCT00006479|stage IV rectal cancer|stage iv rectal cancer
773034|NCT00006479|recurrent colon cancer|recurrent colon cancer
773035|NCT00006479|recurrent rectal cancer|recurrent rectal cancer
773036|NCT00006479|liver metastases|liver metastases
773037|NCT00006478|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
773038|NCT00006478|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
773039|NCT00006478|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
773040|NCT00006477|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
773041|NCT00006476|stage 0 bladder cancer|stage 0 bladder cancer
773042|NCT00006476|stage I bladder cancer|stage i bladder cancer
773043|NCT00006476|recurrent bladder cancer|recurrent bladder cancer
773044|NCT00006474|recurrent adult brain tumor|recurrent adult brain tumor
773045|NCT00006474|adult glioblastoma|adult glioblastoma
773046|NCT00006474|adult anaplastic astrocytoma|adult anaplastic astrocytoma
773047|NCT00006474|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
773048|NCT00006474|adult mixed glioma|adult mixed glioma
773049|NCT00006474|adult oligodendroglioma|adult oligodendroglioma
773050|NCT00006474|adult giant cell glioblastoma|adult giant cell glioblastoma
773051|NCT00006474|adult gliosarcoma|adult gliosarcoma
773052|NCT00006471|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
773053|NCT00006471|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
773054|NCT00006471|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
773055|NCT00006471|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
773056|NCT00006471|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
773057|NCT00006471|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
773058|NCT00006471|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
773059|NCT00006471|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
773060|NCT00006471|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
773061|NCT00006471|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
773062|NCT00006471|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
773063|NCT00006471|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
773064|NCT00006471|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
773065|NCT00006471|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
773066|NCT00006471|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
773067|NCT00006470|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
773068|NCT00006470|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
773069|NCT00006469|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
773070|NCT00006469|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
773071|NCT00006468|stage IV colon cancer|stage iv colon cancer
773072|NCT00006468|stage IV rectal cancer|stage iv rectal cancer
773073|NCT00006468|recurrent colon cancer|recurrent colon cancer
773074|NCT00006468|recurrent rectal cancer|recurrent rectal cancer
773075|NCT00006468|adenocarcinoma of the colon|adenocarcinoma of the colon
773076|NCT00006468|adenocarcinoma of the rectum|adenocarcinoma of the rectum
773077|NCT00006465|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
773078|NCT00006462|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
773079|NCT00006462|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
773080|NCT00006456|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
773081|NCT00006456|lung metastases|lung metastases
773082|NCT00006456|liver metastases|liver metastases
773083|NCT00006455|stage I childhood anaplastic large cell lymphoma|stage i childhood anaplastic large cell lymphoma
773084|NCT00006455|stage II childhood anaplastic large cell lymphoma|stage ii childhood anaplastic large cell lymphoma
773085|NCT00006455|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
773086|NCT00006455|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
773087|NCT00006455|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
773088|NCT00006392|prostate cancer|prostate cancer
773089|NCT00006391|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
773090|NCT00006391|fallopian tube cancer|fallopian tube cancer
773091|NCT00006391|peritoneal cavity cancer|peritoneal cavity cancer
773092|NCT00006390|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
773093|NCT00006390|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
773094|NCT00006390|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
773095|NCT00006390|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
773096|NCT00006390|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
773098|NCT00006386|adult giant cell glioblastoma|adult giant cell glioblastoma
773099|NCT00006386|adult gliosarcoma|adult gliosarcoma
773100|NCT00006385|stage IV melanoma|stage iv melanoma
773101|NCT00006385|recurrent melanoma|recurrent melanoma
773102|NCT00006381|stage IV breast cancer|stage iv breast cancer
773103|NCT00006381|recurrent breast cancer|recurrent breast cancer
773104|NCT00006379|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
773105|NCT00006379|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
773106|NCT00006379|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
773107|NCT00006379|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
773108|NCT00006379|isolated plasmacytoma of bone|isolated plasmacytoma of bone
773109|NCT00006379|extramedullary plasmacytoma|extramedullary plasmacytoma
773110|NCT00006379|refractory multiple myeloma|refractory multiple myeloma
773111|NCT00006379|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
773112|NCT00006379|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
773113|NCT00006379|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
773114|NCT00006379|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
773115|NCT00006379|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
773116|NCT00006379|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
773117|NCT00006379|small intestine lymphoma|small intestine lymphoma
773118|NCT00006379|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
773119|NCT00006379|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
773120|NCT00006379|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
773121|NCT00006379|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
773122|NCT00006379|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
773123|NCT00006379|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
773124|NCT00006379|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
773125|NCT00006379|polycythemia vera|polycythemia vera
773126|NCT00006379|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
773127|NCT00006379|essential thrombocythemia|essential thrombocythemia
773128|NCT00006379|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
773129|NCT00006379|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
773130|NCT00006379|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
773131|NCT00006379|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
773132|NCT00006379|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
773133|NCT00006379|refractory anemia with excess blasts|refractory anemia with excess blasts
773134|NCT00006379|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
773135|NCT00006379|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
773136|NCT00006379|acute undifferentiated leukemia|acute undifferentiated leukemia
773137|NCT00006379|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
773138|NCT00006379|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
773139|NCT00006379|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
773140|NCT00006379|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
773141|NCT00006379|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
773142|NCT00006379|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
773143|NCT00006379|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
773144|NCT00006379|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
773145|NCT00006379|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
773146|NCT00006379|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
773147|NCT00006379|secondary acute myeloid leukemia|secondary acute myeloid leukemia
773148|NCT00006379|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
773149|NCT00006379|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
773150|NCT00006379|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
773151|NCT00006379|prolymphocytic leukemia|prolymphocytic leukemia
773152|NCT00006379|primary systemic amyloidosis|primary systemic amyloidosis
773153|NCT00006379|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
773154|NCT00006379|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
773155|NCT00006379|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
773156|NCT00006379|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
773157|NCT00006379|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
773158|NCT00006379|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
773159|NCT00006379|anaplastic large cell lymphoma|anaplastic large cell lymphoma
773160|NCT00006379|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
773161|NCT00006379|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
773162|NCT00006379|chronic eosinophilic leukemia|chronic eosinophilic leukemia
773163|NCT00006379|chronic neutrophilic leukemia|chronic neutrophilic leukemia
787320|NCT00002277|Neoplasms|neoplasms
773164|NCT00006379|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
773165|NCT00006379|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
773166|NCT00006379|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
773167|NCT00006379|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
773168|NCT00006379|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
773169|NCT00006379|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
773170|NCT00006379|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
773171|NCT00006379|splenic marginal zone lymphoma|splenic marginal zone lymphoma
773172|NCT00006379|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
773173|NCT00006379|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
773174|NCT00006379|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
773175|NCT00006379|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
773176|NCT00006379|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
773177|NCT00006379|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
773178|NCT00006373|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
773179|NCT00006373|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
773180|NCT00006373|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
773181|NCT00006373|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
773182|NCT00006373|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
773183|NCT00006373|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
773184|NCT00006373|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
773185|NCT00006373|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
773186|NCT00006373|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
773187|NCT00006373|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
773188|NCT00006373|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
773189|NCT00006373|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
773190|NCT00006373|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
773191|NCT00006373|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
773192|NCT00006373|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
773193|NCT00006373|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
773194|NCT00006373|splenic marginal zone lymphoma|splenic marginal zone lymphoma
773195|NCT00006372|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
773196|NCT00006366|stage II rectal cancer|stage ii rectal cancer
773197|NCT00006366|stage III rectal cancer|stage iii rectal cancer
773198|NCT00006366|adenocarcinoma of the rectum|adenocarcinoma of the rectum
773199|NCT00006362|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
773200|NCT00006362|isolated plasmacytoma of bone|isolated plasmacytoma of bone
773201|NCT00006362|extramedullary plasmacytoma|extramedullary plasmacytoma
773202|NCT00006362|refractory multiple myeloma|refractory multiple myeloma
773203|NCT00006362|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
773204|NCT00006362|stage III multiple myeloma|stage iii multiple myeloma
773205|NCT00006362|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
773206|NCT00006362|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
773207|NCT00006362|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
773208|NCT00006362|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
773209|NCT00006362|untreated hairy cell leukemia|untreated hairy cell leukemia
773210|NCT00006362|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
773211|NCT00006362|refractory hairy cell leukemia|refractory hairy cell leukemia
773212|NCT00006362|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
773213|NCT00006362|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
773214|NCT00006362|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
773215|NCT00006362|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
773216|NCT00006362|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
773217|NCT00006362|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
773218|NCT00006362|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
773219|NCT00006362|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
773220|NCT00006362|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
773221|NCT00006362|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
773222|NCT00006362|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
773223|NCT00006362|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
773224|NCT00006362|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
773225|NCT00006362|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
773226|NCT00006362|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
773293|NCT00006340|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
773227|NCT00006362|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
773228|NCT00006362|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
773229|NCT00006362|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
773230|NCT00006362|primary systemic amyloidosis|primary systemic amyloidosis
773231|NCT00006362|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
773232|NCT00006362|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
773233|NCT00006362|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
773234|NCT00006362|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
773235|NCT00006362|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
773236|NCT00006362|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
773237|NCT00006362|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
773238|NCT00006362|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
773239|NCT00006362|splenic marginal zone lymphoma|splenic marginal zone lymphoma
773240|NCT00006360|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
773241|NCT00006360|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
773242|NCT00006360|radiation toxicity|radiation toxicity
773243|NCT00006359|adenocarcinoma of the prostate|adenocarcinoma of the prostate
773244|NCT00006359|stage I prostate cancer|stage i prostate cancer
773245|NCT00006359|stage II prostate cancer|stage ii prostate cancer
773246|NCT00006359|stage III prostate cancer|stage iii prostate cancer
773247|NCT00006356|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
773248|NCT00006355|adult glioblastoma|adult glioblastoma
773249|NCT00006355|adult giant cell glioblastoma|adult giant cell glioblastoma
773250|NCT00006355|adult gliosarcoma|adult gliosarcoma
773251|NCT00006354|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
773252|NCT00006351|recurrent bladder cancer|recurrent bladder cancer
773253|NCT00006351|stage IV bladder cancer|stage iv bladder cancer
773254|NCT00006351|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
773255|NCT00006351|recurrent urethral cancer|recurrent urethral cancer
773256|NCT00006351|anterior urethral cancer|anterior urethral cancer
773257|NCT00006351|posterior urethral cancer|posterior urethral cancer
773258|NCT00006351|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
773259|NCT00006351|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
773260|NCT00006351|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
773261|NCT00006347|recurrent small cell lung cancer|recurrent small cell lung cancer
773262|NCT00006340|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
773263|NCT00006340|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
773264|NCT00006340|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
773265|NCT00006340|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
773266|NCT00006340|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
773267|NCT00006340|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
773268|NCT00006340|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
773269|NCT00006340|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
773270|NCT00006340|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
773271|NCT00006340|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
773272|NCT00006340|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
773273|NCT00006340|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
773274|NCT00006340|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
773275|NCT00006340|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
773276|NCT00006340|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
773277|NCT00006340|small intestine lymphoma|small intestine lymphoma
773278|NCT00006340|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
773279|NCT00006340|grade I lymphomatoid granulomatosis|grade i lymphomatoid granulomatosis
773280|NCT00006340|grade II lymphomatoid granulomatosis|grade ii lymphomatoid granulomatosis
773281|NCT00006340|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
773282|NCT00006340|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
773283|NCT00006340|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
773284|NCT00006340|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
773285|NCT00006340|recurrent grade I lymphomatoid granulomatosis|recurrent grade i lymphomatoid granulomatosis
773286|NCT00006340|recurrent grade II lymphomatoid granulomatosis|recurrent grade ii lymphomatoid granulomatosis
773287|NCT00006340|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
773288|NCT00006340|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
773289|NCT00006340|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
773290|NCT00006340|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
773291|NCT00006340|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
773292|NCT00006340|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
773294|NCT00006340|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
773295|NCT00006340|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
773296|NCT00006340|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
773297|NCT00006340|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
773298|NCT00006340|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
773299|NCT00006340|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
773300|NCT00006340|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
773301|NCT00006340|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
773302|NCT00006340|stage II grade 1 follicular lymphoma|stage ii grade 1 follicular lymphoma
773303|NCT00006340|stage II grade 2 follicular lymphoma|stage ii grade 2 follicular lymphoma
773304|NCT00006340|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
773305|NCT00006340|stage II adult diffuse small cleaved cell lymphoma|stage ii adult diffuse small cleaved cell lymphoma
773306|NCT00006340|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
773307|NCT00006340|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
773308|NCT00006340|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
773309|NCT00006340|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
773310|NCT00006340|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
773311|NCT00006340|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
773312|NCT00006340|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
773313|NCT00006340|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
773314|NCT00006340|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
773315|NCT00006340|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
773316|NCT00006340|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
773317|NCT00006340|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
773318|NCT00006340|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
773319|NCT00006340|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
773320|NCT00006340|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
773321|NCT00006340|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
773322|NCT00006340|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
773323|NCT00006340|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
773324|NCT00006340|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
773325|NCT00006340|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
773326|NCT00006340|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
773327|NCT00006340|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
773328|NCT00006340|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
773329|NCT00006340|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
773330|NCT00006340|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
773331|NCT00006340|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
773332|NCT00006340|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
773333|NCT00006340|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
773334|NCT00006340|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
773335|NCT00006340|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
773336|NCT00006340|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
773337|NCT00006340|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
773338|NCT00006340|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
773339|NCT00006340|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
773340|NCT00006340|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
773341|NCT00006340|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
773342|NCT00006340|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
773343|NCT00006340|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
773344|NCT00006340|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
773345|NCT00006340|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
773346|NCT00006340|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
773347|NCT00006340|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
773348|NCT00006340|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
773349|NCT00006340|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
773350|NCT00006340|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
773351|NCT00006340|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
773352|NCT00006340|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
773353|NCT00006340|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
773354|NCT00006340|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
773355|NCT00006340|stage I mantle cell lymphoma|stage i mantle cell lymphoma
773356|NCT00006340|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
773357|NCT00006340|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
773358|NCT00006340|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
773359|NCT00006340|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
773360|NCT00006340|anaplastic large cell lymphoma|anaplastic large cell lymphoma
773361|NCT00006340|stage II mantle cell lymphoma|stage ii mantle cell lymphoma
773362|NCT00006340|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
773363|NCT00006340|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
773364|NCT00006340|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
773365|NCT00006340|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
773366|NCT00006340|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
773367|NCT00006340|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
773368|NCT00006340|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
773369|NCT00006340|stage I marginal zone lymphoma|stage i marginal zone lymphoma
773370|NCT00006340|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
773371|NCT00006340|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
773372|NCT00006340|stage II marginal zone lymphoma|stage ii marginal zone lymphoma
773373|NCT00006340|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
773374|NCT00006340|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
773375|NCT00006340|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
773376|NCT00006340|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
773377|NCT00006340|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
773378|NCT00006340|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
773379|NCT00006340|splenic marginal zone lymphoma|splenic marginal zone lymphoma
773380|NCT00006268|recurrent adult brain tumor|recurrent adult brain tumor
773381|NCT00006268|adult glioblastoma|adult glioblastoma
773382|NCT00006268|adult anaplastic astrocytoma|adult anaplastic astrocytoma
773383|NCT00006268|adult mixed glioma|adult mixed glioma
773384|NCT00006268|adult giant cell glioblastoma|adult giant cell glioblastoma
773385|NCT00006268|adult gliosarcoma|adult gliosarcoma
773386|NCT00006267|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
773387|NCT00006267|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
773388|NCT00006267|primary peritoneal cavity cancer|primary peritoneal cavity cancer
773389|NCT00006264|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
773390|NCT00006263|adult brain stem glioma|adult brain stem glioma
773391|NCT00006263|adult glioblastoma|adult glioblastoma
773392|NCT00006263|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
773393|NCT00006263|adult anaplastic astrocytoma|adult anaplastic astrocytoma
773394|NCT00006263|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
773395|NCT00006263|adult giant cell glioblastoma|adult giant cell glioblastoma
773396|NCT00006263|adult gliosarcoma|adult gliosarcoma
773397|NCT00006260|stage IV breast cancer|stage iv breast cancer
773398|NCT00006260|recurrent breast cancer|recurrent breast cancer
773399|NCT00006258|childhood infratentorial ependymoma|childhood infratentorial ependymoma
773400|NCT00006258|childhood supratentorial ependymoma|childhood supratentorial ependymoma
773401|NCT00006258|adult medulloblastoma|adult medulloblastoma
773402|NCT00006258|adult myxopapillary ependymoma|adult myxopapillary ependymoma
773403|NCT00006258|adult anaplastic ependymoma|adult anaplastic ependymoma
773404|NCT00006258|adult ependymoblastoma|adult ependymoblastoma
773405|NCT00006258|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
773406|NCT00006258|untreated childhood medulloblastoma|untreated childhood medulloblastoma
773407|NCT00006258|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
773408|NCT00006258|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
773409|NCT00006256|stage II breast cancer|stage ii breast cancer
773410|NCT00006256|stage IIIA breast cancer|stage iiia breast cancer
773411|NCT00006256|stage IIIB breast cancer|stage iiib breast cancer
773412|NCT00006256|stage IIIC breast cancer|stage iiic breast cancer
773413|NCT00006255|stage III renal cell cancer|stage iii renal cell cancer
773414|NCT00006255|stage IV renal cell cancer|stage iv renal cell cancer
773415|NCT00006255|recurrent renal cell cancer|recurrent renal cell cancer
773416|NCT00006255|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
773417|NCT00006255|liver metastases|liver metastases
773418|NCT00006252|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
773419|NCT00006252|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
773420|NCT00006252|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
773421|NCT00006252|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
773422|NCT00006252|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
773423|NCT00006252|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
773424|NCT00006252|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
773425|NCT00006252|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
773426|NCT00006252|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
773427|NCT00006252|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
773428|NCT00006252|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
773429|NCT00006252|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
773430|NCT00006252|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
773431|NCT00006252|prolymphocytic leukemia|prolymphocytic leukemia
773432|NCT00006252|stage I mantle cell lymphoma|stage i mantle cell lymphoma
773433|NCT00006252|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
773434|NCT00006252|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
773435|NCT00006252|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
773436|NCT00006252|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
773437|NCT00006252|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
773438|NCT00006252|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
773439|NCT00006252|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
773440|NCT00006252|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
773441|NCT00006252|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
773442|NCT00006252|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
773443|NCT00006252|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
773444|NCT00006252|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
773445|NCT00006252|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
773446|NCT00006252|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
773447|NCT00006252|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
773448|NCT00006252|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
773449|NCT00006252|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
773450|NCT00006252|splenic marginal zone lymphoma|splenic marginal zone lymphoma
773451|NCT00006252|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
773452|NCT00006252|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
773453|NCT00006252|stage I marginal zone lymphoma|stage i marginal zone lymphoma
773454|NCT00006252|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
773455|NCT00006252|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
773456|NCT00006252|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
773457|NCT00006252|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
773458|NCT00006252|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
773459|NCT00006250|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
773460|NCT00006250|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
773461|NCT00006250|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
773462|NCT00006250|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
773463|NCT00006250|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
773464|NCT00006250|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
773465|NCT00006249|stage III melanoma|stage iii melanoma
773466|NCT00006248|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
773467|NCT00006248|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
773468|NCT00006248|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
773469|NCT00006248|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
773470|NCT00006248|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
773471|NCT00006248|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
773472|NCT00006248|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
773473|NCT00006248|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
773474|NCT00006248|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
773475|NCT00006248|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
773476|NCT00006248|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
773477|NCT00006248|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
773478|NCT00006246|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
773479|NCT00006246|childhood infratentorial ependymoma|childhood infratentorial ependymoma
773480|NCT00006246|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
773481|NCT00006246|recurrent childhood brain tumor|recurrent childhood brain tumor
773482|NCT00006246|recurrent retinoblastoma|recurrent retinoblastoma
773483|NCT00006246|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
773484|NCT00006246|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
773485|NCT00006246|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
773486|NCT00006246|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
773487|NCT00006246|leptomeningeal metastases|leptomeningeal metastases
773488|NCT00006246|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
773489|NCT00006246|childhood oligodendroglioma|childhood oligodendroglioma
773490|NCT00006246|childhood choroid plexus tumor|childhood choroid plexus tumor
773491|NCT00006246|childhood grade I meningioma|childhood grade i meningioma
773492|NCT00006246|childhood grade II meningioma|childhood grade ii meningioma
773493|NCT00006246|childhood grade III meningioma|childhood grade iii meningioma
773494|NCT00006246|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
773495|NCT00006246|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
773496|NCT00006246|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
773497|NCT00006246|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
773498|NCT00006246|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
773499|NCT00006246|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
773500|NCT00006246|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
773501|NCT00006246|recurrent childhood ependymoma|recurrent childhood ependymoma
773502|NCT00006246|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
773503|NCT00006245|stage III esophageal cancer|stage iii esophageal cancer
773504|NCT00006245|stage IV esophageal cancer|stage iv esophageal cancer
773505|NCT00006245|recurrent esophageal cancer|recurrent esophageal cancer
773506|NCT00006245|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
773507|NCT00006245|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
773508|NCT00006239|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
773509|NCT00006239|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
773510|NCT00006239|refractory anemia|refractory anemia
773511|NCT00006239|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
773512|NCT00006239|refractory anemia with excess blasts|refractory anemia with excess blasts
773513|NCT00006239|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
773514|NCT00006239|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
773515|NCT00006239|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
773516|NCT00006239|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
773517|NCT00006239|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
773518|NCT00006239|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
773519|NCT00006239|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
773520|NCT00006239|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
773521|NCT00006239|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
773522|NCT00006239|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
773523|NCT00006237|stage III melanoma|stage iii melanoma
773524|NCT00006237|recurrent melanoma|recurrent melanoma
773525|NCT00006234|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
773526|NCT00006234|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
773527|NCT00006234|adult rhabdomyosarcoma|adult rhabdomyosarcoma
773528|NCT00006234|bone metastases|bone metastases
773529|NCT00006234|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
773530|NCT00006234|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
773531|NCT00006234|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
773532|NCT00006234|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
773533|NCT00006233|stage IV melanoma|stage iv melanoma
773534|NCT00006233|recurrent melanoma|recurrent melanoma
773535|NCT00006232|stage II multiple myeloma|stage ii multiple myeloma
773536|NCT00006232|stage III multiple myeloma|stage iii multiple myeloma
773537|NCT00006231|localized malignant mesothelioma|localized malignant mesothelioma
773538|NCT00006231|advanced malignant mesothelioma|advanced malignant mesothelioma
773539|NCT00006231|perioperative/postoperative complications|perioperative/postoperative complications
773540|NCT00006230|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
773541|NCT00006230|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
773542|NCT00006230|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
773543|NCT00006221|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
773544|NCT00006221|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
773545|NCT00006221|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
773546|NCT00006221|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
773547|NCT00006221|small intestine lymphoma|small intestine lymphoma
773548|NCT00006221|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
773549|NCT00006221|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
773550|NCT00006221|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
773551|NCT00006221|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
773552|NCT00006221|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
773553|NCT00006221|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
773554|NCT00006221|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
773555|NCT00006221|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
773556|NCT00006221|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
773557|NCT00006221|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
773558|NCT00006221|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
773559|NCT00006221|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
773560|NCT00006221|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
773561|NCT00006221|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
773562|NCT00006221|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
773563|NCT00006221|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
773564|NCT00006221|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
773565|NCT00006221|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
773566|NCT00006221|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
773567|NCT00006221|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
773568|NCT00006221|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
773569|NCT00006221|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
773570|NCT00006221|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
773571|NCT00006221|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
773572|NCT00006221|intraocular lymphoma|intraocular lymphoma
773573|NCT00006221|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
773574|NCT00006221|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
773575|NCT00006221|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
773576|NCT00006221|anaplastic large cell lymphoma|anaplastic large cell lymphoma
773577|NCT00006221|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
773578|NCT00006221|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
773579|NCT00006221|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
773580|NCT00006221|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
773581|NCT00006221|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
775856|NCT00003938|prolymphocytic leukemia|prolymphocytic leukemia
773582|NCT00006221|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
773583|NCT00006221|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
773584|NCT00006221|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
773585|NCT00006221|splenic marginal zone lymphoma|splenic marginal zone lymphoma
773586|NCT00006219|multiple myeloma|multiple myeloma
773587|NCT00006125|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
773588|NCT00006125|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
773589|NCT00006125|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
773590|NCT00006125|anaplastic large cell lymphoma|anaplastic large cell lymphoma
773591|NCT00006120|stage IV breast cancer|stage iv breast cancer
773592|NCT00006120|stage IIIA breast cancer|stage iiia breast cancer
773593|NCT00006120|recurrent breast cancer|recurrent breast cancer
773594|NCT00006120|stage IIIB breast cancer|stage iiib breast cancer
773595|NCT00006119|recurrent adult brain tumor|recurrent adult brain tumor
773596|NCT00006119|adult grade III meningioma|adult grade iii meningioma
773597|NCT00006119|adult grade I meningioma|adult grade i meningioma
773598|NCT00006119|adult grade II meningioma|adult grade ii meningioma
773599|NCT00006118|stage III bladder cancer|stage iii bladder cancer
773600|NCT00006118|stage IV bladder cancer|stage iv bladder cancer
773601|NCT00006118|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
773602|NCT00006114|adenocarcinoma of the prostate|adenocarcinoma of the prostate
773603|NCT00006114|stage IV prostate cancer|stage iv prostate cancer
773604|NCT00006114|recurrent prostate cancer|recurrent prostate cancer
773605|NCT00006113|stage III melanoma|stage iii melanoma
773606|NCT00006113|stage IV melanoma|stage iv melanoma
773607|NCT00006113|recurrent melanoma|recurrent melanoma
773608|NCT00006110|stage II breast cancer|stage ii breast cancer
773609|NCT00006110|stage IV breast cancer|stage iv breast cancer
773610|NCT00006110|stage IIIA breast cancer|stage iiia breast cancer
773611|NCT00006110|stage IIIB breast cancer|stage iiib breast cancer
773612|NCT00006110|stage IIIC breast cancer|stage iiic breast cancer
773613|NCT00006110|inflammatory breast cancer|inflammatory breast cancer
773614|NCT00006107|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
773615|NCT00006107|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
773616|NCT00006107|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
773617|NCT00006107|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
773618|NCT00006107|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
773619|NCT00006107|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
773620|NCT00006107|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
773621|NCT00006107|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
773622|NCT00006107|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
773623|NCT00006107|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
773624|NCT00006107|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
773625|NCT00006107|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
773626|NCT00006107|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
773627|NCT00006107|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
773628|NCT00006107|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
773629|NCT00006107|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
773630|NCT00006107|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
773631|NCT00006107|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
773632|NCT00006107|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
773633|NCT00006107|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
773634|NCT00006107|recurrent salivary gland cancer|recurrent salivary gland cancer
773635|NCT00006107|stage III salivary gland cancer|stage iii salivary gland cancer
773636|NCT00006107|stage IV salivary gland cancer|stage iv salivary gland cancer
773637|NCT00006107|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
773638|NCT00006107|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
773639|NCT00006107|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
773640|NCT00006107|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
773641|NCT00006107|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
773642|NCT00006107|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
773643|NCT00006107|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
773644|NCT00006105|stage II bladder cancer|stage ii bladder cancer
773645|NCT00006105|stage III bladder cancer|stage iii bladder cancer
773646|NCT00006105|stage IV bladder cancer|stage iv bladder cancer
773647|NCT00006105|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
773648|NCT00006102|childhood infratentorial ependymoma|childhood infratentorial ependymoma
773649|NCT00006102|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
773650|NCT00006102|childhood supratentorial ependymoma|childhood supratentorial ependymoma
773651|NCT00006102|childhood craniopharyngioma|childhood craniopharyngioma
773652|NCT00006102|disseminated neuroblastoma|disseminated neuroblastoma
773653|NCT00006102|recurrent neuroblastoma|recurrent neuroblastoma
773654|NCT00006102|intraocular retinoblastoma|intraocular retinoblastoma
773655|NCT00006102|extraocular retinoblastoma|extraocular retinoblastoma
773656|NCT00006102|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
773657|NCT00006102|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
773658|NCT00006102|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
773659|NCT00006102|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
773660|NCT00006102|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
773661|NCT00006102|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
773662|NCT00006102|childhood oligodendroglioma|childhood oligodendroglioma
773663|NCT00006102|childhood choroid plexus tumor|childhood choroid plexus tumor
773664|NCT00006102|childhood grade I meningioma|childhood grade i meningioma
773665|NCT00006102|childhood grade II meningioma|childhood grade ii meningioma
773666|NCT00006102|childhood grade III meningioma|childhood grade iii meningioma
773667|NCT00006102|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
773668|NCT00006102|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
773669|NCT00006102|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
773670|NCT00006102|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
773671|NCT00006102|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
773672|NCT00006102|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
773673|NCT00006102|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
773674|NCT00006102|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
773675|NCT00006102|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
773676|NCT00006102|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
773677|NCT00006102|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
773678|NCT00006102|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
773679|NCT00006102|recurrent childhood ependymoma|recurrent childhood ependymoma
773680|NCT00006102|recurrent retinoblastoma|recurrent retinoblastoma
773681|NCT00006101|stage I prostate cancer|stage i prostate cancer
773682|NCT00006100|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
773683|NCT00006093|recurrent adult brain tumor|recurrent adult brain tumor
773684|NCT00006093|adult glioblastoma|adult glioblastoma
787321|NCT00002277|Neutropenia|neutropenia
773685|NCT00006093|adult anaplastic astrocytoma|adult anaplastic astrocytoma
773686|NCT00006093|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
773687|NCT00006093|adult giant cell glioblastoma|adult giant cell glioblastoma
773688|NCT00006093|adult gliosarcoma|adult gliosarcoma
773689|NCT00006092|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
773690|NCT00006092|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
773691|NCT00006092|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
773692|NCT00006092|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
773693|NCT00006092|lymphoid leukemia|lymphoid leukemia
773694|NCT00006092|myeloid and monocytic leukemia|myeloid and monocytic leukemia
773695|NCT00006078|prostate cancer|prostate cancer
773696|NCT00006044|stage IV prostate cancer|stage iv prostate cancer
773697|NCT00006044|recurrent prostate cancer|recurrent prostate cancer
773698|NCT00006042|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
773699|NCT00006042|Burkitt lymphoma|burkitt lymphoma
773700|NCT00006042|refractory multiple myeloma|refractory multiple myeloma
773701|NCT00006042|stage II multiple myeloma|stage ii multiple myeloma
773702|NCT00006042|stage III multiple myeloma|stage iii multiple myeloma
773703|NCT00006042|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
773704|NCT00006042|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
773705|NCT00006042|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
773706|NCT00006042|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
773707|NCT00006042|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
773708|NCT00006042|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
773709|NCT00006042|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
773710|NCT00006042|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
773711|NCT00006042|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
773712|NCT00006042|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
773713|NCT00006042|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
773714|NCT00006042|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
773715|NCT00006042|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
773716|NCT00006042|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
773717|NCT00006042|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
773718|NCT00006042|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
773719|NCT00006042|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
773720|NCT00006042|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
773721|NCT00006042|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
773722|NCT00006042|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
773723|NCT00006042|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
773724|NCT00006042|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
773725|NCT00006042|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
773726|NCT00006042|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
773727|NCT00006042|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
773728|NCT00006042|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
773729|NCT00006042|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
773730|NCT00006042|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
773731|NCT00006042|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
773732|NCT00006042|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
773733|NCT00006042|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
773734|NCT00006042|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
773735|NCT00006042|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
773736|NCT00006042|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
773737|NCT00006042|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
773738|NCT00006042|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
773739|NCT00006042|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
773740|NCT00006042|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
773741|NCT00006042|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
773742|NCT00006042|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
773743|NCT00006042|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
773744|NCT00006042|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
773745|NCT00006042|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
773746|NCT00006042|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
773747|NCT00006042|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
773748|NCT00006042|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
773816|NCT00006015|stage IV rectal cancer|stage iv rectal cancer
773749|NCT00006042|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
773750|NCT00006042|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
773751|NCT00006042|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
773752|NCT00006042|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
773753|NCT00006042|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
773754|NCT00006042|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
773755|NCT00006042|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
773756|NCT00006042|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
773757|NCT00006042|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
773758|NCT00006042|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
773759|NCT00006042|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
773760|NCT00006042|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
773761|NCT00006042|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
773762|NCT00006042|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
773763|NCT00006042|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
773764|NCT00006042|splenic marginal zone lymphoma|splenic marginal zone lymphoma
773765|NCT00006042|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
773766|NCT00006042|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
773767|NCT00006042|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
773768|NCT00006042|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
776048|NCT00003838|Donor Apheresis|donor apheresis
773769|NCT00006042|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
773770|NCT00006042|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
773771|NCT00006040|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
773772|NCT00006040|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
773773|NCT00006040|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
773774|NCT00006040|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
773775|NCT00006040|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
773776|NCT00006040|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
773777|NCT00006040|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
773778|NCT00006040|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
773779|NCT00006029|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
773780|NCT00006029|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
773781|NCT00006028|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
773782|NCT00006028|primary peritoneal cavity cancer|primary peritoneal cavity cancer
773783|NCT00006027|stage I endometrial carcinoma|stage i endometrial carcinoma
773784|NCT00006027|stage II endometrial carcinoma|stage ii endometrial carcinoma
773785|NCT00006027|endometrial adenocarcinoma|endometrial adenocarcinoma
773786|NCT00006027|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
773787|NCT00006027|endometrial adenoacanthoma|endometrial adenoacanthoma
773788|NCT00006027|endometrial clear cell carcinoma|endometrial clear cell carcinoma
773789|NCT00006027|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
773790|NCT00006025|recurrent adult brain tumor|recurrent adult brain tumor
773791|NCT00006025|adult glioblastoma|adult glioblastoma
773792|NCT00006025|adult anaplastic astrocytoma|adult anaplastic astrocytoma
773793|NCT00006025|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
773794|NCT00006025|adult mixed glioma|adult mixed glioma
773795|NCT00006025|adult giant cell glioblastoma|adult giant cell glioblastoma
773796|NCT00006025|adult gliosarcoma|adult gliosarcoma
773797|NCT00006024|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
773798|NCT00006022|stage III renal cell cancer|stage iii renal cell cancer
773799|NCT00006022|stage IV renal cell cancer|stage iv renal cell cancer
773800|NCT00006022|recurrent renal cell cancer|recurrent renal cell cancer
773801|NCT00006022|stage III melanoma|stage iii melanoma
773802|NCT00006022|stage IV melanoma|stage iv melanoma
773803|NCT00006022|recurrent melanoma|recurrent melanoma
773804|NCT00006021|refractory multiple myeloma|refractory multiple myeloma
773805|NCT00006021|stage II multiple myeloma|stage ii multiple myeloma
773806|NCT00006021|stage III multiple myeloma|stage iii multiple myeloma
773807|NCT00006020|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
773808|NCT00006020|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
773809|NCT00006020|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
773810|NCT00006020|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
773811|NCT00006020|non-T, non-B adult acute lymphoblastic leukemia|non-t, non-b adult acute lymphoblastic leukemia
773812|NCT00006017|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
773813|NCT00006017|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
773814|NCT00006017|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
773815|NCT00006015|stage IV colon cancer|stage iv colon cancer
773817|NCT00006015|recurrent colon cancer|recurrent colon cancer
773818|NCT00006015|recurrent rectal cancer|recurrent rectal cancer
773819|NCT00006015|adenocarcinoma of the colon|adenocarcinoma of the colon
773820|NCT00006015|adenocarcinoma of the rectum|adenocarcinoma of the rectum
773821|NCT00006010|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
773822|NCT00006010|advanced adult primary liver cancer|advanced adult primary liver cancer
773823|NCT00006010|recurrent adult primary liver cancer|recurrent adult primary liver cancer
773824|NCT00006010|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
773825|NCT00006007|stage IV breast cancer|stage iv breast cancer
773826|NCT00006007|recurrent breast cancer|recurrent breast cancer
773827|NCT00006006|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
773828|NCT00006006|advanced adult primary liver cancer|advanced adult primary liver cancer
773829|NCT00006006|recurrent adult primary liver cancer|recurrent adult primary liver cancer
773830|NCT00006006|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
773831|NCT00006005|stage I uterine sarcoma|stage i uterine sarcoma
773832|NCT00006005|stage II uterine sarcoma|stage ii uterine sarcoma
773833|NCT00006005|stage III uterine sarcoma|stage iii uterine sarcoma
773834|NCT00006005|stage IV uterine sarcoma|stage iv uterine sarcoma
773835|NCT00006005|recurrent uterine sarcoma|recurrent uterine sarcoma
773836|NCT00006005|uterine carcinosarcoma|uterine carcinosarcoma
773837|NCT00006005|uterine leiomyosarcoma|uterine leiomyosarcoma
773838|NCT00006005|endometrial stromal sarcoma|endometrial stromal sarcoma
773839|NCT00006004|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
773840|NCT00006004|squamous cell lung cancer|squamous cell lung cancer
773841|NCT00006004|large cell lung cancer|large cell lung cancer
773842|NCT00006004|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
773843|NCT00006004|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
773844|NCT00006004|adenocarcinoma of the lung|adenocarcinoma of the lung
773845|NCT00006004|adenosquamous cell lung cancer|adenosquamous cell lung cancer
773846|NCT00006004|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
773847|NCT00005997|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
773848|NCT00005997|advanced adult primary liver cancer|advanced adult primary liver cancer
773849|NCT00005997|unresectable gallbladder cancer|unresectable gallbladder cancer
773850|NCT00005997|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
773851|NCT00005997|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
773852|NCT00005997|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
773853|NCT00005997|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
773854|NCT00005997|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
773855|NCT00005990|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
773856|NCT00005987|stage I multiple myeloma|stage i multiple myeloma
773857|NCT00005987|stage II multiple myeloma|stage ii multiple myeloma
773858|NCT00005987|stage III multiple myeloma|stage iii multiple myeloma
773859|NCT00005985|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
773860|NCT00005985|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
773861|NCT00005985|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
773862|NCT00005985|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
773863|NCT00005985|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
773864|NCT00005985|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
773865|NCT00005985|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
773866|NCT00005985|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
773867|NCT00005985|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
773868|NCT00005985|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
773869|NCT00005985|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
773870|NCT00005985|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
773871|NCT00005985|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
773872|NCT00005985|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
773873|NCT00005985|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
773874|NCT00005985|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
773875|NCT00005985|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
773876|NCT00005985|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
773877|NCT00005985|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
773878|NCT00005985|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
773879|NCT00005985|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
773880|NCT00005985|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
773881|NCT00005985|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
773882|NCT00005985|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
773883|NCT00005985|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
773884|NCT00005985|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
773885|NCT00005985|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
773886|NCT00005985|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
773887|NCT00005985|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
773888|NCT00005985|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
773889|NCT00005985|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
773890|NCT00005985|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
773891|NCT00005985|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
773892|NCT00005985|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
773893|NCT00005985|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
773894|NCT00005985|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
773895|NCT00005985|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
773896|NCT00005985|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
773897|NCT00005985|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
773898|NCT00005985|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
773899|NCT00005985|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
773900|NCT00005985|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
773901|NCT00005985|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
773902|NCT00005985|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
773903|NCT00005985|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
773904|NCT00005985|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
773905|NCT00005985|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
773906|NCT00005985|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
773907|NCT00005985|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
773908|NCT00005985|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
773909|NCT00005985|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
773910|NCT00005985|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
773911|NCT00005985|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
773912|NCT00005985|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
773913|NCT00005985|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
773914|NCT00005985|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
773915|NCT00005985|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
773916|NCT00005985|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
773917|NCT00005985|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
773918|NCT00005985|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
773919|NCT00005985|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
773920|NCT00005985|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
773921|NCT00005985|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
773922|NCT00005985|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
773923|NCT00005985|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
773924|NCT00005985|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
773925|NCT00005985|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
773926|NCT00005985|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
773927|NCT00005985|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
773928|NCT00005985|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
773929|NCT00005984|chronic phase myelogenous leukemia|chronic phase myelogenous leukemia
773930|NCT00005984|accelerated phase myelogenous leukemia|accelerated phase myelogenous leukemia
773931|NCT00005983|stage II breast cancer|stage ii breast cancer
773932|NCT00005981|stage IV colon cancer|stage iv colon cancer
773933|NCT00005981|stage IV rectal cancer|stage iv rectal cancer
773934|NCT00005981|recurrent colon cancer|recurrent colon cancer
773935|NCT00005981|recurrent rectal cancer|recurrent rectal cancer
773936|NCT00005980|stage IV breast cancer|stage iv breast cancer
773937|NCT00005980|recurrent breast cancer|recurrent breast cancer
773938|NCT00005979|stage III colon cancer|stage iii colon cancer
773939|NCT00005979|adenocarcinoma of the colon|adenocarcinoma of the colon
773940|NCT00005976|recurrent adult brain tumor|recurrent adult brain tumor
773941|NCT00005976|adult glioblastoma|adult glioblastoma
773942|NCT00005976|adult anaplastic astrocytoma|adult anaplastic astrocytoma
773943|NCT00005976|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
773944|NCT00005976|adult mixed glioma|adult mixed glioma
773945|NCT00005976|adult oligodendroglioma|adult oligodendroglioma
773946|NCT00005976|adult giant cell glioblastoma|adult giant cell glioblastoma
773947|NCT00005976|adult gliosarcoma|adult gliosarcoma
773948|NCT00005967|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
773949|NCT00005967|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
774017|NCT00005957|stage II breast cancer|stage ii breast cancer
773950|NCT00005967|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
773951|NCT00005967|refractory multiple myeloma|refractory multiple myeloma
773952|NCT00005967|stage III multiple myeloma|stage iii multiple myeloma
773953|NCT00005967|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
773954|NCT00005967|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
773955|NCT00005967|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
773956|NCT00005967|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
773957|NCT00005967|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
773958|NCT00005967|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
773959|NCT00005967|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
773960|NCT00005967|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
773961|NCT00005967|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
773962|NCT00005967|refractory anemia with excess blasts|refractory anemia with excess blasts
773963|NCT00005967|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
773964|NCT00005967|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
773965|NCT00005967|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
773966|NCT00005967|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
773967|NCT00005967|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
773968|NCT00005967|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
773969|NCT00005967|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
773970|NCT00005967|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
773971|NCT00005967|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
773972|NCT00005967|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
773973|NCT00005967|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
773974|NCT00005967|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
773975|NCT00005967|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
773976|NCT00005967|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
773977|NCT00005967|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
773978|NCT00005967|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
773979|NCT00005967|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
773980|NCT00005967|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
773981|NCT00005967|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
773982|NCT00005967|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
773983|NCT00005967|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
773984|NCT00005967|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
773985|NCT00005967|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
773986|NCT00005967|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
773987|NCT00005967|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
773988|NCT00005967|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
773989|NCT00005967|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
773990|NCT00005967|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
773991|NCT00005967|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
773992|NCT00005967|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
773993|NCT00005967|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
773994|NCT00005967|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
773995|NCT00005967|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
773996|NCT00005967|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
773997|NCT00005967|polycythemia vera|polycythemia vera
773998|NCT00005967|primary myelofibrosis|primary myelofibrosis
773999|NCT00005967|essential thrombocythemia|essential thrombocythemia
774000|NCT00005967|chronic eosinophilic leukemia|chronic eosinophilic leukemia
774001|NCT00005967|chronic neutrophilic leukemia|chronic neutrophilic leukemia
774002|NCT00005967|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
774003|NCT00005967|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
774004|NCT00005967|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
774005|NCT00005967|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
774006|NCT00005967|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
774007|NCT00005967|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
774008|NCT00005967|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
774009|NCT00005967|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
774010|NCT00005967|splenic marginal zone lymphoma|splenic marginal zone lymphoma
774011|NCT00005966|stage III renal cell cancer|stage iii renal cell cancer
774012|NCT00005966|stage IV renal cell cancer|stage iv renal cell cancer
774013|NCT00005961|stage III melanoma|stage iii melanoma
774014|NCT00005961|stage IV melanoma|stage iv melanoma
774015|NCT00005961|recurrent melanoma|recurrent melanoma
774016|NCT00005957|stage I breast cancer|stage i breast cancer
774018|NCT00005955|childhood infratentorial ependymoma|childhood infratentorial ependymoma
774019|NCT00005955|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
774020|NCT00005955|childhood supratentorial ependymoma|childhood supratentorial ependymoma
774021|NCT00005955|childhood craniopharyngioma|childhood craniopharyngioma
774022|NCT00005955|localized resectable neuroblastoma|localized resectable neuroblastoma
774023|NCT00005955|regional neuroblastoma|regional neuroblastoma
774024|NCT00005955|disseminated neuroblastoma|disseminated neuroblastoma
774025|NCT00005955|stage 4S neuroblastoma|stage 4s neuroblastoma
774026|NCT00005955|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
774027|NCT00005955|childhood oligodendroglioma|childhood oligodendroglioma
774028|NCT00005955|childhood choroid plexus tumor|childhood choroid plexus tumor
774029|NCT00005955|childhood grade I meningioma|childhood grade i meningioma
774030|NCT00005955|childhood grade II meningioma|childhood grade ii meningioma
774031|NCT00005955|childhood grade III meningioma|childhood grade iii meningioma
774032|NCT00005955|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
774033|NCT00005955|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
774034|NCT00005955|untreated childhood medulloblastoma|untreated childhood medulloblastoma
774035|NCT00005955|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
774036|NCT00005955|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
774037|NCT00005955|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
774038|NCT00005955|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
774039|NCT00005955|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
774040|NCT00005955|childhood central nervous system teratoma|childhood central nervous system teratoma
774041|NCT00005955|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
774042|NCT00005954|adult tumors metastatic to brain|adult tumors metastatic to brain
774043|NCT00005952|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
774044|NCT00005952|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
774045|NCT00005952|childhood craniopharyngioma|childhood craniopharyngioma
774046|NCT00005952|disseminated neuroblastoma|disseminated neuroblastoma
774047|NCT00005952|stage 4S neuroblastoma|stage 4s neuroblastoma
774048|NCT00005952|recurrent neuroblastoma|recurrent neuroblastoma
774049|NCT00005952|stage IV Wilms tumor|stage iv wilms tumor
774050|NCT00005952|stage V Wilms tumor|stage v wilms tumor
774051|NCT00005952|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
774052|NCT00005952|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
774053|NCT00005952|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
774054|NCT00005952|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
774055|NCT00005952|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
774056|NCT00005952|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
774057|NCT00005952|childhood germ cell tumor|childhood germ cell tumor
774058|NCT00005952|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
774059|NCT00005952|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
774060|NCT00005952|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
774061|NCT00005952|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
774062|NCT00005952|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
774063|NCT00005952|childhood oligodendroglioma|childhood oligodendroglioma
774064|NCT00005952|childhood choroid plexus tumor|childhood choroid plexus tumor
774065|NCT00005952|untreated childhood brain stem glioma|untreated childhood brain stem glioma
774066|NCT00005952|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
774067|NCT00005952|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
774068|NCT00005952|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
774069|NCT00005952|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
774070|NCT00005952|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
774071|NCT00005952|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
774072|NCT00005952|untreated childhood medulloblastoma|untreated childhood medulloblastoma
774073|NCT00005952|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
774074|NCT00005952|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
774075|NCT00005952|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
774076|NCT00005952|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
774077|NCT00005952|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
774078|NCT00005952|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
774079|NCT00005952|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
774080|NCT00005952|recurrent childhood ependymoma|recurrent childhood ependymoma
774081|NCT00005951|recurrent adult brain tumor|recurrent adult brain tumor
774082|NCT00005951|adult glioblastoma|adult glioblastoma
774083|NCT00005951|adult anaplastic astrocytoma|adult anaplastic astrocytoma
774084|NCT00005951|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
774085|NCT00005951|adult mixed glioma|adult mixed glioma
774086|NCT00005951|adult giant cell glioblastoma|adult giant cell glioblastoma
774087|NCT00005951|adult gliosarcoma|adult gliosarcoma
774088|NCT00005945|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
774089|NCT00005945|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
774090|NCT00005945|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
774091|NCT00005945|L3 childhood acute lymphoblastic leukemia|l3 childhood acute lymphoblastic leukemia
774092|NCT00005941|stage III cervical cancer|stage iii cervical cancer
774093|NCT00005941|recurrent cervical cancer|recurrent cervical cancer
774094|NCT00005941|stage IVB cervical cancer|stage ivb cervical cancer
774095|NCT00005941|stage IVA cervical cancer|stage iva cervical cancer
774096|NCT00005941|stage III vaginal cancer|stage iii vaginal cancer
774097|NCT00005941|stage IVA vaginal cancer|stage iva vaginal cancer
774098|NCT00005941|stage IVB vaginal cancer|stage ivb vaginal cancer
774099|NCT00005941|recurrent vaginal cancer|recurrent vaginal cancer
774100|NCT00005879|breast cancer|breast cancer
774101|NCT00005878|esophageal cancer|esophageal cancer
774102|NCT00005867|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
774103|NCT00005867|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
774104|NCT00005867|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
774105|NCT00005867|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
774106|NCT00005867|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
774107|NCT00005867|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
774108|NCT00005867|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
774109|NCT00005867|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
774110|NCT00005867|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
774111|NCT00005867|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
774112|NCT00005867|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
774113|NCT00005867|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
774114|NCT00005867|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
774115|NCT00005867|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
774116|NCT00005867|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
774117|NCT00005867|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
774118|NCT00005867|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
774119|NCT00005867|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
774120|NCT00005867|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
774121|NCT00005867|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
774122|NCT00005863|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
774123|NCT00005863|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
774124|NCT00005863|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
774125|NCT00005863|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
774126|NCT00005863|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
774127|NCT00005863|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
774128|NCT00005863|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
774129|NCT00005863|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
774130|NCT00005863|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
774131|NCT00005863|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
774132|NCT00005863|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
774133|NCT00005863|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
774134|NCT00005863|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
774135|NCT00005863|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
774136|NCT00005863|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
774137|NCT00005863|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
774138|NCT00005863|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
774139|NCT00005863|secondary acute myeloid leukemia|secondary acute myeloid leukemia
774140|NCT00005863|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
774141|NCT00005863|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
774142|NCT00005863|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
774143|NCT00005863|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
774144|NCT00005863|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
774145|NCT00005863|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
774146|NCT00005863|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
774147|NCT00005863|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
774148|NCT00005863|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
774149|NCT00005863|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
774150|NCT00005863|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
774151|NCT00005863|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
774152|NCT00005863|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
774153|NCT00005859|recurrent adult brain tumor|recurrent adult brain tumor
774154|NCT00005859|adult glioblastoma|adult glioblastoma
774155|NCT00005859|adult giant cell glioblastoma|adult giant cell glioblastoma
774156|NCT00005859|adult gliosarcoma|adult gliosarcoma
774157|NCT00005858|stage III colon cancer|stage iii colon cancer
774158|NCT00005858|stage IV colon cancer|stage iv colon cancer
774159|NCT00005858|stage IV breast cancer|stage iv breast cancer
774160|NCT00005858|stage IIIA breast cancer|stage iiia breast cancer
774161|NCT00005858|recurrent breast cancer|recurrent breast cancer
774162|NCT00005858|stage IIIB breast cancer|stage iiib breast cancer
774163|NCT00005858|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
774164|NCT00005858|stage II pancreatic cancer|stage ii pancreatic cancer
774165|NCT00005858|stage III pancreatic cancer|stage iii pancreatic cancer
774166|NCT00005858|recurrent pancreatic cancer|recurrent pancreatic cancer
774167|NCT00005858|recurrent colon cancer|recurrent colon cancer
774168|NCT00005858|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
774169|NCT00005858|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
774170|NCT00005858|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
774171|NCT00005858|stage III bladder cancer|stage iii bladder cancer
774172|NCT00005858|recurrent bladder cancer|recurrent bladder cancer
774173|NCT00005858|stage IV bladder cancer|stage iv bladder cancer
774174|NCT00005858|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
774175|NCT00005858|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
774176|NCT00005858|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
774177|NCT00005858|ovarian stromal cancer|ovarian stromal cancer
774178|NCT00005858|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
774179|NCT00005858|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
774180|NCT00005858|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
774181|NCT00005858|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
774182|NCT00005858|ovarian sarcoma|ovarian sarcoma
774183|NCT00005858|male breast cancer|male breast cancer
774184|NCT00005858|stage IV pancreatic cancer|stage iv pancreatic cancer
774185|NCT00005855|adult glioblastoma|adult glioblastoma
774186|NCT00005855|adult anaplastic astrocytoma|adult anaplastic astrocytoma
774187|NCT00005855|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
774188|NCT00005855|recurrent adult brain tumor|recurrent adult brain tumor
774189|NCT00005855|adult giant cell glioblastoma|adult giant cell glioblastoma
774190|NCT00005855|adult gliosarcoma|adult gliosarcoma
774191|NCT00005853|refractory anemia|refractory anemia
774192|NCT00005853|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
774193|NCT00005853|refractory anemia with excess blasts|refractory anemia with excess blasts
774194|NCT00005853|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
774195|NCT00005853|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
774196|NCT00005853|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
774197|NCT00005853|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
774198|NCT00005853|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
774199|NCT00005853|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
774200|NCT00005850|stage I non-small cell lung cancer|stage i non-small cell lung cancer
774201|NCT00005850|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
774202|NCT00005850|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
774203|NCT00005850|squamous cell lung cancer|squamous cell lung cancer
774204|NCT00005850|large cell lung cancer|large cell lung cancer
774205|NCT00005850|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
774206|NCT00005850|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
774207|NCT00005850|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
774208|NCT00005850|adenocarcinoma of the lung|adenocarcinoma of the lung
774209|NCT00005850|adenosquamous cell lung cancer|adenosquamous cell lung cancer
774210|NCT00005850|fatigue|fatigue
774211|NCT00005850|anxiety disorder|anxiety disorder
774212|NCT00005850|depression|depression
774213|NCT00005847|adenocarcinoma of the prostate|adenocarcinoma of the prostate
774214|NCT00005847|stage IV prostate cancer|stage iv prostate cancer
774215|NCT00005847|recurrent prostate cancer|recurrent prostate cancer
774216|NCT00005844|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
774217|NCT00005835|regional neuroblastoma|regional neuroblastoma
774218|NCT00005835|disseminated neuroblastoma|disseminated neuroblastoma
774219|NCT00005835|recurrent neuroblastoma|recurrent neuroblastoma
774220|NCT00005835|localized unresectable neuroblastoma|localized unresectable neuroblastoma
774221|NCT00005825|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
774222|NCT00005825|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
774223|NCT00005824|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
774224|NCT00005824|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
774225|NCT00005824|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
774226|NCT00005824|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
774227|NCT00005824|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
774228|NCT00005824|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
774229|NCT00005824|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
774230|NCT00005824|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
774231|NCT00005823|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
774232|NCT00005823|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
774233|NCT00005823|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
774234|NCT00005823|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
774235|NCT00005823|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
774236|NCT00005823|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
774237|NCT00005823|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
774238|NCT00005823|refractory anemia with excess blasts|refractory anemia with excess blasts
774239|NCT00005823|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
774240|NCT00005823|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
774241|NCT00005823|secondary acute myeloid leukemia|secondary acute myeloid leukemia
774242|NCT00005823|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
774243|NCT00005823|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
774244|NCT00005823|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
774245|NCT00005823|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
774246|NCT00005823|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
774247|NCT00005823|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
774248|NCT00005823|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
774249|NCT00005823|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
774250|NCT00005823|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
774251|NCT00005823|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
774252|NCT00005822|stage IV breast cancer|stage iv breast cancer
774253|NCT00005822|recurrent breast cancer|recurrent breast cancer
774254|NCT00005822|stage IIIB breast cancer|stage iiib breast cancer
774255|NCT00005822|inflammatory breast cancer|inflammatory breast cancer
774256|NCT00005822|male breast cancer|male breast cancer
774257|NCT00005821|stage I breast cancer|stage i breast cancer
774258|NCT00005821|stage II breast cancer|stage ii breast cancer
774259|NCT00005819|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
774260|NCT00005815|iris melanoma|iris melanoma
774261|NCT00005815|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
774262|NCT00005815|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
774263|NCT00005815|extraocular extension melanoma|extraocular extension melanoma
774264|NCT00005815|recurrent intraocular melanoma|recurrent intraocular melanoma
774265|NCT00005815|stage III melanoma|stage iii melanoma
774266|NCT00005815|stage IV melanoma|stage iv melanoma
774267|NCT00005815|recurrent melanoma|recurrent melanoma
774268|NCT00005812|leptomeningeal metastases|leptomeningeal metastases
774269|NCT00005812|temozolomide|temozolomide
774270|NCT00005807|stage IV breast cancer|stage iv breast cancer
774271|NCT00005807|stage IIIA breast cancer|stage iiia breast cancer
774272|NCT00005807|recurrent breast cancer|recurrent breast cancer
774273|NCT00005807|stage IIIB breast cancer|stage iiib breast cancer
774274|NCT00005807|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
774275|NCT00005807|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
774276|NCT00005807|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
774277|NCT00005807|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
774278|NCT00005807|ovarian stromal cancer|ovarian stromal cancer
774279|NCT00005807|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
774280|NCT00005807|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
774281|NCT00005807|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
774282|NCT00005807|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
774283|NCT00005807|ovarian sarcoma|ovarian sarcoma
774284|NCT00005807|male breast cancer|male breast cancer
774285|NCT00005802|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
774286|NCT00005802|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
774287|NCT00005802|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
774288|NCT00005802|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
774289|NCT00005802|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
774290|NCT00005802|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
774291|NCT00005802|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
774292|NCT00005802|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
774293|NCT00005802|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
774294|NCT00005797|refractory multiple myeloma|refractory multiple myeloma
774295|NCT00005797|stage II multiple myeloma|stage ii multiple myeloma
774296|NCT00005797|stage III multiple myeloma|stage iii multiple myeloma
774297|NCT00005797|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
774298|NCT00005797|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
774299|NCT00005797|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
774300|NCT00005797|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
774301|NCT00005797|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
774302|NCT00005797|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
774303|NCT00005797|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
774304|NCT00005797|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
774305|NCT00005797|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
774306|NCT00005797|polycythemia vera|polycythemia vera
774307|NCT00005797|primary myelofibrosis|primary myelofibrosis
774308|NCT00005797|essential thrombocythemia|essential thrombocythemia
774309|NCT00005797|refractory anemia|refractory anemia
774310|NCT00005797|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
774311|NCT00005797|refractory anemia with excess blasts|refractory anemia with excess blasts
774312|NCT00005797|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
774313|NCT00005797|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
774314|NCT00005797|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
774315|NCT00005797|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
774316|NCT00005797|chronic eosinophilic leukemia|chronic eosinophilic leukemia
774317|NCT00005797|chronic neutrophilic leukemia|chronic neutrophilic leukemia
774318|NCT00005797|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
774319|NCT00005797|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
774320|NCT00005797|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
774321|NCT00005797|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
774322|NCT00005797|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
774323|NCT00005797|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
774324|NCT00005797|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
774325|NCT00005797|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
774326|NCT00005788|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
774327|NCT00005788|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
774328|NCT00005788|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
774329|NCT00005788|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
774330|NCT00005788|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
774331|NCT00005788|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
774332|NCT00005788|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
774333|NCT00005788|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
774334|NCT00005788|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
774335|NCT00005788|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
774336|NCT00005787|neutropenia|neutropenia
774337|NCT00005787|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
774338|NCT00005787|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
774339|NCT00005787|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
774340|NCT00005787|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
774341|NCT00005787|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
774342|NCT00005787|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
774343|NCT00005787|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
774344|NCT00005787|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
774345|NCT00005787|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
774346|NCT00005787|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
774347|NCT00005787|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
774348|NCT00005787|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
774349|NCT00005787|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
774350|NCT00005787|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
774351|NCT00005787|splenic marginal zone lymphoma|splenic marginal zone lymphoma
774352|NCT00005647|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
774353|NCT00005647|anaplastic thyroid cancer|anaplastic thyroid cancer
774354|NCT00005647|recurrent thyroid cancer|recurrent thyroid cancer
774355|NCT00005647|recurrent salivary gland cancer|recurrent salivary gland cancer
774356|NCT00005647|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
774357|NCT00005647|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
774358|NCT00005647|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
774359|NCT00005647|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
774360|NCT00005647|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
774361|NCT00005647|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
774362|NCT00005647|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
774363|NCT00005647|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
774364|NCT00005647|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
774365|NCT00005647|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
774366|NCT00005647|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
774367|NCT00005647|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
774368|NCT00005647|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
774369|NCT00005647|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
774370|NCT00005647|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
774371|NCT00005647|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
774372|NCT00005647|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
774373|NCT00005647|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
774374|NCT00005647|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
774375|NCT00005644|stage III bladder cancer|stage iii bladder cancer
774376|NCT00005644|recurrent bladder cancer|recurrent bladder cancer
774377|NCT00005644|stage IV bladder cancer|stage iv bladder cancer
774378|NCT00005644|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
774379|NCT00005644|recurrent urethral cancer|recurrent urethral cancer
774380|NCT00005644|distal urethral cancer|distal urethral cancer
774381|NCT00005644|proximal urethral cancer|proximal urethral cancer
774382|NCT00005644|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
774383|NCT00005644|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
774384|NCT00005644|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
774385|NCT00005644|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
774386|NCT00005639|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
774387|NCT00005639|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
774388|NCT00005639|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
774389|NCT00005639|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
774390|NCT00005639|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
774391|NCT00005639|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
774392|NCT00005639|small intestine lymphoma|small intestine lymphoma
774393|NCT00005639|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
774394|NCT00005639|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
774395|NCT00005639|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
774396|NCT00005639|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
774397|NCT00005639|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
774398|NCT00005639|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
774399|NCT00005639|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
774400|NCT00005639|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
774401|NCT00005639|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
774402|NCT00005639|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
774403|NCT00005639|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
774404|NCT00005639|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
774405|NCT00005639|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
774406|NCT00005639|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
774407|NCT00005639|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
774408|NCT00005639|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
774409|NCT00005639|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
774410|NCT00005639|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
774411|NCT00005639|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
774412|NCT00005639|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
774413|NCT00005639|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
774414|NCT00005639|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
774415|NCT00005639|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
774416|NCT00005639|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
774417|NCT00005639|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
774418|NCT00005639|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
774419|NCT00005639|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
774420|NCT00005639|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
774421|NCT00005639|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
774422|NCT00005639|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
774423|NCT00005639|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
774424|NCT00005639|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
774425|NCT00005639|intraocular lymphoma|intraocular lymphoma
774426|NCT00005639|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
774427|NCT00005639|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
774428|NCT00005639|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
774429|NCT00005639|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
774430|NCT00005639|anaplastic large cell lymphoma|anaplastic large cell lymphoma
774431|NCT00005639|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
774432|NCT00005639|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
774433|NCT00005639|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
774434|NCT00005639|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
774435|NCT00005639|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
774436|NCT00005639|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
774437|NCT00005639|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
774438|NCT00005639|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
774439|NCT00005639|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
774440|NCT00005639|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
774441|NCT00005639|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
774442|NCT00005639|splenic marginal zone lymphoma|splenic marginal zone lymphoma
774443|NCT00005638|stage II gastric cancer|stage ii gastric cancer
774444|NCT00005638|stage III gastric cancer|stage iii gastric cancer
774445|NCT00005638|stage II esophageal cancer|stage ii esophageal cancer
774446|NCT00005638|stage III esophageal cancer|stage iii esophageal cancer
774447|NCT00005638|adenocarcinoma of the stomach|adenocarcinoma of the stomach
774448|NCT00005638|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
774449|NCT00005638|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
774450|NCT00005637|adult glioblastoma|adult glioblastoma
774451|NCT00005637|adult anaplastic astrocytoma|adult anaplastic astrocytoma
774452|NCT00005637|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
774453|NCT00005637|adult mixed glioma|adult mixed glioma
774454|NCT00005637|adult giant cell glioblastoma|adult giant cell glioblastoma
774455|NCT00005637|adult gliosarcoma|adult gliosarcoma
774456|NCT00005637|adult anaplastic ependymoma|adult anaplastic ependymoma
774457|NCT00005627|adenocarcinoma of the prostate|adenocarcinoma of the prostate
774458|NCT00005627|recurrent prostate cancer|recurrent prostate cancer
774459|NCT00005623|stage IV prostate cancer|stage iv prostate cancer
774460|NCT00005623|recurrent prostate cancer|recurrent prostate cancer
774461|NCT00005623|hot flashes|hot flashes
774462|NCT00005622|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
774463|NCT00005622|refractory multiple myeloma|refractory multiple myeloma
774464|NCT00005622|stage I multiple myeloma|stage i multiple myeloma
774465|NCT00005622|stage II multiple myeloma|stage ii multiple myeloma
774466|NCT00005622|stage III multiple myeloma|stage iii multiple myeloma
774467|NCT00005622|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
774468|NCT00005622|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
774469|NCT00005622|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
774470|NCT00005622|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
774471|NCT00005622|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
774472|NCT00005622|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
774473|NCT00005622|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
774474|NCT00005622|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
774475|NCT00005622|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
774476|NCT00005622|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
774477|NCT00005622|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
774478|NCT00005622|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
774479|NCT00005622|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
774480|NCT00005622|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
774481|NCT00005622|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
774482|NCT00005622|polycythemia vera|polycythemia vera
774483|NCT00005622|primary myelofibrosis|primary myelofibrosis
774484|NCT00005622|essential thrombocythemia|essential thrombocythemia
774485|NCT00005622|refractory anemia|refractory anemia
774486|NCT00005622|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
774487|NCT00005622|refractory anemia with excess blasts|refractory anemia with excess blasts
774488|NCT00005622|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
774489|NCT00005622|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
774490|NCT00005622|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
774491|NCT00005622|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
774492|NCT00005622|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
774493|NCT00005622|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
774494|NCT00005622|chronic eosinophilic leukemia|chronic eosinophilic leukemia
774495|NCT00005622|chronic neutrophilic leukemia|chronic neutrophilic leukemia
774496|NCT00005622|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
774497|NCT00005622|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
774498|NCT00005622|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
774499|NCT00005622|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
774500|NCT00005622|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
774501|NCT00005622|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
774502|NCT00005622|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
774503|NCT00005622|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
774504|NCT00005617|stage IV melanoma|stage iv melanoma
774505|NCT00005617|recurrent melanoma|recurrent melanoma
774506|NCT00005606|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
774507|NCT00005606|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
774508|NCT00005606|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
774509|NCT00005606|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
774510|NCT00005606|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
774511|NCT00005606|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
774512|NCT00005606|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
774513|NCT00005606|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
774514|NCT00005606|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
774515|NCT00005606|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
774516|NCT00005606|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
774517|NCT00005606|isolated plasmacytoma of bone|isolated plasmacytoma of bone
774518|NCT00005606|extramedullary plasmacytoma|extramedullary plasmacytoma
774519|NCT00005606|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
774520|NCT00005606|stage I multiple myeloma|stage i multiple myeloma
774521|NCT00005606|stage II multiple myeloma|stage ii multiple myeloma
774522|NCT00005606|stage III multiple myeloma|stage iii multiple myeloma
774523|NCT00005606|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
774524|NCT00005606|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
774525|NCT00005606|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
774526|NCT00005606|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
774527|NCT00005606|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
774528|NCT00005606|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
774529|NCT00005606|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
774530|NCT00005606|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
774531|NCT00005606|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
774532|NCT00005606|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
774533|NCT00005606|untreated hairy cell leukemia|untreated hairy cell leukemia
774534|NCT00005606|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
774535|NCT00005606|refractory hairy cell leukemia|refractory hairy cell leukemia
774536|NCT00005606|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
774537|NCT00005606|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
774538|NCT00005606|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
774539|NCT00005606|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
774540|NCT00005606|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
774541|NCT00005606|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
774542|NCT00005606|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
774543|NCT00005606|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
774544|NCT00005606|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
774545|NCT00005606|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
774546|NCT00005606|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
774547|NCT00005606|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
774548|NCT00005606|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
774549|NCT00005606|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
774550|NCT00005606|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
774551|NCT00005606|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
774552|NCT00005606|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
774553|NCT00005606|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
774554|NCT00005606|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
774555|NCT00005606|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
774556|NCT00005606|stage I marginal zone lymphoma|stage i marginal zone lymphoma
774557|NCT00005606|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
774558|NCT00005606|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
774559|NCT00005606|stage II marginal zone lymphoma|stage ii marginal zone lymphoma
774560|NCT00005606|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
774561|NCT00005606|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
774562|NCT00005606|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
774563|NCT00005606|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
774564|NCT00005606|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
774565|NCT00005606|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
774566|NCT00005606|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
774567|NCT00005606|splenic marginal zone lymphoma|splenic marginal zone lymphoma
774568|NCT00005605|osteoporosis|osteoporosis
774569|NCT00005605|stage I breast cancer|stage i breast cancer
774570|NCT00005605|stage II breast cancer|stage ii breast cancer
774571|NCT00005603|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
774572|NCT00005603|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
774573|NCT00005602|untreated childhood brain stem glioma|untreated childhood brain stem glioma
774574|NCT00005601|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
774575|NCT00005601|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
774576|NCT00005601|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
774577|NCT00005601|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
774578|NCT00005601|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
774579|NCT00005601|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
774580|NCT00005601|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
774581|NCT00005601|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
774582|NCT00005601|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
774583|NCT00005601|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
774584|NCT00005601|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
774585|NCT00005601|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
774586|NCT00005601|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
774587|NCT00005601|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
774588|NCT00005601|splenic marginal zone lymphoma|splenic marginal zone lymphoma
774589|NCT00005600|stage I breast cancer|stage i breast cancer
774590|NCT00005600|stage II breast cancer|stage ii breast cancer
774591|NCT00005600|lymphedema|lymphedema
774592|NCT00005600|perioperative/postoperative complications|perioperative/postoperative complications
774593|NCT00005599|stage III gastric cancer|stage iii gastric cancer
774594|NCT00005599|stage IV gastric cancer|stage iv gastric cancer
774595|NCT00005599|recurrent gastric cancer|recurrent gastric cancer
774596|NCT00005599|stage III esophageal cancer|stage iii esophageal cancer
774597|NCT00005599|stage IV esophageal cancer|stage iv esophageal cancer
774598|NCT00005599|recurrent esophageal cancer|recurrent esophageal cancer
774599|NCT00005599|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
774600|NCT00005599|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
774601|NCT00005597|gastrointestinal stromal tumor|gastrointestinal stromal tumor
774602|NCT00005596|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
774603|NCT00005590|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
774604|NCT00005590|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
774605|NCT00005590|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
774606|NCT00005590|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
774607|NCT00005590|recurrent breast cancer|recurrent breast cancer
774608|NCT00005590|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
774609|NCT00005590|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
774610|NCT00005590|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
787322|NCT00002277|Fluconazole|fluconazole
774611|NCT00005590|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
774612|NCT00005590|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
774613|NCT00005590|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
774614|NCT00005590|limited stage small cell lung cancer|limited stage small cell lung cancer
774615|NCT00005590|extensive stage small cell lung cancer|extensive stage small cell lung cancer
774616|NCT00005590|recurrent small cell lung cancer|recurrent small cell lung cancer
774617|NCT00005590|small intestine lymphoma|small intestine lymphoma
774618|NCT00005590|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
774619|NCT00005590|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
774620|NCT00005590|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
774621|NCT00005590|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
774622|NCT00005590|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
774623|NCT00005590|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
774624|NCT00005590|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
774625|NCT00005590|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
774626|NCT00005590|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
774627|NCT00005590|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
774628|NCT00005590|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
774629|NCT00005590|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
774630|NCT00005590|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
774631|NCT00005590|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
774632|NCT00005590|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
774633|NCT00005590|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
774634|NCT00005590|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
774635|NCT00005590|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
774636|NCT00005590|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
774637|NCT00005590|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
774638|NCT00005590|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
774639|NCT00005590|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
774640|NCT00005590|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
774641|NCT00005590|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
774642|NCT00005590|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
774643|NCT00005590|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
774644|NCT00005590|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
774645|NCT00005590|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
774646|NCT00005590|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
774647|NCT00005590|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
774648|NCT00005590|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
774649|NCT00005590|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
774650|NCT00005590|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
774651|NCT00005590|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
774652|NCT00005590|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
774653|NCT00005590|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
774654|NCT00005590|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
774655|NCT00005590|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
774656|NCT00005590|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
774657|NCT00005590|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
774658|NCT00005590|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
774659|NCT00005590|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
774660|NCT00005590|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
774661|NCT00005590|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
774662|NCT00005590|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
774663|NCT00005590|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
774664|NCT00005590|extragonadal germ cell tumor|extragonadal germ cell tumor
774665|NCT00005590|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
774666|NCT00005590|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
774667|NCT00005590|infection|infection
774668|NCT00005590|intraocular lymphoma|intraocular lymphoma
774669|NCT00005590|stage I mantle cell lymphoma|stage i mantle cell lymphoma
774670|NCT00005590|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
774671|NCT00005590|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
774672|NCT00005590|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
774673|NCT00005590|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
788453|NCT00002064|Clindamycin|clindamycin
774674|NCT00005590|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
774675|NCT00005590|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
774676|NCT00005590|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
774677|NCT00005590|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
774678|NCT00005590|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
774679|NCT00005590|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
774680|NCT00005590|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
774681|NCT00005590|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
774682|NCT00005590|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
774683|NCT00005590|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
774684|NCT00005590|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
774685|NCT00005590|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
774686|NCT00005590|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
774687|NCT00005590|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
774688|NCT00005590|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
774689|NCT00005590|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
774690|NCT00005590|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
774691|NCT00005590|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
774692|NCT00005590|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
774693|NCT00005590|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
774694|NCT00005590|anaplastic large cell lymphoma|anaplastic large cell lymphoma
774695|NCT00005590|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
774696|NCT00005590|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
774697|NCT00005590|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
774698|NCT00005590|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
774699|NCT00005590|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
774700|NCT00005590|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
774701|NCT00005590|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
774702|NCT00005590|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
774703|NCT00005590|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
774704|NCT00005590|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
774705|NCT00005590|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
774706|NCT00005590|stage I marginal zone lymphoma|stage i marginal zone lymphoma
774707|NCT00005590|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
774708|NCT00005590|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
774709|NCT00005590|stage II marginal zone lymphoma|stage ii marginal zone lymphoma
774710|NCT00005590|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
774711|NCT00005590|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
774712|NCT00005590|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
774713|NCT00005590|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
774714|NCT00005590|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
774715|NCT00005590|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
774716|NCT00005590|splenic marginal zone lymphoma|splenic marginal zone lymphoma
774717|NCT00005589|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
774718|NCT00005589|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
774719|NCT00005589|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
774720|NCT00005586|stage II colon cancer|stage ii colon cancer
774721|NCT00005586|stage III colon cancer|stage iii colon cancer
774722|NCT00005586|stage II rectal cancer|stage ii rectal cancer
774723|NCT00005586|stage III rectal cancer|stage iii rectal cancer
774724|NCT00005585|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
774725|NCT00005585|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
774726|NCT00005584|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
774727|NCT00005584|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
774728|NCT00005584|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
774729|NCT00005583|stage I endometrial carcinoma|stage i endometrial carcinoma
774730|NCT00005583|stage II endometrial carcinoma|stage ii endometrial carcinoma
774731|NCT00005583|endometrial adenocarcinoma|endometrial adenocarcinoma
774732|NCT00005583|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
774733|NCT00005583|endometrial clear cell carcinoma|endometrial clear cell carcinoma
774734|NCT00005580|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
774735|NCT00005580|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
774736|NCT00005580|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
788540|NCT00002046|Zidovudine|zidovudine
774737|NCT00005580|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
774738|NCT00005580|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
774739|NCT00005580|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
774740|NCT00005580|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
774741|NCT00005580|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
774742|NCT00005580|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
774743|NCT00005580|refractory hairy cell leukemia|refractory hairy cell leukemia
774744|NCT00005580|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
774745|NCT00005580|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
774746|NCT00005580|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
774747|NCT00005580|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
774748|NCT00005580|prolymphocytic leukemia|prolymphocytic leukemia
774749|NCT00005580|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
774750|NCT00005580|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
774751|NCT00005580|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
774752|NCT00005580|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
774753|NCT00005580|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
774754|NCT00005580|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
774755|NCT00005580|splenic marginal zone lymphoma|splenic marginal zone lymphoma
774756|NCT00005579|Waldenström macroglobulinemia|waldenström macroglobulinemia
774757|NCT00005579|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
774758|NCT00005579|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
774759|NCT00005579|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
774760|NCT00005579|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
774761|NCT00005579|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
774762|NCT00005579|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
774763|NCT00005579|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
774764|NCT00005579|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
774765|NCT00005579|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
774766|NCT00005579|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
774767|NCT00005579|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
774768|NCT00005579|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
774769|NCT00005579|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
774770|NCT00005579|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
774771|NCT00005579|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
774772|NCT00005579|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
774773|NCT00005579|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
774774|NCT00005095|ovarian epithelial cancer|ovarian epithelial cancer
774775|NCT00005095|hereditary breast/ovarian cancer (BRCA1, BRCA2)|hereditary breast/ovarian cancer (brca1, brca2)
774776|NCT00005095|fallopian tube cancer|fallopian tube cancer
774777|NCT00005095|ovarian germ cell tumor|ovarian germ cell tumor
774778|NCT00005095|ovarian sarcoma|ovarian sarcoma
774779|NCT00005095|ovarian stromal cancer|ovarian stromal cancer
774780|NCT00005095|endometrial cancer|endometrial cancer
774781|NCT00005095|uterine sarcoma|uterine sarcoma
774782|NCT00005095|vaginal cancer|vaginal cancer
774783|NCT00005095|cervical cancer|cervical cancer
774784|NCT00005095|vulvar cancer|vulvar cancer
774785|NCT00005095|uterine leiomyomata|uterine leiomyomata
774786|NCT00005087|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
774787|NCT00005087|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
774788|NCT00005087|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
774789|NCT00005087|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
774790|NCT00005087|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
774791|NCT00005087|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
774792|NCT00005087|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
774793|NCT00005087|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
774794|NCT00005087|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
774795|NCT00005087|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
774796|NCT00005087|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
774797|NCT00005087|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
774798|NCT00005087|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
774799|NCT00005087|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
774800|NCT00005087|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
774801|NCT00005087|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
774802|NCT00005087|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
774803|NCT00005087|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
774804|NCT00005087|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
774805|NCT00005087|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
774806|NCT00005087|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
774807|NCT00005087|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
774808|NCT00005079|stage I breast cancer|stage i breast cancer
774809|NCT00005079|stage II breast cancer|stage ii breast cancer
774810|NCT00005079|stage IIIA breast cancer|stage iiia breast cancer
774811|NCT00005079|stage IIIB breast cancer|stage iiib breast cancer
774812|NCT00005074|stage I mantle cell lymphoma|stage i mantle cell lymphoma
774813|NCT00005074|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
774814|NCT00005074|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
774815|NCT00005074|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
774816|NCT00005074|stage II mantle cell lymphoma|stage ii mantle cell lymphoma
774817|NCT00005062|limited stage small cell lung cancer|limited stage small cell lung cancer
774818|NCT00005060|stage II gastric cancer|stage ii gastric cancer
774819|NCT00005060|stage III gastric cancer|stage iii gastric cancer
774820|NCT00005052|stage II melanoma|stage ii melanoma
774821|NCT00005051|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
774822|NCT00005051|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
774823|NCT00005051|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
774824|NCT00005051|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
774825|NCT00005049|stage II colon cancer|stage ii colon cancer
774826|NCT00005049|stage III colon cancer|stage iii colon cancer
774827|NCT00005049|stage II gastric cancer|stage ii gastric cancer
774828|NCT00005049|stage III gastric cancer|stage iii gastric cancer
774829|NCT00005049|recurrent gastric cancer|recurrent gastric cancer
774830|NCT00005049|stage II rectal cancer|stage ii rectal cancer
774831|NCT00005049|stage III rectal cancer|stage iii rectal cancer
774832|NCT00005049|recurrent colon cancer|recurrent colon cancer
774833|NCT00005049|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
774834|NCT00005049|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
774835|NCT00005049|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
774836|NCT00005049|small intestine adenocarcinoma|small intestine adenocarcinoma
774837|NCT00005049|small intestine lymphoma|small intestine lymphoma
774838|NCT00005049|small intestine leiomyosarcoma|small intestine leiomyosarcoma
774839|NCT00005049|recurrent small intestine cancer|recurrent small intestine cancer
774840|NCT00005049|peritoneal cavity cancer|peritoneal cavity cancer
774841|NCT00005049|gastrointestinal stromal tumor|gastrointestinal stromal tumor
774842|NCT00005047|stage I bladder cancer|stage i bladder cancer
774843|NCT00005047|stage II bladder cancer|stage ii bladder cancer
774844|NCT00005047|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
774845|NCT00005044|adenocarcinoma of the prostate|adenocarcinoma of the prostate
774846|NCT00005044|stage IIB prostate cancer|stage iib prostate cancer
774847|NCT00005044|stage IIA prostate cancer|stage iia prostate cancer
774848|NCT00005044|stage III prostate cancer|stage iii prostate cancer
774849|NCT00005038|stage IV renal cell cancer|stage iv renal cell cancer
774850|NCT00005038|recurrent renal cell cancer|recurrent renal cell cancer
774851|NCT00005033|recurrent osteosarcoma|recurrent osteosarcoma
774852|NCT00004936|stage III cervical cancer|stage iii cervical cancer
774853|NCT00004936|stage IB cervical cancer|stage ib cervical cancer
774854|NCT00004936|stage IIB cervical cancer|stage iib cervical cancer
774855|NCT00004936|stage IVB cervical cancer|stage ivb cervical cancer
774856|NCT00004936|stage IIA cervical cancer|stage iia cervical cancer
774857|NCT00004936|stage IVA cervical cancer|stage iva cervical cancer
774858|NCT00004936|cervical squamous cell carcinoma|cervical squamous cell carcinoma
774859|NCT00004936|cervical adenocarcinoma|cervical adenocarcinoma
774860|NCT00004936|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
774861|NCT00004935|stage IV breast cancer|stage iv breast cancer
774862|NCT00004935|recurrent breast cancer|recurrent breast cancer
774863|NCT00004934|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
774864|NCT00004934|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
774865|NCT00004934|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
774866|NCT00004934|fallopian tube cancer|fallopian tube cancer
774867|NCT00004934|primary peritoneal cavity cancer|primary peritoneal cavity cancer
774868|NCT00004932|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
774869|NCT00004932|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
774870|NCT00004932|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
774871|NCT00004932|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
774872|NCT00004932|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
788719|NCT00002008|Leukopenia|leukopenia
774873|NCT00004930|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
774874|NCT00004930|extensive stage small cell lung cancer|extensive stage small cell lung cancer
774875|NCT00004930|recurrent small cell lung cancer|recurrent small cell lung cancer
774876|NCT00004930|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
774877|NCT00004930|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
774878|NCT00004930|lung metastases|lung metastases
774879|NCT00004930|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
774880|NCT00004924|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
774881|NCT00004924|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
774882|NCT00004921|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
774883|NCT00004921|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
774884|NCT00004920|localized malignant mesothelioma|localized malignant mesothelioma
774885|NCT00004920|advanced malignant mesothelioma|advanced malignant mesothelioma
774886|NCT00004920|recurrent malignant mesothelioma|recurrent malignant mesothelioma
774887|NCT00004917|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
774888|NCT00004917|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
774889|NCT00004917|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
774890|NCT00004917|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
774891|NCT00004917|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
774892|NCT00004917|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
774893|NCT00004917|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
774894|NCT00004917|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
774895|NCT00004917|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
774896|NCT00004917|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
774897|NCT00004917|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
774898|NCT00004917|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
774899|NCT00004917|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
774900|NCT00004917|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
774901|NCT00004917|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
774902|NCT00004917|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
774903|NCT00004917|anemia|anemia
774904|NCT00004907|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
774905|NCT00004907|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
774906|NCT00004907|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
774907|NCT00004907|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
774908|NCT00004907|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
774909|NCT00004907|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
774910|NCT00004907|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
774911|NCT00004907|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
774912|NCT00004907|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
774913|NCT00004907|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
774914|NCT00004907|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
774915|NCT00004907|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
774916|NCT00004907|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
774917|NCT00004907|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
774918|NCT00004907|splenic marginal zone lymphoma|splenic marginal zone lymphoma
774919|NCT00004899|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
774920|NCT00004899|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
774921|NCT00004899|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
774922|NCT00004899|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
774923|NCT00004899|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
774924|NCT00004899|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
774925|NCT00004899|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
774926|NCT00004899|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
774927|NCT00004899|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
774928|NCT00004899|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
774929|NCT00004899|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
774930|NCT00004899|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
774931|NCT00004899|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
774932|NCT00004899|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
774933|NCT00004899|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
774934|NCT00004899|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
774935|NCT00004899|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
774936|NCT00004899|secondary acute myeloid leukemia|secondary acute myeloid leukemia
774937|NCT00004899|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
774938|NCT00004899|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
774939|NCT00004899|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
774940|NCT00004899|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
774941|NCT00004899|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
774942|NCT00004899|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
774943|NCT00004899|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
774944|NCT00004899|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
774945|NCT00004899|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
774946|NCT00004899|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
774947|NCT00004896|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
774948|NCT00004896|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
774949|NCT00004896|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
774950|NCT00004896|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
774951|NCT00004896|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
774952|NCT00004896|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
774953|NCT00004896|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
774954|NCT00004896|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
774955|NCT00004896|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
774956|NCT00004896|refractory anemia|refractory anemia
774957|NCT00004896|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
774958|NCT00004896|refractory anemia with excess blasts|refractory anemia with excess blasts
774959|NCT00004896|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
774960|NCT00004896|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
774961|NCT00004896|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
774962|NCT00004896|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
774963|NCT00004896|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
774964|NCT00004896|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
774965|NCT00004896|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
774966|NCT00004896|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
774967|NCT00004896|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
774968|NCT00004896|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
774969|NCT00004896|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
774970|NCT00004896|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
774971|NCT00004891|stage II rectal cancer|stage ii rectal cancer
774972|NCT00004891|stage III rectal cancer|stage iii rectal cancer
774973|NCT00004891|stage IV rectal cancer|stage iv rectal cancer
774974|NCT00004879|recurrent renal cell cancer|recurrent renal cell cancer
774975|NCT00004879|recurrent prostate cancer|recurrent prostate cancer
774976|NCT00004879|recurrent colon cancer|recurrent colon cancer
774977|NCT00004879|recurrent rectal cancer|recurrent rectal cancer
774978|NCT00004879|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
774979|NCT00004879|recurrent pancreatic cancer|recurrent pancreatic cancer
774980|NCT00004879|recurrent esophageal cancer|recurrent esophageal cancer
774981|NCT00004876|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
774982|NCT00004876|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
774983|NCT00004876|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
774984|NCT00004876|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
774985|NCT00004876|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
774986|NCT00004876|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
774987|NCT00004876|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
774988|NCT00004876|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
774989|NCT00004873|stage III gastric cancer|stage iii gastric cancer
774990|NCT00004873|stage IV gastric cancer|stage iv gastric cancer
774991|NCT00004873|recurrent gastric cancer|recurrent gastric cancer
774992|NCT00004871|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
774993|NCT00004871|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
774994|NCT00004871|refractory anemia|refractory anemia
774995|NCT00004871|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
774996|NCT00004871|refractory anemia with excess blasts|refractory anemia with excess blasts
774997|NCT00004871|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
774998|NCT00004871|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
789289|NCT00001058|Rifabutin|rifabutin
774999|NCT00004871|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
775000|NCT00004871|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
775001|NCT00004871|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
775002|NCT00004871|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
775003|NCT00004871|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
775004|NCT00004867|stage I esophageal cancer|stage i esophageal cancer
775005|NCT00004867|stage II esophageal cancer|stage ii esophageal cancer
775006|NCT00004867|stage III esophageal cancer|stage iii esophageal cancer
775007|NCT00004867|stage IV esophageal cancer|stage iv esophageal cancer
775008|NCT00004867|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
775009|NCT00004867|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
775010|NCT00004866|stage III cervical cancer|stage iii cervical cancer
775011|NCT00004866|stage IV cervical cancer|stage iv cervical cancer
775012|NCT00004866|recurrent cervical cancer|recurrent cervical cancer
775013|NCT00004866|cervical squamous cell carcinoma|cervical squamous cell carcinoma
775014|NCT00004859|squamous cell lung cancer|squamous cell lung cancer
775015|NCT00004859|large cell lung cancer|large cell lung cancer
775016|NCT00004859|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
775017|NCT00004859|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
775018|NCT00004859|adenocarcinoma of the lung|adenocarcinoma of the lung
775019|NCT00004859|adenosquamous cell lung cancer|adenosquamous cell lung cancer
775020|NCT00004859|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
775021|NCT00004259|adult anaplastic astrocytoma|adult anaplastic astrocytoma
775022|NCT00004259|adult mixed glioma|adult mixed glioma
775023|NCT00004250|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
775024|NCT00004250|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
775025|NCT00004250|stage III melanoma|stage iii melanoma
775026|NCT00004250|stage IV melanoma|stage iv melanoma
775027|NCT00004250|recurrent melanoma|recurrent melanoma
775028|NCT00004250|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
775029|NCT00004245|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
775030|NCT00004245|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
775031|NCT00004245|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
775032|NCT00004245|refractory anemia with excess blasts|refractory anemia with excess blasts
775033|NCT00004245|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
775034|NCT00004245|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
775035|NCT00004245|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
775036|NCT00004245|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
775037|NCT00004245|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
775038|NCT00004245|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
775039|NCT00004245|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
775040|NCT00004245|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
775041|NCT00004245|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
775042|NCT00004245|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
775043|NCT00004244|stage IV renal cell cancer|stage iv renal cell cancer
775044|NCT00004244|recurrent renal cell cancer|recurrent renal cell cancer
775045|NCT00004244|stage IV melanoma|stage iv melanoma
775046|NCT00004244|recurrent melanoma|recurrent melanoma
775047|NCT00004237|stage I breast cancer|stage i breast cancer
775048|NCT00004237|stage II breast cancer|stage ii breast cancer
775049|NCT00004234|oral complications|oral complications
775050|NCT00004234|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
775051|NCT00004234|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
775052|NCT00004234|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
775053|NCT00004234|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
775054|NCT00004234|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
775055|NCT00004234|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
775056|NCT00004234|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
775057|NCT00004234|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
775058|NCT00004234|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
775059|NCT00004234|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
775060|NCT00004234|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
775061|NCT00004234|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
775062|NCT00004234|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
775063|NCT00004234|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
775262|NCT00004141|stage III melanoma|stage iii melanoma
775064|NCT00004234|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
775065|NCT00004234|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
775066|NCT00004234|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
775067|NCT00004234|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
775068|NCT00004234|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
775069|NCT00004234|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
775070|NCT00004234|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
775071|NCT00004234|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
775072|NCT00004234|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
775073|NCT00004234|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
775074|NCT00004234|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
775075|NCT00004231|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
775076|NCT00004231|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
775077|NCT00004231|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
775078|NCT00004228|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
775079|NCT00004228|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
775080|NCT00004227|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
775081|NCT00004227|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
775082|NCT00004227|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
775083|NCT00004227|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
775084|NCT00004227|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
775085|NCT00004227|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
775086|NCT00004227|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
775087|NCT00004227|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
775088|NCT00004227|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
775089|NCT00004226|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
775090|NCT00004226|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
775091|NCT00004226|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
775092|NCT00004226|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
775093|NCT00004226|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
775094|NCT00004226|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
775095|NCT00004225|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
775096|NCT00004224|childhood infratentorial ependymoma|childhood infratentorial ependymoma
775097|NCT00004224|childhood supratentorial ependymoma|childhood supratentorial ependymoma
775098|NCT00004224|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
775099|NCT00004218|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
775100|NCT00004218|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
775101|NCT00004218|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
775102|NCT00004218|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
775103|NCT00004218|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
775104|NCT00004212|childhood infratentorial ependymoma|childhood infratentorial ependymoma
775105|NCT00004212|childhood supratentorial ependymoma|childhood supratentorial ependymoma
775106|NCT00004212|childhood craniopharyngioma|childhood craniopharyngioma
775107|NCT00004212|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
775108|NCT00004212|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
775109|NCT00004212|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
775110|NCT00004212|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
775111|NCT00004212|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
775112|NCT00004212|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
775113|NCT00004212|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
775114|NCT00004212|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
775115|NCT00004212|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
775116|NCT00004212|childhood oligodendroglioma|childhood oligodendroglioma
775117|NCT00004212|childhood choroid plexus tumor|childhood choroid plexus tumor
775118|NCT00004212|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
775119|NCT00004212|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
775120|NCT00004212|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
775121|NCT00004212|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
775122|NCT00004212|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
775123|NCT00004212|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
775124|NCT00004212|untreated childhood brain stem glioma|untreated childhood brain stem glioma
775125|NCT00004212|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
775126|NCT00004212|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
775127|NCT00004212|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
775128|NCT00004212|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
775129|NCT00004212|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
775130|NCT00004212|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
775131|NCT00004212|untreated childhood medulloblastoma|untreated childhood medulloblastoma
775132|NCT00004212|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
775133|NCT00004212|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
775134|NCT00004212|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
775135|NCT00004212|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
775136|NCT00004212|recurrent childhood ependymoma|recurrent childhood ependymoma
775137|NCT00004210|colon cancer|colon cancer
775138|NCT00004210|rectal cancer|rectal cancer
775139|NCT00004208|refractory anemia|refractory anemia
775140|NCT00004208|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
775141|NCT00004208|refractory anemia with excess blasts|refractory anemia with excess blasts
775142|NCT00004208|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
775143|NCT00004208|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
775144|NCT00004208|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
775145|NCT00004205|stage I breast cancer|stage i breast cancer
775146|NCT00004205|stage II breast cancer|stage ii breast cancer
775147|NCT00004205|stage IIIA breast cancer|stage iiia breast cancer
775148|NCT00004205|breast cancer in situ|breast cancer in situ
775149|NCT00004205|recurrent breast cancer|recurrent breast cancer
775150|NCT00004205|ductal breast carcinoma|ductal breast carcinoma
775151|NCT00004205|lobular breast carcinoma in situ|lobular breast carcinoma in situ
775152|NCT00004196|stage I melanoma|stage i melanoma
775153|NCT00004196|stage II melanoma|stage ii melanoma
775154|NCT00004196|stage III melanoma|stage iii melanoma
775155|NCT00004189|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
775156|NCT00004189|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
775157|NCT00004189|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
775158|NCT00004189|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
775159|NCT00004189|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
775160|NCT00004189|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
775161|NCT00004189|small intestine lymphoma|small intestine lymphoma
775162|NCT00004189|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
775163|NCT00004189|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
775164|NCT00004189|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
775165|NCT00004189|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
775166|NCT00004189|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
775167|NCT00004189|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
775168|NCT00004189|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
775169|NCT00004189|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
775170|NCT00004189|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
775171|NCT00004189|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
775172|NCT00004189|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
775173|NCT00004189|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
775174|NCT00004189|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
775175|NCT00004189|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
775176|NCT00004189|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
775177|NCT00004189|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
775178|NCT00004189|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
775179|NCT00004189|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
775180|NCT00004189|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
775181|NCT00004189|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
775182|NCT00004189|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
775183|NCT00004189|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
775184|NCT00004189|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
775185|NCT00004189|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
775186|NCT00004189|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
775187|NCT00004189|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
775188|NCT00004189|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
775189|NCT00004189|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
775190|NCT00004189|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
775191|NCT00004189|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
775192|NCT00004189|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
775193|NCT00004189|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
775194|NCT00004189|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
775195|NCT00004189|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
775196|NCT00004189|intraocular lymphoma|intraocular lymphoma
775197|NCT00004189|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
775198|NCT00004189|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
775199|NCT00004189|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
775200|NCT00004189|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
775201|NCT00004189|anaplastic large cell lymphoma|anaplastic large cell lymphoma
775202|NCT00004189|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
775203|NCT00004189|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
775204|NCT00004189|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
775205|NCT00004189|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
775206|NCT00004189|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
775207|NCT00004189|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
775208|NCT00004189|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
775209|NCT00004189|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
775210|NCT00004189|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
775211|NCT00004189|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
775212|NCT00004189|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
775213|NCT00004189|splenic marginal zone lymphoma|splenic marginal zone lymphoma
775214|NCT00004188|localized resectable neuroblastoma|localized resectable neuroblastoma
775215|NCT00004188|regional neuroblastoma|regional neuroblastoma
775216|NCT00004188|disseminated neuroblastoma|disseminated neuroblastoma
775217|NCT00004188|stage 4S neuroblastoma|stage 4s neuroblastoma
775218|NCT00004188|localized unresectable neuroblastoma|localized unresectable neuroblastoma
775219|NCT00004181|refractory multiple myeloma|refractory multiple myeloma
775220|NCT00004181|stage I multiple myeloma|stage i multiple myeloma
775221|NCT00004181|stage II multiple myeloma|stage ii multiple myeloma
775222|NCT00004181|stage III multiple myeloma|stage iii multiple myeloma
775223|NCT00004181|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
775224|NCT00004181|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
775225|NCT00004181|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
775226|NCT00004179|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
775227|NCT00004179|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
775228|NCT00004179|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
775229|NCT00004179|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
775230|NCT00004179|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
775231|NCT00004179|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
775232|NCT00004179|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
775233|NCT00004179|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
775234|NCT00004179|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
775235|NCT00004173|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
775236|NCT00004165|refractory multiple myeloma|refractory multiple myeloma
775237|NCT00004165|stage I multiple myeloma|stage i multiple myeloma
775238|NCT00004165|stage II multiple myeloma|stage ii multiple myeloma
775239|NCT00004165|stage III multiple myeloma|stage iii multiple myeloma
775240|NCT00004165|primary systemic amyloidosis|primary systemic amyloidosis
775241|NCT00004154|stage 0 bladder cancer|stage 0 bladder cancer
775242|NCT00004154|stage I bladder cancer|stage i bladder cancer
775243|NCT00004154|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
775244|NCT00004153|stage I melanoma|stage i melanoma
775245|NCT00004153|stage II melanoma|stage ii melanoma
775246|NCT00004153|stage III melanoma|stage iii melanoma
775247|NCT00004153|stage IV melanoma|stage iv melanoma
775248|NCT00004150|stage III colon cancer|stage iii colon cancer
775249|NCT00004150|adenocarcinoma of the colon|adenocarcinoma of the colon
775250|NCT00004150|mucinous adenocarcinoma of the colon|mucinous adenocarcinoma of the colon
775251|NCT00004149|stage IV prostate cancer|stage iv prostate cancer
775252|NCT00004149|recurrent prostate cancer|recurrent prostate cancer
775253|NCT00004147|recurrent adult brain tumor|recurrent adult brain tumor
775254|NCT00004147|adult glioblastoma|adult glioblastoma
775255|NCT00004147|adult anaplastic astrocytoma|adult anaplastic astrocytoma
775256|NCT00004147|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
775257|NCT00004147|adult giant cell glioblastoma|adult giant cell glioblastoma
775258|NCT00004147|adult gliosarcoma|adult gliosarcoma
775259|NCT00004144|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
775260|NCT00004143|sickle cell anemia|sickle cell anemia
775261|NCT00004143|severe aplastic anemia|severe aplastic anemia
775263|NCT00004141|stage IV melanoma|stage iv melanoma
775264|NCT00004141|recurrent melanoma|recurrent melanoma
775265|NCT00004138|stage I non-small cell lung cancer|stage i non-small cell lung cancer
775266|NCT00004138|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
775267|NCT00004138|squamous cell lung cancer|squamous cell lung cancer
775268|NCT00004138|large cell lung cancer|large cell lung cancer
775269|NCT00004138|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
775270|NCT00004138|adenocarcinoma of the lung|adenocarcinoma of the lung
775271|NCT00004138|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
775272|NCT00004135|stage IV renal cell cancer|stage iv renal cell cancer
775273|NCT00004135|recurrent renal cell cancer|recurrent renal cell cancer
775274|NCT00004135|stage IV melanoma|stage iv melanoma
775275|NCT00004135|recurrent melanoma|recurrent melanoma
775276|NCT00004129|recurrent adult brain tumor|recurrent adult brain tumor
775277|NCT00004129|adult glioblastoma|adult glioblastoma
775278|NCT00004129|adult giant cell glioblastoma|adult giant cell glioblastoma
775279|NCT00004129|adult gliosarcoma|adult gliosarcoma
775280|NCT00004128|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
775281|NCT00004128|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
775282|NCT00004128|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
775283|NCT00004128|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
775284|NCT00004128|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
775285|NCT00004128|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
775286|NCT00004128|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
775287|NCT00004128|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
775288|NCT00004128|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
775289|NCT00004128|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
775290|NCT00004128|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
775291|NCT00004128|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
775292|NCT00004128|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
775293|NCT00004124|adenocarcinoma of the prostate|adenocarcinoma of the prostate
775294|NCT00004124|stage I prostate cancer|stage i prostate cancer
775295|NCT00004124|stage II prostate cancer|stage ii prostate cancer
775296|NCT00004124|stage III prostate cancer|stage iii prostate cancer
775297|NCT00004115|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
775298|NCT00004115|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
775299|NCT00004115|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
775300|NCT00004115|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
775301|NCT00004115|primary peritoneal cavity cancer|primary peritoneal cavity cancer
775302|NCT00004110|regional neuroblastoma|regional neuroblastoma
775303|NCT00004110|disseminated neuroblastoma|disseminated neuroblastoma
775304|NCT00004110|recurrent neuroblastoma|recurrent neuroblastoma
775305|NCT00004110|localized unresectable neuroblastoma|localized unresectable neuroblastoma
775306|NCT00004106|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
775307|NCT00004106|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
775308|NCT00004106|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
775309|NCT00004106|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
775310|NCT00004106|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
775311|NCT00004106|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
775312|NCT00004106|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
775313|NCT00004106|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
775314|NCT00004106|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
775315|NCT00004106|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
775316|NCT00004103|stage I gastric cancer|stage i gastric cancer
775317|NCT00004103|stage II gastric cancer|stage ii gastric cancer
775318|NCT00004103|stage III gastric cancer|stage iii gastric cancer
775319|NCT00004103|stage IV gastric cancer|stage iv gastric cancer
775320|NCT00004099|stage II gastric cancer|stage ii gastric cancer
775321|NCT00004099|stage III gastric cancer|stage iii gastric cancer
775322|NCT00004099|stage IV gastric cancer|stage iv gastric cancer
775323|NCT00004099|intestinal adenocarcinoma of the stomach|intestinal adenocarcinoma of the stomach
775324|NCT00004099|diffuse adenocarcinoma of the stomach|diffuse adenocarcinoma of the stomach
775325|NCT00004099|mixed adenocarcinoma of the stomach|mixed adenocarcinoma of the stomach
775326|NCT00004092|stage II breast cancer|stage ii breast cancer
775327|NCT00004092|stage IIIA breast cancer|stage iiia breast cancer
775328|NCT00004092|stage IIIB breast cancer|stage iiib breast cancer
775329|NCT00004088|stage I multiple myeloma|stage i multiple myeloma
775330|NCT00004088|stage II multiple myeloma|stage ii multiple myeloma
775331|NCT00004088|stage III multiple myeloma|stage iii multiple myeloma
775332|NCT00004081|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
775333|NCT00004081|peritoneal cavity cancer|peritoneal cavity cancer
775334|NCT00004077|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
775335|NCT00004077|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
775336|NCT00004077|testicular embryonal carcinoma|testicular embryonal carcinoma
775337|NCT00004077|testicular choriocarcinoma|testicular choriocarcinoma
775338|NCT00004077|testicular teratoma|testicular teratoma
775339|NCT00004077|testicular yolk sac tumor|testicular yolk sac tumor
775340|NCT00004077|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
775341|NCT00004077|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
775342|NCT00004077|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
775343|NCT00004077|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
775344|NCT00004077|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
775345|NCT00004077|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
775346|NCT00004075|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
775347|NCT00004075|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
775348|NCT00004075|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
775349|NCT00004075|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
775350|NCT00004075|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
775351|NCT00004075|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
775352|NCT00004075|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
775353|NCT00004075|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
775354|NCT00004075|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
775355|NCT00004075|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
775356|NCT00004075|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
775357|NCT00004075|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
775358|NCT00004075|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
775359|NCT00004075|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
775360|NCT00004075|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
775361|NCT00004075|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
775362|NCT00004075|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
775363|NCT00004075|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
775364|NCT00004075|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
775365|NCT00004075|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
775366|NCT00004075|splenic marginal zone lymphoma|splenic marginal zone lymphoma
775367|NCT00004072|refractory multiple myeloma|refractory multiple myeloma
775368|NCT00004072|stage I multiple myeloma|stage i multiple myeloma
775369|NCT00004072|stage II multiple myeloma|stage ii multiple myeloma
775370|NCT00004072|stage III multiple myeloma|stage iii multiple myeloma
775371|NCT00004067|stage II breast cancer|stage ii breast cancer
775372|NCT00004067|stage IIIA breast cancer|stage iiia breast cancer
775373|NCT00004066|adult leiomyosarcoma|adult leiomyosarcoma
775374|NCT00004066|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
775375|NCT00004066|small intestine leiomyosarcoma|small intestine leiomyosarcoma
775376|NCT00004066|stage IV uterine sarcoma|stage iv uterine sarcoma
775377|NCT00004066|recurrent uterine sarcoma|recurrent uterine sarcoma
775378|NCT00004066|uterine leiomyosarcoma|uterine leiomyosarcoma
775379|NCT00004066|ovarian sarcoma|ovarian sarcoma
775380|NCT00004066|recurrent small intestine cancer|recurrent small intestine cancer
775381|NCT00004066|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
775382|NCT00004065|stage III colon cancer|stage iii colon cancer
775383|NCT00004065|stage IV colon cancer|stage iv colon cancer
775384|NCT00004065|stage IV breast cancer|stage iv breast cancer
775385|NCT00004065|stage IIIA breast cancer|stage iiia breast cancer
775387|NCT00004065|stage III gastric cancer|stage iii gastric cancer
775388|NCT00004065|stage IV gastric cancer|stage iv gastric cancer
775389|NCT00004065|recurrent gastric cancer|recurrent gastric cancer
775390|NCT00004065|stage IIIB breast cancer|stage iiib breast cancer
775391|NCT00004065|stage IIIC breast cancer|stage iiic breast cancer
775392|NCT00004065|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
775393|NCT00004065|recurrent colon cancer|recurrent colon cancer
775394|NCT00004065|stage III renal cell cancer|stage iii renal cell cancer
775395|NCT00004065|stage IV renal cell cancer|stage iv renal cell cancer
775396|NCT00004065|recurrent renal cell cancer|recurrent renal cell cancer
775397|NCT00004065|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
775398|NCT00004065|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
775399|NCT00004065|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
775400|NCT00004065|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
775401|NCT00004065|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
775402|NCT00004065|stage III bladder cancer|stage iii bladder cancer
775403|NCT00004065|recurrent bladder cancer|recurrent bladder cancer
775404|NCT00004065|stage IV bladder cancer|stage iv bladder cancer
775405|NCT00004065|stage III prostate cancer|stage iii prostate cancer
775406|NCT00004065|stage IV prostate cancer|stage iv prostate cancer
775407|NCT00004065|recurrent prostate cancer|recurrent prostate cancer
775408|NCT00004065|stage III melanoma|stage iii melanoma
775409|NCT00004065|stage IV melanoma|stage iv melanoma
775410|NCT00004065|recurrent melanoma|recurrent melanoma
775411|NCT00004065|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
775412|NCT00004065|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
775413|NCT00004065|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
775414|NCT00004065|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
775415|NCT00004065|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
775416|NCT00004065|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
775417|NCT00004065|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
775418|NCT00004065|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
775419|NCT00004065|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
775420|NCT00004065|ovarian stromal cancer|ovarian stromal cancer
775421|NCT00004065|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
775422|NCT00004065|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
775423|NCT00004065|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
775424|NCT00004065|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
775425|NCT00004065|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
775426|NCT00004065|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
775427|NCT00004065|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
775428|NCT00004065|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
775429|NCT00004065|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
775430|NCT00004065|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
775431|NCT00004065|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
775432|NCT00004065|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
775433|NCT00004065|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
775434|NCT00004065|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
775435|NCT00004065|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
775436|NCT00004065|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
775437|NCT00004065|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
775438|NCT00004065|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
775439|NCT00004065|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
775440|NCT00004065|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
775441|NCT00004065|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
775442|NCT00004065|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
775443|NCT00004065|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
775444|NCT00004065|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
775445|NCT00004065|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
775446|NCT00004065|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
775447|NCT00004065|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
775448|NCT00004065|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
775449|NCT00004065|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
775450|NCT00004065|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
775451|NCT00004065|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
775452|NCT00004065|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
775453|NCT00004065|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
775454|NCT00004065|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
775455|NCT00004065|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
775456|NCT00004065|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
775457|NCT00004065|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
775458|NCT00004065|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
775459|NCT00004065|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
775460|NCT00004065|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
775461|NCT00004065|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
775462|NCT00004065|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
776058|NCT00003838|Myeloproliferative Disease|myeloproliferative disease
775463|NCT00004065|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
775464|NCT00004065|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
775465|NCT00004065|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
775466|NCT00004065|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
775467|NCT00004065|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
775468|NCT00004065|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
775469|NCT00004065|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
775470|NCT00004065|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
775471|NCT00004065|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
775472|NCT00004065|ovarian sarcoma|ovarian sarcoma
775473|NCT00004065|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
775474|NCT00004065|recurrent salivary gland cancer|recurrent salivary gland cancer
775475|NCT00004065|stage IV salivary gland cancer|stage iv salivary gland cancer
775476|NCT00004065|stage III salivary gland cancer|stage iii salivary gland cancer
775477|NCT00004063|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
775478|NCT00004058|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
775479|NCT00004058|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
775480|NCT00004058|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
775481|NCT00004058|isolated plasmacytoma of bone|isolated plasmacytoma of bone
775482|NCT00004058|extramedullary plasmacytoma|extramedullary plasmacytoma
775483|NCT00004058|refractory multiple myeloma|refractory multiple myeloma
775484|NCT00004058|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
775485|NCT00004058|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
775486|NCT00004058|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
775487|NCT00004058|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
775488|NCT00004058|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
775489|NCT00004058|polycythemia vera|polycythemia vera
775490|NCT00004058|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
775491|NCT00004058|essential thrombocythemia|essential thrombocythemia
775492|NCT00004058|refractory hairy cell leukemia|refractory hairy cell leukemia
775493|NCT00004058|refractory anemia|refractory anemia
775494|NCT00004058|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
775495|NCT00004058|refractory anemia with excess blasts|refractory anemia with excess blasts
775496|NCT00004058|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
775497|NCT00004058|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
775498|NCT00004058|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
775499|NCT00004058|acute undifferentiated leukemia|acute undifferentiated leukemia
775500|NCT00004058|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
775501|NCT00004058|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
775502|NCT00004058|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
775503|NCT00004058|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
775504|NCT00004058|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
775505|NCT00004058|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
775506|NCT00004058|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
775507|NCT00004058|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
775508|NCT00004058|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
775509|NCT00004058|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
775510|NCT00004058|secondary acute myeloid leukemia|secondary acute myeloid leukemia
775511|NCT00004058|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
775512|NCT00004058|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
775513|NCT00004058|primary central nervous system lymphoma|primary central nervous system lymphoma
775514|NCT00004058|prolymphocytic leukemia|prolymphocytic leukemia
775515|NCT00004058|primary systemic amyloidosis|primary systemic amyloidosis
775516|NCT00004058|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
775517|NCT00004058|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
775518|NCT00004058|anaplastic large cell lymphoma|anaplastic large cell lymphoma
775519|NCT00004058|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
775520|NCT00004058|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
775521|NCT00004058|chronic eosinophilic leukemia|chronic eosinophilic leukemia
775522|NCT00004058|chronic neutrophilic leukemia|chronic neutrophilic leukemia
775523|NCT00004058|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
775524|NCT00004058|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
776460|NCT00003641|stage II melanoma|stage ii melanoma
775525|NCT00004058|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
775526|NCT00004058|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
775527|NCT00004058|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
775528|NCT00004058|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
775529|NCT00004058|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
775530|NCT00004054|stage IIB prostate cancer|stage iib prostate cancer
775531|NCT00004054|stage IIA prostate cancer|stage iia prostate cancer
775532|NCT00004054|stage III prostate cancer|stage iii prostate cancer
775533|NCT00004054|stage IV prostate cancer|stage iv prostate cancer
775534|NCT00004031|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
775535|NCT00004031|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
775536|NCT00004031|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
775537|NCT00004031|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
775538|NCT00004031|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
775539|NCT00004031|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
775540|NCT00004031|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
775541|NCT00004031|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
775542|NCT00004031|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
775543|NCT00004031|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
775544|NCT00004031|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
775545|NCT00004031|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
775546|NCT00004031|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
775547|NCT00004031|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
775548|NCT00004031|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
775549|NCT00004031|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
775550|NCT00004031|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
775551|NCT00004031|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
775552|NCT00004031|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
775553|NCT00004031|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
775554|NCT00004031|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
775555|NCT00004031|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
775556|NCT00004031|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
775557|NCT00004031|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
775558|NCT00004028|recurrent adult brain tumor|recurrent adult brain tumor
775559|NCT00004028|adult glioblastoma|adult glioblastoma
775560|NCT00004028|adult anaplastic astrocytoma|adult anaplastic astrocytoma
775561|NCT00004028|adult anaplastic ependymoma|adult anaplastic ependymoma
775562|NCT00004028|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
775563|NCT00004028|adult mixed glioma|adult mixed glioma
775564|NCT00004028|adult ependymoblastoma|adult ependymoblastoma
775565|NCT00004028|adult giant cell glioblastoma|adult giant cell glioblastoma
775566|NCT00004028|adult gliosarcoma|adult gliosarcoma
775567|NCT00004024|recurrent adult brain tumor|recurrent adult brain tumor
775568|NCT00004024|adult glioblastoma|adult glioblastoma
775569|NCT00004024|adult anaplastic astrocytoma|adult anaplastic astrocytoma
775570|NCT00004024|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
775571|NCT00004024|adult subependymoma|adult subependymoma
775572|NCT00004024|adult oligodendroglioma|adult oligodendroglioma
775573|NCT00004024|adult giant cell glioblastoma|adult giant cell glioblastoma
775574|NCT00004024|adult gliosarcoma|adult gliosarcoma
775575|NCT00004024|adult diffuse astrocytoma|adult diffuse astrocytoma
775576|NCT00004017|recurrent adult brain tumor|recurrent adult brain tumor
775577|NCT00004017|adult glioblastoma|adult glioblastoma
775578|NCT00004017|adult anaplastic astrocytoma|adult anaplastic astrocytoma
775579|NCT00004017|adult giant cell glioblastoma|adult giant cell glioblastoma
775580|NCT00004017|adult gliosarcoma|adult gliosarcoma
775581|NCT00004015|adult glioblastoma|adult glioblastoma
775582|NCT00004015|adult giant cell glioblastoma|adult giant cell glioblastoma
775583|NCT00004015|adult gliosarcoma|adult gliosarcoma
775584|NCT00004011|stage I non-small cell lung cancer|stage i non-small cell lung cancer
775585|NCT00004011|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
775586|NCT00004011|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
775587|NCT00004005|stage III colon cancer|stage iii colon cancer
775588|NCT00004005|stage IV colon cancer|stage iv colon cancer
775589|NCT00004005|stage III rectal cancer|stage iii rectal cancer
775590|NCT00004005|stage IV rectal cancer|stage iv rectal cancer
775591|NCT00004005|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
775658|NCT00003963|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
775592|NCT00004005|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
775593|NCT00004005|adenocarcinoma of unknown primary|adenocarcinoma of unknown primary
775594|NCT00004005|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
775595|NCT00004005|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
775596|NCT00004001|adenocarcinoma of the prostate|adenocarcinoma of the prostate
775597|NCT00004001|stage IV prostate cancer|stage iv prostate cancer
775598|NCT00004001|recurrent prostate cancer|recurrent prostate cancer
775599|NCT00003993|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
775600|NCT00003993|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
775601|NCT00003993|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
775602|NCT00003993|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
775603|NCT00003993|small intestine lymphoma|small intestine lymphoma
775604|NCT00003993|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
775605|NCT00003993|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
775606|NCT00003993|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
775607|NCT00003993|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
775608|NCT00003993|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
775609|NCT00003993|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
775610|NCT00003993|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
775611|NCT00003993|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
775612|NCT00003993|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
775613|NCT00003993|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
775614|NCT00003993|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
775615|NCT00003993|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
775616|NCT00003993|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
775617|NCT00003993|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
775618|NCT00003993|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
775619|NCT00003993|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
775620|NCT00003993|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
775621|NCT00003993|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
775622|NCT00003993|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
775623|NCT00003993|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
775624|NCT00003993|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
775625|NCT00003993|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
775626|NCT00003993|intraocular lymphoma|intraocular lymphoma
775627|NCT00003993|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
775628|NCT00003993|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
775629|NCT00003993|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
775630|NCT00003993|anaplastic large cell lymphoma|anaplastic large cell lymphoma
775631|NCT00003993|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
775632|NCT00003993|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
775633|NCT00003993|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
775634|NCT00003993|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
775635|NCT00003993|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
775636|NCT00003993|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
775637|NCT00003993|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
775638|NCT00003993|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
775639|NCT00003993|splenic marginal zone lymphoma|splenic marginal zone lymphoma
775640|NCT00003981|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
775641|NCT00003979|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
775642|NCT00003977|stage III cervical cancer|stage iii cervical cancer
775643|NCT00003977|recurrent cervical cancer|recurrent cervical cancer
775644|NCT00003977|stage IB cervical cancer|stage ib cervical cancer
775645|NCT00003977|stage IIB cervical cancer|stage iib cervical cancer
775646|NCT00003977|stage IVB cervical cancer|stage ivb cervical cancer
775647|NCT00003977|stage IA cervical cancer|stage ia cervical cancer
775648|NCT00003977|stage IIA cervical cancer|stage iia cervical cancer
775649|NCT00003977|stage IVA cervical cancer|stage iva cervical cancer
775650|NCT00003969|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
775651|NCT00003966|veno-occlusive disease|veno-occlusive disease
775652|NCT00003963|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
775653|NCT00003963|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
775654|NCT00003963|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
775655|NCT00003963|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
775656|NCT00003963|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
775657|NCT00003963|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
775659|NCT00003963|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
775660|NCT00003963|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
775661|NCT00003963|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
775662|NCT00003963|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
775663|NCT00003963|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
775664|NCT00003963|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
775665|NCT00003963|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
778480|NCT00051831|Virus Replication|virus replication
775666|NCT00003963|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
775667|NCT00003963|splenic marginal zone lymphoma|splenic marginal zone lymphoma
775668|NCT00003961|refractory anemia with excess blasts|refractory anemia with excess blasts
775669|NCT00003961|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
775670|NCT00003961|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
775671|NCT00003961|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
775672|NCT00003961|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
775673|NCT00003961|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
775674|NCT00003961|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
775675|NCT00003961|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
775676|NCT00003961|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
775677|NCT00003955|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
775678|NCT00003955|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
775679|NCT00003955|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
775680|NCT00003955|childhood malignant mesenchymoma|childhood malignant mesenchymoma
775681|NCT00003955|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
775682|NCT00003955|adult rhabdomyosarcoma|adult rhabdomyosarcoma
775683|NCT00003955|adult malignant mesenchymoma|adult malignant mesenchymoma
775684|NCT00003955|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
775685|NCT00003945|recurrent cervical cancer|recurrent cervical cancer
775686|NCT00003945|stage IVB cervical cancer|stage ivb cervical cancer
775687|NCT00003945|cervical squamous cell carcinoma|cervical squamous cell carcinoma
775688|NCT00003945|cervical adenocarcinoma|cervical adenocarcinoma
775689|NCT00003945|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
775690|NCT00003941|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
775691|NCT00003941|mediastinal cancer|mediastinal cancer
775692|NCT00003941|testicular embryonal carcinoma|testicular embryonal carcinoma
775693|NCT00003941|testicular choriocarcinoma|testicular choriocarcinoma
775694|NCT00003941|testicular teratoma|testicular teratoma
775695|NCT00003941|testicular yolk sac tumor|testicular yolk sac tumor
775696|NCT00003941|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
775697|NCT00003941|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
775698|NCT00003941|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
775699|NCT00003941|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
775700|NCT00003941|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
775701|NCT00003941|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
775702|NCT00003941|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
775703|NCT00003941|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
775704|NCT00003941|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
775705|NCT00003941|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
775706|NCT00003941|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
775707|NCT00003941|tumors metastatic to brain|tumors metastatic to brain
775708|NCT00003941|liver metastases|liver metastases
775709|NCT00003941|bone metastases|bone metastases
775710|NCT00003938|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
775711|NCT00003938|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
775712|NCT00003938|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
775713|NCT00003938|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
775714|NCT00003938|stage IV breast cancer|stage iv breast cancer
775715|NCT00003938|stage IIIA breast cancer|stage iiia breast cancer
775716|NCT00003938|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
775717|NCT00003938|stage IIIB breast cancer|stage iiib breast cancer
775718|NCT00003938|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
775719|NCT00003938|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
775720|NCT00003938|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
775721|NCT00003938|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
775722|NCT00003938|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
775723|NCT00003938|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
776461|NCT00003641|stage III melanoma|stage iii melanoma
775724|NCT00003938|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
775725|NCT00003938|isolated plasmacytoma of bone|isolated plasmacytoma of bone
775726|NCT00003938|extramedullary plasmacytoma|extramedullary plasmacytoma
775727|NCT00003938|refractory multiple myeloma|refractory multiple myeloma
775728|NCT00003938|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
775729|NCT00003938|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
775730|NCT00003938|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
775731|NCT00003938|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
775732|NCT00003938|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
775733|NCT00003938|disseminated neuroblastoma|disseminated neuroblastoma
775734|NCT00003938|recurrent neuroblastoma|recurrent neuroblastoma
775735|NCT00003938|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
775736|NCT00003938|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
775737|NCT00003938|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
775738|NCT00003938|stage I multiple myeloma|stage i multiple myeloma
775739|NCT00003938|stage II multiple myeloma|stage ii multiple myeloma
775740|NCT00003938|stage III multiple myeloma|stage iii multiple myeloma
775741|NCT00003938|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
775742|NCT00003938|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
775743|NCT00003938|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
775744|NCT00003938|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
775745|NCT00003938|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
775746|NCT00003938|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
775747|NCT00003938|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
775748|NCT00003938|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
775749|NCT00003938|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
775750|NCT00003938|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
775751|NCT00003938|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
775752|NCT00003938|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
775753|NCT00003938|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
775754|NCT00003938|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
775755|NCT00003938|small intestine lymphoma|small intestine lymphoma
775756|NCT00003938|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
775757|NCT00003938|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
775758|NCT00003938|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
775759|NCT00003938|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
775760|NCT00003938|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
775761|NCT00003938|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
775762|NCT00003938|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
775763|NCT00003938|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
775764|NCT00003938|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
775765|NCT00003938|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
775766|NCT00003938|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
775767|NCT00003938|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
775768|NCT00003938|polycythemia vera|polycythemia vera
775769|NCT00003938|primary myelofibrosis|primary myelofibrosis
775770|NCT00003938|essential thrombocythemia|essential thrombocythemia
775771|NCT00003938|fever, sweats, and hot flashes|fever, sweats, and hot flashes
775772|NCT00003938|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
775773|NCT00003938|testicular embryonal carcinoma|testicular embryonal carcinoma
775774|NCT00003938|testicular choriocarcinoma|testicular choriocarcinoma
775775|NCT00003938|testicular teratoma|testicular teratoma
775776|NCT00003938|testicular yolk sac tumor|testicular yolk sac tumor
775777|NCT00003938|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
775778|NCT00003938|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
775779|NCT00003938|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
775780|NCT00003938|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
775781|NCT00003938|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
775782|NCT00003938|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
775783|NCT00003938|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
775784|NCT00003938|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
775785|NCT00003938|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
775786|NCT00003938|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
775787|NCT00003938|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
775788|NCT00003938|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
775789|NCT00003938|refractory hairy cell leukemia|refractory hairy cell leukemia
775790|NCT00003938|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
775791|NCT00003938|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
775792|NCT00003938|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
775793|NCT00003938|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
775794|NCT00003938|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
775795|NCT00003938|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
775796|NCT00003938|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
775797|NCT00003938|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
775798|NCT00003938|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
775799|NCT00003938|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
775800|NCT00003938|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
775801|NCT00003938|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
775802|NCT00003938|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
775803|NCT00003938|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
775804|NCT00003938|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
775805|NCT00003938|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
775806|NCT00003938|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
775807|NCT00003938|ovarian yolk sac tumor|ovarian yolk sac tumor
775808|NCT00003938|ovarian embryonal carcinoma|ovarian embryonal carcinoma
775809|NCT00003938|ovarian polyembryoma|ovarian polyembryoma
775810|NCT00003938|ovarian choriocarcinoma|ovarian choriocarcinoma
775811|NCT00003938|ovarian immature teratoma|ovarian immature teratoma
775812|NCT00003938|ovarian mature teratoma|ovarian mature teratoma
775813|NCT00003938|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
775814|NCT00003938|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
775815|NCT00003938|acute undifferentiated leukemia|acute undifferentiated leukemia
775816|NCT00003938|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
775817|NCT00003938|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
775818|NCT00003938|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
775819|NCT00003938|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
775820|NCT00003938|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
775821|NCT00003938|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
775822|NCT00003938|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
775823|NCT00003938|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
775824|NCT00003938|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
775825|NCT00003938|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
775826|NCT00003938|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
775827|NCT00003938|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
775828|NCT00003938|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
775829|NCT00003938|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
775830|NCT00003938|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
775831|NCT00003938|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
775832|NCT00003938|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
775833|NCT00003938|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
775834|NCT00003938|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
775835|NCT00003938|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
775836|NCT00003938|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
775837|NCT00003938|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
775838|NCT00003938|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
775839|NCT00003938|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
775840|NCT00003938|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
775841|NCT00003938|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
775842|NCT00003938|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
775843|NCT00003938|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
775844|NCT00003938|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
775845|NCT00003938|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
775846|NCT00003938|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
775847|NCT00003938|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
775848|NCT00003938|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
775849|NCT00003938|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
775850|NCT00003938|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
775851|NCT00003938|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
775852|NCT00003938|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
775853|NCT00003938|neutropenia|neutropenia
775854|NCT00003938|infection|infection
789654|NCT00001003|Pentamidine|pentamidine
775855|NCT00003938|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
775857|NCT00003938|primary systemic amyloidosis|primary systemic amyloidosis
775858|NCT00003938|intraocular lymphoma|intraocular lymphoma
775859|NCT00003938|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
775860|NCT00003938|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
775861|NCT00003938|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
775862|NCT00003938|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
775863|NCT00003938|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
775864|NCT00003938|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
775865|NCT00003938|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
775866|NCT00003938|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
775867|NCT00003938|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
775868|NCT00003938|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
775869|NCT00003938|stage I mantle cell lymphoma|stage i mantle cell lymphoma
775870|NCT00003938|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
775871|NCT00003938|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
775872|NCT00003938|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
775873|NCT00003938|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
775874|NCT00003938|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
775875|NCT00003938|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
775876|NCT00003938|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
775877|NCT00003938|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
775878|NCT00003938|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
775879|NCT00003938|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
775880|NCT00003938|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
775881|NCT00003938|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
775882|NCT00003938|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
775883|NCT00003938|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
775884|NCT00003938|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
775885|NCT00003938|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
775886|NCT00003938|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
775887|NCT00003938|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
775888|NCT00003938|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
775889|NCT00003938|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
775890|NCT00003938|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
775891|NCT00003938|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
775892|NCT00003938|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
775893|NCT00003938|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
775894|NCT00003938|anaplastic large cell lymphoma|anaplastic large cell lymphoma
775895|NCT00003938|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
775896|NCT00003938|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
775897|NCT00003938|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
775898|NCT00003938|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
775899|NCT00003938|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
775900|NCT00003938|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
775901|NCT00003938|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
775902|NCT00003938|chronic eosinophilic leukemia|chronic eosinophilic leukemia
775903|NCT00003938|chronic neutrophilic leukemia|chronic neutrophilic leukemia
775904|NCT00003938|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
775905|NCT00003938|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
775906|NCT00003938|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
775907|NCT00003938|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
775908|NCT00003938|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
775909|NCT00003938|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
775910|NCT00003938|stage I marginal zone lymphoma|stage i marginal zone lymphoma
775911|NCT00003938|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
775912|NCT00003938|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
775913|NCT00003938|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
775914|NCT00003938|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
775915|NCT00003938|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
776056|NCT00003838|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
775916|NCT00003938|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
775917|NCT00003938|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
775918|NCT00003938|splenic marginal zone lymphoma|splenic marginal zone lymphoma
775919|NCT00003938|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
775920|NCT00003928|stage IV renal cell cancer|stage iv renal cell cancer
775921|NCT00003928|recurrent renal cell cancer|recurrent renal cell cancer
775922|NCT00003915|adenocarcinoma of the prostate|adenocarcinoma of the prostate
775923|NCT00003915|stage I prostate cancer|stage i prostate cancer
775924|NCT00003913|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
775925|NCT00003913|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
775926|NCT00003913|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
775927|NCT00003913|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
775928|NCT00003913|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
775929|NCT00003913|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
775930|NCT00003913|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
775931|NCT00003913|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
775932|NCT00003913|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
775933|NCT00003913|refractory anemia|refractory anemia
775934|NCT00003913|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
775935|NCT00003913|refractory anemia with excess blasts|refractory anemia with excess blasts
775936|NCT00003913|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
775937|NCT00003913|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
775938|NCT00003913|acute undifferentiated leukemia|acute undifferentiated leukemia
775939|NCT00003913|secondary acute myeloid leukemia|secondary acute myeloid leukemia
775940|NCT00003913|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
775941|NCT00003913|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
775942|NCT00003913|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
775943|NCT00003913|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
775944|NCT00003913|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
775945|NCT00003913|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
775946|NCT00003913|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
775947|NCT00003913|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
775948|NCT00003913|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
775949|NCT00003913|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
775950|NCT00003912|stage I childhood liver cancer|stage i childhood liver cancer
775951|NCT00003912|stage II childhood liver cancer|stage ii childhood liver cancer
775952|NCT00003912|stage III childhood liver cancer|stage iii childhood liver cancer
775953|NCT00003912|stage IV childhood liver cancer|stage iv childhood liver cancer
775954|NCT00003912|recurrent childhood liver cancer|recurrent childhood liver cancer
775955|NCT00003912|childhood hepatoblastoma|childhood hepatoblastoma
775956|NCT00003912|childhood hepatocellular carcinoma|childhood hepatocellular carcinoma
775957|NCT00003910|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
775958|NCT00003910|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
775959|NCT00003910|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
775960|NCT00003910|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
775961|NCT00003910|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
775962|NCT00003910|LGL clone|lgl clone
775963|NCT00003906|breast cancer|breast cancer
775964|NCT00003903|stage I prostate cancer|stage i prostate cancer
775965|NCT00003903|stage IIB prostate cancer|stage iib prostate cancer
775966|NCT00003903|stage IIA prostate cancer|stage iia prostate cancer
775967|NCT00003903|stage III prostate cancer|stage iii prostate cancer
775968|NCT00003903|stage IV prostate cancer|stage iv prostate cancer
775969|NCT00003903|osteoporosis|osteoporosis
775970|NCT00003902|stage IV breast cancer|stage iv breast cancer
775971|NCT00003901|stage I non-small cell lung cancer|stage i non-small cell lung cancer
775972|NCT00003901|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
775973|NCT00003901|squamous cell lung cancer|squamous cell lung cancer
775974|NCT00003901|large cell lung cancer|large cell lung cancer
775975|NCT00003901|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
775976|NCT00003901|adenocarcinoma of the lung|adenocarcinoma of the lung
775977|NCT00003896|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
775978|NCT00003896|peritoneal cavity cancer|peritoneal cavity cancer
775979|NCT00003896|fallopian tube cancer|fallopian tube cancer
775980|NCT00003893|stage I breast cancer|stage i breast cancer
775981|NCT00003878|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
775982|NCT00003878|tumors metastatic to brain|tumors metastatic to brain
775983|NCT00003865|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
775984|NCT00003865|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
776057|NCT00003838|Acute Myelogenous Leukemia|acute myelogenous leukemia
775985|NCT00003863|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
775986|NCT00003863|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
775987|NCT00003863|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
775988|NCT00003863|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
775989|NCT00003863|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
775990|NCT00003863|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
775991|NCT00003863|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
775992|NCT00003863|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
775993|NCT00003863|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
775994|NCT00003863|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
775995|NCT00003863|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
775996|NCT00003863|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
775997|NCT00003863|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
775998|NCT00003863|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
775999|NCT00003863|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
776000|NCT00003863|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
776001|NCT00003863|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
776002|NCT00003863|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
776003|NCT00003863|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
776004|NCT00003863|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
776005|NCT00003863|stage I mantle cell lymphoma|stage i mantle cell lymphoma
776006|NCT00003863|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
776007|NCT00003863|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
776008|NCT00003863|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
776009|NCT00003863|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
776010|NCT00003863|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
776011|NCT00003863|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
776012|NCT00003863|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
776013|NCT00003863|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
776014|NCT00003863|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
776015|NCT00003863|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
776016|NCT00003863|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
776017|NCT00003863|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
776018|NCT00003863|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
776019|NCT00003863|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
776020|NCT00003863|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
776021|NCT00003862|stage I gastric cancer|stage i gastric cancer
776022|NCT00003862|stage II gastric cancer|stage ii gastric cancer
776023|NCT00003862|stage III gastric cancer|stage iii gastric cancer
776024|NCT00003862|stage IV gastric cancer|stage iv gastric cancer
776025|NCT00003862|adenocarcinoma of the stomach|adenocarcinoma of the stomach
776026|NCT00003857|breast cancer in situ|breast cancer in situ
776027|NCT00003857|ductal breast carcinoma in situ|ductal breast carcinoma in situ
776028|NCT00003855|stage IA breast cancer|stage ia breast cancer
776029|NCT00003855|stage IB breast cancer|stage ib breast cancer
776030|NCT00003855|stage II breast cancer|stage ii breast cancer
776031|NCT00003854|stage IA breast cancer|stage ia breast cancer
776032|NCT00003854|stage IB breast cancer|stage ib breast cancer
776033|NCT00003854|stage II breast cancer|stage ii breast cancer
776034|NCT00003851|malnutrition|malnutrition
776035|NCT00003851|stage II pancreatic cancer|stage ii pancreatic cancer
776036|NCT00003851|stage III pancreatic cancer|stage iii pancreatic cancer
776037|NCT00003851|stage IV pancreatic cancer|stage iv pancreatic cancer
776038|NCT00003851|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
776039|NCT00003843|stage IV colon cancer|stage iv colon cancer
776040|NCT00003843|stage IV rectal cancer|stage iv rectal cancer
776041|NCT00003843|recurrent colon cancer|recurrent colon cancer
776042|NCT00003843|recurrent rectal cancer|recurrent rectal cancer
776043|NCT00003838|Graft-Versus-Leukemia|graft-versus-leukemia
776044|NCT00003838|Peripheral Blood Stem Cells|peripheral blood stem cells
776045|NCT00003838|Engraftment|engraftment
776046|NCT00003838|Cyclophosphamide|cyclophosphamide
776047|NCT00003838|Fludarabine|fludarabine
776049|NCT00003838|Nonmyeloablative Bone Marrow Transplantation|nonmyeloablative bone marrow transplantation
776050|NCT00003838|Graft-Versus-Tumor|graft-versus-tumor
776051|NCT00003838|Graft-Versus-Host Disease|graft-versus-host disease
776052|NCT00003838|Multiple Myeloma|multiple myeloma
776053|NCT00003838|Extramedullary Plasmacytoma|extramedullary plasmacytoma
776054|NCT00003838|Chronic Disease|chronic disease
776055|NCT00003838|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
776059|NCT00003838|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
776060|NCT00003838|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
776061|NCT00003838|Aplastic Anemia|aplastic anemia
776062|NCT00003838|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
776063|NCT00003838|Chronic Myelomoncytic Leukemia|chronic myelomoncytic leukemia
776064|NCT00003838|Non-Hodgkin's Lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
776065|NCT00003838|Hodgkin Disease|hodgkin disease
776066|NCT00003838|Pure Red Cell Aplasia|pure red cell aplasia
776067|NCT00003837|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
776068|NCT00003837|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
776069|NCT00003837|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
776070|NCT00003833|stage II colon cancer|stage ii colon cancer
776071|NCT00003833|stage III colon cancer|stage iii colon cancer
776072|NCT00003833|adenocarcinoma of the colon|adenocarcinoma of the colon
776073|NCT00003831|stage I non-small cell lung cancer|stage i non-small cell lung cancer
776074|NCT00003831|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
776075|NCT00003831|squamous cell lung cancer|squamous cell lung cancer
776076|NCT00003831|large cell lung cancer|large cell lung cancer
776077|NCT00003831|adenocarcinoma of the lung|adenocarcinoma of the lung
776078|NCT00003816|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
776079|NCT00003816|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
776080|NCT00003816|Burkitt lymphoma|burkitt lymphoma
776081|NCT00003816|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
776082|NCT00003816|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
776083|NCT00003816|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
776084|NCT00003816|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
776085|NCT00003816|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
776086|NCT00003816|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
776087|NCT00003816|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
776088|NCT00003816|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
776089|NCT00003816|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
776090|NCT00003816|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
776091|NCT00003816|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
776092|NCT00003816|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
776093|NCT00003816|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
776094|NCT00003816|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
776095|NCT00003816|polycythemia vera|polycythemia vera
776096|NCT00003816|essential thrombocythemia|essential thrombocythemia
776097|NCT00003816|refractory anemia|refractory anemia
776098|NCT00003816|refractory anemia with excess blasts|refractory anemia with excess blasts
776099|NCT00003816|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
776100|NCT00003816|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
776101|NCT00003816|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
776102|NCT00003816|acute undifferentiated leukemia|acute undifferentiated leukemia
776103|NCT00003816|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
776104|NCT00003816|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
776105|NCT00003816|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
776106|NCT00003816|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
776107|NCT00003816|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
776108|NCT00003816|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
776109|NCT00003816|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
776110|NCT00003816|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
776111|NCT00003816|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
776112|NCT00003816|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
776113|NCT00003816|secondary acute myeloid leukemia|secondary acute myeloid leukemia
776114|NCT00003816|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
776115|NCT00003816|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
776116|NCT00003816|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
776117|NCT00003816|prolymphocytic leukemia|prolymphocytic leukemia
776118|NCT00003816|intraocular lymphoma|intraocular lymphoma
776119|NCT00003816|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
776120|NCT00003816|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
776121|NCT00003816|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
776122|NCT00003816|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
776123|NCT00003816|anaplastic large cell lymphoma|anaplastic large cell lymphoma
776124|NCT00003816|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
776125|NCT00003816|primary myelofibrosis|primary myelofibrosis
776126|NCT00003816|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
776127|NCT00003816|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
776128|NCT00003816|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
776129|NCT00003816|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
776130|NCT00003816|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
776131|NCT00003816|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
776132|NCT00003816|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
776133|NCT00003816|splenic marginal zone lymphoma|splenic marginal zone lymphoma
776134|NCT00003816|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
776135|NCT00003816|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
776136|NCT00003816|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
776137|NCT00003816|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
776138|NCT00003816|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
776139|NCT00003816|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
776140|NCT00003816|aplastic anemia|aplastic anemia
776141|NCT00003816|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
776142|NCT00003816|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
776143|NCT00003815|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
776144|NCT00003815|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
776145|NCT00003815|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
776146|NCT00003815|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
776147|NCT00003815|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
776148|NCT00003815|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
776149|NCT00003815|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
776150|NCT00003815|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
776151|NCT00003815|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
776152|NCT00003815|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
776153|NCT00003815|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
776154|NCT00003815|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
776155|NCT00003815|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
776156|NCT00003815|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
776157|NCT00003815|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
776158|NCT00003815|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
776159|NCT00003815|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
776160|NCT00003815|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
776161|NCT00003815|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
776162|NCT00003815|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
776163|NCT00003803|stage I non-small cell lung cancer|stage i non-small cell lung cancer
776164|NCT00003803|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
776165|NCT00003803|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
776166|NCT00003800|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
776167|NCT00003800|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
776168|NCT00003800|testicular embryonal carcinoma|testicular embryonal carcinoma
776169|NCT00003800|testicular choriocarcinoma|testicular choriocarcinoma
776170|NCT00003800|testicular teratoma|testicular teratoma
776171|NCT00003800|testicular yolk sac tumor|testicular yolk sac tumor
776172|NCT00003800|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
776173|NCT00003800|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
776174|NCT00003800|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
776175|NCT00003800|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
776176|NCT00003800|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
776177|NCT00003800|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
776178|NCT00003796|stage IV breast cancer|stage iv breast cancer
776179|NCT00003796|recurrent breast cancer|recurrent breast cancer
776180|NCT00003796|male breast cancer|male breast cancer
776181|NCT00003793|secondary acute myeloid leukemia|secondary acute myeloid leukemia
776182|NCT00003793|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
776183|NCT00003793|localized osteosarcoma|localized osteosarcoma
776184|NCT00003793|metastatic osteosarcoma|metastatic osteosarcoma
776185|NCT00003793|childhood soft tissue sarcoma|childhood soft tissue sarcoma
776186|NCT00003793|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
776187|NCT00003793|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
776188|NCT00003793|childhood fibrosarcoma|childhood fibrosarcoma
776189|NCT00003793|childhood synovial sarcoma|childhood synovial sarcoma
776190|NCT00003793|childhood neurofibrosarcoma|childhood neurofibrosarcoma
776191|NCT00003793|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
776192|NCT00003793|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
776193|NCT00003793|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
776194|NCT00003788|recurrent adult brain tumor|recurrent adult brain tumor
776195|NCT00003788|adult glioblastoma|adult glioblastoma
776196|NCT00003788|adult anaplastic astrocytoma|adult anaplastic astrocytoma
776197|NCT00003788|adult giant cell glioblastoma|adult giant cell glioblastoma
776198|NCT00003788|adult gliosarcoma|adult gliosarcoma
776199|NCT00003782|stage I breast cancer|stage i breast cancer
776200|NCT00003782|stage II breast cancer|stage ii breast cancer
776201|NCT00003782|stage IIIA breast cancer|stage iiia breast cancer
776202|NCT00003771|menopausal symptoms|menopausal symptoms
776203|NCT00003771|stage I breast cancer|stage i breast cancer
776204|NCT00003771|stage II breast cancer|stage ii breast cancer
776205|NCT00003771|breast cancer in situ|breast cancer in situ
776206|NCT00003764|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
776207|NCT00003764|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
776208|NCT00003764|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
776209|NCT00003764|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
776210|NCT00003764|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
776211|NCT00003764|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
776212|NCT00003753|stage IV colon cancer|stage iv colon cancer
776213|NCT00003753|stage IV rectal cancer|stage iv rectal cancer
776214|NCT00003753|adenocarcinoma of the colon|adenocarcinoma of the colon
776215|NCT00003753|adenocarcinoma of the rectum|adenocarcinoma of the rectum
776216|NCT00003753|liver metastases|liver metastases
776217|NCT00003753|recurrent colon cancer|recurrent colon cancer
776218|NCT00003753|recurrent rectal cancer|recurrent rectal cancer
776219|NCT00003750|metastatic osteosarcoma|metastatic osteosarcoma
776220|NCT00003750|recurrent neuroblastoma|recurrent neuroblastoma
776221|NCT00003750|recurrent osteosarcoma|recurrent osteosarcoma
776222|NCT00003750|recurrent melanoma|recurrent melanoma
776223|NCT00003750|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
776224|NCT00003750|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
776225|NCT00003750|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
776226|NCT00003749|stage I endometrial carcinoma|stage i endometrial carcinoma
776227|NCT00003749|stage II endometrial carcinoma|stage ii endometrial carcinoma
776228|NCT00003749|endometrial clear cell carcinoma|endometrial clear cell carcinoma
776229|NCT00003749|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
776230|NCT00003746|untreated hairy cell leukemia|untreated hairy cell leukemia
776231|NCT00003746|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
776232|NCT00003746|prolymphocytic leukemia|prolymphocytic leukemia
776233|NCT00003745|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
776234|NCT00003745|recurrent osteosarcoma|recurrent osteosarcoma
776235|NCT00003745|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
776236|NCT00003745|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
776237|NCT00003745|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
776238|NCT00003745|extraosseous Ewing sarcoma/peripheral primitive neuroectodermal tumor|extraosseous ewing sarcoma/peripheral primitive neuroectodermal tumor
776239|NCT00003745|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
776240|NCT00003744|stage III salivary gland cancer|stage iii salivary gland cancer
776241|NCT00003744|stage IV salivary gland cancer|stage iv salivary gland cancer
776242|NCT00003744|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
776243|NCT00003744|salivary gland acinic cell tumor|salivary gland acinic cell tumor
776244|NCT00003744|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
776245|NCT00003744|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
776246|NCT00003744|salivary gland adenocarcinoma|salivary gland adenocarcinoma
776247|NCT00003744|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
776248|NCT00003744|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
776249|NCT00003744|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
776250|NCT00003744|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
776251|NCT00003741|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
776252|NCT00003741|anaplastic large cell lymphoma|anaplastic large cell lymphoma
776253|NCT00003739|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
776254|NCT00003739|fever, sweats, and hot flashes|fever, sweats, and hot flashes
776255|NCT00003739|neutropenia|neutropenia
776256|NCT00003737|recurrent neuroblastoma|recurrent neuroblastoma
776257|NCT00003732|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
776258|NCT00003732|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
776259|NCT00003732|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
776260|NCT00003732|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
776589|NCT00003567|adult glioblastoma|adult glioblastoma
776261|NCT00003732|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
776262|NCT00003732|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
776263|NCT00003730|stage IV breast cancer|stage iv breast cancer
776264|NCT00003730|recurrent breast cancer|recurrent breast cancer
776265|NCT00003728|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
776266|NCT00003728|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
776267|NCT00003728|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
776268|NCT00003728|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
776269|NCT00003728|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
776270|NCT00003728|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
776271|NCT00003728|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
776272|NCT00003728|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
776273|NCT00003728|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
776274|NCT00003728|acute undifferentiated leukemia|acute undifferentiated leukemia
776275|NCT00003727|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
776276|NCT00003727|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
776277|NCT00003727|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
776278|NCT00003727|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
776279|NCT00003727|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
776280|NCT00003696|extensive stage small cell lung cancer|extensive stage small cell lung cancer
776281|NCT00003690|stage IV breast cancer|stage iv breast cancer
776282|NCT00003690|recurrent breast cancer|recurrent breast cancer
776283|NCT00003690|stage IV prostate cancer|stage iv prostate cancer
776284|NCT00003690|recurrent prostate cancer|recurrent prostate cancer
776285|NCT00003690|stage IV melanoma|stage iv melanoma
776286|NCT00003690|recurrent melanoma|recurrent melanoma
776287|NCT00003690|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
776288|NCT00003688|recurrent gestational trophoblastic tumor|recurrent gestational trophoblastic tumor
776289|NCT00003688|nonmetastatic gestational trophoblastic tumor|nonmetastatic gestational trophoblastic tumor
776290|NCT00003688|low risk metastatic gestational trophoblastic tumor|low risk metastatic gestational trophoblastic tumor
776291|NCT00003687|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
776292|NCT00003687|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
776293|NCT00003687|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
776294|NCT00003687|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
776295|NCT00003687|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
776296|NCT00003687|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
776297|NCT00003687|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
776298|NCT00003687|isolated plasmacytoma of bone|isolated plasmacytoma of bone
776299|NCT00003687|extramedullary plasmacytoma|extramedullary plasmacytoma
776300|NCT00003687|refractory multiple myeloma|refractory multiple myeloma
776301|NCT00003687|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
776302|NCT00003687|stage III multiple myeloma|stage iii multiple myeloma
776303|NCT00003687|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
776304|NCT00003687|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
776305|NCT00003687|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
776306|NCT00003687|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
776307|NCT00003687|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
776308|NCT00003687|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
776309|NCT00003687|small intestine lymphoma|small intestine lymphoma
776310|NCT00003687|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
776311|NCT00003687|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
776312|NCT00003687|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
776313|NCT00003687|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
776314|NCT00003687|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
776315|NCT00003687|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
776316|NCT00003687|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
776317|NCT00003687|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
776318|NCT00003687|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
776319|NCT00003687|polycythemia vera|polycythemia vera
776320|NCT00003687|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
776321|NCT00003687|essential thrombocythemia|essential thrombocythemia
776322|NCT00003687|untreated hairy cell leukemia|untreated hairy cell leukemia
776323|NCT00003687|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
776324|NCT00003687|refractory hairy cell leukemia|refractory hairy cell leukemia
776325|NCT00003687|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
776326|NCT00003687|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
776327|NCT00003687|acute undifferentiated leukemia|acute undifferentiated leukemia
776328|NCT00003687|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
776329|NCT00003687|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
776330|NCT00003687|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
776331|NCT00003687|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
776332|NCT00003687|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
776333|NCT00003687|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
776334|NCT00003687|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
776335|NCT00003687|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
776336|NCT00003687|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
776337|NCT00003687|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
776338|NCT00003687|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
776339|NCT00003687|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
776340|NCT00003687|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
776341|NCT00003687|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
776342|NCT00003687|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
776343|NCT00003687|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
776344|NCT00003687|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
776345|NCT00003687|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
776346|NCT00003687|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
776347|NCT00003687|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
776348|NCT00003687|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
776349|NCT00003687|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
776350|NCT00003687|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
776351|NCT00003687|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
776352|NCT00003687|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
776353|NCT00003687|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
776354|NCT00003687|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
776355|NCT00003687|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
776356|NCT00003687|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
776357|NCT00003687|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
776358|NCT00003687|secondary acute myeloid leukemia|secondary acute myeloid leukemia
776359|NCT00003687|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
776360|NCT00003687|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
776361|NCT00003687|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
776362|NCT00003687|pain|pain
776363|NCT00003687|prolymphocytic leukemia|prolymphocytic leukemia
776364|NCT00003687|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
776365|NCT00003687|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
776366|NCT00003687|primary systemic amyloidosis|primary systemic amyloidosis
776367|NCT00003687|non-Hodgkin lymphoma during pregnancy|non-hodgkin lymphoma during pregnancy
776368|NCT00003687|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
776369|NCT00003687|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
776370|NCT00003687|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
776371|NCT00003687|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
776372|NCT00003687|anaplastic large cell lymphoma|anaplastic large cell lymphoma
776373|NCT00003687|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
776374|NCT00003687|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
776375|NCT00003687|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
776376|NCT00003687|chronic eosinophilic leukemia|chronic eosinophilic leukemia
776377|NCT00003687|chronic neutrophilic leukemia|chronic neutrophilic leukemia
776378|NCT00003687|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
776379|NCT00003687|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
776380|NCT00003687|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
776381|NCT00003687|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
776382|NCT00003687|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
776383|NCT00003687|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
776384|NCT00003687|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
776385|NCT00003687|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
776386|NCT00003687|splenic marginal zone lymphoma|splenic marginal zone lymphoma
776387|NCT00003687|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
776388|NCT00003678|stage I breast cancer|stage i breast cancer
776389|NCT00003678|stage II breast cancer|stage ii breast cancer
776390|NCT00003659|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
776391|NCT00003659|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
776392|NCT00003659|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
790123|NCT00000929|Rectum|rectum
776393|NCT00003658|Waldenström macroglobulinemia|waldenström macroglobulinemia
776394|NCT00003658|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
776395|NCT00003658|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
776396|NCT00003658|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
776397|NCT00003658|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
776398|NCT00003658|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
776399|NCT00003658|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
776400|NCT00003658|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
776401|NCT00003658|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
776402|NCT00003658|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
776403|NCT00003658|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
776404|NCT00003658|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
776405|NCT00003658|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
776406|NCT00003658|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
776407|NCT00003658|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
776408|NCT00003658|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
776409|NCT00003658|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
776410|NCT00003658|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
776411|NCT00003658|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
776412|NCT00003658|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
776413|NCT00003658|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
776414|NCT00003658|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
776415|NCT00003658|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
776416|NCT00003658|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
776417|NCT00003656|stage IV renal cell cancer|stage iv renal cell cancer
776418|NCT00003656|recurrent renal cell cancer|recurrent renal cell cancer
776419|NCT00003653|adenocarcinoma of the prostate|adenocarcinoma of the prostate
776420|NCT00003653|recurrent prostate cancer|recurrent prostate cancer
776421|NCT00003652|stage II anal cancer|stage ii anal cancer
776422|NCT00003652|stage III anal cancer|stage iii anal cancer
776423|NCT00003652|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
776424|NCT00003652|cloacogenic carcinoma of the anus|cloacogenic carcinoma of the anus
776425|NCT00003652|basaloid carcinoma of the anus|basaloid carcinoma of the anus
776426|NCT00003650|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
776427|NCT00003650|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
776428|NCT00003650|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
776429|NCT00003650|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
776430|NCT00003644|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
776431|NCT00003644|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
776432|NCT00003644|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
776433|NCT00003644|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
776434|NCT00003644|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
776435|NCT00003644|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
776436|NCT00003644|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
776437|NCT00003644|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
776438|NCT00003644|Brenner tumor|brenner tumor
776439|NCT00003643|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
776440|NCT00003643|testicular seminoma|testicular seminoma
776441|NCT00003643|testicular embryonal carcinoma|testicular embryonal carcinoma
776442|NCT00003643|testicular choriocarcinoma|testicular choriocarcinoma
776443|NCT00003643|testicular yolk sac tumor|testicular yolk sac tumor
776444|NCT00003643|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
776445|NCT00003643|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
776446|NCT00003643|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
776447|NCT00003643|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
776448|NCT00003643|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
776449|NCT00003643|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
776450|NCT00003643|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
776451|NCT00003643|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
776452|NCT00003643|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
776453|NCT00003643|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
776454|NCT00003643|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
776455|NCT00003643|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
776456|NCT00003643|stage IV extragonadal seminoma|stage iv extragonadal seminoma
776457|NCT00003643|testicular immature teratoma|testicular immature teratoma
776458|NCT00003643|testicular mature teratoma|testicular mature teratoma
776459|NCT00003643|adult teratoma|adult teratoma
776462|NCT00003637|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
776463|NCT00003637|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
776464|NCT00003637|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
776465|NCT00003637|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
776466|NCT00003636|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
776467|NCT00003636|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
776468|NCT00003636|fallopian tube cancer|fallopian tube cancer
776469|NCT00003636|primary peritoneal cavity cancer|primary peritoneal cavity cancer
776470|NCT00003633|adenocarcinoma of the prostate|adenocarcinoma of the prostate
776471|NCT00003633|stage IV prostate cancer|stage iv prostate cancer
776472|NCT00003633|recurrent prostate cancer|recurrent prostate cancer
776473|NCT00003631|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
776474|NCT00003631|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
776475|NCT00003612|stage IV breast cancer|stage iv breast cancer
776476|NCT00003612|recurrent breast cancer|recurrent breast cancer
776477|NCT00003611|basal cell carcinoma of the skin|basal cell carcinoma of the skin
776478|NCT00003611|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
776479|NCT00003607|adenocarcinoma of the prostate|adenocarcinoma of the prostate
776480|NCT00003607|stage I prostate cancer|stage i prostate cancer
776481|NCT00003607|stage IIB prostate cancer|stage iib prostate cancer
776482|NCT00003607|stage IIA prostate cancer|stage iia prostate cancer
776483|NCT00003607|stage III prostate cancer|stage iii prostate cancer
776484|NCT00003603|refractory multiple myeloma|refractory multiple myeloma
776485|NCT00003603|stage I multiple myeloma|stage i multiple myeloma
776486|NCT00003603|stage II multiple myeloma|stage ii multiple myeloma
776487|NCT00003603|stage III multiple myeloma|stage iii multiple myeloma
776488|NCT00003602|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
776489|NCT00003602|refractory anemia with excess blasts|refractory anemia with excess blasts
776490|NCT00003602|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
776491|NCT00003602|secondary acute myeloid leukemia|secondary acute myeloid leukemia
776492|NCT00003602|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
776493|NCT00003602|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
776494|NCT00003596|stage II anal cancer|stage ii anal cancer
776495|NCT00003596|stage III anal cancer|stage iii anal cancer
776496|NCT00003596|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
776497|NCT00003596|cloacogenic carcinoma of the anus|cloacogenic carcinoma of the anus
776498|NCT00003596|basaloid carcinoma of the anus|basaloid carcinoma of the anus
776499|NCT00003593|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
776500|NCT00003593|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
776501|NCT00003593|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
776502|NCT00003593|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
776503|NCT00003593|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
776504|NCT00003593|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
776505|NCT00003593|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
776506|NCT00003593|refractory anemia|refractory anemia
776507|NCT00003593|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
776508|NCT00003593|refractory anemia with excess blasts|refractory anemia with excess blasts
776509|NCT00003593|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
776510|NCT00003593|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
776511|NCT00003593|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
776512|NCT00003593|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
776513|NCT00003593|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
776514|NCT00003593|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
776515|NCT00003593|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
776516|NCT00003593|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
776517|NCT00003593|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
776518|NCT00003590|recurrent adult brain tumor|recurrent adult brain tumor
776519|NCT00003590|adult grade I meningioma|adult grade i meningioma
776520|NCT00003577|stage I breast cancer|stage i breast cancer
776521|NCT00003577|stage II breast cancer|stage ii breast cancer
776522|NCT00003576|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
776523|NCT00003576|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
776524|NCT00003576|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
776525|NCT00003576|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
776526|NCT00003576|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
776527|NCT00003576|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
776528|NCT00003576|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
776529|NCT00003576|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
776530|NCT00003576|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
776531|NCT00003576|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
776532|NCT00003569|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
776533|NCT00003569|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
776534|NCT00003569|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
776535|NCT00003569|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
776536|NCT00003569|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
776537|NCT00003569|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
776538|NCT00003569|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
776539|NCT00003569|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
776540|NCT00003569|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
776541|NCT00003569|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
776542|NCT00003569|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
776543|NCT00003569|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
776544|NCT00003569|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
776545|NCT00003569|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
776546|NCT00003569|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
776547|NCT00003569|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
776548|NCT00003569|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
776549|NCT00003569|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
776550|NCT00003569|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
776551|NCT00003569|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
776552|NCT00003569|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
776553|NCT00003569|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
776554|NCT00003569|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
776555|NCT00003569|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
776556|NCT00003569|neurotoxicity|neurotoxicity
776557|NCT00003569|recurrent salivary gland cancer|recurrent salivary gland cancer
776558|NCT00003569|stage IV salivary gland cancer|stage iv salivary gland cancer
776559|NCT00003569|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
776560|NCT00003569|stage III salivary gland cancer|stage iii salivary gland cancer
776561|NCT00003568|stage IV melanoma|stage iv melanoma
776562|NCT00003568|recurrent melanoma|recurrent melanoma
776563|NCT00003567|recurrent adult brain tumor|recurrent adult brain tumor
776564|NCT00003567|adult brain stem glioma|adult brain stem glioma
776565|NCT00003567|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
776566|NCT00003567|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
776567|NCT00003567|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
776568|NCT00003567|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
776569|NCT00003567|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
776570|NCT00003567|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
776571|NCT00003567|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
776572|NCT00003567|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
776573|NCT00003567|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
776574|NCT00003567|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
776575|NCT00003567|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
776576|NCT00003567|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
776577|NCT00003567|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
776578|NCT00003567|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
776579|NCT00003567|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
776580|NCT00003567|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
776581|NCT00003567|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
776582|NCT00003567|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
776583|NCT00003567|adult mixed glioma|adult mixed glioma
776584|NCT00003567|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
776585|NCT00003567|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
776586|NCT00003567|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
776587|NCT00003567|adult anaplastic astrocytoma|adult anaplastic astrocytoma
776588|NCT00003567|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
776590|NCT00003567|adult pilocytic astrocytoma|adult pilocytic astrocytoma
776591|NCT00003567|adult subependymoma|adult subependymoma
776592|NCT00003567|adult anaplastic ependymoma|adult anaplastic ependymoma
776593|NCT00003567|adult myxopapillary ependymoma|adult myxopapillary ependymoma
776594|NCT00003567|adult ependymoblastoma|adult ependymoblastoma
776595|NCT00003567|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
776596|NCT00003567|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
776597|NCT00003567|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
776598|NCT00003567|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
776599|NCT00003567|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
776600|NCT00003567|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
776601|NCT00003567|splenic marginal zone lymphoma|splenic marginal zone lymphoma
776602|NCT00003567|adult oligodendroglioma|adult oligodendroglioma
776603|NCT00003567|adult giant cell glioblastoma|adult giant cell glioblastoma
776604|NCT00003567|adult gliosarcoma|adult gliosarcoma
776605|NCT00003567|adult diffuse astrocytoma|adult diffuse astrocytoma
776606|NCT00003566|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
776607|NCT00003565|stage IV breast cancer|stage iv breast cancer
776608|NCT00003565|stage IIIA breast cancer|stage iiia breast cancer
776609|NCT00003565|recurrent breast cancer|recurrent breast cancer
776610|NCT00003565|stage IIIB breast cancer|stage iiib breast cancer
776611|NCT00003565|stage IIIC breast cancer|stage iiic breast cancer
776612|NCT00003565|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
776613|NCT00003565|extensive stage small cell lung cancer|extensive stage small cell lung cancer
776614|NCT00003565|recurrent small cell lung cancer|recurrent small cell lung cancer
776615|NCT00003565|stage III bladder cancer|stage iii bladder cancer
776616|NCT00003565|recurrent bladder cancer|recurrent bladder cancer
776617|NCT00003565|stage IV bladder cancer|stage iv bladder cancer
776618|NCT00003565|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
776619|NCT00003565|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
776620|NCT00003565|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
776621|NCT00003565|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
776622|NCT00003565|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
776623|NCT00003565|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
776624|NCT00003565|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
776625|NCT00003565|pulmonary carcinoid tumor|pulmonary carcinoid tumor
776626|NCT00003565|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
776627|NCT00003565|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
776628|NCT00003565|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
776629|NCT00003565|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
776630|NCT00003565|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
776631|NCT00003565|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
776632|NCT00003565|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
776633|NCT00003565|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
776634|NCT00003565|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
776635|NCT00003565|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
776636|NCT00003565|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
776637|NCT00003565|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
776638|NCT00003565|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
776639|NCT00003565|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
776640|NCT00003565|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
776641|NCT00003565|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
776642|NCT00003565|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
776643|NCT00003565|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
776644|NCT00003565|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
776645|NCT00003565|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
776646|NCT00003565|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
776647|NCT00003565|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
776648|NCT00003565|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
776649|NCT00003565|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
776650|NCT00003565|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
776651|NCT00003565|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
776652|NCT00003565|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
776653|NCT00003565|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
776654|NCT00003565|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
776655|NCT00003565|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
776656|NCT00003565|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
776657|NCT00003565|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
776658|NCT00003565|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
776659|NCT00003565|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
776660|NCT00003565|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
776661|NCT00003565|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
776662|NCT00003565|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
776663|NCT00003565|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
776664|NCT00003565|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
776665|NCT00003565|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
776666|NCT00003565|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
776667|NCT00003565|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
776668|NCT00003565|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
776669|NCT00003565|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
776670|NCT00003565|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
776671|NCT00003565|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
776672|NCT00003565|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
776673|NCT00003565|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
776674|NCT00003565|recurrent salivary gland cancer|recurrent salivary gland cancer
776675|NCT00003565|stage III salivary gland cancer|stage iii salivary gland cancer
776676|NCT00003565|stage IV salivary gland cancer|stage iv salivary gland cancer
776677|NCT00003560|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
776678|NCT00003560|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
776679|NCT00003560|stage III endometrial carcinoma|stage iii endometrial carcinoma
776680|NCT00003560|stage IV endometrial carcinoma|stage iv endometrial carcinoma
776681|NCT00003560|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
776682|NCT00003560|fallopian tube cancer|fallopian tube cancer
776683|NCT00003560|primary peritoneal cavity cancer|primary peritoneal cavity cancer
776684|NCT00003558|adenocarcinoma of unknown primary|adenocarcinoma of unknown primary
776685|NCT00003558|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
776686|NCT00003553|stage IV renal cell cancer|stage iv renal cell cancer
776687|NCT00003553|recurrent renal cell cancer|recurrent renal cell cancer
776688|NCT00003538|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
776689|NCT00003538|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
776690|NCT00003538|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
776691|NCT00003538|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
776692|NCT00003538|stage IV breast cancer|stage iv breast cancer
776693|NCT00003538|stage IIIA breast cancer|stage iiia breast cancer
776694|NCT00003538|stage IIIB breast cancer|stage iiib breast cancer
776695|NCT00003538|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
776696|NCT00003538|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
776697|NCT00003538|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
776698|NCT00003538|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
776699|NCT00003538|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
776700|NCT00003538|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
776701|NCT00003538|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
776702|NCT00003538|disseminated neuroblastoma|disseminated neuroblastoma
776703|NCT00003538|recurrent neuroblastoma|recurrent neuroblastoma
776704|NCT00003538|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
776705|NCT00003538|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
776706|NCT00003538|stage I multiple myeloma|stage i multiple myeloma
776707|NCT00003538|stage II multiple myeloma|stage ii multiple myeloma
776708|NCT00003538|stage III multiple myeloma|stage iii multiple myeloma
776709|NCT00003538|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
776710|NCT00003538|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
778613|NCT00051155|OAG|oag
776711|NCT00003538|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
776712|NCT00003538|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
776908|NCT00003489|Nasopharyngeal Cancer|nasopharyngeal cancer
776713|NCT00003538|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
776714|NCT00003538|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
776715|NCT00003538|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
776716|NCT00003538|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
776717|NCT00003538|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
776718|NCT00003538|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
776719|NCT00003538|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
776720|NCT00003538|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
776721|NCT00003538|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
776722|NCT00003538|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
776723|NCT00003538|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
776724|NCT00003538|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
776725|NCT00003538|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
776726|NCT00003538|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
776727|NCT00003538|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
776728|NCT00003538|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
776729|NCT00003538|myelodysplastic syndromes|myelodysplastic syndromes
776730|NCT00003538|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
776731|NCT00003538|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
776732|NCT00003538|untreated hairy cell leukemia|untreated hairy cell leukemia
776733|NCT00003538|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
776734|NCT00003538|refractory hairy cell leukemia|refractory hairy cell leukemia
776735|NCT00003538|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
776736|NCT00003538|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
776737|NCT00003538|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
776738|NCT00003538|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
776739|NCT00003538|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
776740|NCT00003538|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
776741|NCT00003538|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
776742|NCT00003538|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
776743|NCT00003538|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
776744|NCT00003538|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
776745|NCT00003538|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
776746|NCT00003538|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
776747|NCT00003538|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
776748|NCT00003538|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
776749|NCT00003538|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
776750|NCT00003538|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
776751|NCT00003538|acute undifferentiated leukemia|acute undifferentiated leukemia
776752|NCT00003538|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
776753|NCT00003538|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
776754|NCT00003538|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
776755|NCT00003538|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
776756|NCT00003538|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
776757|NCT00003538|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
776758|NCT00003538|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
776759|NCT00003538|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
776760|NCT00003538|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
776761|NCT00003538|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
776762|NCT00003538|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
776763|NCT00003538|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
776764|NCT00003538|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
776765|NCT00003538|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
776766|NCT00003538|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
776767|NCT00003538|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
776768|NCT00003538|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
776769|NCT00003538|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
776770|NCT00003538|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
776771|NCT00003538|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
776772|NCT00003538|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
776773|NCT00003538|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
776774|NCT00003538|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
776775|NCT00003538|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
776776|NCT00003538|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
776777|NCT00003538|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
776778|NCT00003538|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
776779|NCT00003538|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
776780|NCT00003538|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
776781|NCT00003538|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
776782|NCT00003538|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
776783|NCT00003538|secondary acute myeloid leukemia|secondary acute myeloid leukemia
776784|NCT00003538|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
776785|NCT00003538|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
776786|NCT00003538|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
776787|NCT00003538|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
776788|NCT00003538|anemia|anemia
776789|NCT00003538|graft versus host disease|graft versus host disease
776790|NCT00003538|prolymphocytic leukemia|prolymphocytic leukemia
776791|NCT00003538|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
776792|NCT00003538|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
776793|NCT00003538|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
776794|NCT00003538|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
776795|NCT00003538|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
776796|NCT00003538|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
776797|NCT00003538|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
776798|NCT00003538|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
776799|NCT00003538|non-Hodgkin lymphoma during pregnancy|non-hodgkin lymphoma during pregnancy
776800|NCT00003538|stage I mantle cell lymphoma|stage i mantle cell lymphoma
776801|NCT00003538|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
776802|NCT00003538|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
778614|NCT00051155|OHT|oht
776803|NCT00003538|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
776804|NCT00003538|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
776805|NCT00003538|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
776806|NCT00003538|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
776807|NCT00003538|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
776808|NCT00003538|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
776809|NCT00003538|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
776810|NCT00003538|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
776811|NCT00003538|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
776812|NCT00003538|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
776813|NCT00003538|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
776814|NCT00003538|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
776815|NCT00003538|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
776816|NCT00003538|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
776817|NCT00003538|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
776818|NCT00003538|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
776819|NCT00003538|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
776820|NCT00003538|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
776821|NCT00003538|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
776822|NCT00003538|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
776823|NCT00003538|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
776824|NCT00003538|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
776825|NCT00003538|anaplastic large cell lymphoma|anaplastic large cell lymphoma
776826|NCT00003538|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
776827|NCT00003538|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
776828|NCT00003538|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
776829|NCT00003538|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
776830|NCT00003538|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
776831|NCT00003538|stage I marginal zone lymphoma|stage i marginal zone lymphoma
776832|NCT00003538|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
776833|NCT00003538|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
776834|NCT00003538|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
776835|NCT00003538|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
776836|NCT00003538|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
776909|NCT00003489|Hypopharyngeal Cancer|hypopharyngeal cancer
776837|NCT00003538|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
776838|NCT00003538|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
776839|NCT00003538|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
776840|NCT00003538|splenic marginal zone lymphoma|splenic marginal zone lymphoma
776841|NCT00003538|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
776842|NCT00003537|adult anaplastic astrocytoma|adult anaplastic astrocytoma
776843|NCT00003535|childhood anaplastic astrocytoma|childhood anaplastic astrocytoma
776844|NCT00003535|childhood glioblastoma multiforme|childhood glioblastoma multiforme
776845|NCT00003534|Refractory stage IV prostate cancer|refractory stage iv prostate cancer
776846|NCT00003533|adenocarcinoma of the prostate|adenocarcinoma of the prostate
776847|NCT00003532|Stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
776848|NCT00003532|Stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
776849|NCT00003532|Stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
776850|NCT00003532|Stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
776851|NCT00003531|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
776852|NCT00003530|Childhood primary liver cancer|childhood primary liver cancer
776853|NCT00003530|Adult primary liver cancer|adult primary liver cancer
776854|NCT00003525|recurrent cervical cancer|recurrent cervical cancer
776855|NCT00003525|recurrent vulvar cancer|recurrent vulvar cancer
776856|NCT00003524|Stage III and IV Stomach (Gastric) Cancer|stage iii and iv stomach (gastric) cancer
776857|NCT00003524|Recurrent Stomach (Gastric) Cancer|recurrent stomach (gastric) cancer
776858|NCT00003522|recurrent small intestine cancer|recurrent small intestine cancer
776859|NCT00003521|Stage III and IV Soft Tissue Sarcoma|stage iii and iv soft tissue sarcoma
776860|NCT00003521|Recurrent Soft Tissue Sarcoma|recurrent soft tissue sarcoma
776861|NCT00003520|stage IV renal cell cancer|stage iv renal cell cancer
776862|NCT00003516|Stage III or Stage IV Prostate Cancer Stage III|stage iii or stage iv prostate cancer stage iii
776863|NCT00003516|Stage III or Stage IV Prostate Cancer Stage IV|stage iii or stage iv prostate cancer stage iv
776864|NCT00003515|Metastatic Primitive Neuroectodermal Tumor|metastatic primitive neuroectodermal tumor
776865|NCT00003515|Recurrent Primitive Neuroectodermal Tumor|recurrent primitive neuroectodermal tumor
776866|NCT00003515|Refractory Primitive Neuroectodermal Tumor|refractory primitive neuroectodermal tumor
776867|NCT00003514|ACTH-producing pituitary tumor|acth-producing pituitary tumor
776868|NCT00003514|prolactin-producing pituitary tumor|prolactin-producing pituitary tumor
776869|NCT00003514|growth hormone-producing pituitary tumor|growth hormone-producing pituitary tumor
776870|NCT00003514|recurrent pituitary tumor|recurrent pituitary tumor
776871|NCT00003514|TSH producing pituitary tumor|tsh producing pituitary tumor
776872|NCT00003514|nonfunctioning pituitary tumor|nonfunctioning pituitary tumor
776873|NCT00003514|somatostatinoma|somatostatinoma
776874|NCT00003514|stage III Merkel cell carcinoma|stage iii merkel cell carcinoma
776875|NCT00003514|recurrent Merkel cell carcinoma|recurrent merkel cell carcinoma
776876|NCT00003514|neuroendocrine carcinoma|neuroendocrine carcinoma
776877|NCT00003513|Metastatic Neuroblastoma|metastatic neuroblastoma
776878|NCT00003513|Recurrent Neuroblastoma|recurrent neuroblastoma
776879|NCT00003513|Refractory Neuroblastoma|refractory neuroblastoma
776880|NCT00003512|Waldenstrom Macroglobulinemia Recurrent|waldenstrom macroglobulinemia recurrent
776881|NCT00003512|Waldenstrom Macroglobulinemia Refractory|waldenstrom macroglobulinemia refractory
776882|NCT00003511|Stage I multiple myeloma|stage i multiple myeloma
776883|NCT00003511|Stage II multiple myeloma|stage ii multiple myeloma
776884|NCT00003511|Stage III multiple myeloma|stage iii multiple myeloma
776885|NCT00003509|Stage IV melanoma of the skin|stage iv melanoma of the skin
776886|NCT00003508|advanced malignant mesothelioma|advanced malignant mesothelioma
776887|NCT00003508|recurrent malignant mesothelioma|recurrent malignant mesothelioma
776888|NCT00003501|Refractory Non-Hodgkin's Lymphoma|refractory non-hodgkin's lymphoma
776889|NCT00003501|Recurrent Non-Hodgkin's Lymphoma|recurrent non-hodgkin's lymphoma
776890|NCT00003501|High-Grade Stage II - IV Non-Hodgkin's Lymphoma|high-grade stage ii - iv non-hodgkin's lymphoma
776891|NCT00003500|Refractory Non-Hodgkin's Lymphoma|refractory non-hodgkin's lymphoma
776892|NCT00003500|Recurrent Non-Hodgkin's Lymphoma|recurrent non-hodgkin's lymphoma
776893|NCT00003500|Intermediate-Grade Stage II - IV Non-Hodgkin's Lymphoma|intermediate-grade stage ii - iv non-hodgkin's lymphoma
776894|NCT00003499|Low-grade non-Hodgkin's lymphoma|low-grade non-hodgkin's lymphoma
776895|NCT00003498|Non Hodgkin Lymphoma Recurrent|non hodgkin lymphoma recurrent
776896|NCT00003498|Non Hodgkin Lymphoma Refractory|non hodgkin lymphoma refractory
776897|NCT00003497|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
776898|NCT00003496|recurrent small cell lung cancer|recurrent small cell lung cancer
776899|NCT00003495|recurrent lung cancer|recurrent lung cancer
776900|NCT00003494|Bronchial Alveolar Cancer Recurrent|bronchial alveolar cancer recurrent
776901|NCT00003494|Bronchial Alveolar Cancer Stage IV|bronchial alveolar cancer stage iv
776902|NCT00003492|Stage IV large cell lung cancer|stage iv large cell lung cancer
776903|NCT00003492|Stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
776904|NCT00003491|non-small cell adenocarcinoma of the lung|non-small cell adenocarcinoma of the lung
776905|NCT00003489|Advanced Head and Neck Cancer|advanced head and neck cancer
776906|NCT00003489|Recurrent Head and Neck Cancer|recurrent head and neck cancer
776907|NCT00003489|Oral Cavity Cancer|oral cavity cancer
776910|NCT00003489|Laryngeal Cancer|laryngeal cancer
776911|NCT00003489|Nasal Cavity Cancer|nasal cavity cancer
776912|NCT00003489|Paranasal Sinus Cancer|paranasal sinus cancer
776913|NCT00003489|Oropharyngeal Cancer|oropharyngeal cancer
776914|NCT00003489|Salivary Gland Cancer|salivary gland cancer
776915|NCT00003489|Stage IV Head and Neck Cancer|stage iv head and neck cancer
776916|NCT00003487|stage IV esophageal cancer|stage iv esophageal cancer
776917|NCT00003487|recurrent esophageal cancer|recurrent esophageal cancer
776918|NCT00003487|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
776919|NCT00003485|stage IV colon cancer|stage iv colon cancer
776920|NCT00003485|unresectable colon cancer|unresectable colon cancer
776921|NCT00003483|adult meningioma|adult meningioma
776922|NCT00003483|recurrent adult meningioma|recurrent adult meningioma
776923|NCT00003479|Ependymoma|ependymoma
776924|NCT00003479|Anaplastic Ependymoma|anaplastic ependymoma
776925|NCT00003478|recurrent adult brain tumor|recurrent adult brain tumor
776926|NCT00003478|adult brain stem glioma|adult brain stem glioma
776927|NCT00003478|adult medulloblastoma|adult medulloblastoma
776928|NCT00003478|adult glioblastoma|adult glioblastoma
776929|NCT00003478|adult anaplastic astrocytoma|adult anaplastic astrocytoma
776930|NCT00003478|adult anaplastic ependymoma|adult anaplastic ependymoma
776931|NCT00003478|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
776932|NCT00003478|adult mixed glioma|adult mixed glioma
776933|NCT00003478|adult ependymoblastoma|adult ependymoblastoma
776934|NCT00003478|adult giant cell glioblastoma|adult giant cell glioblastoma
776935|NCT00003478|adult gliosarcoma|adult gliosarcoma
776936|NCT00003477|visual pathway glioma not amenable to standard therapy|visual pathway glioma not amenable to standard therapy
776937|NCT00003477|visual pathway glioma not responding to standard therapy|visual pathway glioma not responding to standard therapy
776938|NCT00003476|childhood anaplastic astrocytoma|childhood anaplastic astrocytoma
776939|NCT00003476|recurrent childhood anaplastic astrocytoma|recurrent childhood anaplastic astrocytoma
776940|NCT00003476|childhood glioblastoma multiforme|childhood glioblastoma multiforme
776941|NCT00003476|recurrent childhood glioblastoma multiforme|recurrent childhood glioblastoma multiforme
776942|NCT00003476|childhood brainstem glioma|childhood brainstem glioma
776943|NCT00003476|recurrent childhood brainstem glioma|recurrent childhood brainstem glioma
776944|NCT00003476|childhood primitive neuroectodermal tumor|childhood primitive neuroectodermal tumor
776945|NCT00003476|recurrent childhood primitive neuroectodermal tumor|recurrent childhood primitive neuroectodermal tumor
776946|NCT00003475|adult glioblastoma multiforme|adult glioblastoma multiforme
776947|NCT00003475|adult anaplastic astrocytoma|adult anaplastic astrocytoma
776948|NCT00003475|adult anaplastic astrocytoma/Mixed|adult anaplastic astrocytoma/mixed
776949|NCT00003474|adult glioblastoma|adult glioblastoma
776950|NCT00003474|recurrent glioblastoma|recurrent glioblastoma
776951|NCT00003473|recurrent adult mixed glioma|recurrent adult mixed glioma
776952|NCT00003473|refractoy adult mixed glioma|refractoy adult mixed glioma
776953|NCT00003472|Recurrent/progressive adult oligodendroglioma|recurrent/progressive adult oligodendroglioma
776954|NCT00003472|Recurrent/progressive adult anaplastic oligodendroglioma|recurrent/progressive adult anaplastic oligodendroglioma
776955|NCT00003471|Recurrent/progressive adult low grade astrocytoma|recurrent/progressive adult low grade astrocytoma
776956|NCT00003470|persistent anaplastic astrocytoma|persistent anaplastic astrocytoma
776957|NCT00003470|recurrent anaplastic astrocytoma|recurrent anaplastic astrocytoma
776958|NCT00003470|adult anaplastic astrocytoma|adult anaplastic astrocytoma
776959|NCT00003469|childhood rhabdoid tumor|childhood rhabdoid tumor
776960|NCT00003468|childhood low-grade astrocytoma|childhood low-grade astrocytoma
776961|NCT00003468|recurrent childhood astrocytoma|recurrent childhood astrocytoma
776962|NCT00003468|persistent childhood astrocytoma|persistent childhood astrocytoma
776963|NCT00003467|recurrent adult brain tumor|recurrent adult brain tumor
776964|NCT00003467|adult brain stem glioma|adult brain stem glioma
776965|NCT00003467|adult mixed glioma|adult mixed glioma
776966|NCT00003467|adult anaplastic astrocytoma|adult anaplastic astrocytoma
776967|NCT00003467|adult pilocytic astrocytoma|adult pilocytic astrocytoma
776968|NCT00003467|adult oligodendroglioma|adult oligodendroglioma
776969|NCT00003466|recurrent adult brain tumor|recurrent adult brain tumor
776970|NCT00003466|adult mixed glioma|adult mixed glioma
776971|NCT00003466|childhood mixed glioma|childhood mixed glioma
776972|NCT00003466|adult pilocytic astrocytoma|adult pilocytic astrocytoma
776973|NCT00003466|adult subependymoma|adult subependymoma
776974|NCT00003466|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
776975|NCT00003466|adult brain stem glioma|adult brain stem glioma
776976|NCT00003466|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
776977|NCT00003466|untreated childhood brain stem glioma|untreated childhood brain stem glioma
776978|NCT00003466|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
776979|NCT00003466|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
776980|NCT00003466|adult oligodendroglioma|adult oligodendroglioma
776981|NCT00003466|adult diffuse astrocytoma|adult diffuse astrocytoma
776982|NCT00003462|leptomeningeal metastases|leptomeningeal metastases
776983|NCT00003461|localized resectable neuroblastoma|localized resectable neuroblastoma
776984|NCT00003461|recurrent neuroblastoma|recurrent neuroblastoma
776985|NCT00003461|recurrent adult brain tumor|recurrent adult brain tumor
776986|NCT00003461|adult craniopharyngioma|adult craniopharyngioma
776987|NCT00003461|adult medulloblastoma|adult medulloblastoma
776988|NCT00003461|adult meningioma|adult meningioma
776989|NCT00003461|adult glioblastoma|adult glioblastoma
776990|NCT00003461|adult oligodendroglioma|adult oligodendroglioma
776991|NCT00003461|tumors metastatic to brain|tumors metastatic to brain
776992|NCT00003461|adult anaplastic astrocytoma|adult anaplastic astrocytoma
776993|NCT00003461|adult mixed glioma|adult mixed glioma
776994|NCT00003461|adult pineal parenchymal tumor|adult pineal parenchymal tumor
776995|NCT00003461|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
776996|NCT00003461|adult grade III meningioma|adult grade iii meningioma
776997|NCT00003461|adult pilocytic astrocytoma|adult pilocytic astrocytoma
776998|NCT00003461|adult giant cell glioblastoma|adult giant cell glioblastoma
776999|NCT00003461|adult gliosarcoma|adult gliosarcoma
777000|NCT00003461|adult pineal gland astrocytoma|adult pineal gland astrocytoma
777001|NCT00003460|Recurrent primitive neuroectodermal tumor|recurrent primitive neuroectodermal tumor
777002|NCT00003459|recurrent adult brain stem glioma|recurrent adult brain stem glioma
777003|NCT00003459|untreated adult brain stem glioma|untreated adult brain stem glioma
777004|NCT00003459|untreated childhood brain stem glioma|untreated childhood brain stem glioma
777005|NCT00003459|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
777006|NCT00003458|Anaplastic astrocytoma|anaplastic astrocytoma
777007|NCT00003458|Anaplastic glioma|anaplastic glioma
777008|NCT00003458|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
777009|NCT00003458|Astrocytoma|astrocytoma
777010|NCT00003458|Astrocytoma pilocytic|astrocytoma pilocytic
777011|NCT00003458|Brain stem glioma|brain stem glioma
777012|NCT00003458|Craniopharyngioma|craniopharyngioma
777013|NCT00003458|Ganglioglioma|ganglioglioma
777014|NCT00003458|Glioblastoma multiforme|glioblastoma multiforme
777015|NCT00003458|Gliosarcoma|gliosarcoma
777016|NCT00003458|Medulloepithelioma|medulloepithelioma
777017|NCT00003458|Neurocytoma|neurocytoma
777018|NCT00003458|Oligodendroglioma|oligodendroglioma
777019|NCT00003458|Oligodendroglioma-brainstem|oligodendroglioma-brainstem
777020|NCT00003458|Primitive neuroectodermal tumor|primitive neuroectodermal tumor
777021|NCT00003457|Anaplastic astrocytoma|anaplastic astrocytoma
777022|NCT00003457|Anaplastic astrocytoma/Mixed|anaplastic astrocytoma/mixed
777023|NCT00003457|Astrocytoma|astrocytoma
777024|NCT00003457|Astrocytoma/Pilocytic|astrocytoma/pilocytic
777025|NCT00003457|Brainstem glioma|brainstem glioma
777026|NCT00003457|Glioblastoma multiforme|glioblastoma multiforme
777027|NCT00003457|Glioma|glioma
777028|NCT00003457|Neurocytoma|neurocytoma
777029|NCT00003457|Primitive neuroectodermal tumor|primitive neuroectodermal tumor
777030|NCT00003457|Tectal glioma|tectal glioma
777031|NCT00003456|adult glioblastoma|adult glioblastoma
777032|NCT00003454|recurrent breast cancer|recurrent breast cancer
777033|NCT00003453|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
777034|NCT00003452|recurrent bladder cancer|recurrent bladder cancer
777035|NCT00003437|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
777036|NCT00003437|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
777037|NCT00003429|stage I cervical cancer|stage i cervical cancer
777038|NCT00003429|stage II cervical cancer|stage ii cervical cancer
777039|NCT00003429|recurrent cervical cancer|recurrent cervical cancer
777040|NCT00003422|stage I rectal cancer|stage i rectal cancer
777041|NCT00003422|stage II rectal cancer|stage ii rectal cancer
777042|NCT00003422|stage III rectal cancer|stage iii rectal cancer
777043|NCT00003422|adenocarcinoma of the rectum|adenocarcinoma of the rectum
777044|NCT00003420|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
777045|NCT00003420|testicular teratoma|testicular teratoma
777046|NCT00003419|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
777047|NCT00003417|adult glioblastoma|adult glioblastoma
777048|NCT00003417|adult giant cell glioblastoma|adult giant cell glioblastoma
777049|NCT00003417|adult gliosarcoma|adult gliosarcoma
777050|NCT00003404|recurrent breast cancer|recurrent breast cancer
777051|NCT00003404|phyllodes tumor|phyllodes tumor
777052|NCT00003389|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
777053|NCT00003389|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
777054|NCT00003389|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
777055|NCT00003389|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
777056|NCT00003389|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
777057|NCT00003389|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
777058|NCT00003389|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
777059|NCT00003385|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
777060|NCT00003385|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
777061|NCT00003385|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
777062|NCT00003385|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
777063|NCT00003385|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
777064|NCT00003385|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
777065|NCT00003385|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
777066|NCT00003385|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
777067|NCT00003385|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
777068|NCT00003385|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
777069|NCT00003385|fallopian tube cancer|fallopian tube cancer
777070|NCT00003385|primary peritoneal cavity cancer|primary peritoneal cavity cancer
777071|NCT00003385|Brenner tumor|brenner tumor
777072|NCT00003379|stage III cervical cancer|stage iii cervical cancer
777073|NCT00003379|stage IB cervical cancer|stage ib cervical cancer
777074|NCT00003379|stage IIB cervical cancer|stage iib cervical cancer
777075|NCT00003379|stage IIA cervical cancer|stage iia cervical cancer
777076|NCT00003379|stage IVA cervical cancer|stage iva cervical cancer
777077|NCT00003379|cervical squamous cell carcinoma|cervical squamous cell carcinoma
777078|NCT00003379|cervical adenocarcinoma|cervical adenocarcinoma
777079|NCT00003379|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
777080|NCT00003379|cervical small cell carcinoma|cervical small cell carcinoma
777081|NCT00003377|stage III cervical cancer|stage iii cervical cancer
777082|NCT00003377|stage IVA cervical cancer|stage iva cervical cancer
777083|NCT00003377|cervical squamous cell carcinoma|cervical squamous cell carcinoma
777084|NCT00003377|cervical adenocarcinoma|cervical adenocarcinoma
777085|NCT00003377|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
777086|NCT00003375|adult oligodendroglioma|adult oligodendroglioma
777087|NCT00003375|adult diffuse astrocytoma|adult diffuse astrocytoma
777088|NCT00003375|adult pilocytic astrocytoma|adult pilocytic astrocytoma
777089|NCT00003354|stage I colon cancer|stage i colon cancer
777090|NCT00003354|stage II colon cancer|stage ii colon cancer
777091|NCT00003354|stage III colon cancer|stage iii colon cancer
777092|NCT00003354|stage IV colon cancer|stage iv colon cancer
777093|NCT00003354|stage 0 colon cancer|stage 0 colon cancer
777094|NCT00003354|stage 0 rectal cancer|stage 0 rectal cancer
777095|NCT00003354|stage I rectal cancer|stage i rectal cancer
777096|NCT00003354|stage II rectal cancer|stage ii rectal cancer
777097|NCT00003354|stage III rectal cancer|stage iii rectal cancer
777098|NCT00003354|stage IV rectal cancer|stage iv rectal cancer
777099|NCT00003342|stage III bladder cancer|stage iii bladder cancer
777100|NCT00003342|stage IV bladder cancer|stage iv bladder cancer
777101|NCT00003342|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
777102|NCT00003342|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
777103|NCT00003342|localized transitional cell cancer of the renal pelvis and ureter|localized transitional cell cancer of the renal pelvis and ureter
777104|NCT00003342|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
777105|NCT00003336|refractory anemia|refractory anemia
777106|NCT00003336|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
777107|NCT00003336|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
777108|NCT00003336|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
777109|NCT00003336|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
777110|NCT00003336|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
777111|NCT00003336|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
777112|NCT00003336|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
777113|NCT00003335|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
777114|NCT00003335|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
777115|NCT00003335|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
777116|NCT00003335|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
777117|NCT00003335|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
777118|NCT00003335|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
777119|NCT00003335|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
777120|NCT00003335|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
777121|NCT00003335|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
777122|NCT00003335|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
777123|NCT00003335|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
777124|NCT00003335|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
777125|NCT00003335|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
777126|NCT00003335|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
777127|NCT00003335|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
777128|NCT00003335|refractory anemia with excess blasts|refractory anemia with excess blasts
777129|NCT00003335|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
777130|NCT00003335|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
777131|NCT00003335|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
777132|NCT00003335|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
777133|NCT00003335|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
777134|NCT00003335|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
777135|NCT00003335|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
777136|NCT00003335|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
777137|NCT00003335|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
777138|NCT00003335|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
777139|NCT00003335|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
777140|NCT00003335|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
777141|NCT00003335|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
777142|NCT00003335|graft versus host disease|graft versus host disease
777143|NCT00003335|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
777144|NCT00003335|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
777145|NCT00003335|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
777146|NCT00003335|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
777147|NCT00003335|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
777148|NCT00003335|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
777149|NCT00003335|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
777150|NCT00003335|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
777151|NCT00003335|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
777152|NCT00003335|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
777153|NCT00003335|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
777154|NCT00003335|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
777155|NCT00003335|splenic marginal zone lymphoma|splenic marginal zone lymphoma
777156|NCT00003335|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
777157|NCT00003335|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
777158|NCT00003335|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
777159|NCT00003335|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
777160|NCT00003335|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
777161|NCT00003335|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
777162|NCT00003332|stage I pancreatic cancer|stage i pancreatic cancer
777163|NCT00003332|stage II pancreatic cancer|stage ii pancreatic cancer
777164|NCT00003332|stage III pancreatic cancer|stage iii pancreatic cancer
777165|NCT00003332|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
777166|NCT00003329|stage I colon cancer|stage i colon cancer
777167|NCT00003329|stage II colon cancer|stage ii colon cancer
777168|NCT00003329|stage III colon cancer|stage iii colon cancer
777169|NCT00003329|stage IV colon cancer|stage iv colon cancer
777170|NCT00003329|stage I breast cancer|stage i breast cancer
777171|NCT00003329|stage II breast cancer|stage ii breast cancer
777172|NCT00003329|stage IIIA breast cancer|stage iiia breast cancer
777173|NCT00003329|stage IIIB breast cancer|stage iiib breast cancer
777174|NCT00003329|stage IIIC breast cancer|stage iiic breast cancer
777175|NCT00003329|stage IV breast cancer|stage iv breast cancer
777176|NCT00003329|stage I non-small cell lung cancer|stage i non-small cell lung cancer
777177|NCT00003329|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
777178|NCT00003329|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
777179|NCT00003329|limited stage small cell lung cancer|limited stage small cell lung cancer
777180|NCT00003329|extensive stage small cell lung cancer|extensive stage small cell lung cancer
777181|NCT00003329|stage I prostate cancer|stage i prostate cancer
777182|NCT00003329|stage II prostate cancer|stage ii prostate cancer
777183|NCT00003329|stage III prostate cancer|stage iii prostate cancer
777184|NCT00003329|stage IV prostate cancer|stage iv prostate cancer
777185|NCT00003329|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
777186|NCT00003325|stage I vulvar cancer|stage i vulvar cancer
777187|NCT00003325|stage II vulvar cancer|stage ii vulvar cancer
777188|NCT00003325|squamous cell carcinoma of the vulva|squamous cell carcinoma of the vulva
777189|NCT00003309|adult medulloblastoma|adult medulloblastoma
777190|NCT00003309|adult anaplastic ependymoma|adult anaplastic ependymoma
777191|NCT00003309|adult ependymoma|adult ependymoma
777192|NCT00003309|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
777193|NCT00003308|metastatic osteosarcoma|metastatic osteosarcoma
777194|NCT00003308|chondrosarcoma|chondrosarcoma
777195|NCT00003308|stage IV renal cell cancer|stage iv renal cell cancer
777196|NCT00003308|stage IV melanoma|stage iv melanoma
777197|NCT00003308|tumors metastatic to brain|tumors metastatic to brain
777198|NCT00003308|stage IV uterine sarcoma|stage iv uterine sarcoma
777199|NCT00003308|ovarian sarcoma|ovarian sarcoma
777200|NCT00003308|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
777201|NCT00003308|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
777202|NCT00003291|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
777203|NCT00003278|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
777204|NCT00003278|intraocular lymphoma|intraocular lymphoma
777205|NCT00003273|childhood infratentorial ependymoma|childhood infratentorial ependymoma
777206|NCT00003273|childhood supratentorial ependymoma|childhood supratentorial ependymoma
777207|NCT00003273|localized resectable neuroblastoma|localized resectable neuroblastoma
777208|NCT00003273|regional neuroblastoma|regional neuroblastoma
777209|NCT00003273|disseminated neuroblastoma|disseminated neuroblastoma
777210|NCT00003273|stage 4S neuroblastoma|stage 4s neuroblastoma
777211|NCT00003273|extraocular retinoblastoma|extraocular retinoblastoma
777212|NCT00003273|childhood choroid plexus tumor|childhood choroid plexus tumor
777213|NCT00003273|localized unresectable neuroblastoma|localized unresectable neuroblastoma
777214|NCT00003273|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
777215|NCT00003273|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
777216|NCT00003273|untreated childhood medulloblastoma|untreated childhood medulloblastoma
777217|NCT00003273|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
777218|NCT00003268|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
777219|NCT00003268|adult acute monoblastic leukemia and acute monocytic leukemia (M5)|adult acute monoblastic leukemia and acute monocytic leukemia (m5)
777220|NCT00003268|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
777221|NCT00003268|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
777222|NCT00003268|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
777223|NCT00003268|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
777224|NCT00003268|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
777225|NCT00003268|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
777226|NCT00003268|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
777227|NCT00003261|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
777228|NCT00003243|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
777229|NCT00003243|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
777230|NCT00003243|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
777231|NCT00003243|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
777232|NCT00003243|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
777233|NCT00003243|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
777234|NCT00003243|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
777235|NCT00003243|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
777236|NCT00003243|acute undifferentiated leukemia|acute undifferentiated leukemia
777237|NCT00003243|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
777238|NCT00003243|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
777239|NCT00003243|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
777240|NCT00003243|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
777241|NCT00003243|secondary acute myeloid leukemia|secondary acute myeloid leukemia
777242|NCT00003243|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
777243|NCT00003243|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
777244|NCT00003243|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
777245|NCT00003243|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
777246|NCT00003243|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
777247|NCT00003243|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
777248|NCT00003243|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
777249|NCT00003216|stage I pancreatic cancer|stage i pancreatic cancer
777250|NCT00003216|stage II pancreatic cancer|stage ii pancreatic cancer
777251|NCT00003216|stage III pancreatic cancer|stage iii pancreatic cancer
777252|NCT00003216|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
777253|NCT00003216|stage IV pancreatic cancer|stage iv pancreatic cancer
777254|NCT00003215|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
777255|NCT00003215|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
777256|NCT00003215|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
777257|NCT00003215|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
777258|NCT00003215|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
777259|NCT00003215|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
777260|NCT00003215|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
777261|NCT00003215|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
777262|NCT00003215|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
777263|NCT00003215|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
777264|NCT00003215|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
777265|NCT00003215|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
777266|NCT00003215|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
777267|NCT00003215|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
790224|NCT00000908|RNA, Viral|rna, viral
777268|NCT00003215|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
777269|NCT00003215|anaplastic large cell lymphoma|anaplastic large cell lymphoma
777270|NCT00003194|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
777271|NCT00003179|endometrial cancer|endometrial cancer
777272|NCT00003178|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
777273|NCT00003178|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
777274|NCT00003178|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
777275|NCT00003178|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
777276|NCT00003178|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
777277|NCT00003178|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
777278|NCT00003178|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
777279|NCT00003178|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
777280|NCT00003178|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
777281|NCT00003178|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
777282|NCT00003174|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
777283|NCT00003174|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
777284|NCT00003174|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
777285|NCT00003174|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
777286|NCT00003174|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
777287|NCT00003159|stage I non-small cell lung cancer|stage i non-small cell lung cancer
777288|NCT00003159|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
777289|NCT00003159|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
777290|NCT00003159|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
777291|NCT00003159|stage 0 non-small cell lung cancer|stage 0 non-small cell lung cancer
777292|NCT00003153|refractory multiple myeloma|refractory multiple myeloma
777293|NCT00003140|stage I breast cancer|stage i breast cancer
777294|NCT00003140|stage II breast cancer|stage ii breast cancer
777295|NCT00003140|stage IIIA breast cancer|stage iiia breast cancer
777296|NCT00003138|anemia|anemia
777297|NCT00003138|refractory anemia|refractory anemia
777298|NCT00003138|myelodysplastic syndromes|myelodysplastic syndromes
777299|NCT00003138|erythropoietin|erythropoietin
777300|NCT00003138|filgrastim|filgrastim
777301|NCT00003135|stage IV breast cancer|stage iv breast cancer
777302|NCT00003135|recurrent breast cancer|recurrent breast cancer
777303|NCT00003135|recurrent cervical cancer|recurrent cervical cancer
777304|NCT00003135|stage IVB cervical cancer|stage ivb cervical cancer
777305|NCT00003135|stage IVA cervical cancer|stage iva cervical cancer
777306|NCT00003135|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
777307|NCT00003135|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
777308|NCT00003135|stage IV endometrial carcinoma|stage iv endometrial carcinoma
777309|NCT00003135|recurrent endometrial carcinoma|recurrent endometrial carcinoma
777310|NCT00003135|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
777311|NCT00003135|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
777312|NCT00003135|male breast cancer|male breast cancer
777313|NCT00003128|stage III uterine sarcoma|stage iii uterine sarcoma
777314|NCT00003128|stage IV uterine sarcoma|stage iv uterine sarcoma
777315|NCT00003128|recurrent uterine sarcoma|recurrent uterine sarcoma
777316|NCT00003128|uterine carcinosarcoma|uterine carcinosarcoma
777317|NCT00003122|localized resectable neuroblastoma|localized resectable neuroblastoma
777318|NCT00003122|localized unresectable neuroblastoma|localized unresectable neuroblastoma
777319|NCT00003119|localized resectable neuroblastoma|localized resectable neuroblastoma
777320|NCT00003119|stage 4S neuroblastoma|stage 4s neuroblastoma
777321|NCT00003116|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
777322|NCT00003116|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
777323|NCT00003116|refractory multiple myeloma|refractory multiple myeloma
777324|NCT00003116|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
777325|NCT00003116|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
777326|NCT00003116|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
777327|NCT00003116|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
777328|NCT00003116|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
777329|NCT00003116|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
777330|NCT00003116|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
777331|NCT00003116|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
777332|NCT00003116|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
777333|NCT00003116|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
777334|NCT00003116|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
777335|NCT00003116|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
777336|NCT00003116|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
777337|NCT00003116|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
777338|NCT00003116|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
777339|NCT00003116|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
777340|NCT00003116|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
777341|NCT00003116|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
777342|NCT00003116|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
777343|NCT00003116|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
777344|NCT00003116|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
777345|NCT00003116|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
777346|NCT00003116|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
777347|NCT00003116|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
777348|NCT00003116|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
777349|NCT00003116|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
777350|NCT00003116|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
777351|NCT00003116|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
777352|NCT00003116|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
777353|NCT00003116|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
777354|NCT00003116|splenic marginal zone lymphoma|splenic marginal zone lymphoma
777355|NCT00003116|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
777356|NCT00003116|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
777357|NCT00003116|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
777358|NCT00003116|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
777359|NCT00003116|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
777360|NCT00003116|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
777361|NCT00003111|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
777362|NCT00003105|stage III bladder cancer|stage iii bladder cancer
777363|NCT00003105|recurrent bladder cancer|recurrent bladder cancer
777364|NCT00003105|stage IV bladder cancer|stage iv bladder cancer
777365|NCT00003105|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
777366|NCT00003105|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
777367|NCT00003105|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
777368|NCT00003105|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
777369|NCT00003104|adenocarcinoma of the prostate|adenocarcinoma of the prostate
777370|NCT00003104|stage IIB prostate cancer|stage iib prostate cancer
777371|NCT00003104|stage IIA prostate cancer|stage iia prostate cancer
777372|NCT00003096|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
777373|NCT00003096|untreated childhood medulloblastoma|untreated childhood medulloblastoma
777374|NCT00003093|regional neuroblastoma|regional neuroblastoma
777375|NCT00003093|disseminated neuroblastoma|disseminated neuroblastoma
777376|NCT00003093|stage 4S neuroblastoma|stage 4s neuroblastoma
777377|NCT00003093|localized unresectable neuroblastoma|localized unresectable neuroblastoma
777378|NCT00003092|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
777379|NCT00003067|recurrent adult brain tumor|recurrent adult brain tumor
777380|NCT00003067|adult glioblastoma|adult glioblastoma
777381|NCT00003067|adult anaplastic astrocytoma|adult anaplastic astrocytoma
777382|NCT00003067|adult mixed glioma|adult mixed glioma
777383|NCT00003067|adult giant cell glioblastoma|adult giant cell glioblastoma
777384|NCT00003067|adult gliosarcoma|adult gliosarcoma
777385|NCT00003065|recurrent cervical cancer|recurrent cervical cancer
777386|NCT00003065|stage IVB cervical cancer|stage ivb cervical cancer
777387|NCT00003065|stage IVA cervical cancer|stage iva cervical cancer
777388|NCT00003065|cervical squamous cell carcinoma|cervical squamous cell carcinoma
777389|NCT00003065|cervical adenocarcinoma|cervical adenocarcinoma
777390|NCT00003063|stage II colon cancer|stage ii colon cancer
777391|NCT00003063|stage III colon cancer|stage iii colon cancer
777392|NCT00003063|stage II rectal cancer|stage ii rectal cancer
777393|NCT00003063|stage III rectal cancer|stage iii rectal cancer
777394|NCT00003053|stage I non-small cell lung cancer|stage i non-small cell lung cancer
777395|NCT00003053|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
777396|NCT00003053|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
777397|NCT00003052|adult angiosarcoma|adult angiosarcoma
777398|NCT00003052|adult fibrosarcoma|adult fibrosarcoma
777399|NCT00003052|adult leiomyosarcoma|adult leiomyosarcoma
777400|NCT00003052|adult liposarcoma|adult liposarcoma
777401|NCT00003052|adult neurofibrosarcoma|adult neurofibrosarcoma
777402|NCT00003052|adult synovial sarcoma|adult synovial sarcoma
777403|NCT00003052|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
777404|NCT00003052|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
777405|NCT00003052|adult extraskeletal osteosarcoma|adult extraskeletal osteosarcoma
777406|NCT00003052|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
777407|NCT00003052|adult rhabdomyosarcoma|adult rhabdomyosarcoma
777408|NCT00003052|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
777409|NCT00003052|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
777410|NCT00003049|stage I pancreatic cancer|stage i pancreatic cancer
777411|NCT00003049|stage II pancreatic cancer|stage ii pancreatic cancer
777412|NCT00003049|stage III pancreatic cancer|stage iii pancreatic cancer
777413|NCT00003049|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
777414|NCT00003042|stage IIIB breast cancer|stage iiib breast cancer
777415|NCT00003042|inflammatory breast cancer|inflammatory breast cancer
777416|NCT00003034|localized malignant mesothelioma|localized malignant mesothelioma
777417|NCT00003034|advanced malignant mesothelioma|advanced malignant mesothelioma
777418|NCT00003034|recurrent malignant mesothelioma|recurrent malignant mesothelioma
777419|NCT00003029|stage III pancreatic cancer|stage iii pancreatic cancer
777420|NCT00003029|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
777421|NCT00003029|stage IV pancreatic cancer|stage iv pancreatic cancer
777422|NCT00003027|stage IV melanoma|stage iv melanoma
777423|NCT00003026|adenocarcinoma of the prostate|adenocarcinoma of the prostate
777424|NCT00003023|metastatic osteosarcoma|metastatic osteosarcoma
777425|NCT00003023|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
777426|NCT00003023|disseminated neuroblastoma|disseminated neuroblastoma
777427|NCT00003023|stage 4S neuroblastoma|stage 4s neuroblastoma
777428|NCT00003023|recurrent neuroblastoma|recurrent neuroblastoma
777429|NCT00003023|recurrent osteosarcoma|recurrent osteosarcoma
777430|NCT00003023|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
777431|NCT00003023|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
777432|NCT00003023|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
777433|NCT00003022|metastatic osteosarcoma|metastatic osteosarcoma
777434|NCT00003022|childhood infratentorial ependymoma|childhood infratentorial ependymoma
777435|NCT00003022|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
777436|NCT00003022|childhood supratentorial ependymoma|childhood supratentorial ependymoma
777437|NCT00003022|regional neuroblastoma|regional neuroblastoma
777438|NCT00003022|disseminated neuroblastoma|disseminated neuroblastoma
777439|NCT00003022|stage 4S neuroblastoma|stage 4s neuroblastoma
777440|NCT00003022|recurrent neuroblastoma|recurrent neuroblastoma
777441|NCT00003022|retinoblastoma|retinoblastoma
777442|NCT00003022|intraocular retinoblastoma|intraocular retinoblastoma
777443|NCT00003022|extraocular retinoblastoma|extraocular retinoblastoma
777444|NCT00003022|recurrent retinoblastoma|recurrent retinoblastoma
777445|NCT00003022|extensive stage small cell lung cancer|extensive stage small cell lung cancer
777446|NCT00003022|recurrent small cell lung cancer|recurrent small cell lung cancer
777447|NCT00003022|recurrent osteosarcoma|recurrent osteosarcoma
777448|NCT00003022|recurrent adult brain tumor|recurrent adult brain tumor
777449|NCT00003022|iris melanoma|iris melanoma
777450|NCT00003022|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
777451|NCT00003022|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
777452|NCT00003022|extraocular extension melanoma|extraocular extension melanoma
777453|NCT00003022|recurrent intraocular melanoma|recurrent intraocular melanoma
777454|NCT00003022|adult brain stem glioma|adult brain stem glioma
777455|NCT00003022|adult medulloblastoma|adult medulloblastoma
777456|NCT00003022|stage IV melanoma|stage iv melanoma
777457|NCT00003022|recurrent melanoma|recurrent melanoma
777458|NCT00003022|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
777459|NCT00003022|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
777460|NCT00003022|adult myxopapillary ependymoma|adult myxopapillary ependymoma
777461|NCT00003022|adult anaplastic ependymoma|adult anaplastic ependymoma
777462|NCT00003022|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
777463|NCT00003022|adult mixed glioma|adult mixed glioma
777464|NCT00003022|localized unresectable neuroblastoma|localized unresectable neuroblastoma
777465|NCT00003022|adult ependymoblastoma|adult ependymoblastoma
777466|NCT00003022|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
777467|NCT00003022|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
777468|NCT00003022|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
777469|NCT00003022|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
777470|NCT00003022|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
777471|NCT00003022|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
777472|NCT00003022|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
777473|NCT00003022|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
777474|NCT00003022|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
777475|NCT00003022|recurrent childhood ependymoma|recurrent childhood ependymoma
777476|NCT00003022|adult oligodendroglioma|adult oligodendroglioma
777477|NCT00003022|adult anaplastic astrocytoma|adult anaplastic astrocytoma
777548|NCT00002943|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
777478|NCT00003022|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
777479|NCT00003022|adult diffuse astrocytoma|adult diffuse astrocytoma
777480|NCT00003022|adult pilocytic astrocytoma|adult pilocytic astrocytoma
777481|NCT00003022|adult giant cell glioblastoma|adult giant cell glioblastoma
777482|NCT00003022|adult glioblastoma|adult glioblastoma
777483|NCT00003022|adult gliosarcoma|adult gliosarcoma
777484|NCT00003016|stage I breast cancer|stage i breast cancer
777485|NCT00003016|stage II breast cancer|stage ii breast cancer
777486|NCT00003016|stage IIIA breast cancer|stage iiia breast cancer
777487|NCT00003016|stage IIIB breast cancer|stage iiib breast cancer
777488|NCT00003016|stage IIIC breast cancer|stage iiic breast cancer
777489|NCT00003013|stage II breast cancer|stage ii breast cancer
777490|NCT00003013|stage IIIA breast cancer|stage iiia breast cancer
777491|NCT00002996|pain|pain
777492|NCT00002995|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
777493|NCT00002995|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
777494|NCT00002995|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
777495|NCT00002995|adult rhabdomyosarcoma|adult rhabdomyosarcoma
777496|NCT00002995|adult malignant mesenchymoma|adult malignant mesenchymoma
777497|NCT00002995|childhood malignant mesenchymoma|childhood malignant mesenchymoma
778615|NCT00051142|Glaucoma|glaucoma
777498|NCT00002995|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
777499|NCT00002995|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
777500|NCT00002995|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
777501|NCT00002995|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
777502|NCT00002990|stage 0 bladder cancer|stage 0 bladder cancer
777503|NCT00002990|stage I bladder cancer|stage i bladder cancer
777504|NCT00002990|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
777505|NCT00002986|recurrent adult brain tumor|recurrent adult brain tumor
777506|NCT00002982|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
777507|NCT00002982|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
777508|NCT00002982|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
777509|NCT00002982|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
777510|NCT00002982|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
777511|NCT00002982|anaplastic large cell lymphoma|anaplastic large cell lymphoma
777512|NCT00002981|adenocarcinoma of the prostate|adenocarcinoma of the prostate
777513|NCT00002981|stage IV prostate cancer|stage iv prostate cancer
777514|NCT00002981|recurrent prostate cancer|recurrent prostate cancer
777515|NCT00002976|stage I endometrial carcinoma|stage i endometrial carcinoma
777516|NCT00002976|stage II endometrial carcinoma|stage ii endometrial carcinoma
777517|NCT00002976|endometrial adenocarcinoma|endometrial adenocarcinoma
777518|NCT00002975|basal cell carcinoma of the skin|basal cell carcinoma of the skin
777519|NCT00002975|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
777520|NCT00002975|actinic keratosis|actinic keratosis
777521|NCT00002963|basal cell carcinoma of the skin|basal cell carcinoma of the skin
777522|NCT00002963|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
777523|NCT00002951|stage II esophageal cancer|stage ii esophageal cancer
777524|NCT00002951|stage III esophageal cancer|stage iii esophageal cancer
777525|NCT00002951|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
777526|NCT00002951|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
777527|NCT00002951|stage II lip and oral cavity cancer|stage ii lip and oral cavity cancer
777528|NCT00002951|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
777529|NCT00002951|stage II hypopharyngeal cancer|stage ii hypopharyngeal cancer
777530|NCT00002951|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
777531|NCT00002951|stage II laryngeal cancer|stage ii laryngeal cancer
777532|NCT00002951|stage III laryngeal cancer|stage iii laryngeal cancer
777533|NCT00002951|stage II paranasal sinus and nasal cavity cancer|stage ii paranasal sinus and nasal cavity cancer
777534|NCT00002951|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
777535|NCT00002951|stage II oropharyngeal cancer|stage ii oropharyngeal cancer
777536|NCT00002951|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
777537|NCT00002948|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
777538|NCT00002944|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
777539|NCT00002944|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
777540|NCT00002944|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
777541|NCT00002944|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
777542|NCT00002944|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
777543|NCT00002944|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
777544|NCT00002943|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
777545|NCT00002943|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
777546|NCT00002943|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
777547|NCT00002943|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
790323|NCT00000897|Sex Factors|sex factors
777549|NCT00002943|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
777550|NCT00002943|extragonadal germ cell tumor|extragonadal germ cell tumor
777551|NCT00002941|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
777552|NCT00002941|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
777553|NCT00002941|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
777554|NCT00002941|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
777555|NCT00002941|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
777556|NCT00002941|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
777557|NCT00002938|recurrent prostate cancer|recurrent prostate cancer
777558|NCT00002931|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
777559|NCT00002931|testicular seminoma|testicular seminoma
777560|NCT00002931|testicular embryonal carcinoma|testicular embryonal carcinoma
777561|NCT00002931|testicular choriocarcinoma|testicular choriocarcinoma
777562|NCT00002931|testicular yolk sac tumor|testicular yolk sac tumor
777563|NCT00002931|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
777564|NCT00002931|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
777565|NCT00002931|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
777566|NCT00002931|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
777567|NCT00002931|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
777568|NCT00002931|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
777569|NCT00002931|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
777570|NCT00002931|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
777571|NCT00002931|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
777572|NCT00002931|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
777573|NCT00002931|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
777574|NCT00002931|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
777575|NCT00002931|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
777576|NCT00002931|recurrent extragonadal seminoma|recurrent extragonadal seminoma
777577|NCT00002931|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
777578|NCT00002931|adult teratoma|adult teratoma
777579|NCT00002931|testicular immature teratoma|testicular immature teratoma
777580|NCT00002931|testicular mature teratoma|testicular mature teratoma
777581|NCT00002931|ovarian immature teratoma|ovarian immature teratoma
777582|NCT00002931|ovarian mature teratoma|ovarian mature teratoma
777583|NCT00002931|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
777584|NCT00002931|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
777585|NCT00002931|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
777586|NCT00002931|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
777587|NCT00002931|stage IV extragonadal seminoma|stage iv extragonadal seminoma
777588|NCT00002931|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
777589|NCT00002926|secondary acute myeloid leukemia|secondary acute myeloid leukemia
777590|NCT00002926|refractory anemia|refractory anemia
777591|NCT00002926|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
777592|NCT00002926|refractory anemia with excess blasts|refractory anemia with excess blasts
777593|NCT00002926|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
777594|NCT00002926|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
777595|NCT00002926|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
777596|NCT00002926|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
777597|NCT00002926|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
777598|NCT00002926|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
777599|NCT00002926|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
777600|NCT00002920|endometrial cancer|endometrial cancer
777601|NCT00002920|stage I breast cancer|stage i breast cancer
777602|NCT00002920|stage II breast cancer|stage ii breast cancer
777603|NCT00002920|ductal breast carcinoma in situ|ductal breast carcinoma in situ
777604|NCT00002920|lobular breast carcinoma in situ|lobular breast carcinoma in situ
777605|NCT00002920|Paget disease of the breast|paget disease of the breast
777606|NCT00002916|stage IB cervical cancer|stage ib cervical cancer
777607|NCT00002916|stage IIA cervical cancer|stage iia cervical cancer
777608|NCT00002916|cervical squamous cell carcinoma|cervical squamous cell carcinoma
777609|NCT00002916|cervical adenocarcinoma|cervical adenocarcinoma
777610|NCT00002916|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
777611|NCT00002900|stage I breast cancer|stage i breast cancer
777612|NCT00002900|stage II breast cancer|stage ii breast cancer
777613|NCT00002900|ductal breast carcinoma|ductal breast carcinoma
777614|NCT00002900|cardiac toxicity|cardiac toxicity
777615|NCT00002899|tumors metastatic to brain|tumors metastatic to brain
777616|NCT00002898|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
790519|NCT00000874|Stavudine|stavudine
777617|NCT00002898|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
777618|NCT00002898|pleomorphic childhood rhabdomyosarcoma|pleomorphic childhood rhabdomyosarcoma
777619|NCT00002898|mixed childhood rhabdomyosarcoma|mixed childhood rhabdomyosarcoma
777620|NCT00002898|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
777621|NCT00002898|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
777622|NCT00002898|childhood fibrosarcoma|childhood fibrosarcoma
777623|NCT00002898|childhood synovial sarcoma|childhood synovial sarcoma
777624|NCT00002898|childhood malignant hemangiopericytoma|childhood malignant hemangiopericytoma
777625|NCT00002898|childhood liposarcoma|childhood liposarcoma
777626|NCT00002898|childhood alveolar soft-part sarcoma|childhood alveolar soft-part sarcoma
777627|NCT00002898|childhood leiomyosarcoma|childhood leiomyosarcoma
777628|NCT00002898|childhood neurofibrosarcoma|childhood neurofibrosarcoma
777629|NCT00002898|childhood angiosarcoma|childhood angiosarcoma
777630|NCT00002898|childhood epithelioid sarcoma|childhood epithelioid sarcoma
777631|NCT00002898|childhood malignant fibrous histiocytoma of bone|childhood malignant fibrous histiocytoma of bone
777632|NCT00002898|childhood malignant mesenchymoma|childhood malignant mesenchymoma
777633|NCT00002898|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
777634|NCT00002898|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
777635|NCT00002898|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
777636|NCT00002895|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
777637|NCT00002895|primary peritoneal cavity cancer|primary peritoneal cavity cancer
777638|NCT00002895|fallopian tube cancer|fallopian tube cancer
777639|NCT00002894|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
777640|NCT00002894|primary peritoneal cavity cancer|primary peritoneal cavity cancer
777641|NCT00002883|stage I gastric cancer|stage i gastric cancer
777642|NCT00002883|stage II gastric cancer|stage ii gastric cancer
777643|NCT00002883|stage I esophageal cancer|stage i esophageal cancer
777644|NCT00002883|stage II esophageal cancer|stage ii esophageal cancer
777645|NCT00002883|adenocarcinoma of the stomach|adenocarcinoma of the stomach
777646|NCT00002883|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
777647|NCT00002882|stage III melanoma|stage iii melanoma
777648|NCT00002874|stage IIB prostate cancer|stage iib prostate cancer
777649|NCT00002874|stage IIA prostate cancer|stage iia prostate cancer
777650|NCT00002874|stage III prostate cancer|stage iii prostate cancer
777651|NCT00002874|recurrent prostate cancer|recurrent prostate cancer
777652|NCT00002860|stage IV melanoma|stage iv melanoma
777653|NCT00002860|recurrent melanoma|recurrent melanoma
777654|NCT00002855|adenocarcinoma of the prostate|adenocarcinoma of the prostate
777655|NCT00002855|stage III prostate cancer|stage iii prostate cancer
777656|NCT00002855|stage IV prostate cancer|stage iv prostate cancer
777657|NCT00002855|recurrent prostate cancer|recurrent prostate cancer
777658|NCT00002854|stage IV colon cancer|stage iv colon cancer
777659|NCT00002854|stage II breast cancer|stage ii breast cancer
777660|NCT00002854|stage IV breast cancer|stage iv breast cancer
777661|NCT00002854|stage IIIA breast cancer|stage iiia breast cancer
777662|NCT00002854|recurrent breast cancer|recurrent breast cancer
777663|NCT00002854|stage IV gastric cancer|stage iv gastric cancer
777664|NCT00002854|recurrent gastric cancer|recurrent gastric cancer
777665|NCT00002854|localized osteosarcoma|localized osteosarcoma
777666|NCT00002854|metastatic osteosarcoma|metastatic osteosarcoma
777667|NCT00002854|stage IIIB breast cancer|stage iiib breast cancer
777668|NCT00002854|recurrent pancreatic cancer|recurrent pancreatic cancer
777669|NCT00002854|stage IV rectal cancer|stage iv rectal cancer
777670|NCT00002854|recurrent colon cancer|recurrent colon cancer
777671|NCT00002854|recurrent rectal cancer|recurrent rectal cancer
777672|NCT00002854|stage IV anal cancer|stage iv anal cancer
777673|NCT00002854|recurrent anal cancer|recurrent anal cancer
777674|NCT00002854|stage IV esophageal cancer|stage iv esophageal cancer
777675|NCT00002854|recurrent esophageal cancer|recurrent esophageal cancer
777676|NCT00002854|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
777677|NCT00002854|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
777678|NCT00002854|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
777679|NCT00002854|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
777680|NCT00002854|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
777681|NCT00002854|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
777682|NCT00002854|advanced adult primary liver cancer|advanced adult primary liver cancer
777683|NCT00002854|recurrent adult primary liver cancer|recurrent adult primary liver cancer
777684|NCT00002854|recurrent osteosarcoma|recurrent osteosarcoma
777685|NCT00002854|recurrent gallbladder cancer|recurrent gallbladder cancer
777686|NCT00002854|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
777687|NCT00002854|recurrent small intestine cancer|recurrent small intestine cancer
777688|NCT00002854|stage II melanoma|stage ii melanoma
777689|NCT00002854|stage III melanoma|stage iii melanoma
777690|NCT00002854|stage IV melanoma|stage iv melanoma
777691|NCT00002854|recurrent melanoma|recurrent melanoma
777692|NCT00002854|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
777693|NCT00002854|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
777694|NCT00002854|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
777695|NCT00002854|stage IV pancreatic cancer|stage iv pancreatic cancer
777696|NCT00002851|stage I breast cancer|stage i breast cancer
777697|NCT00002851|stage II breast cancer|stage ii breast cancer
777698|NCT00002851|stage IIIA breast cancer|stage iiia breast cancer
777699|NCT00002850|stage I multiple myeloma|stage i multiple myeloma
777700|NCT00002850|stage II multiple myeloma|stage ii multiple myeloma
777701|NCT00002850|stage III multiple myeloma|stage iii multiple myeloma
777702|NCT00002850|infection|infection
777703|NCT00002849|primary systemic amyloidosis|primary systemic amyloidosis
777704|NCT00002848|stage I prostate cancer|stage i prostate cancer
777705|NCT00002848|stage IIB prostate cancer|stage iib prostate cancer
777706|NCT00002848|stage IIA prostate cancer|stage iia prostate cancer
777707|NCT00002848|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
777708|NCT00002847|stage IV renal cell cancer|stage iv renal cell cancer
777709|NCT00002847|recurrent renal cell cancer|recurrent renal cell cancer
777710|NCT00002846|stage IV renal cell cancer|stage iv renal cell cancer
777711|NCT00002846|recurrent renal cell cancer|recurrent renal cell cancer
777712|NCT00002842|stage IV colon cancer|stage iv colon cancer
777713|NCT00002842|stage IV rectal cancer|stage iv rectal cancer
777714|NCT00002842|recurrent colon cancer|recurrent colon cancer
777715|NCT00002842|recurrent rectal cancer|recurrent rectal cancer
777716|NCT00002842|liver metastases|liver metastases
777717|NCT00002839|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
777718|NCT00002839|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
777719|NCT00002839|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
777720|NCT00002839|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
777721|NCT00002839|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
777722|NCT00002810|refractory multiple myeloma|refractory multiple myeloma
777723|NCT00002810|stage I multiple myeloma|stage i multiple myeloma
777724|NCT00002810|stage II multiple myeloma|stage ii multiple myeloma
777725|NCT00002810|stage III multiple myeloma|stage iii multiple myeloma
777726|NCT00002810|primary systemic amyloidosis|primary systemic amyloidosis
777727|NCT00002809|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
777728|NCT00002809|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
777729|NCT00002809|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
777730|NCT00002809|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
777731|NCT00002809|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
777732|NCT00002809|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
777733|NCT00002809|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
777734|NCT00002809|refractory anemia|refractory anemia
777735|NCT00002809|refractory anemia with excess blasts|refractory anemia with excess blasts
777736|NCT00002809|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
777737|NCT00002809|secondary acute myeloid leukemia|secondary acute myeloid leukemia
777738|NCT00002809|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
777739|NCT00002809|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
777740|NCT00002809|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
777741|NCT00002809|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
777742|NCT00002809|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
777743|NCT00002809|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
777744|NCT00002809|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
777745|NCT00002809|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
777746|NCT00002807|stage I endometrial carcinoma|stage i endometrial carcinoma
777747|NCT00002807|stage II endometrial carcinoma|stage ii endometrial carcinoma
777748|NCT00002807|endometrial adenocarcinoma|endometrial adenocarcinoma
777749|NCT00002807|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
777750|NCT00002807|endometrial papillary carcinoma|endometrial papillary carcinoma
777751|NCT00002807|endometrial clear cell carcinoma|endometrial clear cell carcinoma
777752|NCT00002792|polycythemia vera|polycythemia vera
777753|NCT00002792|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
777754|NCT00002792|essential thrombocythemia|essential thrombocythemia
777755|NCT00002792|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
777756|NCT00002792|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
777757|NCT00002778|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
777758|NCT00002778|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
777759|NCT00002778|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
777760|NCT00002778|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
790617|NCT00000862|Labor|labor
777761|NCT00002778|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
777762|NCT00002778|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
777763|NCT00002771|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
777764|NCT00002771|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
777765|NCT00002771|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
777766|NCT00002771|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
777767|NCT00002766|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
777768|NCT00002766|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
777769|NCT00002766|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
777770|NCT00002766|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
777771|NCT00002766|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
777772|NCT00002766|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
777773|NCT00002766|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
777774|NCT00002766|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
777775|NCT00002766|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
777776|NCT00002766|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
777777|NCT00002766|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
777778|NCT00002762|stage I breast cancer|stage i breast cancer
777779|NCT00002762|stage II breast cancer|stage ii breast cancer
777780|NCT00002762|perioperative/postoperative complications|perioperative/postoperative complications
777781|NCT00002757|childhood Burkitt lymphoma|childhood burkitt lymphoma
777782|NCT00002757|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
777783|NCT00002757|L3 childhood acute lymphoblastic leukemia|l3 childhood acute lymphoblastic leukemia
777784|NCT00002757|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
777785|NCT00002757|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
777786|NCT00002757|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
777787|NCT00002757|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
777788|NCT00002757|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
777789|NCT00002757|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
777790|NCT00002757|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
777791|NCT00002757|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
778616|NCT00051142|POAG|poag
777792|NCT00002756|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
777793|NCT00002756|acute undifferentiated leukemia|acute undifferentiated leukemia
777794|NCT00002746|refractory anemia|refractory anemia
777795|NCT00002746|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
777796|NCT00002746|refractory anemia with excess blasts|refractory anemia with excess blasts
777797|NCT00002746|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
777798|NCT00002746|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
777799|NCT00002746|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
777800|NCT00002746|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
777801|NCT00002746|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
777802|NCT00002746|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
777803|NCT00002746|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
777804|NCT00002738|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
777805|NCT00002738|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
777806|NCT00002738|recurrent osteosarcoma|recurrent osteosarcoma
777807|NCT00002738|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
777808|NCT00002738|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
777809|NCT00002727|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
777810|NCT00002720|stage I breast cancer|stage i breast cancer
777811|NCT00002718|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
777812|NCT00002718|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
777813|NCT00002718|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
777814|NCT00002718|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
777815|NCT00002718|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
777816|NCT00002718|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
777817|NCT00002718|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
777818|NCT00002718|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
777819|NCT00002718|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
777820|NCT00002718|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
777821|NCT00002718|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
777953|NCT00002663|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
777822|NCT00002718|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
777823|NCT00002718|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
777824|NCT00002718|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
777825|NCT00002718|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
777826|NCT00002718|secondary acute myeloid leukemia|secondary acute myeloid leukemia
777827|NCT00002718|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
777828|NCT00002718|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
777829|NCT00002718|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
777830|NCT00002718|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
777831|NCT00002718|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
777832|NCT00002718|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
777833|NCT00002718|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
777834|NCT00002718|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
777835|NCT00002718|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
777836|NCT00002716|stage IV colon cancer|stage iv colon cancer
777837|NCT00002716|stage IV rectal cancer|stage iv rectal cancer
777838|NCT00002716|recurrent colon cancer|recurrent colon cancer
777839|NCT00002716|recurrent rectal cancer|recurrent rectal cancer
777840|NCT00002716|adenocarcinoma of the colon|adenocarcinoma of the colon
777841|NCT00002716|adenocarcinoma of the rectum|adenocarcinoma of the rectum
777842|NCT00002716|liver metastases|liver metastases
777843|NCT00002715|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
777844|NCT00002715|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
777845|NCT00002715|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
777846|NCT00002715|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
777847|NCT00002715|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
777848|NCT00002715|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
777849|NCT00002715|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
777850|NCT00002715|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
777851|NCT00002702|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
777852|NCT00002702|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
777853|NCT00002702|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
777854|NCT00002702|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
777855|NCT00002702|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
777856|NCT00002702|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
777857|NCT00002702|tongue cancer|tongue cancer
777858|NCT00002700|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
777859|NCT00002700|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
777860|NCT00002700|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
777861|NCT00002700|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
777862|NCT00002700|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
777863|NCT00002700|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
777864|NCT00002697|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
777865|NCT00002697|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
777866|NCT00002697|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
777867|NCT00002697|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
777868|NCT00002697|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
777869|NCT00002697|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
777870|NCT00002697|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
777871|NCT00002697|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
777872|NCT00002697|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
777873|NCT00002697|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
777874|NCT00002697|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
777875|NCT00002697|splenic marginal zone lymphoma|splenic marginal zone lymphoma
777876|NCT00002696|stage IIIA breast cancer|stage iiia breast cancer
777877|NCT00002696|stage IIIB breast cancer|stage iiib breast cancer
777878|NCT00002696|stage IIIC breast cancer|stage iiic breast cancer
777879|NCT00002689|stage I pancreatic cancer|stage i pancreatic cancer
777880|NCT00002689|stage II pancreatic cancer|stage ii pancreatic cancer
777881|NCT00002689|stage III pancreatic cancer|stage iii pancreatic cancer
777882|NCT00002689|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
777883|NCT00002687|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
777884|NCT00002687|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
778617|NCT00051142|OAG|oag
777885|NCT00002687|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
778080|NCT00002647|adult diffuse astrocytoma|adult diffuse astrocytoma
777886|NCT00002687|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
777887|NCT00002687|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
777888|NCT00002687|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
777889|NCT00002687|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
777890|NCT00002687|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
777891|NCT00002684|stage III bladder cancer|stage iii bladder cancer
777892|NCT00002684|recurrent bladder cancer|recurrent bladder cancer
777893|NCT00002684|stage IV bladder cancer|stage iv bladder cancer
777894|NCT00002684|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
777895|NCT00002684|adenocarcinoma of the bladder|adenocarcinoma of the bladder
777896|NCT00002684|recurrent urethral cancer|recurrent urethral cancer
777897|NCT00002684|distal urethral cancer|distal urethral cancer
777898|NCT00002684|proximal urethral cancer|proximal urethral cancer
777899|NCT00002684|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
777900|NCT00002681|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
777901|NCT00002681|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
777902|NCT00002681|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
777903|NCT00002681|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
777904|NCT00002681|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
777905|NCT00002678|stage I multiple myeloma|stage i multiple myeloma
777906|NCT00002678|stage II multiple myeloma|stage ii multiple myeloma
777907|NCT00002678|stage III multiple myeloma|stage iii multiple myeloma
777908|NCT00002668|stage IV breast cancer|stage iv breast cancer
777909|NCT00002668|recurrent breast cancer|recurrent breast cancer
777910|NCT00002668|stage IV prostate cancer|stage iv prostate cancer
777911|NCT00002668|recurrent prostate cancer|recurrent prostate cancer
777912|NCT00002668|pain|pain
777913|NCT00002663|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
777914|NCT00002663|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
777915|NCT00002663|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
777916|NCT00002663|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
777917|NCT00002663|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
777918|NCT00002663|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
777919|NCT00002663|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
777920|NCT00002663|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
777921|NCT00002663|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
777922|NCT00002663|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
777923|NCT00002663|childhood Burkitt lymphoma|childhood burkitt lymphoma
777924|NCT00002663|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
777925|NCT00002663|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
777926|NCT00002663|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
777927|NCT00002663|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
777928|NCT00002663|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
777929|NCT00002663|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
777930|NCT00002663|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
777931|NCT00002663|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
777932|NCT00002663|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
777933|NCT00002663|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
777934|NCT00002663|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
777935|NCT00002663|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
777936|NCT00002663|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
777937|NCT00002663|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
777938|NCT00002663|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
777939|NCT00002663|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
777940|NCT00002663|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
777941|NCT00002663|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
777942|NCT00002663|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
777943|NCT00002663|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
777944|NCT00002663|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
777945|NCT00002663|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
777946|NCT00002663|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
777947|NCT00002663|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
777948|NCT00002663|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
777949|NCT00002663|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
777950|NCT00002663|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
777951|NCT00002663|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
777952|NCT00002663|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
777954|NCT00002663|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
777955|NCT00002663|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
777956|NCT00002663|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
777957|NCT00002663|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
777958|NCT00002663|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
777959|NCT00002663|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
777960|NCT00002663|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
777961|NCT00002663|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
777962|NCT00002663|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
777963|NCT00002663|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
777964|NCT00002663|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
777965|NCT00002663|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
777966|NCT00002663|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
777967|NCT00002663|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
777968|NCT00002663|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
777969|NCT00002663|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
777970|NCT00002663|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
777971|NCT00002663|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
777972|NCT00002663|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
777973|NCT00002663|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
777974|NCT00002663|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
777975|NCT00002663|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
777976|NCT00002663|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
777977|NCT00002663|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
777978|NCT00002663|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
777979|NCT00002663|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
777980|NCT00002663|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
777981|NCT00002663|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
777982|NCT00002663|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
777983|NCT00002663|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
777984|NCT00002663|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
777985|NCT00002663|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
777986|NCT00002663|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
777987|NCT00002663|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
777988|NCT00002663|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
777989|NCT00002663|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
777990|NCT00002663|stage I mantle cell lymphoma|stage i mantle cell lymphoma
777991|NCT00002663|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
777992|NCT00002663|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
777993|NCT00002663|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
777994|NCT00002663|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
777995|NCT00002663|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
777996|NCT00002663|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
777997|NCT00002663|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
777998|NCT00002663|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
777999|NCT00002663|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
778000|NCT00002663|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
778001|NCT00002663|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
778002|NCT00002663|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
778003|NCT00002663|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
778004|NCT00002663|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
778005|NCT00002663|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
778006|NCT00002663|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
778007|NCT00002663|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
778008|NCT00002663|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
778009|NCT00002663|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
778010|NCT00002663|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
778011|NCT00002663|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
778012|NCT00002663|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
778013|NCT00002663|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
778014|NCT00002663|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
778015|NCT00002663|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
778016|NCT00002663|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
778017|NCT00002663|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
778018|NCT00002663|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
778019|NCT00002663|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
778020|NCT00002663|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
778021|NCT00002663|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
778022|NCT00002663|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
778023|NCT00002663|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
778024|NCT00002663|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
778025|NCT00002663|splenic marginal zone lymphoma|splenic marginal zone lymphoma
778026|NCT00002663|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
778027|NCT00002663|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
778028|NCT00002663|stage I marginal zone lymphoma|stage i marginal zone lymphoma
778029|NCT00002663|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
778030|NCT00002663|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
778031|NCT00002663|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
778032|NCT00002663|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
778033|NCT00002663|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
778034|NCT00002663|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
778035|NCT00002663|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
778036|NCT00002662|stage IV breast cancer|stage iv breast cancer
778037|NCT00002662|stage IIIA breast cancer|stage iiia breast cancer
778038|NCT00002662|recurrent breast cancer|recurrent breast cancer
778039|NCT00002662|stage IIIB breast cancer|stage iiib breast cancer
778040|NCT00002662|stage IIIC breast cancer|stage iiic breast cancer
778041|NCT00002651|adenocarcinoma of the prostate|adenocarcinoma of the prostate
778042|NCT00002651|stage IV prostate cancer|stage iv prostate cancer
778043|NCT00002651|recurrent prostate cancer|recurrent prostate cancer
778044|NCT00002647|recurrent adult brain tumor|recurrent adult brain tumor
778045|NCT00002647|tumors metastatic to brain|tumors metastatic to brain
778046|NCT00002647|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
778047|NCT00002647|recurrent childhood anaplastic astrocytoma|recurrent childhood anaplastic astrocytoma
778048|NCT00002647|recurrent childhood anaplastic oligoastrocytoma|recurrent childhood anaplastic oligoastrocytoma
778049|NCT00002647|recurrent childhood anaplastic oligodendroglioma|recurrent childhood anaplastic oligodendroglioma
778050|NCT00002647|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
778051|NCT00002647|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
778052|NCT00002647|recurrent childhood diffuse astrocytoma|recurrent childhood diffuse astrocytoma
778053|NCT00002647|recurrent childhood fibrillary astrocytoma|recurrent childhood fibrillary astrocytoma
778054|NCT00002647|recurrent childhood gemistocytic astrocytoma|recurrent childhood gemistocytic astrocytoma
778055|NCT00002647|recurrent childhood giant cell glioblastoma|recurrent childhood giant cell glioblastoma
778056|NCT00002647|recurrent childhood glioblastoma|recurrent childhood glioblastoma
778057|NCT00002647|recurrent childhood gliomatosis cerebri|recurrent childhood gliomatosis cerebri
778058|NCT00002647|recurrent childhood gliosarcoma|recurrent childhood gliosarcoma
778059|NCT00002647|recurrent childhood oligodendroglioma|recurrent childhood oligodendroglioma
778060|NCT00002647|recurrent childhood pilocytic astrocytoma|recurrent childhood pilocytic astrocytoma
778061|NCT00002647|recurrent childhood pilomyxoid astrocytoma|recurrent childhood pilomyxoid astrocytoma
778062|NCT00002647|recurrent childhood pleomorphic xanthoastrocytoma|recurrent childhood pleomorphic xanthoastrocytoma
778063|NCT00002647|recurrent childhood protoplasmic astrocytoma|recurrent childhood protoplasmic astrocytoma
778064|NCT00002647|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
778065|NCT00002647|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
778066|NCT00002647|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
778067|NCT00002647|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
778068|NCT00002647|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
778069|NCT00002647|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
778070|NCT00002647|recurrent childhood ependymoma|recurrent childhood ependymoma
778071|NCT00002647|recurrent childhood brain tumor|recurrent childhood brain tumor
778072|NCT00002647|adult anaplastic astrocytoma|adult anaplastic astrocytoma
778073|NCT00002647|adult anaplastic ependymoma|adult anaplastic ependymoma
778074|NCT00002647|adult anaplastic meningioma|adult anaplastic meningioma
778075|NCT00002647|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
778076|NCT00002647|adult brain stem glioma|adult brain stem glioma
778077|NCT00002647|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
778078|NCT00002647|adult choroid plexus tumor|adult choroid plexus tumor
778079|NCT00002647|adult craniopharyngioma|adult craniopharyngioma
778081|NCT00002647|adult ependymoblastoma|adult ependymoblastoma
778082|NCT00002647|adult ependymoma|adult ependymoma
778083|NCT00002647|adult giant cell glioblastoma|adult giant cell glioblastoma
778084|NCT00002647|adult glioblastoma|adult glioblastoma
778085|NCT00002647|adult gliosarcoma|adult gliosarcoma
778086|NCT00002647|adult medulloblastoma|adult medulloblastoma
778087|NCT00002647|meningeal melanocytoma|meningeal melanocytoma
778088|NCT00002647|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
778089|NCT00002647|adult oligodendroglioma|adult oligodendroglioma
778090|NCT00002647|adult papillary meningioma|adult papillary meningioma
778091|NCT00002647|adult pilocytic astrocytoma|adult pilocytic astrocytoma
778092|NCT00002647|adult pineal gland astrocytoma|adult pineal gland astrocytoma
778093|NCT00002647|adult pineoblastoma|adult pineoblastoma
778094|NCT00002647|adult pineocytoma|adult pineocytoma
778095|NCT00002647|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
778096|NCT00002647|adult subependymoma|adult subependymoma
778097|NCT00002647|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
778098|NCT00002647|childhood grade I meningioma|childhood grade i meningioma
778099|NCT00002647|childhood grade II meningioma|childhood grade ii meningioma
778100|NCT00002647|childhood grade III meningioma|childhood grade iii meningioma
778101|NCT00002647|adult grade III meningioma|adult grade iii meningioma
778102|NCT00002647|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
778103|NCT00002647|childhood choroid plexus tumor|childhood choroid plexus tumor
778104|NCT00002647|childhood craniopharyngioma|childhood craniopharyngioma
778105|NCT00002647|childhood infratentorial ependymoma|childhood infratentorial ependymoma
778106|NCT00002647|childhood supratentorial ependymoma|childhood supratentorial ependymoma
778107|NCT00002647|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
778108|NCT00002647|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
778109|NCT00002641|adult angiosarcoma|adult angiosarcoma
778110|NCT00002641|adult fibrosarcoma|adult fibrosarcoma
778111|NCT00002641|adult leiomyosarcoma|adult leiomyosarcoma
778112|NCT00002641|adult liposarcoma|adult liposarcoma
778113|NCT00002641|adult neurofibrosarcoma|adult neurofibrosarcoma
778114|NCT00002641|adult synovial sarcoma|adult synovial sarcoma
778115|NCT00002641|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
778116|NCT00002641|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
778117|NCT00002641|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
778118|NCT00002641|adult epithelioid sarcoma|adult epithelioid sarcoma
778119|NCT00002641|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
778120|NCT00002641|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
778121|NCT00002641|adult malignant mesenchymoma|adult malignant mesenchymoma
778122|NCT00002641|adult rhabdomyosarcoma|adult rhabdomyosarcoma
778123|NCT00002641|localized benign pheochromocytoma|localized benign pheochromocytoma
778124|NCT00002641|regional pheochromocytoma|regional pheochromocytoma
778125|NCT00002641|recurrent pheochromocytoma|recurrent pheochromocytoma
778126|NCT00002641|stage II uterine sarcoma|stage ii uterine sarcoma
778127|NCT00002641|stage III uterine sarcoma|stage iii uterine sarcoma
778128|NCT00002641|recurrent uterine sarcoma|recurrent uterine sarcoma
778129|NCT00002641|uterine carcinosarcoma|uterine carcinosarcoma
778130|NCT00002641|uterine leiomyosarcoma|uterine leiomyosarcoma
778131|NCT00002641|endometrial stromal sarcoma|endometrial stromal sarcoma
778132|NCT00002641|ovarian sarcoma|ovarian sarcoma
778133|NCT00002641|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
778134|NCT00002641|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
778135|NCT00002633|adenocarcinoma of the prostate|adenocarcinoma of the prostate
778136|NCT00002633|stage II prostate cancer|stage ii prostate cancer
778137|NCT00002633|stage III prostate cancer|stage iii prostate cancer
778138|NCT00002633|stage IV prostate cancer|stage iv prostate cancer
778139|NCT00002624|stage I non-small cell lung cancer|stage i non-small cell lung cancer
778140|NCT00002624|squamous cell lung cancer|squamous cell lung cancer
778141|NCT00002624|large cell lung cancer|large cell lung cancer
778142|NCT00002624|adenocarcinoma of the lung|adenocarcinoma of the lung
778143|NCT00002624|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
778144|NCT00002623|squamous cell lung cancer|squamous cell lung cancer
778145|NCT00002623|large cell lung cancer|large cell lung cancer
778146|NCT00002623|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
778147|NCT00002623|adenocarcinoma of the lung|adenocarcinoma of the lung
778148|NCT00002623|adenosquamous cell lung cancer|adenosquamous cell lung cancer
778149|NCT00002623|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
778150|NCT00002615|stage II gastric cancer|stage ii gastric cancer
778151|NCT00002615|stage III gastric cancer|stage iii gastric cancer
778152|NCT00002615|adenocarcinoma of the stomach|adenocarcinoma of the stomach
778153|NCT00002611|stage I Wilms tumor|stage i wilms tumor
778154|NCT00002611|stage II Wilms tumor|stage ii wilms tumor
778155|NCT00002611|stage III Wilms tumor|stage iii wilms tumor
778156|NCT00002611|stage IV Wilms tumor|stage iv wilms tumor
778157|NCT00002611|stage V Wilms tumor|stage v wilms tumor
778158|NCT00002611|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
778360|NCT00002475|stage IV colon cancer|stage iv colon cancer
778159|NCT00002610|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
778160|NCT00002610|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
778161|NCT00002610|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
778162|NCT00002608|childhood brain tumor|childhood brain tumor
778163|NCT00002608|childhood infratentorial ependymoma|childhood infratentorial ependymoma
778164|NCT00002608|childhood supratentorial ependymoma|childhood supratentorial ependymoma
778165|NCT00002608|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
778166|NCT00002608|recurrent childhood brain tumor|recurrent childhood brain tumor
778167|NCT00002608|childhood liver cancer|childhood liver cancer
778168|NCT00002608|stage IV childhood liver cancer|stage iv childhood liver cancer
778169|NCT00002608|recurrent childhood liver cancer|recurrent childhood liver cancer
778170|NCT00002608|advanced malignant mesothelioma|advanced malignant mesothelioma
778171|NCT00002608|recurrent malignant mesothelioma|recurrent malignant mesothelioma
778172|NCT00002608|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
778173|NCT00002608|advanced adult primary liver cancer|advanced adult primary liver cancer
778174|NCT00002608|recurrent adult primary liver cancer|recurrent adult primary liver cancer
778175|NCT00002608|recurrent adult brain tumor|recurrent adult brain tumor
778176|NCT00002608|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
778177|NCT00002608|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
778178|NCT00002608|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
778179|NCT00002608|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
778180|NCT00002608|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
778181|NCT00002608|anaplastic thyroid cancer|anaplastic thyroid cancer
778182|NCT00002608|recurrent thyroid cancer|recurrent thyroid cancer
778183|NCT00002608|adult brain stem glioma|adult brain stem glioma
778184|NCT00002608|adult medulloblastoma|adult medulloblastoma
778185|NCT00002608|adult glioblastoma|adult glioblastoma
778186|NCT00002608|metastatic pheochromocytoma|metastatic pheochromocytoma
778187|NCT00002608|recurrent pheochromocytoma|recurrent pheochromocytoma
778188|NCT00002608|childhood soft tissue sarcoma|childhood soft tissue sarcoma
778189|NCT00002608|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
778190|NCT00002608|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
778191|NCT00002608|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
778192|NCT00002608|childhood oligodendroglioma|childhood oligodendroglioma
778193|NCT00002608|adult anaplastic astrocytoma|adult anaplastic astrocytoma
778194|NCT00002608|adult myxopapillary ependymoma|adult myxopapillary ependymoma
778195|NCT00002608|adult anaplastic ependymoma|adult anaplastic ependymoma
778196|NCT00002608|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
778197|NCT00002608|adult mixed glioma|adult mixed glioma
778198|NCT00002608|adult pilocytic astrocytoma|adult pilocytic astrocytoma
778199|NCT00002608|adult subependymoma|adult subependymoma
778200|NCT00002608|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
778201|NCT00002608|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
778202|NCT00002608|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
778203|NCT00002608|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
778204|NCT00002608|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
778205|NCT00002608|recurrent childhood ependymoma|recurrent childhood ependymoma
778206|NCT00002608|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
778207|NCT00002608|adult oligodendroglioma|adult oligodendroglioma
778208|NCT00002608|adult giant cell glioblastoma|adult giant cell glioblastoma
778209|NCT00002608|adult gliosarcoma|adult gliosarcoma
778210|NCT00002608|adult diffuse astrocytoma|adult diffuse astrocytoma
778211|NCT00002598|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
778212|NCT00002598|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
778213|NCT00002598|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
778214|NCT00002596|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
778215|NCT00002596|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
778216|NCT00002596|testicular seminoma|testicular seminoma
778217|NCT00002596|testicular embryonal carcinoma|testicular embryonal carcinoma
778218|NCT00002596|testicular choriocarcinoma|testicular choriocarcinoma
778219|NCT00002596|testicular teratoma|testicular teratoma
778220|NCT00002596|testicular yolk sac tumor|testicular yolk sac tumor
778221|NCT00002596|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
778222|NCT00002596|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
778223|NCT00002596|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
778224|NCT00002596|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
778225|NCT00002596|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
778226|NCT00002596|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
778227|NCT00002596|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
778228|NCT00002596|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
778229|NCT00002596|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
778230|NCT00002596|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
778231|NCT00002596|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
778232|NCT00002596|extragonadal germ cell tumor|extragonadal germ cell tumor
778233|NCT00002596|childhood teratoma|childhood teratoma
778234|NCT00002596|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
778235|NCT00002596|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
778236|NCT00002594|recurrent childhood brain tumor|recurrent childhood brain tumor
778237|NCT00002594|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
778238|NCT00002594|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
778239|NCT00002589|stage III renal cell cancer|stage iii renal cell cancer
778240|NCT00002589|stage IV renal cell cancer|stage iv renal cell cancer
778241|NCT00002589|recurrent renal cell cancer|recurrent renal cell cancer
778242|NCT00002586|non-small cell lung cancer|non-small cell lung cancer
778243|NCT00002586|small cell lung cancer|small cell lung cancer
778244|NCT00002586|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
778245|NCT00002569|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
778246|NCT00002569|adult mixed glioma|adult mixed glioma
778247|NCT00002560|recurrent neuroblastoma|recurrent neuroblastoma
778248|NCT00002558|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
778249|NCT00002558|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
778250|NCT00002558|extragonadal germ cell tumor|extragonadal germ cell tumor
778251|NCT00002546|stage I uterine sarcoma|stage i uterine sarcoma
778252|NCT00002546|stage II uterine sarcoma|stage ii uterine sarcoma
778253|NCT00002546|stage III uterine sarcoma|stage iii uterine sarcoma
778254|NCT00002546|stage IV uterine sarcoma|stage iv uterine sarcoma
778255|NCT00002546|uterine carcinosarcoma|uterine carcinosarcoma
778256|NCT00002544|stage IV breast cancer|stage iv breast cancer
778257|NCT00002544|recurrent breast cancer|recurrent breast cancer
778258|NCT00002528|stage I breast cancer|stage i breast cancer
778259|NCT00002528|stage II breast cancer|stage ii breast cancer
778260|NCT00002523|stage II rectal cancer|stage ii rectal cancer
778261|NCT00002523|stage III rectal cancer|stage iii rectal cancer
778262|NCT00002523|adenocarcinoma of the rectum|adenocarcinoma of the rectum
778263|NCT00002522|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
778264|NCT00002522|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
778265|NCT00002522|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
778266|NCT00002522|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
778267|NCT00002522|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
778268|NCT00002521|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
778269|NCT00002521|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
778270|NCT00002521|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
778271|NCT00002521|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
778272|NCT00002521|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
778273|NCT00002521|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
778274|NCT00002521|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
778275|NCT00002521|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
778276|NCT00002521|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
778277|NCT00002521|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
778278|NCT00002521|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
778279|NCT00002521|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
778280|NCT00002521|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
778281|NCT00002521|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
778282|NCT00002521|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
778283|NCT00002521|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
778284|NCT00002521|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
778285|NCT00002521|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
778286|NCT00002521|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
778287|NCT00002521|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
778288|NCT00002521|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
778289|NCT00002521|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
778290|NCT00002521|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
778291|NCT00002521|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
778292|NCT00002521|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
778293|NCT00002521|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
778294|NCT00002521|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
778295|NCT00002521|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
778296|NCT00002521|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
778297|NCT00002521|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
778298|NCT00002521|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
778299|NCT00002521|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
778300|NCT00002521|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
778301|NCT00002521|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
778302|NCT00002521|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
778303|NCT00002521|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
778304|NCT00002517|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
778305|NCT00002517|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
778306|NCT00002517|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
778307|NCT00002517|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
778308|NCT00002517|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
778309|NCT00002517|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
778310|NCT00002517|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
778311|NCT00002517|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
778312|NCT00002517|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
778313|NCT00002517|refractory anemia with excess blasts|refractory anemia with excess blasts
778314|NCT00002517|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
778315|NCT00002517|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
778316|NCT00002517|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
778317|NCT00002517|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
778318|NCT00002515|chondrosarcoma|chondrosarcoma
778319|NCT00002515|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
778320|NCT00002515|stage IV childhood liver cancer|stage iv childhood liver cancer
778321|NCT00002515|recurrent neuroblastoma|recurrent neuroblastoma
778322|NCT00002515|recurrent childhood liver cancer|recurrent childhood liver cancer
778323|NCT00002515|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
778324|NCT00002515|stage IV Wilms tumor|stage iv wilms tumor
778325|NCT00002515|recurrent retinoblastoma|recurrent retinoblastoma
778326|NCT00002515|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
778327|NCT00002515|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
778328|NCT00002515|recurrent osteosarcoma|recurrent osteosarcoma
778329|NCT00002515|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
778330|NCT00002515|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
778331|NCT00002515|childhood germ cell tumor|childhood germ cell tumor
778332|NCT00002515|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
778333|NCT00002515|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
778334|NCT00002515|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
778335|NCT00002515|childhood fibrosarcoma|childhood fibrosarcoma
778336|NCT00002515|extragonadal germ cell tumor|extragonadal germ cell tumor
778337|NCT00002515|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
778338|NCT00002515|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
778339|NCT00002515|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
778340|NCT00002515|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
778341|NCT00002515|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
778342|NCT00002515|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
778343|NCT00002515|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
778344|NCT00002515|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
778345|NCT00002515|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
778346|NCT00002515|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
778347|NCT00002514|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
778348|NCT00002511|adenocarcinoma of the prostate|adenocarcinoma of the prostate
778349|NCT00002511|stage I prostate cancer|stage i prostate cancer
778350|NCT00002511|stage IIB prostate cancer|stage iib prostate cancer
778351|NCT00002511|stage IIA prostate cancer|stage iia prostate cancer
778352|NCT00002511|stage III prostate cancer|stage iii prostate cancer
778353|NCT00002490|stage I bladder cancer|stage i bladder cancer
778354|NCT00002490|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
778355|NCT00002484|stage I non-small cell lung cancer|stage i non-small cell lung cancer
778356|NCT00002484|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
778357|NCT00002484|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
778358|NCT00002484|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
778359|NCT00002475|stage III colon cancer|stage iii colon cancer
778361|NCT00002475|stage IV breast cancer|stage iv breast cancer
778362|NCT00002475|stage IIIA breast cancer|stage iiia breast cancer
778363|NCT00002475|recurrent breast cancer|recurrent breast cancer
778364|NCT00002475|stage IIIB breast cancer|stage iiib breast cancer
778365|NCT00002475|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
778366|NCT00002475|stage II pancreatic cancer|stage ii pancreatic cancer
778367|NCT00002475|stage III pancreatic cancer|stage iii pancreatic cancer
778368|NCT00002475|recurrent pancreatic cancer|recurrent pancreatic cancer
778369|NCT00002475|recurrent colon cancer|recurrent colon cancer
778370|NCT00002475|stage III renal cell cancer|stage iii renal cell cancer
778371|NCT00002475|stage IV renal cell cancer|stage iv renal cell cancer
778372|NCT00002475|recurrent renal cell cancer|recurrent renal cell cancer
778373|NCT00002475|extensive stage small cell lung cancer|extensive stage small cell lung cancer
778374|NCT00002475|recurrent small cell lung cancer|recurrent small cell lung cancer
778375|NCT00002475|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
778376|NCT00002475|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
778377|NCT00002475|stage IIIC breast cancer|stage iiic breast cancer
778378|NCT00002475|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
778379|NCT00002475|pulmonary carcinoid tumor|pulmonary carcinoid tumor
778380|NCT00002475|recurrent malignant mesothelioma|recurrent malignant mesothelioma
778381|NCT00002475|stage IV pancreatic cancer|stage iv pancreatic cancer
778382|NCT00002474|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
778383|NCT00002473|stage I renal cell cancer|stage i renal cell cancer
778384|NCT00002473|stage II renal cell cancer|stage ii renal cell cancer
778385|NCT00002472|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
778386|NCT00002472|extragonadal germ cell tumor|extragonadal germ cell tumor
778387|NCT00002472|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
778388|NCT00002472|childhood teratoma|childhood teratoma
778389|NCT00002472|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
778390|NCT00002472|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
778391|NCT00002472|childhood central nervous system germinoma|childhood central nervous system germinoma
778392|NCT00002472|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
778393|NCT00002472|childhood central nervous system teratoma|childhood central nervous system teratoma
778394|NCT00002472|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
778395|NCT00002470|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
778396|NCT00002470|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
778397|NCT00002470|pulmonary carcinoid tumor|pulmonary carcinoid tumor
778398|NCT00002455|stage I colon cancer|stage i colon cancer
778399|NCT00002455|stage II colon cancer|stage ii colon cancer
778400|NCT00002455|stage III colon cancer|stage iii colon cancer
778401|NCT00002455|stage I breast cancer|stage i breast cancer
778402|NCT00002455|stage II breast cancer|stage ii breast cancer
778403|NCT00002455|stage IIIA breast cancer|stage iiia breast cancer
778404|NCT00002455|recurrent breast cancer|recurrent breast cancer
778405|NCT00002455|recurrent colon cancer|recurrent colon cancer
778406|NCT00002455|stage I melanoma|stage i melanoma
778407|NCT00002455|stage II melanoma|stage ii melanoma
778408|NCT00002455|stage III melanoma|stage iii melanoma
778409|NCT00002455|recurrent melanoma|recurrent melanoma
778410|NCT00052143|Huntington's disease|huntington's disease
778411|NCT00052143|HD|hd
778412|NCT00052143|Huntington disease|huntington disease
778413|NCT00051818|chronic HIV infection|chronic hiv infection
778414|NCT00051818|treatment interruption|treatment interruption
778415|NCT00051818|HIV-specific immune response|hiv-specific immune response
778416|NCT00051818|immune response|immune response
778417|NCT00051818|virological response|virological response
778418|NCT00051818|treatment experienced|treatment experienced
778419|NCT00052091|Geriatrics|geriatrics
778420|NCT00052078|Phobic Disorders|phobic disorders
778421|NCT00052078|Anxiety, Separation|anxiety, separation
778422|NCT00052052|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
778423|NCT00052052|IPF|ipf
778424|NCT00052026|Adolescent|adolescent
778425|NCT00052026|Adrenergic alpha-Antagonists/therapeutic use|adrenergic alpha-antagonists/therapeutic use
778426|NCT00052026|Adrenergic alpha-Antagonists/pharmacokinetics|adrenergic alpha-antagonists/pharmacokinetics
778427|NCT00052026|Adrenergic alpha-Antagonists/administration & dosage|adrenergic alpha-antagonists/administration & dosage
778428|NCT00052026|Adrenergic beta-Antagonists/therapeutic use|adrenergic beta-antagonists/therapeutic use
778429|NCT00052026|Adrenergic beta-Antagonists/pharmacokinetics|adrenergic beta-antagonists/pharmacokinetics
778430|NCT00052026|Adrenergic beta-Antagonists/administration & dosage|adrenergic beta-antagonists/administration & dosage
778431|NCT00052026|Age Factors|age factors
778432|NCT00052026|Carbazoles/therapeutic use|carbazoles/therapeutic use
778433|NCT00052026|Carbazoles/administration & dosage|carbazoles/administration & dosage
778434|NCT00052026|Child|child
778435|NCT00052026|Child, Preschool|child, preschool
778436|NCT00052026|Drug Administration Schedule|drug administration schedule
778437|NCT00052026|Female|female
778438|NCT00052026|Heart Failure, Congestive/etiology|heart failure, congestive/etiology
778439|NCT00052026|Heart Failure, Congestive/drug therapy|heart failure, congestive/drug therapy
778440|NCT00052026|Heart Failure, Congestive/blood|heart failure, congestive/blood
778441|NCT00052026|Human|human
778442|NCT00052026|Infant|infant
778443|NCT00052026|Infant, Newborn|infant, newborn
778444|NCT00052026|Male|male
778445|NCT00052026|Natriuretic Peptide, Brain/blood|natriuretic peptide, brain/blood
778446|NCT00052026|Placebos|placebos
778447|NCT00052026|Propanolamines/therapeutic use|propanolamines/therapeutic use
778448|NCT00052026|Propanolamines/administration & dosage|propanolamines/administration & dosage
778449|NCT00052026|Prospective Studies|prospective studies
778450|NCT00052026|Support, Non-U.S. Gov't|support, non-u.s. gov't
778451|NCT00052026|Treatment Outcome|treatment outcome
778452|NCT00052026|Ventricular Dysfunction/drug therapy|ventricular dysfunction/drug therapy
778453|NCT00052026|Ventricular Dysfunction/complications|ventricular dysfunction/complications
778454|NCT00052026|Ventricular Dysfunction/blood|ventricular dysfunction/blood
778455|NCT00052026|Ventricular Function/drug effects|ventricular function/drug effects
778456|NCT00052026|Ventricular Remodeling/drug effects|ventricular remodeling/drug effects
778457|NCT00052039|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
778458|NCT00052013|von Hippel-Lindau disease,|von hippel-lindau disease,
778459|NCT00052013|CNS,|cns,
778460|NCT00052013|hemangioblastoma,|hemangioblastoma,
778461|NCT00052013|retinal|retinal
778462|NCT00051935|Glycogen Storage Disease Type II|glycogen storage disease type ii
778463|NCT00051935|GSD-II|gsd-ii
778464|NCT00051935|Pompe Disease|pompe disease
778465|NCT00051922|HIV Preventive Vaccine|hiv preventive vaccine
778466|NCT00051922|HIV Seronegativity|hiv seronegativity
778467|NCT00051961|Dopamine|dopamine
778468|NCT00051961|Spinal Physiology|spinal physiology
778469|NCT00051961|Flexor Reflex|flexor reflex
778470|NCT00051961|Ropinirole|ropinirole
778471|NCT00051961|Motor Control|motor control
778472|NCT00051961|Dopaminergic|dopaminergic
778473|NCT00051961|Restless Legs|restless legs
778474|NCT00051909|Alzheimer's Disease|alzheimer's disease
778475|NCT00051844|HIV|hiv
778476|NCT00051844|NNRTI Failure|nnrti failure
778477|NCT00051844|HIV Infections|hiv infections
778478|NCT00051831|Treatment Naive|treatment naive
778479|NCT00051831|HIV-1|hiv-1
778481|NCT00051831|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
778482|NCT00051831|Immunologic Memory|immunologic memory
778483|NCT00051831|Pentafuside|pentafuside
778484|NCT00051831|Anti-HIV Agents|anti-hiv agents
778485|NCT00051831|Drug Therapy, Combination|drug therapy, combination
778486|NCT00051831|Saquinavir|saquinavir
778487|NCT00051831|Ritonavir|ritonavir
778488|NCT00051831|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
778489|NCT00051831|RNA, Viral|rna, viral
778490|NCT00051831|Viral Load|viral load
778491|NCT00051831|Fusion Inhibitors|fusion inhibitors
778492|NCT00051831|Entry Inhibitors|entry inhibitors
778493|NCT00051870|Verbal Memory|verbal memory
778494|NCT00051870|Inhibition|inhibition
778495|NCT00051870|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
778496|NCT00051870|Cortical Excitability|cortical excitability
778497|NCT00051870|Nonverbal Memory|nonverbal memory
778498|NCT00051857|Magnetic Resonance Imaging|magnetic resonance imaging
778499|NCT00051857|Muscle|muscle
778500|NCT00051857|Bone|bone
778501|NCT00051857|Dynamics|dynamics
778502|NCT00051857|Visualization|visualization
778503|NCT00051805|Patient Compliance|patient compliance
778504|NCT00051805|Adherence|adherence
778505|NCT00051805|Treatment Experienced|treatment experienced
778506|NCT00051779|CAL|cal
778507|NCT00051779|Parathyroid hormone-related protein (PTHrP)|parathyroid hormone-related protein (pthrp)
778508|NCT00051779|Breast Cancer|breast cancer
778509|NCT00051779|Bone Metastasis|bone metastasis
778510|NCT00051779|Hypercalcemia|hypercalcemia
778511|NCT00051766|compliance|compliance
778512|NCT00051766|medication|medication
778513|NCT00051766|antiretroviral|antiretroviral
778514|NCT00051766|adherence|adherence
778515|NCT00051766|intervention|intervention
778516|NCT00051766|treatment experienced|treatment experienced
778517|NCT00051753|Otitis Media|otitis media
778518|NCT00051753|Acute Otitis Media|acute otitis media
778519|NCT00051753|ear infection|ear infection
778520|NCT00051753|levofloxacin|levofloxacin
778521|NCT00051753|amoxicillin|amoxicillin
778522|NCT00051753|clavulanate|clavulanate
778523|NCT00051701|Non-Hodgkins lymphoma|non-hodgkins lymphoma
778524|NCT00051701|NHL|nhl
778525|NCT00051701|Campath|campath
778526|NCT00051701|alemtuzumab|alemtuzumab
778527|NCT00051675|adenocarcinoma|adenocarcinoma
778528|NCT00051675|monoclonal antibody|monoclonal antibody
778529|NCT00051636|Bisphosphonate|bisphosphonate
778530|NCT00051636|SAP|sap
778531|NCT00051636|SAP excess|sap excess
778532|NCT00051636|non-inferiority|non-inferiority
778533|NCT00051636|therapeutic response|therapeutic response
778534|NCT00051636|extended observation period|extended observation period
778535|NCT00051623|Psoriatic arthritis|psoriatic arthritis
778536|NCT00051623|Infliximab|infliximab
778537|NCT00051623|Remicade|remicade
778538|NCT00051571|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
778862|NCT00006155|VEGF|vegf
778539|NCT00051428|Fibromyalgia, Reiki, Energy Medicine|fibromyalgia, reiki, energy medicine
778540|NCT00051415|Flaxseed|flaxseed
778541|NCT00051415|Cholesterol|cholesterol
778542|NCT00051402|Postmenopausal|postmenopausal
778543|NCT00051402|Memory Loss|memory loss
778544|NCT00051402|Cognition|cognition
778545|NCT00051402|Phytoestrogens|phytoestrogens
778546|NCT00051545|liver|liver
778547|NCT00051545|cancer|cancer
778548|NCT00051545|hepatocellular|hepatocellular
778549|NCT00051545|carcinoma|carcinoma
778550|NCT00051532|hepatocellular|hepatocellular
778551|NCT00051532|carcinoma|carcinoma
778552|NCT00051532|liver|liver
778553|NCT00051532|cancer|cancer
778554|NCT00051493|Non-Small Cell Lung Cancer|non-small cell lung cancer
778555|NCT00051493|Lung Cancer|lung cancer
778556|NCT00051493|NSCLC|nsclc
778557|NCT00051493|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
778558|NCT00051519|HIV|hiv
778559|NCT00051519|AIDS|aids
778560|NCT00051519|Vaccine|vaccine
778561|NCT00051519|HIV-positive|hiv-positive
778562|NCT00051519|Therapy|therapy
778563|NCT00051454|HIV Seronegativity|hiv seronegativity
778564|NCT00051454|HIV Preventive Vaccine|hiv preventive vaccine
778565|NCT00051441|stomatitis|stomatitis
778566|NCT00051441|radiation effects|radiation effects
778567|NCT00051363|Obstructive Sleep Apnea|obstructive sleep apnea
778568|NCT00051337|Kinesiogenic|kinesiogenic
778569|NCT00051337|Psychogenic|psychogenic
778570|NCT00051337|Channelopathy|channelopathy
778571|NCT00051337|Ictal|ictal
778572|NCT00051337|Paroxysmal Dyskinesia|paroxysmal dyskinesia
778573|NCT00051337|Psychogenic Movement Disorders|psychogenic movement disorders
778574|NCT00051337|Single Photon Emission|single photon emission
778575|NCT00051337|Computed Tomography (SPECT)|computed tomography (spect)
778576|NCT00051324|Huntington's disease|huntington's disease
778577|NCT00051324|Huntington disease|huntington disease
778578|NCT00051324|HD|hd
778579|NCT00051285|CHF|chf
778580|NCT00051285|heart|heart
778581|NCT00051285|failure|failure
778582|NCT00051285|congestive|congestive
778583|NCT00051285|enoximone|enoximone
778584|NCT00051285|phosphodiesterase|phosphodiesterase
778585|NCT00051285|inhibitor|inhibitor
778586|NCT00051311|Lymphoma|lymphoma
778587|NCT00051311|Leukemia|leukemia
778588|NCT00051311|Hodgkin's Disease|hodgkin's disease
778589|NCT00051311|Multiple Myeloma|multiple myeloma
778590|NCT00051311|Immunotherapy|immunotherapy
778591|NCT00051272|depression, sexual dysfunction, orgasm disorder, MDD|depression, sexual dysfunction, orgasm disorder, mdd
778592|NCT00051259|depression|depression
778593|NCT00051259|MDD|mdd
778594|NCT00051259|sexual dysfunction|sexual dysfunction
778595|NCT00051259|orgasm disorder|orgasm disorder
778596|NCT00051207|Mood Disorders|mood disorders
778597|NCT00051207|Psychotherapy|psychotherapy
778598|NCT00051207|Comorbidity|comorbidity
778599|NCT00051194|Glaucoma|glaucoma
778600|NCT00051194|POAG|poag
778601|NCT00051194|OAG|oag
778602|NCT00051194|OHT|oht
778603|NCT00051181|Glaucoma|glaucoma
778604|NCT00051181|POAG|poag
778605|NCT00051181|OAG|oag
778606|NCT00051181|OHT|oht
778607|NCT00051168|Glaucoma|glaucoma
778608|NCT00051168|POAG|poag
778609|NCT00051168|OAG|oag
778610|NCT00051168|OHT|oht
778611|NCT00051155|Glaucoma|glaucoma
778612|NCT00051155|POAG|poag
778618|NCT00051142|OHT|oht
778619|NCT00051129|AMD|amd
778620|NCT00051129|anecortave acetate|anecortave acetate
778621|NCT00051129|wet AMD|wet amd
778622|NCT00051129|age-related macular degeneration|age-related macular degeneration
778623|NCT00051129|Macular Degeneration|macular degeneration
778624|NCT00051129|Maculopathy, Age-Related|maculopathy, age-related
778625|NCT00051129|Age-Related Maculopathies|age-related maculopathies
778626|NCT00051129|Age-Related Maculopathy|age-related maculopathy
778627|NCT00051129|Maculopathies, Age-Related|maculopathies, age-related
778628|NCT00051116|Multiple Myeloma|multiple myeloma
778629|NCT00051116|Revimid|revimid
778630|NCT00051116|CC5013|cc5013
778631|NCT00051116|CC-5013|cc-5013
778632|NCT00051103|Refractory|refractory
778633|NCT00051090|Hepatitis B|hepatitis b
778634|NCT00051090|Antiretroviral Therapy, Highly-Active|antiretroviral therapy, highly-active
778635|NCT00051090|HIV Infections|hiv infections
778636|NCT00051090|Lamivudine|lamivudine
778637|NCT00051090|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
778638|NCT00051090|Antiviral Agents|antiviral agents
778639|NCT00051090|Drug Therapy, Combination|drug therapy, combination
778640|NCT00051090|Treatment Naive|treatment naive
778641|NCT00051077|HIV Infections|hiv infections
778642|NCT00051077|Hepatitis B|hepatitis b
778643|NCT00051077|Hepatitis C|hepatitis c
778644|NCT00051077|Interferon Alfa-2a|interferon alfa-2a
778645|NCT00051077|Adefovir dipivoxil|adefovir dipivoxil
778646|NCT00051077|Ribavirin|ribavirin
778647|NCT00051077|Antiviral Agents|antiviral agents
778648|NCT00051077|Drug Resistance, Viral|drug resistance, viral
778649|NCT00051077|Treatment Experienced|treatment experienced
778650|NCT00050986|Brain Neoplasms|brain neoplasms
778651|NCT00050986|CNS Diseases|cns diseases
778652|NCT00050986|Glioblastoma Multiforme|glioblastoma multiforme
778653|NCT00050986|Temozolomide|temozolomide
778654|NCT00050986|Temodar|temodar
778655|NCT00050986|R115777|r115777
778656|NCT00050986|Zarnestra|zarnestra
778657|NCT00050973|NSCLC|nsclc
778658|NCT00050973|Targretin|targretin
778659|NCT00050973|Retinoid|retinoid
778660|NCT00050973|Bexarotene|bexarotene
778661|NCT00050960|NSCLC|nsclc
778662|NCT00050960|Targretin|targretin
778663|NCT00050960|Retinoid|retinoid
778664|NCT00050960|Bexarotene|bexarotene
778665|NCT00050947|partial seizures|partial seizures
778666|NCT00050934|partial seizures|partial seizures
778667|NCT00050921|HIV Infections|hiv infections
778668|NCT00050921|CD4 Lymphocyte Count|cd4 lymphocyte count
778669|NCT00050921|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
778670|NCT00050921|Growth Hormone|growth hormone
778671|NCT00050921|Cell Division|cell division
778672|NCT00050921|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
778673|NCT00050921|Treatment Experienced|treatment experienced
778674|NCT00050908|Brachial Artery|brachial artery
778675|NCT00050908|Endothelium, Vascular|endothelium, vascular
778676|NCT00050908|Vasodilation|vasodilation
778677|NCT00050908|Nitroglycerin|nitroglycerin
778678|NCT00050908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
778679|NCT00050908|HIV Protease Inhibitors|hiv protease inhibitors
778680|NCT00050908|Drug Therapy, Combination|drug therapy, combination
778681|NCT00050908|Ritonavir|ritonavir
778682|NCT00050908|efavirenz|efavirenz
778683|NCT00050908|lopinavir|lopinavir
778684|NCT00050908|stavudine|stavudine
778685|NCT00050908|lamivudine|lamivudine
778686|NCT00050908|zidovudine|zidovudine
778687|NCT00050908|Treatment Naive|treatment naive
778688|NCT00050895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
778689|NCT00050895|HIV Protease Inhibitors|hiv protease inhibitors
778690|NCT00050895|Drug Therapy, Combination|drug therapy, combination
778691|NCT00050895|Delayed Action Preparations|delayed action preparations
778692|NCT00050895|Treatment Naive|treatment naive
778693|NCT00050895|HIV-1|hiv-1
778694|NCT00050882|GM-611|gm-611
778695|NCT00050882|Diabetic gastroparesis|diabetic gastroparesis
778696|NCT00050882|Bloating|bloating
778697|NCT00050882|Delayed gastric emptying|delayed gastric emptying
778698|NCT00050882|Mitemcinal|mitemcinal
778699|NCT00050869|Mirror Neurons|mirror neurons
778700|NCT00050869|Performance|performance
778701|NCT00050869|Use-Dependent Plasticity|use-dependent plasticity
778702|NCT00050869|Attention|attention
778703|NCT00050869|Premotor Cortex|premotor cortex
778704|NCT00050856|Antiretrovial Therapy|antiretrovial therapy
778705|NCT00050856|Salvage|salvage
778706|NCT00050856|CD4+Lymphocyte Count|cd4+lymphocyte count
778707|NCT00050856|HIV-1 RNA Level|hiv-1 rna level
778708|NCT00050856|Subcutaneous Injection|subcutaneous injection
778709|NCT00050817|Embolism|embolism
778710|NCT00050791|Obesity|obesity
778711|NCT00050791|Weightloss|weightloss
778712|NCT00050791|Leptin|leptin
778713|NCT00050791|Diet|diet
778714|NCT00050791|Reducing|reducing
778715|NCT00050791|Overweight|overweight
778716|NCT00050791|Fat|fat
778717|NCT00050778|Multiple Sclerosis|multiple sclerosis
778718|NCT00050778|Active Relapsing-Remitting Multiple Sclerosis|active relapsing-remitting multiple sclerosis
778719|NCT00050804|Acute Stress Disorder|acute stress disorder
778720|NCT00050804|PTSD|ptsd
778721|NCT00050804|Treatment|treatment
778722|NCT00050804|SSRI|ssri
778723|NCT00050804|Startle|startle
778724|NCT00050804|Psychophysiology|psychophysiology
778725|NCT00050804|Trauma|trauma
778726|NCT00050804|Anxiety|anxiety
778727|NCT00050804|Emotion|emotion
778728|NCT00050765|Myocardial Infarction|myocardial infarction
778729|NCT00050765|Heart disease|heart disease
778730|NCT00050765|Coronary bypass graft (CABG) surgery|coronary bypass graft (cabg) surgery
778731|NCT00050765|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
778732|NCT00050765|CABG|cabg
778733|NCT00050765|ICD|icd
778734|NCT00050765|Heart failure|heart failure
778735|NCT00050752|Renal Cancer|renal cancer
778736|NCT00050752|Hereditary Leiomyomatosis|hereditary leiomyomatosis
778737|NCT00050752|Uterine Fibroid|uterine fibroid
778738|NCT00050752|Cutaneous Leiomyoma|cutaneous leiomyoma
778739|NCT00050726|Interleukin-2|interleukin-2
778740|NCT00050726|Immunotherapy|immunotherapy
778741|NCT00050726|HIV|hiv
778742|NCT00050726|IL-2|il-2
778743|NCT00050713|Kidney Disease|kidney disease
778744|NCT00050713|Glomerulonephritis|glomerulonephritis
778745|NCT00050713|Lupus Nephritis|lupus nephritis
778746|NCT00050713|Nephrotic Syndrome|nephrotic syndrome
778747|NCT00050713|Hyperlipidemia|hyperlipidemia
778748|NCT00050700|PET|pet
778749|NCT00050700|[18F]FP-TZTP|[18f]fp-tztp
778750|NCT00050700|Bipolar Disorder|bipolar disorder
778751|NCT00050700|Major Depressive Disorder|major depressive disorder
778752|NCT00050700|Muscarinic 2 Receptors|muscarinic 2 receptors
778753|NCT00050674|lung cancer, oncology, neutropenia, chemotherapy, filgrastim|lung cancer, oncology, neutropenia, chemotherapy, filgrastim
778754|NCT00050661|psoriasis|psoriasis
778755|NCT00050661|Cyclosporine|cyclosporine
778756|NCT00050661|Daclizamub|daclizamub
778757|NCT00050661|anti-TAC|anti-tac
778758|NCT00050661|dermatology|dermatology
778759|NCT00050661|skin|skin
778760|NCT00050661|lesions|lesions
778761|NCT00050648|psoriasis|psoriasis
778762|NCT00050648|Daclizumab|daclizumab
778763|NCT00050648|Cyclosporin|cyclosporin
778764|NCT00050648|anti-TAC|anti-tac
778765|NCT00050648|dermatology|dermatology
778766|NCT00050648|skin|skin
778767|NCT00050635|chemotherapy induced diarrhea|chemotherapy induced diarrhea
778768|NCT00050635|diarrhea|diarrhea
778769|NCT00050635|CTID|ctid
778770|NCT00050635|colorectal cancer|colorectal cancer
778771|NCT00050635|Sandostatin LAR Depot|sandostatin lar depot
778772|NCT00050635|Sandostatin|sandostatin
778773|NCT00050635|adverse events|adverse events
778774|NCT00050635|side effects|side effects
778775|NCT00050427|Trabectedin|trabectedin
778776|NCT00050427|Yondelis|yondelis
778777|NCT00050427|ET743|et743
778778|NCT00050427|Advanced breast cancer|advanced breast cancer
778779|NCT00050427|Breast|breast
778780|NCT00050427|Cancer|cancer
778781|NCT00050427|Antineoplastic Agents, Alkylating Agents|antineoplastic agents, alkylating agents
778782|NCT00050427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
778783|NCT00050518|Smallpox|smallpox
778784|NCT00050518|Aventis Pasteur|aventis pasteur
778785|NCT00050518|Vaccine|vaccine
778786|NCT00050505|smallpox, Dryvax, vaccine, dilution|smallpox, dryvax, vaccine, dilution
778787|NCT00050492|Ocular|ocular
778788|NCT00050492|Cytokine|cytokine
778789|NCT00050492|Chemokine|chemokine
778790|NCT00050492|Viruses|viruses
778791|NCT00050492|Autoantibody|autoantibody
778792|NCT00050492|Retina|retina
778793|NCT00050492|Vasculitis|vasculitis
778794|NCT00050492|Adhesion Molecules|adhesion molecules
778795|NCT00050479|Types 1 and 2 diabetes|types 1 and 2 diabetes
778796|NCT00050479|Diode Laser Photocoagulation|diode laser photocoagulation
778797|NCT00050479|Elevated Low-Density Lipoprotein (LDL-C) Cholesterol|elevated low-density lipoprotein (ldl-c) cholesterol
778798|NCT00050466|Normal Volunteers|normal volunteers
778799|NCT00050466|Dynamic Light Scattering (DLS)|dynamic light scattering (dls)
778800|NCT00050466|Corneal Opacities|corneal opacities
778801|NCT00050466|Cornea|cornea
778802|NCT00050466|Transparency|transparency
778803|NCT00050466|Vision|vision
778804|NCT00050440|Endometrial|endometrial
778805|NCT00050440|Cancer|cancer
778806|NCT00050440|Carcinoma|carcinoma
778807|NCT00050440|Trabectedin|trabectedin
778808|NCT00050440|Ecteinascidin 743|ecteinascidin 743
778809|NCT00050440|ET743|et743
778810|NCT00050440|Antineoplastic Agents|antineoplastic agents
778811|NCT00050440|Alkylating Agents|alkylating agents
778812|NCT00050440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
778813|NCT00050414|Ovarian cancer|ovarian cancer
778814|NCT00050414|Ovary|ovary
778815|NCT00050414|Cancer|cancer
778816|NCT00050414|Trabectedin|trabectedin
778817|NCT00050414|Yondelis|yondelis
778818|NCT00050414|ET743|et743
778819|NCT00050414|Ecteinascidin 743|ecteinascidin 743
778820|NCT00050414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
778821|NCT00050414|Alkylating Agents|alkylating agents
778822|NCT00050401|ventilator-associated|ventilator-associated
778823|NCT00050401|nosocomial|nosocomial
778824|NCT00011635|Caffeine|caffeine
778825|NCT00011635|Cytochrome P 450|cytochrome p 450
778826|NCT00011635|Dextromethorphan|dextromethorphan
778827|NCT00011635|Drug Interaction|drug interaction
778828|NCT00011635|Metabolism|metabolism
778829|NCT00011635|Drug Metabolism|drug metabolism
778830|NCT00011635|Healthy Volunteer|healthy volunteer
778831|NCT00011635|Milk Thistle|milk thistle
778832|NCT00011063|Anti-Epileptic|anti-epileptic
778833|NCT00011063|CYP2C9|cyp2c9
778834|NCT00011063|Herbal|herbal
778835|NCT00011063|Interaction|interaction
778836|NCT00011063|Metabolism|metabolism
778837|NCT00011063|Drug Interaction|drug interaction
778838|NCT00011063|Drug Metabolism|drug metabolism
778839|NCT00011063|Ginko Biloba|ginko biloba
778840|NCT00011063|Healthy Volunteer|healthy volunteer
778841|NCT00009542|Caffeine|caffeine
778842|NCT00009542|Cytochrome P 450|cytochrome p 450
778843|NCT00009542|Dextromethorphan|dextromethorphan
778844|NCT00009542|Herbal|herbal
778845|NCT00009542|Interactions|interactions
778846|NCT00009542|Alternative Therapy|alternative therapy
778847|NCT00009542|Healthy Volunteer|healthy volunteer
778848|NCT00009542|Kava|kava
778849|NCT00006395|Antiepileptic|antiepileptic
778850|NCT00006395|CYP3A4|cyp3a4
778851|NCT00006395|Herbal|herbal
778852|NCT00006395|Induction|induction
778853|NCT00006395|Interaction|interaction
778854|NCT00006191|Antiepileptic Drugs|antiepileptic drugs
778855|NCT00006191|Motor Cortex|motor cortex
778856|NCT00006191|Myoclonus|myoclonus
778857|NCT00006191|Healthy Volunteer|healthy volunteer
778858|NCT00006155|DNA Damage|dna damage
778859|NCT00006155|DNA Repair|dna repair
778860|NCT00006155|FLK-1|flk-1
778861|NCT00006155|Pharmacokinetics|pharmacokinetics
778863|NCT00006155|Fallopian Tube Cancer|fallopian tube cancer
778864|NCT00006155|Ovarian Cancer|ovarian cancer
778865|NCT00006155|Platinum-Refractory Disease|platinum-refractory disease
778866|NCT00006071|Brachial Reactivity|brachial reactivity
778867|NCT00006071|Endothelial Function|endothelial function
778868|NCT00006071|Endothelial Markers|endothelial markers
778869|NCT00006071|Forearm Flow|forearm flow
778870|NCT00006071|Insulin Resistance|insulin resistance
778871|NCT00006071|Elevated Cholesterol|elevated cholesterol
778872|NCT00006071|Hypertension|hypertension
778873|NCT00006062|Liver Impairment|liver impairment
778874|NCT00006062|Pharmacokinetics|pharmacokinetics
778875|NCT00006062|Platinum Analogues|platinum analogues
778876|NCT00005926|Cancer|cancer
778877|NCT00005926|Gemzar|gemzar
778878|NCT00005926|Her-2/Neu|her-2/neu
778879|NCT00005926|Pancreatic|pancreatic
778880|NCT00005926|Radiotherapy|radiotherapy
778881|NCT00005926|Pancreatic Cancer|pancreatic cancer
778882|NCT00005912|Aspergillosis|aspergillosis
778883|NCT00005912|Candidiasis|candidiasis
778884|NCT00005912|Fungal Infections|fungal infections
778885|NCT00005912|Fungemia|fungemia
778886|NCT00005912|Prophylactic Antifungal Therapy|prophylactic antifungal therapy
778887|NCT00005912|Pediatric Fungal Infection|pediatric fungal infection
778888|NCT00005783|Fetal Hemoglobin|fetal hemoglobin
778889|NCT00005783|Hematopoietic Growth Factor|hematopoietic growth factor
778890|NCT00005783|Peripheral Blood CD34 Cells|peripheral blood cd34 cells
778891|NCT00005783|Vasoocclusive Crisis|vasoocclusive crisis
778892|NCT00005783|Sickle Cell Anemia|sickle cell anemia
778893|NCT00005783|Sickle Cell Disease|sickle cell disease
778894|NCT00005783|Sickle Cell Disorder|sickle cell disorder
778895|NCT00005781|Epidemiology|epidemiology
778896|NCT00005781|NHANES|nhanes
778897|NCT00005781|Photography|photography
778898|NCT00005781|Prevalence|prevalence
778899|NCT00005781|Skin Disease|skin disease
778900|NCT00005781|Healthy Volunteer|healthy volunteer
778901|NCT00005574|Becker Muscular Dystrophy|becker muscular dystrophy
778902|NCT00005574|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
778903|NCT00005574|Muscle Disease|muscle disease
778904|NCT00005574|Myopathy|myopathy
778905|NCT00005570|Bleeding|bleeding
778906|NCT00005570|Cytokines|cytokines
778907|NCT00005570|Immune Response|immune response
778908|NCT00005570|Pharmacogenomic|pharmacogenomic
778909|NCT00005570|Serum Antibodies|serum antibodies
778910|NCT00005570|ITP|itp
778911|NCT00005570|Immune Thrombocytopenia Purpura|immune thrombocytopenia purpura
778912|NCT00005111|Blood Flow|blood flow
778913|NCT00005111|Glucose|glucose
778914|NCT00005111|Lysosomal Disease|lysosomal disease
778915|NCT00005111|Metabolic|metabolic
778916|NCT00005111|Uptake|uptake
778917|NCT00005111|Fabry Disease|fabry disease
778918|NCT00005016|Fetal Anomaly|fetal anomaly
778919|NCT00005016|Genetic Counseling|genetic counseling
778920|NCT00005016|Prenatal Diagnosis|prenatal diagnosis
778921|NCT00005016|Psychosocial Issues|psychosocial issues
778922|NCT00005016|Qualitative|qualitative
778923|NCT00005016|HPE|hpe
778924|NCT00005016|Holoprosencephaly|holoprosencephaly
778925|NCT00004851|HCV Antibody Library|hcv antibody library
778926|NCT00004848|AIDS|aids
778927|NCT00004848|Autologous Blood|autologous blood
778928|NCT00004848|Cardiac Surgery|cardiac surgery
778929|NCT00004848|HIV|hiv
778930|NCT00004848|Hepatocellular Inflammation|hepatocellular inflammation
778931|NCT00004848|Liver Biopsy|liver biopsy
778932|NCT00004848|Long Term Sera Storage|long term sera storage
778933|NCT00004848|Non-A Hepatitis|non-a hepatitis
778934|NCT00004848|Non-B Hepatitis|non-b hepatitis
778935|NCT00004576|Dyskinesias|dyskinesias
778936|NCT00004576|Glutamate|glutamate
778937|NCT00004576|Levodopa|levodopa
778938|NCT00004576|Parkinson's Disease|parkinson's disease
778939|NCT00004574|Abetalipoproteinemia|abetalipoproteinemia
778940|NCT00004574|Ataxia|ataxia
778941|NCT00004574|Retinitis Pigmentosa|retinitis pigmentosa
778942|NCT00004574|Vitamin A|vitamin a
778943|NCT00004574|Vitamin E|vitamin e
778944|NCT00004557|Attention|attention
778945|NCT00004557|Cognition|cognition
778946|NCT00004557|Dementia|dementia
778947|NCT00004557|Memory|memory
778948|NCT00004557|Object Recognition|object recognition
778949|NCT00004557|Spatial Processes|spatial processes
778950|NCT00001986|Alcohol|alcohol
778951|NCT00001986|Octanol|octanol
778952|NCT00001986|Treatment|treatment
778953|NCT00001986|Tremor|tremor
778954|NCT00001982|Aminotransferases|aminotransferases
778955|NCT00001982|Anti-HCV|anti-hcv
778956|NCT00001982|Blood Donors|blood donors
778957|NCT00001982|HCV RNA|hcv rna
778958|NCT00001982|Hepatitis C|hepatitis c
778959|NCT00001982|Liver Biopsy|liver biopsy
778960|NCT00001982|Serum Aminotransferases|serum aminotransferases
778961|NCT00001982|Transfusion|transfusion
778962|NCT00001977|Alzheimer's Disease|alzheimer's disease
778963|NCT00001977|Attention|attention
778964|NCT00001977|Brain|brain
778965|NCT00001977|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
778966|NCT00001977|Physostigmine|physostigmine
778967|NCT00001977|Positron Emission Tomography|positron emission tomography
778968|NCT00001977|Working Memory|working memory
778969|NCT00001968|AIDS|aids
778970|NCT00001968|Anti-Retroviral Therapy|anti-retroviral therapy
778971|NCT00001968|Drug Interactions|drug interactions
778972|NCT00001968|HIV|hiv
778973|NCT00001968|Protease Inhibitor|protease inhibitor
778974|NCT00001966|Adjustment|adjustment
778975|NCT00001966|Alternative|alternative
778976|NCT00001966|Anxiety|anxiety
778977|NCT00001966|Guided-Imagery|guided-imagery
778978|NCT00001966|Meditation|meditation
778979|NCT00001966|Ehlers-Danlos Syndrome|ehlers-danlos syndrome
778980|NCT00001965|Calcineurin|calcineurin
778981|NCT00001965|Cardiac Hypertrophy|cardiac hypertrophy
778982|NCT00001965|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
778983|NCT00001963|Blood Flow|blood flow
778984|NCT00001963|Exercise|exercise
778985|NCT00001963|Microcirculation|microcirculation
778986|NCT00001963|S-nitrosohemoglobin|s-nitrosohemoglobin
778987|NCT00001963|Vasodilation|vasodilation
778988|NCT00001963|Healthy Volunteer|healthy volunteer
778989|NCT00001944|Drug Resistance|drug resistance
778990|NCT00001944|MDR-1|mdr-1
778991|NCT00001944|P-Glycoprotein Blocker|p-glycoprotein blocker
778992|NCT00001944|Pgp|pgp
778993|NCT00001944|Resistance Reversal|resistance reversal
778994|NCT00001940|Antifungal Agent|antifungal agent
778995|NCT00001940|Aspergillosis|aspergillosis
778996|NCT00001940|Candidemia|candidemia
778997|NCT00001940|Fungemia|fungemia
778998|NCT00001937|Aspergillosis|aspergillosis
778999|NCT00001937|Candidiasis|candidiasis
779000|NCT00001937|Fungal Infections|fungal infections
779001|NCT00001937|Fungemia|fungemia
779002|NCT00001937|Prophylactic Antifungal Therapy|prophylactic antifungal therapy
779003|NCT00001931|Continuous Stimulation|continuous stimulation
779004|NCT00001931|Dose Finding|dose finding
779005|NCT00001931|Skin Patch|skin patch
779006|NCT00001930|Amantadine|amantadine
779007|NCT00001930|Chorea|chorea
779008|NCT00001930|Glutamate Antagonist|glutamate antagonist
779009|NCT00001929|Dyskinesias|dyskinesias
779010|NCT00001929|Glutamate Antagonist|glutamate antagonist
779011|NCT00001929|Levodopa|levodopa
779012|NCT00001928|Diagnosis|diagnosis
779013|NCT00001928|Infusion|infusion
779014|NCT00001928|Parkinsonism|parkinsonism
779015|NCT00001918|Cognitive Function|cognitive function
779016|NCT00001918|Depression|depression
779017|NCT00001918|EMG|emg
779018|NCT00001918|Eosinophilia Myalgia Syndrome|eosinophilia myalgia syndrome
779019|NCT00001918|Impurities|impurities
779020|NCT00001918|L-5-HTP|l-5-htp
779021|NCT00001918|Memory Impairment|memory impairment
779022|NCT00001918|Nerve-Muscle Biopsy|nerve-muscle biopsy
779023|NCT00001918|Sleep Disorders|sleep disorders
779024|NCT00001916|Bone Remodeling|bone remodeling
779025|NCT00001916|Corticosteroids|corticosteroids
779026|NCT00001916|Cytokine|cytokine
779027|NCT00001916|Depression|depression
779028|NCT00001916|Glucocorticoids|glucocorticoids
779029|NCT00001916|Osteopenia|osteopenia
779030|NCT00001916|Osteoporosis|osteoporosis
779031|NCT00001916|Primary Affective Disorder|primary affective disorder
779032|NCT00001909|Allergy|allergy
779033|NCT00001909|Immunomodulator|immunomodulator
779034|NCT00001909|Inflammation|inflammation
779035|NCT00001909|Interleukin|interleukin
779036|NCT00001909|Th2|th2
779037|NCT00001909|Asthma|asthma
779038|NCT00001906|Alum|alum
779039|NCT00001906|Antigen|antigen
779040|NCT00001906|Cytokine|cytokine
779041|NCT00001906|Parasitic Infection|parasitic infection
779042|NCT00001906|Phase I|phase i
779043|NCT00001906|Cutaneous Leishmaniasis|cutaneous leishmaniasis
779044|NCT00001904|Atherosclerosis|atherosclerosis
779045|NCT00001904|Cardiovascular Disease|cardiovascular disease
779046|NCT00001904|Computerized Edge Reader|computerized edge reader
779047|NCT00001904|Myocardial Infarction|myocardial infarction
779048|NCT00001904|Risk Factor|risk factor
779049|NCT00001903|Immunization|immunization
779050|NCT00001903|Immunocompromised|immunocompromised
779051|NCT00001903|Immunoglobulin|immunoglobulin
779052|NCT00001903|Prophylaxis|prophylaxis
779053|NCT00001903|Respiratory Virus|respiratory virus
779054|NCT00001903|Bone Marrow Transplantation|bone marrow transplantation
779055|NCT00001903|Mini-Transplantation|mini-transplantation
779056|NCT00001903|Peripheral Stem Cell Transplantation|peripheral stem cell transplantation
779057|NCT00001891|CABG|cabg
779058|NCT00001891|Hibernation|hibernation
779059|NCT00001891|LV Function|lv function
779060|NCT00001891|Microbubbles|microbubbles
779061|NCT00001891|Revascularization|revascularization
779062|NCT00001891|Coronary Artery Disease|coronary artery disease
779063|NCT00001890|Cellular Immunity|cellular immunity
779064|NCT00001890|Cytokines|cytokines
779065|NCT00001890|Estrogen|estrogen
779066|NCT00001890|Humoral Immunity|humoral immunity
779067|NCT00001890|Progesterone|progesterone
779068|NCT00001890|Chlamydia Pneumoniae|chlamydia pneumoniae
779069|NCT00001890|Human Cytomegalovirus|human cytomegalovirus
779070|NCT00001890|Postmenopause|postmenopause
779071|NCT00001889|Microbubbles|microbubbles
779072|NCT00001889|Myocardial Blood Flow|myocardial blood flow
779073|NCT00001889|Myocardial Ischemia|myocardial ischemia
779074|NCT00001889|Second Harmonics|second harmonics
779075|NCT00001889|Ultrasound|ultrasound
779076|NCT00001889|Coronary Artery Disease|coronary artery disease
779077|NCT00001887|Airway Inflammation|airway inflammation
779078|NCT00001887|Allergen Challenge|allergen challenge
779079|NCT00001887|Bronchoscopy|bronchoscopy
779080|NCT00001887|Cytokines|cytokines
779081|NCT00001887|Receptors|receptors
779082|NCT00001887|Asthma|asthma
779083|NCT00001887|Normal Volunteer|normal volunteer
779084|NCT00001886|Coronary Artery Disease|coronary artery disease
779085|NCT00001886|Ischemia|ischemia
779086|NCT00001886|Ultrasound|ultrasound
779087|NCT00001886|Ventricular Function|ventricular function
779088|NCT00001886|Wall Motion|wall motion
779089|NCT00001881|Cardiac Hypertrophy|cardiac hypertrophy
779090|NCT00001881|Genetics|genetics
779091|NCT00001881|Phenotypes|phenotypes
779092|NCT00001881|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
779093|NCT00001879|Liver Disease|liver disease
779094|NCT00001879|Novel Agents|novel agents
779095|NCT00001879|Serum|serum
779096|NCT00001879|Viruses|viruses
779097|NCT00001879|non-A,G Hepatitis|non-a,g hepatitis
779098|NCT00001879|Seronegative Acute Hepatitis|seronegative acute hepatitis
779099|NCT00001871|Genetic Mutations|genetic mutations
779100|NCT00001871|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
779101|NCT00001871|Oculopharyngeal Muscular Dystrophy|oculopharyngeal muscular dystrophy
779102|NCT00001867|Cytokine|cytokine
779103|NCT00001867|Gestation|gestation
779104|NCT00001867|Postpartum|postpartum
779105|NCT00001867|Pregnancy|pregnancy
779106|NCT00001867|Th 1 Lymphocyte|th 1 lymphocyte
779107|NCT00001867|Th 2 Lymphocyte|th 2 lymphocyte
779108|NCT00001867|Uveitis|uveitis
779109|NCT00001857|Costimulation|costimulation
779110|NCT00001857|Immunosuppression|immunosuppression
779111|NCT00001857|Tolerance|tolerance
779112|NCT00001840|Infarct|infarct
779113|NCT00001840|Ischemia|ischemia
779114|NCT00001840|MRI|mri
779115|NCT00001840|Natural History|natural history
779116|NCT00001840|Stroke|stroke
779117|NCT00001840|Treatment|treatment
779118|NCT00001840|Brain Stroke|brain stroke
779119|NCT00001839|Anemia|anemia
779120|NCT00001839|Immunosuppressive|immunosuppressive
779121|NCT00001839|Phase II Trial|phase ii trial
779122|NCT00001839|Pre-Leukemia|pre-leukemia
779123|NCT00001839|Therapy|therapy
779124|NCT00001839|Myelodysplastic Syndrome|myelodysplastic syndrome
779125|NCT00001816|Anger|anger
779126|NCT00001816|Loneliness|loneliness
779127|NCT00001816|Mood|mood
779128|NCT00001816|Psychosocial|psychosocial
779129|NCT00001816|Virtual Network|virtual network
779130|NCT00001814|Hereditary|hereditary
779131|NCT00001814|Kidney|kidney
779132|NCT00001814|MET|met
779133|NCT00001814|Oncocytoma|oncocytoma
779134|NCT00001814|VHL|vhl
779135|NCT00001812|Mucositis|mucositis
779136|NCT00001812|Oral Candidiasis|oral candidiasis
779137|NCT00001812|Prophylaxis|prophylaxis
779138|NCT00001812|Stomatitis|stomatitis
779139|NCT00001812|Swish and Swallow|swish and swallow
779140|NCT00001810|Antifungal Agent|antifungal agent
779141|NCT00001810|Aspergillosis|aspergillosis
779142|NCT00001810|Candidiasis|candidiasis
779143|NCT00001810|Fungemia|fungemia
779144|NCT00001805|Breast Cancer|breast cancer
779145|NCT00001805|Colon Cancer|colon cancer
779146|NCT00001805|Gastric Cancer|gastric cancer
779147|NCT00001805|Lung Cancer|lung cancer
779148|NCT00001805|Pancreatic Cancer|pancreatic cancer
779149|NCT00001797|Cytokines|cytokines
779150|NCT00001797|Immunomodulation|immunomodulation
779151|NCT00001797|Inflammation|inflammation
779152|NCT00001797|Skin|skin
779153|NCT00001797|Therapy|therapy
779154|NCT00001790|Aspergillosis|aspergillosis
779155|NCT00001790|Candidiasis|candidiasis
779156|NCT00001790|Empiric Therapy|empiric therapy
779157|NCT00001790|Fungal Infection|fungal infection
779158|NCT00001790|Fungemia|fungemia
779159|NCT00001789|Autoantibody|autoantibody
779160|NCT00001789|Autoimmunity|autoimmunity
779161|NCT00001789|Inflammation|inflammation
779162|NCT00001789|Kidney|kidney
779163|NCT00001789|Lymphocyte|lymphocyte
779164|NCT00001789|Proliferative Lupus Glomerulonephritis|proliferative lupus glomerulonephritis
779165|NCT00001789|SLE-GN|sle-gn
779166|NCT00001782|Deafness|deafness
779167|NCT00001782|Hemisphere Dominance|hemisphere dominance
779168|NCT00001782|Language|language
779169|NCT00001782|Plasticity|plasticity
779170|NCT00001782|Speech|speech
779171|NCT00001782|rTMS|rtms
779172|NCT00001777|Frontal Lobe Dementia|frontal lobe dementia
779173|NCT00001777|Serotonergic Transmission|serotonergic transmission
779174|NCT00001774|Acetylcholine|acetylcholine
779175|NCT00001774|Blood Flow|blood flow
779176|NCT00001774|Blood vessel|blood vessel
779177|NCT00001774|Resistance|resistance
779178|NCT00001774|Sodium Nitroprusside|sodium nitroprusside
779179|NCT00001774|Fabry Disease|fabry disease
779180|NCT00001774|Normal Volunteer|normal volunteer
779181|NCT00001772|Bipolar Disorder|bipolar disorder
779182|NCT00001772|Rapid Cycling|rapid cycling
779184|NCT00001768|Autoimmunity|autoimmunity
779185|NCT00001768|Childhood Onset Schizophrenia|childhood onset schizophrenia
779186|NCT00001768|Intravenous Gammaglobulin|intravenous gammaglobulin
779187|NCT00001763|AIDS|aids
779188|NCT00001763|Cell Mediated Immunity|cell mediated immunity
779189|NCT00001763|Cytokine|cytokine
779190|NCT00001763|MAC|mac
779191|NCT00001763|Thl Response|thl response
779192|NCT00001761|Autoimmunity|autoimmunity
779193|NCT00001761|Cytokine|cytokine
779194|NCT00001761|Inflammation|inflammation
779195|NCT00001761|Interleukin|interleukin
779196|NCT00001761|Vasculitis|vasculitis
779197|NCT00001761|Wegener's Granulomatosis|wegener's granulomatosis
779198|NCT00001759|Allergy|allergy
779199|NCT00001759|Fluorodeoxyglucose|fluorodeoxyglucose
779200|NCT00001759|Imaging|imaging
779201|NCT00001759|PET|pet
779202|NCT00001759|Wegener's Granulomatosis|wegener's granulomatosis
779203|NCT00001759|Asthma|asthma
779204|NCT00001757|Azole|azole
779205|NCT00001757|Immunocompromised|immunocompromised
779206|NCT00001757|Mycosis|mycosis
779207|NCT00001757|Invasive Fungal Infection|invasive fungal infection
779208|NCT00001757|Systemic Fungal Infection|systemic fungal infection
779209|NCT00001754|Dwarfism|dwarfism
779210|NCT00001754|Gene Mapping|gene mapping
779211|NCT00001754|Linkage|linkage
779212|NCT00001754|Mutation Analysis|mutation analysis
779213|NCT00001754|Skeletal Biology|skeletal biology
779214|NCT00001754|Brachydactyly Types C & E|brachydactyly types c & e
779215|NCT00001754|Cartilage-Hair Hypoplasia|cartilage-hair hypoplasia
779216|NCT00001754|Ellis Van Crevald|ellis van crevald
779217|NCT00001754|FgFR-3|fgfr-3
779218|NCT00001754|Proximal Symphalangism|proximal symphalangism
779219|NCT00001754|Pyknodysotosis|pyknodysotosis
779220|NCT00001754|Schmid Metaphyseal|schmid metaphyseal
779221|NCT00001754|Short Stature|short stature
779222|NCT00001754|Skeletal Dysplasia|skeletal dysplasia
779223|NCT00001754|Type II Collagen Disorder|type ii collagen disorder
779224|NCT00001753|Exercise|exercise
779225|NCT00001753|MRI|mri
779226|NCT00001753|MRS|mrs
779227|NCT00001753|Normal Volunteer|normal volunteer
779228|NCT00001753|Tibialix Anterior|tibialix anterior
779229|NCT00001752|Adhesion Molecules|adhesion molecules
779230|NCT00001752|Endothelial Function|endothelial function
779231|NCT00001752|Inflammation|inflammation
779232|NCT00001752|Lipoproteins|lipoproteins
779233|NCT00001752|Nitric Oxide|nitric oxide
779234|NCT00001752|Hormone Therapy|hormone therapy
779235|NCT00001752|Postmenopausal Women|postmenopausal women
779236|NCT00001748|Cyclophosphamide|cyclophosphamide
779237|NCT00001748|Donor Apheresis|donor apheresis
779238|NCT00001748|Graft vs. Host Disease|graft vs. host disease
779239|NCT00001748|Graft-Versus-Leukemia|graft-versus-leukemia
779240|NCT00001748|Leukemic Relapse|leukemic relapse
779241|NCT00001748|Myeloma|myeloma
779242|NCT00001748|Peripheral Blood Stem Cells|peripheral blood stem cells
779243|NCT00001748|Whole Body Irradiation|whole body irradiation
779244|NCT00001748|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
779245|NCT00001748|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
779246|NCT00001748|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
779247|NCT00001748|Hematological Malignancies|hematological malignancies
779248|NCT00001748|Myelodysplastic Syndrome|myelodysplastic syndrome
779249|NCT00001748|Myeloproliferative Disorders|myeloproliferative disorders
779250|NCT00001747|Brachial Artery|brachial artery
779251|NCT00001747|Doppler|doppler
779252|NCT00001747|Endothelium|endothelium
779253|NCT00001747|Nitric Oxide|nitric oxide
779254|NCT00001747|Nitroglycerin|nitroglycerin
779255|NCT00001747|Normal Volunteer|normal volunteer
779256|NCT00001742|Acetylcholine|acetylcholine
779257|NCT00001742|Aspirin|aspirin
779258|NCT00001742|Nitric Oxide|nitric oxide
779259|NCT00001742|Sodium Nitroprusside|sodium nitroprusside
779260|NCT00001742|Hypercholesterolemia|hypercholesterolemia
779261|NCT00001742|Hypertension|hypertension
779262|NCT00001740|Cardiac|cardiac
779263|NCT00001740|Function|function
779264|NCT00001740|MRI|mri
779265|NCT00001740|Reconstruction|reconstruction
779266|NCT00001740|Ultrasound|ultrasound
779267|NCT00001740|Heart Disease (Cardiovascular Disease)|heart disease (cardiovascular disease)
779268|NCT00001738|Intermediate Uveitis|intermediate uveitis
779269|NCT00001738|Pars Planitis|pars planitis
779270|NCT00001738|Retinal Vasculature|retinal vasculature
779271|NCT00001738|Uveitis|uveitis
779272|NCT00001738|Vascular Permeability|vascular permeability
779273|NCT00001738|Vitreous|vitreous
779274|NCT00001736|Corneal Crystals|corneal crystals
779275|NCT00001736|Cysteamine|cysteamine
779276|NCT00001736|Cystinosis|cystinosis
779277|NCT00001736|Eye|eye
779278|NCT00001735|Gene Therapy|gene therapy
779279|NCT00001735|Graft|graft
779280|NCT00001735|Ornithine|ornithine
779281|NCT00001735|Retina|retina
779282|NCT00001735|Retinovirus|retinovirus
779283|NCT00001735|Retrovirus|retrovirus
779284|NCT00001735|Skin|skin
779285|NCT00001735|Gyrate Atrophy|gyrate atrophy
779286|NCT00001731|Conjunctiva|conjunctiva
779287|NCT00001731|Dry Eyes|dry eyes
779288|NCT00001731|Inflammation|inflammation
779289|NCT00001731|Lacrimal Gland|lacrimal gland
779290|NCT00001731|T Lymphocyte|t lymphocyte
779291|NCT00001731|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
779292|NCT00001730|Ablation|ablation
779293|NCT00001730|Activity-Time Curves|activity-time curves
779294|NCT00001730|Iodine Biokinetics|iodine biokinetics
779295|NCT00001730|Thyroid Carcinoma|thyroid carcinoma
779296|NCT00001730|Thyroid Remnant|thyroid remnant
779297|NCT00001718|Biofeedback|biofeedback
779298|NCT00001718|Swallowing|swallowing
779299|NCT00001718|Swallowing Therapy|swallowing therapy
779300|NCT00001718|Tongue/Palate|tongue/palate
779301|NCT00001718|Ultrasound|ultrasound
779302|NCT00001718|Dysphagia|dysphagia
779303|NCT00001717|Compensation|compensation
779304|NCT00001717|Motivations|motivations
779305|NCT00001717|Volunteers|volunteers
779306|NCT00001717|HIV|hiv
779307|NCT00001714|MRI|mri
779308|NCT00001714|Macromolecules|macromolecules
779309|NCT00001714|Magnetization Transfer|magnetization transfer
779310|NCT00001714|Metabolites|metabolites
779311|NCT00001714|Tissue Characterization|tissue characterization
779312|NCT00001714|Normal Volunteer|normal volunteer
779313|NCT00001705|Antigen|antigen
779314|NCT00001705|Cancer|cancer
779315|NCT00001705|Immunotherapy|immunotherapy
779316|NCT00001699|AIDS|aids
779317|NCT00001699|Compliance|compliance
779318|NCT00001699|HIV|hiv
779319|NCT00001699|Medication|medication
779320|NCT00001699|Perceived Threat|perceived threat
779321|NCT00001699|Teenagers|teenagers
779322|NCT00001696|Anti-metastatic|anti-metastatic
779323|NCT00001696|Chemoprevention|chemoprevention
779324|NCT00001696|Isoflavinoid|isoflavinoid
779325|NCT00001696|Prostate Cancer|prostate cancer
779326|NCT00001696|Signal Transduction|signal transduction
779327|NCT00001685|Cancer|cancer
779328|NCT00001685|IL-12|il-12
779329|NCT00001685|IL-2|il-2
779330|NCT00001685|Immunotherapy|immunotherapy
779331|NCT00001685|Vaccine|vaccine
779332|NCT00001681|Cytokines|cytokines
779333|NCT00001681|Gene Regulation|gene regulation
779334|NCT00001681|Immunization|immunization
779335|NCT00001681|Influenza|influenza
779336|NCT00001681|Pathogenesis|pathogenesis
779337|NCT00001680|Double-masked|double-masked
779338|NCT00001680|Neuropathy|neuropathy
779339|NCT00001680|Occlusive Dressing|occlusive dressing
779340|NCT00001680|Pilot|pilot
779341|NCT00001680|Placebo|placebo
779342|NCT00001679|Immunogenetics|immunogenetics
779343|NCT00001679|Joint Damage|joint damage
779344|NCT00001679|Reactive Arthritis|reactive arthritis
779345|NCT00001679|Rheumatoid Arthritis|rheumatoid arthritis
779346|NCT00001679|Synovium|synovium
779347|NCT00001679|Synovitis|synovitis
779348|NCT00001677|Immunosuppression|immunosuppression
779349|NCT00001677|Lymphocytes|lymphocytes
779350|NCT00001677|Magnetic Resonance|magnetic resonance
779351|NCT00001677|Synovial Biopsy|synovial biopsy
779352|NCT00001677|Synovitis|synovitis
779353|NCT00001677|Rheumatoid Arthritis|rheumatoid arthritis
779354|NCT00001672|Brain Mapping|brain mapping
779355|NCT00001672|Cognition|cognition
779356|NCT00001672|Noninvasive|noninvasive
779357|NCT00001672|Temporal Lobe|temporal lobe
779358|NCT00001672|Visual Naming|visual naming
779359|NCT00001669|EAE|eae
779360|NCT00001669|EDSS|edss
779361|NCT00001669|MRI|mri
779362|NCT00001669|SNRS|snrs
779363|NCT00001669|Multiple Sclerosis|multiple sclerosis
779364|NCT00001668|Deafness|deafness
779365|NCT00001668|Hemangioblastoma|hemangioblastoma
779366|NCT00001668|Papillary Carcinoma|papillary carcinoma
779367|NCT00001668|VHL Gene|vhl gene
779368|NCT00001668|Vestibular Function|vestibular function
779369|NCT00001668|von Hippel-Lindau Disease|von hippel-lindau disease
779370|NCT00001667|Family Studies|family studies
779371|NCT00001667|Genetic|genetic
779372|NCT00001667|Myoclonus|myoclonus
779373|NCT00001667|Tics|tics
779374|NCT00001667|Tremor|tremor
779375|NCT00001667|Movement Disorders|movement disorders
779376|NCT00001667|Neurological Disease|neurological disease
779377|NCT00001665|Magnetic Stimulation|magnetic stimulation
779378|NCT00001665|Motor Skills|motor skills
779379|NCT00001665|Parkinson's Disease|parkinson's disease
779380|NCT00001665|rTMS|rtms
779381|NCT00001658|Amoxicillin|amoxicillin
779382|NCT00001658|Antibiotics|antibiotics
779383|NCT00001658|Cytokines|cytokines
779384|NCT00001658|Group A beta-Hemolytic Strep Infections|group a beta-hemolytic strep infections
779385|NCT00001658|Obsessive Compulsive Disorder|obsessive compulsive disorder
779386|NCT00001658|Streptococcal Infection|streptococcal infection
779387|NCT00001658|Tic Disorders|tic disorders
779388|NCT00001657|15 O PET Scanning|15 o pet scanning
779389|NCT00001657|Anxiety|anxiety
779390|NCT00001657|Cerebral Blood Flow|cerebral blood flow
779391|NCT00001657|Depression|depression
779392|NCT00001657|Domestic Abuse|domestic abuse
779393|NCT00001657|Neuroendocrine|neuroendocrine
779394|NCT00001657|PET Scanning|pet scanning
779395|NCT00001657|Police Officers|police officers
779396|NCT00001657|Post Traumatic Stress Disorder|post traumatic stress disorder
779397|NCT00001657|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
779398|NCT00001646|Aspergillus|aspergillus
779399|NCT00001646|Azole|azole
779400|NCT00001646|Immunocompromise|immunocompromise
779401|NCT00001642|Chromosomal Deletion|chromosomal deletion
779402|NCT00001642|Mutations|mutations
779403|NCT00001642|Paucity of Bile Ducts|paucity of bile ducts
779404|NCT00001642|Physical Map|physical map
779405|NCT00001642|Transcript Identification|transcript identification
779406|NCT00001642|Alagille Syndrome|alagille syndrome
779407|NCT00001642|Syndromic Bile Duct Paucity|syndromic bile duct paucity
779408|NCT00001639|Gene Dosage|gene dosage
779409|NCT00001639|Haploinsufficiency|haploinsufficiency
779410|NCT00001639|Karyotype|karyotype
779411|NCT00001639|Malformations|malformations
779412|NCT00001639|Mental Retardation|mental retardation
779413|NCT00001633|Contrast Media|contrast media
779414|NCT00001633|Coronary Artery Disease|coronary artery disease
779415|NCT00001633|Coronary Vessels|coronary vessels
779416|NCT00001633|Magnetic Resonance Angiography|magnetic resonance angiography
779417|NCT00001633|Magnetic Resonance Imaging|magnetic resonance imaging
779418|NCT00001629|Angiotensin AT-1 Receptor|angiotensin at-1 receptor
779419|NCT00001629|Angiotensin Receptor Antagonist|angiotensin receptor antagonist
779420|NCT00001629|Atherosclerosis|atherosclerosis
779421|NCT00001629|Blood Flow|blood flow
779422|NCT00001629|Cold Pressor Test|cold pressor test
779423|NCT00001629|Endothelium|endothelium
779424|NCT00001629|Exercise|exercise
779425|NCT00001629|Coronary Artery Disease|coronary artery disease
779426|NCT00001629|Heart Failure|heart failure
779427|NCT00001628|Angiotensin Receptor Antagonist|angiotensin receptor antagonist
779428|NCT00001628|Atherosclerosis|atherosclerosis
779429|NCT00001628|Blood Flow|blood flow
779430|NCT00001628|Endothelium|endothelium
779431|NCT00001628|Endothelial Dysfunction|endothelial dysfunction
779432|NCT00001624|BQ-123|bq-123
779433|NCT00001624|Endothelin|endothelin
779434|NCT00001624|Insulin|insulin
779435|NCT00001624|Plethysmography|plethysmography
779436|NCT00001624|Vasoconstriction|vasoconstriction
779437|NCT00001624|Healthy Volunteer|healthy volunteer
779438|NCT00001622|Endothelium|endothelium
779439|NCT00001622|Hypercholesterolemia|hypercholesterolemia
779440|NCT00001622|Hypertension|hypertension
779441|NCT00001622|Microvessels|microvessels
779442|NCT00001622|Vasodilation|vasodilation
779443|NCT00001622|Normal Volunteer|normal volunteer
779444|NCT00001617|Aging|aging
779445|NCT00001617|Cataract|cataract
779446|NCT00001617|Eye|eye
779447|NCT00001617|Human Lens|human lens
779448|NCT00001617|Normal Volunteer|normal volunteer
779449|NCT00001615|Age-Related Macular Degeneration|age-related macular degeneration
779450|NCT00001615|Choroidal Neovascularization|choroidal neovascularization
779451|NCT00001615|Disciform|disciform
779452|NCT00001615|Drusen|drusen
779453|NCT00001615|Natural History|natural history
779454|NCT00001615|Periocular|periocular
779455|NCT00001615|Quality of Life|quality of life
779456|NCT00001615|Steroids|steroids
779457|NCT00001615|Corticosteroid|corticosteroid
779458|NCT00001614|Eye|eye
779459|NCT00001614|Immunosuppression|immunosuppression
779460|NCT00001614|Inflammation|inflammation
779461|NCT00001614|Iritis|iritis
779462|NCT00001614|Joint|joint
779463|NCT00001614|Oral Tolerance|oral tolerance
779464|NCT00001614|Juvenile Rheumatoid Arthritis|juvenile rheumatoid arthritis
779465|NCT00001614|Uveitis|uveitis
779466|NCT00001612|Diabetic Retinopathy|diabetic retinopathy
779467|NCT00001612|Long-Term Visual Outcome|long-term visual outcome
779468|NCT00001612|Photocoagulation|photocoagulation
779469|NCT00001612|J. H. Wilmer Eye Institute|j. h. wilmer eye institute
779470|NCT00001605|Conjugate Vaccine|conjugate vaccine
779471|NCT00001605|Detoxified Lipooligosaccharide|detoxified lipooligosaccharide
779472|NCT00001605|Tetanus Toxoid|tetanus toxoid
779473|NCT00001605|Normal Volunteers|normal volunteers
779474|NCT00001587|Hyperthermia|hyperthermia
779475|NCT00001587|Metastases|metastases
779476|NCT00001587|Organ Perfusion|organ perfusion
779477|NCT00001587|Regional Therapy|regional therapy
779478|NCT00001584|Pathogenesis|pathogenesis
779479|NCT00001584|Resistance|resistance
779480|NCT00001584|Sanctuary Sites|sanctuary sites
779481|NCT00001584|Semen|semen
779482|NCT00001584|Sexual Transmission|sexual transmission
779483|NCT00001579|Biochemical Modulation|biochemical modulation
779484|NCT00001579|Dihydropyrimidine Dehydrogenase|dihydropyrimidine dehydrogenase
779485|NCT00001579|Oral Administration|oral administration
779486|NCT00001579|Pharmacokinetics|pharmacokinetics
779487|NCT00001577|Chemotherapy|chemotherapy
779488|NCT00001577|Hyperthermia|hyperthermia
779489|NCT00001577|Isolation perfusion|isolation perfusion
779490|NCT00001577|Regional Therapy|regional therapy
779491|NCT00001573|Glioma|glioma
779492|NCT00001573|PDGF|pdgf
779493|NCT00001573|Pharmacokinetics|pharmacokinetics
779494|NCT00001573|Sarcoma|sarcoma
779495|NCT00001573|Toxicity|toxicity
779496|NCT00001571|Cancer|cancer
779497|NCT00001571|DDT, PCB|ddt, pcb
779498|NCT00001571|Epidemiology|epidemiology
779501|NCT00001570|Cytochrome P 450|cytochrome p 450
779502|NCT00001570|Multi-Drug Resistance|multi-drug resistance
779503|NCT00001570|P-Glycoprotein|p-glycoprotein
779504|NCT00001570|Pharmacokinetics|pharmacokinetics
779505|NCT00001565|Brain Tumors|brain tumors
779506|NCT00001565|Differentiation|differentiation
779507|NCT00001565|Maximally Tolerated Dose|maximally tolerated dose
779508|NCT00001565|Neuroblastoma|neuroblastoma
779509|NCT00001565|Phenylacetate|phenylacetate
779510|NCT00001554|Cortical Localization|cortical localization
779511|NCT00001554|Optical Imaging|optical imaging
779512|NCT00001554|Thermal Imaging|thermal imaging
779513|NCT00001553|Plasticity|plasticity
779514|NCT00001553|Recovery|recovery
779515|NCT00001553|Stroke|stroke
779516|NCT00001553|Use|use
779517|NCT00001553|Cortico-subcortical Stroke|cortico-subcortical stroke
779518|NCT00001546|Biochemical Screening|biochemical screening
779519|NCT00001546|Body Temperature|body temperature
779520|NCT00001546|Consent Form|consent form
779521|NCT00001546|EEG|eeg
779522|NCT00001546|EKG|ekg
779523|NCT00001546|Melatonin|melatonin
779524|NCT00001546|Mood|mood
779525|NCT00001546|Physical Examination|physical examination
779526|NCT00001546|Psychiatric Examination|psychiatric examination
779527|NCT00001546|Sleep Duration|sleep duration
779528|NCT00001546|Sleep Disorders|sleep disorders
779529|NCT00001540|Diagnostic|diagnostic
779530|NCT00001540|Immune Function|immune function
779531|NCT00001540|Immunization|immunization
779532|NCT00001540|Immunodeficiency|immunodeficiency
779533|NCT00001540|Quantitative|quantitative
779534|NCT00001538|AIDS|aids
779535|NCT00001538|DNA Vaccine|dna vaccine
779536|NCT00001538|Naked DNA|naked dna
779537|NCT00001538|Plasmid|plasmid
779538|NCT00001538|gp 160|gp 160
779539|NCT00001536|Disability|disability
779540|NCT00001536|Dwarfism|dwarfism
779541|NCT00001536|Ethics in Genetic Counseling|ethics in genetic counseling
779542|NCT00001536|Quality of Life|quality of life
779543|NCT00001536|Reproductive Issues|reproductive issues
779544|NCT00001536|Support Groups|support groups
779545|NCT00001536|Achondroplasia|achondroplasia
779546|NCT00001533|Anemia|anemia
779547|NCT00001533|Chronic T Cell Lymphocytosis with Neutropenia|chronic t cell lymphocytosis with neutropenia
779548|NCT00001533|Immunosuppression|immunosuppression
779549|NCT00001533|Neutropenia|neutropenia
779550|NCT00001533|T-LGL Leukemia|t-lgl leukemia
779551|NCT00001531|Atherogenesis|atherogenesis
779552|NCT00001531|Cell Mediated Immunity|cell mediated immunity
779553|NCT00001531|Coronary Artery Disease|coronary artery disease
779554|NCT00001530|Cardiac Hypertrophy|cardiac hypertrophy
779555|NCT00001530|Drug-Refractory|drug-refractory
779556|NCT00001530|Hemodynamic Benefits|hemodynamic benefits
779557|NCT00001530|Obstruction|obstruction
779558|NCT00001530|Pacemaker Therapy|pacemaker therapy
779559|NCT00001530|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
779560|NCT00001528|Coronary Artery Disease|coronary artery disease
779561|NCT00001528|Gated Blood Pool Tomography|gated blood pool tomography
779562|NCT00001528|Myocardial Blood Flow|myocardial blood flow
779563|NCT00001528|Myocardial Stunning|myocardial stunning
779564|NCT00001528|Positron Emission Tomography|positron emission tomography
779565|NCT00001527|BQ-123|bq-123
779566|NCT00001527|BQ-788|bq-788
779567|NCT00001527|Endothelin|endothelin
779568|NCT00001527|Endothelium|endothelium
779569|NCT00001527|Plethysmography|plethysmography
779570|NCT00001527|Essential Hypertension|essential hypertension
779571|NCT00001523|Cytology|cytology
779572|NCT00001523|Diagnostic Imaging|diagnostic imaging
779573|NCT00001523|Radiation Damage|radiation damage
779574|NCT00001523|Saliva|saliva
779575|NCT00001523|Serostomia|serostomia
779576|NCT00001523|Xerostomia|xerostomia
779577|NCT00001523|Head Cancer|head cancer
779578|NCT00001523|Neck Cancer|neck cancer
779579|NCT00001520|Endotracheal Intubation|endotracheal intubation
779580|NCT00001520|Neuromuscular Blockade|neuromuscular blockade
779581|NCT00001520|Neuromuscular Blocking Agents|neuromuscular blocking agents
779582|NCT00001520|Paralysis|paralysis
779583|NCT00001520|Reversal Agents|reversal agents
779584|NCT00001519|Exercise|exercise
779585|NCT00001519|Exercise Intensity|exercise intensity
779586|NCT00001519|Non-Linear Regression|non-linear regression
779587|NCT00001519|Oxygen Uptake|oxygen uptake
779588|NCT00001519|Recovery|recovery
779589|NCT00001519|Subject Comparison|subject comparison
779590|NCT00001519|Time Constant|time constant
779591|NCT00001519|VO2|vo2
779592|NCT00001518|Groshong Catheter|groshong catheter
779593|NCT00001518|Heparinized Flush Solution|heparinized flush solution
779594|NCT00001518|Intraluminal Clot|intraluminal clot
779595|NCT00001518|Urokinase|urokinase
779596|NCT00001518|Venous Access Device|venous access device
779597|NCT00001518|Withdrawal Occlusion|withdrawal occlusion
779598|NCT00001509|Differentiation|differentiation
779599|NCT00001509|N-myc Expression|n-myc expression
779600|NCT00001509|Retinoid|retinoid
779601|NCT00001509|Solid Tumor|solid tumor
779602|NCT00001509|Trk Expression|trk expression
779603|NCT00001502|Blood-Brain Barrier|blood-brain barrier
779604|NCT00001502|Bradykinin|bradykinin
779607|NCT00001502|Medulloblastoma|medulloblastoma
779608|NCT00001499|Carcinoma|carcinoma
779609|NCT00001499|Combination Chemotherapy|combination chemotherapy
779610|NCT00001499|Combined Modality Therapy|combined modality therapy
779611|NCT00001499|Infusion|infusion
779612|NCT00001499|Intravenous|intravenous
779613|NCT00001499|Lung Neoplasm|lung neoplasm
779614|NCT00001499|Non-Small Cell Lung Cancer|non-small cell lung cancer
779615|NCT00001498|5-Fluorouracil|5-fluorouracil
779616|NCT00001498|Cyclophosphamide|cyclophosphamide
779617|NCT00001498|Methotrexate|methotrexate
779618|NCT00001498|Thiotepa|thiotepa
779619|NCT00001497|Brain Imaging|brain imaging
779620|NCT00001497|Encephalopathy|encephalopathy
779621|NCT00001497|Hyperactivity|hyperactivity
779622|NCT00001497|Neuroimmunology|neuroimmunology
779623|NCT00001497|Reaction Time Tasks|reaction time tasks
779624|NCT00001495|Camptothecin|camptothecin
779625|NCT00001495|Cancer|cancer
779626|NCT00001495|Chemotherapy|chemotherapy
779627|NCT00001495|Natural Products|natural products
779628|NCT00001495|Neoplasms|neoplasms
779629|NCT00001493|Dose Intensity|dose intensity
779630|NCT00001493|Gene Therapy|gene therapy
779631|NCT00001493|Multidrug Resistance|multidrug resistance
779632|NCT00001489|Cerebral Metabolism|cerebral metabolism
779633|NCT00001489|Complex Partial Seizures|complex partial seizures
779634|NCT00001489|Epilepsy|epilepsy
779635|NCT00001485|Chemical Mediators|chemical mediators
779636|NCT00001485|Circadian Rhythms|circadian rhythms
779637|NCT00001485|Gender Differences|gender differences
779638|NCT00001485|Melatonin|melatonin
779639|NCT00001485|Photoperiodism|photoperiodism
779640|NCT00001485|Seasonal Changes|seasonal changes
779641|NCT00001482|Anticonvulsants|anticonvulsants
779642|NCT00001482|Bipolar Disorder|bipolar disorder
779643|NCT00001482|Depression|depression
779644|NCT00001482|Gabapentin|gabapentin
779645|NCT00001482|Lamotrigine|lamotrigine
779646|NCT00001482|Mania|mania
779647|NCT00001482|Mood Disorders|mood disorders
779648|NCT00001479|ACTH|acth
779649|NCT00001479|Adrenocorticotropic Hormone|adrenocorticotropic hormone
779650|NCT00001479|Antidepressant Treatment|antidepressant treatment
779651|NCT00001479|Chaos Theory|chaos theory
779652|NCT00001479|Chronic Fatigue Syndrome|chronic fatigue syndrome
779653|NCT00001479|Major Depression|major depression
779654|NCT00001479|Normal Volunteer|normal volunteer
779655|NCT00001479|Primary Affective Disorder|primary affective disorder
779656|NCT00001478|Bupropion|bupropion
779657|NCT00001478|Carbamazepine|carbamazepine
779658|NCT00001478|Cerebral Blood Flow|cerebral blood flow
779659|NCT00001478|Gabapentin|gabapentin
779660|NCT00001478|Lamotrigine|lamotrigine
779661|NCT00001478|Mood Disorders|mood disorders
779662|NCT00001478|Nimodipine|nimodipine
779663|NCT00001478|Oxygen-15|oxygen-15
779664|NCT00001478|Positron Emission Tomography|positron emission tomography
779665|NCT00001478|Venlafaxine|venlafaxine
779666|NCT00001477|Communicable Infection|communicable infection
779667|NCT00001477|Monitoring|monitoring
779668|NCT00001477|Non-Invasive Tests|non-invasive tests
779669|NCT00001477|Opportunistic Infection|opportunistic infection
779670|NCT00001468|Behavioral and Attitudinal Changes|behavioral and attitudinal changes
779671|NCT00001468|Breast Cancer|breast cancer
779672|NCT00001468|High Risk Families|high risk families
779673|NCT00001468|Inherited Susceptibility|inherited susceptibility
779674|NCT00001468|Psychological Responses to Risk|psychological responses to risk
779675|NCT00001466|Clinical Genetics|clinical genetics
779676|NCT00001466|Etiology|etiology
779677|NCT00001466|Medical Screening|medical screening
779678|NCT00001466|Prognosis|prognosis
779679|NCT00001466|Genetic Disorders|genetic disorders
779680|NCT00001462|Alpha 1-Antitrypsin Deficiency|alpha 1-antitrypsin deficiency
779681|NCT00001462|Emphysema|emphysema
779682|NCT00001462|Genetic Diseases|genetic diseases
779683|NCT00001462|Inflammation|inflammation
779684|NCT00001462|Nitric Oxide|nitric oxide
779685|NCT00001462|Protease|protease
779686|NCT00001461|Angiotensin Converting Enzyme|angiotensin converting enzyme
779687|NCT00001461|Angiotensin Converting Enzyme Inhibitors|angiotensin converting enzyme inhibitors
779688|NCT00001461|Bradykinin|bradykinin
779689|NCT00001461|Endothelial Function|endothelial function
779690|NCT00001461|Nitric Oxide|nitric oxide
779691|NCT00001461|Coronary Artery Disease|coronary artery disease
779692|NCT00001459|Gated Blood Pool|gated blood pool
779693|NCT00001459|SPECT Scan|spect scan
779694|NCT00001459|Coronary Artery Disease|coronary artery disease
779695|NCT00001459|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
779696|NCT00001459|Microvascular Angina|microvascular angina
779697|NCT00001455|Genetics|genetics
779698|NCT00001455|Hemochromatosis|hemochromatosis
779699|NCT00001455|Iron Metabolism|iron metabolism
779700|NCT00001455|Iron Storage Disorder|iron storage disorder
779701|NCT00001455|Pedigree|pedigree
779702|NCT00001455|Iron Overload|iron overload
779703|NCT00001450|Chemotherapy|chemotherapy
779704|NCT00001450|In Vitro Testing|in vitro testing
779705|NCT00001450|Infusional|infusional
779706|NCT00001450|Lung Neoplasm|lung neoplasm
790714|NCT00000846|HIV-1|hiv-1
779707|NCT00001450|Pharmacokinetics|pharmacokinetics
779708|NCT00001449|Anti-Cancer Agents|anti-cancer agents
779709|NCT00001449|Antimetabolite|antimetabolite
779710|NCT00001449|Palliation|palliation
779711|NCT00001449|Pharmacodynamics|pharmacodynamics
779712|NCT00001449|Pharmacokinetics|pharmacokinetics
779713|NCT00001448|Antifungal Therapy|antifungal therapy
779714|NCT00001448|Articulation|articulation
779715|NCT00001448|Behavior|behavior
779716|NCT00001448|Expressive Language|expressive language
779717|NCT00001448|Thrush|thrush
779718|NCT00001446|Angiogenesis|angiogenesis
779719|NCT00001446|Malignancy|malignancy
779720|NCT00001446|Neuropathy|neuropathy
779721|NCT00001446|Pharmacokinetics|pharmacokinetics
779722|NCT00001446|Sedation|sedation
779723|NCT00001445|Adjuvant-Controlled Study|adjuvant-controlled study
779724|NCT00001445|Double Blind Randomization|double blind randomization
779725|NCT00001445|Env-Deleted Inactivated HIV-1|env-deleted inactivated hiv-1
779726|NCT00001445|Therapeutic HIV Vaccine|therapeutic hiv vaccine
779727|NCT00001443|AIDS|aids
779728|NCT00001443|Bioavailability|bioavailability
779729|NCT00001443|Immunologic Evaluations|immunologic evaluations
779730|NCT00001443|Pharmacokinetics|pharmacokinetics
779731|NCT00001443|Toxicity|toxicity
779732|NCT00001439|Cancer|cancer
779733|NCT00001439|Immunotherapy|immunotherapy
779734|NCT00001438|HIV Infection|hiv infection
779735|NCT00001438|Immune Response|immune response
779736|NCT00001438|Pediatric|pediatric
779737|NCT00001438|Pharmacokinetics|pharmacokinetics
779738|NCT00001438|Toxicity|toxicity
779739|NCT00001437|Cytokines|cytokines
779740|NCT00001437|Fibrosis Intensity|fibrosis intensity
779741|NCT00001437|Post-Radiation Fibrosis|post-radiation fibrosis
779742|NCT00001437|Radiation Injury|radiation injury
779743|NCT00001437|Trental|trental
779744|NCT00001436|Hormone Interactions|hormone interactions
779745|NCT00001436|IGF-I|igf-i
779746|NCT00001436|Metastatic|metastatic
779747|NCT00001436|Pediatric|pediatric
779748|NCT00001436|Recurrent|recurrent
779749|NCT00001435|Anxiety|anxiety
779750|NCT00001435|Depression|depression
779751|NCT00001435|Family Functioning|family functioning
779752|NCT00001435|Psychosocial Adjustment|psychosocial adjustment
779753|NCT00001435|Social Support|social support
779754|NCT00001431|Combined Modality|combined modality
779755|NCT00001431|GI Cancer|gi cancer
779756|NCT00001431|Pancreatic Cancer|pancreatic cancer
779757|NCT00001431|Radiotherapy|radiotherapy
779758|NCT00001428|Chemotherapy|chemotherapy
779759|NCT00001428|Cytokine|cytokine
779760|NCT00001428|Efficacy|efficacy
779761|NCT00001428|Palliation|palliation
779762|NCT00001428|Solid Tumor|solid tumor
779763|NCT00001427|Pharmacodynamic Studies|pharmacodynamic studies
779764|NCT00001427|Pharmacokinetics|pharmacokinetics
779765|NCT00001424|AIDS|aids
779766|NCT00001424|Children|children
779767|NCT00001424|Human Immunodeficiency Virus|human immunodeficiency virus
779768|NCT00001422|Adenine Analogue|adenine analogue
779769|NCT00001422|Apoptosis|apoptosis
779770|NCT00001422|Cytokines|cytokines
779771|NCT00001422|Psoriasis|psoriasis
779772|NCT00001422|Synovium|synovium
779773|NCT00001422|Psoriatic Arthritis|psoriatic arthritis
779774|NCT00001421|Cytotoxicity|cytotoxicity
779775|NCT00001421|HLA Class I|hla class i
779776|NCT00001421|Lymphocytes|lymphocytes
779777|NCT00001421|Muscle|muscle
779778|NCT00001421|Myositis|myositis
779779|NCT00001421|Thionamides|thionamides
779780|NCT00001421|Dermatomyositis|dermatomyositis
779781|NCT00001421|Polymyositis|polymyositis
779782|NCT00001416|Bone Disease|bone disease
779783|NCT00001416|Calcitriol|calcitriol
779784|NCT00001416|Enzyme Replacement Therapy|enzyme replacement therapy
779785|NCT00001416|Gaucher's Disease|gaucher's disease
779786|NCT00001416|Vitamin D|vitamin d
779787|NCT00001415|IL-1|il-1
779788|NCT00001415|IL-6|il-6
779789|NCT00001415|Immune Response|immune response
779790|NCT00001415|Inflammation|inflammation
779791|NCT00001415|Steroids|steroids
779792|NCT00001415|Chronic Fatigue Syndrome|chronic fatigue syndrome
779793|NCT00001415|Depression|depression
779794|NCT00001415|Fibromyalgia|fibromyalgia
779795|NCT00001415|Normal Volunteer|normal volunteer
779796|NCT00001402|Dilated Cardiomyopathy|dilated cardiomyopathy
779797|NCT00001402|Hibernating Myocardium|hibernating myocardium
779798|NCT00001402|Ischemic Cardiomyopathy|ischemic cardiomyopathy
779799|NCT00001402|Metoprolol|metoprolol
779800|NCT00001402|Stress Thallium Scintigraphy|stress thallium scintigraphy
779801|NCT00001402|Congestive Cardiomyopathy|congestive cardiomyopathy
779802|NCT00001402|Congestive Heart Failure|congestive heart failure
779803|NCT00001402|Heart Failure|heart failure
779804|NCT00001395|Cataracts|cataracts
779805|NCT00001395|Complications|complications
779806|NCT00001395|Rates of Progression|rates of progression
779807|NCT00001395|Diabetic Retinopathy|diabetic retinopathy
779808|NCT00001387|Paclitaxel|paclitaxel
779809|NCT00001387|Pediatric|pediatric
779810|NCT00001387|Pharmacokinetics|pharmacokinetics
779811|NCT00001387|Phase I|phase i
779812|NCT00001387|Toxicity|toxicity
779813|NCT00001385|Cancer Diagnosis|cancer diagnosis
779814|NCT00001385|Cancer Metabolism|cancer metabolism
779815|NCT00001385|FDG|fdg
779816|NCT00001385|FDG Breast Imaging|fdg breast imaging
779817|NCT00001385|PET|pet
779818|NCT00001385|Positron Emission Mammography|positron emission mammography
779819|NCT00001385|Radiopharmaceutical|radiopharmaceutical
779820|NCT00001385|Scintimammography|scintimammography
779821|NCT00001384|14-Day Cycle|14-day cycle
779822|NCT00001384|Dose Intensity|dose intensity
779823|NCT00001384|Filgrastim|filgrastim
779824|NCT00001384|Lymph Node Positive|lymph node positive
779825|NCT00001384|Non-Cross Resistant|non-cross resistant
779826|NCT00001383|Cyclosporine Analogue|cyclosporine analogue
779827|NCT00001383|Multidrug Resistance|multidrug resistance
779828|NCT00001383|Pgp Blocker|pgp blocker
779829|NCT00001383|Pump Blocker|pump blocker
779830|NCT00001383|Taxol Over 90 Hours|taxol over 90 hours
779831|NCT00001382|Immunotherapy|immunotherapy
779832|NCT00001382|Vaccine|vaccine
779833|NCT00001381|Adult|adult
779834|NCT00001381|Intravesical Chemotherapy|intravesical chemotherapy
779835|NCT00001378|4-Quadrant Fine Needle Aspiration|4-quadrant fine needle aspiration
779836|NCT00001378|Biomarkers|biomarkers
779837|NCT00001378|Chemoprevention|chemoprevention
779838|NCT00001378|Nipple Suction Aspirates|nipple suction aspirates
779839|NCT00001378|TGF Beta|tgf beta
779840|NCT00001377|Familial|familial
779841|NCT00001377|Inherited Prostate Cancer|inherited prostate cancer
779842|NCT00001377|Linkage|linkage
779843|NCT00001377|Prostate Cancer|prostate cancer
779844|NCT00001376|Androgens|androgens
779845|NCT00001376|Female|female
779846|NCT00001376|Immunology|immunology
779847|NCT00001376|Neuroendocrine Axis|neuroendocrine axis
779848|NCT00001376|Rheumatoid Arthritis|rheumatoid arthritis
779849|NCT00001376|Postpartum|postpartum
779850|NCT00001376|Pregnancy|pregnancy
779851|NCT00001375|Infection|infection
779852|NCT00001375|Reactive Arthritis|reactive arthritis
779853|NCT00001375|Rheumatoid Arthritis|rheumatoid arthritis
779854|NCT00001375|Synovial Biopsy|synovial biopsy
779855|NCT00001375|Synovial Fluid|synovial fluid
779856|NCT00001375|Synovitis|synovitis
779857|NCT00001371|Inflammation|inflammation
779858|NCT00001371|Lipocortin|lipocortin
779859|NCT00001371|Phospholipase A-2|phospholipase a-2
779860|NCT00001371|Skin|skin
779861|NCT00001371|Uteroglobin|uteroglobin
779862|NCT00001371|Psoriasis|psoriasis
779863|NCT00001365|Dextromethorphan|dextromethorphan
779864|NCT00001365|Dextrorphan|dextrorphan
779865|NCT00001365|Glutamate Antagonist|glutamate antagonist
779866|NCT00001365|Parkinson's Disease|parkinson's disease
779867|NCT00001363|Blood Flow|blood flow
779868|NCT00001363|Chess Play|chess play
779869|NCT00001363|Frontal Lobe|frontal lobe
779870|NCT00001363|Neurobehavioral Deficits|neurobehavioral deficits
779871|NCT00001363|Neuropsychology|neuropsychology
779872|NCT00001363|Positron Emission Tomography|positron emission tomography
779873|NCT00001363|Prefrontal Cortex|prefrontal cortex
779874|NCT00001346|Diabetic Macular Edema|diabetic macular edema
779875|NCT00001346|Diabetic Retinopathy|diabetic retinopathy
779876|NCT00001346|Macular Edema|macular edema
779877|NCT00001346|Photocoagulation|photocoagulation
779878|NCT00001346|Psychophysical Testing|psychophysical testing
779879|NCT00001346|Stiles-Crawford Effect|stiles-crawford effect
779880|NCT00001344|Diabetes Mellitus|diabetes mellitus
779881|NCT00001344|Diabetic Neuropathy|diabetic neuropathy
779882|NCT00001344|Memantine|memantine
779883|NCT00001344|NMDA Receptor Antagonists|nmda receptor antagonists
779884|NCT00001344|Neuropathic Pain|neuropathic pain
779885|NCT00001344|Neuropathy|neuropathy
779886|NCT00001344|Post-Herpetic Neuralgia|post-herpetic neuralgia
779887|NCT00001344|Shingles|shingles
779888|NCT00001342|Electrooculography|electrooculography
779889|NCT00001342|Electroretinogram|electroretinogram
779890|NCT00001342|Fluorescein Angiogram|fluorescein angiogram
779891|NCT00001342|Glycogen Storage Disease|glycogen storage disease
779892|NCT00001341|Antifolate|antifolate
779893|NCT00001341|Inhibitor|inhibitor
779894|NCT00001341|Pharmacokinetics|pharmacokinetics
779895|NCT00001341|Thymidylate Synthetase|thymidylate synthetase
779896|NCT00001341|Toxicity|toxicity
779897|NCT00001338|Fusion Protein|fusion protein
779898|NCT00001333|Intraventricular|intraventricular
779899|NCT00001333|Meningeal Malignancy|meningeal malignancy
779900|NCT00001333|NSC 609699|nsc 609699
779901|NCT00001333|SKF 104864|skf 104864
779902|NCT00001333|Topoisomerase 1|topoisomerase 1
779903|NCT00001332|Cancer Treatment|cancer treatment
779904|NCT00001332|Chemotherapy|chemotherapy
779905|NCT00001332|Regional Therapy|regional therapy
779906|NCT00001332|Surgery|surgery
779907|NCT00001330|Autoimmune Diseases|autoimmune diseases
779908|NCT00001330|Connective Tissue Disease|connective tissue disease
779909|NCT00001330|Scleroderma|scleroderma
779910|NCT00001330|Silicone Device Implants|silicone device implants
779911|NCT00001330|Silicone Injection|silicone injection
779912|NCT00001330|Idiopathic Scleroderma|idiopathic scleroderma
779913|NCT00001330|Myositis|myositis
779914|NCT00001330|Systemic Sclerosis|systemic sclerosis
779917|NCT00001324|Motor Learning|motor learning
779918|NCT00001324|Parkinson's Disease|parkinson's disease
779919|NCT00001324|Physiology|physiology
779920|NCT00001324|Positron Emission Tomography|positron emission tomography
779921|NCT00001324|Stroke|stroke
779922|NCT00001324|Tremor|tremor
779923|NCT00001324|Voluntary and Involuntary Movement Physiology|voluntary and involuntary movement physiology
779924|NCT00001324|Movement Disorders|movement disorders
779925|NCT00001324|Normal Volunteer|normal volunteer
779926|NCT00001318|Immune Adjuvant|immune adjuvant
779927|NCT00001318|Phagocytes|phagocytes
779928|NCT00001318|Non-tuberculous Mycobacterial Infection|non-tuberculous mycobacterial infection
779929|NCT00001317|Children|children
779930|NCT00001317|Gamma Interferon|gamma interferon
779931|NCT00001317|Hospitalizations|hospitalizations
779932|NCT00001317|Infection|infection
779933|NCT00001317|Chronic Granulomatous Disease|chronic granulomatous disease
779934|NCT00001314|Aortic Regurgitation|aortic regurgitation
779935|NCT00001314|Dobutamine Stress|dobutamine stress
779936|NCT00001314|Left Ventricular Function|left ventricular function
779937|NCT00001314|Mitral Regurgitation|mitral regurgitation
779938|NCT00001314|Myocardial Contractile Reserve|myocardial contractile reserve
779939|NCT00001314|Transesophageal Echocardiography|transesophageal echocardiography
779940|NCT00001311|Cell/Flare Meter|cell/flare meter
779941|NCT00001311|Heparin Coating|heparin coating
779942|NCT00001311|Inflammation|inflammation
779943|NCT00001311|Laser Cell Flare Photometry|laser cell flare photometry
779944|NCT00001311|Multicentric|multicentric
779945|NCT00001311|Polymethylmetacrylate|polymethylmetacrylate
779946|NCT00001311|Specular Micrography|specular micrography
779947|NCT00001311|Specular Microscopy|specular microscopy
779948|NCT00001301|Adverse Effects|adverse effects
779949|NCT00001301|Burkitt's Lymphoma|burkitt's lymphoma
779950|NCT00001301|Diffuse Large Cell Lymphoma|diffuse large cell lymphoma
779951|NCT00001301|Extended Remission|extended remission
779952|NCT00001301|Health Status|health status
779953|NCT00001301|Lymphoblastic Lymphoma|lymphoblastic lymphoma
779954|NCT00001301|Molecular Studies|molecular studies
779955|NCT00001300|Adjuvant Chemotherapy|adjuvant chemotherapy
779956|NCT00001300|Ifosfamide|ifosfamide
779957|NCT00001300|Randomized Study|randomized study
779958|NCT00001300|Soft Tissue Sarcoma|soft tissue sarcoma
779959|NCT00001298|Antibody|antibody
779960|NCT00001298|DAMPA|dampa
779961|NCT00001298|Enzyme|enzyme
779962|NCT00001298|Kidney|kidney
779963|NCT00001298|Pharmacokinetics|pharmacokinetics
779964|NCT00001298|Thymidine|thymidine
779965|NCT00001298|Toxicity|toxicity
779966|NCT00001296|Interferon-Gamma|interferon-gamma
779967|NCT00001296|Isolated Limb Perfusion|isolated limb perfusion
779968|NCT00001296|Melanoma|melanoma
779969|NCT00001296|Melphalan|melphalan
779970|NCT00001296|TNF|tnf
779971|NCT00001292|DNA Markers|dna markers
779972|NCT00001292|Family Studies|family studies
779973|NCT00001292|Gene Mapping|gene mapping
779974|NCT00001292|Ichthyosis|ichthyosis
779975|NCT00001292|Keratin|keratin
779976|NCT00001292|Linkage Analysis|linkage analysis
779977|NCT00001292|Scaling Disorders|scaling disorders
779978|NCT00001292|Skin|skin
779979|NCT00001291|Osteoarthritis|osteoarthritis
779980|NCT00001291|Psoriatic Arthritis|psoriatic arthritis
779981|NCT00001291|Rheumatoid Arthritis|rheumatoid arthritis
779982|NCT00001291|Synovial Biopsy|synovial biopsy
779983|NCT00001291|Synovitis|synovitis
779984|NCT00001291|Synovium|synovium
779985|NCT00001287|Intravenous High-Dose Immunoglobulin|intravenous high-dose immunoglobulin
779986|NCT00001287|Monoclonal Gammopathies|monoclonal gammopathies
779987|NCT00001287|Peripheral Nerve Demyelination|peripheral nerve demyelination
779988|NCT00001287|CIDP|cidp
779989|NCT00001287|Chronic Inflammatory Demyelinating Polyneuropathy|chronic inflammatory demyelinating polyneuropathy
779990|NCT00001285|Circadian Rhythms|circadian rhythms
779991|NCT00001285|Environmental Light|environmental light
779992|NCT00001285|Estrogen|estrogen
779993|NCT00001285|Melatonin|melatonin
779994|NCT00001285|Progesterone|progesterone
779995|NCT00001285|Rapid Cycling Bipolar Disorder|rapid cycling bipolar disorder
779996|NCT00001285|Sleep|sleep
779997|NCT00001285|Testosterone|testosterone
779998|NCT00001285|Depression|depression
779999|NCT00001285|Hypomania|hypomania
780000|NCT00001285|Mania|mania
780001|NCT00001280|Aspergillosis|aspergillosis
780002|NCT00001280|Phagocyte Defect|phagocyte defect
780003|NCT00001280|Torulopsis|torulopsis
780004|NCT00001280|Chronic Granulomatous Disease|chronic granulomatous disease
780005|NCT00001278|Conjunctival Biopsy|conjunctival biopsy
780006|NCT00001278|Lacrimal Gland Biopsy|lacrimal gland biopsy
780007|NCT00001278|Sarcoid Uveitis|sarcoid uveitis
780008|NCT00001278|Sarcoidosis|sarcoidosis
780009|NCT00001278|Conjunctiva|conjunctiva
780010|NCT00001278|Inflammatory Eye Disease|inflammatory eye disease
780011|NCT00001272|Adult|adult
780012|NCT00001272|Cytotoxic Chemotherapy|cytotoxic chemotherapy
780013|NCT00001272|Hematopoietic Growth Factor|hematopoietic growth factor
780014|NCT00001271|Antigen Modulation|antigen modulation
780015|NCT00001271|Pharmacokinetics|pharmacokinetics
780016|NCT00001271|Ricin A Chain|ricin a chain
780017|NCT00001270|Chemotherapy|chemotherapy
780018|NCT00001270|High Dose|high dose
780019|NCT00001270|Protection|protection
780020|NCT00001269|Dose-Intensive Chemotherapy|dose-intensive chemotherapy
780021|NCT00001269|Hematopoietic Growth Factor|hematopoietic growth factor
780022|NCT00001269|Peripheral Blood Progenitor Cell|peripheral blood progenitor cell
780023|NCT00001267|Anti-Viral|anti-viral
780024|NCT00001267|Dideoxynucleosides|dideoxynucleosides
780025|NCT00001267|HIV|hiv
780026|NCT00001267|Retrovirus|retrovirus
780027|NCT00001249|Interleukin-2 Receptor|interleukin-2 receptor
780028|NCT00001239|5-Fluorouracil|5-fluorouracil
780029|NCT00001239|Adriamycin|adriamycin
780030|NCT00001239|Breast Carcinoma|breast carcinoma
780031|NCT00001239|Leucovorin|leucovorin
780032|NCT00001239|Phase II|phase ii
780033|NCT00001237|Burkitt's Lymphoma|burkitt's lymphoma
780034|NCT00001237|GM-CSF|gm-csf
780035|NCT00001237|High-Grade|high-grade
780036|NCT00001233|Adolescence|adolescence
780037|NCT00001233|Aggressivity|aggressivity
780038|NCT00001233|Anger|anger
780039|NCT00001233|Developmental Psychopathology|developmental psychopathology
780040|NCT00001233|Disruptive Behavior Disorders|disruptive behavior disorders
780041|NCT00001233|Early Onset Aggression|early onset aggression
780042|NCT00001233|Emotion Regulation|emotion regulation
780043|NCT00001233|Family Violence|family violence
780044|NCT00001233|Preschool Conduct Problems|preschool conduct problems
780045|NCT00001232|Depression|depression
780047|NCT00001232|GnRH|gnrh
780048|NCT00001232|LH|lh
780049|NCT00001232|Menopause|menopause
780050|NCT00001232|Menstrual Cycle|menstrual cycle
780051|NCT00001229|Calcium-Pentagastrin|calcium-pentagastrin
780052|NCT00001229|Clonidine|clonidine
780053|NCT00001229|Glucagon|glucagon
780054|NCT00001229|Pheochromocytoma|pheochromocytoma
780055|NCT00001218|Baseline Data|baseline data
780056|NCT00001218|Curve Averaging|curve averaging
780057|NCT00001218|Curve Fitting|curve fitting
780058|NCT00001218|Movement Patterns|movement patterns
780059|NCT00001218|Normative Data|normative data
780060|NCT00001218|Polar Distribution|polar distribution
780061|NCT00001218|Tongue|tongue
780062|NCT00001218|Tongue Shape|tongue shape
780063|NCT00001218|Ultrasound|ultrasound
780064|NCT00001217|Non-Metastatic Osteosarcoma|non-metastatic osteosarcoma
780065|NCT00001217|Presurgical Chemotherapy|presurgical chemotherapy
780066|NCT00001216|Amputations|amputations
780067|NCT00001216|Brainstem Stimulation|brainstem stimulation
780068|NCT00001216|Cerebellar Stimulation|cerebellar stimulation
780069|NCT00001216|Cortical Motor Physiology|cortical motor physiology
780070|NCT00001216|Electrical Stimulation|electrical stimulation
780071|NCT00001216|Motor Cortex|motor cortex
780072|NCT00001216|Plasticity|plasticity
780073|NCT00001216|Spinal Cord Injury|spinal cord injury
780074|NCT00001216|Stroke|stroke
780075|NCT00001211|Ectodermal Dysplasia|ectodermal dysplasia
780076|NCT00001211|Edentulous|edentulous
780077|NCT00001211|Endosseous|endosseous
780078|NCT00001211|Implants|implants
780079|NCT00001211|Mandibular Atrophy|mandibular atrophy
780080|NCT00001211|Oral|oral
780081|NCT00001211|Titanium|titanium
780082|NCT00001210|Blood Donors|blood donors
780083|NCT00001210|Epitopes|epitopes
780084|NCT00001210|HIV|hiv
780085|NCT00001209|Combined Chemotherapy|combined chemotherapy
780086|NCT00001209|Irradiation|irradiation
780087|NCT00001209|Unresectable|unresectable
780088|NCT00001194|Helium Cryogen|helium cryogen
780089|NCT00001194|Magnetic Field|magnetic field
780090|NCT00001194|Multi-Institute|multi-institute
780091|NCT00001194|Nitrogen Cryogen|nitrogen cryogen
780092|NCT00001194|Radiofrequency|radiofrequency
780093|NCT00001193|Autologous|autologous
780094|NCT00001193|Melphalan|melphalan
780095|NCT00001193|Stage III|stage iii
780096|NCT00001193|Transplantation|transplantation
780097|NCT00001189|Adjuvant Radiotherapy|adjuvant radiotherapy
780098|NCT00001189|Low-Grade Sarcoma|low-grade sarcoma
780099|NCT00001189|Radiotherapy|radiotherapy
780100|NCT00001189|Randomized Study|randomized study
780101|NCT00001189|Sarcoma|sarcoma
780102|NCT00001189|Surgery|surgery
780103|NCT00001188|Chemotherapy|chemotherapy
780104|NCT00001188|Radiation Therapy|radiation therapy
780105|NCT00001188|Sarcoma|sarcoma
780106|NCT00001188|Surgery|surgery
780107|NCT00001173|B Cells|b cells
780108|NCT00001173|Humoral Immunity|humoral immunity
780109|NCT00001173|Lymphocytes|lymphocytes
780110|NCT00001173|Tetanus Toxoid|tetanus toxoid
780111|NCT00001169|Chemotherapy|chemotherapy
780112|NCT00001169|Cytokines|cytokines
780113|NCT00001169|Immunology|immunology
780114|NCT00001169|Kala-Azar|kala-azar
780115|NCT00001169|Leishmaniasis|leishmaniasis
780116|NCT00001164|Genetic Evaluation|genetic evaluation
780117|NCT00001164|Immunologic Evaluations|immunologic evaluations
780118|NCT00001164|Inflammatory Skin Disease|inflammatory skin disease
780119|NCT00001164|Muscular Dystrophies|muscular dystrophies
780120|NCT00001164|Neoplastic Skin Diseases|neoplastic skin diseases
780121|NCT00001164|Neuronal Degenerations|neuronal degenerations
780122|NCT00001164|Retinal Degenerations|retinal degenerations
780123|NCT00001164|Viral Diseases|viral diseases
780124|NCT00001158|Cellular Immunity|cellular immunity
780125|NCT00001158|Humoral Immunity|humoral immunity
780126|NCT00001158|Immunodeficiency Disease|immunodeficiency disease
780127|NCT00001153|Albinism|albinism
780128|NCT00001153|Ocular Albinism|ocular albinism
780129|NCT00001153|Oculocutaneous Albinism|oculocutaneous albinism
780130|NCT00001153|Tyrosinase Negative|tyrosinase negative
780131|NCT00001153|Tyrosinase Positive|tyrosinase positive
780132|NCT00001152|Aqueous Humor Dynamics|aqueous humor dynamics
780133|NCT00001152|Glaucoma|glaucoma
780134|NCT00001152|Ocular Hypertension|ocular hypertension
780135|NCT00001152|Pigment Dispersion Syndrome|pigment dispersion syndrome
780136|NCT00001152|Primary Open Angle Glaucoma|primary open angle glaucoma
780137|NCT00001152|Pseudo-Exfoliation of the Lens Capsule|pseudo-exfoliation of the lens capsule
780138|NCT00001142|Body Fat|body fat
780139|NCT00001142|DXA|dxa
780140|NCT00001142|HAART|haart
780141|NCT00001142|Hyperlipidemia|hyperlipidemia
780142|NCT00001142|Insulin Resistance|insulin resistance
780143|NCT00001142|Lipodystrophy|lipodystrophy
780144|NCT00001142|MRI|mri
780145|NCT00001142|Protease Inhibitor|protease inhibitor
780146|NCT00001142|Side-Effects|side-effects
780147|NCT00001142|Visceral Fat|visceral fat
780148|NCT00001142|Chronic Infection|chronic infection
780149|NCT00001142|HIV|hiv
780150|NCT00001142|Healthy Volunteer|healthy volunteer
780151|NCT00050388|Cancer|cancer
780152|NCT00050388|Carcinoma|carcinoma
780153|NCT00050388|Neoplasm|neoplasm
780154|NCT00050388|Head cancer|head cancer
780155|NCT00050388|Neck cancer|neck cancer
780156|NCT00050388|Tongue cancer|tongue cancer
780157|NCT00050388|Lip cancer|lip cancer
780158|NCT00050388|Oral Cavity|oral cavity
780159|NCT00050388|Oropharynx|oropharynx
780160|NCT00050388|Pharynx|pharynx
780161|NCT00050388|Larynx|larynx
780162|NCT00050388|Squamous Cell|squamous cell
780163|NCT00050388|Salivary Glands|salivary glands
780164|NCT00050388|Tumor|tumor
780165|NCT00050388|Lesion|lesion
780166|NCT00050388|Cancer treatment|cancer treatment
780167|NCT00050388|Clinical trial|clinical trial
780168|NCT00050388|Allovectin-7®|allovectin-7®
780169|NCT00050388|Otorhinolaryngologic Neoplasm|otorhinolaryngologic neoplasm
780170|NCT00050388|Otolaryngologic Cancer|otolaryngologic cancer
780171|NCT00050388|Gene therapy|gene therapy
780172|NCT00050388|Immunotherapy|immunotherapy
780173|NCT00050388|Cancer research|cancer research
780174|NCT00050388|Cancer vaccine|cancer vaccine
780175|NCT00050388|Cancer cells|cancer cells
780176|NCT00050375|OvaRex|ovarex
780177|NCT00050375|ovarian|ovarian
780178|NCT00050375|CA125|ca125
780179|NCT00050375|murine|murine
780180|NCT00050375|antibody|antibody
780181|NCT00050375|immunotherapy|immunotherapy
780182|NCT00050362|Pain|pain
780183|NCT00050362|NSAID|nsaid
780184|NCT00050362|Oral Surgery|oral surgery
780185|NCT00050362|Hyperalgesia|hyperalgesia
780186|NCT00050362|Preemptive Analgesia|preemptive analgesia
780187|NCT00050349|cancer|cancer
780188|NCT00050349|tumor|tumor
780189|NCT00050349|tumour|tumour
780190|NCT00050349|neoplasm|neoplasm
780191|NCT00050349|carcinoma|carcinoma
780192|NCT00050349|carcinoid|carcinoid
780193|NCT00050349|neuroendocrine|neuroendocrine
780194|NCT00050349|Islet cell|islet cell
780195|NCT00050349|Gastrinoma|gastrinoma
780196|NCT00050349|VIPoma|vipoma
780197|NCT00050349|metastatic|metastatic
780198|NCT00050349|intravenous|intravenous
780199|NCT00050349|epothilone|epothilone
780200|NCT00050336|Stage 3b or 4 (metastatic) non-small cell lung cancer|stage 3b or 4 (metastatic) non-small cell lung cancer
780201|NCT00050323|Stage IV Renal Cell Carcinoma|stage iv renal cell carcinoma
780202|NCT00050323|Kidney Cancer|kidney cancer
780203|NCT00050323|Cancer (General)|cancer (general)
780204|NCT00050310|Confirmed|confirmed
780205|NCT00050310|Suspected|suspected
780206|NCT00050310|Pathogenesis|pathogenesis
780207|NCT00050310|Bronchoscopy|bronchoscopy
780208|NCT00050310|Cultures|cultures
780209|NCT00050310|Anthrax|anthrax
780210|NCT00050310|Natural History|natural history
780211|NCT00050310|Vaccinated Healthy Volunteer|vaccinated healthy volunteer
780212|NCT00050284|Treatment Experienced|treatment experienced
780213|NCT00050284|Disease Progression|disease progression
780214|NCT00050284|Anti-HIV Agents|anti-hiv agents
780215|NCT00050284|Treatment Interruption|treatment interruption
780216|NCT00050271|Acetylcarnitine|acetylcarnitine
780217|NCT00050271|Dideoxynucleosides|dideoxynucleosides
780218|NCT00050271|Epidermis|epidermis
780219|NCT00050271|Biopsy|biopsy
780220|NCT00050271|Immunohistochemistry|immunohistochemistry
780221|NCT00050271|Nerve Fibers|nerve fibers
780222|NCT00050271|Treatment Experienced|treatment experienced
780223|NCT00050245|Neuropathy|neuropathy
780224|NCT00050245|B Cells|b cells
780225|NCT00050245|Anti-MAG|anti-mag
780226|NCT00050245|Demyelination|demyelination
780227|NCT00050245|MAG|mag
780228|NCT00050245|RITUXAN|rituxan
780229|NCT00050245|Monoclonal Antibodies|monoclonal antibodies
780231|NCT00050245|Demyelinating Neuropathy|demyelinating neuropathy
780232|NCT00050232|Pseudobulbar Affect|pseudobulbar affect
780233|NCT00050232|Uncontrolled|uncontrolled
780234|NCT00050232|Laughing|laughing
780235|NCT00050232|Crying|crying
780236|NCT00050219|Raclopride|raclopride
780237|NCT00050219|D2 Receptors|d2 receptors
780238|NCT00050219|Striatum|striatum
780239|NCT00050219|Low-Response|low-response
780240|NCT00050219|Alcoholism|alcoholism
780241|NCT00050219|Alcohol|alcohol
780242|NCT00050219|Dopamine|dopamine
780243|NCT00050219|Response|response
780244|NCT00050141|Breast cancer|breast cancer
780245|NCT00050141|ZARNESTRA|zarnestra
780246|NCT00050141|tipifarnib|tipifarnib
780247|NCT00050141|R115777|r115777
780248|NCT00050141|Estrogen receptor positive|estrogen receptor positive
780249|NCT00050141|Progesterone receptor positive|progesterone receptor positive
780250|NCT00050141|Anti-estrogen therapy|anti-estrogen therapy
780251|NCT00050167|Breast Cancer|breast cancer
780252|NCT00050167|Capecitabine|capecitabine
780253|NCT00050167|Docetaxel|docetaxel
780254|NCT00050167|Paclitaxel|paclitaxel
780255|NCT00050167|Taxotere|taxotere
780256|NCT00050167|Taxol|taxol
780257|NCT00050167|Xeloda|xeloda
780258|NCT00050167|Taxanes|taxanes
780259|NCT00050167|Operable Breast Cancer|operable breast cancer
780260|NCT00050193|Children|children
780261|NCT00050193|Mast Cells|mast cells
780262|NCT00050193|Urticaria Pigmentosa|urticaria pigmentosa
780263|NCT00050193|Bone Marrow|bone marrow
780264|NCT00050193|Severe|severe
780265|NCT00050193|Mastocytosis|mastocytosis
780266|NCT00050193|Pediatric Mastocytosis|pediatric mastocytosis
780267|NCT00050180|P-Glycoprotein|p-glycoprotein
780268|NCT00050180|Protease Inhibitor|protease inhibitor
780269|NCT00050180|Antiretrovirals|antiretrovirals
780270|NCT00050180|Cytochrome P450|cytochrome p450
780271|NCT00050180|Drug Transporters|drug transporters
780272|NCT00050180|Healthy Volunteer|healthy volunteer
780273|NCT00050180|HV|hv
780274|NCT00050154|R115777|r115777
780275|NCT00050154|Myelodysplastic syndromes|myelodysplastic syndromes
780276|NCT00050154|Tipifarnib|tipifarnib
780277|NCT00050154|Zarnestra|zarnestra
780278|NCT00050128|Rehabilitation|rehabilitation
780279|NCT00050128|Plasticity|plasticity
780280|NCT00050128|Frequency|frequency
780281|NCT00050128|Inhibition|inhibition
780282|NCT00050128|Pinch|pinch
780283|NCT00050128|Stroke|stroke
780284|NCT00050089|AIDS|aids
780285|NCT00050089|antiretrovirals|antiretrovirals
780286|NCT00050089|ART|art
780287|NCT00050089|drug-free period|drug-free period
780288|NCT00050089|HAART|haart
780289|NCT00050089|HIV|hiv
780290|NCT00050089|human immunodeficiency virus|human immunodeficiency virus
780291|NCT00050089|randomized|randomized
780292|NCT00050089|structured treatment interruptions|structured treatment interruptions
780293|NCT00050076|Congestive Heart Failure|congestive heart failure
780294|NCT00050076|Cardiac Failure|cardiac failure
780295|NCT00050076|Heart Decompensation|heart decompensation
780296|NCT00050076|Drug Therapy|drug therapy
780297|NCT00050063|HIV Therapeutic Vaccine|hiv therapeutic vaccine
780298|NCT00050063|Treatment Experienced|treatment experienced
780299|NCT00050063|AIDS Vaccines|aids vaccines
780300|NCT00050063|Treatment Interruption|treatment interruption
780301|NCT00050063|Viral Load|viral load
780302|NCT00050063|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
780303|NCT00050063|T-Lymphocytes, Helper-Inducer|t-lymphocytes, helper-inducer
780304|NCT00050050|Adult|adult
780305|NCT00050050|ADHD|adhd
780306|NCT00050050|ADD|add
780307|NCT00050115|Bone Marrow Failure|bone marrow failure
780308|NCT00050115|Seronegative Hepatitis|seronegative hepatitis
780309|NCT00050115|Fulminate Hepatitis|fulminate hepatitis
780310|NCT00050115|Hepatitis|hepatitis
780311|NCT00050115|Aplastic Anemia|aplastic anemia
780312|NCT00050115|Hepatitis Associated Aplastic Anemia|hepatitis associated aplastic anemia
780313|NCT00050024|TMS|tms
780314|NCT00050024|Afferent Stimulation|afferent stimulation
780315|NCT00050024|Motor Cortex|motor cortex
780316|NCT00050024|Writer's Cramp|writer's cramp
780317|NCT00050024|Surround Inhibition|surround inhibition
780318|NCT00050024|Heterotopic Inhibition|heterotopic inhibition
780319|NCT00050024|Focal Dystonia|focal dystonia
780320|NCT00050024|Writer Cramp|writer cramp
780321|NCT00050011|cancer-treatment related bone loss|cancer-treatment related bone loss
780322|NCT00050011|postmenopausal women|postmenopausal women
780323|NCT00050011|breast cancer|breast cancer
780324|NCT00050011|hormone receptor positive breast cancer|hormone receptor positive breast cancer
780325|NCT00050011|adjuvant therapy|adjuvant therapy
780326|NCT00050011|hormonal therapy|hormonal therapy
780327|NCT00050011|bone loss|bone loss
780328|NCT00050011|bisphosphonates|bisphosphonates
780329|NCT00050011|ZFAST|zfast
780330|NCT00050011|Letrozole|letrozole
780331|NCT00050011|Zoledronic Acid|zoledronic acid
780332|NCT00050011|US32|us32
780333|NCT00049998|Nonsmall Cell Lung cancer|nonsmall cell lung cancer
780334|NCT00049998|advanced|advanced
780335|NCT00049998|Second-line|second-line
780336|NCT00049998|topotecan|topotecan
780340|NCT00049972|Major Depressive Disorder Open-label discontinued|major depressive disorder open-label discontinued
780341|NCT00049959|Verteporfin PDT|verteporfin pdt
780342|NCT00049959|multiple basal cell carcinoma|multiple basal cell carcinoma
780343|NCT00049959|nevoid basal cell carcinoma syndrome|nevoid basal cell carcinoma syndrome
780344|NCT00049946|Talnetant|talnetant
780345|NCT00049946|schizophrenia|schizophrenia
780346|NCT00049946|NK3 receptor antagonist|nk3 receptor antagonist
780347|NCT00049946|psychosis|psychosis
780348|NCT00049829|Bisphosphonate,BMD,Height loss, Hip protectors,HRT,|bisphosphonate,bmd,height loss, hip protectors,hrt,
780349|NCT00049829|Osteoporosis|osteoporosis
780350|NCT00049816|knee|knee
780351|NCT00049816|aerobic exercise|aerobic exercise
780352|NCT00049816|walking|walking
780353|NCT00049816|cycling|cycling
780354|NCT00049816|gait|gait
780355|NCT00049816|MRI|mri
780356|NCT00049803|Narcolepsy|narcolepsy
780357|NCT00049803|Sodium Oxybate|sodium oxybate
780358|NCT00049803|Cataplexy|cataplexy
780359|NCT00049803|Excessive Daytime Sleepiness|excessive daytime sleepiness
780360|NCT00049803|GHB|ghb
780361|NCT00049803|Gamma Hydroxybutyric Acid|gamma hydroxybutyric acid
780362|NCT00049803|Orphan Medical|orphan medical
780363|NCT00049803|Orphan Drug|orphan drug
780364|NCT00049790|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
780365|NCT00049738|Psychosis|psychosis
780366|NCT00049738|Childhood Onset Schizophrenia|childhood onset schizophrenia
780367|NCT00049738|Schizophrenia|schizophrenia
780368|NCT00049738|Schizoaffective|schizoaffective
780369|NCT00049738|Psychotic Disorder|psychotic disorder
780370|NCT00049738|Multidimensionally Impaired Syndrome|multidimensionally impaired syndrome
780371|NCT00049725|Autoimmune Disease|autoimmune disease
780372|NCT00049725|Monoclonal Antibody Therapy|monoclonal antibody therapy
780373|NCT00049725|Anti-IL2 Receptor|anti-il2 receptor
780374|NCT00049725|Platelets|platelets
780375|NCT00049725|Monoclonal Antibody|monoclonal antibody
780376|NCT00049725|Immune Thrombocytopenia|immune thrombocytopenia
780377|NCT00049725|ITP|itp
780378|NCT00048841|Male|male
780379|NCT00048841|Osteoporosis|osteoporosis
780380|NCT00048841|Prostate cancer|prostate cancer
780381|NCT00048841|Hypogonadism|hypogonadism
780382|NCT00048841|Bisphosphonates|bisphosphonates
780383|NCT00048841|Bone mineral density|bone mineral density
780384|NCT00048815|Minor Depression|minor depression
780385|NCT00048815|St. John's Wart|st. john's wart
780386|NCT00048802|Adolescence|adolescence
780387|NCT00048906|Pharmacokinetics|pharmacokinetics
780388|NCT00048906|Enzyme|enzyme
780389|NCT00048906|Lysosomal|lysosomal
780390|NCT00048906|Kidney|kidney
780391|NCT00048906|Stroke|stroke
780392|NCT00048906|Fabry Disease|fabry disease
780393|NCT00048906|Fabrys|fabrys
780394|NCT00048906|Fabry's|fabry's
780395|NCT00048893|CEA vaccine|cea vaccine
780396|NCT00048893|Metastatic Breast Cancer|metastatic breast cancer
780397|NCT00048893|T- Cell Repertoire|t- cell repertoire
780398|NCT00048893|High-dose Chemotherapy|high-dose chemotherapy
780399|NCT00048893|Breast Cancer|breast cancer
780400|NCT00048880|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
780401|NCT00048880|Monoclonal Antibody|monoclonal antibody
780402|NCT00048880|CD30|cd30
780403|NCT00048880|Antibody Saturation|antibody saturation
780404|NCT00048880|Apoptosis|apoptosis
780405|NCT00048880|Flow Cytometry|flow cytometry
780406|NCT00048880|Cancer|cancer
780407|NCT00048776|Secondary Raynaud's|secondary raynaud's
780408|NCT00048776|circulatory|circulatory
780409|NCT00048776|vascular|vascular
780410|NCT00048776|scleroderma|scleroderma
780411|NCT00048776|lupus|lupus
780412|NCT00048776|mixed connective tissue disease|mixed connective tissue disease
780413|NCT00048763|circulatory|circulatory
780414|NCT00048763|vascular|vascular
780415|NCT00048763|idiopathic|idiopathic
780416|NCT00048789|Psoralen|psoralen
780417|NCT00048789|Refractory|refractory
780418|NCT00048789|Transplantation|transplantation
780419|NCT00048789|Stem Cell|stem cell
780420|NCT00048789|UVA|uva
780421|NCT00048789|Graft-versus-host Disease|graft-versus-host disease
780422|NCT00048789|GVHD|gvhd
780423|NCT00048750|Anti-Fungal Therapy|anti-fungal therapy
780424|NCT00048750|Preemptive Anti-Fungal Therapy|preemptive anti-fungal therapy
780425|NCT00048750|Invasive Fungal Infection|invasive fungal infection
780426|NCT00048750|Micafungin|micafungin
780427|NCT00048750|ICU|icu
780428|NCT00048737|Leukemia|leukemia
780429|NCT00048737|Lymphoma|lymphoma
780430|NCT00048737|Lymphoid Malignancy|lymphoid malignancy
780431|NCT00048737|Cyclophosphamide|cyclophosphamide
780432|NCT00048737|Cytoxan|cytoxan
780433|NCT00048737|Neosar|neosar
780434|NCT00048737|Fludarabine|fludarabine
780435|NCT00048737|Fludarabine Phosphate|fludarabine phosphate
780436|NCT00048737|Fludara|fludara
780437|NCT00048737|Rituximab|rituximab
780438|NCT00048737|Rituxan|rituxan
780439|NCT00048737|Zevalin|zevalin
780440|NCT00048737|Indium Zevalin|indium zevalin
780441|NCT00048737|90Y Zevalin|90y zevalin
780442|NCT00048737|CD-20-positive|cd-20-positive
780443|NCT00048737|B-cell Lymphoma|b-cell lymphoma
780444|NCT00048737|CD-20-positive B-cell Lymphoma|cd-20-positive b-cell lymphoma
780447|NCT00048737|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
780448|NCT00048737|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
780449|NCT00048737|ASCT|asct
780450|NCT00048724|Hepatitis C; Cirrhosis|hepatitis c; cirrhosis
780451|NCT00048698|Frontal Lobe|frontal lobe
780452|NCT00048698|Motor Cortex|motor cortex
780453|NCT00048698|Dementia|dementia
780454|NCT00048698|Cognition|cognition
780455|NCT00048698|Healthy Volunteer|healthy volunteer
780456|NCT00048698|HV|hv
780457|NCT00048685|Caries|caries
780458|NCT00048685|Bacteria|bacteria
780459|NCT00048685|Saliva|saliva
780460|NCT00048685|Teeth|teeth
780461|NCT00048685|Autoimmune|autoimmune
780462|NCT00048685|Dry Mouth|dry mouth
780463|NCT00048685|Salivary Gland Dysfunction|salivary gland dysfunction
780464|NCT00048685|Sjogren's Syndrome|sjogren's syndrome
780465|NCT00048672|Early Chronic Phase Chronic Myelogenous Leukemia|early chronic phase chronic myelogenous leukemia
780466|NCT00048672|Leukemia|leukemia
780467|NCT00048672|Gleevec|gleevec
780468|NCT00048672|STI571|sti571
780469|NCT00048672|Imatinib mesylate|imatinib mesylate
780470|NCT00048659|Androgen-independent prostate cancer|androgen-independent prostate cancer
780471|NCT00048646|TBI|tbi
780472|NCT00048646|ProTECT|protect
780473|NCT00048633|Chemotherapy resistance advanced breast cancer|chemotherapy resistance advanced breast cancer
780474|NCT00048542|Polyarticular Juvenile Idiopathic Arthritis|polyarticular juvenile idiopathic arthritis
780475|NCT00048529|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
780476|NCT00048503|Zarnestra|zarnestra
780477|NCT00048503|Acute myeloid leukemia|acute myeloid leukemia
780478|NCT00048503|Tipifarnib|tipifarnib
780479|NCT00048464|Immunotherapy|immunotherapy
780480|NCT00048464|T Cell Therapy|t cell therapy
780481|NCT00048464|Peripheral Blood Stem Cell Transplant|peripheral blood stem cell transplant
780482|NCT00048464|Bone marrow transplant|bone marrow transplant
780483|NCT00048464|Adoptive immunotherapy|adoptive immunotherapy
780484|NCT00048464|Xcellerate|xcellerate
780485|NCT00048425|Decompensated chronic heart failure|decompensated chronic heart failure
780486|NCT00048490|Seizures|seizures
780487|NCT00048490|Magnetism|magnetism
780488|NCT00048490|Brain|brain
780489|NCT00048490|Stimulation|stimulation
780490|NCT00048490|Therapy|therapy
780491|NCT00048490|Epilepsy|epilepsy
780492|NCT00048477|Endothelium|endothelium
780493|NCT00048477|Vasodilation|vasodilation
780494|NCT00048477|Exercise|exercise
780495|NCT00048477|Hemoglobin|hemoglobin
780496|NCT00048477|Blood Flow|blood flow
780497|NCT00048477|Healthy Volunteer|healthy volunteer
780498|NCT00048477|HV|hv
780499|NCT00048373|LANGERHANS|langerhans
780500|NCT00048373|HISTIOCYTOSIS|histiocytosis
780501|NCT00048360|ADD|add
780502|NCT00048360|ADHD|adhd
780503|NCT00048360|attention deficit|attention deficit
780504|NCT00048360|hyperactivity|hyperactivity
780505|NCT00048308|CABG|cabg
780506|NCT00048347|Lymphocyte|lymphocyte
780507|NCT00048347|Monocyte|monocyte
780508|NCT00048347|Inflammation|inflammation
780509|NCT00048347|Th2|th2
780510|NCT00048347|Colonoscopy|colonoscopy
780511|NCT00048347|Ulcerative Colitis|ulcerative colitis
780512|NCT00048334|Histone Acetylation|histone acetylation
780513|NCT00048334|Cancer|cancer
780514|NCT00048282|Incidence|incidence
780515|NCT00048282|HIV Seroprevalence|hiv seroprevalence
780516|NCT00048282|Vagina|vagina
780517|NCT00048282|Anti-Infective Agents|anti-infective agents
780518|NCT00048282|Administration, Topical|administration, topical
780519|NCT00048282|Gels|gels
780520|NCT00048282|HIV Seronegativity|hiv seronegativity
780521|NCT00048230|Relapsed Multiple Myeloma|relapsed multiple myeloma
780522|NCT00048230|Refractory Multiple Myeloma|refractory multiple myeloma
780523|NCT00048217|Treatment Experienced|treatment experienced
780524|NCT00048204|Depression|depression
780525|NCT00048204|Psychiatry|psychiatry
780526|NCT00048204|Major Depressive Disorder|major depressive disorder
780527|NCT00048256|Cancer|cancer
780528|NCT00048256|Personality Assessment|personality assessment
780529|NCT00048256|Coping Styles|coping styles
780530|NCT00048256|Psychological Distress|psychological distress
780531|NCT00048256|Bone Marrow Transplants|bone marrow transplants
780532|NCT00048256|Bone Marrow Transplant|bone marrow transplant
780533|NCT00048113|Crohn's|crohn's
780534|NCT00048100|Dendritic cells|dendritic cells
780535|NCT00048100|Lymphocytes|lymphocytes
780536|NCT00048100|AML|aml
780537|NCT00048087|Non-small cell lung cancer|non-small cell lung cancer
780538|NCT00047983|Kidney Transplantation|kidney transplantation
780539|NCT00047983|Fatty Acids, Omega-3|fatty acids, omega-3
780540|NCT00047983|Erythrocyte Membrane|erythrocyte membrane
780541|NCT00047983|Graft Survival|graft survival
780542|NCT00047970|Breast Cancer|breast cancer
780543|NCT00047970|Sisters|sisters
780544|NCT00047827|Aspergillus|aspergillus
780545|NCT00047827|Aspergillosis|aspergillosis
780546|NCT00047827|Anti-Fungal|anti-fungal
780547|NCT00047827|AmBisome|ambisome
780548|NCT00047827|Micafungin|micafungin
780549|NCT00047814|HCV|hcv
780550|NCT00047957|Transcranial|transcranial
780551|NCT00047957|Magnetic|magnetic
780555|NCT00047957|Motor Cortex|motor cortex
780556|NCT00047957|Afferent Stimulation|afferent stimulation
780557|NCT00047957|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
780558|NCT00047957|Healthy Volunteer|healthy volunteer
780559|NCT00047957|HV|hv
780560|NCT00047944|Attention|attention
780561|NCT00047944|Emotion|emotion
780562|NCT00047944|Amygdala|amygdala
780563|NCT00047944|Prefrontal Cortex|prefrontal cortex
780564|NCT00047944|Facial Expression|facial expression
780565|NCT00047944|Magnetic Resonance Imaging|magnetic resonance imaging
780566|NCT00047944|fMRI|fmri
780567|NCT00047944|Depression|depression
780568|NCT00047944|Anxiety|anxiety
780569|NCT00047944|Adolescence|adolescence
780570|NCT00047944|Children|children
780571|NCT00047931|Healthy|healthy
780572|NCT00047931|HIV-Negative|hiv-negative
780573|NCT00047931|Placebo-Controlled|placebo-controlled
780574|NCT00047931|Volunteer|volunteer
780575|NCT00047931|Dose-Escalation|dose-escalation
780576|NCT00047931|HIV Seronegativity|hiv seronegativity
780577|NCT00047931|Healthy Volunteer|healthy volunteer
780578|NCT00047931|HV|hv
780579|NCT00047918|Mast Cells|mast cells
780580|NCT00047918|Bone Marrow|bone marrow
780581|NCT00047918|Flushing|flushing
780582|NCT00047918|Mutations|mutations
780583|NCT00047918|Mastocytosis|mastocytosis
780584|NCT00047918|Anaphylaxis|anaphylaxis
780585|NCT00047905|Qualitative|qualitative
780586|NCT00047905|Communication Analysis|communication analysis
780587|NCT00047905|RIAS|rias
780588|NCT00047905|Counseling Models|counseling models
780589|NCT00047905|Videotaping|videotaping
780590|NCT00047905|Prenatal Genetic Counselors|prenatal genetic counselors
780591|NCT00047905|Counseling Process|counseling process
780592|NCT00047905|Video Tape Study|video tape study
780593|NCT00047905|Simulated Clients|simulated clients
780594|NCT00047905|Prenatal Genetic Counseling|prenatal genetic counseling
780595|NCT00047879|Brain Tumors|brain tumors
780596|NCT00047879|Experimental|experimental
780597|NCT00047879|Toxicities|toxicities
780598|NCT00047879|Efficacy|efficacy
780599|NCT00047879|Progression-Free|progression-free
780600|NCT00047879|Brain Tumor|brain tumor
780601|NCT00047879|Glioma|glioma
780602|NCT00047866|Limbic System|limbic system
780603|NCT00047866|Amphetamine|amphetamine
780604|NCT00047866|Dopamine|dopamine
780605|NCT00047866|Brain Imaging|brain imaging
780606|NCT00047866|Cerebral Blood Flow|cerebral blood flow
780607|NCT00047866|Cerebral Blood Volume|cerebral blood volume
780608|NCT00047866|Alcoholism|alcoholism
780609|NCT00047866|Tyrosine Depletion|tyrosine depletion
780610|NCT00047866|Amino Acids|amino acids
780611|NCT00047866|Affect|affect
780612|NCT00047866|Healthy Volunteer|healthy volunteer
780613|NCT00047866|HV|hv
780614|NCT00047853|Anxiety|anxiety
780615|NCT00047853|Neuroimaging|neuroimaging
780616|NCT00047853|Affective Neuroscience|affective neuroscience
780617|NCT00047853|Healthy Volunteer|healthy volunteer
780618|NCT00047853|HV|hv
780619|NCT00047788|Relapsed Multiple Myeloma|relapsed multiple myeloma
780620|NCT00047554|open-angle|open-angle
780621|NCT00047554|glaucoma|glaucoma
780622|NCT00047554|ocular|ocular
780623|NCT00047554|hypertension|hypertension
780624|NCT00047554|primary open-angle glaucoma|primary open-angle glaucoma
780625|NCT00047554|iris|iris
780626|NCT00047554|pigmentation|pigmentation
780627|NCT00047541|open-angle|open-angle
780628|NCT00047541|glaucoma|glaucoma
780629|NCT00047541|ocular|ocular
780630|NCT00047541|hypertension|hypertension
780631|NCT00047541|POAG|poag
780632|NCT00047528|open-angle|open-angle
780633|NCT00047528|glaucoma|glaucoma
780634|NCT00047528|ocular|ocular
780635|NCT00047528|hypertension|hypertension
780636|NCT00047528|POAG|poag
780637|NCT00047515|open-angle|open-angle
780638|NCT00047515|glaucoma|glaucoma
780639|NCT00047515|ocular|ocular
780640|NCT00047515|hypertension|hypertension
780641|NCT00047515|POAG|poag
780642|NCT00047749|pain|pain
780643|NCT00047749|ziconotide|ziconotide
780644|NCT00047749|Prialt|prialt
780645|NCT00047749|intrathecal|intrathecal
780646|NCT00047749|Synchromed|synchromed
780647|NCT00047736|Non-small cell lung cancer|non-small cell lung cancer
780648|NCT00047723|ALS|als
780649|NCT00047723|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
780650|NCT00047723|minocycline|minocycline
780651|NCT00047710|pancreatic cancer|pancreatic cancer
780652|NCT00047710|pancreas cancer|pancreas cancer
780653|NCT00047710|pancreas|pancreas
780654|NCT00047684|Child Abuse, Sexual|child abuse, sexual
780655|NCT00047671|Depressive Disorder|depressive disorder
780656|NCT00047645|lung|lung
780657|NCT00047645|IPF|ipf
780658|NCT00047632|ovarian|ovarian
780659|NCT00047632|carcinoma|carcinoma
780660|NCT00047632|peritoneal|peritoneal
780661|NCT00047632|cancer|cancer
780662|NCT00047632|ovary|ovary
780663|NCT00047632|interferon gamma|interferon gamma
780664|NCT00047606|open-angle|open-angle
780665|NCT00047606|glaucoma|glaucoma
780666|NCT00047606|ocular|ocular
780667|NCT00047606|hypertension|hypertension
780668|NCT00047606|POAG|poag
780669|NCT00047606|Iris|iris
780670|NCT00047606|Pigmentation|pigmentation
780671|NCT00047606|Japanese|japanese
780672|NCT00047593|open-angle|open-angle
780673|NCT00047593|glaucoma|glaucoma
780674|NCT00047593|ocular|ocular
780675|NCT00047593|hypertension|hypertension
780676|NCT00047593|POAG|poag
780677|NCT00047593|Iris|iris
780678|NCT00047593|Pigmentation|pigmentation
780679|NCT00047593|Japanese|japanese
780680|NCT00047619|Decubitus Ulcers|decubitus ulcers
780681|NCT00047619|Pulsatile Lavage|pulsatile lavage
780682|NCT00047619|SCI|sci
780683|NCT00047619|Spinal Cord Injury|spinal cord injury
780684|NCT00047619|Wound healing|wound healing
780685|NCT00047619|pressure ulcer|pressure ulcer
780686|NCT00047580|Spasticity|spasticity
780687|NCT00047580|spasticity secondary to Multiple Sclerosis|spasticity secondary to multiple sclerosis
780688|NCT00047580|Spinal Cord Injury|spinal cord injury
780689|NCT00047580|Stroke|stroke
780690|NCT00047567|ZONISAMIDE|zonisamide
780691|NCT00047567|BIPOLAR|bipolar
780692|NCT00046371|Cancer Vaccines|cancer vaccines
780693|NCT00046371|Aromatase|aromatase
780694|NCT00046371|Receptors, Estrogen|receptors, estrogen
780695|NCT00046371|Receptors, Progesterone|receptors, progesterone
780696|NCT00047476|neurobehavioral function|neurobehavioral function
780697|NCT00047476|chemobrain|chemobrain
780698|NCT00047476|chemo brain|chemo brain
780699|NCT00047476|fatigue|fatigue
780700|NCT00047476|memory loss|memory loss
780701|NCT00047476|exhausted|exhausted
780702|NCT00047476|trouble concentrating|trouble concentrating
780703|NCT00047463|epilepsy|epilepsy
780704|NCT00047463|sleep apnea|sleep apnea
780705|NCT00047463|obstructive sleep apnea|obstructive sleep apnea
780706|NCT00047463|continuous positive airway pressure|continuous positive airway pressure
780707|NCT00047463|CPAP|cpap
780708|NCT00047450|Psychotic Disorders|psychotic disorders
780709|NCT00047411|CPR, AED|cpr, aed
780710|NCT00046800|Ovarian Cancer|ovarian cancer
780711|NCT00046787|Small Cell Lung Cancer|small cell lung cancer
780712|NCT00046761|Acute Ischemic Stroke|acute ischemic stroke
780713|NCT00046774|Safety|safety
780714|NCT00046774|Nephritis|nephritis
780715|NCT00046774|Biologic Therapy|biologic therapy
780716|NCT00046774|Lymphocytes|lymphocytes
780717|NCT00046774|Response|response
780718|NCT00046774|Lupus|lupus
780719|NCT00046774|Systemic Lupus Erythematosus|systemic lupus erythematosus
780720|NCT00046774|SLE|sle
780721|NCT00046735|solid tumors|solid tumors
780722|NCT00046735|Revimid|revimid
780723|NCT00046735|CC5013|cc5013
780724|NCT00046735|CC-5013|cc-5013
780725|NCT00046722|treatment experienced|treatment experienced
780726|NCT00046722|complementary therapies|complementary therapies
780727|NCT00046722|Neuropathy|neuropathy
780728|NCT00046722|Peripheral Neuropathy|peripheral neuropathy
780729|NCT00046722|HIV-Related Peripheral Neuropathy|hiv-related peripheral neuropathy
780730|NCT00046722|HIV|hiv
780731|NCT00046527|Metastatic breast cancer|metastatic breast cancer
780732|NCT00046527|Taxol|taxol
780733|NCT00046527|Taxane|taxane
780734|NCT00046514|Metastatic Breast Cancer|metastatic breast cancer
780735|NCT00046514|Taxol|taxol
780736|NCT00046423|Cancer|cancer
780737|NCT00046423|solid tumor|solid tumor
780738|NCT00046423|Advanced malignancy|advanced malignancy
780739|NCT00046423|Taxane therapy|taxane therapy
780740|NCT00046423|Biopsy-proven diagnosis of advanced malignancy|biopsy-proven diagnosis of advanced malignancy
780741|NCT00046423|Various solid tumors which are refractory|various solid tumors which are refractory
780742|NCT00046709|Cancer pain|cancer pain
780743|NCT00046709|All types of cancer except lung cancer|all types of cancer except lung cancer
780744|NCT00046696|Cancer|cancer
780745|NCT00046696|Cancer Alternative Therapies|cancer alternative therapies
780746|NCT00046696|Living with Cancer|living with cancer
780747|NCT00046683|Adult acute leukemia|adult acute leukemia
780748|NCT00046683|Adult chronic leukemia|adult chronic leukemia
780749|NCT00046683|Childhood leukemia|childhood leukemia
780750|NCT00046683|Campath|campath
780751|NCT00046683|Alemtuzumab|alemtuzumab
780752|NCT00046540|Liposome-Encapsulated SN38|liposome-encapsulated sn38
780753|NCT00046540|Irinotecan|irinotecan
780754|NCT00046540|CPT-11|cpt-11
780755|NCT00046540|Malignant Tumors|malignant tumors
780756|NCT00046488|Chronic Lymphoblastic Leukemia|chronic lymphoblastic leukemia
780757|NCT00046488|Leukemia, Lymphoblastic, Chronic|leukemia, lymphoblastic, chronic
780758|NCT00046488|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
780759|NCT00046488|CLL|cll
780760|NCT00046631|built environment|built environment
780761|NCT00046631|parks|parks
780762|NCT00046631|retail outlets|retail outlets
780763|NCT00046631|adolescent girls|adolescent girls
780764|NCT00046631|physical activity|physical activity
780765|NCT00046553|Cortisol|cortisol
780766|NCT00046553|CRH|crh
780767|NCT00046553|HPA Axis|hpa axis
780768|NCT00046553|Hypothalamus|hypothalamus
780769|NCT00046553|Hippocampus|hippocampus
780770|NCT00046553|Post-Traumatic Stress Disorder|post-traumatic stress disorder
780771|NCT00046553|PTSD|ptsd
780772|NCT00046553|Healthy Volunteer|healthy volunteer
780773|NCT00046436|AIDS Serodiagnosis|aids serodiagnosis
780774|NCT00046436|Pregnancy Complications, Infectious|pregnancy complications, infectious
780775|NCT00046436|Anti-HIV Agents|anti-hiv agents
780776|NCT00046436|Disease Transmission, Vertical|disease transmission, vertical
780777|NCT00046410|MRI|mri
780778|NCT00046410|Diffusion|diffusion
780779|NCT00046410|Cognitive|cognitive
780780|NCT00046410|Stroke|stroke
780781|NCT00046410|Heart|heart
780782|NCT00046410|Coronary Artery Disease|coronary artery disease
780783|NCT00046410|Heart Disease|heart disease
780784|NCT00046397|Smallpox|smallpox
780785|NCT00046397|Vaccine|vaccine
780786|NCT00046397|Vaccination|vaccination
780787|NCT00046397|Variola|variola
780788|NCT00046397|Adults|adults
780789|NCT00046397|Smallpox Vaccine|smallpox vaccine
780790|NCT00046397|Healthy Volunteer|healthy volunteer
780791|NCT00046397|Small Pox|small pox
780792|NCT00046345|treatment experienced|treatment experienced
780793|NCT00046332|Integrase inhibitors|integrase inhibitors
780794|NCT00046332|Monotherapy|monotherapy
780795|NCT00046332|HIV-1 infection|hiv-1 infection
780796|NCT00046319|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
780797|NCT00046319|Primary Pulmonary Hypertension|primary pulmonary hypertension
780798|NCT00046306|Oxidative Stress|oxidative stress
780799|NCT00046306|Cardiovascular Disease|cardiovascular disease
780800|NCT00046306|Cancer|cancer
780801|NCT00046358|Cerebrospinal Fluid|cerebrospinal fluid
780802|NCT00046358|Cholesterol|cholesterol
780803|NCT00046358|Statin|statin
780804|NCT00046358|NSAID|nsaid
780805|NCT00046358|Antiinflammatory|antiinflammatory
780806|NCT00046358|Dementia|dementia
780807|NCT00046358|Alzheimer's Disease|alzheimer's disease
780808|NCT00046358|Nonsteroidal Antiinflammatory|nonsteroidal antiinflammatory
780809|NCT00046358|Healthy Volunteer|healthy volunteer
780810|NCT00046293|Stroke|stroke
780811|NCT00046293|Abciximab|abciximab
780812|NCT00046293|Retavase|retavase
780813|NCT00046293|MRI|mri
780814|NCT00046293|Cerebral Blood Flow|cerebral blood flow
780815|NCT00046267|Delayed-Action Preparations|delayed-action preparations
780816|NCT00046267|Blood Glucose|blood glucose
780817|NCT00046267|Insulin|insulin
780818|NCT00046267|Alanine Transaminase|alanine transaminase
780819|NCT00046267|Aspartate Aminotransferases|aspartate aminotransferases
780820|NCT00046267|Fructosamine|fructosamine
780821|NCT00046267|Glucose Tolerance Test|glucose tolerance test
780822|NCT00046267|Treatment Experienced|treatment experienced
780823|NCT00046254|hip fracture|hip fracture
780824|NCT00046254|recurrent fracture|recurrent fracture
780825|NCT00046254|fracture|fracture
780826|NCT00046254|bone loss|bone loss
780827|NCT00046254|bisphosphonate|bisphosphonate
780828|NCT00046254|bone mineral density|bone mineral density
780829|NCT00046254|osteoporosis|osteoporosis
780830|NCT00046254|zoledronic acid|zoledronic acid
780831|NCT00046254|geriatrics|geriatrics
780832|NCT00046254|rehabilitation|rehabilitation
780833|NCT00046254|elderly|elderly
780834|NCT00046254|nursing home|nursing home
780835|NCT00046254|orthopedic|orthopedic
780836|NCT00046241|seasonal depression winter blues winter depression|seasonal depression winter blues winter depression
780837|NCT00046228|Myocardial infarction|myocardial infarction
780838|NCT00046228|percutaneous coronary intervention|percutaneous coronary intervention
780839|NCT00046228|abciximab|abciximab
780840|NCT00046228|reteplase|reteplase
780841|NCT00046228|safety and efficacy|safety and efficacy
780842|NCT00046215|Virtual Lesion Study|virtual lesion study
780843|NCT00046215|Motor Imagery|motor imagery
780844|NCT00046215|Primary Motor Cortex|primary motor cortex
780845|NCT00046215|Motor Inhibition|motor inhibition
780846|NCT00046215|Motor Execution|motor execution
780847|NCT00046215|Healthy Volunteer|healthy volunteer
780848|NCT00046202|Smith-Lemli-Opitz Syndrome|smith-lemli-opitz syndrome
780849|NCT00046202|Sterol|sterol
780850|NCT00046202|Mutations|mutations
780851|NCT00046202|Dysmorphology|dysmorphology
780852|NCT00046202|Mental Retardation|mental retardation
780853|NCT00046202|Inborn Errors of Cholesterol Synthesis|inborn errors of cholesterol synthesis
780854|NCT00046202|Smith-Lemli-Optiz Syndrome|smith-lemli-optiz syndrome
780855|NCT00046202|Lathosterolosis|lathosterolosis
780856|NCT00046202|Desmosterols|desmosterols
780857|NCT00046202|CHILD Syndrome|child syndrome
780858|NCT00046202|Greenberg Dysplasia|greenberg dysplasia
780859|NCT00046202|X Linked Dominant Chrondrodysplasia|x linked dominant chrondrodysplasia
780860|NCT00046189|Sun Exposure|sun exposure
780861|NCT00046189|Xeroderma Pigmentosum|xeroderma pigmentosum
780862|NCT00046189|Skin Cancer|skin cancer
780863|NCT00046189|Family History|family history
780864|NCT00046189|HETEROZYGOTE|heterozygote
780865|NCT00046189|XP|xp
780866|NCT00046176|HIV-1 Abacavir Lamivudine Antiretroviral-experienced|hiv-1 abacavir lamivudine antiretroviral-experienced
780867|NCT00046163|Neurology|neurology
780868|NCT00046163|Cardiology|cardiology
780869|NCT00046111|oral|oral
780870|NCT00046111|Bioequivalence|bioequivalence
780871|NCT00046111|Hycamtin|hycamtin
780872|NCT00046111|Topotecan|topotecan
780873|NCT00046085|Schizophrenia|schizophrenia
780875|NCT00046085|Psychoeducation|psychoeducation
780876|NCT00046085|Internet|internet
780877|NCT00046072|Sepsis|sepsis
780878|NCT00046072|Shock|shock
780879|NCT00046072|Septic|septic
780880|NCT00046072|Sepsis Syndrome|sepsis syndrome
780881|NCT00046072|Septicemia|septicemia
780882|NCT00046072|Endotoxins|endotoxins
780883|NCT00046072|Endotoxemia|endotoxemia
780884|NCT00046072|Infection|infection
780885|NCT00046059|Linkage|linkage
780886|NCT00046059|Gene Identification|gene identification
780887|NCT00046059|ADHD|adhd
780888|NCT00046059|Hyperactivity|hyperactivity
780889|NCT00046059|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
780890|NCT00046033|Dose-Relationship, Drug|dose-relationship, drug
780891|NCT00046033|HIV Protease Inhibitors|hiv protease inhibitors
780892|NCT00046033|Salvage Therapy|salvage therapy
780893|NCT00046033|Viral Load|viral load
780894|NCT00046033|RNA, Viral|rna, viral
780895|NCT00046033|Drug Therapy, Combination|drug therapy, combination
780896|NCT00046020|Depression|depression
780897|NCT00045994|cardiovascular|cardiovascular
780898|NCT00045994|aged|aged
780899|NCT00045994|antihypertensive agents/therapeutic use|antihypertensive agents/therapeutic use
780900|NCT00045994|hypertension/*drug therapy|hypertension/*drug therapy
780901|NCT00045994|blood pressure|blood pressure
780902|NCT00045981|cardiovascular|cardiovascular
780903|NCT00045981|aged|aged
780904|NCT00045981|antihypertensive agents/therapeutic use|antihypertensive agents/therapeutic use
780905|NCT00045981|hypertension/*drug therapy|hypertension/*drug therapy
780906|NCT00045981|blood pressure|blood pressure
780907|NCT00045968|oncology|oncology
780908|NCT00045968|neurology|neurology
780909|NCT00045968|glioma|glioma
780910|NCT00045968|brain tumor|brain tumor
780911|NCT00045968|brain cancer|brain cancer
780912|NCT00045968|glioblastoma multiforme|glioblastoma multiforme
780913|NCT00045968|glioblastoma|glioblastoma
780914|NCT00045968|newly diagnosed glioblastoma|newly diagnosed glioblastoma
780915|NCT00045968|immunotherapy|immunotherapy
780916|NCT00045968|dendritic cells|dendritic cells
780917|NCT00045968|immune therapy|immune therapy
780918|NCT00045968|GBM|gbm
780919|NCT00045968|Brain cancer, primary|brain cancer, primary
780920|NCT00045968|tumor vaccine|tumor vaccine
780921|NCT00045968|grade IV astrocytoma|grade iv astrocytoma
780922|NCT00045968|DCVax|dcvax
780923|NCT00045968|Grade IV brain cancer|grade iv brain cancer
780924|NCT00045942|AML|aml
780925|NCT00045942|MDS|mds
780926|NCT00045942|high risk myelodysplastic syndrome|high risk myelodysplastic syndrome
780927|NCT00045916|Electroconvulsive therapy|electroconvulsive therapy
780928|NCT00045916|Antidepressive Agents|antidepressive agents
780929|NCT00045903|Cognitive Behavioral Therapy|cognitive behavioral therapy
780930|NCT00045877|Low-Grade or Follicular Non-Hodgkin's Lymphoma|low-grade or follicular non-hodgkin's lymphoma
780931|NCT00045864|Intermediate and High-Grade Non-Hodgkin's Lymphoma|intermediate and high-grade non-hodgkin's lymphoma
780932|NCT00045838|Healthy|healthy
780933|NCT00045838|HIV-Negative|hiv-negative
780934|NCT00045838|Placebo Controlled|placebo controlled
780935|NCT00045838|Volunteer|volunteer
780936|NCT00045838|Dose-Escalation|dose-escalation
780937|NCT00045838|Healthy Volunteers|healthy volunteers
780938|NCT00045838|HV|hv
780939|NCT00045838|HIV Seronegativity|hiv seronegativity
780940|NCT00045838|HIV Preventive Vaccine|hiv preventive vaccine
780941|NCT00045812|Cholesterol|cholesterol
780942|NCT00045812|Sitosterol|sitosterol
780943|NCT00045812|Atherosclerosis|atherosclerosis
780944|NCT00045812|Intestine|intestine
780945|NCT00045812|Absorption|absorption
780946|NCT00045812|Homozygous Sitosterolemia|homozygous sitosterolemia
780947|NCT00045812|Sterol Metabolism|sterol metabolism
780948|NCT00045786|myelodysplastic syndrome|myelodysplastic syndrome
780949|NCT00044928|Abdominal Infections|abdominal infections
780950|NCT00044915|Acute Ischemic Stroke Without Hemorrhage|acute ischemic stroke without hemorrhage
780951|NCT00044889|CLO221|clo221
780952|NCT00044889|clolar|clolar
780953|NCT00044863|EGFr|egfr
780954|NCT00044863|Metastatic Colorectal Carcinoma|metastatic colorectal carcinoma
780955|NCT00044837|Lopinavir|lopinavir
780956|NCT00044837|HIV-1|hiv-1
780957|NCT00044837|HIV Protease Inhibitors|hiv protease inhibitors
780958|NCT00044837|Ritonavir|ritonavir
780959|NCT00044837|Postmenopause|postmenopause
780960|NCT00044837|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
780961|NCT00044837|Pharmacokinetics|pharmacokinetics
780962|NCT00044837|Area Under Curve|area under curve
780963|NCT00044837|Hormone Replacement Therapy|hormone replacement therapy
780964|NCT00044837|efavirenz|efavirenz
780965|NCT00044837|estradiol|estradiol
780966|NCT00044876|Endometrium|endometrium
780967|NCT00044876|Progesterone|progesterone
780968|NCT00044876|Estrogen|estrogen
780969|NCT00044876|Leiomyoma|leiomyoma
780970|NCT00044876|Uterine Leiomyoma|uterine leiomyoma
780971|NCT00044876|Uterine Fibroids|uterine fibroids
780972|NCT00044876|Fibroids|fibroids
780973|NCT00044798|Aged|aged
780974|NCT00044785|colorectal cancer|colorectal cancer
780975|NCT00044785|gastric cancer|gastric cancer
780976|NCT00044785|breast cancer|breast cancer
780983|NCT00044733|Stem Cell Transplant|stem cell transplant
780984|NCT00044720|Kidney Transplant|kidney transplant
780985|NCT00044707|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
780986|NCT00044694|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
780987|NCT00044681|Risperidone|risperidone
780988|NCT00044681|depression|depression
780989|NCT00044681|melancholia|melancholia
780990|NCT00044681|depressive disorder|depressive disorder
780991|NCT00044681|antipsychotic agents|antipsychotic agents
780992|NCT00044668|exenatide|exenatide
780993|NCT00044668|exendin-4|exendin-4
780994|NCT00044668|diabetes|diabetes
780995|NCT00044668|Amylin|amylin
780996|NCT00044668|Lilly|lilly
780997|NCT00044642|Anxiety|anxiety
780998|NCT00044629|Sleep Deprivation|sleep deprivation
780999|NCT00044629|Insomnia|insomnia
781000|NCT00044629|Sleep Disorders|sleep disorders
781001|NCT00044603|Pregnancy|pregnancy
781002|NCT00044590|Parkinson's disease|parkinson's disease
781003|NCT00044590|Pesticides|pesticides
781004|NCT00044590|Genetic susceptibility|genetic susceptibility
781005|NCT00044590|Polymorphisms|polymorphisms
781006|NCT00044577|HIV-1 Abacavir Lamivudine Tenofovir|hiv-1 abacavir lamivudine tenofovir
781007|NCT00044564|Taxane|taxane
781008|NCT00044564|Renal Cell Carcinoma|renal cell carcinoma
781009|NCT00044564|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
781010|NCT00044551|Taxane|taxane
781011|NCT00044551|Lymphoma|lymphoma
781012|NCT00044551|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
781013|NCT00044538|Taxane|taxane
781014|NCT00044538|Lung cancer, non-small cell|lung cancer, non-small cell
781015|NCT00044538|NSCLC|nsclc
781016|NCT00044525|Taxane|taxane
781017|NCT00044525|Breast Cancer|breast cancer
781018|NCT00044525|Metastasis|metastasis
781019|NCT00044512|Cancer|cancer
781020|NCT00044512|Liver Cancer|liver cancer
781021|NCT00044512|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
781022|NCT00044486|Prophylaxis|prophylaxis
781023|NCT00044486|neutropenia|neutropenia
781024|NCT00044486|AML|aml
781025|NCT00044486|MDS|mds
781026|NCT00044486|fungal infections|fungal infections
781027|NCT00044486|Acute Myelogenous Leukemia|acute myelogenous leukemia
781028|NCT00044486|Anticipated prolonged profound neutropenia|anticipated prolonged profound neutropenia
781029|NCT00044473|Otitis Media|otitis media
781030|NCT00044473|Ear Diaeases|ear diaeases
781031|NCT00044473|Levofloxacin|levofloxacin
781032|NCT00044473|Quinolones|quinolones
781033|NCT00044460|Type 2 diabetes drug-naive|type 2 diabetes drug-naive
781034|NCT00044382|Revimid|revimid
781035|NCT00044382|CC5013|cc5013
781036|NCT00044382|CC-5013|cc-5013
781037|NCT00044369|Varicocele|varicocele
781038|NCT00044369|environmental toxins|environmental toxins
781039|NCT00044369|male infertility|male infertility
781040|NCT00044369|cadmium|cadmium
781041|NCT00044356|Melanoma|melanoma
781042|NCT00044356|Metastatic Melanoma|metastatic melanoma
781043|NCT00044356|Malignant Melanoma|malignant melanoma
781044|NCT00044356|Skin Cancer|skin cancer
781045|NCT00044356|Tumor|tumor
781046|NCT00044356|Experimental Treatment|experimental treatment
781047|NCT00044356|Clinical Trial|clinical trial
781048|NCT00044356|Gene Therapy|gene therapy
781049|NCT00044356|Gene Delivery|gene delivery
781050|NCT00044356|Gene Transfer|gene transfer
781051|NCT00044356|Immunotherapy|immunotherapy
781052|NCT00044356|Cancer|cancer
781053|NCT00044356|Neoplasm|neoplasm
781054|NCT00044356|Lesion|lesion
781055|NCT00044356|Metastasis|metastasis
781056|NCT00044356|Cancerous mole|cancerous mole
781057|NCT00044356|Melanoma vaccine|melanoma vaccine
781058|NCT00044356|Cancer research|cancer research
781059|NCT00044356|Cancer cells|cancer cells
781060|NCT00044356|Allovectin-7®|allovectin-7®
781061|NCT00044343|colorectal cancer|colorectal cancer
781062|NCT00044343|EGFR inhibitor|egfr inhibitor
781063|NCT00044343|lapatinib|lapatinib
781064|NCT00044343|metastatic|metastatic
781065|NCT00044317|FEV|fev
781066|NCT00044317|Smoking|smoking
781067|NCT00044317|antioxidents|antioxidents
781068|NCT00044317|lung growth|lung growth
781069|NCT00044291|Atamestane|atamestane
781070|NCT00044291|Toremifene|toremifene
781071|NCT00044291|Letrozole|letrozole
781072|NCT00044291|Aromatase inhibitor|aromatase inhibitor
781073|NCT00044291|Receptor-positive|receptor-positive
781074|NCT00044291|First line therapy|first line therapy
781075|NCT00044291|Estrogen blocker|estrogen blocker
781076|NCT00044291|Metastatic breast cancer|metastatic breast cancer
781077|NCT00044291|Locally advanced breast cancer|locally advanced breast cancer
781078|NCT00044291|Locally recurrent breast cancer|locally recurrent breast cancer
781079|NCT00044291|stage IV breast cancer|stage iv breast cancer
781080|NCT00044291|ductal breast carcinoma|ductal breast carcinoma
781081|NCT00044291|lobular breast carcinoma|lobular breast carcinoma
781082|NCT00044291|stage IIIA breast cancer|stage iiia breast cancer
781083|NCT00044291|stage IIIB breast cancer|stage iiib breast cancer
781084|NCT00044291|recurrent breast cancer|recurrent breast cancer
781085|NCT00044304|Treatment|treatment
781086|NCT00044304|Eosinophil|eosinophil
781087|NCT00044304|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
781088|NCT00044304|Hypereosinophilia|hypereosinophilia
781089|NCT00044304|Biologicals|biologicals
781090|NCT00044304|Chemotherapy|chemotherapy
781091|NCT00044304|Gleevec|gleevec
781092|NCT00044304|Eosinophils|eosinophils
781093|NCT00044304|Hypereosinophilic Syndrome|hypereosinophilic syndrome
781095|NCT00044278|epilepsy|epilepsy
781096|NCT00044278|pediatric|pediatric
781097|NCT00044278|partial seizures|partial seizures
781098|NCT00044265|ACE inhibitor|ace inhibitor
781099|NCT00044265|high blood pressure|high blood pressure
781100|NCT00044265|pediatric|pediatric
781101|NCT00044252|Neurosteroids|neurosteroids
781102|NCT00044252|Complex Partial Seizure|complex partial seizure
781103|NCT00044252|Menstrual Cycle|menstrual cycle
781104|NCT00044252|Allopregnanolone|allopregnanolone
781105|NCT00044252|Catamenial Epilepsy|catamenial epilepsy
781106|NCT00044252|Seizures|seizures
781107|NCT00044252|Epilepsy|epilepsy
781108|NCT00044252|Healthy Volunteer|healthy volunteer
781109|NCT00044252|HV|hv
781110|NCT00044252|Normal Control|normal control
781111|NCT00044239|Tic Disorders|tic disorders
781112|NCT00044239|Neurophyschological|neurophyschological
781113|NCT00044239|Immunology|immunology
781114|NCT00044239|Magnetic Resonance Imaging|magnetic resonance imaging
781115|NCT00044239|Basal Ganglia|basal ganglia
781116|NCT00044239|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
781117|NCT00044239|Children|children
781118|NCT00044239|Adolescents|adolescents
781119|NCT00044239|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
781120|NCT00044239|PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated d|pandas (pediatric autoimmune neuropsychiatric disorders associated d
781121|NCT00044239|Obsessive Compulsive Disorder|obsessive compulsive disorder
781122|NCT00044239|OCD|ocd
781123|NCT00044239|Healthy Volunteers|healthy volunteers
781124|NCT00044239|HV|hv
781125|NCT00044226|BPH|bph
781126|NCT00044226|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
781127|NCT00044226|Benign Prostatic Hypertrophy|benign prostatic hypertrophy
781128|NCT00044226|Enlarged Prostate|enlarged prostate
781129|NCT00044187|schizoaffective disorder|schizoaffective disorder
781130|NCT00044187|schizophreniform disorder|schizophreniform disorder
781131|NCT00044187|bipolar I disorder|bipolar i disorder
781132|NCT00044200|Phospholipase A2|phospholipase a2
781133|NCT00044200|Arachidonic Acid|arachidonic acid
781134|NCT00044200|Blood Flow|blood flow
781135|NCT00044200|Coupling|coupling
781136|NCT00044200|Neurotransmission|neurotransmission
781137|NCT00044200|PET|pet
781138|NCT00044200|Signal Transduction|signal transduction
781139|NCT00044200|Activation|activation
781140|NCT00044200|Brain|brain
781141|NCT00044200|[15O]H20|[15o]h20
781142|NCT00044174|Depression|depression
781143|NCT00044174|Mother-Infant Interaction|mother-infant interaction
781144|NCT00044174|Still-face|still-face
781145|NCT00044174|Socioemotional Development|socioemotional development
781146|NCT00044174|Cognitive Development|cognitive development
781147|NCT00044174|Healthy|healthy
781148|NCT00044174|Mothers|mothers
781149|NCT00044174|Postpartum|postpartum
781150|NCT00044174|Postpartum Depression|postpartum depression
781151|NCT00044148|Persistent Albuminuria|persistent albuminuria
781152|NCT00044135|clevudine|clevudine
781153|NCT00044135|hepatitis B|hepatitis b
781154|NCT00044070|ARTIST|artist
781155|NCT00044070|Acute ischemic stroke|acute ischemic stroke
781156|NCT00044057|ARTIST|artist
781157|NCT00044044|Schizophrenia|schizophrenia
781158|NCT00044044|Latuda|latuda
781159|NCT00044044|Lurasidone|lurasidone
781160|NCT00044031|pancreatic cancer|pancreatic cancer
781161|NCT00044031|G17DT|g17dt
781162|NCT00044031|gemcitabine|gemcitabine
781163|NCT00044018|Revimid|revimid
781164|NCT00044018|CC5013|cc5013
781165|NCT00044005|Schizophrenia|schizophrenia
781166|NCT00044005|Latuda|latuda
781167|NCT00044005|Lurasidone|lurasidone
781168|NCT00043329|Registry|registry
781169|NCT00043329|Actimmune|actimmune
781170|NCT00043329|osteopetrosis|osteopetrosis
781171|NCT00044122|Mastocytosis|mastocytosis
781172|NCT00044122|Urticaria Pigmentosa|urticaria pigmentosa
781173|NCT00044122|Classification|classification
781174|NCT00044122|Tryptase|tryptase
781175|NCT00044122|Mutations|mutations
781176|NCT00044109|Pain|pain
781177|NCT00044109|Low Back|low back
781178|NCT00044109|Radiculopathy|radiculopathy
781179|NCT00044109|Electromagnetic Treatment|electromagnetic treatment
781180|NCT00044109|Back Device|back device
781181|NCT00044109|Sciatica|sciatica
781182|NCT00044109|Low Back Pain|low back pain
781183|NCT00044096|SSRI|ssri
781184|NCT00044096|Anxiety|anxiety
781185|NCT00044096|Stress|stress
781186|NCT00044096|Citalopram|citalopram
781187|NCT00044096|Benadryl|benadryl
781188|NCT00044096|Diphenhydramine|diphenhydramine
781189|NCT00044096|Startle|startle
781190|NCT00044096|Fear-Potentiated Startle|fear-potentiated startle
781191|NCT00044096|Fear|fear
781192|NCT00044096|Normal Volunteers|normal volunteers
781193|NCT00044096|Healthy Volunteers|healthy volunteers
781194|NCT00044096|HV|hv
781195|NCT00044083|Catecholamines|catecholamines
781197|NCT00044083|Clinical Trial|clinical trial
781198|NCT00044083|fMRI|fmri
781199|NCT00044083|PFC|pfc
781200|NCT00044083|Vitamin B2|vitamin b2
781201|NCT00044083|Riboflavin|riboflavin
781202|NCT00044083|Tolcapone|tolcapone
781203|NCT00044083|Placebo|placebo
781204|NCT00044083|Normal Volunteers|normal volunteers
781205|NCT00044083|Schizophrenia|schizophrenia
781206|NCT00044083|Healthy Volunteers|healthy volunteers
781207|NCT00044083|HV|hv
781208|NCT00043992|Asthma|asthma
781209|NCT00043992|Allergens|allergens
781210|NCT00043966|treatment naive|treatment naive
781211|NCT00043953|treatment naive|treatment naive
781212|NCT00043888|fosamprenavir|fosamprenavir
781213|NCT00043888|ritonavir|ritonavir
781214|NCT00043888|COMBIVIR|combivir
781215|NCT00043888|TRIZIVIR|trizivir
781216|NCT00043888|abacavir|abacavir
781217|NCT00043888|lamivudine|lamivudine
781218|NCT00043888|zidovudine|zidovudine
781219|NCT00043888|HIV|hiv
781220|NCT00043888|protease inhibitors|protease inhibitors
781221|NCT00043979|Ewing's Sarcoma|ewing's sarcoma
781222|NCT00043979|Rhabdomyosarcoma|rhabdomyosarcoma
781223|NCT00043979|Desmoplastic Small Round Cell Tumor|desmoplastic small round cell tumor
781224|NCT00043979|Sarcoma|sarcoma
781225|NCT00043979|Ewing Sarcoma|ewing sarcoma
781226|NCT00043940|thrombosis|thrombosis
781227|NCT00043940|bivalirudin|bivalirudin
781228|NCT00043940|direct thrombin inhibitor|direct thrombin inhibitor
781229|NCT00043940|HIT|hit
781230|NCT00043940|HITTS|hitts
781231|NCT00043940|HIT/HITTS|hit/hitts
781232|NCT00043927|Chemotherapy-naive|chemotherapy-naive
781233|NCT00043927|Small Cell Lung Cancer|small cell lung cancer
781234|NCT00043927|SCLC|sclc
781235|NCT00043927|Extensive disease|extensive disease
781236|NCT00043927|ED|ed
781237|NCT00043927|topotecan|topotecan
781238|NCT00043927|Hycamtin|hycamtin
781239|NCT00043927|oral|oral
781240|NCT00043914|epilepsy|epilepsy
781241|NCT00043914|monotherapy conversion|monotherapy conversion
781242|NCT00043901|PGTC|pgtc
781243|NCT00043901|Lamotrigine|lamotrigine
781244|NCT00043901|epilepsy|epilepsy
781245|NCT00043901|seizures|seizures
781246|NCT00043901|primary generalized tonic-clonic|primary generalized tonic-clonic
781247|NCT00043875|partial seizures|partial seizures
781248|NCT00043875|pediatric|pediatric
781249|NCT00043875|epilepsy|epilepsy
781250|NCT00043862|Hycamtin|hycamtin
781251|NCT00043862|oral|oral
781252|NCT00043862|Radiation Sensitization|radiation sensitization
781253|NCT00043862|Small Cell Lung Cancer|small cell lung cancer
781254|NCT00043862|newly diagnosed|newly diagnosed
781255|NCT00043862|limited stage|limited stage
781256|NCT00043862|topotecan|topotecan
781257|NCT00043849|Psychosis|psychosis
781258|NCT00043849|Agitation, Psychomotor|agitation, psychomotor
781259|NCT00043836|ejection fraction|ejection fraction
781260|NCT00043836|exercise tolerance|exercise tolerance
781261|NCT00043836|heart failure, congestive|heart failure, congestive
781262|NCT00043836|quality of life|quality of life
781263|NCT00043823|Non-Small Cell Lung Cancer|non-small cell lung cancer
781264|NCT00043823|NSCLC|nsclc
781265|NCT00043823|Lung Cancer|lung cancer
781266|NCT00043823|Avastin|avastin
781267|NCT00043823|Bevacizumab|bevacizumab
781268|NCT00043823|rhuMAb VEGF|rhumab vegf
781269|NCT00043823|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
781270|NCT00043823|Tarceva|tarceva
781271|NCT00043823|OSI-774|osi-774
781272|NCT00043823|Erlotinib Hydrocholoride|erlotinib hydrocholoride
781273|NCT00043810|AML|aml
781274|NCT00043810|MDS|mds
781275|NCT00043810|Gelonin|gelonin
781276|NCT00043810|Purging|purging
781277|NCT00043810|Transplant|transplant
781278|NCT00043810|Peripheral Stem Cell|peripheral stem cell
781279|NCT00043797|ARI|ari
781280|NCT00043797|Diabetic polyneuropathy|diabetic polyneuropathy
781281|NCT00043797|Diabetic complications|diabetic complications
781282|NCT00043784|Acute coronary syndromes|acute coronary syndromes
781283|NCT00043784|non-ST-segment elevation|non-st-segment elevation
781284|NCT00043693|Psychotic Disorders|psychotic disorders
781285|NCT00043693|Schizoaffective Disorder|schizoaffective disorder
781286|NCT00043693|Substance Abuse|substance abuse
781287|NCT00043771|CHF|chf
781288|NCT00043758|CHF|chf
781289|NCT00043745|soy|soy
781290|NCT00043745|isoflavones|isoflavones
781291|NCT00043745|alternative hormone therapy|alternative hormone therapy
781292|NCT00043745|bone loss|bone loss
781293|NCT00043732|Rheumatoid arthritis|rheumatoid arthritis
781294|NCT00043732|Scio-469|scio-469
781295|NCT00043719|Human Female|human female
781296|NCT00043719|Osteoporosis|osteoporosis
781297|NCT00043719|Postmenopausal|postmenopausal
781298|NCT00043719|Nitric Oxide|nitric oxide
781299|NCT00043719|Nitroglycerin|nitroglycerin
781300|NCT00043719|Calcium|calcium
781301|NCT00043719|Vitamin D|vitamin d
781302|NCT00043589|Memory|memory
781303|NCT00043576|Prostate Cancer|prostate cancer
781304|NCT00043576|Androgen Independent Prostate Cancer|androgen independent prostate cancer
781305|NCT00043680|Classic|classic
781306|NCT00043680|Occult|occult
781309|NCT00043680|Age-Related Macular Degeneration|age-related macular degeneration
781310|NCT00043680|Photodynamic Therapy|photodynamic therapy
781311|NCT00043680|Choroidal Neovascularization|choroidal neovascularization
781312|NCT00043680|Cyclooxygenase 2|cyclooxygenase 2
781313|NCT00043680|Macular Degeneration|macular degeneration
781314|NCT00043680|AMD|amd
781315|NCT00043680|Age Related Macular Degeneration|age related macular degeneration
781316|NCT00043667|Interleukin 2|interleukin 2
781317|NCT00043667|IL-2 Receptor|il-2 receptor
781318|NCT00043667|Anti-CD25|anti-cd25
781319|NCT00043667|Anti-Tac|anti-tac
781320|NCT00043667|Anti-IL-2R|anti-il-2r
781321|NCT00043667|Uveitis|uveitis
781322|NCT00043667|Daclizumab|daclizumab
781323|NCT00043667|Inflammatory Eye DIsease|inflammatory eye disease
781324|NCT00043654|Antidepressant|antidepressant
781325|NCT00043654|Manic-Depressive Disorder|manic-depressive disorder
781326|NCT00043654|Cortisol|cortisol
781327|NCT00043654|Neuroendocrine|neuroendocrine
781328|NCT00043654|Cognition|cognition
781329|NCT00043654|Bipolar|bipolar
781330|NCT00043654|Bipolar Disorder|bipolar disorder
781331|NCT00043654|BPD|bpd
781332|NCT00043654|HV|hv
781333|NCT00043641|RT PCR|rt pcr
781334|NCT00043641|Antiretrovial Therapy|antiretrovial therapy
781335|NCT00043641|Drug Intensification|drug intensification
781336|NCT00043641|Ultra-low|ultra-low
781337|NCT00043641|Sequence|sequence
781338|NCT00043641|HIV|hiv
781339|NCT00043641|Treatment Experienced|treatment experienced
781340|NCT00043628|Progenitor Cells|progenitor cells
781341|NCT00043628|MRI|mri
781342|NCT00043628|Coronary Blood Flow|coronary blood flow
781343|NCT00043628|Hematopoiesis|hematopoiesis
781344|NCT00043628|Myocardial Contractility|myocardial contractility
781345|NCT00043628|Coronary Artery Disease|coronary artery disease
781346|NCT00043628|CAD|cad
781347|NCT00043628|Heart Disease|heart disease
781348|NCT00043615|Angiogenesis|angiogenesis
781349|NCT00043615|Drug Resistance|drug resistance
781350|NCT00043615|Signal Transduction|signal transduction
781351|NCT00043615|EGFR|egfr
781352|NCT00043615|Survival Factors|survival factors
781353|NCT00043615|Malignancy|malignancy
781354|NCT00043615|Pre-Cancer Condition|pre-cancer condition
781355|NCT00043615|Cancer Risk|cancer risk
781356|NCT00043563|Cognitive-behavior Therapy|cognitive-behavior therapy
781357|NCT00043563|Minimal Attention Control|minimal attention control
781358|NCT00043550|Major Depressive Disorder|major depressive disorder
781359|NCT00043537|Phobic Disorders|phobic disorders
781360|NCT00043537|Mutism|mutism
781361|NCT00043511|Injections, Intramuscular|injections, intramuscular
781362|NCT00043511|HIV Seronegativity|hiv seronegativity
781363|NCT00043511|Plasmids|plasmids
781364|NCT00043511|Vaccines, DNA|vaccines, dna
781365|NCT00043511|HIV Preventive Vaccine|hiv preventive vaccine
781366|NCT00043498|Pollutants|pollutants
781367|NCT00043459|NHL|nhl
781368|NCT00043433|HCC|hcc
781369|NCT00043420|immunotherapy, lymphoma|immunotherapy, lymphoma
781370|NCT00043407|Renal Cell Carcinoma, Phase I, Phase II, Immunotherapy|renal cell carcinoma, phase i, phase ii, immunotherapy
781371|NCT00043394|CpG 7909 subcutaneous injection combination with Herceptin® metastatic breast cancer.|cpg 7909 subcutaneous injection combination with herceptin® metastatic breast cancer.
781372|NCT00043381|myelodysplastic syndrome|myelodysplastic syndrome
781373|NCT00043381|MDS|mds
781374|NCT00043381|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
781375|NCT00043381|CMML|cmml
781376|NCT00043381|decitabine|decitabine
781377|NCT00043381|5-aza-2'deoxycytidine|5-aza-2'deoxycytidine
781378|NCT00043368|CPG 7909 continuation study|cpg 7909 continuation study
781379|NCT00043355|pulmonary|pulmonary
781380|NCT00043355|mycobacterium avium complex infection|mycobacterium avium complex infection
781381|NCT00043355|MAC|mac
781382|NCT00043355|nontuberculous|nontuberculous
781383|NCT00043355|mycobacteria|mycobacteria
781384|NCT00043355|lung|lung
781385|NCT00043342|cystic fibrosis|cystic fibrosis
781386|NCT00043342|pulmonary impairment|pulmonary impairment
781387|NCT00043472|Screening|screening
781388|NCT00043472|Oophorectomy|oophorectomy
781389|NCT00043472|Hereditary|hereditary
781390|NCT00043472|Genetics|genetics
781391|NCT00043472|Cancer|cancer
781392|NCT00043472|Ovarian Cancer|ovarian cancer
781393|NCT00043472|Ovarian Cancer Risk|ovarian cancer risk
781394|NCT00043316|cystic fibrosis|cystic fibrosis
781395|NCT00043316|pulmonary impairment|pulmonary impairment
781396|NCT00043303|hepatitis C|hepatitis c
781397|NCT00043303|liver fibrosis|liver fibrosis
781398|NCT00043303|liver cirrhosis|liver cirrhosis
781399|NCT00043277|neonates|neonates
781400|NCT00043277|thrombosis|thrombosis
781401|NCT00043277|bivalirudin|bivalirudin
781402|NCT00043277|direct thrombin inhibitor|direct thrombin inhibitor
781403|NCT00043238|PCBs|pcbs
781404|NCT00043238|Thyroid|thyroid
781405|NCT00043238|Hyperactivity|hyperactivity
781406|NCT00043238|School Performance|school performance
781407|NCT00043238|Mohawk Tribe|mohawk tribe
781408|NCT00043212|prostate cancer|prostate cancer
781409|NCT00043212|oncology|oncology
781410|NCT00043212|urology|urology
791083|NCT00000778|Sputum|sputum
781411|NCT00043212|hormone refractory prostate cancer|hormone refractory prostate cancer
781412|NCT00043199|Colorectal Neoplasms|colorectal neoplasms
781413|NCT00043199|Colorectal Cancer|colorectal cancer
781414|NCT00043199|Colorectal Carcinoma|colorectal carcinoma
781415|NCT00043199|Colorectal Tumor|colorectal tumor
781416|NCT00043199|Neoplasms, Colorectal|neoplasms, colorectal
781417|NCT00043199|Unresectable|unresectable
781418|NCT00043199|Metastatic|metastatic
781419|NCT00043199|Refractory|refractory
781420|NCT00043225|Type III Secretion Pathways|type iii secretion pathways
781421|NCT00043225|Exotoxin A Polymorphisms|exotoxin a polymorphisms
781422|NCT00043225|Cystic Fibrosis and Pseudomonas Aeruginosa|cystic fibrosis and pseudomonas aeruginosa
781423|NCT00043225|Adenosine Deaminase Deficiency|adenosine deaminase deficiency
781424|NCT00043225|Severe Combined Immune Deficiency|severe combined immune deficiency
781425|NCT00043225|SCID|scid
781426|NCT00043225|ADA-SCID|ada-scid
781427|NCT00043225|Immune Deficiency|immune deficiency
781428|NCT00043186|bone loss|bone loss
781429|NCT00043186|osteoporosis|osteoporosis
781430|NCT00042718|Chronic Bronchitis|chronic bronchitis
781431|NCT00042718|Acute Bacterial Exacerbation of Chronic Bronchitis|acute bacterial exacerbation of chronic bronchitis
781432|NCT00042705|asthma|asthma
781433|NCT00042705|indoor allergens|indoor allergens
781434|NCT00042692|catechol thioethers|catechol thioethers
781435|NCT00042692|Parkinson's disease|parkinson's disease
781436|NCT00042692|neurodegenerative disease|neurodegenerative disease
781437|NCT00042679|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
781438|NCT00042679|Adenocarcinoma|adenocarcinoma
781439|NCT00042679|Carcinoma Squamous|carcinoma squamous
781440|NCT00042679|Adult Lung Cancer|adult lung cancer
781441|NCT00042588|Safety and Efficacy|safety and efficacy
781442|NCT00042588|Community-Acquired Pneumonia, Sepsis|community-acquired pneumonia, sepsis
781443|NCT00042575|Sad, blue, lack of energy, depressed, hopelessness, guilt|sad, blue, lack of energy, depressed, hopelessness, guilt
781444|NCT00042562|Depressed|depressed
781445|NCT00042562|blues|blues
781446|NCT00042562|sadness|sadness
781447|NCT00042562|feelings of guilt|feelings of guilt
781448|NCT00042562|hopelessness|hopelessness
781449|NCT00042562|lack of energy|lack of energy
781450|NCT00042549|Gallstones|gallstones
781451|NCT00042549|Gallstone|gallstone
781452|NCT00042549|Biliary stones|biliary stones
781453|NCT00042549|Gallbladder stones|gallbladder stones
781454|NCT00042549|Gallbladder|gallbladder
781455|NCT00042549|Lithotripsy|lithotripsy
781456|NCT00042549|Cholelithiasis|cholelithiasis
781457|NCT00042549|ESWL|eswl
781458|NCT00042549|Shock wave|shock wave
781459|NCT00042549|Shock waves|shock waves
781460|NCT00042549|shockwaves|shockwaves
781461|NCT00042549|shockwave|shockwave
781462|NCT00042627|Cataracts|cataracts
781463|NCT00042627|Granulocytapheresis|granulocytapheresis
781464|NCT00042627|Granulocyte Donors|granulocyte donors
781465|NCT00042614|Genes|genes
781466|NCT00042614|Heart|heart
781467|NCT00042614|Lymphocytes|lymphocytes
781468|NCT00042614|Proteomics|proteomics
781469|NCT00042614|Transplant|transplant
781470|NCT00042614|Heart Transplant|heart transplant
781471|NCT00042614|Healthy Volunteer|healthy volunteer
781472|NCT00042614|HV|hv
781473|NCT00042614|Normal Control|normal control
781474|NCT00042536|Yohimbine|yohimbine
781475|NCT00042536|Naltrexone|naltrexone
781476|NCT00042536|Sexual Function|sexual function
781477|NCT00042536|Erectile Dysfunction|erectile dysfunction
781478|NCT00042536|Alpha-2 Adrenoreceptor|alpha-2 adrenoreceptor
781479|NCT00042536|Opiate Receptor|opiate receptor
781480|NCT00042536|Male Impotence|male impotence
781481|NCT00042536|ED|ed
781482|NCT00042536|Healthy Volunteer|healthy volunteer
781483|NCT00042536|HV|hv
781484|NCT00042536|Normal Control|normal control
781485|NCT00042523|Autoantibody|autoantibody
781486|NCT00042523|Anti-DNA Antibody|anti-dna antibody
781487|NCT00042523|Cross-Reactivity|cross-reactivity
781488|NCT00042523|Neuron Loss|neuron loss
781489|NCT00042523|Imaging|imaging
781490|NCT00042523|Lupus|lupus
781491|NCT00042523|SLE|sle
781492|NCT00042523|Systemic Lupus Erythematosus|systemic lupus erythematosus
781493|NCT00042510|Gastroesophageal cancer|gastroesophageal cancer
781494|NCT00042510|Gastric cancer|gastric cancer
781495|NCT00042484|Asthma|asthma
781496|NCT00042484|Children's Health|children's health
781497|NCT00042484|Community Based Research|community based research
781498|NCT00042445|Neoplasm|neoplasm
781499|NCT00042445|Petrochemical|petrochemical
781500|NCT00042445|Leukemia|leukemia
781501|NCT00042445|Taiwan|taiwan
781502|NCT00042419|Industrial Injuries|industrial injuries
781503|NCT00042419|Tendonitis|tendonitis
781504|NCT00042419|Assembly Line|assembly line
781505|NCT00042393|Hepatitis B, Chronic|hepatitis b, chronic
781506|NCT00042354|CLO222|clo222
781507|NCT00042354|clolar|clolar
781508|NCT00042354|Pediatric Acute Myelogenous Leukemia|pediatric acute myelogenous leukemia
781509|NCT00042341|CLO212|clo212
781510|NCT00042341|clolar|clolar
781511|NCT00042341|pediatric ALL|pediatric all
781512|NCT00042341|Leukemia, Lymphoblastic, Acute - pediatric|leukemia, lymphoblastic, acute - pediatric
781515|NCT00042289|Pharmacokinetics|pharmacokinetics
781516|NCT00042289|Treatment Experienced|treatment experienced
781517|NCT00041483|AMD|amd
781518|NCT00041483|age-related macular degeneration|age-related macular degeneration
781519|NCT00041483|Anecortave|anecortave
781520|NCT00041483|Acetate|acetate
781521|NCT00041483|Wet form of age-related macular degeneration|wet form of age-related macular degeneration
781522|NCT00042380|Antidepressant|antidepressant
781523|NCT00042380|Anxiety|anxiety
781524|NCT00042380|Dopamine|dopamine
781525|NCT00042380|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
781526|NCT00042380|Affective Disorder|affective disorder
781527|NCT00042380|Phytoestrogen|phytoestrogen
781528|NCT00042380|Genistein|genistein
781529|NCT00042380|Major Depression|major depression
781530|NCT00042380|Depression|depression
781531|NCT00042276|Pressure Pain Threshold|pressure pain threshold
781532|NCT00042276|MTrP|mtrp
781533|NCT00042276|Musculoskeletal Pain|musculoskeletal pain
781534|NCT00042276|Soft Tissue Pain|soft tissue pain
781535|NCT00042276|Pathophysiology|pathophysiology
781536|NCT00042276|Myofascial Pain|myofascial pain
781537|NCT00042276|Microdialysis|microdialysis
781538|NCT00042276|Myofascial Trigger Points|myofascial trigger points
781539|NCT00042276|Rehabilitation|rehabilitation
781540|NCT00042276|Muscle Pain|muscle pain
781541|NCT00042276|Neck Pain|neck pain
781542|NCT00042276|Healthy Volunteer|healthy volunteer
781543|NCT00042276|HV|hv
781544|NCT00042276|Normal Control|normal control
781545|NCT00042263|health disparities|health disparities
781546|NCT00042263|social environment|social environment
781547|NCT00042263|physical environment|physical environment
781548|NCT00042263|racial health disparities|racial health disparities
781549|NCT00042250|Cell Cycle Interphase|cell cycle interphase
781550|NCT00042250|G0|g0
781551|NCT00042250|G1|g1
781552|NCT00042250|G2|g2
781553|NCT00042250|S Phase|s phase
781554|NCT00042237|Child Abuse, Sexual|child abuse, sexual
781555|NCT00042224|Electroconvulsive Therapy|electroconvulsive therapy
781556|NCT00042211|Depressive Disorder|depressive disorder
781557|NCT00042211|Blindness|blindness
781558|NCT00042211|Aged|aged
781559|NCT00042198|Cognitive therapy|cognitive therapy
781560|NCT00042198|Relaxation techniques|relaxation techniques
781561|NCT00042185|Adolescence|adolescence
781562|NCT00042185|Prevention and Control|prevention and control
781563|NCT00042185|Bulimia|bulimia
781564|NCT00042172|Cognition|cognition
781565|NCT00042172|Memory|memory
781566|NCT00042159|Auditory hallucinations (voices)|auditory hallucinations (voices)
781567|NCT00042146|Insomnia|insomnia
781568|NCT00042146|Sleep Disorders|sleep disorders
781569|NCT00042146|Sleep Deprivation|sleep deprivation
781570|NCT00042133|aging|aging
781571|NCT00042133|disability|disability
781572|NCT00042133|longitudinal studies|longitudinal studies
781573|NCT00042133|neighborhood factors|neighborhood factors
781574|NCT00042133|socio-economic status|socio-economic status
781575|NCT00042133|race|race
781576|NCT00042120|Parkinson's disease|parkinson's disease
781577|NCT00042120|Movement Disorders|movement disorders
781578|NCT00042120|Epidemiological Study|epidemiological study
781579|NCT00042107|Parkinson Disease|parkinson disease
781580|NCT00042107|Neurodegenerative|neurodegenerative
781581|NCT00042094|Smallpox|smallpox
781582|NCT00042094|Smallpox Vaccine|smallpox vaccine
781583|NCT00042094|Vaccinia|vaccinia
781584|NCT00042081|CABG|cabg
781585|NCT00042081|coronary artery bypass surgery|coronary artery bypass surgery
781586|NCT00042081|coronary artery disease|coronary artery disease
781587|NCT00042081|coronary arteriosclerosis|coronary arteriosclerosis
781588|NCT00042081|coronary stenosis|coronary stenosis
781589|NCT00042081|coronary occlusion|coronary occlusion
781590|NCT00042055|Crohn's Disease|crohn's disease
781591|NCT00042055|Inflammatory Bowel Disease|inflammatory bowel disease
781592|NCT00042016|Chronic myelogenous leukemia|chronic myelogenous leukemia
781593|NCT00042016|CML|cml
781594|NCT00042016|CML-CP|cml-cp
781595|NCT00042016|Chronic phase|chronic phase
781596|NCT00042016|Decitabine|decitabine
781597|NCT00042016|5-aza-2'deoxycytidine|5-aza-2'deoxycytidine
781598|NCT00042016|Methylation|methylation
781599|NCT00042016|STI 571|sti 571
781600|NCT00042016|Imatinib mesylate|imatinib mesylate
781601|NCT00042016|Gleevec|gleevec
781602|NCT00042016|BCR/ABL|bcr/abl
781603|NCT00042003|Chronic myelogenous leukemia|chronic myelogenous leukemia
781604|NCT00042003|CML|cml
781605|NCT00042003|CML-BP|cml-bp
781606|NCT00042003|Blast phase|blast phase
781607|NCT00042003|Decitabine|decitabine
781608|NCT00042003|5-aza-2'deoxycytidine|5-aza-2'deoxycytidine
781609|NCT00042003|Methylation|methylation
781610|NCT00042003|STI 571|sti 571
781611|NCT00042003|Imatinib mesylate|imatinib mesylate
781612|NCT00042003|Gleevec|gleevec
781613|NCT00042003|BCR/ABL|bcr/abl
781614|NCT00041990|Chronic myelogenous leukemia|chronic myelogenous leukemia
781615|NCT00041990|CML|cml
781616|NCT00041990|CML-AP|cml-ap
781617|NCT00041990|Accelerated phase|accelerated phase
781618|NCT00041990|Decitabine|decitabine
781619|NCT00041990|5-aza-2'deoxycytidine|5-aza-2'deoxycytidine
781622|NCT00041990|Imatinib mesylate|imatinib mesylate
781623|NCT00041990|Gleevec|gleevec
781624|NCT00041990|BCR/ABL|bcr/abl
781625|NCT00041977|Rosacea|rosacea
781626|NCT00041964|Lopinavir|lopinavir
781627|NCT00041964|Pregnancy Trimester, Third|pregnancy trimester, third
781628|NCT00041964|Pregnancy Complications, Infectious|pregnancy complications, infectious
781629|NCT00041964|HIV Protease Inhibitors|hiv protease inhibitors
781630|NCT00041964|Ritonavir|ritonavir
781631|NCT00041964|Nelfinavir|nelfinavir
781632|NCT00041964|Viral Load|viral load
781633|NCT00041964|puerperium|puerperium
781634|NCT00041951|Childhood Absence Epilepsy|childhood absence epilepsy
781635|NCT00041951|CAE|cae
781636|NCT00041951|Petit Mal|petit mal
781637|NCT00041951|Epilepsy|epilepsy
781638|NCT00041951|Seizures|seizures
781639|NCT00041951|Genes|genes
781640|NCT00041951|Inheritance|inheritance
781641|NCT00041951|Genetics|genetics
781642|NCT00041951|Genetic Linkage|genetic linkage
781643|NCT00041938|heart disease|heart disease
781644|NCT00041938|stroke|stroke
781645|NCT00041938|ischemic heart disease|ischemic heart disease
781646|NCT00041938|myocardial infarction|myocardial infarction
781647|NCT00041938|atrial fibrillation|atrial fibrillation
781648|NCT00041938|low ejection fraction|low ejection fraction
781649|NCT00041938|cardiac failure|cardiac failure
781650|NCT00041938|aspirin|aspirin
781651|NCT00041938|Warfarin|warfarin
781652|NCT00041938|anticoagulant|anticoagulant
781653|NCT00041925|atherosclerotic vascular disease|atherosclerotic vascular disease
781654|NCT00041925|chronic critical limb ischemia|chronic critical limb ischemia
781655|NCT00041925|neointimal hyperplasia|neointimal hyperplasia
781656|NCT00041925|peripheral vein bypass|peripheral vein bypass
781657|NCT00041925|infra-inguinal bypass grafting surgery|infra-inguinal bypass grafting surgery
781658|NCT00041925|graft stenosis|graft stenosis
781659|NCT00041925|occluded grafts|occluded grafts
781660|NCT00041860|Benzene|benzene
781661|NCT00041860|Air pollution|air pollution
781662|NCT00041847|gene|gene
781663|NCT00041847|environment|environment
781664|NCT00041847|occupation|occupation
781665|NCT00041847|diet|diet
781666|NCT00041847|interaction|interaction
781667|NCT00041834|childhood asthma|childhood asthma
781668|NCT00041834|traffic|traffic
781669|NCT00041821|rhinitis|rhinitis
781670|NCT00041821|irritation|irritation
781671|NCT00041821|trigeminal|trigeminal
781672|NCT00041899|Progesterone|progesterone
781673|NCT00041899|Cortisol|cortisol
781674|NCT00041899|Menstrual Cycle|menstrual cycle
781675|NCT00041899|Formulation|formulation
781676|NCT00041899|Endometrium|endometrium
781677|NCT00041899|Estrogen|estrogen
781678|NCT00041886|Minimally Invasive Surgery|minimally invasive surgery
781679|NCT00041886|Percutaneous|percutaneous
781680|NCT00041886|Radiofrequency Ablation|radiofrequency ablation
781681|NCT00041886|Soft Tissue Metastases|soft tissue metastases
781682|NCT00041886|Thermal Ablation|thermal ablation
781683|NCT00041886|Soft Tissue Neoplasm|soft tissue neoplasm
781684|NCT00041886|Tumor|tumor
781685|NCT00041808|Metastatic liver cancer|metastatic liver cancer
781686|NCT00041808|Cholangiocarcinoma|cholangiocarcinoma
781687|NCT00041808|colorectal cancer|colorectal cancer
781688|NCT00041808|esophageal cancer|esophageal cancer
781689|NCT00041808|gastric cancer|gastric cancer
781690|NCT00041808|pancreatic cancer|pancreatic cancer
781691|NCT00041808|breast cancer|breast cancer
781692|NCT00041808|malignant melanoma|malignant melanoma
781693|NCT00041808|sarcoma|sarcoma
781694|NCT00041808|GIST|gist
781695|NCT00041808|gastrointestinal stromal tumor|gastrointestinal stromal tumor
781696|NCT00041808|lung cancer|lung cancer
781697|NCT00041808|liver cancer|liver cancer
781698|NCT00041782|Deep Vein Thrombosis|deep vein thrombosis
781699|NCT00041769|Drug Therapy, Combination|drug therapy, combination
781700|NCT00041769|HIV Protease Inhibitors|hiv protease inhibitors
781701|NCT00041769|Salvage Therapy|salvage therapy
781702|NCT00041769|Viral Load|viral load
781703|NCT00041769|Treatment Experienced|treatment experienced
781704|NCT00041756|Primary Disease: Knee Primary Osteoarthritis|primary disease: knee primary osteoarthritis
781705|NCT00041730|lymphoma|lymphoma
781706|NCT00041730|vaccine|vaccine
781707|NCT00041730|idiotype|idiotype
781708|NCT00041730|KLH|klh
781709|NCT00041730|GM-CSF|gm-csf
781710|NCT00041730|FavId|favid
781711|NCT00041717|spinal cord injury|spinal cord injury
781712|NCT00041717|muscle spasticity|muscle spasticity
781713|NCT00041704|Azole-Refractory Mucosal Candidiasis|azole-refractory mucosal candidiasis
781714|NCT00041704|Mucosal Candidiasis|mucosal candidiasis
781715|NCT00041691|Colorectal Cancer|colorectal cancer
781716|NCT00041691|Colon Cancer|colon cancer
781717|NCT00041691|Rectal Cancer|rectal cancer
781718|NCT00041691|Colorectal Neoplasms|colorectal neoplasms
781719|NCT00041691|Colorectal Carcinoma|colorectal carcinoma
781720|NCT00041691|Colorectal Tumor|colorectal tumor
781721|NCT00041678|Psychosis Associated with Dementia of the Alzheimer's Type|psychosis associated with dementia of the alzheimer's type
781722|NCT00041652|Colorectal Cancer|colorectal cancer
781723|NCT00041652|Colon Cancer|colon cancer
791624|NCT00000693|Zidovudine|zidovudine
781724|NCT00041652|Rectal Cancer|rectal cancer
781725|NCT00041652|Colorectal Neoplasms|colorectal neoplasms
781726|NCT00041652|Colorectal Carcinoma|colorectal carcinoma
781727|NCT00041652|Breast Cancer|breast cancer
781728|NCT00041652|Breast Neoplasms|breast neoplasms
781729|NCT00041639|Pancreatic Cancer|pancreatic cancer
781730|NCT00041639|Pancreatic Carcinoma|pancreatic carcinoma
781731|NCT00041639|Pancreatic Neoplasms|pancreatic neoplasms
781732|NCT00041639|Pancreas Cancer|pancreas cancer
781733|NCT00041639|Pancreatic Tumor|pancreatic tumor
781734|NCT00041626|Recurrent Squamous Cell Carcinoma of the Head and Neck|recurrent squamous cell carcinoma of the head and neck
781735|NCT00041613|Refractory Squamous Cell Carcinoma of the Head and Neck|refractory squamous cell carcinoma of the head and neck
781736|NCT00041600|epilepsy|epilepsy
781737|NCT00041600|seizures|seizures
781738|NCT00041600|disorders of human cognition|disorders of human cognition
781739|NCT00041600|neuronal migration|neuronal migration
781740|NCT00041600|neuronal migration disorders|neuronal migration disorders
781741|NCT00041600|lissencephaly|lissencephaly
781742|NCT00041600|schizencephaly|schizencephaly
781743|NCT00041600|polymicrogyria|polymicrogyria
781744|NCT00041600|agenesis of the corpus callosum|agenesis of the corpus callosum
781745|NCT00041600|heterotopia|heterotopia
781746|NCT00041587|Cancer|cancer
781747|NCT00041587|Recurrent resectable supratentorial malignant glioma|recurrent resectable supratentorial malignant glioma
781748|NCT00041509|venous thromboembolism|venous thromboembolism
781749|NCT00041509|thromboembolism|thromboembolism
781750|NCT00041509|pulmonary embolism|pulmonary embolism
781751|NCT00041509|deep vein thrombosis|deep vein thrombosis
781752|NCT00041496|symptomatic atrial fibrillation|symptomatic atrial fibrillation
781753|NCT00041496|persistent atrial fibrillation|persistent atrial fibrillation
781754|NCT00041561|Acute hypoxemic respiratory failure|acute hypoxemic respiratory failure
781755|NCT00041535|Eye Movements|eye movements
781756|NCT00041535|Saccades|saccades
781757|NCT00041535|Metabolic|metabolic
781758|NCT00041535|Lysosomal|lysosomal
781759|NCT00041535|Myoclonus|myoclonus
781760|NCT00041535|Gaucher Disease|gaucher disease
781761|NCT00041535|Neuronopathic Gaucher Disease|neuronopathic gaucher disease
781762|NCT00040677|sickle cell anemia|sickle cell anemia
781763|NCT00040677|sickle cell disease|sickle cell disease
781764|NCT00040677|anemia|anemia
781765|NCT00040677|ICA-17043|ica-17043
781766|NCT00040677|senicapoc|senicapoc
781767|NCT00040664|pediatrics|pediatrics
781768|NCT00040664|HIV|hiv
781769|NCT00040664|protease inhibitors|protease inhibitors
781770|NCT00040664|ritonavir|ritonavir
781771|NCT00040664|fosamprenavir|fosamprenavir
781772|NCT00040664|LEXIVA|lexiva
781773|NCT00040664|AGENERASE|agenerase
781774|NCT00040664|amprenavir|amprenavir
781775|NCT00040651|Systemic Sclerosis|systemic sclerosis
781776|NCT00040651|Chemotherapy|chemotherapy
781777|NCT00040651|Cyclophosphamide|cyclophosphamide
781778|NCT00040651|Fludarabine|fludarabine
781779|NCT00040651|Leukapheresis|leukapheresis
781780|NCT00040651|Mesna|mesna
781781|NCT00040651|Stem Cell|stem cell
781782|NCT00040651|T-Cell|t-cell
781783|NCT00040651|Thymoglobulin|thymoglobulin
781784|NCT00040651|Scleroderma|scleroderma
781785|NCT00040027|hepatitis C|hepatitis c
781786|NCT00040027|hepatitis C, chronic|hepatitis c, chronic
781787|NCT00040599|Colon Cancer|colon cancer
781788|NCT00040599|Rectal Cancer|rectal cancer
781789|NCT00040599|Colorectal Neoplasms|colorectal neoplasms
781790|NCT00040599|Colorectal Carcinoma|colorectal carcinoma
781791|NCT00040599|Colorectal Tumor|colorectal tumor
781792|NCT00040586|hormone-refractory|hormone-refractory
781793|NCT00040573|Brain neoplasm|brain neoplasm
781794|NCT00040573|Clinical trial, phase I/II|clinical trial, phase i/ii
781795|NCT00040560|Lung Cancer|lung cancer
781796|NCT00040560|Metastatic Brain Cancer|metastatic brain cancer
781797|NCT00040547|Cancer-Advanced Solid Tumors|cancer-advanced solid tumors
781798|NCT00040534|Advanced Cancer|advanced cancer
781799|NCT00040521|Crohn's Disease|crohn's disease
781800|NCT00040521|Active Crohns Disease|active crohns disease
781801|NCT00040495|Peptic|peptic
781802|NCT00040495|Ulcer|ulcer
781803|NCT00040495|Hemorrhage|hemorrhage
781804|NCT00040456|Hemoglobin SC disease|hemoglobin sc disease
781805|NCT00040456|sickle cell-hemoglobin|sickle cell-hemoglobin
781806|NCT00040443|Mild Cognitive Impairment|mild cognitive impairment
781807|NCT00040443|Memory Loss|memory loss
781808|NCT00040443|Alzheimer's Disease|alzheimer's disease
781809|NCT00040443|Brain Aging|brain aging
781810|NCT00040443|Ampalex®|ampalex®
781811|NCT00040443|CX516|cx516
781812|NCT00040508|Proteinuria|proteinuria
781813|NCT00040508|Renal Failure|renal failure
781814|NCT00040508|Fibrosis|fibrosis
781815|NCT00040508|Rapamycin|rapamycin
781816|NCT00040508|Immunosuppression|immunosuppression
781817|NCT00040508|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
781818|NCT00040508|FSGS|fsgs
781819|NCT00040404|Parkinson's disease|parkinson's disease
781820|NCT00040404|Idiopathic Parkinson's disease|idiopathic parkinson's disease
781821|NCT00040404|Idiopathic Parkinson disease|idiopathic parkinson disease
781927|NCT00040105|Imatinib Mesylate|imatinib mesylate
781822|NCT00040404|Parkinson's disease, idiopathic|parkinson's disease, idiopathic
781823|NCT00040391|Pharmacia|pharmacia
781824|NCT00040378|Alzheimer Disease|alzheimer disease
781825|NCT00040378|Vitamin E|vitamin e
781826|NCT00040378|Selenium|selenium
781827|NCT00040365|Prostate Cancer|prostate cancer
781828|NCT00040365|Radiation Therapy|radiation therapy
781829|NCT00040365|Rectal Toxicity|rectal toxicity
781830|NCT00040365|Amifostine|amifostine
781831|NCT00040365|Radioprotector|radioprotector
781832|NCT00040352|Genetics|genetics
781833|NCT00040352|Risk Factors|risk factors
781834|NCT00040352|Natural History|natural history
781835|NCT00040352|Melanoma Precursors|melanoma precursors
781836|NCT00040352|Skin Cancer|skin cancer
781837|NCT00040352|Melanoma|melanoma
781838|NCT00040339|brain injury|brain injury
781839|NCT00040339|hypothermia|hypothermia
781840|NCT00040339|body cooling|body cooling
781841|NCT00040339|body temperature|body temperature
781842|NCT00040326|epilepsy|epilepsy
781843|NCT00040326|mesial temporal lobe epilepsy|mesial temporal lobe epilepsy
781844|NCT00040326|temporal lobe epilepsy|temporal lobe epilepsy
781845|NCT00040326|MTLE|mtle
781846|NCT00040326|seizures|seizures
781847|NCT00040326|anteromesial temporal resection|anteromesial temporal resection
781848|NCT00040326|surgery|surgery
781849|NCT00040326|antiepileptic drugs|antiepileptic drugs
781850|NCT00040326|hippocampal sclerosis|hippocampal sclerosis
781851|NCT00040300|treatment experienced|treatment experienced
781852|NCT00040300|HIV|hiv
781853|NCT00040300|Phase I|phase i
781854|NCT00040300|Combination Therapy|combination therapy
781855|NCT00040287|smoking|smoking
781856|NCT00040287|obesity|obesity
781857|NCT00040287|weight loss|weight loss
781858|NCT00040287|smoking cessation|smoking cessation
781859|NCT00040287|weight control|weight control
781860|NCT00040274|HIV|hiv
781861|NCT00040274|Phase I|phase i
781862|NCT00040183|Tarceva, EGFR, erlotinib, OSI-774|tarceva, egfr, erlotinib, osi-774
781863|NCT00040170|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
781864|NCT00040157|treatment experienced,|treatment experienced,
781865|NCT00040157|Stable triple anti-retroviral combination therapy in HIV-infected,|stable triple anti-retroviral combination therapy in hiv-infected,
781866|NCT00040157|Achillion|achillion
781867|NCT00040144|E-Antigen positive,|e-antigen positive,
781868|NCT00040144|Lamivudine-Resistant Chronic Hepatitis B,|lamivudine-resistant chronic hepatitis b,
781869|NCT00040144|Achillion|achillion
781870|NCT00040261|Antiglutamatergic|antiglutamatergic
781871|NCT00040261|Neuroprotective|neuroprotective
781872|NCT00040261|Unipolar Depression|unipolar depression
781873|NCT00040261|Treatment|treatment
781874|NCT00040261|Antidepressant|antidepressant
781875|NCT00040261|Depression|depression
781876|NCT00040261|Glutamate|glutamate
781877|NCT00040261|Memantine|memantine
781878|NCT00040261|Pathophysiology|pathophysiology
781879|NCT00040261|Positron Emission Tomography|positron emission tomography
781880|NCT00040261|Major Depression|major depression
781881|NCT00040248|Relapse|relapse
781882|NCT00040248|Monoclonal Antibody|monoclonal antibody
781883|NCT00040248|Biologic Agent|biologic agent
781884|NCT00040248|Anti-CD25|anti-cd25
781885|NCT00040248|Activated Lymphocyte|activated lymphocyte
781886|NCT00040248|Wegener Granulomatosis|wegener granulomatosis
781887|NCT00040248|Wegener's Granulomatosis|wegener's granulomatosis
781888|NCT00040248|WG|wg
781889|NCT00040235|Leukapheresis|leukapheresis
781890|NCT00040235|Hypomagnesemia|hypomagnesemia
781891|NCT00040235|Plateletpheresis|plateletpheresis
781892|NCT00040235|Hypocalcemia|hypocalcemia
781893|NCT00040235|Citrate|citrate
781894|NCT00040235|Healthy Volunteer|healthy volunteer
781895|NCT00040235|HV|hv
781896|NCT00040235|Normal Control|normal control
781897|NCT00040222|Counseling/behavioral/psychosocial|counseling/behavioral/psychosocial
781898|NCT00040222|Gene discovery|gene discovery
781899|NCT00040222|Cancer prevention|cancer prevention
781900|NCT00040222|Risk-reduction|risk-reduction
781901|NCT00040222|Hereditary|hereditary
781902|NCT00040222|Breast Cancer|breast cancer
781903|NCT00040222|Ovarian Cancer|ovarian cancer
781904|NCT00040222|Cowden Syndrome|cowden syndrome
781905|NCT00040222|Peutz-Jegher Syndrome|peutz-jegher syndrome
781906|NCT00040222|Li-Fraumeni Syndrome|li-fraumeni syndrome
781907|NCT00040209|JP 1730|jp 1730
781908|NCT00040209|Dyskinesias|dyskinesias
781909|NCT00040209|Levodopa Infusion|levodopa infusion
781910|NCT00040209|Apomorphine Infusion|apomorphine infusion
781911|NCT00040209|Clinical Trial|clinical trial
781912|NCT00040209|Parkinson Disease|parkinson disease
781913|NCT00040209|PD|pd
781914|NCT00040196|Parkinson's Disease|parkinson's disease
781915|NCT00040196|Levodopa|levodopa
781916|NCT00040196|Perfusion fMRI|perfusion fmri
781917|NCT00040196|Aging|aging
781918|NCT00040196|Motor Control|motor control
781919|NCT00040196|PD|pd
781920|NCT00040196|Healthy Volunteer|healthy volunteer
781921|NCT00040196|HV|hv
781922|NCT00040196|Normal Control|normal control
781923|NCT00040105|Chronic Myelogenous Leukemia, Chronic Phase|chronic myelogenous leukemia, chronic phase
781924|NCT00040105|R115777|r115777
781925|NCT00040105|Zarnestra|zarnestra
781933|NCT00040092|Immunotherapy|immunotherapy
781934|NCT00040092|Pancreas|pancreas
781935|NCT00040092|Pancreatic Cancer|pancreatic cancer
781936|NCT00040092|clinical trial|clinical trial
781937|NCT00039988|Treatment Outcome|treatment outcome
781938|NCT00039988|Multiple Sclerosis|multiple sclerosis
781939|NCT00039988|Albuterol|albuterol
781940|NCT00039988|Copolymer 1|copolymer 1
781941|NCT00039975|Drug Interactions|drug interactions
781942|NCT00039975|HIV Protease Inhibitors|hiv protease inhibitors
781943|NCT00039975|Ritonavir|ritonavir
781944|NCT00039975|Indinavir|indinavir
781945|NCT00039975|Calcium Channel Blockers|calcium channel blockers
781946|NCT00039975|Pharmacokinetics|pharmacokinetics
781947|NCT00039975|Diltiazem|diltiazem
781948|NCT00039975|Amlodipine|amlodipine
781949|NCT00039962|hepatitis C|hepatitis c
781950|NCT00039962|hepatitis C, chronic|hepatitis c, chronic
781951|NCT00039962|cirrhosis, liver|cirrhosis, liver
781952|NCT00039936|Binge Eating|binge eating
781953|NCT00039936|Obesity|obesity
781954|NCT00039936|Cognitive|cognitive
781955|NCT00039936|Behavior|behavior
781956|NCT00040053|amphetamine dependence|amphetamine dependence
781957|NCT00039923|Hemolysis|hemolysis
781958|NCT00039923|CD55|cd55
781959|NCT00039923|CD59|cd59
781960|NCT00039923|Transfusion|transfusion
781961|NCT00039923|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
781962|NCT00039923|PNH|pnh
781963|NCT00039884|Cervical cancer|cervical cancer
781964|NCT00039858|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
781965|NCT00039858|heparin-induced thrombocytopenia and thrombosis|heparin-induced thrombocytopenia and thrombosis
781966|NCT00039858|HIT|hit
781967|NCT00039858|HITTS|hitts
781968|NCT00039858|anticoagulation|anticoagulation
781969|NCT00039845|Brain|brain
781970|NCT00039845|Imaging|imaging
781971|NCT00039845|Pediatrics|pediatrics
781972|NCT00039845|Mapping|mapping
781973|NCT00039845|Development|development
781974|NCT00039845|fMRI|fmri
781975|NCT00039845|Children|children
781976|NCT00039845|Language|language
781977|NCT00039845|Healthy Volunteer|healthy volunteer
781978|NCT00039845|HV|hv
781979|NCT00039845|Normal Control|normal control
781980|NCT00039832|Stroke|stroke
781981|NCT00039832|Abciximab|abciximab
781982|NCT00039832|Reteplase|reteplase
781983|NCT00039832|MRI|mri
781984|NCT00039832|Cerebral Blood Flow|cerebral blood flow
781985|NCT00039793|Cancer-related fatigue|cancer-related fatigue
781986|NCT00039793|alternative medicine|alternative medicine
781987|NCT00039793|cancer rehabilitation /care|cancer rehabilitation /care
781988|NCT00039793|fatigue|fatigue
781989|NCT00039793|human therapy evaluation|human therapy evaluation
781990|NCT00039793|physical therapy|physical therapy
781991|NCT00039793|neoplasm /cancer chemotherapy|neoplasm /cancer chemotherapy
781992|NCT00039793|neoplasm /cancer palliative treatment|neoplasm /cancer palliative treatment
781993|NCT00039780|Breast|breast
781994|NCT00039780|Cancer|cancer
781995|NCT00039780|Metastatic|metastatic
781996|NCT00039780|Paclitaxel|paclitaxel
781997|NCT00039780|Peripheral|peripheral
781998|NCT00039780|Taxol|taxol
781999|NCT00039780|Neuropathy|neuropathy
782000|NCT00039780|Neurotoxicity|neurotoxicity
782001|NCT00039780|Paresthesias|paresthesias
782002|NCT00039780|Weekly|weekly
782003|NCT00039780|BNP7787|bnp7787
782004|NCT00039780|7787|7787
782005|NCT00039780|Tavocept|tavocept
782006|NCT00039780|Prevention|prevention
782007|NCT00039819|Spinal Cord|spinal cord
782008|NCT00039819|Sensory Stimulation|sensory stimulation
782009|NCT00039819|Locomotion|locomotion
782010|NCT00039819|Magnetic Stimulation|magnetic stimulation
782011|NCT00039819|Reflexes|reflexes
782012|NCT00039819|Healthy Volunteer|healthy volunteer
782013|NCT00039819|HV|hv
782014|NCT00039819|Normal Control|normal control
782015|NCT00039754|Multiple myeloma|multiple myeloma
782016|NCT00039754|Transplant|transplant
782017|NCT00039754|Skeletal Targeted Radiotherapy|skeletal targeted radiotherapy
782018|NCT00039754|Holmium|holmium
782019|NCT00039741|Drug Therapy, Combination|drug therapy, combination
782020|NCT00039741|HIV Protease Inhibitors|hiv protease inhibitors
782021|NCT00039741|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
782022|NCT00039741|Viral Load|viral load
782023|NCT00039741|Treatment Naive|treatment naive
782024|NCT00039767|Fibrin Sleeves|fibrin sleeves
782025|NCT00039767|Anticoagulants|anticoagulants
782026|NCT00039767|Catheters|catheters
782027|NCT00039767|Thrombosis|thrombosis
782028|NCT00039767|Hirudin|hirudin
782029|NCT00039767|Lepirudin|lepirudin
782030|NCT00039026|Type 2 Diabetes Mellitis|type 2 diabetes mellitis
782031|NCT00039000|Immunotherapy, Cancer, Melanoma, Skin Cancer, tumor|immunotherapy, cancer, melanoma, skin cancer, tumor
782032|NCT00038987|Smallpox|smallpox
782033|NCT00038987|APSV|apsv
782034|NCT00038987|Aventis Pasteur Smallpox Vaccine|aventis pasteur smallpox vaccine
782035|NCT00038987|vaccinia-naive|vaccinia-naive
782036|NCT00038974|Hepatitis C|hepatitis c
782037|NCT00038974|Interferon|interferon
782038|NCT00038974|Ribavirin|ribavirin
782039|NCT00038974|Efficacy|efficacy
782044|NCT00038961|fondaparinux sodium|fondaparinux sodium
782045|NCT00038961|DVT Prevention|dvt prevention
782046|NCT00038961|abdominal surgery|abdominal surgery
782047|NCT00038961|VTE prevention|vte prevention
782048|NCT00038961|venous thromboembolism|venous thromboembolism
782049|NCT00038961|pulmonary embolism|pulmonary embolism
782050|NCT00039715|Glucocorticoid Receptor|glucocorticoid receptor
782051|NCT00039715|Traumatic Reminders|traumatic reminders
782052|NCT00039715|Stress|stress
782053|NCT00039715|Hippocampus|hippocampus
782054|NCT00039715|Flashbacks|flashbacks
782055|NCT00039715|PTSD|ptsd
782056|NCT00039715|Type II GR Receptor|type ii gr receptor
782057|NCT00039715|Hydrocortisone|hydrocortisone
782058|NCT00039715|Memory|memory
782059|NCT00039715|Major Depression|major depression
782060|NCT00039715|Post-Traumatic Stress Disorder|post-traumatic stress disorder
782061|NCT00039715|Healthy Volunteer|healthy volunteer
782062|NCT00039715|HV|hv
782063|NCT00039715|Normal Control|normal control
782064|NCT00039702|Nicotinic Acetylcholine Receptors|nicotinic acetylcholine receptors
782065|NCT00039702|Alzheimer's Disease|alzheimer's disease
782066|NCT00039702|SPECT|spect
782067|NCT00039702|AD|ad
782068|NCT00039702|Healthy Volunteer|healthy volunteer
782069|NCT00039702|HV|hv
782070|NCT00039702|Normal Control|normal control
782071|NCT00039689|Primary HIV Infection|primary hiv infection
782072|NCT00039689|Chronic HIV Infection|chronic hiv infection
782073|NCT00039689|Antiretroviral Therapy|antiretroviral therapy
782074|NCT00039689|Innate Immunity|innate immunity
782075|NCT00039689|B Cell|b cell
782076|NCT00039689|HIV Infection|hiv infection
782077|NCT00039689|Acute Infection|acute infection
782078|NCT00039689|Treatment Naive|treatment naive
782079|NCT00039676|Genetics|genetics
782080|NCT00039676|Risk Factors|risk factors
782081|NCT00039676|Natural History|natural history
782082|NCT00039676|Lymphoma|lymphoma
782083|NCT00039676|Leukemia|leukemia
782084|NCT00039676|Lymph Node Cancer|lymph node cancer
782085|NCT00039663|Hyperlipidemia|hyperlipidemia
782086|NCT00039663|Insulin Resistance|insulin resistance
782087|NCT00039663|Coronary Artery Disease|coronary artery disease
782088|NCT00039663|Lipodystrophy|lipodystrophy
782089|NCT00039663|Antiretroviral Therapy|antiretroviral therapy
782090|NCT00039663|HIV Infection|hiv infection
782091|NCT00039663|Treatment Experienced|treatment experienced
782092|NCT00039650|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
782093|NCT00039650|T Cells|t cells
782094|NCT00039650|Peripheral Blood Stem Cells|peripheral blood stem cells
782095|NCT00039650|Apheresis|apheresis
782096|NCT00039650|Hematopoietic Progenitor Cell Transplantation|hematopoietic progenitor cell transplantation
782097|NCT00039650|Healthy Volunteer|healthy volunteer
782098|NCT00039650|HV|hv
782099|NCT00039650|Normal Control|normal control
782100|NCT00039624|Radiation Therapy|radiation therapy
782101|NCT00039624|Prostate|prostate
782102|NCT00039624|MRI|mri
782103|NCT00039624|Brachytherapy|brachytherapy
782104|NCT00039624|Phase II|phase ii
782105|NCT00039624|Prostate Cancer|prostate cancer
782106|NCT00038948|Renal|renal
782107|NCT00038948|Allograft|allograft
782108|NCT00038948|Recipients|recipients
782109|NCT00038935|Hemophilia|hemophilia
782110|NCT00038922|Left-Sided|left-sided
782111|NCT00038922|Ulcerative|ulcerative
782112|NCT00038922|Colitis|colitis
782113|NCT00038896|Panic|panic
782114|NCT00038896|Disorder|disorder
782115|NCT00038883|Lymphoid Malignancies|lymphoid malignancies
782116|NCT00038883|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
782117|NCT00038883|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
782118|NCT00038883|Low grade Lymphoma|low grade lymphoma
782119|NCT00038883|B and T cell Lymphoma of the intermediate and high grade|b and t cell lymphoma of the intermediate and high grade
782120|NCT00038870|AML|aml
782121|NCT00038870|CML|cml
782122|NCT00038870|Dendritic Cells|dendritic cells
782123|NCT00038857|Acute Myelogenous Leukemia|acute myelogenous leukemia
782124|NCT00038857|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
782125|NCT00038857|Myelodysplastic Syndrome|myelodysplastic syndrome
782126|NCT00038857|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
782127|NCT00038857|Leukemia|leukemia
782128|NCT00038857|Lymphoma|lymphoma
782129|NCT00038857|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
782130|NCT00038857|T cell depletion|t cell depletion
782131|NCT00038857|CD34 selected progenitors cell|cd34 selected progenitors cell
782132|NCT00038857|GVHD|gvhd
782133|NCT00038844|Lymphoma|lymphoma
782134|NCT00038844|Leukemia|leukemia
782135|NCT00038844|Campath-1 H|campath-1 h
782136|NCT00038844|Campath|campath
782137|NCT00038844|Alemtuzumab|alemtuzumab
782138|NCT00038844|Fludarabine|fludarabine
782139|NCT00038844|Fludarabine Phosphate|fludarabine phosphate
782140|NCT00038844|Fludara|fludara
782141|NCT00038844|Cyclophosphamide|cyclophosphamide
782142|NCT00038844|Cytoxan|cytoxan
782143|NCT00038844|Neosar|neosar
782144|NCT00038844|Rituxan|rituxan
782145|NCT00038844|Rituximab|rituximab
782146|NCT00038831|Acute Myelogenous leukemia|acute myelogenous leukemia
782147|NCT00038831|AML|aml
782148|NCT00038831|Myelodysplastic Syndrome|myelodysplastic syndrome
782149|NCT00038831|MDS|mds
782150|NCT00038831|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
782151|NCT00038831|CML|cml
782152|NCT00038831|Mylotarg|mylotarg
782153|NCT00038831|Gemtuzumab|gemtuzumab
782154|NCT00038831|Gemtuzumab ozogamicin|gemtuzumab ozogamicin
782155|NCT00038831|Melphalan|melphalan
782156|NCT00038831|Alkeran|alkeran
782157|NCT00038831|Fludarabine Phosphate|fludarabine phosphate
782158|NCT00038831|Fludarabine|fludarabine
782159|NCT00038831|Fludara|fludara
782160|NCT00038831|Anti-thymocyte globulin|anti-thymocyte globulin
782161|NCT00038831|ATG|atg
782162|NCT00038831|Allogeneic Bone Marrow|allogeneic bone marrow
782163|NCT00038831|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
782164|NCT00038831|Allo PBSCT|allo pbsct
782165|NCT00038831|Allogeneic transplantation|allogeneic transplantation
782166|NCT00038818|CML|cml
782167|NCT00038818|MM|mm
782168|NCT00038818|NHL|nhl
782169|NCT00038818|HD|hd
782170|NCT00038818|CLL|cll
782171|NCT00038818|CD8 Depleted|cd8 depleted
782172|NCT00038818|Donor Lymphocyte|donor lymphocyte
782173|NCT00038805|High Risk Acute Myeloid Leukemia|high risk acute myeloid leukemia
782174|NCT00038805|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
782175|NCT00038805|Chronic Myeloid Leukemia|chronic myeloid leukemia
782176|NCT00038805|Myelodysplastic Syndrome|myelodysplastic syndrome
782177|NCT00038805|ALL|all
782178|NCT00038805|AML|aml
782179|NCT00038805|MDS|mds
782180|NCT00038805|CML|cml
782181|NCT00038805|CMML|cmml
782182|NCT00038805|Nonmyeloablative Preparative Regimen|nonmyeloablative preparative regimen
782183|NCT00038805|Mylotarg|mylotarg
782184|NCT00038805|CMA-676|cma-676
782185|NCT00038792|Acute Graft Versus Host Disease|acute graft versus host disease
782186|NCT00038792|Refractory|refractory
782187|NCT00038779|Lymphoma|lymphoma
782188|NCT00038779|CML|cml
782189|NCT00038779|CLL|cll
782190|NCT00038779|AML|aml
782191|NCT00038779|ALL|all
782192|NCT00038779|MDS|mds
782193|NCT00038779|AA|aa
782194|NCT00038766|Inflammatory Bowel Disease|inflammatory bowel disease
782195|NCT00038753|vision screening|vision screening
782196|NCT00038727|DPP|dpp
782197|NCT00038727|IGT|igt
782198|NCT00038727|Prediabetes|prediabetes
782199|NCT00038727|Type 2 diabetes|type 2 diabetes
782200|NCT00038727|Macrovascular disease|macrovascular disease
782201|NCT00038727|Microvascular disease|microvascular disease
782202|NCT00038727|Lifestyle|lifestyle
782203|NCT00038727|Metformin|metformin
782204|NCT00038727|Obesity|obesity
782205|NCT00038714|HPV|hpv
782206|NCT00038714|Papilloma|papilloma
782207|NCT00038701|Metastatic Pancreas Cancer|metastatic pancreas cancer
782208|NCT00038688|Health Education|health education
782209|NCT00038688|Substance Abuse, Intravenous|substance abuse, intravenous
782210|NCT00038688|Program Evaluation|program evaluation
782211|NCT00038688|Peer Group|peer group
782212|NCT00038688|Risk-Taking|risk-taking
782213|NCT00038688|HIV Seronegativity|hiv seronegativity
782214|NCT00038688|Substance-related Disorders|substance-related disorders
782215|NCT00038675|Leukemia|leukemia
782216|NCT00038675|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
782217|NCT00038675|Chronic Myeloid Leukemia|chronic myeloid leukemia
782218|NCT00038675|Polycythemia Vera|polycythemia vera
782219|NCT00038675|Hypereosinophilic Syndrome|hypereosinophilic syndrome
782220|NCT00038675|Mastocytosis|mastocytosis
782221|NCT00038675|Imatinib Mesylate|imatinib mesylate
782222|NCT00038675|Gleevec|gleevec
782223|NCT00038649|Philadelphia chromosome positive|philadelphia chromosome positive
782224|NCT00038649|early chronic phase (diagnosis < 12 months)|early chronic phase (diagnosis < 12 months)
782225|NCT00038649|Chronic Myelogenous Leukemia, Chronic Phase|chronic myelogenous leukemia, chronic phase
782226|NCT00038649|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
782227|NCT00038649|CML|cml
782228|NCT00038649|Gleevec|gleevec
782229|NCT00038649|STI571|sti571
782230|NCT00038636|HIV|hiv
782231|NCT00038623|Relapsed/Refractory Mantle Cell Lymphoma|relapsed/refractory mantle cell lymphoma
782232|NCT00038623|Yttrium-Ibritumomab|yttrium-ibritumomab
782233|NCT00038623|Zevalin|zevalin
782234|NCT00038610|Leukemia|leukemia
782235|NCT00038610|Lymphoblastic|lymphoblastic
782236|NCT00038610|Acute|acute
782237|NCT00038610|Philadelphia-Positive|philadelphia-positive
782238|NCT00038610|Imatinib Mesylate|imatinib mesylate
782239|NCT00038610|Gleevec|gleevec
782240|NCT00038610|Glivec|glivec
782241|NCT00038610|Imatinib|imatinib
782242|NCT00038610|STI571|sti571
782243|NCT00038610|STI-571|sti-571
782244|NCT00038610|CGP-57148B|cgp-57148b
782245|NCT00038610|NSC-716051|nsc-716051
782246|NCT00038610|Cyclophosphamide|cyclophosphamide
782247|NCT00038610|Cytoxan®,|cytoxan®,
782248|NCT00038610|Neosar®|neosar®
782249|NCT00038610|Doxorubicin|doxorubicin
782250|NCT00038610|Adriamycin ®|adriamycin ®
782251|NCT00038610|Rubex ®|rubex ®
782252|NCT00038610|Adriamycin PFS|adriamycin pfs
782253|NCT00038610|Adriamycin RDF|adriamycin rdf
782254|NCT00038610|Vincristine|vincristine
782255|NCT00038610|Dexamethasone|dexamethasone
782256|NCT00038610|Decadron|decadron
782257|NCT00038610|Methotrexate|methotrexate
782258|NCT00038610|Cytarabine|cytarabine
782259|NCT00038610|Ara-C|ara-c
782260|NCT00038610|Cytosar|cytosar
782261|NCT00038610|DepoCyt|depocyt
782262|NCT00038610|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
782263|NCT00038610|Mesna|mesna
782264|NCT00038610|Mesnex|mesnex
782265|NCT00038610|G-CSF|g-csf
782266|NCT00038610|Filgrastim|filgrastim
782267|NCT00038610|Neupogen|neupogen
782268|NCT00038597|Philadelphia chromosome positive CML|philadelphia chromosome positive cml
782269|NCT00038597|Myelogenous Leukemia, Chronic, Chronic Phase|myelogenous leukemia, chronic, chronic phase
782270|NCT00038597|Myelogenous Leukemia, Chronic, Accelerated Phase|myelogenous leukemia, chronic, accelerated phase
782271|NCT00038571|Cancer|cancer
782272|NCT00038571|Relapsed|relapsed
782273|NCT00038571|Refractory|refractory
782274|NCT00038571|B cell lymphoma|b cell lymphoma
782275|NCT00038571|Proteasome Inhibitor|proteasome inhibitor
782276|NCT00038571|PS-341|ps-341
782277|NCT00038558|Hodgkin's lymphoma|hodgkin's lymphoma
782278|NCT00038558|Dacarbazine|dacarbazine
782279|NCT00038558|DTIC|dtic
782280|NCT00038558|DTIC-Dome|dtic-dome
782281|NCT00038558|Vinblastine|vinblastine
782282|NCT00038558|Velban|velban
782283|NCT00038558|Bleomycin sulfate|bleomycin sulfate
782284|NCT00038558|Blenoxane|blenoxane
782285|NCT00038558|BLM|blm
782286|NCT00038558|Doxorubicin Hydrochloride|doxorubicin hydrochloride
782287|NCT00038558|Adriamycin|adriamycin
782288|NCT00038558|Filgrastim|filgrastim
782289|NCT00038558|G-CSF|g-csf
782290|NCT00038558|Neupogen|neupogen
782291|NCT00038558|Pegfilgrastim|pegfilgrastim
782292|NCT00038558|granulocyte colony-stimulating factor|granulocyte colony-stimulating factor
782293|NCT00038545|LYMPHOMA|lymphoma
782294|NCT00038545|NON-HODGKINS|non-hodgkins
782295|NCT00038545|AGGRESSIVE|aggressive
782296|NCT00038545|RELAPSED AND REFRACTORY|relapsed and refractory
782297|NCT00038532|treatment experienced|treatment experienced
782298|NCT00038532|HIV|hiv
782299|NCT00038519|treatment experienced|treatment experienced
782300|NCT00038519|HIV|hiv
782301|NCT00038506|HIV-1 TRIZIVIR Tenofovir|hiv-1 trizivir tenofovir
782302|NCT00038493|GBM|gbm
782303|NCT00038493|Glioma|glioma
782304|NCT00038493|Brain Tumor|brain tumor
782305|NCT00038480|Lopinavir|lopinavir
782306|NCT00038480|HIV-1|hiv-1
782307|NCT00038480|Drug Therapy, Combination|drug therapy, combination
782308|NCT00038480|HIV Protease Inhibitors|hiv protease inhibitors
782309|NCT00038480|Ritonavir|ritonavir
782310|NCT00038480|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
782311|NCT00038454|Oxygen Therapeutics|oxygen therapeutics
782312|NCT00038454|CABG|cabg
782313|NCT00038454|Transfusion|transfusion
782314|NCT00038441|Malignant Glioma|malignant glioma
782315|NCT00038415|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
782316|NCT00038415|CLL|cll
782317|NCT00038415|Binet Stage A|binet stage a
782318|NCT00038415|Vaccination|vaccination
782319|NCT00038415|Idiotypic|idiotypic
782320|NCT00038415|Genetic|genetic
782321|NCT00038415|Deoxyribonucleic acid|deoxyribonucleic acid
782322|NCT00038415|DNA|dna
782323|NCT00038402|Breast Cancer|breast cancer
782324|NCT00038402|Non-Inflammatory Breast Cancer|non-inflammatory breast cancer
782325|NCT00038402|Operable Breast Cancer|operable breast cancer
782326|NCT00038402|Herceptin|herceptin
782327|NCT00038402|Taxol|taxol
782328|NCT00038402|FEC|fec
782329|NCT00038402|Fluorouracil|fluorouracil
782330|NCT00038402|Cyclophosphamide|cyclophosphamide
782331|NCT00038402|Epirubicin|epirubicin
782332|NCT00038402|Trastuzumab|trastuzumab
782333|NCT00038402|Paclitaxel|paclitaxel
782334|NCT00038402|Neosar|neosar
782335|NCT00038389|Brain Stem Tumor|brain stem tumor
782336|NCT00038376|T-cell lymphoma|t-cell lymphoma
782337|NCT00038376|accutane|accutane
782338|NCT00038376|isotretinoin|isotretinoin
782339|NCT00038376|mycosis fungoides|mycosis fungoides
782340|NCT00038376|T-cell malignancies|t-cell malignancies
782341|NCT00038363|Frail|frail
782342|NCT00038363|Disable|disable
782343|NCT00038363|Disabled Persons|disabled persons
782344|NCT00038363|Physically disabled|physically disabled
782345|NCT00038363|Elderly|elderly
782346|NCT00038363|Rehabilitation|rehabilitation
782347|NCT00038363|Subacute care|subacute care
782348|NCT00038350|Age|age
782349|NCT00038350|Dysphagia|dysphagia
782350|NCT00038350|Swallowing|swallowing
782351|NCT00038337|Health Literacy|health literacy
782352|NCT00038337|Visual|visual
782353|NCT00038337|Cognitive|cognitive
782354|NCT00038285|Amputation|amputation
782355|NCT00038285|Cardiovascular Disease|cardiovascular disease
782356|NCT00038285|PVD|pvd
782357|NCT00038272|Placebos|placebos
782358|NCT00038272|Drug Therapy, Combination|drug therapy, combination
782359|NCT00038272|Anti-HIV Agents|anti-hiv agents
782360|NCT00038272|Mycophenolate Mofetil|mycophenolate mofetil
782361|NCT00038272|2,6-diaminopurine dioxolane|2,6-diaminopurine dioxolane
782362|NCT00038272|Treatment Experienced|treatment experienced
782365|NCT00038259|Interleukin-2|interleukin-2
782366|NCT00038259|Drug Administration Schedule|drug administration schedule
782367|NCT00038259|CD4 Lymphocyte Count|cd4 lymphocyte count
782368|NCT00038259|Anti-HIV Agents|anti-hiv agents
782369|NCT00038259|Viral Load|viral load
782370|NCT00038259|Treatment Interruption|treatment interruption
782371|NCT00038259|Treatment Experienced|treatment experienced
782372|NCT00038259|STI|sti
782373|NCT00038246|Prostate Cancer|prostate cancer
782374|NCT00038233|myeloma|myeloma
782375|NCT00038220|HIV|hiv
782376|NCT00038207|soft tissue sarcoma|soft tissue sarcoma
782377|NCT00038207|Bone sarcomas|bone sarcomas
782378|NCT00038194|Prostate Cancer|prostate cancer
782379|NCT00038194|bone metastasis|bone metastasis
782380|NCT00038181|Prostate Cancer|prostate cancer
782381|NCT00038168|Prostate Cancer|prostate cancer
782382|NCT00038155|Ambulation|ambulation
782383|NCT00038155|Difficulties in ambulation|difficulties in ambulation
782384|NCT00038155|Geriatric|geriatric
782385|NCT00038155|Rehabilitation|rehabilitation
782386|NCT00038142|Ewing's Sarcoma|ewing's sarcoma
782387|NCT00038142|Vincristine|vincristine
782388|NCT00038142|Doxorubicin|doxorubicin
782389|NCT00038142|Adriamycin|adriamycin
782390|NCT00038142|Rubex|rubex
782391|NCT00038142|Cyclophosphamide|cyclophosphamide
782392|NCT00038142|Dexrazoxane|dexrazoxane
782393|NCT00038142|Zinecard|zinecard
782394|NCT00038142|VACdxr|vacdxr
782395|NCT00038142|ImmTher|immther
782396|NCT00038116|Parkinson's disease|parkinson's disease
782397|NCT00038116|PD|pd
782398|NCT00038116|dopamine|dopamine
782399|NCT00038116|embryonic dopamine cell implant surgery|embryonic dopamine cell implant surgery
782400|NCT00038116|tissue implants|tissue implants
782401|NCT00038090|Myeloma|myeloma
782402|NCT00038090|Thalidomide|thalidomide
782403|NCT00038090|Thalomid|thalomid
782404|NCT00038090|Dexamethasone|dexamethasone
782405|NCT00038090|Decadron|decadron
782406|NCT00038064|anemia of cancer/chemotherapy|anemia of cancer/chemotherapy
782407|NCT00038064|non-myeloid malignancies|non-myeloid malignancies
782408|NCT00038064|Drug Therapy|drug therapy
782409|NCT00038051|Acute Myeloid Leukemia|acute myeloid leukemia
782410|NCT00038051|AML|aml
782411|NCT00038051|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
782412|NCT00038051|CMML|cmml
782413|NCT00038051|Myeloproliferative Disorders|myeloproliferative disorders
782414|NCT00038051|Refractory Anemia with Excess of Blasts|refractory anemia with excess of blasts
782415|NCT00038051|RAEB-t|raeb-t
782416|NCT00038051|RAEB|raeb
782417|NCT00038051|Hum-195/rGel|hum-195/rgel
782418|NCT00038038|Squamous cell carcinoma of head and neck|squamous cell carcinoma of head and neck
782419|NCT00038025|Mycosis Fungoides|mycosis fungoides
782420|NCT00038025|Lymphoma|lymphoma
782421|NCT00038025|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
782422|NCT00038025|Deoxycoformycin|deoxycoformycin
782423|NCT00038025|Pentostatin|pentostatin
782424|NCT00038025|All other lymphomas|all other lymphomas
782425|NCT00038025|Nucleoside analogue|nucleoside analogue
782426|NCT00038025|Adenosine deaminase inhibitor|adenosine deaminase inhibitor
782427|NCT00038025|T-cells|t-cells
782428|NCT00038012|Dose-intensified carboplatin|dose-intensified carboplatin
782429|NCT00038012|autologous cryopreserved platelets|autologous cryopreserved platelets
782430|NCT00038012|thrombopoietin|thrombopoietin
782431|NCT00038012|Gynecologic malignancy|gynecologic malignancy
782432|NCT00037999|Muscle strength|muscle strength
782433|NCT00037999|Testosterone|testosterone
782434|NCT00037999|Rehabilitation|rehabilitation
782435|NCT00037999|Impaired muscle strength|impaired muscle strength
782436|NCT00037986|Audiology|audiology
782437|NCT00037986|Hearing|hearing
782438|NCT00037986|Hearing Aids|hearing aids
782439|NCT00037986|Quality of Life|quality of life
782440|NCT00037973|COPD|copd
782441|NCT00037973|Ventilation|ventilation
782442|NCT00037960|Constrained Induced|constrained induced
782443|NCT00037960|CI therapy|ci therapy
782444|NCT00037960|CVA|cva
782445|NCT00037960|Strokes|strokes
782446|NCT00037947|Multiple Sclerosis|multiple sclerosis
782447|NCT00037947|MS|ms
782448|NCT00037947|Hearing|hearing
782449|NCT00037934|Robot|robot
782450|NCT00037934|Stroke|stroke
782451|NCT00037934|Upper Extremity|upper extremity
782452|NCT00037921|SCI|sci
782453|NCT00037921|UTI|uti
782454|NCT00037908|Stroke|stroke
782455|NCT00037908|Hemiparesis|hemiparesis
782456|NCT00037908|Upper limb function|upper limb function
782457|NCT00037908|Strength training|strength training
782458|NCT00037895|Stroke|stroke
782459|NCT00037895|Ambulation Training|ambulation training
782460|NCT00037895|Rehabilitation|rehabilitation
782461|NCT00037895|Treadmill|treadmill
782462|NCT00037882|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
782463|NCT00037882|Interferon alpha|interferon alpha
782464|NCT00037882|Roferon|roferon
782465|NCT00037882|Intron|intron
782466|NCT00037882|Chronic Myelogenous Leukemia-Philadelphia positive|chronic myelogenous leukemia-philadelphia positive
782467|NCT00037869|Metastatic neuroendocrine tumors|metastatic neuroendocrine tumors
782468|NCT00037843|adrenal diseases|adrenal diseases
782469|NCT00037830|Parkinson's disease|parkinson's disease
782471|NCT00037830|GM1 Ganglioside|gm1 ganglioside
782472|NCT00037830|Sygen|sygen
782473|NCT00037817|Toxicity Evaluation|toxicity evaluation
782474|NCT00037817|Pharmacokinetics|pharmacokinetics
782475|NCT00037817|Apoptosis|apoptosis
782476|NCT00037817|Gene Induction|gene induction
782477|NCT00037817|Gene Expression|gene expression
782478|NCT00037817|Lung Cancer|lung cancer
782479|NCT00037817|Small Cell Lung Cancer|small cell lung cancer
782480|NCT00037817|Non-Small Cell Lung Cancer|non-small cell lung cancer
782481|NCT00037817|Pleural Mesothelioma|pleural mesothelioma
782482|NCT00037804|Pharmacia|pharmacia
782483|NCT00004575|Endothelium|endothelium
782484|NCT00004575|Vasodilation|vasodilation
782485|NCT00004575|Vascular Biology|vascular biology
782486|NCT00004575|Venous Occlusion Plethysmography|venous occlusion plethysmography
782487|NCT00001908|Allergy|allergy
782488|NCT00001908|Interleukin|interleukin
782489|NCT00001908|Immunomodulator|immunomodulator
782490|NCT00001908|Th2|th2
782491|NCT00001908|Inflammation|inflammation
782492|NCT00001908|Asthma|asthma
782493|NCT00001866|Eye Movements|eye movements
782494|NCT00001866|Eye Oscillations|eye oscillations
782495|NCT00001866|Extraocular Muscles|extraocular muscles
782496|NCT00001866|Eye Development|eye development
782497|NCT00001866|Pediatric Ophthalmology|pediatric ophthalmology
782498|NCT00001866|Congenital Nystagmus|congenital nystagmus
782499|NCT00001864|Lazy Eye|lazy eye
782500|NCT00001864|Atropine Penalization|atropine penalization
782501|NCT00001864|Patching|patching
782502|NCT00001864|Vision Loss|vision loss
782503|NCT00001864|Amblyopia|amblyopia
782504|NCT00001818|Antiretrovirals|antiretrovirals
782505|NCT00001818|Resistant Virus|resistant virus
782506|NCT00001818|T-cell activation|t-cell activation
782507|NCT00001818|Immune Suppression|immune suppression
782508|NCT00001818|Cytotoxic Agent|cytotoxic agent
782509|NCT00001688|CD4 Cells|cd4 cells
782510|NCT00001688|Cytokines|cytokines
782511|NCT00001688|Anti-Retroviral Activity|anti-retroviral activity
782512|NCT00001688|V Beta Repertoire|v beta repertoire
782513|NCT00001688|CD-4-Naive T Cells|cd-4-naive t cells
782514|NCT00001688|CD-4-Memory T Cells|cd-4-memory t cells
782515|NCT00001542|Candidiasis|candidiasis
782516|NCT00001542|Azole|azole
782517|NCT00001542|Resistance|resistance
782518|NCT00001542|Candida Albicans|candida albicans
782519|NCT00001542|Oropharynx|oropharynx
782520|NCT00001190|Growth|growth
782521|NCT00001190|Adolescence|adolescence
782522|NCT00001190|Children|children
782523|NCT00037713|LD Small Cell Lung Cancer|ld small cell lung cancer
782524|NCT00037713|BEC2, vaccine|bec2, vaccine
782525|NCT00037713|adjuvant, monoclonal antibody|adjuvant, monoclonal antibody
782526|NCT00037713|LD Small Cell Lung Cancer (VA Classification, Zelen, 1973)|ld small cell lung cancer (va classification, zelen, 1973)
782527|NCT00037687|Severe sepsis|severe sepsis
782528|NCT00037687|Platelet-activating factor acetylhydrolase|platelet-activating factor acetylhydrolase
782529|NCT00037674|Bipolar Disorder|bipolar disorder
782530|NCT00037674|Bipolar|bipolar
782531|NCT00037674|Mania|mania
782532|NCT00037674|Topiramate|topiramate
782533|NCT00037674|Lithium|lithium
782534|NCT00037661|dry eye|dry eye
782535|NCT00037622|E-antigen positive, treatment naïve chronic HBV infected, lamivudine resistant chronic Hepatitis B, Achillion|e-antigen positive, treatment naïve chronic hbv infected, lamivudine resistant chronic hepatitis b, achillion
782536|NCT00037609|Metastatic breast cancer|metastatic breast cancer
782537|NCT00037583|Acute|acute
782538|NCT00037583|Myeloid|myeloid
782539|NCT00037583|Leukemia|leukemia
782540|NCT00037570|Peptic|peptic
782541|NCT00037570|Ulcer|ulcer
782542|NCT00037570|Hemorrhage|hemorrhage
782543|NCT00037557|Hemophilia B|hemophilia b
782544|NCT00037544|Severe|severe
782545|NCT00037544|Hemophilia|hemophilia
782546|NCT00037544|A|a
782547|NCT00037531|Transplant|transplant
782548|NCT00037531|Kidney|kidney
782549|NCT00037518|Severe primary hyperparathyroidism|severe primary hyperparathyroidism
782550|NCT00037518|Parathyroid carcinoma|parathyroid carcinoma
782551|NCT00037492|stroke|stroke
782552|NCT00037492|recovery|recovery
782553|NCT00037479|neurologic Lyme disease|neurologic lyme disease
782554|NCT00037479|Lyme disease|lyme disease
782555|NCT00037479|ceftriaxone|ceftriaxone
782556|NCT00037479|Rocephin|rocephin
782557|NCT00037479|PET scans|pet scans
782558|NCT00037479|Lyme encephalopathy|lyme encephalopathy
782559|NCT00037479|neuroborreliosis|neuroborreliosis
782560|NCT00037479|borreliosis|borreliosis
782561|NCT00037219|Anidulafungin|anidulafungin
782562|NCT00037219|Candidemia|candidemia
782563|NCT00037219|Invasive Candidiasis|invasive candidiasis
782564|NCT00037206|Invasive Aspergillosis|invasive aspergillosis
782565|NCT00037167|Fall-Prevention|fall-prevention
782566|NCT00037167|Balance|balance
782567|NCT00037167|Musculoskeletal Systems|musculoskeletal systems
782568|NCT00037167|Protective Devices|protective devices
782569|NCT00037167|Gait|gait
782570|NCT00037167|Equilibrium|equilibrium
782571|NCT00037167|Accidental Falls|accidental falls
782572|NCT00037167|Frail Elderly|frail elderly
782573|NCT00037154|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
782574|NCT00037154|Herbal Therapies|herbal therapies
782575|NCT00037154|Complementary and Alternative Medicine|complementary and alternative medicine
782576|NCT00037154|Men's Health|men's health
782577|NCT00037141|Prostate|prostate
782578|NCT00037141|BPH|bph
782579|NCT00037141|Prostatitis|prostatitis
782580|NCT00037128|Lupus|lupus
782581|NCT00037128|SLE|sle
782582|NCT00037128|DHEA|dhea
782583|NCT00037128|GL701|gl701
782584|NCT00037115|Demyelinating|demyelinating
782585|NCT00037115|Multiple Sclerosis|multiple sclerosis
782586|NCT00037115|Myelitis|myelitis
782587|NCT00037115|Neuritis|neuritis
782588|NCT00037115|Optic Neuritis|optic neuritis
782589|NCT00037115|AVONEX|avonex
782590|NCT00037115|methotrexate|methotrexate
782591|NCT00037115|methylprednisolone|methylprednisolone
782592|NCT00037115|interferon beta 1a|interferon beta 1a
782593|NCT00037115|demyelination|demyelination
782594|NCT00037115|central nervous system|central nervous system
782595|NCT00037115|brain|brain
782596|NCT00037115|nerve|nerve
782597|NCT00037115|lesions|lesions
782598|NCT00037115|enhancement|enhancement
782599|NCT00037115|enhancing|enhancing
782600|NCT00037102|Multiple Sclerosis|multiple sclerosis
782601|NCT00037102|Relapsing|relapsing
782602|NCT00037102|Methotrexate|methotrexate
782603|NCT00037102|AVONEX|avonex
782604|NCT00037102|interferon beta 1a|interferon beta 1a
782605|NCT00037102|demyelinating|demyelinating
782606|NCT00037102|autoimmune|autoimmune
782607|NCT00037076|HIV Seropositivity|hiv seropositivity
782608|NCT00037076|Hepatitis C|hepatitis c
782609|NCT00037076|Polymerase Chain Reaction|polymerase chain reaction
782610|NCT00037076|RNA, Viral|rna, viral
782611|NCT00037076|Prevalence|prevalence
782612|NCT00037076|Disease Transmission, Vertical|disease transmission, vertical
782613|NCT00037076|Hepacivirus|hepacivirus
782614|NCT00037076|Enzyme Immunoassay|enzyme immunoassay
782615|NCT00037076|GB virus C|gb virus c
782616|NCT00037063|Pilot Projects|pilot projects
782617|NCT00037063|Recurrence|recurrence
782618|NCT00037063|Antioxidants|antioxidants
782619|NCT00037063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
782620|NCT00037063|Anti-HIV Agents|anti-hiv agents
782621|NCT00037063|Ascorbic Acid|ascorbic acid
782622|NCT00037063|Alpha-Tocopherol|alpha-tocopherol
782623|NCT00037063|Riboflavin|riboflavin
782624|NCT00037063|Thiamine|thiamine
782625|NCT00037063|Lactic Acid|lactic acid
782626|NCT00036647|Non-Small Cell Lung Cancer|non-small cell lung cancer
782627|NCT00036647|Tarceva|tarceva
782628|NCT00036647|EGFR|egfr
782629|NCT00036647|erlotinib|erlotinib
782630|NCT00036634|treatment naive|treatment naive
782631|NCT00036595|Subdural|subdural
782632|NCT00036595|Epilepsy|epilepsy
782633|NCT00036595|Motor Function|motor function
782634|NCT00036595|Desynchronization|desynchronization
782635|NCT00036595|Coherence|coherence
782636|NCT00036595|Motor Control|motor control
782637|NCT00036582|Psychophysiology|psychophysiology
782638|NCT00036582|Structural MRI|structural mri
782639|NCT00036582|Genetics|genetics
782640|NCT00036582|Bipolar Disorder|bipolar disorder
782641|NCT00036582|Children and Adolescents|children and adolescents
782642|NCT00036582|Clozapine|clozapine
782643|NCT00036582|Placebo|placebo
782644|NCT00036582|Treatment-Refractory|treatment-refractory
782645|NCT00036582|Bipolar|bipolar
782646|NCT00036582|Healthy Volunteer|healthy volunteer
782647|NCT00036582|HV|hv
782648|NCT00036582|BPD|bpd
782649|NCT00036582|Normal Control|normal control
782650|NCT00036569|Brainstem Glioma|brainstem glioma
782651|NCT00036569|Pediatric|pediatric
782652|NCT00036569|Interferon|interferon
782653|NCT00036569|MR Imaging|mr imaging
782654|NCT00036569|Angiogenesis|angiogenesis
782655|NCT00036569|Brain Tumor|brain tumor
782656|NCT00036569|Glioma|glioma
782657|NCT00036569|Pediatric Brain Tumor|pediatric brain tumor
782658|NCT00036556|Hormone-Refractory Prostate Cancer|hormone-refractory prostate cancer
782659|NCT00036543|Hormone-Refractory, Prostate Cancer|hormone-refractory, prostate cancer
782660|NCT00036517|Stage III and Stage IV colorectal cancer|stage iii and stage iv colorectal cancer
782661|NCT00036517|diarrhea|diarrhea
782662|NCT00036517|reduce|reduce
782663|NCT00036517|alleviate|alleviate
782664|NCT00036517|modulate|modulate
782665|NCT00036517|Saltz regimen|saltz regimen
782666|NCT00036517|CPT-11|cpt-11
782667|NCT00036517|irinotecan|irinotecan
782668|NCT00036517|camptosar|camptosar
782669|NCT00036517|5-fluorouracil|5-fluorouracil
782670|NCT00036517|leucovorin|leucovorin
782671|NCT00036517|5-FU|5-fu
782672|NCT00036517|LV|lv
782673|NCT00036517|chemotherapy|chemotherapy
782674|NCT00036517|side effect|side effect
782675|NCT00036517|toxicity|toxicity
782676|NCT00036517|botanical drug|botanical drug
782677|NCT00036517|herbal medicine|herbal medicine
782678|NCT00036517|chinese herbal medicine|chinese herbal medicine
782679|NCT00036517|traditional chinese medicine|traditional chinese medicine
782680|NCT00036517|TCM|tcm
782681|NCT00036517|oral dose|oral dose
782682|NCT00036517|oral administration|oral administration
782683|NCT00036517|concomitant use|concomitant use
782684|NCT00036504|Diabetes mellitus, insulin deficiency, hyperglycemia|diabetes mellitus, insulin deficiency, hyperglycemia
782685|NCT00036491|Systemic Lupus Erythematosus|systemic lupus erythematosus
782686|NCT00036491|SLE|sle
782687|NCT00036491|B-Lymphocytes|b-lymphocytes
782688|NCT00036491|anti-CD20|anti-cd20
782689|NCT00036491|rituximab|rituximab
782690|NCT00036478|Pilot Projects|pilot projects
782691|NCT00036478|Exercise|exercise
782692|NCT00036478|Phosphorus Isotopes|phosphorus isotopes
782693|NCT00036478|Mitochondria|mitochondria
782694|NCT00036478|Lactates|lactates
782695|NCT00036478|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
782696|NCT00036465|Pilot Projects|pilot projects
782697|NCT00036465|HIV-1|hiv-1
782698|NCT00036465|RNA, Viral|rna, viral
782699|NCT00036465|Genotype|genotype
782700|NCT00036465|Viral Load|viral load
782701|NCT00036465|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
782702|NCT00036465|Treatment Experienced|treatment experienced
782703|NCT00036452|Lopinavir|lopinavir
782704|NCT00036452|HIV-1|hiv-1
782705|NCT00036452|Drug Administration Schedule|drug administration schedule
782706|NCT00036452|Stavudine|stavudine
782707|NCT00036452|HIV Protease Inhibitors|hiv protease inhibitors
782708|NCT00036452|Ritonavir|ritonavir
782709|NCT00036452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
782710|NCT00036452|Self Care|self care
782711|NCT00036452|Viral Load|viral load
782712|NCT00036452|Emtricitabine|emtricitabine
782713|NCT00036452|Directly Observed Therapy|directly observed therapy
782714|NCT00036452|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
782715|NCT00036452|Treatment Naive|treatment naive
782716|NCT00036439|ulcerative colitis|ulcerative colitis
782717|NCT00036439|infliximab|infliximab
782718|NCT00036439|Remicade|remicade
782719|NCT00036439|infusion|infusion
782720|NCT00036426|lymphoma|lymphoma
782721|NCT00036426|vaccine|vaccine
782722|NCT00036426|idiotype|idiotype
782723|NCT00036426|KLH|klh
782724|NCT00036426|GM-CSF|gm-csf
782725|NCT00036413|(ALS)|(als)
782726|NCT00036400|Anemia|anemia
782727|NCT00036400|Gastric Cancer|gastric cancer
782728|NCT00036400|Rectal Cancer|rectal cancer
782729|NCT00036400|Epoetin Alfa|epoetin alfa
782730|NCT00036387|Rheumatoid arthritis|rheumatoid arthritis
782731|NCT00036387|infliximab|infliximab
782732|NCT00036387|anti-TNF|anti-tnf
782733|NCT00036387|methotrexate|methotrexate
782734|NCT00036387|safety and efficacy|safety and efficacy
782735|NCT00036387|Remicade|remicade
782736|NCT00036374|Juvenile rheumatoid arthritis|juvenile rheumatoid arthritis
782737|NCT00036374|Infliximab|infliximab
782738|NCT00036374|Methotrexate|methotrexate
782739|NCT00036374|remicade|remicade
782740|NCT00036348|Bipolar I disorder|bipolar i disorder
782741|NCT00036335|depression|depression
782742|NCT00036335|pain|pain
782743|NCT00036335|blues|blues
782744|NCT00036335|sadness|sadness
782745|NCT00036335|aches|aches
782746|NCT00036309|Major Depressive Disorder|major depressive disorder
782747|NCT00036309|Diagnostic and Statistical Manual of Mental Disorders Fourth Edition-defined major depressive disorder without psychotic features|diagnostic and statistical manual of mental disorders fourth edition-defined major depressive disorder without psychotic features
782748|NCT00036296|Involuntary Movements|involuntary movements
782749|NCT00036296|Abnormal Movements|abnormal movements
782750|NCT00036296|Advanced Parkinson's disease|advanced parkinson's disease
782751|NCT00036296|Levodopa induced dyskinesia|levodopa induced dyskinesia
782752|NCT00036257|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
782753|NCT00036257|Leukemia|leukemia
782754|NCT00036257|CLL|cll
782755|NCT00036179|Candidemia|candidemia
782756|NCT00036179|Anti-Fungal|anti-fungal
782757|NCT00036166|Aspergillus|aspergillus
782758|NCT00036166|Anti-Fungal|anti-fungal
782759|NCT00036153|Tacrolimus, Prograf®, FK506|tacrolimus, prograf®, fk506
782760|NCT00036140|Pharmacia|pharmacia
782761|NCT00036127|agitated schizophrenic patients|agitated schizophrenic patients
782762|NCT00036114|Psychosis associated with dementia of the Alzheimer's type|psychosis associated with dementia of the alzheimer's type
782763|NCT00036101|Bipolar I Disorder|bipolar i disorder
782764|NCT00036075|prostate cancer|prostate cancer
782765|NCT00036075|prostate|prostate
782766|NCT00036062|Sivelestat|sivelestat
782767|NCT00036062|acute lung injury|acute lung injury
782768|NCT00036036|renal|renal
782769|NCT00036036|renal cell cancer|renal cell cancer
782770|NCT00036036|renal cell carcinoma|renal cell carcinoma
782771|NCT00036036|kidney cancer|kidney cancer
782772|NCT00035997|Hormone-sensitive Prostate Cancer|hormone-sensitive prostate cancer
782773|NCT00035997|Prostate Cancer|prostate cancer
782774|NCT00035997|Bone Metastasis|bone metastasis
782775|NCT00035984|Type 2 Diabetes Mellitis|type 2 diabetes mellitis
782776|NCT00035958|Juvenile Dermatomyositis|juvenile dermatomyositis
782777|NCT00035958|Pediatric|pediatric
782778|NCT00035958|Randomized Clinical Trial|randomized clinical trial
782779|NCT00035958|Pediatric Rheumatology|pediatric rheumatology
782780|NCT00035919|Colon cancer|colon cancer
791716|NCT00000677|Sch 39304|sch 39304
782781|NCT00035919|Targeted Injectable Vector|targeted injectable vector
782782|NCT00035919|Gene Transfer|gene transfer
782783|NCT00035919|Gene Therapy|gene therapy
782784|NCT00035919|Retroviral vector|retroviral vector
782785|NCT00035906|Diabetes|diabetes
782786|NCT00035906|Macular Edema|macular edema
782787|NCT00035906|Diabetic Macular Edema|diabetic macular edema
782788|NCT00035906|Diabetic Retinopathy|diabetic retinopathy
782789|NCT00035906|Cystoid Macular Edema|cystoid macular edema
782790|NCT00035906|Uveitis|uveitis
782791|NCT00035906|Vision|vision
782792|NCT00035906|Eye|eye
782793|NCT00035906|Retina|retina
782794|NCT00035906|Retinal Vein Occlusion|retinal vein occlusion
782795|NCT00035906|Irvine-Gass Syndrome|irvine-gass syndrome
782796|NCT00035893|treatment interruption|treatment interruption
782797|NCT00035893|HIV Infections|hiv infections
782798|NCT00035880|Acute graft versus host disease|acute graft versus host disease
782799|NCT00035880|Stem Cell Transplantation|stem cell transplantation
782800|NCT00035854|Pharmacia|pharmacia
782801|NCT00035854|Drug Resistance, Microbial|drug resistance, microbial
782802|NCT00035828|COPD|copd
782803|NCT00035828|Chronic bronchitis|chronic bronchitis
782804|NCT00035828|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
782805|NCT00035828|Shortness of breath|shortness of breath
782806|NCT00035828|Dyspnea|dyspnea
782807|NCT00035828|Bronchitis|bronchitis
782808|NCT00035815|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
782809|NCT00035815|ALS|als
782810|NCT00035815|progressive weakness|progressive weakness
782811|NCT00035815|insulin-like growth factor-1|insulin-like growth factor-1
782812|NCT00035815|IGF-I|igf-i
782813|NCT00035815|Myotrophin|myotrophin
782814|NCT00035802|Bipolar|bipolar
782815|NCT00035802|Mania|mania
782816|NCT00035802|Pediatric|pediatric
782817|NCT00035802|Children|children
782818|NCT00035802|Adolescent|adolescent
782819|NCT00035802|Topiramate|topiramate
782820|NCT00035802|Anticonvulsants|anticonvulsants
782821|NCT00035802|Central Nervous System Agents|central nervous system agents
782822|NCT00035802|Protective Agents|protective agents
782823|NCT00035802|Neuroprotectiive Agents|neuroprotectiive agents
782824|NCT00035620|Bone cancer|bone cancer
782825|NCT00035620|Sarcoma|sarcoma
782826|NCT00035620|Neutropenia|neutropenia
782827|NCT00035620|Chemotherapy|chemotherapy
782828|NCT00035594|Breast cancer|breast cancer
782829|NCT00035594|Neutropenia|neutropenia
782830|NCT00035594|Chemotherapy|chemotherapy
782831|NCT00035581|treatment experienced|treatment experienced
782832|NCT00035581|HIV Infections|hiv infections
782833|NCT00035581|HIV|hiv
782834|NCT00035581|HAART|haart
782835|NCT00035581|early virologic failure|early virologic failure
782836|NCT00035568|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
782837|NCT00035555|kidney|kidney
782838|NCT00035555|transplant|transplant
782839|NCT00035555|rejection|rejection
782840|NCT00035542|Diabetes Mellitus, Type II|diabetes mellitus, type ii
782841|NCT00035529|MS|ms
782842|NCT00035438|obsessive compulsive disorder|obsessive compulsive disorder
782843|NCT00035438|ocd|ocd
782844|NCT00035438|Anxiety|anxiety
782845|NCT00035438|St. John’s Wort|st. john’s wort
782846|NCT00035438|Wisconsin|wisconsin
782847|NCT00035438|Psychiatric|psychiatric
782848|NCT00035438|Mental health|mental health
782849|NCT00035412|Social phobia|social phobia
782850|NCT00035412|Social anxiety|social anxiety
782851|NCT00035412|Anxiety|anxiety
782852|NCT00035412|St. John’ Wort|st. john’ wort
782853|NCT00035412|Wisconsin|wisconsin
782854|NCT00035412|Psychiatric|psychiatric
782855|NCT00035412|Mental health|mental health
782856|NCT00035399|acupressure /acupuncture|acupressure /acupuncture
782857|NCT00035399|alternative medicine|alternative medicine
782858|NCT00035399|arthritis therapy|arthritis therapy
782859|NCT00035399|combination therapy|combination therapy
782860|NCT00035399|human therapy evaluation|human therapy evaluation
782861|NCT00035399|knee|knee
782862|NCT00035399|osteoarthritis|osteoarthritis
782863|NCT00035399|physical therapy|physical therapy
782864|NCT00035399|chronic pain|chronic pain
782865|NCT00035399|clinical trial|clinical trial
782866|NCT00035399|functional ability|functional ability
782867|NCT00035360|PEG-Intron|peg-intron
782868|NCT00035360|treatment experienced|treatment experienced
782869|NCT00035386|Outflow Obstruction|outflow obstruction
782870|NCT00035386|ICE|ice
782871|NCT00035386|HCM|hcm
782872|NCT00035386|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
782873|NCT00035386|OHC|ohc
782874|NCT00035386|Obstructive HCM|obstructive hcm
782875|NCT00035386|Cardiomyopathy|cardiomyopathy
782876|NCT00035373|Tumor|tumor
782877|NCT00035373|Brain|brain
782878|NCT00035373|Chemotherapy|chemotherapy
782879|NCT00035373|Anti-Angiogenesis|anti-angiogenesis
782880|NCT00035373|Radiation Therapy|radiation therapy
782881|NCT00035373|CNS Tumor|cns tumor
782882|NCT00035334|Familial Mediterranean Fever|familial mediterranean fever
782883|NCT00035334|Amyloidosis|amyloidosis
782884|NCT00035334|Secondary (AA) Amyloidosis|secondary (aa) amyloidosis
782885|NCT00035334|Nephrotic Syndrome|nephrotic syndrome
782886|NCT00035308|Immunologic Diseases|immunologic diseases
782887|NCT00035308|Autoimmune Diseases|autoimmune diseases
782888|NCT00035308|Systemic Lupus Erythematosus|systemic lupus erythematosus
782890|NCT00035308|Lupus Nephritis|lupus nephritis
782891|NCT00035308|Lupus Glomerulonephritis|lupus glomerulonephritis
782892|NCT00035269|Pharmacia|pharmacia
782893|NCT00035243|kidney cancer|kidney cancer
782894|NCT00035243|renal cancer|renal cancer
782895|NCT00035243|cancer|cancer
782896|NCT00035243|tumor|tumor
782897|NCT00035243|tumour|tumour
782898|NCT00035243|neoplasm|neoplasm
782899|NCT00035243|carcinoma|carcinoma
782900|NCT00035243|clear cell|clear cell
782901|NCT00035243|sarcomatoid|sarcomatoid
782902|NCT00035243|papillary|papillary
782903|NCT00035243|medullary|medullary
782904|NCT00035243|collecting duct|collecting duct
782905|NCT00035243|chromophobe|chromophobe
782906|NCT00035243|intravenous|intravenous
782907|NCT00035243|epothilone|epothilone
782908|NCT00035230|Bipolar disorders|bipolar disorders
782909|NCT00035230|Bipolar|bipolar
782910|NCT00035230|mania|mania
782911|NCT00035230|Topiramate|topiramate
782912|NCT00035230|Lithium|lithium
782913|NCT00035204|Donepezil|donepezil
782914|NCT00035204|Alzheimer's|alzheimer's
782915|NCT00035204|Dementia|dementia
782916|NCT00035204|Cognitive impairment|cognitive impairment
782917|NCT00035204|Aricept|aricept
782918|NCT00035204|Alzheimer's disease|alzheimer's disease
782919|NCT00035204|Razadyne|razadyne
782920|NCT00035204|Galantamine|galantamine
782921|NCT00035191|Dementia|dementia
782922|NCT00035191|vascular dementia|vascular dementia
782923|NCT00035191|cerebral vascular disease|cerebral vascular disease
782924|NCT00035178|ESRD|esrd
782925|NCT00035178|End-stage renal disease|end-stage renal disease
782926|NCT00035178|Hemodialysis|hemodialysis
782927|NCT00035165|melanoma|melanoma
782928|NCT00035165|cancer|cancer
782929|NCT00035165|tumor|tumor
782930|NCT00035165|tumour|tumour
782931|NCT00035165|malignant|malignant
782932|NCT00035165|metastatic|metastatic
782933|NCT00035165|intravenous|intravenous
782934|NCT00035165|epothilone|epothilone
782935|NCT00035139|pediatric traumatic brain injury|pediatric traumatic brain injury
782936|NCT00035126|breast|breast
782937|NCT00035126|cancer|cancer
782938|NCT00035126|tumor|tumor
782939|NCT00035126|tumour|tumour
782940|NCT00035126|intravenous|intravenous
782941|NCT00035126|epothilone|epothilone
782942|NCT00035126|taxane|taxane
782943|NCT00035126|anthracycline|anthracycline
782944|NCT00035113|prostate cancer|prostate cancer
782945|NCT00035113|prostate|prostate
782946|NCT00035113|androgen independent|androgen independent
782947|NCT00035113|cancer|cancer
782948|NCT00035113|tumor|tumor
782949|NCT00035113|tumour|tumour
782950|NCT00035113|neoplasm|neoplasm
782951|NCT00035113|carcinoma|carcinoma
782952|NCT00035113|intravenous|intravenous
782953|NCT00035113|epothilone|epothilone
782954|NCT00035100|ovarian|ovarian
782955|NCT00035100|ovary|ovary
782956|NCT00035100|peritoneal cancer|peritoneal cancer
782957|NCT00035100|fallopian cancer|fallopian cancer
782958|NCT00035100|cancer|cancer
782959|NCT00035100|tumor|tumor
782960|NCT00035100|tumour|tumour
782961|NCT00035100|neoplasm|neoplasm
782962|NCT00035100|carcinoma|carcinoma
782963|NCT00035100|intravenous|intravenous
782964|NCT00035100|epothilone|epothilone
782965|NCT00035087|colon|colon
782966|NCT00035087|rectum|rectum
782967|NCT00035087|colorectal|colorectal
782968|NCT00035087|rectal|rectal
782969|NCT00035087|cancer|cancer
782970|NCT00035087|tumor|tumor
782971|NCT00035087|tumour|tumour
782972|NCT00035087|neoplasm|neoplasm
782973|NCT00035087|carcinoma|carcinoma
782974|NCT00035087|intravenous|intravenous
782975|NCT00035087|epothilone|epothilone
782976|NCT00035061|Bladder Cancer|bladder cancer
782977|NCT00035061|Metastatic|metastatic
782978|NCT00035061|Recurrent|recurrent
782979|NCT00035061|Transitional cell carcinoma of the urothelium|transitional cell carcinoma of the urothelium
782980|NCT00035035|Pancreas|pancreas
782981|NCT00035035|Cancer|cancer
782982|NCT00035035|Unresectable or Metastatic Cancer of the Pancreas|unresectable or metastatic cancer of the pancreas
782983|NCT00035035|Alimta|alimta
782984|NCT00035022|Leukemia, Lymphoma, T-Cell|leukemia, lymphoma, t-cell
782985|NCT00034970|alternative medicine|alternative medicine
782986|NCT00034970|art|art
782987|NCT00034970|cancer|cancer
782988|NCT00034970|combination cancer therapy|combination cancer therapy
782989|NCT00034970|creative-expression|creative-expression
782990|NCT00034970|group therapy|group therapy
782991|NCT00034970|holistic|holistic
782992|NCT00034970|human therapy evaluation|human therapy evaluation
782993|NCT00034970|meditation|meditation
782994|NCT00034970|neoplasm /cancer chemotherapy|neoplasm /cancer chemotherapy
782995|NCT00034970|coping|coping
782996|NCT00034970|gender difference|gender difference
782997|NCT00034970|outcomes research|outcomes research
782998|NCT00034970|psychological aspect of cancer|psychological aspect of cancer
782999|NCT00034970|psychological stressor|psychological stressor
783000|NCT00034970|quality of life|quality of life
783001|NCT00034970|racial /ethnic difference|racial /ethnic difference
783002|NCT00034970|stress management|stress management
783003|NCT00034970|support|support
783004|NCT00034970|behavioral /social science research|behavioral /social science research
783005|NCT00034970|patient oriented research|patient oriented research
783006|NCT00034957|Pharmacia|pharmacia
783007|NCT00034918|Metastatic breast cancer|metastatic breast cancer
783008|NCT00034879|Locally advanced and/or metastatic non-operable|locally advanced and/or metastatic non-operable
783009|NCT00034879|non-small cell lung cancer (stage III or IV)|non-small cell lung cancer (stage iii or iv)
783010|NCT00034879|patients who have failed standard therapy.|patients who have failed standard therapy.
783011|NCT00034866|HIV|hiv
783012|NCT00034866|treatment experienced|treatment experienced
783013|NCT00034866|Boehringer|boehringer
783014|NCT00034866|tipranavir|tipranavir
783015|NCT00034866|ritonavir|ritonavir
783016|NCT00034840|hypertension|hypertension
783017|NCT00034840|telmisartan|telmisartan
783018|NCT00034840|valsartan|valsartan
783019|NCT00034840|boehringer|boehringer
783020|NCT00034801|Depression|depression
783021|NCT00034801|Comorbid Depression|comorbid depression
783022|NCT00034801|Schizophrenia|schizophrenia
783023|NCT00034801|Schizoaffective Disorder|schizoaffective disorder
783024|NCT00034788|Regranex|regranex
783025|NCT00034788|Foot ulcers|foot ulcers
783026|NCT00034788|Diabetes|diabetes
783027|NCT00034788|Diabetes mellitus|diabetes mellitus
783028|NCT00034788|Diabetic foot|diabetic foot
783029|NCT00034775|Schizophrenia|schizophrenia
783030|NCT00034775|intramuscular injection|intramuscular injection
783031|NCT00034775|antipsychotic agents|antipsychotic agents
783032|NCT00034775|risperidone|risperidone
783033|NCT00034762|Alzheimer's disease|alzheimer's disease
783034|NCT00034762|psychosis|psychosis
783035|NCT00034762|elderly|elderly
783036|NCT00034762|dementia|dementia
783037|NCT00034762|risperidone|risperidone
783038|NCT00034762|antipsychotic agents|antipsychotic agents
783039|NCT00034749|Adolescents|adolescents
783040|NCT00034749|Schizophrenia|schizophrenia
783041|NCT00034749|risperidone|risperidone
783042|NCT00034736|Pneumonia|pneumonia
783043|NCT00034736|Bacterial pneumonia|bacterial pneumonia
783044|NCT00034736|Community acquired pneumonia|community acquired pneumonia
783045|NCT00034736|Lung Inflammation|lung inflammation
783046|NCT00034736|Quinolones|quinolones
783047|NCT00034736|Levofloxacin|levofloxacin
783048|NCT00034736|Ceftriaxone|ceftriaxone
783049|NCT00034736|Erythromycin|erythromycin
783050|NCT00034736|Clarithromycin|clarithromycin
783051|NCT00034723|DTI|dti
783052|NCT00034723|MRSI|mrsi
783053|NCT00034723|MTR|mtr
783054|NCT00034723|NAWN|nawn
783055|NCT00034723|Fiber-Tract|fiber-tract
783056|NCT00034723|Normal Control|normal control
783057|NCT00034723|Healthy Volunteer|healthy volunteer
783058|NCT00034723|HV|hv
783059|NCT00034723|HTLV-1 Associated Myelopathy|htlv-1 associated myelopathy
783060|NCT00034723|Tropical Spastic Paraparesis|tropical spastic paraparesis
783061|NCT00034723|HAM/TSP|ham/tsp
783062|NCT00034710|Analgesics/*therapeutic use|analgesics/*therapeutic use
783063|NCT00034710|Capsaicin/*administration & dosage/adverse effects|capsaicin/*administration & dosage/adverse effects
783064|NCT00034710|Herpes Zoster/*complications/drug therapy|herpes zoster/*complications/drug therapy
783065|NCT00034710|Neuralgia/*drug therapy/etiology|neuralgia/*drug therapy/etiology
783066|NCT00034710|Pain|pain
783067|NCT00034710|Capsicum|capsicum
783068|NCT00034710|Pepper|pepper
783069|NCT00034710|Dermal assessment|dermal assessment
783070|NCT00034710|Pain measurement|pain measurement
783071|NCT00034710|Diary|diary
783072|NCT00034710|PHN|phn
783073|NCT00034710|Postherpetic Neuralgia|postherpetic neuralgia
783074|NCT00034710|allodynia|allodynia
783075|NCT00034710|hyperalgesia|hyperalgesia
783076|NCT00034710|shingles|shingles
783077|NCT00034710|varicella|varicella
783078|NCT00034697|Brain mets|brain mets
783079|NCT00034697|non-small cell lung cancer|non-small cell lung cancer
783080|NCT00034684|Leukemia|leukemia
783081|NCT00034684|Myelodysplastic Syndromes|myelodysplastic syndromes
783082|NCT00034684|Leukemia, Myeloid|leukemia, myeloid
783083|NCT00034684|Leukemia, Lymphocytic|leukemia, lymphocytic
783084|NCT00034671|Aspergillosis, Candidiasis, Mucormycosis, Cryptococcosis|aspergillosis, candidiasis, mucormycosis, cryptococcosis
783085|NCT00034671|Invasive Fungal Infections|invasive fungal infections
783086|NCT00034658|Aspergillosis, Candidiasis, Cryptococcosis,|aspergillosis, candidiasis, cryptococcosis,
783087|NCT00034645|Allogenic Stem cell transplantation|allogenic stem cell transplantation
783088|NCT00034645|Fungal infections|fungal infections
783089|NCT00034632|Aspergillosis, Candidiasis, Cryptococcosis, Phaeohyphomycosis|aspergillosis, candidiasis, cryptococcosis, phaeohyphomycosis
783090|NCT00034632|Invasive Fungal Infections|invasive fungal infections
783091|NCT00034606|Lung cancer|lung cancer
783092|NCT00034606|cancer|cancer
783093|NCT00034606|neoplasm|neoplasm
783094|NCT00034606|non-small|non-small
783095|NCT00034606|chemotherapy|chemotherapy
783096|NCT00034593|Bladder cancer|bladder cancer
783098|NCT00034593|transitional cell carcinoma of the urothelium|transitional cell carcinoma of the urothelium
783099|NCT00034580|Bipolar I Disorder|bipolar i disorder
783100|NCT00034567|Prevention|prevention
783101|NCT00034554|AJCC stage III or stage IV malignant melanoma|ajcc stage iii or stage iv malignant melanoma
783102|NCT00034554|melanoma|melanoma
783103|NCT00034554|gp75|gp75
783104|NCT00034554|DNA vaccine|dna vaccine
783105|NCT00034541|cetuximab|cetuximab
783106|NCT00034541|epidermal growth factor receptor|epidermal growth factor receptor
783107|NCT00034541|antibody|antibody
783108|NCT00034541|non-small cell lung cancer|non-small cell lung cancer
783109|NCT00034541|carboplatin|carboplatin
783110|NCT00034541|paclitaxel|paclitaxel
783111|NCT00034489|metastatic breast cancer|metastatic breast cancer
783112|NCT00034489|combination therapy|combination therapy
783113|NCT00034489|Alimta|alimta
783114|NCT00034476|Sepsis, sPLA2 Inhibitor|sepsis, spla2 inhibitor
783115|NCT00034463|metastatic cancer|metastatic cancer
783116|NCT00034463|chemotherapy|chemotherapy
783117|NCT00034450|Terminal Cancer|terminal cancer
783118|NCT00034437|Normal Volunteer|normal volunteer
783119|NCT00034437|Phlebotomy|phlebotomy
783120|NCT00034437|Cytomegalovirus|cytomegalovirus
783121|NCT00034437|CMV|cmv
783122|NCT00034437|CMV Seropositve|cmv seropositve
783123|NCT00034424|Genetics|genetics
783124|NCT00034424|Hereditary|hereditary
783125|NCT00034424|Screening|screening
783126|NCT00034424|Behavioral|behavioral
783127|NCT00034424|Familial Testicular Germ Cell Tumor|familial testicular germ cell tumor
783128|NCT00034424|Testicular Cancer|testicular cancer
783129|NCT00034398|Basal Ganglia|basal ganglia
783130|NCT00034398|Neuroimaging|neuroimaging
783131|NCT00034398|Inhibitory Neurons|inhibitory neurons
783132|NCT00034398|Disinhibition|disinhibition
783133|NCT00034398|Tics|tics
783134|NCT00034398|Tourette's Syndrome|tourette's syndrome
783135|NCT00034398|Tourette Syndrome|tourette syndrome
783136|NCT00034398|Healthy Volunteer|healthy volunteer
783137|NCT00034398|HV|hv
783138|NCT00034398|Normal Control|normal control
783139|NCT00034385|Cytomegalovirus|cytomegalovirus
783140|NCT00034385|Prophylaxis|prophylaxis
783141|NCT00034385|Renal Transplant|renal transplant
783142|NCT00034385|Valcyte|valcyte
783143|NCT00034385|Kidney Transplant|kidney transplant
783144|NCT00034372|immunotherapy|immunotherapy
783145|NCT00034372|monoclonal|monoclonal
783146|NCT00034372|antibody|antibody
783147|NCT00034372|Stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
783148|NCT00034372|Stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
783149|NCT00034359|E-antigen positive|e-antigen positive
783150|NCT00034359|Treatment Naive Chronic Hepatitis B, Achillion|treatment naive chronic hepatitis b, achillion
783151|NCT00017862|Eosinophils|eosinophils
783152|NCT00017862|Monoclonal Antibody|monoclonal antibody
783153|NCT00017862|Hypereosinophilia|hypereosinophilia
783154|NCT00017862|Biologicals|biologicals
783155|NCT00017862|Hypereosinophilic Syndrome|hypereosinophilic syndrome
783156|NCT00034346|Advanced|advanced
783157|NCT00034346|Non-Small-Cell|non-small-cell
783158|NCT00034346|Lung|lung
783159|NCT00034346|Cancer|cancer
783160|NCT00034346|NSCLC|nsclc
783161|NCT00034346|Carcinoma|carcinoma
783162|NCT00034346|Advanced Non-Small-Cell Lung Cancer (NSCLC)|advanced non-small-cell lung cancer (nsclc)
783163|NCT00034333|Hepatoma|hepatoma
783164|NCT00034333|Unresectable adult primary liver cancer|unresectable adult primary liver cancer
783165|NCT00034333|liver cancer|liver cancer
783166|NCT00034333|HCC|hcc
783167|NCT00034333|Hepatocellular Carcinoma|hepatocellular carcinoma
783168|NCT00034294|C. difficile-associated diarrhea|c. difficile-associated diarrhea
783169|NCT00034294|CDAD|cdad
783170|NCT00034294|Clostridium difficile-Associated Diarrhea|clostridium difficile-associated diarrhea
783171|NCT00034294|Clostridium enterocolitis|clostridium enterocolitis
783172|NCT00034294|antibiotic-associated diarrhea|antibiotic-associated diarrhea
783173|NCT00034294|clostridium difficile colitis|clostridium difficile colitis
783174|NCT00034294|infectious diarrhea|infectious diarrhea
783175|NCT00034294|chronic diarrhea|chronic diarrhea
783176|NCT00034294|antibiotic-associated colitis|antibiotic-associated colitis
783177|NCT00034281|Gene, HER2|gene, her2
783178|NCT00034281|Clinical Trial, Phase I|clinical trial, phase i
783179|NCT00034281|Breast neoplasm|breast neoplasm
783180|NCT00034281|Pancreatic neoplasm|pancreatic neoplasm
783181|NCT00034281|Ovarian neoplasm|ovarian neoplasm
783182|NCT00034281|Colorectal neoplasm|colorectal neoplasm
783183|NCT00034281|Renal neoplasm|renal neoplasm
783184|NCT00034281|Prostate neoplasm|prostate neoplasm
783185|NCT00034281|Cancer|cancer
783186|NCT00034268|non-small cell lung cancer|non-small cell lung cancer
783187|NCT00034268|Stage IIIB or IV non-small cell lung cancer (NSCLC)|stage iiib or iv non-small cell lung cancer (nsclc)
783188|NCT00034177|Locally Advanced, Metastatic, or Recurrent Transitional Cell Carcinoma of the Urothelium|locally advanced, metastatic, or recurrent transitional cell carcinoma of the urothelium
783189|NCT00034242|Ataxia|ataxia
783190|NCT00034242|Treatment|treatment
783191|NCT00034242|IVIG|ivig
783192|NCT00034242|SCA|sca
783193|NCT00034242|Cerebellar Degeneration|cerebellar degeneration
783194|NCT00034242|Cerebellar Ataxia|cerebellar ataxia
783196|NCT00034229|Antidepressant|antidepressant
783197|NCT00034229|Anti-Glutamatergic|anti-glutamatergic
783198|NCT00034229|Bipolar Disorder|bipolar disorder
783199|NCT00034229|Depression|depression
783200|NCT00034229|Treatment Refractory|treatment refractory
783201|NCT00034229|Felbamate|felbamate
783202|NCT00034229|Glutamate|glutamate
783203|NCT00034229|Treatment-Resistant|treatment-resistant
783204|NCT00034229|Bipolar|bipolar
783205|NCT00034229|BPD|bpd
783206|NCT00034229|Bipolar Depression|bipolar depression
783207|NCT00034216|Suppressor Cells|suppressor cells
783208|NCT00034216|T-cells|t-cells
783209|NCT00034216|CD4+/CD25+ Cells|cd4+/cd25+ cells
783210|NCT00034216|Cancer|cancer
783211|NCT00034216|Malignancy|malignancy
783212|NCT00034216|Blood Sample|blood sample
783213|NCT00034138|immunotherapy|immunotherapy
783214|NCT00034138|monoclonal|monoclonal
783215|NCT00034138|antibody|antibody
783216|NCT00034138|Stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
783217|NCT00034138|Stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
783218|NCT00034125|cancer|cancer
783219|NCT00034125|metastatic breast cancer|metastatic breast cancer
783220|NCT00034125|hormonal therapy|hormonal therapy
783221|NCT00034112|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
783222|NCT00034112|combination therapy,|combination therapy,
783223|NCT00034112|emphysema|emphysema
783224|NCT00034112|exercise|exercise
783225|NCT00034112|human therapy evaluation|human therapy evaluation
783226|NCT00034112|rehabilitation|rehabilitation
783227|NCT00034112|respiratory disease /disorder therapy|respiratory disease /disorder therapy
783228|NCT00034112|respiratory function|respiratory function
783229|NCT00034112|biomechanics|biomechanics
783230|NCT00034112|body movement|body movement
783231|NCT00034112|diaphragm|diaphragm
783232|NCT00034112|dyspnea|dyspnea
783233|NCT00034112|muscle tension|muscle tension
783234|NCT00034112|musculoskeletal system|musculoskeletal system
783235|NCT00034112|outcomes research|outcomes research
783236|NCT00034112|quality of life|quality of life
783237|NCT00034112|somatic reflex|somatic reflex
783238|NCT00034086|Lopinavir|lopinavir
783239|NCT00034086|OspA Protein|ospa protein
783240|NCT00034086|HIV-1|hiv-1
783241|NCT00034086|HIV Protease Inhibitors|hiv protease inhibitors
783242|NCT00034086|CD4 Lymphocyte Count|cd4 lymphocyte count
783243|NCT00034086|Ritonavir|ritonavir
783244|NCT00034086|Haemophilus Vaccines|haemophilus vaccines
783245|NCT00034086|HAART|haart
783246|NCT00034086|Pneumococcal Vaccines|pneumococcal vaccines
783247|NCT00034086|tenofovir disoproxil|tenofovir disoproxil
783248|NCT00034073|Imaging|imaging
783249|NCT00034073|Pediatrics|pediatrics
783250|NCT00034073|Brain|brain
783251|NCT00034073|Mapping|mapping
783252|NCT00034073|Development|development
783253|NCT00034073|Healthy Volunteer|healthy volunteer
783254|NCT00034073|HV|hv
783255|NCT00034073|Normal Control|normal control
783256|NCT00034060|Cytokines|cytokines
783257|NCT00034060|Exanercept|exanercept
783258|NCT00034060|Cachexia|cachexia
783259|NCT00034060|Body Composition|body composition
783260|NCT00034060|Vascular Endothelial System|vascular endothelial system
783261|NCT00034060|Rheumatoid Arthritis|rheumatoid arthritis
783262|NCT00034060|RA|ra
783263|NCT00034060|Women|women
783264|NCT00034060|Healthy Volunteer|healthy volunteer
783265|NCT00034060|HV|hv
783266|NCT00034060|Normal Control|normal control
783267|NCT00034047|Endometriosis|endometriosis
783268|NCT00034047|Pelvic pain|pelvic pain
783269|NCT00034047|Acupuncture|acupuncture
783270|NCT00034047|Chinese herbs|chinese herbs
783271|NCT00034047|Hormone therapy|hormone therapy
783272|NCT00034047|Nafarelin|nafarelin
783273|NCT00034034|Advanced colorectal cancer|advanced colorectal cancer
783274|NCT00034034|acupressure /acupuncture|acupressure /acupuncture
783275|NCT00034034|anxiety|anxiety
783276|NCT00034034|colorectal neoplasm|colorectal neoplasm
783277|NCT00034034|human therapy evaluation|human therapy evaluation
783278|NCT00034034|neoplasm /cancer palliative treatment|neoplasm /cancer palliative treatment
783279|NCT00034034|quality of life|quality of life
783280|NCT00034034|terminal patient care|terminal patient care
783281|NCT00034034|hypothalamic pituitary adrenal axis|hypothalamic pituitary adrenal axis
783282|NCT00034034|pain|pain
783283|NCT00034034|psychological aspect of cancer|psychological aspect of cancer
783284|NCT00034034|stress management|stress management
783285|NCT00034034|alternative medicine|alternative medicine
783286|NCT00034034|behavioral /social science research tag|behavioral /social science research tag
783287|NCT00034034|human subject|human subject
783288|NCT00034034|patient oriented research|patient oriented research
783289|NCT00034021|Female Sexual Arousal Disorder|female sexual arousal disorder
783290|NCT00034021|Female Orgasmic Disorder|female orgasmic disorder
783291|NCT00034021|ginkgo biloba|ginkgo biloba
783292|NCT00034021|human therapy evaluation|human therapy evaluation
783293|NCT00034021|sex behavior|sex behavior
783294|NCT00034021|antidepressant|antidepressant
783295|NCT00034021|blood flow|blood flow
783296|NCT00034021|clinical trial|clinical trial
792519|NCT00018057|Adolescent|adolescent
783297|NCT00034021|drug adverse effect|drug adverse effect
783298|NCT00034021|mental disorder chemotherapy|mental disorder chemotherapy
783299|NCT00034021|relaxation|relaxation
783300|NCT00034021|smooth muscle|smooth muscle
783301|NCT00034021|alternative medicine|alternative medicine
783302|NCT00034021|blood flow measurement|blood flow measurement
783303|NCT00034021|female|female
783304|NCT00034021|placebo|placebo
783305|NCT00034021|women's health|women's health
783306|NCT00034021|Secondary to either to fluoxetine, sertraline, or paroxetine use.|secondary to either to fluoxetine, sertraline, or paroxetine use.
783307|NCT00034008|Energy Medicine|energy medicine
783308|NCT00034008|Healing Touch|healing touch
783309|NCT00034008|CAM Research|cam research
783310|NCT00034008|Neonates|neonates
783311|NCT00034008|Stress|stress
783312|NCT00034008|Conditions resulting from stress|conditions resulting from stress
783313|NCT00034008|Neonatal intensive care|neonatal intensive care
783314|NCT00034008|Healing of stress and prevention of negative|healing of stress and prevention of negative
783315|NCT00034008|Developmental outcomes – physical and behavioral|developmental outcomes – physical and behavioral
783316|NCT00034008|Therapeutic Touch|therapeutic touch
783317|NCT00034008|Touch therapies|touch therapies
783318|NCT00034008|Energy therapies|energy therapies
783319|NCT00034008|Infant touch|infant touch
783320|NCT00034008|Infant stimulation|infant stimulation
783321|NCT00033995|Tics|tics
783322|NCT00033995|Basal Ganglia|basal ganglia
783323|NCT00033995|Neuroimaging|neuroimaging
783324|NCT00033995|Sleep|sleep
783325|NCT00033995|Suppression of Tics|suppression of tics
783326|NCT00033995|Tourette Syndrome|tourette syndrome
783327|NCT00033995|Tourette's Syndrome|tourette's syndrome
783328|NCT00033995|Tic Disorder|tic disorder
783329|NCT00033995|Healthy Volunteer|healthy volunteer
783330|NCT00033995|HV|hv
783331|NCT00033995|Normal Control|normal control
783332|NCT00033982|Triazole|triazole
783333|NCT00033982|Refractory|refractory
783334|NCT00033982|Antifungal|antifungal
783335|NCT00033982|Fungal Infection|fungal infection
783336|NCT00033969|CRPS|crps
783337|NCT00033969|RSD|rsd
783338|NCT00033969|Causalgia|causalgia
783339|NCT00033969|Chronic Pain|chronic pain
783340|NCT00033969|Neuropathic Pain|neuropathic pain
783341|NCT00033969|Normal Control|normal control
783342|NCT00033969|Complex Regional Pain Syndrome|complex regional pain syndrome
783343|NCT00033969|Healthy Volunteer|healthy volunteer
783344|NCT00033969|HV|hv
783345|NCT00033956|Metastatic Melanoma|metastatic melanoma
783346|NCT00033956|Renal Cell Carcinoma|renal cell carcinoma
783347|NCT00033956|IL-2|il-2
783348|NCT00033956|Interleukin-2|interleukin-2
783349|NCT00033956|Hypotension|hypotension
783350|NCT00033917|intraventricular hemorrhage (IVH)|intraventricular hemorrhage (ivh)
783351|NCT00033917|bleeding in the brain|bleeding in the brain
783352|NCT00033917|indomethacin|indomethacin
783353|NCT00033917|prematurity|prematurity
783354|NCT00033917|very low birth weight infants|very low birth weight infants
783355|NCT00033904|Kidney Cancer, renal, immunotherapy, tumor,|kidney cancer, renal, immunotherapy, tumor,
783356|NCT00033891|Muscle Weakness|muscle weakness
783357|NCT00033891|Muscle Biopsy|muscle biopsy
783358|NCT00033891|Gene Expression Profiling|gene expression profiling
783359|NCT00033891|MRI|mri
783360|NCT00033891|Inflammation|inflammation
783361|NCT00033891|Polymyositis|polymyositis
783362|NCT00033891|Dermatomyositis|dermatomyositis
783363|NCT00033878|Advanced Cancer|advanced cancer
783364|NCT00033865|Insomnia|insomnia
783365|NCT00033865|Yoga|yoga
783366|NCT00033865|Meditation|meditation
783367|NCT00033865|Behavioral treatment|behavioral treatment
783368|NCT00033852|complementary therapies|complementary therapies
783369|NCT00033852|Depression|depression
783370|NCT00033852|HIV|hiv
783371|NCT00033852|Massage Therapy|massage therapy
783372|NCT00033852|Alternative Treatments|alternative treatments
783373|NCT00033839|Headache|headache
783374|NCT00033839|Cluster|cluster
783375|NCT00033839|EC|ec
783376|NCT00033839|Episodic Cluster|episodic cluster
783377|NCT00033826|Vitamin D|vitamin d
783378|NCT00033826|Adipose tissue|adipose tissue
783379|NCT00033826|Metabolism|metabolism
783380|NCT00033813|Duchenne|duchenne
783381|NCT00033813|muscular|muscular
783382|NCT00033813|dystrophy|dystrophy
783383|NCT00033813|controlled clinical trial|controlled clinical trial
783384|NCT00033813|CINRG|cinrg
783385|NCT00033787|Depression|depression
783386|NCT00033787|Tryptophan Depletion|tryptophan depletion
783387|NCT00033787|PET|pet
783388|NCT00033787|Serotonin|serotonin
783389|NCT00033787|Pathophysiology|pathophysiology
783390|NCT00033787|Emotional Stimuli|emotional stimuli
783391|NCT00033787|GABA MRS|gaba mrs
783392|NCT00033787|MDD|mdd
783393|NCT00033787|Healthy Volunteer|healthy volunteer
783394|NCT00033787|HV|hv
783395|NCT00033787|Normal Control|normal control
783396|NCT00033774|Leukapheresis|leukapheresis
783397|NCT00033774|G-CSF|g-csf
783398|NCT00033774|Mobilization|mobilization
783399|NCT00033774|Stem Cells|stem cells
783400|NCT00033774|Adult|adult
783401|NCT00033774|Healthy Volunteer|healthy volunteer
783403|NCT00033774|Normal Control|normal control
783404|NCT00033215|neovascularization|neovascularization
783405|NCT00033215|matrix metalloproteinases|matrix metalloproteinases
783406|NCT00033215|antiangiogenesis|antiangiogenesis
783407|NCT00033215|type IV collagenases|type iv collagenases
783408|NCT00033202|Solid Tumor|solid tumor
783409|NCT00033202|Camptothecin|camptothecin
783410|NCT00033202|Pharmacokinetics|pharmacokinetics
783411|NCT00033189|duchenne|duchenne
783412|NCT00033189|dystrophy|dystrophy
783413|NCT00033189|DMD|dmd
783414|NCT00033189|clinical trial|clinical trial
783415|NCT00033189|CINRG|cinrg
783416|NCT00033176|complementary therapies|complementary therapies
783417|NCT00033176|Immune restoration|immune restoration
783418|NCT00033176|HIV infection|hiv infection
783419|NCT00033176|AIDS|aids
783420|NCT00033176|HAART non-responsiveness|haart non-responsiveness
783421|NCT00033176|glutathione restoration|glutathione restoration
783422|NCT00033176|lipoic acid|lipoic acid
783423|NCT00033176|dithiol|dithiol
783424|NCT00033163|Antiviral Agents|antiviral agents
783425|NCT00033163|Hepatitis B|hepatitis b
783426|NCT00033163|Drug Resistance, Microbial|drug resistance, microbial
783427|NCT00033163|Lamivudine|lamivudine
783428|NCT00033163|DNA, Viral|dna, viral
783429|NCT00033163|Hepatitis B Virus|hepatitis b virus
783430|NCT00033163|Adefovir dipivoxil|adefovir dipivoxil
783431|NCT00033163|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
783432|NCT00033163|Treatment Experienced|treatment experienced
783433|NCT00033150|Specific Language Impairment|specific language impairment
783434|NCT00033150|Fast ForWord|fast forword
783435|NCT00033150|Language therapy|language therapy
783436|NCT00033150|Auditory processing|auditory processing
783437|NCT00033137|Pneumothorax|pneumothorax
783438|NCT00033137|Kidney|kidney
783439|NCT00033137|Fibrofolliculoma|fibrofolliculoma
783440|NCT00033137|BHD|bhd
783441|NCT00033137|Neoplasms|neoplasms
783442|NCT00033137|Kidney Cancer|kidney cancer
783443|NCT00033137|Birt Hogg Dube Syndrome|birt hogg dube syndrome
783444|NCT00033137|Skin Papules|skin papules
783445|NCT00033085|cocaine dependence|cocaine dependence
783446|NCT00033033|cocaine dependence|cocaine dependence
783447|NCT00033020|substance use disorders|substance use disorders
783448|NCT00033007|substance use disorders|substance use disorders
783449|NCT00032994|substance use disorders|substance use disorders
783450|NCT00032981|substance use disorder|substance use disorder
783451|NCT00032968|opiate dependence|opiate dependence
783452|NCT00032955|opiate addiction|opiate addiction
783453|NCT00032955|morphine addiction|morphine addiction
783454|NCT00032942|opiate dependence|opiate dependence
783455|NCT00032929|Cocaine Dependence|cocaine dependence
783456|NCT00032903|Malignant Glioma, Camptothecin, Pharmacokinetics|malignant glioma, camptothecin, pharmacokinetics
783457|NCT00032890|osteoarthritis|osteoarthritis
783458|NCT00032890|knee pain|knee pain
783459|NCT00032877|Linkage Study|linkage study
783460|NCT00032877|Gene Identification Study|gene identification study
783461|NCT00032877|Diaphragmatic Hernia|diaphragmatic hernia
783462|NCT00032877|Fraser Syndrome|fraser syndrome
783463|NCT00032877|Cryptophthalmos|cryptophthalmos
783464|NCT00032877|Fryns Syndrome|fryns syndrome
783465|NCT00032877|Hydrolethalus Syndrome|hydrolethalus syndrome
783466|NCT00032877|Positional Cloning|positional cloning
783467|NCT00032864|amputations, diabetes,|amputations, diabetes,
783468|NCT00032838|Hydrocortisone|hydrocortisone
783469|NCT00032838|Yohimbine|yohimbine
783470|NCT00032838|Cognition|cognition
783471|NCT00032838|Norepinephrine|norepinephrine
783472|NCT00032838|Cortisol|cortisol
783473|NCT00032838|Emotion|emotion
783474|NCT00032838|Healthy Volunteer|healthy volunteer
783475|NCT00032838|HV|hv
783476|NCT00032838|Normal Control|normal control
783477|NCT00032825|Combination|combination
783478|NCT00032825|Microtubule|microtubule
783479|NCT00032825|Hormonal|hormonal
783480|NCT00032825|Chemotherapy|chemotherapy
783481|NCT00032825|Pharmacokinetics|pharmacokinetics
783482|NCT00032825|Prostate Cancer|prostate cancer
783483|NCT00032825|Prostate|prostate
783484|NCT00032773|acute graft versus host disease|acute graft versus host disease
783485|NCT00032773|aGVHD|agvhd
783486|NCT00032773|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
783487|NCT00032773|peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
783488|NCT00032773|cord blood transplant|cord blood transplant
783489|NCT00032773|pentostatin|pentostatin
783490|NCT00032773|Nipent|nipent
783491|NCT00032773|deoxycoformycin|deoxycoformycin
783492|NCT00032812|Motor Learning|motor learning
783493|NCT00032812|Sequencing|sequencing
783494|NCT00032812|Functional Imaging|functional imaging
783495|NCT00032812|Raclopride|raclopride
783496|NCT00032812|Connectivity|connectivity
783497|NCT00032812|Parkinson Disease|parkinson disease
783498|NCT00032812|Parkinson's Disease|parkinson's disease
783499|NCT00032812|PD|pd
783500|NCT00032812|Healthy Volunteer|healthy volunteer
783501|NCT00032812|HV|hv
783502|NCT00032812|Normal Control|normal control
792620|NCT00017810|Food|food
783503|NCT00032760|binge eating disorder|binge eating disorder
783504|NCT00032760|human therapy evaluation|human therapy evaluation
783505|NCT00032760|meditation|meditation
783506|NCT00032760|obesity|obesity
783507|NCT00032760|nutrition education|nutrition education
783508|NCT00032760|psychotherapy|psychotherapy
783509|NCT00032760|racial /ethnic difference|racial /ethnic difference
783510|NCT00032760|adult human|adult human
783511|NCT00032760|alternative medicine|alternative medicine
783512|NCT00032760|patient oriented research|patient oriented research
783513|NCT00032747|Chronic Heart Failure|chronic heart failure
783514|NCT00032747|Heart Disease|heart disease
783515|NCT00032734|Low Blood Sodium (Hyponatremia)|low blood sodium (hyponatremia)
783516|NCT00032734|SIADH|siadh
783517|NCT00032734|Inappropriate ADH Syndrome|inappropriate adh syndrome
783518|NCT00032721|complementary therapies|complementary therapies
783519|NCT00032721|Alternative medicine|alternative medicine
783520|NCT00032721|Complementary and alternative medicine|complementary and alternative medicine
783521|NCT00032721|Subtle energy therapy|subtle energy therapy
783522|NCT00032721|Reiki|reiki
783523|NCT00032721|HIV/AIDS|hiv/aids
783524|NCT00032695|myelopathy|myelopathy
783525|NCT00032695|AIDS-myelopathy|aids-myelopathy
783526|NCT00032695|AIDS vacuolar myelopathy|aids vacuolar myelopathy
783527|NCT00032695|methionine|methionine
783528|NCT00032682|Bowel Movement|bowel movement
783529|NCT00032682|Children|children
783530|NCT00032682|Stool|stool
783531|NCT00032682|Symptom Management|symptom management
783532|NCT00032682|Cancer|cancer
783533|NCT00032682|Constipation|constipation
783534|NCT00032669|Antiretrovirals|antiretrovirals
783535|NCT00032669|Adherence|adherence
783536|NCT00032669|Dose Adjustments|dose adjustments
783537|NCT00032669|Genotypic Resistance|genotypic resistance
783538|NCT00032669|Phenotypic Resistance|phenotypic resistance
783539|NCT00032656|Adolescents|adolescents
783540|NCT00032656|Alternative and complimentary medication use|alternative and complimentary medication use
783541|NCT00032656|Health services utilization|health services utilization
783542|NCT00032656|Communication|communication
783543|NCT00032656|Quality of care|quality of care
783544|NCT00032617|PTSD|ptsd
783545|NCT00032617|Stress Disorder|stress disorder
783546|NCT00032617|Trauma|trauma
783547|NCT00032591|AF|af
783548|NCT00032591|Mechanical heart valve (MHV)|mechanical heart valve (mhv)
783549|NCT00032539|Informed Consent|informed consent
783550|NCT00032513|Herpesvirus|herpesvirus
783551|NCT00032513|Hemophagocytosis|hemophagocytosis
783552|NCT00032513|Lymphoproliferative|lymphoproliferative
783553|NCT00032513|Epstein-Barr|epstein-barr
783554|NCT00032513|Mononucleosis|mononucleosis
783555|NCT00032513|EBV|ebv
783556|NCT00032513|CAEBV|caebv
783557|NCT00032513|Chronic Active Epstein-Barr Virus|chronic active epstein-barr virus
783558|NCT00032513|Virus|virus
783559|NCT00032500|common cold|common cold
783560|NCT00032500|Echinacea|echinacea
783561|NCT00032487|DM|dm
783562|NCT00032487|glycemic control|glycemic control
783563|NCT00032487|insulin|insulin
783564|NCT00032487|type 2 diabetes mellitus|type 2 diabetes mellitus
783565|NCT00032474|Ginkgo biloba|ginkgo biloba
783566|NCT00032474|type 2 diabetes|type 2 diabetes
783567|NCT00032474|platelet function|platelet function
783568|NCT00032474|antioxidant|antioxidant
783569|NCT00032461|chronic fatigue syndrome|chronic fatigue syndrome
783570|NCT00032461|fibromyalgia|fibromyalgia
783571|NCT00032461|post-traumatic stress disorder|post-traumatic stress disorder
783572|NCT00032461|neurologic abnormalities|neurologic abnormalities
783573|NCT00032448|Hernia|hernia
783574|NCT00032448|laparoscopic herniorrhaphy|laparoscopic herniorrhaphy
783575|NCT00032448|tension-free herniorrhaphy|tension-free herniorrhaphy
783576|NCT00032435|folate|folate
783577|NCT00032435|pyridoxine|pyridoxine
783578|NCT00032435|vitamin B6|vitamin b6
783579|NCT00032435|cyanocobalamin|cyanocobalamin
783580|NCT00032435|homoc|homoc
783581|NCT00032422|Acupuncture|acupuncture
783582|NCT00032422|Heart Failure|heart failure
783583|NCT00032422|Autonomic nervous system|autonomic nervous system
783584|NCT00032409|Music Therapy|music therapy
783585|NCT00032409|Relaxation Therapy|relaxation therapy
783586|NCT00032409|Stress Reduction|stress reduction
783587|NCT00032409|Bone Marrow Transplantation|bone marrow transplantation
783588|NCT00032409|Stem Cell Transplantation|stem cell transplantation
783589|NCT00032396|AMD|amd
783590|NCT00032396|ARMD|armd
783591|NCT00032396|Age-Related Macular Degeneration|age-related macular degeneration
783592|NCT00032396|Subfoveal Choroidal Neovascularization|subfoveal choroidal neovascularization
783593|NCT00032396|CNV|cnv
783594|NCT00032383|Rehabilitation|rehabilitation
783595|NCT00032383|Tai Chi|tai chi
783596|NCT00032370|myocardial infarction|myocardial infarction
783597|NCT00032370|Prophylactic coronary artery revascularization|prophylactic coronary artery revascularization
783598|NCT00032357|Ferritin reduction|ferritin reduction
783599|NCT00032357|Peripheral Vascular Disease (PVD)|peripheral vascular disease (pvd)
783600|NCT00032357|phlebotomy|phlebotomy
783601|NCT00032357|Reduction of Total Body Iron Storage(TBIS)|reduction of total body iron storage(tbis)
792827|NCT00015613|Nutrition|nutrition
783602|NCT00032357|Total Body Iron Storage(TBIS)|total body iron storage(tbis)
783603|NCT00032344|large (>1 cm) adenomas|large (>1 cm) adenomas
783604|NCT00032331|PET imaging, benign and malignant solitary pulmonary nodules|pet imaging, benign and malignant solitary pulmonary nodules
783605|NCT00032305|Colitis|colitis
783606|NCT00032305|Gastrointestinal Disease|gastrointestinal disease
783607|NCT00032305|Digestive System Disease|digestive system disease
783608|NCT00032305|Intestinal Disease|intestinal disease
783609|NCT00032305|Colonic Disease|colonic disease
783610|NCT00032240|Biomechanics|biomechanics
783611|NCT00032227|Carpal Tunnel Release|carpal tunnel release
783612|NCT00032227|MR Nerve Imaging|mr nerve imaging
783613|NCT00032227|Wrist MRI|wrist mri
783614|NCT00032201|Surgery|surgery
783615|NCT00032201|Tissue Sample|tissue sample
783616|NCT00032201|Gene Expression Profiling|gene expression profiling
783617|NCT00032201|Tissue Array Gene Expression|tissue array gene expression
783618|NCT00032201|Comparative Genomic Hybridization|comparative genomic hybridization
783619|NCT00032201|Breast Cancer|breast cancer
783620|NCT00032201|Breast Cancer Risk|breast cancer risk
783621|NCT00032201|Breast|breast
783622|NCT00031551|Stomatitis|stomatitis
783623|NCT00031551|Oropharyngeal pain|oropharyngeal pain
783624|NCT00031551|TNF|tnf
783625|NCT00031551|Etanercept|etanercept
783626|NCT00031551|Bone marrow transplantation|bone marrow transplantation
783627|NCT00031551|Chemotherapy|chemotherapy
783628|NCT00031551|Cancer|cancer
783629|NCT00031551|Oral cavity|oral cavity
783630|NCT00031551|Oral mucous membranes|oral mucous membranes
783631|NCT00031551|Randomized controlled clinical trial|randomized controlled clinical trial
783632|NCT00031551|Inflammation|inflammation
783633|NCT00031538|Brain Tumor|brain tumor
783634|NCT00031538|Surgery|surgery
783635|NCT00031538|Molecular|molecular
783636|NCT00031538|Glioma|glioma
783637|NCT00031538|Intraoperative|intraoperative
783638|NCT00031538|Gliomas|gliomas
783639|NCT00031512|enterovirus, enteroviral sepsis, Pleconaril, infants|enterovirus, enteroviral sepsis, pleconaril, infants
783640|NCT00031499|Azithromycin, Syphilis, Penicillin|azithromycin, syphilis, penicillin
783641|NCT00031486|encephalitis, herpes simplex, valacyclovir|encephalitis, herpes simplex, valacyclovir
783642|NCT00031473|Ribavirin|ribavirin
783643|NCT00031473|RSV|rsv
783644|NCT00031460|acyclovir, central nervous system, Herpes Simplex Virus|acyclovir, central nervous system, herpes simplex virus
783645|NCT00031447|Herpes Simplex, Acyclovir, Infants|herpes simplex, acyclovir, infants
783646|NCT00031434|Valganciclovir, congenital cytomegalovirus, ganciclovir|valganciclovir, congenital cytomegalovirus, ganciclovir
783647|NCT00031421|CMV, cytomegalovirus, children, ganciclovir|cmv, cytomegalovirus, children, ganciclovir
783648|NCT00031408|Specimen Handling|specimen handling
783649|NCT00031408|Blood|blood
783650|NCT00031408|Informed Consent|informed consent
783651|NCT00031408|Genetic Screening|genetic screening
783652|NCT00031395|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
783653|NCT00031395|ADHD|adhd
783654|NCT00031395|clonidine|clonidine
783655|NCT00031395|methylphenidate|methylphenidate
783656|NCT00031395|MPH|mph
783657|NCT00031382|Functional MRI|functional mri
783658|NCT00031382|Dual Task|dual task
783659|NCT00031382|Neural Activation|neural activation
783660|NCT00031382|Basal Ganglia|basal ganglia
783661|NCT00031382|Cerebellum|cerebellum
783662|NCT00031382|Healthy Volunteer|healthy volunteer
783663|NCT00031382|HV|hv
783664|NCT00031382|Normal Control|normal control
783665|NCT00031369|MRI|mri
783666|NCT00031369|Writer's Cramp|writer's cramp
783667|NCT00031369|Movement Disorder|movement disorder
783668|NCT00031369|Gray Matter|gray matter
783669|NCT00031369|Brain Morphology|brain morphology
783670|NCT00031369|Dystonia|dystonia
783671|NCT00031369|Focal Hand Dystonia|focal hand dystonia
783672|NCT00031369|Healthy Volunteer|healthy volunteer
783673|NCT00031369|HV|hv
783674|NCT00031369|Normal Control|normal control
783675|NCT00031343|Liver Disease|liver disease
783676|NCT00031343|Virologic Response|virologic response
783677|NCT00031343|Immune Mechanisms|immune mechanisms
783678|NCT00031343|Eradication|eradication
783679|NCT00031343|Antiviral Therapy|antiviral therapy
783680|NCT00031343|HIV|hiv
783681|NCT00031343|Hepatitis C|hepatitis c
783682|NCT00031343|HCV|hcv
783683|NCT00031343|Coinfection|coinfection
783684|NCT00031317|Depression|depression
783685|NCT00031317|Treatment|treatment
783686|NCT00031317|Antidepressant|antidepressant
783687|NCT00031317|Benzodiazepine (clonazepam)|benzodiazepine (clonazepam)
783688|NCT00031317|SSRI (paroxetine)|ssri (paroxetine)
783689|NCT00031317|Combined Treatment|combined treatment
783690|NCT00031317|Panic Disorder (PD)|panic disorder (pd)
783691|NCT00031317|Panic Disorder|panic disorder
783692|NCT00031317|PD|pd
783693|NCT00031304|HIV|hiv
783694|NCT00031304|AIDS|aids
783695|NCT00031304|Vaccine|vaccine
783696|NCT00031304|Screening|screening
783697|NCT00031304|Prevention|prevention
783698|NCT00031304|HV|hv
783699|NCT00031304|Healthy Volunteer|healthy volunteer
783700|NCT00031304|Volunteer|volunteer
783701|NCT00031304|HIV Seronegativity|hiv seronegativity
783702|NCT00031304|HIV Preventive Vaccine|hiv preventive vaccine
783704|NCT00031291|Immune Globulin|immune globulin
783705|NCT00031291|Plasmapheresis|plasmapheresis
783706|NCT00031291|Vaccine|vaccine
783707|NCT00031278|Metastatic|metastatic
783708|NCT00031278|Breast|breast
783709|NCT00031278|Cancer|cancer
783710|NCT00031278|immunotherapy|immunotherapy
783711|NCT00031278|CPG 7909|cpg 7909
783712|NCT00031265|stroke|stroke
783713|NCT00031265|telephone|telephone
783714|NCT00031265|intervention|intervention
783715|NCT00031187|Prostate|prostate
783716|NCT00031187|Lewis Blood-Group System|lewis blood-group system
783717|NCT00031187|Antibodies, Monoclonal|antibodies, monoclonal
783718|NCT00031187|Antigens, Neoplasm|antigens, neoplasm
783719|NCT00031187|Antineoplastic Agents|antineoplastic agents
783720|NCT00031174|Apheresis|apheresis
783721|NCT00031174|Healthy Volunteer|healthy volunteer
783722|NCT00031174|Rheumatoid Disease|rheumatoid disease
783723|NCT00031174|Rheumatic Disease|rheumatic disease
783724|NCT00031174|Lupus|lupus
783725|NCT00031174|Rheumatoid Arthritis|rheumatoid arthritis
783726|NCT00031174|Myositis|myositis
783727|NCT00031174|HV|hv
783728|NCT00031174|Normal Control|normal control
783729|NCT00031161|Tyrosine|tyrosine
783730|NCT00031161|Diet|diet
783731|NCT00031161|2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione|2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione
783732|NCT00031161|4-Hydroxyphenylpyruvate Dioxygenase|4-hydroxyphenylpyruvate dioxygenase
783733|NCT00031161|Enzyme Inhibitors|enzyme inhibitors
783734|NCT00031148|Keratinocyte growth factor|keratinocyte growth factor
783735|NCT00031148|Bone Marrow Transplantation|bone marrow transplantation
783736|NCT00031148|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
783737|NCT00031148|HLA Antigens|hla antigens
783738|NCT00031148|Transplantation, Homologous|transplantation, homologous
783739|NCT00031148|Recombinant Proteins|recombinant proteins
783740|NCT00031135|Parenteral Nutrition, Total|parenteral nutrition, total
783741|NCT00031135|Lipotropic Agents|lipotropic agents
783742|NCT00031135|Choline|choline
783743|NCT00031122|Genetic Predisposition to Disease|genetic predisposition to disease
783744|NCT00031122|Environmental Exposure|environmental exposure
783745|NCT00031122|Chromosome Mapping|chromosome mapping
783746|NCT00031122|Data Collection|data collection
783747|NCT00031109|HIV Antibodies|hiv antibodies
783748|NCT00031109|HIV-1|hiv-1
783749|NCT00031109|HIV Envelope Protein gp160|hiv envelope protein gp160
783750|NCT00031109|Adjuvants, Immunologic|adjuvants, immunologic
783751|NCT00031109|AIDS Vaccines|aids vaccines
783752|NCT00031109|CD4 Lymphocyte Count|cd4 lymphocyte count
783753|NCT00031109|Disease Models, Animal|disease models, animal
783754|NCT00031109|Antibody Formation|antibody formation
783755|NCT00031109|Macaca|macaca
783756|NCT00031109|Neutralization Tests|neutralization tests
783757|NCT00031109|Viral Load|viral load
783758|NCT00031109|aluminum hydroxide|aluminum hydroxide
783759|NCT00031109|HIV Preventive Vaccine|hiv preventive vaccine
783760|NCT00031096|Acne Vulgaris|acne vulgaris
783761|NCT00031096|Propionibacterium acnes|propionibacterium acnes
783762|NCT00031083|Glioma|glioma
783763|NCT00031083|Brain Tumor|brain tumor
783764|NCT00031083|Adenovirus|adenovirus
783765|NCT00031083|Gene Therapy|gene therapy
783766|NCT00031083|Biogen|biogen
783767|NCT00031070|Zidovudine|zidovudine
783768|NCT00031070|CD4 Lymphocyte Count|cd4 lymphocyte count
783769|NCT00031070|Lamivudine|lamivudine
783770|NCT00031070|Cyclosporine|cyclosporine
783771|NCT00031070|Hepatitis A Vaccine|hepatitis a vaccine
783772|NCT00031070|Rabies Vaccine|rabies vaccine
783773|NCT00031070|abacavir|abacavir
783774|NCT00031070|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
783775|NCT00031070|efavirenz|efavirenz
783776|NCT00031070|Treatment Naive|treatment naive
783777|NCT00031057|Administration, Oral|administration, oral
783778|NCT00031057|Blood|blood
783779|NCT00031057|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
783780|NCT00031057|Riboflavin|riboflavin
783781|NCT00031057|Thiamine|thiamine
783782|NCT00031057|Vitamin B Complex|vitamin b complex
783783|NCT00031057|Lactic Acid|lactic acid
783784|NCT00031044|HIV-1|hiv-1
783785|NCT00031044|Drug Therapy, Combination|drug therapy, combination
783786|NCT00031044|RNA, Viral|rna, viral
783787|NCT00031044|Salvage Therapy|salvage therapy
783788|NCT00031044|Anti-HIV Agents|anti-hiv agents
783789|NCT00031044|Viral Load|viral load
783790|NCT00031044|Purines|purines
783791|NCT00031044|T-20 Peptide|t-20 peptide
783792|NCT00031044|ABT 378|abt 378
783793|NCT00031044|Treatment Experienced|treatment experienced
783794|NCT00031031|MTD|mtd
783795|NCT00031031|Safety|safety
783796|NCT00031031|Pharmacokinetics|pharmacokinetics
783797|NCT00031031|Efficacy|efficacy
783798|NCT00031018|Inflammation|inflammation
783799|NCT00031018|immunosenescence|immunosenescence
783800|NCT00031018|autoimmunity|autoimmunity
783801|NCT00031018|atherosclerosis|atherosclerosis
783802|NCT00031018|pro-inflammatory cytokines|pro-inflammatory cytokines
783803|NCT00031018|Hayflick phenomenon|hayflick phenomenon
783804|NCT00031005|Non-Myeloablative|non-myeloablative
783805|NCT00031005|Campath 1-H|campath 1-h
783807|NCT00031005|Immunodeficiency|immunodeficiency
783808|NCT00031005|Infection|infection
783809|NCT00031005|Leukocyte Adhesion Deficiency|leukocyte adhesion deficiency
783810|NCT00031005|LAD|lad
783811|NCT00030992|Epothilone B|epothilone b
783812|NCT00030992|Ixabepilone|ixabepilone
783813|NCT00030992|Renal Cell Carcinoma|renal cell carcinoma
783814|NCT00030992|Kidney Cancer|kidney cancer
783815|NCT00030979|Mild Dementia|mild dementia
783816|NCT00030979|Acetylcholine|acetylcholine
783817|NCT00030979|Memory|memory
783818|NCT00030979|Hallucinations|hallucinations
783819|NCT00030979|Washout|washout
783820|NCT00030979|Parkinson Disease|parkinson disease
783821|NCT00030979|Parkinson's Disease|parkinson's disease
783822|NCT00030979|PD|pd
783823|NCT00030979|Dementia|dementia
783824|NCT00030966|Multiple Sclerosis|multiple sclerosis
783825|NCT00030966|MS|ms
783826|NCT00030953|Tourette's Syndrome|tourette's syndrome
783827|NCT00030953|GABA|gaba
783828|NCT00030953|NAA|naa
783829|NCT00030953|Choline|choline
783830|NCT00030953|Creatine|creatine
783831|NCT00030953|Tourette Syndrome|tourette syndrome
783832|NCT00030953|Healthy Volunteer|healthy volunteer
783833|NCT00030953|HV|hv
783834|NCT00030953|Normal Control|normal control
783835|NCT00030940|Antigenic Epitopes|antigenic epitopes
783836|NCT00030940|Glutamic Acid Decarboxylase (GAD)|glutamic acid decarboxylase (gad)
783837|NCT00030940|Auto-antibodies|auto-antibodies
783838|NCT00030940|Stiffness Index|stiffness index
783839|NCT00030940|SPS|sps
783840|NCT00030940|Anti-GAD|anti-gad
783841|NCT00030940|MR Spectroscopy|mr spectroscopy
783842|NCT00030940|GAD|gad
783843|NCT00030940|Stiff Person Syndrome|stiff person syndrome
783844|NCT00030238|Body Fat|body fat
783845|NCT00030238|Weight Gain|weight gain
783846|NCT00030238|Adult|adult
783847|NCT00030238|Hypertension|hypertension
783848|NCT00030238|Dietary Supplements|dietary supplements
783849|NCT00030238|Healthy Volunteer|healthy volunteer
783850|NCT00030238|HIV|hiv
783851|NCT00030238|Body Weight|body weight
783852|NCT00030225|Fulminant Hepatic Failure|fulminant hepatic failure
783853|NCT00030212|T Cell|t cell
783854|NCT00030212|IBM|ibm
783855|NCT00030212|Inflammatory Myopathies|inflammatory myopathies
783856|NCT00030212|Antigenic Epitopes|antigenic epitopes
783857|NCT00030212|Endomysial T Lymphocytes|endomysial t lymphocytes
783858|NCT00030212|Myositis|myositis
783859|NCT00030212|Inclusion Body Myositis|inclusion body myositis
783860|NCT00030212|Inflammatory Myopathy|inflammatory myopathy
783861|NCT00030199|Transcranial Magnetic Stimuli|transcranial magnetic stimuli
783862|NCT00030199|Eletromyography|eletromyography
783863|NCT00030199|Needle Electrode|needle electrode
783864|NCT00030199|Facial Muscles|facial muscles
783865|NCT00030199|Blink Reflex|blink reflex
783866|NCT00030199|Motor Cortex|motor cortex
783867|NCT00030199|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
783868|NCT00030199|Healthy Volunteer|healthy volunteer
783869|NCT00030199|HV|hv
783870|NCT00030199|Normal Control|normal control
783871|NCT00030186|AML|aml
783872|NCT00030186|FLT-3 mutation|flt-3 mutation
783873|NCT00030173|Epothilone D|epothilone d
783874|NCT00030173|tubulin polymerization|tubulin polymerization
783875|NCT00030160|Obesity|obesity
783876|NCT00030160|Prevention|prevention
783877|NCT00030160|Exercise|exercise
783878|NCT00030147|Gonadal Steroids|gonadal steroids
783879|NCT00030147|Estrogen Receptor|estrogen receptor
783880|NCT00030147|Mood Disorders|mood disorders
783881|NCT00030147|Perimenopause|perimenopause
783882|NCT00030147|Estradiol|estradiol
783883|NCT00030147|Depression|depression
783884|NCT00030147|Estrogen Response Element|estrogen response element
783885|NCT00030147|Perimenopausal|perimenopausal
783886|NCT00030147|Perimenopausal Depression|perimenopausal depression
783887|NCT00030134|Natural History|natural history
783888|NCT00030134|Female Carrier|female carrier
783889|NCT00030134|Alpha-Galactosidase|alpha-galactosidase
783890|NCT00030134|Lysosomal Disease|lysosomal disease
783891|NCT00030134|X-Linked|x-linked
783892|NCT00030134|Fabry|fabry
783893|NCT00030134|Fabry Disease|fabry disease
783894|NCT00030121|Acute Respiratory Distress|acute respiratory distress
783895|NCT00030121|Acute Lung Injury|acute lung injury
783896|NCT00030069|Hematopoiesis|hematopoiesis
783897|NCT00030069|Apoptosis|apoptosis
783898|NCT00030069|Cell Differentiation|cell differentiation
783899|NCT00030069|Bone Marrow Cells|bone marrow cells
783900|NCT00030056|Sargramostim|sargramostim
783901|NCT00030056|Injections, Subcutaneous|injections, subcutaneous
783902|NCT00030043|Electric Stimulation|electric stimulation
783903|NCT00030043|Implants, Artificial|implants, artificial
783904|NCT00030043|Brainstem|brainstem
783905|NCT00030043|Electrodes|electrodes
783906|NCT00030043|Speech Perception|speech perception
783907|NCT00029991|Leg pain|leg pain
783908|NCT00029991|Peripheral angiopathies|peripheral angiopathies
783909|NCT00029991|Vascular Diseases, peripheral|vascular diseases, peripheral
783910|NCT00029965|Tay-Sachs|tay-sachs
783911|NCT00029965|Lysosomal Storage Disease|lysosomal storage disease
783912|NCT00029965|Sandhoff|sandhoff
783913|NCT00029965|GM1 Gangliosidosis|gm1 gangliosidosis
783914|NCT00029965|GM2 Gangliosidosis|gm2 gangliosidosis
783915|NCT00029965|Lysosomal Storage Disorder|lysosomal storage disorder
783916|NCT00029965|Gaucher|gaucher
783917|NCT00029952|Cortisol|cortisol
783918|NCT00029952|Bone Density|bone density
783919|NCT00029952|Cushing Syndrome|cushing syndrome
783920|NCT00029952|Postoperative|postoperative
783921|NCT00029939|Preparation|preparation
783922|NCT00029939|Subconscious|subconscious
783923|NCT00029939|Healthy Volunteer|healthy volunteer
783925|NCT00029939|Normal Control|normal control
783926|NCT00029926|Imaging|imaging
783927|NCT00029926|Immune System|immune system
783928|NCT00029926|Autoimmune Disease|autoimmune disease
783929|NCT00029926|Lymphonodes|lymphonodes
783930|NCT00029926|Spleen|spleen
783931|NCT00029926|Systemic Lupus Erythematosus|systemic lupus erythematosus
783932|NCT00029926|Lupus|lupus
783933|NCT00029926|SLE|sle
783934|NCT00029913|Placebos|placebos
783935|NCT00029913|AIDS Vaccines|aids vaccines
783936|NCT00029913|CD4 Lymphocyte Count|cd4 lymphocyte count
783937|NCT00029913|Disease Progression|disease progression
783938|NCT00029913|Viral Load|viral load
783939|NCT00029913|HIV Preventive Vaccine|hiv preventive vaccine
783940|NCT00029900|Dose-Response Relationship, Drug|dose-response relationship, drug
783941|NCT00029900|Polyethylene Glycol|polyethylene glycol
783942|NCT00029900|Arginine Deiminase|arginine deiminase
783943|NCT00029874|Tetracyclines|tetracyclines
783944|NCT00029874|Dose-Response Relationship, Drug|dose-response relationship, drug
783945|NCT00029861|Weight Loss|weight loss
783946|NCT00029861|Obesity|obesity
783947|NCT00029861|Weight Reduction|weight reduction
783948|NCT00029861|Overweight|overweight
783949|NCT00029848|Diabetes|diabetes
783950|NCT00029848|Obesity|obesity
783951|NCT00029835|Obesity|obesity
783952|NCT00029822|Acute Urinary Retention|acute urinary retention
783953|NCT00029822|AUR|aur
783954|NCT00029822|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
783955|NCT00029822|Benign Prostatic Hypertrophy|benign prostatic hypertrophy
783956|NCT00029822|BPH|bph
783957|NCT00029822|Enlarged Prostate|enlarged prostate
783958|NCT00029809|Parkinsons Disease|parkinsons disease
783959|NCT00029809|Chinese exercise|chinese exercise
783960|NCT00029783|Glioblastoma|glioblastoma
783961|NCT00029783|Brain tumor|brain tumor
783962|NCT00029783|Distant healing|distant healing
783963|NCT00029783|Distance healing|distance healing
783964|NCT00029757|Surgical menopause|surgical menopause
783965|NCT00029744|AIDS Vaccines|aids vaccines
783966|NCT00029744|Clinical Protocols|clinical protocols
783967|NCT00029744|HIV Seronegativity|hiv seronegativity
783968|NCT00029744|Patient Selection|patient selection
783969|NCT00029744|Patient Acceptance of Health Care|patient acceptance of health care
783970|NCT00029744|Demography|demography
783971|NCT00029744|HIV Preventive Vaccine|hiv preventive vaccine
783972|NCT00029731|Nitric Oxide|nitric oxide
783973|NCT00029731|Administration, Oral|administration, oral
783974|NCT00029718|Chronic Stroke|chronic stroke
783975|NCT00029718|Transcallosal Inhibition|transcallosal inhibition
783976|NCT00029718|Motor Cortex|motor cortex
783977|NCT00029718|Motor Control|motor control
783978|NCT00029718|Motor Recovery|motor recovery
783979|NCT00029718|Healthy Volunteer|healthy volunteer
783980|NCT00029718|HV|hv
783981|NCT00029718|Normal Control|normal control
783982|NCT00029666|Motor Cortex|motor cortex
783983|NCT00029666|Sham Stimulation|sham stimulation
783984|NCT00029666|Prefrontal Cortex|prefrontal cortex
783985|NCT00029666|Brain Stimulation|brain stimulation
783986|NCT00029666|Gait|gait
783987|NCT00029666|Parkinson|parkinson
783988|NCT00029666|Parkinson's|parkinson's
783989|NCT00029666|PD|pd
783990|NCT00029653|Frontal Lobe|frontal lobe
783991|NCT00029653|Reaction Time|reaction time
783992|NCT00029653|Movement Preparation|movement preparation
783993|NCT00029653|Motor Threshold|motor threshold
783994|NCT00029653|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
783995|NCT00029653|Motor Cortex|motor cortex
783996|NCT00029653|Healthy Volunteer|healthy volunteer
783997|NCT00029653|Normal Control|normal control
783998|NCT00029653|HV|hv
783999|NCT00029640|MRI|mri
784000|NCT00029640|MRS|mrs
784001|NCT00029640|SSRI|ssri
784002|NCT00029640|Children|children
784003|NCT00029640|Depression|depression
784004|NCT00029640|Augmentation|augmentation
784005|NCT00029640|Magnetic Resonance Imaging|magnetic resonance imaging
784006|NCT00029640|Major Depression|major depression
784007|NCT00029640|MDD|mdd
784008|NCT00029627|Alpha2-Adrenoreceptors|alpha2-adrenoreceptors
784009|NCT00029627|Polymorphisms|polymorphisms
784010|NCT00029627|Challenge Study|challenge study
784011|NCT00029627|Yohimbine|yohimbine
784012|NCT00029627|Clonidine|clonidine
784013|NCT00029627|Subtypes|subtypes
784014|NCT00029627|Normal Control|normal control
784015|NCT00029627|HV|hv
784016|NCT00029627|Healthy Volunteer|healthy volunteer
784017|NCT00029614|ADHD|adhd
784018|NCT00029614|Substance Use|substance use
784019|NCT00029601|Magnetic Stimulation|magnetic stimulation
784020|NCT00029601|Intracortical Inhibition|intracortical inhibition
784021|NCT00029601|Intracortical Facilitation|intracortical facilitation
784022|NCT00029601|Motor Evoked Potential|motor evoked potential
784023|NCT00029601|Reaction Time|reaction time
784024|NCT00029601|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
784025|NCT00029601|Dystonia|dystonia
784026|NCT00029601|Focal Dystonia|focal dystonia
784027|NCT00029601|Healthy Volunteer|healthy volunteer
784028|NCT00029601|HV|hv
784029|NCT00029601|Normal Control|normal control
784030|NCT00029588|fMRI|fmri
784031|NCT00029588|Adolescents and Adults|adolescents and adults
784032|NCT00029588|Depression|depression
784033|NCT00029588|Anxiety|anxiety
784034|NCT00029588|Anxiety Disorder|anxiety disorder
784035|NCT00029588|GAD|gad
784036|NCT00029588|Adolescents|adolescents
784037|NCT00029588|Healthy Volunteer|healthy volunteer
784038|NCT00029588|HV|hv
784039|NCT00029588|Normal Control|normal control
784040|NCT00029575|Atherosclerotic|atherosclerotic
784041|NCT00029575|Plaque|plaque
784042|NCT00029575|Resolution|resolution
784043|NCT00029575|Adventitia|adventitia
784044|NCT00029575|Ultrasound|ultrasound
784045|NCT00029575|Cardiac Catheterization|cardiac catheterization
784046|NCT00029575|Arteriosclerosis|arteriosclerosis
784047|NCT00029575|Coronary Artery Disease|coronary artery disease
784048|NCT00029536|Epilepsy|epilepsy
784049|NCT00029536|Seizure|seizure
784050|NCT00029536|Hormone|hormone
784051|NCT00029536|Progesterone|progesterone
784052|NCT00029536|Catamenial|catamenial
784053|NCT00029523|neoplastic|neoplastic
784054|NCT00029523|meningitis|meningitis
784055|NCT00029523|cerebrospinal fluid|cerebrospinal fluid
784056|NCT00029523|CSF|csf
784057|NCT00029523|meningeal|meningeal
784058|NCT00029523|meninges|meninges
784059|NCT00029523|CNS|cns
784060|NCT00029523|Leptomeningeal Neoplasms|leptomeningeal neoplasms
784061|NCT00029458|Placebo Controlled|placebo controlled
784062|NCT00029458|Atypical Anti-Psychotic|atypical anti-psychotic
784063|NCT00029458|Bipolar Mood Disorder|bipolar mood disorder
784064|NCT00029458|Positron Emission Tomography|positron emission tomography
784065|NCT00029458|Dopamine Receptor Blockade|dopamine receptor blockade
784066|NCT00029458|Antimanic|antimanic
784067|NCT00029458|Mania|mania
784068|NCT00029458|Pathophysiology|pathophysiology
784069|NCT00029458|Treatment-Resistant|treatment-resistant
784070|NCT00029458|Mood Disorder|mood disorder
784071|NCT00029458|BPD|bpd
784072|NCT00029458|Bipolar|bipolar
784073|NCT00029445|HLA B5701|hla b5701
784074|NCT00029445|LTNP|ltnp
784075|NCT00029445|Neutralizing Antibodies|neutralizing antibodies
784076|NCT00029445|CTL|ctl
784077|NCT00029445|Virus Restriction|virus restriction
784078|NCT00029445|HIV|hiv
784079|NCT00029445|HIV-Infected Long Term Nonprogressors|hiv-infected long term nonprogressors
784080|NCT00029341|Drug Therapy, Combination|drug therapy, combination
784081|NCT00029341|Drug Administration Schedule|drug administration schedule
784082|NCT00029341|Drug Resistance, Microbial|drug resistance, microbial
784083|NCT00029341|Genotype|genotype
784084|NCT00029341|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
784085|NCT00029341|Anti-HIV Agents|anti-hiv agents
784086|NCT00029341|Viral Load|viral load
784087|NCT00029341|Pharmacokinetics|pharmacokinetics
784088|NCT00029341|Efavirenz|efavirenz
784089|NCT00029341|Treatment Interruption|treatment interruption
784090|NCT00029328|TNFR-Fc fusion protein|tnfr-fc fusion protein
784091|NCT00029328|Stem Cell Transplantation|stem cell transplantation
784092|NCT00029328|Transplantation, Homologous|transplantation, homologous
784093|NCT00029328|Respiratory Function Tests|respiratory function tests
784094|NCT00029315|Intraventricular hemorrhage|intraventricular hemorrhage
784095|NCT00029315|Subarachnoid hemorrhage|subarachnoid hemorrhage
784096|NCT00029315|Intracerebral hemorrhage|intracerebral hemorrhage
784097|NCT00029315|Pharmacokinetics|pharmacokinetics
784098|NCT00029315|Recombinant Proteins|recombinant proteins
784099|NCT00029315|Anticoagulants|anticoagulants
784100|NCT00029315|Tissue Plasminogen Activator|tissue plasminogen activator
784101|NCT00029315|Pharmacology|pharmacology
784102|NCT00029315|Catheters, Indwelling|catheters, indwelling
784103|NCT00029315|Cerebral Ventricles|cerebral ventricles
784104|NCT00029302|fMRI|fmri
784105|NCT00029302|Voluntary Movement|voluntary movement
784106|NCT00029302|Healthy Volunteer|healthy volunteer
784107|NCT00029302|HV|hv
784108|NCT00029302|Normal Control|normal control
784109|NCT00029276|Parkinson's|parkinson's
784110|NCT00029276|Depression|depression
784111|NCT00029276|Magnetic Stimulation|magnetic stimulation
784112|NCT00029250|complementary therapies|complementary therapies
784113|NCT00029250|garlic|garlic
784114|NCT00029250|Allium sativum|allium sativum
784115|NCT00029250|metabolic diseases|metabolic diseases
784116|NCT00029250|HAART|haart
784117|NCT00029250|Protease inhibitors|protease inhibitors
784118|NCT00029237|Behavioral intervention|behavioral intervention
784119|NCT00029237|Psychoneuroimmunology|psychoneuroimmunology
784120|NCT00029237|Complementary therapy|complementary therapy
784121|NCT00029237|Stress and coping|stress and coping
792828|NCT00015600|Pesticide|pesticide
784122|NCT00029237|complementary therapies|complementary therapies
784123|NCT00029224|bone lesions|bone lesions
784124|NCT00029224|breast cancer|breast cancer
784125|NCT00029224|multiple myeloma|multiple myeloma
784126|NCT00029224|prostate cancer|prostate cancer
784127|NCT00029224|bone metastases|bone metastases
784128|NCT00029224|pain|pain
784129|NCT00029198|Massage Therapy|massage therapy
784130|NCT00029198|Preterm Infants|preterm infants
784131|NCT00029198|Weight Gain|weight gain
784132|NCT00029198|Vagal Tone|vagal tone
784133|NCT00029198|IGF-1|igf-1
784134|NCT00029198|Oxytocin|oxytocin
784135|NCT00029198|Brazelton|brazelton
784136|NCT00029185|Corneal Erosion|corneal erosion
784137|NCT00029185|Dextrans|dextrans
784138|NCT00029185|Administration, Topical|administration, topical
784139|NCT00029185|Ophthalmic Solutions|ophthalmic solutions
784140|NCT00029185|Thimerosal|thimerosal
784141|NCT00029172|stroke|stroke
784142|NCT00029172|depression|depression
784143|NCT00029159|Turner syndrome|turner syndrome
784144|NCT00029159|estrogen|estrogen
784145|NCT00029159|androgen|androgen
784146|NCT00029159|growth hormone|growth hormone
784147|NCT00029146|stroke|stroke
784148|NCT00029146|transient ischemic attack (TIA)|transient ischemic attack (tia)
784149|NCT00029146|carotid arteries|carotid arteries
784150|NCT00029146|cerebral infarction|cerebral infarction
784151|NCT00029133|aneurysm|aneurysm
784152|NCT00029133|hypothermia|hypothermia
784153|NCT00029133|subarachnoid intracranial hemorrhage|subarachnoid intracranial hemorrhage
784154|NCT00028431|Stage III melanoma|stage iii melanoma
784155|NCT00028431|Stage IV melanoma|stage iv melanoma
784156|NCT00028431|Interleukin-12|interleukin-12
784157|NCT00028431|Cancer Vaccines|cancer vaccines
784158|NCT00028431|Antineoplastic Agents, Combined|antineoplastic agents, combined
784159|NCT00028431|Incomplete Freund's adjuvant|incomplete freund's adjuvant
784160|NCT00028431|Monophenol Monooxygenase|monophenol monooxygenase
784161|NCT00028431|Mannitol|mannitol
784162|NCT00028431|Adjuvants, Immunologic|adjuvants, immunologic
784163|NCT00028431|Melan-A Protein|melan-a protein
784164|NCT00028431|Antigens, Neoplasm|antigens, neoplasm
784165|NCT00028431|Antibodies|antibodies
784166|NCT00028431|Melanocyte lineage-specific antigen gp100|melanocyte lineage-specific antigen gp100
784167|NCT00028431|CTLA-4|ctla-4
784168|NCT00028418|Acute Leukemia|acute leukemia
784169|NCT00028418|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
784170|NCT00028418|Antineoplastic Agents|antineoplastic agents
784171|NCT00028418|Nucleosides|nucleosides
784172|NCT00028418|Dose-Response Relationship, Drug|dose-response relationship, drug
784173|NCT00028418|Cladribine|cladribine
784174|NCT00028418|Fludarabine|fludarabine
784175|NCT00028405|Photodynamic Therapy|photodynamic therapy
784176|NCT00028405|Bulky Tumor|bulky tumor
784177|NCT00028405|Refractory Tumor|refractory tumor
784178|NCT00028405|Head and Neck Cancer|head and neck cancer
784179|NCT00028405|Breast Cancer|breast cancer
784180|NCT00028405|Pelvic Tumors|pelvic tumors
784181|NCT00028405|Liver Metastasis|liver metastasis
784182|NCT00028405|Colorectal Cancer|colorectal cancer
784183|NCT00028405|Sarcoma|sarcoma
784184|NCT00028405|Anal Cancer|anal cancer
784185|NCT00028405|Oral Cancer|oral cancer
784186|NCT00028405|Recurrent|recurrent
784187|NCT00028405|Lymphadenopathy|lymphadenopathy
784188|NCT00028405|Ovarian Cancer|ovarian cancer
784189|NCT00028405|Cervical Cancer|cervical cancer
784190|NCT00029120|Alzheimer's Disease|alzheimer's disease
784191|NCT00029120|Spectroscopy|spectroscopy
784192|NCT00029120|Longitudinal|longitudinal
784193|NCT00029120|Perfusion|perfusion
784194|NCT00029120|Hippocampus|hippocampus
784195|NCT00029120|N-acetylaspartic Acid|n-acetylaspartic acid
784196|NCT00029120|Cerebral Blood Flow|cerebral blood flow
784197|NCT00029120|Aging|aging
784198|NCT00029120|Dementia|dementia
784199|NCT00029120|Alzheimer's|alzheimer's
784200|NCT00029120|Memory Disorder|memory disorder
784201|NCT00029120|Memory|memory
784202|NCT00029120|Healthy Volunteer|healthy volunteer
784203|NCT00029120|HV|hv
784204|NCT00029120|Normal Control|normal control
784205|NCT00029107|Hepatitis|hepatitis
784206|NCT00029107|Vasculitis|vasculitis
784207|NCT00029107|Rituximab|rituximab
784208|NCT00029107|Cryoglobulinemia|cryoglobulinemia
784209|NCT00029107|Hepatitis C|hepatitis c
784210|NCT00029107|HcV-cV|hcv-cv
784211|NCT00029107|Cryoglobulinemic Vasculitis|cryoglobulinemic vasculitis
784212|NCT00029068|Neurophysiology|neurophysiology
784213|NCT00029068|Tourette Syndrome|tourette syndrome
784214|NCT00029068|Anorexia|anorexia
784215|NCT00029068|SRIs|sris
784216|NCT00029068|Personality|personality
784217|NCT00029068|Obsessive-Compulsive Disorder (OCD)|obsessive-compulsive disorder (ocd)
784218|NCT00029068|Cortical Excitability|cortical excitability
784219|NCT00029068|Motor Cortex|motor cortex
784220|NCT00029068|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
784221|NCT00029068|OCD Spectrum Disorders|ocd spectrum disorders
784222|NCT00029068|Obsessive Compulsive|obsessive compulsive
784223|NCT00029068|OCD|ocd
784224|NCT00029068|Healthy Volunteer|healthy volunteer
784225|NCT00029068|Normal Control|normal control
784228|NCT00029042|Inflammation|inflammation
784229|NCT00029042|Joint Disability|joint disability
784230|NCT00029042|Imaging|imaging
784231|NCT00029042|Biologic Therapy|biologic therapy
784232|NCT00029042|Rheumatoid Arthritis|rheumatoid arthritis
784233|NCT00029042|Juvenile Rheumatoid Arthritis|juvenile rheumatoid arthritis
784234|NCT00029042|JRA|jra
784235|NCT00029042|Children|children
784236|NCT00029042|Joints|joints
784237|NCT00029042|Joint Inflammation|joint inflammation
784238|NCT00028379|Plasticity|plasticity
784239|NCT00028379|Motor Cortex|motor cortex
784240|NCT00028379|Stroke|stroke
784241|NCT00028379|Somatosensory|somatosensory
784242|NCT00028379|Hemiparesis|hemiparesis
784243|NCT00028366|HIV-1|hiv-1
784244|NCT00028366|Drug Therapy, Combination|drug therapy, combination
784245|NCT00028366|HIV Protease Inhibitors|hiv protease inhibitors
784246|NCT00028366|Ritonavir|ritonavir
784247|NCT00028366|RNA, Viral|rna, viral
784248|NCT00028366|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
784249|NCT00028366|Viral Load|viral load
784250|NCT00028366|ABT 378|abt 378
784251|NCT00028366|tenofovir disoproxil|tenofovir disoproxil
784252|NCT00028366|VX-175|vx-175
784253|NCT00028366|Treatment Experienced|treatment experienced
784254|NCT00028353|PIN|pin
784255|NCT00028353|High Grade Prostate Intraepithelial Neoplasia (PIN)|high grade prostate intraepithelial neoplasia (pin)
784256|NCT00028340|Breast Cancer|breast cancer
784257|NCT00028340|Post Menopausal|post menopausal
784258|NCT00028340|Breast Duct|breast duct
784259|NCT00028340|Healthy Volunteer|healthy volunteer
784260|NCT00028340|HV|hv
784261|NCT00028340|Normal Control|normal control
784262|NCT00028327|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
784263|NCT00028327|Zidovudine|zidovudine
784264|NCT00028327|HIV Protease Inhibitors|hiv protease inhibitors
784265|NCT00028327|CD4 Lymphocyte Count|cd4 lymphocyte count
784266|NCT00028327|Lamivudine|lamivudine
784267|NCT00028327|Pneumonia|pneumonia
784268|NCT00028327|Nelfinavir|nelfinavir
784269|NCT00028327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
784270|NCT00028327|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
784271|NCT00028327|Efavirenz|efavirenz
784272|NCT00028327|Intensive Care Units|intensive care units
784273|NCT00028327|Sepsis|sepsis
784274|NCT00028314|HIV-1|hiv-1
784275|NCT00028314|Abacavir|abacavir
784276|NCT00028314|Nevirapine|nevirapine
784277|NCT00028314|Ritonavir|ritonavir
784278|NCT00028314|RNA, Viral|rna, viral
784279|NCT00028314|HIV Protease Inhibitors|hiv protease inhibitors
784280|NCT00028314|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
784281|NCT00028314|Anti-HIV Agents|anti-hiv agents
784282|NCT00028314|Viral Load|viral load
784283|NCT00028314|HIV Wasting Syndrome|hiv wasting syndrome
784284|NCT00028314|ABT 378|abt 378
784285|NCT00028314|Treatment Experienced|treatment experienced
784286|NCT00028301|HIV Protease Inhibitors|hiv protease inhibitors
784287|NCT00028301|RNA, Viral|rna, viral
784288|NCT00028301|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
784289|NCT00028301|Anti-HIV Agents|anti-hiv agents
784290|NCT00028301|Viral Load|viral load
784291|NCT00028301|Lipids|lipids
784292|NCT00028301|ABT 378|abt 378
784293|NCT00028301|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
784294|NCT00028301|Lipoproteins, LDL Cholesterol|lipoproteins, ldl cholesterol
784295|NCT00028288|Asthma|asthma
784296|NCT00028288|Daclizumab|daclizumab
784297|NCT00028288|anti-Tac monoclonal antibody|anti-tac monoclonal antibody
784298|NCT00028288|anti-IL-2|anti-il-2
784299|NCT00028288|Zenapax|zenapax
784300|NCT00028275|Hepatitis C Virus|hepatitis c virus
784301|NCT00028275|Cirrhosis|cirrhosis
784302|NCT00028275|Antiviral Agents|antiviral agents
784303|NCT00028275|Viral Resistance|viral resistance
784304|NCT00028275|Alpha Interferon|alpha interferon
784305|NCT00028275|Hepatitis C|hepatitis c
784306|NCT00028275|Hepatitis|hepatitis
784307|NCT00028262|Palmitoyl-Protein Thioesterase|palmitoyl-protein thioesterase
784308|NCT00028262|Lysosomes|lysosomes
784309|NCT00028262|Batten Disease|batten disease
784310|NCT00028262|Encephalopathy|encephalopathy
784311|NCT00028262|Progressive Neurodegeneration|progressive neurodegeneration
784312|NCT00028262|CLN 1|cln 1
784313|NCT00028262|Infantile Neuronal Ceroid Lipofuscinosis|infantile neuronal ceroid lipofuscinosis
784314|NCT00028262|Cystagon|cystagon
784315|NCT00028249|Patient Satisfaction|patient satisfaction
784316|NCT00028249|Self Efficacy|self efficacy
784317|NCT00028249|Social Support|social support
784318|NCT00028249|Symptom Management|symptom management
784319|NCT00028249|Advanced Malignancies|advanced malignancies
784320|NCT00028249|Pain Intervention|pain intervention
784321|NCT00028236|Peripheral Blood Stem Cells|peripheral blood stem cells
784322|NCT00028236|Common Gamma Chain (GC)|common gamma chain (gc)
784323|NCT00028236|Immune Reconstitution|immune reconstitution
784324|NCT00028236|T Lymphocytes|t lymphocytes
784325|NCT00028236|B Lymphocytes|b lymphocytes
784326|NCT00028236|X-Linked Severe Combined Immune Deficiency (XSCID)|x-linked severe combined immune deficiency (xscid)
784327|NCT00028236|Gene Therapy|gene therapy
784329|NCT00028236|Bone Marrow Transplantation|bone marrow transplantation
784330|NCT00028236|Engraftment|engraftment
784331|NCT00028236|XSCID|xscid
784332|NCT00028236|Immune Deficiency|immune deficiency
784333|NCT00028236|Immune System|immune system
784334|NCT00028210|Amputee|amputee
784335|NCT00028210|Plasticity|plasticity
784336|NCT00028210|Somatosensory|somatosensory
784337|NCT00028210|Upper Limb Amputation|upper limb amputation
784338|NCT00028210|Tactile Performance|tactile performance
784339|NCT00028210|Cortical Reorganization|cortical reorganization
784340|NCT00028210|Healthy Volunteer|healthy volunteer
784341|NCT00028210|HV|hv
784342|NCT00028210|Normal Control|normal control
784343|NCT00028197|Voluntary Movement|voluntary movement
784344|NCT00028197|Functional MRI|functional mri
784345|NCT00028197|Sensorimotor Integration|sensorimotor integration
784346|NCT00028197|Superior Parietal Lobe|superior parietal lobe
784347|NCT00028197|Supplementary Motor Area|supplementary motor area
784348|NCT00028197|Normal Control|normal control
784349|NCT00028197|HV|hv
784350|NCT00028197|Healthy Volunteer|healthy volunteer
784351|NCT00028184|Chronic Stroke|chronic stroke
784352|NCT00028184|Ipsilateral Motor Cortex|ipsilateral motor cortex
784353|NCT00028184|Motor Control|motor control
784354|NCT00028184|Motor Recovery|motor recovery
784355|NCT00028184|Stroke|stroke
784356|NCT00028184|Healthy Volunteer|healthy volunteer
784357|NCT00028184|HV|hv
784358|NCT00028184|Healthy Control|healthy control
784359|NCT00028158|Antineoplastic agents|antineoplastic agents
784360|NCT00028158|Herpes virus|herpes virus
784361|NCT00028158|Brain tumor|brain tumor
784362|NCT00028158|Oncolytic virs|oncolytic virs
784363|NCT00028145|Women's Health|women's health
784364|NCT00028145|Disease Transmission, Vertical|disease transmission, vertical
784365|NCT00028145|Preventive Medicine|preventive medicine
784366|NCT00028145|Treatment Experienced|treatment experienced
784367|NCT00028132|Risk Factors|risk factors
784368|NCT00028132|Mucous Membrane|mucous membrane
784369|NCT00028132|Anti-Infective Agents|anti-infective agents
784370|NCT00028132|Cervix Uteri|cervix uteri
784371|NCT00028132|Vagina|vagina
784372|NCT00028132|Anti-HIV Agents|anti-hiv agents
784373|NCT00028132|Pharmacokinetics|pharmacokinetics
784374|NCT00028132|Vulva|vulva
784375|NCT00028132|9-(2-phosphonylmethoxypropyl)adenine|9-(2-phosphonylmethoxypropyl)adenine
784376|NCT00028132|HIV Seronegativity|hiv seronegativity
784377|NCT00028119|Clinical Trials|clinical trials
784378|NCT00028119|Sexual Partners|sexual partners
784379|NCT00028119|Risk Factors|risk factors
784380|NCT00028119|Incidence|incidence
784381|NCT00028119|HIV Seronegativity|hiv seronegativity
784382|NCT00028119|India|india
784383|NCT00028119|Patient Compliance|patient compliance
784384|NCT00028119|Preventive Health Services|preventive health services
784385|NCT00028106|Cancer|cancer
784386|NCT00028106|Metastasis|metastasis
784387|NCT00028106|Fluorodopamine|fluorodopamine
784388|NCT00028106|PET|pet
784389|NCT00028106|Methylprednisolone|methylprednisolone
784390|NCT00028106|Catecholamines|catecholamines
784391|NCT00028106|Metanephrines|metanephrines
784392|NCT00028106|Alpha-Methyl-Para-Tyrosine|alpha-methyl-para-tyrosine
784393|NCT00028106|Retinoic Acid|retinoic acid
784394|NCT00028106|Carbidopa|carbidopa
784395|NCT00028093|Chronic Hepatitis|chronic hepatitis
784396|NCT00028093|Cirrhosis|cirrhosis
784397|NCT00028093|Hepatitis C Virus|hepatitis c virus
784398|NCT00028093|Hemolysis|hemolysis
784399|NCT00028093|Ribavirin|ribavirin
784400|NCT00028093|Alpha Interferon|alpha interferon
784401|NCT00028093|Peginterferon|peginterferon
784402|NCT00028093|Antiviral Agents|antiviral agents
784403|NCT00028093|Viral Hepatitis|viral hepatitis
784404|NCT00028093|Hemolytic Anemia|hemolytic anemia
784405|NCT00028093|Renal Failure|renal failure
784406|NCT00028093|Renal Dialysis|renal dialysis
784407|NCT00028093|Hepatitis|hepatitis
784408|NCT00028093|Hepatitis C|hepatitis c
784409|NCT00028080|Borrelia Burgdorferi|borrelia burgdorferi
784410|NCT00028080|Lyme Disease|lyme disease
784411|NCT00028080|Infection|infection
784412|NCT00028080|Therapy|therapy
784413|NCT00028080|Lyme|lyme
784414|NCT00028067|Drug Therapy, Combination|drug therapy, combination
784415|NCT00028067|HIV Protease Inhibitors|hiv protease inhibitors
784416|NCT00028067|RNA, Viral|rna, viral
784417|NCT00028067|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
784418|NCT00028067|Viral Load|viral load
784419|NCT00028067|BMS 232632|bms 232632
784420|NCT00027482|T Cell|t cell
784421|NCT00027482|B Cell|b cell
784422|NCT00027482|Flow Cytometry|flow cytometry
784423|NCT00027482|Cell-Mediated Immunity|cell-mediated immunity
784424|NCT00027482|Thymus|thymus
784425|NCT00027482|HIV|hiv
784426|NCT00027482|Immunity|immunity
784427|NCT00027482|Lymphocytes|lymphocytes
784428|NCT00027482|Monocytes|monocytes
784429|NCT00027482|Healthy Volunteer|healthy volunteer
784430|NCT00027482|HV|hv
784431|NCT00027482|Normal Control|normal control
784432|NCT00027469|Atheroembolism|atheroembolism
784433|NCT00027469|Atherosclerosis|atherosclerosis
784434|NCT00027469|MRI|mri
784435|NCT00027469|Renal Artery Stenosis|renal artery stenosis
784436|NCT00027469|Renovascular Hypertension|renovascular hypertension
784437|NCT00027469|ARAS|aras
784438|NCT00027469|Renovascular Disease|renovascular disease
784439|NCT00027469|Renal Artery Stenting|renal artery stenting
784440|NCT00027469|PTRAS|ptras
784441|NCT00027456|Insulin Resistance|insulin resistance
784442|NCT00027456|Diabetes Mellitus|diabetes mellitus
784443|NCT00027456|Adipocytes|adipocytes
784444|NCT00027456|Rabson Mendenhall Syndrome|rabson mendenhall syndrome
784445|NCT00027456|Leprechaunism|leprechaunism
784446|NCT00027456|Leptin|leptin
784447|NCT00027443|Giant Cell Myocarditis|giant cell myocarditis
784448|NCT00027417|Congenital heart defects|congenital heart defects
784449|NCT00027417|Hypoplastic left heart syndrome|hypoplastic left heart syndrome
784450|NCT00027417|Complete atrioventricular canal defect|complete atrioventricular canal defect
784451|NCT00027417|Triostat|triostat
784452|NCT00027417|Cardiac surgery|cardiac surgery
784453|NCT00027404|Adult, Autism|adult, autism
784454|NCT00027391|Muscle Weakness, Muscular Dystrophy|muscle weakness, muscular dystrophy
784455|NCT00027378|fluoxetine,|fluoxetine,
784456|NCT00027378|adolescents,|adolescents,
784457|NCT00027378|alcohol dependence,|alcohol dependence,
784458|NCT00027378|major depression|major depression
784459|NCT00027378|Alcoholism|alcoholism
784460|NCT00027365|HIV Seronegativity|hiv seronegativity
784461|NCT00027365|HIV Preventive Vaccine|hiv preventive vaccine
784462|NCT00027365|Injections, Intramuscular|injections, intramuscular
784463|NCT00027365|HIV Antibodies|hiv antibodies
784464|NCT00027365|HIV-1|hiv-1
784465|NCT00027365|HIV Envelope Protein gp120|hiv envelope protein gp120
784466|NCT00027365|Gene Products, tat|gene products, tat
784467|NCT00027365|AIDS Vaccines|aids vaccines
784468|NCT00027365|Neutralization Tests|neutralization tests
784469|NCT00027365|Vaccines, Combined|vaccines, combined
784470|NCT00027365|AIDS Seronegativity|aids seronegativity
784471|NCT00027365|Gene Products, nef|gene products, nef
784472|NCT00027352|Physician's Practice Patterns|physician's practice patterns
784473|NCT00027352|Anti-HIV Agents|anti-hiv agents
784474|NCT00027339|HIV-1|hiv-1
784475|NCT00027339|HIV Protease Inhibitors|hiv protease inhibitors
784476|NCT00027339|RNA, Viral|rna, viral
784477|NCT00027339|Phenotype|phenotype
784478|NCT00027339|Viral Load|viral load
784479|NCT00027339|Pharmacokinetics|pharmacokinetics
784480|NCT00027339|Treatment Experienced|treatment experienced
784481|NCT00027326|Blood|blood
784482|NCT00027326|Samples|samples
784483|NCT00027326|Radiation|radiation
784484|NCT00027326|Urine|urine
784485|NCT00027326|Cancer|cancer
784486|NCT00027326|Radiation Therapy|radiation therapy
784487|NCT00027300|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
784488|NCT00027287|Type I Diabetes|type i diabetes
784489|NCT00027287|Type 2 Diabetes|type 2 diabetes
784490|NCT00027287|Diode Laser Photocoagulation|diode laser photocoagulation
784491|NCT00027287|Vitamin E|vitamin e
784492|NCT00027287|Elevated Low-Density Lipoprotein (LDL-C) Cholesterol|elevated low-density lipoprotein (ldl-c) cholesterol
784493|NCT00027287|Diabetic Retinopathy|diabetic retinopathy
784494|NCT00027287|Macular Edema|macular edema
784495|NCT00027287|Type II Diabetes|type ii diabetes
784496|NCT00027274|Fanconi's Anemia|fanconi's anemia
784497|NCT00027274|Diamond Blackfan Anemia|diamond blackfan anemia
784498|NCT00027274|Dyskeratosis Congenita|dyskeratosis congenita
784499|NCT00027274|Shwachman-Diamond Syndrome|shwachman-diamond syndrome
784500|NCT00027274|Hereditary|hereditary
784501|NCT00027274|Bone Marrow|bone marrow
784502|NCT00027274|Inherited Bone Marrow Failure Syndromes|inherited bone marrow failure syndromes
784503|NCT00027274|IBMFS|ibmfs
784504|NCT00027274|Familial Cancer|familial cancer
784505|NCT00027261|Vaccines, Synthetic|vaccines, synthetic
784506|NCT00027261|HIV-1|hiv-1
784507|NCT00027261|AIDS Vaccines|aids vaccines
784508|NCT00027261|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
784509|NCT00027261|HIV Seronegativity|hiv seronegativity
784510|NCT00027261|Avipoxvirus|avipoxvirus
784511|NCT00027261|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
784512|NCT00027261|HIV Preventive Vaccine|hiv preventive vaccine
784513|NCT00027248|central venous catheter|central venous catheter
784514|NCT00027248|bloodstream infection|bloodstream infection
784515|NCT00027248|CVC|cvc
784516|NCT00027248|catheter colonization|catheter colonization
784517|NCT00027248|local catheter site infection|local catheter site infection
784518|NCT00027209|seizures|seizures
784519|NCT00027209|epilepsy|epilepsy
784520|NCT00027209|menopause|menopause
784521|NCT00027196|Genetics|genetics
784522|NCT00027196|Cardiac Diseases|cardiac diseases
784523|NCT00027196|Cardiac Hypertrophy|cardiac hypertrophy
784524|NCT00027196|Sudden Death|sudden death
784525|NCT00027196|Arrhythmias|arrhythmias
784526|NCT00027183|Cystic Fibrosis|cystic fibrosis
784527|NCT00027183|Effector Proteins|effector proteins
784528|NCT00027183|Cytotoxin|cytotoxin
784529|NCT00027183|Lung Injury|lung injury
784530|NCT00027183|Genetic Screen|genetic screen
784531|NCT00027170|Myocardial Infarction|myocardial infarction
784532|NCT00027170|Myocardial Viability|myocardial viability
784533|NCT00027170|Myocardial Perfusion|myocardial perfusion
784534|NCT00027170|Myocardial Ischemia|myocardial ischemia
784535|NCT00027170|Atherosclerosis|atherosclerosis
784536|NCT00027170|Cardiovascular Disease|cardiovascular disease
784537|NCT00027170|Coronary Artery Disease|coronary artery disease
784538|NCT00027157|Coronary Spasm|coronary spasm
784539|NCT00027157|Endothelial-Derived-Relaxation Factor|endothelial-derived-relaxation factor
784540|NCT00027157|Nitric Oxide Synthase|nitric oxide synthase
784541|NCT00027157|Susceptibility Genes|susceptibility genes
784542|NCT00027157|Tetrahydrobiopterin|tetrahydrobiopterin
784543|NCT00027144|Leukemia|leukemia
784544|NCT00027144|Vaccine|vaccine
784545|NCT00027131|vaccine|vaccine
784546|NCT00027131|immunotherapy|immunotherapy
784547|NCT00027118|Shoulder|shoulder
784548|NCT00027118|Breast Cancer|breast cancer
784549|NCT00027118|Physical Therapy|physical therapy
784550|NCT00027118|Lymphedema|lymphedema
784551|NCT00027118|Quality of Life|quality of life
784552|NCT00027118|Breast Cancer Surgery|breast cancer surgery
784553|NCT00027118|Healthy Volunteer|healthy volunteer
784554|NCT00027118|HV|hv
784555|NCT00027118|Normal Control|normal control
784556|NCT00027105|Fatigue|fatigue
784557|NCT00027105|Shoulder function|shoulder function
784558|NCT00027105|Lymphedema|lymphedema
784559|NCT00027105|Breast Cancer|breast cancer
784560|NCT00027105|Breast Cancer Surgery|breast cancer surgery
784561|NCT00027105|Quality of Life|quality of life
784562|NCT00027092|Infusions, Intravenous|infusions, intravenous
784563|NCT00027092|Testosterone|testosterone
784564|NCT00027092|Insulin Resistance|insulin resistance
784565|NCT00027092|Hormone Replacement Therapy|hormone replacement therapy
784566|NCT00027092|Glucose Tolerance Test|glucose tolerance test
784567|NCT00027066|stroke|stroke
784568|NCT00027066|aspirin|aspirin
784569|NCT00027066|warfarin|warfarin
784570|NCT00027053|alcoholism|alcoholism
784571|NCT00027053|alcohol dependence|alcohol dependence
784572|NCT00027053|trazadone|trazadone
784573|NCT00027053|sleep|sleep
784574|NCT00027040|AIDS Dementia Complex|aids dementia complex
784575|NCT00027040|Selegiline|selegiline
784576|NCT00027040|Oxidative Stress|oxidative stress
784577|NCT00027040|Cognition|cognition
784578|NCT00027040|Neuroprotective Agents|neuroprotective agents
784579|NCT00027040|Brain Injuries|brain injuries
784580|NCT00027040|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
784581|NCT00027040|Protons|protons
784582|NCT00027014|opioid|opioid
784583|NCT00027014|St. John's wort|st. john's wort
784584|NCT00027014|analgesia|analgesia
784585|NCT00027014|metabolism|metabolism
784586|NCT00027014|transporter|transporter
784587|NCT00027001|Qigong, exercise, circulatory assist devices|qigong, exercise, circulatory assist devices
784588|NCT00026988|Huntington's disease|huntington's disease
784589|NCT00026988|creatine|creatine
784590|NCT00026988|energy depletion|energy depletion
784591|NCT00026975|Laryngeal Cancer|laryngeal cancer
784592|NCT00026975|Laryngectomy|laryngectomy
784593|NCT00026975|Tissue Oxygenation|tissue oxygenation
784594|NCT00026975|Irradiated Tissue|irradiated tissue
784595|NCT00026975|Hyperbaric Oxygen|hyperbaric oxygen
784596|NCT00026975|Angiogenesis|angiogenesis
784597|NCT00026975|EF5|ef5
784598|NCT00026962|Breast|breast
784599|NCT00026962|Hormones|hormones
784600|NCT00026962|Prevention|prevention
784601|NCT00026962|Saliva|saliva
784602|NCT00026962|Serum|serum
784603|NCT00026949|Etoposide|etoposide
784604|NCT00026949|Breast Cancer|breast cancer
784605|NCT00026949|Pharmacokinetics|pharmacokinetics
784606|NCT00026936|External Beam Radiotherapy|external beam radiotherapy
784607|NCT00026936|TCP|tcp
784608|NCT00026936|DVH|dvh
784609|NCT00026936|NTCP|ntcp
784610|NCT00026936|3-D Programming|3-d programming
784611|NCT00026923|Laparoscopy|laparoscopy
784612|NCT00026923|Telemedicine|telemedicine
784613|NCT00026923|Surgery|surgery
784614|NCT00026923|Endoscopy|endoscopy
784615|NCT00026910|Cell-Cycle|cell-cycle
784616|NCT00026910|Apoptosis|apoptosis
784617|NCT00026910|Molecular Prognosis|molecular prognosis
784618|NCT00026897|Adoptive Immunotherapy|adoptive immunotherapy
784619|NCT00026897|Cellular Therapy|cellular therapy
784620|NCT00026897|Lymphocyte Migration|lymphocyte migration
784621|NCT00026897|Tumor Imaging|tumor imaging
784622|NCT00026884|Serum|serum
784623|NCT00026884|Collection of Tissue|collection of tissue
784624|NCT00026884|Malignant Disease|malignant disease
784625|NCT00026884|Molecular Basis|molecular basis
784626|NCT00026884|Genome Sequencing|genome sequencing
784627|NCT00026871|Non-Therapeutic|non-therapeutic
784628|NCT00026871|Radiation Therapy|radiation therapy
784629|NCT00026871|Dosimetry|dosimetry
784630|NCT00026871|Dose-Rate|dose-rate
784631|NCT00026871|Fiberoptic|fiberoptic
784632|NCT00026858|Bone Marrow Transplantation|bone marrow transplantation
784633|NCT00026858|Leukemia|leukemia
784634|NCT00026858|Breast Cancer|breast cancer
784635|NCT00026858|Multiple Myeloma|multiple myeloma
784636|NCT00026858|Total Body Irradiation|total body irradiation
784637|NCT00026832|PET|pet
784638|NCT00026832|Major Depression|major depression
784640|NCT00026832|Cerebral Blood Flow|cerebral blood flow
784641|NCT00026832|Neuroendocrine|neuroendocrine
784642|NCT00026832|Bipolar Disorder|bipolar disorder
784643|NCT00026832|Serotonin1A|serotonin1a
784644|NCT00026832|Mood Disorder|mood disorder
784645|NCT00026832|Major Depressive Disorder|major depressive disorder
784646|NCT00026832|MDD|mdd
784647|NCT00026832|Depression|depression
784648|NCT00026832|Healthy Volunteer|healthy volunteer
784649|NCT00026832|HV|hv
784650|NCT00026832|Normal Control|normal control
784651|NCT00026819|NSAID|nsaid
784652|NCT00026819|Acute Pain Model|acute pain model
784653|NCT00026819|Hyperalgesia|hyperalgesia
784654|NCT00026819|Central Sensitization|central sensitization
784655|NCT00026819|Wisdom Teeth|wisdom teeth
784656|NCT00026819|Wisdom Teeth Extraction|wisdom teeth extraction
784657|NCT00026819|Third Molar|third molar
784658|NCT00026806|HIV Infection|hiv infection
784659|NCT00026806|Mental Health|mental health
784660|NCT00026806|Risk Behaviors|risk behaviors
784661|NCT00026806|Post-Traumatic Stress Disorder|post-traumatic stress disorder
784662|NCT00026806|Youth|youth
784663|NCT00026806|HIV|hiv
784664|NCT00026806|Long Term Survivor|long term survivor
784665|NCT00026793|Kaposi Sarcoma|kaposi sarcoma
784666|NCT00026793|Doppler|doppler
784667|NCT00026793|Infrared|infrared
784668|NCT00026793|HIV|hiv
784669|NCT00026793|Imaging|imaging
784670|NCT00026793|Kaposi's Sarcoma|kaposi's sarcoma
784671|NCT00026793|Laser Imaging|laser imaging
784672|NCT00026793|Infrared Imaging|infrared imaging
784673|NCT00026780|CT Scan|ct scan
784674|NCT00026780|MRI Scan|mri scan
784675|NCT00026780|Childhood Cancer|childhood cancer
784676|NCT00026780|Eligibility Screening|eligibility screening
784677|NCT00026780|Tissue Procurement|tissue procurement
784678|NCT00026780|Pediatric|pediatric
784679|NCT00026780|Children|children
784680|NCT00026780|Screening|screening
784681|NCT00026767|Risk Factors|risk factors
784682|NCT00026767|Epidemiology|epidemiology
784683|NCT00026767|BMT/SCT|bmt/sct
784684|NCT00026767|Fungal Infection|fungal infection
784685|NCT00026767|Bone Marrow Stem Cell Transplant|bone marrow stem cell transplant
784686|NCT00026767|Organ Transplant|organ transplant
784687|NCT00026754|Screening|screening
784688|NCT00026754|Cancer|cancer
784689|NCT00026754|HIV Infection|hiv infection
784690|NCT00026754|Scans|scans
784691|NCT00026754|Laboratory Tests|laboratory tests
784692|NCT00026754|HIV|hiv
784693|NCT00026754|Skin Disorders|skin disorders
784694|NCT00026741|Cytokine|cytokine
784695|NCT00026741|Inflammation|inflammation
784696|NCT00026741|Lymphocyte|lymphocyte
784697|NCT00026741|T Cell|t cell
784698|NCT00026741|Migration|migration
784699|NCT00026741|Healthy Volunteer|healthy volunteer
784700|NCT00026741|Skin Biopsy|skin biopsy
784701|NCT00026728|Human Herpesvirus B|human herpesvirus b
784702|NCT00026728|NHANES|nhanes
784703|NCT00026728|Epidemiology|epidemiology
784704|NCT00026728|Population-Based Study|population-based study
784705|NCT00026728|Kaposi's Sarcoma Herpes Virus|kaposi's sarcoma herpes virus
784706|NCT00026715|Renal Function|renal function
784707|NCT00026715|Iothalamate|iothalamate
784708|NCT00026702|Acute Renal Failure|acute renal failure
784709|NCT00026702|Biomarkers|biomarkers
784710|NCT00026689|Evaluation|evaluation
784711|NCT00026689|Screening|screening
784712|NCT00026689|Cancer|cancer
784713|NCT00026689|Radiation|radiation
784714|NCT00026689|Eligibility|eligibility
784715|NCT00026676|Surrogate Markers|surrogate markers
784716|NCT00026676|Genotypic Resistance|genotypic resistance
784717|NCT00026676|Phenotypic Resistance|phenotypic resistance
784718|NCT00026676|Selenium|selenium
784719|NCT00026663|Assays|assays
784720|NCT00026663|Resistance|resistance
784721|NCT00026663|Biopsy Samples|biopsy samples
784722|NCT00026663|Specimen Acquisition|specimen acquisition
784723|NCT00026663|Cancer Cells|cancer cells
784724|NCT00026650|Late Effects|late effects
784725|NCT00026650|Radiation Therapy|radiation therapy
784726|NCT00026650|Cancer|cancer
784727|NCT00026637|depression|depression
784728|NCT00026637|epilepsy|epilepsy
784729|NCT00026637|seizures|seizures
784730|NCT00026624|Virus Replication|virus replication
784731|NCT00026624|Injections, Subcutaneous|injections, subcutaneous
784732|NCT00026624|HIV-1|hiv-1
784733|NCT00026624|AIDS Vaccines|aids vaccines
784734|NCT00026624|Dendritic Cells|dendritic cells
784735|NCT00026624|Adoptive Transfer|adoptive transfer
784736|NCT00026624|Keyhole-Limpet Hemocyanin|keyhole-limpet hemocyanin
784737|NCT00026624|HIV Therapeutic Vaccine|hiv therapeutic vaccine
784738|NCT00026611|Vaccine prophylaxis|vaccine prophylaxis
784739|NCT00026598|Basal Ganglia|basal ganglia
784740|NCT00026598|Cerebral Cortex|cerebral cortex
784741|NCT00026598|Functional Neuroanatomy|functional neuroanatomy
784742|NCT00026598|Bradykinesia|bradykinesia
784743|NCT00026598|Bradyphrenia|bradyphrenia
784744|NCT00026598|Parkinson's Disease|parkinson's disease
784745|NCT00026598|Parkinson Disease|parkinson disease
784746|NCT00026598|PD|pd
784747|NCT00026598|Healthy Volunteer|healthy volunteer
784749|NCT00026598|Normal Control|normal control
784750|NCT00026585|Bipolar Disorder|bipolar disorder
784751|NCT00026585|Antimanic|antimanic
784752|NCT00026585|Placebo Controlled|placebo controlled
784753|NCT00026585|Randomized|randomized
784754|NCT00026585|Cytochrome P450|cytochrome p450
784755|NCT00026585|Mania|mania
784756|NCT00026585|PKC Inhibitor|pkc inhibitor
784757|NCT00026585|Tamoxifen|tamoxifen
784758|NCT00026585|Bipolar|bipolar
784759|NCT00026585|Manic|manic
784760|NCT00026585|BPD|bpd
784761|NCT00026559|Classical Conditioning|classical conditioning
784762|NCT00026559|Fear Conditioning|fear conditioning
784763|NCT00026559|Stress|stress
784764|NCT00026559|Anxiety|anxiety
784765|NCT00026559|Learning|learning
784766|NCT00026559|Normal Volunteers|normal volunteers
784767|NCT00026559|Adults|adults
784768|NCT00026559|Healthy Volunteer|healthy volunteer
784769|NCT00026559|Normal Control|normal control
784770|NCT00026546|Stop Task|stop task
784771|NCT00026546|Functional (BOLD) MRI|functional (bold) mri
784772|NCT00026546|Developmental|developmental
784773|NCT00026546|Inhibitory Control|inhibitory control
784774|NCT00026546|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
784775|NCT00026546|ADHD|adhd
784776|NCT00026546|Impulsivity|impulsivity
784777|NCT00026546|Healthy Volunteer|healthy volunteer
784778|NCT00026546|Normal Volunteer|normal volunteer
784779|NCT00026546|HV|hv
784780|NCT00026065|Hypertension|hypertension
784781|NCT00026065|BIofeedback|biofeedback
784782|NCT00026065|Non-pharmacological treatment|non-pharmacological treatment
784783|NCT00026065|Prediction|prediction
784784|NCT00026052|Riluzole|riluzole
784785|NCT00026052|Neuroprotective|neuroprotective
784786|NCT00026052|Open-Label Study|open-label study
784787|NCT00026052|Glutamate Dysfunction|glutamate dysfunction
784788|NCT00026052|Unipolar Depression|unipolar depression
784789|NCT00026052|Antidepressant|antidepressant
784790|NCT00026052|Depression|depression
784791|NCT00026052|Major Depression|major depression
784792|NCT00026039|stroke|stroke
784793|NCT00026039|estrogen|estrogen
784794|NCT00026026|Human tooth agenesis|human tooth agenesis
784795|NCT00026013|contraception|contraception
784796|NCT00026013|hormonal contraception|hormonal contraception
784797|NCT00026013|herbal remedies|herbal remedies
784798|NCT00026013|hypericum perforatum|hypericum perforatum
784799|NCT00026013|contraceptive effectiveness|contraceptive effectiveness
784800|NCT00026000|Voluntary Movement|voluntary movement
784801|NCT00026000|Basal Ganglia|basal ganglia
784802|NCT00026000|Frontal Lobe|frontal lobe
784803|NCT00026000|Motor Cortex|motor cortex
784804|NCT00026000|Motor Tic Disorder|motor tic disorder
784805|NCT00026000|Tourette's Syndrome|tourette's syndrome
784806|NCT00026000|Vocal Tic Disorder|vocal tic disorder
784807|NCT00026000|Tic|tic
784808|NCT00026000|Healthy Volunteer|healthy volunteer
784809|NCT00026000|HV|hv
784810|NCT00026000|Normal Control|normal control
784811|NCT00025987|Brain|brain
784812|NCT00025987|Temperature|temperature
784813|NCT00025987|Lower|lower
784814|NCT00025987|Tympanic|tympanic
784815|NCT00025987|Rectal|rectal
784816|NCT00025987|Cooling of the Head and Neck|cooling of the head and neck
784817|NCT00025987|Control|control
784818|NCT00025987|Epilepsy|epilepsy
784819|NCT00025987|Healthy Volunteer|healthy volunteer
784820|NCT00025987|HV|hv
784821|NCT00025974|PET|pet
784822|NCT00025974|5-HT1A Receptors|5-ht1a receptors
784823|NCT00025974|Benzodiazepine Receptors|benzodiazepine receptors
784824|NCT00025974|Panic Disorder|panic disorder
784825|NCT00025974|PTSD|ptsd
784826|NCT00025974|Serotonin Type 1A Receptors|serotonin type 1a receptors
784827|NCT00025974|Post-Traumatic Stress Disorder|post-traumatic stress disorder
784828|NCT00025974|Major Depression|major depression
784829|NCT00025974|Anxiety|anxiety
784830|NCT00025974|Depression|depression
784831|NCT00025974|Healthy Volunteer|healthy volunteer
784832|NCT00025974|HV|hv
784833|NCT00025974|Normal Control|normal control
784834|NCT00025935|Mood Disorders|mood disorders
784835|NCT00025935|Bipolar Disorder|bipolar disorder
784836|NCT00025935|Neuroimaging|neuroimaging
784837|NCT00025935|Psychophysiology|psychophysiology
784838|NCT00025935|Frustration|frustration
784839|NCT00025935|Emotional Dysregulation|emotional dysregulation
784840|NCT00025935|Lithium|lithium
784841|NCT00025935|Conduct Disorder|conduct disorder
784842|NCT00025935|Children and Adolescents|children and adolescents
784843|NCT00025935|Affective Neuroscience|affective neuroscience
784844|NCT00025935|Behavioral Dysregulation|behavioral dysregulation
784845|NCT00025935|Mood Disorder|mood disorder
784846|NCT00025935|Behavior|behavior
784847|NCT00025935|Children|children
784848|NCT00025935|Adolescent|adolescent
784849|NCT00025935|Healthy Volunteer|healthy volunteer
784850|NCT00025935|HV|hv
784851|NCT00025935|Normal Control|normal control
784852|NCT00025922|Immunization|immunization
784853|NCT00025922|Titers|titers
784854|NCT00025922|Immune Activation|immune activation
784855|NCT00025922|Antibody|antibody
784856|NCT00025922|CD4 Cell Count|cd4 cell count
784857|NCT00025922|HIV|hiv
784858|NCT00025909|Therapy|therapy
784859|NCT00025909|Antiretrovirals|antiretrovirals
784860|NCT00025909|Interruption|interruption
784861|NCT00025909|CD4+ T Cell|cd4+ t cell
784862|NCT00025909|Plasma Viremia|plasma viremia
784863|NCT00025909|HIV|hiv
784864|NCT00025909|Treatment Experienced|treatment experienced
784865|NCT00025909|Treatment Interuption|treatment interuption
784866|NCT00025883|Lipoatrophic Diabetes|lipoatrophic diabetes
784867|NCT00025883|Diabetes Mellitus|diabetes mellitus
784868|NCT00025883|Hypertriglyceridemia|hypertriglyceridemia
784869|NCT00025883|NASH|nash
784870|NCT00025883|Lipodystrophy|lipodystrophy
784871|NCT00025883|Leptin|leptin
784872|NCT00025883|Diabetes|diabetes
784873|NCT00025870|Genetics|genetics
784874|NCT00025870|Metabolic|metabolic
784875|NCT00025870|Dysmorphology|dysmorphology
784876|NCT00025870|Training|training
784877|NCT00025870|DNA|dna
784878|NCT00025870|DNA Testing|dna testing
784879|NCT00025870|Dysmorphic Syndromes|dysmorphic syndromes
784880|NCT00025870|Developmental Delay|developmental delay
784881|NCT00025870|Genetic Counseling|genetic counseling
784882|NCT00025870|Molecular Genetics|molecular genetics
784883|NCT00025857|fMRI|fmri
784884|NCT00025857|Depression|depression
784885|NCT00025857|PTSD|ptsd
784886|NCT00025857|Emotion|emotion
784887|NCT00025857|Magnetic Resonance Imaging|magnetic resonance imaging
784888|NCT00025857|Anxiety|anxiety
784889|NCT00025857|Normal Volunteers|normal volunteers
784890|NCT00025857|Adolescence|adolescence
784891|NCT00025857|Memory|memory
784892|NCT00025857|Physical/Sexual Abuse History|physical/sexual abuse history
784893|NCT00025857|Post-Traumatic Stress Disorder|post-traumatic stress disorder
784894|NCT00025857|Adolescent|adolescent
784895|NCT00025857|Healthy Volunteer|healthy volunteer
784896|NCT00025857|HV|hv
784897|NCT00025857|Normal Control|normal control
784898|NCT00025844|Stress|stress
784899|NCT00025844|Anxiety|anxiety
784900|NCT00025844|Adults|adults
784901|NCT00025844|Fear Conditioning|fear conditioning
784902|NCT00025844|Normal Volunteers|normal volunteers
784903|NCT00025844|Associative Learning|associative learning
784904|NCT00025844|Virtual Reality|virtual reality
784905|NCT00025844|Context Conditioning|context conditioning
784906|NCT00025844|Healthy Volunteer|healthy volunteer
784907|NCT00025844|HV|hv
784908|NCT00025844|Normal Control|normal control
784909|NCT00025831|Buccal|buccal
784910|NCT00025831|DNA|dna
784911|NCT00025831|Pooling|pooling
784912|NCT00025831|Genotyping|genotyping
784913|NCT00025831|Mouthwash|mouthwash
784914|NCT00025831|Healthy Volunteer|healthy volunteer
784915|NCT00025831|HV|hv
784916|NCT00025831|Normal Control|normal control
784917|NCT00025818|dry eyes|dry eyes
784918|NCT00025818|rheumatoid arthritis|rheumatoid arthritis
784919|NCT00025818|Lupus|lupus
784920|NCT00025818|Sjogren's syndrome|sjogren's syndrome
784921|NCT00025818|myositis|myositis
784922|NCT00025818|scleroderma|scleroderma
784923|NCT00025818|autoimmune disorder|autoimmune disorder
784924|NCT00025805|Cytokines|cytokines
784925|NCT00025805|Th1 Th2 Response|th1 th2 response
784926|NCT00025805|Inflammatory Bowel Dx|inflammatory bowel dx
784927|NCT00025805|Lymphocyte|lymphocyte
784928|NCT00025805|Colonoscopy|colonoscopy
784929|NCT00025805|Crohn's Disease|crohn's disease
784930|NCT00025805|Crohn's|crohn's
784931|NCT00025792|Pramipexole|pramipexole
784932|NCT00025792|Neuroprotective|neuroprotective
784933|NCT00025792|Placebo Controlled|placebo controlled
784934|NCT00025792|Depression|depression
784935|NCT00025792|Brain Imaging|brain imaging
784936|NCT00025792|Antidepressant|antidepressant
784937|NCT00025792|Bipolar Disorder|bipolar disorder
784938|NCT00025792|Bipolar|bipolar
784939|NCT00025792|BPD|bpd
784940|NCT00025792|Bipolar Depression|bipolar depression
784941|NCT00025779|Hyperactivity|hyperactivity
784942|NCT00025779|Distractibility|distractibility
784943|NCT00025779|Impulsiveness|impulsiveness
784944|NCT00025779|Pervasive Development Disorders|pervasive development disorders
784945|NCT00025740|SSRI (paroxetine)|ssri (paroxetine)
784946|NCT00025740|Benzodiazepine (clonazepam)|benzodiazepine (clonazepam)
784947|NCT00025740|Post-Traumatic Stress Disorder (PTSD)|post-traumatic stress disorder (ptsd)
784948|NCT00025740|Combined Treatment|combined treatment
784949|NCT00025740|Rapid Treatment|rapid treatment
784950|NCT00025740|Post-Traumatic Stress Disorder|post-traumatic stress disorder
784951|NCT00025740|PTSD|ptsd
784952|NCT00025727|HIV-1|hiv-1
784953|NCT00025727|HIV Protease Inhibitors|hiv protease inhibitors
784954|NCT00025727|Ritonavir|ritonavir
784955|NCT00025727|RNA, Viral|rna, viral
784956|NCT00025727|Anti-HIV Agents|anti-hiv agents
784957|NCT00025727|Viral Load|viral load
784958|NCT00025727|ABT 378|abt 378
784959|NCT00025727|VX-175|vx-175
784960|NCT00025714|Serotonin Receptor|serotonin receptor
784961|NCT00025714|Cell Culture|cell culture
784962|NCT00025714|Temporal Lobe|temporal lobe
784963|NCT00025714|Endothelial Cells|endothelial cells
784964|NCT00025714|Superficial Temporal Artery|superficial temporal artery
784965|NCT00025714|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
784966|NCT00025714|Epilepsy|epilepsy
784967|NCT00025714|Intractable Epilepsy|intractable epilepsy
784968|NCT00025701|Cortex|cortex
784969|NCT00025701|Inhibition|inhibition
784970|NCT00025701|Motor Control|motor control
784971|NCT00025701|Event-Related Synchronization|event-related synchronization
784972|NCT00025701|Event-Related Desynchronization|event-related desynchronization
784973|NCT00025701|Focal Hand Dystonia|focal hand dystonia
784974|NCT00025701|Focal Dystonia|focal dystonia
784975|NCT00025701|Dystonia|dystonia
784976|NCT00025701|Hand|hand
784977|NCT00025701|Healthy Volunteer|healthy volunteer
784978|NCT00025701|HV|hv
784979|NCT00024999|Movement|movement
784980|NCT00024999|Coordination|coordination
784981|NCT00024999|Correlation|correlation
784982|NCT00024999|Coherence|coherence
784983|NCT00024999|Parietofrontal Circuitry|parietofrontal circuitry
784984|NCT00024999|Apraxia|apraxia
784985|NCT00024999|Ideomotor Apraxia|ideomotor apraxia
784986|NCT00024999|Healthy Volunteer|healthy volunteer
784987|NCT00024999|HV|hv
784988|NCT00024999|Normal Control|normal control
784989|NCT00024986|HAART|haart
784990|NCT00024986|Genotypic Resistance|genotypic resistance
784991|NCT00024986|Phenotypic Resistance|phenotypic resistance
784992|NCT00024986|Immune Reconstitution|immune reconstitution
784993|NCT00024986|Bone Density|bone density
784994|NCT00024986|HIV|hiv
784995|NCT00024986|Children|children
784996|NCT00024986|Pediatric HIV Infection|pediatric hiv infection
784997|NCT00024960|Speech|speech
784998|NCT00024960|Motor Control|motor control
784999|NCT00024960|Phenotype|phenotype
785000|NCT00024960|Dysfluency|dysfluency
785001|NCT00024960|Fluency|fluency
785002|NCT00024960|Stuttering|stuttering
785003|NCT00024960|Healthy Volunteer|healthy volunteer
785004|NCT00024960|HV|hv
785005|NCT00024960|Normal Control|normal control
785006|NCT00024934|Immunodeficiency|immunodeficiency
785007|NCT00024934|Primary|primary
785008|NCT00024934|Cancer|cancer
785009|NCT00024934|Genetics|genetics
785010|NCT00024934|IGA Deficiency|iga deficiency
785011|NCT00024934|Immune Deficiency|immune deficiency
785012|NCT00024908|Cognition|cognition
785013|NCT00024908|Frontal Lobes|frontal lobes
785014|NCT00024908|Frontotemporal Dementia|frontotemporal dementia
785015|NCT00024908|Focal Lesions|focal lesions
785016|NCT00024908|Executive Functions|executive functions
785017|NCT00024908|Frontotemporal Lobe Dementia|frontotemporal lobe dementia
785018|NCT00024908|Frontal Lobe|frontal lobe
785019|NCT00024908|Frontal Lobe Dementia|frontal lobe dementia
785020|NCT00024908|Healthy Volunteer|healthy volunteer
785021|NCT00024908|HV|hv
785022|NCT00024908|Normal Control|normal control
785023|NCT00024804|SKELETAL DISEASE|skeletal disease
785024|NCT00024804|Osteoporosis|osteoporosis
785025|NCT00024804|Dysplasia|dysplasia
785026|NCT00024804|Osteomalacia|osteomalacia
785027|NCT00024804|Bone Diseases|bone diseases
785028|NCT00024791|Cerebral Palsy|cerebral palsy
785029|NCT00024791|Pediatric|pediatric
785030|NCT00024791|Cognition|cognition
785031|NCT00024791|Motor Learning|motor learning
785032|NCT00024791|Visuomotor Integration|visuomotor integration
785033|NCT00024791|Corticospinal Tracts|corticospinal tracts
785034|NCT00024791|Cortical Re-Organization|cortical re-organization
785035|NCT00024791|Spastic Hemiplegia|spastic hemiplegia
785036|NCT00024791|Spastic Diplegia|spastic diplegia
785037|NCT00024791|Functional Outcome|functional outcome
785038|NCT00024791|Children|children
785039|NCT00024791|Healthy Volunteer|healthy volunteer
785040|NCT00024791|HV|hv
785041|NCT00024791|Normal Control|normal control
785042|NCT00024687|SS1(dsFv)-PE38 Anti-Mesothelin Immunotoxin|ss1(dsfv)-pe38 anti-mesothelin immunotoxin
785043|NCT00024687|advanced malignancy|advanced malignancy
785044|NCT00024674|SS1(dsFv)-PE38|ss1(dsfv)-pe38
785045|NCT00024674|SS1P|ss1p
785046|NCT00024674|anti-mesothelin immunotoxin|anti-mesothelin immunotoxin
785047|NCT00024674|advanced malignancy|advanced malignancy
785048|NCT00024661|recurrent solid tumors|recurrent solid tumors
785049|NCT00024661|liposomes containing AON to c-raf protein (LErafAON)|liposomes containing aon to c-raf protein (lerafaon)
785050|NCT00024648|advanced malignancy|advanced malignancy
785051|NCT00024648|liposomes containing AON to c-raf messenger RNA|liposomes containing aon to c-raf messenger rna
785052|NCT00024648|antisense oligodeoxynucleotide (AON)|antisense oligodeoxynucleotide (aon)
785053|NCT00024648|LErafAON|lerafaon
785054|NCT00024622|Familial|familial
785055|NCT00024622|Genetic|genetic
785056|NCT00024622|Symptomatic|symptomatic
785057|NCT00024622|Equivocally Affected|equivocally affected
785058|NCT00024622|18F-Fluoro-L-dopa|18f-fluoro-l-dopa
785059|NCT00024622|O-15 Labelled Water|o-15 labelled water
785060|NCT00024622|Carbidopa|carbidopa
785061|NCT00024622|Adult|adult
785062|NCT00024622|Schizophrenia|schizophrenia
785063|NCT00024622|Parkinson's Disease|parkinson's disease
785064|NCT00024622|PD|pd
785065|NCT00024622|Parkinson|parkinson
785066|NCT00024622|Healthy Control|healthy control
785067|NCT00024622|HV|hv
785068|NCT00024622|Normal Control|normal control
785069|NCT00024570|neurosurgery, craniotomy|neurosurgery, craniotomy
785070|NCT00024570|convection-enhanced delivery|convection-enhanced delivery
785071|NCT00024570|CNS interstitial infusion|cns interstitial infusion
785072|NCT00024570|recombinant toxins|recombinant toxins
785073|NCT00024570|malignant glioma, recurrent|malignant glioma, recurrent
785074|NCT00024570|catheter, stereotaxic|catheter, stereotaxic
785075|NCT00024570|intratumoral therapy|intratumoral therapy
785076|NCT00024570|positive pressure microinfusion|positive pressure microinfusion
785077|NCT00024557|neurosurgery, craniotomy|neurosurgery, craniotomy
785078|NCT00024557|convection-enhanced delivery|convection-enhanced delivery
785079|NCT00024557|CNS interstitial infusion|cns interstitial infusion
785080|NCT00024557|recombinant toxins|recombinant toxins
785081|NCT00024557|malignant glioma, recurrent|malignant glioma, recurrent
785082|NCT00024557|intratumoral therapy|intratumoral therapy
785083|NCT00024557|positive pressure microinfusion|positive pressure microinfusion
785084|NCT00024544|asthma|asthma
785085|NCT00024544|anti-IL-4 monoclonal antibody|anti-il-4 monoclonal antibody
785086|NCT00024544|pascolizumab|pascolizumab
785087|NCT00024531|Alzheimer disease|alzheimer disease
785088|NCT00024531|Cholesterol-lowering drugs|cholesterol-lowering drugs
785089|NCT00024518|Diabetes|diabetes
785090|NCT00024518|Immunotherapy|immunotherapy
785091|NCT00024518|Study Drug|study drug
785092|NCT00024518|Insulin Dependent Diabetes|insulin dependent diabetes
785093|NCT00024518|Diabetes Mellitus|diabetes mellitus
785094|NCT00024518|TIBM|tibm
785095|NCT00024492|Liposome Encapsulated Mitoxantrone (LEM)|liposome encapsulated mitoxantrone (lem)
785096|NCT00024492|solid tumors|solid tumors
785097|NCT00024479|Minorities|minorities
785098|NCT00024479|Rheumatic Disease|rheumatic disease
785099|NCT00024479|Community Based|community based
785100|NCT00024479|Ethnicity|ethnicity
785101|NCT00024479|Health Disparities|health disparities
785102|NCT00023582|Syphilis|syphilis
785103|NCT00023582|Herpes Genitalis|herpes genitalis
785104|NCT00023582|Risk Factors|risk factors
785105|NCT00023582|Incidence|incidence
785106|NCT00023582|Prevalence|prevalence
785107|NCT00023582|Homosexuality, Male|homosexuality, male
785108|NCT00023582|Informed Consent|informed consent
785109|NCT00023582|Peru|peru
785110|NCT00023582|HIV Seronegativity|hiv seronegativity
785111|NCT00023569|TMS|tms
785112|NCT00023569|Conjoint Movement|conjoint movement
785113|NCT00023569|Chronic Hemiplegia|chronic hemiplegia
785114|NCT00023569|Brain Plasticity|brain plasticity
785115|NCT00023569|Electrical Stimulation|electrical stimulation
785116|NCT00023569|Stroke|stroke
785117|NCT00023569|CVA|cva
785118|NCT00023504|Immunization|immunization
785119|NCT00023504|Antibody|antibody
785120|NCT00023504|Immunodeficiency|immunodeficiency
785121|NCT00023504|Pneumococcal Vaccines|pneumococcal vaccines
785122|NCT00023504|Phi-X 174|phi-x 174
785123|NCT00023504|Primary Immune Disorders|primary immune disorders
785124|NCT00023452|Latent TB infection|latent tb infection
785125|NCT00023439|tuberculosis|tuberculosis
785126|NCT00023439|TB|tb
785127|NCT00023426|tuberculosis|tuberculosis
785128|NCT00023426|tb|tb
785129|NCT00023426|rifapentine|rifapentine
785130|NCT00023426|safety|safety
785131|NCT00023426|dose|dose
785132|NCT00023413|tuberculosis|tuberculosis
785133|NCT00023413|TB|tb
785134|NCT00023400|tuberculosis|tuberculosis
785135|NCT00023400|TB|tb
785136|NCT00023374|tuberculosis|tuberculosis
785137|NCT00023374|TB|tb
785138|NCT00023374|isoniazid resistance|isoniazid resistance
785139|NCT00023374|isoniazid intolerance|isoniazid intolerance
785140|NCT00023374|treatment|treatment
785141|NCT00023374|efficacy|efficacy
785142|NCT00023374|toxicity|toxicity
785143|NCT00023361|tuberculosis|tuberculosis
785144|NCT00023361|TB|tb
785145|NCT00023348|Tuberculosis|tuberculosis
785146|NCT00023348|TB|tb
785147|NCT00023491|Sjogren's Syndrome|sjogren's syndrome
785148|NCT00023491|Peripheral Blood Stem Cell|peripheral blood stem cell
785149|NCT00023491|Tissue Regeneration|tissue regeneration
785150|NCT00023491|Graft-versus-host Disease|graft-versus-host disease
785151|NCT00023491|Head and Neck Cancer|head and neck cancer
785152|NCT00023491|Salivary Gland|salivary gland
785153|NCT00023491|Saliva Gland|saliva gland
785154|NCT00023491|Salivary Gland Dysfunction|salivary gland dysfunction
785155|NCT00023322|Cirrhosis|cirrhosis
785156|NCT00023322|Chronic Hepatitis|chronic hepatitis
785157|NCT00023322|Alpha Interferon|alpha interferon
785158|NCT00023322|Hepatitis D Virus|hepatitis d virus
785159|NCT00023322|Delta Hepatitis|delta hepatitis
785160|NCT00023322|Viral Hepatitis|viral hepatitis
785161|NCT00023322|Antiviral Agents|antiviral agents
785162|NCT00023322|Hepatitis D|hepatitis d
785163|NCT00023322|HDV|hdv
785164|NCT00023322|Liver|liver
785165|NCT00023322|Hepatitis|hepatitis
785166|NCT00023309|Adefovir Dipivoxil|adefovir dipivoxil
785167|NCT00023309|Lamivudine|lamivudine
785168|NCT00023309|Nucleoside/Nucleotide Analogue|nucleoside/nucleotide analogue
785169|NCT00023309|Chronic Hepatitis B|chronic hepatitis b
785170|NCT00023309|Hepatitis B Mutants|hepatitis b mutants
785171|NCT00023309|Liver Biopsy|liver biopsy
785172|NCT00023309|Hepatitis B|hepatitis b
785173|NCT00023309|Hepatitis|hepatitis
785174|NCT00023309|HBV|hbv
785175|NCT00023309|Liver|liver
785176|NCT00023296|Acute Chest Syndrome|acute chest syndrome
785177|NCT00023296|Blood Flow|blood flow
785178|NCT00023296|Nitric Oxide|nitric oxide
785179|NCT00023296|NO Therapy|no therapy
785180|NCT00023296|Vaso-Occlusive Crisis|vaso-occlusive crisis
785181|NCT00023296|Sickle Cell Anemia|sickle cell anemia
785182|NCT00023296|Sickle Cell|sickle cell
785183|NCT00023296|ACS|acs
785184|NCT00023296|Pulmonary Hypertension|pulmonary hypertension
785185|NCT00023218|Liver|liver
785186|NCT00023218|HIV-1|hiv-1
785187|NCT00023218|HIV Protease Inhibitors|hiv protease inhibitors
785188|NCT00023218|Ritonavir|ritonavir
785189|NCT00023218|Biopsy|biopsy
785190|NCT00023218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
785191|NCT00023218|Anti-HIV Agents|anti-hiv agents
785192|NCT00023218|ABT 378|abt 378
785193|NCT00023218|Acidosis, Lactic|acidosis, lactic
785194|NCT00023218|efavirenz|efavirenz
785195|NCT00023218|Alanine Transaminase|alanine transaminase
785196|NCT00023205|Arthritis|arthritis
785197|NCT00023205|Health literacy|health literacy
785198|NCT00023205|Patient education|patient education
785199|NCT00023205|Self-efficacy|self-efficacy
785200|NCT00022763|Anti-HIV Agents|anti-hiv agents
785201|NCT00022763|pentafuside|pentafuside
785202|NCT00021775|Risk Factors|risk factors
785203|NCT00021775|Incidence|incidence
785204|NCT00021775|Patient Selection|patient selection
785205|NCT00021775|HIV Seronegativity|hiv seronegativity
785206|NCT00021762|Virus Replication|virus replication
785207|NCT00021762|HIV-1|hiv-1
785208|NCT00021762|Drug Administration Schedule|drug administration schedule
785209|NCT00021762|AIDS Vaccines|aids vaccines
785210|NCT00021762|RNA, Viral|rna, viral
785211|NCT00021762|Viral Load|viral load
785212|NCT00021762|HIV-1 immunogen, incomplete Freund's adjuvant|hiv-1 immunogen, incomplete freund's adjuvant
785213|NCT00021762|Treatment Interruption|treatment interruption
785214|NCT00021762|HIV Therapeutic Vaccine|hiv therapeutic vaccine
785215|NCT00021671|Drug Therapy, Combination|drug therapy, combination
785216|NCT00021671|Ampicillin|ampicillin
785217|NCT00021671|Nevirapine|nevirapine
785218|NCT00021671|Disease Transmission, Vertical|disease transmission, vertical
785219|NCT00021671|Anti-Infective Agents|anti-infective agents
785220|NCT00021671|Erythromycin|erythromycin
785221|NCT00021671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
785222|NCT00021671|Metronidazole|metronidazole
785223|NCT00021671|Anti-HIV Agents|anti-hiv agents
785224|NCT00021671|Chorioamnionitis|chorioamnionitis
785225|NCT00021671|HIV Seronegativity|hiv seronegativity
785226|NCT00021632|Ribavirin|ribavirin
785227|NCT00021632|Drug Interactions|drug interactions
785228|NCT00021632|Drug Therapy, Combination|drug therapy, combination
785229|NCT00021632|Zidovudine|zidovudine
785230|NCT00021632|Stavudine|stavudine
785231|NCT00021632|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
785232|NCT00021632|Anti-HIV Agents|anti-hiv agents
785233|NCT00021632|Pharmacokinetics|pharmacokinetics
785234|NCT00021632|Area Under Curve|area under curve
785235|NCT00021554|HIV-1|hiv-1
785236|NCT00021554|Drug Therapy, Combination|drug therapy, combination
785237|NCT00021554|HIV Protease Inhibitors|hiv protease inhibitors
785238|NCT00021554|RNA, Viral|rna, viral
785239|NCT00021554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
785240|NCT00021554|Anti-HIV Agents|anti-hiv agents
785241|NCT00021554|Viral Load|viral load
785242|NCT00021554|pentafuside|pentafuside
785243|NCT00021489|Placebos|placebos
785244|NCT00021489|Drug Therapy, Combination|drug therapy, combination
785245|NCT00021489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
785246|NCT00021489|Anti-HIV Agents|anti-hiv agents
785247|NCT00021489|abacavir|abacavir
785248|NCT00021489|mycophenolate mofetil|mycophenolate mofetil
785249|NCT00021463|Nevirapine|nevirapine
785250|NCT00021463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
785251|NCT00021463|Anti-HIV Agents|anti-hiv agents
785252|NCT00021463|Triglycerides|triglycerides
785253|NCT00021463|abacavir|abacavir
785254|NCT00021463|efavirenz|efavirenz
785255|NCT00021463|Lipoproteins, LDL Cholesterol|lipoproteins, ldl cholesterol
785256|NCT00017992|HIV-1|hiv-1
785257|NCT00017992|Drug Administration Schedule|drug administration schedule
785258|NCT00017992|Stavudine|stavudine
785259|NCT00017992|HIV Protease Inhibitors|hiv protease inhibitors
785260|NCT00017992|Ritonavir|ritonavir
785261|NCT00017992|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
785262|NCT00017992|Anti-HIV Agents|anti-hiv agents
785263|NCT00017992|Pharmacokinetics|pharmacokinetics
785264|NCT00017992|ABT 378|abt 378
785265|NCT00017992|emtricitabine|emtricitabine
785266|NCT00017797|Pregnancy Complications, Infectious|pregnancy complications, infectious
785267|NCT00017797|HIV-1|hiv-1
785268|NCT00017797|HIV Protease Inhibitors|hiv protease inhibitors
785269|NCT00017797|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
785270|NCT00017797|Anti-HIV Agents|anti-hiv agents
785271|NCT00017797|Glucose Intolerance|glucose intolerance
785272|NCT00017784|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
785273|NCT00017784|Infusions, Intravenous|infusions, intravenous
785274|NCT00017784|Antiviral Agents|antiviral agents
785275|NCT00017784|Cytomegalovirus Retinitis|cytomegalovirus retinitis
785276|NCT00017784|valganciclovir|valganciclovir
785277|NCT00017771|HIV-1|hiv-1
785278|NCT00017771|CD4 Lymphocyte Count|cd4 lymphocyte count
785279|NCT00017771|Risk Factors|risk factors
785280|NCT00017771|Hydroxyurea|hydroxyurea
785281|NCT00017771|Disease Progression|disease progression
785282|NCT00017771|Alcohol Drinking|alcohol drinking
785283|NCT00017771|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
785284|NCT00017771|Anti-HIV Agents|anti-hiv agents
785285|NCT00017771|Viral Load|viral load
785286|NCT00017771|Polyneuropathies|polyneuropathies
785287|NCT00017771|Treatment Experienced|treatment experienced
785288|NCT00017758|Drug Interactions|drug interactions
785289|NCT00017758|Nelfinavir|nelfinavir
785290|NCT00017758|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
785291|NCT00017758|Anti-HIV Agents|anti-hiv agents
785292|NCT00017758|Pharmacokinetics|pharmacokinetics
785293|NCT00017758|Pravastatin|pravastatin
785294|NCT00017758|efavirenz|efavirenz
785295|NCT00017758|Simvastatin|simvastatin
785296|NCT00017758|atorvastatin|atorvastatin
785297|NCT00017758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
785298|NCT00017719|Pregnancy Complications, Infectious|pregnancy complications, infectious
785299|NCT00017719|HIV Protease Inhibitors|hiv protease inhibitors
785300|NCT00017719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
785301|NCT00017719|Anti-HIV Agents|anti-hiv agents
785302|NCT00017719|Viral Load|viral load
785303|NCT00017719|Combivir|combivir
785304|NCT00017719|Treatment Naive|treatment naive
785305|NCT00017693|Recombinant Proteins|recombinant proteins
785306|NCT00017693|Aerosols|aerosols
785307|NCT00017693|Asthma|asthma
785308|NCT00017693|Receptors, Interleukin-4|receptors, interleukin-4
785309|NCT00017693|Forced Expiratory Volume|forced expiratory volume
785310|NCT00016783|Drug Therapy, Combination|drug therapy, combination
785311|NCT00016783|Drug Administration Schedule|drug administration schedule
785312|NCT00016783|HIV Protease Inhibitors|hiv protease inhibitors
785313|NCT00016783|CD4 Lymphocyte Count|cd4 lymphocyte count
785314|NCT00016783|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
785315|NCT00016783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
785316|NCT00016783|Anti-HIV Agents|anti-hiv agents
785317|NCT00016783|Viral Load|viral load
785318|NCT00016783|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
785319|NCT00016783|Treatment Experienced|treatment experienced
785320|NCT00016783|Treatment Interruption|treatment interruption
785321|NCT00016718|Didanosine|didanosine
785322|NCT00016718|Drug Therapy, Combination|drug therapy, combination
785323|NCT00016718|Drug Administration Schedule|drug administration schedule
785324|NCT00016718|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
785325|NCT00016718|Anti-HIV Agents|anti-hiv agents
785326|NCT00016718|Pharmacokinetics|pharmacokinetics
785327|NCT00016718|Deoxycytidine|deoxycytidine
785328|NCT00016718|Efavirenz|efavirenz
785329|NCT00016718|Treatment Naive|treatment naive
785330|NCT00016692|Drug tolerance|drug tolerance
785331|NCT00016692|Acute Infection|acute infection
785332|NCT00016601|Delayed-Action Preparations|delayed-action preparations
785333|NCT00016601|Drug Interactions|drug interactions
785334|NCT00016601|Drug Therapy, Combination|drug therapy, combination
785335|NCT00016601|Nevirapine|nevirapine
785336|NCT00016601|HIV Protease Inhibitors|hiv protease inhibitors
785337|NCT00016601|Ritonavir|ritonavir
785338|NCT00016601|Indinavir|indinavir
785339|NCT00016601|Nelfinavir|nelfinavir
785340|NCT00016601|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
785341|NCT00016601|Anti-HIV Agents|anti-hiv agents
785342|NCT00016601|Pharmacokinetics|pharmacokinetics
785343|NCT00016601|Medroxyprogesterone 17-Acetate|medroxyprogesterone 17-acetate
785344|NCT00016601|efavirenz|efavirenz
785345|NCT00016588|HIV-1|hiv-1
785346|NCT00016588|Adenine|adenine
785347|NCT00016588|Anti-HIV Agents|anti-hiv agents
785348|NCT00016588|Viral Load|viral load
785349|NCT00016588|Organophosphorus Compounds|organophosphorus compounds
785350|NCT00016536|Antiviral Agents|antiviral agents
785351|NCT00016536|Mucous Membrane|mucous membrane
785352|NCT00016536|Spermatocidal Agents|spermatocidal agents
785353|NCT00016536|Penis|penis
785354|NCT00016536|Epithelium|epithelium
785355|NCT00016536|PRO 2000|pro 2000
785356|NCT00016536|Urethra|urethra
785357|NCT00016536|HIV Seronegativity|hiv seronegativity
785358|NCT00015704|Treatment Experienced|treatment experienced
785359|NCT00015704|Treatment Interruption|treatment interruption
785360|NCT00015704|Drug Administration Schedule|drug administration schedule
785361|NCT00015704|CD4 Lymphocyte Count|cd4 lymphocyte count
785362|NCT00015704|Anti-HIV Agents|anti-hiv agents
785363|NCT00015704|Tetanus Toxoid|tetanus toxoid
785364|NCT00015704|Aldesleukin|aldesleukin
785365|NCT00015704|Diphtheria Toxoid|diphtheria toxoid
785366|NCT00015691|Drug Therapy, Combination|drug therapy, combination
785367|NCT00015691|Adipose Tissue|adipose tissue
785368|NCT00015691|Area Under Curve|area under curve
785369|NCT00015691|Hypoglycemic Agents|hypoglycemic agents
785370|NCT00015691|Anthropometry|anthropometry
785371|NCT00015691|Hyperinsulinemia|hyperinsulinemia
785372|NCT00015691|Metformin|metformin
785373|NCT00015691|BRL 49653|brl 49653
785374|NCT00015691|Insulin|insulin
785375|NCT00015691|Glucose Tolerance Test|glucose tolerance test
785376|NCT00015652|Ribavirin|ribavirin
785377|NCT00015652|Polyethylene Glycols|polyethylene glycols
785378|NCT00015652|Interferon Alfa-2b|interferon alfa-2b
785379|NCT00015652|Dose-Response Relationship, Drug|dose-response relationship, drug
785380|NCT00015652|Drug Therapy, Combination|drug therapy, combination
785381|NCT00015652|Antiviral Agents|antiviral agents
785382|NCT00015652|Hepatitis C|hepatitis c
785383|NCT00015652|Aldesleukin|aldesleukin
785384|NCT00015652|Peginterferon|peginterferon
785385|NCT00014937|HIV-1|hiv-1
785386|NCT00014937|Didanosine|didanosine
785387|NCT00014937|Drug Therapy, Combination|drug therapy, combination
785388|NCT00014937|Zidovudine|zidovudine
785389|NCT00014937|Nevirapine|nevirapine
785390|NCT00014937|Stavudine|stavudine
785391|NCT00014937|HIV Protease Inhibitors|hiv protease inhibitors
785392|NCT00014937|Ritonavir|ritonavir
785393|NCT00014937|Lamivudine|lamivudine
785394|NCT00014937|RNA, Viral|rna, viral
785395|NCT00014937|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
785396|NCT00014937|Anti-HIV Agents|anti-hiv agents
785397|NCT00014937|Viral Load|viral load
785398|NCT00014937|ABT 378|abt 378
785399|NCT00014937|Combivir|combivir
785400|NCT00014937|Efavirenz|efavirenz
785401|NCT00014937|Treatment Experienced|treatment experienced
785402|NCT00014053|Reference Values|reference values
785403|NCT00014053|HIV Seropositivity|hiv seropositivity
785404|NCT00014053|Immune System|immune system
785405|NCT00014053|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
785406|NCT00014053|HIV Seronegativity|hiv seronegativity
785407|NCT00014053|Antigens, CD|antigens, cd
785408|NCT00014014|Zidovudine|zidovudine
785409|NCT00014014|Phosphorylation|phosphorylation
785410|NCT00014014|Drug Administration Schedule|drug administration schedule
785411|NCT00014014|Lamivudine|lamivudine
785412|NCT00014014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
785413|NCT00014014|Anti-HIV Agents|anti-hiv agents
785414|NCT00014014|Pharmacokinetics|pharmacokinetics
785415|NCT00014014|Combivir|combivir
785416|NCT00013897|Placebos|placebos
785417|NCT00013897|Drug Therapy, Combination|drug therapy, combination
785418|NCT00013897|Zidovudine|zidovudine
785419|NCT00013897|HIV Protease Inhibitors|hiv protease inhibitors
785420|NCT00013897|Lamivudine|lamivudine
785421|NCT00013897|RNA, Viral|rna, viral
785422|NCT00013897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
785423|NCT00013897|Anti-HIV Agents|anti-hiv agents
785424|NCT00013897|Viral Load|viral load
785425|NCT00013897|BMS 232632|bms 232632
785426|NCT00013897|efavirenz|efavirenz
785427|NCT00013871|Measles-Mumps-Rubella Vaccine|measles-mumps-rubella vaccine
785428|NCT00013871|Antibodies, Viral|antibodies, viral
785429|NCT00013871|Hepatitis B Vaccines|hepatitis b vaccines
785430|NCT00013871|Immunization, Secondary|immunization, secondary
785431|NCT00013871|Pneumococcal Vaccines|pneumococcal vaccines
785432|NCT00013871|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
785433|NCT00013871|Diphtheria-Tetanus-acellular Pertussis Vaccines|diphtheria-tetanus-acellular pertussis vaccines
785434|NCT00013663|Virus Replication|virus replication
785435|NCT00013663|HIV-1|hiv-1
785436|NCT00013663|AIDS Vaccines|aids vaccines
785437|NCT00013663|RNA, Viral|rna, viral
785438|NCT00013663|Avipoxvirus|avipoxvirus
785439|NCT00013663|Genetic Vectors|genetic vectors
785440|NCT00013663|Viral Load|viral load
785441|NCT00013663|aldesleukin|aldesleukin
785442|NCT00013663|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
785443|NCT00013663|HIV Therapeutic Vaccine|hiv therapeutic vaccine
785444|NCT00013663|Treatment Interruption|treatment interruption
785445|NCT00013585|Cognitive Disorders|cognitive disorders
785446|NCT00013585|AIDS Dementia Complex|aids dementia complex
785447|NCT00013585|Selegiline|selegiline
785448|NCT00013585|Administration, Cutaneous|administration, cutaneous
785449|NCT00013585|Neuroprotective Agents|neuroprotective agents
785450|NCT00013572|Injections, Intramuscular|injections, intramuscular
785451|NCT00013572|Injections, Intradermal|injections, intradermal
785452|NCT00013572|Injections, Subcutaneous|injections, subcutaneous
785453|NCT00013572|HIV-1|hiv-1
785454|NCT00013572|AIDS Vaccines|aids vaccines
785455|NCT00013572|Dendritic Cells|dendritic cells
785456|NCT00013572|HIV Seronegativity|hiv seronegativity
785457|NCT00013572|Genes, env|genes, env
785458|NCT00013572|Genes, pol|genes, pol
785459|NCT00013572|Genes, gag|genes, gag
785460|NCT00013572|Transfection|transfection
785461|NCT00013572|HIV Preventive Vaccine|hiv preventive vaccine
785462|NCT00013520|HIV-1|hiv-1
785463|NCT00013520|Didanosine|didanosine
785464|NCT00013520|Drug Therapy, Combination|drug therapy, combination
785465|NCT00013520|Zidovudine|zidovudine
785466|NCT00013520|Nevirapine|nevirapine
785470|NCT00013520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
785471|NCT00013520|Anti-HIV Agents|anti-hiv agents
785472|NCT00013520|Viral Load|viral load
785473|NCT00013520|Combivir|combivir
785474|NCT00013520|BMS 232632|bms 232632
785475|NCT00013520|Efavirenz|efavirenz
785476|NCT00013520|Treatment Naive|treatment naive
785477|NCT00012519|Dose-Response Relationship, Drug|dose-response relationship, drug
785478|NCT00012519|Drug Therapy, Combination|drug therapy, combination
785479|NCT00012519|HIV Protease Inhibitors|hiv protease inhibitors
785480|NCT00012519|Ritonavir|ritonavir
785481|NCT00012519|Indinavir|indinavir
785482|NCT00012519|Anti-HIV Agents|anti-hiv agents
785483|NCT00012519|Viral Load|viral load
785484|NCT00012519|Pharmacokinetics|pharmacokinetics
785485|NCT00012519|Treatment Experienced|treatment experienced
785486|NCT00012467|Interferon-gamma, Recombinant|interferon-gamma, recombinant
785487|NCT00012467|Injections, Subcutaneous|injections, subcutaneous
785488|NCT00012467|Itraconazole|itraconazole
785489|NCT00012467|Dose-Response Relationship, Drug|dose-response relationship, drug
785490|NCT00012467|Fluconazole|fluconazole
785491|NCT00012467|Flucytosine|flucytosine
785492|NCT00012467|Antifungal Agents|antifungal agents
785493|NCT00012467|Amphotericin B|amphotericin b
785494|NCT00012467|Meningitis, Cryptococcal|meningitis, cryptococcal
785495|NCT00011895|HIV-1|hiv-1
785496|NCT00011895|Drug Therapy, Combination|drug therapy, combination
785497|NCT00011895|Zidovudine|zidovudine
785498|NCT00011895|Lamivudine|lamivudine
785499|NCT00011895|Drug Combinations|drug combinations
785500|NCT00011895|RNA, Viral|rna, viral
785501|NCT00011895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
785502|NCT00011895|Anti-HIV Agents|anti-hiv agents
785503|NCT00011895|Viral Load|viral load
785504|NCT00011895|abacavir|abacavir
785505|NCT00011895|efavirenz|efavirenz
785506|NCT00011479|Administration, Oral|administration, oral
785507|NCT00011479|Drug Administration Schedule|drug administration schedule
785508|NCT00011479|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
785509|NCT00011479|Anti-HIV Agents|anti-hiv agents
785510|NCT00011479|Pharmacokinetics|pharmacokinetics
785511|NCT00011479|abacavir|abacavir
785512|NCT00011128|HIV-1|hiv-1
785513|NCT00011128|Drug Resistance, Microbial|drug resistance, microbial
785514|NCT00011128|Microbial Sensitivity Tests|microbial sensitivity tests
785515|NCT00011128|Salvage Therapy|salvage therapy
785516|NCT00011128|Anti-HIV Agents|anti-hiv agents
785517|NCT00011128|Viral Load|viral load
785518|NCT00011128|Treatment Experienced|treatment experienced
785519|NCT00011089|HIV-1|hiv-1
785520|NCT00011089|Disease Progression|disease progression
785521|NCT00011089|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
785522|NCT00011089|Anti-HIV Agents|anti-hiv agents
785523|NCT00011089|9-(2-phosphonylmethoxypropyl)adenine|9-(2-phosphonylmethoxypropyl)adenine
785524|NCT00011050|Specimen Handling|specimen handling
785525|NCT00011050|Blood|blood
785526|NCT00011050|Cryopreservation|cryopreservation
785527|NCT00011050|Lactic Acid|lactic acid
785528|NCT00011050|Sodium Fluoride|sodium fluoride
785529|NCT00011050|Oxalates|oxalates
785530|NCT00011037|HIV Antibodies|hiv antibodies
785531|NCT00011037|HIV Antigens|hiv antigens
785532|NCT00011037|HIV Envelope Protein gp120|hiv envelope protein gp120
785533|NCT00011037|AIDS Vaccines|aids vaccines
785534|NCT00011037|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
785535|NCT00011037|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
785536|NCT00011037|Neutralization Tests|neutralization tests
785537|NCT00011037|Haiti|haiti
785538|NCT00011037|Brazil|brazil
785539|NCT00011037|Cytotoxicity, Immunologic|cytotoxicity, immunologic
785540|NCT00011037|Epitopes|epitopes
785541|NCT00011037|Viral Proteins|viral proteins
785542|NCT00011037|Trinidad and Tobago|trinidad and tobago
785543|NCT00011037|Peru|peru
785544|NCT00011037|HIV Preventive Vaccine|hiv preventive vaccine
785545|NCT00011037|HIV Seronegativity|hiv seronegativity
785546|NCT00011011|HIV-1|hiv-1
785547|NCT00011011|Drug Administration Schedule|drug administration schedule
785548|NCT00011011|AIDS Vaccines|aids vaccines
785549|NCT00011011|CD4 Lymphocyte Count|cd4 lymphocyte count
785550|NCT00011011|RNA, Viral|rna, viral
785551|NCT00011011|Anti-HIV Agents|anti-hiv agents
785552|NCT00011011|Viral Load|viral load
785553|NCT00011011|HIV Therapeutic Vaccine|hiv therapeutic vaccine
785554|NCT00011011|Treatment Interruption|treatment interruption
785555|NCT00009555|Testosterone|testosterone
785556|NCT00009555|Anthropometry|anthropometry
785557|NCT00009555|Obesity|obesity
785558|NCT00009555|Abdomen|abdomen
785559|NCT00009061|HIV-1|hiv-1
785560|NCT00009061|Drug Therapy, Combination|drug therapy, combination
785561|NCT00009061|HIV Protease Inhibitors|hiv protease inhibitors
785562|NCT00009061|Ritonavir|ritonavir
785563|NCT00009061|Lamivudine|lamivudine
785564|NCT00009061|Nelfinavir|nelfinavir
785565|NCT00009061|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
785566|NCT00009061|Anti-HIV Agents|anti-hiv agents
785567|NCT00009061|abacavir|abacavir
785568|NCT00008866|HIV-1|hiv-1
785569|NCT00008866|Didanosine|didanosine
785570|NCT00008866|Drug Therapy, Combination|drug therapy, combination
785571|NCT00008866|Drug Administration Schedule|drug administration schedule
785572|NCT00008866|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
785573|NCT00008866|Hydroxyurea|hydroxyurea
785574|NCT00008866|RNA, Viral|rna, viral
785575|NCT00008866|Genotype|genotype
785576|NCT00008866|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
785577|NCT00008866|Anti-HIV Agents|anti-hiv agents
785578|NCT00008866|Viral Load|viral load
785579|NCT00008853|Clinical Evaluation|clinical evaluation
785580|NCT00008554|HIV-1|hiv-1
785581|NCT00008554|Drug Therapy, Combination|drug therapy, combination
785582|NCT00008554|HIV Protease Inhibitors|hiv protease inhibitors
785583|NCT00008554|Lamivudine|lamivudine
785584|NCT00008554|Nelfinavir|nelfinavir
785585|NCT00008554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
785586|NCT00008554|Anti-HIV Agents|anti-hiv agents
785587|NCT00008554|abacavir|abacavir
785588|NCT00008528|HIV-1|hiv-1
785589|NCT00008528|Drug Therapy, Combination|drug therapy, combination
785590|NCT00008528|Drug Resistance, Microbial|drug resistance, microbial
785591|NCT00008528|RNA, Viral|rna, viral
785592|NCT00008528|Membrane Fusion|membrane fusion
785593|NCT00008528|Anti-HIV Agents|anti-hiv agents
785594|NCT00008528|Viral Load|viral load
785595|NCT00008489|Didanosine|didanosine
785596|NCT00008489|Gastrointestinal System|gastrointestinal system
785597|NCT00008489|Tablets|tablets
785598|NCT00008489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
785599|NCT00008489|Anti-HIV Agents|anti-hiv agents
785600|NCT00008489|Capsules|capsules
785601|NCT00008463|Ribavirin|ribavirin
785602|NCT00008463|Polyethylene Glycols|polyethylene glycols
785603|NCT00008463|Interferon Alfa-2a|interferon alfa-2a
785604|NCT00008463|HIV-1|hiv-1
785605|NCT00008463|Antiviral Agents|antiviral agents
785606|NCT00008463|Hepatitis C, Chronic|hepatitis c, chronic
785607|NCT00007488|HIV-1|hiv-1
785608|NCT00007488|Lymphoid Tissue|lymphoid tissue
785609|NCT00007488|Viremia|viremia
785610|NCT00007488|RNA, Viral|rna, viral
785611|NCT00007488|Saliva|saliva
785612|NCT00007488|Anti-HIV Agents|anti-hiv agents
785613|NCT00007488|Viral Load|viral load
785614|NCT00007488|Genitalia, Female|genitalia, female
785615|NCT00007488|Genitalia, Male|genitalia, male
785616|NCT00007449|HIV-1|hiv-1
785617|NCT00007449|Drug Therapy, Combination|drug therapy, combination
785618|NCT00007449|RNA, Viral|rna, viral
785619|NCT00007449|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
785620|NCT00007449|Anti-HIV Agents|anti-hiv agents
785621|NCT00007449|Viral Load|viral load
785622|NCT00007436|HIV-1|hiv-1
785623|NCT00007436|Drug Therapy, Combination|drug therapy, combination
785624|NCT00007436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
785625|NCT00007436|Anti-HIV Agents|anti-hiv agents
785626|NCT00007436|9-(2-phosphonylmethoxypropyl)adenine|9-(2-phosphonylmethoxypropyl)adenine
785627|NCT00007423|HIV Antibodies|hiv antibodies
785628|NCT00007423|HIV-1|hiv-1
785629|NCT00007423|AIDS Vaccines|aids vaccines
785630|NCT00007423|HIV Seronegativity|hiv seronegativity
785631|NCT00007423|Uganda|uganda
785632|NCT00007423|Cross Reactions|cross reactions
785633|NCT00007423|HIV Preventive Vaccine|hiv preventive vaccine
785634|NCT00007332|Drug Therapy, Combination|drug therapy, combination
785635|NCT00007332|HIV Envelope Protein gp120|hiv envelope protein gp120
785636|NCT00007332|AIDS Vaccines|aids vaccines
785637|NCT00007332|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
785638|NCT00007332|HIV Seronegativity|hiv seronegativity
785639|NCT00007332|AIDSVAX|aidsvax
785640|NCT00007332|HIV Preventive Vaccine|hiv preventive vaccine
785641|NCT00007319|HIV Protease Inhibitors|hiv protease inhibitors
785642|NCT00007319|Risk Factors|risk factors
785643|NCT00007319|HIV Seronegativity|hiv seronegativity
785644|NCT00007319|Anti-HIV Agents|anti-hiv agents
785645|NCT00007319|Carotid Artery|carotid artery
785646|NCT00007319|Tunica Intima|tunica intima
785647|NCT00007319|Atherosclerosis|atherosclerosis
785648|NCT00007202|Virus Replication|virus replication
785649|NCT00007202|HIV-1|hiv-1
785650|NCT00007202|Didanosine|didanosine
785651|NCT00007202|Drug Therapy, Combination|drug therapy, combination
785652|NCT00007202|Stavudine|stavudine
785653|NCT00007202|HIV Protease Inhibitors|hiv protease inhibitors
785654|NCT00007202|Sensitivity and Specificity|sensitivity and specificity
785655|NCT00007202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
785656|NCT00007202|Anti-HIV Agents|anti-hiv agents
785657|NCT00007202|Viral Load|viral load
785658|NCT00007202|Reverse Transcriptase Polymerase Chain Reaction|reverse transcriptase polymerase chain reaction
785659|NCT00007202|Acute Infection|acute infection
785660|NCT00006643|Liver|liver
785661|NCT00006643|Hepatitis C|hepatitis c
785662|NCT00006643|Biopsy|biopsy
785663|NCT00006643|Tomography, Emission-Computed, Single-Photon|tomography, emission-computed, single-photon
785664|NCT00006630|Smallpox Vaccine|smallpox vaccine
785665|NCT00006630|Injections, Intramuscular|injections, intramuscular
785666|NCT00006630|Immunoglobulins|immunoglobulins
785667|NCT00006630|Orthopoxvirus|orthopoxvirus
785668|NCT00006617|HIV-1|hiv-1
785669|NCT00006617|Drug Therapy, Combination|drug therapy, combination
785671|NCT00006617|Lymphoid Tissue|lymphoid tissue
785672|NCT00006617|Gastrointestinal System|gastrointestinal system
785673|NCT00006617|HIV Protease Inhibitors|hiv protease inhibitors
785674|NCT00006617|Lamivudine|lamivudine
785675|NCT00006617|Lymphocyte Subsets|lymphocyte subsets
785676|NCT00006617|VX 478|vx 478
785677|NCT00006617|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
785678|NCT00006617|Anti-HIV Agents|anti-hiv agents
785679|NCT00006617|Viral Load|viral load
785680|NCT00006617|Cerebrospinal Fluid|cerebrospinal fluid
785681|NCT00006617|abacavir|abacavir
785682|NCT00006604|Dose-Response Relationship, Drug|dose-response relationship, drug
785683|NCT00006604|Drug Therapy, Combination|drug therapy, combination
785684|NCT00006604|Drug Administration Schedule|drug administration schedule
785685|NCT00006604|HIV Protease Inhibitors|hiv protease inhibitors
785686|NCT00006604|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
785687|NCT00006604|Anti-HIV Agents|anti-hiv agents
785688|NCT00006604|Pharmacokinetics|pharmacokinetics
785689|NCT00006604|Treatment Experienced|treatment experienced
785690|NCT00006604|Treatment Naive|treatment naive
785691|NCT00006591|Drug Therapy, Combination|drug therapy, combination
785692|NCT00006591|HIV Protease Inhibitors|hiv protease inhibitors
785693|NCT00006591|Ritonavir|ritonavir
785694|NCT00006591|VX 478|vx 478
785695|NCT00006591|Salvage Therapy|salvage therapy
785696|NCT00006591|Anti-HIV Agents|anti-hiv agents
785697|NCT00006591|Drug Monitoring|drug monitoring
785698|NCT00006591|Nelfinavir|nelfinavir
785699|NCT00006591|Treatment Experienced|treatment experienced
785700|NCT00006578|Drug Therapy, Combination|drug therapy, combination
785701|NCT00006578|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
785702|NCT00006578|HIV Protease Inhibitors|hiv protease inhibitors
785703|NCT00006578|Ritonavir|ritonavir
785704|NCT00006578|Lamivudine|lamivudine
785705|NCT00006578|Stem Cells|stem cells
785706|NCT00006578|VX 478|vx 478
785707|NCT00006578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
785708|NCT00006578|Anti-HIV Agents|anti-hiv agents
785709|NCT00006578|Antigens, CD34|antigens, cd34
785710|NCT00006578|abacavir|abacavir
785711|NCT00006578|Treatment Naive|treatment naive
785712|NCT00006509|Recombinant Proteins|recombinant proteins
785713|NCT00006509|HIV Envelope Protein gp160|hiv envelope protein gp160
785714|NCT00006509|AIDS Vaccines|aids vaccines
785715|NCT00006509|Anti-HIV Agents|anti-hiv agents
785716|NCT00006509|Treatment Experienced|treatment experienced
785717|NCT00006509|HIV Therapeutic Vaccine|hiv therapeutic vaccine
785718|NCT00006495|Placebos|placebos
785719|NCT00006495|T-Lymphocytes, Helper-Inducer|t-lymphocytes, helper-inducer
785720|NCT00006495|AIDS Vaccines|aids vaccines
785721|NCT00006495|RNA, Viral|rna, viral
785722|NCT00006495|HIV Core Protein p24|hiv core protein p24
785723|NCT00006495|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
785724|NCT00006495|Anti-HIV Agents|anti-hiv agents
785725|NCT00006495|HIV Therapeutic Vaccine|hiv therapeutic vaccine
785726|NCT00006490|HIV-1|hiv-1
785727|NCT00006490|Drug Resistance, Microbial|drug resistance, microbial
785728|NCT00006490|Sequence Analysis, DNA|sequence analysis, dna
785729|NCT00006490|Microbial Sensitivity Tests|microbial sensitivity tests
785730|NCT00006490|Genotype|genotype
785731|NCT00006490|Phenotype|phenotype
785732|NCT00006490|Anti-HIV Agents|anti-hiv agents
785733|NCT00006444|Drug Therapy, Combination|drug therapy, combination
785734|NCT00006444|Papillomavirus, Human|papillomavirus, human
785735|NCT00006444|DNA, Viral|dna, viral
785736|NCT00006444|Anti-HIV Agent|anti-hiv agent
785737|NCT00006444|Treatment Naive|treatment naive
785738|NCT00006443|T-Lymphocytes|t-lymphocytes
785739|NCT00006443|HIV-1|hiv-1
785740|NCT00006443|Lymphoid Tissue|lymphoid tissue
785741|NCT00006443|Stavudine|stavudine
785742|NCT00006443|HIV Protease Inhibitors|hiv protease inhibitors
785743|NCT00006443|Polymerase Chain Reaction|polymerase chain reaction
785744|NCT00006443|Biological Markers|biological markers
785745|NCT00006443|Lamivudine|lamivudine
785746|NCT00006443|Indinavir|indinavir
785747|NCT00006443|RNA, Viral|rna, viral
785748|NCT00006443|Genotype|genotype
785749|NCT00006443|Phenotype|phenotype
785750|NCT00006443|Cytokines|cytokines
785751|NCT00006443|Nelfinavir|nelfinavir
785752|NCT00006443|Macrophages|macrophages
785753|NCT00006443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
785754|NCT00006443|In Situ Hybridization|in situ hybridization
785755|NCT00006443|Anti-HIV Agents|anti-hiv agents
785756|NCT00006443|Viral Load|viral load
785757|NCT00006443|Cell Membrane|cell membrane
785758|NCT00006443|Acute Infection|acute infection
785759|NCT00006443|Treatment Naive|treatment naive
785760|NCT00006442|Lymphocytes|lymphocytes
785761|NCT00006442|HIV-1|hiv-1
785762|NCT00006442|Lymphoid Tissue|lymphoid tissue
785763|NCT00006442|Blood|blood
785764|NCT00006442|Anti-HIV Agents|anti-hiv agents
785765|NCT00006442|Viral Load|viral load
785766|NCT00006441|Virus Replication|virus replication
785767|NCT00006441|HIV-1|hiv-1
785768|NCT00006441|Interleukin-2|interleukin-2
785769|NCT00006441|Drug Therapy, Combination|drug therapy, combination
785770|NCT00006441|Zidovudine|zidovudine
785771|NCT00006441|HIV Protease Inhibitors|hiv protease inhibitors
785772|NCT00006441|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
785773|NCT00006441|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
785774|NCT00006441|Biological Markers|biological markers
785775|NCT00006441|Lamivudine|lamivudine
785776|NCT00006441|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
785777|NCT00006441|Anti-HIV Agents|anti-hiv agents
785778|NCT00006441|Nelfinavir|nelfinavir
785779|NCT00006441|Cytotoxicity, Immunologic|cytotoxicity, immunologic
785780|NCT00006441|Acute Infection|acute infection
785781|NCT00006440|Risk Factors|risk factors
785782|NCT00006440|Behavior Therapy|behavior therapy
785783|NCT00006440|Substance-Related Disorders|substance-related disorders
785784|NCT00006440|Feasibility Studies|feasibility studies
785785|NCT00006415|Virus Replication|virus replication
785786|NCT00006415|HIV-1|hiv-1
785787|NCT00006415|Polymerase Chain Reaction|polymerase chain reaction
785788|NCT00006415|DNA, Viral|dna, viral
785789|NCT00006415|RNA, Viral|rna, viral
785790|NCT00006415|Sensitivity and Specificity|sensitivity and specificity
785791|NCT00006415|Anti-HIV Agents|anti-hiv agents
785792|NCT00006415|Viral Load|viral load
785793|NCT00006415|Proviruses|proviruses
785794|NCT00006415|Acute Infection|acute infection
785795|NCT00006412|Hyperlipidemia|hyperlipidemia
785796|NCT00006412|Procetofen|procetofen
785797|NCT00006412|Pravastatin|pravastatin
785798|NCT00006412|Antilipemic Agents|antilipemic agents
785799|NCT00006397|Didanosine|didanosine
785800|NCT00006397|Drug Therapy, Combination|drug therapy, combination
785801|NCT00006397|Stavudine|stavudine
785802|NCT00006397|HIV Protease Inhibitors|hiv protease inhibitors
785803|NCT00006397|Sex Factors|sex factors
785804|NCT00006397|Ritonavir|ritonavir
785805|NCT00006397|Indinavir|indinavir
785806|NCT00006397|Dosage Forms|dosage forms
785807|NCT00006397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
785808|NCT00006397|Anti-HIV Agents|anti-hiv agents
785809|NCT00006396|Pregnancy Complications, Infectious|pregnancy complications, infectious
785810|NCT00006396|HIV-1|hiv-1
785811|NCT00006396|Administration, Oral|administration, oral
785812|NCT00006396|Zidovudine|zidovudine
785813|NCT00006396|Nevirapine|nevirapine
785814|NCT00006396|RNA, Viral|rna, viral
785815|NCT00006396|Disease Transmission, Vertical|disease transmission, vertical
785816|NCT00006396|Enzyme-Linked Immunosorbent Assay|enzyme-linked immunosorbent assay
785817|NCT00006396|Blotting, Western|blotting, western
785818|NCT00006396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
785819|NCT00006396|Anti-HIV Agents|anti-hiv agents
785820|NCT00006396|Viral Load|viral load
785821|NCT00006396|HIV Seronegativity|hiv seronegativity
785822|NCT00006339|Prospective Studies|prospective studies
785823|NCT00006339|HIV-1|hiv-1
785824|NCT00006339|Didanosine|didanosine
785825|NCT00006339|Drug Therapy, Combination|drug therapy, combination
785826|NCT00006339|Stavudine|stavudine
785827|NCT00006339|HIV Protease Inhibitors|hiv protease inhibitors
785828|NCT00006339|Hydroxyurea|hydroxyurea
785829|NCT00006339|Ritonavir|ritonavir
785830|NCT00006339|Indinavir|indinavir
785831|NCT00006339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
785832|NCT00006339|Anti-HIV Agents|anti-hiv agents
785833|NCT00006339|Viral Load|viral load
785834|NCT00006339|Reverse Transcriptase Polymerase Chain Reaction|reverse transcriptase polymerase chain reaction
785835|NCT00006327|Recombinant Proteins|recombinant proteins
785836|NCT00006327|HIV-1|hiv-1
785837|NCT00006327|AIDS Serodiagnosis|aids serodiagnosis
785838|NCT00006327|Substance Abuse, Intravenous|substance abuse, intravenous
785839|NCT00006327|Enzyme-Linked Immunosorbent Assay|enzyme-linked immunosorbent assay
785840|NCT00006327|Blotting, Western|blotting, western
785841|NCT00006327|HIV Envelope Protein gp120|hiv envelope protein gp120
785842|NCT00006327|AIDSVAX|aidsvax
785843|NCT00006326|Drug Therapy, Combination|drug therapy, combination
785844|NCT00006326|HIV Protease Inhibitors|hiv protease inhibitors
785845|NCT00006326|Ritonavir|ritonavir
785846|NCT00006326|Indinavir|indinavir
785847|NCT00006326|Delavirdine|delavirdine
785848|NCT00006326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
785849|NCT00006326|Salvage Therapy|salvage therapy
785850|NCT00006326|Anti-HIV Agents|anti-hiv agents
785851|NCT00006326|Viral Load|viral load
785852|NCT00006326|Nelfinavir|nelfinavir
785853|NCT00006325|Polyethylene Glycols|polyethylene glycols
785854|NCT00006325|Interferon Alfa-2b|interferon alfa-2b
785855|NCT00006325|HIV-1|hiv-1
785856|NCT00006325|Dose-Response Relationship, Drug|dose-response relationship, drug
785857|NCT00006325|Drug Therapy, Combination|drug therapy, combination
785858|NCT00006325|Virus Inhibitors|virus inhibitors
785859|NCT00006325|Anti-HIV Agents|anti-hiv agents
785860|NCT00006325|Pharmacokinetics|pharmacokinetics
785861|NCT00006324|HIV Seronegativity|hiv seronegativity
785862|NCT00006324|Delayed-Action Preparations|delayed-action preparations
785863|NCT00006324|Risk Factors|risk factors
785864|NCT00006324|Prevalence|prevalence
785865|NCT00006324|Contraceptive Agents, Female|contraceptive agents, female
785866|NCT00006324|Contraceptives, Oral, Combined|contraceptives, oral, combined
785867|NCT00006324|Medroxyprogesterone 17-Acetate|medroxyprogesterone 17-acetate
785868|NCT00006316|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
785869|NCT00006316|Histoplasmosis|histoplasmosis
785870|NCT00006316|Antifungal Agents|antifungal agents
785871|NCT00006316|Recurrence|recurrence
785872|NCT00006316|Anti-HIV Agents|anti-hiv agents
785873|NCT00006304|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
785874|NCT00006304|AIDS-Related Complex|aids-related complex
785875|NCT00006298|HIV Antibodies|hiv antibodies
785876|NCT00006298|HIV-1|hiv-1
785877|NCT00006298|CD4 Lymphocyte Count|cd4 lymphocyte count
785878|NCT00006298|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
785879|NCT00006298|Genotype|genotype
785880|NCT00006298|Species Specificity|species specificity
785881|NCT00006298|Neutralization Tests|neutralization tests
785882|NCT00006298|Viral Load|viral load
785883|NCT00006298|Alleles|alleles
785884|NCT00006298|HLA Antigens|hla antigens
785885|NCT00006298|Cross Reactions|cross reactions
785886|NCT00006298|Immunodominant Epitopes|immunodominant epitopes
785887|NCT00006298|Haplotypes|haplotypes
785888|NCT00006291|Virus Replication|virus replication
785889|NCT00006291|T-Lymphocytes|t-lymphocytes
785890|NCT00006291|Lymphocyte Transformation|lymphocyte transformation
785891|NCT00006291|AIDS Vaccines|aids vaccines
785892|NCT00006291|Anti-HIV Agents|anti-hiv agents
785893|NCT00006291|Viral Load|viral load
785894|NCT00006291|Aldesleukin|aldesleukin
785895|NCT00006291|HIV Therapeutic Vaccine|hiv therapeutic vaccine
785896|NCT00006290|Drug Therapy, Combination|drug therapy, combination
785897|NCT00006290|Questionnaires|questionnaires
785898|NCT00006290|Quality of Life|quality of life
785899|NCT00006290|Patient Compliance|patient compliance
785900|NCT00006290|Body Composition|body composition
785901|NCT00006290|Anti-HIV Agents|anti-hiv agents
785902|NCT00006290|Adipose Tissue|adipose tissue
785903|NCT00006290|Body Image|body image
785904|NCT00006279|Pregnancy Complications, Infectious|pregnancy complications, infectious
785905|NCT00006279|Dose-Response Relationship, Drug|dose-response relationship, drug
785906|NCT00006279|Drug Administration Schedule|drug administration schedule
785907|NCT00006279|Nevirapine|nevirapine
785908|NCT00006279|Disease Transmission, Vertical|disease transmission, vertical
785909|NCT00006279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
785910|NCT00006279|Anti-HIV Agents|anti-hiv agents
785911|NCT00006279|Breast Feeding|breast feeding
785912|NCT00006211|Drug Therapy, Combination|drug therapy, combination
785913|NCT00006211|HIV Protease Inhibitors|hiv protease inhibitors
785914|NCT00006211|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
785915|NCT00006211|Anti-HIV Agents|anti-hiv agents
785916|NCT00006211|Viral Load|viral load
785917|NCT00006211|Nelfinavir|nelfinavir
785918|NCT00006209|HIV-1|hiv-1
785919|NCT00006209|Immunity, Cellular|immunity, cellular
785920|NCT00006209|Drug Therapy, Combination|drug therapy, combination
785921|NCT00006209|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
785922|NCT00006209|Antigens|antigens
785923|NCT00006209|Anti-HIV Agents|anti-hiv agents
785924|NCT00006209|Viral Load|viral load
785925|NCT00006209|tucaresol|tucaresol
785926|NCT00006208|HIV-1|hiv-1
785927|NCT00006208|Didanosine|didanosine
785928|NCT00006208|Drug Therapy, Combination|drug therapy, combination
785929|NCT00006208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
785930|NCT00006208|Anti-HIV Agents|anti-hiv agents
785931|NCT00006208|Deoxycytidine|deoxycytidine
785932|NCT00006208|efavirenz|efavirenz
785933|NCT00006207|HIV Seropositivity|hiv seropositivity
785934|NCT00006207|Dose-Response Relationship, Drug|dose-response relationship, drug
785935|NCT00006207|HIV Seronegativity|hiv seronegativity
785936|NCT00006207|Mucous Membrane|mucous membrane
785937|NCT00006207|Ulcer|ulcer
785938|NCT00006207|Vagina|vagina
785939|NCT00006207|Anti-HIV Agents|anti-hiv agents
785940|NCT00006207|Sexual Abstinence|sexual abstinence
785941|NCT00006207|Irritants|irritants
785942|NCT00006207|PRO 2000|pro 2000
785943|NCT00006154|Interleukin-2|interleukin-2
785944|NCT00006154|Didanosine|didanosine
785945|NCT00006154|Drug Therapy, Combination|drug therapy, combination
785946|NCT00006154|Stavudine|stavudine
785947|NCT00006154|HIV Protease Inhibitors|hiv protease inhibitors
785948|NCT00006154|Ritonavir|ritonavir
785949|NCT00006154|Indinavir|indinavir
785950|NCT00006154|Virus Latency|virus latency
785951|NCT00006154|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
785952|NCT00006154|Anti-HIV Agents|anti-hiv agents
785953|NCT00006154|abacavir|abacavir
785954|NCT00006154|efavirenz|efavirenz
785955|NCT00006154|Acute Infection|acute infection
785956|NCT00006153|HIV Antibodies|hiv antibodies
785957|NCT00006153|Immunity, Cellular|immunity, cellular
785958|NCT00006153|Drug Therapy, Combination|drug therapy, combination
785959|NCT00006153|Anti-HIV Agents|anti-hiv agents
785960|NCT00006153|remune|remune
785961|NCT00006153|HIV Therapeutic Vaccine|hiv therapeutic vaccine
785962|NCT00006152|Drug Therapy, Combination|drug therapy, combination
785963|NCT00006152|HIV Protease Inhibitors|hiv protease inhibitors
785964|NCT00006152|Ritonavir|ritonavir
785965|NCT00006152|VX 478|vx 478
785966|NCT00006152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
785967|NCT00006152|Anti-HIV Agents|anti-hiv agents
785968|NCT00006152|Viral Load|viral load
785969|NCT00006152|abacavir|abacavir
785970|NCT00006145|Ganciclovir|ganciclovir
785971|NCT00006145|Cytomegalovirus|cytomegalovirus
785972|NCT00006145|Cytomegalovirus Infections|cytomegalovirus infections
785973|NCT00006145|Administration, Oral|administration, oral
785974|NCT00006145|Antiviral Agents|antiviral agents
785975|NCT00006145|Polymerase Chain Reaction|polymerase chain reaction
785976|NCT00006145|Viremia|viremia
785977|NCT00006145|DNA, Viral|dna, viral
785978|NCT00006144|Drug Therapy, Combination|drug therapy, combination
785979|NCT00006144|Stavudine|stavudine
785980|NCT00006144|HIV Protease Inhibitors|hiv protease inhibitors
785981|NCT00006144|Cohort Studies|cohort studies
785982|NCT00006144|Ritonavir|ritonavir
785983|NCT00006144|Disease Progression|disease progression
785984|NCT00006144|Antigens, CD|antigens, cd
785985|NCT00006144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
785986|NCT00006144|Anti-HIV Agents|anti-hiv agents
785987|NCT00006144|Immunophenotyping|immunophenotyping
785988|NCT00006144|Deoxycytidine|deoxycytidine
785989|NCT00006143|Treatment Outcome|treatment outcome
785990|NCT00006143|serostim|serostim
785991|NCT00006143|Developmental Disabilities|developmental disabilities
785992|NCT00006075|Pregnancy Complications, Infectious|pregnancy complications, infectious
785993|NCT00006075|Dose-Response Relationship, Drug|dose-response relationship, drug
785994|NCT00006075|Polymerase Chain Reaction|polymerase chain reaction
785995|NCT00006075|Disease Transmission, Vertical|disease transmission, vertical
785996|NCT00006075|Labor|labor
785997|NCT00006075|Disinfectants|disinfectants
785998|NCT00006075|Vagina|vagina
785999|NCT00006075|Chlorhexidine|chlorhexidine
786000|NCT00006075|Irrigation|irrigation
786001|NCT00006066|Injections, Subcutaneous|injections, subcutaneous
786002|NCT00006066|Interleukin-2|interleukin-2
786003|NCT00006066|Dose-Response Relationship, Drug|dose-response relationship, drug
786004|NCT00006066|Drug Therapy, Combination|drug therapy, combination
786005|NCT00006066|Immunocompromised Host|immunocompromised host
786006|NCT00006066|CD4 Lymphocyte Count|cd4 lymphocyte count
786007|NCT00006066|Anti-HIV Agents|anti-hiv agents
786008|NCT00006064|Tumor Necrosis Factor|tumor necrosis factor
786009|NCT00006064|CD4 Lymphocyte Count|cd4 lymphocyte count
786010|NCT00006064|Polymerase Chain Reaction|polymerase chain reaction
786011|NCT00006064|Enzyme-Linked Immunosorbent Assay|enzyme-linked immunosorbent assay
786012|NCT00006064|RNA, Messenger|rna, messenger
786013|NCT00006064|Interleukin-1|interleukin-1
786014|NCT00006064|Body Composition|body composition
786015|NCT00006064|Anti-HIV Agents|anti-hiv agents
786016|NCT00006064|Viral Load|viral load
786017|NCT00006064|Age Factors|age factors
786018|NCT00006064|Anthropometry|anthropometry
786019|NCT00005931|Skin Neoplasms|skin neoplasms
786020|NCT00005931|Sarcoma, Kaposi|sarcoma, kaposi
786021|NCT00005931|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
786022|NCT00005931|Antineoplastic Agents|antineoplastic agents
786023|NCT00005931|Enzyme Inhibitors|enzyme inhibitors
786024|NCT00005931|SU 5416|su 5416
786025|NCT00005931|Protein-Tyrosine Kinase|protein-tyrosine kinase
786026|NCT00005921|Dose-Response Relationship, Drug|dose-response relationship, drug
786027|NCT00005921|Antifungal Agents|antifungal agents
786028|NCT00005921|Candidiasis|candidiasis
786029|NCT00005921|Esophageal Diseases|esophageal diseases
786030|NCT00005921|MK 0991|mk 0991
786031|NCT00005920|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
786032|NCT00005920|Dose-Response Relationship, Drug|dose-response relationship, drug
786033|NCT00005920|Fluconazole|fluconazole
786034|NCT00005920|Antifungal Agents|antifungal agents
786035|NCT00005920|Candidiasis, Oral|candidiasis, oral
786036|NCT00005920|Pharyngeal Diseases|pharyngeal diseases
786037|NCT00005920|MK 0991|mk 0991
786038|NCT00005918|Drug Therapy, Combination|drug therapy, combination
786039|NCT00005918|Stavudine|stavudine
786040|NCT00005918|Lamivudine|lamivudine
786041|NCT00005918|RNA, Viral|rna, viral
786042|NCT00005918|Dosage Forms|dosage forms
786043|NCT00005918|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786044|NCT00005918|Anti-HIV Agents|anti-hiv agents
786045|NCT00005918|Viral Load|viral load
786046|NCT00005918|efavirenz|efavirenz
786047|NCT00005915|HIV-1|hiv-1
786048|NCT00005915|Drug Administration Schedule|drug administration schedule
786049|NCT00005915|Drug Resistance, Microbial|drug resistance, microbial
786050|NCT00005915|Disease Progression|disease progression
786051|NCT00005915|Genotype|genotype
786052|NCT00005915|Phenotype|phenotype
786053|NCT00005915|Drug Resistance, Multiple|drug resistance, multiple
786054|NCT00005915|Anti-HIV Agents|anti-hiv agents
786055|NCT00005915|Treatment Experienced|treatment experienced
786056|NCT00005779|Virus Replication|virus replication
786057|NCT00005779|HIV-1|hiv-1
786058|NCT00005779|AIDS Vaccines|aids vaccines
786059|NCT00005779|CD4 Lymphocyte Count|cd4 lymphocyte count
786060|NCT00005779|Cohort Studies|cohort studies
786061|NCT00005779|Interleukin-12|interleukin-12
786062|NCT00005779|HIV Therapeutic Vaccine|hiv therapeutic vaccine
786063|NCT00005764|HIV-1|hiv-1
786064|NCT00005764|Zalcitabine|zalcitabine
786066|NCT00005764|Drug Therapy, Combination|drug therapy, combination
786067|NCT00005764|Zidovudine|zidovudine
786068|NCT00005764|Stavudine|stavudine
786069|NCT00005764|Lamivudine|lamivudine
786070|NCT00005764|Blood|blood
786071|NCT00005764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786072|NCT00005764|Anti-HIV Agents|anti-hiv agents
786073|NCT00005764|Lipodystrophy|lipodystrophy
786074|NCT00005764|Combivir|combivir
786075|NCT00005764|Lactic Acid|lactic acid
786076|NCT00005764|abacavir|abacavir
786077|NCT00005762|Drug Interactions|drug interactions
786078|NCT00005762|Drug Therapy, Combination|drug therapy, combination
786079|NCT00005762|HIV Protease Inhibitors|hiv protease inhibitors
786080|NCT00005762|Ritonavir|ritonavir
786081|NCT00005762|Dosage Forms|dosage forms
786082|NCT00005762|Saquinavir|saquinavir
786083|NCT00005762|VX 478|vx 478
786084|NCT00005762|Anti-HIV Agents|anti-hiv agents
786085|NCT00005762|Nelfinavir|nelfinavir
786086|NCT00005762|Pharmacokinetics|pharmacokinetics
786087|NCT00005762|efavirenz|efavirenz
786088|NCT00005758|T-Lymphocytes, Helper-Inducer|t-lymphocytes, helper-inducer
786089|NCT00005758|Combined Modality Therapy|combined modality therapy
786090|NCT00005758|HIV Envelope Protein gp120|hiv envelope protein gp120
786091|NCT00005758|AIDS Vaccines|aids vaccines
786092|NCT00005758|RNA, Viral|rna, viral
786093|NCT00005758|HIV Core Protein p24|hiv core protein p24
786094|NCT00005758|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
786095|NCT00005758|Anti-HIV Agents|anti-hiv agents
786096|NCT00005758|Viral Load|viral load
786097|NCT00005758|HIV Therapeutic Vaccine|hiv therapeutic vaccine
786098|NCT00005663|Herpes Simplex|herpes simplex
786099|NCT00005663|Antiviral Agents|antiviral agents
786100|NCT00005663|Anus Diseases|anus diseases
786101|NCT00005663|Herpes Genitalis|herpes genitalis
786102|NCT00005663|Recurrence|recurrence
786103|NCT00005663|valacyclovir|valacyclovir
786104|NCT00005572|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
786105|NCT00005572|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
786106|NCT00005572|Lymphocytes|lymphocytes
786107|NCT00005572|Histoplasmosis|histoplasmosis
786108|NCT00005572|Recurrence|recurrence
786109|NCT00005572|Cytomegalovirus Retinitis|cytomegalovirus retinitis
786110|NCT00005572|Cell Division|cell division
786111|NCT00005572|Immunocompetence|immunocompetence
786112|NCT00005572|Anti-HIV Agents|anti-hiv agents
786113|NCT00005120|CD4 Lymphocyte Count|cd4 lymphocyte count
786114|NCT00005120|Biological Markers|biological markers
786115|NCT00005120|Anti-HIV Agents|anti-hiv agents
786116|NCT00005120|Viral Load|viral load
786117|NCT00005120|Pharmacokinetics|pharmacokinetics
786118|NCT00005120|calanolide A|calanolide a
786119|NCT00005118|HIV-1|hiv-1
786120|NCT00005118|Drug Therapy, Combination|drug therapy, combination
786121|NCT00005118|HIV Protease Inhibitors|hiv protease inhibitors
786122|NCT00005118|Ritonavir|ritonavir
786123|NCT00005118|Indinavir|indinavir
786124|NCT00005118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786125|NCT00005118|Anti-HIV Agents|anti-hiv agents
786126|NCT00005118|Viral Load|viral load
786127|NCT00005118|Nelfinavir|nelfinavir
786128|NCT00005106|Drug Therapy, Combination|drug therapy, combination
786129|NCT00005106|Zidovudine|zidovudine
786130|NCT00005106|Stavudine|stavudine
786131|NCT00005106|HIV Protease Inhibitors|hiv protease inhibitors
786132|NCT00005106|Lamivudine|lamivudine
786133|NCT00005106|Nelfinavir|nelfinavir
786134|NCT00005106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786135|NCT00005106|Anti-HIV Agents|anti-hiv agents
786136|NCT00005106|Adipose Tissue|adipose tissue
786137|NCT00005106|Lipodystrophy|lipodystrophy
786138|NCT00005106|abacavir|abacavir
786139|NCT00005020|CD4 Lymphocyte Count|cd4 lymphocyte count
786140|NCT00005020|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
786141|NCT00005020|Phenotype|phenotype
786142|NCT00005020|Viral Load|viral load
786143|NCT00005020|Acute Infection|acute infection
786144|NCT00005018|HIV-1|hiv-1
786145|NCT00005018|Didanosine|didanosine
786146|NCT00005018|Drug Therapy, Combination|drug therapy, combination
786147|NCT00005018|Zidovudine|zidovudine
786148|NCT00005018|Stavudine|stavudine
786149|NCT00005018|HIV Protease Inhibitors|hiv protease inhibitors
786150|NCT00005018|Hydroxyurea|hydroxyurea
786151|NCT00005018|RNA, Viral|rna, viral
786152|NCT00005018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786153|NCT00005018|Anti-HIV Agents|anti-hiv agents
786154|NCT00005018|Viral Load|viral load
786155|NCT00005018|abacavir|abacavir
786156|NCT00005018|efavirenz|efavirenz
786157|NCT00005017|HIV-1|hiv-1
786158|NCT00005017|Drug Therapy, Combination|drug therapy, combination
786159|NCT00005017|Stavudine|stavudine
786160|NCT00005017|HIV Protease Inhibitors|hiv protease inhibitors
786161|NCT00005017|Ritonavir|ritonavir
786162|NCT00005017|Lamivudine|lamivudine
786163|NCT00005017|VX 478|vx 478
786164|NCT00005017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786165|NCT00005017|Anti-HIV Agents|anti-hiv agents
786166|NCT00005017|abacavir|abacavir
786167|NCT00005017|efavirenz|efavirenz
786168|NCT00005012|Interferon Alfa-2b|interferon alfa-2b
786169|NCT00005012|Lymphocyte Transformation|lymphocyte transformation
786170|NCT00005012|CD4 Lymphocyte Count|cd4 lymphocyte count
786171|NCT00005012|RNA, Viral|rna, viral
786172|NCT00005012|Virus Inhibitors|virus inhibitors
786173|NCT00005012|Anti-HIV Agents|anti-hiv agents
786174|NCT00005012|Viral Load|viral load
786175|NCT00005009|pediatric renal transplant recipients|pediatric renal transplant recipients
786176|NCT00005009|varicella zoster virus (VZV) vaccine|varicella zoster virus (vzv) vaccine
786177|NCT00005009|herpes zoster vaccine|herpes zoster vaccine
786178|NCT00005009|VZV susceptible|vzv susceptible
786179|NCT00005009|safety|safety
786180|NCT00005009|immunogenicity|immunogenicity
786181|NCT00005002|HIV-1|hiv-1
786182|NCT00005002|Drug Therapy, Combination|drug therapy, combination
786183|NCT00005002|HIV Protease Inhibitors|hiv protease inhibitors
786184|NCT00005002|CD4 Lymphocyte Count|cd4 lymphocyte count
786185|NCT00005002|Nelfinavir|nelfinavir
786186|NCT00005002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786187|NCT00005002|Anti-HIV Agents|anti-hiv agents
786188|NCT00005002|Viral Load|viral load
786189|NCT00005002|remune|remune
786190|NCT00005002|Combivir|combivir
786191|NCT00005001|HIV-1|hiv-1
786192|NCT00005001|Drug Therapy, Combination|drug therapy, combination
786193|NCT00005001|RNA, Viral|rna, viral
786194|NCT00005001|Anti-HIV Agents|anti-hiv agents
786195|NCT00005001|Viral Load|viral load
786196|NCT00005001|remune|remune
786197|NCT00005000|HIV-1|hiv-1
786198|NCT00005000|Drug Therapy, Combination|drug therapy, combination
786199|NCT00005000|Lymphoid Tissue|lymphoid tissue
786200|NCT00005000|HIV Protease Inhibitors|hiv protease inhibitors
786201|NCT00005000|Genotype|genotype
786202|NCT00005000|Phenotype|phenotype
786203|NCT00005000|Nelfinavir|nelfinavir
786204|NCT00005000|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786205|NCT00005000|Anti-HIV Agents|anti-hiv agents
786206|NCT00005000|Viral Load|viral load
786207|NCT00005000|Adipose Tissue|adipose tissue
786208|NCT00005000|Glucose|glucose
786209|NCT00005000|Lipids|lipids
786210|NCT00005000|Immunophenotyping|immunophenotyping
786211|NCT00005000|efavirenz|efavirenz
786212|NCT00004999|Drug Therapy, Combination|drug therapy, combination
786213|NCT00004999|Zidovudine|zidovudine
786214|NCT00004999|HIV Protease Inhibitors|hiv protease inhibitors
786215|NCT00004999|Lamivudine|lamivudine
786216|NCT00004999|Disease Progression|disease progression
786217|NCT00004999|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786218|NCT00004999|Anti-HIV Agents|anti-hiv agents
786219|NCT00004999|Viral Load|viral load
786220|NCT00004999|Nelfinavir|nelfinavir
786221|NCT00004999|Combivir|combivir
786222|NCT00004998|Drug Therapy, Combination|drug therapy, combination
786223|NCT00004998|Zidovudine|zidovudine
786224|NCT00004998|HIV Protease Inhibitors|hiv protease inhibitors
786225|NCT00004998|Lamivudine|lamivudine
786226|NCT00004998|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786227|NCT00004998|Anti-HIV Agents|anti-hiv agents
786228|NCT00004998|Nelfinavir|nelfinavir
786229|NCT00004998|Combivir|combivir
786230|NCT00004987|Anti-HIV Agents|anti-hiv agents
786231|NCT00004987|Viral Load|viral load
786232|NCT00004987|dextrin 2-sulfate|dextrin 2-sulfate
786233|NCT00004987|Infusions, Parenteral|infusions, parenteral
786234|NCT00004986|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
786235|NCT00004986|Cryptosporidiosis|cryptosporidiosis
786236|NCT00004986|Drug Evaluation|drug evaluation
786237|NCT00004986|Antiprotozoal Agents|antiprotozoal agents
786238|NCT00004986|Treatment Failure|treatment failure
786239|NCT00004986|nitazoxanide|nitazoxanide
786240|NCT00004985|HIV-1|hiv-1
786241|NCT00004985|Drug Therapy, Combination|drug therapy, combination
786242|NCT00004985|HIV Protease Inhibitors|hiv protease inhibitors
786243|NCT00004985|RNA, Viral|rna, viral
786244|NCT00004985|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786245|NCT00004985|Anti-HIV Agents|anti-hiv agents
786246|NCT00004985|Viral Load|viral load
786247|NCT00004985|Nelfinavir|nelfinavir
786248|NCT00004981|Drug Therapy, Combination|drug therapy, combination
786249|NCT00004981|Zidovudine|zidovudine
786250|NCT00004981|Drug Administration Schedule|drug administration schedule
786251|NCT00004981|Lamivudine|lamivudine
786252|NCT00004981|RNA, Viral|rna, viral
786253|NCT00004981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786254|NCT00004981|Anti-HIV Agents|anti-hiv agents
786255|NCT00004981|Viral Load|viral load
786256|NCT00004981|Combivir|combivir
786257|NCT00004981|abacavir|abacavir
786258|NCT00004978|Recombinant Proteins|recombinant proteins
786259|NCT00004978|Injections, Subcutaneous|injections, subcutaneous
786260|NCT00004978|HIV-1|hiv-1
786261|NCT00004978|Interleukin-2|interleukin-2
786262|NCT00004978|Drug Therapy, Combination|drug therapy, combination
786263|NCT00004978|CD4 Lymphocyte Count|cd4 lymphocyte count
786264|NCT00004978|Disease Progression|disease progression
786265|NCT00004978|Follow-Up Studies|follow-up studies
786266|NCT00004978|Anti-HIV Agents|anti-hiv agents
786267|NCT00004855|Drug Therapy, Combination|drug therapy, combination
786270|NCT00004855|HIV Protease Inhibitors|hiv protease inhibitors
786271|NCT00004855|Ritonavir|ritonavir
786272|NCT00004855|Lamivudine|lamivudine
786273|NCT00004855|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786274|NCT00004855|Anti-HIV Agents|anti-hiv agents
786275|NCT00004855|ABT 378|abt 378
786276|NCT00004855|abacavir|abacavir
786277|NCT00004852|HIV-1|hiv-1
786278|NCT00004852|Drug Therapy, Combination|drug therapy, combination
786279|NCT00004852|Zidovudine|zidovudine
786280|NCT00004852|Drug Administration Schedule|drug administration schedule
786281|NCT00004852|Lamivudine|lamivudine
786282|NCT00004852|Genotype|genotype
786283|NCT00004852|Phenotype|phenotype
786284|NCT00004852|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786285|NCT00004852|Anti-HIV Agents|anti-hiv agents
786286|NCT00004852|Viral Load|viral load
786287|NCT00004852|efavirenz|efavirenz
786288|NCT00004736|Tuberculosis|tuberculosis
786289|NCT00004736|Rifabutin|rifabutin
786290|NCT00004736|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
786291|NCT00004736|Drug Therapy, Combination|drug therapy, combination
786292|NCT00004736|Antitubercular Agents|antitubercular agents
786293|NCT00004736|Anti-HIV Agents|anti-hiv agents
786294|NCT00004735|Viral Vaccines|viral vaccines
786295|NCT00004735|Drug Therapy, Combination|drug therapy, combination
786296|NCT00004735|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
786297|NCT00004735|Immunologic Memory|immunologic memory
786298|NCT00004735|Antibody Formation|antibody formation
786299|NCT00004735|Anti-HIV Agents|anti-hiv agents
786300|NCT00004735|Tetanus Toxoid|tetanus toxoid
786301|NCT00004735|Hepatitis A Virus, Human|hepatitis a virus, human
786302|NCT00004735|Enfuvirtide|enfuvirtide
786303|NCT00004735|T-20|t-20
786304|NCT00004735|Treatment Naive|treatment naive
786305|NCT00004735|Treatment Experienced|treatment experienced
786306|NCT00004585|Drug Therapy, Combination|drug therapy, combination
786307|NCT00004585|Zidovudine|zidovudine
786308|NCT00004585|Lamivudine|lamivudine
786309|NCT00004585|RNA, Viral|rna, viral
786310|NCT00004585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786311|NCT00004585|Anti-HIV Agents|anti-hiv agents
786312|NCT00004585|Viral Load|viral load
786313|NCT00004585|abacavir|abacavir
786314|NCT00004585|efavirenz|efavirenz
786315|NCT00004584|Dose-Response Relationship, Drug|dose-response relationship, drug
786316|NCT00004584|Drug Therapy, Combination|drug therapy, combination
786317|NCT00004584|HIV Protease Inhibitors|hiv protease inhibitors
786318|NCT00004584|Ritonavir|ritonavir
786319|NCT00004584|Saquinavir|saquinavir
786320|NCT00004584|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786321|NCT00004584|Anti-HIV Agents|anti-hiv agents
786322|NCT00004583|Drug Therapy, Combination|drug therapy, combination
786323|NCT00004583|Administration, Oral|administration, oral
786324|NCT00004583|Stavudine|stavudine
786325|NCT00004583|HIV Protease Inhibitors|hiv protease inhibitors
786326|NCT00004583|Lamivudine|lamivudine
786327|NCT00004583|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786328|NCT00004583|Anti-HIV Agents|anti-hiv agents
786329|NCT00004583|Nelfinavir|nelfinavir
786330|NCT00004583|ABT 378|abt 378
786331|NCT00004582|HIV Protease Inhibitors|hiv protease inhibitors
786332|NCT00004582|Ritonavir|ritonavir
786333|NCT00004582|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786334|NCT00004582|Anti-HIV Agents|anti-hiv agents
786335|NCT00004582|Viral Load|viral load
786336|NCT00004582|ABT 378|abt 378
786337|NCT00004582|efavirenz|efavirenz
786338|NCT00004581|Drug Therapy, Combination|drug therapy, combination
786339|NCT00004581|Nevirapine|nevirapine
786340|NCT00004581|HIV Protease Inhibitors|hiv protease inhibitors
786341|NCT00004581|Ritonavir|ritonavir
786342|NCT00004581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786343|NCT00004581|Anti-HIV Agents|anti-hiv agents
786344|NCT00004581|ABT 378|abt 378
786345|NCT00004580|Drug Therapy, Combination|drug therapy, combination
786346|NCT00004580|Nevirapine|nevirapine
786347|NCT00004580|HIV Protease Inhibitors|hiv protease inhibitors
786348|NCT00004580|Ritonavir|ritonavir
786349|NCT00004580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786350|NCT00004579|Vaccines, Synthetic|vaccines, synthetic
786351|NCT00004579|Viral Vaccines|viral vaccines
786352|NCT00004579|HIV-1|hiv-1
786353|NCT00004579|Dose-Response Relationship, Drug|dose-response relationship, drug
786354|NCT00004579|HIV Envelope Protein gp160|hiv envelope protein gp160
786355|NCT00004579|AIDS Vaccines|aids vaccines
786356|NCT00004579|HIV Seronegativity|hiv seronegativity
786357|NCT00004579|Avipoxvirus|avipoxvirus
786358|NCT00004579|Immunization|immunization
786359|NCT00004579|HIV Envelope Protein gp120|hiv envelope protein gp120
786360|NCT00004579|Recombination, Genetic|recombination, genetic
786361|NCT00004578|Stavudine|stavudine
786362|NCT00004578|HIV Protease Inhibitors|hiv protease inhibitors
786363|NCT00004578|Ritonavir|ritonavir
786364|NCT00004578|Lamivudine|lamivudine
786365|NCT00004578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786366|NCT00002453|HIV-1|hiv-1
786367|NCT00002453|Drug Therapy, Combination|drug therapy, combination
792829|NCT00015600|Farmworker|farmworker
786368|NCT00002453|Disease Progression|disease progression
786369|NCT00002453|Anti-HIV Agents|anti-hiv agents
786370|NCT00002452|Drug Therapy, Combination|drug therapy, combination
786371|NCT00002452|HIV Protease Inhibitors|hiv protease inhibitors
786372|NCT00002452|Indinavir|indinavir
786373|NCT00002452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786374|NCT00002452|Anti-HIV Agents|anti-hiv agents
786375|NCT00002452|Viral Load|viral load
786376|NCT00002451|Drug Therapy, Combination|drug therapy, combination
786377|NCT00002451|Stavudine|stavudine
786378|NCT00002451|HIV Protease Inhibitors|hiv protease inhibitors
786379|NCT00002451|CD4 Lymphocyte Count|cd4 lymphocyte count
786380|NCT00002451|Ritonavir|ritonavir
786381|NCT00002451|Lamivudine|lamivudine
786382|NCT00002451|Indinavir|indinavir
786383|NCT00002451|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786384|NCT00002451|Anti-HIV Agents|anti-hiv agents
786385|NCT00002451|Viral Load|viral load
786386|NCT00002450|HIV-1|hiv-1
786387|NCT00002450|Drug Therapy, Combination|drug therapy, combination
786388|NCT00002450|Drug Administration Schedule|drug administration schedule
786389|NCT00002450|RNA, Viral|rna, viral
786390|NCT00002450|Anti-HIV Agents|anti-hiv agents
786391|NCT00002450|Viral Load|viral load
786392|NCT00002449|Recombinant Proteins|recombinant proteins
786393|NCT00002449|Injections, Subcutaneous|injections, subcutaneous
786394|NCT00002449|Interleukin-2|interleukin-2
786395|NCT00002449|Dose-Response Relationship, Drug|dose-response relationship, drug
786396|NCT00002449|CD4 Lymphocyte Count|cd4 lymphocyte count
786397|NCT00002449|Anti-HIV Agents|anti-hiv agents
786398|NCT00002449|Viral Load|viral load
786399|NCT00002449|Pharmacokinetics|pharmacokinetics
786400|NCT00002448|Drug Therapy, Combination|drug therapy, combination
786401|NCT00002448|HIV Protease Inhibitors|hiv protease inhibitors
786402|NCT00002448|Ritonavir|ritonavir
786403|NCT00002448|Dosage Forms|dosage forms
786404|NCT00002448|Saquinavir|saquinavir
786405|NCT00002448|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786406|NCT00002448|Anti-HIV Agents|anti-hiv agents
786407|NCT00002448|efavirenz|efavirenz
786408|NCT00002447|Drug Therapy, Combination|drug therapy, combination
786409|NCT00002447|Saquinavir|saquinavir
786410|NCT00002447|HIV Protease Inhibitors|hiv protease inhibitors
786411|NCT00002447|Ritonavir|ritonavir
786412|NCT00002447|Dosage Forms|dosage forms
786413|NCT00002447|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786414|NCT00002447|Anti-HIV Agents|anti-hiv agents
786415|NCT00002447|efavirenz|efavirenz
786416|NCT00002446|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
786417|NCT00002446|Fluconazole|fluconazole
786418|NCT00002446|Administration, Oral|administration, oral
786419|NCT00002446|Antifungal Agents|antifungal agents
786420|NCT00002446|Candidiasis, Oral|candidiasis, oral
786421|NCT00002446|Pharyngeal Diseases|pharyngeal diseases
786422|NCT00002446|posaconazole|posaconazole
786423|NCT00002445|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
786424|NCT00002445|Placebos|placebos
786425|NCT00002445|Sarcoma, Kaposi|sarcoma, kaposi
786426|NCT00002445|Antineoplastic Agents|antineoplastic agents
786427|NCT00002445|Treatment Outcome|treatment outcome
786428|NCT00002445|Quality of Life|quality of life
786429|NCT00002442|Drug Therapy, Combination|drug therapy, combination
786430|NCT00002442|Zidovudine|zidovudine
786431|NCT00002442|Drug Administration Schedule|drug administration schedule
786432|NCT00002442|Stavudine|stavudine
786433|NCT00002442|HIV Protease Inhibitors|hiv protease inhibitors
786434|NCT00002442|Lamivudine|lamivudine
786435|NCT00002442|Indinavir|indinavir
786436|NCT00002442|Dosage Forms|dosage forms
786437|NCT00002442|Nelfinavir|nelfinavir
786438|NCT00002442|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786439|NCT00002442|Anti-HIV Agents|anti-hiv agents
786440|NCT00002441|HIV-1|hiv-1
786441|NCT00002441|Dose-Response Relationship, Drug|dose-response relationship, drug
786442|NCT00002441|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
786443|NCT00002441|AIDS Vaccines|aids vaccines
786444|NCT00002441|Sexually Transmitted Diseases|sexually transmitted diseases
786445|NCT00002441|Risk Factors|risk factors
786446|NCT00002441|HIV Seronegativity|hiv seronegativity
786447|NCT00002441|Antigens, Viral|antigens, viral
786448|NCT00002441|Alum Compounds|alum compounds
786449|NCT00002440|HIV-1|hiv-1
786450|NCT00002440|Drug Therapy, Combination|drug therapy, combination
786451|NCT00002440|HIV Protease Inhibitors|hiv protease inhibitors
786452|NCT00002440|Mutation|mutation
786453|NCT00002440|HIV-1 Reverse Transcriptase|hiv-1 reverse transcriptase
786454|NCT00002440|HIV Protease|hiv protease
786455|NCT00002440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786456|NCT00002440|Anti-HIV Agents|anti-hiv agents
786457|NCT00002440|abacavir|abacavir
786458|NCT00002438|Itraconazole|itraconazole
786459|NCT00002438|Histoplasmosis|histoplasmosis
786460|NCT00002438|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
786461|NCT00002437|Retinitis|retinitis
786462|NCT00002437|Probenecid|probenecid
786463|NCT00002437|Drug Therapy, Combination|drug therapy, combination
793425|NCT00011115|overweight|overweight
786464|NCT00002437|Cytomegalovirus Infections|cytomegalovirus infections
786465|NCT00002437|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
786466|NCT00002437|Antiviral Agents|antiviral agents
786467|NCT00002437|cidofovir|cidofovir
786468|NCT00002436|Zalcitabine|zalcitabine
786469|NCT00002436|Drug Therapy, Combination|drug therapy, combination
786470|NCT00002436|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
786471|NCT00002436|AIDS-Related Complex|aids-related complex
786472|NCT00002436|Antiviral Agents|antiviral agents
786473|NCT00002436|Zidovudine|zidovudine
786474|NCT00002435|Drug Therapy, Combination|drug therapy, combination
786475|NCT00002435|Antiviral Agents|antiviral agents
786476|NCT00002435|Zidovudine|zidovudine
786477|NCT00002435|thymic humoral factor gamma 2|thymic humoral factor gamma 2
786478|NCT00002434|Trimetrexate|trimetrexate
786479|NCT00002434|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
786480|NCT00002434|Leucovorin|leucovorin
786481|NCT00002434|Drug Therapy, Combination|drug therapy, combination
786482|NCT00002434|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
786483|NCT00002433|Pulmonary Alveoli|pulmonary alveoli
786484|NCT00002433|Macrophage Activation|macrophage activation
786485|NCT00002433|Interferon-gamma, Recombinant|interferon-gamma, recombinant
786486|NCT00002433|Injections, Subcutaneous|injections, subcutaneous
786487|NCT00002433|Aerosols|aerosols
786488|NCT00002433|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
786489|NCT00002432|Retinitis|retinitis
786490|NCT00002432|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
786491|NCT00002432|Foscarnet|foscarnet
786492|NCT00002432|Cytomegalovirus Infections|cytomegalovirus infections
786493|NCT00002432|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
786494|NCT00002431|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
786495|NCT00002431|chlorhexidine gluconate|chlorhexidine gluconate
786496|NCT00002431|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
786497|NCT00002431|Anti-Infective Agents, Local|anti-infective agents, local
786498|NCT00002431|AIDS-Related Complex|aids-related complex
786499|NCT00002431|Candidiasis, Oral|candidiasis, oral
786500|NCT00002430|Drug Therapy, Combination|drug therapy, combination
786501|NCT00002430|HIV Protease Inhibitors|hiv protease inhibitors
786502|NCT00002430|Lamivudine|lamivudine
786503|NCT00002430|Indinavir|indinavir
786504|NCT00002430|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786505|NCT00002430|Anti-HIV Agents|anti-hiv agents
786506|NCT00002430|Nelfinavir|nelfinavir
786507|NCT00002429|Didanosine|didanosine
786508|NCT00002429|Drug Therapy, Combination|drug therapy, combination
786509|NCT00002429|Stavudine|stavudine
786510|NCT00002429|RNA, Viral|rna, viral
786511|NCT00002429|Nelfinavir|nelfinavir
786512|NCT00002429|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786513|NCT00002429|Anti-HIV Agents|anti-hiv agents
786514|NCT00002428|Vaccines, Synthetic|vaccines, synthetic
786515|NCT00002428|HIV-1|hiv-1
786516|NCT00002428|HIV Envelope Protein gp120|hiv envelope protein gp120
786517|NCT00002428|AIDS Vaccines|aids vaccines
786518|NCT00002428|HIV Seronegativity|hiv seronegativity
786519|NCT00002427|Didanosine|didanosine
786520|NCT00002427|Dose-Response Relationship, Drug|dose-response relationship, drug
786521|NCT00002427|Drug Therapy, Combination|drug therapy, combination
786522|NCT00002427|Stavudine|stavudine
786523|NCT00002427|Hydroxyurea|hydroxyurea
786524|NCT00002427|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786525|NCT00002427|Anti-HIV Agents|anti-hiv agents
786526|NCT00002426|HIV-1|hiv-1
786527|NCT00002426|RNA, Viral|rna, viral
786528|NCT00002426|VX 478|vx 478
786529|NCT00002426|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786530|NCT00002426|Anti-HIV Agents|anti-hiv agents
786531|NCT00002426|Viral Load|viral load
786532|NCT00002425|Drug Therapy, Combination|drug therapy, combination
786533|NCT00002425|Saquinavir|saquinavir
786534|NCT00002425|HIV Protease Inhibitors|hiv protease inhibitors
786535|NCT00002425|Dosage Forms|dosage forms
786536|NCT00002425|Anti-HIV Agents|anti-hiv agents
786537|NCT00002424|Drug Therapy, Combination|drug therapy, combination
786538|NCT00002424|Drug Administration Schedule|drug administration schedule
786539|NCT00002424|Stavudine|stavudine
786540|NCT00002424|HIV Protease Inhibitors|hiv protease inhibitors
786541|NCT00002424|Lamivudine|lamivudine
786542|NCT00002424|Indinavir|indinavir
786543|NCT00002424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786544|NCT00002424|Anti-HIV Agents|anti-hiv agents
786545|NCT00002423|Drug Therapy, Combination|drug therapy, combination
786546|NCT00002423|HIV Protease Inhibitors|hiv protease inhibitors
786547|NCT00002423|Lamivudine|lamivudine
786548|NCT00002423|Indinavir|indinavir
786549|NCT00002423|Nelfinavir|nelfinavir
786550|NCT00002423|VX 478|vx 478
786551|NCT00002423|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786552|NCT00002423|Anti-HIV Agents|anti-hiv agents
786553|NCT00002423|Viral Load|viral load
786554|NCT00002423|abacavir|abacavir
786555|NCT00002422|Injections, Intramuscular|injections, intramuscular
786556|NCT00002422|Drug Interactions|drug interactions
786557|NCT00002422|Salvage Therapy|salvage therapy
786558|NCT00002422|Anti-HIV Agents|anti-hiv agents
786559|NCT00002420|Drug Therapy, Combination|drug therapy, combination
786560|NCT00002420|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786561|NCT00002420|Anti-HIV Agents|anti-hiv agents
786562|NCT00002419|Drug Therapy, Combination|drug therapy, combination
786563|NCT00002419|HIV Protease Inhibitors|hiv protease inhibitors
786564|NCT00002419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786565|NCT00002419|Anti-HIV Agents|anti-hiv agents
786566|NCT00002418|Drug Therapy, Combination|drug therapy, combination
786567|NCT00002418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786568|NCT00002418|Anti-HIV Agents|anti-hiv agents
786569|NCT00002418|Viral Load|viral load
786570|NCT00002417|Drug Therapy, Combination|drug therapy, combination
786571|NCT00002417|HIV Protease Inhibitors|hiv protease inhibitors
786572|NCT00002417|VX 478|vx 478
786573|NCT00002417|Lipodystrophy|lipodystrophy
786574|NCT00002417|Hyperlipidemia|hyperlipidemia
786575|NCT00002416|HIV-1|hiv-1
786576|NCT00002416|Zalcitabine|zalcitabine
786577|NCT00002416|Zidovudine|zidovudine
786578|NCT00002416|Stavudine|stavudine
786579|NCT00002416|HIV Protease Inhibitors|hiv protease inhibitors
786580|NCT00002416|Lamivudine|lamivudine
786581|NCT00002416|RNA, Viral|rna, viral
786582|NCT00002416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786583|NCT00002416|Anti-HIV Agents|anti-hiv agents
786584|NCT00002415|Drug Therapy, Combination|drug therapy, combination
786585|NCT00002415|Prodrugs|prodrugs
786586|NCT00002415|Anti-HIV Agents|anti-hiv agents
786587|NCT00002414|AIDS Dementia Complex|aids dementia complex
786588|NCT00002414|Anti-HIV Agents|anti-hiv agents
786589|NCT00002413|Anti-HIV Agents|anti-hiv agents
786590|NCT00002413|Viral Load|viral load
786591|NCT00002413|MKC 442|mkc 442
786592|NCT00002412|Didanosine|didanosine
786593|NCT00002412|Drug Therapy, Combination|drug therapy, combination
786594|NCT00002412|Stavudine|stavudine
786595|NCT00002412|Hydroxyurea|hydroxyurea
786596|NCT00002412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786597|NCT00002412|Anti-HIV Agents|anti-hiv agents
786598|NCT00002412|Viral Load|viral load
786599|NCT00002412|MKC 442|mkc 442
786600|NCT00002411|HIV-1|hiv-1
786601|NCT00002411|Didanosine|didanosine
786602|NCT00002411|Drug Therapy, Combination|drug therapy, combination
786603|NCT00002411|Zidovudine|zidovudine
786604|NCT00002411|Stavudine|stavudine
786605|NCT00002411|Lamivudine|lamivudine
786606|NCT00002411|RNA, Viral|rna, viral
786607|NCT00002411|Nelfinavir|nelfinavir
786608|NCT00002411|Anti-HIV Agents|anti-hiv agents
786609|NCT00002411|Viral Load|viral load
786610|NCT00002410|HIV-1|hiv-1
786611|NCT00002410|Drug Therapy, Combination|drug therapy, combination
786612|NCT00002410|Zidovudine|zidovudine
786613|NCT00002410|Drug Resistance, Microbial|drug resistance, microbial
786614|NCT00002410|HIV Protease Inhibitors|hiv protease inhibitors
786615|NCT00002410|Lamivudine|lamivudine
786616|NCT00002410|Indinavir|indinavir
786617|NCT00002410|Genotype|genotype
786618|NCT00002410|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786619|NCT00002410|efavirenz|efavirenz
786620|NCT00002409|Drug Therapy, Combination|drug therapy, combination
786621|NCT00002409|Zidovudine|zidovudine
786622|NCT00002409|HIV Protease Inhibitors|hiv protease inhibitors
786623|NCT00002409|Lamivudine|lamivudine
786624|NCT00002409|Patient Education|patient education
786625|NCT00002409|Patient Compliance|patient compliance
786626|NCT00002409|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786627|NCT00002409|Anti-HIV Agents|anti-hiv agents
786628|NCT00002409|Viral Load|viral load
786629|NCT00002409|abacavir|abacavir
786630|NCT00002408|Diarrhea|diarrhea
786631|NCT00002408|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
786632|NCT00002406|HIV-1|hiv-1
786633|NCT00002406|Dose-Response Relationship, Drug|dose-response relationship, drug
786634|NCT00002406|HIV Protease Inhibitors|hiv protease inhibitors
786635|NCT00002406|Indinavir|indinavir
786636|NCT00002406|RNA, Viral|rna, viral
786637|NCT00002406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786638|NCT00002405|Drug Therapy, Combination|drug therapy, combination
786639|NCT00002405|HIV Protease Inhibitors|hiv protease inhibitors
786640|NCT00002405|VX 478|vx 478
786641|NCT00002405|Anti-HIV Agents|anti-hiv agents
786642|NCT00002404|HIV-1|hiv-1
786643|NCT00002404|Antiviral Agents|antiviral agents
786644|NCT00002404|Herpes Genitalis|herpes genitalis
786645|NCT00002404|Recurrence|recurrence
786646|NCT00002404|DNA, Viral|dna, viral
786647|NCT00002404|RNA, Viral|rna, viral
786648|NCT00002404|valacyclovir|valacyclovir
786649|NCT00002404|Herpesvirus 2, Human|herpesvirus 2, human
786650|NCT00002403|HIV-1|hiv-1
786651|NCT00002403|Dose-Response Relationship, Drug|dose-response relationship, drug
786652|NCT00002403|HIV Integrase Inhibitors|hiv integrase inhibitors
786653|NCT00002403|HIV Integrase|hiv integrase
786654|NCT00002402|HIV-1|hiv-1
786655|NCT00002402|Dose-Response Relationship, Drug|dose-response relationship, drug
786656|NCT00002402|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
786657|NCT00002402|AIDS Vaccines|aids vaccines
786658|NCT00002402|HIV Seronegativity|hiv seronegativity
786659|NCT00002402|Antigens, Viral|antigens, viral
786660|NCT00002402|Alum Compounds|alum compounds
786661|NCT00002401|HIV-1|hiv-1
786662|NCT00002401|Zidovudine|zidovudine
786663|NCT00002401|HIV Protease Inhibitors|hiv protease inhibitors
786664|NCT00002401|Lamivudine|lamivudine
786665|NCT00002401|Indinavir|indinavir
786666|NCT00002401|RNA, Viral|rna, viral
786667|NCT00002401|Delavirdine|delavirdine
786668|NCT00002401|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786669|NCT00002401|Viral Load|viral load
786670|NCT00002400|HIV-1|hiv-1
786671|NCT00002400|Drug Therapy, Combination|drug therapy, combination
786672|NCT00002400|Zidovudine|zidovudine
786673|NCT00002400|HIV Protease Inhibitors|hiv protease inhibitors
786674|NCT00002400|Lamivudine|lamivudine
786675|NCT00002400|Indinavir|indinavir
786676|NCT00002400|RNA, Viral|rna, viral
786677|NCT00002400|Delavirdine|delavirdine
786678|NCT00002400|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786679|NCT00002399|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
786680|NCT00002399|Fluconazole|fluconazole
786681|NCT00002399|Antifungal Agents|antifungal agents
786682|NCT00002399|Candidiasis|candidiasis
786683|NCT00002399|Triazoles|triazoles
786684|NCT00002398|HIV-1|hiv-1
786685|NCT00002398|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
786686|NCT00002398|Adenine|adenine
786687|NCT00002398|Anti-HIV Agents|anti-hiv agents
786688|NCT00002397|Kidney Failure, Chronic|kidney failure, chronic
786689|NCT00002397|HIV-1|hiv-1
786690|NCT00002397|Drug Therapy, Combination|drug therapy, combination
786691|NCT00002397|Stavudine|stavudine
786692|NCT00002397|HIV Protease Inhibitors|hiv protease inhibitors
786693|NCT00002397|Lamivudine|lamivudine
786694|NCT00002397|Saquinavir|saquinavir
786695|NCT00002397|AIDS-Associated Nephropathy|aids-associated nephropathy
786696|NCT00002397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786697|NCT00002397|Viral Load|viral load
786698|NCT00002397|Nelfinavir|nelfinavir
786699|NCT00002396|Dose-Response Relationship, Drug|dose-response relationship, drug
786700|NCT00002396|Adenine|adenine
786701|NCT00002396|Anti-HIV Agents|anti-hiv agents
786702|NCT00002395|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
786703|NCT00002395|Leukoencephalopathy, Progressive Multifocal|leukoencephalopathy, progressive multifocal
786704|NCT00002395|Infusions, Intravenous|infusions, intravenous
786705|NCT00002395|Drug Administration Schedule|drug administration schedule
786706|NCT00002395|Topotecan|topotecan
786707|NCT00002394|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
786708|NCT00002394|Dose-Response Relationship, Drug|dose-response relationship, drug
786709|NCT00002394|Fluconazole|fluconazole
786710|NCT00002394|Antifungal Agents|antifungal agents
786711|NCT00002394|Candidiasis, Oral|candidiasis, oral
786712|NCT00002394|Drug Administration Schedule|drug administration schedule
786713|NCT00002394|terbinafine|terbinafine
786714|NCT00002393|Placebos|placebos
786715|NCT00002393|Drug Therapy, Combination|drug therapy, combination
786716|NCT00002393|HIV Protease Inhibitors|hiv protease inhibitors
786717|NCT00002393|Indinavir|indinavir
786718|NCT00002393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786719|NCT00002393|efavirenz|efavirenz
786720|NCT00002392|Lymphocyte Transformation|lymphocyte transformation
786721|NCT00002392|Immunity, Cellular|immunity, cellular
786722|NCT00002392|Drug Therapy, Combination|drug therapy, combination
786723|NCT00002392|Adjuvants, Immunologic|adjuvants, immunologic
786724|NCT00002392|Thalidomide|thalidomide
786725|NCT00002392|Immunologic Memory|immunologic memory
786726|NCT00002392|Streptococcus pneumoniae|streptococcus pneumoniae
786727|NCT00002392|Tetanus Toxoid|tetanus toxoid
786728|NCT00002392|Pneumococcal Vaccines|pneumococcal vaccines
786729|NCT00002391|HIV-1|hiv-1
786730|NCT00002391|Drug Therapy, Combination|drug therapy, combination
786731|NCT00002391|Zidovudine|zidovudine
786732|NCT00002391|Lamivudine|lamivudine
786733|NCT00002391|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786734|NCT00002391|Anti-HIV Agents|anti-hiv agents
786735|NCT00002391|Viral Load|viral load
786736|NCT00002391|Child Development|child development
786737|NCT00002391|abacavir|abacavir
786738|NCT00002389|HIV-1|hiv-1
786739|NCT00002389|Drug Therapy, Combination|drug therapy, combination
786740|NCT00002389|Antiviral Agents|antiviral agents
786741|NCT00002389|Zidovudine|zidovudine
786742|NCT00002389|CD4 Lymphocyte Count|cd4 lymphocyte count
786743|NCT00002389|Lamivudine|lamivudine
786744|NCT00002389|RNA, Viral|rna, viral
786745|NCT00002389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786746|NCT00002389|Anti-HIV Agents|anti-hiv agents
786747|NCT00002389|Viral Load|viral load
786748|NCT00002389|abacavir|abacavir
786749|NCT00002388|HIV-1|hiv-1
786750|NCT00002388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786751|NCT00002388|Anti-HIV Agents|anti-hiv agents
786752|NCT00002387|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
786753|NCT00002387|Drug Administration Schedule|drug administration schedule
786754|NCT00002387|HIV Protease Inhibitors|hiv protease inhibitors
786756|NCT00002387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786757|NCT00002387|Anti-HIV Agents|anti-hiv agents
786758|NCT00002387|efavirenz|efavirenz
786759|NCT00002386|Drug Therapy, Combination|drug therapy, combination
786760|NCT00002386|HIV Protease Inhibitors|hiv protease inhibitors
786761|NCT00002386|Indinavir|indinavir
786762|NCT00002386|Factor VIII|factor viii
786763|NCT00002386|Factor IX|factor ix
786764|NCT00002386|Half-Life|half-life
786765|NCT00002386|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786766|NCT00002386|Anti-HIV Agents|anti-hiv agents
786767|NCT00002386|Platelet Aggregation|platelet aggregation
786768|NCT00002386|Hemophilia A|hemophilia a
786769|NCT00002386|Hemophilia B|hemophilia b
786770|NCT00002385|Dose-Response Relationship, Drug|dose-response relationship, drug
786771|NCT00002385|Cohort Studies|cohort studies
786772|NCT00002385|Anti-HIV Agents|anti-hiv agents
786773|NCT00002383|Drug Administration Schedule|drug administration schedule
786774|NCT00002383|HIV Protease Inhibitors|hiv protease inhibitors
786775|NCT00002383|Dosage Forms|dosage forms
786776|NCT00002383|Saquinavir|saquinavir
786777|NCT00002383|Anti-HIV Agents|anti-hiv agents
786778|NCT00002382|Zalcitabine|zalcitabine
786779|NCT00002382|Didanosine|didanosine
786780|NCT00002382|Drug Therapy, Combination|drug therapy, combination
786781|NCT00002382|Zidovudine|zidovudine
786782|NCT00002382|HIV Protease Inhibitors|hiv protease inhibitors
786783|NCT00002382|Saquinavir|saquinavir
786784|NCT00002382|Patient Selection|patient selection
786785|NCT00002382|Anti-HIV Agents|anti-hiv agents
786786|NCT00002381|HIV-1|hiv-1
786787|NCT00002381|Drug Therapy, Combination|drug therapy, combination
786788|NCT00002381|Nevirapine|nevirapine
786789|NCT00002381|Stavudine|stavudine
786790|NCT00002381|RNA, Viral|rna, viral
786791|NCT00002381|Nelfinavir|nelfinavir
786792|NCT00002381|Anti-HIV Agents|anti-hiv agents
786793|NCT00002381|Viral Load|viral load
786794|NCT00002380|Drug Therapy, Combination|drug therapy, combination
786795|NCT00002380|HIV Protease Inhibitors|hiv protease inhibitors
786796|NCT00002380|Dosage Forms|dosage forms
786797|NCT00002380|Saquinavir|saquinavir
786798|NCT00002380|Nelfinavir|nelfinavir
786799|NCT00002380|Anti-HIV Agents|anti-hiv agents
786800|NCT00002379|HIV-1|hiv-1
786801|NCT00002379|Drug Therapy, Combination|drug therapy, combination
786802|NCT00002379|Administration, Oral|administration, oral
786803|NCT00002379|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
786804|NCT00002379|Zidovudine|zidovudine
786805|NCT00002379|Stavudine|stavudine
786806|NCT00002379|HIV Protease Inhibitors|hiv protease inhibitors
786807|NCT00002379|CD4 Lymphocyte Count|cd4 lymphocyte count
786808|NCT00002379|Lamivudine|lamivudine
786809|NCT00002379|Indinavir|indinavir
786810|NCT00002379|RNA, Viral|rna, viral
786811|NCT00002379|Adenine|adenine
786812|NCT00002379|Anti-HIV Agents|anti-hiv agents
786813|NCT00002379|Viral Load|viral load
786814|NCT00002378|HIV-1|hiv-1
786815|NCT00002378|Drug Therapy, Combination|drug therapy, combination
786816|NCT00002378|Zidovudine|zidovudine
786817|NCT00002378|Stavudine|stavudine
786818|NCT00002378|HIV Protease Inhibitors|hiv protease inhibitors
786819|NCT00002378|Lamivudine|lamivudine
786820|NCT00002378|RNA, Viral|rna, viral
786821|NCT00002378|Dosage Forms|dosage forms
786822|NCT00002378|Saquinavir|saquinavir
786823|NCT00002378|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786824|NCT00002378|Anti-HIV Agents|anti-hiv agents
786825|NCT00002378|Viral Load|viral load
786826|NCT00002378|Nelfinavir|nelfinavir
786827|NCT00002376|HIV-1|hiv-1
786828|NCT00002376|CD4 Lymphocyte Count|cd4 lymphocyte count
786829|NCT00002376|RNA, Viral|rna, viral
786830|NCT00002376|Anti-HIV Agents|anti-hiv agents
786831|NCT00002376|Viral Load|viral load
786832|NCT00002375|Drug Therapy, Combination|drug therapy, combination
786833|NCT00002375|HIV Protease Inhibitors|hiv protease inhibitors
786834|NCT00002375|Indinavir|indinavir
786835|NCT00002375|Nelfinavir|nelfinavir
786836|NCT00002375|Anti-HIV Agents|anti-hiv agents
786837|NCT00002374|HIV-1|hiv-1
786838|NCT00002374|Drug Therapy, Combination|drug therapy, combination
786839|NCT00002374|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
786840|NCT00002374|HIV Protease Inhibitors|hiv protease inhibitors
786841|NCT00002374|RNA, Viral|rna, viral
786842|NCT00002374|Saquinavir|saquinavir
786843|NCT00002374|Anti-HIV Agents|anti-hiv agents
786844|NCT00002374|Viral Load|viral load
786845|NCT00002373|Cytomegalovirus|cytomegalovirus
786846|NCT00002373|Cytomegalovirus Infections|cytomegalovirus infections
786847|NCT00002373|Administration, Oral|administration, oral
786848|NCT00002373|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
786849|NCT00002373|Antiviral Agents|antiviral agents
786850|NCT00002373|Virus Shedding|virus shedding
786851|NCT00002373|Viral Load|viral load
786852|NCT00002372|Drug Therapy, Combination|drug therapy, combination
786853|NCT00002372|Administration, Oral|administration, oral
786854|NCT00002372|HIV Protease Inhibitors|hiv protease inhibitors
786855|NCT00002372|Indinavir|indinavir
786856|NCT00002372|Saquinavir|saquinavir
786857|NCT00002372|Nelfinavir|nelfinavir
786860|NCT00002371|Drug Therapy, Combination|drug therapy, combination
786861|NCT00002371|Stavudine|stavudine
786862|NCT00002371|Lamivudine|lamivudine
786863|NCT00002371|RNA, Viral|rna, viral
786864|NCT00002371|Anti-HIV Agents|anti-hiv agents
786865|NCT00002371|Viral Load|viral load
786866|NCT00002370|Itraconazole|itraconazole
786867|NCT00002370|Administration, Oral|administration, oral
786868|NCT00002370|Antifungal Agents|antifungal agents
786869|NCT00002370|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
786870|NCT00002370|Drug Administration Schedule|drug administration schedule
786871|NCT00002369|Drug Therapy, Combination|drug therapy, combination
786872|NCT00002369|Zidovudine|zidovudine
786873|NCT00002369|Stavudine|stavudine
786874|NCT00002369|HIV Protease Inhibitors|hiv protease inhibitors
786875|NCT00002369|CD4 Lymphocyte Count|cd4 lymphocyte count
786876|NCT00002369|Lamivudine|lamivudine
786877|NCT00002369|Indinavir|indinavir
786878|NCT00002369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786879|NCT00002369|Anti-HIV Agents|anti-hiv agents
786880|NCT00002369|Viral Load|viral load
786881|NCT00002368|Drug Therapy, Combination|drug therapy, combination
786882|NCT00002368|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
786883|NCT00002368|Nevirapine|nevirapine
786884|NCT00002368|Lamivudine|lamivudine
786885|NCT00002368|Disease Progression|disease progression
786886|NCT00002368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786887|NCT00002368|Anti-HIV Agents|anti-hiv agents
786888|NCT00002367|Drug Therapy, Combination|drug therapy, combination
786889|NCT00002367|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
786890|NCT00002367|Zidovudine|zidovudine
786891|NCT00002367|HIV Protease Inhibitors|hiv protease inhibitors
786892|NCT00002367|Lamivudine|lamivudine
786893|NCT00002367|Saquinavir|saquinavir
786894|NCT00002367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786895|NCT00002367|Anti-HIV Agents|anti-hiv agents
786896|NCT00002366|Skin Neoplasms|skin neoplasms
786897|NCT00002366|Sarcoma, Kaposi|sarcoma, kaposi
786898|NCT00002366|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
786899|NCT00002366|HIV Protease Inhibitors|hiv protease inhibitors
786900|NCT00002366|Ritonavir|ritonavir
786901|NCT00002365|Dose-Response Relationship, Drug|dose-response relationship, drug
786902|NCT00002365|Administration, Oral|administration, oral
786903|NCT00002365|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
786904|NCT00002365|Anti-HIV Agents|anti-hiv agents
786905|NCT00002364|Drug Therapy, Combination|drug therapy, combination
786906|NCT00002364|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
786907|NCT00002364|AIDS-Related Complex|aids-related complex
786908|NCT00002364|Antiviral Agents|antiviral agents
786909|NCT00002363|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
786910|NCT00002363|AIDS-Related Complex|aids-related complex
786911|NCT00002363|Antiviral Agents|antiviral agents
786912|NCT00002362|Dideoxynucleosides|dideoxynucleosides
786913|NCT00002362|Drug Therapy, Combination|drug therapy, combination
786914|NCT00002362|Stavudine|stavudine
786915|NCT00002362|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786916|NCT00002362|abacavir|abacavir
786917|NCT00002362|efavirenz|efavirenz
786918|NCT00002361|Drug Therapy, Combination|drug therapy, combination
786919|NCT00002361|HIV Protease Inhibitors|hiv protease inhibitors
786920|NCT00002361|Ritonavir|ritonavir
786921|NCT00002361|Indinavir|indinavir
786922|NCT00002361|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786923|NCT00002361|Anti-HIV Agents|anti-hiv agents
786924|NCT00002361|Viral Load|viral load
786925|NCT00002360|Didanosine|didanosine
786926|NCT00002360|Tablets|tablets
786927|NCT00002360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
786928|NCT00002360|Anti-HIV Agents|anti-hiv agents
786929|NCT00002360|Therapeutic Equivalency|therapeutic equivalency
786930|NCT00002359|Vaccines, Synthetic|vaccines, synthetic
786931|NCT00002359|Viral Vaccines|viral vaccines
786932|NCT00002359|HIV-1|hiv-1
786933|NCT00002359|AIDS-Related Complex|aids-related complex
786934|NCT00002359|AIDS Vaccines|aids vaccines
786935|NCT00002359|Salk HIV Immunogen|salk hiv immunogen
786936|NCT00002358|Herpes Zoster|herpes zoster
786937|NCT00002358|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
786938|NCT00002358|AIDS-Related Complex|aids-related complex
786939|NCT00002358|Antiviral Agents|antiviral agents
786940|NCT00002358|sorivudine|sorivudine
786941|NCT00002358|Chickenpox|chickenpox
786942|NCT00002357|Drug Therapy, Combination|drug therapy, combination
786943|NCT00002357|AIDS-Related Complex|aids-related complex
786944|NCT00002357|Antiviral Agents|antiviral agents
786945|NCT00002357|Zidovudine|zidovudine
786946|NCT00002356|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
786947|NCT00002356|Antiviral Agents|antiviral agents
786948|NCT00002356|Cytomegalovirus Retinitis|cytomegalovirus retinitis
786949|NCT00002355|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
786950|NCT00002355|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
786951|NCT00002355|Antiviral Agents|antiviral agents
786952|NCT00002355|Cytomegalovirus Retinitis|cytomegalovirus retinitis
786953|NCT00002354|Drug Therapy, Combination|drug therapy, combination
786954|NCT00002354|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
786955|NCT00002354|AIDS-Related Complex|aids-related complex
786956|NCT00002354|Stavudine|stavudine
786957|NCT00002354|HIV Protease Inhibitors|hiv protease inhibitors
786958|NCT00002354|Indinavir|indinavir
786959|NCT00002353|Vaccines, Synthetic|vaccines, synthetic
786960|NCT00002353|AIDS Vaccines|aids vaccines
786961|NCT00002352|Cytomegalovirus Infections|cytomegalovirus infections
786962|NCT00002352|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
786963|NCT00002352|Antiviral Agents|antiviral agents
786964|NCT00002351|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
786965|NCT00002351|AIDS-Related Complex|aids-related complex
786966|NCT00002351|HIV Protease Inhibitors|hiv protease inhibitors
786967|NCT00002351|Indinavir|indinavir
786968|NCT00002350|Vaccines, Synthetic|vaccines, synthetic
786969|NCT00002350|AIDS Vaccines|aids vaccines
786970|NCT00002350|DNA, Viral|dna, viral
786971|NCT00002349|AIDS-Related Complex|aids-related complex
786972|NCT00002349|Stavudine|stavudine
786973|NCT00002348|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
786974|NCT00002348|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
786975|NCT00002348|Lymphoma, AIDS-Related|lymphoma, aids-related
786976|NCT00002348|Mitoguazone|mitoguazone
786977|NCT00002347|Zalcitabine|zalcitabine
786978|NCT00002347|Drug Therapy, Combination|drug therapy, combination
786979|NCT00002347|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
786980|NCT00002347|AIDS-Related Complex|aids-related complex
786981|NCT00002347|Zidovudine|zidovudine
786982|NCT00002347|Nevirapine|nevirapine
786983|NCT00002347|Saquinavir|saquinavir
786984|NCT00002346|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
786985|NCT00002346|AIDS-Related Complex|aids-related complex
786986|NCT00002346|Antiviral Agents|antiviral agents
786987|NCT00002346|Adenine|adenine
786988|NCT00002345|Megestrol|megestrol
786989|NCT00002345|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
786990|NCT00002345|Anorexia|anorexia
786991|NCT00002345|Cachexia|cachexia
786992|NCT00002345|Suspensions|suspensions
786993|NCT00002344|Azithromycin|azithromycin
786994|NCT00002344|Bacterial Infections|bacterial infections
786995|NCT00002343|Rifabutin|rifabutin
786996|NCT00002343|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
786997|NCT00002343|Drug Therapy, Combination|drug therapy, combination
786998|NCT00002343|Ethambutol|ethambutol
786999|NCT00002343|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787000|NCT00002342|Neoplasms|neoplasms
787001|NCT00002342|Sarcoma, Kaposi|sarcoma, kaposi
787002|NCT00002342|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787003|NCT00002342|Antineoplastic Agents|antineoplastic agents
787004|NCT00002342|tecogalan|tecogalan
787005|NCT00002341|Itraconazole|itraconazole
787006|NCT00002341|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787007|NCT00002341|AIDS-Related Complex|aids-related complex
787008|NCT00002341|Candidiasis, Oral|candidiasis, oral
787009|NCT00002340|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
787010|NCT00002340|Pentamidine|pentamidine
787011|NCT00002340|Antifungal Agents|antifungal agents
787012|NCT00002340|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787013|NCT00002340|AIDS-Related Complex|aids-related complex
787014|NCT00002340|atovaquone|atovaquone
787015|NCT00002339|Esophagitis|esophagitis
787016|NCT00002339|Fluconazole|fluconazole
787017|NCT00002339|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787018|NCT00002339|Candidiasis|candidiasis
787019|NCT00002339|Immunocompromised Host|immunocompromised host
787020|NCT00002338|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787021|NCT00002338|AIDS-Related Complex|aids-related complex
787022|NCT00002338|Antiviral Agents|antiviral agents
787023|NCT00002337|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787024|NCT00002337|Antiviral Agents|antiviral agents
787025|NCT00002337|vesnarinone|vesnarinone
787026|NCT00002336|Mycobacterium avium-intracellular Infection|mycobacterium avium-intracellular infection
787027|NCT00002336|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787028|NCT00002336|Clarithromycin|clarithromycin
787029|NCT00002335|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787030|NCT00002335|AIDS-Related Complex|aids-related complex
787031|NCT00002335|Antiviral Agents|antiviral agents
787032|NCT00002334|Drug Therapy, Combination|drug therapy, combination
787033|NCT00002334|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787034|NCT00002334|AIDS-Related Complex|aids-related complex
787035|NCT00002334|Zidovudine|zidovudine
787036|NCT00002334|Saquinavir|saquinavir
787037|NCT00002334|HIV Protease Inhibitors|hiv protease inhibitors
787038|NCT00002333|Zalcitabine|zalcitabine
787039|NCT00002333|Drug Therapy, Combination|drug therapy, combination
787040|NCT00002333|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787041|NCT00002333|AIDS-Related Complex|aids-related complex
787042|NCT00002333|Saquinavir|saquinavir
787043|NCT00002333|HIV Protease Inhibitors|hiv protease inhibitors
787044|NCT00002332|Thymopentin|thymopentin
787045|NCT00002332|AIDS-Related Complex|aids-related complex
787046|NCT00002331|Mycobacterium avium-intracellular Infection|mycobacterium avium-intracellular infection
787047|NCT00002331|Drug Therapy, Combination|drug therapy, combination
787048|NCT00002331|Ethambutol|ethambutol
787049|NCT00002331|Clofazimine|clofazimine
787050|NCT00002331|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787051|NCT00002331|Clarithromycin|clarithromycin
787052|NCT00002330|Retinitis|retinitis
787053|NCT00002330|Ganciclovir|ganciclovir
787054|NCT00002330|Cytomegalovirus Infections|cytomegalovirus infections
787055|NCT00002330|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787056|NCT00002329|MDL 28574|mdl 28574
787057|NCT00002328|Antidiarrheals|antidiarrheals
787058|NCT00002328|Cryptosporidiosis|cryptosporidiosis
787059|NCT00002328|Diarrhea|diarrhea
787060|NCT00002328|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787061|NCT00002328|Azithromycin|azithromycin
787062|NCT00002327|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
787063|NCT00002327|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787064|NCT00002327|AIDS-Related Complex|aids-related complex
787065|NCT00002327|Antiviral Agents|antiviral agents
787066|NCT00002327|Condylomata Acuminata|condylomata acuminata
787067|NCT00002327|cidofovir|cidofovir
787068|NCT00002326|Drug Therapy, Combination|drug therapy, combination
787069|NCT00002326|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787070|NCT00002326|AIDS-Related Complex|aids-related complex
787071|NCT00002326|Antiviral Agents|antiviral agents
787072|NCT00002326|Zidovudine|zidovudine
787073|NCT00002326|Adenine|adenine
787074|NCT00002325|Mycoses|mycoses
787075|NCT00002325|Fluconazole|fluconazole
787076|NCT00002325|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787077|NCT00002325|AIDS-Related Complex|aids-related complex
787078|NCT00002325|Coccidioidomycosis|coccidioidomycosis
787079|NCT00002324|Drug Therapy, Combination|drug therapy, combination
787080|NCT00002324|AIDS-Related Complex|aids-related complex
787081|NCT00002324|Zidovudine|zidovudine
787082|NCT00002324|Nevirapine|nevirapine
787083|NCT00002323|Drug Therapy, Combination|drug therapy, combination
787084|NCT00002323|Zidovudine|zidovudine
787085|NCT00002323|Nevirapine|nevirapine
787086|NCT00002322|Drug Therapy, Combination|drug therapy, combination
787087|NCT00002322|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787088|NCT00002322|AIDS-Related Complex|aids-related complex
787089|NCT00002322|Antiviral Agents|antiviral agents
787090|NCT00002321|Retinitis|retinitis
787091|NCT00002321|Interleukin-2|interleukin-2
787092|NCT00002321|Ganciclovir|ganciclovir
787093|NCT00002321|Drug Therapy, Combination|drug therapy, combination
787094|NCT00002321|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787095|NCT00002321|Antiviral Agents|antiviral agents
787096|NCT00002320|Drug Therapy, Combination|drug therapy, combination
787097|NCT00002320|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787098|NCT00002320|AIDS-Related Complex|aids-related complex
787099|NCT00002320|Antiviral Agents|antiviral agents
787100|NCT00002320|Zidovudine|zidovudine
787101|NCT00002319|Sarcoma, Kaposi|sarcoma, kaposi
787102|NCT00002319|Liposomes|liposomes
787103|NCT00002319|Doxorubicin|doxorubicin
787104|NCT00002319|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787105|NCT00002319|Drug Carriers|drug carriers
787106|NCT00002318|Vincristine|vincristine
787107|NCT00002318|Sarcoma, Kaposi|sarcoma, kaposi
787108|NCT00002318|Liposomes|liposomes
787109|NCT00002318|Doxorubicin|doxorubicin
787110|NCT00002318|Drug Therapy, Combination|drug therapy, combination
787111|NCT00002318|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787112|NCT00002318|Bleomycin|bleomycin
787113|NCT00002318|Drug Carriers|drug carriers
787114|NCT00002317|Trimetrexate|trimetrexate
787115|NCT00002317|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
787116|NCT00002317|Leucovorin|leucovorin
787117|NCT00002317|Drug Therapy, Combination|drug therapy, combination
787118|NCT00002317|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787119|NCT00002316|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
787120|NCT00002316|Meningitis|meningitis
787121|NCT00002316|Drug Therapy, Combination|drug therapy, combination
787122|NCT00002316|Antifungal Agents|antifungal agents
787123|NCT00002316|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787124|NCT00002316|Amphotericin B|amphotericin b
787125|NCT00002315|Herpes Zoster|herpes zoster
787126|NCT00002315|Acyclovir|acyclovir
787127|NCT00002315|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787128|NCT00002315|AIDS-Related Complex|aids-related complex
787129|NCT00002315|Antiviral Agents|antiviral agents
787130|NCT00002314|Sarcoma, Kaposi|sarcoma, kaposi
787131|NCT00002314|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787132|NCT00002314|Antineoplastic Agents|antineoplastic agents
787133|NCT00002314|Gene Products, tat|gene products, tat
787134|NCT00002313|Nystatin|nystatin
787135|NCT00002313|Didanosine|didanosine
787136|NCT00002313|Drug Therapy, Combination|drug therapy, combination
787228|NCT00002295|AIDS-Related Complex|aids-related complex
787137|NCT00002313|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787138|NCT00002313|AIDS-Related Complex|aids-related complex
787139|NCT00002312|Drug Interactions|drug interactions
787140|NCT00002312|Antiviral Agents|antiviral agents
787141|NCT00002312|Zidovudine|zidovudine
787142|NCT00002311|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787143|NCT00002311|AIDS-Related Complex|aids-related complex
787144|NCT00002311|Wobenzym|wobenzym
787145|NCT00002311|Hydrolases|hydrolases
787146|NCT00002310|Herpes Simplex|herpes simplex
787147|NCT00002310|HIV-1|hiv-1
787148|NCT00002310|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787149|NCT00002310|Antiviral Agents|antiviral agents
787150|NCT00002310|Administration, Topical|administration, topical
787151|NCT00002309|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
787152|NCT00002309|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787153|NCT00002309|AIDS-Related Complex|aids-related complex
787154|NCT00002309|Azithromycin|azithromycin
787155|NCT00002308|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787156|NCT00002308|AIDS-Related Complex|aids-related complex
787157|NCT00002308|Stavudine|stavudine
787158|NCT00002307|Zidovudine|zidovudine
787159|NCT00002307|Stavudine|stavudine
787160|NCT00002306|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
787161|NCT00002306|Meningitis|meningitis
787162|NCT00002306|Cryptococcosis|cryptococcosis
787163|NCT00002306|Fluconazole|fluconazole
787164|NCT00002306|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787165|NCT00002306|Amphotericin B|amphotericin b
787166|NCT00002305|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
787167|NCT00002305|Meningitis|meningitis
787168|NCT00002305|Cryptococcosis|cryptococcosis
787169|NCT00002305|Drug Therapy, Combination|drug therapy, combination
787170|NCT00002305|Fluconazole|fluconazole
787171|NCT00002305|Flucytosine|flucytosine
787408|NCT00002258|AIDS-Related Complex|aids-related complex
787172|NCT00002305|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787173|NCT00002305|Amphotericin B|amphotericin b
787174|NCT00002304|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
787175|NCT00002304|Immune Tolerance|immune tolerance
787176|NCT00002304|Ketoconazole|ketoconazole
787177|NCT00002304|Esophagitis|esophagitis
787178|NCT00002304|Fluconazole|fluconazole
787179|NCT00002304|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787180|NCT00002304|Candidiasis, Oral|candidiasis, oral
787181|NCT00002303|Recombinant Proteins|recombinant proteins
787182|NCT00002303|Erythropoietin|erythropoietin
787183|NCT00002303|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787184|NCT00002303|Anemia|anemia
787185|NCT00002303|AIDS-Related Complex|aids-related complex
787186|NCT00002303|Zidovudine|zidovudine
787187|NCT00002302|Recombinant Proteins|recombinant proteins
787188|NCT00002302|Injections, Subcutaneous|injections, subcutaneous
787189|NCT00002302|Erythropoietin|erythropoietin
787190|NCT00002302|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787191|NCT00002302|Anemia|anemia
787192|NCT00002302|Zidovudine|zidovudine
787193|NCT00002301|Retinitis|retinitis
787194|NCT00002301|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
787195|NCT00002301|Ganciclovir|ganciclovir
787196|NCT00002301|Foscarnet|foscarnet
787197|NCT00002301|Cytomegalovirus Infections|cytomegalovirus infections
787198|NCT00002301|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787199|NCT00002301|Antiviral Agents|antiviral agents
787200|NCT00002300|T-Lymphocytes|t-lymphocytes
787201|NCT00002300|Megestrol|megestrol
787202|NCT00002300|Dose-Response Relationship, Drug|dose-response relationship, drug
787203|NCT00002300|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787204|NCT00002300|Anorexia|anorexia
787205|NCT00002300|Cachexia|cachexia
787206|NCT00002299|Retinitis|retinitis
787207|NCT00002299|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
787208|NCT00002299|Ganciclovir|ganciclovir
787209|NCT00002299|Drug Therapy, Combination|drug therapy, combination
787210|NCT00002299|Cytomegalovirus Infections|cytomegalovirus infections
787211|NCT00002299|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787212|NCT00002299|Interferon Type I|interferon type i
787213|NCT00002298|Ribavirin|ribavirin
787214|NCT00002298|AIDS-Related Complex|aids-related complex
787215|NCT00002297|Inosine Pranobex|inosine pranobex
787216|NCT00002297|AIDS-Related Complex|aids-related complex
787217|NCT00002296|T-Lymphocytes|t-lymphocytes
787218|NCT00002296|Immune Tolerance|immune tolerance
787219|NCT00002296|Inosine Pranobex|inosine pranobex
787220|NCT00002296|Killer Cells|killer cells
787221|NCT00002296|T-Lymphocytes, Helper-Inducer|t-lymphocytes, helper-inducer
787222|NCT00002296|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787223|NCT00002296|AIDS-Related Complex|aids-related complex
787224|NCT00002295|Infusions, Intravenous|infusions, intravenous
787225|NCT00002295|Drug Evaluation|drug evaluation
787226|NCT00002295|Administration, Oral|administration, oral
787227|NCT00002295|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787230|NCT00002295|Biological Availability|biological availability
787231|NCT00002294|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
787232|NCT00002294|Meningitis|meningitis
787233|NCT00002294|Cryptococcosis|cryptococcosis
787234|NCT00002294|Fluconazole|fluconazole
787235|NCT00002294|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787236|NCT00002293|Nystatin|nystatin
787237|NCT00002293|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
787238|NCT00002293|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787239|NCT00002293|AIDS-Related Complex|aids-related complex
787240|NCT00002293|Candidiasis, Oral|candidiasis, oral
787241|NCT00002292|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
787242|NCT00002292|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
787243|NCT00002292|Pentamidine|pentamidine
787244|NCT00002292|Injections, Intravenous|injections, intravenous
787245|NCT00002292|Administration, Inhalation|administration, inhalation
787246|NCT00002292|Aerosols|aerosols
787247|NCT00002292|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787248|NCT00002291|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
787249|NCT00002291|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
787250|NCT00002291|Pentamidine|pentamidine
787251|NCT00002291|Dose-Response Relationship, Drug|dose-response relationship, drug
787252|NCT00002291|Aerosols|aerosols
787253|NCT00002291|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787254|NCT00002290|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
787255|NCT00002290|Drug Therapy, Combination|drug therapy, combination
787256|NCT00002290|Acyclovir|acyclovir
787257|NCT00002290|AIDS-Related Complex|aids-related complex
787258|NCT00002290|Zidovudine|zidovudine
787259|NCT00002289|Semen|semen
787260|NCT00002289|Thymopentin|thymopentin
787261|NCT00002289|Leukocytes, Mononuclear|leukocytes, mononuclear
787262|NCT00002289|HIV Seropositivity|hiv seropositivity
787263|NCT00002289|AIDS-Related Complex|aids-related complex
787264|NCT00002288|Neuropsychological Tests|neuropsychological tests
787265|NCT00002288|AIDS-Related Complex|aids-related complex
787266|NCT00002288|Zidovudine|zidovudine
787267|NCT00002287|Health Manpower|health manpower
787268|NCT00002287|Accidents, Occupational|accidents, occupational
787269|NCT00002287|Zidovudine|zidovudine
787270|NCT00002286|Pilot Projects|pilot projects
787271|NCT00002286|Psoriasis|psoriasis
787272|NCT00002286|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787273|NCT00002286|Zidovudine|zidovudine
787274|NCT00002285|Virus Replication|virus replication
787275|NCT00002285|Pilot Projects|pilot projects
787276|NCT00002285|Immune Tolerance|immune tolerance
787277|NCT00002285|Lymphocytes|lymphocytes
787278|NCT00002285|Drug Evaluation|drug evaluation
787279|NCT00002285|Combined Modality Therapy|combined modality therapy
787280|NCT00002285|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787281|NCT00002285|Transplantation, Homologous|transplantation, homologous
787282|NCT00002285|Zidovudine|zidovudine
787283|NCT00002284|Lymphoma, Large-Cell|lymphoma, large-cell
787284|NCT00002284|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787285|NCT00002284|AIDS-Related Complex|aids-related complex
787286|NCT00002284|Zidovudine|zidovudine
787287|NCT00002284|Bone Marrow Transplantation|bone marrow transplantation
787288|NCT00002283|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
787409|NCT00002258|Thrombocytopenia|thrombocytopenia
787289|NCT00002283|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
787290|NCT00002283|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
787291|NCT00002283|Dapsone|dapsone
787292|NCT00002283|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787293|NCT00002282|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
787294|NCT00002282|Fluconazole|fluconazole
787295|NCT00002282|Clotrimazole|clotrimazole
787296|NCT00002282|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787297|NCT00002282|Candidiasis, Oral|candidiasis, oral
787298|NCT00002281|Injections, Subcutaneous|injections, subcutaneous
787299|NCT00002281|Erythropoietin|erythropoietin
787300|NCT00002281|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787301|NCT00002281|AIDS-Related Complex|aids-related complex
787302|NCT00002281|Zidovudine|zidovudine
787303|NCT00002280|Didanosine|didanosine
787304|NCT00002280|Drugs, Investigational|drugs, investigational
787305|NCT00002280|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787306|NCT00002280|Zidovudine|zidovudine
787307|NCT00002279|Zalcitabine|zalcitabine
787308|NCT00002279|Didanosine|didanosine
787309|NCT00002279|Drugs, Investigational|drugs, investigational
787310|NCT00002279|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787311|NCT00002279|AIDS-Related Complex|aids-related complex
787312|NCT00002279|Zidovudine|zidovudine
787313|NCT00002278|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
787314|NCT00002278|Cryptosporidiosis|cryptosporidiosis
787315|NCT00002278|Diarrhea|diarrhea
787316|NCT00002278|diclazuril|diclazuril
787317|NCT00002278|Coccidiostats|coccidiostats
787318|NCT00002278|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787323|NCT00002277|Amphotericin B|amphotericin b
787324|NCT00002276|Blood Platelets|blood platelets
787325|NCT00002276|Ibuprofen|ibuprofen
787326|NCT00002276|Drug Interactions|drug interactions
787327|NCT00002276|Zidovudine|zidovudine
787328|NCT00002276|Hemophilia A|hemophilia a
787329|NCT00002275|Weight Loss|weight loss
787330|NCT00002275|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
787331|NCT00002275|Parenteral Nutrition|parenteral nutrition
787332|NCT00002275|Liposyn|liposyn
787333|NCT00002275|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787334|NCT00002274|Didanosine|didanosine
787335|NCT00002274|Drugs, Investigational|drugs, investigational
787336|NCT00002274|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787337|NCT00002274|Zidovudine|zidovudine
787338|NCT00002273|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
787339|NCT00002273|Ganciclovir|ganciclovir
787340|NCT00002273|Cytomegalovirus Infections|cytomegalovirus infections
787341|NCT00002273|Colitis|colitis
787342|NCT00002273|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787343|NCT00002272|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
787344|NCT00002272|Immune Tolerance|immune tolerance
787345|NCT00002272|Injections, Intravenous|injections, intravenous
787346|NCT00002272|Herpes Simplex|herpes simplex
787347|NCT00002272|Immunity, Cellular|immunity, cellular
787348|NCT00002272|Drug Resistance|drug resistance
787349|NCT00002272|Foscarnet|foscarnet
787350|NCT00002272|Acyclovir|acyclovir
787351|NCT00002272|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787352|NCT00002272|Antiviral Agents|antiviral agents
787353|NCT00002271|Thymidine|thymidine
787354|NCT00002271|Nucleosides|nucleosides
787355|NCT00002271|Antiviral Agents|antiviral agents
787356|NCT00002270|Leukoencephalopathy, Progressive Multifocal|leukoencephalopathy, progressive multifocal
787357|NCT00002270|Interferon Alfa-2b|interferon alfa-2b
787358|NCT00002270|Drug Evaluation|drug evaluation
787359|NCT00002270|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787360|NCT00002270|Zidovudine|zidovudine
787361|NCT00002269|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787362|NCT00002269|ampligen|ampligen
787363|NCT00002269|AIDS-Related Complex|aids-related complex
787364|NCT00002269|Zidovudine|zidovudine
787365|NCT00002268|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
787366|NCT00002268|Immunotherapy|immunotherapy
787367|NCT00002268|Drug Evaluation|drug evaluation
787368|NCT00002268|Cytomegalovirus Infections|cytomegalovirus infections
787369|NCT00002268|Antibodies, Monoclonal|antibodies, monoclonal
787370|NCT00002267|Rifabutin|rifabutin
787371|NCT00002267|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
787372|NCT00002267|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
787373|NCT00002267|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787374|NCT00002267|Antitubercular Agents|antitubercular agents
787375|NCT00002266|Drug Therapy, Combination|drug therapy, combination
787376|NCT00002266|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787377|NCT00002266|AIDS-Related Complex|aids-related complex
787378|NCT00002266|ammonium trichloro(dioxoethylene-O,O'-)tellurute|ammonium trichloro(dioxoethylene-o,o'-)tellurute
787379|NCT00002265|Zalcitabine|zalcitabine
787380|NCT00002265|Drug Evaluation|drug evaluation
787381|NCT00002265|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787382|NCT00002265|AIDS-Related Complex|aids-related complex
787383|NCT00002265|Zidovudine|zidovudine
787384|NCT00002263|Pilot Projects|pilot projects
787385|NCT00002263|Neutropenia|neutropenia
787386|NCT00002263|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
787387|NCT00002263|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787388|NCT00002263|Zidovudine|zidovudine
787389|NCT00002262|Skin Neoplasms|skin neoplasms
787390|NCT00002262|Tumor Necrosis Factor|tumor necrosis factor
787391|NCT00002262|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787392|NCT00002261|Vaccines, Synthetic|vaccines, synthetic
787393|NCT00002261|Vaccinia Virus|vaccinia virus
787394|NCT00002261|Viral Vaccines|viral vaccines
787395|NCT00002261|Smallpox Vaccine|smallpox vaccine
787396|NCT00002261|HIV-1|hiv-1
787397|NCT00002261|AIDS Vaccines|aids vaccines
787398|NCT00002261|HIV Seronegativity|hiv seronegativity
787399|NCT00002260|Biological Availability|biological availability
787400|NCT00002260|alovudine|alovudine
787401|NCT00002260|Food|food
787402|NCT00002259|Mitoxantrone|mitoxantrone
787403|NCT00002259|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787404|NCT00002258|Interleukin-3|interleukin-3
787405|NCT00002258|Recombinant Proteins|recombinant proteins
787406|NCT00002258|Leukopenia|leukopenia
787407|NCT00002258|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787410|NCT00002257|Retinitis|retinitis
787411|NCT00002257|Ganciclovir|ganciclovir
787412|NCT00002257|Cytomegalovirus Infections|cytomegalovirus infections
787413|NCT00002257|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787414|NCT00002256|Zalcitabine|zalcitabine
787415|NCT00002256|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
793426|NCT00011102|weight gain|weight gain
787416|NCT00002256|AIDS-Related Complex|aids-related complex
787417|NCT00002256|Zidovudine|zidovudine
787418|NCT00002255|Erythropoietin|erythropoietin
787419|NCT00002255|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
787420|NCT00002255|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787421|NCT00002255|AIDS-Related Complex|aids-related complex
787422|NCT00002255|Zidovudine|zidovudine
787423|NCT00002254|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787424|NCT00002253|Octreotide|octreotide
787425|NCT00002253|Diarrhea|diarrhea
787426|NCT00002253|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787427|NCT00002253|AIDS-Related Complex|aids-related complex
787428|NCT00002252|Octreotide|octreotide
787429|NCT00002252|Diarrhea|diarrhea
787430|NCT00002252|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787431|NCT00002252|AIDS-Related Complex|aids-related complex
787432|NCT00002251|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
787433|NCT00002251|Ganciclovir|ganciclovir
787434|NCT00002251|Cytomegalovirus Infections|cytomegalovirus infections
787435|NCT00002251|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787436|NCT00002251|Biological Availability|biological availability
787437|NCT00002250|Recombinant Proteins|recombinant proteins
787438|NCT00002250|IgG|igg
787439|NCT00002250|Drug Evaluation|drug evaluation
787440|NCT00002250|Antigens, CD4|antigens, cd4
787441|NCT00002249|Anti-Infective Agents, Quinolone|anti-infective agents, quinolone
787442|NCT00002249|Ofloxacin|ofloxacin
787443|NCT00002249|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787444|NCT00002248|Antidiarrheals|antidiarrheals
787445|NCT00002248|Cryptosporidiosis|cryptosporidiosis
787446|NCT00002248|Diarrhea|diarrhea
787447|NCT00002248|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787448|NCT00002248|Cryptosporidium|cryptosporidium
787449|NCT00002248|Immunization, Passive|immunization, passive
787450|NCT00002247|Retinitis|retinitis
787451|NCT00002247|Ganciclovir|ganciclovir
787452|NCT00002247|Cytomegalovirus Infections|cytomegalovirus infections
787453|NCT00002247|Administration, Oral|administration, oral
787454|NCT00002247|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787455|NCT00002246|AIDS Dementia Complex|aids dementia complex
787456|NCT00002246|Zidovudine|zidovudine
787457|NCT00002246|Stavudine|stavudine
787458|NCT00002246|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
787459|NCT00002245|Drug Therapy, Combination|drug therapy, combination
787460|NCT00002245|HIV Protease Inhibitors|hiv protease inhibitors
787461|NCT00002245|Lamivudine|lamivudine
787462|NCT00002245|Carbohydrates|carbohydrates
787463|NCT00002245|VX 478|vx 478
787464|NCT00002245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
787465|NCT00002245|Anti-HIV Agents|anti-hiv agents
787466|NCT00002245|Lipids|lipids
787467|NCT00002245|Insulin Resistance|insulin resistance
787468|NCT00002245|abacavir|abacavir
787469|NCT00002244|Placebos|placebos
787470|NCT00002244|Infusions, Intravenous|infusions, intravenous
787471|NCT00002244|Quality of Life|quality of life
787472|NCT00002244|Anti-HIV Agents|anti-hiv agents
787473|NCT00002244|tetrachlorodecaoxide|tetrachlorodecaoxide
787474|NCT00002243|Anti-HIV Agents|anti-hiv agents
787475|NCT00002241|Drug Therapy, Combination|drug therapy, combination
787476|NCT00002241|Stavudine|stavudine
787477|NCT00002241|HIV Protease Inhibitors|hiv protease inhibitors
787478|NCT00002241|Ritonavir|ritonavir
787479|NCT00002241|Lamivudine|lamivudine
787480|NCT00002241|Indinavir|indinavir
787481|NCT00002241|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
787482|NCT00002241|Anti-HIV Agents|anti-hiv agents
787483|NCT00002241|Viral Load|viral load
787484|NCT00002240|Didanosine|didanosine
787485|NCT00002240|Dose-Response Relationship, Drug|dose-response relationship, drug
787486|NCT00002240|Drug Therapy, Combination|drug therapy, combination
787487|NCT00002240|Stavudine|stavudine
787488|NCT00002240|HIV Protease Inhibitors|hiv protease inhibitors
787489|NCT00002240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
787490|NCT00002240|Anti-HIV Agents|anti-hiv agents
787491|NCT00002240|Nelfinavir|nelfinavir
787492|NCT00002239|HIV-1|hiv-1
787493|NCT00002239|Dose-Response Relationship, Drug|dose-response relationship, drug
787494|NCT00002239|Drug Therapy, Combination|drug therapy, combination
787495|NCT00002239|VX 478|vx 478
787496|NCT00002239|Anti-HIV Agents|anti-hiv agents
787497|NCT00002239|pentafuside|pentafuside
787498|NCT00002239|abacavir|abacavir
787499|NCT00002239|efavirenz|efavirenz
787500|NCT00002238|Drug Therapy, Combination|drug therapy, combination
787501|NCT00002238|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787502|NCT00002238|AIDS-Related Complex|aids-related complex
787503|NCT00002238|Zidovudine|zidovudine
787504|NCT00002238|Interferon Type I|interferon type i
787505|NCT00002237|Placebos|placebos
787506|NCT00002237|Administration, Oral|administration, oral
787507|NCT00002237|Anti-HIV Agents|anti-hiv agents
787508|NCT00002237|Viral Load|viral load
787509|NCT00002237|peldesine|peldesine
787510|NCT00002236|Drug Therapy, Combination|drug therapy, combination
787511|NCT00002236|Zidovudine|zidovudine
787512|NCT00002236|Drug Administration Schedule|drug administration schedule
787513|NCT00002236|HIV Protease Inhibitors|hiv protease inhibitors
787514|NCT00002236|CD4 Lymphocyte Count|cd4 lymphocyte count
787515|NCT00002236|Indinavir|indinavir
787516|NCT00002236|Delavirdine|delavirdine
787517|NCT00002236|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
787518|NCT00002236|Anti-HIV Agents|anti-hiv agents
787519|NCT00002236|Viral Load|viral load
787520|NCT00002235|Drug Therapy, Combination|drug therapy, combination
787521|NCT00002235|HIV Protease Inhibitors|hiv protease inhibitors
787522|NCT00002235|Indinavir|indinavir
787523|NCT00002235|Nelfinavir|nelfinavir
787524|NCT00002235|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
787525|NCT00002235|Anti-HIV Agents|anti-hiv agents
787526|NCT00002235|efavirenz|efavirenz
787527|NCT00002234|Drug Therapy, Combination|drug therapy, combination
787528|NCT00002234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
787529|NCT00002234|Anti-HIV Agents|anti-hiv agents
787530|NCT00002233|Drug Therapy, Combination|drug therapy, combination
787531|NCT00002233|HIV Protease Inhibitors|hiv protease inhibitors
787532|NCT00002233|CD4 Lymphocyte Count|cd4 lymphocyte count
787533|NCT00002233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
787534|NCT00002233|Anti-HIV Agents|anti-hiv agents
787535|NCT00002233|Viral Load|viral load
787536|NCT00002232|Injections, Intradermal|injections, intradermal
787537|NCT00002232|Injections, Intramuscular|injections, intramuscular
787538|NCT00002232|HIV Antibodies|hiv antibodies
787539|NCT00002232|Immunity, Cellular|immunity, cellular
787540|NCT00002232|AIDS Vaccines|aids vaccines
787541|NCT00002232|HIV Seronegativity|hiv seronegativity
787542|NCT00002232|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
787543|NCT00002232|Vaccines, DNA|vaccines, dna
787544|NCT00002232|Immunity, Mucosal|immunity, mucosal
787545|NCT00002231|Injections, Intramuscular|injections, intramuscular
787546|NCT00002231|HIV Antibodies|hiv antibodies
787547|NCT00002231|Immunity, Cellular|immunity, cellular
787548|NCT00002231|AIDS Vaccines|aids vaccines
787549|NCT00002231|HIV Seronegativity|hiv seronegativity
787550|NCT00002231|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
787551|NCT00002231|Vaccines, DNA|vaccines, dna
787552|NCT00002230|Didanosine|didanosine
787553|NCT00002230|Drug Therapy, Combination|drug therapy, combination
787554|NCT00002230|Stavudine|stavudine
787555|NCT00002230|Hydroxyurea|hydroxyurea
787556|NCT00002230|Anti-HIV Agents|anti-hiv agents
787557|NCT00002229|Drug Therapy, Combination|drug therapy, combination
787558|NCT00002229|HIV Protease Inhibitors|hiv protease inhibitors
787559|NCT00002229|Dosage Forms|dosage forms
787560|NCT00002229|Saquinavir|saquinavir
787561|NCT00002229|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
787562|NCT00002229|Anti-HIV Agents|anti-hiv agents
787563|NCT00002228|Injections, Subcutaneous|injections, subcutaneous
787564|NCT00002228|HIV-1|hiv-1
787565|NCT00002228|Anti-HIV Agents|anti-hiv agents
787566|NCT00002228|peptide T20|peptide t20
787567|NCT00002227|Drug Therapy, Combination|drug therapy, combination
787568|NCT00002227|Stavudine|stavudine
787569|NCT00002227|Lamivudine|lamivudine
787570|NCT00002227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
787571|NCT00002227|efavirenz|efavirenz
787572|NCT00002226|Skin Neoplasms|skin neoplasms
787573|NCT00002226|Sarcoma, Kaposi|sarcoma, kaposi
787574|NCT00002226|Antineoplastic Agents|antineoplastic agents
787575|NCT00002225|Didanosine|didanosine
787576|NCT00002225|Drug Therapy, Combination|drug therapy, combination
787577|NCT00002225|Stavudine|stavudine
787578|NCT00002225|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
787579|NCT00002225|efavirenz|efavirenz
787580|NCT00002224|Didanosine|didanosine
787581|NCT00002224|Drug Therapy, Combination|drug therapy, combination
787582|NCT00002224|Drug Administration Schedule|drug administration schedule
787583|NCT00002224|Stavudine|stavudine
787584|NCT00002224|HIV Protease Inhibitors|hiv protease inhibitors
787585|NCT00002224|Nelfinavir|nelfinavir
787586|NCT00002224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
787587|NCT00002224|Anti-HIV Agents|anti-hiv agents
787588|NCT00002224|Viral Load|viral load
787589|NCT00002223|Drug Therapy, Combination|drug therapy, combination
787590|NCT00002223|Adolescent Behavior|adolescent behavior
787591|NCT00002223|HIV Protease Inhibitors|hiv protease inhibitors
787592|NCT00002223|Ritonavir|ritonavir
787593|NCT00002223|Indinavir|indinavir
787594|NCT00002222|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
787595|NCT00002222|Ganciclovir|ganciclovir
787596|NCT00002222|Antiviral Agents|antiviral agents
787597|NCT00002222|Drug Administration Schedule|drug administration schedule
787598|NCT00002222|Cytomegalovirus Retinitis|cytomegalovirus retinitis
787599|NCT00002222|Prodrugs|prodrugs
787600|NCT00002221|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
787601|NCT00002221|Bone Marrow|bone marrow
787602|NCT00002221|Lymphocyte Transformation|lymphocyte transformation
787603|NCT00002221|HIV-1|hiv-1
787604|NCT00002221|Retroviridae|retroviridae
787605|NCT00002221|Lymphoma, AIDS-Related|lymphoma, aids-related
787606|NCT00002221|Genetic Vectors|genetic vectors
787607|NCT00002221|Transduction, Genetic|transduction, genetic
787608|NCT00002221|Gene Transfer Techniques|gene transfer techniques
787609|NCT00002220|Drug Resistance|drug resistance
787610|NCT00002220|Drug Therapy, Combination|drug therapy, combination
787611|NCT00002220|Antiviral Agents|antiviral agents
787612|NCT00002220|HIV Protease Inhibitors|hiv protease inhibitors
787613|NCT00002220|Indinavir|indinavir
787614|NCT00002220|RNA, Viral|rna, viral
787615|NCT00002220|Adenine|adenine
787616|NCT00002220|efavirenz|efavirenz
787617|NCT00002219|Dose-Response Relationship, Drug|dose-response relationship, drug
787618|NCT00002219|Antiviral Agents|antiviral agents
787619|NCT00002219|HIV Protease Inhibitors|hiv protease inhibitors
787620|NCT00002219|Disease Progression|disease progression
787621|NCT00002219|RNA, Viral|rna, viral
787622|NCT00002219|Adenine|adenine
787623|NCT00002219|Viral Load|viral load
787624|NCT00002219|Age Factors|age factors
787625|NCT00002219|Nelfinavir|nelfinavir
787626|NCT00002218|HIV-1|hiv-1
787627|NCT00002218|Dose-Response Relationship, Drug|dose-response relationship, drug
787628|NCT00002218|Anti-HIV Agents|anti-hiv agents
787629|NCT00002217|Drug Therapy, Combination|drug therapy, combination
787630|NCT00002217|Patient Compliance|patient compliance
787631|NCT00002217|Anti-HIV Agents|anti-hiv agents
787632|NCT00002217|abacavir|abacavir
787633|NCT00002216|Drug Therapy, Combination|drug therapy, combination
787634|NCT00002216|HIV Protease Inhibitors|hiv protease inhibitors
787635|NCT00002216|VX 478|vx 478
787636|NCT00002216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
787637|NCT00002216|Anti-HIV Agents|anti-hiv agents
787638|NCT00002216|abacavir|abacavir
787639|NCT00002215|Drug Therapy, Combination|drug therapy, combination
787640|NCT00002215|HIV Protease Inhibitors|hiv protease inhibitors
787641|NCT00002215|RNA, Viral|rna, viral
787642|NCT00002215|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
787643|NCT00002215|Viral Load|viral load
787644|NCT00002215|Nelfinavir|nelfinavir
787645|NCT00002215|Uracil|uracil
787646|NCT00002214|Dose-Response Relationship, Drug|dose-response relationship, drug
787647|NCT00002214|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
787648|NCT00002213|HIV-1|hiv-1
787649|NCT00002213|Drug Therapy, Combination|drug therapy, combination
787650|NCT00002213|Antiviral Agents|antiviral agents
787651|NCT00002213|HIV Protease Inhibitors|hiv protease inhibitors
787652|NCT00002213|RNA, Viral|rna, viral
787653|NCT00002213|VX 478|vx 478
787654|NCT00002213|Anti-HIV Agents|anti-hiv agents
787655|NCT00002213|abacavir|abacavir
787656|NCT00002213|efavirenz|efavirenz
787657|NCT00002212|Sarcoma, Kaposi|sarcoma, kaposi
787658|NCT00002212|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787659|NCT00002212|Anticarcinogenic Agents|anticarcinogenic agents
787660|NCT00002211|HIV-1|hiv-1
787661|NCT00002211|Didanosine|didanosine
787662|NCT00002211|Stavudine|stavudine
787663|NCT00002211|HIV Protease Inhibitors|hiv protease inhibitors
787664|NCT00002211|RNA, Viral|rna, viral
787665|NCT00002211|Delavirdine|delavirdine
787666|NCT00002211|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
787667|NCT00002211|Viral Load|viral load
787668|NCT00002211|Nelfinavir|nelfinavir
787669|NCT00002210|HIV-1|hiv-1
787670|NCT00002210|Drug Therapy, Combination|drug therapy, combination
787671|NCT00002210|Delavirdine|delavirdine
787672|NCT00002210|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
787673|NCT00002209|Dose-Response Relationship, Drug|dose-response relationship, drug
787674|NCT00002209|Drug Therapy, Combination|drug therapy, combination
787675|NCT00002209|AIDS Dementia Complex|aids dementia complex
787676|NCT00002209|Zidovudine|zidovudine
787677|NCT00002209|Lamivudine|lamivudine
787678|NCT00002209|Indinavir|indinavir
787679|NCT00002209|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
787680|NCT00002208|HIV-1|hiv-1
787681|NCT00002208|Drug Therapy, Combination|drug therapy, combination
787682|NCT00002208|Zidovudine|zidovudine
787683|NCT00002208|HIV Protease Inhibitors|hiv protease inhibitors
787684|NCT00002208|Lamivudine|lamivudine
787685|NCT00002208|Indinavir|indinavir
787686|NCT00002208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
787687|NCT00002207|Didanosine|didanosine
787688|NCT00002207|Drug Therapy, Combination|drug therapy, combination
787689|NCT00002207|Stavudine|stavudine
787690|NCT00002207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
787691|NCT00002206|HIV-1|hiv-1
787692|NCT00002206|Adenine|adenine
787693|NCT00002206|Anti-HIV Agents|anti-hiv agents
787694|NCT00002205|HIV Protease Inhibitors|hiv protease inhibitors
787695|NCT00002205|VX 478|vx 478
787696|NCT00002205|Anti-HIV Agents|anti-hiv agents
787697|NCT00002205|abacavir|abacavir
787698|NCT00002204|Reference Values|reference values
787699|NCT00002204|Placebos|placebos
787700|NCT00002204|AIDS Vaccines|aids vaccines
787701|NCT00002204|HIV Core Protein p24|hiv core protein p24
787702|NCT00002204|HIV Seronegativity|hiv seronegativity
787703|NCT00002204|MF59 oil emulsion|mf59 oil emulsion
787704|NCT00002203|Drug Therapy, Combination|drug therapy, combination
787705|NCT00002203|Zidovudine|zidovudine
793924|NCT00006445|Pregnancy|pregnancy
787706|NCT00002203|HIV Protease Inhibitors|hiv protease inhibitors
787707|NCT00002203|CD4 Lymphocyte Count|cd4 lymphocyte count
787708|NCT00002203|CD4-CD8 Ratio|cd4-cd8 ratio
787709|NCT00002203|Lamivudine|lamivudine
787710|NCT00002203|Patient Compliance|patient compliance
787711|NCT00002203|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
787712|NCT00002203|Anti-HIV Agents|anti-hiv agents
787713|NCT00002203|Viral Load|viral load
787714|NCT00002202|HIV-1|hiv-1
787715|NCT00002202|Drug Therapy, Combination|drug therapy, combination
787716|NCT00002202|HIV Protease Inhibitors|hiv protease inhibitors
787717|NCT00002202|Indinavir|indinavir
787718|NCT00002202|RNA, Viral|rna, viral
787719|NCT00002202|VX 478|vx 478
787720|NCT00002202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
787721|NCT00002202|Anti-HIV Agents|anti-hiv agents
787722|NCT00002202|Viral Load|viral load
787723|NCT00002201|Drug Therapy, Combination|drug therapy, combination
787724|NCT00002201|HIV Protease Inhibitors|hiv protease inhibitors
787725|NCT00002201|Ritonavir|ritonavir
787726|NCT00002201|Nelfinavir|nelfinavir
787727|NCT00002201|Anti-HIV Agents|anti-hiv agents
787728|NCT00002200|HIV-1|hiv-1
787729|NCT00002200|Administration, Oral|administration, oral
787730|NCT00002200|CD4 Lymphocyte Count|cd4 lymphocyte count
787731|NCT00002200|RNA, Viral|rna, viral
787732|NCT00002200|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
787733|NCT00002200|Anti-HIV Agents|anti-hiv agents
787734|NCT00002200|Viral Load|viral load
787735|NCT00002200|abacavir|abacavir
787736|NCT00002199|HIV-1|hiv-1
787737|NCT00002199|Drug Therapy, Combination|drug therapy, combination
787738|NCT00002199|Zidovudine|zidovudine
787739|NCT00002199|Drug Resistance, Microbial|drug resistance, microbial
787740|NCT00002199|HIV Protease Inhibitors|hiv protease inhibitors
787741|NCT00002199|Lamivudine|lamivudine
787742|NCT00002199|Indinavir|indinavir
787743|NCT00002199|Genotype|genotype
787744|NCT00002199|Phenotype|phenotype
787745|NCT00002199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
787746|NCT00002199|Anti-HIV Agents|anti-hiv agents
787747|NCT00002199|abacavir|abacavir
787748|NCT00002198|Drug Interactions|drug interactions
787749|NCT00002198|Antiviral Agents|antiviral agents
787750|NCT00002198|Ethanol|ethanol
787751|NCT00002198|abacavir|abacavir
787752|NCT00002197|HIV-1|hiv-1
787753|NCT00002197|CD4 Lymphocyte Count|cd4 lymphocyte count
787754|NCT00002197|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
787755|NCT00002197|Anti-HIV Agents|anti-hiv agents
787756|NCT00002197|Viral Load|viral load
787757|NCT00002197|abacavir|abacavir
787758|NCT00002196|Dose-Response Relationship, Drug|dose-response relationship, drug
787759|NCT00002196|Administration, Oral|administration, oral
787760|NCT00002196|Drug Administration Schedule|drug administration schedule
787761|NCT00002196|CD4 Lymphocyte Count|cd4 lymphocyte count
787762|NCT00002196|Anti-HIV Agents|anti-hiv agents
787763|NCT00002195|Drug Therapy, Combination|drug therapy, combination
787764|NCT00002195|Zidovudine|zidovudine
787765|NCT00002195|HIV Protease Inhibitors|hiv protease inhibitors
787766|NCT00002195|Lamivudine|lamivudine
787767|NCT00002195|VX 478|vx 478
787768|NCT00002195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
787769|NCT00002195|Anti-HIV Agents|anti-hiv agents
787770|NCT00002195|Viral Load|viral load
787771|NCT00002194|Antibiotics, Macrolide|antibiotics, macrolide
787772|NCT00002194|Clarithromycin|clarithromycin
787773|NCT00002194|Nevirapine|nevirapine
787774|NCT00002194|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
787775|NCT00002194|Cytochrome P-450|cytochrome p-450
787776|NCT00002194|Anti-HIV Agents|anti-hiv agents
787777|NCT00002193|HIV-1|hiv-1
787778|NCT00002193|Drug Therapy, Combination|drug therapy, combination
787779|NCT00002193|HIV Protease Inhibitors|hiv protease inhibitors
787780|NCT00002193|RNA, Viral|rna, viral
787781|NCT00002193|VX 478|vx 478
787782|NCT00002193|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
787783|NCT00002193|Anti-HIV Agents|anti-hiv agents
787784|NCT00002193|Viral Load|viral load
787785|NCT00002192|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
787786|NCT00002192|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
787787|NCT00002192|Drug Therapy, Combination|drug therapy, combination
787788|NCT00002192|Antitubercular Agents|antitubercular agents
787789|NCT00002192|Azithromycin|azithromycin
787790|NCT00002192|Clarithromycin|clarithromycin
787791|NCT00002192|Bacteremia|bacteremia
787792|NCT00002192|rifapentine|rifapentine
787793|NCT00002191|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
787794|NCT00002191|Placebos|placebos
787795|NCT00002191|Protozoan Infections|protozoan infections
787796|NCT00002191|Intestinal Diseases|intestinal diseases
787797|NCT00002191|Albendazole|albendazole
787798|NCT00002191|Microsporida|microsporida
787799|NCT00002191|Anthelmintics|anthelmintics
787800|NCT00002190|Drug Therapy, Combination|drug therapy, combination
787801|NCT00002190|Zidovudine|zidovudine
787802|NCT00002190|HIV Protease Inhibitors|hiv protease inhibitors
787803|NCT00002190|Lamivudine|lamivudine
787804|NCT00002190|Saquinavir|saquinavir
787805|NCT00002190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
787806|NCT00002190|Anti-HIV Agents|anti-hiv agents
787807|NCT00002189|Sarcoma, Kaposi|sarcoma, kaposi
787808|NCT00002189|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787809|NCT00002189|Paclitaxel|paclitaxel
787810|NCT00002189|Treatment Outcome|treatment outcome
787811|NCT00002189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic
787812|NCT00002188|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
787813|NCT00002188|Sarcoma, Kaposi|sarcoma, kaposi
787814|NCT00002188|Antineoplastic Agents|antineoplastic agents
787815|NCT00002187|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
787816|NCT00002187|Antiviral Agents|antiviral agents
787817|NCT00002187|Drug Administration Schedule|drug administration schedule
787818|NCT00002187|Cytomegalovirus Retinitis|cytomegalovirus retinitis
787819|NCT00002187|fomivirsen|fomivirsen
787820|NCT00002187|Vitreous Body|vitreous body
787821|NCT00002186|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
787822|NCT00002186|Herpes Simplex|herpes simplex
787823|NCT00002186|Drug Therapy, Combination|drug therapy, combination
787824|NCT00002186|Acyclovir|acyclovir
787825|NCT00002186|Antiviral Agents|antiviral agents
787826|NCT00002186|Gels|gels
787827|NCT00002186|SP 303|sp 303
787828|NCT00002185|Skin Neoplasms|skin neoplasms
787829|NCT00002185|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
787830|NCT00002185|Sarcoma, Kaposi|sarcoma, kaposi
787831|NCT00002185|Drug Therapy, Combination|drug therapy, combination
787832|NCT00002185|HIV Protease Inhibitors|hiv protease inhibitors
787833|NCT00002185|Mucous Membrane|mucous membrane
787834|NCT00002185|Nelfinavir|nelfinavir
787835|NCT00002185|Anti-HIV Agents|anti-hiv agents
787836|NCT00002184|HIV-1|hiv-1
787837|NCT00002184|Dose-Response Relationship, Drug|dose-response relationship, drug
787838|NCT00002184|Drug Therapy, Combination|drug therapy, combination
787839|NCT00002184|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787840|NCT00002184|Zidovudine|zidovudine
787841|NCT00002184|Stavudine|stavudine
787842|NCT00002184|HIV Protease Inhibitors|hiv protease inhibitors
787843|NCT00002184|CD4 Lymphocyte Count|cd4 lymphocyte count
787844|NCT00002184|Lamivudine|lamivudine
787845|NCT00002184|RNA, Viral|rna, viral
787846|NCT00002184|Saquinavir|saquinavir
787847|NCT00002184|Nelfinavir|nelfinavir
787848|NCT00002184|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
787849|NCT00002184|Adenine|adenine
787850|NCT00002184|Anti-HIV Agents|anti-hiv agents
787851|NCT00002184|Viral Load|viral load
787852|NCT00002183|Drug Therapy, Combination|drug therapy, combination
787853|NCT00002183|Drug Administration Schedule|drug administration schedule
787854|NCT00002183|HIV Protease Inhibitors|hiv protease inhibitors
787855|NCT00002183|VX 478|vx 478
787856|NCT00002183|Anti-HIV Agents|anti-hiv agents
787857|NCT00002182|Placebos|placebos
787858|NCT00002182|Appetite Stimulants|appetite stimulants
787859|NCT00002182|Megestrol Acetate|megestrol acetate
787860|NCT00002182|Failure to Thrive|failure to thrive
787861|NCT00002181|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
787862|NCT00002181|Herpes Simplex|herpes simplex
787863|NCT00002181|Acyclovir|acyclovir
787864|NCT00002181|Antiviral Agents|antiviral agents
787865|NCT00002181|Gels|gels
787866|NCT00002181|cidofovir|cidofovir
787867|NCT00002180|Placebos|placebos
787868|NCT00002180|Anti-HIV Agents|anti-hiv agents
787869|NCT00002180|Adenine|adenine
787870|NCT00002179|Semen|semen
787871|NCT00002179|Monocytes|monocytes
787872|NCT00002179|HIV-1|hiv-1
787873|NCT00002179|Drug Therapy, Combination|drug therapy, combination
787874|NCT00002179|Zidovudine|zidovudine
787875|NCT00002179|Lymph Nodes|lymph nodes
787876|NCT00002179|HIV Protease Inhibitors|hiv protease inhibitors
787877|NCT00002179|Lamivudine|lamivudine
787878|NCT00002179|Indinavir|indinavir
787879|NCT00002179|RNA, Viral|rna, viral
787880|NCT00002179|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
787881|NCT00002179|Anti-HIV Agents|anti-hiv agents
787882|NCT00002179|Viral Load|viral load
787883|NCT00002178|HIV-1|hiv-1
787884|NCT00002178|Drug Therapy, Combination|drug therapy, combination
787885|NCT00002178|HIV Protease Inhibitors|hiv protease inhibitors
787886|NCT00002178|RNA, Viral|rna, viral
787887|NCT00002178|Dosage Forms|dosage forms
787888|NCT00002178|Saquinavir|saquinavir
787889|NCT00002178|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
787890|NCT00002178|Anti-HIV Agents|anti-hiv agents
787891|NCT00002178|Viral Load|viral load
787892|NCT00002177|Pilot Projects|pilot projects
787893|NCT00002177|HIV-1|hiv-1
787894|NCT00002177|Didanosine|didanosine
787895|NCT00002177|Drug Therapy, Combination|drug therapy, combination
787896|NCT00002177|Stavudine|stavudine
787897|NCT00002177|Hydroxyurea|hydroxyurea
787898|NCT00002177|RNA, Viral|rna, viral
787899|NCT00002177|Nelfinavir|nelfinavir
787900|NCT00002177|Anti-HIV Agents|anti-hiv agents
787901|NCT00002177|Viral Load|viral load
787902|NCT00002176|Pilot Projects|pilot projects
787903|NCT00002176|Didanosine|didanosine
793925|NCT00006445|Ultrasound|ultrasound
787904|NCT00002176|Drug Therapy, Combination|drug therapy, combination
787905|NCT00002176|Stavudine|stavudine
787906|NCT00002176|Hydroxyurea|hydroxyurea
787907|NCT00002176|Nelfinavir|nelfinavir
787908|NCT00002176|Anti-HIV Agents|anti-hiv agents
787909|NCT00002176|Viral Load|viral load
787910|NCT00002175|Cohort Studies|cohort studies
787911|NCT00002175|RNA, Viral|rna, viral
787912|NCT00002175|Administration, Cutaneous|administration, cutaneous
787913|NCT00002175|Anti-HIV Agents|anti-hiv agents
787914|NCT00002175|Dinitrobenzenes|dinitrobenzenes
787915|NCT00002174|Adjuvants, Immunologic|adjuvants, immunologic
787916|NCT00002174|Thalidomide|thalidomide
787917|NCT00002174|Cytokines|cytokines
787918|NCT00002174|Viral Load|viral load
787919|NCT00002173|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787920|NCT00002173|AIDS Vaccines|aids vaccines
787921|NCT00002173|CD4 Lymphocyte Count|cd4 lymphocyte count
787922|NCT00002173|Salk HIV Immunogen|salk hiv immunogen
787923|NCT00002172|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787924|NCT00002172|AIDS Vaccines|aids vaccines
787925|NCT00002172|CD4 Lymphocyte Count|cd4 lymphocyte count
787926|NCT00002172|Salk HIV Immunogen|salk hiv immunogen
787927|NCT00002171|Placebos|placebos
787928|NCT00002171|Drug Therapy, Combination|drug therapy, combination
787929|NCT00002171|Stavudine|stavudine
787930|NCT00002171|HIV Protease Inhibitors|hiv protease inhibitors
787931|NCT00002171|Lamivudine|lamivudine
787932|NCT00002171|Nelfinavir|nelfinavir
787933|NCT00002171|Anti-HIV Agents|anti-hiv agents
787934|NCT00002170|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
787935|NCT00002170|Placebos|placebos
787936|NCT00002170|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
787937|NCT00002170|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787938|NCT00002170|HIV Protease Inhibitors|hiv protease inhibitors
787939|NCT00002170|Nelfinavir|nelfinavir
787940|NCT00002170|Anti-Infective Agents|anti-infective agents
787941|NCT00002170|Anti-HIV Agents|anti-hiv agents
787942|NCT00002169|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
787943|NCT00002169|Placebos|placebos
787944|NCT00002169|Antiviral Agents|antiviral agents
787945|NCT00002169|Cytomegalovirus Retinitis|cytomegalovirus retinitis
787946|NCT00002169|Treatment Outcome|treatment outcome
787947|NCT00002169|Nelfinavir|nelfinavir
787948|NCT00002168|Didanosine|didanosine
787949|NCT00002168|Drug Therapy, Combination|drug therapy, combination
787950|NCT00002168|Zidovudine|zidovudine
787951|NCT00002168|Stavudine|stavudine
787952|NCT00002168|HIV Protease Inhibitors|hiv protease inhibitors
787953|NCT00002168|CD4 Lymphocyte Count|cd4 lymphocyte count
787954|NCT00002168|Lamivudine|lamivudine
787955|NCT00002168|Indinavir|indinavir
787956|NCT00002168|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
787957|NCT00002168|Anti-HIV Agents|anti-hiv agents
787958|NCT00002168|Viral Load|viral load
787959|NCT00002167|Skin Neoplasms|skin neoplasms
787960|NCT00002167|Sarcoma, Kaposi|sarcoma, kaposi
787961|NCT00002167|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787962|NCT00002167|Photochemotherapy|photochemotherapy
787963|NCT00002167|tin etiopurpurin|tin etiopurpurin
787964|NCT00002167|Radiation-Sensitizing Agents|radiation-sensitizing agents
787965|NCT00002166|Nevirapine|nevirapine
787966|NCT00002166|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
787967|NCT00002166|Anti-HIV Agents|anti-hiv agents
787968|NCT00002165|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787969|NCT00002165|HIV Protease Inhibitors|hiv protease inhibitors
787970|NCT00002165|CD4 Lymphocyte Count|cd4 lymphocyte count
787971|NCT00002165|Nelfinavir|nelfinavir
787972|NCT00002165|Anti-HIV Agents|anti-hiv agents
787973|NCT00002164|Biological Availability|biological availability
787974|NCT00002164|HIV Protease Inhibitors|hiv protease inhibitors
787975|NCT00002164|Dosage Forms|dosage forms
787976|NCT00002164|Nelfinavir|nelfinavir
787977|NCT00002163|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787978|NCT00002163|AIDS Dementia Complex|aids dementia complex
787979|NCT00002163|Antiviral Agents|antiviral agents
787980|NCT00002163|abacavir|abacavir
787981|NCT00002162|Drug Therapy, Combination|drug therapy, combination
787982|NCT00002162|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787983|NCT00002162|AIDS-Related Complex|aids-related complex
787984|NCT00002162|Antiviral Agents|antiviral agents
787985|NCT00002162|Saquinavir|saquinavir
787986|NCT00002161|Drug Therapy, Combination|drug therapy, combination
787987|NCT00002161|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787988|NCT00002161|AIDS-Related Complex|aids-related complex
787989|NCT00002161|Antiviral Agents|antiviral agents
787990|NCT00002161|Adenine|adenine
787991|NCT00002160|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
787992|NCT00002160|AIDS-Related Complex|aids-related complex
787993|NCT00002160|Pain|pain
787994|NCT00002160|Palliative Care|palliative care
787995|NCT00002160|omega-conopeptide MVIIA|omega-conopeptide mviia
787996|NCT00002160|Calcium Channel Blockers|calcium channel blockers
787997|NCT00002159|Itraconazole|itraconazole
787998|NCT00002159|Histoplasmosis|histoplasmosis
787999|NCT00002159|Antifungal Agents|antifungal agents
788000|NCT00002159|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788001|NCT00002159|Amphotericin B|amphotericin b
788002|NCT00002159|AIDS-Related Complex|aids-related complex
788003|NCT00002159|Blastomycosis|blastomycosis
788004|NCT00002159|Antibiotics, Antifungal|antibiotics, antifungal
788005|NCT00002158|Cryptosporidiosis|cryptosporidiosis
788006|NCT00002158|Diarrhea|diarrhea
788007|NCT00002158|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788008|NCT00002158|nitazoxanide|nitazoxanide
788009|NCT00002158|Antiparasitic Agents|antiparasitic agents
788010|NCT00002157|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788011|NCT00002157|Cachexia|cachexia
788012|NCT00002157|Thalidomide|thalidomide
788013|NCT00002156|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
788014|NCT00002156|Ganciclovir|ganciclovir
788015|NCT00002156|Drug Therapy, Combination|drug therapy, combination
788016|NCT00002156|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788017|NCT00002156|Antiviral Agents|antiviral agents
788018|NCT00002156|Cytomegalovirus Retinitis|cytomegalovirus retinitis
788019|NCT00002156|Injections|injections
788020|NCT00002155|Drug Therapy, Combination|drug therapy, combination
788021|NCT00002155|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788022|NCT00002155|Antiviral Agents|antiviral agents
788023|NCT00002155|Zidovudine|zidovudine
788024|NCT00002155|HIV Protease Inhibitors|hiv protease inhibitors
788025|NCT00002155|Lamivudine|lamivudine
788026|NCT00002155|Indinavir|indinavir
788027|NCT00002154|Drug Therapy, Combination|drug therapy, combination
788028|NCT00002154|Cognition Disorders|cognition disorders
788029|NCT00002154|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788030|NCT00002154|AIDS-Related Complex|aids-related complex
788031|NCT00002154|Thioctic Acid|thioctic acid
788032|NCT00002154|Selegiline|selegiline
788033|NCT00002153|Skin Neoplasms|skin neoplasms
788034|NCT00002153|Sarcoma, Kaposi|sarcoma, kaposi
788035|NCT00002153|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788036|NCT00002153|Antineoplastic Agents|antineoplastic agents
788037|NCT00002152|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788038|NCT00002152|Antiviral Agents|antiviral agents
788039|NCT00002151|Drug Therapy, Combination|drug therapy, combination
788040|NCT00002151|AIDS-Related Complex|aids-related complex
788041|NCT00002151|Zidovudine|zidovudine
788042|NCT00002151|MDL 28574|mdl 28574
788043|NCT00002150|Drug Therapy, Combination|drug therapy, combination
788044|NCT00002150|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788045|NCT00002150|AIDS-Related Complex|aids-related complex
788046|NCT00002150|Zidovudine|zidovudine
788047|NCT00002150|MDL 28574|mdl 28574
788048|NCT00002149|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
788049|NCT00002149|Drug Therapy, Combination|drug therapy, combination
788050|NCT00002149|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788051|NCT00002149|AIDS-Related Complex|aids-related complex
788052|NCT00002149|Sinusitis|sinusitis
788053|NCT00002149|Ephedrine|ephedrine
788054|NCT00002149|Acupuncture Therapy|acupuncture therapy
788055|NCT00002149|Drugs, Chinese Herbal|drugs, chinese herbal
788056|NCT00002149|Medicine, Chinese Traditional|medicine, chinese traditional
788057|NCT00002149|Drug Combinations|drug combinations
788058|NCT00002149|Antibiotics, Combined|antibiotics, combined
788059|NCT00002149|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination
788060|NCT00002148|Cognition Disorders|cognition disorders
788061|NCT00002148|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788062|NCT00002148|AIDS-Related Complex|aids-related complex
788063|NCT00002148|Free Radical Scavengers|free radical scavengers
788064|NCT00002148|Antioxidants|antioxidants
788065|NCT00002148|OPC 14117|opc 14117
788066|NCT00002147|Sarcoma, Kaposi|sarcoma, kaposi
788067|NCT00002147|Liposomes|liposomes
788068|NCT00002147|Doxorubicin|doxorubicin
788069|NCT00002147|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788070|NCT00002147|Drug Carriers|drug carriers
788071|NCT00002146|Infusions, Intravenous|infusions, intravenous
788072|NCT00002146|Foscarnet|foscarnet
788073|NCT00002146|Cytomegalovirus Infections|cytomegalovirus infections
788074|NCT00002146|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788075|NCT00002146|Magnesium Sulfate|magnesium sulfate
788076|NCT00002146|Magnesium Deficiency|magnesium deficiency
788077|NCT00002146|Hypocalcemia|hypocalcemia
788078|NCT00002145|Foscarnet|foscarnet
788079|NCT00002145|Cytomegalovirus Infections|cytomegalovirus infections
788080|NCT00002145|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788081|NCT00002144|Herpes Simplex|herpes simplex
788082|NCT00002144|Foscarnet|foscarnet
788083|NCT00002144|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788084|NCT00002143|Psoriasis|psoriasis
788085|NCT00002143|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788086|NCT00002143|AIDS-Related Complex|aids-related complex
788087|NCT00002143|Acitretin|acitretin
788088|NCT00002142|Retinitis|retinitis
788089|NCT00002142|Probenecid|probenecid
794131|NCT00006289|CRPS|crps
788090|NCT00002142|Drug Therapy, Combination|drug therapy, combination
788091|NCT00002142|Cytomegalovirus Infections|cytomegalovirus infections
788092|NCT00002142|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788093|NCT00002142|Antiviral Agents|antiviral agents
788094|NCT00002142|cidofovir|cidofovir
788095|NCT00002141|Biological Availability|biological availability
788096|NCT00002141|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
788097|NCT00002141|Food-Drug Interactions|food-drug interactions
788098|NCT00002141|abacavir|abacavir
788099|NCT00002140|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
788100|NCT00002140|Drug Therapy, Combination|drug therapy, combination
788101|NCT00002140|Ethambutol|ethambutol
788102|NCT00002140|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788103|NCT00002140|Azithromycin|azithromycin
788104|NCT00002140|Clarithromycin|clarithromycin
788105|NCT00002139|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788106|NCT00002139|Azithromycin|azithromycin
788107|NCT00002139|Bacterial Infections|bacterial infections
788108|NCT00002138|Neoplasms|neoplasms
788109|NCT00002138|Sarcoma, Kaposi|sarcoma, kaposi
788110|NCT00002138|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788111|NCT00002138|Antineoplastic Agents|antineoplastic agents
788112|NCT00002138|tecogalan|tecogalan
788113|NCT00002137|Neoplasms|neoplasms
788114|NCT00002137|Sarcoma, Kaposi|sarcoma, kaposi
788115|NCT00002137|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788116|NCT00002137|Antineoplastic Agents|antineoplastic agents
788117|NCT00002137|tecogalan|tecogalan
788118|NCT00002136|Neoplasms|neoplasms
788119|NCT00002136|Sarcoma, Kaposi|sarcoma, kaposi
788120|NCT00002136|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788121|NCT00002136|Antineoplastic Agents|antineoplastic agents
788122|NCT00002136|tecogalan|tecogalan
788123|NCT00002135|Retinitis|retinitis
788124|NCT00002135|Ganciclovir|ganciclovir
788125|NCT00002135|Administration, Oral|administration, oral
788126|NCT00002135|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788127|NCT00002134|Retinitis|retinitis
788128|NCT00002134|Ganciclovir|ganciclovir
788129|NCT00002134|Administration, Oral|administration, oral
788130|NCT00002134|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788131|NCT00002133|Itraconazole|itraconazole
788132|NCT00002133|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788133|NCT00002133|AIDS-Related Complex|aids-related complex
788134|NCT00002133|Candidiasis, Oral|candidiasis, oral
788135|NCT00002132|Itraconazole|itraconazole
788136|NCT00002132|Fluconazole|fluconazole
788137|NCT00002132|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788138|NCT00002132|Candidiasis|candidiasis
788139|NCT00002132|Immunocompromised Host|immunocompromised host
788140|NCT00002131|Sarcoma, Kaposi|sarcoma, kaposi
788141|NCT00002131|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788142|NCT00002131|Antiviral Agents|antiviral agents
788143|NCT00002131|vesnarinone|vesnarinone
788144|NCT00002130|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788145|NCT00002130|Antiviral Agents|antiviral agents
788146|NCT00002130|vesnarinone|vesnarinone
788147|NCT00002129|vesnarinone|vesnarinone
788148|NCT00002128|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788149|NCT00002128|AIDS-Related Complex|aids-related complex
788150|NCT00002128|Antiviral Agents|antiviral agents
788151|NCT00002128|Adenine|adenine
788152|NCT00002127|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788153|NCT00002127|Cachexia|cachexia
788154|NCT00002127|Thalidomide|thalidomide
788155|NCT00002126|Neutropenia|neutropenia
788156|NCT00002126|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
788157|NCT00002126|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788158|NCT00002125|Retinitis|retinitis
788159|NCT00002125|Infusions, Intravenous|infusions, intravenous
788160|NCT00002125|Foscarnet|foscarnet
788161|NCT00002125|Cytomegalovirus Infections|cytomegalovirus infections
788162|NCT00002125|Administration, Oral|administration, oral
788163|NCT00002125|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788164|NCT00002125|Fluid Therapy|fluid therapy
788165|NCT00002124|Drug Therapy, Combination|drug therapy, combination
788166|NCT00002124|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788167|NCT00002124|AIDS-Related Complex|aids-related complex
788168|NCT00002124|Antiviral Agents|antiviral agents
788169|NCT00002124|Zidovudine|zidovudine
788170|NCT00002123|Didanosine|didanosine
788171|NCT00002123|Drug Therapy, Combination|drug therapy, combination
788172|NCT00002123|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788173|NCT00002123|AIDS-Related Complex|aids-related complex
788174|NCT00002123|Antiviral Agents|antiviral agents
788175|NCT00002122|Rifabutin|rifabutin
788176|NCT00002122|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
788177|NCT00002122|Mycoses|mycoses
788178|NCT00002122|Drug Therapy, Combination|drug therapy, combination
788179|NCT00002122|Fluconazole|fluconazole
788180|NCT00002122|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788181|NCT00002122|Azithromycin|azithromycin
788182|NCT00002121|Antidiarrheals|antidiarrheals
788183|NCT00002121|Diarrhea|diarrhea
788184|NCT00002121|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788185|NCT00002121|AIDS-Related Complex|aids-related complex
788186|NCT00002121|N(1),N(14)-bis(ethyl)homospermine|n(1),n(14)-bis(ethyl)homospermine
788187|NCT00002120|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
788188|NCT00002120|Trimetrexate|trimetrexate
788189|NCT00002120|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
788190|NCT00002120|Leucovorin|leucovorin
788191|NCT00002120|Dapsone|dapsone
788192|NCT00002120|Drug Therapy, Combination|drug therapy, combination
788193|NCT00002120|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788194|NCT00002119|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788195|NCT00002119|AIDS-Related Complex|aids-related complex
788196|NCT00002119|Antiviral Agents|antiviral agents
788197|NCT00002118|Zalcitabine|zalcitabine
788198|NCT00002118|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788199|NCT00002118|AIDS-Related Complex|aids-related complex
788200|NCT00002117|Zalcitabine|zalcitabine
788201|NCT00002117|Drug Therapy, Combination|drug therapy, combination
788202|NCT00002117|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788203|NCT00002117|AIDS-Related Complex|aids-related complex
788204|NCT00002117|Zidovudine|zidovudine
788205|NCT00002116|Herpes Simplex|herpes simplex
788206|NCT00002116|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788207|NCT00002116|Antiviral Agents|antiviral agents
788208|NCT00002116|cidofovir|cidofovir
788209|NCT00002115|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788210|NCT00002115|Antiviral Agents|antiviral agents
788211|NCT00002115|Adenine|adenine
788212|NCT00002113|Meningitis|meningitis
788213|NCT00002113|Cryptococcosis|cryptococcosis
788214|NCT00002113|Drug Therapy, Combination|drug therapy, combination
788215|NCT00002113|Fluconazole|fluconazole
788216|NCT00002113|Flucytosine|flucytosine
788217|NCT00002113|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788218|NCT00002112|Nystatin|nystatin
788219|NCT00002112|Fluconazole|fluconazole
788220|NCT00002112|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788221|NCT00002112|AIDS-Related Complex|aids-related complex
788222|NCT00002112|Candidiasis, Oral|candidiasis, oral
788223|NCT00002111|AIDS-Related Complex|aids-related complex
788224|NCT00002111|Saquinavir|saquinavir
788225|NCT00002111|HIV Protease Inhibitors|hiv protease inhibitors
788226|NCT00002110|Drug Therapy, Combination|drug therapy, combination
788227|NCT00002110|AIDS-Related Complex|aids-related complex
788228|NCT00002110|Zidovudine|zidovudine
788229|NCT00002110|Cysteamine|cysteamine
788230|NCT00002109|Thymopentin|thymopentin
788231|NCT00002109|Zalcitabine|zalcitabine
788232|NCT00002109|Didanosine|didanosine
788233|NCT00002109|Drug Therapy, Combination|drug therapy, combination
788234|NCT00002109|Zidovudine|zidovudine
788235|NCT00002109|Stavudine|stavudine
788236|NCT00002108|Drug Therapy, Combination|drug therapy, combination
788237|NCT00002108|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788238|NCT00002108|AIDS-Related Complex|aids-related complex
788239|NCT00002108|Antiviral Agents|antiviral agents
788240|NCT00002108|Zidovudine|zidovudine
788241|NCT00002107|Interleukin-2|interleukin-2
788242|NCT00002107|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788243|NCT00002107|AIDS-Related Complex|aids-related complex
788244|NCT00002106|Ranitidine|ranitidine
788245|NCT00002105|Vincristine|vincristine
788246|NCT00002105|Sarcoma, Kaposi|sarcoma, kaposi
788247|NCT00002105|Liposomes|liposomes
788248|NCT00002105|Doxorubicin|doxorubicin
788249|NCT00002105|Drug Therapy, Combination|drug therapy, combination
788250|NCT00002105|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788251|NCT00002105|Bleomycin|bleomycin
788252|NCT00002105|Drug Carriers|drug carriers
788253|NCT00002104|Mycobacterium tuberculosis|mycobacterium tuberculosis
788254|NCT00002104|Mycobacterium Infections|mycobacterium infections
788255|NCT00002104|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
788256|NCT00002104|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
788257|NCT00002104|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788258|NCT00002104|AIDS-Related Complex|aids-related complex
788607|NCT00002032|Rifabutin|rifabutin
788259|NCT00002104|Mycobacterium Infections, Atypical|mycobacterium infections, atypical
788260|NCT00002104|Thalidomide|thalidomide
788261|NCT00002103|Trimetrexate|trimetrexate
788262|NCT00002103|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
788263|NCT00002103|Leucovorin|leucovorin
788264|NCT00002103|Drug Therapy, Combination|drug therapy, combination
788265|NCT00002103|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788266|NCT00002102|Trimetrexate|trimetrexate
788267|NCT00002102|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
788268|NCT00002102|Leucovorin|leucovorin
788269|NCT00002102|Drug Therapy, Combination|drug therapy, combination
788270|NCT00002102|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788271|NCT00002101|Rifabutin|rifabutin
788272|NCT00002101|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
788273|NCT00002101|Drug Therapy, Combination|drug therapy, combination
788274|NCT00002101|Ethambutol|ethambutol
788275|NCT00002101|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788276|NCT00002101|Clarithromycin|clarithromycin
788277|NCT00002100|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788278|NCT00002100|AIDS-Related Complex|aids-related complex
788279|NCT00002100|curdlan sulfate|curdlan sulfate
788280|NCT00002099|Didanosine|didanosine
788281|NCT00002099|Drug Therapy, Combination|drug therapy, combination
788282|NCT00002099|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788283|NCT00002099|AIDS-Related Complex|aids-related complex
788284|NCT00002099|Lentinan|lentinan
788285|NCT00002098|Didanosine|didanosine
788286|NCT00002098|Drug Therapy, Combination|drug therapy, combination
788287|NCT00002098|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788288|NCT00002098|AIDS-Related Complex|aids-related complex
788289|NCT00002098|Lentinan|lentinan
788290|NCT00002097|Nystatin|nystatin
788291|NCT00002097|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788292|NCT00002097|AIDS-Related Complex|aids-related complex
788293|NCT00002096|Didanosine|didanosine
788294|NCT00002096|Ganciclovir|ganciclovir
788295|NCT00002096|Drug Interactions|drug interactions
788296|NCT00002096|Cytomegalovirus Infections|cytomegalovirus infections
788297|NCT00002096|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788298|NCT00002096|Zidovudine|zidovudine
788299|NCT00002095|Ganciclovir|ganciclovir
788300|NCT00002095|Cytomegalovirus Infections|cytomegalovirus infections
788301|NCT00002095|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788302|NCT00002094|Virus Replication|virus replication
788303|NCT00002094|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788304|NCT00002094|Antiviral Agents|antiviral agents
788305|NCT00002093|Vincristine|vincristine
788306|NCT00002093|Sarcoma, Kaposi|sarcoma, kaposi
788307|NCT00002093|Liposomes|liposomes
788308|NCT00002093|Doxorubicin|doxorubicin
788309|NCT00002093|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788310|NCT00002093|Bleomycin|bleomycin
788311|NCT00002093|Daunorubicin|daunorubicin
788312|NCT00002093|Drug Carriers|drug carriers
788313|NCT00002092|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788314|NCT00002092|AIDS-Related Complex|aids-related complex
788315|NCT00002092|Cimetidine|cimetidine
788316|NCT00002091|Pentoxifylline|pentoxifylline
788317|NCT00002091|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788318|NCT00002091|AIDS-Related Complex|aids-related complex
788319|NCT00002090|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
788320|NCT00002090|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788321|NCT00002090|Azithromycin|azithromycin
788322|NCT00002089|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
788323|NCT00002089|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788324|NCT00002089|Azithromycin|azithromycin
788325|NCT00002088|Diarrhea|diarrhea
788326|NCT00002088|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788327|NCT00002088|AIDS-Related Complex|aids-related complex
788328|NCT00002088|Saccharomyces|saccharomyces
788329|NCT00002087|Recombinant Proteins|recombinant proteins
788330|NCT00002087|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788331|NCT00002087|Antigens, CD4|antigens, cd4
788332|NCT00002087|AIDS-Related Complex|aids-related complex
788333|NCT00002086|Zalcitabine|zalcitabine
788334|NCT00002086|Drug Therapy, Combination|drug therapy, combination
788335|NCT00002086|AIDS-Related Complex|aids-related complex
788336|NCT00002086|Zidovudine|zidovudine
788337|NCT00002086|Interferon-alpha|interferon-alpha
788338|NCT00002085|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
788339|NCT00002085|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788340|NCT00002085|Azithromycin|azithromycin
788341|NCT00002085|Mycobacterium Infections, Atypical|mycobacterium infections, atypical
788342|NCT00002084|Acyclovir|acyclovir
788343|NCT00002084|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788344|NCT00002084|AIDS-Related Complex|aids-related complex
788345|NCT00002084|Antiviral Agents|antiviral agents
788346|NCT00002084|Anus Diseases|anus diseases
788347|NCT00002084|Herpes Genitalis|herpes genitalis
788348|NCT00002083|Peptide T|peptide t
788349|NCT00002083|HIV-1|hiv-1
788350|NCT00002083|Administration, Intranasal|administration, intranasal
788351|NCT00002083|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788352|NCT00002083|Peripheral Nervous System Diseases|peripheral nervous system diseases
788353|NCT00002082|Cryptosporidiosis|cryptosporidiosis
788354|NCT00002082|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788355|NCT00002082|Azithromycin|azithromycin
788356|NCT00002081|Zalcitabine|zalcitabine
788357|NCT00002081|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788358|NCT00002081|AIDS-Related Complex|aids-related complex
788359|NCT00002081|Zidovudine|zidovudine
788360|NCT00002080|Rifabutin|rifabutin
788361|NCT00002080|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788362|NCT00002080|AIDS-Related Complex|aids-related complex
788363|NCT00002080|Mycobacterium avium Complex|mycobacterium avium complex
788364|NCT00002080|Bacteremia|bacteremia
788365|NCT00002079|Zidovudine|zidovudine
788366|NCT00002079|1-Deoxynojirimycin|1-deoxynojirimycin
788367|NCT00002078|Drug Evaluation|drug evaluation
788368|NCT00002078|Interferon-alpha|interferon-alpha
788369|NCT00002077|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
788370|NCT00002077|Meningitis|meningitis
788371|NCT00002077|Injections, Intravenous|injections, intravenous
788372|NCT00002077|Cryptococcosis|cryptococcosis
788373|NCT00002077|Fluconazole|fluconazole
788374|NCT00002077|Administration, Oral|administration, oral
788375|NCT00002077|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788376|NCT00002076|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
788377|NCT00002076|Meningitis|meningitis
788378|NCT00002076|Cryptococcosis|cryptococcosis
788379|NCT00002076|Fluconazole|fluconazole
788380|NCT00002076|Administration, Oral|administration, oral
788381|NCT00002076|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788382|NCT00002075|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
788383|NCT00002075|Meningitis|meningitis
788384|NCT00002075|Cryptococcosis|cryptococcosis
788385|NCT00002075|Drug Therapy, Combination|drug therapy, combination
788386|NCT00002075|Fluconazole|fluconazole
788387|NCT00002075|Flucytosine|flucytosine
788388|NCT00002075|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788389|NCT00002075|Amphotericin B|amphotericin b
788390|NCT00002074|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
788391|NCT00002074|Meningitis|meningitis
788392|NCT00002074|Cryptococcosis|cryptococcosis
788393|NCT00002074|Fluconazole|fluconazole
788394|NCT00002074|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788395|NCT00002074|Amphotericin B|amphotericin b
788396|NCT00002073|Recombinant Proteins|recombinant proteins
788397|NCT00002073|Injections, Subcutaneous|injections, subcutaneous
788398|NCT00002073|Erythropoietin|erythropoietin
788399|NCT00002073|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788400|NCT00002073|Anemia|anemia
788401|NCT00002073|Zidovudine|zidovudine
788402|NCT00002072|Recombinant Proteins|recombinant proteins
788403|NCT00002072|Erythropoietin|erythropoietin
788404|NCT00002072|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788405|NCT00002072|Anemia|anemia
788406|NCT00002072|Zidovudine|zidovudine
788407|NCT00002071|Recombinant Proteins|recombinant proteins
788408|NCT00002071|Erythropoietin|erythropoietin
788409|NCT00002071|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788410|NCT00002071|Anemia|anemia
788411|NCT00002071|Zidovudine|zidovudine
788412|NCT00002070|Recombinant Proteins|recombinant proteins
788413|NCT00002070|Retinitis|retinitis
788414|NCT00002070|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
788415|NCT00002070|Neutropenia|neutropenia
788416|NCT00002070|Ganciclovir|ganciclovir
788417|NCT00002070|Drug Therapy, Combination|drug therapy, combination
788418|NCT00002070|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
788419|NCT00002070|Cytomegalovirus Infections|cytomegalovirus infections
788420|NCT00002070|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788421|NCT00002069|Ditiocarb|ditiocarb
788422|NCT00002069|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788423|NCT00002069|AIDS-Related Complex|aids-related complex
788424|NCT00002068|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
788425|NCT00002068|Meningitis|meningitis
788426|NCT00002068|Cryptococcosis|cryptococcosis
788427|NCT00002068|Drug Therapy, Combination|drug therapy, combination
788428|NCT00002068|Fluconazole|fluconazole
788429|NCT00002068|Flucytosine|flucytosine
788430|NCT00002068|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788431|NCT00002068|Amphotericin B|amphotericin b
788432|NCT00002067|Body Weight|body weight
788433|NCT00002067|T-Lymphocytes|t-lymphocytes
788434|NCT00002067|Nutritional Status|nutritional status
788435|NCT00002067|Megestrol|megestrol
788436|NCT00002067|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788437|NCT00002067|Anorexia|anorexia
788438|NCT00002067|Cachexia|cachexia
788439|NCT00002067|Energy Intake|energy intake
788440|NCT00002066|Thymopentin|thymopentin
788441|NCT00002066|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788442|NCT00002065|Delayed-Action Preparations|delayed-action preparations
788443|NCT00002065|Disulfiram|disulfiram
788444|NCT00002065|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788445|NCT00002065|AIDS-Related Complex|aids-related complex
788446|NCT00002064|Sulfonamides|sulfonamides
788447|NCT00002064|Toxoplasmosis|toxoplasmosis
788448|NCT00002064|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
788449|NCT00002064|Pyrimethamine|pyrimethamine
788450|NCT00002064|Drug Therapy, Combination|drug therapy, combination
788451|NCT00002064|Encephalitis|encephalitis
788452|NCT00002064|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788454|NCT00002063|Immune Tolerance|immune tolerance
788455|NCT00002063|AIDS-Related Complex|aids-related complex
788456|NCT00002063|Zidovudine|zidovudine
788457|NCT00002062|Spiramycin|spiramycin
788458|NCT00002062|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
788459|NCT00002062|Immune Tolerance|immune tolerance
788460|NCT00002062|Cryptosporidiosis|cryptosporidiosis
788461|NCT00002062|Diarrhea|diarrhea
788462|NCT00002062|Drugs, Investigational|drugs, investigational
788463|NCT00002062|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788464|NCT00002061|T-Lymphocytes|t-lymphocytes
788465|NCT00002061|Immune Tolerance|immune tolerance
788466|NCT00002061|Inosine Pranobex|inosine pranobex
788467|NCT00002061|Killer Cells|killer cells
788468|NCT00002061|T-Lymphocytes, Helper-Inducer|t-lymphocytes, helper-inducer
788469|NCT00002061|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788470|NCT00002061|AIDS-Related Complex|aids-related complex
788471|NCT00002060|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
788472|NCT00002060|Inosine Pranobex|inosine pranobex
788473|NCT00002060|Homosexuality|homosexuality
788474|NCT00002060|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788475|NCT00002060|AIDS-Related Complex|aids-related complex
788476|NCT00002059|T-Lymphocytes, Suppressor-Effector|t-lymphocytes, suppressor-effector
788477|NCT00002059|Neoplasms|neoplasms
788478|NCT00002059|Inosine Pranobex|inosine pranobex
788479|NCT00002059|Killer Cells|killer cells
788480|NCT00002059|T-Lymphocytes, Helper-Inducer|t-lymphocytes, helper-inducer
788481|NCT00002059|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788482|NCT00002059|AIDS-Related Complex|aids-related complex
788483|NCT00002058|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
788484|NCT00002058|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
788485|NCT00002058|Clofazimine|clofazimine
788486|NCT00002058|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788487|NCT00002057|Nystatin|nystatin
788488|NCT00002057|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
788489|NCT00002057|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788490|NCT00002057|AIDS-Related Complex|aids-related complex
788491|NCT00002057|Candidiasis, Oral|candidiasis, oral
788492|NCT00002056|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
788493|NCT00002056|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
788494|NCT00002056|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
788495|NCT00002056|Pentamidine|pentamidine
788496|NCT00002056|Injections, Intravenous|injections, intravenous
788497|NCT00002056|Administration, Oral|administration, oral
788498|NCT00002056|Aerosols|aerosols
788499|NCT00002056|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788500|NCT00002055|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
788501|NCT00002055|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
788502|NCT00002055|Pentamidine|pentamidine
788503|NCT00002055|Dose-Response Relationship, Drug|dose-response relationship, drug
788504|NCT00002055|Aerosols|aerosols
788505|NCT00002055|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788506|NCT00002054|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
788507|NCT00002054|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
788508|NCT00002054|Pentamidine|pentamidine
788509|NCT00002054|Dose-Response Relationship, Drug|dose-response relationship, drug
788510|NCT00002054|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788511|NCT00002053|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
788512|NCT00002053|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
788513|NCT00002053|Pentamidine|pentamidine
788514|NCT00002053|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788515|NCT00002052|Salmonella Infections|salmonella infections
788516|NCT00002052|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
788517|NCT00002052|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788518|NCT00002052|Amoxicillin|amoxicillin
788519|NCT00002052|Ceftriaxone|ceftriaxone
788520|NCT00002051|Thymopentin|thymopentin
788521|NCT00002051|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788522|NCT00002050|Semen|semen
788523|NCT00002050|Thymopentin|thymopentin
788524|NCT00002050|Leukocytes, Mononuclear|leukocytes, mononuclear
788525|NCT00002050|AIDS-Related Complex|aids-related complex
788526|NCT00002049|Semen|semen
788527|NCT00002049|Thymopentin|thymopentin
788528|NCT00002049|Leukocytes, Mononuclear|leukocytes, mononuclear
788529|NCT00002049|HIV Seropositivity|hiv seropositivity
788530|NCT00002049|AIDS-Related Complex|aids-related complex
788531|NCT00002048|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788532|NCT00002048|Zidovudine|zidovudine
788533|NCT00002047|Kidney Failure, Chronic|kidney failure, chronic
788534|NCT00002047|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788535|NCT00002047|AIDS-Related Complex|aids-related complex
788536|NCT00002047|Zidovudine|zidovudine
788537|NCT00002047|Renal Dialysis|renal dialysis
788538|NCT00002046|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788539|NCT00002046|AIDS-Related Complex|aids-related complex
788541|NCT00002045|Prospective Studies|prospective studies
788542|NCT00002045|Zidovudine|zidovudine
788543|NCT00002044|Pilot Projects|pilot projects
788544|NCT00002044|Neuromuscular Diseases|neuromuscular diseases
788545|NCT00002044|Drug Evaluation|drug evaluation
788546|NCT00002044|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788547|NCT00002044|AIDS Dementia Complex|aids dementia complex
788548|NCT00002044|AIDS-Related Complex|aids-related complex
788549|NCT00002044|Zidovudine|zidovudine
788550|NCT00002043|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
788551|NCT00002043|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
788552|NCT00002043|Leukoplakia, Oral|leukoplakia, oral
788553|NCT00002043|Dapsone|dapsone
788554|NCT00002043|AIDS-Related Complex|aids-related complex
788555|NCT00002043|Candidiasis, Oral|candidiasis, oral
788556|NCT00002042|Recombinant Proteins|recombinant proteins
788557|NCT00002042|Erythropoietin|erythropoietin
788558|NCT00002042|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788559|NCT00002042|Anemia|anemia
788560|NCT00002042|AIDS-Related Complex|aids-related complex
788561|NCT00002042|Zidovudine|zidovudine
788562|NCT00002041|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
788563|NCT00002041|Esophagitis|esophagitis
788564|NCT00002041|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788565|NCT00002041|Amphotericin B|amphotericin b
788566|NCT00002041|Candidiasis, Oral|candidiasis, oral
788567|NCT00002040|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
788568|NCT00002040|Meningitis|meningitis
788569|NCT00002040|Injections, Intravenous|injections, intravenous
788570|NCT00002040|Cryptococcosis|cryptococcosis
788571|NCT00002040|Fluconazole|fluconazole
788572|NCT00002040|Administration, Oral|administration, oral
788573|NCT00002040|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788574|NCT00002039|Retinitis|retinitis
788575|NCT00002039|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
788576|NCT00002039|Drug Therapy, Combination|drug therapy, combination
788577|NCT00002039|Foscarnet|foscarnet
788578|NCT00002039|Cytomegalovirus Infections|cytomegalovirus infections
788579|NCT00002039|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788580|NCT00002039|Antiviral Agents|antiviral agents
788581|NCT00002039|Zidovudine|zidovudine
788582|NCT00002038|Mycoses|mycoses
788583|NCT00002038|Drugs, Investigational|drugs, investigational
788584|NCT00002038|Fluconazole|fluconazole
788585|NCT00002037|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
788586|NCT00002037|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
788587|NCT00002037|Interferon-gamma, Recombinant|interferon-gamma, recombinant
788588|NCT00002037|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788589|NCT00002036|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788590|NCT00002036|AIDS-Related Complex|aids-related complex
788591|NCT00002036|Immunization, Passive|immunization, passive
788592|NCT00002035|Didanosine|didanosine
788593|NCT00002035|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788594|NCT00002035|AIDS-Related Complex|aids-related complex
788595|NCT00002035|Zidovudine|zidovudine
788596|NCT00002034|Retinitis|retinitis
788597|NCT00002034|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
788598|NCT00002034|Ganciclovir|ganciclovir
788599|NCT00002034|Drug Interactions|drug interactions
788600|NCT00002034|Cytomegalovirus Infections|cytomegalovirus infections
788601|NCT00002034|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788602|NCT00002034|Zidovudine|zidovudine
788603|NCT00002033|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788604|NCT00002033|AIDS-Related Complex|aids-related complex
788605|NCT00002033|ammonium trichloro(dioxoethylene-O,O'-)tellurute|ammonium trichloro(dioxoethylene-o,o'-)tellurute
788606|NCT00002033|Zidovudine|zidovudine
788608|NCT00002032|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
788609|NCT00002032|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
788610|NCT00002032|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788611|NCT00002032|Antitubercular Agents|antitubercular agents
788612|NCT00002031|Langerhans Cells|langerhans cells
788613|NCT00002031|Dinitrochlorobenzene|dinitrochlorobenzene
788614|NCT00002031|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788615|NCT00002031|AIDS-Related Complex|aids-related complex
788616|NCT00002030|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
788617|NCT00002030|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
788618|NCT00002030|Pentamidine|pentamidine
788619|NCT00002030|Aerosols|aerosols
788620|NCT00002030|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788621|NCT00002029|Weight Loss|weight loss
788622|NCT00002029|Parenteral Nutrition, Total|parenteral nutrition, total
788623|NCT00002029|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
788624|NCT00002029|Liposyn|liposyn
788625|NCT00002029|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788626|NCT00002028|Didanosine|didanosine
788627|NCT00002028|Drugs, Investigational|drugs, investigational
788628|NCT00002028|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788629|NCT00002028|AIDS-Related Complex|aids-related complex
788630|NCT00002028|Zidovudine|zidovudine
788631|NCT00002027|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
788632|NCT00002027|Cryptosporidiosis|cryptosporidiosis
788633|NCT00002027|Diarrhea|diarrhea
788634|NCT00002027|diclazuril|diclazuril
788635|NCT00002027|Coccidiostats|coccidiostats
788636|NCT00002027|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788637|NCT00002026|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
788638|NCT00002026|Leukoplakia, Oral|leukoplakia, oral
788639|NCT00002026|Herpesvirus 4, Human|herpesvirus 4, human
788640|NCT00002026|Acyclovir|acyclovir
788641|NCT00002026|AIDS-Related Complex|aids-related complex
788642|NCT00002025|Retinitis|retinitis
788643|NCT00002025|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
788644|NCT00002025|Immune Tolerance|immune tolerance
788645|NCT00002025|Injections, Intravenous|injections, intravenous
788646|NCT00002025|Ganciclovir|ganciclovir
788647|NCT00002025|Cytomegalovirus Infections|cytomegalovirus infections
788648|NCT00002025|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788649|NCT00002024|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
788650|NCT00002024|Immune Tolerance|immune tolerance
788651|NCT00002024|Ganciclovir|ganciclovir
788652|NCT00002024|Drugs, Investigational|drugs, investigational
788653|NCT00002024|Cytomegalovirus Infections|cytomegalovirus infections
788654|NCT00002024|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788655|NCT00002023|Dose-Response Relationship, Drug|dose-response relationship, drug
788656|NCT00002023|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788657|NCT00002023|AIDS-Related Complex|aids-related complex
788658|NCT00002023|Zidovudine|zidovudine
788659|NCT00002022|Recombinant Proteins|recombinant proteins
788660|NCT00002022|Drugs, Investigational|drugs, investigational
788661|NCT00002022|Erythropoietin|erythropoietin
788662|NCT00002022|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788663|NCT00002022|Anemia|anemia
788664|NCT00002022|Zidovudine|zidovudine
788665|NCT00002021|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
788666|NCT00002021|Immune Tolerance|immune tolerance
788667|NCT00002021|Injections, Intravenous|injections, intravenous
788668|NCT00002021|Herpes Simplex|herpes simplex
788669|NCT00002021|Immunity, Cellular|immunity, cellular
788670|NCT00002021|Foscarnet|foscarnet
788671|NCT00002021|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788672|NCT00002021|Antiviral Agents|antiviral agents
788673|NCT00002020|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788674|NCT00002020|AIDS-Related Complex|aids-related complex
788675|NCT00002020|Zidovudine|zidovudine
788676|NCT00002019|Meningitis|meningitis
788677|NCT00002019|Liposomes|liposomes
788678|NCT00002019|Cryptococcosis|cryptococcosis
788679|NCT00002019|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788680|NCT00002019|Amphotericin B|amphotericin b
788681|NCT00002019|Chemistry, Pharmaceutical|chemistry, pharmaceutical
788682|NCT00002018|Interferon Type I|interferon type i
788683|NCT00002017|Polyethylene Glycols|polyethylene glycols
788684|NCT00002017|Interleukin-2|interleukin-2
788685|NCT00002016|Retinitis|retinitis
788686|NCT00002016|Ganciclovir|ganciclovir
788687|NCT00002016|Cytomegalovirus|cytomegalovirus
788688|NCT00002016|Cytomegalovirus Infections|cytomegalovirus infections
788689|NCT00002016|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788690|NCT00002016|Antibodies, Monoclonal|antibodies, monoclonal
788691|NCT00002015|Retinitis|retinitis
788692|NCT00002015|Ganciclovir|ganciclovir
788693|NCT00002015|Cytomegalovirus Infections|cytomegalovirus infections
788694|NCT00002015|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788695|NCT00002015|Immunocompromised Host|immunocompromised host
788696|NCT00002014|Didanosine|didanosine
788697|NCT00002014|Drug Evaluation|drug evaluation
788698|NCT00002014|Zidovudine|zidovudine
788699|NCT00002013|Drug Therapy, Combination|drug therapy, combination
788700|NCT00002013|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788701|NCT00002013|AIDS-Related Complex|aids-related complex
788702|NCT00002013|ammonium trichloro(dioxoethylene-O,O'-)tellurute|ammonium trichloro(dioxoethylene-o,o'-)tellurute
788703|NCT00002013|Zidovudine|zidovudine
788704|NCT00002012|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788705|NCT00002012|AIDS-Related Complex|aids-related complex
788706|NCT00002012|Interferon Type I, Recombinant|interferon type i, recombinant
788707|NCT00002011|PUVA Therapy|puva therapy
788708|NCT00002011|Methoxsalen|methoxsalen
788709|NCT00002011|AIDS-Related Complex|aids-related complex
788710|NCT00002010|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
788711|NCT00002010|Meningitis|meningitis
788712|NCT00002010|Fluconazole|fluconazole
788713|NCT00002010|Coccidioidin|coccidioidin
788714|NCT00002010|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788715|NCT00002010|Coccidioidomycosis|coccidioidomycosis
788716|NCT00002009|Leukopenia|leukopenia
788717|NCT00002009|Drug Evaluation|drug evaluation
788718|NCT00002009|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
788720|NCT00002008|Drug Evaluation|drug evaluation
788721|NCT00002008|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
788722|NCT00002007|Leukopenia|leukopenia
788961|NCT00001113|Interferon Type I|interferon type i
788723|NCT00002007|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
788724|NCT00002007|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788725|NCT00002007|Zidovudine|zidovudine
788726|NCT00002006|Neutropenia|neutropenia
788727|NCT00002006|Drug Interactions|drug interactions
788728|NCT00002006|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
788729|NCT00002006|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788730|NCT00002006|Zidovudine|zidovudine
788731|NCT00002005|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788732|NCT00002005|Antigens, CD4|antigens, cd4
788733|NCT00002005|AIDS-Related Complex|aids-related complex
788734|NCT00002004|Recombinant Proteins|recombinant proteins
788735|NCT00002004|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788736|NCT00002004|Antigens, CD4|antigens, cd4
788737|NCT00002004|AIDS-Related Complex|aids-related complex
788738|NCT00002003|Mitoxantrone|mitoxantrone
788739|NCT00002003|Lymphoma, Large-Cell|lymphoma, large-cell
788740|NCT00002003|Etoposide|etoposide
788741|NCT00002003|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788742|NCT00002002|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
788743|NCT00002002|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
788744|NCT00002002|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
788745|NCT00002002|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788746|NCT00002001|Zalcitabine|zalcitabine
788747|NCT00002001|Didanosine|didanosine
788748|NCT00002001|Drug Therapy, Combination|drug therapy, combination
788749|NCT00002001|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788750|NCT00002001|Zidovudine|zidovudine
788751|NCT00002000|Acyclovir|acyclovir
788752|NCT00002000|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788753|NCT00002000|AIDS-Related Complex|aids-related complex
788754|NCT00002000|Antiviral Agents|antiviral agents
788755|NCT00002000|Anus Diseases|anus diseases
788756|NCT00002000|Herpes Genitalis|herpes genitalis
788757|NCT00001999|Retinitis|retinitis
788758|NCT00001999|Gamma-Globulins|gamma-globulins
788759|NCT00001999|Ganciclovir|ganciclovir
788760|NCT00001999|Drug Therapy, Combination|drug therapy, combination
788761|NCT00001999|Cytomegalovirus Infections|cytomegalovirus infections
788762|NCT00001999|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788763|NCT00001999|Immunization, Passive|immunization, passive
788764|NCT00001998|Nystatin|nystatin
788765|NCT00001998|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788766|NCT00001998|AIDS-Related Complex|aids-related complex
788767|NCT00001997|Recombinant Proteins|recombinant proteins
788768|NCT00001997|Polyethylene Glycols|polyethylene glycols
788769|NCT00001997|Interleukin-2|interleukin-2
788770|NCT00001997|Didanosine|didanosine
788771|NCT00001997|Zidovudine|zidovudine
788772|NCT00001996|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
788773|NCT00001996|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
788774|NCT00001996|Pentamidine|pentamidine
788775|NCT00001996|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788776|NCT00001996|atovaquone|atovaquone
788777|NCT00001995|Rifabutin|rifabutin
788778|NCT00001995|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
788779|NCT00001995|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788780|NCT00001994|Toxoplasmosis|toxoplasmosis
788781|NCT00001994|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
788782|NCT00001994|Naphthoquinones|naphthoquinones
788783|NCT00001994|Encephalitis|encephalitis
788784|NCT00001994|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788785|NCT00001993|Drug Therapy, Combination|drug therapy, combination
788786|NCT00001993|Zidovudine|zidovudine
788787|NCT00001992|Vaccines, Synthetic|vaccines, synthetic
788788|NCT00001992|Drug Evaluation|drug evaluation
788789|NCT00001992|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788790|NCT00001992|AIDS Vaccines|aids vaccines
788791|NCT00001991|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
788792|NCT00001991|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
788793|NCT00001991|Antifungal Agents|antifungal agents
788794|NCT00001991|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788795|NCT00001991|atovaquone|atovaquone
788796|NCT00001990|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
788797|NCT00001990|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
788798|NCT00001990|Pentamidine|pentamidine
788799|NCT00001990|Antifungal Agents|antifungal agents
788800|NCT00001990|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788801|NCT00001990|atovaquone|atovaquone
788802|NCT00001989|Trichosanthin|trichosanthin
788803|NCT00001989|Drug Evaluation|drug evaluation
788804|NCT00001989|Drug Therapy, Combination|drug therapy, combination
788902|NCT00001121|HIV Therapeutic Vaccine|hiv therapeutic vaccine
788805|NCT00001989|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788806|NCT00001989|AIDS-Related Complex|aids-related complex
788807|NCT00001989|Antiviral Agents|antiviral agents
788808|NCT00001989|Zidovudine|zidovudine
788809|NCT00001137|Treatment Experienced|treatment experienced
788810|NCT00001137|Treatment Naive|treatment naive
788811|NCT00001137|Virus Replication|virus replication
788812|NCT00001137|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
788813|NCT00001137|HIV-1|hiv-1
788814|NCT00001137|Risk Factors|risk factors
788815|NCT00001137|Incidence|incidence
788816|NCT00001137|RNA, Viral|rna, viral
788817|NCT00001137|Anti-HIV Agents|anti-hiv agents
788818|NCT00001137|Viral Load|viral load
788819|NCT00001137|Lipodystrophy|lipodystrophy
788820|NCT00001137|Nervous System|nervous system
788821|NCT00001137|Cardiovascular System|cardiovascular system
788822|NCT00001137|Neurologic Symptoms|neurologic symptoms
788823|NCT00001136|Injections, Intramuscular|injections, intramuscular
788824|NCT00001136|HIV-1|hiv-1
788825|NCT00001136|AIDS Vaccines|aids vaccines
788826|NCT00001136|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
788827|NCT00001136|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
788828|NCT00001136|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
788829|NCT00001136|Gene Products, gag|gene products, gag
788830|NCT00001136|HIV Seronegativity|hiv seronegativity
788831|NCT00001136|Immunologic Memory|immunologic memory
788832|NCT00001136|Antibodies, Viral|antibodies, viral
788833|NCT00001136|Genetic Vectors|genetic vectors
788834|NCT00001136|Gene Products, env|gene products, env
788835|NCT00001136|Poxviridae|poxviridae
788836|NCT00001136|HIV Preventive Vaccine|hiv preventive vaccine
788837|NCT00001135|Placebos|placebos
788838|NCT00001135|Pregnancy|pregnancy
788962|NCT00001112|Monocytes|monocytes
788839|NCT00001135|Pregnancy Complications, Infectious|pregnancy complications, infectious
788840|NCT00001135|Nevirapine|nevirapine
788841|NCT00001135|Disease Transmission, Vertical|disease transmission, vertical
788842|NCT00001135|Labor|labor
788843|NCT00001135|Anti-HIV Agents|anti-hiv agents
788844|NCT00001133|Dose-Response Relationship, Drug|dose-response relationship, drug
788845|NCT00001133|Drug Therapy, Combination|drug therapy, combination
788846|NCT00001133|HIV Protease Inhibitors|hiv protease inhibitors
788847|NCT00001133|Ritonavir|ritonavir
788848|NCT00001133|Indinavir|indinavir
788849|NCT00001133|Anti-HIV Agents|anti-hiv agents
788850|NCT00001133|Pharmacokinetics|pharmacokinetics
788851|NCT00001133|Treatment Experienced|treatment experienced
788852|NCT00001132|Placebos|placebos
788853|NCT00001132|HIV-1|hiv-1
788854|NCT00001132|Drug Therapy, Combination|drug therapy, combination
788855|NCT00001132|RNA, Viral|rna, viral
788856|NCT00001132|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
788857|NCT00001132|Anti-HIV Agents|anti-hiv agents
788858|NCT00001132|Viral Load|viral load
788859|NCT00001132|abacavir|abacavir
788860|NCT00001131|Interleukin-2|interleukin-2
788861|NCT00001131|Drug Therapy, Combination|drug therapy, combination
788862|NCT00001131|Drug Administration Schedule|drug administration schedule
788863|NCT00001131|Viremia|viremia
788864|NCT00001131|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
788865|NCT00001131|Anti-HIV Agents|anti-hiv agents
788866|NCT00001131|Treatment Experienced|treatment experienced
788867|NCT00001130|Questionnaires|questionnaires
788868|NCT00001130|Antibodies, Viral|antibodies, viral
788869|NCT00001130|Emergency Service, Hospital|emergency service, hospital
788870|NCT00001129|Drug Therapy, Combination|drug therapy, combination
788871|NCT00001129|RNA, Viral|rna, viral
788872|NCT00001129|Patient Compliance|patient compliance
788873|NCT00001129|Anti-HIV Agents|anti-hiv agents
788874|NCT00001129|Viral Load|viral load
788875|NCT00001129|Reminder Systems|reminder systems
788876|NCT00001129|Treatment Experienced|treatment experienced
788877|NCT00001129|Treatment Naive|treatment naive
788878|NCT00001128|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
788879|NCT00001128|Cryptosporidiosis|cryptosporidiosis
788880|NCT00001128|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788881|NCT00001128|Azithromycin|azithromycin
788882|NCT00001128|Paromomycin|paromomycin
788883|NCT00001128|Interleukin-12|interleukin-12
788884|NCT00001125|Antibodies, Viral|antibodies, viral
788885|NCT00001125|Chickenpox|chickenpox
788886|NCT00001125|Chickenpox Vaccine|chickenpox vaccine
788887|NCT00001122|Didanosine|didanosine
788888|NCT00001122|Drug Therapy, Combination|drug therapy, combination
788889|NCT00001122|Stavudine|stavudine
788890|NCT00001122|HIV Protease Inhibitors|hiv protease inhibitors
788891|NCT00001122|CD4 Lymphocyte Count|cd4 lymphocyte count
788892|NCT00001122|Nelfinavir|nelfinavir
788893|NCT00001122|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
788894|NCT00001122|Self Care|self care
788895|NCT00001122|Anti-HIV Agents|anti-hiv agents
788896|NCT00001122|Viral Load|viral load
788897|NCT00001122|efavirenz|efavirenz
788898|NCT00001122|Treatment Naive|treatment naive
788899|NCT00001121|Placebos|placebos
788900|NCT00001121|AIDS Vaccines|aids vaccines
788901|NCT00001121|Follow-Up Studies|follow-up studies
788903|NCT00001120|Prospective Studies|prospective studies
788904|NCT00001120|Sarcoma, Kaposi|sarcoma, kaposi
788905|NCT00001120|Herpesvirus 4, Human|herpesvirus 4, human
788906|NCT00001120|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788907|NCT00001120|Cohort Studies|cohort studies
788908|NCT00001120|Risk Factors|risk factors
788909|NCT00001120|Lymphoma, AIDS-Related|lymphoma, aids-related
788910|NCT00001120|Antibodies, Viral|antibodies, viral
788911|NCT00001120|Lymphoproliferative Disorders|lymphoproliferative disorders
788912|NCT00001120|Viral Load|viral load
788913|NCT00001120|Herpesvirus, Kaposi Sarcoma-Associated|herpesvirus, kaposi sarcoma-associated
788914|NCT00001120|Translocation (Genetics)|translocation (genetics)
788915|NCT00001119|Immunity, Cellular|immunity, cellular
788916|NCT00001119|Drug Therapy, Combination|drug therapy, combination
788917|NCT00001119|HIV Protease Inhibitors|hiv protease inhibitors
788918|NCT00001119|Antibody Formation|antibody formation
788919|NCT00001119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
788920|NCT00001119|Anti-HIV Agents|anti-hiv agents
788921|NCT00001119|Viral Load|viral load
788922|NCT00001119|Tetanus Toxoid|tetanus toxoid
788923|NCT00001119|Case-Control Studies|case-control studies
788924|NCT00001119|Hepatitis B Surface Antigens|hepatitis b surface antigens
788925|NCT00001119|Acute Infection|acute infection
788926|NCT00001118|Injections, Intravenous|injections, intravenous
788927|NCT00001118|Injections, Subcutaneous|injections, subcutaneous
788928|NCT00001118|Drug Therapy, Combination|drug therapy, combination
788929|NCT00001118|HIV Protease Inhibitors|hiv protease inhibitors
788930|NCT00001118|Membrane Fusion|membrane fusion
788931|NCT00001118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
788932|NCT00001118|Anti-HIV Agents|anti-hiv agents
788933|NCT00001118|Viral Load|viral load
788934|NCT00001118|peptide T20|peptide t20
788935|NCT00001117|HIV-1|hiv-1
788936|NCT00001117|Drug Therapy, Combination|drug therapy, combination
788937|NCT00001117|Hepatitis C|hepatitis c
788938|NCT00001117|RNA, Viral|rna, viral
788939|NCT00001117|Anti-HIV Agents|anti-hiv agents
788940|NCT00001116|Tumor Necrosis Factor|tumor necrosis factor
788941|NCT00001116|Interleukin-2|interleukin-2
788942|NCT00001116|Immunity, Cellular|immunity, cellular
788943|NCT00001116|Antiviral Agents|antiviral agents
788944|NCT00001116|Interleukin-6|interleukin-6
788945|NCT00001116|Receptors, Tumor Necrosis Factor|receptors, tumor necrosis factor
788946|NCT00001115|Herpes Simplex|herpes simplex
788947|NCT00001115|Acyclovir|acyclovir
788948|NCT00001115|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788949|NCT00001114|Sarcoma, Kaposi|sarcoma, kaposi
788950|NCT00001114|Didanosine|didanosine
788951|NCT00001114|Drug Interactions|drug interactions
788952|NCT00001114|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788953|NCT00001114|Interferon-alpha|interferon-alpha
788954|NCT00001113|Interferon Alfa-2a|interferon alfa-2a
788955|NCT00001113|Sarcoma, Kaposi|sarcoma, kaposi
788956|NCT00001113|Dose-Response Relationship, Drug|dose-response relationship, drug
788957|NCT00001113|Drug Evaluation|drug evaluation
788958|NCT00001113|Drug Therapy, Combination|drug therapy, combination
788959|NCT00001113|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788960|NCT00001113|Zidovudine|zidovudine
788963|NCT00001112|Interferon-gamma, Recombinant|interferon-gamma, recombinant
788964|NCT00001112|Injections, Subcutaneous|injections, subcutaneous
788965|NCT00001112|Immune System|immune system
788966|NCT00001112|Drug Evaluation|drug evaluation
788967|NCT00001112|Drug Therapy, Combination|drug therapy, combination
788968|NCT00001112|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788969|NCT00001112|Zidovudine|zidovudine
788970|NCT00001112|Blood Bactericidal Activity|blood bactericidal activity
788971|NCT00001111|Drug Therapy, Combination|drug therapy, combination
788972|NCT00001111|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788973|NCT00001111|AIDS-Related Complex|aids-related complex
788974|NCT00001111|Antiviral Agents|antiviral agents
788975|NCT00001111|Zidovudine|zidovudine
788976|NCT00001111|Nevirapine|nevirapine
788977|NCT00001110|Lung|lung
788978|NCT00001110|HIV-1|hiv-1
788979|NCT00001110|Viremia|viremia
788980|NCT00001110|Anti-HIV Agents|anti-hiv agents
788981|NCT00001110|Viral Load|viral load
788982|NCT00001110|Bronchoalveolar Lavage Fluid|bronchoalveolar lavage fluid
788983|NCT00001109|Monocytes|monocytes
788984|NCT00001109|Flow Cytometry|flow cytometry
788985|NCT00001109|HIV Seronegativity|hiv seronegativity
788986|NCT00001109|Phenotype|phenotype
788987|NCT00001109|Lymphocyte Subsets|lymphocyte subsets
788988|NCT00001108|Dose-Response Relationship, Drug|dose-response relationship, drug
788989|NCT00001108|Drug Therapy, Combination|drug therapy, combination
788990|NCT00001108|HIV Protease Inhibitors|hiv protease inhibitors
788991|NCT00001108|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
788992|NCT00001108|Salvage Therapy|salvage therapy
788993|NCT00001108|Anti-HIV Agents|anti-hiv agents
788994|NCT00001106|Pregnancy|pregnancy
788995|NCT00001106|Pregnancy Complications, Infectious|pregnancy complications, infectious
788996|NCT00001106|Prenatal Exposure Delayed Effects|prenatal exposure delayed effects
788997|NCT00001106|Drug Evaluation|drug evaluation
788998|NCT00001106|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
788999|NCT00001106|Zidovudine|zidovudine
789000|NCT00001105|Antibodies, Monoclonal|antibodies, monoclonal
789001|NCT00001105|AIDS-Related Complex|aids-related complex
789002|NCT00001105|Immunization, Passive|immunization, passive
789003|NCT00001104|Sex Behavior|sex behavior
789004|NCT00001104|T-Lymphocytes|t-lymphocytes
789005|NCT00001104|HIV Antibodies|hiv antibodies
789006|NCT00001104|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789007|NCT00001104|AIDS-Related Complex|aids-related complex
789008|NCT00001104|Zidovudine|zidovudine
789009|NCT00001104|Hemophilia A|hemophilia a
789010|NCT00001103|Neuropsychological Tests|neuropsychological tests
789011|NCT00001103|HIV-1|hiv-1
789012|NCT00001103|RNA, Viral|rna, viral
789013|NCT00001103|Anti-HIV Agents|anti-hiv agents
789014|NCT00001103|Viral Load|viral load
789015|NCT00001102|Drug Therapy, Combination|drug therapy, combination
789016|NCT00001102|HIV Protease Inhibitors|hiv protease inhibitors
789017|NCT00001102|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
789018|NCT00001102|Body Composition|body composition
789019|NCT00001102|Anti-HIV Agents|anti-hiv agents
789020|NCT00001102|Cholesterol|cholesterol
789021|NCT00001102|Triglycerides|triglycerides
789022|NCT00001097|Drug Therapy, Combination|drug therapy, combination
789023|NCT00001097|HIV Protease Inhibitors|hiv protease inhibitors
789024|NCT00001097|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
789025|NCT00001097|Anti-HIV Agents|anti-hiv agents
789026|NCT00001096|Vaccines, Synthetic|vaccines, synthetic
789027|NCT00001096|HIV Antibodies|hiv antibodies
789028|NCT00001096|HIV Antigens|hiv antigens
789029|NCT00001096|HIV-1|hiv-1
789030|NCT00001096|Adjuvants, Immunologic|adjuvants, immunologic
789031|NCT00001096|AIDS Vaccines|aids vaccines
789032|NCT00001096|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
789033|NCT00001096|HIV Seronegativity|hiv seronegativity
789034|NCT00001096|HIV Envelope Protein gp120|hiv envelope protein gp120
789035|NCT00001096|Alum Compounds|alum compounds
789036|NCT00001096|HIV Preventive Vaccine|hiv preventive vaccine
789037|NCT00001095|Drug Therapy, Combination|drug therapy, combination
789038|NCT00001095|Zidovudine|zidovudine
789039|NCT00001095|Nevirapine|nevirapine
789040|NCT00001095|Stavudine|stavudine
789041|NCT00001095|HIV Protease Inhibitors|hiv protease inhibitors
789042|NCT00001095|Lamivudine|lamivudine
789043|NCT00001095|VX 478|vx 478
789044|NCT00001095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
789045|NCT00001095|Anti-HIV Agents|anti-hiv agents
789046|NCT00001095|Viral Load|viral load
789047|NCT00001094|HIV-1|hiv-1
789048|NCT00001094|Drug Therapy, Combination|drug therapy, combination
789049|NCT00001094|Zidovudine|zidovudine
789050|NCT00001094|Lamivudine|lamivudine
789051|NCT00001094|RNA, Viral|rna, viral
789052|NCT00001094|Saquinavir|saquinavir
789053|NCT00001094|Delavirdine|delavirdine
789054|NCT00001094|Anti-HIV Agents|anti-hiv agents
789055|NCT00001094|Nelfinavir|nelfinavir
789056|NCT00001093|Immunity, Cellular|immunity, cellular
789057|NCT00001093|Sexual Partners|sexual partners
789058|NCT00001093|Treatment Outcome|treatment outcome
789059|NCT00001093|Anti-HIV Agents|anti-hiv agents
789060|NCT00001093|Viral Load|viral load
789061|NCT00001093|Acute Infection|acute infection
789062|NCT00001092|Semen|semen
789063|NCT00001092|HIV-1|hiv-1
789064|NCT00001092|Sexual Partners|sexual partners
789065|NCT00001092|Drug Resistance, Microbial|drug resistance, microbial
789066|NCT00001092|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
789067|NCT00001092|Saliva|saliva
789068|NCT00001092|Blood|blood
789069|NCT00001092|Cervix Uteri|cervix uteri
789070|NCT00001092|Vagina|vagina
789071|NCT00001092|Acute Infection|acute infection
789072|NCT00001091|Drug Therapy, Combination|drug therapy, combination
789073|NCT00001091|Nevirapine|nevirapine
789074|NCT00001091|Stavudine|stavudine
789075|NCT00001091|HIV Protease Inhibitors|hiv protease inhibitors
789076|NCT00001091|Ritonavir|ritonavir
789077|NCT00001091|Lamivudine|lamivudine
789078|NCT00001091|Nelfinavir|nelfinavir
789079|NCT00001091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
789080|NCT00001090|Reference Values|reference values
789081|NCT00001090|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
789082|NCT00001090|AIDS Vaccines|aids vaccines
789083|NCT00001090|HIV Seronegativity|hiv seronegativity
789084|NCT00001090|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
789085|NCT00001090|HIV Preventive Vaccine|hiv preventive vaccine
789086|NCT00001089|Prospective Studies|prospective studies
789087|NCT00001089|HIV-1|hiv-1
789088|NCT00001089|Cytomegalovirus|cytomegalovirus
789089|NCT00001089|Cytomegalovirus Infections|cytomegalovirus infections
789090|NCT00001089|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789091|NCT00001089|Anti-HIV Agents|anti-hiv agents
789092|NCT00001089|Viral Load|viral load
789093|NCT00001089|Multiple Organ Failure|multiple organ failure
789094|NCT00001088|Injections, Intramuscular|injections, intramuscular
789095|NCT00001088|AIDS Vaccines|aids vaccines
789096|NCT00001088|HIV Seronegativity|hiv seronegativity
789097|NCT00001088|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
789098|NCT00001088|Fusion Proteins, gag-pol|fusion proteins, gag-pol
789099|NCT00001088|Vaccines, DNA|vaccines, dna
789100|NCT00001088|HIV Preventive Vaccine|hiv preventive vaccine
789101|NCT00001087|Drug Therapy, Combination|drug therapy, combination
789102|NCT00001087|Antiviral Agents|antiviral agents
789103|NCT00001087|HIV Protease Inhibitors|hiv protease inhibitors
789104|NCT00001087|Ritonavir|ritonavir
789105|NCT00001087|Saquinavir|saquinavir
789106|NCT00001087|Nelfinavir|nelfinavir
789107|NCT00001087|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
789108|NCT00001087|Adenine|adenine
789109|NCT00001087|Anti-HIV Agents|anti-hiv agents
789110|NCT00001087|efavirenz|efavirenz
789111|NCT00001086|Placebos|placebos
789112|NCT00001086|HIV-1|hiv-1
789113|NCT00001086|Drug Therapy, Combination|drug therapy, combination
789114|NCT00001086|HIV Protease Inhibitors|hiv protease inhibitors
789115|NCT00001086|Indinavir|indinavir
789116|NCT00001086|RNA, Viral|rna, viral
789117|NCT00001086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
789118|NCT00001086|Anti-HIV Agents|anti-hiv agents
789119|NCT00001086|Viral Load|viral load
789120|NCT00001086|efavirenz|efavirenz
789121|NCT00001085|HIV-1|hiv-1
789122|NCT00001085|Drug Therapy, Combination|drug therapy, combination
789123|NCT00001085|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789124|NCT00001085|Zidovudine|zidovudine
789125|NCT00001085|HIV Protease Inhibitors|hiv protease inhibitors
789126|NCT00001085|Lamivudine|lamivudine
789127|NCT00001085|RNA, Viral|rna, viral
789128|NCT00001085|VX 478|vx 478
789129|NCT00001085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
789130|NCT00001085|Anti-HIV Agents|anti-hiv agents
789131|NCT00001085|Viral Load|viral load
789132|NCT00001084|Prospective Studies|prospective studies
789133|NCT00001084|Drug Therapy, Combination|drug therapy, combination
789134|NCT00001084|Zidovudine|zidovudine
789135|NCT00001084|HIV Protease Inhibitors|hiv protease inhibitors
789136|NCT00001084|Lamivudine|lamivudine
789137|NCT00001084|Indinavir|indinavir
789138|NCT00001084|RNA, Viral|rna, viral
789139|NCT00001084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
789140|NCT00001084|Anti-HIV Agents|anti-hiv agents
789141|NCT00001084|Viral Load|viral load
789142|NCT00001083|HIV-1|hiv-1
789143|NCT00001083|Drug Therapy, Combination|drug therapy, combination
789144|NCT00001083|Zidovudine|zidovudine
789145|NCT00001083|Nevirapine|nevirapine
789146|NCT00001083|Stavudine|stavudine
789147|NCT00001083|HIV Protease Inhibitors|hiv protease inhibitors
789148|NCT00001083|Ritonavir|ritonavir
789149|NCT00001083|Lamivudine|lamivudine
789150|NCT00001083|Indinavir|indinavir
789151|NCT00001083|RNA, Viral|rna, viral
789152|NCT00001083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
789153|NCT00001083|Anti-HIV Agents|anti-hiv agents
789154|NCT00001082|Cytomegalovirus Infections|cytomegalovirus infections
789155|NCT00001082|Antiviral Agents|antiviral agents
789156|NCT00001082|CD4 Lymphocyte Count|cd4 lymphocyte count
789157|NCT00001082|Prodrugs|prodrugs
789158|NCT00001082|Survival|survival
789159|NCT00001082|Adenine|adenine
789160|NCT00001081|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
789161|NCT00001081|Cryptosporidiosis|cryptosporidiosis
789162|NCT00001081|Antiprotozoal Agents|antiprotozoal agents
789163|NCT00001081|nitazoxanide|nitazoxanide
789164|NCT00001080|Lymphocyte Transformation|lymphocyte transformation
789165|NCT00001080|HIV-1|hiv-1
789166|NCT00001080|Drug Resistance, Microbial|drug resistance, microbial
789167|NCT00001080|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
789168|NCT00001080|Lamivudine|lamivudine
789169|NCT00001080|Influenza Vaccine|influenza vaccine
789170|NCT00001080|RNA, Viral|rna, viral
789171|NCT00001080|Bacterial Vaccines|bacterial vaccines
789172|NCT00001080|Anti-HIV Agents|anti-hiv agents
789173|NCT00001080|Pneumonia, Pneumococcal|pneumonia, pneumococcal
789174|NCT00001080|Viral Load|viral load
789175|NCT00001079|Placebos|placebos
789176|NCT00001079|Drug Therapy, Combination|drug therapy, combination
789177|NCT00001079|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789178|NCT00001079|AIDS-Related Complex|aids-related complex
789179|NCT00001079|HIV Wasting Syndrome|hiv wasting syndrome
789180|NCT00001079|Megestrol Acetate|megestrol acetate
789181|NCT00001079|dihydrotestosterone heptanoate|dihydrotestosterone heptanoate
789182|NCT00001078|Viral Vaccines|viral vaccines
789183|NCT00001078|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
789184|NCT00001078|Anti-HIV Agents|anti-hiv agents
789185|NCT00001078|Hepatitis A Virus, Human|hepatitis a virus, human
789186|NCT00001077|Weight Loss|weight loss
789187|NCT00001077|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789188|NCT00001077|Nutritional Support|nutritional support
789189|NCT00001076|Vaccines, Synthetic|vaccines, synthetic
789190|NCT00001076|HIV Envelope Protein gp120|hiv envelope protein gp120
789191|NCT00001076|AIDS Vaccines|aids vaccines
789192|NCT00001076|HIV Seronegativity|hiv seronegativity
789193|NCT00001076|Avipoxvirus|avipoxvirus
789194|NCT00001076|HIV Preventive Vaccine|hiv preventive vaccine
789195|NCT00001075|Drug Therapy, Combination|drug therapy, combination
789196|NCT00001075|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789197|NCT00001075|AIDS-Related Complex|aids-related complex
789198|NCT00001075|Antiviral Agents|antiviral agents
789199|NCT00001075|Zidovudine|zidovudine
789200|NCT00001075|HIV Protease Inhibitors|hiv protease inhibitors
789201|NCT00001075|Ritonavir|ritonavir
789202|NCT00001075|Lamivudine|lamivudine
789203|NCT00001074|Didanosine|didanosine
789204|NCT00001074|Drug Therapy, Combination|drug therapy, combination
789205|NCT00001074|Antiviral Agents|antiviral agents
789206|NCT00001074|Hydroxyurea|hydroxyurea
789207|NCT00001073|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789208|NCT00001073|AIDS-Related Complex|aids-related complex
789209|NCT00001073|Cervix Dysplasia|cervix dysplasia
789210|NCT00001073|Cervix Diseases|cervix diseases
789211|NCT00001073|Isotretinoin|isotretinoin
789212|NCT00001073|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
789213|NCT00001073|Cervix Neoplasms|cervix neoplasms
789214|NCT00001073|Keratolytic Agents|keratolytic agents
789215|NCT00001072|Vaccines, Synthetic|vaccines, synthetic
789216|NCT00001072|HIV Envelope Protein gp120|hiv envelope protein gp120
789217|NCT00001072|AIDS Vaccines|aids vaccines
789218|NCT00001072|HIV Seronegativity|hiv seronegativity
789219|NCT00001072|Avipoxvirus|avipoxvirus
789220|NCT00001072|HIV Preventive Vaccine|hiv preventive vaccine
789221|NCT00001071|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
789222|NCT00001071|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789223|NCT00001071|AIDS-Related Complex|aids-related complex
789224|NCT00001071|Stem Cells|stem cells
789225|NCT00001069|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789226|NCT00001069|AIDS-Related Complex|aids-related complex
789227|NCT00001069|Antiviral Agents|antiviral agents
789228|NCT00001069|Decision Making|decision making
789229|NCT00001069|Physician's Practice Patterns|physician's practice patterns
789230|NCT00001068|Zalcitabine|zalcitabine
789231|NCT00001068|Didanosine|didanosine
789232|NCT00001068|Drug Therapy, Combination|drug therapy, combination
789233|NCT00001068|AIDS-Related Complex|aids-related complex
789234|NCT00001068|Antiviral Agents|antiviral agents
789235|NCT00001068|Zidovudine|zidovudine
789236|NCT00001068|Lamivudine|lamivudine
789237|NCT00001067|Drug Therapy, Combination|drug therapy, combination
789238|NCT00001067|AIDS-Related Complex|aids-related complex
789239|NCT00001067|Zidovudine|zidovudine
789240|NCT00001067|Stavudine|stavudine
789241|NCT00001067|Lamivudine|lamivudine
789242|NCT00001066|Didanosine|didanosine
789243|NCT00001066|Drug Therapy, Combination|drug therapy, combination
789244|NCT00001066|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789245|NCT00001066|AIDS-Related Complex|aids-related complex
789246|NCT00001066|Zidovudine|zidovudine
789247|NCT00001066|Lamivudine|lamivudine
789248|NCT00001065|Administration, Oral|administration, oral
789249|NCT00001065|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789250|NCT00001065|Amphotericin B|amphotericin b
789251|NCT00001065|AIDS-Related Complex|aids-related complex
789252|NCT00001065|Candidiasis, Oral|candidiasis, oral
789253|NCT00001065|Suspensions|suspensions
789254|NCT00001064|HIV Antigens|hiv antigens
789255|NCT00001064|Immunotherapy, Adoptive|immunotherapy, adoptive
789256|NCT00001064|Dendritic Cells|dendritic cells
789257|NCT00001063|Didanosine|didanosine
789258|NCT00001063|Drug Therapy, Combination|drug therapy, combination
789259|NCT00001063|AIDS-Related Complex|aids-related complex
789260|NCT00001063|Zidovudine|zidovudine
789261|NCT00001063|Stavudine|stavudine
789262|NCT00001062|Infusions, Intravenous|infusions, intravenous
789263|NCT00001062|Ganciclovir|ganciclovir
789264|NCT00001062|Administration, Oral|administration, oral
789265|NCT00001062|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789266|NCT00001062|Antiviral Agents|antiviral agents
789267|NCT00001062|Cytomegalovirus Retinitis|cytomegalovirus retinitis
789268|NCT00001061|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
789269|NCT00001061|Ganciclovir|ganciclovir
789270|NCT00001061|Foscarnet|foscarnet
789271|NCT00001061|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789272|NCT00001061|Antibodies, Monoclonal|antibodies, monoclonal
789273|NCT00001061|Cytomegalovirus Retinitis|cytomegalovirus retinitis
789274|NCT00001060|Vaccines, Synthetic|vaccines, synthetic
789275|NCT00001060|HIV-1|hiv-1
789276|NCT00001060|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789277|NCT00001060|AIDS-Related Complex|aids-related complex
789278|NCT00001060|AIDS Vaccines|aids vaccines
789279|NCT00001060|HIV Therapeutic Vaccine|hiv therapeutic vaccine
789280|NCT00001059|Vincristine|vincristine
789281|NCT00001059|Sarcoma, Kaposi|sarcoma, kaposi
789282|NCT00001059|Liposomes|liposomes
789283|NCT00001059|Doxorubicin|doxorubicin
789284|NCT00001059|Drug Therapy, Combination|drug therapy, combination
789285|NCT00001059|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
789286|NCT00001059|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789287|NCT00001059|Bleomycin|bleomycin
789288|NCT00001059|Drug Carriers|drug carriers
789290|NCT00001058|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
789291|NCT00001058|Drug Therapy, Combination|drug therapy, combination
789292|NCT00001058|Ethambutol|ethambutol
789293|NCT00001058|Clofazimine|clofazimine
789294|NCT00001058|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789295|NCT00001058|Ciprofloxacin|ciprofloxacin
789296|NCT00001058|Clarithromycin|clarithromycin
789297|NCT00001057|Didanosine|didanosine
789298|NCT00001057|Drug Therapy, Combination|drug therapy, combination
789299|NCT00001057|Zidovudine|zidovudine
789300|NCT00001056|Vaccines, Synthetic|vaccines, synthetic
789301|NCT00001056|Vaccinia Virus|vaccinia virus
789302|NCT00001056|Viral Vaccines|viral vaccines
789303|NCT00001056|HIV-1|hiv-1
789304|NCT00001056|HIV Envelope Protein gp160|hiv envelope protein gp160
789305|NCT00001056|AIDS Vaccines|aids vaccines
789306|NCT00001056|HIV Seronegativity|hiv seronegativity
789307|NCT00001056|HIV Preventive Vaccine|hiv preventive vaccine
789308|NCT00001055|Vaccines, Synthetic|vaccines, synthetic
789309|NCT00001055|HIV Envelope Protein gp120|hiv envelope protein gp120
789310|NCT00001055|AIDS Vaccines|aids vaccines
789311|NCT00001055|HIV Seronegativity|hiv seronegativity
789312|NCT00001055|Avipoxvirus|avipoxvirus
789313|NCT00001055|HIV Preventive Vaccine|hiv preventive vaccine
789314|NCT00001054|Herpes Zoster|herpes zoster
789315|NCT00001054|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
789316|NCT00001054|Herpes Simplex|herpes simplex
789317|NCT00001054|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789318|NCT00001054|AIDS-Related Complex|aids-related complex
789319|NCT00001054|valacyclovir|valacyclovir
789320|NCT00001054|Chickenpox|chickenpox
789321|NCT00001053|Vaccines, Synthetic|vaccines, synthetic
789322|NCT00001053|Recombinant Proteins|recombinant proteins
789323|NCT00001053|HIV-1|hiv-1
789324|NCT00001053|AIDS Vaccines|aids vaccines
789325|NCT00001053|HIV Core Protein p24|hiv core protein p24
789326|NCT00001053|p24-VLP vaccine|p24-vlp vaccine
789327|NCT00001053|Gene Products, gag|gene products, gag
789328|NCT00001053|HIV Seronegativity|hiv seronegativity
789329|NCT00001053|HIV Preventive Vaccine|hiv preventive vaccine
789330|NCT00001052|Vaccines, Synthetic|vaccines, synthetic
789331|NCT00001052|Drug Therapy, Combination|drug therapy, combination
789332|NCT00001052|Adjuvants, Immunologic|adjuvants, immunologic
789333|NCT00001052|HIV Envelope Protein gp120|hiv envelope protein gp120
789334|NCT00001052|AIDS Vaccines|aids vaccines
789335|NCT00001052|HIV Seronegativity|hiv seronegativity
789336|NCT00001052|HIV Preventive Vaccine|hiv preventive vaccine
789337|NCT00001049|Didanosine|didanosine
789338|NCT00001049|Drug Therapy, Combination|drug therapy, combination
789339|NCT00001049|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789340|NCT00001049|AIDS-Related Complex|aids-related complex
789341|NCT00001049|Zidovudine|zidovudine
789342|NCT00001048|Leukoencephalopathy, Progressive Multifocal|leukoencephalopathy, progressive multifocal
789343|NCT00001048|Infusions, Intravenous|infusions, intravenous
789344|NCT00001048|Cytarabine|cytarabine
789345|NCT00001048|Zalcitabine|zalcitabine
789346|NCT00001048|Didanosine|didanosine
789347|NCT00001048|Drug Therapy, Combination|drug therapy, combination
789348|NCT00001048|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
789349|NCT00001048|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789350|NCT00001048|Zidovudine|zidovudine
789351|NCT00001048|Injections, Spinal|injections, spinal
789352|NCT00001047|Rifabutin|rifabutin
789353|NCT00001047|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
789354|NCT00001047|Drug Therapy, Combination|drug therapy, combination
789355|NCT00001047|Ethambutol|ethambutol
789356|NCT00001047|Clofazimine|clofazimine
789357|NCT00001047|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789358|NCT00001047|Clarithromycin|clarithromycin
789359|NCT00001046|Vaccines, Synthetic|vaccines, synthetic
789360|NCT00001046|Pregnancy|pregnancy
789361|NCT00001046|Pregnancy Complications, Infectious|pregnancy complications, infectious
789362|NCT00001046|AIDS-Related Complex|aids-related complex
789363|NCT00001046|HIV Envelope Protein gp120|hiv envelope protein gp120
789364|NCT00001046|HIV Preventive Vaccine|hiv preventive vaccine
789365|NCT00001046|HIV Therapeutic Vaccine|hiv therapeutic vaccine
789366|NCT00001045|Didanosine|didanosine
789367|NCT00001045|Drug Therapy, Combination|drug therapy, combination
789368|NCT00001045|Zidovudine|zidovudine
789369|NCT00001045|Nevirapine|nevirapine
789370|NCT00001044|Vaccines, Synthetic|vaccines, synthetic
789371|NCT00001044|Drug Therapy, Combination|drug therapy, combination
789372|NCT00001044|Adjuvants, Immunologic|adjuvants, immunologic
789373|NCT00001044|HIV Envelope Protein gp120|hiv envelope protein gp120
789374|NCT00001044|AIDS Vaccines|aids vaccines
789375|NCT00001044|HIV Seronegativity|hiv seronegativity
789376|NCT00001044|HIV Preventive Vaccine|hiv preventive vaccine
789377|NCT00001043|Vaccines, Synthetic|vaccines, synthetic
789378|NCT00001043|Vaccinia Virus|vaccinia virus
789379|NCT00001043|Viral Vaccines|viral vaccines
789380|NCT00001043|Smallpox Vaccine|smallpox vaccine
789381|NCT00001043|HIV-1|hiv-1
789382|NCT00001043|HIV Envelope Protein gp160|hiv envelope protein gp160
789383|NCT00001043|AIDS Vaccines|aids vaccines
789384|NCT00001043|HIV Seronegativity|hiv seronegativity
789385|NCT00001043|HIV Preventive Vaccine|hiv preventive vaccine
789386|NCT00001042|Vaccines, Synthetic|vaccines, synthetic
789387|NCT00001042|Drug Therapy, Combination|drug therapy, combination
789388|NCT00001042|Adjuvants, Immunologic|adjuvants, immunologic
789389|NCT00001042|HIV Envelope Protein gp120|hiv envelope protein gp120
789390|NCT00001042|Acetylmuramyl-Alanyl-Isoglutamine|acetylmuramyl-alanyl-isoglutamine
789391|NCT00001042|monophosphoryl lipid A|monophosphoryl lipid a
789392|NCT00001042|AIDS Vaccines|aids vaccines
789393|NCT00001042|HIV Seronegativity|hiv seronegativity
789394|NCT00001042|HIV Preventive Vaccine|hiv preventive vaccine
789395|NCT00001041|Vaccines, Synthetic|vaccines, synthetic
789396|NCT00001041|Pregnancy|pregnancy
789397|NCT00001041|Pregnancy Complications, Infectious|pregnancy complications, infectious
789398|NCT00001041|HIV Envelope Protein gp120|hiv envelope protein gp120
789399|NCT00001041|AIDS Vaccines|aids vaccines
789400|NCT00001041|HIV Therapeutic Vaccine|hiv therapeutic vaccine
789401|NCT00001040|Zalcitabine|zalcitabine
789402|NCT00001040|Drug Therapy, Combination|drug therapy, combination
789403|NCT00001040|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789404|NCT00001040|AIDS-Related Complex|aids-related complex
789405|NCT00001040|Zidovudine|zidovudine
789406|NCT00001040|Saquinavir|saquinavir
789407|NCT00001040|HIV Protease Inhibitors|hiv protease inhibitors
789408|NCT00001039|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
789409|NCT00001039|Drug Therapy, Combination|drug therapy, combination
789410|NCT00001039|Ethambutol|ethambutol
789411|NCT00001039|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789412|NCT00001039|Clarithromycin|clarithromycin
789413|NCT00001038|Cytomegalovirus Infections|cytomegalovirus infections
789414|NCT00001038|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789415|NCT00001038|Antiviral Agents|antiviral agents
789416|NCT00001037|Vaccines, Synthetic|vaccines, synthetic
789417|NCT00001037|HIV-1|hiv-1
789418|NCT00001037|HIV Envelope Protein gp160|hiv envelope protein gp160
789419|NCT00001037|AIDS Vaccines|aids vaccines
789420|NCT00001037|HIV Seronegativity|hiv seronegativity
789421|NCT00001037|HIV Preventive Vaccine|hiv preventive vaccine
789422|NCT00001036|T-Lymphocytes|t-lymphocytes
789423|NCT00001036|Polyethylene Glycols|polyethylene glycols
789424|NCT00001036|Interleukin-2|interleukin-2
789425|NCT00001036|Drug Therapy, Combination|drug therapy, combination
789426|NCT00001036|Adjuvants, Immunologic|adjuvants, immunologic
789427|NCT00001036|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789428|NCT00001036|Zidovudine|zidovudine
789429|NCT00001036|thymosin alpha(1)|thymosin alpha(1)
789430|NCT00001035|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
789431|NCT00001035|Interferon Alfa-2b|interferon alfa-2b
789432|NCT00001035|Zalcitabine|zalcitabine
789433|NCT00001035|Didanosine|didanosine
789434|NCT00001035|Drug Therapy, Combination|drug therapy, combination
789435|NCT00001035|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789436|NCT00001035|Zidovudine|zidovudine
789437|NCT00001035|Hepatitis C|hepatitis c
789438|NCT00001034|Retinitis|retinitis
789439|NCT00001034|Ganciclovir|ganciclovir
789440|NCT00001034|Cytomegalovirus Infections|cytomegalovirus infections
789441|NCT00001034|Administration, Oral|administration, oral
789442|NCT00001034|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789443|NCT00001034|Gastrointestinal System|gastrointestinal system
789444|NCT00001033|Isoniazid|isoniazid
789445|NCT00001033|Tuberculosis, Pulmonary|tuberculosis, pulmonary
789446|NCT00001033|Pyrazinamide|pyrazinamide
789447|NCT00001033|Pyridoxine|pyridoxine
789448|NCT00001033|Ofloxacin|ofloxacin
789449|NCT00001033|Rifampin|rifampin
789450|NCT00001033|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
789451|NCT00001033|Ethambutol|ethambutol
789452|NCT00001033|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789453|NCT00001032|Zalcitabine|zalcitabine
789454|NCT00001032|Drug Therapy, Combination|drug therapy, combination
789455|NCT00001032|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789456|NCT00001032|AIDS-Related Complex|aids-related complex
789457|NCT00001032|Zidovudine|zidovudine
789458|NCT00001031|Vaccines, Synthetic|vaccines, synthetic
789459|NCT00001031|HIV-1|hiv-1
789460|NCT00001031|HIV Envelope Protein gp120|hiv envelope protein gp120
789461|NCT00001031|AIDS Vaccines|aids vaccines
789462|NCT00001031|HIV Seronegativity|hiv seronegativity
789463|NCT00001031|HIV Preventive Vaccine|hiv preventive vaccine
789464|NCT00001030|Rifabutin|rifabutin
789465|NCT00001030|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
789466|NCT00001030|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789467|NCT00001030|Clarithromycin|clarithromycin
789468|NCT00001029|Zalcitabine|zalcitabine
789469|NCT00001029|Didanosine|didanosine
789470|NCT00001029|Drug Therapy, Combination|drug therapy, combination
789471|NCT00001029|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789472|NCT00001029|Zidovudine|zidovudine
789473|NCT00001028|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
789474|NCT00001028|Pentamidine|pentamidine
789475|NCT00001028|Dapsone|dapsone
789476|NCT00001028|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789477|NCT00001028|AIDS-Related Complex|aids-related complex
789478|NCT00001027|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
789479|NCT00001027|Pentamidine|pentamidine
789480|NCT00001027|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789481|NCT00001027|AIDS-Related Complex|aids-related complex
789482|NCT00001026|Vaccines, Synthetic|vaccines, synthetic
789483|NCT00001026|Vaccinia Virus|vaccinia virus
789484|NCT00001026|Viral Vaccines|viral vaccines
789485|NCT00001026|HIV Envelope Protein gp160|hiv envelope protein gp160
789486|NCT00001026|HIV Envelope Protein gp120|hiv envelope protein gp120
789487|NCT00001026|AIDS Vaccines|aids vaccines
789488|NCT00001026|HIV Seronegativity|hiv seronegativity
789489|NCT00001026|HIV Preventive Vaccine|hiv preventive vaccine
789490|NCT00001025|Virus Replication|virus replication
789491|NCT00001025|Didanosine|didanosine
789492|NCT00001025|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789493|NCT00001025|AIDS-Related Complex|aids-related complex
789494|NCT00001025|Zidovudine|zidovudine
789495|NCT00001024|Didanosine|didanosine
789496|NCT00001024|AIDS-Related Complex|aids-related complex
789497|NCT00001024|Zidovudine|zidovudine
789498|NCT00001024|Lymph Nodes|lymph nodes
789499|NCT00001024|Lymphoid Tissue|lymphoid tissue
789500|NCT00001023|Rifabutin|rifabutin
789501|NCT00001023|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
789502|NCT00001023|Drug Interactions|drug interactions
789503|NCT00001023|Azithromycin|azithromycin
789504|NCT00001023|Clarithromycin|clarithromycin
789505|NCT00001022|Zalcitabine|zalcitabine
789506|NCT00001022|Didanosine|didanosine
789507|NCT00001022|Drug Therapy, Combination|drug therapy, combination
789508|NCT00001022|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789509|NCT00001022|AIDS-Related Complex|aids-related complex
789510|NCT00001022|Zidovudine|zidovudine
789511|NCT00001021|Vaccines, Synthetic|vaccines, synthetic
789512|NCT00001021|HIV-1|hiv-1
789513|NCT00001021|HIV Envelope Protein gp120|hiv envelope protein gp120
789514|NCT00001021|AIDS Vaccines|aids vaccines
789515|NCT00001021|HIV Seronegativity|hiv seronegativity
789516|NCT00001021|HIV Preventive Vaccine|hiv preventive vaccine
789517|NCT00001020|Vaccines, Synthetic|vaccines, synthetic
789518|NCT00001020|Viral Vaccines|viral vaccines
789519|NCT00001020|HIV-1|hiv-1
789520|NCT00001020|HIV Envelope Protein gp120|hiv envelope protein gp120
789521|NCT00001020|AIDS Vaccines|aids vaccines
789522|NCT00001020|HIV Seronegativity|hiv seronegativity
789523|NCT00001020|HIV Preventive Vaccine|hiv preventive vaccine
789524|NCT00001019|Vaccines, Synthetic|vaccines, synthetic
789525|NCT00001019|Adjuvants, Immunologic|adjuvants, immunologic
789526|NCT00001019|HIV Envelope Protein gp120|hiv envelope protein gp120
789527|NCT00001019|AIDS Vaccines|aids vaccines
789528|NCT00001019|HIV Seronegativity|hiv seronegativity
789529|NCT00001019|HIV Preventive Vaccine|hiv preventive vaccine
789530|NCT00001018|Cryptosporidiosis|cryptosporidiosis
789531|NCT00001018|Diarrhea|diarrhea
789532|NCT00001018|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789533|NCT00001018|Antiprotozoal Agents|antiprotozoal agents
789534|NCT00001018|Triazines|triazines
789535|NCT00001017|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
789536|NCT00001017|Meningitis|meningitis
789537|NCT00001017|Injections, Intravenous|injections, intravenous
789538|NCT00001017|Cryptococcosis|cryptococcosis
789539|NCT00001017|Fluconazole|fluconazole
789540|NCT00001017|Administration, Oral|administration, oral
789541|NCT00001017|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789542|NCT00001017|Amphotericin B|amphotericin b
789543|NCT00001016|Trimetrexate|trimetrexate
789544|NCT00001016|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
789545|NCT00001016|Quinazolines|quinazolines
789546|NCT00001016|Infusions, Intravenous|infusions, intravenous
789547|NCT00001016|Injections, Intravenous|injections, intravenous
789548|NCT00001016|Leucovorin|leucovorin
789549|NCT00001016|Drug Evaluation|drug evaluation
789550|NCT00001016|Drug Therapy, Combination|drug therapy, combination
789551|NCT00001016|Administration, Oral|administration, oral
789552|NCT00001016|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789553|NCT00001016|Antiprotozoal Agents|antiprotozoal agents
789554|NCT00001016|AIDS-Related Complex|aids-related complex
789555|NCT00001015|Ribavirin|ribavirin
789556|NCT00001015|T-Lymphocytes|t-lymphocytes
789557|NCT00001015|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789558|NCT00001015|AIDS-Related Complex|aids-related complex
789559|NCT00001014|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
789560|NCT00001014|Trimetrexate|trimetrexate
789561|NCT00001014|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
789562|NCT00001014|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
789563|NCT00001014|Infusions, Intravenous|infusions, intravenous
789564|NCT00001014|Leucovorin|leucovorin
789565|NCT00001014|Drug Therapy, Combination|drug therapy, combination
789566|NCT00001014|Administration, Oral|administration, oral
789801|NCT00000977|Vaccines, Synthetic|vaccines, synthetic
794337|NCT00006168|Hepatology|hepatology
789567|NCT00001014|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789568|NCT00001014|Antiprotozoal Agents|antiprotozoal agents
789569|NCT00001014|AIDS-Related Complex|aids-related complex
789570|NCT00001014|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
789571|NCT00001013|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
789572|NCT00001013|Trimetrexate|trimetrexate
789573|NCT00001013|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
789574|NCT00001013|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
789575|NCT00001013|Pentamidine|pentamidine
789576|NCT00001013|Infusions, Intravenous|infusions, intravenous
789577|NCT00001013|Leucovorin|leucovorin
789578|NCT00001013|Drug Therapy, Combination|drug therapy, combination
789579|NCT00001013|Folic Acid Antagonists|folic acid antagonists
789580|NCT00001013|Aerosols|aerosols
789581|NCT00001013|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789582|NCT00001013|Antiprotozoal Agents|antiprotozoal agents
789583|NCT00001013|AIDS-Related Complex|aids-related complex
789584|NCT00001013|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
789585|NCT00001012|Virus Replication|virus replication
789586|NCT00001012|T-Lymphocytes|t-lymphocytes
789587|NCT00001012|Dose-Response Relationship, Drug|dose-response relationship, drug
789588|NCT00001012|Drug Evaluation|drug evaluation
789589|NCT00001012|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789590|NCT00001012|AL 721|al 721
789591|NCT00001012|AIDS-Related Complex|aids-related complex
789592|NCT00001012|Antiviral Agents|antiviral agents
789593|NCT00001011|Virus Replication|virus replication
789594|NCT00001011|AIDS-Related Complex|aids-related complex
789595|NCT00001011|Zidovudine|zidovudine
789596|NCT00001010|Immune Tolerance|immune tolerance
789597|NCT00001010|Dose-Response Relationship, Drug|dose-response relationship, drug
789598|NCT00001010|Drug Evaluation|drug evaluation
789599|NCT00001010|Drug Therapy, Combination|drug therapy, combination
789600|NCT00001010|Acyclovir|acyclovir
789601|NCT00001010|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789602|NCT00001010|AIDS-Related Complex|aids-related complex
789603|NCT00001010|Zidovudine|zidovudine
789604|NCT00001009|T-Lymphocytes|t-lymphocytes
789605|NCT00001009|HIV Antigens|hiv antigens
789606|NCT00001009|Dextran Sulfate|dextran sulfate
789607|NCT00001009|Dose-Response Relationship, Drug|dose-response relationship, drug
789608|NCT00001009|Drug Evaluation|drug evaluation
789609|NCT00001009|Drug Therapy, Combination|drug therapy, combination
789610|NCT00001009|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789611|NCT00001009|AIDS-Related Complex|aids-related complex
789612|NCT00001008|Substance Withdrawal Syndrome|substance withdrawal syndrome
789613|NCT00001008|Methadone|methadone
789614|NCT00001008|Opioid-Related Disorders|opioid-related disorders
789615|NCT00001008|Drug Evaluation|drug evaluation
789616|NCT00001008|Drug Interactions|drug interactions
789617|NCT00001008|Drug Therapy, Combination|drug therapy, combination
789618|NCT00001008|Administration, Oral|administration, oral
789619|NCT00001008|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789620|NCT00001008|AIDS-Related Complex|aids-related complex
789621|NCT00001008|Zidovudine|zidovudine
789622|NCT00001007|Pregnancy|pregnancy
789623|NCT00001007|Pregnancy Complications, Infectious|pregnancy complications, infectious
789624|NCT00001007|Infant, Newborn, Diseases|infant, newborn, diseases
789625|NCT00001007|Infusions, Intravenous|infusions, intravenous
789626|NCT00001007|Drug Evaluation|drug evaluation
789627|NCT00001007|Administration, Oral|administration, oral
789628|NCT00001007|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789629|NCT00001007|Zidovudine|zidovudine
789630|NCT00001006|Infusions, Intravenous|infusions, intravenous
789631|NCT00001006|Immunologic Surveillance|immunologic surveillance
789632|NCT00001006|Drug Evaluation|drug evaluation
789633|NCT00001006|Adjuvants, Immunologic|adjuvants, immunologic
789634|NCT00001006|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789635|NCT00001006|AIDS-Related Complex|aids-related complex
789636|NCT00001006|ammonium trichloro(dioxoethylene-O,O'-)tellurute|ammonium trichloro(dioxoethylene-o,o'-)tellurute
789637|NCT00001005|Recombinant Proteins|recombinant proteins
789638|NCT00001005|HIV Seropositivity|hiv seropositivity
789639|NCT00001005|Interleukin-2|interleukin-2
789640|NCT00001005|Drug Evaluation|drug evaluation
789641|NCT00001005|Drug Therapy, Combination|drug therapy, combination
789642|NCT00001005|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789643|NCT00001005|AIDS-Related Complex|aids-related complex
789644|NCT00001005|Zidovudine|zidovudine
789645|NCT00001004|Tumor Necrosis Factor|tumor necrosis factor
789646|NCT00001004|Interferon-gamma, Recombinant|interferon-gamma, recombinant
789647|NCT00001004|HIV Antigens|hiv antigens
789648|NCT00001004|Immunologic Surveillance|immunologic surveillance
789649|NCT00001004|Drug Therapy, Combination|drug therapy, combination
789650|NCT00001004|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789651|NCT00001004|AIDS-Related Complex|aids-related complex
789652|NCT00001003|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
789653|NCT00001003|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
789655|NCT00001003|Nebulizers and Vaporizers|nebulizers and vaporizers
789656|NCT00001003|Lung|lung
789657|NCT00001003|Administration, Inhalation|administration, inhalation
789658|NCT00001003|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789659|NCT00001003|Zidovudine|zidovudine
789660|NCT00001002|Drug Therapy, Combination|drug therapy, combination
789661|NCT00001002|Foscarnet|foscarnet
789662|NCT00001002|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789663|NCT00001002|AIDS-Related Complex|aids-related complex
789664|NCT00001002|Antiviral Agents|antiviral agents
789665|NCT00001002|Zidovudine|zidovudine
789666|NCT00001001|Liver|liver
789667|NCT00001001|Liver Diseases|liver diseases
789668|NCT00001001|Liver Function Tests|liver function tests
789669|NCT00001001|HIV Seropositivity|hiv seropositivity
789670|NCT00001001|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789671|NCT00001001|Zidovudine|zidovudine
789672|NCT00001001|Biological Availability|biological availability
789673|NCT00001000|Macrophage Activation|macrophage activation
789674|NCT00001000|Lymphocyte Transformation|lymphocyte transformation
789675|NCT00001000|Immunologic Surveillance|immunologic surveillance
789676|NCT00001000|ampligen|ampligen
789677|NCT00001000|Antiviral Agents|antiviral agents
789678|NCT00000999|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789679|NCT00000999|AIDS-Related Complex|aids-related complex
789680|NCT00000999|Zidovudine|zidovudine
789681|NCT00000998|Trimetrexate|trimetrexate
789682|NCT00000998|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
789683|NCT00000998|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
789684|NCT00000998|Injections, Intravenous|injections, intravenous
789685|NCT00000998|Leucovorin|leucovorin
789686|NCT00000998|Dose-Response Relationship, Drug|dose-response relationship, drug
789687|NCT00000998|Drug Therapy, Combination|drug therapy, combination
789688|NCT00000998|Folic Acid Antagonists|folic acid antagonists
789689|NCT00000998|Administration, Oral|administration, oral
789690|NCT00000998|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789691|NCT00000998|Antineoplastic Agents|antineoplastic agents
789692|NCT00000997|Zalcitabine|zalcitabine
789693|NCT00000997|Drug Evaluation|drug evaluation
789694|NCT00000997|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789695|NCT00000997|AIDS-Related Complex|aids-related complex
789696|NCT00000997|Biological Availability|biological availability
789697|NCT00000996|Doxorubicin|doxorubicin
789698|NCT00000996|Drug Evaluation|drug evaluation
789699|NCT00000996|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789700|NCT00000995|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
789701|NCT00000995|Ganciclovir|ganciclovir
789702|NCT00000995|Drug Evaluation|drug evaluation
789703|NCT00000995|Drug Therapy, Combination|drug therapy, combination
789704|NCT00000995|Cytomegalovirus Infections|cytomegalovirus infections
789705|NCT00000995|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789706|NCT00000995|Zidovudine|zidovudine
789707|NCT00000994|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
789708|NCT00000994|Sarcoma, Kaposi|sarcoma, kaposi
789709|NCT00000994|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789710|NCT00000994|Zidovudine|zidovudine
789711|NCT00000993|HIV-1|hiv-1
789712|NCT00000993|Drug Evaluation|drug evaluation
789713|NCT00000993|Accidents|accidents
789714|NCT00000993|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789715|NCT00000993|AIDS Serodiagnosis|aids serodiagnosis
789716|NCT00000993|Zidovudine|zidovudine
789717|NCT00000992|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
789718|NCT00000992|Ketoconazole|ketoconazole
789719|NCT00000992|Histoplasmosis|histoplasmosis
789720|NCT00000992|Drug Evaluation|drug evaluation
789721|NCT00000992|Antifungal Agents|antifungal agents
789722|NCT00000992|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789723|NCT00000991|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
789724|NCT00000991|Toxoplasmosis|toxoplasmosis
789725|NCT00000991|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
789726|NCT00000991|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
789727|NCT00000991|Pentamidine|pentamidine
789728|NCT00000991|Dapsone|dapsone
789729|NCT00000991|Drug Evaluation|drug evaluation
789730|NCT00000991|Drug Therapy, Combination|drug therapy, combination
789731|NCT00000991|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789732|NCT00000991|Zidovudine|zidovudine
789733|NCT00000991|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
789734|NCT00000990|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
789735|NCT00000990|Pulmonary Fibrosis|pulmonary fibrosis
789736|NCT00000990|Zidovudine|zidovudine
789737|NCT00000989|Retinitis|retinitis
789738|NCT00000989|Ganciclovir|ganciclovir
789739|NCT00000989|Drug Evaluation|drug evaluation
789740|NCT00000989|Drug Therapy, Combination|drug therapy, combination
789741|NCT00000989|Cytomegalovirus Infections|cytomegalovirus infections
789742|NCT00000989|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789743|NCT00000989|Zidovudine|zidovudine
789744|NCT00000988|Injections, Intravenous|injections, intravenous
789745|NCT00000988|Drug Evaluation|drug evaluation
789746|NCT00000988|Administration, Oral|administration, oral
789747|NCT00000988|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789748|NCT00000988|AIDS-Related Complex|aids-related complex
789749|NCT00000988|Antiviral Agents|antiviral agents
789750|NCT00000987|Vincristine|vincristine
789751|NCT00000987|Doxorubicin|doxorubicin
789752|NCT00000987|Drug Therapy, Combination|drug therapy, combination
789753|NCT00000987|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789754|NCT00000987|Zidovudine|zidovudine
789755|NCT00000987|Bleomycin|bleomycin
789756|NCT00000986|Recombinant Proteins|recombinant proteins
789757|NCT00000986|Interleukin-2|interleukin-2
789758|NCT00000986|Drug Interactions|drug interactions
789759|NCT00000986|Drug Therapy, Combination|drug therapy, combination
789760|NCT00000986|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789761|NCT00000986|AIDS-Related Complex|aids-related complex
789762|NCT00000986|Zidovudine|zidovudine
789763|NCT00000985|Vidarabine|vidarabine
789764|NCT00000985|Phosphonoacetic Acid|phosphonoacetic acid
789765|NCT00000985|Herpes Simplex|herpes simplex
789766|NCT00000985|Foscarnet|foscarnet
789767|NCT00000985|Acyclovir|acyclovir
789768|NCT00000985|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789769|NCT00000984|Recombinant Proteins|recombinant proteins
789770|NCT00000984|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789771|NCT00000984|Antigens, CD4|antigens, cd4
789772|NCT00000984|Antiviral Agents|antiviral agents
789773|NCT00000983|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789774|NCT00000983|Zidovudine|zidovudine
789775|NCT00000982|Central Nervous System Diseases|central nervous system diseases
789776|NCT00000982|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789777|NCT00000982|Zidovudine|zidovudine
789778|NCT00000981|Retinitis|retinitis
789779|NCT00000981|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
789780|NCT00000981|Pyrimidine Nucleosides|pyrimidine nucleosides
789781|NCT00000981|Drug Evaluation|drug evaluation
789782|NCT00000981|fiacitabine|fiacitabine
789783|NCT00000981|Cytomegalovirus Infections|cytomegalovirus infections
789784|NCT00000981|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789785|NCT00000981|Antiviral Agents|antiviral agents
789786|NCT00000980|Single-Blind Method|single-blind method
789787|NCT00000980|Spiramycin|spiramycin
789788|NCT00000980|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
789789|NCT00000980|Injections, Intravenous|injections, intravenous
789790|NCT00000980|Cryptosporidiosis|cryptosporidiosis
789791|NCT00000980|Diarrhea|diarrhea
789792|NCT00000980|Drug Evaluation|drug evaluation
789793|NCT00000980|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789794|NCT00000979|Didanosine|didanosine
789795|NCT00000979|Zidovudine|zidovudine
789796|NCT00000978|Zalcitabine|zalcitabine
789797|NCT00000978|Drug Therapy, Combination|drug therapy, combination
789798|NCT00000978|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789799|NCT00000978|AIDS-Related Complex|aids-related complex
789800|NCT00000978|Zidovudine|zidovudine
789802|NCT00000977|HIV Seropositivity|hiv seropositivity
789803|NCT00000977|HIV-1|hiv-1
789804|NCT00000977|Drug Evaluation|drug evaluation
789805|NCT00000977|AIDS Vaccines|aids vaccines
789806|NCT00000977|HIV Therapeutic Vaccine|hiv therapeutic vaccine
789807|NCT00000976|Recombinant Proteins|recombinant proteins
789808|NCT00000976|Injections, Intravenous|injections, intravenous
789809|NCT00000976|IgG|igg
789810|NCT00000976|Drug Evaluation|drug evaluation
789811|NCT00000976|Administration, Oral|administration, oral
789812|NCT00000976|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789813|NCT00000976|Antigens, CD4|antigens, cd4
789814|NCT00000976|Zidovudine|zidovudine
789815|NCT00000976|Carrier Proteins|carrier proteins
789816|NCT00000975|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
789817|NCT00000975|Histoplasmosis|histoplasmosis
789818|NCT00000975|Drug Evaluation|drug evaluation
789819|NCT00000975|Antifungal Agents|antifungal agents
789820|NCT00000975|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789821|NCT00000974|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
789822|NCT00000974|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
789823|NCT00000974|Pentamidine|pentamidine
789824|NCT00000974|Injections, Intravenous|injections, intravenous
789825|NCT00000974|Drug Evaluation|drug evaluation
789826|NCT00000974|Aerosols|aerosols
789827|NCT00000974|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789828|NCT00000973|Toxoplasmosis|toxoplasmosis
789829|NCT00000973|Toxoplasma|toxoplasma
789830|NCT00000973|Pyrimethamine|pyrimethamine
789831|NCT00000973|Leucovorin|leucovorin
789832|NCT00000973|Drug Evaluation|drug evaluation
789833|NCT00000973|Encephalitis|encephalitis
789834|NCT00000973|Zidovudine|zidovudine
789835|NCT00000972|Vaccines, Synthetic|vaccines, synthetic
789836|NCT00000972|Drug Evaluation|drug evaluation
789837|NCT00000972|Adjuvants, Immunologic|adjuvants, immunologic
789838|NCT00000972|AIDS Vaccines|aids vaccines
789839|NCT00000972|HIV Preventive Vaccine|hiv preventive vaccine
789840|NCT00000971|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
789841|NCT00000971|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
789842|NCT00000971|Didanosine|didanosine
789843|NCT00000971|Drug Evaluation|drug evaluation
789844|NCT00000971|Drug Interactions|drug interactions
789845|NCT00000971|Drug Therapy, Combination|drug therapy, combination
789846|NCT00000971|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789847|NCT00000971|Zidovudine|zidovudine
789848|NCT00000970|Retinitis|retinitis
789849|NCT00000970|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
789850|NCT00000970|Ganciclovir|ganciclovir
789851|NCT00000970|Drug Evaluation|drug evaluation
789852|NCT00000970|Drug Therapy, Combination|drug therapy, combination
789853|NCT00000970|Foscarnet|foscarnet
789854|NCT00000970|Cytomegalovirus Infections|cytomegalovirus infections
789855|NCT00000970|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789856|NCT00000969|Zalcitabine|zalcitabine
789857|NCT00000969|Didanosine|didanosine
789858|NCT00000969|Drug Evaluation|drug evaluation
789859|NCT00000969|Zidovudine|zidovudine
789860|NCT00000968|Vaccines, Synthetic|vaccines, synthetic
789861|NCT00000968|Drug Evaluation|drug evaluation
789862|NCT00000968|HIV Envelope Protein gp160|hiv envelope protein gp160
789863|NCT00000968|AIDS Vaccines|aids vaccines
789864|NCT00000968|HIV Seronegativity|hiv seronegativity
789865|NCT00000968|HIV Preventive Vaccine|hiv preventive vaccine
789866|NCT00000967|Drug Therapy, Combination|drug therapy, combination
789867|NCT00000967|AIDS-Related Complex|aids-related complex
789868|NCT00000967|Zidovudine|zidovudine
789869|NCT00000967|Interferon Type I|interferon type i
789870|NCT00000966|Toxoplasmosis|toxoplasmosis
789871|NCT00000966|Toxoplasma|toxoplasma
789872|NCT00000966|Pyrimethamine|pyrimethamine
789873|NCT00000966|Leucovorin|leucovorin
789874|NCT00000966|Drug Evaluation|drug evaluation
789875|NCT00000966|Drug Therapy, Combination|drug therapy, combination
789876|NCT00000966|Encephalitis|encephalitis
789877|NCT00000966|Administration, Oral|administration, oral
789878|NCT00000966|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789879|NCT00000966|Azithromycin|azithromycin
789880|NCT00000965|Leukocytes, Mononuclear|leukocytes, mononuclear
789881|NCT00000965|Drug Evaluation|drug evaluation
789882|NCT00000965|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789883|NCT00000965|AIDS-Related Complex|aids-related complex
789884|NCT00000965|Zidovudine|zidovudine
789885|NCT00000965|Phosphorylation|phosphorylation
789886|NCT00000964|Ranitidine|ranitidine
789887|NCT00000964|Phosphorus Acids|phosphorus acids
789888|NCT00000964|Drug Evaluation|drug evaluation
789889|NCT00000964|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789890|NCT00000963|Didanosine|didanosine
789891|NCT00000963|Drug Evaluation|drug evaluation
789892|NCT00000963|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789893|NCT00000963|AIDS-Related Complex|aids-related complex
789894|NCT00000963|Zidovudine|zidovudine
789895|NCT00000962|Drug Evaluation|drug evaluation
789896|NCT00000962|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789897|NCT00000962|AIDS-Related Complex|aids-related complex
789898|NCT00000962|Nevirapine|nevirapine
789899|NCT00000961|Drug Therapy, Combination|drug therapy, combination
789900|NCT00000961|Zidovudine|zidovudine
789901|NCT00000960|Pregnancy|pregnancy
789902|NCT00000960|Pregnancy Complications, Infectious|pregnancy complications, infectious
789903|NCT00000960|Prenatal Exposure Delayed Effects|prenatal exposure delayed effects
789904|NCT00000960|Administration, Oral|administration, oral
789905|NCT00000960|AIDS-Related Complex|aids-related complex
789906|NCT00000960|Zidovudine|zidovudine
789907|NCT00000959|Tuberculosis|tuberculosis
789908|NCT00000959|Isoniazid|isoniazid
789909|NCT00000959|Pyridoxine|pyridoxine
789910|NCT00000959|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
789911|NCT00000959|Drug Evaluation|drug evaluation
789912|NCT00000959|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789913|NCT00000959|Antitubercular Agents|antitubercular agents
789914|NCT00000958|Vaccines, Synthetic|vaccines, synthetic
789915|NCT00000958|Recombinant Proteins|recombinant proteins
789916|NCT00000958|Adjuvants, Immunologic|adjuvants, immunologic
789917|NCT00000958|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789918|NCT00000958|HIV Envelope Protein gp120|hiv envelope protein gp120
789919|NCT00000958|AIDS Vaccines|aids vaccines
789920|NCT00000958|HIV Therapeutic Vaccine|hiv therapeutic vaccine
789921|NCT00000957|Vaccines, Synthetic|vaccines, synthetic
789922|NCT00000957|Vaccinia Virus|vaccinia virus
789923|NCT00000957|Viral Vaccines|viral vaccines
789924|NCT00000957|HIV-1|hiv-1
789925|NCT00000957|Drug Evaluation|drug evaluation
789926|NCT00000957|HIV Envelope Protein gp160|hiv envelope protein gp160
789927|NCT00000957|Drug Administration Schedule|drug administration schedule
789928|NCT00000957|AIDS Vaccines|aids vaccines
789929|NCT00000957|HIV Seronegativity|hiv seronegativity
789930|NCT00000957|HIV Preventive Vaccine|hiv preventive vaccine
789931|NCT00000956|Vaccines, Synthetic|vaccines, synthetic
789932|NCT00000956|Vaccinia Virus|vaccinia virus
789933|NCT00000956|HIV-1|hiv-1
789934|NCT00000956|HIV Envelope Protein gp160|hiv envelope protein gp160
789935|NCT00000956|AIDS Vaccines|aids vaccines
789936|NCT00000956|HIV Seronegativity|hiv seronegativity
789937|NCT00000956|HIV Preventive Vaccine|hiv preventive vaccine
789938|NCT00000955|Tuberculosis|tuberculosis
789939|NCT00000955|Immunologic Tests|immunologic tests
789940|NCT00000955|Tuberculin|tuberculin
789941|NCT00000955|Tuberculin Test|tuberculin test
789942|NCT00000955|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
789943|NCT00000955|Injections, Intradermal|injections, intradermal
789944|NCT00000955|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789945|NCT00000955|AIDS-Related Complex|aids-related complex
789946|NCT00000955|Hypersensitivity, Delayed|hypersensitivity, delayed
789947|NCT00000954|Vincristine|vincristine
789948|NCT00000954|Sarcoma, Kaposi|sarcoma, kaposi
789949|NCT00000954|Zalcitabine|zalcitabine
789950|NCT00000954|Didanosine|didanosine
789951|NCT00000954|Doxorubicin|doxorubicin
789952|NCT00000954|Drug Evaluation|drug evaluation
789953|NCT00000954|Drug Interactions|drug interactions
789954|NCT00000954|Drug Therapy, Combination|drug therapy, combination
789955|NCT00000954|Combined Modality Therapy|combined modality therapy
789956|NCT00000954|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789957|NCT00000954|Antineoplastic Agents|antineoplastic agents
789958|NCT00000954|Antineoplastic Agents, Combined|antineoplastic agents, combined
789959|NCT00000954|Antiviral Agents|antiviral agents
789960|NCT00000954|Bleomycin|bleomycin
789961|NCT00000953|Herpes Zoster|herpes zoster
789962|NCT00000953|Acyclovir|acyclovir
789963|NCT00000953|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789964|NCT00000953|AIDS-Related Complex|aids-related complex
789965|NCT00000953|Antiviral Agents|antiviral agents
789966|NCT00000953|sorivudine|sorivudine
789967|NCT00000952|Dose-Response Relationship, Drug|dose-response relationship, drug
789968|NCT00000952|Drug Therapy, Combination|drug therapy, combination
789969|NCT00000952|Zidovudine|zidovudine
789970|NCT00000952|HIV Protease Inhibitors|hiv protease inhibitors
789971|NCT00000952|Ritonavir|ritonavir
789972|NCT00000952|Lamivudine|lamivudine
789973|NCT00000952|Anti-HIV Agents|anti-hiv agents
789974|NCT00000951|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
789975|NCT00000951|Fluconazole|fluconazole
789976|NCT00000951|Antifungal Agents|antifungal agents
789977|NCT00000951|Candidiasis, Oral|candidiasis, oral
789978|NCT00000951|Drug Administration Schedule|drug administration schedule
789979|NCT00000951|Pharyngeal Diseases|pharyngeal diseases
789980|NCT00000950|Tuberculosis|tuberculosis
789981|NCT00000950|Isoniazid|isoniazid
789982|NCT00000950|Pyrazinamide|pyrazinamide
789983|NCT00000950|Pyridoxine|pyridoxine
789984|NCT00000950|Rifampin|rifampin
789985|NCT00000950|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
789986|NCT00000950|Drug Therapy, Combination|drug therapy, combination
789987|NCT00000950|Ethambutol|ethambutol
789988|NCT00000950|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
789989|NCT00000950|Antitubercular Agents|antitubercular agents
789990|NCT00000949|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
789991|NCT00000949|Interleukin-2|interleukin-2
789992|NCT00000949|Dose-Response Relationship, Drug|dose-response relationship, drug
789993|NCT00000949|Adolescent Behavior|adolescent behavior
789994|NCT00000949|CD4 Lymphocyte Count|cd4 lymphocyte count
789995|NCT00000949|RNA, Viral|rna, viral
789996|NCT00000949|Quality of Life|quality of life
789997|NCT00000949|Anti-HIV Agents|anti-hiv agents
789998|NCT00000949|Viral Load|viral load
789999|NCT00000948|Injections, Subcutaneous|injections, subcutaneous
790000|NCT00000948|Interleukin-2|interleukin-2
790001|NCT00000948|Dose-Response Relationship, Drug|dose-response relationship, drug
790002|NCT00000948|Drug Therapy, Combination|drug therapy, combination
790003|NCT00000948|CD4 Lymphocyte Count|cd4 lymphocyte count
790004|NCT00000948|Anti-HIV Agents|anti-hiv agents
790005|NCT00000947|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
790006|NCT00000947|Placebos|placebos
790007|NCT00000947|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
790008|NCT00000947|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
790009|NCT00000947|Antitubercular Agents|antitubercular agents
790010|NCT00000947|Azithromycin|azithromycin
790011|NCT00000947|Drug Resistance, Microbial|drug resistance, microbial
790012|NCT00000947|CD4 Lymphocyte Count|cd4 lymphocyte count
790013|NCT00000947|Antibiotics|antibiotics
790014|NCT00000947|Time Factors|time factors
790015|NCT00000947|Anti-HIV Agents|anti-hiv agents
790016|NCT00000947|Pneumonia, Bacterial|pneumonia, bacterial
790017|NCT00000947|Streptococcus pneumoniae|streptococcus pneumoniae
790018|NCT00000946|Drug Evaluation|drug evaluation
790019|NCT00000946|Drug Therapy, Combination|drug therapy, combination
790020|NCT00000946|AIDS Vaccines|aids vaccines
790021|NCT00000946|HIV Seronegativity|hiv seronegativity
790022|NCT00000946|HIV Preventive Vaccine|hiv preventive vaccine
790023|NCT00000945|Leukoencephalopathy, Progressive Multifocal|leukoencephalopathy, progressive multifocal
790024|NCT00000945|Probenecid|probenecid
790025|NCT00000945|HIV-1|hiv-1
790026|NCT00000945|Central Nervous System Diseases|central nervous system diseases
790027|NCT00000945|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
790028|NCT00000945|DNA, Viral|dna, viral
790029|NCT00000945|cidofovir|cidofovir
790030|NCT00000945|Anti-HIV Agents|anti-hiv agents
790031|NCT00000945|Neurologic Examination|neurologic examination
790032|NCT00000945|Renal Agents|renal agents
790033|NCT00000944|Pregnancy|pregnancy
790034|NCT00000944|Pregnancy Complications, Infectious|pregnancy complications, infectious
790035|NCT00000944|Drug Therapy, Combination|drug therapy, combination
790036|NCT00000944|Zidovudine|zidovudine
790037|NCT00000944|HIV Protease Inhibitors|hiv protease inhibitors
790038|NCT00000944|Lamivudine|lamivudine
790039|NCT00000944|Indinavir|indinavir
790040|NCT00000944|Disease Transmission, Vertical|disease transmission, vertical
790041|NCT00000944|Anti-HIV Agents|anti-hiv agents
790042|NCT00000943|Lymphocytes|lymphocytes
790043|NCT00000943|Interleukin-2|interleukin-2
790044|NCT00000943|Drug Therapy, Combination|drug therapy, combination
790045|NCT00000943|AIDS Vaccines|aids vaccines
790046|NCT00000943|CD4 Lymphocyte Count|cd4 lymphocyte count
790047|NCT00000943|Cell Division|cell division
790048|NCT00000943|HIV Core Protein p24|hiv core protein p24
790049|NCT00000943|Anti-HIV Agents|anti-hiv agents
790050|NCT00000943|HIV Therapeutic Vaccine|hiv therapeutic vaccine
790051|NCT00000942|Placebos|placebos
790052|NCT00000942|Pregnancy|pregnancy
790053|NCT00000942|Pregnancy Complications, Infectious|pregnancy complications, infectious
790054|NCT00000942|Nevirapine|nevirapine
790055|NCT00000942|Disease Transmission, Vertical|disease transmission, vertical
790056|NCT00000942|Labor|labor
790057|NCT00000942|Anti-HIV Agents|anti-hiv agents
790058|NCT00000941|Drug Interactions|drug interactions
790059|NCT00000941|HIV Protease Inhibitors|hiv protease inhibitors
790060|NCT00000941|Ritonavir|ritonavir
790061|NCT00000941|HIV Seronegativity|hiv seronegativity
790062|NCT00000941|Saquinavir|saquinavir
790063|NCT00000941|Nelfinavir|nelfinavir
790064|NCT00000941|Anticholesteremic Agents|anticholesteremic agents
790065|NCT00000940|Drug Therapy, Combination|drug therapy, combination
790066|NCT00000940|Stavudine|stavudine
790067|NCT00000940|Amprenavir/Ritonavir|amprenavir/ritonavir
790068|NCT00000940|Protease Inhibitors|protease inhibitors
790069|NCT00000940|Lamivudine|lamivudine
790070|NCT00000940|VX 478|vx 478
790071|NCT00000940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
790072|NCT00000940|Anti-HIV Agents|anti-hiv agents
790073|NCT00000940|Viral Load|viral load
790074|NCT00000940|Abacavir Sulfate|abacavir sulfate
790075|NCT00000940|Acute Infection|acute infection
790076|NCT00000940|Treatment Interruption|treatment interruption
790077|NCT00000939|Didanosine|didanosine
790078|NCT00000939|Drug Therapy, Combination|drug therapy, combination
790079|NCT00000939|Stavudine|stavudine
790080|NCT00000939|HIV Protease Inhibitors|hiv protease inhibitors
790081|NCT00000939|Hydroxyurea|hydroxyurea
790082|NCT00000939|RNA, Viral|rna, viral
790083|NCT00000939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
790084|NCT00000939|Anti-HIV Agents|anti-hiv agents
790085|NCT00000939|Viral Load|viral load
790086|NCT00000939|efavirenz|efavirenz
790087|NCT00000933|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
790088|NCT00000933|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
790089|NCT00000933|Antibiotics, Macrolide|antibiotics, macrolide
790090|NCT00000933|Azithromycin|azithromycin
790091|NCT00000933|Drug Administration Schedule|drug administration schedule
790092|NCT00000933|Drug Resistance, Microbial|drug resistance, microbial
790093|NCT00000933|Carrier State|carrier state
790094|NCT00000933|Streptococcus pneumoniae|streptococcus pneumoniae
790095|NCT00000932|Prospective Studies|prospective studies
790096|NCT00000932|HIV-1|hiv-1
790097|NCT00000932|Drug Therapy, Combination|drug therapy, combination
790098|NCT00000932|Drug Resistance, Microbial|drug resistance, microbial
790099|NCT00000932|CD4 Lymphocyte Count|cd4 lymphocyte count
790100|NCT00000932|Disease Progression|disease progression
790101|NCT00000932|Treatment Outcome|treatment outcome
790102|NCT00000932|Genotype|genotype
790103|NCT00000932|Anti-HIV Agents|anti-hiv agents
790104|NCT00000932|Viral Load|viral load
790105|NCT00000931|Homosexuality, Male|homosexuality, male
790106|NCT00000931|Risk-Taking|risk-taking
790107|NCT00000931|Behavior Therapy|behavior therapy
790108|NCT00000931|HIV Seronegativity|hiv seronegativity
790109|NCT00000930|Sexual Partners|sexual partners
790110|NCT00000930|Drug Resistance, Microbial|drug resistance, microbial
790111|NCT00000930|Cohort Studies|cohort studies
790112|NCT00000930|Risk Factors|risk factors
790113|NCT00000930|Substance Abuse, Intravenous|substance abuse, intravenous
790114|NCT00000930|Disease Progression|disease progression
790115|NCT00000930|Homosexuality, Male|homosexuality, male
790116|NCT00000930|Genotype|genotype
790117|NCT00000930|Phenotype|phenotype
790118|NCT00000929|Sexual Partners|sexual partners
790119|NCT00000929|Homosexuality, Male|homosexuality, male
790120|NCT00000929|Anti-Infective Agents|anti-infective agents
790121|NCT00000929|Patient Compliance|patient compliance
790122|NCT00000929|Nonoxynol|nonoxynol
790124|NCT00000928|Sexual Partners|sexual partners
790125|NCT00000928|Condoms|condoms
790126|NCT00000928|Counseling|counseling
790127|NCT00000927|Administration, Topical|administration, topical
790128|NCT00000927|Mucous Membrane|mucous membrane
790129|NCT00000927|Anti-Infective Agents|anti-infective agents
790130|NCT00000927|Cervix Uteri|cervix uteri
790131|NCT00000927|Vagina|vagina
790132|NCT00000927|Vulva|vulva
790133|NCT00000927|Buffers|buffers
790134|NCT00000926|Nonoxynol|nonoxynol
790135|NCT00000925|Dietary Proteins|dietary proteins
790136|NCT00000925|HIV Wasting Syndrome|hiv wasting syndrome
790137|NCT00000924|Drug Therapy, Combination|drug therapy, combination
790138|NCT00000924|HIV Protease Inhibitors|hiv protease inhibitors
790139|NCT00000924|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
790140|NCT00000924|Anti-HIV Agents|anti-hiv agents
790141|NCT00000923|Interleukin-2|interleukin-2
790142|NCT00000923|Drug Therapy, Combination|drug therapy, combination
790143|NCT00000923|CD4 Lymphocyte Count|cd4 lymphocyte count
790144|NCT00000923|Anti-HIV Agents|anti-hiv agents
790145|NCT00000923|Viral Load|viral load
790146|NCT00000922|Drug Therapy, Combination|drug therapy, combination
790147|NCT00000922|HIV Protease Inhibitors|hiv protease inhibitors
790148|NCT00000922|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
790149|NCT00000922|Anti-HIV Agents|anti-hiv agents
790150|NCT00000922|Treatment Naive|treatment naive
790151|NCT00000921|Drug Therapy, Combination|drug therapy, combination
790152|NCT00000921|Prednisone|prednisone
790153|NCT00000921|Anti-HIV Agents|anti-hiv agents
790154|NCT00000920|Pregnancy|pregnancy
790155|NCT00000920|Drug Therapy, Combination|drug therapy, combination
790156|NCT00000920|Zidovudine|zidovudine
790157|NCT00000920|Pregnancy Complications|pregnancy complications
790158|NCT00000920|Ritonavir|ritonavir
790159|NCT00000920|Lamivudine|lamivudine
790160|NCT00000920|Saquinavir|saquinavir
790161|NCT00000920|Anti-HIV Agents|anti-hiv agents
790162|NCT00000919|HIV Protease Inhibitors|hiv protease inhibitors
790163|NCT00000919|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
790164|NCT00000919|Anti-HIV Agents|anti-hiv agents
790165|NCT00000919|Viral Load|viral load
790166|NCT00000918|Drug Therapy, Combination|drug therapy, combination
790167|NCT00000918|HIV Protease Inhibitors|hiv protease inhibitors
790168|NCT00000918|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
790169|NCT00000918|Salvage Therapy|salvage therapy
790170|NCT00000918|Anti-HIV Agents|anti-hiv agents
790171|NCT00000918|Viral Load|viral load
790172|NCT00000917|Gene Therapy|gene therapy
790173|NCT00000917|Specimen Handling|specimen handling
790174|NCT00000917|Blood Banks|blood banks
790175|NCT00000917|Fetal Blood|fetal blood
790176|NCT00000916|Drug Therapy, Combination|drug therapy, combination
790177|NCT00000916|HIV Protease Inhibitors|hiv protease inhibitors
790178|NCT00000916|Hydroxyurea|hydroxyurea
790179|NCT00000916|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
790180|NCT00000916|Anti-HIV Agents|anti-hiv agents
790181|NCT00000916|Viral Load|viral load
790182|NCT00000915|AIDS Vaccines|aids vaccines
790183|NCT00000915|Incidence|incidence
790184|NCT00000915|Knowledge, Attitudes, Practice|knowledge, attitudes, practice
790185|NCT00000915|Risk-Taking|risk-taking
790186|NCT00000914|Drug Therapy, Combination|drug therapy, combination
790187|NCT00000914|HIV Protease Inhibitors|hiv protease inhibitors
790188|NCT00000914|Ritonavir|ritonavir
790189|NCT00000914|Indinavir|indinavir
790190|NCT00000914|Saquinavir|saquinavir
790191|NCT00000914|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
790192|NCT00000914|Viral Load|viral load
790193|NCT00000914|Nelfinavir|nelfinavir
790194|NCT00000913|Saquinavir|saquinavir
790195|NCT00000913|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
790196|NCT00000913|Anti-HIV Agents|anti-hiv agents
790197|NCT00000913|Viral Load|viral load
790198|NCT00000912|Placebos|placebos
790199|NCT00000912|Drug Therapy, Combination|drug therapy, combination
790200|NCT00000912|HIV Protease Inhibitors|hiv protease inhibitors
790201|NCT00000912|VX 478|vx 478
790202|NCT00000912|Anti-HIV Agents|anti-hiv agents
790203|NCT00000912|Viral Load|viral load
790204|NCT00000912|efavirenz|efavirenz
790205|NCT00000911|Semen|semen
790206|NCT00000911|HIV-1|hiv-1
790207|NCT00000911|Immunity, Cellular|immunity, cellular
790208|NCT00000911|Lymph Nodes|lymph nodes
790209|NCT00000911|Viremia|viremia
790210|NCT00000911|Antibodies, Viral|antibodies, viral
790211|NCT00000911|Vagina|vagina
790212|NCT00000911|Viral Load|viral load
790213|NCT00000911|Acute Infection|acute infection
790214|NCT00000910|Pregnancy|pregnancy
790215|NCT00000910|Anti-HIV Agents|anti-hiv agents
790216|NCT00000909|Interleukin-2|interleukin-2
790217|NCT00000909|Dose-Response Relationship, Drug|dose-response relationship, drug
790218|NCT00000909|CD4 Lymphocyte Count|cd4 lymphocyte count
790219|NCT00000909|RNA, Viral|rna, viral
790220|NCT00000908|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
790221|NCT00000908|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
790222|NCT00000908|Antiviral Agents|antiviral agents
790223|NCT00000908|CD4 Lymphocyte Count|cd4 lymphocyte count
790225|NCT00000907|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
790226|NCT00000907|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
790227|NCT00000907|Immunity, Cellular|immunity, cellular
790228|NCT00000907|Antibiotics, Macrolide|antibiotics, macrolide
790229|NCT00000907|Mycobacterium avium Complex|mycobacterium avium complex
790230|NCT00000907|CD4 Lymphocyte Count|cd4 lymphocyte count
790231|NCT00000907|Disease Progression|disease progression
790232|NCT00000907|Anti-HIV Agents|anti-hiv agents
790233|NCT00000906|Methadone|methadone
790234|NCT00000906|HIV-1|hiv-1
790235|NCT00000906|Dose-Response Relationship, Drug|dose-response relationship, drug
790236|NCT00000906|Drug Interactions|drug interactions
790237|NCT00000906|Drug Therapy, Combination|drug therapy, combination
790238|NCT00000906|Saquinavir|saquinavir
790239|NCT00000906|Adolescent Behavior|adolescent behavior
790240|NCT00000906|HIV Protease Inhibitors|hiv protease inhibitors
790241|NCT00000906|Ritonavir|ritonavir
790242|NCT00000906|Narcotics|narcotics
790243|NCT00000906|Substance-Related Disorders|substance-related disorders
790244|NCT00000905|Immunity, Cellular|immunity, cellular
790245|NCT00000905|Disease Progression|disease progression
790246|NCT00000905|Cytomegalovirus Retinitis|cytomegalovirus retinitis
790247|NCT00000905|DNA, Viral|dna, viral
790248|NCT00000905|Prognosis|prognosis
790249|NCT00000904|Vaccines, Synthetic|vaccines, synthetic
790250|NCT00000904|Viral Vaccines|viral vaccines
790251|NCT00000904|HIV Antibodies|hiv antibodies
790252|NCT00000904|HIV Envelope Protein gp160|hiv envelope protein gp160
790253|NCT00000904|AIDS Vaccines|aids vaccines
790254|NCT00000904|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
790255|NCT00000904|HIV Seronegativity|hiv seronegativity
790256|NCT00000904|Antibody Formation|antibody formation
790257|NCT00000904|Risk-Taking|risk-taking
790258|NCT00000904|Avipoxvirus|avipoxvirus
790259|NCT00000904|Genetic Vectors|genetic vectors
790260|NCT00000904|Immunization|immunization
790261|NCT00000904|HIV Preventive Vaccine|hiv preventive vaccine
790262|NCT00000903|Drug Therapy, Combination|drug therapy, combination
790263|NCT00000903|Zidovudine|zidovudine
790264|NCT00000903|HIV Protease Inhibitors|hiv protease inhibitors
790265|NCT00000903|Lamivudine|lamivudine
790266|NCT00000903|Indinavir|indinavir
790267|NCT00000903|RNA, Viral|rna, viral
790268|NCT00000903|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
790269|NCT00000903|Nelfinavir|nelfinavir
790270|NCT00000903|efavirenz|efavirenz
790271|NCT00000902|Zalcitabine|zalcitabine
790272|NCT00000902|Didanosine|didanosine
790273|NCT00000902|Drug Therapy, Combination|drug therapy, combination
790274|NCT00000902|Zidovudine|zidovudine
790275|NCT00000902|Nevirapine|nevirapine
790276|NCT00000902|Stavudine|stavudine
790277|NCT00000902|Ritonavir|ritonavir
790278|NCT00000902|Lamivudine|lamivudine
790279|NCT00000902|RNA, Viral|rna, viral
790280|NCT00000902|Anti-HIV Agents|anti-hiv agents
790281|NCT00000902|Nelfinavir|nelfinavir
790282|NCT00000901|Dose-Response Relationship, Drug|dose-response relationship, drug
790283|NCT00000901|Drug Therapy, Combination|drug therapy, combination
790284|NCT00000901|Stavudine|stavudine
790285|NCT00000901|HIV Protease Inhibitors|hiv protease inhibitors
790286|NCT00000901|Lamivudine|lamivudine
790287|NCT00000901|Indinavir|indinavir
790288|NCT00000901|RNA, Viral|rna, viral
790289|NCT00000901|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
790290|NCT00000901|Viral Load|viral load
790291|NCT00000900|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
790292|NCT00000900|HIV-1|hiv-1
790293|NCT00000900|Antiviral Agents|antiviral agents
790294|NCT00000900|CD4 Lymphocyte Count|cd4 lymphocyte count
790295|NCT00000900|Polymerase Chain Reaction|polymerase chain reaction
790296|NCT00000900|RNA, Viral|rna, viral
790297|NCT00000900|Fever|fever
790298|NCT00000900|Viral Load|viral load
790299|NCT00000899|Cyclophosphamide|cyclophosphamide
790300|NCT00000899|Dose-Response Relationship, Drug|dose-response relationship, drug
790301|NCT00000899|Drug Therapy, Combination|drug therapy, combination
790302|NCT00000899|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
790303|NCT00000899|Combined Modality Therapy|combined modality therapy
790304|NCT00000899|Antineoplastic Agents|antineoplastic agents
790305|NCT00000899|Lymph Nodes|lymph nodes
790306|NCT00000899|Stavudine|stavudine
790307|NCT00000899|HIV Protease Inhibitors|hiv protease inhibitors
790308|NCT00000899|Lamivudine|lamivudine
790309|NCT00000899|DNA, Viral|dna, viral
790310|NCT00000899|RNA, Viral|rna, viral
790311|NCT00000899|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
790312|NCT00000899|Anti-HIV Agents|anti-hiv agents
790313|NCT00000899|Nelfinavir|nelfinavir
790314|NCT00000899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
790315|NCT00000898|Drug Interactions|drug interactions
790316|NCT00000898|Drug Therapy, Combination|drug therapy, combination
790317|NCT00000898|Saquinavir|saquinavir
790318|NCT00000898|HIV Protease Inhibitors|hiv protease inhibitors
790319|NCT00000898|Ritonavir|ritonavir
790320|NCT00000898|Nelfinavir|nelfinavir
790321|NCT00000897|Drug Interactions|drug interactions
790322|NCT00000897|Zidovudine|zidovudine
790324|NCT00000897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
790325|NCT00000897|Contraceptives, Oral|contraceptives, oral
790326|NCT00000897|Progestational Hormones, Synthetic|progestational hormones, synthetic
790327|NCT00000897|Anti-HIV Agents|anti-hiv agents
790328|NCT00000897|Viral Load|viral load
790329|NCT00000897|Estrogens|estrogens
790330|NCT00000896|HIV-1|hiv-1
790331|NCT00000896|Drug Therapy, Combination|drug therapy, combination
790332|NCT00000896|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
790333|NCT00000896|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
790334|NCT00000896|Zidovudine|zidovudine
790335|NCT00000896|Nevirapine|nevirapine
790336|NCT00000896|Stavudine|stavudine
790337|NCT00000896|HIV Protease Inhibitors|hiv protease inhibitors
790338|NCT00000896|Lamivudine|lamivudine
790339|NCT00000896|Indinavir|indinavir
790340|NCT00000896|Interleukin-12|interleukin-12
790341|NCT00000896|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
790342|NCT00000895|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
790343|NCT00000895|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
790344|NCT00000895|HIV-1|hiv-1
790345|NCT00000895|Drug Therapy, Combination|drug therapy, combination
790346|NCT00000895|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
790347|NCT00000895|Mycobacterium avium Complex|mycobacterium avium complex
790348|NCT00000895|Bacteremia|bacteremia
790349|NCT00000895|Nevirapine|nevirapine
790350|NCT00000895|HIV Protease Inhibitors|hiv protease inhibitors
790351|NCT00000895|Risk Factors|risk factors
790352|NCT00000895|RNA, Viral|rna, viral
790353|NCT00000895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
790354|NCT00000895|Nelfinavir|nelfinavir
790355|NCT00000894|Infusions, Intravenous|infusions, intravenous
790356|NCT00000894|Ganciclovir|ganciclovir
790357|NCT00000894|Drug Therapy, Combination|drug therapy, combination
790358|NCT00000894|Administration, Oral|administration, oral
790359|NCT00000894|Antiviral Agents|antiviral agents
790360|NCT00000894|Drug Implants|drug implants
790361|NCT00000894|Cytomegalovirus Retinitis|cytomegalovirus retinitis
790362|NCT00000894|Eye|eye
790363|NCT00000894|cidofovir|cidofovir
790364|NCT00000893|Dose-Response Relationship, Drug|dose-response relationship, drug
790365|NCT00000893|Drug Therapy, Combination|drug therapy, combination
790366|NCT00000893|HIV Protease Inhibitors|hiv protease inhibitors
790367|NCT00000893|Nelfinavir|nelfinavir
790368|NCT00000893|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
790369|NCT00000893|Area Under Curve|area under curve
790370|NCT00000893|efavirenz|efavirenz
790371|NCT00000892|HIV-1|hiv-1
790372|NCT00000892|Drug Therapy, Combination|drug therapy, combination
790373|NCT00000892|HIV Protease Inhibitors|hiv protease inhibitors
790374|NCT00000892|Ritonavir|ritonavir
790375|NCT00000892|Indinavir|indinavir
790376|NCT00000892|RNA, Viral|rna, viral
790377|NCT00000892|Saquinavir|saquinavir
790378|NCT00000892|Delavirdine|delavirdine
790379|NCT00000892|Nelfinavir|nelfinavir
790380|NCT00000892|Adenine|adenine
790381|NCT00000892|Anti-HIV Agents|anti-hiv agents
790382|NCT00000892|Viral Load|viral load
790383|NCT00000891|Drug Therapy, Combination|drug therapy, combination
790384|NCT00000891|Hypersensitivity, Delayed|hypersensitivity, delayed
790385|NCT00000891|Follow-Up Studies|follow-up studies
790386|NCT00000891|Anti-HIV Agents|anti-hiv agents
790387|NCT00000891|Viral Load|viral load
790388|NCT00000890|HIV-1|hiv-1
790389|NCT00000890|Muscles|muscles
790390|NCT00000890|RNA, Viral|rna, viral
790391|NCT00000890|Body Composition|body composition
790392|NCT00000890|Anti-HIV Agents|anti-hiv agents
790393|NCT00000890|Viral Load|viral load
790394|NCT00000889|Interleukin-2|interleukin-2
790395|NCT00000889|CD4 Lymphocyte Count|cd4 lymphocyte count
790396|NCT00000889|Anti-HIV Agents|anti-hiv agents
790397|NCT00000888|Pregnancy|pregnancy
790398|NCT00000888|Pregnancy Complications, Infectious|pregnancy complications, infectious
790399|NCT00000888|Drug Therapy, Combination|drug therapy, combination
790400|NCT00000888|Administration, Oral|administration, oral
790401|NCT00000888|Zidovudine|zidovudine
790402|NCT00000888|HIV Protease Inhibitors|hiv protease inhibitors
790403|NCT00000888|Ritonavir|ritonavir
790404|NCT00000888|Disease Transmission, Vertical|disease transmission, vertical
790405|NCT00000888|Anti-HIV Agents|anti-hiv agents
790406|NCT00000888|Fetal Blood|fetal blood
790407|NCT00000887|Pregnancy|pregnancy
790408|NCT00000887|Pregnancy Complications, Infectious|pregnancy complications, infectious
790409|NCT00000887|Drug Therapy, Combination|drug therapy, combination
790410|NCT00000887|Zidovudine|zidovudine
790411|NCT00000887|HIV Protease Inhibitors|hiv protease inhibitors
790412|NCT00000887|Lamivudine|lamivudine
790413|NCT00000887|Disease Transmission, Vertical|disease transmission, vertical
790414|NCT00000887|Nelfinavir|nelfinavir
790415|NCT00000887|Anti-HIV Agents|anti-hiv agents
790416|NCT00000886|HIV Antibodies|hiv antibodies
790417|NCT00000886|HIV Envelope Protein gp120|hiv envelope protein gp120
790418|NCT00000886|Drug Carriers|drug carriers
790419|NCT00000886|Hypersensitivity, Delayed|hypersensitivity, delayed
790420|NCT00000886|AIDS Vaccines|aids vaccines
790421|NCT00000886|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
790422|NCT00000886|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
790423|NCT00000886|HIV Seronegativity|hiv seronegativity
790424|NCT00000886|Neutralization Tests|neutralization tests
790425|NCT00000886|Mineral Oil|mineral oil
790426|NCT00000886|Oleic Acids|oleic acids
790428|NCT00000886|HLA-B7 Antigen|hla-b7 antigen
790429|NCT00000886|HLA-A2 Antigen|hla-a2 antigen
790430|NCT00000886|HIV Preventive Vaccine|hiv preventive vaccine
790431|NCT00000885|HIV-1|hiv-1
790432|NCT00000885|Drug Therapy, Combination|drug therapy, combination
790433|NCT00000885|Zidovudine|zidovudine
790434|NCT00000885|HIV Protease Inhibitors|hiv protease inhibitors
790435|NCT00000885|Lamivudine|lamivudine
790436|NCT00000885|Indinavir|indinavir
790437|NCT00000885|RNA, Viral|rna, viral
790438|NCT00000885|Treatment Failure|treatment failure
790439|NCT00000885|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
790440|NCT00000885|Anti-HIV Agents|anti-hiv agents
790441|NCT00000885|Viral Load|viral load
790442|NCT00000884|Vaccines, Synthetic|vaccines, synthetic
790443|NCT00000884|Injections, Intramuscular|injections, intramuscular
790444|NCT00000884|HIV-1|hiv-1
790445|NCT00000884|Immunity, Cellular|immunity, cellular
790446|NCT00000884|AIDS Vaccines|aids vaccines
790447|NCT00000884|HIV Seronegativity|hiv seronegativity
790448|NCT00000884|Mucous Membrane|mucous membrane
790449|NCT00000884|Antibodies, Viral|antibodies, viral
790450|NCT00000884|Avipoxvirus|avipoxvirus
790451|NCT00000884|Genetic Vectors|genetic vectors
790452|NCT00000884|HIV Envelope Protein gp120|hiv envelope protein gp120
790453|NCT00000884|Immunity, Mucosal|immunity, mucosal
790454|NCT00000884|Rabies Vaccines|rabies vaccines
790455|NCT00000884|HIV Preventive Vaccine|hiv preventive vaccine
790456|NCT00000883|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
790457|NCT00000883|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
790458|NCT00000883|Antibiotics, Macrolide|antibiotics, macrolide
790459|NCT00000883|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
790460|NCT00000883|Azithromycin|azithromycin
790461|NCT00000883|CD4 Lymphocyte Count|cd4 lymphocyte count
790462|NCT00000883|Anti-HIV Agents|anti-hiv agents
790463|NCT00000882|HIV-1|hiv-1
790464|NCT00000882|Drug Therapy, Combination|drug therapy, combination
790465|NCT00000882|Stavudine|stavudine
790466|NCT00000882|HIV Protease Inhibitors|hiv protease inhibitors
790467|NCT00000882|Lamivudine|lamivudine
790468|NCT00000882|Indinavir|indinavir
790469|NCT00000882|RNA, Viral|rna, viral
790470|NCT00000882|Delavirdine|delavirdine
790471|NCT00000882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
790472|NCT00000882|Anti-HIV Agents|anti-hiv agents
790473|NCT00000882|Viral Load|viral load
790474|NCT00000881|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
790475|NCT00000881|Cytomegalovirus Infections|cytomegalovirus infections
790476|NCT00000881|Antiviral Agents|antiviral agents
790477|NCT00000881|cidofovir|cidofovir
790478|NCT00000880|T-Lymphocytes|t-lymphocytes
790479|NCT00000880|Lymphocyte Transformation|lymphocyte transformation
790480|NCT00000880|HIV-1|hiv-1
790481|NCT00000880|Drug Therapy, Combination|drug therapy, combination
790482|NCT00000880|Immunosuppressive Agents|immunosuppressive agents
790483|NCT00000880|Apoptosis|apoptosis
790484|NCT00000880|Cyclosporine|cyclosporine
790485|NCT00000880|Anti-HIV Agents|anti-hiv agents
790486|NCT00000879|Pregnancy|pregnancy
790487|NCT00000879|Pregnancy Complications, Infectious|pregnancy complications, infectious
790488|NCT00000879|AIDS Vaccines|aids vaccines
790489|NCT00000879|Disease Transmission, Vertical|disease transmission, vertical
790490|NCT00000879|Avipoxvirus|avipoxvirus
790491|NCT00000879|HIV Preventive Vaccine|hiv preventive vaccine
790492|NCT00000879|HIV Therapeutic Vaccine|hiv therapeutic vaccine
790493|NCT00000878|Pregnancy|pregnancy
790494|NCT00000878|Pregnancy Complications, Infectious|pregnancy complications, infectious
790495|NCT00000878|Drug Therapy, Combination|drug therapy, combination
790496|NCT00000878|Stavudine|stavudine
790497|NCT00000878|Lamivudine|lamivudine
790498|NCT00000878|Disease Transmission, Vertical|disease transmission, vertical
790499|NCT00000878|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
790500|NCT00000878|Anti-HIV Agents|anti-hiv agents
790501|NCT00000878|Viral Load|viral load
790502|NCT00000877|Rifabutin|rifabutin
790503|NCT00000877|Drug Therapy, Combination|drug therapy, combination
790504|NCT00000877|HIV Protease Inhibitors|hiv protease inhibitors
790505|NCT00000877|Indinavir|indinavir
790506|NCT00000877|HIV Seronegativity|hiv seronegativity
790507|NCT00000877|Anti-HIV Agents|anti-hiv agents
790508|NCT00000876|Antiviral Agents|antiviral agents
790509|NCT00000876|CD4-IgG(2)|cd4-igg(2)
790510|NCT00000876|PRO 542|pro 542
790511|NCT00000875|Drug Therapy, Combination|drug therapy, combination
790512|NCT00000875|Immunotherapy, Adoptive|immunotherapy, adoptive
790513|NCT00000875|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
790514|NCT00000875|Anti-HIV Agents|anti-hiv agents
790515|NCT00000875|Viral Load|viral load
790516|NCT00000874|HIV-1|hiv-1
790517|NCT00000874|Drug Therapy, Combination|drug therapy, combination
790518|NCT00000874|Zidovudine|zidovudine
790520|NCT00000874|Drug Resistance, Microbial|drug resistance, microbial
790521|NCT00000874|HIV Protease Inhibitors|hiv protease inhibitors
790522|NCT00000874|CD4 Lymphocyte Count|cd4 lymphocyte count
790523|NCT00000874|Ritonavir|ritonavir
790524|NCT00000874|Lamivudine|lamivudine
790525|NCT00000874|Indinavir|indinavir
790526|NCT00000874|RNA, Viral|rna, viral
790527|NCT00000874|Genotype|genotype
790528|NCT00000874|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
790529|NCT00000874|Anti-HIV Agents|anti-hiv agents
790530|NCT00000874|Viral Load|viral load
790531|NCT00000873|Nutritional Status|nutritional status
790532|NCT00000873|HIV Seronegativity|hiv seronegativity
790533|NCT00000873|Infant Food|infant food
790534|NCT00000872|Virus Replication|virus replication
790535|NCT00000872|HIV-1|hiv-1
790536|NCT00000872|Drug Therapy, Combination|drug therapy, combination
790537|NCT00000872|Zidovudine|zidovudine
790538|NCT00000872|Nevirapine|nevirapine
790539|NCT00000872|Stavudine|stavudine
790540|NCT00000872|HIV Protease Inhibitors|hiv protease inhibitors
790541|NCT00000872|CD4 Lymphocyte Count|cd4 lymphocyte count
790542|NCT00000872|Lamivudine|lamivudine
790543|NCT00000872|RNA, Viral|rna, viral
790544|NCT00000872|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
790545|NCT00000872|Anti-HIV Agents|anti-hiv agents
790546|NCT00000872|Viral Load|viral load
790547|NCT00000872|Nelfinavir|nelfinavir
790548|NCT00000871|Vaccines, Synthetic|vaccines, synthetic
790549|NCT00000871|AIDS Vaccines|aids vaccines
790550|NCT00000871|HIV Seronegativity|hiv seronegativity
790551|NCT00000871|Avipoxvirus|avipoxvirus
790552|NCT00000871|HIV Preventive Vaccine|hiv preventive vaccine
790553|NCT00000870|Recombinant Proteins|recombinant proteins
790554|NCT00000870|Infusions, Intravenous|infusions, intravenous
790555|NCT00000870|Injections, Intravenous|injections, intravenous
790556|NCT00000870|Injections, Subcutaneous|injections, subcutaneous
790557|NCT00000870|Interleukin-2|interleukin-2
790558|NCT00000870|Drug Administration Schedule|drug administration schedule
790559|NCT00000870|CD4 Lymphocyte Count|cd4 lymphocyte count
790560|NCT00000870|Quality of Life|quality of life
790561|NCT00000870|Anti-HIV Agents|anti-hiv agents
790562|NCT00000869|Pregnancy Trimester, Third|pregnancy trimester, third
790563|NCT00000869|Placebos|placebos
790564|NCT00000869|Pregnancy|pregnancy
790565|NCT00000869|Pregnancy Complications, Infectious|pregnancy complications, infectious
790566|NCT00000869|Administration, Oral|administration, oral
790567|NCT00000869|Nevirapine|nevirapine
790568|NCT00000869|Disease Transmission, Vertical|disease transmission, vertical
790569|NCT00000869|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
790570|NCT00000869|Anti-HIV Agents|anti-hiv agents
790571|NCT00000868|Vaccines, Synthetic|vaccines, synthetic
790572|NCT00000868|HIV-1|hiv-1
790573|NCT00000868|Administration, Oral|administration, oral
790574|NCT00000868|AIDS Vaccines|aids vaccines
790575|NCT00000868|HIV Seronegativity|hiv seronegativity
790576|NCT00000868|HIV Envelope Protein gp120|hiv envelope protein gp120
790577|NCT00000868|Recombination, Genetic|recombination, genetic
790578|NCT00000868|Salmonella typhi|salmonella typhi
790579|NCT00000868|HIV Preventive Vaccine|hiv preventive vaccine
790580|NCT00000867|Drug Therapy, Combination|drug therapy, combination
790581|NCT00000867|Administration, Oral|administration, oral
790582|NCT00000867|AIDS Dementia Complex|aids dementia complex
790583|NCT00000867|Zidovudine|zidovudine
790584|NCT00000867|Anti-HIV Agents|anti-hiv agents
790585|NCT00000867|Memantine|memantine
790586|NCT00000866|Vaccines, Synthetic|vaccines, synthetic
790587|NCT00000866|Vaccinia Virus|vaccinia virus
790588|NCT00000866|Placebos|placebos
790589|NCT00000866|HIV-1|hiv-1
790590|NCT00000866|AIDS Vaccines|aids vaccines
790591|NCT00000866|HIV Seronegativity|hiv seronegativity
790592|NCT00000866|Genes, env|genes, env
790593|NCT00000866|Genes, pol|genes, pol
790594|NCT00000866|Genes, gag|genes, gag
790595|NCT00000866|HIV Preventive Vaccine|hiv preventive vaccine
790596|NCT00000865|Drug Therapy, Combination|drug therapy, combination
790597|NCT00000865|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
790598|NCT00000865|Anti-HIV Agents|anti-hiv agents
790599|NCT00000864|Pregnancy|pregnancy
790600|NCT00000864|Pregnancy Complications, Infectious|pregnancy complications, infectious
790601|NCT00000864|HIV-1|hiv-1
790602|NCT00000864|Drug Therapy, Combination|drug therapy, combination
790603|NCT00000864|Zidovudine|zidovudine
790604|NCT00000864|Drug Administration Schedule|drug administration schedule
790605|NCT00000864|Disease Transmission, Vertical|disease transmission, vertical
790606|NCT00000864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
790607|NCT00000864|Anti-HIV Agents|anti-hiv agents
790608|NCT00000863|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
790609|NCT00000863|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
790610|NCT00000863|Administration, Oral|administration, oral
790611|NCT00000863|WR 6026|wr 6026
790612|NCT00000862|Pregnancy|pregnancy
790613|NCT00000862|Pregnancy Complications, Infectious|pregnancy complications, infectious
790614|NCT00000862|Administration, Oral|administration, oral
790615|NCT00000862|Zidovudine|zidovudine
790616|NCT00000862|Delivery|delivery
790618|NCT00000862|Anti-HIV Agents|anti-hiv agents
790619|NCT00000861|Drug Administration Schedule|drug administration schedule
790620|NCT00000861|HIV Protease Inhibitors|hiv protease inhibitors
790621|NCT00000861|CD4 Lymphocyte Count|cd4 lymphocyte count
790622|NCT00000861|Indinavir|indinavir
790623|NCT00000861|RNA, Viral|rna, viral
790624|NCT00000861|Anti-HIV Agents|anti-hiv agents
790625|NCT00000861|Viral Load|viral load
790626|NCT00000860|Tumor Necrosis Factor|tumor necrosis factor
790627|NCT00000860|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
790628|NCT00000860|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
790629|NCT00000860|Drug Therapy, Combination|drug therapy, combination
790630|NCT00000860|Anti-HIV Agents|anti-hiv agents
790631|NCT00000859|HIV-1|hiv-1
790632|NCT00000859|Drug Resistance|drug resistance
790633|NCT00000859|Drug Therapy, Combination|drug therapy, combination
790634|NCT00000859|HIV Protease Inhibitors|hiv protease inhibitors
790635|NCT00000859|CD4 Lymphocyte Count|cd4 lymphocyte count
790636|NCT00000859|Ritonavir|ritonavir
790637|NCT00000859|Indinavir|indinavir
790638|NCT00000859|Disease Progression|disease progression
790639|NCT00000859|RNA, Viral|rna, viral
790640|NCT00000859|Genotype|genotype
790641|NCT00000859|Nelfinavir|nelfinavir
790642|NCT00000859|Anti-HIV Agents|anti-hiv agents
790643|NCT00000859|Viral Load|viral load
790644|NCT00000858|HIV-1|hiv-1
790645|NCT00000858|Vagina|vagina
790646|NCT00000857|Recombinant Proteins|recombinant proteins
790647|NCT00000857|T-Lymphocytes|t-lymphocytes
790648|NCT00000857|Dose-Response Relationship, Drug|dose-response relationship, drug
790649|NCT00000857|Mycobacterium avium Complex|mycobacterium avium complex
790650|NCT00000857|CD4 Lymphocyte Count|cd4 lymphocyte count
790651|NCT00000857|Interleukin-12|interleukin-12
790652|NCT00000857|Killer Cells, Natural|killer cells, natural
790653|NCT00000857|Th1 Cells|th1 cells
790654|NCT00000857|Interferon Type II|interferon type ii
790655|NCT00000856|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
790656|NCT00000856|Ganciclovir|ganciclovir
790657|NCT00000856|Drug Therapy, Combination|drug therapy, combination
790658|NCT00000856|Encephalitis|encephalitis
790659|NCT00000856|Foscarnet|foscarnet
790660|NCT00000856|Cytomegalovirus Infections|cytomegalovirus infections
790661|NCT00000856|Antiviral Agents|antiviral agents
790662|NCT00000856|Radiculopathy|radiculopathy
790663|NCT00000855|Zidovudine|zidovudine
790664|NCT00000855|Anti-HIV Agents|anti-hiv agents
790665|NCT00000854|Placebos|placebos
790666|NCT00000854|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
790667|NCT00000854|AIDS-Related Complex|aids-related complex
790668|NCT00000854|Anabolic Steroids|anabolic steroids
790669|NCT00000854|HIV Wasting Syndrome|hiv wasting syndrome
790670|NCT00000854|nandrolone decanoate|nandrolone decanoate
790671|NCT00000853|Vaccines, Synthetic|vaccines, synthetic
790672|NCT00000853|HIV-1|hiv-1
790673|NCT00000853|HIV Envelope Protein gp120|hiv envelope protein gp120
790674|NCT00000853|AIDS Vaccines|aids vaccines
790675|NCT00000853|HIV Seronegativity|hiv seronegativity
790676|NCT00000853|HIV Preventive Vaccine|hiv preventive vaccine
790677|NCT00000852|T-Lymphocytes|t-lymphocytes
790678|NCT00000852|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
790679|NCT00000852|Transplantation, Homologous|transplantation, homologous
790680|NCT00000852|Immunotherapy, Adoptive|immunotherapy, adoptive
790681|NCT00000851|Didanosine|didanosine
790682|NCT00000851|Drug Therapy, Combination|drug therapy, combination
790683|NCT00000851|Antiviral Agents|antiviral agents
790684|NCT00000851|Stavudine|stavudine
790685|NCT00000850|HIV-1|hiv-1
790686|NCT00000850|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
790687|NCT00000850|RNA, Viral|rna, viral
790688|NCT00000850|Anti-HIV Agents|anti-hiv agents
790689|NCT00000850|Viral Load|viral load
790690|NCT00000850|Receptors, Chemokine|receptors, chemokine
790691|NCT00000849|Interleukin-2|interleukin-2
790692|NCT00000849|Immunity, Cellular|immunity, cellular
790693|NCT00000849|Dose-Response Relationship, Drug|dose-response relationship, drug
790694|NCT00000849|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
790695|NCT00000849|AIDS-Related Complex|aids-related complex
790696|NCT00000849|Viral Load|viral load
790697|NCT00000848|Administration, Oral|administration, oral
790698|NCT00000848|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
790699|NCT00000848|AIDS-Related Complex|aids-related complex
790700|NCT00000848|Antiviral Agents|antiviral agents
790701|NCT00000848|HIV Protease Inhibitors|hiv protease inhibitors
790702|NCT00000848|Biological Markers|biological markers
790703|NCT00000848|Indinavir|indinavir
790704|NCT00000848|Viremia|viremia
790705|NCT00000848|RNA, Viral|rna, viral
790706|NCT00000848|Saquinavir|saquinavir
790707|NCT00000847|Vaccines, Synthetic|vaccines, synthetic
790708|NCT00000847|HIV Envelope Protein gp120|hiv envelope protein gp120
790709|NCT00000847|AIDS Vaccines|aids vaccines
790710|NCT00000847|HIV Seronegativity|hiv seronegativity
790711|NCT00000847|Avipoxvirus|avipoxvirus
790712|NCT00000847|HIV Preventive Vaccine|hiv preventive vaccine
790713|NCT00000846|Vaccines, Synthetic|vaccines, synthetic
790715|NCT00000846|AIDS Vaccines|aids vaccines
790716|NCT00000846|HIV Seronegativity|hiv seronegativity
790717|NCT00000846|HIV Preventive Vaccine|hiv preventive vaccine
790718|NCT00000845|Vaccines, Synthetic|vaccines, synthetic
790719|NCT00000845|AIDS Vaccines|aids vaccines
790720|NCT00000845|HIV Seronegativity|hiv seronegativity
790721|NCT00000845|HIV Preventive Vaccine|hiv preventive vaccine
790722|NCT00000844|Drug Therapy, Combination|drug therapy, combination
790723|NCT00000844|Adjuvants, Immunologic|adjuvants, immunologic
790724|NCT00000844|Administration, Oral|administration, oral
790725|NCT00000844|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
790726|NCT00000844|AIDS-Related Complex|aids-related complex
790727|NCT00000844|Interferon-alpha|interferon-alpha
790728|NCT00000843|Antiviral Agents|antiviral agents
790729|NCT00000843|Adenine|adenine
790730|NCT00000842|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
790731|NCT00000842|AIDS-Related Complex|aids-related complex
790732|NCT00000842|Peripheral Nervous System Diseases|peripheral nervous system diseases
790733|NCT00000842|Nerve Growth Factors|nerve growth factors
790734|NCT00000842|Growth Substances|growth substances
790735|NCT00000841|Drug Therapy, Combination|drug therapy, combination
790736|NCT00000841|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
790737|NCT00000841|Antiviral Agents|antiviral agents
790738|NCT00000841|Zidovudine|zidovudine
790739|NCT00000841|Stavudine|stavudine
790740|NCT00000841|HIV Protease Inhibitors|hiv protease inhibitors
790741|NCT00000841|Lamivudine|lamivudine
790742|NCT00000841|Indinavir|indinavir
790743|NCT00000840|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
790744|NCT00000840|AIDS-Related Complex|aids-related complex
790745|NCT00000840|Antiviral Agents|antiviral agents
790746|NCT00000840|Zidovudine|zidovudine
790747|NCT00000840|Biological Markers|biological markers
790748|NCT00000840|Viremia|viremia
790749|NCT00000840|RNA, Viral|rna, viral
790750|NCT00000839|Pregnancy Trimester, Third|pregnancy trimester, third
790751|NCT00000839|Pregnancy|pregnancy
790752|NCT00000839|Pregnancy Complications, Infectious|pregnancy complications, infectious
790753|NCT00000839|Didanosine|didanosine
790754|NCT00000839|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
790755|NCT00000839|AIDS-Related Complex|aids-related complex
790756|NCT00000838|Didanosine|didanosine
790757|NCT00000838|Drug Therapy, Combination|drug therapy, combination
790758|NCT00000838|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
790759|NCT00000838|AIDS-Related Complex|aids-related complex
790760|NCT00000838|Antiviral Agents|antiviral agents
790761|NCT00000838|Zidovudine|zidovudine
790762|NCT00000838|Stavudine|stavudine
790763|NCT00000838|Lamivudine|lamivudine
790764|NCT00000837|Herpesvirus 3, Human|herpesvirus 3, human
790765|NCT00000837|Viral Vaccines|viral vaccines
790766|NCT00000837|AIDS-Related Complex|aids-related complex
790767|NCT00000837|Vaccines, Attenuated|vaccines, attenuated
790768|NCT00000837|Chickenpox|chickenpox
790769|NCT00000837|Chickenpox Vaccine|chickenpox vaccine
790770|NCT00000836|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
790771|NCT00000836|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
790772|NCT00000836|Antibodies, Monoclonal|antibodies, monoclonal
790773|NCT00000836|Cytomegalovirus Retinitis|cytomegalovirus retinitis
790774|NCT00000834|Methotrexate|methotrexate
790775|NCT00000834|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
790776|NCT00000834|AIDS-Related Complex|aids-related complex
790777|NCT00000834|Zidovudine|zidovudine
790778|NCT00000834|Lamivudine|lamivudine
790779|NCT00000834|Disease Progression|disease progression
790780|NCT00000834|Anti-Inflammatory Agents|anti-inflammatory agents
790781|NCT00000834|Anti-HIV Agents|anti-hiv agents
790782|NCT00000833|Ribavirin|ribavirin
790783|NCT00000833|Didanosine|didanosine
790784|NCT00000833|Drug Therapy, Combination|drug therapy, combination
790785|NCT00000833|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
790786|NCT00000833|AIDS-Related Complex|aids-related complex
790787|NCT00000833|Antiviral Agents|antiviral agents
790788|NCT00000832|Vaccines, Synthetic|vaccines, synthetic
790789|NCT00000832|HIV-1|hiv-1
790790|NCT00000832|Adjuvants, Immunologic|adjuvants, immunologic
790791|NCT00000832|HIV Envelope Protein gp120|hiv envelope protein gp120
790792|NCT00000832|AIDS Vaccines|aids vaccines
790793|NCT00000832|HIV Seronegativity|hiv seronegativity
790794|NCT00000832|HIV Preventive Vaccine|hiv preventive vaccine
790795|NCT00000831|Didanosine|didanosine
790796|NCT00000831|Drug Therapy, Combination|drug therapy, combination
790797|NCT00000831|AIDS-Related Complex|aids-related complex
790798|NCT00000831|Antiviral Agents|antiviral agents
790799|NCT00000831|Zidovudine|zidovudine
790800|NCT00000831|Stavudine|stavudine
790801|NCT00000831|Lamivudine|lamivudine
790802|NCT00000831|Drug Combinations|drug combinations
790803|NCT00000829|Vaccines, Synthetic|vaccines, synthetic
790804|NCT00000829|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
790805|NCT00000829|AIDS-Related Complex|aids-related complex
790806|NCT00000829|Pneumococcal Infections|pneumococcal infections
790807|NCT00000829|Bacterial Vaccines|bacterial vaccines
790808|NCT00000828|Pregnancy|pregnancy
790809|NCT00000828|Pregnancy Complications, Infectious|pregnancy complications, infectious
790810|NCT00000828|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
790811|NCT00000828|AIDS-Related Complex|aids-related complex
790812|NCT00000828|Zidovudine|zidovudine
790813|NCT00000828|Drug Resistance, Microbial|drug resistance, microbial
790814|NCT00000828|Disease Transmission, Vertical|disease transmission, vertical
790815|NCT00000827|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
790816|NCT00000827|AIDS-Related Complex|aids-related complex
790817|NCT00000827|Immunoglobulins, Intravenous|immunoglobulins, intravenous
790818|NCT00000827|Immunization, Passive|immunization, passive
790819|NCT00000826|Rifabutin|rifabutin
790820|NCT00000826|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
790821|NCT00000826|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
790822|NCT00000826|Dapsone|dapsone
790823|NCT00000826|Drug Interactions|drug interactions
790824|NCT00000826|Fluconazole|fluconazole
790825|NCT00000826|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
790826|NCT00000826|AIDS-Related Complex|aids-related complex
790827|NCT00000826|Clarithromycin|clarithromycin
790828|NCT00000826|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
790829|NCT00000825|HIV-1|hiv-1
790830|NCT00000825|Interleukin-2|interleukin-2
790831|NCT00000825|Dose-Response Relationship, Drug|dose-response relationship, drug
790832|NCT00000825|Antiviral Agents|antiviral agents
790833|NCT00000825|CD4 Lymphocyte Count|cd4 lymphocyte count
790834|NCT00000825|DNA, Viral|dna, viral
790835|NCT00000824|Immunotherapy, Adoptive|immunotherapy, adoptive
790836|NCT00000824|T-Lymphocyte Subsets|t-lymphocyte subsets
790837|NCT00000824|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
790838|NCT00000824|Dendritic Cells|dendritic cells
790839|NCT00000823|Didanosine|didanosine
790840|NCT00000823|Drug Therapy, Combination|drug therapy, combination
790841|NCT00000823|Zidovudine|zidovudine
790842|NCT00000823|Drug Administration Schedule|drug administration schedule
790843|NCT00000822|Vaccines, Synthetic|vaccines, synthetic
790844|NCT00000822|Didanosine|didanosine
790845|NCT00000822|Drug Therapy, Combination|drug therapy, combination
790846|NCT00000822|HIV Envelope Protein gp160|hiv envelope protein gp160
790847|NCT00000822|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
790848|NCT00000822|AIDS-Related Complex|aids-related complex
790849|NCT00000822|Stavudine|stavudine
790850|NCT00000822|HIV Protease Inhibitors|hiv protease inhibitors
790851|NCT00000822|AIDS Vaccines|aids vaccines
790852|NCT00000822|Ritonavir|ritonavir
790853|NCT00000822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
790854|NCT00000822|HIV Therapeutic Vaccine|hiv therapeutic vaccine
790855|NCT00000821|Interleukin-2|interleukin-2
790856|NCT00000821|AIDS-Related Complex|aids-related complex
790857|NCT00000820|Interleukin-2|interleukin-2
790858|NCT00000820|Drug Therapy, Combination|drug therapy, combination
790859|NCT00000820|AIDS-Related Complex|aids-related complex
790860|NCT00000820|Antiviral Agents|antiviral agents
790861|NCT00000819|AIDS-Related Complex|aids-related complex
790862|NCT00000819|Prednisone|prednisone
790863|NCT00000819|AIDS-Associated Nephropathy|aids-associated nephropathy
790864|NCT00000818|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
790865|NCT00000818|AIDS-Related Complex|aids-related complex
790866|NCT00000818|Zidovudine|zidovudine
790867|NCT00000818|Lymph Nodes|lymph nodes
790868|NCT00000818|Lymphoid Tissue|lymphoid tissue
790869|NCT00000817|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
790870|NCT00000817|AIDS-Related Complex|aids-related complex
790871|NCT00000817|Peripheral Nervous System Diseases|peripheral nervous system diseases
790872|NCT00000817|Amitriptyline|amitriptyline
790873|NCT00000817|Pain|pain
790874|NCT00000817|Acupuncture Therapy|acupuncture therapy
790875|NCT00000816|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
790876|NCT00000816|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
790877|NCT00000816|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
790878|NCT00000816|AIDS-Related Complex|aids-related complex
790879|NCT00000816|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
790880|NCT00000815|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
790881|NCT00000815|AIDS-Related Complex|aids-related complex
790882|NCT00000815|Measles-Mumps-Rubella Vaccine|measles-mumps-rubella vaccine
790883|NCT00000815|Vaccines, Attenuated|vaccines, attenuated
790884|NCT00000815|Measles Vaccine|measles vaccine
790885|NCT00000815|Immunization Schedule|immunization schedule
790886|NCT00000815|Measles Virus|measles virus
790887|NCT00000815|Measles|measles
790888|NCT00000814|Didanosine|didanosine
790889|NCT00000814|Drug Therapy, Combination|drug therapy, combination
790890|NCT00000814|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
790891|NCT00000814|AIDS-Related Complex|aids-related complex
790892|NCT00000814|Zidovudine|zidovudine
790893|NCT00000814|Nevirapine|nevirapine
790894|NCT00000813|Vaccines, Synthetic|vaccines, synthetic
790895|NCT00000813|HIV Envelope Protein gp160|hiv envelope protein gp160
790896|NCT00000813|HIV Envelope Protein gp120|hiv envelope protein gp120
790897|NCT00000813|AIDS Vaccines|aids vaccines
795091|NCT00004997|DHFR Enzyme|dhfr enzyme
790898|NCT00000813|HIV Seronegativity|hiv seronegativity
790899|NCT00000813|Avipoxvirus|avipoxvirus
790900|NCT00000813|HIV Preventive Vaccine|hiv preventive vaccine
790901|NCT00000812|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
790902|NCT00000812|AIDS-Related Complex|aids-related complex
790903|NCT00000812|Thalidomide|thalidomide
790904|NCT00000811|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
790905|NCT00000811|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
790906|NCT00000811|Drug Therapy, Combination|drug therapy, combination
790907|NCT00000811|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
790908|NCT00000811|Antiprotozoal Agents|antiprotozoal agents
790909|NCT00000811|AIDS-Related Complex|aids-related complex
790910|NCT00000811|Azithromycin|azithromycin
790911|NCT00000811|Bacterial Infections|bacterial infections
790912|NCT00000811|atovaquone|atovaquone
790913|NCT00000810|Didanosine|didanosine
790914|NCT00000810|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
790915|NCT00000810|AIDS-Related Complex|aids-related complex
790916|NCT00000810|Antiviral Agents|antiviral agents
790917|NCT00000810|Zidovudine|zidovudine
790918|NCT00000809|HIV Preventive Vaccine|hiv preventive vaccine
790919|NCT00000809|HIV Therapeutic Vaccine|hiv therapeutic vaccine
790920|NCT00000808|Pregnancy|pregnancy
790921|NCT00000808|Pregnancy Complications, Infectious|pregnancy complications, infectious
790922|NCT00000808|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
790923|NCT00000808|AIDS-Related Complex|aids-related complex
790924|NCT00000808|Nevirapine|nevirapine
790925|NCT00000807|Sarcoma, Kaposi|sarcoma, kaposi
790926|NCT00000807|Etoposide|etoposide
790927|NCT00000807|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
790928|NCT00000806|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
790929|NCT00000806|AIDS-Related Complex|aids-related complex
790930|NCT00000806|HIV Protease Inhibitors|hiv protease inhibitors
790931|NCT00000805|Ganciclovir|ganciclovir
790932|NCT00000805|Cytomegalovirus Infections|cytomegalovirus infections
790933|NCT00000805|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
790934|NCT00000803|Didanosine|didanosine
790935|NCT00000803|Drug Therapy, Combination|drug therapy, combination
790936|NCT00000803|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
790937|NCT00000803|AIDS-Related Complex|aids-related complex
790938|NCT00000803|Antiviral Agents|antiviral agents
790939|NCT00000803|Zidovudine|zidovudine
790940|NCT00000802|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
790942|NCT00000802|Antifungal Agents|antifungal agents
790943|NCT00000802|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
790944|NCT00000802|atovaquone|atovaquone
790945|NCT00000801|Vincristine|vincristine
790946|NCT00000801|Cyclophosphamide|cyclophosphamide
790947|NCT00000801|Cytarabine|cytarabine
790948|NCT00000801|Dexamethasone|dexamethasone
790949|NCT00000801|Doxorubicin|doxorubicin
790950|NCT00000801|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
790951|NCT00000801|Combined Modality Therapy|combined modality therapy
790952|NCT00000801|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
790953|NCT00000801|Antineoplastic Agents, Combined|antineoplastic agents, combined
790954|NCT00000801|Brain Neoplasms|brain neoplasms
790955|NCT00000801|Lymphoma, High-Grade|lymphoma, high-grade
790956|NCT00000801|Lymphoma, Intermediate-Grade|lymphoma, intermediate-grade
790957|NCT00000800|Methadone|methadone
790958|NCT00000800|Drug Interactions|drug interactions
790959|NCT00000800|Drug Therapy, Combination|drug therapy, combination
790960|NCT00000800|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
790961|NCT00000800|AIDS-Related Complex|aids-related complex
790962|NCT00000800|Zidovudine|zidovudine
790963|NCT00000799|Retinitis|retinitis
790964|NCT00000799|Cytomegalovirus Infections|cytomegalovirus infections
790965|NCT00000799|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
790966|NCT00000799|Antiviral Agents|antiviral agents
790967|NCT00000799|cidofovir|cidofovir
790968|NCT00000798|Vaccines, Synthetic|vaccines, synthetic
790969|NCT00000798|HIV-1|hiv-1
790970|NCT00000798|Administration, Oral|administration, oral
790971|NCT00000798|AIDS Vaccines|aids vaccines
790972|NCT00000798|HIV Seronegativity|hiv seronegativity
790973|NCT00000798|HIV Preventive Vaccine|hiv preventive vaccine
790974|NCT00000796|Isoniazid|isoniazid
790975|NCT00000796|Tuberculosis, Pulmonary|tuberculosis, pulmonary
790976|NCT00000796|Pyrazinamide|pyrazinamide
790977|NCT00000796|Pyridoxine|pyridoxine
790978|NCT00000796|Ofloxacin|ofloxacin
790979|NCT00000796|Rifampin|rifampin
790980|NCT00000796|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
790981|NCT00000796|Drug Therapy, Combination|drug therapy, combination
790982|NCT00000796|Ethambutol|ethambutol
790983|NCT00000796|Clofazimine|clofazimine
790984|NCT00000796|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
790985|NCT00000796|Amikacin|amikacin
790986|NCT00000796|Drug Resistance, Microbial|drug resistance, microbial
790987|NCT00000796|Cycloserine|cycloserine
790988|NCT00000796|Capreomycin Sulfate|capreomycin sulfate
790989|NCT00000796|Ethionamide|ethionamide
790990|NCT00000796|Aminosalicylic Acids|aminosalicylic acids
790991|NCT00000796|Streptomycin|streptomycin
790992|NCT00000796|p-Aminosalicylic Acid|p-aminosalicylic acid
790993|NCT00000795|Vaccines, Synthetic|vaccines, synthetic
790994|NCT00000795|HIV-1|hiv-1
790995|NCT00000795|AIDS Vaccines|aids vaccines
790996|NCT00000795|HIV Seronegativity|hiv seronegativity
790997|NCT00000795|HIV Preventive Vaccine|hiv preventive vaccine
790998|NCT00000794|Pyrimethamine|pyrimethamine
790999|NCT00000794|Leucovorin|leucovorin
791000|NCT00000794|Drug Therapy, Combination|drug therapy, combination
791001|NCT00000794|Encephalitis|encephalitis
791002|NCT00000794|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791003|NCT00000794|Antiprotozoal Agents|antiprotozoal agents
791004|NCT00000794|Clarithromycin|clarithromycin
791005|NCT00000794|atovaquone|atovaquone
791006|NCT00000794|Toxoplasmosis, Cerebral|toxoplasmosis, cerebral
791007|NCT00000794|Sulfadiazine|sulfadiazine
791008|NCT00000793|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791009|NCT00000793|AIDS-Related Complex|aids-related complex
791010|NCT00000793|Peripheral Nervous System Diseases|peripheral nervous system diseases
791011|NCT00000793|Amitriptyline|amitriptyline
791012|NCT00000793|Pain|pain
791013|NCT00000793|Mexiletine|mexiletine
791014|NCT00000793|benzatropine methanesulfonate|benzatropine methanesulfonate
791015|NCT00000793|Parasympatholytics|parasympatholytics
791016|NCT00000792|Administration, Oral|administration, oral
791017|NCT00000792|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791018|NCT00000792|AIDS-Related Complex|aids-related complex
791019|NCT00000792|Antiviral Agents|antiviral agents
791020|NCT00000791|Drug Therapy, Combination|drug therapy, combination
791021|NCT00000791|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791022|NCT00000791|AIDS-Related Complex|aids-related complex
791023|NCT00000791|Antiviral Agents|antiviral agents
791024|NCT00000791|Zidovudine|zidovudine
791025|NCT00000790|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791026|NCT00000790|AIDS-Related Complex|aids-related complex
791027|NCT00000790|Thalidomide|thalidomide
791028|NCT00000790|Stomatitis, Aphthous|stomatitis, aphthous
791029|NCT00000789|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791030|NCT00000789|AIDS-Related Complex|aids-related complex
791031|NCT00000789|Zidovudine|zidovudine
791032|NCT00000789|Stavudine|stavudine
791033|NCT00000788|Methadone|methadone
791034|NCT00000788|Drug Interactions|drug interactions
791035|NCT00000788|Drug Therapy, Combination|drug therapy, combination
791036|NCT00000788|Fluconazole|fluconazole
791037|NCT00000788|Antifungal Agents|antifungal agents
791038|NCT00000788|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791039|NCT00000788|AIDS-Related Complex|aids-related complex
791040|NCT00000787|Sex Behavior|sex behavior
791041|NCT00000785|Tuberculosis|tuberculosis
791042|NCT00000785|Mycobacterium tuberculosis|mycobacterium tuberculosis
791043|NCT00000785|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
791044|NCT00000785|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791045|NCT00000785|Drug Resistance, Microbial|drug resistance, microbial
791046|NCT00000784|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791047|NCT00000784|AIDS-Related Complex|aids-related complex
791048|NCT00000783|Sex Behavior|sex behavior
791049|NCT00000783|Sexual Partners|sexual partners
791050|NCT00000782|Vaccines, Synthetic|vaccines, synthetic
791051|NCT00000782|Injections, Intradermal|injections, intradermal
791052|NCT00000782|HIV Antigens|hiv antigens
791053|NCT00000782|HIV-1|hiv-1
791054|NCT00000782|HIV Envelope Protein gp160|hiv envelope protein gp160
791055|NCT00000782|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791056|NCT00000782|AIDS-Related Complex|aids-related complex
791057|NCT00000782|Hypersensitivity, Delayed|hypersensitivity, delayed
791058|NCT00000782|AIDS Vaccines|aids vaccines
791059|NCT00000782|HIV Therapeutic Vaccine|hiv therapeutic vaccine
791060|NCT00000781|Zalcitabine|zalcitabine
791061|NCT00000781|Didanosine|didanosine
791062|NCT00000781|Drug Therapy, Combination|drug therapy, combination
791063|NCT00000781|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791064|NCT00000781|Zidovudine|zidovudine
791065|NCT00000781|Nevirapine|nevirapine
791066|NCT00000780|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791067|NCT00000780|AIDS-Related Complex|aids-related complex
791068|NCT00000780|Adolescent Behavior|adolescent behavior
791069|NCT00000779|Vaccines, Synthetic|vaccines, synthetic
791070|NCT00000779|HIV-1|hiv-1
791071|NCT00000779|Adjuvants, Immunologic|adjuvants, immunologic
791072|NCT00000779|AIDS-Related Complex|aids-related complex
791073|NCT00000779|HIV Envelope Protein gp120|hiv envelope protein gp120
791074|NCT00000779|AIDS Vaccines|aids vaccines
791075|NCT00000779|HIV Therapeutic Vaccine|hiv therapeutic vaccine
791076|NCT00000778|Isoniazid|isoniazid
791077|NCT00000778|Tuberculosis, Pulmonary|tuberculosis, pulmonary
791078|NCT00000778|Pyridoxine|pyridoxine
791079|NCT00000778|Ofloxacin|ofloxacin
791080|NCT00000778|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
791081|NCT00000778|Drug Evaluation|drug evaluation
791082|NCT00000778|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791084|NCT00000778|Colony Count, Microbial|colony count, microbial
791085|NCT00000777|Vaccines, Synthetic|vaccines, synthetic
791086|NCT00000777|Pregnancy|pregnancy
791087|NCT00000777|Pregnancy Complications, Infectious|pregnancy complications, infectious
791088|NCT00000777|HIV Envelope Protein gp160|hiv envelope protein gp160
791089|NCT00000777|AIDS Vaccines|aids vaccines
791090|NCT00000777|HIV Preventive Vaccine|hiv preventive vaccine
791091|NCT00000777|HIV Therapeutic Vaccine|hiv therapeutic vaccine
791092|NCT00000776|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
791093|NCT00000776|Meningitis|meningitis
791094|NCT00000776|Cryptococcosis|cryptococcosis
791095|NCT00000776|Dexamethasone|dexamethasone
791096|NCT00000776|Drug Therapy, Combination|drug therapy, combination
791097|NCT00000776|Fluconazole|fluconazole
791098|NCT00000776|Flucytosine|flucytosine
791099|NCT00000776|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791100|NCT00000776|Amphotericin B|amphotericin b
791101|NCT00000776|Brain Diseases|brain diseases
791102|NCT00000775|Vaccines, Synthetic|vaccines, synthetic
791103|NCT00000775|HIV-1|hiv-1
791104|NCT00000775|HIV Envelope Protein gp120|hiv envelope protein gp120
791105|NCT00000775|AIDS Vaccines|aids vaccines
791106|NCT00000775|HIV Seronegativity|hiv seronegativity
791107|NCT00000775|HIV Preventive Vaccine|hiv preventive vaccine
791108|NCT00000774|Vaccines, Synthetic|vaccines, synthetic
791109|NCT00000774|Virus Replication|virus replication
791110|NCT00000774|HIV Envelope Protein gp120|hiv envelope protein gp120
791111|NCT00000774|AIDS Vaccines|aids vaccines
791112|NCT00000774|HIV Preventive Vaccine|hiv preventive vaccine
791113|NCT00000774|HIV Therapeutic Vaccine|hiv therapeutic vaccine
791114|NCT00000773|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
791115|NCT00000773|Antifungal Agents|antifungal agents
791116|NCT00000773|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791117|NCT00000773|AIDS-Related Complex|aids-related complex
791118|NCT00000773|Biological Availability|biological availability
791119|NCT00000773|atovaquone|atovaquone
791120|NCT00000772|Ribavirin|ribavirin
791121|NCT00000772|Didanosine|didanosine
791122|NCT00000772|Drug Therapy, Combination|drug therapy, combination
791123|NCT00000772|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791124|NCT00000772|AIDS-Related Complex|aids-related complex
791125|NCT00000771|Cryptosporidiosis|cryptosporidiosis
791126|NCT00000771|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791127|NCT00000771|Paromomycin|paromomycin
791128|NCT00000770|Didanosine|didanosine
791129|NCT00000770|Drug Therapy, Combination|drug therapy, combination
791130|NCT00000770|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791131|NCT00000770|AIDS-Related Complex|aids-related complex
791132|NCT00000770|Zidovudine|zidovudine
791133|NCT00000770|Nevirapine|nevirapine
791134|NCT00000769|Sarcoma, Kaposi|sarcoma, kaposi
791135|NCT00000769|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791136|NCT00000769|Interleukin-4|interleukin-4
791137|NCT00000768|Intestinal Absorption|intestinal absorption
791138|NCT00000768|Ganciclovir|ganciclovir
791139|NCT00000768|Drug Therapy, Combination|drug therapy, combination
791140|NCT00000768|Cytomegalovirus Infections|cytomegalovirus infections
791141|NCT00000768|Colitis|colitis
791142|NCT00000768|Administration, Oral|administration, oral
791143|NCT00000768|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791144|NCT00000768|Biological Availability|biological availability
791145|NCT00000768|Glutamic Acid|glutamic acid
791146|NCT00000767|Vaccines, Synthetic|vaccines, synthetic
791147|NCT00000767|Vaccinia Virus|vaccinia virus
791148|NCT00000767|Viral Vaccines|viral vaccines
791149|NCT00000767|Smallpox Vaccine|smallpox vaccine
791150|NCT00000767|HIV-1|hiv-1
791151|NCT00000767|AIDS Vaccines|aids vaccines
791152|NCT00000767|HIV Seronegativity|hiv seronegativity
791153|NCT00000767|HIV Preventive Vaccine|hiv preventive vaccine
791154|NCT00000766|Retinitis|retinitis
791155|NCT00000766|Ganciclovir|ganciclovir
791156|NCT00000766|Foscarnet|foscarnet
791157|NCT00000766|Cytomegalovirus Infections|cytomegalovirus infections
791158|NCT00000766|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791159|NCT00000765|Zidovudine|zidovudine
791160|NCT00000764|Interferon Alfa-2a|interferon alfa-2a
791161|NCT00000764|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791162|NCT00000764|AIDS-Related Complex|aids-related complex
791163|NCT00000764|Anus Neoplasms|anus neoplasms
791164|NCT00000764|Papillomavirus, Human|papillomavirus, human
791165|NCT00000764|Papovaviridae Infections|papovaviridae infections
791166|NCT00000764|Tumor Virus Infections|tumor virus infections
791167|NCT00000764|Isotretinoin|isotretinoin
791168|NCT00000763|Sarcoma, Kaposi|sarcoma, kaposi
791169|NCT00000763|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791170|NCT00000763|Antineoplastic Agents|antineoplastic agents
791171|NCT00000762|Vaccines, Synthetic|vaccines, synthetic
791172|NCT00000762|HIV Envelope Protein gp160|hiv envelope protein gp160
791173|NCT00000762|HIV Envelope Protein gp120|hiv envelope protein gp120
791174|NCT00000762|AIDS Vaccines|aids vaccines
791175|NCT00000762|HIV Therapeutic Vaccine|hiv therapeutic vaccine
791176|NCT00000761|Interferon-gamma, Recombinant|interferon-gamma, recombinant
791177|NCT00000761|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791178|NCT00000761|AIDS-Related Complex|aids-related complex
791179|NCT00000760|Didanosine|didanosine
791180|NCT00000760|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791181|NCT00000760|AIDS-Related Complex|aids-related complex
791182|NCT00000760|Antiviral Agents|antiviral agents
791183|NCT00000760|Zidovudine|zidovudine
791184|NCT00000760|Gene Products, tat|gene products, tat
791185|NCT00000759|Central Nervous System Diseases|central nervous system diseases
791186|NCT00000759|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791187|NCT00000759|AIDS-Related Complex|aids-related complex
791188|NCT00000759|Peripheral Nervous System Diseases|peripheral nervous system diseases
791189|NCT00000758|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791190|NCT00000758|AIDS-Related Complex|aids-related complex
791191|NCT00000758|Fluorouracil|fluorouracil
791192|NCT00000758|Cervix Dysplasia|cervix dysplasia
791193|NCT00000758|Cervix Diseases|cervix diseases
791194|NCT00000757|Vaccines, Synthetic|vaccines, synthetic
791195|NCT00000757|Vaccinia Virus|vaccinia virus
791196|NCT00000757|HIV-1|hiv-1
791197|NCT00000757|HIV Envelope Protein gp160|hiv envelope protein gp160
791198|NCT00000757|AIDS Vaccines|aids vaccines
791199|NCT00000757|HIV Seronegativity|hiv seronegativity
791200|NCT00000757|HIV Preventive Vaccine|hiv preventive vaccine
791201|NCT00000756|T-Lymphocytes|t-lymphocytes
791202|NCT00000756|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791203|NCT00000756|AIDS-Related Complex|aids-related complex
791204|NCT00000756|Immunotherapy, Adoptive|immunotherapy, adoptive
791205|NCT00000756|Transplantation, Autologous|transplantation, autologous
791206|NCT00000755|Vaccines, Synthetic|vaccines, synthetic
791207|NCT00000755|HIV-1|hiv-1
791208|NCT00000755|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791209|NCT00000755|AIDS-Related Complex|aids-related complex
791210|NCT00000755|Zidovudine|zidovudine
791211|NCT00000755|HIV Envelope Protein gp120|hiv envelope protein gp120
791212|NCT00000755|AIDS Vaccines|aids vaccines
791213|NCT00000755|HIV Therapeutic Vaccine|hiv therapeutic vaccine
791214|NCT00000754|Zalcitabine|zalcitabine
791215|NCT00000754|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791216|NCT00000754|AIDS-Related Complex|aids-related complex
791217|NCT00000754|Zidovudine|zidovudine
791218|NCT00000754|Interferon-alpha|interferon-alpha
791219|NCT00000753|Zalcitabine|zalcitabine
791220|NCT00000753|Didanosine|didanosine
791221|NCT00000753|Drug Therapy, Combination|drug therapy, combination
791222|NCT00000753|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791223|NCT00000753|AIDS-Related Complex|aids-related complex
791224|NCT00000753|Antiviral Agents|antiviral agents
791225|NCT00000753|Zidovudine|zidovudine
791226|NCT00000752|Drug Therapy, Combination|drug therapy, combination
791227|NCT00000752|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791228|NCT00000752|AIDS-Related Complex|aids-related complex
791229|NCT00000752|cefuroxime axetil|cefuroxime axetil
791230|NCT00000752|Beclomethasone|beclomethasone
791231|NCT00000752|Guaiacol Glyceryl Ether|guaiacol glyceryl ether
791232|NCT00000752|Sinusitis|sinusitis
791233|NCT00000752|Ephedrine|ephedrine
791234|NCT00000751|Pregnancy|pregnancy
791235|NCT00000751|Pregnancy Complications, Infectious|pregnancy complications, infectious
791236|NCT00000751|Drug Therapy, Combination|drug therapy, combination
791237|NCT00000751|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791238|NCT00000751|AIDS-Related Complex|aids-related complex
791239|NCT00000751|Zidovudine|zidovudine
791240|NCT00000751|Immunoglobulins, Intravenous|immunoglobulins, intravenous
791241|NCT00000751|Immunization, Passive|immunization, passive
791242|NCT00000750|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791243|NCT00000750|AIDS-Related Complex|aids-related complex
791244|NCT00000750|Zidovudine|zidovudine
791245|NCT00000749|Vaccines, Synthetic|vaccines, synthetic
791246|NCT00000749|HIV Envelope Protein gp120|hiv envelope protein gp120
791247|NCT00000749|AIDS Vaccines|aids vaccines
791248|NCT00000749|HIV Seronegativity|hiv seronegativity
791249|NCT00000749|HIV Preventive Vaccine|hiv preventive vaccine
791250|NCT00000748|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
791251|NCT00000748|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
791252|NCT00000748|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791253|NCT00000748|AIDS-Related Complex|aids-related complex
791254|NCT00000748|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
791255|NCT00000747|Drug Resistance|drug resistance
791256|NCT00000747|AIDS-Related Complex|aids-related complex
791257|NCT00000747|Antiviral Agents|antiviral agents
791258|NCT00000747|Nevirapine|nevirapine
791259|NCT00000746|Vaccines, Synthetic|vaccines, synthetic
791260|NCT00000746|Vaccinia Virus|vaccinia virus
791261|NCT00000746|Viral Vaccines|viral vaccines
791262|NCT00000746|HIV-1|hiv-1
791263|NCT00000746|HIV Envelope Protein gp160|hiv envelope protein gp160
791264|NCT00000746|HIV Envelope Protein gp120|hiv envelope protein gp120
791265|NCT00000746|AIDS Vaccines|aids vaccines
791266|NCT00000746|HIV Seronegativity|hiv seronegativity
791267|NCT00000746|HIV Preventive Vaccine|hiv preventive vaccine
791268|NCT00000745|Vaccines, Synthetic|vaccines, synthetic
791269|NCT00000745|Vaccinia Virus|vaccinia virus
791270|NCT00000745|Viral Vaccines|viral vaccines
791271|NCT00000745|HIV-1|hiv-1
791272|NCT00000745|HIV Envelope Protein gp160|hiv envelope protein gp160
791273|NCT00000745|AIDS Vaccines|aids vaccines
791274|NCT00000745|HIV Seronegativity|hiv seronegativity
791275|NCT00000745|HIV Preventive Vaccine|hiv preventive vaccine
791276|NCT00000744|Fluconazole|fluconazole
791277|NCT00000744|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791278|NCT00000744|AIDS-Related Complex|aids-related complex
791279|NCT00000744|Candidiasis|candidiasis
791280|NCT00000743|Recombinant Proteins|recombinant proteins
791281|NCT00000743|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791282|NCT00000743|Antigens, CD4|antigens, cd4
791283|NCT00000743|AIDS-Related Complex|aids-related complex
791284|NCT00000743|Zidovudine|zidovudine
791285|NCT00000742|Didanosine|didanosine
791286|NCT00000742|Drug Therapy, Combination|drug therapy, combination
791287|NCT00000742|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791288|NCT00000742|AIDS-Related Complex|aids-related complex
791289|NCT00000742|Antiviral Agents|antiviral agents
791290|NCT00000742|Zidovudine|zidovudine
791291|NCT00000741|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
791292|NCT00000741|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791293|NCT00000741|Methylprednisolone|methylprednisolone
791294|NCT00000740|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
791295|NCT00000740|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791296|NCT00000740|AIDS-Related Complex|aids-related complex
791297|NCT00000740|WR 6026|wr 6026
791298|NCT00000739|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
791299|NCT00000739|Dapsone|dapsone
791300|NCT00000739|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791301|NCT00000739|AIDS-Related Complex|aids-related complex
791302|NCT00000739|Drug Administration Schedule|drug administration schedule
791303|NCT00000738|Central Nervous System Diseases|central nervous system diseases
791304|NCT00000738|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791305|NCT00000738|AIDS Dementia Complex|aids dementia complex
791306|NCT00000738|AIDS-Related Complex|aids-related complex
791307|NCT00000738|Zidovudine|zidovudine
791308|NCT00000738|Nimodipine|nimodipine
791309|NCT00000737|Weight Loss|weight loss
791310|NCT00000737|Megestrol|megestrol
791311|NCT00000737|Cachexia|cachexia
791312|NCT00000737|Eating Disorders|eating disorders
791313|NCT00000737|Tetrahydrocannabinol|tetrahydrocannabinol
791314|NCT00000737|Appetite|appetite
791315|NCT00000736|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791316|NCT00000736|AIDS-Related Complex|aids-related complex
791317|NCT00000736|Zidovudine|zidovudine
791318|NCT00000735|Virus Replication|virus replication
791319|NCT00000735|T-Lymphocytes|t-lymphocytes
791320|NCT00000735|Infusions, Intravenous|infusions, intravenous
791321|NCT00000735|Immunologic Surveillance|immunologic surveillance
791322|NCT00000735|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791323|NCT00000735|ampligen|ampligen
791324|NCT00000735|AIDS-Related Complex|aids-related complex
791325|NCT00000735|Antiviral Agents|antiviral agents
791326|NCT00000734|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
791327|NCT00000734|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
791328|NCT00000734|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
791329|NCT00000734|Drug Interactions|drug interactions
791330|NCT00000734|Drug Therapy, Combination|drug therapy, combination
791331|NCT00000734|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791332|NCT00000734|AIDS-Related Complex|aids-related complex
791333|NCT00000734|Zidovudine|zidovudine
791334|NCT00000734|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
791335|NCT00000733|Ribavirin|ribavirin
791336|NCT00000733|T-Lymphocytes|t-lymphocytes
791337|NCT00000733|Infusions, Intravenous|infusions, intravenous
791338|NCT00000733|Immunologic Surveillance|immunologic surveillance
791339|NCT00000733|Administration, Oral|administration, oral
791340|NCT00000733|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791341|NCT00000732|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
791342|NCT00000732|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
791343|NCT00000732|Drug Interactions|drug interactions
791344|NCT00000732|Drug Therapy, Combination|drug therapy, combination
791345|NCT00000732|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791346|NCT00000732|AIDS-Related Complex|aids-related complex
791347|NCT00000732|Zidovudine|zidovudine
791348|NCT00000732|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
791349|NCT00000731|Acetaminophen|acetaminophen
791350|NCT00000731|Drug Interactions|drug interactions
791351|NCT00000731|Drug Therapy, Combination|drug therapy, combination
791352|NCT00000731|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791353|NCT00000731|AIDS-Related Complex|aids-related complex
791354|NCT00000731|Zidovudine|zidovudine
791355|NCT00000730|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
791356|NCT00000730|Trimetrexate|trimetrexate
791357|NCT00000730|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
791358|NCT00000730|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
791359|NCT00000730|Leucovorin|leucovorin
791360|NCT00000730|Folic Acid Antagonists|folic acid antagonists
791361|NCT00000730|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791362|NCT00000730|Antiprotozoal Agents|antiprotozoal agents
791363|NCT00000730|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
791364|NCT00000729|Virus Replication|virus replication
791365|NCT00000729|Infusions, Intravenous|infusions, intravenous
791366|NCT00000729|Dose-Response Relationship, Drug|dose-response relationship, drug
791367|NCT00000729|Foscarnet|foscarnet
791368|NCT00000729|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791369|NCT00000729|AIDS-Related Complex|aids-related complex
791370|NCT00000729|Antiviral Agents|antiviral agents
791371|NCT00000729|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
791372|NCT00000728|Immune Tolerance|immune tolerance
791373|NCT00000728|Interleukin-2|interleukin-2
791374|NCT00000728|Drug Therapy, Combination|drug therapy, combination
791375|NCT00000728|AIDS-Related Complex|aids-related complex
791376|NCT00000728|Zidovudine|zidovudine
791377|NCT00000728|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
791378|NCT00000727|Sulfadoxine|sulfadoxine
791379|NCT00000727|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
791380|NCT00000727|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
791381|NCT00000727|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
791382|NCT00000727|Pentamidine|pentamidine
791383|NCT00000727|Pyrimethamine|pyrimethamine
791384|NCT00000727|Drug Evaluation|drug evaluation
791385|NCT00000727|Administration, Inhalation|administration, inhalation
791386|NCT00000727|Administration, Oral|administration, oral
791387|NCT00000727|Aerosols|aerosols
791388|NCT00000727|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791389|NCT00000727|Zidovudine|zidovudine
791390|NCT00000726|Retinitis|retinitis
791391|NCT00000726|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
791392|NCT00000726|Foscarnet|foscarnet
791393|NCT00000726|Cytomegalovirus Infections|cytomegalovirus infections
791394|NCT00000726|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791395|NCT00000726|Antiviral Agents|antiviral agents
791396|NCT00000725|Interferon Alfa-2a|interferon alfa-2a
791397|NCT00000725|Sarcoma, Kaposi|sarcoma, kaposi
791398|NCT00000725|Dose-Response Relationship, Drug|dose-response relationship, drug
791399|NCT00000725|Drug Therapy, Combination|drug therapy, combination
791400|NCT00000725|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791401|NCT00000725|Zidovudine|zidovudine
791402|NCT00000725|Interferon Type I|interferon type i
791403|NCT00000724|Trimetrexate|trimetrexate
791404|NCT00000724|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
791405|NCT00000724|Injections, Intravenous|injections, intravenous
791406|NCT00000724|Leucovorin|leucovorin
791407|NCT00000724|Drug Evaluation|drug evaluation
791408|NCT00000724|Drug Therapy, Combination|drug therapy, combination
791409|NCT00000724|Folic Acid Antagonists|folic acid antagonists
791410|NCT00000724|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791411|NCT00000724|Antiprotozoal Agents|antiprotozoal agents
791412|NCT00000723|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
791413|NCT00000723|Lymphoma|lymphoma
791414|NCT00000723|Methotrexate|methotrexate
791415|NCT00000723|Leucovorin|leucovorin
791416|NCT00000723|Dexamethasone|dexamethasone
791417|NCT00000723|Drug Evaluation|drug evaluation
791418|NCT00000723|Drug Therapy, Combination|drug therapy, combination
791419|NCT00000723|Combined Modality Therapy|combined modality therapy
791420|NCT00000723|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791421|NCT00000723|Zidovudine|zidovudine
791422|NCT00000723|Brain Neoplasms|brain neoplasms
791423|NCT00000722|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
791424|NCT00000722|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
791425|NCT00000722|Pentamidine|pentamidine
791426|NCT00000722|Injections, Intravenous|injections, intravenous
791427|NCT00000722|Lung|lung
791428|NCT00000722|Administration, Inhalation|administration, inhalation
791429|NCT00000722|Aerosols|aerosols
791430|NCT00000722|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791431|NCT00000721|Recombinant Proteins|recombinant proteins
791432|NCT00000721|Infusions, Intravenous|infusions, intravenous
791433|NCT00000721|Injections, Intramuscular|injections, intramuscular
791434|NCT00000721|Injections, Intravenous|injections, intravenous
791435|NCT00000721|Injections, Subcutaneous|injections, subcutaneous
791436|NCT00000721|Dose-Response Relationship, Drug|dose-response relationship, drug
791437|NCT00000721|Drug Evaluation|drug evaluation
791438|NCT00000721|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791439|NCT00000721|Antigens, CD4|antigens, cd4
791440|NCT00000721|AIDS-Related Complex|aids-related complex
791441|NCT00000720|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
791442|NCT00000720|Placebos|placebos
791443|NCT00000720|Infusions, Intravenous|infusions, intravenous
791444|NCT00000720|Gamma-Globulins|gamma-globulins
795092|NCT00004997|Anemia|anemia
791445|NCT00000720|Combined Modality Therapy|combined modality therapy
791446|NCT00000720|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791447|NCT00000720|Zidovudine|zidovudine
791448|NCT00000720|Bacterial Infections|bacterial infections
791449|NCT00000720|Immunization, Passive|immunization, passive
791450|NCT00000719|Zalcitabine|zalcitabine
791451|NCT00000719|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791452|NCT00000719|Zidovudine|zidovudine
791453|NCT00000718|Zalcitabine|zalcitabine
791454|NCT00000718|Dose-Response Relationship, Drug|dose-response relationship, drug
791455|NCT00000718|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791456|NCT00000718|AIDS-Related Complex|aids-related complex
791457|NCT00000718|Zidovudine|zidovudine
791458|NCT00000717|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
791459|NCT00000717|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
791460|NCT00000717|Primaquine|primaquine
791461|NCT00000717|Infusions, Intravenous|infusions, intravenous
791462|NCT00000717|Drug Evaluation|drug evaluation
791463|NCT00000717|Drug Therapy, Combination|drug therapy, combination
791464|NCT00000717|Administration, Oral|administration, oral
791465|NCT00000717|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791466|NCT00000717|Clindamycin|clindamycin
791467|NCT00000716|Drug Evaluation|drug evaluation
791468|NCT00000716|Administration, Oral|administration, oral
791469|NCT00000716|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791470|NCT00000716|Zidovudine|zidovudine
791471|NCT00000715|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
791472|NCT00000715|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
791473|NCT00000715|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
791474|NCT00000715|Pentamidine|pentamidine
791475|NCT00000715|Infusions, Intravenous|infusions, intravenous
791476|NCT00000715|Administration, Inhalation|administration, inhalation
791477|NCT00000715|Aerosols|aerosols
791478|NCT00000715|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791479|NCT00000715|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
791480|NCT00000714|Trimetrexate|trimetrexate
791481|NCT00000714|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
791482|NCT00000714|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
791483|NCT00000714|Leucovorin|leucovorin
791484|NCT00000714|Drug Evaluation|drug evaluation
791485|NCT00000714|Drug Therapy, Combination|drug therapy, combination
791486|NCT00000714|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791487|NCT00000714|Antiprotozoal Agents|antiprotozoal agents
791488|NCT00000713|Polyribonucleotides|polyribonucleotides
791489|NCT00000713|HIV Seropositivity|hiv seropositivity
791490|NCT00000713|Dose-Response Relationship, Drug|dose-response relationship, drug
791491|NCT00000713|Drug Evaluation|drug evaluation
791492|NCT00000713|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791493|NCT00000713|ampligen|ampligen
791494|NCT00000713|AIDS-Related Complex|aids-related complex
791495|NCT00000713|Antiviral Agents|antiviral agents
791496|NCT00000712|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
791497|NCT00000712|Herpesviridae Infections|herpesviridae infections
791498|NCT00000712|Drug Evaluation|drug evaluation
791499|NCT00000712|Drug Therapy, Combination|drug therapy, combination
791500|NCT00000712|Herpesvirus 4, Human|herpesvirus 4, human
791501|NCT00000712|Cytomegalovirus Infections|cytomegalovirus infections
791502|NCT00000712|Acyclovir|acyclovir
791503|NCT00000712|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791504|NCT00000712|Antiviral Agents|antiviral agents
791505|NCT00000712|Zidovudine|zidovudine
791506|NCT00000711|Neutropenia|neutropenia
791507|NCT00000711|Drug Evaluation|drug evaluation
791508|NCT00000711|Drug Therapy, Combination|drug therapy, combination
791509|NCT00000711|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
791510|NCT00000711|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791511|NCT00000711|AIDS-Related Complex|aids-related complex
791512|NCT00000711|Zidovudine|zidovudine
791513|NCT00000710|Injections, Intravenous|injections, intravenous
791514|NCT00000710|Didanosine|didanosine
791515|NCT00000710|Dose-Response Relationship, Drug|dose-response relationship, drug
791516|NCT00000710|Drug Evaluation|drug evaluation
791517|NCT00000710|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791518|NCT00000710|AIDS-Related Complex|aids-related complex
791519|NCT00000709|Neuropsychological Tests|neuropsychological tests
791520|NCT00000709|AIDS Dementia Complex|aids dementia complex
791521|NCT00000709|Zidovudine|zidovudine
791522|NCT00000709|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
791523|NCT00000708|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
791524|NCT00000708|Meningitis|meningitis
791525|NCT00000708|Injections, Intravenous|injections, intravenous
791526|NCT00000708|Cryptococcus neoformans|cryptococcus neoformans
791527|NCT00000708|Cryptococcosis|cryptococcosis
791528|NCT00000708|Drug Therapy, Combination|drug therapy, combination
791529|NCT00000708|Fluconazole|fluconazole
791530|NCT00000708|Administration, Oral|administration, oral
791531|NCT00000708|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791532|NCT00000708|Amphotericin B|amphotericin b
791533|NCT00000707|Respiratory Function Tests|respiratory function tests
791534|NCT00000707|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
791535|NCT00000707|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
791536|NCT00000707|Pentamidine|pentamidine
791537|NCT00000707|Lung|lung
791538|NCT00000707|HIV Seropositivity|hiv seropositivity
791539|NCT00000707|Drug Evaluation|drug evaluation
791540|NCT00000707|Administration, Inhalation|administration, inhalation
791541|NCT00000707|Aerosols|aerosols
791542|NCT00000707|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791543|NCT00000706|Quinine|quinine
791544|NCT00000706|Probenecid|probenecid
791545|NCT00000706|Drug Therapy, Combination|drug therapy, combination
791546|NCT00000706|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791547|NCT00000706|AIDS-Related Complex|aids-related complex
791548|NCT00000706|Zidovudine|zidovudine
791549|NCT00000705|Drug Evaluation|drug evaluation
791550|NCT00000705|Zidovudine|zidovudine
791551|NCT00000705|Hemophilia A|hemophilia a
791552|NCT00000704|HIV Antigens|hiv antigens
791553|NCT00000704|Immunologic Surveillance|immunologic surveillance
791554|NCT00000704|Zalcitabine|zalcitabine
791555|NCT00000704|Dose-Response Relationship, Drug|dose-response relationship, drug
791556|NCT00000704|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791557|NCT00000704|AIDS-Related Complex|aids-related complex
791558|NCT00000704|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
791559|NCT00000703|Vincristine|vincristine
791560|NCT00000703|Lymphoma|lymphoma
791561|NCT00000703|Methotrexate|methotrexate
791562|NCT00000703|Cyclophosphamide|cyclophosphamide
791563|NCT00000703|Cytarabine|cytarabine
791564|NCT00000703|Dexamethasone|dexamethasone
791565|NCT00000703|Doxorubicin|doxorubicin
791566|NCT00000703|Drug Therapy, Combination|drug therapy, combination
791567|NCT00000703|Combined Modality Therapy|combined modality therapy
791568|NCT00000703|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791569|NCT00000703|Antineoplastic Agents, Combined|antineoplastic agents, combined
791570|NCT00000703|Zidovudine|zidovudine
791571|NCT00000703|Bleomycin|bleomycin
791572|NCT00000702|AIDS Dementia Complex|aids dementia complex
791573|NCT00000702|Zidovudine|zidovudine
791574|NCT00000701|Drug Evaluation|drug evaluation
791575|NCT00000701|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791576|NCT00000701|AIDS-Related Complex|aids-related complex
791577|NCT00000701|Zidovudine|zidovudine
791578|NCT00000700|United States|united states
791579|NCT00000700|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
791580|NCT00000700|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
791581|NCT00000700|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791582|NCT00000700|Zidovudine|zidovudine
791583|NCT00000699|Ribavirin|ribavirin
791584|NCT00000699|Inosine Pranobex|inosine pranobex
791585|NCT00000699|Dose-Response Relationship, Drug|dose-response relationship, drug
791586|NCT00000699|Drug Evaluation|drug evaluation
791587|NCT00000699|Drug Therapy, Combination|drug therapy, combination
791588|NCT00000699|AIDS-Related Complex|aids-related complex
791589|NCT00000698|Retinitis|retinitis
791590|NCT00000698|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
791591|NCT00000698|Ganciclovir|ganciclovir
791592|NCT00000698|Cytomegalovirus Infections|cytomegalovirus infections
791593|NCT00000698|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791594|NCT00000697|Retinitis|retinitis
791595|NCT00000697|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
791596|NCT00000697|Bone Marrow|bone marrow
791597|NCT00000697|Ganciclovir|ganciclovir
791598|NCT00000697|Foscarnet|foscarnet
791599|NCT00000697|Cytomegalovirus Infections|cytomegalovirus infections
791600|NCT00000697|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791601|NCT00000697|Antiviral Agents|antiviral agents
791602|NCT00000696|Interferon Alfa-2a|interferon alfa-2a
791603|NCT00000696|Drug Therapy, Combination|drug therapy, combination
791604|NCT00000696|AIDS-Related Complex|aids-related complex
791605|NCT00000696|Zidovudine|zidovudine
791606|NCT00000695|Drug Evaluation|drug evaluation
791607|NCT00000695|Drug Therapy, Combination|drug therapy, combination
791608|NCT00000695|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791609|NCT00000695|Zidovudine|zidovudine
791610|NCT00000695|Interferon Type I|interferon type i
791611|NCT00000694|Interferon Alfa-2b|interferon alfa-2b
791612|NCT00000694|Immune System|immune system
791613|NCT00000694|Drug Evaluation|drug evaluation
791614|NCT00000694|Drug Therapy, Combination|drug therapy, combination
791615|NCT00000694|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
791616|NCT00000694|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791617|NCT00000694|Zidovudine|zidovudine
791618|NCT00000693|Retinitis|retinitis
791619|NCT00000693|Drug Evaluation|drug evaluation
791620|NCT00000693|Drug Therapy, Combination|drug therapy, combination
791621|NCT00000693|Cytomegalovirus Infections|cytomegalovirus infections
791622|NCT00000693|Acyclovir|acyclovir
791623|NCT00000693|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791625|NCT00000692|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791626|NCT00000692|AIDS-Related Complex|aids-related complex
791627|NCT00000692|Antiviral Agents|antiviral agents
791628|NCT00000692|Biological Availability|biological availability
791629|NCT00000692|1-Deoxynojirimycin|1-deoxynojirimycin
791630|NCT00000691|Retinitis|retinitis
791631|NCT00000691|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
791632|NCT00000691|Ganciclovir|ganciclovir
791633|NCT00000691|Drug Evaluation|drug evaluation
791634|NCT00000691|Foscarnet|foscarnet
791635|NCT00000691|Cytomegalovirus Infections|cytomegalovirus infections
791636|NCT00000691|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791637|NCT00000691|Antiviral Agents|antiviral agents
791638|NCT00000690|Reference Values|reference values
791639|NCT00000690|Infusions, Intravenous|infusions, intravenous
791640|NCT00000690|Intestinal Absorption|intestinal absorption
791641|NCT00000690|Dextran Sulfate|dextran sulfate
791642|NCT00000690|Administration, Oral|administration, oral
791643|NCT00000690|Blood Coagulation|blood coagulation
791644|NCT00000689|M-BACOD protocol|m-bacod protocol
791645|NCT00000689|Nervous System Neoplasms|nervous system neoplasms
791646|NCT00000689|Infusions, Intravenous|infusions, intravenous
791647|NCT00000689|Injections, Intravenous|injections, intravenous
791648|NCT00000689|Leucovorin|leucovorin
791649|NCT00000689|Cytarabine|cytarabine
791650|NCT00000689|Drug Evaluation|drug evaluation
791651|NCT00000689|Drug Therapy, Combination|drug therapy, combination
791652|NCT00000689|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
791653|NCT00000689|Administration, Oral|administration, oral
791654|NCT00000689|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791655|NCT00000689|Antineoplastic Agents, Combined|antineoplastic agents, combined
791656|NCT00000688|Retinitis|retinitis
791657|NCT00000688|Injections, Intravenous|injections, intravenous
791658|NCT00000688|Ganciclovir|ganciclovir
791659|NCT00000688|Cytomegalovirus Infections|cytomegalovirus infections
791660|NCT00000688|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791661|NCT00000687|Interferon Alfa-2a|interferon alfa-2a
791662|NCT00000687|Drug Evaluation|drug evaluation
791663|NCT00000687|Drug Therapy, Combination|drug therapy, combination
791664|NCT00000687|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791665|NCT00000687|Zidovudine|zidovudine
791666|NCT00000686|Drug Evaluation|drug evaluation
791667|NCT00000686|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791668|NCT00000686|AIDS-Related Complex|aids-related complex
791669|NCT00000686|Antiviral Agents|antiviral agents
791670|NCT00000686|Zidovudine|zidovudine
791671|NCT00000685|Kidney Diseases|kidney diseases
791672|NCT00000685|Drug Evaluation|drug evaluation
791673|NCT00000685|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791674|NCT00000685|Zidovudine|zidovudine
791675|NCT00000685|Renal Dialysis|renal dialysis
791676|NCT00000684|Infusions, Intravenous|infusions, intravenous
791677|NCT00000684|Dextran Sulfate|dextran sulfate
791678|NCT00000684|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791679|NCT00000683|Vaccines, Synthetic|vaccines, synthetic
791680|NCT00000683|Vaccinia Virus|vaccinia virus
791681|NCT00000683|Viral Envelope Proteins|viral envelope proteins
791682|NCT00000683|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791683|NCT00000683|AIDS Vaccines|aids vaccines
791684|NCT00000683|HIV Seronegativity|hiv seronegativity
791685|NCT00000683|HIV Preventive Vaccine|hiv preventive vaccine
791686|NCT00000682|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
791687|NCT00000682|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
791688|NCT00000682|Zalcitabine|zalcitabine
791689|NCT00000682|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791690|NCT00000682|Zidovudine|zidovudine
791691|NCT00000681|Vincristine|vincristine
791692|NCT00000681|Doxorubicin|doxorubicin
791693|NCT00000681|Drug Evaluation|drug evaluation
791694|NCT00000681|Drug Therapy, Combination|drug therapy, combination
791695|NCT00000681|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
791696|NCT00000681|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791697|NCT00000681|Zidovudine|zidovudine
791698|NCT00000681|Bleomycin|bleomycin
791699|NCT00000680|T-Lymphocytes, Suppressor-Effector|t-lymphocytes, suppressor-effector
791700|NCT00000680|Indium Radioisotopes|indium radioisotopes
791701|NCT00000680|Leukapheresis|leukapheresis
791702|NCT00000680|Interleukin-2|interleukin-2
791703|NCT00000680|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791704|NCT00000680|AIDS-Related Complex|aids-related complex
791705|NCT00000680|Zidovudine|zidovudine
791706|NCT00000680|Immunization, Passive|immunization, passive
791707|NCT00000679|Zalcitabine|zalcitabine
791708|NCT00000679|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791709|NCT00000679|AIDS-Related Complex|aids-related complex
791710|NCT00000679|Zidovudine|zidovudine
791711|NCT00000678|Zalcitabine|zalcitabine
791712|NCT00000678|Drug Evaluation|drug evaluation
791713|NCT00000678|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791714|NCT00000678|AIDS-Related Complex|aids-related complex
791715|NCT00000678|Zidovudine|zidovudine
791717|NCT00000677|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
791718|NCT00000677|Meningitis|meningitis
791719|NCT00000677|Cryptococcosis|cryptococcosis
791720|NCT00000677|Drug Evaluation|drug evaluation
791721|NCT00000677|Antifungal Agents|antifungal agents
791722|NCT00000677|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791723|NCT00000676|Mycoses|mycoses
791724|NCT00000676|Fluconazole|fluconazole
791725|NCT00000676|Clotrimazole|clotrimazole
791726|NCT00000676|Antifungal Agents|antifungal agents
791727|NCT00000676|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791728|NCT00000676|AIDS-Related Complex|aids-related complex
791729|NCT00000675|Recombinant Proteins|recombinant proteins
791730|NCT00000675|IgG|igg
791731|NCT00000675|Drug Evaluation|drug evaluation
791732|NCT00000675|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791733|NCT00000675|Antigens, CD4|antigens, cd4
791734|NCT00000675|AIDS-Related Complex|aids-related complex
791735|NCT00000675|Carrier Proteins|carrier proteins
791736|NCT00000674|Toxoplasmosis|toxoplasmosis
791737|NCT00000674|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
791738|NCT00000674|Pyrimethamine|pyrimethamine
791739|NCT00000674|Leucovorin|leucovorin
791740|NCT00000674|Drug Evaluation|drug evaluation
791741|NCT00000674|Drug Therapy, Combination|drug therapy, combination
791742|NCT00000674|Encephalitis|encephalitis
791743|NCT00000674|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791744|NCT00000674|Clindamycin|clindamycin
791745|NCT00000673|Retinitis|retinitis
791746|NCT00000673|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
791747|NCT00000673|Ganciclovir|ganciclovir
791748|NCT00000673|Cytomegalovirus Infections|cytomegalovirus infections
791749|NCT00000673|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791750|NCT00000672|Didanosine|didanosine
791751|NCT00000672|Zidovudine|zidovudine
791752|NCT00000671|Didanosine|didanosine
791753|NCT00000671|Zidovudine|zidovudine
791754|NCT00000670|Probenecid|probenecid
791755|NCT00000670|Drug Evaluation|drug evaluation
791756|NCT00000670|Drug Interactions|drug interactions
791757|NCT00000670|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791758|NCT00000670|Zidovudine|zidovudine
791759|NCT00000669|Didanosine|didanosine
791760|NCT00000669|Drug Evaluation|drug evaluation
791761|NCT00000669|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791762|NCT00000669|AIDS-Related Complex|aids-related complex
791763|NCT00000668|Retinitis|retinitis
791764|NCT00000668|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
791765|NCT00000668|Ganciclovir|ganciclovir
791766|NCT00000668|Cytomegalovirus Infections|cytomegalovirus infections
791767|NCT00000668|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791768|NCT00000667|Vaccines, Synthetic|vaccines, synthetic
791769|NCT00000667|Injections, Intradermal|injections, intradermal
791770|NCT00000667|HIV Antigens|hiv antigens
791771|NCT00000667|HIV Seropositivity|hiv seropositivity
791772|NCT00000667|HIV-1|hiv-1
791773|NCT00000667|Drug Evaluation|drug evaluation
791774|NCT00000667|Hypersensitivity, Delayed|hypersensitivity, delayed
791775|NCT00000667|AIDS Vaccines|aids vaccines
791776|NCT00000667|HIV Therapeutic Vaccine|hiv therapeutic vaccine
791777|NCT00000666|Toxoplasmosis|toxoplasmosis
791778|NCT00000666|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
791779|NCT00000666|Pyrimethamine|pyrimethamine
791780|NCT00000666|Drug Evaluation|drug evaluation
791781|NCT00000666|Encephalitis|encephalitis
791782|NCT00000666|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791783|NCT00000665|Retinitis|retinitis
791784|NCT00000665|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
791785|NCT00000665|Ganciclovir|ganciclovir
791786|NCT00000665|Foscarnet|foscarnet
791787|NCT00000665|Cytomegalovirus Infections|cytomegalovirus infections
791788|NCT00000665|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791789|NCT00000665|Antiviral Agents|antiviral agents
791790|NCT00000664|Polyethylene Glycols|polyethylene glycols
791791|NCT00000664|Interleukin-2|interleukin-2
791792|NCT00000664|Drug Evaluation|drug evaluation
791793|NCT00000664|Zidovudine|zidovudine
791794|NCT00000663|Recombinant Proteins|recombinant proteins
791795|NCT00000663|Injections, Intravenous|injections, intravenous
791796|NCT00000663|IgG|igg
791797|NCT00000663|Drug Evaluation|drug evaluation
791798|NCT00000663|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791799|NCT00000663|Antigens, CD4|antigens, cd4
791800|NCT00000663|Carrier Proteins|carrier proteins
791801|NCT00000662|Drugs, Investigational|drugs, investigational
791802|NCT00000662|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791803|NCT00000662|AIDS-Related Complex|aids-related complex
791804|NCT00000662|Zidovudine|zidovudine
791805|NCT00000661|Oxazepam|oxazepam
791806|NCT00000661|Drug Evaluation|drug evaluation
791807|NCT00000661|Drug Interactions|drug interactions
791808|NCT00000661|Zidovudine|zidovudine
791809|NCT00000660|Sarcoma, Kaposi|sarcoma, kaposi
791810|NCT00000660|Drug Evaluation|drug evaluation
791811|NCT00000660|Etoposide|etoposide
795093|NCT00004997|Folic Acid|folic acid
791812|NCT00000660|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791813|NCT00000659|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791814|NCT00000659|Antigens, CD4|antigens, cd4
791815|NCT00000659|AIDS-Related Complex|aids-related complex
791816|NCT00000659|Zidovudine|zidovudine
791817|NCT00000658|M-BACOD protocol|m-bacod protocol
791818|NCT00000658|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
791819|NCT00000658|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791820|NCT00000658|Allopurinol|allopurinol
791821|NCT00000658|Antineoplastic Agents, Combined|antineoplastic agents, combined
791822|NCT00000657|Didanosine|didanosine
791823|NCT00000657|Drug Evaluation|drug evaluation
791824|NCT00000657|Drugs, Investigational|drugs, investigational
791825|NCT00000657|AIDS Dementia Complex|aids dementia complex
791826|NCT00000657|Zidovudine|zidovudine
791827|NCT00000656|Didanosine|didanosine
791828|NCT00000656|Drug Therapy, Combination|drug therapy, combination
791829|NCT00000656|Zidovudine|zidovudine
791830|NCT00000655|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
791831|NCT00000655|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
791832|NCT00000655|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
791833|NCT00000655|Naphthoquinones|naphthoquinones
791834|NCT00000655|Antifungal Agents|antifungal agents
791835|NCT00000655|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791836|NCT00000655|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
791837|NCT00000654|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
791838|NCT00000654|Pyrimidine Nucleosides|pyrimidine nucleosides
791839|NCT00000654|Herpesviridae Infections|herpesviridae infections
791840|NCT00000654|Drug Evaluation|drug evaluation
791841|NCT00000654|Antiviral Agents|antiviral agents
791842|NCT00000654|Hepatitis B|hepatitis b
791843|NCT00000653|Zalcitabine|zalcitabine
791844|NCT00000653|Drug Evaluation|drug evaluation
791845|NCT00000653|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791846|NCT00000653|AIDS-Related Complex|aids-related complex
791847|NCT00000652|Didanosine|didanosine
791848|NCT00000652|Drug Evaluation|drug evaluation
791849|NCT00000652|Drug Therapy, Combination|drug therapy, combination
791850|NCT00000652|Zidovudine|zidovudine
791851|NCT00000651|Zalcitabine|zalcitabine
791852|NCT00000651|Antiviral Agents|antiviral agents
791853|NCT00000651|Zidovudine|zidovudine
791854|NCT00000650|Drug Evaluation|drug evaluation
791855|NCT00000650|Ditiocarb|ditiocarb
791856|NCT00000650|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791857|NCT00000649|Drug Therapy, Combination|drug therapy, combination
791858|NCT00000649|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791859|NCT00000649|AIDS-Related Complex|aids-related complex
791860|NCT00000649|Zidovudine|zidovudine
791861|NCT00000649|Nevirapine|nevirapine
791862|NCT00000648|Penicillin G|penicillin g
791863|NCT00000648|Neurosyphilis|neurosyphilis
791864|NCT00000648|Drug Evaluation|drug evaluation
791865|NCT00000648|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791866|NCT00000648|AIDS-Related Complex|aids-related complex
791867|NCT00000648|Ceftriaxone|ceftriaxone
791868|NCT00000647|Recombinant Proteins|recombinant proteins
791870|NCT00000647|Drug Evaluation|drug evaluation
791871|NCT00000647|Drug Therapy, Combination|drug therapy, combination
791872|NCT00000647|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791873|NCT00000647|Antigens, CD4|antigens, cd4
791874|NCT00000647|Zidovudine|zidovudine
791875|NCT00000647|Carrier Proteins|carrier proteins
791876|NCT00000647|Interferon Type I|interferon type i
791877|NCT00000646|Pentoxifylline|pentoxifylline
791878|NCT00000646|Virus Replication|virus replication
791879|NCT00000646|Tumor Necrosis Factor|tumor necrosis factor
791880|NCT00000646|Drug Evaluation|drug evaluation
791881|NCT00000646|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791882|NCT00000646|Cachexia|cachexia
791883|NCT00000646|Drug Synergism|drug synergism
791884|NCT00000645|Drug Evaluation|drug evaluation
791885|NCT00000645|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791886|NCT00000645|AIDS-Related Complex|aids-related complex
791887|NCT00000645|Antiviral Agents|antiviral agents
791888|NCT00000644|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
791889|NCT00000644|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
791890|NCT00000644|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791891|NCT00000644|Clarithromycin|clarithromycin
791892|NCT00000643|Toxoplasmosis|toxoplasmosis
791893|NCT00000643|Pyrimethamine|pyrimethamine
791894|NCT00000643|Leucovorin|leucovorin
791895|NCT00000643|Drug Evaluation|drug evaluation
791896|NCT00000643|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791897|NCT00000643|AIDS-Related Complex|aids-related complex
791898|NCT00000643|Brain Diseases|brain diseases
791899|NCT00000642|Recombinant Proteins|recombinant proteins
791900|NCT00000642|Pregnancy Trimester, Third|pregnancy trimester, third
791901|NCT00000642|Pregnancy|pregnancy
791902|NCT00000642|Pregnancy Complications, Infectious|pregnancy complications, infectious
791903|NCT00000642|IgG|igg
791904|NCT00000642|Drug Evaluation|drug evaluation
791905|NCT00000642|Antigens, CD4|antigens, cd4
791906|NCT00000642|AIDS-Related Complex|aids-related complex
791907|NCT00000642|Immunization, Passive|immunization, passive
791908|NCT00000641|Rifampin|rifampin
791909|NCT00000641|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
791910|NCT00000641|Drug Evaluation|drug evaluation
791911|NCT00000641|Drug Therapy, Combination|drug therapy, combination
791912|NCT00000641|Ethambutol|ethambutol
791913|NCT00000641|Clofazimine|clofazimine
791914|NCT00000641|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791915|NCT00000641|Amikacin|amikacin
791916|NCT00000641|Azithromycin|azithromycin
791917|NCT00000641|Ciprofloxacin|ciprofloxacin
791918|NCT00000640|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
791919|NCT00000640|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
791920|NCT00000640|Primaquine|primaquine
791921|NCT00000640|Dapsone|dapsone
791922|NCT00000640|Drug Therapy, Combination|drug therapy, combination
791923|NCT00000640|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791924|NCT00000640|Clindamycin|clindamycin
791925|NCT00000640|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
791926|NCT00000639|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
791927|NCT00000639|Meningitis|meningitis
791928|NCT00000639|Cryptococcosis|cryptococcosis
791929|NCT00000639|Drug Evaluation|drug evaluation
791930|NCT00000639|Drug Therapy, Combination|drug therapy, combination
791931|NCT00000639|Fluconazole|fluconazole
791932|NCT00000639|Flucytosine|flucytosine
791933|NCT00000639|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791934|NCT00000639|Amphotericin B|amphotericin b
791935|NCT00000639|Brain Diseases|brain diseases
791936|NCT00000638|Tuberculosis|tuberculosis
791937|NCT00000638|Isoniazid|isoniazid
791938|NCT00000638|Mycobacterium tuberculosis|mycobacterium tuberculosis
791939|NCT00000638|Pyrazinamide|pyrazinamide
791940|NCT00000638|Pyridoxine|pyridoxine
791941|NCT00000638|Rifampin|rifampin
791942|NCT00000638|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
791943|NCT00000638|Drug Therapy, Combination|drug therapy, combination
791944|NCT00000638|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791945|NCT00000638|Antitubercular Agents|antitubercular agents
791946|NCT00000638|AIDS-Related Complex|aids-related complex
791947|NCT00000637|Didanosine|didanosine
791948|NCT00000637|Drug Evaluation|drug evaluation
791949|NCT00000637|Drug Therapy, Combination|drug therapy, combination
791950|NCT00000637|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791951|NCT00000637|AIDS-Related Complex|aids-related complex
791952|NCT00000637|Zidovudine|zidovudine
791953|NCT00000636|Tuberculosis|tuberculosis
791954|NCT00000636|Isoniazid|isoniazid
791955|NCT00000636|Pyrazinamide|pyrazinamide
791956|NCT00000636|Pyridoxine|pyridoxine
791957|NCT00000636|Rifampin|rifampin
791958|NCT00000636|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
791959|NCT00000636|Drug Therapy, Combination|drug therapy, combination
791960|NCT00000636|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791961|NCT00000636|Antitubercular Agents|antitubercular agents
791962|NCT00000636|AIDS-Related Complex|aids-related complex
791963|NCT00000635|Bacitracin|bacitracin
791964|NCT00000635|Polymyxin B|polymyxin b
791965|NCT00000635|Trifluridine|trifluridine
791966|NCT00000635|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
791967|NCT00000635|Herpesviridae Infections|herpesviridae infections
791968|NCT00000635|Drug Evaluation|drug evaluation
791969|NCT00000635|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791970|NCT00000635|Anti-Infective Agents, Local|anti-infective agents, local
791971|NCT00000635|Antiviral Agents|antiviral agents
791972|NCT00000634|Benzodiazepines|benzodiazepines
791973|NCT00000634|Drug Evaluation|drug evaluation
791974|NCT00000634|Drugs, Investigational|drugs, investigational
791975|NCT00000634|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791976|NCT00000634|Antiviral Agents|antiviral agents
791977|NCT00000633|Vaccines, Synthetic|vaccines, synthetic
791978|NCT00000633|Vaccinia Virus|vaccinia virus
791979|NCT00000633|Viral Vaccines|viral vaccines
791980|NCT00000633|HIV-1|hiv-1
791981|NCT00000633|HIV Envelope Protein gp160|hiv envelope protein gp160
791982|NCT00000633|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
791983|NCT00000633|AIDS-Related Complex|aids-related complex
791984|NCT00000633|AIDS Vaccines|aids vaccines
791985|NCT00000633|HIV Therapeutic Vaccine|hiv therapeutic vaccine
791986|NCT00000632|Vaccines, Synthetic|vaccines, synthetic
791987|NCT00000632|Drug Evaluation|drug evaluation
791988|NCT00000632|Adjuvants, Immunologic|adjuvants, immunologic
791989|NCT00000632|AIDS Vaccines|aids vaccines
791990|NCT00000632|HIV Preventive Vaccine|hiv preventive vaccine
791991|NCT00000631|Vaccines, Synthetic|vaccines, synthetic
791992|NCT00000631|Vaccinia Virus|vaccinia virus
791993|NCT00000631|Viral Envelope Proteins|viral envelope proteins
791994|NCT00000631|Viral Vaccines|viral vaccines
791995|NCT00000631|AIDS Vaccines|aids vaccines
791996|NCT00000631|HIV Seronegativity|hiv seronegativity
791997|NCT00000631|HIV Preventive Vaccine|hiv preventive vaccine
791998|NCT00000630|Vaccines, Synthetic|vaccines, synthetic
791999|NCT00000630|Vaccinia Virus|vaccinia virus
792000|NCT00000630|Viral Envelope Proteins|viral envelope proteins
792001|NCT00000630|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
792002|NCT00000630|AIDS Vaccines|aids vaccines
792003|NCT00000630|HIV Seronegativity|hiv seronegativity
792004|NCT00000630|HIV Preventive Vaccine|hiv preventive vaccine
792005|NCT00000629|Valproic Acid|valproic acid
792006|NCT00000629|Zidovudine|zidovudine
792007|NCT00000628|Drug Evaluation|drug evaluation
792008|NCT00000628|Drugs, Investigational|drugs, investigational
792009|NCT00000628|Drug Therapy, Combination|drug therapy, combination
792010|NCT00000628|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
792011|NCT00000628|AIDS-Related Complex|aids-related complex
792012|NCT00000628|Antiviral Agents|antiviral agents
792013|NCT00000627|Pilot Projects|pilot projects
792014|NCT00000627|Histoplasmosis|histoplasmosis
792015|NCT00000627|Drug Evaluation|drug evaluation
792016|NCT00000627|Fluconazole|fluconazole
792017|NCT00000627|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
792018|NCT00000627|Recurrence|recurrence
792019|NCT00000626|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
792020|NCT00000626|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
792021|NCT00000626|Antineoplastic Agents, Combined|antineoplastic agents, combined
792022|NCT00000626|AIDS-Related Complex|aids-related complex
792023|NCT00000626|Hodgkin Disease|hodgkin disease
792024|NCT00000626|ABVD protocol|abvd protocol
792025|NCT00000625|Zalcitabine|zalcitabine
792026|NCT00000625|Didanosine|didanosine
792027|NCT00000625|Drug Therapy, Combination|drug therapy, combination
792028|NCT00000625|AIDS-Related Complex|aids-related complex
792029|NCT00000625|Antiviral Agents|antiviral agents
792030|NCT00000625|Zidovudine|zidovudine
792031|NCT00023192|Campath 1-H|campath 1-h
792032|NCT00023192|T-Cell Depletion|t-cell depletion
792033|NCT00023192|Therapy|therapy
792034|NCT00023192|Stem Cell Transplantation|stem cell transplantation
792035|NCT00023192|Chronic Granulomatous Disease|chronic granulomatous disease
792036|NCT00023192|CGD|cgd
792037|NCT00023166|Phase I|phase i
792038|NCT00023166|Open label|open label
792039|NCT00023166|Safety/efficacy|safety/efficacy
792040|NCT00023166|Lymphomas|lymphomas
792041|NCT00023166|Advanced primary and/or metastatic solid tumors|advanced primary and/or metastatic solid tumors
792042|NCT00023166|Neoplasms|neoplasms
792043|NCT00023166|Neoplasm metastasis|neoplasm metastasis
792044|NCT00023153|Drug Resistance|drug resistance
792045|NCT00023153|Viral Load|viral load
792046|NCT00023153|Liver|liver
792047|NCT00023153|Immunology|immunology
792048|NCT00023153|Liver Histology|liver histology
792049|NCT00023153|Hepatitis B|hepatitis b
792050|NCT00023153|HBV|hbv
792051|NCT00023153|HIV|hiv
792052|NCT00023140|biomarkers|biomarkers
792053|NCT00023140|exposure|exposure
792054|NCT00023140|adducts|adducts
792055|NCT00023140|metabolites|metabolites
792056|NCT00023140|butadiene|butadiene
792057|NCT00023127|Asthma|asthma
792058|NCT00023127|Allergen|allergen
792059|NCT00023127|Cockroach|cockroach
792060|NCT00023114|lung function|lung function
792061|NCT00023114|smoking|smoking
792062|NCT00023114|metabolism|metabolism
792063|NCT00023101|lead|lead
792064|NCT00023101|endocrine dysfunction|endocrine dysfunction
792065|NCT00023088|Rehabilitation|rehabilitation
792066|NCT00023088|Functional Level|functional level
792067|NCT00023088|Activity of Daily Living|activity of daily living
792068|NCT00023088|Mobility|mobility
792069|NCT00023088|Normal Volunteer|normal volunteer
792070|NCT00023075|MRI|mri
792071|NCT00023075|Neuromuscular Disease|neuromuscular disease
792072|NCT00023075|N-Acetyl Aspartate|n-acetyl aspartate
792073|NCT00023075|Choline|choline
792074|NCT00023075|Creatine|creatine
792075|NCT00023075|Spasms|spasms
792076|NCT00023075|Spasticity|spasticity
792077|NCT00023075|Primary Lateral Sclerosis|primary lateral sclerosis
792078|NCT00023075|Hereditary Spastic Paraplegia|hereditary spastic paraplegia
792079|NCT00023075|Spastic Paraparesis|spastic paraparesis
792080|NCT00023075|Healthy Volunteer|healthy volunteer
792081|NCT00023075|HV|hv
792082|NCT00023075|Normal Control|normal control
792083|NCT00023062|Natural History|natural history
792084|NCT00023062|Motor Cortex|motor cortex
792085|NCT00023062|Behavior|behavior
792086|NCT00023062|Healthy Volunteers|healthy volunteers
792087|NCT00023062|Motor Control|motor control
792088|NCT00023062|Parkinson Disease|parkinson disease
792089|NCT00023062|Parkinson's|parkinson's
792090|NCT00023062|Healthy Volunteer|healthy volunteer
792091|NCT00023062|HV|hv
792092|NCT00023062|Normal Control|normal control
792093|NCT00023049|Deafness|deafness
792094|NCT00023049|Genes|genes
792095|NCT00023049|Impairment|impairment
792096|NCT00023049|Auditory|auditory
792097|NCT00023049|Vestibular|vestibular
792098|NCT00023049|Hereditary Hearing Disorder|hereditary hearing disorder
792099|NCT00023049|Hearing Impairment|hearing impairment
792100|NCT00023049|Sensorineural Hearing Loss|sensorineural hearing loss
792101|NCT00023049|Vestibular Dysfunction|vestibular dysfunction
792102|NCT00023049|SNHL|snhl
792103|NCT00023036|Genetics|genetics
792104|NCT00023036|Deafness|deafness
792105|NCT00023036|EVA|eva
792106|NCT00023036|Pendred|pendred
792107|NCT00023036|Hearing|hearing
792108|NCT00023036|Hearing Impairment|hearing impairment
792109|NCT00023036|Nonsyndromic Hereditary Hearing Impairment|nonsyndromic hereditary hearing impairment
792110|NCT00023036|SNHL|snhl
792111|NCT00023036|Inner Ear|inner ear
792112|NCT00023036|Enlarged Vestibular Aqueducts|enlarged vestibular aqueducts
792113|NCT00023023|Hepatitis|hepatitis
792114|NCT00023023|Blood Bank|blood bank
792115|NCT00023023|Viruses|viruses
792116|NCT00023023|Blood Donors|blood donors
792117|NCT00023023|Blood Recipients|blood recipients
792118|NCT00023010|CD18|cd18
792119|NCT00023010|Retrovirus|retrovirus
792120|NCT00023010|RCR|rcr
792121|NCT00023010|Stem Cell|stem cell
792122|NCT00023010|Gene Transfer|gene transfer
792123|NCT00023010|Leukocyte Adhesion Deficiency|leukocyte adhesion deficiency
792124|NCT00023010|LAD|lad
792125|NCT00022997|Phenylthiocarbamide|phenylthiocarbamide
792126|NCT00022997|Phlebotomy|phlebotomy
792127|NCT00022997|Chemoreceptors|chemoreceptors
792128|NCT00022997|Population Associations|population associations
792129|NCT00022997|Non-Tasters|non-tasters
792130|NCT00022997|Taste|taste
792131|NCT00022997|Healthy Volunteer|healthy volunteer
792132|NCT00022997|HV|hv
792133|NCT00022997|Normal Control|normal control
792134|NCT00022984|Attitudes Towards Technology|attitudes towards technology
792135|NCT00022984|Cardiovascular Disease|cardiovascular disease
792136|NCT00022984|Illness Representation|illness representation
792137|NCT00022984|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
792138|NCT00022984|Symptom Distress|symptom distress
792139|NCT00022984|Heart Disease|heart disease
792140|NCT00022984|ICD|icd
792141|NCT00022971|Monoclonal Antibody|monoclonal antibody
792142|NCT00022971|Lymphoma|lymphoma
792143|NCT00022971|Rituximab|rituximab
792144|NCT00022971|Hu1D10|hu1d10
792145|NCT00022971|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
792146|NCT00022971|NHL|nhl
792147|NCT00022971|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
792148|NCT00022971|CLL|cll
792149|NCT00022971|Leukemia|leukemia
792150|NCT00022958|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
792151|NCT00022958|Radioimmunotherapy|radioimmunotherapy
792152|NCT00022958|Monoclonal Antibody|monoclonal antibody
792153|NCT00022958|Corixa|corixa
792154|NCT00022958|Bexxar|bexxar
792155|NCT00022958|Anti-B1 Antibody|anti-b1 antibody
792156|NCT00022958|Tositumomab|tositumomab
792157|NCT00022958|Iodine -131 Anti-B1 Antibody|iodine -131 anti-b1 antibody
792158|NCT00022958|Iodine I 131 Tositumomab|iodine i 131 tositumomab
792159|NCT00022945|Mantle Cell Lymphoma|mantle cell lymphoma
792160|NCT00022945|Radioimmunotherapy|radioimmunotherapy
792161|NCT00022945|Monoclonal Antibody|monoclonal antibody
792162|NCT00022945|Corixa|corixa
792163|NCT00022945|Bexxar|bexxar
792164|NCT00022945|Anti-B1 Antibody|anti-b1 antibody
792165|NCT00022945|Tositumomab|tositumomab
792166|NCT00022945|Iodine -131 Anti-B1 Antibody|iodine -131 anti-b1 antibody
792167|NCT00022945|Iodine I 131 Tositumomab|iodine i 131 tositumomab
792168|NCT00022932|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
792169|NCT00022932|Radioimmunotherapy|radioimmunotherapy
792170|NCT00022932|Monoclonal Antibody|monoclonal antibody
792171|NCT00022932|Corixa|corixa
792172|NCT00022932|Bexxar|bexxar
792173|NCT00022932|Anti-B1 Antibody|anti-b1 antibody
792174|NCT00022932|Tositumomab|tositumomab
792175|NCT00022932|Iodine -131 Anti-B1 Antibody|iodine -131 anti-b1 antibody
792176|NCT00022932|Iodine I 131 Tositumomab|iodine i 131 tositumomab
792177|NCT00022919|Microdissection|microdissection
792178|NCT00022919|Chromosome|chromosome
792179|NCT00022919|Karyotype|karyotype
792180|NCT00022919|Tumor|tumor
792181|NCT00022919|Malignancy|malignancy
792182|NCT00022919|Prostate Adenocarcinoma|prostate adenocarcinoma
792183|NCT00022919|Prostate Intraepithelial Neoplasia|prostate intraepithelial neoplasia
792184|NCT00022919|Prostate Cancer|prostate cancer
792185|NCT00022919|Prostate|prostate
792186|NCT00022906|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
792187|NCT00022906|Radioimmunotherapy|radioimmunotherapy
792188|NCT00022906|Monoclonal Antibody|monoclonal antibody
792189|NCT00022906|Corixa|corixa
792190|NCT00022906|Bexxar|bexxar
792191|NCT00022906|Anti-B1 Antibody|anti-b1 antibody
792192|NCT00022906|Tositumomab|tositumomab
792193|NCT00022906|Iodine -131 Anti-B1 Antibody|iodine -131 anti-b1 antibody
792194|NCT00022906|Iodine I 131 Tositumomab|iodine i 131 tositumomab
792195|NCT00022893|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
792196|NCT00022893|Radioimmunotherapy|radioimmunotherapy
792197|NCT00022893|Monoclonal Antibody|monoclonal antibody
792198|NCT00022893|Corixa|corixa
792199|NCT00022893|Bexxar|bexxar
792200|NCT00022893|Anti-B1 Antibody|anti-b1 antibody
792201|NCT00022893|Tositumomab|tositumomab
792202|NCT00022893|Iodine -131 Anti-B1 Antibody|iodine -131 anti-b1 antibody
792203|NCT00022893|Iodine I 131 Tositumomab|iodine i 131 tositumomab
795094|NCT00004997|MDS|mds
792204|NCT00022880|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
792205|NCT00022880|Dose-Escalation|dose-escalation
792206|NCT00022880|Radioimmunotherapy|radioimmunotherapy
792207|NCT00022880|Monoclonal Antibody|monoclonal antibody
792208|NCT00022880|Corixa|corixa
792209|NCT00022880|Bexxar|bexxar
792210|NCT00022880|Anti-B1 Antibody|anti-b1 antibody
792211|NCT00022880|Tositumomab|tositumomab
792212|NCT00022880|Iodine -131 Anti-B1 Antibody|iodine -131 anti-b1 antibody
792213|NCT00022880|Iodine I 131 Tositumomab|iodine i 131 tositumomab
792214|NCT00022867|Bone growth|bone growth
792215|NCT00022867|Calcium|calcium
792216|NCT00022867|Children|children
792217|NCT00022867|Diet|diet
792218|NCT00022867|Puberty|puberty
792219|NCT00022854|ACL|acl
792220|NCT00022854|Nerve block|nerve block
792221|NCT00022854|Knee|knee
792222|NCT00022854|Outcome survey|outcome survey
792223|NCT00022854|Anesthesia|anesthesia
792224|NCT00022854|Analgesia|analgesia
792225|NCT00022854|Pain|pain
792226|NCT00022841|Bone mineral density (BMD)|bone mineral density (bmd)
792227|NCT00022841|Children|children
792228|NCT00022841|Glucocorticoids|glucocorticoids
792229|NCT00022841|Osteoporosis|osteoporosis
792230|NCT00022841|Pediatric|pediatric
792231|NCT00022841|Pamidronate|pamidronate
792232|NCT00022841|Steroids|steroids
792233|NCT00022828|Laser|laser
792234|NCT00022828|Cervical|cervical
792235|NCT00022828|Spinal|spinal
792236|NCT00022828|Spine|spine
792237|NCT00022828|Neck|neck
792238|NCT00022828|Illinois|illinois
792239|NCT00022815|Compartment syndrome|compartment syndrome
792240|NCT00022815|Tissue ultrafiltration|tissue ultrafiltration
792241|NCT00022815|Reperfusion injury|reperfusion injury
792242|NCT00022815|Ischemia|ischemia
792243|NCT00022802|Biomedical equipment development|biomedical equipment development
792244|NCT00022802|Computer assisted patient care|computer assisted patient care
792245|NCT00022802|Digital imaging|digital imaging
792246|NCT00022802|Hip surgery|hip surgery
792247|NCT00022802|Orthopedics|orthopedics
792248|NCT00022802|Trauma|trauma
792249|NCT00022802|Radiography|radiography
792250|NCT00022802|Biomedical imaging|biomedical imaging
792251|NCT00022776|Human therapy evaluation|human therapy evaluation
792252|NCT00022776|Orthopedics|orthopedics
792253|NCT00022776|Physical therapy|physical therapy
792254|NCT00022776|Nonsurgical treatment|nonsurgical treatment
792255|NCT00022776|Surgical decompression|surgical decompression
792256|NCT00022776|Surgery|surgery
792257|NCT00022776|Lumbar|lumbar
792258|NCT00022776|Spine disorder|spine disorder
792259|NCT00022776|Spinal stenosis|spinal stenosis
792260|NCT00022776|Gender difference|gender difference
792261|NCT00022776|Medical rehabilitation|medical rehabilitation
792262|NCT00022789|Sleep-Disordered Breathing|sleep-disordered breathing
792263|NCT00022750|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
792264|NCT00022750|Nurse Case Manager|nurse case manager
792265|NCT00022750|Community Health Worker|community health worker
792266|NCT00022750|Behavioral Interventions|behavioral interventions
792267|NCT00022750|Cost-effectiveness|cost-effectiveness
792268|NCT00022750|Randomized trial|randomized trial
792269|NCT00021866|epilepsy|epilepsy
792270|NCT00021866|seizure|seizure
792271|NCT00021866|pregnancy|pregnancy
792272|NCT00021866|antiepileptic|antiepileptic
792273|NCT00021866|AED|aed
792274|NCT00021866|carbamazepine|carbamazepine
792275|NCT00021866|phenytoin|phenytoin
792276|NCT00021866|valproate|valproate
792277|NCT00021866|lamotrigine|lamotrigine
792278|NCT00021866|child|child
792279|NCT00021866|behavior|behavior
792280|NCT00021853|Individualized|individualized
792281|NCT00021853|Finger|finger
792282|NCT00021853|Training|training
792283|NCT00021853|Splinting|splinting
792284|NCT00021853|TMS|tms
792285|NCT00021853|Dystonia|dystonia
792286|NCT00021853|Focal Dystonia|focal dystonia
792287|NCT00021853|Movement Disorder|movement disorder
792288|NCT00021853|Focal Hand Dystonia|focal hand dystonia
792289|NCT00021853|Writer's Cramp|writer's cramp
792290|NCT00021827|parathyroid hormone-related protein|parathyroid hormone-related protein
792291|NCT00021827|parathyroid hormone|parathyroid hormone
792292|NCT00021827|anabolic skeletal therapy|anabolic skeletal therapy
792293|NCT00021827|postmenopausal women|postmenopausal women
792294|NCT00021814|BPH progression|bph progression
792295|NCT00021814|Medical Therapy|medical therapy
792296|NCT00021814|Finasteride|finasteride
792297|NCT00021814|Doxazosin|doxazosin
792298|NCT00021814|Randomized|randomized
792299|NCT00021814|Multi-center|multi-center
792300|NCT00021814|Clinical Trial|clinical trial
792301|NCT00021814|Proscar|proscar
792302|NCT00021814|Cardura|cardura
792303|NCT00021801|Type I Diabetes Mellitus|type i diabetes mellitus
792304|NCT00021801|Immunosuppression|immunosuppression
792305|NCT00021801|Islet Cell Transplant|islet cell transplant
792306|NCT00021801|Percutaneous Transhepatic Portal|percutaneous transhepatic portal
792307|NCT00021788|Type I Diabetes Mellitus|type i diabetes mellitus
792308|NCT00021788|Immunosuppression|immunosuppression
792309|NCT00021788|Islet Cell Transplantation|islet cell transplantation
792310|NCT00021788|PercutaneousTranshepaticPortalVein Catheterization|percutaneoustranshepaticportalvein catheterization
792311|NCT00021749|CLL|cll
792312|NCT00021749|Leukemia|leukemia
792313|NCT00021749|Chronic|chronic
792314|NCT00021749|Cancer|cancer
792315|NCT00021749|Adult|adult
792316|NCT00021749|Lymphocytic|lymphocytic
792317|NCT00021749|Genasense|genasense
792318|NCT00021749|G3139|g3139
792319|NCT00021749|Genta|genta
792320|NCT00021749|Bcl-2|bcl-2
792321|NCT00021749|Antisense|antisense
792322|NCT00021749|Oligonucleotide|oligonucleotide
792323|NCT00021749|oblimerson|oblimerson
792324|NCT00021736|choroidal neovascularization (CNV)|choroidal neovascularization (cnv)
792325|NCT00021736|subretinal neovascularization|subretinal neovascularization
792326|NCT00021723|Alzheimer's|alzheimer's
792327|NCT00021723|AN-1792|an-1792
792328|NCT00021723|AIP-001|aip-001
792329|NCT00021710|Stroke|stroke
792330|NCT00021710|Learning|learning
792331|NCT00021710|Plasticity|plasticity
792332|NCT00021710|Motor|motor
792333|NCT00021710|Rehabilitation|rehabilitation
792334|NCT00021710|Premotor|premotor
792335|NCT00021710|Normal Control|normal control
792336|NCT00021710|Healthy Volunteer|healthy volunteer
792337|NCT00021710|HV|hv
792338|NCT00021710|Motor Learning|motor learning
792339|NCT00021697|AVP-923|avp-923
792340|NCT00021697|Dextromethorphan|dextromethorphan
792341|NCT00021697|Quinidine|quinidine
792342|NCT00021697|Pseudobulbar Affect|pseudobulbar affect
792343|NCT00021658|Epidemiology|epidemiology
792344|NCT00021658|pesticide|pesticide
792345|NCT00021658|asthma|asthma
792346|NCT00021658|children|children
792347|NCT00021658|exposure|exposure
792348|NCT00021645|Corticosteroids|corticosteroids
792349|NCT00021645|Immunosuppressives|immunosuppressives
792350|NCT00021645|Intraocular Inflammatory Disease|intraocular inflammatory disease
792351|NCT00021645|Uveitis|uveitis
792352|NCT00021645|Macular Edema|macular edema
792353|NCT00021567|Pneumonia|pneumonia
792354|NCT00021567|Cytokine|cytokine
792355|NCT00021567|Aerosol|aerosol
792356|NCT00021567|Therapy|therapy
792357|NCT00021567|Mycobacteria|mycobacteria
792358|NCT00021567|Mycobacterium Avium Complex|mycobacterium avium complex
792359|NCT00021567|MAC|mac
792360|NCT00021567|Pulmonary Infection|pulmonary infection
792361|NCT00021567|Lung Infection|lung infection
792362|NCT00021541|Surrogate Markers|surrogate markers
792363|NCT00021541|3-Dimensional Magnetic Resonance Imaging (MRI)|3-dimensional magnetic resonance imaging (mri)
792364|NCT00021541|Natural History of Neurofibromatosis Type 1 (NF1)|natural history of neurofibromatosis type 1 (nf1)
792365|NCT00021541|Tumor Tissue Bank|tumor tissue bank
792366|NCT00021541|Neurofibromatosis|neurofibromatosis
792367|NCT00021541|NF1|nf1
792368|NCT00021541|Neurofibromatosis Type 1|neurofibromatosis type 1
792369|NCT00021541|Plexiform Neurofibroma|plexiform neurofibroma
792370|NCT00021541|Neurofibroma|neurofibroma
792371|NCT00021528|Sequential Treatment|sequential treatment
792372|NCT00021528|Major Depression|major depression
792373|NCT00021528|Treatment Resistant Depression|treatment resistant depression
792374|NCT00021502|Pyridoxalated hemoglobin polyoxyethylene conjugate (PHP)|pyridoxalated hemoglobin polyoxyethylene conjugate (php)
792375|NCT00021502|Systemic Inflammatory Response Syndrome (SIRS)|systemic inflammatory response syndrome (sirs)
792376|NCT00021502|Nitric oxide (NO)|nitric oxide (no)
792377|NCT00021502|Shock|shock
792378|NCT00021476|Whiplash|whiplash
792379|NCT00021476|Chronic pain|chronic pain
792380|NCT00021476|Motor vehicle accidents|motor vehicle accidents
792381|NCT00021437|Bloom syndrome protein|bloom syndrome protein
792382|NCT00018902|Depressive Disorder|depressive disorder
792383|NCT00018902|Adolescents|adolescents
792384|NCT00018902|Teenagers|teenagers
792385|NCT00018902|Teens|teens
792386|NCT00018902|Cognitive Behavior Therapy|cognitive behavior therapy
792387|NCT00018889|Clinical Evaluation|clinical evaluation
792388|NCT00018889|Genetic Study|genetic study
792389|NCT00018889|Essential Tremor|essential tremor
792390|NCT00018889|Familial Myoclonus|familial myoclonus
792391|NCT00018889|Hereditary Ataxia|hereditary ataxia
792392|NCT00018889|Movement Disorder|movement disorder
792393|NCT00018889|Inherited Movement Disorder|inherited movement disorder
792394|NCT00018876|Epidural fibrosis|epidural fibrosis
792395|NCT00018876|Failed back surgery syndrome|failed back surgery syndrome
792396|NCT00018876|Postlaminectomy syndrome|postlaminectomy syndrome
792397|NCT00018876|Lumbar laminectomy|lumbar laminectomy
792398|NCT00018876|Radiotherapy|radiotherapy
792399|NCT00018876|Radiation|radiation
792400|NCT00018876|Perineural scar formation|perineural scar formation
792401|NCT00018876|Peridural fibrosis|peridural fibrosis
792402|NCT00018876|Back surgery|back surgery
792403|NCT00018863|ADHD|adhd
792404|NCT00018850|schizophrenia|schizophrenia
792405|NCT00018850|ondansetron|ondansetron
792406|NCT00018850|nicotine|nicotine
792407|NCT00018850|haloperidol|haloperidol
792408|NCT00018811|Relaxation Techniques|relaxation techniques
792409|NCT00018811|Behavior Therapy Feedback|behavior therapy feedback
792410|NCT00018811|Psychophysiology|psychophysiology
792518|NCT00018057|Evaluative Learning|evaluative learning
792411|NCT00018798|Combat-Related PTSD, Vietnam Veterans|combat-related ptsd, vietnam veterans
792412|NCT00018785|kidney transplantation|kidney transplantation
792413|NCT00018785|immunosuppression|immunosuppression
792414|NCT00018785|bone marrow|bone marrow
792415|NCT00018772|coagulation|coagulation
792416|NCT00018772|thrombosis genetic markers|thrombosis genetic markers
792417|NCT00018759|Serotonin, Hypertension, Depression|serotonin, hypertension, depression
792418|NCT00018733|Depression|depression
792419|NCT00018720|triglyceride|triglyceride
792420|NCT00018720|bile acids|bile acids
792421|NCT00018720|cholelithias|cholelithias
792422|NCT00018694|bile acid synthesis|bile acid synthesis
792423|NCT00018694|chenodeoxycholic acid|chenodeoxycholic acid
792424|NCT00018694|sterol 27-hydroxylase|sterol 27-hydroxylase
792425|NCT00018668|Antipsychotics|antipsychotics
792426|NCT00018668|schizophrenia|schizophrenia
792427|NCT00018668|motor retardation|motor retardation
792428|NCT00018668|bradykinesia|bradykinesia
792429|NCT00018655|Mood Disorders|mood disorders
792430|NCT00018655|Substance-Related Disorders|substance-related disorders
792431|NCT00018642|quetiapine|quetiapine
792432|NCT00018642|haloperidol decanoate|haloperidol decanoate
792433|NCT00018629|Aging|aging
792434|NCT00018629|Neuropsychology|neuropsychology
792435|NCT00018629|Psychotherapy|psychotherapy
792436|NCT00018629|Rehabilitation|rehabilitation
792437|NCT00018629|Schizophrenia|schizophrenia
792438|NCT00018616|compliance|compliance
792439|NCT00018616|MEMS|mems
792440|NCT00018616|metformin|metformin
792441|NCT00018603|PTSD|ptsd
792442|NCT00018590|Vascular Diseases|vascular diseases
792443|NCT00018538|vitamin D|vitamin d
792444|NCT00018538|prostatic neoplasms|prostatic neoplasms
792445|NCT00018538|neoplasm recurrence|neoplasm recurrence
792446|NCT00018512|dental implant|dental implant
792447|NCT00018499|Traumatic Brain Injury|traumatic brain injury
792448|NCT00018473|Risk Factors|risk factors
792449|NCT00018473|Genes|genes
792450|NCT00018473|Epidemiology|epidemiology
792451|NCT00018473|Apolipoproteins E|apolipoproteins e
792452|NCT00018473|Alzheimer's Disease|alzheimer's disease
792453|NCT00018460|geriatrics|geriatrics
792454|NCT00018460|vitamin B complex|vitamin b complex
792455|NCT00018460|thrombomodulin|thrombomodulin
792456|NCT00018460|anticoagulants|anticoagulants
792457|NCT00018447|osteoporosis|osteoporosis
792458|NCT00018434|Infection|infection
792459|NCT00018421|Cerebrovascular Disorders|cerebrovascular disorders
792460|NCT00018421|Exercise|exercise
792461|NCT00018421|Rehabilitation|rehabilitation
792462|NCT00018408|COPD|copd
792463|NCT00018408|Smoking|smoking
792464|NCT00018395|Calcium Metabolism|calcium metabolism
792465|NCT00018369|Aging|aging
792466|NCT00018369|Hydrocortisone Corticotropin Feedback|hydrocortisone corticotropin feedback
792467|NCT00018356|Aging|aging
792468|NCT00018356|nutrition|nutrition
792469|NCT00018356|rehabilitation|rehabilitation
792470|NCT00018330|Behavioral|behavioral
792471|NCT00018330|Weight Loss|weight loss
792472|NCT00018330|Genetics|genetics
792473|NCT00018330|Lipoprotein lipase|lipoprotein lipase
792474|NCT00018330|Visceral fat|visceral fat
792475|NCT00018330|Lipoprotein|lipoprotein
792476|NCT00018317|Diet|diet
792477|NCT00018317|exercise|exercise
792478|NCT00018304|blood pressure|blood pressure
792479|NCT00018304|insulin sensitivity|insulin sensitivity
792480|NCT00018304|blood flow|blood flow
792481|NCT00018291|Dementia|dementia
792482|NCT00018291|Agitated Behavior|agitated behavior
792483|NCT00018291|Behavioral disturbance|behavioral disturbance
792484|NCT00018265|Rehabilitation|rehabilitation
792485|NCT00018265|exercise test|exercise test
792486|NCT00018265|aging|aging
792487|NCT00018213|Naltrexone|naltrexone
792488|NCT00018213|Nicotine patch|nicotine patch
792489|NCT00018213|Tobacco dependence|tobacco dependence
792490|NCT00018200|analgesia|analgesia
792491|NCT00018200|Back pain|back pain
792492|NCT00018200|sciatica|sciatica
792493|NCT00018187|smoking cessation|smoking cessation
792494|NCT00018187|bupropion|bupropion
792495|NCT00018187|mecamylamine|mecamylamine
792496|NCT00018187|nicotine|nicotine
792497|NCT00018174|Depression|depression
792498|NCT00018174|Fluoxetine|fluoxetine
792499|NCT00018174|Nicotine dependence|nicotine dependence
792500|NCT00018161|Nicotine|nicotine
792501|NCT00018161|addiction|addiction
792502|NCT00018161|cigarette smoking|cigarette smoking
792503|NCT00018148|smoking cessation|smoking cessation
792504|NCT00018135|high iPTH levels|high ipth levels
792505|NCT00018122|Islet cell transplant|islet cell transplant
792506|NCT00018096|Genetics|genetics
792507|NCT00018096|Lipopolysaccharide|lipopolysaccharide
792508|NCT00018070|Age-Related Macular Degeneration|age-related macular degeneration
792509|NCT00018070|Choroid|choroid
792510|NCT00018070|Blood Vessels|blood vessels
792511|NCT00018070|Choroidal Neovascularization|choroidal neovascularization
792512|NCT00018070|Laser|laser
792513|NCT00018070|Macular Degeneration|macular degeneration
792515|NCT00018057|fMRI|fmri
792516|NCT00018057|SSRI|ssri
792517|NCT00018057|Neuropsychological|neuropsychological
792520|NCT00018057|Normal Volunteers|normal volunteers
792521|NCT00018057|Magnetic Resonance Imaging|magnetic resonance imaging
792522|NCT00018057|CBT|cbt
792523|NCT00018057|IPT|ipt
792524|NCT00018057|Anxiety|anxiety
792525|NCT00018057|Anxiety Disorder|anxiety disorder
792526|NCT00018057|Mood Disorder|mood disorder
792527|NCT00018057|Depression|depression
792528|NCT00018057|Healthy Volunteer|healthy volunteer
792529|NCT00018057|Normal Control|normal control
792530|NCT00018044|Morphotype|morphotype
792531|NCT00018044|Pulmonary|pulmonary
792532|NCT00018044|Infection|infection
792533|NCT00018044|Mycobacterium|mycobacterium
792534|NCT00018044|Nontuberculous|nontuberculous
792535|NCT00018044|Mycobacterial Infection|mycobacterial infection
792536|NCT00018044|Nontuberculous Mycobacterial Infection|nontuberculous mycobacterial infection
792537|NCT00018044|NTM|ntm
792538|NCT00018044|Job's Syndrome|job's syndrome
792539|NCT00018044|Job Syndrome|job syndrome
792540|NCT00018044|Cystic Fibrosis|cystic fibrosis
792541|NCT00018044|CF|cf
792542|NCT00018031|Liver Disease|liver disease
792543|NCT00018031|Virologic Response|virologic response
792544|NCT00018031|Immune Mechanisms|immune mechanisms
792545|NCT00018031|Cirrhosis|cirrhosis
792546|NCT00018031|Eradication|eradication
792547|NCT00018031|HIV|hiv
792548|NCT00018031|Hepatitis C|hepatitis c
792549|NCT00018018|Gene Therapy|gene therapy
792550|NCT00018018|ADA-SCID|ada-scid
792551|NCT00018018|Stem Cells|stem cells
792552|NCT00018018|Retroviruses|retroviruses
792553|NCT00018018|Immune Deficiency Disease|immune deficiency disease
792554|NCT00018018|Adenosine Deaminase Deficiency|adenosine deaminase deficiency
792555|NCT00018018|ADA-Deficiency|ada-deficiency
792556|NCT00018018|Retroviral Vectors|retroviral vectors
792557|NCT00018018|Hematopoietic Progenitors|hematopoietic progenitors
792558|NCT00018018|Severe Combined Immunodeficiency|severe combined immunodeficiency
792559|NCT00018018|SCID|scid
792560|NCT00018018|Immune Deficiency|immune deficiency
792561|NCT00018005|Heart Failure|heart failure
792562|NCT00018005|Self-Management|self-management
792563|NCT00018005|Behavioral Clinical Trial|behavioral clinical trial
792564|NCT00017979|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
792565|NCT00017979|Motor Cortex|motor cortex
792566|NCT00017979|Motor Imagery|motor imagery
792567|NCT00017979|Reaction Time|reaction time
792568|NCT00017979|Cerebral Inhibition|cerebral inhibition
792569|NCT00017979|Healthy Volunteer|healthy volunteer
792570|NCT00017979|Normal Control|normal control
792571|NCT00017966|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
792572|NCT00017966|Motor Cortex|motor cortex
792573|NCT00017966|Cerebral Inhibition|cerebral inhibition
792574|NCT00017966|Corpus Callosum|corpus callosum
792575|NCT00017966|Evoked Potential|evoked potential
792576|NCT00017966|Healthy Volunteer|healthy volunteer
792577|NCT00017966|Normal Control|normal control
792578|NCT00017940|Gene Therapy|gene therapy
792579|NCT00017953|Diabetes|diabetes
792580|NCT00017953|Weight loss|weight loss
792581|NCT00017953|Heart Attack|heart attack
792582|NCT00017953|Heart disease|heart disease
792583|NCT00017953|Lifestyle Intervention|lifestyle intervention
792584|NCT00017953|Physical Fitness/Physical Activity|physical fitness/physical activity
792585|NCT00017953|Psychosocial outcomes (e.g., depression, eating disorders)|psychosocial outcomes (e.g., depression, eating disorders)
792586|NCT00017953|Bone Density|bone density
792587|NCT00017927|Acromegaly|acromegaly
792588|NCT00017927|McCune-Albright Syndrome|mccune-albright syndrome
792589|NCT00017927|IGF-1|igf-1
792590|NCT00017927|Adenoma|adenoma
792591|NCT00017927|Hyperplasia|hyperplasia
792592|NCT00017927|MAS|mas
792593|NCT00017927|Polyostotic Fibrous Dysplasia|polyostotic fibrous dysplasia
792594|NCT00017927|PFD|pfd
792595|NCT00017914|Adult and Pediatric Disease|adult and pediatric disease
792596|NCT00017914|Idiopathic Inflammatory Myopathies|idiopathic inflammatory myopathies
792597|NCT00017914|Autoimmunity Pathogenesis|autoimmunity pathogenesis
792598|NCT00017914|Disease Assessment|disease assessment
792599|NCT00017914|Genetic and Environmental Risk Factors|genetic and environmental risk factors
792600|NCT00017914|Idiopathic Inflammatory Myopathy|idiopathic inflammatory myopathy
792601|NCT00017875|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
792602|NCT00017875|Intracortical Inhibition|intracortical inhibition
792603|NCT00017875|Dystonia|dystonia
792604|NCT00017875|Focal Dystonia|focal dystonia
792605|NCT00017875|Dystonic Disorder|dystonic disorder
792606|NCT00017875|DYTI Dystonia|dyti dystonia
792607|NCT00017875|Movement Disorder|movement disorder
792608|NCT00017875|Generalized Dystonia|generalized dystonia
792609|NCT00017875|Healthy Control|healthy control
792610|NCT00017875|Normal Volunteer|normal volunteer
792611|NCT00017823|complementary therapies|complementary therapies
792612|NCT00017823|Acupressure|acupressure
792613|NCT00017823|HIV Infections|hiv infections
792614|NCT00017823|Nausea|nausea
792615|NCT00017823|Vomiting|vomiting
792616|NCT00017810|complementary therapies|complementary therapies
792617|NCT00017810|Behavior Therapy|behavior therapy
792618|NCT00017810|Diarrhea|diarrhea
792619|NCT00017810|Diet Therapy|diet therapy
792621|NCT00017810|HIV Seropositivity|hiv seropositivity
792623|NCT00017745|Hereditary Myopathies|hereditary myopathies
792624|NCT00017745|Intermediate Filaments|intermediate filaments
792625|NCT00017745|Cardiomyopathies|cardiomyopathies
792626|NCT00017745|Genetic Testing|genetic testing
792627|NCT00017745|Myopathy|myopathy
792628|NCT00017745|Inherited Neuromuscular Disorder|inherited neuromuscular disorder
792629|NCT00017732|Malformations|malformations
792630|NCT00017732|Ethnicity|ethnicity
792631|NCT00017732|Mutations|mutations
792632|NCT00017732|Cholesterol|cholesterol
792633|NCT00017732|Metabolism|metabolism
792634|NCT00017732|Smith-Lemli-Opitz Syndrome|smith-lemli-opitz syndrome
792635|NCT00017732|SLOS|slos
792636|NCT00017732|Cholesterol Metabolism|cholesterol metabolism
792637|NCT00017706|physician education|physician education
792638|NCT00017706|behavioral weight control|behavioral weight control
792639|NCT00017706|physician intervention|physician intervention
792640|NCT00017706|obesity counseling|obesity counseling
792641|NCT00016848|Obesity|obesity
792642|NCT00016848|Endocrine|endocrine
792643|NCT00016848|Diet|diet
792644|NCT00016848|Metabolism|metabolism
792645|NCT00016848|Macronutrients|macronutrients
792646|NCT00016835|Type 2 diabetes mellitus|type 2 diabetes mellitus
792647|NCT00016835|Glycemic control|glycemic control
792648|NCT00016835|Periodontal therapy|periodontal therapy
792649|NCT00017680|amyloidosis|amyloidosis
792650|NCT00017680|arthritis & connective tissue diseases|arthritis & connective tissue diseases
792651|NCT00017680|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
792652|NCT00017680|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
792653|NCT00017680|oncologic disorders|oncologic disorders
792654|NCT00017680|plasma cell neoplasm|plasma cell neoplasm
792655|NCT00017680|primary systemic amyloidosis|primary systemic amyloidosis
792656|NCT00017680|rare disease|rare disease
792657|NCT00017654|aplastic anemia|aplastic anemia
792658|NCT00017654|disease-related problem/condition|disease-related problem/condition
792659|NCT00017654|graft versus host disease|graft versus host disease
792660|NCT00017654|hematologic disorders|hematologic disorders
792661|NCT00017654|rare disease|rare disease
792662|NCT00017641|arthritis & connective tissue diseases|arthritis & connective tissue diseases
792663|NCT00017641|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
792664|NCT00017641|rare disease|rare disease
792665|NCT00017641|systemic lupus erythematosus|systemic lupus erythematosus
792666|NCT00017628|multiple sclerosis|multiple sclerosis
792667|NCT00017628|neurologic and psychiatric disorders|neurologic and psychiatric disorders
792668|NCT00017628|rare disease|rare disease
792669|NCT00016796|Reading|reading
792670|NCT00016796|Naming|naming
792671|NCT00016731|Depression|depression
792672|NCT00016731|Anxiety|anxiety
792673|NCT00016731|CAH|cah
792674|NCT00016731|Adults|adults
792675|NCT00016731|FMPP|fmpp
792676|NCT00016731|Emotion|emotion
792677|NCT00016731|Cushing's Syndrome|cushing's syndrome
792678|NCT00016731|Adolescence|adolescence
792679|NCT00016731|Magnetic Resonance Imaging|magnetic resonance imaging
792680|NCT00016731|fMRI|fmri
792681|NCT00016731|Healthy Volunteer|healthy volunteer
792682|NCT00016731|HV|hv
792683|NCT00016731|MRI|mri
792684|NCT00016679|Pharmacokinetics|pharmacokinetics
792685|NCT00016679|Metabolism|metabolism
792686|NCT00016679|Toxicity|toxicity
792687|NCT00016679|Side Effects|side effects
792688|NCT00016679|Essential Tremor|essential tremor
792689|NCT00016679|Tremor|tremor
792690|NCT00016679|Movement Disorder|movement disorder
792691|NCT00016666|Season|season
792692|NCT00016666|Light|light
792693|NCT00016666|Propranolol|propranolol
792694|NCT00016666|Photoperiod|photoperiod
792695|NCT00016666|Pharmacokinetics|pharmacokinetics
792696|NCT00016666|Circadian Rhythm|circadian rhythm
792697|NCT00016666|Seasonal Rhythm|seasonal rhythm
792698|NCT00016666|Seasonal Affective Disorder|seasonal affective disorder
792699|NCT00016666|Pineal Gland|pineal gland
792700|NCT00016666|Suprachiasmatic Nucleus|suprachiasmatic nucleus
792701|NCT00016666|Healthy Volunteer|healthy volunteer
792702|NCT00016666|HV|hv
792703|NCT00016666|Winter Depression|winter depression
792704|NCT00016666|SAD|sad
792705|NCT00016653|Duchenne|duchenne
792706|NCT00016653|muscular|muscular
792707|NCT00016653|dystrophy|dystrophy
792708|NCT00016653|treatment|treatment
792709|NCT00016562|Genetic|genetic
792710|NCT00016562|Degenerative|degenerative
792711|NCT00016562|Lysosomal|lysosomal
792712|NCT00016562|Brain|brain
792713|NCT00016562|Mental Retardation|mental retardation
792714|NCT00016562|Neurodegenerative Disorder|neurodegenerative disorder
792715|NCT00016562|Neurometabolic|neurometabolic
792716|NCT00016562|Metabolic Neurological Disorder|metabolic neurological disorder
792717|NCT00016562|Abnormal Metabolism|abnormal metabolism
792718|NCT00016549|Endothelial Proliferation|endothelial proliferation
792719|NCT00016549|Endothelial Apoptosis|endothelial apoptosis
792720|NCT00016549|VEGF|vegf
792721|NCT00016549|Magnetic Resonance Imaging|magnetic resonance imaging
792722|NCT00016549|Molecular Targets|molecular targets
792723|NCT00016549|Breast Cancer|breast cancer
792724|NCT00016549|Inflammatory Breast Cancer|inflammatory breast cancer
792725|NCT00016549|IBC|ibc
792726|NCT00016523|NICHD Neonatal Research Network|nichd neonatal research network
792727|NCT00016523|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
792728|NCT00016523|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
792729|NCT00016523|Prematurity|prematurity
792730|NCT00016523|Inhaled nitric oxide|inhaled nitric oxide
792731|NCT00016523|Aspiration syndrome|aspiration syndrome
792732|NCT00016523|Idiopathic pulmonary hypertension|idiopathic pulmonary hypertension
792733|NCT00016523|Pulmonary hypoplasia|pulmonary hypoplasia
792734|NCT00016510|Bilingualism|bilingualism
792735|NCT00016510|Fluency|fluency
792736|NCT00016510|Age at Acquisition|age at acquisition
792737|NCT00016510|Words and Sentences|words and sentences
792738|NCT00016510|Cortical Area|cortical area
792739|NCT00016510|Healthy Volunteer|healthy volunteer
792740|NCT00016510|HV|hv
792741|NCT00016510|Bilingual|bilingual
792742|NCT00016510|Second Language|second language
792743|NCT00016497|otitis media with effusion|otitis media with effusion
792744|NCT00016497|children|children
792745|NCT00016497|tympanostomy tubes|tympanostomy tubes
792746|NCT00016497|adenoidectomy|adenoidectomy
792747|NCT00016458|arthritis & connective tissue diseases|arthritis & connective tissue diseases
792748|NCT00016458|rare disease|rare disease
792749|NCT00016458|systemic sclerosis|systemic sclerosis
792750|NCT00016445|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
792751|NCT00016445|cystic fibrosis|cystic fibrosis
792752|NCT00016445|disease-related problem/condition|disease-related problem/condition
792753|NCT00016445|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
792754|NCT00016445|quality of life|quality of life
792755|NCT00016445|rare disease|rare disease
792756|NCT00015808|Neurodegeneration|neurodegeneration
792757|NCT00015808|Anti-Oxidant|anti-oxidant
792758|NCT00015808|Neuropathy|neuropathy
792759|NCT00015808|Hereditary|hereditary
792760|NCT00015808|Spinocerebellar|spinocerebellar
792761|NCT00015808|Friedreich's Ataxia|friedreich's ataxia
792762|NCT00015808|Friedreich Ataxia|friedreich ataxia
792763|NCT00015808|FRDA|frda
792764|NCT00015795|Pressure|pressure
792765|NCT00015795|Botulinum Toxin|botulinum toxin
792766|NCT00015795|Voice|voice
792767|NCT00015795|Dystonia|dystonia
792768|NCT00015795|Pathophysiology|pathophysiology
792769|NCT00015795|Healthy Volunteer|healthy volunteer
792770|NCT00015795|HV|hv
792771|NCT00015795|ABSD|absd
792772|NCT00015795|Spasmodic Dysphonia|spasmodic dysphonia
792773|NCT00015795|Abductor Spasmodic Dysphonia|abductor spasmodic dysphonia
792774|NCT00015782|Metabolic|metabolic
792775|NCT00015782|Genetic|genetic
792776|NCT00015782|Storage|storage
792777|NCT00015782|Retinal Disease|retinal disease
792778|NCT00015782|Degenerative|degenerative
792779|NCT00015782|Mucolipidosis Type IV|mucolipidosis type iv
792780|NCT00015782|ML-IV|ml-iv
792781|NCT00015769|Mania|mania
792782|NCT00015769|Depression|depression
792783|NCT00015769|Anticonvulsants|anticonvulsants
792784|NCT00015769|Mood Stabilizers|mood stabilizers
792785|NCT00015769|Bipolar|bipolar
792786|NCT00015769|Mood Stabilizer|mood stabilizer
792787|NCT00015756|Apheresis|apheresis
792788|NCT00015756|Transplantation|transplantation
792789|NCT00015756|Type III Secretion Pathway|type iii secretion pathway
792790|NCT00015756|Exotoxins|exotoxins
792791|NCT00015756|Pseudomonas Aeruginosa|pseudomonas aeruginosa
792792|NCT00015756|Cystic Fibrosis|cystic fibrosis
792793|NCT00015756|CF|cf
792794|NCT00015717|Imaging|imaging
792795|NCT00015717|Complications|complications
792796|NCT00015717|Stenosis|stenosis
792797|NCT00015717|Treatment|treatment
792798|NCT00015717|Strokes|strokes
792799|NCT00015717|Cerebral Ischemia|cerebral ischemia
792800|NCT00015717|Cranial Cervical Angioplasty|cranial cervical angioplasty
792801|NCT00015678|Motor Cortex|motor cortex
792802|NCT00015678|Drug|drug
792803|NCT00015678|GABA|gaba
792804|NCT00015678|Cortical Modulation|cortical modulation
792805|NCT00015678|Magnetic Stimulation|magnetic stimulation
792806|NCT00015678|Healthy Volunteer|healthy volunteer
792807|NCT00015665|Fungal|fungal
792808|NCT00015665|Immunodeficiency|immunodeficiency
792809|NCT00015665|Infection|infection
792810|NCT00015665|Refractory|refractory
792811|NCT00015665|Severe|severe
792812|NCT00015665|Fungal Infections|fungal infections
792813|NCT00015639|Blood Donors|blood donors
792814|NCT00015639|Employees|employees
792815|NCT00015639|Heparin|heparin
792816|NCT00015639|Histidine-Rich Glycoprotein|histidine-rich glycoprotein
792817|NCT00015639|Membrane|membrane
792818|NCT00015639|Healthy Volunteer|healthy volunteer
792819|NCT00015613|Hispanics|hispanics
792820|NCT00015613|Acculturation|acculturation
792821|NCT00015613|Maternal Exposure|maternal exposure
792822|NCT00015613|Infant, Low Birth Weight|infant, low birth weight
792823|NCT00015613|Infant, Premature|infant, premature
792824|NCT00015613|Organophosphates|organophosphates
792825|NCT00015613|Pesticides|pesticides
792826|NCT00015613|Stress|stress
792830|NCT00015600|Occupational health|occupational health
792831|NCT00015587|Molecular Epidemiology|molecular epidemiology
792832|NCT00015587|Case Control|case control
792833|NCT00015574|arrhythmia|arrhythmia
792834|NCT00015574|cardiac|cardiac
792835|NCT00015574|air pollution|air pollution
792836|NCT00015574|time series|time series
792837|NCT00015561|population studies|population studies
792838|NCT00015561|laboratory evaluation|laboratory evaluation
792839|NCT00015561|hormone analysis|hormone analysis
792840|NCT00015561|semen analysis|semen analysis
792841|NCT00015561|chromosome studies|chromosome studies
792842|NCT00015548|antipsychotic treatment|antipsychotic treatment
792843|NCT00015548|Alzheimer's disease|alzheimer's disease
792844|NCT00015548|agitation|agitation
792845|NCT00015548|dementia|dementia
792846|NCT00015548|psychosis|psychosis
792847|NCT00015548|behavioral symptoms|behavioral symptoms
792848|NCT00015548|hallucinations|hallucinations
792849|NCT00015548|delusions|delusions
792850|NCT00015483|Hematotoxicity|hematotoxicity
792851|NCT00015483|Benzene|benzene
792852|NCT00015483|Bone Marrow|bone marrow
792853|NCT00015470|Myopathy|myopathy
792854|NCT00015470|Dystrophy|dystrophy
792855|NCT00015470|Neuropathy|neuropathy
792856|NCT00015470|Muscle Weakness|muscle weakness
792857|NCT00015470|Muscle Cramps and Pains|muscle cramps and pains
792858|NCT00015470|Neuromuscular Disorders|neuromuscular disorders
792859|NCT00015457|Writer's Cramp|writer's cramp
792860|NCT00015457|Calcium Channel Antagonists|calcium channel antagonists
792861|NCT00015457|Torticollis|torticollis
792862|NCT00015457|Chemodenervation|chemodenervation
792863|NCT00015444|Apparently Sporadic Spastic Paraplegia|apparently sporadic spastic paraplegia
792864|NCT00015444|Spasticity|spasticity
792865|NCT00015444|Motor Neuron Disease|motor neuron disease
792866|NCT00015444|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
792867|NCT00015444|Primary Lateral Sclerosis|primary lateral sclerosis
792868|NCT00015444|Muscle Stiffness|muscle stiffness
792869|NCT00015444|Involuntary Muscle Contraction|involuntary muscle contraction
792870|NCT00015444|Isaacs Syndrome|isaacs syndrome
792871|NCT00015431|Malabsorption|malabsorption
792872|NCT00015431|Endoscopy|endoscopy
792873|NCT00015431|Cytokine|cytokine
792874|NCT00015431|Immunophenotype|immunophenotype
792875|NCT00015431|Lymphocyte|lymphocyte
792876|NCT00015431|Common Variable Immunodeficiency|common variable immunodeficiency
792877|NCT00015431|Gastrointestinal|gastrointestinal
792878|NCT00015015|Dichloroacetate|dichloroacetate
792879|NCT00015015|Chlorinated hydrocarbons|chlorinated hydrocarbons
792880|NCT00015015|Genetic disease|genetic disease
792881|NCT00015015|Toxicology|toxicology
792882|NCT00015015|Biotransformation|biotransformation
792883|NCT00015340|Opioid Dependence|opioid dependence
792884|NCT00015249|cocaine dependence|cocaine dependence
792885|NCT00015210|Cocaine Use Disorders Dependence Depression|cocaine use disorders dependence depression
792886|NCT00015171|opioid dependence|opioid dependence
792887|NCT00015132|cocaine dependence|cocaine dependence
792888|NCT00015106|cocaine dependence|cocaine dependence
792889|NCT00015080|cocaine dependence|cocaine dependence
792890|NCT00015054|cocaine dependence|cocaine dependence
792891|NCT00015041|opiate dependence|opiate dependence
792892|NCT00015028|opioid dependence|opioid dependence
792893|NCT00015002|Antenatal corticosteroids|antenatal corticosteroids
792894|NCT00015002|Preterm delivery|preterm delivery
792895|NCT00014989|Preterm delivery|preterm delivery
792896|NCT00014989|Cerebral palsy|cerebral palsy
792897|NCT00014989|Magnesium sulfate|magnesium sulfate
792898|NCT00014976|Pyramidal Tract|pyramidal tract
792899|NCT00014976|Primary Lateral Sclerosis|primary lateral sclerosis
792900|NCT00014976|Spastic Paraparesis|spastic paraparesis
792901|NCT00014976|EMG|emg
792902|NCT00014976|Magnetic Stimulation|magnetic stimulation
792903|NCT00014976|Muscle Spasticity|muscle spasticity
792904|NCT00014976|Healthy Volunteer|healthy volunteer
792905|NCT00014963|benzene|benzene
792906|NCT00014963|biomarkers|biomarkers
792907|NCT00014963|air pollution|air pollution
792908|NCT00014963|muconic acid|muconic acid
792909|NCT00014963|phenylmercapturic acid|phenylmercapturic acid
792910|NCT00014950|Cystic Fibrosis|cystic fibrosis
792911|NCT00014950|Immunoreactive trypsinogen|immunoreactive trypsinogen
792912|NCT00014950|deltaF508- CFTR gene|deltaf508- cftr gene
792913|NCT00014950|newborn screening|newborn screening
792914|NCT00014950|Pseudomonas aeruginosa infection|pseudomonas aeruginosa infection
792915|NCT00014950|nutrition|nutrition
792916|NCT00014950|pulmonary status|pulmonary status
792917|NCT00014950|meconium ileus|meconium ileus
792918|NCT00014950|growth|growth
792919|NCT00014950|Genetic counseling|genetic counseling
792920|NCT00014950|risk communication|risk communication
792921|NCT00014898|Lead exposure|lead exposure
792922|NCT00014898|Bone lead|bone lead
792923|NCT00014898|Attention deficit|attention deficit
792924|NCT00014885|Lead exposure|lead exposure
792925|NCT00014885|Bone lead|bone lead
792926|NCT00014885|Cognitive function|cognitive function
792927|NCT00014885|Academic achievement|academic achievement
792928|NCT00014885|Neurobehavior|neurobehavior
792929|NCT00014859|Pulmonary surfactant|pulmonary surfactant
792930|NCT00014859|Surfactant protein B|surfactant protein b
792931|NCT00014859|Surfactant protein C|surfactant protein c
792932|NCT00014859|ABCA3|abca3
792933|NCT00014859|NKX2-1|nkx2-1
792934|NCT00014807|Pesticide exposure|pesticide exposure
792935|NCT00014807|Organophosphate|organophosphate
792936|NCT00014807|Biomarkers of exposure|biomarkers of exposure
792937|NCT00014807|Poisoning|poisoning
792938|NCT00014807|Occupational Health|occupational health
792939|NCT00014794|Arthritis|arthritis
792940|NCT00014794|Vascularity|vascularity
792941|NCT00014794|Angiogenesis|angiogenesis
792942|NCT00014794|Imaging|imaging
792943|NCT00014794|MRI|mri
792944|NCT00014794|Rheumatoid Arthritis|rheumatoid arthritis
792945|NCT00014794|PET Scan|pet scan
792946|NCT00014794|Synovitis|synovitis
792947|NCT00014781|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
792948|NCT00014781|cystic fibrosis|cystic fibrosis
792949|NCT00014781|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
792950|NCT00014781|rare disease|rare disease
792951|NCT00014768|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
792952|NCT00014768|cystic fibrosis|cystic fibrosis
792953|NCT00014768|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
792954|NCT00014768|rare disease|rare disease
792955|NCT00014755|multiple sclerosis|multiple sclerosis
792956|NCT00014755|neurologic and psychiatric disorders|neurologic and psychiatric disorders
792957|NCT00014755|rare disease|rare disease
792958|NCT00014742|Dupuytren's disease|dupuytren's disease
792959|NCT00014742|arthritis & connective tissue diseases|arthritis & connective tissue diseases
792960|NCT00014742|rare disease|rare disease
792961|NCT00014729|dermatologic disorders|dermatologic disorders
792962|NCT00014729|epidermolysis bullosa|epidermolysis bullosa
792963|NCT00014729|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
792964|NCT00014729|rare disease|rare disease
792965|NCT00014040|Angina Pectoris|angina pectoris
792966|NCT00014040|Endothelium|endothelium
792967|NCT00014040|Platelets|platelets
792968|NCT00014040|Inflammation|inflammation
792969|NCT00014040|Atherosclerosis|atherosclerosis
792970|NCT00014040|Coronary Artery Disease|coronary artery disease
792971|NCT00014040|Chest Pain|chest pain
792972|NCT00014040|Nitrous Oxide Inhalation|nitrous oxide inhalation
792973|NCT00014040|Treadmill Exercise|treadmill exercise
792974|NCT00014027|Omega-3 Fatty Acids|omega-3 fatty acids
792975|NCT00014027|Cerebrospinal Fluid|cerebrospinal fluid
792976|NCT00014027|Neurotransmitters|neurotransmitters
792977|NCT00014027|Cardiovascular|cardiovascular
792978|NCT00014027|Reactivity|reactivity
792979|NCT00014027|Healthy Volunteer|healthy volunteer
792980|NCT00014027|Lumbar Puncture|lumbar puncture
792981|NCT00014027|MRI|mri
792982|NCT00014001|Antipsychotic Treatment|antipsychotic treatment
792983|NCT00014001|Effectiveness|effectiveness
792984|NCT00013975|Framingham Risk Scoring|framingham risk scoring
792985|NCT00013975|Brachial Artery Reactivity|brachial artery reactivity
792986|NCT00013975|EPC Colony Assay|epc colony assay
792987|NCT00013975|Healthy Volunteer|healthy volunteer
792988|NCT00013975|Atherosclerosis Risk Factors|atherosclerosis risk factors
792989|NCT00013975|Cholesterol|cholesterol
792990|NCT00013975|Hypertension|hypertension
792991|NCT00013975|Smoking|smoking
792992|NCT00013975|Diabetes|diabetes
792993|NCT00013975|Postmenopausal|postmenopausal
792994|NCT00013975|Heart Disease Risk Factors|heart disease risk factors
792995|NCT00013975|Risk Factors|risk factors
792996|NCT00013949|Holter monitoring|holter monitoring
792997|NCT00013949|ECG|ecg
792998|NCT00013949|Cardiac|cardiac
792999|NCT00013949|particulate exposure|particulate exposure
793000|NCT00013936|Instrument Development|instrument development
793001|NCT00013936|Psychophysical Methods|psychophysical methods
793002|NCT00013936|ETDRS|etdrs
793003|NCT00013936|Computer-Based Methods|computer-based methods
793004|NCT00013936|Validation Study|validation study
793005|NCT00013936|Visual Acuity|visual acuity
793006|NCT00013936|Vision Tests/Instrumentation|vision tests/instrumentation
793007|NCT00013936|Psychophysics|psychophysics
793008|NCT00013936|Modified Binary Search|modified binary search
793009|NCT00013936|Visual Acuity Test|visual acuity test
793010|NCT00013923|Nutritional Supplement|nutritional supplement
793011|NCT00013910|glucagon-like peptide 1|glucagon-like peptide 1
793012|NCT00013858|methylmercury|methylmercury
793013|NCT00013858|PCBs|pcbs
793014|NCT00013858|lead|lead
793015|NCT00013858|fish consumption|fish consumption
793016|NCT00013858|breast-feeding|breast-feeding
793017|NCT00013884|HIV|hiv
793018|NCT00013884|T20|t20
793019|NCT00013884|HAART|haart
793020|NCT00013884|Interruption|interruption
793021|NCT00013884|Therapy|therapy
793022|NCT00013884|Fusion Inhibitor T20|fusion inhibitor t20
793023|NCT00013884|Treatment Interuption|treatment interuption
793024|NCT00013845|Seizures|seizures
793025|NCT00013845|Anti-Epileptic Drugs|anti-epileptic drugs
793026|NCT00013845|Pharmacotherapy|pharmacotherapy
793027|NCT00013845|Neuropsychology|neuropsychology
793028|NCT00013845|Temporal Lobe Epilepsy|temporal lobe epilepsy
796236|NCT00001910|Asthma|asthma
793029|NCT00013845|Frontal Lobe Epilepsy|frontal lobe epilepsy
793030|NCT00013845|Complex Partial Seizures|complex partial seizures
793031|NCT00013845|Grand Mal Seizures|grand mal seizures
793032|NCT00013845|Generalized Seizures|generalized seizures
793033|NCT00013845|Epilepsy|epilepsy
793034|NCT00013832|Pressure|pressure
793035|NCT00013832|Swallowing|swallowing
793036|NCT00013832|Tongue|tongue
793037|NCT00013832|Healthy Volunteer|healthy volunteer
793038|NCT00013832|Dysphagia|dysphagia
793039|NCT00013819|lead poisoning|lead poisoning
793040|NCT00013819|central nervous system|central nervous system
793041|NCT00013819|peripheral nervous system|peripheral nervous system
793042|NCT00013819|occupational health|occupational health
793043|NCT00013819|genetic susceptibility|genetic susceptibility
793044|NCT00013806|Relapsed and refractory neuroblastoma|relapsed and refractory neuroblastoma
793045|NCT00013780|ozone uptake|ozone uptake
793046|NCT00013780|inhalation toxicology|inhalation toxicology
793047|NCT00013780|nasal cavities|nasal cavities
793048|NCT00013780|antioxidants|antioxidants
793049|NCT00013767|Pesticide|pesticide
793050|NCT00013767|Insecticide|insecticide
793051|NCT00013767|Organophosphate|organophosphate
793052|NCT00013767|Child Health|child health
793053|NCT00013767|Exposure Prevention|exposure prevention
793054|NCT00013754|pesticide|pesticide
793055|NCT00013754|insecticide|insecticide
793056|NCT00013754|organophosphate|organophosphate
793057|NCT00013754|exposure|exposure
793058|NCT00013754|child health|child health
793059|NCT00013741|Acute Myocardial Infarction|acute myocardial infarction
793060|NCT00013741|Diabetes Mellitus|diabetes mellitus
793061|NCT00013741|Renal Dialysis|renal dialysis
793062|NCT00013741|Heart Attack|heart attack
793063|NCT00013741|Coronary Heart Disease|coronary heart disease
793064|NCT00013728|asthma|asthma
793065|NCT00013728|particulate matter|particulate matter
793066|NCT00013715|Asthma|asthma
793067|NCT00013715|Rhinovirus|rhinovirus
793068|NCT00013715|Ozone|ozone
793069|NCT00013702|Immunology|immunology
793070|NCT00013702|Cirrhosis|cirrhosis
793071|NCT00013702|Ascites|ascites
793072|NCT00013702|Open-Label|open-label
793073|NCT00013702|Chronic|chronic
793074|NCT00013702|HIV|hiv
793075|NCT00013702|Hepatitis B|hepatitis b
793076|NCT00013689|Lymphadenopathy|lymphadenopathy
793077|NCT00013689|Splenomegaly|splenomegaly
793078|NCT00013689|Children|children
793079|NCT00013689|Tomography|tomography
793080|NCT00013689|Autoimmune Lymphoproliferative Syndrome (ALPS)|autoimmune lymphoproliferative syndrome (alps)
793081|NCT00013650|Alzheimer's Disease|alzheimer's disease
793082|NCT00013650|Immunomodulatory|immunomodulatory
793083|NCT00013650|Antiinflammatory|antiinflammatory
793084|NCT00013650|Cyclophosphamide|cyclophosphamide
793085|NCT00013650|Non-steroidal|non-steroidal
793086|NCT00013650|Complement|complement
793087|NCT00013650|Immune Function|immune function
793088|NCT00013650|Immunotherapy|immunotherapy
793089|NCT00013637|Osteoporosis|osteoporosis
793090|NCT00013637|Lead|lead
793091|NCT00013624|Riluzole|riluzole
793092|NCT00013624|Dyskinesias|dyskinesias
793093|NCT00013624|L-Dopa Infusion|l-dopa infusion
793094|NCT00013624|Parkinson's Disease|parkinson's disease
793095|NCT00013611|HIV|hiv
793096|NCT00013611|Proleukin|proleukin
793097|NCT00013611|IL-2|il-2
793098|NCT00013611|Adult|adult
793099|NCT00013611|HAART|haart
793100|NCT00013611|Treatment Experienced|treatment experienced
793101|NCT00013598|Insulin Resistance|insulin resistance
793102|NCT00013598|Obesity|obesity
793103|NCT00013598|Diabetes|diabetes
793104|NCT00013598|Fatty Liver|fatty liver
793105|NCT00013598|Cirrhosis|cirrhosis
793106|NCT00013598|Thiazolidinediones|thiazolidinediones
793107|NCT00013598|Peroxisome Proliferator-Activated Receptor Gamma|peroxisome proliferator-activated receptor gamma
793108|NCT00013598|PPARgamma|ppargamma
793109|NCT00013598|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
793110|NCT00013598|Pioglitazone|pioglitazone
793111|NCT00013598|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
793112|NCT00013598|Liver Biopsy|liver biopsy
793113|NCT00013598|Pharmacotherapy|pharmacotherapy
793114|NCT00013559|Sleep Disturbance|sleep disturbance
793115|NCT00013559|Developmental Delay/ MR|developmental delay/ mr
793116|NCT00013559|Deletion 17p11.2|deletion 17p11.2
793117|NCT00013559|Chromosomal Abnormalities|chromosomal abnormalities
793118|NCT00013559|Behavioral Phenotype|behavioral phenotype
793119|NCT00013559|Smith-Magenis Syndrome|smith-magenis syndrome
793120|NCT00013559|Genetics|genetics
793121|NCT00013546|Osteoporosis|osteoporosis
793122|NCT00013546|Body Composition|body composition
793123|NCT00013546|Estrogen|estrogen
793124|NCT00013546|Androgen|androgen
793125|NCT00013546|Ovarian Failure|ovarian failure
793126|NCT00013546|Turner's Syndrome|turner's syndrome
793127|NCT00013546|Hormone Replacement|hormone replacement
793129|NCT00013546|Turner's|turner's
793130|NCT00013546|TS|ts
793131|NCT00013533|Leukemia|leukemia
793132|NCT00013533|Myelodysplastic Syndrome|myelodysplastic syndrome
793133|NCT00013533|Bone Marrow Transplant|bone marrow transplant
793134|NCT00013533|Pediatric Oncology|pediatric oncology
793135|NCT00013533|Lymphoma|lymphoma
793136|NCT00013533|Efficacy|efficacy
793137|NCT00013533|Safety|safety
793138|NCT00013533|Childhood Cancer|childhood cancer
793139|NCT00013507|Frail|frail
793140|NCT00013507|FIT|fit
793141|NCT00013507|transfer|transfer
793142|NCT00013507|continence|continence
793143|NCT00013507|ambulation|ambulation
793144|NCT00013507|balance|balance
793145|NCT00013507|fall risk|fall risk
793146|NCT00013507|strength,endurance|strength,endurance
793147|NCT00013494|Hemiplegia|hemiplegia
793148|NCT00013494|elderly|elderly
793149|NCT00013494|Video|video
793150|NCT00013494|F-PAT,Functional Performance|f-pat,functional performance
793151|NCT00013494|digitized videoclips|digitized videoclips
793152|NCT00013481|stroke, hemiparesis, CNS, motor coordination|stroke, hemiparesis, cns, motor coordination
793153|NCT00013468|Hearing loss, ear, steroids, auditory|hearing loss, ear, steroids, auditory
793154|NCT00013455|Hearing aid, hearing impaired|hearing aid, hearing impaired
793155|NCT00013442|Aphasia, auditory evoked, aging|aphasia, auditory evoked, aging
793156|NCT00013429|Vision, Opthalmology, blindness, aging|vision, opthalmology, blindness, aging
793157|NCT00013416|Hearing loss, hearing aid, amplification|hearing loss, hearing aid, amplification
793158|NCT00013403|Vision, quality of life|vision, quality of life
793159|NCT00013390|Auditory, tinnitus|auditory, tinnitus
793160|NCT00013377|Low vision, Driving rehabilitation|low vision, driving rehabilitation
793161|NCT00013364|Hearing loss, speech recognition|hearing loss, speech recognition
793162|NCT00013351|Aging adult, attention, falls, vision|aging adult, attention, falls, vision
793163|NCT00013338|Spinal cord injury, ambulation, treadmill|spinal cord injury, ambulation, treadmill
793164|NCT00013325|Spinal cord injury, heart disease, electrocardiography|spinal cord injury, heart disease, electrocardiography
793165|NCT00013312|Spinal cord injury, gastrointestinal motility, gastrointestinal transit|spinal cord injury, gastrointestinal motility, gastrointestinal transit
793166|NCT00013299|Foot ulcers, amputation prevention, diabetes, footwear, insoles|foot ulcers, amputation prevention, diabetes, footwear, insoles
793167|NCT00013286|Diabetes mellitus, foot ulcer, endothelium|diabetes mellitus, foot ulcer, endothelium
793168|NCT00013273|Venous insufficiency, plethysmography, hypertension|venous insufficiency, plethysmography, hypertension
793169|NCT00013260|Case management|case management
793170|NCT00013260|Nurse intervention|nurse intervention
793171|NCT00013195|Telephone|telephone
793172|NCT00013026|Congestive Heart Failure|congestive heart failure
793173|NCT00012844|Musculoskeletal Disorders|musculoskeletal disorders
793174|NCT00012844|Patient Lifting|patient lifting
793175|NCT00012844|Occupational Accidents|occupational accidents
793176|NCT00012779|Health Care Education|health care education
793177|NCT00012779|Health Care Cost|health care cost
793178|NCT00012558|Psychotic Disorders|psychotic disorders
793179|NCT00012558|Mood Disorders|mood disorders
793180|NCT00012558|Manic-Depressive Illness|manic-depressive illness
793181|NCT00012558|Hypomania|hypomania
793182|NCT00012558|Mania|mania
793183|NCT00012558|Mood Stabilizer|mood stabilizer
793184|NCT00012545|Stem Cells|stem cells
793185|NCT00012545|Sickle Cell Disease|sickle cell disease
793186|NCT00012545|Umbilical Cord Blood|umbilical cord blood
793187|NCT00012493|Cardiac event|cardiac event
793188|NCT00012493|Heart disease|heart disease
793189|NCT00012493|Particulate Matter|particulate matter
793190|NCT00012480|Lead|lead
793191|NCT00012480|Male infertility|male infertility
793192|NCT00012480|Gene expression|gene expression
793193|NCT00012480|Economics, Medical|economics, medical
793194|NCT00012441|Renal Dialysis|renal dialysis
793195|NCT00012428|Cognitive development|cognitive development
793196|NCT00012428|Prenatal exposure|prenatal exposure
793197|NCT00012428|PCBs|pcbs
793198|NCT00011908|Safety|safety
793199|NCT00011908|B-Lymphocyte Depletion|b-lymphocyte depletion
793200|NCT00011908|Anti-CD22|anti-cd22
793201|NCT00011908|Response|response
793202|NCT00011908|Efficacy|efficacy
793203|NCT00011908|Lupus|lupus
793204|NCT00011908|Immunotherapy|immunotherapy
793205|NCT00011856|Intracranial Aneurysms|intracranial aneurysms
793206|NCT00011856|Cerebral|cerebral
793207|NCT00011856|Loci|loci
793208|NCT00011856|Susceptibility Genes|susceptibility genes
793209|NCT00011856|Cerebral Aneurysm|cerebral aneurysm
793210|NCT00011856|Familial Cerebral Aneurysm|familial cerebral aneurysm
793211|NCT00011856|Genetics|genetics
793212|NCT00011843|X-Linked|x-linked
793213|NCT00011843|Heterogeneous|heterogeneous
793214|NCT00011843|Embryologic Development|embryologic development
793215|NCT00011843|Mental Retardation|mental retardation
793216|NCT00011843|Brain Development|brain development
793217|NCT00011843|Microphthalmia|microphthalmia
793218|NCT00011843|Anophthalmia|anophthalmia
793219|NCT00011843|Malformations|malformations
793220|NCT00011843|Lenz Dysplasia|lenz dysplasia
793221|NCT00011843|Microphthalmia/Anophthalmia|microphthalmia/anophthalmia
793222|NCT00011843|Mutation Screening|mutation screening
793223|NCT00011843|Gene Characterization|gene characterization
793224|NCT00011830|Stem Cell Cryopreservation|stem cell cryopreservation
793225|NCT00011830|Leukapheresis|leukapheresis
793226|NCT00011817|Evaluation and Treatment|evaluation and treatment
793227|NCT00011817|Ophthalmic Genetic Diseases|ophthalmic genetic diseases
793228|NCT00011817|Genetic Testing|genetic testing
793229|NCT00011817|Genetic Eye Diseases|genetic eye diseases
793230|NCT00011817|Evaluation|evaluation
793231|NCT00011804|Low Back Pain|low back pain
793232|NCT00011804|Lumbar Radiculopathy|lumbar radiculopathy
793233|NCT00011804|Anticonvulsants|anticonvulsants
793234|NCT00011804|Neuropathic Pain|neuropathic pain
793235|NCT00011804|Analgesia|analgesia
793236|NCT00011804|Sciatica|sciatica
793237|NCT00011791|CAH|cah
793238|NCT00011791|Catecholamines|catecholamines
793239|NCT00011791|Adrenal Medulla|adrenal medulla
793240|NCT00011791|Endocrine|endocrine
793241|NCT00011791|Congenital Adrenal Hyperplasia|congenital adrenal hyperplasia
793242|NCT00011791|Exercise|exercise
793243|NCT00011791|Healthy Volunteer|healthy volunteer
793244|NCT00011778|Cell Cycle|cell cycle
793245|NCT00011778|NFKB|nfkb
793246|NCT00011778|Combined Modality|combined modality
793247|NCT00011778|Radiosensitizer|radiosensitizer
793248|NCT00011778|Ubiquitin|ubiquitin
793249|NCT00011778|Head and Neck Cancer|head and neck cancer
793250|NCT00011778|Squamous Cell Carcinoma|squamous cell carcinoma
793251|NCT00011778|Radiation Therapy|radiation therapy
793252|NCT00011778|Protease Inhibitor|protease inhibitor
793253|NCT00011765|Aggression|aggression
793254|NCT00011765|Serotonin Reuptake Inhibitors (SSRI)|serotonin reuptake inhibitors (ssri)
793255|NCT00011765|Rage|rage
793256|NCT00011765|Fear|fear
793257|NCT00011765|Violence|violence
793258|NCT00011765|Domestic Violence|domestic violence
793259|NCT00011765|Physical Aggression|physical aggression
793260|NCT00011765|Serotonin Reuptake Inhibitor|serotonin reuptake inhibitor
793261|NCT00011752|Serotonin Reuptake|serotonin reuptake
793262|NCT00011752|Large Neutral Amino Acids|large neutral amino acids
793263|NCT00011752|5-Hydroxyindoleacetic Acid|5-hydroxyindoleacetic acid
793264|NCT00011752|Alcoholism|alcoholism
793265|NCT00011752|PET|pet
793266|NCT00011752|TRP|trp
793267|NCT00011752|Tryptophan Depletion|tryptophan depletion
793268|NCT00011752|Healthy Volunteer|healthy volunteer
793269|NCT00011739|Low back pain, Magnetic resonance imaging (MRI),|low back pain, magnetic resonance imaging (mri),
793270|NCT00011726|Pregnancy|pregnancy
793271|NCT00011726|Lead Exposure|lead exposure
793272|NCT00011726|Lactation|lactation
793273|NCT00011726|Bone Mineralization|bone mineralization
793274|NCT00011726|Maternal-Fetal Exchange|maternal-fetal exchange
793275|NCT00011713|Semen|semen
793276|NCT00011713|Infertility|infertility
793277|NCT00011713|ART - Assisted Reproduction Technology|art - assisted reproduction technology
793278|NCT00011713|Phthalates|phthalates
793279|NCT00011713|Bisphenol A|bisphenol a
793280|NCT00011700|idiopathic pulmonary hemorrhage in infants,|idiopathic pulmonary hemorrhage in infants,
793281|NCT00011700|toxigenic mold exposure|toxigenic mold exposure
793282|NCT00011687|Fertility|fertility
793283|NCT00011687|Hormones|hormones
793284|NCT00011687|Semen|semen
793285|NCT00011687|Reproductive Health|reproductive health
793286|NCT00011674|Lead|lead
793287|NCT00011674|Prenatal|prenatal
793288|NCT00011674|Development|development
793289|NCT00011674|Children|children
793290|NCT00011674|Psychology|psychology
793291|NCT00011674|Toxicology|toxicology
793292|NCT00011674|Teratology|teratology
793293|NCT00011661|Lead poisoning|lead poisoning
793294|NCT00011661|Native Americans|native americans
793295|NCT00011648|Echocardiogram|echocardiogram
793296|NCT00011648|Morbidity|morbidity
793297|NCT00011648|Mortality|mortality
793298|NCT00011648|Sickle Cell Anemia|sickle cell anemia
793299|NCT00011648|Secondary Pulmonary Hypertension|secondary pulmonary hypertension
793300|NCT00011609|Robotics; Activities of Daily Living; Spinal Cord Injuries|robotics; activities of daily living; spinal cord injuries
793301|NCT00011596|Hemiplegia, gait, electric stimulation|hemiplegia, gait, electric stimulation
793302|NCT00011583|Cerebrovascular|cerebrovascular
793303|NCT00011583|Hemiplegia|hemiplegia
793304|NCT00011583|Robotics|robotics
793305|NCT00011570|defecation|defecation
793306|NCT00011570|electrical stimulation|electrical stimulation
793307|NCT00011570|penile erection|penile erection
793308|NCT00011570|Spinal cord injury|spinal cord injury
793309|NCT00011570|urology|urology
793310|NCT00011557|Bladder, electromagnetic fields, Spinal cord injury|bladder, electromagnetic fields, spinal cord injury
793311|NCT00011544|wheelchair, biomechanics, aging, functional outcome, disability|wheelchair, biomechanics, aging, functional outcome, disability
793312|NCT00011531|Decubitus Ulcers|decubitus ulcers
793313|NCT00011531|dehiscence|dehiscence
793314|NCT00011531|SCI|sci
793315|NCT00011531|wound healing|wound healing
793316|NCT00011518|Arsenic|arsenic
793317|NCT00011518|Bladder Cancer|bladder cancer
793318|NCT00011518|Drinking Water|drinking water
793319|NCT00011505|G-CSF|g-csf
793320|NCT00011505|Leukapheresis|leukapheresis
793321|NCT00011505|Stem Cell Cryopreservation|stem cell cryopreservation
793322|NCT00011505|Central Line Placement|central line placement
793323|NCT00011505|G-CSF Administration|g-csf administration
793324|NCT00011505|Stem Cell Preservation|stem cell preservation
793325|NCT00011505|Diamond Blackfan Anemia|diamond blackfan anemia
796237|NCT00001910|Cytokine|cytokine
793326|NCT00011505|Healthy Volunteer|healthy volunteer
793327|NCT00011492|Oral Cancer|oral cancer
793328|NCT00011492|Squamous Cell Cancer|squamous cell cancer
793329|NCT00011492|Head and Neck Cancer|head and neck cancer
793330|NCT00011492|Laryngeal Cancer|laryngeal cancer
793331|NCT00011492|Pharnygeal Cancer|pharnygeal cancer
793332|NCT00011492|Squamous Cell Carcinoma|squamous cell carcinoma
793333|NCT00011466|ADHD|adhd
793334|NCT00011466|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
793335|NCT00011466|Carbohydrate Craving|carbohydrate craving
793336|NCT00011453|NQO1|nqo1
793337|NCT00011453|DT-diaphorase|dt-diaphorase
793338|NCT00011453|Benzene|benzene
793339|NCT00011453|Leukemia|leukemia
793340|NCT00011453|Aplastic anemia|aplastic anemia
793341|NCT00011440|Allergy|allergy
793342|NCT00011440|Air pollution|air pollution
793343|NCT00011440|Lung function|lung function
793344|NCT00011440|Inflammation|inflammation
793345|NCT00011414|Drug Resistance|drug resistance
793346|NCT00011414|PEDIATRIC SOLID TUMORS|pediatric solid tumors
793347|NCT00011414|Chemotherapy|chemotherapy
793348|NCT00011414|p-glycoprotien|p-glycoprotien
793349|NCT00011414|Brain Tumors|brain tumors
793350|NCT00011414|Childhood Cancer|childhood cancer
793351|NCT00011414|Brain Tumor|brain tumor
793352|NCT00011388|Organochlorine compounds|organochlorine compounds
793353|NCT00011388|Endocrine disruptors|endocrine disruptors
793354|NCT00011388|Sex Hormones|sex hormones
793355|NCT00011388|Reproductive function|reproductive function
793356|NCT00011388|Menstrual Disturbances|menstrual disturbances
793357|NCT00011375|Phosphodiesterase Inhibitor|phosphodiesterase inhibitor
793358|NCT00011375|Immunology|immunology
793359|NCT00011375|Immunomodulation|immunomodulation
793360|NCT00011375|Antidepressant|antidepressant
793361|NCT00011375|Therapy|therapy
793362|NCT00011375|Multiple Sclerosis|multiple sclerosis
793363|NCT00011375|Immunotherapy|immunotherapy
793364|NCT00011362|NICHD Neonatal Research Network|nichd neonatal research network
793365|NCT00011362|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
793366|NCT00011362|Prematurity|prematurity
793367|NCT00011362|Dexamethasone|dexamethasone
793368|NCT00011362|Glucocorticoids|glucocorticoids
793369|NCT00011362|Respiratory Distress Syndrome|respiratory distress syndrome
793370|NCT00011362|Respiratory insufficiency|respiratory insufficiency
793371|NCT00011362|Steroids|steroids
793372|NCT00011349|Prostate Cancer|prostate cancer
793373|NCT00011336|SCI|sci
793374|NCT00011336|chronic respiratory symptoms|chronic respiratory symptoms
793375|NCT00011336|measures of pulmonary function|measures of pulmonary function
793376|NCT00011336|respiratory illness|respiratory illness
793377|NCT00011323|osteoporosis,smoking, alcohol, caffeine|osteoporosis,smoking, alcohol, caffeine
793378|NCT00011310|Particulates|particulates
793379|NCT00011310|Air Pollution|air pollution
793380|NCT00011310|Cardiopulmonary Disease|cardiopulmonary disease
793381|NCT00011310|Lung|lung
793382|NCT00011310|Inflammation|inflammation
793383|NCT00011284|Liver|liver
793384|NCT00011284|Inflammation|inflammation
793385|NCT00011284|Endotoxin|endotoxin
793386|NCT00011284|Neutrophils|neutrophils
793387|NCT00011284|Hepatocytes|hepatocytes
793388|NCT00011258|Atherosclerosis of the carotid arteries|atherosclerosis of the carotid arteries
793389|NCT00011258|stroke|stroke
793390|NCT00011258|lipoprotein metabolism|lipoprotein metabolism
793391|NCT00011258|paraoxonase|paraoxonase
793392|NCT00011245|Arachnoiditis|arachnoiditis
793393|NCT00011245|Myelography|myelography
793394|NCT00011245|Intraoperative Ultrasonography|intraoperative ultrasonography
793395|NCT00011245|Magnetic Resonance|magnetic resonance
793396|NCT00011245|CSF Pressure|csf pressure
793397|NCT00011245|Trauma|trauma
793398|NCT00011245|Meningitis|meningitis
793399|NCT00011245|Paralysis|paralysis
793400|NCT00011245|Spondylosis|spondylosis
793401|NCT00011245|Spinal Syringomyelia|spinal syringomyelia
793402|NCT00011245|Presyringomyelia|presyringomyelia
793403|NCT00011245|Spinal Cord Edema|spinal cord edema
793404|NCT00011245|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
793405|NCT00011245|Intraoperative Radiation|intraoperative radiation
793406|NCT00011245|Ultrasonography|ultrasonography
793407|NCT00011141|Immune-mediated diabetes mellitus|immune-mediated diabetes mellitus
793408|NCT00011193|Cardiovascular Diseases|cardiovascular diseases
793409|NCT00011193|Hypertension|hypertension
793410|NCT00011193|Postmenopausal|postmenopausal
793411|NCT00011193|Overweight or Obese|overweight or obese
793412|NCT00011193|Women|women
793413|NCT00011193|Sedentary|sedentary
793414|NCT00011180|Venous thromboembolism (VTE)|venous thromboembolism (vte)
793415|NCT00011180|Deep vein thrombosis (DVT)|deep vein thrombosis (dvt)
793416|NCT00011180|Pulmonary embolism (PE)|pulmonary embolism (pe)
793417|NCT00011076|Deskar|deskar
793418|NCT00011076|Fibrosis|fibrosis
793419|NCT00011076|Myocardium|myocardium
793420|NCT00011076|Scarring|scarring
793421|NCT00011076|Arrhythmia|arrhythmia
793422|NCT00011076|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
793423|NCT00011076|Left Ventricular Diastolic Dysfunction|left ventricular diastolic dysfunction
793424|NCT00011076|Myocardial Fibrosis|myocardial fibrosis
793427|NCT00010998|Multiple Sclerosis|multiple sclerosis
793428|NCT00010998|Yoga|yoga
793429|NCT00010985|Backpain|backpain
793430|NCT00010985|Pain|pain
793431|NCT00010985|Alternative Medicine|alternative medicine
793432|NCT00010985|Acupuncture|acupuncture
793433|NCT00010985|Chiropractic|chiropractic
793434|NCT00010985|Massage Therapy|massage therapy
793435|NCT00010959|menopause|menopause
793436|NCT00010959|hot flashes|hot flashes
793437|NCT00010959|botanicals|botanicals
793438|NCT00010946|acupuncture|acupuncture
793439|NCT00010946|osteoarthritis|osteoarthritis
793440|NCT00010946|elderly|elderly
793441|NCT00010868|bipolar disorder|bipolar disorder
793442|NCT00010868|omega-3 fatty acids|omega-3 fatty acids
793443|NCT00010868|eicosapentaenoic acid|eicosapentaenoic acid
793444|NCT00010868|docosahexaenoic acid|docosahexaenoic acid
793445|NCT00010855|hypnosis|hypnosis
793446|NCT00010855|relaxation|relaxation
793447|NCT00010855|invasive medical procedures|invasive medical procedures
793448|NCT00010855|interventional radiology|interventional radiology
793449|NCT00010855|conscious sedation|conscious sedation
793450|NCT00010855|anesthesia|anesthesia
793451|NCT00010855|complications|complications
793452|NCT00010855|cost analysis|cost analysis
793453|NCT00010855|Interventional procedures, complications|interventional procedures, complications
793454|NCT00010855|Angiography|angiography
793455|NCT00010855|Nephrostomy|nephrostomy
793456|NCT00010855|Hepatic chemoembolization|hepatic chemoembolization
793457|NCT00010855|Fibroid Embolization|fibroid embolization
793458|NCT00010829|Cardiovascular Diseases|cardiovascular diseases
793459|NCT00010829|Osteoporosis|osteoporosis
793460|NCT00010829|Breast Cancer|breast cancer
793461|NCT00010829|Endometrial Cancer|endometrial cancer
793462|NCT00010725|CVD|cvd
793463|NCT00010712|Menopause|menopause
793464|NCT00010712|Hot Flashes|hot flashes
793465|NCT00010712|Osteoporosis|osteoporosis
793466|NCT00010712|Postmenopausal|postmenopausal
793467|NCT00010699|cvd|cvd
793468|NCT00010608|CVD|cvd
793469|NCT00010530|CVD|cvd
793470|NCT00010504|acupuncture|acupuncture
793471|NCT00010504|fibromyalgia|fibromyalgia
793472|NCT00010504|pain|pain
793473|NCT00010504|analgesia|analgesia
793474|NCT00010491|Diarrhea|diarrhea
793475|NCT00010491|complementary therapies|complementary therapies
793476|NCT00009685|Vaccine|vaccine
793477|NCT00009685|HIV|hiv
793478|NCT00009685|Codon-Optimized|codon-optimized
793479|NCT00009685|HIV Vaccine|hiv vaccine
793480|NCT00009685|Healthy Volunteer|healthy volunteer
793481|NCT00009685|HIV-1 DNA Vaccine|hiv-1 dna vaccine
793482|NCT00009685|HIV Seronegativity|hiv seronegativity
793483|NCT00009685|HIV Preventive Vaccine|hiv preventive vaccine
793484|NCT00009672|Low Back Pain|low back pain
793485|NCT00009672|Opioid|opioid
793486|NCT00009672|Antidepressant|antidepressant
793487|NCT00009672|Randomized Controlled Trial|randomized controlled trial
793488|NCT00009672|Analgesic|analgesic
793489|NCT00009672|Sciatica|sciatica
793490|NCT00009659|Endometrium|endometrium
793491|NCT00009659|Estrogen|estrogen
793492|NCT00009659|Antihormone|antihormone
793493|NCT00009659|Menopause|menopause
793494|NCT00009659|Progesterone|progesterone
793495|NCT00009659|Postmenopausal Women|postmenopausal women
793496|NCT00009659|Hormone Replacement|hormone replacement
793497|NCT00009646|Chronic lung disease|chronic lung disease
793498|NCT00009646|Indocin|indocin
793499|NCT00009646|Indomethacin|indomethacin
793500|NCT00009646|Infants, very low birth weight|infants, very low birth weight
793501|NCT00009646|Intraventricular hemorrhage|intraventricular hemorrhage
793502|NCT00009646|Necrotizing enterocolitis|necrotizing enterocolitis
793503|NCT00009646|Patent ductus arteriosus|patent ductus arteriosus
793504|NCT00009646|Pulmonary hemorrhage|pulmonary hemorrhage
793505|NCT00009633|NICHD Neonatal Research Network|nichd neonatal research network
793506|NCT00009633|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
793507|NCT00009633|Prematurity|prematurity
793508|NCT00009633|Neurodevelopmental Outcome|neurodevelopmental outcome
793509|NCT00009633|Follow up studies|follow up studies
793510|NCT00009620|NICHD Neonatal Research Network|nichd neonatal research network
793511|NCT00009620|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
793512|NCT00009620|Prematurity|prematurity
793513|NCT00009620|Cerebral hemorrhage|cerebral hemorrhage
793514|NCT00009620|Phenobarbital|phenobarbital
793515|NCT00009620|Pregnancy|pregnancy
793516|NCT00009620|Prenatal care|prenatal care
793517|NCT00009620|Intraventricular hemorrhage|intraventricular hemorrhage
793518|NCT00009620|Periventricular leukomalacia|periventricular leukomalacia
793519|NCT00009620|Brain injury|brain injury
793520|NCT00009620|Brain hemorrhage|brain hemorrhage
793521|NCT00010452|cystic hygroma|cystic hygroma
793522|NCT00010452|lymphangiomas|lymphangiomas
793523|NCT00010452|lymphatic malformations|lymphatic malformations
793524|NCT00010439|arthritis & connective tissue diseases|arthritis & connective tissue diseases
793525|NCT00010439|idiopathic juvenile osteoporosis|idiopathic juvenile osteoporosis
793526|NCT00010439|rare disease|rare disease
793527|NCT00010426|cystinosis|cystinosis
793528|NCT00010426|rare disease|rare disease
793529|NCT00010426|renal and genitourinary disorders|renal and genitourinary disorders
793530|NCT00010413|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
793531|NCT00010413|pemphigus|pemphigus
793532|NCT00010413|rare disease|rare disease
793533|NCT00010400|antiphospholipid antibody syndrome|antiphospholipid antibody syndrome
793534|NCT00010400|arthritis & connective tissue diseases|arthritis & connective tissue diseases
793535|NCT00010400|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
793536|NCT00010400|rare disease|rare disease
793537|NCT00010400|systemic lupus erythematosus|systemic lupus erythematosus
793538|NCT00010387|Felty syndrome|felty syndrome
793539|NCT00010387|autoimmune hemolytic anemia|autoimmune hemolytic anemia
793540|NCT00010387|autoimmune neutropenia|autoimmune neutropenia
793541|NCT00010387|hematologic disorders|hematologic disorders
793542|NCT00010387|immune thrombocytopenic purpura|immune thrombocytopenic purpura
793543|NCT00010387|rare disease|rare disease
793544|NCT00010374|Diaphragm for Ventilatory Assist|diaphragm for ventilatory assist
793545|NCT00010374|environmental/toxic disorders|environmental/toxic disorders
793546|NCT00010374|neurologic and psychiatric disorders|neurologic and psychiatric disorders
793547|NCT00010374|rare disease|rare disease
793548|NCT00010374|spinal cord injury|spinal cord injury
793549|NCT00010335|arthritis & connective tissue diseases|arthritis & connective tissue diseases
793550|NCT00010335|dermatomyositis|dermatomyositis
793551|NCT00010335|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
793552|NCT00010335|juvenile rheumatoid arthritis|juvenile rheumatoid arthritis
793553|NCT00010335|rare disease|rare disease
793554|NCT00010335|systemic lupus erythematosus|systemic lupus erythematosus
793555|NCT00010335|systemic sclerosis|systemic sclerosis
793556|NCT00009581|Endothelial Function|endothelial function
793557|NCT00009581|Hydroxyurea|hydroxyurea
793558|NCT00009581|Leukocyte Gene Expression|leukocyte gene expression
793559|NCT00009581|Nitrosylated Hemoglobin|nitrosylated hemoglobin
793560|NCT00009581|Sickle Cell Anemia|sickle cell anemia
793561|NCT00009581|Nitric Oxide|nitric oxide
793562|NCT00009568|Antidepressants|antidepressants
793563|NCT00009568|Platelet Function|platelet function
793564|NCT00009568|SSRI|ssri
793565|NCT00009568|Depression|depression
793566|NCT00009568|Bleeding Time|bleeding time
793567|NCT00009256|Quasispecies Variation|quasispecies variation
793568|NCT00009256|Genotyping|genotyping
793569|NCT00009256|Phenotyping|phenotyping
793570|NCT00009256|Antiretroviral Therapy|antiretroviral therapy
793571|NCT00009256|Drug Naive Patients|drug naive patients
793572|NCT00009256|HIV|hiv
793573|NCT00009256|Treatment Naive|treatment naive
793574|NCT00009243|Brain Scans|brain scans
793575|NCT00009243|Brain Imaging|brain imaging
793576|NCT00009243|Brain|brain
793577|NCT00009243|Alteplase|alteplase
793578|NCT00009243|Acute Stroke|acute stroke
793579|NCT00009243|Stroke|stroke
793580|NCT00009243|TIA|tia
793581|NCT00009230|Age associated memory impairment|age associated memory impairment
793582|NCT00009230|Mild cognitive impairment|mild cognitive impairment
793583|NCT00009217|Alzheimer's disease|alzheimer's disease
793584|NCT00009217|psychosis|psychosis
793585|NCT00009217|agitation|agitation
793586|NCT00009217|haloperidol|haloperidol
793587|NCT00009204|Behavioral problems|behavioral problems
793588|NCT00009204|Agitation|agitation
793589|NCT00009048|Dyskinesias|dyskinesias
793590|NCT00009048|L-Dopa Infusion|l-dopa infusion
793591|NCT00009048|Clinical Trial|clinical trial
793592|NCT00009048|Motor Function|motor function
793593|NCT00009048|Psychosis|psychosis
793594|NCT00009048|Parkinson's Disease|parkinson's disease
793595|NCT00009035|Brain|brain
793596|NCT00009035|Tumor|tumor
793597|NCT00009035|Chemotherapy|chemotherapy
793598|NCT00009035|Antiangiogenesis|antiangiogenesis
793599|NCT00009035|Radiation|radiation
793600|NCT00009035|CNS Tumor|cns tumor
793601|NCT00009035|Glioma|glioma
793602|NCT00009035|Medulloblastoma|medulloblastoma
793603|NCT00009035|Astrocytoma|astrocytoma
793604|NCT00009035|Glioblastoma|glioblastoma
793605|NCT00009178|Primary Care|primary care
793606|NCT00009178|Fluoxetine|fluoxetine
793607|NCT00009009|Immune System|immune system
793608|NCT00009009|Biopsy|biopsy
793609|NCT00009009|AIDS|aids
793610|NCT00009009|HIV|hiv
793611|NCT00009009|End Stage Renal Disease|end stage renal disease
793612|NCT00009009|Kidney Transplant|kidney transplant
793613|NCT00008892|Magnetic Resonance Imaging|magnetic resonance imaging
793614|NCT00008892|Diffusion Tensor Imaging|diffusion tensor imaging
793615|NCT00008892|Twin Study|twin study
793616|NCT00008892|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
793617|NCT00008892|Normal Volunteers|normal volunteers
793618|NCT00008814|Cognition|cognition
793619|NCT00008814|Infant Development|infant development
793620|NCT00008814|MRI, Functional|mri, functional
793621|NCT00008736|Feeding intolerance|feeding intolerance
793622|NCT00008736|Infant, premature|infant, premature
793623|NCT00008827|Obesity|obesity
793624|NCT00008827|Behavioral weight control|behavioral weight control
793625|NCT00008827|Internet|internet
793626|NCT00008541|Keratitis|keratitis
793627|NCT00008541|Conjunctivitis|conjunctivitis
793628|NCT00008541|Meibomitis|meibomitis
793629|NCT00008541|Corneal Infiltrates|corneal infiltrates
793630|NCT00008541|Dacryocystitis|dacryocystitis
793631|NCT00008541|Blepharitis|blepharitis
793632|NCT00008541|Dacryoadenitis|dacryoadenitis
793633|NCT00008541|Corneal Eye Disease|corneal eye disease
793634|NCT00008515|Steroids|steroids
793635|NCT00008515|Age-Related Macular Degeneration|age-related macular degeneration
793636|NCT00008515|Implant|implant
793637|NCT00008515|Choroidal Neovascularization|choroidal neovascularization
793638|NCT00008515|Sustained Release Implant|sustained release implant
793639|NCT00008502|Genetics|genetics
793640|NCT00008502|African Americans|african americans
793641|NCT00008502|Skin|skin
793642|NCT00008502|Keloids|keloids
793643|NCT00008502|Familial Disposition|familial disposition
793644|NCT00008476|Preemptive Analgesia|preemptive analgesia
793645|NCT00008476|Vanilloid|vanilloid
793646|NCT00008476|Vanilloid Receptor (VR)|vanilloid receptor (vr)
793647|NCT00008476|Capsaicin|capsaicin
793648|NCT00008476|Acute Pain|acute pain
793649|NCT00008476|Orofacial|orofacial
793650|NCT00008476|Visual Analog Scale (VAS)|visual analog scale (vas)
793651|NCT00008476|Resiniferatoxin|resiniferatoxin
793652|NCT00008476|Healthy Volunteer|healthy volunteer
793653|NCT00008476|Wisdom Teeth|wisdom teeth
793654|NCT00008476|Pain|pain
793655|NCT00007800|obesity treatment|obesity treatment
793656|NCT00007800|non insulin dependent diabetes|non insulin dependent diabetes
793657|NCT00007800|type 2 diabetes|type 2 diabetes
793658|NCT00007800|behavioral weight control|behavioral weight control
793659|NCT00007800|motivational interviewing|motivational interviewing
793660|NCT00007800|motivational enhancement|motivational enhancement
793661|NCT00007696|Diabetes Mellitus,DM,glycemic control|diabetes mellitus,dm,glycemic control
793662|NCT00007670|gabapentin|gabapentin
793663|NCT00007670|lamotrigine|lamotrigine
793664|NCT00007670|seizures in the elderly|seizures in the elderly
793665|NCT00007670|Carbamazepine|carbamazepine
793666|NCT00007657|PCI plus intensive medical therapy|pci plus intensive medical therapy
793667|NCT00007774|Olanzapine, haloperidol, schizophrenia, schisoaffe|olanzapine, haloperidol, schizophrenia, schisoaffe
793668|NCT00007761|Bipolar Disease Program intervention|bipolar disease program intervention
793669|NCT00007748|aerobic exercise|aerobic exercise
793670|NCT00007748|cognitive behavioral therapy|cognitive behavioral therapy
793671|NCT00007748|CBT|cbt
793672|NCT00007748|Gulf War Illnesses|gulf war illnesses
793673|NCT00007748|GWI|gwi
793674|NCT00007735|antibiotic treatment|antibiotic treatment
793675|NCT00007735|mycoplasma species|mycoplasma species
793676|NCT00007735|Gulf War Veterans' Illnesses (GWI)|gulf war veterans' illnesses (gwi)
793677|NCT00007735|mycoplasma positive|mycoplasma positive
793678|NCT00007735|Gulf War Syndrome|gulf war syndrome
793679|NCT00007722|ALS|als
793680|NCT00007722|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
793681|NCT00007722|Gulf War Veterans|gulf war veterans
793682|NCT00007709|Hepatitis C|hepatitis c
793683|NCT00007709|HIV|hiv
793684|NCT00007709|severe mental illness (SMI)|severe mental illness (smi)
793685|NCT00007683|aspirin|aspirin
793686|NCT00007683|clopidogrel|clopidogrel
793687|NCT00007683|embolic events|embolic events
793688|NCT00007683|Left ventricular ejection fraction less than or eq|left ventricular ejection fraction less than or eq
793689|NCT00007683|NYHA Class II, III or IV CHF|nyha class ii, iii or iv chf
793690|NCT00007683|symptomatic CHF|symptomatic chf
793691|NCT00007683|warfarin|warfarin
793692|NCT00007644|cancer of the prostate (CAP)|cancer of the prostate (cap)
793693|NCT00007644|cancer treatment|cancer treatment
793694|NCT00007644|chronic diseases|chronic diseases
793695|NCT00007644|expectant management|expectant management
793696|NCT00007644|genitourinary|genitourinary
793697|NCT00007644|prostate|prostate
793698|NCT00007644|prostate specific cancer mortality|prostate specific cancer mortality
793699|NCT00007644|radical prostatectomy|radical prostatectomy
793700|NCT00007631|NMSC|nmsc
793701|NCT00007631|nonmelanoma skin cancer|nonmelanoma skin cancer
793702|NCT00007631|topical tretinoin cream|topical tretinoin cream
793703|NCT00007618|colorectal cancer|colorectal cancer
793704|NCT00007605|amiodarone|amiodarone
793705|NCT00007605|atrial fibrillation converted to sinus rhythm|atrial fibrillation converted to sinus rhythm
793706|NCT00007605|cardiac mortality|cardiac mortality
793707|NCT00007605|major and minor bleeds|major and minor bleeds
793708|NCT00007605|sinus rhythm|sinus rhythm
793709|NCT00007605|sotalol|sotalol
793710|NCT00007592|Hypertension|hypertension
793711|NCT00007592|national data base on the treatment of hypertension|national data base on the treatment of hypertension
793712|NCT00007592|cost of different antihypertensive regimens|cost of different antihypertensive regimens
793713|NCT00007579|prostate cancer|prostate cancer
793714|NCT00007540|Prostate cancer|prostate cancer
793715|NCT00007540|CAG repeat sequence|cag repeat sequence
793716|NCT00007527|buprenorphine and naloxone|buprenorphine and naloxone
793717|NCT00007527|opiate dependence|opiate dependence
793718|NCT00007527|narcotic treatment|narcotic treatment
793719|NCT00007514|olfactory functioning|olfactory functioning
793720|NCT00007514|neurotoxic exposure|neurotoxic exposure
796238|NCT00001910|Vaccine|vaccine
793721|NCT00007514|Gulf War-era veterans|gulf war-era veterans
793722|NCT00007501|varicella-zoster vaccine|varicella-zoster vaccine
793723|NCT00007475|Plasma Exchange|plasma exchange
793724|NCT00007475|Cyclophosphamide|cyclophosphamide
793725|NCT00007475|Proteinuria|proteinuria
793726|NCT00007475|Hemodialysis|hemodialysis
793727|NCT00007475|Expression Profiling|expression profiling
793728|NCT00007358|Dexamethasone|dexamethasone
793729|NCT00007358|Anti-SSA/Ro antibodies|anti-ssa/ro antibodies
793730|NCT00007358|Anti-SSB/La antibodies|anti-ssb/la antibodies
793731|NCT00007358|Ultrasound|ultrasound
793732|NCT00007358|Atrioventricular (AV) nodal dysfunction|atrioventricular (av) nodal dysfunction
793733|NCT00007358|Echocardiograms|echocardiograms
793734|NCT00007358|Mothers|mothers
793735|NCT00007345|Histone Acetylase|histone acetylase
793736|NCT00007345|Differentiation|differentiation
793737|NCT00007345|Sezary Syndrome|sezary syndrome
793738|NCT00007345|Mycosis Fungoides|mycosis fungoides
793739|NCT00007345|CD 30 Lymphoma|cd 30 lymphoma
793740|NCT00007306|Parathyroid hormone|parathyroid hormone
793741|NCT00007306|Psoriasis|psoriasis
793742|NCT00007306|Lesions|lesions
793743|NCT00007306|Topical medications|topical medications
793744|NCT00007306|Ointment|ointment
793745|NCT00007306|Calcium metabolism|calcium metabolism
793746|NCT00007306|Skin biopsy|skin biopsy
793747|NCT00007293|Phototherapy|phototherapy
793748|NCT00007293|Psoriasis|psoriasis
793749|NCT00007293|Scalp psoriasis|scalp psoriasis
793750|NCT00007293|Fiber optic|fiber optic
793751|NCT00007293|Light comb|light comb
793752|NCT00007293|UV source|uv source
793753|NCT00007280|Bioengineered skin|bioengineered skin
793754|NCT00007280|Venous leg ulcer|venous leg ulcer
793755|NCT00007267|Scleroderma|scleroderma
793756|NCT00007267|Systemic sclerosis|systemic sclerosis
793757|NCT00007267|Depression|depression
793758|NCT00007267|Pain|pain
793759|NCT00007267|Disfigurement|disfigurement
793760|NCT00007267|Body image dissatisfaction|body image dissatisfaction
793761|NCT00007267|Cognitive-behavioral therapy|cognitive-behavioral therapy
793762|NCT00007267|Self-help|self-help
793763|NCT00007267|Psychological intervention|psychological intervention
793764|NCT00007254|Analgesia|analgesia
793765|NCT00007254|Bedsore|bedsore
793766|NCT00007254|Morphine gel|morphine gel
793767|NCT00007254|Pressure ulcer|pressure ulcer
793768|NCT00007254|Pain|pain
793769|NCT00007254|Ulcer|ulcer
793770|NCT00007241|Osteoarthritis|osteoarthritis
793771|NCT00007241|Knee|knee
793773|NCT00007241|Isometric|isometric
793774|NCT00007241|Exercise|exercise
793775|NCT00007241|Strengthening|strengthening
793776|NCT00007241|Joint-related pain|joint-related pain
793777|NCT00007228|Chorea|chorea
793778|NCT00007228|DCM|dcm
793779|NCT00007228|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
793780|NCT00007228|Sudden Death|sudden death
793781|NCT00007228|Neuroacanthocytosis|neuroacanthocytosis
793782|NCT00007215|Cataract|cataract
793783|NCT00007215|Early Lens Changes|early lens changes
793784|NCT00007215|Protein Aggregation|protein aggregation
793785|NCT00007215|Blindness|blindness
793786|NCT00007215|Vision|vision
793787|NCT00007215|Dynamic Laser Scattering (DLS)|dynamic laser scattering (dls)
793788|NCT00007215|Age-Related Changes|age-related changes
793789|NCT00007215|Test Re-test Reproducibility|test re-test reproducibility
793790|NCT00007215|Normal Volunteers|normal volunteers
793791|NCT00007215|Lens|lens
793792|NCT00007215|Healthy Volunteer|healthy volunteer
793793|NCT00007189|Alzheimer disease|alzheimer disease
793794|NCT00007189|Anti-inflammatory drugs|anti-inflammatory drugs
793795|NCT00007163|Immunosuppression|immunosuppression
793796|NCT00007163|Recombinant IgG1|recombinant igg1
793797|NCT00007163|Apoptosis|apoptosis
793798|NCT00007163|Interferon Gamma|interferon gamma
793799|NCT00007163|Colonoscopy|colonoscopy
793800|NCT00007163|Crohn's Disease|crohn's disease
793801|NCT00007163|Immunotherapy|immunotherapy
793802|NCT00007163|IL-12|il-12
793803|NCT00007150|Phlebotomy Therapy|phlebotomy therapy
793804|NCT00007150|Hemochromatosis|hemochromatosis
793805|NCT00007150|Iron Overload|iron overload
793806|NCT00007150|Hereditary Hemochromatosis|hereditary hemochromatosis
793807|NCT00007150|Blood Donation|blood donation
793808|NCT00007137|3D MRI|3d mri
793809|NCT00007137|Diffusion Tensor|diffusion tensor
793810|NCT00007137|Tongue|tongue
793811|NCT00007137|Ultrasound|ultrasound
793812|NCT00007137|Volume|volume
793813|NCT00007137|Healthy Volunteer|healthy volunteer
793814|NCT00007137|Swallowing|swallowing
793815|NCT00007137|Tongue Weakness|tongue weakness
793816|NCT00007137|Tongue Movement Coordination Problem|tongue movement coordination problem
793817|NCT00007124|Myoclonus|myoclonus
793818|NCT00007124|Epilepsy|epilepsy
793819|NCT00007124|Dementia|dementia
793820|NCT00007124|Polyglucosan|polyglucosan
793821|NCT00007124|Insulin|insulin
793822|NCT00007124|Lafora Disease|lafora disease
793823|NCT00007124|Restrictive Carbohydrate Diet|restrictive carbohydrate diet
793824|NCT00007059|disease-related problem/condition|disease-related problem/condition
793825|NCT00007059|graft versus host disease|graft versus host disease
793826|NCT00007059|rare disease|rare disease
793827|NCT00007046|arthritis & connective tissue diseases|arthritis & connective tissue diseases
793828|NCT00007046|bone cancer|bone cancer
793829|NCT00007046|diaphyseal medullary stenosis|diaphyseal medullary stenosis
793830|NCT00007046|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
793831|NCT00007046|malignant fibrous histiocytoma of bone|malignant fibrous histiocytoma of bone
793832|NCT00007046|musculoskeletal/mesodermal cancer|musculoskeletal/mesodermal cancer
793833|NCT00007046|oncologic disorders|oncologic disorders
793834|NCT00007046|rare disease|rare disease
793835|NCT00007033|Alagille syndrome|alagille syndrome
793836|NCT00007033|biliary atresia|biliary atresia
793837|NCT00007033|cholestasis|cholestasis
793838|NCT00007033|gastrointestinal disorders|gastrointestinal disorders
793839|NCT00007033|rare disease|rare disease
793840|NCT00006565|asthma|asthma
793841|NCT00006565|HEPA|hepa
793842|NCT00006565|ETS|ets
793843|NCT00006519|Pharmacokinetic|pharmacokinetic
793844|NCT00006519|Pediatric AIDS|pediatric aids
793845|NCT00006519|Resistance Testing|resistance testing
793846|NCT00006519|Combination Therapy|combination therapy
793847|NCT00006519|Viral Drug Dynamics|viral drug dynamics
793848|NCT00006519|Treatment Experienced|treatment experienced
793849|NCT00006518|Tumor|tumor
793850|NCT00006518|Viruses|viruses
793851|NCT00006518|HIV|hiv
793852|NCT00006518|KSHV|kshv
793853|NCT00006518|AIDS|aids
793854|NCT00006517|Seasonal Affective Disorder (SAD)|seasonal affective disorder (sad)
793855|NCT00006517|Winter Depression|winter depression
793856|NCT00006517|Mood disorders|mood disorders
793857|NCT00006517|Bipolar I and II disorders|bipolar i and ii disorders
793858|NCT00006517|Major Depressive Disorder, Recurrent|major depressive disorder, recurrent
793859|NCT00006517|Light therapy|light therapy
793860|NCT00006517|Phototherapy|phototherapy
793861|NCT00006517|Dawn Simulation therapy|dawn simulation therapy
793862|NCT00006517|Negative air ionization therapy|negative air ionization therapy
793863|NCT00006517|Chronobiology|chronobiology
793864|NCT00006517|Biological rhythms|biological rhythms
793865|NCT00006516|Neonatal brain injury|neonatal brain injury
793866|NCT00006516|Brain Hypoxia|brain hypoxia
793867|NCT00006516|Cerebral Hypoxia|cerebral hypoxia
793868|NCT00006516|Brain Hypoxia-Ischemia|brain hypoxia-ischemia
793869|NCT00006516|Brain Ischemia-Hypoxia|brain ischemia-hypoxia
793870|NCT00006516|Cerebral Hypoxia-Ischemia|cerebral hypoxia-ischemia
793871|NCT00006516|Cerebral Ischemia-Hypoxia|cerebral ischemia-hypoxia
793872|NCT00006516|Environmental enrichment|environmental enrichment
793873|NCT00006516|Cognitive/sensorimotor stimulation|cognitive/sensorimotor stimulation
793874|NCT00006516|Parent-infant interactions|parent-infant interactions
793875|NCT00006516|Prenatal hypoxia|prenatal hypoxia
793876|NCT00006515|Pediatric|pediatric
793877|NCT00006515|Sarcoma|sarcoma
793878|NCT00006515|Effects|effects
793879|NCT00006515|Survivors|survivors
793880|NCT00006515|Pilot|pilot
793881|NCT00006505|Islet Isolation|islet isolation
793882|NCT00006505|Diabetes|diabetes
793883|NCT00006494|AIDS|aids
793884|NCT00006494|Antiretroviral Therapy|antiretroviral therapy
793885|NCT00006494|Drug Resistance|drug resistance
793886|NCT00006494|Phenotype|phenotype
793887|NCT00006494|HIV|hiv
793888|NCT00006494|Genotype|genotype
793889|NCT00006494|Treatment Experienced|treatment experienced
793890|NCT00006493|HIV-associated hyperlipidemia|hiv-associated hyperlipidemia
793891|NCT00006492|Celiac Disease|celiac disease
793892|NCT00006492|Cerebellar Ataxia|cerebellar ataxia
793893|NCT00006492|Gluten-Free Diet|gluten-free diet
793894|NCT00006489|Alcoholism|alcoholism
793895|NCT00006489|Alcohol Dependence|alcohol dependence
793896|NCT00006489|Post-Traumatic Stress Disorder|post-traumatic stress disorder
793897|NCT00006489|Naltrexone|naltrexone
793898|NCT00006489|Cognitive Behavior Therapy|cognitive behavior therapy
793899|NCT00006450|Children|children
793900|NCT00006450|Brain|brain
793901|NCT00006450|Maturation|maturation
793902|NCT00006450|Phenylacetate|phenylacetate
793903|NCT00006450|Differentiation|differentiation
793904|NCT00006507|Sensory integration|sensory integration
793905|NCT00006507|Occupational therapy|occupational therapy
793906|NCT00006507|Sensory Modulation Dysfunction (SMD)|sensory modulation dysfunction (smd)
793907|NCT00006448|Spinal cord injury|spinal cord injury
793908|NCT00006448|Amputation|amputation
793909|NCT00006448|Pain management|pain management
793910|NCT00006447|Brain Injuries|brain injuries
793911|NCT00006447|Trauma|trauma
793912|NCT00006447|Caregivers|caregivers
793913|NCT00006447|Burden and Dependency|burden and dependency
793914|NCT00006447|Rehabilitation|rehabilitation
793915|NCT00006447|Support, social|support, social
793916|NCT00006447|Information System|information system
793917|NCT00006447|Information Resources (PT)|information resources (pt)
793918|NCT00006447|Disability, persons with|disability, persons with
793919|NCT00006446|Behavioral disorders|behavioral disorders
793920|NCT00006446|Parenting skills and communication|parenting skills and communication
793921|NCT00006446|Parent-child interactions|parent-child interactions
793922|NCT00006446|At-risk preschooler|at-risk preschooler
793923|NCT00006446|Head Start|head start
793926|NCT00006445|Serum screen|serum screen
793927|NCT00006445|Pregnancy associated plasma protein-A (PAPP-A)|pregnancy associated plasma protein-a (papp-a)
793928|NCT00006445|Free-beta human chorionic gonadotropin (FbhCG)|free-beta human chorionic gonadotropin (fbhcg)
793929|NCT00006445|Alpha fetoprotein|alpha fetoprotein
793930|NCT00006445|Unconjugated estriol|unconjugated estriol
793931|NCT00006445|Inhibin-A|inhibin-a
793932|NCT00006445|Down syndrome|down syndrome
793933|NCT00006445|Aneuploidy|aneuploidy
793934|NCT00006439|HIV|hiv
793935|NCT00006438|Rocker sole|rocker sole
793936|NCT00006438|Plantar pressure|plantar pressure
793937|NCT00006438|Diabetic feet|diabetic feet
793938|NCT00006438|Insensate feet|insensate feet
793939|NCT00006438|gait analysis|gait analysis
793940|NCT00006438|Pedorthics|pedorthics
793941|NCT00006438|Gait abnormalities|gait abnormalities
793942|NCT00006437|MMP|mmp
793943|NCT00006437|Proteases|proteases
793944|NCT00006437|Adhesion|adhesion
793945|NCT00006437|Migration|migration
793946|NCT00006437|Extracellular Matrix|extracellular matrix
793947|NCT00006436|AIDS|aids
793948|NCT00006436|Malignancy|malignancy
793949|NCT00006436|Antiretroviral|antiretroviral
793950|NCT00006436|Chemotherapy|chemotherapy
793951|NCT00006436|Monoclonal|monoclonal
793952|NCT00006435|Tissue Repository|tissue repository
793953|NCT00006435|Growth Rate|growth rate
793954|NCT00006435|Volumetric MRI|volumetric mri
793955|NCT00006434|Dendritic cells|dendritic cells
793956|NCT00006429|Spinal Cord Injury|spinal cord injury
793957|NCT00006429|Body Weight Supported Ambulation Training|body weight supported ambulation training
793958|NCT00006429|Treadmill Training|treadmill training
793959|NCT00006429|Physical therapy|physical therapy
793960|NCT00006429|Gait|gait
793961|NCT00006429|Assisted Ambulation|assisted ambulation
793962|NCT00006428|Spinal Cord injury (SCI)|spinal cord injury (sci)
793963|NCT00006428|Chronic Pain|chronic pain
793964|NCT00006428|Amitriptyline|amitriptyline
793965|NCT00006427|Amputation|amputation
793966|NCT00006427|Chronic Pain|chronic pain
793967|NCT00006427|Amitriptyline|amitriptyline
793968|NCT00006426|Foot ulcers|foot ulcers
793969|NCT00006426|Diabetes|diabetes
793970|NCT00006426|Peripheral neuropathy|peripheral neuropathy
793971|NCT00006426|Casting|casting
793972|NCT00006426|Achilles Lengthening|achilles lengthening
793973|NCT00006426|Ambulatory surgery|ambulatory surgery
793974|NCT00006426|Foot deformity|foot deformity
793975|NCT00006425|Breast MRI|breast mri
793976|NCT00006425|Ductal lavage|ductal lavage
793977|NCT00006425|Nipple Aspirate Fluid|nipple aspirate fluid
793978|NCT00006425|Transvaginal ultrasound|transvaginal ultrasound
793979|NCT00006425|Healthy Volunteer|healthy volunteer
793980|NCT00006424|Plasticity|plasticity
793981|NCT00006424|Motor|motor
793982|NCT00006424|Stroke|stroke
793983|NCT00006424|Amphetamine|amphetamine
793984|NCT00006424|fMRI|fmri
793985|NCT00006424|Cortical Reorganization|cortical reorganization
793986|NCT00006424|Spectroscopy|spectroscopy
793987|NCT00006422|Lazy Eye|lazy eye
793988|NCT00006422|Amblyopia|amblyopia
793989|NCT00006422|Nystagmus|nystagmus
793990|NCT00006422|Eye Movements|eye movements
793991|NCT00006422|Child Vision|child vision
793992|NCT00006421|Breast MRI|breast mri
793993|NCT00006421|Nipple Aspirate Fluid|nipple aspirate fluid
793994|NCT00006421|Transvaginal ultrasound|transvaginal ultrasound
793995|NCT00006421|Ductal lavage|ductal lavage
793996|NCT00006418|Schizophrenia|schizophrenia
793997|NCT00006418|Genetics|genetics
793998|NCT00006417|Fludarabine|fludarabine
793999|NCT00006417|Non-Myeloablative BMT|non-myeloablative bmt
794000|NCT00006417|Immunodeficiency|immunodeficiency
794001|NCT00006417|Neutrophils|neutrophils
794002|NCT00006417|Oxidase|oxidase
794003|NCT00006417|Engraftment|engraftment
794004|NCT00006417|Graft-versus-host Disease|graft-versus-host disease
794005|NCT00006417|Cyclophosphamide|cyclophosphamide
794006|NCT00006417|Donor Apheresis|donor apheresis
794007|NCT00006417|Peripheral Blood Stem Cells|peripheral blood stem cells
794008|NCT00006417|Therapy|therapy
794009|NCT00006414|Anesthesia|anesthesia
794010|NCT00006414|Magnetic Stimulation|magnetic stimulation
794011|NCT00006414|Motor|motor
794012|NCT00006414|Neuroplasticity|neuroplasticity
794013|NCT00006414|Practice|practice
794014|NCT00006414|Rehabilitation|rehabilitation
794015|NCT00006414|Stroke|stroke
794016|NCT00006413|Peripheral Blood Stem Cells|peripheral blood stem cells
794017|NCT00006413|Non-Myeloablative Bone Marrow Transplantation|non-myeloablative bone marrow transplantation
794018|NCT00006413|Engraftment|engraftment
794019|NCT00006413|Graft-versus-host Disease|graft-versus-host disease
794020|NCT00006413|Graft-Versus-Leukemia|graft-versus-leukemia
794021|NCT00006413|Graft-Versus-Mast Cell|graft-versus-mast cell
794022|NCT00006413|Cyclophosphamide|cyclophosphamide
794023|NCT00006413|Fludarabine|fludarabine
794024|NCT00006413|Donor Apheresis|donor apheresis
794025|NCT00006413|Mast Cells|mast cells
794026|NCT00006411|cornea transplant|cornea transplant
794027|NCT00006411|corneal endothelial cell density|corneal endothelial cell density
794132|NCT00006289|Neuropathic Pain|neuropathic pain
794028|NCT00006411|moderate risk corneal diseases requiring corneal transplantation|moderate risk corneal diseases requiring corneal transplantation
794029|NCT00006411|corneal transplantation|corneal transplantation
794030|NCT00006400|Blood Diseases|blood diseases
794031|NCT00006400|Sickle Cell Anemia|sickle cell anemia
794032|NCT00006398|cirrhosis|cirrhosis
794033|NCT00006398|esophageal varices|esophageal varices
794034|NCT00006398|variceal hemorrhage|variceal hemorrhage
794035|NCT00006398|beta-adrenergic blocker|beta-adrenergic blocker
794036|NCT00006394|disease-related problem/condition|disease-related problem/condition
794037|NCT00006394|endocrine disorders|endocrine disorders
794038|NCT00006394|growth hormone deficiency|growth hormone deficiency
794039|NCT00006394|osteoporosis|osteoporosis
794040|NCT00006394|quality of life|quality of life
794041|NCT00006394|rare disease|rare disease
794042|NCT00006393|arthritis & connective tissue diseases|arthritis & connective tissue diseases
794043|NCT00006393|rare disease|rare disease
794044|NCT00006393|systemic sclerosis|systemic sclerosis
794045|NCT00006337|Clinical Trial|clinical trial
794046|NCT00006337|Dyskinesias|dyskinesias
794047|NCT00006337|Levodopa Infusion|levodopa infusion
794048|NCT00006336|Gap Detection Test|gap detection test
794049|NCT00006336|Fahn-Scale|fahn-scale
794050|NCT00006336|Visual Analog and Verbal Scale|visual analog and verbal scale
794051|NCT00006336|Writing Standard Paragraph|writing standard paragraph
794052|NCT00006336|Braille Reading Grade I|braille reading grade i
794053|NCT00006335|Genetic|genetic
794054|NCT00006335|Analysis|analysis
794055|NCT00006335|Immune|immune
794056|NCT00006335|Teenage|teenage
794057|NCT00006335|Girls|girls
794058|NCT00006335|Severe Combined Immune Deficiency (SCID)|severe combined immune deficiency (scid)
794059|NCT00006335|XSCID|xscid
794060|NCT00006335|Carrier Testing|carrier testing
794061|NCT00006335|X-Linked Disease|x-linked disease
794062|NCT00006335|Adolescent|adolescent
794063|NCT00006334|Genes|genes
794064|NCT00006334|X-Chromosome|x-chromosome
794065|NCT00006334|Osteoporosis|osteoporosis
794066|NCT00006334|Ovarian Failure|ovarian failure
794067|NCT00006334|Imprinting|imprinting
794068|NCT00006334|Turner's|turner's
794069|NCT00006334|Turner|turner
794070|NCT00006334|TS|ts
794071|NCT00006333|Rheumatoid Arthritis|rheumatoid arthritis
794072|NCT00006333|Inflammation|inflammation
794073|NCT00006333|Synovitis|synovitis
794074|NCT00006333|Genetics|genetics
794075|NCT00006333|Synovial Biopsy|synovial biopsy
794076|NCT00006333|Arthritis|arthritis
794077|NCT00006333|Juvenile Rheumatoid Arthritis|juvenile rheumatoid arthritis
794078|NCT00006333|JRA|jra
794079|NCT00006332|Molybdenum|molybdenum
794080|NCT00006331|Kidney transplantation|kidney transplantation
794081|NCT00006331|Immunology|immunology
794082|NCT00006330|Digoxin|digoxin
794083|NCT00006330|Effect modifiers (Epidemiology)|effect modifiers (epidemiology)
794084|NCT00006330|Rosales|rosales
794085|NCT00006330|Drug Interaction|drug interaction
794086|NCT00006329|Radionuclide imaging|radionuclide imaging
794087|NCT00006329|Surgery|surgery
794088|NCT00006328|Chronic Allograft Nephropathy (CAN)|chronic allograft nephropathy (can)
794089|NCT00006328|Transplantation immunology|transplantation immunology
794090|NCT00006328|Genetics|genetics
794091|NCT00006328|Graft Rejection|graft rejection
794092|NCT00006320|Reverse Transcriptase Inhibitor|reverse transcriptase inhibitor
794093|NCT00006320|Protease Inhibitor|protease inhibitor
794094|NCT00006319|X-Linked Agammagloblinemia|x-linked agammagloblinemia
794095|NCT00006319|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
794096|NCT00006319|Jak-3 SCID|jak-3 scid
794097|NCT00006319|X-Linked SCID|x-linked scid
794098|NCT00006319|X-Linked Hyper-IgM Syndrome|x-linked hyper-igm syndrome
794099|NCT00006319|Primary Immunodeficiencies|primary immunodeficiencies
794100|NCT00006319|ADA-SCID|ada-scid
794101|NCT00006318|Cerebral Blood Flow|cerebral blood flow
794102|NCT00006318|CO2 Inhalation|co2 inhalation
794103|NCT00006318|Imaging|imaging
794104|NCT00006318|MRI|mri
794105|NCT00006318|Perfusion|perfusion
794106|NCT00006318|Functional Activation|functional activation
794107|NCT00006301|Hepatitis C|hepatitis c
794108|NCT00006301|Viral Sequence|viral sequence
794109|NCT00006301|PCR|pcr
794110|NCT00006301|T Cell|t cell
794111|NCT00006301|Seroconversion|seroconversion
794112|NCT00006301|Cytokines|cytokines
794113|NCT00006300|Immunosuppression|immunosuppression
794114|NCT00006300|Treatment Recommendations|treatment recommendations
794115|NCT00006300|Pancytopenia|pancytopenia
794116|NCT00006300|Schizophrenia|schizophrenia
794117|NCT00006300|Inpatient Population|inpatient population
794118|NCT00006299|Celecoxib|celecoxib
794119|NCT00006299|Thromboxane B2|thromboxane b2
794120|NCT00006299|Prostaglandin E2|prostaglandin e2
794121|NCT00006299|Microdialysis|microdialysis
794122|NCT00006299|Ibuprofen|ibuprofen
794123|NCT00006292|Biologic Therapy|biologic therapy
794124|NCT00006292|Bone Erosion|bone erosion
794125|NCT00006292|CT|ct
794126|NCT00006292|MRI|mri
794127|NCT00006292|Rheumatoid Arthritis|rheumatoid arthritis
794128|NCT00006292|RA|ra
794129|NCT00006289|Analgesia|analgesia
794130|NCT00006289|Causalgia|causalgia
794133|NCT00006289|Oral Surgery|oral surgery
794134|NCT00006289|Reflex Sympathetic Dystrophy|reflex sympathetic dystrophy
794135|NCT00006289|Sympathetic Nervous System|sympathetic nervous system
794136|NCT00006289|Chronic Regional Pain Syndrome|chronic regional pain syndrome
794137|NCT00006285|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
794138|NCT00006285|Parietal Lobe|parietal lobe
794139|NCT00006285|fMRI|fmri
794140|NCT00006285|Cognition|cognition
794141|NCT00006285|Perception|perception
794142|NCT00006285|Cortical Stimulation|cortical stimulation
794143|NCT00006285|Spatial Attention|spatial attention
794144|NCT00006286|Depression|depression
794145|NCT00006286|Major Depressive Disorder|major depressive disorder
794146|NCT00006286|Fluoxetine|fluoxetine
794147|NCT00006286|Prozac|prozac
794148|NCT00006286|SSRI|ssri
794149|NCT00006286|Psychotherapy|psychotherapy
794150|NCT00006286|CBT|cbt
794151|NCT00006286|Teenagers|teenagers
794152|NCT00006286|Adolescents|adolescents
794153|NCT00006286|Teens|teens
794154|NCT00006278|Cushing's Syndrome|cushing's syndrome
794155|NCT00006278|Adrenal Glands|adrenal glands
794156|NCT00006278|Proteomics|proteomics
794157|NCT00006278|Cortisol|cortisol
794158|NCT00006276|Angiogenesis Inhibition|angiogenesis inhibition
794159|NCT00006276|Skin Disease|skin disease
794160|NCT00006276|Blood Vessels|blood vessels
794161|NCT00006276|Cytokines|cytokines
794162|NCT00006276|Autoimmune Disease|autoimmune disease
794163|NCT00006280|Cystic Fibrosis|cystic fibrosis
794164|NCT00006275|dermatologic disorders|dermatologic disorders
794165|NCT00006275|psoriasis|psoriasis
794166|NCT00006275|rare disease|rare disease
794167|NCT00006274|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
794168|NCT00006274|neonatal disorders|neonatal disorders
794169|NCT00006274|rare disease|rare disease
794170|NCT00006274|respiratory distress syndrome|respiratory distress syndrome
794171|NCT00006273|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
794172|NCT00006273|cystic fibrosis|cystic fibrosis
794173|NCT00006273|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
794174|NCT00006273|rare disease|rare disease
794175|NCT00006272|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
794176|NCT00006272|heart defects|heart defects
794177|NCT00006272|rare disease|rare disease
794178|NCT00006271|brain injury|brain injury
794179|NCT00006271|neurologic and psychiatric disorders|neurologic and psychiatric disorders
794180|NCT00006271|rare disease|rare disease
794181|NCT00006270|brain injury|brain injury
794182|NCT00006270|neurologic and psychiatric disorders|neurologic and psychiatric disorders
794183|NCT00006270|rare disease|rare disease
794184|NCT00006205|alcoholism|alcoholism
794185|NCT00006205|alcohol addiction|alcohol addiction
794186|NCT00006204|Alcoholism|alcoholism
794187|NCT00006204|Alcohol Dependence|alcohol dependence
794188|NCT00006204|Depression|depression
794189|NCT00006204|Naltrexone|naltrexone
794190|NCT00006204|Fluoxetine|fluoxetine
794191|NCT00006202|Serum levels of Lutein|serum levels of lutein
794192|NCT00006202|Age-Related Macular Degeneration|age-related macular degeneration
794193|NCT00006202|Safety|safety
794194|NCT00006202|Toxicity|toxicity
794195|NCT00006199|solid tumor|solid tumor
794196|NCT00006196|Vitamin D resistance|vitamin d resistance
794197|NCT00006194|sarcopenia|sarcopenia
794198|NCT00006190|Lipoproteins|lipoproteins
794199|NCT00006190|Insulin resistance|insulin resistance
794200|NCT00006190|Adipose tissue|adipose tissue
794201|NCT00006188|Behcet's Disease|behcet's disease
794202|NCT00006188|Sarcoidosis|sarcoidosis
794203|NCT00006188|Iritis|iritis
794204|NCT00006188|Choroiditis|choroiditis
794205|NCT00006188|Iridocyclitis|iridocyclitis
794206|NCT00006188|Retinal Disease|retinal disease
794207|NCT00006188|Cystoid Macular Edema|cystoid macular edema
794208|NCT00006188|Uveitis|uveitis
794209|NCT00006188|Intraocular Inflammation|intraocular inflammation
794210|NCT00006188|Inflammatory Eye DIsease|inflammatory eye disease
794211|NCT00006187|Investigational Drug|investigational drug
794212|NCT00006186|dilutional coagulopathy|dilutional coagulopathy
794213|NCT00006184|Immunoablative|immunoablative
794214|NCT00006184|Mobilization|mobilization
794215|NCT00006184|Apheresis|apheresis
794216|NCT00006184|Multiple Myeloma|multiple myeloma
794217|NCT00006184|IgG Multiple Myeloma|igg multiple myeloma
794218|NCT00006184|IgA Multiple Myeloma|iga multiple myeloma
794219|NCT00006185|peripheral fat wasting|peripheral fat wasting
794220|NCT00006185|truncal adiposity|truncal adiposity
794221|NCT00006185|fat biopsy|fat biopsy
794222|NCT00006185|muscle biopsy|muscle biopsy
794223|NCT00006185|intravenous lines|intravenous lines
794224|NCT00006185|blood draws|blood draws
794225|NCT00006185|insulin administration|insulin administration
794226|NCT00006185|sugar water|sugar water
794227|NCT00006185|screening|screening
794228|NCT00006399|Alzheimer disease|alzheimer disease
794229|NCT00006399|Estrogen therapy|estrogen therapy
794230|NCT00006399|Post-menopausal women|post-menopausal women
794231|NCT00006181|Health behavior change|health behavior change
794336|NCT00006168|MTX|mtx
794232|NCT00006181|Motivational interviewing|motivational interviewing
794233|NCT00006181|Motivational enhancement|motivational enhancement
794234|NCT00006181|Health counseling|health counseling
794235|NCT00006181|Team intervention|team intervention
794236|NCT00006181|One-on-one intervention|one-on-one intervention
794237|NCT00006181|Physical activity|physical activity
794238|NCT00006181|Exercise|exercise
794239|NCT00006181|Nutrition|nutrition
794240|NCT00006181|Health assessments|health assessments
794241|NCT00006181|Strength|strength
794242|NCT00006181|Flexibility|flexibility
794243|NCT00006181|Percent body fat|percent body fat
794244|NCT00006181|Social-learning theory|social-learning theory
794245|NCT00006181|PHLAME|phlame
794246|NCT00006181|Fire fighters|fire fighters
794247|NCT00006181|Fire stations|fire stations
794248|NCT00006181|Cancer|cancer
794249|NCT00006181|Cardiovascular diseases|cardiovascular diseases
794250|NCT00006180|Preventive Medicine|preventive medicine
794251|NCT00006180|Women's Health|women's health
794252|NCT00006180|Bone Formation|bone formation
794253|NCT00006180|Mood Disorders|mood disorders
794254|NCT00006180|Bone Resorption|bone resorption
794255|NCT00006180|Major Depression|major depression
794256|NCT00006180|Osteopenia|osteopenia
794257|NCT00006180|Osteoporosis|osteoporosis
794258|NCT00006180|Bone Fracture|bone fracture
794259|NCT00006180|Bisphosphonate|bisphosphonate
794260|NCT00006180|Depression|depression
794261|NCT00006180|Bone Density|bone density
794262|NCT00006180|Healthy Volunteer|healthy volunteer
794263|NCT00006180|HV|hv
794264|NCT00006180|Normal Control|normal control
794265|NCT00006178|Renal Failure|renal failure
794266|NCT00006178|Anti-rejection|anti-rejection
794267|NCT00006178|Apoptosis|apoptosis
794268|NCT00006178|Polyclonal Antibody|polyclonal antibody
794269|NCT00006178|Kidney Transplant|kidney transplant
794270|NCT00006177|Emotion|emotion
794271|NCT00006177|Children and Adolescents|children and adolescents
794272|NCT00006177|Affective Neuroscience|affective neuroscience
794273|NCT00006177|Bipolar Disorder|bipolar disorder
794274|NCT00006177|Child|child
794275|NCT00006177|Child Bipolar|child bipolar
794276|NCT00006177|BPD|bpd
794277|NCT00006177|Adolescent Bipolar|adolescent bipolar
794278|NCT00006176|FENIB|fenib
794279|NCT00006176|Presenile Dementia|presenile dementia
794280|NCT00006176|Progressive Myoclonic Epilepsy|progressive myoclonic epilepsy
794281|NCT00006176|Dementia|dementia
794282|NCT00006176|Early Onset Progressive Dementia|early onset progressive dementia
794283|NCT00006176|Familial Presenile Dementia|familial presenile dementia
794284|NCT00006176|FDNIB|fdnib
794285|NCT00006176|familial encephalopathy with neuroserpin inclusion bodies|familial encephalopathy with neuroserpin inclusion bodies
794286|NCT00006176|Heredodegenerative Disorders, Nervous System|heredodegenerative disorders, nervous system
794287|NCT00006175|Cyclooxygenase|cyclooxygenase
794288|NCT00006175|COX-1|cox-1
794289|NCT00006175|COX-2|cox-2
794290|NCT00006175|Prostanoids|prostanoids
794291|NCT00006175|P.C.R.|p.c.r.
794292|NCT00006175|Healthy Volunteer|healthy volunteer
794293|NCT00006174|Precocious Puberty|precocious puberty
794294|NCT00006174|Polyostotic|polyostotic
794295|NCT00006174|Fibrous Dysplasia|fibrous dysplasia
794296|NCT00006174|PFD|pfd
794297|NCT00006174|McCune-Albright Syndrome (MAS)|mccune-albright syndrome (mas)
794298|NCT00006173|Atherosclerosis|atherosclerosis
794299|NCT00006173|Hypertension|hypertension
794300|NCT00006173|Magnetic Resonance Angiography|magnetic resonance angiography
794301|NCT00006172|Antidepressive Agents|antidepressive agents
794302|NCT00006172|Chronobiology|chronobiology
794303|NCT00006172|Chronotherapy|chronotherapy
794304|NCT00006172|Circadian rhythms|circadian rhythms
794305|NCT00006172|Depressive Disorder|depressive disorder
794306|NCT00006172|Ions|ions
794307|NCT00006172|Light|light
794308|NCT00006172|Lighting|lighting
794309|NCT00006172|Mood disorders|mood disorders
794310|NCT00006172|Phototherapy.|phototherapy.
794311|NCT00006171|HHV-8|hhv-8
794312|NCT00006171|Pathophysiology|pathophysiology
794313|NCT00006171|AIDS|aids
794314|NCT00006171|Cancer|cancer
794315|NCT00006171|Anti-Retroviral|anti-retroviral
794316|NCT00006171|Kaposi's Sarcoma|kaposi's sarcoma
794317|NCT00006171|HIV|hiv
794318|NCT00006170|smoking cessation|smoking cessation
794319|NCT00006170|Women|women
794320|NCT00006170|bupropion|bupropion
794321|NCT00006170|weight concerns|weight concerns
794322|NCT00006170|weight|weight
794323|NCT00006156|Ovarian Failure|ovarian failure
794324|NCT00006156|Ovary|ovary
794325|NCT00006156|Aging|aging
794326|NCT00006156|Healthy Volunteer|healthy volunteer
794327|NCT00006156|Primary Ovarian Insufficiency(POI)|primary ovarian insufficiency(poi)
794328|NCT00006156|Premature Menopause|premature menopause
794329|NCT00006156|Premature Ovarian Failure (POF)|premature ovarian failure (pof)
794330|NCT00006169|Nutrition|nutrition
794331|NCT00006169|Behavior Therapy|behavior therapy
794332|NCT00006169|Cystic Fibrosis|cystic fibrosis
794333|NCT00006168|primary biliary cirrhosis|primary biliary cirrhosis
794334|NCT00006168|Ursodeoxycholic acid|ursodeoxycholic acid
794335|NCT00006168|UDCA|udca
794338|NCT00006168|methotrexate|methotrexate
794339|NCT00006168|liver|liver
794340|NCT00006167|oxandrolone|oxandrolone
794341|NCT00006167|AIDS wasting|aids wasting
794342|NCT00006167|strength training|strength training
794343|NCT00006167|progressive resistance training|progressive resistance training
794344|NCT00006167|exercise|exercise
794345|NCT00006167|dietary intervention|dietary intervention
794346|NCT00006166|refractory ascites|refractory ascites
794347|NCT00006166|paracenteses|paracenteses
794348|NCT00006165|Native Hawaiian|native hawaiian
794349|NCT00006165|Diabetes Mellitus|diabetes mellitus
794350|NCT00006165|Lifestyle Intervention|lifestyle intervention
794351|NCT00006165|Family Support|family support
794352|NCT00006165|Diabetes Mellitus, at-risk|diabetes mellitus, at-risk
794353|NCT00006164|liver disease|liver disease
794354|NCT00006164|hepatitis c virus|hepatitis c virus
794355|NCT00006164|antiviral agent|antiviral agent
794356|NCT00006164|cirrhosis|cirrhosis
794357|NCT00006163|diabetes|diabetes
794358|NCT00006163|self-management|self-management
794359|NCT00006163|randomized trial|randomized trial
794360|NCT00006163|RE-AIM evaluation|re-aim evaluation
794361|NCT00006163|participation|participation
794362|NCT00006163|maintenance|maintenance
794363|NCT00006163|community resources|community resources
794364|NCT00006163|dietary change|dietary change
794365|NCT00006162|low fat diet|low fat diet
794366|NCT00006162|aerobic exercise|aerobic exercise
794367|NCT00006162|impaired glucose tolerance|impaired glucose tolerance
794368|NCT00006162|Japanese Americans|japanese americans
794369|NCT00006162|metabolic risk factors|metabolic risk factors
794370|NCT00006161|TIPS|tips
794371|NCT00006161|DSRS|dsrs
794372|NCT00006161|Varices|varices
794373|NCT00006161|Variceal bleeding|variceal bleeding
794374|NCT00006161|Splenorenal Shunt|splenorenal shunt
794375|NCT00006161|Transjugular Intrahepatic Portosystemic Shunt|transjugular intrahepatic portosystemic shunt
794376|NCT00006161|Cirrhosis|cirrhosis
794377|NCT00006161|Portal hypertension|portal hypertension
794378|NCT00006161|Liver disease|liver disease
794379|NCT00006159|diabetes|diabetes
794380|NCT00006159|lifestyle intervention|lifestyle intervention
794381|NCT00006159|Native American|native american
794382|NCT00006159|community intervention|community intervention
794383|NCT00006159|diet|diet
794384|NCT00006159|exercise|exercise
794385|NCT00006158|AIDS|aids
794386|NCT00006158|HIV|hiv
794387|NCT00006158|weight loss|weight loss
794388|NCT00006158|Wasting Syndrome|wasting syndrome
794389|NCT00006158|testosterone|testosterone
794390|NCT00006158|androgen levels|androgen levels
794391|NCT00006158|hormones|hormones
794392|NCT00006157|Functional bowel disorder|functional bowel disorder
794393|NCT00006157|Irritable bowel syndrome|irritable bowel syndrome
794394|NCT00006157|Painful constipation|painful constipation
794395|NCT00006157|Unspecified functional bowel disorder|unspecified functional bowel disorder
794396|NCT00006157|Chronic functional abdominal pain|chronic functional abdominal pain
794397|NCT00006157|Cognitive-behavioral psychological treatment|cognitive-behavioral psychological treatment
794398|NCT00006157|IBS|ibs
794399|NCT00006157|CFAP|cfap
794400|NCT00006151|nicotine fading|nicotine fading
794401|NCT00006151|Accu Drop|accu drop
794402|NCT00006151|cigarette tapering|cigarette tapering
794403|NCT00006151|smoking cessation|smoking cessation
794404|NCT00006151|motivational interviewing|motivational interviewing
794405|NCT00006150|IgE|ige
794406|NCT00006150|Fractures|fractures
794407|NCT00006150|Pneumonia|pneumonia
794408|NCT00006150|Scoliosis|scoliosis
794409|NCT00006150|Eczema|eczema
794410|NCT00006150|Job's Syndrome|job's syndrome
794411|NCT00006150|Hyperimmunologobulin E Syndrome|hyperimmunologobulin e syndrome
794412|NCT00006150|HIE Syndrome|hie syndrome
794413|NCT00006148|Granulocyte Colony - Stimulation Factor|granulocyte colony - stimulation factor
794414|NCT00006148|Peripheral Blood Stem Cells|peripheral blood stem cells
794415|NCT00006148|Splenomegaly|splenomegaly
794416|NCT00006077|Clinical Trial|clinical trial
794417|NCT00006077|Dyskinesias|dyskinesias
794418|NCT00006077|Levodopa Infusion|levodopa infusion
794419|NCT00006077|Parkinson's Disease|parkinson's disease
794420|NCT00006142|inborn errors of metabolism|inborn errors of metabolism
794421|NCT00006142|phenylketonuria|phenylketonuria
794422|NCT00006142|rare disease|rare disease
794423|NCT00006138|disease-related problem/condition|disease-related problem/condition
794424|NCT00006138|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
794425|NCT00006138|hematologic disorders|hematologic disorders
794426|NCT00006138|osteoporosis|osteoporosis
794427|NCT00006138|rare disease|rare disease
794428|NCT00006138|thalassemia major|thalassemia major
794429|NCT00006137|IgA glomerulonephritis|iga glomerulonephritis
794430|NCT00006137|rare disease|rare disease
794431|NCT00006137|renal and genitourinary disorders|renal and genitourinary disorders
794432|NCT00006136|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
794433|NCT00006136|hematologic disorders|hematologic disorders
794434|NCT00006136|rare disease|rare disease
794435|NCT00006136|thalassemia intermedia|thalassemia intermedia
794436|NCT00006135|herpes simplex virus infection|herpes simplex virus infection
794437|NCT00006135|herpesvirus infection|herpesvirus infection
794438|NCT00006135|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
794439|NCT00006135|rare disease|rare disease
794440|NCT00006135|viral infection|viral infection
794441|NCT00006134|arthritis & connective tissue diseases|arthritis & connective tissue diseases
794442|NCT00006134|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
794443|NCT00006134|rare disease|rare disease
794444|NCT00006134|systemic lupus erythematosus|systemic lupus erythematosus
794445|NCT00006133|arthritis & connective tissue diseases|arthritis & connective tissue diseases
794446|NCT00006133|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
794447|NCT00006133|rare disease|rare disease
794448|NCT00006133|systemic lupus erythematosus|systemic lupus erythematosus
794449|NCT00006132|herpes simplex virus infection|herpes simplex virus infection
794450|NCT00006132|herpes virus infection|herpes virus infection
794451|NCT00006132|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
794452|NCT00006132|rare disease|rare disease
794453|NCT00006132|viral infection|viral infection
794454|NCT00006130|arthritis & connective tissue diseases|arthritis & connective tissue diseases
794455|NCT00006130|avascular necrosis|avascular necrosis
794456|NCT00006130|disease-related problem/condition|disease-related problem/condition
794457|NCT00006130|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
794458|NCT00006130|hematologic disorders|hematologic disorders
794459|NCT00006130|pain|pain
794460|NCT00006130|rare disease|rare disease
794461|NCT00006130|sickle cell anemia|sickle cell anemia
794462|NCT00006129|burns|burns
794463|NCT00006129|dermatologic disorders|dermatologic disorders
794464|NCT00006129|rare disease|rare disease
794465|NCT00006128|neurologic and psychiatric disorders|neurologic and psychiatric disorders
794466|NCT00006128|rare disease|rare disease
794467|NCT00006127|Fanconi's anemia|fanconi's anemia
794468|NCT00006127|aplastic anemia|aplastic anemia
794469|NCT00006127|hematologic disorders|hematologic disorders
794470|NCT00006127|rare disease|rare disease
794471|NCT00006076|Hearing|hearing
794472|NCT00006076|Auditory Processing|auditory processing
794473|NCT00006076|Pitch Recognition|pitch recognition
794474|NCT00006076|Tone Deafness|tone deafness
794475|NCT00006076|Tune Deafness|tune deafness
794476|NCT00006076|HV|hv
794477|NCT00006076|Deafness|deafness
794478|NCT00006076|Congenital Amusia|congenital amusia
794479|NCT00006076|Healthy Volunteer|healthy volunteer
794480|NCT00006070|Oral Surgery|oral surgery
794481|NCT00006070|Swelling|swelling
794482|NCT00006070|Pain|pain
794483|NCT00006070|TNF|tnf
794484|NCT00006070|Etanercept|etanercept
794485|NCT00005937|MDS|mds
794486|NCT00005937|Immunosuppression|immunosuppression
794487|NCT00005937|ATG|atg
794488|NCT00005937|Cyclosporine|cyclosporine
794489|NCT00005937|Myelodysplastic Syndrome|myelodysplastic syndrome
794490|NCT00005936|Fulminant Hepatitis|fulminant hepatitis
794491|NCT00005936|Parvovirus|parvovirus
794492|NCT00005936|Hepatitis|hepatitis
794493|NCT00005936|Biopsy|biopsy
794494|NCT00005936|Control|control
794495|NCT00005936|Liver Biopsy|liver biopsy
794496|NCT00005935|Immunosuppression|immunosuppression
794497|NCT00005935|T Cells|t cells
794498|NCT00005935|Autoimmunity|autoimmunity
794499|NCT00005935|Bone Marrow Failure|bone marrow failure
794500|NCT00005935|Hematopoiesis|hematopoiesis
794501|NCT00005935|Relapsing Aplastic Anemia|relapsing aplastic anemia
794502|NCT00005934|Fetal Hemoglobin|fetal hemoglobin
794503|NCT00005934|5-Azacytidine|5-azacytidine
794504|NCT00005934|Phenylbutyrate|phenylbutyrate
794505|NCT00005934|Thalassemia|thalassemia
794506|NCT00005934|Hemoglobin|hemoglobin
794507|NCT00005934|Anemia|anemia
794508|NCT00005934|Blood|blood
794509|NCT00005934|Thalassemia Major|thalassemia major
794510|NCT00005934|Beta Thalassemia|beta thalassemia
794511|NCT00006063|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
794512|NCT00006063|cystic fibrosis|cystic fibrosis
794513|NCT00006063|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
794514|NCT00006063|rare disease|rare disease
794515|NCT00006061|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
794516|NCT00006061|inborn errors of metabolism|inborn errors of metabolism
794517|NCT00006061|methionine adenosyltransferase deficiency|methionine adenosyltransferase deficiency
794518|NCT00006061|rare disease|rare disease
794519|NCT00006060|multiple sclerosis|multiple sclerosis
794520|NCT00006060|neurologic and psychiatric disorders|neurologic and psychiatric disorders
794521|NCT00006060|rare disease|rare disease
794522|NCT00006059|epilepsy|epilepsy
794523|NCT00006059|neurologic and psychiatric disorders|neurologic and psychiatric disorders
794524|NCT00006059|rare disease|rare disease
794525|NCT00006059|seizures|seizures
794526|NCT00006058|bronchopulmonary dysplasia|bronchopulmonary dysplasia
794527|NCT00006058|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
794528|NCT00006058|neonatal disorders|neonatal disorders
794529|NCT00006058|rare disease|rare disease
794530|NCT00006058|respiratory distress syndrome|respiratory distress syndrome
794531|NCT00006056|Chediak-Higashi syndrome|chediak-higashi syndrome
794532|NCT00006056|X-linked lymphoproliferative syndrome|x-linked lymphoproliferative syndrome
794533|NCT00006056|disease-related problem/condition|disease-related problem/condition
794534|NCT00006056|familial erythrophagocytic lymphohistiocytosis|familial erythrophagocytic lymphohistiocytosis
794535|NCT00006056|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
794536|NCT00006056|graft versus host disease|graft versus host disease
794537|NCT00006056|hematologic disorders|hematologic disorders
794538|NCT00006056|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
794539|NCT00006056|histiocytosis|histiocytosis
794540|NCT00006056|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
794541|NCT00006056|primary immunodeficiency disease|primary immunodeficiency disease
794542|NCT00006056|rare disease|rare disease
794543|NCT00006056|virus-associated hemophagocytic syndrome|virus-associated hemophagocytic syndrome
794544|NCT00006055|Churg-Strauss syndrome|churg-strauss syndrome
794545|NCT00006055|Schonlein-Henoch purpura|schonlein-henoch purpura
794546|NCT00006055|Takayasu arteritis|takayasu arteritis
794547|NCT00006055|Wegener's granulomatosis|wegener's granulomatosis
794548|NCT00006055|arthritis & connective tissue diseases|arthritis & connective tissue diseases
794549|NCT00006055|autoimmune hemolytic anemia|autoimmune hemolytic anemia
794550|NCT00006055|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
794551|NCT00006055|disease-related problem/condition|disease-related problem/condition
794552|NCT00006055|giant cell arteritis|giant cell arteritis
794553|NCT00006055|graft versus host disease|graft versus host disease
794554|NCT00006055|hematologic disorders|hematologic disorders
794555|NCT00006055|hypersensitivity vasculitis|hypersensitivity vasculitis
794556|NCT00006055|immune thrombocytopenic purpura|immune thrombocytopenic purpura
794557|NCT00006055|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
794558|NCT00006055|juvenile rheumatoid arthritis|juvenile rheumatoid arthritis
794559|NCT00006055|polyarteritis nodosa|polyarteritis nodosa
794560|NCT00006055|pure red cell aplasia|pure red cell aplasia
794561|NCT00006055|rare disease|rare disease
794562|NCT00006055|rheumatoid arthritis|rheumatoid arthritis
794563|NCT00006055|systemic lupus erythematosus|systemic lupus erythematosus
794564|NCT00006055|vasculitis|vasculitis
794565|NCT00006054|Chediak-Higashi syndrome|chediak-higashi syndrome
794566|NCT00006054|Langerhans cell histiocytosis|langerhans cell histiocytosis
794567|NCT00006054|Wiskott-Aldrich syndrome|wiskott-aldrich syndrome
794568|NCT00006054|X-linked agammaglobulinemia|x-linked agammaglobulinemia
794569|NCT00006054|X-linked hyper IgM syndrome|x-linked hyper igm syndrome
794570|NCT00006054|X-linked lymphoproliferative syndrome|x-linked lymphoproliferative syndrome
794571|NCT00006054|chronic granulomatous disease|chronic granulomatous disease
794572|NCT00006054|common variable immunodeficiency|common variable immunodeficiency
794573|NCT00006054|complement deficiency|complement deficiency
794574|NCT00006054|disease-related problem/condition|disease-related problem/condition
794575|NCT00006054|familial erythrophagocytic lymphohistiocytosis|familial erythrophagocytic lymphohistiocytosis
794576|NCT00006054|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
794577|NCT00006054|graft versus host disease|graft versus host disease
794578|NCT00006054|hematologic disorders|hematologic disorders
794579|NCT00006054|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
794580|NCT00006054|histiocytosis|histiocytosis
794581|NCT00006054|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
794582|NCT00006054|leukocyte adhesion deficiency syndrome|leukocyte adhesion deficiency syndrome
794583|NCT00006054|primary immunodeficiency disease|primary immunodeficiency disease
794584|NCT00006054|rare disease|rare disease
794585|NCT00006054|severe combined immunodeficiency|severe combined immunodeficiency
794586|NCT00006054|virus-associated hemophagocytic syndrome|virus-associated hemophagocytic syndrome
794587|NCT00005933|Chronic Disease|chronic disease
794588|NCT00005933|Pediatric|pediatric
794589|NCT00005933|Pulmonary|pulmonary
794590|NCT00005933|Intelligence|intelligence
794591|NCT00005933|Coping|coping
794592|NCT00005933|Chronic Illness|chronic illness
794593|NCT00005933|Learning|learning
794594|NCT00005928|ACE Inhibitor|ace inhibitor
794595|NCT00005928|Vascular Inflammation|vascular inflammation
794596|NCT00005928|Vascular Compliance|vascular compliance
794597|NCT00005928|Cell Adhesion Molecules|cell adhesion molecules
794598|NCT00005928|Coronary Artery Disease|coronary artery disease
794599|NCT00005927|Adrenal Adenoma|adrenal adenoma
794600|NCT00005927|Adrenal Cancer|adrenal cancer
794601|NCT00005927|Macronodular Adrenals|macronodular adrenals
794602|NCT00005927|Ectopic Receptors|ectopic receptors
794603|NCT00005927|Gene Profiling|gene profiling
794604|NCT00005927|Adrenocortical Carcinoma|adrenocortical carcinoma
794605|NCT00005927|Cushing Syndrome|cushing syndrome
794606|NCT00005927|Virilizing Adrenal Tumor|virilizing adrenal tumor
794607|NCT00005927|Feminizing Adrenal Tumor|feminizing adrenal tumor
794608|NCT00005927|Massive Macronodular Adrenocortical Disease|massive macronodular adrenocortical disease
794609|NCT00005927|Adrenal Gland Tumor|adrenal gland tumor
794610|NCT00005925|Video-EEG|video-eeg
794611|NCT00005925|Muscimol|muscimol
794612|NCT00005925|Depth Electrode|depth electrode
794613|NCT00005925|Brain Catheter|brain catheter
794614|NCT00005925|Pharmacology|pharmacology
794615|NCT00005925|Epilepsy|epilepsy
794616|NCT00005925|Infusion|infusion
794617|NCT00005925|Magnetic Resonance Imaging|magnetic resonance imaging
794618|NCT00005924|B Cell|b cell
794619|NCT00005924|Epstein-Barr Virus|epstein-barr virus
794620|NCT00005923|Joint Instability|joint instability
794621|NCT00005922|Conditioning|conditioning
794622|NCT00005922|Corticosteroid|corticosteroid
794623|NCT00005922|Lesions|lesions
794624|NCT00005922|Pharmacotherapy|pharmacotherapy
794625|NCT00005922|Placebo effect|placebo effect
794626|NCT00005922|Psoriasis|psoriasis
794627|NCT00005922|Psychoneuroimmunology|psychoneuroimmunology
794628|NCT00005919|Pigment Dispersion|pigment dispersion
794629|NCT00005919|Ocular Hypertension|ocular hypertension
794630|NCT00005919|Glaucoma|glaucoma
794631|NCT00005919|Pupil Reaction|pupil reaction
794632|NCT00005919|Natural History|natural history
794633|NCT00005919|Pigment Dispersion Syndrome|pigment dispersion syndrome
794634|NCT00005919|Gene Mutation|gene mutation
794635|NCT00005917|Albinism|albinism
794636|NCT00005917|Giant Granules|giant granules
794637|NCT00005917|Infection|infection
794638|NCT00005917|Melanosomes|melanosomes
794639|NCT00005917|Platelet Storage Pool Defect|platelet storage pool defect
794640|NCT00005916|Immunotherapy|immunotherapy
794641|NCT00005916|Radiation|radiation
794642|NCT00005916|Immunology|immunology
794643|NCT00005916|Prostvac|prostvac
794644|NCT00005916|Prostate Cancer|prostate cancer
794645|NCT00005914|Depression|depression
794646|NCT00005914|Depressive Disorder|depressive disorder
794647|NCT00005914|Family|family
794648|NCT00005914|Genes|genes
794649|NCT00005914|Genetic Techniques|genetic techniques
794650|NCT00005914|Genetics|genetics
794651|NCT00005914|Linkage (Genetics)|linkage (genetics)
794652|NCT00005914|Nuclear Family|nuclear family
794653|NCT00005914|Recurrence|recurrence
794654|NCT00005914|Severity of Illness Index|severity of illness index
794655|NCT00005911|Magnetic Resonance Imaging|magnetic resonance imaging
794656|NCT00005911|Human Eye|human eye
794657|NCT00005911|Lens|lens
794658|NCT00005911|Normal Volunteers|normal volunteers
794659|NCT00005911|Cataract|cataract
794660|NCT00005911|Human Lens|human lens
794661|NCT00005911|Healthy Volunteer|healthy volunteer
794662|NCT00005910|Islet Cell Tumors|islet cell tumors
794663|NCT00005910|Surgery|surgery
794664|NCT00005910|Ultrasound|ultrasound
794665|NCT00005910|Insulin|insulin
794666|NCT00005910|Rapid Assay|rapid assay
794667|NCT00005910|Arteriogram|arteriogram
794668|NCT00005910|Pancreas|pancreas
794669|NCT00005910|Laparoscopy|laparoscopy
794670|NCT00005910|Insulinoma|insulinoma
794671|NCT00005910|Localization|localization
794672|NCT00005910|Hypoglycemia|hypoglycemia
794673|NCT00005909|Homogentisic Acid|homogentisic acid
794674|NCT00005909|Ochronosis|ochronosis
794675|NCT00005909|Inborn Error of Metabolism|inborn error of metabolism
794676|NCT00005909|Arthritis|arthritis
794677|NCT00005909|Enzyme Defect|enzyme defect
794678|NCT00005909|Alkaptonuria|alkaptonuria
794679|NCT00005909|Homogentisic Acid Oxidase|homogentisic acid oxidase
794680|NCT00005908|cDNA Microarray|cdna microarray
794681|NCT00005908|Stage II and Stage III Breast Cancer|stage ii and stage iii breast cancer
794682|NCT00005908|Biological Response|biological response
794683|NCT00005908|Molecular Profiling|molecular profiling
794684|NCT00005908|Fine Needle Aspirate|fine needle aspirate
794685|NCT00005908|Breast Cancer|breast cancer
794686|NCT00005907|B Cell|b cell
794687|NCT00005907|Reconstitution|reconstitution
794688|NCT00005907|T Cell|t cell
794689|NCT00005907|Transplant|transplant
794690|NCT00005907|Vaccine|vaccine
794691|NCT00005906|Chylous Ascites|chylous ascites
794692|NCT00005906|Chylous Pleural Effusion|chylous pleural effusion
794693|NCT00005906|Inhibitory Effects|inhibitory effects
794694|NCT00005906|Lymphangioleiomyoma|lymphangioleiomyoma
794695|NCT00005906|Somatostatin|somatostatin
794696|NCT00005906|Lymphangioleiomyomatosis (LAM)|lymphangioleiomyomatosis (lam)
794697|NCT00005905|Adipocyte - Development|adipocyte - development
794698|NCT00005905|Insulin Resistance|insulin resistance
794699|NCT00005905|Dyslipidemia|dyslipidemia
794700|NCT00005905|Diabetes Mellitus|diabetes mellitus
794701|NCT00005905|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
794702|NCT00005905|Leptin Replacement|leptin replacement
794703|NCT00005903|Parkinsonism|parkinsonism
794704|NCT00005903|Trophic Factor|trophic factor
794705|NCT00005903|Neurodegenerative Disorder|neurodegenerative disorder
794706|NCT00005903|Progressive Supranuclear Palsy|progressive supranuclear palsy
794707|NCT00005902|Brain|brain
794708|NCT00005902|Brainstem|brainstem
794709|NCT00005902|Cyst|cyst
794710|NCT00005902|Magnetic Resonance Imaging|magnetic resonance imaging
794711|NCT00005902|Spinal Cord|spinal cord
794712|NCT00005902|von Hippel-Lindau|von hippel-lindau
794713|NCT00005901|Bisphosphonates|bisphosphonates
794714|NCT00005901|Growth Hormone|growth hormone
794715|NCT00005901|Bone Density|bone density
796239|NCT00001905|Neutrophil|neutrophil
794716|NCT00005901|Osteogenesis Imperfecta|osteogenesis imperfecta
794717|NCT00005900|Gaucher's disease|gaucher's disease
794718|NCT00005900|I cell disease|i cell disease
794719|NCT00005900|Niemann-Pick disease|niemann-pick disease
794720|NCT00005900|Wolman disease|wolman disease
794721|NCT00005900|adrenoleukodystrophy|adrenoleukodystrophy
794722|NCT00005900|disease-related problem/condition|disease-related problem/condition
794723|NCT00005900|fucosidosis|fucosidosis
794724|NCT00005900|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
794725|NCT00005900|globoid cell leukodystrophy|globoid cell leukodystrophy
794726|NCT00005900|inborn errors of metabolism|inborn errors of metabolism
794727|NCT00005900|mannosidosis|mannosidosis
794964|NCT00005654|hyperinsulinism|hyperinsulinism
794728|NCT00005900|metachromatic leukodystrophy|metachromatic leukodystrophy
794729|NCT00005900|mucopolysaccharidosis|mucopolysaccharidosis
794730|NCT00005900|mucopolysaccharidosis I|mucopolysaccharidosis i
794731|NCT00005900|mucopolysaccharidosis VI|mucopolysaccharidosis vi
794732|NCT00005900|oncologic disorders|oncologic disorders
794733|NCT00005900|pulmonary complications|pulmonary complications
794734|NCT00005900|rare disease|rare disease
794735|NCT00005900|sphingolipidoses|sphingolipidoses
794736|NCT00005896|Fanconi's anemia|fanconi's anemia
794737|NCT00005896|aplastic anemia|aplastic anemia
794738|NCT00005896|hematologic disorders|hematologic disorders
794739|NCT00005896|rare disease|rare disease
794740|NCT00005893|chronic congenital neutropenia|chronic congenital neutropenia
794741|NCT00005893|chronic neutropenia|chronic neutropenia
794742|NCT00005893|congenital pure red cell aplasia|congenital pure red cell aplasia
794743|NCT00005893|disease-related problem/condition|disease-related problem/condition
794744|NCT00005893|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
794745|NCT00005893|hematologic disorders|hematologic disorders
794746|NCT00005893|neutropenia|neutropenia
794747|NCT00005893|pure red cell aplasia|pure red cell aplasia
794748|NCT00005893|rare disease|rare disease
794749|NCT00005893|sickle cell anemia|sickle cell anemia
794750|NCT00005893|thalassemia major|thalassemia major
794751|NCT00005892|Fanconi's anemia|fanconi's anemia
794752|NCT00005892|acute leukemia|acute leukemia
794753|NCT00005892|acute lymphocytic leukemia|acute lymphocytic leukemia
794754|NCT00005892|acute myeloid leukemia|acute myeloid leukemia
794755|NCT00005892|acute undifferentiated leukemia|acute undifferentiated leukemia
794756|NCT00005892|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
794757|NCT00005892|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
794758|NCT00005892|adult acute myeloid leukemia|adult acute myeloid leukemia
794759|NCT00005892|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
794760|NCT00005892|aplastic anemia|aplastic anemia
794761|NCT00005892|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
794762|NCT00005892|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
794763|NCT00005892|childhood acute myeloid leukemia|childhood acute myeloid leukemia
794764|NCT00005892|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
794765|NCT00005892|de novo myelodysplastic syndrome|de novo myelodysplastic syndrome
794766|NCT00005892|hematologic disorders|hematologic disorders
794767|NCT00005892|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
794768|NCT00005892|leukemia|leukemia
794769|NCT00005892|myelodysplastic syndrome|myelodysplastic syndrome
794770|NCT00005892|oncologic disorders|oncologic disorders
794771|NCT00005892|previously treated myelodysplastic syndrome|previously treated myelodysplastic syndrome
794772|NCT00005892|rare disease|rare disease
794773|NCT00005892|secondary myelodysplastic syndrome|secondary myelodysplastic syndrome
794774|NCT00005891|Fanconi's Anemia|fanconi's anemia
794775|NCT00005891|aplastic anemia|aplastic anemia
794776|NCT00005891|hematologic disorders|hematologic disorders
794777|NCT00005891|rare disease|rare disease
794778|NCT00005890|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
794779|NCT00005890|rare disease|rare disease
794780|NCT00005890|sepsis|sepsis
794781|NCT00005890|septic shock|septic shock
794782|NCT00005889|endocrine disorders|endocrine disorders
794783|NCT00005889|hyperglycemia|hyperglycemia
794784|NCT00005889|low birth weight|low birth weight
794785|NCT00005889|neonatal disorders|neonatal disorders
794786|NCT00005889|rare disease|rare disease
794787|NCT00005888|gastrointestinal disorders|gastrointestinal disorders
794788|NCT00005888|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
794789|NCT00005888|low birth weight|low birth weight
794790|NCT00005888|necrotizing enterocolitis|necrotizing enterocolitis
794791|NCT00005888|neonatal disorders|neonatal disorders
794792|NCT00005888|rare disease|rare disease
794793|NCT00005888|sepsis|sepsis
794794|NCT00005785|Peripheral Blood Stem Cells|peripheral blood stem cells
794795|NCT00005785|Engraftment|engraftment
794796|NCT00005785|Graft vs. Host Disease|graft vs. host disease
794797|NCT00005785|Graft-Versus-Leukemia|graft-versus-leukemia
794798|NCT00005785|Donor Apheresis|donor apheresis
794799|NCT00005785|Cyclophosphamide|cyclophosphamide
794800|NCT00005785|Fludarabine|fludarabine
794801|NCT00005785|HIV|hiv
794802|NCT00005785|AIDS|aids
794803|NCT00005785|Gene Therapy|gene therapy
794804|NCT00005785|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
794805|NCT00005785|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
794806|NCT00005785|Acute Myelogenous Leukemia|acute myelogenous leukemia
794807|NCT00005785|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
794808|NCT00005784|Macular Degeneration|macular degeneration
794809|NCT00005784|Diabetic Retinopathy|diabetic retinopathy
794810|NCT00005784|Vascular Occlusive Disease|vascular occlusive disease
794811|NCT00005784|Central Serous Retinopathy|central serous retinopathy
794812|NCT00005784|Rare/Unknown Retinal Disease|rare/unknown retinal disease
794813|NCT00005784|Retinal Disease|retinal disease
794814|NCT00005784|Age-Related Macular Degeneration|age-related macular degeneration
794815|NCT00005782|Donor Apheresis|donor apheresis
794816|NCT00005782|Sickle Cell Trait|sickle cell trait
794817|NCT00005782|Red Cell Alloimmunization|red cell alloimmunization
794818|NCT00005780|Lymphoma Vaccines|lymphoma vaccines
794819|NCT00005780|Immune Response Against Lymphoma|immune response against lymphoma
794820|NCT00005780|Molecular Complete Remissions|molecular complete remissions
794821|NCT00005780|Novel Treatment Approach|novel treatment approach
794822|NCT00005780|Mantle Cell Lymphoma|mantle cell lymphoma
794823|NCT00005778|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
794824|NCT00005778|Cytoxan|cytoxan
794825|NCT00005778|Cyclophosphamide|cyclophosphamide
794826|NCT00005778|High-dose immunoablative therapy|high-dose immunoablative therapy
794827|NCT00005777|NICHD Neonatal Research Network|nichd neonatal research network
794828|NCT00005777|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
794829|NCT00005777|Prematurity|prematurity
794830|NCT00005777|Chronic Lung Disease (CLD)|chronic lung disease (cld)
794831|NCT00005777|Dexamethasone|dexamethasone
794832|NCT00005777|Glucocorticoids|glucocorticoids
794833|NCT00005777|Respiration, Artificial|respiration, artificial
794834|NCT00005777|Mechanical ventilation|mechanical ventilation
794835|NCT00005777|Respiratory Insufficiency|respiratory insufficiency
794836|NCT00005776|NICHD Neonatal Research Network|nichd neonatal research network
794837|NCT00005776|Hypertension, pulmonary|hypertension, pulmonary
794838|NCT00005776|Hypoxic respiratory failure|hypoxic respiratory failure
794839|NCT00005776|Meconium aspiration|meconium aspiration
794840|NCT00005776|Methemoglobinemia|methemoglobinemia
794841|NCT00005776|Nitric oxide|nitric oxide
794842|NCT00005776|Oxygen inhalation therapy|oxygen inhalation therapy
794843|NCT00005776|Persistent Fetal Circulation Syndrome|persistent fetal circulation syndrome
794844|NCT00005776|Pneumonia, aspiration|pneumonia, aspiration
794845|NCT00005776|Respiratory distress syndrome|respiratory distress syndrome
794846|NCT00005776|Respiratory insufficiency|respiratory insufficiency
794847|NCT00005776|Severe respiratory failure|severe respiratory failure
794848|NCT00005775|NICHD Neonatal Research Network|nichd neonatal research network
794849|NCT00005775|Extremely Low Birth Weight (ELBW) infants|extremely low birth weight (elbw) infants
794850|NCT00005775|Prematurity|prematurity
794851|NCT00005775|Glutamine|glutamine
794852|NCT00005775|Total parenteral nutrition|total parenteral nutrition
794853|NCT00005775|Nutrition|nutrition
794854|NCT00005775|Very low birth weight (VLBW) infants|very low birth weight (vlbw) infants
794855|NCT00005774|NICHD Neonatal Research Network|nichd neonatal research network
794856|NCT00005774|Pulmonary ventilation|pulmonary ventilation
794857|NCT00005774|Respiratory distress syndrome|respiratory distress syndrome
794858|NCT00005774|Respiratory insufficiency|respiratory insufficiency
794859|NCT00005774|Surfactant, pulmonary|surfactant, pulmonary
794860|NCT00005774|Mechanical Ventilation|mechanical ventilation
794861|NCT00005774|Survanta|survanta
794862|NCT00005773|NICHD Neonatal Research Network|nichd neonatal research network
794863|NCT00005773|Hypertension, pulmonary|hypertension, pulmonary
794864|NCT00005773|Hypoxic respiratory failure|hypoxic respiratory failure
794865|NCT00005773|Meconium aspiration|meconium aspiration
794866|NCT00005773|Methemoglobinemia|methemoglobinemia
794867|NCT00005773|Nitric oxide|nitric oxide
794868|NCT00005773|Oxygen inhalation therapy|oxygen inhalation therapy
794869|NCT00005773|Persistent Fetal Circulation Syndrome|persistent fetal circulation syndrome
794870|NCT00005773|Pneumonia, aspiration|pneumonia, aspiration
794871|NCT00005773|Respiratory distress syndrome|respiratory distress syndrome
794872|NCT00005773|Respiratory insufficiency|respiratory insufficiency
794873|NCT00005773|Severe respiratory failure|severe respiratory failure
794874|NCT00005772|NICHD Neonatal Research Network|nichd neonatal research network
794875|NCT00005772|Hypoxic-ischemic encephalopathy (HIE)|hypoxic-ischemic encephalopathy (hie)
794876|NCT00005772|Hypothermia|hypothermia
794877|NCT00005772|Neonatal depression|neonatal depression
794878|NCT00005772|Perinatal asphyxia|perinatal asphyxia
794879|NCT00005771|Abdominal Hollowing Exercises|abdominal hollowing exercises
794880|NCT00005770|elastic property of skin|elastic property of skin
794881|NCT00005767|Amino Acid Metabolism|amino acid metabolism
794882|NCT00005766|ALS|als
794883|NCT00005761|Types 1 & 2 Diabetes|types 1 & 2 diabetes
794884|NCT00005761|Cell Adhesion Molecules|cell adhesion molecules
794885|NCT00005761|Chemokines|chemokines
794886|NCT00005761|Vascular Endothelial Growth Factor|vascular endothelial growth factor
794887|NCT00005761|Cross-Sectional|cross-sectional
794888|NCT00005761|Serum Levels|serum levels
794889|NCT00005761|Diabetic Retinopathy|diabetic retinopathy
794890|NCT00005760|Dyslipidemia|dyslipidemia
794891|NCT00005760|Hypertension|hypertension
794892|NCT00005760|Metabolic Syndrome X|metabolic syndrome x
794893|NCT00005760|Obesity|obesity
794894|NCT00005760|Subcutaneous Adipose Tissue|subcutaneous adipose tissue
794895|NCT00005760|Visceral Abdominal Adipose Tissue|visceral abdominal adipose tissue
794896|NCT00005675|Systemic Scleroderma (SSc)|systemic scleroderma (ssc)
794897|NCT00005675|Bovine Type I Collagen (CI)|bovine type i collagen (ci)
794898|NCT00005675|Multicenter|multicenter
794899|NCT00005727|Nutrition|nutrition
794900|NCT00005727|Education|education
794901|NCT00005520|Hypertension|hypertension
794902|NCT00005520|Pharmacogenetics|pharmacogenetics
794903|NCT00005520|Hydrochlorothiazide|hydrochlorothiazide
794904|NCT00005520|Candesartan|candesartan
794905|NCT00005487|Coronary Arteriosclerosis|coronary arteriosclerosis
794906|NCT00005487|Cerebrovascular Accident|cerebrovascular accident
794907|NCT00005487|Heart Failure, Congestive|heart failure, congestive
794908|NCT00005487|Diabetes Mellitus, Non-Insulin Dependent|diabetes mellitus, non-insulin dependent
794909|NCT00005673|HIV|hiv
794910|NCT00005673|Antiretroviral|antiretroviral
794911|NCT00005673|NNRTI|nnrti
794912|NCT00005671|Angina|angina
794913|NCT00005671|Condition Specific|condition specific
794914|NCT00005671|Heart Failure|heart failure
794915|NCT00005671|Symptom Distress|symptom distress
794916|NCT00005671|Revascularization|revascularization
794917|NCT00005671|Coronary Artery Disease|coronary artery disease
794918|NCT00005671|Ischemic Heart Disease|ischemic heart disease
794919|NCT00005669|Child|child
794920|NCT00005669|Body Fat|body fat
794921|NCT00005669|Food Intake|food intake
794922|NCT00005669|Diabetes Mellitus|diabetes mellitus
794923|NCT00005669|Dyslipidemia|dyslipidemia
794924|NCT00005669|Vitamin B12|vitamin b12
794925|NCT00005669|Childhood Obesity|childhood obesity
794926|NCT00005667|liver transplantation|liver transplantation
794927|NCT00005667|vancomycin resistance|vancomycin resistance
794928|NCT00005666|Diagnostic imaging|diagnostic imaging
794929|NCT00005664|Healthy Volunteers|healthy volunteers
794930|NCT00005664|Endocrine Related Conditions|endocrine related conditions
794931|NCT00005664|Endocrine Dysfunction|endocrine dysfunction
794932|NCT00005664|Early Pubertal Development|early pubertal development
794933|NCT00005660|Hypertriglyceridemia|hypertriglyceridemia
794934|NCT00005660|Teratogenicity|teratogenicity
794935|NCT00005660|Ichthyosis|ichthyosis
794936|NCT00005660|Darier's Disease|darier's disease
794937|NCT00005660|Retinoids|retinoids
794938|NCT00005660|Skin|skin
794939|NCT00005660|Psoriasis|psoriasis
794940|NCT00005660|Basal cell carcinoma|basal cell carcinoma
794941|NCT00005660|Skin Cancer|skin cancer
794942|NCT00005658|Biochemical|biochemical
794943|NCT00005658|Schizophrenia|schizophrenia
794944|NCT00005658|NMDA|nmda
794945|NCT00005658|Adolescence|adolescence
794946|NCT00005658|Psychosis|psychosis
794947|NCT00005658|Child Psychosis|child psychosis
794948|NCT00005658|Biochemical Correlates|biochemical correlates
794949|NCT00005658|Brain Imaging|brain imaging
794950|NCT00005658|Glycine|glycine
794951|NCT00005658|Adjunctive Glycine Therapy|adjunctive glycine therapy
794952|NCT00005657|Cytokines|cytokines
794953|NCT00005657|Treatment|treatment
794954|NCT00005657|Genetic Polymorphism|genetic polymorphism
794955|NCT00005657|Chronic Hepatitis C|chronic hepatitis c
794956|NCT00005657|Mononuclear Cells|mononuclear cells
794957|NCT00005655|Gene Expression|gene expression
794958|NCT00005655|Neovascularization|neovascularization
794959|NCT00005655|antiangiogenic therapy|antiangiogenic therapy
794960|NCT00005655|immunomodulatory therapy|immunomodulatory therapy
794961|NCT00005655|Immunotherapy|immunotherapy
794962|NCT00005655|Tumor|tumor
794963|NCT00005654|endocrine disorders|endocrine disorders
794965|NCT00005654|polycystic ovarian syndrome|polycystic ovarian syndrome
794966|NCT00005654|rare disease|rare disease
794967|NCT00005652|hematologic disorders|hematologic disorders
794968|NCT00005652|immune thrombocytopenic purpura|immune thrombocytopenic purpura
794969|NCT00005652|rare disease|rare disease
794970|NCT00005650|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
794971|NCT00005650|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
794972|NCT00005650|primary ciliary dyskinesia|primary ciliary dyskinesia
794973|NCT00005650|rare disease|rare disease
794974|NCT00005575|Imipramine|imipramine
794975|NCT00005575|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
794976|NCT00005571|Skin|skin
794977|NCT00005571|Humoral Immunity|humoral immunity
794978|NCT00005571|Myositis|myositis
794979|NCT00005571|Complement|complement
794980|NCT00005571|Antibody|antibody
794981|NCT00005571|Dermatomyositis|dermatomyositis
794982|NCT00005569|Elastase|elastase
794983|NCT00005569|Inflammation|inflammation
794984|NCT00005569|Age|age
794985|NCT00005569|Gender|gender
794986|NCT00005569|Cytokine|cytokine
794987|NCT00005569|Healthy Volunteer|healthy volunteer
794988|NCT00005566|Suicide|suicide
794989|NCT00005119|Premenstrual Dysphoric Disorder|premenstrual dysphoric disorder
794990|NCT00005119|Severe Premenstrual Syndrome|severe premenstrual syndrome
794991|NCT00005119|Calcium metabolism|calcium metabolism
794992|NCT00005119|Vitamin D|vitamin d
794993|NCT00005119|Bone Markers|bone markers
794994|NCT00005119|Premenopausal|premenopausal
794995|NCT00005119|Menstrual Cycle|menstrual cycle
794996|NCT00005117|endothelial dysfunction|endothelial dysfunction
794997|NCT00005116|depression|depression
794998|NCT00005108|Menopause|menopause
794999|NCT00005108|Atherosclerosis|atherosclerosis
795000|NCT00005108|Estrogen|estrogen
795001|NCT00005108|MRI|mri
795002|NCT00005108|Ultrasound|ultrasound
795003|NCT00005105|endocrine disorders|endocrine disorders
795004|NCT00005105|intrauterine growth retardation|intrauterine growth retardation
795005|NCT00005105|rare disease|rare disease
795006|NCT00005104|endocrine disorders|endocrine disorders
795007|NCT00005104|hyperinsulinism|hyperinsulinism
795008|NCT00005104|polycystic ovarian syndrome|polycystic ovarian syndrome
795009|NCT00005104|rare disease|rare disease
795010|NCT00005103|inborn errors of metabolism|inborn errors of metabolism
795011|NCT00005103|porphyria|porphyria
795012|NCT00005103|porphyria cutanea tarda|porphyria cutanea tarda
795013|NCT00005103|rare disease|rare disease
795014|NCT00005102|DiGeorge syndrome|digeorge syndrome
795015|NCT00005102|Shprintzen syndrome|shprintzen syndrome
795016|NCT00005102|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
795017|NCT00005102|conotruncal cardiac defects|conotruncal cardiac defects
795018|NCT00005102|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
795019|NCT00005102|rare disease|rare disease
795020|NCT00005101|disease-related problem/condition|disease-related problem/condition
795021|NCT00005101|osteoporosis|osteoporosis
795022|NCT00005101|rare disease|rare disease
795023|NCT00005100|acromegaly|acromegaly
795024|NCT00005100|endocrine disorders|endocrine disorders
795025|NCT00005100|rare disease|rare disease
795026|NCT00005098|alpha 1-antitrypsin deficiency|alpha 1-antitrypsin deficiency
795027|NCT00005098|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
795028|NCT00005098|rare disease|rare disease
795029|NCT00005015|Bipolar Disorder|bipolar disorder
795030|NCT00005015|Depression|depression
795031|NCT00005015|Fluoxetine|fluoxetine
795032|NCT00005014|Autistic Disorder|autistic disorder
795033|NCT00005014|Risperidone|risperidone
795034|NCT00005013|Antidepressive Agents|antidepressive agents
795035|NCT00005013|Depression|depression
795036|NCT00005013|Depressive Disorder|depressive disorder
795037|NCT00005013|Herbs|herbs
795038|NCT00005013|Hypericum|hypericum
795039|NCT00005013|Medicine, Herbal|medicine, herbal
795040|NCT00005013|Plant Extracts|plant extracts
795041|NCT00005013|Alternative Medicine|alternative medicine
795042|NCT00005011|Depression|depression
795043|NCT00005011|Menstrual Cycle|menstrual cycle
795044|NCT00005011|Gonadal Steroids|gonadal steroids
795045|NCT00005011|GnRH Agonist|gnrh agonist
795046|NCT00005011|PMS|pms
795047|NCT00005011|Estradiol|estradiol
795048|NCT00005011|Progesterone|progesterone
795049|NCT00005011|Mood|mood
795050|NCT00005011|MRMD|mrmd
795051|NCT00005011|PMDD|pmdd
795052|NCT00005011|Menstrually Related Mood Disorders|menstrually related mood disorders
795053|NCT00005007|Wegener's granulomatosis|wegener's granulomatosis
795054|NCT00005007|Vasculitis|vasculitis
795055|NCT00005007|Etanercept|etanercept
795056|NCT00005007|Tumor necrosis factor|tumor necrosis factor
795057|NCT00005006|Anabolic agent|anabolic agent
795058|NCT00005006|hPTH|hpth
795059|NCT00005006|PTH|pth
795060|NCT00005006|Parathyroid hormone|parathyroid hormone
795061|NCT00005006|Bone mass|bone mass
795062|NCT00005006|Bone turnover|bone turnover
795063|NCT00005006|Bone formation|bone formation
795064|NCT00005006|Alendronate|alendronate
795065|NCT00005006|Osteoporosis|osteoporosis
795066|NCT00005006|Cyclical therapy|cyclical therapy
795067|NCT00005005|PTH|pth
795068|NCT00005005|Alendronate|alendronate
795069|NCT00005005|Parathyroid hormone|parathyroid hormone
795070|NCT00005005|Osteoporosis|osteoporosis
795071|NCT00005005|Postmenopausal|postmenopausal
795072|NCT00005004|Cognitive Processes|cognitive processes
795073|NCT00005004|Inferential Ambiguities|inferential ambiguities
795074|NCT00005004|Language Processes|language processes
795075|NCT00005004|Lexical Ambiguities|lexical ambiguities
795076|NCT00005004|Suppression Mechanism|suppression mechanism
795077|NCT00005004|Discourse Processes|discourse processes
795078|NCT00005004|Discourse Production Analysis|discourse production analysis
795079|NCT00005004|Magnetic Resonance Imaging|magnetic resonance imaging
795080|NCT00005004|Prefrontal Cortex Function|prefrontal cortex function
795081|NCT00005004|Aging Effects|aging effects
795082|NCT00005004|Garden Path Phenomena|garden path phenomena
795083|NCT00005004|Text Integration|text integration
795084|NCT00005003|Handedness|handedness
795085|NCT00005003|Laterality|laterality
795086|NCT00005003|Linkage|linkage
795087|NCT00005003|VNTR/Dinucleotide|vntr/dinucleotide
795088|NCT00005003|Dinucleotide|dinucleotide
795089|NCT00005003|High-Frequency-Trait Analysis|high-frequency-trait analysis
795090|NCT00004997|Hematopoietic|hematopoietic
795095|NCT00004997|Myelodysplasia|myelodysplasia
795096|NCT00004997|Myelodysplastic|myelodysplastic
795097|NCT00004996|Antigen Presentation|antigen presentation
795098|NCT00004996|Cytokines|cytokines
795099|NCT00004996|Helminth|helminth
795100|NCT00004996|Healthy Volunteer|healthy volunteer
795101|NCT00004996|Cross-Over Study|cross-over study
795102|NCT00004996|Helminth Infection|helminth infection
795103|NCT00004994|Allogeneic Transplant|allogeneic transplant
795104|NCT00004994|Function|function
795105|NCT00004994|Mini-Transplant|mini-transplant
795106|NCT00004994|Physical Symptoms|physical symptoms
795107|NCT00004994|Symptom Distress|symptom distress
795108|NCT00004993|Parathyroid hormone (1-34)|parathyroid hormone (1-34)
795109|NCT00004993|Glucocorticoid-induced osteoporosis|glucocorticoid-induced osteoporosis
795110|NCT00004993|Postmenopausal women|postmenopausal women
795111|NCT00004993|osteoporotic fractures|osteoporotic fractures
795112|NCT00004992|clinical trial|clinical trial
795113|NCT00004992|multi-center|multi-center
795114|NCT00004992|NIDDM|niddm
795115|NCT00004992|NIDDK|niddk
795116|NCT00004992|Diabetes Prevention Program (DPP)|diabetes prevention program (dpp)
795117|NCT00004992|diabetes risk factors|diabetes risk factors
795118|NCT00004992|diabetes|diabetes
795119|NCT00004992|glycemia|glycemia
795120|NCT00004992|cardiovascular risk factors|cardiovascular risk factors
795121|NCT00004992|quality of life|quality of life
795122|NCT00004992|physical activity and nutrition|physical activity and nutrition
795123|NCT00004992|occurrence of adverse events|occurrence of adverse events
795124|NCT00004992|insulin secretion and sensitivity|insulin secretion and sensitivity
795125|NCT00004992|prevention|prevention
795126|NCT00004992|abnormal glucose metabolism|abnormal glucose metabolism
795127|NCT00004992|lifestyle intervention|lifestyle intervention
795128|NCT00004992|drug intervention|drug intervention
795129|NCT00004991|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
795130|NCT00004991|Stuttering|stuttering
795131|NCT00004991|Speech Perception|speech perception
795132|NCT00004991|Speech Production|speech production
795133|NCT00004991|Phonology|phonology
795134|NCT00004991|Development|development
795135|NCT00004991|Motor Control|motor control
795136|NCT00004991|Neural Networks|neural networks
795137|NCT00004991|Phonological Disorders|phonological disorders
795138|NCT00004990|Nephrotic Syndrome|nephrotic syndrome
795139|NCT00004990|Steroids|steroids
795140|NCT00004990|Osteoporosis|osteoporosis
795141|NCT00004990|Adrenal Suppression|adrenal suppression
795142|NCT00004990|Proteinuria|proteinuria
795143|NCT00004990|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
795144|NCT00004988|Anti-Tumor Effects|anti-tumor effects
795145|NCT00004988|Maximum Tolerated Dose (MTD)|maximum tolerated dose (mtd)
795146|NCT00004988|Metastatic Cancer|metastatic cancer
795147|NCT00004988|Pharmacokinetics|pharmacokinetics
795148|NCT00004988|Solid Tumors|solid tumors
795149|NCT00004988|Tumor|tumor
795150|NCT00004984|diabetes|diabetes
795151|NCT00004984|insulin|insulin
795152|NCT00004984|prediction|prediction
795153|NCT00004984|prevention|prevention
795154|NCT00004984|C-peptide levels|c-peptide levels
795155|NCT00004984|insulin autoantibodies|insulin autoantibodies
795156|NCT00004984|pancreatic beta cell autoantibodies|pancreatic beta cell autoantibodies
795157|NCT00004984|cellular immune responses|cellular immune responses
795158|NCT00004984|prediction of type 1 diabetes|prediction of type 1 diabetes
795159|NCT00004983|diabetes mellitus, type 2|diabetes mellitus, type 2
795160|NCT00004983|diabetes self-management education|diabetes self-management education
795161|NCT00004983|diabetes self-care|diabetes self-care
795162|NCT00004983|blood glucose self-monitoring|blood glucose self-monitoring
795163|NCT00004983|health education|health education
795164|NCT00004983|patient education|patient education
795165|NCT00004982|chelation therapy|chelation therapy
795166|NCT00004982|combination chemotherapy|combination chemotherapy
795167|NCT00004982|iron poisoning|iron poisoning
795168|NCT00004982|thalassemia|thalassemia
795169|NCT00004982|chelating agent|chelating agent
795170|NCT00004982|deferoxamine|deferoxamine
795171|NCT00004982|drug screening /evaluation|drug screening /evaluation
795172|NCT00004982|therapy evaluation|therapy evaluation
795173|NCT00004980|neurologic and psychiatric disorders|neurologic and psychiatric disorders
795174|NCT00004980|rare disease|rare disease
795175|NCT00004980|schizophrenia|schizophrenia
795176|NCT00004854|moderate heart failure|moderate heart failure
795177|NCT00004853|AMGEN|amgen
795178|NCT00004853|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
795179|NCT00004853|MPNST|mpnst
795180|NCT00004853|Randomized|randomized
795181|NCT00004853|Sarcoma|sarcoma
795182|NCT00004853|Tumor|tumor
795183|NCT00004850|Hepatitis C Virus|hepatitis c virus
795184|NCT00004850|Blood Donors|blood donors
795185|NCT00004850|Liver Biopsy|liver biopsy
795186|NCT00004850|ALT|alt
795187|NCT00004850|Natural History|natural history
795188|NCT00004847|Neurofibromatosis|neurofibromatosis
795189|NCT00004847|Multiple Endocrine Neoplasia (MEN)|multiple endocrine neoplasia (men)
795190|NCT00004847|Von Hippel-Lindau Disease|von hippel-lindau disease
795191|NCT00004847|Norepinephrine|norepinephrine
795192|NCT00004847|Epinephrine|epinephrine
795193|NCT00004847|Metanephrines|metanephrines
795194|NCT00004847|PET|pet
795195|NCT00004847|Paraganglioma|paraganglioma
795196|NCT00004847|Pheochromocytoma|pheochromocytoma
795197|NCT00004846|Viral Gene Amplification|viral gene amplification
795198|NCT00004846|Blood Transmitted Infections|blood transmitted infections
795199|NCT00004846|Transfusion Risks|transfusion risks
795200|NCT00004846|Transcription Mediated Analysis|transcription mediated analysis
795201|NCT00004846|Viral Detection Assays|viral detection assays
795202|NCT00004846|HIV Seronegativity|hiv seronegativity
795203|NCT00004739|Pediatric HIV infection|pediatric hiv infection
795204|NCT00004845|Anti-inflammatory|anti-inflammatory
795205|NCT00004738|Arnold Chiari Malformation|arnold chiari malformation
795206|NCT00004738|Skeletal Dysplasia|skeletal dysplasia
795207|NCT00004738|Syringomyelia|syringomyelia
795208|NCT00004738|Genetics|genetics
795209|NCT00004738|Chiari I Malformation|chiari i malformation
795210|NCT00004734|stroke|stroke
795211|NCT00004734|cerebral infarction|cerebral infarction
795212|NCT00004734|homocysteine|homocysteine
795213|NCT00004734|vitamin|vitamin
795214|NCT00004734|folic acid|folic acid
795215|NCT00004734|pyridoxine|pyridoxine
795216|NCT00004734|vitamin B6|vitamin b6
795217|NCT00004734|cyanocobalamin|cyanocobalamin
795218|NCT00004734|vitamin B12|vitamin b12
795219|NCT00004734|multivitamin|multivitamin
795220|NCT00004733|Parkinson's|parkinson's
795221|NCT00004733|ELLDOPA|elldopa
795222|NCT00004733|L-dopa|l-dopa
795223|NCT00004733|levodopa|levodopa
795224|NCT00004733|Sinemet|sinemet
795225|NCT00004733|tremor|tremor
795226|NCT00004732|angioplasty|angioplasty
795227|NCT00004732|asymptomatic|asymptomatic
795228|NCT00004732|atherosclerosis|atherosclerosis
795229|NCT00004732|carotid endarterectomy|carotid endarterectomy
795230|NCT00004732|carotid stenting|carotid stenting
795231|NCT00004732|CREST|crest
795232|NCT00004732|Cerebral Infarction|cerebral infarction
795233|NCT00004732|device|device
795234|NCT00004732|intervention|intervention
795235|NCT00004732|restenosis|restenosis
795236|NCT00004732|revascularization|revascularization
795237|NCT00004732|stenosis|stenosis
795238|NCT00004732|stent|stent
795239|NCT00004732|stroke|stroke
795240|NCT00004732|symptomatic|symptomatic
795241|NCT00004732|surgery|surgery
795242|NCT00004732|transient ischemic attack|transient ischemic attack
795243|NCT00004731|Parkinson's disease|parkinson's disease
795244|NCT00004731|coenzyme Q10|coenzyme q10
795245|NCT00004730|head injury|head injury
795246|NCT00004730|traumatic brain injury|traumatic brain injury
795247|NCT00004730|concussion|concussion
795248|NCT00004730|magnesium sulfate|magnesium sulfate
795249|NCT00004730|neuroprotection|neuroprotection
795250|NCT00004729|child|child
795251|NCT00004729|children|children
795252|NCT00004729|epilepsy|epilepsy
795253|NCT00004729|seizure|seizure
795254|NCT00004729|ketogenic|ketogenic
795255|NCT00004729|diet|diet
795256|NCT00004729|Lennox-Gastaut Syndrome|lennox-gastaut syndrome
795257|NCT00004729|LGS|lgs
795258|NCT00004728|stroke|stroke
795259|NCT00004728|cerebral infarction|cerebral infarction
795260|NCT00004728|warfarin|warfarin
795261|NCT00004728|coumadin|coumadin
795262|NCT00004728|aspirin|aspirin
795263|NCT00004728|ASA|asa
795264|NCT00004728|acetysalicylic acid|acetysalicylic acid
795265|NCT00004728|atherosclerosis|atherosclerosis
795266|NCT00004728|stenosis|stenosis
795267|NCT00004728|intracranial|intracranial
795268|NCT00004728|artery|artery
795269|NCT00004728|arteries|arteries
795270|NCT00004728|transient ischemic attack|transient ischemic attack
795271|NCT00004728|TIA|tia
795272|NCT00004728|minorities|minorities
795273|NCT00004727|African American|african american
795274|NCT00004727|antiplatelet|antiplatelet
795275|NCT00004727|aspirin|aspirin
795276|NCT00004727|ASA|asa
795277|NCT00004727|acetylsalicylic acid|acetylsalicylic acid
795278|NCT00004727|ticlopidine|ticlopidine
795279|NCT00004727|prevention|prevention
795280|NCT00004727|stroke|stroke
795281|NCT00004727|cerebral infarction|cerebral infarction
795282|NCT00004727|Chicago|chicago
795283|NCT00004727|non-cardioembolic ischemic stroke|non-cardioembolic ischemic stroke
795284|NCT00004941|Crohn's disease|crohn's disease
795285|NCT00004941|gastrointestinal disorders|gastrointestinal disorders
795286|NCT00004941|rare disease|rare disease
795287|NCT00004940|erythropoietic protoporphyria|erythropoietic protoporphyria
795288|NCT00004940|inborn errors of metabolism|inborn errors of metabolism
795289|NCT00004940|porphyria|porphyria
795290|NCT00004940|rare disease|rare disease
795291|NCT00004939|demyelinating neuropathy|demyelinating neuropathy
795292|NCT00004939|neurologic and psychiatric disorders|neurologic and psychiatric disorders
795293|NCT00004939|rare disease|rare disease
795294|NCT00004938|fungal infection|fungal infection
795295|NCT00004938|rare disease|rare disease
795296|NCT00004938|sporotrichosis|sporotrichosis
795297|NCT00004844|Parkinson Disease|parkinson disease
796443|NCT00001853|Diabetes|diabetes
795298|NCT00004844|neurologic and psychiatric disorders|neurologic and psychiatric disorders
795299|NCT00004844|rare disease|rare disease
795300|NCT00004843|disease-related problem/condition|disease-related problem/condition
795301|NCT00004843|endocrine disorders|endocrine disorders
795302|NCT00004843|hyperparathyroidism|hyperparathyroidism
795303|NCT00004843|quality of life|quality of life
795304|NCT00004843|rare disease|rare disease
795305|NCT00004842|cirrhosis|cirrhosis
795306|NCT00004842|gastrointestinal disorders|gastrointestinal disorders
795307|NCT00004842|primary biliary cirrhosis|primary biliary cirrhosis
795308|NCT00004842|primary sclerosing cholangitis|primary sclerosing cholangitis
795309|NCT00004842|rare disease|rare disease
795310|NCT00004840|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
795311|NCT00004840|neonatal disorders|neonatal disorders
795312|NCT00004840|rare disease|rare disease
795313|NCT00004840|respiratory distress syndrome|respiratory distress syndrome
795314|NCT00004838|environmental/toxic disorders|environmental/toxic disorders
795315|NCT00004838|lead poisoning|lead poisoning
795316|NCT00004838|rare disease|rare disease
795317|NCT00004834|anxiety disorder|anxiety disorder
795318|NCT00004834|disease-related problem/condition|disease-related problem/condition
795319|NCT00004834|neurologic and psychiatric disorders|neurologic and psychiatric disorders
795320|NCT00004834|panic disorder|panic disorder
795321|NCT00004834|rare disease|rare disease
795322|NCT00004833|Guillain-Barre syndrome|guillain-barre syndrome
795323|NCT00004833|demyelinating neuropathy|demyelinating neuropathy
795324|NCT00004833|neurologic and psychiatric disorders|neurologic and psychiatric disorders
795325|NCT00004833|rare disease|rare disease
795326|NCT00004832|Lambert-Eaton myasthenic syndrome|lambert-eaton myasthenic syndrome
795327|NCT00004832|neurologic and psychiatric disorders|neurologic and psychiatric disorders
795328|NCT00004832|rare disease|rare disease
795329|NCT00004831|erythropoietic protoporphyria|erythropoietic protoporphyria
795330|NCT00004831|inborn errors of metabolism|inborn errors of metabolism
795331|NCT00004831|porphyria|porphyria
795332|NCT00004831|rare disease|rare disease
795333|NCT00004829|bacterial infection|bacterial infection
795334|NCT00004829|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
795335|NCT00004829|cystic fibrosis|cystic fibrosis
795336|NCT00004829|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
795337|NCT00004829|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
795338|NCT00004829|rare disease|rare disease
795339|NCT00004828|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
795340|NCT00004828|heart defects|heart defects
795341|NCT00004828|rare disease|rare disease
795342|NCT00004827|ophthalmologic disorders|ophthalmologic disorders
795343|NCT00004827|rare disease|rare disease
795344|NCT00004827|retinitis pigmentosa|retinitis pigmentosa
795345|NCT00004826|Parkinson disease|parkinson disease
795346|NCT00004826|neurologic and psychiatric disorders|neurologic and psychiatric disorders
795347|NCT00004826|rare disease|rare disease
795348|NCT00004825|endocrine disorders|endocrine disorders
795349|NCT00004825|hyperinsulinism|hyperinsulinism
795350|NCT00004825|rare disease|rare disease
795351|NCT00004817|neurologic and psychiatric disorders|neurologic and psychiatric disorders
795352|NCT00004817|rare disease|rare disease
795353|NCT00004817|seizures|seizures
795354|NCT00004816|multiple sclerosis|multiple sclerosis
795355|NCT00004816|neurologic and psychiatric disorders|neurologic and psychiatric disorders
795356|NCT00004816|rare disease|rare disease
795357|NCT00004815|Werner's syndrome|werner's syndrome
795358|NCT00004815|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
795359|NCT00004815|rare disease|rare disease
795360|NCT00004814|multiple sclerosis|multiple sclerosis
795361|NCT00004814|neurologic and psychiatric disorders|neurologic and psychiatric disorders
795362|NCT00004814|rare disease|rare disease
795363|NCT00004812|environmental/toxic disorders|environmental/toxic disorders
795364|NCT00004812|neurologic and psychiatric disorders|neurologic and psychiatric disorders
795365|NCT00004812|rare disease|rare disease
795366|NCT00004812|spinal cord injury|spinal cord injury
795367|NCT00004811|blastomycosis|blastomycosis
795368|NCT00004811|fungal infection|fungal infection
795369|NCT00004811|histoplasmosis|histoplasmosis
795370|NCT00004811|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
795371|NCT00004811|rare disease|rare disease
795372|NCT00004811|sporotrichosis|sporotrichosis
795373|NCT00004810|gastrointestinal disorders|gastrointestinal disorders
795374|NCT00004810|rare disease|rare disease
795375|NCT00004810|ulcerative colitis|ulcerative colitis
795376|NCT00004809|familial hypercholesterolemia|familial hypercholesterolemia
795377|NCT00004809|inborn errors of metabolism|inborn errors of metabolism
795378|NCT00004809|rare disease|rare disease
795379|NCT00004808|blastomycosis|blastomycosis
795380|NCT00004808|fungal infection|fungal infection
795381|NCT00004808|histoplasmosis|histoplasmosis
795382|NCT00004808|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
795383|NCT00004808|rare disease|rare disease
795384|NCT00004808|sporotrichosis|sporotrichosis
795385|NCT00004807|Rett syndrome|rett syndrome
795386|NCT00004807|neurologic and psychiatric disorders|neurologic and psychiatric disorders
795387|NCT00004807|rare disease|rare disease
795388|NCT00004806|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
795389|NCT00004806|cystic fibrosis|cystic fibrosis
795390|NCT00004806|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
795391|NCT00004806|rare disease|rare disease
795392|NCT00004805|bronchopulmonary dysplasia|bronchopulmonary dysplasia
795393|NCT00004805|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
795394|NCT00004805|disease-related problem/condition|disease-related problem/condition
795395|NCT00004805|educational needs|educational needs
795396|NCT00004805|hypertensive disorder|hypertensive disorder
795397|NCT00004805|neonatal disorders|neonatal disorders
795398|NCT00004805|primary pulmonary hypertension|primary pulmonary hypertension
795399|NCT00004805|rare disease|rare disease
795400|NCT00004805|respiratory distress syndrome|respiratory distress syndrome
795401|NCT00004804|hepatitis C|hepatitis c
795402|NCT00004804|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
795403|NCT00004804|rare disease|rare disease
795404|NCT00004804|viral infection|viral infection
795405|NCT00004802|neurologic and psychiatric disorders|neurologic and psychiatric disorders
795406|NCT00004802|periodic paralysis|periodic paralysis
795407|NCT00004802|rare disease|rare disease
795408|NCT00004801|hematologic disorders|hematologic disorders
795409|NCT00004801|rare disease|rare disease
795410|NCT00004800|bacterial infection|bacterial infection
795411|NCT00004800|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
795412|NCT00004800|pertussis|pertussis
795413|NCT00004800|rare disease|rare disease
795414|NCT00004799|bacterial infection|bacterial infection
795415|NCT00004799|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
795416|NCT00004799|pertussis|pertussis
795417|NCT00004799|rare disease|rare disease
795418|NCT00004797|disease-related problem/condition|disease-related problem/condition
795419|NCT00004797|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
795420|NCT00004797|hematologic disorders|hematologic disorders
795421|NCT00004797|pain|pain
795422|NCT00004797|rare disease|rare disease
795423|NCT00004797|sickle cell anemia|sickle cell anemia
795424|NCT00004796|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
795425|NCT00004796|cirrhosis|cirrhosis
795426|NCT00004796|gastrointestinal disorders|gastrointestinal disorders
795427|NCT00004796|hypertensive disorder|hypertensive disorder
795428|NCT00004796|portal hypertension|portal hypertension
795429|NCT00004796|rare disease|rare disease
795430|NCT00004795|arthritis & connective tissue diseases|arthritis & connective tissue diseases
795431|NCT00004795|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
795432|NCT00004795|rare disease|rare disease
795433|NCT00004795|systemic lupus erythematosus|systemic lupus erythematosus
795434|NCT00004794|cytomegalovirus retinitis|cytomegalovirus retinitis
795435|NCT00004794|ophthalmologic disorders|ophthalmologic disorders
795436|NCT00004794|rare disease|rare disease
795437|NCT00004793|constitutional growth delay|constitutional growth delay
795438|NCT00004793|endocrine disorders|endocrine disorders
795439|NCT00004793|rare disease|rare disease
795440|NCT00004791|dermatologic disorders|dermatologic disorders
795441|NCT00004791|epidermolysis bullosa|epidermolysis bullosa
795442|NCT00004791|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
795443|NCT00004791|rare disease|rare disease
795444|NCT00004789|inborn errors of metabolism|inborn errors of metabolism
795445|NCT00004789|acute porphyria|acute porphyria
795446|NCT00004789|rare disease|rare disease
795447|NCT00004788|inborn errors of metabolism|inborn errors of metabolism
795448|NCT00004788|porphyria|porphyria
795449|NCT00004788|rare disease|rare disease
795450|NCT00004787|Fanconi's anemia|fanconi's anemia
795451|NCT00004787|Shwachman syndrome|shwachman syndrome
795452|NCT00004787|aplastic anemia|aplastic anemia
795453|NCT00004787|dermatologic disorders|dermatologic disorders
795454|NCT00004787|dyskeratosis congenita|dyskeratosis congenita
795455|NCT00004787|hematologic disorders|hematologic disorders
795456|NCT00004787|rare disease|rare disease
795457|NCT00004787|thrombocytopenia|thrombocytopenia
795458|NCT00004786|Raynaud's syndrome|raynaud's syndrome
795459|NCT00004786|arthritis & connective tissue diseases|arthritis & connective tissue diseases
795460|NCT00004786|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
795461|NCT00004786|rare disease|rare disease
795462|NCT00004786|systemic sclerosis|systemic sclerosis
795463|NCT00004785|bronchopulmonary dysplasia|bronchopulmonary dysplasia
795464|NCT00004785|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
795465|NCT00004785|neonatal disorders|neonatal disorders
795466|NCT00004785|rare disease|rare disease
795467|NCT00004784|cirrhosis|cirrhosis
795468|NCT00004784|gastrointestinal disorders|gastrointestinal disorders
795469|NCT00004784|primary biliary cirrhosis|primary biliary cirrhosis
795470|NCT00004784|rare disease|rare disease
795471|NCT00004781|HIV-associated candidiasis|hiv-associated candidiasis
795472|NCT00004781|candidiasis|candidiasis
796548|NCT00001826|HIV|hiv
795473|NCT00004781|disease-related problem/condition|disease-related problem/condition
795474|NCT00004781|fungal infection|fungal infection
795475|NCT00004781|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
795476|NCT00004781|infection|infection
795477|NCT00004781|rare disease|rare disease
795478|NCT00004779|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
795479|NCT00004779|cystic fibrosis|cystic fibrosis
795480|NCT00004779|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
795481|NCT00004779|rare disease|rare disease
795482|NCT00004778|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
795483|NCT00004778|neonatal disorders|neonatal disorders
795484|NCT00004778|rare disease|rare disease
795485|NCT00004778|respiratory distress syndrome|respiratory distress syndrome
795486|NCT00004776|Lennox-Gastaut syndrome|lennox-gastaut syndrome
795487|NCT00004776|epilepsy|epilepsy
795488|NCT00004776|neurologic and psychiatric disorders|neurologic and psychiatric disorders
795489|NCT00004776|rare disease|rare disease
795490|NCT00004776|seizures|seizures
795491|NCT00004773|Rett syndrome|rett syndrome
795492|NCT00004773|neurologic and psychiatric disorders|neurologic and psychiatric disorders
795493|NCT00004773|rare disease|rare disease
795494|NCT00004772|demyelinating neuropathy|demyelinating neuropathy
795495|NCT00004772|neurologic and psychiatric disorders|neurologic and psychiatric disorders
795496|NCT00004772|rare disease|rare disease
795497|NCT00004771|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
795498|NCT00004771|motor neuron disease|motor neuron disease
795499|NCT00004771|neurologic and psychiatric disorders|neurologic and psychiatric disorders
795500|NCT00004771|rare disease|rare disease
795501|NCT00004771|spinal and bulbar muscular atrophy|spinal and bulbar muscular atrophy
795502|NCT00004771|spinal muscular atrophy|spinal muscular atrophy
795503|NCT00004771|Kennedy's Syndrome|kennedy's syndrome
795504|NCT00004770|inborn errors of metabolism|inborn errors of metabolism
795505|NCT00004770|mitochondrial myopathy|mitochondrial myopathy
795506|NCT00004770|rare disease|rare disease
795507|NCT00004769|Genetic diseases|genetic diseases
795508|NCT00004769|Myotonic muscular dystrophy|myotonic muscular dystrophy
795509|NCT00004769|Facioscapulohumeral muscular dystrophy|facioscapulohumeral muscular dystrophy
795510|NCT00004769|CMT|cmt
795511|NCT00004769|Rare disease|rare disease
795512|NCT00004767|inborn errors of metabolism|inborn errors of metabolism
795513|NCT00004767|rare disease|rare disease
795514|NCT00004767|urea cycle disorder|urea cycle disorder
795515|NCT00004763|endocrine disorders|endocrine disorders
795516|NCT00004763|hyperandrogenism|hyperandrogenism
795517|NCT00004763|rare disease|rare disease
795518|NCT00004762|gastrointestinal disorders|gastrointestinal disorders
795519|NCT00004762|primary sclerosing cholangitis|primary sclerosing cholangitis
795520|NCT00004762|rare disease|rare disease
795521|NCT00004761|dermatologic disorders|dermatologic disorders
795522|NCT00004761|epidermolysis bullosa|epidermolysis bullosa
795523|NCT00004761|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
795524|NCT00004761|rare disease|rare disease
795525|NCT00004760|Parkinson disease|parkinson disease
795526|NCT00004760|Neurologic and psychiatric disorders|neurologic and psychiatric disorders
795527|NCT00004760|Rare disease|rare disease
795528|NCT00004759|environmental/toxic disorders|environmental/toxic disorders
795529|NCT00004759|neurologic and psychiatric disorders|neurologic and psychiatric disorders
795530|NCT00004759|rare disease|rare disease
795531|NCT00004759|spinal cord injury|spinal cord injury
795532|NCT00004758|infantile spasms|infantile spasms
795533|NCT00004758|epilepsy|epilepsy
795534|NCT00004758|neurologic and psychiatric disorders|neurologic and psychiatric disorders
795535|NCT00004758|rare disease|rare disease
795536|NCT00004758|seizures|seizures
795537|NCT00004757|herpes simplex virus infection|herpes simplex virus infection
795538|NCT00004757|herpesvirus infection|herpesvirus infection
795539|NCT00004757|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
795540|NCT00004757|rare disease|rare disease
795541|NCT00004757|viral infection|viral infection
795542|NCT00004756|arthritis & connective tissue diseases|arthritis & connective tissue diseases
795543|NCT00004756|disease-related problem/condition|disease-related problem/condition
795544|NCT00004756|educational needs|educational needs
795545|NCT00004756|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
795546|NCT00004756|rare disease|rare disease
795547|NCT00004756|systemic lupus erythematosus|systemic lupus erythematosus
795548|NCT00004755|dermatologic disorders|dermatologic disorders
795549|NCT00004755|environmental/toxic disorders|environmental/toxic disorders
795550|NCT00004755|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
795551|NCT00004755|leishmaniasis|leishmaniasis
795552|NCT00004755|rare disease|rare disease
795553|NCT00004754|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
795554|NCT00004754|hypertensive disorder|hypertensive disorder
795555|NCT00004754|primary pulmonary hypertension|primary pulmonary hypertension
795556|NCT00004754|rare disease|rare disease
795557|NCT00004753|Huntington's disease|huntington's disease
796968|NCT00001654|Sadness|sadness
795558|NCT00004753|neurologic and psychiatric disorders|neurologic and psychiatric disorders
795559|NCT00004753|rare disease|rare disease
795560|NCT00004751|cerebral palsy|cerebral palsy
795561|NCT00004751|neurologic and psychiatric disorders|neurologic and psychiatric disorders
795562|NCT00004751|rare disease|rare disease
795563|NCT00004751|spastic diplegia|spastic diplegia
795564|NCT00004748|cirrhosis|cirrhosis
795565|NCT00004748|gastrointestinal disorders|gastrointestinal disorders
795566|NCT00004748|primary biliary cirrhosis|primary biliary cirrhosis
795567|NCT00004748|rare disease|rare disease
795568|NCT00004747|bacterial infections|bacterial infections
795569|NCT00004747|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
795570|NCT00004747|cystic fibrosis|cystic fibrosis
795571|NCT00004747|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
795572|NCT00004747|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
795573|NCT00004747|rare disease|rare disease
795574|NCT00004744|multiple sclerosis|multiple sclerosis
795575|NCT00004744|neurologic and psychiatric disorders|neurologic and psychiatric disorders
795576|NCT00004744|rare disease|rare disease
795577|NCT00004740|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
795578|NCT00004740|rare disease|rare disease
795579|NCT00004740|tuberculosis|tuberculosis
795580|NCT00004705|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
795581|NCT00004705|cystic fibrosis|cystic fibrosis
795582|NCT00004705|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
795583|NCT00004705|rare disease|rare disease
795584|NCT00004700|endocrine disorders|endocrine disorders
795585|NCT00004700|hyperinsulinism|hyperinsulinism
795586|NCT00004700|rare disease|rare disease
795587|NCT00004699|endocrine disorders|endocrine disorders
795588|NCT00004699|hyperinsulinism|hyperinsulinism
795589|NCT00004699|rare disease|rare disease
795590|NCT00004697|gastrointestinal disorders|gastrointestinal disorders
795591|NCT00004697|hepatic steatosis|hepatic steatosis
795592|NCT00004697|rare disease|rare disease
795593|NCT00004696|disease-related problem/condition|disease-related problem/condition
795594|NCT00004696|pain|pain
795595|NCT00004696|intraoperative/postoperative complications|intraoperative/postoperative complications
795596|NCT00004696|rare disease|rare disease
795597|NCT00004695|common variable immunodeficiency|common variable immunodeficiency
795598|NCT00004695|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
795599|NCT00004695|primary immunodeficiency disease|primary immunodeficiency disease
795600|NCT00004695|rare disease|rare disease
795601|NCT00004694|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
795602|NCT00004694|hereditary angioedema|hereditary angioedema
795603|NCT00004694|rare disease|rare disease
795604|NCT00004690|dermatologic disorders|dermatologic disorders
795605|NCT00004690|ichthyosis|ichthyosis
795606|NCT00004690|rare disease|rare disease
795607|NCT00004689|bacterial infection|bacterial infection
795608|NCT00004689|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
795609|NCT00004689|mycobacterium avium infection|mycobacterium avium infection
795610|NCT00004689|mycobacterium infection|mycobacterium infection
795611|NCT00004689|rare disease|rare disease
795612|NCT00004688|adult anaplastic astrocytoma|adult anaplastic astrocytoma
795613|NCT00004688|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
795614|NCT00004688|adult brain stem glioma|adult brain stem glioma
795615|NCT00004688|adult brain tumor|adult brain tumor
795616|NCT00004688|adult glioblastoma multiforme|adult glioblastoma multiforme
795617|NCT00004688|adult infiltrating astrocytoma|adult infiltrating astrocytoma
795618|NCT00004688|brain tumor|brain tumor
795619|NCT00004688|genetic condition|genetic condition
795620|NCT00004688|miscellaneous sites/terms|miscellaneous sites/terms
795621|NCT00004688|mixed gliomas|mixed gliomas
795622|NCT00004688|nervous tissue tumors|nervous tissue tumors
795623|NCT00004688|oncologic disorders|oncologic disorders
795624|NCT00004688|rare disease|rare disease
795625|NCT00004688|recurrent adult brain tumor|recurrent adult brain tumor
795626|NCT00004686|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
795627|NCT00004686|giant cell arteritis|giant cell arteritis
795628|NCT00004686|rare disease|rare disease
795629|NCT00004685|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
795630|NCT00004685|muscular dystrophy|muscular dystrophy
795631|NCT00004685|neurologic and psychiatric disorders|neurologic and psychiatric disorders
795632|NCT00004685|rare disease|rare disease
795633|NCT00004682|myasthenia gravis|myasthenia gravis
795634|NCT00004682|neurologic and psychiatric disorders|neurologic and psychiatric disorders
795635|NCT00004682|rare disease|rare disease
795636|NCT00004670|Parkinson disease|parkinson disease
795637|NCT00004670|neurologic and psychiatric disorders|neurologic and psychiatric disorders
795638|NCT00004670|rare disease|rare disease
795639|NCT00004669|bronchopulmonary dysplasia|bronchopulmonary dysplasia
795640|NCT00004669|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
795641|NCT00004669|neonatal disorders|neonatal disorders
795642|NCT00004669|rare disease|rare disease
795643|NCT00004667|hematologic disorders|hematologic disorders
795644|NCT00004667|rare disease|rare disease
795645|NCT00004667|von Willebrand's disease|von willebrand's disease
795646|NCT00004665|arthritis & connective tissue diseases|arthritis & connective tissue diseases
795647|NCT00004665|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
795648|NCT00004665|rare disease|rare disease
795649|NCT00004665|systemic lupus erythematosus|systemic lupus erythematosus
795650|NCT00004664|disease-related problem/condition|disease-related problem/condition
795651|NCT00004664|human immunodeficiency virus infection|human immunodeficiency virus infection
795652|NCT00004664|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
795653|NCT00004664|nutrition|nutrition
795654|NCT00004664|rare disease|rare disease
795655|NCT00004664|viral infection|viral infection
795656|NCT00004663|arthritis & connective tissue diseases|arthritis & connective tissue diseases
795657|NCT00004663|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
795658|NCT00004663|rare disease|rare disease
795659|NCT00004663|systemic lupus erythematosus|systemic lupus erythematosus
795660|NCT00004662|arthritis & connective tissue diseases|arthritis & connective tissue diseases
795661|NCT00004662|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
795662|NCT00004662|rare disease|rare disease
795663|NCT00004662|systemic lupus erythematosus|systemic lupus erythematosus
795664|NCT00004661|endocrine disorders|endocrine disorders
795665|NCT00004661|pseudohypoparathyroidism|pseudohypoparathyroidism
795666|NCT00004661|rare disease|rare disease
795667|NCT00004660|Graves' disease|graves' disease
795668|NCT00004660|thyroid disease|thyroid disease
795669|NCT00004660|endocrine disorders|endocrine disorders
795670|NCT00004660|rare disease|rare disease
795671|NCT00004659|adult brain tumor|adult brain tumor
795672|NCT00004659|brain tumor|brain tumor
795673|NCT00004659|childhood brain tumor|childhood brain tumor
795674|NCT00004659|genetic condition|genetic condition
795675|NCT00004659|nervous tissue tumors|nervous tissue tumors
795676|NCT00004659|oncologic disorders|oncologic disorders
795677|NCT00004659|rare disease|rare disease
795678|NCT00004658|5'-nucleotidase syndrome|5'-nucleotidase syndrome
795679|NCT00004658|inborn errors of metabolism|inborn errors of metabolism
795680|NCT00004658|rare disease|rare disease
795681|NCT00004656|Rett syndrome|rett syndrome
795682|NCT00004656|neurologic and psychiatric disorders|neurologic and psychiatric disorders
795683|NCT00004656|rare disease|rare disease
795684|NCT00004654|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
795685|NCT00004654|hematologic disorders|hematologic disorders
795686|NCT00004654|hereditary hemorrhagic telangiectasia|hereditary hemorrhagic telangiectasia
795687|NCT00004654|rare disease|rare disease
795688|NCT00004652|Tourette syndrome|tourette syndrome
795689|NCT00004652|neurologic and psychiatric disorders|neurologic and psychiatric disorders
795690|NCT00004652|rare disease|rare disease
795691|NCT00004650|disease-related problem/condition|disease-related problem/condition
795692|NCT00004650|osteoporosis|osteoporosis
795693|NCT00004650|rare disease|rare disease
795694|NCT00004649|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
795695|NCT00004649|hematologic disorders|hematologic disorders
795696|NCT00004649|hereditary hemorrhagic telangiectasia|hereditary hemorrhagic telangiectasia
795697|NCT00004649|rare disease|rare disease
795698|NCT00004648|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
795699|NCT00004648|hematologic disorders|hematologic disorders
795700|NCT00004648|hereditary hemorrhagic telangiectasia|hereditary hemorrhagic telangiectasia
795701|NCT00004648|rare disease|rare disease
795702|NCT00004648|Osler-Rendu-Weber disease|osler-rendu-weber disease
795703|NCT00004647|diabetic neuropathy|diabetic neuropathy
795704|NCT00004647|disease-related problem/condition|disease-related problem/condition
795705|NCT00004647|neurologic and psychiatric disorders|neurologic and psychiatric disorders
795706|NCT00004647|pain|pain
795707|NCT00004647|rare disease|rare disease
795708|NCT00004646|Duchenne muscular dystrophy|duchenne muscular dystrophy
795709|NCT00004646|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
795710|NCT00004646|muscular dystrophy|muscular dystrophy
795711|NCT00004646|neurologic and psychiatric disorders|neurologic and psychiatric disorders
795712|NCT00004646|rare disease|rare disease
795713|NCT00004645|Balo's concentric sclerosis|balo's concentric sclerosis
795714|NCT00004645|Devic's syndrome|devic's syndrome
795715|NCT00004645|Marburg's variant of multiple sclerosis|marburg's variant of multiple sclerosis
795716|NCT00004645|acute disseminated encephalomyelitis|acute disseminated encephalomyelitis
795717|NCT00004645|acute transverse myelitis|acute transverse myelitis
795718|NCT00004645|multiple sclerosis|multiple sclerosis
795719|NCT00004645|neurologic and psychiatric disorders|neurologic and psychiatric disorders
795720|NCT00004645|rare disease|rare disease
795721|NCT00004644|herpes simplex virus infection|herpes simplex virus infection
795722|NCT00004644|herpesvirus infection|herpesvirus infection
795723|NCT00004644|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
795724|NCT00004644|rare disease|rare disease
795725|NCT00004644|viral infection|viral infection
795726|NCT00004643|arthritis & connective tissue diseases|arthritis & connective tissue diseases
795727|NCT00004643|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
795728|NCT00004643|rare disease|rare disease
795729|NCT00004643|systemic lupus erythematosus|systemic lupus erythematosus
795730|NCT00004642|congenital cytomegalovirus infection|congenital cytomegalovirus infection
795731|NCT00004642|cytomegalovirus infection|cytomegalovirus infection
795732|NCT00004642|herpesvirus infection|herpesvirus infection
795733|NCT00004642|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
795734|NCT00004642|neonatal disorders|neonatal disorders
795735|NCT00004642|rare disease|rare disease
795736|NCT00004642|viral infection|viral infection
795737|NCT00004638|chronic sinusitis|chronic sinusitis
795738|NCT00004635|Angiogenesis|angiogenesis
795739|NCT00004635|Cancer|cancer
795740|NCT00004635|Hormonal Therapy|hormonal therapy
795741|NCT00004635|Prostate|prostate
795742|NCT00004635|Thalidomide|thalidomide
795743|NCT00004635|Prostate Cancer|prostate cancer
795744|NCT00004577|BOLD Effect|bold effect
795745|NCT00004577|Cerebral Blood Flow|cerebral blood flow
795746|NCT00004577|Cerebral Blood Volume|cerebral blood volume
795747|NCT00004577|Functional Imaging|functional imaging
795748|NCT00004577|Magnetic Resonance Imaging|magnetic resonance imaging
795749|NCT00004577|Technical Developments|technical developments
795750|NCT00004573|cytomegalovirus viremia|cytomegalovirus viremia
795751|NCT00004572|Type 2 Diabetes|type 2 diabetes
795752|NCT00004571|Magnetic Resonance Imaging|magnetic resonance imaging
795753|NCT00004571|Brain Metabolism|brain metabolism
795754|NCT00004571|Brain Physiology|brain physiology
795755|NCT00004571|Neuropsychiatric Disorders|neuropsychiatric disorders
795756|NCT00004571|Cognitition|cognitition
795757|NCT00004570|Temporal Processing|temporal processing
795758|NCT00004570|Language Impairment|language impairment
795759|NCT00004570|Linkage Analysis|linkage analysis
795760|NCT00004570|Inheritance|inheritance
795761|NCT00004570|Language Delay|language delay
795762|NCT00004570|Healthy|healthy
795763|NCT00004570|Auditory Temporal Processing Disorder|auditory temporal processing disorder
795764|NCT00004570|Speech Impediment|speech impediment
795765|NCT00004568|Peripheral Neuropathies|peripheral neuropathies
795766|NCT00004568|Myopathy|myopathy
795767|NCT00004568|Muscular Dystrophy|muscular dystrophy
795768|NCT00004568|Motor Neuron Disease|motor neuron disease
795769|NCT00004568|Neurological Disorders|neurological disorders
795770|NCT00004567|Relapse|relapse
795771|NCT00004567|Immunosuppressive|immunosuppressive
795772|NCT00004567|Toxicity|toxicity
795773|NCT00004567|Purineantimetabolite|purineantimetabolite
795774|NCT00004567|Alternative Agents|alternative agents
795775|NCT00004567|Wegener's Granulomatosis|wegener's granulomatosis
795776|NCT00004567|Wegener's Disease|wegener's disease
795777|NCT00004567|Blood Vessel Disorder|blood vessel disorder
795778|NCT00004567|Systemic Vasculitis|systemic vasculitis
795779|NCT00004566|3D Imaging|3d imaging
795780|NCT00004566|Swallowing|swallowing
795781|NCT00004566|Fetal Development|fetal development
795782|NCT00004566|High-Risk Pregnancy|high-risk pregnancy
795783|NCT00004566|Ultrasound|ultrasound
795784|NCT00004565|Breast Cancer|breast cancer
795785|NCT00004565|Genetics|genetics
795786|NCT00004565|High Risk|high risk
795787|NCT00004565|Polymorphisms|polymorphisms
795788|NCT00004565|Susceptibility|susceptibility
795789|NCT00004565|Biomarkers|biomarkers
795790|NCT00004565|Estrogen|estrogen
795791|NCT00004565|Genes|genes
795792|NCT00004564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
795793|NCT00004564|Cerebrovascular accident|cerebrovascular accident
795794|NCT00004563|Lung Diseases|lung diseases
795795|NCT00004563|Pulmonary Fibrosis|pulmonary fibrosis
795796|NCT00004563|Systemic Scleroderma|systemic scleroderma
795797|NCT00004563|Scleroderma, systemic|scleroderma, systemic
795798|NCT00004556|Stimulants|stimulants
795799|NCT00004556|Affect|affect
795800|NCT00004556|Cognition|cognition
795801|NCT00004556|Brain Physiology|brain physiology
795802|NCT00004556|Brain Metabolism|brain metabolism
795803|NCT00004556|Catecholamines|catecholamines
795804|NCT00004556|Brain Imaging|brain imaging
795805|NCT00004556|Cognitive Efficiency|cognitive efficiency
795806|NCT00004556|Dopamine Genes|dopamine genes
795807|NCT00004553|Single Fiber EMG|single fiber emg
795808|NCT00004553|Macro-EMG|macro-emg
795809|NCT00004553|Myasthenia|myasthenia
795810|NCT00004553|Post-Polio Syndrome|post-polio syndrome
795811|NCT00004553|Neuromuscular Transmission|neuromuscular transmission
795812|NCT00004553|Motor Dysfunction|motor dysfunction
795813|NCT00004553|Neuromuscular Disorder|neuromuscular disorder
795814|NCT00004550|Screening|screening
795815|NCT00004550|Longitudinal|longitudinal
795816|NCT00004550|Transition|transition
795817|NCT00004550|Treatment|treatment
795818|NCT00004550|Comorbidity|comorbidity
795819|NCT00004550|Obsessive Compulsive Disorder|obsessive compulsive disorder
795820|NCT00004550|Evaluation|evaluation
795821|NCT00004550|Follow-Up|follow-up
795822|NCT00004550|OC Spectrum Disorders|oc spectrum disorders
795823|NCT00004550|OCD|ocd
795824|NCT00004549|Atherosclerosis|atherosclerosis
795825|NCT00004549|Endothelium|endothelium
795826|NCT00004549|Peripheral Vascular Disease|peripheral vascular disease
795827|NCT00004549|Markers of Inflammation|markers of inflammation
795828|NCT00004549|Claudication|claudication
795829|NCT00004547|Surgery|surgery
795830|NCT00004547|Mesothelioma|mesothelioma
795831|NCT00004547|Pseudomyxoma|pseudomyxoma
795832|NCT00004547|Colon Cancer|colon cancer
795833|NCT00004547|Chemotherapy|chemotherapy
795834|NCT00004533|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
795835|NCT00004533|cystic fibrosis|cystic fibrosis
795836|NCT00004533|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
795837|NCT00004533|rare disease|rare disease
795838|NCT00001987|Diabetes Mellitus|diabetes mellitus
795839|NCT00001987|Severe Insulin Resistance|severe insulin resistance
795840|NCT00001987|Type B Insulin Resistance|type b insulin resistance
795841|NCT00000436|Hip fracture|hip fracture
795842|NCT00000436|Self-efficacy|self-efficacy
795843|NCT00000436|Strength training|strength training
795844|NCT00000436|Rehabilitation|rehabilitation
795845|NCT00000436|Postoperative|postoperative
795846|NCT00001985|Diabetes|diabetes
795847|NCT00001985|Gene|gene
795848|NCT00001984|Immunosuppression|immunosuppression
795849|NCT00001984|Tolerance|tolerance
795850|NCT00001984|DSG|dsg
795851|NCT00001984|Alemtuzumab|alemtuzumab
795852|NCT00001983|Questionnaires|questionnaires
795853|NCT00001983|Eligibility|eligibility
795854|NCT00001983|History|history
795855|NCT00001983|Physical Examination|physical examination
795856|NCT00001983|Tests|tests
795857|NCT00001983|Fibromyalgia|fibromyalgia
795858|NCT00001981|Somatostatin Analogue|somatostatin analogue
795859|NCT00001981|Acromegaly|acromegaly
795860|NCT00001981|TSH Producing Tumor|tsh producing tumor
795861|NCT00001981|Islet Cell Tumor|islet cell tumor
795862|NCT00001981|Ursodeoxycholate|ursodeoxycholate
795863|NCT00001981|Pituitary|pituitary
795864|NCT00001981|Irradiation|irradiation
795865|NCT00001981|Treatment|treatment
795866|NCT00000435|RA|ra
795867|NCT00000435|Immune Modulation|immune modulation
795868|NCT00000435|Oral Tolerance|oral tolerance
795869|NCT00000435|Peptide|peptide
795870|NCT00000435|dnaJ|dnaj
795871|NCT00000434|Osteoarthritis|osteoarthritis
795872|NCT00000434|Health education|health education
795873|NCT00000434|Aerobic exercise|aerobic exercise
795874|NCT00000434|Self-efficacy|self-efficacy
795875|NCT00000434|Muscle strength|muscle strength
795876|NCT00000434|Outcomes research|outcomes research
795877|NCT00000434|Longitudinal study|longitudinal study
795878|NCT00001979|Kidney Disease|kidney disease
795879|NCT00001979|Autoimmune Diseases|autoimmune diseases
795880|NCT00001979|Nephrotic Syndrome|nephrotic syndrome
795881|NCT00001978|Kidney Disease|kidney disease
795882|NCT00001978|Kidney Function Tests|kidney function tests
795883|NCT00001978|Proteinuria|proteinuria
795884|NCT00001976|CMV|cmv
795885|NCT00001976|Infection|infection
795886|NCT00001976|Comparison|comparison
795887|NCT00001976|Observational|observational
795888|NCT00001976|Cytomegalovirus|cytomegalovirus
795889|NCT00001976|RT-PCR|rt-pcr
795890|NCT00001975|Skin Biopsy|skin biopsy
795891|NCT00001975|Familial Tumor Syndrome|familial tumor syndrome
795892|NCT00001975|Cell Growth|cell growth
795893|NCT00001975|Loss of Heterozygosity|loss of heterozygosity
795894|NCT00001975|Cytokines|cytokines
795895|NCT00001975|Tuberous Sclerosis|tuberous sclerosis
795896|NCT00001973|G Protein Mutation|g protein mutation
795897|NCT00001973|McCune-Albright Syndrome|mccune-albright syndrome
795898|NCT00001973|Fibrous Dysplasia|fibrous dysplasia
795899|NCT00001973|Mutation|mutation
795900|NCT00001973|Pathology|pathology
795901|NCT00001973|Immunohistochemistry|immunohistochemistry
795902|NCT00001973|PCR|pcr
795903|NCT00001973|In Situ Hybridization|in situ hybridization
795904|NCT00001973|Juvenile Dermatomyositis|juvenile dermatomyositis
795905|NCT00001973|Calcinosis|calcinosis
795906|NCT00001972|Alzheimer's Disease|alzheimer's disease
795907|NCT00001972|Positron Emission Tomography|positron emission tomography
795908|NCT00001972|Brain Phospholipid|brain phospholipid
795909|NCT00001972|Fatty Acids|fatty acids
795910|NCT00001972|11C Arachidonate|11c arachidonate
795911|NCT00001972|Signal Transduction|signal transduction
795912|NCT00001972|Brain|brain
795913|NCT00001971|Hepatitis B|hepatitis b
795914|NCT00001971|Hepatitis C|hepatitis c
795915|NCT00001971|Hepatitis D|hepatitis d
795916|NCT00001971|Chronic Cholestatic Syndromes|chronic cholestatic syndromes
795917|NCT00001971|Primary Biliary Cirrhosis|primary biliary cirrhosis
795918|NCT00001971|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
795919|NCT00001971|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
795920|NCT00001971|Wilson's Disease|wilson's disease
795921|NCT00001971|Hemochromatosis|hemochromatosis
795922|NCT00001971|Liver Biopsy|liver biopsy
795923|NCT00001971|Noncirrhotic Portal Hypertension|noncirrhotic portal hypertension
795924|NCT00001971|Liver Disease|liver disease
795925|NCT00001969|Cardiovascular Disease|cardiovascular disease
795926|NCT00001969|Glucose Clamp|glucose clamp
795927|NCT00001969|Hypercortisolism|hypercortisolism
796969|NCT00001654|Emotion|emotion
795928|NCT00001969|Insulin Sensitivity|insulin sensitivity
795929|NCT00001969|Major Depression Disorder|major depression disorder
795930|NCT00001969|Inflammation|inflammation
795931|NCT00001969|Coagulation|coagulation
795932|NCT00001969|Metabolic|metabolic
795933|NCT00001969|Insulin|insulin
795934|NCT00001969|Cytokine|cytokine
795935|NCT00001969|Depression|depression
795936|NCT00001969|Volunteer|volunteer
795937|NCT00001969|Healthy Volunteer|healthy volunteer
795939|NCT00001967|HAART|haart
795940|NCT00001967|Immunity|immunity
795941|NCT00001967|Toxicity|toxicity
795942|NCT00001967|Resistance|resistance
795943|NCT00001967|Treatment Interruption|treatment interruption
795944|NCT00001964|Hematopoiesis|hematopoiesis
795945|NCT00001964|Bone Marrow Failure|bone marrow failure
795946|NCT00001964|Aplastic Anemia|aplastic anemia
795947|NCT00001962|Immunosuppression|immunosuppression
795948|NCT00001962|T-cells|t-cells
795949|NCT00001962|Hematopoiesis|hematopoiesis
795950|NCT00001962|Monoclonal Antibody Therapy|monoclonal antibody therapy
795951|NCT00001962|Immunosuppressive Therapy|immunosuppressive therapy
795952|NCT00001962|Aplastic Anemia|aplastic anemia
795953|NCT00001961|Myocardial Infarction|myocardial infarction
795954|NCT00001961|Coronary Artery Disease|coronary artery disease
795955|NCT00001961|Adenosine|adenosine
795956|NCT00001961|Stress Testing|stress testing
795957|NCT00001961|Perfusion|perfusion
795958|NCT00001960|HCM|hcm
795959|NCT00001960|Pediatric|pediatric
795960|NCT00001960|Pacemaker|pacemaker
795961|NCT00001960|Treatment|treatment
795962|NCT00001960|Symptoms|symptoms
795963|NCT00001959|Fibrosis|fibrosis
795964|NCT00001959|Nephrotic Syndrome|nephrotic syndrome
795965|NCT00001959|Proteinuria|proteinuria
795966|NCT00001959|Renal Failure|renal failure
795967|NCT00001959|TGF-Beta|tgf-beta
795968|NCT00001959|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
795969|NCT00001959|FSGS|fsgs
795970|NCT00001958|Gamma Gene|gamma gene
795971|NCT00001958|Hemoglobin Switching|hemoglobin switching
795972|NCT00001958|Erythropoiesis|erythropoiesis
795973|NCT00001958|HbE Hemoglobin Chain Synthesis Imbalance|hbe hemoglobin chain synthesis imbalance
795974|NCT00001958|Cooley's Anemia|cooley's anemia
795975|NCT00001958|Beta-Thalassemia Intermedia|beta-thalassemia intermedia
795976|NCT00001957|Ostoacoustic Emission|ostoacoustic emission
795977|NCT00001957|Central Auditory Processing|central auditory processing
795978|NCT00001957|CAPD|capd
795979|NCT00001957|Medial Olivocochlear Bundle|medial olivocochlear bundle
795980|NCT00001957|Speech Impediment|speech impediment
795981|NCT00001956|Genetic Markers|genetic markers
795982|NCT00001956|Thermal Pain|thermal pain
795983|NCT00001956|Hyperalgesia|hyperalgesia
795984|NCT00001956|Oral Surgery|oral surgery
795985|NCT00001956|Cold Pain|cold pain
795986|NCT00001956|Peripheral Nerve|peripheral nerve
795987|NCT00001956|Allodynia|allodynia
795988|NCT00001956|Spinal Cord|spinal cord
795989|NCT00001956|Personality Traits|personality traits
795990|NCT00001956|Pain Ratings|pain ratings
795991|NCT00001955|Clinical Trial|clinical trial
795992|NCT00001955|Temporomandibular Joints|temporomandibular joints
795993|NCT00001955|Celecoxib|celecoxib
795994|NCT00001955|Etanercept|etanercept
795995|NCT00001955|Tumor Necrosis Factor|tumor necrosis factor
795996|NCT00001955|TMJ|tmj
795997|NCT00001955|TMD|tmd
795998|NCT00001954|Clinical Trial|clinical trial
795999|NCT00001954|Autoimmune|autoimmune
796000|NCT00001954|Disease Activity|disease activity
796001|NCT00001954|Cytokine|cytokine
796002|NCT00001954|Saliva|saliva
796003|NCT00001954|Xerostomia|xerostomia
796004|NCT00001954|Salivary Glands|salivary glands
796005|NCT00001954|Sjogren's Syndrome|sjogren's syndrome
796006|NCT00001953|Endocrine System|endocrine system
796007|NCT00001953|Autoimmunity|autoimmunity
796008|NCT00001953|Salivary Glands|salivary glands
796009|NCT00001953|Glucose Tolerance Test|glucose tolerance test
796010|NCT00001953|Growth Hormone|growth hormone
796011|NCT00001953|Somatostatin|somatostatin
796012|NCT00001953|Sjogren's Syndrome|sjogren's syndrome
796013|NCT00001952|Fentanyl|fentanyl
796014|NCT00001952|Intraosseous-Anesthesia|intraosseous-anesthesia
796015|NCT00001952|Endodontics|endodontics
796016|NCT00001952|Denti Patch|denti patch
796017|NCT00001952|Pain|pain
796018|NCT00001952|Chronic Inflammation|chronic inflammation
796019|NCT00001951|Bone|bone
796020|NCT00001951|Cognition|cognition
796021|NCT00001951|Estrogen|estrogen
796022|NCT00001951|Mood|mood
796023|NCT00001951|Testosterone|testosterone
796024|NCT00001951|Osteoporosis|osteoporosis
796025|NCT00001951|Ovarian Failure|ovarian failure
796026|NCT00001951|Hormone Replacement Therapy|hormone replacement therapy
796027|NCT00001951|POF|pof
796028|NCT00001951|Premature Ovarian Failure|premature ovarian failure
796029|NCT00001950|Cognition|cognition
796030|NCT00001950|Infancy|infancy
796031|NCT00001950|Perception|perception
796032|NCT00001948|Human Immunodeficiency Virus|human immunodeficiency virus
796033|NCT00001948|Symptom Distress|symptom distress
796034|NCT00001948|Immune Function|immune function
796035|NCT00001948|Medication Trial|medication trial
796036|NCT00001948|Physical Symptoms|physical symptoms
796037|NCT00001946|Magnetic Resonance Angiography|magnetic resonance angiography
796038|NCT00001946|Gadolinium|gadolinium
796039|NCT00001946|Suburban Hospital|suburban hospital
796040|NCT00001946|Atherosclerosis|atherosclerosis
796041|NCT00001941|Interleukin-2 Receptor alpha chain|interleukin-2 receptor alpha chain
796042|NCT00001941|Interleukin-2|interleukin-2
796043|NCT00001941|HTLV-I|htlv-i
796044|NCT00001941|Adult T-Cell Leukemia (ATL)|adult t-cell leukemia (atl)
796045|NCT00001941|Monoclonal Antibody (Daclizumab, Zenapax)|monoclonal antibody (daclizumab, zenapax)
796046|NCT00001938|Ovarian Cancer|ovarian cancer
796047|NCT00001938|Proteomics|proteomics
796048|NCT00000433|Spondylitis|spondylitis
796049|NCT00000433|Etanercept|etanercept
796050|NCT00000433|ENBREL|enbrel
796051|NCT00000433|Tumor necrosis factor-alpha|tumor necrosis factor-alpha
796052|NCT00000432|Lyme disease|lyme disease
796053|NCT00000432|Education evaluation|education evaluation
796054|NCT00000432|Communicable disease control|communicable disease control
796055|NCT00000432|Outcomes research|outcomes research
796056|NCT00000432|Tick-transmitted diseases|tick-transmitted diseases
796057|NCT00000431|Venous leg ulcer|venous leg ulcer
796058|NCT00000431|Wound healing|wound healing
796059|NCT00000431|Somatic gene therapy|somatic gene therapy
796060|NCT00000431|PDGF-B|pdgf-b
796061|NCT00000430|Osteoporosis|osteoporosis
796062|NCT00000430|Osteopenia|osteopenia
796063|NCT00000430|Postmenopausal women|postmenopausal women
796064|NCT00000430|Hormone replacement therapy|hormone replacement therapy
796065|NCT00000430|Alendronate|alendronate
796066|NCT00000429|JRA|jra
796067|NCT00000429|Osteopenia|osteopenia
796068|NCT00000429|Dietary calcium|dietary calcium
796069|NCT00000429|Diet therapy|diet therapy
796070|NCT00000429|Bone density|bone density
796071|NCT00000429|Ossification|ossification
796072|NCT00000429|Biomarker|biomarker
796073|NCT00000429|Dietary supplement|dietary supplement
796074|NCT00000428|Fibromyalgia Syndrome (FMS)|fibromyalgia syndrome (fms)
796075|NCT00000428|Amitriptyline|amitriptyline
796076|NCT00000428|Fluoxetine|fluoxetine
796077|NCT00000427|Parathyroid Hormone (PTH)|parathyroid hormone (pth)
796078|NCT00000427|Alendronate|alendronate
796079|NCT00000427|Bone metabolism|bone metabolism
796080|NCT00000427|Bone mineral density (BMD)|bone mineral density (bmd)
796081|NCT00000427|Bone loss|bone loss
796082|NCT00000427|Postmenopausal osteoporosis|postmenopausal osteoporosis
796083|NCT00000427|Osteoporosis in men|osteoporosis in men
796084|NCT00000111|mouth mucosa|mouth mucosa
796085|NCT00000111|transplants|transplants
796086|NCT00000110|exercise|exercise
796087|NCT00000110|exertion|exertion
796088|NCT00000110|physical fitness|physical fitness
796089|NCT00000110|lipids|lipids
796090|NCT00000110|nutrition|nutrition
796091|NCT00000108|exercise|exercise
796092|NCT00000107|Cyanotic Congenital Heart Disease|cyanotic congenital heart disease
796093|NCT00000106|Rheumatoid Diseases|rheumatoid diseases
796094|NCT00000393|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
796095|NCT00000392|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
796096|NCT00000392|AIDS-Related Complex|aids-related complex
796097|NCT00000391|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
796098|NCT00000391|AIDS-Related Complex|aids-related complex
796099|NCT00000390|Adult|adult
796100|NCT00000390|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
796101|NCT00000390|Depression|depression
796102|NCT00000390|Female|female
796103|NCT00000390|Human|human
796104|NCT00000390|Imipramine|imipramine
796105|NCT00000390|Male|male
796106|NCT00000390|Middle Age|middle age
796107|NCT00000390|Acquired Immunodeficiency Syndrome -- *complications|acquired immunodeficiency syndrome -- *complications
796108|NCT00000390|Depression -- *drug therapy|depression -- *drug therapy
796109|NCT00000390|Depression -- etiology|depression -- etiology
796110|NCT00000390|Imipramine -- *therapeutic use|imipramine -- *therapeutic use
796111|NCT00001936|Neuromuscular Stimulation|neuromuscular stimulation
796112|NCT00001936|Laryngeal Elevation|laryngeal elevation
796113|NCT00001936|Dysphagia|dysphagia
796114|NCT00001936|Stroke|stroke
796115|NCT00001936|Neuroprosthesis|neuroprosthesis
796116|NCT00001936|Dysphonia|dysphonia
796117|NCT00001936|Aspiration|aspiration
796118|NCT00001936|Motor Control|motor control
796119|NCT00001936|Videofluoroscopy|videofluoroscopy
796120|NCT00001936|Upper Esophageal Sphincter|upper esophageal sphincter
796121|NCT00001936|Healthy Volunteer|healthy volunteer
796122|NCT00001936|Swallowing Disorders|swallowing disorders
796123|NCT00001934|Multiple Sclerosis|multiple sclerosis
796124|NCT00001934|Immunotherapy|immunotherapy
796125|NCT00001934|MRI|mri
796126|NCT00001933|Acetylcholine|acetylcholine
796127|NCT00001933|Clinical Trial|clinical trial
796128|NCT00001933|GABA|gaba
796129|NCT00001933|Cognition|cognition
796130|NCT00001933|Nicotine|nicotine
796131|NCT00001932|Epilepsy|epilepsy
796132|NCT00001932|Temporal Lobe|temporal lobe
796133|NCT00001932|Blood Flow|blood flow
796134|NCT00001932|Metabolism|metabolism
796135|NCT00001932|Localization|localization
796136|NCT00001927|Factor V Leiden|factor v leiden
796137|NCT00001927|Prothrombin Mutation|prothrombin mutation
796138|NCT00001927|Antiphospholipids|antiphospholipids
796139|NCT00001927|Cerebral Infarction|cerebral infarction
796140|NCT00001927|Thrombophilia|thrombophilia
796141|NCT00001927|Porencephaly|porencephaly
796142|NCT00001927|Perinatal Stroke|perinatal stroke
796143|NCT00001927|Healthy Mothers|healthy mothers
796144|NCT00001927|Healthy Children|healthy children
796145|NCT00001926|Plasticity|plasticity
796146|NCT00001926|Magnetic Stimulation|magnetic stimulation
796147|NCT00001926|PET|pet
796148|NCT00001926|Blind|blind
796149|NCT00001926|Braille|braille
796150|NCT00001926|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
796151|NCT00001925|Inferior Olives|inferior olives
796152|NCT00001925|Calcium Channels|calcium channels
796153|NCT00001925|Accelerometry|accelerometry
796154|NCT00001925|Electromyography|electromyography
796155|NCT00001925|Palatal Tremor|palatal tremor
796156|NCT00001923|Pain|pain
796157|NCT00001923|Amputee|amputee
796158|NCT00001923|Phantom Limb|phantom limb
796159|NCT00001923|Amputation|amputation
796160|NCT00001923|Magnetic Stimulation|magnetic stimulation
796161|NCT00001923|Phantom|phantom
796162|NCT00001922|Evoked Response|evoked response
796163|NCT00001922|Spasmodic Dysphonia|spasmodic dysphonia
796164|NCT00001922|Aerodynamic|aerodynamic
796165|NCT00001922|Vibration|vibration
796166|NCT00001922|Laryngeal|laryngeal
796167|NCT00001922|Voice Disorders|voice disorders
796168|NCT00001922|Laryngeal Brainstem Evoked Responses|laryngeal brainstem evoked responses
796169|NCT00001922|Long-latency Responses|long-latency responses
796170|NCT00001922|Muscular Tension Dysphonia|muscular tension dysphonia
796171|NCT00001921|Functional Connectivity|functional connectivity
796172|NCT00001921|Frontotemporal Interaction|frontotemporal interaction
796173|NCT00001921|Electrophysiology|electrophysiology
796174|NCT00001921|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
796175|NCT00001921|Healthy Subjects|healthy subjects
796176|NCT00001921|Schizophrenia|schizophrenia
796177|NCT00001921|MEG|meg
796178|NCT00001921|Neuroimaging|neuroimaging
796179|NCT00001921|EEG|eeg
796180|NCT00001921|MRI|mri
796181|NCT00001920|Schizophrenia|schizophrenia
796182|NCT00001920|Eyeblink|eyeblink
796183|NCT00001920|Evoked Potentials|evoked potentials
796184|NCT00001920|Learning|learning
796185|NCT00001920|Normal Volunteer|normal volunteer
796186|NCT00001920|Healthy Volunteer|healthy volunteer
796187|NCT00001919|Mechanism of Action|mechanism of action
796188|NCT00001919|BCIT-SPECT|bcit-spect
796189|NCT00001919|St. John's Wort|st. john's wort
796190|NCT00001919|Hypericum Perforatum|hypericum perforatum
796191|NCT00001919|Depression|depression
796192|NCT00001919|Serotonin|serotonin
796193|NCT00001919|Dopamine Transporter|dopamine transporter
796194|NCT00001919|SPECT|spect
796195|NCT00001919|Brain Disorders|brain disorders
796196|NCT00001917|Positron Emission Tomography|positron emission tomography
796197|NCT00001917|Physostigmine|physostigmine
796198|NCT00001917|Visual Stimulation|visual stimulation
796199|NCT00001917|Cholinergic Stimulation|cholinergic stimulation
796200|NCT00001917|[F-18] FP-TZIP|[f-18] fp-tzip
796201|NCT00001917|Aging|aging
796202|NCT00001917|Alzheimer's Disease|alzheimer's disease
796203|NCT00001917|Visual Activation|visual activation
796204|NCT00001915|Cortical Stimulation|cortical stimulation
796205|NCT00001915|Motor Control|motor control
796206|NCT00001915|Neuromotor Maturation|neuromotor maturation
796207|NCT00001915|Magnetic Stimulation|magnetic stimulation
796208|NCT00001915|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
796209|NCT00001915|Hearing Loss|hearing loss
796210|NCT00001915|Hearing Conservation|hearing conservation
796211|NCT00001915|Hearing Protective Devices|hearing protective devices
796212|NCT00001915|Safety Study|safety study
796213|NCT00001915|Noise Induced Hearing Loss|noise induced hearing loss
796214|NCT00001915|Normal Volunteer|normal volunteer
796215|NCT00001913|Visual Processing|visual processing
796216|NCT00001913|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
796217|NCT00001913|Maternal Behavior|maternal behavior
796218|NCT00001913|Attachment|attachment
796219|NCT00001913|Bereavement|bereavement
796220|NCT00001912|Cysticercosis|cysticercosis
796221|NCT00001912|T. Solium|t. solium
796222|NCT00001912|MRI|mri
796223|NCT00001912|Seizures|seizures
796224|NCT00001912|Calcified Cysts|calcified cysts
796225|NCT00001912|Taenia|taenia
796226|NCT00001911|Cytokine|cytokine
796227|NCT00001911|Interferon Gamma|interferon gamma
796228|NCT00001911|Pulmonary|pulmonary
796229|NCT00001911|Disseminated|disseminated
796230|NCT00001911|Refractory|refractory
796231|NCT00001911|Mycobacterial Infection|mycobacterial infection
796232|NCT00001911|Nontuberculosis Mycobacterial Infection|nontuberculosis mycobacterial infection
796233|NCT00001911|Pulmonary Nontuberculous Mycobacterial Infection|pulmonary nontuberculous mycobacterial infection
796234|NCT00001910|T Cells|t cells
796235|NCT00001910|Allergy|allergy
796240|NCT00001905|Immunodeficiency|immunodeficiency
796241|NCT00001905|Cytokine|cytokine
796242|NCT00001905|Treatment|treatment
796243|NCT00001905|Trafficking|trafficking
796244|NCT00001905|Leukocyte Adhesion Deficiency Type I|leukocyte adhesion deficiency type i
796245|NCT00001905|LAD I|lad i
796246|NCT00001901|Vasculitis|vasculitis
796247|NCT00001901|Prednisone-sparing|prednisone-sparing
796248|NCT00001901|Methotrexate|methotrexate
796249|NCT00001901|Tumor Necrosis Factor|tumor necrosis factor
796250|NCT00001901|Remission|remission
796251|NCT00001901|Wegener's Granulomatosis|wegener's granulomatosis
796252|NCT00001899|Viral Suppression|viral suppression
796253|NCT00001899|Latency|latency
796254|NCT00001899|AIDS Therapy|aids therapy
796255|NCT00001899|Viral Relapse|viral relapse
796256|NCT00001899|Immunodeficiency|immunodeficiency
796257|NCT00001899|HIV|hiv
796258|NCT00001899|Treatment Interruption|treatment interruption
796259|NCT00001898|Melanoma|melanoma
796260|NCT00001898|Breast Cancer|breast cancer
796261|NCT00001898|Gene Expression|gene expression
796262|NCT00001898|DNA Chip Technology|dna chip technology
796263|NCT00001898|Expressed Sequence Tags|expressed sequence tags
796264|NCT00001895|Electromechanical Mapping|electromechanical mapping
796265|NCT00001895|Myocardial Viability|myocardial viability
796266|NCT00001895|Myocardial Ischemia|myocardial ischemia
796267|NCT00001895|Positron Emission Tomography|positron emission tomography
796268|NCT00001895|Magnetic Resonance Imaging|magnetic resonance imaging
796269|NCT00001894|HCM|hcm
796270|NCT00001894|Alcohol|alcohol
796271|NCT00001894|Septal Ablation|septal ablation
796272|NCT00001894|Pacemaker|pacemaker
796273|NCT00001893|Bronchoprovocation|bronchoprovocation
796274|NCT00001893|Airway Inflammation|airway inflammation
796275|NCT00001893|Tumor Necrosis Factor|tumor necrosis factor
796276|NCT00001893|Bronchoalveolar Lavage|bronchoalveolar lavage
796277|NCT00001893|Pulmonary Function Test|pulmonary function test
796278|NCT00001893|Asthma|asthma
796279|NCT00001888|Induced Sputum|induced sputum
796280|NCT00001888|Exhaled Breath Condensate|exhaled breath condensate
796281|NCT00001888|Fiberoptic Bronchoscopy|fiberoptic bronchoscopy
796282|NCT00001888|Bronchoscopy|bronchoscopy
796283|NCT00001888|mRNA|mrna
796284|NCT00001888|Asthma|asthma
796285|NCT00001888|Normal Volunteer|normal volunteer
796286|NCT00001885|Interstitial Lung Disease|interstitial lung disease
796287|NCT00001885|Inherited Disease|inherited disease
796288|NCT00001885|Genetic Markers|genetic markers
796289|NCT00001885|Alpha 1 Protease Inhibitor|alpha 1 protease inhibitor
796290|NCT00001885|DNA Mutations|dna mutations
796291|NCT00001885|Rheumatoid Arthritis|rheumatoid arthritis
796292|NCT00001885|Pulmonary Fibrosis|pulmonary fibrosis
796293|NCT00001885|Normal Volunteer|normal volunteer
796294|NCT00001884|Bronchoscopy|bronchoscopy
796295|NCT00001884|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
796296|NCT00001884|Proteases|proteases
796297|NCT00001884|Fibroblast Proliferation|fibroblast proliferation
796298|NCT00001884|Reactive Proteins|reactive proteins
796299|NCT00001884|Rheumatoid Arthritis|rheumatoid arthritis
796300|NCT00001884|Pulmonary Fibrosis|pulmonary fibrosis
796301|NCT00001883|Treadmill|treadmill
796302|NCT00001883|Bicycle|bicycle
796303|NCT00001883|Lung Function|lung function
796304|NCT00001883|Physiology|physiology
796305|NCT00001883|Quality Control|quality control
796306|NCT00001883|Normal Volunteers|normal volunteers
796307|NCT00001880|Graft-Versus-Tumor|graft-versus-tumor
796308|NCT00001880|Peripheral Blood Stem Cells|peripheral blood stem cells
796309|NCT00001880|Non-Myeloablative Bone Marrow Transplantation|non-myeloablative bone marrow transplantation
796310|NCT00001880|Metastatic Solid Tumors|metastatic solid tumors
796311|NCT00001880|Engraftment|engraftment
796312|NCT00001880|Cyclophosphamide|cyclophosphamide
796313|NCT00001880|Fludarabine|fludarabine
796314|NCT00001880|Donor Apheresis|donor apheresis
796315|NCT00001880|Graft-Versus-Host Disease|graft-versus-host disease
796316|NCT00001880|Cancer|cancer
796317|NCT00001880|Tumor|tumor
796318|NCT00001878|Growth Hormone|growth hormone
796319|NCT00001878|Cardiac Hypertrophy|cardiac hypertrophy
796320|NCT00001878|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
796321|NCT00001878|Sarcomeric Gene Mutations|sarcomeric gene mutations
796322|NCT00001877|Tumor Necrosis Factor|tumor necrosis factor
796323|NCT00001877|Corticosteroids|corticosteroids
796324|NCT00001877|Macrophages|macrophages
796325|NCT00001877|Phosphodiesterase|phosphodiesterase
796326|NCT00001877|Autoimmune|autoimmune
796327|NCT00001877|Pulmonary Sarcoidosis|pulmonary sarcoidosis
796328|NCT00001876|Interstitial Lung Disease|interstitial lung disease
796329|NCT00001876|Collagen Vascular Disease|collagen vascular disease
796330|NCT00001876|Extracellular Matrix|extracellular matrix
796331|NCT00001876|Pulmonary Function|pulmonary function
796332|NCT00001876|DTPA Lung Clearance Scan|dtpa lung clearance scan
796333|NCT00001876|Rheumatoid Arthritis|rheumatoid arthritis
796334|NCT00001876|Pulmonary Fibrosis|pulmonary fibrosis
796335|NCT00001876|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
796336|NCT00001874|Imaging|imaging
796337|NCT00001874|Spectroscopy|spectroscopy
796338|NCT00001874|MRI|mri
796339|NCT00001874|Cardiovascular|cardiovascular
796340|NCT00001874|Technical Development|technical development
796341|NCT00001874|Safety|safety
796342|NCT00001874|Gadolinium|gadolinium
796343|NCT00001874|Heart|heart
796344|NCT00001874|Toxicity|toxicity
796345|NCT00001874|Adverse Events|adverse events
796346|NCT00001874|Normal Volunteer|normal volunteer
796347|NCT00001873|Peripheral Blood Stem Cells|peripheral blood stem cells
796348|NCT00001873|Cyclosporine|cyclosporine
796349|NCT00001873|Cyclosphosphamide|cyclosphosphamide
796350|NCT00001873|Whole Body Irradiation|whole body irradiation
796351|NCT00001873|Donor Apheresis|donor apheresis
796352|NCT00001873|Leukemic Relapse|leukemic relapse
796353|NCT00001873|Graft vs. Host Disease|graft vs. host disease
796354|NCT00001873|Graft-Versus-Leukemia|graft-versus-leukemia
796355|NCT00001873|Graft-Versus-Myeloma|graft-versus-myeloma
796356|NCT00001873|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
796357|NCT00001873|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
796358|NCT00001873|Acute Myelogenous Leukemia|acute myelogenous leukemia
796359|NCT00001873|Myelodysplastic Syndromes|myelodysplastic syndromes
796360|NCT00001873|Multiple Myeloma|multiple myeloma
796361|NCT00001873|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
796362|NCT00001873|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
796363|NCT00001872|Volunteer|volunteer
796364|NCT00001872|Leukocyte Donors|leukocyte donors
796365|NCT00001872|Family Members|family members
796366|NCT00001872|Leukocyte Collection|leukocyte collection
796367|NCT00001872|No Reimbursement|no reimbursement
796368|NCT00001870|Insulin Resistance|insulin resistance
796369|NCT00001870|Oxidative Stress|oxidative stress
796370|NCT00001870|Antioxidant|antioxidant
796371|NCT00001870|Endothelial Function|endothelial function
796372|NCT00001870|Glucose Clamp|glucose clamp
796373|NCT00001870|Type 2 Diabetes|type 2 diabetes
796374|NCT00001870|Vitamin C Deficiency|vitamin c deficiency
796375|NCT00001869|Progesterone|progesterone
796376|NCT00001869|Pulmonary Function Tests|pulmonary function tests
796377|NCT00001869|Pneumothorax|pneumothorax
796378|NCT00001869|Oopherectomy|oopherectomy
796379|NCT00001869|High Resolution CT|high resolution ct
796380|NCT00001869|Tuberous Sclerosis Complex|tuberous sclerosis complex
796381|NCT00001869|Lymphangioleiomyomatosis (LAM)|lymphangioleiomyomatosis (lam)
796382|NCT00001865|Behcet's|behcet's
796383|NCT00001865|Monoclonal Antibody|monoclonal antibody
796384|NCT00001865|Uveitis|uveitis
796385|NCT00001865|Interleukin 2|interleukin 2
796386|NCT00001865|Retinal Vasculitis|retinal vasculitis
796387|NCT00001865|Hyopyon|hyopyon
796388|NCT00001865|Interleukin 2 Receptor|interleukin 2 receptor
796389|NCT00001865|Bechet's Disease|bechet's disease
796390|NCT00001865|Ocular Disease|ocular disease
796391|NCT00001863|Immunosuppression|immunosuppression
796392|NCT00001863|Inflammation|inflammation
796393|NCT00001863|Eye|eye
796394|NCT00001863|Vision|vision
796395|NCT00001863|Medication|medication
796396|NCT00001863|Uveitis|uveitis
796397|NCT00001863|Leflunomide|leflunomide
796398|NCT00001863|Vitritis|vitritis
796399|NCT00001862|Ocular Inflammation|ocular inflammation
796400|NCT00001862|Children|children
796401|NCT00001862|Immunotherapy|immunotherapy
796402|NCT00001862|Cytokine|cytokine
796403|NCT00001862|Clinical Trial|clinical trial
796404|NCT00001862|Uveitis|uveitis
796405|NCT00001862|Immunosuppression|immunosuppression
796406|NCT00001862|Joint|joint
796407|NCT00001862|Inflammation|inflammation
796408|NCT00001861|Eye Movements|eye movements
796409|NCT00001861|Amblyopia|amblyopia
796410|NCT00001861|Orthoptics|orthoptics
796411|NCT00001861|Lazy Eye|lazy eye
796412|NCT00001861|Eye Development|eye development
796413|NCT00001861|Nystagmus|nystagmus
796414|NCT00001861|Strabismus|strabismus
796415|NCT00001861|Screening Protocol|screening protocol
796416|NCT00001861|Eye Movement Disorders|eye movement disorders
796417|NCT00001860|Growth Hormone|growth hormone
796418|NCT00001860|Somatostatin|somatostatin
796419|NCT00001860|Insulin-like Growth Factor-One|insulin-like growth factor-one
796420|NCT00001860|Acromegaly|acromegaly
796421|NCT00001860|Macroadenoma|macroadenoma
796422|NCT00001859|Evaluation|evaluation
796423|NCT00001859|Diabetes|diabetes
796424|NCT00001859|Renal Failure|renal failure
796425|NCT00001858|Biopsy|biopsy
796426|NCT00001858|Immune System|immune system
796427|NCT00001858|Renal|renal
796428|NCT00001856|Living Donor|living donor
796429|NCT00001856|Transplantation|transplantation
796430|NCT00001856|Nephrectomy|nephrectomy
796431|NCT00001854|Ribavirin|ribavirin
796432|NCT00001854|Liver Disease|liver disease
796433|NCT00001854|Antiviral Agent|antiviral agent
796434|NCT00001854|Cirrhosis|cirrhosis
796435|NCT00001854|Chronic Hepatitis|chronic hepatitis
796436|NCT00001854|Iron|iron
796437|NCT00001854|Viral Hepatitis|viral hepatitis
796438|NCT00001854|Hepatitis C Virus|hepatitis c virus
796439|NCT00001854|Hemolytic Anemia|hemolytic anemia
796440|NCT00001854|Hemolysis|hemolysis
796441|NCT00001853|Healthy Volunteers|healthy volunteers
796442|NCT00001853|Health Disparities|health disparities
796444|NCT00001853|Cardiovascular Disease|cardiovascular disease
796445|NCT00001852|Xerostomia|xerostomia
796446|NCT00001852|Oral Dryness|oral dryness
796447|NCT00001852|Salivary Function|salivary function
796448|NCT00001851|Marrow|marrow
796449|NCT00001851|Grafting|grafting
796450|NCT00001851|Imaging|imaging
796451|NCT00001851|Injection|injection
796452|NCT00001851|Aspiration|aspiration
796453|NCT00001851|Bone Marrow Stromal Cells|bone marrow stromal cells
796454|NCT00001851|Bone Grafting|bone grafting
796455|NCT00001851|Bone Graft Substitutes|bone graft substitutes
796456|NCT00001851|Bio and Pharmacological Regulators of Bone Turnover|bio and pharmacological regulators of bone turnover
796457|NCT00001850|Training|training
796458|NCT00001850|Reproduction|reproduction
796459|NCT00001850|Infertility|infertility
796460|NCT00001850|Women's Health|women's health
796461|NCT00001850|Hormone|hormone
796462|NCT00001849|PET|pet
796463|NCT00001849|(18F)-DOPA|(18f)-dopa
796464|NCT00001849|Pentetreotide|pentetreotide
796465|NCT00001849|ACTH|acth
796466|NCT00001849|Octreotide|octreotide
796467|NCT00001849|Cushing's Syndrome|cushing's syndrome
796468|NCT00001849|Ectopic Cushing Syndrome|ectopic cushing syndrome
796469|NCT00001848|Estrogen Receptor|estrogen receptor
796470|NCT00001848|Laparoscopy|laparoscopy
796471|NCT00001848|Surgical Excision|surgical excision
796472|NCT00001848|Raloxifene|raloxifene
796473|NCT00001848|Selective Estrogen Receptor Modulator|selective estrogen receptor modulator
796474|NCT00001848|Estrogen|estrogen
796475|NCT00001848|Endometriosis|endometriosis
796476|NCT00001848|Pelvic Pain|pelvic pain
796477|NCT00001846|Volunteer Donor|volunteer donor
796478|NCT00001846|Research Samples|research samples
796479|NCT00001846|Leukapheresis|leukapheresis
796480|NCT00001846|Plateletpheresis|plateletpheresis
796481|NCT00001846|Plasmapheresis|plasmapheresis
796482|NCT00001846|Healthy Volunteer|healthy volunteer
796483|NCT00001846|Normal Volunteer|normal volunteer
796484|NCT00001845|MRI|mri
796485|NCT00001845|Cerebral Blood Flow|cerebral blood flow
796486|NCT00001845|CO2 Inhalation|co2 inhalation
796487|NCT00001845|Acetazolamide|acetazolamide
796488|NCT00001845|Perfusion|perfusion
796489|NCT00001845|Healthy Volunteer|healthy volunteer
796490|NCT00001844|MRI/MRS|mri/mrs
796491|NCT00001844|Functional MRI|functional mri
796492|NCT00001844|Metabolic Imaging|metabolic imaging
796493|NCT00001844|Brain|brain
796494|NCT00001844|Healthy Volunteer|healthy volunteer
796495|NCT00001842|Granulocytes|granulocytes
796496|NCT00001842|Granulocyte Colony Stimulating Factor|granulocyte colony stimulating factor
796497|NCT00001842|Granulocyte Transfusion Factor|granulocyte transfusion factor
796498|NCT00001842|Apheresis|apheresis
796499|NCT00001842|Blood Donors|blood donors
796500|NCT00001842|Healthy Volunteer|healthy volunteer
796501|NCT00001841|Arteriosclerosis|arteriosclerosis
796502|NCT00001841|Imaging|imaging
796503|NCT00001841|MRA|mra
796504|NCT00001841|Narrowing of Vessels|narrowing of vessels
796505|NCT00001841|Hardening of Arteries|hardening of arteries
796506|NCT00001837|Sonohysterography|sonohysterography
796507|NCT00001837|Color Doppler Sonography|color doppler sonography
796508|NCT00001837|Endometrium|endometrium
796509|NCT00001837|Gynecologic|gynecologic
796510|NCT00001837|Menstrual Cycle|menstrual cycle
796511|NCT00001837|Premenopause|premenopause
796512|NCT00001836|Coronary Artery Disease|coronary artery disease
796513|NCT00001836|EBCT|ebct
796514|NCT00001836|Volumetric Scan|volumetric scan
796515|NCT00001836|Coronary Artery Calcium|coronary artery calcium
796516|NCT00001836|Prospective Gating|prospective gating
796517|NCT00001835|Renal Dysfunction|renal dysfunction
796518|NCT00001835|Pharmacokinetics|pharmacokinetics
796519|NCT00001835|Platinum Analogues|platinum analogues
796520|NCT00001835|Renal Cancer|renal cancer
796521|NCT00001835|Kidney Cancer|kidney cancer
796522|NCT00001832|Immunotherapy|immunotherapy
796523|NCT00001832|Adoptive Transfer|adoptive transfer
796524|NCT00001832|IL-2|il-2
796525|NCT00001832|Toxicity|toxicity
796526|NCT00001832|Clinical Response|clinical response
796527|NCT00001832|Breast Cancer|breast cancer
796528|NCT00001830|Bone Marrow Transplantation|bone marrow transplantation
796529|NCT00001830|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
796530|NCT00001830|Immunotherapy|immunotherapy
796531|NCT00001830|Lymphoma|lymphoma
796532|NCT00001830|Multiple Myeloma|multiple myeloma
796533|NCT00001830|Graft vs. Host Disease|graft vs. host disease
796534|NCT00001830|Lymphoid Malignancy|lymphoid malignancy
796535|NCT00001830|Leukemia|leukemia
796536|NCT00001827|Immunotherapy|immunotherapy
796537|NCT00001827|Cancer|cancer
796538|NCT00001827|Oncogenes|oncogenes
796539|NCT00001827|T-cells|t-cells
796540|NCT00001827|Vaccine Therapy|vaccine therapy
796541|NCT00001827|p53 Peptide|p53 peptide
796542|NCT00001827|Ovarian Cancer|ovarian cancer
796543|NCT00001826|CD-4-Naive T Cells|cd-4-naive t cells
796544|NCT00001826|CD-4-Memory T Cells|cd-4-memory t cells
796545|NCT00001826|Antiviral Activity|antiviral activity
796546|NCT00001826|VB Repertoire|vb repertoire
796547|NCT00001826|Immunizations|immunizations
796549|NCT00001826|Treatment Experienced|treatment experienced
796550|NCT00001823|Cancer|cancer
796551|NCT00001823|Gene Therapy|gene therapy
796552|NCT00001823|Immunotherapy|immunotherapy
796553|NCT00001823|Melanoma|melanoma
796554|NCT00001823|Clinical Trial|clinical trial
796555|NCT00001813|Xeroderma Pigmentosum|xeroderma pigmentosum
796556|NCT00001813|Trichothiodystrophy|trichothiodystrophy
796557|NCT00001813|Cockayne Syndrome|cockayne syndrome
796558|NCT00001813|Skin Cancer|skin cancer
796559|NCT00001813|DNA Repair|dna repair
796560|NCT00001807|CNS directed therapy|cns directed therapy
796561|NCT00001807|Neurotoxicity|neurotoxicity
796562|NCT00001807|H-NMRS|h-nmrs
796563|NCT00001807|MRI|mri
796564|NCT00001806|Genetic Testing|genetic testing
796565|NCT00001806|Genetic Counseling|genetic counseling
796566|NCT00001806|BRCA1/BRCA2|brca1/brca2
796567|NCT00001806|Genetic Education|genetic education
796568|NCT00001806|Informed Consent|informed consent
796569|NCT00001806|Breast Cancer|breast cancer
796570|NCT00001806|Ovarian Cancer|ovarian cancer
796571|NCT00001806|Known Family Mutation|known family mutation
796572|NCT00001803|Gene-Environment Interaction|gene-environment interaction
796573|NCT00001803|Kidney Cancer|kidney cancer
796574|NCT00001803|VHL|vhl
796575|NCT00001803|Genetic Epidemiology|genetic epidemiology
796576|NCT00001788|Cytokine|cytokine
796577|NCT00001788|Stat|stat
796578|NCT00001788|Jak|jak
796579|NCT00001788|IL-12|il-12
796580|NCT00001788|Mutation|mutation
796581|NCT00001788|Immunodeficiency|immunodeficiency
796582|NCT00001785|HTLV-1-Associated Myelopathy|htlv-1-associated myelopathy
796583|NCT00001785|Virus|virus
796584|NCT00001785|Spontaneous Proliferation|spontaneous proliferation
796585|NCT00001784|Blepharospasm|blepharospasm
796586|NCT00001784|Writer's Cramp|writer's cramp
796587|NCT00001784|Muscle Spindle Afferents|muscle spindle afferents
796588|NCT00001784|Sodium Channels|sodium channels
796589|NCT00001784|Sensorimotor Integration|sensorimotor integration
796590|NCT00001784|Focal Dystonia|focal dystonia
796591|NCT00001783|Rehabilitation|rehabilitation
796592|NCT00001783|Plasticity|plasticity
796593|NCT00001783|Stroke|stroke
796594|NCT00001783|Amphetamine|amphetamine
796595|NCT00001783|Motor|motor
796596|NCT00001783|Hemiparetic|hemiparetic
796597|NCT00001783|Thromboembolic Non-Hemorrhagic Infarction|thromboembolic non-hemorrhagic infarction
796598|NCT00001781|Multiple Sclerosis|multiple sclerosis
796599|NCT00001781|Immunology|immunology
796600|NCT00001781|Treatment|treatment
796601|NCT00001780|Myelopathy|myelopathy
796602|NCT00001780|Demyelination|demyelination
796603|NCT00001780|Leukodystrophy|leukodystrophy
796604|NCT00001780|Motor Neuron Disease|motor neuron disease
796605|NCT00001780|Movement Disorders|movement disorders
796606|NCT00001780|Normal Volunteer|normal volunteer
796607|NCT00001778|Immune Response|immune response
796608|NCT00001778|Sero-Indeterminant|sero-indeterminant
796609|NCT00001778|Transmission|transmission
796610|NCT00001778|Tropical Spastic Paraparesis|tropical spastic paraparesis
796611|NCT00001778|Viral Load|viral load
796612|NCT00001778|HTLV-I|htlv-i
796613|NCT00001778|HAM/TSP|ham/tsp
796614|NCT00001776|Magnetic Stimulation|magnetic stimulation
796615|NCT00001776|Plasticity|plasticity
796616|NCT00001776|SRTT|srtt
796617|NCT00001776|Sequence|sequence
796618|NCT00001776|Implicit Memory|implicit memory
796619|NCT00001776|Explicit Memory|explicit memory
796620|NCT00001776|Memory|memory
796621|NCT00001776|Parkinson's Disease|parkinson's disease
796622|NCT00001776|Cerebellar Deficit|cerebellar deficit
796623|NCT00001776|Frontal Lobe Lesions|frontal lobe lesions
796624|NCT00001776|Frontal Lobe Dementia|frontal lobe dementia
796625|NCT00001776|Normal Volunteer|normal volunteer
796626|NCT00001771|Receptors|receptors
796627|NCT00001771|Re-Uptake|re-uptake
796628|NCT00001771|Neurotransmitters|neurotransmitters
796629|NCT00001771|Neuroimaging|neuroimaging
796630|NCT00001771|Drug Abuse|drug abuse
796631|NCT00001771|Serotonin|serotonin
796632|NCT00001771|Brain Scan|brain scan
796633|NCT00001771|Tourette's Syndrome|tourette's syndrome
796634|NCT00001771|Obsessive Compulsive Disorder|obsessive compulsive disorder
796635|NCT00001771|Schizophrenia|schizophrenia
796636|NCT00001771|Normal Volunteer|normal volunteer
796637|NCT00001770|Depression|depression
796638|NCT00001770|Estrogen|estrogen
796639|NCT00001770|Hormone Replacement Therapy|hormone replacement therapy
796640|NCT00001770|Mood|mood
796641|NCT00001770|Progestin|progestin
796642|NCT00001770|Progesterone|progesterone
796643|NCT00001770|Anxiety|anxiety
796644|NCT00001766|Abacavir|abacavir
796645|NCT00001766|Salvage|salvage
796646|NCT00001766|Drug Interaction|drug interaction
796647|NCT00001766|Drug Levels|drug levels
796648|NCT00001766|Anti-Viral|anti-viral
796649|NCT00001766|HIV|hiv
796650|NCT00001765|Engraftment|engraftment
796651|NCT00001765|Minitransplant|minitransplant
796652|NCT00001765|Fludarabine|fludarabine
796653|NCT00001765|Neutrophil|neutrophil
796654|NCT00001765|Allogenic|allogenic
796655|NCT00001765|Donor Apheresis|donor apheresis
796656|NCT00001765|Anti-Thymocyte Globin|anti-thymocyte globin
796657|NCT00001765|Cyclophosphamide|cyclophosphamide
796658|NCT00001765|Nonmyeloablative Bone Marrow Transplantation|nonmyeloablative bone marrow transplantation
796659|NCT00001765|Graft-versus-host Disease|graft-versus-host disease
796660|NCT00001765|Chronic Granulomatous Disease|chronic granulomatous disease
796661|NCT00001764|Alternative agent|alternative agent
796662|NCT00001764|Purine Antimetabolite|purine antimetabolite
796663|NCT00001764|Immunosuppressive|immunosuppressive
796664|NCT00001764|Previous relapse|previous relapse
796665|NCT00001764|Drug Intolerance|drug intolerance
796666|NCT00001764|Wegener's Granulomatosis|wegener's granulomatosis
796667|NCT00001762|Protease Inhibitor|protease inhibitor
796668|NCT00001762|HIV Infection|hiv infection
796669|NCT00001762|Appearance|appearance
796670|NCT00001762|Subcutaneous Fat|subcutaneous fat
796671|NCT00001762|Facial Wasting|facial wasting
796672|NCT00001760|Stem Cell Factor|stem cell factor
796673|NCT00001760|Cytokine|cytokine
796674|NCT00001760|Chemokines|chemokines
796675|NCT00001760|Chemotaxis|chemotaxis
796676|NCT00001760|Mast Cells|mast cells
796677|NCT00001760|Normal Volunteer|normal volunteer
796678|NCT00001760|Systemic Mastocytosis|systemic mastocytosis
796679|NCT00001760|Atopic Dermatitis|atopic dermatitis
796680|NCT00001758|Antiretroviral|antiretroviral
796681|NCT00001758|HIV-1|hiv-1
796682|NCT00001758|1592U89|1592u89
796683|NCT00001758|141W94|141w94
796684|NCT00001758|DMP 266|dmp 266
796685|NCT00001756|Leukapheresis|leukapheresis
796686|NCT00001756|Mastocytosis|mastocytosis
796687|NCT00001756|G-CSF|g-csf
796688|NCT00001756|Mast Cells|mast cells
796689|NCT00001756|Normal Volunteer|normal volunteer
796690|NCT00001756|Systemic Mastocytosis|systemic mastocytosis
796691|NCT00001750|G-CSF|g-csf
796692|NCT00001750|Cell-Cycle|cell-cycle
796693|NCT00001750|Stem Cell|stem cell
796694|NCT00001750|Apheresis|apheresis
796695|NCT00001750|Melphalan|melphalan
796696|NCT00001750|Gene Transfer|gene transfer
796697|NCT00001750|Retroviral Receptor|retroviral receptor
796698|NCT00001750|Stem Cell Expansion|stem cell expansion
796699|NCT00001750|Multiple Myeloma|multiple myeloma
796700|NCT00001749|Immune Suppression|immune suppression
796701|NCT00001749|Erythroid Hypoplasia|erythroid hypoplasia
796702|NCT00001749|Congenital Anemia|congenital anemia
796703|NCT00001749|Reticulocytopenia|reticulocytopenia
796704|NCT00001749|Diamond Blackfan Anemia|diamond blackfan anemia
796705|NCT00001746|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
796707|NCT00001746|Evaluation for Research|evaluation for research
796708|NCT00001746|Medical Advice|medical advice
796709|NCT00001741|Angiotensin II Receptor|angiotensin ii receptor
796710|NCT00001741|Polymorphism, Genetic|polymorphism, genetic
796711|NCT00001741|Vascular Tone|vascular tone
796712|NCT00001741|Angiotensin II|angiotensin ii
796713|NCT00001741|Losartan|losartan
796714|NCT00001737|Eye|eye
796715|NCT00001737|Immunosuppression|immunosuppression
796716|NCT00001737|Inflammation|inflammation
796717|NCT00001737|Therapy|therapy
796718|NCT00001737|Vitreous|vitreous
796719|NCT00001737|Uveitis|uveitis
796720|NCT00001734|Uveitis|uveitis
796721|NCT00001734|Conjunctivitis|conjunctivitis
796722|NCT00001734|Iritis|iritis
796723|NCT00001734|Retinitis|retinitis
796724|NCT00001734|Keratitis|keratitis
796725|NCT00001734|Screening Protocol|screening protocol
796726|NCT00001734|Ocular Immunology|ocular immunology
796727|NCT00001734|Inflammation|inflammation
796728|NCT00001734|Eye Inflammation|eye inflammation
796729|NCT00001733|Diabetic Retinopathy|diabetic retinopathy
796730|NCT00001733|Age-Related Macular Degeneration|age-related macular degeneration
796731|NCT00001733|Neovascularization|neovascularization
796732|NCT00001733|Macular Degeneration|macular degeneration
796733|NCT00001733|Retinal Disease|retinal disease
796734|NCT00001733|Diabetes|diabetes
796735|NCT00001732|Genetics|genetics
796736|NCT00001732|Diagnosis|diagnosis
796737|NCT00001732|Screening Protocol|screening protocol
796738|NCT00001732|Ophthalmic Genetic Diseases|ophthalmic genetic diseases
796739|NCT00001732|Genetic Testing|genetic testing
796740|NCT00001732|Family Studies|family studies
796741|NCT00001729|Cirrhosis|cirrhosis
796742|NCT00001729|Liver Disease|liver disease
796743|NCT00001729|Hemolytic Anemia|hemolytic anemia
796744|NCT00001729|Liver Biopsy|liver biopsy
796745|NCT00001729|Ribavirin|ribavirin
796746|NCT00001729|Alpha Interferon|alpha interferon
796747|NCT00001729|Viral Hepatitis|viral hepatitis
796748|NCT00001729|Hepatitis C Virus|hepatitis c virus
796749|NCT00001729|Chronic Hepatitis|chronic hepatitis
796750|NCT00001729|Antiviral Agents|antiviral agents
796751|NCT00001728|Bone Marrow Stromal Cells|bone marrow stromal cells
796752|NCT00001728|Bone Turnover|bone turnover
796753|NCT00001728|Fibrous Dysplastic Lesion|fibrous dysplastic lesion
796754|NCT00001728|Polyostotic Fibrous Dysplasia|polyostotic fibrous dysplasia
796755|NCT00001728|McCune-Albright Syndrome|mccune-albright syndrome
796756|NCT00001727|Fibrous Dysplasia (FD)|fibrous dysplasia (fd)
796757|NCT00001727|McCune-Albright Syndrome|mccune-albright syndrome
796758|NCT00001727|Polyostotic Fibrous Dysplasia|polyostotic fibrous dysplasia
796759|NCT00001726|Bacterial Colonization|bacterial colonization
796760|NCT00001726|Plaque|plaque
796761|NCT00001726|Mouth|mouth
796762|NCT00001726|Saliva|saliva
796763|NCT00001726|Adhesion|adhesion
796764|NCT00001726|Dental Plaque Formation|dental plaque formation
796765|NCT00001726|Dental Caries|dental caries
796766|NCT00001725|Trigeminal Neuralgia|trigeminal neuralgia
796767|NCT00001725|Dextromethorphan|dextromethorphan
796768|NCT00001725|Topiramate|topiramate
796769|NCT00001725|Orofacial Pain|orofacial pain
796770|NCT00001725|Neuropathic Pain|neuropathic pain
796771|NCT00001725|Facial Neuralgia|facial neuralgia
796772|NCT00001724|Pain|pain
796773|NCT00001724|Microencapsulated Drug|microencapsulated drug
796774|NCT00001724|NSAID|nsaid
796775|NCT00001724|Acute Inflammation|acute inflammation
796776|NCT00001724|Peripheral Administration|peripheral administration
796777|NCT00001724|Dose-Response|dose-response
796778|NCT00001724|Relative Potency Assay|relative potency assay
796779|NCT00001724|Pharmacokinetics|pharmacokinetics
796780|NCT00001723|Dyslipidemia|dyslipidemia
796781|NCT00001723|Race|race
796782|NCT00001723|Body Fat|body fat
796783|NCT00001723|Visceral Fat|visceral fat
796784|NCT00001723|Sleep Apnea|sleep apnea
796785|NCT00001723|Fat-Soluble Vitamins|fat-soluble vitamins
796786|NCT00001723|Type 2 Diabetes|type 2 diabetes
796787|NCT00001723|Obesity|obesity
796788|NCT00001723|Childhood Obesity|childhood obesity
796789|NCT00001722|Obesity|obesity
796790|NCT00001722|Sympathetic Nervous System|sympathetic nervous system
796791|NCT00001722|Fat Tissue|fat tissue
796792|NCT00001722|Metabolism|metabolism
796793|NCT00001722|Adipose Tissue|adipose tissue
796794|NCT00001722|Microdialysis|microdialysis
796795|NCT00001722|Leptin|leptin
796796|NCT00001722|Lipolysis|lipolysis
796797|NCT00001722|Normal Volunteer|normal volunteer
796798|NCT00001721|Dysmorphology|dysmorphology
796799|NCT00001721|Cholesterol|cholesterol
796800|NCT00001721|Endocrine|endocrine
796801|NCT00001721|MRI|mri
796802|NCT00001721|Demyelination|demyelination
796803|NCT00001721|Smith-Lemli-Opitz Syndrome (SLO)|smith-lemli-opitz syndrome (slo)
796804|NCT00001720|Glucocorticoids|glucocorticoids
796805|NCT00001720|Bone Mineral Density|bone mineral density
796806|NCT00001720|Bisphosphonates|bisphosphonates
796807|NCT00001720|Vertebral Fracture|vertebral fracture
796808|NCT00001720|Childhood Osteoporosis|childhood osteoporosis
796809|NCT00001719|Blood Flow|blood flow
796810|NCT00001719|Hepatic Disease|hepatic disease
796811|NCT00001719|Liver|liver
796812|NCT00001719|Modeling|modeling
796813|NCT00001719|Rheology|rheology
796814|NCT00001719|Normal Volunteer|normal volunteer
796815|NCT00001716|Hemoglobin|hemoglobin
796816|NCT00001716|P50|p50
796817|NCT00001716|Microvascular|microvascular
796818|NCT00001716|Perfusion|perfusion
796819|NCT00001716|Magnetic Resonance Imaging|magnetic resonance imaging
796820|NCT00001716|Sickle Cell Anemia|sickle cell anemia
796821|NCT00001715|Consultation|consultation
796822|NCT00001715|Training|training
796823|NCT00001715|Referral|referral
796824|NCT00001715|Fellowship Program|fellowship program
796825|NCT00001715|Outpatient|outpatient
796826|NCT00001715|Blood Disorder|blood disorder
796827|NCT00001713|rtPA|rtpa
796828|NCT00001713|Catheter Directed|catheter directed
796829|NCT00001713|Thrombolysis|thrombolysis
796830|NCT00001713|Anticoagulation|anticoagulation
796831|NCT00001713|Emboli|emboli
796832|NCT00001713|Acute Deep Venous Thrombosis|acute deep venous thrombosis
796833|NCT00001713|TPA|tpa
796834|NCT00001713|DVT|dvt
796835|NCT00001712|Healthcare Worker|healthcare worker
796836|NCT00001712|Bloodborne Diseases|bloodborne diseases
796837|NCT00001712|Hepatitis B|hepatitis b
796838|NCT00001712|Hepatitis C|hepatitis c
796839|NCT00001712|Human Immunodeficiency Virus|human immunodeficiency virus
796840|NCT00001712|Parenteral Exposure|parenteral exposure
796841|NCT00001712|Non-Parenteral Exposure|non-parenteral exposure
796842|NCT00001712|Blood and Body Substances|blood and body substances
796843|NCT00001712|Universal Precautions|universal precautions
796844|NCT00001712|HIV Seronegativity|hiv seronegativity
796845|NCT00001711|Magnetic Resonance Imaging|magnetic resonance imaging
796846|NCT00001711|Gadolinium|gadolinium
796847|NCT00001711|Magnetic Resonance Angiography|magnetic resonance angiography
796848|NCT00001711|Normal Volunteer|normal volunteer
796849|NCT00001703|Immunotherapy|immunotherapy
796850|NCT00001703|Kidney|kidney
796851|NCT00001703|Genes|genes
796852|NCT00001703|Vaccine Therapy|vaccine therapy
796853|NCT00001703|Renal Cell Carcinoma|renal cell carcinoma
796854|NCT00001702|Genetic|genetic
796855|NCT00001702|Variant Alleles|variant alleles
796856|NCT00001702|Risk Factor|risk factor
796857|NCT00001702|Cancer|cancer
796858|NCT00001702|Transplantation|transplantation
796859|NCT00001701|Risk Factor|risk factor
796860|NCT00001701|Genetic|genetic
796861|NCT00001701|Variant Alleles|variant alleles
796862|NCT00001701|Cancer|cancer
796863|NCT00001701|Transplantation|transplantation
797173|NCT00001604|DNA Samples|dna samples
796864|NCT00001698|Chemoprevention|chemoprevention
796865|NCT00001698|Direct Epithelial Delivery|direct epithelial delivery
796866|NCT00001698|Tobacco-induced Cancer|tobacco-induced cancer
796867|NCT00001698|Field Cancerization|field cancerization
796868|NCT00001695|Complementary Medicine|complementary medicine
796869|NCT00001695|Unproven Treatments|unproven treatments
796870|NCT00001695|Herbal|herbal
796871|NCT00001693|Chemoprevention|chemoprevention
796872|NCT00001693|Biomarkers|biomarkers
796873|NCT00001693|Endoscopy|endoscopy
796874|NCT00001693|Colorectal|colorectal
796875|NCT00001693|Celecoxib|celecoxib
796876|NCT00001689|Neurotoxicity|neurotoxicity
796877|NCT00001689|A.L.L.|a.l.l.
796878|NCT00001689|Limited Sampling|limited sampling
796879|NCT00001689|Dose Individualization|dose individualization
796880|NCT00001689|Vinca Alkaloids|vinca alkaloids
796881|NCT00001686|Leukemia|leukemia
796882|NCT00001686|Ewing's Sarcoma|ewing's sarcoma
796883|NCT00001686|Neuroectodermal Tumors|neuroectodermal tumors
796884|NCT00001686|Lymphoma, Osteosarcoma|lymphoma, osteosarcoma
796885|NCT00001686|Brain Tumors, Rhabdomyosarcoma|brain tumors, rhabdomyosarcoma
796886|NCT00001686|Lymphoma|lymphoma
796887|NCT00001686|Neoplasm|neoplasm
796888|NCT00001686|Sarcoma|sarcoma
796889|NCT00001683|Collagen Breakdown|collagen breakdown
796890|NCT00001683|Pharmacokinetics|pharmacokinetics
796891|NCT00001683|Rapid Escalation Phase I|rapid escalation phase i
796892|NCT00001683|Angiogenesis|angiogenesis
796893|NCT00001683|Tissue Inhibitors of Metalloproteinase|tissue inhibitors of metalloproteinase
796894|NCT00001678|Autoimmunity|autoimmunity
796895|NCT00001678|Sibling Pairs|sibling pairs
796896|NCT00001678|Genes|genes
796897|NCT00001678|Rheumatoid Arthritis|rheumatoid arthritis
796898|NCT00001678|Bone Erosion|bone erosion
796899|NCT00001676|Remission|remission
796900|NCT00001676|Renal Function|renal function
796901|NCT00001676|Infection|infection
796902|NCT00001676|Germinal Center|germinal center
796903|NCT00001676|Immunoglobulin|immunoglobulin
796904|NCT00001676|Glomerulonephritis|glomerulonephritis
796905|NCT00001676|Systemic Lupus Erythematosus|systemic lupus erythematosus
796906|NCT00001676|Lupus Nephritis|lupus nephritis
796907|NCT00001671|White Matter|white matter
796908|NCT00001671|Myelin|myelin
796909|NCT00001671|Degenerative Diseases|degenerative diseases
796910|NCT00001671|Genetic|genetic
796911|NCT00001671|Oligodendrocytes|oligodendrocytes
796912|NCT00001671|Leukodystrophy|leukodystrophy
796913|NCT00001666|Seizures|seizures
796914|NCT00001666|Partial Epilepsy|partial epilepsy
796915|NCT00001666|Intractable|intractable
796916|NCT00001666|TMS|tms
796917|NCT00001664|Narcolepsy|narcolepsy
796918|NCT00001664|Polysomnography|polysomnography
796919|NCT00001664|Multiple Sleep Latency Test|multiple sleep latency test
796920|NCT00001664|Sleep Disorders|sleep disorders
796921|NCT00001664|Hypersomnia|hypersomnia
796922|NCT00001664|Periodic Leg Movements|periodic leg movements
796923|NCT00001663|Neurological Disorders|neurological disorders
796924|NCT00001663|Movement Disorders|movement disorders
796925|NCT00001663|Physiology|physiology
796926|NCT00001663|Noninvasive|noninvasive
796927|NCT00001663|Brain Stimulation|brain stimulation
796928|NCT00001663|Cortical Myoclonus|cortical myoclonus
796929|NCT00001662|Dementia|dementia
796930|NCT00001662|Glutamate|glutamate
796931|NCT00001662|Clinical Trial|clinical trial
796932|NCT00001662|Neurotransmitter|neurotransmitter
796933|NCT00001662|Alzheimer's Disease|alzheimer's disease
796934|NCT00001661|Plasticity|plasticity
796935|NCT00001661|Use|use
796936|NCT00001661|Stroke|stroke
796937|NCT00001661|Spinal Cord Injury|spinal cord injury
796938|NCT00001661|Amputation|amputation
796939|NCT00001661|Intracortical Inhibition|intracortical inhibition
796940|NCT00001659|Bereavement|bereavement
796941|NCT00001659|Depression|depression
796942|NCT00001659|Suicide|suicide
796943|NCT00001659|Activity of Daily Living|activity of daily living
796944|NCT00001659|Immune Function|immune function
796945|NCT00001659|Occupational Performance|occupational performance
796946|NCT00001659|Sleep Disorders|sleep disorders
796947|NCT00001659|Mood Changes|mood changes
796948|NCT00001656|Clozapine|clozapine
796949|NCT00001656|Olanzapine|olanzapine
796950|NCT00001656|Drug Response|drug response
796951|NCT00001656|Safety|safety
796952|NCT00001656|Childhood Onset Schizophrenia|childhood onset schizophrenia
796953|NCT00001656|Schizoaffective Disorder|schizoaffective disorder
796954|NCT00001656|Multidimensionally Impaired Syndrome|multidimensionally impaired syndrome
796955|NCT00001656|Phenomenology|phenomenology
796956|NCT00001656|Biochemical Correlates|biochemical correlates
796957|NCT00001656|Brain Imaging|brain imaging
796958|NCT00001656|Schizophrenia|schizophrenia
796959|NCT00001656|Childhood Schizophrenia|childhood schizophrenia
796960|NCT00001656|Psychosis|psychosis
796961|NCT00001654|Adolescence|adolescence
796962|NCT00001654|Comorbid Disorders|comorbid disorders
796963|NCT00001654|Physiology|physiology
796964|NCT00001654|Socialization|socialization
796965|NCT00001654|Gender|gender
796966|NCT00001654|Conduct Problems|conduct problems
796967|NCT00001654|Anxiety|anxiety
796970|NCT00001654|Psychophysiology|psychophysiology
796971|NCT00001652|Life-Charting|life-charting
796972|NCT00001652|Cerebrospinal Fluid|cerebrospinal fluid
796973|NCT00001652|Diagnostic Tests|diagnostic tests
796974|NCT00001652|Cognitive Testing|cognitive testing
796975|NCT00001652|Course of Illness|course of illness
796976|NCT00001652|Bipolar Disorder|bipolar disorder
796977|NCT00001651|Deuterium|deuterium
796978|NCT00001651|HIV|hiv
796979|NCT00001651|Labeling|labeling
796980|NCT00001651|CD4 Cells|cd4 cells
796981|NCT00001651|Immunodeficiency|immunodeficiency
796982|NCT00001650|BrDU|brdu
796983|NCT00001650|HIV|hiv
796984|NCT00001650|Labeling|labeling
796985|NCT00001650|CD4 Cells|cd4 cells
796986|NCT00001650|Immunodeficiency|immunodeficiency
796987|NCT00001649|Clinical Trial|clinical trial
796988|NCT00001649|Sexual Transmitted Disease|sexual transmitted disease
796989|NCT00001649|Phase III|phase iii
796990|NCT00001649|HSV|hsv
796991|NCT00001649|Valtrex|valtrex
796992|NCT00001649|Valaciclovir|valaciclovir
796993|NCT00001649|HS2A/B3009|hs2a/b3009
796994|NCT00001649|Herpes Simplex Virus Transmission|herpes simplex virus transmission
796995|NCT00001649|Heterosexual Couples|heterosexual couples
796996|NCT00001648|HVEM Gene|hvem gene
796997|NCT00001648|HSV|hsv
796998|NCT00001648|Herpes Simplex Virus|herpes simplex virus
796999|NCT00001647|AIDS|aids
797000|NCT00001647|Immunotherapy|immunotherapy
797001|NCT00001647|Adoptive Cell Transfers|adoptive cell transfers
797002|NCT00001647|T Cell Repertoire|t cell repertoire
797003|NCT00001647|Identical Twins|identical twins
797004|NCT00001645|Chagas' Disease|chagas' disease
797005|NCT00001645|Trypanosomiasis|trypanosomiasis
797006|NCT00001645|Malaria|malaria
797007|NCT00001645|Parasitic Infection|parasitic infection
797008|NCT00001644|Immunodeficiency|immunodeficiency
797009|NCT00001644|Latency|latency
797010|NCT00001644|T Cell Turnover|t cell turnover
797011|NCT00001644|Infected Cell Turnover|infected cell turnover
797012|NCT00001644|Follicular Dendritic Cells|follicular dendritic cells
797013|NCT00001643|Lewy Body|lewy body
797014|NCT00001643|Mutation|mutation
797015|NCT00001643|Hereditary|hereditary
797016|NCT00001643|Dominant|dominant
797017|NCT00001643|Sporadic|sporadic
797018|NCT00001643|Parkinson's Disease|parkinson's disease
797019|NCT00001641|Fibrillin|fibrillin
797020|NCT00001641|Collagen|collagen
797021|NCT00001641|Marfan Syndrome|marfan syndrome
797022|NCT00001641|Stickler Syndrome|stickler syndrome
797023|NCT00001641|Aortic Dissection|aortic dissection
797024|NCT00001641|Ehlers-Danlos|ehlers-danlos
797025|NCT00001641|Connective Tissue Disorders|connective tissue disorders
797026|NCT00001641|Ehlers-Danlos Syndrome|ehlers-danlos syndrome
797027|NCT00001641|Nail-Patella Syndrome|nail-patella syndrome
797028|NCT00001640|Parkinson's Disease|parkinson's disease
797029|NCT00001638|Echocardiography|echocardiography
797030|NCT00001638|Heart|heart
797031|NCT00001638|Gadolinium|gadolinium
797032|NCT00001638|Dobutamine|dobutamine
797033|NCT00001638|Toxicity|toxicity
797034|NCT00001638|Adverse Events|adverse events
797035|NCT00001638|Myocardial Infarction|myocardial infarction
797036|NCT00001638|Myocardial Viability|myocardial viability
797037|NCT00001638|Myocardial Perfusion|myocardial perfusion
797038|NCT00001638|Myocardial Function|myocardial function
797039|NCT00001638|Cardiovascular Disease|cardiovascular disease
797040|NCT00001637|Peripheral Blood Stem Cells|peripheral blood stem cells
797041|NCT00001637|Engraftment|engraftment
797042|NCT00001637|Fludarabine|fludarabine
797043|NCT00001637|Nonmyeloablative|nonmyeloablative
797044|NCT00001637|Graft-Versus-Leukemia|graft-versus-leukemia
797045|NCT00001637|Graft vs. Host Disease|graft vs. host disease
797046|NCT00001637|Cyclophosphamide|cyclophosphamide
797047|NCT00001637|Donor Apheresis|donor apheresis
797048|NCT00001637|Nonmyeloablative Bone Marrow Transplantation|nonmyeloablative bone marrow transplantation
797049|NCT00001637|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
797050|NCT00001637|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
797051|NCT00001637|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
797052|NCT00001637|Myelodysplastic Syndromes|myelodysplastic syndromes
797053|NCT00001637|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
797054|NCT00001637|Prolymphocytic Leukemia|prolymphocytic leukemia
797055|NCT00001632|Hypertrophy|hypertrophy
797056|NCT00001632|Integrated|integrated
797057|NCT00001632|Backscatter|backscatter
797058|NCT00001632|Cyclic|cyclic
797059|NCT00001632|Echocardiography|echocardiography
797060|NCT00001632|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
797061|NCT00001631|Gadolinium|gadolinium
797062|NCT00001631|Ischemia|ischemia
797063|NCT00001631|Coronary Artery Disease|coronary artery disease
797064|NCT00001631|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
797065|NCT00001631|Dipyridamole|dipyridamole
797066|NCT00001630|Immunosuppression|immunosuppression
797067|NCT00001630|Thrombocytopenia|thrombocytopenia
797068|NCT00001630|Autoimmune Disease|autoimmune disease
797069|NCT00001630|Evan's Syndrome|evan's syndrome
797070|NCT00001630|Autoimmune Hemolytic Anemia|autoimmune hemolytic anemia
797071|NCT00001630|Episodic Bleeding|episodic bleeding
797072|NCT00001627|Bone Marrow|bone marrow
797073|NCT00001627|Hematopoiesis|hematopoiesis
797074|NCT00001627|DNA|dna
797075|NCT00001627|RNA|rna
797076|NCT00001627|Viruses|viruses
797077|NCT00001627|Normal Volunteer|normal volunteer
797078|NCT00001627|Aplastic Anemia|aplastic anemia
797079|NCT00001627|Myelodysplasia|myelodysplasia
797080|NCT00001627|Fanconi's Anemia|fanconi's anemia
797081|NCT00001627|Single Lineage Cytopenia|single lineage cytopenia
797082|NCT00001626|Cytopenia|cytopenia
797083|NCT00001626|Randomized|randomized
797084|NCT00001626|Immunosuppression|immunosuppression
797085|NCT00001626|Severe Aplastic Anemia|severe aplastic anemia
797086|NCT00001625|Insulin Resistance|insulin resistance
797087|NCT00001625|Obesity|obesity
797088|NCT00001625|Hypertension|hypertension
797089|NCT00001625|Diabetes|diabetes
797090|NCT00001625|Mathematical Modeling|mathematical modeling
797091|NCT00001625|Normal Volunteer|normal volunteer
797092|NCT00001623|Peripheral Blood Stem Cells|peripheral blood stem cells
797093|NCT00001623|Graft-Versus-Leukemia|graft-versus-leukemia
797094|NCT00001623|Graft vs. Host Disease|graft vs. host disease
797095|NCT00001623|Whole Body Irradiation|whole body irradiation
797096|NCT00001623|Donor Apheresis|donor apheresis
797097|NCT00001623|Cyclophosphamide|cyclophosphamide
797098|NCT00001623|Graft-Versus-Myeloma|graft-versus-myeloma
797099|NCT00001623|Leukemic Relapse|leukemic relapse
797100|NCT00001623|Multiple Myeloma|multiple myeloma
797101|NCT00001623|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
797102|NCT00001623|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
797103|NCT00001623|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
797104|NCT00001623|Myelodysplastic Syndromes|myelodysplastic syndromes
797105|NCT00001623|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
797106|NCT00001621|Teaching|teaching
797107|NCT00001621|Pulmonary Disease|pulmonary disease
797108|NCT00001621|Routine Testing|routine testing
797109|NCT00001621|Medically Indicated|medically indicated
797110|NCT00001621|Pulmonary Function Test|pulmonary function test
797111|NCT00001620|Thrombocytopenia|thrombocytopenia
797112|NCT00001620|Anemia|anemia
797113|NCT00001620|Neutropenia|neutropenia
797114|NCT00001620|Dysplasia|dysplasia
797115|NCT00001620|Cytopenia|cytopenia
797116|NCT00001620|Hematologic Malignancy|hematologic malignancy
797117|NCT00001619|Imaging|imaging
797118|NCT00001619|Spectroscopy|spectroscopy
797119|NCT00001619|MRI|mri
797120|NCT00001619|Cardiovascular|cardiovascular
797121|NCT00001619|Technical Development|technical development
797122|NCT00001619|Heart|heart
797123|NCT00001619|Safety|safety
797124|NCT00001619|Toxicity|toxicity
797125|NCT00001619|Gadolinium|gadolinium
797126|NCT00001619|Adverse Events|adverse events
797127|NCT00001619|Normal Volunteer|normal volunteer
797128|NCT00001618|Cystic Fibrosis|cystic fibrosis
797129|NCT00001618|Healthy Volunteers|healthy volunteers
797130|NCT00001618|Asthma|asthma
797131|NCT00001618|Normal Volunteer|normal volunteer
797132|NCT00001618|Chronic Lung Disease|chronic lung disease
797133|NCT00001613|Cataract Surgery|cataract surgery
797134|NCT00001613|Human Lens|human lens
797135|NCT00001613|Crystallins|crystallins
797136|NCT00001613|Post-Translational|post-translational
797137|NCT00001613|Protein Modification|protein modification
797138|NCT00001613|Nuclear Cataract|nuclear cataract
797139|NCT00001613|Cataract Extraction|cataract extraction
797140|NCT00001611|AIDS|aids
797141|NCT00001611|Eye|eye
797142|NCT00001611|Treatment|treatment
797143|NCT00001611|Opportunistic Infection|opportunistic infection
797144|NCT00001611|Immunology|immunology
797145|NCT00001611|Retinitis|retinitis
797146|NCT00001610|Standing Potential|standing potential
797147|NCT00001610|Fast Oscillation|fast oscillation
797148|NCT00001610|Slow Oscillation|slow oscillation
797149|NCT00001610|Retinal Pigment|retinal pigment
797150|NCT00001610|Epithelium|epithelium
797151|NCT00001610|Electro-oculogram|electro-oculogram
797152|NCT00001610|Cellular Immune Response|cellular immune response
797153|NCT00001610|Retinal Antigens|retinal antigens
797154|NCT00001610|IRBP|irbp
797155|NCT00001610|S-Antigen|s-antigen
797156|NCT00001610|Normal Volunteer|normal volunteer
797157|NCT00001609|Linkage|linkage
797158|NCT00001609|Genetic Analysis|genetic analysis
797159|NCT00001609|Lens|lens
797160|NCT00001609|Opacity|opacity
797161|NCT00001609|Inherited|inherited
797162|NCT00001609|Linkage Analysis|linkage analysis
797163|NCT00001609|Genomic DNA|genomic dna
797164|NCT00001609|Risk Prediction|risk prediction
797165|NCT00001609|Pedigree Analysis|pedigree analysis
797166|NCT00001609|Congenital Cataracts|congenital cataracts
797167|NCT00001609|Hereditary Cataracts|hereditary cataracts
797168|NCT00001606|Linkage Analysis|linkage analysis
797169|NCT00001606|Positional Cloning|positional cloning
797170|NCT00001606|Mutation Screening|mutation screening
797171|NCT00001606|Syndromic Hearing Impairment|syndromic hearing impairment
797172|NCT00001606|Non-Syndromic Hearing Impairment|non-syndromic hearing impairment
797174|NCT00001604|Buccal Swab|buccal swab
797175|NCT00001604|Genotyping|genotyping
797176|NCT00001604|Statistical Analysis|statistical analysis
797177|NCT00001604|Computers|computers
797178|NCT00001604|Stuttering|stuttering
797179|NCT00001603|Cytokines|cytokines
797180|NCT00001603|Squamous Cell Carcinoma|squamous cell carcinoma
797181|NCT00001603|Papilloma|papilloma
797182|NCT00001603|Communication|communication
797183|NCT00001603|Immunity|immunity
797184|NCT00001603|Head|head
797185|NCT00001603|Neck|neck
797186|NCT00001603|Head and Neck Cancer|head and neck cancer
797187|NCT00001602|Dysfluency|dysfluency
797188|NCT00001602|Polymorphism|polymorphism
797189|NCT00001602|Stuttering|stuttering
797190|NCT00001602|Dopamine|dopamine
797191|NCT00001602|Family Studies|family studies
797192|NCT00001602|Receptors|receptors
797193|NCT00001602|Serotonin|serotonin
797194|NCT00001602|Enzymes|enzymes
797195|NCT00001602|Genetics|genetics
797196|NCT00001602|Linkage Analysis|linkage analysis
797197|NCT00001601|Oral Medicine|oral medicine
797198|NCT00001601|Clinical Experience|clinical experience
797199|NCT00001601|Therapy|therapy
797200|NCT00001601|Educational Training|educational training
797201|NCT00001601|Pathogenesis|pathogenesis
797202|NCT00001601|Oral Lesions|oral lesions
797203|NCT00001601|Aphthous Ulcers|aphthous ulcers
797204|NCT00001601|Lichen Planus|lichen planus
797205|NCT00001601|Burning Mouth|burning mouth
797206|NCT00001601|Temporomandibular Dysfunction (TMD)|temporomandibular dysfunction (tmd)
797207|NCT00001601|Oral Disease|oral disease
797208|NCT00001601|Oral Manifestations|oral manifestations
797209|NCT00001600|Screening Protocol|screening protocol
797210|NCT00001600|Temporomandibular Disorders|temporomandibular disorders
797211|NCT00001600|Oral Surgery|oral surgery
797212|NCT00001600|Chronic Orofacial Pain|chronic orofacial pain
797213|NCT00001599|Xerostomia|xerostomia
797214|NCT00001599|Autoimmunity|autoimmunity
797215|NCT00001599|Salivary Glands|salivary glands
797216|NCT00001599|Lacrimal Function|lacrimal function
797217|NCT00001599|Immunomodulator|immunomodulator
797218|NCT00001599|Sjogren's Syndrome|sjogren's syndrome
797219|NCT00001599|Dry Mouth|dry mouth
797220|NCT00001598|Xerostomia|xerostomia
797221|NCT00001598|Autoimmunity|autoimmunity
797222|NCT00001598|Salivary Glands|salivary glands
797223|NCT00001598|Androgen Therapy|androgen therapy
797224|NCT00001598|Lacrimal Function|lacrimal function
797225|NCT00001598|DHEA|dhea
797226|NCT00001598|Sjogren's Syndrome|sjogren's syndrome
797227|NCT00001598|Dehydroepiandrosterone|dehydroepiandrosterone
797228|NCT00001597|Psychophysics|psychophysics
797229|NCT00001597|Validation|validation
797230|NCT00001597|Fentanyl|fentanyl
797231|NCT00001597|Normal Volunteer|normal volunteer
797232|NCT00001597|Pain|pain
797233|NCT00001596|Albinism|albinism
797234|NCT00001596|Platelet Storage Pool Deficiency|platelet storage pool deficiency
797235|NCT00001596|Pulmonary Fibrosis|pulmonary fibrosis
797236|NCT00001596|Hermansky-Pudlak Syndrome|hermansky-pudlak syndrome
797237|NCT00001595|Oncogenesis|oncogenesis
797238|NCT00001595|Adenoma|adenoma
797239|NCT00001595|Craniopharyngioma|craniopharyngioma
797240|NCT00001595|Cushing Syndrome|cushing syndrome
797241|NCT00001595|Homeobox-Containing Genes|homeobox-containing genes
797242|NCT00001595|Developmental Defect|developmental defect
797243|NCT00001595|Pituitary Gland|pituitary gland
797244|NCT00001594|Osteogenesis Imperfecta|osteogenesis imperfecta
797245|NCT00001594|Basilar Invagination|basilar invagination
797246|NCT00001591|Central Nervous System|central nervous system
797247|NCT00001591|Technical Development|technical development
797248|NCT00001591|Activation Studies|activation studies
797249|NCT00001591|Pulse Sequences|pulse sequences
797250|NCT00001591|Metabolites|metabolites
797251|NCT00001591|Normal Volunteer|normal volunteer
797252|NCT00001589|Ferritin|ferritin
797253|NCT00001589|Atherosclerosis|atherosclerosis
797254|NCT00001589|Myocardial Infarction|myocardial infarction
797255|NCT00001589|Blood Donors|blood donors
797256|NCT00001589|Low Density Lipoprotein|low density lipoprotein
797257|NCT00001589|Asymptomatic Carotid Atherosclerosis|asymptomatic carotid atherosclerosis
797258|NCT00001586|Genetics|genetics
797259|NCT00001586|Bone Marrow Transplantation|bone marrow transplantation
797260|NCT00001586|Immunosuppression|immunosuppression
797261|NCT00001586|T Lymphocytes|t lymphocytes
797262|NCT00001586|Marrow Purging|marrow purging
797263|NCT00001582|Autoimmune Disorder|autoimmune disorder
797264|NCT00001582|Immune System Evaluation|immune system evaluation
797265|NCT00001582|Human Response Investigation|human response investigation
797266|NCT00001582|Tissue Acquisition|tissue acquisition
797267|NCT00001580|Molecular Diagnostics|molecular diagnostics
797268|NCT00001580|Ovary|ovary
797269|NCT00001580|Tissue Acquisition|tissue acquisition
797270|NCT00001580|cDNA Library|cdna library
797271|NCT00001580|CGAP|cgap
797272|NCT00001576|Regional Therapy|regional therapy
797273|NCT00001576|Organ Perfusion|organ perfusion
797274|NCT00001576|Metastases|metastases
797275|NCT00001576|Hyperthermia|hyperthermia
797276|NCT00001575|Yttrium 90|yttrium 90
797277|NCT00001575|Radiolabeled|radiolabeled
797278|NCT00001575|Anti -Tac|anti -tac
797279|NCT00001575|Calcium DTPA|calcium dtpa
797280|NCT00001574|Metabolites|metabolites
797281|NCT00001574|Proton Nuclear Magnetic Resonance Spectroscopic Imaging|proton nuclear magnetic resonance spectroscopic imaging
797282|NCT00001574|Scans|scans
797283|NCT00001572|B-Cell Lymphoma|b-cell lymphoma
797284|NCT00001572|BCL- 2 Positive Tumor|bcl- 2 positive tumor
797285|NCT00001572|Immunization|immunization
797286|NCT00001572|Induction Chemotherapy|induction chemotherapy
797287|NCT00001572|Lymphoma Vaccine|lymphoma vaccine
797288|NCT00001572|Follicular Lymphoma|follicular lymphoma
797289|NCT00001572|Tumor-Derived Immunoglobulin Idiotype|tumor-derived immunoglobulin idiotype
797290|NCT00001569|Gastrointestinal|gastrointestinal
797291|NCT00001569|Adenocarcinoma|adenocarcinoma
797292|NCT00001569|Taxol|taxol
797293|NCT00001568|Tumors|tumors
797294|NCT00001568|Detection|detection
797295|NCT00001568|Follow-Up|follow-up
797296|NCT00001568|Markers|markers
797297|NCT00001568|Radiolabeled|radiolabeled
797298|NCT00001567|Follow-Up Study|follow-up study
797299|NCT00001567|Relapse-Free Survival|relapse-free survival
797300|NCT00001567|Serum Soluble IL-2 Receptor|serum soluble il-2 receptor
797301|NCT00001567|Hematologic Malignancy|hematologic malignancy
797302|NCT00001567|Chronic Therapy|chronic therapy
797303|NCT00001566|Rhabdomyosarcoma|rhabdomyosarcoma
797304|NCT00001566|Ewing's Sarcoma|ewing's sarcoma
797305|NCT00001566|Immunotherapy|immunotherapy
797306|NCT00001566|Tumor Vaccine|tumor vaccine
797307|NCT00001566|Interleukin-2|interleukin-2
797308|NCT00001564|Rhabdomyosarcoma|rhabdomyosarcoma
797309|NCT00001564|Ewing's Sarcoma|ewing's sarcoma
797310|NCT00001564|Immunotherapy|immunotherapy
797311|NCT00001564|Tumor Vaccine|tumor vaccine
797312|NCT00001564|Fusion Protein|fusion protein
797313|NCT00001563|Lymphomagenesis|lymphomagenesis
797314|NCT00001563|Molecular markers of drug resistance|molecular markers of drug resistance
797315|NCT00001563|Refractory, progressive, or relapsed HIV + NHL|refractory, progressive, or relapsed hiv + nhl
797316|NCT00001563|AIDS-related NHL|aids-related nhl
797317|NCT00001561|Multiple Myeloma|multiple myeloma
797318|NCT00001561|Vaccine|vaccine
797319|NCT00001561|Idiotype-Specific Immunity|idiotype-specific immunity
797320|NCT00001561|Immune Transfer|immune transfer
797321|NCT00001561|Myeloma Immunoglobulin|myeloma immunoglobulin
797322|NCT00001560|AIDS|aids
797323|NCT00001560|Multidisciplinary|multidisciplinary
797324|NCT00001560|Leukemia|leukemia
797325|NCT00001560|Lymphoma|lymphoma
797326|NCT00001560|Kaposi's Sarcoma|kaposi's sarcoma
797327|NCT00001552|Spasmodic Dysphonia|spasmodic dysphonia
797328|NCT00001552|Pedigree|pedigree
797329|NCT00001552|Vocal Fold Paralysis|vocal fold paralysis
797330|NCT00001552|Voice Disorder|voice disorder
797331|NCT00001551|Stuttering|stuttering
797332|NCT00001551|Linkage|linkage
797333|NCT00001551|Pedigree|pedigree
797334|NCT00001551|Speech Articulation|speech articulation
797335|NCT00001551|Phonological Processing Disorders|phonological processing disorders
797336|NCT00001551|Speech Disorder|speech disorder
797337|NCT00001550|Immunotherapy|immunotherapy
797338|NCT00001550|Muscle Stiffness|muscle stiffness
797339|NCT00001550|Rigidity|rigidity
797340|NCT00001550|Anti-GAD Antibodies|anti-gad antibodies
797341|NCT00001550|Episodic Spasms|episodic spasms
797342|NCT00001550|Intravenous High-Dose Immunoglobulin|intravenous high-dose immunoglobulin
797343|NCT00001550|Stiff-man Syndrome|stiff-man syndrome
797344|NCT00001549|Movement Disorders|movement disorders
797345|NCT00001549|Parkinson's|parkinson's
797346|NCT00001549|Alzheimer's|alzheimer's
797347|NCT00001549|Screening|screening
797348|NCT00001549|Diagnostic Puzzles|diagnostic puzzles
797349|NCT00001549|Alzheimer Disease|alzheimer disease
797350|NCT00001549|Progressive Supranuclear Palsy|progressive supranuclear palsy
797351|NCT00001549|PSP|psp
797352|NCT00001549|Restless Leg Syndrome|restless leg syndrome
797353|NCT00001549|RLS|rls
797354|NCT00001549|Parkinsonism|parkinsonism
797355|NCT00001549|PD|pd
797356|NCT00001548|Genetic|genetic
797357|NCT00001548|Psychiatric Disorder|psychiatric disorder
797358|NCT00001548|Affected Sib Pairs|affected sib pairs
797359|NCT00001548|Obsessions|obsessions
797360|NCT00001548|Compulsions|compulsions
797361|NCT00001548|Family Study|family study
797362|NCT00001548|OCD Spectrum Disorders|ocd spectrum disorders
797363|NCT00001548|Trichotillomania|trichotillomania
797364|NCT00001548|Tourette's Syndrome|tourette's syndrome
797365|NCT00001547|Drug|drug
797366|NCT00001547|Imaging|imaging
797367|NCT00001547|Brain|brain
797368|NCT00001547|Metabolism|metabolism
797369|NCT00001547|Organic Mental Syndrome|organic mental syndrome
797370|NCT00001547|Magnetic Resonance Imaging|magnetic resonance imaging
797371|NCT00001547|Spectroscopy|spectroscopy
797372|NCT00001547|Neuropsychiatric Disorders|neuropsychiatric disorders
797373|NCT00001547|Drug Effects|drug effects
797374|NCT00001547|Interferon-alpha|interferon-alpha
797375|NCT00001545|Affective Disorders|affective disorders
797376|NCT00001545|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
797377|NCT00001545|Mania|mania
797378|NCT00001545|Bipolar Disorder|bipolar disorder
797379|NCT00001545|Depression|depression
797380|NCT00001545|Unipolar Disorder|unipolar disorder
797381|NCT00001545|Unipolar Depression|unipolar depression
797382|NCT00001544|DNA Probes|dna probes
797383|NCT00001544|Trinucleotide Repeats|trinucleotide repeats
797384|NCT00001544|Family Studies|family studies
797385|NCT00001544|Lymphoblast Cell Lines|lymphoblast cell lines
797386|NCT00001544|Genotyping|genotyping
797387|NCT00001544|Bipolar Affective Disorders|bipolar affective disorders
797388|NCT00001544|Schizophrenia|schizophrenia
797389|NCT00001544|Mental Retardation|mental retardation
797390|NCT00001544|Neuropsychiatric Disorders|neuropsychiatric disorders
797391|NCT00001543|Major Depression|major depression
797392|NCT00001543|Metabolic Clearance Rate|metabolic clearance rate
797393|NCT00001543|Pulsatility|pulsatility
797394|NCT00001543|Adrenocorticotropic Hormone|adrenocorticotropic hormone
797395|NCT00001543|Cortisol|cortisol
797396|NCT00001543|Corticotropin Releasing Hormone Binding Protein|corticotropin releasing hormone binding protein
797397|NCT00001543|Pharmacokinetics|pharmacokinetics
797398|NCT00001543|Half-Life|half-life
797399|NCT00001543|Bioavailability|bioavailability
797400|NCT00001543|Cushing's Syndrome|cushing's syndrome
797401|NCT00001541|Vasculitis|vasculitis
797402|NCT00001541|Inflammation|inflammation
797403|NCT00001541|Bronchoscopy|bronchoscopy
797404|NCT00001541|Cytokines|cytokines
797405|NCT00001541|Inflammatory Mediators|inflammatory mediators
797406|NCT00001541|Wegener's Granulomatosis|wegener's granulomatosis
797407|NCT00001539|Central Nervous System|central nervous system
797408|NCT00001539|Lyme Disease|lyme disease
797409|NCT00001539|Borrelia Burgdorferi|borrelia burgdorferi
797410|NCT00001539|Neuroborreliosis|neuroborreliosis
797411|NCT00001539|Chronic Symptoms|chronic symptoms
797412|NCT00001535|Intracellular Immunization|intracellular immunization
797413|NCT00001535|Immune Based Therapy|immune based therapy
797414|NCT00001535|Ex Vivo Cell Processing|ex vivo cell processing
797415|NCT00001535|Identical Twins|identical twins
797416|NCT00001535|HIV/AIDS|hiv/aids
797417|NCT00001535|Kaposi's Sarcoma|kaposi's sarcoma
797418|NCT00001534|Genetics|genetics
797419|NCT00001534|Myocardial Ischemia|myocardial ischemia
797420|NCT00001534|Diastolic Dysfunction|diastolic dysfunction
797421|NCT00001534|Renin-Angiotensin System|renin-angiotensin system
797422|NCT00001534|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
797423|NCT00001534|Left Ventricular (LV) Hypertrophy|left ventricular (lv) hypertrophy
797424|NCT00001532|Genetic Polymorphism|genetic polymorphism
797425|NCT00001532|Nitric Oxide Synthase|nitric oxide synthase
797426|NCT00001532|Alpha 1-Antitrypsin|alpha 1-antitrypsin
797427|NCT00001532|Candidate Genes|candidate genes
797428|NCT00001532|Lung Pathology|lung pathology
797429|NCT00001532|Asthma|asthma
797430|NCT00001532|Lung Disease|lung disease
797431|NCT00001532|Cystic Fibrosis|cystic fibrosis
797432|NCT00001529|G-CSF|g-csf
797433|NCT00001529|Donor Apheresis|donor apheresis
797434|NCT00001529|Graft vs. Host Disease|graft vs. host disease
797435|NCT00001529|Graft-Versus-Leukemia|graft-versus-leukemia
797436|NCT00001529|Dexamethasone|dexamethasone
797437|NCT00001529|Transient Lymphopenia|transient lymphopenia
797438|NCT00001529|Improved T-Cell Depletion|improved t-cell depletion
797439|NCT00001529|Normal Volunteer|normal volunteer
797440|NCT00001526|Uveitis|uveitis
797441|NCT00001526|Interleukin 2 Receptor|interleukin 2 receptor
797442|NCT00001526|Daclizumab|daclizumab
797443|NCT00001526|HAT|hat
797444|NCT00001526|Zenapax|zenapax
797445|NCT00001526|Interleukin 2|interleukin 2
797446|NCT00001524|Thalidomide|thalidomide
797447|NCT00001524|Clinical Trial|clinical trial
797448|NCT00001524|Tumor Necrosis Factor|tumor necrosis factor
797449|NCT00001524|Delayed Healing|delayed healing
797450|NCT00001524|Painful Oral Lesions|painful oral lesions
797451|NCT00001524|HIV/AIDS|hiv/aids
797452|NCT00001524|Mouth Ulcers|mouth ulcers
797453|NCT00001524|Aphthous Ulcers|aphthous ulcers
797454|NCT00001524|Healing|healing
797455|NCT00001524|Cytokines|cytokines
797456|NCT00001522|Insulin Resistance|insulin resistance
797457|NCT00001522|Race|race
797458|NCT00001522|Body Fat|body fat
797459|NCT00001522|Body Composition|body composition
797460|NCT00001522|Obesity|obesity
797461|NCT00001521|21-Hydroxylase Deficiency|21-hydroxylase deficiency
797462|NCT00001521|11-Hydroxylase Deficiency|11-hydroxylase deficiency
797463|NCT00001521|Antiandrogen|antiandrogen
797464|NCT00001521|Aromatase Inhibitor|aromatase inhibitor
797465|NCT00001521|Growth Disorder|growth disorder
797466|NCT00001521|Congenital Adrenal Hyperplasia (CAH)|congenital adrenal hyperplasia (cah)
797467|NCT00001516|Case Study Design|case study design
797468|NCT00001516|Rehabilitation|rehabilitation
797469|NCT00001516|Treatment Efficacy|treatment efficacy
797470|NCT00001516|Occupational Therapy Process|occupational therapy process
797471|NCT00001516|Reflection|reflection
797472|NCT00001516|Occupational Therapy|occupational therapy
797473|NCT00001515|Wegener's Granulomatosis|wegener's granulomatosis
797474|NCT00001515|Computer Assisted Visualization|computer assisted visualization
797475|NCT00001515|Lung Cavities|lung cavities
797476|NCT00001515|Endobronchial Lesions|endobronchial lesions
797477|NCT00001515|Computed Tomography (CT)|computed tomography (ct)
797478|NCT00001515|Bronchogenic Carcinoma|bronchogenic carcinoma
797479|NCT00001512|ProMace Chemotherapy|promace chemotherapy
797480|NCT00001512|Indolent Lymphoma|indolent lymphoma
797481|NCT00001512|Anti-Idiotype Antibody|anti-idiotype antibody
797483|NCT00001512|B-Cell Lymphoma|b-cell lymphoma
797484|NCT00001507|T-cells|t-cells
797485|NCT00001507|CD34+ Selection|cd34+ selection
797486|NCT00001507|T-Cell Depletion|t-cell depletion
797487|NCT00001507|Apheresis|apheresis
797488|NCT00001507|Mobilization|mobilization
797489|NCT00001506|Training Protocol|training protocol
797490|NCT00001506|Natural History|natural history
797491|NCT00001506|Consultation|consultation
797492|NCT00001506|Standard Therapy|standard therapy
797493|NCT00001506|Standard Tests|standard tests
797494|NCT00001506|Training|training
797495|NCT00001505|Biopsy|biopsy
797496|NCT00001505|Research|research
797497|NCT00001505|Autoimmune|autoimmune
797498|NCT00001505|Blistering|blistering
797499|NCT00001505|Compensation|compensation
797500|NCT00001504|Retinoids|retinoids
797501|NCT00001504|Biomarkers|biomarkers
797502|NCT00001503|Cancer|cancer
797503|NCT00001503|Late Effects|late effects
797504|NCT00001503|Survival|survival
797505|NCT00001503|Follow-Up|follow-up
797506|NCT00001500|Smoking|smoking
797507|NCT00001500|Alcohol|alcohol
797508|NCT00001500|HIV|hiv
797509|NCT00001500|AIDS|aids
797510|NCT00001500|DNA Markers|dna markers
797511|NCT00001500|Personality|personality
797512|NCT00001500|Healthy Volunteers|healthy volunteers
797513|NCT00001500|Normal Volunteer|normal volunteer
797514|NCT00001496|BRCA-1|brca-1
797515|NCT00001496|Familial Breast Cancer|familial breast cancer
797516|NCT00001496|Breast Cell Culture|breast cell culture
797517|NCT00001496|High Risk|high risk
797518|NCT00001491|Ceramidetrihexosidase Deficiency|ceramidetrihexosidase deficiency
797519|NCT00001491|Sural Nerve Biopsy|sural nerve biopsy
797520|NCT00001491|Nerve Conduction Studies|nerve conduction studies
797521|NCT00001491|Quantitative Sensory Testing|quantitative sensory testing
797522|NCT00001491|PGP 9.5 Levels (Skin, Serum and CSF)|pgp 9.5 levels (skin, serum and csf)
797523|NCT00001491|Fabry Disease|fabry disease
797524|NCT00001491|Fabrys|fabrys
797525|NCT00001491|Fabry's|fabry's
797526|NCT00001487|Menopause|menopause
797527|NCT00001487|Andropause|andropause
797528|NCT00001487|Depression|depression
797529|NCT00001487|DHEA|dhea
797530|NCT00001487|Steroids|steroids
797531|NCT00001487|Mid-Life Depression|mid-life depression
797532|NCT00001487|Mid Life|mid life
797533|NCT00001487|Perimenopause|perimenopause
797534|NCT00001487|Climecteric-Related Mood Disorder|climecteric-related mood disorder
797535|NCT00001486|Paranoia|paranoia
797536|NCT00001486|Schizophrenic Research|schizophrenic research
797537|NCT00001486|Hallucinations|hallucinations
797538|NCT00001486|Delusions|delusions
797539|NCT00001486|Brain Scans|brain scans
797540|NCT00001486|Negative Symptoms|negative symptoms
797541|NCT00001486|Symptoms of Schizophrenia|symptoms of schizophrenia
797542|NCT00001486|Causes of Schizophrenia|causes of schizophrenia
797543|NCT00001486|Psychosis and Schizophrenia|psychosis and schizophrenia
797544|NCT00001486|Compensation|compensation
797545|NCT00001486|Schizophrenia|schizophrenia
797546|NCT00001486|Schizoaffective Disorder|schizoaffective disorder
797547|NCT00001486|Psychosis|psychosis
797548|NCT00001486|Manic-Depression|manic-depression
797549|NCT00001483|Manic-Depressive Disorder|manic-depressive disorder
797550|NCT00001483|Antidepressants|antidepressants
797551|NCT00001483|Re-Randomization|re-randomization
797552|NCT00001483|Continuation|continuation
797553|NCT00001483|Ratings|ratings
797554|NCT00001483|Bipolar Illness|bipolar illness
797555|NCT00001483|Depression|depression
797556|NCT00001483|Bupropion|bupropion
797557|NCT00001483|Sertraline|sertraline
797558|NCT00001481|Postpartum Disorders|postpartum disorders
797559|NCT00001481|Depression|depression
797560|NCT00001481|Mood|mood
797561|NCT00001481|Postpartum Depression|postpartum depression
797562|NCT00001481|Hormones|hormones
797563|NCT00001481|Pregnancy|pregnancy
797564|NCT00001481|Estrogen|estrogen
797565|NCT00001481|Progesterone|progesterone
797566|NCT00001481|Gonadal Steroids|gonadal steroids
797567|NCT00001481|GnRH Agonist|gnrh agonist
797568|NCT00001481|Postpartum|postpartum
797569|NCT00001481|Mood Disorder|mood disorder
797570|NCT00001480|Dementia|dementia
797571|NCT00001480|Alzheimer's Disease|alzheimer's disease
797572|NCT00001480|Cerebrospinal Fluid|cerebrospinal fluid
797573|NCT00001480|Diagnostic Test|diagnostic test
797574|NCT00001480|Cognitive Testing|cognitive testing
797575|NCT00001480|Memory Disorder|memory disorder
797576|NCT00001480|Normal Volunteer|normal volunteer
797577|NCT00001476|CD34+ Progenitor|cd34+ progenitor
797578|NCT00001476|Retrovirus|retrovirus
797579|NCT00001476|Leukapheresis|leukapheresis
797580|NCT00001476|Transduction|transduction
797581|NCT00001476|Granulocytes|granulocytes
797582|NCT00001476|Chronic Granulomatous Disease|chronic granulomatous disease
797583|NCT00001475|AIDS|aids
797584|NCT00001475|Cytokines|cytokines
797585|NCT00001475|Thalidomide|thalidomide
797586|NCT00001475|Monoclonal Antibody|monoclonal antibody
797587|NCT00001475|Immunomodulator|immunomodulator
797588|NCT00001474|Cytokines|cytokines
797589|NCT00001474|Immunoregulation|immunoregulation
797590|NCT00001474|Infusion Duration|infusion duration
797591|NCT00001474|CD4 Cells|cd4 cells
797592|NCT00001473|Vasculitis|vasculitis
797593|NCT00001473|Remission|remission
797594|NCT00001473|Relapse|relapse
797595|NCT00001473|Toxicity|toxicity
797596|NCT00001473|ANCA|anca
797597|NCT00001473|Wegener's Granulomatosis|wegener's granulomatosis
797598|NCT00001471|AIDS|aids
797599|NCT00001471|HIV|hiv
797600|NCT00001471|Retrovirus|retrovirus
797601|NCT00001471|Therapy|therapy
797602|NCT00001471|Response|response
797603|NCT00001469|Cancer Susceptibility Alleles|cancer susceptibility alleles
797604|NCT00001469|Prostate Cancer|prostate cancer
797605|NCT00001469|Cancer Genetics|cancer genetics
797606|NCT00001469|Cancer|cancer
797607|NCT00001469|Prostate Cancer (hereditary)|prostate cancer (hereditary)
797608|NCT00001467|Primary Immunodeficiency Disorders|primary immunodeficiency disorders
797609|NCT00001467|Immunologic Disorders|immunologic disorders
797610|NCT00001465|Smooth Muscle Proliferation|smooth muscle proliferation
797611|NCT00001465|Bronchoscopy|bronchoscopy
797612|NCT00001465|Female|female
797613|NCT00001465|Pneumothorax|pneumothorax
797614|NCT00001465|Tuberous Sclerosis|tuberous sclerosis
797615|NCT00001465|Lymphangioleiomyomatosis (LAM)|lymphangioleiomyomatosis (lam)
797616|NCT00001464|Oxygen|oxygen
797617|NCT00001464|Bronchoalveolar Lavage|bronchoalveolar lavage
797618|NCT00001464|DNA Repair|dna repair
797619|NCT00001464|Carbonyl Groups|carbonyl groups
797620|NCT00001464|Serum|serum
797621|NCT00001464|ADP-ribosylation|adp-ribosylation
797622|NCT00001464|Defensin|defensin
797623|NCT00001464|Protein Oxidation|protein oxidation
797624|NCT00001464|Human Volunteers|human volunteers
797625|NCT00001460|Training Protocol|training protocol
797626|NCT00001460|Cardiac Diagnosis|cardiac diagnosis
797627|NCT00001460|Congenital Heart Disease|congenital heart disease
797628|NCT00001460|Acquired Heart Disease|acquired heart disease
797629|NCT00001460|Arrhythmias|arrhythmias
797630|NCT00001458|Exercise Testing|exercise testing
797631|NCT00001458|Echocardiography|echocardiography
797632|NCT00001458|Cardiac Catheterization|cardiac catheterization
797633|NCT00001458|Radionuclide Stress Testing|radionuclide stress testing
797634|NCT00001458|Holter Monitoring|holter monitoring
797635|NCT00001458|Heart Disease|heart disease
797636|NCT00001458|Muscle Leg Pain|muscle leg pain
797637|NCT00001458|Leg Pain|leg pain
797638|NCT00001458|Circulation|circulation
797639|NCT00001458|Peripheral Arterial Disease|peripheral arterial disease
797640|NCT00001458|Intermittent Claudication|intermittent claudication
797641|NCT00001458|Renal Vascular Disease|renal vascular disease
797642|NCT00001458|Uncontrolled Hypertension|uncontrolled hypertension
797643|NCT00001457|Nucleoside Analogues|nucleoside analogues
797644|NCT00001457|Delta Hepatitis|delta hepatitis
797645|NCT00001457|Glomerulonephritis|glomerulonephritis
797646|NCT00001457|Polyarteritis Nodosa|polyarteritis nodosa
797647|NCT00001457|Hepatitis Mutants|hepatitis mutants
797648|NCT00001457|3TC|3tc
797649|NCT00001457|Chronic Hepatitis B|chronic hepatitis b
797650|NCT00001457|Chronic Hepatitis D|chronic hepatitis d
797651|NCT00001457|Cirrhosis|cirrhosis
797652|NCT00001457|Lamivudine|lamivudine
797653|NCT00001456|Albinism|albinism
797654|NCT00001456|Platelet Storage Pool Deficiency|platelet storage pool deficiency
797655|NCT00001456|Metabolic Disease|metabolic disease
797656|NCT00001456|Hermansky-Pudlak Syndrome|hermansky-pudlak syndrome
797657|NCT00001454|Estrogen|estrogen
797658|NCT00001454|Progesterone|progesterone
797659|NCT00001454|Menses|menses
797660|NCT00001454|Endometrium|endometrium
797661|NCT00001454|Normal Volunteer|normal volunteer
797662|NCT00001453|Petrosal Sinus Sampling|petrosal sinus sampling
797663|NCT00001453|Corticotropin Releasing Hormone|corticotropin releasing hormone
797664|NCT00001453|Cushing Syndrome|cushing syndrome
797665|NCT00001453|Internal Jugular Vein Sampling|internal jugular vein sampling
797666|NCT00001453|Corticotropin Releasing Hormone Stimulation|corticotropin releasing hormone stimulation
797667|NCT00001452|Cushing Syndrome|cushing syndrome
797668|NCT00001452|Gene Mapping|gene mapping
797669|NCT00001452|Linkage|linkage
797670|NCT00001452|Oncogene|oncogene
797671|NCT00001452|Linkage Analysis|linkage analysis
797672|NCT00001452|Gene Identification|gene identification
797673|NCT00001452|Tumors|tumors
797674|NCT00001452|Familial Neoplasia|familial neoplasia
797675|NCT00001452|Adrenal Gland|adrenal gland
797676|NCT00001452|Lentigines|lentigines
797677|NCT00001452|Carney Complex|carney complex
797678|NCT00001451|Bone Marrow Transplantation|bone marrow transplantation
797679|NCT00001451|Bone Marrow Donor|bone marrow donor
797680|NCT00001451|Marrow Transplant|marrow transplant
797681|NCT00001451|National Marrow Donor Program (NMDP)|national marrow donor program (nmdp)
797682|NCT00001451|Unrelated Marrow Donor|unrelated marrow donor
797683|NCT00001451|Healthy Volunteer|healthy volunteer
797684|NCT00001444|Pharmacokinetics|pharmacokinetics
797685|NCT00001444|Natural Products|natural products
797686|NCT00001444|Salvage Therapy|salvage therapy
797687|NCT00001444|Protein Kinase Antagonist|protein kinase antagonist
797688|NCT00001442|Taxol|taxol
797689|NCT00001442|Squamous Cell Carcinoma|squamous cell carcinoma
797690|NCT00001442|Radiosensitizer|radiosensitizer
797691|NCT00001442|Radiotherapy|radiotherapy
797692|NCT00001442|Tumor Potential Doubling Time (Tpot)|tumor potential doubling time (tpot)
797693|NCT00001440|p53|p53
797694|NCT00001440|Interleukin-2|interleukin-2
797695|NCT00001440|T-Cell Repopulation|t-cell repopulation
797696|NCT00001440|Apheresis|apheresis
797697|NCT00001440|RAS|ras
797698|NCT00001432|Purging|purging
797699|NCT00001432|Apheresis|apheresis
797700|NCT00001432|Long Term Culture|long term culture
797701|NCT00001432|T Cells|t cells
797702|NCT00001432|Stem Cell|stem cell
797703|NCT00001430|IL-2|il-2
797704|NCT00001430|Drug Resistance|drug resistance
797705|NCT00001430|Continuous Infusion|continuous infusion
797706|NCT00001430|Peripheral Stem Cells|peripheral stem cells
797707|NCT00001430|MDR|mdr
797708|NCT00001426|Ovarian Cancer|ovarian cancer
797709|NCT00001426|Initial Therapy|initial therapy
797710|NCT00001426|Paclitaxel|paclitaxel
797711|NCT00001426|Cisplatin|cisplatin
797712|NCT00001426|Cyclophosphamide|cyclophosphamide
797713|NCT00001420|Lymphocytes|lymphocytes
797714|NCT00001420|Cytokines|cytokines
797715|NCT00001420|Apoptosis|apoptosis
797716|NCT00001420|Psoriasis|psoriasis
797717|NCT00001420|Genetics|genetics
797718|NCT00001420|Psoriatic Arthritis|psoriatic arthritis
797719|NCT00001418|Sympathetic Nervous System|sympathetic nervous system
797720|NCT00001418|Dysautonomias|dysautonomias
797721|NCT00001418|Postural Tachycardia Syndrome|postural tachycardia syndrome
797722|NCT00001418|Neurocardiogenic Syncope|neurocardiogenic syncope
797723|NCT00001418|Hypernoradrenergic Hypertension|hypernoradrenergic hypertension
797724|NCT00001418|Sympathectomy|sympathectomy
797725|NCT00001418|Fluorodopamine|fluorodopamine
797726|NCT00001418|Positron Emission Tomography|positron emission tomography
797727|NCT00001418|Norepinephrine|norepinephrine
797728|NCT00001418|Dopamine|dopamine
797729|NCT00001418|Neurocardiologic Disorder|neurocardiologic disorder
797730|NCT00001417|Needle Biopsy|needle biopsy
797731|NCT00001417|Computed Tomography|computed tomography
797732|NCT00001417|Magnetic Resonance Imaging|magnetic resonance imaging
797733|NCT00001417|Spinal Angiography|spinal angiography
797734|NCT00001417|Intratumoral Pressure|intratumoral pressure
797735|NCT00001417|Vertebral Hemangioma|vertebral hemangioma
797736|NCT00001417|Spinal Metastasis|spinal metastasis
797737|NCT00001417|Absolute Ethanol|absolute ethanol
797738|NCT00001417|Spinal Tumor|spinal tumor
797739|NCT00001417|Vertebral Tumor|vertebral tumor
797740|NCT00001414|Behavior Genetics|behavior genetics
797741|NCT00001414|Normal Personality|normal personality
797742|NCT00001414|Intelligence|intelligence
797743|NCT00001414|Siblings|siblings
797744|NCT00001414|Sixteen Personality Factor Questionnaire|sixteen personality factor questionnaire
797745|NCT00001414|NEO-Personality Inventory (Revised)|neo-personality inventory (revised)
797746|NCT00001414|X-Chromosome|x-chromosome
797747|NCT00001413|Corticosteroids|corticosteroids
797748|NCT00001413|Osteoporosis|osteoporosis
797749|NCT00001413|Depression|depression
797750|NCT00001413|DEXA Scan|dexa scan
797751|NCT00001413|Body Mass|body mass
797752|NCT00001413|Dual X-Ray|dual x-ray
797753|NCT00001413|Energy Absorptiometry|energy absorptiometry
797754|NCT00001413|Normal Volunteer|normal volunteer
797755|NCT00001412|Gonadal Steroids|gonadal steroids
797756|NCT00001412|Central Nervous System Function|central nervous system function
797757|NCT00001412|GnRH Agonist|gnrh agonist
797758|NCT00001412|Testosterone|testosterone
797759|NCT00001412|Leuprolide Acetate|leuprolide acetate
797760|NCT00001412|Mood|mood
797761|NCT00001412|Behavior|behavior
797762|NCT00001412|Cognitive Function|cognitive function
797763|NCT00001410|Recombinant Production|recombinant production
797764|NCT00001410|Inherited Disease|inherited disease
797765|NCT00001410|Lysosomal Disorder|lysosomal disorder
797766|NCT00001410|Inborn Error of Metabolism|inborn error of metabolism
797767|NCT00001410|Enzyme Replacement Therapy|enzyme replacement therapy
797768|NCT00001410|Glucocerebrosidase|glucocerebrosidase
797769|NCT00001410|Polyethylene Glycol|polyethylene glycol
797770|NCT00001410|Gaucher Disease|gaucher disease
797771|NCT00001410|Recombinant Enzyme|recombinant enzyme
797772|NCT00001409|AIDS|aids
797773|NCT00001409|Gene Therapy|gene therapy
797774|NCT00001409|T Cell Universal Receptor|t cell universal receptor
797775|NCT00001409|Ex Vivo Activation|ex vivo activation
797776|NCT00001408|Lymphocytes|lymphocytes
797777|NCT00001408|Asthma|asthma
797778|NCT00001408|Cytokines|cytokines
797779|NCT00001408|Interleukin-5|interleukin-5
797780|NCT00001408|Late Phase Response|late phase response
797781|NCT00001407|Cytokines|cytokines
797782|NCT00001407|Mycobacteria|mycobacteria
797783|NCT00001407|Pneumonia|pneumonia
797784|NCT00001407|Multiple Drug Resistant Tuberculosis|multiple drug resistant tuberculosis
797785|NCT00001406|Eosinophils|eosinophils
797786|NCT00001406|Helminth Parasites|helminth parasites
797787|NCT00001406|Hypereosinophilia|hypereosinophilia
797788|NCT00001406|Allergy|allergy
797789|NCT00001406|Asthma|asthma
797790|NCT00001405|Chronic Granulomatous Disease|chronic granulomatous disease
797791|NCT00001405|Apheresis|apheresis
797792|NCT00001405|CD34 Cells|cd34 cells
797793|NCT00001405|Infection|infection
797794|NCT00001405|Nadph Oxidase|nadph oxidase
797795|NCT00001405|Normal Volunteer|normal volunteer
797796|NCT00001404|Abnormalities, Multiple|abnormalities, multiple
797797|NCT00001404|Hypothalamic Hamartoma|hypothalamic hamartoma
797798|NCT00001404|Polysyndactyly|polysyndactyly
797799|NCT00001404|Autosomal Dominant|autosomal dominant
797800|NCT00001404|Mutation|mutation
797801|NCT00001404|Gelastic|gelastic
797802|NCT00001404|Gelastic Seizure|gelastic seizure
797803|NCT00001404|Hypothalamic|hypothalamic
797804|NCT00001404|Malformations|malformations
797805|NCT00001404|Polydactyly|polydactyly
797806|NCT00001404|Pallister-Hall Syndrome|pallister-hall syndrome
797807|NCT00001403|Proteus Syndrome|proteus syndrome
797808|NCT00001403|Overgrowth|overgrowth
797809|NCT00001400|Heart Disease|heart disease
797810|NCT00001400|Screening|screening
797811|NCT00001400|Follow-Up|follow-up
797812|NCT00001399|Gene Therapy|gene therapy
797813|NCT00001399|Stem Cell Rescue|stem cell rescue
797814|NCT00001399|Bone Marrow Failure|bone marrow failure
797815|NCT00001399|Fanconi Anemia|fanconi anemia
797816|NCT00001398|Hematopoiesis|hematopoiesis
797817|NCT00001398|Stem Cell Cycling|stem cell cycling
797818|NCT00001398|Bone Marrow Failure|bone marrow failure
797819|NCT00001398|Acquired Aplastic Anemia|acquired aplastic anemia
797820|NCT00001397|Hematologic Malignancies|hematologic malignancies
797821|NCT00001396|Pacemaker|pacemaker
797822|NCT00001396|Pediatric|pediatric
797823|NCT00001396|Obstructive HCM|obstructive hcm
797824|NCT00001394|Hyperparathyroidism|hyperparathyroidism
797825|NCT00001394|Arterial Stimulation|arterial stimulation
797826|NCT00001394|Venous Sampling|venous sampling
797827|NCT00001394|Parathyroid Adenoma|parathyroid adenoma
797828|NCT00001394|Parathyroid Hyperplasia|parathyroid hyperplasia
797829|NCT00001393|Collapsing Glomerulopathy|collapsing glomerulopathy
797830|NCT00001393|Renal Disease|renal disease
797831|NCT00001393|HIV Associated Nephropathy|hiv associated nephropathy
797832|NCT00001392|Retrovirus|retrovirus
797833|NCT00001392|PCR|pcr
797834|NCT00001392|Renal Failure|renal failure
797835|NCT00001392|HIV|hiv
797836|NCT00001392|Rituximab|rituximab
797837|NCT00001391|Augmentation|augmentation
797838|NCT00001391|Osteogenesis|osteogenesis
797839|NCT00001391|Stem Cells|stem cells
797840|NCT00001391|Bone Formation|bone formation
797841|NCT00001391|Bone Induction|bone induction
797842|NCT00001390|Saliva|saliva
797843|NCT00001390|Parotid|parotid
797844|NCT00001390|Lip Biopsy|lip biopsy
797845|NCT00001390|Health|health
797846|NCT00001390|Exocrine|exocrine
797847|NCT00001390|Normal Volunteer|normal volunteer
797848|NCT00001386|AIDS|aids
797849|NCT00001386|Retrovirus|retrovirus
797850|NCT00001386|Therapeutic Vaccine|therapeutic vaccine
797851|NCT00001386|Vaccine|vaccine
797852|NCT00001386|Helper T Cells|helper t cells
797853|NCT00001379|Epstein-Barr Virus|epstein-barr virus
797854|NCT00001379|Lymphoproliferative Disorder|lymphoproliferative disorder
797855|NCT00001379|Viral|viral
797856|NCT00001379|Immunosuppression|immunosuppression
797857|NCT00001379|Lymphoma|lymphoma
797858|NCT00001373|Auto-Inflammation|auto-inflammation
797859|NCT00001373|Familial Mediterranean Fever|familial mediterranean fever
797860|NCT00001373|Genetics|genetics
797861|NCT00001373|Periodic Fever|periodic fever
797862|NCT00001372|Systemic Lupus Erythematosus|systemic lupus erythematosus
797863|NCT00001372|Natural History|natural history
797864|NCT00001372|Lupus Nephritis|lupus nephritis
797865|NCT00001372|Lupus|lupus
797866|NCT00001372|Systemic Lupus|systemic lupus
797867|NCT00001372|SLE|sle
797868|NCT00001368|Cerebral Ischemia|cerebral ischemia
797869|NCT00001368|Hypertension|hypertension
797870|NCT00001368|Immune Response|immune response
797871|NCT00001368|Carotid Stenosis|carotid stenosis
797872|NCT00001368|Atherosclerosis|atherosclerosis
797873|NCT00001367|Human|human
797874|NCT00001367|Movement|movement
797875|NCT00001367|Non-Investigational to Diagnostic Puzzle|non-investigational to diagnostic puzzle
797876|NCT00001367|Parkinson's|parkinson's
797877|NCT00001367|Dystonia|dystonia
797878|NCT00001367|Cerebellar|cerebellar
797879|NCT00001367|Puzzles|puzzles
797880|NCT00001367|Neurological Disorders|neurological disorders
797881|NCT00001367|Movement Disorders|movement disorders
797882|NCT00001366|Neuroimaging|neuroimaging
797883|NCT00001366|Seizures|seizures
797884|NCT00001366|Cerebral Localization|cerebral localization
797885|NCT00001366|Partial Epilepsy|partial epilepsy
797886|NCT00001366|Epilepsy|epilepsy
797887|NCT00001364|Spinal Arteriovenous Malformations|spinal arteriovenous malformations
797888|NCT00001364|Spinal Dural Arteriovenous Fistulas|spinal dural arteriovenous fistulas
797889|NCT00001364|Surgery|surgery
797890|NCT00001364|Embolization|embolization
797891|NCT00001364|Spinal Arteriography|spinal arteriography
797892|NCT00001362|Magnetic Resonance Imaging|magnetic resonance imaging
797893|NCT00001362|Contrast Enhancement|contrast enhancement
797894|NCT00001362|Neuroanatomic Morphometry|neuroanatomic morphometry
797895|NCT00001362|Neurobehavioral Deficits|neurobehavioral deficits
797896|NCT00001362|Neurological Disorders|neurological disorders
797897|NCT00001362|Blood Flow|blood flow
797898|NCT00001362|Blood Volume|blood volume
797899|NCT00001362|Normal Volunteer|normal volunteer
797900|NCT00001361|Movement Disorders|movement disorders
797901|NCT00001361|Sensory Processing|sensory processing
797902|NCT00001361|Stroke|stroke
797903|NCT00001361|Spinal Cord Injury|spinal cord injury
797904|NCT00001361|Blood Flow|blood flow
797905|NCT00001361|Blood Volume|blood volume
797906|NCT00001361|Cognitive Function|cognitive function
797907|NCT00001361|Neurobehavioral Deficits|neurobehavioral deficits
797908|NCT00001361|Neurological Disorders|neurological disorders
797909|NCT00001361|Magnetic Resonance Imaging|magnetic resonance imaging
797910|NCT00001361|Plasticity|plasticity
797911|NCT00001361|Normal Volunteer|normal volunteer
797912|NCT00001360|Cognition|cognition
797913|NCT00001360|Vision|vision
797914|NCT00001360|Cortex|cortex
797915|NCT00001360|Visual Processing|visual processing
797916|NCT00001360|Magnetic Resonance Imaging|magnetic resonance imaging
797917|NCT00001359|Obsessive Compulsive Disorder|obsessive compulsive disorder
797918|NCT00001359|PANDAS Associated with Streptococcal Infections|pandas associated with streptococcal infections
797919|NCT00001359|Adolescents|adolescents
797920|NCT00001359|Autoimmune Illness|autoimmune illness
797921|NCT00001359|Children|children
797922|NCT00001359|Tic Disorders|tic disorders
797923|NCT00001359|Streptococcal Infections|streptococcal infections
797924|NCT00001359|Childhood Onset Neuropsychiatric Disorder|childhood onset neuropsychiatric disorder
797925|NCT00001357|Cytokines|cytokines
797926|NCT00001357|Immunoregulation|immunoregulation
797927|NCT00001357|CD4 Cells|cd4 cells
797928|NCT00001356|IL-3|il-3
797929|NCT00001356|Stem Cell Factor|stem cell factor
797930|NCT00001356|Cytokines|cytokines
797931|NCT00001356|Cell Differentiation|cell differentiation
797932|NCT00001356|Receptors|receptors
797933|NCT00001356|Bone Marrow|bone marrow
797934|NCT00001356|Mastocytosis|mastocytosis
797935|NCT00001355|Immunodeficiency|immunodeficiency
797936|NCT00001355|Infections|infections
797937|NCT00001355|Phagocytes|phagocytes
797938|NCT00001355|Cytokines|cytokines
797939|NCT00001355|Genetics|genetics
797940|NCT00001354|AIDS|aids
797941|NCT00001354|Immunotherapy|immunotherapy
797942|NCT00001354|CD4 Cells|cd4 cells
797943|NCT00001354|Immunomodulator|immunomodulator
797944|NCT00001354|Cytokines|cytokines
797945|NCT00001353|AIDS|aids
797946|NCT00001353|Immune Based Therapy|immune based therapy
797947|NCT00001353|Adoptive Immunotherapy|adoptive immunotherapy
797948|NCT00001353|Lymphapheresis|lymphapheresis
797949|NCT00001353|Ex Vivo Activation|ex vivo activation
797950|NCT00001353|HIV|hiv
797951|NCT00001353|Gene Therapy|gene therapy
797952|NCT00001353|Protease Inhibitor|protease inhibitor
797953|NCT00001353|Interleukin-2|interleukin-2
797954|NCT00001353|Indinavir|indinavir
797955|NCT00001352|Cryptococcus Neoformans|cryptococcus neoformans
797956|NCT00001352|Cryptococcosis|cryptococcosis
797957|NCT00001352|CD4|cd4
797958|NCT00001351|Chronic Infection|chronic infection
797959|NCT00001351|Infectious Diseases|infectious diseases
797960|NCT00001351|Host Response|host response
797961|NCT00001351|Immunologic Disorders|immunologic disorders
797962|NCT00001351|Acute Infection|acute infection
797963|NCT00001350|Immunoregulation|immunoregulation
797964|NCT00001350|T Cell Receptor Alpha/Beta|t cell receptor alpha/beta
797965|NCT00001350|Lymphadenopathy|lymphadenopathy
797966|NCT00001350|ALPS|alps
797967|NCT00001350|Autoimmune Lymphoproliferative Syndrome|autoimmune lymphoproliferative syndrome
797968|NCT00001349|Plasmapheresis|plasmapheresis
797969|NCT00001349|Lymphocytes|lymphocytes
797970|NCT00001349|Eosinophils|eosinophils
797971|NCT00001349|Neutrophils|neutrophils
797972|NCT00001347|Linkage Analysis|linkage analysis
797973|NCT00001347|Genomic DNA|genomic dna
797974|NCT00001347|Pedigree Analysis|pedigree analysis
797975|NCT00001347|Usher Syndrome|usher syndrome
797976|NCT00001347|Usher Syndrome Type 1|usher syndrome type 1
797977|NCT00001347|Usher Syndrome Type 2|usher syndrome type 2
797978|NCT00001345|Hypercalcemia|hypercalcemia
797979|NCT00001345|Multiple Endocrine Neoplasia (MEN)|multiple endocrine neoplasia (men)
797980|NCT00001345|Familial Hypocalciuric Hypercalcemia|familial hypocalciuric hypercalcemia
797981|NCT00001345|Hyperparathyroidism|hyperparathyroidism
797982|NCT00001345|Linkage Analysis|linkage analysis
797983|NCT00001343|Turner's Syndrome|turner's syndrome
797984|NCT00001343|Short Stature|short stature
797985|NCT00001343|Cognitive Function|cognitive function
797986|NCT00001343|Sex Steroids|sex steroids
797987|NCT00001343|Turner Syndrome|turner syndrome
797988|NCT00001343|TS|ts
797989|NCT00001339|Multidrug Resistance|multidrug resistance
797990|NCT00001339|Reversal of Drug Resistance|reversal of drug resistance
797991|NCT00001339|P-Glycoprotein|p-glycoprotein
797992|NCT00001339|MDR-1|mdr-1
797993|NCT00001337|Primary Mediastinal B-Cell Lymphoma|primary mediastinal b-cell lymphoma
797994|NCT00001337|CD20 +|cd20 +
797995|NCT00001337|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
797996|NCT00001337|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
797997|NCT00001337|De Novo|de novo
797998|NCT00001336|Transplantation|transplantation
797999|NCT00001336|Cancer|cancer
798000|NCT00001336|Cellular Immunity|cellular immunity
798001|NCT00001336|Stem Cell Function|stem cell function
798002|NCT00001336|Immunodeficiency|immunodeficiency
798003|NCT00001335|Peripheral Stem Cell Transfusion|peripheral stem cell transfusion
798004|NCT00001335|Up-Front Phase II Window|up-front phase ii window
798005|NCT00001335|Dose-Intensive Vincristine|dose-intensive vincristine
798006|NCT00001335|Dose-Intensive Doxorubicin|dose-intensive doxorubicin
798007|NCT00001335|Dose-Intensive Cyclophosphamide|dose-intensive cyclophosphamide
798008|NCT00001335|ADR-529 for Cardioprotection|adr-529 for cardioprotection
798009|NCT00001335|BID Radiation Therapy for Local Control|bid radiation therapy for local control
798010|NCT00001331|Myopathy|myopathy
798011|NCT00001331|Phosphofructokinase|phosphofructokinase
798012|NCT00001331|Acid Maltase|acid maltase
798013|NCT00001331|Pompe|pompe
798014|NCT00001331|Muscle Diseases|muscle diseases
798015|NCT00001331|Genetic Muscle Diseases|genetic muscle diseases
798016|NCT00001329|Yohimbine|yohimbine
798017|NCT00001329|Catecholamines|catecholamines
798018|NCT00001329|Sympathoadrenal Response|sympathoadrenal response
798019|NCT00001329|Sympathetic Nervous System|sympathetic nervous system
798020|NCT00001329|Stress|stress
798021|NCT00001329|Hypertension|hypertension
798022|NCT00001329|Autonomic Failure|autonomic failure
798023|NCT00001328|Cancer|cancer
798024|NCT00001328|Gene Transfer|gene transfer
798025|NCT00001328|Recurrent Tumors|recurrent tumors
798026|NCT00001328|Primary Tumors|primary tumors
798027|NCT00001328|Metastases|metastases
798028|NCT00001328|Anti-Viral Drugs|anti-viral drugs
798029|NCT00001328|Chemosensitization|chemosensitization
798030|NCT00001328|Brain Tumors|brain tumors
798031|NCT00001328|Gene Therapy|gene therapy
798032|NCT00001328|Ganciclovir|ganciclovir
798033|NCT00001327|Syringomyelia|syringomyelia
798034|NCT00001327|Chiari Malformation|chiari malformation
798035|NCT00001327|Magnetic Resonance Imaging|magnetic resonance imaging
798036|NCT00001327|Intraoperative Ultrasonography|intraoperative ultrasonography
798037|NCT00001327|Hydrocephalus|hydrocephalus
798038|NCT00001327|Spinal Cord|spinal cord
798039|NCT00001327|Ventriculostomy|ventriculostomy
798040|NCT00001327|Lumbar Puncture|lumbar puncture
798041|NCT00001327|Pressure Measurement|pressure measurement
798042|NCT00001325|Positron|positron
798043|NCT00001325|Tomography|tomography
798044|NCT00001325|Seizures|seizures
798045|NCT00001325|Epileptic Focus|epileptic focus
798046|NCT00001325|Electroencephalography|electroencephalography
798047|NCT00001325|Metabolism|metabolism
798048|NCT00001325|Glucose|glucose
798049|NCT00001325|Cerebral|cerebral
798050|NCT00001325|Positron Emission Tomography|positron emission tomography
798051|NCT00001325|Lennox Gastaut Syndrome|lennox gastaut syndrome
798052|NCT00001323|Cognition|cognition
798053|NCT00001323|Neuropsychology|neuropsychology
798054|NCT00001323|Neuropsychological Tests|neuropsychological tests
798055|NCT00001323|Neurological Exam|neurological exam
798056|NCT00001323|Psychiatric|psychiatric
798057|NCT00001323|Attention|attention
798058|NCT00001323|Schizophrenic|schizophrenic
798059|NCT00001323|Schizoaffective|schizoaffective
798060|NCT00001323|Working Memory|working memory
798061|NCT00001323|Memory|memory
798062|NCT00001322|Gonadal Steroids|gonadal steroids
798063|NCT00001322|Mood|mood
798064|NCT00001322|Menstrual Cycle|menstrual cycle
798065|NCT00001322|Neuropsychological Testing|neuropsychological testing
798066|NCT00001322|Estrogen|estrogen
798067|NCT00001322|Dexamethasone|dexamethasone
798068|NCT00001322|Progesterone|progesterone
798069|NCT00001322|Central Nervous System Function|central nervous system function
798070|NCT00001322|Estradiol|estradiol
798071|NCT00001322|GnRH Agonist|gnrh agonist
798072|NCT00001320|Parkinson's Disease|parkinson's disease
798073|NCT00001320|Schizophrenia|schizophrenia
798074|NCT00001320|Dopamine D2/D3 receptors|dopamine d2/d3 receptors
798075|NCT00001320|Brain Imaging|brain imaging
798076|NCT00001320|SPECT|spect
798077|NCT00001320|Equilibrium|equilibrium
798078|NCT00001320|Brain Scan|brain scan
798079|NCT00001320|Brain Research|brain research
798080|NCT00001320|Brain Disorders|brain disorders
798081|NCT00001320|Schizoaffective Disorder|schizoaffective disorder
798082|NCT00001320|Normal Volunteer|normal volunteer
798083|NCT00001319|HIV Negative|hiv negative
798084|NCT00001319|CD4 Deficiency|cd4 deficiency
798085|NCT00001319|Retrovirus|retrovirus
798086|NCT00001316|Lymph Node|lymph node
798087|NCT00001316|Polymerase Chain Reaction (PCR)|polymerase chain reaction (pcr)
798192|NCT00001275|Menopause|menopause
798088|NCT00001316|In Situ Hybridization|in situ hybridization
798089|NCT00001316|AIDS|aids
798090|NCT00001316|Excisional Biopsy|excisional biopsy
798091|NCT00001313|Cardiac Diagnosis|cardiac diagnosis
798092|NCT00001313|Chest Pain|chest pain
798093|NCT00001313|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
798094|NCT00001313|Coronary Artery Disease|coronary artery disease
798095|NCT00001313|Microvascular Angina|microvascular angina
798096|NCT00001313|Cardiac Investigation|cardiac investigation
798097|NCT00001313|Follow-up|follow-up
798098|NCT00001313|Heart Disease|heart disease
798099|NCT00001310|Retinal Disease|retinal disease
798100|NCT00001310|Diabetic Retinopathy|diabetic retinopathy
798101|NCT00001310|Uveitis|uveitis
798102|NCT00001310|Age-Related Macular Degeneration|age-related macular degeneration
798103|NCT00001310|Corneal Disease|corneal disease
798104|NCT00001310|Ocular Disease|ocular disease
798105|NCT00001309|Pharmacokinetics|pharmacokinetics
798106|NCT00001309|Biodistribution|biodistribution
798107|NCT00001309|Ascorbic Acid|ascorbic acid
798108|NCT00001308|Stuttering|stuttering
798109|NCT00001308|Tourette's Syndrome|tourette's syndrome
798110|NCT00001308|Spasmodic Dysphonia|spasmodic dysphonia
798111|NCT00001308|Dysarthria|dysarthria
798112|NCT00001308|Parkinson's Disease|parkinson's disease
798113|NCT00001308|Verbal Dyspraxia|verbal dyspraxia
798114|NCT00001308|Aphasia|aphasia
798115|NCT00001308|Speech|speech
798116|NCT00001308|Motor Control|motor control
798117|NCT00001307|Analgesia|analgesia
798118|NCT00001307|PET|pet
798119|NCT00001307|Positron Emission|positron emission
798120|NCT00001307|Functional Brain Imaging|functional brain imaging
798121|NCT00001307|Allodynia|allodynia
798122|NCT00001307|Thalamus|thalamus
798123|NCT00001307|Somatosensory Cortex|somatosensory cortex
798124|NCT00001307|Reflex Sympathetic Dystrophy|reflex sympathetic dystrophy
798125|NCT00001307|Normal Volunteer|normal volunteer
798126|NCT00001307|Chronic Pain|chronic pain
798127|NCT00001306|Infertility|infertility
798128|NCT00001306|Ovulation|ovulation
798129|NCT00001306|Autoimmune|autoimmune
798130|NCT00001306|Follicle|follicle
798131|NCT00001306|Menopause|menopause
798132|NCT00001306|Biopsy|biopsy
798133|NCT00001306|Glucocorticoids|glucocorticoids
798134|NCT00001306|Premature Ovarian Failure|premature ovarian failure
798135|NCT00001306|Amenorrhea|amenorrhea
798136|NCT00001306|Ovarian Failure|ovarian failure
798137|NCT00001306|POF|pof
798138|NCT00001305|Osteogenesis Imperfecta|osteogenesis imperfecta
798139|NCT00001304|Hypoparathyroidism|hypoparathyroidism
798140|NCT00001304|Parathyroid Hormone|parathyroid hormone
798141|NCT00001304|Vitamin D|vitamin d
798142|NCT00001304|Calcium Metabolism|calcium metabolism
798143|NCT00001304|PTH 1-34|pth 1-34
798144|NCT00001304|Bone|bone
798145|NCT00001303|Hemodynamics|hemodynamics
798146|NCT00001303|Lung Permeability|lung permeability
798147|NCT00001303|Endotoxin Tolerance|endotoxin tolerance
798148|NCT00001303|Bronchoscopy|bronchoscopy
798149|NCT00001303|Human Recombinant Interleukin-1 Receptor|human recombinant interleukin-1 receptor
798150|NCT00001303|Normal Volunteer|normal volunteer
798151|NCT00001302|Vinblastine|vinblastine
798152|NCT00001302|Multidrug Resistance|multidrug resistance
798153|NCT00001302|Resistance Reversal|resistance reversal
798154|NCT00001302|Pgp Blocker|pgp blocker
798155|NCT00001302|Pharmacokinetics|pharmacokinetics
798156|NCT00001302|Cyclosporine|cyclosporine
798157|NCT00001302|Drug Interactions|drug interactions
798158|NCT00001295|Follow-Up|follow-up
798159|NCT00001295|Treatment|treatment
798160|NCT00001294|Genetic Linkage|genetic linkage
798161|NCT00001294|Sex Behavior|sex behavior
798162|NCT00001294|AIDS|aids
798163|NCT00001294|Alcohol Dependence|alcohol dependence
798164|NCT00001294|HLA System|hla system
798165|NCT00001294|Cancer|cancer
798166|NCT00001289|Enzyme Replacement|enzyme replacement
798167|NCT00001289|Type 3 Gaucher's Disease|type 3 gaucher's disease
798168|NCT00001289|Lysosomal Storage|lysosomal storage
798169|NCT00001289|Supranuclear Gaze Palsy|supranuclear gaze palsy
798170|NCT00001289|Seizures|seizures
798171|NCT00001289|Mental Retardation|mental retardation
798172|NCT00001289|Gaucher Disease|gaucher disease
798173|NCT00001288|Positron Emission Tomography|positron emission tomography
798174|NCT00001288|Epilepsy|epilepsy
798175|NCT00001288|Stroke|stroke
798176|NCT00001284|Cognition|cognition
798177|NCT00001284|Schizophrenia|schizophrenia
798178|NCT00001284|Magnetic Resonance Imaging|magnetic resonance imaging
798179|NCT00001284|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
798180|NCT00001284|Dopaminergic Mechanisms|dopaminergic mechanisms
798181|NCT00001282|HIV|hiv
798182|NCT00001282|Immunomodulator|immunomodulator
798183|NCT00001282|Anti-Viral|anti-viral
798184|NCT00001281|Lymphocytes|lymphocytes
798185|NCT00001281|Venipuncture|venipuncture
798186|NCT00001281|Mononuclear Cells|mononuclear cells
798187|NCT00001277|Hypoglycemia|hypoglycemia
798188|NCT00001277|Genetics|genetics
798189|NCT00001277|Hyperparathyroidism|hyperparathyroidism
798190|NCT00001276|Hypoglycemia|hypoglycemia
798191|NCT00001276|Insulinoma|insulinoma
798193|NCT00001275|Estrogen|estrogen
798194|NCT00001275|Infertility|infertility
798195|NCT00001275|Ovulation|ovulation
798196|NCT00001275|Amenorrhea|amenorrhea
798197|NCT00001275|Hypergonadotropic Hypogonadism|hypergonadotropic hypogonadism
798198|NCT00001275|Young Women|young women
798199|NCT00001275|Gonadal Steroid Deficiency|gonadal steroid deficiency
798200|NCT00001275|Mineralocorticoid Deficiency|mineralocorticoid deficiency
798201|NCT00001275|Premature Ovarian Failure|premature ovarian failure
798202|NCT00001275|POF|pof
798203|NCT00001266|Bayesian|bayesian
798204|NCT00001266|Hydroxy-Flutamide|hydroxy-flutamide
798205|NCT00001266|Combined Androgen Ablation|combined androgen ablation
798206|NCT00001266|Prostate Specific Antigen|prostate specific antigen
798207|NCT00001265|Autoimmune Diseases|autoimmune diseases
798208|NCT00001265|Idiopathic Inflammatory Myopathies|idiopathic inflammatory myopathies
798209|NCT00001265|Polymyositis|polymyositis
798210|NCT00001265|Dermatomyositis|dermatomyositis
798211|NCT00001265|Inclusion Body Myositis|inclusion body myositis
798212|NCT00001265|Pathogenesis|pathogenesis
798213|NCT00001265|Connective Tissue Diseases|connective tissue diseases
798214|NCT00001262|Menkes|menkes
798215|NCT00001262|Copper|copper
798216|NCT00001262|X-Linked|x-linked
798217|NCT00001262|Neurodegeneration|neurodegeneration
798218|NCT00001262|ATP7A|atp7a
798219|NCT00001261|Polymyositis/Dermatomyositis|polymyositis/dermatomyositis
798220|NCT00001261|Muscle Immunopathology|muscle immunopathology
798221|NCT00001261|Intravenous High-Dose Immunoglobulin|intravenous high-dose immunoglobulin
798222|NCT00001261|Inclusion Body Myositis|inclusion body myositis
798223|NCT00001260|Schizophrenia|schizophrenia
798224|NCT00001260|Neuropathology|neuropathology
798225|NCT00001260|Neurochemistry|neurochemistry
798226|NCT00001260|Substance Abuse|substance abuse
798227|NCT00001260|Bipolar Disorder|bipolar disorder
798228|NCT00001260|Aging|aging
798229|NCT00001260|Normal Development|normal development
798230|NCT00001260|Depression|depression
798231|NCT00001260|Anxiety Disorders|anxiety disorders
798232|NCT00001260|Suicide|suicide
798233|NCT00001260|Dementia|dementia
798234|NCT00001260|Neuropsychiatric Disorders|neuropsychiatric disorders
798235|NCT00001260|Tourette's Syndrome|tourette's syndrome
798236|NCT00001260|Normal Controls|normal controls
798237|NCT00001259|Depression|depression
798238|NCT00001259|Menstrual Cycle|menstrual cycle
798239|NCT00001259|Gonadal Steroids|gonadal steroids
798240|NCT00001259|GnRH Agonist|gnrh agonist
798241|NCT00001259|Mood Disorders|mood disorders
798242|NCT00001258|Neuropsychology|neuropsychology
798243|NCT00001258|Cerebral Blood Flow|cerebral blood flow
798244|NCT00001258|Cognitive Disorders|cognitive disorders
798245|NCT00001258|Prefrontal Cortex|prefrontal cortex
798246|NCT00001258|Hormones|hormones
798247|NCT00001258|Psychosis|psychosis
798248|NCT00001258|Neuroimaging|neuroimaging
798249|NCT00001258|Brain Scan|brain scan
798250|NCT00001258|Healthy Volunteers|healthy volunteers
798251|NCT00001258|Schizophrenia|schizophrenia
798252|NCT00001257|Lymphokines|lymphokines
798253|NCT00001257|LTB4|ltb4
798254|NCT00001257|Inflammation|inflammation
798255|NCT00001257|Normal Volunteer|normal volunteer
798256|NCT00001257|Abnormal Phagocyte Function|abnormal phagocyte function
798257|NCT00001256|Vasculitis|vasculitis
798258|NCT00001256|Cytotoxic Therapy|cytotoxic therapy
798259|NCT00001256|Inflammation|inflammation
798260|NCT00001256|Glomerulonephritis|glomerulonephritis
798261|NCT00001256|Inflammatory Sinusitis|inflammatory sinusitis
798262|NCT00001255|Retroviral Vector|retroviral vector
798263|NCT00001255|Gene Therapy|gene therapy
798264|NCT00001255|PEG-ADA|peg-ada
798265|NCT00001255|Severe Combined Immunodeficiency (SCID)|severe combined immunodeficiency (scid)
798266|NCT00001255|Adenosine Deaminase Deficiency (ADA)|adenosine deaminase deficiency (ada)
798267|NCT00001254|Islet Cell Tumors|islet cell tumors
798268|NCT00001253|Turner's Syndrome|turner's syndrome
798269|NCT00001253|Estrogen|estrogen
798270|NCT00001253|Ethinyl estradiol|ethinyl estradiol
798271|NCT00001253|Learning|learning
798272|NCT00001253|Ovarian dysgenesis|ovarian dysgenesis
798273|NCT00001252|Biomechanics|biomechanics
798274|NCT00001252|Kinesiology|kinesiology
798275|NCT00001252|Walking|walking
798276|NCT00001252|ACL|acl
798277|NCT00001252|Stroke|stroke
798278|NCT00001252|Leg Weakness|leg weakness
798279|NCT00001252|Paralysis|paralysis
798280|NCT00001252|Anterior Cruciate Ligament|anterior cruciate ligament
798281|NCT00001252|Gait Degicit|gait degicit
798282|NCT00001251|Meningeal Malignancy|meningeal malignancy
798283|NCT00001251|Pediatric|pediatric
798284|NCT00001251|Alkylating Agents|alkylating agents
798285|NCT00001250|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
798286|NCT00001250|Dose Intense Chemotherapy|dose intense chemotherapy
798287|NCT00001250|Stage II Breast Cancer|stage ii breast cancer
798288|NCT00001250|Early Stage Breast Cancer|early stage breast cancer
798289|NCT00001248|Multiple Sclerosis|multiple sclerosis
798290|NCT00001248|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
798291|NCT00001247|Schizophrenia|schizophrenia
798292|NCT00001247|Psychosis|psychosis
799817|NCT00004350|cystinosis|cystinosis
798293|NCT00001247|Neuroleptics|neuroleptics
798294|NCT00001247|Schizoaffective Disorder|schizoaffective disorder
798295|NCT00001246|Cognitive|cognitive
798296|NCT00001246|Genetics|genetics
798297|NCT00001246|Development|development
798298|NCT00001246|Klinefelter Syndrome|klinefelter syndrome
798299|NCT00001246|Jacob Syndrome|jacob syndrome
798300|NCT00001246|Trisomy X|trisomy x
798301|NCT00001246|Healthy Volunteer|healthy volunteer
798302|NCT00001246|XXY|xxy
798303|NCT00001246|XXXY|xxxy
798304|NCT00001246|XXXXY|xxxxy
798305|NCT00001246|XYY|xyy
798306|NCT00001246|XXYY|xxyy
798307|NCT00001246|XO|xo
798308|NCT00001246|XXXX|xxxx
798309|NCT00001246|XXX|xxx
798310|NCT00001246|XXXXX|xxxxx
798311|NCT00001246|Triple X|triple x
798312|NCT00001246|Congenital Adrenal Hyperplasia|congenital adrenal hyperplasia
798313|NCT00001246|Twin|twin
798314|NCT00001245|Strongyloidiasis|strongyloidiasis
798315|NCT00001245|Immediate Hypersensitivity Skin Test|immediate hypersensitivity skin test
798316|NCT00001245|IgE|ige
798317|NCT00001245|Nematode|nematode
798318|NCT00001245|Immunosuppression|immunosuppression
798319|NCT00001245|Skin Test|skin test
798320|NCT00001245|Diagnosis|diagnosis
798321|NCT00001245|Intestinal Helminth|intestinal helminth
798322|NCT00001245|Immediate Hypersensitivity|immediate hypersensitivity
798323|NCT00001244|Agammaglobulinemia|agammaglobulinemia
798324|NCT00001244|Primary Immune Deficiency|primary immune deficiency
798325|NCT00001244|Immune Response|immune response
798326|NCT00001243|AIDS|aids
798327|NCT00001243|Myeloid Progenitors|myeloid progenitors
798328|NCT00001243|Monocytes|monocytes
798329|NCT00001243|Plasmid Libraries|plasmid libraries
798330|NCT00001243|Cytokines|cytokines
798331|NCT00001242|Calcium|calcium
798332|NCT00001242|Vitamin D|vitamin d
798333|NCT00001242|Calcitriol|calcitriol
798334|NCT00001242|Parathyroid|parathyroid
798335|NCT00001242|Cyclic AMP|cyclic amp
798336|NCT00001242|Rickets|rickets
798337|NCT00001241|Gastric Acid Secretion|gastric acid secretion
798338|NCT00001241|Histamine H2-Receptor Antagonists|histamine h2-receptor antagonists
798339|NCT00001240|Stomach|stomach
798340|NCT00001240|Hypersecretion|hypersecretion
798341|NCT00001240|Hyposecretion|hyposecretion
798342|NCT00001240|Gastrinoma|gastrinoma
798343|NCT00001240|Zollinger-Ellison Syndrome|zollinger-ellison syndrome
798344|NCT00001238|Urologic Malignant Disorders|urologic malignant disorders
798345|NCT00001238|Birt Hogg Dube|birt hogg dube
798346|NCT00001238|Von Hippel Lindau|von hippel lindau
798347|NCT00001238|Hereditary Papillary Renal Cancer/Renal Cell Acarcinoma|hereditary papillary renal cancer/renal cell acarcinoma
798348|NCT00001235|Primary Neuronal Degeneration|primary neuronal degeneration
798349|NCT00001235|Genetics|genetics
798350|NCT00001235|Neurotransmitters|neurotransmitters
798351|NCT00001235|DNA|dna
798352|NCT00001235|Lymphoblasts|lymphoblasts
798353|NCT00001235|Skin Fibroblast|skin fibroblast
798354|NCT00001235|Alzheimer's Disease|alzheimer's disease
798355|NCT00001234|Bone Marrow|bone marrow
798356|NCT00001234|Retroviral-Mediated Gene Transfer|retroviral-mediated gene transfer
798357|NCT00001234|Hematopoietic Progenitor Cell|hematopoietic progenitor cell
798358|NCT00001231|Mood|mood
798359|NCT00001231|Behavior|behavior
798360|NCT00001231|Cognition|cognition
798361|NCT00001231|Climacteric|climacteric
798362|NCT00001231|Menopause|menopause
798363|NCT00001231|Perimenopause|perimenopause
798364|NCT00001231|Midlife|midlife
798365|NCT00001231|Depression|depression
798366|NCT00001230|Wuchereria Bancrofti|wuchereria bancrofti
798367|NCT00001230|Loa Loa|loa loa
798368|NCT00001230|Brugia Malayi|brugia malayi
798369|NCT00001230|Brugia Timori|brugia timori
798370|NCT00001230|Onchocerca Volvulus|onchocerca volvulus
798371|NCT00001230|Mansonella Perstans|mansonella perstans
798372|NCT00001230|Mansonella Ozzardi|mansonella ozzardi
798373|NCT00001230|Diethylcarbamazine (DEC)|diethylcarbamazine (dec)
798374|NCT00001230|Suramin|suramin
798375|NCT00001230|Ivermectin|ivermectin
798376|NCT00001230|Filarial Infection|filarial infection
798377|NCT00001228|Interferon|interferon
798378|NCT00001228|Zollinger-Ellison Syndrome|zollinger-ellison syndrome
798379|NCT00001226|Nonradioactive Isotopes|nonradioactive isotopes
798380|NCT00001226|Lipoprotein Kinetics|lipoprotein kinetics
798381|NCT00001226|Apolipoproteins|apolipoproteins
798382|NCT00001226|Dyslipoproteinemia|dyslipoproteinemia
798383|NCT00001226|Healthy Volunteers|healthy volunteers
798384|NCT00001225|DNA Polymorphisms|dna polymorphisms
798385|NCT00001225|Echocardiography|echocardiography
798386|NCT00001225|Gene Mapping|gene mapping
798387|NCT00001225|Linkage Analysis|linkage analysis
798388|NCT00001225|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
798389|NCT00001224|Ocular Inflammatory Disease|ocular inflammatory disease
798390|NCT00001224|Cataracts|cataracts
798391|NCT00001224|Vitrectomy|vitrectomy
798392|NCT00001224|Extracapsular|extracapsular
798393|NCT00001224|Cataract Surgery|cataract surgery
798394|NCT00001224|Uveitis|uveitis
798395|NCT00001224|Lenticular Opacity|lenticular opacity
798396|NCT00001224|Vitreal Opacity|vitreal opacity
798397|NCT00001223|Cystic Fibrosis|cystic fibrosis
798398|NCT00001223|Pancreatic Insufficiency|pancreatic insufficiency
798399|NCT00001223|Bronchiectasis|bronchiectasis
798400|NCT00001221|Growth|growth
798401|NCT00001221|Gonadal Dysgenesis|gonadal dysgenesis
798402|NCT00001221|Estrogen|estrogen
798403|NCT00001221|Somatotropin|somatotropin
798404|NCT00001221|Turner's Syndrome|turner's syndrome
798405|NCT00001221|Growth Hormone|growth hormone
798406|NCT00001220|Swallowing Disorders|swallowing disorders
798407|NCT00001220|Neuromotor Dysfunction|neuromotor dysfunction
798408|NCT00001220|Aspiration|aspiration
798409|NCT00001220|Imaging|imaging
798410|NCT00001219|Magnetic Resonance Imaging|magnetic resonance imaging
798411|NCT00001219|Pulse Sequences|pulse sequences
798412|NCT00001215|Lysosomal Storage Disorders|lysosomal storage disorders
798413|NCT00001215|Variants|variants
798414|NCT00001215|Chemical Phenotype|chemical phenotype
798415|NCT00001215|Proteins|proteins
798416|NCT00001215|Genes|genes
798417|NCT00001215|Phenotype|phenotype
798418|NCT00001215|Mutations|mutations
798419|NCT00001215|Parkinsonism|parkinsonism
798420|NCT00001214|Bone Marrow Failure|bone marrow failure
798421|NCT00001214|Lymphocytapheresis|lymphocytapheresis
798422|NCT00001214|Pancytopenia|pancytopenia
798423|NCT00001214|Aplastic Anemia|aplastic anemia
798424|NCT00001214|Hematosuppressive Disease|hematosuppressive disease
798425|NCT00001213|Cysteamine Eye Drops|cysteamine eye drops
798426|NCT00001213|Nephropathic Cystinosis|nephropathic cystinosis
798427|NCT00001213|Corneal Crystals|corneal crystals
798428|NCT00001213|Benzalkonium|benzalkonium
798429|NCT00001213|Toxicity|toxicity
798430|NCT00001213|Efficacy|efficacy
798431|NCT00001213|Cystinosis|cystinosis
798432|NCT00001212|Systemic Lupus Erythematosus|systemic lupus erythematosus
798433|NCT00001212|Nephrotic Syndrome|nephrotic syndrome
798434|NCT00001212|Immunosuppressive Drugs|immunosuppressive drugs
798435|NCT00001212|Prednisone|prednisone
798436|NCT00001212|Methylprednisolone|methylprednisolone
798437|NCT00001212|Cyclophosphamide|cyclophosphamide
798438|NCT00001212|Cyclosporine|cyclosporine
798439|NCT00001212|Cyclosporin A|cyclosporin a
798440|NCT00001208|Spasmodic Torticollis|spasmodic torticollis
798441|NCT00001208|Writer's Cramp|writer's cramp
798442|NCT00001208|Spasmodic Dysphonia|spasmodic dysphonia
798443|NCT00001208|Stuttering|stuttering
798444|NCT00001208|Oromandibular Dystonia|oromandibular dystonia
798445|NCT00001208|Palatal Myoclonus|palatal myoclonus
798446|NCT00001208|Dystonia|dystonia
798447|NCT00001208|Essential Tremor|essential tremor
798448|NCT00001208|Movement Disorders|movement disorders
798449|NCT00001206|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
798450|NCT00001206|Disruptive Behavior Disorders|disruptive behavior disorders
798451|NCT00001206|Cerebrospinal Fluid|cerebrospinal fluid
798452|NCT00001206|Lumbar Puncture|lumbar puncture
798453|NCT00001206|CSF|csf
798454|NCT00001206|Longitudinal Prospective Follow-Up|longitudinal prospective follow-up
798455|NCT00001206|Psychosocial Functioning|psychosocial functioning
798456|NCT00001206|Risk Factors|risk factors
798457|NCT00001206|Genetics|genetics
798458|NCT00001205|Taenia Solium|taenia solium
798459|NCT00001205|Cysticercosis|cysticercosis
798460|NCT00001205|Praziquantel|praziquantel
798461|NCT00001204|Dyslipoprotein|dyslipoprotein
798462|NCT00001204|Hypercholesterolemia|hypercholesterolemia
798463|NCT00001204|Atherosclerosis|atherosclerosis
798464|NCT00001203|Desferal|desferal
798465|NCT00001203|Thalassemia|thalassemia
798466|NCT00001203|Liver Iron Concentration|liver iron concentration
798467|NCT00001203|Endocrine Evaluation|endocrine evaluation
798468|NCT00001203|Diabetes Mellitus|diabetes mellitus
798469|NCT00001203|Cardiac Disease|cardiac disease
798470|NCT00001203|Acquired Anemia|acquired anemia
798471|NCT00001202|Luteinizing Hormone|luteinizing hormone
798472|NCT00001202|High Serum Testosterone Levels|high serum testosterone levels
798473|NCT00001202|Low Baseline Gonadotropin|low baseline gonadotropin
798474|NCT00001202|LHRH|lhrh
798475|NCT00001202|Precocious Puberty|precocious puberty
798476|NCT00001202|Familial Isosexual Precocious Puberty|familial isosexual precocious puberty
798477|NCT00001201|Nerve Conduction Studies|nerve conduction studies
798478|NCT00001201|EMG|emg
798479|NCT00001201|Normal Volunteer|normal volunteer
798480|NCT00001201|Electrophysiology|electrophysiology
798481|NCT00001201|Peripheral Neuropathies|peripheral neuropathies
798482|NCT00001201|Myopathies|myopathies
798483|NCT00001198|Schizophrenia|schizophrenia
798484|NCT00001198|Observational|observational
798485|NCT00001197|Gene Expression Therapy|gene expression therapy
798486|NCT00001197|Gamma Globin Gene|gamma globin gene
798487|NCT00001197|Hemoglobin Switching|hemoglobin switching
798488|NCT00001197|Bone Marrow|bone marrow
798489|NCT00001197|Sickle Cell Anemia|sickle cell anemia
798490|NCT00001196|Salivary Function|salivary function
798491|NCT00001196|Salivary Gland|salivary gland
798492|NCT00001196|Sjogren's Syndrome|sjogren's syndrome
798493|NCT00001196|Dry Mouth|dry mouth
798494|NCT00001195|Development|development
798495|NCT00001195|Hormones|hormones
798496|NCT00001195|Growth|growth
798497|NCT00001195|Metabolism|metabolism
798498|NCT00001195|Eating Behavior|eating behavior
798499|NCT00001195|Body Composition|body composition
798500|NCT00001195|Normal Volunteer|normal volunteer
798501|NCT00001192|Executive Functions|executive functions
798502|NCT00001192|Language|language
798503|NCT00001192|Attention|attention
798504|NCT00001192|Visual-Spatial Ability|visual-spatial ability
798505|NCT00001192|Memory|memory
798506|NCT00001192|Motor Behavior|motor behavior
798507|NCT00001192|Intelligence|intelligence
798508|NCT00001192|Personality|personality
798509|NCT00001192|Visual and Auditory Functioning|visual and auditory functioning
798510|NCT00001192|Hand and Eye Dominance|hand and eye dominance
798511|NCT00001192|Normal Volunteer|normal volunteer
798512|NCT00001192|Neuropsychiatric Disorders|neuropsychiatric disorders
798513|NCT00001191|Zollinger-Ellison Syndrome|zollinger-ellison syndrome
798514|NCT00001191|Gastrinoma|gastrinoma
798515|NCT00001191|Acid Hypersecretion|acid hypersecretion
798516|NCT00001191|H+-K+ ATPase Inhibitor|h+-k+ atpase inhibitor
798517|NCT00001186|Psychosocial|psychosocial
798518|NCT00001186|Self Esteem|self esteem
798519|NCT00001186|Oncology|oncology
798520|NCT00001186|Well-Being|well-being
798521|NCT00001186|Pediatrics|pediatrics
798522|NCT00001185|Poliomyelitis|poliomyelitis
798523|NCT00001185|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
798524|NCT00001185|Motor Neurons|motor neurons
798525|NCT00001185|Late Viral Infection|late viral infection
798526|NCT00001185|Motor Neuron Firing|motor neuron firing
798527|NCT00001185|Immune Defects|immune defects
798528|NCT00001185|Post-polio Syndrome|post-polio syndrome
798529|NCT00001185|Post-polio Motor Neuron Disease|post-polio motor neuron disease
798530|NCT00001184|Inflammatory Bowel Disease|inflammatory bowel disease
798531|NCT00001184|Regional Enteritis|regional enteritis
798532|NCT00001184|Crohn's Disease|crohn's disease
798533|NCT00001184|Ulcerative Colitis|ulcerative colitis
798535|NCT00001183|Computed Tomography|computed tomography
798536|NCT00001183|Fiberoptic Bronchoscopy|fiberoptic bronchoscopy
798537|NCT00001183|Pulmonary Function Testing|pulmonary function testing
798538|NCT00001183|Cardiopulmonary Exercise Testing|cardiopulmonary exercise testing
798539|NCT00001183|Allergen Skin Testing|allergen skin testing
798540|NCT00001183|Chronic Lung Disease|chronic lung disease
798541|NCT00001182|General Dental|general dental
798542|NCT00001182|Diagnostic|diagnostic
798543|NCT00001182|Therapeutic|therapeutic
798544|NCT00001181|McCune-Albright Syndrome|mccune-albright syndrome
798545|NCT00001181|Aromatase Inhibitor|aromatase inhibitor
798546|NCT00001181|Teslac|teslac
798547|NCT00001180|Corticotropin Releasing Hormone|corticotropin releasing hormone
798548|NCT00001180|Cushing Syndrome|cushing syndrome
798549|NCT00001180|Psychiatric Hypercortisolism|psychiatric hypercortisolism
798550|NCT00001180|Adrenal Insufficiency|adrenal insufficiency
798551|NCT00001180|Normal Volunteer|normal volunteer
798552|NCT00001178|Alzheimer's Disease|alzheimer's disease
798553|NCT00001178|Cerebral Metabolism|cerebral metabolism
798554|NCT00001178|Cerebrospinal Fluid|cerebrospinal fluid
798555|NCT00001178|Dementia of the Alzheimer Type|dementia of the alzheimer type
798556|NCT00001178|18-F-Fluoro-2-Deoxy-D-Glucose (FDG)|18-f-fluoro-2-deoxy-d-glucose (fdg)
798557|NCT00001178|Magnetic Resonance Imaging|magnetic resonance imaging
798558|NCT00001178|Positron Emission Tomography|positron emission tomography
798559|NCT00001178|X-Ray Computed Tomography (CT)|x-ray computed tomography (ct)
798560|NCT00001178|Senile Dementia|senile dementia
798561|NCT00001178|Down Syndrome|down syndrome
798562|NCT00001178|Trisomy 21|trisomy 21
798563|NCT00001177|Mood|mood
798564|NCT00001177|Depression|depression
798565|NCT00001177|Cognition|cognition
798566|NCT00001177|Menstrual|menstrual
798567|NCT00001177|Neuroendocrine|neuroendocrine
798568|NCT00001177|Genetics|genetics
798569|NCT00001177|PMDD|pmdd
798570|NCT00001177|PMS Premenstrual Syndrome|pms premenstrual syndrome
798571|NCT00001177|MRMD Menstrually Related Mood Disorder|mrmd menstrually related mood disorder
798572|NCT00001176|Adrenergic Nervous System|adrenergic nervous system
798573|NCT00001176|Dopaminergic Nervous System|dopaminergic nervous system
798574|NCT00001176|Salt-Sensitive Hypertension|salt-sensitive hypertension
798575|NCT00001176|Hypertension|hypertension
798576|NCT00001176|Primary Aldosteronism|primary aldosteronism
798577|NCT00001174|Bipolar Manic-Depressive Illness|bipolar manic-depressive illness
798578|NCT00001174|Affective Disorder|affective disorder
798579|NCT00001174|Depression|depression
798580|NCT00001174|Genetic|genetic
798581|NCT00001174|DNA|dna
798582|NCT00001174|Mania|mania
798583|NCT00001174|Affected Sibling Pairs|affected sibling pairs
798584|NCT00001174|Family Study|family study
798585|NCT00001174|Genome-Wide Scan|genome-wide scan
798586|NCT00001174|Lymphoblastoid Cell Lines|lymphoblastoid cell lines
798587|NCT00001174|Diagnostic Interview for Genetic Studies (DIGS)|diagnostic interview for genetic studies (digs)
798588|NCT00001174|Panic Disorder|panic disorder
798589|NCT00001174|Bipolar Disorder|bipolar disorder
798590|NCT00001172|Vision|vision
798591|NCT00001172|Eye Movement|eye movement
798592|NCT00001172|Perception|perception
798593|NCT00001172|Healthy Volunteer|healthy volunteer
798594|NCT00001171|Brain Tumors|brain tumors
798595|NCT00001171|Glioma|glioma
798596|NCT00001171|Glioblastoma Multiforme|glioblastoma multiforme
798597|NCT00001171|Pituitary Adenoma|pituitary adenoma
798598|NCT00001170|Parental Psychopathology|parental psychopathology
798599|NCT00001170|Child Rearing|child rearing
798600|NCT00001170|Depression|depression
798601|NCT00001170|Bipolar Affective Disorders|bipolar affective disorders
798602|NCT00001170|Manic-Depression|manic-depression
798603|NCT00001170|Social-Emotional Development|social-emotional development
798604|NCT00001170|Cognitive Development|cognitive development
798605|NCT00001170|Child Psychopathology|child psychopathology
798606|NCT00001170|Affective Disorder|affective disorder
798607|NCT00001170|Children at Risk|children at risk
798608|NCT00001168|Dyslipoproteinemia|dyslipoproteinemia
798609|NCT00001168|Hypercholesterolemia|hypercholesterolemia
798610|NCT00001168|Hypertriglyceridemia|hypertriglyceridemia
798611|NCT00001168|hypoalphalipoproteinemia|hypoalphalipoproteinemia
798612|NCT00001168|Atherosclerosis|atherosclerosis
798613|NCT00001168|Type III Hyperlipoproteinemia|type iii hyperlipoproteinemia
798614|NCT00001168|Plasma Lipoproteins|plasma lipoproteins
798615|NCT00001167|Dysphagia|dysphagia
798616|NCT00001167|Dysarthria|dysarthria
798617|NCT00001167|Tongue Motion|tongue motion
798618|NCT00001167|Xerostomia|xerostomia
798619|NCT00001167|Swallowing|swallowing
798620|NCT00001167|Speech|speech
798621|NCT00001167|Polymyositis|polymyositis
798622|NCT00001167|Speech Disorders|speech disorders
798623|NCT00001167|Oral-Facial Paralysis|oral-facial paralysis
798624|NCT00001167|Ultrasound|ultrasound
798625|NCT00001166|Hyperornithinemia|hyperornithinemia
798626|NCT00001166|Ornithine-Aminotransferase (OAT)|ornithine-aminotransferase (oat)
798627|NCT00001166|Tissue Culture|tissue culture
798628|NCT00001166|Pyridoxine Hydrochloride|pyridoxine hydrochloride
798629|NCT00001166|Pyridoxal Phosphate|pyridoxal phosphate
798630|NCT00001166|Arginine|arginine
798631|NCT00001166|Skin Fibroblast|skin fibroblast
798632|NCT00001166|Gyrate Atrophy|gyrate atrophy
798633|NCT00001166|Autosomal Recessive Retinitis Pigmentosa|autosomal recessive retinitis pigmentosa
798634|NCT00001166|Bietti's Crystalline Retinopathy|bietti's crystalline retinopathy
798635|NCT00001166|Chorioretinal Degeneration|chorioretinal degeneration
798636|NCT00001165|Gastrinoma|gastrinoma
798637|NCT00001165|Acid Secretion|acid secretion
798638|NCT00001165|Toxicity|toxicity
798639|NCT00001163|Cancer|cancer
798640|NCT00001163|Genes/Genetics|genes/genetics
798641|NCT00001163|Hereditary Neoplasms|hereditary neoplasms
798642|NCT00001163|Environment|environment
798643|NCT00001162|Giardia|giardia
798644|NCT00001162|Helminth|helminth
798645|NCT00001162|Cryptosporidium|cryptosporidium
798646|NCT00001162|Hookworms|hookworms
798647|NCT00001162|Trichuris|trichuris
798648|NCT00001162|Strongyloides|strongyloides
798649|NCT00001162|Protozoa|protozoa
798650|NCT00001162|Small Bowel Biopsy|small bowel biopsy
798651|NCT00001162|E. Histolytica|e. histolytica
798652|NCT00001162|Duodenal Aspiration|duodenal aspiration
798653|NCT00001162|Coccidiosis|coccidiosis
798654|NCT00001162|Clonorchis|clonorchis
798655|NCT00001162|Amebiasis|amebiasis
798656|NCT00001162|Parasitic Disease|parasitic disease
798657|NCT00001162|Tapeworm|tapeworm
798658|NCT00001162|Trichinosis|trichinosis
798659|NCT00001162|Gastrointestinal Trematodes|gastrointestinal trematodes
798660|NCT00001162|Opisthorchis|opisthorchis
798661|NCT00001162|Paragonimiasis|paragonimiasis
798662|NCT00001162|Echinococcus|echinococcus
798663|NCT00001161|Irido Corneal Angle|irido corneal angle
798664|NCT00001161|Mesothelium|mesothelium
798665|NCT00001161|Congenital Anomalies|congenital anomalies
798666|NCT00001161|Neural Crest|neural crest
798667|NCT00001161|Increased Intraocular Pressure|increased intraocular pressure
798668|NCT00001161|Glaucoma|glaucoma
798669|NCT00001161|Axenfeld's Syndrome|axenfeld's syndrome
798670|NCT00001161|Rieger's Anomaly|rieger's anomaly
798671|NCT00001161|Peter's Anomaly|peter's anomaly
798672|NCT00001161|Iridocorneal Endothelial Syndrome|iridocorneal endothelial syndrome
798673|NCT00001161|Aniridia|aniridia
798674|NCT00001161|Pigment Dispersion Syndrome|pigment dispersion syndrome
798675|NCT00001161|Megalocornea|megalocornea
798676|NCT00001160|Thyroid Fine Needle Biopsy|thyroid fine needle biopsy
798677|NCT00001160|Radioiodine|radioiodine
798678|NCT00001160|Dosimetry|dosimetry
798679|NCT00001159|Hyperthyroidism|hyperthyroidism
798680|NCT00001159|Hypothyroidism|hypothyroidism
798681|NCT00001159|Thyroid-Stimulating Hormone Secreting Pituitary Adenomas|thyroid-stimulating hormone secreting pituitary adenomas
798682|NCT00001156|Immunogenetics|immunogenetics
798683|NCT00001156|Tropical Spastic Paraplegia|tropical spastic paraplegia
798684|NCT00001156|Twins|twins
798685|NCT00001156|Epstein-Barr Virus|epstein-barr virus
798686|NCT00001156|HTLV-I|htlv-i
798687|NCT00001156|Vasculitis|vasculitis
798688|NCT00001156|Cerebrospinal Fluid|cerebrospinal fluid
798689|NCT00001156|Immunity to Viruses|immunity to viruses
798690|NCT00001156|Multiple Sclerosis|multiple sclerosis
798691|NCT00001156|Magnetic Resonance Imaging|magnetic resonance imaging
798692|NCT00001155|Vasculitis|vasculitis
798693|NCT00001155|Prednisone|prednisone
798694|NCT00001155|Granuloma|granuloma
798695|NCT00001155|Wegener's Granulomatosis|wegener's granulomatosis
798696|NCT00001155|Cyclophosphamide|cyclophosphamide
798697|NCT00001155|Renal Biopsy|renal biopsy
798698|NCT00001154|Cholesterol|cholesterol
798699|NCT00001154|Apolipoproteins|apolipoproteins
798700|NCT00001154|Kinetics|kinetics
798701|NCT00001151|Calciferol|calciferol
798702|NCT00001151|Hypocalcemia|hypocalcemia
798703|NCT00001151|Rickets|rickets
798704|NCT00001150|Blister Formation|blister formation
798705|NCT00001150|Inflammatory Mediator Assay|inflammatory mediator assay
798706|NCT00001150|Ultraviolet Radiation|ultraviolet radiation
798707|NCT00001149|Anticonvulsants|anticonvulsants
798708|NCT00001149|Intensive Monitoring|intensive monitoring
798709|NCT00001149|Epilepsy|epilepsy
798710|NCT00001148|Metastasis|metastasis
798711|NCT00001148|Glioma|glioma
798712|NCT00001148|Venous|venous
798713|NCT00001148|Sampling|sampling
798714|NCT00001148|p53 Mutation|p53 mutation
798715|NCT00001148|Glioblastoma Multiforme|glioblastoma multiforme
798716|NCT00001148|Circulating Tumor Cells|circulating tumor cells
798717|NCT00001148|Mutation|mutation
798718|NCT00001148|Anaplastic Astrocytoma|anaplastic astrocytoma
798719|NCT00001147|Dopamine|dopamine
798720|NCT00001147|Metanephrine|metanephrine
798721|NCT00001147|Norepinephrine|norepinephrine
798722|NCT00001147|Epinephrine|epinephrine
798723|NCT00001147|Catecholamines|catecholamines
798724|NCT00001147|Tyrosine Hydroxylase|tyrosine hydroxylase
798725|NCT00001147|Monoamine Oxidase|monoamine oxidase
798726|NCT00001147|Phenosulfotransferase|phenosulfotransferase
798727|NCT00001147|Sympathetic Nervous System|sympathetic nervous system
798728|NCT00001147|Normetanephrine|normetanephrine
798729|NCT00001146|Bipolar Disorder|bipolar disorder
798730|NCT00001146|Clinical Trial|clinical trial
798731|NCT00001146|Eicosapentaenoic Ethyl Ester|eicosapentaenoic ethyl ester
798732|NCT00001146|Life Chart Methodology|life chart methodology
798733|NCT00001146|Mood Disorders|mood disorders
798734|NCT00001146|Omega-3 Fatty Acid|omega-3 fatty acid
798735|NCT00001146|Rapid Cycling|rapid cycling
798736|NCT00001146|Treatment|treatment
798737|NCT00001145|Primary Immunodeficiency|primary immunodeficiency
798738|NCT00001145|Gamma Globulin (IgG) Immunization|gamma globulin (igg) immunization
798740|NCT00001145|Phi-X 174|phi-x 174
798741|NCT00001145|X-linked HyperIgM Syndrome|x-linked hyperigm syndrome
798742|NCT00001144|Peripheral Blood Stem Cells|peripheral blood stem cells
798743|NCT00001144|Engraftment|engraftment
798744|NCT00001144|Graft vs. Host Disease|graft vs. host disease
798745|NCT00001144|Graft-Versus-Leukemia|graft-versus-leukemia
798746|NCT00001144|Graft-Versus-Tumor/Melanoma|graft-versus-tumor/melanoma
798747|NCT00001144|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
798748|NCT00001143|Eye Movements|eye movements
798749|NCT00001143|Strabismus|strabismus
798750|NCT00001143|Infants|infants
798751|NCT00001143|Development|development
798752|NCT00001143|Ocular Motor System|ocular motor system
798753|NCT00000426|Calcium deficiency|calcium deficiency
798754|NCT00000426|Dietary calcium|dietary calcium
798755|NCT00000426|Dietary protein|dietary protein
798756|NCT00000426|Osteoporosis|osteoporosis
798757|NCT00000426|Calcium supplement|calcium supplement
798758|NCT00000426|Bone density|bone density
798759|NCT00000426|Bone mass|bone mass
798760|NCT00000426|Bone mass accumulation|bone mass accumulation
798761|NCT00000425|Osteoarthritis|osteoarthritis
798762|NCT00000425|Skeletal disorder|skeletal disorder
798763|NCT00000425|Chemotherapy|chemotherapy
798764|NCT00000425|Nonsteroidal anti-inflammatory drugs (NSAIDs)|nonsteroidal anti-inflammatory drugs (nsaids)
798765|NCT00000425|Arthroplasty|arthroplasty
798766|NCT00000425|Cartilage metabolism|cartilage metabolism
798767|NCT00000425|Hip|hip
798768|NCT00000425|Knee|knee
798769|NCT00000425|Outcomes research|outcomes research
798770|NCT00000424|Osteoarthritis (OA)|osteoarthritis (oa)
798771|NCT00000424|Knee|knee
798772|NCT00000424|Sham lavage|sham lavage
798773|NCT00000424|Tidal lavage|tidal lavage
798774|NCT00000424|Lavage therapy|lavage therapy
798775|NCT00000424|Nonsteroidal anti-inflammatory drug (NSAID)|nonsteroidal anti-inflammatory drug (nsaid)
798776|NCT00000424|Placebo|placebo
798777|NCT00000424|Radiography|radiography
798778|NCT00000424|Human therapy evaluation|human therapy evaluation
798779|NCT00000424|WOMAC|womac
798780|NCT00000423|Fibromyalgia|fibromyalgia
798781|NCT00000423|Health education|health education
798782|NCT00000423|Program evaluation|program evaluation
798783|NCT00000423|Social support|social support
798784|NCT00000423|Managed care|managed care
798785|NCT00000423|Quality of well-being|quality of well-being
798786|NCT00000422|Fibromyalgia Syndrome (FMS)|fibromyalgia syndrome (fms)
798787|NCT00000422|Physical therapy|physical therapy
798788|NCT00000422|Psychotherapy|psychotherapy
798789|NCT00000422|Group counseling|group counseling
798790|NCT00000422|Human therapy relations|human therapy relations
798791|NCT00000422|Interpersonal relations|interpersonal relations
798792|NCT00000422|Chronic pain|chronic pain
798793|NCT00000422|Cognition|cognition
798794|NCT00000422|Emotion|emotion
798795|NCT00000422|Memory|memory
798796|NCT00000422|Musculoskeletal disorder|musculoskeletal disorder
798797|NCT00000422|Psychological stressor|psychological stressor
798798|NCT00000422|Psychological adaptation|psychological adaptation
798799|NCT00000422|Outcomes research|outcomes research
798800|NCT00000421|SLE|sle
798801|NCT00000421|Lupus|lupus
798802|NCT00000421|Anti-double-stranded DNA antibody|anti-double-stranded dna antibody
798803|NCT00000421|Corticosteroid treatment|corticosteroid treatment
798804|NCT00000421|Hormone therapy|hormone therapy
798805|NCT00000421|Complement|complement
798806|NCT00000421|Hypertension|hypertension
798807|NCT00000421|Estrogen|estrogen
798808|NCT00000421|SELENA|selena
798809|NCT00000420|SLE|sle
798810|NCT00000420|SELENA|selena
798811|NCT00000420|Oral contraceptives|oral contraceptives
798812|NCT00000420|The pill|the pill
798813|NCT00000420|Birth control|birth control
798814|NCT00000420|Condom|condom
798815|NCT00000420|Diaphragm|diaphragm
798816|NCT00000420|Estrogen|estrogen
798817|NCT00000420|Lupus|lupus
798818|NCT00000420|Placebo|placebo
798819|NCT00000419|SLE|sle
798820|NCT00000419|SELENA|selena
798821|NCT00000419|Estrogen Replacement Therapy (ERT)|estrogen replacement therapy (ert)
798822|NCT00000419|Postmenopause|postmenopause
798823|NCT00000419|Osteoporosis|osteoporosis
798824|NCT00000419|Estrogens|estrogens
798825|NCT00000419|Steroids|steroids
798826|NCT00000419|Progestin|progestin
798827|NCT00000419|Placebo|placebo
798828|NCT00000418|OA|oa
798829|NCT00000418|Patient education|patient education
798830|NCT00000418|Acute low back pain (ALBP)|acute low back pain (albp)
798831|NCT00000418|Social support systems|social support systems
798832|NCT00000417|SLE|sle
798833|NCT00000417|Lupus|lupus
798834|NCT00000417|Educational intervention|educational intervention
798835|NCT00000417|Health education|health education
798836|NCT00000417|Social support network|social support network
798837|NCT00000417|Outcomes research|outcomes research
798838|NCT00000417|Self-help|self-help
798839|NCT00000416|Arthritis|arthritis
798840|NCT00000416|Rheumatic disorders|rheumatic disorders
798841|NCT00000416|Work-related disability|work-related disability
798842|NCT00000416|Vocational rehabilitation (VR)|vocational rehabilitation (vr)
798843|NCT00000416|Job retention services|job retention services
798844|NCT00000416|Work limitations|work limitations
798845|NCT00000416|Work instability|work instability
798846|NCT00000415|Calcium|calcium
798847|NCT00000415|Physical activity|physical activity
798848|NCT00000415|Children|children
798849|NCT00000415|Bone mass accretion|bone mass accretion
798850|NCT00000415|Bone mineral density (BMD)|bone mineral density (bmd)
798851|NCT00000415|Bone response to activity and calcium supplements|bone response to activity and calcium supplements
798852|NCT00000415|Placebo|placebo
798853|NCT00000415|Bone growth|bone growth
798854|NCT00000414|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
798855|NCT00000414|Osteoarthritis (OA)|osteoarthritis (oa)
798856|NCT00000414|Arthritis education|arthritis education
798857|NCT00000414|Health care service evaluation|health care service evaluation
798858|NCT00000414|Outcomes research|outcomes research
798859|NCT00000414|Arthritis Self-Management Program (ASMP)|arthritis self-management program (asmp)
798860|NCT00000414|Self-Managed Arthritis Relief Therapy (SMART) Program|self-managed arthritis relief therapy (smart) program
798861|NCT00000413|Osteoporosis prevention|osteoporosis prevention
798862|NCT00000413|Behavioral/educational intervention|behavioral/educational intervention
798863|NCT00000413|Preadolescent|preadolescent
798864|NCT00000413|Calcium|calcium
798865|NCT00000413|Exercise|exercise
798866|NCT00000413|Peak bone mass|peak bone mass
798867|NCT00000413|Bone density|bone density
798868|NCT00000412|Osteoporosis|osteoporosis
798869|NCT00000412|Osteopenia|osteopenia
798870|NCT00000412|Heart transplant|heart transplant
798871|NCT00000412|Bone fracture|bone fracture
798872|NCT00000412|Bone density|bone density
798873|NCT00000412|Dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
798874|NCT00000411|Spinal stenosis (SpS)|spinal stenosis (sps)
798875|NCT00000411|Intervertebral disc herniation (IDH)|intervertebral disc herniation (idh)
798876|NCT00000411|Degenerative spondylolisthesis (DS)|degenerative spondylolisthesis (ds)
798877|NCT00000411|Low back pain (LBP)|low back pain (lbp)
798878|NCT00000411|Surgical therapy|surgical therapy
798879|NCT00000411|Nonsurgical therapy|nonsurgical therapy
798880|NCT00000411|Randomized study|randomized study
798881|NCT00000411|Multicenter|multicenter
798882|NCT00000411|MRI|mri
798883|NCT00000410|Intervertebral disc herniation (IDH)|intervertebral disc herniation (idh)
798884|NCT00000410|Stenosis with degenerative spondylolisthesis (DS)|stenosis with degenerative spondylolisthesis (ds)
798885|NCT00000410|Spinal stenosis (SpS)|spinal stenosis (sps)
798886|NCT00000410|Low back pain (LBP)|low back pain (lbp)
798887|NCT00000410|Leg pain|leg pain
798888|NCT00000410|Surgical therapy|surgical therapy
798889|NCT00000410|Non-surgical therapy|non-surgical therapy
798890|NCT00000410|Randomized study|randomized study
798891|NCT00000410|Multicenter|multicenter
798892|NCT00000410|MRI|mri
798893|NCT00000409|Intervertebral disc herniation (IDH)|intervertebral disc herniation (idh)
798894|NCT00000409|Degenerative spondylolisthesis (DS)|degenerative spondylolisthesis (ds)
798895|NCT00000409|Spinal stenosis (SpS)|spinal stenosis (sps)
798896|NCT00000409|Low back pain (LBP)|low back pain (lbp)
798897|NCT00000409|Leg pain|leg pain
798898|NCT00000409|Surgical therapy|surgical therapy
798899|NCT00000409|Randomized study|randomized study
798900|NCT00000409|Multicenter|multicenter
798901|NCT00000409|MRI|mri
798902|NCT00000409|Nonsurgical therapy|nonsurgical therapy
798903|NCT00000408|Health education|health education
798904|NCT00000408|Back injury|back injury
798905|NCT00000408|Chronic pain|chronic pain
798906|NCT00000408|Education/evaluation planning|education/evaluation planning
798907|NCT00000408|Outcomes research|outcomes research
798908|NCT00000407|Arthritis and related musculoskeletal disorders (ARMD)|arthritis and related musculoskeletal disorders (armd)
798909|NCT00000407|Vocational rehabilitation (VR)|vocational rehabilitation (vr)
798910|NCT00000407|Agency enhancement intervention|agency enhancement intervention
798911|NCT00000407|Health care service evaluation|health care service evaluation
798912|NCT00000407|Musculoskeletal disability|musculoskeletal disability
798913|NCT00000407|Return to work|return to work
798914|NCT00000407|Outcomes research|outcomes research
798915|NCT00000407|Unemployment|unemployment
798916|NCT00000407|Work disability|work disability
798917|NCT00000406|Osteoarthritis (OA)|osteoarthritis (oa)
798918|NCT00000406|Knee|knee
798919|NCT00000406|Radiographic OA|radiographic oa
798920|NCT00000406|Strength training|strength training
798921|NCT00000406|Physical therapy|physical therapy
798922|NCT00000406|Exercise|exercise
798923|NCT00000406|Body composition|body composition
798924|NCT00000406|Striated muscle|striated muscle
798925|NCT00000406|Depression|depression
798926|NCT00000406|Radiographic OA with knee pain|radiographic oa with knee pain
798927|NCT00000406|Radiographic OA without knee pain|radiographic oa without knee pain
798928|NCT00000406|Knee pain without radiographic OA|knee pain without radiographic oa
798929|NCT00000406|Normal elderly (no radiographic OA, no knee pain)|normal elderly (no radiographic oa, no knee pain)
798930|NCT00000405|Osteoporosis|osteoporosis
798931|NCT00000405|Bone fractures|bone fractures
798932|NCT00000405|Bone mass|bone mass
798933|NCT00000405|Bone mineral density (BMD)|bone mineral density (bmd)
798934|NCT00000405|Ossification|ossification
798935|NCT00000405|Biomechanics|biomechanics
798936|NCT00000405|Exercise|exercise
798937|NCT00000405|Diet|diet
798938|NCT00000405|Spine|spine
798939|NCT00000405|Middle childhood (6-11)|middle childhood (6-11)
798940|NCT00000404|Osteoarthritis (OA)|osteoarthritis (oa)
798941|NCT00000404|Knee|knee
798942|NCT00000404|HMO|hmo
798943|NCT00000404|Comprehensive care|comprehensive care
798944|NCT00000403|Osteoarthritis (OA)|osteoarthritis (oa)
798945|NCT00000403|Knee|knee
798946|NCT00000403|Doxycycline|doxycycline
798947|NCT00000403|Skeletal disorder|skeletal disorder
798948|NCT00000403|Placebo|placebo
798949|NCT00000403|Urinalysis|urinalysis
798950|NCT00000403|NSAIDs|nsaids
798951|NCT00000403|Joint space narrowing (JSN)|joint space narrowing (jsn)
798952|NCT00000403|WOMAC|womac
798953|NCT00000402|Osteoporosis|osteoporosis
798954|NCT00000402|Dietary calcium|dietary calcium
798955|NCT00000402|Puberty|puberty
798956|NCT00000402|Bone density|bone density
798957|NCT00000402|Bone mass|bone mass
798958|NCT00000402|Primary prevention of osteoporosis|primary prevention of osteoporosis
798959|NCT00000401|NSAIDs|nsaids
798960|NCT00000401|Oral Tolerance|oral tolerance
798961|NCT00000401|Drug Interaction|drug interaction
798962|NCT00000401|Oral Administration|oral administration
798963|NCT00000401|Interleukin 10|interleukin 10
798964|NCT00000401|Collagen|collagen
798965|NCT00000401|Chemotherapy|chemotherapy
798966|NCT00000401|Human Therapy Evaluation|human therapy evaluation
798967|NCT00000401|DMARDs|dmards
798968|NCT00000401|RA|ra
798969|NCT00000401|IL-10|il-10
798970|NCT00000400|Osteoporosis|osteoporosis
798971|NCT00000400|Bone formation|bone formation
798972|NCT00000400|Bone resorption|bone resorption
798973|NCT00000400|Parathyroid hormone (PTH)|parathyroid hormone (pth)
798974|NCT00000400|Postmenopause|postmenopause
798975|NCT00000399|Estrogen|estrogen
798976|NCT00000399|Hormone therapy|hormone therapy
798977|NCT00000399|Strength training|strength training
798978|NCT00000399|Exercise|exercise
798979|NCT00000399|Postmenopause|postmenopause
798980|NCT00000399|Disorder prevention|disorder prevention
798981|NCT00000399|Osteoporosis|osteoporosis
798982|NCT00000399|Bone mineral density|bone mineral density
798983|NCT00000399|Bone mass|bone mass
798984|NCT00000399|Cholesterol|cholesterol
798985|NCT00000399|Body composition|body composition
798986|NCT00000398|Fibromyalgia|fibromyalgia
798987|NCT00000398|Pain|pain
798988|NCT00000398|Coping skills training|coping skills training
798989|NCT00000398|Physical exercise training|physical exercise training
798990|NCT00000398|Combined coping skills training and exercise training|combined coping skills training and exercise training
798991|NCT00000397|Fibromyalgia|fibromyalgia
798992|NCT00000397|Insomnia|insomnia
798993|NCT00000397|Cognitive-behavioral therapy (CBT)|cognitive-behavioral therapy (cbt)
798994|NCT00000397|Behavioral insomnia therapy|behavioral insomnia therapy
798995|NCT00000396|Arthritis|arthritis
798996|NCT00000396|Arthritis education|arthritis education
798997|NCT00000396|African Americans|african americans
798998|NCT00000396|Self-help|self-help
798999|NCT00000396|Self-management|self-management
799000|NCT00000396|Cultural beliefs|cultural beliefs
799001|NCT00000395|Rheumatoid arthritis|rheumatoid arthritis
799002|NCT00000395|Lewis rat adjuvant arthritis|lewis rat adjuvant arthritis
799003|NCT00000395|Antifolate efficacy|antifolate efficacy
799004|NCT00000395|Autoimmunity|autoimmunity
799005|NCT00000395|Adenosine metabolism|adenosine metabolism
799006|NCT00000395|Methotrexate therapy|methotrexate therapy
799007|NCT00000395|Skeletal disorder|skeletal disorder
799008|NCT00000395|Dietary supplement|dietary supplement
799009|NCT00000395|Antiarthritic agent|antiarthritic agent
799010|NCT00000395|Folic acid|folic acid
799011|NCT00000394|Carpal tunnel syndrome|carpal tunnel syndrome
799012|NCT00000394|Acupuncture|acupuncture
799013|NCT00000394|Median nerve|median nerve
799014|NCT00000394|Single-blind mute methodology|single-blind mute methodology
799015|NCT00000104|lead overburden|lead overburden
799016|NCT00000456|Alcoholism|alcoholism
799017|NCT00000456|Alcohol Dependence|alcohol dependence
799018|NCT00000456|Naltrexone|naltrexone
799019|NCT00000456|Cognitive Behavioral Therapy|cognitive behavioral therapy
799020|NCT00000451|Alcoholism|alcoholism
799021|NCT00000451|Alcohol Dependence|alcohol dependence
799022|NCT00000389|Adolescence|adolescence
799023|NCT00000389|Anxiety Disorders|anxiety disorders
799024|NCT00000389|Child|child
799025|NCT00000389|Female|female
799026|NCT00000389|Fluvoxamine|fluvoxamine
799027|NCT00000389|Human|human
799028|NCT00000389|Male|male
799029|NCT00000389|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
799030|NCT00000389|Anxiety Disorders -- *drug therapy|anxiety disorders -- *drug therapy
799031|NCT00000389|Fluvoxamine -- *therapeutic use|fluvoxamine -- *therapeutic use
799032|NCT00000389|Serotonin Uptake Inhibitors -- *therapeutic use|serotonin uptake inhibitors -- *therapeutic use
799033|NCT00000388|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
799034|NCT00000388|Adolescence|adolescence
799035|NCT00000388|Child|child
799036|NCT00000388|Cognition|cognition
799037|NCT00000388|Combined Modality Therapy|combined modality therapy
799038|NCT00000388|Female|female
799039|NCT00000388|Human|human
799040|NCT00000388|Male|male
799041|NCT00000388|Peer Group|peer group
799042|NCT00000388|Risk Factors|risk factors
799043|NCT00000388|Treatment Outcome|treatment outcome
799044|NCT00000388|Attention Deficit Disorder with Hyperactivity -- *therapy|attention deficit disorder with hyperactivity -- *therapy
799045|NCT00000388|Attention Deficit Disorder with Hyperactivity -- drug therapy|attention deficit disorder with hyperactivity -- drug therapy
799046|NCT00000388|Attention Deficit Disorder with Hyperactivity -- psychology|attention deficit disorder with hyperactivity -- psychology
799047|NCT00000387|Adolescence|adolescence
799048|NCT00000387|Family|family
799049|NCT00000387|Female|female
799050|NCT00000387|Human|human
799051|NCT00000387|Male|male
799052|NCT00000387|Schizophrenia|schizophrenia
799053|NCT00000387|Self Care|self care
799054|NCT00000387|Community Health Services|community health services
799055|NCT00000386|Adolescence|adolescence
799056|NCT00000386|Child|child
799057|NCT00000386|Comparative Study|comparative study
799058|NCT00000386|Family|family
799059|NCT00000386|Female|female
799060|NCT00000386|Human|human
799061|NCT00000386|Male|male
799062|NCT00000386|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
799063|NCT00000386|Relaxation Techniques|relaxation techniques
799064|NCT00000386|Obsessive-Compulsive Disorder -- *therapy|obsessive-compulsive disorder -- *therapy
799065|NCT00000385|Aggressive conduct disorder|aggressive conduct disorder
799066|NCT00000385|Adolescence|adolescence
799067|NCT00000385|Child|child
799068|NCT00000385|Conduct Disorder|conduct disorder
799069|NCT00000385|Female|female
799070|NCT00000385|Lithium|lithium
799071|NCT00000385|Male|male
799072|NCT00000385|Placebos|placebos
799073|NCT00000385|Conduct Disorder -- *drug therapy|conduct disorder -- *drug therapy
799074|NCT00000385|Lithium -- *therapeutic use|lithium -- *therapeutic use
799075|NCT00000384|Adolescence|adolescence
799076|NCT00000384|Child|child
799077|NCT00000384|Cognitive Therapy|cognitive therapy
799078|NCT00000384|Combined Modality Therapy|combined modality therapy
799079|NCT00000384|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
799080|NCT00000384|Placebos|placebos
799081|NCT00000384|Sertraline|sertraline
799082|NCT00000384|Patient Education|patient education
799083|NCT00000384|Psychotherapy|psychotherapy
799084|NCT00000383|Adolescence|adolescence
799085|NCT00000383|Child|child
799086|NCT00000383|Cognitive Therapy|cognitive therapy
799087|NCT00000383|Comparative Study|comparative study
799088|NCT00000383|Female|female
799089|NCT00000383|Human|human
799090|NCT00000383|Male|male
799091|NCT00000383|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
799092|NCT00000383|Child Abuse, Sexual|child abuse, sexual
799093|NCT00000383|Stress Disorders, Post-Traumatic -- *therapy|stress disorders, post-traumatic -- *therapy
799094|NCT00000383|Child Abuse, Sexual -- *psychology|child abuse, sexual -- *psychology
799095|NCT00000382|Child Abuse|child abuse
799096|NCT00000382|Female|female
799097|NCT00000382|Human|human
799098|NCT00000382|Infant|infant
799099|NCT00000382|Male|male
799100|NCT00000382|Caregivers|caregivers
799101|NCT00000382|Patient Education|patient education
799102|NCT00000382|Psychotherapy|psychotherapy
799103|NCT00000382|Child Abuse -- *prevention & control|child abuse -- *prevention & control
799104|NCT00000381|Adolescence|adolescence
799105|NCT00000381|Anxiety Disorders|anxiety disorders
799106|NCT00000381|Child|child
799107|NCT00000381|Female|female
799108|NCT00000381|Fluoxetine|fluoxetine
799109|NCT00000381|Male|male
799110|NCT00000381|Placebos|placebos
799111|NCT00000381|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
799112|NCT00000381|Anxiety Disorders -- *drug therapy|anxiety disorders -- *drug therapy
799113|NCT00000381|Fluoxetine -- *therapeutic use|fluoxetine -- *therapeutic use
799114|NCT00000381|Serotonin Uptake Inhibitors -- *therapeutic use|serotonin uptake inhibitors -- *therapeutic use
799115|NCT00000380|Adult|adult
799116|NCT00000380|Estrogen Replacement Therapy|estrogen replacement therapy
799117|NCT00000380|Female|female
799118|NCT00000380|Hormone Replacement Therapy|hormone replacement therapy
799119|NCT00000380|Human|human
799120|NCT00000380|Insulin-Like Growth Factor I|insulin-like growth factor i
799121|NCT00000380|Male|male
799122|NCT00000380|Placebos|placebos
799123|NCT00000380|Sleep Disorders|sleep disorders
799124|NCT00000380|Somatotropin-Releasing Hormone|somatotropin-releasing hormone
799125|NCT00000380|Somatotropin|somatotropin
799126|NCT00000380|Insulin-Like Growth Factor I -- secretion|insulin-like growth factor i -- secretion
799127|NCT00000380|Sleep Disorders -- *drug therapy|sleep disorders -- *drug therapy
799128|NCT00000380|Somatotropin-Releasing Hormone -- *therapeutic use|somatotropin-releasing hormone -- *therapeutic use
799129|NCT00000380|Somatotropin -- secretion|somatotropin -- secretion
799130|NCT00000379|Adult|adult
799131|NCT00000379|Comparative Study|comparative study
799132|NCT00000379|Desensitization, Psychologic|desensitization, psychologic
799133|NCT00000379|Eye Movements|eye movements
799134|NCT00000379|Female|female
799135|NCT00000379|Fluoxetine|fluoxetine
799136|NCT00000379|Human|human
799137|NCT00000379|Male|male
799138|NCT00000379|Placebos|placebos
799139|NCT00000379|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
799140|NCT00000379|Treatment Outcome|treatment outcome
799141|NCT00000379|Desensitization, Psychologic -- *methods|desensitization, psychologic -- *methods
799142|NCT00000379|Fluoxetine -- *therapeutic use|fluoxetine -- *therapeutic use
799143|NCT00000379|Stress Disorders, Post-Traumatic -- *therapy|stress disorders, post-traumatic -- *therapy
799144|NCT00000379|Stress Disorders, Post-Traumatic -- drug therapy|stress disorders, post-traumatic -- drug therapy
799145|NCT00000378|Aged|aged
799146|NCT00000378|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic
799147|NCT00000378|Depression|depression
799148|NCT00000378|Female|female
799149|NCT00000378|Human|human
799150|NCT00000378|Male|male
799151|NCT00000378|Middle Age|middle age
799152|NCT00000378|Nortriptyline|nortriptyline
799153|NCT00000378|Sertraline|sertraline
799154|NCT00000378|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
799155|NCT00000378|Antidepressive Agents, Tricyclic -- *therapeutic use|antidepressive agents, tricyclic -- *therapeutic use
799156|NCT00000378|Antidepressive Agents, Tricyclic -- adverse effects|antidepressive agents, tricyclic -- adverse effects
799157|NCT00000378|Depression -- *drug therapy|depression -- *drug therapy
799158|NCT00000378|Nortriptyline -- *therapeutic use|nortriptyline -- *therapeutic use
799159|NCT00000378|Nortriptyline -- adverse effects|nortriptyline -- adverse effects
799160|NCT00000378|Sertraline -- *therapeutic use|sertraline -- *therapeutic use
799161|NCT00000378|Sertraline -- adverse effects|sertraline -- adverse effects
799162|NCT00000378|Serotonin Uptake Inhibitors -- *therapeutic use|serotonin uptake inhibitors -- *therapeutic use
799163|NCT00000378|Serotonin Uptake Inhibitors -- adverse effects|serotonin uptake inhibitors -- adverse effects
799164|NCT00000377|Aged|aged
799165|NCT00000377|Antidepressive Agents|antidepressive agents
799166|NCT00000377|Depression|depression
799167|NCT00000377|Dose-Response Relationship, Drug|dose-response relationship, drug
799168|NCT00000377|Female|female
799169|NCT00000377|Human|human
799170|NCT00000377|Male|male
799171|NCT00000377|Middle Age|middle age
799172|NCT00000377|Nortriptyline|nortriptyline
799173|NCT00000377|Placebos|placebos
799174|NCT00000377|Recurrence|recurrence
799175|NCT00000377|Aged, 80 and over|aged, 80 and over
799176|NCT00000377|Antidepressive Agents -- *therapeutic use|antidepressive agents -- *therapeutic use
799177|NCT00000377|Antidepressive Agents -- administration & dosage|antidepressive agents -- administration & dosage
799178|NCT00000377|Depression -- *drug therapy|depression -- *drug therapy
799179|NCT00000377|Nortriptyline -- *therapeutic use|nortriptyline -- *therapeutic use
799180|NCT00000377|Nortriptyline -- administration & dosage|nortriptyline -- administration & dosage
799181|NCT00000376|Adult|adult
799182|NCT00000376|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic
799183|NCT00000376|Anxiety Disorders|anxiety disorders
799184|NCT00000376|Cognitive Therapy|cognitive therapy
799185|NCT00000376|Combined Modality Therapy|combined modality therapy
799186|NCT00000376|Depression|depression
799187|NCT00000376|Desipramine|desipramine
799188|NCT00000376|Female|female
799189|NCT00000376|Human|human
799190|NCT00000376|Male|male
799191|NCT00000376|Personality Disorders|personality disorders
799192|NCT00000376|Pilot Projects|pilot projects
799193|NCT00000376|Patient Care Team|patient care team
799194|NCT00000376|Antidepressive Agents, Tricyclic -- *therapeutic use|antidepressive agents, tricyclic -- *therapeutic use
799195|NCT00000376|Depression -- *therapy|depression -- *therapy
799196|NCT00000376|Depression -- drug therapy|depression -- drug therapy
799197|NCT00000376|Desipramine -- *therapeutic use|desipramine -- *therapeutic use
799198|NCT00000375|Adult|adult
799199|NCT00000375|Antidepressive Agents|antidepressive agents
799200|NCT00000375|Depressive Disorder|depressive disorder
799201|NCT00000375|Electroconvulsive Therapy|electroconvulsive therapy
799202|NCT00000375|Female|female
799203|NCT00000375|Human|human
799204|NCT00000375|Lithium|lithium
799205|NCT00000375|Male|male
799206|NCT00000375|Nortriptyline|nortriptyline
799207|NCT00000375|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
799208|NCT00000375|Antidepressive Agents -- *therapeutic use|antidepressive agents -- *therapeutic use
799209|NCT00000375|Antidepressive Agents -- adverse effects|antidepressive agents -- adverse effects
799210|NCT00000375|Lithium -- *therapeutic use|lithium -- *therapeutic use
799211|NCT00000375|Lithium -- adverse effects|lithium -- adverse effects
799212|NCT00000375|Nortriptyline -- *therapeutic use|nortriptyline -- *therapeutic use
799213|NCT00000375|Nortriptyline -- adverse effects|nortriptyline -- adverse effects
799214|NCT00000374|Adolescence|adolescence
799215|NCT00000374|Adult|adult
799216|NCT00000374|Antipsychotic Agents|antipsychotic agents
799217|NCT00000374|Female|female
799218|NCT00000374|Human|human
799219|NCT00000374|Male|male
799220|NCT00000374|olanzapine|olanzapine
799221|NCT00000374|Risperidone|risperidone
799222|NCT00000374|Schizophrenia|schizophrenia
799223|NCT00000374|Antipsychotic Agents -- *therapeutic use|antipsychotic agents -- *therapeutic use
799224|NCT00000374|olanzapine -- *therapeutic use|olanzapine -- *therapeutic use
799225|NCT00000374|Risperidone -- *therapeutic use|risperidone -- *therapeutic use
799350|NCT00000179|Behavioral symptoms|behavioral symptoms
799226|NCT00000374|Schizophrenia -- *drug therapy|schizophrenia -- *drug therapy
799227|NCT00000373|Adolescence|adolescence
799228|NCT00000373|Adult|adult
799229|NCT00000373|Antipsychotic Agents|antipsychotic agents
799230|NCT00000373|Dopamine Antagonists|dopamine antagonists
799231|NCT00000373|Female|female
799232|NCT00000373|Fluvoxamine|fluvoxamine
799233|NCT00000373|Haloperidol|haloperidol
799234|NCT00000373|Human|human
799235|NCT00000373|Male|male
799236|NCT00000373|Middle Age|middle age
799237|NCT00000373|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
799238|NCT00000373|Placebos|placebos
799239|NCT00000373|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
799240|NCT00000373|Tourette Syndrome|tourette syndrome
799241|NCT00000373|Tryptophan|tryptophan
799242|NCT00000373|Drug Combinations|drug combinations
799243|NCT00000373|Antipsychotic Agents -- *therapeutic use|antipsychotic agents -- *therapeutic use
799244|NCT00000373|Fluvoxamine -- *therapeutic use|fluvoxamine -- *therapeutic use
799245|NCT00000373|Haloperidol -- *therapeutic use|haloperidol -- *therapeutic use
799246|NCT00000373|Obsessive-Compulsive Disorder -- *drug therapy|obsessive-compulsive disorder -- *drug therapy
799247|NCT00000373|Obsessive-Compulsive Disorder -- physiopathology|obsessive-compulsive disorder -- physiopathology
799248|NCT00000373|Serotonin Uptake Inhibitors -- *therapeutic use|serotonin uptake inhibitors -- *therapeutic use
799249|NCT00000372|Adult|adult
799250|NCT00000372|Amino Acids|amino acids
799251|NCT00000372|Cycloserine|cycloserine
799252|NCT00000372|Female|female
799253|NCT00000372|Glycine|glycine
799254|NCT00000372|Human|human
799255|NCT00000372|Male|male
799256|NCT00000372|N-Methylaspartate|n-methylaspartate
799257|NCT00000372|Placebos|placebos
799258|NCT00000372|Schizophrenia|schizophrenia
799259|NCT00000372|Amino Acids -- blood|amino acids -- blood
799260|NCT00000372|Cycloserine -- *therapeutic use|cycloserine -- *therapeutic use
799261|NCT00000372|Glycine -- *therapeutic use|glycine -- *therapeutic use
799262|NCT00000372|Schizophrenia -- *drug therapy|schizophrenia -- *drug therapy
799263|NCT00000372|Schizophrenia -- physiopathology|schizophrenia -- physiopathology
799264|NCT00000371|Adult|adult
799265|NCT00000371|Cognition|cognition
799266|NCT00000371|Cycloserine|cycloserine
799267|NCT00000371|Dopamine|dopamine
799268|NCT00000371|Female|female
799269|NCT00000371|Glutamic Acid|glutamic acid
799270|NCT00000371|Human|human
799271|NCT00000371|Male|male
799272|NCT00000371|Receptors, N-Methyl-D-Aspartate|receptors, n-methyl-d-aspartate
799273|NCT00000371|Schizophrenia|schizophrenia
799274|NCT00000371|Serotonin|serotonin
799275|NCT00000371|Quality of Life|quality of life
799276|NCT00000371|Cycloserine -- *therapeutic use|cycloserine -- *therapeutic use
799277|NCT00000371|Dopamine -- blood|dopamine -- blood
799278|NCT00000371|Dopamine -- cerebrospinal fluid|dopamine -- cerebrospinal fluid
799279|NCT00000371|Glutamic Acid -- blood|glutamic acid -- blood
799280|NCT00000371|Glutamic Acid -- cerebrospinal fluid|glutamic acid -- cerebrospinal fluid
799281|NCT00000371|Serotonin -- blood|serotonin -- blood
799282|NCT00000371|Serotonin -- cerebrospinal fluid|serotonin -- cerebrospinal fluid
799283|NCT00000370|Cognitive Therapy|cognitive therapy
799284|NCT00000370|Cost of Illness|cost of illness
799285|NCT00000370|Female|female
799286|NCT00000370|Human|human
799287|NCT00000370|Male|male
799288|NCT00000370|Phobic Disorders|phobic disorders
799289|NCT00000370|Phobic Disorders -- *therapy|phobic disorders -- *therapy
799290|NCT00000370|Phobic Disorders -- pathology|phobic disorders -- pathology
799291|NCT00000369|Adult|adult
799292|NCT00000369|Antidepressive Agents|antidepressive agents
799293|NCT00000369|Bipolar Disorder|bipolar disorder
799294|NCT00000369|Combined Modality Therapy|combined modality therapy
799295|NCT00000369|Female|female
799296|NCT00000369|Human|human
799297|NCT00000369|Lithium Carbonate|lithium carbonate
799298|NCT00000369|Male|male
799299|NCT00000369|Psychotherapy|psychotherapy
799300|NCT00000369|Antidepressive Agents -- *therapeutic use|antidepressive agents -- *therapeutic use
799301|NCT00000369|Bipolar Disorder -- *therapy|bipolar disorder -- *therapy
799302|NCT00000369|Bipolar Disorder -- drug therapy|bipolar disorder -- drug therapy
799303|NCT00000369|Lithium Carbonate -- *therapeutic use|lithium carbonate -- *therapeutic use
799304|NCT00000368|Adult|adult
799305|NCT00000368|Cognitive Behavioral Therapy|cognitive behavioral therapy
799306|NCT00000368|Pharmacotherapy|pharmacotherapy
799307|NCT00000368|Long term treatment|long term treatment
799308|NCT00000368|Remission and relapse|remission and relapse
799309|NCT00000368|Male|male
799310|NCT00000368|Panic Disorder|panic disorder
799311|NCT00000368|Paroxetine|paroxetine
799312|NCT00000368|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
799313|NCT00000368|Panic Disorder -- *therapy|panic disorder -- *therapy
799314|NCT00000368|Panic Disorder -- drug therapy|panic disorder -- drug therapy
799315|NCT00000368|Paroxetine -- *therapeutic use|paroxetine -- *therapeutic use
799316|NCT00000368|Serotonin Uptake Inhibitors -- *therapeutic use|serotonin uptake inhibitors -- *therapeutic use
799317|NCT00000367|Depression|depression
799318|NCT00000367|Family|family
799319|NCT00000367|Female|female
799320|NCT00000367|Human|human
799321|NCT00000367|Male|male
799322|NCT00000367|Practice Guidelines|practice guidelines
799323|NCT00000367|Education, Medical, Continuing|education, medical, continuing
799324|NCT00000367|Patient Education|patient education
799325|NCT00000367|Suicide|suicide
799326|NCT00000363|Antibiotics|antibiotics
799327|NCT00000363|Adrenal Cortex Hormones|adrenal cortex hormones
799328|NCT00000363|Histamine H1 Antagonists|histamine h1 antagonists
799329|NCT00000363|Infant|infant
799330|NCT00000363|Otitis Media|otitis media
799331|NCT00000362|Deglutition Disorders|deglutition disorders
799332|NCT00000362|Dementia|dementia
799333|NCT00000362|Parkinson Disease|parkinson disease
799334|NCT00000362|Pneumonia, Aspiration|pneumonia, aspiration
799335|NCT00000361|Autoimmune Diseases|autoimmune diseases
799336|NCT00000361|Cyclophosphamide|cyclophosphamide
799337|NCT00000361|Hearing|hearing
799338|NCT00000361|Labyrinth Diseases|labyrinth diseases
799339|NCT00000361|Methotrexate|methotrexate
799340|NCT00000361|Prednisone|prednisone
799341|NCT00000359|Physical Therapy|physical therapy
799342|NCT00000359|Vertigo|vertigo
799343|NCT00000359|rehabilitation|rehabilitation
799344|NCT00000359|occupational therapy|occupational therapy
799345|NCT00000180|Memory|memory
799346|NCT00000180|Mild cognitive impairment|mild cognitive impairment
799347|NCT00000180|Nerve growth factors|nerve growth factors
799348|NCT00000179|Alzheimer's disease|alzheimer's disease
799349|NCT00000179|Psychomotor agitation|psychomotor agitation
799351|NCT00000179|Haloperidol|haloperidol
799352|NCT00000179|Trazodone|trazodone
799353|NCT00000179|Anti-psychotic agents|anti-psychotic agents
799354|NCT00000179|Anti-depressant agents|anti-depressant agents
799355|NCT00000178|Alzheimer's disease|alzheimer's disease
799356|NCT00000178|Prednisone|prednisone
799357|NCT00000178|Anti-inflammatory agents|anti-inflammatory agents
799358|NCT00000177|Alzheimer's disease|alzheimer's disease
799359|NCT00000177|Estrogen|estrogen
799360|NCT00000176|Alzheimer's disease|alzheimer's disease
799361|NCT00000176|memory loss|memory loss
799362|NCT00000176|Estrogen|estrogen
799363|NCT00000175|Emotions|emotions
799364|NCT00000175|Cognition|cognition
799365|NCT00000175|Aging|aging
799366|NCT00000175|Memory|memory
799367|NCT00000174|Mild cognitive impairment|mild cognitive impairment
799368|NCT00000174|Alzheimer's disease|alzheimer's disease
799369|NCT00000174|Memory|memory
799370|NCT00000174|Cholinergic agents|cholinergic agents
799371|NCT00000174|Cholinesterase inhibitors|cholinesterase inhibitors
799372|NCT00000173|Mild cognitive impairment|mild cognitive impairment
799373|NCT00000173|Alzheimer's disease|alzheimer's disease
799374|NCT00000173|Memory|memory
799375|NCT00000173|Donepezil|donepezil
799376|NCT00000173|Vitamin E|vitamin e
799377|NCT00000173|Antioxidants|antioxidants
799378|NCT00000173|Cholinergic agents|cholinergic agents
799379|NCT00000173|Cholinesterase inhibitors|cholinesterase inhibitors
799380|NCT00000172|Alzheimer's disease|alzheimer's disease
799381|NCT00000172|Cholinergic agents|cholinergic agents
799382|NCT00000172|Cholinergic agonists|cholinergic agonists
799383|NCT00000172|Cholinesterase inhibitors|cholinesterase inhibitors
799384|NCT00000171|Alzheimer's disease|alzheimer's disease
799385|NCT00000171|Sleep disorders|sleep disorders
799386|NCT00000171|Melatonin|melatonin
799387|NCT00000623|chelator|chelator
799388|NCT00000623|iron|iron
799389|NCT00000623|transfusion|transfusion
799390|NCT00000623|anemia|anemia
799391|NCT00000623|thalassemia|thalassemia
799392|NCT00000620|Diabetes Mellitus, Non-Insulin-Dependent|diabetes mellitus, non-insulin-dependent
799393|NCT00004500|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
799394|NCT00004500|meconium aspiration syndrome|meconium aspiration syndrome
799395|NCT00004500|rare disease|rare disease
799396|NCT00004498|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
799397|NCT00004498|inborn errors of metabolism|inborn errors of metabolism
799398|NCT00004498|ornithine transcarbamylase deficiency|ornithine transcarbamylase deficiency
799399|NCT00004498|rare disease|rare disease
799400|NCT00004498|urea cycle disorder|urea cycle disorder
799401|NCT00004497|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
799402|NCT00004497|hypertensive disorder|hypertensive disorder
799403|NCT00004497|primary pulmonary hypertension|primary pulmonary hypertension
799404|NCT00004497|rare disease|rare disease
799405|NCT00004496|acute renal failure|acute renal failure
799406|NCT00004496|rare disease|rare disease
799407|NCT00004496|renal and genitourinary disorders|renal and genitourinary disorders
799408|NCT00004495|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
799409|NCT00004495|end stage renal disease|end stage renal disease
799410|NCT00004495|hyperhomocysteinemia|hyperhomocysteinemia
799411|NCT00004495|rare disease|rare disease
799412|NCT00004495|renal and genitourinary disorders|renal and genitourinary disorders
799413|NCT00004494|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
799414|NCT00004494|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
799415|NCT00004494|neonatal disorders|neonatal disorders
799416|NCT00004494|rare disease|rare disease
799417|NCT00004494|respiratory distress syndrome|respiratory distress syndrome
799418|NCT00004494|sepsis|sepsis
799419|NCT00004493|inborn errors of metabolism|inborn errors of metabolism
799420|NCT00004493|lactic acidosis|lactic acidosis
799421|NCT00004493|rare disease|rare disease
799422|NCT00004492|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
799423|NCT00004492|hematologic disorders|hematologic disorders
799424|NCT00004492|rare disease|rare disease
799425|NCT00004492|sickle cell anemia|sickle cell anemia
799426|NCT00004490|disease-related problem/condition|disease-related problem/condition
799427|NCT00004490|inborn errors of metabolism|inborn errors of metabolism
799428|NCT00004490|lactic acidosis|lactic acidosis
799429|NCT00004490|quality of life|quality of life
799430|NCT00004490|rare disease|rare disease
799431|NCT00004489|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
799432|NCT00004489|cystic fibrosis|cystic fibrosis
799433|NCT00004489|disease-related problem/condition|disease-related problem/condition
799434|NCT00004489|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
799435|NCT00004489|osteoporosis|osteoporosis
799436|NCT00004489|rare disease|rare disease
799437|NCT00004488|Gaucher's disease|gaucher's disease
799438|NCT00004488|inborn errors of metabolism|inborn errors of metabolism
799439|NCT00004488|rare disease|rare disease
799440|NCT00004488|sphingolipidoses|sphingolipidoses
799441|NCT00004487|rare disease|rare disease
799442|NCT00004487|renal and genitourinary disorders|renal and genitourinary disorders
799443|NCT00004487|vesicoureteral reflux|vesicoureteral reflux
799444|NCT00004486|autism|autism
799445|NCT00004486|neurologic and psychiatric disorders|neurologic and psychiatric disorders
799446|NCT00004486|rare disease|rare disease
799447|NCT00004485|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
799448|NCT00004485|hematologic disorders|hematologic disorders
799449|NCT00004485|rare disease|rare disease
799450|NCT00004485|sickle cell anemia|sickle cell anemia
799451|NCT00004482|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
799452|NCT00004482|giant cell myocarditis|giant cell myocarditis
799453|NCT00004482|rare disease|rare disease
799454|NCT00004481|endocrine disorders|endocrine disorders
799455|NCT00004481|inborn errors of metabolism|inborn errors of metabolism
799456|NCT00004481|rare disease|rare disease
799457|NCT00004481|sitosterolemia|sitosterolemia
799458|NCT00004480|dermatologic disorders|dermatologic disorders
799459|NCT00004480|hyperhidrosis|hyperhidrosis
799460|NCT00004480|rare disease|rare disease
799461|NCT00004479|neurologic and psychiatric disorders|neurologic and psychiatric disorders
799462|NCT00004479|rare disease|rare disease
799463|NCT00004479|syncope|syncope
799464|NCT00004478|Shy-Drager Syndrome|shy-drager syndrome
799465|NCT00004478|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
799466|NCT00004478|neurologic and psychiatric disorders|neurologic and psychiatric disorders
799467|NCT00004478|orthostatic hypotension|orthostatic hypotension
799468|NCT00004478|rare disease|rare disease
799469|NCT00004474|Hematologic Disorders|hematologic disorders
799470|NCT00004474|Rare Disease|rare disease
799471|NCT00004471|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
799472|NCT00004471|cystic fibrosis|cystic fibrosis
799473|NCT00004471|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
799474|NCT00004471|rare disease|rare disease
799475|NCT00004468|dermatologic disorders|dermatologic disorders
799476|NCT00004468|psoriasis|psoriasis
799477|NCT00004468|rare disease|rare disease
799478|NCT00004467|acute liver failure|acute liver failure
799479|NCT00004467|gastrointestinal disorders|gastrointestinal disorders
799480|NCT00004467|rare disease|rare disease
799481|NCT00004466|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
799482|NCT00004466|hyperlipidemia|hyperlipidemia
799483|NCT00004466|nephrotic syndrome|nephrotic syndrome
799484|NCT00004466|rare disease|rare disease
799485|NCT00004466|renal and genitourinary disorders|renal and genitourinary disorders
799486|NCT00004465|E. coli infection|e. coli infection
799487|NCT00004465|bacterial infection|bacterial infection
799488|NCT00004465|hemolytic uremic syndrome|hemolytic uremic syndrome
799489|NCT00004465|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
799490|NCT00004465|rare disease|rare disease
799491|NCT00004465|renal and genitourinary disorders|renal and genitourinary disorders
799492|NCT00004464|aplastic anemia|aplastic anemia
799493|NCT00004464|hematologic disorders|hematologic disorders
799494|NCT00004464|paroxysmal nocturnal hemoglobinuria|paroxysmal nocturnal hemoglobinuria
799495|NCT00004464|rare disease|rare disease
799496|NCT00004458|autism|autism
799497|NCT00004458|childhood disintegrative disorder|childhood disintegrative disorder
799498|NCT00004458|neurologic and psychiatric disorders|neurologic and psychiatric disorders
799499|NCT00004458|rare disease|rare disease
799500|NCT00004457|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
799501|NCT00004457|motor neuron disease|motor neuron disease
799502|NCT00004457|neurologic and psychiatric disorders|neurologic and psychiatric disorders
799503|NCT00004457|rare disease|rare disease
799504|NCT00004454|inborn errors of metabolism|inborn errors of metabolism
799505|NCT00004454|mucopolysaccharidosis|mucopolysaccharidosis
799506|NCT00004454|mucopolysaccharidosis II|mucopolysaccharidosis ii
799507|NCT00004454|rare disease|rare disease
799508|NCT00004451|Parkinson disease|parkinson disease
799509|NCT00004451|neurologic and psychiatric disorders|neurologic and psychiatric disorders
799510|NCT00004451|rare disease|rare disease
799511|NCT00004450|adrenoleukodystrophy|adrenoleukodystrophy
799512|NCT00004450|inborn errors of metabolism|inborn errors of metabolism
799513|NCT00004450|rare disease|rare disease
799514|NCT00004450|sphingolipidoses|sphingolipidoses
799515|NCT00004449|autism|autism
799516|NCT00004449|neurologic and psychiatric disorders|neurologic and psychiatric disorders
799517|NCT00004449|rare disease|rare disease
799518|NCT00004448|IgA glomerulonephritis|iga glomerulonephritis
799519|NCT00004448|rare disease|rare disease
799520|NCT00004448|renal and genitourinary disorders|renal and genitourinary disorders
799521|NCT00004446|depersonalization disorder|depersonalization disorder
799522|NCT00004446|neurologic and psychiatric disorders|neurologic and psychiatric disorders
799523|NCT00004446|rare disease|rare disease
799524|NCT00004445|environmental/toxic disorders|environmental/toxic disorders
799525|NCT00004445|neurologic and psychiatric disorders|neurologic and psychiatric disorders
799526|NCT00004445|rare disease|rare disease
799527|NCT00004445|spinal cord injury|spinal cord injury
799528|NCT00004444|bacterial infection|bacterial infection
799529|NCT00004444|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
799530|NCT00004444|mycobacterium infection|mycobacterium infection
799531|NCT00004444|mycobacterium tuberculosis infection|mycobacterium tuberculosis infection
799532|NCT00004444|rare disease|rare disease
799533|NCT00004443|inborn errors of metabolism|inborn errors of metabolism
799534|NCT00004443|rare disease|rare disease
799535|NCT00004443|tyrosinemia I|tyrosinemia i
799536|NCT00004442|Zellweger syndrome|zellweger syndrome
799537|NCT00004442|adrenoleukodystrophy|adrenoleukodystrophy
799538|NCT00004442|bifunctional enzyme deficiency|bifunctional enzyme deficiency
799539|NCT00004442|inborn errors of metabolism|inborn errors of metabolism
799540|NCT00004442|infantile Refsum's disease|infantile refsum's disease
799541|NCT00004442|peroxisomal disorders|peroxisomal disorders
799542|NCT00004442|pseudo-Zellweger syndrome|pseudo-zellweger syndrome
799543|NCT00004442|rare disease|rare disease
799544|NCT00004442|sphingolipidoses|sphingolipidoses
799545|NCT00004441|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
799546|NCT00004441|cystic fibrosis|cystic fibrosis
799547|NCT00004441|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
799548|NCT00004441|rare disease|rare disease
799549|NCT00004440|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
799550|NCT00004440|cystic fibrosis|cystic fibrosis
799551|NCT00004440|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
799552|NCT00004440|rare disease|rare disease
799553|NCT00004438|endocrine disorders|endocrine disorders
799554|NCT00004438|hypogonadism|hypogonadism
799555|NCT00004438|rare disease|rare disease
799556|NCT00004437|acoustic neuroma|acoustic neuroma
799557|NCT00004437|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
799558|NCT00004437|hearing loss|hearing loss
799559|NCT00004437|neurofibromatosis|neurofibromatosis
799560|NCT00004437|neurologic and psychiatric disorders|neurologic and psychiatric disorders
799561|NCT00004437|rare disease|rare disease
799562|NCT00004436|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
799563|NCT00004436|hemangioma|hemangioma
799564|NCT00004436|rare disease|rare disease
799565|NCT00004433|Tourette syndrome|tourette syndrome
799566|NCT00004433|neurologic and psychiatric disorders|neurologic and psychiatric disorders
799567|NCT00004433|rare disease|rare disease
799568|NCT00004431|neurologic and psychiatric disorders|neurologic and psychiatric disorders
799569|NCT00004431|rare disease|rare disease
799570|NCT00004431|trigeminal neuralgia|trigeminal neuralgia
799571|NCT00004430|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
799572|NCT00004430|corneal neovascularization|corneal neovascularization
799573|NCT00004430|rare disease|rare disease
799574|NCT00004429|end stage renal disease|end stage renal disease
799575|NCT00004429|rare disease|rare disease
799576|NCT00004429|renal and genitourinary disorders|renal and genitourinary disorders
799577|NCT00004428|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
799578|NCT00004428|cystic fibrosis|cystic fibrosis
799579|NCT00004428|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
799580|NCT00004428|rare disease|rare disease
799581|NCT00004426|endocrine disorders|endocrine disorders
799582|NCT00004426|hypogonadism|hypogonadism
799583|NCT00004426|rare disease|rare disease
799584|NCT00004424|disease-related problem/condition|disease-related problem/condition
799585|NCT00004424|oncologic disorders|oncologic disorders
799586|NCT00004424|pulmonary complications|pulmonary complications
799587|NCT00004424|rare disease|rare disease
799588|NCT00004424|Respiration, Artificial|respiration, artificial
799589|NCT00004423|Crohn's disease|crohn's disease
799590|NCT00004423|gastrointestinal disorders|gastrointestinal disorders
799591|NCT00004423|rare disease|rare disease
799592|NCT00004422|bacterial infection|bacterial infection
799593|NCT00004422|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
799594|NCT00004422|pertussis|pertussis
799595|NCT00004422|rare disease|rare disease
799596|NCT00004421|dystonia|dystonia
799597|NCT00004421|neurologic and psychiatric disorders|neurologic and psychiatric disorders
799598|NCT00004421|rare disease|rare disease
799599|NCT00004420|arthritis & connective tissue diseases|arthritis & connective tissue diseases
799600|NCT00004420|juvenile rheumatoid arthritis|juvenile rheumatoid arthritis
799601|NCT00004420|rare disease|rare disease
799602|NCT00004419|endocrine disorders|endocrine disorders
799603|NCT00004419|insulin resistance|insulin resistance
799604|NCT00004419|rare disease|rare disease
799605|NCT00004418|adrenoleukodystrophy|adrenoleukodystrophy
799606|NCT00004418|inborn errors of metabolism|inborn errors of metabolism
799607|NCT00004418|rare disease|rare disease
799608|NCT00004418|sphingolipidoses|sphingolipidoses
799609|NCT00004416|achalasia|achalasia
799610|NCT00004416|gastrointestinal disorders|gastrointestinal disorders
799611|NCT00004416|rare disease|rare disease
799612|NCT00004415|environmental/toxic disorders|environmental/toxic disorders
799613|NCT00004415|neurologic and psychiatric disorders|neurologic and psychiatric disorders
799614|NCT00004415|rare disease|rare disease
799615|NCT00004415|spinal cord injury|spinal cord injury
799616|NCT00004414|cholestasis|cholestasis
799617|NCT00004414|gastrointestinal disorders|gastrointestinal disorders
799618|NCT00004414|rare disease|rare disease
799619|NCT00004412|dermatologic disorders|dermatologic disorders
799620|NCT00004412|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
799621|NCT00004412|hematologic disorders|hematologic disorders
799622|NCT00004412|rare disease|rare disease
799623|NCT00004412|sickle cell anemia|sickle cell anemia
799624|NCT00004412|skin ulcers|skin ulcers
799625|NCT00004412|thalassemia major|thalassemia major
799626|NCT00004410|cholestasis|cholestasis
799627|NCT00004410|gastrointestinal disorders|gastrointestinal disorders
799628|NCT00004410|rare disease|rare disease
799629|NCT00004409|Dupuytren's disease|dupuytren's disease
799630|NCT00004409|arthritis & connective tissue diseases|arthritis & connective tissue diseases
799631|NCT00004409|rare disease|rare disease
799632|NCT00004408|disease-related problem/condition|disease-related problem/condition
799633|NCT00004408|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
799634|NCT00004408|hematologic disorders|hematologic disorders
799635|NCT00004408|pain|pain
799636|NCT00004408|rare disease|rare disease
799637|NCT00004408|sickle cell anemia|sickle cell anemia
799638|NCT00004407|diabetic amyotrophy|diabetic amyotrophy
799639|NCT00004407|diabetic lumbosacral radiculoplexus neuropathy|diabetic lumbosacral radiculoplexus neuropathy
799640|NCT00004407|diabetic neuropathy|diabetic neuropathy
799641|NCT00004407|diabetic proximal neuropathy|diabetic proximal neuropathy
799642|NCT00004407|neurologic and psychiatric disorders|neurologic and psychiatric disorders
799643|NCT00004407|rare disease|rare disease
799644|NCT00004406|disease-related problem/condition|disease-related problem/condition
799645|NCT00004406|osteoporosis|osteoporosis
799646|NCT00004406|rare disease|rare disease
799647|NCT00004404|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
799648|NCT00004404|hematologic disorders|hematologic disorders
799649|NCT00004404|rare disease|rare disease
799650|NCT00004404|sickle cell anemia|sickle cell anemia
799651|NCT00004403|cysticercosis|cysticercosis
799652|NCT00004403|epilepsy|epilepsy
799653|NCT00004403|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
799654|NCT00004403|neurologic and psychiatric disorders|neurologic and psychiatric disorders
799655|NCT00004403|parasitic infection|parasitic infection
799656|NCT00004403|rare disease|rare disease
799657|NCT00004403|seizures|seizures
799658|NCT00004402|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
799659|NCT00004402|osteopetrosis|osteopetrosis
799660|NCT00004402|rare disease|rare disease
799661|NCT00004401|bacterial infection|bacterial infection
799662|NCT00004401|clostridium infection|clostridium infection
799663|NCT00004401|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
799664|NCT00004401|infant botulism|infant botulism
799665|NCT00004401|rare disease|rare disease
799666|NCT00004400|cachexia|cachexia
799667|NCT00004400|disease-related problem/condition|disease-related problem/condition
799668|NCT00004400|human immunodeficiency virus infection|human immunodeficiency virus infection
799669|NCT00004400|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
799670|NCT00004400|nutrition|nutrition
799671|NCT00004400|quality of life|quality of life
799672|NCT00004400|rare disease|rare disease
799673|NCT00004400|viral infection|viral infection
799674|NCT00004399|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
799675|NCT00004399|hypertensive disorder|hypertensive disorder
799676|NCT00004399|pre-eclampsia|pre-eclampsia
799677|NCT00004399|rare disease|rare disease
799678|NCT00004398|inborn errors of metabolism|inborn errors of metabolism
799679|NCT00004398|porphyria|porphyria
799680|NCT00004398|rare disease|rare disease
799681|NCT00004397|inborn errors of metabolism|inborn errors of metabolism
799682|NCT00004397|porphyria|porphyria
799683|NCT00004397|rare disease|rare disease
799684|NCT00004396|inborn errors of metabolism|inborn errors of metabolism
799685|NCT00004396|porphyria|porphyria
799686|NCT00004396|rare disease|rare disease
799687|NCT00004393|Tourette syndrome|tourette syndrome
799688|NCT00004393|neurologic and psychiatric disorders|neurologic and psychiatric disorders
799689|NCT00004393|rare disease|rare disease
799690|NCT00004392|apnea|apnea
799691|NCT00004392|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
799692|NCT00004392|neurologic and psychiatric disorders|neurologic and psychiatric disorders
799693|NCT00004392|rare disease|rare disease
799694|NCT00004392|sudden infant death syndrome|sudden infant death syndrome
799695|NCT00004390|disease-related problem/condition|disease-related problem/condition
799696|NCT00004390|herpes zoster infection|herpes zoster infection
799697|NCT00004390|herpesvirus infection|herpesvirus infection
799698|NCT00004390|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
799699|NCT00004390|pain|pain
799700|NCT00004390|rare disease|rare disease
799701|NCT00004390|viral infection|viral infection
799702|NCT00004387|Parkinson disease|parkinson disease
799703|NCT00004387|neurologic and psychiatric disorders|neurologic and psychiatric disorders
799704|NCT00004387|rare disease|rare disease
799705|NCT00004386|inborn errors of metabolism|inborn errors of metabolism
799706|NCT00004386|rare disease|rare disease
799707|NCT00004386|urea cycle disorder|urea cycle disorder
799708|NCT00004382|hematologic disorders|hematologic disorders
799709|NCT00004382|hyperbilirubinemia|hyperbilirubinemia
799710|NCT00004382|rare disease|rare disease
799711|NCT00004381|glucose-6-phosphate dehydrogenase deficiency|glucose-6-phosphate dehydrogenase deficiency
799712|NCT00004381|hematologic disorders|hematologic disorders
799713|NCT00004381|hemolytic disease|hemolytic disease
799714|NCT00004381|hyperbilirubinemia|hyperbilirubinemia
799715|NCT00004381|neonatal disorders|neonatal disorders
799716|NCT00004381|rare disease|rare disease
799717|NCT00004380|arthritis & connective tissue diseases|arthritis & connective tissue diseases
799718|NCT00004380|rare disease|rare disease
799719|NCT00004380|systemic sclerosis|systemic sclerosis
799720|NCT00004378|Fanconi's anemia|fanconi's anemia
799721|NCT00004378|amegakaryocytic thrombocytopenia|amegakaryocytic thrombocytopenia
799722|NCT00004378|aplastic anemia|aplastic anemia
799723|NCT00004378|congenital pure red cell aplasia|congenital pure red cell aplasia
799724|NCT00004378|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
799725|NCT00004378|hematologic disorders|hematologic disorders
799726|NCT00004378|inborn errors of metabolism|inborn errors of metabolism
799727|NCT00004378|metachromatic leukodystrophy|metachromatic leukodystrophy
799728|NCT00004378|pure red cell aplasia|pure red cell aplasia
799729|NCT00004378|rare disease|rare disease
799730|NCT00004378|sphingolipidoses|sphingolipidoses
799731|NCT00004378|thalassemia major|thalassemia major
799732|NCT00004376|Tourette syndrome|tourette syndrome
799733|NCT00004376|neurologic and psychiatric disorders|neurologic and psychiatric disorders
799734|NCT00004376|rare disease|rare disease
799735|NCT00004375|arthritis & connective tissue diseases|arthritis & connective tissue diseases
799736|NCT00004375|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
799737|NCT00004375|rare disease|rare disease
799738|NCT00004375|systemic lupus erythematosus|systemic lupus erythematosus
799739|NCT00004374|amyloidosis|amyloidosis
799740|NCT00004374|arthritis & connective tissue diseases|arthritis & connective tissue diseases
799741|NCT00004374|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
799742|NCT00004374|rare disease|rare disease
799743|NCT00004373|anxiety disorder|anxiety disorder
799744|NCT00004373|disease-related problem/condition|disease-related problem/condition
799745|NCT00004373|neurologic and psychiatric disorders|neurologic and psychiatric disorders
799746|NCT00004373|panic disorder|panic disorder
799747|NCT00004373|rare disease|rare disease
799748|NCT00004368|hepatic cirrhosis|hepatic cirrhosis
799749|NCT00004368|gastrointestinal disorders|gastrointestinal disorders
799750|NCT00004368|rare disease|rare disease
799751|NCT00004367|anxiety disorder|anxiety disorder
799752|NCT00004367|disease-related problem/condition|disease-related problem/condition
799753|NCT00004367|neurologic and psychiatric disorders|neurologic and psychiatric disorders
799754|NCT00004367|panic disorder|panic disorder
799755|NCT00004367|rare disease|rare disease
799756|NCT00004366|agoraphobia|agoraphobia
799757|NCT00004366|anxiety disorder|anxiety disorder
799758|NCT00004366|disease-related problem/condition|disease-related problem/condition
799759|NCT00004366|neurologic and psychiatric disorders|neurologic and psychiatric disorders
799760|NCT00004366|panic disorder|panic disorder
799761|NCT00004366|rare disease|rare disease
799762|NCT00004366|vestibular diseases|vestibular diseases
799763|NCT00004365|endocrine disorders|endocrine disorders
799764|NCT00004365|growth hormone deficiency|growth hormone deficiency
799765|NCT00004365|rare disease|rare disease
799766|NCT00004364|diabetes insipidus|diabetes insipidus
799767|NCT00004364|endocrine disorders|endocrine disorders
799768|NCT00004364|rare disease|rare disease
799769|NCT00004363|diabetes insipidus|diabetes insipidus
799770|NCT00004363|endocrine disorders|endocrine disorders
799771|NCT00004363|rare disease|rare disease
799772|NCT00004361|DiGeorge syndrome|digeorge syndrome
799773|NCT00004361|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
799774|NCT00004361|conotruncal cardiac defects|conotruncal cardiac defects
799775|NCT00004361|endocrine disorders|endocrine disorders
799776|NCT00004361|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
799777|NCT00004361|hypoparathyroidism|hypoparathyroidism
799778|NCT00004361|pulmonary valve stenosis|pulmonary valve stenosis
799779|NCT00004361|rare disease|rare disease
799780|NCT00004361|tetralogy of Fallot|tetralogy of fallot
799781|NCT00004360|diabetes insipidus|diabetes insipidus
799782|NCT00004360|endocrine disorders|endocrine disorders
799783|NCT00004360|rare disease|rare disease
799784|NCT00004359|dermatologic disorders|dermatologic disorders
799785|NCT00004359|epidermolysis bullosa|epidermolysis bullosa
799786|NCT00004359|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
799787|NCT00004359|rare disease|rare disease
799788|NCT00004358|arthritis & connective tissue diseases|arthritis & connective tissue diseases
799789|NCT00004358|rare disease|rare disease
799790|NCT00004358|tumoral calcinosis|tumoral calcinosis
799791|NCT00004357|Cardiovascular Disease|cardiovascular disease
799792|NCT00004357|Respiratory Disease|respiratory disease
799793|NCT00004357|Rare Diseases|rare diseases
799794|NCT00004357|Vasculitis|vasculitis
799795|NCT00004356|homocystinuria|homocystinuria
799796|NCT00004356|inborn errors of metabolism|inborn errors of metabolism
799797|NCT00004356|rare disease|rare disease
799798|NCT00004354|endocrine disorders|endocrine disorders
799799|NCT00004354|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
799800|NCT00004354|hyperaldosteronism|hyperaldosteronism
799801|NCT00004354|rare disease|rare disease
799802|NCT00004353|MELAS syndrome|melas syndrome
799803|NCT00004353|inborn errors of metabolism|inborn errors of metabolism
799804|NCT00004353|lactic acidosis|lactic acidosis
799805|NCT00004353|mitochondrial myopathy|mitochondrial myopathy
799806|NCT00004353|rare disease|rare disease
799807|NCT00004351|Angelman syndrome|angelman syndrome
799808|NCT00004351|DiGeorge syndrome|digeorge syndrome
799809|NCT00004351|Prader-Willi syndrome|prader-willi syndrome
799810|NCT00004351|Shprintzen syndrome|shprintzen syndrome
799811|NCT00004351|Smith-Magenis syndrome|smith-magenis syndrome
799812|NCT00004351|Williams syndrome|williams syndrome
799813|NCT00004351|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
799814|NCT00004351|neurologic and psychiatric disorders|neurologic and psychiatric disorders
799815|NCT00004351|rare disease|rare disease
799816|NCT00004350|Fanconi syndrome|fanconi syndrome
799818|NCT00004350|rare disease|rare disease
799819|NCT00004350|renal and genitourinary disorders|renal and genitourinary disorders
799820|NCT00004348|beta-oxidation disorder|beta-oxidation disorder
799821|NCT00004348|inborn errors of metabolism|inborn errors of metabolism
799822|NCT00004348|rare disease|rare disease
799823|NCT00004347|Smith-Lemli-Opitz syndrome|smith-lemli-opitz syndrome
799824|NCT00004347|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
799825|NCT00004347|rare disease|rare disease
799826|NCT00004346|cerebrotendinous xanthomatosis|cerebrotendinous xanthomatosis
799827|NCT00004346|inborn errors of metabolism|inborn errors of metabolism
799828|NCT00004346|rare disease|rare disease
799829|NCT00004345|Usher syndrome|usher syndrome
799830|NCT00004345|ophthalmologic disorders|ophthalmologic disorders
799831|NCT00004345|rare disease|rare disease
799832|NCT00004345|retinitis pigmentosa|retinitis pigmentosa
799833|NCT00004344|endocrine disorders|endocrine disorders
799834|NCT00004344|precocious puberty|precocious puberty
799835|NCT00004344|rare disease|rare disease
799836|NCT00004343|Cushing's syndrome|cushing's syndrome
799837|NCT00004343|endocrine disorders|endocrine disorders
799838|NCT00004343|rare disease|rare disease
799839|NCT00004342|chronic neutropenia|chronic neutropenia
799840|NCT00004342|disease-related problem/condition|disease-related problem/condition
799841|NCT00004342|hematologic disorders|hematologic disorders
799842|NCT00004342|neutropenia|neutropenia
799843|NCT00004342|rare disease|rare disease
799844|NCT00004342|severe chronic neutropenia|severe chronic neutropenia
799845|NCT00004341|Wiskott-Aldrich syndrome|wiskott-aldrich syndrome
799846|NCT00004341|X-linked agammaglobulinemia|x-linked agammaglobulinemia
799847|NCT00004341|X-linked hyper IgM syndrome|x-linked hyper igm syndrome
799848|NCT00004341|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
799849|NCT00004341|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
799850|NCT00004341|leukocyte adhesion deficiency syndrome|leukocyte adhesion deficiency syndrome
799851|NCT00004341|primary immunodeficiency disease|primary immunodeficiency disease
799852|NCT00004341|rare disease|rare disease
799853|NCT00004340|end stage renal disease|end stage renal disease
799854|NCT00004340|rare disease|rare disease
799855|NCT00004340|renal and genitourinary disorders|renal and genitourinary disorders
799856|NCT00004340|renal osteodystrophy|renal osteodystrophy
799857|NCT00004339|Wilson disease|wilson disease
799858|NCT00004339|inborn errors of metabolism|inborn errors of metabolism
799859|NCT00004339|rare disease|rare disease
799860|NCT00004338|Wilson disease|wilson disease
799861|NCT00004338|inborn errors of metabolism|inborn errors of metabolism
799862|NCT00004338|rare disease|rare disease
799863|NCT00004336|Mondini dysplasia|mondini dysplasia
799864|NCT00004336|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
799865|NCT00004336|rare disease|rare disease
799866|NCT00004335|endocrine disorders|endocrine disorders
799867|NCT00004335|growth hormone deficiency|growth hormone deficiency
799868|NCT00004335|hypogonadism|hypogonadism
799869|NCT00004335|precocious puberty|precocious puberty
799870|NCT00004335|rare disease|rare disease
799871|NCT00004334|Cushing's syndrome|cushing's syndrome
799872|NCT00004334|endocrine disorders|endocrine disorders
799873|NCT00004334|rare disease|rare disease
799874|NCT00004333|inborn errors of metabolism|inborn errors of metabolism
799875|NCT00004333|rare disease|rare disease
799876|NCT00004333|tyrosinemia I|tyrosinemia i
799877|NCT00004332|acromegaly|acromegaly
799878|NCT00004332|endocrine disorders|endocrine disorders
799879|NCT00004332|rare disease|rare disease
799880|NCT00004331|inborn errors of metabolism|inborn errors of metabolism
799881|NCT00004331|porphyria|porphyria
799882|NCT00004331|rare disease|rare disease
799883|NCT00004330|inborn errors of metabolism|inborn errors of metabolism
799884|NCT00004330|porphyria|porphyria
799885|NCT00004330|rare disease|rare disease
799886|NCT00004329|endocrine disorders|endocrine disorders
799887|NCT00004329|rare disease|rare disease
799888|NCT00004328|endocrine disorders|endocrine disorders
799889|NCT00004328|pseudohypoaldosteronism|pseudohypoaldosteronism
799890|NCT00004328|rare disease|rare disease
799891|NCT00004327|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
799892|NCT00004327|hematologic disorders|hematologic disorders
799893|NCT00004327|hereditary hemorrhagic telangiectasia|hereditary hemorrhagic telangiectasia
799894|NCT00004327|rare disease|rare disease
799895|NCT00004327|senile ectasia|senile ectasia
799896|NCT00004326|Cushing's syndrome|cushing's syndrome
799897|NCT00004326|endocrine disorders|endocrine disorders
799898|NCT00004326|rare disease|rare disease
799899|NCT00004325|Tourette syndrome|tourette syndrome
799900|NCT00004325|anxiety disorder|anxiety disorder
799901|NCT00004325|disease-related problem/condition|disease-related problem/condition
799902|NCT00004325|neurologic and psychiatric disorders|neurologic and psychiatric disorders
799903|NCT00004325|obsessive compulsive disorder|obsessive compulsive disorder
799904|NCT00004325|oncologic disorders|oncologic disorders
799905|NCT00004325|rare disease|rare disease
799906|NCT00004324|Tourette syndrome|tourette syndrome
799907|NCT00004324|anxiety disorder|anxiety disorder
799908|NCT00004324|disease-related problem/condition|disease-related problem/condition
799909|NCT00004324|neurologic and psychiatric disorders|neurologic and psychiatric disorders
799910|NCT00004324|obsessive compulsive disorder|obsessive compulsive disorder
799911|NCT00004324|oncologic disorders|oncologic disorders
799912|NCT00004324|rare disease|rare disease
799913|NCT00004323|aplastic anemia|aplastic anemia
799914|NCT00004323|hematologic disorders|hematologic disorders
799915|NCT00004323|rare disease|rare disease
799916|NCT00004317|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
799917|NCT00004317|rare disease|rare disease
799918|NCT00004317|toxoplasmosis|toxoplasmosis
799919|NCT00004316|interstitial cystitis|interstitial cystitis
799920|NCT00004316|rare disease|rare disease
799921|NCT00004316|renal and genitourinary disorders|renal and genitourinary disorders
799922|NCT00004316|vulvar vestibulitis|vulvar vestibulitis
799923|NCT00004315|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
799924|NCT00004315|cholestasis|cholestasis
799925|NCT00004315|cystic fibrosis|cystic fibrosis
799926|NCT00004315|gastrointestinal disorders|gastrointestinal disorders
799927|NCT00004315|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
799928|NCT00004315|rare disease|rare disease
799929|NCT00004314|Lesch-Nyhan syndrome|lesch-nyhan syndrome
799930|NCT00004314|inborn errors of metabolism|inborn errors of metabolism
799931|NCT00004314|neurologic and psychiatric disorders|neurologic and psychiatric disorders
799932|NCT00004314|rare disease|rare disease
799933|NCT00004313|Addison's disease|addison's disease
799934|NCT00004313|endocrine disorders|endocrine disorders
799935|NCT00004313|rare disease|rare disease
799936|NCT00004313|primary adrenal insufficiency|primary adrenal insufficiency
799937|NCT00004312|cystinosis|cystinosis
799938|NCT00004312|rare disease|rare disease
799939|NCT00004312|renal and genitourinary disorders|renal and genitourinary disorders
799940|NCT00004311|acanthosis nigricans|acanthosis nigricans
799941|NCT00004311|dermatologic disorders|dermatologic disorders
799942|NCT00004311|endocrine disorders|endocrine disorders
799943|NCT00004311|polycystic ovarian syndrome|polycystic ovarian syndrome
799944|NCT00004311|rare disease|rare disease
799945|NCT00004310|anxiety disorder|anxiety disorder
799946|NCT00004310|disease-related problem/condition|disease-related problem/condition
799947|NCT00004310|neurologic and psychiatric disorders|neurologic and psychiatric disorders
799948|NCT00004310|obsessive compulsive disorder|obsessive compulsive disorder
799949|NCT00004310|oncologic disorders|oncologic disorders
799950|NCT00004310|rare disease|rare disease
799951|NCT00004307|inborn errors of metabolism|inborn errors of metabolism
799952|NCT00004307|rare disease|rare disease
799953|NCT00004307|urea cycle disorder|urea cycle disorder
799954|NCT00004306|hereditary ataxia|hereditary ataxia
799955|NCT00004306|neurologic and psychiatric disorders|neurologic and psychiatric disorders
799956|NCT00004306|rare disease|rare disease
799957|NCT00004305|IgA glomerulonephritis|iga glomerulonephritis
799958|NCT00004305|rare disease|rare disease
799959|NCT00004305|renal and genitourinary disorders|renal and genitourinary disorders
799960|NCT00004300|mental retardation|mental retardation
799961|NCT00004300|neurologic and psychiatric disorders|neurologic and psychiatric disorders
799962|NCT00004300|rare disease|rare disease
799963|NCT00004300|stereotyped behavior|stereotyped behavior
799964|NCT00004297|epilepsy|epilepsy
799965|NCT00004297|neurologic and psychiatric disorders|neurologic and psychiatric disorders
799966|NCT00004297|rare disease|rare disease
799967|NCT00004297|seizures|seizures
799968|NCT00004297|status epilepticus|status epilepticus
799969|NCT00004296|atypical mycobacterium infection|atypical mycobacterium infection
799970|NCT00004296|bacterial infection|bacterial infection
799971|NCT00004296|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
799972|NCT00004296|cystic fibrosis|cystic fibrosis
799973|NCT00004296|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
799974|NCT00004296|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
799975|NCT00004296|mycobacterium infection|mycobacterium infection
799976|NCT00004296|rare disease|rare disease
799977|NCT00004294|Gaucher's disease|gaucher's disease
799978|NCT00004294|inborn errors of metabolism|inborn errors of metabolism
799979|NCT00004294|rare disease|rare disease
799980|NCT00004294|sphingolipidoses|sphingolipidoses
799981|NCT00004293|Gaucher's disease|gaucher's disease
799982|NCT00004293|inborn errors of metabolism|inborn errors of metabolism
799983|NCT00004293|rare disease|rare disease
799984|NCT00004293|sphingolipidoses|sphingolipidoses
799985|NCT00004288|ankylosing spondylitis|ankylosing spondylitis
799986|NCT00004288|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
799987|NCT00004288|rare disease|rare disease
799988|NCT00004287|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
799989|NCT00004287|cystic fibrosis|cystic fibrosis
799990|NCT00004287|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
799991|NCT00004287|rare disease|rare disease
799992|NCT00004286|demyelinating neuropathy|demyelinating neuropathy
799993|NCT00004286|neurologic and psychiatric disorders|neurologic and psychiatric disorders
799994|NCT00004286|rare disease|rare disease
799995|NCT00004285|end stage renal disease|end stage renal disease
799996|NCT00004285|rare disease|rare disease
799997|NCT00004285|renal and genitourinary disorders|renal and genitourinary disorders
799998|NCT00004284|hypercalciuria|hypercalciuria
799999|NCT00004284|nephrolithiasis|nephrolithiasis
800000|NCT00004284|rare disease|rare disease
800001|NCT00004284|renal and genitourinary disorders|renal and genitourinary disorders
800002|NCT00004278|congenital cytomegalovirus infection|congenital cytomegalovirus infection
800003|NCT00004278|cytomegalovirus infection|cytomegalovirus infection
800004|NCT00004278|herpesvirus infection|herpesvirus infection
800005|NCT00004278|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
800006|NCT00004278|neonatal disorders|neonatal disorders
800007|NCT00004278|rare disease|rare disease
800008|NCT00004278|viral infection|viral infection
800009|NCT00004276|bacterial infection|bacterial infection
800010|NCT00004276|human immunodeficiency virus infection|human immunodeficiency virus infection
800011|NCT00004276|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
800012|NCT00004276|mycobacterium infection|mycobacterium infection
800013|NCT00004276|mycobacterium tuberculosis infection|mycobacterium tuberculosis infection
800014|NCT00004276|rare disease|rare disease
800015|NCT00004276|viral infection|viral infection
800016|NCT00004275|Turner's syndrome|turner's syndrome
800017|NCT00004275|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
800018|NCT00004275|rare disease|rare disease
800019|NCT00004274|Turner's syndrome|turner's syndrome
800020|NCT00004274|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
800021|NCT00004274|rare disease|rare disease
800022|NCT00004268|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
800023|NCT00004268|disease-related problem/condition|disease-related problem/condition
800024|NCT00004268|orthostatic hypotension|orthostatic hypotension
800025|NCT00004268|quality of life|quality of life
800026|NCT00004268|rare disease|rare disease
800027|NCT00004266|diabetic nephropathy|diabetic nephropathy
800028|NCT00004266|rare disease|rare disease
800029|NCT00004266|renal and genitourinary disorders|renal and genitourinary disorders
800030|NCT00000170|Amblyopia|amblyopia
800031|NCT00000170|patching|patching
800032|NCT00000170|atropine|atropine
800033|NCT00000167|Age-Related Macular Degeneration|age-related macular degeneration
800034|NCT00000163|Congenital Esotropia|congenital esotropia
800035|NCT00000161|Age-Related Macular Degeneration|age-related macular degeneration
800036|NCT00000160|Vision Loss|vision loss
800037|NCT00000158|photocoagulation|photocoagulation
800038|NCT00000158|argon blue-green laser|argon blue-green laser
800039|NCT00000158|krypton red laser|krypton red laser
800040|NCT00000153|Diabetic Disc Neovascularization|diabetic disc neovascularization
800041|NCT00000153|Optic Disk|optic disk
800042|NCT00000152|Age-Related Macular Degeneration|age-related macular degeneration
800043|NCT00000150|Ocular Histoplasmosis Syndrome|ocular histoplasmosis syndrome
800044|NCT00000150|Idiopathic Choroidal Neovascularization|idiopathic choroidal neovascularization
800045|NCT00000145|Age-Related Macular Degeneration|age-related macular degeneration
800046|NCT00000139|Herpes Simplex Stromal Keratitis|herpes simplex stromal keratitis
800047|NCT00000138|Herpes Simplex Stromal Keratitis|herpes simplex stromal keratitis
800048|NCT00000131|Central Vein Occlusion|central vein occlusion
800049|NCT00000131|Ischemic Retina|ischemic retina
800050|NCT00000130|Bacterial Endophthalmitis|bacterial endophthalmitis
800051|NCT00000128|Near-point Esophoria|near-point esophoria
800052|NCT00000127|Non-arteritic Ischemic Optic Neuropathy|non-arteritic ischemic optic neuropathy
800053|NCT00000126|Non-arteritic Ischemic Optic Neuropathy|non-arteritic ischemic optic neuropathy
800054|NCT00000124|Choroidal Melanoma|choroidal melanoma
800055|NCT00000124|Ocular Melanoma|ocular melanoma
800056|NCT00000121|strabismus|strabismus
800057|NCT00000120|Neonatal Conjunctivitis|neonatal conjunctivitis
800058|NCT00000114|retinitis pigmentosa|retinitis pigmentosa
800059|NCT00000114|vitamin supplements|vitamin supplements
800060|NCT00000113|myopia|myopia
800061|NCT00000113|nearsightedness|nearsightedness
800062|NCT00000357|opiate dependence|opiate dependence
800063|NCT00000356|opiate dependence|opiate dependence
800064|NCT00000355|opiate dependence|opiate dependence
800065|NCT00000354|opiate dependence|opiate dependence
800066|NCT00000353|opiate dependence|opiate dependence
800067|NCT00000352|opiate dependence|opiate dependence
800068|NCT00000350|amphetamine dependence|amphetamine dependence
800069|NCT00000349|cocaine dependence|cocaine dependence
800070|NCT00000348|cocaine dependence|cocaine dependence
800071|NCT00000347|cocaine dependence|cocaine dependence
800072|NCT00000346|amphetamine dependence|amphetamine dependence
800073|NCT00000345|opioid dependence|opioid dependence
800074|NCT00000344|opioid dependence|opioid dependence
800075|NCT00000343|stimulant dependence|stimulant dependence
800076|NCT00000342|cocaine dependence|cocaine dependence
800077|NCT00000341|opioid dependence|opioid dependence
800078|NCT00000340|cocaine dependence|cocaine dependence
800079|NCT00000339|cocaine dependence|cocaine dependence
800080|NCT00000338|cocaine dependence|cocaine dependence
800081|NCT00000337|cocaine dependence|cocaine dependence
800082|NCT00000336|cocaine dependence|cocaine dependence
800083|NCT00000335|opioid dependence|opioid dependence
800084|NCT00000331|Heroin Dependence|heroin dependence
800085|NCT00000330|Heroin Dependence|heroin dependence
800086|NCT00000329|drug dependence|drug dependence
800087|NCT00000328|drug dependence|drug dependence
800088|NCT00000327|drug dependence|drug dependence
800089|NCT00000326|Heroin Dependence|heroin dependence
800090|NCT00000325|cocaine dependence|cocaine dependence
800091|NCT00000323|cocaine dependence|cocaine dependence
800092|NCT00000322|amphetamine dependence|amphetamine dependence
800093|NCT00000321|methamphetamine dependence|methamphetamine dependence
800094|NCT00000320|opioid dependence|opioid dependence
800095|NCT00000318|opioid dependence|opioid dependence
800096|NCT00000317|Cocaine|cocaine
800097|NCT00000317|METHADONE PATIENTS|methadone patients
800098|NCT00000317|RISPERIDONE|risperidone
800099|NCT00000316|cocaine dependence|cocaine dependence
800100|NCT00000315|cocaine dependence|cocaine dependence
800101|NCT00000314|cocaine dependence|cocaine dependence
800102|NCT00000313|cocaine dependence|cocaine dependence
800103|NCT00000311|Cocaine-Related Disorders|cocaine-related disorders
800104|NCT00000311|Opioid-Related Disorders|opioid-related disorders
800105|NCT00000311|Substance-Related Disorders|substance-related disorders
800106|NCT00000310|cocaine dependence|cocaine dependence
800107|NCT00000309|cocaine abuse, cocaine addiction|cocaine abuse, cocaine addiction
800108|NCT00000308|cocaine dependence|cocaine dependence
800109|NCT00000307|alcohol dependence|alcohol dependence
800110|NCT00000306|cocaine dependence|cocaine dependence
800111|NCT00000304|cocaine dependence|cocaine dependence
800112|NCT00000303|Cocaine dependence|cocaine dependence
800113|NCT00000301|Amantadine|amantadine
800114|NCT00000301|Cocaine|cocaine
800115|NCT00000301|Pharmacotherapy|pharmacotherapy
800116|NCT00000301|Outpatient|outpatient
800117|NCT00000300|opiate|opiate
800118|NCT00000300|dependence|dependence
800119|NCT00000299|Opioid-Related Disorders|opioid-related disorders
800120|NCT00000296|nicotine dependence|nicotine dependence
800121|NCT00000293|cocaine dependence|cocaine dependence
800122|NCT00000291|cocaine dependence|cocaine dependence
800123|NCT00000290|cocaine dependence|cocaine dependence
800124|NCT00000288|nicotine dependence|nicotine dependence
800125|NCT00000287|Cocaine-Related Disorders|cocaine-related disorders
800126|NCT00000286|cocaine dependence|cocaine dependence
800127|NCT00000285|cocaine dependence|cocaine dependence
800128|NCT00000284|nicotine dependence|nicotine dependence
800129|NCT00000282|pemoline|pemoline
800130|NCT00000281|anti psychotic agents|anti psychotic agents
800131|NCT00000280|cocaine|cocaine
800132|NCT00000275|cocaine dependence|cocaine dependence
800133|NCT00000274|cocaine dependence|cocaine dependence
800134|NCT00000273|heroin, opioid disorders, substance related disorders|heroin, opioid disorders, substance related disorders
800135|NCT00000271|Desipramine, cocaine, depression|desipramine, cocaine, depression
800136|NCT00000270|cocaine|cocaine
800137|NCT00000269|cocaine dependence|cocaine dependence
800138|NCT00000268|cocaine dependence|cocaine dependence
800139|NCT00000267|cocaine dependence|cocaine dependence
800140|NCT00000266|cocaine dependence|cocaine dependence
800141|NCT00000265|nitrous oxide|nitrous oxide
800142|NCT00000265|anxiety|anxiety
800143|NCT00000265|subjective effects|subjective effects
800144|NCT00000265|dental|dental
800145|NCT00000265|patients|patients
800146|NCT00000264|nitrous oxide|nitrous oxide
800147|NCT00000264|inhalant|inhalant
800148|NCT00000264|ethanol|ethanol
800149|NCT00000264|subjective effects|subjective effects
800150|NCT00000264|psychomotor effects|psychomotor effects
800151|NCT00000264|healthy volunteer|healthy volunteer
800152|NCT00000263|nitrous oxide|nitrous oxide
800153|NCT00000263|ethanol|ethanol
800154|NCT00000263|drug interaction|drug interaction
800155|NCT00000263|subjective effects|subjective effects
800156|NCT00000263|healthy volunteer|healthy volunteer
800157|NCT00000262|nitrous oxide|nitrous oxide
800158|NCT00000262|sevoflurane|sevoflurane
800159|NCT00000262|drug interaction|drug interaction
800160|NCT00000262|subjective effects|subjective effects
800161|NCT00000262|analgesia|analgesia
800162|NCT00000262|healthy volunteers|healthy volunteers
800163|NCT00000261|nitrous oxide|nitrous oxide
800164|NCT00000261|sevoflurane|sevoflurane
800165|NCT00000261|ethanol|ethanol
800166|NCT00000261|subjective effects|subjective effects
800167|NCT00000261|healthy volunteer|healthy volunteer
800168|NCT00000260|nitrous oxide|nitrous oxide
800169|NCT00000260|subjective effects|subjective effects
800170|NCT00000260|reinforcer|reinforcer
800171|NCT00000260|inhalant|inhalant
800172|NCT00000260|healthy volunteer|healthy volunteer
800173|NCT00000259|sevoflurane|sevoflurane
800174|NCT00000259|nitrous oxide|nitrous oxide
800175|NCT00000259|subjective effects|subjective effects
800176|NCT00000259|healthy volunteer|healthy volunteer
800177|NCT00000258|nitrous oxide|nitrous oxide
800178|NCT00000258|instruction|instruction
800179|NCT00000258|subjective effects|subjective effects
800180|NCT00000258|reinforcer|reinforcer
800181|NCT00000258|healthy volunteer|healthy volunteer
800182|NCT00000257|nitrous oxide|nitrous oxide
800183|NCT00000257|subjective effects|subjective effects
800184|NCT00000257|ethanol|ethanol
800185|NCT00000257|healthy volunteer|healthy volunteer
800186|NCT00000256|nitrous oxide|nitrous oxide
800187|NCT00000256|reinforcer|reinforcer
800188|NCT00000256|subjective effects|subjective effects
800189|NCT00000256|healthy volunteer|healthy volunteer
800190|NCT00000255|nitrous oxide|nitrous oxide
800191|NCT00000255|acute tolerance|acute tolerance
800192|NCT00000255|subjective effects|subjective effects
800193|NCT00000255|analgesia|analgesia
800194|NCT00000255|psychomotor|psychomotor
800195|NCT00000255|healthy volunteer|healthy volunteer
800196|NCT00000254|isoflurane|isoflurane
800197|NCT00000254|general anesthetic|general anesthetic
800198|NCT00000254|inhalant|inhalant
800199|NCT00000254|subjective effects|subjective effects
800200|NCT00000254|healthy volunteer|healthy volunteer
800201|NCT00000253|nitrous oxide|nitrous oxide
800202|NCT00000253|inhalant|inhalant
800203|NCT00000253|subjective effects|subjective effects
800204|NCT00000253|healthy volunteer|healthy volunteer
800205|NCT00000252|nitrous oxide|nitrous oxide
800206|NCT00000252|acute tolerance|acute tolerance
800207|NCT00000252|subjective effects|subjective effects
800208|NCT00000252|psychomotor|psychomotor
800209|NCT00000252|analgesia|analgesia
800210|NCT00000252|healthy volunteer|healthy volunteer
800211|NCT00000251|nitrous oxide|nitrous oxide
800212|NCT00000251|isoflurane|isoflurane
800213|NCT00000251|subjective effects|subjective effects
800214|NCT00000251|psychomotor|psychomotor
800215|NCT00000251|healthy volunteer|healthy volunteer
800216|NCT00000251|drug interaction|drug interaction
800217|NCT00000250|nitrous oxide|nitrous oxide
800218|NCT00000250|choice|choice
800219|NCT00000250|subjective effects|subjective effects
800220|NCT00000250|pain|pain
800221|NCT00000250|analgesia|analgesia
800222|NCT00000250|reinforcer|reinforcer
800223|NCT00000250|healthy volunteer|healthy volunteer
800224|NCT00000249|nitrous oxide|nitrous oxide
800225|NCT00000249|subjective effects|subjective effects
800226|NCT00000249|healthy volunteer|healthy volunteer
800227|NCT00000246|Substance-Related Disorders|substance-related disorders
800228|NCT00000245|cocaine dependence|cocaine dependence
800229|NCT00000244|addiction|addiction
800230|NCT00000244|opiate|opiate
800231|NCT00000244|heroin|heroin
800232|NCT00000244|dynorphin|dynorphin
800233|NCT00000243|opioid dependence|opioid dependence
800234|NCT00000242|Cocaine|cocaine
800235|NCT00000242|Substance Abuse|substance abuse
800236|NCT00000241|methamphetamine dependence|methamphetamine dependence
800237|NCT00000218|cocaine dependence|cocaine dependence
800238|NCT00000217|drug abuse|drug abuse
800239|NCT00000215|cocaine dependence|cocaine dependence
800240|NCT00000214|intravenous abuse|intravenous abuse
800241|NCT00000213|intravenous abuse|intravenous abuse
800242|NCT00000212|crack cocaine|crack cocaine
800243|NCT00000210|opioid addiction|opioid addiction
800244|NCT00000210|cocaine addiction|cocaine addiction
800245|NCT00000207|Buprenorphine|buprenorphine
800246|NCT00000207|Opioid|opioid
800247|NCT00000206|Opioid|opioid
800248|NCT00000201|cocaine dependence|cocaine dependence
800249|NCT00000200|self-administration|self-administration
800250|NCT00000199|cocaine|cocaine
800251|NCT00000198|cocaine|cocaine
800252|NCT00000197|cocaine|cocaine
800253|NCT00000195|opioid disorders|opioid disorders
800254|NCT00000194|opioid disorders|opioid disorders
800255|NCT00000193|Opioid disorders|opioid disorders
800256|NCT00000192|opioid disorders|opioid disorders
800257|NCT00000191|Cocaine Dependence|cocaine dependence
800258|NCT00000191|Carbamazepine|carbamazepine
800259|NCT00000190|Cocaine Detection|cocaine detection
800260|NCT00000190|Parotid Saliva|parotid saliva
800261|NCT00000189|Cocaine Dependence|cocaine dependence
800262|NCT00000189|Gepirone|gepirone
800263|NCT00000188|Cocaine Dependence|cocaine dependence
800264|NCT00000188|Selegiline|selegiline
800265|NCT00000187|Cocaine Dependence|cocaine dependence
800266|NCT00000187|ritanserin|ritanserin
800267|NCT00004640|Aging|aging
800268|NCT00004640|Elderly|elderly
800269|NCT00004640|Periodontal Disease|periodontal disease
800270|NCT00004640|Dental Caries|dental caries
800271|NCT00004640|Fluoride|fluoride
800272|NCT00004640|Antibacterial rinse|antibacterial rinse
800273|NCT00004640|Chlorhexidine|chlorhexidine
800274|NCT00004640|Tooth Mortality|tooth mortality
800275|NCT00004639|cleft lip and palate|cleft lip and palate
800276|NCT00004639|children|children
800277|NCT00004639|speech|speech
800278|NCT00004639|velopharyngeal function|velopharyngeal function
800279|NCT00004639|congenital facial malformation|congenital facial malformation
800280|NCT00004639|von Langenbeck procedure|von langenbeck procedure
800281|NCT00004639|Furlow procedure|furlow procedure
800282|NCT00004639|cleft lip and palate repair|cleft lip and palate repair
800283|NCT00004639|Unilateral cleft lip and palate|unilateral cleft lip and palate
